BindingDB Reactant_set_id	Ligand SMILES	Ligand InChI	Ligand InChI Key	BindingDB MonomerID	BindingDB Ligand Name	Target Name	Target Source Organism According to Curator or DataSource	Ki (nM)	IC50 (nM)	Kd (nM)	EC50 (nM)	kon (M-1-s-1)	koff (s-1)	pH	Temp (C)	Curation/DataSource	Article DOI	BindingDB Entry DOI	PMID	PubChem AID	Patent Number	Authors	Institution	Link to Ligand in BindingDB	Link to Target in BindingDB	Link to Ligand-Target Pair in BindingDB	Ligand HET ID in PDB	PDB ID(s) for Ligand-Target Complex	PubChem CID of Ligand	PubChem SID of Ligand	ChEBI ID of Ligand	ChEMBL ID of Ligand	DrugBank ID of Ligand	IUPHAR_GRAC ID of Ligand	KEGG ID of Ligand	ZINC ID of Ligand	Number of Protein Chains in Target (>1 implies a multichain complex)	BindingDB Target Chain Sequence	PDB ID(s) of Target Chain	UniProt (SwissProt) Recommended Name of Target Chain	UniProt (SwissProt) Entry Name of Target Chain	UniProt (SwissProt) Primary ID of Target Chain	UniProt (SwissProt) Secondary ID(s) of Target Chain	UniProt (SwissProt) Alternative ID(s) of Target Chain	UniProt (TrEMBL) Submitted Name of Target Chain	UniProt (TrEMBL) Entry Name of Target Chain	UniProt (TrEMBL) Primary ID of Target Chain	UniProt (TrEMBL) Secondary ID(s) of Target Chain	UniProt (TrEMBL) Alternative ID(s) of Target Chain
51057302	C[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSCc3cc(CSC[C@H](NC(=O)[C@H](Cc4ccc(O)cc4)NC1=O)C(=O)NCC(O)=O)cc(CSC[C@H](NC(=O)CN)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N2)c3	InChI=1S/C59H82N16O15S3/c1-32-50(82)70-39(21-33-10-12-37(76)13-11-33)53(85)71-41(52(84)66-25-49(80)81)30-92-27-35-18-34-19-36(20-35)28-93-31-42(57(89)75-17-5-9-45(75)58(90)74-16-4-7-43(74)54(86)67-32)72-55(87)44-8-3-15-73(44)56(88)38(6-2-14-63-59(61)62)68-48(79)24-64-47(78)23-65-51(83)40(29-91-26-34)69-46(77)22-60/h10-13,18-20,32,38-45,76H,2-9,14-17,21-31,60H2,1H3,(H,64,78)(H,65,83)(H,66,84)(H,67,86)(H,68,79)(H,69,77)(H,70,82)(H,71,85)(H,72,87)(H,80,81)(H4,61,62,63)/t32-,38?,39-,40-,41-,42-,43-,44-,45-/m0/s1	GGDVXOIJAKRXLL-IFWVOVRYSA-N	50431213	CHEMBL2332604	Plasma kallikrein		>120000								ChEMBL	10.1021/jm400236j	10.7270/Q2GX4CXF	23586812			Baeriswyl, V; Calzavarini, S; Gerschheimer, C; Diderich, P; Angelillo-Scherrer, A; Heinis, C	Ecole Polytechnique F�d�rale de Lausanne EPFL	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50431213	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50431213&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71716975	164160088		CHEMBL2332604					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51057323	C[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSCc3cc(CSC[C@H](NC(=O)[C@H](Cc4ccc(O)cc4)NC1=O)C(=O)NCC(O)=O)cc(CSC[C@H](NC(=O)CN)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N2)c3	InChI=1S/C59H82N16O15S3/c1-32-50(82)70-39(21-33-10-12-37(76)13-11-33)53(85)71-41(52(84)66-25-49(80)81)30-92-27-35-18-34-19-36(20-35)28-93-31-42(57(89)75-17-5-9-45(75)58(90)74-16-4-7-43(74)54(86)67-32)72-55(87)44-8-3-15-73(44)56(88)38(6-2-14-63-59(61)62)68-48(79)24-64-47(78)23-65-51(83)40(29-91-26-34)69-46(77)22-60/h10-13,18-20,32,38-45,76H,2-9,14-17,21-31,60H2,1H3,(H,64,78)(H,65,83)(H,66,84)(H,67,86)(H,68,79)(H,69,77)(H,70,82)(H,71,85)(H,72,87)(H,80,81)(H4,61,62,63)/t32-,38?,39-,40-,41-,42-,43-,44-,45-/m0/s1	GGDVXOIJAKRXLL-IFWVOVRYSA-N	50431213	CHEMBL2332604	Plasma kallikrein		 0.300000								ChEMBL	10.1021/jm400236j	10.7270/Q2GX4CXF	23586812			Baeriswyl, V; Calzavarini, S; Gerschheimer, C; Diderich, P; Angelillo-Scherrer, A; Heinis, C	Ecole Polytechnique F�d�rale de Lausanne EPFL	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50431213	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50431213&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71716975	164160088		CHEMBL2332604					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51057331	C[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSCc3cc(CSC[C@H](NC(=O)[C@@H](N)CO)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N4CCC[C@H]4C(=O)N2)cc(CSC[C@H](NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O)C(=O)N[C@@H](CCCCN)C(O)=O)c3	InChI=1S/C64H93N17O16S3/c1-35-53(86)75-44(25-36-13-15-40(83)16-14-36)56(89)77-46(57(90)74-43(63(96)97)8-2-3-17-65)33-99-30-38-22-37-23-39(24-38)31-100-34-47(61(94)81-21-7-12-50(81)62(95)80-20-6-10-48(80)58(91)72-35)78-59(92)49-11-5-19-79(49)60(93)42(9-4-18-69-64(67)68)73-52(85)27-70-51(84)26-71-55(88)45(32-98-29-37)76-54(87)41(66)28-82/h13-16,22-24,35,41-50,82-83H,2-12,17-21,25-34,65-66H2,1H3,(H,70,84)(H,71,88)(H,72,91)(H,73,85)(H,74,90)(H,75,86)(H,76,87)(H,77,89)(H,78,92)(H,96,97)(H4,67,68,69)/t35-,41-,42?,43-,44-,45-,46-,47-,48-,49-,50-/m0/s1	JRYGECRIWPBGKA-NTWVPDEFSA-N	50431220	CHEMBL2332610	Plasma kallikrein		>120000								ChEMBL	10.1021/jm400236j	10.7270/Q2GX4CXF	23586812			Baeriswyl, V; Calzavarini, S; Gerschheimer, C; Diderich, P; Angelillo-Scherrer, A; Heinis, C	Ecole Polytechnique F�d�rale de Lausanne EPFL	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50431220	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50431220&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71716976	164160095		CHEMBL2332610					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
22824	CS(=O)(=O)c1ccccc1-c1ccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c(F)c1	InChI=1S/C25H20F4N4O3S/c1-37(35,36)22-8-3-2-7-18(22)16-9-10-20(19(26)12-16)31-24(34)21-13-23(25(27,28)29)32-33(21)17-6-4-5-15(11-17)14-30/h2-13H,14,30H2,1H3,(H,31,34)	ZLUOAFAJSUPHOG-UHFFFAOYSA-N	12657	1-[3-(Aminomethyl)phenyl]-N-[3-fluoro-2-(methylsulfonyl)-[1,1-biphenyl]-4-yl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::1-[3-(aminomethyl)phenyl]-N-[2-fluoro-4-(2-methanesulfonylphenyl)phenyl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::CHEMBL559015::DPC 423::DPC423	Plasma kallikrein		 61								Curated from the literature by BindingDB	10.1021/jm0497949	10.7270/Q2BK19K9	15771420	aid1796932		Quan, ML; Lam, PY; Han, Q; Pinto, DJ; He, MY; Li, R; Ellis, CD; Clark, CG; Teleha, CA; Sun, JH; Alexander, RS; Bai, S; Luettgen, JM; Knabb, RM; Wong, PC; Wexler, RR	Bristol-Myers Squibb Pharmaceutical Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12657	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=12657&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	M35	3M35,3M36	9895762	46513110		CHEMBL559015				ZINC01490578	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
22825	CS(=O)(=O)c1ccccc1-c1ccc(NC(=O)c2cc(nn2-c2ccc3onc(N)c3c2)C(F)(F)F)c(F)c1	InChI=1S/C25H17F4N5O4S/c1-39(36,37)21-5-3-2-4-15(21)13-6-8-18(17(26)10-13)31-24(35)19-12-22(25(27,28)29)32-34(19)14-7-9-20-16(11-14)23(30)33-38-20/h2-12H,1H3,(H2,30,33)(H,31,35)	GTYYDEJOAHEDLZ-UHFFFAOYSA-N	12659	1-(3-Aminobenzisoxazol-5-yl)-3-trifluoromethyl-5-[(2-methylsulfonyl-3-fluoro[1,1]biphen-4-yl)aminocarbonyl]-pyrazole, Trifluoroacetic Acid::1-(3-amino-1,2-benzoxazol-5-yl)-N-[2-fluoro-4-(2-methanesulfonylphenyl)phenyl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide; 2,2,2-trifluoroacetic acid::CHEMBL554926::Razaxaban Analogue::aminobenzisoxazole 38	Plasma kallikrein		>2300								Curated from the literature by BindingDB	10.1021/jm0497949	10.7270/Q2BK19K9	15771420	aid1796932		Quan, ML; Lam, PY; Han, Q; Pinto, DJ; He, MY; Li, R; Ellis, CD; Clark, CG; Teleha, CA; Sun, JH; Alexander, RS; Bai, S; Luettgen, JM; Knabb, RM; Wong, PC; Wexler, RR	Bristol-Myers Squibb Pharmaceutical Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12659	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=12659&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			11479420	46513111		CHEMBL554926				ZINC14950374	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
22826	CN(C)Cc1nccn1-c1ccc(NC(=O)c2cc(nn2-c2ccc3onc(N)c3c2)C(F)(F)F)c(F)c1	InChI=1S/C24H20F4N8O2/c1-34(2)12-21-30-7-8-35(21)13-3-5-17(16(25)10-13)31-23(37)18-11-20(24(26,27)28)32-36(18)14-4-6-19-15(9-14)22(29)33-38-19/h3-11H,12H2,1-2H3,(H2,29,33)(H,31,37)	OFJRNBWSFXEHSA-UHFFFAOYSA-N	12676	1-(3-Aminobenzisoxazol-5-yl)-3-trifluoromethyl-N-[2-fluoro-4-[(2-dimethylaminomethyl)imidazol-1-yl]phenyl]-1H-pyrazole-5-carboxyamide Hydrochloride Salt::1-(3-amino-1,2-benzoxazol-5-yl)-N-(4-{2-[(dimethylamino)methyl]-1H-imidazol-1-yl}-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::BMS-561389::CHEMBL206335::CHEMBL558198::DPC 906::Razaxaban	Plasma kallikrein		>2300								Curated from the literature by BindingDB	10.1021/jm0497949	10.7270/Q2BK19K9	15771420	aid1796932		Quan, ML; Lam, PY; Han, Q; Pinto, DJ; He, MY; Li, R; Ellis, CD; Clark, CG; Teleha, CA; Sun, JH; Alexander, RS; Bai, S; Luettgen, JM; Knabb, RM; Wong, PC; Wexler, RR	Bristol-Myers Squibb Pharmaceutical Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12676	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=12676&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	IK8	1Z6E	204102	46513128		CHEMBL206335CHEMBL558198				ZINC03633839	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
26845	CCOc1cc(OCC)c(F)c(c1)[C@@H](Nc1ccc(C(N)=N)c(O)c1)C(=O)NS(=O)(=O)c1cccc(N)c1	InChI=1S/C25H28FN5O6S/c1-3-36-16-12-19(22(26)21(13-16)37-4-2)23(30-15-8-9-18(24(28)29)20(32)11-15)25(33)31-38(34,35)17-7-5-6-14(27)10-17/h5-13,23,30,32H,3-4,27H2,1-2H3,(H3,28,29)(H,31,33)/t23-/m1/s1	MLPXCKVDBGAVRJ-HSZRJFAPSA-N	14714	(2R)-N-[(3-aminobenzene)sulfonyl]-2-[(4-carbamimidoyl-3-hydroxyphenyl)amino]-2-(3,5-diethoxy-2-fluorophenyl)acetamide::G17905::R-4-[2-(3-aminobenzenesulfonylamino)-1-(3,5-diethoxy-2-fluorophenyl)-2-oxoethylamino]-2-hydroxy-benzamidine.TFA	Plasma kallikrein		 114						7.8	22.00 C	Curated from the literature by BindingDB	10.1074/jbc.M409068200	10.7270/Q2JM27W3	15632123	aid1797275		Olivero, AG; Eigenbrot, C; Goldsmith, R; Robarge, K; Artis, DR; Flygare, J; Rawson, T; Sutherlin, DP; Kadkhodayan, S; Beresini, M; Elliott, LO; DeGuzman, GG; Banner, DW; Ultsch, M; Marzec, U; Hanson, SR; Refino, C; Bunting, S; Kirchhofer, D	Genentech	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=14714	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=14714&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	905	1YGC	5326937	46515044						ZINC12338906	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
42783	Cc1ccc2oc(=O)c(cc2c1)C(=O)NC1CCCCCCCCCCC1	InChI=1S/C23H31NO3/c1-17-13-14-21-18(15-17)16-20(23(26)27-21)22(25)24-19-11-9-7-5-3-2-4-6-8-10-12-19/h13-16,19H,2-12H2,1H3,(H,24,25)	VWQOVCCGOGWSCR-UHFFFAOYSA-N	23536	3-Carboxamide-coumarin deriv., 22::N-cyclododecyl-6-methyl-2-oxo-2H-chromene-3-carboxamide	Plasma kallikrein										Curated from the literature by BindingDB	10.1021/jm8002697	10.7270/Q2610XNH	18459730	aid1798332		Robert, S; Bertolla, C; Masereel, B; Dogné, JM; Pochet, L	University of Namur	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23536	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23536&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			24860434	50091797						ZINC40955744	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
42784	Cc1ccc2oc(=O)c(cc2c1)C(=O)NC12CC3CC(CC(C3)C1)C2	InChI=1S/C21H23NO3/c1-12-2-3-18-16(4-12)8-17(20(24)25-18)19(23)22-21-9-13-5-14(10-21)7-15(6-13)11-21/h2-4,8,13-15H,5-7,9-11H2,1H3,(H,22,23)	GNLDGWVBEXHJII-UHFFFAOYSA-N	23537	3-Carboxamide-coumarin deriv., 23::N-(adamantan-1-yl)-6-methyl-2-oxo-2H-chromene-3-carboxamide	Plasma kallikrein										Curated from the literature by BindingDB	10.1021/jm8002697	10.7270/Q2610XNH	18459730	aid1798332		Robert, S; Bertolla, C; Masereel, B; Dogné, JM; Pochet, L	University of Namur	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23537	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23537&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			24860435	50091798						ZINC40955747	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
42785	Cc1ccc2oc(=O)c(cc2c1)C(=O)Nc1ccccc1	InChI=1S/C17H13NO3/c1-11-7-8-15-12(9-11)10-14(17(20)21-15)16(19)18-13-5-3-2-4-6-13/h2-10H,1H3,(H,18,19)	JUQDUATUBQVGDN-UHFFFAOYSA-N	23538	3-Carboxamide-coumarin deriv., 20::6-methyl-2-oxo-N-phenyl-2H-chromene-3-carboxamide	Plasma kallikrein			>50000							Curated from the literature by BindingDB	10.1021/jm8002697	10.7270/Q2610XNH	18459730	aid1798332		Robert, S; Bertolla, C; Masereel, B; Dogné, JM; Pochet, L	University of Namur	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23538	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23538&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			10423722	50091799						ZINC38816294	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
42786	Cc1ccc2oc(=O)c(cc2c1)C(=O)NCc1ccccc1	InChI=1S/C18H15NO3/c1-12-7-8-16-14(9-12)10-15(18(21)22-16)17(20)19-11-13-5-3-2-4-6-13/h2-10H,11H2,1H3,(H,19,20)	ZEYLUFWPGDCIRE-UHFFFAOYSA-N	23539	3-Carboxamide-coumarin deriv., 24::N-benzyl-6-methyl-2-oxo-2H-chromene-3-carboxamide	Plasma kallikrein										Curated from the literature by BindingDB	10.1021/jm8002697	10.7270/Q2610XNH	18459730	aid1798332		Robert, S; Bertolla, C; Masereel, B; Dogné, JM; Pochet, L	University of Namur	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23539	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23539&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			24860436	50091800						ZINC40955750	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
42787	Cc1ccc2oc(=O)c(cc2c1)C(=O)NCCc1ccccc1	InChI=1S/C19H17NO3/c1-13-7-8-17-15(11-13)12-16(19(22)23-17)18(21)20-10-9-14-5-3-2-4-6-14/h2-8,11-12H,9-10H2,1H3,(H,20,21)	AOIFLQZKMIKPNH-UHFFFAOYSA-N	23540	3-Carboxamide-coumarin deriv., 25::6-methyl-2-oxo-N-(2-phenylethyl)-2H-chromene-3-carboxamide	Plasma kallikrein										Curated from the literature by BindingDB	10.1021/jm8002697	10.7270/Q2610XNH	18459730	aid1798332		Robert, S; Bertolla, C; Masereel, B; Dogné, JM; Pochet, L	University of Namur	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23540	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23540&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			24860437	50091801						ZINC40431329	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
42788	Cc1ccc2oc(=O)c(cc2c1)C(=O)NCc1cccc2ccccc12	InChI=1S/C22H17NO3/c1-14-9-10-20-17(11-14)12-19(22(25)26-20)21(24)23-13-16-7-4-6-15-5-2-3-8-18(15)16/h2-12H,13H2,1H3,(H,23,24)	AVGJZESYBKYYGZ-UHFFFAOYSA-N	23541	3-Carboxamide-coumarin deriv., 26::6-methyl-N-(naphthalen-1-ylmethyl)-2-oxo-2H-chromene-3-carboxamide	Plasma kallikrein										Curated from the literature by BindingDB	10.1021/jm8002697	10.7270/Q2610XNH	18459730	aid1798332		Robert, S; Bertolla, C; Masereel, B; Dogné, JM; Pochet, L	University of Namur	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23541	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23541&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			24860438	50091802						ZINC40430494	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
42789	Cc1ccc2oc(=O)c(cc2c1)C(=O)Nc1cnc2ccccc2c1	InChI=1S/C20H14N2O3/c1-12-6-7-18-14(8-12)10-16(20(24)25-18)19(23)22-15-9-13-4-2-3-5-17(13)21-11-15/h2-11H,1H3,(H,22,23)	VZCIAGCETBUMJW-UHFFFAOYSA-N	23542	3-Carboxamide-coumarin deriv., 27::6-methyl-2-oxo-N-(quinolin-3-yl)-2H-chromene-3-carboxamide	Plasma kallikrein										Curated from the literature by BindingDB	10.1021/jm8002697	10.7270/Q2610XNH	18459730	aid1798332		Robert, S; Bertolla, C; Masereel, B; Dogné, JM; Pochet, L	University of Namur	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23542	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23542&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			24860439	50091803						ZINC40827710	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
42790	O=C(Nc1ccccc1)c1cc2ccccc2oc1=O	InChI=1S/C16H11NO3/c18-15(17-12-7-2-1-3-8-12)13-10-11-6-4-5-9-14(11)20-16(13)19/h1-10H,(H,17,18)	IMFBGZCBLOPVCJ-UHFFFAOYSA-N	23543	2-oxo-N-phenyl-2H-chromene-3-carboxamide::3-Carboxamide-coumarin deriv., 18::JMC521935 Compound 6	Plasma kallikrein										Curated from the literature by BindingDB	10.1021/jm8002697	10.7270/Q2610XNH	18459730	aid1798332		Robert, S; Bertolla, C; Masereel, B; Dogné, JM; Pochet, L	University of Namur	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23543	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23543&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			341782	50091804						ZINC00042178	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
42791	ClCc1ccc2oc(=O)c(cc2c1)C(=O)Nc1ccccc1	InChI=1S/C17H12ClNO3/c18-10-11-6-7-15-12(8-11)9-14(17(21)22-15)16(20)19-13-4-2-1-3-5-13/h1-9H,10H2,(H,19,20)	RUYAFFMOCORBIV-UHFFFAOYSA-N	23544	3-Carboxamide-coumarin deriv., 4::6-(chloromethyl)-2-oxo-N-phenyl-2H-chromene-3-carboxamide	Plasma kallikrein										Curated from the literature by BindingDB	10.1021/jm8002697	10.7270/Q2610XNH	18459730	aid1798332		Robert, S; Bertolla, C; Masereel, B; Dogné, JM; Pochet, L	University of Namur	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23544	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23544&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			402501	50091805						ZINC01660778	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
42792	[O-][N+](=O)c1ccc2oc(=O)c(cc2c1)C(=O)Nc1ccccc1	InChI=1S/C16H10N2O5/c19-15(17-11-4-2-1-3-5-11)13-9-10-8-12(18(21)22)6-7-14(10)23-16(13)20/h1-9H,(H,17,19)	NDMMIVPXGAPYKM-UHFFFAOYSA-N	23545	3-Carboxamide-coumarin deriv., 35::6-nitro-2-oxo-N-phenyl-2H-chromene-3-carboxamide	Plasma kallikrein										Curated from the literature by BindingDB	10.1021/jm8002697	10.7270/Q2610XNH	18459730	aid1798332		Robert, S; Bertolla, C; Masereel, B; Dogné, JM; Pochet, L	University of Namur	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23545	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23545&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			739350	50091806						ZINC00174967	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
42793	Brc1ccc2oc(=O)c(cc2c1)C(=O)Nc1ccccc1	InChI=1S/C16H10BrNO3/c17-11-6-7-14-10(8-11)9-13(16(20)21-14)15(19)18-12-4-2-1-3-5-12/h1-9H,(H,18,19)	PNVSYOXGZZSDQM-UHFFFAOYSA-N	23546	3-Carboxamide-coumarin deriv., 36::6-bromo-2-oxo-N-phenyl-2H-chromene-3-carboxamide	Plasma kallikrein										Curated from the literature by BindingDB	10.1021/jm8002697	10.7270/Q2610XNH	18459730	aid1798332		Robert, S; Bertolla, C; Masereel, B; Dogné, JM; Pochet, L	University of Namur	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23546	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23546&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			747661	50091807						ZINC00192816	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
42794	Clc1cc(Cl)c2oc(=O)c(cc2c1)C(=O)Nc1ccccc1	InChI=1S/C16H9Cl2NO3/c17-10-6-9-7-12(16(21)22-14(9)13(18)8-10)15(20)19-11-4-2-1-3-5-11/h1-8H,(H,19,20)	RCCAMTUJQYPMED-UHFFFAOYSA-N	23547	3-Carboxamide-coumarin deriv., 41::6,8-dichloro-2-oxo-N-phenyl-2H-chromene-3-carboxamide	Plasma kallikrein			>50000							Curated from the literature by BindingDB	10.1021/jm8002697	10.7270/Q2610XNH	18459730	aid1798332		Robert, S; Bertolla, C; Masereel, B; Dogné, JM; Pochet, L	University of Namur	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23547	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23547&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			741761	50091808						ZINC00180530	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
42795	Clc1cc(Br)c2oc(=O)c(cc2c1)C(=O)Nc1ccccc1	InChI=1S/C16H9BrClNO3/c17-13-8-10(18)6-9-7-12(16(21)22-14(9)13)15(20)19-11-4-2-1-3-5-11/h1-8H,(H,19,20)	IUBMSLQOIUSAFA-UHFFFAOYSA-N	23548	3-Carboxamide-coumarin deriv., 44::8-bromo-6-chloro-2-oxo-N-phenyl-2H-chromene-3-carboxamide	Plasma kallikrein										Curated from the literature by BindingDB	10.1021/jm8002697	10.7270/Q2610XNH	18459730	aid1798332		Robert, S; Bertolla, C; Masereel, B; Dogné, JM; Pochet, L	University of Namur	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23548	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23548&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			24860440	50091809						ZINC40429502	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
42796	COc1cc(Br)cc2cc(C(=O)Nc3ccccc3)c(=O)oc12	InChI=1S/C17H12BrNO4/c1-22-14-9-11(18)7-10-8-13(17(21)23-15(10)14)16(20)19-12-5-3-2-4-6-12/h2-9H,1H3,(H,19,20)	LIBPMSGKTCOWCM-UHFFFAOYSA-N	23549	3-Carboxamide-coumarin deriv., 47::6-bromo-8-methoxy-2-oxo-N-phenyl-2H-chromene-3-carboxamide	Plasma kallikrein										Curated from the literature by BindingDB	10.1021/jm8002697	10.7270/Q2610XNH	18459730	aid1798332		Robert, S; Bertolla, C; Masereel, B; Dogné, JM; Pochet, L	University of Namur	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23549	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23549&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			24860441	50091810						ZINC26842740	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
42797	ClCc1ccc2oc(=O)c(cc2c1)C(=O)Oc1ccccc1	InChI=1S/C17H11ClO4/c18-10-11-6-7-15-12(8-11)9-14(17(20)22-15)16(19)21-13-4-2-1-3-5-13/h1-9H,10H2	VLAVQNSKKDLVGI-UHFFFAOYSA-N	23563	3-Carboxylate-coumarin deriv., 3::CHEMBL13357::phenyl 6-(chloromethyl)-2-oxo-2H-chromene-3-carboxylate	Plasma kallikrein										Curated from the literature by BindingDB	10.1021/jm8002697	10.7270/Q2610XNH	18459730	aid1798332		Robert, S; Bertolla, C; Masereel, B; Dogné, JM; Pochet, L	University of Namur	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23563	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23563&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			402499	50091824		CHEMBL13357				ZINC01660776	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
42798	Cc1ccc2oc(=O)c(cc2c1)C(=O)Nc1ccccc1Cl	InChI=1S/C17H12ClNO3/c1-10-6-7-15-11(8-10)9-12(17(21)22-15)16(20)19-14-5-3-2-4-13(14)18/h2-9H,1H3,(H,19,20)	FPUSGBFAZGKFJK-UHFFFAOYSA-N	23555	3-Carboxamide-coumarin deriv., 31::N-(2-chlorophenyl)-6-methyl-2-oxo-2H-chromene-3-carboxamide	Plasma kallikrein										Curated from the literature by BindingDB	10.1021/jm8002697	10.7270/Q2610XNH	18459730	aid1798332		Robert, S; Bertolla, C; Masereel, B; Dogné, JM; Pochet, L	University of Namur	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23555	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23555&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			24860442	50091816						ZINC40953963	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
42799	Cc1ccc2oc(=O)c(cc2c1)C(=O)Nc1cccc(Cl)c1	InChI=1S/C17H12ClNO3/c1-10-5-6-15-11(7-10)8-14(17(21)22-15)16(20)19-13-4-2-3-12(18)9-13/h2-9H,1H3,(H,19,20)	OOLBPPCJUQNAAW-UHFFFAOYSA-N	23556	3-Carboxamide-coumarin deriv., 32::N-(3-chlorophenyl)-6-methyl-2-oxo-2H-chromene-3-carboxamide	Plasma kallikrein										Curated from the literature by BindingDB	10.1021/jm8002697	10.7270/Q2610XNH	18459730	aid1798332		Robert, S; Bertolla, C; Masereel, B; Dogné, JM; Pochet, L	University of Namur	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23556	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23556&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			24860443	50091817						ZINC40431165	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
42800	Cc1ccc2oc(=O)c(cc2c1)C(=O)Nc1ccc(Cl)cc1	InChI=1S/C17H12ClNO3/c1-10-2-7-15-11(8-10)9-14(17(21)22-15)16(20)19-13-5-3-12(18)4-6-13/h2-9H,1H3,(H,19,20)	KLSTVAQJRQHMEW-UHFFFAOYSA-N	23557	3-Carboxamide-coumarin deriv., 33::N-(4-chlorophenyl)-6-methyl-2-oxo-2H-chromene-3-carboxamide	Plasma kallikrein										Curated from the literature by BindingDB	10.1021/jm8002697	10.7270/Q2610XNH	18459730	aid1798332		Robert, S; Bertolla, C; Masereel, B; Dogné, JM; Pochet, L	University of Namur	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23557	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23557&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			24860444	50091818						ZINC40954603	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
42801	Cc1ccc2oc(=O)c(cc2c1)C(=O)Nc1ccccc1C	InChI=1S/C18H15NO3/c1-11-7-8-16-13(9-11)10-14(18(21)22-16)17(20)19-15-6-4-3-5-12(15)2/h3-10H,1-2H3,(H,19,20)	FCSXWWMASMRVEL-UHFFFAOYSA-N	23558	3-Carboxamide-coumarin deriv., 28::6-methyl-N-(2-methylphenyl)-2-oxo-2H-chromene-3-carboxamide	Plasma kallikrein										Curated from the literature by BindingDB	10.1021/jm8002697	10.7270/Q2610XNH	18459730	aid1798332		Robert, S; Bertolla, C; Masereel, B; Dogné, JM; Pochet, L	University of Namur	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23558	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23558&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			24860445	50091819						ZINC40424127	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
42802	Cc1cccc(NC(=O)c2cc3cc(C)ccc3oc2=O)c1	InChI=1S/C18H15NO3/c1-11-4-3-5-14(9-11)19-17(20)15-10-13-8-12(2)6-7-16(13)22-18(15)21/h3-10H,1-2H3,(H,19,20)	BYMDGQZMHMAQIC-UHFFFAOYSA-N	23559	3-Carboxamide-coumarin deriv., 29::6-methyl-N-(3-methylphenyl)-2-oxo-2H-chromene-3-carboxamide	Plasma kallikrein										Curated from the literature by BindingDB	10.1021/jm8002697	10.7270/Q2610XNH	18459730	aid1798332		Robert, S; Bertolla, C; Masereel, B; Dogné, JM; Pochet, L	University of Namur	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23559	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23559&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			24860446	50091820						ZINC40431053	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
42803	Cc1ccc(NC(=O)c2cc3cc(C)ccc3oc2=O)cc1	InChI=1S/C18H15NO3/c1-11-3-6-14(7-4-11)19-17(20)15-10-13-9-12(2)5-8-16(13)22-18(15)21/h3-10H,1-2H3,(H,19,20)	MFUWDBLYKLNULI-UHFFFAOYSA-N	23560	3-Carboxamide-coumarin deriv., 30::6-methyl-N-(4-methylphenyl)-2-oxo-2H-chromene-3-carboxamide	Plasma kallikrein										Curated from the literature by BindingDB	10.1021/jm8002697	10.7270/Q2610XNH	18459730	aid1798332		Robert, S; Bertolla, C; Masereel, B; Dogné, JM; Pochet, L	University of Namur	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23560	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23560&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			24860447	50091821						ZINC40955216	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
42813	Cc1ccc2oc(=O)c(cc2c1)C(=O)Nc1cc(C)cc(C)c1	InChI=1S/C19H17NO3/c1-11-4-5-17-14(7-11)10-16(19(22)23-17)18(21)20-15-8-12(2)6-13(3)9-15/h4-10H,1-3H3,(H,20,21)	LQLUAXVECOARTB-UHFFFAOYSA-N	23564	3-Carboxamide-coumarin deriv., 34::N-(3,5-dimethylphenyl)-6-methyl-2-oxo-2H-chromene-3-carboxamide	Plasma kallikrein										Curated from the literature by BindingDB	10.1021/jm8002697	10.7270/Q2610XNH	18459730	aid1798332		Robert, S; Bertolla, C; Masereel, B; Dogné, JM; Pochet, L	University of Namur	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23564	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23564&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			24860448	50091825						ZINC40955680	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
42815	Cc1cccc(NC(=O)c2cc3cc(Cl)cc(Cl)c3oc2=O)c1	InChI=1S/C17H11Cl2NO3/c1-9-3-2-4-12(5-9)20-16(21)13-7-10-6-11(18)8-14(19)15(10)23-17(13)22/h2-8H,1H3,(H,20,21)	SONVRVRNPLMRNE-UHFFFAOYSA-N	23565	3-Carboxamide-coumarin deriv., 42::6,8-dichloro-N-(3-methylphenyl)-2-oxo-2H-chromene-3-carboxamide	Plasma kallikrein										Curated from the literature by BindingDB	10.1021/jm8002697	10.7270/Q2610XNH	18459730	aid1798332		Robert, S; Bertolla, C; Masereel, B; Dogné, JM; Pochet, L	University of Namur	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23565	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23565&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			3753834	50091826						ZINC00192848	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
42816	Cc1cc(C)cc(NC(=O)c2cc3cc(Cl)cc(Cl)c3oc2=O)c1	InChI=1S/C18H13Cl2NO3/c1-9-3-10(2)5-13(4-9)21-17(22)14-7-11-6-12(19)8-15(20)16(11)24-18(14)23/h3-8H,1-2H3,(H,21,22)	OGDFRBNWXDWIQT-UHFFFAOYSA-N	23566	3-Carboxamide-coumarin deriv., 43::6,8-dichloro-N-(3,5-dimethylphenyl)-2-oxo-2H-chromene-3-carboxamide	Plasma kallikrein			>50000							Curated from the literature by BindingDB	10.1021/jm8002697	10.7270/Q2610XNH	18459730	aid1798332		Robert, S; Bertolla, C; Masereel, B; Dogné, JM; Pochet, L	University of Namur	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23566	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23566&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			24860449	50091827						ZINC26843164	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
42818	Cc1cccc(NC(=O)c2cc3cc(Cl)cc(Br)c3oc2=O)c1	InChI=1S/C17H11BrClNO3/c1-9-3-2-4-12(5-9)20-16(21)13-7-10-6-11(19)8-14(18)15(10)23-17(13)22/h2-8H,1H3,(H,20,21)	AOZYTCBDNDDZPR-UHFFFAOYSA-N	23567	3-Carboxamide-coumarin deriv., 45::8-bromo-6-chloro-N-(3-methylphenyl)-2-oxo-2H-chromene-3-carboxamide	Plasma kallikrein										Curated from the literature by BindingDB	10.1021/jm8002697	10.7270/Q2610XNH	18459730	aid1798332		Robert, S; Bertolla, C; Masereel, B; Dogné, JM; Pochet, L	University of Namur	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23567	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23567&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			24860450	50091828						ZINC40972363	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
42819	Cc1cc(C)cc(NC(=O)c2cc3cc(Cl)cc(Br)c3oc2=O)c1	InChI=1S/C18H13BrClNO3/c1-9-3-10(2)5-13(4-9)21-17(22)14-7-11-6-12(20)8-15(19)16(11)24-18(14)23/h3-8H,1-2H3,(H,21,22)	NIYAHNDDVVFHBG-UHFFFAOYSA-N	23568	3-Carboxamide-coumarin deriv., 46::8-bromo-6-chloro-N-(3,5-dimethylphenyl)-2-oxo-2H-chromene-3-carboxamide	Plasma kallikrein			>50000							Curated from the literature by BindingDB	10.1021/jm8002697	10.7270/Q2610XNH	18459730	aid1798332		Robert, S; Bertolla, C; Masereel, B; Dogné, JM; Pochet, L	University of Namur	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23568	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23568&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			24860451	50091829						ZINC40972365	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
42820	NC(N)=NCCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H]1CCCN1)C(=O)CCl	InChI=1S/C21H31ClN6O3/c22-13-18(29)15(8-4-11-26-21(23)24)27-20(31)17(12-14-6-2-1-3-7-14)28-19(30)16-9-5-10-25-16/h1-3,6-7,15-17,25H,4-5,8-13H2,(H,27,31)(H,28,30)(H4,23,24,26)/t15-,16+,17-/m0/s1	HCCRRLVJBLDSLL-BBWFWOEESA-N	23569	(2S)-N-[(3S)-6-carbamimidamido-1-chloro-2-oxohexan-3-yl]-3-phenyl-2-[(2R)-pyrrolidin-2-ylformamido]propanamide::D-Pro-Phe-Arg chloromethyl ketone (PCK)	Plasma kallikrein			 31							Curated from the literature by BindingDB	10.1021/jm8002697	10.7270/Q2610XNH	18459730	aid1798332		Robert, S; Bertolla, C; Masereel, B; Dogné, JM; Pochet, L	University of Namur	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23569	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23569&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			10456438	50091830						ZINC13507825	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
43073	Fc1ccc(cc1)C(=O)n1cc(Cl)cn1	InChI=1S/C10H6ClFN2O/c11-8-5-13-14(6-8)10(15)7-1-3-9(12)4-2-7/h1-6H	FTDJTWUEACFTRX-UHFFFAOYSA-N	23698	4-chloro-1-[(4-fluorophenyl)carbonyl]-1H-pyrazole::N-Benzoylpyrazole deriv., 1	Plasma kallikrein			 6600							Curated from the literature by BindingDB	10.1021/jm070600+	10.7270/Q2ST7N5S	17850059	aid1798347		Schepetkin, IA; Khlebnikov, AI; Quinn, MT	Montana State University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23698	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23698&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			674652	50091959						ZINC00037184	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
43074	COC(=O)c1ccnn1C(=O)c1ccc(Cl)cc1	InChI=1S/C12H9ClN2O3/c1-18-12(17)10-6-7-14-15(10)11(16)8-2-4-9(13)5-3-8/h2-7H,1H3	POSTYOWAJZBEMF-UHFFFAOYSA-N	23700	N-Benzoylpyrazole deriv., 2::methyl 1-[(4-chlorophenyl)carbonyl]-1H-pyrazole-5-carboxylate	Plasma kallikrein			 11900							Curated from the literature by BindingDB	10.1021/jm070600+	10.7270/Q2ST7N5S	17850059	aid1798347		Schepetkin, IA; Khlebnikov, AI; Quinn, MT	Montana State University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23700	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23700&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			674593	50091960						ZINC00037095	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
43075	[O-][N+](=O)c1cccc(c1)C(=O)n1cc(Cl)cn1	InChI=1S/C10H6ClN3O3/c11-8-5-12-13(6-8)10(15)7-2-1-3-9(4-7)14(16)17/h1-6H	BKMXGSZQEWHCJH-UHFFFAOYSA-N	23701	4-chloro-1-[(3-nitrophenyl)carbonyl]-1H-pyrazole::N-Benzoylpyrazole deriv., 3	Plasma kallikrein			 11300							Curated from the literature by BindingDB	10.1021/jm070600+	10.7270/Q2ST7N5S	17850059	aid1798347		Schepetkin, IA; Khlebnikov, AI; Quinn, MT	Montana State University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23701	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23701&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			674632	50091961						ZINC00037160	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
43076	Cc1ccc(C(=O)c2ccn(n2)C(=O)c2ccc(F)cc2)c(C)c1	InChI=1S/C19H15FN2O2/c1-12-3-8-16(13(2)11-12)18(23)17-9-10-22(21-17)19(24)14-4-6-15(20)7-5-14/h3-11H,1-2H3	XNRMQSNQFCESPA-UHFFFAOYSA-N	23702	3-[(2,4-dimethylphenyl)carbonyl]-1-[(4-fluorophenyl)carbonyl]-1H-pyrazole::N-Benzoylpyrazole deriv., 4	Plasma kallikrein										Curated from the literature by BindingDB	10.1021/jm070600+	10.7270/Q2ST7N5S	17850059	aid1798347		Schepetkin, IA; Khlebnikov, AI; Quinn, MT	Montana State University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23702	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23702&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			680939	50091962						ZINC00045767	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
43077	[O-][N+](=O)c1cnn(c1)C(=O)c1ccccc1	InChI=1S/C10H7N3O3/c14-10(8-4-2-1-3-5-8)12-7-9(6-11-12)13(15)16/h1-7H	DLDKTRBBAKTGJH-UHFFFAOYSA-N	23703	1-benzoyl-4-nitro-1H-pyrazole::N-Benzoylpyrazole deriv., 5	Plasma kallikrein										Curated from the literature by BindingDB	10.1021/jm070600+	10.7270/Q2ST7N5S	17850059	aid1798347		Schepetkin, IA; Khlebnikov, AI; Quinn, MT	Montana State University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23703	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23703&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			674651	50091963						ZINC00037183	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
43078	O=C(Nc1ccccc1)c1ccn(n1)C(=O)c1ccccc1	InChI=1S/C17H13N3O2/c21-16(18-14-9-5-2-6-10-14)15-11-12-20(19-15)17(22)13-7-3-1-4-8-13/h1-12H,(H,18,21)	ZYYMCOZRPAHLRN-UHFFFAOYSA-N	23704	1-benzoyl-N-phenyl-1H-pyrazole-3-carboxamide::N-Benzoylpyrazole deriv., 6	Plasma kallikrein			 12300							Curated from the literature by BindingDB	10.1021/jm070600+	10.7270/Q2ST7N5S	17850059	aid1798347		Schepetkin, IA; Khlebnikov, AI; Quinn, MT	Montana State University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23704	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23704&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			716930	50091964						ZINC00115253	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
43079	Cc1ccc(cc1)C(=O)n1cc(Br)cn1	InChI=1S/C11H9BrN2O/c1-8-2-4-9(5-3-8)11(15)14-7-10(12)6-13-14/h2-7H,1H3	ZIILQHVFVJLRAB-UHFFFAOYSA-N	23705	4-bromo-1-[(4-methylphenyl)carbonyl]-1H-pyrazole::N-Benzoylpyrazole deriv., 7	Plasma kallikrein			 6200							Curated from the literature by BindingDB	10.1021/jm070600+	10.7270/Q2ST7N5S	17850059	aid1798347		Schepetkin, IA; Khlebnikov, AI; Quinn, MT	Montana State University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23705	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23705&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			674656	50091965						ZINC00037188	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
43080	Clc1ccc(cc1Cl)C(=O)n1cccn1	InChI=1S/C10H6Cl2N2O/c11-8-3-2-7(6-9(8)12)10(15)14-5-1-4-13-14/h1-6H	PPOZMMBGUFTQOQ-UHFFFAOYSA-N	23706	1-[(3,4-dichlorophenyl)carbonyl]-1H-pyrazole::N-Benzoylpyrazole deriv., 8	Plasma kallikrein			 5700							Curated from the literature by BindingDB	10.1021/jm070600+	10.7270/Q2ST7N5S	17850059	aid1798347		Schepetkin, IA; Khlebnikov, AI; Quinn, MT	Montana State University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23706	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23706&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			674628	50091966						ZINC00037156	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
43081	Cc1cc(nn1C(=O)c1ccccc1F)[N+]([O-])=O	InChI=1S/C11H8FN3O3/c1-7-6-10(15(17)18)13-14(7)11(16)8-4-2-3-5-9(8)12/h2-6H,1H3	INYGHXGUCFFZOM-UHFFFAOYSA-N	23707	1-[(2-fluorophenyl)carbonyl]-5-methyl-3-nitro-1H-pyrazole::N-Benzoylpyrazole deriv., 9	Plasma kallikrein			 4400							Curated from the literature by BindingDB	10.1021/jm070600+	10.7270/Q2ST7N5S	17850059	aid1798347		Schepetkin, IA; Khlebnikov, AI; Quinn, MT	Montana State University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23707	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23707&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			674629	50091967						ZINC00037157	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
43082	Fc1cccc(F)c1C(=O)n1cc(Br)cn1	InChI=1S/C10H5BrF2N2O/c11-6-4-14-15(5-6)10(16)9-7(12)2-1-3-8(9)13/h1-5H	PZQVUIJLKBCLOG-UHFFFAOYSA-N	23708	4-bromo-1-[(2,6-difluorophenyl)carbonyl]-1H-pyrazole::N-Benzoylpyrazole deriv., 13	Plasma kallikrein										Curated from the literature by BindingDB	10.1021/jm070600+	10.7270/Q2ST7N5S	17850059	aid1798347		Schepetkin, IA; Khlebnikov, AI; Quinn, MT	Montana State University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23708	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23708&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			674642	50091968						ZINC00037171	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
43083	COc1cc(cc(OC)c1OC)C(=O)n1ccc(C)n1	InChI=1S/C14H16N2O4/c1-9-5-6-16(15-9)14(17)10-7-11(18-2)13(20-4)12(8-10)19-3/h5-8H,1-4H3	OYKZCMONWDBMLU-UHFFFAOYSA-N	23709	3-methyl-1-[(3,4,5-trimethoxyphenyl)carbonyl]-1H-pyrazole::N-Benzoylpyrazole deriv., 17	Plasma kallikrein			 42200  							Curated from the literature by BindingDB	10.1021/jm070600+	10.7270/Q2ST7N5S	17850059	aid1798347		Schepetkin, IA; Khlebnikov, AI; Quinn, MT	Montana State University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23709	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23709&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			899247	50091969						ZINC00477315	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
43084	Cc1ccc(cc1)C(=O)n1ccc(n1)[N+]([O-])=O	InChI=1S/C11H9N3O3/c1-8-2-4-9(5-3-8)11(15)13-7-6-10(12-13)14(16)17/h2-7H,1H3	PQRIEIACDJITID-UHFFFAOYSA-N	23710	1-[(4-methylphenyl)carbonyl]-3-nitro-1H-pyrazole::N-Benzoylpyrazole deriv., 18	Plasma kallikrein			 6100							Curated from the literature by BindingDB	10.1021/jm070600+	10.7270/Q2ST7N5S	17850059	aid1798347		Schepetkin, IA; Khlebnikov, AI; Quinn, MT	Montana State University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23710	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23710&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			699665	50091970						ZINC00078678	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
43085	[O-][N+](=O)c1ccn(n1)C(=O)c1ccccc1	InChI=1S/C10H7N3O3/c14-10(8-4-2-1-3-5-8)12-7-6-9(11-12)13(15)16/h1-7H	MIWUBRDWBKJULS-UHFFFAOYSA-N	23711	1-benzoyl-3-nitro-1H-pyrazole::N-Benzoylpyrazole deriv., 19	Plasma kallikrein			 18800							Curated from the literature by BindingDB	10.1021/jm070600+	10.7270/Q2ST7N5S	17850059	aid1798347		Schepetkin, IA; Khlebnikov, AI; Quinn, MT	Montana State University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23711	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23711&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			700133	50091971						ZINC00079624	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
43086	Cc1ccccc1C(=O)n1cc(cn1)[N+]([O-])=O	InChI=1S/C11H9N3O3/c1-8-4-2-3-5-10(8)11(15)13-7-9(6-12-13)14(16)17/h2-7H,1H3	ORXYMBYYSLQOLK-UHFFFAOYSA-N	23712	1-[(2-methylphenyl)carbonyl]-4-nitro-1H-pyrazole::N-Benzoylpyrazole deriv., 20	Plasma kallikrein										Curated from the literature by BindingDB	10.1021/jm070600+	10.7270/Q2ST7N5S	17850059	aid1798347		Schepetkin, IA; Khlebnikov, AI; Quinn, MT	Montana State University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23712	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23712&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			674641	50091972						ZINC00037170	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
43087	Cc1ccccc1C(=O)n1cc(Cl)cn1	InChI=1S/C11H9ClN2O/c1-8-4-2-3-5-10(8)11(15)14-7-9(12)6-13-14/h2-7H,1H3	LBFRMVGIANQWAQ-UHFFFAOYSA-N	23713	4-chloro-1-[(2-methylphenyl)carbonyl]-1H-pyrazole::N-Benzoylpyrazole deriv., 21	Plasma kallikrein										Curated from the literature by BindingDB	10.1021/jm070600+	10.7270/Q2ST7N5S	17850059	aid1798347		Schepetkin, IA; Khlebnikov, AI; Quinn, MT	Montana State University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23713	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23713&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			577102	50091973						ZINC00037175	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
43088	Cc1cccc(c1)C(=O)n1cc(Br)cn1	InChI=1S/C11H9BrN2O/c1-8-3-2-4-9(5-8)11(15)14-7-10(12)6-13-14/h2-7H,1H3	WACJMZOPBBWBAJ-UHFFFAOYSA-N	23714	4-bromo-1-[(3-methylphenyl)carbonyl]-1H-pyrazole::N-Benzoylpyrazole deriv., 22	Plasma kallikrein										Curated from the literature by BindingDB	10.1021/jm070600+	10.7270/Q2ST7N5S	17850059	aid1798347		Schepetkin, IA; Khlebnikov, AI; Quinn, MT	Montana State University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23714	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23714&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			674653	50091974						ZINC00037185	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
43089	Cc1ccccc1C(=O)n1cc(Br)cn1	InChI=1S/C11H9BrN2O/c1-8-4-2-3-5-10(8)11(15)14-7-9(12)6-13-14/h2-7H,1H3	PNYXHXJNRYYIKD-UHFFFAOYSA-N	23715	4-bromo-1-[(2-methylphenyl)carbonyl]-1H-pyrazole::N-Benzoylpyrazole deriv., 23	Plasma kallikrein										Curated from the literature by BindingDB	10.1021/jm070600+	10.7270/Q2ST7N5S	17850059	aid1798347		Schepetkin, IA; Khlebnikov, AI; Quinn, MT	Montana State University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23715	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23715&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			674650	50091975						ZINC00037182	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
43090	CC(=O)Nc1ccc(cc1)C(=O)n1ccc(C)n1	InChI=1S/C13H13N3O2/c1-9-7-8-16(15-9)13(18)11-3-5-12(6-4-11)14-10(2)17/h3-8H,1-2H3,(H,14,17)	UESFVOIMQABCRW-UHFFFAOYSA-N	23716	N-Benzoylpyrazole deriv., 24::N-{4-[(3-methyl-1H-pyrazol-1-yl)carbonyl]phenyl}acetamide	Plasma kallikrein										Curated from the literature by BindingDB	10.1021/jm070600+	10.7270/Q2ST7N5S	17850059	aid1798347		Schepetkin, IA; Khlebnikov, AI; Quinn, MT	Montana State University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23716	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23716&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			833517	50091976						ZINC00359012	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
43091	Clc1cnn(c1)C(=O)c1ccccc1Cl	InChI=1S/C10H6Cl2N2O/c11-7-5-13-14(6-7)10(15)8-3-1-2-4-9(8)12/h1-6H	JPCNAVHGWAJRRU-UHFFFAOYSA-N	23717	4-chloro-1-[(2-chlorophenyl)carbonyl]-1H-pyrazole::N-Benzoylpyrazole deriv., 25	Plasma kallikrein										Curated from the literature by BindingDB	10.1021/jm070600+	10.7270/Q2ST7N5S	17850059	aid1798347		Schepetkin, IA; Khlebnikov, AI; Quinn, MT	Montana State University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23717	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23717&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			674633	50091977						ZINC00037161	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
43092	Cc1ccccc1C(=O)n1cccn1	InChI=1S/C11H10N2O/c1-9-5-2-3-6-10(9)11(14)13-8-4-7-12-13/h2-8H,1H3	RYSRFZOAAPABLM-UHFFFAOYSA-N	23718	1-[(2-methylphenyl)carbonyl]-1H-pyrazole::N-Benzoylpyrazole deriv., 26	Plasma kallikrein										Curated from the literature by BindingDB	10.1021/jm070600+	10.7270/Q2ST7N5S	17850059	aid1798347		Schepetkin, IA; Khlebnikov, AI; Quinn, MT	Montana State University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23718	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23718&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			685230	50091978						ZINC00052093	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
43093	Fc1cc(Cl)c(cc1F)C(=O)n1cc(Br)cn1	InChI=1S/C10H4BrClF2N2O/c11-5-3-15-16(4-5)10(17)6-1-8(13)9(14)2-7(6)12/h1-4H	SSRIKTAQJWMPPG-UHFFFAOYSA-N	23719	4-bromo-1-[(2-chloro-4,5-difluorophenyl)carbonyl]-1H-pyrazole::N-Benzoylpyrazole deriv., 27	Plasma kallikrein										Curated from the literature by BindingDB	10.1021/jm070600+	10.7270/Q2ST7N5S	17850059	aid1798347		Schepetkin, IA; Khlebnikov, AI; Quinn, MT	Montana State University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23719	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23719&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			674635	50091979						ZINC00037163	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
43094	CC(C)(C)c1ccc(cc1)C(=O)n1cc(Cl)cn1	InChI=1S/C14H15ClN2O/c1-14(2,3)11-6-4-10(5-7-11)13(18)17-9-12(15)8-16-17/h4-9H,1-3H3	WCECOHLCWVOPOI-UHFFFAOYSA-N	23720	1-[(4-tert-butylphenyl)carbonyl]-4-chloro-1H-pyrazole::N-Benzoylpyrazole deriv., 28	Plasma kallikrein										Curated from the literature by BindingDB	10.1021/jm070600+	10.7270/Q2ST7N5S	17850059	aid1798347		Schepetkin, IA; Khlebnikov, AI; Quinn, MT	Montana State University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23720	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23720&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			674639	50091980						ZINC00037168	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
43095	Cc1nn(C(=O)c2ccccc2F)c(C)c1Cl	InChI=1S/C12H10ClFN2O/c1-7-11(13)8(2)16(15-7)12(17)9-5-3-4-6-10(9)14/h3-6H,1-2H3	LGPJDOCFLPQZPI-UHFFFAOYSA-N	23721	4-chloro-1-[(2-fluorophenyl)carbonyl]-3,5-dimethyl-1H-pyrazole::N-Benzoylpyrazole deriv., 29	Plasma kallikrein										Curated from the literature by BindingDB	10.1021/jm070600+	10.7270/Q2ST7N5S	17850059	aid1798347		Schepetkin, IA; Khlebnikov, AI; Quinn, MT	Montana State University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23721	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23721&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			674640	50091981						ZINC00037169	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
43096	Cc1nn(C(=O)c2ccc(Cl)cc2)c(C)c1Cl	InChI=1S/C12H10Cl2N2O/c1-7-11(14)8(2)16(15-7)12(17)9-3-5-10(13)6-4-9/h3-6H,1-2H3	NTPKEXXMJVFTKE-UHFFFAOYSA-N	23722	4-chloro-1-[(4-chlorophenyl)carbonyl]-3,5-dimethyl-1H-pyrazole::N-Benzoylpyrazole deriv., 30	Plasma kallikrein										Curated from the literature by BindingDB	10.1021/jm070600+	10.7270/Q2ST7N5S	17850059	aid1798347		Schepetkin, IA; Khlebnikov, AI; Quinn, MT	Montana State University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23722	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23722&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			685663	50091982						ZINC00052672	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
43097	COc1ccc(cc1)C(=O)n1nc(C)c(Br)c1C	InChI=1S/C13H13BrN2O2/c1-8-12(14)9(2)16(15-8)13(17)10-4-6-11(18-3)7-5-10/h4-7H,1-3H3	NLSJGZBQMCEPIO-UHFFFAOYSA-N	23723	4-bromo-1-[(4-methoxyphenyl)carbonyl]-3,5-dimethyl-1H-pyrazole::N-Benzoylpyrazole deriv., 31::cid_714833	Plasma kallikrein										Curated from the literature by BindingDB	10.1021/jm070600+	10.7270/Q2ST7N5S	17850059	aid1798347		Schepetkin, IA; Khlebnikov, AI; Quinn, MT	Montana State University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23723	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23723&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			714833	50091983						ZINC00110635	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
43098	Brc1ccccc1C(=O)n1cccn1	InChI=1S/C10H7BrN2O/c11-9-5-2-1-4-8(9)10(14)13-7-3-6-12-13/h1-7H	JDDYZNBYEUVUHO-UHFFFAOYSA-N	23724	1-[(2-bromophenyl)carbonyl]-1H-pyrazole::N-Benzoylpyrazole deriv., 32	Plasma kallikrein										Curated from the literature by BindingDB	10.1021/jm070600+	10.7270/Q2ST7N5S	17850059	aid1798347		Schepetkin, IA; Khlebnikov, AI; Quinn, MT	Montana State University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23724	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23724&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			2213207	50091984						ZINC02859946	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
43099	COc1cc(cc(OC)c1OC)C(=O)n1nc(C)c(C)c1C	InChI=1S/C16H20N2O4/c1-9-10(2)17-18(11(9)3)16(19)12-7-13(20-4)15(22-6)14(8-12)21-5/h7-8H,1-6H3	ZQCWCMVYVBHUNF-UHFFFAOYSA-N	23725	3,4,5-trimethyl-1-[(3,4,5-trimethoxyphenyl)carbonyl]-1H-pyrazole::N-Benzoylpyrazole deriv., 33	Plasma kallikrein										Curated from the literature by BindingDB	10.1021/jm070600+	10.7270/Q2ST7N5S	17850059	aid1798347		Schepetkin, IA; Khlebnikov, AI; Quinn, MT	Montana State University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23725	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23725&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			753830	50091985						ZINC00206769	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
198687	NC(=N)c1ccc(CNC(=O)[C@H](CCC2CCNCC2)NC(=O)[C@@H](CCCc2ccccc2)NS(=O)(=O)Cc2ccccc2)cc1	InChI=1S/C35H46N6O4S/c36-33(37)30-17-14-28(15-18-30)24-39-34(42)31(19-16-27-20-22-38-23-21-27)40-35(43)32(13-7-12-26-8-3-1-4-9-26)41-46(44,45)25-29-10-5-2-6-11-29/h1-6,8-11,14-15,17-18,27,31-32,38,41H,7,12-13,16,19-25H2,(H3,36,37)(H,39,42)(H,40,43)/t31-,32+/m0/s1	MCDKKKIUEGNSPK-AJQTZOPKSA-N	108110	US8598206, Table 6, 19	Plasma kallikrein		>50000								US Patent		10.7270/Q25T3J5F		aid1800212	US8598206	Herold, P; Daghish, M; Jelakovic, S; Ludwig, F; Reichelt, C; Schulze, A; Schweinitz, A	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=108110	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=108110&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			53345652	186524980							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
198688	NC(=N)c1ccc(CNC(=O)[C@H](CCC2CCNCC2)NC(=O)[C@@H](CCC2CCN(CC2)C(=O)C2CC2)NS(=O)(=O)Cc2ccccc2)cc1	InChI=1S/C37H53N7O5S/c38-34(39)30-10-6-28(7-11-30)24-41-35(45)32(14-8-26-16-20-40-21-17-26)42-36(46)33(43-50(48,49)25-29-4-2-1-3-5-29)15-9-27-18-22-44(23-19-27)37(47)31-12-13-31/h1-7,10-11,26-27,31-33,40,43H,8-9,12-25H2,(H3,38,39)(H,41,45)(H,42,46)/t32-,33+/m0/s1	DIFGLRSYVDIDJS-JHOUSYSJSA-N	108098	US8598206, Table 6, 7	Plasma kallikrein		>50000								US Patent		10.7270/Q25T3J5F		aid1800212	US8598206	Herold, P; Daghish, M; Jelakovic, S; Ludwig, F; Reichelt, C; Schulze, A; Schweinitz, A	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=108098	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=108098&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			53345968	186524968							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
198689	NC(=N)c1ccc(CNC(=O)[C@H](CCC2CCNCC2)NC(=O)[C@@H](CCCc2ccncc2)NS(=O)(=O)Cc2ccccc2)cc1	InChI=1S/C34H45N7O4S/c35-32(36)29-12-9-27(10-13-29)23-39-33(42)30(14-11-26-17-21-38-22-18-26)40-34(43)31(8-4-7-25-15-19-37-20-16-25)41-46(44,45)24-28-5-2-1-3-6-28/h1-3,5-6,9-10,12-13,15-16,19-20,26,30-31,38,41H,4,7-8,11,14,17-18,21-24H2,(H3,35,36)(H,39,42)(H,40,43)/t30-,31+/m0/s1	VNKFZBCCJJVXJG-IOWSJCHKSA-N	108117	US8598206, Table 6, 2	Plasma kallikrein		>80000								US Patent		10.7270/Q25T3J5F		aid1800212	US8598206	Herold, P; Daghish, M; Jelakovic, S; Ludwig, F; Reichelt, C; Schulze, A; Schweinitz, A	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=108117	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=108117&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			53345653	186524987							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
198690	CC(C)C(=O)N1CCC(CC[C@@H](NS(=O)(=O)Cc2ccccc2)C(=O)N[C@@H](CCC2CCNCC2)C(=O)NCc2ccc(cc2)C(N)=N)CC1	InChI=1S/C37H55N7O5S/c1-26(2)37(47)44-22-18-28(19-23-44)11-15-33(43-50(48,49)25-30-6-4-3-5-7-30)36(46)42-32(14-10-27-16-20-40-21-17-27)35(45)41-24-29-8-12-31(13-9-29)34(38)39/h3-9,12-13,26-28,32-33,40,43H,10-11,14-25H2,1-2H3,(H3,38,39)(H,41,45)(H,42,46)/t32-,33+/m0/s1	RRYHCECMCWJEIU-JHOUSYSJSA-N	108109	US8598206, 118::US8598206, 122	Plasma kallikrein		>200000								US Patent		10.7270/Q25T3J5F		aid1800212	US8598206	Herold, P; Daghish, M; Jelakovic, S; Ludwig, F; Reichelt, C; Schulze, A; Schweinitz, A	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=108109	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=108109&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			53345970	186524979							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
198691	COC(=O)N1CCC(CC[C@@H](NS(=O)(=O)Cc2ccccc2)C(=O)N[C@@H](CCC2CCNCC2)C(=O)NCc2ccc(cc2)C(N)=N)CC1	InChI=1S/C35H51N7O6S/c1-48-35(45)42-21-17-26(18-22-42)10-14-31(41-49(46,47)24-28-5-3-2-4-6-28)34(44)40-30(13-9-25-15-19-38-20-16-25)33(43)39-23-27-7-11-29(12-8-27)32(36)37/h2-8,11-12,25-26,30-31,38,41H,9-10,13-24H2,1H3,(H3,36,37)(H,39,43)(H,40,44)/t30-,31+/m0/s1	ZTXALZIIFRKUGE-IOWSJCHKSA-N	108107	US8598206, Table 6, 16	Plasma kallikrein		>200000								US Patent		10.7270/Q25T3J5F		aid1800212	US8598206	Herold, P; Daghish, M; Jelakovic, S; Ludwig, F; Reichelt, C; Schulze, A; Schweinitz, A	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=108107	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=108107&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			53345861	186524977							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
198692	CN(C)C(=O)N1CCC(CC[C@@H](NS(=O)(=O)Cc2ccccc2)C(=O)N[C@@H](CCC2CCNCC2)C(=O)NCc2ccc(cc2)C(N)=N)CC1	InChI=1S/C36H54N8O5S/c1-43(2)36(47)44-22-18-27(19-23-44)11-15-32(42-50(48,49)25-29-6-4-3-5-7-29)35(46)41-31(14-10-26-16-20-39-21-17-26)34(45)40-24-28-8-12-30(13-9-28)33(37)38/h3-9,12-13,26-27,31-32,39,42H,10-11,14-25H2,1-2H3,(H3,37,38)(H,40,45)(H,41,46)/t31-,32+/m0/s1	WYOJURVOHOBMRY-AJQTZOPKSA-N	108104	US8598206, Table 6, 13	Plasma kallikrein		>200000								US Patent		10.7270/Q25T3J5F		aid1800212	US8598206	Herold, P; Daghish, M; Jelakovic, S; Ludwig, F; Reichelt, C; Schulze, A; Schweinitz, A	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=108104	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=108104&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			53345967	186524974							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
198693	CCC(=O)N1CCC(CC[C@@H](NS(=O)(=O)Cc2ccccc2)C(=O)N[C@@H](CCC2CCNCC2)C(=O)NCc2ccc(cc2)C(N)=N)CC1	InChI=1S/C36H53N7O5S/c1-2-33(44)43-22-18-27(19-23-43)11-15-32(42-49(47,48)25-29-6-4-3-5-7-29)36(46)41-31(14-10-26-16-20-39-21-17-26)35(45)40-24-28-8-12-30(13-9-28)34(37)38/h3-9,12-13,26-27,31-32,39,42H,2,10-11,14-25H2,1H3,(H3,37,38)(H,40,45)(H,41,46)/t31-,32+/m0/s1	LWFLIRIWEPBXFX-AJQTZOPKSA-N	108099	US8598206, Table 6, 8	Plasma kallikrein		>60000								US Patent		10.7270/Q25T3J5F		aid1800212	US8598206	Herold, P; Daghish, M; Jelakovic, S; Ludwig, F; Reichelt, C; Schulze, A; Schweinitz, A	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=108099	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=108099&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			53346082	186524969							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
198694	COC(=O)N1CCC(CCC[C@@H](NS(=O)(=O)Cc2ccccc2)C(=O)N[C@@H](CCC2CCNCC2)C(=O)NCc2ccc(cc2)C(N)=N)CC1	InChI=1S/C36H53N7O6S/c1-49-36(46)43-22-18-26(19-23-43)8-5-9-32(42-50(47,48)25-29-6-3-2-4-7-29)35(45)41-31(15-12-27-16-20-39-21-17-27)34(44)40-24-28-10-13-30(14-11-28)33(37)38/h2-4,6-7,10-11,13-14,26-27,31-32,39,42H,5,8-9,12,15-25H2,1H3,(H3,37,38)(H,40,44)(H,41,45)/t31-,32+/m0/s1	BJSIWIFJSRFHPS-AJQTZOPKSA-N	108115	US8598206, Table 6, 24	Plasma kallikrein		>100000								US Patent		10.7270/Q25T3J5F		aid1800212	US8598206	Herold, P; Daghish, M; Jelakovic, S; Ludwig, F; Reichelt, C; Schulze, A; Schweinitz, A	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=108115	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=108115&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			53346081	186524985							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
198695	CNC(=O)N1CCC(CC[C@@H](NS(=O)(=O)Cc2ccccc2)C(=O)N[C@@H](CCC2CCNCC2)C(=O)NCc2ccc(cc2)C(N)=N)CC1	InChI=1S/C35H52N8O5S/c1-38-35(46)43-21-17-26(18-22-43)10-14-31(42-49(47,48)24-28-5-3-2-4-6-28)34(45)41-30(13-9-25-15-19-39-20-16-25)33(44)40-23-27-7-11-29(12-8-27)32(36)37/h2-8,11-12,25-26,30-31,39,42H,9-10,13-24H2,1H3,(H3,36,37)(H,38,46)(H,40,44)(H,41,45)/t30-,31+/m0/s1	OGCGKERBEQPTBU-IOWSJCHKSA-N	108105	US8598206, Table 6, 14	Plasma kallikrein		>200000								US Patent		10.7270/Q25T3J5F		aid1800212	US8598206	Herold, P; Daghish, M; Jelakovic, S; Ludwig, F; Reichelt, C; Schulze, A; Schweinitz, A	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=108105	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=108105&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			53345863	186524975							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
198696	COCC(=O)N1CCC(CC[C@@H](NS(=O)(=O)Cc2ccccc2)C(=O)N[C@@H](CCC2CCNCC2)C(=O)NCc2ccc(cc2)C(N)=N)CC1	InChI=1S/C36H53N7O6S/c1-49-24-33(44)43-21-17-27(18-22-43)10-14-32(42-50(47,48)25-29-5-3-2-4-6-29)36(46)41-31(13-9-26-15-19-39-20-16-26)35(45)40-23-28-7-11-30(12-8-28)34(37)38/h2-8,11-12,26-27,31-32,39,42H,9-10,13-25H2,1H3,(H3,37,38)(H,40,45)(H,41,46)/t31-,32+/m0/s1	DTIUMOLBWQXRPH-AJQTZOPKSA-N	108102	US8598206, Table 6, 11	Plasma kallikrein		>100000								US Patent		10.7270/Q25T3J5F		aid1800212	US8598206	Herold, P; Daghish, M; Jelakovic, S; Ludwig, F; Reichelt, C; Schulze, A; Schweinitz, A	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=108102	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=108102&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			53345862	186524972							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
198697	NC(=N)c1ccc(CNC(=O)[C@H](CCC2CCNCC2)NC(=O)[C@@H](CCCC2=CC=[N](O)C=C2)NS(=O)(=O)Cc2ccccc2)cc1	InChI=1S/C34H46N7O5S/c35-32(36)29-12-9-27(10-13-29)23-38-33(42)30(14-11-26-15-19-37-20-16-26)39-34(43)31(8-4-7-25-17-21-41(44)22-18-25)40-47(45,46)24-28-5-2-1-3-6-28/h1-3,5-6,9-10,12-13,17-18,21-22,26,30-31,37,40,44H,4,7-8,11,14-16,19-20,23-24H2,(H3,35,36)(H,38,42)(H,39,43)/t30-,31+/m0/s1	LBBUQPWJBKYVNI-IOWSJCHKSA-N	108108	US8598206, 117::US8598206, 123	Plasma kallikrein		>200000								US Patent		10.7270/Q25T3J5F		aid1800212	US8598206	Herold, P; Daghish, M; Jelakovic, S; Ludwig, F; Reichelt, C; Schulze, A; Schweinitz, A	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=108108	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=108108&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			91663788	186524978							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
198698	CC(=O)N1CCC(CCC[C@@H](NS(=O)(=O)Cc2ccccc2)C(=O)N[C@@H](CCC2CCNCC2)C(=O)NCc2ccc(cc2)C(N)=N)CC1	InChI=1S/C36H53N7O5S/c1-26(44)43-22-18-27(19-23-43)8-5-9-33(42-49(47,48)25-30-6-3-2-4-7-30)36(46)41-32(15-12-28-16-20-39-21-17-28)35(45)40-24-29-10-13-31(14-11-29)34(37)38/h2-4,6-7,10-11,13-14,27-28,32-33,39,42H,5,8-9,12,15-25H2,1H3,(H3,37,38)(H,40,45)(H,41,46)/t32-,33+/m0/s1	QCJKXYYLKAMQSD-JHOUSYSJSA-N	47177	BDBM108100::US8598206, Table 6, 9	Plasma kallikrein		>500000								US Patent		10.7270/Q25T3J5F		aid1800212	US8598206	Herold, P; Daghish, M; Jelakovic, S; Ludwig, F; Reichelt, C; Schulze, A; Schweinitz, A	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=47177	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=47177&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			53346080	313362578							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
198699	NC(=N)c1ccc(CNC(=O)[C@H](CCC2CCNCC2)NC(=O)[C@@H](CCc2ccncc2)NS(=O)(=O)Cc2ccccc2)cc1	InChI=1S/C33H43N7O4S/c34-31(35)28-10-6-26(7-11-28)22-38-32(41)29(12-8-24-14-18-36-19-15-24)39-33(42)30(13-9-25-16-20-37-21-17-25)40-45(43,44)23-27-4-2-1-3-5-27/h1-7,10-11,16-17,20-21,24,29-30,36,40H,8-9,12-15,18-19,22-23H2,(H3,34,35)(H,38,41)(H,39,42)/t29-,30+/m0/s1	ZYKYKDNQGMXJQR-XZWHSSHBSA-N	47178	BDBM108103::US8598206, Table 6, 12	Plasma kallikrein		>200000								US Patent		10.7270/Q25T3J5F		aid1800212	US8598206	Herold, P; Daghish, M; Jelakovic, S; Ludwig, F; Reichelt, C; Schulze, A; Schweinitz, A	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=47178	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=47178&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			53345752	313362579							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
198700	CC(=O)N1CCC(CC[C@@H](NS(=O)(=O)Cc2ccccc2)C(=O)N[C@@H](CCC2CCNCC2)C(=O)NCc2ccc(cc2)C(N)=N)CC1	InChI=1S/C35H51N7O5S/c1-25(43)42-21-17-27(18-22-42)10-14-32(41-48(46,47)24-29-5-3-2-4-6-29)35(45)40-31(13-9-26-15-19-38-20-16-26)34(44)39-23-28-7-11-30(12-8-28)33(36)37/h2-8,11-12,26-27,31-32,38,41H,9-10,13-24H2,1H3,(H3,36,37)(H,39,44)(H,40,45)/t31-,32+/m0/s1	XATHBXYKVIAZOR-AJQTZOPKSA-N	108096	US8598206, Table 6, 5	Plasma kallikrein		>20000								US Patent		10.7270/Q25T3J5F		aid1800212	US8598206	Herold, P; Daghish, M; Jelakovic, S; Ludwig, F; Reichelt, C; Schulze, A; Schweinitz, A	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=108096	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=108096&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			53345860	186524966							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
198701	NC(=N)c1ccc(CNC(=O)[C@H](CCC2CCNCC2)NC(=O)[C@@H](CCCC2CCNCC2)NS(=O)(=O)Cc2ccccc2)cc1	InChI=1S/C34H51N7O4S/c35-32(36)29-12-9-27(10-13-29)23-39-33(42)30(14-11-26-17-21-38-22-18-26)40-34(43)31(8-4-7-25-15-19-37-20-16-25)41-46(44,45)24-28-5-2-1-3-6-28/h1-3,5-6,9-10,12-13,25-26,30-31,37-38,41H,4,7-8,11,14-24H2,(H3,35,36)(H,39,42)(H,40,43)/t30-,31+/m0/s1	FDLUVBKZNIPEQR-IOWSJCHKSA-N	108097	US8598206, Table 6, 6	Plasma kallikrein		>50000								US Patent		10.7270/Q25T3J5F		aid1800212	US8598206	Herold, P; Daghish, M; Jelakovic, S; Ludwig, F; Reichelt, C; Schulze, A; Schweinitz, A	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=108097	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=108097&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			53346079	186524967							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
198702	CCc1nc(N)nc(N2CCC(C)(O)CC2)c1C#Cc1cnc(C)c(NS(C)(=O)=O)c1	InChI=1S/C21H28N6O3S/c1-5-17-16(7-6-15-12-18(14(2)23-13-15)26-31(4,29)30)19(25-20(22)24-17)27-10-8-21(3,28)9-11-27/h12-13,26,28H,5,8-11H2,1-4H3,(H2,22,24,25)	DJQKSEJOUSHOAB-UHFFFAOYSA-N	108166	US8598157, I-43	Plasma kallikrein		>20000								US Patent		10.7270/Q25T3J5F		aid1800212	US8598206	Herold, P; Daghish, M; Jelakovic, S; Ludwig, F; Reichelt, C; Schulze, A; Schweinitz, A	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=108166	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=108166&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			60141050	186525036							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
198704	NC(=N)c1ccc(CNC(=O)[C@H](CCC2CCNCC2)NC(=O)[C@@H](CCCc2ccccc2)NS(=O)(=O)Cc2cccc(c2)C(O)=O)cc1	InChI=1S/C36H46N6O6S/c37-33(38)29-15-12-27(13-16-29)23-40-34(43)31(17-14-26-18-20-39-21-19-26)41-35(44)32(11-5-8-25-6-2-1-3-7-25)42-49(47,48)24-28-9-4-10-30(22-28)36(45)46/h1-4,6-7,9-10,12-13,15-16,22,26,31-32,39,42H,5,8,11,14,17-21,23-24H2,(H3,37,38)(H,40,43)(H,41,44)(H,45,46)/t31-,32+/m0/s1	OITRKHUOZGPBJI-AJQTZOPKSA-N	108095	US8598206, Table 6, 4	Plasma kallikrein		>20000								US Patent		10.7270/Q25T3J5F		aid1800212	US8598206	Herold, P; Daghish, M; Jelakovic, S; Ludwig, F; Reichelt, C; Schulze, A; Schweinitz, A	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=108095	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=108095&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			53345755	186524965							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
198705	NC(=N)c1ccc(CNC(=O)[C@H](CCC2CCNCC2)NC(=O)[C@@H](CCC2CCNCC2)NS(=O)(=O)Cc2ccccc2)cc1	InChI=1S/C33H49N7O4S/c34-31(35)28-10-6-26(7-11-28)22-38-32(41)29(12-8-24-14-18-36-19-15-24)39-33(42)30(13-9-25-16-20-37-21-17-25)40-45(43,44)23-27-4-2-1-3-5-27/h1-7,10-11,24-25,29-30,36-37,40H,8-9,12-23H2,(H3,34,35)(H,38,41)(H,39,42)/t29-,30+/m0/s1	ZTJVQQCXGUIYTL-XZWHSSHBSA-N	108101	US8598206, Table 6, 10	Plasma kallikrein		>100000								US Patent		10.7270/Q25T3J5F		aid1800212	US8598206	Herold, P; Daghish, M; Jelakovic, S; Ludwig, F; Reichelt, C; Schulze, A; Schweinitz, A	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=108101	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=108101&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			53346181	186524971							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
198706	NC(=N)c1ccc(CNC(=O)[C@H](CCC2CCNCC2)NC(=O)[C@@H](CCC2=CC=[N](O)C=C2)NS(=O)(=O)Cc2ccccc2)cc1	InChI=1S/C33H44N7O5S/c34-31(35)28-10-6-26(7-11-28)22-37-32(41)29(12-8-24-14-18-36-19-15-24)38-33(42)30(13-9-25-16-20-40(43)21-17-25)39-46(44,45)23-27-4-2-1-3-5-27/h1-7,10-11,16-17,20-21,24,29-30,36,39,43H,8-9,12-15,18-19,22-23H2,(H3,34,35)(H,37,41)(H,38,42)/t29-,30+/m0/s1	CKZGCUFXVIRNEZ-XZWHSSHBSA-N	108112	US8598206, Table 6, 21	Plasma kallikrein		>100000								US Patent		10.7270/Q25T3J5F		aid1800212	US8598206	Herold, P; Daghish, M; Jelakovic, S; Ludwig, F; Reichelt, C; Schulze, A; Schweinitz, A	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=108112	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=108112&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			91663789	186524982							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
198707	NC(=N)c1ccc(CNC(=O)[C@H](CCC2CCNCC2)NC(=O)[C@@H](CCCn2cnnn2)NS(=O)(=O)Cc2ccccc2)cc1	InChI=1S/C30H42N10O4S/c31-28(32)25-11-8-23(9-12-25)19-34-29(41)26(13-10-22-14-16-33-17-15-22)36-30(42)27(7-4-18-40-21-35-38-39-40)37-45(43,44)20-24-5-2-1-3-6-24/h1-3,5-6,8-9,11-12,21-22,26-27,33,37H,4,7,10,13-20H2,(H3,31,32)(H,34,41)(H,36,42)/t26-,27+/m0/s1	RUUQARAMINJWGP-RRPNLBNLSA-N	108118	US8598206, Table 6, 1	Plasma kallikrein		>200000								US Patent		10.7270/Q25T3J5F		aid1800212	US8598206	Herold, P; Daghish, M; Jelakovic, S; Ludwig, F; Reichelt, C; Schulze, A; Schweinitz, A	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=108118	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=108118&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			53345654	186524988							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
228103	NC(=N)c1ccc(CNC(=O)[C@H](CCC2CCNCC2)NC(=O)[C@@H](CCCn2cnnn2)NS(=O)(=O)Cc2ccccc2)cc1	InChI=1S/C30H42N10O4S/c31-28(32)25-11-8-23(9-12-25)19-34-29(41)26(13-10-22-14-16-33-17-15-22)36-30(42)27(7-4-18-40-21-35-38-39-40)37-45(43,44)20-24-5-2-1-3-6-24/h1-3,5-6,8-9,11-12,21-22,26-27,33,37H,4,7,10,13-20H2,(H3,31,32)(H,34,41)(H,36,42)/t26-,27+/m0/s1	RUUQARAMINJWGP-RRPNLBNLSA-N	108118	US8598206, Table 6, 1	Plasma kallikrein		 5.3								US Patent		10.7270/Q25T3J5F		aid1800213	US8598206	Herold, P; Daghish, M; Jelakovic, S; Ludwig, F; Reichelt, C; Schulze, A; Schweinitz, A	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=108118	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=108118&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			53345654	186524988							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
228104	NC(=N)c1ccc(CNC(=O)[C@H](CCC2CCNCC2)NC(=O)[C@@H](CCCc2ccncc2)NS(=O)(=O)Cc2ccccc2)cc1	InChI=1S/C34H45N7O4S/c35-32(36)29-12-9-27(10-13-29)23-39-33(42)30(14-11-26-17-21-38-22-18-26)40-34(43)31(8-4-7-25-15-19-37-20-16-25)41-46(44,45)24-28-5-2-1-3-6-28/h1-3,5-6,9-10,12-13,15-16,19-20,26,30-31,38,41H,4,7-8,11,14,17-18,21-24H2,(H3,35,36)(H,39,42)(H,40,43)/t30-,31+/m0/s1	VNKFZBCCJJVXJG-IOWSJCHKSA-N	108117	US8598206, Table 6, 2	Plasma kallikrein		 2.7								US Patent		10.7270/Q25T3J5F		aid1800213	US8598206	Herold, P; Daghish, M; Jelakovic, S; Ludwig, F; Reichelt, C; Schulze, A; Schweinitz, A	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=108117	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=108117&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			53345653	186524987							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
228105	COC(=O)c1cccc(CS(=O)(=O)N[C@H](CCCc2ccccc2)C(=O)N[C@@H](CCC2CCNCC2)C(=O)NCc2ccc(cc2)C(N)=N)c1	InChI=1S/C37H48N6O6S/c1-49-37(46)31-11-5-10-29(23-31)25-50(47,48)43-33(12-6-9-26-7-3-2-4-8-26)36(45)42-32(18-15-27-19-21-40-22-20-27)35(44)41-24-28-13-16-30(17-14-28)34(38)39/h2-5,7-8,10-11,13-14,16-17,23,27,32-33,40,43H,6,9,12,15,18-22,24-25H2,1H3,(H3,38,39)(H,41,44)(H,42,45)/t32-,33+/m0/s1	JPGNXUNXIAMWMQ-JHOUSYSJSA-N	108116	US8598206, Table 6, 3	Plasma kallikrein		 9.4								US Patent		10.7270/Q25T3J5F		aid1800213	US8598206	Herold, P; Daghish, M; Jelakovic, S; Ludwig, F; Reichelt, C; Schulze, A; Schweinitz, A	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=108116	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=108116&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			53345754	186524986							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
228106	NC(=N)c1ccc(CNC(=O)[C@H](CCC2CCNCC2)NC(=O)[C@@H](CCCc2ccccc2)NS(=O)(=O)Cc2cccc(c2)C(O)=O)cc1	InChI=1S/C36H46N6O6S/c37-33(38)29-15-12-27(13-16-29)23-40-34(43)31(17-14-26-18-20-39-21-19-26)41-35(44)32(11-5-8-25-6-2-1-3-7-25)42-49(47,48)24-28-9-4-10-30(22-28)36(45)46/h1-4,6-7,9-10,12-13,15-16,22,26,31-32,39,42H,5,8,11,14,17-21,23-24H2,(H3,37,38)(H,40,43)(H,41,44)(H,45,46)/t31-,32+/m0/s1	OITRKHUOZGPBJI-AJQTZOPKSA-N	108095	US8598206, Table 6, 4	Plasma kallikrein		 3								US Patent		10.7270/Q25T3J5F		aid1800213	US8598206	Herold, P; Daghish, M; Jelakovic, S; Ludwig, F; Reichelt, C; Schulze, A; Schweinitz, A	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=108095	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=108095&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			53345755	186524965							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
228107	CC(=O)N1CCC(CC[C@@H](NS(=O)(=O)Cc2ccccc2)C(=O)N[C@@H](CCC2CCNCC2)C(=O)NCc2ccc(cc2)C(N)=N)CC1	InChI=1S/C35H51N7O5S/c1-25(43)42-21-17-27(18-22-42)10-14-32(41-48(46,47)24-29-5-3-2-4-6-29)35(45)40-31(13-9-26-15-19-38-20-16-26)34(44)39-23-28-7-11-30(12-8-28)33(36)37/h2-8,11-12,26-27,31-32,38,41H,9-10,13-24H2,1H3,(H3,36,37)(H,39,44)(H,40,45)/t31-,32+/m0/s1	XATHBXYKVIAZOR-AJQTZOPKSA-N	108096	US8598206, Table 6, 5	Plasma kallikrein		 5								US Patent		10.7270/Q25T3J5F		aid1800213	US8598206	Herold, P; Daghish, M; Jelakovic, S; Ludwig, F; Reichelt, C; Schulze, A; Schweinitz, A	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=108096	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=108096&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			53345860	186524966							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
228108	NC(=N)c1ccc(CNC(=O)[C@H](CCC2CCNCC2)NC(=O)[C@@H](CCCC2CCNCC2)NS(=O)(=O)Cc2ccccc2)cc1	InChI=1S/C34H51N7O4S/c35-32(36)29-12-9-27(10-13-29)23-39-33(42)30(14-11-26-17-21-38-22-18-26)40-34(43)31(8-4-7-25-15-19-37-20-16-25)41-46(44,45)24-28-5-2-1-3-6-28/h1-3,5-6,9-10,12-13,25-26,30-31,37-38,41H,4,7-8,11,14-24H2,(H3,35,36)(H,39,42)(H,40,43)/t30-,31+/m0/s1	FDLUVBKZNIPEQR-IOWSJCHKSA-N	108097	US8598206, Table 6, 6	Plasma kallikrein		 7.5								US Patent		10.7270/Q25T3J5F		aid1800213	US8598206	Herold, P; Daghish, M; Jelakovic, S; Ludwig, F; Reichelt, C; Schulze, A; Schweinitz, A	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=108097	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=108097&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			53346079	186524967							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
228110	CCC(=O)N1CCC(CC[C@@H](NS(=O)(=O)Cc2ccccc2)C(=O)N[C@@H](CCC2CCNCC2)C(=O)NCc2ccc(cc2)C(N)=N)CC1	InChI=1S/C36H53N7O5S/c1-2-33(44)43-22-18-27(19-23-43)11-15-32(42-49(47,48)25-29-6-4-3-5-7-29)36(46)41-31(14-10-26-16-20-39-21-17-26)35(45)40-24-28-8-12-30(13-9-28)34(37)38/h3-9,12-13,26-27,31-32,39,42H,2,10-11,14-25H2,1H3,(H3,37,38)(H,40,45)(H,41,46)/t31-,32+/m0/s1	LWFLIRIWEPBXFX-AJQTZOPKSA-N	108099	US8598206, Table 6, 8	Plasma kallikrein		 0.9								US Patent		10.7270/Q25T3J5F		aid1800213	US8598206	Herold, P; Daghish, M; Jelakovic, S; Ludwig, F; Reichelt, C; Schulze, A; Schweinitz, A	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=108099	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=108099&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			53346082	186524969							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
228111	CC(=O)N1CCC(CCC[C@@H](NS(=O)(=O)Cc2ccccc2)C(=O)N[C@@H](CCC2CCNCC2)C(=O)NCc2ccc(cc2)C(N)=N)CC1	InChI=1S/C36H53N7O5S/c1-26(44)43-22-18-27(19-23-43)8-5-9-33(42-49(47,48)25-30-6-3-2-4-7-30)36(46)41-32(15-12-28-16-20-39-21-17-28)35(45)40-24-29-10-13-31(14-11-29)34(37)38/h2-4,6-7,10-11,13-14,27-28,32-33,39,42H,5,8-9,12,15-25H2,1H3,(H3,37,38)(H,40,45)(H,41,46)/t32-,33+/m0/s1	QCJKXYYLKAMQSD-JHOUSYSJSA-N	47177	BDBM108100::US8598206, Table 6, 9	Plasma kallikrein		 2								US Patent		10.7270/Q25T3J5F		aid1800213	US8598206	Herold, P; Daghish, M; Jelakovic, S; Ludwig, F; Reichelt, C; Schulze, A; Schweinitz, A	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=47177	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=47177&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			53346080	313362578							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
228112	NC(=N)c1ccc(CNC(=O)[C@H](CCC2CCNCC2)NC(=O)[C@@H](CCC2CCNCC2)NS(=O)(=O)Cc2ccccc2)cc1	InChI=1S/C33H49N7O4S/c34-31(35)28-10-6-26(7-11-28)22-38-32(41)29(12-8-24-14-18-36-19-15-24)39-33(42)30(13-9-25-16-20-37-21-17-25)40-45(43,44)23-27-4-2-1-3-5-27/h1-7,10-11,24-25,29-30,36-37,40H,8-9,12-23H2,(H3,34,35)(H,38,41)(H,39,42)/t29-,30+/m0/s1	ZTJVQQCXGUIYTL-XZWHSSHBSA-N	108101	US8598206, Table 6, 10	Plasma kallikrein		 7.5								US Patent		10.7270/Q25T3J5F		aid1800213	US8598206	Herold, P; Daghish, M; Jelakovic, S; Ludwig, F; Reichelt, C; Schulze, A; Schweinitz, A	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=108101	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=108101&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			53346181	186524971							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
228113	COCC(=O)N1CCC(CC[C@@H](NS(=O)(=O)Cc2ccccc2)C(=O)N[C@@H](CCC2CCNCC2)C(=O)NCc2ccc(cc2)C(N)=N)CC1	InChI=1S/C36H53N7O6S/c1-49-24-33(44)43-21-17-27(18-22-43)10-14-32(42-50(47,48)25-29-5-3-2-4-6-29)36(46)41-31(13-9-26-15-19-39-20-16-26)35(45)40-23-28-7-11-30(12-8-28)34(37)38/h2-8,11-12,26-27,31-32,39,42H,9-10,13-25H2,1H3,(H3,37,38)(H,40,45)(H,41,46)/t31-,32+/m0/s1	DTIUMOLBWQXRPH-AJQTZOPKSA-N	108102	US8598206, Table 6, 11	Plasma kallikrein		 1.3								US Patent		10.7270/Q25T3J5F		aid1800213	US8598206	Herold, P; Daghish, M; Jelakovic, S; Ludwig, F; Reichelt, C; Schulze, A; Schweinitz, A	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=108102	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=108102&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			53345862	186524972							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
228114	NC(=N)c1ccc(CNC(=O)[C@H](CCC2CCNCC2)NC(=O)[C@@H](CCc2ccncc2)NS(=O)(=O)Cc2ccccc2)cc1	InChI=1S/C33H43N7O4S/c34-31(35)28-10-6-26(7-11-28)22-38-32(41)29(12-8-24-14-18-36-19-15-24)39-33(42)30(13-9-25-16-20-37-21-17-25)40-45(43,44)23-27-4-2-1-3-5-27/h1-7,10-11,16-17,20-21,24,29-30,36,40H,8-9,12-15,18-19,22-23H2,(H3,34,35)(H,38,41)(H,39,42)/t29-,30+/m0/s1	ZYKYKDNQGMXJQR-XZWHSSHBSA-N	47178	BDBM108103::US8598206, Table 6, 12	Plasma kallikrein		 9								US Patent		10.7270/Q25T3J5F		aid1800213	US8598206	Herold, P; Daghish, M; Jelakovic, S; Ludwig, F; Reichelt, C; Schulze, A; Schweinitz, A	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=47178	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=47178&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			53345752	313362579							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
228115	CN(C)C(=O)N1CCC(CC[C@@H](NS(=O)(=O)Cc2ccccc2)C(=O)N[C@@H](CCC2CCNCC2)C(=O)NCc2ccc(cc2)C(N)=N)CC1	InChI=1S/C36H54N8O5S/c1-43(2)36(47)44-22-18-27(19-23-44)11-15-32(42-50(48,49)25-29-6-4-3-5-7-29)35(46)41-31(14-10-26-16-20-39-21-17-26)34(45)40-24-28-8-12-30(13-9-28)33(37)38/h3-9,12-13,26-27,31-32,39,42H,10-11,14-25H2,1-2H3,(H3,37,38)(H,40,45)(H,41,46)/t31-,32+/m0/s1	WYOJURVOHOBMRY-AJQTZOPKSA-N	108104	US8598206, Table 6, 13	Plasma kallikrein		 4								US Patent		10.7270/Q25T3J5F		aid1800213	US8598206	Herold, P; Daghish, M; Jelakovic, S; Ludwig, F; Reichelt, C; Schulze, A; Schweinitz, A	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=108104	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=108104&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			53345967	186524974							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
228116	CNC(=O)N1CCC(CC[C@@H](NS(=O)(=O)Cc2ccccc2)C(=O)N[C@@H](CCC2CCNCC2)C(=O)NCc2ccc(cc2)C(N)=N)CC1	InChI=1S/C35H52N8O5S/c1-38-35(46)43-21-17-26(18-22-43)10-14-31(42-49(47,48)24-28-5-3-2-4-6-28)34(45)41-30(13-9-25-15-19-39-20-16-25)33(44)40-23-27-7-11-29(12-8-27)32(36)37/h2-8,11-12,25-26,30-31,39,42H,9-10,13-24H2,1H3,(H3,36,37)(H,38,46)(H,40,44)(H,41,45)/t30-,31+/m0/s1	OGCGKERBEQPTBU-IOWSJCHKSA-N	108105	US8598206, Table 6, 14	Plasma kallikrein		 2								US Patent		10.7270/Q25T3J5F		aid1800213	US8598206	Herold, P; Daghish, M; Jelakovic, S; Ludwig, F; Reichelt, C; Schulze, A; Schweinitz, A	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=108105	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=108105&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			53345863	186524975							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
228117	CCCC(=O)N1CCC(CC[C@@H](NS(=O)(=O)Cc2ccccc2)C(=O)N[C@@H](CCC2CCNCC2)C(=O)NCc2ccc(cc2)C(N)=N)CC1	InChI=1S/C37H55N7O5S/c1-2-6-34(45)44-23-19-28(20-24-44)12-16-33(43-50(48,49)26-30-7-4-3-5-8-30)37(47)42-32(15-11-27-17-21-40-22-18-27)36(46)41-25-29-9-13-31(14-10-29)35(38)39/h3-5,7-10,13-14,27-28,32-33,40,43H,2,6,11-12,15-26H2,1H3,(H3,38,39)(H,41,46)(H,42,47)/t32-,33+/m0/s1	GWZGMZVWURNLOZ-JHOUSYSJSA-N	108106	US8598206, Table 6, 15	Plasma kallikrein		 2								US Patent		10.7270/Q25T3J5F		aid1800213	US8598206	Herold, P; Daghish, M; Jelakovic, S; Ludwig, F; Reichelt, C; Schulze, A; Schweinitz, A	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=108106	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=108106&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			53345969	186524976							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
228118	COC(=O)N1CCC(CC[C@@H](NS(=O)(=O)Cc2ccccc2)C(=O)N[C@@H](CCC2CCNCC2)C(=O)NCc2ccc(cc2)C(N)=N)CC1	InChI=1S/C35H51N7O6S/c1-48-35(45)42-21-17-26(18-22-42)10-14-31(41-49(46,47)24-28-5-3-2-4-6-28)34(44)40-30(13-9-25-15-19-38-20-16-25)33(43)39-23-27-7-11-29(12-8-27)32(36)37/h2-8,11-12,25-26,30-31,38,41H,9-10,13-24H2,1H3,(H3,36,37)(H,39,43)(H,40,44)/t30-,31+/m0/s1	ZTXALZIIFRKUGE-IOWSJCHKSA-N	108107	US8598206, Table 6, 16	Plasma kallikrein		 2								US Patent		10.7270/Q25T3J5F		aid1800213	US8598206	Herold, P; Daghish, M; Jelakovic, S; Ludwig, F; Reichelt, C; Schulze, A; Schweinitz, A	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=108107	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=108107&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			53345861	186524977							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
228119	NC(=N)c1ccc(CNC(=O)[C@H](CCC2CCNCC2)NC(=O)[C@@H](CCCC2=CC=[N](O)C=C2)NS(=O)(=O)Cc2ccccc2)cc1	InChI=1S/C34H46N7O5S/c35-32(36)29-12-9-27(10-13-29)23-38-33(42)30(14-11-26-15-19-37-20-16-26)39-34(43)31(8-4-7-25-17-21-41(44)22-18-25)40-47(45,46)24-28-5-2-1-3-6-28/h1-3,5-6,9-10,12-13,17-18,21-22,26,30-31,37,40,44H,4,7-8,11,14-16,19-20,23-24H2,(H3,35,36)(H,38,42)(H,39,43)/t30-,31+/m0/s1	LBBUQPWJBKYVNI-IOWSJCHKSA-N	108108	US8598206, 117::US8598206, 123	Plasma kallikrein		 4								US Patent		10.7270/Q25T3J5F		aid1800213	US8598206	Herold, P; Daghish, M; Jelakovic, S; Ludwig, F; Reichelt, C; Schulze, A; Schweinitz, A	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=108108	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=108108&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			91663788	186524978							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
228120	CC(C)C(=O)N1CCC(CC[C@@H](NS(=O)(=O)Cc2ccccc2)C(=O)N[C@@H](CCC2CCNCC2)C(=O)NCc2ccc(cc2)C(N)=N)CC1	InChI=1S/C37H55N7O5S/c1-26(2)37(47)44-22-18-28(19-23-44)11-15-33(43-50(48,49)25-30-6-4-3-5-7-30)36(46)42-32(14-10-27-16-20-40-21-17-27)35(45)41-24-29-8-12-31(13-9-29)34(38)39/h3-9,12-13,26-28,32-33,40,43H,10-11,14-25H2,1-2H3,(H3,38,39)(H,41,45)(H,42,46)/t32-,33+/m0/s1	RRYHCECMCWJEIU-JHOUSYSJSA-N	108109	US8598206, 118::US8598206, 122	Plasma kallikrein		 1.5								US Patent		10.7270/Q25T3J5F		aid1800213	US8598206	Herold, P; Daghish, M; Jelakovic, S; Ludwig, F; Reichelt, C; Schulze, A; Schweinitz, A	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=108109	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=108109&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			53345970	186524979							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
228121	NC(=N)c1ccc(CNC(=O)[C@H](CCC2CCNCC2)NC(=O)[C@@H](CCCc2ccccc2)NS(=O)(=O)Cc2ccccc2)cc1	InChI=1S/C35H46N6O4S/c36-33(37)30-17-14-28(15-18-30)24-39-34(42)31(19-16-27-20-22-38-23-21-27)40-35(43)32(13-7-12-26-8-3-1-4-9-26)41-46(44,45)25-29-10-5-2-6-11-29/h1-6,8-11,14-15,17-18,27,31-32,38,41H,7,12-13,16,19-25H2,(H3,36,37)(H,39,42)(H,40,43)/t31-,32+/m0/s1	MCDKKKIUEGNSPK-AJQTZOPKSA-N	108110	US8598206, Table 6, 19	Plasma kallikrein		 1.5								US Patent		10.7270/Q25T3J5F		aid1800213	US8598206	Herold, P; Daghish, M; Jelakovic, S; Ludwig, F; Reichelt, C; Schulze, A; Schweinitz, A	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=108110	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=108110&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			53345652	186524980							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
228122	NC(=N)c1ccc(CNC(=O)[C@H](CCC2CCNCC2)NC(=O)[C@H](NS(=O)(=O)Cc2ccccc2)c2ccccc2)cc1	InChI=1S/C32H40N6O4S/c33-30(34)27-14-11-24(12-15-27)21-36-31(39)28(16-13-23-17-19-35-20-18-23)37-32(40)29(26-9-5-2-6-10-26)38-43(41,42)22-25-7-3-1-4-8-25/h1-12,14-15,23,28-29,35,38H,13,16-22H2,(H3,33,34)(H,36,39)(H,37,40)/t28-,29+/m0/s1	BQJXMSPBOZFQJJ-URLMMPGGSA-N	108111	US8598206, Table 6, 20	Plasma kallikrein		 20								US Patent		10.7270/Q25T3J5F		aid1800213	US8598206	Herold, P; Daghish, M; Jelakovic, S; Ludwig, F; Reichelt, C; Schulze, A; Schweinitz, A	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=108111	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=108111&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			53345655	186524981							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
228123	NC(=N)c1ccc(CNC(=O)[C@H](CCC2CCNCC2)NC(=O)[C@@H](CCC2=CC=[N](O)C=C2)NS(=O)(=O)Cc2ccccc2)cc1	InChI=1S/C33H44N7O5S/c34-31(35)28-10-6-26(7-11-28)22-37-32(41)29(12-8-24-14-18-36-19-15-24)38-33(42)30(13-9-25-16-20-40(43)21-17-25)39-46(44,45)23-27-4-2-1-3-5-27/h1-7,10-11,16-17,20-21,24,29-30,36,39,43H,8-9,12-15,18-19,22-23H2,(H3,34,35)(H,37,41)(H,38,42)/t29-,30+/m0/s1	CKZGCUFXVIRNEZ-XZWHSSHBSA-N	108112	US8598206, Table 6, 21	Plasma kallikrein		 20								US Patent		10.7270/Q25T3J5F		aid1800213	US8598206	Herold, P; Daghish, M; Jelakovic, S; Ludwig, F; Reichelt, C; Schulze, A; Schweinitz, A	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=108112	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=108112&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			91663789	186524982							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
228124	CC(C)C(=O)N1CCC(CC[C@@H](NS(=O)(=O)Cc2ccccc2)C(=O)N[C@@H](CCC2CCNCC2)C(=O)NCc2ccc(cc2)C(N)=N)CC1	InChI=1S/C37H55N7O5S/c1-26(2)37(47)44-22-18-28(19-23-44)11-15-33(43-50(48,49)25-30-6-4-3-5-7-30)36(46)42-32(14-10-27-16-20-40-21-17-27)35(45)41-24-29-8-12-31(13-9-29)34(38)39/h3-9,12-13,26-28,32-33,40,43H,10-11,14-25H2,1-2H3,(H3,38,39)(H,41,45)(H,42,46)/t32-,33+/m0/s1	RRYHCECMCWJEIU-JHOUSYSJSA-N	108109	US8598206, 118::US8598206, 122	Plasma kallikrein		 1.5								US Patent		10.7270/Q25T3J5F		aid1800213	US8598206	Herold, P; Daghish, M; Jelakovic, S; Ludwig, F; Reichelt, C; Schulze, A; Schweinitz, A	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=108109	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=108109&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			53345970	186524979							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
228125	NC(=N)c1ccc(CNC(=O)[C@H](CCC2CCNCC2)NC(=O)[C@@H](CCCC2=CC=[N](O)C=C2)NS(=O)(=O)Cc2ccccc2)cc1	InChI=1S/C34H46N7O5S/c35-32(36)29-12-9-27(10-13-29)23-38-33(42)30(14-11-26-15-19-37-20-16-26)39-34(43)31(8-4-7-25-17-21-41(44)22-18-25)40-47(45,46)24-28-5-2-1-3-6-28/h1-3,5-6,9-10,12-13,17-18,21-22,26,30-31,37,40,44H,4,7-8,11,14-16,19-20,23-24H2,(H3,35,36)(H,38,42)(H,39,43)/t30-,31+/m0/s1	LBBUQPWJBKYVNI-IOWSJCHKSA-N	108108	US8598206, 117::US8598206, 123	Plasma kallikrein		 4								US Patent		10.7270/Q25T3J5F		aid1800213	US8598206	Herold, P; Daghish, M; Jelakovic, S; Ludwig, F; Reichelt, C; Schulze, A; Schweinitz, A	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=108108	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=108108&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			91663788	186524978							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
228126	COC(=O)N1CCC(CCC[C@@H](NS(=O)(=O)Cc2ccccc2)C(=O)N[C@@H](CCC2CCNCC2)C(=O)NCc2ccc(cc2)C(N)=N)CC1	InChI=1S/C36H53N7O6S/c1-49-36(46)43-22-18-26(19-23-43)8-5-9-32(42-50(47,48)25-29-6-3-2-4-7-29)35(45)41-31(15-12-27-16-20-39-21-17-27)34(44)40-24-28-10-13-30(14-11-28)33(37)38/h2-4,6-7,10-11,13-14,26-27,31-32,39,42H,5,8-9,12,15-25H2,1H3,(H3,37,38)(H,40,44)(H,41,45)/t31-,32+/m0/s1	BJSIWIFJSRFHPS-AJQTZOPKSA-N	108115	US8598206, Table 6, 24	Plasma kallikrein		 1.5								US Patent		10.7270/Q25T3J5F		aid1800213	US8598206	Herold, P; Daghish, M; Jelakovic, S; Ludwig, F; Reichelt, C; Schulze, A; Schweinitz, A	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=108115	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=108115&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			53346081	186524985							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
228109	NC(=N)c1ccc(CNC(=O)[C@H](CCC2CCNCC2)NC(=O)[C@@H](CCC2CCN(CC2)C(=O)C2CC2)NS(=O)(=O)Cc2ccccc2)cc1	InChI=1S/C37H53N7O5S/c38-34(39)30-10-6-28(7-11-30)24-41-35(45)32(14-8-26-16-20-40-21-17-26)42-36(46)33(43-50(48,49)25-29-4-2-1-3-5-29)15-9-27-18-22-44(23-19-27)37(47)31-12-13-31/h1-7,10-11,26-27,31-33,40,43H,8-9,12-25H2,(H3,38,39)(H,41,45)(H,42,46)/t32-,33+/m0/s1	DIFGLRSYVDIDJS-JHOUSYSJSA-N	108098	US8598206, Table 6, 7	Plasma kallikrein		 0.3								US Patent		10.7270/Q25T3J5F		aid1800213	US8598206	Herold, P; Daghish, M; Jelakovic, S; Ludwig, F; Reichelt, C; Schulze, A; Schweinitz, A	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=108098	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=108098&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			53345968	186524968							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
276670	NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3cn(Cc4cccc(Cn5cc(C[C@@H](NS(=O)(=O)Cc6ccccc6)C(=O)N2)nn5)c4)nn3)cc1	InChI=1S/C33H35N11O4S/c34-31(35)26-11-9-22(10-12-26)16-36-32(45)29-14-27-19-43(41-38-27)17-24-7-4-8-25(13-24)18-44-20-28(39-42-44)15-30(33(46)37-29)40-49(47,48)21-23-5-2-1-3-6-23/h1-13,19-20,29-30,40H,14-18,21H2,(H3,34,35)(H,36,45)(H,37,46)/t29-,30+/m0/s1	BKSCOHJNKDJECO-XZWHSSHBSA-N	50380617	CHEMBL2016873	Plasma kallikrein		 2.4						8		US Patent		10.7270/Q2RX99S6		aid1800815	US8921319	Steinmetzer, T; Saupe, SM	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50380617	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50380617&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56599309	160859700		CHEMBL2016873				ZINC84596939	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
276671	NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3cn(Cc4cccc(Cn5cc(C[C@@H](NS(=O)(=O)Cc6ccccc6)C(=O)N2)nn5)n4)nn3)cc1	InChI=1S/C32H34N12O4S/c33-30(34)23-11-9-21(10-12-23)15-35-31(45)28-13-26-18-43(41-38-26)16-24-7-4-8-25(36-24)17-44-19-27(39-42-44)14-29(32(46)37-28)40-49(47,48)20-22-5-2-1-3-6-22/h1-12,18-19,28-29,40H,13-17,20H2,(H3,33,34)(H,35,45)(H,37,46)/t28-,29+/m0/s1	PODBMIDYMFKRKE-URLMMPGGSA-N	50380626	CHEMBL2016874	Plasma kallikrein		 10.1						8		US Patent		10.7270/Q2RX99S6		aid1800815	US8921319	Steinmetzer, T; Saupe, SM	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50380626	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50380626&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56954952	160859709		CHEMBL2016874				ZINC84596940	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
276672	NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3ccc(CNC(=O)Cc4cccc(CC(=O)NCc5ccc(C[C@@H](NS(=O)(=O)Cc6ccccc6)C(=O)N2)cc5)c4)cc3)cc1	InChI=1S/C45H47N7O6S/c46-43(47)38-19-17-34(18-20-38)28-50-44(55)39-22-30-9-13-32(14-10-30)26-48-41(53)24-36-7-4-8-37(21-36)25-42(54)49-27-33-15-11-31(12-16-33)23-40(45(56)51-39)52-59(57,58)29-35-5-2-1-3-6-35/h1-21,39-40,52H,22-29H2,(H3,46,47)(H,48,53)(H,49,54)(H,50,55)(H,51,56)/t39-,40+/m0/s1	VQUIFQIXWHRTLG-IOLBBIBUSA-N	141387	US8921319, 3	Plasma kallikrein		 550						8		US Patent		10.7270/Q2RX99S6		aid1800815	US8921319	Steinmetzer, T; Saupe, SM	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=141387	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=141387&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			89843663	251855665							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
276673	NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3ccc(CNC(=O)Cc4ccc(CC(=O)NCc5ccc(C[C@@H](NS(=O)(=O)Cc6ccccc6)C(=O)N2)cc5)cc4)cc3)cc1	InChI=1S/C45H47N7O6S/c46-43(47)38-20-18-36(19-21-38)28-50-44(55)39-22-30-10-14-34(15-11-30)26-48-41(53)24-32-6-8-33(9-7-32)25-42(54)49-27-35-16-12-31(13-17-35)23-40(45(56)51-39)52-59(57,58)29-37-4-2-1-3-5-37/h1-21,39-40,52H,22-29H2,(H3,46,47)(H,48,53)(H,49,54)(H,50,55)(H,51,56)/t39-,40+/m0/s1	XNDGXBNDCNRYDE-IOLBBIBUSA-N	50380621	CHEMBL2016864	Plasma kallikrein		 868						8		US Patent		10.7270/Q2RX99S6		aid1800815	US8921319	Steinmetzer, T; Saupe, SM	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50380621	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50380621&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56954732	160859704		CHEMBL2016864				ZINC95550988	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
276674	NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3cccc(CNC(=O)Cc4cccc(CC(=O)NCc5cccc(C[C@@H](NS(=O)(=O)Cc6ccccc6)C(=O)N2)c5)c4)c3)cc1	InChI=1S/C45H47N7O6S/c46-43(47)38-17-15-30(16-18-38)26-50-44(55)39-22-32-9-5-13-36(20-32)27-48-41(53)24-34-11-4-12-35(19-34)25-42(54)49-28-37-14-6-10-33(21-37)23-40(45(56)51-39)52-59(57,58)29-31-7-2-1-3-8-31/h1-21,39-40,52H,22-29H2,(H3,46,47)(H,48,53)(H,49,54)(H,50,55)(H,51,56)/t39-,40+/m0/s1	MLVTZWQEWUGCSC-IOLBBIBUSA-N	50380623	CHEMBL2016870	Plasma kallikrein		 17.4						8		US Patent		10.7270/Q2RX99S6		aid1800815	US8921319	Steinmetzer, T; Saupe, SM	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50380623	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50380623&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56954834	160859706		CHEMBL2016870				ZINC95550895	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
276675	NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3cccc(CNC(=O)Cc4ccc(CC(=O)NCc5cccc(C[C@@H](NS(=O)(=O)Cc6ccccc6)C(=O)N2)c5)cc4)c3)cc1	InChI=1S/C45H47N7O6S/c46-43(47)38-18-16-32(17-19-38)26-50-44(55)39-22-34-8-4-10-36(20-34)27-48-41(53)24-30-12-14-31(15-13-30)25-42(54)49-28-37-11-5-9-35(21-37)23-40(45(56)51-39)52-59(57,58)29-33-6-2-1-3-7-33/h1-21,39-40,52H,22-29H2,(H3,46,47)(H,48,53)(H,49,54)(H,50,55)(H,51,56)/t39-,40+/m0/s1	UIBUHBYTPNMHCK-IOLBBIBUSA-N	50380618	CHEMBL2016868	Plasma kallikrein		 136						8		US Patent		10.7270/Q2RX99S6		aid1800815	US8921319	Steinmetzer, T; Saupe, SM	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50380618	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50380618&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56640092	160859701		CHEMBL2016868				ZINC95550857	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
276676	NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3cccc(CNC(=O)Cc4ccccc4CC(=O)NCc4cccc(C[C@@H](NS(=O)(=O)Cc5ccccc5)C(=O)N2)c4)c3)cc1	InChI=1S/C45H47N7O6S/c46-43(47)36-18-16-30(17-19-36)26-50-44(55)39-22-32-10-6-12-34(20-32)27-48-41(53)24-37-14-4-5-15-38(37)25-42(54)49-28-35-13-7-11-33(21-35)23-40(45(56)51-39)52-59(57,58)29-31-8-2-1-3-9-31/h1-21,39-40,52H,22-29H2,(H3,46,47)(H,48,53)(H,49,54)(H,50,55)(H,51,56)/t39-,40+/m0/s1	ZLYCPBBJASZKFG-IOLBBIBUSA-N	141388	US8921319, 7	Plasma kallikrein		 8.9						8		US Patent		10.7270/Q2RX99S6		aid1800815	US8921319	Steinmetzer, T; Saupe, SM	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=141388	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=141388&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			89843744	251855666							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
276677	NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3cccc(CNC(=O)CN4CCN(CC4)CC(=O)NCc4cccc(C[C@@H](NS(=O)(=O)Cc5ccccc5)C(=O)N2)c4)c3)cc1	InChI=1S/C43H51N9O6S/c44-41(45)36-14-12-30(13-15-36)24-48-42(55)37-22-32-8-4-10-34(20-32)25-46-39(53)27-51-16-18-52(19-17-51)28-40(54)47-26-35-11-5-9-33(21-35)23-38(43(56)49-37)50-59(57,58)29-31-6-2-1-3-7-31/h1-15,20-21,37-38,50H,16-19,22-29H2,(H3,44,45)(H,46,53)(H,47,54)(H,48,55)(H,49,56)/t37-,38+/m0/s1	UPFBONOEYAFXQG-QPPIDDCLSA-N	50380616	CHEMBL2016869	Plasma kallikrein		 31.6						8		US Patent		10.7270/Q2RX99S6		aid1800815	US8921319	Steinmetzer, T; Saupe, SM	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50380616	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50380616&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56640160	160859699		CHEMBL2016869				ZINC95550858	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
276678	NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3ccc(CNC(=O)CN4CCN(CC4)CC(=O)NCc4ccc(C[C@@H](NS(=O)(=O)Cc5ccccc5)C(=O)N2)cc4)cc3)cc1	InChI=1S/C43H51N9O6S/c44-41(45)36-16-14-34(15-17-36)26-48-42(55)37-22-30-6-10-32(11-7-30)24-46-39(53)27-51-18-20-52(21-19-51)28-40(54)47-25-33-12-8-31(9-13-33)23-38(43(56)49-37)50-59(57,58)29-35-4-2-1-3-5-35/h1-17,37-38,50H,18-29H2,(H3,44,45)(H,46,53)(H,47,54)(H,48,55)(H,49,56)/t37-,38+/m0/s1	IHGDLTOMAAIKHD-QPPIDDCLSA-N	50380622	CHEMBL2016867	Plasma kallikrein		 493						8		US Patent		10.7270/Q2RX99S6		aid1800815	US8921319	Steinmetzer, T; Saupe, SM	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50380622	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50380622&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56954733	160859705		CHEMBL2016867				ZINC95550902	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
276679	NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3ccc(OC\C=C/COc4ccc(C[C@@H](NS(=O)(=O)Cc5ccccc5)C(=O)N2)cc4)cc3)cc1	InChI=1S/C37H39N5O6S/c38-35(39)30-14-8-28(9-15-30)24-40-36(43)33-22-26-10-16-31(17-11-26)47-20-4-5-21-48-32-18-12-27(13-19-32)23-34(37(44)41-33)42-49(45,46)25-29-6-2-1-3-7-29/h1-19,33-34,42H,20-25H2,(H3,38,39)(H,40,43)(H,41,44)/b5-4-/t33-,34+/m0/s1	XWJGZMVWOIPRDB-CLIZBVFSSA-N	141389	US8921319, 10	Plasma kallikrein		 9.4						8		US Patent		10.7270/Q2RX99S6		aid1800815	US8921319	Steinmetzer, T; Saupe, SM	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=141389	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=141389&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56954835	251855667							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
276680	NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3ccc(OCCCCOc4ccc(C[C@@H](NS(=O)(=O)Cc5ccccc5)C(=O)N2)cc4)cc3)cc1	InChI=1S/C37H41N5O6S/c38-35(39)30-14-8-28(9-15-30)24-40-36(43)33-22-26-10-16-31(17-11-26)47-20-4-5-21-48-32-18-12-27(13-19-32)23-34(37(44)41-33)42-49(45,46)25-29-6-2-1-3-7-29/h1-3,6-19,33-34,42H,4-5,20-25H2,(H3,38,39)(H,40,43)(H,41,44)/t33-,34+/m0/s1	HFYJVMKRIIAVFV-SZAHLOSFSA-N	50380625	CHEMBL2016872	Plasma kallikrein		 34.2						8		US Patent		10.7270/Q2RX99S6		aid1800815	US8921319	Steinmetzer, T; Saupe, SM	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50380625	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50380625&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56640226	160859708		CHEMBL2016872				ZINC84596938	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
276681	NC(=N)c1ccc(CNC(=O)[C@@H]2CCCCNC(=O)c3cccc(c3)C(=O)NCCCC[C@@H](NS(=O)(=O)Cc3ccccc3)C(=O)N2)cc1	InChI=1S/C35H43N7O6S/c36-31(37)26-17-15-24(16-18-26)22-40-34(45)29-13-4-6-19-38-32(43)27-11-8-12-28(21-27)33(44)39-20-7-5-14-30(35(46)41-29)42-49(47,48)23-25-9-2-1-3-10-25/h1-3,8-12,15-18,21,29-30,42H,4-7,13-14,19-20,22-23H2,(H3,36,37)(H,38,43)(H,39,44)(H,40,45)(H,41,46)/t29-,30+/m0/s1	FYBDWVPJOGSTDV-XZWHSSHBSA-N	141390	US8921319, 12	Plasma kallikrein		 18						8		US Patent		10.7270/Q2RX99S6		aid1800815	US8921319	Steinmetzer, T; Saupe, SM	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=141390	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=141390&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			89843696	251855668							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
276682	NC(=N)c1ccc(CNC(=O)[C@@H]2CCC(=O)NCc3cccc(CNC(=O)CC[C@@H](NS(=O)(=O)Cc4ccccc4)C(=O)N2)c3)cc1	InChI=1S/C33H39N7O6S/c34-31(35)26-11-9-22(10-12-26)18-38-32(43)27-13-15-29(41)36-19-24-7-4-8-25(17-24)20-37-30(42)16-14-28(33(44)39-27)40-47(45,46)21-23-5-2-1-3-6-23/h1-12,17,27-28,40H,13-16,18-21H2,(H3,34,35)(H,36,41)(H,37,42)(H,38,43)(H,39,44)/t27-,28+/m0/s1	DBLYNSSCIKMVDW-WUFINQPMSA-N	50380620	CHEMBL2016866	Plasma kallikrein		 25						8		US Patent		10.7270/Q2RX99S6		aid1800815	US8921319	Steinmetzer, T; Saupe, SM	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50380620	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50380620&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56954620	160859703		CHEMBL2016866				ZINC84632384	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
276683	NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3cn(Cc4ccc(Cn5cc(C[C@@H](NS(=O)(=O)Cc6ccccc6)C(=O)N2)nn5)cc4)nn3)cc1	InChI=1S/C33H35N11O4S/c34-31(35)26-12-10-22(11-13-26)16-36-32(45)29-14-27-19-43(41-38-27)17-23-6-8-24(9-7-23)18-44-20-28(39-42-44)15-30(33(46)37-29)40-49(47,48)21-25-4-2-1-3-5-25/h1-13,19-20,29-30,40H,14-18,21H2,(H3,34,35)(H,36,45)(H,37,46)/t29-,30+/m0/s1	YPIIFDXBWMJKHY-XZWHSSHBSA-N	141392	US8921319, 14	Plasma kallikrein		 12						8		US Patent		10.7270/Q2RX99S6		aid1800815	US8921319	Steinmetzer, T; Saupe, SM	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=141392	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=141392&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90145679	251855670							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
276684	OC(=O)[C@@H]1Cc2ccc(NC(=O)CN3CCN(CC3)CC(=O)Nc3ccc(C[C@@H](NS(=O)(=O)Cc4ccccc4)C(=O)N1)cc3)cc2	InChI=1S/C33H38N6O7S/c40-30-20-38-14-16-39(17-15-38)21-31(41)35-27-12-8-24(9-13-27)19-29(33(43)44)36-32(42)28(18-23-6-10-26(34-30)11-7-23)37-47(45,46)22-25-4-2-1-3-5-25/h1-13,28-29,37H,14-22H2,(H,34,40)(H,35,41)(H,36,42)(H,43,44)/t28-,29+/m1/s1	MQTMFZBGEJWSRJ-WDYNHAJCSA-N	141391	US8921319, 15	Plasma kallikrein		 320						8		US Patent		10.7270/Q2RX99S6		aid1800815	US8921319	Steinmetzer, T; Saupe, SM	The Medicines Company (Leipzig) GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=141391	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=141391&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71563253	251855669							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355777	CCOc1ccc(CC(=O)CNN([C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)C(=O)CC)cc1	InChI=1S/C31H38N4O4/c1-3-30(37)35(34-22-27(36)18-24-14-16-28(17-15-24)39-4-2)29(19-23-8-6-5-7-9-23)31(38)33-21-26-12-10-25(20-32)11-13-26/h5-17,29,34H,3-4,18-22,32H2,1-2H3,(H,33,38)/t29-/m0/s1	HIZICQRQZNAZQO-LJAQVGFWSA-N	200010	US9234000, 1	Plasma kallikrein			 89							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200010	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200010&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71186049	318589840							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355778	CCOc1ccc(C[C@@H](NS(C)(=O)=O)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C29H36N4O5S/c1-3-38-25-15-13-22(14-16-25)18-27(33-39(2,36)37)29(35)32-26(17-21-7-5-4-6-8-21)28(34)31-20-24-11-9-23(19-30)10-12-24/h4-16,26-27,33H,3,17-20,30H2,1-2H3,(H,31,34)(H,32,35)/t26-,27+/m0/s1	FRZFKIXOXWONFI-RRPNLBNLSA-N	200011	US9234000, 2	Plasma kallikrein			 820							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200011	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200011&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185488	318589841							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355779	CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C35H38N4O4/c1-2-43-30-19-17-26(18-20-30)22-32(38-33(40)29-11-7-4-8-12-29)35(42)39-31(21-25-9-5-3-6-10-25)34(41)37-24-28-15-13-27(23-36)14-16-28/h3-20,31-32H,2,21-24,36H2,1H3,(H,37,41)(H,38,40)(H,39,42)/t31-,32+/m0/s1	UCIXIQRCAGGOJY-AJQTZOPKSA-N	200012	US9234000, 3::US9512065, N-[(R)-1-[(S)-1-(4-aminomethyl-benzylcarbamoyl)-2-phenyl-ethylcarbamoyl]-2-(4-ethoxy-phenyl)-ethyl]-benzamide	Plasma kallikrein			 22							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200012	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200012&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185716	318589842							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355780	NCc1ccc(CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](CC2CCCCC2)NCC(O)=O)cc1	InChI=1S/C28H38N4O4/c29-17-22-11-13-23(14-12-22)18-31-27(35)25(16-21-9-5-2-6-10-21)32-28(36)24(30-19-26(33)34)15-20-7-3-1-4-8-20/h2,5-6,9-14,20,24-25,30H,1,3-4,7-8,15-19,29H2,(H,31,35)(H,32,36)(H,33,34)/t24-,25+/m1/s1	CFVWQRMYGPSOPB-RPBOFIJWSA-N	200013	US9234000, 4	Plasma kallikrein			 230							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200013	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200013&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185578	318589843							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355781	CCOc1ccc(C[C@@H](N)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C28H34N4O3/c1-2-35-24-14-12-21(13-15-24)16-25(30)27(33)32-26(17-20-6-4-3-5-7-20)28(34)31-19-23-10-8-22(18-29)9-11-23/h3-15,25-26H,2,16-19,29-30H2,1H3,(H,31,34)(H,32,33)/t25-,26+/m1/s1	CKNDVDLSIUTQOV-FTJBHMTQSA-N	200014	US9234000, 5	Plasma kallikrein			 460							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200014	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200014&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185684	318589844							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355782	CCOc1ccc(C[C@@H](N)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)c(F)c2)cc1	InChI=1S/C28H33FN4O3/c1-2-36-23-12-9-20(10-13-23)15-25(31)27(34)33-26(16-19-6-4-3-5-7-19)28(35)32-18-21-8-11-22(17-30)24(29)14-21/h3-14,25-26H,2,15-18,30-31H2,1H3,(H,32,35)(H,33,34)/t25-,26+/m1/s1	DYSQLBNPCSMIDI-FTJBHMTQSA-N	200015	US9234000, 6	Plasma kallikrein			 1000							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200015	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200015&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185696	318589845							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355783	CCOc1ccc(CC(=O)CNN([C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)c(F)c2)C(=O)CC)cc1	InChI=1S/C31H37FN4O4/c1-3-30(38)36(35-21-26(37)16-23-11-14-27(15-12-23)40-4-2)29(18-22-8-6-5-7-9-22)31(39)34-20-24-10-13-25(19-33)28(32)17-24/h5-15,17,29,35H,3-4,16,18-21,33H2,1-2H3,(H,34,39)/t29-/m0/s1	QGGICRDCUBZHLM-LJAQVGFWSA-N	200016	US9234000, 7	Plasma kallikrein			 74							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200016	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200016&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185568	318589846							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355784	NCc1ccc(CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](N)CC2CCCCC2)cc1	InChI=1S/C26H36N4O2/c27-17-21-11-13-22(14-12-21)18-29-26(32)24(16-20-9-5-2-6-10-20)30-25(31)23(28)15-19-7-3-1-4-8-19/h2,5-6,9-14,19,23-24H,1,3-4,7-8,15-18,27-28H2,(H,29,32)(H,30,31)/t23-,24+/m1/s1	DYXWMPUBPWGOBS-RPWUZVMVSA-N	200017	US9234000, 8	Plasma kallikrein			 740							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200017	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200017&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185917	318589847							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355785	CN(C)[C@H](CC1CCCCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1	InChI=1S/C28H40N4O2/c1-32(2)26(18-22-11-7-4-8-12-22)28(34)31-25(17-21-9-5-3-6-10-21)27(33)30-20-24-15-13-23(19-29)14-16-24/h3,5-6,9-10,13-16,22,25-26H,4,7-8,11-12,17-20,29H2,1-2H3,(H,30,33)(H,31,34)/t25-,26+/m0/s1	YGGDYXYGFDZJQM-IZZNHLLZSA-N	200018	US9234000, 9	Plasma kallikrein			 2000							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200018	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200018&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185478	318589848							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355786	CCC(=O)N[C@H](CC1CCCCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1	InChI=1S/C29H40N4O3/c1-2-27(34)32-26(18-22-11-7-4-8-12-22)29(36)33-25(17-21-9-5-3-6-10-21)28(35)31-20-24-15-13-23(19-30)14-16-24/h3,5-6,9-10,13-16,22,25-26H,2,4,7-8,11-12,17-20,30H2,1H3,(H,31,35)(H,32,34)(H,33,36)/t25-,26+/m0/s1	QLIXNVHPGDHCMQ-IZZNHLLZSA-N	200019	US9234000, 10	Plasma kallikrein			 7200							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200019	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200019&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185589	318589849							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355787	CS(=O)(=O)N[C@H](CC1CCCCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1	InChI=1S/C27H38N4O4S/c1-36(34,35)31-25(17-21-10-6-3-7-11-21)27(33)30-24(16-20-8-4-2-5-9-20)26(32)29-19-23-14-12-22(18-28)13-15-23/h2,4-5,8-9,12-15,21,24-25,31H,3,6-7,10-11,16-19,28H2,1H3,(H,29,32)(H,30,33)/t24-,25+/m0/s1	BHGMFBIBURKARK-LOSJGSFVSA-N	200020	US9234000, 11	Plasma kallikrein			 1700							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200020	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200020&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185506	318589850							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355788	CCOc1ccc(CC(=O)CNN([C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2Cl)C(=O)CC)cc1	InChI=1S/C31H37ClN4O4/c1-3-30(38)36(35-21-26(37)16-23-11-14-27(15-12-23)40-4-2)29(18-22-8-6-5-7-9-22)31(39)34-20-25-13-10-24(19-33)17-28(25)32/h5-15,17,29,35H,3-4,16,18-21,33H2,1-2H3,(H,34,39)/t29-/m0/s1	WLMGFSPBGBMIGW-LJAQVGFWSA-N	200021	US9234000, 12	Plasma kallikrein			 290							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200021	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200021&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185705	318589851							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355789	CCOc1ccc(C[C@@H](N(C)C)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C30H38N4O3/c1-4-37-26-16-14-23(15-17-26)19-28(34(2)3)30(36)33-27(18-22-8-6-5-7-9-22)29(35)32-21-25-12-10-24(20-31)11-13-25/h5-17,27-28H,4,18-21,31H2,1-3H3,(H,32,35)(H,33,36)/t27-,28+/m0/s1	VTDDUYHUEDESOS-WUFINQPMSA-N	200022	US9234000, 13	Plasma kallikrein			 10000							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200022	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200022&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185941	318589852							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355790	CCOc1ccc(C[C@@H](N)C(=O)N[C@@H](Cc2ccc(Cl)c(Cl)c2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C28H32Cl2N4O3/c1-2-37-22-10-7-18(8-11-22)14-25(32)27(35)34-26(15-21-9-12-23(29)24(30)13-21)28(36)33-17-20-5-3-19(16-31)4-6-20/h3-13,25-26H,2,14-17,31-32H2,1H3,(H,33,36)(H,34,35)/t25-,26+/m1/s1	VZESEHUJGZLJDE-FTJBHMTQSA-N	200023	US9234000, 14	Plasma kallikrein			 400							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200023	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200023&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185604	318589853							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355791	CCOc1ccc(C[C@@H](NS(=O)(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C34H38N4O5S/c1-2-43-29-19-17-26(18-20-29)22-32(38-44(41,42)30-11-7-4-8-12-30)34(40)37-31(21-25-9-5-3-6-10-25)33(39)36-24-28-15-13-27(23-35)14-16-28/h3-20,31-32,38H,2,21-24,35H2,1H3,(H,36,39)(H,37,40)/t31-,32+/m0/s1	TYAFGBNTZJXKOW-AJQTZOPKSA-N	200024	US9234000, 15	Plasma kallikrein			 470							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200024	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200024&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185519	318589854							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355792	CCOc1ccc(CC(=O)CNN([C@@H](Cc2ccc(Cl)c(Cl)c2)C(=O)NCc2ccc(CN)cc2)C(=O)CC)cc1	InChI=1S/C31H36Cl2N4O4/c1-3-30(39)37(36-20-25(38)15-21-9-12-26(13-10-21)41-4-2)29(17-24-11-14-27(32)28(33)16-24)31(40)35-19-23-7-5-22(18-34)6-8-23/h5-14,16,29,36H,3-4,15,17-20,34H2,1-2H3,(H,35,40)/t29-/m0/s1	VVTPHYNAXUAJJK-LJAQVGFWSA-N	200025	US9234000, 16	Plasma kallikrein			 53							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200025	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200025&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185539	318589855							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355793	CCOc1ccc(C[C@@H](NCC(O)=O)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C30H36N4O5/c1-2-39-25-14-12-22(13-15-25)16-26(32-20-28(35)36)30(38)34-27(17-21-6-4-3-5-7-21)29(37)33-19-24-10-8-23(18-31)9-11-24/h3-15,26-27,32H,2,16-20,31H2,1H3,(H,33,37)(H,34,38)(H,35,36)/t26-,27+/m1/s1	LCJSVWIPKDJPSR-SXOMAYOGSA-N	200026	US9234000, 17	Plasma kallikrein			 5800							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200026	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200026&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90302159	318589856							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355794	NCc1ccc(CNC(=O)[C@H](Cc2ccc(Cl)c(Cl)c2)NC(=O)[C@H](N)Cc2ccc(cc2)C(F)(F)F)cc1	InChI=1S/C27H27Cl2F3N4O2/c28-21-10-7-19(11-22(21)29)13-24(26(38)35-15-18-3-1-17(14-33)2-4-18)36-25(37)23(34)12-16-5-8-20(9-6-16)27(30,31)32/h1-11,23-24H,12-15,33-34H2,(H,35,38)(H,36,37)/t23-,24+/m1/s1	MSIDCYYMNINMSP-RPWUZVMVSA-N	200027	US9234000, 18	Plasma kallikrein			 8800							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200027	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200027&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185666	318589857							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355795	CC(=O)CN([C@@H](Cc1ccc(Cl)c(Cl)c1)C(=O)NCc1ccc(CN)cc1)[C@H](CC(N)=O)c1ccc(cc1)C(F)(F)F	InChI=1S/C30H31Cl2F3N4O3/c1-18(40)17-39(26(14-28(37)41)22-7-9-23(10-8-22)30(33,34)35)27(13-21-6-11-24(31)25(32)12-21)29(42)38-16-20-4-2-19(15-36)3-5-20/h2-12,26-27H,13-17,36H2,1H3,(H2,37,41)(H,38,42)/t26-,27+/m1/s1	STTPARYKVKFFLP-SXOMAYOGSA-N	200028	US9234000, 19	Plasma kallikrein			 10000							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200028	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200028&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185662	318589858							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355796	NCc1ccc(CNC(=O)[C@H](Cc2ccc(Cl)c(Cl)c2)NC(=O)[C@H](N)CC2CCCCC2)cc1	InChI=1S/C26H34Cl2N4O2/c27-21-11-10-20(12-22(21)28)14-24(26(34)31-16-19-8-6-18(15-29)7-9-19)32-25(33)23(30)13-17-4-2-1-3-5-17/h6-12,17,23-24H,1-5,13-16,29-30H2,(H,31,34)(H,32,33)/t23-,24+/m1/s1	HGSLIAPVEOZQPN-RPWUZVMVSA-N	200029	US9234000, 20	Plasma kallikrein			 730							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200029	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200029&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185567	318589859							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355797	NCc1ccc(CNC(=O)[C@H](Cc2ccc(Cl)c(Cl)c2)N(CCC(N)=O)CC(=O)CC2CCCCC2)cc1	InChI=1S/C29H38Cl2N4O3/c30-25-11-10-23(15-26(25)31)16-27(29(38)34-18-22-8-6-21(17-32)7-9-22)35(13-12-28(33)37)19-24(36)14-20-4-2-1-3-5-20/h6-11,15,20,27H,1-5,12-14,16-19,32H2,(H2,33,37)(H,34,38)/t27-/m0/s1	NJCMMYULSKXGQU-MHZLTWQESA-N	200030	US9234000, 21	Plasma kallikrein			 5100							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200030	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200030&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90301817	318589860							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355798	C[C@@H](NC(=O)c1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1	InChI=1S/C27H30N4O3/c1-19(30-26(33)23-10-6-3-7-11-23)25(32)31-24(16-20-8-4-2-5-9-20)27(34)29-18-22-14-12-21(17-28)13-15-22/h2-15,19,24H,16-18,28H2,1H3,(H,29,34)(H,30,33)(H,31,32)/t19-,24+/m1/s1	ZVKJQLYOLHGKQK-DVECYGJZSA-N	200031	US9234000, 22	Plasma kallikrein			 10000							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200031	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200031&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185645	318589861							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355799	CCOc1ccc(CC(=O)CNN([C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)c(Cl)c2)C(=O)CC)cc1	InChI=1S/C31H37ClN4O4/c1-3-30(38)36(35-21-26(37)16-23-11-14-27(15-12-23)40-4-2)29(18-22-8-6-5-7-9-22)31(39)34-20-24-10-13-25(19-33)28(32)17-24/h5-15,17,29,35H,3-4,16,18-21,33H2,1-2H3,(H,34,39)/t29-/m0/s1	SBMXVJAAZJABGK-LJAQVGFWSA-N	200032	US9234000, 23	Plasma kallikrein			 31							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200032	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200032&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71186002	318589862							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355800	CCOc1ccc(CC(=O)CNN([C@@H](Cc2ccccc2)C(=O)N(C)Cc2ccc(CN)cc2)C(=O)CC)cc1	InChI=1S/C32H40N4O4/c1-4-31(38)36(34-22-28(37)19-25-15-17-29(18-16-25)40-5-2)30(20-24-9-7-6-8-10-24)32(39)35(3)23-27-13-11-26(21-33)12-14-27/h6-18,30,34H,4-5,19-23,33H2,1-3H3/t30-/m0/s1	RKOQPQPBBDKART-PMERELPUSA-N	200033	US9234000, 24	Plasma kallikrein			 450							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200033	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200033&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185838	318589863							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355801	CCOc1ccc(C[C@@H](N)C(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C29H36N4O3/c1-3-36-25-15-13-22(14-16-25)17-26(31)29(35)33(2)27(18-21-7-5-4-6-8-21)28(34)32-20-24-11-9-23(19-30)10-12-24/h4-16,26-27H,3,17-20,30-31H2,1-2H3,(H,32,34)/t26-,27+/m1/s1	JQDLBRDUISCYPO-SXOMAYOGSA-N	200034	US9234000, 25	Plasma kallikrein			 340							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200034	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200034&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185646	318589864							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355802	CCOc1ccc(CC(=O)CNCCC(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C32H40N4O4/c1-3-40-29-15-13-25(14-16-29)19-28(37)23-34-18-17-31(38)36(2)30(20-24-7-5-4-6-8-24)32(39)35-22-27-11-9-26(21-33)10-12-27/h4-16,30,34H,3,17-23,33H2,1-2H3,(H,35,39)/t30-/m0/s1	MFCPDGVWAVFAEY-PMERELPUSA-N	200035	US9234000, 26	Plasma kallikrein			 81							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200035	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200035&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185879	318589865							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355803	CCOc1ccc(C[C@@H](NC)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C29H36N4O3/c1-3-36-25-15-13-22(14-16-25)17-26(31-2)29(35)33-27(18-21-7-5-4-6-8-21)28(34)32-20-24-11-9-23(19-30)10-12-24/h4-16,26-27,31H,3,17-20,30H2,1-2H3,(H,32,34)(H,33,35)/t26-,27+/m1/s1	ACUWRQFKSMMPOB-SXOMAYOGSA-N	200036	US9234000, 27	Plasma kallikrein			 1300							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200036	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200036&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71186096	318589866							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355804	CC(C)C[C@@H](NCC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1	InChI=1S/C25H34N4O4/c1-17(2)12-21(27-16-23(30)31)25(33)29-22(13-18-6-4-3-5-7-18)24(32)28-15-20-10-8-19(14-26)9-11-20/h3-11,17,21-22,27H,12-16,26H2,1-2H3,(H,28,32)(H,29,33)(H,30,31)/t21-,22+/m1/s1	NZZLBZLVTPDYDB-YADHBBJMSA-N	200037	US9234000, 28	Plasma kallikrein			 8900							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200037	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200037&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185650	318589867							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355805	CN(CC(O)=O)[C@H](CC1CCCCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1	InChI=1S/C29H40N4O4/c1-33(20-27(34)35)26(17-22-10-6-3-7-11-22)29(37)32-25(16-21-8-4-2-5-9-21)28(36)31-19-24-14-12-23(18-30)13-15-24/h2,4-5,8-9,12-15,22,25-26H,3,6-7,10-11,16-20,30H2,1H3,(H,31,36)(H,32,37)(H,34,35)/t25-,26+/m0/s1	DOFSTNRBTSKYAL-IZZNHLLZSA-N	200038	US9234000, 29	Plasma kallikrein			 300							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200038	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200038&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185561	318589868							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355806	CN([C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1)C(=O)[C@@H](CC1CCCCC1)NCC(O)=O	InChI=1S/C29H40N4O4/c1-33(29(37)25(31-20-27(34)35)16-21-8-4-2-5-9-21)26(17-22-10-6-3-7-11-22)28(36)32-19-24-14-12-23(18-30)13-15-24/h3,6-7,10-15,21,25-26,31H,2,4-5,8-9,16-20,30H2,1H3,(H,32,36)(H,34,35)/t25-,26+/m1/s1	AEVWSCHVTRCRRI-FTJBHMTQSA-N	200039	US9234000, 30	Plasma kallikrein			 580							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200039	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200039&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185756	318589869							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355807	CCOc1ccc(C[C@@H](N(C)C(=O)CC)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C32H40N4O4/c1-4-30(37)36(3)29(20-24-15-17-27(18-16-24)40-5-2)32(39)35-28(19-23-9-7-6-8-10-23)31(38)34-22-26-13-11-25(21-33)12-14-26/h6-18,28-29H,4-5,19-22,33H2,1-3H3,(H,34,38)(H,35,39)/t28-,29+/m0/s1	VCUKNDNIFAKRDT-URLMMPGGSA-N	200040	US9234000, 31	Plasma kallikrein			 4300							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200040	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200040&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185842	318589870							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355808	CCOc1ccc(CC(=O)CNCCC(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)c(F)c2)cc1	InChI=1S/C32H39FN4O4/c1-3-41-28-13-10-24(11-14-28)17-27(38)22-35-16-15-31(39)37(2)30(19-23-7-5-4-6-8-23)32(40)36-21-25-9-12-26(20-34)29(33)18-25/h4-14,18,30,35H,3,15-17,19-22,34H2,1-2H3,(H,36,40)/t30-/m0/s1	QRDHDDSDKPGPTM-PMERELPUSA-N	200041	US9234000, 32	Plasma kallikrein			 200							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200041	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200041&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185658	318589871							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355809	CN[C@H](CC1CCCCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1	InChI=1S/C27H38N4O2/c1-29-24(16-20-8-4-2-5-9-20)27(33)31-25(17-21-10-6-3-7-11-21)26(32)30-19-23-14-12-22(18-28)13-15-23/h3,6-7,10-15,20,24-25,29H,2,4-5,8-9,16-19,28H2,1H3,(H,30,32)(H,31,33)/t24-,25+/m1/s1	RQFBFAXVOLVFAX-RPBOFIJWSA-N	200042	US9234000, 33	Plasma kallikrein			 1100							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200042	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200042&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185895	318589872							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355810	CN([C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)c(F)c1)C(=O)[C@@H](CC1CCCCC1)NCC(O)=O	InChI=1S/C29H39FN4O4/c1-34(29(38)25(32-19-27(35)36)15-20-8-4-2-5-9-20)26(16-21-10-6-3-7-11-21)28(37)33-18-22-12-13-23(17-31)24(30)14-22/h3,6-7,10-14,20,25-26,32H,2,4-5,8-9,15-19,31H2,1H3,(H,33,37)(H,35,36)/t25-,26+/m1/s1	PGHCXWHUESPXEI-FTJBHMTQSA-N	200043	US9234000, 34	Plasma kallikrein			 1400							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200043	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200043&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71186135	318589873							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355811	CCCN[C@H](Cc1ccc(OCC)cc1)C(=O)N(C)[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1	InChI=1S/C32H42N4O3/c1-4-19-34-29(20-25-15-17-28(18-16-25)39-5-2)32(38)36(3)30(21-24-9-7-6-8-10-24)31(37)35-23-27-13-11-26(22-33)12-14-27/h6-18,29-30,34H,4-5,19-23,33H2,1-3H3,(H,35,37)/t29-,30+/m1/s1	RRCQNIGKGMQKJC-IHLOFXLRSA-N	200044	US9234000, 35	Plasma kallikrein			 2000							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200044	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200044&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185610	318589874							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355812	CN(Cc1ccc(CN)cc1)C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](CC1CCCCC1)NCC(O)=O	InChI=1S/C29H40N4O4/c1-33(20-24-14-12-23(18-30)13-15-24)29(37)26(17-22-10-6-3-7-11-22)32-28(36)25(31-19-27(34)35)16-21-8-4-2-5-9-21/h3,6-7,10-15,21,25-26,31H,2,4-5,8-9,16-20,30H2,1H3,(H,32,36)(H,34,35)/t25-,26+/m1/s1	KHVBQTPTSZCNFR-FTJBHMTQSA-N	200045	US9234000, 36	Plasma kallikrein			 8200							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200045	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200045&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71186065	318589875							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355813	CCCN[C@H](CC1CCCCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1	InChI=1S/C29H42N4O2/c1-2-17-31-26(18-22-9-5-3-6-10-22)29(35)33-27(19-23-11-7-4-8-12-23)28(34)32-21-25-15-13-24(20-30)14-16-25/h4,7-8,11-16,22,26-27,31H,2-3,5-6,9-10,17-21,30H2,1H3,(H,32,34)(H,33,35)/t26-,27+/m1/s1	YAKWNMILEUXLOF-SXOMAYOGSA-N	200046	US9234000, 37	Plasma kallikrein			 910							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200046	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200046&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185698	318589876							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355814	CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C36H40N4O4/c1-3-44-31-20-18-27(19-21-31)22-32(39-34(41)30-12-8-5-9-13-30)36(43)40(2)33(23-26-10-6-4-7-11-26)35(42)38-25-29-16-14-28(24-37)15-17-29/h4-21,32-33H,3,22-25,37H2,1-2H3,(H,38,42)(H,39,41)/t32-,33+/m1/s1	HQJNEZIZFKIRDE-SAIUNTKASA-N	200047	US9234000, 38	Plasma kallikrein			 47							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200047	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200047&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185593	318589877							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355815	CCOc1ccc(C[C@@H](NC(C)=O)C(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C31H38N4O4/c1-4-39-27-16-14-24(15-17-27)18-28(34-22(2)36)31(38)35(3)29(19-23-8-6-5-7-9-23)30(37)33-21-26-12-10-25(20-32)11-13-26/h5-17,28-29H,4,18-21,32H2,1-3H3,(H,33,37)(H,34,36)/t28-,29+/m1/s1	GYGCSETUDMGRCZ-WDYNHAJCSA-N	200048	US9234000, 39	Plasma kallikrein			 310							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200048	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200048&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185632	318589878							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355816	CN[C@H](CC1CCCCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)c(F)c1	InChI=1S/C27H37FN4O2/c1-30-24(15-19-8-4-2-5-9-19)27(34)32-25(16-20-10-6-3-7-11-20)26(33)31-18-21-12-13-22(17-29)23(28)14-21/h3,6-7,10-14,19,24-25,30H,2,4-5,8-9,15-18,29H2,1H3,(H,31,33)(H,32,34)/t24-,25+/m1/s1	PNOIBJDGHAETSB-RPBOFIJWSA-N	200049	US9234000, 40	Plasma kallikrein			 1800							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200049	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200049&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185943	318589879							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355817	CN[C@H](CC1CCCCC1)C(=O)N[C@@H](Cc1ccc(Cl)c(Cl)c1)C(=O)NCc1ccc(CN)c(F)c1	InChI=1S/C27H35Cl2FN4O2/c1-32-24(13-17-5-3-2-4-6-17)27(36)34-25(14-18-8-10-21(28)22(29)11-18)26(35)33-16-19-7-9-20(15-31)23(30)12-19/h7-12,17,24-25,32H,2-6,13-16,31H2,1H3,(H,33,35)(H,34,36)/t24-,25+/m1/s1	FYRDRWKGCKJBPX-RPBOFIJWSA-N	200050	US9234000, 41	Plasma kallikrein			 1300							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200050	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200050&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71186174	318589880							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355818	CN(CC(O)=O)[C@H](CC1CCCCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)c(F)c1	InChI=1S/C29H39FN4O4/c1-34(19-27(35)36)26(16-21-10-6-3-7-11-21)29(38)33-25(15-20-8-4-2-5-9-20)28(37)32-18-22-12-13-23(17-31)24(30)14-22/h2,4-5,8-9,12-14,21,25-26H,3,6-7,10-11,15-19,31H2,1H3,(H,32,37)(H,33,38)(H,35,36)/t25-,26+/m0/s1	DJSDHDNLNWSZRP-IZZNHLLZSA-N	200051	US9234000, 42	Plasma kallikrein			 530							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200051	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200051&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185845	318589881							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355819	CN(CC(O)=O)[C@H](CC1CCCCC1)C(=O)N[C@@H](Cc1ccc(Cl)c(Cl)c1)C(=O)NCc1ccc(CN)c(F)c1	InChI=1S/C29H37Cl2FN4O4/c1-36(17-27(37)38)26(14-18-5-3-2-4-6-18)29(40)35-25(13-19-8-10-22(30)23(31)11-19)28(39)34-16-20-7-9-21(15-33)24(32)12-20/h7-12,18,25-26H,2-6,13-17,33H2,1H3,(H,34,39)(H,35,40)(H,37,38)/t25-,26+/m0/s1	ATUSQERKXIHTKL-IZZNHLLZSA-N	200052	US9234000, 43	Plasma kallikrein			 1300							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200052	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200052&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185818	318589882							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355820	CCOc1ccc(C[C@@H](NC(=O)C(C)C)C(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C33H42N4O4/c1-5-41-28-17-15-25(16-18-28)19-29(36-31(38)23(2)3)33(40)37(4)30(20-24-9-7-6-8-10-24)32(39)35-22-27-13-11-26(21-34)12-14-27/h6-18,23,29-30H,5,19-22,34H2,1-4H3,(H,35,39)(H,36,38)/t29-,30+/m1/s1	FHGLIRVEEZTGIK-IHLOFXLRSA-N	200053	US9234000, 44	Plasma kallikrein			 180							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200053	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200053&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185980	318589883							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355821	CCCN(C)[C@H](CC1CCCCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1	InChI=1S/C30H44N4O2/c1-3-18-34(2)28(20-24-12-8-5-9-13-24)30(36)33-27(19-23-10-6-4-7-11-23)29(35)32-22-26-16-14-25(21-31)15-17-26/h4,6-7,10-11,14-17,24,27-28H,3,5,8-9,12-13,18-22,31H2,1-2H3,(H,32,35)(H,33,36)/t27-,28+/m0/s1	MAPVPFDRQHBDES-WUFINQPMSA-N	200054	US9234000, 45	Plasma kallikrein			 790							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200054	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200054&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185799	318589884							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355822	COC(=O)CN[C@H](CC1CCCCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1	InChI=1S/C29H40N4O4/c1-37-27(34)20-31-25(16-21-8-4-2-5-9-21)29(36)33-26(17-22-10-6-3-7-11-22)28(35)32-19-24-14-12-23(18-30)13-15-24/h3,6-7,10-15,21,25-26,31H,2,4-5,8-9,16-20,30H2,1H3,(H,32,35)(H,33,36)/t25-,26+/m1/s1	MLHZEVRUXMVMRU-FTJBHMTQSA-N	200055	US9234000, 46::US9234000, 47	Plasma kallikrein			 1200							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200055	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200055&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185707	318589885							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355823	COC(=O)CN[C@H](CC1CCCCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1	InChI=1S/C29H40N4O4/c1-37-27(34)20-31-25(16-21-8-4-2-5-9-21)29(36)33-26(17-22-10-6-3-7-11-22)28(35)32-19-24-14-12-23(18-30)13-15-24/h3,6-7,10-15,21,25-26,31H,2,4-5,8-9,16-20,30H2,1H3,(H,32,35)(H,33,36)/t25-,26+/m1/s1	MLHZEVRUXMVMRU-FTJBHMTQSA-N	200055	US9234000, 46::US9234000, 47	Plasma kallikrein			 2100							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200055	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200055&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185707	318589885							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355824	CN(CC(N)=O)[C@H](CC1CCCCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1	InChI=1S/C29H41N5O3/c1-34(20-27(31)35)26(17-22-10-6-3-7-11-22)29(37)33-25(16-21-8-4-2-5-9-21)28(36)32-19-24-14-12-23(18-30)13-15-24/h2,4-5,8-9,12-15,22,25-26H,3,6-7,10-11,16-20,30H2,1H3,(H2,31,35)(H,32,36)(H,33,37)/t25-,26+/m0/s1	VBCWKMGQHTXCLL-IZZNHLLZSA-N	200057	US9234000, 48	Plasma kallikrein			 4700							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200057	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200057&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185545	318589886							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355825	CN(CCO)[C@H](CC1CCCCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1	InChI=1S/C29H42N4O3/c1-33(16-17-34)27(19-23-10-6-3-7-11-23)29(36)32-26(18-22-8-4-2-5-9-22)28(35)31-21-25-14-12-24(20-30)13-15-25/h2,4-5,8-9,12-15,23,26-27,34H,3,6-7,10-11,16-21,30H2,1H3,(H,31,35)(H,32,36)/t26-,27+/m0/s1	XOHMZWIMXZQRIG-RRPNLBNLSA-N	200058	US9234000, 49	Plasma kallikrein			 2200							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200058	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200058&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71186020	318589887							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355826	NCc1ccc(CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](CC2CCCCC2)NCC(N)=O)cc1	InChI=1S/C28H39N5O3/c29-17-22-11-13-23(14-12-22)18-32-27(35)25(16-21-9-5-2-6-10-21)33-28(36)24(31-19-26(30)34)15-20-7-3-1-4-8-20/h2,5-6,9-14,20,24-25,31H,1,3-4,7-8,15-19,29H2,(H2,30,34)(H,32,35)(H,33,36)/t24-,25+/m1/s1	AVERXCDVOOTDJJ-RPBOFIJWSA-N	200059	US9234000, 50	Plasma kallikrein			 4300							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200059	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200059&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185878	318589888							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355827	NCc1ccc(CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](CC2CCCCC2)NCCO)cc1	InChI=1S/C28H40N4O3/c29-19-23-11-13-24(14-12-23)20-31-27(34)26(18-22-9-5-2-6-10-22)32-28(35)25(30-15-16-33)17-21-7-3-1-4-8-21/h2,5-6,9-14,21,25-26,30,33H,1,3-4,7-8,15-20,29H2,(H,31,34)(H,32,35)/t25-,26+/m1/s1	ASILWFVMBOPQGU-FTJBHMTQSA-N	200060	US9234000, 51	Plasma kallikrein			 1000							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200060	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200060&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71186165	318589889							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355828	NCc1ccc(CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](N)C(C2CCCCC2)C2CCCCC2)cc1	InChI=1S/C32H46N4O2/c33-21-24-16-18-25(19-17-24)22-35-31(37)28(20-23-10-4-1-5-11-23)36-32(38)30(34)29(26-12-6-2-7-13-26)27-14-8-3-9-15-27/h1,4-5,10-11,16-19,26-30H,2-3,6-9,12-15,20-22,33-34H2,(H,35,37)(H,36,38)/t28-,30+/m0/s1	FIYJIRGYSCICSS-MFMCTBQISA-N	200061	US9234000, 52	Plasma kallikrein			 860							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200061	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200061&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118520054	318589890							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355829	CCCN(CCC)[C@H](CC1CCCCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1	InChI=1S/C32H48N4O2/c1-3-19-36(20-4-2)30(22-26-13-9-6-10-14-26)32(38)35-29(21-25-11-7-5-8-12-25)31(37)34-24-28-17-15-27(23-33)16-18-28/h5,7-8,11-12,15-18,26,29-30H,3-4,6,9-10,13-14,19-24,33H2,1-2H3,(H,34,37)(H,35,38)/t29-,30+/m0/s1	DBIDWJMCWRJUME-XZWHSSHBSA-N	200062	US9234000, 53	Plasma kallikrein			 650							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200062	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200062&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185648	318589891							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355830	CCOc1ccc(C[C@@H](NC(=O)c2cccc3ccccc23)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C39H40N4O4/c1-2-47-32-21-19-28(20-22-32)24-36(42-37(44)34-14-8-12-31-11-6-7-13-33(31)34)39(46)43-35(23-27-9-4-3-5-10-27)38(45)41-26-30-17-15-29(25-40)16-18-30/h3-22,35-36H,2,23-26,40H2,1H3,(H,41,45)(H,42,44)(H,43,46)/t35-,36+/m0/s1	TYYQIBDJBZYMOH-MPQUPPDSSA-N	200063	US9234000, 54	Plasma kallikrein			 83							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200063	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200063&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71499476	318589892							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355831	CCOc1ccc(C[C@@H](NC(=O)c2ccc(Cl)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C35H37ClN4O4/c1-2-44-30-18-12-25(13-19-30)21-32(39-33(41)28-14-16-29(36)17-15-28)35(43)40-31(20-24-6-4-3-5-7-24)34(42)38-23-27-10-8-26(22-37)9-11-27/h3-19,31-32H,2,20-23,37H2,1H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1	WQZFDLDYUJSANS-AJQTZOPKSA-N	200064	US9234000, 55	Plasma kallikrein			 31							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200064	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200064&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185521	318589893							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355832	CCOc1ccc(C[C@@H](NC(=O)c2ccc(cc2)C(F)(F)F)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C36H37F3N4O4/c1-2-47-30-18-12-25(13-19-30)21-32(42-33(44)28-14-16-29(17-15-28)36(37,38)39)35(46)43-31(20-24-6-4-3-5-7-24)34(45)41-23-27-10-8-26(22-40)9-11-27/h3-19,31-32H,2,20-23,40H2,1H3,(H,41,45)(H,42,44)(H,43,46)/t31-,32+/m0/s1	RPLAYKBFXJXCRD-AJQTZOPKSA-N	200065	US9234000, 56	Plasma kallikrein			 500							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200065	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200065&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185495	318589894							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355833	CCOc1ccc(C[C@@H](NC(=O)c2ccc(cc2)-c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C41H42N4O4/c1-2-49-36-23-17-30(18-24-36)26-38(44-39(46)35-21-19-34(20-22-35)33-11-7-4-8-12-33)41(48)45-37(25-29-9-5-3-6-10-29)40(47)43-28-32-15-13-31(27-42)14-16-32/h3-24,37-38H,2,25-28,42H2,1H3,(H,43,47)(H,44,46)(H,45,48)/t37-,38+/m0/s1	IHQOKEGBCZMVLO-QPPIDDCLSA-N	200066	US9234000, 57	Plasma kallikrein			 10000							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200066	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200066&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			122199206	318589895							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355834	CCOc1ccc(C[C@@H](NC(=O)c2ccc(Cl)cc2Cl)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C35H36Cl2N4O4/c1-2-45-28-15-12-24(13-16-28)19-32(40-33(42)29-17-14-27(36)20-30(29)37)35(44)41-31(18-23-6-4-3-5-7-23)34(43)39-22-26-10-8-25(21-38)9-11-26/h3-17,20,31-32H,2,18-19,21-22,38H2,1H3,(H,39,43)(H,40,42)(H,41,44)/t31-,32+/m0/s1	NXZSBRDPYXWYMY-AJQTZOPKSA-N	200067	US9234000, 58	Plasma kallikrein			 170							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200067	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200067&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185771	318589896							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355835	CCOc1ccc(C[C@@H](NC(=O)c2ccc(F)c(F)c2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C35H36F2N4O4/c1-2-45-28-15-12-24(13-16-28)19-32(40-33(42)27-14-17-29(36)30(37)20-27)35(44)41-31(18-23-6-4-3-5-7-23)34(43)39-22-26-10-8-25(21-38)9-11-26/h3-17,20,31-32H,2,18-19,21-22,38H2,1H3,(H,39,43)(H,40,42)(H,41,44)/t31-,32+/m0/s1	QWEGEWLFUNVAFH-AJQTZOPKSA-N	200068	US9234000, 59	Plasma kallikrein			 78							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200068	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200068&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185746	318589897							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355836	CCOc1ccc(C[C@@H](N)C(=O)N[C@H]([C@@H](O)c2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C28H34N4O4/c1-2-36-23-14-12-19(13-15-23)16-24(30)27(34)32-25(26(33)22-6-4-3-5-7-22)28(35)31-18-21-10-8-20(17-29)9-11-21/h3-15,24-26,33H,2,16-18,29-30H2,1H3,(H,31,35)(H,32,34)/t24-,25-,26+/m1/s1	PHBWBJVPZUGFDM-CYXNTTPDSA-N	200069	US9234000, 60	Plasma kallikrein			 10000							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200069	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200069&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185766	318589898							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355837	CCOc1ccc(C[C@@H](N)C(=O)N[C@@H]([C@@H](O)c2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C28H34N4O4/c1-2-36-23-14-12-19(13-15-23)16-24(30)27(34)32-25(26(33)22-6-4-3-5-7-22)28(35)31-18-21-10-8-20(17-29)9-11-21/h3-15,24-26,33H,2,16-18,29-30H2,1H3,(H,31,35)(H,32,34)/t24-,25+,26+/m1/s1	PHBWBJVPZUGFDM-ZNZIZOMTSA-N	200070	US9234000, 61	Plasma kallikrein			 220							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200070	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200070&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71187198	318589899							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355838	CCOc1ccc(CC(=O)CNN([C@H]([C@@H](O)c2ccccc2)C(=O)NCc2ccc(CN)cc2)C(=O)CC)cc1	InChI=1S/C31H38N4O5/c1-3-28(37)35(34-21-26(36)18-22-14-16-27(17-15-22)40-4-2)29(30(38)25-8-6-5-7-9-25)31(39)33-20-24-12-10-23(19-32)11-13-24/h5-17,29-30,34,38H,3-4,18-21,32H2,1-2H3,(H,33,39)/t29-,30+/m1/s1	BSPQPRZBRYQAEB-IHLOFXLRSA-N	200071	US9234000, 62	Plasma kallikrein			 10000							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200071	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200071&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185712	318589900							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355839	CCOc1ccc(CC(=O)CNN([C@@H]([C@@H](O)c2ccccc2)C(=O)NCc2ccc(CN)cc2)C(=O)CC)cc1	InChI=1S/C31H38N4O5/c1-3-28(37)35(34-21-26(36)18-22-14-16-27(17-15-22)40-4-2)29(30(38)25-8-6-5-7-9-25)31(39)33-20-24-12-10-23(19-32)11-13-24/h5-17,29-30,34,38H,3-4,18-21,32H2,1-2H3,(H,33,39)/t29-,30-/m0/s1	BSPQPRZBRYQAEB-KYJUHHDHSA-N	200072	US9234000, 63	Plasma kallikrein			 52							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200072	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200072&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185613	318589901							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355840	CCOc1ccc(CC(=O)CNCCC(=O)N(CC)[C@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C33H42N4O4/c1-3-37(32(39)18-19-35-24-29(38)20-26-14-16-30(17-15-26)41-4-2)31(21-25-8-6-5-7-9-25)33(40)36-23-28-12-10-27(22-34)11-13-28/h5-17,31,35H,3-4,18-24,34H2,1-2H3,(H,36,40)/t31-/m1/s1	RSCJURCKNJMFSM-WJOKGBTCSA-N	200073	US9234000, 64	Plasma kallikrein			 3400							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200073	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200073&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185627	318589902							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355841	CCOc1ccc(CC(=O)CNCCC(=O)N(CC)[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C33H42N4O4/c1-3-37(32(39)18-19-35-24-29(38)20-26-14-16-30(17-15-26)41-4-2)31(21-25-8-6-5-7-9-25)33(40)36-23-28-12-10-27(22-34)11-13-28/h5-17,31,35H,3-4,18-24,34H2,1-2H3,(H,36,40)/t31-/m0/s1	RSCJURCKNJMFSM-HKBQPEDESA-N	200074	US9234000, 65	Plasma kallikrein			 10000							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200074	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200074&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185720	318589903							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355842	CCOc1ccc(C[C@H](N(C)C(=O)CC)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C32H40N4O4/c1-4-30(37)36(3)29(20-24-15-17-27(18-16-24)40-5-2)32(39)35-28(19-23-9-7-6-8-10-23)31(38)34-22-26-13-11-25(21-33)12-14-26/h6-18,28-29H,4-5,19-22,33H2,1-3H3,(H,34,38)(H,35,39)/t28-,29-/m0/s1	VCUKNDNIFAKRDT-VMPREFPWSA-N	200075	US9234000, 66	Plasma kallikrein			 10000							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200075	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200075&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185787	318589904							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355843	CCOc1ccc(C[C@@H](NC(=O)CC)C(=O)N2CC[C@@H]([C@H]2C(=O)NCc2ccc(CN)cc2)c2ccccc2)cc1	InChI=1S/C33H40N4O4/c1-3-30(38)36-29(20-23-14-16-27(17-15-23)41-4-2)33(40)37-19-18-28(26-8-6-5-7-9-26)31(37)32(39)35-22-25-12-10-24(21-34)11-13-25/h5-17,28-29,31H,3-4,18-22,34H2,1-2H3,(H,35,39)(H,36,38)/t28-,29-,31+/m1/s1	RBKLUGLZBDESOH-XQKNLLDYSA-N	200076	US9234000, 67	Plasma kallikrein			 1600							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200076	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200076&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90306458	318589905							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355844	CCOc1ccc(C[C@@H](NC(=O)NCc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C36H41N5O4/c1-2-45-31-19-17-27(18-20-31)22-33(41-36(44)39-25-29-11-7-4-8-12-29)35(43)40-32(21-26-9-5-3-6-10-26)34(42)38-24-30-15-13-28(23-37)14-16-30/h3-20,32-33H,2,21-25,37H2,1H3,(H,38,42)(H,40,43)(H2,39,41,44)/t32-,33+/m0/s1	HUDMDOPCYOIBRF-JHOUSYSJSA-N	200077	US9234000, 68	Plasma kallikrein			 861							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200077	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200077&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71186043	318589906							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355845	CCOc1ccc(C[C@@H](NC(=O)Nc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C35H39N5O4/c1-2-44-30-19-17-26(18-20-30)22-32(40-35(43)38-29-11-7-4-8-12-29)34(42)39-31(21-25-9-5-3-6-10-25)33(41)37-24-28-15-13-27(23-36)14-16-28/h3-20,31-32H,2,21-24,36H2,1H3,(H,37,41)(H,39,42)(H2,38,40,43)/t31-,32+/m0/s1	ZYYGRTWFLBZSQX-AJQTZOPKSA-N	200078	US9234000, 69	Plasma kallikrein			 621							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200078	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200078&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185798	318589907							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355846	CCOc1ccc(C[C@@H](NC(=O)c2cccnc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C34H37N5O4/c1-2-43-29-16-14-25(15-17-29)20-31(38-32(40)28-9-6-18-36-23-28)34(42)39-30(19-24-7-4-3-5-8-24)33(41)37-22-27-12-10-26(21-35)11-13-27/h3-18,23,30-31H,2,19-22,35H2,1H3,(H,37,41)(H,38,40)(H,39,42)/t30-,31+/m0/s1	NBUOOLFOHRYQNL-IOWSJCHKSA-N	200079	US9234000, 70	Plasma kallikrein			 126							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200079	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200079&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185653	318589908							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355847	CCOc1ccc(C[C@@H](NC(=O)c2ccncc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C34H37N5O4/c1-2-43-29-14-12-25(13-15-29)21-31(38-32(40)28-16-18-36-19-17-28)34(42)39-30(20-24-6-4-3-5-7-24)33(41)37-23-27-10-8-26(22-35)9-11-27/h3-19,30-31H,2,20-23,35H2,1H3,(H,37,41)(H,38,40)(H,39,42)/t30-,31+/m0/s1	KUPKLNUHJXRSMI-IOWSJCHKSA-N	200080	US9234000, 71	Plasma kallikrein			 77							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200080	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200080&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71186147	318589909							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355848	CCOc1ccc(C[C@@H](NC(=O)c2ccsc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C33H36N4O4S/c1-2-41-28-14-12-24(13-15-28)19-30(36-31(38)27-16-17-42-22-27)33(40)37-29(18-23-6-4-3-5-7-23)32(39)35-21-26-10-8-25(20-34)9-11-26/h3-17,22,29-30H,2,18-21,34H2,1H3,(H,35,39)(H,36,38)(H,37,40)/t29-,30+/m0/s1	GCFLQXXLUPHFNT-XZWHSSHBSA-N	200081	US9234000, 72	Plasma kallikrein			 46							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200081	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200081&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185793	318589910							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355849	CCOc1ccc(C[C@@H](NC(=O)c2cccs2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C33H36N4O4S/c1-2-41-27-16-14-24(15-17-27)20-29(37-33(40)30-9-6-18-42-30)32(39)36-28(19-23-7-4-3-5-8-23)31(38)35-22-26-12-10-25(21-34)11-13-26/h3-18,28-29H,2,19-22,34H2,1H3,(H,35,38)(H,36,39)(H,37,40)/t28-,29+/m0/s1	DICZPEIYHIDRDH-URLMMPGGSA-N	200082	US9234000, 73	Plasma kallikrein			 25							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200082	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200082&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71499165	318589911							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355850	CCOc1ccc(C[C@@H](NC(=O)C2CC2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C32H38N4O4/c1-2-40-27-16-12-23(13-17-27)19-29(35-30(37)26-14-15-26)32(39)36-28(18-22-6-4-3-5-7-22)31(38)34-21-25-10-8-24(20-33)9-11-25/h3-13,16-17,26,28-29H,2,14-15,18-21,33H2,1H3,(H,34,38)(H,35,37)(H,36,39)/t28-,29+/m0/s1	DQVRDTGGMOXTHF-URLMMPGGSA-N	200083	US9234000, 74	Plasma kallikrein			 545							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200083	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200083&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			122199207	318589912							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355851	CCOc1ccc(C[C@@H](NC(=O)C2CCCCC2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C35H44N4O4/c1-2-43-30-19-17-26(18-20-30)22-32(38-33(40)29-11-7-4-8-12-29)35(42)39-31(21-25-9-5-3-6-10-25)34(41)37-24-28-15-13-27(23-36)14-16-28/h3,5-6,9-10,13-20,29,31-32H,2,4,7-8,11-12,21-24,36H2,1H3,(H,37,41)(H,38,40)(H,39,42)/t31-,32+/m0/s1	ZBMHBTNVTBWRGV-AJQTZOPKSA-N	200084	US9234000, 75	Plasma kallikrein			 270							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200084	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200084&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71499166	318589913							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355852	CCCCCC(=O)N[C@H](Cc1ccc(OCC)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1	InChI=1S/C34H44N4O4/c1-3-5-7-12-32(39)37-31(22-26-17-19-29(20-18-26)42-4-2)34(41)38-30(21-25-10-8-6-9-11-25)33(40)36-24-28-15-13-27(23-35)14-16-28/h6,8-11,13-20,30-31H,3-5,7,12,21-24,35H2,1-2H3,(H,36,40)(H,37,39)(H,38,41)/t30-,31+/m0/s1	YWYFEVDIUZIFCH-IOWSJCHKSA-N	200085	US9234000, 76	Plasma kallikrein			 452							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200085	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200085&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			122199208	318589914							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355853	CCOc1ccc(C[C@@H](NC(=O)NC(C)C)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C32H41N5O4/c1-4-41-27-16-14-24(15-17-27)19-29(37-32(40)35-22(2)3)31(39)36-28(18-23-8-6-5-7-9-23)30(38)34-21-26-12-10-25(20-33)11-13-26/h5-17,22,28-29H,4,18-21,33H2,1-3H3,(H,34,38)(H,36,39)(H2,35,37,40)/t28-,29+/m0/s1	SXAOLDSQZYCDDQ-URLMMPGGSA-N	200086	US9234000, 77	Plasma kallikrein			 1959							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200086	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200086&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71186101	318589915							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355854	CCCCCCNC(=O)N[C@H](Cc1ccc(OCC)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1	InChI=1S/C35H47N5O4/c1-3-5-6-10-21-37-35(43)40-32(23-27-17-19-30(20-18-27)44-4-2)34(42)39-31(22-26-11-8-7-9-12-26)33(41)38-25-29-15-13-28(24-36)14-16-29/h7-9,11-20,31-32H,3-6,10,21-25,36H2,1-2H3,(H,38,41)(H,39,42)(H2,37,40,43)/t31-,32+/m0/s1	KRKRLMQLCYJAFZ-AJQTZOPKSA-N	200087	US9234000, 78	Plasma kallikrein			 10000							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200087	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200087&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71186011	318589916							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355855	CCOc1ccc(C[C@@H](NC(=O)c2ccno2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C32H35N5O5/c1-2-41-26-14-12-23(13-15-26)19-28(37-32(40)29-16-17-35-42-29)31(39)36-27(18-22-6-4-3-5-7-22)30(38)34-21-25-10-8-24(20-33)9-11-25/h3-17,27-28H,2,18-21,33H2,1H3,(H,34,38)(H,36,39)(H,37,40)/t27-,28+/m0/s1	FLWSQHNEOSDTLW-WUFINQPMSA-N	200088	US9234000, 79	Plasma kallikrein			 38							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200088	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200088&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71499167	318589917							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355856	CCOc1ccc(C[C@@H](NC(=O)c2ccc(OC(F)(F)F)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C36H37F3N4O5/c1-2-47-29-16-12-25(13-17-29)21-32(42-33(44)28-14-18-30(19-15-28)48-36(37,38)39)35(46)43-31(20-24-6-4-3-5-7-24)34(45)41-23-27-10-8-26(22-40)9-11-27/h3-19,31-32H,2,20-23,40H2,1H3,(H,41,45)(H,42,44)(H,43,46)/t31-,32+/m0/s1	DNNSVHAVKIOBSA-AJQTZOPKSA-N	200089	US9234000, 80	Plasma kallikrein			 398							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200089	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200089&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185541	318589918							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355857	CCOc1ccc(C[C@@H](NC(=O)c2ccccn2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C34H37N5O4/c1-2-43-28-17-15-25(16-18-28)21-31(39-33(41)29-10-6-7-19-36-29)34(42)38-30(20-24-8-4-3-5-9-24)32(40)37-23-27-13-11-26(22-35)12-14-27/h3-19,30-31H,2,20-23,35H2,1H3,(H,37,40)(H,38,42)(H,39,41)/t30-,31+/m0/s1	LOIWWQRBLCDGHA-IOWSJCHKSA-N	200090	US9234000, 81	Plasma kallikrein			 40							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200090	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200090&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71499172	318589919							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355858	CCOc1ccc(C[C@@H](NC(=O)c2cc(C)nn2C)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C34H40N6O4/c1-4-44-28-16-14-25(15-17-28)20-30(38-34(43)31-18-23(2)39-40(31)3)33(42)37-29(19-24-8-6-5-7-9-24)32(41)36-22-27-12-10-26(21-35)11-13-27/h5-18,29-30H,4,19-22,35H2,1-3H3,(H,36,41)(H,37,42)(H,38,43)/t29-,30+/m0/s1	SGTZLYYWDILAOO-XZWHSSHBSA-N	200091	US9234000, 82	Plasma kallikrein			 539							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200091	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200091&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			122199209	318589920							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355859	CCOc1ccc(C[C@@H](NC(=O)c2cc3ccccc3s2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C37H38N4O4S/c1-2-45-30-18-16-26(17-19-30)21-32(41-37(44)34-22-29-10-6-7-11-33(29)46-34)36(43)40-31(20-25-8-4-3-5-9-25)35(42)39-24-28-14-12-27(23-38)13-15-28/h3-19,22,31-32H,2,20-21,23-24,38H2,1H3,(H,39,42)(H,40,43)(H,41,44)/t31-,32+/m0/s1	OEGGOURQVSOADE-AJQTZOPKSA-N	200092	US9234000, 83	Plasma kallikrein			 254							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200092	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200092&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185907	318589921							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355860	CCOc1ccc(C[C@@H](NS(=O)(=O)c2ccc(Cl)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C34H37ClN4O5S/c1-2-44-29-16-12-25(13-17-29)21-32(39-45(42,43)30-18-14-28(35)15-19-30)34(41)38-31(20-24-6-4-3-5-7-24)33(40)37-23-27-10-8-26(22-36)9-11-27/h3-19,31-32,39H,2,20-23,36H2,1H3,(H,37,40)(H,38,41)/t31-,32+/m0/s1	ACETVQBBGBLDQG-AJQTZOPKSA-N	200093	US9234000, 84	Plasma kallikrein			 219							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200093	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200093&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185886	318589922							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355861	CCOc1ccc(cc1)[C@H](C(=O)NCCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1)c1ccccc1	InChI=1S/C36H40N4O4/c1-2-44-31-19-17-30(18-20-31)34(29-11-7-4-8-12-29)36(43)38-22-21-33(41)40-32(23-26-9-5-3-6-10-26)35(42)39-25-28-15-13-27(24-37)14-16-28/h3-20,32,34H,2,21-25,37H2,1H3,(H,38,43)(H,39,42)(H,40,41)/t32-,34+/m0/s1	SWVKHIKGEAHJDC-UZNNEEJFSA-N	200094	US9234000, 85	Plasma kallikrein			 485							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200094	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200094&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			122199210	318589923							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355862	CCOc1ccc(C[C@@H](NC(=O)CCc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C37H42N4O4/c1-2-45-32-20-17-29(18-21-32)24-34(40-35(42)22-19-27-9-5-3-6-10-27)37(44)41-33(23-28-11-7-4-8-12-28)36(43)39-26-31-15-13-30(25-38)14-16-31/h3-18,20-21,33-34H,2,19,22-26,38H2,1H3,(H,39,43)(H,40,42)(H,41,44)/t33-,34+/m0/s1	CQYKVCYPAHTPER-SZAHLOSFSA-N	200095	US9234000, 86	Plasma kallikrein			 423							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200095	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200095&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71186092	318589924							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355863	CCOc1ccc(C[C@@H](NC(=O)CCCc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C38H44N4O4/c1-2-46-33-22-20-30(21-23-33)25-35(41-36(43)15-9-14-28-10-5-3-6-11-28)38(45)42-34(24-29-12-7-4-8-13-29)37(44)40-27-32-18-16-31(26-39)17-19-32/h3-8,10-13,16-23,34-35H,2,9,14-15,24-27,39H2,1H3,(H,40,44)(H,41,43)(H,42,45)/t34-,35+/m0/s1	SOQHHEZZSQAXRS-OIDHKYIRSA-N	200096	US9234000, 87	Plasma kallikrein			 755							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200096	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200096&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185839	318589925							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355864	CCOc1ccc(C[C@@H](NC(=O)c2cccc(Cl)c2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C35H37ClN4O4/c1-2-44-30-17-15-25(16-18-30)20-32(39-33(41)28-9-6-10-29(36)21-28)35(43)40-31(19-24-7-4-3-5-8-24)34(42)38-23-27-13-11-26(22-37)12-14-27/h3-18,21,31-32H,2,19-20,22-23,37H2,1H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1	SGUFCVJNEPZKMW-AJQTZOPKSA-N	200097	US9234000, 88	Plasma kallikrein			 90							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200097	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200097&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185964	318589926							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355865	CCOc1ccc(C[C@@H](NC(=O)c2ccccc2Cl)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C35H37ClN4O4/c1-2-44-28-18-16-25(17-19-28)21-32(39-33(41)29-10-6-7-11-30(29)36)35(43)40-31(20-24-8-4-3-5-9-24)34(42)38-23-27-14-12-26(22-37)13-15-27/h3-19,31-32H,2,20-23,37H2,1H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1	ZJPROBBYIUYLCH-AJQTZOPKSA-N	200098	US9234000, 89	Plasma kallikrein			 99							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200098	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200098&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185775	318589927							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355866	CCOc1ccc(C[C@@H](NC(=O)c2cccc(c2)C(F)(F)F)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C36H37F3N4O4/c1-2-47-30-17-15-25(16-18-30)20-32(42-33(44)28-9-6-10-29(21-28)36(37,38)39)35(46)43-31(19-24-7-4-3-5-8-24)34(45)41-23-27-13-11-26(22-40)12-14-27/h3-18,21,31-32H,2,19-20,22-23,40H2,1H3,(H,41,45)(H,42,44)(H,43,46)/t31-,32+/m0/s1	TYGDGTFXXYUGSN-AJQTZOPKSA-N	200099	US9234000, 90::US9234000, 91	Plasma kallikrein			 276							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200099	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200099&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185601	318589928							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355867	CCOc1ccc(C[C@@H](NC(=O)C23CC4CC(CC(C4)C2)C3)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C39H48N4O4/c1-2-47-33-14-12-27(13-15-33)20-35(43-38(46)39-21-30-16-31(22-39)18-32(17-30)23-39)37(45)42-34(19-26-6-4-3-5-7-26)36(44)41-25-29-10-8-28(24-40)9-11-29/h3-15,30-32,34-35H,2,16-25,40H2,1H3,(H,41,44)(H,42,45)(H,43,46)/t30?,31?,32?,34-,35+,39?/m0/s1	XNXBICLEPKJLOV-VLRPPYJTSA-N	60914	US9234000, 91	Plasma kallikrein			 2083							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=60914	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=60914&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			122362656	319494464						ZINC15952940	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355868	CCOc1ccc(C[C@@H](NC(=O)c2ccc(C)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C36H40N4O4/c1-3-44-31-19-15-27(16-20-31)22-33(39-34(41)30-17-9-25(2)10-18-30)36(43)40-32(21-26-7-5-4-6-8-26)35(42)38-24-29-13-11-28(23-37)12-14-29/h4-20,32-33H,3,21-24,37H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t32-,33+/m0/s1	PQYXYUJVSKCKFL-JHOUSYSJSA-N	200101	US9234000, 92	Plasma kallikrein			 32							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200101	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200101&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185979	318589929							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355869	CCOc1ccc(C[C@@H](NC(=O)c2ccc(Cl)c(Cl)c2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C35H36Cl2N4O4/c1-2-45-28-15-12-24(13-16-28)19-32(40-33(42)27-14-17-29(36)30(37)20-27)35(44)41-31(18-23-6-4-3-5-7-23)34(43)39-22-26-10-8-25(21-38)9-11-26/h3-17,20,31-32H,2,18-19,21-22,38H2,1H3,(H,39,43)(H,40,42)(H,41,44)/t31-,32+/m0/s1	MOIZOCHEDGLANE-AJQTZOPKSA-N	200102	US9234000, 93	Plasma kallikrein			 175							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200102	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200102&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185695	318589930							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355870	CCOc1ccc(C[C@@H](NC(=O)c2cc(Cl)cc(Cl)c2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C35H36Cl2N4O4/c1-2-45-30-14-12-24(13-15-30)17-32(40-33(42)27-18-28(36)20-29(37)19-27)35(44)41-31(16-23-6-4-3-5-7-23)34(43)39-22-26-10-8-25(21-38)9-11-26/h3-15,18-20,31-32H,2,16-17,21-22,38H2,1H3,(H,39,43)(H,40,42)(H,41,44)/t31-,32+/m0/s1	SLIWSHXFSMCYGU-AJQTZOPKSA-N	200103	US9234000, 94	Plasma kallikrein			 1080							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200103	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200103&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90302844	318589931							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355871	CCOc1ccc(C[C@@H](NC(=O)c2ccc(OC)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C36H40N4O5/c1-3-45-31-17-13-26(14-18-31)22-33(39-34(41)29-15-19-30(44-2)20-16-29)36(43)40-32(21-25-7-5-4-6-8-25)35(42)38-24-28-11-9-27(23-37)10-12-28/h4-20,32-33H,3,21-24,37H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t32-,33+/m0/s1	HODNEEJOSRVWQT-JHOUSYSJSA-N	200104	US9234000, 95	Plasma kallikrein			 46							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200104	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200104&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185996	318589932							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355872	CCOc1ccc(C[C@@H](NC(=O)\C=C\c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C37H40N4O4/c1-2-45-32-20-17-29(18-21-32)24-34(40-35(42)22-19-27-9-5-3-6-10-27)37(44)41-33(23-28-11-7-4-8-12-28)36(43)39-26-31-15-13-30(25-38)14-16-31/h3-22,33-34H,2,23-26,38H2,1H3,(H,39,43)(H,40,42)(H,41,44)/b22-19+/t33-,34+/m0/s1	CQESEBINUPDTGP-FCVYXQAUSA-N	200105	US9234000, 96	Plasma kallikrein			 764							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200105	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200105&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			89350829	318589933							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355873	CCOc1ccc(C[C@@H](N(NC(=O)Cc2ccccc2)C(C)=O)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C38H43N5O5/c1-3-48-33-20-18-30(19-21-33)23-35(43(27(2)44)42-36(45)24-29-12-8-5-9-13-29)38(47)41-34(22-28-10-6-4-7-11-28)37(46)40-26-32-16-14-31(25-39)15-17-32/h4-21,34-35H,3,22-26,39H2,1-2H3,(H,40,46)(H,41,47)(H,42,45)/t34-,35+/m0/s1	KNHURXIHYWTCFE-OIDHKYIRSA-N	200106	US9234000, 97	Plasma kallikrein			 241							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200106	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200106&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185507	318589934							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355874	CCOc1ccc(C[C@@H](NC(=O)CNC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C37H41N5O5/c1-2-47-31-19-17-27(18-20-31)22-33(41-34(43)25-40-35(44)30-11-7-4-8-12-30)37(46)42-32(21-26-9-5-3-6-10-26)36(45)39-24-29-15-13-28(23-38)14-16-29/h3-20,32-33H,2,21-25,38H2,1H3,(H,39,45)(H,40,44)(H,41,43)(H,42,46)/t32-,33+/m0/s1	TZECEBPYZPAKRE-JHOUSYSJSA-N	200107	US9234000, 98	Plasma kallikrein			 576							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200107	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200107&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71186105	318589935							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355875	CCOc1ccc(C[C@@H](NC(=O)c2ccc(F)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C35H37FN4O4/c1-2-44-30-18-12-25(13-19-30)21-32(39-33(41)28-14-16-29(36)17-15-28)35(43)40-31(20-24-6-4-3-5-7-24)34(42)38-23-27-10-8-26(22-37)9-11-27/h3-19,31-32H,2,20-23,37H2,1H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1	HAVAYEXOBKJLDE-AJQTZOPKSA-N	200108	US9234000, 99	Plasma kallikrein			 95							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200108	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200108&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185850	318589936							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355876	CCOc1ccc(C[C@@H](NS(=O)(=O)Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C35H40N4O5S/c1-2-44-31-19-17-27(18-20-31)22-33(39-45(42,43)25-30-11-7-4-8-12-30)35(41)38-32(21-26-9-5-3-6-10-26)34(40)37-24-29-15-13-28(23-36)14-16-29/h3-20,32-33,39H,2,21-25,36H2,1H3,(H,37,40)(H,38,41)/t32-,33+/m0/s1	HUGJQCPQXGEXGY-JHOUSYSJSA-N	200109	US9234000, 100	Plasma kallikrein			 474							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200109	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200109&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71186063	318589937							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355877	CCOc1ccc(C[C@@H](NC(=O)CNS(=O)(=O)c2ccc(C)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C37H43N5O6S/c1-3-48-31-17-15-28(16-18-31)22-34(41-35(43)25-40-49(46,47)32-19-9-26(2)10-20-32)37(45)42-33(21-27-7-5-4-6-8-27)36(44)39-24-30-13-11-29(23-38)12-14-30/h4-20,33-34,40H,3,21-25,38H2,1-2H3,(H,39,44)(H,41,43)(H,42,45)/t33-,34+/m0/s1	CFJPNXPRDSFZJB-SZAHLOSFSA-N	200110	US9234000, 101	Plasma kallikrein			 1113							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200110	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200110&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185485	318589938							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355878	CCOc1ccc(C[C@@H](NC(=O)Nc2ccc(Cl)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C35H38ClN5O4/c1-2-45-30-18-12-25(13-19-30)21-32(41-35(44)39-29-16-14-28(36)15-17-29)34(43)40-31(20-24-6-4-3-5-7-24)33(42)38-23-27-10-8-26(22-37)9-11-27/h3-19,31-32H,2,20-23,37H2,1H3,(H,38,42)(H,40,43)(H2,39,41,44)/t31-,32+/m0/s1	ZXWPCHGBHJMEBT-AJQTZOPKSA-N	200111	US9234000, 102	Plasma kallikrein			 10000							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200111	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200111&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185801	318589939							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355879	CCOc1ccc(C[C@@H](NC(=O)N(CC)Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C38H45N5O4/c1-3-43(27-32-13-9-6-10-14-32)38(46)42-35(24-29-19-21-33(22-20-29)47-4-2)37(45)41-34(23-28-11-7-5-8-12-28)36(44)40-26-31-17-15-30(25-39)16-18-31/h5-22,34-35H,3-4,23-27,39H2,1-2H3,(H,40,44)(H,41,45)(H,42,46)/t34-,35+/m0/s1	YNTCROSKIQJMBI-OIDHKYIRSA-N	200112	US9234000, 103	Plasma kallikrein			 10000							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200112	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200112&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185811	318589940							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355880	CCOc1ccc(C[C@@H](NC(=O)c2ccc(C)nc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C35H39N5O4/c1-3-44-30-17-14-26(15-18-30)20-32(39-33(41)29-16-9-24(2)37-23-29)35(43)40-31(19-25-7-5-4-6-8-25)34(42)38-22-28-12-10-27(21-36)11-13-28/h4-18,23,31-32H,3,19-22,36H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1	AWZDEIQJFXSYJV-AJQTZOPKSA-N	200113	US9234000, 104	Plasma kallikrein			 159							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200113	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200113&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185969	318589941							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355881	CCOc1ccc(C[C@@H](NC(=O)c2cccnc2C)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C35H39N5O4/c1-3-44-29-17-15-26(16-18-29)21-32(39-33(41)30-10-7-19-37-24(30)2)35(43)40-31(20-25-8-5-4-6-9-25)34(42)38-23-28-13-11-27(22-36)12-14-28/h4-19,31-32H,3,20-23,36H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1	ALBLURFVONFERJ-AJQTZOPKSA-N	200114	US9234000, 105	Plasma kallikrein			 185							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200114	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200114&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185978	318589942							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355882	CCOc1ccc(C[C@@H](NC(=O)c2ccc(Cl)nc2Cl)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C34H35Cl2N5O4/c1-2-45-26-14-12-23(13-15-26)19-29(39-32(42)27-16-17-30(35)41-31(27)36)34(44)40-28(18-22-6-4-3-5-7-22)33(43)38-21-25-10-8-24(20-37)9-11-25/h3-17,28-29H,2,18-21,37H2,1H3,(H,38,43)(H,39,42)(H,40,44)/t28-,29+/m0/s1	QQYJHIVCRMOELR-URLMMPGGSA-N	200115	US9234000, 106	Plasma kallikrein			 256							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200115	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200115&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71499475	318589943							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355883	CCOc1ccc(C[C@@H](NC(=O)c2cnc(Cl)c(Cl)c2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C34H35Cl2N5O4/c1-2-45-27-14-12-23(13-15-27)17-30(40-32(42)26-18-28(35)31(36)38-21-26)34(44)41-29(16-22-6-4-3-5-7-22)33(43)39-20-25-10-8-24(19-37)9-11-25/h3-15,18,21,29-30H,2,16-17,19-20,37H2,1H3,(H,39,43)(H,40,42)(H,41,44)/t29-,30+/m0/s1	XKUREAYXZXNALY-XZWHSSHBSA-N	200116	US9234000, 107	Plasma kallikrein			 133							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200116	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200116&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71499184	318589944							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355884	CCOc1ccc(C[C@@H](NC(=O)c2cc(F)nc(F)c2F)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C34H34F3N5O4/c1-2-46-25-14-12-22(13-15-25)17-28(40-32(43)26-18-29(35)42-31(37)30(26)36)34(45)41-27(16-21-6-4-3-5-7-21)33(44)39-20-24-10-8-23(19-38)9-11-24/h3-15,18,27-28H,2,16-17,19-20,38H2,1H3,(H,39,44)(H,40,43)(H,41,45)/t27-,28+/m0/s1	DCOSMQNHYNPFQB-WUFINQPMSA-N	200117	US9234000, 108	Plasma kallikrein			 232							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200117	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200117&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185751	318589945							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355885	CCOc1ccc(C[C@@H](NC(=O)CC(F)(F)F)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C31H35F3N4O4/c1-2-42-25-14-12-22(13-15-25)17-27(37-28(39)18-31(32,33)34)30(41)38-26(16-21-6-4-3-5-7-21)29(40)36-20-24-10-8-23(19-35)9-11-24/h3-15,26-27H,2,16-20,35H2,1H3,(H,36,40)(H,37,39)(H,38,41)/t26-,27+/m0/s1	DBUIROVIMOGHBT-RRPNLBNLSA-N	200118	US9234000, 109	Plasma kallikrein			 155							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200118	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200118&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185989	318589946							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355886	CCOc1ccc(C[C@@H](NC(=O)c2cc(C)nc(Cl)c2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C35H38ClN5O4/c1-3-45-29-15-13-25(14-16-29)19-31(40-33(42)28-17-23(2)39-32(36)20-28)35(44)41-30(18-24-7-5-4-6-8-24)34(43)38-22-27-11-9-26(21-37)10-12-27/h4-17,20,30-31H,3,18-19,21-22,37H2,1-2H3,(H,38,43)(H,40,42)(H,41,44)/t30-,31+/m0/s1	ZAYPOTLKQDKQAV-IOWSJCHKSA-N	200119	US9234000, 110	Plasma kallikrein			 598							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200119	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200119&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			89350754	318589947							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355887	CCOc1ccc(C[C@@H](NC(=O)c2sc(C)nc2C)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C34H39N5O4S/c1-4-43-28-16-14-25(15-17-28)19-30(39-34(42)31-22(2)37-23(3)44-31)33(41)38-29(18-24-8-6-5-7-9-24)32(40)36-21-27-12-10-26(20-35)11-13-27/h5-17,29-30H,4,18-21,35H2,1-3H3,(H,36,40)(H,38,41)(H,39,42)/t29-,30+/m0/s1	WBCSMOPGOQKPQY-XZWHSSHBSA-N	200120	US9234000, 111	Plasma kallikrein			 58							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200120	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200120&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71499173	318589948							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355888	CCOc1ccc(C[C@@H](NC(=O)c2cnc(C)s2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C33H37N5O4S/c1-3-42-27-15-13-24(14-16-27)18-29(38-33(41)30-21-35-22(2)43-30)32(40)37-28(17-23-7-5-4-6-8-23)31(39)36-20-26-11-9-25(19-34)10-12-26/h4-16,21,28-29H,3,17-20,34H2,1-2H3,(H,36,39)(H,37,40)(H,38,41)/t28-,29+/m0/s1	DQAPTUCUKSNJTQ-URLMMPGGSA-N	200121	US9234000, 112	Plasma kallikrein			 298							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200121	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200121&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71499183	318589949							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355889	CCOc1ccc(C[C@@H](NC(=O)c2nc(C)oc2C)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C34H39N5O5/c1-4-43-28-16-14-25(15-17-28)19-30(39-34(42)31-22(2)44-23(3)37-31)33(41)38-29(18-24-8-6-5-7-9-24)32(40)36-21-27-12-10-26(20-35)11-13-27/h5-17,29-30H,4,18-21,35H2,1-3H3,(H,36,40)(H,38,41)(H,39,42)/t29-,30+/m0/s1	NHVBFYCADPVHQX-XZWHSSHBSA-N	200122	US9234000, 113	Plasma kallikrein			 455							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200122	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200122&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			122199211	318589950							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355890	CCOc1ccc(C[C@@H](NC(=O)c2ccc3nc(C)ccc3c2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C39H41N5O4/c1-3-48-33-18-14-28(15-19-33)22-36(43-37(45)32-17-20-34-31(23-32)16-9-26(2)42-34)39(47)44-35(21-27-7-5-4-6-8-27)38(46)41-25-30-12-10-29(24-40)11-13-30/h4-20,23,35-36H,3,21-22,24-25,40H2,1-2H3,(H,41,46)(H,43,45)(H,44,47)/t35-,36+/m0/s1	WBYJFERZJIJQIQ-MPQUPPDSSA-N	200123	US9234000, 114	Plasma kallikrein			 427							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200123	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200123&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			122199212	318589951							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355891	CCOc1ccc(C[C@@H](NC(=O)c2cnc3cc(Cl)ccc3c2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C38H38ClN5O4/c1-2-48-32-16-12-26(13-17-32)19-35(43-36(45)30-20-29-14-15-31(39)21-33(29)41-24-30)38(47)44-34(18-25-6-4-3-5-7-25)37(46)42-23-28-10-8-27(22-40)9-11-28/h3-17,20-21,24,34-35H,2,18-19,22-23,40H2,1H3,(H,42,46)(H,43,45)(H,44,47)/t34-,35+/m0/s1	GRBCXZQPXFWSKI-OIDHKYIRSA-N	200124	US9234000, 115	Plasma kallikrein			 417							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200124	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200124&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			122199213	318589952							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355892	CCOc1ccc(C[C@@H](NC(=O)c2sccc2Cl)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C33H35ClN4O4S/c1-2-42-26-14-12-23(13-15-26)19-29(38-33(41)30-27(34)16-17-43-30)32(40)37-28(18-22-6-4-3-5-7-22)31(39)36-21-25-10-8-24(20-35)9-11-25/h3-17,28-29H,2,18-21,35H2,1H3,(H,36,39)(H,37,40)(H,38,41)/t28-,29+/m0/s1	PUJHQMNZVXXXHE-URLMMPGGSA-N	200125	US9234000, 116	Plasma kallikrein			 18							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200125	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200125&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71499185	318589953							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355893	CCOc1ccc(C[C@@H](NC(=O)c2scnc2C)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C33H37N5O4S/c1-3-42-27-15-13-24(14-16-27)18-29(38-33(41)30-22(2)36-21-43-30)32(40)37-28(17-23-7-5-4-6-8-23)31(39)35-20-26-11-9-25(19-34)10-12-26/h4-16,21,28-29H,3,17-20,34H2,1-2H3,(H,35,39)(H,37,40)(H,38,41)/t28-,29+/m0/s1	NKONHEXDLBKQFF-URLMMPGGSA-N	200126	US9234000, 117	Plasma kallikrein			 48							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200126	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200126&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185569	318589954							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355894	CCOc1ccc(C[C@@H](NC(=O)c2ccco2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C33H36N4O5/c1-2-41-27-16-14-24(15-17-27)20-29(37-33(40)30-9-6-18-42-30)32(39)36-28(19-23-7-4-3-5-8-23)31(38)35-22-26-12-10-25(21-34)11-13-26/h3-18,28-29H,2,19-22,34H2,1H3,(H,35,38)(H,36,39)(H,37,40)/t28-,29+/m0/s1	KXEHMWWWSGDRNZ-URLMMPGGSA-N	200127	US9234000, 118	Plasma kallikrein			 61							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200127	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200127&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71499200	318589955							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355895	CCOc1ccc(C[C@@H](NC(=O)c2sccc2C)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C34H38N4O4S/c1-3-42-28-15-13-25(14-16-28)20-30(38-34(41)31-23(2)17-18-43-31)33(40)37-29(19-24-7-5-4-6-8-24)32(39)36-22-27-11-9-26(21-35)10-12-27/h4-18,29-30H,3,19-22,35H2,1-2H3,(H,36,39)(H,37,40)(H,38,41)/t29-,30+/m0/s1	HBWHYKRQSALKFK-XZWHSSHBSA-N	200128	US9234000, 119	Plasma kallikrein			 15							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200128	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200128&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71499201	318589956							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355896	CCOc1ccc(C[C@@H](NC(=O)c2cccc(OC)n2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C35H39N5O5/c1-3-45-28-18-16-25(17-19-28)21-31(40-34(42)29-10-7-11-32(38-29)44-2)35(43)39-30(20-24-8-5-4-6-9-24)33(41)37-23-27-14-12-26(22-36)13-15-27/h4-19,30-31H,3,20-23,36H2,1-2H3,(H,37,41)(H,39,43)(H,40,42)/t30-,31+/m0/s1	QJNCCZAUPWBOQN-IOWSJCHKSA-N	200129	US9234000, 120	Plasma kallikrein			 540							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200129	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200129&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			122199214	318589957							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355897	CCOc1ccc(C[C@@H](NC(=O)c2cncc(OC)c2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C35H39N5O5/c1-3-45-29-15-13-25(14-16-29)18-32(39-33(41)28-19-30(44-2)23-37-22-28)35(43)40-31(17-24-7-5-4-6-8-24)34(42)38-21-27-11-9-26(20-36)10-12-27/h4-16,19,22-23,31-32H,3,17-18,20-21,36H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1	OGBRQNGKSNMMFK-AJQTZOPKSA-N	200130	US9234000, 121	Plasma kallikrein			 310							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200130	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200130&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71186187	318589958							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355898	CCOc1ccc(C[C@@H](NC(=O)c2sccc2OC)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C34H38N4O5S/c1-3-43-27-15-13-24(14-16-27)20-29(38-34(41)31-30(42-2)17-18-44-31)33(40)37-28(19-23-7-5-4-6-8-23)32(39)36-22-26-11-9-25(21-35)10-12-26/h4-18,28-29H,3,19-22,35H2,1-2H3,(H,36,39)(H,37,40)(H,38,41)/t28-,29+/m0/s1	WVUHHNJRARDZRJ-URLMMPGGSA-N	200131	US9234000, 122	Plasma kallikrein			 519							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200131	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200131&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			122199215	318589959							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355899	CCOc1ccc(C[C@@H](NC(=O)c2ccnc(OC)c2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C35H39N5O5/c1-3-45-29-15-13-25(14-16-29)20-31(39-33(41)28-17-18-37-32(21-28)44-2)35(43)40-30(19-24-7-5-4-6-8-24)34(42)38-23-27-11-9-26(22-36)10-12-27/h4-18,21,30-31H,3,19-20,22-23,36H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t30-,31+/m0/s1	MHNXCQNJTDJPBJ-IOWSJCHKSA-N	200132	US9234000, 123	Plasma kallikrein			 214							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200132	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200132&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185938	318589960							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355900	CCOc1ccc(C[C@@H](NC(=O)c2[nH]ccc2C)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C34H39N5O4/c1-3-43-28-15-13-25(14-16-28)20-30(39-34(42)31-23(2)17-18-36-31)33(41)38-29(19-24-7-5-4-6-8-24)32(40)37-22-27-11-9-26(21-35)10-12-27/h4-18,29-30,36H,3,19-22,35H2,1-2H3,(H,37,40)(H,38,41)(H,39,42)/t29-,30+/m0/s1	CIHUARIXQZFRDX-XZWHSSHBSA-N	200133	US9234000, 124	Plasma kallikrein			 20							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200133	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200133&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71499278	318589961							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355901	CCOc1ccc(C[C@@H](NC(=O)c2sccc2N)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C33H37N5O4S/c1-2-42-26-14-12-23(13-15-26)19-29(38-33(41)30-27(35)16-17-43-30)32(40)37-28(18-22-6-4-3-5-7-22)31(39)36-21-25-10-8-24(20-34)9-11-25/h3-17,28-29H,2,18-21,34-35H2,1H3,(H,36,39)(H,37,40)(H,38,41)/t28-,29+/m0/s1	YNMNVDUWPIIZMN-URLMMPGGSA-N	200134	US9234000, 125	Plasma kallikrein			 10							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200134	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200134&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71499277	318589962							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355902	NCc1ccc(CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](CC2CCCCC2)NC(=O)c2ccccc2)cc1	InChI=1S/C33H40N4O3/c34-22-26-16-18-27(19-17-26)23-35-32(39)29(20-24-10-4-1-5-11-24)37-33(40)30(21-25-12-6-2-7-13-25)36-31(38)28-14-8-3-9-15-28/h1,3-5,8-11,14-19,25,29-30H,2,6-7,12-13,20-23,34H2,(H,35,39)(H,36,38)(H,37,40)/t29-,30+/m0/s1	YIFIDQFIPIUXTH-XZWHSSHBSA-N	200135	US9234000, 126	Plasma kallikrein			 4013							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200135	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200135&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185486	318589963							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355903	NCc1ccc(CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)c2ccccc2)cc1	InChI=1S/C33H33ClN4O3/c34-28-17-15-24(16-18-28)20-30(37-31(39)27-9-5-2-6-10-27)33(41)38-29(19-23-7-3-1-4-8-23)32(40)36-22-26-13-11-25(21-35)12-14-26/h1-18,29-30H,19-22,35H2,(H,36,40)(H,37,39)(H,38,41)/t29-,30+/m0/s1	DFTDXVAGVUMEML-XZWHSSHBSA-N	200136	US9234000, 127	Plasma kallikrein			 521							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200136	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200136&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71186001	318589964							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355904	NCc1ccc(CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccc(OCc3ccc(Cl)cc3)cc2)NC(=O)c2ccccc2)cc1	InChI=1S/C40H39ClN4O4/c41-34-19-15-32(16-20-34)27-49-35-21-17-29(18-22-35)24-37(44-38(46)33-9-5-2-6-10-33)40(48)45-36(23-28-7-3-1-4-8-28)39(47)43-26-31-13-11-30(25-42)12-14-31/h1-22,36-37H,23-27,42H2,(H,43,47)(H,44,46)(H,45,48)/t36-,37+/m0/s1	IHLBOTCKEIVMGZ-PQQNNWGCSA-N	200137	US9234000, 128	Plasma kallikrein			 2009							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200137	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200137&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71186172	318589965							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355905	NCc1ccc(CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)c2ccccc2)cc1	InChI=1S/C33H34N4O4/c34-21-25-11-13-26(14-12-25)22-35-32(40)29(19-23-7-3-1-4-8-23)37-33(41)30(20-24-15-17-28(38)18-16-24)36-31(39)27-9-5-2-6-10-27/h1-18,29-30,38H,19-22,34H2,(H,35,40)(H,36,39)(H,37,41)/t29-,30+/m0/s1	ZDQNDZXAURUSJI-XZWHSSHBSA-N	200138	US9234000, 129	Plasma kallikrein			 10000							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200138	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200138&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185520	318589966							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355906	NCc1ccc(CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccc(OCc3ccc(F)cc3)cc2)NC(=O)c2ccccc2)cc1	InChI=1S/C40H39FN4O4/c41-34-19-15-32(16-20-34)27-49-35-21-17-29(18-22-35)24-37(44-38(46)33-9-5-2-6-10-33)40(48)45-36(23-28-7-3-1-4-8-28)39(47)43-26-31-13-11-30(25-42)12-14-31/h1-22,36-37H,23-27,42H2,(H,43,47)(H,44,46)(H,45,48)/t36-,37+/m0/s1	WEVQLDNHQXUOLS-PQQNNWGCSA-N	200139	US9234000, 130	Plasma kallikrein			 2491							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200139	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200139&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71186175	318589967							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355907	CCCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C36H40N4O4/c1-2-21-44-31-19-17-27(18-20-31)23-33(39-34(41)30-11-7-4-8-12-30)36(43)40-32(22-26-9-5-3-6-10-26)35(42)38-25-29-15-13-28(24-37)14-16-29/h3-20,32-33H,2,21-25,37H2,1H3,(H,38,42)(H,39,41)(H,40,43)/t32-,33+/m0/s1	OTUOSRRHYVCHTB-JHOUSYSJSA-N	200140	US9234000, 131	Plasma kallikrein			 40							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200140	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200140&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185674	318589968							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355908	NCc1ccc(CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccc(OCc3ccccc3)cc2)NC(=O)c2ccccc2)cc1	InChI=1S/C40H40N4O4/c41-26-31-16-18-32(19-17-31)27-42-39(46)36(24-29-10-4-1-5-11-29)44-40(47)37(43-38(45)34-14-8-3-9-15-34)25-30-20-22-35(23-21-30)48-28-33-12-6-2-7-13-33/h1-23,36-37H,24-28,41H2,(H,42,46)(H,43,45)(H,44,47)/t36-,37+/m0/s1	QGCXWVPWNLGRGP-PQQNNWGCSA-N	200141	US9234000, 132	Plasma kallikrein			 1209							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200141	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200141&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185535	318589969							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355909	CC(C)C[C@@H](NC(=O)c1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1	InChI=1S/C30H36N4O3/c1-21(2)17-26(33-28(35)25-11-7-4-8-12-25)30(37)34-27(18-22-9-5-3-6-10-22)29(36)32-20-24-15-13-23(19-31)14-16-24/h3-16,21,26-27H,17-20,31H2,1-2H3,(H,32,36)(H,33,35)(H,34,37)/t26-,27+/m1/s1	SWCPUEOSXZSMHD-SXOMAYOGSA-N	200142	US9234000, 133	Plasma kallikrein			 10000							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200142	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200142&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185530	318589970							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355910	NCc1ccc(CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccc(OCc3c(Cl)cccc3Cl)cc2)NC(=O)c2ccccc2)cc1	InChI=1S/C40H38Cl2N4O4/c41-34-12-7-13-35(42)33(34)26-50-32-20-18-28(19-21-32)23-37(45-38(47)31-10-5-2-6-11-31)40(49)46-36(22-27-8-3-1-4-9-27)39(48)44-25-30-16-14-29(24-43)15-17-30/h1-21,36-37H,22-26,43H2,(H,44,48)(H,45,47)(H,46,49)/t36-,37+/m0/s1	XCVRNFXSJAMNSP-PQQNNWGCSA-N	200143	US9234000, 134	Plasma kallikrein			 10000							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200143	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200143&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71186163	318589971							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355911	Cc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C34H36N4O3/c1-24-12-14-26(15-13-24)21-31(37-32(39)29-10-6-3-7-11-29)34(41)38-30(20-25-8-4-2-5-9-25)33(40)36-23-28-18-16-27(22-35)17-19-28/h2-19,30-31H,20-23,35H2,1H3,(H,36,40)(H,37,39)(H,38,41)/t30-,31+/m0/s1	HXMCBSSHSYKQRK-IOWSJCHKSA-N	200144	US9234000, 135	Plasma kallikrein			 424							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200144	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200144&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185534	318589972							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355912	NCc1ccc(CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccc(OCc3cccc(F)c3)cc2)NC(=O)c2ccccc2)cc1	InChI=1S/C40H39FN4O4/c41-34-13-7-10-32(22-34)27-49-35-20-18-29(19-21-35)24-37(44-38(46)33-11-5-2-6-12-33)40(48)45-36(23-28-8-3-1-4-9-28)39(47)43-26-31-16-14-30(25-42)15-17-31/h1-22,36-37H,23-27,42H2,(H,43,47)(H,44,46)(H,45,48)/t36-,37+/m0/s1	QLUQCWBEOZNKTG-PQQNNWGCSA-N	200145	US9234000, 136	Plasma kallikrein			 1017							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200145	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200145&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185576	318589973							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355913	COc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cn1	InChI=1S/C33H35N5O4/c1-42-30-17-16-26(22-35-30)19-29(37-31(39)27-10-6-3-7-11-27)33(41)38-28(18-23-8-4-2-5-9-23)32(40)36-21-25-14-12-24(20-34)13-15-25/h2-17,22,28-29H,18-21,34H2,1H3,(H,36,40)(H,37,39)(H,38,41)/t28-,29+/m0/s1	WVHMGGCVTKVQNI-URLMMPGGSA-N	200146	US9234000, 137	Plasma kallikrein			 7540							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200146	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200146&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185782	318589974							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355914	COc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C34H36N4O4/c1-42-29-18-16-25(17-19-29)21-31(37-32(39)28-10-6-3-7-11-28)34(41)38-30(20-24-8-4-2-5-9-24)33(40)36-23-27-14-12-26(22-35)13-15-27/h2-19,30-31H,20-23,35H2,1H3,(H,36,40)(H,37,39)(H,38,41)/t30-,31+/m0/s1	YOYSQDNQEZYVLQ-IOWSJCHKSA-N	200147	US9234000, 138	Plasma kallikrein			 310							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200147	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200147&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185997	318589975							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355915	NCc1ccc(CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)c2ccccc2)cc1	InChI=1S/C33H34N4O3/c34-22-26-16-18-27(19-17-26)23-35-32(39)29(20-24-10-4-1-5-11-24)37-33(40)30(21-25-12-6-2-7-13-25)36-31(38)28-14-8-3-9-15-28/h1-19,29-30H,20-23,34H2,(H,35,39)(H,36,38)(H,37,40)/t29-,30+/m0/s1	NGTNYFZFCLPYMX-XZWHSSHBSA-N	200148	US9234000, 139	Plasma kallikrein			 1141							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200148	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200148&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185608	318589976							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355916	CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccccn2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C34H37N5O4/c1-2-43-29-17-15-24(16-18-29)20-30(38-32(40)27-8-4-3-5-9-27)34(42)39-31(21-28-10-6-7-19-36-28)33(41)37-23-26-13-11-25(22-35)12-14-26/h3-19,30-31H,2,20-23,35H2,1H3,(H,37,41)(H,38,40)(H,39,42)/t30-,31+/m1/s1	BHVUGAWTPFXTSW-JSOSNVBQSA-N	200149	US9234000, 140	Plasma kallikrein			 45							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200149	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200149&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71499250	318589977							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355917	CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccc(Cl)c(Cl)c2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C35H36Cl2N4O4/c1-2-45-28-15-12-23(13-16-28)19-32(40-33(42)27-6-4-3-5-7-27)35(44)41-31(20-26-14-17-29(36)30(37)18-26)34(43)39-22-25-10-8-24(21-38)9-11-25/h3-18,31-32H,2,19-22,38H2,1H3,(H,39,43)(H,40,42)(H,41,44)/t31-,32+/m0/s1	MZNWXAJMLAFTSG-AJQTZOPKSA-N	200150	US9234000, 141	Plasma kallikrein			 55							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200150	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200150&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71499248	318589978							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355918	CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccc(Cl)cc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C35H37ClN4O4/c1-2-44-30-18-14-25(15-19-30)21-32(39-33(41)28-6-4-3-5-7-28)35(43)40-31(20-24-12-16-29(36)17-13-24)34(42)38-23-27-10-8-26(22-37)9-11-27/h3-19,31-32H,2,20-23,37H2,1H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1	XRXPBLITZSRMPK-AJQTZOPKSA-N	200151	US9234000, 142	Plasma kallikrein			 96							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200151	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200151&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71499249	318589979							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355919	CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccc(F)cc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C35H37FN4O4/c1-2-44-30-18-14-25(15-19-30)21-32(39-33(41)28-6-4-3-5-7-28)35(43)40-31(20-24-12-16-29(36)17-13-24)34(42)38-23-27-10-8-26(22-37)9-11-27/h3-19,31-32H,2,20-23,37H2,1H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1	OVUYMWPCQQBURI-AJQTZOPKSA-N	200152	US9234000, 143	Plasma kallikrein			 83							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200152	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200152&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185963	318589980							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355920	CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2cccc(c2)C(F)(F)F)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C36H37F3N4O4/c1-2-47-30-17-15-24(16-18-30)20-32(42-33(44)28-8-4-3-5-9-28)35(46)43-31(21-27-7-6-10-29(19-27)36(37,38)39)34(45)41-23-26-13-11-25(22-40)12-14-26/h3-19,31-32H,2,20-23,40H2,1H3,(H,41,45)(H,42,44)(H,43,46)/t31-,32+/m0/s1	NAYGGTQDFNWPNS-AJQTZOPKSA-N	200153	US9234000, 144	Plasma kallikrein			 340							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200153	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200153&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185586	318589981							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355921	CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2cccnc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C34H37N5O4/c1-2-43-29-16-14-24(15-17-29)19-31(38-32(40)28-8-4-3-5-9-28)34(42)39-30(20-27-7-6-18-36-22-27)33(41)37-23-26-12-10-25(21-35)11-13-26/h3-18,22,30-31H,2,19-21,23,35H2,1H3,(H,37,41)(H,38,40)(H,39,42)/t30-,31+/m0/s1	IOKOMILCLYAEGO-IOWSJCHKSA-N	200154	US9234000, 145	Plasma kallikrein			 25							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200154	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200154&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185660	318589982							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355922	CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccc(OC)cc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C36H40N4O5/c1-3-45-31-19-15-26(16-20-31)22-33(39-34(41)29-7-5-4-6-8-29)36(43)40-32(21-25-13-17-30(44-2)18-14-25)35(42)38-24-28-11-9-27(23-37)10-12-28/h4-20,32-33H,3,21-24,37H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t32-,33+/m0/s1	MNENVOCWAYYIHM-JHOUSYSJSA-N	200155	US9234000, 146	Plasma kallikrein			 232							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200155	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200155&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71499276	318589983							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355923	CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccncc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C34H37N5O4/c1-2-43-29-14-12-24(13-15-29)20-31(38-32(40)28-6-4-3-5-7-28)34(42)39-30(21-25-16-18-36-19-17-25)33(41)37-23-27-10-8-26(22-35)9-11-27/h3-19,30-31H,2,20-23,35H2,1H3,(H,37,41)(H,38,40)(H,39,42)/t30-,31+/m0/s1	MGPOPQVVNMABOI-IOWSJCHKSA-N	200156	US9234000, 147	Plasma kallikrein			 284							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200156	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200156&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71499304	318589984							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355924	CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccc(cc2)C(F)(F)F)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C36H37F3N4O4/c1-2-47-30-18-14-25(15-19-30)21-32(42-33(44)28-6-4-3-5-7-28)35(46)43-31(20-24-12-16-29(17-13-24)36(37,38)39)34(45)41-23-27-10-8-26(22-40)9-11-27/h3-19,31-32H,2,20-23,40H2,1H3,(H,41,45)(H,42,44)(H,43,46)/t31-,32+/m0/s1	KMFPQSSNRGUHHI-AJQTZOPKSA-N	200157	US9234000, 148	Plasma kallikrein			 934							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200157	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200157&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185663	318589985							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355925	CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2cccc(F)c2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C35H37FN4O4/c1-2-44-30-17-15-24(16-18-30)20-32(39-33(41)28-8-4-3-5-9-28)35(43)40-31(21-27-7-6-10-29(36)19-27)34(42)38-23-26-13-11-25(22-37)12-14-26/h3-19,31-32H,2,20-23,37H2,1H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1	OYMHEDPIXZJWGT-AJQTZOPKSA-N	200158	US9234000, 149	Plasma kallikrein			 91							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200158	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200158&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71186117	318589986							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355926	CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2cccs2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C33H36N4O4S/c1-2-41-27-16-14-23(15-17-27)19-29(36-31(38)26-7-4-3-5-8-26)33(40)37-30(20-28-9-6-18-42-28)32(39)35-22-25-12-10-24(21-34)11-13-25/h3-18,29-30H,2,19-22,34H2,1H3,(H,35,39)(H,36,38)(H,37,40)/t29-,30+/m1/s1	IBCRPNPROJRPGD-IHLOFXLRSA-N	200159	US9234000, 150	Plasma kallikrein			 51							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200159	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200159&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71499399	318589987							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355927	CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccsc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C33H36N4O4S/c1-2-41-28-14-12-23(13-15-28)18-30(36-31(38)27-6-4-3-5-7-27)33(40)37-29(19-26-16-17-42-22-26)32(39)35-21-25-10-8-24(20-34)9-11-25/h3-17,22,29-30H,2,18-21,34H2,1H3,(H,35,39)(H,36,38)(H,37,40)/t29-,30+/m0/s1	FEEFLICHCNTQCS-XZWHSSHBSA-N	200160	US9234000, 151	Plasma kallikrein			 9							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200160	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200160&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71499365	318589988							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355928	CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2cscn2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C32H35N5O4S/c1-2-41-27-14-12-22(13-15-27)16-28(36-30(38)25-6-4-3-5-7-25)32(40)37-29(17-26-20-42-21-35-26)31(39)34-19-24-10-8-23(18-33)9-11-24/h3-15,20-21,28-29H,2,16-19,33H2,1H3,(H,34,39)(H,36,38)(H,37,40)/t28-,29+/m1/s1	FHHIRUSMTLKWSO-WDYNHAJCSA-N	200161	US9234000, 152	Plasma kallikrein			 23							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200161	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200161&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71499363	318589989							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355929	CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2csc3ccccc23)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C37H38N4O4S/c1-2-45-30-18-16-25(17-19-30)20-32(40-35(42)28-8-4-3-5-9-28)37(44)41-33(21-29-24-46-34-11-7-6-10-31(29)34)36(43)39-23-27-14-12-26(22-38)13-15-27/h3-19,24,32-33H,2,20-23,38H2,1H3,(H,39,43)(H,40,42)(H,41,44)/t32-,33+/m1/s1	XQQTZKDEZFNLED-SAIUNTKASA-N	200162	US9234000, 153	Plasma kallikrein			 10							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200162	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200162&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71499364	318589990							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355930	CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)c(F)c2)cc1	InChI=1S/C35H37FN4O4/c1-2-44-29-17-14-25(15-18-29)21-32(39-33(41)27-11-7-4-8-12-27)35(43)40-31(20-24-9-5-3-6-10-24)34(42)38-23-26-13-16-28(22-37)30(36)19-26/h3-19,31-32H,2,20-23,37H2,1H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1	UXHKCWBMPOSFQY-AJQTZOPKSA-N	200163	US9234000, 154	Plasma kallikrein			 21							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200163	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200163&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185721	318589991							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355931	CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)c(Cl)c2)cc1	InChI=1S/C35H37ClN4O4/c1-2-44-29-17-14-25(15-18-29)21-32(39-33(41)27-11-7-4-8-12-27)35(43)40-31(20-24-9-5-3-6-10-24)34(42)38-23-26-13-16-28(22-37)30(36)19-26/h3-19,31-32H,2,20-23,37H2,1H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1	NOORMTUTGSQYIZ-AJQTZOPKSA-N	200164	US9234000, 155	Plasma kallikrein			 22							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200164	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200164&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71499400	318589992							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355932	CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)c(c2)C(F)(F)F)cc1	InChI=1S/C36H37F3N4O4/c1-2-47-29-17-14-25(15-18-29)21-32(42-33(44)27-11-7-4-8-12-27)35(46)43-31(20-24-9-5-3-6-10-24)34(45)41-23-26-13-16-28(22-40)30(19-26)36(37,38)39/h3-19,31-32H,2,20-23,40H2,1H3,(H,41,45)(H,42,44)(H,43,46)/t31-,32+/m0/s1	KEMDZFGHDRNLTH-AJQTZOPKSA-N	200165	US9234000, 156	Plasma kallikrein			 1083							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200165	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200165&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185671	318589993							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355933	CCOc1ccc(C[C@@H](NC(=O)c2ccccn2)C(=O)N[C@@H](Cc2cccs2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C32H35N5O4S/c1-2-41-25-14-12-22(13-15-25)18-28(36-31(39)27-7-3-4-16-34-27)32(40)37-29(19-26-6-5-17-42-26)30(38)35-21-24-10-8-23(20-33)9-11-24/h3-17,28-29H,2,18-21,33H2,1H3,(H,35,38)(H,36,39)(H,37,40)/t28-,29+/m1/s1	DOEHDNHECCZREA-WDYNHAJCSA-N	200166	US9234000, 157	Plasma kallikrein			 36							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200166	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200166&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71499431	318589994							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355934	CCOc1ccc(C[C@@H](NC(=O)c2ccc(OC)cc2)C(=O)N[C@@H](Cc2ccccn2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C35H39N5O5/c1-3-45-30-15-11-24(12-16-30)20-31(39-33(41)27-13-17-29(44-2)18-14-27)35(43)40-32(21-28-6-4-5-19-37-28)34(42)38-23-26-9-7-25(22-36)8-10-26/h4-19,31-32H,3,20-23,36H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m1/s1	KGASRYBCGZUNAS-ZWXJPIIXSA-N	200167	US9234000, 158	Plasma kallikrein			 47							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200167	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200167&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71499401	318589995							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355935	CCOc1ccc(C[C@@H](NC(=O)c2ccccn2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)c(Cl)c2)cc1	InChI=1S/C34H36ClN5O4/c1-2-44-27-15-12-24(13-16-27)20-31(40-33(42)29-10-6-7-17-37-29)34(43)39-30(19-23-8-4-3-5-9-23)32(41)38-22-25-11-14-26(21-36)28(35)18-25/h3-18,30-31H,2,19-22,36H2,1H3,(H,38,41)(H,39,43)(H,40,42)/t30-,31+/m0/s1	GBUZITZBMSHALN-IOWSJCHKSA-N	200168	US9234000, 159	Plasma kallikrein			 15							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200168	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200168&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71499432	318589996							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355936	CCOc1ccc(C[C@@H](NC(=O)c2ccc(OC)cc2)C(=O)N[C@@H](Cc2cccnc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C35H39N5O5/c1-3-45-30-14-10-24(11-15-30)19-32(39-33(41)28-12-16-29(44-2)17-13-28)35(43)40-31(20-27-5-4-18-37-22-27)34(42)38-23-26-8-6-25(21-36)7-9-26/h4-18,22,31-32H,3,19-21,23,36H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1	AJYZUIMBRBUFPQ-AJQTZOPKSA-N	200169	US9234000, 160	Plasma kallikrein			 10							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200169	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200169&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185939	318589997							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355937	CCOc1ccc(C[C@@H](NC(=O)c2ccncc2)C(=O)N[C@@H](Cc2ccc(F)c(F)c2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C34H35F2N5O4/c1-2-45-27-10-7-22(8-11-27)18-31(40-32(42)26-13-15-38-16-14-26)34(44)41-30(19-25-9-12-28(35)29(36)17-25)33(43)39-21-24-5-3-23(20-37)4-6-24/h3-17,30-31H,2,18-21,37H2,1H3,(H,39,43)(H,40,42)(H,41,44)/t30-,31+/m0/s1	UIKVVUURJYWPFD-IOWSJCHKSA-N	200170	US9234000, 161	Plasma kallikrein			 49							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200170	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200170&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71499433	318589998							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355938	CCOc1ccc(C[C@@H](NC(=O)c2cccs2)C(=O)N[C@@H](Cc2cccnc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C32H35N5O4S/c1-2-41-26-13-11-22(12-14-26)17-28(37-32(40)29-6-4-16-42-29)31(39)36-27(18-25-5-3-15-34-20-25)30(38)35-21-24-9-7-23(19-33)8-10-24/h3-16,20,27-28H,2,17-19,21,33H2,1H3,(H,35,38)(H,36,39)(H,37,40)/t27-,28+/m0/s1	QICJOCRBSRBUHC-WUFINQPMSA-N	200171	US9234000, 162	Plasma kallikrein			 10							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200171	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200171&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71499451	318589999							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355939	CCOc1ccc(C[C@@H](NC(=O)c2ccc(Cl)cc2)C(=O)N[C@@H](Cc2ccccn2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C34H36ClN5O4/c1-2-44-29-16-10-23(11-17-29)19-30(39-32(41)26-12-14-27(35)15-13-26)34(43)40-31(20-28-5-3-4-18-37-28)33(42)38-22-25-8-6-24(21-36)7-9-25/h3-18,30-31H,2,19-22,36H2,1H3,(H,38,42)(H,39,41)(H,40,43)/t30-,31+/m1/s1	SJQWETDPGAMVES-JSOSNVBQSA-N	200172	US9234000, 163	Plasma kallikrein			 64							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200172	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200172&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185934	318590000							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355940	CCOc1ccc(C[C@@H](NC(=O)c2ccc(C)cc2)C(=O)N[C@@H](Cc2ccccn2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C35H39N5O4/c1-3-44-30-17-13-25(14-18-30)20-31(39-33(41)28-15-7-24(2)8-16-28)35(43)40-32(21-29-6-4-5-19-37-29)34(42)38-23-27-11-9-26(22-36)10-12-27/h4-19,31-32H,3,20-23,36H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m1/s1	XTDUCJDRKRNRPM-ZWXJPIIXSA-N	200173	US9234000, 164	Plasma kallikrein			 50							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200173	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200173&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185860	318590001							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355941	CCOc1ccc(C[C@@H](NC(=O)c2ccccn2)C(=O)N[C@@H](Cc2ccc(Cl)c(Cl)c2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C34H35Cl2N5O4/c1-2-45-26-13-10-22(11-14-26)18-31(41-33(43)29-5-3-4-16-38-29)34(44)40-30(19-25-12-15-27(35)28(36)17-25)32(42)39-21-24-8-6-23(20-37)7-9-24/h3-17,30-31H,2,18-21,37H2,1H3,(H,39,42)(H,40,44)(H,41,43)/t30-,31+/m0/s1	ORHWIOJJYJCEEN-IOWSJCHKSA-N	200174	US9234000, 165	Plasma kallikrein			 70							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200174	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200174&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71499452	318590002							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355942	CCOc1ccc(CC(=O)CN(CCC(N)=O)[C@@H](Cc2ccccn2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C30H37N5O4/c1-2-39-27-12-10-22(11-13-27)17-26(36)21-35(16-14-29(32)37)28(18-25-5-3-4-15-33-25)30(38)34-20-24-8-6-23(19-31)7-9-24/h3-13,15,28H,2,14,16-21,31H2,1H3,(H2,32,37)(H,34,38)/t28-/m0/s1	DILSGXCGLKYUGX-NDEPHWFRSA-N	200175	US9234000, 166	Plasma kallikrein			 262							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200175	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200175&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185872	318590003							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355943	CCOc1ccc(C[C@@H](NC(=O)c2ccncc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)c(F)c2)cc1	InChI=1S/C34H36FN5O4/c1-2-44-28-12-9-24(10-13-28)20-31(39-32(41)26-14-16-37-17-15-26)34(43)40-30(19-23-6-4-3-5-7-23)33(42)38-22-25-8-11-27(21-36)29(35)18-25/h3-18,30-31H,2,19-22,36H2,1H3,(H,38,42)(H,39,41)(H,40,43)/t30-,31+/m0/s1	LVBXETRZHVPVHL-IOWSJCHKSA-N	200176	US9234000, 167	Plasma kallikrein			 80							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200176	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200176&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71186140	318590004							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355944	CCOc1ccc(C[C@@H](NC(=O)c2ccccn2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)c(F)c2)cc1	InChI=1S/C34H36FN5O4/c1-2-44-27-15-12-24(13-16-27)20-31(40-33(42)29-10-6-7-17-37-29)34(43)39-30(19-23-8-4-3-5-9-23)32(41)38-22-25-11-14-26(21-36)28(35)18-25/h3-18,30-31H,2,19-22,36H2,1H3,(H,38,41)(H,39,43)(H,40,42)/t30-,31+/m0/s1	JJQFJIAMVLGSKU-IOWSJCHKSA-N	200177	US9234000, 168	Plasma kallikrein			 76							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200177	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200177&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71499222	318590005							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355945	CCOc1ccc(C[C@@H](NC(=O)c2cccs2)C(=O)N[C@@H](Cc2ccc(Cl)c(Cl)c2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C33H34Cl2N4O4S/c1-2-43-25-12-9-21(10-13-25)17-29(39-33(42)30-4-3-15-44-30)32(41)38-28(18-24-11-14-26(34)27(35)16-24)31(40)37-20-23-7-5-22(19-36)6-8-23/h3-16,28-29H,2,17-20,36H2,1H3,(H,37,40)(H,38,41)(H,39,42)/t28-,29+/m0/s1	GBOFJZGDOGSEJK-URLMMPGGSA-N	200178	US9234000, 169	Plasma kallikrein			 44							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200178	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200178&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71499221	318590006							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355946	CCOc1ccc(CC(=O)CN(CCC(N)=O)[C@@H](Cc2cccnc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C30H37N5O4/c1-2-39-27-11-9-22(10-12-27)16-26(36)21-35(15-13-29(32)37)28(17-25-4-3-14-33-19-25)30(38)34-20-24-7-5-23(18-31)6-8-24/h3-12,14,19,28H,2,13,15-18,20-21,31H2,1H3,(H2,32,37)(H,34,38)/t28-/m0/s1	VDZMJOARFXFULW-NDEPHWFRSA-N	200179	US9234000, 170	Plasma kallikrein			 51							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200179	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200179&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90302182	318590007							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355947	CCOc1ccc(C[C@@H](NC(=O)c2ccncc2)C(=O)N[C@@H](Cc2ccc(Cl)c(Cl)c2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C34H35Cl2N5O4/c1-2-45-27-10-7-22(8-11-27)18-31(40-32(42)26-13-15-38-16-14-26)34(44)41-30(19-25-9-12-28(35)29(36)17-25)33(43)39-21-24-5-3-23(20-37)4-6-24/h3-17,30-31H,2,18-21,37H2,1H3,(H,39,43)(H,40,42)(H,41,44)/t30-,31+/m0/s1	OKGHJSOTBPWZDZ-IOWSJCHKSA-N	200180	US9234000, 171	Plasma kallikrein			 123							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200180	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200180&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71499303	318590008							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355948	CCOc1ccc(C[C@@H](NC(=O)CC(F)(F)F)C(=O)N[C@@H](Cc2ccc(Cl)c(Cl)c2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C31H33Cl2F3N4O4/c1-2-44-23-10-7-19(8-11-23)14-27(39-28(41)16-31(34,35)36)30(43)40-26(15-22-9-12-24(32)25(33)13-22)29(42)38-18-21-5-3-20(17-37)4-6-21/h3-13,26-27H,2,14-18,37H2,1H3,(H,38,42)(H,39,41)(H,40,43)/t26-,27+/m0/s1	BAAMDLCQQMJQAZ-RRPNLBNLSA-N	200181	US9234000, 172	Plasma kallikrein			 881							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200181	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200181&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71499332	318590009							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355949	CCOc1ccc(C[C@@H](NC(=O)c2ccc(Cl)cc2)C(=O)N[C@@H](Cc2cccnc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C34H36ClN5O4/c1-2-44-29-15-9-23(10-16-29)18-31(39-32(41)27-11-13-28(35)14-12-27)34(43)40-30(19-26-4-3-17-37-21-26)33(42)38-22-25-7-5-24(20-36)6-8-25/h3-17,21,30-31H,2,18-20,22,36H2,1H3,(H,38,42)(H,39,41)(H,40,43)/t30-,31+/m0/s1	COXMDBLAIZHMPI-IOWSJCHKSA-N	200182	US9234000, 173	Plasma kallikrein			 213							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200182	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200182&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71499330	318590010							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355950	CCOc1ccc(C[C@@H](NC(=O)c2ccno2)C(=O)N[C@@H](Cc2cccnc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C31H34N6O5/c1-2-41-25-11-9-21(10-12-25)16-27(37-31(40)28-13-15-35-42-28)30(39)36-26(17-24-4-3-14-33-19-24)29(38)34-20-23-7-5-22(18-32)6-8-23/h3-15,19,26-27H,2,16-18,20,32H2,1H3,(H,34,38)(H,36,39)(H,37,40)/t26-,27+/m0/s1	GWSFNRAHPBVBJY-RRPNLBNLSA-N	200183	US9234000, 174	Plasma kallikrein			 45							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200183	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200183&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71499331	318590011							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355951	CCOc1ccc(C[C@@H](NC(=O)c2sccc2Cl)C(=O)N[C@@H](Cc2cccnc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C32H34ClN5O4S/c1-2-42-25-11-9-21(10-12-25)16-28(38-32(41)29-26(33)13-15-43-29)31(40)37-27(17-24-4-3-14-35-19-24)30(39)36-20-23-7-5-22(18-34)6-8-23/h3-15,19,27-28H,2,16-18,20,34H2,1H3,(H,36,39)(H,37,40)(H,38,41)/t27-,28+/m0/s1	YYYMEQVUGUUKPY-WUFINQPMSA-N	200184	US9234000, 175	Plasma kallikrein			 3							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200184	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200184&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71499477	318590012							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355952	CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C37H39N5O4/c1-2-46-30-18-16-25(17-19-30)20-33(41-35(43)28-8-4-3-5-9-28)37(45)42-34(21-29-24-39-32-11-7-6-10-31(29)32)36(44)40-23-27-14-12-26(22-38)13-15-27/h3-19,24,33-34,39H,2,20-23,38H2,1H3,(H,40,44)(H,41,43)(H,42,45)/t33-,34+/m1/s1	GAEPCQZQRDPARJ-NOCHOARKSA-N	200185	US9234000, 176	Plasma kallikrein			 28							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200185	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200185&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71187144	318590013							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355953	CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2c[nH]cn2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C32H36N6O4/c1-2-42-27-14-12-22(13-15-27)16-28(37-30(39)25-6-4-3-5-7-25)32(41)38-29(17-26-20-34-21-36-26)31(40)35-19-24-10-8-23(18-33)9-11-24/h3-15,20-21,28-29H,2,16-19,33H2,1H3,(H,34,36)(H,35,40)(H,37,39)(H,38,41)/t28-,29+/m1/s1	AEYJQJFQRCNAIM-WDYNHAJCSA-N	200186	US9234000, 177	Plasma kallikrein			 457							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200186	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200186&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71187364	318590014					C00615		1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355954	CCOc1ccc(C[C@@H](NC(=O)c2ccncc2)C(=O)N[C@@H](Cc2csc3ccccc23)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C36H37N5O4S/c1-2-45-29-13-11-24(12-14-29)19-31(40-34(42)27-15-17-38-18-16-27)36(44)41-32(20-28-23-46-33-6-4-3-5-30(28)33)35(43)39-22-26-9-7-25(21-37)8-10-26/h3-18,23,31-32H,2,19-22,37H2,1H3,(H,39,43)(H,40,42)(H,41,44)/t31-,32+/m1/s1	ZLHMUZNFVDTJHM-ZWXJPIIXSA-N	200187	US9234000, 178	Plasma kallikrein			 42							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200187	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200187&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			76901379	318590015							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355955	CCOc1ccc(C[C@@H](NC(=O)c2sccc2NC(C)=O)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C35H39N5O5S/c1-3-45-28-15-13-25(14-16-28)20-31(40-35(44)32-29(17-18-46-32)38-23(2)41)34(43)39-30(19-24-7-5-4-6-8-24)33(42)37-22-27-11-9-26(21-36)10-12-27/h4-18,30-31H,3,19-22,36H2,1-2H3,(H,37,42)(H,38,41)(H,39,43)(H,40,44)/t30-,31+/m0/s1	KDRURSLBLPTKEJ-IOWSJCHKSA-N	200188	US9234000, 179	Plasma kallikrein			 22							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200188	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200188&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185867	318590016							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355956	CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2F)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C35H37FN4O4/c1-2-44-29-18-16-24(17-19-29)20-31(39-33(41)27-8-4-3-5-9-27)35(43)40-32(21-28-10-6-7-11-30(28)36)34(42)38-23-26-14-12-25(22-37)13-15-26/h3-19,31-32H,2,20-23,37H2,1H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m1/s1	SYUQOCGTPPIJGB-ZWXJPIIXSA-N	200189	US9234000, 180	Plasma kallikrein			 73							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200189	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200189&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71499497	318590017							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355957	CCOc1ccc(C[C@@H](NC(=O)c2sccc2C)C(=O)N[C@@H](Cc2cccnc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C33H37N5O4S/c1-3-42-27-12-10-23(11-13-27)17-29(38-33(41)30-22(2)14-16-43-30)32(40)37-28(18-26-5-4-15-35-20-26)31(39)36-21-25-8-6-24(19-34)7-9-25/h4-16,20,28-29H,3,17-19,21,34H2,1-2H3,(H,36,39)(H,37,40)(H,38,41)/t28-,29+/m0/s1	VEGWZKIUWVMXBY-URLMMPGGSA-N	200190	US9234000, 181	Plasma kallikrein			 10							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200190	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200190&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71499479	318590018							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355958	CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)c(C)c2)cc1	InChI=1S/C36H40N4O4/c1-3-44-31-18-15-27(16-19-31)22-33(39-34(41)29-12-8-5-9-13-29)36(43)40-32(21-26-10-6-4-7-11-26)35(42)38-24-28-14-17-30(23-37)25(2)20-28/h4-20,32-33H,3,21-24,37H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t32-,33+/m0/s1	ZSQXKFNZFSFYRJ-JHOUSYSJSA-N	200191	US9234000, 182	Plasma kallikrein			 15							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200191	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200191&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71499478	318590019							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355959	CCOc1ccc(C[C@@H](NC(=O)c2sccc2N)C(=O)N[C@@H](Cc2cscn2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C30H34N6O4S2/c1-2-40-23-9-7-19(8-10-23)13-25(36-30(39)27-24(32)11-12-42-27)29(38)35-26(14-22-17-41-18-34-22)28(37)33-16-21-5-3-20(15-31)4-6-21/h3-12,17-18,25-26H,2,13-16,31-32H2,1H3,(H,33,37)(H,35,38)(H,36,39)/t25-,26+/m1/s1	HDDOGAGGUYGJLQ-FTJBHMTQSA-N	200192	US9234000, 183::US9234000, 187	Plasma kallikrein			 16							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200192	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200192&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			76901757	318590020							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355960	CCOc1ccc(C[C@@H](NC(=O)c2sccc2Cl)C(=O)N[C@@H](Cc2cscn2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C30H32ClN5O4S2/c1-2-40-23-9-7-19(8-10-23)13-25(36-30(39)27-24(31)11-12-42-27)29(38)35-26(14-22-17-41-18-34-22)28(37)33-16-21-5-3-20(15-32)4-6-21/h3-12,17-18,25-26H,2,13-16,32H2,1H3,(H,33,37)(H,35,38)(H,36,39)/t25-,26+/m1/s1	PMTPLZNRQDJDQN-FTJBHMTQSA-N	200193	US9234000, 184	Plasma kallikrein			 10							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200193	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200193&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90302004	318590021							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355961	CCOc1ccc(C[C@@H](NC(=O)c2ccc(C)cc2)C(=O)N[C@@H](Cc2cscn2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C33H37N5O4S/c1-3-42-28-14-10-23(11-15-28)16-29(37-31(39)26-12-4-22(2)5-13-26)33(41)38-30(17-27-20-43-21-36-27)32(40)35-19-25-8-6-24(18-34)7-9-25/h4-15,20-21,29-30H,3,16-19,34H2,1-2H3,(H,35,40)(H,37,39)(H,38,41)/t29-,30+/m1/s1	XXXMZDCXONCQMR-IHLOFXLRSA-N	200194	US9234000, 185	Plasma kallikrein			 49							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200194	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200194&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71499498	318590022							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355962	CCOc1ccc(C[C@@H](NC(=O)c2[nH]ccc2C)C(=O)N[C@@H](Cc2csc3ccccc23)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C36H39N5O4S/c1-3-45-28-14-12-24(13-15-28)18-30(41-36(44)33-23(2)16-17-38-33)35(43)40-31(19-27-22-46-32-7-5-4-6-29(27)32)34(42)39-21-26-10-8-25(20-37)9-11-26/h4-17,22,30-31,38H,3,18-21,37H2,1-2H3,(H,39,42)(H,40,43)(H,41,44)/t30-,31+/m1/s1	GCTFSBZKSCJATJ-JSOSNVBQSA-N	200195	US9234000, 186	Plasma kallikrein			 14							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200195	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200195&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71499499	318590023							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355963	CCOc1ccc(C[C@@H](NC(=O)c2sccc2N)C(=O)N[C@@H](Cc2cscn2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C30H34N6O4S2/c1-2-40-23-9-7-19(8-10-23)13-25(36-30(39)27-24(32)11-12-42-27)29(38)35-26(14-22-17-41-18-34-22)28(37)33-16-21-5-3-20(15-31)4-6-21/h3-12,17-18,25-26H,2,13-16,31-32H2,1H3,(H,33,37)(H,35,38)(H,36,39)/t25-,26+/m1/s1	HDDOGAGGUYGJLQ-FTJBHMTQSA-N	200192	US9234000, 183::US9234000, 187	Plasma kallikrein			 7							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200192	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200192&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			76901757	318590020							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355964	CCOc1ccc(C[C@@H](NC(=O)c2sccc2NC(C)=O)C(=O)N[C@@H](Cc2csc3ccccc23)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C37H39N5O5S2/c1-3-47-28-14-12-24(13-15-28)18-31(42-37(46)34-30(16-17-48-34)40-23(2)43)36(45)41-32(19-27-22-49-33-7-5-4-6-29(27)33)35(44)39-21-26-10-8-25(20-38)9-11-26/h4-17,22,31-32H,3,18-21,38H2,1-2H3,(H,39,44)(H,40,43)(H,41,45)(H,42,46)/t31-,32+/m1/s1	GKOAHNGAVMWGNA-ZWXJPIIXSA-N	200197	US9234000, 188::US9234000, 195	Plasma kallikrein			 36							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200197	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200197&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71499156	318590024							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355965	CCOc1ccc(C[C@@H](NC(=O)c2cccc(C)c2)C(=O)N[C@@H](Cc2cccnc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C35H39N5O4/c1-3-44-30-15-13-25(14-16-30)19-32(39-33(41)29-8-4-6-24(2)18-29)35(43)40-31(20-28-7-5-17-37-22-28)34(42)38-23-27-11-9-26(21-36)10-12-27/h4-18,22,31-32H,3,19-21,23,36H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1	SYHVZEPQLZQVQE-AJQTZOPKSA-N	200198	US9234000, 189	Plasma kallikrein			 23							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200198	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200198&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71499155	318590025							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355966	CCOc1ccc(C[C@@H](NC(=O)c2ccccc2C)C(=O)N[C@@H](Cc2cccnc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C35H39N5O4/c1-3-44-29-16-14-25(15-17-29)19-32(39-33(41)30-9-5-4-7-24(30)2)35(43)40-31(20-28-8-6-18-37-22-28)34(42)38-23-27-12-10-26(21-36)11-13-27/h4-18,22,31-32H,3,19-21,23,36H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1	YBYIYRFQMSDYKZ-AJQTZOPKSA-N	200199	US9234000, 190	Plasma kallikrein			 28							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200199	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200199&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71499500	318590026							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355967	CCOc1ccc(C[C@@H](NC(=O)c2[nH]c(C)cc2C)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C35H41N5O4/c1-4-44-29-16-14-26(15-17-29)20-31(40-35(43)32-23(2)18-24(3)38-32)34(42)39-30(19-25-8-6-5-7-9-25)33(41)37-22-28-12-10-27(21-36)11-13-28/h5-18,30-31,38H,4,19-22,36H2,1-3H3,(H,37,41)(H,39,42)(H,40,43)/t30-,31+/m0/s1	WJCYGURKBSTJEJ-IOWSJCHKSA-N	200200	US9234000, 191	Plasma kallikrein			 20							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200200	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200200&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71499157	318590027							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355968	CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2cccnc2)C(=O)NCc2ccc(CN)c(C)c2)cc1	InChI=1S/C35H39N5O4/c1-3-44-30-15-12-25(13-16-30)19-32(39-33(41)28-9-5-4-6-10-28)35(43)40-31(20-26-8-7-17-37-22-26)34(42)38-23-27-11-14-29(21-36)24(2)18-27/h4-18,22,31-32H,3,19-21,23,36H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1	KFOYMQXIDOVWGR-AJQTZOPKSA-N	200201	US9234000, 192	Plasma kallikrein			 12							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200201	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200201&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71499168	318590028							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355969	CCOc1ccc(C[C@@H](NC(=O)c2sccc2NC(C)=O)C(=O)N[C@@H](Cc2ccsc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C33H37N5O5S2/c1-3-43-26-10-8-22(9-11-26)16-29(38-33(42)30-27(13-15-45-30)36-21(2)39)32(41)37-28(17-25-12-14-44-20-25)31(40)35-19-24-6-4-23(18-34)5-7-24/h4-15,20,28-29H,3,16-19,34H2,1-2H3,(H,35,40)(H,36,39)(H,37,41)(H,38,42)/t28-,29+/m0/s1	FQQAMJLKTANPGO-URLMMPGGSA-N	200202	US9234000, 193	Plasma kallikrein			 25							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200202	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200202&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71499158	318590029							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355970	CCOc1ccc(C[C@@H](NC(=O)c2sccc2N)C(=O)N[C@@H](Cc2csc3ccccc23)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C35H37N5O4S2/c1-2-44-26-13-11-22(12-14-26)17-29(40-35(43)32-28(37)15-16-45-32)34(42)39-30(18-25-21-46-31-6-4-3-5-27(25)31)33(41)38-20-24-9-7-23(19-36)8-10-24/h3-16,21,29-30H,2,17-20,36-37H2,1H3,(H,38,41)(H,39,42)(H,40,43)/t29-,30+/m1/s1	CYVSDXJVCZURLD-IHLOFXLRSA-N	200203	US9234000, 194	Plasma kallikrein			 13							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200203	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200203&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			76901380	318590030							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355971	CCOc1ccc(C[C@@H](NC(=O)c2sccc2NC(C)=O)C(=O)N[C@@H](Cc2csc3ccccc23)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C37H39N5O5S2/c1-3-47-28-14-12-24(13-15-28)18-31(42-37(46)34-30(16-17-48-34)40-23(2)43)36(45)41-32(19-27-22-49-33-7-5-4-6-29(27)33)35(44)39-21-26-10-8-25(20-38)9-11-26/h4-17,22,31-32H,3,18-21,38H2,1-2H3,(H,39,44)(H,40,43)(H,41,45)(H,42,46)/t31-,32+/m1/s1	GKOAHNGAVMWGNA-ZWXJPIIXSA-N	200197	US9234000, 188::US9234000, 195	Plasma kallikrein			 14							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200197	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200197&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71499156	318590024							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355972	CCOc1ccc(C[C@@H](NC(=O)c2sccc2Cl)C(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C34H37ClN4O4S/c1-3-43-27-15-13-24(14-16-27)19-29(38-33(41)31-28(35)17-18-44-31)34(42)39(2)30(20-23-7-5-4-6-8-23)32(40)37-22-26-11-9-25(21-36)10-12-26/h4-18,29-30H,3,19-22,36H2,1-2H3,(H,37,40)(H,38,41)/t29-,30+/m1/s1	OQLWNLNQMCZSSV-IHLOFXLRSA-N	200205	US9234000, 196	Plasma kallikrein			 32							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200205	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200205&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			76901566	318590031							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355973	CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H]([C@H](O)c2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C35H38N4O5/c1-2-44-29-19-17-24(18-20-29)21-30(38-33(41)28-11-7-4-8-12-28)34(42)39-31(32(40)27-9-5-3-6-10-27)35(43)37-23-26-15-13-25(22-36)14-16-26/h3-20,30-32,40H,2,21-23,36H2,1H3,(H,37,43)(H,38,41)(H,39,42)/t30-,31+,32-/m1/s1	BCBPQVFOASQXEY-YKILCQELSA-N	200206	US9234000, 197	Plasma kallikrein			 12							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200206	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200206&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185740	318590032							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355974	CCOc1ccc(C[C@@H](NC(=O)c2sccc2Cl)C(=O)N[C@@H]([C@H](O)c2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C33H35ClN4O5S/c1-2-43-25-14-12-21(13-15-25)18-27(37-33(42)30-26(34)16-17-44-30)31(40)38-28(29(39)24-6-4-3-5-7-24)32(41)36-20-23-10-8-22(19-35)9-11-23/h3-17,27-29,39H,2,18-20,35H2,1H3,(H,36,41)(H,37,42)(H,38,40)/t27-,28+,29-/m1/s1	JPIQGCNQXOHJHE-SSBOKUKZSA-N	200207	US9234000, 198	Plasma kallikrein			 7							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200207	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200207&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			76901567	318590033							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355975	CCOc1ccc(C[C@@H](NC(=O)c2ccc(C)cc2)C(=O)N[C@@H](Cc2cccnc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C35H39N5O4/c1-3-44-30-16-12-25(13-17-30)19-32(39-33(41)29-14-6-24(2)7-15-29)35(43)40-31(20-28-5-4-18-37-22-28)34(42)38-23-27-10-8-26(21-36)9-11-27/h4-18,22,31-32H,3,19-21,23,36H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1	QLQUHMZRFARDGM-AJQTZOPKSA-N	200208	US9234000, 199	Plasma kallikrein			 10							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200208	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200208&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71204163	318590034							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355976	CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccc(F)c(F)c2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C35H36F2N4O4/c1-2-45-28-15-12-23(13-16-28)19-32(40-33(42)27-6-4-3-5-7-27)35(44)41-31(20-26-14-17-29(36)30(37)18-26)34(43)39-22-25-10-8-24(21-38)9-11-25/h3-18,31-32H,2,19-22,38H2,1H3,(H,39,43)(H,40,42)(H,41,44)/t31-,32+/m0/s1	WOXROINLYXJADA-AJQTZOPKSA-N	200209	US9234000, 200	Plasma kallikrein			 45							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200209	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200209&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71204124	318590035							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
355977	NCc1ccc(CNC(=O)[C@H](Cc2ccccc2)NC(=O)C(Cc2ccc(OCC(F)(F)F)cc2)NC(=O)c2ccccc2)cc1	InChI=1S/C35H35F3N4O4/c36-35(37,38)23-46-29-17-15-25(16-18-29)20-31(41-32(43)28-9-5-2-6-10-28)34(45)42-30(19-24-7-3-1-4-8-24)33(44)40-22-27-13-11-26(21-39)12-14-27/h1-18,30-31H,19-23,39H2,(H,40,44)(H,41,43)(H,42,45)/t30-,31?/m0/s1	ZFMHHRGGDRODQQ-FSRLHOSWSA-N	200210	US9234000, 201	Plasma kallikrein			 12							US Patent		10.7270/Q2X065W0		aid1802099	US9234000	Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200210	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200210&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71186113	318590036							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373530	Cc1cc(N)nc(C)c1CNC(=O)c1ccc(Cn2ccc3ccccc3c2=O)o1	InChI=1S/C23H22N4O3/c1-14-11-21(24)26-15(2)19(14)12-25-22(28)20-8-7-17(30-20)13-27-10-9-16-5-3-4-6-18(16)23(27)29/h3-11H,12-13H2,1-2H3,(H2,24,26)(H,25,28)	PCYFGXWDBASQBM-UHFFFAOYSA-N	211969	US9290485, 1	Plasma kallikrein			 810					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211969	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211969&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081186	329587846							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373531	Cc1cc(N)nc(C)c1CNC(=O)c1nc(Cc2ccccc2)n(C)n1	InChI=1S/C19H22N6O/c1-12-9-16(20)22-13(2)15(12)11-21-19(26)18-23-17(25(3)24-18)10-14-7-5-4-6-8-14/h4-9H,10-11H2,1-3H3,(H2,20,22)(H,21,26)	ZUDXQKDTYUIMKT-UHFFFAOYSA-N	211970	US9290485, 2	Plasma kallikrein			 7670					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211970	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211970&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836122	329587847							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373532	Cc1cc(N)nc(C)c1CNC(=O)c1cc(Cc2ccccc2)no1	InChI=1S/C19H20N4O2/c1-12-8-18(20)22-13(2)16(12)11-21-19(24)17-10-15(23-25-17)9-14-6-4-3-5-7-14/h3-8,10H,9,11H2,1-2H3,(H2,20,22)(H,21,24)	BAVNYPNHVRRHET-UHFFFAOYSA-N	211971	US9290485, 3	Plasma kallikrein			 2260					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211971	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211971&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836124	329587848							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373533	Cc1cc(N)nc(C)c1CNC(=O)c1nnc(Cc2ccccc2)o1	InChI=1S/C18H19N5O2/c1-11-8-15(19)21-12(2)14(11)10-20-17(24)18-23-22-16(25-18)9-13-6-4-3-5-7-13/h3-8H,9-10H2,1-2H3,(H2,19,21)(H,20,24)	ZNFBXTCTSGUQHW-UHFFFAOYSA-N	211972	US9290485, 4	Plasma kallikrein			 7600					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211972	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211972&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836125	329587849							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373534	Cc1cc(N)nc(C)c1CNC(=O)c1nc(Cc2ccccc2)no1	InChI=1S/C18H19N5O2/c1-11-8-15(19)21-12(2)14(11)10-20-17(24)18-22-16(23-25-18)9-13-6-4-3-5-7-13/h3-8H,9-10H2,1-2H3,(H2,19,21)(H,20,24)	AXZFTDBLZQVAAF-UHFFFAOYSA-N	211973	US9290485, 5	Plasma kallikrein			 4500					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211973	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211973&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081292	329587850							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373535	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc(Cn3cccn3)cc2)cn1	InChI=1S/C23H25N7O/c1-16-10-22(24)28-17(2)20(16)11-25-23(31)21-14-29(15-26-21)12-18-4-6-19(7-5-18)13-30-9-3-8-27-30/h3-10,14-15H,11-13H2,1-2H3,(H2,24,28)(H,25,31)	OUKWTWSWNLIIED-UHFFFAOYSA-N	211974	US9290485, 6	Plasma kallikrein			 0.2					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211974	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211974&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836188	329587851							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373536	Cc1cc(N)nc(C)c1CNC(=O)c1ncc(Cc2ccccc2)o1	InChI=1S/C19H20N4O2/c1-12-8-17(20)23-13(2)16(12)11-21-18(24)19-22-10-15(25-19)9-14-6-4-3-5-7-14/h3-8,10H,9,11H2,1-2H3,(H2,20,23)(H,21,24)	CHSCMCOWGWDCQR-UHFFFAOYSA-N	211975	US9290485, 7	Plasma kallikrein			 2030					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211975	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211975&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836192	329587852							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373537	COc1ccc(Cc2nc(co2)C(=O)NCc2c(C)cc(N)nc2C)cc1	InChI=1S/C20H22N4O3/c1-12-8-18(21)23-13(2)16(12)10-22-20(25)17-11-27-19(24-17)9-14-4-6-15(26-3)7-5-14/h4-8,11H,9-10H2,1-3H3,(H2,21,23)(H,22,25)	DCMBPCSGDIXGHI-UHFFFAOYSA-N	211976	US9290485, 8	Plasma kallikrein			 2640					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211976	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211976&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836123	329587853							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373538	COc1cc(Cn2cc(cn2)C(=O)NCc2c(C)cc(N)nc2C)ccc1Cn1cccn1	InChI=1S/C24H27N7O2/c1-16-9-23(25)29-17(2)21(16)12-26-24(32)20-11-28-31(15-20)13-18-5-6-19(22(10-18)33-3)14-30-8-4-7-27-30/h4-11,15H,12-14H2,1-3H3,(H2,25,29)(H,26,32)	GISSAZULDJGQMV-UHFFFAOYSA-N	211977	US9290485, 9	Plasma kallikrein			 0.0912					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211977	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211977&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836191	329587854							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373539	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc(cc2)-c2ccccc2)nn1	InChI=1S/C24H24N6O/c1-16-12-23(25)27-17(2)21(16)13-26-24(31)22-15-30(29-28-22)14-18-8-10-20(11-9-18)19-6-4-3-5-7-19/h3-12,15H,13-14H2,1-2H3,(H2,25,27)(H,26,31)	OIQHYMFFSWKLDO-UHFFFAOYSA-N	211978	US9290485, 10	Plasma kallikrein			 30					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211978	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211978&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836193	329587855							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373540	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(c1)C(CO)c1ccccc1	InChI=1S/C20H23N5O2/c1-13-8-19(21)24-14(2)17(13)10-22-20(27)16-9-23-25(11-16)18(12-26)15-6-4-3-5-7-15/h3-9,11,18,26H,10,12H2,1-2H3,(H2,21,24)(H,22,27)	LBJVICZKRMLNCJ-UHFFFAOYSA-N	211979	US9290485, 11	Plasma kallikrein			 12200					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211979	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211979&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836257	329587856							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373541	COc1ccc(cc1)S(=O)(=O)n1ccc(c1)C(=O)NCc1c(C)cc(N)nc1C	InChI=1S/C20H22N4O4S/c1-13-10-19(21)23-14(2)18(13)11-22-20(25)15-8-9-24(12-15)29(26,27)17-6-4-16(28-3)5-7-17/h4-10,12H,11H2,1-3H3,(H2,21,23)(H,22,25)	RMZCBHPQDPGLTG-UHFFFAOYSA-N	211980	US9290485, 12	Plasma kallikrein			 1370					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211980	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211980&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081158	329587857							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373542	COc1ccc(Cn2cc(cn2)C(=O)NCc2c(C)cc(N)nc2C)cc1	InChI=1S/C20H23N5O2/c1-13-8-19(21)24-14(2)18(13)10-22-20(26)16-9-23-25(12-16)11-15-4-6-17(27-3)7-5-15/h4-9,12H,10-11H2,1-3H3,(H2,21,24)(H,22,26)	ULUARQDPFVJPMB-UHFFFAOYSA-N	211981	US9290485, 13	Plasma kallikrein			 150					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211981	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211981&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836258	329587858							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373543	COc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccccc2)c1	InChI=1S/C19H21N5O2/c1-13-16(17(26-2)8-18(20)23-13)10-21-19(25)15-9-22-24(12-15)11-14-6-4-3-5-7-14/h3-9,12H,10-11H2,1-2H3,(H2,20,23)(H,21,25)	LNNAHRUKLVTDBH-UHFFFAOYSA-N	211982	US9290485, 14	Plasma kallikrein			 320					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211982	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211982&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836190	329587859							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373544	Cc1nc(N)cc(OC2CCCCC2)c1CNC(=O)c1cnn(Cc2ccccc2)c1	InChI=1S/C24H29N5O2/c1-17-21(22(12-23(25)28-17)31-20-10-6-3-7-11-20)14-26-24(30)19-13-27-29(16-19)15-18-8-4-2-5-9-18/h2,4-5,8-9,12-13,16,20H,3,6-7,10-11,14-15H2,1H3,(H2,25,28)(H,26,30)	ZRENHNGQWBVIAI-UHFFFAOYSA-N	211983	US9290485, 15	Plasma kallikrein			 230					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211983	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211983&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836259	329587860							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373545	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc(CO)cc2)c1	InChI=1S/C20H23N5O2/c1-13-7-19(21)24-14(2)18(13)9-22-20(27)17-8-23-25(11-17)10-15-3-5-16(12-26)6-4-15/h3-8,11,26H,9-10,12H2,1-2H3,(H2,21,24)(H,22,27)	ACHRVCHEYBBWEO-UHFFFAOYSA-N	211984	US9290485, 16	Plasma kallikrein			 150					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211984	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211984&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836189	329587861							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373546	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc(CN3C(=O)CCC3=O)cc2)c1	InChI=1S/C24H26N6O3/c1-15-9-21(25)28-16(2)20(15)11-26-24(33)19-10-27-29(14-19)12-17-3-5-18(6-4-17)13-30-22(31)7-8-23(30)32/h3-6,9-10,14H,7-8,11-13H2,1-2H3,(H2,25,28)(H,26,33)	OIUPJAOKWHMNEH-UHFFFAOYSA-N	211985	US9290485, 17	Plasma kallikrein			 98					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211985	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211985&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081267	329587862							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373547	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccncc2)c1	InChI=1S/C18H20N6O/c1-12-7-17(19)23-13(2)16(12)9-21-18(25)15-8-22-24(11-15)10-14-3-5-20-6-4-14/h3-8,11H,9-10H2,1-2H3,(H2,19,23)(H,21,25)	LRMLBIIGBOPUPH-UHFFFAOYSA-N	211986	US9290485, 18	Plasma kallikrein			 1100					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211986	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211986&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081287	329587863							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373548	CNC(=O)COc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccccc2)c1	InChI=1S/C21H24N6O3/c1-14-17(18(8-19(22)26-14)30-13-20(28)23-2)10-24-21(29)16-9-25-27(12-16)11-15-6-4-3-5-7-15/h3-9,12H,10-11,13H2,1-2H3,(H2,22,26)(H,23,28)(H,24,29)	BSFUNWYPRPHBQM-UHFFFAOYSA-N	211987	US9290485, 19	Plasma kallikrein			 70					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211987	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211987&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081255	329587864							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373549	Cc1cc(N)nc(C)c1CNC(=O)c1coc(Nc2ccccc2)n1	InChI=1S/C18H19N5O2/c1-11-8-16(19)21-12(2)14(11)9-20-17(24)15-10-25-18(23-15)22-13-6-4-3-5-7-13/h3-8,10H,9H2,1-2H3,(H2,19,21)(H,20,24)(H,22,23)	PEBVXZHHVAKSFQ-UHFFFAOYSA-N	211988	US9290485, 20	Plasma kallikrein			 7400					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211988	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211988&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081340	329587865							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373550	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccccc2)nn1	InChI=1S/C18H20N6O/c1-12-8-17(19)21-13(2)15(12)9-20-18(25)16-11-24(23-22-16)10-14-6-4-3-5-7-14/h3-8,11H,9-10H2,1-2H3,(H2,19,21)(H,20,25)	QVQMFVXDJUTIKG-UHFFFAOYSA-N	211989	US9290485, 21	Plasma kallikrein			 2540					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211989	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211989&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836260	329587866							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373551	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccccc2)cn1	InChI=1S/C19H21N5O/c1-13-8-18(20)23-14(2)16(13)9-21-19(25)17-11-24(12-22-17)10-15-6-4-3-5-7-15/h3-8,11-12H,9-10H2,1-2H3,(H2,20,23)(H,21,25)	FBAPNPFIJBPEIT-UHFFFAOYSA-N	211990	US9290485, 22	Plasma kallikrein			 1700					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211990	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211990&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836327	329587867							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373552	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc(Oc3ccccc3)cc2)cn1	InChI=1S/C25H25N5O2/c1-17-12-24(26)29-18(2)22(17)13-27-25(31)23-15-30(16-28-23)14-19-8-10-21(11-9-19)32-20-6-4-3-5-7-20/h3-12,15-16H,13-14H2,1-2H3,(H2,26,29)(H,27,31)	GTRZDWXIXSFZSJ-UHFFFAOYSA-N	211991	US9290485, 23	Plasma kallikrein			 9					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211991	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211991&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836330	329587868							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373553	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc(cc2)-n2cccn2)cn1	InChI=1S/C22H23N7O/c1-15-10-21(23)27-16(2)19(15)11-24-22(30)20-13-28(14-25-20)12-17-4-6-18(7-5-17)29-9-3-8-26-29/h3-10,13-14H,11-12H2,1-2H3,(H2,23,27)(H,24,30)	SDKNXFXFIWAGHW-UHFFFAOYSA-N	211992	US9290485, 24	Plasma kallikrein			 238					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211992	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211992&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836329	329587869							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373554	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2csc(Nc3ccccc3)n2)c1	InChI=1S/C22H23N7OS/c1-14-8-20(23)26-15(2)19(14)10-24-21(30)16-9-25-29(11-16)12-18-13-31-22(28-18)27-17-6-4-3-5-7-17/h3-9,11,13H,10,12H2,1-2H3,(H2,23,26)(H,24,30)(H,27,28)	KRVANXMIFRIDJT-UHFFFAOYSA-N	211993	US9290485, 25	Plasma kallikrein			 109					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211993	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211993&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836262	329587870							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373555	Cc1nc(sc1Cn1cc(cn1)C(=O)NCc1c(C)cc(N)nc1C)-c1ccccc1	InChI=1S/C23H24N6OS/c1-14-9-21(24)27-15(2)19(14)11-25-22(30)18-10-26-29(12-18)13-20-16(3)28-23(31-20)17-7-5-4-6-8-17/h4-10,12H,11,13H2,1-3H3,(H2,24,27)(H,25,30)	OOHSVGGUTZAFJG-UHFFFAOYSA-N	211994	US9290485, 26	Plasma kallikrein			 19					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211994	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211994&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836261	329587871							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373556	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2csc(Cc3ccccc3)n2)c1	InChI=1S/C23H24N6OS/c1-15-8-21(24)27-16(2)20(15)11-25-23(30)18-10-26-29(12-18)13-19-14-31-22(28-19)9-17-6-4-3-5-7-17/h3-8,10,12,14H,9,11,13H2,1-2H3,(H2,24,27)(H,25,30)	XXJKFEZCNLMZSU-UHFFFAOYSA-N	211995	US9290485, 27	Plasma kallikrein			 21					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211995	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211995&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836332	329587872							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373557	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2csc(n2)C(C)(C)C)c1	InChI=1S/C20H26N6OS/c1-12-6-17(21)24-13(2)16(12)8-22-18(27)14-7-23-26(9-14)10-15-11-28-19(25-15)20(3,4)5/h6-7,9,11H,8,10H2,1-5H3,(H2,21,24)(H,22,27)	XXOBCKZLTYYIFO-UHFFFAOYSA-N	211996	US9290485, 28	Plasma kallikrein			 343					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211996	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211996&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836328	329587873							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373558	CN(C)C(=O)Cc1nc(Cn2cc(cn2)C(=O)NCc2c(C)cc(N)nc2C)cs1	InChI=1S/C20H25N7O2S/c1-12-5-17(21)24-13(2)16(12)8-22-20(29)14-7-23-27(9-14)10-15-11-30-18(25-15)6-19(28)26(3)4/h5,7,9,11H,6,8,10H2,1-4H3,(H2,21,24)(H,22,29)	UVQHJBUGKGJWEA-UHFFFAOYSA-N	211997	US9290485, 29	Plasma kallikrein			 248					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211997	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211997&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836331	329587874							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373559	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2cn3ccccc3n2)c1	InChI=1S/C20H21N7O/c1-13-7-18(21)24-14(2)17(13)9-22-20(28)15-8-23-27(10-15)12-16-11-26-6-4-3-5-19(26)25-16/h3-8,10-11H,9,12H2,1-2H3,(H2,21,24)(H,22,28)	OYLJPVORLWINFY-UHFFFAOYSA-N	211998	US9290485, 30	Plasma kallikrein			 204					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211998	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211998&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836408	329587875							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373560	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2cc3ccccc3o2)c1	InChI=1S/C21H21N5O2/c1-13-7-20(22)25-14(2)18(13)10-23-21(27)16-9-24-26(11-16)12-17-8-15-5-3-4-6-19(15)28-17/h3-9,11H,10,12H2,1-2H3,(H2,22,25)(H,23,27)	YZWTUMFQPSCKHC-UHFFFAOYSA-N	211999	US9290485, 31	Plasma kallikrein			 143					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211999	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211999&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836622	329587876							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373561	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2coc(n2)-c2ccccc2)c1	InChI=1S/C22H22N6O2/c1-14-8-20(23)26-15(2)19(14)10-24-21(29)17-9-25-28(11-17)12-18-13-30-22(27-18)16-6-4-3-5-7-16/h3-9,11,13H,10,12H2,1-2H3,(H2,23,26)(H,24,29)	URNQLIMTVRDZCM-UHFFFAOYSA-N	212000	US9290485, 32	Plasma kallikrein			 41					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212000	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212000&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836623	329587877							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373562	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc3[nH]cnc3c2)c1	InChI=1S/C20H21N7O/c1-12-5-19(21)26-13(2)16(12)8-22-20(28)15-7-25-27(10-15)9-14-3-4-17-18(6-14)24-11-23-17/h3-7,10-11H,8-9H2,1-2H3,(H2,21,26)(H,22,28)(H,23,24)	WLIVFTPRFJQPPD-UHFFFAOYSA-N	212001	US9290485, 33	Plasma kallikrein			 262					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212001	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212001&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836411	329587878							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373563	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc3ccn(C)c3c2)c1	InChI=1S/C22H24N6O/c1-14-8-21(23)26-15(2)19(14)11-24-22(29)18-10-25-28(13-18)12-16-4-5-17-6-7-27(3)20(17)9-16/h4-10,13H,11-12H2,1-3H3,(H2,23,26)(H,24,29)	MHLALIQKGDASOX-UHFFFAOYSA-N	212002	US9290485, 34	Plasma kallikrein			 46					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212002	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212002&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836409	329587879							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373564	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ncoc2-c2ccccc2)c1	InChI=1S/C22H22N6O2/c1-14-8-20(23)27-15(2)18(14)10-24-22(29)17-9-26-28(11-17)12-19-21(30-13-25-19)16-6-4-3-5-7-16/h3-9,11,13H,10,12H2,1-2H3,(H2,23,27)(H,24,29)	SLKNIQINJJTWTN-UHFFFAOYSA-N	212003	US9290485, 35	Plasma kallikrein			 3900					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212003	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212003&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836485	329587880							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373565	Cc1cc(C)n(Cc2ccc(Cn3cc(cn3)C(=O)NCc3c(C)cc(N)nc3C)cc2)n1	InChI=1S/C25H29N7O/c1-16-9-24(26)29-19(4)23(16)12-27-25(33)22-11-28-31(15-22)13-20-5-7-21(8-6-20)14-32-18(3)10-17(2)30-32/h5-11,15H,12-14H2,1-4H3,(H2,26,29)(H,27,33)	MAGLWMOZQOEIRW-UHFFFAOYSA-N	212004	US9290485, 36	Plasma kallikrein			 0.134					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212004	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212004&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836410	329587881							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373566	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(c1)S(=O)(=O)c1cccc(c1)C#N	InChI=1S/C19H18N6O3S/c1-12-6-18(21)24-13(2)17(12)10-22-19(26)15-9-23-25(11-15)29(27,28)16-5-3-4-14(7-16)8-20/h3-7,9,11H,10H2,1-2H3,(H2,21,24)(H,22,26)	RFWGXKVXWYEDIE-UHFFFAOYSA-N	212005	US9290485, 37	Plasma kallikrein			 5300					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212005	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212005&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836556	329587882							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373567	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc(Oc3ccccc3)cc2)nn1	InChI=1S/C24H24N6O2/c1-16-12-23(25)27-17(2)21(16)13-26-24(31)22-15-30(29-28-22)14-18-8-10-20(11-9-18)32-19-6-4-3-5-7-19/h3-12,15H,13-14H2,1-2H3,(H2,25,27)(H,26,31)	MHSBTTJCQQJZNU-UHFFFAOYSA-N	212006	US9290485, 38	Plasma kallikrein			 19					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212006	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212006&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836412	329587883							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373568	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2cccc3ccccc23)nn1	InChI=1S/C22H22N6O/c1-14-10-21(23)25-15(2)19(14)11-24-22(29)20-13-28(27-26-20)12-17-8-5-7-16-6-3-4-9-18(16)17/h3-10,13H,11-12H2,1-2H3,(H2,23,25)(H,24,29)	NLRLSHYJGRTPLS-UHFFFAOYSA-N	212007	US9290485, 39	Plasma kallikrein			 634					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212007	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212007&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836487	329587884							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373569	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ccccc3c2)nn1	InChI=1S/C22H22N6O/c1-14-9-21(23)25-15(2)19(14)11-24-22(29)20-13-28(27-26-20)12-16-7-8-17-5-3-4-6-18(17)10-16/h3-10,13H,11-12H2,1-2H3,(H2,23,25)(H,24,29)	MBRKUBPARWQXHD-UHFFFAOYSA-N	212008	US9290485, 40	Plasma kallikrein			 9					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212008	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212008&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836484	329587885							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373570	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc(cc2)-n2cccn2)nn1	InChI=1S/C21H22N8O/c1-14-10-20(22)25-15(2)18(14)11-23-21(30)19-13-28(27-26-19)12-16-4-6-17(7-5-16)29-9-3-8-24-29/h3-10,13H,11-12H2,1-2H3,(H2,22,25)(H,23,30)	WIYPUZPBXBLMSM-UHFFFAOYSA-N	212009	US9290485, 41	Plasma kallikrein			 108					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212009	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212009&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836553	329587886							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373571	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2cccc(c2)-n2cccn2)nn1	InChI=1S/C21H22N8O/c1-14-9-20(22)25-15(2)18(14)11-23-21(30)19-13-28(27-26-19)12-16-5-3-6-17(10-16)29-8-4-7-24-29/h3-10,13H,11-12H2,1-2H3,(H2,22,25)(H,23,30)	BCZGTKJOMVDJJZ-UHFFFAOYSA-N	212010	US9290485, 42	Plasma kallikrein			 145					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212010	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212010&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836557	329587887							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373572	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2cccc(c2)N2CCCC2)nn1	InChI=1S/C22H27N7O/c1-15-10-21(23)25-16(2)19(15)12-24-22(30)20-14-29(27-26-20)13-17-6-5-7-18(11-17)28-8-3-4-9-28/h5-7,10-11,14H,3-4,8-9,12-13H2,1-2H3,(H2,23,25)(H,24,30)	YRTJJYKZLPYTIN-UHFFFAOYSA-N	212011	US9290485, 43	Plasma kallikrein			 113					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212011	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212011&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836483	329587888							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373573	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2cc3ccccc3o2)n1	InChI=1S/C20H20N6O2/c1-12-7-19(21)24-13(2)16(12)9-22-20(27)17-10-23-26(25-17)11-15-8-14-5-3-4-6-18(14)28-15/h3-8,10H,9,11H2,1-2H3,(H2,21,24)(H,22,27)	UNTRPEXZLPRKLH-UHFFFAOYSA-N	212012	US9290485, 44	Plasma kallikrein			 215					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212012	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212012&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836413	329587889							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373574	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc(Cn3ccnc3)cc2)nn1	InChI=1S/C22H24N8O/c1-15-9-21(23)26-16(2)19(15)10-25-22(31)20-13-30(28-27-20)12-18-5-3-17(4-6-18)11-29-8-7-24-14-29/h3-9,13-14H,10-12H2,1-2H3,(H2,23,26)(H,25,31)	HHSFVRDDLHLDJJ-UHFFFAOYSA-N	212013	US9290485, 45	Plasma kallikrein			 45					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212013	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212013&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836554	329587890							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373575	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2cccc(Cn3ccnc3)c2)nn1	InChI=1S/C22H24N8O/c1-15-8-21(23)26-16(2)19(15)10-25-22(31)20-13-30(28-27-20)12-18-5-3-4-17(9-18)11-29-7-6-24-14-29/h3-9,13-14H,10-12H2,1-2H3,(H2,23,26)(H,25,31)	JNYWMWTXMOIBGI-UHFFFAOYSA-N	212014	US9290485, 46	Plasma kallikrein			 1100					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212014	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212014&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836486	329587891							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373576	Cc1cc(N)nc(C)c1CNC(=O)c1csc(Cc2ccccc2)n1	InChI=1S/C19H20N4OS/c1-12-8-17(20)22-13(2)15(12)10-21-19(24)16-11-25-18(23-16)9-14-6-4-3-5-7-14/h3-8,11H,9-10H2,1-2H3,(H2,20,22)(H,21,24)	PHYSWHLTJDIWFC-UHFFFAOYSA-N	212015	US9290485, 47	Plasma kallikrein			 3200					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212015	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212015&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836555	329587892							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373577	Cc1cc(N)nc(C)c1CNC(=O)c1ccc(Oc2ccccc2)o1	InChI=1S/C19H19N3O3/c1-12-10-17(20)22-13(2)15(12)11-21-19(23)16-8-9-18(25-16)24-14-6-4-3-5-7-14/h3-10H,11H2,1-2H3,(H2,20,22)(H,21,23)	GTGHMBBKODSHRE-UHFFFAOYSA-N	212016	US9290485, 48	Plasma kallikrein			 35500					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212016	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212016&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836488	329587893							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373578	Cc1nn(Cc2ccccc2)cc1C(=O)NCc1c(C)cc(N)nc1C	InChI=1S/C20H23N5O/c1-13-9-19(21)23-14(2)17(13)10-22-20(26)18-12-25(24-15(18)3)11-16-7-5-4-6-8-16/h4-9,12H,10-11H2,1-3H3,(H2,21,23)(H,22,26)	NOUMDPPDURVRDC-UHFFFAOYSA-N	212017	US9290485, 49	Plasma kallikrein			 679					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212017	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212017&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836552	329587894							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373579	Cc1cc(C(=O)NCc2c(C)cc(N)nc2C)c(C)n1Cc1ccco1	InChI=1S/C20H24N4O2/c1-12-8-19(21)23-14(3)18(12)10-22-20(25)17-9-13(2)24(15(17)4)11-16-6-5-7-26-16/h5-9H,10-11H2,1-4H3,(H2,21,23)(H,22,25)	RPXMSPHMCUCZNH-UHFFFAOYSA-N	212018	US9290485, 50	Plasma kallikrein			 739					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212018	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212018&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836781	329587895							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373580	CC(c1ccccc1)n1c(C)cc(C(=O)NCc2c(C)cc(N)nc2C)c1C	InChI=1S/C23H28N4O/c1-14-11-22(24)26-16(3)21(14)13-25-23(28)20-12-15(2)27(18(20)5)17(4)19-9-7-6-8-10-19/h6-12,17H,13H2,1-5H3,(H2,24,26)(H,25,28)	JRMWHJBSUIUNBW-UHFFFAOYSA-N	212019	US9290485, 51	Plasma kallikrein			 7000					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212019	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212019&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836782	329587896							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373581	Cc1cc(N)nc(C)c1CNC(=O)c1cc(c[nH]1)S(=O)(=O)N1CCOCC1	InChI=1S/C17H23N5O4S/c1-11-7-16(18)21-12(2)14(11)10-20-17(23)15-8-13(9-19-15)27(24,25)22-3-5-26-6-4-22/h7-9,19H,3-6,10H2,1-2H3,(H2,18,21)(H,20,23)	ILFBOPLUPHMIDD-UHFFFAOYSA-N	212020	US9290485, 52	Plasma kallikrein			 5700					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212020	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212020&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081279	329587897							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373582	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2c(F)cccc2F)nn1	InChI=1S/C18H18F2N6O/c1-10-6-17(21)23-11(2)12(10)7-22-18(27)16-9-26(25-24-16)8-13-14(19)4-3-5-15(13)20/h3-6,9H,7-8H2,1-2H3,(H2,21,23)(H,22,27)	YLDIKIAHQGCTTE-UHFFFAOYSA-N	212021	US9290485, 53	Plasma kallikrein			 3600					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212021	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212021&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836783	329587898							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373583	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2cccc(c2)C#N)nn1	InChI=1S/C19H19N7O/c1-12-6-18(21)23-13(2)16(12)9-22-19(27)17-11-26(25-24-17)10-15-5-3-4-14(7-15)8-20/h3-7,11H,9-10H2,1-2H3,(H2,21,23)(H,22,27)	RFUVSHLZUAOYPH-UHFFFAOYSA-N	212022	US9290485, 54	Plasma kallikrein			 1800					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212022	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212022&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836624	329587899							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373584	Cc1nc(Cc2ccccc2)sc1C(=O)NCc1c(C)cc(N)nc1C	InChI=1S/C20H22N4OS/c1-12-9-17(21)23-13(2)16(12)11-22-20(25)19-14(3)24-18(26-19)10-15-7-5-4-6-8-15/h4-9H,10-11H2,1-3H3,(H2,21,23)(H,22,25)	JEFVBYDUOMVLHI-UHFFFAOYSA-N	212023	US9290485, 55	Plasma kallikrein			 6300					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212023	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212023&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836626	329587900							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373585	Cc1cc(N)nc(C)c1CNC(=O)c1ncn(Cc2ccccc2)n1	InChI=1S/C18H20N6O/c1-12-8-16(19)22-13(2)15(12)9-20-18(25)17-21-11-24(23-17)10-14-6-4-3-5-7-14/h3-8,11H,9-10H2,1-2H3,(H2,19,22)(H,20,25)	VDVDOLCDTIHJHO-UHFFFAOYSA-N	212024	US9290485, 56	Plasma kallikrein			 4400					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212024	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212024&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836709	329587901							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373586	Cc1cncc(Oc2ccc(Cn3cc(cn3)C(=O)NCc3c(C)cc(N)nc3C)cc2)n1	InChI=1S/C24H25N7O2/c1-15-8-22(25)30-17(3)21(15)11-27-24(32)19-10-28-31(14-19)13-18-4-6-20(7-5-18)33-23-12-26-9-16(2)29-23/h4-10,12,14H,11,13H2,1-3H3,(H2,25,30)(H,27,32)	LMKPUGVRQMCJJU-UHFFFAOYSA-N	212025	US9290485, 57	Plasma kallikrein			 144					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212025	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212025&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836625	329587902							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373587	Cc1cc(N)nc(C)c1CNC(=O)c1coc(Cc2ccccc2)n1	InChI=1S/C19H20N4O2/c1-12-8-17(20)22-13(2)15(12)10-21-19(24)16-11-25-18(23-16)9-14-6-4-3-5-7-14/h3-8,11H,9-10H2,1-2H3,(H2,20,22)(H,21,24)	HQQHQZXVVZJXRZ-UHFFFAOYSA-N	212026	US9290485, 58	Plasma kallikrein			 3800					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212026	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212026&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836708	329587903							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373588	Cc1cc(N)nc(C)c1CNC(=O)c1ncn(Cc2ccc(Cn3cncn3)cc2)n1	InChI=1S/C21H23N9O/c1-14-7-19(22)27-15(2)18(14)8-24-21(31)20-25-13-30(28-20)10-17-5-3-16(4-6-17)9-29-12-23-11-26-29/h3-7,11-13H,8-10H2,1-2H3,(H2,22,27)(H,24,31)	FUJWXPYTYXJWOD-UHFFFAOYSA-N	212027	US9290485, 59	Plasma kallikrein			 209					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212027	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212027&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836707	329587904							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373589	COCCOc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccccc2)c1	InChI=1S/C21H25N5O3/c1-15-18(19(10-20(22)25-15)29-9-8-28-2)12-23-21(27)17-11-24-26(14-17)13-16-6-4-3-5-7-16/h3-7,10-11,14H,8-9,12-13H2,1-2H3,(H2,22,25)(H,23,27)	ZUXZPMVAQHMLQJ-UHFFFAOYSA-N	212028	US9290485, 60	Plasma kallikrein			 379					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212028	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212028&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836704	329587905							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373590	Cc1cc(N)nc(C)c1CNC(=O)c1ncn(Cc2ccc(cc2)-c2ccccc2)n1	InChI=1S/C24H24N6O/c1-16-12-22(25)28-17(2)21(16)13-26-24(31)23-27-15-30(29-23)14-18-8-10-20(11-9-18)19-6-4-3-5-7-19/h3-12,15H,13-14H2,1-2H3,(H2,25,28)(H,26,31)	KHZULTQYMYJBPY-UHFFFAOYSA-N	212029	US9290485, 61	Plasma kallikrein			 46					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212029	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212029&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836627	329587906							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373591	Cc1cc(N)nc(C)c1CNC(=O)c1ncn(Cc2cccc3ccccc23)n1	InChI=1S/C22H22N6O/c1-14-10-20(23)26-15(2)19(14)11-24-22(29)21-25-13-28(27-21)12-17-8-5-7-16-6-3-4-9-18(16)17/h3-10,13H,11-12H2,1-2H3,(H2,23,26)(H,24,29)	VFUVLOZRLJAPPU-UHFFFAOYSA-N	212030	US9290485, 62	Plasma kallikrein			 681					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212030	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212030&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836705	329587907							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373592	Cc1cc(N)nc(C)c1CNC(=O)c1ncn(Cc2ccc(Oc3ccccc3)cc2)n1	InChI=1S/C24H24N6O2/c1-16-12-22(25)28-17(2)21(16)13-26-24(31)23-27-15-30(29-23)14-18-8-10-20(11-9-18)32-19-6-4-3-5-7-19/h3-12,15H,13-14H2,1-2H3,(H2,25,28)(H,26,31)	QVIJKFUZGKPKSV-UHFFFAOYSA-N	212031	US9290485, 63	Plasma kallikrein			 11					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212031	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212031&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836706	329587908							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373593	Cc1cc(N)nc(C)c1CNC(=O)c1ncn(Cc2ccc3ccccc3c2)n1	InChI=1S/C22H22N6O/c1-14-9-20(23)26-15(2)19(14)11-24-22(29)21-25-13-28(27-21)12-16-7-8-17-5-3-4-6-18(17)10-16/h3-10,13H,11-12H2,1-2H3,(H2,23,26)(H,24,29)	BOINRHSOFVSNQU-UHFFFAOYSA-N	212032	US9290485, 64	Plasma kallikrein			 14					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212032	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212032&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836929	329587909							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373594	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc(cc2)N2CCCC2=O)c1	InChI=1S/C23H26N6O2/c1-15-10-21(24)27-16(2)20(15)12-25-23(31)18-11-26-28(14-18)13-17-5-7-19(8-6-17)29-9-3-4-22(29)30/h5-8,10-11,14H,3-4,9,12-13H2,1-2H3,(H2,24,27)(H,25,31)	YSBPDXVFLIPXTO-UHFFFAOYSA-N	212033	US9290485, 65	Plasma kallikrein			 29					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212033	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212033&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836930	329587910							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373595	Cc1cc(N)nc(C)c1CNC(=O)c1ncn(Cc2ccc(cc2)-n2cccn2)n1	InChI=1S/C21H22N8O/c1-14-10-19(22)26-15(2)18(14)11-23-21(30)20-24-13-28(27-20)12-16-4-6-17(7-5-16)29-9-3-8-25-29/h3-10,13H,11-12H2,1-2H3,(H2,22,26)(H,23,30)	FWDWMFHWEGGMGL-UHFFFAOYSA-N	212034	US9290485, 66	Plasma kallikrein			 325					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212034	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212034&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56835797	329587911							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373596	Cc1cc(N)nc(C)c1CNC(=O)c1ncn(Cc2cccc(c2)-n2cccn2)n1	InChI=1S/C21H22N8O/c1-14-9-19(22)26-15(2)18(14)11-23-21(30)20-24-13-28(27-20)12-16-5-3-6-17(10-16)29-8-4-7-25-29/h3-10,13H,11-12H2,1-2H3,(H2,22,26)(H,23,30)	QXYBMUQNHRDNIX-UHFFFAOYSA-N	212035	US9290485, 67	Plasma kallikrein			 60					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212035	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212035&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836786	329587912							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373597	Cc1cc(N)nc(C)c1CNC(=O)c1ncn(Cc2cccc(c2)N2CCCC2)n1	InChI=1S/C22H27N7O/c1-15-10-20(23)26-16(2)19(15)12-24-22(30)21-25-14-29(27-21)13-17-6-5-7-18(11-17)28-8-3-4-9-28/h5-7,10-11,14H,3-4,8-9,12-13H2,1-2H3,(H2,23,26)(H,24,30)	NUMQRUYULXVQRY-UHFFFAOYSA-N	212036	US9290485, 68	Plasma kallikrein			 34					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212036	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212036&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081301	329587913							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373598	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccnc(c2)N2CCOCC2)c1	InChI=1S/C22H27N7O2/c1-15-9-20(23)27-16(2)19(15)12-25-22(30)18-11-26-29(14-18)13-17-3-4-24-21(10-17)28-5-7-31-8-6-28/h3-4,9-11,14H,5-8,12-13H2,1-2H3,(H2,23,27)(H,25,30)	GDDDMMNDJRDZCI-UHFFFAOYSA-N	212037	US9290485, 69	Plasma kallikrein			 1600					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212037	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212037&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836784	329587914							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373599	Cc1cc(N)nc(C)c1CNC(=O)c1ccn(Cc2ccccc2)c1	InChI=1S/C20H22N4O/c1-14-10-19(21)23-15(2)18(14)11-22-20(25)17-8-9-24(13-17)12-16-6-4-3-5-7-16/h3-10,13H,11-12H2,1-2H3,(H2,21,23)(H,22,25)	JYWSLTHIABTUOB-UHFFFAOYSA-N	212038	US9290485, 70	Plasma kallikrein			 4100					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212038	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212038&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836928	329587915							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373600	COCCc1cccc(Cn2cc(cn2)C(=O)NCc2c(C)cc(N)nc2C)c1	InChI=1S/C22H27N5O2/c1-15-9-21(23)26-16(2)20(15)12-24-22(28)19-11-25-27(14-19)13-18-6-4-5-17(10-18)7-8-29-3/h4-6,9-11,14H,7-8,12-13H2,1-3H3,(H2,23,26)(H,24,28)	VIGDTVWBASSIEN-UHFFFAOYSA-N	212039	US9290485, 71	Plasma kallikrein			 190					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212039	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212039&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836785	329587916							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373601	Cc1cc(C(=O)NCc2c(C)cc(N)nc2C)c(C)n1S(=O)(=O)c1ccccc1	InChI=1S/C21H24N4O3S/c1-13-10-20(22)24-15(3)19(13)12-23-21(26)18-11-14(2)25(16(18)4)29(27,28)17-8-6-5-7-9-17/h5-11H,12H2,1-4H3,(H2,22,24)(H,23,26)	CSWCXDDXKQWSRB-UHFFFAOYSA-N	212040	US9290485, 72	Plasma kallikrein			 937					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212040	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212040&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836926	329587917							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373602	COc1cc(Cn2cc(cn2)C(=O)NCc2c(C)cc(N)nc2C)cc(OC)c1	InChI=1S/C21H25N5O3/c1-13-5-20(22)25-14(2)19(13)10-23-21(27)16-9-24-26(12-16)11-15-6-17(28-3)8-18(7-15)29-4/h5-9,12H,10-11H2,1-4H3,(H2,22,25)(H,23,27)	UTAJKCOBLAFYDW-UHFFFAOYSA-N	212041	US9290485, 73	Plasma kallikrein			 114					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212041	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212041&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836927	329587918							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373603	Cc1cn(cc1C(=O)NCc1c(C)cc(N)nc1C)S(=O)(=O)c1ccccc1	InChI=1S/C20H22N4O3S/c1-13-9-19(21)23-15(3)17(13)10-22-20(25)18-12-24(11-14(18)2)28(26,27)16-7-5-4-6-8-16/h4-9,11-12H,10H2,1-3H3,(H2,21,23)(H,22,25)	BYMDCGFTGBZJBB-UHFFFAOYSA-N	212042	US9290485, 74	Plasma kallikrein			 595					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212042	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212042&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081165	329587919							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373604	Cc1[nH]c2ccc(Cn3cc(cn3)C(=O)NCc3c(C)cc(N)nc3C)cc2c1C	InChI=1S/C23H26N6O/c1-13-7-22(24)28-16(4)20(13)10-25-23(30)18-9-26-29(12-18)11-17-5-6-21-19(8-17)14(2)15(3)27-21/h5-9,12,27H,10-11H2,1-4H3,(H2,24,28)(H,25,30)	HGVKEHICKRVVTE-UHFFFAOYSA-N	212043	US9290485, 75	Plasma kallikrein			 3.1					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212043	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212043&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836858	329587920							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373605	Cc1cn(Cc2ccccc2)cc1C(=O)NCc1c(C)cc(N)nc1C	InChI=1S/C21H24N4O/c1-14-9-20(22)24-16(3)18(14)10-23-21(26)19-13-25(11-15(19)2)12-17-7-5-4-6-8-17/h4-9,11,13H,10,12H2,1-3H3,(H2,22,24)(H,23,26)	PHHWNVCZAXETDR-UHFFFAOYSA-N	212044	US9290485, 76	Plasma kallikrein			 949					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212044	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212044&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836925	329587921							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373606	Cc1nc(N)cc(OCC(N)=O)c1CNC(=O)c1cnn(Cc2ccccc2)c1	InChI=1S/C20H22N6O3/c1-13-16(17(7-18(21)25-13)29-12-19(22)27)9-23-20(28)15-8-24-26(11-15)10-14-5-3-2-4-6-14/h2-8,11H,9-10,12H2,1H3,(H2,21,25)(H2,22,27)(H,23,28)	SGCNQIHFCKWCTH-UHFFFAOYSA-N	212045	US9290485, 77	Plasma kallikrein			 72					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212045	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212045&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081342	329587922							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373607	Cc1cc(N)nc(C)c1CNC(=O)c1coc(Oc2ccccc2)n1	InChI=1S/C18H18N4O3/c1-11-8-16(19)21-12(2)14(11)9-20-17(23)15-10-24-18(22-15)25-13-6-4-3-5-7-13/h3-8,10H,9H2,1-2H3,(H2,19,21)(H,20,23)	ONJQDAWDADMDRL-UHFFFAOYSA-N	212046	US9290485, 78	Plasma kallikrein			 10100					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212046	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212046&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081339	329587923							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373608	Cc1oc(Cn2ccc3ccccc3c2=O)cc1C(=O)NCc1c(C)cc(N)nc1C	InChI=1S/C24H24N4O3/c1-14-10-22(25)27-15(2)21(14)12-26-23(29)20-11-18(31-16(20)3)13-28-9-8-17-6-4-5-7-19(17)24(28)30/h4-11H,12-13H2,1-3H3,(H2,25,27)(H,26,29)	OJKPTFGDSOLUFF-UHFFFAOYSA-N	212047	US9290485, 79	Plasma kallikrein			 166					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212047	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212047&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836861	329587924							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373609	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc(OC(F)(F)F)cc2)c1	InChI=1S/C20H20F3N5O2/c1-12-7-18(24)27-13(2)17(12)9-25-19(29)15-8-26-28(11-15)10-14-3-5-16(6-4-14)30-20(21,22)23/h3-8,11H,9-10H2,1-2H3,(H2,24,27)(H,25,29)	HRLLYAUDNOMZTA-UHFFFAOYSA-N	212048	US9290485, 80	Plasma kallikrein			 117					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212048	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212048&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836860	329587925							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373610	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2cccc(c2)C#N)c1	InChI=1S/C20H20N6O/c1-13-6-19(22)25-14(2)18(13)10-23-20(27)17-9-24-26(12-17)11-16-5-3-4-15(7-16)8-21/h3-7,9,12H,10-11H2,1-2H3,(H2,22,25)(H,23,27)	JKQQCHADIMQVBM-UHFFFAOYSA-N	212049	US9290485, 81	Plasma kallikrein			 411					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212049	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212049&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836863	329587926							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373611	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc(cc2)C#N)c1	InChI=1S/C20H20N6O/c1-13-7-19(22)25-14(2)18(13)10-23-20(27)17-9-24-26(12-17)11-16-5-3-15(8-21)4-6-16/h3-7,9,12H,10-11H2,1-2H3,(H2,22,25)(H,23,27)	OMKHCIFLCNZFGN-UHFFFAOYSA-N	212050	US9290485, 82	Plasma kallikrein			 678					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212050	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212050&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836862	329587927							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373612	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc3ccccc3c2)c1	InChI=1S/C23H23N5O/c1-15-9-22(24)27-16(2)21(15)12-25-23(29)20-11-26-28(14-20)13-17-7-8-18-5-3-4-6-19(18)10-17/h3-11,14H,12-13H2,1-2H3,(H2,24,27)(H,25,29)	VWGVJQZHMBOLSQ-UHFFFAOYSA-N	212051	US9290485, 83	Plasma kallikrein			 18					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212051	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212051&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836859	329587928							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373613	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2cccc(F)c2)c1	InChI=1S/C19H20FN5O/c1-12-6-18(21)24-13(2)17(12)9-22-19(26)15-8-23-25(11-15)10-14-4-3-5-16(20)7-14/h3-8,11H,9-10H2,1-2H3,(H2,21,24)(H,22,26)	ADHPVJPGQKBDKM-UHFFFAOYSA-N	212052	US9290485, 84	Plasma kallikrein			 498					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212052	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212052&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56835993	329587929							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373614	Cc1nc(N)ccc1CNC(=O)c1cnn(Cc2ccccc2)c1	InChI=1S/C18H19N5O/c1-13-15(7-8-17(19)22-13)9-20-18(24)16-10-21-23(12-16)11-14-5-3-2-4-6-14/h2-8,10,12H,9,11H2,1H3,(H2,19,22)(H,20,24)	OWFDEFYDWUKBDA-UHFFFAOYSA-N	212053	US9290485, 85	Plasma kallikrein			 4100					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212053	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212053&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56835928	329587930							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373615	Cc1cccc(Cn2cc(cn2)C(=O)NCc2c(C)cc(N)nc2C)n1	InChI=1S/C19H22N6O/c1-12-7-18(20)24-14(3)17(12)9-21-19(26)15-8-22-25(10-15)11-16-6-4-5-13(2)23-16/h4-8,10H,9,11H2,1-3H3,(H2,20,24)(H,21,26)	CCLJREZEJQOIAB-UHFFFAOYSA-N	212054	US9290485, 86::US9290485, 99	Plasma kallikrein			 7500					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212054	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212054&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081200	329587931							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373616	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccccc2Cl)c1	InChI=1S/C19H20ClN5O/c1-12-7-18(21)24-13(2)16(12)9-22-19(26)15-8-23-25(11-15)10-14-5-3-4-6-17(14)20/h3-8,11H,9-10H2,1-2H3,(H2,21,24)(H,22,26)	ARQXIEWAUSQQHM-UHFFFAOYSA-N	212055	US9290485, 87	Plasma kallikrein			 1300					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212055	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212055&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56835799	329587932							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373617	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(CC2CCCCC2)c1	InChI=1S/C19H27N5O/c1-13-8-18(20)23-14(2)17(13)10-21-19(25)16-9-22-24(12-16)11-15-6-4-3-5-7-15/h8-9,12,15H,3-7,10-11H2,1-2H3,(H2,20,23)(H,21,25)	HOPVDEHOWTWUDS-UHFFFAOYSA-N	212056	US9290485, 88	Plasma kallikrein			 1800					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212056	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212056&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56835926	329587933							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373618	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc(COc3ccccc3)cc2)c1	InChI=1S/C26H27N5O2/c1-18-12-25(27)30-19(2)24(18)14-28-26(32)22-13-29-31(16-22)15-20-8-10-21(11-9-20)17-33-23-6-4-3-5-7-23/h3-13,16H,14-15,17H2,1-2H3,(H2,27,30)(H,28,32)	LNIQFEDZTVICMH-UHFFFAOYSA-N	212057	US9290485, 89	Plasma kallikrein			 6					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212057	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212057&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56835798	329587934							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373619	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc(F)c(F)c2)c1	InChI=1S/C19H19F2N5O/c1-11-5-18(22)25-12(2)15(11)8-23-19(27)14-7-24-26(10-14)9-13-3-4-16(20)17(21)6-13/h3-7,10H,8-9H2,1-2H3,(H2,22,25)(H,23,27)	USAJQBGNUADRAW-UHFFFAOYSA-N	212058	US9290485, 90	Plasma kallikrein			 2000					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212058	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212058&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56835801	329587935							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373620	Cc1noc(n1)-c1ccc(Cn2cc(cn2)C(=O)NCc2c(C)cc(N)nc2C)cc1	InChI=1S/C22H23N7O2/c1-13-8-20(23)26-14(2)19(13)10-24-21(30)18-9-25-29(12-18)11-16-4-6-17(7-5-16)22-27-15(3)28-31-22/h4-9,12H,10-11H2,1-3H3,(H2,23,26)(H,24,30)	HIKVSELABJYTAG-UHFFFAOYSA-N	212059	US9290485, 91	Plasma kallikrein			 133					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212059	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212059&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56835800	329587936							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373621	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2cccc(Cl)c2)c1	InChI=1S/C19H20ClN5O/c1-12-6-18(21)24-13(2)17(12)9-22-19(26)15-8-23-25(11-15)10-14-4-3-5-16(20)7-14/h3-8,11H,9-10H2,1-2H3,(H2,21,24)(H,22,26)	KUZFJXVHEYBFPA-UHFFFAOYSA-N	212060	US9290485, 92	Plasma kallikrein			 867					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212060	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212060&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56835922	329587937							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373622	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc(F)cc2F)c1	InChI=1S/C19H19F2N5O/c1-11-5-18(22)25-12(2)16(11)8-23-19(27)14-7-24-26(10-14)9-13-3-4-15(20)6-17(13)21/h3-7,10H,8-9H2,1-2H3,(H2,22,25)(H,23,27)	FFIADOLVJVDAEG-UHFFFAOYSA-N	212061	US9290485, 93	Plasma kallikrein			 674					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212061	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212061&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56835927	329587938							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373623	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc(OCc3ccccc3)cc2)c1	InChI=1S/C26H27N5O2/c1-18-12-25(27)30-19(2)24(18)14-28-26(32)22-13-29-31(16-22)15-20-8-10-23(11-9-20)33-17-21-6-4-3-5-7-21/h3-13,16H,14-15,17H2,1-2H3,(H2,27,30)(H,28,32)	QFRKZOVMPPMBKQ-UHFFFAOYSA-N	212062	US9290485, 94	Plasma kallikrein			 2.1					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212062	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212062&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56835923	329587939							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373624	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2cccc3OCCCOc23)c1	InChI=1S/C22H25N5O3/c1-14-9-20(23)26-15(2)18(14)11-24-22(28)17-10-25-27(13-17)12-16-5-3-6-19-21(16)30-8-4-7-29-19/h3,5-6,9-10,13H,4,7-8,11-12H2,1-2H3,(H2,23,26)(H,24,28)	UQNKWXZAHWAEIU-UHFFFAOYSA-N	212063	US9290485, 95	Plasma kallikrein			 485					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212063	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212063&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56835863	329587940							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373625	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc(Cl)cc2)c1	InChI=1S/C19H20ClN5O/c1-12-7-18(21)24-13(2)17(12)9-22-19(26)15-8-23-25(11-15)10-14-3-5-16(20)6-4-14/h3-8,11H,9-10H2,1-2H3,(H2,21,24)(H,22,26)	LPFUKCAHGQSIMR-UHFFFAOYSA-N	212064	US9290485, 96	Plasma kallikrein			 291					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212064	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212064&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56835925	329587941							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373626	Cc1nc(Cn2cc(cn2)C(=O)NCc2c(C)cc(N)nc2C)cs1	InChI=1S/C17H20N6OS/c1-10-4-16(18)21-11(2)15(10)6-19-17(24)13-5-20-23(7-13)8-14-9-25-12(3)22-14/h4-5,7,9H,6,8H2,1-3H3,(H2,18,21)(H,19,24)	MGSHKJBZVVLKLV-UHFFFAOYSA-N	212065	US9290485, 97	Plasma kallikrein			 1900					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212065	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212065&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56835924	329587942							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373627	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2cccnc2)c1	InChI=1S/C18H20N6O/c1-12-6-17(19)23-13(2)16(12)9-21-18(25)15-8-22-24(11-15)10-14-4-3-5-20-7-14/h3-8,11H,9-10H2,1-2H3,(H2,19,23)(H,21,25)	UQJLGQSSCJBZFY-UHFFFAOYSA-N	212066	US9290485, 98	Plasma kallikrein			 3800					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212066	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212066&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56835858	329587943							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373628	Cc1cccc(Cn2cc(cn2)C(=O)NCc2c(C)cc(N)nc2C)n1	InChI=1S/C19H22N6O/c1-12-7-18(20)24-14(3)17(12)9-21-19(26)15-8-22-25(10-15)11-16-6-4-5-13(2)23-16/h4-8,10H,9,11H2,1-3H3,(H2,20,24)(H,21,26)	CCLJREZEJQOIAB-UHFFFAOYSA-N	212054	US9290485, 86::US9290485, 99	Plasma kallikrein			 7000					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212054	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212054&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081200	329587931							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373629	CC(c1ccccc1)n1cc(cn1)C(=O)NCc1c(C)cc(N)nc1C	InChI=1S/C20H23N5O/c1-13-9-19(21)24-14(2)18(13)11-22-20(26)17-10-23-25(12-17)15(3)16-7-5-4-6-8-16/h4-10,12,15H,11H2,1-3H3,(H2,21,24)(H,22,26)	DTLRUZKFZYHOBO-UHFFFAOYSA-N	212068	US9290485, 100	Plasma kallikrein			 642					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212068	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212068&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56835860	329587944							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373630	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc3n(C)nnc3c2)c1	InChI=1S/C20H22N8O/c1-12-6-19(21)24-13(2)16(12)9-22-20(29)15-8-23-28(11-15)10-14-4-5-18-17(7-14)25-26-27(18)3/h4-8,11H,9-10H2,1-3H3,(H2,21,24)(H,22,29)	XBPJTCIEOJFPKF-UHFFFAOYSA-N	212069	US9290485, 101	Plasma kallikrein			 70					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212069	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212069&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56835859	329587945							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373631	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2cccc(c2)C(N)=O)c1	InChI=1S/C20H22N6O2/c1-12-6-18(21)25-13(2)17(12)9-23-20(28)16-8-24-26(11-16)10-14-4-3-5-15(7-14)19(22)27/h3-8,11H,9-10H2,1-2H3,(H2,21,25)(H2,22,27)(H,23,28)	GHBUWRIQURZTTE-UHFFFAOYSA-N	212070	US9290485, 102	Plasma kallikrein			 4000					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212070	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212070&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081345	329587946							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373632	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc3OCOc3c2)c1	InChI=1S/C20H21N5O3/c1-12-5-19(21)24-13(2)16(12)8-22-20(26)15-7-23-25(10-15)9-14-3-4-17-18(6-14)28-11-27-17/h3-7,10H,8-9,11H2,1-2H3,(H2,21,24)(H,22,26)	YZMKHZZIPJZJTR-UHFFFAOYSA-N	212071	US9290485, 103	Plasma kallikrein			 299					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212071	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212071&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081321	329587947							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373633	Cc1cc(N)nc(C)c1CNC(=O)C1=CN(Cc2nc3ccccc3nc2C)NC1	InChI=1S/C22H25N7O/c1-13-8-21(23)27-14(2)17(13)10-24-22(30)16-9-25-29(11-16)12-20-15(3)26-18-6-4-5-7-19(18)28-20/h4-8,11,25H,9-10,12H2,1-3H3,(H2,23,27)(H,24,30)	HEGIOVVAOMIEIX-UHFFFAOYSA-N	212072	US9290485, 104	Plasma kallikrein			 113					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212072	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212072&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081207	329587948							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373634	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2nc3ccccc3s2)c1	InChI=1S/C20H20N6OS/c1-12-7-18(21)24-13(2)15(12)9-22-20(27)14-8-23-26(10-14)11-19-25-16-5-3-4-6-17(16)28-19/h3-8,10H,9,11H2,1-2H3,(H2,21,24)(H,22,27)	JYZQONPRENTMRB-UHFFFAOYSA-N	212073	US9290485, 105	Plasma kallikrein			 168					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212073	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212073&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			66723764	329587949							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373635	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2noc3ccccc23)c1	InChI=1S/C20H20N6O2/c1-12-7-19(21)24-13(2)16(12)9-22-20(27)14-8-23-26(10-14)11-17-15-5-3-4-6-18(15)28-25-17/h3-8,10H,9,11H2,1-2H3,(H2,21,24)(H,22,27)	JYXGVWDNVCBLEQ-UHFFFAOYSA-N	212074	US9290485, 106	Plasma kallikrein			 415					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212074	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212074&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			66723614	329587950							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373636	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccccc2C#N)c2ccccc12	InChI=1S/C25H23N5O/c1-16-11-24(27)29-17(2)21(16)13-28-25(31)22-15-30(23-10-6-5-9-20(22)23)14-19-8-4-3-7-18(19)12-26/h3-11,15H,13-14H2,1-2H3,(H2,27,29)(H,28,31)	WKOPMVAENVMDCB-UHFFFAOYSA-N	212075	US9290485, 107	Plasma kallikrein			 1800					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212075	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212075&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081241	329587951							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373637	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccccc2)c2ccccc12	InChI=1S/C24H24N4O/c1-16-12-23(25)27-17(2)20(16)13-26-24(29)21-15-28(14-18-8-4-3-5-9-18)22-11-7-6-10-19(21)22/h3-12,15H,13-14H2,1-2H3,(H2,25,27)(H,26,29)	YPTGBOUDNLIXLS-UHFFFAOYSA-N	212076	US9290485, 108	Plasma kallikrein			 798					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212076	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212076&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081196	329587952							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373638	Cc1cc(C(=O)NCc2c(C)cc(N)nc2C)c(C)n1Cc1ccccc1	InChI=1S/C22H26N4O/c1-14-10-21(23)25-16(3)20(14)12-24-22(27)19-11-15(2)26(17(19)4)13-18-8-6-5-7-9-18/h5-11H,12-13H2,1-4H3,(H2,23,25)(H,24,27)	VGRRUJVAMGPQKT-UHFFFAOYSA-N	212077	US9290485, 109	Plasma kallikrein			 1300					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212077	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212077&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			66723409	329587953							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373639	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc(CN3CCOCC3)cc2)c1	InChI=1S/C24H30N6O2/c1-17-11-23(25)28-18(2)22(17)13-26-24(31)21-12-27-30(16-21)15-20-5-3-19(4-6-20)14-29-7-9-32-10-8-29/h3-6,11-12,16H,7-10,13-15H2,1-2H3,(H2,25,28)(H,26,31)	KKNGSIWKXILPAS-UHFFFAOYSA-N	212078	US9290485, 110	Plasma kallikrein			 249					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212078	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212078&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081367	329587954							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373640	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc(cc2)C(=O)NC2CCS(=O)(=O)C2)c1	InChI=1S/C24H28N6O4S/c1-15-9-22(25)28-16(2)21(15)11-26-23(31)19-10-27-30(13-19)12-17-3-5-18(6-4-17)24(32)29-20-7-8-35(33,34)14-20/h3-6,9-10,13,20H,7-8,11-12,14H2,1-2H3,(H2,25,28)(H,26,31)(H,29,32)	KBULNAMTSRWGCU-UHFFFAOYSA-N	212079	US9290485, 111	Plasma kallikrein			 2100					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212079	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212079&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081310	329587955							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373641	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc(NC(=O)NC3CC3)cc2)c1	InChI=1S/C23H27N7O2/c1-14-9-21(24)27-15(2)20(14)11-25-22(31)17-10-26-30(13-17)12-16-3-5-18(6-4-16)28-23(32)29-19-7-8-19/h3-6,9-10,13,19H,7-8,11-12H2,1-2H3,(H2,24,27)(H,25,31)(H2,28,29,32)	LMXYYMDFPJEEJA-UHFFFAOYSA-N	212080	US9290485, 112	Plasma kallikrein			 229					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212080	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212080&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081206	329587956							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373642	Cc1cc(N)nc(C)c1CNC(=O)c1n[nH]c(Cc2ccccc2)n1	InChI=1S/C18H20N6O/c1-11-8-15(19)21-12(2)14(11)10-20-18(25)17-22-16(23-24-17)9-13-6-4-3-5-7-13/h3-8H,9-10H2,1-2H3,(H2,19,21)(H,20,25)(H,22,23,24)	CJTYZSXAGJVLIH-UHFFFAOYSA-N	212081	US9290485, 113	Plasma kallikrein			 5800					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212081	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212081&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			66723583	329587957							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373643	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc(cc2)-c2ccncc2)c1	InChI=1S/C24H24N6O/c1-16-11-23(25)29-17(2)22(16)13-27-24(31)21-12-28-30(15-21)14-18-3-5-19(6-4-18)20-7-9-26-10-8-20/h3-12,15H,13-14H2,1-2H3,(H2,25,29)(H,27,31)	KCGGXHJBWUPJKT-UHFFFAOYSA-N	212082	US9290485, 114	Plasma kallikrein			 30					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212082	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212082&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			66723687	329587958							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373644	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2cccc(c2)-c2ccccc2)c1	InChI=1S/C25H25N5O/c1-17-11-24(26)29-18(2)23(17)14-27-25(31)22-13-28-30(16-22)15-19-7-6-10-21(12-19)20-8-4-3-5-9-20/h3-13,16H,14-15H2,1-2H3,(H2,26,29)(H,27,31)	HIHNCZYPMFGJEZ-UHFFFAOYSA-N	212083	US9290485, 115	Plasma kallikrein			 3.3					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212083	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212083&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			66723766	329587959							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373645	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2cccc(c2)S(=O)(=O)N2CCOCC2)c1	InChI=1S/C23H28N6O4S/c1-16-10-22(24)27-17(2)21(16)13-25-23(30)19-12-26-28(15-19)14-18-4-3-5-20(11-18)34(31,32)29-6-8-33-9-7-29/h3-5,10-12,15H,6-9,13-14H2,1-2H3,(H2,24,27)(H,25,30)	HTWOQJUTMHGZAY-UHFFFAOYSA-N	212084	US9290485, 116	Plasma kallikrein			 197					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212084	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212084&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081180	329587960							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373646	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2cccc(c2)C(=O)Nc2ccccc2)c1	InChI=1S/C26H26N6O2/c1-17-11-24(27)30-18(2)23(17)14-28-25(33)21-13-29-32(16-21)15-19-7-6-8-20(12-19)26(34)31-22-9-4-3-5-10-22/h3-13,16H,14-15H2,1-2H3,(H2,27,30)(H,28,33)(H,31,34)	MIRDRGNIUOZRES-UHFFFAOYSA-N	212085	US9290485, 117	Plasma kallikrein			 152					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212085	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212085&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			66723596	329587961							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373647	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc(CN3CCCC3)cc2)c1	InChI=1S/C24H30N6O/c1-17-11-23(25)28-18(2)22(17)13-26-24(31)21-12-27-30(16-21)15-20-7-5-19(6-8-20)14-29-9-3-4-10-29/h5-8,11-12,16H,3-4,9-10,13-15H2,1-2H3,(H2,25,28)(H,26,31)	VRZRCOIKEHKLQS-UHFFFAOYSA-N	212086	US9290485, 118	Plasma kallikrein			 183					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212086	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212086&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			66723843	329587962							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373648	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2cccc(c2)C(=O)N2CCCCC2)c1	InChI=1S/C25H30N6O2/c1-17-11-23(26)29-18(2)22(17)14-27-24(32)21-13-28-31(16-21)15-19-7-6-8-20(12-19)25(33)30-9-4-3-5-10-30/h6-8,11-13,16H,3-5,9-10,14-15H2,1-2H3,(H2,26,29)(H,27,32)	BVBHSYHAYCYSAG-UHFFFAOYSA-N	212087	US9290485, 119	Plasma kallikrein			 289					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212087	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212087&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081316	329587963							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373649	CC(C)NC(=O)c1ccc(Cn2cc(cn2)C(=O)NCc2c(C)cc(N)nc2C)cc1	InChI=1S/C23H28N6O2/c1-14(2)27-23(31)18-7-5-17(6-8-18)12-29-13-19(10-26-29)22(30)25-11-20-15(3)9-21(24)28-16(20)4/h5-10,13-14H,11-12H2,1-4H3,(H2,24,28)(H,25,30)(H,27,31)	UYHOBBIURQGOSN-UHFFFAOYSA-N	212088	US9290485, 120	Plasma kallikrein			 223					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212088	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212088&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081263	329587964							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373651	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc(cc2)C(=O)Nc2ccn(C)n2)c1	InChI=1S/C24H26N8O2/c1-15-10-21(25)28-16(2)20(15)12-26-23(33)19-11-27-32(14-19)13-17-4-6-18(7-5-17)24(34)29-22-8-9-31(3)30-22/h4-11,14H,12-13H2,1-3H3,(H2,25,28)(H,26,33)(H,29,30,34)	NOWFJDCOFMTWBJ-UHFFFAOYSA-N	212090	US9290485, 122	Plasma kallikrein			 752					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212090	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212090&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56835861	329587966							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373652	Cc1cc(N)nc(C)c1CNC(=O)c1n[nH]c(n1)[C@@H](N)c1ccccc1			212091	US9290485, 123	Plasma kallikrein			 15800					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212091	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212091&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			66723607	329587967							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373653	Cc1cc(N)nc(C)c1CNC(=O)c1nc(Cc2ccc(cc2)-c2ccccc2)n[nH]1	InChI=1S/C24H24N6O/c1-15-12-21(25)27-16(2)20(15)14-26-24(31)23-28-22(29-30-23)13-17-8-10-19(11-9-17)18-6-4-3-5-7-18/h3-12H,13-14H2,1-2H3,(H2,25,27)(H,26,31)(H,28,29,30)	MFSQIIIHVBIHND-UHFFFAOYSA-N	212092	US9290485, 124	Plasma kallikrein			 71					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212092	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212092&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56835996	329587968							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373654	Cc1cc(N)nc(C)c1CNC(=O)c1nc(Cc2ccc(Oc3ccccc3)cc2)n[nH]1	InChI=1S/C24H24N6O2/c1-15-12-21(25)27-16(2)20(15)14-26-24(31)23-28-22(29-30-23)13-17-8-10-19(11-9-17)32-18-6-4-3-5-7-18/h3-12H,13-14H2,1-2H3,(H2,25,27)(H,26,31)(H,28,29,30)	MUXCZCRVQFQAIS-UHFFFAOYSA-N	212093	US9290485, 125	Plasma kallikrein			 36					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212093	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212093&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56835998	329587969							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373655	CN(C)S(=O)(=O)c1ccc(Cn2cc(cn2)C(=O)NCc2c(C)cc(N)nc2C)cc1	InChI=1S/C21H26N6O3S/c1-14-9-20(22)25-15(2)19(14)11-23-21(28)17-10-24-27(13-17)12-16-5-7-18(8-6-16)31(29,30)26(3)4/h5-10,13H,11-12H2,1-4H3,(H2,22,25)(H,23,28)	JVJHGRCLLMUDAN-UHFFFAOYSA-N	212094	US9290485, 126	Plasma kallikrein			 670					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212094	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212094&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56835997	329587970							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373656	Cc1cc(N)nc(C)c1CNC(=O)c1ccn(c1)S(=O)(=O)c1ccc(cc1)-c1ccccc1	InChI=1S/C25H24N4O3S/c1-17-14-24(26)28-18(2)23(17)15-27-25(30)21-12-13-29(16-21)33(31,32)22-10-8-20(9-11-22)19-6-4-3-5-7-19/h3-14,16H,15H2,1-2H3,(H2,26,28)(H,27,30)	UQGMQMRTUNUSCX-UHFFFAOYSA-N	212095	US9290485, 127	Plasma kallikrein			 16					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212095	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212095&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			66723684	329587971							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373657	Cc1cc(N)nc(C)c1CNC(=O)c1ccn(c1)S(=O)(=O)c1ccc(Cl)s1	InChI=1S/C17H17ClN4O3S2/c1-10-7-15(19)21-11(2)13(10)8-20-17(23)12-5-6-22(9-12)27(24,25)16-4-3-14(18)26-16/h3-7,9H,8H2,1-2H3,(H2,19,21)(H,20,23)	DOSCTASBPDFRET-UHFFFAOYSA-N	212096	US9290485, 128	Plasma kallikrein			 301					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212096	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212096&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081208	329587972							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373658	COc1cccc(c1)S(=O)(=O)n1ccc(c1)C(=O)NCc1c(C)cc(N)nc1C	InChI=1S/C20H22N4O4S/c1-13-9-19(21)23-14(2)18(13)11-22-20(25)15-7-8-24(12-15)29(26,27)17-6-4-5-16(10-17)28-3/h4-10,12H,11H2,1-3H3,(H2,21,23)(H,22,25)	XBDPGGCIEKUDKJ-UHFFFAOYSA-N	212097	US9290485, 129	Plasma kallikrein			 244					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212097	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212097&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081360	329587973							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373659	CN1CCOc2ccc(cc12)S(=O)(=O)n1ccc(c1)C(=O)NCc1c(C)cc(N)nc1C	InChI=1S/C22H25N5O4S/c1-14-10-21(23)25-15(2)18(14)12-24-22(28)16-6-7-27(13-16)32(29,30)17-4-5-20-19(11-17)26(3)8-9-31-20/h4-7,10-11,13H,8-9,12H2,1-3H3,(H2,23,25)(H,24,28)	KBMZZOSYJTUSCB-UHFFFAOYSA-N	212098	US9290485, 130	Plasma kallikrein			 67					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212098	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212098&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081184	329587974							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373660	Cc1cc(N)nc(C)c1CNC(=O)c1ccn(c1)S(=O)(=O)c1ccc2n(C)ccc2c1	InChI=1S/C22H23N5O3S/c1-14-10-21(23)25-15(2)19(14)12-24-22(28)17-7-9-27(13-17)31(29,30)18-4-5-20-16(11-18)6-8-26(20)3/h4-11,13H,12H2,1-3H3,(H2,23,25)(H,24,28)	WPZSHZWTNBNXEO-UHFFFAOYSA-N	212099	US9290485, 131	Plasma kallikrein			 9					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212099	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212099&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56835995	329587975							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373661	Cc1cc(N)nc(C)c1CNC(=O)c1ccn(c1)S(=O)(=O)c1cccc(c1)-c1ncccn1	InChI=1S/C23H22N6O3S/c1-15-11-21(24)28-16(2)20(15)13-27-23(30)18-7-10-29(14-18)33(31,32)19-6-3-5-17(12-19)22-25-8-4-9-26-22/h3-12,14H,13H2,1-2H3,(H2,24,28)(H,27,30)	CFNRXFVWMJQCAJ-UHFFFAOYSA-N	212100	US9290485, 132	Plasma kallikrein			 71					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212100	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212100&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			66723385	329587976							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373662	Cc1cc(C)n(n1)-c1ccc(cc1)S(=O)(=O)n1ccc(c1)C(=O)NCc1c(C)cc(N)nc1C	InChI=1S/C24H26N6O3S/c1-15-11-23(25)27-18(4)22(15)13-26-24(31)19-9-10-29(14-19)34(32,33)21-7-5-20(6-8-21)30-17(3)12-16(2)28-30/h5-12,14H,13H2,1-4H3,(H2,25,27)(H,26,31)	OHBJDBJVZSAGFU-UHFFFAOYSA-N	212101	US9290485, 133	Plasma kallikrein			 196					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212101	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212101&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081288	329587977							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373663	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc(OCC(O)=O)cc2)c1	InChI=1S/C21H23N5O4/c1-13-7-19(22)25-14(2)18(13)9-23-21(29)16-8-24-26(11-16)10-15-3-5-17(6-4-15)30-12-20(27)28/h3-8,11H,9-10,12H2,1-2H3,(H2,22,25)(H,23,29)(H,27,28)	FOEOJKNUMDSKMO-UHFFFAOYSA-N	212102	US9290485, 134	Plasma kallikrein			 1100					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212102	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212102&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081177	329587978							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373664	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc(OCC#N)cc2)c1	InChI=1S/C21H22N6O2/c1-14-9-20(23)26-15(2)19(14)11-24-21(28)17-10-25-27(13-17)12-16-3-5-18(6-4-16)29-8-7-22/h3-6,9-10,13H,8,11-12H2,1-2H3,(H2,23,26)(H,24,28)	CWYCUONCOWMQFA-UHFFFAOYSA-N	212103	US9290485, 135	Plasma kallikrein			 89					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212103	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212103&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081309	329587979							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373665	Cc1nc(N)cc(OCC(=O)C(C)(C)C)c1CNC(=O)c1cn(Cc2ccccc2)nn1	InChI=1S/C23H28N6O3/c1-15-17(19(10-21(24)26-15)32-14-20(30)23(2,3)4)11-25-22(31)18-13-29(28-27-18)12-16-8-6-5-7-9-16/h5-10,13H,11-12,14H2,1-4H3,(H2,24,26)(H,25,31)	FWRKGUCVNZBFQQ-UHFFFAOYSA-N	212104	US9290485, 136	Plasma kallikrein			 24					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212104	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212104&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081296	329587980							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373666	Cc1nc(N)cc(OCc2ncco2)c1CNC(=O)c1cn(Cc2ccccc2)nn1	InChI=1S/C21H21N7O3/c1-14-16(18(9-19(22)25-14)31-13-20-23-7-8-30-20)10-24-21(29)17-12-28(27-26-17)11-15-5-3-2-4-6-15/h2-9,12H,10-11,13H2,1H3,(H2,22,25)(H,24,29)	QWLJELCBJXPMEB-UHFFFAOYSA-N	212105	US9290485, 137	Plasma kallikrein			 127					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212105	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212105&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081334	329587981							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373667	Cc1cc(N)ncc1CNC(=O)c1cnn(Cc2ccccc2)c1	InChI=1S/C18H19N5O/c1-13-7-17(19)20-8-15(13)9-21-18(24)16-10-22-23(12-16)11-14-5-3-2-4-6-14/h2-8,10,12H,9,11H2,1H3,(H2,19,20)(H,21,24)	VEZNOACNEPSKKA-UHFFFAOYSA-N	212106	US9290485, 138	Plasma kallikrein			 62700					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212106	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212106&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081323	329587982							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373668	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc(Cn3ccc(=O)[nH]3)cc2)c1	InChI=1S/C23H25N7O2/c1-15-9-21(24)27-16(2)20(15)11-25-23(32)19-10-26-30(14-19)13-18-5-3-17(4-6-18)12-29-8-7-22(31)28-29/h3-10,14H,11-13H2,1-2H3,(H2,24,27)(H,25,32)(H,28,31)	XMWLUGVHOMCRDL-UHFFFAOYSA-N	212107	US9290485, 139	Plasma kallikrein			 4.9					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212107	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212107&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081365	329587983							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373669	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc(Cn3ccnn3)cc2)c1	InChI=1S/C22H24N8O/c1-15-9-21(23)27-16(2)20(15)11-24-22(31)19-10-26-30(14-19)13-18-5-3-17(4-6-18)12-29-8-7-25-28-29/h3-10,14H,11-13H2,1-2H3,(H2,23,27)(H,24,31)	AWOCNKRELUFWTO-UHFFFAOYSA-N	212108	US9290485, 140	Plasma kallikrein			 4.6					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212108	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212108&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081346	329587984							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373670	Cc1cc(=O)n(C)n1Cc1ccc(Cn2cc(cn2)C(=O)NCc2c(C)cc(N)nc2C)cc1	InChI=1S/C25H29N7O2/c1-16-9-23(26)29-18(3)22(16)12-27-25(34)21-11-28-31(15-21)13-19-5-7-20(8-6-19)14-32-17(2)10-24(33)30(32)4/h5-11,15H,12-14H2,1-4H3,(H2,26,29)(H,27,34)	MBRYIDMDONOJKC-UHFFFAOYSA-N	212109	US9290485, 141	Plasma kallikrein			 1.2					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212109	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212109&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081338	329587985							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373671	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc(Cn3ccccc3=O)cc2)c1	InChI=1S/C25H26N6O2/c1-17-11-23(26)29-18(2)22(17)13-27-25(33)21-12-28-31(16-21)15-20-8-6-19(7-9-20)14-30-10-4-3-5-24(30)32/h3-12,16H,13-15H2,1-2H3,(H2,26,29)(H,27,33)	LAHWWHTYCCSIGH-UHFFFAOYSA-N	212110	US9290485, 142	Plasma kallikrein			 0.0224					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212110	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212110&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081164	329587986							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373672	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc(CN3CCCC3=O)cc2)c1	InChI=1S/C24H28N6O2/c1-16-10-22(25)28-17(2)21(16)12-26-24(32)20-11-27-30(15-20)14-19-7-5-18(6-8-19)13-29-9-3-4-23(29)31/h5-8,10-11,15H,3-4,9,12-14H2,1-2H3,(H2,25,28)(H,26,32)	MKNQOJGNOABDKI-UHFFFAOYSA-N	212111	US9290485, 143	Plasma kallikrein			 2.6					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212111	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212111&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081271	329587987							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373673	Cc1nc(N)cc(Cl)c1CNC(=O)c1cnn(Cc2ccccc2)c1	InChI=1S/C18H18ClN5O/c1-12-15(16(19)7-17(20)23-12)9-21-18(25)14-8-22-24(11-14)10-13-5-3-2-4-6-13/h2-8,11H,9-10H2,1H3,(H2,20,23)(H,21,25)	DTPXJVVBPLQWBN-UHFFFAOYSA-N	212112	US9290485, 144	Plasma kallikrein			 42400					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212112	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212112&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081275	329587988							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373674	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc(Cn3cccn3)cc2)c1	InChI=1S/C23H25N7O/c1-16-10-22(24)28-17(2)21(16)12-25-23(31)20-11-27-30(15-20)14-19-6-4-18(5-7-19)13-29-9-3-8-26-29/h3-11,15H,12-14H2,1-2H3,(H2,24,28)(H,25,31)	OINOKQVNBGAIMA-UHFFFAOYSA-N	212113	US9290485, 145	Plasma kallikrein			 0.2					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212113	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212113&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	7SD	6O1G,6O1S	58081298	329587989							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373675	Cc1cnn(Cc2ccc(Cn3cc(cn3)C(=O)NCc3c(C)cc(N)nc3C)cc2)c1	InChI=1S/C24H27N7O/c1-16-9-27-30(12-16)13-19-4-6-20(7-5-19)14-31-15-21(10-28-31)24(32)26-11-22-17(2)8-23(25)29-18(22)3/h4-10,12,15H,11,13-14H2,1-3H3,(H2,25,29)(H,26,32)	DSOFMKFSFNBAPY-UHFFFAOYSA-N	212114	US9290485, 146	Plasma kallikrein			 0.04					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212114	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212114&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081264	329587990							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373676	Cc1ccnn1Cc1ccc(Cn2cc(nn2)C(=O)NCc2c(C)cc(N)nc2C)cc1	InChI=1S/C23H26N8O/c1-15-10-22(24)27-17(3)20(15)11-25-23(32)21-14-30(29-28-21)12-18-4-6-19(7-5-18)13-31-16(2)8-9-26-31/h4-10,14H,11-13H2,1-3H3,(H2,24,27)(H,25,32)	IFSHKFMSDUJWRO-UHFFFAOYSA-N	212115	US9290485, 147	Plasma kallikrein			 0.1					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212115	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212115&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081254	329587991							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373677	Cc1cc(C)n(Cc2ccc(Cn3cc(nn3)C(=O)NCc3c(C)cc(N)nc3C)cc2)n1	InChI=1S/C24H28N8O/c1-15-9-23(25)27-18(4)21(15)11-26-24(33)22-14-31(30-28-22)12-19-5-7-20(8-6-19)13-32-17(3)10-16(2)29-32/h5-10,14H,11-13H2,1-4H3,(H2,25,27)(H,26,33)	FGZWHKYFVTWNMF-UHFFFAOYSA-N	212116	US9290485, 148	Plasma kallikrein			 0.03					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212116	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212116&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081260	329587992							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373678	Cc1nc(N)cc(OCC(=O)C(C)(C)C)c1CNC(=O)c1cnn(Cc2ccc3ccccc3c2)c1	InChI=1S/C28H31N5O3/c1-18-23(24(12-26(29)32-18)36-17-25(34)28(2,3)4)14-30-27(35)22-13-31-33(16-22)15-19-9-10-20-7-5-6-8-21(20)11-19/h5-13,16H,14-15,17H2,1-4H3,(H2,29,32)(H,30,35)	QXVKLXZLQIBRSP-UHFFFAOYSA-N	212117	US9290485, 149	Plasma kallikrein			 7.8					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212117	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212117&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081227	329587993							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373679	COCCN1CCCc2ccc(Cn3cc(cn3)C(=O)NCc3c(C)cc(N)nc3C)cc12	InChI=1S/C25H32N6O2/c1-17-11-24(26)29-18(2)22(17)14-27-25(32)21-13-28-31(16-21)15-19-6-7-20-5-4-8-30(9-10-33-3)23(20)12-19/h6-7,11-13,16H,4-5,8-10,14-15H2,1-3H3,(H2,26,29)(H,27,32)	KEIRCROKHGIIMH-UHFFFAOYSA-N	212118	US9290485, 150	Plasma kallikrein			 10					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212118	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212118&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081205	329587994							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373680	CN1C(=O)COc2ccc(Cn3cc(cn3)C(=O)NCc3c(C)cc(N)nc3C)cc12	InChI=1S/C22H24N6O3/c1-13-6-20(23)26-14(2)17(13)9-24-22(30)16-8-25-28(11-16)10-15-4-5-19-18(7-15)27(3)21(29)12-31-19/h4-8,11H,9-10,12H2,1-3H3,(H2,23,26)(H,24,30)	CMPHNRMQWUYGHK-UHFFFAOYSA-N	212119	US9290485, 151	Plasma kallikrein			 13					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212119	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212119&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081195	329587995							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373681	CN1CCCc2ccc(Cn3cc(cn3)C(=O)NCc3c(C)cc(N)nc3C)cc12	InChI=1S/C23H28N6O/c1-15-9-22(24)27-16(2)20(15)12-25-23(30)19-11-26-29(14-19)13-17-6-7-18-5-4-8-28(3)21(18)10-17/h6-7,9-11,14H,4-5,8,12-13H2,1-3H3,(H2,24,27)(H,25,30)	WUCCRPGGMBVFRY-UHFFFAOYSA-N	212120	US9290485, 152	Plasma kallikrein			 4					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212120	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212120&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081327	329587996							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373682	Cc1ccc2cc(Cn3cc(nn3)C(=O)NCc3c(C)cc(N)nc3C)ccc2n1	InChI=1S/C22H23N7O/c1-13-8-21(23)26-15(3)18(13)10-24-22(30)20-12-29(28-27-20)11-16-5-7-19-17(9-16)6-4-14(2)25-19/h4-9,12H,10-11H2,1-3H3,(H2,23,26)(H,24,30)	BYZNGWXDOMLVBH-UHFFFAOYSA-N	212121	US9290485, 153	Plasma kallikrein			 16					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212121	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212121&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081326	329587997							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373683	Cc1ccc2cc(Cn3cc(cn3)C(=O)NCc3c(C)cc(N)nc3C)ccc2n1	InChI=1S/C23H24N6O/c1-14-8-22(24)28-16(3)20(14)11-25-23(30)19-10-26-29(13-19)12-17-5-7-21-18(9-17)6-4-15(2)27-21/h4-10,13H,11-12H2,1-3H3,(H2,24,28)(H,25,30)	AGUSXZKRBGJRHP-UHFFFAOYSA-N	212122	US9290485, 154	Plasma kallikrein			 2					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212122	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212122&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081204	329587998							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373684	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2cnc3ccccc3c2)c1	InChI=1S/C22H22N6O/c1-14-7-21(23)27-15(2)19(14)11-25-22(29)18-10-26-28(13-18)12-16-8-17-5-3-4-6-20(17)24-9-16/h3-10,13H,11-12H2,1-2H3,(H2,23,27)(H,25,29)	RMYXWNNWPXHXJT-UHFFFAOYSA-N	212123	US9290485, 155	Plasma kallikrein			 3					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212123	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212123&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081265	329587999							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373685	Cc1ccc2cc(Cn3cc(nn3)C(=O)NCc3c(C)cc(N)nc3C)cnc2c1	InChI=1S/C22H23N7O/c1-13-4-5-17-8-16(9-24-19(17)6-13)11-29-12-20(27-28-29)22(30)25-10-18-14(2)7-21(23)26-15(18)3/h4-9,12H,10-11H2,1-3H3,(H2,23,26)(H,25,30)	GKNSRNKGBOLEPP-UHFFFAOYSA-N	212124	US9290485, 156	Plasma kallikrein			 0.92					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212124	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212124&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081222	329588000							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373686	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc3ccc(Cl)cc3n2)c1	InChI=1S/C22H21ClN6O/c1-13-7-21(24)27-14(2)19(13)10-25-22(30)16-9-26-29(11-16)12-18-6-4-15-3-5-17(23)8-20(15)28-18/h3-9,11H,10,12H2,1-2H3,(H2,24,27)(H,25,30)	NAGACJGTMZTIRV-UHFFFAOYSA-N	212125	US9290485, 157	Plasma kallikrein			 2					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212125	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212125&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081168	329588001							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373687	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ccc(Cl)cc3n2)nn1	InChI=1S/C21H20ClN7O/c1-12-7-20(23)25-13(2)17(12)9-24-21(30)19-11-29(28-27-19)10-16-6-4-14-3-5-15(22)8-18(14)26-16/h3-8,11H,9-10H2,1-2H3,(H2,23,25)(H,24,30)	GXNNDHNHDUFBEI-UHFFFAOYSA-N	212126	US9290485, 158	Plasma kallikrein			 4					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212126	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212126&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081333	329588002							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373688	Cc1ccc2cc(Cn3cc(cn3)C(=O)NCc3ccc(N)nc3C)ccc2n1	InChI=1S/C22H22N6O/c1-14-3-5-17-9-16(4-7-20(17)26-14)12-28-13-19(11-25-28)22(29)24-10-18-6-8-21(23)27-15(18)2/h3-9,11,13H,10,12H2,1-2H3,(H2,23,27)(H,24,29)	ATRKABUPNXFPKF-UHFFFAOYSA-N	212127	US9290485, 159	Plasma kallikrein			 7					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212127	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212127&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			66723582	329588003							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373689	Cc1nc(N)ccc1CNC(=O)c1cnn(Cc2cc(c3cc(F)ccc3n2)C(F)(F)F)c1	InChI=1S/C22H18F4N6O/c1-12-13(2-5-20(27)30-12)8-28-21(33)14-9-29-32(10-14)11-16-7-18(22(24,25)26)17-6-15(23)3-4-19(17)31-16/h2-7,9-10H,8,11H2,1H3,(H2,27,30)(H,28,33)	LRSBELBIYXLLQU-UHFFFAOYSA-N	212128	US9290485, 160	Plasma kallikrein			 20					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212128	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212128&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081343	329588004							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373690	Cc1cc(C)c2cc(Cn3cc(cn3)C(=O)NCc3ccc(N)nc3C)c(C)nc2c1	InChI=1S/C24H26N6O/c1-14-7-15(2)21-9-19(17(4)28-22(21)8-14)12-30-13-20(11-27-30)24(31)26-10-18-5-6-23(25)29-16(18)3/h5-9,11,13H,10,12H2,1-4H3,(H2,25,29)(H,26,31)	LVJONVYRGYYEGZ-UHFFFAOYSA-N	212129	US9290485, 161	Plasma kallikrein			 4					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212129	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212129&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081359	329588005							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373691	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2cc(c3cc(F)ccc3n2)C(F)(F)F)c1	InChI=1S/C23H20F4N6O/c1-12-5-21(28)31-13(2)18(12)9-29-22(34)14-8-30-33(10-14)11-16-7-19(23(25,26)27)17-6-15(24)3-4-20(17)32-16/h3-8,10H,9,11H2,1-2H3,(H2,28,31)(H,29,34)	GWWXECIWSOTRAV-UHFFFAOYSA-N	212130	US9290485, 162	Plasma kallikrein			 5					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212130	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212130&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081320	329588006							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373692	COc1ccc2cc(Cn3cc(cn3)C(=O)NCc3c(C)cc(N)nc3C)ccc2c1	InChI=1S/C24H25N5O2/c1-15-8-23(25)28-16(2)22(15)12-26-24(30)20-11-27-29(14-20)13-17-4-5-19-10-21(31-3)7-6-18(19)9-17/h4-11,14H,12-13H2,1-3H3,(H2,25,28)(H,26,30)	LNJDBRCEILQTPH-UHFFFAOYSA-N	212131	US9290485, 163	Plasma kallikrein			 5					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212131	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212131&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081299	329588007							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373693	Cc1ccc2cc(Cn3cc(nn3)C(=O)NC3(CC3)c3c(C)cc(N)nc3C)ccc2n1	InChI=1S/C24H25N7O/c1-14-10-21(25)27-16(3)22(14)24(8-9-24)28-23(32)20-13-31(30-29-20)12-17-5-7-19-18(11-17)6-4-15(2)26-19/h4-7,10-11,13H,8-9,12H2,1-3H3,(H2,25,27)(H,28,32)	IGVXGJBTGGNVPI-UHFFFAOYSA-N	212132	US9290485, 164	Plasma kallikrein			 1200					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212132	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212132&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081291	329588008							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373694	Cc1nc2cc(Cn3cc(cn3)C(=O)NCc3c(C)cc(N)nc3C)ccc2n1C	InChI=1S/C22H25N7O/c1-13-7-21(23)26-14(2)18(13)10-24-22(30)17-9-25-29(12-17)11-16-5-6-20-19(8-16)27-15(3)28(20)4/h5-9,12H,10-11H2,1-4H3,(H2,23,26)(H,24,30)	ZGMRJKJEDUMBBI-UHFFFAOYSA-N	212133	US9290485, 165	Plasma kallikrein			 6					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212133	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212133&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081190	329588009							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373695	Cc1c(C)c2cc(Cn3cc(nn3)C(=O)NCc3c(C)cc(N)nc3C)ccc2n1C	InChI=1S/C23H27N7O/c1-13-8-22(24)26-15(3)19(13)10-25-23(31)20-12-30(28-27-20)11-17-6-7-21-18(9-17)14(2)16(4)29(21)5/h6-9,12H,10-11H2,1-5H3,(H2,24,26)(H,25,31)	KXTIOXUGQMYWJG-UHFFFAOYSA-N	212134	US9290485, 166	Plasma kallikrein			 0.2					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212134	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212134&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081259	329588010							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373696	Cc1nc(N)cc(Cl)c1CNC(=O)c1cnn(Cc2ccc(Cn3ccccc3=O)cc2)c1	InChI=1S/C24H23ClN6O2/c1-16-20(21(25)10-22(26)29-16)12-27-24(33)19-11-28-31(15-19)14-18-7-5-17(6-8-18)13-30-9-3-2-4-23(30)32/h2-11,15H,12-14H2,1H3,(H2,26,29)(H,27,33)	VAWBDPGLZYEYPL-UHFFFAOYSA-N	212135	US9290485, 167	Plasma kallikrein			 0.2					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212135	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212135&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081243	329588011							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373697	Cc1cc2cc(Cn3cc(cn3)C(=O)NCc3c(C)cc(N)nc3C)ccc2n1C	InChI=1S/C23H26N6O/c1-14-7-22(24)27-16(3)20(14)11-25-23(30)19-10-26-29(13-19)12-17-5-6-21-18(9-17)8-15(2)28(21)4/h5-10,13H,11-12H2,1-4H3,(H2,24,27)(H,25,30)	IYSFGGFTJDDAJG-UHFFFAOYSA-N	212136	US9290485, 168	Plasma kallikrein			 0.1					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212136	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212136&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081242	329588012							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373698	Cc1cn2cc(Cn3cc(cn3)C(=O)NCc3c(C)cc(N)nc3C)ccc2n1	InChI=1S/C21H23N7O/c1-13-6-19(22)26-15(3)18(13)8-23-21(29)17-7-24-28(12-17)11-16-4-5-20-25-14(2)9-27(20)10-16/h4-7,9-10,12H,8,11H2,1-3H3,(H2,22,26)(H,23,29)	XFBVLADKLOFZNC-UHFFFAOYSA-N	212137	US9290485, 169	Plasma kallikrein			 3					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212137	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212137&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081250	329588013							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373699	Cc1ccc2cc(Cc3nc(co3)C(=O)NCc3c(C)cc(N)nc3C)ccc2n1	InChI=1S/C23H23N5O2/c1-13-8-21(24)27-15(3)18(13)11-25-23(29)20-12-30-22(28-20)10-16-5-7-19-17(9-16)6-4-14(2)26-19/h4-9,12H,10-11H2,1-3H3,(H2,24,27)(H,25,29)	DCCOZLDILLONDD-UHFFFAOYSA-N	212138	US9290485, 170	Plasma kallikrein			 9.7					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212138	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212138&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081230	329588014							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373700	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2cc3ccsc3c(N)n2)c1	InChI=1S/C20H21N7OS/c1-11-5-17(21)25-12(2)16(11)8-23-20(28)14-7-24-27(9-14)10-15-6-13-3-4-29-18(13)19(22)26-15/h3-7,9H,8,10H2,1-2H3,(H2,21,25)(H2,22,26)(H,23,28)	DZSUGJUGHRYZIA-UHFFFAOYSA-N	212139	US9290485, 171	Plasma kallikrein			 26					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212139	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212139&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081335	329588015							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373701	Cc1nc(N)cc(Cl)c1CNC(=O)c1cnn(Cc2ccc3ccccc3c2)c1	InChI=1S/C22H20ClN5O/c1-14-19(20(23)9-21(24)27-14)11-25-22(29)18-10-26-28(13-18)12-15-6-7-16-4-2-3-5-17(16)8-15/h2-10,13H,11-12H2,1H3,(H2,24,27)(H,25,29)	OGGNUGUPULLVNE-UHFFFAOYSA-N	212140	US9290485, 172	Plasma kallikrein			 60					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212140	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212140&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081244	329588016							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373702	Cc1cc(NC(=O)OC(C)(C)C)nc(C)c1CNC(=O)c1cnn(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C27H29ClN6O3/c1-16-8-24(33-26(36)37-27(3,4)5)32-17(2)22(16)13-30-25(35)20-11-31-34(15-20)14-18-6-7-23-19(9-18)10-21(28)12-29-23/h6-12,15H,13-14H2,1-5H3,(H,30,35)(H,32,33,36)	AFGHJBPCMHFPQX-UHFFFAOYSA-N	212141	US9290485, 173	Plasma kallikrein			 0.4					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212141	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212141&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081248	329588017							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373703	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc3c(CCS3(=O)=O)c2)c1	InChI=1S/C21H23N5O3S/c1-13-7-20(22)25-14(2)18(13)10-23-21(27)17-9-24-26(12-17)11-15-3-4-19-16(8-15)5-6-30(19,28)29/h3-4,7-9,12H,5-6,10-11H2,1-2H3,(H2,22,25)(H,23,27)	FTBOOYITHPHSSO-UHFFFAOYSA-N	212142	US9290485, 174	Plasma kallikrein			 75					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212142	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212142&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836061	329588018							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373704	Cc1ccc2cc(Cn3cc(nn3)C(=O)NCc3c(Cl)cc(N)nc3C)ccc2n1	InChI=1S/C21H20ClN7O/c1-12-3-5-15-7-14(4-6-18(15)25-12)10-29-11-19(27-28-29)21(30)24-9-16-13(2)26-20(23)8-17(16)22/h3-8,11H,9-10H2,1-2H3,(H2,23,26)(H,24,30)	HLXKJAGGYKLWEY-UHFFFAOYSA-N	212143	US9290485, 175	Plasma kallikrein			 61					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212143	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212143&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836060	329588019							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373705	Cc1c(ccn1S(=O)(=O)c1ccccc1)C(=O)NCc1c(C)cc(N)nc1C	InChI=1S/C20H22N4O3S/c1-13-11-19(21)23-14(2)18(13)12-22-20(25)17-9-10-24(15(17)3)28(26,27)16-7-5-4-6-8-16/h4-11H,12H2,1-3H3,(H2,21,23)(H,22,25)	SMURPCKCNPZWTD-UHFFFAOYSA-N	212144	US9290485, 176	Plasma kallikrein			 45000					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212144	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212144&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081219	329588020							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373706	Cc1c(nnn1Cc1ccccc1)C(=O)NCc1c(C)cc(N)nc1C	InChI=1S/C19H22N6O/c1-12-9-17(20)22-13(2)16(12)10-21-19(26)18-14(3)25(24-23-18)11-15-7-5-4-6-8-15/h4-9H,10-11H2,1-3H3,(H2,20,22)(H,21,26)	FEWIUHKNNUCBBN-UHFFFAOYSA-N	212145	US9290485, 177	Plasma kallikrein			 52100					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212145	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212145&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			66723765	329588021							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373707	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ncccn2)nn1	InChI=1S/C16H18N8O/c1-10-6-14(17)21-11(2)12(10)7-20-16(25)13-8-24(23-22-13)9-15-18-4-3-5-19-15/h3-6,8H,7,9H2,1-2H3,(H2,17,21)(H,20,25)	AQIFTEIUPQGAPT-UHFFFAOYSA-N	212146	US9290485, 178	Plasma kallikrein			 67300					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212146	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212146&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081362	329588022							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373708	Cc1c(ccn1Cc1ccccc1)C(=O)NCc1c(C)cc(N)nc1C	InChI=1S/C21H24N4O/c1-14-11-20(22)24-15(2)19(14)12-23-21(26)18-9-10-25(16(18)3)13-17-7-5-4-6-8-17/h4-11H,12-13H2,1-3H3,(H2,22,24)(H,23,26)	DNEXVDGNWUQELI-UHFFFAOYSA-N	212147	US9290485, 179	Plasma kallikrein			 85800					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212147	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212147&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081350	329588023							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373709	Cc1nc(N)cc(OC(F)F)c1CNC(=O)c1cnn(Cc2ccccc2)c1	InChI=1S/C19H19F2N5O2/c1-12-15(16(28-19(20)21)7-17(22)25-12)9-23-18(27)14-8-24-26(11-14)10-13-5-3-2-4-6-13/h2-8,11,19H,9-10H2,1H3,(H2,22,25)(H,23,27)	QEIKRESSDYUHLL-UHFFFAOYSA-N	212148	US9290485, 180	Plasma kallikrein			>100000					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212148	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212148&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081224	329588024							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373710	Cc1nc(N)cc(Br)c1CNC(=O)c1cnn(Cc2ccccc2)c1	InChI=1S/C18H18BrN5O/c1-12-15(16(19)7-17(20)23-12)9-21-18(25)14-8-22-24(11-14)10-13-5-3-2-4-6-13/h2-8,11H,9-10H2,1H3,(H2,20,23)(H,21,25)	YOKRBWLNEMLPSA-UHFFFAOYSA-N	212149	US9290485, 181	Plasma kallikrein			 37000					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212149	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212149&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081304	329588025							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373711	Nc1ccc(CNC(=O)c2cnn(Cc3ccccc3)c2)cn1	InChI=1S/C17H17N5O/c18-16-7-6-14(8-19-16)9-20-17(23)15-10-21-22(12-15)11-13-4-2-1-3-5-13/h1-8,10,12H,9,11H2,(H2,18,19)(H,20,23)	KCWIESVYZILAHZ-UHFFFAOYSA-N	212150	US9290485, 182	Plasma kallikrein			>100000					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212150	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212150&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081303	329588026							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373712	Cc1c(C)n(c(C)c1C(=O)NCc1c(C)cc(N)nc1C)S(=O)(=O)c1ccccc1	InChI=1S/C22H26N4O3S/c1-13-11-20(23)25-15(3)19(13)12-24-22(27)21-14(2)16(4)26(17(21)5)30(28,29)18-9-7-6-8-10-18/h6-11H,12H2,1-5H3,(H2,23,25)(H,24,27)	GXOARBSQHJYFIT-UHFFFAOYSA-N	212151	US9290485, 183	Plasma kallikrein			>100000					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212151	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212151&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081313	329588027							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
373650	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc(cc2)C(=O)N2CCOCC2)c1	InChI=1S/C24H28N6O3/c1-16-11-22(25)28-17(2)21(16)13-26-23(31)20-12-27-30(15-20)14-18-3-5-19(6-4-18)24(32)29-7-9-33-10-8-29/h3-6,11-12,15H,7-10,13-14H2,1-2H3,(H2,25,28)(H,26,31)	XNEXYQNHODUCKT-UHFFFAOYSA-N	212089	US9290485, 121	Plasma kallikrein			 369					7.8	25.00 C	US Patent		10.7270/Q26H4G73		aid1802368	US9290485	Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T	Novartis AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212089	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212089&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56835862	329587965							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
382551	CSCc1cc(CSC)cc(CSC)c1	InChI=1S/C12H18S3/c1-13-7-10-4-11(8-14-2)6-12(5-10)9-15-3/h4-6H,7-9H2,1-3H3	PPCUFDQPSJJGLN-UHFFFAOYSA-N	218837	TBMB-PK15 (10)	Plasma kallikrein		 1.3						7.4		Curated from the literature by BindingDB	10.1002/cbic.201600612	10.7270/Q2H9942B	27982494	aid1802515		van de Langemheen, H; Korotkovs, V; Bijl, J; Wilson, C; Kale, SS; Heinis, C; Liskamp, RM	University of Glasgow	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=218837	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=218837&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124222758	329994062							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
382552	CSCC(=O)N1CN(CN(C1)C(=O)CSC)C(=O)CSC	InChI=1S/C12H21N3O3S3/c1-19-4-10(16)13-7-14(11(17)5-20-2)9-15(8-13)12(18)6-21-3/h4-9H2,1-3H3	SESLACGWCLIGCW-UHFFFAOYSA-N	218838	TATB-FXII618 (15)::TATB-PK15 (11)	Plasma kallikrein		 540						7.4		Curated from the literature by BindingDB	10.1002/cbic.201600612	10.7270/Q2H9942B	27982494	aid1802515		van de Langemheen, H; Korotkovs, V; Bijl, J; Wilson, C; Kale, SS; Heinis, C; Liskamp, RM	University of Glasgow	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=218838	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=218838&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124222759	329994063							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
382553	CSCc1nc(CSC)nc(CSC)n1	InChI=1S/C9H15N3S3/c1-13-4-7-10-8(5-14-2)12-9(11-7)6-15-3/h4-6H2,1-3H3	LLRKYJLGNJXILI-UHFFFAOYSA-N	218839	TBMT-FX618 (16)::TBMT-PK15 (12)	Plasma kallikrein		 20						7.4		Curated from the literature by BindingDB	10.1002/cbic.201600612	10.7270/Q2H9942B	27982494	aid1802515		van de Langemheen, H; Korotkovs, V; Bijl, J; Wilson, C; Kale, SS; Heinis, C; Liskamp, RM	University of Glasgow	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=218839	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=218839&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124222760	329994064							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421425	COC(=O)Nc1ccc2-c3nc([nH]c3C)[C@H](CCC[C@@H](C)C(=O)Nc2c1)N1CCC(=CC1=O)c1c(F)ccc(Cl)c1F			241528	US9409908, 160::US9951071, Example 160	Plasma kallikrein		 2							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241528	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241528&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060520	341093840							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421426	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)c(Cl)ccc3Br)c3cccc-2c3)c1	InChI=1S/C32H30BrClFN3O4/c1-18-5-3-8-27(38-14-13-21(16-28(38)39)29-24(33)11-12-25(34)30(29)35)20-7-4-6-19(15-20)23-10-9-22(36-32(41)42-2)17-26(23)37-31(18)40/h4,6-7,9-12,15-18,27H,3,5,8,13-14H2,1-2H3,(H,36,41)(H,37,40)/t18-,27+/m1/s1	YPAISRDCVKHFMI-CLYVBNDRSA-N	241529	US9409908, 161::US9951071, Example 161	Plasma kallikrein		 21.57							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241529	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241529&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060605	341093841							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421427	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cccc(c2)-c2ccccc2NC1=O	InChI=1S/C30H27ClF2N2O2/c1-18-6-4-11-26(20-8-5-7-19(16-20)22-9-2-3-10-25(22)34-30(18)37)35-15-14-21(17-27(35)36)28-24(32)13-12-23(31)29(28)33/h2-3,5,7-10,12-13,16-18,26H,4,6,11,14-15H2,1H3,(H,34,37)/t18-,26+/m1/s1	SXZFGGAOSJYHKQ-DWXRJYCRSA-N	241530	US9409908, 162::US9951071, Example 162	Plasma kallikrein		 124.9							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241530	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241530&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060601	341093842							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421428	COC(=O)c1ccc2NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)c(Cl)ccc3Br)c3cccc(c3)-c2c1	InChI=1S/C32H29BrClFN2O4/c1-18-5-3-8-27(37-14-13-21(17-28(37)38)29-24(33)10-11-25(34)30(29)35)20-7-4-6-19(15-20)23-16-22(32(40)41-2)9-12-26(23)36-31(18)39/h4,6-7,9-12,15-18,27H,3,5,8,13-14H2,1-2H3,(H,36,39)/t18-,27+/m1/s1	BSNSKODJGQKGRG-CLYVBNDRSA-N	241531	US9409908, 163::US9409908, 176::US9951071, Example 176	Plasma kallikrein		 223.8							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241531	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241531&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060611	341093843							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421429	COC(=O)c1ccc2NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)ccc(Cl)c3F)c3cccc(c3)-c2c1	InChI=1S/C32H29ClF2N2O4/c1-18-5-3-8-27(37-14-13-21(17-28(37)38)29-25(34)11-10-24(33)30(29)35)20-7-4-6-19(15-20)23-16-22(32(40)41-2)9-12-26(23)36-31(18)39/h4,6-7,9-12,15-18,27H,3,5,8,13-14H2,1-2H3,(H,36,39)/t18-,27+/m1/s1	PQMIPRJGMKRLRT-CLYVBNDRSA-N	241532	US9409908, 164::US9409908, 174::US9951071, Example 174	Plasma kallikrein		 442.2							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241532	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241532&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060592	341093844							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421430	COC(=O)c1ccc2NC(=O)[C@H](C)CCC[C@@H](N3CCC(=CC3=O)c3c(F)ccc(Cl)c3F)c3cccc(c3)-c2c1	InChI=1S/C32H29ClF2N2O4/c1-18-5-3-8-27(37-14-13-21(17-28(37)38)29-25(34)11-10-24(33)30(29)35)20-7-4-6-19(15-20)23-16-22(32(40)41-2)9-12-26(23)36-31(18)39/h4,6-7,9-12,15-18,27H,3,5,8,13-14H2,1-2H3,(H,36,39)/t18-,27-/m1/s1	PQMIPRJGMKRLRT-DNOBIOAJSA-N	241533	US9409908, 165::US9951071, Example 165	Plasma kallikrein		 9471							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241533	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241533&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060412	341093845							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421431	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cccc(c2)-c2cc(ccc2NC1=O)C(O)=O	InChI=1S/C31H27ClF2N2O4/c1-17-4-2-7-26(36-13-12-20(16-27(36)37)28-24(33)10-9-23(32)29(28)34)19-6-3-5-18(14-19)22-15-21(31(39)40)8-11-25(22)35-30(17)38/h3,5-6,8-11,14-17,26H,2,4,7,12-13H2,1H3,(H,35,38)(H,39,40)/t17-,26+/m1/s1	VNKIWRSSMQDOEY-QUGAMOGWSA-N	241534	US9409908, 166::US9951071, Example 166	Plasma kallikrein		 112.6							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241534	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241534&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060540	341093846							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421432	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(Cl)ccc2Br)c2cccc(c2)-c2cc(ccc2NC1=O)C(O)=O	InChI=1S/C31H27BrClFN2O4/c1-17-4-2-7-26(36-13-12-20(16-27(36)37)28-23(32)9-10-24(33)29(28)34)19-6-3-5-18(14-19)22-15-21(31(39)40)8-11-25(22)35-30(17)38/h3,5-6,8-11,14-17,26H,2,4,7,12-13H2,1H3,(H,35,38)(H,39,40)/t17-,26+/m1/s1	AMKLNLCMEAFCLA-QUGAMOGWSA-N	241535	US9409908, 167::US9951071, Example 167	Plasma kallikrein		 20.08							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241535	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241535&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060613	341093847							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421433	COC(=O)c1ccc2NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)c(ccc3C#N)C#N)c3cccc(c3)-c2c1	InChI=1S/C34H29FN4O4/c1-20-5-3-8-29(39-14-13-23(17-30(39)40)31-25(18-36)9-10-26(19-37)32(31)35)22-7-4-6-21(15-22)27-16-24(34(42)43-2)11-12-28(27)38-33(20)41/h4,6-7,9-12,15-17,20,29H,3,5,8,13-14H2,1-2H3,(H,38,41)/t20-,29+/m1/s1	UVLCKUPXQUONLR-OLILMLBXSA-N	241536	US9409908, 168::US9951071, Example 168	Plasma kallikrein		 1916							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241536	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241536&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060517	341093848							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421434	COC(=O)c1ccc2NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3cccc(Cl)c3F)c3cccc(c3)-c2c1	InChI=1S/C32H30ClFN2O4/c1-19-6-3-11-28(36-15-14-21(18-29(36)37)24-9-5-10-26(33)30(24)34)22-8-4-7-20(16-22)25-17-23(32(39)40-2)12-13-27(25)35-31(19)38/h4-5,7-10,12-13,16-19,28H,3,6,11,14-15H2,1-2H3,(H,35,38)/t19-,28+/m1/s1	WJFXOEOEEZYWCV-GDJIYFAZSA-N	241537	US9409908, 169::US9951071, Example 169	Plasma kallikrein		 768.4							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241537	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241537&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060486	341093849							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421435	COC(=O)c1ccc2NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)c(Cl)ccc3C#N)c3cccc(c3)-c2c1	InChI=1S/C33H29ClFN3O4/c1-19-5-3-8-28(38-14-13-22(17-29(38)39)30-24(18-36)9-11-26(34)31(30)35)21-7-4-6-20(15-21)25-16-23(33(41)42-2)10-12-27(25)37-32(19)40/h4,6-7,9-12,15-17,19,28H,3,5,8,13-14H2,1-2H3,(H,37,40)/t19-,28+/m1/s1	QENGYZQWMBJJRV-GDJIYFAZSA-N	241538	US9409908, 170::US9951071, Example 170	Plasma kallikrein		 7.73							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241538	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241538&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060590	341093850							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421436	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)c(Cl)ccc3C(C)=O)c3cccc-2c3)c1	InChI=1S/C34H33ClFN3O5/c1-19-6-4-9-29(39-15-14-23(17-30(39)41)31-25(20(2)40)12-13-27(35)32(31)36)22-8-5-7-21(16-22)26-11-10-24(37-34(43)44-3)18-28(26)38-33(19)42/h5,7-8,10-13,16-19,29H,4,6,9,14-15H2,1-3H3,(H,37,43)(H,38,42)/t19-,29+/m1/s1	XTUFVXUJJQAYGD-XBBWARJSSA-N	241539	US9409908, 171::US9951071, Example 171	Plasma kallikrein		 8.87							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241539	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241539&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060524	341093851							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421437	COC(=O)c1ccc2NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)ccc(Cl)c3F)c3cccc(c3)-c2c1	InChI=1S/C32H29ClF2N2O4/c1-18-5-3-8-27(37-14-13-21(17-28(37)38)29-25(34)11-10-24(33)30(29)35)20-7-4-6-19(15-20)23-16-22(32(40)41-2)9-12-26(23)36-31(18)39/h4,6-7,9-12,15-18,27H,3,5,8,13-14H2,1-2H3,(H,36,39)/t18-,27+/m1/s1	PQMIPRJGMKRLRT-CLYVBNDRSA-N	241532	US9409908, 164::US9409908, 174::US9951071, Example 174	Plasma kallikrein		 1398							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241532	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241532&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060592	341093844							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421438	COC(=O)c1ccc2NC(=O)[C@H](C)CCC[C@@H](N3CCC(=CC3=O)c3c(F)c(Cl)ccc3Br)c3cccc(c3)-c2c1	InChI=1S/C32H29BrClFN2O4/c1-18-5-3-8-27(37-14-13-21(17-28(37)38)29-24(33)10-11-25(34)30(29)35)20-7-4-6-19(15-20)23-16-22(32(40)41-2)9-12-26(23)36-31(18)39/h4,6-7,9-12,15-18,27H,3,5,8,13-14H2,1-2H3,(H,36,39)/t18-,27-/m1/s1	BSNSKODJGQKGRG-DNOBIOAJSA-N	241543	US9409908, 175::US9951071, Example 175	Plasma kallikrein		 3809							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241543	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241543&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060617	341093854							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421439	COC(=O)c1ccc2NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)c(Cl)ccc3Br)c3cccc(c3)-c2c1	InChI=1S/C32H29BrClFN2O4/c1-18-5-3-8-27(37-14-13-21(17-28(37)38)29-24(33)10-11-25(34)30(29)35)20-7-4-6-19(15-20)23-16-22(32(40)41-2)9-12-26(23)36-31(18)39/h4,6-7,9-12,15-18,27H,3,5,8,13-14H2,1-2H3,(H,36,39)/t18-,27+/m1/s1	BSNSKODJGQKGRG-CLYVBNDRSA-N	241531	US9409908, 163::US9409908, 176::US9951071, Example 176	Plasma kallikrein		 522.6							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241531	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241531&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060611	341093843							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421440	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CC(C)C(=CC3=O)c3c(F)ccc(Cl)c3F)c3cc-2ccn3)c1	InChI=1S/C32H31ClF2N4O4/c1-17-5-4-6-27(39-16-18(2)22(15-28(39)40)29-24(34)10-9-23(33)30(29)35)26-13-19(11-12-36-26)21-8-7-20(37-32(42)43-3)14-25(21)38-31(17)41/h7-15,17-18,27H,4-6,16H2,1-3H3,(H,37,42)(H,38,41)/t17-,18?,27+/m1/s1	NPKCSHLGQLVUNO-ILPYMAIGSA-N	241441	US9409908, 177::US9409908, 178::US9409908, 73::US9951071, Example 73	Plasma kallikrein		 4.02							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241441	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241441&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060513	341093756							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421441	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CC(C)C(=CC3=O)c3c(F)ccc(Cl)c3F)c3cc-2ccn3)c1	InChI=1S/C32H31ClF2N4O4/c1-17-5-4-6-27(39-16-18(2)22(15-28(39)40)29-24(34)10-9-23(33)30(29)35)26-13-19(11-12-36-26)21-8-7-20(37-32(42)43-3)14-25(21)38-31(17)41/h7-15,17-18,27H,4-6,16H2,1-3H3,(H,37,42)(H,38,41)/t17-,18?,27+/m1/s1	NPKCSHLGQLVUNO-ILPYMAIGSA-N	241441	US9409908, 177::US9409908, 178::US9409908, 73::US9951071, Example 73	Plasma kallikrein		 5.68							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241441	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241441&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060513	341093756							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421442	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(Cl)ccc2NC(=O)C(F)(F)F)c2cc(ccn2)-c2ccccc2NC1=O	InChI=1S/C31H27ClF4N4O3/c1-17-5-4-8-25(24-15-18(11-13-37-24)20-6-2-3-7-22(20)38-29(17)42)40-14-12-19(16-26(40)41)27-23(10-9-21(32)28(27)33)39-30(43)31(34,35)36/h2-3,6-7,9-11,13,15-17,25H,4-5,8,12,14H2,1H3,(H,38,42)(H,39,43)/t17-,25+/m1/s1	ORFSGGJRUOCUTD-NSYGIPOTSA-N	241547	US9409908, 179::US9951071, Example 179	Plasma kallikrein		 50.11							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241547	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241547&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060492	341093855							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421443	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)C(F)CC[C@H](N3CCC(=CC3=O)c3c(F)ccc(Cl)c3F)c3cc-2ccn3)c1	InChI=1S/C31H28ClF3N4O4/c1-16-22(33)7-8-26(39-12-10-18(14-27(39)40)28-23(34)6-5-21(32)29(28)35)25-13-17(9-11-36-25)20-4-3-19(37-31(42)43-2)15-24(20)38-30(16)41/h3-6,9,11,13-16,22,26H,7-8,10,12H2,1-2H3,(H,37,42)(H,38,41)/t16-,22?,26+/m1/s1	QMJWWNVVTLEZIW-ALZQUROESA-N	241548	US9409908, 180	Plasma kallikrein		 2.42							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241548	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241548&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060607	341093856							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421444	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)c(Cl)ccc3C#C)c3cc-2ccn3)c1	InChI=1S/C33H30ClFN4O4/c1-4-20-8-11-25(34)31(35)30(20)22-13-15-39(29(40)17-22)28-7-5-6-19(2)32(41)38-26-18-23(37-33(42)43-3)9-10-24(26)21-12-14-36-27(28)16-21/h1,8-12,14,16-19,28H,5-7,13,15H2,2-3H3,(H,37,42)(H,38,41)/t19-,28+/m1/s1	QYWRPJPBRRCNJD-GDJIYFAZSA-N	241549	US9409908, 181::US9951071, Example 181	Plasma kallikrein		 3.29							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241549	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241549&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060531	341093857							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421445	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)c(Cl)ccc3-c3c[nH]nn3)c3cc-2ccn3)c1			241550	US9409908, 182::US9951071, Example 182	Plasma kallikrein		 14.31							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241550	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241550&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060498	341093858							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421446	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(Cl)ccc2NC(C)=O)c2cc(ccn2)-c2ccccc2NC1=O	InChI=1S/C31H30ClFN4O3/c1-18-6-5-9-27(26-16-20(12-14-34-26)22-7-3-4-8-24(22)36-31(18)40)37-15-13-21(17-28(37)39)29-25(35-19(2)38)11-10-23(32)30(29)33/h3-4,7-8,10-12,14,16-18,27H,5-6,9,13,15H2,1-2H3,(H,35,38)(H,36,40)/t18-,27+/m1/s1	WTYSEXAPGLRBCV-CLYVBNDRSA-N	241551	US9409908, 183::US9951071, Example 183	Plasma kallikrein		 297							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241551	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241551&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060536	341093859							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421447	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(Cl)ccc2-n2cnnn2)c2cc(ccn2)-c2cc(F)ccc2NC1=O	InChI=1S/C30H26ClF2N7O2/c1-17-3-2-4-25(24-13-18(9-11-34-24)21-15-20(32)5-7-23(21)36-30(17)42)39-12-10-19(14-27(39)41)28-26(40-16-35-37-38-40)8-6-22(31)29(28)33/h5-9,11,13-17,25H,2-4,10,12H2,1H3,(H,36,42)/t17-,25+/m1/s1	BBDIEHHRWQGMIS-NSYGIPOTSA-N	241552	US9409908, 184::US9951071, Example 184	Plasma kallikrein		 2.51							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241552	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241552&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060538	341093860							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421448	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccncc2NC1=O	InChI=1S/C28H25ClF2N4O2/c1-16-3-2-4-24(22-13-17(7-11-33-22)19-8-10-32-15-23(19)34-28(16)37)35-12-9-18(14-25(35)36)26-21(30)6-5-20(29)27(26)31/h5-8,10-11,13-16,24H,2-4,9,12H2,1H3,(H,34,37)/t16-,24+/m1/s1	XYICNNPOQLZANR-GYCJOSAFSA-N	241440	US9409908, 185::US9409908, 72::US9951071, Example 72	Plasma kallikrein		 47.4							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241440	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241440&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060363	341093755							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421449	COC(=O)c1ccc2NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)c(Cl)ccc3C(F)(F)F)c3cc(ccn3)-c2c1	InChI=1S/C32H28ClF4N3O4/c1-17-4-3-5-26(40-13-11-19(16-27(40)41)28-22(32(35,36)37)7-8-23(33)29(28)34)25-15-18(10-12-38-25)21-14-20(31(43)44-2)6-9-24(21)39-30(17)42/h6-10,12,14-17,26H,3-5,11,13H2,1-2H3,(H,39,42)/t17-,26+/m1/s1	KGBUFRIXAWSHKU-QUGAMOGWSA-N	241554	US9409908, 186::US9951071, Example 186	Plasma kallikrein		 60.46							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241554	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241554&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060544	341093861							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421450	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(Cl)ccc2C(F)(F)F)c2cc(ccn2)-c2cc(ccc2NC1=O)C(O)=O	InChI=1S/C31H26ClF4N3O4/c1-16-3-2-4-25(24-14-17(9-11-37-24)20-13-19(30(42)43)5-8-23(20)38-29(16)41)39-12-10-18(15-26(39)40)27-21(31(34,35)36)6-7-22(32)28(27)33/h5-9,11,13-16,25H,2-4,10,12H2,1H3,(H,38,41)(H,42,43)/t16-,25+/m1/s1	OUXKGHOTTHIOQL-CPJLOUKISA-N	241555	US9409908, 187::US9951071, Example 187	Plasma kallikrein		 17.38							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241555	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241555&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060491	341093862							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421451	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2cc(Cl)ccc2-n2ccnn2)c2cc(ccn2)-c2cc(F)ccc2NC1=O	InChI=1S/C31H28ClFN6O2/c1-19-3-2-4-29(27-15-20(9-11-34-27)24-18-23(33)6-7-26(24)36-31(19)41)38-13-10-21(16-30(38)40)25-17-22(32)5-8-28(25)39-14-12-35-37-39/h5-9,11-12,14-19,29H,2-4,10,13H2,1H3,(H,36,41)/t19-,29+/m1/s1	NUAGLWKIGCGSTL-XBBWARJSSA-N	241556	US9409908, 188::US9951071, Example 188	Plasma kallikrein		 23.16							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241556	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241556&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060622	341093863							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421452	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2cc(Cl)ccc2-n2ccnn2)c2cc(ccn2)-c2ccccc2NC1=O	InChI=1S/C31H29ClN6O2/c1-20-5-4-8-29(27-17-21(11-13-33-27)24-6-2-3-7-26(24)35-31(20)40)37-15-12-22(18-30(37)39)25-19-23(32)9-10-28(25)38-16-14-34-36-38/h2-3,6-7,9-11,13-14,16-20,29H,4-5,8,12,15H2,1H3,(H,35,40)/t20-,29+/m1/s1	IOMDGXNOZMTGIL-OLILMLBXSA-N	241557	US9409908, 189::US9951071, Example 189	Plasma kallikrein		 40.42							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241557	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241557&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060618	341093864							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421453	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)ccc(Br)c3F)c3cc-2ccn3)c1	InChI=1S/C31H29BrF2N4O4/c1-17-4-3-5-26(38-13-11-19(15-27(38)39)28-23(33)9-8-22(32)29(28)34)25-14-18(10-12-35-25)21-7-6-20(36-31(41)42-2)16-24(21)37-30(17)40/h6-10,12,14-17,26H,3-5,11,13H2,1-2H3,(H,36,41)(H,37,40)/t17-,26+/m1/s1	IMCXJEIDVWMIBG-QUGAMOGWSA-N	241558	US9409908, 190::US9951071, Example 190	Plasma kallikrein		 1.11							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241558	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241558&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060603	341093865							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421454	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)c(Cl)ccc3C(C)=O)c3cc(F)cc-2c3)c1	InChI=1S/C34H32ClF2N3O5/c1-18-5-4-6-29(40-12-11-20(16-30(40)42)31-25(19(2)41)9-10-27(35)32(31)37)22-13-21(14-23(36)15-22)26-8-7-24(38-34(44)45-3)17-28(26)39-33(18)43/h7-10,13-18,29H,4-6,11-12H2,1-3H3,(H,38,44)(H,39,43)/t18-,29+/m1/s1	WKGAFUMVYFTGCQ-LBEKAKSKSA-N	241559	US9409908, 191::US9951071, Example 191	Plasma kallikrein		 19.25							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241559	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241559&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060515	341093866							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421455	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(NC(N)=N)cc2NC1=O	InChI=1S/C30H29ClF2N6O2/c1-16-3-2-4-25(39-12-10-18(14-26(39)40)27-22(32)8-7-21(31)28(27)33)24-13-17(9-11-36-24)20-6-5-19(37-30(34)35)15-23(20)38-29(16)41/h5-9,11,13-16,25H,2-4,10,12H2,1H3,(H,38,41)(H4,34,35,37)/t16-,25+/m1/s1	BWKUSQPAEGPWQY-CPJLOUKISA-N	241560	US9409908, 192::US9951071, Example 192	Plasma kallikrein		 181.6							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241560	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241560&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060545	341093867							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421456	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2cc(Br)c(N)cc2NC1=O	InChI=1S/C29H26BrClF2N4O2/c1-15-3-2-4-25(37-10-8-17(12-26(37)38)27-21(32)6-5-20(31)28(27)33)24-11-16(7-9-35-24)18-13-19(30)22(34)14-23(18)36-29(15)39/h5-7,9,11-15,25H,2-4,8,10,34H2,1H3,(H,36,39)/t15-,25+/m1/s1	DZZRWRHLIZMWFJ-BZQUYTCOSA-N	241561	US9409908, 193::US9951071, Example 193	Plasma kallikrein		 3.91							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241561	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241561&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060511	341093868							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421457	COC(=O)Nc1ccc2-c3ccnc(c3)[C@H](CCC[C@@H](C)NC(=O)c2c1)N1CCC(=CC1=O)c1c(F)ccc(Cl)c1F	InChI=1S/C31H29ClF2N4O4/c1-17-4-3-5-26(38-13-11-19(15-27(38)39)28-24(33)9-8-23(32)29(28)34)25-14-18(10-12-35-25)21-7-6-20(37-31(41)42-2)16-22(21)30(40)36-17/h6-10,12,14-17,26H,3-5,11,13H2,1-2H3,(H,36,40)(H,37,41)/t17-,26+/m1/s1	JORBAAKNOUMANA-QUGAMOGWSA-N	241562	US9409908, 194	Plasma kallikrein		 310							25.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241562	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241562&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			122466893	341093869							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421458	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(Nc3cccnc3)cc2NC1=O	InChI=1S/C34H30ClF2N5O2/c1-20-4-2-6-30(42-15-12-22(17-31(42)43)32-27(36)10-9-26(35)33(32)37)29-16-21(11-14-39-29)25-8-7-23(18-28(25)41-34(20)44)40-24-5-3-13-38-19-24/h3,5,7-11,13-14,16-20,30,40H,2,4,6,12,15H2,1H3,(H,41,44)/t20-,30+/m1/s1	OCWLBXWNNDGCER-KEEVHDRGSA-N	241563	US9409908, 195::US9951071, Example 195	Plasma kallikrein		 2.96							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241563	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241563&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060548	341093870							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421459	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(Nc3cccnn3)cc2NC1=O	InChI=1S/C33H29ClF2N6O2/c1-19-4-2-5-28(42-15-12-21(17-30(42)43)31-25(35)10-9-24(34)32(31)36)27-16-20(11-14-37-27)23-8-7-22(18-26(23)40-33(19)44)39-29-6-3-13-38-41-29/h3,6-11,13-14,16-19,28H,2,4-5,12,15H2,1H3,(H,39,41)(H,40,44)/t19-,28+/m1/s1	QWMGKGHSOYXEJP-GDJIYFAZSA-N	241564	US9409908, 196::US9951071, Example 196	Plasma kallikrein		 1.52							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241564	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241564&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060616	341093871							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421460	COC(=O)c1cc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)ccc(Cl)c3F)c3cc-2ccn3)cc1N	InChI=1S/C31H29ClF2N4O4/c1-16-4-3-5-26(38-11-9-18(13-27(38)39)28-22(33)7-6-21(32)29(28)34)25-12-17(8-10-36-25)19-14-20(31(41)42-2)23(35)15-24(19)37-30(16)40/h6-8,10,12-16,26H,3-5,9,11,35H2,1-2H3,(H,37,40)/t16-,26+/m1/s1	KZXNHUNTABHMLN-DXPJPUQTSA-N	241565	US9409908, 197::US9951071, Example 197	Plasma kallikrein		 4.83							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241565	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241565&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060620	341093872							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421461	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2cc(C(O)=O)c(N)cc2NC1=O	InChI=1S/C30H27ClF2N4O4/c1-15-3-2-4-25(37-10-8-17(12-26(37)38)27-21(32)6-5-20(31)28(27)33)24-11-16(7-9-35-24)18-13-19(30(40)41)22(34)14-23(18)36-29(15)39/h5-7,9,11-15,25H,2-4,8,10,34H2,1H3,(H,36,39)(H,40,41)/t15-,25+/m1/s1	RDKBQIHAKHPESW-BZQUYTCOSA-N	241566	US9409908, 198::US9951071, Example 198	Plasma kallikrein		 1							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241566	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241566&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060514	341093873							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421462	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2cc3c(O)cc(=O)[nH]c3cc2NC1=O			241567	US9409908, 199::US9951071, Example 199	Plasma kallikrein		 1.79							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241567	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241567&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			129625767	341093874							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421463	C[C@@H]1CCC[C@@H](c2cc(ccn2)-c2c(F)cccc2NC1=O)n1ccc(cc1=O)-c1c(F)ccc(Cl)c1F	InChI=1S/C29H23ClF3N3O2/c1-16-4-2-7-24(36-13-11-18(15-25(36)37)27-21(32)9-8-19(30)28(27)33)23-14-17(10-12-34-23)26-20(31)5-3-6-22(26)35-29(16)38/h3,5-6,8-16,24H,2,4,7H2,1H3,(H,35,38)/t16-,24+/m1/s1	IWFAEMIVPFQUEI-GYCJOSAFSA-N	241568	US9409908, 200::US9951071, Example 200	Plasma kallikrein		 28.71							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241568	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241568&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060553	341093875							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421464	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2c(F)cc(F)cc2NC1=O	InChI=1S/C29H24ClF4N3O2/c1-15-3-2-4-24(37-10-8-17(12-25(37)38)27-20(32)6-5-19(30)28(27)34)22-11-16(7-9-35-22)26-21(33)13-18(31)14-23(26)36-29(15)39/h5-7,9,11-15,24H,2-4,8,10H2,1H3,(H,36,39)/t15-,24+/m1/s1	KPESKXMOJFJEFE-MYYSRTQBSA-N	241569	US9409908, 201::US9951071, Example 201	Plasma kallikrein		 105							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241569	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241569&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060639	341093876							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421465	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(Br)ccc(Cl)c2F)c2cc(ccn2)-c2c(F)cc(F)cc2NC1=O	InChI=1S/C29H24BrClF3N3O2/c1-15-3-2-4-24(37-10-8-17(12-25(37)38)26-19(30)5-6-20(31)28(26)34)22-11-16(7-9-35-22)27-21(33)13-18(32)14-23(27)36-29(15)39/h5-7,9,11-15,24H,2-4,8,10H2,1H3,(H,36,39)/t15-,24+/m1/s1	DSYKFFMSBGSONK-MYYSRTQBSA-N	241570	US9409908, 202::US9951071, Example 202	Plasma kallikrein		 30.11							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241570	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241570&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060494	341093877							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421466	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2c(F)c(F)ccc2NC1=O	InChI=1S/C29H24ClF4N3O2/c1-15-3-2-4-23(37-12-10-17(14-24(37)38)25-19(31)6-5-18(30)27(25)33)22-13-16(9-11-35-22)26-21(36-29(15)39)8-7-20(32)28(26)34/h5-9,11,13-15,23H,2-4,10,12H2,1H3,(H,36,39)/t15-,23+/m1/s1	FHTHEOCGYPFYBM-CMJOXMDJSA-N	241571	US9409908, 203::US9951071, Example 203	Plasma kallikrein		 44.05							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241571	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241571&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060602	341093878							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421467	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(Br)ccc(Cl)c2F)c2cc(ccn2)-c2c(F)c(F)ccc2NC1=O	InChI=1S/C29H24BrClF3N3O2/c1-15-3-2-4-23(37-12-10-17(14-24(37)38)25-18(30)5-6-19(31)27(25)33)22-13-16(9-11-35-22)26-21(36-29(15)39)8-7-20(32)28(26)34/h5-9,11,13-15,23H,2-4,10,12H2,1H3,(H,36,39)/t15-,23+/m1/s1	TXRMRQKQNYNOAW-CMJOXMDJSA-N	241572	US9409908, 204::US9951071, Example 204	Plasma kallikrein		 15.98							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241572	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241572&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060539	341093879							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421468	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2cc(F)c(F)cc2NC1=O	InChI=1S/C29H24ClF4N3O2/c1-15-3-2-4-25(37-10-8-17(12-26(37)38)27-20(31)6-5-19(30)28(27)34)24-11-16(7-9-35-24)18-13-21(32)22(33)14-23(18)36-29(15)39/h5-7,9,11-15,25H,2-4,8,10H2,1H3,(H,36,39)/t15-,25+/m1/s1	SOEFIQITYNWYLZ-BZQUYTCOSA-N	241573	US9409908, 205::US9951071, Example 205	Plasma kallikrein		 88.36							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241573	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241573&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060621	341093880							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421469	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(Br)ccc(Cl)c2F)c2cc(ccn2)-c2cc(F)c(F)cc2NC1=O	InChI=1S/C29H24BrClF3N3O2/c1-15-3-2-4-25(37-10-8-17(12-26(37)38)27-19(30)5-6-20(31)28(27)34)24-11-16(7-9-35-24)18-13-21(32)22(33)14-23(18)36-29(15)39/h5-7,9,11-15,25H,2-4,8,10H2,1H3,(H,36,39)/t15-,25+/m1/s1	VTBXUUQDJAJGJV-BZQUYTCOSA-N	241574	US9409908, 206::US9951071, Example 206	Plasma kallikrein		 27.46							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241574	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241574&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060428	341093881							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421470	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(Cl)ccc2C#N)c2cc(ccn2)-c2c(F)cc(F)cc2NC1=O	InChI=1S/C30H24ClF3N4O2/c1-16-3-2-4-25(38-10-8-18(12-26(38)39)27-19(15-35)5-6-21(31)29(27)34)23-11-17(7-9-36-23)28-22(33)13-20(32)14-24(28)37-30(16)40/h5-7,9,11-14,16,25H,2-4,8,10H2,1H3,(H,37,40)/t16-,25+/m1/s1	UUUYIBUJURRXLR-CPJLOUKISA-N	241575	US9409908, 207::US9951071, Example 207	Plasma kallikrein		 5.8							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241575	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241575&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060555	341093882							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421471	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(Cl)ccc2C#N)c2cc(ccn2)-c2c(F)c(F)ccc2NC1=O	InChI=1S/C30H24ClF3N4O2/c1-16-3-2-4-24(38-12-10-18(14-25(38)39)26-19(15-35)5-6-20(31)28(26)33)23-13-17(9-11-36-23)27-22(37-30(16)40)8-7-21(32)29(27)34/h5-9,11,13-14,16,24H,2-4,10,12H2,1H3,(H,37,40)/t16-,24+/m1/s1	DUPDRBCVCXMPPE-GYCJOSAFSA-N	241576	US9409908, 208::US9951071, Example 208	Plasma kallikrein		 3.1							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241576	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241576&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060604	341093883							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421472	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(ccc2C#N)C#N)c2cc(ccn2)-c2c(F)c(F)ccc2NC1=O	InChI=1S/C31H24F3N5O2/c1-17-3-2-4-25(24-13-18(9-11-37-24)28-23(38-31(17)41)8-7-22(32)30(28)34)39-12-10-19(14-26(39)40)27-20(15-35)5-6-21(16-36)29(27)33/h5-9,11,13-14,17,25H,2-4,10,12H2,1H3,(H,38,41)/t17-,25+/m1/s1	FDTVUOVYASYRLD-NSYGIPOTSA-N	241577	US9409908, 209::US9951071, Example 209	Plasma kallikrein		 457.3							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241577	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241577&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060512	341093884							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421473	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(ccc2C#N)C#N)c2cc(ccn2)-c2cc(F)c(F)cc2NC1=O	InChI=1S/C31H24F3N5O2/c1-17-3-2-4-27(26-11-18(7-9-37-26)22-13-23(32)24(33)14-25(22)38-31(17)41)39-10-8-19(12-28(39)40)29-20(15-35)5-6-21(16-36)30(29)34/h5-7,9,11-14,17,27H,2-4,8,10H2,1H3,(H,38,41)/t17-,27+/m1/s1	LLKMMHWUWOEVMR-CRYYWNKWSA-N	241578	US9409908, 210::US9951071, Example 210	Plasma kallikrein		 1200							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241578	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241578&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060623	341093885							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421474	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(Cl)ccc2C#N)c2cc(ccn2)-c2cc(F)c(F)cc2NC1=O	InChI=1S/C30H24ClF3N4O2/c1-16-3-2-4-26(38-10-8-18(12-27(38)39)28-19(15-35)5-6-21(31)29(28)34)25-11-17(7-9-36-25)20-13-22(32)23(33)14-24(20)37-30(16)40/h5-7,9,11-14,16,26H,2-4,8,10H2,1H3,(H,37,40)/t16-,26+/m1/s1	GTMQLRVEOBBFGO-DXPJPUQTSA-N	241579	US9409908, 211::US9951071, Example 211	Plasma kallikrein		 6.46							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241579	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241579&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060566	341093886							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421475	C[C@@H]1CCC[C@@H](c2cc(ccn2)-c2c(F)cc(F)cc2NC1=O)n1ccc(cc1=O)-c1cccc(Cl)c1F	InChI=1S/C29H23ClF3N3O2/c1-16-4-2-7-25(36-11-9-17(13-26(36)37)20-5-3-6-21(30)28(20)33)23-12-18(8-10-34-23)27-22(32)14-19(31)15-24(27)35-29(16)38/h3,5-6,8-16,25H,2,4,7H2,1H3,(H,35,38)/t16-,25+/m1/s1	ZPJLQXFNQCVGJK-CPJLOUKISA-N	241580	US9409908, 212::US9951071, Example 212	Plasma kallikrein		 286.2							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241580	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241580&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060449	341093887							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421476	COC(=O)c1cccc2NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)ccc(Cl)c3F)c3cc(ccn3)-c12	InChI=1S/C31H28ClF2N3O4/c1-17-5-3-8-25(37-14-12-19(16-26(37)38)28-22(33)10-9-21(32)29(28)34)24-15-18(11-13-35-24)27-20(31(40)41-2)6-4-7-23(27)36-30(17)39/h4,6-7,9-11,13,15-17,25H,3,5,8,12,14H2,1-2H3,(H,36,39)/t17-,25+/m1/s1	CXESAZISLSPVSR-NSYGIPOTSA-N	241581	US9409908, 213::US9951071, Example 213	Plasma kallikrein		 3370							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241581	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241581&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060624	341093888							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421477	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2c(NC1=O)cccc2C(O)=O	InChI=1S/C30H26ClF2N3O4/c1-16-4-2-7-24(36-13-11-18(15-25(36)37)27-21(32)9-8-20(31)28(27)33)23-14-17(10-12-34-23)26-19(30(39)40)5-3-6-22(26)35-29(16)38/h3,5-6,8-10,12,14-16,24H,2,4,7,11,13H2,1H3,(H,35,38)(H,39,40)/t16-,24+/m1/s1	OROOHDNCDLETBU-GYCJOSAFSA-N	241582	US9409908, 214::US9951071, Example 214	Plasma kallikrein		>13020.00							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241582	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241582&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060629	341093889							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421478	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(Cl)ccc2-n2cnnn2)c2cc(ccn2)-c2cc(F)c(F)cc2NC1=O	InChI=1S/C30H25ClF3N7O2/c1-16-3-2-4-25(24-11-17(7-9-35-24)19-13-21(32)22(33)14-23(19)37-30(16)43)40-10-8-18(12-27(40)42)28-26(41-15-36-38-39-41)6-5-20(31)29(28)34/h5-7,9,11-16,25H,2-4,8,10H2,1H3,(H,37,43)/t16-,25+/m1/s1	JKKGBKZFKPXHDS-CPJLOUKISA-N	241583	US9409908, 215::US9951071, Example 215	Plasma kallikrein		 3.61							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241583	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241583&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060551	341093890							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421479	COC(=O)Nc1ccc2-c3ccnc(c3)[C@H](C\C=C\CCNC(=O)c2c1)N1CCC(=CC1=O)c1c(F)ccc(Cl)c1F	InChI=1S/C31H27ClF2N4O4/c1-42-31(41)37-20-6-7-21-18-10-13-35-25(15-18)26(5-3-2-4-12-36-30(40)22(21)17-20)38-14-11-19(16-27(38)39)28-24(33)9-8-23(32)29(28)34/h2-3,6-10,13,15-17,26H,4-5,11-12,14H2,1H3,(H,36,40)(H,37,41)/b3-2+/t26-/m0/s1	YWQXBKNISYYIMA-HPHQOREJSA-N	241584	US9409908, 216::US9951071, Example 216	Plasma kallikrein		 212.3							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241584	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241584&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060552	341093891							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421480	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2c(NC1=O)cccc2C#N	InChI=1S/C30H25ClF2N4O2/c1-17-4-2-7-25(37-13-11-19(15-26(37)38)28-22(32)9-8-21(31)29(28)33)24-14-18(10-12-35-24)27-20(16-34)5-3-6-23(27)36-30(17)39/h3,5-6,8-10,12,14-15,17,25H,2,4,7,11,13H2,1H3,(H,36,39)/t17-,25+/m1/s1	VPKWFQMGARBSGB-NSYGIPOTSA-N	241585	US9409908, 217	Plasma kallikrein		 154.5							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241585	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241585&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060432	341093892							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421481	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)C3CCCC(C)C3)c3cc-2ccn3)c1	InChI=1S/C32H40N4O4/c1-20-6-4-8-22(16-20)23-13-15-36(30(37)18-23)29-9-5-7-21(2)31(38)35-27-19-25(34-32(39)40-3)10-11-26(27)24-12-14-33-28(29)17-24/h10-12,14,17-22,29H,4-9,13,15-16H2,1-3H3,(H,34,39)(H,35,38)/t20?,21-,22?,29+/m1/s1	NTRPAMBLEXVPQJ-BELJIYFPSA-N	241521	BDBM241596::US9409908, 153::US9409908, 159::US9409908, 218::US9409908, 225::US9951071, Example 225	Plasma kallikrein		 377.6							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241521	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241521&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060429	341093834							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421482	COC(=O)Nc1ccc-2c(NC(=O)CCCCC[C@H](N3CCC(=CC3=O)c3c(F)ccc(Cl)c3F)c3cc-2ccn3)c1	InChI=1S/C31H29ClF2N4O4/c1-42-31(41)36-20-7-8-21-18-11-13-35-25(15-18)26(5-3-2-4-6-27(39)37-24(21)17-20)38-14-12-19(16-28(38)40)29-23(33)10-9-22(32)30(29)34/h7-11,13,15-17,26H,2-6,12,14H2,1H3,(H,36,41)(H,37,39)/t26-/m0/s1	QGEHSULTCOSTKP-SANMLTNESA-N	241587	US9409908, 219::US9951071, Example 219	Plasma kallikrein		 6.85							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241587	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241587&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060521	341093893							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421483	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2nc(c(C)[nH]2)-c2ccccc2NC1=O			241588	US9409908, 220::US9951071, Example 220	Plasma kallikrein		 50.16							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241588	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241588&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060434	341093894							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421484	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2cn[nH]c2NC1=O			241589	US9409908, 221::US9951071, Example 221	Plasma kallikrein		 1317							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241589	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241589&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060532	341093895							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421485	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-n2nc(cc2NC1=O)C(O)=O	InChI=1S/C27H24ClF2N5O4/c1-14-3-2-4-21(34-10-8-15(11-23(34)36)24-18(29)6-5-17(28)25(24)30)19-12-16(7-9-31-19)35-22(32-26(14)37)13-20(33-35)27(38)39/h5-7,9,11-14,21H,2-4,8,10H2,1H3,(H,32,37)(H,38,39)/t14-,21+/m1/s1	NPHHNMJIOHQPCH-SZNDQCEHSA-N	241590	US9409908, 222::US9951071, Example 222	Plasma kallikrein		 501.2							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241590	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241590&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060636	341093896							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421486	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-n2nc(cc2NC1=O)C1CC1	InChI=1S/C29H28ClF2N5O2/c1-16-3-2-4-24(36-12-10-18(13-26(36)38)27-21(31)8-7-20(30)28(27)32)23-14-19(9-11-33-23)37-25(34-29(16)39)15-22(35-37)17-5-6-17/h7-9,11,13-17,24H,2-6,10,12H2,1H3,(H,34,39)/t16-,24+/m1/s1	ZSIJVOIVCNQFGT-GYCJOSAFSA-N	241591	US9409908, 223::US9951071, Example 223	Plasma kallikrein		 146.4							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241591	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241591&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060518	341093897							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421487	COC(=O)Nc1cc2NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)ccc(Cl)c3F)c3cc(ccn3)-n2n1	InChI=1S/C28H27ClF2N6O4/c1-15-4-3-5-21(36-11-9-16(12-24(36)38)25-19(30)7-6-18(29)26(25)31)20-13-17(8-10-32-20)37-23(34-27(15)39)14-22(35-37)33-28(40)41-2/h6-8,10,12-15,21H,3-5,9,11H2,1-2H3,(H,34,39)(H,33,35,40)/t15-,21+/m1/s1	XVHYFJOHASTAFQ-VFNWGFHPSA-N	241592	US9409908, 224::US9951071, Example 224	Plasma kallikrein		 270.8							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241592	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241592&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060497	341093898							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421488	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)C3CCCC(C)C3)c3cc-2ccn3)c1	InChI=1S/C32H40N4O4/c1-20-6-4-8-22(16-20)23-13-15-36(30(37)18-23)29-9-5-7-21(2)31(38)35-27-19-25(34-32(39)40-3)10-11-26(27)24-12-14-33-28(29)17-24/h10-12,14,17-22,29H,4-9,13,15-16H2,1-3H3,(H,34,39)(H,35,38)/t20?,21-,22?,29+/m1/s1	NTRPAMBLEXVPQJ-BELJIYFPSA-N	241521	BDBM241596::US9409908, 153::US9409908, 159::US9409908, 218::US9409908, 225::US9951071, Example 225	Plasma kallikrein		 95.55							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241521	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241521&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060429	341093834							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421489	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)C3CCCC(C)C3)c3cc-2ccn3)c1	InChI=1S/C32H40N4O4/c1-20-6-4-8-22(16-20)23-13-15-36(30(37)18-23)29-9-5-7-21(2)31(38)35-27-19-25(34-32(39)40-3)10-11-26(27)24-12-14-33-28(29)17-24/h10-12,14,17-22,29H,4-9,13,15-16H2,1-3H3,(H,34,39)(H,35,38)/t20?,21-,22?,29+/m1/s1	NTRPAMBLEXVPQJ-BELJIYFPSA-N	241521	BDBM241596::US9409908, 153::US9409908, 159::US9409908, 218::US9409908, 225::US9951071, Example 225	Plasma kallikrein		 164.8							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241521	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241521&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060429	341093834							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421490	COC(=O)Nc1cccc(NC(=O)[C@H](C)CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2ncc([nH]2)-c2cncnc2)c1			241594	US9409908, 227	Plasma kallikrein		 3.9							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241594	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241594&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			122466941	341093899							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421273	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)c(Cl)ccc3OC)c3cc-2ccn3)c1	InChI=1S/C32H32ClFN4O5/c1-18-5-4-6-26(38-14-12-20(16-28(38)39)29-27(42-2)10-9-23(33)30(29)34)25-15-19(11-13-35-25)22-8-7-21(36-32(41)43-3)17-24(22)37-31(18)40/h7-11,13,15-18,26H,4-6,12,14H2,1-3H3,(H,36,41)(H,37,40)/t18-,26+/m1/s1	NVKNABMCMNHCSO-DWXRJYCRSA-N	241369	US9409908, 1::US9951071, Example 1	Plasma kallikrein		 10							25.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241369	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241369&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			73052833	341093684							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421274	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(C)ccc(Cl)c3F)c3cc-2ccn3)c1	InChI=1S/C32H32ClFN4O4/c1-18-7-10-24(33)30(34)29(18)21-12-14-38(28(39)16-21)27-6-4-5-19(2)31(40)37-25-17-22(36-32(41)42-3)8-9-23(25)20-11-13-35-26(27)15-20/h7-11,13,15-17,19,27H,4-6,12,14H2,1-3H3,(H,36,41)(H,37,40)/t19-,27+/m1/s1	VZCFMFWKMXXTFA-WINIVTDRSA-N	241370	US9409908, 2::US9951071, Example 2	Plasma kallikrein		 5							25.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241370	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241370&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			73052989	341093685							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421275	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)c(Cl)ccc3C#N)c3cc-2ccn3)c1	InChI=1S/C32H29ClFN5O4/c1-18-4-3-5-27(39-13-11-20(15-28(39)40)29-21(17-35)6-9-24(33)30(29)34)26-14-19(10-12-36-26)23-8-7-22(37-32(42)43-2)16-25(23)38-31(18)41/h6-10,12,14-16,18,27H,3-5,11,13H2,1-2H3,(H,37,42)(H,38,41)/t18-,27+/m1/s1	WSDKNZUBTLXSPM-CLYVBNDRSA-N	241371	US9409908, 3::US9951071, Example 3	Plasma kallikrein		 1							25.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241371	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241371&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			72792440	341093686							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421276	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)cccc3C#N)c3cc-2ccn3)c1	InChI=1S/C32H30FN5O4/c1-19-5-3-8-28(38-14-12-21(16-29(38)39)30-22(18-34)6-4-7-25(30)33)27-15-20(11-13-35-27)24-10-9-23(36-32(41)42-2)17-26(24)37-31(19)40/h4,6-7,9-11,13,15-17,19,28H,3,5,8,12,14H2,1-2H3,(H,36,41)(H,37,40)/t19-,28+/m1/s1	HLWOCEXYCJLWGO-GDJIYFAZSA-N	241372	US9409908, 4::US9951071, Example 4	Plasma kallikrein		 1							25.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241372	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241372&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			73053131	341093687							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421277	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3nccc(Cl)c3F)c3cc-2cc(OC)n3)c1	InChI=1S/C31H31ClFN5O5/c1-17-5-4-6-25(38-12-10-18(15-27(38)39)29-28(33)22(32)9-11-34-29)24-13-19(14-26(36-24)42-2)21-8-7-20(35-31(41)43-3)16-23(21)37-30(17)40/h7-9,11,13-17,25H,4-6,10,12H2,1-3H3,(H,35,41)(H,37,40)/t17-,25+/m1/s1	IEVMGHWIRRVDRB-NSYGIPOTSA-N	241373	US9409908, 5::US9951071, Example 5	Plasma kallikrein		 3							25.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241373	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241373&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			73052988	341093688							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421278	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3nccc(Cl)c3OC)c3cc-2cc(OC)n3)c1	InChI=1S/C32H34ClN5O6/c1-18-6-5-7-26(38-13-11-19(16-28(38)39)29-30(43-3)23(33)10-12-34-29)25-14-20(15-27(36-25)42-2)22-9-8-21(35-32(41)44-4)17-24(22)37-31(18)40/h8-10,12,14-18,26H,5-7,11,13H2,1-4H3,(H,35,41)(H,37,40)/t18-,26+/m1/s1	YRVVTNRXDLFTOG-DWXRJYCRSA-N	241374	US9409908, 6::US9951071, Example 6	Plasma kallikrein		 303							25.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241374	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241374&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			73053132	341093689							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421279	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)c(ccc3C#N)C#N)c3cc-2cc(OC)n3)c1	InChI=1S/C34H31FN6O5/c1-19-5-4-6-28(41-12-11-20(15-30(41)42)31-21(17-36)7-8-22(18-37)32(31)35)27-13-23(14-29(39-27)45-2)25-10-9-24(38-34(44)46-3)16-26(25)40-33(19)43/h7-10,13-16,19,28H,4-6,11-12H2,1-3H3,(H,38,44)(H,40,43)/t19-,28+/m1/s1	FJMCAFXMYKYZAO-GDJIYFAZSA-N	241375	US9409908, 7::US9951071, Example 7	Plasma kallikrein		 10							25.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241375	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241375&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			73053133	341093690							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421280	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(ccc4c(N)n[nH]c34)C#N)c3cc-2cc(OC)n3)c1			241376	US9409908, 8::US9951071, Example 8	Plasma kallikrein		 173							25.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241376	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241376&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			73053134	341093691							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421281	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(ccc4c(N)noc34)C#N)c3cc-2cc(OC)n3)c1	InChI=1S/C34H33N7O6/c1-18-5-4-6-27(41-12-11-19(15-29(41)42)30-20(17-35)7-9-24-31(30)47-40-32(24)36)26-13-21(14-28(38-26)45-2)23-10-8-22(37-34(44)46-3)16-25(23)39-33(18)43/h7-10,13-16,18,27H,4-6,11-12H2,1-3H3,(H2,36,40)(H,37,44)(H,39,43)/t18-,27+/m1/s1	ZWUUYRIAOVUGDT-CLYVBNDRSA-N	241377	US9409908, 9::US9951071, Example 9	Plasma kallikrein		 46							25.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241377	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241377&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			73053279	341093692							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421282	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3nccc(Cl)c3F)c3cc-2ccn3)c1	InChI=1S/C30H29ClFN5O4/c1-17-4-3-5-25(37-13-10-19(15-26(37)38)28-27(32)22(31)9-12-34-28)24-14-18(8-11-33-24)21-7-6-20(35-30(40)41-2)16-23(21)36-29(17)39/h6-9,11-12,14-17,25H,3-5,10,13H2,1-2H3,(H,35,40)(H,36,39)/t17-,25+/m1/s1	XXPYQZDZFMYLHR-NSYGIPOTSA-N	241378	US9409908, 10::US9951071, Example 10	Plasma kallikrein		 1							25.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241378	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241378&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118236087	341093693							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421283	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@@H](c3cc-2ccn3)n2ncc(cc2=O)-c2c(F)ccc(Cl)c2F)c1	InChI=1S/C30H26ClF2N5O4/c1-16-4-3-5-25(38-26(39)13-18(15-35-38)27-22(32)9-8-21(31)28(27)33)24-12-17(10-11-34-24)20-7-6-19(36-30(41)42-2)14-23(20)37-29(16)40/h6-16,25H,3-5H2,1-2H3,(H,36,41)(H,37,40)/t16-,25+/m1/s1	HXEKGJHLQWBYKJ-CPJLOUKISA-N	241379	US9409908, 11::US9951071, Example 11	Plasma kallikrein		 14							25.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241379	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241379&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060516	341093694							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421284	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(N)cc2NC1=O	InChI=1S/C29H27ClF2N4O2/c1-16-3-2-4-25(36-12-10-18(14-26(36)37)27-22(31)8-7-21(30)28(27)32)24-13-17(9-11-34-24)20-6-5-19(33)15-23(20)35-29(16)38/h5-9,11,13-16,25H,2-4,10,12,33H2,1H3,(H,35,38)/t16-,25+/m1/s1	VSUYWTSSABVZTL-CPJLOUKISA-N	241380	US9409908, 12::US9951071, Example 12	Plasma kallikrein		 1							25.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241380	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241380&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			73053281	341093695							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421285	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccccc2NC1=O	InChI=1S/C29H26ClF2N3O2/c1-17-5-4-8-25(24-15-18(11-13-33-24)20-6-2-3-7-23(20)34-29(17)37)35-14-12-19(16-26(35)36)27-22(31)10-9-21(30)28(27)32/h2-3,6-7,9-11,13,15-17,25H,4-5,8,12,14H2,1H3,(H,34,37)/t17-,25+/m1/s1	UZTAEKUHQOCYGB-NSYGIPOTSA-N	241381	US9409908, 13::US9951071, Example 13	Plasma kallikrein		 8							25.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241381	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241381&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			73053282	341093696							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421286	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(F)cc2NC1=O	InChI=1S/C29H25ClF3N3O2/c1-16-3-2-4-25(36-12-10-18(14-26(36)37)27-22(32)8-7-21(30)28(27)33)24-13-17(9-11-34-24)20-6-5-19(31)15-23(20)35-29(16)38/h5-9,11,13-16,25H,2-4,10,12H2,1H3,(H,35,38)/t16-,25+/m1/s1	MNAHWSVGTPZXHY-CPJLOUKISA-N	241382	US9409908, 14::US9951071, Example 14	Plasma kallikrein		 25							25.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241382	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241382&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			73053283	341093697							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421287	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(Cl)cc2NC1=O	InChI=1S/C29H25Cl2F2N3O2/c1-16-3-2-4-25(36-12-10-18(14-26(36)37)27-22(32)8-7-21(31)28(27)33)24-13-17(9-11-34-24)20-6-5-19(30)15-23(20)35-29(16)38/h5-9,11,13-16,25H,2-4,10,12H2,1H3,(H,35,38)/t16-,25+/m1/s1	RPJZNKIGALAKBZ-CPJLOUKISA-N	241383	US9409908, 15::US9951071, Example 15	Plasma kallikrein		 77							25.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241383	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241383&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			73050939	341093698							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421288	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(Nc3ncccn3)cc2NC1=O	InChI=1S/C33H29ClF2N6O2/c1-19-4-2-5-28(42-15-11-21(17-29(42)43)30-25(35)9-8-24(34)31(30)36)27-16-20(10-14-37-27)23-7-6-22(18-26(23)41-32(19)44)40-33-38-12-3-13-39-33/h3,6-10,12-14,16-19,28H,2,4-5,11,15H2,1H3,(H,41,44)(H,38,39,40)/t19-,28+/m1/s1	SEYYELZSACSHCW-GDJIYFAZSA-N	241384	US9409908, 16::US9951071, Example 16	Plasma kallikrein		 1							25.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241384	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241384&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			73050940	341093699							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421289	COc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)ccc(Cl)c3F)c3cc-2ccn3)c1	InChI=1S/C30H28ClF2N3O3/c1-17-4-3-5-26(36-13-11-19(15-27(36)37)28-23(32)9-8-22(31)29(28)33)25-14-18(10-12-34-25)21-7-6-20(39-2)16-24(21)35-30(17)38/h6-10,12,14-17,26H,3-5,11,13H2,1-2H3,(H,35,38)/t17-,26+/m1/s1	BFURPWNKSPOHBU-QUGAMOGWSA-N	241385	US9409908, 17::US9951071, Example 17	Plasma kallikrein		 114							25.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241385	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241385&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			73050941	341093700							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421290	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(O)cc2NC1=O	InChI=1S/C29H26ClF2N3O3/c1-16-3-2-4-25(35-12-10-18(14-26(35)37)27-22(31)8-7-21(30)28(27)32)24-13-17(9-11-33-24)20-6-5-19(36)15-23(20)34-29(16)38/h5-9,11,13-16,25,36H,2-4,10,12H2,1H3,(H,34,38)/t16-,25+/m1/s1	YDTFCSKLISVNDE-CPJLOUKISA-N	241386	US9409908, 18::US9951071, Example 18	Plasma kallikrein		 4							25.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241386	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241386&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060431	341093701							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421291	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2cc(Cl)c(O)cc2NC1=O	InChI=1S/C29H25Cl2F2N3O3/c1-15-3-2-4-24(36-10-8-17(12-26(36)38)27-21(32)6-5-19(30)28(27)33)23-11-16(7-9-34-23)18-13-20(31)25(37)14-22(18)35-29(15)39/h5-7,9,11-15,24,37H,2-4,8,10H2,1H3,(H,35,39)/t15-,24+/m1/s1	RPNKMAIYDGDARV-MYYSRTQBSA-N	241387	US9409908, 19::US9951071, Example 19	Plasma kallikrein		 52							25.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241387	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241387&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			73050942	341093702							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421292	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2cc(Cl)c(O)c(Cl)c2NC1=O	InChI=1S/C29H24Cl3F2N3O3/c1-14-3-2-4-22(37-10-8-16(12-23(37)38)24-20(33)6-5-18(30)26(24)34)21-11-15(7-9-35-21)17-13-19(31)28(39)25(32)27(17)36-29(14)40/h5-7,9,11-14,22,39H,2-4,8,10H2,1H3,(H,36,40)/t14-,22+/m1/s1	CCYMFXPYIKCNFP-PEBXRYMYSA-N	241388	US9409908, 20::US9951071, Example 20	Plasma kallikrein		 973							25.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241388	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241388&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060427	341093703							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421293	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(Nc3nnc(C)o3)cc2NC1=O	InChI=1S/C32H29ClF2N6O3/c1-17-4-3-5-27(41-13-11-20(15-28(41)42)29-24(34)9-8-23(33)30(29)35)26-14-19(10-12-36-26)22-7-6-21(16-25(22)38-31(17)43)37-32-40-39-18(2)44-32/h6-10,12,14-17,27H,3-5,11,13H2,1-2H3,(H,37,40)(H,38,43)/t17-,27+/m1/s1	WNNVCOPVUBHDRW-CRYYWNKWSA-N	241389	US9409908, 21::US9951071, Example 21	Plasma kallikrein		 1							25.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241389	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241389&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			73051092	341093704							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421294	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CC(=O)C[C@H](N3CCC(=CC3=O)c3c(F)ccc(Cl)c3F)c3cc-2ccn3)c1	InChI=1S/C31H27ClF2N4O5/c1-16-11-20(39)15-26(38-10-8-18(13-27(38)40)28-23(33)6-5-22(32)29(28)34)25-12-17(7-9-35-25)21-4-3-19(36-31(42)43-2)14-24(21)37-30(16)41/h3-7,9,12-14,16,26H,8,10-11,15H2,1-2H3,(H,36,42)(H,37,41)/t16-,26+/m1/s1	JMHUINMWXFHURP-DXPJPUQTSA-N	241390	US9409908, 22::US9951071, Example 22	Plasma kallikrein		 352							25.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241390	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241390&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			89955508	341093705							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421295	COC(=O)Nc1ccc2-c3ccnc(c3)[C@H](CCCCNC(=O)c2c1)N1CCC(=CC1=O)c1c(F)ccc(Cl)c1F	InChI=1S/C30H27ClF2N4O4/c1-41-30(40)36-19-5-6-20-17-9-12-34-24(14-17)25(4-2-3-11-35-29(39)21(20)16-19)37-13-10-18(15-26(37)38)27-23(32)8-7-22(31)28(27)33/h5-9,12,14-16,25H,2-4,10-11,13H2,1H3,(H,35,39)(H,36,40)/t25-/m0/s1	WLTAHYDRUHDZHH-VWLOTQADSA-N	241392	US9409908, 24::US9951071, Example 24	Plasma kallikrein		 214							25.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241392	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241392&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060422	341093707							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421296	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)c(Cl)ccc3C(F)(F)F)c3cc-2ccn3)c1	InChI=1S/C32H29ClF4N4O4/c1-17-4-3-5-26(41-13-11-19(15-27(41)42)28-22(32(35,36)37)8-9-23(33)29(28)34)25-14-18(10-12-38-25)21-7-6-20(39-31(44)45-2)16-24(21)40-30(17)43/h6-10,12,14-17,26H,3-5,11,13H2,1-2H3,(H,39,44)(H,40,43)/t17-,26+/m1/s1	XSTSJEFWXNDBQO-QUGAMOGWSA-N	241393	US9409908, 25::US9951071, Example 25	Plasma kallikrein		 12							25.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241393	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241393&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060388	341093708							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421297	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)c(Cl)ccc3C#N)c3cc-2cc(OC)n3)c1	InChI=1S/C33H31ClFN5O5/c1-18-5-4-6-27(40-12-11-19(15-29(40)41)30-20(17-36)7-10-24(34)31(30)35)26-13-21(14-28(38-26)44-2)23-9-8-22(37-33(43)45-3)16-25(23)39-32(18)42/h7-10,13-16,18,27H,4-6,11-12H2,1-3H3,(H,37,43)(H,39,42)/t18-,27+/m1/s1	QUNVBYGAKUPYEF-CLYVBNDRSA-N	241394	US9409908, 26::US9951071, Example 26	Plasma kallikrein		 1							25.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241394	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241394&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060527	341093709							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421298	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(Cl)ccc2C#N)c2cc(ccn2)-c2ccc(NC(=O)OC(C)(C)C)cc2NC1=O	InChI=1S/C35H35ClFN5O4/c1-20-6-5-7-29(42-15-13-22(17-30(42)43)31-23(19-38)8-11-26(36)32(31)37)28-16-21(12-14-39-28)25-10-9-24(18-27(25)41-33(20)44)40-34(45)46-35(2,3)4/h8-12,14,16-18,20,29H,5-7,13,15H2,1-4H3,(H,40,45)(H,41,44)/t20-,29+/m1/s1	QPZHXHADRNKKOK-OLILMLBXSA-N	241395	US9409908, 27	Plasma kallikrein		 15							25.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241395	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241395&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			122466883	341093710							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421299	CC1CCC[C@H](N2CCC(=CC2=O)c2c(Br)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(cc2NC1=O)C(O)=O	InChI=1S/C30H26BrClFN3O4/c1-16-3-2-4-25(36-12-10-18(15-26(36)37)27-21(31)7-8-22(32)28(27)33)24-13-17(9-11-34-24)20-6-5-19(30(39)40)14-23(20)35-29(16)38/h5-9,11,13-16,25H,2-4,10,12H2,1H3,(H,35,38)(H,39,40)/t16?,25-/m0/s1	NSUXTCLEARCMHH-JIKORUOASA-N	241396	US9409908, 28	Plasma kallikrein		 196							25.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241396	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241396&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060542	341093711							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421300	CC1CCC[C@H](N2CCC(=CC2=O)c2c(Br)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(cc2NC1=O)C(N)=O	InChI=1S/C30H27BrClFN4O3/c1-16-3-2-4-25(37-12-10-18(15-26(37)38)27-21(31)7-8-22(32)28(27)33)24-13-17(9-11-35-24)20-6-5-19(29(34)39)14-23(20)36-30(16)40/h5-9,11,13-16,25H,2-4,10,12H2,1H3,(H2,34,39)(H,36,40)/t16?,25-/m0/s1	GZIWAJRNQSUBEG-JIKORUOASA-N	241397	US9409908, 29	Plasma kallikrein		 3							25.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241397	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241397&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060534	341093712							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421301	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)c(Cl)ccc3C#N)c3cc-2cc(=O)[nH]3)c1			241398	US9409908, 30::US9951071, Example 30	Plasma kallikrein		 3							25.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241398	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241398&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			129625765	341093713							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421302	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)c(Cl)ccc3OC(F)F)c3ccnc-2c3)c1	InChI=1S/C32H30ClF3N4O5/c1-17-4-3-5-25(40-13-11-19(15-27(40)41)28-26(45-31(35)36)9-8-22(33)29(28)34)18-10-12-37-23(14-18)21-7-6-20(38-32(43)44-2)16-24(21)39-30(17)42/h6-10,12,14-17,25,31H,3-5,11,13H2,1-2H3,(H,38,43)(H,39,42)/t17-,25+/m1/s1	WUPABZDGAQQKAU-NSYGIPOTSA-N	241399	US9409908, 31::US9951071, Example 31	Plasma kallikrein		 3							25.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241399	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241399&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060356	341093714							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421303	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)c(Cl)ccc3OC(F)F)c3cc-2ccn3)c1	InChI=1S/C32H30ClF3N4O5/c1-17-4-3-5-25(40-13-11-19(15-27(40)41)28-26(45-31(35)36)9-8-22(33)29(28)34)24-14-18(10-12-37-24)21-7-6-20(38-32(43)44-2)16-23(21)39-30(17)42/h6-10,12,14-17,25,31H,3-5,11,13H2,1-2H3,(H,38,43)(H,39,42)/t17-,25+/m1/s1	MWSHJNLPNRIIFT-NSYGIPOTSA-N	241400	US9409908, 32::US9951071, Example 32	Plasma kallikrein		 6							25.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241400	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241400&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060350	341093715							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421304	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(Cl)ccc2C#N)c2cc(ccn2)-c2ccc(cc2NC1=O)C(N)=O	InChI=1S/C31H27ClFN5O3/c1-17-3-2-4-26(38-12-10-19(15-27(38)39)28-21(16-34)6-8-23(32)29(28)33)25-13-18(9-11-36-25)22-7-5-20(30(35)40)14-24(22)37-31(17)41/h5-9,11,13-15,17,26H,2-4,10,12H2,1H3,(H2,35,40)(H,37,41)/t17-,26+/m1/s1	AKZWUAZVOXSXOH-QUGAMOGWSA-N	241401	US9409908, 33	Plasma kallikrein		 3							25.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241401	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241401&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060362	341093716							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421305	CC1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(Cl)ccc2C(C)=O)c2cc(ccn2)-c2ccc(cc2NC1=O)C(N)=O	InChI=1S/C32H30ClFN4O4/c1-17-4-3-5-27(38-13-11-20(16-28(38)40)29-22(18(2)39)8-9-24(33)30(29)34)26-14-19(10-12-36-26)23-7-6-21(31(35)41)15-25(23)37-32(17)42/h6-10,12,14-17,27H,3-5,11,13H2,1-2H3,(H2,35,41)(H,37,42)/t17?,27-/m0/s1	NPYVUTHLJTXPCZ-LYTHVRBOSA-N	241402	US9409908, 34::US9951071, Example 34	Plasma kallikrein		 15							25.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241402	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241402&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060546	341093717							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421306	CC1CCC[C@H](N2CCC(=CC2=O)c2cccc(Cl)c2F)c2cc(ccn2)-c2ccc(cc2NC1=O)C(N)=O	InChI=1S/C30H28ClFN4O3/c1-17-4-2-7-26(36-13-11-19(16-27(36)37)22-5-3-6-23(31)28(22)32)25-14-18(10-12-34-25)21-9-8-20(29(33)38)15-24(21)35-30(17)39/h3,5-6,8-10,12,14-17,26H,2,4,7,11,13H2,1H3,(H2,33,38)(H,35,39)/t17?,26-/m0/s1	UUGIAJZFMUNAQO-KKFPZRRJSA-N	241403	US9409908, 35::US9951071, Example 35	Plasma kallikrein		 26							25.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241403	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241403&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060550	341093718							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421307	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3cc(Cl)ccc3C(F)(F)F)c3cc-2ccn3)c1	InChI=1S/C32H30ClF3N4O4/c1-18-4-3-5-28(40-13-11-20(15-29(40)41)24-16-21(33)6-9-25(24)32(34,35)36)27-14-19(10-12-37-27)23-8-7-22(38-31(43)44-2)17-26(23)39-30(18)42/h6-10,12,14-18,28H,3-5,11,13H2,1-2H3,(H,38,43)(H,39,42)/t18-,28+/m1/s1	YGFGZLKRXRBORE-WRHNGFHOSA-N	241404	US9409908, 36::US9951071, Example 36	Plasma kallikrein		 8							25.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241404	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241404&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060451	341093719							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421308	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2ccnc(c2)-c2ccc(Nc3nnc(C)o3)cc2NC1=O	InChI=1S/C32H29ClF2N6O3/c1-17-4-3-5-27(41-13-11-20(15-28(41)42)29-24(34)9-8-23(33)30(29)35)19-10-12-36-25(14-19)22-7-6-21(16-26(22)38-31(17)43)37-32-40-39-18(2)44-32/h6-10,12,14-17,27H,3-5,11,13H2,1-2H3,(H,37,40)(H,38,43)/t17-,27+/m1/s1	WIOGTPFOPDWSIT-CRYYWNKWSA-N	241405	US9409908, 37::US9951071, Example 37	Plasma kallikrein		 1							25.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241405	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241405&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060444	341093720							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421309	CC1CCC[C@H](N2CCC(=CC2=O)c2c(Br)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(cc2NC1=O)-c1nnc[nH]1			241406	US9409908, 38::US9951071, Example 38	Plasma kallikrein		 6							25.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241406	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241406&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060547	341093721							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421310	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(Nc3nnc(o3)C3CC3)cc2NC1=O	InChI=1S/C34H31ClF2N6O3/c1-18-3-2-4-28(43-14-12-21(16-29(43)44)30-25(36)10-9-24(35)31(30)37)27-15-20(11-13-38-27)23-8-7-22(17-26(23)40-32(18)45)39-34-42-41-33(46-34)19-5-6-19/h7-11,13,15-19,28H,2-6,12,14H2,1H3,(H,39,42)(H,40,45)/t18-,28+/m1/s1	XRRSNWWFDKBFCV-WRHNGFHOSA-N	241407	US9409908, 39::US9951071, Example 39	Plasma kallikrein		 2							25.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241407	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241407&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060448	341093722							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421311	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(Nc3nnc(CC#N)o3)cc2NC1=O	InChI=1S/C33H28ClF2N7O3/c1-18-3-2-4-27(43-14-11-20(16-29(43)44)30-24(35)8-7-23(34)31(30)36)26-15-19(10-13-38-26)22-6-5-21(17-25(22)40-32(18)45)39-33-42-41-28(46-33)9-12-37/h5-8,10,13,15-18,27H,2-4,9,11,14H2,1H3,(H,39,42)(H,40,45)/t18-,27+/m1/s1	KJPOONPDKYPIKE-CLYVBNDRSA-N	241408	US9409908, 40::US9951071, Example 40	Plasma kallikrein		 4							25.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241408	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241408&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060450	341093723							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421312	COCc1nnc(Nc2ccc-3c(NC(=O)[C@H](C)CCC[C@H](N4CCC(=CC4=O)c4c(F)ccc(Cl)c4F)c4cc-3ccn4)c2)o1	InChI=1S/C33H31ClF2N6O4/c1-18-4-3-5-27(42-13-11-20(15-29(42)43)30-24(35)9-8-23(34)31(30)36)26-14-19(10-12-37-26)22-7-6-21(16-25(22)39-32(18)44)38-33-41-40-28(46-33)17-45-2/h6-10,12,14-16,18,27H,3-5,11,13,17H2,1-2H3,(H,38,41)(H,39,44)/t18-,27+/m1/s1	YCPIFMNZNHRZMY-CLYVBNDRSA-N	241409	US9409908, 41::US9951071, Example 41	Plasma kallikrein		 2							25.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241409	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241409&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118236062	341093724							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421313	CCOC(=O)Cc1nnc(Nc2ccc-3c(NC(=O)[C@H](C)CCC[C@H](N4CCC(=CC4=O)c4c(F)ccc(Cl)c4F)c4cc-3ccn4)c2)o1	InChI=1S/C35H33ClF2N6O5/c1-3-48-31(46)18-29-42-43-35(49-29)40-22-7-8-23-20-11-13-39-27(15-20)28(6-4-5-19(2)34(47)41-26(23)17-22)44-14-12-21(16-30(44)45)32-25(37)10-9-24(36)33(32)38/h7-11,13,15-17,19,28H,3-6,12,14,18H2,1-2H3,(H,40,43)(H,41,47)/t19-,28+/m1/s1	LRJDBUKQKSAXJD-GDJIYFAZSA-N	241410	US9409908, 42::US9951071, Example 42	Plasma kallikrein		 2							25.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241410	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241410&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118236118	341093725							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421314	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(Br)ccc(Cl)c2F)c2cc(ccn2)-c2ccccc2NC1=O	InChI=1S/C29H26BrClFN3O2/c1-17-5-4-8-25(24-15-18(11-13-33-24)20-6-2-3-7-23(20)34-29(17)37)35-14-12-19(16-26(35)36)27-21(30)9-10-22(31)28(27)32/h2-3,6-7,9-11,13,15-17,25H,4-5,8,12,14H2,1H3,(H,34,37)/t17-,25+/m1/s1	MUMWTBPFGOZRHX-NSYGIPOTSA-N	241413	US9409908, 45::US9951071, Example 45	Plasma kallikrein		 7							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241413	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241413&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060445	341093728							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421315	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(ccc2C#N)C#N)c2cc(ccn2)-c2ccccc2NC1=O	InChI=1S/C31H26FN5O2/c1-19-5-4-8-27(26-15-20(11-13-35-26)24-6-2-3-7-25(24)36-31(19)39)37-14-12-21(16-28(37)38)29-22(17-33)9-10-23(18-34)30(29)32/h2-3,6-7,9-11,13,15-16,19,27H,4-5,8,12,14H2,1H3,(H,36,39)/t19-,27+/m1/s1	IGRHHNIJWDUEGX-WINIVTDRSA-N	241414	US9409908, 46::US9951071, Example 46	Plasma kallikrein		 669							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241414	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241414&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060442	341093729							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421316	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2cccc(Cl)c2F)c2cc(ccn2)-c2ccccc2NC1=O	InChI=1S/C29H27ClFN3O2/c1-18-6-4-11-26(34-15-13-20(17-27(34)35)22-8-5-9-23(30)28(22)31)25-16-19(12-14-32-25)21-7-2-3-10-24(21)33-29(18)36/h2-3,5,7-10,12,14,16-18,26H,4,6,11,13,15H2,1H3,(H,33,36)/t18-,26+/m1/s1	CIECXKZOQDYMLR-DWXRJYCRSA-N	241415	US9409908, 47::US9951071, Example 47	Plasma kallikrein		 66							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241415	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241415&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060474	341093730							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421317	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(Cl)ccc2C(C)=O)c2cc(ccn2)-c2ccccc2NC1=O	InChI=1S/C31H29ClFN3O3/c1-18-6-5-9-27(26-16-20(12-14-34-26)23-7-3-4-8-25(23)35-31(18)39)36-15-13-21(17-28(36)38)29-22(19(2)37)10-11-24(32)30(29)33/h3-4,7-8,10-12,14,16-18,27H,5-6,9,13,15H2,1-2H3,(H,35,39)/t18-,27+/m1/s1	KZFXDGGAQOKLCK-CLYVBNDRSA-N	241416	US9409908, 48::US9951071, Example 48	Plasma kallikrein		 49							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241416	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241416&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060344	341093731							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421318	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(Cl)ccc2C#N)c2cc(ccn2)-c2ccccc2NC1=O	InChI=1S/C30H26ClFN4O2/c1-18-5-4-8-26(25-15-19(11-13-34-25)22-6-2-3-7-24(22)35-30(18)38)36-14-12-20(16-27(36)37)28-21(17-33)9-10-23(31)29(28)32/h2-3,6-7,9-11,13,15-16,18,26H,4-5,8,12,14H2,1H3,(H,35,38)/t18-,26+/m1/s1	BYCWLOQDZYMODR-DWXRJYCRSA-N	241417	US9409908, 49::US9951071, Example 49	Plasma kallikrein		 3							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241417	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241417&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060478	341093732							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421319	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)cccc2C#N)c2cc(ccn2)-c2ccccc2NC1=O	InChI=1S/C30H27FN4O2/c1-19-6-4-11-27(26-16-20(12-14-33-26)23-8-2-3-10-25(23)34-30(19)37)35-15-13-21(17-28(35)36)29-22(18-32)7-5-9-24(29)31/h2-3,5,7-10,12,14,16-17,19,27H,4,6,11,13,15H2,1H3,(H,34,37)/t19-,27+/m1/s1	SPRNNBTVEOFNCO-WINIVTDRSA-N	241418	US9409908, 50::US9951071, Example 50	Plasma kallikrein		 130							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241418	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241418&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060533	341093733							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421320	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(C)ccc(Cl)c2F)c2cc(ccn2)-c2ccccc2NC1=O	InChI=1S/C30H29ClFN3O2/c1-18-10-11-23(31)29(32)28(18)21-13-15-35(27(36)17-21)26-9-5-6-19(2)30(37)34-24-8-4-3-7-22(24)20-12-14-33-25(26)16-20/h3-4,7-8,10-12,14,16-17,19,26H,5-6,9,13,15H2,1-2H3,(H,34,37)/t19-,26+/m1/s1	JDSFHGPELLRDCN-BCHFMIIMSA-N	241419	US9409908, 51::US9951071, Example 51	Plasma kallikrein		 38							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241419	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241419&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060480	341093734							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421321	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(Cl)ccc2C2CC2)c2cc(ccn2)-c2ccccc2NC1=O	InChI=1S/C32H31ClFN3O2/c1-19-5-4-8-28(27-17-21(13-15-35-27)23-6-2-3-7-26(23)36-32(19)39)37-16-14-22(18-29(37)38)30-24(20-9-10-20)11-12-25(33)31(30)34/h2-3,6-7,11-13,15,17-20,28H,4-5,8-10,14,16H2,1H3,(H,36,39)/t19-,28+/m1/s1	HSEAXCFUYVIPDA-GDJIYFAZSA-N	241420	US9409908, 52::US9951071, Example 52	Plasma kallikrein		 193							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241420	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241420&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060360	341093735							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421322	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(NC(=O)OCCOC(C)(C)C)cc2NC1=O	InChI=1S/C36H39ClF2N4O5/c1-21-6-5-7-30(43-15-13-23(19-31(43)44)32-27(38)11-10-26(37)33(32)39)29-18-22(12-14-40-29)25-9-8-24(20-28(25)42-34(21)45)41-35(46)47-16-17-48-36(2,3)4/h8-12,14,18-21,30H,5-7,13,15-17H2,1-4H3,(H,41,46)(H,42,45)/t21-,30+/m1/s1	URTZZBQNKCNCOJ-DFXYEROKSA-N	241421	US9409908, 53::US9951071, Example 53	Plasma kallikrein		 2							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241421	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241421&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060558	341093736							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421323	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(NC(=O)OCCO)cc2NC1=O	InChI=1S/C32H31ClF2N4O5/c1-18-3-2-4-27(39-12-10-20(16-28(39)41)29-24(34)8-7-23(33)30(29)35)26-15-19(9-11-36-26)22-6-5-21(17-25(22)38-31(18)42)37-32(43)44-14-13-40/h5-9,11,15-18,27,40H,2-4,10,12-14H2,1H3,(H,37,43)(H,38,42)/t18-,27+/m1/s1	BAQBTVHTGIAQPV-CLYVBNDRSA-N	241422	US9409908, 54::US9951071, Example 54	Plasma kallikrein		 1							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241422	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241422&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060475	341093737							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421324	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(Cl)ccc2-c2cn[nH]c2)c2cc(ccn2)-c2ccccc2NC1=O			241423	US9409908, 55::US9951071, Example 55	Plasma kallikrein		 19							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241423	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241423&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060488	341093738							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421325	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(Cl)ccc2-c2ccncc2)c2cc(ccn2)-c2ccccc2NC1=O	InChI=1S/C34H30ClFN4O2/c1-21-5-4-8-30(29-19-23(13-17-38-29)25-6-2-3-7-28(25)39-34(21)42)40-18-14-24(20-31(40)41)32-26(9-10-27(35)33(32)36)22-11-15-37-16-12-22/h2-3,6-7,9-13,15-17,19-21,30H,4-5,8,14,18H2,1H3,(H,39,42)/t21-,30+/m1/s1	GHPODOFIYRAVAI-DFXYEROKSA-N	241424	US9409908, 56::US9951071, Example 56	Plasma kallikrein		 137							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241424	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241424&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060499	341093739							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421326	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(Cl)ccc2-c2ccccc2)c2cc(ccn2)-c2ccccc2NC1=O	InChI=1S/C35H31ClFN3O2/c1-22-8-7-13-31(30-20-24(16-18-38-30)26-11-5-6-12-29(26)39-35(22)42)40-19-17-25(21-32(40)41)33-27(14-15-28(36)34(33)37)23-9-3-2-4-10-23/h2-6,9-12,14-16,18,20-22,31H,7-8,13,17,19H2,1H3,(H,39,42)/t22-,31+/m1/s1	GRKZZDPEPPSASR-UVDDSOTQSA-N	241425	US9409908, 57::US9951071, Example 57	Plasma kallikrein		 351							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241425	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241425&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060541	341093740							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421327	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(Cl)ccc2-c2cccnc2)c2cc(ccn2)-c2ccccc2NC1=O	InChI=1S/C34H30ClFN4O2/c1-21-6-4-10-30(29-18-22(13-16-38-29)25-8-2-3-9-28(25)39-34(21)42)40-17-14-23(19-31(40)41)32-26(11-12-27(35)33(32)36)24-7-5-15-37-20-24/h2-3,5,7-9,11-13,15-16,18-21,30H,4,6,10,14,17H2,1H3,(H,39,42)/t21-,30+/m1/s1	VKSXRXMDAQLCIZ-DFXYEROKSA-N	241426	US9409908, 58::US9951071, Example 58	Plasma kallikrein		 179							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241426	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241426&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060463	341093741							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421328	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(Cl)ccc2-c2cnn(C)c2)c2cc(ccn2)-c2ccccc2NC1=O	InChI=1S/C33H31ClFN5O2/c1-20-6-5-9-29(28-16-21(12-14-36-28)24-7-3-4-8-27(24)38-33(20)42)40-15-13-22(17-30(40)41)31-25(10-11-26(34)32(31)35)23-18-37-39(2)19-23/h3-4,7-8,10-12,14,16-20,29H,5-6,9,13,15H2,1-2H3,(H,38,42)/t20-,29+/m1/s1	IRQQHHGYQUYTOU-OLILMLBXSA-N	241427	US9409908, 59::US9951071, Example 59	Plasma kallikrein		 68							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241427	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241427&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060404	341093742							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421329	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(Cl)ccc2-c2cn(C)nc2C)c2cc(ccn2)-c2ccccc2NC1=O	InChI=1S/C34H33ClFN5O2/c1-20-7-6-10-30(29-17-22(13-15-37-29)24-8-4-5-9-28(24)38-34(20)43)41-16-14-23(18-31(41)42)32-25(11-12-27(35)33(32)36)26-19-40(3)39-21(26)2/h4-5,8-9,11-13,15,17-20,30H,6-7,10,14,16H2,1-3H3,(H,38,43)/t20-,30+/m1/s1	CMVGISXWABZZHF-KEEVHDRGSA-N	241428	US9409908, 60::US9951071, Example 60	Plasma kallikrein		 1090							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241428	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241428&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060495	341093743							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421330	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2cc(I)c(N)cc2NC1=O	InChI=1S/C29H26ClF2IN4O2/c1-15-3-2-4-25(37-10-8-17(12-26(37)38)27-20(31)6-5-19(30)28(27)32)24-11-16(7-9-35-24)18-13-21(33)22(34)14-23(18)36-29(15)39/h5-7,9,11-15,25H,2-4,8,10,34H2,1H3,(H,36,39)/t15-,25+/m1/s1	FEZYZPVXOKHVHG-BZQUYTCOSA-N	241429	US9409908, 61::US9951071, Example 61	Plasma kallikrein		 7							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241429	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241429&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118236110	341093744							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421331	COC(=O)Nc1cc2NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)ccc(Cl)c3F)c3cc(ccn3)-c2cc1I	InChI=1S/C31H28ClF2IN4O4/c1-16-4-3-5-26(39-11-9-18(13-27(39)40)28-21(33)7-6-20(32)29(28)34)25-12-17(8-10-36-25)19-14-22(35)24(38-31(42)43-2)15-23(19)37-30(16)41/h6-8,10,12-16,26H,3-5,9,11H2,1-2H3,(H,37,41)(H,38,42)/t16-,26+/m1/s1	RGLBUVNDXXCFGZ-DXPJPUQTSA-N	241430	US9409908, 62::US9951071, Example 62	Plasma kallikrein		 1095							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241430	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241430&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060461	341093745							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421332	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(NC(=S)NC(C)=O)cc2NC1=O	InChI=1S/C32H30ClF2N5O3S/c1-17-4-3-5-27(40-13-11-20(15-28(40)42)29-24(34)9-8-23(33)30(29)35)26-14-19(10-12-36-26)22-7-6-21(16-25(22)39-31(17)43)38-32(44)37-18(2)41/h6-10,12,14-17,27H,3-5,11,13H2,1-2H3,(H,39,43)(H2,37,38,41,44)/t17-,27+/m1/s1	CMZZDHRYQQNSPO-CRYYWNKWSA-N	241431	US9409908, 63::US9951071, Example 63	Plasma kallikrein		 48							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241431	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241431&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060500	341093746							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421333	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=C(C)C3=O)c3c(F)ccc(Cl)c3F)c3cc-2ccn3)c1	InChI=1S/C32H31ClF2N4O4/c1-17-5-4-6-27(39-14-12-21(18(2)31(39)41)28-24(34)10-9-23(33)29(28)35)26-15-19(11-13-36-26)22-8-7-20(37-32(42)43-3)16-25(22)38-30(17)40/h7-11,13,15-17,27H,4-6,12,14H2,1-3H3,(H,37,42)(H,38,40)/t17-,27+/m1/s1	VUZOUHVXCSHECJ-CRYYWNKWSA-N	241432	US9409908, 64::US9951071, Example 64	Plasma kallikrein		 171							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241432	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241432&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060554	341093747							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421334	C[C@@H]1CCC[C@@H](c2cc(ccn2)-c2ccccc2NC1=O)n1ccc(cc1=O)-c1cccc(Cl)c1F	InChI=1S/C29H25ClFN3O2/c1-18-6-4-11-26(34-15-13-20(17-27(34)35)22-8-5-9-23(30)28(22)31)25-16-19(12-14-32-25)21-7-2-3-10-24(21)33-29(18)36/h2-3,5,7-10,12-18,26H,4,6,11H2,1H3,(H,33,36)/t18-,26+/m1/s1	DMHPUWZFOHKVNM-DWXRJYCRSA-N	241433	US9409908, 65::US9951071, Example 65	Plasma kallikrein		 53							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241433	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241433&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060559	341093748							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421335	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(N)ccc(Cl)c2F)c2cc(ccn2)-c2ccccc2NC1=O	InChI=1S/C29H28ClFN4O2/c1-17-5-4-8-25(24-15-18(11-13-33-24)20-6-2-3-7-23(20)34-29(17)37)35-14-12-19(16-26(35)36)27-22(32)10-9-21(30)28(27)31/h2-3,6-7,9-11,13,15-17,25H,4-5,8,12,14,32H2,1H3,(H,34,37)/t17-,25+/m1/s1	RBNWLYPYPBBIBI-NSYGIPOTSA-N	241434	US9409908, 66::US9951071, Example 66	Plasma kallikrein		 45							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241434	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241434&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060358	341093749							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421336	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(Cl)ccc2C(F)(F)F)c2cc(ccn2)-c2ccccc2NC1=O	InChI=1S/C30H26ClF4N3O2/c1-17-5-4-8-25(24-15-18(11-13-36-24)20-6-2-3-7-23(20)37-29(17)40)38-14-12-19(16-26(38)39)27-21(30(33,34)35)9-10-22(31)28(27)32/h2-3,6-7,9-11,13,15-17,25H,4-5,8,12,14H2,1H3,(H,37,40)/t17-,25+/m1/s1	SPQJJBABLHIVSF-NSYGIPOTSA-N	241435	US9409908, 67::US9951071, Example 67	Plasma kallikrein		 19							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241435	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241435&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060403	341093750							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421337	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(Cl)ccc2-n2cnnn2)c2cc(ccn2)-c2ccccc2NC1=O	InChI=1S/C30H27ClFN7O2/c1-18-5-4-8-25(24-15-19(11-13-33-24)21-6-2-3-7-23(21)35-30(18)41)38-14-12-20(16-27(38)40)28-26(39-17-34-36-37-39)10-9-22(31)29(28)32/h2-3,6-7,9-11,13,15-18,25H,4-5,8,12,14H2,1H3,(H,35,41)/t18-,25+/m1/s1	JSZAYFVPBHXVCY-CJAUYULYSA-N	241436	US9409908, 68::US9951071, Example 68	Plasma kallikrein		 3							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241436	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241436&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060476	341093751							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421338	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(Br)cc2NC1=O	InChI=1S/C29H25BrClF2N3O2/c1-16-3-2-4-25(36-12-10-18(14-26(36)37)27-22(32)8-7-21(31)28(27)33)24-13-17(9-11-34-24)20-6-5-19(30)15-23(20)35-29(16)38/h5-9,11,13-16,25H,2-4,10,12H2,1H3,(H,35,38)/t16-,25+/m1/s1	DAYSEIQDDXRVTA-CPJLOUKISA-N	241437	US9409908, 69::US9951071, Example 69	Plasma kallikrein		 338							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241437	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241437&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060481	341093752							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421339	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(cc[n+]2[O-])-c2ccc(N)cc2NC1=O	InChI=1S/C29H27ClF2N4O3/c1-16-3-2-4-24(35-11-9-18(14-26(35)37)27-22(31)8-7-21(30)28(27)32)25-13-17(10-12-36(25)39)20-6-5-19(33)15-23(20)34-29(16)38/h5-8,10,12-16,24H,2-4,9,11,33H2,1H3,(H,34,38)/t16-,24+/m1/s1	SKANAQYYDPFGRP-GYCJOSAFSA-N	241438	US9409908, 70::US9951071, Example 70	Plasma kallikrein		 18							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241438	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241438&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118236100	341093753							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421340	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2cc(Cl)ccc2-n2cncn2)c2cc(ccn2)-c2ccccc2NC1=O	InChI=1S/C31H29ClN6O2/c1-20-5-4-8-29(27-15-21(11-13-34-27)24-6-2-3-7-26(24)36-31(20)40)37-14-12-22(16-30(37)39)25-17-23(32)9-10-28(25)38-19-33-18-35-38/h2-3,6-7,9-11,13,15-20,29H,4-5,8,12,14H2,1H3,(H,36,40)/t20-,29+/m1/s1	WOYLVPNPEGMMRB-OLILMLBXSA-N	241439	US9409908, 71::US9951071, Example 71	Plasma kallikrein		 60							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241439	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241439&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060367	341093754							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421341	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccncc2NC1=O	InChI=1S/C28H25ClF2N4O2/c1-16-3-2-4-24(22-13-17(7-11-33-22)19-8-10-32-15-23(19)34-28(16)37)35-12-9-18(14-25(35)36)26-21(30)6-5-20(29)27(26)31/h5-8,10-11,13-16,24H,2-4,9,12H2,1H3,(H,34,37)/t16-,24+/m1/s1	XYICNNPOQLZANR-GYCJOSAFSA-N	241440	US9409908, 185::US9409908, 72::US9951071, Example 72	Plasma kallikrein		 19							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241440	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241440&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060363	341093755							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421342	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CC(C)C(=CC3=O)c3c(F)ccc(Cl)c3F)c3cc-2ccn3)c1	InChI=1S/C32H31ClF2N4O4/c1-17-5-4-6-27(39-16-18(2)22(15-28(39)40)29-24(34)10-9-23(33)30(29)35)26-13-19(11-12-36-26)21-8-7-20(37-32(42)43-3)14-25(21)38-31(17)41/h7-15,17-18,27H,4-6,16H2,1-3H3,(H,37,42)(H,38,41)/t17-,18?,27+/m1/s1	NPKCSHLGQLVUNO-ILPYMAIGSA-N	241441	US9409908, 177::US9409908, 178::US9409908, 73::US9951071, Example 73	Plasma kallikrein		 6							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241441	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241441&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060513	341093756							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421343	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2cc(Cl)ccc2-n2cnc(C)n2)c2cc(ccn2)-c2ccccc2NC1=O	InChI=1S/C32H31ClN6O2/c1-20-6-5-9-30(28-16-22(12-14-34-28)25-7-3-4-8-27(25)36-32(20)41)38-15-13-23(17-31(38)40)26-18-24(33)10-11-29(26)39-19-35-21(2)37-39/h3-4,7-8,10-12,14,16-20,30H,5-6,9,13,15H2,1-2H3,(H,36,41)/t20-,30+/m1/s1	ANAMVZJDWRVIRM-KEEVHDRGSA-N	241442	US9409908, 74::US9951071, Example 74	Plasma kallikrein		 238							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241442	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241442&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060425	341093757							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421344	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(NC(C)=O)cc2NC1=O	InChI=1S/C31H29ClF2N4O3/c1-17-4-3-5-27(38-13-11-20(15-28(38)40)29-24(33)9-8-23(32)30(29)34)26-14-19(10-12-35-26)22-7-6-21(36-18(2)39)16-25(22)37-31(17)41/h6-10,12,14-17,27H,3-5,11,13H2,1-2H3,(H,36,39)(H,37,41)/t17-,27+/m1/s1	FSWZRDMSLCEJGG-CRYYWNKWSA-N	241443	US9409908, 75::US9951071, Example 75	Plasma kallikrein		 4							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241443	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241443&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060529	341093758							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421345	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(NS(C)(=O)=O)cc2NC1=O	InChI=1S/C30H29ClF2N4O4S/c1-17-4-3-5-26(37-13-11-19(15-27(37)38)28-23(32)9-8-22(31)29(28)33)25-14-18(10-12-34-25)21-7-6-20(36-42(2,40)41)16-24(21)35-30(17)39/h6-10,12,14-17,26,36H,3-5,11,13H2,1-2H3,(H,35,39)/t17-,26+/m1/s1	XXVLKIDHEHHRBJ-QUGAMOGWSA-N	241444	US9409908, 76::US9951071, Example 76	Plasma kallikrein		 15							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241444	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241444&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060573	341093759							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421346	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)\C=C\C[C@H](N3CCC(=CC3=O)c3c(F)ccc(Cl)c3F)c3cc-2ccn3)c1	InChI=1S/C31H27ClF2N4O4/c1-17-4-3-5-26(38-13-11-19(15-27(38)39)28-23(33)9-8-22(32)29(28)34)25-14-18(10-12-35-25)21-7-6-20(36-31(41)42-2)16-24(21)37-30(17)40/h3-4,6-10,12,14-17,26H,5,11,13H2,1-2H3,(H,36,41)(H,37,40)/b4-3+/t17-,26+/m1/s1	QCWKHDNSZZEEOE-NZCDSGJISA-N	241445	US9409908, 77::US9951071, Example 77	Plasma kallikrein		 67							25.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241445	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241445&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060436	341093760							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421347	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@@H](c3cc-2ccn3)n2ncc(cc2=O)-c2c(F)c(Cl)ccc2Br)c1	InChI=1S/C30H26BrClFN5O4/c1-16-4-3-5-25(38-26(39)13-18(15-35-38)27-21(31)8-9-22(32)28(27)33)24-12-17(10-11-34-24)20-7-6-19(36-30(41)42-2)14-23(20)37-29(16)40/h6-16,25H,3-5H2,1-2H3,(H,36,41)(H,37,40)/t16-,25+/m1/s1	NEHLLAYKPWEYRL-CPJLOUKISA-N	241446	US9409908, 78::US9951071, Example 78	Plasma kallikrein		 5							25.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241446	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241446&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060583	341093761							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421348	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@@H](c3cc-2ccn3)n2ncc(cc2=O)-c2c(F)c(Cl)ccc2C#N)c1	InChI=1S/C31H26ClFN6O4/c1-17-4-3-5-26(39-27(40)13-20(16-36-39)28-19(15-34)6-9-23(32)29(28)33)25-12-18(10-11-35-25)22-8-7-21(37-31(42)43-2)14-24(22)38-30(17)41/h6-14,16-17,26H,3-5H2,1-2H3,(H,37,42)(H,38,41)/t17-,26+/m1/s1	SUNUOUSWUILJOO-QUGAMOGWSA-N	241447	US9409908, 79::US9951071, Example 79	Plasma kallikrein		 3							25.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241447	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241447&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060505	341093762							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421349	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2c(F)cccc2NC1=O	InChI=1S/C29H25ClF3N3O2/c1-16-4-2-7-24(36-13-11-18(15-25(36)37)27-21(32)9-8-19(30)28(27)33)23-14-17(10-12-34-23)26-20(31)5-3-6-22(26)35-29(16)38/h3,5-6,8-10,12,14-16,24H,2,4,7,11,13H2,1H3,(H,35,38)/t16-,24+/m1/s1	MTXDKYJYHRVQFC-GYCJOSAFSA-N	241448	US9409908, 80::US9951071, Example 80	Plasma kallikrein		 38							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241448	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241448&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060509	341093763							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421350	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2cc3ccc(=O)[nH]c3cc2NC1=O			241449	US9409908, 81::US9951071, Example 81	Plasma kallikrein		 1							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241449	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241449&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			129625766	341093764							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421351	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2cc(\C=C/C(O)=O)c(N)cc2NC1=O	InChI=1S/C32H29ClF2N4O4/c1-17-3-2-4-27(39-12-10-20(15-28(39)40)30-23(34)7-6-22(33)31(30)35)26-14-18(9-11-37-26)21-13-19(5-8-29(41)42)24(36)16-25(21)38-32(17)43/h5-9,11,13-17,27H,2-4,10,12,36H2,1H3,(H,38,43)(H,41,42)/b8-5-/t17-,27+/m1/s1	XKWQQMINHXZTDQ-XVRNRBCSSA-N	241450	US9409908, 82::US9951071, Example 82	Plasma kallikrein		 22							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241450	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241450&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060537	341093765							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421352	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2cc3c(C(O)=O)c(C)[nH]c3cc2NC1=O			241451	US9409908, 83::US9951071, Example 83	Plasma kallikrein		 7							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241451	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241451&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060510	341093766							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421353	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2cc3CC(=O)Nc3cc2NC1=O	InChI=1S/C31H27ClF2N4O3/c1-16-3-2-4-26(38-10-8-18(14-28(38)40)29-22(33)6-5-21(32)30(29)34)25-12-17(7-9-35-25)20-11-19-13-27(39)36-23(19)15-24(20)37-31(16)41/h5-7,9,11-12,14-16,26H,2-4,8,10,13H2,1H3,(H,36,39)(H,37,41)/t16-,26+/m1/s1	KLNQZPSOKNUSPH-DXPJPUQTSA-N	241452	US9409908, 84::US9951071, Example 84	Plasma kallikrein		 16							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241452	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241452&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060471	341093767							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421354	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2cc3cc(C)[nH]c3cc2NC1=O			241453	US9409908, 85::US9951071, Example 85	Plasma kallikrein		 47							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241453	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241453&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060409	341093768							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421355	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2cc3CCC(=O)Nc3cc2NC1=O	InChI=1S/C32H29ClF2N4O3/c1-17-3-2-4-27(39-12-10-20(15-29(39)41)30-23(34)7-6-22(33)31(30)35)26-14-18(9-11-36-26)21-13-19-5-8-28(40)37-24(19)16-25(21)38-32(17)42/h6-7,9,11,13-17,27H,2-5,8,10,12H2,1H3,(H,37,40)(H,38,42)/t17-,27+/m1/s1	BPYVSZXRXGLXFP-CRYYWNKWSA-N	241454	US9409908, 86::US9951071, Example 86	Plasma kallikrein		 1							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241454	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241454&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060483	341093769							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421356	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(NC(=O)CC(=O)OC(C)(C)C)cc2NC1=O	InChI=1S/C36H37ClF2N4O5/c1-20-6-5-7-29(43-15-13-22(17-31(43)45)33-26(38)11-10-25(37)34(33)39)28-16-21(12-14-40-28)24-9-8-23(18-27(24)42-35(20)47)41-30(44)19-32(46)48-36(2,3)4/h8-12,14,16-18,20,29H,5-7,13,15,19H2,1-4H3,(H,41,44)(H,42,47)/t20-,29+/m1/s1	NZUBFOCJZIJKEH-OLILMLBXSA-N	241455	US9409908, 87::US9951071, Example 87	Plasma kallikrein		 63							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241455	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241455&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060438	341093770							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421357	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(Nc3ccccn3)cc2NC1=O	InChI=1S/C34H30ClF2N5O2/c1-20-5-4-6-29(42-16-13-22(18-31(42)43)32-26(36)11-10-25(35)33(32)37)28-17-21(12-15-38-28)24-9-8-23(19-27(24)41-34(20)44)40-30-7-2-3-14-39-30/h2-3,7-12,14-15,17-20,29H,4-6,13,16H2,1H3,(H,39,40)(H,41,44)/t20-,29+/m1/s1	QMPSRRLYDPGUKS-OLILMLBXSA-N	241456	US9409908, 88::US9951071, Example 88	Plasma kallikrein		 5							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241456	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241456&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060502	341093771							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421358	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(Nc3ccncc3)cc2NC1=O	InChI=1S/C34H30ClF2N5O2/c1-20-3-2-4-30(42-16-12-22(18-31(42)43)32-27(36)8-7-26(35)33(32)37)29-17-21(9-15-39-29)25-6-5-24(19-28(25)41-34(20)44)40-23-10-13-38-14-11-23/h5-11,13-15,17-20,30H,2-4,12,16H2,1H3,(H,38,40)(H,41,44)/t20-,30+/m1/s1	BHHIIHJGDBVRNZ-KEEVHDRGSA-N	241457	US9409908, 89::US9951071, Example 89	Plasma kallikrein		 5							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241457	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241457&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060455	341093772							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421359	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(Nc3ccncn3)cc2NC1=O	InChI=1S/C33H29ClF2N6O2/c1-19-3-2-4-28(42-14-11-21(16-30(42)43)31-25(35)8-7-24(34)32(31)36)27-15-20(9-13-38-27)23-6-5-22(17-26(23)41-33(19)44)40-29-10-12-37-18-39-29/h5-10,12-13,15-19,28H,2-4,11,14H2,1H3,(H,41,44)(H,37,39,40)/t19-,28+/m1/s1	MOLMATGEEFSJHI-GDJIYFAZSA-N	241458	US9409908, 90::US9951071, Example 90	Plasma kallikrein		 4							25.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241458	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241458&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060528	341093773							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421360	C[C@@H]1CCC[C@@H](c2cc(ccn2)-c2ccc(N)cc2NC1=O)n1ccc(cc1=O)-c1c(F)ccc(Cl)c1F	InChI=1S/C29H25ClF2N4O2/c1-16-3-2-4-25(36-12-10-18(14-26(36)37)27-22(31)8-7-21(30)28(27)32)24-13-17(9-11-34-24)20-6-5-19(33)15-23(20)35-29(16)38/h5-16,25H,2-4,33H2,1H3,(H,35,38)/t16-,25+/m1/s1	QFJLWQWOKYLTEQ-CPJLOUKISA-N	241459	US9409908, 91::US9951071, Example 91	Plasma kallikrein		 3							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241459	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241459&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060507	341093774							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421361	C[C@@H]1CCC[C@@H](c2cc(ccn2)-c2ccc(Nc3ncccn3)cc2NC1=O)n1ccc(cc1=O)-c1c(F)ccc(Cl)c1F	InChI=1S/C33H27ClF2N6O2/c1-19-4-2-5-28(42-15-11-21(17-29(42)43)30-25(35)9-8-24(34)31(30)36)27-16-20(10-14-37-27)23-7-6-22(18-26(23)41-32(19)44)40-33-38-12-3-13-39-33/h3,6-19,28H,2,4-5H2,1H3,(H,41,44)(H,38,39,40)/t19-,28+/m1/s1	ONIHHUWDVFUCAR-GDJIYFAZSA-N	241460	US9409908, 92::US9951071, Example 92	Plasma kallikrein		 3							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241460	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241460&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060453	341093775							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421362	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(Nc3cnccn3)cc2NC1=O	InChI=1S/C33H29ClF2N6O2/c1-19-3-2-4-28(42-14-10-21(16-30(42)43)31-25(35)8-7-24(34)32(31)36)27-15-20(9-11-38-27)23-6-5-22(17-26(23)41-33(19)44)40-29-18-37-12-13-39-29/h5-9,11-13,15-19,28H,2-4,10,14H2,1H3,(H,39,40)(H,41,44)/t19-,28+/m1/s1	KKQBOZNOYSOFLO-GDJIYFAZSA-N	241461	US9409908, 93::US9951071, Example 93	Plasma kallikrein		 3							25.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241461	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241461&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060482	341093776							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421363	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CC(=CC3=O)c3c(F)ccc(Cl)c3F)c3cc-2ccn3)c1	InChI=1S/C30H27ClF2N4O4/c1-16-4-3-5-25(37-15-18(13-26(37)38)27-22(32)9-8-21(31)28(27)33)24-12-17(10-11-34-24)20-7-6-19(35-30(40)41-2)14-23(20)36-29(16)39/h6-14,16,25H,3-5,15H2,1-2H3,(H,35,40)(H,36,39)/t16-,25+/m1/s1	PHUHUYPFMRUNQX-CPJLOUKISA-N	241462	US9409908, 94	Plasma kallikrein		 1027							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241462	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241462&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			122466884	341093777							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421364	CC(C)[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccccc2NC1=O	InChI=1S/C31H30ClF2N3O2/c1-18(2)21-7-5-9-27(26-16-19(12-14-35-26)22-6-3-4-8-25(22)36-31(21)39)37-15-13-20(17-28(37)38)29-24(33)11-10-23(32)30(29)34/h3-4,6,8,10-12,14,16-18,21,27H,5,7,9,13,15H2,1-2H3,(H,36,39)/t21-,27-/m0/s1	JPRPVMXGMBRZJQ-IDISGSTGSA-N	241463	US9409908, 95::US9951071, Example 95	Plasma kallikrein		 107							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241463	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241463&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060582	341093778							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421365	CC(C)[C@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccccc2NC1=O	InChI=1S/C31H30ClF2N3O2/c1-18(2)21-7-5-9-27(26-16-19(12-14-35-26)22-6-3-4-8-25(22)36-31(21)39)37-15-13-20(17-28(37)38)29-24(33)11-10-23(32)30(29)34/h3-4,6,8,10-12,14,16-18,21,27H,5,7,9,13,15H2,1-2H3,(H,36,39)/t21-,27+/m1/s1	JPRPVMXGMBRZJQ-ZBLYBZFDSA-N	241464	US9409908, 96::US9951071, Example 96	Plasma kallikrein		 1968							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241464	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241464&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060371	341093779							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421366	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)C3CCCCC3)c3cc-2ccn3)c1	InChI=1S/C31H38N4O4/c1-20-7-6-10-28(35-16-14-22(18-29(35)36)21-8-4-3-5-9-21)27-17-23(13-15-32-27)25-12-11-24(33-31(38)39-2)19-26(25)34-30(20)37/h11-13,15,17-21,28H,3-10,14,16H2,1-2H3,(H,33,38)(H,34,37)/t20-,28+/m1/s1	WKTKDNDIPWKADW-NGOKVRLYSA-N	241466	US9409908, 98::US9951071, Example 98	Plasma kallikrein		 36							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241466	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241466&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060519	341093781							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421367	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3cncc(Cl)c3)c3cc-2ccn3)c1	InChI=1S/C30H30ClN5O4/c1-18-4-3-5-27(36-11-9-19(14-28(36)37)21-12-22(31)17-32-16-21)26-13-20(8-10-33-26)24-7-6-23(34-30(39)40-2)15-25(24)35-29(18)38/h6-8,10,12-18,27H,3-5,9,11H2,1-2H3,(H,34,39)(H,35,38)/t18-,27+/m1/s1	OQSIAGIBPDNVSD-CLYVBNDRSA-N	241467	US9409908, 99::US9951071, Example 99	Plasma kallikrein		 2402							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241467	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241467&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060370	341093782							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421368	CC(C)[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(Cl)ccc2-n2cnnn2)c2cc(ccn2)-c2ccccc2NC1=O	InChI=1S/C32H31ClFN7O2/c1-19(2)22-7-5-9-27(26-16-20(12-14-35-26)23-6-3-4-8-25(23)37-32(22)43)40-15-13-21(17-29(40)42)30-28(41-18-36-38-39-41)11-10-24(33)31(30)34/h3-4,6,8,10-12,14,16-19,22,27H,5,7,9,13,15H2,1-2H3,(H,37,43)/t22-,27-/m0/s1	OWBNSFCRELNSPK-CUNXSJBXSA-N	241468	US9409908, 100::US9951071, Example 100	Plasma kallikrein		 4							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241468	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241468&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060373	341093783							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421369	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(Nc3nnc(o3)-c3ccco3)cc2NC1=O	InChI=1S/C35H29ClF2N6O4/c1-19-4-2-5-28(44-14-12-21(17-30(44)45)31-25(37)10-9-24(36)32(31)38)27-16-20(11-13-39-27)23-8-7-22(18-26(23)41-33(19)46)40-35-43-42-34(48-35)29-6-3-15-47-29/h3,6-11,13,15-19,28H,2,4-5,12,14H2,1H3,(H,40,43)(H,41,46)/t19-,28+/m1/s1	SLEPXNVLHDFXGN-GDJIYFAZSA-N	241471	US9409908, 103::US9951071, Example 103	Plasma kallikrein		 13							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241471	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241471&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060585	341093786							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421370	CC1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(cc2NC1=O)C(O)=O	InChI=1S/C30H26ClF2N3O4/c1-16-3-2-4-25(36-12-10-18(15-26(36)37)27-22(32)8-7-21(31)28(27)33)24-13-17(9-11-34-24)20-6-5-19(30(39)40)14-23(20)35-29(16)38/h5-9,11,13-16,25H,2-4,10,12H2,1H3,(H,35,38)(H,39,40)/t16?,25-/m0/s1	UKWDMAVKJJGCDP-JIKORUOASA-N	241473	US9409908, 105::US9951071, Example 105	Plasma kallikrein		 3920							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241473	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241473&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060437	341093788							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421371	CC1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(Cl)ccc2C(F)(F)F)c2cc(ccn2)-c2ccc(cc2NC1=O)C(O)=O	InChI=1S/C31H26ClF4N3O4/c1-16-3-2-4-25(24-13-17(9-11-37-24)20-6-5-19(30(42)43)14-23(20)38-29(16)41)39-12-10-18(15-26(39)40)27-21(31(34,35)36)7-8-22(32)28(27)33/h5-9,11,13-16,25H,2-4,10,12H2,1H3,(H,38,41)(H,42,43)/t16?,25-/m0/s1	MXNBAKPXIVRTNV-JIKORUOASA-N	241474	US9409908, 106::US9951071, Example 106	Plasma kallikrein		 890							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241474	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241474&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060487	341093789							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421372	CC1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(cc2NC1=O)C(N)=O	InChI=1S/C30H27ClF2N4O3/c1-16-3-2-4-25(37-12-10-18(15-26(37)38)27-22(32)8-7-21(31)28(27)33)24-13-17(9-11-35-24)20-6-5-19(29(34)39)14-23(20)36-30(16)40/h5-9,11,13-16,25H,2-4,10,12H2,1H3,(H2,34,39)(H,36,40)/t16?,25-/m0/s1	WDKWHOHDPBEVOR-JIKORUOASA-N	241475	US9409908, 107::US9951071, Example 107	Plasma kallikrein		 88							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241475	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241475&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060346	341093790							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421373	CC1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(Cl)ccc2C(F)(F)F)c2cc(ccn2)-c2ccc(cc2NC1=O)C(N)=O	InChI=1S/C31H27ClF4N4O3/c1-16-3-2-4-25(24-13-17(9-11-38-24)20-6-5-19(29(37)42)14-23(20)39-30(16)43)40-12-10-18(15-26(40)41)27-21(31(34,35)36)7-8-22(32)28(27)33/h5-9,11,13-16,25H,2-4,10,12H2,1H3,(H2,37,42)(H,39,43)/t16?,25-/m0/s1	HCTAXDGSXWTQSI-JIKORUOASA-N	241476	US9409908, 108::US9951071, Example 108	Plasma kallikrein		 29							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241476	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241476&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060522	341093791							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421374	CC1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(cc2NC1=O)C#N	InChI=1S/C30H25ClF2N4O2/c1-17-3-2-4-26(37-12-10-20(15-27(37)38)28-23(32)8-7-22(31)29(28)33)25-14-19(9-11-35-25)21-6-5-18(16-34)13-24(21)36-30(17)39/h5-9,11,13-15,17,26H,2-4,10,12H2,1H3,(H,36,39)/t17?,26-/m0/s1	BKSCSZWESYMLPD-KKFPZRRJSA-N	241391	US9409908, 109::US9409908, 23::US9951071, Example 109	Plasma kallikrein		 40							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241391	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241391&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060433	341093706							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421375	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3cc(Cl)ccc3C)c3cc-2ccn3)c1	InChI=1S/C32H33ClN4O4/c1-19-7-8-23(33)17-26(19)22-12-14-37(30(38)16-22)29-6-4-5-20(2)31(39)36-27-18-24(35-32(40)41-3)9-10-25(27)21-11-13-34-28(29)15-21/h7-11,13,15-18,20,29H,4-6,12,14H2,1-3H3,(H,35,40)(H,36,39)/t20-,29+/m1/s1	KMNWQMKSCBCXNX-OLILMLBXSA-N	241478	US9409908, 110::US9951071, Example 110	Plasma kallikrein		 3.91							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241478	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241478&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060378	341093792							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421376	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)ccc(C)c3F)c3cc-2ccn3)c1	InChI=1S/C32H32F2N4O4/c1-18-7-10-24(33)29(30(18)34)21-12-14-38(28(39)16-21)27-6-4-5-19(2)31(40)37-25-17-22(36-32(41)42-3)8-9-23(25)20-11-13-35-26(27)15-20/h7-11,13,15-17,19,27H,4-6,12,14H2,1-3H3,(H,36,41)(H,37,40)/t19-,27+/m1/s1	QNXVSHDBEGAVAR-WINIVTDRSA-N	241479	US9409908, 111::US9951071, Example 111	Plasma kallikrein		 3.25							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241479	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241479&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060596	341093793							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421377	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3cccc(C)c3F)c3cc-2ccn3)c1	InChI=1S/C32H33FN4O4/c1-19-6-4-8-25(30(19)33)22-13-15-37(29(38)17-22)28-9-5-7-20(2)31(39)36-26-18-23(35-32(40)41-3)10-11-24(26)21-12-14-34-27(28)16-21/h4,6,8,10-12,14,16-18,20,28H,5,7,9,13,15H2,1-3H3,(H,35,40)(H,36,39)/t20-,28+/m1/s1	VABZDZOISVDIRI-NGOKVRLYSA-N	241480	US9409908, 112::US9951071, Example 112	Plasma kallikrein		 6.44							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241480	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241480&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060385	341093794							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421378	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3cc(C)ccc3F)c3cc-2ccn3)c1	InChI=1S/C32H33FN4O4/c1-19-7-10-26(33)25(15-19)22-12-14-37(30(38)17-22)29-6-4-5-20(2)31(39)36-27-18-23(35-32(40)41-3)8-9-24(27)21-11-13-34-28(29)16-21/h7-11,13,15-18,20,29H,4-6,12,14H2,1-3H3,(H,35,40)(H,36,39)/t20-,29+/m1/s1	MXRDZXPUYIWTCH-OLILMLBXSA-N	241481	US9409908, 113::US9951071, Example 113	Plasma kallikrein		 15.62							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241481	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241481&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060464	341093795							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421379	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3cccc(C)c3C)c3cc-2ccn3)c1	InChI=1S/C33H36N4O4/c1-20-7-5-9-26(22(20)3)24-14-16-37(31(38)18-24)30-10-6-8-21(2)32(39)36-28-19-25(35-33(40)41-4)11-12-27(28)23-13-15-34-29(30)17-23/h5,7,9,11-13,15,17-19,21,30H,6,8,10,14,16H2,1-4H3,(H,35,40)(H,36,39)/t21-,30+/m1/s1	FMPJBVHOCLIHLL-DFXYEROKSA-N	241482	US9409908, 114::US9951071, Example 114	Plasma kallikrein		 143.2							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241482	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241482&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060564	341093796							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421380	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3cccc(OC)c3F)c3cc-2ccn3)c1	InChI=1S/C32H33FN4O5/c1-19-6-4-8-27(37-15-13-21(17-29(37)38)24-7-5-9-28(41-2)30(24)33)26-16-20(12-14-34-26)23-11-10-22(35-32(40)42-3)18-25(23)36-31(19)39/h5,7,9-12,14,16-19,27H,4,6,8,13,15H2,1-3H3,(H,35,40)(H,36,39)/t19-,27+/m1/s1	QGKFVNQGQIVBFN-WINIVTDRSA-N	241483	US9409908, 115::US9951071, Example 115	Plasma kallikrein		 362.2							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241483	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241483&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060477	341093797							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421381	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3ccccc3OC)c3cc-2ccn3)c1	InChI=1S/C32H34N4O5/c1-20-7-6-9-28(36-16-14-22(18-30(36)37)25-8-4-5-10-29(25)40-2)27-17-21(13-15-33-27)24-12-11-23(34-32(39)41-3)19-26(24)35-31(20)38/h4-5,8,10-13,15,17-20,28H,6-7,9,14,16H2,1-3H3,(H,34,39)(H,35,38)/t20-,28+/m1/s1	NRQMSCAXOVOPLH-NGOKVRLYSA-N	241484	US9409908, 116::US9951071, Example 116	Plasma kallikrein		 738.8							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241484	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241484&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060557	341093798							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421382	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3ccc(OC)cc3)c3cc-2ccn3)c1	InChI=1S/C32H34N4O5/c1-20-5-4-6-29(36-16-14-22(18-30(36)37)21-7-10-25(40-2)11-8-21)28-17-23(13-15-33-28)26-12-9-24(34-32(39)41-3)19-27(26)35-31(20)38/h7-13,15,17-20,29H,4-6,14,16H2,1-3H3,(H,34,39)(H,35,38)/t20-,29+/m1/s1	XNPLCUMDJXLFEW-OLILMLBXSA-N	241485	US9409908, 117::US9951071, Example 117	Plasma kallikrein		>13020.00							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241485	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241485&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060586	341093799							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421383	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3cccc(Cl)c3OC)c3cc-2ccn3)c1	InChI=1S/C32H33ClN4O5/c1-19-6-4-9-28(37-15-13-21(17-29(37)38)24-7-5-8-25(33)30(24)41-2)27-16-20(12-14-34-27)23-11-10-22(35-32(40)42-3)18-26(23)36-31(19)39/h5,7-8,10-12,14,16-19,28H,4,6,9,13,15H2,1-3H3,(H,35,40)(H,36,39)/t19-,28+/m1/s1	GJWIXJQSUJTPHG-GDJIYFAZSA-N	241486	US9409908, 118::US9951071, Example 118	Plasma kallikrein		 2027							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241486	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241486&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060525	341093800							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421384	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3cccc(OC)c3)c3cc-2ccn3)c1	InChI=1S/C32H34N4O5/c1-20-6-4-9-29(36-15-13-22(18-30(36)37)21-7-5-8-25(16-21)40-2)28-17-23(12-14-33-28)26-11-10-24(34-32(39)41-3)19-27(26)35-31(20)38/h5,7-8,10-12,14,16-20,29H,4,6,9,13,15H2,1-3H3,(H,34,39)(H,35,38)/t20-,29+/m1/s1	BURCJSBKPJCHNP-OLILMLBXSA-N	241487	US9409908, 119::US9951071, Example 119	Plasma kallikrein		 534.5							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241487	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241487&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060484	341093801							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421385	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3cccc(Cl)c3C)c3cc-2ccn3)c1	InChI=1S/C32H33ClN4O4/c1-19-6-4-9-29(37-15-13-22(17-30(37)38)24-7-5-8-26(33)20(24)2)28-16-21(12-14-34-28)25-11-10-23(35-32(40)41-3)18-27(25)36-31(19)39/h5,7-8,10-12,14,16-19,29H,4,6,9,13,15H2,1-3H3,(H,35,40)(H,36,39)/t19-,29+/m1/s1	WZNODWFKHIBNND-XBBWARJSSA-N	241488	US9409908, 120::US9951071, Example 120	Plasma kallikrein		 187.4							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241488	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241488&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060587	341093802							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421386	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3cc(Cl)ccc3OC)c3cc-2ccn3)c1	InChI=1S/C32H33ClN4O5/c1-19-5-4-6-28(37-14-12-21(16-30(37)38)25-17-22(33)7-10-29(25)41-2)27-15-20(11-13-34-27)24-9-8-23(35-32(40)42-3)18-26(24)36-31(19)39/h7-11,13,15-19,28H,4-6,12,14H2,1-3H3,(H,35,40)(H,36,39)/t19-,28+/m1/s1	DYPKGMLWFCORQB-GDJIYFAZSA-N	241489	US9409908, 121::US9951071, Example 121	Plasma kallikrein		 39.29							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241489	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241489&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060589	341093803							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421387	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3ccc(OC)c(Cl)c3)c3cc-2ccn3)c1	InChI=1S/C32H33ClN4O5/c1-19-5-4-6-28(37-14-12-21(17-30(37)38)20-7-10-29(41-2)25(33)15-20)27-16-22(11-13-34-27)24-9-8-23(35-32(40)42-3)18-26(24)36-31(19)39/h7-11,13,15-19,28H,4-6,12,14H2,1-3H3,(H,35,40)(H,36,39)/t19-,28+/m1/s1	QFXGUOYKINAAEP-GDJIYFAZSA-N	241490	US9409908, 122::US9951071, Example 122	Plasma kallikrein		 9318							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241490	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241490&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060374	341093804							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421388	COC(=O)Nc1ccc-2c(NC(=O)C(C)(O)CCC[C@H](N3CCC(=CC3=O)c3c(F)ccc(Cl)c3F)c3cc-2ccn3)c1	InChI=1S/C31H29ClF2N4O5/c1-31(42)11-3-4-25(38-13-10-18(15-26(38)39)27-22(33)8-7-21(32)28(27)34)24-14-17(9-12-35-24)20-6-5-19(36-30(41)43-2)16-23(20)37-29(31)40/h5-9,12,14-16,25,42H,3-4,10-11,13H2,1-2H3,(H,36,41)(H,37,40)/t25-,31?/m0/s1	WTXJOYYHXJPKFK-ZGAORZAOSA-N	241491	US9409908, 123::US9409908, 124::US9951071, Example 123	Plasma kallikrein		 26.1							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241491	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241491&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060543	341093805							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421389	COC(=O)Nc1ccc-2c(NC(=O)C(C)(O)CCC[C@H](N3CCC(=CC3=O)c3c(F)ccc(Cl)c3F)c3cc-2ccn3)c1	InChI=1S/C31H29ClF2N4O5/c1-31(42)11-3-4-25(38-13-10-18(15-26(38)39)27-22(33)8-7-21(32)28(27)34)24-14-17(9-12-35-24)20-6-5-19(36-30(41)43-2)16-23(20)37-29(31)40/h5-9,12,14-16,25,42H,3-4,10-11,13H2,1-2H3,(H,36,41)(H,37,40)/t25-,31?/m0/s1	WTXJOYYHXJPKFK-ZGAORZAOSA-N	241491	US9409908, 123::US9409908, 124::US9951071, Example 123	Plasma kallikrein		 483.4							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241491	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241491&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060543	341093805							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421390	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(NC3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3O)cc2NC1=O	InChI=1S/C35H37ClF2N4O7/c1-17-3-2-4-26(42-12-10-19(14-28(42)44)29-23(37)8-7-22(36)30(29)38)25-13-18(9-11-39-25)21-6-5-20(15-24(21)41-34(17)48)40-35-33(47)32(46)31(45)27(16-43)49-35/h5-9,11,13-15,17,26-27,31-33,35,40,43,45-47H,2-4,10,12,16H2,1H3,(H,41,48)/t17-,26+,27-,31-,32+,33+,35?/m1/s1	IKJOOTAXPJZGLI-NZHWWQFHSA-N	241493	US9409908, 125::US9951071, Example 125	Plasma kallikrein		 11.6							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241493	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241493&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060594	341093806							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421391	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(NC3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)cc2NC1=O	InChI=1S/C35H37ClF2N4O7/c1-17-3-2-4-26(42-12-10-19(14-28(42)44)29-23(37)8-7-22(36)30(29)38)25-13-18(9-11-39-25)21-6-5-20(15-24(21)41-34(17)48)40-35-33(47)32(46)31(45)27(16-43)49-35/h5-9,11,13-15,17,26-27,31-33,35,40,43,45-47H,2-4,10,12,16H2,1H3,(H,41,48)/t17-,26+,27-,31-,32+,33-,35?/m1/s1	IKJOOTAXPJZGLI-KKHJKUPUSA-N	241494	US9409908, 126::US9951071, Example 126	Plasma kallikrein		 37.58							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241494	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241494&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060493	341093807							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421392	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(NC3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3N)cc2NC1=O	InChI=1S/C35H38ClF2N5O6/c1-17-3-2-4-26(43-12-10-19(14-28(43)45)29-23(37)8-7-22(36)30(29)38)25-13-18(9-11-40-25)21-6-5-20(15-24(21)42-34(17)48)41-35-31(39)33(47)32(46)27(16-44)49-35/h5-9,11,13-15,17,26-27,31-33,35,41,44,46-47H,2-4,10,12,16,39H2,1H3,(H,42,48)/t17-,26+,27-,31+,32-,33-,35?/m1/s1	SITZZDVPGOZBMP-IQBWVKGISA-N	241495	US9409908, 127::US9951071, Example 127	Plasma kallikrein		 9.97							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241495	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241495&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			122443679	341093808							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421393	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(NC3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)cc2NC1=O	InChI=1S/C35H35ClF2N4O8/c1-16-3-2-4-25(42-12-10-18(14-26(42)43)27-22(37)8-7-21(36)28(27)38)24-13-17(9-11-39-24)20-6-5-19(15-23(20)41-33(16)47)40-34-31(46)29(44)30(45)32(50-34)35(48)49/h5-9,11,13-16,25,29-32,34,40,44-46H,2-4,10,12H2,1H3,(H,41,47)(H,48,49)/t16-,25+,29+,30+,31-,32+,34?/m1/s1	VWHKOZYYJGJUSB-QUIQRVKYSA-N	241496	US9409908, 128::US9951071, Example 128	Plasma kallikrein		 25.46							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241496	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241496&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060406	341093809							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421394	CO[C@H]1[C@H](O)[C@@H](CO)OC(Nc2ccc-3c(NC(=O)[C@H](C)CCC[C@H](N4CCC(=CC4=O)c4c(F)ccc(Cl)c4F)c4cc-3ccn4)c2)[C@@H]1O	InChI=1S/C36H39ClF2N4O7/c1-18-4-3-5-27(43-13-11-20(15-29(43)45)30-24(38)9-8-23(37)31(30)39)26-14-19(10-12-40-26)22-7-6-21(16-25(22)42-35(18)48)41-36-33(47)34(49-2)32(46)28(17-44)50-36/h6-10,12,14-16,18,27-28,32-34,36,41,44,46-47H,3-5,11,13,17H2,1-2H3,(H,42,48)/t18-,27+,28-,32-,33-,34+,36?/m1/s1	QRZWBLRZWNFZEW-RXKREALZSA-N	241497	US9409908, 129::US9951071, Example 129	Plasma kallikrein		 21.67							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241497	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241497&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060402	341093810							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421395	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(NC3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3NC(C)=O)cc2NC1=O	InChI=1S/C37H40ClF2N5O7/c1-18-4-3-5-28(45-13-11-21(15-30(45)48)31-25(39)9-8-24(38)32(31)40)27-14-20(10-12-41-27)23-7-6-22(16-26(23)44-36(18)51)43-37-33(42-19(2)47)35(50)34(49)29(17-46)52-37/h6-10,12,14-16,18,28-29,33-35,37,43,46,49-50H,3-5,11,13,17H2,1-2H3,(H,42,47)(H,44,51)/t18-,28+,29-,33+,34-,35-,37?/m1/s1	KOIOMLLRGBAMQW-ADUISHHQSA-N	241498	US9409908, 130::US9951071, Example 130	Plasma kallikrein		 26.49							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241498	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241498&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			122443678	341093811							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421396	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(NC3O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]3O)cc2NC1=O	InChI=1S/C35H37ClF2N4O7/c1-17-3-2-4-26(42-12-10-19(14-28(42)44)29-23(37)8-7-22(36)30(29)38)25-13-18(9-11-39-25)21-6-5-20(15-24(21)41-34(17)48)40-35-33(47)32(46)31(45)27(16-43)49-35/h5-9,11,13-15,17,26-27,31-33,35,40,43,45-47H,2-4,10,12,16H2,1H3,(H,41,48)/t17-,26+,27+,31+,32-,33+,35?/m1/s1	IKJOOTAXPJZGLI-ZXGJDRJESA-N	241499	US9409908, 131::US9951071, Example 131	Plasma kallikrein		 20.82							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241499	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241499&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060376	341093812							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421397	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(NC3O[C@H](CO)[C@@H](O)[C@@H](O)[C@H]3NC(=O)OC(C)(C)C)cc2NC1=O	InChI=1S/C40H46ClF2N5O8/c1-20-6-5-7-29(48-15-13-22(17-31(48)50)32-26(42)11-10-25(41)33(32)43)28-16-21(12-14-44-28)24-9-8-23(18-27(24)46-37(20)53)45-38-34(47-39(54)56-40(2,3)4)36(52)35(51)30(19-49)55-38/h8-12,14,16-18,20,29-30,34-36,38,45,49,51-52H,5-7,13,15,19H2,1-4H3,(H,46,53)(H,47,54)/t20-,29+,30-,34-,35-,36+,38?/m1/s1	CUMIMQRZHBVFHF-FODBMTDKSA-N	241500	US9409908, 132::US9951071, Example 132	Plasma kallikrein		 17.32							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241500	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241500&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			122443681	341093813							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421398	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(NC3O[C@H](CO)[C@@H](O[C@H]4O[C@H](CO)[C@@H](O[C@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O)cc2NC1=O	InChI=1S/C47H57ClF2N4O17/c1-19-3-2-4-28(54-12-10-21(14-32(54)58)33-25(49)8-7-24(48)34(33)50)27-13-20(9-11-51-27)23-6-5-22(15-26(23)53-44(19)66)52-45-39(63)37(61)42(30(17-56)67-45)70-47-41(65)38(62)43(31(18-57)69-47)71-46-40(64)36(60)35(59)29(16-55)68-46/h5-9,11,13-15,19,28-31,35-43,45-47,52,55-57,59-65H,2-4,10,12,16-18H2,1H3,(H,53,66)/t19-,28+,29-,30-,31-,35-,36+,37-,38-,39-,40-,41-,42-,43-,45?,46-,47-/m1/s1	LENBBWGIXLGPPR-DAKYFYASSA-N	241501	US9409908, 133::US9951071, Example 133	Plasma kallikrein		 12.61							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241501	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241501&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			122466887	341093814					C01140		1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421399	COC(=O)[C@H]1OC(Nc2ccc-3c(NC(=O)[C@H](C)CCC[C@H](N4CCC(=CC4=O)c4c(F)ccc(Cl)c4F)c4cc-3ccn4)c2)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O	InChI=1S/C42H43ClF2N4O11/c1-20-7-6-8-32(49-16-14-25(18-33(49)53)34-29(44)12-11-28(43)35(34)45)31-17-24(13-15-46-31)27-10-9-26(19-30(27)48-40(20)54)47-41-38(59-23(4)52)36(57-21(2)50)37(58-22(3)51)39(60-41)42(55)56-5/h9-13,15,17-20,32,36-39,41,47H,6-8,14,16H2,1-5H3,(H,48,54)/t20-,32+,36+,37+,38-,39+,41?/m1/s1	NGYYEMLUUNCVGC-LDGUVKFUSA-N	241502	US9409908, 134::US9951071, Example 134	Plasma kallikrein		 192.4							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241502	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241502&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			122466885	341093815							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421400	COC(=O)Nc1ccc2-c3nc([nH]c3Cl)[C@H](CCC[C@@H](C)C(=O)Nc2c1)N1CCC(=CC1=O)c1c(F)ccc(Cl)c1F			241503	US9409908, 135::US9951071, Example 135	Plasma kallikrein		 0.56							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241503	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241503&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060560	341093816							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421401	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)C(=O)CC[C@H](N3CCC(=CC3=O)c3c(F)ccc(Cl)c3F)c3cc-2ccn3)c1	InChI=1S/C31H27ClF2N4O5/c1-16-26(39)8-7-25(38-12-10-18(14-27(38)40)28-22(33)6-5-21(32)29(28)34)24-13-17(9-11-35-24)20-4-3-19(36-31(42)43-2)15-23(20)37-30(16)41/h3-6,9,11,13-16,25H,7-8,10,12H2,1-2H3,(H,36,42)(H,37,41)/t16-,25+/m1/s1	YLFZHPYQZPGMGB-CPJLOUKISA-N	241504	US9409908, 136::US9951071, Example 136	Plasma kallikrein		 117.9							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241504	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241504&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060599	341093817							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421402	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2cc(Br)ccc2NC1=O	InChI=1S/C29H25BrClF2N3O2/c1-16-3-2-4-25(36-12-10-18(14-26(36)37)27-22(32)7-6-21(31)28(27)33)24-13-17(9-11-34-24)20-15-19(30)5-8-23(20)35-29(16)38/h5-9,11,13-16,25H,2-4,10,12H2,1H3,(H,35,38)/t16-,25+/m1/s1	AEJIUIRHFAEGHI-CPJLOUKISA-N	241505	US9409908, 137::US9951071, Example 137	Plasma kallikrein		 91.28							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241505	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241505&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060447	341093818							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421403	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2cc(ccc2NC1=O)C#N	InChI=1S/C30H25ClF2N4O2/c1-17-3-2-4-26(37-12-10-20(15-27(37)38)28-23(32)7-6-22(31)29(28)33)25-14-19(9-11-35-25)21-13-18(16-34)5-8-24(21)36-30(17)39/h5-9,11,13-15,17,26H,2-4,10,12H2,1H3,(H,36,39)/t17-,26+/m1/s1	OQVHPCHZBPUBCJ-QUGAMOGWSA-N	241506	US9409908, 138::US9951071, Example 138	Plasma kallikrein		 31.7							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241506	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241506&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060503	341093819							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421404	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(C#N)c2F)c2cc(ccn2)-c2cc(ccc2NC1=O)C#N	InChI=1S/C31H25F2N5O2/c1-18-3-2-4-27(38-12-10-21(15-28(38)39)29-24(32)7-6-22(17-35)30(29)33)26-14-20(9-11-36-26)23-13-19(16-34)5-8-25(23)37-31(18)40/h5-9,11,13-15,18,27H,2-4,10,12H2,1H3,(H,37,40)/t18-,27+/m1/s1	MFZYQWVLTUKKTJ-CLYVBNDRSA-N	241507	US9409908, 139::US9951071, Example 139	Plasma kallikrein		 6046							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241507	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241507&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060504	341093820							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421405	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2cc(ccc2NC1=O)-c1nn[nH]n1			241508	US9409908, 140::US9951071, Example 140	Plasma kallikrein		 28.71							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241508	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241508&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060372	341093821							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421406	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2cc(C)ccc2NC1=O	InChI=1S/C30H28ClF2N3O2/c1-17-6-9-24-21(14-17)19-10-12-34-25(15-19)26(5-3-4-18(2)30(38)35-24)36-13-11-20(16-27(36)37)28-23(32)8-7-22(31)29(28)33/h6-10,12,14-16,18,26H,3-5,11,13H2,1-2H3,(H,35,38)/t18-,26+/m1/s1	BNZCCWRWIPSVFG-DWXRJYCRSA-N	241509	US9409908, 141::US9951071, Example 141	Plasma kallikrein		 123.1							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241509	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241509&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060593	341093822							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421407	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CC=C(CC3=O)c3c(F)ccc(Cl)c3F)c3cc-2ccn3)c1	InChI=1S/C31H29ClF2N4O4/c1-17-4-3-5-26(38-13-11-19(15-27(38)39)28-23(33)9-8-22(32)29(28)34)25-14-18(10-12-35-25)21-7-6-20(36-31(41)42-2)16-24(21)37-30(17)40/h6-12,14,16-17,26H,3-5,13,15H2,1-2H3,(H,36,41)(H,37,40)/t17-,26+/m1/s1	DGSNYQOOWLOGKI-QUGAMOGWSA-N	241510	US9409908, 142::US9951071, Example 142	Plasma kallikrein		 7.76							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241510	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241510&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060479	341093823							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421408	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2cc(F)c(N)cc2NC1=O	InChI=1S/C29H26ClF3N4O2/c1-15-3-2-4-25(37-10-8-17(12-26(37)38)27-20(31)6-5-19(30)28(27)33)24-11-16(7-9-35-24)18-13-21(32)22(34)14-23(18)36-29(15)39/h5-7,9,11-15,25H,2-4,8,10,34H2,1H3,(H,36,39)/t15-,25+/m1/s1	LIFWZDTWISKRBJ-BZQUYTCOSA-N	241511	US9409908, 143::US9951071, Example 143	Plasma kallikrein		 3.38							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241511	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241511&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060600	341093824							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421409	COC(=O)c1ccc2NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)ccc(Cl)c3F)c3cc(ccn3)-c2c1	InChI=1S/C31H28ClF2N3O4/c1-17-4-3-5-26(37-13-11-19(16-27(37)38)28-23(33)8-7-22(32)29(28)34)25-15-18(10-12-35-25)21-14-20(31(40)41-2)6-9-24(21)36-30(17)39/h6-10,12,14-17,26H,3-5,11,13H2,1-2H3,(H,36,39)/t17-,26+/m1/s1	DGDPVCXANRRSLR-QUGAMOGWSA-N	241512	US9409908, 144::US9951071, Example 144	Plasma kallikrein		 107.9							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241512	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241512&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060597	341093825							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421410	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2cc(F)ccc2NC1=O	InChI=1S/C29H25ClF3N3O2/c1-16-3-2-4-25(36-12-10-18(14-26(36)37)27-22(32)7-6-21(30)28(27)33)24-13-17(9-11-34-24)20-15-19(31)5-8-23(20)35-29(16)38/h5-9,11,13-16,25H,2-4,10,12H2,1H3,(H,35,38)/t16-,25+/m1/s1	RUOAINJRKCJLQF-CPJLOUKISA-N	241513	US9409908, 145::US9951071, Example 145	Plasma kallikrein		 28.01							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241513	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241513&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060395	341093826							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421411	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2cc(ccc2NC1=O)C(O)=O	InChI=1S/C30H26ClF2N3O4/c1-16-3-2-4-25(36-12-10-18(15-26(36)37)27-22(32)7-6-21(31)28(27)33)24-14-17(9-11-34-24)20-13-19(30(39)40)5-8-23(20)35-29(16)38/h5-9,11,13-16,25H,2-4,10,12H2,1H3,(H,35,38)(H,39,40)/t16-,25+/m1/s1	LWMFRBAXSOWUDH-CPJLOUKISA-N	241514	US9409908, 146::US9951071, Example 146	Plasma kallikrein		 56.46							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241514	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241514&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060416	341093827							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421412	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(Br)ccc(Cl)c2F)c2cc(ccn2)-c2cc(F)ccc2NC1=O	InChI=1S/C29H25BrClF2N3O2/c1-16-3-2-4-25(36-12-10-18(14-26(36)37)27-21(30)6-7-22(31)28(27)33)24-13-17(9-11-34-24)20-15-19(32)5-8-23(20)35-29(16)38/h5-9,11,13-16,25H,2-4,10,12H2,1H3,(H,35,38)/t16-,25+/m1/s1	OBSGJFCIYCQJEU-CPJLOUKISA-N	241515	US9409908, 147::US9951071, Example 147	Plasma kallikrein		 7.51							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241515	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241515&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060523	341093828							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421413	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2cc(CO)ccc2NC1=O	InChI=1S/C30H28ClF2N3O3/c1-17-3-2-4-26(36-12-10-20(15-27(36)38)28-23(32)7-6-22(31)29(28)33)25-14-19(9-11-34-25)21-13-18(16-37)5-8-24(21)35-30(17)39/h5-9,11,13-15,17,26,37H,2-4,10,12,16H2,1H3,(H,35,39)/t17-,26+/m1/s1	NNLOEPDADGZRFE-QUGAMOGWSA-N	241516	US9409908, 148::US9951071, Example 148	Plasma kallikrein		 118.1							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241516	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241516&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060496	341093829							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421414	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(CO)cc2NC1=O	InChI=1S/C30H28ClF2N3O3/c1-17-3-2-4-26(36-12-10-20(15-27(36)38)28-23(32)8-7-22(31)29(28)33)25-14-19(9-11-34-25)21-6-5-18(16-37)13-24(21)35-30(17)39/h5-9,11,13-15,17,26,37H,2-4,10,12,16H2,1H3,(H,35,39)/t17-,26+/m1/s1	NMONIMGTMZNNBY-QUGAMOGWSA-N	241517	US9409908, 149::US9951071, Example 149	Plasma kallikrein		 22.55							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241517	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241517&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060588	341093830							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421415	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(Cl)ccc2C#N)c2cc(ccn2)-c2cc(F)ccc2NC1=O	InChI=1S/C30H25ClF2N4O2/c1-17-3-2-4-26(25-13-18(9-11-35-25)22-15-21(32)6-8-24(22)36-30(17)39)37-12-10-19(14-27(37)38)28-20(16-34)5-7-23(31)29(28)33/h5-9,11,13-15,17,26H,2-4,10,12H2,1H3,(H,36,39)/t17-,26+/m1/s1	HWKYPMGUMIKDKT-QUGAMOGWSA-N	241518	US9409908, 150::US9951071, Example 150	Plasma kallikrein		 2.27							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241518	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241518&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060526	341093831							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421416	COC(=O)Nc1ccc2-c3nc([nH]c3C)[C@H](CCC[C@@H](C)C(=O)Nc2c1)N1CCC(=CC1=O)c1cccc(Cl)c1F			241519	US9409908, 151::US9951071, Example 151	Plasma kallikrein		 23.82							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241519	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241519&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060389	341093832							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421417	COC(=O)Nc1ccc2-c3ccnc(c3)[C@H](CCCCCNC(=O)c2c1)N1CCC(=CC1=O)c1c(F)ccc(Cl)c1F	InChI=1S/C31H29ClF2N4O4/c1-42-31(41)37-20-6-7-21-18-10-13-35-25(15-18)26(5-3-2-4-12-36-30(40)22(21)17-20)38-14-11-19(16-27(38)39)28-24(33)9-8-23(32)29(28)34/h6-10,13,15-17,26H,2-5,11-12,14H2,1H3,(H,36,40)(H,37,41)/t26-/m0/s1	HSFYNSBFBKRIIH-SANMLTNESA-N	241520	US9409908, 152::US9951071, Example 152	Plasma kallikrein		 24.3							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241520	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241520&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060469	341093833							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421418	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)C3CCCC(C)C3)c3cc-2ccn3)c1	InChI=1S/C32H40N4O4/c1-20-6-4-8-22(16-20)23-13-15-36(30(37)18-23)29-9-5-7-21(2)31(38)35-27-19-25(34-32(39)40-3)10-11-26(27)24-12-14-33-28(29)17-24/h10-12,14,17-22,29H,4-9,13,15-16H2,1-3H3,(H,34,39)(H,35,38)/t20?,21-,22?,29+/m1/s1	NTRPAMBLEXVPQJ-BELJIYFPSA-N	241521	BDBM241596::US9409908, 153::US9409908, 159::US9409908, 218::US9409908, 225::US9951071, Example 225	Plasma kallikrein		 21.16							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241521	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241521&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060429	341093834							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421419	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3ccnc(N)c3)c3cc-2ccn3)c1	InChI=1S/C30H32N6O4/c1-18-4-3-5-26(36-13-10-20(16-28(36)37)19-8-12-33-27(31)15-19)25-14-21(9-11-32-25)23-7-6-22(34-30(39)40-2)17-24(23)35-29(18)38/h6-9,11-12,14-18,26H,3-5,10,13H2,1-2H3,(H2,31,33)(H,34,39)(H,35,38)/t18-,26+/m1/s1	RMRRVQDJORWNCJ-DWXRJYCRSA-N	241522	US9409908, 154::US9951071, Example 154	Plasma kallikrein		 117.5							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241522	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241522&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060489	341093835							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421420	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)C3CCNCC3)c3cc-2ccn3)c1	InChI=1S/C30H37N5O4/c1-19-4-3-5-27(35-15-11-21(17-28(35)36)20-8-12-31-13-9-20)26-16-22(10-14-32-26)24-7-6-23(33-30(38)39-2)18-25(24)34-29(19)37/h6-7,10,14,16-20,27,31H,3-5,8-9,11-13,15H2,1-2H3,(H,33,38)(H,34,37)/t19-,27+/m1/s1	LEQIDBQAUYONLV-WINIVTDRSA-N	241523	US9409908, 155::US9951071, Example 155	Plasma kallikrein		 198.9							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241523	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241523&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060508	341093836							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421421	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3ccnc(Cl)c3)c3cc-2ccn3)c1	InChI=1S/C30H30ClN5O4/c1-18-4-3-5-26(36-13-10-20(16-28(36)37)19-8-12-33-27(31)15-19)25-14-21(9-11-32-25)23-7-6-22(34-30(39)40-2)17-24(23)35-29(18)38/h6-9,11-12,14-18,26H,3-5,10,13H2,1-2H3,(H,34,39)(H,35,38)/t18-,26+/m1/s1	RVFWLEJQHJVOBX-DWXRJYCRSA-N	241524	US9409908, 156::US9951071, Example 156	Plasma kallikrein		 3249							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241524	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241524&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060575	341093837							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421422	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3cccc(Cl)n3)c3cc-2ccn3)c1	InChI=1S/C30H30ClN5O4/c1-18-5-3-7-26(36-14-12-20(16-28(36)37)23-6-4-8-27(31)34-23)25-15-19(11-13-32-25)22-10-9-21(33-30(39)40-2)17-24(22)35-29(18)38/h4,6,8-11,13,15-18,26H,3,5,7,12,14H2,1-2H3,(H,33,39)(H,35,38)/t18-,26+/m1/s1	MXTYQFYCUOGQNN-DWXRJYCRSA-N	241525	US9409908, 157::US9951071, Example 157	Plasma kallikrein		 108							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241525	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241525&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060501	341093838							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421423	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)C3CCCCN3C)c3cc-2ccn3)c1	InChI=1S/C31H39N5O4/c1-20-7-6-9-28(36-16-13-22(18-29(36)37)27-8-4-5-15-35(27)2)26-17-21(12-14-32-26)24-11-10-23(33-31(39)40-3)19-25(24)34-30(20)38/h10-12,14,17-20,27-28H,4-9,13,15-16H2,1-3H3,(H,33,39)(H,34,38)/t20-,27?,28+/m1/s1	IJBHJOXFQYQUMY-VDHQWJSESA-N	241526	US9409908, 158::US9951071, Example 158	Plasma kallikrein		 10900							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241526	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241526&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060584	341093839							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
421424	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)C3CCCC(C)C3)c3cc-2ccn3)c1	InChI=1S/C32H40N4O4/c1-20-6-4-8-22(16-20)23-13-15-36(30(37)18-23)29-9-5-7-21(2)31(38)35-27-19-25(34-32(39)40-3)10-11-26(27)24-12-14-33-28(29)17-24/h10-12,14,17-22,29H,4-9,13,15-16H2,1-3H3,(H,34,39)(H,35,38)/t20?,21-,22?,29+/m1/s1	NTRPAMBLEXVPQJ-BELJIYFPSA-N	241521	BDBM241596::US9409908, 153::US9409908, 159::US9409908, 218::US9409908, 225::US9951071, Example 225	Plasma kallikrein		 58.9							37.00 C	US Patent		10.7270/Q27943K8		aid1803271	US9409908	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241521	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241521&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060429	341093834							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
431694	C[C@@H]1CCC[C@@H](c2cc(ccn2)-c2c(NC1=O)cnn2C(F)F)n1cnc(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C28H23Cl2F2N9O2/c1-15-3-2-4-23(20-9-16(7-8-33-20)26-21(36-27(15)43)12-35-41(26)28(31)32)39-14-34-19(11-25(39)42)18-10-17(29)5-6-22(18)40-13-24(30)37-38-40/h5-15,23,28H,2-4H2,1H3,(H,36,43)/t15-,23+/m1/s1	FSWFYCYPTDLKON-CMJOXMDJSA-N	247411	US10336754, Example 353::US11053247, Example 353::US9453018, 353	Plasma kallikrein		 28						7.5	37.00 C	US Patent		10.7270/Q25X27VB		aid1803431	US9453018	Dilger, AK; Corte, JR; De Lucca, I; Fang, T; Yang, W; Wang, Y; Pabbisetty, KB; Ewing, WR; Zhu, Y; Wexler, RR; Pinto, DJ; Orwat, MJ; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=247411	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=247411&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	YXG	7MBO	131635534	346541954							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
431695	C[C@@H]1CCC[C@@H](c2cc(ccn2)-c2nn(cc2NC1=O)-c1cccnc1)n1cnc(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C32H26Cl2N10O2/c1-19-4-2-6-28(42-18-37-24(14-30(42)45)23-13-21(33)7-8-27(23)44-17-29(34)39-41-44)25-12-20(9-11-36-25)31-26(38-32(19)46)16-43(40-31)22-5-3-10-35-15-22/h3,5,7-19,28H,2,4,6H2,1H3,(H,38,46)/t19-,28+/m1/s1	ASWFFXNYMLHVMO-GDJIYFAZSA-N	247412	US10336754, Example 354::US11053247, Example 354::US9453018, 354	Plasma kallikrein		 10						7.5	37.00 C	US Patent		10.7270/Q25X27VB		aid1803431	US9453018	Dilger, AK; Corte, JR; De Lucca, I; Fang, T; Yang, W; Wang, Y; Pabbisetty, KB; Ewing, WR; Zhu, Y; Wexler, RR; Pinto, DJ; Orwat, MJ; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=247412	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=247412&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			131635535	346541955							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
431696	C[C@@H]1CCC[C@@H](c2ccnc(c2)-c2c(NC1=O)cnn2C)n1cnc(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C28H25Cl2N9O2/c1-16-4-3-5-23(17-8-9-31-21(10-17)27-22(34-28(16)41)13-33-37(27)2)38-15-32-20(12-26(38)40)19-11-18(29)6-7-24(19)39-14-25(30)35-36-39/h6-16,23H,3-5H2,1-2H3,(H,34,41)/t16-,23+/m1/s1	PYWPRMLFPPPQRF-MWTRTKDXSA-N	247413	US10336754, Example 363::US11053247, Example 363::US9453018, 362::US9453018, 363	Plasma kallikrein		 23						7.5	37.00 C	US Patent		10.7270/Q25X27VB		aid1803431	US9453018	Dilger, AK; Corte, JR; De Lucca, I; Fang, T; Yang, W; Wang, Y; Pabbisetty, KB; Ewing, WR; Zhu, Y; Wexler, RR; Pinto, DJ; Orwat, MJ; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=247413	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=247413&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			131635536	346541956							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
431697	C[C@@H]1CCC[C@@H](c2ccnc(c2)-c2c(NC1=O)cnn2C)n1cnc(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C28H25Cl2N9O2/c1-16-4-3-5-23(17-8-9-31-21(10-17)27-22(34-28(16)41)13-33-37(27)2)38-15-32-20(12-26(38)40)19-11-18(29)6-7-24(19)39-14-25(30)35-36-39/h6-16,23H,3-5H2,1-2H3,(H,34,41)/t16-,23+/m1/s1	PYWPRMLFPPPQRF-MWTRTKDXSA-N	247413	US10336754, Example 363::US11053247, Example 363::US9453018, 362::US9453018, 363	Plasma kallikrein		 22						7.5	37.00 C	US Patent		10.7270/Q25X27VB		aid1803431	US9453018	Dilger, AK; Corte, JR; De Lucca, I; Fang, T; Yang, W; Wang, Y; Pabbisetty, KB; Ewing, WR; Zhu, Y; Wexler, RR; Pinto, DJ; Orwat, MJ; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=247413	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=247413&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			131635536	346541956							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
431698	C[C@@H]1CCC[C@@H](c2cc(ccn2)-c2c(NC1=O)cnn2C)n1cnc(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)(F)F	InChI=1S/C29H25ClF3N9O2/c1-16-4-3-5-24(21-10-17(8-9-34-21)27-22(37-28(16)44)13-36-40(27)2)41-15-35-20(12-26(41)43)19-11-18(30)6-7-23(19)42-14-25(38-39-42)29(31,32)33/h6-16,24H,3-5H2,1-2H3,(H,37,44)/t16-,24+/m1/s1	SDMTXZKAASAJMI-GYCJOSAFSA-N	247414	US10336754, Example 368::US11053247, Example 368::US9453018, 367::US9453018, 368	Plasma kallikrein		 24						7.5	37.00 C	US Patent		10.7270/Q25X27VB		aid1803431	US9453018	Dilger, AK; Corte, JR; De Lucca, I; Fang, T; Yang, W; Wang, Y; Pabbisetty, KB; Ewing, WR; Zhu, Y; Wexler, RR; Pinto, DJ; Orwat, MJ; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=247414	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=247414&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			131635537	346541957							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
431699	C[C@@H]1CCC[C@@H](c2cc(ccn2)-c2c(NC1=O)cnn2C)n1cnc(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)(F)F	InChI=1S/C29H25ClF3N9O2/c1-16-4-3-5-24(21-10-17(8-9-34-21)27-22(37-28(16)44)13-36-40(27)2)41-15-35-20(12-26(41)43)19-11-18(30)6-7-23(19)42-14-25(38-39-42)29(31,32)33/h6-16,24H,3-5H2,1-2H3,(H,37,44)/t16-,24+/m1/s1	SDMTXZKAASAJMI-GYCJOSAFSA-N	247414	US10336754, Example 368::US11053247, Example 368::US9453018, 367::US9453018, 368	Plasma kallikrein		 32						7.5	37.00 C	US Patent		10.7270/Q25X27VB		aid1803431	US9453018	Dilger, AK; Corte, JR; De Lucca, I; Fang, T; Yang, W; Wang, Y; Pabbisetty, KB; Ewing, WR; Zhu, Y; Wexler, RR; Pinto, DJ; Orwat, MJ; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=247414	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=247414&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			131635537	346541957							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
431700	C[C@@H]1CCC[C@@H](c2cc(ccn2)-c2c(NC1=O)cnn2C(F)F)n1cnc(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)(F)F	InChI=1S/C29H23ClF5N9O2/c1-15-3-2-4-23(20-9-16(7-8-36-20)26-21(39-27(15)46)12-38-44(26)28(31)32)42-14-37-19(11-25(42)45)18-10-17(30)5-6-22(18)43-13-24(40-41-43)29(33,34)35/h5-15,23,28H,2-4H2,1H3,(H,39,46)/t15-,23+/m1/s1	OEFZCPJFLZPAHN-CMJOXMDJSA-N	247416	US10336754, Example 369::US11053247, Example 369::US9453018, 369	Plasma kallikrein		 33						7.5	37.00 C	US Patent		10.7270/Q25X27VB		aid1803431	US9453018	Dilger, AK; Corte, JR; De Lucca, I; Fang, T; Yang, W; Wang, Y; Pabbisetty, KB; Ewing, WR; Zhu, Y; Wexler, RR; Pinto, DJ; Orwat, MJ; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=247416	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=247416&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			131635538	346541958							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
431701	C[C@@H]1CCC[C@@H](c2ccnc(c2)-c2c(NC1=O)cnn2C)n1cnc(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)(F)F	InChI=1S/C29H25ClF3N9O2/c1-16-4-3-5-23(17-8-9-34-21(10-17)27-22(37-28(16)44)13-36-40(27)2)41-15-35-20(12-26(41)43)19-11-18(30)6-7-24(19)42-14-25(38-39-42)29(31,32)33/h6-16,23H,3-5H2,1-2H3,(H,37,44)/t16-,23+/m1/s1	FQRJWJILLRZDIQ-MWTRTKDXSA-N	247417	US10336754, Example 371::US11053247, Example 371::US9453018, 370::US9453018, 371	Plasma kallikrein		 17						7.5	37.00 C	US Patent		10.7270/Q25X27VB		aid1803431	US9453018	Dilger, AK; Corte, JR; De Lucca, I; Fang, T; Yang, W; Wang, Y; Pabbisetty, KB; Ewing, WR; Zhu, Y; Wexler, RR; Pinto, DJ; Orwat, MJ; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=247417	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=247417&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			131635539	346541959							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
431702	C[C@@H]1CCC[C@@H](c2ccnc(c2)-c2c(NC1=O)cnn2C)n1cnc(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)(F)F	InChI=1S/C29H25ClF3N9O2/c1-16-4-3-5-23(17-8-9-34-21(10-17)27-22(37-28(16)44)13-36-40(27)2)41-15-35-20(12-26(41)43)19-11-18(30)6-7-24(19)42-14-25(38-39-42)29(31,32)33/h6-16,23H,3-5H2,1-2H3,(H,37,44)/t16-,23+/m1/s1	FQRJWJILLRZDIQ-MWTRTKDXSA-N	247417	US10336754, Example 371::US11053247, Example 371::US9453018, 370::US9453018, 371	Plasma kallikrein		 19						7.5	37.00 C	US Patent		10.7270/Q25X27VB		aid1803431	US9453018	Dilger, AK; Corte, JR; De Lucca, I; Fang, T; Yang, W; Wang, Y; Pabbisetty, KB; Ewing, WR; Zhu, Y; Wexler, RR; Pinto, DJ; Orwat, MJ; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=247417	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=247417&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			131635539	346541959							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
431703	C[C@@H]1CCC[C@@H](c2ccnc(c2)-c2c(NC1=O)cnn2C)n1cnc(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(O)=O	InChI=1S/C29H26ClN9O4/c1-16-4-3-5-24(17-8-9-31-21(10-17)27-22(34-28(16)41)13-33-37(27)2)38-15-32-20(12-26(38)40)19-11-18(30)6-7-25(19)39-14-23(29(42)43)35-36-39/h6-16,24H,3-5H2,1-2H3,(H,34,41)(H,42,43)/t16-,24+/m1/s1	ZEUDFUNISLCCKE-GYCJOSAFSA-N	247418	US10336754, Example 372::US11053247, Example 372::US9453018, 372	Plasma kallikrein		 35						7.5	37.00 C	US Patent		10.7270/Q25X27VB		aid1803431	US9453018	Dilger, AK; Corte, JR; De Lucca, I; Fang, T; Yang, W; Wang, Y; Pabbisetty, KB; Ewing, WR; Zhu, Y; Wexler, RR; Pinto, DJ; Orwat, MJ; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=247418	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=247418&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			131635540	346541960							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
431704	C[C@@H]1CCC[C@@H](c2cc(ccn2)-c2c(NC1=O)cnn2C)n1cnc(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(O)=O	InChI=1S/C29H26ClN9O4/c1-16-4-3-5-25(21-10-17(8-9-31-21)27-22(34-28(16)41)13-33-37(27)2)38-15-32-20(12-26(38)40)19-11-18(30)6-7-24(19)39-14-23(29(42)43)35-36-39/h6-16,25H,3-5H2,1-2H3,(H,34,41)(H,42,43)/t16-,25+/m1/s1	MLTHDTRXOVPWLH-CPJLOUKISA-N	247419	US10336754, Example 373::US11053247, Example 373::US9453018, 373	Plasma kallikrein		 37						7.5	37.00 C	US Patent		10.7270/Q25X27VB		aid1803431	US9453018	Dilger, AK; Corte, JR; De Lucca, I; Fang, T; Yang, W; Wang, Y; Pabbisetty, KB; Ewing, WR; Zhu, Y; Wexler, RR; Pinto, DJ; Orwat, MJ; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=247419	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=247419&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			131635541	346541961							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429380	CC(C(=O)Nc1ccc(cc1)-c1nnn[nH]1)n1ccc(cc1=O)-c1cc(Cl)ccc1C#N			246096	US10183932, Example 1::US9434690, 1::US9822102, Example 1	Plasma kallikrein			 600					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246096	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246096&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622715	341103945							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429381	CC(C(=O)Nc1ccc(cc1)-c1ncc[nH]1)n1ccc(cc1=O)-c1cc(Cl)ccc1C#N			246099	US10183932, Example 4::US9434690, 4::US9822102, Example 4	Plasma kallikrein			 590					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246099	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246099&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622607	341103948							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429382	CC(C(=O)Nc1ccc(cc1)-c1c[nH]c(n1)C(F)(F)F)n1ccc(cc1=O)-c1cc(Cl)ccc1C#N			246101	US10183932, Example 6::US9434690, 6::US9822102, Example 6	Plasma kallikrein			 640					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246101	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246101&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622723	341103950							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429383	CC(C(=O)Nc1ccc(cc1)-c1noc(=O)[nH]1)n1ccc(cc1=O)-c1cc(Cl)ccc1C#N			246103	US10183932, Example 8::US9434690, 8::US9822102, Example 8	Plasma kallikrein			 490					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246103	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246103&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			129626902	341103952							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429384	CC(C(=O)Nc1ccc2c(c1)[nH]n(C)c2=O)n1ccc(cc1=O)-c1cc(Cl)ccc1C#N			246112	US10183932, Example 17::US9434690, 17::US9822102, Example 17	Plasma kallikrein			 630					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246112	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246112&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			129626903	341103961							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429385	CCC(C(=O)Nc1ccc(cc1)-c1nnn[nH]1)n1ccc(cc1=O)-c1cc(Cl)ccc1C#N			246114	US10183932, Example 21::US9434690, 19::US9434690, 20::US9434690, 21::US9822102, Example 21	Plasma kallikrein			 120					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246114	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246114&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622611	341103963							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429386	CCCCC(C(=O)Nc1ccc(cc1)-c1nnn[nH]1)n1ccc(cc1=O)-c1cc(Cl)ccc1C#N			246118	US10183932, Example 23::US9434690, 23::US9822102, Example 23	Plasma kallikrein			 520					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246118	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246118&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622898	341103965							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429387	OC(=O)c1ccc(NC(=O)C(Cc2ccccn2)n2ccc(cc2=O)-c2cc(Cl)ccc2C(F)(F)F)cc1	InChI=1S/C27H19ClF3N3O4/c28-18-6-9-22(27(29,30)31)21(14-18)17-10-12-34(24(35)13-17)23(15-20-3-1-2-11-32-20)25(36)33-19-7-4-16(5-8-19)26(37)38/h1-14,23H,15H2,(H,33,36)(H,37,38)	CKFCLGOBAUZLCA-UHFFFAOYSA-N	246122	US10183932, Example 27::US9434690, 27::US9822102, Example 27	Plasma kallikrein			 780					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246122	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246122&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622905	341103969							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429388	OC(=O)c1ccc(NC(=O)C(Cc2cccnc2)n2ccc(cc2=O)-c2cc(Cl)ccc2Br)cc1	InChI=1S/C26H19BrClN3O4/c27-22-8-5-19(28)14-21(22)18-9-11-31(24(32)13-18)23(12-16-2-1-10-29-15-16)25(33)30-20-6-3-17(4-7-20)26(34)35/h1-11,13-15,23H,12H2,(H,30,33)(H,34,35)	FJLLPUNDAQQFCD-UHFFFAOYSA-N	246124	US10183932, Example 29::US9434690, 29::US9822102, Example 29	Plasma kallikrein			 350					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246124	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246124&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622939	341103971							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429389	OC(=O)c1ccc(NC(=O)C(Cc2ccncc2)n2ccc(cc2=O)-c2cc(Cl)ccc2C(F)(F)F)cc1	InChI=1S/C27H19ClF3N3O4/c28-19-3-6-22(27(29,30)31)21(15-19)18-9-12-34(24(35)14-18)23(13-16-7-10-32-11-8-16)25(36)33-20-4-1-17(2-5-20)26(37)38/h1-12,14-15,23H,13H2,(H,33,36)(H,37,38)	VOEMZDCOWSMTBH-UHFFFAOYSA-N	246125	US10183932, Example 32::US9434690, 30::US9434690, 31::US9434690, 32::US9822102, Example 32	Plasma kallikrein			 800					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246125	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246125&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622752	341103972							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429390	CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(F)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C22H15ClFN3O4/c1-12(21(29)26-16-6-3-13(4-7-16)22(30)31)27-11-19(24)18(9-20(27)28)17-8-15(23)5-2-14(17)10-25/h2-9,11-12H,1H3,(H,26,29)(H,30,31)	BFAOKCDIFBZLTD-UHFFFAOYSA-N	246129	US10183932, Example 34::US9434690, 34::US9822102, Example 34	Plasma kallikrein			 310					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246129	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246129&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622987	341103974							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429391	CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(Cl)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C22H15Cl2N3O4/c1-12(21(29)26-16-6-3-13(4-7-16)22(30)31)27-11-19(24)18(9-20(27)28)17-8-15(23)5-2-14(17)10-25/h2-9,11-12H,1H3,(H,26,29)(H,30,31)	MYLKJUSMRUADNT-UHFFFAOYSA-N	246130	US10183932, Example 37::US9434690, 35::US9434690, 36::US9434690, 37::US9822102, Example 37	Plasma kallikrein			 275					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246130	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246130&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622690	341103975							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429392	CC(C(=O)Nc1ccc(cc1)-c1nc(n[nH]1)C(F)(F)F)n1cc(Cl)c(cc1=O)-c1cc(Cl)ccc1C#N			246136	US10183932, Example 41::US9434690, 41::US9822102, Example 41	Plasma kallikrein			 1600					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246136	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246136&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622989	341103979							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429393	CC(C(=O)Nc1ccc(cc1)-c1cnc[nH]1)n1cc(Cl)c(cc1=O)-c1cc(Cl)ccc1C#N			246138	US10183932, Example 43::US9434690, 43::US9822102, Example 43	Plasma kallikrein			 230					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246138	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246138&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622610	341103981							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429394	OC(=O)c1ccc(NC(=O)C(CC2CC2)n2cc(Cl)c(cc2=O)-c2cc(Cl)ccc2C#N)cc1	InChI=1S/C25H19Cl2N3O4/c26-17-6-3-16(12-28)19(10-17)20-11-23(31)30(13-21(20)27)22(9-14-1-2-14)24(32)29-18-7-4-15(5-8-18)25(33)34/h3-8,10-11,13-14,22H,1-2,9H2,(H,29,32)(H,33,34)	APZJTXHPPDAWRM-UHFFFAOYSA-N	246140	US10183932, Example 47::US9434690, 45::US9434690, 46::US9434690, 47::US9822102, Example 47	Plasma kallikrein			 200					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246140	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246140&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622732	341103983							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429395	COc1cn(C(C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C23H18ClN3O5/c1-13(22(29)26-17-7-4-14(5-8-17)23(30)31)27-12-20(32-2)19(10-21(27)28)18-9-16(24)6-3-15(18)11-25/h3-10,12-13H,1-2H3,(H,26,29)(H,30,31)	MPSQYCLTAAEIDL-UHFFFAOYSA-N	246150	US10183932, Example 57::US9434690, 55::US9434690, 56::US9434690, 57::US9822102, Example 57	Plasma kallikrein			 31					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246150	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246150&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622624	341103991							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429396	COc1cn(C(C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1[N+]([O-])=O	InChI=1S/C22H18ClN3O7/c1-12(21(28)24-15-6-3-13(4-7-15)22(29)30)25-11-19(33-2)17(10-20(25)27)16-9-14(23)5-8-18(16)26(31)32/h3-12H,1-2H3,(H,24,28)(H,29,30)	PTHBJYOJADPDRP-UHFFFAOYSA-N	246153	US10183932, Example 58::US9434690, 58::US9822102, Example 58	Plasma kallikrein			 46					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246153	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246153&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86297546	341103992							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429397	COc1cn(C(CC#C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C25H18ClN3O5/c1-3-4-21(24(31)28-18-9-6-15(7-10-18)25(32)33)29-14-22(34-2)20(12-23(29)30)19-11-17(26)8-5-16(19)13-27/h1,5-12,14,21H,4H2,2H3,(H,28,31)(H,32,33)	BVJKTUAUDCSIJC-UHFFFAOYSA-N	246156	US10183932, Example 61::US9434690, 61::US9822102, Example 61	Plasma kallikrein			 29					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246156	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246156&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622828	341103994							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429398	COc1cn(C(CC(C)C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C26H24ClN3O5/c1-15(2)10-22(25(32)29-19-8-5-16(6-9-19)26(33)34)30-14-23(35-3)21(12-24(30)31)20-11-18(27)7-4-17(20)13-28/h4-9,11-12,14-15,22H,10H2,1-3H3,(H,29,32)(H,33,34)	PDLAMRDOLIUATC-UHFFFAOYSA-N	246158	US10183932, Example 65::US9434690, 63::US9434690, 64::US9434690, 65::US9822102, Example 65	Plasma kallikrein			 25					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246158	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246158&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622627	341103996							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429399	CCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C24H20ClN3O5/c1-3-20(23(30)27-17-8-5-14(6-9-17)24(31)32)28-13-21(33-2)19(11-22(28)29)18-10-16(25)7-4-15(18)12-26/h4-11,13,20H,3H2,1-2H3,(H,27,30)(H,31,32)	HUXWVMXMMHUYLB-UHFFFAOYSA-N	246161	US10183932, Example 140::US9434690, 140::US9434690, 66::US9434690, 67::US9434690, 68::US9822102, Example 140	Plasma kallikrein			 14.5					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246161	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246161&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622754	341103997							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429400	CCC(C(=O)Nc1ccc2c(c1)[nH]n(C)c2=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N			246165	US10183932, Example 70::US9434690, 70::US9822102, Example 70	Plasma kallikrein			 16					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246165	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246165&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			129626908	341103999							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429401	CCC(C(=O)Nc1ccc(cc1)-c1c[nH]c(=O)o1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N			246167	US10183932, Example 72::US9434690, 72::US9822102, Example 72	Plasma kallikrein			 29					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246167	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246167&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622993	341104001							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429402	CCC(C(=O)Nc1ccc2cc([nH]c2c1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N			246169	US10183932, Example 74::US9434690, 74::US9822102, Example 74	Plasma kallikrein			 10					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246169	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246169&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622760	341104003							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429403	COCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C25H22ClN3O6/c1-34-10-9-21(24(31)28-18-7-4-15(5-8-18)25(32)33)29-14-22(35-2)20(12-23(29)30)19-11-17(26)6-3-16(19)13-27/h3-8,11-12,14,21H,9-10H2,1-2H3,(H,28,31)(H,32,33)	XAYFQGTYMRMPAS-UHFFFAOYSA-N	246171	US10183932, Example 78::US9434690, 76::US9434690, 77::US9434690, 78::US9822102, Example 78	Plasma kallikrein			 12					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246171	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246171&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86297748	341104005							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429404	CO[C@@H](C)CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C26H24ClN3O6/c1-15(35-2)10-22(25(32)29-19-8-5-16(6-9-19)26(33)34)30-14-23(36-3)21(12-24(30)31)20-11-18(27)7-4-17(20)13-28/h4-9,11-12,14-15,22H,10H2,1-3H3,(H,29,32)(H,33,34)/t15-,22?/m0/s1	DYNSAJCVHKUDFF-UEDXYCIISA-N	246174	US10183932, Example 81::US9434690, 79::US9434690, 80::US9434690, 81::US9822102, Example 81	Plasma kallikrein			 15					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246174	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246174&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118877945	341104006							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429405	CO[C@H](C)CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C26H24ClN3O6/c1-15(35-2)10-22(25(32)29-19-8-5-16(6-9-19)26(33)34)30-14-23(36-3)21(12-24(30)31)20-11-18(27)7-4-17(20)13-28/h4-9,11-12,14-15,22H,10H2,1-3H3,(H,29,32)(H,33,34)/t15-,22?/m1/s1	DYNSAJCVHKUDFF-JGHKVMFLSA-N	246177	US10183932, Example 83::US9434690, 82::US9434690, 83::US9822102, Example 83	Plasma kallikrein			 45					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246177	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246177&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118877889	341104007							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429406	COc1cn(C(C[C@H]2CCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C27H24ClN3O6/c1-36-24-15-31(25(32)13-22(24)21-11-18(28)7-4-17(21)14-29)23(12-20-3-2-10-37-20)26(33)30-19-8-5-16(6-9-19)27(34)35/h4-9,11,13,15,20,23H,2-3,10,12H2,1H3,(H,30,33)(H,34,35)/t20-,23?/m1/s1	AETBCOOBUYAHJM-PPUHSXQSSA-N	246179	US10183932, Example 86::US9434690, 84::US9434690, 85::US9434690, 86::US9822102, Example 86	Plasma kallikrein			 40					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246179	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246179&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622620	341104008							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429407	COc1cn(C(C[C@@H]2CCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C27H24ClN3O6/c1-36-24-15-31(25(32)13-22(24)21-11-18(28)7-4-17(21)14-29)23(12-20-3-2-10-37-20)26(33)30-19-8-5-16(6-9-19)27(34)35/h4-9,11,13,15,20,23H,2-3,10,12H2,1H3,(H,30,33)(H,34,35)/t20-,23?/m0/s1	AETBCOOBUYAHJM-AJZOCDQUSA-N	246182	US10183932, Example 89::US9434690, 87::US9434690, 88::US9434690, 89::US9822102, Example 89	Plasma kallikrein			 14					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246182	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246182&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118877947	341104009							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429408	COc1cn(C(C[C@@H]2CCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C27H24ClN3O6/c1-36-24-15-31(25(32)13-22(24)21-11-18(28)7-4-17(21)14-29)23(12-20-3-2-10-37-20)26(33)30-19-8-5-16(6-9-19)27(34)35/h4-9,11,13,15,20,23H,2-3,10,12H2,1H3,(H,30,33)(H,34,35)/t20-,23?/m0/s1	AETBCOOBUYAHJM-AJZOCDQUSA-N	246182	US10183932, Example 89::US9434690, 87::US9434690, 88::US9434690, 89::US9822102, Example 89	Plasma kallikrein			 850					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246182	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246182&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118877947	341104009							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429409	COc1cn(C(CC2CCOC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C27H24ClN3O6/c1-36-24-14-31(25(32)12-22(24)21-11-19(28)5-2-18(21)13-29)23(10-16-8-9-37-15-16)26(33)30-20-6-3-17(4-7-20)27(34)35/h2-7,11-12,14,16,23H,8-10,15H2,1H3,(H,30,33)(H,34,35)	UPJPTNTVAMVKSD-UHFFFAOYSA-N	246185	US10183932, Example 93::US9434690, 90::US9434690, 91::US9434690, 92::US9434690, 93::US9822102, Example 93	Plasma kallikrein			 35					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246185	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246185&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86297749	341104010							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429410	COc1cn(C(CC2CCOCC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C28H26ClN3O6/c1-37-25-16-32(26(33)14-23(25)22-13-20(29)5-2-19(22)15-30)24(12-17-8-10-38-11-9-17)27(34)31-21-6-3-18(4-7-21)28(35)36/h2-7,13-14,16-17,24H,8-12H2,1H3,(H,31,34)(H,35,36)	BMRPDPXXIHCBMO-UHFFFAOYSA-N	246189	US10183932, Example 96::US9434690, 94::US9434690, 95::US9434690, 96::US9822102, Example 96	Plasma kallikrein			 48					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246189	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246189&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86297750	341104011							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429411	COc1cn(C(CC2CCCOC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C28H26ClN3O6/c1-37-25-15-32(26(33)13-23(25)22-12-20(29)7-4-19(22)14-30)24(11-17-3-2-10-38-16-17)27(34)31-21-8-5-18(6-9-21)28(35)36/h4-9,12-13,15,17,24H,2-3,10-11,16H2,1H3,(H,31,34)(H,35,36)	SNVIVXDTJLCEGY-UHFFFAOYSA-N	246192	US10183932, Example 100::US9434690, 100::US9434690, 97::US9434690, 98::US9434690, 99::US9822102, Example 100	Plasma kallikrein			 26					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246192	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246192&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622761	341104012							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429412	COc1cn(C(CC2CCCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C28H26ClN3O6/c1-37-25-16-32(26(33)14-23(25)22-12-19(29)8-5-18(22)15-30)24(13-21-4-2-3-11-38-21)27(34)31-20-9-6-17(7-10-20)28(35)36/h5-10,12,14,16,21,24H,2-4,11,13H2,1H3,(H,31,34)(H,35,36)	WVQIDDPAQZTNTF-UHFFFAOYSA-N	246196	US10183932, Example 105::US9434690, 101::US9434690, 102::US9434690, 103::US9434690, 104::US9434690, 105::US9822102, Example 105	Plasma kallikrein			 19					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246196	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246196&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622618	341104013							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429413	COc1cn(C(CC2CCCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C28H26ClN3O6/c1-37-25-16-32(26(33)14-23(25)22-12-19(29)8-5-18(22)15-30)24(13-21-4-2-3-11-38-21)27(34)31-20-9-6-17(7-10-20)28(35)36/h5-10,12,14,16,21,24H,2-4,11,13H2,1H3,(H,31,34)(H,35,36)	WVQIDDPAQZTNTF-UHFFFAOYSA-N	246196	US10183932, Example 105::US9434690, 101::US9434690, 102::US9434690, 103::US9434690, 104::US9434690, 105::US9822102, Example 105	Plasma kallikrein			 67					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246196	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246196&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622618	341104013							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429414	COc1cn(C(CC2COCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C27H24ClN3O7/c1-36-24-14-31(25(32)12-22(24)21-10-18(28)5-2-17(21)13-29)23(11-20-15-37-8-9-38-20)26(33)30-19-6-3-16(4-7-19)27(34)35/h2-7,10,12,14,20,23H,8-9,11,15H2,1H3,(H,30,33)(H,34,35)	BHLQGSGEFNRQIY-UHFFFAOYSA-N	246201	US10183932, Example 106::US9434690, 106::US9822102, Example 106	Plasma kallikrein			 21					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246201	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246201&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622773	341104014							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429415	COc1cn(C(CC(F)F)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C24H18ClF2N3O5/c1-35-20-12-30(22(31)9-18(20)17-8-15(25)5-2-14(17)11-28)19(10-21(26)27)23(32)29-16-6-3-13(4-7-16)24(33)34/h2-9,12,19,21H,10H2,1H3,(H,29,32)(H,33,34)	MGICMZBKNIZMHA-UHFFFAOYSA-N	246203	US10183932, Example 108::US9434690, 108::US9822102, Example 108	Plasma kallikrein			 59					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246203	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246203&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622933	341104016							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429416	COc1cn(C(CC(C)F)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C25H21ClFN3O5/c1-14(27)9-21(24(32)29-18-7-4-15(5-8-18)25(33)34)30-13-22(35-2)20(11-23(30)31)19-10-17(26)6-3-16(19)12-28/h3-8,10-11,13-14,21H,9H2,1-2H3,(H,29,32)(H,33,34)	ZQIKHBBWQGREQS-UHFFFAOYSA-N	246205	US10183932, Example 110::US9434690, 110::US9822102, Example 110	Plasma kallikrein			 78					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246205	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246205&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86297752	341104018							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429417	COc1cn(C(CC(C)(C)C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C27H26ClN3O5/c1-27(2,3)13-22(25(33)30-19-9-6-16(7-10-19)26(34)35)31-15-23(36-4)21(12-24(31)32)20-11-18(28)8-5-17(20)14-29/h5-12,15,22H,13H2,1-4H3,(H,30,33)(H,34,35)	JQVBPYPYIBVMCC-UHFFFAOYSA-N	246207	US10183932, Example 112::US9434690, 112::US9822102, Example 112	Plasma kallikrein			 200					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246207	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246207&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86297948	341104020							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429418	COc1cn(C(CC2CC2(F)F)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C26H20ClF2N3O5/c1-37-22-13-32(23(33)10-20(22)19-9-17(27)5-2-15(19)12-30)21(8-16-11-26(16,28)29)24(34)31-18-6-3-14(4-7-18)25(35)36/h2-7,9-10,13,16,21H,8,11H2,1H3,(H,31,34)(H,35,36)	PPOMRFJZWPHFPA-UHFFFAOYSA-N	246208	US10183932, Example 115::US9434690, 113::US9434690, 114::US9434690, 115::US9822102, Example 115	Plasma kallikrein			 16					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246208	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246208&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86297949	341104021							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429419	COc1cn(C(CC2CCC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C27H24ClN3O5/c1-36-24-15-31(25(32)13-22(24)21-12-19(28)8-5-18(21)14-29)23(11-16-3-2-4-16)26(33)30-20-9-6-17(7-10-20)27(34)35/h5-10,12-13,15-16,23H,2-4,11H2,1H3,(H,30,33)(H,34,35)	BXIDJSNINHKLLQ-UHFFFAOYSA-N	246212	US10183932, Example 117::US9434690, 117::US9822102, Example 117	Plasma kallikrein			 12					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246212	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246212&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86297950	341104023							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429420	COc1cn(CC(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C22H16ClN3O5/c1-31-19-11-26(12-20(27)25-16-6-3-13(4-7-16)22(29)30)21(28)9-18(19)17-8-15(23)5-2-14(17)10-24/h2-9,11H,12H2,1H3,(H,25,27)(H,29,30)	SAHCVGAZLPRNEE-UHFFFAOYSA-N	246214	US10183932, Example 119::US9434690, 119::US9822102, Example 119	Plasma kallikrein			 200					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246214	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246214&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622872	341104025							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429421	COc1cn(C(C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C	InChI=1S/C23H21ClN2O5/c1-13-4-7-16(24)10-18(13)19-11-21(27)26(12-20(19)31-3)14(2)22(28)25-17-8-5-15(6-9-17)23(29)30/h4-12,14H,1-3H3,(H,25,28)(H,29,30)	CVTZPKKDPIRSKS-UHFFFAOYSA-N	246217	US10183932, Example 122::US9434690, 122::US9822102, Example 122	Plasma kallikrein			 700					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246217	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246217&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622769	341104028							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429422	CCC(CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N)OC	InChI=1S/C27H26ClN3O6/c1-4-20(36-2)12-23(26(33)30-19-9-6-16(7-10-19)27(34)35)31-15-24(37-3)22(13-25(31)32)21-11-18(28)8-5-17(21)14-29/h5-11,13,15,20,23H,4,12H2,1-3H3,(H,30,33)(H,34,35)	NWTLKQWFPQKMLC-UHFFFAOYSA-N	246220	US10183932, Example 144::US9434690, 125::US9434690, 141::US9434690, 142::US9434690, 143::US9434690, 144::US9822102, Example 144	Plasma kallikrein			 23					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246220	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246220&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86297952	341104031							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429423	COc1cn(C(C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1OC(F)F	InChI=1S/C23H19ClF2N2O6/c1-12(21(30)27-15-6-3-13(4-7-15)22(31)32)28-11-19(33-2)17(10-20(28)29)16-9-14(24)5-8-18(16)34-23(25)26/h3-12,23H,1-2H3,(H,27,30)(H,31,32)	YRKPZRMKWAQTNS-UHFFFAOYSA-N	246222	US10183932, Example 127::US9434690, 127::US9822102, Example 127	Plasma kallikrein			 160					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246222	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246222&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622893	341104033							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429424	CCOc1cn(C(C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C24H20ClN3O5/c1-3-33-21-13-28(14(2)23(30)27-18-8-5-15(6-9-18)24(31)32)22(29)11-20(21)19-10-17(25)7-4-16(19)12-26/h4-11,13-14H,3H2,1-2H3,(H,27,30)(H,31,32)	MHLRUCJOXJQBOK-UHFFFAOYSA-N	246224	US10183932, Example 129::US9434690, 129::US9822102, Example 129	Plasma kallikrein			 390					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246224	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246224&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622947	341104035							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429425	COc1cn(C(CC2CCC(O)CC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C29H28ClN3O6/c1-39-26-16-33(27(35)14-24(26)23-13-20(30)7-4-19(23)15-31)25(12-17-2-10-22(34)11-3-17)28(36)32-21-8-5-18(6-9-21)29(37)38/h4-9,13-14,16-17,22,25,34H,2-3,10-12H2,1H3,(H,32,36)(H,37,38)	CJNBXUGWBBVSDD-UHFFFAOYSA-N	246227	US10183932, Example 135::US9434690, 132::US9434690, 133::US9434690, 134::US9434690, 135::US9822102, Example 135	Plasma kallikrein			 18					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246227	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246227&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86298154	341104038							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429426	COc1cn(C(CC2CCC(O)CC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C29H28ClN3O6/c1-39-26-16-33(27(35)14-24(26)23-13-20(30)7-4-19(23)15-31)25(12-17-2-10-22(34)11-3-17)28(36)32-21-8-5-18(6-9-21)29(37)38/h4-9,13-14,16-17,22,25,34H,2-3,10-12H2,1H3,(H,32,36)(H,37,38)	CJNBXUGWBBVSDD-UHFFFAOYSA-N	246227	US10183932, Example 135::US9434690, 132::US9434690, 133::US9434690, 134::US9434690, 135::US9822102, Example 135	Plasma kallikrein			 19					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246227	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246227&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86298154	341104038							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429427	COc1cn(C(CCOC(F)(F)F)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C25H19ClF3N3O6/c1-37-21-13-32(22(33)11-19(21)18-10-16(26)5-2-15(18)12-30)20(8-9-38-25(27,28)29)23(34)31-17-6-3-14(4-7-17)24(35)36/h2-7,10-11,13,20H,8-9H2,1H3,(H,31,34)(H,35,36)	YNXCWDXRPDZZLO-UHFFFAOYSA-N	246231	US10183932, Example 138::US9434690, 136::US9434690, 137::US9434690, 138::US9822102, Example 138	Plasma kallikrein			 6.5					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246231	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246231&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622873	341104039							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429428	CCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C24H20ClN3O5/c1-3-20(23(30)27-17-8-5-14(6-9-17)24(31)32)28-13-21(33-2)19(11-22(28)29)18-10-16(25)7-4-15(18)12-26/h4-11,13,20H,3H2,1-2H3,(H,27,30)(H,31,32)	HUXWVMXMMHUYLB-UHFFFAOYSA-N	246161	US10183932, Example 140::US9434690, 140::US9434690, 66::US9434690, 67::US9434690, 68::US9822102, Example 140	Plasma kallikrein			 32					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246161	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246161&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622754	341103997							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429429	CCC(CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N)OC	InChI=1S/C27H26ClN3O6/c1-4-20(36-2)12-23(26(33)30-19-9-6-16(7-10-19)27(34)35)31-15-24(37-3)22(13-25(31)32)21-11-18(28)8-5-17(21)14-29/h5-11,13,15,20,23H,4,12H2,1-3H3,(H,30,33)(H,34,35)	NWTLKQWFPQKMLC-UHFFFAOYSA-N	246220	US10183932, Example 144::US9434690, 125::US9434690, 141::US9434690, 142::US9434690, 143::US9434690, 144::US9822102, Example 144	Plasma kallikrein			 18					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246220	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246220&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86297952	341104031							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429430	CCC(CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N)OC	InChI=1S/C27H26ClN3O6/c1-4-20(36-2)12-23(26(33)30-19-9-6-16(7-10-19)27(34)35)31-15-24(37-3)22(13-25(31)32)21-11-18(28)8-5-17(21)14-29/h5-11,13,15,20,23H,4,12H2,1-3H3,(H,30,33)(H,34,35)	NWTLKQWFPQKMLC-UHFFFAOYSA-N	246220	US10183932, Example 144::US9434690, 125::US9434690, 141::US9434690, 142::US9434690, 143::US9434690, 144::US9822102, Example 144	Plasma kallikrein			 1000					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246220	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246220&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86297952	341104031							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429431	COc1cn(C(CC2(CC2)C(F)(F)F)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C27H21ClF3N3O5/c1-39-22-14-34(23(35)11-20(22)19-10-17(28)5-2-16(19)13-32)21(12-26(8-9-26)27(29,30)31)24(36)33-18-6-3-15(4-7-18)25(37)38/h2-7,10-11,14,21H,8-9,12H2,1H3,(H,33,36)(H,37,38)	PNSIVGGUCOLACI-UHFFFAOYSA-N	246239	US10183932, Example 147::US9434690, 145::US9434690, 146::US9434690, 147::US9822102, Example 147	Plasma kallikrein			 1500					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246239	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246239&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86298155	341104041							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429432	COc1cn(C(CC2(CCC2)C(F)(F)F)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C28H23ClF3N3O5/c1-40-23-15-35(24(36)12-21(23)20-11-18(29)6-3-17(20)14-33)22(13-27(9-2-10-27)28(30,31)32)25(37)34-19-7-4-16(5-8-19)26(38)39/h3-8,11-12,15,22H,2,9-10,13H2,1H3,(H,34,37)(H,38,39)	NNYYRFPFZSEPNY-UHFFFAOYSA-N	246242	US10183932, Example 148::US9434690, 148::US9822102, Example 148	Plasma kallikrein			 430					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246242	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246242&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117623022	341104042							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429433	COc1cn(C(CC2(C)COC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C27H24ClN3O6/c1-27(14-37-15-27)11-22(25(33)30-19-7-4-16(5-8-19)26(34)35)31-13-23(36-2)21(10-24(31)32)20-9-18(28)6-3-17(20)12-29/h3-10,13,22H,11,14-15H2,1-2H3,(H,30,33)(H,34,35)	UCSCLOQQIVMMIJ-UHFFFAOYSA-N	246244	US10183932, Example 150::US9434690, 150::US9822102, Example 150	Plasma kallikrein			 18					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246244	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246244&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622630	341104044							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429434	CO[C@@H]1CC[C@H](CC(C(=O)Nc2ccc(cc2)C(O)=O)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2C#N)CC1	InChI=1S/C30H30ClN3O6/c1-39-23-11-3-18(4-12-23)13-26(29(36)33-22-9-6-19(7-10-22)30(37)38)34-17-27(40-2)25(15-28(34)35)24-14-21(31)8-5-20(24)16-32/h5-10,14-15,17-18,23,26H,3-4,11-13H2,1-2H3,(H,33,36)(H,37,38)/t18-,23+,26?	LARGKTWCHAEXEF-CIGLETDBSA-N	246246	US10183932, Example 154::US9434690, 152::US9434690, 153::US9434690, 154::US9822102, Example 154	Plasma kallikrein			 75					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246246	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246246&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622774	341104046							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429435	CO[C@H]1CC[C@H](CC(C(=O)Nc2ccc(cc2)C(O)=O)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2C#N)CC1	InChI=1S/C30H30ClN3O6/c1-39-23-11-3-18(4-12-23)13-26(29(36)33-22-9-6-19(7-10-22)30(37)38)34-17-27(40-2)25(15-28(34)35)24-14-21(31)8-5-20(24)16-32/h5-10,14-15,17-18,23,26H,3-4,11-13H2,1-2H3,(H,33,36)(H,37,38)/t18-,23-,26?	LARGKTWCHAEXEF-QDTYANCNSA-N	246249	US10183932, Example 157::US9434690, 155::US9434690, 156::US9434690, 157::US9822102, Example 157	Plasma kallikrein			 10					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246249	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246249&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622774	341104047							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429436	COc1cn(C(CC2CCC2)C(=O)Nc2ccc(cc2)-c2c[nH]c(=O)o2)c(=O)cc1-c1cc(Cl)ccc1C#N			246252	US10183932, Example 158::US9434690, 158::US9822102, Example 158	Plasma kallikrein			 29					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246252	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246252&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622778	341104048							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429437	COc1cn(C(C(C)C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C25H22ClN3O5/c1-14(2)23(24(31)28-18-8-5-15(6-9-18)25(32)33)29-13-21(34-3)20(11-22(29)30)19-10-17(26)7-4-16(19)12-27/h4-11,13-14,23H,1-3H3,(H,28,31)(H,32,33)	SGNRWMZAJNVPLX-UHFFFAOYSA-N	246254	US10183932, Example 160::US9434690, 160::US9822102, Example 160	Plasma kallikrein			 240					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246254	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246254&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622781	341104050							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429438	COc1cn(C(C(C)C)C(=O)Nc2ccc3nc([nH]c3c2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N			246256	US10183932, Example 162::US9434690, 162::US9822102, Example 162	Plasma kallikrein			 250					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246256	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246256&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622907	341104052							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429439	COCCC(C(=O)Nc1ccc2c(c1)[nH][nH]c2=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C25H20ClN5O5/c1-35-8-7-21(25(34)28-16-5-6-17-20(10-16)29-30-24(17)33)31-13-22(36-2)19(11-23(31)32)18-9-15(26)4-3-14(18)12-27/h3-6,9-11,13,21H,7-8H2,1-2H3,(H,28,34)	LSOXVFXTZIMGBB-UHFFFAOYSA-N	246258	US10183932, Example 164::US9434690, 164::US9822102, Example 164	Plasma kallikrein			 1.9					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246258	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246258&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			129626913	341104054							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429440	COCCC(C(=O)Nc1ccc2[nH]ncc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N			246260	US10183932, Example 166::US9434690, 166::US9822102, Example 166	Plasma kallikrein			 6.3					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246260	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246260&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			129626915	341104056							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429441	COCCC(C(=O)Nc1ccc2cc([nH]c2c1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N			246262	US10183932, Example 168::US9434690, 168::US9822102, Example 168	Plasma kallikrein			 3.1					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246262	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246262&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622955	341104058							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429442	CC(C)CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(Cl)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C25H21Cl2N3O4/c1-14(2)9-22(24(32)29-18-7-4-15(5-8-18)25(33)34)30-13-21(27)20(11-23(30)31)19-10-17(26)6-3-16(19)12-28/h3-8,10-11,13-14,22H,9H2,1-2H3,(H,29,32)(H,33,34)	AMIQZUOXODCISO-UHFFFAOYSA-N	246264	US10183932, Example 170::US9434690, 170::US9822102, Example 170	Plasma kallikrein			 670					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246264	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246264&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622957	341104060							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429443	COc1cn(C(CC(C)C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1OC(F)F	InChI=1S/C26H25ClF2N2O6/c1-14(2)10-20(24(33)30-17-7-4-15(5-8-17)25(34)35)31-13-22(36-3)19(12-23(31)32)18-11-16(27)6-9-21(18)37-26(28)29/h4-9,11-14,20,26H,10H2,1-3H3,(H,30,33)(H,34,35)	PONZAFSAZRCPMW-UHFFFAOYSA-N	246266	US10183932, Example 172::US9434690, 172::US9822102, Example 172	Plasma kallikrein			 360					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246266	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246266&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117623021	341104062							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429444	COCCC(C(=O)Nc1ccc2c(c1)[nH]n(C)c2=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1OC(F)F			246268	US10183932, Example 174::US9434690, 174::US9822102, Example 174	Plasma kallikrein			 28					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246268	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246268&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			129626917	341104064							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429445	COc1cn(C(CCOC(F)(F)F)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1OC(F)F	InChI=1S/C25H20ClF5N2O7/c1-38-20-12-33(21(34)11-17(20)16-10-14(26)4-7-19(16)40-24(27)28)18(8-9-39-25(29,30)31)22(35)32-15-5-2-13(3-6-15)23(36)37/h2-7,10-12,18,24H,8-9H2,1H3,(H,32,35)(H,36,37)	MQEMRRKVUTYPQR-UHFFFAOYSA-N	246270	US10183932, Example 176::US9434690, 176::US9822102, Example 176	Plasma kallikrein			 58					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246270	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246270&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622904	341104066							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429446	CCC(C(=O)Nc1ccc(C(O)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C24H19ClFN3O5/c1-3-20(23(31)28-15-6-7-16(24(32)33)19(26)9-15)29-12-21(34-2)18(10-22(29)30)17-8-14(25)5-4-13(17)11-27/h4-10,12,20H,3H2,1-2H3,(H,28,31)(H,32,33)	LRTKHAKNKDKNGN-UHFFFAOYSA-N	246272	US10183932, Example 179::US9434690, 178::US9434690, 179::US9822102, Example 179	Plasma kallikrein			 33					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246272	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246272&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622926	341104068							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429447	CCC(C(=O)Nc1ccc(cc1F)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C24H19ClFN3O5/c1-3-20(23(31)28-19-7-5-13(24(32)33)8-18(19)26)29-12-21(34-2)17(10-22(29)30)16-9-15(25)6-4-14(16)11-27/h4-10,12,20H,3H2,1-2H3,(H,28,31)(H,32,33)	JXWVATDLTXDPIQ-UHFFFAOYSA-N	246274	US10183932, Example 181::US9434690, 180::US9434690, 181::US9822102, Example 181	Plasma kallikrein			 78					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246274	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246274&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622633	341104069							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429448	CCC(C(=O)Nc1cc(F)c(cc1F)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C24H18ClF2N3O5/c1-3-20(23(32)29-19-9-17(26)16(24(33)34)7-18(19)27)30-11-21(35-2)15(8-22(30)31)14-6-13(25)5-4-12(14)10-28/h4-9,11,20H,3H2,1-2H3,(H,29,32)(H,33,34)	ZVXCULUAQHRZBD-UHFFFAOYSA-N	246276	US10183932, Example 183::US9434690, 182::US9434690, 183::US9822102, Example 183	Plasma kallikrein			 130					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246276	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246276&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622968	341104070							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429449	CCC(C(=O)Nc1ccc(C(O)=O)c(F)c1F)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C24H18ClF2N3O5/c1-3-18(23(32)29-17-7-6-14(24(33)34)21(26)22(17)27)30-11-19(35-2)16(9-20(30)31)15-8-13(25)5-4-12(15)10-28/h4-9,11,18H,3H2,1-2H3,(H,29,32)(H,33,34)	BSTJIMFCDNVZGR-UHFFFAOYSA-N	246278	US10183932, Example 184::US9434690, 184::US9822102, Example 184	Plasma kallikrein			 110					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246278	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246278&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622631	341104071							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429450	CCC(C(=O)Nc1ccc(cc1)-c1nsc(=O)[nH]1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N			246280	US10183932, Example 187::US9434690, 186::US9434690, 187::US9822102, Example 187	Plasma kallikrein			 31					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246280	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246280&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			129626919	341104073							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429451	CCC(C(=O)Nc1ccc(cc1)-c1noc(=S)[nH]1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N			246282	US10183932, Example 188::US9434690, 188::US9822102, Example 188	Plasma kallikrein			 31					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246282	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246282&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			129626920	341104074							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429452	CCC(C(=O)Nc1ccc(cc1)-c1ncon1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C25H20ClN5O4/c1-3-21(25(33)29-18-8-5-15(6-9-18)24-28-14-35-30-24)31-13-22(34-2)20(11-23(31)32)19-10-17(26)7-4-16(19)12-27/h4-11,13-14,21H,3H2,1-2H3,(H,29,33)	JIVAXRBOSDSXCF-UHFFFAOYSA-N	246284	US10183932, Example 190::US9434690, 190::US9822102, Example 190	Plasma kallikrein			 35					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246284	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246284&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117623031	341104076							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429453	CCC(C(=O)Nc1ccc(cc1)-c1nnc([nH]1)C(F)(F)C(F)(F)C(=O)OC)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N			246286	US10183932, Example 192::US9434690, 192::US9822102, Example 192	Plasma kallikrein			 61					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246286	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246286&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622636	341104078							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429454	CCC(C(=O)Nc1cc(F)c2c(c1)[nH][nH]c2=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C24H17ClFN5O4/c1-3-19(23(33)28-14-7-17(26)22-18(8-14)29-30-24(22)34)31-11-20(35-2)16(9-21(31)32)15-6-13(25)5-4-12(15)10-27/h4-9,11,19H,3H2,1-2H3,(H,28,33)	GKSXPUJAHJCWDQ-UHFFFAOYSA-N	246288	US10183932, Example 194::US9434690, 194::US9822102, Example 194	Plasma kallikrein			 6.3					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246288	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246288&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			129626921	341104080							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429455	CCC(C(=O)Nc1ccc2[nH]nc(Cl)c2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N			246290	US10183932, Example 196::US9434690, 196::US9822102, Example 196	Plasma kallikrein			 21					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246290	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246290&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622966	341104082							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429456	COc1cn(C(CC2CCS(=O)(=O)CC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C28H26ClN3O7S/c1-39-25-16-32(26(33)14-23(25)22-13-20(29)5-2-19(22)15-30)24(12-17-8-10-40(37,38)11-9-17)27(34)31-21-6-3-18(4-7-21)28(35)36/h2-7,13-14,16-17,24H,8-12H2,1H3,(H,31,34)(H,35,36)	PDHWFIGBHMGYOO-UHFFFAOYSA-N	246292	US10183932, Example 198::US9434690, 198::US9822102, Example 198	Plasma kallikrein			 39					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246292	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246292&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622799	341104084							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429457	OC(=O)c1ccc(NC(=O)C(C[C@@H]2CCCCO2)n2cc(Cl)c(cc2=O)-c2cc(Cl)ccc2C#N)cc1	InChI=1S/C27H23Cl2N3O5/c28-18-7-4-17(14-30)21(11-18)22-13-25(33)32(15-23(22)29)24(12-20-3-1-2-10-37-20)26(34)31-19-8-5-16(6-9-19)27(35)36/h4-9,11,13,15,20,24H,1-3,10,12H2,(H,31,34)(H,35,36)/t20-,24?/m0/s1	KBFYCDAOFYYRQQ-QHELBMECSA-N	246296	US10183932, Example 202::US9434690, 202::US9822102, Example 202	Plasma kallikrein			 82					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246296	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246296&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622964	341104086							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429458	COCc1n[nH]c(n1)-c1ccc(NC(=O)C(C)n2ccc(cc2=O)-c2cc(Cl)ccc2C#N)cc1			246098	US9434690, 3::US9822102, Example 3	Plasma kallikrein			 650					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246098	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246098&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118877955	341103947							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429459	CC(C(=O)Nc1ccc(cc1)-c1c[nH]cn1)n1ccc(cc1=O)-c1cc(Cl)ccc1C#N			246100	US10183932, Example 5::US9434690, 5::US9822102, Example 5	Plasma kallikrein			 330					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246100	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246100&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86297545	341103949							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429460	CC(C(=O)Nc1ccc(cc1)-c1cc(=O)[nH][nH]1)n1ccc(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C24H16ClN5O3/c1-14(24(33)27-19-6-3-15(4-7-19)21-12-22(31)29-28-21)30-9-8-16(10-23(30)32)20-11-18(25)5-2-17(20)13-26/h2-12,14H,1H3,(H,27,33)	MHOPKDGSPNBRDE-UHFFFAOYSA-N	246102	US10183932, Example 7::US9434690, 7::US9822102, Example 7	Plasma kallikrein			 220					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246102	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246102&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			129626901	341103951							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429461	CC(C(=O)Nc1ccc(cc1)C(O)=O)n1ccc(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C22H16ClN3O4/c1-13(21(28)25-18-6-3-14(4-7-18)22(29)30)26-9-8-15(10-20(26)27)19-11-17(23)5-2-16(19)12-24/h2-11,13H,1H3,(H,25,28)(H,29,30)	IVAMXDIDNRHTRD-UHFFFAOYSA-N	246104	US10183932, Example 9::US9434690, 9::US9822102, Example 9	Plasma kallikrein			 840					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246104	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246104&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622737	341103953							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429462	CC(C(=O)Nc1ccc2nc[nH]c2c1)n1ccc(cc1=O)-c1cc(Cl)ccc1C#N			246113	US10183932, Example 18::US9434690, 18::US9822102, Example 18	Plasma kallikrein			 490					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246113	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246113&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86297342	341103962							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429463	CC(C)C(C(=O)Nc1ccc(cc1)-c1nnn[nH]1)n1ccc(cc1=O)-c1cc(Cl)ccc1C#N			246117	US10183932, Example 22::US9434690, 22::US9822102, Example 22	Plasma kallikrein			 595					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246117	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246117&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622744	341103964							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429464	Clc1ccc(C#N)c(c1)-c1ccn(C(Cc2ccccc2)C(=O)Nc2ccc(cc2)-c2nnn[nH]2)c(=O)c1			246121	US10183932, Example 26::US9434690, 26::US9822102, Example 26	Plasma kallikrein			 67					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246121	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246121&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			129626904	341103968							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429465	OC(=O)c1ccc(NC(=O)C(Cc2cccnc2)n2ccc(cc2=O)-c2cc(Cl)ccc2C(F)(F)F)cc1	InChI=1S/C27H19ClF3N3O4/c28-19-5-8-22(27(29,30)31)21(14-19)18-9-11-34(24(35)13-18)23(12-16-2-1-10-32-15-16)25(36)33-20-6-3-17(4-7-20)26(37)38/h1-11,13-15,23H,12H2,(H,33,36)(H,37,38)	LODANOLKNFDNSD-UHFFFAOYSA-N	246123	US10183932, Example 28::US9434690, 28::US9822102, Example 28	Plasma kallikrein			 570					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246123	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246123&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622612	341103970							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429466	OC(=O)c1ccc(NC(=O)C(Cc2ccncc2)n2ccc(cc2=O)-c2cc(Cl)ccc2C(F)(F)F)cc1	InChI=1S/C27H19ClF3N3O4/c28-19-3-6-22(27(29,30)31)21(15-19)18-9-12-34(24(35)14-18)23(13-16-7-10-32-11-8-16)25(36)33-20-4-1-17(2-5-20)26(37)38/h1-12,14-15,23H,13H2,(H,33,36)(H,37,38)	VOEMZDCOWSMTBH-UHFFFAOYSA-N	246125	US10183932, Example 32::US9434690, 30::US9434690, 31::US9434690, 32::US9822102, Example 32	Plasma kallikrein			 620					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246125	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246125&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622752	341103972							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429467	OC(=O)c1ccc(NC(=O)C(Cc2ccncc2)n2ccc(cc2=O)-c2cc(Cl)ccc2Br)cc1	InChI=1S/C26H19BrClN3O4/c27-22-6-3-19(28)15-21(22)18-9-12-31(24(32)14-18)23(13-16-7-10-29-11-8-16)25(33)30-20-4-1-17(2-5-20)26(34)35/h1-12,14-15,23H,13H2,(H,30,33)(H,34,35)	NBSDLGUPVWYUGD-UHFFFAOYSA-N	246128	US10183932, Example 33::US9434690, 33::US9822102, Example 33	Plasma kallikrein			 320					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246128	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246128&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622617	341103973							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429468	CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(Cl)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C22H15Cl2N3O4/c1-12(21(29)26-16-6-3-13(4-7-16)22(30)31)27-11-19(24)18(9-20(27)28)17-8-15(23)5-2-14(17)10-25/h2-9,11-12H,1H3,(H,26,29)(H,30,31)	MYLKJUSMRUADNT-UHFFFAOYSA-N	246130	US10183932, Example 37::US9434690, 35::US9434690, 36::US9434690, 37::US9822102, Example 37	Plasma kallikrein			 510					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246130	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246130&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622690	341103975							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429469	CC(C(=O)Nc1ccc(C(O)=O)c(F)c1)n1cc(Cl)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C22H14Cl2FN3O4/c1-11(21(30)27-14-4-5-15(22(31)32)19(25)7-14)28-10-18(24)17(8-20(28)29)16-6-13(23)3-2-12(16)9-26/h2-8,10-11H,1H3,(H,27,30)(H,31,32)	IAFAJANRVZTTGY-UHFFFAOYSA-N	246135	US10183932, Example 40::US9434690, 40::US9822102, Example 40	Plasma kallikrein			 550					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246135	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246135&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622831	341103978							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429470	CC(C(=O)Nc1ccc(cc1)-c1cc(=O)[nH][nH]1)n1cc(Cl)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C24H15Cl2N5O3/c1-13(24(34)28-17-6-3-14(4-7-17)21-10-22(32)30-29-21)31-12-20(26)19(9-23(31)33)18-8-16(25)5-2-15(18)11-27/h2-10,12-13H,1H3,(H,28,34)	AXABJGPJVKQRBN-UHFFFAOYSA-N	246137	US10183932, Example 42::US9434690, 42::US9822102, Example 42	Plasma kallikrein			 110					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246137	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246137&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			129626905	341103980							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429471	CC(C(=O)Nc1ccc2nc([nH]c2c1)C(F)(F)F)n1cc(Cl)c(cc1=O)-c1cc(Cl)ccc1C#N			246139	US10183932, Example 44::US9434690, 44::US9822102, Example 44	Plasma kallikrein			 140					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246139	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246139&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622619	341103982							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429472	OC(=O)c1ccc(NC(=O)C(CC2CC2)n2cc(Cl)c(cc2=O)-c2cc(Cl)ccc2C#N)cc1	InChI=1S/C25H19Cl2N3O4/c26-17-6-3-16(12-28)19(10-17)20-11-23(31)30(13-21(20)27)22(9-14-1-2-14)24(32)29-18-7-4-15(5-8-18)25(33)34/h3-8,10-11,13-14,22H,1-2,9H2,(H,29,32)(H,33,34)	APZJTXHPPDAWRM-UHFFFAOYSA-N	246140	US10183932, Example 47::US9434690, 45::US9434690, 46::US9434690, 47::US9822102, Example 47	Plasma kallikrein			 150					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246140	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246140&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622732	341103983							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429473	COc1cn(C(C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C23H18ClN3O5/c1-13(22(29)26-17-7-4-14(5-8-17)23(30)31)27-12-20(32-2)19(10-21(27)28)18-9-16(24)6-3-15(18)11-25/h3-10,12-13H,1-2H3,(H,26,29)(H,30,31)	MPSQYCLTAAEIDL-UHFFFAOYSA-N	246150	US10183932, Example 57::US9434690, 55::US9434690, 56::US9434690, 57::US9822102, Example 57	Plasma kallikrein			 17					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246150	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246150&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622624	341103991							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429474	COc1cn(C(CC2CC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C26H22ClN3O5/c1-35-23-14-30(24(31)12-21(23)20-11-18(27)7-4-17(20)13-28)22(10-15-2-3-15)25(32)29-19-8-5-16(6-9-19)26(33)34/h4-9,11-12,14-15,22H,2-3,10H2,1H3,(H,29,32)(H,33,34)	YEOQEAASRZWJNV-UHFFFAOYSA-N	246154	US10183932, Example 60::US9434690, 59::US9434690, 60::US9822102, Example 60	Plasma kallikrein			 15.5					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246154	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246154&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622901	341103993							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429475	COc1cn(C(CC(C)C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C26H24ClN3O5/c1-15(2)10-22(25(32)29-19-8-5-16(6-9-19)26(33)34)30-14-23(35-3)21(12-24(30)31)20-11-18(27)7-4-17(20)13-28/h4-9,11-12,14-15,22H,10H2,1-3H3,(H,29,32)(H,33,34)	PDLAMRDOLIUATC-UHFFFAOYSA-N	246158	US10183932, Example 65::US9434690, 63::US9434690, 64::US9434690, 65::US9822102, Example 65	Plasma kallikrein			 67					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246158	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246158&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622627	341103996							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429476	CCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C24H20ClN3O5/c1-3-20(23(30)27-17-8-5-14(6-9-17)24(31)32)28-13-21(33-2)19(11-22(28)29)18-10-16(25)7-4-15(18)12-26/h4-11,13,20H,3H2,1-2H3,(H,27,30)(H,31,32)	HUXWVMXMMHUYLB-UHFFFAOYSA-N	246161	US10183932, Example 140::US9434690, 140::US9434690, 66::US9434690, 67::US9434690, 68::US9822102, Example 140	Plasma kallikrein			 31					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246161	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246161&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622754	341103997							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429477	CCC(C(=O)Nc1ccc(cc1)-c1cc(=O)[nH][nH]1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C26H20ClN5O4/c1-3-22(26(35)29-18-8-5-15(6-9-18)21-12-24(33)31-30-21)32-14-23(36-2)20(11-25(32)34)19-10-17(27)7-4-16(19)13-28/h4-12,14,22H,3H2,1-2H3,(H,29,35)	UBQSSKXXBQWBRF-UHFFFAOYSA-N	246164	US10183932, Example 69::US9434690, 69::US9822102, Example 69	Plasma kallikrein			 11					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246164	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246164&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			129626907	341103998							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429478	CCC(C(=O)Nc1ccc2[nH]c(=O)[nH]c2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C24H18ClN5O4/c1-3-20(23(32)27-15-6-7-18-19(9-15)29-24(33)28-18)30-12-21(34-2)17(10-22(30)31)16-8-14(25)5-4-13(16)11-26/h4-10,12,20H,3H2,1-2H3,(H,27,32)	MYCQSHUBJLXZMN-UHFFFAOYSA-N	246166	US10183932, Example 71::US9434690, 71::US9822102, Example 71	Plasma kallikrein			 17					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246166	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246166&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			129626909	341104000							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429479	CCC(C(=O)Nc1ccc2nc([nH]c2c1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N			246168	US10183932, Example 73::US9434690, 73::US9822102, Example 73	Plasma kallikrein			 16					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246168	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246168&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622919	341104002							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429480	CCC(C(=O)Nc1ccc2[nH]c(cc2c1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N			246170	US10183932, Example 75::US9434690, 75::US9822102, Example 75	Plasma kallikrein			 28					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246170	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246170&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622951	341104004							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429481	COCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C25H22ClN3O6/c1-34-10-9-21(24(31)28-18-7-4-15(5-8-18)25(32)33)29-14-22(35-2)20(12-23(29)30)19-11-17(26)6-3-16(19)13-27/h3-8,11-12,14,21H,9-10H2,1-2H3,(H,28,31)(H,32,33)	XAYFQGTYMRMPAS-UHFFFAOYSA-N	246171	US10183932, Example 78::US9434690, 76::US9434690, 77::US9434690, 78::US9822102, Example 78	Plasma kallikrein			 4.1					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246171	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246171&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86297748	341104005							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429482	CO[C@@H](C)CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C26H24ClN3O6/c1-15(35-2)10-22(25(32)29-19-8-5-16(6-9-19)26(33)34)30-14-23(36-3)21(12-24(30)31)20-11-18(27)7-4-17(20)13-28/h4-9,11-12,14-15,22H,10H2,1-3H3,(H,29,32)(H,33,34)/t15-,22?/m0/s1	DYNSAJCVHKUDFF-UEDXYCIISA-N	246174	US10183932, Example 81::US9434690, 79::US9434690, 80::US9434690, 81::US9822102, Example 81	Plasma kallikrein			 7.6					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246174	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246174&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118877945	341104006							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429483	CO[C@H](C)CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C26H24ClN3O6/c1-15(35-2)10-22(25(32)29-19-8-5-16(6-9-19)26(33)34)30-14-23(36-3)21(12-24(30)31)20-11-18(27)7-4-17(20)13-28/h4-9,11-12,14-15,22H,10H2,1-3H3,(H,29,32)(H,33,34)/t15-,22?/m1/s1	DYNSAJCVHKUDFF-JGHKVMFLSA-N	246177	US10183932, Example 83::US9434690, 82::US9434690, 83::US9822102, Example 83	Plasma kallikrein			 15					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246177	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246177&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118877889	341104007							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429484	COc1cn(C(C[C@H]2CCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C27H24ClN3O6/c1-36-24-15-31(25(32)13-22(24)21-11-18(28)7-4-17(21)14-29)23(12-20-3-2-10-37-20)26(33)30-19-8-5-16(6-9-19)27(34)35/h4-9,11,13,15,20,23H,2-3,10,12H2,1H3,(H,30,33)(H,34,35)/t20-,23?/m1/s1	AETBCOOBUYAHJM-PPUHSXQSSA-N	246179	US10183932, Example 86::US9434690, 84::US9434690, 85::US9434690, 86::US9822102, Example 86	Plasma kallikrein			 16.5					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246179	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246179&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622620	341104008							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429485	COc1cn(C(C[C@@H]2CCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C27H24ClN3O6/c1-36-24-15-31(25(32)13-22(24)21-11-18(28)7-4-17(21)14-29)23(12-20-3-2-10-37-20)26(33)30-19-8-5-16(6-9-19)27(34)35/h4-9,11,13,15,20,23H,2-3,10,12H2,1H3,(H,30,33)(H,34,35)/t20-,23?/m0/s1	AETBCOOBUYAHJM-AJZOCDQUSA-N	246182	US10183932, Example 89::US9434690, 87::US9434690, 88::US9434690, 89::US9822102, Example 89	Plasma kallikrein			 7.9					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246182	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246182&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118877947	341104009							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429486	COc1cn(C(CC2CCOC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C27H24ClN3O6/c1-36-24-14-31(25(32)12-22(24)21-11-19(28)5-2-18(21)13-29)23(10-16-8-9-37-15-16)26(33)30-20-6-3-17(4-7-20)27(34)35/h2-7,11-12,14,16,23H,8-10,15H2,1H3,(H,30,33)(H,34,35)	UPJPTNTVAMVKSD-UHFFFAOYSA-N	246185	US10183932, Example 93::US9434690, 90::US9434690, 91::US9434690, 92::US9434690, 93::US9822102, Example 93	Plasma kallikrein			 54					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246185	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246185&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86297749	341104010							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429487	COc1cn(C(CC2CCOC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C27H24ClN3O6/c1-36-24-14-31(25(32)12-22(24)21-11-19(28)5-2-18(21)13-29)23(10-16-8-9-37-15-16)26(33)30-20-6-3-17(4-7-20)27(34)35/h2-7,11-12,14,16,23H,8-10,15H2,1H3,(H,30,33)(H,34,35)	UPJPTNTVAMVKSD-UHFFFAOYSA-N	246185	US10183932, Example 93::US9434690, 90::US9434690, 91::US9434690, 92::US9434690, 93::US9822102, Example 93	Plasma kallikrein			 18					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246185	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246185&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86297749	341104010							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429488	COc1cn(C(CC2CCOCC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C28H26ClN3O6/c1-37-25-16-32(26(33)14-23(25)22-13-20(29)5-2-19(22)15-30)24(12-17-8-10-38-11-9-17)27(34)31-21-6-3-18(4-7-21)28(35)36/h2-7,13-14,16-17,24H,8-12H2,1H3,(H,31,34)(H,35,36)	BMRPDPXXIHCBMO-UHFFFAOYSA-N	246189	US10183932, Example 96::US9434690, 94::US9434690, 95::US9434690, 96::US9822102, Example 96	Plasma kallikrein			 19					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246189	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246189&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86297750	341104011							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429489	COc1cn(C(CC2CCCOC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C28H26ClN3O6/c1-37-25-15-32(26(33)13-23(25)22-12-20(29)7-4-19(22)14-30)24(11-17-3-2-10-38-16-17)27(34)31-21-8-5-18(6-9-21)28(35)36/h4-9,12-13,15,17,24H,2-3,10-11,16H2,1H3,(H,31,34)(H,35,36)	SNVIVXDTJLCEGY-UHFFFAOYSA-N	246192	US10183932, Example 100::US9434690, 100::US9434690, 97::US9434690, 98::US9434690, 99::US9822102, Example 100	Plasma kallikrein			 15					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246192	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246192&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622761	341104012							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429490	COc1cn(C(CC2CCCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C28H26ClN3O6/c1-37-25-16-32(26(33)14-23(25)22-12-19(29)8-5-18(22)15-30)24(13-21-4-2-3-11-38-21)27(34)31-20-9-6-17(7-10-20)28(35)36/h5-10,12,14,16,21,24H,2-4,11,13H2,1H3,(H,31,34)(H,35,36)	WVQIDDPAQZTNTF-UHFFFAOYSA-N	246196	US10183932, Example 105::US9434690, 101::US9434690, 102::US9434690, 103::US9434690, 104::US9434690, 105::US9822102, Example 105	Plasma kallikrein			 5.9					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246196	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246196&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622618	341104013							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429491	COc1cn(C(CC2CCCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C28H26ClN3O6/c1-37-25-16-32(26(33)14-23(25)22-12-19(29)8-5-18(22)15-30)24(13-21-4-2-3-11-38-21)27(34)31-20-9-6-17(7-10-20)28(35)36/h5-10,12,14,16,21,24H,2-4,11,13H2,1H3,(H,31,34)(H,35,36)	WVQIDDPAQZTNTF-UHFFFAOYSA-N	246196	US10183932, Example 105::US9434690, 101::US9434690, 102::US9434690, 103::US9434690, 104::US9434690, 105::US9822102, Example 105	Plasma kallikrein			 13					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246196	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246196&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622618	341104013							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429492	COc1cn(C(CCF)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C24H19ClFN3O5/c1-34-21-13-29(22(30)11-19(21)18-10-16(25)5-2-15(18)12-27)20(8-9-26)23(31)28-17-6-3-14(4-7-17)24(32)33/h2-7,10-11,13,20H,8-9H2,1H3,(H,28,31)(H,32,33)	UUJSOQRGXUGTOX-UHFFFAOYSA-N	246202	US10183932, Example 107::US9434690, 107::US9822102, Example 107	Plasma kallikrein			 56					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246202	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246202&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86297751	341104015							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429493	COc1cn(C(CC(F)(F)F)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C24H17ClF3N3O5/c1-36-20-12-31(21(32)9-18(20)17-8-15(25)5-2-14(17)11-29)19(10-24(26,27)28)22(33)30-16-6-3-13(4-7-16)23(34)35/h2-9,12,19H,10H2,1H3,(H,30,33)(H,34,35)	JTNKIBBMWHFHLA-UHFFFAOYSA-N	246204	US10183932, Example 109::US9434690, 109::US9822102, Example 109	Plasma kallikrein			 220					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246204	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246204&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622628	341104017							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429494	COc1cn(C(CC(C)C(F)(F)F)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C26H21ClF3N3O5/c1-14(26(28,29)30)9-21(24(35)32-18-7-4-15(5-8-18)25(36)37)33-13-22(38-2)20(11-23(33)34)19-10-17(27)6-3-16(19)12-31/h3-8,10-11,13-14,21H,9H2,1-2H3,(H,32,35)(H,36,37)	BHOCMFJOQHDNNX-UHFFFAOYSA-N	246206	US10183932, Example 111::US9434690, 111::US9822102, Example 111	Plasma kallikrein			 220					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246206	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246206&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117623008	341104019							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429495	COc1cn(C(CC2CC2(F)F)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C26H20ClF2N3O5/c1-37-22-13-32(23(33)10-20(22)19-9-17(27)5-2-15(19)12-30)21(8-16-11-26(16,28)29)24(34)31-18-6-3-14(4-7-18)25(35)36/h2-7,9-10,13,16,21H,8,11H2,1H3,(H,31,34)(H,35,36)	PPOMRFJZWPHFPA-UHFFFAOYSA-N	246208	US10183932, Example 115::US9434690, 113::US9434690, 114::US9434690, 115::US9822102, Example 115	Plasma kallikrein			 39					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246208	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246208&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86297949	341104021							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429496	COc1cn(C(CC2(C)CC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C27H24ClN3O5/c1-27(9-10-27)13-22(25(33)30-19-7-4-16(5-8-19)26(34)35)31-15-23(36-2)21(12-24(31)32)20-11-18(28)6-3-17(20)14-29/h3-8,11-12,15,22H,9-10,13H2,1-2H3,(H,30,33)(H,34,35)	DCFGHORVDDAJPY-UHFFFAOYSA-N	246211	US10183932, Example 116::US9434690, 116::US9822102, Example 116	Plasma kallikrein			 11					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246211	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246211&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622788	341104022							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429497	CCOC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C24H20ClN3O6/c1-3-34-23(22(30)27-17-8-5-14(6-9-17)24(31)32)28-13-20(33-2)19(11-21(28)29)18-10-16(25)7-4-15(18)12-26/h4-11,13,23H,3H2,1-2H3,(H,27,30)(H,31,32)	MUNUHSGUPNMRDO-UHFFFAOYSA-N	246213	US10183932, Example 118::US9434690, 118::US9822102, Example 118	Plasma kallikrein			 210					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246213	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246213&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117623009	341104024							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429498	COc1cn(C(C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1Br	InChI=1S/C22H18BrClN2O5/c1-12(21(28)25-15-6-3-13(4-7-15)22(29)30)26-11-19(31-2)17(10-20(26)27)16-9-14(24)5-8-18(16)23/h3-12H,1-2H3,(H,25,28)(H,29,30)	BZZDCJXMIRUBDL-UHFFFAOYSA-N	246216	US10183932, Example 121::US9434690, 121::US9822102, Example 121	Plasma kallikrein			 220					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246216	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246216&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86297951	341104027							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429499	COc1cn(C(C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C(F)(F)F	InChI=1S/C23H18ClF3N2O5/c1-12(21(31)28-15-6-3-13(4-7-15)22(32)33)29-11-19(34-2)17(10-20(29)30)16-9-14(24)5-8-18(16)23(25,26)27/h3-12H,1-2H3,(H,28,31)(H,32,33)	AHLPDNRPHFMHAO-UHFFFAOYSA-N	246218	US10183932, Example 123::US9434690, 123::US9822102, Example 123	Plasma kallikrein			 1100					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246218	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246218&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622932	341104029							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429500	COc1cn(C(CCO)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C24H20ClN3O6/c1-34-21-13-28(22(30)11-19(21)18-10-16(25)5-2-15(18)12-26)20(8-9-29)23(31)27-17-6-3-14(4-7-17)24(32)33/h2-7,10-11,13,20,29H,8-9H2,1H3,(H,27,31)(H,32,33)	BKTRHZIMQRNWEQ-UHFFFAOYSA-N	246221	US10183932, Example 126::US9434690, 126::US9822102, Example 126	Plasma kallikrein			 64					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246221	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246221&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622878	341104032							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429501	CCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1OC(F)F	InChI=1S/C24H21ClF2N2O6/c1-3-18(22(31)28-15-7-4-13(5-8-15)23(32)33)29-12-20(34-2)17(11-21(29)30)16-10-14(25)6-9-19(16)35-24(26)27/h4-12,18,24H,3H2,1-2H3,(H,28,31)(H,32,33)	BGDFMSJIOCVRBT-UHFFFAOYSA-N	246223	US10183932, Example 128::US9434690, 128::US9822102, Example 128	Plasma kallikrein			 180					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246223	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246223&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622790	341104034							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429502	CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC(F)F)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C23H16ClF2N3O5/c1-12(21(31)28-16-6-3-13(4-7-16)22(32)33)29-11-19(34-23(25)26)18(9-20(29)30)17-8-15(24)5-2-14(17)10-27/h2-9,11-12,23H,1H3,(H,28,31)(H,32,33)	XEVLNKRJTMYBIC-UHFFFAOYSA-N	246225	US10183932, Example 130::US9434690, 130::US9822102, Example 130	Plasma kallikrein			 1300					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246225	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246225&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622897	341104036							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429503	COc1cn(C(CC2CCC(O)CC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C29H28ClN3O6/c1-39-26-16-33(27(35)14-24(26)23-13-20(30)7-4-19(23)15-31)25(12-17-2-10-22(34)11-3-17)28(36)32-21-8-5-18(6-9-21)29(37)38/h4-9,13-14,16-17,22,25,34H,2-3,10-12H2,1H3,(H,32,36)(H,37,38)	CJNBXUGWBBVSDD-UHFFFAOYSA-N	246227	US10183932, Example 135::US9434690, 132::US9434690, 133::US9434690, 134::US9434690, 135::US9822102, Example 135	Plasma kallikrein			 5.8					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246227	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246227&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86298154	341104038							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429504	COc1cn(C(CCOC(F)(F)F)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C25H19ClF3N3O6/c1-37-21-13-32(22(33)11-19(21)18-10-16(26)5-2-15(18)12-30)20(8-9-38-25(27,28)29)23(34)31-17-6-3-14(4-7-17)24(35)36/h2-7,10-11,13,20H,8-9H2,1H3,(H,31,34)(H,35,36)	YNXCWDXRPDZZLO-UHFFFAOYSA-N	246231	US10183932, Example 138::US9434690, 136::US9434690, 137::US9434690, 138::US9822102, Example 138	Plasma kallikrein			 9.4					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246231	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246231&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622873	341104039							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429505	CCC1(CC(C(=O)Nc2ccc(cc2)-c2noc(=O)[nH]2)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2C#N)COC1			246234	US10183932, Example 139::US9434690, 139::US9822102, Example 139	Plasma kallikrein			 9.4					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246234	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246234&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			129626910	341104040							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429506	CCC(CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N)OC	InChI=1S/C27H26ClN3O6/c1-4-20(36-2)12-23(26(33)30-19-9-6-16(7-10-19)27(34)35)31-15-24(37-3)22(13-25(31)32)21-11-18(28)8-5-17(21)14-29/h5-11,13,15,20,23H,4,12H2,1-3H3,(H,30,33)(H,34,35)	NWTLKQWFPQKMLC-UHFFFAOYSA-N	246220	US10183932, Example 144::US9434690, 125::US9434690, 141::US9434690, 142::US9434690, 143::US9434690, 144::US9822102, Example 144	Plasma kallikrein			 1600					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246220	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246220&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86297952	341104031							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429507	CCC(CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N)OC	InChI=1S/C27H26ClN3O6/c1-4-20(36-2)12-23(26(33)30-19-9-6-16(7-10-19)27(34)35)31-15-24(37-3)22(13-25(31)32)21-11-18(28)8-5-17(21)14-29/h5-11,13,15,20,23H,4,12H2,1-3H3,(H,30,33)(H,34,35)	NWTLKQWFPQKMLC-UHFFFAOYSA-N	246220	US10183932, Example 144::US9434690, 125::US9434690, 141::US9434690, 142::US9434690, 143::US9434690, 144::US9822102, Example 144	Plasma kallikrein			 4.6					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246220	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246220&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86297952	341104031							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429508	COc1cn(C(CC2(CC2)C(F)(F)F)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C27H21ClF3N3O5/c1-39-22-14-34(23(35)11-20(22)19-10-17(28)5-2-16(19)13-32)21(12-26(8-9-26)27(29,30)31)24(36)33-18-6-3-15(4-7-18)25(37)38/h2-7,10-11,14,21H,8-9,12H2,1H3,(H,33,36)(H,37,38)	PNSIVGGUCOLACI-UHFFFAOYSA-N	246239	US10183932, Example 147::US9434690, 145::US9434690, 146::US9434690, 147::US9822102, Example 147	Plasma kallikrein			 98					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246239	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246239&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86298155	341104041							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429509	COc1cn(C(CC2(CC2)C(F)(F)F)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C27H21ClF3N3O5/c1-39-22-14-34(23(35)11-20(22)19-10-17(28)5-2-16(19)13-32)21(12-26(8-9-26)27(29,30)31)24(36)33-18-6-3-15(4-7-18)25(37)38/h2-7,10-11,14,21H,8-9,12H2,1H3,(H,33,36)(H,37,38)	PNSIVGGUCOLACI-UHFFFAOYSA-N	246239	US10183932, Example 147::US9434690, 145::US9434690, 146::US9434690, 147::US9822102, Example 147	Plasma kallikrein			 70					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246239	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246239&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86298155	341104041							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429510	COc1cn(C(CC2CC(F)(F)C2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C27H22ClF2N3O5/c1-38-23-14-33(24(34)10-21(23)20-9-18(28)5-2-17(20)13-31)22(8-15-11-27(29,30)12-15)25(35)32-19-6-3-16(4-7-19)26(36)37/h2-7,9-10,14-15,22H,8,11-12H2,1H3,(H,32,35)(H,36,37)	IIHVYKJYWMUBJC-UHFFFAOYSA-N	246243	US10183932, Example 149::US9434690, 149::US9822102, Example 149	Plasma kallikrein			 27					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246243	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246243&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622900	341104043							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429511	COc1cn(C(CC2(C)CCOCC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C29H28ClN3O6/c1-29(9-11-39-12-10-29)15-24(27(35)32-21-7-4-18(5-8-21)28(36)37)33-17-25(38-2)23(14-26(33)34)22-13-20(30)6-3-19(22)16-31/h3-8,13-14,17,24H,9-12,15H2,1-2H3,(H,32,35)(H,36,37)	PAESNLCGOZMSMT-UHFFFAOYSA-N	246245	US10183932, Example 151::US9434690, 151::US9822102, Example 151	Plasma kallikrein			 110					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246245	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246245&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117623020	341104045							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429512	CO[C@@H]1CC[C@H](CC(C(=O)Nc2ccc(cc2)C(O)=O)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2C#N)CC1	InChI=1S/C30H30ClN3O6/c1-39-23-11-3-18(4-12-23)13-26(29(36)33-22-9-6-19(7-10-22)30(37)38)34-17-27(40-2)25(15-28(34)35)24-14-21(31)8-5-20(24)16-32/h5-10,14-15,17-18,23,26H,3-4,11-13H2,1-2H3,(H,33,36)(H,37,38)/t18-,23+,26?	LARGKTWCHAEXEF-CIGLETDBSA-N	246246	US10183932, Example 154::US9434690, 152::US9434690, 153::US9434690, 154::US9822102, Example 154	Plasma kallikrein			 45					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246246	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246246&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622774	341104046							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429513	CO[C@H]1CC[C@H](CC(C(=O)Nc2ccc(cc2)C(O)=O)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2C#N)CC1	InChI=1S/C30H30ClN3O6/c1-39-23-11-3-18(4-12-23)13-26(29(36)33-22-9-6-19(7-10-22)30(37)38)34-17-27(40-2)25(15-28(34)35)24-14-21(31)8-5-20(24)16-32/h5-10,14-15,17-18,23,26H,3-4,11-13H2,1-2H3,(H,33,36)(H,37,38)/t18-,23-,26?	LARGKTWCHAEXEF-QDTYANCNSA-N	246249	US10183932, Example 157::US9434690, 155::US9434690, 156::US9434690, 157::US9822102, Example 157	Plasma kallikrein			 5.2					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246249	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246249&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622774	341104047							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429514	COc1cn(C(CC2CCC2)C(=O)Nc2ccc3c(c2)[nH]n(C)c3=O)c(=O)cc1-c1cc(Cl)ccc1C#N			246253	US10183932, Example 159::US9434690, 159::US9822102, Example 159	Plasma kallikrein			 16					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246253	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246253&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			129626911	341104049							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429515	COc1cn(C(C(C)C)C(=O)Nc2ccc(C(O)=O)c(C)c2)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C26H24ClN3O5/c1-14(2)24(25(32)29-18-7-8-19(26(33)34)15(3)9-18)30-13-22(35-4)21(11-23(30)31)20-10-17(27)6-5-16(20)12-28/h5-11,13-14,24H,1-4H3,(H,29,32)(H,33,34)	ZYWDBAHJEMNANX-UHFFFAOYSA-N	246255	US10183932, Example 161::US9434690, 161::US9822102, Example 161	Plasma kallikrein			 1500					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246255	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246255&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622965	341104051							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429516	COCCC(C(=O)Nc1ccc2[nH]c(=O)[nH]c2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C25H20ClN5O5/c1-35-8-7-21(24(33)28-16-5-6-19-20(10-16)30-25(34)29-19)31-13-22(36-2)18(11-23(31)32)17-9-15(26)4-3-14(17)12-27/h3-6,9-11,13,21H,7-8H2,1-2H3,(H,28,33)	LVYGLUYPTDVDIW-UHFFFAOYSA-N	246257	US10183932, Example 163::US9434690, 163::US9822102, Example 163	Plasma kallikrein			 3.6					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246257	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246257&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			129626912	341104053							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429517	COCCC(C(=O)Nc1ccc2c(c1)[nH]n(C)c2=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N			246259	US10183932, Example 165::US9434690, 165::US9822102, Example 165	Plasma kallikrein			 8.2					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246259	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246259&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			129626914	341104055							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429518	COCCC(C(=O)Nc1ccc2[nH]nc(Cl)c2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N			246261	US10183932, Example 167::US9434690, 167::US9822102, Example 167	Plasma kallikrein			 8.4					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246261	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246261&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			129626916	341104057							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429519	COCCC(C(=O)Nc1cc2[nH]c(cc2cc1OC)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N			246263	US10183932, Example 169::US9434690, 169::US9822102, Example 169	Plasma kallikrein			 54					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246263	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246263&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622918	341104059							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429520	OC(=O)c1ccc(NC(=O)C(CCOC(F)(F)F)n2cc(Cl)c(cc2=O)-c2cc(Cl)ccc2C#N)cc1	InChI=1S/C24H16Cl2F3N3O5/c25-15-4-1-14(11-30)17(9-15)18-10-21(33)32(12-19(18)26)20(7-8-37-24(27,28)29)22(34)31-16-5-2-13(3-6-16)23(35)36/h1-6,9-10,12,20H,7-8H2,(H,31,34)(H,35,36)	AHPKGYGFEFPFAF-UHFFFAOYSA-N	246265	US10183932, Example 171::US9434690, 171::US9822102, Example 171	Plasma kallikrein			 89					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246265	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246265&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622783	341104061							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429521	COCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1OC(F)F	InChI=1S/C25H23ClF2N2O7/c1-35-10-9-19(23(32)29-16-6-3-14(4-7-16)24(33)34)30-13-21(36-2)18(12-22(30)31)17-11-15(26)5-8-20(17)37-25(27)28/h3-8,11-13,19,25H,9-10H2,1-2H3,(H,29,32)(H,33,34)	BRLSWNMQGWOZIZ-UHFFFAOYSA-N	246267	US10183932, Example 173::US9434690, 173::US9822102, Example 173	Plasma kallikrein			 54					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246267	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246267&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622938	341104063							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429522	COCCC(C(=O)Nc1ccc2[nH]c(=O)[nH]c2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1OC(F)F	InChI=1S/C25H21ClF2N4O6/c1-36-8-7-19(23(34)29-14-4-5-17-18(10-14)31-25(35)30-17)32-12-21(37-2)16(11-22(32)33)15-9-13(26)3-6-20(15)38-24(27)28/h3-6,9-12,19,24H,7-8H2,1-2H3,(H,29,34)	NKCAKTVAUQJXMR-UHFFFAOYSA-N	246269	US10183932, Example 175::US9434690, 175::US9822102, Example 175	Plasma kallikrein			 20					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246269	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246269&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			129626918	341104065							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429523	COc1cn(C(C[C@H]2CCCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1OC(F)F	InChI=1S/C28H27ClF2N2O7/c1-38-24-15-33(25(34)14-21(24)20-12-17(29)7-10-23(20)40-28(30)31)22(13-19-4-2-3-11-39-19)26(35)32-18-8-5-16(6-9-18)27(36)37/h5-10,12,14-15,19,22,28H,2-4,11,13H2,1H3,(H,32,35)(H,36,37)/t19-,22?/m1/s1	OTYWURKUSAPCDC-LCQOSCCDSA-N	246271	US10183932, Example 177::US9434690, 177::US9822102, Example 177	Plasma kallikrein			 120					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246271	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246271&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622940	341104067							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429524	CCC(C(=O)Nc1ccc(C(O)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C24H19ClFN3O5/c1-3-20(23(31)28-15-6-7-16(24(32)33)19(26)9-15)29-12-21(34-2)18(10-22(29)30)17-8-14(25)5-4-13(17)11-27/h4-10,12,20H,3H2,1-2H3,(H,28,31)(H,32,33)	LRTKHAKNKDKNGN-UHFFFAOYSA-N	246272	US10183932, Example 179::US9434690, 178::US9434690, 179::US9822102, Example 179	Plasma kallikrein			 24					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246272	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246272&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622926	341104068							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429525	CCC(C(=O)Nc1ccc(cc1F)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C24H19ClFN3O5/c1-3-20(23(31)28-19-7-5-13(24(32)33)8-18(19)26)29-12-21(34-2)17(10-22(29)30)16-9-15(25)6-4-14(16)11-27/h4-10,12,20H,3H2,1-2H3,(H,28,31)(H,32,33)	JXWVATDLTXDPIQ-UHFFFAOYSA-N	246274	US10183932, Example 181::US9434690, 180::US9434690, 181::US9822102, Example 181	Plasma kallikrein			 45					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246274	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246274&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622633	341104069							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429526	CCC(C(=O)Nc1cc(F)c(cc1F)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C24H18ClF2N3O5/c1-3-20(23(32)29-19-9-17(26)16(24(33)34)7-18(19)27)30-11-21(35-2)15(8-22(30)31)14-6-13(25)5-4-12(14)10-28/h4-9,11,20H,3H2,1-2H3,(H,29,32)(H,33,34)	ZVXCULUAQHRZBD-UHFFFAOYSA-N	246276	US10183932, Example 183::US9434690, 182::US9434690, 183::US9822102, Example 183	Plasma kallikrein			 62					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246276	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246276&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622968	341104070							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429527	CCC(C(=O)Nc1cc(F)c(C(O)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C24H18ClF2N3O5/c1-3-19(23(32)29-14-7-17(26)22(24(33)34)18(27)8-14)30-11-20(35-2)16(9-21(30)31)15-6-13(25)5-4-12(15)10-28/h4-9,11,19H,3H2,1-2H3,(H,29,32)(H,33,34)	UALXRLIAFKMVEE-UHFFFAOYSA-N	246279	US10183932, Example 185::US9434690, 185::US9822102, Example 185	Plasma kallikrein			 40					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246279	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246279&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622950	341104072							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429528	CCC(C(=O)Nc1ccc(cc1)-c1nsc(=O)[nH]1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N			246280	US10183932, Example 187::US9434690, 186::US9434690, 187::US9822102, Example 187	Plasma kallikrein			 14					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246280	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246280&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			129626919	341104073							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429529	CCC(C(=O)Nc1ccc(cc1)-c1ncco1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C26H21ClN4O4/c1-3-22(25(33)30-19-8-5-16(6-9-19)26-29-10-11-35-26)31-15-23(34-2)21(13-24(31)32)20-12-18(27)7-4-17(20)14-28/h4-13,15,22H,3H2,1-2H3,(H,30,33)	WOVKYOZMJFJOLI-UHFFFAOYSA-N	246283	US10183932, Example 189::US9434690, 189::US9822102, Example 189	Plasma kallikrein			 63					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246283	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246283&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622969	341104075							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429530	CCC(C(=O)Nc1ccc(cc1)-c1nnc(C)o1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C26H22ClN5O4/c1-4-22(25(34)29-19-9-6-16(7-10-19)26-31-30-15(2)36-26)32-14-23(35-3)21(12-24(32)33)20-11-18(27)8-5-17(20)13-28/h5-12,14,22H,4H2,1-3H3,(H,29,34)	IWJPZYSOUYLTNJ-UHFFFAOYSA-N	246285	US10183932, Example 191::US9434690, 191::US9822102, Example 191	Plasma kallikrein			 35					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246285	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246285&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622798	341104077							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429531	CCC(C(=O)Nc1ccc(cc1)-c1nnc([nH]1)C(F)(F)C(F)(F)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N			246287	US10183932, Example 193::US9434690, 193::US9822102, Example 193	Plasma kallikrein			 46					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246287	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246287&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622923	341104079							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429532	CCC(C(=O)Nc1ccc2c(n[nH]c2c1)C(F)(F)F)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N			246289	US10183932, Example 195::US9434690, 195::US9822102, Example 195	Plasma kallikrein			 59					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246289	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246289&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118877926	341104081							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429533	CCC(C(=O)Nc1ccc2[nH]ncc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N			246291	US10183932, Example 197::US9434690, 197::US9822102, Example 197	Plasma kallikrein			 10					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246291	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246291&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622970	341104083							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429534	COc1cn(C(C[C@@H]2CCCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1OC(F)F	InChI=1S/C28H27ClF2N2O7/c1-38-24-15-33(25(34)14-21(24)20-12-17(29)7-10-23(20)40-28(30)31)22(13-19-4-2-3-11-39-19)26(35)32-18-8-5-16(6-9-18)27(36)37/h5-10,12,14-15,19,22,28H,2-4,11,13H2,1H3,(H,32,35)(H,36,37)/t19-,22?/m0/s1	OTYWURKUSAPCDC-YDNXMHBPSA-N	246293	US10183932, Example 199::US9434690, 199::US9822102, Example 199	Plasma kallikrein			 34					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246293	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246293&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622782	341104085							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
429535	COCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(Cl)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C24H19Cl2N3O5/c1-34-9-8-21(23(31)28-17-6-3-14(4-7-17)24(32)33)29-13-20(26)19(11-22(29)30)18-10-16(25)5-2-15(18)12-27/h2-7,10-11,13,21H,8-9H2,1H3,(H,28,31)(H,32,33)	YWIBKDIZKZBHGC-UHFFFAOYSA-N	246299	US10183932, Example 205::US9434690, 205::US9822102, Example 205	Plasma kallikrein			 68					7.4	25.00 C	US Patent		10.7270/Q2K936FF		aid1803376	US9434690	Rohrig, S; Hillisch, A; Straβburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246299	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246299&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622796	341104087							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287337	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc2CCNCc2cc1F)C(F)(F)F	InChI=1S/C21H19F4N5O/c22-16-7-14-11-27-5-4-13(14)8-17(16)28-20(31)18-9-19(21(23,24)25)29-30(18)15-3-1-2-12(6-15)10-26/h1-3,6-9,27H,4-5,10-11,26H2,(H,28,31)	XCBOZBQFIYATFU-UHFFFAOYSA-N	416716	1-(3-(aminomethyl)phenyl)-N-(7-fluoro-1,2,3,4-tetrahydroisoquinolin-6-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 161e::US10633345, Compound 161e::US10689346, Compound 161e::US11203574, Compound 161e::US11230530, Compound 161e::US11685721, Compound 161e	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416716	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416716&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356276	433916630							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50087887	CN1CC(=O)N(Cc2cc3cnc(nc3n2C)C(=O)N[C@@H](CCCCN)C#N)C1=O	InChI=1S/C19H24N8O3/c1-25-11-15(28)27(19(25)30)10-14-7-12-9-22-16(24-17(12)26(14)2)18(29)23-13(8-21)5-3-4-6-20/h7,9,13H,3-6,10-11,20H2,1-2H3,(H,23,29)/t13-/m0/s1	JTUDGJWOIZWPOE-ZDUSSCGKSA-N	50009170	CHEMBL3238361	Plasma kallikrein			>1000000							ChEMBL	10.1016/j.bmc.2014.02.002	10.7270/Q2KH0PVJ	24613052			Teno, N; Gohda, K; Wanaka, K; Tsuda, Y; Sueda, T; Yamashita, Y; Otsubo, T	Hiroshima International University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50009170	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50009170&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90655485	103922227		CHEMBL3238361				ZINC04654897	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50087888	Cn1c(CN2C(=O)CN(C2=O)c2ccc(F)cc2)cc2cnc(nc12)C(=O)N[C@@H](CCCCN)C#N	InChI=1S/C24H25FN8O3/c1-31-19(13-33-20(34)14-32(24(33)36)18-7-5-16(25)6-8-18)10-15-12-28-21(30-22(15)31)23(35)29-17(11-27)4-2-3-9-26/h5-8,10,12,17H,2-4,9,13-14,26H2,1H3,(H,29,35)/t17-/m0/s1	WTOFIEIGFUSGDJ-KRWDZBQOSA-N	50009171	CHEMBL3238362	Plasma kallikrein			 740000							ChEMBL	10.1016/j.bmc.2014.02.002	10.7270/Q2KH0PVJ	24613052			Teno, N; Gohda, K; Wanaka, K; Tsuda, Y; Sueda, T; Yamashita, Y; Otsubo, T	Hiroshima International University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50009171	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50009171&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90655486	103922228		CHEMBL3238362				ZINC13821478	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50087889	COc1ccc(cc1)N1CC(=O)N(Cc2cc3cnc(nc3n2C)C(=O)N[C@@H](CCCCN)C#N)C1=O	InChI=1S/C25H28N8O4/c1-31-19(14-33-21(34)15-32(25(33)36)18-6-8-20(37-2)9-7-18)11-16-13-28-22(30-23(16)31)24(35)29-17(12-27)5-3-4-10-26/h6-9,11,13,17H,3-5,10,14-15,26H2,1-2H3,(H,29,35)/t17-/m0/s1	NJCONWUQJAZYBT-KRWDZBQOSA-N	50009172	CHEMBL3238363	Plasma kallikrein			>1000000							ChEMBL	10.1016/j.bmc.2014.02.002	10.7270/Q2KH0PVJ	24613052			Teno, N; Gohda, K; Wanaka, K; Tsuda, Y; Sueda, T; Yamashita, Y; Otsubo, T	Hiroshima International University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50009172	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50009172&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90655487	103922229		CHEMBL3238363				ZINC13821474	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50087890	CCCc1ccc(cc1)N1CC(=O)N(Cc2cc3cnc(nc3n2C)C(=O)N[C@@H](CCCCN)C#N)C1=O	InChI=1S/C27H32N8O3/c1-3-6-18-8-10-21(11-9-18)34-17-23(36)35(27(34)38)16-22-13-19-15-30-24(32-25(19)33(22)2)26(37)31-20(14-29)7-4-5-12-28/h8-11,13,15,20H,3-7,12,16-17,28H2,1-2H3,(H,31,37)/t20-/m0/s1	TWDYFGPKBAIZRB-FQEVSTJZSA-N	50009173	CHEMBL3238364	Plasma kallikrein			>1000000							ChEMBL	10.1016/j.bmc.2014.02.002	10.7270/Q2KH0PVJ	24613052			Teno, N; Gohda, K; Wanaka, K; Tsuda, Y; Sueda, T; Yamashita, Y; Otsubo, T	Hiroshima International University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50009173	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50009173&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90655488	103922230		CHEMBL3238364				ZINC13821482	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50087891	Cn1c(CN2C(=O)CN(C2=O)c2ccc(cc2)S(N)(=O)=O)cc2cnc(nc12)C(=O)N[C@@H](CCCCN)C#N	InChI=1S/C24H27N9O5S/c1-31-18(10-15-12-28-21(30-22(15)31)23(35)29-16(11-26)4-2-3-9-25)13-33-20(34)14-32(24(33)36)17-5-7-19(8-6-17)39(27,37)38/h5-8,10,12,16H,2-4,9,13-14,25H2,1H3,(H,29,35)(H2,27,37,38)/t16-/m0/s1	JPGRZQSDJVIPBG-INIZCTEOSA-N	50009174	CHEMBL3238365	Plasma kallikrein			>1000000							ChEMBL	10.1016/j.bmc.2014.02.002	10.7270/Q2KH0PVJ	24613052			Teno, N; Gohda, K; Wanaka, K; Tsuda, Y; Sueda, T; Yamashita, Y; Otsubo, T	Hiroshima International University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50009174	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50009174&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90655489	103922231		CHEMBL3238365				ZINC13821462	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50087892	Cn1c(CN2C(=O)CN(C2=O)c2ccc(cc2)C(N)=O)cc2cnc(nc12)C(=O)N[C@@H](CCCCN)C#N	InChI=1S/C25H27N9O4/c1-32-19(13-34-20(35)14-33(25(34)38)18-7-5-15(6-8-18)21(28)36)10-16-12-29-22(31-23(16)32)24(37)30-17(11-27)4-2-3-9-26/h5-8,10,12,17H,2-4,9,13-14,26H2,1H3,(H2,28,36)(H,30,37)/t17-/m0/s1	GGMLULLQUFYMIU-KRWDZBQOSA-N	50009175	CHEMBL3238366	Plasma kallikrein			>1000000							ChEMBL	10.1016/j.bmc.2014.02.002	10.7270/Q2KH0PVJ	24613052			Teno, N; Gohda, K; Wanaka, K; Tsuda, Y; Sueda, T; Yamashita, Y; Otsubo, T	Hiroshima International University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50009175	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50009175&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90655490	103922232		CHEMBL3238366				ZINC13821490	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50087893	Cn1c(CN2C(=O)CN(C2=O)c2ccc(cc2)C#N)cc2cnc(nc12)C(=O)N[C@@H](CCCCN)C#N	InChI=1S/C25H25N9O3/c1-32-20(14-34-21(35)15-33(25(34)37)19-7-5-16(11-27)6-8-19)10-17-13-29-22(31-23(17)32)24(36)30-18(12-28)4-2-3-9-26/h5-8,10,13,18H,2-4,9,14-15,26H2,1H3,(H,30,36)/t18-/m0/s1	IUDIWFPRTCQYFA-SFHVURJKSA-N	50009176	CHEMBL3238367	Plasma kallikrein			>1000000							ChEMBL	10.1016/j.bmc.2014.02.002	10.7270/Q2KH0PVJ	24613052			Teno, N; Gohda, K; Wanaka, K; Tsuda, Y; Sueda, T; Yamashita, Y; Otsubo, T	Hiroshima International University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50009176	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50009176&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90655491	103922233		CHEMBL3238367				ZINC13734065	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50087894	Cn1c(CN2C(=O)CN(C2=O)c2cccc(c2)S(N)(=O)=O)cc2cnc(nc12)C(=O)N[C@@H](CCCCN)C#N	InChI=1S/C24H27N9O5S/c1-31-18(9-15-12-28-21(30-22(15)31)23(35)29-16(11-26)5-2-3-8-25)13-33-20(34)14-32(24(33)36)17-6-4-7-19(10-17)39(27,37)38/h4,6-7,9-10,12,16H,2-3,5,8,13-14,25H2,1H3,(H,29,35)(H2,27,37,38)/t16-/m0/s1	JWRDSNXILJTFIV-INIZCTEOSA-N	50009177	CHEMBL3238368	Plasma kallikrein			>1000000							ChEMBL	10.1016/j.bmc.2014.02.002	10.7270/Q2KH0PVJ	24613052			Teno, N; Gohda, K; Wanaka, K; Tsuda, Y; Sueda, T; Yamashita, Y; Otsubo, T	Hiroshima International University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50009177	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50009177&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90655492	103922234		CHEMBL3238368				ZINC05761494	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50087895	Cn1c(CN2C(=O)CN(C2=O)c2cccc(c2)C(N)=O)cc2cnc(nc12)C(=O)N[C@@H](CCCCN)C#N	InChI=1S/C25H27N9O4/c1-32-19(13-34-20(35)14-33(25(34)38)18-7-4-5-15(9-18)21(28)36)10-16-12-29-22(31-23(16)32)24(37)30-17(11-27)6-2-3-8-26/h4-5,7,9-10,12,17H,2-3,6,8,13-14,26H2,1H3,(H2,28,36)(H,30,37)/t17-/m0/s1	VVRGFJGBCVZUPT-KRWDZBQOSA-N	50009178	CHEMBL3238369	Plasma kallikrein			>1000000							ChEMBL	10.1016/j.bmc.2014.02.002	10.7270/Q2KH0PVJ	24613052			Teno, N; Gohda, K; Wanaka, K; Tsuda, Y; Sueda, T; Yamashita, Y; Otsubo, T	Hiroshima International University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50009178	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50009178&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90655493	103922235		CHEMBL3238369				ZINC13821458	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50087896	Cn1c(CN2C(=O)CN(C2=O)c2cccc(c2)C#N)cc2cnc(nc12)C(=O)N[C@@H](CCCCN)C#N	InChI=1S/C25H25N9O3/c1-32-20(14-34-21(35)15-33(25(34)37)19-7-4-5-16(9-19)11-27)10-17-13-29-22(31-23(17)32)24(36)30-18(12-28)6-2-3-8-26/h4-5,7,9-10,13,18H,2-3,6,8,14-15,26H2,1H3,(H,30,36)/t18-/m0/s1	WHZQYKIIFMNEQT-SFHVURJKSA-N	50009179	CHEMBL3238370	Plasma kallikrein			>1000000							ChEMBL	10.1016/j.bmc.2014.02.002	10.7270/Q2KH0PVJ	24613052			Teno, N; Gohda, K; Wanaka, K; Tsuda, Y; Sueda, T; Yamashita, Y; Otsubo, T	Hiroshima International University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50009179	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50009179&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90655494	103922236		CHEMBL3238370		2363		ZINC04654899	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50087897	CC(=O)COc1ccc(cc1)N1CC(=O)N(Cc2cc3cnc(nc3n2C)C(=O)N[C@@H](CCCCN)C#N)C1=O	InChI=1S/C27H30N8O5/c1-17(36)16-40-22-8-6-20(7-9-22)34-15-23(37)35(27(34)39)14-21-11-18-13-30-24(32-25(18)33(21)2)26(38)31-19(12-29)5-3-4-10-28/h6-9,11,13,19H,3-5,10,14-16,28H2,1-2H3,(H,31,38)/t19-/m0/s1	QERSBLADVXIVER-IBGZPJMESA-N	50009188	CHEMBL3238371	Plasma kallikrein			>1000000							ChEMBL	10.1016/j.bmc.2014.02.002	10.7270/Q2KH0PVJ	24613052			Teno, N; Gohda, K; Wanaka, K; Tsuda, Y; Sueda, T; Yamashita, Y; Otsubo, T	Hiroshima International University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50009188	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50009188&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90655495	103922245		CHEMBL3238371				ZINC96178791	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50087898	Cn1c(CN2C(=O)CN(C2=O)c2ccc(OCC(N)=O)cc2)cc2cnc(nc12)C(=O)N[C@@H](CCCCN)C#N	InChI=1S/C26H29N9O5/c1-33-19(10-16-12-30-23(32-24(16)33)25(38)31-17(11-28)4-2-3-9-27)13-35-22(37)14-34(26(35)39)18-5-7-20(8-6-18)40-15-21(29)36/h5-8,10,12,17H,2-4,9,13-15,27H2,1H3,(H2,29,36)(H,31,38)/t17-/m0/s1	QKECEOLHIWTLIO-KRWDZBQOSA-N	50009197	CHEMBL3238372	Plasma kallikrein			>1000000							ChEMBL	10.1016/j.bmc.2014.02.002	10.7270/Q2KH0PVJ	24613052			Teno, N; Gohda, K; Wanaka, K; Tsuda, Y; Sueda, T; Yamashita, Y; Otsubo, T	Hiroshima International University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50009197	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50009197&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90655496	103922254		CHEMBL3238372				ZINC29402459	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50087899	Cn1c(CN2C(=O)CN(C2=O)c2ccc(OCC#N)cc2)cc2cnc(nc12)C(=O)N[C@@H](CCCCN)C#N	InChI=1S/C26H27N9O4/c1-33-20(12-17-14-30-23(32-24(17)33)25(37)31-18(13-29)4-2-3-9-27)15-35-22(36)16-34(26(35)38)19-5-7-21(8-6-19)39-11-10-28/h5-8,12,14,18H,2-4,9,11,15-16,27H2,1H3,(H,31,37)/t18-/m0/s1	GJNVEPSIQRSYMX-SFHVURJKSA-N	50009199	CHEMBL3238373	Plasma kallikrein			>1000000							ChEMBL	10.1016/j.bmc.2014.02.002	10.7270/Q2KH0PVJ	24613052			Teno, N; Gohda, K; Wanaka, K; Tsuda, Y; Sueda, T; Yamashita, Y; Otsubo, T	Hiroshima International University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50009199	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50009199&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90655497	103922256		CHEMBL3238373				ZINC13821907	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50087900	Cn1c(CN2C(=O)CN(C2=O)c2ccc(Oc3ccccc3)cc2)cc2cnc(nc12)C(=O)N[C@@H](CCCCN)C#N	InChI=1S/C30H30N8O4/c1-36-23(15-20-17-33-27(35-28(20)36)29(40)34-21(16-32)7-5-6-14-31)18-38-26(39)19-37(30(38)41)22-10-12-25(13-11-22)42-24-8-3-2-4-9-24/h2-4,8-13,15,17,21H,5-7,14,18-19,31H2,1H3,(H,34,40)/t21-/m0/s1	XNRITNLETHMDDQ-NRFANRHFSA-N	50009200	CHEMBL3238374	Plasma kallikrein			>1000000							ChEMBL	10.1016/j.bmc.2014.02.002	10.7270/Q2KH0PVJ	24613052			Teno, N; Gohda, K; Wanaka, K; Tsuda, Y; Sueda, T; Yamashita, Y; Otsubo, T	Hiroshima International University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50009200	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50009200&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86302628	103922257		CHEMBL3238374				ZINC13821903	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50087901	COc1ccc(Oc2ccc(cc2)N2CC(=O)N(Cc3cc4cnc(nc4n3C)C(=O)N[C@@H](CCCCN)C#N)C2=O)cc1	InChI=1S/C31H32N8O5/c1-37-23(15-20-17-34-28(36-29(20)37)30(41)35-21(16-33)5-3-4-14-32)18-39-27(40)19-38(31(39)42)22-6-8-25(9-7-22)44-26-12-10-24(43-2)11-13-26/h6-13,15,17,21H,3-5,14,18-19,32H2,1-2H3,(H,35,41)/t21-/m0/s1	LAMGHZOZXZSKRU-NRFANRHFSA-N	50009201	CHEMBL3238375	Plasma kallikrein			>1000000							ChEMBL	10.1016/j.bmc.2014.02.002	10.7270/Q2KH0PVJ	24613052			Teno, N; Gohda, K; Wanaka, K; Tsuda, Y; Sueda, T; Yamashita, Y; Otsubo, T	Hiroshima International University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50009201	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50009201&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90655498	103922258		CHEMBL3238375				ZINC13821934	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50087902	Cn1c(CN2C(=O)CN(C2=O)c2ccc(OCc3ccncc3)cc2)cc2cnc(nc12)C(=O)N[C@@H](CCCCN)C#N	InChI=1S/C30H31N9O4/c1-37-24(14-21-16-34-27(36-28(21)37)29(41)35-22(15-32)4-2-3-11-31)17-39-26(40)18-38(30(39)42)23-5-7-25(8-6-23)43-19-20-9-12-33-13-10-20/h5-10,12-14,16,22H,2-4,11,17-19,31H2,1H3,(H,35,41)/t22-/m0/s1	OYYRMXSYCBELQQ-QFIPXVFZSA-N	50009202	CHEMBL3238376	Plasma kallikrein			>1000000							ChEMBL	10.1016/j.bmc.2014.02.002	10.7270/Q2KH0PVJ	24613052			Teno, N; Gohda, K; Wanaka, K; Tsuda, Y; Sueda, T; Yamashita, Y; Otsubo, T	Hiroshima International University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50009202	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50009202&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90655499	103922259		CHEMBL3238376				ZINC13821931	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50087903	Cn1c(CN2C(=O)CN(C2=O)c2ccc(Oc3ccc4ncccc4c3)cc2)cc2cnc(nc12)C(=O)N[C@@H](CCCCN)C#N	InChI=1S/C33H31N9O4/c1-40-25(15-22-18-37-30(39-31(22)40)32(44)38-23(17-35)6-2-3-13-34)19-42-29(43)20-41(33(42)45)24-7-9-26(10-8-24)46-27-11-12-28-21(16-27)5-4-14-36-28/h4-5,7-12,14-16,18,23H,2-3,6,13,19-20,34H2,1H3,(H,38,44)/t23-/m0/s1	CEYRKKBEJXYPBU-QHCPKHFHSA-N	50009203	CHEMBL3238377	Plasma kallikrein			>1000000							ChEMBL	10.1016/j.bmc.2014.02.002	10.7270/Q2KH0PVJ	24613052			Teno, N; Gohda, K; Wanaka, K; Tsuda, Y; Sueda, T; Yamashita, Y; Otsubo, T	Hiroshima International University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50009203	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50009203&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90655500	103922260		CHEMBL3238377				ZINC13821913	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50087904	Cn1c(CN2C(=O)CN(C2=O)c2ccc(Oc3ccccc3C(N)=O)cc2)cc2cnc(nc12)C(=O)N[C@@H](CCCCN)C#N	InChI=1S/C31H31N9O5/c1-38-22(14-19-16-35-28(37-29(19)38)30(43)36-20(15-33)6-4-5-13-32)17-40-26(41)18-39(31(40)44)21-9-11-23(12-10-21)45-25-8-3-2-7-24(25)27(34)42/h2-3,7-12,14,16,20H,4-6,13,17-18,32H2,1H3,(H2,34,42)(H,36,43)/t20-/m0/s1	IPBNNPJVBLKLFO-FQEVSTJZSA-N	50009204	CHEMBL3238378	Plasma kallikrein			>1000000							ChEMBL	10.1016/j.bmc.2014.02.002	10.7270/Q2KH0PVJ	24613052			Teno, N; Gohda, K; Wanaka, K; Tsuda, Y; Sueda, T; Yamashita, Y; Otsubo, T	Hiroshima International University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50009204	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50009204&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90655501	103922261		CHEMBL3238378				ZINC01626015	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50087905	Cn1c(CN2C(=O)CN(C2=O)c2ccc(Oc3ccccc3)c(c2)C(N)=O)cc2cnc(nc12)C(=O)N[C@@H](CCCCN)C#N	InChI=1S/C31H31N9O5/c1-38-22(13-19-16-35-28(37-29(19)38)30(43)36-20(15-33)7-5-6-12-32)17-40-26(41)18-39(31(40)44)21-10-11-25(24(14-21)27(34)42)45-23-8-3-2-4-9-23/h2-4,8-11,13-14,16,20H,5-7,12,17-18,32H2,1H3,(H2,34,42)(H,36,43)/t20-/m0/s1	ZLMROGSLYUZRSG-FQEVSTJZSA-N	50009205	CHEMBL3238379	Plasma kallikrein			>1000000							ChEMBL	10.1016/j.bmc.2014.02.002	10.7270/Q2KH0PVJ	24613052			Teno, N; Gohda, K; Wanaka, K; Tsuda, Y; Sueda, T; Yamashita, Y; Otsubo, T	Hiroshima International University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50009205	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50009205&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90655502	103922262		CHEMBL3238379				ZINC13821938	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50087906	Cn1c(CN2C(=O)CN(C2=O)c2ccc(OCc3ccncc3)c(c2)C(N)=O)cc2cnc(nc12)C(=O)N[C@@H](CCCCN)C#N	InChI=1S/C31H32N10O5/c1-39-23(12-20-15-36-28(38-29(20)39)30(44)37-21(14-33)4-2-3-9-32)16-41-26(42)17-40(31(41)45)22-5-6-25(24(13-22)27(34)43)46-18-19-7-10-35-11-8-19/h5-8,10-13,15,21H,2-4,9,16-18,32H2,1H3,(H2,34,43)(H,37,44)/t21-/m0/s1	JZWSOYTZZLPQDL-NRFANRHFSA-N	50009206	CHEMBL3233150	Plasma kallikrein			>1000000							ChEMBL	10.1016/j.bmc.2014.02.002	10.7270/Q2KH0PVJ	24613052			Teno, N; Gohda, K; Wanaka, K; Tsuda, Y; Sueda, T; Yamashita, Y; Otsubo, T	Hiroshima International University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50009206	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50009206&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90655503	103922263		CHEMBL3233150				ZINC13821915	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50087907	Cn1c(CN2CN(CC2=O)c2ccc(F)cc2)cc2cnc(nc12)C(=O)N[C@@H](CCCCN)C#N	InChI=1S/C24H27FN8O2/c1-31-20(13-33-15-32(14-21(33)34)19-7-5-17(25)6-8-19)10-16-12-28-22(30-23(16)31)24(35)29-18(11-27)4-2-3-9-26/h5-8,10,12,18H,2-4,9,13-15,26H2,1H3,(H,29,35)/t18-/m0/s1	KAPYHIMZCZSZKR-SFHVURJKSA-N	50009208	CHEMBL3233151	Plasma kallikrein			>1000000							ChEMBL	10.1016/j.bmc.2014.02.002	10.7270/Q2KH0PVJ	24613052			Teno, N; Gohda, K; Wanaka, K; Tsuda, Y; Sueda, T; Yamashita, Y; Otsubo, T	Hiroshima International University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50009208	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50009208&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90655504	103922265		CHEMBL3233151				ZINC13821919	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50087908	Cn1c(CN2CN(CC2=O)c2ccc(Oc3ccccc3)cc2)cc2cnc(nc12)C(=O)N[C@@H](CCCCN)C#N	InChI=1S/C30H32N8O3/c1-36-24(15-21-17-33-28(35-29(21)36)30(40)34-22(16-32)7-5-6-14-31)18-38-20-37(19-27(38)39)23-10-12-26(13-11-23)41-25-8-3-2-4-9-25/h2-4,8-13,15,17,22H,5-7,14,18-20,31H2,1H3,(H,34,40)/t22-/m0/s1	UHPTWLGAKPAHEK-QFIPXVFZSA-N	50009209	CHEMBL3233152	Plasma kallikrein			>1000000							ChEMBL	10.1016/j.bmc.2014.02.002	10.7270/Q2KH0PVJ	24613052			Teno, N; Gohda, K; Wanaka, K; Tsuda, Y; Sueda, T; Yamashita, Y; Otsubo, T	Hiroshima International University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50009209	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50009209&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90655505	103922266		CHEMBL3233152				ZINC13821940	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50087909	Cn1c(CN2CC(=O)N(CC2=O)c2ccc(Oc3ccccc3)cc2)cc2cnc(nc12)C(=O)N[C@@H](CCCCN)C#N	InChI=1S/C31H32N8O4/c1-37-24(15-21-17-34-29(36-30(21)37)31(42)35-22(16-33)7-5-6-14-32)18-38-19-28(41)39(20-27(38)40)23-10-12-26(13-11-23)43-25-8-3-2-4-9-25/h2-4,8-13,15,17,22H,5-7,14,18-20,32H2,1H3,(H,35,42)/t22-/m0/s1	LQTYLIHKDZLCLN-QFIPXVFZSA-N	50009210	CHEMBL3233153	Plasma kallikrein			>1000000							ChEMBL	10.1016/j.bmc.2014.02.002	10.7270/Q2KH0PVJ	24613052			Teno, N; Gohda, K; Wanaka, K; Tsuda, Y; Sueda, T; Yamashita, Y; Otsubo, T	Hiroshima International University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50009210	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50009210&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90655506	103922267		CHEMBL3233153				ZINC13821905	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50091017	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(Br)ccc(Cl)c3F)c3cc-2ccn3)c1	InChI=1S/C31H29BrClFN4O4/c1-17-4-3-5-26(38-13-11-19(15-27(38)39)28-22(32)8-9-23(33)29(28)34)25-14-18(10-12-35-25)21-7-6-20(36-31(41)42-2)16-24(21)37-30(17)40/h6-10,12,14-17,26H,3-5,11,13H2,1-2H3,(H,36,41)(H,37,40)/t17-,26+/m1/s1	NFRBICAIEMTSJZ-QUGAMOGWSA-N	50011242	CHEMBL3260339	Plasma kallikrein		 3.0								ChEMBL	10.1021/ml500084u	10.7270/Q2J67JFR	24900827			Abdel-Magid, AF	Therachem Research Medilab (India) Pvt. Ltd.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50011242	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50011242&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			73051877	103923877		CHEMBL3260339					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50091019	COC(=O)Nc1ccc-2c(NC(=O)[C@@H](C)CCC[C@H](N3CCC(=CC3=O)c3cccc(Cl)c3F)c3ccnc-2c3)c1	InChI=1S/C31H30ClFN4O4/c1-18-5-3-8-27(37-14-12-19(16-28(37)38)22-6-4-7-24(32)29(22)33)20-11-13-34-25(15-20)23-10-9-21(35-31(40)41-2)17-26(23)36-30(18)39/h4,6-7,9-11,13,15-18,27H,3,5,8,12,14H2,1-2H3,(H,35,40)(H,36,39)/t18-,27-/m0/s1	DEZNHCICTWBFEH-MYUZEXMDSA-N	50011245	CHEMBL3260340	Plasma kallikrein		 9.0								ChEMBL	10.1021/ml500084u	10.7270/Q2J67JFR	24900827			Abdel-Magid, AF	Therachem Research Medilab (India) Pvt. Ltd.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50011245	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50011245&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			73052197	103923880		CHEMBL3260340				ZINC13819965	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50091021	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@@H](c3cc-2ccn3)n2ccc(cc2=O)-c2c(F)ccc(Cl)c2F)c1	InChI=1S/C31H27ClF2N4O4/c1-17-4-3-5-26(38-13-11-19(15-27(38)39)28-23(33)9-8-22(32)29(28)34)25-14-18(10-12-35-25)21-7-6-20(36-31(41)42-2)16-24(21)37-30(17)40/h6-17,26H,3-5H2,1-2H3,(H,36,41)(H,37,40)/t17-,26+/m1/s1	CXCGNTAXXPYSAK-QUGAMOGWSA-N	50011250	CHEMBL3260341	Plasma kallikrein		 1.000000								ChEMBL	10.1021/ml500084u	10.7270/Q2J67JFR	24900827			Abdel-Magid, AF	Therachem Research Medilab (India) Pvt. Ltd.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50011250	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50011250&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			73052510	103923885		CHEMBL3260341				ZINC27557170	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50091023	COC(=O)Nc1ccc-2c(NC(=O)CCCC[C@@H](c3cc-2ccn3)n2ccc(cc2=O)-c2c(F)ccc(Cl)c2F)c1	InChI=1S/C30H25ClF2N4O4/c1-41-30(40)35-19-6-7-20-17-10-12-34-24(14-17)25(4-2-3-5-26(38)36-23(20)16-19)37-13-11-18(15-27(37)39)28-22(32)9-8-21(31)29(28)33/h6-16,25H,2-5H2,1H3,(H,35,40)(H,36,38)/t25-/m0/s1	GJQARFAKHMCMDU-VWLOTQADSA-N	50011254	CHEMBL3260342	Plasma kallikrein		 2.4								ChEMBL	10.1021/ml500084u	10.7270/Q2J67JFR	24900827			Abdel-Magid, AF	Therachem Research Medilab (India) Pvt. Ltd.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50011254	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50011254&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			73052831	103923889		CHEMBL3260342				ZINC13819967	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50089322	NC(=[NH2+])SCc1ccc(CS(=O)(=O)Oc2ccc(cc2)[N+]([O-])=O)cc1	InChI=1S/C15H15N3O5S2.BrH/c16-15(17)24-9-11-1-3-12(4-2-11)10-25(21,22)23-14-7-5-13(6-8-14)18(19)20;/h1-8H,9-10H2,(H3,16,17);1H	LEVRBPUPQLAKHA-UHFFFAOYSA-N	50009926	CHEMBL3250026	Plasma kallikrein		 320000						6		ChEMBL	10.1021/jm00203a009	10.7270/Q2736SFF	660589			Wong, SC; Green, GD; Shaw, E	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50009926	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50009926&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90655701	242057437		CHEMBL3250026					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50096698	N[C@H](C(C1CCCCC1)C1CCCCC1)C(=O)N1CCC[C@H]1C(=O)NCC1CCC(N)CC1	InChI=1S/C27H48N4O2/c28-22-15-13-19(14-16-22)18-30-26(32)23-12-7-17-31(23)27(33)25(29)24(20-8-3-1-4-9-20)21-10-5-2-6-11-21/h19-25H,1-18,28-29H2,(H,30,32)/t19?,22?,23-,25+/m0/s1	SYJMIXHRYXUAGD-FEROLFGZSA-N	50057826	(S)-1-((R)-2-Amino-3,3-dicyclohexyl-propionyl)-pyrrolidine-2-carboxylic acid (4-amino-cyclohexylmethyl)-amide::1-(2-Amino-3,3-dicyclohexyl-propionyl)-pyrrolidine-2-carboxylic acid (4-amino-cyclohexylmethyl)-amide::CHEMBL289395	Plasma kallikrein		 5000								ChEMBL	10.1021/jm970140s	10.7270/Q2PR7V29	9171866			Tucker, TJ; Lumma, WC; Lewis, SD; Gardell, SJ; Lucas, BJ; Baskin, EP; Woltmann, R; Lynch, JJ; Lyle, EA; Appleby, SD; Chen, IW; Dancheck, KB; Vacca, JP	Merck Research Laboratories	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50057826	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50057826&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			10367012	103953805		CHEMBL289395				ZINC13761994	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50116443	NC(=N)c1ccc(cc1)S(=O)(=O)NCC(=O)NC(Cc1cccc(c1)C(N)=N)C(O)=O	InChI=1S/C19H22N6O5S/c20-17(21)12-4-6-14(7-5-12)31(29,30)24-10-16(26)25-15(19(27)28)9-11-2-1-3-13(8-11)18(22)23/h1-8,15,24H,9-10H2,(H3,20,21)(H3,22,23)(H,25,26)(H,27,28)	ALBBEOUDFZPYNJ-UHFFFAOYSA-N	50067523	2-[2-(4-Carbamimidoyl-benzenesulfonylamino)-acetylamino]-3-(3-carbamimidoyl-phenyl)-propionic acid::CHEMBL133027	Plasma kallikrein		 36000								ChEMBL	10.1021/jm980227t	10.7270/Q27D2T86	9784099			Gabriel, B; Stubbs, MT; Bergner, A; Hauptmann, J; Bode, W; Sturzebecher, J; Moroder, L	Institut für Biochemie	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50067523	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50067523&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			10718240	103961962		CHEMBL133027				ZINC13781581	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50116450	NC(=N)c1ccc(CC(NC(=O)CNS(=O)(=O)c2ccc(cc2)C(N)=N)C(O)=O)cc1	InChI=1S/C19H22N6O5S/c20-17(21)12-3-1-11(2-4-12)9-15(19(27)28)25-16(26)10-24-31(29,30)14-7-5-13(6-8-14)18(22)23/h1-8,15,24H,9-10H2,(H3,20,21)(H3,22,23)(H,25,26)(H,27,28)	MREBMJAXNFLJHN-UHFFFAOYSA-N	50067526	2-[2-(4-Carbamimidoyl-benzenesulfonylamino)-acetylamino]-3-(4-carbamimidoyl-phenyl)-propionic acid::CHEMBL341933	Plasma kallikrein		 19000								ChEMBL	10.1021/jm980227t	10.7270/Q27D2T86	9784099			Gabriel, B; Stubbs, MT; Bergner, A; Hauptmann, J; Bode, W; Sturzebecher, J; Moroder, L	Institut für Biochemie	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50067526	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50067526&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			10095093	103961965		CHEMBL341933				ZINC34208274	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50116459	CCOC(=O)C(Cc1ccc(cc1)C(N)=N)NC(=O)CNS(=O)(=O)c1ccc(cc1)C(N)=N	InChI=1S/C21H26N6O5S/c1-2-32-21(29)17(11-13-3-5-14(6-4-13)19(22)23)27-18(28)12-26-33(30,31)16-9-7-15(8-10-16)20(24)25/h3-10,17,26H,2,11-12H2,1H3,(H3,22,23)(H3,24,25)(H,27,28)	RHXBSZXVGSHOPS-UHFFFAOYSA-N	50067522	2-[2-(4-Carbamimidoyl-benzenesulfonylamino)-acetylamino]-3-(4-carbamimidoyl-phenyl)-propionic acid ethyl ester::CHEMBL135815	Plasma kallikrein		 8600								ChEMBL	10.1021/jm980227t	10.7270/Q27D2T86	9784099			Gabriel, B; Stubbs, MT; Bergner, A; Hauptmann, J; Bode, W; Sturzebecher, J; Moroder, L	Institut für Biochemie	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50067522	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50067522&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			10435038	103961961		CHEMBL135815				ZINC13781570	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50116497	CCOC(=O)C(Cc1cccc(c1)C(N)=N)NC(=O)CNS(=O)(=O)c1ccc(cc1)C(N)=S	InChI=1S/C21H25N5O5S2/c1-2-31-21(28)17(11-13-4-3-5-15(10-13)19(22)23)26-18(27)12-25-33(29,30)16-8-6-14(7-9-16)20(24)32/h3-10,17,25H,2,11-12H2,1H3,(H3,22,23)(H2,24,32)(H,26,27)	YFHANJZAFYUYQQ-UHFFFAOYSA-N	50067528	3-(3-Carbamimidoyl-phenyl)-2-[2-(4-thiocarbamoyl-benzenesulfonylamino)-acetylamino]-propionic acid ethyl ester::CHEMBL336844	Plasma kallikrein		 12000								ChEMBL	10.1021/jm980227t	10.7270/Q27D2T86	9784099			Gabriel, B; Stubbs, MT; Bergner, A; Hauptmann, J; Bode, W; Sturzebecher, J; Moroder, L	Institut für Biochemie	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50067528	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50067528&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			10624948	103961967		CHEMBL336844				ZINC13781578	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50116501	CCOC(=O)C(Cc1ccc(cc1)C(N)=N)NC(=O)CNS(=O)(=O)c1ccc(cc1)C(N)=S	InChI=1S/C21H25N5O5S2/c1-2-31-21(28)17(11-13-3-5-14(6-4-13)19(22)23)26-18(27)12-25-33(29,30)16-9-7-15(8-10-16)20(24)32/h3-10,17,25H,2,11-12H2,1H3,(H3,22,23)(H2,24,32)(H,26,27)	XUBBHZIMNINHAR-UHFFFAOYSA-N	50067527	3-(4-Carbamimidoyl-phenyl)-2-[2-(4-thiocarbamoyl-benzenesulfonylamino)-acetylamino]-propionic acid ethyl ester::CHEMBL137311	Plasma kallikrein		 29000								ChEMBL	10.1021/jm980227t	10.7270/Q27D2T86	9784099			Gabriel, B; Stubbs, MT; Bergner, A; Hauptmann, J; Bode, W; Sturzebecher, J; Moroder, L	Institut für Biochemie	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50067527	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50067527&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			10767421	103961966		CHEMBL137311				ZINC13781576	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50116508	CCOC(=O)C(Cc1cccc(c1)C(N)=N)NC(=O)CNS(=O)(=O)c1ccc(cc1)C#N	InChI=1S/C21H23N5O5S/c1-2-31-21(28)18(11-15-4-3-5-16(10-15)20(23)24)26-19(27)13-25-32(29,30)17-8-6-14(12-22)7-9-17/h3-10,18,25H,2,11,13H2,1H3,(H3,23,24)(H,26,27)	KKUDJWAGBDOUJA-UHFFFAOYSA-N	50067524	3-(3-Carbamimidoyl-phenyl)-2-[2-(4-cyano-benzenesulfonylamino)-acetylamino]-propionic acid ethyl ester::CHEMBL135998	Plasma kallikrein		 14000								ChEMBL	10.1021/jm980227t	10.7270/Q27D2T86	9784099			Gabriel, B; Stubbs, MT; Bergner, A; Hauptmann, J; Bode, W; Sturzebecher, J; Moroder, L	Institut für Biochemie	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50067524	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50067524&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			11798089	103961963		CHEMBL135998				ZINC13781575	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50116512	CCOC(=O)C(Cc1ccc(cc1)C(N)=N)NC(=O)CNS(=O)(=O)c1ccc(cc1)C#N	InChI=1S/C21H23N5O5S/c1-2-31-21(28)18(11-14-3-7-16(8-4-14)20(23)24)26-19(27)13-25-32(29,30)17-9-5-15(12-22)6-10-17/h3-10,18,25H,2,11,13H2,1H3,(H3,23,24)(H,26,27)	CMUBVICFNAQVEP-UHFFFAOYSA-N	50067530	3-(4-Carbamimidoyl-phenyl)-2-[2-(4-cyano-benzenesulfonylamino)-acetylamino]-propionic acid ethyl ester::CHEMBL135198	Plasma kallikrein		 18000								ChEMBL	10.1021/jm980227t	10.7270/Q27D2T86	9784099			Gabriel, B; Stubbs, MT; Bergner, A; Hauptmann, J; Bode, W; Sturzebecher, J; Moroder, L	Institut für Biochemie	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50067530	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50067530&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			10695159	103961969		CHEMBL135198				ZINC13781573	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50116521	CCOC(=O)C(Cc1cccc(c1)C(N)=N)NC(=O)CNS(=O)(=O)c1ccc(cc1)C(N)=N	InChI=1S/C21H26N6O5S/c1-2-32-21(29)17(11-13-4-3-5-15(10-13)20(24)25)27-18(28)12-26-33(30,31)16-8-6-14(7-9-16)19(22)23/h3-10,17,26H,2,11-12H2,1H3,(H3,22,23)(H3,24,25)(H,27,28)	PQBCMKLFEMRYGK-UHFFFAOYSA-N	50067529	2-[2-(4-Carbamimidoyl-benzenesulfonylamino)-acetylamino]-3-(3-carbamimidoyl-phenyl)-propionic acid ethyl ester::CHEMBL137780	Plasma kallikrein		 7600								ChEMBL	10.1021/jm980227t	10.7270/Q27D2T86	9784099			Gabriel, B; Stubbs, MT; Bergner, A; Hauptmann, J; Bode, W; Sturzebecher, J; Moroder, L	Institut für Biochemie	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50067529	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50067529&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			10648196	103961968		CHEMBL137780				ZINC13781571	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50114127	N[C@H](C1CCCCC1)C(=O)N1CCC[C@H]1C(=O)NCc1cc(Cl)ccc1OCC(N)=O	InChI=1S/C22H31ClN4O4/c23-16-8-9-18(31-13-19(24)28)15(11-16)12-26-21(29)17-7-4-10-27(17)22(30)20(25)14-5-2-1-3-6-14/h8-9,11,14,17,20H,1-7,10,12-13,25H2,(H2,24,28)(H,26,29)/t17-,20+/m0/s1	FWIBHIYGJBNQCZ-FXAWDEMLSA-N	50066332	(S)-1-((R)-2-Amino-2-cyclohexyl-acetyl)-pyrrolidine-2-carboxylic acid 2-carbamoylmethoxy-5-chloro-benzylamide::CHEMBL108717	Plasma kallikrein		 816000								ChEMBL	10.1021/jm9801713	10.7270/Q24Q7T4G	9703466			Tucker, TJ; Brady, SF; Lumma, WC; Lewis, SD; Gardell, SJ; Naylor-Olsen, AM; Yan, Y; Sisko, JT; Stauffer, KJ; Lucas, BJ; Lynch, JJ; Cook, JJ; Stranieri, MT; Holahan, MA; Lyle, EA; Baskin, EP; Chen, IW; Dancheck, KB; Krueger, JA; Cooper, CM; Vacca, JP	Merck Research Laboratories	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50066332	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50066332&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			10742217	103960986		CHEMBL108717				ZINC13780844	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50114131	N[C@H](C1CCCCC1)C(=O)N1CCC[C@H]1C(=O)NCc1cc(Cl)ccc1OCC(=O)NC1CC1	InChI=1S/C25H35ClN4O4/c26-18-8-11-21(34-15-22(31)29-19-9-10-19)17(13-18)14-28-24(32)20-7-4-12-30(20)25(33)23(27)16-5-2-1-3-6-16/h8,11,13,16,19-20,23H,1-7,9-10,12,14-15,27H2,(H,28,32)(H,29,31)/t20-,23+/m0/s1	QTRLBFOGRYRBHO-NZQKXSOJSA-N	50066333	(S)-1-((R)-2-Amino-2-cyclohexyl-acetyl)-pyrrolidine-2-carboxylic acid 5-chloro-2-cyclopropylcarbamoylmethoxy-benzylamide::CHEMBL108202	Plasma kallikrein		 79000								ChEMBL	10.1021/jm9801713	10.7270/Q24Q7T4G	9703466			Tucker, TJ; Brady, SF; Lumma, WC; Lewis, SD; Gardell, SJ; Naylor-Olsen, AM; Yan, Y; Sisko, JT; Stauffer, KJ; Lucas, BJ; Lynch, JJ; Cook, JJ; Stranieri, MT; Holahan, MA; Lyle, EA; Baskin, EP; Chen, IW; Dancheck, KB; Krueger, JA; Cooper, CM; Vacca, JP	Merck Research Laboratories	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50066333	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50066333&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			10529121	103960987		CHEMBL108202				ZINC03831797	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50114134	N[C@H](C1CCCCC1)C(=O)N1CCC[C@H]1C(=O)NCc1cc(Cl)ccc1Cl	InChI=1S/C20H27Cl2N3O2/c21-15-8-9-16(22)14(11-15)12-24-19(26)17-7-4-10-25(17)20(27)18(23)13-5-2-1-3-6-13/h8-9,11,13,17-18H,1-7,10,12,23H2,(H,24,26)/t17-,18+/m0/s1	IKGYVUZSXPRLMO-ZWKOTPCHSA-N	50066336	(S)-1-((R)-2-Amino-2-cyclohexyl-acetyl)-pyrrolidine-2-carboxylic acid 2,5-dichloro-benzylamide::(S)-1-(2-Amino-2-cyclohexyl-acetyl)-pyrrolidine-2-carboxylic acid 2,5-dichloro-benzylamide::CHEMBL42495	Plasma kallikrein		 586000								ChEMBL	10.1021/jm9801713	10.7270/Q24Q7T4G	9703466			Tucker, TJ; Brady, SF; Lumma, WC; Lewis, SD; Gardell, SJ; Naylor-Olsen, AM; Yan, Y; Sisko, JT; Stauffer, KJ; Lucas, BJ; Lynch, JJ; Cook, JJ; Stranieri, MT; Holahan, MA; Lyle, EA; Baskin, EP; Chen, IW; Dancheck, KB; Krueger, JA; Cooper, CM; Vacca, JP	Merck Research Laboratories	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50066336	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50066336&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			10669349	103960990		CHEMBL42495				ZINC03831804	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50114138	CCN(CC)C(=O)CN[C@H](C1CCCCC1)C(=O)N1CCC[C@H]1C(=O)NCc1cc(Cl)ccc1Cl	InChI=1S/C26H38Cl2N4O3/c1-3-31(4-2)23(33)17-29-24(18-9-6-5-7-10-18)26(35)32-14-8-11-22(32)25(34)30-16-19-15-20(27)12-13-21(19)28/h12-13,15,18,22,24,29H,3-11,14,16-17H2,1-2H3,(H,30,34)/t22-,24+/m0/s1	PGTZOYPMRUMGFH-LADGPHEKSA-N	50066331	(S)-1-[(R)-2-Cyclohexyl-2-(diethylcarbamoylmethyl-amino)-acetyl]-pyrrolidine-2-carboxylic acid 2,5-dichloro-benzylamide::CHEMBL441468	Plasma kallikrein		 399000								ChEMBL	10.1021/jm9801713	10.7270/Q24Q7T4G	9703466			Tucker, TJ; Brady, SF; Lumma, WC; Lewis, SD; Gardell, SJ; Naylor-Olsen, AM; Yan, Y; Sisko, JT; Stauffer, KJ; Lucas, BJ; Lynch, JJ; Cook, JJ; Stranieri, MT; Holahan, MA; Lyle, EA; Baskin, EP; Chen, IW; Dancheck, KB; Krueger, JA; Cooper, CM; Vacca, JP	Merck Research Laboratories	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50066331	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50066331&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			10744643	103960985		CHEMBL441468				ZINC03831805	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50144191	CCOC(=O)N1CCN(CC1)C(=O)[C@H](Cc1cccc(c1)C(N)=N)NS(=O)(=O)c1c(cc(cc1C(C)C)C(C)C)C(C)C	InChI=1S/C32H47N5O5S/c1-8-42-32(39)37-14-12-36(13-15-37)31(38)28(17-23-10-9-11-24(16-23)30(33)34)35-43(40,41)29-26(21(4)5)18-25(20(2)3)19-27(29)22(6)7/h9-11,16,18-22,28,35H,8,12-15,17H2,1-7H3,(H3,33,34)/t28-/m0/s1	ISJSHQTWOHGCMM-NDEPHWFRSA-N	23891	3-amidinophenylalanine deriv., 35::CHEMBL107955::ethyl 4-[(2S)-3-(3-carbamimidoylphenyl)-2-{[2,4,6-tris(propan-2-yl)benzene]sulfonamido}propanoyl]piperazine-1-carboxylate	Plasma kallikrein		 7200								ChEMBL	10.1016/s0960-894x(99)00541-7	10.7270/Q2RB73S3	10560742			Sturzebecher, J; Vieweg, H; Steinmetzer, T; Schweinitz, A; Stubbs, MT; Renatus, M; Wikstrom, P	Universität Jena	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23891	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=23891&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			9895193	53785895		CHEMBL107955		6498		ZINC04426028	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50254273	CCc1ccc(NC(=O)c2ccc3cc(ccc3c2)C(N)=N)cc1	InChI=1S/C20H19N3O/c1-2-13-3-9-18(10-4-13)23-20(24)17-8-6-14-11-16(19(21)22)7-5-15(14)12-17/h3-12H,2H2,1H3,(H3,21,22)(H,23,24)	SHHNTNYQWYJYKN-UHFFFAOYSA-N	50138657	6-Carbamimidoyl-naphthalene-2-carboxylic acid (4-ethyl-phenyl)-amide::CHEMBL111660	Plasma kallikrein		 18100								ChEMBL	10.1021/jm0300072	10.7270/Q2BR8RMH	14711304			Wendt, MD; Rockway, TW; Geyer, A; McClellan, W; Weitzberg, M; Zhao, X; Mantei, R; Nienaber, VL; Stewart, K; Klinghofer, V; Giranda, VL	Abbott Laboratories	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50138657	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50138657&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			11347670	104028693		CHEMBL111660				ZINC13532771	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50254274	NC(=N)c1ccc2cc(ccc2c1)C(=O)Nc1ccc2CNCCc2c1	InChI=1S/C21H20N4O/c22-20(23)16-3-1-14-10-17(4-2-13(14)9-16)21(26)25-19-6-5-18-12-24-8-7-15(18)11-19/h1-6,9-11,24H,7-8,12H2,(H3,22,23)(H,25,26)	RCWPAPFNFNQLML-UHFFFAOYSA-N	50138656	6-Carbamimidoyl-naphthalene-2-carboxylic acid (1,2,3,4-tetrahydro-isoquinolin-6-yl)-amide::6-carbamimidoyl-N-(1,2,3,4-tetrahydroisoquinolin-6-yl)-2-naphthamide::CHEMBL111567	Plasma kallikrein		 112								ChEMBL	10.1021/jm0300072	10.7270/Q2BR8RMH	14711304			Wendt, MD; Rockway, TW; Geyer, A; McClellan, W; Weitzberg, M; Zhao, X; Mantei, R; Nienaber, VL; Stewart, K; Klinghofer, V; Giranda, VL	Abbott Laboratories	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50138656	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50138656&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			11739438	104028692		CHEMBL111567				ZINC13532843	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50254275	NC(=N)c1ccc2cc(ccc2c1)C(=O)Nc1ccc2CCNC(C3CCCC3)c2c1	InChI=1S/C26H28N4O/c27-25(28)20-7-5-19-14-21(8-6-18(19)13-20)26(31)30-22-10-9-16-11-12-29-24(23(16)15-22)17-3-1-2-4-17/h5-10,13-15,17,24,29H,1-4,11-12H2,(H3,27,28)(H,30,31)	KORAEYDOYHOKIN-UHFFFAOYSA-N	50138658	6-Carbamimidoyl-naphthalene-2-carboxylic acid (1-cyclopentyl-1,2,3,4-tetrahydro-isoquinolin-7-yl)-amide::CHEMBL111338	Plasma kallikrein		 400								ChEMBL	10.1021/jm0300072	10.7270/Q2BR8RMH	14711304			Wendt, MD; Rockway, TW; Geyer, A; McClellan, W; Weitzberg, M; Zhao, X; Mantei, R; Nienaber, VL; Stewart, K; Klinghofer, V; Giranda, VL	Abbott Laboratories	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50138658	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50138658&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			11361949	104028694		CHEMBL111338				ZINC13532840	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50254279	NC(=N)c1ccc2ccccc2c1	InChI=1S/C11H10N2/c12-11(13)10-6-5-8-3-1-2-4-9(8)7-10/h1-7H,(H3,12,13)	URXJHZXEUUFNKM-UHFFFAOYSA-N	50138663	2-naphthimidamide::CHEMBL105171::Naphthalene-2-carboxamidine::US11584714, Compound 53::uPa_6	Plasma kallikrein		 22500								ChEMBL	10.1021/jm0300072	10.7270/Q2BR8RMH	14711304			Wendt, MD; Rockway, TW; Geyer, A; McClellan, W; Weitzberg, M; Zhao, X; Mantei, R; Nienaber, VL; Stewart, K; Klinghofer, V; Giranda, VL	Abbott Laboratories	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50138663	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50138663&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	2UP	5RU6,4FU8	193409	104028699		CHEMBL105171				ZINC01442764	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50254284	NC(=N)c1ccc2cc(ccc2c1)C(=O)Nc1ccc(CO)cc1	InChI=1S/C19H17N3O2/c20-18(21)15-5-3-14-10-16(6-4-13(14)9-15)19(24)22-17-7-1-12(11-23)2-8-17/h1-10,23H,11H2,(H3,20,21)(H,22,24)	DDKWYWKPXNAXSP-UHFFFAOYSA-N	50138666	6-Carbamimidoyl-naphthalene-2-carboxylic acid (4-hydroxymethyl-phenyl)-amide::CHEMBL111432	Plasma kallikrein		 2570								ChEMBL	10.1021/jm0300072	10.7270/Q2BR8RMH	14711304			Wendt, MD; Rockway, TW; Geyer, A; McClellan, W; Weitzberg, M; Zhao, X; Mantei, R; Nienaber, VL; Stewart, K; Klinghofer, V; Giranda, VL	Abbott Laboratories	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50138666	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50138666&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			11186243	104028702		CHEMBL111432				ZINC13532767	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50254290	NC(=N)c1ccc2cc(ccc2c1)C(=O)Nc1ccc2CCN=C(C3CCCC3)c2c1	InChI=1S/C26H26N4O/c27-25(28)20-7-5-19-14-21(8-6-18(19)13-20)26(31)30-22-10-9-16-11-12-29-24(23(16)15-22)17-3-1-2-4-17/h5-10,13-15,17H,1-4,11-12H2,(H3,27,28)(H,30,31)	YWZCPTFDCKPYIP-UHFFFAOYSA-N	50138668	6-Carbamimidoyl-naphthalene-2-carboxylic acid (1-cyclopentyl-3,4-dihydro-isoquinolin-7-yl)-amide::CHEMBL323387	Plasma kallikrein		 849								ChEMBL	10.1021/jm0300072	10.7270/Q2BR8RMH	14711304			Wendt, MD; Rockway, TW; Geyer, A; McClellan, W; Weitzberg, M; Zhao, X; Mantei, R; Nienaber, VL; Stewart, K; Klinghofer, V; Giranda, VL	Abbott Laboratories	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50138668	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50138668&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			11350400	104028704		CHEMBL323387				ZINC13532833	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50254308	CC(C)CC1NCCc2ccc(NC(=O)c3ccc4cc(ccc4c3)C(N)=N)cc12	InChI=1S/C25H28N4O/c1-15(2)11-23-22-14-21(8-7-16(22)9-10-28-23)29-25(30)20-6-4-17-12-19(24(26)27)5-3-18(17)13-20/h3-8,12-15,23,28H,9-11H2,1-2H3,(H3,26,27)(H,29,30)	GQMKJIVMMQHGLX-UHFFFAOYSA-N	50138669	6-Carbamimidoyl-naphthalene-2-carboxylic acid (1-isobutyl-1,2,3,4-tetrahydro-isoquinolin-7-yl)-amide::CHEMBL109535	Plasma kallikrein		 1350								ChEMBL	10.1021/jm0300072	10.7270/Q2BR8RMH	14711304			Wendt, MD; Rockway, TW; Geyer, A; McClellan, W; Weitzberg, M; Zhao, X; Mantei, R; Nienaber, VL; Stewart, K; Klinghofer, V; Giranda, VL	Abbott Laboratories	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50138669	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50138669&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			11188793	104028705		CHEMBL109535				ZINC13532829	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50254312	O=C(Nc1ccc2cc(ccc2c1)C#N)c1ccccc1	InChI=1S/C18H12N2O/c19-12-13-6-7-16-11-17(9-8-15(16)10-13)20-18(21)14-4-2-1-3-5-14/h1-11H,(H,20,21)	JSQZSRPBQIAKNZ-UHFFFAOYSA-N	50138672	CHEMBL109287::N-(6-Carbamimidoyl-naphthalen-2-yl)-benzamide	Plasma kallikrein		 8000								ChEMBL	10.1021/jm0300072	10.7270/Q2BR8RMH	14711304			Wendt, MD; Rockway, TW; Geyer, A; McClellan, W; Weitzberg, M; Zhao, X; Mantei, R; Nienaber, VL; Stewart, K; Klinghofer, V; Giranda, VL	Abbott Laboratories	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50138672	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50138672&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			11149953	104028708		CHEMBL109287				ZINC13532763	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50254323	NC(=N)c1ccc2cc(ccc2c1)C(=O)Nc1cccc(OC2CCCC2)c1	InChI=1S/C23H23N3O2/c24-22(25)17-10-8-16-13-18(11-9-15(16)12-17)23(27)26-19-4-3-7-21(14-19)28-20-5-1-2-6-20/h3-4,7-14,20H,1-2,5-6H2,(H3,24,25)(H,26,27)	FWTQOPWAMQXIMI-UHFFFAOYSA-N	50138674	6-Carbamimidoyl-naphthalene-2-carboxylic acid (3-cyclopentyloxy-phenyl)-amide::6-[(Z)-AMINO(IMINO)METHYL]-N-[3-(CYCLOPENTYLOXY)PHENYL]-2-NAPHTHAMIDE::6-carbamimidoyl-N-(3-(cyclopentyloxy)phenyl)-2-naphthamide::CHEMBL111575	Plasma kallikrein		 2720								ChEMBL	10.1021/jm0300072	10.7270/Q2BR8RMH	14711304			Wendt, MD; Rockway, TW; Geyer, A; McClellan, W; Weitzberg, M; Zhao, X; Mantei, R; Nienaber, VL; Stewart, K; Klinghofer, V; Giranda, VL	Abbott Laboratories	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50138674	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50138674&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	426	1OWI	447734	104028710		CHEMBL111575	DB07076			ZINC02047484	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50254328	NCc1ccc(NC(=O)c2ccc3cc(ccc3c2)C(N)=N)cc1	InChI=1S/C19H18N4O/c20-11-12-1-7-17(8-2-12)23-19(24)16-6-4-13-9-15(18(21)22)5-3-14(13)10-16/h1-10H,11,20H2,(H3,21,22)(H,23,24)	NLBDETRVUYOIHQ-UHFFFAOYSA-N	50138662	6-Carbamimidoyl-naphthalene-2-carboxylic acid (4-aminomethyl-phenyl)-amide::6-[(Z)-AMINO(IMINO)METHYL]-N-[4-(AMINOMETHYL)PHENYL]-2-NAPHTHAMIDE::CHEMBL324168::N-(4-(aminomethyl)phenyl)-6-carbamimidoyl-2-naphthamide::uPa_9	Plasma kallikrein		 7170								ChEMBL	10.1021/jm0300072	10.7270/Q2BR8RMH	14711304			Wendt, MD; Rockway, TW; Geyer, A; McClellan, W; Weitzberg, M; Zhao, X; Mantei, R; Nienaber, VL; Stewart, K; Klinghofer, V; Giranda, VL	Abbott Laboratories	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50138662	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50138662&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	239	4FUC,1OWH	447733	104028698		CHEMBL324168	DB02398			ZINC02047485	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50254334	NC(=N)c1ccc2cc(ccc2c1)C(=O)Nc1ccccc1	InChI=1S/C18H15N3O/c19-17(20)14-8-6-13-11-15(9-7-12(13)10-14)18(22)21-16-4-2-1-3-5-16/h1-11H,(H3,19,20)(H,21,22)	AECPTICWHONWNW-UHFFFAOYSA-N	50138670	6-Carbamimidoyl-naphthalene-2-carboxylic acid phenylamide::6-[(Z)-AMINO(IMINO)METHYL]-N-PHENYL-2-NAPHTHAMIDE::6-carbamimidoyl-N-phenyl-2-naphthamide::CHEMBL104937::uPa_7	Plasma kallikrein		 2500								ChEMBL	10.1021/jm0300072	10.7270/Q2BR8RMH	14711304			Wendt, MD; Rockway, TW; Geyer, A; McClellan, W; Weitzberg, M; Zhao, X; Mantei, R; Nienaber, VL; Stewart, K; Klinghofer, V; Giranda, VL	Abbott Laboratories	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50138670	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50138670&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	675	4FU9,1OWE	447732	104028706		CHEMBL104937	DB01977			ZINC02047486	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50254335	CCC1CNCc2ccc(NC(=O)c3ccc4cc(ccc4c3)C(N)=N)cc12	InChI=1S/C23H24N4O/c1-2-14-12-26-13-19-7-8-20(11-21(14)19)27-23(28)18-6-4-15-9-17(22(24)25)5-3-16(15)10-18/h3-11,14,26H,2,12-13H2,1H3,(H3,24,25)(H,27,28)	LVNMYQLXKMSQTG-UHFFFAOYSA-N	50138673	6-Carbamimidoyl-naphthalene-2-carboxylic acid (4-ethyl-1,2,3,4-tetrahydro-isoquinolin-6-yl)-amide::6-carbamimidoyl-N-(4-ethyl-1,2,3,4-tetrahydroisoquinolin-6-yl)-2-naphthamide::CHEMBL108447	Plasma kallikrein		 145								ChEMBL	10.1021/jm0300072	10.7270/Q2BR8RMH	14711304			Wendt, MD; Rockway, TW; Geyer, A; McClellan, W; Weitzberg, M; Zhao, X; Mantei, R; Nienaber, VL; Stewart, K; Klinghofer, V; Giranda, VL	Abbott Laboratories	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50138673	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50138673&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	497	1OWD	9799627	104028709		CHEMBL108447				ZINC26955039	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50254338	NC(=N)c1ccc2cc(ccc2c1)C(=O)Nc1ccc(cc1)C(N)=O	InChI=1S/C19H16N4O2/c20-17(21)14-3-1-13-10-15(4-2-12(13)9-14)19(25)23-16-7-5-11(6-8-16)18(22)24/h1-10H,(H3,20,21)(H2,22,24)(H,23,25)	OZCONSDLQBPMQO-UHFFFAOYSA-N	50138675	6-Carbamimidoyl-naphthalene-2-carboxylic acid (4-carbamoyl-phenyl)-amide::CHEMBL320749	Plasma kallikrein		 2430								ChEMBL	10.1021/jm0300072	10.7270/Q2BR8RMH	14711304			Wendt, MD; Rockway, TW; Geyer, A; McClellan, W; Weitzberg, M; Zhao, X; Mantei, R; Nienaber, VL; Stewart, K; Klinghofer, V; Giranda, VL	Abbott Laboratories	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50138675	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50138675&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			11244460	104028711		CHEMBL320749				ZINC13532775	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50254346	CC(C)Oc1cc(NC(=O)c2ccc3cc(ccc3c2)C(N)=N)cc(OC2CCCC2)c1	InChI=1S/C26H29N3O3/c1-16(2)31-23-13-21(14-24(15-23)32-22-5-3-4-6-22)29-26(30)20-10-8-17-11-19(25(27)28)9-7-18(17)12-20/h7-16,22H,3-6H2,1-2H3,(H3,27,28)(H,29,30)	GKFHRQMCFNIZHA-UHFFFAOYSA-N	50138676	6-Carbamimidoyl-naphthalene-2-carboxylic acid (3-cyclopentyloxy-5-isopropoxy-phenyl)-amide::CHEMBL418839	Plasma kallikrein		 3330								ChEMBL	10.1021/jm0300072	10.7270/Q2BR8RMH	14711304			Wendt, MD; Rockway, TW; Geyer, A; McClellan, W; Weitzberg, M; Zhao, X; Mantei, R; Nienaber, VL; Stewart, K; Klinghofer, V; Giranda, VL	Abbott Laboratories	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50138676	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50138676&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			10432907	104028712		CHEMBL418839				ZINC13532814	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50254355	CC(C)C1NCCc2ccc(NC(=O)c3ccc4cc(ccc4c3)C(N)=N)cc12	InChI=1S/C24H26N4O/c1-14(2)22-21-13-20(8-7-15(21)9-10-27-22)28-24(29)19-6-4-16-11-18(23(25)26)5-3-17(16)12-19/h3-8,11-14,22,27H,9-10H2,1-2H3,(H3,25,26)(H,28,29)	DARQQJKHXPXSRO-UHFFFAOYSA-N	50138665	6-Carbamimidoyl-naphthalene-2-carboxylic acid (1-isopropyl-1,2,3,4-tetrahydro-isoquinolin-7-yl)-amide::6-carbamimidoyl-N-(1-isopropyl-1,2,3,4-tetrahydroisoquinolin-7-yl)-2-naphthamide::CHEMBL442201	Plasma kallikrein		 230								ChEMBL	10.1021/jm0300072	10.7270/Q2BR8RMH	14711304			Wendt, MD; Rockway, TW; Geyer, A; McClellan, W; Weitzberg, M; Zhao, X; Mantei, R; Nienaber, VL; Stewart, K; Klinghofer, V; Giranda, VL	Abbott Laboratories	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50138665	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50138665&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	303	1OWK	11292119	104028701		CHEMBL442201				ZINC06486999	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50254377	CC(C)Oc1cc(NC(=O)c2ccc3cc(ccc3c2)C(N)=N)cc(OC(C)C)c1	InChI=1S/C24H27N3O3/c1-14(2)29-21-11-20(12-22(13-21)30-15(3)4)27-24(28)19-8-6-16-9-18(23(25)26)7-5-17(16)10-19/h5-15H,1-4H3,(H3,25,26)(H,27,28)	DXFJLEXWZBCHSJ-UHFFFAOYSA-N	50138661	6-Carbamimidoyl-naphthalene-2-carboxylic acid (3,5-diisopropoxy-phenyl)-amide::CHEMBL111543	Plasma kallikrein		 4300								ChEMBL	10.1021/jm0300072	10.7270/Q2BR8RMH	14711304			Wendt, MD; Rockway, TW; Geyer, A; McClellan, W; Weitzberg, M; Zhao, X; Mantei, R; Nienaber, VL; Stewart, K; Klinghofer, V; Giranda, VL	Abbott Laboratories	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50138661	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50138661&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			11774107	104028697		CHEMBL111543				ZINC13532810	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50254382	CC(C)Oc1cccc(NC(=O)c2ccc3cc(ccc3c2)C(N)=N)c1	InChI=1S/C21H21N3O2/c1-13(2)26-19-5-3-4-18(12-19)24-21(25)17-9-7-14-10-16(20(22)23)8-6-15(14)11-17/h3-13H,1-2H3,(H3,22,23)(H,24,25)	RNMLDMHQKBIMRF-UHFFFAOYSA-N	50138671	6-Carbamimidoyl-naphthalene-2-carboxylic acid (3-isopropoxy-phenyl)-amide::6-carbamimidoyl-N-(3-isopropoxyphenyl)-2-naphthamide::CHEMBL111471	Plasma kallikrein		 1370								ChEMBL	10.1021/jm0300072	10.7270/Q2BR8RMH	14711304			Wendt, MD; Rockway, TW; Geyer, A; McClellan, W; Weitzberg, M; Zhao, X; Mantei, R; Nienaber, VL; Stewart, K; Klinghofer, V; Giranda, VL	Abbott Laboratories	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50138671	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50138671&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			11473486	104028707		CHEMBL111471				ZINC13532789	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50254387	CC(C)C1=NCCc2ccc(NC(=O)c3ccc4cc(ccc4c3)C(N)=N)cc12	InChI=1S/C24H24N4O/c1-14(2)22-21-13-20(8-7-15(21)9-10-27-22)28-24(29)19-6-4-16-11-18(23(25)26)5-3-17(16)12-19/h3-8,11-14H,9-10H2,1-2H3,(H3,25,26)(H,28,29)	XRHANBWAKSYPEN-UHFFFAOYSA-N	50138667	6-Carbamimidoyl-naphthalene-2-carboxylic acid (1-isopropyl-3,4-dihydro-isoquinolin-7-yl)-amide::6-[(Z)-AMINO(IMINO)METHYL]-N-(1-ISOPROPYL-3,4-DIHYDROISOQUINOLIN-7-YL)-2-NAPHTHAMIDE::6-carbamimidoyl-N-(1-isopropyl-3,4-dihydroisoquinolin-7-yl)-2-naphthamide::CHEMBL109367	Plasma kallikrein		 436.0								ChEMBL	10.1021/jm0300072	10.7270/Q2BR8RMH	14711304			Wendt, MD; Rockway, TW; Geyer, A; McClellan, W; Weitzberg, M; Zhao, X; Mantei, R; Nienaber, VL; Stewart, K; Klinghofer, V; Giranda, VL	Abbott Laboratories	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50138667	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50138667&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	155	1OWJ	447735	104028703		CHEMBL109367	DB02473			ZINC05962501	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50248479	NC[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](Cc1ccccc1)c1nc(c[nH]1)-c1ccccc1			50032866	CHEMBL3355664	Plasma kallikrein		 330								ChEMBL	10.1021/jm5010607	10.7270/Q2RV0Q9S	25405503			Hangeland, JJ; Friends, TJ; Rossi, KA; Smallheer, JM; Wang, C; Sun, Z; Corte, JR; Fang, T; Wong, PC; Rendina, AR; Barbera, FA; Bozarth, JM; Luettgen, JM; Watson, CA; Zhang, G; Wei, A; Ramamurthy, V; Morin, PE; Bisacchi, GS; Subramaniam, S; Arunachalam, P; Mathur, A; Seiffert, DA; Wexler, RR; Quan, ML	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50032866	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50032866&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			11509611	313066248		CHEMBL3355664					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50248480	NC[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](Cc1ccccc1)c1nc(c[nH]1)-c1ccc(cc1)C#N			50032865	CHEMBL3355665	Plasma kallikrein		 940								ChEMBL	10.1021/jm5010607	10.7270/Q2RV0Q9S	25405503			Hangeland, JJ; Friends, TJ; Rossi, KA; Smallheer, JM; Wang, C; Sun, Z; Corte, JR; Fang, T; Wong, PC; Rendina, AR; Barbera, FA; Bozarth, JM; Luettgen, JM; Watson, CA; Zhang, G; Wei, A; Ramamurthy, V; Morin, PE; Bisacchi, GS; Subramaniam, S; Arunachalam, P; Mathur, A; Seiffert, DA; Wexler, RR; Quan, ML	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50032865	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50032865&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			11524737	313066247		CHEMBL3355665					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50248481	COC(=O)c1ccc(cc1)-c1c[nH]c(n1)[C@H](Cc1ccccc1)NC(=O)[C@H]1CC[C@H](CN)CC1			50032864	CHEMBL3355666	Plasma kallikrein		 1924								ChEMBL	10.1021/jm5010607	10.7270/Q2RV0Q9S	25405503			Hangeland, JJ; Friends, TJ; Rossi, KA; Smallheer, JM; Wang, C; Sun, Z; Corte, JR; Fang, T; Wong, PC; Rendina, AR; Barbera, FA; Bozarth, JM; Luettgen, JM; Watson, CA; Zhang, G; Wei, A; Ramamurthy, V; Morin, PE; Bisacchi, GS; Subramaniam, S; Arunachalam, P; Mathur, A; Seiffert, DA; Wexler, RR; Quan, ML	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50032864	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50032864&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			66674821	313066246		CHEMBL3355666					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50248482	OC(=O)C(F)(F)F.CCOC(=O)Cc1ccc(cc1)-c1c[nH]c(n1)[C@H](Cc1ccccc1)NC(=O)[C@H]1CC[C@H](CN)CC1	InChI=1S/C29H36N4O3.C2HF3O2/c1-2-36-27(34)17-21-8-12-23(13-9-21)26-19-31-28(32-26)25(16-20-6-4-3-5-7-20)33-29(35)24-14-10-22(18-30)11-15-24;3-2(4,5)1(6)7/h3-9,12-13,19,22,24-25H,2,10-11,14-18,30H2,1H3,(H,31,32)(H,33,35);(H,6,7)/t22-,24-,25-;/m0./s1	NLBOKXXRSIXQSX-IUXZIFGMSA-N	50032863	CHEMBL3355667	Plasma kallikrein		 1360								ChEMBL	10.1021/jm5010607	10.7270/Q2RV0Q9S	25405503			Hangeland, JJ; Friends, TJ; Rossi, KA; Smallheer, JM; Wang, C; Sun, Z; Corte, JR; Fang, T; Wong, PC; Rendina, AR; Barbera, FA; Bozarth, JM; Luettgen, JM; Watson, CA; Zhang, G; Wei, A; Ramamurthy, V; Morin, PE; Bisacchi, GS; Subramaniam, S; Arunachalam, P; Mathur, A; Seiffert, DA; Wexler, RR; Quan, ML	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50032863	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50032863&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118720988	103941292		CHEMBL3355667				ZINC03870086	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50248483	NC[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](Cc1ccccc1)c1nc(c[nH]1)-c1cccc(c1)C#N			50032862	CHEMBL3355668	Plasma kallikrein		 1170								ChEMBL	10.1021/jm5010607	10.7270/Q2RV0Q9S	25405503			Hangeland, JJ; Friends, TJ; Rossi, KA; Smallheer, JM; Wang, C; Sun, Z; Corte, JR; Fang, T; Wong, PC; Rendina, AR; Barbera, FA; Bozarth, JM; Luettgen, JM; Watson, CA; Zhang, G; Wei, A; Ramamurthy, V; Morin, PE; Bisacchi, GS; Subramaniam, S; Arunachalam, P; Mathur, A; Seiffert, DA; Wexler, RR; Quan, ML	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50032862	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50032862&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118720990	313066245		CHEMBL3355668					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50248484	OC(=O)C(F)(F)F.CCOC(=O)Cc1cccc(c1)-c1c[nH]c(n1)[C@H](Cc1ccccc1)NC(=O)[C@H]1CC[C@H](CN)CC1	InChI=1S/C29H36N4O3.C2HF3O2/c1-2-36-27(34)17-22-9-6-10-24(15-22)26-19-31-28(32-26)25(16-20-7-4-3-5-8-20)33-29(35)23-13-11-21(18-30)12-14-23;3-2(4,5)1(6)7/h3-10,15,19,21,23,25H,2,11-14,16-18,30H2,1H3,(H,31,32)(H,33,35);(H,6,7)/t21-,23-,25-;/m0./s1	AVANNKANBWVKGX-IELCCSRCSA-N	50032860	CHEMBL3355669	Plasma kallikrein		 1470								ChEMBL	10.1021/jm5010607	10.7270/Q2RV0Q9S	25405503			Hangeland, JJ; Friends, TJ; Rossi, KA; Smallheer, JM; Wang, C; Sun, Z; Corte, JR; Fang, T; Wong, PC; Rendina, AR; Barbera, FA; Bozarth, JM; Luettgen, JM; Watson, CA; Zhang, G; Wei, A; Ramamurthy, V; Morin, PE; Bisacchi, GS; Subramaniam, S; Arunachalam, P; Mathur, A; Seiffert, DA; Wexler, RR; Quan, ML	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50032860	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50032860&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	ST1	1IVD,1IVB	118720991	103941290		CHEMBL3355669				ZINC03833968	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50248485	NC[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](Cc1ccccc1)c1nc(c[nH]1)-c1ccc(cc1)S(N)(=O)=O			50032859	CHEMBL3352850	Plasma kallikrein		 5540								ChEMBL	10.1021/jm5010607	10.7270/Q2RV0Q9S	25405503			Hangeland, JJ; Friends, TJ; Rossi, KA; Smallheer, JM; Wang, C; Sun, Z; Corte, JR; Fang, T; Wong, PC; Rendina, AR; Barbera, FA; Bozarth, JM; Luettgen, JM; Watson, CA; Zhang, G; Wei, A; Ramamurthy, V; Morin, PE; Bisacchi, GS; Subramaniam, S; Arunachalam, P; Mathur, A; Seiffert, DA; Wexler, RR; Quan, ML	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50032859	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50032859&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118720993	313066244		CHEMBL3352850					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50248486	OC(=O)C(F)(F)F.NC[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](Cc1ccccc1)c1nc(c[nH]1)-c1ccc(cc1)C(N)=O	InChI=1S/C26H31N5O2.C2HF3O2/c27-15-18-6-8-21(9-7-18)26(33)31-22(14-17-4-2-1-3-5-17)25-29-16-23(30-25)19-10-12-20(13-11-19)24(28)32;3-2(4,5)1(6)7/h1-5,10-13,16,18,21-22H,6-9,14-15,27H2,(H2,28,32)(H,29,30)(H,31,33);(H,6,7)/t18-,21-,22-;/m0./s1	CROUIJYHXVQHRA-OVXWWNFRSA-N	50032858	CHEMBL3355670	Plasma kallikrein		 60								ChEMBL	10.1021/jm5010607	10.7270/Q2RV0Q9S	25405503			Hangeland, JJ; Friends, TJ; Rossi, KA; Smallheer, JM; Wang, C; Sun, Z; Corte, JR; Fang, T; Wong, PC; Rendina, AR; Barbera, FA; Bozarth, JM; Luettgen, JM; Watson, CA; Zhang, G; Wei, A; Ramamurthy, V; Morin, PE; Bisacchi, GS; Subramaniam, S; Arunachalam, P; Mathur, A; Seiffert, DA; Wexler, RR; Quan, ML	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50032858	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50032858&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	ST2	1IVC	118720994	103941289		CHEMBL3355670				ZINC03581100	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50248487	NC[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](Cc1ccccc1)c1nc(c[nH]1)-c1ccc(cc1)C(O)=O			50032886	CHEMBL3355671	Plasma kallikrein		 3820								ChEMBL	10.1021/jm5010607	10.7270/Q2RV0Q9S	25405503			Hangeland, JJ; Friends, TJ; Rossi, KA; Smallheer, JM; Wang, C; Sun, Z; Corte, JR; Fang, T; Wong, PC; Rendina, AR; Barbera, FA; Bozarth, JM; Luettgen, JM; Watson, CA; Zhang, G; Wei, A; Ramamurthy, V; Morin, PE; Bisacchi, GS; Subramaniam, S; Arunachalam, P; Mathur, A; Seiffert, DA; Wexler, RR; Quan, ML	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50032886	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50032886&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			66674079	313066252		CHEMBL3355671					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50248488	OC(=O)C(F)(F)F.CNC(=O)c1ccc(cc1)-c1c[nH]c(n1)[C@H](Cc1ccccc1)NC(=O)[C@H]1CC[C@H](CN)CC1	InChI=1S/C27H33N5O2.C2HF3O2/c1-29-26(33)21-13-11-20(12-14-21)24-17-30-25(31-24)23(15-18-5-3-2-4-6-18)32-27(34)22-9-7-19(16-28)8-10-22;3-2(4,5)1(6)7/h2-6,11-14,17,19,22-23H,7-10,15-16,28H2,1H3,(H,29,33)(H,30,31)(H,32,34);(H,6,7)/t19-,22-,23-;/m0./s1	QOHYPPFPTBEEEU-HJYMGNQYSA-N	50032885	CHEMBL3355672	Plasma kallikrein		 220								ChEMBL	10.1021/jm5010607	10.7270/Q2RV0Q9S	25405503			Hangeland, JJ; Friends, TJ; Rossi, KA; Smallheer, JM; Wang, C; Sun, Z; Corte, JR; Fang, T; Wong, PC; Rendina, AR; Barbera, FA; Bozarth, JM; Luettgen, JM; Watson, CA; Zhang, G; Wei, A; Ramamurthy, V; Morin, PE; Bisacchi, GS; Subramaniam, S; Arunachalam, P; Mathur, A; Seiffert, DA; Wexler, RR; Quan, ML	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50032885	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50032885&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118720996	103941308		CHEMBL3355672				ZINC13603439	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50248489	OC(=O)C(F)(F)F.CN(C)C(=O)c1ccc(cc1)-c1c[nH]c(n1)[C@H](Cc1ccccc1)NC(=O)[C@H]1CC[C@H](CN)CC1	InChI=1S/C28H35N5O2.C2HF3O2/c1-33(2)28(35)23-14-12-21(13-15-23)25-18-30-26(31-25)24(16-19-6-4-3-5-7-19)32-27(34)22-10-8-20(17-29)9-11-22;3-2(4,5)1(6)7/h3-7,12-15,18,20,22,24H,8-11,16-17,29H2,1-2H3,(H,30,31)(H,32,34);(H,6,7)/t20-,22-,24-;/m0./s1	FYQXCNURGKPUAC-LEONTYCUSA-N	50032884	CHEMBL3355673	Plasma kallikrein		 5270								ChEMBL	10.1021/jm5010607	10.7270/Q2RV0Q9S	25405503			Hangeland, JJ; Friends, TJ; Rossi, KA; Smallheer, JM; Wang, C; Sun, Z; Corte, JR; Fang, T; Wong, PC; Rendina, AR; Barbera, FA; Bozarth, JM; Luettgen, JM; Watson, CA; Zhang, G; Wei, A; Ramamurthy, V; Morin, PE; Bisacchi, GS; Subramaniam, S; Arunachalam, P; Mathur, A; Seiffert, DA; Wexler, RR; Quan, ML	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50032884	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50032884&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118720997	103941307		CHEMBL3355673				ZINC26944037	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50248490	OC(=O)C(F)(F)F.NC[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](Cc1ccccc1)c1nc(c[nH]1)-c1ccc(CC(O)=O)cc1	InChI=1S/C27H32N4O3.C2HF3O2/c28-16-20-8-12-22(13-9-20)27(34)31-23(14-18-4-2-1-3-5-18)26-29-17-24(30-26)21-10-6-19(7-11-21)15-25(32)33;3-2(4,5)1(6)7/h1-7,10-11,17,20,22-23H,8-9,12-16,28H2,(H,29,30)(H,31,34)(H,32,33);(H,6,7)/t20-,22-,23-;/m0./s1	MONXMXCBSGQDTC-SATZCXPZSA-N	50032883	CHEMBL3355674	Plasma kallikrein		 765								ChEMBL	10.1021/jm5010607	10.7270/Q2RV0Q9S	25405503			Hangeland, JJ; Friends, TJ; Rossi, KA; Smallheer, JM; Wang, C; Sun, Z; Corte, JR; Fang, T; Wong, PC; Rendina, AR; Barbera, FA; Bozarth, JM; Luettgen, JM; Watson, CA; Zhang, G; Wei, A; Ramamurthy, V; Morin, PE; Bisacchi, GS; Subramaniam, S; Arunachalam, P; Mathur, A; Seiffert, DA; Wexler, RR; Quan, ML	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50032883	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50032883&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118720998	103941306		CHEMBL3355674				ZINC13603430	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50248491	OC(=O)C(F)(F)F.NC[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](Cc1ccccc1)c1nc(c[nH]1)-c1ccc(CC(N)=O)cc1	InChI=1S/C27H33N5O2.C2HF3O2/c28-16-20-8-12-22(13-9-20)27(34)32-23(14-18-4-2-1-3-5-18)26-30-17-24(31-26)21-10-6-19(7-11-21)15-25(29)33;3-2(4,5)1(6)7/h1-7,10-11,17,20,22-23H,8-9,12-16,28H2,(H2,29,33)(H,30,31)(H,32,34);(H,6,7)/t20-,22-,23-;/m0./s1	BCCZLQYGKJAHNX-SATZCXPZSA-N	50032882	CHEMBL3355675	Plasma kallikrein		 1310								ChEMBL	10.1021/jm5010607	10.7270/Q2RV0Q9S	25405503			Hangeland, JJ; Friends, TJ; Rossi, KA; Smallheer, JM; Wang, C; Sun, Z; Corte, JR; Fang, T; Wong, PC; Rendina, AR; Barbera, FA; Bozarth, JM; Luettgen, JM; Watson, CA; Zhang, G; Wei, A; Ramamurthy, V; Morin, PE; Bisacchi, GS; Subramaniam, S; Arunachalam, P; Mathur, A; Seiffert, DA; Wexler, RR; Quan, ML	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50032882	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50032882&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118720999	103941305		CHEMBL3355675				ZINC26965455	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50248492	OC(=O)C(F)(F)F.NC[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](Cc1ccccc1)c1nc(c[nH]1)-c1cccc(c1)C(N)=O	InChI=1S/C26H31N5O2.C2HF3O2/c27-15-18-9-11-19(12-10-18)26(33)31-22(13-17-5-2-1-3-6-17)25-29-16-23(30-25)20-7-4-8-21(14-20)24(28)32;3-2(4,5)1(6)7/h1-8,14,16,18-19,22H,9-13,15,27H2,(H2,28,32)(H,29,30)(H,31,33);(H,6,7)/t18-,19-,22-;/m0./s1	OIBNJVRCTCTXOL-NXAKCKNPSA-N	50032881	CHEMBL3355676	Plasma kallikrein		 910								ChEMBL	10.1021/jm5010607	10.7270/Q2RV0Q9S	25405503			Hangeland, JJ; Friends, TJ; Rossi, KA; Smallheer, JM; Wang, C; Sun, Z; Corte, JR; Fang, T; Wong, PC; Rendina, AR; Barbera, FA; Bozarth, JM; Luettgen, JM; Watson, CA; Zhang, G; Wei, A; Ramamurthy, V; Morin, PE; Bisacchi, GS; Subramaniam, S; Arunachalam, P; Mathur, A; Seiffert, DA; Wexler, RR; Quan, ML	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50032881	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50032881&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118721000	103941304		CHEMBL3355676				ZINC13603443	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50248493	OC(=O)C(F)(F)F.NC[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](Cc1ccccc1)c1nc(c[nH]1)-c1cccc(CC(O)=O)c1	InChI=1S/C27H32N4O3.C2HF3O2/c28-16-19-9-11-21(12-10-19)27(34)31-23(14-18-5-2-1-3-6-18)26-29-17-24(30-26)22-8-4-7-20(13-22)15-25(32)33;3-2(4,5)1(6)7/h1-8,13,17,19,21,23H,9-12,14-16,28H2,(H,29,30)(H,31,34)(H,32,33);(H,6,7)/t19-,21-,23-;/m0./s1	CZIMQHOYBSEVQT-AHLSRPLNSA-N	50032880	CHEMBL3355677	Plasma kallikrein		 920								ChEMBL	10.1021/jm5010607	10.7270/Q2RV0Q9S	25405503			Hangeland, JJ; Friends, TJ; Rossi, KA; Smallheer, JM; Wang, C; Sun, Z; Corte, JR; Fang, T; Wong, PC; Rendina, AR; Barbera, FA; Bozarth, JM; Luettgen, JM; Watson, CA; Zhang, G; Wei, A; Ramamurthy, V; Morin, PE; Bisacchi, GS; Subramaniam, S; Arunachalam, P; Mathur, A; Seiffert, DA; Wexler, RR; Quan, ML	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50032880	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50032880&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118721001	103941303		CHEMBL3355677				ZINC26974268	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50248494	OC(=O)C(F)(F)F.NC[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](Cc1ccccc1)c1nc(c[nH]1)-c1cccc(CC(N)=O)c1	InChI=1S/C27H33N5O2.C2HF3O2/c28-16-19-9-11-21(12-10-19)27(34)32-23(14-18-5-2-1-3-6-18)26-30-17-24(31-26)22-8-4-7-20(13-22)15-25(29)33;3-2(4,5)1(6)7/h1-8,13,17,19,21,23H,9-12,14-16,28H2,(H2,29,33)(H,30,31)(H,32,34);(H,6,7)/t19-,21-,23-;/m0./s1	ABKXFVWKFAXVFL-AHLSRPLNSA-N	50032879	CHEMBL3355678	Plasma kallikrein		 1902								ChEMBL	10.1021/jm5010607	10.7270/Q2RV0Q9S	25405503			Hangeland, JJ; Friends, TJ; Rossi, KA; Smallheer, JM; Wang, C; Sun, Z; Corte, JR; Fang, T; Wong, PC; Rendina, AR; Barbera, FA; Bozarth, JM; Luettgen, JM; Watson, CA; Zhang, G; Wei, A; Ramamurthy, V; Morin, PE; Bisacchi, GS; Subramaniam, S; Arunachalam, P; Mathur, A; Seiffert, DA; Wexler, RR; Quan, ML	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50032879	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50032879&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118721002	103941302		CHEMBL3355678				ZINC26979248	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50248495	OC(=O)C(F)(F)F.NC[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](Cc1ccccc1)c1nc(c(Br)[nH]1)-c1ccc(cc1)C(N)=O	InChI=1S/C26H30BrN5O2.C2HF3O2/c27-23-22(18-10-12-19(13-11-18)24(29)33)31-25(32-23)21(14-16-4-2-1-3-5-16)30-26(34)20-8-6-17(15-28)7-9-20;3-2(4,5)1(6)7/h1-5,10-13,17,20-21H,6-9,14-15,28H2,(H2,29,33)(H,30,34)(H,31,32);(H,6,7)/t17-,20-,21-;/m0./s1	DTJLQSIMCTZPDP-KXGBIOHPSA-N	50032878	CHEMBL3355679	Plasma kallikrein		 45								ChEMBL	10.1021/jm5010607	10.7270/Q2RV0Q9S	25405503			Hangeland, JJ; Friends, TJ; Rossi, KA; Smallheer, JM; Wang, C; Sun, Z; Corte, JR; Fang, T; Wong, PC; Rendina, AR; Barbera, FA; Bozarth, JM; Luettgen, JM; Watson, CA; Zhang, G; Wei, A; Ramamurthy, V; Morin, PE; Bisacchi, GS; Subramaniam, S; Arunachalam, P; Mathur, A; Seiffert, DA; Wexler, RR; Quan, ML	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50032878	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50032878&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118721003	103941301		CHEMBL3355679				ZINC26975478	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50248496	OC(=O)C(F)(F)F.NC[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](Cc1ccccc1)c1nc(c(Cl)[nH]1)-c1ccc(cc1)C(N)=O	InChI=1S/C26H30ClN5O2.C2HF3O2/c27-23-22(18-10-12-19(13-11-18)24(29)33)31-25(32-23)21(14-16-4-2-1-3-5-16)30-26(34)20-8-6-17(15-28)7-9-20;3-2(4,5)1(6)7/h1-5,10-13,17,20-21H,6-9,14-15,28H2,(H2,29,33)(H,30,34)(H,31,32);(H,6,7)/t17-,20-,21-;/m0./s1	XALLZNDKDDAFQO-KXGBIOHPSA-N	50032877	CHEMBL3355680	Plasma kallikrein		 20								ChEMBL	10.1021/jm5010607	10.7270/Q2RV0Q9S	25405503			Hangeland, JJ; Friends, TJ; Rossi, KA; Smallheer, JM; Wang, C; Sun, Z; Corte, JR; Fang, T; Wong, PC; Rendina, AR; Barbera, FA; Bozarth, JM; Luettgen, JM; Watson, CA; Zhang, G; Wei, A; Ramamurthy, V; Morin, PE; Bisacchi, GS; Subramaniam, S; Arunachalam, P; Mathur, A; Seiffert, DA; Wexler, RR; Quan, ML	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50032877	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50032877&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118721004	103941300		CHEMBL3355680				ZINC26959458	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50248497	OC(=O)C(F)(F)F.NC[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](Cc1ccccc1)c1nc(c(F)[nH]1)-c1ccc(cc1)C(N)=O	InChI=1S/C26H30FN5O2.C2HF3O2/c27-23-22(18-10-12-19(13-11-18)24(29)33)31-25(32-23)21(14-16-4-2-1-3-5-16)30-26(34)20-8-6-17(15-28)7-9-20;3-2(4,5)1(6)7/h1-5,10-13,17,20-21H,6-9,14-15,28H2,(H2,29,33)(H,30,34)(H,31,32);(H,6,7)/t17-,20-,21-;/m0./s1	GPSHLHZVRVCPHY-KXGBIOHPSA-N	50032876	CHEMBL3355681	Plasma kallikrein		 8.0								ChEMBL	10.1021/jm5010607	10.7270/Q2RV0Q9S	25405503			Hangeland, JJ; Friends, TJ; Rossi, KA; Smallheer, JM; Wang, C; Sun, Z; Corte, JR; Fang, T; Wong, PC; Rendina, AR; Barbera, FA; Bozarth, JM; Luettgen, JM; Watson, CA; Zhang, G; Wei, A; Ramamurthy, V; Morin, PE; Bisacchi, GS; Subramaniam, S; Arunachalam, P; Mathur, A; Seiffert, DA; Wexler, RR; Quan, ML	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50032876	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50032876&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118721005	103941299		CHEMBL3355681				ZINC26965807	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50248498	OC(=O)C(F)(F)F.NC[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](Cc1ccccc1)c1nc(c[nH]1)-c1ccc2c(N)n[nH]c2c1	InChI=1S/C26H31N7O.C2HF3O2/c27-14-17-6-8-18(9-7-17)26(34)31-22(12-16-4-2-1-3-5-16)25-29-15-23(30-25)19-10-11-20-21(13-19)32-33-24(20)28;3-2(4,5)1(6)7/h1-5,10-11,13,15,17-18,22H,6-9,12,14,27H2,(H,29,30)(H,31,34)(H3,28,32,33);(H,6,7)/t17-,18-,22-;/m0./s1	QJLDODSSPFOUCS-JIXBSQRZSA-N	50032875	CHEMBL3355682	Plasma kallikrein		 50								ChEMBL	10.1021/jm5010607	10.7270/Q2RV0Q9S	25405503			Hangeland, JJ; Friends, TJ; Rossi, KA; Smallheer, JM; Wang, C; Sun, Z; Corte, JR; Fang, T; Wong, PC; Rendina, AR; Barbera, FA; Bozarth, JM; Luettgen, JM; Watson, CA; Zhang, G; Wei, A; Ramamurthy, V; Morin, PE; Bisacchi, GS; Subramaniam, S; Arunachalam, P; Mathur, A; Seiffert, DA; Wexler, RR; Quan, ML	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50032875	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50032875&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118721007	103941298		CHEMBL3355682				ZINC13603428	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50248499	OC(=O)C(F)(F)F.NC[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](Cc1ccccc1)c1nc(c(Cl)[nH]1)-c1ccc2c(N)n[nH]c2c1	InChI=1S/C26H30ClN7O.C2HF3O2/c27-23-22(18-10-11-19-20(13-18)33-34-24(19)29)31-25(32-23)21(12-15-4-2-1-3-5-15)30-26(35)17-8-6-16(14-28)7-9-17;3-2(4,5)1(6)7/h1-5,10-11,13,16-17,21H,6-9,12,14,28H2,(H,30,35)(H,31,32)(H3,29,33,34);(H,6,7)/t16-,17-,21-;/m0./s1	LHBYFFXOUVRTCW-WUZJXDRUSA-N	50032874	CHEMBL3355683	Plasma kallikrein		 5.0								ChEMBL	10.1021/jm5010607	10.7270/Q2RV0Q9S	25405503			Hangeland, JJ; Friends, TJ; Rossi, KA; Smallheer, JM; Wang, C; Sun, Z; Corte, JR; Fang, T; Wong, PC; Rendina, AR; Barbera, FA; Bozarth, JM; Luettgen, JM; Watson, CA; Zhang, G; Wei, A; Ramamurthy, V; Morin, PE; Bisacchi, GS; Subramaniam, S; Arunachalam, P; Mathur, A; Seiffert, DA; Wexler, RR; Quan, ML	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50032874	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50032874&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118721008	103941297		CHEMBL3355683				ZINC26968177	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50248500	OC(=O)C(F)(F)F.NC[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](Cc1ccccc1)c1nc(c(F)[nH]1)-c1ccc2c(N)n[nH]c2c1	InChI=1S/C26H30FN7O.C2HF3O2/c27-23-22(18-10-11-19-20(13-18)33-34-24(19)29)31-25(32-23)21(12-15-4-2-1-3-5-15)30-26(35)17-8-6-16(14-28)7-9-17;3-2(4,5)1(6)7/h1-5,10-11,13,16-17,21H,6-9,12,14,28H2,(H,30,35)(H,31,32)(H3,29,33,34);(H,6,7)/t16-,17-,21-;/m0./s1	IWZOTNVKWURQGU-WUZJXDRUSA-N	50032873	CHEMBL3355684	Plasma kallikrein		 2.0								ChEMBL	10.1021/jm5010607	10.7270/Q2RV0Q9S	25405503			Hangeland, JJ; Friends, TJ; Rossi, KA; Smallheer, JM; Wang, C; Sun, Z; Corte, JR; Fang, T; Wong, PC; Rendina, AR; Barbera, FA; Bozarth, JM; Luettgen, JM; Watson, CA; Zhang, G; Wei, A; Ramamurthy, V; Morin, PE; Bisacchi, GS; Subramaniam, S; Arunachalam, P; Mathur, A; Seiffert, DA; Wexler, RR; Quan, ML	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50032873	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50032873&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118721009	103941296		CHEMBL3355684				ZINC03799478	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50248501	NC[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](Cc1ccccc1)c1ncc(o1)-c1ccccc1	InChI=1S/C25H29N3O2/c26-16-19-11-13-21(14-12-19)24(29)28-22(15-18-7-3-1-4-8-18)25-27-17-23(30-25)20-9-5-2-6-10-20/h1-10,17,19,21-22H,11-16,26H2,(H,28,29)/t19-,21-,22-/m0/s1	GKDIFYSGHKBGCN-BVSLBCMMSA-N	50032872	CHEMBL3355685	Plasma kallikrein		 3440								ChEMBL	10.1021/jm5010607	10.7270/Q2RV0Q9S	25405503			Hangeland, JJ; Friends, TJ; Rossi, KA; Smallheer, JM; Wang, C; Sun, Z; Corte, JR; Fang, T; Wong, PC; Rendina, AR; Barbera, FA; Bozarth, JM; Luettgen, JM; Watson, CA; Zhang, G; Wei, A; Ramamurthy, V; Morin, PE; Bisacchi, GS; Subramaniam, S; Arunachalam, P; Mathur, A; Seiffert, DA; Wexler, RR; Quan, ML	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50032872	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50032872&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			66674212	103941295		CHEMBL3355685				ZINC13603432	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50248502	NC[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](Cc1ccccc1)c1nc(n[nH]1)-c1ccccc1	InChI=1S/C24H29N5O/c25-16-18-11-13-20(14-12-18)24(30)26-21(15-17-7-3-1-4-8-17)23-27-22(28-29-23)19-9-5-2-6-10-19/h1-10,18,20-21H,11-16,25H2,(H,26,30)(H,27,28,29)/t18-,20-,21-/m0/s1	WATXLIITIVMJEL-JBACZVJFSA-N	50032871	CHEMBL3355686	Plasma kallikrein		 2217								ChEMBL	10.1021/jm5010607	10.7270/Q2RV0Q9S	25405503			Hangeland, JJ; Friends, TJ; Rossi, KA; Smallheer, JM; Wang, C; Sun, Z; Corte, JR; Fang, T; Wong, PC; Rendina, AR; Barbera, FA; Bozarth, JM; Luettgen, JM; Watson, CA; Zhang, G; Wei, A; Ramamurthy, V; Morin, PE; Bisacchi, GS; Subramaniam, S; Arunachalam, P; Mathur, A; Seiffert, DA; Wexler, RR; Quan, ML	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50032871	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50032871&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			66674351	103941294		CHEMBL3355686				ZINC03799481	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50248478	CC(C)CC(=O)Nc1cc(cc(c1)-c1ccc(cc1C(O)=O)C(N)=O)[C@@H]1C[C@](C)(c2ccccc2)c2cc(ccc2N1)C(N)=N	InChI=1S/C36H37N5O4/c1-20(2)13-32(42)40-26-15-23(27-11-9-22(34(39)43)17-28(27)35(44)45)14-24(16-26)31-19-36(3,25-7-5-4-6-8-25)29-18-21(33(37)38)10-12-30(29)41-31/h4-12,14-18,20,31,41H,13,19H2,1-3H3,(H3,37,38)(H2,39,43)(H,40,42)(H,44,45)/t31-,36+/m0/s1	PDUMJXCNOKHQKH-SVXHESJVSA-N	50448583	CHEMBL3127491	Plasma kallikrein		 2.0								ChEMBL	10.1021/jm5010607	10.7270/Q2RV0Q9S	25405503			Hangeland, JJ; Friends, TJ; Rossi, KA; Smallheer, JM; Wang, C; Sun, Z; Corte, JR; Fang, T; Wong, PC; Rendina, AR; Barbera, FA; Bozarth, JM; Luettgen, JM; Watson, CA; Zhang, G; Wei, A; Ramamurthy, V; Morin, PE; Bisacchi, GS; Subramaniam, S; Arunachalam, P; Mathur, A; Seiffert, DA; Wexler, RR; Quan, ML	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50448583	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50448583&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	1T5	4NA7	60154989	194946479		CHEMBL3127491					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50248503	NC[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](Cc1ccccc1)c1cc(n[nH]1)-c1ccccc1			50032870	CHEMBL3355687	Plasma kallikrein		 5023								ChEMBL	10.1021/jm5010607	10.7270/Q2RV0Q9S	25405503			Hangeland, JJ; Friends, TJ; Rossi, KA; Smallheer, JM; Wang, C; Sun, Z; Corte, JR; Fang, T; Wong, PC; Rendina, AR; Barbera, FA; Bozarth, JM; Luettgen, JM; Watson, CA; Zhang, G; Wei, A; Ramamurthy, V; Morin, PE; Bisacchi, GS; Subramaniam, S; Arunachalam, P; Mathur, A; Seiffert, DA; Wexler, RR; Quan, ML	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50032870	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50032870&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118987627	313066251		CHEMBL3355687					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50248504	NC[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](Cc1ccccc1)c1nn(-c2ccccc2)c(=O)[nH]1			50032868	CHEMBL3355688	Plasma kallikrein		 4820								ChEMBL	10.1021/jm5010607	10.7270/Q2RV0Q9S	25405503			Hangeland, JJ; Friends, TJ; Rossi, KA; Smallheer, JM; Wang, C; Sun, Z; Corte, JR; Fang, T; Wong, PC; Rendina, AR; Barbera, FA; Bozarth, JM; Luettgen, JM; Watson, CA; Zhang, G; Wei, A; Ramamurthy, V; Morin, PE; Bisacchi, GS; Subramaniam, S; Arunachalam, P; Mathur, A; Seiffert, DA; Wexler, RR; Quan, ML	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50032868	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50032868&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			66674633	313066250		CHEMBL3355688					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50248505	NC[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](Cc1ccccc1)c1c[nH]c(n1)-c1ccccc1			50032867	CHEMBL3355689	Plasma kallikrein		 4500								ChEMBL	10.1021/jm5010607	10.7270/Q2RV0Q9S	25405503			Hangeland, JJ; Friends, TJ; Rossi, KA; Smallheer, JM; Wang, C; Sun, Z; Corte, JR; Fang, T; Wong, PC; Rendina, AR; Barbera, FA; Bozarth, JM; Luettgen, JM; Watson, CA; Zhang, G; Wei, A; Ramamurthy, V; Morin, PE; Bisacchi, GS; Subramaniam, S; Arunachalam, P; Mathur, A; Seiffert, DA; Wexler, RR; Quan, ML	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50032867	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50032867&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			66674475	313066249		CHEMBL3355689					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50270417	COc1ccc(cc1)-n1nc(C(N)=O)c2CCN(C(=O)c12)c1ccc(cc1)C(C)(C)CO	InChI=1S/C24H26N4O4/c1-24(2,14-29)15-4-6-16(7-5-15)27-13-12-19-20(22(25)30)26-28(21(19)23(27)31)17-8-10-18(32-3)11-9-17/h4-11,29H,12-14H2,1-3H3,(H2,25,30)	OKARASJFKYWZSK-UHFFFAOYSA-N	50046425	CHEMBL3314440	Plasma kallikrein		>11000								ChEMBL	10.1016/j.bmcl.2014.05.101	10.7270/Q2Z039R1	24951330			Orwat, MJ; Qiao, JX; He, K; Rendina, AR; Luettgen, JM; Rossi, KA; Xin, B; Knabb, RM; Wexler, RR; Lam, PY; Pinto, DJ	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50046425	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50046425&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			59020200	103977210		CHEMBL3314440				ZINC95546482	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50261172	CN(C)Cc1ccc(cc1)C(=O)Nc1ccc(Cl)cc1C(=O)Nc1ccc(Cl)cn1	InChI=1S/C22H20Cl2N4O2/c1-28(2)13-14-3-5-15(6-4-14)21(29)26-19-9-7-16(23)11-18(19)22(30)27-20-10-8-17(24)12-25-20/h3-12H,13H2,1-2H3,(H,26,29)(H,25,27,30)	MNVTXUPCTQRIEV-UHFFFAOYSA-N	50142146	5-Chloro-N-(5-chloro-pyridin-2-yl)-2-(4-dimethylaminomethyl-benzoylamino)-benzamide::CHEMBL369086	Plasma kallikrein			 500							ChEMBL	10.1016/j.bmcl.2003.11.080	10.7270/Q2X34WXD	15013007			Zhang, P; Bao, L; Zuckett, JF; Jia, ZJ; Woolfrey, J; Arfsten, A; Edwards, S; Sinha, U; Hutchaleelaha, A; Lambing, JL; Hollenbach, SJ; Scarborough, RM; Zhu, BY	Millennium Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50142146	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50142146&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			44385935	104031576		CHEMBL369086				ZINC28098610	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50261179	CN(Cc1ccc(cc1)C(=O)Nc1ccc(Cl)cc1C(=O)Nc1ccc(Cl)cn1)C(N)=N	InChI=1S/C22H20Cl2N6O2/c1-30(22(25)26)12-13-2-4-14(5-3-13)20(31)28-18-8-6-15(23)10-17(18)21(32)29-19-9-7-16(24)11-27-19/h2-11H,12H2,1H3,(H3,25,26)(H,28,31)(H,27,29,32)	RTAQWGSGYVZCLM-UHFFFAOYSA-N	50142139	5-Chloro-N-(5-chloro-pyridin-2-yl)-2-{4-[(N-methyl-guanidino)-methyl]-benzoylamino}-benzamide::CHEMBL174558	Plasma kallikrein			 380							ChEMBL	10.1016/j.bmcl.2003.11.080	10.7270/Q2X34WXD	15013007			Zhang, P; Bao, L; Zuckett, JF; Jia, ZJ; Woolfrey, J; Arfsten, A; Edwards, S; Sinha, U; Hutchaleelaha, A; Lambing, JL; Hollenbach, SJ; Scarborough, RM; Zhu, BY	Millennium Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50142139	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50142139&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			44386059	104031569		CHEMBL174558				ZINC28089155	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50261241	NC1=NCCN1Cc1ccc(cc1)C(=O)Nc1ccc(Cl)cc1C(=O)Nc1ccc(Cl)cn1	InChI=1S/C23H20Cl2N6O2/c24-16-5-7-19(18(11-16)22(33)30-20-8-6-17(25)12-28-20)29-21(32)15-3-1-14(2-4-15)13-31-10-9-27-23(31)26/h1-8,11-12H,9-10,13H2,(H2,26,27)(H,29,32)(H,28,30,33)	PQVFCLMXCUWYFV-UHFFFAOYSA-N	50142158	5-Chloro-N-(5-chloro-pyridin-2-yl)-2-[4-(2-imino-imidazolidin-1-ylmethyl)-benzoylamino]-benzamide::5-chloro-N-(5-chloropyridin-2-yl)-2-(4-((2-iminoimidazolidin-1-yl)methyl)benzamido)benzamide::CHEMBL172360	Plasma kallikrein			 210							ChEMBL	10.1016/j.bmcl.2003.11.080	10.7270/Q2X34WXD	15013007			Zhang, P; Bao, L; Zuckett, JF; Jia, ZJ; Woolfrey, J; Arfsten, A; Edwards, S; Sinha, U; Hutchaleelaha, A; Lambing, JL; Hollenbach, SJ; Scarborough, RM; Zhu, BY	Millennium Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50142158	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50142158&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			44385679	104031588		CHEMBL172360				ZINC28014765	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50261265	Clc1ccc(NC(=O)c2cc(Cl)ccc2NC(=O)c2ccc(CN3CCOC3=N)cc2)nc1	InChI=1S/C23H19Cl2N5O3/c24-16-5-7-19(18(11-16)22(32)29-20-8-6-17(25)12-27-20)28-21(31)15-3-1-14(2-4-15)13-30-9-10-33-23(30)26/h1-8,11-12,26H,9-10,13H2,(H,28,31)(H,27,29,32)	QTXVVWRWTOUXLI-UHFFFAOYSA-N	50142163	5-Chloro-N-(5-chloro-pyridin-2-yl)-2-[4-(2-imino-oxazolidin-3-ylmethyl)-benzoylamino]-benzamide::5-chloro-N-(5-chloropyridin-2-yl)-2-(4-((2-iminooxazolidin-3-yl)methyl)benzamido)benzamide::CHEMBL367953	Plasma kallikrein			 560.0							ChEMBL	10.1016/j.bmcl.2003.11.080	10.7270/Q2X34WXD	15013007			Zhang, P; Bao, L; Zuckett, JF; Jia, ZJ; Woolfrey, J; Arfsten, A; Edwards, S; Sinha, U; Hutchaleelaha, A; Lambing, JL; Hollenbach, SJ; Scarborough, RM; Zhu, BY	Millennium Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50142163	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50142163&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			10480463	104031593		CHEMBL367953				ZINC03948383	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50261311	CN(Cc1ccc(cc1)C(=O)Nc1ccc(Cl)cc1C(=O)Nc1ccc(Cl)cn1)C1=NCCN1C	InChI=1S/C25H24Cl2N6O2/c1-32-12-11-28-25(32)33(2)15-16-3-5-17(6-4-16)23(34)30-21-9-7-18(26)13-20(21)24(35)31-22-10-8-19(27)14-29-22/h3-10,13-14H,11-12,15H2,1-2H3,(H,30,34)(H,29,31,35)	HSOCJKVGABNCFC-UHFFFAOYSA-N	50142161	5-Chloro-N-(5-chloro-pyridin-2-yl)-2-(4-{[methyl-(1-methyl-4,5-dihydro-1H-imidazol-2-yl)-amino]-methyl}-benzoylamino)-benzamide::CHEMBL175130	Plasma kallikrein			 300							ChEMBL	10.1016/j.bmcl.2003.11.080	10.7270/Q2X34WXD	15013007			Zhang, P; Bao, L; Zuckett, JF; Jia, ZJ; Woolfrey, J; Arfsten, A; Edwards, S; Sinha, U; Hutchaleelaha, A; Lambing, JL; Hollenbach, SJ; Scarborough, RM; Zhu, BY	Millennium Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50142161	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50142161&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			18727836	104031591		CHEMBL175130				ZINC28094529	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50261339	CNC(=N)N(C)Cc1ccc(cc1)C(=O)Nc1ccc(Cl)cc1C(=O)Nc1ccc(Cl)cn1	InChI=1S/C23H22Cl2N6O2/c1-27-23(26)31(2)13-14-3-5-15(6-4-14)21(32)29-19-9-7-16(24)11-18(19)22(33)30-20-10-8-17(25)12-28-20/h3-12H,13H2,1-2H3,(H2,26,27)(H,29,32)(H,28,30,33)	ZZWYWUIPVCUVLM-UHFFFAOYSA-N	50142169	5-Chloro-N-(5-chloro-pyridin-2-yl)-2-[4-(N,N'-dimethyl-guanidinomethyl)-benzoylamino]-benzamide::CHEMBL369681	Plasma kallikrein			 790.0							ChEMBL	10.1016/j.bmcl.2003.11.080	10.7270/Q2X34WXD	15013007			Zhang, P; Bao, L; Zuckett, JF; Jia, ZJ; Woolfrey, J; Arfsten, A; Edwards, S; Sinha, U; Hutchaleelaha, A; Lambing, JL; Hollenbach, SJ; Scarborough, RM; Zhu, BY	Millennium Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50142169	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50142169&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			44385998	104031599		CHEMBL369681				ZINC28099250	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50261391	CN(C)NCc1ccc(cc1)C(=O)Nc1ccc(Cl)cc1C(=O)Nc1ccc(Cl)cn1	InChI=1S/C22H21Cl2N5O2/c1-29(2)26-12-14-3-5-15(6-4-14)21(30)27-19-9-7-16(23)11-18(19)22(31)28-20-10-8-17(24)13-25-20/h3-11,13,26H,12H2,1-2H3,(H,27,30)(H,25,28,31)	XPKNJXWMMWULIE-UHFFFAOYSA-N	50142142	5-Chloro-N-(5-chloro-pyridin-2-yl)-2-[4-(N',N'-dimethyl-hydrazinomethyl)-benzoylamino]-benzamide::CHEMBL176671	Plasma kallikrein			 640							ChEMBL	10.1016/j.bmcl.2003.11.080	10.7270/Q2X34WXD	15013007			Zhang, P; Bao, L; Zuckett, JF; Jia, ZJ; Woolfrey, J; Arfsten, A; Edwards, S; Sinha, U; Hutchaleelaha, A; Lambing, JL; Hollenbach, SJ; Scarborough, RM; Zhu, BY	Millennium Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50142142	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50142142&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			44385729	104031572		CHEMBL176671				ZINC28022740	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50261443	CN(Cc1ccc(cc1)C(=O)Nc1ccc(Cl)cc1C(=O)Nc1ccc(Cl)cn1)C(C)=N	InChI=1S/C23H21Cl2N5O2/c1-14(26)30(2)13-15-3-5-16(6-4-15)22(31)28-20-9-7-17(24)11-19(20)23(32)29-21-10-8-18(25)12-27-21/h3-12,26H,13H2,1-2H3,(H,28,31)(H,27,29,32)	XKNLDUVCXUEIJO-UHFFFAOYSA-N	50142177	2-{4-[(Acetimidoyl-methyl-amino)-methyl]-benzoylamino}-5-chloro-N-(5-chloro-pyridin-2-yl)-benzamide::CHEMBL176243	Plasma kallikrein			 500							ChEMBL	10.1016/j.bmcl.2003.11.080	10.7270/Q2X34WXD	15013007			Zhang, P; Bao, L; Zuckett, JF; Jia, ZJ; Woolfrey, J; Arfsten, A; Edwards, S; Sinha, U; Hutchaleelaha, A; Lambing, JL; Hollenbach, SJ; Scarborough, RM; Zhu, BY	Millennium Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50142177	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50142177&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			44386934	104031607		CHEMBL176243				ZINC28110512	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50261464	C[N+](C)(C)Cc1ccc(cc1)C(=O)Nc1ccc(Cl)cc1C(=O)Nc1ccc(Cl)cn1	InChI=1S/C23H22Cl2N4O2/c1-29(2,3)14-15-4-6-16(7-5-15)22(30)27-20-10-8-17(24)12-19(20)23(31)28-21-11-9-18(25)13-26-21/h4-13H,14H2,1-3H3,(H-,26,27,28,30,31)/p+1	QQJRQLNVCYHBED-UHFFFAOYSA-O	50142154	CHEMBL174499::{4-[4-Chloro-2-(5-chloro-pyridin-2-ylcarbamoyl)-phenylcarbamoyl]-benzyl}-trimethyl-ammonium	Plasma kallikrein			 130							ChEMBL	10.1016/j.bmcl.2003.11.080	10.7270/Q2X34WXD	15013007			Zhang, P; Bao, L; Zuckett, JF; Jia, ZJ; Woolfrey, J; Arfsten, A; Edwards, S; Sinha, U; Hutchaleelaha, A; Lambing, JL; Hollenbach, SJ; Scarborough, RM; Zhu, BY	Millennium Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50142154	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50142154&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			9959749	104031584		CHEMBL174499				ZINC34049451	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50298045	NC[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](Cc1ccccc1)c1nc(c(Cl)[nH]1)-c1ccc2c(N)n[nH]c2c1	InChI=1S/C26H28ClN7O/c27-23-22(18-10-11-19-20(13-18)33-34-24(19)29)31-25(32-23)21(12-15-4-2-1-3-5-15)30-26(35)17-8-6-16(14-28)7-9-17/h1-5,10-11,13,16-17,21H,6-9,12,14,28-29H2,(H,30,35)/b22-18-/t16-,17-,21-/m0/s1	JOQPSWPCSAWTEY-PGKZFUBTSA-N	50063581	CHEMBL3398612	Plasma kallikrein		 5.0								ChEMBL	10.1016/j.bmcl.2015.01.028	10.7270/Q2319XJN	25728130			Pinto, DJ; Smallheer, JM; Corte, JR; Austin, EJ; Wang, C; Fang, T; Smith, LM; Rossi, KA; Rendina, AR; Bozarth, JM; Zhang, G; Wei, A; Ramamurthy, V; Sheriff, S; Myers, JE; Morin, PE; Luettgen, JM; Seiffert, DA; Quan, ML; Wexler, RR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50063581	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50063581&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			11684611	313071065		CHEMBL3398612					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50298046	COC(=O)Nc1ccc(cc1)-c1c[nH]c(n1)[C@H](Cc1ccccc1)NC(=O)\C=C\c1cc(Cl)ccc1-n1cnnn1			50063582	CHEMBL3398642	Plasma kallikrein		 240								ChEMBL	10.1016/j.bmcl.2015.01.028	10.7270/Q2319XJN	25728130			Pinto, DJ; Smallheer, JM; Corte, JR; Austin, EJ; Wang, C; Fang, T; Smith, LM; Rossi, KA; Rendina, AR; Bozarth, JM; Zhang, G; Wei, A; Ramamurthy, V; Sheriff, S; Myers, JE; Morin, PE; Luettgen, JM; Seiffert, DA; Quan, ML; Wexler, RR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50063582	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50063582&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			57976446	313071066		CHEMBL3398642					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50298047	Nc1n[nH]c2cc(ccc12)-c1nc([nH]c1Cl)[C@H](Cc1ccccc1)NC(=O)\C=C\c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C28H20Cl2N10O/c29-19-8-10-23(40-15-32-38-39-40)17(13-19)7-11-24(41)33-22(12-16-4-2-1-3-5-16)28-34-25(26(30)35-28)18-6-9-20-21(14-18)36-37-27(20)31/h1-11,13-15,22H,12,31H2,(H,33,41)/b11-7+,25-18-/t22-/m0/s1	MAOCGEBGEDRKAA-UVSILEEUSA-N	50063583	CHEMBL3398644	Plasma kallikrein		 41								ChEMBL	10.1016/j.bmcl.2015.01.028	10.7270/Q2319XJN	25728130			Pinto, DJ; Smallheer, JM; Corte, JR; Austin, EJ; Wang, C; Fang, T; Smith, LM; Rossi, KA; Rendina, AR; Bozarth, JM; Zhang, G; Wei, A; Ramamurthy, V; Sheriff, S; Myers, JE; Morin, PE; Luettgen, JM; Seiffert, DA; Quan, ML; Wexler, RR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50063583	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50063583&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			57976444	313071067		CHEMBL3398644					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50323533	Cc1cc2cc(ccc2o1)N=C(N[C@H]1CCCCN(CC(=O)N2CCCC2)C1=O)C(C#N)C(=O)OCCCCO	InChI=1S/C29H37N5O6/c1-20-16-21-17-22(9-10-25(21)40-20)31-27(23(18-30)29(38)39-15-7-6-14-35)32-24-8-2-3-13-34(28(24)37)19-26(36)33-11-4-5-12-33/h9-10,16-17,23-24,35H,2-8,11-15,19H2,1H3,(H,31,32)/t23?,24-/m0/s1	CMLPKFXOBMIEHA-CGAIIQECSA-N	50175075	(S,Z)-4-hydroxybutyl 2-cyano-3-(2-methylbenzofuran-5-ylamino)-3-(2-oxo-1-(2-oxo-2-(pyrrolidin-1-yl)ethyl)azepan-3-ylamino)acrylate::CHEMBL198629	Plasma kallikrein		>19400								ChEMBL	10.1016/j.bmcl.2005.08.107	10.7270/Q2KH0MW5	16213711			Shi, Y; Zhang, J; Stein, PD; Shi, M; O'Connor, SP; Bisaha, SN; Li, C; Atwal, KS; Bisacchi, GS; Sitkoff, D; Pudzianowski, AT; Liu, EC; Hartl, KS; Seiler, SM; Youssef, S; Steinbacher, TE; Schumacher, WA; Rendina, AR; Bozarth, JM; Peterson, TL; Zhang, G; Zahler, R	Bristol-Myers Squibb Pharmaceutical Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50175075	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50175075&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90928933	104060816		CHEMBL198629				ZINC34689198	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50334425	NC(=N)c1ccc2nc([nH]c2c1)-c1cc(cc(-c2cccc(Cl)c2)c1O)C(CC(O)=O)C(O)=O	InChI=1S/C24H19ClN4O5/c25-14-3-1-2-11(6-14)15-7-13(16(24(33)34)10-20(30)31)8-17(21(15)32)23-28-18-5-4-12(22(26)27)9-19(18)29-23/h1-9,16,32H,10H2,(H3,26,27)(H,28,29)(H,30,31)(H,33,34)	FXBYCOIBSNRTHQ-UHFFFAOYSA-N	14917	2-[3-(5-carbamimidoyl-1H-1,3-benzodiazol-2-yl)-5-(3-chlorophenyl)-4-hydroxyphenyl]butanedioic acid::5-amidino benzimidazole analog 28::CHEMBL203055	Plasma kallikrein		 3								ChEMBL	10.1016/j.bmcl.2005.12.060	10.7270/Q2P55N3N	16413183			Young, WB; Rai, R; Shrader, WD; Burgess-Henry, J; Hu, H; Elrod, KC; Sprengeler, PA; Katz, BA; Sukbuntherng, J; Mordenti, J	Celera Genomics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=14917	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=14917&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			23646902	46515236		CHEMBL203055				ZINC14956893	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50334426	Cc1cccc(c1)-c1cc(cc(-c2nc3ccc(cc3[nH]2)C(N)=N)c1O)C(CC(O)=O)C(O)=O	InChI=1S/C25H22N4O5/c1-12-3-2-4-13(7-12)16-8-15(17(25(33)34)11-21(30)31)9-18(22(16)32)24-28-19-6-5-14(23(26)27)10-20(19)29-24/h2-10,17,32H,11H2,1H3,(H3,26,27)(H,28,29)(H,30,31)(H,33,34)	WNBXSHDGFJUTNR-UHFFFAOYSA-N	14914	2-[3-(5-carbamimidoyl-1H-1,3-benzodiazol-2-yl)-4-hydroxy-5-(3-methylphenyl)phenyl]butanedioic acid::5-amidino benzimidazole analog 25::CHEMBL205208	Plasma kallikrein		 4								ChEMBL	10.1016/j.bmcl.2005.12.060	10.7270/Q2P55N3N	16413183			Young, WB; Rai, R; Shrader, WD; Burgess-Henry, J; Hu, H; Elrod, KC; Sprengeler, PA; Katz, BA; Sukbuntherng, J; Mordenti, J	Celera Genomics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=14914	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=14914&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			23646899	46515233		CHEMBL205208				ZINC14956872	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50334427	COc1ccccc1-c1cc(cc(-c2nc3ccc(cc3[nH]2)C(N)=N)c1O)C(CC(O)=O)C(O)=O	InChI=1S/C25H22N4O6/c1-35-20-5-3-2-4-14(20)16-8-13(15(25(33)34)11-21(30)31)9-17(22(16)32)24-28-18-7-6-12(23(26)27)10-19(18)29-24/h2-10,15,32H,11H2,1H3,(H3,26,27)(H,28,29)(H,30,31)(H,33,34)	HVNXYZZCSQONQC-UHFFFAOYSA-N	14927	2-[3-(5-carbamimidoyl-1H-1,3-benzodiazol-2-yl)-4-hydroxy-5-(2-methoxyphenyl)phenyl]butanedioic acid::5-amidino benzimidazole analog 38::CHEMBL381120	Plasma kallikrein		 6								ChEMBL	10.1016/j.bmcl.2005.12.060	10.7270/Q2P55N3N	16413183			Young, WB; Rai, R; Shrader, WD; Burgess-Henry, J; Hu, H; Elrod, KC; Sprengeler, PA; Katz, BA; Sukbuntherng, J; Mordenti, J	Celera Genomics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=14927	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=14927&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search		1O2Z	23646910	46515245		CHEMBL381120				ZINC14956963	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50334428	Cc1ccc(cc1)-c1cc(cc(-c2nc3ccc(cc3[nH]2)C(N)=N)c1O)C(CC(O)=O)C(O)=O	InChI=1S/C25H22N4O5/c1-12-2-4-13(5-3-12)16-8-15(17(25(33)34)11-21(30)31)9-18(22(16)32)24-28-19-7-6-14(23(26)27)10-20(19)29-24/h2-10,17,32H,11H2,1H3,(H3,26,27)(H,28,29)(H,30,31)(H,33,34)	FGURUUFOCDEVRF-UHFFFAOYSA-N	14937	2-[3-(5-carbamimidoyl-1H-1,3-benzodiazol-2-yl)-4-hydroxy-5-(4-methylphenyl)phenyl]butanedioic acid::5-amidino benzimidazole analog 48::CHEMBL205771	Plasma kallikrein		 18								ChEMBL	10.1016/j.bmcl.2005.12.060	10.7270/Q2P55N3N	16413183			Young, WB; Rai, R; Shrader, WD; Burgess-Henry, J; Hu, H; Elrod, KC; Sprengeler, PA; Katz, BA; Sukbuntherng, J; Mordenti, J	Celera Genomics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=14937	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=14937&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			23646920	46515255		CHEMBL205771				ZINC14957026	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50334429	Cc1ccccc1-c1cc(cc(-c2nc3ccc(cc3[nH]2)C(N)=N)c1O)C(CC(O)=O)C(O)=O	InChI=1S/C25H22N4O5/c1-12-4-2-3-5-15(12)17-8-14(16(25(33)34)11-21(30)31)9-18(22(17)32)24-28-19-7-6-13(23(26)27)10-20(19)29-24/h2-10,16,32H,11H2,1H3,(H3,26,27)(H,28,29)(H,30,31)(H,33,34)	LLJXUBIQRITYHZ-UHFFFAOYSA-N	14939	2-[3-(5-carbamimidoyl-1H-1,3-benzodiazol-2-yl)-4-hydroxy-5-(2-methylphenyl)phenyl]butanedioic acid::5-amidino benzimidazole analog 50::CHEMBL204283	Plasma kallikrein		 6								ChEMBL	10.1016/j.bmcl.2005.12.060	10.7270/Q2P55N3N	16413183			Young, WB; Rai, R; Shrader, WD; Burgess-Henry, J; Hu, H; Elrod, KC; Sprengeler, PA; Katz, BA; Sukbuntherng, J; Mordenti, J	Celera Genomics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=14939	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=14939&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			23646922	46515257		CHEMBL204283				ZINC14957042	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50334430	NC(=N)c1ccc2nc([nH]c2c1)-c1cc(cc(-c2ccc(O)cc2)c1O)C(CC(O)=O)C(O)=O	InChI=1S/C24H20N4O6/c25-22(26)12-3-6-18-19(9-12)28-23(27-18)17-8-13(16(24(33)34)10-20(30)31)7-15(21(17)32)11-1-4-14(29)5-2-11/h1-9,16,29,32H,10H2,(H3,25,26)(H,27,28)(H,30,31)(H,33,34)	VWHRLIBRGCHQPR-UHFFFAOYSA-N	14943	2-[3-(5-carbamimidoyl-1H-1,3-benzodiazol-2-yl)-4-hydroxy-5-(4-hydroxyphenyl)phenyl]butanedioic acid::5-amidino benzimidazole analog 54::CHEMBL205880	Plasma kallikrein		 65								ChEMBL	10.1016/j.bmcl.2005.12.060	10.7270/Q2P55N3N	16413183			Young, WB; Rai, R; Shrader, WD; Burgess-Henry, J; Hu, H; Elrod, KC; Sprengeler, PA; Katz, BA; Sukbuntherng, J; Mordenti, J	Celera Genomics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=14943	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=14943&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			23646926	46515261		CHEMBL205880				ZINC14957071	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50334431	NC(=N)c1ccc2nc([nH]c2c1)-c1cc(cc(-c2cccc(c2)C#N)c1O)C(CC(O)=O)C(O)=O	InChI=1S/C25H19N5O5/c26-11-12-2-1-3-13(6-12)16-7-15(17(25(34)35)10-21(31)32)8-18(22(16)33)24-29-19-5-4-14(23(27)28)9-20(19)30-24/h1-9,17,33H,10H2,(H3,27,28)(H,29,30)(H,31,32)(H,34,35)	GGKPWIXGKBVTFC-UHFFFAOYSA-N	14920	2-[3-(5-carbamimidoyl-1H-1,3-benzodiazol-2-yl)-5-(3-cyanophenyl)-4-hydroxyphenyl]butanedioic acid::5-amidino benzimidazole analog 31::CHEMBL205128	Plasma kallikrein		 10								ChEMBL	10.1016/j.bmcl.2005.12.060	10.7270/Q2P55N3N	16413183			Young, WB; Rai, R; Shrader, WD; Burgess-Henry, J; Hu, H; Elrod, KC; Sprengeler, PA; Katz, BA; Sukbuntherng, J; Mordenti, J	Celera Genomics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=14920	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=14920&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			23646905	46515239		CHEMBL205128				ZINC14956918	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50334432	COc1cccc(c1)-c1cc(cc(-c2nc3ccc(cc3[nH]2)C(N)=N)c1O)C(CC(O)=O)C(O)=O	InChI=1S/C25H22N4O6/c1-35-15-4-2-3-12(7-15)16-8-14(17(25(33)34)11-21(30)31)9-18(22(16)32)24-28-19-6-5-13(23(26)27)10-20(19)29-24/h2-10,17,32H,11H2,1H3,(H3,26,27)(H,28,29)(H,30,31)(H,33,34)	ZINRKMQKYFVMPO-UHFFFAOYSA-N	50180516	2-[5-(5-carbamimidoyl-1H-benzoimidazol-2-yl)-6-hydroxy-3'-methoxy-biphenyl-3-yl]-succinic acid::CHEMBL204614	Plasma kallikrein		 5								ChEMBL	10.1016/j.bmcl.2005.12.060	10.7270/Q2P55N3N	16413183			Young, WB; Rai, R; Shrader, WD; Burgess-Henry, J; Hu, H; Elrod, KC; Sprengeler, PA; Katz, BA; Sukbuntherng, J; Mordenti, J	Celera Genomics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50180516	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50180516&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			44410135	104065596		CHEMBL204614				ZINC36242969	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50334433	NC(=N)c1ccc2nc([nH]c2c1)-c1cc(cc(c1O)-c1ccccc1F)C(CC(O)=O)C(O)=O	InChI=1S/C24H19FN4O5/c25-17-4-2-1-3-13(17)15-7-12(14(24(33)34)10-20(30)31)8-16(21(15)32)23-28-18-6-5-11(22(26)27)9-19(18)29-23/h1-9,14,32H,10H2,(H3,26,27)(H,28,29)(H,30,31)(H,33,34)	XCOFROALSAFROV-UHFFFAOYSA-N	14929	2-[3-(5-carbamimidoyl-1H-1,3-benzodiazol-2-yl)-5-(2-fluorophenyl)-4-hydroxyphenyl]butanedioic acid::5-amidino benzimidazole analog 40::CHEMBL203008	Plasma kallikrein		 12								ChEMBL	10.1016/j.bmcl.2005.12.060	10.7270/Q2P55N3N	16413183			Young, WB; Rai, R; Shrader, WD; Burgess-Henry, J; Hu, H; Elrod, KC; Sprengeler, PA; Katz, BA; Sukbuntherng, J; Mordenti, J	Celera Genomics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=14929	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=14929&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search		1O30	23646912	46515247		CHEMBL203008				ZINC12501046	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50334434	NC(=N)c1ccc2nc([nH]c2c1)-c1cc(cc(-c2ccccc2)c1O)C(CC(O)=O)C(O)=O	InChI=1S/C24H20N4O5/c25-22(26)13-6-7-18-19(10-13)28-23(27-18)17-9-14(16(24(32)33)11-20(29)30)8-15(21(17)31)12-4-2-1-3-5-12/h1-10,16,31H,11H2,(H3,25,26)(H,27,28)(H,29,30)(H,32,33)	FXLFNEVHWHPROF-UHFFFAOYSA-N	14897	2-[3-(5-carbamimidoyl-1H-1,3-benzodiazol-2-yl)-4-hydroxy-5-phenylphenyl]butanedioic acid::5-amidino benzimidazole analog 1::CHEMBL206069	Plasma kallikrein		 8								ChEMBL	10.1016/j.bmcl.2005.12.060	10.7270/Q2P55N3N	16413183			Young, WB; Rai, R; Shrader, WD; Burgess-Henry, J; Hu, H; Elrod, KC; Sprengeler, PA; Katz, BA; Sukbuntherng, J; Mordenti, J	Celera Genomics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=14897	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=14897&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			23646884	46515216		CHEMBL206069				ZINC14956750	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50334435	COc1ccc(cc1)-c1cc(cc(-c2nc3ccc(cc3[nH]2)C(N)=N)c1O)C(CC(O)=O)C(O)=O	InChI=1S/C25H22N4O6/c1-35-15-5-2-12(3-6-15)16-8-14(17(25(33)34)11-21(30)31)9-18(22(16)32)24-28-19-7-4-13(23(26)27)10-20(19)29-24/h2-10,17,32H,11H2,1H3,(H3,26,27)(H,28,29)(H,30,31)(H,33,34)	XSPQZTPEIVTUKK-UHFFFAOYSA-N	14944	2-[3-(5-carbamimidoyl-1H-1,3-benzodiazol-2-yl)-4-hydroxy-5-(4-methoxyphenyl)phenyl]butanedioic acid::5-amidino benzimidazole analog 55::CHEMBL381702	Plasma kallikrein		 27								ChEMBL	10.1016/j.bmcl.2005.12.060	10.7270/Q2P55N3N	16413183			Young, WB; Rai, R; Shrader, WD; Burgess-Henry, J; Hu, H; Elrod, KC; Sprengeler, PA; Katz, BA; Sukbuntherng, J; Mordenti, J	Celera Genomics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=14944	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=14944&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			23646927	46515262		CHEMBL381702				ZINC14957079	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50334436	NC(=N)c1ccc2nc([nH]c2c1)-c1cc(cc(-c2cccc(O)c2)c1O)C(CC(O)=O)C(O)=O	InChI=1S/C24H20N4O6/c25-22(26)12-4-5-18-19(9-12)28-23(27-18)17-8-13(16(24(33)34)10-20(30)31)7-15(21(17)32)11-2-1-3-14(29)6-11/h1-9,16,29,32H,10H2,(H3,25,26)(H,27,28)(H,30,31)(H,33,34)	AQESQZZCMQJOJU-UHFFFAOYSA-N	14921	2-[3-(5-carbamimidoyl-1H-1,3-benzodiazol-2-yl)-4-hydroxy-5-(3-hydroxyphenyl)phenyl]butanedioic acid::5-amidino benzimidazole analog 32::CHEMBL382418	Plasma kallikrein		 3								ChEMBL	10.1016/j.bmcl.2005.12.060	10.7270/Q2P55N3N	16413183			Young, WB; Rai, R; Shrader, WD; Burgess-Henry, J; Hu, H; Elrod, KC; Sprengeler, PA; Katz, BA; Sukbuntherng, J; Mordenti, J	Celera Genomics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=14921	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=14921&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			23646906	46515240		CHEMBL382418				ZINC14956925	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50334437	NC(=N)c1ccc2nc([nH]c2c1)-c1cc(cc(c1O)-c1ccccc1O)C(CC(O)=O)C(O)=O	InChI=1S/C24H20N4O6/c25-22(26)11-5-6-17-18(9-11)28-23(27-17)16-8-12(14(24(33)34)10-20(30)31)7-15(21(16)32)13-3-1-2-4-19(13)29/h1-9,14,29,32H,10H2,(H3,25,26)(H,27,28)(H,30,31)(H,33,34)	ZWPGTVHFMUKOEV-UHFFFAOYSA-N	14903	2-[3-(5-carbamimidoyl-1H-1,3-benzodiazol-2-yl)-4-hydroxy-5-(2-hydroxyphenyl)phenyl]butanedioic acid::5-amidino benzimidazole analog 14::CHEMBL444622	Plasma kallikrein		 13								ChEMBL	10.1016/j.bmcl.2005.12.060	10.7270/Q2P55N3N	16413183			Young, WB; Rai, R; Shrader, WD; Burgess-Henry, J; Hu, H; Elrod, KC; Sprengeler, PA; Katz, BA; Sukbuntherng, J; Mordenti, J	Celera Genomics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=14903	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=14903&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			23646890	46515222		CHEMBL444622				ZINC14956794	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50334438	NC(=N)c1ccc2nc([nH]c2c1)-c1cc(cc(-c2ccc(Cl)cc2)c1O)C(CC(O)=O)C(O)=O	InChI=1S/C24H19ClN4O5/c25-14-4-1-11(2-5-14)15-7-13(16(24(33)34)10-20(30)31)8-17(21(15)32)23-28-18-6-3-12(22(26)27)9-19(18)29-23/h1-9,16,32H,10H2,(H3,26,27)(H,28,29)(H,30,31)(H,33,34)	DKGHIUFVWYTNAF-UHFFFAOYSA-N	14938	2-[3-(5-carbamimidoyl-1H-1,3-benzodiazol-2-yl)-5-(4-chlorophenyl)-4-hydroxyphenyl]butanedioic acid::5-amidino benzimidazole analog 49::CHEMBL206337	Plasma kallikrein		 37								ChEMBL	10.1016/j.bmcl.2005.12.060	10.7270/Q2P55N3N	16413183			Young, WB; Rai, R; Shrader, WD; Burgess-Henry, J; Hu, H; Elrod, KC; Sprengeler, PA; Katz, BA; Sukbuntherng, J; Mordenti, J	Celera Genomics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=14938	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=14938&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			23646921	46515256		CHEMBL206337				ZINC14957038	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50334439	CC(=O)c1cccc(c1)-c1cc(cc(-c2nc3ccc(cc3[nH]2)C(N)=N)c1O)C(CC(O)=O)C(O)=O	InChI=1S/C26H22N4O6/c1-12(31)13-3-2-4-14(7-13)17-8-16(18(26(35)36)11-22(32)33)9-19(23(17)34)25-29-20-6-5-15(24(27)28)10-21(20)30-25/h2-10,18,34H,11H2,1H3,(H3,27,28)(H,29,30)(H,32,33)(H,35,36)	YZJXJVFIOXDWAC-UHFFFAOYSA-N	14912	2-[3-(5-carbamimidoyl-1H-1,3-benzodiazol-2-yl)-5-(3-acetylphenyl)-4-hydroxyphenyl]butanedioic acid::5-amidino benzimidazole analog 23::CHEMBL379906	Plasma kallikrein		 6								ChEMBL	10.1016/j.bmcl.2005.12.060	10.7270/Q2P55N3N	16413183			Young, WB; Rai, R; Shrader, WD; Burgess-Henry, J; Hu, H; Elrod, KC; Sprengeler, PA; Katz, BA; Sukbuntherng, J; Mordenti, J	Celera Genomics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=14912	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=14912&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			23646897	46515231		CHEMBL379906				ZINC14956856	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50334440	NC(=N)c1ccc2nc([nH]c2c1)-c1cc(cc(-c2cccc(c2)C(N)=O)c1O)C(CC(O)=O)C(O)=O	InChI=1S/C25H21N5O6/c26-22(27)12-4-5-18-19(9-12)30-24(29-18)17-8-14(16(25(35)36)10-20(31)32)7-15(21(17)33)11-2-1-3-13(6-11)23(28)34/h1-9,16,33H,10H2,(H3,26,27)(H2,28,34)(H,29,30)(H,31,32)(H,35,36)	CBYXBTCUKCVBGI-UHFFFAOYSA-N	50180517	2-[5-(5-carbamimidoyl-1H-benzoimidazol-2-yl)-3'-carbamoyl-6-hydroxy-biphenyl-3-yl]-succinic acid::CHEMBL206454	Plasma kallikrein		 0.5								ChEMBL	10.1016/j.bmcl.2005.12.060	10.7270/Q2P55N3N	16413183			Young, WB; Rai, R; Shrader, WD; Burgess-Henry, J; Hu, H; Elrod, KC; Sprengeler, PA; Katz, BA; Sukbuntherng, J; Mordenti, J	Celera Genomics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50180517	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50180517&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			44410198	104065597		CHEMBL206454				ZINC28572523	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50347553	CCOC(=O)N[C@@H](CCCCN)C(=O)c1noc(Cc2ccc(OCCc3ccccc3)cc2)n1	InChI=1S/C26H32N4O5/c1-2-33-26(32)28-22(10-6-7-16-27)24(31)25-29-23(35-30-25)18-20-11-13-21(14-12-20)34-17-15-19-8-4-3-5-9-19/h3-5,8-9,11-14,22H,2,6-7,10,15-18,27H2,1H3,(H,28,32)/t22-/m0/s1	PQVCEZVKPWHTFF-QFIPXVFZSA-N	50187800	(S)-ethyl 1-(5-(4-phenethoxybenzyl)-1,2,4-oxadiazol-3-yl)-6-amino-1-oxohexan-2-ylcarbamate::CHEMBL211561	Plasma kallikrein		 43000								ChEMBL	10.1016/j.bmcl.2006.04.088	10.7270/Q2X929W7	16725321			Sperandio, D; Tai, VW; Lohman, J; Hirschbein, B; Mendonca, R; Lee, CS; Spencer, JR; Janc, J; Nguyen, M; Beltman, J; Sprengeler, P; Scheerens, H; Lin, T; Liu, L; Gadre, A; Kellogg, A; Green, MJ; McGrath, ME	Celera Genomics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50187800	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50187800&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			15984063	104071626		CHEMBL211561				ZINC34803967	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50360469	CN1CCN(CC1)C(=O)C[C@H](NC(=O)\C=C\c1cc(Cl)ccc1-n1cnnn1)c1nc(c(Cl)[nH]1)-c1ccc2[nH]c(=O)cc(O)c2c1	InChI=1S/C30H26Cl2N10O4/c1-40-8-10-41(11-9-40)27(46)14-22(35-25(44)7-3-17-12-19(31)4-6-23(17)42-16-33-38-39-42)30-36-28(29(32)37-30)18-2-5-21-20(13-18)24(43)15-26(45)34-21/h2-7,12-13,15-16,22,43H,8-11,14H2,1H3,(H,35,44)/b7-3+,28-18-/t22-/m0/s1	QURJCLPLOGZUQW-ZIMJUVOESA-N	50096792	CHEMBL3580759	Plasma kallikrein		 7.0								ChEMBL	10.1021/acsmedchemlett.5b00066	10.7270/Q2B27X24	26005539			Hu, Z; Wong, PC; Gilligan, PJ; Han, W; Pabbisetty, KB; Bozarth, JM; Crain, EJ; Harper, T; Luettgen, JM; Myers, JE; Ramamurthy, V; Rossi, KA; Sheriff, S; Watson, CA; Wei, A; Zheng, JJ; Seiffert, DA; Wexler, RR; Quan, ML	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50096792	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50096792&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	4CE	4Y8Z	122363020	319496385		CHEMBL3580759					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50374336	NC[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](Cc1ccccc1)c1cc(ccn1)-c1ccc2c(N)n[nH]c2c1			50103200	CHEMBL3393386	Plasma kallikrein		 24								ChEMBL	10.1016/j.bmcl.2014.12.050	10.7270/Q2CF9RWP	25592713			Corte, JR; Fang, T; Hangeland, JJ; Friends, TJ; Rendina, AR; Luettgen, JM; Bozarth, JM; Barbera, FA; Rossi, KA; Wei, A; Ramamurthy, V; Morin, PE; Seiffert, DA; Wexler, RR; Quan, ML	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50103200	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50103200&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86583041	318491166		CHEMBL3393386					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50366475	CCS(=O)(=O)c1ccc2NC(=O)CCCc3ccc(cc3C)[C@@H](Nc3ccc4c(N)nccc4c3)C(=O)NCc1c2	InChI=1S/C31H33N5O4S/c1-3-41(39,40)27-12-10-24-17-23(27)18-34-31(38)29(36-25-9-11-26-21(16-25)13-14-33-30(26)32)22-8-7-20(19(2)15-22)5-4-6-28(37)35-24/h7-17,29,36H,3-6,18H2,1-2H3,(H2,32,33)(H,34,38)(H,35,37)/t29-/m1/s1	YLOURKKYJRCESD-GDLZYMKVSA-N	50098595	CHEMBL3594314	Plasma kallikrein		 1700								ChEMBL	10.1021/acs.jmedchem.5b00788	10.7270/Q2DN46TN	26151189			Priestley, ES; Cheney, DL; DeLucca, I; Wei, A; Luettgen, JM; Rendina, AR; Wong, PC; Wexler, RR	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50098595	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50098595&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			57842913	318490490		CHEMBL3594314					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50366479	CCS(=O)(=O)c1ccc2NC(=O)CCCc3ccc(cc3)[C@@H](Nc3ccc(cc3)C(N)=N)C(=O)NCc1c2	InChI=1S/C28H31N5O4S/c1-2-38(36,37)24-15-14-23-16-21(24)17-31-28(35)26(33-22-12-10-20(11-13-22)27(29)30)19-8-6-18(7-9-19)4-3-5-25(34)32-23/h6-16,26,33H,2-5,17H2,1H3,(H3,29,30)(H,31,35)(H,32,34)/t26-/m1/s1	HLENBKTVSREWEE-AREMUKBSSA-N	50098596	CHEMBL3594313	Plasma kallikrein		 50								ChEMBL	10.1021/acs.jmedchem.5b00788	10.7270/Q2DN46TN	26151189			Priestley, ES; Cheney, DL; DeLucca, I; Wei, A; Luettgen, JM; Rendina, AR; Wong, PC; Wexler, RR	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50098596	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50098596&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			57842812	318490491		CHEMBL3594313					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50366484	CC(C)(C)S(=O)(=O)c1ccc2NC(=O)CCCc3ccc(cc3)C(Nc3ccc4c(N)nccc4c3)C(=O)NCc1c2	InChI=1S/C32H35N5O4S/c1-32(2,3)42(40,41)27-14-12-24-18-23(27)19-35-31(39)29(21-9-7-20(8-10-21)5-4-6-28(38)36-24)37-25-11-13-26-22(17-25)15-16-34-30(26)33/h7-18,29,37H,4-6,19H2,1-3H3,(H2,33,34)(H,35,39)(H,36,38)	ZOWREHOVFWKKPQ-UHFFFAOYSA-N	50098597	CHEMBL3594312	Plasma kallikrein		>6000								ChEMBL	10.1021/acs.jmedchem.5b00788	10.7270/Q2DN46TN	26151189			Priestley, ES; Cheney, DL; DeLucca, I; Wei, A; Luettgen, JM; Rendina, AR; Wong, PC; Wexler, RR	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50098597	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50098597&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			57842560	318490492		CHEMBL3594312					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50366494	CC(C)S(=O)(=O)c1ccc2NC(=O)CCCc3ccc(cc3)[C@@H](Nc3ccc4c(N)nccc4c3)C(=O)NCc1c2	InChI=1S/C31H33N5O4S/c1-19(2)41(39,40)27-13-11-24-17-23(27)18-34-31(38)29(21-8-6-20(7-9-21)4-3-5-28(37)35-24)36-25-10-12-26-22(16-25)14-15-33-30(26)32/h6-17,19,29,36H,3-5,18H2,1-2H3,(H2,32,33)(H,34,38)(H,35,37)/t29-/m1/s1	WZPQELXAUSQFQX-GDLZYMKVSA-N	50098598	CHEMBL3594311	Plasma kallikrein		 3600								ChEMBL	10.1021/acs.jmedchem.5b00788	10.7270/Q2DN46TN	26151189			Priestley, ES; Cheney, DL; DeLucca, I; Wei, A; Luettgen, JM; Rendina, AR; Wong, PC; Wexler, RR	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50098598	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50098598&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			57842624	318490493		CHEMBL3594311					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50366496	CCS(=O)(=O)c1ccc2NC(=O)CCCc3ccc(cc3)[C@@H](Nc3ccc4c(N)nccc4c3)C(=O)NCc1c2	InChI=1S/C30H31N5O4S/c1-2-40(38,39)26-13-11-23-17-22(26)18-33-30(37)28(20-8-6-19(7-9-20)4-3-5-27(36)34-23)35-24-10-12-25-21(16-24)14-15-32-29(25)31/h6-17,28,35H,2-5,18H2,1H3,(H2,31,32)(H,33,37)(H,34,36)/t28-/m1/s1	JODGCVISYXBBJZ-MUUNZHRXSA-N	50098599	CHEMBL3594310	Plasma kallikrein		 4600								ChEMBL	10.1021/acs.jmedchem.5b00788	10.7270/Q2DN46TN	26151189			Priestley, ES; Cheney, DL; DeLucca, I; Wei, A; Luettgen, JM; Rendina, AR; Wong, PC; Wexler, RR	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50098599	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50098599&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			57842850	318490494		CHEMBL3594310					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50366499	Nc1nccc2cc(N[C@@H]3c4ccc(CCCC(=O)Nc5cccc(CNC3=O)c5)cc4)ccc12	InChI=1S/C28H27N5O2/c29-27-24-12-11-23(16-21(24)13-14-30-27)33-26-20-9-7-18(8-10-20)3-2-6-25(34)32-22-5-1-4-19(15-22)17-31-28(26)35/h1,4-5,7-16,26,33H,2-3,6,17H2,(H2,29,30)(H,31,35)(H,32,34)/t26-/m1/s1	LXFPTSIBSQOGTO-AREMUKBSSA-N	50098591	CHEMBL3594305	Plasma kallikrein		>6000								ChEMBL	10.1021/acs.jmedchem.5b00788	10.7270/Q2DN46TN	26151189			Priestley, ES; Cheney, DL; DeLucca, I; Wei, A; Luettgen, JM; Rendina, AR; Wong, PC; Wexler, RR	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50098591	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50098591&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	4T1	4ZXY	57842673	318490486		CHEMBL3594305					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50394305	CCS(=O)(=O)N1C[C@@H](NC(=O)c2ccc(Cl)s2)[C@H](C1)NC(=O)c1ccc(cc1)-n1ccccc1=O	InChI=1S/C23H23ClN4O5S2/c1-2-35(32,33)27-13-17(18(14-27)26-23(31)19-10-11-20(24)34-19)25-22(30)15-6-8-16(9-7-15)28-12-4-3-5-21(28)29/h3-12,17-18H,2,13-14H2,1H3,(H,25,30)(H,26,31)/t17-,18+/m0/s1	YPEJQZNLCKSDCY-ZWKOTPCHSA-N	50218283	5-chloro-N-((3R,4S)-1-(ethylsulfonyl)-4-(4-(2-oxopyridin-1(2H)-yl)benzamido)pyrrolidin-3-yl)thiophene-2-carboxamide::CHEMBL392297	Plasma kallikrein		>10800								ChEMBL	10.1016/j.bmcl.2007.07.020	10.7270/Q23J3CPQ	17643988			Qiao, JX; Wang, TC; Wang, GZ; Cheney, DL; He, K; Rendina, AR; Xin, B; Luettgen, JM; Knabb, RM; Wexler, RR; Lam, PY	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50218283	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50218283&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			44434835	104092053		CHEMBL392297				ZINC28826231	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50394346	CCOC(=O)N1C[C@@H](NC(=O)c2ccc(Cl)s2)[C@H](C1)NC(=O)c1ccc(cc1)-n1ccccc1=O	InChI=1S/C24H23ClN4O5S/c1-2-34-24(33)28-13-17(18(14-28)27-23(32)19-10-11-20(25)35-19)26-22(31)15-6-8-16(9-7-15)29-12-4-3-5-21(29)30/h3-12,17-18H,2,13-14H2,1H3,(H,26,31)(H,27,32)/t17-,18+/m0/s1	VCOPBIUVMSEQNG-ZWKOTPCHSA-N	50218282	(3R,4S)-ethyl 3-(2-chlorothiophene-5-carboxamido)-4-(4-(2-oxopyridin-1(2H)-yl)benzamido)pyrrolidine-1-carboxylate::CHEMBL437555	Plasma kallikrein		>6000								ChEMBL	10.1016/j.bmcl.2007.07.020	10.7270/Q23J3CPQ	17643988			Qiao, JX; Wang, TC; Wang, GZ; Cheney, DL; He, K; Rendina, AR; Xin, B; Luettgen, JM; Knabb, RM; Wexler, RR; Lam, PY	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50218282	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50218282&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			24180463	104092052		CHEMBL437555				ZINC28826215	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50394362	OC(=O)[C@@H]1C[C@@H](NC(=O)c2ccc(Cl)s2)[C@H](C1)NC(=O)c1ccc(cc1)-n1ccccc1=O	InChI=1S/C23H20ClN3O5S/c24-19-9-8-18(33-19)22(30)26-17-12-14(23(31)32)11-16(17)25-21(29)13-4-6-15(7-5-13)27-10-2-1-3-20(27)28/h1-10,14,16-17H,11-12H2,(H,25,29)(H,26,30)(H,31,32)/t14-,16-,17+/m0/s1	YCMDRFHFKJJFQF-BHYGNILZSA-N	50218287	(1S,3R,4S)-3-(2-chlorothiophene-5-carboxamido)-4-(4-(2-oxopyridin-1(2H)-yl)benzamido)cyclopentanecarboxylic acid::CHEMBL401235	Plasma kallikrein		>6000								ChEMBL	10.1016/j.bmcl.2007.07.020	10.7270/Q23J3CPQ	17643988			Qiao, JX; Wang, TC; Wang, GZ; Cheney, DL; He, K; Rendina, AR; Xin, B; Luettgen, JM; Knabb, RM; Wexler, RR; Lam, PY	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50218287	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50218287&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			44434809	104092057		CHEMBL401235				ZINC28826183	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50394382	OC[C@@H]1C[C@@H](NC(=O)c2ccc(Cl)s2)[C@H](C1)NC(=O)c1ccc(cc1)-n1ccccc1=O	InChI=1S/C23H22ClN3O4S/c24-20-9-8-19(32-20)23(31)26-18-12-14(13-28)11-17(18)25-22(30)15-4-6-16(7-5-15)27-10-2-1-3-21(27)29/h1-10,14,17-18,28H,11-13H2,(H,25,30)(H,26,31)/t14-,17-,18+/m0/s1	LWARIAPUYJUPKK-JCGIZDLHSA-N	50218290	5-chloro-N-((1R,2S,4S)-4-(hydroxymethyl)-2-(4-(2-oxopyridin-1(2H)-yl)benzamido)cyclopentyl)thiophene-2-carboxamide::CHEMBL237065	Plasma kallikrein		>10800								ChEMBL	10.1016/j.bmcl.2007.07.020	10.7270/Q23J3CPQ	17643988			Qiao, JX; Wang, TC; Wang, GZ; Cheney, DL; He, K; Rendina, AR; Xin, B; Luettgen, JM; Knabb, RM; Wexler, RR; Lam, PY	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50218290	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50218290&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			44434808	104092060		CHEMBL237065				ZINC28826182	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50394383	CC(=O)N1C[C@@H](NC(=O)c2ccc(Cl)s2)[C@H](C1)NC(=O)c1ccc(cc1)-n1ccccc1=O	InChI=1S/C23H21ClN4O4S/c1-14(29)27-12-17(18(13-27)26-23(32)19-9-10-20(24)33-19)25-22(31)15-5-7-16(8-6-15)28-11-3-2-4-21(28)30/h2-11,17-18H,12-13H2,1H3,(H,25,31)(H,26,32)/t17-,18+/m0/s1	UBBAAVPYXDEHOX-ZWKOTPCHSA-N	50218291	CHEMBL394129::N-((3R,4S)-1-acetyl-4-(4-(2-oxopyridin-1(2H)-yl)benzamido)pyrrolidin-3-yl)-5-chlorothiophene-2-carboxamide	Plasma kallikrein		>6000								ChEMBL	10.1016/j.bmcl.2007.07.020	10.7270/Q23J3CPQ	17643988			Qiao, JX; Wang, TC; Wang, GZ; Cheney, DL; He, K; Rendina, AR; Xin, B; Luettgen, JM; Knabb, RM; Wexler, RR; Lam, PY	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50218291	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50218291&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			44434818	104092061		CHEMBL394129				ZINC28826208	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50381719	C[C@H](N1CC[C@H](NS(=O)(=O)\C=C(/C)c2ccc(Cl)s2)C1=O)C(=O)N1CCOCC1	InChI=1S/C18H24ClN3O5S2/c1-12(15-3-4-16(19)28-15)11-29(25,26)20-14-5-6-22(18(14)24)13(2)17(23)21-7-9-27-10-8-21/h3-4,11,13-14,20H,5-10H2,1-2H3/b12-11+/t13-,14-/m0/s1	YMJHMJLNQLVUAV-GHYUOPHCSA-N	50206984	(2R)-2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}PROPENE-1-SULFONAMIDE::(E)-2-(5-chlorothiophen-2-yl)-N-((S)-1-((S)-1-morpholino-1-oxopropan-2-yl)-2-oxopyrrolidin-3-yl)prop-1-ene-1-sulfonamide::2-(5-chlorothiophen-2-yl)-N-((S)-1-((S)-1-morpholino-1-oxopropan-2-yl)-2-oxopyrrolidin-3-yl)prop-1-ene-1-sulfonamide::CHEMBL391640	Plasma kallikrein			 5010							ChEMBL	10.1016/j.bmcl.2007.03.080	10.7270/Q22V2FTR	17420122			Young, RJ; Brown, D; Burns-Kurtis, CL; Chan, C; Convery, MA; Hubbard, JA; Kelly, HA; Pateman, AJ; Patikis, A; Senger, S; Shah, GP; Toomey, JR; Watson, NS; Zhou, P	GlaxoSmithKline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50206984	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50206984&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	701	2JH0,2UWO	10095865	104084775		CHEMBL391640	DB07211			ZINC16052246	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50381731	C[C@H](N1CC[C@H](NS(=O)(=O)\C=C\c2ccc(Cl)s2)C1=O)C(=O)N1CCOCC1	InChI=1S/C17H22ClN3O5S2/c1-12(16(22)20-7-9-26-10-8-20)21-6-4-14(17(21)23)19-28(24,25)11-5-13-2-3-15(18)27-13/h2-3,5,11-12,14,19H,4,6-10H2,1H3/b11-5+/t12-,14-/m0/s1	ACEFOQMQINFMRW-DYCFVMESSA-N	17643	(E)-2-(5-chlorothiophen-2-yl)-N-[(3S)-1-[(2S)-1-(morpholin-4-yl)-1-oxopropan-2-yl]-2-oxopyrrolidin-3-yl]ethene-1-sulfonamide::CHEMBL220050::N-[(3S)-2-oxopyrrolidin-3-yl]sulfonamide, 1f	Plasma kallikrein			 15800							ChEMBL	10.1016/j.bmcl.2007.03.080	10.7270/Q22V2FTR	17420122			Young, RJ; Brown, D; Burns-Kurtis, CL; Chan, C; Convery, MA; Hubbard, JA; Kelly, HA; Pateman, AJ; Patikis, A; Senger, S; Shah, GP; Toomey, JR; Watson, NS; Zhou, P	GlaxoSmithKline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17643	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=17643&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	895	2JH5,2UWL	9911502	46517805		CHEMBL220050	DB07278			ZINC14965157	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50381732	C[C@H](N1CC[C@H](NS(=O)(=O)CCc2ccc(Cl)s2)C1=O)C(=O)N1CCOCC1	InChI=1S/C17H24ClN3O5S2/c1-12(16(22)20-7-9-26-10-8-20)21-6-4-14(17(21)23)19-28(24,25)11-5-13-2-3-15(18)27-13/h2-3,12,14,19H,4-11H2,1H3/t12-,14-/m0/s1	IAUZEBLXCOCAFL-JSGCOSHPSA-N	50206985	2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHANESULFONAMIDE::2-(5-chlorothiophen-2-yl)-N-((S)-1-((S)-1-morpholino-1-oxopropan-2-yl)-2-oxopyrrolidin-3-yl)ethanesulfonamide::CHEMBL391737	Plasma kallikrein			 25100							ChEMBL	10.1016/j.bmcl.2007.03.080	10.7270/Q22V2FTR	17420122			Young, RJ; Brown, D; Burns-Kurtis, CL; Chan, C; Convery, MA; Hubbard, JA; Kelly, HA; Pateman, AJ; Patikis, A; Senger, S; Shah, GP; Toomey, JR; Watson, NS; Zhou, P	GlaxoSmithKline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50206985	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50206985&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	894	2JH6,2UWP	10343728	104084776		CHEMBL391737	DB07277			ZINC16052247	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50464384	CN[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)c1ccccc1	InChI=1S/C20H30N6O4/c1-23-16(13-7-3-2-4-8-13)18(28)26-12-6-10-15(26)17(27)25-14(19(29)30)9-5-11-24-20(21)22/h2-4,7-8,14-16,23H,5-6,9-12H2,1H3,(H,25,27)(H,29,30)(H4,21,22,24)/t14-,15-,16-/m0/s1	CJUOBXSVMSLLKV-JYJNAYRXSA-N	50280654	(S)-5-Guanidino-2-{[(S)-1-((S)-2-methylamino-2-phenyl-acetyl)-pyrrolidine-2-carbonyl]-amino}-pentanoic acid::CHEMBL8108	Plasma kallikrein			 12000							ChEMBL	10.1016/S0960-894X(00)80611-3	10.7270/Q2X066XV				Sall, DJ; Berry, DR; Coffman, WJ; Craft, TJ; Denney, ML; Gifford-Moore, DS; Kellam, ML; Smith, GF	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50280654	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50280654&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			44265055	104122358		CHEMBL8108			C04026	ZINC25980495	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50464386	COC(=O)c1oc2c(sc3ccccc23)c1OC(=O)C(C)C	InChI=1S/C16H14O5S/c1-8(2)15(17)21-12-13(16(18)19-3)20-11-9-6-4-5-7-10(9)22-14(11)12/h4-8H,1-3H3	STCBJZIZCOASHY-UHFFFAOYSA-N	50280655	3-Isobutyryloxy-benzo[4,5]thieno[3,2-b]furan-2-carboxylic acid methyl ester::CHEMBL268367	Plasma kallikrein			 7200							ChEMBL	10.1016/S0960-894X(00)80611-3	10.7270/Q2X066XV				Sall, DJ; Berry, DR; Coffman, WJ; Craft, TJ; Denney, ML; Gifford-Moore, DS; Kellam, ML; Smith, GF	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50280655	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50280655&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			3660962	104122359		CHEMBL268367				ZINC00005466	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50449501	COC(=O)Nc1ccc(NC(=O)[C@H](Cc2ccccc2)NC(=O)\C=C\c2cc(Cl)ccc2-n2cnnn2)cc1	InChI=1S/C27H24ClN7O4/c1-39-27(38)31-22-11-9-21(10-12-22)30-26(37)23(15-18-5-3-2-4-6-18)32-25(36)14-7-19-16-20(28)8-13-24(19)35-17-29-33-34-35/h2-14,16-17,23H,15H2,1H3,(H,30,37)(H,31,38)(H,32,36)/b14-7+/t23-/m0/s1	CPUWTXJIWZVTKG-HANTZDOSSA-N	50136580	CHEMBL3753890	Plasma kallikrein		 120								ChEMBL	10.1016/j.bmcl.2015.11.089	10.7270/Q27H1MFM	26704266			Smith, LM; Orwat, MJ; Hu, Z; Han, W; Wang, C; Rossi, KA; Gilligan, PJ; Pabbisetty, KB; Osuna, H; Corte, JR; Rendina, AR; Luettgen, JM; Wong, PC; Narayanan, R; Harper, TW; Bozarth, JM; Crain, EJ; Wei, A; Ramamurthy, V; Morin, PE; Xin, B; Zheng, J; Seiffert, DA; Quan, ML; Lam, PY; Wexler, RR; Pinto, DJ	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50136580	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50136580&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			25167018	336951932		CHEMBL3753890					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50449502	Nc1n[nH]c2cc(NC(=O)[C@H](Cc3ccccc3)NC(=O)\C=C\c3cc(Cl)ccc3-n3cnnn3)ccc12	InChI=1S/C26H22ClN9O2/c27-18-7-10-23(36-15-29-34-35-36)17(13-18)6-11-24(37)31-22(12-16-4-2-1-3-5-16)26(38)30-19-8-9-20-21(14-19)32-33-25(20)28/h1-11,13-15,22H,12H2,(H,30,38)(H,31,37)(H3,28,32,33)/b11-6+/t22-/m0/s1	FPYZHLSIZHYDRL-PQCZLFTGSA-N	50136581	CHEMBL3754635	Plasma kallikrein		 24								ChEMBL	10.1016/j.bmcl.2015.11.089	10.7270/Q27H1MFM	26704266			Smith, LM; Orwat, MJ; Hu, Z; Han, W; Wang, C; Rossi, KA; Gilligan, PJ; Pabbisetty, KB; Osuna, H; Corte, JR; Rendina, AR; Luettgen, JM; Wong, PC; Narayanan, R; Harper, TW; Bozarth, JM; Crain, EJ; Wei, A; Ramamurthy, V; Morin, PE; Xin, B; Zheng, J; Seiffert, DA; Quan, ML; Lam, PY; Wexler, RR; Pinto, DJ	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50136581	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50136581&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			59401943	336951933		CHEMBL3754635					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50449503	Oc1cc(=O)[nH]c2ccc(NC(=O)[C@H](Cc3ccccc3)NC(=O)\C=C\c3cc(Cl)ccc3-n3cnnn3)cc12	InChI=1S/C28H22ClN7O4/c29-19-7-10-24(36-16-30-34-35-36)18(13-19)6-11-26(38)33-23(12-17-4-2-1-3-5-17)28(40)31-20-8-9-22-21(14-20)25(37)15-27(39)32-22/h1-11,13-16,23H,12H2,(H,31,40)(H,33,38)(H2,32,37,39)/b11-6+/t23-/m0/s1	QVMGBIWUCADQAI-VMMLISQSSA-N	50136582	CHEMBL3754712	Plasma kallikrein		 28								ChEMBL	10.1016/j.bmcl.2015.11.089	10.7270/Q27H1MFM	26704266			Smith, LM; Orwat, MJ; Hu, Z; Han, W; Wang, C; Rossi, KA; Gilligan, PJ; Pabbisetty, KB; Osuna, H; Corte, JR; Rendina, AR; Luettgen, JM; Wong, PC; Narayanan, R; Harper, TW; Bozarth, JM; Crain, EJ; Wei, A; Ramamurthy, V; Morin, PE; Xin, B; Zheng, J; Seiffert, DA; Quan, ML; Lam, PY; Wexler, RR; Pinto, DJ	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50136582	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50136582&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			54741583	336951934		CHEMBL3754712					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50449504	OC(=O)c1ccc(NC(=O)[C@H](Cc2ccccc2)NC(=O)\C=C\c2cc(Cl)ccc2-n2cnnn2)cc1	InChI=1S/C26H21ClN6O4/c27-20-9-12-23(33-16-28-31-32-33)19(15-20)8-13-24(34)30-22(14-17-4-2-1-3-5-17)25(35)29-21-10-6-18(7-11-21)26(36)37/h1-13,15-16,22H,14H2,(H,29,35)(H,30,34)(H,36,37)/b13-8+/t22-/m0/s1	FMPAHDTULKAUPN-SYZXBLONSA-N	50136608	CHEMBL3754069	Plasma kallikrein		 122								ChEMBL	10.1016/j.bmcl.2015.11.089	10.7270/Q27H1MFM	26704266			Smith, LM; Orwat, MJ; Hu, Z; Han, W; Wang, C; Rossi, KA; Gilligan, PJ; Pabbisetty, KB; Osuna, H; Corte, JR; Rendina, AR; Luettgen, JM; Wong, PC; Narayanan, R; Harper, TW; Bozarth, JM; Crain, EJ; Wei, A; Ramamurthy, V; Morin, PE; Xin, B; Zheng, J; Seiffert, DA; Quan, ML; Lam, PY; Wexler, RR; Pinto, DJ	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50136608	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50136608&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	5JM	5E2O	25166809	336951935		CHEMBL3754069					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50449505	OC(=O)Cc1ccc(NC(=O)[C@H](Cc2ccccc2)NC(=O)\C=C\c2cc(Cl)ccc2-n2cnnn2)cc1	InChI=1S/C27H23ClN6O4/c28-21-9-12-24(34-17-29-32-33-34)20(16-21)8-13-25(35)31-23(14-18-4-2-1-3-5-18)27(38)30-22-10-6-19(7-11-22)15-26(36)37/h1-13,16-17,23H,14-15H2,(H,30,38)(H,31,35)(H,36,37)/b13-8+/t23-/m0/s1	DRNNIJVASSWYII-NWMLYGLHSA-N	50136609	CHEMBL3752772	Plasma kallikrein		 210								ChEMBL	10.1016/j.bmcl.2015.11.089	10.7270/Q27H1MFM	26704266			Smith, LM; Orwat, MJ; Hu, Z; Han, W; Wang, C; Rossi, KA; Gilligan, PJ; Pabbisetty, KB; Osuna, H; Corte, JR; Rendina, AR; Luettgen, JM; Wong, PC; Narayanan, R; Harper, TW; Bozarth, JM; Crain, EJ; Wei, A; Ramamurthy, V; Morin, PE; Xin, B; Zheng, J; Seiffert, DA; Quan, ML; Lam, PY; Wexler, RR; Pinto, DJ	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50136609	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50136609&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			59402239	336951936		CHEMBL3752772			C03768		1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50449529	NC(=O)c1ccc(NC(=O)[C@H](Cc2ccccc2)NC(=O)\C=C\c2cc(Cl)ccc2-n2cnnn2)cc1	InChI=1S/C26H22ClN7O3/c27-20-9-12-23(34-16-29-32-33-34)19(15-20)8-13-24(35)31-22(14-17-4-2-1-3-5-17)26(37)30-21-10-6-18(7-11-21)25(28)36/h1-13,15-16,22H,14H2,(H2,28,36)(H,30,37)(H,31,35)/b13-8+/t22-/m0/s1	ALMCJLSDCHRPPQ-SYZXBLONSA-N	50136610	CHEMBL3754262	Plasma kallikrein		 130								ChEMBL	10.1016/j.bmcl.2015.11.089	10.7270/Q27H1MFM	26704266			Smith, LM; Orwat, MJ; Hu, Z; Han, W; Wang, C; Rossi, KA; Gilligan, PJ; Pabbisetty, KB; Osuna, H; Corte, JR; Rendina, AR; Luettgen, JM; Wong, PC; Narayanan, R; Harper, TW; Bozarth, JM; Crain, EJ; Wei, A; Ramamurthy, V; Morin, PE; Xin, B; Zheng, J; Seiffert, DA; Quan, ML; Lam, PY; Wexler, RR; Pinto, DJ	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50136610	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50136610&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			25166807	336951937		CHEMBL3754262					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50449530	Clc1ccc(c(\C=C\C(=O)N[C@@H](Cc2ccccc2)C(=O)Nc2ccc(cc2)C#N)c1)-n1cnnn1	InChI=1S/C26H20ClN7O2/c27-21-9-12-24(34-17-29-32-33-34)20(15-21)8-13-25(35)31-23(14-18-4-2-1-3-5-18)26(36)30-22-10-6-19(16-28)7-11-22/h1-13,15,17,23H,14H2,(H,30,36)(H,31,35)/b13-8+/t23-/m0/s1	BSDZOISNKQJKRM-NWMLYGLHSA-N	50136611	CHEMBL3752147	Plasma kallikrein		 170								ChEMBL	10.1016/j.bmcl.2015.11.089	10.7270/Q27H1MFM	26704266			Smith, LM; Orwat, MJ; Hu, Z; Han, W; Wang, C; Rossi, KA; Gilligan, PJ; Pabbisetty, KB; Osuna, H; Corte, JR; Rendina, AR; Luettgen, JM; Wong, PC; Narayanan, R; Harper, TW; Bozarth, JM; Crain, EJ; Wei, A; Ramamurthy, V; Morin, PE; Xin, B; Zheng, J; Seiffert, DA; Quan, ML; Lam, PY; Wexler, RR; Pinto, DJ	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50136611	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50136611&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			25166808	336951938		CHEMBL3752147					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50449531	COC(=O)Nc1cccc(NC(=O)[C@H](Cc2ccccc2)NC(=O)\C=C\c2cc(Cl)ccc2-n2cnnn2)c1	InChI=1S/C27H24ClN7O4/c1-39-27(38)31-22-9-5-8-21(16-22)30-26(37)23(14-18-6-3-2-4-7-18)32-25(36)13-10-19-15-20(28)11-12-24(19)35-17-29-33-34-35/h2-13,15-17,23H,14H2,1H3,(H,30,37)(H,31,38)(H,32,36)/b13-10+/t23-/m0/s1	HADFRPUJFZOUES-YYVWFHOOSA-N	50136612	CHEMBL3752735	Plasma kallikrein		 350								ChEMBL	10.1016/j.bmcl.2015.11.089	10.7270/Q27H1MFM	26704266			Smith, LM; Orwat, MJ; Hu, Z; Han, W; Wang, C; Rossi, KA; Gilligan, PJ; Pabbisetty, KB; Osuna, H; Corte, JR; Rendina, AR; Luettgen, JM; Wong, PC; Narayanan, R; Harper, TW; Bozarth, JM; Crain, EJ; Wei, A; Ramamurthy, V; Morin, PE; Xin, B; Zheng, J; Seiffert, DA; Quan, ML; Lam, PY; Wexler, RR; Pinto, DJ	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50136612	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50136612&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			59401924	336951939		CHEMBL3752735					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50449532	OC(=O)c1cccc(NC(=O)[C@H](Cc2ccccc2)NC(=O)\C=C\c2cc(Cl)ccc2-n2cnnn2)c1	InChI=1S/C26H21ClN6O4/c27-20-10-11-23(33-16-28-31-32-33)18(14-20)9-12-24(34)30-22(13-17-5-2-1-3-6-17)25(35)29-21-8-4-7-19(15-21)26(36)37/h1-12,14-16,22H,13H2,(H,29,35)(H,30,34)(H,36,37)/b12-9+/t22-/m0/s1	COFIKGMOVADSSV-FQTAANOTSA-N	50136613	CHEMBL3753374	Plasma kallikrein		 270								ChEMBL	10.1016/j.bmcl.2015.11.089	10.7270/Q27H1MFM	26704266			Smith, LM; Orwat, MJ; Hu, Z; Han, W; Wang, C; Rossi, KA; Gilligan, PJ; Pabbisetty, KB; Osuna, H; Corte, JR; Rendina, AR; Luettgen, JM; Wong, PC; Narayanan, R; Harper, TW; Bozarth, JM; Crain, EJ; Wei, A; Ramamurthy, V; Morin, PE; Xin, B; Zheng, J; Seiffert, DA; Quan, ML; Lam, PY; Wexler, RR; Pinto, DJ	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50136613	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50136613&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			25166810	336951940		CHEMBL3753374					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50449533	Clc1ccc(c(\C=C\C(=O)N[C@@H](Cc2ccccc2)C(=O)Nc2ccc(cc2)-c2nnn[nH]2)c1)-n1cnnn1	InChI=1S/C26H21ClN10O2/c27-20-9-12-23(37-16-28-33-36-37)19(15-20)8-13-24(38)30-22(14-17-4-2-1-3-5-17)26(39)29-21-10-6-18(7-11-21)25-31-34-35-32-25/h1-13,15-16,22H,14H2,(H,29,39)(H,30,38)(H,31,32,34,35)/b13-8+/t22-/m0/s1	YGQQLNQKNAXOKN-SYZXBLONSA-N	50136614	CHEMBL3753020	Plasma kallikrein		 23								ChEMBL	10.1016/j.bmcl.2015.11.089	10.7270/Q27H1MFM	26704266			Smith, LM; Orwat, MJ; Hu, Z; Han, W; Wang, C; Rossi, KA; Gilligan, PJ; Pabbisetty, KB; Osuna, H; Corte, JR; Rendina, AR; Luettgen, JM; Wong, PC; Narayanan, R; Harper, TW; Bozarth, JM; Crain, EJ; Wei, A; Ramamurthy, V; Morin, PE; Xin, B; Zheng, J; Seiffert, DA; Quan, ML; Lam, PY; Wexler, RR; Pinto, DJ	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50136614	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50136614&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	OTM	4CRC	59402039	336951941		CHEMBL3753020					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50449534	Clc1ccc(c(\C=C\C(=O)N[C@@H](Cc2ccccc2)C(=O)Nc2ccc(cc2)-n2cnnn2)c1)-n1cnnn1	InChI=1S/C26H21ClN10O2/c27-20-7-12-24(37-17-29-33-35-37)19(15-20)6-13-25(38)31-23(14-18-4-2-1-3-5-18)26(39)30-21-8-10-22(11-9-21)36-16-28-32-34-36/h1-13,15-17,23H,14H2,(H,30,39)(H,31,38)/b13-6+/t23-/m0/s1	JETYKMQJWVKTJR-APYIBEOOSA-N	50136615	CHEMBL3751935	Plasma kallikrein		 240								ChEMBL	10.1016/j.bmcl.2015.11.089	10.7270/Q27H1MFM	26704266			Smith, LM; Orwat, MJ; Hu, Z; Han, W; Wang, C; Rossi, KA; Gilligan, PJ; Pabbisetty, KB; Osuna, H; Corte, JR; Rendina, AR; Luettgen, JM; Wong, PC; Narayanan, R; Harper, TW; Bozarth, JM; Crain, EJ; Wei, A; Ramamurthy, V; Morin, PE; Xin, B; Zheng, J; Seiffert, DA; Quan, ML; Lam, PY; Wexler, RR; Pinto, DJ	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50136615	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50136615&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			59402125	336951942		CHEMBL3751935					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50449535	Clc1ccc(c(\C=C\C(=O)N[C@@H](Cc2ccccc2)C(=O)Nc2ccc(cc2)-c2ncc[nH]2)c1)-n1cnnn1	InChI=1S/C28H23ClN8O2/c29-22-9-12-25(37-18-32-35-36-37)21(17-22)8-13-26(38)34-24(16-19-4-2-1-3-5-19)28(39)33-23-10-6-20(7-11-23)27-30-14-15-31-27/h1-15,17-18,24H,16H2,(H,30,31)(H,33,39)(H,34,38)/b13-8+/t24-/m0/s1	XLXJXSYABWWLCS-IEKAHNGHSA-N	50136616	CHEMBL3752951	Plasma kallikrein		 150								ChEMBL	10.1016/j.bmcl.2015.11.089	10.7270/Q27H1MFM	26704266			Smith, LM; Orwat, MJ; Hu, Z; Han, W; Wang, C; Rossi, KA; Gilligan, PJ; Pabbisetty, KB; Osuna, H; Corte, JR; Rendina, AR; Luettgen, JM; Wong, PC; Narayanan, R; Harper, TW; Bozarth, JM; Crain, EJ; Wei, A; Ramamurthy, V; Morin, PE; Xin, B; Zheng, J; Seiffert, DA; Quan, ML; Lam, PY; Wexler, RR; Pinto, DJ	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50136616	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50136616&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			127029802	336951943		CHEMBL3752951					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50449536	Clc1ccc(c(\C=C\C(=O)N[C@@H](Cc2ccccc2)C(=O)Nc2ccc(cc2)-c2nc[nH]n2)c1)-n1cnnn1	InChI=1S/C27H22ClN9O2/c28-21-9-12-24(37-17-31-35-36-37)20(15-21)8-13-25(38)33-23(14-18-4-2-1-3-5-18)27(39)32-22-10-6-19(7-11-22)26-29-16-30-34-26/h1-13,15-17,23H,14H2,(H,32,39)(H,33,38)(H,29,30,34)/b13-8+/t23-/m0/s1	WHOXDSZCKOLBJX-NWMLYGLHSA-N	50136617	CHEMBL3753468	Plasma kallikrein		 120								ChEMBL	10.1016/j.bmcl.2015.11.089	10.7270/Q27H1MFM	26704266			Smith, LM; Orwat, MJ; Hu, Z; Han, W; Wang, C; Rossi, KA; Gilligan, PJ; Pabbisetty, KB; Osuna, H; Corte, JR; Rendina, AR; Luettgen, JM; Wong, PC; Narayanan, R; Harper, TW; Bozarth, JM; Crain, EJ; Wei, A; Ramamurthy, V; Morin, PE; Xin, B; Zheng, J; Seiffert, DA; Quan, ML; Lam, PY; Wexler, RR; Pinto, DJ	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50136617	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50136617&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			127029803	336951944		CHEMBL3753468					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50449537	Clc1ccc(c(\C=C\C(=O)N[C@@H](Cc2ccccc2)C(=O)Nc2ccc(cc2)-c2nc(=O)o[nH]2)c1)-n1cnnn1	InChI=1S/C27H21ClN8O4/c28-20-9-12-23(36-16-29-34-35-36)19(15-20)8-13-24(37)31-22(14-17-4-2-1-3-5-17)26(38)30-21-10-6-18(7-11-21)25-32-27(39)40-33-25/h1-13,15-16,22H,14H2,(H,30,38)(H,31,37)(H,32,33,39)/b13-8+/t22-/m0/s1	YBHMTFZXRDJTMT-SYZXBLONSA-N	50136618	CHEMBL3752251	Plasma kallikrein		 36								ChEMBL	10.1016/j.bmcl.2015.11.089	10.7270/Q27H1MFM	26704266			Smith, LM; Orwat, MJ; Hu, Z; Han, W; Wang, C; Rossi, KA; Gilligan, PJ; Pabbisetty, KB; Osuna, H; Corte, JR; Rendina, AR; Luettgen, JM; Wong, PC; Narayanan, R; Harper, TW; Bozarth, JM; Crain, EJ; Wei, A; Ramamurthy, V; Morin, PE; Xin, B; Zheng, J; Seiffert, DA; Quan, ML; Lam, PY; Wexler, RR; Pinto, DJ	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50136618	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50136618&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			59402083	336951945		CHEMBL3752251					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50449538	Clc1ccc(c(\C=C\C(=O)N[C@@H](Cc2ccccc2)C(=O)Nc2ccc(cc2)-c2n[nH]c(=O)o2)c1)-n1cnnn1	InChI=1S/C27H21ClN8O4/c28-20-9-12-23(36-16-29-34-35-36)19(15-20)8-13-24(37)31-22(14-17-4-2-1-3-5-17)25(38)30-21-10-6-18(7-11-21)26-32-33-27(39)40-26/h1-13,15-16,22H,14H2,(H,30,38)(H,31,37)(H,33,39)/b13-8+/t22-/m0/s1	RCCJGKQQAVJFBG-SYZXBLONSA-N	50136619	CHEMBL3754487	Plasma kallikrein		 20								ChEMBL	10.1016/j.bmcl.2015.11.089	10.7270/Q27H1MFM	26704266			Smith, LM; Orwat, MJ; Hu, Z; Han, W; Wang, C; Rossi, KA; Gilligan, PJ; Pabbisetty, KB; Osuna, H; Corte, JR; Rendina, AR; Luettgen, JM; Wong, PC; Narayanan, R; Harper, TW; Bozarth, JM; Crain, EJ; Wei, A; Ramamurthy, V; Morin, PE; Xin, B; Zheng, J; Seiffert, DA; Quan, ML; Lam, PY; Wexler, RR; Pinto, DJ	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50136619	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50136619&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			59402077	336951946		CHEMBL3754487					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50449539	OC(=O)c1ccc(NC(=O)[C@H](Cc2ccccc2)NC(=O)\C=C\c2c(F)c(Cl)ccc2-n2cnnn2)cc1	InChI=1S/C26H20ClFN6O4/c27-20-11-12-22(34-15-29-32-33-34)19(24(20)28)10-13-23(35)31-21(14-16-4-2-1-3-5-16)25(36)30-18-8-6-17(7-9-18)26(37)38/h1-13,15,21H,14H2,(H,30,36)(H,31,35)(H,37,38)/b13-10+/t21-/m0/s1	FMCXAYDODUGZCO-BGVYSJOJSA-N	50136570	CHEMBL3752669	Plasma kallikrein		 46								ChEMBL	10.1016/j.bmcl.2015.11.089	10.7270/Q27H1MFM	26704266			Smith, LM; Orwat, MJ; Hu, Z; Han, W; Wang, C; Rossi, KA; Gilligan, PJ; Pabbisetty, KB; Osuna, H; Corte, JR; Rendina, AR; Luettgen, JM; Wong, PC; Narayanan, R; Harper, TW; Bozarth, JM; Crain, EJ; Wei, A; Ramamurthy, V; Morin, PE; Xin, B; Zheng, J; Seiffert, DA; Quan, ML; Lam, PY; Wexler, RR; Pinto, DJ	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50136570	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50136570&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			59402220	336951922		CHEMBL3752669					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50449540	CCCc1ccc(C[C@H](NC(=O)\C=C\c2cc(Cl)ccc2-n2cnnn2)C(=O)Nc2ccc(cc2)C(O)=O)cc1	InChI=1S/C29H27ClN6O4/c1-2-3-19-4-6-20(7-5-19)16-25(28(38)32-24-12-8-21(9-13-24)29(39)40)33-27(37)15-10-22-17-23(30)11-14-26(22)36-18-31-34-35-36/h4-15,17-18,25H,2-3,16H2,1H3,(H,32,38)(H,33,37)(H,39,40)/b15-10+/t25-/m0/s1	ZOYNBBLZWSJHEP-HFRIYAALSA-N	50136571	CHEMBL3752830	Plasma kallikrein		 804								ChEMBL	10.1016/j.bmcl.2015.11.089	10.7270/Q27H1MFM	26704266			Smith, LM; Orwat, MJ; Hu, Z; Han, W; Wang, C; Rossi, KA; Gilligan, PJ; Pabbisetty, KB; Osuna, H; Corte, JR; Rendina, AR; Luettgen, JM; Wong, PC; Narayanan, R; Harper, TW; Bozarth, JM; Crain, EJ; Wei, A; Ramamurthy, V; Morin, PE; Xin, B; Zheng, J; Seiffert, DA; Quan, ML; Lam, PY; Wexler, RR; Pinto, DJ	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50136571	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50136571&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			127027302	336951923		CHEMBL3752830					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50449548	OC(=O)c1ccc(NC(=O)[C@H](Cc2ccc(cc2)-c2ccccc2)NC(=O)\C=C\c2cc(Cl)ccc2-n2cnnn2)cc1	InChI=1S/C32H25ClN6O4/c33-26-13-16-29(39-20-34-37-38-39)25(19-26)12-17-30(40)36-28(31(41)35-27-14-10-24(11-15-27)32(42)43)18-21-6-8-23(9-7-21)22-4-2-1-3-5-22/h1-17,19-20,28H,18H2,(H,35,41)(H,36,40)(H,42,43)/b17-12+/t28-/m0/s1	QAYHDWLYPLIDEB-OFMVJSOZSA-N	50136572	CHEMBL3754443	Plasma kallikrein		 317								ChEMBL	10.1016/j.bmcl.2015.11.089	10.7270/Q27H1MFM	26704266			Smith, LM; Orwat, MJ; Hu, Z; Han, W; Wang, C; Rossi, KA; Gilligan, PJ; Pabbisetty, KB; Osuna, H; Corte, JR; Rendina, AR; Luettgen, JM; Wong, PC; Narayanan, R; Harper, TW; Bozarth, JM; Crain, EJ; Wei, A; Ramamurthy, V; Morin, PE; Xin, B; Zheng, J; Seiffert, DA; Quan, ML; Lam, PY; Wexler, RR; Pinto, DJ	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50136572	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50136572&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			127027303	336951924		CHEMBL3754443					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50449549	CN1CCN(CC1)C(=O)Nc1ccc(C[C@H](NC(=O)\C=C\c2cc(Cl)ccc2-n2cnnn2)C(=O)Nc2ccc(cc2)C(O)=O)cc1	InChI=1S/C32H32ClN9O5/c1-40-14-16-41(17-15-40)32(47)36-26-8-2-21(3-9-26)18-27(30(44)35-25-10-4-22(5-11-25)31(45)46)37-29(43)13-6-23-19-24(33)7-12-28(23)42-20-34-38-39-42/h2-13,19-20,27H,14-18H2,1H3,(H,35,44)(H,36,47)(H,37,43)(H,45,46)/b13-6+/t27-/m0/s1	NWILZYMDURQVEC-PEOFMFGLSA-N	50136573	CHEMBL3752047	Plasma kallikrein		 59								ChEMBL	10.1016/j.bmcl.2015.11.089	10.7270/Q27H1MFM	26704266			Smith, LM; Orwat, MJ; Hu, Z; Han, W; Wang, C; Rossi, KA; Gilligan, PJ; Pabbisetty, KB; Osuna, H; Corte, JR; Rendina, AR; Luettgen, JM; Wong, PC; Narayanan, R; Harper, TW; Bozarth, JM; Crain, EJ; Wei, A; Ramamurthy, V; Morin, PE; Xin, B; Zheng, J; Seiffert, DA; Quan, ML; Lam, PY; Wexler, RR; Pinto, DJ	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50136573	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50136573&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			127027635	336951925		CHEMBL3752047					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50449550	CN1CCN(CC1)C(=O)Nc1ccc(C[C@H](NC(=O)\C=C\c2c(F)c(Cl)ccc2-n2cnnn2)C(=O)Nc2ccc(cc2)C(O)=O)cc1	InChI=1S/C32H31ClFN9O5/c1-41-14-16-42(17-15-41)32(48)37-23-6-2-20(3-7-23)18-26(30(45)36-22-8-4-21(5-9-22)31(46)47)38-28(44)13-10-24-27(43-19-35-39-40-43)12-11-25(33)29(24)34/h2-13,19,26H,14-18H2,1H3,(H,36,45)(H,37,48)(H,38,44)(H,46,47)/b13-10+/t26-/m0/s1	HXXPVILFSJCGAF-ITMPFJHPSA-N	50136574	CHEMBL3752266	Plasma kallikrein		 55								ChEMBL	10.1016/j.bmcl.2015.11.089	10.7270/Q27H1MFM	26704266			Smith, LM; Orwat, MJ; Hu, Z; Han, W; Wang, C; Rossi, KA; Gilligan, PJ; Pabbisetty, KB; Osuna, H; Corte, JR; Rendina, AR; Luettgen, JM; Wong, PC; Narayanan, R; Harper, TW; Bozarth, JM; Crain, EJ; Wei, A; Ramamurthy, V; Morin, PE; Xin, B; Zheng, J; Seiffert, DA; Quan, ML; Lam, PY; Wexler, RR; Pinto, DJ	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50136574	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50136574&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			127027636	336951926		CHEMBL3752266					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50449551	CC1CC1C(=O)Nc1ccc(C[C@H](NC(=O)\C=C\c2c(F)c(Cl)ccc2-n2cnnn2)C(=O)Nc2ccc(cc2)C(O)=O)cc1	InChI=1S/C31H27ClFN7O5/c1-17-14-23(17)29(42)35-20-6-2-18(3-7-20)15-25(30(43)36-21-8-4-19(5-9-21)31(44)45)37-27(41)13-10-22-26(40-16-34-38-39-40)12-11-24(32)28(22)33/h2-13,16-17,23,25H,14-15H2,1H3,(H,35,42)(H,36,43)(H,37,41)(H,44,45)/b13-10+/t17?,23?,25-/m0/s1	XWIQXLQKQCPYLC-RAWMAVSUSA-N	50136575	CHEMBL3752610	Plasma kallikrein		 7.5								ChEMBL	10.1016/j.bmcl.2015.11.089	10.7270/Q27H1MFM	26704266			Smith, LM; Orwat, MJ; Hu, Z; Han, W; Wang, C; Rossi, KA; Gilligan, PJ; Pabbisetty, KB; Osuna, H; Corte, JR; Rendina, AR; Luettgen, JM; Wong, PC; Narayanan, R; Harper, TW; Bozarth, JM; Crain, EJ; Wei, A; Ramamurthy, V; Morin, PE; Xin, B; Zheng, J; Seiffert, DA; Quan, ML; Lam, PY; Wexler, RR; Pinto, DJ	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50136575	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50136575&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			127025168	336951927		CHEMBL3752610					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50449552	OC(=O)c1ccc(cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCCc1cc(Cl)ccc1-n1cnnn1	InChI=1S/C26H23ClN6O4/c27-21-10-11-23(33-16-29-31-32-33)20(15-21)12-13-28-25(35)22(14-17-4-2-1-3-5-17)30-24(34)18-6-8-19(9-7-18)26(36)37/h1-11,15-16,22H,12-14H2,(H,28,35)(H,30,34)(H,36,37)/t22-/m0/s1	ZQQORFVNQRTACB-QFIPXVFZSA-N	50136576	CHEMBL3753069	Plasma kallikrein		>6000								ChEMBL	10.1016/j.bmcl.2015.11.089	10.7270/Q27H1MFM	26704266			Smith, LM; Orwat, MJ; Hu, Z; Han, W; Wang, C; Rossi, KA; Gilligan, PJ; Pabbisetty, KB; Osuna, H; Corte, JR; Rendina, AR; Luettgen, JM; Wong, PC; Narayanan, R; Harper, TW; Bozarth, JM; Crain, EJ; Wei, A; Ramamurthy, V; Morin, PE; Xin, B; Zheng, J; Seiffert, DA; Quan, ML; Lam, PY; Wexler, RR; Pinto, DJ	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50136576	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50136576&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			59402226	336951928		CHEMBL3753069					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50449553	Clc1ccc(c(CCNC(=O)[C@H](Cc2ccccc2)NC(=O)c2ccc(cc2)-c2nnn[nH]2)c1)-n1cnnn1	InChI=1S/C26H23ClN10O2/c27-21-10-11-23(37-16-29-33-36-37)20(15-21)12-13-28-26(39)22(14-17-4-2-1-3-5-17)30-25(38)19-8-6-18(7-9-19)24-31-34-35-32-24/h1-11,15-16,22H,12-14H2,(H,28,39)(H,30,38)(H,31,32,34,35)/t22-/m0/s1	DCSWPKKYPICTAU-QFIPXVFZSA-N	50136577	CHEMBL3752071	Plasma kallikrein		>6000								ChEMBL	10.1016/j.bmcl.2015.11.089	10.7270/Q27H1MFM	26704266			Smith, LM; Orwat, MJ; Hu, Z; Han, W; Wang, C; Rossi, KA; Gilligan, PJ; Pabbisetty, KB; Osuna, H; Corte, JR; Rendina, AR; Luettgen, JM; Wong, PC; Narayanan, R; Harper, TW; Bozarth, JM; Crain, EJ; Wei, A; Ramamurthy, V; Morin, PE; Xin, B; Zheng, J; Seiffert, DA; Quan, ML; Lam, PY; Wexler, RR; Pinto, DJ	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50136577	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50136577&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			59402046	336951929		CHEMBL3752071					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50449554	COC(=O)Nc1ccc(cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCCc1cc(Cl)ccc1-n1cnnn1	InChI=1S/C27H26ClN7O4/c1-39-27(38)31-22-10-7-19(8-11-22)25(36)32-23(15-18-5-3-2-4-6-18)26(37)29-14-13-20-16-21(28)9-12-24(20)35-17-30-33-34-35/h2-12,16-17,23H,13-15H2,1H3,(H,29,37)(H,31,38)(H,32,36)/t23-/m0/s1	ONNWDJBBJBVVPP-QHCPKHFHSA-N	50136578	CHEMBL3752066	Plasma kallikrein		 340								ChEMBL	10.1016/j.bmcl.2015.11.089	10.7270/Q27H1MFM	26704266			Smith, LM; Orwat, MJ; Hu, Z; Han, W; Wang, C; Rossi, KA; Gilligan, PJ; Pabbisetty, KB; Osuna, H; Corte, JR; Rendina, AR; Luettgen, JM; Wong, PC; Narayanan, R; Harper, TW; Bozarth, JM; Crain, EJ; Wei, A; Ramamurthy, V; Morin, PE; Xin, B; Zheng, J; Seiffert, DA; Quan, ML; Lam, PY; Wexler, RR; Pinto, DJ	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50136578	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50136578&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			59401978	336951930		CHEMBL3752066					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50449555	Oc1cc(=O)[nH]c2ccc(cc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCCc1cc(Cl)ccc1-n1cnnn1	InChI=1S/C28H24ClN7O4/c29-20-7-9-24(36-16-31-34-35-36)18(13-20)10-11-30-28(40)23(12-17-4-2-1-3-5-17)33-27(39)19-6-8-22-21(14-19)25(37)15-26(38)32-22/h1-9,13-16,23H,10-12H2,(H,30,40)(H,33,39)(H2,32,37,38)/t23-/m0/s1	JAUUPTJHJIUVMZ-QHCPKHFHSA-N	50136579	CHEMBL3754781	Plasma kallikrein		 110								ChEMBL	10.1016/j.bmcl.2015.11.089	10.7270/Q27H1MFM	26704266			Smith, LM; Orwat, MJ; Hu, Z; Han, W; Wang, C; Rossi, KA; Gilligan, PJ; Pabbisetty, KB; Osuna, H; Corte, JR; Rendina, AR; Luettgen, JM; Wong, PC; Narayanan, R; Harper, TW; Bozarth, JM; Crain, EJ; Wei, A; Ramamurthy, V; Morin, PE; Xin, B; Zheng, J; Seiffert, DA; Quan, ML; Lam, PY; Wexler, RR; Pinto, DJ	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50136579	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50136579&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	7P0	5E2P,4CRB	59402011	336951931		CHEMBL3754781					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50482129	COC(=O)Nc1ccc(cc1)-c1ccnc(c1)[C@H](Cc1ccccc1)NC(=O)\C=C\c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C31H26ClN7O3/c1-42-31(41)35-26-11-7-22(8-12-26)23-15-16-33-27(19-23)28(17-21-5-3-2-4-6-21)36-30(40)14-9-24-18-25(32)10-13-29(24)39-20-34-37-38-39/h2-16,18-20,28H,17H2,1H3,(H,35,41)(H,36,40)/b14-9+/t28-/m0/s1	ZBUQQUJRHVSUJI-CWBDRXANSA-N	50153004	CHEMBL3781319	Plasma kallikrein		 1850								ChEMBL	10.1016/j.bmc.2016.03.062	10.7270/Q2DN46X0	27073051			Corte, JR; Fang, T; Pinto, DJ; Orwat, MJ; Rendina, AR; Luettgen, JM; Rossi, KA; Wei, A; Ramamurthy, V; Myers, JE; Sheriff, S; Narayanan, R; Harper, TW; Zheng, JJ; Li, YX; Seiffert, DA; Wexler, RR; Quan, ML	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50153004	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50153004&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	5SU	5EXN	57976410	340133048		CHEMBL3781319					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50482160	COC(=O)Nc1ccc(cc1)-c1ccnc(c1)[C@H](Cc1ccccc1)NC(=O)[C@H]1CC[C@H](CN)CC1	InChI=1S/C29H34N4O3/c1-36-29(35)32-25-13-11-22(12-14-25)24-15-16-31-26(18-24)27(17-20-5-3-2-4-6-20)33-28(34)23-9-7-21(19-30)8-10-23/h2-6,11-16,18,21,23,27H,7-10,17,19,30H2,1H3,(H,32,35)(H,33,34)/t21-,23-,27-/m0/s1	YAJFVXIHHOXQOV-MYIHVTGJSA-N	50153049	CHEMBL3781788	Plasma kallikrein		 42								ChEMBL	10.1016/j.bmc.2016.03.062	10.7270/Q2DN46X0	27073051			Corte, JR; Fang, T; Pinto, DJ; Orwat, MJ; Rendina, AR; Luettgen, JM; Rossi, KA; Wei, A; Ramamurthy, V; Myers, JE; Sheriff, S; Narayanan, R; Harper, TW; Zheng, JJ; Li, YX; Seiffert, DA; Wexler, RR; Quan, ML	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50153049	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50153049&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	5ST	5EXM	118987013	340133053		CHEMBL3781788					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50475944	NC[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](Cc1ccccc1)c1cc(ccn1)-c1ccc2c(N)n[nH]c2c1			50103200	CHEMBL3393386	Plasma kallikrein		 24								ChEMBL	10.1016/j.bmc.2016.03.062	10.7270/Q2DN46X0	27073051			Corte, JR; Fang, T; Pinto, DJ; Orwat, MJ; Rendina, AR; Luettgen, JM; Rossi, KA; Wei, A; Ramamurthy, V; Myers, JE; Sheriff, S; Narayanan, R; Harper, TW; Zheng, JJ; Li, YX; Seiffert, DA; Wexler, RR; Quan, ML	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50103200	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50103200&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86583041	318491166		CHEMBL3393386					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50475945	NC[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](Cc1ccccc1)c1cc(ccn1)-c1ccc2[nH]nc(O)c2c1	InChI=1S/C28H31N5O2/c29-17-19-6-8-20(9-7-19)27(34)31-26(14-18-4-2-1-3-5-18)25-16-22(12-13-30-25)21-10-11-24-23(15-21)28(35)33-32-24/h1-5,10-13,15-16,19-20,26H,6-9,14,17,29H2,(H,31,34)(H2,32,33,35)/t19-,20-,26-/m0/s1	OTOUCEKJIQXXLM-DYLHXGEVSA-N	50153057	CHEMBL3780324	Plasma kallikrein		 550								ChEMBL	10.1016/j.bmc.2016.03.062	10.7270/Q2DN46X0	27073051			Corte, JR; Fang, T; Pinto, DJ; Orwat, MJ; Rendina, AR; Luettgen, JM; Rossi, KA; Wei, A; Ramamurthy, V; Myers, JE; Sheriff, S; Narayanan, R; Harper, TW; Zheng, JJ; Li, YX; Seiffert, DA; Wexler, RR; Quan, ML	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50153057	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50153057&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	5SS	5EXL	127031390	340133061		CHEMBL3780324					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50594677	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](C)N)C(=O)N[C@@H](CS)C(=O)NCC(N)=O	InChI=1S/C72H115N25O25S3/c1-32(2)22-40(62(114)95-46(29-123)58(110)82-27-51(75)100)88-56(108)34(4)83-59(111)39(17-18-52(101)102)87-65(117)43(25-53(103)104)89-57(109)35(5)84-69(121)49-16-11-21-97(49)70(122)48(31-125)96-64(116)42(24-50(74)99)91-61(113)38(15-10-20-81-72(78)79)85-63(115)41(23-36-12-7-6-8-13-36)90-60(112)37(14-9-19-80-71(76)77)86-66(118)44(26-54(105)106)92-67(119)45(28-98)93-68(120)47(30-124)94-55(107)33(3)73/h6-8,12-13,32-35,37-49,98,123-125H,9-11,14-31,73H2,1-5H3,(H2,74,99)(H2,75,100)(H,82,110)(H,83,111)(H,84,121)(H,85,115)(H,86,118)(H,87,117)(H,88,108)(H,89,109)(H,90,112)(H,91,113)(H,92,119)(H,93,120)(H,94,107)(H,95,114)(H,96,116)(H,101,102)(H,103,104)(H,105,106)(H4,76,77,80)(H4,78,79,81)/t33-,34-,35-,37-,38-,39-,40-,41-,42-,43-,44-,45-,46-,47-,48-,49-/m0/s1	IHCIVWJSOFPNDK-BKIIEESMSA-N	50326019	(2R,5S,8S,11S,14S,17S)-1-((S)-2-((5R,8S,11S,14S,17S,20S)-1-amino-14-(2-carboxyethyl)-17-(carboxymethyl)-8-isobutyl-5-(mercaptomethyl)-11-methyl-1,4,7,10,13,16,19-heptaoxo-3,6,9,12,15,18-hexaazahenicosan-20-ylcarbamoyl)pyrrolidin-1-yl)-5-(2-amino-2-oxoethyl)-17-((S)-2-((R)-2-((S)-2-aminopropanamido)-3-mercaptopropanamido)-3-hydroxypropanamido)-11-benzyl-8,14-bis(3-guanidinopropyl)-2-(mercaptomethyl)-1,4,7,10,13,16-hexaoxo-3,6,9,12,15-pentaazanonadecan-19-oic acid::CHEMBL1240701	Plasma kallikrein			>10000							ChEMBL	10.1038/nchembio.184	10.7270/Q2Z60P9P	19483697			Heinis, C; Rutherford, T; Freund, S; Winter, G	Laboratory of Molecular Biology, Medical Research Council	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50326019	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50326019&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			91933378	123105134		CHEMBL1240701			C02248		1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50594678	CC(C)[C@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCCN=C(N)N)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H](C)N)[C@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)NCC(N)=O	InChI=1S/C70H112N26O22S3/c1-31(2)53(67(117)89-42(22-47(72)99)62(112)88-41(21-35-23-80-37-12-7-6-11-36(35)37)63(113)95-55(34(5)98)68(118)96-20-10-15-46(96)65(115)92-44(29-120)58(108)81-24-48(73)100)94-61(111)39(14-9-19-79-70(76)77)87-64(114)45(30-121)91-60(110)38(13-8-18-78-69(74)75)85-49(101)25-82-57(107)40(16-17-52(104)105)86-50(102)26-84-66(116)54(33(4)97)93-51(103)27-83-59(109)43(28-119)90-56(106)32(3)71/h6-7,11-12,23,31-34,38-46,53-55,80,97-98,119-121H,8-10,13-22,24-30,71H2,1-5H3,(H2,72,99)(H2,73,100)(H,81,108)(H,82,107)(H,83,109)(H,84,116)(H,85,101)(H,86,102)(H,87,114)(H,88,112)(H,89,117)(H,90,106)(H,91,110)(H,92,115)(H,93,103)(H,94,111)(H,95,113)(H,104,105)(H4,74,75,78)(H4,76,77,79)/t32-,33+,34-,38+,39+,40+,41+,42+,43+,44+,45+,46+,53+,54+,55+/m1/s1	YKZKODLTIIYGAU-KTWGUHOGSA-N	50326020	(2R,3S,6S,9S,12S,15S,18R,21S,27S)-6-((1H-indol-3-yl)methyl)-9-(2-amino-2-oxoethyl)-3-((S)-2-((R)-1-(2-amino-2-oxoethylamino)-3-mercapto-1-oxopropan-2-ylcarbamoyl)pyrrolidine-1-carbonyl)-27-((5S,11R,14R)-14-amino-5-((S)-1-hydroxyethyl)-11-(mercaptomethyl)-4,7,10,13-tetraoxo-3,6,9,12-tetraazapentadecanamido)-15,21-bis(3-guanidinopropyl)-2-hydroxy-12-isopropyl-18-(mercaptomethyl)-5,8,11,14,17,20,23,26-octaoxo-4,7,10,13,16,19,22,25-octaazatriacontan-30-oic acid::CHEMBL1240700	Plasma kallikrein			>10000							ChEMBL	10.1038/nchembio.184	10.7270/Q2Z60P9P	19483697			Heinis, C; Rutherford, T; Freund, S; Winter, G	Laboratory of Molecular Biology, Medical Research Council	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50326020	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50326020&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			91933379	123105135		CHEMBL1240700			C02248		1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50594679	CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](C)N)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)NCC(N)=O	InChI=1S/C86H123N23O23S4/c1-41(2)30-57(76(123)99-56(26-29-136-7)74(121)102-59(32-47-35-92-52-16-10-8-14-50(47)52)79(126)107-62(38-133)72(119)94-37-66(88)112)100-80(127)61(34-68(115)116)103-73(120)55(24-25-67(113)114)98-77(124)58(31-46-20-22-49(111)23-21-46)101-82(129)64(40-135)106-71(118)43(4)95-84(131)69(45(6)110)108-75(122)54(18-12-27-91-86(89)90)97-78(125)60(33-48-36-93-53-17-11-9-15-51(48)53)104-83(130)65-19-13-28-109(65)85(132)44(5)96-81(128)63(39-134)105-70(117)42(3)87/h8-11,14-17,20-23,35-36,41-45,54-65,69,92-93,110-111,133-135H,12-13,18-19,24-34,37-40,87H2,1-7H3,(H2,88,112)(H,94,119)(H,95,131)(H,96,128)(H,97,125)(H,98,124)(H,99,123)(H,100,127)(H,101,129)(H,102,121)(H,103,120)(H,104,130)(H,105,117)(H,106,118)(H,107,126)(H,108,122)(H,113,114)(H,115,116)(H4,89,90,91)/t42-,43-,44-,45+,54-,55-,56-,57-,58-,59-,60-,61-,62-,63-,64-,65-,69-/m0/s1	HFLGKAMEZPGPCA-HJGMZIALSA-N	50326021	CHEMBL1240699	Plasma kallikrein			 5707							ChEMBL	10.1038/nchembio.184	10.7270/Q2Z60P9P	19483697			Heinis, C; Rutherford, T; Freund, S; Winter, G	Laboratory of Molecular Biology, Medical Research Council	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50326021	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50326021&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			91933380	123105136		CHEMBL1240699			C02248		1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50594680	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCC(O)=O)NC(=O)C(NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](C)N)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)NCC(N)=O	InChI=1S/C83H130N24O24S3/c1-7-41(3)63(78(128)98-53(35-45-16-10-9-11-17-45)80(130)106-32-14-20-58(106)75(125)101-55(38-132)67(117)92-36-60(85)111)103-71(121)51(27-29-62(114)115)95-77(127)64(42(4)8-2)104-76(126)59-21-15-33-107(59)81(131)57(40-134)102-72(122)52(34-46-22-24-47(110)25-23-46)97-69(119)49(19-13-31-91-83(88)89)93-68(118)48(18-12-30-90-82(86)87)94-70(120)50(26-28-61(112)113)96-79(129)65(44(6)109)105-73(123)54(37-108)99-74(124)56(39-133)100-66(116)43(5)84/h9-11,16-17,22-25,41-44,48-59,63-65,108-110,132-134H,7-8,12-15,18-21,26-40,84H2,1-6H3,(H2,85,111)(H,92,117)(H,93,118)(H,94,120)(H,95,127)(H,96,129)(H,97,119)(H,98,128)(H,99,124)(H,100,116)(H,101,125)(H,102,122)(H,103,121)(H,104,126)(H,105,123)(H,112,113)(H,114,115)(H4,86,87,90)(H4,88,89,91)/t41-,42-,43-,44+,48-,49-,50-,51-,52-,53-,54-,55-,56-,57-,58-,59-,63-,64-,65?/m0/s1	MRHOQWMKYGJTRH-HPNNBLMSSA-N	50326022	CHEMBL1240698	Plasma kallikrein			 7181							ChEMBL	10.1038/nchembio.184	10.7270/Q2Z60P9P	19483697			Heinis, C; Rutherford, T; Freund, S; Winter, G	Laboratory of Molecular Biology, Medical Research Council	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50326022	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50326022&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			91933381	123105137		CHEMBL1240698			C02248		1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50594681	CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)NCC(N)=O	InChI=1S/C77H118N26O23S3/c1-36(2)23-45(66(117)93-47(25-40-28-87-42-16-9-8-15-41(40)42)68(119)97-50(31-104)62(113)89-30-58(109)102-60(38(4)106)74(125)100-52(33-127)63(114)88-29-57(80)108)96-73(124)55-19-12-22-103(55)75(126)54(35-129)101-69(120)48(26-56(79)107)94-65(116)44(18-11-21-86-77(83)84)90-67(118)46(24-39-13-6-5-7-14-39)92-64(115)43(17-10-20-85-76(81)82)91-70(121)49(27-59(110)111)95-71(122)51(32-105)98-72(123)53(34-128)99-61(112)37(3)78/h5-9,13-16,28,36-38,43-55,60,87,104-106,127-129H,10-12,17-27,29-35,78H2,1-4H3,(H2,79,107)(H2,80,108)(H,88,114)(H,89,113)(H,90,118)(H,91,121)(H,92,115)(H,93,117)(H,94,116)(H,95,122)(H,96,124)(H,97,119)(H,98,123)(H,99,112)(H,100,125)(H,101,120)(H,102,109)(H,110,111)(H4,81,82,85)(H4,83,84,86)/t37-,38+,43-,44-,45-,46-,47-,48-,49-,50-,51-,52-,53-,54-,55-,60-/m0/s1	SYPVWRFLOBCZKO-MELGYJOSSA-N	50326023	(2R,5S,8S,11S,14S,17S)-1-((S)-2-((5R,8S,14S,17S,20S)-17-((1H-indol-3-yl)methyl)-1-amino-8-((R)-1-hydroxyethyl)-14-(hydroxymethyl)-5-(mercaptomethyl)-22-methyl-1,4,7,10,13,16,19-heptaoxo-3,6,9,12,15,18-hexaazatricosan-20-ylcarbamoyl)pyrrolidin-1-yl)-5-(2-amino-2-oxoethyl)-17-((S)-2-((R)-2-((S)-2-aminopropanamido)-3-mercaptopropanamido)-3-hydroxypropanamido)-11-benzyl-8,14-bis(3-guanidinopropyl)-2-(mercaptomethyl)-1,4,7,10,13,16-hexaoxo-3,6,9,12,15-pentaazanonadecan-19-oic acid::CHEMBL1240697	Plasma kallikrein			>10000							ChEMBL	10.1038/nchembio.184	10.7270/Q2Z60P9P	19483697			Heinis, C; Rutherford, T; Freund, S; Winter, G	Laboratory of Molecular Biology, Medical Research Council	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50326023	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50326023&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			52948030	123105138		CHEMBL1240697			C02248		1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50594695	CC[C@H](C)[C@@H]1NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]2CSCc3cc(CSC[C@H](NC(=O)[C@H](CO)NC1=O)C(=O)NCC(N)=O)cc(CSC[C@H](NC(=O)[C@H](C)N)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N2)c3)C(C)C	InChI=1S/C72H115N27O24S3/c1-6-32(4)56-70(123)94-44(24-101)67(120)96-46(58(111)85-20-51(77)105)29-125-26-35-13-34-14-36(15-35)27-126-30-47(68(121)89-38(10-8-12-83-72(80)81)61(114)98-55(31(2)3)69(122)92-40(17-49(75)103)63(116)90-41(18-50(76)104)65(118)99-56)97-60(113)37(9-7-11-82-71(78)79)88-64(117)42(19-54(108)109)91-66(119)43(23-100)93-62(115)39(16-48(74)102)87-53(107)22-84-52(106)21-86-59(112)45(28-124-25-34)95-57(110)33(5)73/h13-15,31-33,37-47,55-56,100-101H,6-12,16-30,73H2,1-5H3,(H2,74,102)(H2,75,103)(H2,76,104)(H2,77,105)(H,84,106)(H,85,111)(H,86,112)(H,87,107)(H,88,117)(H,89,121)(H,90,116)(H,91,119)(H,92,122)(H,93,115)(H,94,123)(H,95,110)(H,96,120)(H,97,113)(H,98,114)(H,99,118)(H,108,109)(H4,78,79,82)(H4,80,81,83)/t32-,33-,37-,38-,39-,40-,41-,42-,43-,44-,45-,46-,47-,55-,56-/m0/s1	FAWGFZSKQMGFDW-GPWGALKDSA-N	50326037	CHEMBL1240604	Plasma kallikrein			 2000							ChEMBL	10.1038/nchembio.184	10.7270/Q2Z60P9P	19483697			Heinis, C; Rutherford, T; Freund, S; Winter, G	Laboratory of Molecular Biology, Medical Research Council	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50326037	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50326037&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			52944043	123105152		CHEMBL1240604			C03803		1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50594698	CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSCc3cc(CSC[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc4ccc(O)cc4)C(=O)N2)cc(CSC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC1=O)[C@@H](C)CC)C(=O)NCC(N)=O)c3	InChI=1S/C92H136N24O24S3/c1-7-47(3)72-87(137)107-62(38-51-16-10-9-11-17-51)89(139)115-32-14-20-67(115)84(134)110-64(76(126)101-39-69(94)120)44-141-41-53-34-54-36-55(35-53)43-143-46-66(90(140)116-33-15-21-68(116)85(135)113-73(48(4)8-2)86(136)104-60(80(130)112-72)27-29-71(123)124)111-81(131)61(37-52-22-24-56(119)25-23-52)106-78(128)58(19-13-31-100-92(97)98)102-77(127)57(18-12-30-99-91(95)96)103-79(129)59(26-28-70(121)122)105-88(138)74(50(6)118)114-82(132)63(40-117)108-83(133)65(45-142-42-54)109-75(125)49(5)93/h9-11,16-17,22-25,34-36,47-50,57-68,72-74,117-119H,7-8,12-15,18-21,26-33,37-46,93H2,1-6H3,(H2,94,120)(H,101,126)(H,102,127)(H,103,129)(H,104,136)(H,105,138)(H,106,128)(H,107,137)(H,108,133)(H,109,125)(H,110,134)(H,111,131)(H,112,130)(H,113,135)(H,114,132)(H,121,122)(H,123,124)(H4,95,96,99)(H4,97,98,100)/t47-,48-,49-,50-,57-,58-,59-,60-,61-,62-,63-,64-,65-,66-,67-,68-,72-,73?,74-/m0/s1	RXSWLHXOULKHGB-UZJLTCPZSA-N	50326040	CHEMBL1240598	Plasma kallikrein			 33							ChEMBL	10.1038/nchembio.184	10.7270/Q2Z60P9P	19483697			Heinis, C; Rutherford, T; Freund, S; Winter, G	Laboratory of Molecular Biology, Medical Research Council	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50326040	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50326040&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			91933385	123105155		CHEMBL1240598			C03803		1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50594700	CSCC[C@@H]1NC(=O)[C@H](CO)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSCc3cc(CSC[C@H](NC(=O)CNC(=O)[C@H](CO)NC1=O)C(=O)NCC(N)=O)cc(CSC[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N2)c3	InChI=1S/C84H120N26O23S4/c1-42(85)68(119)108-61-40-136-37-45-23-44-24-46(25-45)38-137-41-62(109-76(127)55(28-64(86)114)102-72(123)50(15-8-19-92-83(88)89)98-74(125)53(26-43-11-4-3-5-12-43)101-71(122)51(16-9-20-93-84(90)91)99-78(129)58(34-112)107-77(128)56(29-67(117)118)103-80(61)131)82(133)110-21-10-17-63(110)81(132)104-54(27-47-30-94-49-14-7-6-13-48(47)49)75(126)106-59(35-113)79(130)100-52(18-22-134-2)73(124)105-57(33-111)69(120)96-32-66(116)97-60(39-135-36-44)70(121)95-31-65(87)115/h3-7,11-14,23-25,30,42,50-63,94,111-113H,8-10,15-22,26-29,31-41,85H2,1-2H3,(H2,86,114)(H2,87,115)(H,95,121)(H,96,120)(H,97,116)(H,98,125)(H,99,129)(H,100,130)(H,101,122)(H,102,123)(H,103,131)(H,104,132)(H,105,124)(H,106,126)(H,107,128)(H,108,119)(H,109,127)(H,117,118)(H4,88,89,92)(H4,90,91,93)/t42-,50-,51-,52-,53-,54?,55-,56-,57-,58-,59-,60-,61-,62-,63-/m0/s1	KNJXXDLWQHWAJJ-SXJJNWPVSA-N	50326042	CHEMBL1240595	Plasma kallikrein			 1500							ChEMBL	10.1038/nchembio.184	10.7270/Q2Z60P9P	19483697			Heinis, C; Rutherford, T; Freund, S; Winter, G	Laboratory of Molecular Biology, Medical Research Council	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50326042	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50326042&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			91933386	123105157		CHEMBL1240595			C03803		1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50651759	NC(=N)NCCC[C@@H](NS(=O)(=O)Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)NCc1ccc(cc1)C(N)=N	InChI=1S/C26H36N8O4S/c27-23(28)20-12-10-18(11-13-20)16-32-24(35)22-9-5-15-34(22)25(36)21(8-4-14-31-26(29)30)33-39(37,38)17-19-6-2-1-3-7-19/h1-3,6-7,10-13,21-22,33H,4-5,8-9,14-17H2,(H3,27,28)(H,32,35)(H4,29,30,31)/t21-,22+/m1/s1	QKFCYPKTTJCUSZ-YADHBBJMSA-N	50324475	Benzylsulfonyl-D-argininyl-proline-(4-amidinobenzyl)amide Bis-(trifluoroacetate)::CHEMBL1215083::CHEMBL1229259	Plasma kallikrein		 8.3								ChEMBL	10.1016/j.bmcl.2011.06.033	10.7270/Q2ST7Q5M	21741839			Sielaff, F; Bottcher-Friebertshauser, E; Meyer, D; Saupe, SM; Volk, IM; Garten, W; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50324475	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50324475&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	BJA	3U98	46899577	117645796		CHEMBL1215083CHEMBL1229259				ZINC58548617	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50704169	COc1ccc(cc1)C(=O)Nc1cccc(O[C@@H]2O[C@@H]([C@@H](O)[C@H](O)[C@H]2O)C(O)=O)c1NC(=O)c1ccc(cc1)N1CCCN(C)CC1	InChI=1S/C33H38N4O10/c1-36-15-4-16-37(18-17-36)21-11-7-19(8-12-21)31(42)35-25-23(34-30(41)20-9-13-22(45-2)14-10-20)5-3-6-24(25)46-33-28(40)26(38)27(39)29(47-33)32(43)44/h3,5-14,26-29,33,38-40H,4,15-18H2,1-2H3,(H,34,41)(H,35,42)(H,43,44)/t26-,27-,28+,29-,33+/m0/s1	IOUMBCGOXOKZAE-CLIYFGAVSA-N	50358251	CHEMBL1922344	Plasma kallikrein		 17000								ChEMBL	10.1021/jm200868m	10.7270/Q2D50ND9	21995444			Hirayama, F; Koshio, H; Ishihara, T; Hachiya, S; Sugasawa, K; Koga, Y; Seki, N; Shiraki, R; Shigenaga, T; Iwatsuki, Y; Moritani, Y; Mori, K; Kadokura, T; Kawasaki, T; Matsumoto, Y; Sakamoto, S; Tsukamoto, S	Astellas Pharma Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50358251	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50358251&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			10168444	136962275		CHEMBL1922344			C03033	ZINC82137939	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50704170	COc1ccc(cc1)C(=O)Nc1cccc(O)c1NC(=O)c1ccc(cc1)N1CCCN(C)CC1	InChI=1S/C27H30N4O4/c1-30-15-4-16-31(18-17-30)21-11-7-19(8-12-21)27(34)29-25-23(5-3-6-24(25)32)28-26(33)20-9-13-22(35-2)14-10-20/h3,5-14,32H,4,15-18H2,1-2H3,(H,28,33)(H,29,34)	IJNIQYINMSGIPS-UHFFFAOYSA-N	50358252	CHEMBL1922235	Plasma kallikrein		 11000								ChEMBL	10.1021/jm200868m	10.7270/Q2D50ND9	21995444			Hirayama, F; Koshio, H; Ishihara, T; Hachiya, S; Sugasawa, K; Koga, Y; Seki, N; Shiraki, R; Shigenaga, T; Iwatsuki, Y; Moritani, Y; Mori, K; Kadokura, T; Kawasaki, T; Matsumoto, Y; Sakamoto, S; Tsukamoto, S	Astellas Pharma Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50358252	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50358252&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			9912771	136962276		CHEMBL1922235				ZINC70647134	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50707096	CC[C@H](C)[C@H]1NC(=O)C[C@H](Cc2cccc(CN)c2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CNC(=O)\C=C\[C@H](Cc2ccc(O)cc2)NC1=O)NC(C)=O	InChI=1S/C38H51N7O7/c1-4-23(2)35-37(51)42-28(18-25-10-13-30(47)14-11-25)12-15-33(48)40-22-31(41-24(3)46)38(52)45-16-6-9-32(45)36(50)43-29(20-34(49)44-35)19-26-7-5-8-27(17-26)21-39/h5,7-8,10-15,17,23,28-29,31-32,35,47H,4,6,9,16,18-22,39H2,1-3H3,(H,40,48)(H,41,46)(H,42,51)(H,43,50)(H,44,49)/b15-12+/t23-,28+,29-,31-,32-,35+/m0/s1	TWTJLEWMIFXFCW-OWQZSLJZSA-N	50359552	CHEMBL1927307	Plasma kallikrein		 3300000								ChEMBL	10.1016/j.bmc.2011.09.050	10.7270/Q2KD1ZBG	22047802			Janke, D; Sommerhoff, CP; Schaschke, N	Universit£t Bielefeld	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50359552	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50359552&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			57395841	136963576		CHEMBL1927307				ZINC82155225	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50707097	CC[C@H](C)[C@H]1NC(=O)C[C@H](Cc2cccc(CN)c2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CNC(=O)\C=C\[C@H](Cc2ccc(O)cc2)NC1=O)NC(=O)CCCCCN	InChI=1S/C42H60N8O7/c1-3-27(2)39-41(56)46-31(22-28-13-16-33(51)17-14-28)15-18-36(52)45-26-34(48-37(53)12-5-4-6-19-43)42(57)50-20-8-11-35(50)40(55)47-32(24-38(54)49-39)23-29-9-7-10-30(21-29)25-44/h7,9-10,13-18,21,27,31-32,34-35,39,51H,3-6,8,11-12,19-20,22-26,43-44H2,1-2H3,(H,45,52)(H,46,56)(H,47,55)(H,48,53)(H,49,54)/b18-15+/t27-,31+,32-,34-,35-,39+/m0/s1	WOROYUZJDCRVSY-HWPFHCMGSA-N	50359553	CHEMBL1927450	Plasma kallikrein		 2000000								ChEMBL	10.1016/j.bmc.2011.09.050	10.7270/Q2KD1ZBG	22047802			Janke, D; Sommerhoff, CP; Schaschke, N	Universit£t Bielefeld	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50359553	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50359553&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			57392333	136963577		CHEMBL1927450				ZINC95548775	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50698941	NCCCC[C@H](NC(=O)c1ccc(OCc2ccncc2)c(NC(=O)Cc2ccc3ccccc3c2)c1)C#N	InChI=1S/C31H31N5O3/c32-14-4-3-7-27(20-33)35-31(38)26-10-11-29(39-21-22-12-15-34-16-13-22)28(19-26)36-30(37)18-23-8-9-24-5-1-2-6-25(24)17-23/h1-2,5-6,8-13,15-17,19,27H,3-4,7,14,18,21,32H2,(H,35,38)(H,36,37)/t27-/m0/s1	ANJFEXRYZRQAGL-MHZLTWQESA-N	50355956	CHEMBL1910638	Plasma kallikrein			 380000							ChEMBL	10.1016/j.bmcl.2011.08.121	10.7270/Q2DR2VX4	21944858			Teno, N; Gohda, K; Wanaka, K; Sueda, T; Tsuda, Y	Hiroshima International University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355956	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355956&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			57393799	136959980		CHEMBL1910638				ZINC73139893	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50698942	CC(C)(C)OC(=O)n1cc(CCC(=O)Nc2cc(ccc2OCc2ccncc2)C(=O)N[C@@H](CCCCN)C#N)c2ccccc12	InChI=1S/C35H40N6O5/c1-35(2,3)46-34(44)41-22-26(28-9-4-5-10-30(28)41)12-14-32(42)40-29-20-25(33(43)39-27(21-37)8-6-7-17-36)11-13-31(29)45-23-24-15-18-38-19-16-24/h4-5,9-11,13,15-16,18-20,22,27H,6-8,12,14,17,23,36H2,1-3H3,(H,39,43)(H,40,42)/t27-/m0/s1	HVHAHUNFHGIMED-MHZLTWQESA-N	50355958	CHEMBL1910640	Plasma kallikrein			 910000							ChEMBL	10.1016/j.bmcl.2011.08.121	10.7270/Q2DR2VX4	21944858			Teno, N; Gohda, K; Wanaka, K; Sueda, T; Tsuda, Y	Hiroshima International University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355958	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355958&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			57390236	136959982		CHEMBL1910640				ZINC73139417	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50698943	NCCCC[C@H](NC(=O)c1ccc(OCc2ccncc2)c(NC(=O)Cc2cccc3ccccc23)c1)C#N	InChI=1S/C31H31N5O3/c32-15-4-3-9-26(20-33)35-31(38)25-11-12-29(39-21-22-13-16-34-17-14-22)28(18-25)36-30(37)19-24-8-5-7-23-6-1-2-10-27(23)24/h1-2,5-8,10-14,16-18,26H,3-4,9,15,19,21,32H2,(H,35,38)(H,36,37)/t26-/m0/s1	PYQJVQBSQZRXTN-SANMLTNESA-N	50355957	CHEMBL1910639	Plasma kallikrein			 680000							ChEMBL	10.1016/j.bmcl.2011.08.121	10.7270/Q2DR2VX4	21944858			Teno, N; Gohda, K; Wanaka, K; Sueda, T; Tsuda, Y	Hiroshima International University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355957	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355957&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			57400764	136959981		CHEMBL1910639				ZINC73139414	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50729926	CC(C)[C@@H](NC(=O)OC12CC3CC(CC(C3)C1)C2)C(=O)N[C@@H](Cc1ccccc1)C(=O)NC(Cc1ccc(NC(N)=[NH2+])cc1)C(=O)C(F)(F)F	InChI=1S/C36H45F3N6O5/c1-20(2)29(45-34(49)50-35-17-23-12-24(18-35)14-25(13-23)19-35)32(48)44-28(16-21-6-4-3-5-7-21)31(47)43-27(30(46)36(37,38)39)15-22-8-10-26(11-9-22)42-33(40)41/h3-11,20,23-25,27-29H,12-19H2,1-2H3,(H,43,47)(H,44,48)(H,45,49)(H4,40,41,42)/p+1/t23?,24?,25?,27?,28-,29+,35?/m0/s1	AKQUVFNDHGSFAN-XRCFIFCTSA-O	50074915	((R)-2-Methyl-1-{(S)-2-phenyl-1-[3,3,3-trifluoro-1-(4-guanidino-benzyl)-2-oxo-propylcarbamoyl]-ethylcarbamoyl}-propyl)-carbamic acid adamantan-1-yl ester	Plasma kallikrein		 5								ChEMBL	10.1016/s0960-894x(98)00562-9	10.7270/Q2C24WX3	10091673			Garrett, GS; McPhail, SJ; Tornheim, K; Correa, PE; McIver, JM	The Procter & Gamble Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50074915	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50074915&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			44334000	103968107						ZINC26821725	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50729928	CC(C)(C)[C@@H](NC(=O)N1CCOCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NC(Cc1ccc(NC(N)=[NH2+])cc1)C(=O)C(F)(F)F	InChI=1S/C31H40F3N7O5/c1-30(2,3)24(40-29(45)41-13-15-46-16-14-41)27(44)39-23(18-19-7-5-4-6-8-19)26(43)38-22(25(42)31(32,33)34)17-20-9-11-21(12-10-20)37-28(35)36/h4-12,22-24H,13-18H2,1-3H3,(H,38,43)(H,39,44)(H,40,45)(H4,35,36,37)/p+1/t22?,23-,24-/m0/s1	FTLDPBFWZHZPSN-VYCPFJESSA-O	50074917	Morpholine-4-carboxylic acid ((R)-2,2-dimethyl-1-{(S)-2-phenyl-1-[3,3,3-trifluoro-1-(4-guanidino-benzyl)-2-oxo-propylcarbamoyl]-ethylcarbamoyl}-propyl)-amide	Plasma kallikrein		 28								ChEMBL	10.1016/s0960-894x(98)00562-9	10.7270/Q2C24WX3	10091673			Garrett, GS; McPhail, SJ; Tornheim, K; Correa, PE; McIver, JM	The Procter & Gamble Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50074917	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50074917&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			44333954	103968109						ZINC26832621	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50729930	CC(C)(C)[C@@H](NC(=O)OC12CC3CC(CC(C3)C1)C2)C(=O)N[C@H](C(=O)NC(Cc1ccc(NC(N)=[NH2+])cc1)C(=O)C(F)(F)F)c1ccc2ccccc2c1	InChI=1S/C40H47F3N6O5/c1-38(2,3)32(49-37(53)54-39-19-23-14-24(20-39)16-25(15-23)21-39)35(52)48-31(28-11-10-26-6-4-5-7-27(26)18-28)34(51)47-30(33(50)40(41,42)43)17-22-8-12-29(13-9-22)46-36(44)45/h4-13,18,23-25,30-32H,14-17,19-21H2,1-3H3,(H,47,51)(H,48,52)(H,49,53)(H4,44,45,46)/p+1/t23?,24?,25?,30?,31-,32-,39?/m0/s1	FSQMPBMPAVBLCK-RQEWZCSHSA-O	50074916	[(R)-2,2-Dimethyl-1-({(S)-naphthalen-2-yl-[3,3,3-trifluoro-1-(4-guanidino-benzyl)-2-oxo-propylcarbamoyl]-methyl}-carbamoyl)-propyl]-carbamic acid adamantan-1-yl ester	Plasma kallikrein		 500								ChEMBL	10.1016/s0960-894x(98)00562-9	10.7270/Q2C24WX3	10091673			Garrett, GS; McPhail, SJ; Tornheim, K; Correa, PE; McIver, JM	The Procter & Gamble Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50074916	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50074916&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			44333956	103968108						ZINC95539428	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50729932	CC(C)(C)[C@@H](NC(=O)N1CCOCC1)C(=O)NCC(=O)NC(Cc1ccc(NC(N)=[NH2+])cc1)C(=O)C(F)(F)F	InChI=1S/C24H34F3N7O5/c1-23(2,3)18(33-22(38)34-8-10-39-11-9-34)20(37)30-13-17(35)32-16(19(36)24(25,26)27)12-14-4-6-15(7-5-14)31-21(28)29/h4-7,16,18H,8-13H2,1-3H3,(H,30,37)(H,32,35)(H,33,38)(H4,28,29,31)/p+1/t16?,18-/m0/s1	CHUNZFVEPFJQIA-DAFXYXGESA-O	50074919	Morpholine-4-carboxylic acid [(R)-2,2-dimethyl-1-({[3,3,3-trifluoro-1-(4-guanidino-benzyl)-2-oxo-propylcarbamoyl]-methyl}-carbamoyl)-propyl]-amide	Plasma kallikrein		 15500								ChEMBL	10.1016/s0960-894x(98)00562-9	10.7270/Q2C24WX3	10091673			Garrett, GS; McPhail, SJ; Tornheim, K; Correa, PE; McIver, JM	The Procter & Gamble Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50074919	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50074919&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			44333944	103968111						ZINC26822398	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50729933	NC(=[NH2+])Nc1ccc(CC(NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](CCc2ccccc2)NC(=O)OC23CC4CC(CC(C4)C2)C3)C(=O)C(F)(F)F)cc1	InChI=1S/C41H47F3N6O5/c42-41(43,44)35(51)33(20-27-11-14-31(15-12-27)47-38(45)46)48-37(53)34(21-26-9-5-2-6-10-26)49-36(52)32(16-13-25-7-3-1-4-8-25)50-39(54)55-40-22-28-17-29(23-40)19-30(18-28)24-40/h1-12,14-15,28-30,32-34H,13,16-24H2,(H,48,53)(H,49,52)(H,50,54)(H4,45,46,47)/p+1/t28?,29?,30?,32-,33?,34+,40?/m1/s1	XLHSSBIQAHXJLK-ARJXSWPHSA-O	50074920	((R)-3-Phenyl-1-{(S)-2-phenyl-1-[3,3,3-trifluoro-1-(4-guanidino-benzyl)-2-oxo-propylcarbamoyl]-ethylcarbamoyl}-propyl)-carbamic acid adamantan-1-yl ester	Plasma kallikrein		 4								ChEMBL	10.1016/s0960-894x(98)00562-9	10.7270/Q2C24WX3	10091673			Garrett, GS; McPhail, SJ; Tornheim, K; Correa, PE; McIver, JM	The Procter & Gamble Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50074920	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50074920&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			44333985	103968112						ZINC95539556	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50729942	CC(C)(C)[C@@H](NC(=O)OC12CC3CC(CC(C3)C1)C2)C(=O)N[C@@H](Cc1ccccc1)C(=O)NC(Cc1ccc(NC(N)=[NH2+])cc1)C(=O)C(F)(F)F	InChI=1S/C37H47F3N6O5/c1-35(2,3)29(46-34(50)51-36-18-23-13-24(19-36)15-25(14-23)20-36)32(49)45-28(17-21-7-5-4-6-8-21)31(48)44-27(30(47)37(38,39)40)16-22-9-11-26(12-10-22)43-33(41)42/h4-12,23-25,27-29H,13-20H2,1-3H3,(H,44,48)(H,45,49)(H,46,50)(H4,41,42,43)/p+1/t23?,24?,25?,27?,28-,29-,36?/m0/s1	MOTVVQLGXZCTOJ-NKCWJFQASA-O	50074918	((R)-2,2-Dimethyl-1-{(S)-2-phenyl-1-[3,3,3-trifluoro-1-(4-guanidino-benzyl)-2-oxo-propylcarbamoyl]-ethylcarbamoyl}-propyl)-carbamic acid adamantan-1-yl ester	Plasma kallikrein		 2								ChEMBL	10.1016/s0960-894x(98)00562-9	10.7270/Q2C24WX3	10091673			Garrett, GS; McPhail, SJ; Tornheim, K; Correa, PE; McIver, JM	The Procter & Gamble Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50074918	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50074918&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			44334159	103968110						ZINC26835373	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50729943	CC(C)(C)OC(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NC(Cc1ccc(NC(N)=[NH2+])cc1)C(=O)C(F)(F)F)c1ccc2ccccc2c1	InChI=1S/C37H39F3N6O5/c1-36(2,3)51-35(50)45-29(20-22-9-5-4-6-10-22)32(48)46-30(26-16-15-24-11-7-8-12-25(24)21-26)33(49)44-28(31(47)37(38,39)40)19-23-13-17-27(18-14-23)43-34(41)42/h4-18,21,28-30H,19-20H2,1-3H3,(H,44,49)(H,45,50)(H,46,48)(H4,41,42,43)/p+1/t28?,29-,30+/m1/s1	NGYXFSALIODLKO-ZECMKTFBSA-O	50074921	[(R)-1-({(S)-Naphthalen-2-yl-[3,3,3-trifluoro-1-(4-guanidino-benzyl)-2-oxo-propylcarbamoyl]-methyl}-carbamoyl)-2-phenyl-ethyl]-carbamic acid tert-butyl ester	Plasma kallikrein		 89								ChEMBL	10.1016/s0960-894x(98)00562-9	10.7270/Q2C24WX3	10091673			Garrett, GS; McPhail, SJ; Tornheim, K; Correa, PE; McIver, JM	The Procter & Gamble Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50074921	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50074921&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			44333998	103968113						ZINC26821714	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50726280	Cc1ccc(NS(=O)(=O)Cc2ccccc2)c(=O)n1CC(=O)NCC1CCN(CC1)C(N)=N	InChI=1S/C22H30N6O4S/c1-16-7-8-19(26-33(31,32)15-18-5-3-2-4-6-18)21(30)28(16)14-20(29)25-13-17-9-11-27(12-10-17)22(23)24/h2-8,17,26H,9-15H2,1H3,(H3,23,24)(H,25,29)	HKBQMUGJGVGZIB-UHFFFAOYSA-N	50069190	CHEMBL287614::N-(1-Carbamimidoyl-piperidin-4-ylmethyl)-2-(6-methyl-2-oxo-3-phenylmethanesulfonylamino-2H-pyridin-1-yl)-acetamide	Plasma kallikrein		>20000								ChEMBL	10.1016/S0960-894X(97)00257-6	10.7270/Q2P55P15				Sanderson, PE; Dyer, DL; Naylor-Olsen, AM; Vacca, JP; Gardell, SJ; Dale Lewis, S; Lucas, BJ; Lyle, EA; Lynch, JJ; Mulichak, AM	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50069190	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50069190&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			9956559	103963305		CHEMBL287614				ZINC03814027	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50782941	NC1CCC(CNC(=O)[C@@H]2CCCN2C(=O)CC2c3ccccc3C=Cc3ccccc23)CC1	InChI=1S/C29H35N3O2/c30-23-15-11-20(12-16-23)19-31-29(34)27-10-5-17-32(27)28(33)18-26-24-8-3-1-6-21(24)13-14-22-7-2-4-9-25(22)26/h1-4,6-9,13-14,20,23,26-27H,5,10-12,15-19,30H2,(H,31,34)/t20?,23?,27-/m0/s1	HBBDFTMFTGYXBM-ONHYFPECSA-N	50060704	(S)-1-(2-5H-Dibenzo[a,d]cyclohepten-5-yl-acetyl)-pyrrolidine-2-carboxylic acid (4-amino-cyclohexylmethyl)-amide; hydrochloride::CHEMBL555753	Plasma kallikrein		 775000								ChEMBL	10.1021/jm970397q	10.7270/Q20Z73ZQ	9357536			Tucker, TJ; Lumma, WC; Lewis, SD; Gardell, SJ; Lucas, BJ; Sisko, JT; Lynch, JJ; Lyle, EA; Baskin, EP; Woltmann, RF; Appleby, SD; Chen, IW; Dancheck, KB; Naylor-Olsen, AM; Krueger, JA; Cooper, CM; Vacca, JP	Merck Research Laboratories	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50060704	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50060704&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			10696511	103956340		CHEMBL555753				ZINC13766196	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50782945	NC1CCC(CNC(=O)[C@@H]2CCCN2C(=O)CC(c2ccccc2)c2cccnc2)CC1	InChI=1S/C26H34N4O2/c27-22-12-10-19(11-13-22)17-29-26(32)24-9-5-15-30(24)25(31)16-23(20-6-2-1-3-7-20)21-8-4-14-28-18-21/h1-4,6-8,14,18-19,22-24H,5,9-13,15-17,27H2,(H,29,32)/t19?,22?,23?,24-/m0/s1	RSQVIWGRLAYAKO-NCXVZUCISA-N	50060707	(S)-1-(3-Phenyl-3-pyridin-3-yl-propionyl)-pyrrolidine-2-carboxylic acid (4-amino-cyclohexylmethyl)-amide; TFA::CHEMBL333238	Plasma kallikrein		 476000								ChEMBL	10.1021/jm970397q	10.7270/Q20Z73ZQ	9357536			Tucker, TJ; Lumma, WC; Lewis, SD; Gardell, SJ; Lucas, BJ; Sisko, JT; Lynch, JJ; Lyle, EA; Baskin, EP; Woltmann, RF; Appleby, SD; Chen, IW; Dancheck, KB; Naylor-Olsen, AM; Krueger, JA; Cooper, CM; Vacca, JP	Merck Research Laboratories	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50060707	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50060707&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			44347480	103956343		CHEMBL333238				ZINC13766213	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50782954	NC1CCC(CNC(=O)[C@@H]2CCCN2C(=O)CC(c2cccnc2)c2ccc3OCOc3c2)CC1	InChI=1S/C27H34N4O4/c28-21-8-5-18(6-9-21)15-30-27(33)23-4-2-12-31(23)26(32)14-22(20-3-1-11-29-16-20)19-7-10-24-25(13-19)35-17-34-24/h1,3,7,10-11,13,16,18,21-23H,2,4-6,8-9,12,14-15,17,28H2,(H,30,33)/t18?,21?,22?,23-/m0/s1	KVIUJYWANGOCNH-FTVZZTLYSA-N	50060708	(S)-1-(3-Benzo[1,3]dioxol-5-yl-3-pyridin-3-yl-propionyl)-pyrrolidine-2-carboxylic acid (4-amino-cyclohexylmethyl)-amide; TFA::CHEMBL330791	Plasma kallikrein		 1000000								ChEMBL	10.1021/jm970397q	10.7270/Q20Z73ZQ	9357536			Tucker, TJ; Lumma, WC; Lewis, SD; Gardell, SJ; Lucas, BJ; Sisko, JT; Lynch, JJ; Lyle, EA; Baskin, EP; Woltmann, RF; Appleby, SD; Chen, IW; Dancheck, KB; Naylor-Olsen, AM; Krueger, JA; Cooper, CM; Vacca, JP	Merck Research Laboratories	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50060708	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50060708&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			44347624	103956344		CHEMBL330791				ZINC13766228	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50782955	NC1CCC(CNC(=O)[C@@H]2CCCN2C(=O)CC(c2ccccc2)c2ccncc2)CC1	InChI=1S/C26H34N4O2/c27-22-10-8-19(9-11-22)18-29-26(32)24-7-4-16-30(24)25(31)17-23(20-5-2-1-3-6-20)21-12-14-28-15-13-21/h1-3,5-6,12-15,19,22-24H,4,7-11,16-18,27H2,(H,29,32)/t19?,22?,23?,24-/m0/s1	UDXDAUOTKAPZMJ-NCXVZUCISA-N	50060703	(S)-1-(3-Phenyl-3-pyridin-4-yl-propionyl)-pyrrolidine-2-carboxylic acid (4-amino-cyclohexylmethyl)-amide; TFA::CHEMBL431675	Plasma kallikrein		>1000000								ChEMBL	10.1021/jm970397q	10.7270/Q20Z73ZQ	9357536			Tucker, TJ; Lumma, WC; Lewis, SD; Gardell, SJ; Lucas, BJ; Sisko, JT; Lynch, JJ; Lyle, EA; Baskin, EP; Woltmann, RF; Appleby, SD; Chen, IW; Dancheck, KB; Naylor-Olsen, AM; Krueger, JA; Cooper, CM; Vacca, JP	Merck Research Laboratories	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50060703	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50060703&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			44347478	103956339		CHEMBL431675				ZINC13766221	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50782986	NC1CCC(CNC(=O)[C@@H]2CCCN2C(=O)CC(c2ccccc2)c2ccccc2)CC1	InChI=1S/C27H35N3O2/c28-23-15-13-20(14-16-23)19-29-27(32)25-12-7-17-30(25)26(31)18-24(21-8-3-1-4-9-21)22-10-5-2-6-11-22/h1-6,8-11,20,23-25H,7,12-19,28H2,(H,29,32)/t20?,23?,25-/m0/s1	ZLJLYLMJZPDBSJ-QNAFOZIXSA-N	50060705	(S)-1-(3,3-Diphenyl-propionyl)-pyrrolidine-2-carboxylic acid (4-amino-cyclohexylmethyl)-amide; TFA::CHEMBL122894	Plasma kallikrein		>1000000								ChEMBL	10.1021/jm970397q	10.7270/Q20Z73ZQ	9357536			Tucker, TJ; Lumma, WC; Lewis, SD; Gardell, SJ; Lucas, BJ; Sisko, JT; Lynch, JJ; Lyle, EA; Baskin, EP; Woltmann, RF; Appleby, SD; Chen, IW; Dancheck, KB; Naylor-Olsen, AM; Krueger, JA; Cooper, CM; Vacca, JP	Merck Research Laboratories	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50060705	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50060705&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			10342843	103956341		CHEMBL122894				ZINC03831912	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50783005	NC1CCC(CNC(=O)[C@@H]2CCCN2C(=O)CC(C2CCCCC2)C2CCCCC2)CC1	InChI=1S/C27H47N3O2/c28-23-15-13-20(14-16-23)19-29-27(32)25-12-7-17-30(25)26(31)18-24(21-8-3-1-4-9-21)22-10-5-2-6-11-22/h20-25H,1-19,28H2,(H,29,32)/t20?,23?,25-/m0/s1	CZXNACPIFMZJFW-QNAFOZIXSA-N	50060711	(S)-1-(3,3-Dicyclohexyl-propionyl)-pyrrolidine-2-carboxylic acid (4-amino-cyclohexylmethyl)-amide; hydrochloride::CHEMBL555333	Plasma kallikrein		 170000								ChEMBL	10.1021/jm970397q	10.7270/Q20Z73ZQ	9357536			Tucker, TJ; Lumma, WC; Lewis, SD; Gardell, SJ; Lucas, BJ; Sisko, JT; Lynch, JJ; Lyle, EA; Baskin, EP; Woltmann, RF; Appleby, SD; Chen, IW; Dancheck, KB; Naylor-Olsen, AM; Krueger, JA; Cooper, CM; Vacca, JP	Merck Research Laboratories	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50060711	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50060711&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			10719580	103956347		CHEMBL555333				ZINC13766188	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50783007	NC1CCC(CNC(=O)[C@@H]2CCCN2C(=O)CC(c2ccccc2)c2ccccn2)CC1	InChI=1S/C26H34N4O2/c27-21-13-11-19(12-14-21)18-29-26(32)24-10-6-16-30(24)25(31)17-22(20-7-2-1-3-8-20)23-9-4-5-15-28-23/h1-5,7-9,15,19,21-22,24H,6,10-14,16-18,27H2,(H,29,32)/t19?,21?,22?,24-/m0/s1	RNMRZBAGAMQNNF-PDHDYEDSSA-N	50060709	(S)-1-(3-Phenyl-3-pyridin-2-yl-propionyl)-pyrrolidine-2-carboxylic acid (4-amino-cyclohexylmethyl)-amide; TFA::CHEMBL332870	Plasma kallikrein		 767000								ChEMBL	10.1021/jm970397q	10.7270/Q20Z73ZQ	9357536			Tucker, TJ; Lumma, WC; Lewis, SD; Gardell, SJ; Lucas, BJ; Sisko, JT; Lynch, JJ; Lyle, EA; Baskin, EP; Woltmann, RF; Appleby, SD; Chen, IW; Dancheck, KB; Naylor-Olsen, AM; Krueger, JA; Cooper, CM; Vacca, JP	Merck Research Laboratories	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50060709	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50060709&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			44347534	103956345		CHEMBL332870				ZINC13766206	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50766970	CC(C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(C)=O)C(=O)N[C@@H](CCCN=C(N)N)C=O	InChI=1S/C22H34N6O4/c1-14(2)19(21(32)27-17(13-29)10-7-11-25-22(23)24)28-20(31)18(26-15(3)30)12-16-8-5-4-6-9-16/h4-6,8-9,13-14,17-19H,7,10-12H2,1-3H3,(H,26,30)(H,27,32)(H,28,31)(H4,23,24,25)/t17-,18-,19-/m0/s1	RMRDWWFGHSBDRE-FHWLQOOXSA-N	50046885	2-(2-Acetylamino-3-phenyl-propionylamino)-N-(1-formyl-4-guanidino-butyl)-3-methyl-butyramide::CHEMBL2373041	Plasma kallikrein			 12000							ChEMBL	10.1021/jm00060a016	10.7270/Q24F1RCR	8478905			McConnell, RM; York, JL; Frizzell, D; Ezell, C	University of Arkansas	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50046885	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50046885&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			10253001	103977573		CHEMBL2373041				ZINC36242765	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50766973	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(C)=O)C(=O)N[C@@H](CCCN=C(N)N)C=O	InChI=1S/C23H36N6O4/c1-15(2)12-19(21(32)28-18(14-30)10-7-11-26-23(24)25)29-22(33)20(27-16(3)31)13-17-8-5-4-6-9-17/h4-6,8-9,14-15,18-20H,7,10-13H2,1-3H3,(H,27,31)(H,28,32)(H,29,33)(H4,24,25,26)/t18-,19-,20-/m0/s1	ZBVOKNNZQMOXNA-UFYCRDLUSA-N	50046887	2-(2-Acetylamino-3-phenyl-propionylamino)-4-methyl-pentanoic acid (1-formyl-4-guanidino-butyl)-amide::CHEMBL2373060	Plasma kallikrein			 1500							ChEMBL	10.1021/jm00060a016	10.7270/Q24F1RCR	8478905			McConnell, RM; York, JL; Frizzell, D; Ezell, C	University of Arkansas	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50046887	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50046887&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			10411941	103977575		CHEMBL2373060				ZINC36338452	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50766975	CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C(N)N)C=O	InChI=1S/C19H36N6O4/c1-11(2)9-15(23-13(5)27)17(28)25-16(12(3)4)18(29)24-14(10-26)7-6-8-22-19(20)21/h10-12,14-16H,6-9H2,1-5H3,(H,23,27)(H,24,29)(H,25,28)(H4,20,21,22)/t14-,15-,16-/m0/s1	SEQYPUIPGIGBNQ-JYJNAYRXSA-N	50046889	2-Acetylamino-4-methyl-pentanoic acid [1-(1-formyl-4-guanidino-butylcarbamoyl)-2-methyl-propyl]-amide::CHEMBL2373061	Plasma kallikrein			 130000							ChEMBL	10.1021/jm00060a016	10.7270/Q24F1RCR	8478905			McConnell, RM; York, JL; Frizzell, D; Ezell, C	University of Arkansas	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50046889	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50046889&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			10386993	103977577		CHEMBL2373061				ZINC26027358	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50766984	CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O)C(=O)N[C@@H](CCCN=C(N)N)C=O	InChI=1S/C23H36N6O5/c1-14(2)11-19(21(33)28-17(13-30)5-4-10-26-23(24)25)29-22(34)20(27-15(3)31)12-16-6-8-18(32)9-7-16/h6-9,13-14,17,19-20,32H,4-5,10-12H2,1-3H3,(H,27,31)(H,28,33)(H,29,34)(H4,24,25,26)/t17-,19-,20-/m0/s1	ZXRMYKJEEMKDBR-IHPCNDPISA-N	50046893	2-[2-Acetylamino-3-(4-hydroxy-phenyl)-propionylamino]-4-methyl-pentanoic acid (1-formyl-4-guanidino-butyl)-amide::CHEMBL2373044	Plasma kallikrein			 78000							ChEMBL	10.1021/jm00060a016	10.7270/Q24F1RCR	8478905			McConnell, RM; York, JL; Frizzell, D; Ezell, C	University of Arkansas	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50046893	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50046893&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			11754749	103977581		CHEMBL2373044				ZINC40368905	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50766995	CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O	InChI=1S/C20H38N6O5/c1-11(2)9-15(24-13(5)27)17(28)26-16(10-12(3)4)18(29)25-14(19(30)31)7-6-8-23-20(21)22/h11-12,14-16H,6-10H2,1-5H3,(H,24,27)(H,25,29)(H,26,28)(H,30,31)(H4,21,22,23)/t14-,15-,16-/m0/s1	OLNJKAXRBXUBTB-JYJNAYRXSA-N	50286441	(S)-2-((S)-2-Acetylamino-4-(S)-methyl-pentanoylamino)-4-methyl-pentanoic acid (1-formyl-4-guanidino-butyl)-amide::(S)-2-Acetylamino-4-methyl-pentanoic acid [(R)-1-((S)-1-formyl-4-guanidino-butylcarbamoyl)-3-methyl-butyl]-amide::(S)-2-Acetylamino-4-methyl-pentanoic acid [(S)-1-((S)-1-formyl-4-guanidino-butylcarbamoyl)-3-methyl-butyl]-amide::(S)-2-[(S)-2-((S)-2-Acetylamino-4-methyl-pentanoylamino)-4-methyl-pentanoylamino]-5-guanidino-pentanoic acid::(S)-2-acetylamino-4-methyl-pentanoic acid [(S)-2-(1-formyl-4-guanidino-butylamino)-4-methyl-pentanoyl]-amide::2-Acetylamino-4-methyl-pentanoic acid [1-(1-formyl-4-guanidino-butylcarbamoyl)-3-methyl-butyl]-amide::Ac-LLR-CHO::Ac-Leu-Leu-Arg-H::CHEMBL129157	Plasma kallikrein			 40000							ChEMBL	10.1021/jm00060a016	10.7270/Q24F1RCR	8478905			McConnell, RM; York, JL; Frizzell, D; Ezell, C	University of Arkansas	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50286441	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50286441&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			189069	104128012		CHEMBL129157			C04026		1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50766998	CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCN=C(N)N)C=O	InChI=1S/C23H36N6O5/c1-14(2)11-19(27-15(3)31)22(34)29-20(12-16-6-8-18(32)9-7-16)21(33)28-17(13-30)5-4-10-26-23(24)25/h6-9,13-14,17,19-20,32H,4-5,10-12H2,1-3H3,(H,27,31)(H,28,33)(H,29,34)(H4,24,25,26)/t17-,19-,20-/m0/s1	WBCDJYUJONNYJF-IHPCNDPISA-N	50046892	2-Acetylamino-4-methyl-pentanoic acid [1-(1-formyl-4-guanidino-butylcarbamoyl)-2-(4-hydroxy-phenyl)-ethyl]-amide::CHEMBL2373064	Plasma kallikrein			 66000							ChEMBL	10.1021/jm00060a016	10.7270/Q24F1RCR	8478905			McConnell, RM; York, JL; Frizzell, D; Ezell, C	University of Arkansas	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50046892	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50046892&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			10050676	103977580		CHEMBL2373064				ZINC26021604	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50767001	CC[C@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C=O	InChI=1S/C20H38N6O4/c1-6-13(4)17(24-14(5)28)19(30)26-16(10-12(2)3)18(29)25-15(11-27)8-7-9-23-20(21)22/h11-13,15-17H,6-10H2,1-5H3,(H,24,28)(H,25,29)(H,26,30)(H4,21,22,23)/t13-,15-,16-,17-/m0/s1	CRVFSZJBXPGLOQ-HJWJTTGWSA-N	50046897	2-Acetylamino-3-methyl-pentanoic acid [1-(1-formyl-4-guanidino-butylcarbamoyl)-3-methyl-butyl]-amide::CHEMBL2373047	Plasma kallikrein			 54000							ChEMBL	10.1021/jm00060a016	10.7270/Q24F1RCR	8478905			McConnell, RM; York, JL; Frizzell, D; Ezell, C	University of Arkansas	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50046897	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50046897&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			10455169	103977585		CHEMBL2373047				ZINC26021490	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50767004	CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C(N)N)C=O	InChI=1S/C23H36N6O4/c1-15(2)12-19(27-16(3)31)22(33)29-20(13-17-8-5-4-6-9-17)21(32)28-18(14-30)10-7-11-26-23(24)25/h4-6,8-9,14-15,18-20H,7,10-13H2,1-3H3,(H,27,31)(H,28,32)(H,29,33)(H4,24,25,26)/t18-,19-,20-/m0/s1	JTGHAZICFSZUOB-UFYCRDLUSA-N	50046896	2-Acetylamino-4-methyl-pentanoic acid [1-(1-formyl-4-guanidino-butylcarbamoyl)-2-phenyl-ethyl]-amide::CHEMBL2373053	Plasma kallikrein			 1100							ChEMBL	10.1021/jm00060a016	10.7270/Q24F1RCR	8478905			McConnell, RM; York, JL; Frizzell, D; Ezell, C	University of Arkansas	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50046896	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50046896&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			9981709	103977584		CHEMBL2373053				ZINC26026154	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50767015	CC(C)C[C@H](NC(=O)[C@@H](NC(C)=O)C(C)C)C(=O)N[C@@H](CCCN=C(N)N)C=O	InChI=1S/C19H36N6O4/c1-11(2)9-15(25-18(29)16(12(3)4)23-13(5)27)17(28)24-14(10-26)7-6-8-22-19(20)21/h10-12,14-16H,6-9H2,1-5H3,(H,23,27)(H,24,28)(H,25,29)(H4,20,21,22)/t14-,15-,16-/m0/s1	VTOGQBLCPOHMEG-JYJNAYRXSA-N	50046894	2-(2-Acetylamino-3-methyl-butyrylamino)-4-methyl-pentanoic acid (1-formyl-4-guanidino-butyl)-amide::CHEMBL2373062	Plasma kallikrein			 65000							ChEMBL	10.1021/jm00060a016	10.7270/Q24F1RCR	8478905			McConnell, RM; York, JL; Frizzell, D; Ezell, C	University of Arkansas	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50046894	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50046894&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			10024676	103977582		CHEMBL2373062				ZINC40639505	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50766988	CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(C)=O)C(=O)N[C@@H](CCCN=C(N)N)C=O	InChI=1S/C20H38N6O4/c1-6-13(4)17(26-18(29)16(10-12(2)3)24-14(5)28)19(30)25-15(11-27)8-7-9-23-20(21)22/h11-13,15-17H,6-10H2,1-5H3,(H,24,28)(H,25,30)(H,26,29)(H4,21,22,23)/t13-,15-,16-,17-/m0/s1	FVYMUBVDOSCORG-HJWJTTGWSA-N	50046891	2-(2-Acetylamino-4-methyl-pentanoylamino)-3-methyl-pentanoic acid (1-formyl-4-guanidino-butyl)-amide::CHEMBL2373046	Plasma kallikrein			 18000							ChEMBL	10.1021/jm00060a016	10.7270/Q24F1RCR	8478905			McConnell, RM; York, JL; Frizzell, D; Ezell, C	University of Arkansas	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50046891	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50046891&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			10365153	103977579		CHEMBL2373046				ZINC26024887	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50782115	Cc1c(C)c(c(C)c2CCC(C)(C)Oc12)S(=O)(=O)N[C@H](Cc1cccc(c1)C(N)=N)C(=O)N1CCN(CC1)S(C)(=O)=O	InChI=1S/C29H41N5O6S2/c1-18-19(2)26(20(3)23-10-11-29(4,5)40-25(18)23)42(38,39)32-24(17-21-8-7-9-22(16-21)27(30)31)28(35)33-12-14-34(15-13-33)41(6,36)37/h7-9,16,24,32H,10-15,17H2,1-6H3,(H3,30,31)/t24-/m1/s1	ONUNOWVVELQNRN-XMMPIXPASA-N	50060019	3-[(R)-3-(4-Methanesulfonyl-piperazin-1-yl)-3-oxo-2-(2,2,5,7,8-pentamethyl-chroman-6-sulfonylamino)-propyl]-benzamidine::CHEMBL107743	Plasma kallikrein		 97000								ChEMBL	10.1021/jm960668h	10.7270/Q2Z60PRH	9301673			Sturzebecher, J; Prasa, D; Hauptmann, J; Vieweg, H; Wikstrom, P	Klinikum der Friedrich-Schiller-Universit£t Jena	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50060019	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50060019&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			44335624	103955792		CHEMBL107743				ZINC26833273	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50782116	CS(=O)(=O)N1CCN(CC1)C(=O)[C@@H](Cc1cccc(c1)C(N)=N)NS(=O)(=O)c1ccc2ccccc2c1	InChI=1S/C25H29N5O5S2/c1-36(32,33)30-13-11-29(12-14-30)25(31)23(16-18-5-4-8-21(15-18)24(26)27)28-37(34,35)22-10-9-19-6-2-3-7-20(19)17-22/h2-10,15,17,23,28H,11-14,16H2,1H3,(H3,26,27)/t23-/m1/s1	ROHIQEZPGXXMND-HSZRJFAPSA-N	50060017	3-[(R)-3-(4-Methanesulfonyl-piperazin-1-yl)-2-(naphthalene-2-sulfonylamino)-3-oxo-propyl]-benzamidine::CHEMBL107392	Plasma kallikrein		 58000								ChEMBL	10.1021/jm960668h	10.7270/Q2Z60PRH	9301673			Sturzebecher, J; Prasa, D; Hauptmann, J; Vieweg, H; Wikstrom, P	Klinikum der Friedrich-Schiller-Universit£t Jena	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50060017	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50060017&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			10816339	103955790		CHEMBL107392					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50782156	CC(=O)N1CCN(CC1)C(=O)[C@@H](Cc1cccc(c1)C(N)=N)NS(=O)(=O)c1ccc2ccccc2c1	InChI=1S/C26H29N5O4S/c1-18(32)30-11-13-31(14-12-30)26(33)24(16-19-5-4-8-22(15-19)25(27)28)29-36(34,35)23-10-9-20-6-2-3-7-21(20)17-23/h2-10,15,17,24,29H,11-14,16H2,1H3,(H3,27,28)/t24-/m1/s1	ZUWBXGHMVKDMQO-XMMPIXPASA-N	50060029	3-[(R)-3-(4-Acetyl-piperazin-1-yl)-2-(naphthalene-2-sulfonylamino)-3-oxo-propyl]-benzamidine::CHEMBL322901	Plasma kallikrein		 15000								ChEMBL	10.1021/jm960668h	10.7270/Q2Z60PRH	9301673			Sturzebecher, J; Prasa, D; Hauptmann, J; Vieweg, H; Wikstrom, P	Klinikum der Friedrich-Schiller-Universit£t Jena	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50060029	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50060029&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			10696955	103955802		CHEMBL322901				ZINC12504151	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50782169	CN(C)C(=O)N1CCN(CC1)C(=O)[C@@H](Cc1cccc(c1)C(N)=N)NS(=O)(=O)c1ccc2ccccc2c1	InChI=1S/C27H32N6O4S/c1-31(2)27(35)33-14-12-32(13-15-33)26(34)24(17-19-6-5-9-22(16-19)25(28)29)30-38(36,37)23-11-10-20-7-3-4-8-21(20)18-23/h3-11,16,18,24,30H,12-15,17H2,1-2H3,(H3,28,29)/t24-/m1/s1	AMRRXWBRMUATPJ-XMMPIXPASA-N	50060035	4-[(R)-3-(3-Carbamimidoyl-phenyl)-2-(naphthalene-2-sulfonylamino)-propionyl]-piperazine-1-carboxylic acid dimethylamide::CHEMBL107627	Plasma kallikrein		 7300								ChEMBL	10.1021/jm960668h	10.7270/Q2Z60PRH	9301673			Sturzebecher, J; Prasa, D; Hauptmann, J; Vieweg, H; Wikstrom, P	Klinikum der Friedrich-Schiller-Universit£t Jena	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50060035	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50060035&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			10578280	103955808		CHEMBL107627				ZINC26839714	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50782176	CC1(C)C2CCC1(CCS(=O)(=O)N[C@H](Cc1cccc(c1)C(N)=N)C(=O)N1CCN(CC1)S(C)(=O)=O)C(=O)C2	InChI=1S/C26H39N5O6S2/c1-25(2)20-7-8-26(25,22(32)17-20)9-14-39(36,37)29-21(16-18-5-4-6-19(15-18)23(27)28)24(33)30-10-12-31(13-11-30)38(3,34)35/h4-6,15,20-21,29H,7-14,16-17H2,1-3H3,(H3,27,28)/t20?,21-,26?/m1/s1	JNPJLUMJGJWVKP-QLSBTUPBSA-N	50060046	3-[(R)-2-[2-(7,7-Dimethyl-2-oxo-bicyclo[2.2.1]hept-1-yl)-ethanesulfonylamino]-3-(4-methanesulfonyl-piperazin-1-yl)-3-oxo-propyl]-benzamidine::CHEMBL319035	Plasma kallikrein		 22000								ChEMBL	10.1021/jm960668h	10.7270/Q2Z60PRH	9301673			Sturzebecher, J; Prasa, D; Hauptmann, J; Vieweg, H; Wikstrom, P	Klinikum der Friedrich-Schiller-Universit£t Jena	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50060046	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50060046&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			44335601	103955819		CHEMBL319035				ZINC36242769	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50782227	NC(=N)c1cccc(C[C@@H](NS(=O)(=O)c2ccc3ccccc3c2)C(=O)N2CCN(CC2)C=O)c1	InChI=1S/C25H27N5O4S/c26-24(27)21-7-3-4-18(14-21)15-23(25(32)30-12-10-29(17-31)11-13-30)28-35(33,34)22-9-8-19-5-1-2-6-20(19)16-22/h1-9,14,16-17,23,28H,10-13,15H2,(H3,26,27)/t23-/m1/s1	CCIUEYWVRCQMRD-HSZRJFAPSA-N	50060023	3-[(R)-3-(4-Formyl-piperazin-1-yl)-2-(naphthalene-2-sulfonylamino)-3-oxo-propyl]-benzamidine::CHEMBL322165	Plasma kallikrein		 3300								ChEMBL	10.1021/jm960668h	10.7270/Q2Z60PRH	9301673			Sturzebecher, J; Prasa, D; Hauptmann, J; Vieweg, H; Wikstrom, P	Klinikum der Friedrich-Schiller-Universit£t Jena	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50060023	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50060023&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			10624997	103955796		CHEMBL322165				ZINC13765419	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50782232	NC(=N)c1cccc(C[C@@H](NS(=O)(=O)c2ccc3ccccc3c2)C(=O)N2CCN(CCO)CC2)c1	InChI=1S/C26H31N5O4S/c27-25(28)22-7-3-4-19(16-22)17-24(26(33)31-12-10-30(11-13-31)14-15-32)29-36(34,35)23-9-8-20-5-1-2-6-21(20)18-23/h1-9,16,18,24,29,32H,10-15,17H2,(H3,27,28)/t24-/m1/s1	SVQXGJDWUSQUPO-XMMPIXPASA-N	50060024	3-[(R)-3-[4-(2-Hydroxy-ethyl)-piperazin-1-yl]-2-(naphthalene-2-sulfonylamino)-3-oxo-propyl]-benzamidine::CHEMBL107282	Plasma kallikrein		 27000								ChEMBL	10.1021/jm960668h	10.7270/Q2Z60PRH	9301673			Sturzebecher, J; Prasa, D; Hauptmann, J; Vieweg, H; Wikstrom, P	Klinikum der Friedrich-Schiller-Universit£t Jena	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50060024	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50060024&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			10815545	103955797		CHEMBL107282					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50782313	CN1CCN(CC1)C(=O)[C@@H](Cc1cccc(c1)C(N)=N)NS(=O)(=O)c1ccc2ccccc2c1	InChI=1S/C25H29N5O3S/c1-29-11-13-30(14-12-29)25(31)23(16-18-5-4-8-21(15-18)24(26)27)28-34(32,33)22-10-9-19-6-2-3-7-20(19)17-22/h2-10,15,17,23,28H,11-14,16H2,1H3,(H3,26,27)/t23-/m1/s1	NRTKDGANVXKTQD-HSZRJFAPSA-N	50060031	3-[(R)-3-(4-Methyl-piperazin-1-yl)-2-(naphthalene-2-sulfonylamino)-3-oxo-propyl]-benzamidine::CHEMBL107911	Plasma kallikrein		 35000								ChEMBL	10.1021/jm960668h	10.7270/Q2Z60PRH	9301673			Sturzebecher, J; Prasa, D; Hauptmann, J; Vieweg, H; Wikstrom, P	Klinikum der Friedrich-Schiller-Universit£t Jena	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50060031	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50060031&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			10648370	103955804		CHEMBL107911				ZINC13765411	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50803975	CS(=O)(=O)c1ccccc1-c1ccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c(F)c1	InChI=1S/C25H20F4N4O3S/c1-37(35,36)22-8-3-2-7-18(22)16-9-10-20(19(26)12-16)31-24(34)21-13-23(25(27,28)29)32-33(21)17-6-4-5-15(11-17)14-30/h2-13H,14,30H2,1H3,(H,31,34)	ZLUOAFAJSUPHOG-UHFFFAOYSA-N	12657	1-[3-(Aminomethyl)phenyl]-N-[3-fluoro-2-(methylsulfonyl)-[1,1-biphenyl]-4-yl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::1-[3-(aminomethyl)phenyl]-N-[2-fluoro-4-(2-methanesulfonylphenyl)phenyl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::CHEMBL559015::DPC 423::DPC423	Plasma kallikrein		 61								ChEMBL	10.1021/jm000409z	10.7270/Q2RF5VQK	11170646			Pinto, DJ; Orwat, MJ; Wang, S; Fevig, JM; Quan, ML; Amparo, E; Cacciola, J; Rossi, KA; Alexander, RS; Smallwood, AM; Luettgen, JM; Liang, L; Aungst, BJ; Wright, MR; Knabb, RM; Wong, PC; Wexler, RR; Lam, PY	DuPont Pharmaceuticals Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12657	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=12657&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	M35	3M35,3M36	9895762	46513110		CHEMBL559015				ZINC01490578	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50799359	NC(=N)c1ccc2cc(OC(=O)c3ccc(NC4=NCCN4)cc3)ccc2c1	InChI=1S/C21H19N5O2/c22-19(23)16-2-1-15-12-18(8-5-14(15)11-16)28-20(27)13-3-6-17(7-4-13)26-21-24-9-10-25-21/h1-8,11-12H,9-10H2,(H3,22,23)(H2,24,25,26)	QMRJOIUGPCVZPH-UHFFFAOYSA-N	50369774	SEPIMOSTAT MESYLATE::Sepimostat	Plasma kallikrein		 570								ChEMBL	10.1021/jm990412m	10.7270/Q2JD4XH4	10669559			Leung, D; Abbenante, G; Fairlie, DP	University of Queensland	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50369774	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50369774&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			108041	160848876						ZINC03778392	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50833968	COC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CC[C@H]1CCC[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)OCc2ccccc2)C(=O)[C@@H](N)Cc2c[nH]c3ccccc23)C(=O)[C@@H](N)Cc2c[nH]c3ccccc23)C1=O)C(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)[C@@H](N)Cc1ccc(O)cc1	InChI=1S/C68H74N12O14/c1-93-67(91)58(63(87)46(69)28-36-22-25-42(81)26-23-36)79-65(89)55(60(84)47(70)29-39-32-73-50-18-8-5-15-43(39)50)77-54(82)27-24-38-14-11-21-53(59(38)83)76-64(88)56(61(85)48(71)30-40-33-74-51-19-9-6-16-44(40)51)78-66(90)57(80-68(92)94-35-37-12-3-2-4-13-37)62(86)49(72)31-41-34-75-52-20-10-7-17-45(41)52/h2-10,12-13,15-20,22-23,25-26,32-34,38,46-49,53,55-58,73-75,81H,11,14,21,24,27-31,35,69-72H2,1H3,(H,76,88)(H,77,82)(H,78,90)(H,79,89)(H,80,92)/t38-,46+,47+,48+,49+,53-,55+,56+,57+,58+/m1/s1	ZVHPVNKHJJNPRR-YIPFKETKSA-N	50292271	CHEMBL265127::Cyclohexanone derivative	Plasma kallikrein			>400000							ChEMBL	10.1021/jm050488k	10.7270/Q24M959K	16250649			Xue, F; Seto, CT	Brown University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50292271	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50292271&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			44404049	104133822		CHEMBL265127					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50815969	CS(=O)(=O)c1ccccc1-c1ccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c(F)c1	InChI=1S/C25H20F4N4O3S/c1-37(35,36)22-8-3-2-7-18(22)16-9-10-20(19(26)12-16)31-24(34)21-13-23(25(27,28)29)32-33(21)17-6-4-5-15(11-17)14-30/h2-13H,14,30H2,1H3,(H,31,34)	ZLUOAFAJSUPHOG-UHFFFAOYSA-N	12657	1-[3-(Aminomethyl)phenyl]-N-[3-fluoro-2-(methylsulfonyl)-[1,1-biphenyl]-4-yl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::1-[3-(aminomethyl)phenyl]-N-[2-fluoro-4-(2-methanesulfonylphenyl)phenyl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::CHEMBL559015::DPC 423::DPC423	Plasma kallikrein		 61								ChEMBL	10.1021/jm030212h	10.7270/Q2ZW1MP2	14640539			Pruitt, JR; Pinto, DJ; Galemmo, RA; Alexander, RS; Rossi, KA; Wells, BL; Drummond, S; Bostrom, LL; Burdick, D; Bruckner, R; Chen, H; Smallwood, A; Wong, PC; Wright, MR; Bai, S; Luettgen, JM; Knabb, RM; Lam, PY; Wexler, RR	Pharmaceutical Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12657	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=12657&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	M35	3M35,3M36	9895762	46513110		CHEMBL559015				ZINC01490578	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50815975	NCc1ccccc1-n1nc(cc1C(=O)Nc1ccc(cc1F)-c1ccccc1S(N)(=O)=O)C(F)(F)F	InChI=1S/C24H19F4N5O3S/c25-17-11-14(16-6-2-4-8-21(16)37(30,35)36)9-10-18(17)31-23(34)20-12-22(24(26,27)28)32-33(20)19-7-3-1-5-15(19)13-29/h1-12H,13,29H2,(H,31,34)(H2,30,35,36)	TYPXEIGMGZWOGB-UHFFFAOYSA-N	50135945	1-[2-(aminomethyl)phenyl]-N-(3-fluoro-2'-sulfamoylbiphenyl-4-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::2-(2-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic acid (3-fluoro-2'-sulfamoyl-biphenyl-4-yl)-amide::CHEMBL151939	Plasma kallikrein		 58								ChEMBL	10.1021/jm030212h	10.7270/Q2ZW1MP2	14640539			Pruitt, JR; Pinto, DJ; Galemmo, RA; Alexander, RS; Rossi, KA; Wells, BL; Drummond, S; Bostrom, LL; Burdick, D; Bruckner, R; Chen, H; Smallwood, A; Wong, PC; Wright, MR; Bai, S; Luettgen, JM; Knabb, RM; Lam, PY; Wexler, RR	Pharmaceutical Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50135945	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50135945&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	M37	3M37	9915041	104026281		CHEMBL151939				ZINC01493713	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50853487	COc1ccc(cc1)-n1nc(cc1C(=O)Cc1ccc(cc1F)-n1ccccc1=O)C(N)=O	InChI=1S/C24H19FN4O4/c1-33-18-9-7-16(8-10-18)29-21(14-20(27-29)24(26)32)22(30)12-15-5-6-17(13-19(15)25)28-11-3-2-4-23(28)31/h2-11,13-14H,12H2,1H3,(H2,26,32)	MRPLIGSOQUCMBC-UHFFFAOYSA-N	50228914	5-(2-(2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl)acetyl)-1-(4-methoxyphenyl)-1H-pyrazole-3-carboxamide::CHEMBL403042	Plasma kallikrein		 8900								ChEMBL	10.1016/j.bmcl.2007.11.040	10.7270/Q2DV1KQS	18054227			Varnes, JG; Wacker, DA; Pinto, DJ; Orwat, MJ; Theroff, JP; Wells, B; Galemo, RA; Luettgen, JM; Knabb, RM; Bai, S; He, K; Lam, PY; Wexler, RR	Bristol-Myers Squibb Research and Development	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50228914	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50228914&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			10275412	104097981		CHEMBL403042				ZINC29037718	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50853504	CN(C)Cc1nccn1-c1ccc(NC(=O)c2cc(nn2-c2ccc3onc(N)c3c2)C(F)(F)F)c(F)c1	InChI=1S/C24H20F4N8O2/c1-34(2)12-21-30-7-8-35(21)13-3-5-17(16(25)10-13)31-23(37)18-11-20(24(26,27)28)32-36(18)14-4-6-19-15(9-14)22(29)33-38-19/h3-11H,12H2,1-2H3,(H2,29,33)(H,31,37)	OFJRNBWSFXEHSA-UHFFFAOYSA-N	12676	1-(3-Aminobenzisoxazol-5-yl)-3-trifluoromethyl-N-[2-fluoro-4-[(2-dimethylaminomethyl)imidazol-1-yl]phenyl]-1H-pyrazole-5-carboxyamide Hydrochloride Salt::1-(3-amino-1,2-benzoxazol-5-yl)-N-(4-{2-[(dimethylamino)methyl]-1H-imidazol-1-yl}-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::BMS-561389::CHEMBL206335::CHEMBL558198::DPC 906::Razaxaban	Plasma kallikrein		>2300								ChEMBL	10.1016/j.bmcl.2007.11.040	10.7270/Q2DV1KQS	18054227			Varnes, JG; Wacker, DA; Pinto, DJ; Orwat, MJ; Theroff, JP; Wells, B; Galemo, RA; Luettgen, JM; Knabb, RM; Bai, S; He, K; Lam, PY; Wexler, RR	Bristol-Myers Squibb Research and Development	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12676	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=12676&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	IK8	1Z6E	204102	46513128		CHEMBL206335CHEMBL558198				ZINC03633839	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50848830	Clc1ccc(s1)C(=O)N[C@@H]1CCC[C@@H]1NC(=O)c1ccc(cc1)-n1ccccc1=O	InChI=1S/C22H20ClN3O3S/c23-19-12-11-18(30-19)22(29)25-17-5-3-4-16(17)24-21(28)14-7-9-15(10-8-14)26-13-2-1-6-20(26)27/h1-2,6-13,16-17H,3-5H2,(H,24,28)(H,25,29)/t16-,17+/m0/s1	QCPYHSAHOYXXQK-DLBZAZTESA-N	50216554	5-CHLORO-N-((1R,2S)-2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO) CYCLOPENTYL)THIOPHENE-2-CARBOXAMIDE::5-chloro-N-((1R,2S)-2-(4-(2-oxopyridin-1(2H)-yl)benzamido)cyclopentyl)thiophene-2-carboxamide::CHEMBL233992	Plasma kallikrein		>16000								ChEMBL	10.1016/j.bmcl.2007.06.029	10.7270/Q2416XVV	17588746			Qiao, JX; Chang, CH; Cheney, DL; Morin, PE; Wang, GZ; King, SR; Wang, TC; Rendina, AR; Luettgen, JM; Knabb, RM; Wexler, RR; Lam, PY	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50216554	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50216554&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	ME5	2P95	9954980	104090901		CHEMBL233992	DB08174			ZINC16052356	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50848875	Clc1c[nH]c2cc(ccc12)C(=O)N[C@@H]1CCCC[C@@H]1NC(=O)c1ccc(cc1)-n1ccccc1=O	InChI=1S/C27H25ClN4O3/c28-21-16-29-24-15-18(10-13-20(21)24)27(35)31-23-6-2-1-5-22(23)30-26(34)17-8-11-19(12-9-17)32-14-4-3-7-25(32)33/h3-4,7-16,22-23,29H,1-2,5-6H2,(H,30,34)(H,31,35)/t22-,23+/m0/s1	PMRPPULYFDNTHJ-XZOQPEGZSA-N	50216556	3-CHLORO-N-((1R,2S) -2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO)CYCLOHEXYL)-1H-INDOLE-6-CARBOXAMIDE::3-chloro-N-((1R,2S)-2-(4-(2-oxopyridin-1(2H)-yl)benzamido)cyclohexyl)-1H-indole-6-carboxamide::CHEMBL398380	Plasma kallikrein		 8458								ChEMBL	10.1016/j.bmcl.2007.06.029	10.7270/Q2416XVV	17588746			Qiao, JX; Chang, CH; Cheney, DL; Morin, PE; Wang, GZ; King, SR; Wang, TC; Rendina, AR; Luettgen, JM; Knabb, RM; Wexler, RR; Lam, PY	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50216556	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50216556&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	ME4	2P94	11237163	104090903		CHEMBL398380				ZINC16052355	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50848879	Clc1ccc(s1)C(=O)N[C@@H]1CCC[C@@H]1NC(=O)c1ccc(cc1)C1(CN2CCCC2)CC1	InChI=1S/C25H30ClN3O2S/c26-22-11-10-21(32-22)24(31)28-20-5-3-4-19(20)27-23(30)17-6-8-18(9-7-17)25(12-13-25)16-29-14-1-2-15-29/h6-11,19-20H,1-5,12-16H2,(H,27,30)(H,28,31)/t19-,20+/m0/s1	GSQQRIKCCGDNLT-VQTJNVASSA-N	50216572	5-chloro-N-((1R,2S)-2-(4-(1-(pyrrolidin-1-ylmethyl)cyclopropyl)benzamido)cyclopentyl)thiophene-2-carboxamide::CHEMBL450578	Plasma kallikrein		>10000								ChEMBL	10.1016/j.bmcl.2007.06.029	10.7270/Q2416XVV	17588746			Qiao, JX; Chang, CH; Cheney, DL; Morin, PE; Wang, GZ; King, SR; Wang, TC; Rendina, AR; Luettgen, JM; Knabb, RM; Wexler, RR; Lam, PY	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50216572	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50216572&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			44432538	104090919		CHEMBL450578				ZINC28822898	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50848892	Clc1ccc(s1)C(=O)N[C@@H]1CCC[C@@H]1NC(=O)c1ccc(cc1)N1CCCCC1=O	InChI=1S/C22H24ClN3O3S/c23-19-12-11-18(30-19)22(29)25-17-5-3-4-16(17)24-21(28)14-7-9-15(10-8-14)26-13-2-1-6-20(26)27/h7-12,16-17H,1-6,13H2,(H,24,28)(H,25,29)/t16-,17+/m0/s1	FIUKRBJFYYATCX-DLBZAZTESA-N	50216557	5-chloro-N-((1R,2S)-2-(4-(2-oxopiperidin-1-yl)benzamido)cyclopentyl)thiophene-2-carboxamide::CHEMBL399593	Plasma kallikrein		>10000								ChEMBL	10.1016/j.bmcl.2007.06.029	10.7270/Q2416XVV	17588746			Qiao, JX; Chang, CH; Cheney, DL; Morin, PE; Wang, GZ; King, SR; Wang, TC; Rendina, AR; Luettgen, JM; Knabb, RM; Wexler, RR; Lam, PY	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50216557	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50216557&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			11351302	104090904		CHEMBL399593				ZINC28822880	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50861757	NC(N)=NCCC[C@H](NC(=O)CNC(=O)[C@@H](CCCN=C(N)N)NS(=O)(=O)Cc1ccccc1)C(=O)c1nccs1	InChI=1S/C24H36N10O5S2/c25-23(26)30-10-4-8-17(20(36)22-29-12-13-40-22)33-19(35)14-32-21(37)18(9-5-11-31-24(27)28)34-41(38,39)15-16-6-2-1-3-7-16/h1-3,6-7,12-13,17-18,34H,4-5,8-11,14-15H2,(H,32,37)(H,33,35)(H4,25,26,30)(H4,27,28,31)/t17-,18+/m0/s1	BZGZTAKGLPGMAV-ZWKOTPCHSA-N	50328697	(R)-5-guanidino-N-(2-((S)-5-guanidino-1-oxo-1-(thiazol-2-yl)pentan-2-ylamino)-2-oxoethyl)-2-(phenylmethylsulfonamido)pentanamide::CHEMBL414002	Plasma kallikrein			 14							ChEMBL	10.1016/j.bmc.2007.11.015	10.7270/Q21J9BNH	18053726			Maryanoff, BE; Costanzo, MJ	Johnson & Johnson Pharmaceutical Research & Development	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50328697	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50328697&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			9916876	123107812		CHEMBL414002				ZINC03929532	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50861781	NC(N)=NCCC[C@@H](NS(=O)(=O)CCc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCN=C(N)N)C(=O)c1nc2ccccc2o1	InChI=1S/C29H40N10O6S/c30-28(31)34-15-6-11-21(25(41)27-38-20-10-4-5-13-23(20)45-27)37-24(40)18-36-26(42)22(12-7-16-35-29(32)33)39-46(43,44)17-14-19-8-2-1-3-9-19/h1-5,8-10,13,21-22,39H,6-7,11-12,14-18H2,(H,36,42)(H,37,40)(H4,30,31,34)(H4,32,33,35)/t21-,22+/m0/s1	WOLHGVQMGPTOEN-FCHUYYIVSA-N	50374312	CHEMBL270834	Plasma kallikrein			 13							ChEMBL	10.1016/j.bmc.2007.11.015	10.7270/Q21J9BNH	18053726			Maryanoff, BE; Costanzo, MJ	Johnson & Johnson Pharmaceutical Research & Development	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50374312	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50374312&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			44453827	160853402		CHEMBL270834				ZINC29126390	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50861782	NC(N)=NCCC[C@@H](NS(=O)(=O)CCc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCN=C(N)N)C(=O)c1nccs1	InChI=1S/C25H38N10O5S2/c26-24(27)31-11-4-8-18(21(37)23-30-13-14-41-23)34-20(36)16-33-22(38)19(9-5-12-32-25(28)29)35-42(39,40)15-10-17-6-2-1-3-7-17/h1-3,6-7,13-14,18-19,35H,4-5,8-12,15-16H2,(H,33,38)(H,34,36)(H4,26,27,31)(H4,28,29,32)/t18-,19+/m0/s1	XPKIPPYWISUECU-RBUKOAKNSA-N	50374329	CHEMBL256427	Plasma kallikrein			 120							ChEMBL	10.1016/j.bmc.2007.11.015	10.7270/Q21J9BNH	18053726			Maryanoff, BE; Costanzo, MJ	Johnson & Johnson Pharmaceutical Research & Development	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50374329	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50374329&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			9939021	160853419		CHEMBL256427				ZINC29126430	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50861876	NC(N)=NCCC[C@@H](NS(=O)(=O)CCc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCN=C(N)N)C(=O)c1nc2ccccc2s1	InChI=1S/C29H40N10O5S2/c30-28(31)34-15-6-11-21(25(41)27-38-20-10-4-5-13-23(20)45-27)37-24(40)18-36-26(42)22(12-7-16-35-29(32)33)39-46(43,44)17-14-19-8-2-1-3-9-19/h1-5,8-10,13,21-22,39H,6-7,11-12,14-18H2,(H,36,42)(H,37,40)(H4,30,31,34)(H4,32,33,35)/t21-,22+/m0/s1	FFYWSDGJFSQDBD-FCHUYYIVSA-N	50374313	CHEMBL271047	Plasma kallikrein			 29							ChEMBL	10.1016/j.bmc.2007.11.015	10.7270/Q21J9BNH	18053726			Maryanoff, BE; Costanzo, MJ	Johnson & Johnson Pharmaceutical Research & Development	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50374313	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50374313&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			9917846	160853403		CHEMBL271047				ZINC29126392	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50862055	CC(C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)N[C@H](C)c1ccc(Br)cc1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)c1nccs1	InChI=1S/C32H41BrN8O5S/c1-18(2)26(29(45)39-24(5-4-14-37-31(34)35)27(43)30-36-15-16-47-30)41-28(44)25(17-20-6-12-23(42)13-7-20)40-32(46)38-19(3)21-8-10-22(33)11-9-21/h6-13,15-16,18-19,24-26,42H,4-5,14,17H2,1-3H3,(H,39,45)(H,41,44)(H4,34,35,37)(H2,38,40,46)/t19-,24+,25+,26+/m1/s1	XOPHHKQWDWBCDG-DCSNJQJVSA-N	12972	(2S)-2-[(2S)-2-({[(1R)-1-(4-bromophenyl)ethyl]carbamoyl}amino)-3-(4-hydroxyphenyl)propanamido]-N-[(2S)-5-carbamimidamido-1-oxo-1-(1,3-thiazol-2-yl)pentan-2-yl]-3-methylbutanamide::alpha-ketothiazole analogue 32	Plasma kallikrein			 10							ChEMBL	10.1016/j.bmc.2007.11.015	10.7270/Q21J9BNH	18053726			Maryanoff, BE; Costanzo, MJ	Johnson & Johnson Pharmaceutical Research & Development	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12972	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=12972&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			16098910	46509411						ZINC29125472	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50905179	COC(=O)[C@@H]1CCCN1C(=O)[C@@H](Cc1ccccc1)N(C)C(=O)[C@H](C)NC(=O)[C@@H](NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](OC(=O)[C@@H](OC(=O)[C@H](C(C)C)N(C)C)C(C)C)C(C)C)[C@@H](C)O	InChI=1S/C58H95N9O16/c1-30(2)25-38(43(69)29-45(71)64-46(36(12)68)52(74)60-35(11)54(76)66(15)42(27-37-21-18-17-19-22-37)55(77)67-24-20-23-41(67)56(78)81-16)61-51(73)40(28-44(59)70)62-50(72)39(26-31(3)4)63-53(75)48(33(7)8)82-58(80)49(34(9)10)83-57(79)47(32(5)6)65(13)14/h17-19,21-22,30-36,38-43,46-49,68-69H,20,23-29H2,1-16H3,(H2,59,70)(H,60,74)(H,61,73)(H,62,72)(H,63,75)(H,64,71)/t35-,36+,38-,39-,40-,41-,42+,43-,46-,47-,48+,49-/m0/s1	JZYWSTGTBRHGTL-BIXXXADNSA-N	50302107	CHEMBL567893::Grassystatin A	Plasma kallikrein			 10000							ChEMBL	10.1021/jm9009394	10.7270/Q2BG2PXP	19715320			Kwan, JC; Eksioglu, EA; Liu, C; Paul, VJ; Luesch, H	University of Florida	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50302107	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50302107&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			44255320	104156468		CHEMBL567893					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50928411	NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3cn(Cc4cccc(Cn5cc(C[C@@H](NS(=O)(=O)Cc6ccccc6)C(=O)N2)nn5)c4)nn3)cc1	InChI=1S/C33H35N11O4S/c34-31(35)26-11-9-22(10-12-26)16-36-32(45)29-14-27-19-43(41-38-27)17-24-7-4-8-25(13-24)18-44-20-28(39-42-44)15-30(33(46)37-29)40-49(47,48)21-23-5-2-1-3-6-23/h1-13,19-20,29-30,40H,14-18,21H2,(H3,34,35)(H,36,45)(H,37,46)/t29-,30+/m0/s1	BKSCOHJNKDJECO-XZWHSSHBSA-N	50380617	CHEMBL2016873	Plasma kallikrein		 2.4								ChEMBL	10.1021/jm2011996	10.7270/Q26T0NN4	22276953			Saupe, SM; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50380617	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50380617&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56599309	160859700		CHEMBL2016873				ZINC84596939	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50928427	NC(N)=NCc1cccc(C[C@H](NC(=O)[C@@H](CCCc2ccccc2)NS(=O)(=O)Cc2cccc(c2)C(O)=O)C(=O)NCc2ccc(cc2)C(N)=N)c1	InChI=1S/C38H44N8O6S/c39-34(40)30-17-15-26(16-18-30)22-43-35(47)33(21-27-10-4-11-28(19-27)23-44-38(41)42)45-36(48)32(14-6-9-25-7-2-1-3-8-25)46-53(51,52)24-29-12-5-13-31(20-29)37(49)50/h1-5,7-8,10-13,15-20,32-33,46H,6,9,14,21-24H2,(H3,39,40)(H,43,47)(H,45,48)(H,49,50)(H4,41,42,44)/t32-,33+/m1/s1	HJCCPKALMCCVEK-SAIUNTKASA-N	50380619	CHEMBL2016865	Plasma kallikrein		 0.075								ChEMBL	10.1021/jm2011996	10.7270/Q26T0NN4	22276953			Saupe, SM; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50380619	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50380619&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			70683249	160859702		CHEMBL2016865				ZINC84620107	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50928428	NC(=N)c1ccc(CNC(=O)[C@@H]2CCC(=O)NCc3cccc(CNC(=O)CC[C@@H](NS(=O)(=O)Cc4ccccc4)C(=O)N2)c3)cc1	InChI=1S/C33H39N7O6S/c34-31(35)26-11-9-22(10-12-26)18-38-32(43)27-13-15-29(41)36-19-24-7-4-8-25(17-24)20-37-30(42)16-14-28(33(44)39-27)40-47(45,46)21-23-5-2-1-3-6-23/h1-12,17,27-28,40H,13-16,18-21H2,(H3,34,35)(H,36,41)(H,37,42)(H,38,43)(H,39,44)/t27-,28+/m0/s1	DBLYNSSCIKMVDW-WUFINQPMSA-N	50380620	CHEMBL2016866	Plasma kallikrein		 25.4								ChEMBL	10.1021/jm2011996	10.7270/Q26T0NN4	22276953			Saupe, SM; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50380620	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50380620&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56954620	160859703		CHEMBL2016866				ZINC84632384	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50928429	NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3ccc(CNC(=O)Cc4ccc(CC(=O)NCc5ccc(C[C@@H](NS(=O)(=O)Cc6ccccc6)C(=O)N2)cc5)cc4)cc3)cc1	InChI=1S/C45H47N7O6S/c46-43(47)38-20-18-36(19-21-38)28-50-44(55)39-22-30-10-14-34(15-11-30)26-48-41(53)24-32-6-8-33(9-7-32)25-42(54)49-27-35-16-12-31(13-17-35)23-40(45(56)51-39)52-59(57,58)29-37-4-2-1-3-5-37/h1-21,39-40,52H,22-29H2,(H3,46,47)(H,48,53)(H,49,54)(H,50,55)(H,51,56)/t39-,40+/m0/s1	XNDGXBNDCNRYDE-IOLBBIBUSA-N	50380621	CHEMBL2016864	Plasma kallikrein		 868								ChEMBL	10.1021/jm2011996	10.7270/Q26T0NN4	22276953			Saupe, SM; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50380621	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50380621&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56954732	160859704		CHEMBL2016864				ZINC95550988	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50928430	NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3ccc(CNC(=O)CN4CCN(CC4)CC(=O)NCc4ccc(C[C@@H](NS(=O)(=O)Cc5ccccc5)C(=O)N2)cc4)cc3)cc1	InChI=1S/C43H51N9O6S/c44-41(45)36-16-14-34(15-17-36)26-48-42(55)37-22-30-6-10-32(11-7-30)24-46-39(53)27-51-18-20-52(21-19-51)28-40(54)47-25-33-12-8-31(9-13-33)23-38(43(56)49-37)50-59(57,58)29-35-4-2-1-3-5-35/h1-17,37-38,50H,18-29H2,(H3,44,45)(H,46,53)(H,47,54)(H,48,55)(H,49,56)/t37-,38+/m0/s1	IHGDLTOMAAIKHD-QPPIDDCLSA-N	50380622	CHEMBL2016867	Plasma kallikrein		 493								ChEMBL	10.1021/jm2011996	10.7270/Q26T0NN4	22276953			Saupe, SM; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50380622	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50380622&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56954733	160859705		CHEMBL2016867				ZINC95550902	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50928431	NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3cccc(CNC(=O)Cc4ccc(CC(=O)NCc5cccc(C[C@@H](NS(=O)(=O)Cc6ccccc6)C(=O)N2)c5)cc4)c3)cc1	InChI=1S/C45H47N7O6S/c46-43(47)38-18-16-32(17-19-38)26-50-44(55)39-22-34-8-4-10-36(20-34)27-48-41(53)24-30-12-14-31(15-13-30)25-42(54)49-28-37-11-5-9-35(21-37)23-40(45(56)51-39)52-59(57,58)29-33-6-2-1-3-7-33/h1-21,39-40,52H,22-29H2,(H3,46,47)(H,48,53)(H,49,54)(H,50,55)(H,51,56)/t39-,40+/m0/s1	UIBUHBYTPNMHCK-IOLBBIBUSA-N	50380618	CHEMBL2016868	Plasma kallikrein		 136								ChEMBL	10.1021/jm2011996	10.7270/Q26T0NN4	22276953			Saupe, SM; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50380618	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50380618&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56640092	160859701		CHEMBL2016868				ZINC95550857	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50928432	NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3cccc(CNC(=O)CN4CCN(CC4)CC(=O)NCc4cccc(C[C@@H](NS(=O)(=O)Cc5ccccc5)C(=O)N2)c4)c3)cc1	InChI=1S/C43H51N9O6S/c44-41(45)36-14-12-30(13-15-36)24-48-42(55)37-22-32-8-4-10-34(20-32)25-46-39(53)27-51-16-18-52(19-17-51)28-40(54)47-26-35-11-5-9-33(21-35)23-38(43(56)49-37)50-59(57,58)29-31-6-2-1-3-7-31/h1-15,20-21,37-38,50H,16-19,22-29H2,(H3,44,45)(H,46,53)(H,47,54)(H,48,55)(H,49,56)/t37-,38+/m0/s1	UPFBONOEYAFXQG-QPPIDDCLSA-N	50380616	CHEMBL2016869	Plasma kallikrein		 25.3								ChEMBL	10.1021/jm2011996	10.7270/Q26T0NN4	22276953			Saupe, SM; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50380616	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50380616&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56640160	160859699		CHEMBL2016869				ZINC95550858	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50928433	NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3cccc(CNC(=O)Cc4cccc(CC(=O)NCc5cccc(C[C@@H](NS(=O)(=O)Cc6ccccc6)C(=O)N2)c5)c4)c3)cc1	InChI=1S/C45H47N7O6S/c46-43(47)38-17-15-30(16-18-38)26-50-44(55)39-22-32-9-5-13-36(20-32)27-48-41(53)24-34-11-4-12-35(19-34)25-42(54)49-28-37-14-6-10-33(21-37)23-40(45(56)51-39)52-59(57,58)29-31-7-2-1-3-8-31/h1-21,39-40,52H,22-29H2,(H3,46,47)(H,48,53)(H,49,54)(H,50,55)(H,51,56)/t39-,40+/m0/s1	MLVTZWQEWUGCSC-IOLBBIBUSA-N	50380623	CHEMBL2016870	Plasma kallikrein		 17.4								ChEMBL	10.1021/jm2011996	10.7270/Q26T0NN4	22276953			Saupe, SM; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50380623	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50380623&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56954834	160859706		CHEMBL2016870				ZINC95550895	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50928434	NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3ccc(OCC=CCOc4ccc(C[C@@H](NS(=O)(=O)Cc5ccccc5)C(=O)N2)cc4)cc3)cc1	InChI=1S/C37H39N5O6S/c38-35(39)30-14-8-28(9-15-30)24-40-36(43)33-22-26-10-16-31(17-11-26)47-20-4-5-21-48-32-18-12-27(13-19-32)23-34(37(44)41-33)42-49(45,46)25-29-6-2-1-3-7-29/h1-19,33-34,42H,20-25H2,(H3,38,39)(H,40,43)(H,41,44)/t33-,34+/m0/s1	XWJGZMVWOIPRDB-SZAHLOSFSA-N	50380624	CHEMBL2016871	Plasma kallikrein		 9.4								ChEMBL	10.1021/jm2011996	10.7270/Q26T0NN4	22276953			Saupe, SM; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50380624	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50380624&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			70687492	160859707		CHEMBL2016871				ZINC84631988	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50928435	NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3ccc(OCCCCOc4ccc(C[C@@H](NS(=O)(=O)Cc5ccccc5)C(=O)N2)cc4)cc3)cc1	InChI=1S/C37H41N5O6S/c38-35(39)30-14-8-28(9-15-30)24-40-36(43)33-22-26-10-16-31(17-11-26)47-20-4-5-21-48-32-18-12-27(13-19-32)23-34(37(44)41-33)42-49(45,46)25-29-6-2-1-3-7-29/h1-3,6-19,33-34,42H,4-5,20-25H2,(H3,38,39)(H,40,43)(H,41,44)/t33-,34+/m0/s1	HFYJVMKRIIAVFV-SZAHLOSFSA-N	50380625	CHEMBL2016872	Plasma kallikrein		 19								ChEMBL	10.1021/jm2011996	10.7270/Q26T0NN4	22276953			Saupe, SM; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50380625	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50380625&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56640226	160859708		CHEMBL2016872				ZINC84596938	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50928436	NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3cn(Cc4cccc(Cn5cc(C[C@@H](NS(=O)(=O)Cc6ccccc6)C(=O)N2)nn5)n4)nn3)cc1	InChI=1S/C32H34N12O4S/c33-30(34)23-11-9-21(10-12-23)15-35-31(45)28-13-26-18-43(41-38-26)16-24-7-4-8-25(36-24)17-44-19-27(39-42-44)14-29(32(46)37-28)40-49(47,48)20-22-5-2-1-3-6-22/h1-12,18-19,28-29,40H,13-17,20H2,(H3,33,34)(H,35,45)(H,37,46)/t28-,29+/m0/s1	PODBMIDYMFKRKE-URLMMPGGSA-N	50380626	CHEMBL2016874	Plasma kallikrein		 10.1								ChEMBL	10.1021/jm2011996	10.7270/Q26T0NN4	22276953			Saupe, SM; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50380626	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50380626&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56954952	160859709		CHEMBL2016874				ZINC84596940	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50928437	NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3cn(CC4=CCC=C(Cn5cc(C[C@@H](NS(=O)(=O)Cc6ccccc6)C(=O)N2)nn5)N4O)nn3)cc1	InChI=1S/C32H36N12O5S/c33-30(34)23-11-9-21(10-12-23)15-35-31(45)28-13-24-16-42(40-37-24)18-26-7-4-8-27(44(26)47)19-43-17-25(38-41-43)14-29(32(46)36-28)39-50(48,49)20-22-5-2-1-3-6-22/h1-3,5-12,16-17,28-29,39,47H,4,13-15,18-20H2,(H3,33,34)(H,35,45)(H,36,46)/t28-,29+/m0/s1	KOFPLCRLJGKZIC-URLMMPGGSA-N	50380627	CHEMBL2016875	Plasma kallikrein		 67								ChEMBL	10.1021/jm2011996	10.7270/Q26T0NN4	22276953			Saupe, SM; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50380627	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50380627&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			91929823	160859710		CHEMBL2016875				ZINC84596684	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50926386	NCC1CC[C@@H](CC1)C(=O)NC(Cc1ccc(Oc2ncccn2)cc1)C(=O)Nc1cccc(c1)C(O)=O	InChI=1S/C28H31N5O5/c29-17-19-5-9-20(10-6-19)25(34)33-24(26(35)32-22-4-1-3-21(16-22)27(36)37)15-18-7-11-23(12-8-18)38-28-30-13-2-14-31-28/h1-4,7-8,11-14,16,19-20,24H,5-6,9-10,15,17,29H2,(H,32,35)(H,33,34)(H,36,37)/t19?,20-,24?	DPPAJPSBFDNXML-VFWMNFPYSA-N	50092336	3-{2-[(4-Aminomethyl-cyclohexanecarbonyl)-amino]-3-[4-(pyrimidin-2-yloxy)-phenyl]-propionylamino}-benzoic acid::CHEMBL70520	Plasma kallikrein			 710							ChEMBL	10.1016/j.bmcl.2012.02.014	10.7270/Q21G0N9N	22386244			Liang, G; Chen, X; Aldous, S; Pu, SF; Mehdi, S; Powers, E; Xia, T; Wang, R	Sanofi Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50092336	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50092336&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			44310877	103990486		CHEMBL70520				ZINC26294128	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51042621	C[C@H]1CN2CC(=O)Nc3ccc(C[C@H](NC(=O)[C@@H](Cc4ccc(CNC(=O)CN1C[C@@H]2C)cc4)NS(=O)(=O)Cc1ccccc1)C(=O)NCc1ccc(cc1)C(N)=N)cc3	InChI=1S/C44H53N9O6S/c1-29-25-53-27-41(55)49-37-18-14-32(15-19-37)20-38(43(56)48-23-34-12-16-36(17-13-34)42(45)46)50-44(57)39(51-60(58,59)28-35-6-4-3-5-7-35)21-31-8-10-33(11-9-31)22-47-40(54)26-52(29)24-30(53)2/h3-19,29-30,38-39,51H,20-28H2,1-2H3,(H3,45,46)(H,47,54)(H,48,56)(H,49,55)(H,50,57)/t29-,30-,38-,39+/m0/s1	IZMQFNBELARFJP-ZSSLFURESA-N	50425650	CHEMBL2315238	Plasma kallikrein		 116								ChEMBL	10.1021/jm3012917	10.7270/Q2RB75W8	23294255			Saupe, SM; Leubner, S; Betz, M; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50425650	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50425650&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71563125	164154525		CHEMBL2315238				ZINC95593641	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51042622	NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3ccc(NC(=O)CN4CCCN(CC4)CC(=O)NCc4ccc(C[C@@H](NS(=O)(=O)Cc5ccccc5)C(=O)N2)cc4)cc3)cc1	InChI=1S/C43H51N9O6S/c44-41(45)35-15-11-33(12-16-35)26-47-42(55)37-23-31-13-17-36(18-14-31)48-40(54)28-52-20-4-19-51(21-22-52)27-39(53)46-25-32-9-7-30(8-10-32)24-38(43(56)49-37)50-59(57,58)29-34-5-2-1-3-6-34/h1-3,5-18,37-38,50H,4,19-29H2,(H3,44,45)(H,46,53)(H,47,55)(H,48,54)(H,49,56)/t37-,38+/m0/s1	ZIDLTLIDVYHHIR-QPPIDDCLSA-N	50425653	CHEMBL2315237	Plasma kallikrein		 440								ChEMBL	10.1021/jm3012917	10.7270/Q2RB75W8	23294255			Saupe, SM; Leubner, S; Betz, M; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50425653	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50425653&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71563124	164154528		CHEMBL2315237				ZINC95597516	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51042623	NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3ccc(NC(=O)CN4CCN(CC4)CC(=O)NCc4ccc(C[C@@H](NS(=O)(=O)Cc5ccccc5)C(=O)N2)cc4)cc3)cc1	InChI=1S/C42H49N9O6S/c43-40(44)34-14-10-32(11-15-34)25-46-41(54)36-22-30-12-16-35(17-13-30)47-39(53)27-51-20-18-50(19-21-51)26-38(52)45-24-31-8-6-29(7-9-31)23-37(42(55)48-36)49-58(56,57)28-33-4-2-1-3-5-33/h1-17,36-37,49H,18-28H2,(H3,43,44)(H,45,52)(H,46,54)(H,47,53)(H,48,55)/t36-,37+/m0/s1	XVWZMIZDGMJNFD-PQQNNWGCSA-N	50425654	CHEMBL2315236	Plasma kallikrein		 187								ChEMBL	10.1021/jm3012917	10.7270/Q2RB75W8	23294255			Saupe, SM; Leubner, S; Betz, M; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50425654	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50425654&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71561557	164154529		CHEMBL2315236				ZINC95596900	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51042624	C[C@H]1CN2CC(=O)Nc3ccc(C[C@@H](NS(=O)(=O)Cc4ccccc4)C(=O)N[C@@H](Cc4ccc(NC(=O)CN1C[C@@H]2C)cc4)C(=O)NCc1ccc(cc1)C(N)=N)cc3	InChI=1S/C43H51N9O6S/c1-28-24-52-26-40(54)48-36-18-12-31(13-19-36)21-38(50-59(57,58)27-33-6-4-3-5-7-33)43(56)49-37(42(55)46-22-32-8-14-34(15-9-32)41(44)45)20-30-10-16-35(17-11-30)47-39(53)25-51(28)23-29(52)2/h3-19,28-29,37-38,50H,20-27H2,1-2H3,(H3,44,45)(H,46,55)(H,47,53)(H,48,54)(H,49,56)/t28-,29-,37-,38+/m0/s1	YTOPOMUWWWKQQR-QZVHGAHDSA-N	50425651	CHEMBL2315235	Plasma kallikrein		 242								ChEMBL	10.1021/jm3012917	10.7270/Q2RB75W8	23294255			Saupe, SM; Leubner, S; Betz, M; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50425651	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50425651&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71563007	164154526		CHEMBL2315235				ZINC95595445	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51042625	C[C@H]1CN2CC(=O)Nc3ccc(C[C@@H](NS(=O)(=O)Cc4ccccc4)C(=O)N[C@@H](Cc4ccc(NC(=O)CN1C[C@H]2C)cc4)C(=O)NCc1ccc(cc1)C(N)=N)cc3	InChI=1S/C43H51N9O6S/c1-28-24-52-26-40(54)48-36-18-12-31(13-19-36)21-38(50-59(57,58)27-33-6-4-3-5-7-33)43(56)49-37(42(55)46-22-32-8-14-34(15-9-32)41(44)45)20-30-10-16-35(17-11-30)47-39(53)25-51(28)23-29(52)2/h3-19,28-29,37-38,50H,20-27H2,1-2H3,(H3,44,45)(H,46,55)(H,47,53)(H,48,54)(H,49,56)/t28-,29+,37-,38+/m0/s1	YTOPOMUWWWKQQR-MCKYZGRYSA-N	50425652	CHEMBL2315234	Plasma kallikrein		 500								ChEMBL	10.1021/jm3012917	10.7270/Q2RB75W8	23294255			Saupe, SM; Leubner, S; Betz, M; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50425652	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50425652&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71563006	164154527		CHEMBL2315234				ZINC95595948	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51042626	NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3ccc(NC(=O)CCN4CCCN(CC4)CCC(=O)Nc4ccc(C[C@@H](NS(=O)(=O)Cc5ccccc5)C(=O)N2)cc4)cc3)cc1	InChI=1S/C44H53N9O6S/c45-42(46)35-13-7-33(8-14-35)29-47-43(56)38-27-31-9-15-36(16-10-31)48-40(54)19-23-52-21-4-22-53(26-25-52)24-20-41(55)49-37-17-11-32(12-18-37)28-39(44(57)50-38)51-60(58,59)30-34-5-2-1-3-6-34/h1-3,5-18,38-39,51H,4,19-30H2,(H3,45,46)(H,47,56)(H,48,54)(H,49,55)(H,50,57)/t38-,39+/m0/s1	HNUIINDFHXJLJD-ZESVVUHVSA-N	50425655	CHEMBL2315247	Plasma kallikrein		 422								ChEMBL	10.1021/jm3012917	10.7270/Q2RB75W8	23294255			Saupe, SM; Leubner, S; Betz, M; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50425655	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50425655&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71562883	164154530		CHEMBL2315247				ZINC95598171	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51042627	NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3ccc(NC(=O)CN4CCCN(CC4)CC(=O)Nc4ccc(C[C@@H](NS(=O)(=O)Cc5ccccc5)C(=O)N2)cc4)cc3)cc1	InChI=1S/C42H49N9O6S/c43-40(44)33-13-7-31(8-14-33)25-45-41(54)36-23-29-9-15-34(16-10-29)46-38(52)26-50-19-4-20-51(22-21-50)27-39(53)47-35-17-11-30(12-18-35)24-37(42(55)48-36)49-58(56,57)28-32-5-2-1-3-6-32/h1-3,5-18,36-37,49H,4,19-28H2,(H3,43,44)(H,45,54)(H,46,52)(H,47,53)(H,48,55)/t36-,37+/m0/s1	XLAHTLJMVQSDTK-PQQNNWGCSA-N	50425656	CHEMBL2315246	Plasma kallikrein		 392								ChEMBL	10.1021/jm3012917	10.7270/Q2RB75W8	23294255			Saupe, SM; Leubner, S; Betz, M; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50425656	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50425656&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			68020667	164154531		CHEMBL2315246				ZINC95593213	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51042628	NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3ccc(NC(=O)CCN4CCN(CC4)CCC(=O)Nc4cccc(C[C@@H](NS(=O)(=O)Cc5ccccc5)C(=O)N2)c4)cc3)cc1	InChI=1S/C43H51N9O6S/c44-41(45)34-13-9-31(10-14-34)28-46-42(55)37-26-30-11-15-35(16-12-30)47-39(53)17-19-51-21-23-52(24-22-51)20-18-40(54)48-36-8-4-7-33(25-36)27-38(43(56)49-37)50-59(57,58)29-32-5-2-1-3-6-32/h1-16,25,37-38,50H,17-24,26-29H2,(H3,44,45)(H,46,55)(H,47,53)(H,48,54)(H,49,56)/t37-,38+/m0/s1	MUPOOEYBTKHNTC-QPPIDDCLSA-N	50425657	CHEMBL2315245	Plasma kallikrein		 240								ChEMBL	10.1021/jm3012917	10.7270/Q2RB75W8	23294255			Saupe, SM; Leubner, S; Betz, M; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50425657	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50425657&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71562882	164154532		CHEMBL2315245				ZINC95594779	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51042629	NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3cccc(NC(=O)CCN4CCN(CC4)CCC(=O)Nc4ccc(C[C@@H](NS(=O)(=O)Cc5ccccc5)C(=O)N2)cc4)c3)cc1	InChI=1S/C43H51N9O6S/c44-41(45)34-13-9-31(10-14-34)28-46-42(55)37-27-33-7-4-8-36(25-33)48-40(54)18-20-52-23-21-51(22-24-52)19-17-39(53)47-35-15-11-30(12-16-35)26-38(43(56)49-37)50-59(57,58)29-32-5-2-1-3-6-32/h1-16,25,37-38,50H,17-24,26-29H2,(H3,44,45)(H,46,55)(H,47,53)(H,48,54)(H,49,56)/t37-,38+/m0/s1	DOEPKHLCEFPBEX-QPPIDDCLSA-N	50425658	CHEMBL2315244	Plasma kallikrein		 24								ChEMBL	10.1021/jm3012917	10.7270/Q2RB75W8	23294255			Saupe, SM; Leubner, S; Betz, M; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50425658	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50425658&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71562761	164154533		CHEMBL2315244				ZINC95596485	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51042630	NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3ccc(NC(=O)CCN4CCN(CC4)CCC(=O)Nc4ccc(C[C@@H](NS(=O)(=O)Cc5ccccc5)C(=O)N2)cc4)cc3)cc1	InChI=1S/C43H51N9O6S/c44-41(45)34-12-6-32(7-13-34)28-46-42(55)37-26-30-8-14-35(15-9-30)47-39(53)18-20-51-22-24-52(25-23-51)21-19-40(54)48-36-16-10-31(11-17-36)27-38(43(56)49-37)50-59(57,58)29-33-4-2-1-3-5-33/h1-17,37-38,50H,18-29H2,(H3,44,45)(H,46,55)(H,47,53)(H,48,54)(H,49,56)/t37-,38+/m0/s1	VGPDGESAAIVXNO-QPPIDDCLSA-N	50425648	CHEMBL2315243	Plasma kallikrein		 1000								ChEMBL	10.1021/jm3012917	10.7270/Q2RB75W8	23294255			Saupe, SM; Leubner, S; Betz, M; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50425648	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50425648&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71561420	164154523		CHEMBL2315243				ZINC95593581	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51042631	NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3ccc(NC(=O)CN4CCN(CC4)CC(=O)Nc4cccc(C[C@@H](NS(=O)(=O)Cc5ccccc5)C(=O)N2)c4)cc3)cc1	InChI=1S/C41H47N9O6S/c42-39(43)32-13-9-29(10-14-32)24-44-40(53)35-22-28-11-15-33(16-12-28)45-37(51)25-49-17-19-50(20-18-49)26-38(52)46-34-8-4-7-31(21-34)23-36(41(54)47-35)48-57(55,56)27-30-5-2-1-3-6-30/h1-16,21,35-36,48H,17-20,22-27H2,(H3,42,43)(H,44,53)(H,45,51)(H,46,52)(H,47,54)/t35-,36+/m0/s1	IGCAUFKCIHSDQS-MPQUPPDSSA-N	50425659	CHEMBL2315242	Plasma kallikrein		 118								ChEMBL	10.1021/jm3012917	10.7270/Q2RB75W8	23294255			Saupe, SM; Leubner, S; Betz, M; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50425659	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50425659&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71562760	164154534		CHEMBL2315242				ZINC95593718	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51042632	OC(=O)C(F)(F)F.NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3cccc(NC(=O)CN4CCN(CC4)CC(=O)Nc4ccc(C[C@@H](NS(=O)(=O)Cc5ccccc5)C(=O)N2)cc4)c3)cc1	InChI=1S/C41H47N9O6S.C2HF3O2/c42-39(43)32-13-9-29(10-14-32)24-44-40(53)35-23-31-7-4-8-34(21-31)46-38(52)26-50-19-17-49(18-20-50)25-37(51)45-33-15-11-28(12-16-33)22-36(41(54)47-35)48-57(55,56)27-30-5-2-1-3-6-30;3-2(4,5)1(6)7/h1-16,21,35-36,48H,17-20,22-27H2,(H3,42,43)(H,44,53)(H,45,51)(H,46,52)(H,47,54);(H,6,7)/t35-,36+;/m0./s1	AUCAZZWPUGEUHN-LTJSBYPUSA-N	50425660	CHEMBL2315241	Plasma kallikrein		 13								ChEMBL	10.1021/jm3012917	10.7270/Q2RB75W8	23294255			Saupe, SM; Leubner, S; Betz, M; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50425660	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50425660&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71719191	164154535		CHEMBL2315241				ZINC95596461	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51042633	NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3cccc(NC(=O)CN4CCN(CC4)CC(=O)Nc4cccc(C[C@@H](NS(=O)(=O)Cc5ccccc5)C(=O)N2)c4)c3)cc1	InChI=1S/C41H47N9O6S/c42-39(43)32-14-12-28(13-15-32)24-44-40(53)35-22-30-8-4-10-33(20-30)45-37(51)25-49-16-18-50(19-17-49)26-38(52)46-34-11-5-9-31(21-34)23-36(41(54)47-35)48-57(55,56)27-29-6-2-1-3-7-29/h1-15,20-21,35-36,48H,16-19,22-27H2,(H3,42,43)(H,44,53)(H,45,51)(H,46,52)(H,47,54)/t35-,36+/m0/s1	OXHLIVRHOPCUSV-MPQUPPDSSA-N	50425661	CHEMBL2315240	Plasma kallikrein		 3.2								ChEMBL	10.1021/jm3012917	10.7270/Q2RB75W8	23294255			Saupe, SM; Leubner, S; Betz, M; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50425661	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50425661&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71562631	164154536		CHEMBL2315240				ZINC95596383	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51042634	NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3ccc(NC(=O)CN4CCN(CC4)CC(=O)Nc4ccc(C[C@@H](NS(=O)(=O)Cc5ccccc5)C(=O)N2)cc4)cc3)cc1	InChI=1S/C41H47N9O6S/c42-39(43)32-12-6-30(7-13-32)24-44-40(53)35-22-28-8-14-33(15-9-28)45-37(51)25-49-18-20-50(21-19-49)26-38(52)46-34-16-10-29(11-17-34)23-36(41(54)47-35)48-57(55,56)27-31-4-2-1-3-5-31/h1-17,35-36,48H,18-27H2,(H3,42,43)(H,44,53)(H,45,51)(H,46,52)(H,47,54)/t35-,36+/m0/s1	KODRHCNJBWRWGP-MPQUPPDSSA-N	50425649	CHEMBL2315239	Plasma kallikrein		 320								ChEMBL	10.1021/jm3012917	10.7270/Q2RB75W8	23294255			Saupe, SM; Leubner, S; Betz, M; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50425649	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50425649&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			60162406	164154524		CHEMBL2315239				ZINC95594270	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51002999	CCOC(=O)N[C@@H](CCCCN)C(=O)c1noc(Cc2ccc(OCCc3ccccc3)cc2)n1	InChI=1S/C26H32N4O5/c1-2-33-26(32)28-22(10-6-7-16-27)24(31)25-29-23(35-30-25)18-20-11-13-21(14-12-20)34-17-15-19-8-4-3-5-9-19/h3-5,8-9,11-14,22H,2,6-7,10,15-18,27H2,1H3,(H,28,32)/t22-/m0/s1	PQVCEZVKPWHTFF-QFIPXVFZSA-N	50187800	(S)-ethyl 1-(5-(4-phenethoxybenzyl)-1,2,4-oxadiazol-3-yl)-6-amino-1-oxohexan-2-ylcarbamate::CHEMBL211561	Plasma kallikrein		 43000								ChEMBL	10.1016/j.bmcl.2006.04.013	10.7270/Q2G44RHP	16644215			Palmer, JT; Rydzewski, RM; Mendonca, RV; Sperandio, D; Spencer, JR; Hirschbein, BL; Lohman, J; Beltman, J; Nguyen, M; Liu, L	Celera Genomics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50187800	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50187800&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			15984063	104071626		CHEMBL211561				ZINC34803967	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51003013	NCCCC[C@H](NC(=O)c1ccc(F)c(F)c1)C(=O)c1noc(Cc2ccc(OCCc3ccc(Cl)c(Cl)c3)cc2)n1	InChI=1S/C30H28Cl2F2N4O4/c31-22-10-6-19(15-23(22)32)12-14-41-21-8-4-18(5-9-21)16-27-37-29(38-42-27)28(39)26(3-1-2-13-35)36-30(40)20-7-11-24(33)25(34)17-20/h4-11,15,17,26H,1-3,12-14,16,35H2,(H,36,40)/t26-/m0/s1	PVQSDEDYOLUWOI-SANMLTNESA-N	50410995	CHEMBL536972	Plasma kallikrein		 83000								ChEMBL	10.1016/j.bmcl.2006.04.013	10.7270/Q2G44RHP	16644215			Palmer, JT; Rydzewski, RM; Mendonca, RV; Sperandio, D; Spencer, JR; Hirschbein, BL; Lohman, J; Beltman, J; Nguyen, M; Liu, L	Celera Genomics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50410995	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50410995&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			44412781	163360019		CHEMBL536972				ZINC42963798	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469110	COc1ccccc1C(=O)n1nc(cc1NCc1ccc(Cl)s1)-c1cccnc1=O			162652	US9687479, 132 3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-[(2-methoxyphenyl)carbonyl]-1H-pyrazol-3-yl)-1,2-dihydropyridin-2-one	Plasma kallikrein			 5500					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=162652	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=162652&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081217	363890655							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469112	COc1ccccc1C(=O)n1nc(cc1NCc1ccc(Cl)s1)-c1cccn(Cc2cccnn2)c1=O	InChI=1S/C26H21ClN6O3S/c1-36-22-9-3-2-7-20(22)26(35)33-24(28-15-18-10-11-23(27)37-18)14-21(31-33)19-8-5-13-32(25(19)34)16-17-6-4-12-29-30-17/h2-14,28H,15-16H2,1H3	AYBKJUITSXEHDN-UHFFFAOYSA-N	162658	US9687479, 138 3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-[(2-methoxyphenyl)carbonyl]-1H-pyrazol-3-yl)-1-(pyridazin-3-ylmethyl)-1,2-dihydropyridin-2-one	Plasma kallikrein			 550					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=162658	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=162658&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081223	363890661							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469113	COc1ccccc1C(=O)n1nc(cc1NCc1ccc(Cl)s1)-c1cccn(Cc2cccnc2)c1=O	InChI=1S/C27H22ClN5O3S/c1-36-23-9-3-2-7-21(23)27(35)33-25(30-16-19-10-11-24(28)37-19)14-22(31-33)20-8-5-13-32(26(20)34)17-18-6-4-12-29-15-18/h2-15,30H,16-17H2,1H3	RQJPCXDOJJIPTA-UHFFFAOYSA-N	162660	US9687479, 140 3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-[(2-methoxyphenyl)carbonyl]-1H-pyrazol-3-yl)-1-(pyridin-3-ylmethyl)-1,2-dihydropyridin-2-one	Plasma kallikrein			 550					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=162660	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=162660&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081225	363890663							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469115	COc1ccccc1C(=O)n1nc(cc1NCc1ccc(Cl)s1)-c1cccn(CC(=O)N2CCOCC2)c1=O	InChI=1S/C27H26ClN5O5S/c1-37-22-7-3-2-5-20(22)27(36)33-24(29-16-18-8-9-23(28)39-18)15-21(30-33)19-6-4-10-32(26(19)35)17-25(34)31-11-13-38-14-12-31/h2-10,15,29H,11-14,16-17H2,1H3	QGQSQYHSNDSKPF-UHFFFAOYSA-N	162665	US9687479, 145 3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-[(2-methoxyphenyl)carbonyl]-1H-pyrazol-3-yl)-1-[2-(morpholin-4-yl)-2-oxoethyl]-1,2-dihydropyridin-2-one	Plasma kallikrein			 5500					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=162665	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=162665&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081230	363890668							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469117	COCCn1cccc(-c2cc(NCc3ccc(Cl)s3)n(n2)C(=O)C2(C)CCOCC2)c1=O	InChI=1S/C23H27ClN4O4S/c1-23(7-11-32-12-8-23)22(30)28-20(25-15-16-5-6-19(24)33-16)14-18(26-28)17-4-3-9-27(21(17)29)10-13-31-2/h3-6,9,14,25H,7-8,10-13,15H2,1-2H3	GAPYIVKIKLHHKJ-UHFFFAOYSA-N	162669	US9687479, 149 3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-[(4-methyloxan-4-yl)carbonyl]-1H-pyrazol-3-yl)-1-(2-methoxyethyl)-1,2-dihydropyridin-2-one	Plasma kallikrein			 5500					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=162669	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=162669&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081234	363890672							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469118	CC1(CCOCC1)C(=O)n1nc(cc1NCc1ccc(Cl)s1)-c1cccn(Cc2cccs2)c1=O	InChI=1S/C25H25ClN4O3S2/c1-25(8-11-33-12-9-25)24(32)30-22(27-15-17-6-7-21(26)35-17)14-20(28-30)19-5-2-10-29(23(19)31)16-18-4-3-13-34-18/h2-7,10,13-14,27H,8-9,11-12,15-16H2,1H3	ARYBFHXODIABJO-UHFFFAOYSA-N	162677	US9687479, 157 3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-[(4-methyloxan-4-yl)carbonyl]-1H-pyrazol-3-yl)-1-(thiophen-2-ylmethyl)-1,2-dihydropyridin-2-one	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=162677	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=162677&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081242	363890680							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469119	COCCn1cccc(-c2cc(NCc3ccc(Cl)s3)n(n2)C(=O)c2ccco2)c1=O	InChI=1S/C21H19ClN4O4S/c1-29-11-9-25-8-2-4-15(20(25)27)16-12-19(23-13-14-6-7-18(22)31-14)26(24-16)21(28)17-5-3-10-30-17/h2-8,10,12,23H,9,11,13H2,1H3	OZJXZNWGPKADJB-UHFFFAOYSA-N	162680	US9687479, 160 3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-[(furan-2-yl)carbonyl]-1H-pyrazol-3-yl)-1-(2-methoxyethyl)-1,2-dihydropyridin-2-one	Plasma kallikrein			 550					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=162680	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=162680&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081245	363890683							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469120	Clc1ccc(CNc2cc(nn2C(=O)c2ccoc2)-c2cccn(Cc3ccsc3)c2=O)s1	InChI=1S/C23H17ClN4O3S2/c24-20-4-3-17(33-20)11-25-21-10-19(26-28(21)22(29)16-5-8-31-13-16)18-2-1-7-27(23(18)30)12-15-6-9-32-14-15/h1-10,13-14,25H,11-12H2	SACYUHLOPMCLOU-UHFFFAOYSA-N	163252	US9687479, 179 3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-[(furan-3-yl)carbonyl]-1H-pyrazol-3-yl)-1-(thiophen-3-ylmethyl)-1,2-dihydropyridin-2-one	Plasma kallikrein			 55000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163252	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163252&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081264	363890702							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469121	COCCn1cccc(-c2cc(NCc3ccc(Cl)s3)n(n2)C(=O)c2cccs2)c1=O	InChI=1S/C21H19ClN4O3S2/c1-29-10-9-25-8-2-4-15(20(25)27)16-12-19(23-13-14-6-7-18(22)31-14)26(24-16)21(28)17-5-3-11-30-17/h2-8,11-12,23H,9-10,13H2,1H3	MTJUVRRCHJCRTL-UHFFFAOYSA-N	163255	US9687479, 182 3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-[(thiophen-2-yl)carbonyl]-1H-pyrazol-3-yl)-1-(2-methoxyethyl)-1,2-dihydropyridin-2-one	Plasma kallikrein			 5500					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163255	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163255&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081267	363890705							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469122	Clc1cc(Cl)c(CNc2cc(nn2C(=O)c2cccs2)-c2cccn(Cc3ccoc3)c2=O)s1	InChI=1S/C23H16Cl2N4O3S2/c24-16-9-20(25)34-19(16)11-26-21-10-17(27-29(21)23(31)18-4-2-8-33-18)15-3-1-6-28(22(15)30)12-14-5-7-32-13-14/h1-10,13,26H,11-12H2	JIMQAAKJNGYALT-UHFFFAOYSA-N	163258	US9687479, 184 3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-[(thiophen-2-yl)carbonyl]-1H-pyrazol-3-yl)-1-(furan-3-ylmethyl)-1,2-dihydropyridin-2-one	Plasma kallikrein			 55000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163258	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163258&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081269	363890707							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469123	COCCn1cccc(-c2cc(NCc3ccc(Cl)s3)n(n2)C(=O)c2ccsc2)c1=O	InChI=1S/C21H19ClN4O3S2/c1-29-9-8-25-7-2-3-16(21(25)28)17-11-19(23-12-15-4-5-18(22)31-15)26(24-17)20(27)14-6-10-30-13-14/h2-7,10-11,13,23H,8-9,12H2,1H3	YTDQTCKLZVSMIV-UHFFFAOYSA-N	163272	US9687479, 194 3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-[(thiophen-3-yl)carbonyl]-1H-pyrazol-3-yl)-1-(2-methoxyethyl)-1,2-dihydropyridin-2-one	Plasma kallikrein			 550					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163272	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163272&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081279	363890717							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469124	Clc1ccc(CNc2cc(nn2C(=O)c2ccsc2)-c2cccn(Cc3ccoc3)c2=O)s1	InChI=1S/C23H17ClN4O3S2/c24-20-4-3-17(33-20)11-25-21-10-19(26-28(21)22(29)16-6-9-32-14-16)18-2-1-7-27(23(18)30)12-15-5-8-31-13-15/h1-10,13-14,25H,11-12H2	QKTVHDBCLKORAD-UHFFFAOYSA-N	163274	US9687479, 196 3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-[(thiophen-3-yl)carbonyl]-1H-pyrazol-3-yl)-1-(furan-3-ylmethyl)-1,2-dihydropyridin-2-one	Plasma kallikrein			 550					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163274	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163274&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081281	363890719							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469125	Clc1ccc(CNc2cc(nn2C(=O)c2ccsc2)-c2cccn(Cc3ccccn3)c2=O)s1	InChI=1S/C24H18ClN5O2S2/c25-21-7-6-18(34-21)13-27-22-12-20(28-30(22)23(31)16-8-11-33-15-16)19-5-3-10-29(24(19)32)14-17-4-1-2-9-26-17/h1-12,15,27H,13-14H2	GUJZWXCDEWPYOY-UHFFFAOYSA-N	163276	US9687479, 198 3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-[(thiophen-3-yl)carbonyl]-1H-pyrazol-3-yl)-1-(pyridin-2-ylmethyl)-1,2-dihydropyridin-2-one	Plasma kallikrein			 550					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163276	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163276&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081283	363890721							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469126	Clc1ccc(CNc2cc(nn2C(=O)c2ccsc2)-c2cccn(Cc3ncccn3)c2=O)s1	InChI=1S/C23H17ClN6O2S2/c24-19-5-4-16(34-19)12-27-21-11-18(28-30(21)22(31)15-6-10-33-14-15)17-3-1-9-29(23(17)32)13-20-25-7-2-8-26-20/h1-11,14,27H,12-13H2	UQMBRMNCNDYWDJ-UHFFFAOYSA-N	163280	US9687479, 201 3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-[(thiophen-3-yl)carbonyl]-1H-pyrazol-3-yl)-1-(pyrimidin-2-ylmethyl)-1,2-dihydropyridin-2-one	Plasma kallikrein			 550					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163280	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163280&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081286	363890724							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469127	Clc1ccc(CNc2cc(nn2C(=O)c2ccsc2)-c2cccn(Cc3ccsc3)c2=O)s1	InChI=1S/C23H17ClN4O2S3/c24-20-4-3-17(33-20)11-25-21-10-19(26-28(21)22(29)16-6-9-32-14-16)18-2-1-7-27(23(18)30)12-15-5-8-31-13-15/h1-10,13-14,25H,11-12H2	BDUKBOMDEGJNIQ-UHFFFAOYSA-N	163282	US9687479, 203 3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-[(thiophen-3-yl)carbonyl]-1H-pyrazol-3-yl)-1-(thiophen-3-ylmethyl)-1,2-dihydropyridin-2-one	Plasma kallikrein			 550					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163282	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163282&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081288	363890726							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469128	COCCn1cccc(-c2cc(NCc3ccc(Cl)s3)n(n2)C(=O)c2ccc(cc2)N2CCOCC2)c1=O	InChI=1S/C27H28ClN5O4S/c1-36-14-11-32-10-2-3-22(27(32)35)23-17-25(29-18-21-8-9-24(28)38-21)33(30-23)26(34)19-4-6-20(7-5-19)31-12-15-37-16-13-31/h2-10,17,29H,11-16,18H2,1H3	BSYSDMBOKZQMPH-UHFFFAOYSA-N	163291	US9687479, 208 3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-[4-(morpholin-4-yl)phenyl]carbonyl-1H-pyrazol-3-yl)-1-(2-methoxyethyl)-1,2-dihydropyridin-2-one	Plasma kallikrein			 5500					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163291	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163291&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081293	363890731							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469129	Clc1ccc(CNc2cc(nn2C(=O)c2ccc(cc2)N2CCOCC2)-c2cccn(Cc3ccoc3)c2=O)s1	InChI=1S/C29H26ClN5O4S/c30-26-8-7-23(40-26)17-31-27-16-25(24-2-1-10-34(29(24)37)18-20-9-13-39-19-20)32-35(27)28(36)21-3-5-22(6-4-21)33-11-14-38-15-12-33/h1-10,13,16,19,31H,11-12,14-15,17-18H2	OFAPDVQKOKMNOU-UHFFFAOYSA-N	163293	US9687479, 210 3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-[4-(morpholin-4-yl)phenyl]carbonyl-1H-pyrazol-3-yl)-1-(furan-3-ylmethyl)-1,2-dihydropyridin-2-one	Plasma kallikrein			 55000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163293	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163293&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081295	363890733							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469131	Clc1ccc(CNc2cc(nn2C(=O)c2ccc(cc2)N2CCOCC2)-c2cccn(Cc3cccnc3)c2=O)s1	InChI=1S/C30H27ClN6O3S/c31-27-10-9-24(41-27)19-33-28-17-26(25-4-2-12-36(30(25)39)20-21-3-1-11-32-18-21)34-37(28)29(38)22-5-7-23(8-6-22)35-13-15-40-16-14-35/h1-12,17-18,33H,13-16,19-20H2	ADSGNGOCCAOAPO-UHFFFAOYSA-N	163297	US9687479, 213 3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-[4-(morpholin-4-yl)phenyl]carbonyl-1H-pyrazol-3-yl)-1-(pyridin-3-ylmethyl)-1,2-dihydropyridin-2-one	Plasma kallikrein			 550					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163297	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163297&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081298	363890736							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469132	Clc1ccc(CNc2cc(nn2C(=O)c2ccc(cc2)N2CCOCC2)-c2cccn(Cc3ccncc3)c2=O)s1	InChI=1S/C30H27ClN6O3S/c31-27-8-7-24(41-27)19-33-28-18-26(25-2-1-13-36(30(25)39)20-21-9-11-32-12-10-21)34-37(28)29(38)22-3-5-23(6-4-22)35-14-16-40-17-15-35/h1-13,18,33H,14-17,19-20H2	IGOHVDYIMFAFCW-UHFFFAOYSA-N	163298	US9687479, 214 3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-[4-(morpholin-4-yl)phenyl]carbonyl-1H-pyrazol-3-yl)-1-(pyridin-4-ylmethyl)-1,2-dihydropyridin-2-one	Plasma kallikrein			 550					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163298	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163298&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081299	363890737							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469133	Clc1ccc(CNc2cc(nn2C(=O)c2ccc(cc2)N2CCOCC2)-c2cccn(CCN3CCOCC3)c2=O)s1	InChI=1S/C30H33ClN6O4S/c31-27-8-7-24(42-27)21-32-28-20-26(25-2-1-9-36(30(25)39)11-10-34-12-16-40-17-13-34)33-37(28)29(38)22-3-5-23(6-4-22)35-14-18-41-19-15-35/h1-9,20,32H,10-19,21H2	LMADDUZENSEZSH-UHFFFAOYSA-N	163304	US9687479, 218 3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-[4-(morpholin-4-yl)phenyl]carbonyl-1H-pyrazol-3-yl)-1-[2-(morpholin-4-yl)ethyl]-1,2-dihydropyridin-2-one	Plasma kallikrein			 550					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163304	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163304&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081303	363890741							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469134	Clc1ccc(CNc2cc(nn2)-c2cccn(Cc3ccccn3)c2=O)s1	InChI=1S/C19H15ClN5OS/c20-17-7-6-14(27-17)11-22-18-10-16(23-24-18)15-5-3-9-25(19(15)26)12-13-4-1-2-8-21-13/h1-10H,11-12H2,(H,22,24)	ZHEQJPPNBMLFMX-UHFFFAOYSA-N	163319	US9687479, 227 3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1H-pyrazol-3-yl)-1-(pyridin-2-ylmethyl)-1,2-dihydropyridin-2-one	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163319	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163319&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081312	363890750							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469135	Clc1ccc(CNc2cc(nn2)-c2cccn(Cc3ccncc3)c2=O)s1	InChI=1S/C19H15ClN5OS/c20-17-4-3-14(27-17)11-22-18-10-16(23-24-18)15-2-1-9-25(19(15)26)12-13-5-7-21-8-6-13/h1-10H,11-12H2,(H,22,24)	FHTNVSBXSKUVDI-UHFFFAOYSA-N	163322	US9687479, 229 3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1H-pyrazol-3-yl)-1-(pyridin-4-ylmethyl)-1,2-dihydropyridin-2-one	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163322	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163322&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081314	363890752							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469136	Clc1ccc(CNc2cc(nn2)-c2cccn(CCc3ccccn3)c2=O)s1	InChI=1S/C20H17ClN5OS/c21-18-7-6-15(28-18)13-23-19-12-17(24-25-19)16-5-3-10-26(20(16)27)11-8-14-4-1-2-9-22-14/h1-7,9-10,12H,8,11,13H2,(H,23,25)	OKEVQFAXFHVXOZ-UHFFFAOYSA-N	163328	US9687479, 235 3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1H-pyrazol-3-yl)-1-[2-(pyridin-2-yl)ethyl]-1,2-dihydropyridin-2-one	Plasma kallikrein			 55000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163328	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163328&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081320	363890758							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469137	O=C(c1ccco1)n1nc(cc1NCc1ccccc1)-c1cccnc1=O			163330	US9687479, 237 3-[5-(benzylamino)-1-[(furan-2-yl)carbonyl]-1H-pyrazol-3-yl]-1,2-dihydropyridin-2-one	Plasma kallikrein			 55000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163330	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163330&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081322	363890760							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469138	O=C(c1ccco1)n1nc(cc1NCc1ccccc1)-c1cccn(Cc2ccccn2)c1=O	InChI=1S/C26H21N5O3/c32-25-21(11-6-14-30(25)18-20-10-4-5-13-27-20)22-16-24(28-17-19-8-2-1-3-9-19)31(29-22)26(33)23-12-7-15-34-23/h1-16,28H,17-18H2	HMXGYIJCUWXCBX-UHFFFAOYSA-N	163333	US9687479, 238 3-[5-(benzylamino)-1-[(furan-2-yl)carbonyl]-1H-pyrazol-3-yl]-1-(pyridin-2-ylmethyl)-1,2-dihydropyridin-2-one	Plasma kallikrein			 5500					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163333	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163333&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081323	363890761							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469140	COCCn1cccc(-c2cc(NCc3ccc(Cl)s3)n(n2)C(=O)c2ccccc2Cl)c1=O	InChI=1S/C23H20Cl2N4O3S/c1-32-12-11-28-10-4-6-17(22(28)30)19-13-21(26-14-15-8-9-20(25)33-15)29(27-19)23(31)16-5-2-3-7-18(16)24/h2-10,13,26H,11-12,14H2,1H3	XZWICAXMDQHYNP-UHFFFAOYSA-N	163338	US9687479, 242 3-1-[(2-chlorophenyl)carbonyl]-5-[(5-chlorothiophen-2-yl)methyl]amino-1H-pyrazol-3-yl-1-(2-methoxyethyl)-1,2-dihydropyridin-2-one	Plasma kallikrein			 550					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163338	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163338&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081327	363890765							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469141	Clc1ccc(CNc2cc(nn2C(=O)c2ccccc2Cl)-c2cccn(Cc3cccs3)c2=O)s1	InChI=1S/C25H18Cl2N4O2S2/c26-20-8-2-1-6-18(20)25(33)31-23(28-14-16-9-10-22(27)35-16)13-21(29-31)19-7-3-11-30(24(19)32)15-17-5-4-12-34-17/h1-13,28H,14-15H2	RRZALISNZGSQOS-UHFFFAOYSA-N	163340	US9687479, 243 3-1-[(2-chlorophenyl)carbonyl]-5-[(5-chlorothiophen-2-yl)methyl]amino-1H-pyrazol-3-yl-1-(furan-2-ylmethyl)-1,2-dihydropyridin-2-one::US9687479, 250 3-1-[(2-chlorophenyl)carbonyl]-5-[(5-chlorothiophen-2-yl)methyl]amino-1H-pyrazol-3-yl-1-(thiophen-2-ylmethyl)-1,2-dihydropyridin-2-one	Plasma kallikrein			 550					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163340	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163340&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081328	363890766							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469142	Clc1ccc(CNc2cc(nn2C(=O)c2ccccc2Cl)-c2cccn(Cc3ccsc3)c2=O)s1	InChI=1S/C25H18Cl2N4O2S2/c26-20-6-2-1-4-18(20)25(33)31-23(28-13-17-7-8-22(27)35-17)12-21(29-31)19-5-3-10-30(24(19)32)14-16-9-11-34-15-16/h1-12,15,28H,13-14H2	JFWOZEXCXHNMKU-UHFFFAOYSA-N	163341	US9687479, 244 3-1-[(2-chlorophenyl)carbonyl]-5-[(5-chlorothiophen-2-yl)methyl]amino-1H-pyrazol-3-yl-1-(furan-3-ylmethyl)-1,2-dihydropyridin-2-one::US9687479, 251 3-1-[(2-chlorophenyl)carbonyl]-5-[(5-chlorothiophen-2-yl)methyl]amino-1H-pyrazol-3-yl-1-(thiophen-3-ylmethyl)-1,2-dihydropyridin-2-one	Plasma kallikrein			 550					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163341	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163341&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081329	363890767							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469144	Clc1ccc(CNc2cc(nn2C(=O)c2ccccc2Cl)-c2cccn(Cc3cccnc3)c2=O)s1	InChI=1S/C26H19Cl2N5O2S/c27-21-8-2-1-6-19(21)26(35)33-24(30-15-18-9-10-23(28)36-18)13-22(31-33)20-7-4-12-32(25(20)34)16-17-5-3-11-29-14-17/h1-14,30H,15-16H2	VDHHZCTYQRAQFW-UHFFFAOYSA-N	163346	US9687479, 247 3-1-[(2-chlorophenyl)carbonyl]-5-[(5-chlorothiophen-2-yl)methyl]amino-1H-pyrazol-3-yl-1-(pyridin-3-ylmethyl)-1,2-dihydropyridin-2-one	Plasma kallikrein			<100					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163346	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163346&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081332	363890770							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50518186	C[C@H]1COC(=O)Nc2ccc(c(CN(C)C(=O)[C@H](Nc3ccc4c(N)ncc(F)c4c3)c3ccc1c(C)c3)c2)S(=O)(=O)C1CC1	InChI=1S/C33H34FN5O5S/c1-18-12-20-4-9-25(18)19(2)17-44-33(41)38-22-6-11-29(45(42,43)24-7-8-24)21(13-22)16-39(3)32(40)30(20)37-23-5-10-26-27(14-23)28(34)15-36-31(26)35/h4-6,9-15,19,24,30,37H,7-8,16-17H2,1-3H3,(H2,35,36)(H,38,41)/t19-,30+/m0/s1	ZVYUEFHDJYEETD-WWOZWPLTSA-N	189434	US9174974, Example 19	Plasma kallikrein		 520								ChEMBL	10.1021/acs.jmedchem.6b00469	10.7270/Q2TM7D37	27455395			Zhang, X; Glunz, PW; Johnson, JA; Jiang, W; Jacutin-Porte, S; Ladziata, V; Zou, Y; Phillips, MS; Wurtz, NR; Parkhurst, B; Rendina, AR; Harper, TM; Cheney, DL; Luettgen, JM; Wong, PC; Seiffert, D; Wexler, RR; Priestley, ES	Bristol-Myers Squibb R & D	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=189434	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=189434&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			72551247	316890926							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477029	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1csc(n1)-c1ccccc1	InChI=1S/C25H26N4OS/c1-17-12-23(24(30)27-14-20-10-8-19(13-26)9-11-20)18(2)29(17)15-22-16-31-25(28-22)21-6-4-3-5-7-21/h3-12,16H,13-15,26H2,1-2H3,(H,27,30)	SJVAITNWGSDKNM-UHFFFAOYSA-N	186835	US9670157, 1 2,5-Dimethyl-1-(2-phenyl-thiazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 1	Plasma kallikrein			 63							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186835	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186835&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290252	373987407							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477030	Cc1cc(C(=O)NCc2ccc(CN)cc2C)c(C)n1Cc1csc(n1)-c1ccccc1	InChI=1S/C26H28N4OS/c1-17-11-20(13-27)9-10-22(17)14-28-25(31)24-12-18(2)30(19(24)3)15-23-16-32-26(29-23)21-7-5-4-6-8-21/h4-12,16H,13-15,27H2,1-3H3,(H,28,31)	LRLXLIQZQCBDLR-UHFFFAOYSA-N	186836	US9670157, 2 2,5-Dimethyl-1-(2-phenyl-thiazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-2-methyl-benzylamide::US9834513, 2	Plasma kallikrein			 15							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186836	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186836&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290253	373987408							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477031	Cc1cc(C(=O)NCc2c(C)cc(CN)cc2C)c(C)n1Cc1csc(n1)-c1ccccc1	InChI=1S/C27H30N4OS/c1-17-10-21(13-28)11-18(2)25(17)14-29-26(32)24-12-19(3)31(20(24)4)15-23-16-33-27(30-23)22-8-6-5-7-9-22/h5-12,16H,13-15,28H2,1-4H3,(H,29,32)	XFFLHTLNQQRHNA-UHFFFAOYSA-N	186837	US9670157, 3 2,5-Dimethyl-1-(2-phenyl-thiazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-2,6-dimethyl-benzylamide::US9834513, 3	Plasma kallikrein			 6.00							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186837	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186837&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290254	373987409							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477032	Cc1cc(C(=O)NCc2ccc(cc2)C2(N)CC2)c(C)n1Cc1csc(n1)-c1ccccc1	InChI=1S/C27H28N4OS/c1-18-14-24(25(32)29-15-20-8-10-22(11-9-20)27(28)12-13-27)19(2)31(18)16-23-17-33-26(30-23)21-6-4-3-5-7-21/h3-11,14,17H,12-13,15-16,28H2,1-2H3,(H,29,32)	JDDOXSIDIBNPSA-UHFFFAOYSA-N	186838	US9670157, 4 2,5-Dimethyl-1-(2-phenyl-thiazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-(1-amino-cyclopropyl)-benzylamide::US9834513, 4	Plasma kallikrein			 121							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186838	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186838&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290298	373987410							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477033	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1csc(c1)-c1cccnc1	InChI=1S/C25H26N4OS/c1-17-10-23(25(30)28-13-20-7-5-19(12-26)6-8-20)18(2)29(17)15-21-11-24(31-16-21)22-4-3-9-27-14-22/h3-11,14,16H,12-13,15,26H2,1-2H3,(H,28,30)	UIJXPAQBXCMOQM-UHFFFAOYSA-N	186842	US9670157, 19 2,5-Dimethyl-1-(5-methyl-2-phenyl-oxazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9670157, 8 2,5-Dimethyl-1-(5-pyridin-3-yl-thiophen-3-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 8	Plasma kallikrein			 348							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186842	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186842&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280284	373987411							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477034	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1cc(cs1)-c1cccnc1	InChI=1S/C25H26N4OS/c1-17-10-24(25(30)28-13-20-7-5-19(12-26)6-8-20)18(2)29(17)15-23-11-22(16-31-23)21-4-3-9-27-14-21/h3-11,14,16H,12-13,15,26H2,1-2H3,(H,28,30)	PGWYTVSRTREBIS-UHFFFAOYSA-N	186843	US9670157, 13 2,5-Dimethyl-1-(4-pyridin-3-yl-thiophen-2-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9670157, 9 2,5-Dimethyl-1-(4-phenyl-thiophen-2-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 13	Plasma kallikrein			 543							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186843	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186843&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280182	373987412							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477035	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1csc(c1)-c1ccccc1	InChI=1S/C26H27N3OS/c1-18-12-24(26(30)28-15-21-10-8-20(14-27)9-11-21)19(2)29(18)16-22-13-25(31-17-22)23-6-4-3-5-7-23/h3-13,17H,14-16,27H2,1-2H3,(H,28,30)	AKTNRYFLMYWXLM-UHFFFAOYSA-N	186844	US9670157, 10 2,5-Dimethyl-1-(5-phenyl-thiophen-3-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 10	Plasma kallikrein			 571							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186844	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186844&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280153	373987413							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477036	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1cc(no1)-c1ccccc1	InChI=1S/C25H26N4O2/c1-17-12-23(25(30)27-15-20-10-8-19(14-26)9-11-20)18(2)29(17)16-22-13-24(28-31-22)21-6-4-3-5-7-21/h3-13H,14-16,26H2,1-2H3,(H,27,30)	NQJSPLMQDLYQOM-UHFFFAOYSA-N	186845	US9670157, 11 2,5-Dimethyl-1-(3-phenyl-isoxazol-5-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 11	Plasma kallikrein			 2419							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186845	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186845&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280287	373987414							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477037	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1nc2ccccc2s1	InChI=1S/C23H24N4OS/c1-15-11-19(23(28)25-13-18-9-7-17(12-24)8-10-18)16(2)27(15)14-22-26-20-5-3-4-6-21(20)29-22/h3-11H,12-14,24H2,1-2H3,(H,25,28)	CUWABYMPFZECKG-UHFFFAOYSA-N	186846	US9670157, 12 1-Benzothiazol-2-ylmethyl-2,5-dimethyl-1H-pyrrole-3-carboxylicacid 4-aminomethyl-benzylamide::US9834513, 12	Plasma kallikrein			 5119							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186846	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186846&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280357	373987415							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477038	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1cc(cs1)-c1cccnc1	InChI=1S/C25H26N4OS/c1-17-10-24(25(30)28-13-20-7-5-19(12-26)6-8-20)18(2)29(17)15-23-11-22(16-31-23)21-4-3-9-27-14-21/h3-11,14,16H,12-13,15,26H2,1-2H3,(H,28,30)	PGWYTVSRTREBIS-UHFFFAOYSA-N	186843	US9670157, 13 2,5-Dimethyl-1-(4-pyridin-3-yl-thiophen-2-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9670157, 9 2,5-Dimethyl-1-(4-phenyl-thiophen-2-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 13	Plasma kallikrein			 2383							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186843	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186843&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280182	373987412							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477039	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1cc(cs1)-c1ccncc1	InChI=1S/C25H26N4OS/c1-17-11-24(25(30)28-14-20-5-3-19(13-26)4-6-20)18(2)29(17)15-23-12-22(16-31-23)21-7-9-27-10-8-21/h3-12,16H,13-15,26H2,1-2H3,(H,28,30)	FFHGQGZOGJPGRM-UHFFFAOYSA-N	186848	US9670157, 14 2,5-Dimethyl-1-(4-pyridin-4-yl-thiophen-2-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 14	Plasma kallikrein			 2295							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186848	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186848&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280263	373987416							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477040	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1cccc(n1)N1CCOCC1	InChI=1S/C25H31N5O2/c1-18-14-23(25(31)27-16-21-8-6-20(15-26)7-9-21)19(2)30(18)17-22-4-3-5-24(28-22)29-10-12-32-13-11-29/h3-9,14H,10-13,15-17,26H2,1-2H3,(H,27,31)	UUXDGEGFHRYLQP-UHFFFAOYSA-N	186849	US9670157, 15 2,5-Dimethyl-1-(6-morpholin-4-yl-pyridin-2-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 15	Plasma kallikrein			 5694							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186849	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186849&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280313	373987417							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477041	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1cccc(n1)-c1ccccc1	InChI=1S/C27H28N4O/c1-19-15-25(27(32)29-17-22-13-11-21(16-28)12-14-22)20(2)31(19)18-24-9-6-10-26(30-24)23-7-4-3-5-8-23/h3-15H,16-18,28H2,1-2H3,(H,29,32)	ANTXTTKCONNLSC-UHFFFAOYSA-N	186850	US9670157, 16 2,5-Dimethyl-1-(6-phenyl-pyridin-2-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 16	Plasma kallikrein			 186							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186850	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186850&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290299	373987418							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477042	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1cccc(n1)-c1cccnc1	InChI=1S/C26H27N5O/c1-18-13-24(26(32)29-15-21-10-8-20(14-27)9-11-21)19(2)31(18)17-23-6-3-7-25(30-23)22-5-4-12-28-16-22/h3-13,16H,14-15,17,27H2,1-2H3,(H,29,32)	PBAAHHAGMWJRRK-UHFFFAOYSA-N	186851	US9670157, 17 1-[2,3&#8242;]Bipyridinyl-6-ylmethyl-2,5-dimethyl-1H-pyrrole-3-carboxylicacid 4-aminomethyl-benzylamide::US9834513, 17	Plasma kallikrein			 492							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186851	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186851&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280261	373987419							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477043	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1nc(oc1C)-c1ccccc1	InChI=1S/C26H28N4O2/c1-17-13-23(25(31)28-15-21-11-9-20(14-27)10-12-21)18(2)30(17)16-24-19(3)32-26(29-24)22-7-5-4-6-8-22/h4-13H,14-16,27H2,1-3H3,(H,28,31)	GBMCJVKROFUGFO-UHFFFAOYSA-N	186852	US9670157, 18 2,5-Methyl-1-(2-phenyl-oxazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 19	Plasma kallikrein			 435							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186852	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186852&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280165	373987420							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477044	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1csc(c1)-c1cccnc1	InChI=1S/C25H26N4OS/c1-17-10-23(25(30)28-13-20-7-5-19(12-26)6-8-20)18(2)29(17)15-21-11-24(31-16-21)22-4-3-9-27-14-22/h3-11,14,16H,12-13,15,26H2,1-2H3,(H,28,30)	UIJXPAQBXCMOQM-UHFFFAOYSA-N	186842	US9670157, 19 2,5-Dimethyl-1-(5-methyl-2-phenyl-oxazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9670157, 8 2,5-Dimethyl-1-(5-pyridin-3-yl-thiophen-3-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 8	Plasma kallikrein			 768							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186842	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186842&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280284	373987411							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477045	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1cccs1	InChI=1S/C20H23N3OS/c1-14-10-19(15(2)23(14)13-18-4-3-9-25-18)20(24)22-12-17-7-5-16(11-21)6-8-17/h3-10H,11-13,21H2,1-2H3,(H,22,24)	ZMXSBHQMBIJZCD-UHFFFAOYSA-N	186854	US9670157, 20 2,5-Dimethyl-1-thiophen-2-ylmethyl-1H-pyrrole-3-carboxylic acid4-amidomethyl-benzylamide::US9834513, 20	Plasma kallikrein			 4947							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186854	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186854&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90281198	373987421							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477046	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1ccc(s1)-c1cccnc1	InChI=1S/C25H26N4OS/c1-17-12-23(25(30)28-14-20-7-5-19(13-26)6-8-20)18(2)29(17)16-22-9-10-24(31-22)21-4-3-11-27-15-21/h3-12,15H,13-14,16,26H2,1-2H3,(H,28,30)	NGXUVEXRUCXBJO-UHFFFAOYSA-N	186855	US9670157, 21 2,5-Dimethyl-1-(5-pyridin-4-yl-thiophen-2-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide	Plasma kallikrein			 4522							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186855	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186855&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134128242	373987422							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477047	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1ccc(s1)-c1ccccc1	InChI=1S/C26H27N3OS/c1-18-14-24(26(30)28-16-21-10-8-20(15-27)9-11-21)19(2)29(18)17-23-12-13-25(31-23)22-6-4-3-5-7-22/h3-14H,15-17,27H2,1-2H3,(H,28,30)	SEOPPKFHBLYACK-UHFFFAOYSA-N	186856	US9670157, 22 2,5-Dimethyl-1-(5-phenyl-thiophen-2-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 22	Plasma kallikrein			 3269							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186856	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186856&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280292	373987423							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477048	Cc1nc(cs1)-c1ccc(Cn2c(C)cc(C(=O)NCc3ccc(CN)cc3)c2C)s1	InChI=1S/C24H26N4OS2/c1-15-10-21(24(29)26-12-19-6-4-18(11-25)5-7-19)16(2)28(15)13-20-8-9-23(31-20)22-14-30-17(3)27-22/h4-10,14H,11-13,25H2,1-3H3,(H,26,29)	ZSZFPNYSEHIILX-UHFFFAOYSA-N	186857	US9670157, 23 2,5-Dimethyl-1-[5-(2-methyl-thiazol-4-yl)-thiophen-2-ylmethyl]-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 23	Plasma kallikrein			 1596							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186857	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186857&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126614087	373987424							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477049	Cc1c(cc(-c2ccccc2)n1Cc1csc(n1)-c1ccccc1)C(=O)NCc1ccc(CN)cc1	InChI=1S/C30H28N4OS/c1-21-27(29(35)32-18-23-14-12-22(17-31)13-15-23)16-28(24-8-4-2-5-9-24)34(21)19-26-20-36-30(33-26)25-10-6-3-7-11-25/h2-16,20H,17-19,31H2,1H3,(H,32,35)	NLMFUZOQHBWKLZ-UHFFFAOYSA-N	186858	US9670157, 24 5-Methyl-2-phenyl-1-(2-phenyl-thiazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide	Plasma kallikrein			 431							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186858	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186858&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134128243	373987425							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477050	Cc1cc(cn1Cc1csc(n1)-c1ccccc1)C(=O)NCc1ccc(CN)cc1	InChI=1S/C24H24N4OS/c1-17-11-21(23(29)26-13-19-9-7-18(12-25)8-10-19)14-28(17)15-22-16-30-24(27-22)20-5-3-2-4-6-20/h2-11,14,16H,12-13,15,25H2,1H3,(H,26,29)	KGCLXGFOIFRXDD-UHFFFAOYSA-N	186859	US9670157, 25 2-Methyl-1-(2-phenyl-thiazol-4-ylmethyl)-1H-pyrrole-3-carboxylicacid 4-aminomethyl-benzylamide	Plasma kallikrein			 1327							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186859	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186859&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134128244	373987426							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477051	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1csc(n1)-c1cccs1	InChI=1S/C23H24N4OS2/c1-15-10-20(22(28)25-12-18-7-5-17(11-24)6-8-18)16(2)27(15)13-19-14-30-23(26-19)21-4-3-9-29-21/h3-10,14H,11-13,24H2,1-2H3,(H,25,28)	VHJPNQYKEKNZTP-UHFFFAOYSA-N	186860	US9670157, 26 2,5-Dimethyl-1-[2-(2-thienyl)-thiazol-4-ylmethyl]-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 26	Plasma kallikrein			 437							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186860	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186860&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280075	373987427							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477052	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1csc(n1)-c1cccc(Cl)c1	InChI=1S/C25H25ClN4OS/c1-16-10-23(24(31)28-13-19-8-6-18(12-27)7-9-19)17(2)30(16)14-22-15-32-25(29-22)20-4-3-5-21(26)11-20/h3-11,15H,12-14,27H2,1-2H3,(H,28,31)	MVOBCBLLGMUFLX-UHFFFAOYSA-N	186861	US9670157, 27 2,5-Dimethyl-1-[2-(3-chlorophenyl)-thiazol-4-ylmethyl]-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 27	Plasma kallikrein			 848							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186861	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186861&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280111	373987428							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477053	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1csc(n1)-c1ccc(Cl)cc1	InChI=1S/C25H25ClN4OS/c1-16-11-23(24(31)28-13-19-5-3-18(12-27)4-6-19)17(2)30(16)14-22-15-32-25(29-22)20-7-9-21(26)10-8-20/h3-11,15H,12-14,27H2,1-2H3,(H,28,31)	GOXMUZWIQWXYSI-UHFFFAOYSA-N	186862	US9670157, 28 2,5-Dimethyl-1-[2-(4-chlorophenyl)-thiazol-4-ylmethyl]-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 28	Plasma kallikrein			 1326							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186862	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186862&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280224	373987429							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477054	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1csc(n1)-c1cccc(F)c1	InChI=1S/C25H25FN4OS/c1-16-10-23(24(31)28-13-19-8-6-18(12-27)7-9-19)17(2)30(16)14-22-15-32-25(29-22)20-4-3-5-21(26)11-20/h3-11,15H,12-14,27H2,1-2H3,(H,28,31)	RGTMXBFSDAULGX-UHFFFAOYSA-N	186863	US9670157, 29 1-[2-(3-Fluoro-phenyl)-thiazol-4-ylmethyl]-2,5-dimethyl-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 29	Plasma kallikrein			 140							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186863	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186863&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280151	373987430							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477055	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1csc(n1)-c1cccc(C)c1	InChI=1S/C26H28N4OS/c1-17-5-4-6-22(11-17)26-29-23(16-32-26)15-30-18(2)12-24(19(30)3)25(31)28-14-21-9-7-20(13-27)8-10-21/h4-12,16H,13-15,27H2,1-3H3,(H,28,31)	LOLRGICQBGBJJG-UHFFFAOYSA-N	186864	US9670157, 30 2,5-Dimethyl-1-(2-m-tolyl-thiazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 30	Plasma kallikrein			 773							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186864	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186864&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280383	373987431							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477056	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1csc(n1)-c1cccnc1	InChI=1S/C24H25N5OS/c1-16-10-22(23(30)27-12-19-7-5-18(11-25)6-8-19)17(2)29(16)14-21-15-31-24(28-21)20-4-3-9-26-13-20/h3-10,13,15H,11-12,14,25H2,1-2H3,(H,27,30)	CWVNAOJNXQJVGV-UHFFFAOYSA-N	186865	US9670157, 31 2,5-Dimethyl-1-(2-pyridin-3-yl-thiazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 31	Plasma kallikrein			 251							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186865	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186865&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280099	373987432							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477057	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1csc(n1)-c1ccncc1	InChI=1S/C24H25N5OS/c1-16-11-22(23(30)27-13-19-5-3-18(12-25)4-6-19)17(2)29(16)14-21-15-31-24(28-21)20-7-9-26-10-8-20/h3-11,15H,12-14,25H2,1-2H3,(H,27,30)	ROUDVONQVMIJDR-UHFFFAOYSA-N	186866	US9670157, 32 2,5-Dimethyl-1-(2-pyridin-4-yl-thiazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 32	Plasma kallikrein			 732							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186866	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186866&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280388	373987433							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477058	COc1cccc(c1)-c1nc(Cn2c(C)cc(C(=O)NCc3ccc(CN)cc3)c2C)cs1	InChI=1S/C26H28N4O2S/c1-17-11-24(25(31)28-14-20-9-7-19(13-27)8-10-20)18(2)30(17)15-22-16-33-26(29-22)21-5-4-6-23(12-21)32-3/h4-12,16H,13-15,27H2,1-3H3,(H,28,31)	BOCHSZJKJXQNMB-UHFFFAOYSA-N	186867	US9670157, 33 2,5-Dimethyl-1-(3-methoxyphenyl-thiazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide	Plasma kallikrein			 919							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186867	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186867&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134128245	373987434							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477059	COc1ccc(cc1)-c1nc(Cn2c(C)cc(C(=O)NCc3ccc(CN)cc3)c2C)cs1	InChI=1S/C26H28N4O2S/c1-17-12-24(25(31)28-14-20-6-4-19(13-27)5-7-20)18(2)30(17)15-22-16-33-26(29-22)21-8-10-23(32-3)11-9-21/h4-12,16H,13-15,27H2,1-3H3,(H,28,31)	FEZDLHIVDRJMCY-UHFFFAOYSA-N	186868	US9670157, 34 2,5-Dimethyl-1-(4-methoxyphenyl-thiazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide	Plasma kallikrein			 3599							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186868	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186868&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134128246	373987435							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477060	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1csc(n1)-c1ccc(C)cc1	InChI=1S/C26H28N4OS/c1-17-4-10-22(11-5-17)26-29-23(16-32-26)15-30-18(2)12-24(19(30)3)25(31)28-14-21-8-6-20(13-27)7-9-21/h4-12,16H,13-15,27H2,1-3H3,(H,28,31)	RDXOSTLWPPAKRM-UHFFFAOYSA-N	186869	US9670157, 35 2,5-Dimethyl-1-(2-p-tolyl-thiazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 35	Plasma kallikrein			 2100							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186869	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186869&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280376	373987436							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477061	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1csc(n1)-c1ccccn1	InChI=1S/C24H25N5OS/c1-16-11-21(23(30)27-13-19-8-6-18(12-25)7-9-19)17(2)29(16)14-20-15-31-24(28-20)22-5-3-4-10-26-22/h3-11,15H,12-14,25H2,1-2H3,(H,27,30)	CUZADIYTJRHRIY-UHFFFAOYSA-N	186870	US9670157, 36 2,5-Dimethyl-1-(2-pyridin-2-yl-thiazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 36	Plasma kallikrein			 203							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186870	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186870&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280150	373987437							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469146	Clc1ccc(CNc2cc(nn2C(=O)c2ccccc2Cl)-c2cccn(Cc3ccncc3)c2=O)s1	InChI=1S/C26H19Cl2N5O2S/c27-21-6-2-1-4-19(21)26(35)33-24(30-15-18-7-8-23(28)36-18)14-22(31-33)20-5-3-13-32(25(20)34)16-17-9-11-29-12-10-17/h1-14,30H,15-16H2	VDOXVFDIROWWHE-UHFFFAOYSA-N	163348	US9687479, 248 3-1-[(2-chlorophenyl)carbonyl]-5-[(5-chlorothiophen-2-yl)methyl]amino-1H-pyrazol-3-yl-1-(pyridin-4-ylmethyl)-1,2-dihydropyridin-2-one	Plasma kallikrein			 550					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163348	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163348&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081333	363890771							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469147	Cn1cccc(-c2cc(NCc3ccc(Cl)s3)n(n2)C(=O)C2(COC(=O)C3(CO)CC3)CC2)c1=O	InChI=1S/C24H25ClN4O5S/c1-28-10-2-3-16(20(28)31)17-11-19(26-12-15-4-5-18(25)35-15)29(27-17)21(32)24(8-9-24)14-34-22(33)23(13-30)6-7-23/h2-5,10-11,26,30H,6-9,12-14H2,1H3	RIBYPDGFLDSMAU-UHFFFAOYSA-N	163373	US9687479, 265 1-[(5-[(5-chlorothiophen-2-yl)methyl]amino-3-(1-methyl-2-oxo-1,2-dihydropyridin-3-yl)-1H-pyrazol-1-yl)carbonyl]cyclopropylmethyl1-(hydroxymethyl)cyclopropane-1-carboxylate	Plasma kallikrein			 5500					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163373	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163373&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081340	363890786							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469148	CC(C)(C)C(=O)n1nc(cc1NCc1ccc(F)cc1)-c1cccnn1	InChI=1S/C19H20FN5O/c1-19(2,3)18(26)25-17(21-12-13-6-8-14(20)9-7-13)11-16(24-25)15-5-4-10-22-23-15/h4-11,21H,12H2,1-3H3	JQKBNXFGPDJRHZ-UHFFFAOYSA-N	163386	US9687479, 266 1-(5-[(4-fluorophenyl)methyl]amino-3-(pyridazin-3-yl)-1H-pyrazol-1-yl)-2,2-dimethylpropan-1-one	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163386	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163386&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081343	363890791							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469149	CC(C)(C)C(=O)n1nc(cc1NCc1ccc(F)cc1)-c1ccncn1	InChI=1S/C19H20FN5O/c1-19(2,3)18(26)25-17(22-11-13-4-6-14(20)7-5-13)10-16(24-25)15-8-9-21-12-23-15/h4-10,12,22H,11H2,1-3H3	SNQPUMUXIBVAKB-UHFFFAOYSA-N	163387	US9687479, 267 1-(5-[(4-fluorophenyl)methyl]amino-3-(pyrimidin-4-yl)-1H-pyrazol-1-yl)-2,2-dimethylpropan-1-one	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163387	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163387&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081344	363890792							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469150	CCC(=O)n1nc(cc1NCc1ccc(F)cc1)-c1ccccc1	InChI=1S/C19H18FN3O/c1-2-19(24)23-18(21-13-14-8-10-16(20)11-9-14)12-17(22-23)15-6-4-3-5-7-15/h3-12,21H,2,13H2,1H3	COBQUVAXSMTDGK-UHFFFAOYSA-N	163388	US9687479, 268 1-(5-[(4-fluorophenyl)methyl]amino-3-phenyl-1H-pyrazol-1-yl)propan-1-one	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163388	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163388&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90428436	363890793							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469151	CC(C)(C)C(=O)n1nc(cc1NCc1ccc(Cl)s1)-c1ncccc1F	InChI=1S/C18H18ClFN4OS/c1-18(2,3)17(25)24-15(22-10-11-6-7-14(19)26-11)9-13(23-24)16-12(20)5-4-8-21-16/h4-9,22H,10H2,1-3H3	IZYPJKWNNQPJBH-UHFFFAOYSA-N	163389	US9687479, 269 1-(5-[(5-chlorothiophen-2-yl)methyl]amino-3-(3-fluoropyridin-2-yl)-1H-pyrazol-1-yl)-2,2-dimethylpropan-1-one	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163389	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163389&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081345	363890794							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469152	CC(C)(C)C(=O)n1nc(cc1NCc1ccc(Cl)s1)-c1ccco1	InChI=1S/C17H18ClN3O2S/c1-17(2,3)16(22)21-15(19-10-11-6-7-14(18)24-11)9-12(20-21)13-5-4-8-23-13/h4-9,19H,10H2,1-3H3	LBADDYPPPCESCE-UHFFFAOYSA-N	163390	US9687479, 270 1-(5-[(5-chlorothiophen-2-yl)methyl]amino-3-(furan-2-yl)-1H-pyrazol-1-yl)-2,2-dimethylpropan-1-one	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163390	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163390&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081346	363890795							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469153	CC(C)(C)C(=O)n1nc(cc1NCc1ccc(Cl)s1)-c1ccccn1	InChI=1S/C18H19ClN4OS/c1-18(2,3)17(24)23-16(21-11-12-7-8-15(19)25-12)10-14(22-23)13-6-4-5-9-20-13/h4-10,21H,11H2,1-3H3	OWDDFDCTOXWCPW-UHFFFAOYSA-N	163391	US9687479, 271 1-(5-[(5-chlorothiophen-2-yl)methyl]amino-3-(pyridin-2-yl)-1H-pyrazol-1-yl)-2,2-dimethylpropan-1-one	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163391	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163391&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081347	363890796							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469154	COCC(C)(C)C(=O)n1nc(cc1NCc1ccc(Cl)s1)-c1ccccn1	InChI=1S/C19H21ClN4O2S/c1-19(2,12-26-3)18(25)24-17(22-11-13-7-8-16(20)27-13)10-15(23-24)14-6-4-5-9-21-14/h4-10,22H,11-12H2,1-3H3	JYCQSYBSMIPDLR-UHFFFAOYSA-N	163396	US9687479, 272 1-(5-[(5-chlorothiophen-2-yl)methyl]amino-3-(pyridin-2-yl)-1H-pyrazol-1-yl)-3-methoxy-2,2-dimethylpropan-1-one	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163396	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163396&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081348	363890797							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469155	CC(C)(CO)C(=O)n1nc(C2CCOCC2)c(F)c1NCc1ccc(Cl)s1	InChI=1S/C18H23ClFN3O3S/c1-18(2,10-24)17(25)23-16(21-9-12-3-4-13(19)27-12)14(20)15(22-23)11-5-7-26-8-6-11/h3-4,11,21,24H,5-10H2,1-2H3	KEJQPLBDPVKEMM-UHFFFAOYSA-N	163397	US9687479, 273 1-(5-[(5-chlorothiophen-2-yl)methyl]amino-4-fluoro-3-(oxan-4-yl)-1H-pyrazol-1-yl)-3-hydroxy-2,2-dimethylpropan-1-one	Plasma kallikrein			 55000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163397	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163397&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86274356	363890798							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469156	CC(C)(CO)C(=O)n1nc(C2CCNCC2)c(F)c1NCc1ccc(Cl)s1	InChI=1S/C18H24ClFN4O2S/c1-18(2,10-25)17(26)24-16(22-9-12-3-4-13(19)27-12)14(20)15(23-24)11-5-7-21-8-6-11/h3-4,11,21-22,25H,5-10H2,1-2H3	DJVJRNGBPQDBJO-UHFFFAOYSA-N	163399	US9687479, 274 1-(5-[(5-chlorothiophen-2-yl)methyl]amino-4-fluoro-3-(piperidin-4-yl)-1H-pyrazol-1-yl)-3-hydroxy-2,2-dimethylpropan-1-one	Plasma kallikrein			 5500					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163399	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163399&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86274355	363890799							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469157	CC(C)(CO)C(=O)n1nc(c(F)c1NCc1ccc(Cl)s1)-c1ccccc1	InChI=1S/C19H19ClFN3O2S/c1-19(2,11-25)18(26)24-17(22-10-13-8-9-14(20)27-13)15(21)16(23-24)12-6-4-3-5-7-12/h3-9,22,25H,10-11H2,1-2H3	YMUNSTMHICDGNC-UHFFFAOYSA-N	163400	US9687479, 275 1-(5-[(5-chlorothiophen-2-yl)methyl]amino-4-fluoro-3-phenyl-1H-pyrazol-1-yl)-3-hydroxy-2,2-dimethylpropan-1-one	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163400	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163400&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86274353	363890800							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469159	Nc1ccccc1C(=O)n1nc(c(F)c1NCc1ccc(Cl)s1)-c1ncccc1F	InChI=1S/C20H14ClF2N5OS/c21-15-8-7-11(30-15)10-26-19-16(23)18(17-13(22)5-3-9-25-17)27-28(19)20(29)12-4-1-2-6-14(12)24/h1-9,26H,10,24H2	XNFINXKLUFINJT-UHFFFAOYSA-N	163403	US9687479, 276 1-[(2-aminophenyl)carbonyl]-N-[(5-chlorothiophen-2-yl)methyl]-3-(3-fluoropyridin-2-yl)-1H-pyrazol-5-amine	Plasma kallikrein			 5500					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163403	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163403&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081349	363890801							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469161	Nc1ccccc1C(=O)n1nc(c(F)c1NCc1ccc(Cl)s1)-c1ccco1	InChI=1S/C19H14ClFN4O2S/c20-15-8-7-11(28-15)10-23-18-16(21)17(14-6-3-9-27-14)24-25(18)19(26)12-4-1-2-5-13(12)22/h1-9,23H,10,22H2	WEXHQMMIVHZXTL-UHFFFAOYSA-N	163404	US9687479, 277 1-[(2-aminophenyl)carbonyl]-N-[(5-chlorothiophen-2-yl)methyl]-3-(furan-2-yl)-1H-pyrazol-5-amine	Plasma kallikrein			 5500					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163404	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163404&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081350	363890802							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469162	COc1ccccc1C(=O)n1nc(cc1NCc1ccc(Cl)s1)-c1ccccn1	InChI=1S/C21H17ClN4O2S/c1-28-18-8-3-2-6-15(18)21(27)26-20(24-13-14-9-10-19(22)29-14)12-17(25-26)16-7-4-5-11-23-16/h2-12,24H,13H2,1H3	CPBDFCXKCBYWQN-UHFFFAOYSA-N	163407	US9687479, 278 1-[(2-methoxyphenyl)carbonyl]-3-(pyridin-2-yl)-N-(thiophen-2-ylmethyl)-1H-pyrazol-5-amine::US9687479, 285 N-[(5-chlorothiophen-2-yl)methyl]-1-[(2-methoxyphenyl)carbonyl]-3-(pyridin-2-yl)-1H-pyrazol-5-amine	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163407	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163407&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081351	363890803							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469163	CC(C)(C)C(=O)n1nc(c(F)c1NCc1ccccc1)-c1ccccn1	InChI=1S/C20H21FN4O/c1-20(2,3)19(26)25-18(23-13-14-9-5-4-6-10-14)16(21)17(24-25)15-11-7-8-12-22-15/h4-12,23H,13H2,1-3H3	JYCHAIMVFMTDKR-UHFFFAOYSA-N	163408	US9687479, 279 1-[5-(benzylamino)-4-fluoro-3-(pyridin-2-yl)-1H-pyrazol-1-yl]-2,2-dimethylpropan-1-one	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163408	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163408&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86274351	363890804							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469164	CC(C)(C)C(=O)n1nc(cc1NCc1ccco1)-c1ccccn1	InChI=1S/C18H20N4O2/c1-18(2,3)17(23)22-16(20-12-13-7-6-10-24-13)11-15(21-22)14-8-4-5-9-19-14/h4-11,20H,12H2,1-3H3	HDTFOGSBXRWPPT-UHFFFAOYSA-N	163412	US9687479, 280 1-5-[(furan-2-ylmethyl)amino]-3-(pyridin-2-yl)-1H-pyrazol-1-yl-2,2-dimethylpropan-1-one	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163412	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163412&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081352	363890805							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469165	CC(C)(C)C(=O)n1nc(cc1NCc1cccs1)-c1ccccn1	InChI=1S/C18H20N4OS/c1-18(2,3)17(23)22-16(20-12-13-7-6-10-24-13)11-15(21-22)14-8-4-5-9-19-14/h4-11,20H,12H2,1-3H3	DEUONUPINQDKIZ-UHFFFAOYSA-N	163413	US9687479, 281 2,2-dimethyl-1-[3-(pyridin-2-yl)-5-[(thiophen-2-ylmethyl)amino]-1H-pyrazol-1-yl]propan-1-one	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163413	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163413&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			53491794	363890806							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469167	COc1ccccc1C(=O)n1nc(cc1NCc1ccc(Cl)s1)C1CCCCC1O	InChI=1S/C22H24ClN3O3S/c1-29-19-9-5-3-7-16(19)22(28)26-21(24-13-14-10-11-20(23)30-14)12-17(25-26)15-6-2-4-8-18(15)27/h3,5,7,9-12,15,18,24,27H,2,4,6,8,13H2,1H3	HHLABOMECJDCHH-UHFFFAOYSA-N	163414	US9687479, 282 2-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-[(2-methoxyphenyl)carbonyl]-1H-pyrazol-3-yl)cyclohexan-1-ol	Plasma kallikrein			 5500					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163414	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163414&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081353	363890807							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469168	COc1ccccc1C(=O)n1nc(cc1NCc1cccs1)-c1ccccn1	InChI=1S/C21H18N4O2S/c1-27-19-10-3-2-8-16(19)21(26)25-20(23-14-15-7-6-12-28-15)13-18(24-25)17-9-4-5-11-22-17/h2-13,23H,14H2,1H3	LUXBPHZBKWRWJS-UHFFFAOYSA-N	163415	US9687479, 283 N-(furan-2-ylmethyl)-1-[(2-methoxyphenyl)carbonyl]-3-(pyridin-2-yl)-1H-pyrazol-5-amine	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163415	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163415&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081354	363890808							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469169	COc1ccccc1C(=O)n1nc(cc1NCc1ccc(Cl)s1)C1CCOCC1	InChI=1S/C21H22ClN3O3S/c1-27-18-5-3-2-4-16(18)21(26)25-20(23-13-15-6-7-19(22)29-15)12-17(24-25)14-8-10-28-11-9-14/h2-7,12,14,23H,8-11,13H2,1H3	ZCMYSYJWDJLIJN-UHFFFAOYSA-N	163416	US9687479, 284 N-[(5-chlorothiophen-2-yl)methyl]-1-[(2-methoxyphenyl)carbonyl]-3-(oxan-4-yl)-1H-pyrazol-5-amine	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163416	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163416&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081355	363890809							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469171	COc1ccccc1C(=O)n1nc(cc1NCc1ccc(Cl)s1)-c1ccccn1	InChI=1S/C21H17ClN4O2S/c1-28-18-8-3-2-6-15(18)21(27)26-20(24-13-14-9-10-19(22)29-14)12-17(25-26)16-7-4-5-11-23-16/h2-12,24H,13H2,1H3	CPBDFCXKCBYWQN-UHFFFAOYSA-N	163407	US9687479, 278 1-[(2-methoxyphenyl)carbonyl]-3-(pyridin-2-yl)-N-(thiophen-2-ylmethyl)-1H-pyrazol-5-amine::US9687479, 285 N-[(5-chlorothiophen-2-yl)methyl]-1-[(2-methoxyphenyl)carbonyl]-3-(pyridin-2-yl)-1H-pyrazol-5-amine	Plasma kallikrein			 5500					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163407	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163407&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081351	363890803							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469172	Clc1ccc(CNc2cc(nn2C(=O)c2ccccc2Oc2ccccc2)-c2ccccn2)s1	InChI=1S/C26H19ClN4O2S/c27-24-14-13-19(34-24)17-29-25-16-22(21-11-6-7-15-28-21)30-31(25)26(32)20-10-4-5-12-23(20)33-18-8-2-1-3-9-18/h1-16,29H,17H2	QLALEVWEHUWBIP-UHFFFAOYSA-N	163419	US9687479, 286 N-[(5-chlorothiophen-2-yl)methyl]-1-[(2-phenoxyphenyl)carbonyl]-3-(pyridin-2-yl)-1H-pyrazol-5-amine	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163419	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163419&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081356	363890810							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469173	CC1(CCOCC1)C(=O)n1nc(cc1NCc1ccc(Cl)s1)-c1ccccn1	InChI=1S/C20H21ClN4O2S/c1-20(7-10-27-11-8-20)19(26)25-18(23-13-14-5-6-17(21)28-14)12-16(24-25)15-4-2-3-9-22-15/h2-6,9,12,23H,7-8,10-11,13H2,1H3	BQWCAFQHPZYVRU-UHFFFAOYSA-N	163420	US9687479, 287 N-[(5-chlorothiophen-2-yl)methyl]-1-[(4-methyloxan-4-yl)carbonyl]-3-(pyridin-2-yl)-1H-pyrazol-5-amine	Plasma kallikrein			 55000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163420	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163420&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081357	363890811							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469174	Clc1ccc(CNc2cc(nn2C(=O)c2ccoc2)-c2ccccn2)s1	InChI=1S/C18H13ClN4O2S/c19-16-5-4-13(26-16)10-21-17-9-15(14-3-1-2-7-20-14)22-23(17)18(24)12-6-8-25-11-12/h1-9,11,21H,10H2	BYVJWTIMUGEKIN-UHFFFAOYSA-N	163421	US9687479, 288 N-[(5-chlorothiophen-2-yl)methyl]-1-[(furan-3-yl)carbonyl]-3-(pyridin-2-yl)-1H-pyrazol-5-amine::US9687479, 293 N-[(5-chlorothiophen-2-yl)methyl]-3-(pyridin-2-yl)-1-[(thiophen-3-yl)carbonyl]-1H-pyrazol-5-amine	Plasma kallikrein			 55000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163421	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163421&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081358	363890812							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469175	Clc1ccc(CNc2cc(nn2C(=O)c2ccoc2)-c2cccs2)s1	InChI=1S/C17H12ClN3O2S2/c18-15-4-3-12(25-15)9-19-16-8-13(14-2-1-7-24-14)20-21(16)17(22)11-5-6-23-10-11/h1-8,10,19H,9H2	SLVWGFHFEVXFJW-UHFFFAOYSA-N	163422	US9687479, 289 N-[(5-chlorothiophen-2-yl)methyl]-1-[(furan-3-yl)carbonyl]-3-(thiophen-2-yl)-1H-pyrazol-5-amine	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163422	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163422&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081359	363890813							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469176	COc1ccccc1C(=O)n1nc(cc1NCc1ccc(Cl)s1)-c1ncccc1F	InChI=1S/C21H16ClFN4O2S/c1-29-17-7-3-2-5-14(17)21(28)27-19(25-12-13-8-9-18(22)30-13)11-16(26-27)20-15(23)6-4-10-24-20/h2-11,25H,12H2,1H3	LXPXVURHXAZQLK-UHFFFAOYSA-N	163423	US9687479, 290 N-[(5-chlorothiophen-2-yl)methyl]-3-(3-fluoropyridin-2-yl)-1-[(2-methoxyphenyl)carbonyl]-1H-pyrazol-5-amine	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163423	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163423&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081360	363890814							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469177	Fc1cccnc1-c1cc(NCc2ccc(Cl)s2)n(n1)C(=O)c1ccoc1	InChI=1S/C18H12ClFN4O2S/c19-15-4-3-12(27-15)9-22-16-8-14(17-13(20)2-1-6-21-17)23-24(16)18(25)11-5-7-26-10-11/h1-8,10,22H,9H2	GAJRRSHWVYKPLZ-UHFFFAOYSA-N	163424	US9687479, 291 N-[(5-chlorothiophen-2-yl)methyl]-3-(3-fluoropyridin-2-yl)-1-[(furan-3-yl)carbonyl]-1H-pyrazol-5-amine	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163424	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163424&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081361	363890815							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469179	Clc1ccc(CNc2cc(nn2C(=O)c2ccoc2)-c2cccnn2)s1	InChI=1S/C17H12ClN5O2S/c18-15-4-3-12(26-15)9-19-16-8-14(13-2-1-6-20-21-13)22-23(16)17(24)11-5-7-25-10-11/h1-8,10,19H,9H2	HSLGZJLKYMWBCL-UHFFFAOYSA-N	163425	US9687479, 292 N-[(5-chlorothiophen-2-yl)methyl]-3-(pyridazin-3-yl)-1-[(thiophen-3-yl)carbonyl]-1H-pyrazol-5-amine	Plasma kallikrein			 550					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163425	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163425&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081362	363890816							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469181	Clc1ccc(CNc2cc(nn2C(=O)c2ccoc2)-c2ccccn2)s1	InChI=1S/C18H13ClN4O2S/c19-16-5-4-13(26-16)10-21-17-9-15(14-3-1-2-7-20-14)22-23(17)18(24)12-6-8-25-11-12/h1-9,11,21H,10H2	BYVJWTIMUGEKIN-UHFFFAOYSA-N	163421	US9687479, 288 N-[(5-chlorothiophen-2-yl)methyl]-1-[(furan-3-yl)carbonyl]-3-(pyridin-2-yl)-1H-pyrazol-5-amine::US9687479, 293 N-[(5-chlorothiophen-2-yl)methyl]-3-(pyridin-2-yl)-1-[(thiophen-3-yl)carbonyl]-1H-pyrazol-5-amine	Plasma kallikrein			 550					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163421	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163421&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081358	363890812							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469183	Fc1c(NCc2ccc(Cl)s2)n(nc1C1CCOCC1)C(=O)c1ccoc1	InChI=1S/C18H17ClFN3O3S/c19-14-2-1-13(27-14)9-21-17-15(20)16(11-3-6-25-7-4-11)22-23(17)18(24)12-5-8-26-10-12/h1-2,5,8,10-11,21H,3-4,6-7,9H2	YDQDBKJMDXVZLY-UHFFFAOYSA-N	163427	US9687479, 294 N-[(5-chlorothiophen-2-yl)methyl]-4-fluoro-1-[(furan-3-yl)carbonyl]-3-(oxan-4-yl)-1H-pyrazol-5-amine	Plasma kallikrein			 5500					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163427	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163427&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86273629	363890817							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469184	Fc1c(NCc2ccc(Cl)s2)n(nc1-c1ccccc1)C(=O)c1ccoc1	InChI=1S/C19H13ClFN3O2S/c20-15-7-6-14(27-15)10-22-18-16(21)17(12-4-2-1-3-5-12)23-24(18)19(25)13-8-9-26-11-13/h1-9,11,22H,10H2	BHUNAZGKKNUSFE-UHFFFAOYSA-N	163428	US9687479, 295 N-[(5-chlorothiophen-2-yl)methyl]-4-fluoro-1-[(furan-3-yl)carbonyl]-3-phenyl-1H-pyrazol-5-amine	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163428	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163428&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86272673	363890818							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477062	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1csc(n1)-c1ccsc1	InChI=1S/C23H24N4OS2/c1-15-9-21(22(28)25-11-18-5-3-17(10-24)4-6-18)16(2)27(15)12-20-14-30-23(26-20)19-7-8-29-13-19/h3-9,13-14H,10-12,24H2,1-2H3,(H,25,28)	NJTXQIBROXFAJJ-UHFFFAOYSA-N	186871	US9670157, 37 2,5-Dimethyl-1-(2-thiophen-3-yl-thiazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 37	Plasma kallikrein			 170							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186871	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186871&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290301	373987438							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477063	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1csc(Cc2ccccc2)n1	InChI=1S/C26H28N4OS/c1-18-12-24(26(31)28-15-22-10-8-21(14-27)9-11-22)19(2)30(18)16-23-17-32-25(29-23)13-20-6-4-3-5-7-20/h3-12,17H,13-16,27H2,1-2H3,(H,28,31)	KWYMDWISISCNQW-UHFFFAOYSA-N	186872	US9670157, 38 1-(2-Benzyl-thiazol-4-ylmethyl)-2,5-dimethyl-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 38	Plasma kallikrein			 2311							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186872	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186872&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280246	373987439							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477064	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1csc(n1)-c1ccco1	InChI=1S/C23H24N4O2S/c1-15-10-20(22(28)25-12-18-7-5-17(11-24)6-8-18)16(2)27(15)13-19-14-30-23(26-19)21-4-3-9-29-21/h3-10,14H,11-13,24H2,1-2H3,(H,25,28)	UMKRMIHRHRVVMX-UHFFFAOYSA-N	186873	US9670157, 39 2,5-Dimethyl-1-(2-furan-3-yl-thiazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide	Plasma kallikrein			 1092							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186873	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186873&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134128247	373987440							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477065	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1csc(n1)-c1cnccn1	InChI=1S/C23H24N6OS/c1-15-9-20(22(30)27-11-18-5-3-17(10-24)4-6-18)16(2)29(15)13-19-14-31-23(28-19)21-12-25-7-8-26-21/h3-9,12,14H,10-11,13,24H2,1-2H3,(H,27,30)	GEUSEXYWZZDBQX-UHFFFAOYSA-N	186874	US9670157, 40 2,5-Dimethyl-1-(2-pyrazin-2-yl-thiazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 40	Plasma kallikrein			 1661							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186874	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186874&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280229	373987441							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477066	CCOc1ccc(cc1)-c1nc(Cn2c(C)cc(C(=O)NCc3ccc(CN)cc3)c2C)cs1	InChI=1S/C27H30N4O2S/c1-4-33-24-11-9-22(10-12-24)27-30-23(17-34-27)16-31-18(2)13-25(19(31)3)26(32)29-15-21-7-5-20(14-28)6-8-21/h5-13,17H,4,14-16,28H2,1-3H3,(H,29,32)	DJNXGSWGJXAIJL-UHFFFAOYSA-N	186875	US9670157, 41 1-[2-(4-Ethoxy-phenyl)-thiazol-4-ylmethyl]-2,5-dimethyl-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 41	Plasma kallikrein			 4704							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186875	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186875&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126614035	373987442							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477067	CC(NC(=O)c1cc(C)n(Cc2csc(n2)-c2ccccc2)c1C)c1ccc(CN)nc1	InChI=1S/C25H27N5OS/c1-16-11-23(24(31)28-17(2)20-9-10-21(12-26)27-13-20)18(3)30(16)14-22-15-32-25(29-22)19-7-5-4-6-8-19/h4-11,13,15,17H,12,14,26H2,1-3H3,(H,28,31)	JOSCRKCAXAFNGY-UHFFFAOYSA-N	186876	US9670157, 42 2,5-Dimethyl-1-(2-phenyl-thiazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid [(R)-1-(4-aminomethyl-phenyl)-ethyl]-amide	Plasma kallikrein			 953							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186876	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186876&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134128248	373987443							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477068	Cc1cc(C(=O)NCc2ccc(CN)nc2)c(C)n1Cc1csc(n1)-c1ccccc1	InChI=1S/C24H25N5OS/c1-16-10-22(23(30)27-13-18-8-9-20(11-25)26-12-18)17(2)29(16)14-21-15-31-24(28-21)19-6-4-3-5-7-19/h3-10,12,15H,11,13-14,25H2,1-2H3,(H,27,30)	SMPAEILCYAFKDO-UHFFFAOYSA-N	186877	US9670157, 43 2,5-Dimethyl-1-(2-phenyl-thiazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid (6-aminomethyl-pyridin-3-ylmethyl)-amide::US9834513, 43	Plasma kallikrein			 196							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186877	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186877&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290302	373987444							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477069	Cc1cc(C(=O)NCc2ccc(CN)nc2)c(C)n1Cc1csc(n1)-c1cccc(F)c1	InChI=1S/C24H24FN5OS/c1-15-8-22(23(31)28-12-17-6-7-20(10-26)27-11-17)16(2)30(15)13-21-14-32-24(29-21)18-4-3-5-19(25)9-18/h3-9,11,14H,10,12-13,26H2,1-2H3,(H,28,31)	LNJDJWSMFMSGEH-UHFFFAOYSA-N	186878	US9670157, 44 1-[2-(3-Fluoro-phenyl)-thiazol-4-ylmethyl]-2,5-dimethyl-1H-pyrrole-3-carboxylic acid (6-aminomethyl-pyridin-3-ylmethyl)-amide::US9834513, 44	Plasma kallikrein			 355							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186878	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186878&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134128249	373987445							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477070	Cc1cc(C(=O)NCc2ccc(CN)c(F)c2)c(C)n1Cc1csc(n1)-c1ccccc1	InChI=1S/C25H25FN4OS/c1-16-10-22(24(31)28-13-18-8-9-20(12-27)23(26)11-18)17(2)30(16)14-21-15-32-25(29-21)19-6-4-3-5-7-19/h3-11,15H,12-14,27H2,1-2H3,(H,28,31)	ICSBZJSGYBSVLI-UHFFFAOYSA-N	186879	US9670157, 45 2,5-Dimethyl-1-(2-phenyl-thiazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-3-fluoro-benzylamide::US9834513, 45	Plasma kallikrein			 135							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186879	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186879&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			76285426	373987446							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477071	Cc1cc(C(=O)NCc2ccc(CN)c(C)c2)c(C)n1Cc1csc(n1)-c1ccccc1	InChI=1S/C26H28N4OS/c1-17-11-20(9-10-22(17)13-27)14-28-25(31)24-12-18(2)30(19(24)3)15-23-16-32-26(29-23)21-7-5-4-6-8-21/h4-12,16H,13-15,27H2,1-3H3,(H,28,31)	SYWALHZYILGMMA-UHFFFAOYSA-N	186880	US9670157, 46 2,5-Dimethyl-1-(2-phenyl-thiazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-3-methyl-benzylamide::US9834513, 46	Plasma kallikrein			 1164							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186880	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186880&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280311	373987447							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477072	Cc1cc(C(=O)NCc2ccc(CN)cc2F)c(C)n1Cc1csc(n1)-c1ccccc1	InChI=1S/C25H25FN4OS/c1-16-10-22(24(31)28-13-20-9-8-18(12-27)11-23(20)26)17(2)30(16)14-21-15-32-25(29-21)19-6-4-3-5-7-19/h3-11,15H,12-14,27H2,1-2H3,(H,28,31)	UNKAHMHMAXWBRJ-UHFFFAOYSA-N	186881	US9670157, 47 2,5-Dimethyl-1-(2-phenyl-thiazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-2-fluoro-benzylamide::US9834513, 47	Plasma kallikrein			 74							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186881	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186881&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290303	373987448							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477073	C[C@H](N)c1ccc(CNC(=O)c2cc(C)n(Cc3csc(n3)-c3ccccc3)c2C)cn1	InChI=1S/C25H27N5OS/c1-16-11-22(24(31)28-13-19-9-10-23(17(2)26)27-12-19)18(3)30(16)14-21-15-32-25(29-21)20-7-5-4-6-8-20/h4-12,15,17H,13-14,26H2,1-3H3,(H,28,31)/t17-/m0/s1	WECQBLYMKWKPRV-KRWDZBQOSA-N	186882	US9670157, 48 2,5-Dimethyl-1-(2-phenyl-thiazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-((R)-1-amino-ethyl)-benzylamide	Plasma kallikrein			 624							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186882	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186882&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134128250	373987449							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477074	Cc1cc(C(=O)NCc2ccc(CN)cc2Cl)c(C)n1Cc1csc(n1)-c1ccccc1	InChI=1S/C25H25ClN4OS/c1-16-10-22(24(31)28-13-20-9-8-18(12-27)11-23(20)26)17(2)30(16)14-21-15-32-25(29-21)19-6-4-3-5-7-19/h3-11,15H,12-14,27H2,1-2H3,(H,28,31)	LXZGTPFYSZITPH-UHFFFAOYSA-N	186883	US9670157, 49 2,5-Dimethyl-1-(2-phenyl-thiazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-2-chloro-benzylamide::US9834513, 49	Plasma kallikrein			 89							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186883	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186883&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290346	373987450							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477075	Cc1cc(C(=O)NCc2ccc(CN)cc2C(F)(F)F)c(C)n1Cc1csc(n1)-c1ccccc1	InChI=1S/C26H25F3N4OS/c1-16-10-22(24(34)31-13-20-9-8-18(12-30)11-23(20)26(27,28)29)17(2)33(16)14-21-15-35-25(32-21)19-6-4-3-5-7-19/h3-11,15H,12-14,30H2,1-2H3,(H,31,34)	GSVROUVRXWFULX-UHFFFAOYSA-N	186884	US9670157, 50 2,5-Dimethyl-1-(2-phenyl-thiazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-2-trifluoromethyl-benzylamide::US9834513, 50	Plasma kallikrein			 56							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186884	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186884&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290347	373987451							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477076	C[C@@H](N)c1ccc(CNC(=O)c2cc(C)n(Cc3csc(n3)-c3ccccc3)c2C)cn1	InChI=1S/C25H27N5OS/c1-16-11-22(24(31)28-13-19-9-10-23(17(2)26)27-12-19)18(3)30(16)14-21-15-32-25(29-21)20-7-5-4-6-8-20/h4-12,15,17H,13-14,26H2,1-3H3,(H,28,31)/t17-/m1/s1	WECQBLYMKWKPRV-QGZVFWFLSA-N	186885	US9670157, 51 2,5-Dimethyl-1-(2-phenyl-thiazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid-4-((S)-1-amino-ethyl)-benzylamide	Plasma kallikrein			 341							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186885	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186885&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134128251	373987452							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477077	Cc1cc(C(=O)NC2(CC2)c2ccc(CN)cc2)c(C)n1Cc1csc(n1)-c1ccccc1	InChI=1S/C27H28N4OS/c1-18-14-24(25(32)30-27(12-13-27)22-10-8-20(15-28)9-11-22)19(2)31(18)16-23-17-33-26(29-23)21-6-4-3-5-7-21/h3-11,14,17H,12-13,15-16,28H2,1-2H3,(H,30,32)	DSUFTYRAXNTLED-UHFFFAOYSA-N	186886	US9670157, 52 2,5-Dimethyl-1-(2-phenyl-thiazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid [1-(4-aminomethyl-phenyl)-cyclopropyl]-amide::US9834513, 52	Plasma kallikrein			 475							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186886	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186886&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134128252	373987453							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477078	COc1cc(CNC(=O)c2cc(C)n(Cc3csc(n3)-c3ccccc3)c2C)ccc1CN	InChI=1S/C26H28N4O2S/c1-17-11-23(25(31)28-14-19-9-10-21(13-27)24(12-19)32-3)18(2)30(17)15-22-16-33-26(29-22)20-7-5-4-6-8-20/h4-12,16H,13-15,27H2,1-3H3,(H,28,31)	MAGFCMDPSMQSNK-UHFFFAOYSA-N	186887	US9670157, 53 2,5-Dimethyl-1-(2-phenyl-thiazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-3-methoxy-benzylamide::US9834513, 53	Plasma kallikrein			 677							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186887	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186887&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126614069	373987454							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477079	COc1cc(CN)ccc1CNC(=O)c1cc(C)n(Cc2csc(n2)-c2ccccc2)c1C	InChI=1S/C26H28N4O2S/c1-17-11-23(25(31)28-14-21-10-9-19(13-27)12-24(21)32-3)18(2)30(17)15-22-16-33-26(29-22)20-7-5-4-6-8-20/h4-12,16H,13-15,27H2,1-3H3,(H,28,31)	IBULPWHWUWJTMW-UHFFFAOYSA-N	186888	US9670157, 54 2,5-Dimethyl-1-(2-phenyl-thiazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-2-methoxy-benzylamide::US9834513, 54	Plasma kallikrein			 30							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186888	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186888&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290348	373987455							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477080	Cc1cc(cn1Cc1ccccc1)C(=O)NCc1ccc(CN)cc1	InChI=1S/C21H23N3O/c1-16-11-20(15-24(16)14-19-5-3-2-4-6-19)21(25)23-13-18-9-7-17(12-22)8-10-18/h2-11,15H,12-14,22H2,1H3,(H,23,25)	HFSFXHXZTZIAGT-UHFFFAOYSA-N	186889	US9670157, 55 1-Benzyl-2,5-dimethyl-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide	Plasma kallikrein			 3267							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186889	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186889&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134128253	373987456							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477081	Cc1cc(cn1Cc1ccccc1)C(=O)NCc1ccc(CN)cc1Cl	InChI=1S/C21H22ClN3O/c1-15-9-19(14-25(15)13-16-5-3-2-4-6-16)21(26)24-12-18-8-7-17(11-23)10-20(18)22/h2-10,14H,11-13,23H2,1H3,(H,24,26)	FWHVEBNGIXMPER-UHFFFAOYSA-N	186890	US9670157, 56 1-Benzyl-2,5-dimethyl-1H-pyrrole-3-carboxylic acid 4-aminomethyl-2-chloro-benzylamide	Plasma kallikrein			 3856							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186890	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186890&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134128254	373987457							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477082	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(-c2ccccc2)n1Cc1ccccc1	InChI=1S/C27H27N3O/c1-20-16-25(27(31)29-18-22-14-12-21(17-28)13-15-22)26(24-10-6-3-7-11-24)30(20)19-23-8-4-2-5-9-23/h2-16H,17-19,28H2,1H3,(H,29,31)	RKXLHVKAYMREQS-UHFFFAOYSA-N	186891	US9670157, 57 1-Benzyl-5-methyl-2-phenyl-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 57	Plasma kallikrein			 7178							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186891	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186891&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280195	373987458							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477083	CCOc1cccc(Cn2c(C)cc(C(=O)NCc3ccc(CN)cc3)c2C)c1	InChI=1S/C24H29N3O2/c1-4-29-22-7-5-6-21(13-22)16-27-17(2)12-23(18(27)3)24(28)26-15-20-10-8-19(14-25)9-11-20/h5-13H,4,14-16,25H2,1-3H3,(H,26,28)	OSOIQLFGFDLMQI-UHFFFAOYSA-N	186892	US9670157, 58 1-(3-Ethoxy-benzyl)-2,5-dimethyl-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 58	Plasma kallikrein			 4915							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186892	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186892&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280285	373987459							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477084	CCOc1ccc(Cn2c(C)cc(C(=O)NCc3ccc(CN)cc3)c2C)cc1	InChI=1S/C24H29N3O2/c1-4-29-22-11-9-21(10-12-22)16-27-17(2)13-23(18(27)3)24(28)26-15-20-7-5-19(14-25)6-8-20/h5-13H,4,14-16,25H2,1-3H3,(H,26,28)	DTHFKIRITMWVOZ-UHFFFAOYSA-N	186893	US9670157, 59 1-(4-Ethoxy-benzyl)-2,5-dimethyl-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 59	Plasma kallikrein			 2742							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186893	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186893&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280164	373987460							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477085	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1ccc(OCc2ccccc2)cc1	InChI=1S/C29H31N3O2/c1-21-16-28(29(33)31-18-24-10-8-23(17-30)9-11-24)22(2)32(21)19-25-12-14-27(15-13-25)34-20-26-6-4-3-5-7-26/h3-16H,17-20,30H2,1-2H3,(H,31,33)	ZPOGIPJTCZOOTF-UHFFFAOYSA-N	186894	US9670157, 60 1-(4-Benzyloxy-benzyl)-2,5-dimethyl-1H-pyrrole-3-carboxylic acid4-aminomethyl-benzylamide	Plasma kallikrein			 3115							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186894	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186894&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280146	373987461							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477086	COc1ccc(Cn2c(C)cc(C(=O)NCc3ccc(CN)cc3)c2C)cc1	InChI=1S/C23H27N3O2/c1-16-12-22(23(27)25-14-19-6-4-18(13-24)5-7-19)17(2)26(16)15-20-8-10-21(28-3)11-9-20/h4-12H,13-15,24H2,1-3H3,(H,25,27)	AEINFUDDNRIDPG-UHFFFAOYSA-N	186895	US9670157, 61 1-(4-Methoxy-benzyl)-2,5-dimethyl-1H-pyrrole-3-carboxylic acid4-aminomethyl-benzylamide	Plasma kallikrein			 2990							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186895	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186895&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280364	373987462							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477087	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1cccc(c1)C(N)=O	InChI=1S/C23H26N4O2/c1-15-10-21(23(29)26-13-18-8-6-17(12-24)7-9-18)16(2)27(15)14-19-4-3-5-20(11-19)22(25)28/h3-11H,12-14,24H2,1-2H3,(H2,25,28)(H,26,29)	HPZHVSKNZIIGRR-UHFFFAOYSA-N	186896	US9670157, 62 1-(3-Carbamoyl-benzyl)-2,5-dimethyl-1H-pyrrole-3-carboxylic acid4-aminomethyl-benzylamide	Plasma kallikrein			 6034							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186896	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186896&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280271	373987463							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477088	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1ccc(cc1)C(N)=O	InChI=1S/C23H26N4O2/c1-15-11-21(23(29)26-13-18-5-3-17(12-24)4-6-18)16(2)27(15)14-19-7-9-20(10-8-19)22(25)28/h3-11H,12-14,24H2,1-2H3,(H2,25,28)(H,26,29)	QAMFGZOCKZUTSH-UHFFFAOYSA-N	186897	US9670157, 63 1-(4-Carbamoyl-benzyl)-2,5-dimethyl-1H-pyrrole-3-carboxylic acid4-aminomethyl-benzylamide	Plasma kallikrein			 7338							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186897	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186897&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280219	373987464							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477089	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1cccc(c1)C#N	InChI=1S/C23H24N4O/c1-16-10-22(23(28)26-14-19-8-6-18(12-24)7-9-19)17(2)27(16)15-21-5-3-4-20(11-21)13-25/h3-11H,12,14-15,24H2,1-2H3,(H,26,28)	HZSKGFNWATXCGJ-UHFFFAOYSA-N	186898	US9670157, 64 1-(3-Cyano-benzyl)-2,5-dimethyl-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 64	Plasma kallikrein			 6253							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186898	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186898&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280205	373987465							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477090	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1ccc(cc1)C#N	InChI=1S/C23H24N4O/c1-16-11-22(23(28)26-14-20-7-3-18(12-24)4-8-20)17(2)27(16)15-21-9-5-19(13-25)6-10-21/h3-11H,12,14-15,24H2,1-2H3,(H,26,28)	PDWMJRDCYAVGDP-UHFFFAOYSA-N	186899	US9670157, 65 1-(4-Cyano-benzyl)-2,5-dimethyl-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 65	Plasma kallikrein			 4558							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186899	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186899&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280064	373987466							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477091	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1cccc(CN)c1	InChI=1S/C23H28N4O/c1-16-10-22(23(28)26-14-19-8-6-18(12-24)7-9-19)17(2)27(16)15-21-5-3-4-20(11-21)13-25/h3-11H,12-15,24-25H2,1-2H3,(H,26,28)	OPSYIFLJCDVWBB-UHFFFAOYSA-N	186900	US9670157, 66 1-(3-Aminomethyl-benzyl)-2,5-dimethyl-1H-pyrrole-3-carboxylicacid 4-aminomethyl-benzylamide::US9834513, 66	Plasma kallikrein			 5383							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186900	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186900&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280266	373987467							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477092	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1ccc(CN)cc1	InChI=1S/C23H28N4O/c1-16-11-22(23(28)26-14-20-7-3-18(12-24)4-8-20)17(2)27(16)15-21-9-5-19(13-25)6-10-21/h3-11H,12-15,24-25H2,1-2H3,(H,26,28)	HACVLVRJTRLUNN-UHFFFAOYSA-N	186901	US9670157, 67 1-(4-Aminomethyl-benzyl)-2,5-dimethyl-1H-pyrrole-3-carboxylicacid 4-aminomethyl-benzylamide::US9834513, 67	Plasma kallikrein			 3503							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186901	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186901&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280280	373987468							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477093	CNC(=O)Cc1ccc(Cn2c(C)cc(C(=O)NCc3ccc(CN)cc3)c2C)cc1	InChI=1S/C25H30N4O2/c1-17-12-23(25(31)28-15-21-8-6-20(14-26)7-9-21)18(2)29(17)16-22-10-4-19(5-11-22)13-24(30)27-3/h4-12H,13-16,26H2,1-3H3,(H,27,30)(H,28,31)	MZDMHDROPPGLPC-UHFFFAOYSA-N	186902	US9670157, 68 1-[4-(Acetylamino-methyl)-benzyl]-2,5-dimethyl-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide	Plasma kallikrein			 2093							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186902	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186902&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134128255	373987469							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477094	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1cccc(c1)-c1ccccc1	InChI=1S/C28H29N3O/c1-20-15-27(28(32)30-18-23-13-11-22(17-29)12-14-23)21(2)31(20)19-24-7-6-10-26(16-24)25-8-4-3-5-9-25/h3-16H,17-19,29H2,1-2H3,(H,30,32)	UPJXJSJQGXMKHH-UHFFFAOYSA-N	186903	US9670157, 69 1-Biphenyl-3-ylmethyl-2,5-dimethyl-1H-pyrrole-3-carboxylic acid4-aminomethyl-benzylamide::US9834513, 69	Plasma kallikrein			 689							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186903	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186903&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280297	373987470							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477095	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1ccc(cc1)-c1ccccc1	InChI=1S/C28H29N3O/c1-20-16-27(28(32)30-18-23-10-8-22(17-29)9-11-23)21(2)31(20)19-24-12-14-26(15-13-24)25-6-4-3-5-7-25/h3-16H,17-19,29H2,1-2H3,(H,30,32)	DRILYKUMENWWJU-UHFFFAOYSA-N	186904	US9670157, 70 1-Biphenyl-4-ylmethyl-2,5-dimethyl-1H-pyrrole-3-carboxylic acid4-aminomethyl-benzylamide::US9834513, 70	Plasma kallikrein			 4593							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186904	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186904&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280290	373987471							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477096	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1cccc(c1)-c1cccnc1	InChI=1S/C27H28N4O/c1-19-13-26(27(32)30-16-22-10-8-21(15-28)9-11-22)20(2)31(19)18-23-5-3-6-24(14-23)25-7-4-12-29-17-25/h3-14,17H,15-16,18,28H2,1-2H3,(H,30,32)	ZHSQJZFBBUWKBF-UHFFFAOYSA-N	186905	US9670157, 71 2,5-Dimethyl-1-(3-pyridin-3-yl-benzyl)-1H-pyrrole-3-carboxylicacid 4-aminomethyl-benzylamide::US9834513, 71	Plasma kallikrein			 702							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186905	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186905&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280260	373987472							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477097	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1cccc(c1)-c1ccncc1	InChI=1S/C27H28N4O/c1-19-14-26(27(32)30-17-22-8-6-21(16-28)7-9-22)20(2)31(19)18-23-4-3-5-25(15-23)24-10-12-29-13-11-24/h3-15H,16-18,28H2,1-2H3,(H,30,32)	IBDFYEMJUQJHTL-UHFFFAOYSA-N	186906	US9670157, 72 2,5-Dimethyl-1-(3-pyridin-4-yl-benzyl)-1H-pyrrole-3-carboxylicacid 4-aminomethyl-benzylamide	Plasma kallikrein			 3021							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186906	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186906&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280269	373987473							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477098	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1cccc(c1)N1CCOCC1	InChI=1S/C26H32N4O2/c1-19-14-25(26(31)28-17-22-8-6-21(16-27)7-9-22)20(2)30(19)18-23-4-3-5-24(15-23)29-10-12-32-13-11-29/h3-9,14-15H,10-13,16-18,27H2,1-2H3,(H,28,31)	OLCGTUICNZOAOJ-UHFFFAOYSA-N	186907	US9670157, 73 2,5-Dimethyl-1-(3-morpholin-4-yl-benzyl)-1H-pyrrole-3-carboxylicacid 4-aminomethyl-benzylamide::US9834513, 73	Plasma kallikrein			 7580							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186907	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186907&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280127	373987474							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477099	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1cccc(c1)N1CCCCC1	InChI=1S/C27H34N4O/c1-20-15-26(27(32)29-18-23-11-9-22(17-28)10-12-23)21(2)31(20)19-24-7-6-8-25(16-24)30-13-4-3-5-14-30/h6-12,15-16H,3-5,13-14,17-19,28H2,1-2H3,(H,29,32)	ITDCKEYZHSCEEN-UHFFFAOYSA-N	186908	US9670157, 74 2,5-Dimethyl-1-(3-piperidin-1-yl-benzyl)-1H-pyrrole-3-carboxylicacid 4-aminomethyl-benzylamide::US9834513, 74	Plasma kallikrein			 1584							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186908	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186908&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280213	373987475							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477100	Cc1cc(C(=O)NCc2ccc(CN)cc2)n(C)c1Cc1ccccc1	InChI=1S/C22H25N3O/c1-16-12-21(25(2)20(16)13-17-6-4-3-5-7-17)22(26)24-15-19-10-8-18(14-23)9-11-19/h3-12H,13-15,23H2,1-2H3,(H,24,26)	QKCMLEDBXHOENV-UHFFFAOYSA-N	186909	US9670157, 75 5-Benzyl-1,4-dimethyl-1H-pyrrole-2-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 75	Plasma kallikrein			 4499							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186909	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186909&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280304	373987476							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477101	Cc1cc(nc1Cc1ccccc1)C(=O)NCc1ccc(CN)cc1	InChI=1S/C21H22N3O/c1-15-11-20(24-19(15)12-16-5-3-2-4-6-16)21(25)23-14-18-9-7-17(13-22)8-10-18/h2-11H,12-14,22H2,1H3,(H,23,25)	VOBHFYLQMIAUBK-UHFFFAOYSA-N	186910	US9670157, 76 5-Benzyl-4-methyl-1H-pyrrole-2-carboxylic acid 4-aminomethyl-benzylamide	Plasma kallikrein			 8767							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186910	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186910&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280356	373987477							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477102	CCCn1c(Cc2ccccc2)c(C)cc1C(=O)NCc1ccc(CN)cc1	InChI=1S/C24H29N3O/c1-3-13-27-22(15-19-7-5-4-6-8-19)18(2)14-23(27)24(28)26-17-21-11-9-20(16-25)10-12-21/h4-12,14H,3,13,15-17,25H2,1-2H3,(H,26,28)	TXFLOUBVCQUPIW-UHFFFAOYSA-N	186911	US9670157, 77 5-Benzyl-1-ethyl-4-methyl-1H-pyrrole-2-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 78	Plasma kallikrein			 3722							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186911	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186911&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280303	373987478							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469185	COc1ccccc1C(=O)n1nc(c(F)c1NCc1ccccc1)-c1ccccc1	InChI=1S/C24H20FN3O2/c1-30-20-15-9-8-14-19(20)24(29)28-23(26-16-17-10-4-2-5-11-17)21(25)22(27-28)18-12-6-3-7-13-18/h2-15,26H,16H2,1H3	VQFCADVXAYMBNM-UHFFFAOYSA-N	163429	US9687479, 296 N-benzyl-4-fluoro-1-[(2-methoxyphenyl)carbonyl]-3-phenyl-1H-pyrazol-5-amine	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163429	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163429&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86274830	363890819							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469186	CC(C)(C)OC(=O)N1CCC(CC1)c1cc(NCc2ccc(Cl)s2)n(n1)C(=O)C(C)(C)C	InChI=1S/C23H33ClN4O3S/c1-22(2,3)20(29)28-19(25-14-16-7-8-18(24)32-16)13-17(26-28)15-9-11-27(12-10-15)21(30)31-23(4,5)6/h7-8,13,15,25H,9-12,14H2,1-6H3	HIPOYIRGZQFRRV-UHFFFAOYSA-N	163431	US9687479, 297 tert-butyl 4-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-(2,2-dimethylpropanoyl)-1H-pyrazol-3-yl)piperidine-1-carboxylate	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163431	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163431&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			122509173	363890820							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469187	CC(C)(C)OC(=O)N1CCC(CC1)c1cc(NCc2ccc(Cl)s2)n(n1)C(=O)c1ccsc1	InChI=1S/C23H27ClN4O3S2/c1-23(2,3)31-22(30)27-9-6-15(7-10-27)18-12-20(25-13-17-4-5-19(24)33-17)28(26-18)21(29)16-8-11-32-14-16/h4-5,8,11-12,14-15,25H,6-7,9-10,13H2,1-3H3	KXJWMLVPZKZDOI-UHFFFAOYSA-N	163432	US9687479, 298 tert-butyl 4-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-[(thiophen-3-yl)carbonyl]-1H-pyrazol-3-yl)piperidine-1-carboxylateIUPACname	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163432	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163432&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081363	363890821							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469188	CCC(=O)n1nc(nc1NCc1ccc(F)cc1)-c1cccnc1	InChI=1S/C17H16FN5O/c1-2-15(24)23-17(20-10-12-5-7-14(18)8-6-12)21-16(22-23)13-4-3-9-19-11-13/h3-9,11H,2,10H2,1H3,(H,20,21,22)	HWYXHDNBDAGMIR-UHFFFAOYSA-N	33812	1-[5-[(4-fluorobenzyl)amino]-3-(3-pyridyl)-1,2,4-triazol-1-yl]propan-1-one::1-[5-[(4-fluorophenyl)methylamino]-3-(3-pyridinyl)-1,2,4-triazol-1-yl]-1-propanone::1-[5-[(4-fluorophenyl)methylamino]-3-pyridin-3-yl-1,2,4-triazol-1-yl]propan-1-one::MLS000719020::SMR000291288::US9687479, 7 1-(5-[(4-fluorophenyl)methyl]amino-3-(pyridin-3-yl)-1H-1,2,4-triazol-1-yl)propan-1-one::cid_3922884	Plasma kallikrein			 55000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=33812	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=33812&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			3922884	252616712						ZINC05002130	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469189	O=C(c1ccco1)n1nc(nc1NCc1ccccc1)-c1ccccn1	InChI=1S/C19H15N5O2/c25-18(16-10-6-12-26-16)24-19(21-13-14-7-2-1-3-8-14)22-17(23-24)15-9-4-5-11-20-15/h1-12H,13H2,(H,21,22,23)	PZTUKBQTXCXKEF-UHFFFAOYSA-N	163434	US9687479, 404 N-benzyl-3-(pyridin-2-yl)-1-[(thiophen-2-yl)carbonyl]-1H-1,2,4-triazol-5-amine::US9687479, 8 N-benzyl-1-[(furan-2-yl)carbonyl]-3-(pyridin-2-yl)-1H-1,2,4-triazol-5-amine	Plasma kallikrein			 5500					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163434	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163434&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			68230292	363890823							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469190	O=C(CCc1ccccc1)n1nc(nc1NCc1ccccc1)-c1ccccn1	InChI=1S/C23H21N5O/c29-21(15-14-18-9-3-1-4-10-18)28-23(25-17-19-11-5-2-6-12-19)26-22(27-28)20-13-7-8-16-24-20/h1-13,16H,14-15,17H2,(H,25,26,27)	CTUFMWURMCIBKN-UHFFFAOYSA-N	163435	US9687479, 9 1-[5-(benzylamino)-3-(pyridin-2-yl)-1H-1,2,4-triazol-1-yl]-3-phenylpropan-1-one	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163435	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163435&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71263072	363890824							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469191	Fc1ccc(CNc2nc(nn2C(=O)c2ccco2)-c2ccccn2)cc1	InChI=1S/C19H14FN5O2/c20-14-8-6-13(7-9-14)12-22-19-23-17(15-4-1-2-10-21-15)24-25(19)18(26)16-5-3-11-27-16/h1-11H,12H2,(H,22,23,24)	DKWXCXZOTMMAFV-UHFFFAOYSA-N	163436	US9687479, 10 N-[(4-fluorophenyl)methyl]-3-(pyridin-2-yl)-1-[(thiophen-2-yl)carbonyl]-1H-1,2,4-triazol-5-amine::US9687479, 369 N-[(4-fluorophenyl)methyl]-1-[(furan-2-yl)carbonyl]-3-(pyridin-2-yl)-1H-1,2,4-triazol-5-amine	Plasma kallikrein			 5500					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163436	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163436&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081364	363890825							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469192	Fc1ccc(CNc2nc(nn2C(=O)c2ccco2)-c2ccncc2)cc1	InChI=1S/C19H14FN5O2/c20-15-5-3-13(4-6-15)12-22-19-23-17(14-7-9-21-10-8-14)24-25(19)18(26)16-2-1-11-27-16/h1-11H,12H2,(H,22,23,24)	STINAMZIOJIHKX-UHFFFAOYSA-N	163454	US9687479, 11 N-[(4-fluorophenyl)methyl]-3-(pyridin-4-yl)-1-[(thiophen-3-yl)carbonyl]-1H-1,2,4-triazol-5-amine::US9687479, 378 N-[(4-fluorophenyl)methyl]-3-(pyridin-4-yl)-1-[(thiophen-2-yl)carbonyl]-1H-1,2,4-triazol-5-amine	Plasma kallikrein			 5500					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163454	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163454&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081365	363890826							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469193	Fc1ccc(CNc2nc(nn2C(=O)N2CCOCC2)-c2cccnc2)cc1	InChI=1S/C19H19FN6O2/c20-16-5-3-14(4-6-16)12-22-18-23-17(15-2-1-7-21-13-15)24-26(18)19(27)25-8-10-28-11-9-25/h1-7,13H,8-12H2,(H,22,23,24)	JVSUVSZHUINLHG-UHFFFAOYSA-N	163455	US9687479, 12 N-[(4-fluorophenyl)methyl]-1-[(morpholin-4-yl)carbonyl]-3-(pyridin-3-yl)-1H-1,2,4-triazol-5-amine	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163455	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163455&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			68229651	363890827							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469194	CCC(=O)n1nc(nc1N(C)C)-c1cccnc1	InChI=1S/C12H15N5O/c1-4-10(18)17-12(16(2)3)14-11(15-17)9-6-5-7-13-8-9/h5-8H,4H2,1-3H3	YPIRIKWGZTUZDB-UHFFFAOYSA-N	163456	US9687479, 13 1-[5-(dimethylamino)-3-(pyridin-3-yl)-1H-1,2,4-triazol-1-yl]propan-1-one	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163456	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163456&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			53492422	363890828							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469195	COc1ccccc1C(=O)n1nc(nc1SCc1ccc(F)cc1)-c1cccnc1	InChI=1S/C22H17FN4O2S/c1-29-19-7-3-2-6-18(19)21(28)27-22(30-14-15-8-10-17(23)11-9-15)25-20(26-27)16-5-4-12-24-13-16/h2-13H,14H2,1H3	QSXJROHZJFBGNA-UHFFFAOYSA-N	163457	US9687479, 14 3-(5-[(4-fluorophenyl)methyl]sulfanyl-1-[(2-methoxyphenyl)carbonyl]-1H-1,2,4-triazol-3-yl)pyridine	Plasma kallikrein			 550					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163457	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163457&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			53492677	363890829							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469197	COc1ccccc1C(=O)n1nc(nc1SC)-c1cccs1	InChI=1S/C15H13N3O2S2/c1-20-11-7-4-3-6-10(11)14(19)18-15(21-2)16-13(17-18)12-8-5-9-22-12/h3-9H,1-2H3	ZVMHAVKBABGGTK-UHFFFAOYSA-N	163475	US9687479, 15 1-[(2-methoxyphenyl)carbonyl]-5-(methylsulfanyl)-3-(thiophen-2-yl)-1H-1,2,4-triazole	Plasma kallikrein			 5500					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163475	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163475&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			53492676	363890830							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469198	COc1ccccc1C(=O)n1nc(nc1NCc1ccccc1)-c1ccncn1	InChI=1S/C21H18N6O2/c1-29-18-10-6-5-9-16(18)20(28)27-21(23-13-15-7-3-2-4-8-15)25-19(26-27)17-11-12-22-14-24-17/h2-12,14H,13H2,1H3,(H,23,25,26)	GRGVROWQGFPRLX-UHFFFAOYSA-N	163476	US9687479, 16 N-benzyl-1-[(2-methoxyphenyl)carbonyl]-3-(pyrimidin-4-yl)-1H-1,2,4-triazol-5-amine	Plasma kallikrein			 550					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163476	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163476&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			68230188	363890831							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469199	COc1ccccc1C(=O)n1nc(nc1NCc1ccccc1)-c1cncnc1	InChI=1S/C21H18N6O2/c1-29-18-10-6-5-9-17(18)20(28)27-21(24-11-15-7-3-2-4-8-15)25-19(26-27)16-12-22-14-23-13-16/h2-10,12-14H,11H2,1H3,(H,24,25,26)	ZQSURCAHYOQTCT-UHFFFAOYSA-N	163477	US9687479, 17 N-benzyl-1-[(2-methoxyphenyl)carbonyl]-3-(pyrimidin-5-yl)-1H-1,2,4-triazol-5-amine	Plasma kallikrein			 550					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163477	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163477&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71263062	363890832							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469201	COc1ccccc1C(=O)n1nc(nc1NCc1ccccc1)-c1ncccn1	InChI=1S/C21H18N6O2/c1-29-17-11-6-5-10-16(17)20(28)27-21(24-14-15-8-3-2-4-9-15)25-19(26-27)18-22-12-7-13-23-18/h2-13H,14H2,1H3,(H,24,25,26)	WZKVTXQOHSLYRJ-UHFFFAOYSA-N	163478	US9687479, 18 N-benzyl-1-[(2-methoxyphenyl)carbonyl]-3-(pyrimidin-2-yl)-1H-1,2,4-triazol-5-amine	Plasma kallikrein			 550					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163478	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163478&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			68229981	363890833							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469203	COc1ccccc1C(=O)n1nc(nc1NCc1ccc(Cl)s1)-c1ccccn1	InChI=1S/C20H16ClN5O2S/c1-28-16-8-3-2-6-14(16)19(27)26-20(23-12-13-9-10-17(21)29-13)24-18(25-26)15-7-4-5-11-22-15/h2-11H,12H2,1H3,(H,23,24,25)	UVDLZNNZPDZTET-UHFFFAOYSA-N	163508	US9687479, 22 N-[(5-chlorothiophen-2-yl)methyl]-1-[(2-methoxyphenyl)carbonyl]-3-(pyridin-2-yl)-1H-1,2,4-triazol-5-amine::US9687479, 391 N-[(5-chlorothiophen-2-yl)methyl]-1-[(2-methylphenyl)carbonyl]-3-(pyridin-2-yl)-1H-1,2,4-triazol-5-amine	Plasma kallikrein			<100					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163508	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163508&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081366	363890834							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469204	Fc1ccc(CNc2nc(nn2C(=O)c2nc3ccccc3s2)-c2ccccn2)cc1	InChI=1S/C22H15FN6OS/c23-15-10-8-14(9-11-15)13-25-22-27-19(17-6-3-4-12-24-17)28-29(22)21(30)20-26-16-5-1-2-7-18(16)31-20/h1-12H,13H2,(H,25,27,28)	ORFJICQTFZXDTF-UHFFFAOYSA-N	163509	US9687479, 299 1-(1,3-benzothiazol-2-yl)-N-[(4-fluorophenyl)methyl]-3-(pyridin-2-yl)-1H-1,2,4-triazol-5-amine	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163509	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163509&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081367	363890835							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469205	CC(C)(C)C(=O)n1nc(nc1NCc1ccc(F)cc1)-c1ccco1	InChI=1S/C18H19FN4O2/c1-18(2,3)16(24)23-17(20-11-12-6-8-13(19)9-7-12)21-15(22-23)14-5-4-10-25-14/h4-10H,11H2,1-3H3,(H,20,21,22)	JSEBPJRQHLVPRC-UHFFFAOYSA-N	163512	US9687479, 300 1-(5-[(4-fluorophenyl)methyl]amino-3-(furan-2-yl)-1H-1,2,4-triazol-1-yl)-2,2-dimethylpropan-1-one	Plasma kallikrein			 55000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163512	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163512&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			23612712	363890836							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469206	CC(C)(C)C(=O)n1nc(nc1NCc1ccc(F)cc1)-c1ccccn1	InChI=1S/C19H20FN5O/c1-19(2,3)17(26)25-18(22-12-13-7-9-14(20)10-8-13)23-16(24-25)15-6-4-5-11-21-15/h4-11H,12H2,1-3H3,(H,22,23,24)	YXPRTMWKIGRBPY-UHFFFAOYSA-N	163513	US9687479, 301 1-(5-[(4-fluorophenyl)methyl]amino-3-(pyridin-2-yl)-1H-1,2,4-triazol-1-yl)-2,2-dimethylpropan-1-one	Plasma kallikrein			 55000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163513	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163513&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081368	363890837							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469207	CC(C)C(=O)n1nc(nc1NCc1ccc(F)cc1)-c1ccccn1	InChI=1S/C18H18FN5O/c1-12(2)17(25)24-18(21-11-13-6-8-14(19)9-7-13)22-16(23-24)15-5-3-4-10-20-15/h3-10,12H,11H2,1-2H3,(H,21,22,23)	JJBCWWGLFWYYKV-UHFFFAOYSA-N	163515	US9687479, 302 1-(5-[(4-fluorophenyl)methyl]amino-3-(pyridin-2-yl)-1H-1,2,4-triazol-1-yl)-2-methylpropan-1-one	Plasma kallikrein			 55000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163515	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163515&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081369	363890838							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469208	CC(C)(C(=O)n1nc(nc1NCc1ccc(F)cc1)-c1ccccn1)c1ccccc1	InChI=1S/C24H22FN5O/c1-24(2,18-8-4-3-5-9-18)22(31)30-23(27-16-17-11-13-19(25)14-12-17)28-21(29-30)20-10-6-7-15-26-20/h3-15H,16H2,1-2H3,(H,27,28,29)	QRUPMGNJYVCZTJ-UHFFFAOYSA-N	163516	US9687479, 303 1-(5-[(4-fluorophenyl)methyl]amino-3-(pyridin-2-yl)-1H-1,2,4-triazol-1-yl)-2-phenylethan-1-one	Plasma kallikrein			 5500					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163516	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163516&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081370	363890839							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469209	CC(C)CC(=O)n1nc(nc1NCc1ccc(F)cc1)-c1ccccn1	InChI=1S/C19H20FN5O/c1-13(2)11-17(26)25-19(22-12-14-6-8-15(20)9-7-14)23-18(24-25)16-5-3-4-10-21-16/h3-10,13H,11-12H2,1-2H3,(H,22,23,24)	HZHJEJZGZKPGKG-UHFFFAOYSA-N	163517	US9687479, 304 1-(5-[(4-fluorophenyl)methyl]amino-3-(pyridin-2-yl)-1H-1,2,4-triazol-1-yl)-3-methylbutan-1-one	Plasma kallikrein			 55000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163517	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163517&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081371	363890840							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469210	Fc1ccc(CNc2nc(nn2C(=O)CCc2ccccc2)-c2ccccn2)cc1	InChI=1S/C23H20FN5O/c24-19-12-9-18(10-13-19)16-26-23-27-22(20-8-4-5-15-25-20)28-29(23)21(30)14-11-17-6-2-1-3-7-17/h1-10,12-13,15H,11,14,16H2,(H,26,27,28)	RVZDABPUQLQWBF-UHFFFAOYSA-N	163519	US9687479, 305 1-(5-[(4-fluorophenyl)methyl]amino-3-(pyridin-2-yl)-1H-1,2,4-triazol-1-yl)-3-phenylpropan-1-one	Plasma kallikrein			 55000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163519	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163519&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081372	363890841							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469211	CCCC(=O)n1nc(nc1NCc1ccc(F)cc1)-c1ccccn1	InChI=1S/C18H18FN5O/c1-2-5-16(25)24-18(21-12-13-7-9-14(19)10-8-13)22-17(23-24)15-6-3-4-11-20-15/h3-4,6-11H,2,5,12H2,1H3,(H,21,22,23)	YNHHXWUXGOCAAU-UHFFFAOYSA-N	163520	US9687479, 306 1-(5-[(4-fluorophenyl)methyl]amino-3-(pyridin-2-yl)-1H-1,2,4-triazol-1-yl)butan-1-one	Plasma kallikrein			 55000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163520	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163520&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081373	363890842							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469212	CCC(=O)n1nc(nc1NCc1ccc(F)cc1)-c1ccccn1	InChI=1S/C17H16FN5O/c1-2-15(24)23-17(20-11-12-6-8-13(18)9-7-12)21-16(22-23)14-5-3-4-10-19-14/h3-10H,2,11H2,1H3,(H,20,21,22)	DRWGWPOWNIGMME-UHFFFAOYSA-N	163522	US9687479, 307 1-(5-[(4-fluorophenyl)methyl]amino-3-(pyridin-2-yl)-1H-1,2,4-triazol-1-yl)propan-1-one	Plasma kallikrein			 55000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163522	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163522&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123221672	363890843							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469213	CC(C)(C)C(=O)n1nc(nc1NCc1ccc(F)cc1)-c1cccnc1	InChI=1S/C19H20FN5O/c1-19(2,3)17(26)25-18(22-11-13-6-8-15(20)9-7-13)23-16(24-25)14-5-4-10-21-12-14/h4-10,12H,11H2,1-3H3,(H,22,23,24)	HSDXUHIFNBXJJY-UHFFFAOYSA-N	163523	US9687479, 308 1-(5-[(4-fluorophenyl)methyl]amino-3-(pyridin-3-yl)-1H-1,2,4-triazol-1-yl)-2,2-dimethylpropan-1-one	Plasma kallikrein			 55000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163523	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163523&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081374	363890844							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469214	COCC(=O)n1nc(nc1NCc1ccc(F)cc1)-c1cccnc1	InChI=1S/C17H16FN5O2/c1-25-11-15(24)23-17(20-9-12-4-6-14(18)7-5-12)21-16(22-23)13-3-2-8-19-10-13/h2-8,10H,9,11H2,1H3,(H,20,21,22)	YAHYOIPVVQQKNV-UHFFFAOYSA-N	163525	US9687479, 309 1-(5-[(4-fluorophenyl)methyl]amino-3-(pyridin-3-yl)-1H-1,2,4-triazol-1-yl)-2-methoxyethan-1-one	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163525	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163525&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			3610385	363890845							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469215	CC(C)C(=O)n1nc(nc1NCc1ccc(F)cc1)-c1cccnc1	InChI=1S/C18H18FN5O/c1-12(2)17(25)24-18(21-10-13-5-7-15(19)8-6-13)22-16(23-24)14-4-3-9-20-11-14/h3-9,11-12H,10H2,1-2H3,(H,21,22,23)	YPCJTDICOPOBBN-UHFFFAOYSA-N	33791	1-[5-[(4-fluorobenzyl)amino]-3-(3-pyridyl)-1,2,4-triazol-1-yl]-2-methyl-propan-1-one::1-[5-[(4-fluorophenyl)methylamino]-3-(3-pyridinyl)-1,2,4-triazol-1-yl]-2-methyl-1-propanone::1-[5-[(4-fluorophenyl)methylamino]-3-pyridin-3-yl-1,2,4-triazol-1-yl]-2-methyl-propan-1-one::1-[5-[(4-fluorophenyl)methylamino]-3-pyridin-3-yl-1,2,4-triazol-1-yl]-2-methylpropan-1-one::MLS000719021::SMR000291289::US9687479, 315 1-(5-[(4-fluorophenyl)methyl]amino-3-(pyridin-4-yl)-1H-1,2,4-triazol-1-yl)-2-methylpropan-1-one::cid_3934876	Plasma kallikrein			 55000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=33791	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=33791&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			3934876	252616691						ZINC05002131	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469216	Fc1ccc(CNc2nc(nn2C(=O)Cc2ccccc2)-c2cccnc2)cc1	InChI=1S/C22H18FN5O/c23-19-10-8-17(9-11-19)14-25-22-26-21(18-7-4-12-24-15-18)27-28(22)20(29)13-16-5-2-1-3-6-16/h1-12,15H,13-14H2,(H,25,26,27)	RORUCYPKDLSCNG-UHFFFAOYSA-N	163528	US9687479, 311 1-(5-[(4-fluorophenyl)methyl]amino-3-(pyridin-3-yl)-1H-1,2,4-triazol-1-yl)-2-phenylethan-1-one	Plasma kallikrein			 5500					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163528	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163528&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			3452314	363890847							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469217	CC(C)CC(=O)n1nc(nc1NCc1ccc(F)cc1)-c1cccnc1	InChI=1S/C19H20FN5O/c1-13(2)10-17(26)25-19(22-11-14-5-7-16(20)8-6-14)23-18(24-25)15-4-3-9-21-12-15/h3-9,12-13H,10-11H2,1-2H3,(H,22,23,24)	YNIBBMVQLONSJS-UHFFFAOYSA-N	163529	US9687479, 312 1-(5-[(4-fluorophenyl)methyl]amino-3-(pyridin-3-yl)-1H-1,2,4-triazol-1-yl)-3-methylbutan-1-one	Plasma kallikrein			 55000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163529	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163529&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			3476108	363890848							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469218	Fc1ccc(CNc2nc(nn2C(=O)CCc2ccccc2)-c2cccnc2)cc1	InChI=1S/C23H20FN5O/c24-20-11-8-18(9-12-20)15-26-23-27-22(19-7-4-14-25-16-19)28-29(23)21(30)13-10-17-5-2-1-3-6-17/h1-9,11-12,14,16H,10,13,15H2,(H,26,27,28)	BPDDZRPNPTWZCH-UHFFFAOYSA-N	163530	US9687479, 313 1-(5-[(4-fluorophenyl)methyl]amino-3-(pyridin-3-yl)-1H-1,2,4-triazol-1-yl)-3-phenylpropan-1-one	Plasma kallikrein			 55000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163530	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163530&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			3642821	363890849							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469219	CCCC(=O)n1nc(nc1NCc1ccc(F)cc1)-c1cccnc1	InChI=1S/C18H18FN5O/c1-2-4-16(25)24-18(21-11-13-6-8-15(19)9-7-13)22-17(23-24)14-5-3-10-20-12-14/h3,5-10,12H,2,4,11H2,1H3,(H,21,22,23)	USZXPZGQZBFJRB-UHFFFAOYSA-N	163532	US9687479, 314 1-(5-[(4-fluorophenyl)methyl]amino-3-(pyridin-3-yl)-1H-1,2,4-triazol-1-yl)butan-1-one	Plasma kallikrein			 55000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163532	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163532&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			3418675	363890850							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469220	CC(C)C(=O)n1nc(nc1NCc1ccc(F)cc1)-c1cccnc1	InChI=1S/C18H18FN5O/c1-12(2)17(25)24-18(21-10-13-5-7-15(19)8-6-13)22-16(23-24)14-4-3-9-20-11-14/h3-9,11-12H,10H2,1-2H3,(H,21,22,23)	YPCJTDICOPOBBN-UHFFFAOYSA-N	33791	1-[5-[(4-fluorobenzyl)amino]-3-(3-pyridyl)-1,2,4-triazol-1-yl]-2-methyl-propan-1-one::1-[5-[(4-fluorophenyl)methylamino]-3-(3-pyridinyl)-1,2,4-triazol-1-yl]-2-methyl-1-propanone::1-[5-[(4-fluorophenyl)methylamino]-3-pyridin-3-yl-1,2,4-triazol-1-yl]-2-methyl-propan-1-one::1-[5-[(4-fluorophenyl)methylamino]-3-pyridin-3-yl-1,2,4-triazol-1-yl]-2-methylpropan-1-one::MLS000719021::SMR000291289::US9687479, 315 1-(5-[(4-fluorophenyl)methyl]amino-3-(pyridin-4-yl)-1H-1,2,4-triazol-1-yl)-2-methylpropan-1-one::cid_3934876	Plasma kallikrein			 55000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=33791	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=33791&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			3934876	252616691						ZINC05002131	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469221	CC(C)CC(=O)n1nc(nc1NCc1ccc(F)cc1)-c1ccncc1	InChI=1S/C19H20FN5O/c1-13(2)11-17(26)25-19(22-12-14-3-5-16(20)6-4-14)23-18(24-25)15-7-9-21-10-8-15/h3-10,13H,11-12H2,1-2H3,(H,22,23,24)	NLXQEROCZURREY-UHFFFAOYSA-N	163536	US9687479, 316 1-(5-[(4-fluorophenyl)methyl]amino-3-(pyridin-4-yl)-1H-1,2,4-triazol-1-yl)-3-methylbutan-1-one	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163536	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163536&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081375	363890852							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469222	CCCC(=O)n1nc(nc1NCc1ccc(F)cc1)-c1ccncc1	InChI=1S/C18H18FN5O/c1-2-3-16(25)24-18(21-12-13-4-6-15(19)7-5-13)22-17(23-24)14-8-10-20-11-9-14/h4-11H,2-3,12H2,1H3,(H,21,22,23)	DVYXAGOGYXEAOY-UHFFFAOYSA-N	163537	US9687479, 317 1-(5-[(4-fluorophenyl)methyl]amino-3-(pyridin-4-yl)-1H-1,2,4-triazol-1-yl)butan-1-one	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163537	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163537&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081376	363890853							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469223	CCC(=O)n1nc(nc1NCc1ccc(F)cc1)-c1ccncc1	InChI=1S/C17H16FN5O/c1-2-15(24)23-17(20-11-12-3-5-14(18)6-4-12)21-16(22-23)13-7-9-19-10-8-13/h3-10H,2,11H2,1H3,(H,20,21,22)	GQSGYXWMAAUGAK-UHFFFAOYSA-N	163538	US9687479, 318 1-(5-[(4-fluorophenyl)methyl]amino-3-(pyridin-4-yl)-1H-1,2,4-triazol-1-yl)propan-1-one	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163538	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163538&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081377	363890854							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469224	COc1ccc(CNc2nc(nn2C(=O)C(C)(C)C)-c2ccccn2)cc1	InChI=1S/C20H23N5O2/c1-20(2,3)18(26)25-19(22-13-14-8-10-15(27-4)11-9-14)23-17(24-25)16-7-5-6-12-21-16/h5-12H,13H2,1-4H3,(H,22,23,24)	VIDTVJXJNNXQMK-UHFFFAOYSA-N	163539	US9687479, 319 1-(5-[(4-methoxyphenyl)methyl]amino-3-(pyridin-2-yl)-1H-1,2,4-triazol-1-yl)-2,2-dimethylpropan-1-one	Plasma kallikrein			 55000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163539	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163539&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081378	363890855							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469225	COc1ccc(CNc2nc(nn2C(=O)C(C)C)-c2ccccn2)cc1	InChI=1S/C19H21N5O2/c1-13(2)18(25)24-19(21-12-14-7-9-15(26-3)10-8-14)22-17(23-24)16-6-4-5-11-20-16/h4-11,13H,12H2,1-3H3,(H,21,22,23)	HROQRMWAZXBYNQ-UHFFFAOYSA-N	163540	US9687479, 320 1-(5-[(4-methoxyphenyl)methyl]amino-3-(pyridin-2-yl)-1H-1,2,4-triazol-1-yl)-2-methylpropan-1-one	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163540	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163540&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081379	363890856							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469226	COc1ccc(CNc2nc(nn2C(=O)Cc2ccccc2)-c2ccccn2)cc1	InChI=1S/C23H21N5O2/c1-30-19-12-10-18(11-13-19)16-25-23-26-22(20-9-5-6-14-24-20)27-28(23)21(29)15-17-7-3-2-4-8-17/h2-14H,15-16H2,1H3,(H,25,26,27)	MXTNAKIZZDYJRP-UHFFFAOYSA-N	163541	US9687479, 321 1-(5-[(4-methoxyphenyl)methyl]amino-3-(pyridin-2-yl)-1H-1,2,4-triazol-1-yl)-2-phenylethan-1-one	Plasma kallikrein			 55000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163541	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163541&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081380	363890857							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477103	CCn1c(Cc2ccccc2)c(C)cc1C(=O)NCc1ccc(CN)cc1	InChI=1S/C23H27N3O/c1-3-26-21(14-18-7-5-4-6-8-18)17(2)13-22(26)23(27)25-16-20-11-9-19(15-24)10-12-20/h4-13H,3,14-16,24H2,1-2H3,(H,25,27)	SJUHCJNXJPBLHB-UHFFFAOYSA-N	186912	US9670157, 78 5-Benzyl-4-methyl-1-propyl-1H-pyrrole-2-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 77	Plasma kallikrein			 4133							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186912	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186912&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280100	373987479							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477104	CC(C)NC(=O)c1ccc(Cn2cc(cn2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C23H27N5O2/c1-16(2)27-23(30)20-9-7-19(8-10-20)14-28-15-21(13-26-28)22(29)25-12-18-5-3-17(11-24)4-6-18/h3-10,13,15-16H,11-12,14,24H2,1-2H3,(H,25,29)(H,27,30)	GUERQUBALZWKPI-UHFFFAOYSA-N	186913	US9670157, 79 1-(4-Isopropylcarbamoyl-benzyl)-1H-pyrazole-4-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 79	Plasma kallikrein			 5546							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186913	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186913&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90281707	373987480							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477105	Cc1c(cnn1Cc1csc(n1)-c1ccccc1)C(=O)NCc1ccc(CN)cc1	InChI=1S/C23H23N5OS/c1-16-21(22(29)25-12-18-9-7-17(11-24)8-10-18)13-26-28(16)14-20-15-30-23(27-20)19-5-3-2-4-6-19/h2-10,13,15H,11-12,14,24H2,1H3,(H,25,29)	FFETVVLFKYPIEY-UHFFFAOYSA-N	186914	US9670157, 80 5-Methyl-1-(2-phenyl-thiazol-4-ylmethyl)-1H-pyrazole-4-carboxylicacid 4-aminomethyl-benzylamide::US9834513, 80	Plasma kallikrein			 2340							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186914	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186914&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280087	373987481							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477106	Cc1nn(Cc2csc(n2)-c2ccccc2)cc1C(=O)NCc1ccc(CN)cc1	InChI=1S/C23H23N5OS/c1-16-21(22(29)25-12-18-9-7-17(11-24)8-10-18)14-28(27-16)13-20-15-30-23(26-20)19-5-3-2-4-6-19/h2-10,14-15H,11-13,24H2,1H3,(H,25,29)	KJQLRTOJIBPKRC-UHFFFAOYSA-N	186915	US9670157, 81 3-Methyl-1-(2-phenyl-thiazol-4-ylmethyl)-1H-pyrazole-4-carboxylicacid 4-aminomethyl-benzylamide::US9834513, 81	Plasma kallikrein			 695							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186915	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186915&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280108	373987482							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477107	NCc1ccc(CNC(=O)c2cnn(Cc3csc(n3)-c3ccccc3)c2C(F)(F)F)cc1	InChI=1S/C23H20F3N5OS/c24-23(25,26)20-19(21(32)28-11-16-8-6-15(10-27)7-9-16)12-29-31(20)13-18-14-33-22(30-18)17-4-2-1-3-5-17/h1-9,12,14H,10-11,13,27H2,(H,28,32)	ZOGFWBZPASWNGT-UHFFFAOYSA-N	186916	US9670157, 82 1-(2-Phenyl-thiazol-4-ylmethyl)-5-trifluoromethyl-1H-pyrazole-4-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 82	Plasma kallikrein			 488							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186916	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186916&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280110	373987483							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477108	NCc1ccc(CNC(=O)c2cn(Cc3csc(n3)-c3ccccc3)nc2C(F)(F)F)cc1	InChI=1S/C23H20F3N5OS/c24-23(25,26)20-19(21(32)28-11-16-8-6-15(10-27)7-9-16)13-31(30-20)12-18-14-33-22(29-18)17-4-2-1-3-5-17/h1-9,13-14H,10-12,27H2,(H,28,32)	XKNWUHBAMSZYGY-UHFFFAOYSA-N	186917	US9670157, 83 1-(2-Phenyl-thiazol-4-ylmethyl)-3-trifluoromethyl-1H-pyrazole-4-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 83	Plasma kallikrein			 452							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186917	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186917&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280225	373987484							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477109	NCc1ccc(CNC(=O)c2cn(Cc3ccccc3)nc2-c2ccccc2)cc1	InChI=1S/C25H24N4O/c26-15-19-11-13-20(14-12-19)16-27-25(30)23-18-29(17-21-7-3-1-4-8-21)28-24(23)22-9-5-2-6-10-22/h1-14,18H,15-17,26H2,(H,27,30)	WADOCDNXVIYFEL-UHFFFAOYSA-N	186918	US9670157, 84 1-Benzyl-3-phenyl-1H-pyrazole-4-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 84	Plasma kallikrein			 8379							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186918	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186918&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280333	373987485							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477110	Cc1cnn(Cc2ccc(Cn3cc(cn3)C(=O)NCc3ccc(CN)cc3)cc2)c1	InChI=1S/C24H26N6O/c1-18-11-27-29(14-18)15-21-6-8-22(9-7-21)16-30-17-23(13-28-30)24(31)26-12-20-4-2-19(10-25)3-5-20/h2-9,11,13-14,17H,10,12,15-16,25H2,1H3,(H,26,31)	HPJLQUVYLPKVEH-UHFFFAOYSA-N	186919	US9670157, 85 1-[4-(4-Methyl-pyrazol-1-ylmethyl)-benzyl]-1H-pyrazole-4-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 85	Plasma kallikrein			 11							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186919	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186919&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290349	373987486							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477111	Cc1cc(C)n(Cc2ccc(Cn3cc(cn3)C(=O)NCc3ccc(CN)cc3)cc2)n1	InChI=1S/C25H28N6O/c1-18-11-19(2)31(29-18)16-23-9-7-22(8-10-23)15-30-17-24(14-28-30)25(32)27-13-21-5-3-20(12-26)4-6-21/h3-11,14,17H,12-13,15-16,26H2,1-2H3,(H,27,32)	BWBYPOROCPLNGV-UHFFFAOYSA-N	186920	US9670157, 86 1-[4-(3,5-Dimethyl-pyrazol-1-ylmethyl)-benzyl]-1H-pyrazole-4-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 86	Plasma kallikrein			 7.00							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186920	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186920&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290350	373987487							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477112	NCc1ccc(CNC(=O)c2cnn(Cc3ccc(cc3)C(=O)N3CCCCC3)c2)cc1	InChI=1S/C25H29N5O2/c26-14-19-4-6-20(7-5-19)15-27-24(31)23-16-28-30(18-23)17-21-8-10-22(11-9-21)25(32)29-12-2-1-3-13-29/h4-11,16,18H,1-3,12-15,17,26H2,(H,27,31)	VRVDDLVGBPHXNP-UHFFFAOYSA-N	186921	US9670157, 87 1-[4-(Piperidine-1-carbonyl)-benzyl]-1H-pyrazole-4-carboxylicacid 4-aminomethyl-benzylamide::US9834513, 87	Plasma kallikrein			 5480							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186921	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186921&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280091	373987488							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477113	NCc1ccc(CNC(=O)c2ncn(Cc3ccc(Oc4ccccc4)cc3)n2)cc1	InChI=1S/C24H23N5O2/c25-14-18-6-8-19(9-7-18)15-26-24(30)23-27-17-29(28-23)16-20-10-12-22(13-11-20)31-21-4-2-1-3-5-21/h1-13,17H,14-16,25H2,(H,26,30)	SGIOOJDXIKXIQM-UHFFFAOYSA-N	186946	US9670157, 88 1-(4-Phenoxy-benzyl)-1H-[1,2,4]triazole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 88	Plasma kallikrein			 6989							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186946	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186946&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280336	373987489							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477114	NC1(CC1)c1ccc(CNC(=O)c2cnn(Cc3ccc(Cn4ccccc4=O)cc3)c2)cc1	InChI=1S/C27H27N5O2/c28-27(12-13-27)24-10-8-20(9-11-24)15-29-26(34)23-16-30-32(19-23)18-22-6-4-21(5-7-22)17-31-14-2-1-3-25(31)33/h1-11,14,16,19H,12-13,15,17-18,28H2,(H,29,34)	MTPSFLBOMANTAH-UHFFFAOYSA-N	186947	US9670157, 89 1-[4-(2-Oxo-2H-pyridin-1-ylmethyl)-benzyl]-1H-pyrazole-4-carboxylic acid 4-(1-amino-cyclopropyl)-benzylamide::US9834513, 89	Plasma kallikrein			 226							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186947	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186947&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280105	373987490							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477115	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1ccc(Cn2ccccc2=O)cc1	InChI=1S/C28H30N4O2/c1-20-15-26(28(34)30-17-23-8-6-22(16-29)7-9-23)21(2)32(20)19-25-12-10-24(11-13-25)18-31-14-4-3-5-27(31)33/h3-15H,16-19,29H2,1-2H3,(H,30,34)	KVCQGKXGOOUPLT-UHFFFAOYSA-N	186948	US9670157, 90 2,5-Dimethyl-1-[4-(2-oxo-2H-pyridin-1-ylmethyl)-benzyl]-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 90	Plasma kallikrein			 114							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186948	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186948&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290351	373987491							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477116	Cc1cc(C(=O)NCc2ccc(CN)cc2C)c(C)n1Cc1ccc(Cn2ccccc2=O)cc1	InChI=1S/C29H32N4O2/c1-20-14-25(16-30)11-12-26(20)17-31-29(35)27-15-21(2)33(22(27)3)19-24-9-7-23(8-10-24)18-32-13-5-4-6-28(32)34/h4-15H,16-19,30H2,1-3H3,(H,31,35)	LJVGJJDTMUPYFI-UHFFFAOYSA-N	186949	US9670157, 91 2,5-Dimethyl-1-[4-(2-oxo-2H-pyridin-1-ylmethyl)-benzyl]-1H-pyrrole-3-carboxylic acid 4-aminomethyl-2-methyl-benzylamide::US9834513, 91	Plasma kallikrein			 29							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186949	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186949&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290390	373987492							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477117	CCn1c(Cc2ccc(Cn3ccccc3=O)cc2)c(C)cc1C(=O)NCc1ccc(CN)cc1C	InChI=1S/C30H34N4O2/c1-4-34-27(17-23-8-10-24(11-9-23)20-33-14-6-5-7-29(33)35)22(3)16-28(34)30(36)32-19-26-13-12-25(18-31)15-21(26)2/h5-16H,4,17-20,31H2,1-3H3,(H,32,36)	WERWYUINAJCXQE-UHFFFAOYSA-N	186950	US9670157, 92 1-Ethyl-4-methyl-5-[4-(2-oxo-2H-pyridin-1-ylmethyl)-benzyl]-1H-pyrrole-2-carboxylic acid 4-aminomethyl-2-methyl-benzylamide::US9834513, 92	Plasma kallikrein			 40							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186950	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186950&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290391	373987493							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477118	CCn1c(Cc2ccc(Cn3ccccc3=O)cc2)c(C)cc1C(=O)NCc1ccc(cc1)C1(N)CC1	InChI=1S/C31H34N4O2/c1-3-35-27(19-23-7-9-25(10-8-23)21-34-17-5-4-6-29(34)36)22(2)18-28(35)30(37)33-20-24-11-13-26(14-12-24)31(32)15-16-31/h4-14,17-18H,3,15-16,19-21,32H2,1-2H3,(H,33,37)	OGIRNMXNFGBTMG-UHFFFAOYSA-N	186951	US9670157, 93 1-Ethyl-4-methyl-5-[4-(2-oxo-2H-pyridin-1-ylmethyl)-benzyl]-1H-pyrrole-2-carboxylic acid 4-(1-amino-cyclopropyl)-benzylamide::US9834513, 93	Plasma kallikrein			 2845							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186951	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186951&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126614054	373987494							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477119	Cc1cc(C(=O)NCc2c(C)cc(CN)cc2C)c(C)n1Cc1ccc(Cn2ccccc2=O)cc1	InChI=1S/C30H34N4O2/c1-20-13-26(16-31)14-21(2)28(20)17-32-30(36)27-15-22(3)34(23(27)4)19-25-10-8-24(9-11-25)18-33-12-6-5-7-29(33)35/h5-15H,16-19,31H2,1-4H3,(H,32,36)	DNOYFEGEXZEIGB-UHFFFAOYSA-N	186952	US9670157, 94 2,5-Dimethyl-1-[4-(2-oxo-2H-pyridin-1-ylmethyl)-benzyl]-1H-pyrrole-3-carboxylic acid 4-aminomethyl-2,6-dimethyl-benzylamide::US9834513, 94	Plasma kallikrein			 11							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186952	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186952&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290392	373987495							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477120	CCc1c(Cc2ccc(Cn3ccccc3=O)cc2)c(C)cc1C(=O)NCc1c(C)cc(CN)cc1C	InChI=1S/C32H36N3O2/c1-5-27-28(17-24-9-11-25(12-10-24)20-35-13-7-6-8-31(35)36)23(4)16-29(27)32(37)34-19-30-21(2)14-26(18-33)15-22(30)3/h6-16H,5,17-20,33H2,1-4H3,(H,34,37)	HRFOXVIRWJKZIA-UHFFFAOYSA-N	186954	US9670157, 95 1-Ethyl-4-methyl-5-[4-(2-oxo-2H-pyridin-1-ylmethyl)-benzyl]-1H-pyrrole-2-carboxylic acid 4-aminomethyl-2,6-dimethyl-benzylamide	Plasma kallikrein			 16							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186954	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186954&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134128256	373987496							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477121	Cc1cnn(Cc2ccc(Cn3c(C)cc(C(=O)NCc4ccc(CN)cc4)c3C)cc2)c1	InChI=1S/C27H31N5O/c1-19-14-30-31(16-19)17-24-8-10-25(11-9-24)18-32-20(2)12-26(21(32)3)27(33)29-15-23-6-4-22(13-28)5-7-23/h4-12,14,16H,13,15,17-18,28H2,1-3H3,(H,29,33)	ZQYKZHHAAMTVKK-UHFFFAOYSA-N	186955	US9670157, 96 2,5-Dimethyl-1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 96	Plasma kallikrein			 63							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186955	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186955&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290636	373987497							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477122	Cc1cnn(Cc2ccc(Cn3c(C)cc(C(=O)NCc4ccc(CN)cc4C)c3C)cc2)c1	InChI=1S/C28H33N5O/c1-19-14-31-32(16-19)17-23-5-7-24(8-6-23)18-33-21(3)12-27(22(33)4)28(34)30-15-26-10-9-25(13-29)11-20(26)2/h5-12,14,16H,13,15,17-18,29H2,1-4H3,(H,30,34)	PRNAVRPSAWUWHK-UHFFFAOYSA-N	186956	US9670157, 97 2,5-Dimethyl-1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-1H-pyrrole-3-carboxylic acid 4-aminomethyl-2-methyl-benzylamide::US9834513, 97	Plasma kallikrein			 28							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186956	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186956&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290394	373987498							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477123	Cc1cnn(Cc2ccc(Cn3c(C)cc(C(=O)NCc4ccc(cc4)C4(N)CC4)c3C)cc2)c1	InChI=1S/C29H33N5O/c1-20-15-32-33(17-20)18-24-4-6-25(7-5-24)19-34-21(2)14-27(22(34)3)28(35)31-16-23-8-10-26(11-9-23)29(30)12-13-29/h4-11,14-15,17H,12-13,16,18-19,30H2,1-3H3,(H,31,35)	ZGUGDENZORCLQB-UHFFFAOYSA-N	186958	US9670157, 98 2,5-Dimethyl-1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-1H-pyrrole-3-carboxylic acid 4-(1-amino-cyclopropyl)-benzylamide::US9834513, 98	Plasma kallikrein			 701							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186958	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186958&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126614077	373987499							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477124	CCc1c(cc(C)n1Cc1ccc(Cn2cc(C)cn2)cc1)C(=O)NCc1ccc(CN)cc1C	InChI=1S/C29H35N5O/c1-5-28-27(29(35)31-16-26-11-10-25(14-30)12-21(26)3)13-22(4)34(28)19-24-8-6-23(7-9-24)18-33-17-20(2)15-32-33/h6-13,15,17H,5,14,16,18-19,30H2,1-4H3,(H,31,35)	XUYXTDFGUCHHPW-UHFFFAOYSA-N	186959	US9670157, 99 1-Ethyl-4-methyl-5-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-1H-pyrrole-2-carboxylic acid 4-aminomethyl-2-methyl-benzylamide	Plasma kallikrein			 38							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186959	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186959&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134128257	373987500							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477125	CCc1c(cc(C)n1Cc1ccc(Cn2cc(C)cn2)cc1)C(=O)NCc1ccc(cc1)C1(N)CC1	InChI=1S/C30H35N5O/c1-4-28-27(29(36)32-17-23-9-11-26(12-10-23)30(31)13-14-30)15-22(3)35(28)20-25-7-5-24(6-8-25)19-34-18-21(2)16-33-34/h5-12,15-16,18H,4,13-14,17,19-20,31H2,1-3H3,(H,32,36)	FFVCMVUDNLQISO-UHFFFAOYSA-N	187086	US9670157, 100 1-Ethyl-4-methyl-5-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-1H-pyrrole-2-carboxylic acid 4-(1-amino-cyclopropyl)-benzylamide	Plasma kallikrein			 2321							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=187086	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=187086&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134128258	373987501							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477126	Cc1cnn(Cc2ccc(Cn3c(C)cc(C(=O)NCc4c(C)cc(CN)cc4C)c3C)cc2)c1	InChI=1S/C29H35N5O/c1-19-14-32-33(16-19)17-24-6-8-25(9-7-24)18-34-22(4)12-27(23(34)5)29(35)31-15-28-20(2)10-26(13-30)11-21(28)3/h6-12,14,16H,13,15,17-18,30H2,1-5H3,(H,31,35)	CRSNMWANUJQZPT-UHFFFAOYSA-N	187087	US9670157, 101 2,5-Dimethyl-1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-1H-pyrrole-3-carboxylic acid 4-aminomethyl-2,6-dimethyl-benzylamide::US9834513, 101	Plasma kallikrein			 4.00							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=187087	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=187087&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290436	373987502							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477127	CCn1c(cc(C)c1Cc1ccc(Cn2cc(C)cn2)cc1)C(=O)NCc1c(C)cc(CN)cc1C	InChI=1S/C30H37N5O/c1-6-35-28(14-24-7-9-25(10-8-24)19-34-18-20(2)16-33-34)23(5)13-29(35)30(36)32-17-27-21(3)11-26(15-31)12-22(27)4/h7-13,16,18H,6,14-15,17,19,31H2,1-5H3,(H,32,36)	IJDZNHRRDCMJBE-UHFFFAOYSA-N	187088	US9670157, 102 1-Ethyl-4-methyl-5-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-1H-pyrrole-2-carboxylic acid 4-aminomethyl-2,6-dimethyl-benzylamide::US9834513, 102	Plasma kallikrein			 11							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=187088	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=187088&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290437	373987503							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477128	CC1C(C=NN1Cc1ccc(Cn2cc(C)cn2)cc1)C(=O)NCc1ccc(cc1)C1(N)CC1	InChI=1S/C27H32N6O/c1-19-13-30-32(16-19)17-22-3-5-23(6-4-22)18-33-20(2)25(15-31-33)26(34)29-14-21-7-9-24(10-8-21)27(28)11-12-27/h3-10,13,15-16,20,25H,11-12,14,17-18,28H2,1-2H3,(H,29,34)	LDEAUWUKTOVHRU-UHFFFAOYSA-N	187089	US9670157, 103 1-[4-(4-Methyl-pyrazol-1-ylmethyl)-benzyl]-1H-pyrazole-4-carboxylic acid 4-(1-amino-cyclopropyl)-benzylamide	Plasma kallikrein			 694							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=187089	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=187089&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134128259	373987504							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477129	Cc1cnn(Cc2ccc(Cn3cnc(c3)C(=O)NCc3ccc(CN)cc3)cc2)c1	InChI=1S/C24H26N6O/c1-18-11-28-30(13-18)15-22-8-6-21(7-9-22)14-29-16-23(27-17-29)24(31)26-12-20-4-2-19(10-25)3-5-20/h2-9,11,13,16-17H,10,12,14-15,25H2,1H3,(H,26,31)	XWRFLHKXCPPUJD-UHFFFAOYSA-N	187090	US9670157, 104 1-[4-(4-Methyl-pyrazol-1-ylmethyl)-benzyl]-1H-imidazole-4-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 104	Plasma kallikrein			 30							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=187090	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=187090&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290438	373987505							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477130	Cc1cnn(Cc2ccc(Cn3cnc(c3)C(=O)NCc3ccc(cc3)C3(N)CC3)cc2)c1	InChI=1S/C26H28N6O/c1-19-12-30-32(14-19)16-22-4-2-21(3-5-22)15-31-17-24(29-18-31)25(33)28-13-20-6-8-23(9-7-20)26(27)10-11-26/h2-9,12,14,17-18H,10-11,13,15-16,27H2,1H3,(H,28,33)	GGTIQPJNKCQXGL-UHFFFAOYSA-N	187091	US9670157, 105 1-[4-(4-Methyl-pyrazol-1-ylmethyl)-benzyl]-1H-imidazole-4-carboxylic acid 4-(1-amino-cyclopropyl)-benzylamide::US9834513, 105	Plasma kallikrein			 941							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=187091	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=187091&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126614033	373987506							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477131	Cc1cnn(Cc2ccc(Cn3cc(cn3)C(=O)NCc3ccc(CN)cc3C)cc2)c1	InChI=1S/C25H28N6O/c1-18-11-28-30(14-18)15-20-3-5-21(6-4-20)16-31-17-24(13-29-31)25(32)27-12-23-8-7-22(10-26)9-19(23)2/h3-9,11,13-14,17H,10,12,15-16,26H2,1-2H3,(H,27,32)	KMRPNZXNLYKBNI-UHFFFAOYSA-N	187092	US9670157, 106 1-[4-(4-Methyl-pyrazol-1-ylmethyl)-benzyl]-1H-pyrazole-4-carboxylic acid 4-aminomethyl-2-methyl-benzylamide::US9834513, 106	Plasma kallikrein			 2.00							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=187092	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=187092&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290439	373987507							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477132	Cc1cnn(Cc2ccc(Cn3cnc(c3)C(=O)NCc3ccc(CN)cc3C)cc2)c1	InChI=1S/C25H28N6O/c1-18-11-29-31(13-18)15-21-5-3-20(4-6-21)14-30-16-24(28-17-30)25(32)27-12-23-8-7-22(10-26)9-19(23)2/h3-9,11,13,16-17H,10,12,14-15,26H2,1-2H3,(H,27,32)	HNTAKOBIRREIDW-UHFFFAOYSA-N	187093	US9670157, 107 1-[4-(4-Methyl-pyrazol-1-ylmethyl)-benzyl]-1H-imidazole-4-carboxylic acid 4-aminomethyl-2-methyl-benzylamide::US9834513, 107	Plasma kallikrein			 3.00							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=187093	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=187093&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290440	373987508							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477133	Cc1cnn(Cc2ccc(Cn3cc(nn3)C(=O)NCc3ccc(CN)cc3)cc2)c1	InChI=1S/C23H25N7O/c1-17-11-26-29(13-17)14-20-6-8-21(9-7-20)15-30-16-22(27-28-30)23(31)25-12-19-4-2-18(10-24)3-5-19/h2-9,11,13,16H,10,12,14-15,24H2,1H3,(H,25,31)	QYIHBTUUQFBDIT-UHFFFAOYSA-N	187094	US9670157, 108 1-[4-(4-Methyl-pyrazol-1-ylmethyl)-benzyl]-1H-[1,2,3]triazole-4-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 108	Plasma kallikrein			 33							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=187094	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=187094&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290480	373987509							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477134	Cc1cnn(Cc2ccc(Cn3cc(nn3)C(=O)NCc3ccc(CN)cc3C)cc2)c1	InChI=1S/C24H27N7O/c1-17-11-27-30(13-17)14-19-3-5-20(6-4-19)15-31-16-23(28-29-31)24(32)26-12-22-8-7-21(10-25)9-18(22)2/h3-9,11,13,16H,10,12,14-15,25H2,1-2H3,(H,26,32)	YJGCZOIOIYXKFC-UHFFFAOYSA-N	187095	US9670157, 109 1-[4-(4-Methyl-pyrazol-1-ylmethyl)-benzyl]-1H-[1,2,3]triazole-4-carboxylic acid 4-aminomethyl-2-methyl-benzylamide::US9834513, 109	Plasma kallikrein			 5.00							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=187095	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=187095&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290481	373987510							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477135	Cc1cnn(Cc2ccc(Cn3cc(nn3)C(=O)NCc3ccc(cc3)C3(N)CC3)cc2)c1	InChI=1S/C25H27N7O/c1-18-12-28-31(14-18)15-20-2-4-21(5-3-20)16-32-17-23(29-30-32)24(33)27-13-19-6-8-22(9-7-19)25(26)10-11-25/h2-9,12,14,17H,10-11,13,15-16,26H2,1H3,(H,27,33)	QMDVOIRCHJYCMU-UHFFFAOYSA-N	187096	US9670157, 110 1-[4-(4-Methyl-pyrazol-1-ylmethyl)-benzyl]-1H-[1,2,3]triazole-4-carboxylic acid 4-(1-amino-cyclopropyl)-benzylamide::US9834513, 110	Plasma kallikrein			 2584							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=187096	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=187096&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126614036	373987511							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477136	Cc1cnn(Cc2ccc(Cn3cc(cn3)C(=O)NCc3c(C)cc(CN)cc3C)cc2)c1	InChI=1S/C26H30N6O/c1-18-11-29-31(14-18)15-21-4-6-22(7-5-21)16-32-17-24(12-30-32)26(33)28-13-25-19(2)8-23(10-27)9-20(25)3/h4-9,11-12,14,17H,10,13,15-16,27H2,1-3H3,(H,28,33)	NVKWHXBTNJQAIY-UHFFFAOYSA-N	187097	US9670157, 111 1-[4-(4-Methyl-pyrazol-1-ylmethyl)-benzyl]-1H-pyrazole-4-carboxylic acid 4-aminomethyl-2,6-dimethyl-benzylamide::US9670157, 115 5-Methyl-1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-1H-pyrazole-4-carboxylic acid 4-aminomethyl-2,6-dimethyl-benzylamide::US9834513, 111	Plasma kallikrein			 1.00							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=187097	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=187097&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290482	373987512							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477137	Cc1cnn(Cc2ccc(Cn3cnc(c3)C(=O)NCc3c(C)cc(CN)cc3C)cc2)c1	InChI=1S/C26H30N6O/c1-18-11-30-32(13-18)15-22-6-4-21(5-7-22)14-31-16-25(29-17-31)26(33)28-12-24-19(2)8-23(10-27)9-20(24)3/h4-9,11,13,16-17H,10,12,14-15,27H2,1-3H3,(H,28,33)	SEKJKDZFHSHSNB-UHFFFAOYSA-N	187098	US9670157, 112 1-[4-(4-Methyl-pyrazol-1-ylmethyl)-benzyl]-1H-imidazole-4-carboxylic acid 4-aminomethyl-2,6-dimethyl-benzylamide::US9834513, 112	Plasma kallikrein			 2.00							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=187098	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=187098&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290483	373987513							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477138	Cc1cnn(Cc2ccc(Cn3cc(nn3)C(=O)NCc3c(C)cc(CN)cc3C)cc2)c1	InChI=1S/C25H29N7O/c1-17-11-28-31(13-17)14-20-4-6-21(7-5-20)15-32-16-24(29-30-32)25(33)27-12-23-18(2)8-22(10-26)9-19(23)3/h4-9,11,13,16H,10,12,14-15,26H2,1-3H3,(H,27,33)	TWZMQQMXQBBUHW-UHFFFAOYSA-N	187099	US9670157, 113 1-[4-(4-Methyl-pyrazol-1-ylmethyl)-benzyl]-1H-[1,2,3]triazole-4-carboxylic acid 4-aminomethyl-2,6-dimethyl-benzylamide::US9834513, 113	Plasma kallikrein			 2.00							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=187099	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=187099&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290484	373987514							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477139	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4c(C)cc(CN)cc4C)c(C)n3)cc2)c1	InChI=1S/C27H32N6O/c1-18-12-30-32(14-18)15-22-5-7-23(8-6-22)16-33-17-26(21(4)31-33)27(34)29-13-25-19(2)9-24(11-28)10-20(25)3/h5-10,12,14,17H,11,13,15-16,28H2,1-4H3,(H,29,34)	PGMCAGSURRYVFE-UHFFFAOYSA-N	187100	US9670157, 114 3-Methyl-1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-1H-pyrazole-4-carboxylic acid 4-aminomethyl-2,6-dimethyl-benzylamide::US9834513, 114	Plasma kallikrein			 0.60							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=187100	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=187100&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126614028	373987515							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477140	Cc1cnn(Cc2ccc(Cn3cc(cn3)C(=O)NCc3c(C)cc(CN)cc3C)cc2)c1	InChI=1S/C26H30N6O/c1-18-11-29-31(14-18)15-21-4-6-22(7-5-21)16-32-17-24(12-30-32)26(33)28-13-25-19(2)8-23(10-27)9-20(25)3/h4-9,11-12,14,17H,10,13,15-16,27H2,1-3H3,(H,28,33)	NVKWHXBTNJQAIY-UHFFFAOYSA-N	187097	US9670157, 111 1-[4-(4-Methyl-pyrazol-1-ylmethyl)-benzyl]-1H-pyrazole-4-carboxylic acid 4-aminomethyl-2,6-dimethyl-benzylamide::US9670157, 115 5-Methyl-1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-1H-pyrazole-4-carboxylic acid 4-aminomethyl-2,6-dimethyl-benzylamide::US9834513, 111	Plasma kallikrein			 8.00							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=187097	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=187097&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290482	373987512							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469227	COc1ccc(CNc2nc(nn2C(=O)CC(C)C)-c2ccccn2)cc1	InChI=1S/C20H23N5O2/c1-14(2)12-18(26)25-20(22-13-15-7-9-16(27-3)10-8-15)23-19(24-25)17-6-4-5-11-21-17/h4-11,14H,12-13H2,1-3H3,(H,22,23,24)	YQHGSZCBIHLXJR-UHFFFAOYSA-N	163542	US9687479, 322 1-(5-[(4-methoxyphenyl)methyl]amino-3-(pyridin-2-yl)-1H-1,2,4-triazol-1-yl)-3-methylbutan-1-one	Plasma kallikrein			 55000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163542	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163542&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081381	363890858							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469229	COc1ccc(CNc2nc(nn2C(=O)CCc2ccccc2)-c2ccccn2)cc1	InChI=1S/C24H23N5O2/c1-31-20-13-10-19(11-14-20)17-26-24-27-23(21-9-5-6-16-25-21)28-29(24)22(30)15-12-18-7-3-2-4-8-18/h2-11,13-14,16H,12,15,17H2,1H3,(H,26,27,28)	KKCIDLBRYQMWGB-UHFFFAOYSA-N	163544	US9687479, 323 1-(5-[(4-methoxyphenyl)methyl]amino-3-(pyridin-2-yl)-1H-1,2,4-triazol-1-yl)-3-phenylpropan-1-one	Plasma kallikrein			 5500					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163544	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163544&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			53491664	363890859							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469230	CCCC(=O)n1nc(nc1NCc1ccc(OC)cc1)-c1ccccn1	InChI=1S/C19H21N5O2/c1-3-6-17(25)24-19(21-13-14-8-10-15(26-2)11-9-14)22-18(23-24)16-7-4-5-12-20-16/h4-5,7-12H,3,6,13H2,1-2H3,(H,21,22,23)	XEMTVQBVUZTNTN-UHFFFAOYSA-N	163545	US9687479, 324 1-(5-[(4-methoxyphenyl)methyl]amino-3-(pyridin-2-yl)-1H-1,2,4-triazol-1-yl)butan-1-one	Plasma kallikrein			 55000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163545	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163545&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081382	363890860							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469231	CCC(=O)n1nc(nc1NCc1ccc(OC)cc1)-c1ccccn1	InChI=1S/C18H19N5O2/c1-3-16(24)23-18(20-12-13-7-9-14(25-2)10-8-13)21-17(22-23)15-6-4-5-11-19-15/h4-11H,3,12H2,1-2H3,(H,20,21,22)	CVJXSGABZNXHRA-UHFFFAOYSA-N	163546	US9687479, 325 1-(5-[(4-methoxyphenyl)methyl]amino-3-(pyridin-2-yl)-1H-1,2,4-triazol-1-yl)propan-1-one	Plasma kallikrein			 55000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163546	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163546&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081383	363890861							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469232	COc1ccc(CNc2nc(nn2C(=O)C(C)(C)C)-c2cccnc2)cc1	InChI=1S/C20H23N5O2/c1-20(2,3)18(26)25-19(22-12-14-7-9-16(27-4)10-8-14)23-17(24-25)15-6-5-11-21-13-15/h5-11,13H,12H2,1-4H3,(H,22,23,24)	CZBXTWZEUBAZSO-UHFFFAOYSA-N	163547	US9687479, 326 1-(5-[(4-methoxyphenyl)methyl]amino-3-(pyridin-3-yl)-1H-1,2,4-triazol-1-yl)-2,2-dimethylpropan-1-one	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163547	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163547&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081384	363890862							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469233	COc1ccc(CNc2nc(nn2C(=O)Cc2ccccc2)-c2cccnc2)cc1	InChI=1S/C23H21N5O2/c1-30-20-11-9-18(10-12-20)15-25-23-26-22(19-8-5-13-24-16-19)27-28(23)21(29)14-17-6-3-2-4-7-17/h2-13,16H,14-15H2,1H3,(H,25,26,27)	DPVVIIVCUOZEHJ-UHFFFAOYSA-N	163548	US9687479, 327 1-(5-[(4-methoxyphenyl)methyl]amino-3-(pyridin-3-yl)-1H-1,2,4-triazol-1-yl)-2-phenylethan-1-one	Plasma kallikrein			 55000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163548	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163548&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			3536686	363890863							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469234	COc1ccc(CNc2nc(nn2C(=O)CC(C)C)-c2cccnc2)cc1	InChI=1S/C20H23N5O2/c1-14(2)11-18(26)25-20(22-12-15-6-8-17(27-3)9-7-15)23-19(24-25)16-5-4-10-21-13-16/h4-10,13-14H,11-12H2,1-3H3,(H,22,23,24)	JGLZAGGMZRVTFO-UHFFFAOYSA-N	33865	1-[5-[(4-methoxyphenyl)methylamino]-3-(3-pyridinyl)-1,2,4-triazol-1-yl]-3-methyl-1-butanone::1-[5-[(4-methoxyphenyl)methylamino]-3-pyridin-3-yl-1,2,4-triazol-1-yl]-3-methyl-butan-1-one::1-[5-[(4-methoxyphenyl)methylamino]-3-pyridin-3-yl-1,2,4-triazol-1-yl]-3-methylbutan-1-one::3-methyl-1-[5-(p-anisylamino)-3-(3-pyridyl)-1,2,4-triazol-1-yl]butan-1-one::MLS000660758::N-(4-methoxybenzyl)-1-(3-methylbutanoyl)-3-pyridin-3-yl-1H-1,2,4-triazol-5-amine::SMR000310276::US9687479, 328 1-(5-[(4-methoxyphenyl)methyl]amino-3-(pyridin-3-yl)-1H-1,2,4-triazol-1-yl)-3-methylbutan-1-one::cid_3360319	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=33865	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=33865&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			3360319	252616763						ZINC04739984	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469235	COc1ccc(CNc2nc(nn2C(=O)CCc2ccccc2)-c2cccnc2)cc1	InChI=1S/C24H23N5O2/c1-31-21-12-9-19(10-13-21)16-26-24-27-23(20-8-5-15-25-17-20)28-29(24)22(30)14-11-18-6-3-2-4-7-18/h2-10,12-13,15,17H,11,14,16H2,1H3,(H,26,27,28)	POCWEUUPLMBFSJ-UHFFFAOYSA-N	163550	US9687479, 329 1-(5-[(4-methoxyphenyl)methyl]amino-3-(pyridin-3-yl)-1H-1,2,4-triazol-1-yl)-3-phenylpropan-1-one	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163550	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163550&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			3930952	363890865							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469236	CCCC(=O)n1nc(nc1NCc1ccc(OC)cc1)-c1cccnc1	InChI=1S/C19H21N5O2/c1-3-5-17(25)24-19(21-12-14-7-9-16(26-2)10-8-14)22-18(23-24)15-6-4-11-20-13-15/h4,6-11,13H,3,5,12H2,1-2H3,(H,21,22,23)	GPRVGNYBRCIJBM-UHFFFAOYSA-N	33811	1-[5-(p-anisylamino)-3-(3-pyridyl)-1,2,4-triazol-1-yl]butan-1-one::1-[5-[(4-methoxyphenyl)methylamino]-3-(3-pyridinyl)-1,2,4-triazol-1-yl]-1-butanone::1-[5-[(4-methoxyphenyl)methylamino]-3-pyridin-3-yl-1,2,4-triazol-1-yl]butan-1-one::MLS000719016::SMR000291284::US9687479, 330 1-(5-[(4-methoxyphenyl)methyl]amino-3-(pyridin-3-yl)-1H-1,2,4-triazol-1-yl)butan-1-one::cid_4007214	Plasma kallikrein			 55000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=33811	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=33811&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			4007214	252616711						ZINC05002123	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469237	CC(C)(C)C(=O)n1nc(nc1NCc1ccc(Cl)s1)C1CCCCO1	InChI=1S/C17H23ClN4O2S/c1-17(2,3)15(23)22-16(19-10-11-7-8-13(18)25-11)20-14(21-22)12-6-4-5-9-24-12/h7-8,12H,4-6,9-10H2,1-3H3,(H,19,20,21)	FWBLJBMXBIMXHG-UHFFFAOYSA-N	163553	US9687479, 331 1-(5-[(5-chlorothiophen-2-yl)methyl]amino-3-(oxolan-2-yl)-1H-1,2,4-triazol-1-yl)-2,2-dimethylpropan-1-one	Plasma kallikrein			 5500					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163553	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163553&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081385	363890866							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469239	COc1ccccc1C(=O)n1nc(nc1NCc1nccs1)-c1ccccn1	InChI=1S/C19H16N6O2S/c1-27-15-8-3-2-6-13(15)18(26)25-19(22-12-16-21-10-11-28-16)23-17(24-25)14-7-4-5-9-20-14/h2-11H,12H2,1H3,(H,22,23,24)	FTRPBLCXOADDPQ-UHFFFAOYSA-N	163554	US9687479, 332 1-[(2-methoxyphenyl)carbonyl]-3-(pyridin-2-yl)-N-(1,3-thiazol-2-ylmethyl)-1H-1,2,4-triazol-5-amine	Plasma kallikrein			 55000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163554	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163554&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081386	363890867							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469240	COc1ccccc1C(=O)n1nc(nc1NCc1nccs1)-c1ccccc1	InChI=1S/C20H17N5O2S/c1-27-16-10-6-5-9-15(16)19(26)25-20(22-13-17-21-11-12-28-17)23-18(24-25)14-7-3-2-4-8-14/h2-12H,13H2,1H3,(H,22,23,24)	VBFPXKDBGLUJQT-UHFFFAOYSA-N	163555	US9687479, 333 1-[(2-methoxyphenyl)carbonyl]-3-phenyl-N-(1,3-thiazol-2-ylmethyl)-1H-1,2,4-triazol-5-amine	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163555	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163555&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081387	363890868							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469241	COc1ccccc1C(=O)n1nc(nc1NCc1cccs1)-c1ccccc1	InChI=1S/C21H18N4O2S/c1-27-18-12-6-5-11-17(18)20(26)25-21(22-14-16-10-7-13-28-16)23-19(24-25)15-8-3-2-4-9-15/h2-13H,14H2,1H3,(H,22,23,24)	JPOQAZCPBZGOHE-UHFFFAOYSA-N	163556	US9687479, 334 1-[(2-methoxyphenyl)carbonyl]-3-phenyl-N-(thiophen-2-ylmethyl)-1H-1,2,4-triazol-5-amine	Plasma kallikrein			 55000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163556	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163556&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			2973889	363890869							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469242	COc1ccccc1C(=O)n1nc(nc1NCc1ccsc1)-c1ccccc1	InChI=1S/C21H18N4O2S/c1-27-18-10-6-5-9-17(18)20(26)25-21(22-13-15-11-12-28-14-15)23-19(24-25)16-7-3-2-4-8-16/h2-12,14H,13H2,1H3,(H,22,23,24)	WRLYCMMVJCFBNY-UHFFFAOYSA-N	163557	US9687479, 335 1-[(2-methoxyphenyl)carbonyl]-3-phenyl-N-(thiophen-3-ylmethyl)-1H-1,2,4-triazol-5-amine	Plasma kallikrein			 55000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163557	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163557&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081388	363890870							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469243	COc1ccc(CNc2nc(nn2C(=O)c2ccco2)-c2ccccn2)cc1	InChI=1S/C20H17N5O3/c1-27-15-9-7-14(8-10-15)13-22-20-23-18(16-5-2-3-11-21-16)24-25(20)19(26)17-6-4-12-28-17/h2-12H,13H2,1H3,(H,22,23,24)	RSYCIWYBXHHZNB-UHFFFAOYSA-N	163558	US9687479, 336 1-[(furan-2-yl)carbonyl]-N-[(4-methoxyphenyl)methyl]-3-(pyridin-2-yl)-1H-1,2,4-triazol-5-amine::US9687479, 379 N-[(4-methoxyphenyl)methyl]-3-(pyridin-2-yl)-1-[(thiophen-2-yl)carbonyl]-1H-1,2,4-triazol-5-amine	Plasma kallikrein			 5500					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163558	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163558&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081389	363890871							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469244	COc1ccc(CNc2nc(nn2C(=O)c2ccco2)-c2ccncc2)cc1	InChI=1S/C20H17N5O3/c1-27-16-6-4-14(5-7-16)13-22-20-23-18(15-8-10-21-11-9-15)24-25(20)19(26)17-3-2-12-28-17/h2-12H,13H2,1H3,(H,22,23,24)	OHJGWITXEGSJGI-UHFFFAOYSA-N	163559	US9687479, 337 1-[(furan-2-yl)carbonyl]-N-[(4-methoxyphenyl)methyl]-3-(pyridin-4-yl)-1H-1,2,4-triazol-5-amine	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163559	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163559&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081390	363890872							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469245	COc1ccc(CNc2nc(nn2C(=O)c2ccoc2)-c2ccccn2)cc1	InChI=1S/C20H17N5O3/c1-27-16-7-5-14(6-8-16)12-22-20-23-18(17-4-2-3-10-21-17)24-25(20)19(26)15-9-11-28-13-15/h2-11,13H,12H2,1H3,(H,22,23,24)	BVQGYCDMQASERH-UHFFFAOYSA-N	163560	US9687479, 338 1-[(furan-3-yl)carbonyl]-N-[(4-methoxyphenyl)methyl]-3-(pyridin-2-yl)-1H-1,2,4-triazol-5-amine::US9687479, 380 N-[(4-methoxyphenyl)methyl]-3-(pyridin-2-yl)-1-[(thiophen-3-yl)carbonyl]-1H-1,2,4-triazol-5-amine	Plasma kallikrein			 55000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163560	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163560&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			53491732	363890873							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469246	COc1ccc(CNc2nc(nn2C(=O)c2ccoc2)-c2cccnc2)cc1	InChI=1S/C20H17N5O3/c1-27-17-6-4-14(5-7-17)11-22-20-23-18(15-3-2-9-21-12-15)24-25(20)19(26)16-8-10-28-13-16/h2-10,12-13H,11H2,1H3,(H,22,23,24)	CCPCUQLAGBNCCW-UHFFFAOYSA-N	163563	US9687479, 339 1-[(furan-3-yl)carbonyl]-N-[(4-methoxyphenyl)methyl]-3-(pyridin-3-yl)-1H-1,2,4-triazol-5-amine::US9687479, 382 N-[(4-methoxyphenyl)methyl]-3-(pyridin-3-yl)-1-[(thiophen-3-yl)carbonyl]-1H-1,2,4-triazol-5-amine	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163563	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163563&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081391	363890874							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469247	CCC(=O)n1nc(nc1NCc1cccs1)-c1cccnc1	InChI=1S/C15H15N5OS/c1-2-13(21)20-15(17-10-12-6-4-8-22-12)18-14(19-20)11-5-3-7-16-9-11/h3-9H,2,10H2,1H3,(H,17,18,19)	USPONIIDTPKNCY-UHFFFAOYSA-N	33807	1-[3-(3-pyridinyl)-5-(thiophen-2-ylmethylamino)-1,2,4-triazol-1-yl]-1-propanone::1-[3-(3-pyridyl)-5-(2-thenylamino)-1,2,4-triazol-1-yl]propan-1-one::1-[3-pyridin-3-yl-5-(thiophen-2-ylmethylamino)-1,2,4-triazol-1-yl]propan-1-one::MLS000719010::SMR000291278::US9687479, 340 1-[3-(pyridin-3-yl)-5-[(thiophen-2-ylmethyl)amino]-1H-1,2,4-triazol-1-yl]propan-1-one::cid_3978169	Plasma kallikrein			 55000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=33807	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=33807&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			3978169	252616707						ZINC05002106	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469248	COc1ccccc1C(=O)n1nc(nc1NCc1ccc(Cl)s1)C1CCN(CC1)C(=O)C(C)(C)C	InChI=1S/C25H30ClN5O3S/c1-25(2,3)23(33)30-13-11-16(12-14-30)21-28-24(27-15-17-9-10-20(26)35-17)31(29-21)22(32)18-7-5-6-8-19(18)34-4/h5-10,16H,11-15H2,1-4H3,(H,27,28,29)	RJGQEVZNAIQXRC-UHFFFAOYSA-N	163570	US9687479, 341 1-[4-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-[(2-methoxyphenyl)carbonyl]-1H-1,2,4-triazol-3-yl)piperidin-1-yl]-2,2-dimethylpropan-1-one	Plasma kallikrein			 550					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163570	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163570&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71544597	363890876							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469249	CC(C)(C)C(=O)n1nc(nc1NCc1ccccc1)-c1ccco1	InChI=1S/C18H20N4O2/c1-18(2,3)16(23)22-17(19-12-13-8-5-4-6-9-13)20-15(21-22)14-10-7-11-24-14/h4-11H,12H2,1-3H3,(H,19,20,21)	ZMXMRVZSYJQFPQ-UHFFFAOYSA-N	163571	US9687479, 342 1-[5-(benzylamino)-3-(furan-2-yl)-1H-1,2,4-triazol-1-yl]-2,2-dimethylpropan-1-one	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163571	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163571&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081392	363890877							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469250	O=C(Cc1ccccc1)n1nc(nc1NCc1ccccc1)-c1ccco1	InChI=1S/C21H18N4O2/c26-19(14-16-8-3-1-4-9-16)25-21(22-15-17-10-5-2-6-11-17)23-20(24-25)18-12-7-13-27-18/h1-13H,14-15H2,(H,22,23,24)	ZWPFBNNFMYRPEV-UHFFFAOYSA-N	163572	US9687479, 343 1-[5-(benzylamino)-3-(furan-2-yl)-1H-1,2,4-triazol-1-yl]-2-phenylethan-1-one	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163572	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163572&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			4038040	363890878							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469251	CC(C)(C)C(=O)n1nc(nc1NCc1ccccc1)-c1ccccn1	InChI=1S/C19H21N5O/c1-19(2,3)17(25)24-18(21-13-14-9-5-4-6-10-14)22-16(23-24)15-11-7-8-12-20-15/h4-12H,13H2,1-3H3,(H,21,22,23)	KGSUWGZCLXVVJN-UHFFFAOYSA-N	163573	US9687479, 344 1-[5-(benzylamino)-3-(pyridin-2-yl)-1H-1,2,4-triazol-1-yl]-2,2-dimethylpropan-1-one::US9687479, 357 1-[5-(benzylamino)-3-(thiophen-2-yl)-1H-1,2,4-triazol-1-yl]-2,2-dimethylpropan-1-one	Plasma kallikrein			 55000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163573	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163573&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081393	363890879							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469252	CC(C)C(=O)n1nc(nc1NCc1ccccc1)-c1ccccn1	InChI=1S/C18H19N5O/c1-13(2)17(24)23-18(20-12-14-8-4-3-5-9-14)21-16(22-23)15-10-6-7-11-19-15/h3-11,13H,12H2,1-2H3,(H,20,21,22)	UBMXVAJBNNYOEK-UHFFFAOYSA-N	163574	US9687479, 345 1-[5-(benzylamino)-3-(pyridin-2-yl)-1H-1,2,4-triazol-1-yl]-2-methylpropan-1-one	Plasma kallikrein			 55000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163574	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163574&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081394	363890880							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469253	CC(C)CC(=O)n1nc(nc1NCc1ccccc1)-c1ccccn1	InChI=1S/C19H21N5O/c1-14(2)12-17(25)24-19(21-13-15-8-4-3-5-9-15)22-18(23-24)16-10-6-7-11-20-16/h3-11,14H,12-13H2,1-2H3,(H,21,22,23)	LMDGUGCYCOVEGX-UHFFFAOYSA-N	163575	US9687479, 346 1-[5-(benzylamino)-3-(pyridin-2-yl)-1H-1,2,4-triazol-1-yl]-3-methylbutan-1-one	Plasma kallikrein			 55000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163575	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163575&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081395	363890881							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469254	CCCC(=O)n1nc(nc1NCc1ccccc1)-c1ccccn1	InChI=1S/C18H19N5O/c1-2-8-16(24)23-18(20-13-14-9-4-3-5-10-14)21-17(22-23)15-11-6-7-12-19-15/h3-7,9-12H,2,8,13H2,1H3,(H,20,21,22)	ZDHSCKANDAIICB-UHFFFAOYSA-N	163576	US9687479, 347 1-[5-(benzylamino)-3-(pyridin-2-yl)-1H-1,2,4-triazol-1-yl]butan-1-one	Plasma kallikrein			 55000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163576	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163576&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081396	363890882							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469255	CCC(=O)n1nc(nc1NCc1ccccc1)-c1ccccn1	InChI=1S/C17H17N5O/c1-2-15(23)22-17(19-12-13-8-4-3-5-9-13)20-16(21-22)14-10-6-7-11-18-14/h3-11H,2,12H2,1H3,(H,19,20,21)	MPSJBYFGZHSLRS-UHFFFAOYSA-N	163577	US9687479, 348 1-[5-(benzylamino)-3-(pyridin-2-yl)-1H-1,2,4-triazol-1-yl]propan-1-one	Plasma kallikrein			 55000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163577	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163577&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081397	363890883							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469256	CCC(=O)n1nc(nc1NCc1ccccc1)-c1cccnc1	InChI=1S/C17H17N5O/c1-2-15(23)22-17(19-11-13-7-4-3-5-8-13)20-16(21-22)14-9-6-10-18-12-14/h3-10,12H,2,11H2,1H3,(H,19,20,21)	MKACFBYRQPQGRJ-UHFFFAOYSA-N	33789	1-[5-(benzylamino)-3-(3-pyridyl)-1,2,4-triazol-1-yl]propan-1-one::1-[5-(benzylamino)-3-pyridin-3-yl-1,2,4-triazol-1-yl]propan-1-one::1-[5-[(phenylmethyl)amino]-3-(3-pyridinyl)-1,2,4-triazol-1-yl]-1-propanone::1-[5-[(phenylmethyl)amino]-3-pyridin-3-yl-1,2,4-triazol-1-yl]propan-1-one::MLS000719013::SMR000291281::US9687479, 349 1-[5-(benzylamino)-3-(pyridin-3-yl)-1H-1,2,4-triazol-1-yl]propan-1-one::cid_4686951	Plasma kallikrein			 55000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=33789	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=33789&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			4686951	252616689						ZINC05002120	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469257	CC(C)(C)C(=O)n1nc(nc1NCc1ccccc1)-c1ccncc1	InChI=1S/C19H21N5O/c1-19(2,3)17(25)24-18(21-13-14-7-5-4-6-8-14)22-16(23-24)15-9-11-20-12-10-15/h4-12H,13H2,1-3H3,(H,21,22,23)	KDRUWTFVHSVSBQ-UHFFFAOYSA-N	163580	US9687479, 350 1-[5-(benzylamino)-3-(pyridin-4-yl)-1H-1,2,4-triazol-1-yl]-2,2-dimethylpropan-1-one	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163580	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163580&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081398	363890884							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469258	CC(C)C(=O)n1nc(nc1NCc1ccccc1)-c1ccncc1	InChI=1S/C18H19N5O/c1-13(2)17(24)23-18(20-12-14-6-4-3-5-7-14)21-16(22-23)15-8-10-19-11-9-15/h3-11,13H,12H2,1-2H3,(H,20,21,22)	AHRMDGPHYFONJL-UHFFFAOYSA-N	163582	US9687479, 351 1-[5-(benzylamino)-3-(pyridin-4-yl)-1H-1,2,4-triazol-1-yl]-2-methylpropan-1-one	Plasma kallikrein			 5500					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163582	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163582&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081399	363890885							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469259	O=C(Cc1ccccc1)n1nc(nc1NCc1ccccc1)-c1ccncc1	InChI=1S/C22H19N5O/c28-20(15-17-7-3-1-4-8-17)27-22(24-16-18-9-5-2-6-10-18)25-21(26-27)19-11-13-23-14-12-19/h1-14H,15-16H2,(H,24,25,26)	UROJBUVOJGZFOV-UHFFFAOYSA-N	163583	US9687479, 352 1-[5-(benzylamino)-3-(pyridin-4-yl)-1H-1,2,4-triazol-1-yl]-2-phenylethan-1-one	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163583	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163583&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081400	363890886							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469260	CC(C)CC(=O)n1nc(nc1NCc1ccccc1)-c1ccncc1	InChI=1S/C19H21N5O/c1-14(2)12-17(25)24-19(21-13-15-6-4-3-5-7-15)22-18(23-24)16-8-10-20-11-9-16/h3-11,14H,12-13H2,1-2H3,(H,21,22,23)	NICBKGKMAUIIMB-UHFFFAOYSA-N	163584	US9687479, 353 1-[5-(benzylamino)-3-(pyridin-4-yl)-1H-1,2,4-triazol-1-yl]-3-methylbutan-1-one	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163584	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163584&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081401	363890887							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469261	O=C(CCc1ccccc1)n1nc(nc1NCc1ccccc1)-c1ccncc1	InChI=1S/C23H21N5O/c29-21(12-11-18-7-3-1-4-8-18)28-23(25-17-19-9-5-2-6-10-19)26-22(27-28)20-13-15-24-16-14-20/h1-10,13-16H,11-12,17H2,(H,25,26,27)	DVLYAAQHRRZOQM-UHFFFAOYSA-N	163585	US9687479, 354 1-[5-(benzylamino)-3-(pyridin-4-yl)-1H-1,2,4-triazol-1-yl]-3-phenylpropan-1-one	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163585	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163585&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081402	363890888							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469262	CCCC(=O)n1nc(nc1NCc1ccccc1)-c1ccncc1	InChI=1S/C18H19N5O/c1-2-6-16(24)23-18(20-13-14-7-4-3-5-8-14)21-17(22-23)15-9-11-19-12-10-15/h3-5,7-12H,2,6,13H2,1H3,(H,20,21,22)	KMPZOQHRGVLBLJ-UHFFFAOYSA-N	163586	US9687479, 355 1-[5-(benzylamino)-3-(pyridin-4-yl)-1H-1,2,4-triazol-1-yl]butan-1-one	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163586	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163586&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081403	363890889							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469263	CCC(=O)n1nc(nc1NCc1ccccc1)-c1ccncc1	InChI=1S/C17H17N5O/c1-2-15(23)22-17(19-12-13-6-4-3-5-7-13)20-16(21-22)14-8-10-18-11-9-14/h3-11H,2,12H2,1H3,(H,19,20,21)	NYUUKGOTGFGRKO-UHFFFAOYSA-N	163590	US9687479, 356 1-[5-(benzylamino)-3-(pyridin-4-yl)-1H-1,2,4-triazol-1-yl]propan-1-one	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163590	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163590&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081404	363890890							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469264	CC(C)(C)C(=O)n1nc(nc1NCc1ccccc1)-c1ccccn1	InChI=1S/C19H21N5O/c1-19(2,3)17(25)24-18(21-13-14-9-5-4-6-10-14)22-16(23-24)15-11-7-8-12-20-15/h4-12H,13H2,1-3H3,(H,21,22,23)	KGSUWGZCLXVVJN-UHFFFAOYSA-N	163573	US9687479, 344 1-[5-(benzylamino)-3-(pyridin-2-yl)-1H-1,2,4-triazol-1-yl]-2,2-dimethylpropan-1-one::US9687479, 357 1-[5-(benzylamino)-3-(thiophen-2-yl)-1H-1,2,4-triazol-1-yl]-2,2-dimethylpropan-1-one	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163573	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163573&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081393	363890879							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469266	Fc1ccc(CNc2nc(nn2C(=O)c2ccccc2)-c2ccccn2)cc1	InChI=1S/C21H16FN5O/c22-17-11-9-15(10-12-17)14-24-21-25-19(18-8-4-5-13-23-18)26-27(21)20(28)16-6-2-1-3-7-16/h1-13H,14H2,(H,24,25,26)	QINGREKOIHZHSD-UHFFFAOYSA-N	163592	US9687479, 358 1-benzoyl-N-[(4-fluorophenyl)methyl]-3-(pyridin-2-yl)-1H-1,2,4-triazol-5-amine	Plasma kallikrein			 550					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163592	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163592&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081405	363890891							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469267	Fc1ccc(CNc2nc(nn2C(=O)c2ccccc2)-c2cccnc2)cc1	InChI=1S/C21H16FN5O/c22-18-10-8-15(9-11-18)13-24-21-25-19(17-7-4-12-23-14-17)26-27(21)20(28)16-5-2-1-3-6-16/h1-12,14H,13H2,(H,24,25,26)	ULJUGNXHZYHNGL-UHFFFAOYSA-N	163594	US9687479, 359 1-benzoyl-N-[(4-fluorophenyl)methyl]-3-(pyridin-3-yl)-1H-1,2,4-triazol-5-amine	Plasma kallikrein			 550					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163594	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163594&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			3930657	363890892							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469269	COc1ccc(CNc2nc(nn2C(=O)c2ccccc2)-c2ccccn2)cc1	InChI=1S/C22H19N5O2/c1-29-18-12-10-16(11-13-18)15-24-22-25-20(19-9-5-6-14-23-19)26-27(22)21(28)17-7-3-2-4-8-17/h2-14H,15H2,1H3,(H,24,25,26)	HPICQAXGWFUSTF-UHFFFAOYSA-N	163595	US9687479, 360 1-benzoyl-N-[(4-methoxyphenyl)methyl]-3-(pyridin-2-yl)-1H-1,2,4-triazol-5-amine	Plasma kallikrein			 5500					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163595	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163595&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081406	363890893							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477141	Cc1cnn(Cc2ccc(Cn3nc(C)c(C(=O)NCc4c(C)cc(CN)cc4C)c3C)cc2)c1	InChI=1S/C28H34N6O/c1-18-13-31-33(15-18)16-23-6-8-24(9-7-23)17-34-22(5)27(21(4)32-34)28(35)30-14-26-19(2)10-25(12-29)11-20(26)3/h6-11,13,15H,12,14,16-17,29H2,1-5H3,(H,30,35)	QNIDRKXJPLTCKV-UHFFFAOYSA-N	187102	US9670157, 116 3,5-Dimethyl-1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-1H-pyrazole-4-carboxylic acid 4-aminomethyl-2,6-dimethyl-benzylamide::US9834513, 116	Plasma kallikrein			 11699							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=187102	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=187102&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126614044	373987516							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477142	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4ccc(CN)c(F)c4)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C25H24F4N6O/c1-16-10-32-34(12-16)13-17-2-4-18(5-3-17)14-35-15-21(23(33-35)25(27,28)29)24(36)31-11-19-6-7-20(9-30)22(26)8-19/h2-8,10,12,15H,9,11,13-14,30H2,1H3,(H,31,36)	KVZULUTYGQJNAW-UHFFFAOYSA-N	187103	US9670157, 117 1-[4-(4-Methyl-pyrazol-1-ylmethyl)-benzyl]-3-trifluoromethyl-1H-pyrazole-4-carboxylic acid 4-aminomethyl-3-fluoro-benzylamide::US9834513, 117	Plasma kallikrein			 51							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=187103	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=187103&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290528	373987517							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477143	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4c(C)cc(CN)cc4C)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C27H29F3N6O/c1-17-11-33-35(13-17)14-20-4-6-21(7-5-20)15-36-16-24(25(34-36)27(28,29)30)26(37)32-12-23-18(2)8-22(10-31)9-19(23)3/h4-9,11,13,16H,10,12,14-15,31H2,1-3H3,(H,32,37)	KODUDZPOXFRWEI-UHFFFAOYSA-N	187104	US9670157, 118 1-[4-(4-Methyl-pyrazol-1-ylmethyl)-benzyl]-3-trifluoromethyl-1H-pyrazole-4-carboxylic acid 4-aminomethyl-2,6-dimethyl-benzylamide::US9834513, 118	Plasma kallikrein			 1.00							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=187104	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=187104&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290529	373987518							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477144	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4ccc(CN)c(F)c4C)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C26H26F4N6O/c1-16-10-33-35(12-16)13-18-3-5-19(6-4-18)14-36-15-22(24(34-36)26(28,29)30)25(37)32-11-21-8-7-20(9-31)23(27)17(21)2/h3-8,10,12,15H,9,11,13-14,31H2,1-2H3,(H,32,37)	PKZHZUNPMZRBCV-UHFFFAOYSA-N	187105	US9670157, 119 1-[4-(4-Methyl-pyrazol-1-ylmethyl)-benzyl]-3-trifluoromethyl-1H-pyrazole-4-carboxylic acid 4-aminomethyl-3-fluoro-2-methyl-benzylamide::US9834513, 119	Plasma kallikrein			 9.00							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=187105	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=187105&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290530	373987519							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477145	CCn1c(cc(C)c1Cc1ccc(Cn2cc(C)cn2)cc1)C(=O)NCc1ccc(CN)cc1	InChI=1S/C28H33N5O/c1-4-33-26(14-22-5-11-25(12-6-22)19-32-18-20(2)16-31-32)21(3)13-27(33)28(34)30-17-24-9-7-23(15-29)8-10-24/h5-13,16,18H,4,14-15,17,19,29H2,1-3H3,(H,30,34)	APSRMPANLLTMGB-UHFFFAOYSA-N	187107	US9670157, 121 1-Ethyl-4-methyl-5-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-1H-pyrrole-2-carboxylic acid 4-aminomethyl-benzylamide::US9670157, 122 1-Ethyl-4-methyl-5-[4-(2-oxo-2H-pyridin-1-ylmethyl)-benzyl]-1H-pyrrole-2-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 121	Plasma kallikrein			 155							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=187107	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=187107&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290485	373987520							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477146	CCn1c(cc(C)c1Cc1ccc(Cn2cc(C)cn2)cc1)C(=O)NCc1ccc(CN)cc1	InChI=1S/C28H33N5O/c1-4-33-26(14-22-5-11-25(12-6-22)19-32-18-20(2)16-31-32)21(3)13-27(33)28(34)30-17-24-9-7-23(15-29)8-10-24/h5-13,16,18H,4,14-15,17,19,29H2,1-3H3,(H,30,34)	APSRMPANLLTMGB-UHFFFAOYSA-N	187107	US9670157, 121 1-Ethyl-4-methyl-5-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-1H-pyrrole-2-carboxylic acid 4-aminomethyl-benzylamide::US9670157, 122 1-Ethyl-4-methyl-5-[4-(2-oxo-2H-pyridin-1-ylmethyl)-benzyl]-1H-pyrrole-2-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 121	Plasma kallikrein			 151							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=187107	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=187107&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290485	373987520							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477147	CCn1c(Cc2ccc(Cn3ccccc3=O)cc2)c(C)cc1C(=O)NCc1ccc(CN)cc1	InChI=1S/C29H32N4O2/c1-3-33-26(17-22-7-13-25(14-8-22)20-32-15-5-4-6-28(32)34)21(2)16-27(33)29(35)31-19-24-11-9-23(18-30)10-12-24/h4-16H,3,17-20,30H2,1-2H3,(H,31,35)	ULZKXPDTHIUETL-UHFFFAOYSA-N	187109	US9670157, 123 1-Ethyl-4-methyl-5-(2-phenyl-thiazol-4-ylmethyl)-1H-pyrrole-2-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 122	Plasma kallikrein			 2149							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=187109	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=187109&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290526	373987521							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477148	Cc1nn(Cc2ccc3nc(C)ccc3c2)cc1C(=O)NCc1c(C)cc(CN)cc1C	InChI=1S/C26H29N5O/c1-16-9-21(12-27)10-17(2)23(16)13-28-26(32)24-15-31(30-19(24)4)14-20-6-8-25-22(11-20)7-5-18(3)29-25/h5-11,15H,12-14,27H2,1-4H3,(H,28,32)	NKFYMWBVMOGCMS-UHFFFAOYSA-N	187110	US9670157, 124 3-Methyl-1-(2-methyl-quinolin-6-ylmethyl)-1H-pyrazole-4-carboxylic acid 4-aminomethyl-2,6-dimethyl-benzylamide::US9834513, 124	Plasma kallikrein			 2.00							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=187110	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=187110&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290565	373987522							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477149	Cc1c(cnn1Cc1ccc2nc(C)ccc2c1)C(=O)NCc1c(C)cc(CN)cc1C	InChI=1S/C26H29N5O/c1-16-9-21(12-27)10-17(2)23(16)13-28-26(32)24-14-29-31(19(24)4)15-20-6-8-25-22(11-20)7-5-18(3)30-25/h5-11,14H,12-13,15,27H2,1-4H3,(H,28,32)	SVWVNWWLYZGNGT-UHFFFAOYSA-N	187111	US9670157, 125 5-Methyl-1-(2-methyl-quinolin-6-ylmethyl)-1H-pyrazole-4-carboxylic acid 4-aminomethyl-2,6-dimethyl-benzylamide::US9834513, 125	Plasma kallikrein			 3.00							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=187111	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=187111&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290566	373987523							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477150	Cc1ccc2cc(Cn3cc(C(=O)NCc4c(C)cc(CN)cc4C)c(n3)C(F)(F)F)ccc2n1	InChI=1S/C26H26F3N5O/c1-15-8-19(11-30)9-16(2)21(15)12-31-25(35)22-14-34(33-24(22)26(27,28)29)13-18-5-7-23-20(10-18)6-4-17(3)32-23/h4-10,14H,11-13,30H2,1-3H3,(H,31,35)	ASPQAQDFTSKEAM-UHFFFAOYSA-N	187112	US9670157, 126 1-(2-Methyl-quinolin-6-ylmethyl)-3-trifluoromethyl-1H-pyrazole-4-carboxylic acid 4-aminomethyl-2,6-dimethyl-benzylamide::US9834513, 126	Plasma kallikrein			 3.00							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=187112	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=187112&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290567	373987524							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477151	Cc1ccc2cc(Cn3ncc(C(=O)NCc4c(C)cc(CN)cc4C)c3C(F)(F)F)ccc2n1	InChI=1S/C26H26F3N5O/c1-15-8-19(11-30)9-16(2)21(15)12-31-25(35)22-13-32-34(24(22)26(27,28)29)14-18-5-7-23-20(10-18)6-4-17(3)33-23/h4-10,13H,11-12,14,30H2,1-3H3,(H,31,35)	VJTIBJURDVORHW-UHFFFAOYSA-N	187113	US9670157, 127 1-(2-Methyl-quinolin-6-ylmethyl)-5-trifluoromethyl-1H-pyrazole-4-carboxylic acid 4-aminomethyl-2,6-dimethyl-benzylamide::US9834513, 127	Plasma kallikrein			 731							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=187113	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=187113&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280088	373987525							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477152	Cc1cc(C(=O)NCc2c(C)cc(CN)cc2C)c(C)n1Cc1ccc2nc(C)ccc2c1	InChI=1S/C28H32N4O/c1-17-10-23(14-29)11-18(2)26(17)15-30-28(33)25-12-20(4)32(21(25)5)16-22-7-9-27-24(13-22)8-6-19(3)31-27/h6-13H,14-16,29H2,1-5H3,(H,30,33)	QQCDDUJPDRCOTN-UHFFFAOYSA-N	187114	US9670157, 128 2,5-Dimethyl-1-(2-methyl-quinolin-6-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-2,6-dimethyl-benzylamide::US9834513, 128	Plasma kallikrein			 934							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=187114	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=187114&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280273	373987526							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
477153	Cc1cc(CN)cc(C)c1CNC(=O)c1cn(Cc2ccnc(c2)N2CCCC2)nc1C(F)(F)F	InChI=1S/C25H29F3N6O/c1-16-9-19(12-29)10-17(2)20(16)13-31-24(35)21-15-34(32-23(21)25(26,27)28)14-18-5-6-30-22(11-18)33-7-3-4-8-33/h5-6,9-11,15H,3-4,7-8,12-14,29H2,1-2H3,(H,31,35)	YWMLIFJICOBECK-UHFFFAOYSA-N	187115	US9670157, 129 1-(2-Pyrrolidin-1-yl-pyridin-4-ylmethyl)-3-trifluoromethyl-1H-pyrazole-4-carboxylic acid 4-aminomethyl-2,6-dimethyl-benzylamide::US9834513, 129	Plasma kallikrein			 24							US Patent		10.7270/Q2F769QG		aid1795026	US9670157	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=187115	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=187115&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290568	373987527							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469271	COc1ccc(CNc2nc(nn2C(=O)c2ccccc2)-c2cccnc2)cc1	InChI=1S/C22H19N5O2/c1-29-19-11-9-16(10-12-19)14-24-22-25-20(18-8-5-13-23-15-18)26-27(22)21(28)17-6-3-2-4-7-17/h2-13,15H,14H2,1H3,(H,24,25,26)	SBKDLUCGOBKRMP-UHFFFAOYSA-N	163596	US9687479, 361 1-benzoyl-N-[(4-methoxyphenyl)methyl]-3-(pyridin-3-yl)-1H-1,2,4-triazol-5-amine	Plasma kallikrein			 5500					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163596	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163596&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			5223330	363890894							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469273	O=C(c1ccccc1)n1nc(nc1NCc1ccccc1)-c1ccccn1	InChI=1S/C21H17N5O/c27-20(17-11-5-2-6-12-17)26-21(23-15-16-9-3-1-4-10-16)24-19(25-26)18-13-7-8-14-22-18/h1-14H,15H2,(H,23,24,25)	LKFKXDWTOJHLSW-UHFFFAOYSA-N	163597	US9687479, 362 1-benzoyl-N-benzyl-3-(pyridin-2-yl)-1H-1,2,4-triazol-5-amine	Plasma kallikrein			 550					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163597	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163597&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71544425	363890895							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469274	O=C(c1ccccc1)n1nc(nc1NCc1ccccc1)-c1ccncc1	InChI=1S/C21H17N5O/c27-20(18-9-5-2-6-10-18)26-21(23-15-16-7-3-1-4-8-16)24-19(25-26)17-11-13-22-14-12-17/h1-14H,15H2,(H,23,24,25)	IKCZEQGZTCHUAD-UHFFFAOYSA-N	163598	US9687479, 363 1-benzoyl-N-benzyl-3-(pyridin-4-yl)-1H-1,2,4-triazol-5-amine	Plasma kallikrein			 550					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163598	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163598&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71544482	363890896							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469275	COc1ccccc1C(=O)n1nc(nc1NCc1ccc(Cl)s1)C1CN(C1)S(=O)(=O)N(C)C	InChI=1S/C20H23ClN6O4S2/c1-25(2)33(29,30)26-11-13(12-26)18-23-20(22-10-14-8-9-17(21)32-14)27(24-18)19(28)15-6-4-5-7-16(15)31-3/h4-9,13H,10-12H2,1-3H3,(H,22,23,24)	WJVWYNJXYHRVTF-UHFFFAOYSA-N	163599	US9687479, 364 3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-[(2-methoxyphenyl)carbonyl]-1H-1,2,4-triazol-3-yl)-N,N-dimethylazetidine-1-sulfonamide	Plasma kallikrein			<100					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163599	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163599&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081407	363890897							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469276	Clc1ccc(CNc2nc(nn2C(=O)c2cccnc2)-c2cccnc2)s1	InChI=1S/C18H13ClN6OS/c19-15-6-5-14(27-15)11-22-18-23-16(12-3-1-7-20-9-12)24-25(18)17(26)13-4-2-8-21-10-13/h1-10H,11H2,(H,22,23,24)	ZNYMRWKIVQTALJ-UHFFFAOYSA-N	163600	US9687479, 365 3-(pyridin-3-yl)-1-[(pyridin-3-yl)carbonyl]-N-(thiophen-2-ylmethyl)-1H-1,2,4-triazol-5-amine	Plasma kallikrein			 5500					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163600	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163600&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081408	363890898							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469278	COc1ccccc1C(=O)n1nc(nc1SC)-c1cccnc1	InChI=1S/C16H14N4O2S/c1-22-13-8-4-3-7-12(13)15(21)20-16(23-2)18-14(19-20)11-6-5-9-17-10-11/h3-10H,1-2H3	BQULIDBUUVETFS-UHFFFAOYSA-N	163601	US9687479, 366 3-1-[(2-methoxyphenyl)carbonyl]-5-(methylsulfanyl)-1H-1,2,4-triazol-3-ylpyridine	Plasma kallikrein			 5500					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163601	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163601&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			68230035	363890899							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469279	COc1ccccc1C(=O)n1nc(nc1NCc1ccc(F)cc1)-c1ccccn1	InChI=1S/C22H18FN5O2/c1-30-19-8-3-2-6-17(19)21(29)28-22(25-14-15-9-11-16(23)12-10-15)26-20(27-28)18-7-4-5-13-24-18/h2-13H,14H2,1H3,(H,25,26,27)	MWONLFLWDWHANV-UHFFFAOYSA-N	163675	US9687479, 367 N-[(4-fluorophenyl)methyl]-1-[(2-methoxyphenyl)carbonyl]-3-(pyridin-2-yl)-1H-1,2,4-triazol-5-amine	Plasma kallikrein			 5500					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163675	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163675&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71544481	363890900							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469280	COc1ccccc1C(=O)n1nc(nc1NCc1ccc(F)cc1)-c1cccnc1	InChI=1S/C22H18FN5O2/c1-30-19-7-3-2-6-18(19)21(29)28-22(25-13-15-8-10-17(23)11-9-15)26-20(27-28)16-5-4-12-24-14-16/h2-12,14H,13H2,1H3,(H,25,26,27)	SQUFFUIKKHIUPN-UHFFFAOYSA-N	163676	US9687479, 368 N-[(4-fluorophenyl)methyl]-1-[(2-methoxyphenyl)carbonyl]-3-(pyridin-3-yl)-1H-1,2,4-triazol-5-amine	Plasma kallikrein			 5500					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163676	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163676&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			4331730	363890901							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469281	Fc1ccc(CNc2nc(nn2C(=O)c2ccco2)-c2ccccn2)cc1	InChI=1S/C19H14FN5O2/c20-14-8-6-13(7-9-14)12-22-19-23-17(15-4-1-2-10-21-15)24-25(19)18(26)16-5-3-11-27-16/h1-11H,12H2,(H,22,23,24)	DKWXCXZOTMMAFV-UHFFFAOYSA-N	163436	US9687479, 10 N-[(4-fluorophenyl)methyl]-3-(pyridin-2-yl)-1-[(thiophen-2-yl)carbonyl]-1H-1,2,4-triazol-5-amine::US9687479, 369 N-[(4-fluorophenyl)methyl]-1-[(furan-2-yl)carbonyl]-3-(pyridin-2-yl)-1H-1,2,4-triazol-5-amine	Plasma kallikrein			 5500					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163436	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163436&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081364	363890825							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469282	Fc1ccc(CNc2nc(nn2C(=O)c2ccco2)-c2cccnc2)cc1	InChI=1S/C19H14FN5O2/c20-15-7-5-13(6-8-15)11-22-19-23-17(14-3-1-9-21-12-14)24-25(19)18(26)16-4-2-10-27-16/h1-10,12H,11H2,(H,22,23,24)	YEPOSLFYIVGVDR-UHFFFAOYSA-N	163678	US9687479, 370 N-[(4-fluorophenyl)methyl]-1-[(furan-2-yl)carbonyl]-3-(pyridin-3-yl)-1H-1,2,4-triazol-5-amine::US9687479, 376 N-[(4-fluorophenyl)methyl]-3-(pyridin-3-yl)-1-[(thiophen-2-yl)carbonyl]-1H-1,2,4-triazol-5-amine	Plasma kallikrein			 5500					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163678	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163678&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			4542106	363890902							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469283	Fc1ccc(CNc2nc(nn2C(=O)c2ccoc2)-c2ccccn2)cc1	InChI=1S/C19H14FN5O2/c20-15-6-4-13(5-7-15)11-22-19-23-17(16-3-1-2-9-21-16)24-25(19)18(26)14-8-10-27-12-14/h1-10,12H,11H2,(H,22,23,24)	HLIBNGPPBHGNAZ-UHFFFAOYSA-N	163702	US9687479, 371 N-[(4-fluorophenyl)methyl]-1-[(furan-3-yl)carbonyl]-3-(pyridin-2-yl)-1H-1,2,4-triazol-5-amine::US9687479, 375 N-[(4-fluorophenyl)methyl]-3-(pyridin-2-yl)-1-[(thiophen-3-yl)carbonyl]-1H-1,2,4-triazol-5-amine	Plasma kallikrein			 5500					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163702	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163702&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081409	363890903							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469284	Fc1ccc(CNc2nc(nn2C(=O)c2ccoc2)-c2cccnc2)cc1	InChI=1S/C19H14FN5O2/c20-16-5-3-13(4-6-16)10-22-19-23-17(14-2-1-8-21-11-14)24-25(19)18(26)15-7-9-27-12-15/h1-9,11-12H,10H2,(H,22,23,24)	XFUOMOSPWASMTC-UHFFFAOYSA-N	163703	US9687479, 372 N-[(4-fluorophenyl)methyl]-1-[(furan-3-yl)carbonyl]-3-(pyridin-3-yl)-1H-1,2,4-triazol-5-amine::US9687479, 377 N-[(4-fluorophenyl)methyl]-3-(pyridin-3-yl)-1-[(thiophen-3-yl)carbonyl]-1H-1,2,4-triazol-5-amine	Plasma kallikrein			 5500					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163703	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163703&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081410	363890904							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469285	Fc1ccc(CNc2nc(nn2C(=O)c2ccoc2)-c2ccncc2)cc1	InChI=1S/C19H14FN5O2/c20-16-3-1-13(2-4-16)11-22-19-23-17(14-5-8-21-9-6-14)24-25(19)18(26)15-7-10-27-12-15/h1-10,12H,11H2,(H,22,23,24)	WWHGTLFSXPCARY-UHFFFAOYSA-N	163704	US9687479, 373 N-[(4-fluorophenyl)methyl]-1-[(furan-3-yl)carbonyl]-3-(pyridin-4-yl)-1H-1,2,4-triazol-5-amine	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163704	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163704&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081411	363890905							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469286	CCCn1nc(nc1NCc1ccc(F)cc1)-c1ccccn1	InChI=1S/C17H18FN5/c1-2-11-23-17(20-12-13-6-8-14(18)9-7-13)21-16(22-23)15-5-3-4-10-19-15/h3-10H,2,11-12H2,1H3,(H,20,21,22)	YCFXPBGRVJCEGQ-UHFFFAOYSA-N	163705	US9687479, 374 N-[(4-fluorophenyl)methyl]-1-propyl-3-(pyridin-2-yl)-1H-1,2,4-triazol-5-amine	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163705	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163705&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081412	363890906							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469287	Fc1ccc(CNc2nc(nn2C(=O)c2ccoc2)-c2ccccn2)cc1	InChI=1S/C19H14FN5O2/c20-15-6-4-13(5-7-15)11-22-19-23-17(16-3-1-2-9-21-16)24-25(19)18(26)14-8-10-27-12-14/h1-10,12H,11H2,(H,22,23,24)	HLIBNGPPBHGNAZ-UHFFFAOYSA-N	163702	US9687479, 371 N-[(4-fluorophenyl)methyl]-1-[(furan-3-yl)carbonyl]-3-(pyridin-2-yl)-1H-1,2,4-triazol-5-amine::US9687479, 375 N-[(4-fluorophenyl)methyl]-3-(pyridin-2-yl)-1-[(thiophen-3-yl)carbonyl]-1H-1,2,4-triazol-5-amine	Plasma kallikrein			 550					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163702	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163702&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081409	363890903							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469288	Fc1ccc(CNc2nc(nn2C(=O)c2ccco2)-c2cccnc2)cc1	InChI=1S/C19H14FN5O2/c20-15-7-5-13(6-8-15)11-22-19-23-17(14-3-1-9-21-12-14)24-25(19)18(26)16-4-2-10-27-16/h1-10,12H,11H2,(H,22,23,24)	YEPOSLFYIVGVDR-UHFFFAOYSA-N	163678	US9687479, 370 N-[(4-fluorophenyl)methyl]-1-[(furan-2-yl)carbonyl]-3-(pyridin-3-yl)-1H-1,2,4-triazol-5-amine::US9687479, 376 N-[(4-fluorophenyl)methyl]-3-(pyridin-3-yl)-1-[(thiophen-2-yl)carbonyl]-1H-1,2,4-triazol-5-amine	Plasma kallikrein			 5500					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163678	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163678&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			4542106	363890902							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469289	Fc1ccc(CNc2nc(nn2C(=O)c2ccoc2)-c2cccnc2)cc1	InChI=1S/C19H14FN5O2/c20-16-5-3-13(4-6-16)10-22-19-23-17(14-2-1-8-21-11-14)24-25(19)18(26)15-7-9-27-12-15/h1-9,11-12H,10H2,(H,22,23,24)	XFUOMOSPWASMTC-UHFFFAOYSA-N	163703	US9687479, 372 N-[(4-fluorophenyl)methyl]-1-[(furan-3-yl)carbonyl]-3-(pyridin-3-yl)-1H-1,2,4-triazol-5-amine::US9687479, 377 N-[(4-fluorophenyl)methyl]-3-(pyridin-3-yl)-1-[(thiophen-3-yl)carbonyl]-1H-1,2,4-triazol-5-amine	Plasma kallikrein			 550					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163703	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163703&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081410	363890904							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469290	Fc1ccc(CNc2nc(nn2C(=O)c2ccco2)-c2ccncc2)cc1	InChI=1S/C19H14FN5O2/c20-15-5-3-13(4-6-15)12-22-19-23-17(14-7-9-21-10-8-14)24-25(19)18(26)16-2-1-11-27-16/h1-11H,12H2,(H,22,23,24)	STINAMZIOJIHKX-UHFFFAOYSA-N	163454	US9687479, 11 N-[(4-fluorophenyl)methyl]-3-(pyridin-4-yl)-1-[(thiophen-3-yl)carbonyl]-1H-1,2,4-triazol-5-amine::US9687479, 378 N-[(4-fluorophenyl)methyl]-3-(pyridin-4-yl)-1-[(thiophen-2-yl)carbonyl]-1H-1,2,4-triazol-5-amine	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163454	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163454&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081365	363890826							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469291	COc1ccc(CNc2nc(nn2C(=O)c2ccco2)-c2ccccn2)cc1	InChI=1S/C20H17N5O3/c1-27-15-9-7-14(8-10-15)13-22-20-23-18(16-5-2-3-11-21-16)24-25(20)19(26)17-6-4-12-28-17/h2-12H,13H2,1H3,(H,22,23,24)	RSYCIWYBXHHZNB-UHFFFAOYSA-N	163558	US9687479, 336 1-[(furan-2-yl)carbonyl]-N-[(4-methoxyphenyl)methyl]-3-(pyridin-2-yl)-1H-1,2,4-triazol-5-amine::US9687479, 379 N-[(4-methoxyphenyl)methyl]-3-(pyridin-2-yl)-1-[(thiophen-2-yl)carbonyl]-1H-1,2,4-triazol-5-amine	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163558	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163558&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081389	363890871							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469292	COc1ccc(CNc2nc(nn2C(=O)c2ccoc2)-c2ccccn2)cc1	InChI=1S/C20H17N5O3/c1-27-16-7-5-14(6-8-16)12-22-20-23-18(17-4-2-3-10-21-17)24-25(20)19(26)15-9-11-28-13-15/h2-11,13H,12H2,1H3,(H,22,23,24)	BVQGYCDMQASERH-UHFFFAOYSA-N	163560	US9687479, 338 1-[(furan-3-yl)carbonyl]-N-[(4-methoxyphenyl)methyl]-3-(pyridin-2-yl)-1H-1,2,4-triazol-5-amine::US9687479, 380 N-[(4-methoxyphenyl)methyl]-3-(pyridin-2-yl)-1-[(thiophen-3-yl)carbonyl]-1H-1,2,4-triazol-5-amine	Plasma kallikrein			 5500					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163560	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163560&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			53491732	363890873							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469293	COc1ccc(CNc2nc(nn2C(=O)c2ccco2)-c2cccnc2)cc1	InChI=1S/C20H17N5O3/c1-27-16-8-6-14(7-9-16)12-22-20-23-18(15-4-2-10-21-13-15)24-25(20)19(26)17-5-3-11-28-17/h2-11,13H,12H2,1H3,(H,22,23,24)	YOUZYXOPBZHMJQ-UHFFFAOYSA-N	33600	1-(2-furoyl)-N-(4-methoxybenzyl)-3-(3-pyridinyl)-1H-1,2,4-triazol-5-amine::2-furanyl-[5-[(4-methoxyphenyl)methylamino]-3-(3-pyridinyl)-1,2,4-triazol-1-yl]methanone::2-furyl-[5-(p-anisylamino)-3-(3-pyridyl)-1,2,4-triazol-1-yl]methanone::MLS000066704::SMR000082089::US9687479, 381 N-[(4-methoxyphenyl)methyl]-3-(pyridin-3-yl)-1-[(thiophen-2-yl)carbonyl]-1H-1,2,4-triazol-5-amine::cid_2235222::furan-2-yl-[5-[(4-methoxyphenyl)methylamino]-3-pyridin-3-yl-1,2,4-triazol-1-yl]methanone	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=33600	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=33600&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			2235222	252616505						ZINC02882948	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469294	COc1ccc(CNc2nc(nn2C(=O)c2ccoc2)-c2cccnc2)cc1	InChI=1S/C20H17N5O3/c1-27-17-6-4-14(5-7-17)11-22-20-23-18(15-3-2-9-21-12-15)24-25(20)19(26)16-8-10-28-13-16/h2-10,12-13H,11H2,1H3,(H,22,23,24)	CCPCUQLAGBNCCW-UHFFFAOYSA-N	163563	US9687479, 339 1-[(furan-3-yl)carbonyl]-N-[(4-methoxyphenyl)methyl]-3-(pyridin-3-yl)-1H-1,2,4-triazol-5-amine::US9687479, 382 N-[(4-methoxyphenyl)methyl]-3-(pyridin-3-yl)-1-[(thiophen-3-yl)carbonyl]-1H-1,2,4-triazol-5-amine	Plasma kallikrein			 5500					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163563	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163563&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081391	363890874							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469295	COc1ccccc1C(=O)n1nc(nc1NCc1ccc(Cl)s1)-c1ccccc1	InChI=1S/C21H17ClN4O2S/c1-28-17-10-6-5-9-16(17)20(27)26-21(23-13-15-11-12-18(22)29-15)24-19(25-26)14-7-3-2-4-8-14/h2-12H,13H2,1H3,(H,23,24,25)	WYPYYUPYCYVRGI-UHFFFAOYSA-N	164103	US9687479, 383 N-[(5-chlorofuran-2-yl)methyl]-1-[(2-methoxyphenyl)carbonyl]-3-phenyl-1H-1,2,4-triazol-5-amine::US9687479, 387 N-[(5-chlorothiophen-2-yl)methyl]-1-[(2-methoxyphenyl)carbonyl]-3-(piperidin-4-yl)-1H-1,2,4-triazol-5-amine::US9687479, 390 N-[(5-chlorothiophen-2-yl)methyl]-1-[(2-methoxyphenyl)carbonyl]-3-phenyl-1H-1,2,4-triazol-5-amine	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164103	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164103&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71543848	363890907							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469297	COc1ccc(C(=O)n2nc(nc2NCc2ccc(Cl)s2)C2CCOCC2)c(OC)c1	InChI=1S/C21H23ClN4O4S/c1-28-14-3-5-16(17(11-14)29-2)20(27)26-21(23-12-15-4-6-18(22)31-15)24-19(25-26)13-7-9-30-10-8-13/h3-6,11,13H,7-10,12H2,1-2H3,(H,23,24,25)	KVIQDQUIYIPWCU-UHFFFAOYSA-N	164104	US9687479, 384 N-[(5-chlorothiophen-2-yl)methyl]-1-[(2,4-dimethoxyphenyl)carbonyl]-3-(oxan-4-yl)-1H-1,2,4-triazol-5-amine	Plasma kallikrein			 550					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164104	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164104&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71543775	374883915							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469298	COc1ccccc1C(=O)n1nc(nc1NCc1ccc(Cl)s1)C1CCOCC1	InChI=1S/C20H21ClN4O3S/c1-27-16-5-3-2-4-15(16)19(26)25-20(22-12-14-6-7-17(21)29-14)23-18(24-25)13-8-10-28-11-9-13/h2-7,13H,8-12H2,1H3,(H,22,23,24)	RDLONQQHFXHNTA-UHFFFAOYSA-N	164168	US9687479, 385 N-[(5-chlorothiophen-2-yl)methyl]-1-[(2-methoxyphenyl)carbonyl]-3-(oxan-4-yl)-1H-1,2,4-triazol-5-amine	Plasma kallikrein			 550					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164168	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164168&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71543778	363890908							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469299	COc1ccccc1C(=O)n1nc(nc1NCc1ccc(Cl)s1)C1CCCCO1	InChI=1S/C20H21ClN4O3S/c1-27-15-7-3-2-6-14(15)19(26)25-20(22-12-13-9-10-17(21)29-13)23-18(24-25)16-8-4-5-11-28-16/h2-3,6-7,9-10,16H,4-5,8,11-12H2,1H3,(H,22,23,24)	SVSSDPHIBNCNAW-UHFFFAOYSA-N	164169	US9687479, 386 N-[(5-chlorothiophen-2-yl)methyl]-1-[(2-methoxyphenyl)carbonyl]-3-(oxolan-2-yl)-1H-1,2,4-triazol-5-amine	Plasma kallikrein			 550					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164169	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164169&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081413	363890909							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469301	COc1ccccc1C(=O)n1nc(nc1NCc1ccc(Cl)s1)-c1ccccc1	InChI=1S/C21H17ClN4O2S/c1-28-17-10-6-5-9-16(17)20(27)26-21(23-13-15-11-12-18(22)29-15)24-19(25-26)14-7-3-2-4-8-14/h2-12H,13H2,1H3,(H,23,24,25)	WYPYYUPYCYVRGI-UHFFFAOYSA-N	164103	US9687479, 383 N-[(5-chlorofuran-2-yl)methyl]-1-[(2-methoxyphenyl)carbonyl]-3-phenyl-1H-1,2,4-triazol-5-amine::US9687479, 387 N-[(5-chlorothiophen-2-yl)methyl]-1-[(2-methoxyphenyl)carbonyl]-3-(piperidin-4-yl)-1H-1,2,4-triazol-5-amine::US9687479, 390 N-[(5-chlorothiophen-2-yl)methyl]-1-[(2-methoxyphenyl)carbonyl]-3-phenyl-1H-1,2,4-triazol-5-amine	Plasma kallikrein			<100					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164103	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164103&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71543848	363890907							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469302	COc1ccccc1C(=O)n1nc(nc1NCc1ccc(Cl)s1)C1CN(C1)S(=O)(=O)N1CCCC1	InChI=1S/C22H25ClN6O4S2/c1-33-18-7-3-2-6-17(18)21(30)29-22(24-12-16-8-9-19(23)34-16)25-20(26-29)15-13-28(14-15)35(31,32)27-10-4-5-11-27/h2-3,6-9,15H,4-5,10-14H2,1H3,(H,24,25,26)	IQSLUFCLAIXJFW-UHFFFAOYSA-N	164171	US9687479, 388 N-[(5-chlorothiophen-2-yl)methyl]-1-[(2-methoxyphenyl)carbonyl]-3-[1-(pyrrolidine-1-sulfonyl)azetidin-3-yl]-1H-1,2,4-triazol-5-amine	Plasma kallikrein			<100					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164171	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164171&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081414	363890910							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469303	COc1ccccc1C(=O)n1nc(nc1NCc1ccc(Cl)s1)-c1ccc(cc1)N1CCOCC1	InChI=1S/C25H24ClN5O3S/c1-33-21-5-3-2-4-20(21)24(32)31-25(27-16-19-10-11-22(26)35-19)28-23(29-31)17-6-8-18(9-7-17)30-12-14-34-15-13-30/h2-11H,12-16H2,1H3,(H,27,28,29)	SMJFJMRDLUXNKZ-UHFFFAOYSA-N	164172	US9687479, 389 N-[(5-chlorothiophen-2-yl)methyl]-1-[(2-methoxyphenyl)carbonyl]-3-[4-(morpholin-4-yl)phenyl]-1H-1,2,4-triazol-5-amine	Plasma kallikrein			 5500					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164172	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164172&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081415	363890911							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469304	COc1ccccc1C(=O)n1nc(nc1NCc1ccc(Cl)s1)-c1ccccc1	InChI=1S/C21H17ClN4O2S/c1-28-17-10-6-5-9-16(17)20(27)26-21(23-13-15-11-12-18(22)29-15)24-19(25-26)14-7-3-2-4-8-14/h2-12H,13H2,1H3,(H,23,24,25)	WYPYYUPYCYVRGI-UHFFFAOYSA-N	164103	US9687479, 383 N-[(5-chlorofuran-2-yl)methyl]-1-[(2-methoxyphenyl)carbonyl]-3-phenyl-1H-1,2,4-triazol-5-amine::US9687479, 387 N-[(5-chlorothiophen-2-yl)methyl]-1-[(2-methoxyphenyl)carbonyl]-3-(piperidin-4-yl)-1H-1,2,4-triazol-5-amine::US9687479, 390 N-[(5-chlorothiophen-2-yl)methyl]-1-[(2-methoxyphenyl)carbonyl]-3-phenyl-1H-1,2,4-triazol-5-amine	Plasma kallikrein			 550					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164103	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164103&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71543848	363890907							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469306	COc1ccccc1C(=O)n1nc(nc1NCc1ccc(Cl)s1)-c1ccccn1	InChI=1S/C20H16ClN5O2S/c1-28-16-8-3-2-6-14(16)19(27)26-20(23-12-13-9-10-17(21)29-13)24-18(25-26)15-7-4-5-11-22-15/h2-11H,12H2,1H3,(H,23,24,25)	UVDLZNNZPDZTET-UHFFFAOYSA-N	163508	US9687479, 22 N-[(5-chlorothiophen-2-yl)methyl]-1-[(2-methoxyphenyl)carbonyl]-3-(pyridin-2-yl)-1H-1,2,4-triazol-5-amine::US9687479, 391 N-[(5-chlorothiophen-2-yl)methyl]-1-[(2-methylphenyl)carbonyl]-3-(pyridin-2-yl)-1H-1,2,4-triazol-5-amine	Plasma kallikrein			 550					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163508	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163508&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081366	363890834							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469307	Clc1ccc(CNc2nc(nn2C(=O)c2ccoc2)C2CCCCO2)s1	InChI=1S/C17H17ClN4O3S/c18-14-5-4-12(26-14)9-19-17-20-15(13-3-1-2-7-25-13)21-22(17)16(23)11-6-8-24-10-11/h4-6,8,10,13H,1-3,7,9H2,(H,19,20,21)	VGCGGMNASHXNKL-UHFFFAOYSA-N	164175	US9687479, 392 N-[(5-chlorothiophen-2-yl)methyl]-1-[(furan-3-yl)carbonyl]-3-(oxolan-2-yl)-1H-1,2,4-triazol-5-amine	Plasma kallikrein			 550					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164175	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164175&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081416	363890912							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469309	COc1ccccc1C(=O)n1nc(nc1NCc1ccc(Cl)s1)-c1ccc(cc1)N(C)C	InChI=1S/C23H22ClN5O2S/c1-28(2)16-10-8-15(9-11-16)21-26-23(25-14-17-12-13-20(24)32-17)29(27-21)22(30)18-6-4-5-7-19(18)31-3/h4-13H,14H2,1-3H3,(H,25,26,27)	LQOTVZQAEBLFTC-UHFFFAOYSA-N	164176	US9687479, 393 N-[(5-chlorothiophen-2-yl)methyl]-3-[4-(dimethylamino)phenyl]-1-[(2-methoxyphenyl)carbonyl]-1H-1,2,4-triazol-5-amine	Plasma kallikrein			 550					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164176	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164176&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081417	363890913							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469310	Fc1cccc(F)c1C(=O)n1nc(nc1NCc1ccccc1)-c1ccccn1	InChI=1S/C21H15F2N5O/c22-15-9-6-10-16(23)18(15)20(29)28-21(25-13-14-7-2-1-3-8-14)26-19(27-28)17-11-4-5-12-24-17/h1-12H,13H2,(H,25,26,27)	CXNYYNFQTFJEHD-UHFFFAOYSA-N	164177	US9687479, 394 N-benzyl-1-[(2,6-difluorophenyl)carbonyl]-3-(pyridin-2-yl)-1H-1,2,4-triazol-5-amine	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164177	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164177&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081418	363890914							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469311	Clc1ccccc1C(=O)n1nc(nc1NCc1ccccc1)-c1ccccn1	InChI=1S/C21H16ClN5O/c22-17-11-5-4-10-16(17)20(28)27-21(24-14-15-8-2-1-3-9-15)25-19(26-27)18-12-6-7-13-23-18/h1-13H,14H2,(H,24,25,26)	PVNXUXQPRPLIJL-UHFFFAOYSA-N	164178	US9687479, 395 N-benzyl-1-[(2-chlorophenyl)carbonyl]-3-(pyridin-2-yl)-1H-1,2,4-triazol-5-amine	Plasma kallikrein			 550					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164178	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164178&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71544427	363890915							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469312	Clc1ccccc1C(=O)n1nc(nc1NCc1ccccc1)-c1ccco1	InChI=1S/C20H15ClN4O2/c21-16-10-5-4-9-15(16)19(26)25-20(22-13-14-7-2-1-3-8-14)23-18(24-25)17-11-6-12-27-17/h1-12H,13H2,(H,22,23,24)	UELOILJFEOKTML-UHFFFAOYSA-N	164179	US9687479, 396 N-benzyl-1-[(2-chlorophenyl)carbonyl]-3-(thiophen-2-yl)-1H-1,2,4-triazol-5-amine	Plasma kallikrein			 550					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164179	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164179&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			4300574	363890916							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469313	COc1ccccc1C(=O)n1nc(nc1NCc1ccccc1)-c1ccccn1	InChI=1S/C22H19N5O2/c1-29-19-13-6-5-11-17(19)21(28)27-22(24-15-16-9-3-2-4-10-16)25-20(26-27)18-12-7-8-14-23-18/h2-14H,15H2,1H3,(H,24,25,26)	DCCNZIMOOBWFDR-UHFFFAOYSA-N	164180	US9687479, 397 N-benzyl-1-[(2-methoxyphenyl)carbonyl]-3-(pyridin-2-yl)-1H-1,2,4-triazol-5-amine	Plasma kallikrein			 5500					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164180	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164180&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71544093	363890917							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469314	COc1ccccc1C(=O)n1nc(nc1NCc1ccccc1)-c1cccs1	InChI=1S/C21H18N4O2S/c1-27-17-11-6-5-10-16(17)20(26)25-21(22-14-15-8-3-2-4-9-15)23-19(24-25)18-12-7-13-28-18/h2-13H,14H2,1H3,(H,22,23,24)	RFQYNOOEOHGOPK-UHFFFAOYSA-N	164181	US9687479, 398 N-benzyl-1-[(2-methoxyphenyl)carbonyl]-3-(thiophen-2-yl)-1H-1,2,4-triazol-5-amine	Plasma kallikrein			 5500					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164181	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164181&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081419	363890918							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469315	Clc1ccc(cc1)C(=O)n1nc(nc1NCc1ccccc1)-c1ccccn1	InChI=1S/C21H16ClN5O/c22-17-11-9-16(10-12-17)20(28)27-21(24-14-15-6-2-1-3-7-15)25-19(26-27)18-8-4-5-13-23-18/h1-13H,14H2,(H,24,25,26)	DGFNCNUBEMBEJH-UHFFFAOYSA-N	164182	US9687479, 399 N-benzyl-1-[(4-chlorophenyl)carbonyl]-3-(pyridin-2-yl)-1H-1,2,4-triazol-5-amine	Plasma kallikrein			 550					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164182	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164182&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71544428	363890919							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469316	O=C(c1ccco1)n1nc(nc1NCc1ccccc1)-c1ccncc1	InChI=1S/C19H15N5O2/c25-18(16-7-4-12-26-16)24-19(21-13-14-5-2-1-3-6-14)22-17(23-24)15-8-10-20-11-9-15/h1-12H,13H2,(H,21,22,23)	MMZCMJSNNKYPHJ-UHFFFAOYSA-N	164183	US9687479, 400 N-benzyl-1-[(furan-2-yl)carbonyl]-3-(pyridin-4-yl)-1H-1,2,4-triazol-5-amine::US9687479, 406 N-benzyl-3-(pyridin-4-yl)-1-[(thiophen-2-yl)carbonyl]-1H-1,2,4-triazol-5-amine	Plasma kallikrein			 5500					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164183	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164183&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081420	363890920							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469317	O=C(c1ccoc1)n1nc(nc1NCc1ccccc1)-c1ccccn1	InChI=1S/C19H15N5O2/c25-18(15-9-11-26-13-15)24-19(21-12-14-6-2-1-3-7-14)22-17(23-24)16-8-4-5-10-20-16/h1-11,13H,12H2,(H,21,22,23)	SEIXRCLNEHHJJB-UHFFFAOYSA-N	164184	US9687479, 401 N-benzyl-1-[(furan-3-yl)carbonyl]-3-(pyridin-2-yl)-1H-1,2,4-triazol-5-amine::US9687479, 405 N-benzyl-3-(pyridin-2-yl)-1-[(thiophen-3-yl)carbonyl]-1H-1,2,4-triazol-5-amine	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164184	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164184&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081421	363890921							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469318	O=C(c1ccoc1)n1nc(nc1NCc1ccccc1)-c1ccncc1	InChI=1S/C19H15N5O2/c25-18(16-8-11-26-13-16)24-19(21-12-14-4-2-1-3-5-14)22-17(23-24)15-6-9-20-10-7-15/h1-11,13H,12H2,(H,21,22,23)	DDZQUXJBMPJFPD-UHFFFAOYSA-N	164185	US9687479, 402 N-benzyl-1-[(furan-3-yl)carbonyl]-3-(pyridin-4-yl)-1H-1,2,4-triazol-5-amine::US9687479, 407 N-benzyl-3-(pyridin-4-yl)-1-[(thiophen-3-yl)carbonyl]-1H-1,2,4-triazol-5-amine	Plasma kallikrein			 55000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164185	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164185&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081422	363890922							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469319	COc1ccccc1C(=O)n1nc(nc1NCc1ccccc1)-c1ccco1	InChI=1S/C21H18N4O3/c1-27-17-11-6-5-10-16(17)20(26)25-21(22-14-15-8-3-2-4-9-15)23-19(24-25)18-12-7-13-28-18/h2-13H,14H2,1H3,(H,22,23,24)	JZZDWLKBMZHEJZ-UHFFFAOYSA-N	164186	US9687479, 403 N-benzyl-3-(furan-2-yl)-1-[(2-methoxyphenyl)carbonyl]-1H-1,2,4-triazol-5-amine	Plasma kallikrein			 5500					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164186	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164186&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			2981014	363890923							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469320	O=C(c1ccco1)n1nc(nc1NCc1ccccc1)-c1ccccn1	InChI=1S/C19H15N5O2/c25-18(16-10-6-12-26-16)24-19(21-13-14-7-2-1-3-8-14)22-17(23-24)15-9-4-5-11-20-15/h1-12H,13H2,(H,21,22,23)	PZTUKBQTXCXKEF-UHFFFAOYSA-N	163434	US9687479, 404 N-benzyl-3-(pyridin-2-yl)-1-[(thiophen-2-yl)carbonyl]-1H-1,2,4-triazol-5-amine::US9687479, 8 N-benzyl-1-[(furan-2-yl)carbonyl]-3-(pyridin-2-yl)-1H-1,2,4-triazol-5-amine	Plasma kallikrein			 5500					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163434	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163434&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			68230292	363890823							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469321	O=C(c1ccoc1)n1nc(nc1NCc1ccccc1)-c1ccccn1	InChI=1S/C19H15N5O2/c25-18(15-9-11-26-13-15)24-19(21-12-14-6-2-1-3-7-14)22-17(23-24)16-8-4-5-10-20-16/h1-11,13H,12H2,(H,21,22,23)	SEIXRCLNEHHJJB-UHFFFAOYSA-N	164184	US9687479, 401 N-benzyl-1-[(furan-3-yl)carbonyl]-3-(pyridin-2-yl)-1H-1,2,4-triazol-5-amine::US9687479, 405 N-benzyl-3-(pyridin-2-yl)-1-[(thiophen-3-yl)carbonyl]-1H-1,2,4-triazol-5-amine	Plasma kallikrein			 55000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164184	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164184&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081421	363890921							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469322	O=C(c1ccco1)n1nc(nc1NCc1ccccc1)-c1ccncc1	InChI=1S/C19H15N5O2/c25-18(16-7-4-12-26-16)24-19(21-13-14-5-2-1-3-6-14)22-17(23-24)15-8-10-20-11-9-15/h1-12H,13H2,(H,21,22,23)	MMZCMJSNNKYPHJ-UHFFFAOYSA-N	164183	US9687479, 400 N-benzyl-1-[(furan-2-yl)carbonyl]-3-(pyridin-4-yl)-1H-1,2,4-triazol-5-amine::US9687479, 406 N-benzyl-3-(pyridin-4-yl)-1-[(thiophen-2-yl)carbonyl]-1H-1,2,4-triazol-5-amine	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164183	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164183&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081420	363890920							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469324	O=C(c1ccoc1)n1nc(nc1NCc1ccccc1)-c1ccncc1	InChI=1S/C19H15N5O2/c25-18(16-8-11-26-13-16)24-19(21-12-14-4-2-1-3-5-14)22-17(23-24)15-6-9-20-10-7-15/h1-11,13H,12H2,(H,21,22,23)	DDZQUXJBMPJFPD-UHFFFAOYSA-N	164185	US9687479, 402 N-benzyl-1-[(furan-3-yl)carbonyl]-3-(pyridin-4-yl)-1H-1,2,4-triazol-5-amine::US9687479, 407 N-benzyl-3-(pyridin-4-yl)-1-[(thiophen-3-yl)carbonyl]-1H-1,2,4-triazol-5-amine	Plasma kallikrein			 550					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164185	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164185&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081422	363890922							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469325	COC(=O)c1nc(NC(=O)c2ccc(C)cc2)n(n1)C(=O)c1ccco1	InChI=1S/C17H14N4O5/c1-10-5-7-11(8-6-10)14(22)19-17-18-13(16(24)25-2)20-21(17)15(23)12-4-3-9-26-12/h3-9H,1-2H3,(H,18,19,20,22)	NRPWACBKHTTXIJ-UHFFFAOYSA-N	164191	US9687479, 408 methyl 5-[(4-methylbenzene)amido]-1H-1,2,4-triazole-3-carboxylate	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164191	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164191&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081423	363890924							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469326	Fc1ccc(CNc2nc(nn2C(=O)Oc2ccccc2)-c2cccnc2)cc1	InChI=1S/C21H16FN5O2/c22-17-10-8-15(9-11-17)13-24-20-25-19(16-5-4-12-23-14-16)26-27(20)21(28)29-18-6-2-1-3-7-18/h1-12,14H,13H2,(H,24,25,26)	DBYUARKMKHIEDM-UHFFFAOYSA-N	164192	US9687479, 409 phenyl 5-[(4-fluorophenyl)methyl]amino-3-(pyridin-3-yl)-1H-1,2,4-triazole-1-carboxylate	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164192	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164192&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081424	363890925							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469327	CC(C)OC(=O)n1nc(nc1NCc1ccc(F)cc1)-c1cccnc1	InChI=1S/C18H18FN5O2/c1-12(2)26-18(25)24-17(21-10-13-5-7-15(19)8-6-13)22-16(23-24)14-4-3-9-20-11-14/h3-9,11-12H,10H2,1-2H3,(H,21,22,23)	KDWNFLIBHMVJKX-UHFFFAOYSA-N	164193	US9687479, 410 propan-2-yl 5-[(4-fluorophenyl)methyl]amino-3-(pyridin-3-yl)-1H-1,2,4-triazole-1-carboxylate	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164193	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164193&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081425	363890926							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469328	COc1ccccc1C(=O)n1nc(nc1NCc1ccc(Cl)s1)C1CN(C1)C(=O)OC(C)(C)C	InChI=1S/C23H26ClN5O4S/c1-23(2,3)33-22(31)28-12-14(13-28)19-26-21(25-11-15-9-10-18(24)34-15)29(27-19)20(30)16-7-5-6-8-17(16)32-4/h5-10,14H,11-13H2,1-4H3,(H,25,26,27)	IINLRSKYVODXJD-UHFFFAOYSA-N	164194	US9687479, 411 tert-butyl 3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-[(2-methoxyphenyl)carbonyl]-1H-1,2,4-triazol-3-yl)azetidine-1-carboxylate	Plasma kallikrein			 550					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164194	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164194&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71544097	363890927							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469329	COc1ccccc1C(=O)n1nc(nc1NCc1ccc(Cl)s1)C1CCN(CC1)C(=O)OC(C)(C)C	InChI=1S/C25H30ClN5O4S/c1-25(2,3)35-24(33)30-13-11-16(12-14-30)21-28-23(27-15-17-9-10-20(26)36-17)31(29-21)22(32)18-7-5-6-8-19(18)34-4/h5-10,16H,11-15H2,1-4H3,(H,27,28,29)	MOXNKBJGRDPORF-UHFFFAOYSA-N	164195	US9687479, 412 tert-butyl4-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-[(2-methoxyphenyl)carbonyl]-1H-1,2,4-triazol-3-yl)piperidine-1-carboxylate	Plasma kallikrein			 550					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164195	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164195&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71544147	363890928							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469330	CC(C)(C)OC(=O)n1nc(nc1NCc1ccc(F)cc1)-c1cccnc1	InChI=1S/C19H20FN5O2/c1-19(2,3)27-18(26)25-17(22-11-13-6-8-15(20)9-7-13)23-16(24-25)14-5-4-10-21-12-14/h4-10,12H,11H2,1-3H3,(H,22,23,24)	WNALHYFHCUKAGO-UHFFFAOYSA-N	164196	US9687479, 413 tert-butyl 5-[(4-fluorophenyl)methyl]amino-3-(pyridin-3-yl)-1H-1,2,4-triazole-1-carboxylate	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164196	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164196&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081426	363890929							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469060	Clc1ccc(CNc2cc(nn2C(=O)c2ccoc2)-c2ccc[nH]c2=O)s1	InChI=1S/C18H13ClN4O3S/c19-15-4-3-12(27-15)9-21-16-8-14(13-2-1-6-20-17(13)24)22-23(16)18(25)11-5-7-26-10-11/h1-8,10,21H,9H2,(H,20,24)	ZPZMUYKLUQEYBK-UHFFFAOYSA-N	162367	US9687479, 4 3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-[(furan-3-yl)carbonyl]-1H-pyrazol-3-yl)-1,2-dihydropyridin-2-one	Plasma kallikrein			 5500					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=162367	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=162367&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081097	363890531							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469061	Clc1ccc(CNc2cc(nn2C(=O)c2ccoc2)-c2cccn(-c3cccs3)c2=O)s1	InChI=1S/C22H15ClN4O3S2/c23-18-6-5-15(32-18)12-24-19-11-17(25-27(19)21(28)14-7-9-30-13-14)16-3-1-8-26(22(16)29)20-4-2-10-31-20/h1-11,13,24H,12H2	LWYSFQLIJXNGSD-UHFFFAOYSA-N	162368	US9687479, 5 3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-[(furan-3-yl)carbonyl]-1H-pyrazol-3-yl)-1-(thiophen-2-ylmethyl)-1,2-dihydropyridin-2-one	Plasma kallikrein			 5500					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=162368	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=162368&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081098	363890532							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469062	CC(C)(C)C(=O)n1nc(cc1NCc1ccc(F)cc1)-c1ccccc1	InChI=1S/C21H22FN3O/c1-21(2,3)20(26)25-19(23-14-15-9-11-17(22)12-10-15)13-18(24-25)16-7-5-4-6-8-16/h4-13,23H,14H2,1-3H3	QIQQZXIOGUZOFW-UHFFFAOYSA-N	163374	US9687479, 19 1-(5-[(4-fluorophenyl)methyl]amino-3-phenyl-1H-pyrazol-1-yl)-2,2-dimethylpropan-1-one	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163374	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163374&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			68231000	363890787							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469063	CC(C)(C)C(=O)n1nc(cc1NCc1ccc(F)cc1)-c1ccccn1	InChI=1S/C20H21FN4O/c1-20(2,3)19(26)25-18(23-13-14-7-9-15(21)10-8-14)12-17(24-25)16-6-4-5-11-22-16/h4-12,23H,13H2,1-3H3	OGNIMYSUUNODCI-UHFFFAOYSA-N	163375	US9687479, 20 1-(5-[(4-fluorophenyl)methyl]amino-3-(pyridin-2-yl)-1H-pyrazol-1-yl)-2,2-dimethylpropan-1-one	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163375	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163375&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			68230999	363890788							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469064	CCOC(=O)c1cn(nc1CNc1ccc(F)cc1)-c1ccccn1	InChI=1S/C18H17FN4O2/c1-2-25-18(24)15-12-23(17-5-3-4-10-20-17)22-16(15)11-21-14-8-6-13(19)7-9-14/h3-10,12,21H,2,11H2,1H3	PWJQOWGKZLBDBB-UHFFFAOYSA-N	163378	US9687479, 21 ethyl 3-[(4-fluorophenyl)methyl]amino-1-(pyridin-2-yl)-1H-pyrazole-4-carboxylate	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163378	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163378&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081341	363890789							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469066	Cn1cccc(-c2cc(NCc3ccc(Cl)s3)n(n2)C(=O)c2ccoc2)c1=O	InChI=1S/C19H15ClN4O3S/c1-23-7-2-3-14(19(23)26)15-9-17(21-10-13-4-5-16(20)28-13)24(22-15)18(25)12-6-8-27-11-12/h2-9,11,21H,10H2,1H3	AJFWSHCJQZKNMM-UHFFFAOYSA-N	162370	US9687479, 23 3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-[(furan-3-yl)carbonyl]-1H-pyrazol-3-yl)-1-methyl-1,2-dihydropyridin-2-one	Plasma kallikrein			 5500					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=162370	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=162370&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081100	363890534							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469067	CC(C)(C)C(=O)n1nc(C2CCNCC2)c(F)c1NCc1ccc(Cl)s1	InChI=1S/C18H24ClFN4OS/c1-18(2,3)17(25)24-16(22-10-12-4-5-13(19)26-12)14(20)15(23-24)11-6-8-21-9-7-11/h4-5,11,21-22H,6-10H2,1-3H3	QYHLFIWGLVWPSH-UHFFFAOYSA-N	163385	US9687479, 24 1-(5-[(5-chlorothiophen-2-yl)methyl]amino-4-fluoro-3-(piperidin-4-yl)-1H-pyrazol-1-yl)-2,2-dimethylpropan-1-one	Plasma kallikrein			 550					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163385	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163385&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081342	363890790							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469069	Clc1ccc(CNc2cc(nn2C(=O)c2ccoc2)-c2cccn(Cc3ccccn3)c2=O)s1	InChI=1S/C24H18ClN5O3S/c25-21-7-6-18(34-21)13-27-22-12-20(28-30(22)23(31)16-8-11-33-15-16)19-5-3-10-29(24(19)32)14-17-4-1-2-9-26-17/h1-12,15,27H,13-14H2	ZWCKLWNGZSFYIB-UHFFFAOYSA-N	162371	US9687479, 25 3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-[(furan-3-yl)carbonyl]-1H-pyrazol-3-yl)-1-(pyridin-2-ylmethyl)-1,2-dihydropyridin-2-one	Plasma kallikrein			 550					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=162371	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=162371&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081101	363890535							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469071	Clc1ccc(CNc2cc(nn2C(=O)c2ccoc2)-c2cccn(Cc3ccco3)c2=O)s1	InChI=1S/C23H17ClN4O4S/c24-20-6-5-17(33-20)12-25-21-11-19(26-28(21)22(29)15-7-10-31-14-15)18-4-1-8-27(23(18)30)13-16-3-2-9-32-16/h1-11,14,25H,12-13H2	YEKHCRPLRFIKRV-UHFFFAOYSA-N	162372	US9687479, 26 3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-[(furan-3-yl)carbonyl]-1H-pyrazol-3-yl)-1-(furan-2-ylmethyl)-1,2-dihydropyridin-2-one	Plasma kallikrein			 5500					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=162372	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=162372&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081102	363890536							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469072	COc1ccc(C(=O)n2nc(cc2NCc2ccc(Cl)s2)-c2cccn(Cc3ccccc3)c2=O)c(OC)c1	InChI=1S/C29H25ClN4O4S/c1-37-20-10-12-23(25(15-20)38-2)29(36)34-27(31-17-21-11-13-26(30)39-21)16-24(32-34)22-9-6-14-33(28(22)35)18-19-7-4-3-5-8-19/h3-16,31H,17-18H2,1-2H3	RWMBYQKHOAAMAE-UHFFFAOYSA-N	162566	US9687479, 46 1-benzyl-3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-[(2,4-dimethoxyphenyl)carbonyl]-1H-pyrazol-3-yl)-1,2-dihydropyridin-2-one	Plasma kallikrein			 55000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=162566	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=162566&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081136	363890570							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469073	CC1(CCOCC1)C(=O)n1nc(cc1NCc1ccc(Cl)s1)-c1cccn(Cc2ccccc2)c1=O	InChI=1S/C27H27ClN4O3S/c1-27(11-14-35-15-12-27)26(34)32-24(29-17-20-9-10-23(28)36-20)16-22(30-32)21-8-5-13-31(25(21)33)18-19-6-3-2-4-7-19/h2-10,13,16,29H,11-12,14-15,17-18H2,1H3	HGLWAQZECSPOPZ-UHFFFAOYSA-N	162568	US9687479, 48 1-benzyl-3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-[(4-methyloxan-4-yl)carbonyl]-1H-pyrazol-3-yl)-1,2-dihydropyridin-2-one	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=162568	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=162568&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081138	363890572							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469074	Clc1ccc(CNc2cc(nn2C(=O)c2ccco2)-c2cccn(Cc3ccccc3)c2=O)s1	InChI=1S/C25H19ClN4O3S/c26-22-11-10-18(34-22)15-27-23-14-20(28-30(23)25(32)21-9-5-13-33-21)19-8-4-12-29(24(19)31)16-17-6-2-1-3-7-17/h1-14,27H,15-16H2	YVMOSFQZLVZFMD-UHFFFAOYSA-N	162569	US9687479, 49 1-benzyl-3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-[(furan-2-yl)carbonyl]-1H-pyrazol-3-yl)-1,2-dihydropyridin-2-one	Plasma kallikrein			 550					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=162569	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=162569&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081139	363890573							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469075	Clc1ccc(CNc2cc(nn2C(=O)c2ccoc2)-c2cccn(Cc3ccccc3)c2=O)s1	InChI=1S/C25H19ClN4O3S/c26-22-9-8-19(34-22)14-27-23-13-21(28-30(23)24(31)18-10-12-33-16-18)20-7-4-11-29(25(20)32)15-17-5-2-1-3-6-17/h1-13,16,27H,14-15H2	OJKCWONNWDEBDG-UHFFFAOYSA-N	162570	US9687479, 50 1-benzyl-3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-[(furan-3-yl)carbonyl]-1H-pyrazol-3-yl)-1,2-dihydropyridin-2-one	Plasma kallikrein			 55000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=162570	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=162570&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081140	363890574							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469076	Clc1ccc(CNc2cc(nn2C(=O)c2cccs2)-c2cccn(Cc3ccccc3)c2=O)s1	InChI=1S/C25H19ClN4O2S2/c26-22-11-10-18(34-22)15-27-23-14-20(28-30(23)25(32)21-9-5-13-33-21)19-8-4-12-29(24(19)31)16-17-6-2-1-3-7-17/h1-14,27H,15-16H2	QBWHBKRBXMELPB-UHFFFAOYSA-N	162571	US9687479, 51 1-benzyl-3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-[(thiophen-2-yl)carbonyl]-1H-pyrazol-3-yl)-1,2-dihydropyridin-2-one	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=162571	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=162571&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081141	363890575							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469077	Clc1ccc(CNc2cc(nn2C(=O)c2ccsc2)-c2cccn(Cc3ccccc3)c2=O)s1	InChI=1S/C25H19ClN4O2S2/c26-22-9-8-19(34-22)14-27-23-13-21(28-30(23)24(31)18-10-12-33-16-18)20-7-4-11-29(25(20)32)15-17-5-2-1-3-6-17/h1-13,16,27H,14-15H2	GMHPAUJERUQCDU-UHFFFAOYSA-N	162572	US9687479, 52 1-benzyl-3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-[(thiophen-3-yl)carbonyl]-1H-pyrazol-3-yl)-1,2-dihydropyridin-2-one	Plasma kallikrein			 550					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=162572	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=162572&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081142	363890576							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469078	Clc1ccc(CNc2cc(nn2C(=O)c2ccc(cc2)N2CCOCC2)-c2cccn(Cc3ccccc3)c2=O)s1	InChI=1S/C31H28ClN5O3S/c32-28-13-12-25(41-28)20-33-29-19-27(26-7-4-14-36(31(26)39)21-22-5-2-1-3-6-22)34-37(29)30(38)23-8-10-24(11-9-23)35-15-17-40-18-16-35/h1-14,19,33H,15-18,20-21H2	OUXBTOZXEHMZEA-UHFFFAOYSA-N	162573	US9687479, 53 1-benzyl-3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-[4-(morpholin-4-yl)phenyl]carbonyl-1H-pyrazol-3-yl)-1,2-dihydropyridin-2-one	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=162573	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=162573&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081143	363890577							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469080	OC(=O)n1cccc(-c2cc(NCc3ccc(Cl)s3)nn2)c1=O	InChI=1S/C14H10ClN4O3S/c15-11-4-3-8(23-11)7-16-12-6-10(17-18-12)9-2-1-5-19(13(9)20)14(21)22/h1-6H,7H2,(H,16,18)(H,21,22)	YRYSZZBZOFDNRC-UHFFFAOYSA-N	162579	US9687479, 59 2-[3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1H-pyrazol-3-yl)-2-oxo-1,2-dihydropyridin-1-yl]acetic acid	Plasma kallikrein			 5500					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=162579	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=162579&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081147	363890583							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469081	COCCn1cccc(-c2cc(NCc3ccc(Cl)s3)n(n2)C(=O)c2ccccc2)c1=O	InChI=1S/C23H21ClN4O3S/c1-31-13-12-27-11-5-8-18(23(27)30)19-14-21(25-15-17-9-10-20(24)32-17)28(26-19)22(29)16-6-3-2-4-7-16/h2-11,14,25H,12-13,15H2,1H3	MPPXUTXEBYMPIB-UHFFFAOYSA-N	162582	US9687479, 62 3-(1-benzoyl-5-[(5-chlorothiophen-2-yl)methyl]amino-1H-pyrazol-3-yl)-1-(2-methoxyethyl)-1,2-dihydropyridin-2-one	Plasma kallikrein			 5500					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=162582	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=162582&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081149	363890586							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469082	Cn1cccc(-c2cc(NCc3ccc(Cl)s3)n(n2)C(=O)c2ccccc2)c1=O	InChI=1S/C21H17ClN4O2S/c1-25-11-5-8-16(21(25)28)17-12-19(23-13-15-9-10-18(22)29-15)26(24-17)20(27)14-6-3-2-4-7-14/h2-12,23H,13H2,1H3	FYGKHEKXADLQAT-UHFFFAOYSA-N	162593	US9687479, 73 3-(1-benzoyl-5-[(5-chlorothiophen-2-yl)methyl]amino-1H-pyrazol-3-yl)-1-methyl-1,2-dihydropyridin-2-one	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=162593	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=162593&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081160	363890597							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469083	CC(C)(C)C(=O)n1nc(cc1NCc1ccc(Cl)s1)-c1cccn(Cc2ccco2)c1=O	InChI=1S/C23H23ClN4O3S/c1-23(2,3)22(30)28-20(25-13-16-8-9-19(24)32-16)12-18(26-28)17-7-4-10-27(21(17)29)14-15-6-5-11-31-15/h4-12,25H,13-14H2,1-3H3	IVWUGHYHTPAHRH-UHFFFAOYSA-N	162597	US9687479, 77 3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-(2,2-dimethylpropanoyl)-1H-pyrazol-3-yl)-1-(furan-2-ylmethyl)-1,2-dihydropyridin-2-one	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=162597	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=162597&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081164	363890601							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469085	CC(C)(C)C(=O)n1nc(cc1NCc1ccc(Cl)s1)-c1cccn(Cc2cccnn2)c1=O	InChI=1S/C23H23ClN6O2S/c1-23(2,3)22(32)30-20(25-13-16-8-9-19(24)33-16)12-18(28-30)17-7-5-11-29(21(17)31)14-15-6-4-10-26-27-15/h4-12,25H,13-14H2,1-3H3	YEQOTFQTNRMTMJ-UHFFFAOYSA-N	162601	US9687479, 81 3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-(2,2-dimethylpropanoyl)-1H-pyrazol-3-yl)-1-(pyridazin-3-ylmethyl)-1,2-dihydropyridin-2-one	Plasma kallikrein			 5500					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=162601	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=162601&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081168	363890605							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469086	COCCn1cccc(-c2cc(NCc3ccc(Cl)s3)n(n2)C(=O)C(C)(C)CO)c1=O	InChI=1S/C21H25ClN4O4S/c1-21(2,13-27)20(29)26-18(23-12-14-6-7-17(22)31-14)11-16(24-26)15-5-4-8-25(19(15)28)9-10-30-3/h4-8,11,23,27H,9-10,12-13H2,1-3H3	GNYAUENMEQGNTM-UHFFFAOYSA-N	162612	US9687479, 92 3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-(3-hydroxy-2,2-dimethylpropanoyl)-1H-pyrazol-3-yl)-1-(2-methoxyethyl)-1,2-dihydropyridin-2-one	Plasma kallikrein			 55000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=162612	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=162612&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081177	363890615							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469087	CC(C)(CO)C(=O)n1nc(cc1NCc1ccc(Cl)s1)-c1cccn(Cc2ccco2)c1=O	InChI=1S/C23H23ClN4O4S/c1-23(2,14-29)22(31)28-20(25-12-16-7-8-19(24)33-16)11-18(26-28)17-6-3-9-27(21(17)30)13-15-5-4-10-32-15/h3-11,25,29H,12-14H2,1-2H3	RXOFOKLGYNDAHX-UHFFFAOYSA-N	162613	US9687479, 93 3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-(3-hydroxy-2,2-dimethylpropanoyl)-1H-pyrazol-3-yl)-1-(furan-2-ylmethyl)-1,2-dihydropyridin-2-one	Plasma kallikrein			 55000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=162613	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=162613&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081178	363890616							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469088	CC(C)(CO)C(=O)n1nc(cc1NCc1ccc(Cl)s1)-c1cccn(Cc2cccnc2)c1=O	InChI=1S/C24H24ClN5O3S/c1-24(2,15-31)23(33)30-21(27-13-17-7-8-20(25)34-17)11-19(28-30)18-6-4-10-29(22(18)32)14-16-5-3-9-26-12-16/h3-12,27,31H,13-15H2,1-2H3	PHFMTBJWZLSXOO-UHFFFAOYSA-N	162614	US9687479, 94 3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-(3-hydroxy-2,2-dimethylpropanoyl)-1H-pyrazol-3-yl)-1-(pyridin-3-ylmethyl)-1,2-dihydropyridin-2-one	Plasma kallikrein			 5500					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=162614	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=162614&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081179	363890617							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469089	COCCn1cccc(-c2cc(NCc3ccc(Cl)s3)n(n2)C(=O)C(C)(C)COC)c1=O	InChI=1S/C22H27ClN4O4S/c1-22(2,14-31-4)21(29)27-19(24-13-15-7-8-18(23)32-15)12-17(25-27)16-6-5-9-26(20(16)28)10-11-30-3/h5-9,12,24H,10-11,13-14H2,1-4H3	QLCLXAFYVPVRPY-UHFFFAOYSA-N	162617	US9687479, 97 3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-(3-methoxy-2,2-dimethylpropanoyl)-1H-pyrazol-3-yl)-1-(2-methoxyethyl)-1,2-dihydropyridin-2-one	Plasma kallikrein			 55000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=162617	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=162617&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081182	363890620							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469090	COCC(C)(C)C(=O)n1nc(cc1NCc1ccc(Cl)s1)-c1cccn(Cc2ccco2)c1=O	InChI=1S/C24H25ClN4O4S/c1-24(2,15-32-3)23(31)29-21(26-13-17-8-9-20(25)34-17)12-19(27-29)18-7-4-10-28(22(18)30)14-16-6-5-11-33-16/h4-12,26H,13-15H2,1-3H3	GQVVQCIUGAQKNX-UHFFFAOYSA-N	162618	US9687479, 98 3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-(3-methoxy-2,2-dimethylpropanoyl)-1H-pyrazol-3-yl)-1-(furan-2-ylmethyl)-1,2-dihydropyridin-2-one	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=162618	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=162618&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081183	363890621							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469091	COCC(C)(C)C(=O)n1nc(cc1NCc1ccc(Cl)s1)-c1cccn(Cc2cccnn2)c1=O	InChI=1S/C24H25ClN6O3S/c1-24(2,15-34-3)23(33)31-21(26-13-17-8-9-20(25)35-17)12-19(29-31)18-7-5-11-30(22(18)32)14-16-6-4-10-27-28-16/h4-12,26H,13-15H2,1-3H3	MWSSEXKMZWBKCW-UHFFFAOYSA-N	162620	US9687479, 100 3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-(3-methoxy-2,2-dimethylpropanoyl)-1H-pyrazol-3-yl)-1-(pyridazin-3-ylmethyl)-1,2-dihydropyridin-2-one	Plasma kallikrein			 5500					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=162620	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=162620&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081185	363890623							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469092	COCC(C)(C)C(=O)n1nc(cc1NCc1ccc(Cl)s1)-c1cccn(Cc2ccccn2)c1=O	InChI=1S/C25H26ClN5O3S/c1-25(2,16-34-3)24(33)31-22(28-14-18-9-10-21(26)35-18)13-20(29-31)19-8-6-12-30(23(19)32)15-17-7-4-5-11-27-17/h4-13,28H,14-16H2,1-3H3	IMCJDIBSQRXSON-UHFFFAOYSA-N	162621	US9687479, 101 3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-(3-methoxy-2,2-dimethylpropanoyl)-1H-pyrazol-3-yl)-1-(pyridin-2-ylmethyl)-1,2-dihydropyridin-2-one	Plasma kallikrein			 55000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=162621	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=162621&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081186	363890624							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469093	COCC(C)(C)C(=O)n1nc(cc1NCc1ccc(Cl)s1)-c1cccn(Cc2cccnc2)c1=O	InChI=1S/C25H26ClN5O3S/c1-25(2,16-34-3)24(33)31-22(28-14-18-8-9-21(26)35-18)12-20(29-31)19-7-5-11-30(23(19)32)15-17-6-4-10-27-13-17/h4-13,28H,14-16H2,1-3H3	RYFSKTVMORWCDC-UHFFFAOYSA-N	162622	US9687479, 102 3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-(3-methoxy-2,2-dimethylpropanoyl)-1H-pyrazol-3-yl)-1-(pyridin-3-ylmethyl)-1,2-dihydropyridin-2-one	Plasma kallikrein			 55000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=162622	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=162622&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081187	363890625							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469094	COCC(C)(C)C(=O)n1nc(cc1NCc1ccc(Cl)s1)-c1cccn(Cc2ccncc2)c1=O	InChI=1S/C25H26ClN5O3S/c1-25(2,16-34-3)24(33)31-22(28-14-18-6-7-21(26)35-18)13-20(29-31)19-5-4-12-30(23(19)32)15-17-8-10-27-11-9-17/h4-13,28H,14-16H2,1-3H3	FGYAHTCNARRPRO-UHFFFAOYSA-N	162623	US9687479, 103 3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-(3-methoxy-2,2-dimethylpropanoyl)-1H-pyrazol-3-yl)-1-(pyridin-4-ylmethyl)-1,2-dihydropyridin-2-one	Plasma kallikrein			 55000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=162623	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=162623&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081188	363890626							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469095	COCC(C)(C)C(=O)n1nc(cc1NCc1ccc(Cl)s1)-c1cccn(Cc2ncccn2)c1=O	InChI=1S/C24H25ClN6O3S/c1-24(2,15-34-3)23(33)31-21(28-13-16-7-8-19(25)35-16)12-18(29-31)17-6-4-11-30(22(17)32)14-20-26-9-5-10-27-20/h4-12,28H,13-15H2,1-3H3	HRBPIURDHJVNMR-UHFFFAOYSA-N	162624	US9687479, 104 3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-(3-methoxy-2,2-dimethylpropanoyl)-1H-pyrazol-3-yl)-1-(pyrimidin-2-ylmethyl)-1,2-dihydropyridin-2-one	Plasma kallikrein			 5500					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=162624	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=162624&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081189	363890627							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469096	COCC(C)(C)C(=O)n1nc(cc1NCc1ccc(Cl)s1)-c1cccn(Cc2cccs2)c1=O	InChI=1S/C24H25ClN4O3S2/c1-24(2,15-32-3)23(31)29-21(26-13-16-8-9-20(25)34-16)12-19(27-29)18-7-4-10-28(22(18)30)14-17-6-5-11-33-17/h4-12,26H,13-15H2,1-3H3	VRURYSOJALBZSD-UHFFFAOYSA-N	162625	US9687479, 105 3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-(3-methoxy-2,2-dimethylpropanoyl)-1H-pyrazol-3-yl)-1-(thiophen-2-ylmethyl)-1,2-dihydropyridin-2-one	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=162625	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=162625&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081190	363890628							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469097	COCC(C)(C)C(=O)n1nc(cc1NCc1ccc(Cl)s1)-c1cccn(Cc2ccsc2)c1=O	InChI=1S/C24H25ClN4O3S2/c1-24(2,15-32-3)23(31)29-21(26-12-17-6-7-20(25)34-17)11-19(27-29)18-5-4-9-28(22(18)30)13-16-8-10-33-14-16/h4-11,14,26H,12-13,15H2,1-3H3	SJBBIZHPAPZCOJ-UHFFFAOYSA-N	162626	US9687479, 106 3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-(3-methoxy-2,2-dimethylpropanoyl)-1H-pyrazol-3-yl)-1-(thiophen-3-ylmethyl)-1,2-dihydropyridin-2-one	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=162626	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=162626&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081191	363890629							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469098	COCCn1cccc(-c2cc(NCc3ccc(Cl)s3)n(n2)C(=O)c2cccc3OCCOc23)c1=O	InChI=1S/C25H23ClN4O5S/c1-33-11-10-29-9-3-5-17(24(29)31)19-14-22(27-15-16-7-8-21(26)36-16)30(28-19)25(32)18-4-2-6-20-23(18)35-13-12-34-20/h2-9,14,27H,10-13,15H2,1H3	QIPXCTVJXJLOKX-UHFFFAOYSA-N	162629	US9687479, 109 3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-[(2,3-dihydro-1,4-benzodioxin-5-yl)carbonyl]-1H-pyrazol-3-yl)-1-(2-methoxyethyl)-1,2-dihydropyridin-2-one	Plasma kallikrein			 5500					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=162629	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=162629&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081194	363890632							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469100	Clc1ccc(CNc2cc(nn2C(=O)c2cccc3OCCOc23)-c2cccn(Cc3ccccn3)c2=O)s1	InChI=1S/C28H22ClN5O4S/c29-24-10-9-19(39-24)16-31-25-15-22(20-7-4-12-33(27(20)35)17-18-5-1-2-11-30-18)32-34(25)28(36)21-6-3-8-23-26(21)38-14-13-37-23/h1-12,15,31H,13-14,16-17H2	KEPWGKRYDTUVBA-UHFFFAOYSA-N	162633	US9687479, 113 3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-[(2,3-dihydro-1,4-benzodioxin-5-yl)carbonyl]-1H-pyrazol-3-yl)-1-(pyridin-2-ylmethyl)-1,2-dihydropyridin-2-one	Plasma kallikrein			 550					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=162633	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=162633&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081198	363890636							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469101	Clc1ccc(CNc2cc(nn2C(=O)c2cccc3OCCOc23)-c2cccn(Cc3ncccn3)c2=O)s1	InChI=1S/C27H21ClN6O4S/c28-22-8-7-17(39-22)15-31-24-14-20(18-5-2-11-33(26(18)35)16-23-29-9-3-10-30-23)32-34(24)27(36)19-4-1-6-21-25(19)38-13-12-37-21/h1-11,14,31H,12-13,15-16H2	SIBTYXMDPUYXOZ-UHFFFAOYSA-N	162636	US9687479, 116 3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-[(2,3-dihydro-1,4-benzodioxin-5-yl)carbonyl]-1H-pyrazol-3-yl)-1-(pyrimidin-2-ylmethyl)-1,2-dihydropyridin-2-one	Plasma kallikrein			 5500					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=162636	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=162636&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081201	363890639							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469102	Clc1ccc(CNc2cc(nn2C(=O)c2cccc3OCCOc23)-c2cccn(Cc3cccs3)c2=O)s1	InChI=1S/C27H21ClN4O4S2/c28-23-9-8-17(38-23)15-29-24-14-21(19-6-2-10-31(26(19)33)16-18-4-3-13-37-18)30-32(24)27(34)20-5-1-7-22-25(20)36-12-11-35-22/h1-10,13-14,29H,11-12,15-16H2	RCGPREZFRAJRDO-UHFFFAOYSA-N	162637	US9687479, 117 3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-[(2,3-dihydro-1,4-benzodioxin-5-yl)carbonyl]-1H-pyrazol-3-yl)-1-(thiophen-2-ylmethyl)-1,2-dihydropyridin-2-one	Plasma kallikrein			>100000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=162637	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=162637&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081202	363890640							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469103	COCCn1cccc(-c2cc(NCc3ccc(Cl)s3)n(n2)C(=O)c2ccc(OC)cc2OC)c1=O	InChI=1S/C25H25ClN4O5S/c1-33-12-11-29-10-4-5-18(24(29)31)20-14-23(27-15-17-7-9-22(26)36-17)30(28-20)25(32)19-8-6-16(34-2)13-21(19)35-3/h4-10,13-14,27H,11-12,15H2,1-3H3	QKXNKJWRSSLXPI-UHFFFAOYSA-N	162642	US9687479, 122 3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-[(2,4-dimethoxyphenyl)carbonyl]-1H-pyrazol-3-yl)-1-(2-methoxyethyl)-1,2-dihydropyridin-2-one	Plasma kallikrein			 5500					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=162642	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=162642&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081207	363890645							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469104	COc1ccc(C(=O)n2nc(cc2NCc2ccc(Cl)s2)-c2cccn(Cc3ccoc3)c2=O)c(OC)c1	InChI=1S/C27H23ClN4O5S/c1-35-18-5-7-21(23(12-18)36-2)27(34)32-25(29-14-19-6-8-24(28)38-19)13-22(30-32)20-4-3-10-31(26(20)33)15-17-9-11-37-16-17/h3-13,16,29H,14-15H2,1-2H3	YOBWHGGDONILMS-UHFFFAOYSA-N	162643	US9687479, 123 3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-[(2,4-dimethoxyphenyl)carbonyl]-1H-pyrazol-3-yl)-1-(furan-3-ylmethyl)-1,2-dihydropyridin-2-one	Plasma kallikrein			 55000					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=162643	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=162643&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081208	363890646							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469105	COc1ccc(C(=O)n2nc(cc2NCc2ccc(Cl)s2)-c2cccn(Cc3ccccn3)c2=O)c(OC)c1	InChI=1S/C28H24ClN5O4S/c1-37-19-8-10-22(24(14-19)38-2)28(36)34-26(31-16-20-9-11-25(29)39-20)15-23(32-34)21-7-5-13-33(27(21)35)17-18-6-3-4-12-30-18/h3-15,31H,16-17H2,1-2H3	NLOBXKBUMIJYMU-UHFFFAOYSA-N	162645	US9687479, 125 3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-[(2,4-dimethoxyphenyl)carbonyl]-1H-pyrazol-3-yl)-1-(pyridin-2-ylmethyl)-1,2-dihydropyridin-2-one	Plasma kallikrein			 5500					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=162645	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=162645&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081210	363890648							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469107	COc1ccc(C(=O)n2nc(cc2NCc2ccc(Cl)s2)-c2cccn(Cc3cccnc3)c2=O)c(OC)c1	InChI=1S/C28H24ClN5O4S/c1-37-19-7-9-22(24(13-19)38-2)28(36)34-26(31-16-20-8-10-25(29)39-20)14-23(32-34)21-6-4-12-33(27(21)35)17-18-5-3-11-30-15-18/h3-15,31H,16-17H2,1-2H3	YFQJGNJWXSYLMF-UHFFFAOYSA-N	162646	US9687479, 126 3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-[(2,4-dimethoxyphenyl)carbonyl]-1H-pyrazol-3-yl)-1-(pyridin-3-ylmethyl)-1,2-dihydropyridin-2-one	Plasma kallikrein			 5500					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=162646	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=162646&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081211	363890649							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
469108	COc1ccc(C(=O)n2nc(cc2NCc2ccc(Cl)s2)-c2cccn(CCN3CCOCC3)c2=O)c(OC)c1	InChI=1S/C28H30ClN5O5S/c1-37-19-5-7-22(24(16-19)38-2)28(36)34-26(30-18-20-6-8-25(29)40-20)17-23(31-34)21-4-3-9-33(27(21)35)11-10-32-12-14-39-15-13-32/h3-9,16-17,30H,10-15,18H2,1-2H3	OTBZVBNLUBUGGT-UHFFFAOYSA-N	162651	US9687479, 131 3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-[(2,4-dimethoxyphenyl)carbonyl]-1H-pyrazol-3-yl)-1-[2-(morpholin-4-yl)ethyl]-1,2-dihydropyridin-2-one	Plasma kallikrein			 550					7.4	25.00 C	US Patent		10.7270/Q2N29V4R		aid1794953	US9687479	Short, KM; Pham, SM; Williams, DC; Kita, DB	VERSEON CORPORATION	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=162651	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=162651&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081216	363890654							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498482	Cc1cc(C(=O)NCc2ccc3c(N)nccc3c2)c(C)n1Cc1csc(n1)-c1ccccc1	InChI=1S/C27H25N5OS/c1-17-12-24(26(33)30-14-19-8-9-23-21(13-19)10-11-29-25(23)28)18(2)32(17)15-22-16-34-27(31-22)20-6-4-3-5-7-20/h3-13,16H,14-15H2,1-2H3,(H2,28,29)(H,30,33)	NDPHLXVHICHOPO-UHFFFAOYSA-N	229983	2,5-dimethyl-1-(2-phenyl-thiazol-4-ylmethyl)-1h-pyrrole-3-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 1	Plasma kallikrein			 54.7							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=229983	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=229983&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86344381	377002119							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498483	Cc1cc(C(=O)NCc2ccc3ccnc(N)c3c2)c(C)n1Cc1csc(n1)-c1ccccc1	InChI=1S/C27H25N5OS/c1-17-12-23(26(33)30-14-19-8-9-20-10-11-29-25(28)24(20)13-19)18(2)32(17)15-22-16-34-27(31-22)21-6-4-3-5-7-21/h3-13,16H,14-15H2,1-2H3,(H2,28,29)(H,30,33)	UMCCHSIVSAJUQF-UHFFFAOYSA-N	229995	2,5-dimethyl-1-(2-phenyl-thiazol-4-ylmethyl)-1h-pyrrole-3-carboxylic acid (1-amino-isoquinolin-7-ylmethyl)-amide::US9533987, example 2	Plasma kallikrein			 2110							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=229995	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=229995&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117715045	377002120							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498484	Cc1cc(C(=O)NCc2ccc3[nH]ccc3c2)c(C)n1Cc1csc(n1)-c1ccccc1	InChI=1S/C26H24N4OS/c1-17-12-23(25(31)28-14-19-8-9-24-21(13-19)10-11-27-24)18(2)30(17)15-22-16-32-26(29-22)20-6-4-3-5-7-20/h3-13,16,27H,14-15H2,1-2H3,(H,28,31)	KFDUPHCWKNCSJB-UHFFFAOYSA-N	230010	2,5-dimethyl-1-(2-phenyl-thiazol-4-ylmethyl)-1h-pyrrole-3-carboxylic acid (1h-pyrrolo[2,3-b]pyridin-5-ylmethyl)-amide::US9533987, example 3	Plasma kallikrein			 2690							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=230010	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=230010&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121288937	377002121							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498485	CCn1c(cc(C)c1Cc1ccc(Cn2ccccc2=O)cc1)C(=O)NCc1ccc2c(N)nccc2c1	InChI=1S/C31H31N5O2/c1-3-36-27(18-22-7-9-23(10-8-22)20-35-15-5-4-6-29(35)37)21(2)16-28(36)31(38)34-19-24-11-12-26-25(17-24)13-14-33-30(26)32/h4-17H,3,18-20H2,1-2H3,(H2,32,33)(H,34,38)	RAUIBWGXUJDXBK-UHFFFAOYSA-N	254026	1-ethyl-4-methyl-5-[4-(2-oxo-2h-pyridin-1-ylmethyl)-benzyl]-1h-pyrrole-2-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 6	Plasma kallikrein			 9460							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=254026	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=254026&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86344563	377002122							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498486	FC(F)(F)c1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cnc2[nH]ccc2c1	InChI=1S/C26H21F3N6O2/c27-26(28,29)23-21(25(37)32-13-19-11-20-8-9-30-24(20)31-12-19)16-35(33-23)15-18-6-4-17(5-7-18)14-34-10-2-1-3-22(34)36/h1-12,16H,13-15H2,(H,30,31)(H,32,37)	ZNSUFNBJZUAHMQ-UHFFFAOYSA-N	261344	1-[4-(2-oxo-2h-pyridin-1-ylmethyl)-benzyl]-3-trifluoromethyl-1h-pyrazole-4-carboxylic acid (1h-pyrrolo[2,3-b]pyridin-5-ylmethyl)-amide::US9533987, example 7	Plasma kallikrein			 5.38							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261344	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261344&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117715239	377002124							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498487	Cc1nc2[nH]ccc2c(C)c1CNC(=O)c1cn(Cc2ccc(Cn3ccccc3=O)cc2)nc1C(F)(F)F	InChI=1S/C28H25F3N6O2/c1-17-21-10-11-32-26(21)34-18(2)22(17)13-33-27(39)23-16-37(35-25(23)28(29,30)31)15-20-8-6-19(7-9-20)14-36-12-4-3-5-24(36)38/h3-12,16H,13-15H2,1-2H3,(H,32,34)(H,33,39)	ZXPGXTZEIVIBIC-UHFFFAOYSA-N	263213	1-[4-(2-oxo-2h-pyridin-1-ylmethyl)-benzyl]-3-trifluoromethyl-1h-pyrazole-4-carboxylic acid (4,6-dimethyl-1h-pyrrolo[2,3-b]pyridin-5-ylmethyl)-amide::US9533987, example 8	Plasma kallikrein			 3.72							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263213	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263213&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121288939	377002125							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498488	Cc1cnn(Cc2ccc(Cn3c(C)cc(C(=O)NCc4ccc5c(N)nccc5c4)c3C)cc2)c1	InChI=1S/C29H30N6O/c1-19-14-33-34(16-19)17-22-4-6-23(7-5-22)18-35-20(2)12-27(21(35)3)29(36)32-15-24-8-9-26-25(13-24)10-11-31-28(26)30/h4-14,16H,15,17-18H2,1-3H3,(H2,30,31)(H,32,36)	OUIUBQFLHJFGIC-UHFFFAOYSA-N	263214	2,5-dimethyl-1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-1h-pyrrole-3-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 9	Plasma kallikrein			 14.3							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263214	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263214&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86344561	377002126							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498489	Cc1cnn(Cc2ccc(Cn3cnc(c3)C(=O)NCc3ccc4c(N)nccc4c3)cc2)c1	InChI=1S/C26H25N7O/c1-18-11-31-33(13-18)15-20-4-2-19(3-5-20)14-32-16-24(30-17-32)26(34)29-12-21-6-7-23-22(10-21)8-9-28-25(23)27/h2-11,13,16-17H,12,14-15H2,1H3,(H2,27,28)(H,29,34)	MCLBVPPTLFLLSH-UHFFFAOYSA-N	263215	1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-1h-imidazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 10::US9533987, example 32	Plasma kallikrein			 2.4							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263215	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263215&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86344559	377002127							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498490	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4ccc5c(N)nccc5c4)c(C)n3)cc2)c1	InChI=1S/C27H27N7O/c1-18-12-31-33(14-18)15-20-3-5-21(6-4-20)16-34-17-25(19(2)32-34)27(35)30-13-22-7-8-24-23(11-22)9-10-29-26(24)28/h3-12,14,17H,13,15-16H2,1-2H3,(H2,28,29)(H,30,35)	PXZBRJHSOLRAIJ-UHFFFAOYSA-N	263221	3-methyl-1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 11	Plasma kallikrein			 1.89							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263221	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263221&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86344749	377002133							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498491	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4ccc5c(N)nccc5c4)c(n3)C3CC3)cc2)c1	InChI=1S/C29H29N7O/c1-19-13-33-35(15-19)16-20-2-4-21(5-3-20)17-36-18-26(27(34-36)23-7-8-23)29(37)32-14-22-6-9-25-24(12-22)10-11-31-28(25)30/h2-6,9-13,15,18,23H,7-8,14,16-17H2,1H3,(H2,30,31)(H,32,37)	KEVAPGHQGBLBGH-UHFFFAOYSA-N	263223	3-cyclopropyl-1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 12	Plasma kallikrein			 2.58							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263223	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263223&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86344750	377002135							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498492	CC(C)c1nn(Cc2ccc(Cn3cc(C)cn3)cc2)cc1C(=O)NCc1ccc2c(N)nccc2c1	InChI=1S/C29H31N7O/c1-19(2)27-26(29(37)32-14-23-8-9-25-24(12-23)10-11-31-28(25)30)18-36(34-27)17-22-6-4-21(5-7-22)16-35-15-20(3)13-33-35/h4-13,15,18-19H,14,16-17H2,1-3H3,(H2,30,31)(H,32,37)	URCKKASOEPCAIT-UHFFFAOYSA-N	263224	3-isopropyl-1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 13	Plasma kallikrein			 2.14							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263224	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263224&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86344930	377002136							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498493	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4ccc5c(N)nccc5c4)c(n3)C3CCC3)cc2)c1	InChI=1S/C30H31N7O/c1-20-14-34-36(16-20)17-21-5-7-22(8-6-21)18-37-19-27(28(35-37)24-3-2-4-24)30(38)33-15-23-9-10-26-25(13-23)11-12-32-29(26)31/h5-14,16,19,24H,2-4,15,17-18H2,1H3,(H2,31,32)(H,33,38)	VUTOLLLOTRHDTA-UHFFFAOYSA-N	263228	3-cyclobutyl-1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 14	Plasma kallikrein			 4.62							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263228	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263228&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86344931	377002140							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498494	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4ccc5c(N)nccc5c4)c(CO)n3)cc2)c1	InChI=1S/C27H27N7O2/c1-18-11-31-33(13-18)14-19-2-4-20(5-3-19)15-34-16-24(25(17-35)32-34)27(36)30-12-21-6-7-23-22(10-21)8-9-29-26(23)28/h2-11,13,16,35H,12,14-15,17H2,1H3,(H2,28,29)(H,30,36)	VMIWCYSSHRTVOL-UHFFFAOYSA-N	263229	3-hydroxymethyl-1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 15	Plasma kallikrein			 1.17							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263229	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263229&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86344932	377002141							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498495	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4ccc5c(N)nccc5c4)c(n3)C#N)cc2)c1	InChI=1S/C27H24N8O/c1-18-12-32-34(14-18)15-19-2-4-20(5-3-19)16-35-17-24(25(11-28)33-35)27(36)31-13-21-6-7-23-22(10-21)8-9-30-26(23)29/h2-10,12,14,17H,13,15-16H2,1H3,(H2,29,30)(H,31,36)	BDJNNTFQHLXNDS-UHFFFAOYSA-N	263231	3-cyano-1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 16	Plasma kallikrein			 0.74							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263231	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263231&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86344933	377002143							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498496	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4ccc5c(N)nccc5c4)c(n3)C(O)=O)cc2)c1	InChI=1S/C27H25N7O3/c1-17-11-31-33(13-17)14-18-2-4-19(5-3-18)15-34-16-23(24(32-34)27(36)37)26(35)30-12-20-6-7-22-21(10-20)8-9-29-25(22)28/h2-11,13,16H,12,14-15H2,1H3,(H2,28,29)(H,30,35)(H,36,37)	RGTBACCSTBZIEJ-UHFFFAOYSA-N	263232	4-[(1-amino-isoquinolin-6-ylmethyl)-carbamoyl]-1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-1h-pyrazole-3-carboxylic acid::US9533987, example 17	Plasma kallikrein			 1190							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263232	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263232&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117704510	377002144							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498497	Cc1cnn(Cc2ccc(Cc3nc(C)c(s3)C(=O)NCc3ccc4c(N)nccc4c3)cc2)c1	InChI=1S/C27H26N6OS/c1-17-13-31-33(15-17)16-20-5-3-19(4-6-20)12-24-32-18(2)25(35-24)27(34)30-14-21-7-8-23-22(11-21)9-10-29-26(23)28/h3-11,13,15H,12,14,16H2,1-2H3,(H2,28,29)(H,30,34)	UAXGFNOVXFRLLA-UHFFFAOYSA-N	263233	4-methyl-2-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-thiazole-5-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 18	Plasma kallikrein			 32.0							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263233	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263233&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86344934	377002145							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498498	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4ccc5c(N)nccc5c4)c(=O)[nH]3)cc2)c1	InChI=1S/C26H25N7O2/c1-17-11-30-32(13-17)14-18-2-4-19(5-3-18)15-33-16-23(26(35)31-33)25(34)29-12-20-6-7-22-21(10-20)8-9-28-24(22)27/h2-11,13,16H,12,14-15H2,1H3,(H2,27,28)(H,29,34)(H,31,35)	KKXYEKFXLACNPF-UHFFFAOYSA-N	263234	1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-3-oxo-2,3-dihydro-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 19	Plasma kallikrein			 994.0							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263234	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263234&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121291125	377002146							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498499	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4ccc5c(N)nccc5c4)c(n3)-c3c(C)noc3C)cc2)c1	InChI=1S/C31H30N8O2/c1-19-13-35-38(15-19)16-22-4-6-23(7-5-22)17-39-18-27(29(36-39)28-20(2)37-41-21(28)3)31(40)34-14-24-8-9-26-25(12-24)10-11-33-30(26)32/h4-13,15,18H,14,16-17H2,1-3H3,(H2,32,33)(H,34,40)	QRXZKSAIEGYFFV-UHFFFAOYSA-N	263235	3-(3,5-dimethyl-isoxazol-4-yl)-1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 20	Plasma kallikrein			 0.89							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263235	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263235&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86345115	377002147							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498500	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4ccc5c(N)nccc5c4)c(n3)N3CCOCC3)cc2)c1	InChI=1S/C30H32N8O2/c1-21-15-34-37(17-21)18-22-2-4-23(5-3-22)19-38-20-27(29(35-38)36-10-12-40-13-11-36)30(39)33-16-24-6-7-26-25(14-24)8-9-32-28(26)31/h2-9,14-15,17,20H,10-13,16,18-19H2,1H3,(H2,31,32)(H,33,39)	DWHBFTOTOHZYPK-UHFFFAOYSA-N	263236	1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-3-morpholin-4-yl-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 21	Plasma kallikrein			 6.46							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263236	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263236&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86345116	377002148							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498501	Cc1cnn(Cc2ccc(Cn3cc(cn3)C(=O)NCc3cc4cc[nH]c4nc3C)cc2)c1	InChI=1S/C25H25N7O/c1-17-10-28-31(13-17)14-19-3-5-20(6-4-19)15-32-16-23(12-29-32)25(33)27-11-22-9-21-7-8-26-24(21)30-18(22)2/h3-10,12-13,16H,11,14-15H2,1-2H3,(H,26,30)(H,27,33)	RLGSNUDWQPXRKW-UHFFFAOYSA-N	263237	1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-1h-pyrazole-4-carboxylic acid (6-methyl-1h-pyrrolo[2,3-b]pyridin-5-ylmethyl)-amide::US9533987, example 22	Plasma kallikrein			 132							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263237	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263237&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117715174	377002149							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498502	Nc1nn(Cc2ccc(Cn3cccn3)cc2)cc1C(=O)NCc1ccc2c(N)nccc2c1	InChI=1S/C25H24N8O/c26-23-21-7-6-19(12-20(21)8-10-28-23)13-29-25(34)22-16-33(31-24(22)27)15-18-4-2-17(3-5-18)14-32-11-1-9-30-32/h1-12,16H,13-15H2,(H2,26,28)(H2,27,31)(H,29,34)	OKTHKQKJNXEEHR-UHFFFAOYSA-N	263238	5-amino-1-(4-pyrazol-1-ylmethyl-benzyl)-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 23	Plasma kallikrein			 0.33							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263238	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263238&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121288942	377002150							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498503	Nc1nccc2cc(CNC(=O)c3cn(Cc4ccc(nc4)N4CCCC4)nc3C(F)(F)F)ccc12	InChI=1S/C25H24F3N7O/c26-25(27,28)22-20(24(36)32-12-16-3-5-19-18(11-16)7-8-30-23(19)29)15-35(33-22)14-17-4-6-21(31-13-17)34-9-1-2-10-34/h3-8,11,13,15H,1-2,9-10,12,14H2,(H2,29,30)(H,32,36)	SLRCFYCDNOSNHM-UHFFFAOYSA-N	263239	1-(6-pyrrolidin-1-yl-pyridin-3-ylmethyl)-3-trifluoromethyl-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 24	Plasma kallikrein			 9.66							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263239	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263239&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86280656	377002151							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498504	COc1cc(Cn2cc(C(=O)NCc3ccc4c(N)nccc4c3)c(n2)C2CC2)cnc1N1CCCC1	InChI=1S/C28H31N7O2/c1-37-24-13-19(15-31-27(24)34-10-2-3-11-34)16-35-17-23(25(33-35)20-5-6-20)28(36)32-14-18-4-7-22-21(12-18)8-9-30-26(22)29/h4,7-9,12-13,15,17,20H,2-3,5-6,10-11,14,16H2,1H3,(H2,29,30)(H,32,36)	CUQLASPMTDPMRH-UHFFFAOYSA-N	263240	3-cyclopropyl-1-(5-methoxy-6-pyrrolidin-1-yl-pyridin-3-ylmethyl)-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 25	Plasma kallikrein			 7.31							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263240	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263240&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86345118	377002152							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498505	CCOc1ccc(Cn2cc(C(=O)NCc3ccc4c(N)nccc4c3)c(n2)-c2ccccc2)cn1	InChI=1S/C28H26N6O2/c1-2-36-25-11-9-20(16-31-25)17-34-18-24(26(33-34)21-6-4-3-5-7-21)28(35)32-15-19-8-10-23-22(14-19)12-13-30-27(23)29/h3-14,16,18H,2,15,17H2,1H3,(H2,29,30)(H,32,35)	JZAMENORGXQFAK-UHFFFAOYSA-N	263242	1-(6-ethoxy-pyridin-3-ylmethyl)-3-phenyl-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 26	Plasma kallikrein			 205							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263242	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263242&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121291114	377002154							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498506	CCOc1ccc(Cn2cc(C(=O)NCc3ccc4c(N)nccc4c3)c(NC(=O)COC)n2)cn1	InChI=1S/C25H27N7O4/c1-3-36-22-7-5-17(12-28-22)13-32-14-20(24(31-32)30-21(33)15-35-2)25(34)29-11-16-4-6-19-18(10-16)8-9-27-23(19)26/h4-10,12,14H,3,11,13,15H2,1-2H3,(H2,26,27)(H,29,34)(H,30,31,33)	JSUZMXJTHHQZII-UHFFFAOYSA-N	263243	1-(6-ethoxy-pyridin-3-ylmethyl)-3-(2-methoxy-acetylamino)-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 27	Plasma kallikrein			 128							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263243	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263243&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121291115	377002155							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498507	CCn1c(Cc2ccc(Cn3cc(C)cn3)cc2)c(C)cc1C(=O)NCc1ccc2c(N)nccc2c1	InChI=1S/C30H32N6O/c1-4-36-27(15-22-5-7-23(8-6-22)19-35-18-20(2)16-34-35)21(3)13-28(36)30(37)33-17-24-9-10-26-25(14-24)11-12-32-29(26)31/h5-14,16,18H,4,15,17,19H2,1-3H3,(H2,31,32)(H,33,37)	BMLMQNFIWXYERL-UHFFFAOYSA-N	263245	1-ethyl-4-methyl-5-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-1h-pyrrole-2-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 28	Plasma kallikrein			 63.7							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263245	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263245&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86344562	377002157							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498508	CCn1c(Cc2csc(n2)-c2ccccc2)c(C)cc1C(=O)NCc1ccc2c(N)nccc2c1	InChI=1S/C28H27N5OS/c1-3-33-24(15-22-17-35-28(32-22)20-7-5-4-6-8-20)18(2)13-25(33)27(34)31-16-19-9-10-23-21(14-19)11-12-30-26(23)29/h4-14,17H,3,15-16H2,1-2H3,(H2,29,30)(H,31,34)	XGNPIYHFSIDBIG-UHFFFAOYSA-N	263246	1-ethyl-4-methyl-5-(2-phenyl-thiazol-4-ylmethyl)-1h-pyrrole-2-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 29	Plasma kallikrein			 620							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263246	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263246&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135120927	377002158							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498509	CCn1c(Cc2ccc(nc2)N2CCCC2)c(C)cc1C(=O)NCc1ccc2c(N)nccc2c1	InChI=1S/C28H32N6O/c1-3-34-24(16-21-7-9-26(31-17-21)33-12-4-5-13-33)19(2)14-25(34)28(35)32-18-20-6-8-23-22(15-20)10-11-30-27(23)29/h6-11,14-15,17H,3-5,12-13,16,18H2,1-2H3,(H2,29,30)(H,32,35)	TUHUTZRIVHTTRL-UHFFFAOYSA-N	263247	1-ethyl-4-methyl-5-(6-pyrrolidin-1-yl-pyridin-3-ylmethyl)-1h-pyrrole-2-carboxylicacid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 30	Plasma kallikrein			 1470							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263247	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263247&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135120928	377002159							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498510	Cc1cnn(Cc2ccc(Cn3cc(cn3)C(=O)NCc3ccc4c(N)nccc4c3)cc2)c1	InChI=1S/C26H25N7O/c1-18-11-30-32(14-18)15-19-2-4-20(5-3-19)16-33-17-23(13-31-33)26(34)29-12-21-6-7-24-22(10-21)8-9-28-25(24)27/h2-11,13-14,17H,12,15-16H2,1H3,(H2,27,28)(H,29,34)	FMTLECFLQCXJHV-UHFFFAOYSA-N	263248	1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 31	Plasma kallikrein			 2.0							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263248	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263248&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86344746	377002160							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498511	Cc1cnn(Cc2ccc(Cn3cnc(c3)C(=O)NCc3ccc4c(N)nccc4c3)cc2)c1	InChI=1S/C26H25N7O/c1-18-11-31-33(13-18)15-20-4-2-19(3-5-20)14-32-16-24(30-17-32)26(34)29-12-21-6-7-23-22(10-21)8-9-28-25(23)27/h2-11,13,16-17H,12,14-15H2,1H3,(H2,27,28)(H,29,34)	MCLBVPPTLFLLSH-UHFFFAOYSA-N	263215	1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-1h-imidazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 10::US9533987, example 32	Plasma kallikrein			 2.4							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263215	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263215&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86344559	377002127							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498512	Cc1cnn(Cc2ccc(Cn3cc(nn3)C(=O)NCc3ccc4c(N)nccc4c3)cc2)c1	InChI=1S/C25H24N8O/c1-17-11-29-32(13-17)14-18-2-4-19(5-3-18)15-33-16-23(30-31-33)25(34)28-12-20-6-7-22-21(10-20)8-9-27-24(22)26/h2-11,13,16H,12,14-15H2,1H3,(H2,26,27)(H,28,34)	LXFSFWAHJIMQCH-UHFFFAOYSA-N	263250	1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-1h-[1,2,3]triazole-4-carboxylic acid(1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 33	Plasma kallikrein			 2.8							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263250	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263250&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86344747	377002161							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498513	Cc1cnn(Cc2ccc(Cn3nc(C)c(C(=O)NCc4ccc5c(N)nccc5c4)c3C)cc2)c1	InChI=1S/C28H29N7O/c1-18-13-32-34(15-18)16-21-4-6-22(7-5-21)17-35-20(3)26(19(2)33-35)28(36)31-14-23-8-9-25-24(12-23)10-11-30-27(25)29/h4-13,15H,14,16-17H2,1-3H3,(H2,29,30)(H,31,36)	WWAQGWUJZQTMMC-UHFFFAOYSA-N	263251	3,5-dimethyl-1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 34	Plasma kallikrein			 142							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263251	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263251&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135120929	377002162							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498514	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4ccc5c(N)nccc5c4)c(n3)-c3ccccc3)cc2)c1	InChI=1S/C32H29N7O/c1-22-16-36-38(18-22)19-23-7-9-24(10-8-23)20-39-21-29(30(37-39)26-5-3-2-4-6-26)32(40)35-17-25-11-12-28-27(15-25)13-14-34-31(28)33/h2-16,18,21H,17,19-20H2,1H3,(H2,33,34)(H,35,40)	DCUMHGNRKGNEGD-UHFFFAOYSA-N	263252	1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-3-phenyl-1h-pyrazole-4-carboxylicacid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 35	Plasma kallikrein			 3.68							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263252	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263252&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86345119	377002163							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498515	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4ccc5c(N)nccc5c4)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C27H24F3N7O/c1-17-11-34-36(13-17)14-18-2-4-19(5-3-18)15-37-16-23(24(35-37)27(28,29)30)26(38)33-12-20-6-7-22-21(10-20)8-9-32-25(22)31/h2-11,13,16H,12,14-15H2,1H3,(H2,31,32)(H,33,38)	HXLUIKPALDGUQR-UHFFFAOYSA-N	263253	1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-3-trifluoromethyl-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 36	Plasma kallikrein			 2.16							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263253	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263253&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86345287	377002164							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498516	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4ccc5c(N)nccc5c4)c(N)n3)cc2)c1	InChI=1S/C26H26N8O/c1-17-11-31-33(13-17)14-18-2-4-19(5-3-18)15-34-16-23(25(28)32-34)26(35)30-12-20-6-7-22-21(10-20)8-9-29-24(22)27/h2-11,13,16H,12,14-15H2,1H3,(H2,27,29)(H2,28,32)(H,30,35)	GJNUIQWJKPAZQA-UHFFFAOYSA-N	263258	3-amino-1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-1h-pyrazole-4-carboxylicacid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 37	Plasma kallikrein			 0.67							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263258	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263258&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86345288	377002169							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498517	COCc1nn(Cc2ccc(Cn3cc(C)cn3)cc2)cc1C(=O)NCc1ccc2c(N)nccc2c1	InChI=1S/C28H29N7O2/c1-19-12-32-34(14-19)15-20-3-5-21(6-4-20)16-35-17-25(26(33-35)18-37-2)28(36)31-13-22-7-8-24-23(11-22)9-10-30-27(24)29/h3-12,14,17H,13,15-16,18H2,1-2H3,(H2,29,30)(H,31,36)	XRSMOUUDULMQKD-UHFFFAOYSA-N	263259	3-methoxymethyl-1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 38	Plasma kallikrein			 1.27							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263259	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263259&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86345289	377002170							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498518	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4ccc5c(N)nccc5c4)c(n3)C(F)F)cc2)c1	InChI=1S/C27H25F2N7O/c1-17-11-33-35(13-17)14-18-2-4-19(5-3-18)15-36-16-23(24(34-36)25(28)29)27(37)32-12-20-6-7-22-21(10-20)8-9-31-26(22)30/h2-11,13,16,25H,12,14-15H2,1H3,(H2,30,31)(H,32,37)	VOHVWMYNYDPMER-UHFFFAOYSA-N	263261	3-difluoromethyl-1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 39	Plasma kallikrein			 1.68							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263261	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263261&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86345290	377002171							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498519	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4ccc5c(N)nccc5c4)c(n3)-c3ccsc3)cc2)c1	InChI=1S/C30H27N7OS/c1-20-13-34-36(15-20)16-21-2-4-22(5-3-21)17-37-18-27(28(35-37)25-9-11-39-19-25)30(38)33-14-23-6-7-26-24(12-23)8-10-32-29(26)31/h2-13,15,18-19H,14,16-17H2,1H3,(H2,31,32)(H,33,38)	CYHCYCIPTGUNKX-UHFFFAOYSA-N	263262	1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-3-thiophen-3-yl-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 42	Plasma kallikrein			 4.85							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263262	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263262&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86345291	377002172							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498520	Cc1cc(C(=O)NCc2ccc3c(N)nccc3c2)c(C)n1Cc1ccc(Cn2ccccc2=O)cc1	InChI=1S/C30H29N5O2/c1-20-15-27(30(37)33-17-24-10-11-26-25(16-24)12-13-32-29(26)31)21(2)35(20)19-23-8-6-22(7-9-23)18-34-14-4-3-5-28(34)36/h3-16H,17-19H2,1-2H3,(H2,31,32)(H,33,37)	GBMUDCZNXCHCOS-UHFFFAOYSA-N	263263	2,5-dimethyl-1-[4-(2-oxo-2h-pyridin-1-ylmethyl)-benzyl]-1h-pyrrole-3-carboxylicacid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 44	Plasma kallikrein			 3.9							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263263	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263263&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86344560	377002173							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498521	Nc1nccc2cc(CNC(=O)c3cnn(CCc4ccc5OCCOc5c4)c3)ccc12	InChI=1S/C24H23N5O3/c25-23-20-3-1-17(11-18(20)5-7-26-23)13-27-24(30)19-14-28-29(15-19)8-6-16-2-4-21-22(12-16)32-10-9-31-21/h1-5,7,11-12,14-15H,6,8-10,13H2,(H2,25,26)(H,27,30)	BWPZRHUPPPVQPP-UHFFFAOYSA-N	263264	1-[2-(2,3-dihydro-benzo[1,4]dioxin-6-yl)-ethyl]-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 45	Plasma kallikrein			 3060							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263264	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263264&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135120930	377002174							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498522	CN(Cc1ccc(Cn2cc(cn2)C(=O)NCc2ccc3c(N)nccc3c2)cc1)c1sc(C)nc1C	InChI=1S/C28H29N7OS/c1-18-28(37-19(2)33-18)34(3)15-20-4-6-21(7-5-20)16-35-17-24(14-32-35)27(36)31-13-22-8-9-25-23(12-22)10-11-30-26(25)29/h4-12,14,17H,13,15-16H2,1-3H3,(H2,29,30)(H,31,36)	KMFMUNJUOQFNQC-UHFFFAOYSA-N	263265	1-(4-{[(2,4-dimethyl-thiazol-5-yl)-methyl-amino]-methyl}-benzyl)-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 46	Plasma kallikrein			 803							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263265	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263265&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135120931	377002175							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498523	Nc1nccc2cc(CNC(=O)c3cnn(Cc4cccc(Oc5ccccc5)n4)c3)ccc12	InChI=1S/C26H22N6O2/c27-25-23-10-9-18(13-19(23)11-12-28-25)14-29-26(33)20-15-30-32(16-20)17-21-5-4-8-24(31-21)34-22-6-2-1-3-7-22/h1-13,15-16H,14,17H2,(H2,27,28)(H,29,33)	IHOQTAVOKVKVJP-UHFFFAOYSA-N	263266	1-(6-phenoxy-pyridin-2-ylmethyl)-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 47	Plasma kallikrein			 2030							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263266	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263266&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135120932	377002176							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498524	Nc1nccc2cc(CNC(=O)c3cnn(Cc4cccc(Oc5ncccc5F)c4)c3)ccc12	InChI=1S/C26H21FN6O2/c27-23-5-2-9-30-26(23)35-21-4-1-3-18(12-21)15-33-16-20(14-32-33)25(34)31-13-17-6-7-22-19(11-17)8-10-29-24(22)28/h1-12,14,16H,13,15H2,(H2,28,29)(H,31,34)	VPQPBLGITAICNB-UHFFFAOYSA-N	263267	1-[3-(3-fluoro-pyridin-2-yloxy)-benzyl]-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 48	Plasma kallikrein			 820							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263267	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263267&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135120933	377002177							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498525	Nc1nccc2cc(CNC(=O)c3cnn(Cc4ccc(Oc5ccccn5)cc4)c3)ccc12	InChI=1S/C26H22N6O2/c27-25-23-9-6-19(13-20(23)10-12-29-25)14-30-26(33)21-15-31-32(17-21)16-18-4-7-22(8-5-18)34-24-3-1-2-11-28-24/h1-13,15,17H,14,16H2,(H2,27,29)(H,30,33)	FUTTZVOEDLBCEH-UHFFFAOYSA-N	263268	1-[4-(pyridin-2-yloxy)-benzyl]-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 49	Plasma kallikrein			 186							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263268	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263268&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86344748	377002178							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498526	Nc1nccc2cc(CNC(=O)c3cnn(Cc4ccc(COc5cccc(F)n5)cc4)c3)ccc12	InChI=1S/C27H23FN6O2/c28-24-2-1-3-25(33-24)36-17-19-6-4-18(5-7-19)15-34-16-22(14-32-34)27(35)31-13-20-8-9-23-21(12-20)10-11-30-26(23)29/h1-12,14,16H,13,15,17H2,(H2,29,30)(H,31,35)	AYJARRSFXGHJFS-UHFFFAOYSA-N	263269	1-[4-(6-fluoro-pyridin-2-yloxymethyl)-benzyl]-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 50	Plasma kallikrein			 203							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263269	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263269&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135120934	377002179							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498527	Nc1nccc2cc(CNC(=O)c3cnn(Cc4ccnc(c4)N4CCCC4)c3C(F)(F)F)ccc12	InChI=1S/C25H24F3N7O/c26-25(27,28)22-20(24(36)32-13-16-3-4-19-18(11-16)6-8-31-23(19)29)14-33-35(22)15-17-5-7-30-21(12-17)34-9-1-2-10-34/h3-8,11-12,14H,1-2,9-10,13,15H2,(H2,29,31)(H,32,36)	PMDDQXTWJATRKP-UHFFFAOYSA-N	263270	1-(2-pyrrolidin-1-yl-pyridin-4-ylmethyl)-5-trifluoromethyl-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 51	Plasma kallikrein			 576							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263270	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263270&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135120935	377002180							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498528	Nc1nccc2cc(CNC(=O)c3cnn(Cc4cc5cc(OC(F)(F)F)ccc5[nH]4)c3)ccc12	InChI=1S/C24H19F3N6O2/c25-24(26,27)35-19-2-4-21-16(9-19)8-18(32-21)13-33-12-17(11-31-33)23(34)30-10-14-1-3-20-15(7-14)5-6-29-22(20)28/h1-9,11-12,32H,10,13H2,(H2,28,29)(H,30,34)	YICVUCXCOBVMLR-UHFFFAOYSA-N	263274	1-(5-trifluoromethoxy-1h-indol-2-ylmethyl)-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 52	Plasma kallikrein			 300							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263274	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263274&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135120936	377002181							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498529	Nc1c(cnn1Cc1ccc(Cn2cccn2)cc1)C(=O)NCc1ccc2c(N)nccc2c1	InChI=1S/C25H24N8O/c26-23-21-7-6-19(12-20(21)8-10-28-23)13-29-25(34)22-14-31-33(24(22)27)16-18-4-2-17(3-5-18)15-32-11-1-9-30-32/h1-12,14H,13,15-16,27H2,(H2,26,28)(H,29,34)	QTARJTQMMMFRRC-UHFFFAOYSA-N	263275	5-amino-1-(4-pyrazol-1-ylmethyl-benzyl)-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 53	Plasma kallikrein			 16.8							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263275	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263275&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86345117	377002182							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498530	Nc1nccc2cc(CNC(=O)c3cn(Cc4ccnc(c4)N4CCCC4)nc3C(F)(F)F)ccc12	InChI=1S/C25H24F3N7O/c26-25(27,28)22-20(24(36)32-13-16-3-4-19-18(11-16)6-8-31-23(19)29)15-35(33-22)14-17-5-7-30-21(12-17)34-9-1-2-10-34/h3-8,11-12,15H,1-2,9-10,13-14H2,(H2,29,31)(H,32,36)	DAOSBZHACYXGLP-UHFFFAOYSA-N	263276	1-(2-pyrrolidin-1-yl-pyridin-4-ylmethyl)-3-trifluoromethyl-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 54	Plasma kallikrein			 46.7							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263276	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263276&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86342511	377002183							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498531	CCOc1ccc(Cn2cc(C(=O)NCc3ccc4c(N)nccc4c3)c(n2)C(F)(F)F)cn1	InChI=1S/C23H21F3N6O2/c1-2-34-19-6-4-15(11-29-19)12-32-13-18(20(31-32)23(24,25)26)22(33)30-10-14-3-5-17-16(9-14)7-8-28-21(17)27/h3-9,11,13H,2,10,12H2,1H3,(H2,27,28)(H,30,33)	GKPBRBZRCXWGEQ-UHFFFAOYSA-N	263277	1-(6-ethoxy-pyridin-3-ylmethyl)-3-trifluoromethyl-1h-pyrazole-4-carboxylic acid(1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 55	Plasma kallikrein			 79.2							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263277	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263277&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86342512	377002184							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498532	Nc1nccc2cc(CNC(=O)c3cn(Cc4ccnc(c4)N4CCC(F)(F)C4)nc3C(F)(F)F)ccc12	InChI=1S/C25H22F5N7O/c26-24(27)5-8-36(14-24)20-10-16(3-6-32-20)12-37-13-19(21(35-37)25(28,29)30)23(38)34-11-15-1-2-18-17(9-15)4-7-33-22(18)31/h1-4,6-7,9-10,13H,5,8,11-12,14H2,(H2,31,33)(H,34,38)	JDKUOGQJUSGAJP-UHFFFAOYSA-N	263278	1-[2-(3,3-difluoro-pyrrolidin-1-yl)-pyridin-4-ylmethyl]-3-trifluoromethyl-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 56	Plasma kallikrein			 71.8							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263278	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263278&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86342513	377002185							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498533	Nc1nccc2cc(CNC(=O)c3cn(Cc4ccc(nc4)N4CCC(F)(F)C4)nc3C(F)(F)F)ccc12	InChI=1S/C25H22F5N7O/c26-24(27)6-8-36(14-24)20-4-2-16(11-33-20)12-37-13-19(21(35-37)25(28,29)30)23(38)34-10-15-1-3-18-17(9-15)5-7-32-22(18)31/h1-5,7,9,11,13H,6,8,10,12,14H2,(H2,31,32)(H,34,38)	QPYRDSITLOWSHX-UHFFFAOYSA-N	263279	1-[6-(3,3-difluoro-pyrrolidin-1-yl)-pyridin-3-ylmethyl]-3-trifluoromethyl-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 57	Plasma kallikrein			 14.9							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263279	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263279&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86342514	377002186							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498534	C[C@@H]1CCN(C1)c1ccc(Cn2cc(C(=O)NCc3ccc4c(N)nccc4c3)c(n2)C(F)(F)F)cn1	InChI=1S/C26H26F3N7O/c1-16-7-9-35(13-16)22-5-3-18(12-32-22)14-36-15-21(23(34-36)26(27,28)29)25(37)33-11-17-2-4-20-19(10-17)6-8-31-24(20)30/h2-6,8,10,12,15-16H,7,9,11,13-14H2,1H3,(H2,30,31)(H,33,37)/t16-/m1/s1	WETAMWXIAPCHJG-MRXNPFEDSA-N	263280	1-[6-((r)-3-methyl-pyrrolidin-1-yl)-pyridin-3-ylmethyl]-3-trifluoromethyl-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 58	Plasma kallikrein			 13.3							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263280	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263280&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86342515	377002187							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498535	C[C@H]1CCN(C1)c1ccc(Cn2cc(C(=O)NCc3ccc4c(N)nccc4c3)c(n2)C(F)(F)F)cn1	InChI=1S/C26H26F3N7O/c1-16-7-9-35(13-16)22-5-3-18(12-32-22)14-36-15-21(23(34-36)26(27,28)29)25(37)33-11-17-2-4-20-19(10-17)6-8-31-24(20)30/h2-6,8,10,12,15-16H,7,9,11,13-14H2,1H3,(H2,30,31)(H,33,37)/t16-/m0/s1	WETAMWXIAPCHJG-INIZCTEOSA-N	263281	1-[6-((s)-3-methyl-pyrrolidin-1-yl)-pyridin-3-ylmethyl]-3-trifluoromethyl-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 59	Plasma kallikrein			 5.84							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263281	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263281&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86342694	377002188							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498536	Nc1nccc2cc(CNC(=O)c3cn(Cc4ccc(nc4)N4CC[C@H](F)C4)nc3C(F)(F)F)ccc12	InChI=1S/C25H23F4N7O/c26-18-6-8-35(13-18)21-4-2-16(11-32-21)12-36-14-20(22(34-36)25(27,28)29)24(37)33-10-15-1-3-19-17(9-15)5-7-31-23(19)30/h1-5,7,9,11,14,18H,6,8,10,12-13H2,(H2,30,31)(H,33,37)/t18-/m0/s1	HEUBVBUOFPIUJA-SFHVURJKSA-N	263282	1-[6-((s)-3-fluoro-pyrrolidin-1-yl)-pyridin-3-ylmethyl]-3-trifluoromethyl-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 60	Plasma kallikrein			 9.61							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263282	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263282&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86342695	377002189							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498537	Nc1nccc2cc(CNC(=O)c3cn(Cc4ccc(nc4)N4CC[C@@H](F)C4)nc3C(F)(F)F)ccc12	InChI=1S/C25H23F4N7O/c26-18-6-8-35(13-18)21-4-2-16(11-32-21)12-36-14-20(22(34-36)25(27,28)29)24(37)33-10-15-1-3-19-17(9-15)5-7-31-23(19)30/h1-5,7,9,11,14,18H,6,8,10,12-13H2,(H2,30,31)(H,33,37)/t18-/m1/s1	HEUBVBUOFPIUJA-GOSISDBHSA-N	263283	1-[6-((r)-3-fluoro-pyrrolidin-1-yl)-pyridin-3-ylmethyl]-3-trifluoromethyl-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 61	Plasma kallikrein			 18.1							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263283	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263283&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86342696	377002190							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498538	C[C@H]1CCCN1c1ccc(Cn2cc(C(=O)NCc3ccc4c(N)nccc4c3)c(n2)C(F)(F)F)cn1	InChI=1S/C26H26F3N7O/c1-16-3-2-10-36(16)22-7-5-18(13-32-22)14-35-15-21(23(34-35)26(27,28)29)25(37)33-12-17-4-6-20-19(11-17)8-9-31-24(20)30/h4-9,11,13,15-16H,2-3,10,12,14H2,1H3,(H2,30,31)(H,33,37)/t16-/m0/s1	DSSWHEZOLVGIOD-INIZCTEOSA-N	263284	1-[6-((s)-2-methyl-pyrrolidin-1-yl)-pyridin-3-ylmethyl]-3-trifluoromethyl-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 62	Plasma kallikrein			 13.58							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263284	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263284&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86342697	377002191							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498539	C[C@@H]1CCCN1c1ccc(Cn2cc(C(=O)NCc3ccc4c(N)nccc4c3)c(n2)C(F)(F)F)cn1	InChI=1S/C26H26F3N7O/c1-16-3-2-10-36(16)22-7-5-18(13-32-22)14-35-15-21(23(34-35)26(27,28)29)25(37)33-12-17-4-6-20-19(11-17)8-9-31-24(20)30/h4-9,11,13,15-16H,2-3,10,12,14H2,1H3,(H2,30,31)(H,33,37)/t16-/m1/s1	DSSWHEZOLVGIOD-MRXNPFEDSA-N	263285	1-[6-((r)-2-methyl-pyrrolidin-1-yl)-pyridin-3-ylmethyl]-3-trifluoromethyl-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 63	Plasma kallikrein			 12.3							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263285	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263285&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86342698	377002192							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498540	Nc1nccc2cc(CNC(=O)c3cn(Cc4cnc(nc4)N4CCCC4)nc3C(F)(F)F)ccc12	InChI=1S/C24H23F3N8O/c25-24(26,27)20-19(22(36)30-10-15-3-4-18-17(9-15)5-6-29-21(18)28)14-35(33-20)13-16-11-31-23(32-12-16)34-7-1-2-8-34/h3-6,9,11-12,14H,1-2,7-8,10,13H2,(H2,28,29)(H,30,36)	BGFWCDCOIGUICN-UHFFFAOYSA-N	263286	1-(2-pyrrolidin-1-yl-pyrimidin-5-ylmethyl)-3-trifluoromethyl-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 64	Plasma kallikrein			 10.4							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263286	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263286&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86342885	377002193							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498541	Nc1nccc2cc(CNC(=O)c3cn(Cc4cnc(cn4)N4CCCC4)nc3C(F)(F)F)ccc12	InChI=1S/C24H23F3N8O/c25-24(26,27)21-19(23(36)32-10-15-3-4-18-16(9-15)5-6-29-22(18)28)14-35(33-21)13-17-11-31-20(12-30-17)34-7-1-2-8-34/h3-6,9,11-12,14H,1-2,7-8,10,13H2,(H2,28,29)(H,32,36)	GTQYYNKRYLNCBH-UHFFFAOYSA-N	263287	1-(5-pyrrolidin-1-yl-pyrazin-2-ylmethyl)-3-trifluoromethyl-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 65	Plasma kallikrein			 14.9							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263287	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263287&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86342886	377002194							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498542	CC(C)Oc1cc(Cn2cc(C(=O)NCc3ccc4c(N)nccc4c3)c(n2)C(F)(F)F)ccn1	InChI=1S/C24H23F3N6O2/c1-14(2)35-20-10-16(5-7-29-20)12-33-13-19(21(32-33)24(25,26)27)23(34)31-11-15-3-4-18-17(9-15)6-8-30-22(18)28/h3-10,13-14H,11-12H2,1-2H3,(H2,28,30)(H,31,34)	PDSPJKUKZKXBMC-UHFFFAOYSA-N	263288	1-(2-isopropoxy-pyridin-4-ylmethyl)-3-trifluoromethyl-1h-pyrazole-4-carboxylicacid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 66	Plasma kallikrein			 281							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263288	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263288&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135120937	377002195							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498543	C[C@@H]1CCN(C1)c1cc(Cn2cc(C(=O)NCc3ccc4c(N)nccc4c3)c(n2)C(F)(F)F)ccn1	InChI=1S/C26H26F3N7O/c1-16-6-9-35(13-16)22-11-18(4-7-31-22)14-36-15-21(23(34-36)26(27,28)29)25(37)33-12-17-2-3-20-19(10-17)5-8-32-24(20)30/h2-5,7-8,10-11,15-16H,6,9,12-14H2,1H3,(H2,30,32)(H,33,37)/t16-/m1/s1	SCXKYBZCYMWSLK-MRXNPFEDSA-N	263289	1-[2-((r)-3-methyl-pyrrolidin-1-yl)-pyridin-4-ylmethyl]-3-trifluoromethyl-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 67	Plasma kallikrein			 108							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263289	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263289&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135120938	377002196							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498544	C[C@H]1CCN(C1)c1cc(Cn2cc(C(=O)NCc3ccc4c(N)nccc4c3)c(n2)C(F)(F)F)ccn1	InChI=1S/C26H26F3N7O/c1-16-6-9-35(13-16)22-11-18(4-7-31-22)14-36-15-21(23(34-36)26(27,28)29)25(37)33-12-17-2-3-20-19(10-17)5-8-32-24(20)30/h2-5,7-8,10-11,15-16H,6,9,12-14H2,1H3,(H2,30,32)(H,33,37)/t16-/m0/s1	SCXKYBZCYMWSLK-INIZCTEOSA-N	263290	1-[2-((s)-3-methyl-pyrrolidin-1-yl)-pyridin-4-ylmethyl]-3-trifluoromethyl-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 68	Plasma kallikrein			 59.0							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263290	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263290&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86342887	377002197							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498545	Nc1nccc2cc(CNC(=O)c3cn(Cc4ccc(nc4)N4CCC(CO)C4)nc3C(F)(F)F)ccc12	InChI=1S/C26H26F3N7O2/c27-26(28,29)23-21(25(38)33-10-16-1-3-20-19(9-16)5-7-31-24(20)30)14-36(34-23)13-17-2-4-22(32-11-17)35-8-6-18(12-35)15-37/h1-5,7,9,11,14,18,37H,6,8,10,12-13,15H2,(H2,30,31)(H,33,38)	LQCMCNVSZTUNJE-UHFFFAOYSA-N	263291	1-[6-(3-hydroxymethyl-pyrrolidin-1-yl)-pyridin-3-ylmethyl]-3-trifluoromethyl-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 69	Plasma kallikrein			 32.3							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263291	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263291&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86342888	377002198							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498546	Nc1nccc2cc(CNC(=O)c3cn(Cc4ccc(nc4)N4CC[C@@H](CO)C4)nc3C(F)(F)F)ccc12	InChI=1S/C26H26F3N7O2/c27-26(28,29)23-21(25(38)33-10-16-1-3-20-19(9-16)5-7-31-24(20)30)14-36(34-23)13-17-2-4-22(32-11-17)35-8-6-18(12-35)15-37/h1-5,7,9,11,14,18,37H,6,8,10,12-13,15H2,(H2,30,31)(H,33,38)/t18-/m1/s1	LQCMCNVSZTUNJE-GOSISDBHSA-N	263292	1-[6-((r)-3-hydroxymethyl-pyrrolidin-1-yl)-pyridin-3-ylmethyl]-3-trifluoromethyl-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 70	Plasma kallikrein			 66.9							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263292	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263292&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86342889	377002199							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498547	CCCOc1ccc(Cn2cc(C(=O)NCc3ccc4c(N)nccc4c3)c(n2)C(F)(F)F)cn1	InChI=1S/C24H23F3N6O2/c1-2-9-35-20-6-4-16(12-30-20)13-33-14-19(21(32-33)24(25,26)27)23(34)31-11-15-3-5-18-17(10-15)7-8-29-22(18)28/h3-8,10,12,14H,2,9,11,13H2,1H3,(H2,28,29)(H,31,34)	DWFRBDIXHQEHJF-UHFFFAOYSA-N	263293	1-(6-propoxy-pyridin-3-ylmethyl)-3-trifluoromethyl-1h-pyrazole-4-carboxylic acid(1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 71	Plasma kallikrein			 63.6							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263293	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263293&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86343083	377002200							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498548	CCC(C)Oc1ccc(Cn2cc(C(=O)NCc3ccc4c(N)nccc4c3)c(n2)C(F)(F)F)cn1	InChI=1S/C25H25F3N6O2/c1-3-15(2)36-21-7-5-17(12-31-21)13-34-14-20(22(33-34)25(26,27)28)24(35)32-11-16-4-6-19-18(10-16)8-9-30-23(19)29/h4-10,12,14-15H,3,11,13H2,1-2H3,(H2,29,30)(H,32,35)	OJKIMQGUIHLKNY-UHFFFAOYSA-N	263294	1-(6-sec-butoxy-pyridin-3-ylmethyl)-3-trifluoromethyl-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl) amide::US9533987, example 72	Plasma kallikrein			 118							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263294	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263294&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135120939	377002201							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498549	Nc1nccc2cc(CNC(=O)c3cn(Cc4cnc(N5CCCC5)c(F)c4)nc3C(F)(F)F)ccc12	InChI=1S/C25H23F4N7O/c26-20-10-16(12-32-23(20)35-7-1-2-8-35)13-36-14-19(21(34-36)25(27,28)29)24(37)33-11-15-3-4-18-17(9-15)5-6-31-22(18)30/h3-6,9-10,12,14H,1-2,7-8,11,13H2,(H2,30,31)(H,33,37)	XCDBZZWRWFCHFE-UHFFFAOYSA-N	263295	1-(5-fluoro-6-pyrrolidin-1-yl-pyridin-3-ylmethyl)-3-trifluoromethyl-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 73	Plasma kallikrein			 22.6							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263295	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263295&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86343084	377002202							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498550	CCOc1cc(Cn2cc(C(=O)NCc3ccc4c(N)nccc4c3)c(n2)C(F)(F)F)cnc1Cl	InChI=1S/C23H20ClF3N6O2/c1-2-35-18-8-14(10-30-20(18)24)11-33-12-17(19(32-33)23(25,26)27)22(34)31-9-13-3-4-16-15(7-13)5-6-29-21(16)28/h3-8,10,12H,2,9,11H2,1H3,(H2,28,29)(H,31,34)	GIYBKPYBWPNICY-UHFFFAOYSA-N	263296	1-(6-chloro-5-ethoxy-pyridin-3-ylmethyl)-3-trifluoromethyl-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 74	Plasma kallikrein			 425							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263296	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263296&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135120940	377002203							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498551	CCOc1ncc(Cn2cc(C(=O)NCc3ccc4c(N)nccc4c3)c(n2)C(F)(F)F)cc1F	InChI=1S/C23H20F4N6O2/c1-2-35-22-18(24)8-14(10-31-22)11-33-12-17(19(32-33)23(25,26)27)21(34)30-9-13-3-4-16-15(7-13)5-6-29-20(16)28/h3-8,10,12H,2,9,11H2,1H3,(H2,28,29)(H,30,34)	GGVYRGRBULRJBJ-UHFFFAOYSA-N	263297	1-(6-ethoxy-5-fluoro-pyridin-3-ylmethyl)-3-trifluoromethyl-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 75	Plasma kallikrein			 98.3							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263297	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263297&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86343085	377002204							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498552	Nc1nccc2cc(CNC(=O)c3cn(Cc4ccc(Cn5cccn5)cc4)nc3C(F)(F)F)ccc12	InChI=1S/C26H22F3N7O/c27-26(28,29)23-22(25(37)32-13-19-6-7-21-20(12-19)8-10-31-24(21)30)16-36(34-23)15-18-4-2-17(3-5-18)14-35-11-1-9-33-35/h1-12,16H,13-15H2,(H2,30,31)(H,32,37)	VRYHLJFFMXJWLQ-UHFFFAOYSA-N	263298	1-(4-pyrazol-1-ylmethyl-benzyl)-3-trifluoromethyl-1h-pyrazole-4-carboxylic acid(1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 76	Plasma kallikrein			 0.92							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263298	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263298&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86343086	377002205							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498553	Nc1nccc2cc(CNC(=O)c3cn(Cc4ccc(Cn5cc(cn5)C#N)cc4)nc3C(F)(F)F)ccc12	InChI=1S/C27H21F3N8O/c28-27(29,30)24-23(26(39)34-11-19-5-6-22-21(9-19)7-8-33-25(22)32)16-38(36-24)14-18-3-1-17(2-4-18)13-37-15-20(10-31)12-35-37/h1-9,12,15-16H,11,13-14H2,(H2,32,33)(H,34,39)	ZSWFNMZXDBXLIE-UHFFFAOYSA-N	263299	1-[4-(4-cyano-pyrazol-1-ylmethyl)-benzyl]-3-trifluoromethyl-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 77	Plasma kallikrein			 85.4							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263299	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263299&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86343087	377002206							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498554	NC(=O)c1cnn(Cc2ccc(Cn3cc(C(=O)NCc4ccc5c(N)nccc5c4)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C27H23F3N8O2/c28-27(29,30)23-22(26(40)34-10-18-5-6-21-19(9-18)7-8-33-24(21)31)15-38(36-23)13-17-3-1-16(2-4-17)12-37-14-20(11-35-37)25(32)39/h1-9,11,14-15H,10,12-13H2,(H2,31,33)(H2,32,39)(H,34,40)	NWLUWTWQKQUQDZ-UHFFFAOYSA-N	263300	1-[4-(4-carbamoyl-pyrazol-1-ylmethyl)-benzyl]-3-trifluoromethyl-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 78	Plasma kallikrein			 91.1							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263300	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263300&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86343275	377002207							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498555	Nc1nccc2cc(CNC(=O)c3cn(Cc4ccc(Cn5cccn5)nc4)nc3C(F)(F)F)ccc12	InChI=1S/C25H21F3N8O/c26-25(27,28)22-21(24(37)32-11-16-3-5-20-18(10-16)6-8-30-23(20)29)15-36(34-22)13-17-2-4-19(31-12-17)14-35-9-1-7-33-35/h1-10,12,15H,11,13-14H2,(H2,29,30)(H,32,37)	LBMILRLEZDRJSC-UHFFFAOYSA-N	263301	1-(6-pyrazol-1-ylmethyl-pyridin-3-ylmethyl)-3-trifluoromethyl-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 79	Plasma kallikrein			 2.29							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263301	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263301&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86343276	377002208							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498556	CCOc1cc(Cn2cc(C(=O)NCc3ccc4c(N)nccc4c3)c(n2)C(F)(F)F)ccn1	InChI=1S/C23H21F3N6O2/c1-2-34-19-10-15(5-7-28-19)12-32-13-18(20(31-32)23(24,25)26)22(33)30-11-14-3-4-17-16(9-14)6-8-29-21(17)27/h3-10,13H,2,11-12H2,1H3,(H2,27,29)(H,30,33)	QAQZSCLKFHYZCZ-UHFFFAOYSA-N	263302	1-(2-ethoxy-pyridin-4-ylmethyl)-3-trifluoromethyl-1h-pyrazole-4-carboxylic acid(1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 80	Plasma kallikrein			 206							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263302	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263302&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135120941	377002209							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498557	Nc1nccc2cc(CNC(=O)c3cn(Cc4csc(Cn5cccn5)n4)nc3C(F)(F)F)ccc12	InChI=1S/C23H19F3N8OS/c24-23(25,26)20-18(22(35)29-9-14-2-3-17-15(8-14)4-6-28-21(17)27)11-34(32-20)10-16-13-36-19(31-16)12-33-7-1-5-30-33/h1-8,11,13H,9-10,12H2,(H2,27,28)(H,29,35)	NTKGSHJOYRJNMU-UHFFFAOYSA-N	263303	1-(2-pyrazol-1-ylmethyl-thiazol-4-ylmethyl)-3-trifluoromethyl-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 81	Plasma kallikrein			 26.5							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263303	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263303&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86343277	377002210							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498558	Cc1cnn(Cc2nc(Cn3cc(C(=O)NCc4ccc5c(N)nccc5c4)c(n3)C(F)(F)F)cs2)c1	InChI=1S/C24H21F3N8OS/c1-14-7-31-34(9-14)12-20-32-17(13-37-20)10-35-11-19(21(33-35)24(25,26)27)23(36)30-8-15-2-3-18-16(6-15)4-5-29-22(18)28/h2-7,9,11,13H,8,10,12H2,1H3,(H2,28,29)(H,30,36)	PNKCTJJHKZQMAW-UHFFFAOYSA-N	263304	1-[2-(4-methyl-pyrazol-1-ylmethyl)-thiazol-4-ylmethyl]-3-trifluoromethyl-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 82	Plasma kallikrein			 21.2							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263304	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263304&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86343278	377002211							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498559	COCCN(C)c1ccc(Cn2cc(C(=O)NCc3ccc4c(N)nccc4c3)c(n2)C2CC2)cn1	InChI=1S/C27H31N7O2/c1-33(11-12-36-2)24-8-4-19(15-30-24)16-34-17-23(25(32-34)20-5-6-20)27(35)31-14-18-3-7-22-21(13-18)9-10-29-26(22)28/h3-4,7-10,13,15,17,20H,5-6,11-12,14,16H2,1-2H3,(H2,28,29)(H,31,35)	NMSFIEGOGDYLKU-UHFFFAOYSA-N	263305	3-cyclopropyl-1-{6-[(2-methoxy-ethyl)-methyl-amino]-pyridin-3-ylmethyl}-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 86	Plasma kallikrein			 56.1							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263305	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263305&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86343279	377002212							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498560	Nc1nccc2cc(CNC(=O)c3cn(Cc4ccc(nc4)N4CCC(F)(F)C4)nc3C3CC3)ccc12	InChI=1S/C27H27F2N7O/c28-27(29)8-10-35(16-27)23-6-2-18(13-32-23)14-36-15-22(24(34-36)19-3-4-19)26(37)33-12-17-1-5-21-20(11-17)7-9-31-25(21)30/h1-2,5-7,9,11,13,15,19H,3-4,8,10,12,14,16H2,(H2,30,31)(H,33,37)	JPOJBUJCQDGKSB-UHFFFAOYSA-N	263306	3-cyclopropyl-1-[6-(3,3-difluoro-pyrrolidin-1-yl)-pyridin-3-ylmethyl]-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 87	Plasma kallikrein			 23.2							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263306	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263306&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86343472	377002213							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498561	COc1cc(Cn2cc(C(=O)NCc3ccc4c(N)nccc4c3)c(n2)C2CC2)cc(n1)N1CCCC1	InChI=1S/C28H31N7O2/c1-37-25-14-19(13-24(32-25)34-10-2-3-11-34)16-35-17-23(26(33-35)20-5-6-20)28(36)31-15-18-4-7-22-21(12-18)8-9-30-27(22)29/h4,7-9,12-14,17,20H,2-3,5-6,10-11,15-16H2,1H3,(H2,29,30)(H,31,36)	CMTYRZPGALYYCZ-UHFFFAOYSA-N	263307	3-cyclopropyl-1-(2-methoxy-6-pyrrolidin-1-yl-pyridin-4-ylmethyl)-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 88	Plasma kallikrein			 112							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263307	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263307&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135120942	377002214							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498562	COc1cc(ncc1Cn1cc(C(=O)NCc2ccc3c(N)nccc3c2)c(n1)C1CC1)N1CCCC1	InChI=1S/C28H31N7O2/c1-37-24-13-25(34-10-2-3-11-34)31-15-21(24)16-35-17-23(26(33-35)19-5-6-19)28(36)32-14-18-4-7-22-20(12-18)8-9-30-27(22)29/h4,7-9,12-13,15,17,19H,2-3,5-6,10-11,14,16H2,1H3,(H2,29,30)(H,32,36)	SBMNLZABUQEIIC-UHFFFAOYSA-N	263308	3-cyclopropyl-1-(4-methoxy-6-pyrrolidin-1-yl-pyridin-3-ylmethyl)-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 89	Plasma kallikrein			 17.8							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263308	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263308&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86343473	377002215							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498563	Nc1nccc2cc(CNC(=O)c3cn(Cc4ccc(nc4)N4CCCC4)nc3C3CC3)ccc12	InChI=1S/C27H29N7O/c28-26-22-7-3-18(13-21(22)9-10-29-26)14-31-27(35)23-17-34(32-25(23)20-5-6-20)16-19-4-8-24(30-15-19)33-11-1-2-12-33/h3-4,7-10,13,15,17,20H,1-2,5-6,11-12,14,16H2,(H2,28,29)(H,31,35)	PMJBHWGXJWWQJR-UHFFFAOYSA-N	263309	3-cyclopropyl-1-(6-pyrrolidin-1-yl-pyridin-3-ylmethyl)-1h-pyrazole-4-carboxylicacid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 90	Plasma kallikrein			 11.6							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263309	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263309&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86343474	377002216							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498564	Nc1nccc2cc(CNC(=O)c3cn(Cc4ccc(Cn5ccnn5)cc4)nc3C3CC3)ccc12	InChI=1S/C27H26N8O/c28-26-23-8-5-20(13-22(23)9-10-29-26)14-30-27(36)24-17-35(32-25(24)21-6-7-21)16-19-3-1-18(2-4-19)15-34-12-11-31-33-34/h1-5,8-13,17,21H,6-7,14-16H2,(H2,28,29)(H,30,36)	DYRPOBCRRDNPMT-UHFFFAOYSA-N	263310	3-cyclopropyl-1-(4-[1,2,3]triazol-1-ylmethyl-benzyl)-1h-pyrazole-4-carboxylicacid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 91	Plasma kallikrein			 13.8							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263310	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263310&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86343475	377002217							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498565	Nc1nccc2cc(CNC(=O)c3cn(Cc4ccc(OCC(F)(F)F)nc4)nc3C3CC3)ccc12	InChI=1S/C25H23F3N6O2/c26-25(27,28)14-36-21-6-2-16(11-31-21)12-34-13-20(22(33-34)17-3-4-17)24(35)32-10-15-1-5-19-18(9-15)7-8-30-23(19)29/h1-2,5-9,11,13,17H,3-4,10,12,14H2,(H2,29,30)(H,32,35)	ZZHDZCOBOHDVDZ-UHFFFAOYSA-N	263311	3-cyclopropyl-1-[6-(2,2,2-trifluoro-ethoxy)-pyridin-3-ylmethyl]-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 92	Plasma kallikrein			 109							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263311	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263311&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135120943	377002218							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498566	Nc1nccc2cc(CNC(=O)c3cn(Cc4ccc(Oc5ccccc5)nc4)nc3C3CC3)ccc12	InChI=1S/C29H26N6O2/c30-28-24-10-6-19(14-22(24)12-13-31-28)15-33-29(36)25-18-35(34-27(25)21-8-9-21)17-20-7-11-26(32-16-20)37-23-4-2-1-3-5-23/h1-7,10-14,16,18,21H,8-9,15,17H2,(H2,30,31)(H,33,36)	MDTXJNQVRIMIES-UHFFFAOYSA-N	263312	3-cyclopropyl-1-(6-phenoxy-pyridin-3-ylmethyl)-1h-pyrazole-4-carboxylic acid(1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 93	Plasma kallikrein			 75.1							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263312	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263312&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86343476	377002219							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498567	CCOc1ncc(Cn2cc(C(=O)NCc3ccc4c(N)nccc4c3)c(n2)C2CC2)cc1Cl	InChI=1S/C25H25ClN6O2/c1-2-34-25-21(26)10-16(12-30-25)13-32-14-20(22(31-32)17-4-5-17)24(33)29-11-15-3-6-19-18(9-15)7-8-28-23(19)27/h3,6-10,12,14,17H,2,4-5,11,13H2,1H3,(H2,27,28)(H,29,33)	KXNHEPBASBKDTB-UHFFFAOYSA-N	263313	1-(5-chloro-6-ethoxy-pyridin-3-ylmethyl)-3-cyclopropyl-1h-pyrazole-4-carboxylicacid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 94	Plasma kallikrein			 53.2							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263313	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263313&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86343664	377002220							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498568	CCN(CC)c1ncc(Cn2cc(C(=O)NCc3ccc4c(N)nccc4c3)c(n2)C2CC2)cc1F	InChI=1S/C27H30FN7O/c1-3-34(4-2)26-23(28)12-18(14-31-26)15-35-16-22(24(33-35)19-6-7-19)27(36)32-13-17-5-8-21-20(11-17)9-10-30-25(21)29/h5,8-12,14,16,19H,3-4,6-7,13,15H2,1-2H3,(H2,29,30)(H,32,36)	MJXNVOXGGURCQI-UHFFFAOYSA-N	263314	3-cyclopropyl-1-(6-diethylamino-5-fluoro-pyridin-3-ylmethyl)-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 95	Plasma kallikrein			 34.0							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263314	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263314&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86343665	377002221							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498569	Nc1nccc2cc(CNC(=O)c3cn(Cc4cnc(N5CCCC5)c(Cl)c4)nc3C3CC3)ccc12	InChI=1S/C27H28ClN7O/c28-23-12-18(14-31-26(23)34-9-1-2-10-34)15-35-16-22(24(33-35)19-4-5-19)27(36)32-13-17-3-6-21-20(11-17)7-8-30-25(21)29/h3,6-8,11-12,14,16,19H,1-2,4-5,9-10,13,15H2,(H2,29,30)(H,32,36)	AKRGGXIRZBHZIN-UHFFFAOYSA-N	263315	1-(5-chloro-6-pyrrolidin-1-yl-pyridin-3-ylmethyl)-3-cyclopropyl-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 97	Plasma kallikrein			 18.5							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263315	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263315&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86343666	377002222							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498570	CCOc1ccc(Cn2cc(C(=O)NCc3ccc4c(N)nccc4c3)c(N)n2)cn1	InChI=1S/C22H23N7O2/c1-2-31-19-6-4-15(11-26-19)12-29-13-18(21(24)28-29)22(30)27-10-14-3-5-17-16(9-14)7-8-25-20(17)23/h3-9,11,13H,2,10,12H2,1H3,(H2,23,25)(H2,24,28)(H,27,30)	PWINZESYUZCYRY-UHFFFAOYSA-N	263316	3-amino-1-(6-ethoxy-pyridin-3-ylmethyl)-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 98	Plasma kallikrein			 62.4							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263316	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263316&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86343667	377002223							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498571	Nc1nn(Cc2ccc(nc2)N2CCCC2)cc1C(=O)NCc1ccc2c(N)nccc2c1	InChI=1S/C24H26N8O/c25-22-19-5-3-16(11-18(19)7-8-27-22)12-29-24(33)20-15-32(30-23(20)26)14-17-4-6-21(28-13-17)31-9-1-2-10-31/h3-8,11,13,15H,1-2,9-10,12,14H2,(H2,25,27)(H2,26,30)(H,29,33)	HIYGQPZTBFIDNY-UHFFFAOYSA-N	263317	3-amino-1-(6-pyrrolidin-1-yl-pyridin-3-ylmethyl)-1h-pyrazole-4-carboxylic acid(1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 99	Plasma kallikrein			 4.15							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263317	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263317&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86343668	377002224							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498572	CN(Cc1ccc(Cn2cc(cn2)C(=O)NCc2cnc3[nH]ccc3c2)cc1)c1sc(C)nc1C	InChI=1S/C26H27N7OS/c1-17-26(35-18(2)31-17)32(3)14-19-4-6-20(7-5-19)15-33-16-23(13-30-33)25(34)29-12-21-10-22-8-9-27-24(22)28-11-21/h4-11,13,16H,12,14-15H2,1-3H3,(H,27,28)(H,29,34)	GCPHYNUSXHOXGP-UHFFFAOYSA-N	263318	1-(4-{[(2,4-dimethyl-thiazol-5-yl)-methyl-amino]-methyl}-benzyl)-1h-pyrazole-4-carboxylic acid (1h-pyrrolo[2,3-b]pyridin-5-ylmethyl)-amide::US9533987, example 105	Plasma kallikrein			 17000							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263318	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263318&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135120944	377002225							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498573	Fc1cccnc1Oc1cccc(Cn2cc(cn2)C(=O)NCc2cnc3[nH]ccc3c2)c1	InChI=1S/C24H19FN6O2/c25-21-5-2-7-27-24(21)33-20-4-1-3-16(10-20)14-31-15-19(13-30-31)23(32)29-12-17-9-18-6-8-26-22(18)28-11-17/h1-11,13,15H,12,14H2,(H,26,28)(H,29,32)	MDIAEHFRRWCKQW-UHFFFAOYSA-N	263319	1-[3-(3-fluoro-pyridin-2-yloxy)-benzyl]-1h-pyrazole-4-carboxylic acid (1h-pyrrolo[2,3-b]pyridin-5-ylmethyl)-amide::US9533987, example 106	Plasma kallikrein			 12000							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263319	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263319&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135120945	377002226							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498574	O=C(NCc1cnc2[nH]ccc2c1)c1cnn(Cc2ccc(Oc3ccccn3)cc2)c1	InChI=1S/C24H20N6O2/c31-24(28-13-18-11-19-8-10-26-23(19)27-12-18)20-14-29-30(16-20)15-17-4-6-21(7-5-17)32-22-3-1-2-9-25-22/h1-12,14,16H,13,15H2,(H,26,27)(H,28,31)	YXQUIICHGMFDRY-UHFFFAOYSA-N	263320	1-[4-(pyridin-2-yloxy)-benzyl]-1h-pyrazole-4-carboxylic acid (1h-pyrrolo[2,3-b]pyridin-5-ylmethyl)-amide::US9533987, example 107	Plasma kallikrein			 2300							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263320	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263320&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135120946	377002227							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498575	O=C(NCc1cnc2[nH]ccc2c1)c1cnn(Cc2cccc(Oc3ccccc3)c2)c1	InChI=1S/C25H21N5O2/c31-25(28-14-19-11-20-9-10-26-24(20)27-13-19)21-15-29-30(17-21)16-18-5-4-8-23(12-18)32-22-6-2-1-3-7-22/h1-13,15,17H,14,16H2,(H,26,27)(H,28,31)	MHEVBBRLOVIVPI-UHFFFAOYSA-N	263321	1-(3-phenoxy-benzyl)-1h-pyrazole-4-carboxylic acid (1h-pyrrolo[2,3-b]pyridin-5-ylmethyl)-amide::US9533987, example 108	Plasma kallikrein			 22000							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263321	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263321&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135120947	377002228							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498576	Fc1cccc(OCc2ccc(Cn3cc(cn3)C(=O)NCc3cnc4[nH]ccc4c3)cc2)n1	InChI=1S/C25H21FN6O2/c26-22-2-1-3-23(31-22)34-16-18-6-4-17(5-7-18)14-32-15-21(13-30-32)25(33)29-12-19-10-20-8-9-27-24(20)28-11-19/h1-11,13,15H,12,14,16H2,(H,27,28)(H,29,33)	JXTTVBILPNBROK-UHFFFAOYSA-N	263322	1-[4-(6-fluoro-pyridin-2-yloxymethyl)-benzyl]-1h-pyrazole-4-carboxylic acid (1h-pyrrolo[2,3-b]pyridin-5-ylmethyl)-amide::US9533987, example 109	Plasma kallikrein			 4200							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263322	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263322&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135120948	377002229							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498577	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4ccc5[nH]c(C)cc5c4)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C27H25F3N6O/c1-17-11-32-35(13-17)14-19-3-5-20(6-4-19)15-36-16-23(25(34-36)27(28,29)30)26(37)31-12-21-7-8-24-22(10-21)9-18(2)33-24/h3-11,13,16,33H,12,14-15H2,1-2H3,(H,31,37)	LGFPVXYSXMEZGQ-UHFFFAOYSA-N	263323	1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-3-trifluoromethyl-1h-pyrazole-4-carboxylic acid (2-methyl-1h-indol-5-ylmethyl)-amide::US9533987, example 110	Plasma kallikrein			 562							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263323	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263323&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135120949	377002230							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498578	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4ccc5[nH]ncc5c4)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C25H22F3N7O/c1-16-9-31-34(12-16)13-17-2-4-18(5-3-17)14-35-15-21(23(33-35)25(26,27)28)24(36)29-10-19-6-7-22-20(8-19)11-30-32-22/h2-9,11-12,15H,10,13-14H2,1H3,(H,29,36)(H,30,32)	TYIUVXKSOYVUCX-UHFFFAOYSA-N	263324	1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-3-trifluoromethyl-1h-pyrazole-4-carboxylic acid (1h-indazol-5-ylmethyl)-amide::US9533987, example 111	Plasma kallikrein			 217							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263324	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263324&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135120950	377002231							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498579	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4ccc5[nH]ccc5c4)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C26H23F3N6O/c1-17-11-32-34(13-17)14-18-2-4-19(5-3-18)15-35-16-22(24(33-35)26(27,28)29)25(36)31-12-20-6-7-23-21(10-20)8-9-30-23/h2-11,13,16,30H,12,14-15H2,1H3,(H,31,36)	GOKGDYJODZLJNF-UHFFFAOYSA-N	263325	1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-3-trifluoromethyl-1h-pyrazole-4-carboxylic acid (1h-indol-5-ylmethyl)-amide::US9533987, example 112	Plasma kallikrein			 60.6							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263325	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263325&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135120951	377002232							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498580	Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cccc2[nH]ncc12	InChI=1S/C25H23N7O2/c26-24-21(25(34)27-12-19-4-3-5-22-20(19)13-28-29-22)16-32(30-24)15-18-9-7-17(8-10-18)14-31-11-2-1-6-23(31)33/h1-11,13,16H,12,14-15H2,(H2,26,30)(H,27,34)(H,28,29)	XAOAFFYPRSRGEH-UHFFFAOYSA-N	263326	3-amino-1-[4-(2-oxo-2h-pyridin-1-ylmethyl)-benzyl]-1h-pyrazole-4-carboxylicacid (1h-indazol-4-ylmethyl)-amide::US9533987, example 113	Plasma kallikrein			 13.3							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263326	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263326&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135120952	377002233							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498581	FC(F)(F)c1nn(Cc2ccc(nc2)N2CCCC2)cc1C(=O)NCc1cnc2[nH]ccc2c1	InChI=1S/C23H22F3N7O/c24-23(25,26)20-18(22(34)30-12-16-9-17-5-6-27-21(17)29-11-16)14-33(31-20)13-15-3-4-19(28-10-15)32-7-1-2-8-32/h3-6,9-11,14H,1-2,7-8,12-13H2,(H,27,29)(H,30,34)	QQCYTTGMUWAXFJ-UHFFFAOYSA-N	263327	1-(6-pyrrolidin-1-yl-pyridin-3-ylmethyl)-3-trifluoromethyl-1h-pyrazole-4-carboxylic acid (1h-pyrrolo[2,3-b]pyridin-5-ylmethyl)-amide::US9533987, example 114	Plasma kallikrein			 304							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263327	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263327&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135120953	377002234							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498582	Cc1cnn(Cc2ccc(Cn3cc(nn3)C(=O)NCc3cnc4[nH]ccc4c3)cc2)c1	InChI=1S/C23H22N8O/c1-16-9-27-30(12-16)13-17-2-4-18(5-3-17)14-31-15-21(28-29-31)23(32)26-11-19-8-20-6-7-24-22(20)25-10-19/h2-10,12,15H,11,13-14H2,1H3,(H,24,25)(H,26,32)	FWDCGUXNYSXIAJ-UHFFFAOYSA-N	263328	1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-1h-[1,2,3]triazole-4-carboxylic acid(1h-pyrrolo[2,3-b]pyridin-5-ylmethyl)-amide::US9533987, example 115	Plasma kallikrein			 177							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263328	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263328&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135120954	377002235							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498583	Cc1cnn(Cc2ccc(Cn3cc(nn3)C(=O)NCc3cc4cc[nH]c4nc3C)cc2)c1	InChI=1S/C24H24N8O/c1-16-10-27-31(12-16)13-18-3-5-19(6-4-18)14-32-15-22(29-30-32)24(33)26-11-21-9-20-7-8-25-23(20)28-17(21)2/h3-10,12,15H,11,13-14H2,1-2H3,(H,25,28)(H,26,33)	WJIZTRQCOWDWFN-UHFFFAOYSA-N	263329	1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-1h-[1,2,3]triazole-4-carboxylic acid(6-methyl-1h-pyrrolo[2,3-b]pyridin-5-ylmethyl)-amide::US9533987, example 116	Plasma kallikrein			 507							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263329	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263329&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135120955	377002236							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498584	Cc1cnn(Cc2ccc(Cn3cc(cn3)C(=O)NCc3cnc4[nH]ccc4c3)cc2)c1	InChI=1S/C24H23N7O/c1-17-9-28-30(13-17)14-18-2-4-19(5-3-18)15-31-16-22(12-29-31)24(32)27-11-20-8-21-6-7-25-23(21)26-10-20/h2-10,12-13,16H,11,14-15H2,1H3,(H,25,26)(H,27,32)	YORRWDVNDGSRIN-UHFFFAOYSA-N	263330	1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-1h-pyrazole-4-carboxylic acid (1h-pyrrolo[2,3-b]pyridin-5-ylmethyl)-amide::US9533987, example 117	Plasma kallikrein			 78							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263330	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263330&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135120956	377002237							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498585	Cc1cnn(Cc2ccc(Cn3cc(cn3)C(=O)NCc3c(C)nc4[nH]ccc4c3C)cc2)c1	InChI=1S/C26H27N7O/c1-17-10-29-32(13-17)14-20-4-6-21(7-5-20)15-33-16-22(11-30-33)26(34)28-12-24-18(2)23-8-9-27-25(23)31-19(24)3/h4-11,13,16H,12,14-15H2,1-3H3,(H,27,31)(H,28,34)	VAMAGHITSPCHFP-UHFFFAOYSA-N	263331	1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-1h-pyrazole-4-carboxylic acid (4,6-dimethyl-1h-pyrrolo[2,3-b]pyridin-5-ylmethyl)-amide::US9533987, example 118	Plasma kallikrein			 14							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263331	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263331&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135120957	377002238							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498586	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4c(C)nc5[nH]ccc5c4C)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C27H26F3N7O/c1-16-10-33-36(12-16)13-19-4-6-20(7-5-19)14-37-15-23(24(35-37)27(28,29)30)26(38)32-11-22-17(2)21-8-9-31-25(21)34-18(22)3/h4-10,12,15H,11,13-14H2,1-3H3,(H,31,34)(H,32,38)	PYSGSTYUQNZDJG-UHFFFAOYSA-N	263332	1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-3-trifluoromethyl-1h-pyrazole-4-carboxylic acid (4,6-dimethyl-1h-pyrrolo[2,3-b]pyridin-5-ylmethyl)-amide::US9533987, example 119	Plasma kallikrein			 86.6							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263332	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263332&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135120958	377002239							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498587	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4cnc5[nH]ccc5c4)c(n3)C3CC3)cc2)c1	InChI=1S/C27H27N7O/c1-18-11-31-33(14-18)15-19-2-4-20(5-3-19)16-34-17-24(25(32-34)22-6-7-22)27(35)30-13-21-10-23-8-9-28-26(23)29-12-21/h2-5,8-12,14,17,22H,6-7,13,15-16H2,1H3,(H,28,29)(H,30,35)	FMTPKGLRZYVBDW-UHFFFAOYSA-N	263333	3-cyclopropyl-1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-1h-pyrazole-4-carboxylic acid (1h-pyrrolo[2,3-b]pyridin-5-ylmethyl)-amide::US9533987, example 120	Plasma kallikrein			 118							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263333	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263333&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135120959	377002240							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498588	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4cnc5[nH]ccc5c4)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C25H22F3N7O/c1-16-9-32-34(12-16)13-17-2-4-18(5-3-17)14-35-15-21(22(33-35)25(26,27)28)24(36)31-11-19-8-20-6-7-29-23(20)30-10-19/h2-10,12,15H,11,13-14H2,1H3,(H,29,30)(H,31,36)	CLZJGBDROZBBHL-UHFFFAOYSA-N	263334	1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-3-trifluoromethyl-1h-pyrazole-4-carboxylic acid (1h-pyrrolo[2,3-b]pyridin-5-ylmethyl)-amide::US9533987, example 121	Plasma kallikrein			 62.0							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263334	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263334&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			129017356	377002241							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498589	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4c(C)nc5[nH]ccc5c4C)c(n3)C3CC3)cc2)c1	InChI=1S/C29H31N7O/c1-18-12-32-35(14-18)15-21-4-6-22(7-5-21)16-36-17-26(27(34-36)23-8-9-23)29(37)31-13-25-19(2)24-10-11-30-28(24)33-20(25)3/h4-7,10-12,14,17,23H,8-9,13,15-16H2,1-3H3,(H,30,33)(H,31,37)	DLSZVXCWIMIBDV-UHFFFAOYSA-N	263335	3-cyclopropyl-1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-1h-pyrazole-4-carboxylic acid (4,6-dimethyl-1h-pyrrolo[2,3-b]pyridin-5-ylmethyl)-amide::US9533987, example 122	Plasma kallikrein			 101							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263335	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263335&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135120960	377002242							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498590	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4cccc5[nH]ccc45)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C26H23F3N6O/c1-17-11-32-34(13-17)14-18-5-7-19(8-6-18)15-35-16-22(24(33-35)26(27,28)29)25(36)31-12-20-3-2-4-23-21(20)9-10-30-23/h2-11,13,16,30H,12,14-15H2,1H3,(H,31,36)	UEJRHWYEPHWIOF-UHFFFAOYSA-N	263336	1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-3-trifluoromethyl-1h-pyrazole-4-carboxylic acid (1h-indol-4-ylmethyl)-amide::US9533987, example 123	Plasma kallikrein			 545							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263336	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263336&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135120961	377002243							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498591	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4cccc5[nH]ncc45)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C25H22F3N7O/c1-16-9-31-34(12-16)13-17-5-7-18(8-6-17)14-35-15-21(23(33-35)25(26,27)28)24(36)29-10-19-3-2-4-22-20(19)11-30-32-22/h2-9,11-12,15H,10,13-14H2,1H3,(H,29,36)(H,30,32)	VCGJVSUALWGSID-UHFFFAOYSA-N	263337	1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-3-trifluoromethyl-1h-pyrazole-4-carboxylic acid (1h-indazol-4-ylmethyl)-amide::US9533987, example 124	Plasma kallikrein			 146							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263337	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263337&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135120962	377002244							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498592	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4ccnc5[nH]ccc45)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C25H22F3N7O/c1-16-10-32-34(12-16)13-17-2-4-18(5-3-17)14-35-15-21(22(33-35)25(26,27)28)24(36)31-11-19-6-8-29-23-20(19)7-9-30-23/h2-10,12,15H,11,13-14H2,1H3,(H,29,30)(H,31,36)	AIXPIMRNUXHKBZ-UHFFFAOYSA-N	263338	1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-3-trifluoromethyl-1h-pyrazole-4-carboxylic acid (1h-pyrrolo[2,3-b]pyridin-4-ylmethyl)-amide::US9533987, example 125	Plasma kallikrein			 4010							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263338	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263338&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135120963	377002245							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498593	FC(F)(F)c1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cccc2[nH]ncc12	InChI=1S/C26H21F3N6O2/c27-26(28,29)24-21(25(37)30-12-19-4-3-5-22-20(19)13-31-32-22)16-35(33-24)15-18-9-7-17(8-10-18)14-34-11-2-1-6-23(34)36/h1-11,13,16H,12,14-15H2,(H,30,37)(H,31,32)	QNSQGYAARJURPT-UHFFFAOYSA-N	263339	1-[4-(2-oxo-2h-pyridin-1-ylmethyl)-benzyl]-3-trifluoromethyl-1h-pyrazole-4-carboxylic acid (1h-indazol-4-ylmethyl)-amide::US9533987, example 126	Plasma kallikrein			 22.9							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263339	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263339&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135120964	377002246							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498594	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4n[nH]c5ccc(Cl)cc45)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C25H21ClF3N7O/c1-15-9-31-35(11-15)12-16-2-4-17(5-3-16)13-36-14-20(23(34-36)25(27,28)29)24(37)30-10-22-19-8-18(26)6-7-21(19)32-33-22/h2-9,11,14H,10,12-13H2,1H3,(H,30,37)(H,32,33)	ZUNRRNHOIDIDMU-UHFFFAOYSA-N	263340	1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-3-trifluoromethyl-1h-pyrazole-4-carboxylic acid (5-chloro-1h-indazol-3-ylmethyl)-amide::US9533987, example 127	Plasma kallikrein			 537							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263340	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263340&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135120965	377002247							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498595	FC(F)(F)c1nn(Cc2ccc(nc2)N2CCCC2)cc1C(=O)ONC(=O)c1n[nH]c2ccc(Cl)cc12	InChI=1S/C23H19ClF3N7O3/c24-14-4-5-17-15(9-14)19(30-29-17)21(35)32-37-22(36)16-12-34(31-20(16)23(25,26)27)11-13-3-6-18(28-10-13)33-7-1-2-8-33/h3-6,9-10,12H,1-2,7-8,11H2,(H,29,30)(H,32,35)	DGUKQNBEAXNMER-UHFFFAOYSA-N	263341	1-(6-pyrrolidin-1-yl-pyridin-3-ylmethyl)-3-trifluoromethyl-1h-pyrazole-4-carboxylic acid (5-chloro-1h-indazol-3-ylmethyl)-amide::US9533987, example 128	Plasma kallikrein			 24.9							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263341	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263341&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135120966	377002248							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
498596	FC(F)(F)c1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1n[nH]c2ccc(Cl)cc12	InChI=1S/C26H20ClF3N6O2/c27-18-8-9-21-19(11-18)22(33-32-21)12-31-25(38)20-15-36(34-24(20)26(28,29)30)14-17-6-4-16(5-7-17)13-35-10-2-1-3-23(35)37/h1-11,15H,12-14H2,(H,31,38)(H,32,33)	LQMUSHCKCADHQE-UHFFFAOYSA-N	263342	1-[4-(2-oxo-2h-pyridin-1-ylmethyl)-benzyl]-3-trifluoromethyl-1h-pyrazole-4-carboxylic acid (5-chloro-1h-indazol-3-ylmethyl)-amide::US9533987, example 129	Plasma kallikrein			 2.14							US Patent		10.7270/Q2SX6G78		aid1795230	US9533987	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Miller, I; Novak, AR; Smith, AJ; Stocks, MJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263342	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263342&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135120967	377002249							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50527625	COC(=O)Nc1ccc(c(c1)[C@H]1CCCN1C(=O)[C@H](Nc1ccc2cc[nH]c(=O)c2c1)c1ccc(OC)c(OC)c1)S(=O)(=O)C(C)C	InChI=1S/C34H38N4O8S/c1-20(2)47(42,43)30-13-11-24(37-34(41)46-5)19-26(30)27-7-6-16-38(27)33(40)31(22-9-12-28(44-3)29(17-22)45-4)36-23-10-8-21-14-15-35-32(39)25(21)18-23/h8-15,17-20,27,31,36H,6-7,16H2,1-5H3,(H,35,39)(H,37,41)/t27-,31-/m1/s1	QMDGBKOOYLXRQW-DLFZDVPBSA-N	50201262	CHEMBL3949343	Plasma kallikrein		>1000								ChEMBL	10.1021/acsmedchemlett.6b00282	10.7270/Q2GB2613	27994741			Wurtz, NR; Parkhurst, BL; Jiang, W; DeLucca, I; Zhang, X; Ladziata, V; Cheney, DL; Bozarth, JR; Rendina, AR; Wei, A; Luettgen, JM; Wu, Y; Wong, PC; Seiffert, DA; Wexler, RR; Priestley, ES	Bristol-Myers Squibb R & D	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50201262	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50201262&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			24999867	375979330		CHEMBL3949343					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50527640	COC(=O)Nc1ccc(c(c1)[C@H]1CCCN1C(=O)[C@H](Nc1cc2C(=O)NCc2cc1F)c1ccc(OC)c(OC)c1)S(=O)(=O)C(C)C	InChI=1S/C33H37FN4O8S/c1-18(2)47(42,43)29-11-9-21(36-33(41)46-5)15-23(29)26-7-6-12-38(26)32(40)30(19-8-10-27(44-3)28(14-19)45-4)37-25-16-22-20(13-24(25)34)17-35-31(22)39/h8-11,13-16,18,26,30,37H,6-7,12,17H2,1-5H3,(H,35,39)(H,36,41)/t26-,30-/m1/s1	BPIJQVAKJCDFPD-PDDLMNHVSA-N	50201263	CHEMBL3962367	Plasma kallikrein		>1000								ChEMBL	10.1021/acsmedchemlett.6b00282	10.7270/Q2GB2613	27994741			Wurtz, NR; Parkhurst, BL; Jiang, W; DeLucca, I; Zhang, X; Ladziata, V; Cheney, DL; Bozarth, JR; Rendina, AR; Wei, A; Luettgen, JM; Wu, Y; Wong, PC; Seiffert, DA; Wexler, RR; Priestley, ES	Bristol-Myers Squibb R & D	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50201263	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50201263&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			25001205	375979331		CHEMBL3962367					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50551365	Cc1nc(N)cc2OCCC=CCCCOc3cc(Cn4cccn4)ccc3Cn3cc(cn3)C(=O)NCc12	InChI=1S/C29H33N7O3/c1-21-25-17-31-29(37)24-16-33-36(20-24)19-23-9-8-22(18-35-11-7-10-32-35)14-26(23)38-12-5-3-2-4-6-13-39-27(25)15-28(30)34-21/h2,4,7-11,14-16,20H,3,5-6,12-13,17-19H2,1H3,(H2,30,34)(H,31,37)	ZVYLYYBRLJOHMS-UHFFFAOYSA-N	50210075	CHEMBL3883788	Plasma kallikrein			 4.8							ChEMBL	10.1021/acsmedchemlett.6b00384	10.7270/Q2DB83V8	28197309			Li, Z; Partridge, J; Silva-Garcia, A; Rademacher, P; Betz, A; Xu, Q; Sham, H; Hu, Y; Shan, Y; Liu, B; Zhang, Y; Shi, H; Xu, Q; Ma, X; Zhang, L	Global Blood Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50210075	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50210075&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	GBT	5TJX	134131303	375982548		CHEMBL3883788					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50551369	Cc1nc(N)cc2OCCC\C=C\CCOc3cc(Cn4cccn4)ccc3Cn3cc(cn3)C(=O)NCc12	InChI=1S/C29H33N7O3/c1-21-25-17-31-29(37)24-16-33-36(20-24)19-23-9-8-22(18-35-11-7-10-32-35)14-26(23)38-12-5-3-2-4-6-13-39-27(25)15-28(30)34-21/h2-3,7-11,14-16,20H,4-6,12-13,17-19H2,1H3,(H2,30,34)(H,31,37)/b3-2+	OSLSJEGJCLYVFN-NSCUHMNNSA-N	50210074	CHEMBL3883423	Plasma kallikrein			 153							ChEMBL	10.1021/acsmedchemlett.6b00384	10.7270/Q2DB83V8	28197309			Li, Z; Partridge, J; Silva-Garcia, A; Rademacher, P; Betz, A; Xu, Q; Sham, H; Hu, Y; Shan, Y; Liu, B; Zhang, Y; Shi, H; Xu, Q; Ma, X; Zhang, L	Global Blood Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50210074	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50210074&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134131077	375982547		CHEMBL3883423					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50551370	Cc1nc(N)cc2OCCCCCCOc3cc(Cn4cccn4)ccc3Cn3cc(cn3)C(=O)NCc12	InChI=1S/C28H33N7O3/c1-20-24-16-30-28(36)23-15-32-35(19-23)18-22-8-7-21(17-34-10-6-9-31-34)13-25(22)37-11-4-2-3-5-12-38-26(24)14-27(29)33-20/h6-10,13-15,19H,2-5,11-12,16-18H2,1H3,(H2,29,33)(H,30,36)	IPWVZDMBFWEZMI-UHFFFAOYSA-N	50210076	CHEMBL3884030	Plasma kallikrein			 8310							ChEMBL	10.1021/acsmedchemlett.6b00384	10.7270/Q2DB83V8	28197309			Li, Z; Partridge, J; Silva-Garcia, A; Rademacher, P; Betz, A; Xu, Q; Sham, H; Hu, Y; Shan, Y; Liu, B; Zhang, Y; Shi, H; Xu, Q; Ma, X; Zhang, L	Global Blood Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50210076	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50210076&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134131107	375982549		CHEMBL3884030					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50551371	Cc1cc(N)nc2OCC\C=C\CCOc3cc(Cn4cccn4)ccc3Cn3cc(cn3)C(=O)NCc12	InChI=1S/C28H31N7O3/c1-20-13-26(29)33-28-24(20)16-30-27(36)23-15-32-35(19-23)18-22-8-7-21(17-34-10-6-9-31-34)14-25(22)37-11-4-2-3-5-12-38-28/h2-3,6-10,13-15,19H,4-5,11-12,16-18H2,1H3,(H2,29,33)(H,30,36)/b3-2+	QLDMRELKHSVKDE-NSCUHMNNSA-N	50210077	CHEMBL3883550	Plasma kallikrein			 53200							ChEMBL	10.1021/acsmedchemlett.6b00384	10.7270/Q2DB83V8	28197309			Li, Z; Partridge, J; Silva-Garcia, A; Rademacher, P; Betz, A; Xu, Q; Sham, H; Hu, Y; Shan, Y; Liu, B; Zhang, Y; Shi, H; Xu, Q; Ma, X; Zhang, L	Global Blood Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50210077	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50210077&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134131498	375982550		CHEMBL3883550					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50551385	Cc1cc(N)nc2OCC\C=C/CCOc3cc(Cn4cccn4)ccc3Cn3cc(cn3)C(=O)NCc12	InChI=1S/C28H31N7O3/c1-20-13-26(29)33-28-24(20)16-30-27(36)23-15-32-35(19-23)18-22-8-7-21(17-34-10-6-9-31-34)14-25(22)37-11-4-2-3-5-12-38-28/h2-3,6-10,13-15,19H,4-5,11-12,16-18H2,1H3,(H2,29,33)(H,30,36)/b3-2-	QLDMRELKHSVKDE-IHWYPQMZSA-N	50210128	CHEMBL3884218	Plasma kallikrein			>3000000							ChEMBL	10.1021/acsmedchemlett.6b00384	10.7270/Q2DB83V8	28197309			Li, Z; Partridge, J; Silva-Garcia, A; Rademacher, P; Betz, A; Xu, Q; Sham, H; Hu, Y; Shan, Y; Liu, B; Zhang, Y; Shi, H; Xu, Q; Ma, X; Zhang, L	Global Blood Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50210128	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50210128&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134130030	375982552		CHEMBL3884218					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50551387	Cc1nc(N)cc2OCC\C=C/CCCOc3cc(Cn4cccn4)ccc3Cn3cc(cn3)C(=O)NCc12	InChI=1S/C29H33N7O3/c1-21-25-17-31-29(37)24-16-33-36(20-24)19-23-9-8-22(18-35-11-7-10-32-35)14-26(23)38-12-5-3-2-4-6-13-39-27(25)15-28(30)34-21/h2,4,7-11,14-16,20H,3,5-6,12-13,17-19H2,1H3,(H2,30,34)(H,31,37)/b4-2-	ZVYLYYBRLJOHMS-RQOWECAXSA-N	50210073	CHEMBL3883461	Plasma kallikrein			 42							ChEMBL	10.1021/acsmedchemlett.6b00384	10.7270/Q2DB83V8	28197309			Li, Z; Partridge, J; Silva-Garcia, A; Rademacher, P; Betz, A; Xu, Q; Sham, H; Hu, Y; Shan, Y; Liu, B; Zhang, Y; Shi, H; Xu, Q; Ma, X; Zhang, L	Global Blood Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50210073	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50210073&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134131084	375982546		CHEMBL3883461					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50551388	Cc1nc(N)cc2OCC\C=C\CCOc3cc(Cn4cccn4)ccc3Cn3cc(cn3)C(=O)NCc12	InChI=1S/C28H31N7O3/c1-20-24-16-30-28(36)23-15-32-35(19-23)18-22-8-7-21(17-34-10-6-9-31-34)13-25(22)37-11-4-2-3-5-12-38-26(24)14-27(29)33-20/h2-3,6-10,13-15,19H,4-5,11-12,16-18H2,1H3,(H2,29,33)(H,30,36)/b3-2+	RENCCYNTJOPRRX-NSCUHMNNSA-N	50210129	CHEMBL3885334	Plasma kallikrein			 1210							ChEMBL	10.1021/acsmedchemlett.6b00384	10.7270/Q2DB83V8	28197309			Li, Z; Partridge, J; Silva-Garcia, A; Rademacher, P; Betz, A; Xu, Q; Sham, H; Hu, Y; Shan, Y; Liu, B; Zhang, Y; Shi, H; Xu, Q; Ma, X; Zhang, L	Global Blood Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50210129	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50210129&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134131383	375982553		CHEMBL3885334					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50551389	Cc1nc(N)ccc1CNC(=O)c1cnn(Cc2ccc(Cn3cccn3)cc2)c1	InChI=1S/C22H23N7O/c1-16-19(7-8-21(23)27-16)11-24-22(30)20-12-26-29(15-20)14-18-5-3-17(4-6-18)13-28-10-2-9-25-28/h2-10,12,15H,11,13-14H2,1H3,(H2,23,27)(H,24,30)	WWJLNLGOEPGLIB-UHFFFAOYSA-N	50210072	CHEMBL3884830	Plasma kallikrein			 2.4							ChEMBL	10.1021/acsmedchemlett.6b00384	10.7270/Q2DB83V8	28197309			Li, Z; Partridge, J; Silva-Garcia, A; Rademacher, P; Betz, A; Xu, Q; Sham, H; Hu, Y; Shan, Y; Liu, B; Zhang, Y; Shi, H; Xu, Q; Ma, X; Zhang, L	Global Blood Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50210072	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50210072&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134130781	375982545		CHEMBL3884830					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50551390	Cc1nc(N)cc2OCC\C=C\CCCOc3cc(Cn4cccn4)ccc3Cn3cc(cn3)C(=O)NCc12	InChI=1S/C29H33N7O3/c1-21-25-17-31-29(37)24-16-33-36(20-24)19-23-9-8-22(18-35-11-7-10-32-35)14-26(23)38-12-5-3-2-4-6-13-39-27(25)15-28(30)34-21/h2,4,7-11,14-16,20H,3,5-6,12-13,17-19H2,1H3,(H2,30,34)(H,31,37)/b4-2+	ZVYLYYBRLJOHMS-DUXPYHPUSA-N	50210127	CHEMBL3884851	Plasma kallikrein			 2.0							ChEMBL	10.1021/acsmedchemlett.6b00384	10.7270/Q2DB83V8	28197309			Li, Z; Partridge, J; Silva-Garcia, A; Rademacher, P; Betz, A; Xu, Q; Sham, H; Hu, Y; Shan, Y; Liu, B; Zhang, Y; Shi, H; Xu, Q; Ma, X; Zhang, L	Global Blood Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50210127	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50210127&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	GBT	5TJX	134131589	375982551		CHEMBL3884851					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50551391	Cc1nc(N)cc2OCC\C=C/CCOc3cc(Cn4cccn4)ccc3Cn3cc(cn3)C(=O)NCc12	InChI=1S/C28H31N7O3/c1-20-24-16-30-28(36)23-15-32-35(19-23)18-22-8-7-21(17-34-10-6-9-31-34)13-25(22)37-11-4-2-3-5-12-38-26(24)14-27(29)33-20/h2-3,6-10,13-15,19H,4-5,11-12,16-18H2,1H3,(H2,29,33)(H,30,36)/b3-2-	RENCCYNTJOPRRX-IHWYPQMZSA-N	50210130	CHEMBL3885037	Plasma kallikrein			 1570							ChEMBL	10.1021/acsmedchemlett.6b00384	10.7270/Q2DB83V8	28197309			Li, Z; Partridge, J; Silva-Garcia, A; Rademacher, P; Betz, A; Xu, Q; Sham, H; Hu, Y; Shan, Y; Liu, B; Zhang, Y; Shi, H; Xu, Q; Ma, X; Zhang, L	Global Blood Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50210130	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50210130&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134131040	375982554		CHEMBL3885037					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
543406	CCC(C(=O)Nc1ccn2ncc(C(O)=O)c2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C25H20ClN5O5/c1-3-20(24(33)29-16-6-7-31-21(9-16)19(12-28-31)25(34)35)30-13-22(36-2)18(10-23(30)32)17-8-15(26)5-4-14(17)11-27/h4-10,12-13,20H,3H2,1-2H3,(H,29,33)(H,34,35)	XPDGYJOFZSUFCY-UHFFFAOYSA-N	285514	5-({2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]butanoyl}amino)pyrazolo-[1,5-a]pyridine-3-carboxylic acid (racemate)::US10077265, Example 1	Plasma kallikrein			 5.00					7.4	25.00 C	US Patent		10.7270/Q2XS5XFT		aid1795680	US10077265	Rohrig, S; Hillisch, A; Stra&#946;burger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Teller, H; Jimenez Nunez, E; Schirok, H; Klar, J; Lobell, M	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285514	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285514&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121246714	378169154							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
543407	COCCC(C(=O)Nc1ccn2ncc(C(O)=O)c2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C26H22ClN5O6/c1-37-8-6-21(25(34)30-17-5-7-32-22(10-17)20(13-29-32)26(35)36)31-14-23(38-2)19(11-24(31)33)18-9-16(27)4-3-15(18)12-28/h3-5,7,9-11,13-14,21H,6,8H2,1-2H3,(H,30,34)(H,35,36)	SOLNGYFEBLRSAN-UHFFFAOYSA-N	285515	5-({2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}-amino)pyrazolo[1,5-a]pyridine-3-carboxylic acid (racemate)::US10077265, Example 2	Plasma kallikrein			 2.50					7.4	25.00 C	US Patent		10.7270/Q2XS5XFT		aid1795680	US10077265	Rohrig, S; Hillisch, A; Stra&#946;burger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Teller, H; Jimenez Nunez, E; Schirok, H; Klar, J; Lobell, M	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285515	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285515&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121246715	378169155							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
543408	CCC(C(=O)Nc1ccn2ncc(C(N)=O)c2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C25H21ClN6O4/c1-3-20(25(35)30-16-6-7-32-21(9-16)19(12-29-32)24(28)34)31-13-22(36-2)18(10-23(31)33)17-8-15(26)5-4-14(17)11-27/h4-10,12-13,20H,3H2,1-2H3,(H2,28,34)(H,30,35)	NAVJAUKFYAXRGE-UHFFFAOYSA-N	285516	5-({2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]butanoyl}amino)pyrazolo-[1,5-a]pyridine-3-carboxamide (racemate)::US10077265, Example 3	Plasma kallikrein			 11.0					7.4	25.00 C	US Patent		10.7270/Q2XS5XFT		aid1795680	US10077265	Rohrig, S; Hillisch, A; Stra&#946;burger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Teller, H; Jimenez Nunez, E; Schirok, H; Klar, J; Lobell, M	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285516	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285516&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121246716	378169156							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
543409	COCCC(C(=O)Nc1ccn2ncc(C(N)=O)c2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C26H23ClN6O5/c1-37-8-6-21(26(36)31-17-5-7-33-22(10-17)20(13-30-33)25(29)35)32-14-23(38-2)19(11-24(32)34)18-9-16(27)4-3-15(18)12-28/h3-5,7,9-11,13-14,21H,6,8H2,1-2H3,(H2,29,35)(H,31,36)	OCRCHYZWRKVQCQ-UHFFFAOYSA-N	285517	5-({2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)pyrazolo[1,5-a]pyridine-3-carboxamide (racemate)::US10077265, Example 4::US10077265, Example 5	Plasma kallikrein			 2.70					7.4	25.00 C	US Patent		10.7270/Q2XS5XFT		aid1795680	US10077265	Rohrig, S; Hillisch, A; Stra&#946;burger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Teller, H; Jimenez Nunez, E; Schirok, H; Klar, J; Lobell, M	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285517	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285517&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121246612	378169157							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
543410	COCCC(C(=O)Nc1ccn2ncc(C(N)=O)c2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C26H23ClN6O5/c1-37-8-6-21(26(36)31-17-5-7-33-22(10-17)20(13-30-33)25(29)35)32-14-23(38-2)19(11-24(32)34)18-9-16(27)4-3-15(18)12-28/h3-5,7,9-11,13-14,21H,6,8H2,1-2H3,(H2,29,35)(H,31,36)	OCRCHYZWRKVQCQ-UHFFFAOYSA-N	285517	5-({2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)pyrazolo[1,5-a]pyridine-3-carboxamide (racemate)::US10077265, Example 4::US10077265, Example 5	Plasma kallikrein			 0.800					7.4	25.00 C	US Patent		10.7270/Q2XS5XFT		aid1795680	US10077265	Rohrig, S; Hillisch, A; Stra&#946;burger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Teller, H; Jimenez Nunez, E; Schirok, H; Klar, J; Lobell, M	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285517	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285517&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121246612	378169157							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
543411	COCCC(C(=O)Nc1ccn2ncc(C(=O)N(C)C)c2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C28H27ClN6O5/c1-33(2)28(38)22-15-31-35-9-7-19(12-24(22)35)32-27(37)23(8-10-39-3)34-16-25(40-4)21(13-26(34)36)20-11-18(29)6-5-17(20)14-30/h5-7,9,11-13,15-16,23H,8,10H2,1-4H3,(H,32,37)	PAYFVGMTFBHCRS-UHFFFAOYSA-N	285519	5-({2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)-N,N-dimethylpyrazolo[1,5-a]pyridine-3-carboxamide (racemate)::US10077265, Example 6	Plasma kallikrein			 18.0					7.4	25.00 C	US Patent		10.7270/Q2XS5XFT		aid1795680	US10077265	Rohrig, S; Hillisch, A; Stra&#946;burger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Teller, H; Jimenez Nunez, E; Schirok, H; Klar, J; Lobell, M	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285519	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285519&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121246646	378169158							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
543412	CCCNC(=O)c1cnn2ccc(NC(=O)C(CCOC)n3cc(OC)c(cc3=O)-c3cc(Cl)ccc3C#N)cc12	InChI=1S/C29H29ClN6O5/c1-4-9-32-28(38)23-16-33-36-10-7-20(13-25(23)36)34-29(39)24(8-11-40-2)35-17-26(41-3)22(14-27(35)37)21-12-19(30)6-5-18(21)15-31/h5-7,10,12-14,16-17,24H,4,8-9,11H2,1-3H3,(H,32,38)(H,34,39)	QFMWDGOSYMZTRR-UHFFFAOYSA-N	285520	5-({2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)-N-propylpyrazolo[1,5-a]pyridine-3-carboxamide (racemate)::US10077265, Example 7	Plasma kallikrein			 6.40					7.4	25.00 C	US Patent		10.7270/Q2XS5XFT		aid1795680	US10077265	Rohrig, S; Hillisch, A; Stra&#946;burger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Teller, H; Jimenez Nunez, E; Schirok, H; Klar, J; Lobell, M	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285520	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285520&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121246448	378169159							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
543413	COCCNC(=O)c1cnn2ccc(NC(=O)C(CCOC)n3cc(OC)c(cc3=O)-c3cc(Cl)ccc3C#N)cc12	InChI=1S/C29H29ClN6O6/c1-40-10-7-24(35-17-26(42-3)22(14-27(35)37)21-12-19(30)5-4-18(21)15-31)29(39)34-20-6-9-36-25(13-20)23(16-33-36)28(38)32-8-11-41-2/h4-6,9,12-14,16-17,24H,7-8,10-11H2,1-3H3,(H,32,38)(H,34,39)	FAUPYRQOQINXOL-UHFFFAOYSA-N	285521	5-({2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)-N-(2-methoxyethyl)pyrazolo[1,5-a]pyridine-3-carboxamide (racemate)::US10077265, Example 8	Plasma kallikrein			 3.80					7.4	25.00 C	US Patent		10.7270/Q2XS5XFT		aid1795680	US10077265	Rohrig, S; Hillisch, A; Stra&#946;burger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Teller, H; Jimenez Nunez, E; Schirok, H; Klar, J; Lobell, M	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285521	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285521&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121246652	378169160							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
543414	COCCCNC(=O)c1cnn2ccc(NC(=O)C(CCOC)n3cc(OC)c(cc3=O)-c3cc(Cl)ccc3C#N)cc12	InChI=1S/C30H31ClN6O6/c1-41-11-4-9-33-29(39)24-17-34-37-10-7-21(14-26(24)37)35-30(40)25(8-12-42-2)36-18-27(43-3)23(15-28(36)38)22-13-20(31)6-5-19(22)16-32/h5-7,10,13-15,17-18,25H,4,8-9,11-12H2,1-3H3,(H,33,39)(H,35,40)	YBAIRJKLWQYRGC-UHFFFAOYSA-N	285522	5-({2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)-N-(3-methoxypropyl)pyrazolo[1,5-a]pyridine-3-carboxamide (racemate)::US10077265, Example 9	Plasma kallikrein			 3.00					7.4	25.00 C	US Patent		10.7270/Q2XS5XFT		aid1795680	US10077265	Rohrig, S; Hillisch, A; Stra&#946;burger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Teller, H; Jimenez Nunez, E; Schirok, H; Klar, J; Lobell, M	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285522	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285522&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121246653	378169161							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
543415	COCCC(C(=O)Nc1ccn2ncc(C(=O)NCCOC(F)(F)F)c2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C29H26ClF3N6O6/c1-43-9-6-23(38-16-25(44-2)21(13-26(38)40)20-11-18(30)4-3-17(20)14-34)28(42)37-19-5-8-39-24(12-19)22(15-36-39)27(41)35-7-10-45-29(31,32)33/h3-5,8,11-13,15-16,23H,6-7,9-10H2,1-2H3,(H,35,41)(H,37,42)	DDOFNAVOJKWETH-UHFFFAOYSA-N	285523	5-({2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)-N-[2-(trifluoromethoxy)ethyl]pyrazolo[1,5-a]pyridine-3-carboxamide (racemate)::US10077265, Example 10	Plasma kallikrein			 9.50					7.4	25.00 C	US Patent		10.7270/Q2XS5XFT		aid1795680	US10077265	Rohrig, S; Hillisch, A; Stra&#946;burger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Teller, H; Jimenez Nunez, E; Schirok, H; Klar, J; Lobell, M	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285523	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285523&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121246654	378169162							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
543416	COCCC(C(=O)Nc1ccn2ncc(C(=O)NCCC(F)(F)F)c2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C29H26ClF3N6O5/c1-43-10-6-23(38-16-25(44-2)21(13-26(38)40)20-11-18(30)4-3-17(20)14-34)28(42)37-19-5-9-39-24(12-19)22(15-36-39)27(41)35-8-7-29(31,32)33/h3-5,9,11-13,15-16,23H,6-8,10H2,1-2H3,(H,35,41)(H,37,42)	SYZUSCSRAOJBQO-UHFFFAOYSA-N	285524	5-({2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)-N-(3,3,3-trifluoropropyl)pyrazolo[1,5-a]pyridine-3-carboxamide (racemate)::US10077265, Example 11	Plasma kallikrein			 6.60					7.4	25.00 C	US Patent		10.7270/Q2XS5XFT		aid1795680	US10077265	Rohrig, S; Hillisch, A; Stra&#946;burger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Teller, H; Jimenez Nunez, E; Schirok, H; Klar, J; Lobell, M	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285524	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285524&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121246717	378169163							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
543417	COCCC(C(=O)Nc1ccn2ncc(C(=O)NCC(F)(F)F)c2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C28H24ClF3N6O5/c1-42-8-6-22(37-14-24(43-2)20(11-25(37)39)19-9-17(29)4-3-16(19)12-33)27(41)36-18-5-7-38-23(10-18)21(13-35-38)26(40)34-15-28(30,31)32/h3-5,7,9-11,13-14,22H,6,8,15H2,1-2H3,(H,34,40)(H,36,41)	VZEPGFGHCQNEFC-UHFFFAOYSA-N	285525	5-({2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)-N-(2,2,2-trifluoroethyl)pyrazolo[1,5-a]pyridine-3-carboxamide (racemate)::US10077265, Example 12	Plasma kallikrein			 5.00					7.4	25.00 C	US Patent		10.7270/Q2XS5XFT		aid1795680	US10077265	Rohrig, S; Hillisch, A; Stra&#946;burger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Teller, H; Jimenez Nunez, E; Schirok, H; Klar, J; Lobell, M	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285525	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285525&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121246719	378169164							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
543418	COCCC(C(=O)Nc1ccn2ncc(C(=O)NCCCO)c2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C29H29ClN6O6/c1-41-11-7-24(35-17-26(42-2)22(14-27(35)38)21-12-19(30)5-4-18(21)15-31)29(40)34-20-6-9-36-25(13-20)23(16-33-36)28(39)32-8-3-10-37/h4-6,9,12-14,16-17,24,37H,3,7-8,10-11H2,1-2H3,(H,32,39)(H,34,40)	FUNCNRULOWTKJU-UHFFFAOYSA-N	285526	5-({2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)-N-(3-hydroxypropyl)pyrazolo[1,5-a]pyridine-3-carboxamide (racemate)::US10077265, Example 13	Plasma kallikrein			 5.20					7.4	25.00 C	US Patent		10.7270/Q2XS5XFT		aid1795680	US10077265	Rohrig, S; Hillisch, A; Stra&#946;burger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Teller, H; Jimenez Nunez, E; Schirok, H; Klar, J; Lobell, M	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285526	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285526&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121246721	378169165							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
543419	COCCC(C(=O)Nc1ccn2ncc(C(=O)NCCO)c2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C28H27ClN6O6/c1-40-10-6-23(28(39)33-19-5-8-35-24(12-19)22(15-32-35)27(38)31-7-9-36)34-16-25(41-2)21(13-26(34)37)20-11-18(29)4-3-17(20)14-30/h3-5,8,11-13,15-16,23,36H,6-7,9-10H2,1-2H3,(H,31,38)(H,33,39)	YGSSAEZAISFQSW-UHFFFAOYSA-N	285527	5-({2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)-N-(2-hydroxyethyl)pyrazolo[1,5-a]pyridine-3-carboxamide (racemate)::US10077265, Example 14	Plasma kallikrein			 3.80					7.4	25.00 C	US Patent		10.7270/Q2XS5XFT		aid1795680	US10077265	Rohrig, S; Hillisch, A; Stra&#946;burger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Teller, H; Jimenez Nunez, E; Schirok, H; Klar, J; Lobell, M	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285527	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285527&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121246655	378169166					C04080		1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540202	NC(=O)c1ccc2cc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)ccc2n1	InChI=1S/C26H19ClFN5O2/c27-20-13-31-24-11-21(28)17(10-19(20)24)12-32-26(35)16-5-6-30-18(9-16)8-14-1-3-22-15(7-14)2-4-23(33-22)25(29)34/h1-7,9-11,13,31H,8,12H2,(H2,29,34)(H,32,35)	QFADKPXVEQNUDC-UHFFFAOYSA-N	283349	6-((4-(((3-chloro-6-fluoro-1H-indol-5- yl)methyl)carbamoyl)pyridin-2- yl)methyl)quinoline-2-carboxamide::US10023557, Example 1::US10266515, Example 1::US10308637, Example 1::US11021463, Example 1::US9611252, Example 1	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283349	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283349&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665333	378164678							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540203	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3nc(ccc3c2)C(N)=O)c1	InChI=1S/C25H24N6O2/c1-14-9-23(26)30-15(2)20(14)13-29-25(33)18-7-8-28-19(12-18)11-16-3-5-21-17(10-16)4-6-22(31-21)24(27)32/h3-10,12H,11,13H2,1-2H3,(H2,26,30)(H2,27,32)(H,29,33)	STXHTXUTWCUJHH-UHFFFAOYSA-N	283350	6-((4-(((6-amino-2,4-dimethylpyridin-3- yl)methyl)carbamoyl)pyridin-2- yl)methyl)quinoline-2-carboxamide::US10023557, Example 2::US10266515, Example 2::US10308637, Example 2::US11021463, Example 2::US9611252, Example 2	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283350	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283350&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665160	378164679							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540204	Nc1nccc2cc(CNC(=O)c3ccnc(Cc4ccc5nc(ccc5c4)C#N)c3)ccc12	InChI=1S/C27H20N6O/c28-15-22-4-3-20-11-17(2-6-25(20)33-22)13-23-14-21(8-9-30-23)27(34)32-16-18-1-5-24-19(12-18)7-10-31-26(24)29/h1-12,14H,13,16H2,(H2,29,31)(H,32,34)	DMXHLBYRSDVDMO-UHFFFAOYSA-N	283351	N-((1-aminoisoquinolin-6-yl)methyl)-2-((2- cyanoquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 3::US10266515, Example 3::US10308637, Example 3::US11021463, Example 3::US9611252, Example 3	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283351	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283351&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665133	378164680							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540205	NC(=O)c1ccc2cc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)ccc2n1	InChI=1S/C27H22N6O2/c28-25-22-4-1-17(12-18(22)7-10-31-25)15-32-27(35)20-8-9-30-21(14-20)13-16-2-5-23-19(11-16)3-6-24(33-23)26(29)34/h1-12,14H,13,15H2,(H2,28,31)(H2,29,34)(H,32,35)	SPVRYWSSDGGGFK-UHFFFAOYSA-N	283352	6-((4-(((1-aminoisoquinolin-6- yl)methyl)carbamoyl)pyridin-2- yl)methyl)quinoline-2-carboxamide::US10023557, Example 4::US10266515, Example 4::US10308637, Example 4::US11021463, Example 4::US9611252, Example 4	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283352	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283352&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665212	378164681							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540206	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1ccnc(Cc2ccc3ncc(cc3c2)C#N)c1	InChI=1S/C26H17ClFN5O/c27-22-14-32-25-10-23(28)19(9-21(22)25)13-33-26(34)17-3-4-30-20(8-17)7-15-1-2-24-18(5-15)6-16(11-29)12-31-24/h1-6,8-10,12,14,32H,7,13H2,(H,33,34)	UMGVLTPEGADZAJ-UHFFFAOYSA-N	283353	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3-cyanoquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 5::US10266515, Example 5::US10308637, Example 5::US11021463, Example 5::US9611252, Example 5	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283353	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283353&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665332	378164682							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540207	Nc1nccc2cc(CNC(=O)c3ccnc(Cc4ccc5ncc(cc5c4)C#N)c3)ccc12	InChI=1S/C27H20N6O/c28-14-19-11-22-9-17(2-4-25(22)32-16-19)12-23-13-21(6-7-30-23)27(34)33-15-18-1-3-24-20(10-18)5-8-31-26(24)29/h1-11,13,16H,12,15H2,(H2,29,31)(H,33,34)	KYRAMUYNXMHHJI-UHFFFAOYSA-N	283354	N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- cyanoquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 6::US10266515, Example 6::US10308637, Example 6::US11021463, Example 6::US9611252, Example 6	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283354	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283354&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665279	378164683							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540208	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3ncc(cc3c2)C#N)c1	InChI=1S/C25H22N6O/c1-15-7-24(27)31-16(2)22(15)14-30-25(32)19-5-6-28-21(11-19)10-17-3-4-23-20(8-17)9-18(12-26)13-29-23/h3-9,11,13H,10,14H2,1-2H3,(H2,27,31)(H,30,32)	CBKARQMZIQUSSI-UHFFFAOYSA-N	283355	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-cyanoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 7::US10266515, Example 7::US10308637, Example 7::US11021463, Example 7::US9611252, Example 7	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283355	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283355&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665185	378164684							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540209	Nc1nccc2cc(CNC(=O)c3ccnc(Cc4cnc5ccc(F)cc5n4)c3)ccc12	InChI=1S/C25H19FN6O/c26-18-2-4-22-23(11-18)32-20(14-30-22)12-19-10-17(6-7-28-19)25(33)31-13-15-1-3-21-16(9-15)5-8-29-24(21)27/h1-11,14H,12-13H2,(H2,27,29)(H,31,33)	NAEBTWZBUODUEA-UHFFFAOYSA-N	283356	N-((1-aminoisoquinolin-6-yl)methyl)-2-((7- fluoroquinoxalin-2-yl)methyl)isonicotinamide::US10023557, Example 8::US10266515, Example 8::US10308637, Example 8::US11021463, Example 8::US9611252, Example 8	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283356	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283356&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665180	378164685							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540210	CC(=O)NCc1ccc2cc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)ccc2n1	InChI=1S/C28H23ClFN5O2/c1-16(36)32-14-21-4-3-18-8-17(2-5-26(18)35-21)9-22-10-19(6-7-31-22)28(37)34-13-20-11-23-24(29)15-33-27(23)12-25(20)30/h2-8,10-12,15,33H,9,13-14H2,1H3,(H,32,36)(H,34,37)	VKZVWMJENMIADE-UHFFFAOYSA-N	283357	2-((2-(acetamidomethyl)quinolin-6-yl)methyl)- N-((3-chloro-6-fluoro-1H-indol-5- yl)methyl)isonicotinamide::US10023557, Example 9::US10266515, Example 9::US10308637, Example 9::US11021463, Example 9::US9611252, Example 9	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283357	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283357&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665193	378164686							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540211	CC(=O)NCc1ccc2cc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)ccc2n1	InChI=1S/C29H26N6O2/c1-18(36)33-17-24-5-4-22-12-19(3-7-27(22)35-24)14-25-15-23(9-10-31-25)29(37)34-16-20-2-6-26-21(13-20)8-11-32-28(26)30/h2-13,15H,14,16-17H2,1H3,(H2,30,32)(H,33,36)(H,34,37)	ZYSYOACDZZDUSZ-UHFFFAOYSA-N	283358	2-((2-(acetamidomethyl)quinolin-6-yl)methyl)- N-((1-aminoisoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 10::US10266515, Example 10::US10308637, Example 10::US11021463, Example 10::US9611252, Example 10	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283358	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283358&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665233	378164687							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540212	CC(=O)NCc1ccc2cc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)ccc2n1	InChI=1S/C27H28N6O2/c1-16-10-26(28)32-17(2)24(16)15-31-27(35)21-8-9-29-23(13-21)12-19-4-7-25-20(11-19)5-6-22(33-25)14-30-18(3)34/h4-11,13H,12,14-15H2,1-3H3,(H2,28,32)(H,30,34)(H,31,35)	GCIYNSCGYKCNRO-UHFFFAOYSA-N	283359	2-((2-(acetamidomethyl)quinolin-6-yl)methyl)- N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)isonicotinamide::US10023557, Example 11::US10266515, Example 11::US10308637, Example 11::US11021463, Example 11::US9611252, Example 11	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283359	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283359&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665205	378164688							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540213	CS(=O)(=O)c1ccc2ncc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)cc2c1	InChI=1S/C26H20ClFN4O3S/c1-36(34,35)20-2-3-24-17(9-20)6-15(12-30-24)7-19-8-16(4-5-29-19)26(33)32-13-18-10-21-22(27)14-31-25(21)11-23(18)28/h2-6,8-12,14,31H,7,13H2,1H3,(H,32,33)	QNAPNSFSYRBKHH-UHFFFAOYSA-N	283360	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((6-(methylsulfonyl)quinolin-3- yl)methyl)isonicotinamide::US10023557, Example 12::US10266515, Example 12::US10308637, Example 12::US11021463, Example 12::US9611252, Example 12	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283360	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283360&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665393	378164689							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540214	CS(=O)(=O)c1ccc2ncc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)cc2c1	InChI=1S/C27H23N5O3S/c1-36(34,35)23-3-5-25-21(14-23)11-18(16-31-25)12-22-13-20(7-8-29-22)27(33)32-15-17-2-4-24-19(10-17)6-9-30-26(24)28/h2-11,13-14,16H,12,15H2,1H3,(H2,28,30)(H,32,33)	WYQOOVPHNNJHMZ-UHFFFAOYSA-N	283361	N-((1-aminoisoquinolin-6-yl)methyl)-2-((6- (methylsulfonyl)quinolin-3- yl)methyl)isonicotinamide::US10023557, Example 13::US10266515, Example 13::US10308637, Example 13::US11021463, Example 13::US9611252, Example 13	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283361	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283361&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665105	378164690							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540215	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cnc3ccc(cc3c2)S(C)(=O)=O)c1	InChI=1S/C25H25N5O3S/c1-15-8-24(26)30-16(2)22(15)14-29-25(31)18-6-7-27-20(11-18)10-17-9-19-12-21(34(3,32)33)4-5-23(19)28-13-17/h4-9,11-13H,10,14H2,1-3H3,(H2,26,30)(H,29,31)	IISORMHFXQMHMH-UHFFFAOYSA-N	283362	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((6-(methylsulfonyl)quinolin-3- yl)methyl)isonicotinamide::US10023557, Example 14::US10266515, Example 14::US10308637, Example 14::US11021463, Example 14::US9611252, Example 14	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283362	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283362&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665164	378164691							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540216	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2c1)S(C)(=O)=O	InChI=1S/C26H27N5O3S/c1-15-7-20-9-18(11-23(35(4,33)34)25(20)29-13-15)10-21-12-19(5-6-28-21)26(32)30-14-22-16(2)8-24(27)31-17(22)3/h5-9,11-13H,10,14H2,1-4H3,(H2,27,31)(H,30,32)	HXOKVKXTISERDZ-UHFFFAOYSA-N	283363	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-methyl-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 15::US10266515, Example 15::US10308637, Example 15::US11021463, Example 15::US9611252, Example 15	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283363	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283363&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213052	378164692							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540217	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)cc2c1)S(C)(=O)=O	InChI=1S/C28H25N5O3S/c1-17-9-22-11-19(13-25(37(2,35)36)26(22)32-15-17)12-23-14-21(6-7-30-23)28(34)33-16-18-3-4-24-20(10-18)5-8-31-27(24)29/h3-11,13-15H,12,16H2,1-2H3,(H2,29,31)(H,33,34)	AGLYWDINMJNVRE-UHFFFAOYSA-N	283364	N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- methyl-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 16::US10266515, Example 16::US10308637, Example 16::US11021463, Example 16::US9611252, Example 16	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283364	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283364&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665230	378164693							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540218	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)cc2c1)S(C)(=O)=O	InChI=1S/C27H22ClFN4O3S/c1-15-5-18-6-16(8-25(37(2,35)36)26(18)32-12-15)7-20-9-17(3-4-30-20)27(34)33-13-19-10-21-22(28)14-31-24(21)11-23(19)29/h3-6,8-12,14,31H,7,13H2,1-2H3,(H,33,34)	KNWYWDACHSZACS-UHFFFAOYSA-N	283365	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3-methyl-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 17::US10266515, Example 17::US10308637, Example 17::US11021463, Example 17::US9611252, Example 17	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283365	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283365&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213042	378164694							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540219	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cc4cc[nH]c4cc3F)cc2c1)S(C)(=O)=O	InChI=1S/C27H23FN4O3S/c1-16-7-20-8-17(10-25(36(2,34)35)26(20)31-14-16)9-22-12-19(4-5-29-22)27(33)32-15-21-11-18-3-6-30-24(18)13-23(21)28/h3-8,10-14,30H,9,15H2,1-2H3,(H,32,33)	JOIGNBGOTQEXSU-UHFFFAOYSA-N	283366	N-((6-fluoro-1H-indol-5-yl)methyl)-2-((3- methyl-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 18::US10266515, Example 18::US10308637, Example 18::US11021463, Example 18::US9611252, Example 18	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283366	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283366&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665345	378164695							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540220	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cnc4[nH]cc(Cl)c4c3)cc2c1)S(C)(=O)=O	InChI=1S/C26H22ClN5O3S/c1-15-5-19-6-16(9-23(36(2,34)35)24(19)29-11-15)7-20-10-18(3-4-28-20)26(33)32-13-17-8-21-22(27)14-31-25(21)30-12-17/h3-6,8-12,14H,7,13H2,1-2H3,(H,30,31)(H,32,33)	IIORZUFKRKFNHD-UHFFFAOYSA-N	283367	N-((3-chloro-1H-pyrrolo[2,3-b]pyridin-5- yl)methyl)-2-((3-methyl-8- (methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 19::US10266515, Example 19::US10308637, Example 19::US11021463, Example 19::US9611252, Example 19	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283367	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283367&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665214	378164696							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540221	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3n[nH]c4ccc(Cl)cc34)cc2c1)S(C)(=O)=O	InChI=1S/C26H22ClN5O3S/c1-15-7-18-8-16(10-24(36(2,34)35)25(18)29-13-15)9-20-11-17(5-6-28-20)26(33)30-14-23-21-12-19(27)3-4-22(21)31-32-23/h3-8,10-13H,9,14H2,1-2H3,(H,30,33)(H,31,32)	INPUBOYBDZWEOS-UHFFFAOYSA-N	283368	N-((5-chloro-1H-indazol-3-yl)methyl)-2-((3- methyl-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 20::US10266515, Example 20::US10308637, Example 20::US11021463, Example 20::US9611252, Example 20	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283368	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283368&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665285	378164697							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540222	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3ccc4[nH]cc(Cl)c4c3F)cc2c1)S(C)(=O)=O	InChI=1S/C27H22ClFN4O3S/c1-15-7-19-8-16(10-23(37(2,35)36)26(19)32-12-15)9-20-11-17(5-6-30-20)27(34)33-13-18-3-4-22-24(25(18)29)21(28)14-31-22/h3-8,10-12,14,31H,9,13H2,1-2H3,(H,33,34)	RIPJTLFXOCXAJL-UHFFFAOYSA-N	283369	N-((3-chloro-4-fluoro-1H-indol-5-yl)methyl)-2- ((3-methyl-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 21::US10266515, Example 21::US10308637, Example 21::US11021463, Example 21::US9611252, Example 21	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283369	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283369&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213012	378164698							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540223	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cn2ccc3c(Cl)cccc3c2=O)c1	InChI=1S/C24H22ClN5O2/c1-14-10-22(26)29-15(2)20(14)12-28-23(31)16-6-8-27-17(11-16)13-30-9-7-18-19(24(30)32)4-3-5-21(18)25/h3-11H,12-13H2,1-2H3,(H2,26,29)(H,28,31)	MEZFXRCCCIIGIW-UHFFFAOYSA-N	283370	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((5-chloro-1-oxoisoquinolin-2(1H)- yl)methyl)isonicotinamide::US10023557, Example 22::US10266515, Example 22::US10308637, Example 22::US11021463, Example 22::US9611252, Example 22	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283370	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283370&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665187	378164699							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540224	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cn2ccc3cc(Cl)ccc3c2=O)c1	InChI=1S/C24H22ClN5O2/c1-14-9-22(26)29-15(2)21(14)12-28-23(31)17-5-7-27-19(11-17)13-30-8-6-16-10-18(25)3-4-20(16)24(30)32/h3-11H,12-13H2,1-2H3,(H2,26,29)(H,28,31)	AXAISOZEVYRCNQ-UHFFFAOYSA-N	283371	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((6-chloro-1-oxoisoquinolin-2(1H)- yl)methyl)isonicotinamide::US10023557, Example 23::US10266515, Example 23::US10308637, Example 23::US11021463, Example 23::US9611252, Example 23	Plasma kallikrein			 5500					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283371	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283371&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665258	378164700							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540225	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3[nH]cc(Cl)c3c2)c1	InChI=1S/C23H22ClN5O/c1-13-7-22(25)29-14(2)19(13)11-28-23(30)16-5-6-26-17(10-16)8-15-3-4-21-18(9-15)20(24)12-27-21/h3-7,9-10,12,27H,8,11H2,1-2H3,(H2,25,29)(H,28,30)	WGAUJZUEMJFDBD-UHFFFAOYSA-N	283372	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloro-1H-indol-5- yl)methyl)isonicotinamide::US10023557, Example 24::US10266515, Example 24::US10308637, Example 24::US11021463, Example 24::US9611252, Example 24	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283372	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283372&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665371	378164701							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540226	Cc1c[nH]c2ccc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc12	InChI=1S/C24H25N5O/c1-14-8-23(25)29-16(3)21(14)13-28-24(30)18-6-7-26-19(11-18)9-17-4-5-22-20(10-17)15(2)12-27-22/h4-8,10-12,27H,9,13H2,1-3H3,(H2,25,29)(H,28,30)	POUWYQSQNNTBKE-UHFFFAOYSA-N	283373	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-methyl-1H-indol-5- yl)methyl)isonicotinamide::US10023557, Example 25::US10266515, Example 25::US10308637, Example 25::US11021463, Example 25::US9611252, Example 25	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283373	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283373&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665395	378164702							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540227	Cc1nc(N)c(cc1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1)C#N	InChI=1S/C24H19ClN6O/c1-14-19(8-18(11-26)23(27)31-14)12-30-24(32)16-4-5-28-21(10-16)7-15-2-3-22-17(6-15)9-20(25)13-29-22/h2-6,8-10,13H,7,12H2,1H3,(H2,27,31)(H,30,32)	BSYAUMQSIQHPBV-UHFFFAOYSA-N	283374	N-((6-amino-5-cyano-2-methylpyridin-3- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 26::US10266515, Example 26::US10308637, Example 26::US11021463, Example 26::US9611252, Example 26	Plasma kallikrein			 5500					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283374	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283374&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665238	378164703							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540228	Cc1nc(N)c(cc1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1)C(N)=O	InChI=1S/C24H21ClN6O2/c1-13-17(10-20(23(27)32)22(26)31-13)11-30-24(33)15-4-5-28-19(9-15)7-14-2-3-21-16(6-14)8-18(25)12-29-21/h2-6,8-10,12H,7,11H2,1H3,(H2,26,31)(H2,27,32)(H,30,33)	AUZYMVREUCDBQL-UHFFFAOYSA-N	283375	2-amino-5-((2-((3-chloroquinolin-6- yl)methyl)isonicotinamido)methyl)-6- methylnicotinamide::US10023557, Example 27::US10266515, Example 27::US10308637, Example 27::US11021463, Example 27::US9611252, Example 27	Plasma kallikrein			>10000					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283375	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283375&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665169	378164704							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540229	Cc1nc(N)c(Cl)cc1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C23H19Cl2N5O/c1-13-17(10-20(25)22(26)30-13)11-29-23(31)15-4-5-27-19(9-15)7-14-2-3-21-16(6-14)8-18(24)12-28-21/h2-6,8-10,12H,7,11H2,1H3,(H2,26,30)(H,29,31)	QTDAMOULKXIHPX-UHFFFAOYSA-N	283376	N-((6-amino-5-chloro-2-methylpyridin-3- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 28::US10266515, Example 28::US10308637, Example 28::US11021463, Example 28::US9611252, Example 28	Plasma kallikrein			 5500					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283376	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283376&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665175	378164705							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540230	Cc1cc(N)ncc1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C23H20ClN5O/c1-14-6-22(25)28-11-18(14)12-29-23(30)16-4-5-26-20(10-16)8-15-2-3-21-17(7-15)9-19(24)13-27-21/h2-7,9-11,13H,8,12H2,1H3,(H2,25,28)(H,29,30)	VFDBWWVOFNVCCV-UHFFFAOYSA-N	283377	N-((6-amino-4-methylpyridin-3-yl)methyl)-2- ((3-chloroquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 29::US10266515, Example 29::US10308637, Example 29::US11021463, Example 29::US9611252, Example 29	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283377	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283377&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212275	378164706							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540231	Nc1ccc(CNC(=O)c2ccnc(Cc3ccc4ncc(Cl)cc4c3)c2)c(n1)C(F)(F)F	InChI=1S/C23H17ClF3N5O/c24-17-9-16-7-13(1-3-19(16)30-12-17)8-18-10-14(5-6-29-18)22(33)31-11-15-2-4-20(28)32-21(15)23(25,26)27/h1-7,9-10,12H,8,11H2,(H2,28,32)(H,31,33)	JQBVZTITQKTVTP-UHFFFAOYSA-N	283378	N-((6-amino-2-(trifluoromoethyl)pyridin-3- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 30::US10266515, Example 30::US10308637, Example 30::US11021463, Example 30::US9611252, Example 30	Plasma kallikrein			>10000					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283378	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283378&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665299	378164707							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540232	Nc1nccc2cc(CNC(=O)c3ccnc(Cc4ccc5ncc(Cl)cc5c4)c3)ccc12	InChI=1S/C26H20ClN5O/c27-21-12-20-9-16(2-4-24(20)31-15-21)11-22-13-19(6-7-29-22)26(33)32-14-17-1-3-23-18(10-17)5-8-30-25(23)28/h1-10,12-13,15H,11,14H2,(H2,28,30)(H,32,33)	WHHMKDFLRDNMQE-UHFFFAOYSA-N	283379	N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- chloroquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 179::US10023557, Example 31::US10266515, Example 31::US10308637, Example 179::US11021463, Example 31::US9611252, Example 31	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283379	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283379&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212700	378164708							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540233	Fc1cc2[nH]ncc2cc1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C24H17ClFN5O/c25-19-8-16-5-14(1-2-22(16)28-13-19)6-20-9-15(3-4-27-20)24(32)29-11-17-7-18-12-30-31-23(18)10-21(17)26/h1-5,7-10,12-13H,6,11H2,(H,29,32)(H,30,31)	AUINKNGACHEZIV-UHFFFAOYSA-N	283380	2-((3-chloroquinolin-6-yl)methyl)-N-((6-fluoro- 1H-indazol-5-yl)methyl)isonicotinamide::US10023557, Example 260::US10023557, Example 32::US10266515, Example 32::US10308637, Example 32::US11021463, Example 32::US9611252, Example 32	Plasma kallikrein			 5500					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283380	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283380&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665325	378164709							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540234	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C25H17Cl2FN4O/c26-18-7-16-5-14(1-2-23(16)30-12-18)6-19-8-15(3-4-29-19)25(33)32-11-17-9-20-21(27)13-31-24(20)10-22(17)28/h1-5,7-10,12-13,31H,6,11H2,(H,32,33)	XZUNAOLBBRHEMP-UHFFFAOYSA-N	283381	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3-chloroquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 33::US10266515, Example 33::US10308637, Example 33::US11021463, Example 33::US9611252, Example 33	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283381	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283381&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212875	378164710							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540235	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C23H20ClN5O/c1-14-17(3-5-22(25)29-14)12-28-23(30)16-6-7-26-20(11-16)9-15-2-4-21-18(8-15)10-19(24)13-27-21/h2-8,10-11,13H,9,12H2,1H3,(H2,25,29)(H,28,30)	ZGYIOYKVCAJRKO-UHFFFAOYSA-N	283382	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-chloroquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 34::US10266515, Example 39::US10308637, Example 39::US11021463, Example 39::US9611252, Example 39	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283382	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283382&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213054	378164711							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540236	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C24H22ClN5O/c1-14-7-23(26)30-15(2)21(14)13-29-24(31)17-5-6-27-20(11-17)9-16-3-4-22-18(8-16)10-19(25)12-28-22/h3-8,10-12H,9,13H2,1-2H3,(H2,26,30)(H,29,31)	BDLURRLRBKLEDL-UHFFFAOYSA-N	283383	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 35::US10266515, Example 35::US10308637, Example 35::US11021463, Example 35::US9611252, Example 35	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283383	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283383&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665163	378164712							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540237	Nc1noc2cc(CNC(=O)c3ccnc(Cc4ccc5ncc(Cl)cc5c4)c3)ccc12	InChI=1S/C24H18ClN5O2/c25-18-10-17-7-14(2-4-21(17)28-13-18)8-19-11-16(5-6-27-19)24(31)29-12-15-1-3-20-22(9-15)32-30-23(20)26/h1-7,9-11,13H,8,12H2,(H2,26,30)(H,29,31)	HNXHQCQPXRYRIC-UHFFFAOYSA-N	283384	N-((3-aminobenzo[d]isoxazol-6-yl)methyl)-2- ((3-chloroquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 36::US10266515, Example 36::US10308637, Example 36::US11021463, Example 36::US9611252, Example 36	Plasma kallikrein			 5500					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283384	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283384&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665141	378164713							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540238	Clc1ccc2[nH]nc(CNC(=O)c3ccnc(Cc4ccc5ncc(Cl)cc5c4)c3)c2c1	InChI=1S/C24H17Cl2N5O/c25-17-2-4-22-20(11-17)23(31-30-22)13-29-24(32)15-5-6-27-19(10-15)8-14-1-3-21-16(7-14)9-18(26)12-28-21/h1-7,9-12H,8,13H2,(H,29,32)(H,30,31)	YXHGJDJGKSPRKX-UHFFFAOYSA-N	283385	N-((5-chloro-1H-indazol-3-yl)methyl)-2-((3- chloroquinolin-6-yl)methyl)isonictotinamide::US10023557, Example 37::US10266515, Example 37::US10308637, Example 37::US11021463, Example 37::US9611252, Example 37	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283385	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283385&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212832	378164714							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540239	Clc1c[nH]c2ncc(CNC(=O)c3ccnc(Cc4ccc5ncc(Cl)cc5c4)c3)cc12	InChI=1S/C24H17Cl2N5O/c25-18-8-17-5-14(1-2-22(17)28-12-18)6-19-9-16(3-4-27-19)24(32)31-11-15-7-20-21(26)13-30-23(20)29-10-15/h1-5,7-10,12-13H,6,11H2,(H,29,30)(H,31,32)	QFSDBAJWKWRDTA-UHFFFAOYSA-N	283386	N-((3-chloro-1H-pyrrolo[2,3-b]pyridin-5- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 38::US10266515, Example 38::US10308637, Example 38::US11021463, Example 38::US9611252, Example 38	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283386	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283386&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665363	378164715							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540240	Cc1nc(N)ccc1CNC(=O)c1ccnc(CC2=CC3C=C(Cl)C=NC3C=C2)c1	InChI=1S/C23H22ClN5O/c1-14-17(3-5-22(25)29-14)12-28-23(30)16-6-7-26-20(11-16)9-15-2-4-21-18(8-15)10-19(24)13-27-21/h2-8,10-11,13,18,21H,9,12H2,1H3,(H2,25,29)(H,28,30)	NIYJHTYTWUQRKB-UHFFFAOYSA-N	283387	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-chloroquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 39	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283387	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283387&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126501502	378164716							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540241	Fc1c(CNC(=O)c2ccnc(Cc3ccc4ncc(Cl)cc4c3)c2)ccc2[nH]cc(Cl)c12	InChI=1S/C25H17Cl2FN4O/c26-18-9-17-7-14(1-3-21(17)30-12-18)8-19-10-15(5-6-29-19)25(33)32-11-16-2-4-22-23(24(16)28)20(27)13-31-22/h1-7,9-10,12-13,31H,8,11H2,(H,32,33)	GVFULHFYDFFIFD-UHFFFAOYSA-N	283388	N-((3-chloro-4-fluoro-1H-indol-5-yl)methyl)-2- ((3-chloroquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 40::US10266515, Example 40::US10308637, Example 40::US11021463, Example 40::US9611252, Example 40	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283388	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283388&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665357	378164717							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540242	Fc1cc2[nH]ccc2cc1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C25H18ClFN4O/c26-20-10-18-7-15(1-2-23(18)30-14-20)8-21-11-17(4-5-28-21)25(32)31-13-19-9-16-3-6-29-24(16)12-22(19)27/h1-7,9-12,14,29H,8,13H2,(H,31,32)	SVAFKWRLBOEKGD-UHFFFAOYSA-N	283389	2-((3-chloroquinolin-6-yl)methyl)-N-((6-fluoro- 1H-indol-5-yl)methyl)isonicotinamide::US10023557, Example 259::US10023557, Example 41::US10266515, Example 41::US10308637, Example 41::US11021463, Example 41::US9611252, Example 41	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283389	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283389&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665368	378164718							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540243	CNc1ccc(CNC(=O)c2ccnc(Cc3ccc4ncc(Cl)cc4c3)c2)c(C)n1	InChI=1S/C24H22ClN5O/c1-15-18(4-6-23(26-2)30-15)13-29-24(31)17-7-8-27-21(12-17)10-16-3-5-22-19(9-16)11-20(25)14-28-22/h3-9,11-12,14H,10,13H2,1-2H3,(H,26,30)(H,29,31)	KRORJRNMSXNFRV-UHFFFAOYSA-N	283390	2-((3-chloroquinolin-6-yl)methyl)-N-((2-methyl- 6-(methylamino)pyridin-3- yl)methyl)isonicotinamide::US10023557, Example 42::US10266515, Example 42::US10308637, Example 42::US11021463, Example 42::US9611252, Example 42	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283390	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283390&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665110	378164719							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540244	Nc1ccc(CNC(=O)c2ccnc(Cc3ccc4ncc(Cl)cc4c3)c2)c(n1)C1CC1	InChI=1S/C25H22ClN5O/c26-20-11-19-9-15(1-5-22(19)29-14-20)10-21-12-17(7-8-28-21)25(32)30-13-18-4-6-23(27)31-24(18)16-2-3-16/h1,4-9,11-12,14,16H,2-3,10,13H2,(H2,27,31)(H,30,32)	CZYMIYVLJPMDKR-UHFFFAOYSA-N	283391	N-((6-amino-2-cyclopropylpyridin-3-yl)methyl)- 2-((3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 43::US10266515, Example 43::US10308637, Example 43::US11021463, Example 43::US9611252, Example 43	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283391	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283391&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665372	378164720							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540245	CN(C)c1ccc(CNC(=O)c2ccnc(Cc3ccc4ncc(Cl)cc4c3)c2)c(C)n1	InChI=1S/C25H24ClN5O/c1-16-19(5-7-24(30-16)31(2)3)14-29-25(32)18-8-9-27-22(13-18)11-17-4-6-23-20(10-17)12-21(26)15-28-23/h4-10,12-13,15H,11,14H2,1-3H3,(H,29,32)	RUFAAOLTGJTOMH-UHFFFAOYSA-N	283392	2-((3-chloroquinolin-6-yl)methyl)-N-((6- (dimethylamino)-2-methylpyridin-3- yl)methyl)isonicotinamide::US10023557, Example 44::US10266515, Example 44::US10308637, Example 44::US11021463, Example 44::US9611252, Example 44	Plasma kallikrein			>10000					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283392	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283392&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665107	378164721							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540246	NCc1ccc2cc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)ccc2n1	InChI=1S/C26H21ClFN5O/c27-22-14-31-25-11-23(28)18(10-21(22)25)13-32-26(34)17-5-6-30-20(9-17)8-15-1-4-24-16(7-15)2-3-19(12-29)33-24/h1-7,9-11,14,31H,8,12-13,29H2,(H,32,34)	JRFVVGICARMPKA-UHFFFAOYSA-N	283393	2-((2-(aminomethyl)quinolin-6-yl)methyl)-N- ((3-chloro-6-fluoro-1H-indol-5- yl)methyl)isonicotinamide::US10023557, Example 45::US10308637, Example 45::US11021463, Example 45::US9611252, Example 45	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283393	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283393&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212391	378164722							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540247	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3nc(CN)ccc3c2)c1	InChI=1S/C25H26N6O/c1-15-9-24(27)30-16(2)22(15)14-29-25(32)19-7-8-28-21(12-19)11-17-3-6-23-18(10-17)4-5-20(13-26)31-23/h3-10,12H,11,13-14,26H2,1-2H3,(H2,27,30)(H,29,32)	VJXDXEYDWIAFJF-UHFFFAOYSA-N	283394	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((2-(aminomethyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 46::US10266515, Example 46::US10308637, Example 46::US11021463, Example 46::US9611252, Example 46	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283394	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283394&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212365	378164723							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540248	Cc1cnc2ccc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)noc4c3)cc2c1	InChI=1S/C25H21N5O2/c1-15-8-19-9-16(3-5-22(19)28-13-15)10-20-12-18(6-7-27-20)25(31)29-14-17-2-4-21-23(11-17)32-30-24(21)26/h2-9,11-13H,10,14H2,1H3,(H2,26,30)(H,29,31)	JIGUMEUDUOTSCV-UHFFFAOYSA-N	283395	N-((3-aminobenzo[d]isoxazol-6-yl)methyl)-2- ((3-methylquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 47::US10266515, Example 47::US10308637, Example 47::US11021463, Example 47::US9611252, Example 47	Plasma kallikrein			 5500					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283395	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283395&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212412	378164724							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540249	Cc1ccc2ncc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)noc4c3)cc2c1	InChI=1S/C25H21N5O2/c1-15-2-5-22-19(8-15)9-17(14-28-22)10-20-12-18(6-7-27-20)25(31)29-13-16-3-4-21-23(11-16)32-30-24(21)26/h2-9,11-12,14H,10,13H2,1H3,(H2,26,30)(H,29,31)	ZCNHTDLBGJQFLS-UHFFFAOYSA-N	283396	N-((3-aminobenzo[d]isoxazol-6-yl)methyl)-2- ((6-methylquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 48::US10266515, Example 48::US10308637, Example 48::US11021463, Example 48::US9611252, Example 48	Plasma kallikrein			>10000					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283396	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283396&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665294	378164725							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540250	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1ccnc(Cc2cc(C#N)c3ncc(Cl)cc3c2)c1	InChI=1S/C26H16Cl2FN5O/c27-19-6-16-3-14(4-17(10-30)25(16)33-12-19)5-20-7-15(1-2-31-20)26(35)34-11-18-8-21-22(28)13-32-24(21)9-23(18)29/h1-4,6-9,12-13,32H,5,11H2,(H,34,35)	GDWMEKXUNIOULX-UHFFFAOYSA-N	283397	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3-chloro-8-cyanoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 49::US10308637, Example 49::US11021463, Example 49::US9611252, Example 49	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283397	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283397&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665225	378164726							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540251	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc(C#N)c3ncc(Cl)cc3c2)c1	InChI=1S/C25H21ClN6O/c1-14-5-23(28)32-15(2)22(14)13-31-25(33)17-3-4-29-21(10-17)8-16-6-18-9-20(26)12-30-24(18)19(7-16)11-27/h3-7,9-10,12H,8,13H2,1-2H3,(H2,28,32)(H,31,33)	VSKYRJRRAUSIED-UHFFFAOYSA-N	283398	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloro-8-cyanoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 50::US10266515, Example 50::US10308637, Example 50::US11021463, Example 50::US9611252, Example 50	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283398	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283398&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665177	378164727							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540252	Fc1c(CNC(=O)c2ccnc(Cc3cc(C#N)c4ncc(Cl)cc4c3)c2)ccc2[nH]cc(Cl)c12	InChI=1S/C26H16Cl2FN5O/c27-19-8-17-5-14(6-18(10-30)25(17)33-12-19)7-20-9-15(3-4-31-20)26(35)34-11-16-1-2-22-23(24(16)29)21(28)13-32-22/h1-6,8-9,12-13,32H,7,11H2,(H,34,35)	RGFJCIZRNQJUFS-UHFFFAOYSA-N	283399	N-((3-chloro-4-fluoro-1H-indol-5-yl)methyl)-2- ((3-chloro-8-cyanoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 51::US10266515, Example 51::US10308637, Example 51::US11021463, Example 51::US9611252, Example 51	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283399	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283399&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665441	378164728							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540253	Fc1cc2[nH]ccc2cc1CNC(=O)c1ccnc(Cc2cc(C#N)c3ncc(Cl)cc3c2)c1	InChI=1S/C26H17ClFN5O/c27-21-9-18-5-15(6-19(12-29)25(18)32-14-21)7-22-10-17(2-3-30-22)26(34)33-13-20-8-16-1-4-31-24(16)11-23(20)28/h1-6,8-11,14,31H,7,13H2,(H,33,34)	DGMHYZXVTQSHTG-UHFFFAOYSA-N	283400	2-((3-chloro-8-cyanoquinolin-6-yl)methyl)-N- ((6-fluoro-1H-indol-5-yl)methyl)isonicotinamide::US10023557, Example 52::US10266515, Example 52::US10308637, Example 52::US11021463, Example 52::US9611252, Example 52	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283400	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283400&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665338	378164729							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540254	Cc1cc(N)ncc1CNC(=O)c1ccnc(Cc2cc(C#N)c3ncc(Cl)cc3c2)c1	InChI=1S/C24H19ClN6O/c1-14-4-22(27)29-11-19(14)12-31-24(32)16-2-3-28-21(9-16)7-15-5-17-8-20(25)13-30-23(17)18(6-15)10-26/h2-6,8-9,11,13H,7,12H2,1H3,(H2,27,29)(H,31,32)	WNDNOSDBRCNUAW-UHFFFAOYSA-N	283401	N-((6-amino-4-methylpyridin-3-yl)methyl)-2- ((3-chloro-8-cyanoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 53::US10266515, Example 53::US10308637, Example 53::US11021463, Example 53::US9611252, Example 53	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283401	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283401&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665126	378164730							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540255	Clc1ccc2[nH]nc(CNC(=O)c3ccnc(Cc4cc(C#N)c5ncc(Cl)cc5c4)c3)c2c1	InChI=1S/C25H16Cl2N6O/c26-18-1-2-22-21(10-18)23(33-32-22)13-31-25(34)15-3-4-29-20(9-15)7-14-5-16-8-19(27)12-30-24(16)17(6-14)11-28/h1-6,8-10,12H,7,13H2,(H,31,34)(H,32,33)	KUYYPMPLUCLDIX-UHFFFAOYSA-N	283402	N-((5-chloro-1H-indazol-3-yl)methyl)-2-((3- chloro-8-cyanoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 54::US10266515, Example 54::US10308637, Example 54::US11021463, Example 54::US9611252, Example 54	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283402	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283402&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665197	378164731							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540256	Clc1c[nH]c2ncc(CNC(=O)c3ccnc(Cc4cc(C#N)c5ncc(Cl)cc5c4)c3)cc12	InChI=1S/C25H16Cl2N6O/c26-19-7-17-3-14(4-18(9-28)23(17)30-12-19)5-20-8-16(1-2-29-20)25(34)33-11-15-6-21-22(27)13-32-24(21)31-10-15/h1-4,6-8,10,12-13H,5,11H2,(H,31,32)(H,33,34)	DLZBPOOKWFQHBR-UHFFFAOYSA-N	283403	N-((3-chloro-1H-pyrrolo[2,3-b]pyridin-5- yl)methyl)-2-((3-chloro-8-cyanoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 55::US10266515, Example 55::US10308637, Example 55::US11021463, Example 55::US9611252, Example 55	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283403	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283403&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665328	378164732							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540257	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2cc(C#N)c3ncc(Cl)cc3c2)c1	InChI=1S/C24H19ClN6O/c1-14-17(2-3-22(27)31-14)12-30-24(32)16-4-5-28-21(10-16)8-15-6-18-9-20(25)13-29-23(18)19(7-15)11-26/h2-7,9-10,13H,8,12H2,1H3,(H2,27,31)(H,30,32)	FDKNUBSGWSPNRT-UHFFFAOYSA-N	283404	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-chloro-8-cyanoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 56::US10266515, Example 56::US10308637, Example 56::US11021463, Example 56::US9611252, Example 56	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283404	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283404&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665146	378164733							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540258	Nc1nccc2cc(CNC(=O)c3ccnc(Cc4cc(C#N)c5ncc(Cl)cc5c4)c3)ccc12	InChI=1S/C27H19ClN6O/c28-22-11-20-8-17(9-21(13-29)25(20)33-15-22)10-23-12-19(4-5-31-23)27(35)34-14-16-1-2-24-18(7-16)3-6-32-26(24)30/h1-9,11-12,15H,10,14H2,(H2,30,32)(H,34,35)	IDTYIYATNJINLX-UHFFFAOYSA-N	283405	N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- chloro-8-cyanoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 57::US10266515, Example 57::US10308637, Example 57::US11021463, Example 57::US9611252, Example 57	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283405	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283405&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665382	378164734							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540259	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc(C(N)=O)c3ncc(Cl)cc3c2)c1	InChI=1S/C25H23ClN6O2/c1-13-5-22(27)32-14(2)21(13)12-31-25(34)16-3-4-29-19(10-16)7-15-6-17-9-18(26)11-30-23(17)20(8-15)24(28)33/h3-6,8-11H,7,12H2,1-2H3,(H2,27,32)(H2,28,33)(H,31,34)	INWUNFFPSCFXCA-UHFFFAOYSA-N	283406	6-((4-(((6-amino-2,4-dimethylpyridin-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- chloroquinoline-8-carboxamide::US10023557, Example 58::US10266515, Example 58::US10308637, Example 58::US11021463, Example 58::US9611252, Example 58	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283406	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283406&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665386	378164735							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540260	NC(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2cc3c(Cl)c[nH]c3cc2F)cc2cc(Cl)cnc12	InChI=1S/C26H18Cl2FN5O2/c27-17-6-15-3-13(5-20(25(30)35)24(15)33-11-17)4-18-7-14(1-2-31-18)26(36)34-10-16-8-19-21(28)12-32-23(19)9-22(16)29/h1-3,5-9,11-12,32H,4,10H2,(H2,30,35)(H,34,36)	QMNRPOHMXWHKMB-UHFFFAOYSA-N	283407	3-chloro-6-((4-(((3-chloro-6-fluoro-1H-indol-5- yl)methyl)carbamoyl)pyridin-2- yl)methyl)quinoline-8-carboxamide::US10023557, Example 59::US10266515, Example 59::US11021463, Example 59::US9611252, Example 59	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283407	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283407&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665413	378164736							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540261	NC(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2n[nH]c3ccc(Cl)cc23)cc2cc(Cl)cnc12	InChI=1S/C25H18Cl2N6O2/c26-16-1-2-21-19(10-16)22(33-32-21)12-31-25(35)14-3-4-29-18(9-14)6-13-5-15-8-17(27)11-30-23(15)20(7-13)24(28)34/h1-5,7-11H,6,12H2,(H2,28,34)(H,31,35)(H,32,33)	RTJGKEBRSSQCHQ-UHFFFAOYSA-N	283408	3-chloro-6-((4-(((5-chloro-1H-indazol-3- yl)methyl)carbamoyl)pyridin-2- yl)methyl)quinoline-8-carboxamide::US10023557, Example 60::US10266515, Example 60::US10308637, Example 60::US11021463, Example 60::US9611252, Example 60	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283408	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283408&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665317	378164737							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540262	NC(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2cnc3[nH]cc(Cl)c3c2)cc2cc(Cl)cnc12	InChI=1S/C25H18Cl2N6O2/c26-17-7-16-3-13(5-20(23(28)34)22(16)30-11-17)4-18-8-15(1-2-29-18)25(35)33-10-14-6-19-21(27)12-32-24(19)31-9-14/h1-3,5-9,11-12H,4,10H2,(H2,28,34)(H,31,32)(H,33,35)	QHIFWJFJAOUBPC-UHFFFAOYSA-N	283409	3-chloro-6-((4-(((3-chloro-1H-pyrrolo[2,3- b]pyridin-5-yl)methyl)carbamoyl)pyridin-2- yl)methyl)quinoline-8-carboxamide::US10023557, Example 61::US10266515, Example 61::US10308637, Example 61::US11021463, Example 61::US9611252, Example 61	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283409	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283409&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665370	378164738							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540263	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2cc(C(N)=O)c3ncc(Cl)cc3c2)c1	InChI=1S/C24H21ClN6O2/c1-13-16(2-3-21(26)31-13)11-30-24(33)15-4-5-28-19(10-15)7-14-6-17-9-18(25)12-29-22(17)20(8-14)23(27)32/h2-6,8-10,12H,7,11H2,1H3,(H2,26,31)(H2,27,32)(H,30,33)	WTBBASBLRSFZPD-UHFFFAOYSA-N	283410	6-((4-(((6-amino-2-methylpyridin-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- chloroquinoline-8-carboxamide::US10023557, Example 62::US10266515, Example 62::US10308637, Example 62::US11021463, Example 62::US9611252, Example 62	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283410	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283410&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665142	378164739							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540264	Cc1cc(N)ncc1CNC(=O)c1ccnc(Cc2cc(C(N)=O)c3ncc(Cl)cc3c2)c1	InChI=1S/C24H21ClN6O2/c1-13-4-21(26)29-10-17(13)11-31-24(33)15-2-3-28-19(9-15)6-14-5-16-8-18(25)12-30-22(16)20(7-14)23(27)32/h2-5,7-10,12H,6,11H2,1H3,(H2,26,29)(H2,27,32)(H,31,33)	ZAZOBWBMBQVKFV-UHFFFAOYSA-N	283411	6-((4-(((6-amino-4-methylpyridin-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- chloroquinoline-8-carboxamide::US10023557, Example 63::US10266515, Example 63::US10308637, Example 63::US11021463, Example 63::US9611252, Example 63	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283411	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283411&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665130	378164740							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540265	NC(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2ccc3c(N)nccc3c2)cc2cc(Cl)cnc12	InChI=1S/C27H21ClN6O2/c28-20-11-19-8-16(10-23(26(30)35)24(19)33-14-20)9-21-12-18(4-5-31-21)27(36)34-13-15-1-2-22-17(7-15)3-6-32-25(22)29/h1-8,10-12,14H,9,13H2,(H2,29,32)(H2,30,35)(H,34,36)	ZEVNHPCICZZSBU-UHFFFAOYSA-N	283412	6-((4-(((1-aminoisoquinolin-6- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- chloroquinoline-8-carboxamide::US10023557, Example 64::US10266515, Example 64::US10308637, Example 64::US11021463, Example 64::US9611252, Example 64	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283412	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283412&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665252	378164741							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540266	NC(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2ccc3[nH]cc(Cl)c3c2F)cc2cc(Cl)cnc12	InChI=1S/C26H18Cl2FN5O2/c27-17-8-16-5-13(7-19(25(30)35)24(16)33-11-17)6-18-9-14(3-4-31-18)26(36)34-10-15-1-2-21-22(23(15)29)20(28)12-32-21/h1-5,7-9,11-12,32H,6,10H2,(H2,30,35)(H,34,36)	PBEXDTRCFFOFDU-UHFFFAOYSA-N	283413	3-chloro-6-((4-(((3-chloro-4-fluoro-1H-indol-5- yl)methyl)carbamoyl)pyridin-2- yl)methyl)quinoline-8-carboxamide::US10023557, Example 65::US10266515, Example 65::US10308637, Example 65::US11021463, Example 65::US9611252, Example 65	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283413	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283413&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665414	378164742							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540267	NC(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2cc3cc[nH]c3cc2F)cc2cc(Cl)cnc12	InChI=1S/C26H19ClFN5O2/c27-19-9-17-5-14(7-21(25(29)34)24(17)32-13-19)6-20-10-16(2-3-30-20)26(35)33-12-18-8-15-1-4-31-23(15)11-22(18)28/h1-5,7-11,13,31H,6,12H2,(H2,29,34)(H,33,35)	ZDVUWSXSXIPPGM-UHFFFAOYSA-N	283414	3-chloro-6-((4-(((6-fluoro-1H-indol-5- yl)methyl)carbamoyl)pyridin-2- yl)methyl)quinoline-8-carboxamide::US10023557, Example 66::US10266515, Example 66::US10308637, Example 66::US11021463, Example 66::US9611252, Example 66	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283414	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283414&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665192	378164743							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540268	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc(c3ncc(Cl)cc3c2)S(C)(=O)=O)c1	InChI=1S/C25H24ClN5O3S/c1-14-6-23(27)31-15(2)21(14)13-30-25(32)17-4-5-28-20(11-17)8-16-7-18-10-19(26)12-29-24(18)22(9-16)35(3,33)34/h4-7,9-12H,8,13H2,1-3H3,(H2,27,31)(H,30,32)	LOAAVKXHIOVCPQ-UHFFFAOYSA-N	283415	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloro-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 67::US10266515, Example 67::US10308637, Example 67::US11021463, Example 67::US9611252, Example 67	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283415	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283415&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213160	378164744							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540269	CS(=O)(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2cc3c(Cl)c[nH]c3cc2F)cc2cc(Cl)cnc12	InChI=1S/C26H19Cl2FN4O3S/c1-37(35,36)24-6-14(4-16-7-18(27)12-32-25(16)24)5-19-8-15(2-3-30-19)26(34)33-11-17-9-20-21(28)13-31-23(20)10-22(17)29/h2-4,6-10,12-13,31H,5,11H2,1H3,(H,33,34)	JHEOACUKXNFFDI-UHFFFAOYSA-N	283416	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3-chloro-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 68::US10266515, Example 68::US10308637, Example 68::US11021463, Example 68::US9611252, Example 68	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283416	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283416&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212213	378164745							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540270	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2cc(c3ncc(Cl)cc3c2)S(C)(=O)=O)c1	InChI=1S/C24H22ClN5O3S/c1-14-17(3-4-22(26)30-14)12-29-24(31)16-5-6-27-20(11-16)8-15-7-18-10-19(25)13-28-23(18)21(9-15)34(2,32)33/h3-7,9-11,13H,8,12H2,1-2H3,(H2,26,30)(H,29,31)	DAYVOWICNMKAHH-UHFFFAOYSA-N	283417	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-chloro-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 69::US10266515, Example 69::US10308637, Example 69::US11021463, Example 69::US9611252, Example 69	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283417	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283417&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665120	378164746							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540271	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2c1)C#N	InChI=1S/C26H24N6O/c1-15-6-20-8-18(9-21(12-27)25(20)30-13-15)10-22-11-19(4-5-29-22)26(33)31-14-23-16(2)7-24(28)32-17(23)3/h4-9,11,13H,10,14H2,1-3H3,(H2,28,32)(H,31,33)	FWOVJYZAXZFOSD-UHFFFAOYSA-N	283418	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((8-cyano-3-methylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 70::US10266515, Example 70::US10308637, Example 70::US11021463, Example 70::US9611252, Example 70	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283418	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283418&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665112	378164747							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540272	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)cc2c1)C#N	InChI=1S/C28H22N6O/c1-17-8-22-10-19(11-23(14-29)26(22)33-15-17)12-24-13-21(5-6-31-24)28(35)34-16-18-2-3-25-20(9-18)4-7-32-27(25)30/h2-11,13,15H,12,16H2,1H3,(H2,30,32)(H,34,35)	XJVZLICIUISDSM-UHFFFAOYSA-N	283419	N-((1-aminoisoquinolin-6-yl)methyl)-2-((8- cyano-3-methylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 71::US10266515, Example 71::US10308637, Example 71::US11021463, Example 71::US9611252, Example 71	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283419	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283419&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665353	378164748							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540273	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)cc2c1)C#N	InChI=1S/C27H19ClFN5O/c1-15-4-18-5-16(6-19(11-30)26(18)33-12-15)7-21-8-17(2-3-31-21)27(35)34-13-20-9-22-23(28)14-32-25(22)10-24(20)29/h2-6,8-10,12,14,32H,7,13H2,1H3,(H,34,35)	KVEDUIDZCUQFJJ-UHFFFAOYSA-N	283420	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((8-cyano-3-methylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 72::US10308637, Example 72::US11021463, Example 72::US9611252, Example 72	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283420	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283420&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665256	378164749							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540274	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cnc4[nH]cc(Cl)c4c3)cc2c1)C#N	InChI=1S/C26H19ClN6O/c1-15-4-19-5-16(6-20(10-28)24(19)30-11-15)7-21-9-18(2-3-29-21)26(34)33-13-17-8-22-23(27)14-32-25(22)31-12-17/h2-6,8-9,11-12,14H,7,13H2,1H3,(H,31,32)(H,33,34)	DUPQBZNXOTZIFE-UHFFFAOYSA-N	283421	N-((3-chloro-1H-pyrrolo[2,3-b]pyridin-5- yl)methyl)-2-((8-cyano-3-methylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 73::US10266515, Example 73::US10308637, Example 73::US11021463, Example 73::US9611252, Example 73	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283421	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283421&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665369	378164750							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540275	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3ccc4[nH]cc(Cl)c4c3F)cc2c1)C#N	InChI=1S/C27H19ClFN5O/c1-15-6-19-7-16(8-20(11-30)26(19)33-12-15)9-21-10-17(4-5-31-21)27(35)34-13-18-2-3-23-24(25(18)29)22(28)14-32-23/h2-8,10,12,14,32H,9,13H2,1H3,(H,34,35)	UJWAIKJCZKWWSO-UHFFFAOYSA-N	283422	N-((3-chloro-4-fluoro-1H-indol-5-yl)methyl)-2- ((8-cyano-3-methylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 74::US10266515, Example 74::US10308637, Example 74::US11021463, Example 74::US9611252, Example 74	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283422	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283422&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665323	378164751							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540276	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3n[nH]c4ccc(Cl)cc34)cc2c1)C#N	InChI=1S/C26H19ClN6O/c1-15-6-18-7-16(8-19(12-28)25(18)30-13-15)9-21-10-17(4-5-29-21)26(34)31-14-24-22-11-20(27)2-3-23(22)32-33-24/h2-8,10-11,13H,9,14H2,1H3,(H,31,34)(H,32,33)	SABOZYHOSJEBNR-UHFFFAOYSA-N	283423	N-((5-chloro-1H-indazol-3-yl)methyl)-2-((8- cyano-3-methylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 75::US10266515, Example 75::US10308637, Example 75::US11021463, Example 75::US9611252, Example 75	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283423	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283423&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665301	378164752							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540277	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cc4cc[nH]c4cc3F)cc2c1)C#N	InChI=1S/C27H20FN5O/c1-16-6-20-7-17(8-21(13-29)26(20)32-14-16)9-23-11-19(3-4-30-23)27(34)33-15-22-10-18-2-5-31-25(18)12-24(22)28/h2-8,10-12,14,31H,9,15H2,1H3,(H,33,34)	ZWLALZHUQUAZOX-UHFFFAOYSA-N	283424	2-((8-cyano-3-methylquinolin-6-yl)methyl)-N- ((6-fluoro-1H-indol-5-yl)methyl)isonicotinamide::US10023557, Example 76::US10266515, Example 76::US10308637, Example 76::US11021463, Example 76::US9611252, Example 76	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283424	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283424&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665344	378164753							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540278	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2c1)C(N)=O	InChI=1S/C26H26N6O2/c1-14-6-19-8-17(10-21(25(28)33)24(19)30-12-14)9-20-11-18(4-5-29-20)26(34)31-13-22-15(2)7-23(27)32-16(22)3/h4-8,10-12H,9,13H2,1-3H3,(H2,27,32)(H2,28,33)(H,31,34)	OOWBJQXCALEAFC-UHFFFAOYSA-N	283425	6-((4-(((6-amino-2,4-dimethylpyridin-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- methylquinoline-8-carboxamide::US10023557, Example 77::US10266515, Example 77::US10308637, Example 77::US11021463, Example 77::US9611252, Example 77	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283425	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283425&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665125	378164754							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540279	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)cc2c1)C(N)=O	InChI=1S/C27H21ClFN5O2/c1-14-4-17-5-15(7-21(26(30)35)25(17)33-11-14)6-19-8-16(2-3-31-19)27(36)34-12-18-9-20-22(28)13-32-24(20)10-23(18)29/h2-5,7-11,13,32H,6,12H2,1H3,(H2,30,35)(H,34,36)	WETFPOPVXHIHFG-UHFFFAOYSA-N	283426	6-((4-(((3-chloro-6-fluoro-1H-indol-5- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- methylquinoline-8-carboxamide::US10023557, Example 78::US10266515, Example 78::US10308637, Example 78::US11021463, Example 78::US9611252, Example 78	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283426	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283426&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665427	378164755							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540280	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)cc2c1)C(N)=O	InChI=1S/C28H24N6O2/c1-16-8-21-10-18(12-24(27(30)35)25(21)33-14-16)11-22-13-20(5-6-31-22)28(36)34-15-17-2-3-23-19(9-17)4-7-32-26(23)29/h2-10,12-14H,11,15H2,1H3,(H2,29,32)(H2,30,35)(H,34,36)	AVMNYBKKWARJKT-UHFFFAOYSA-N	283427	6-((4-(((1-aminoisoquinolin-6- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- methylquinoline-8-carboxamide::US10023557, Example 79::US10266515, Example 79::US10308637, Example 79::US11021463, Example 79::US9611252, Example 79	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283427	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283427&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665123	378164756							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540281	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cnc4[nH]cc(Cl)c4c3)cc2c1)C(N)=O	InChI=1S/C26H21ClN6O2/c1-14-4-18-5-15(7-21(24(28)34)23(18)30-10-14)6-19-9-17(2-3-29-19)26(35)33-12-16-8-20-22(27)13-32-25(20)31-11-16/h2-5,7-11,13H,6,12H2,1H3,(H2,28,34)(H,31,32)(H,33,35)	CFJXZEDRAADQFI-UHFFFAOYSA-N	283428	6-((4-(((3-chloro-1H-pyrrolo[2,3-b]pyridin-5- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- methylquinoline-8-carboxamide::US10023557, Example 80::US10266515, Example 80::US10308637, Example 80::US11021463, Example 80::US9611252, Example 80	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283428	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283428&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665254	378164757							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540282	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3ccc4[nH]cc(Cl)c4c3F)cc2c1)C(N)=O	InChI=1S/C27H21ClFN5O2/c1-14-6-18-7-15(9-20(26(30)35)25(18)33-11-14)8-19-10-16(4-5-31-19)27(36)34-12-17-2-3-22-23(24(17)29)21(28)13-32-22/h2-7,9-11,13,32H,8,12H2,1H3,(H2,30,35)(H,34,36)	LJDMUPONZYUBTQ-UHFFFAOYSA-N	283429	6-((4-(((3-chloro-4-fluoro-1H-indol-5- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- methylquinoline-8-carboxamide::US10023557, Example 81::US10266515, Example 81::US10308637, Example 81::US11021463, Example 81::US9611252, Example 81	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283429	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283429&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665251	378164758							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540283	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3n[nH]c4ccc(Cl)cc34)cc2c1)C(N)=O	InChI=1S/C26H21ClN6O2/c1-14-6-17-7-15(9-21(25(28)34)24(17)30-12-14)8-19-10-16(4-5-29-19)26(35)31-13-23-20-11-18(27)2-3-22(20)32-33-23/h2-7,9-12H,8,13H2,1H3,(H2,28,34)(H,31,35)(H,32,33)	KIVLLFJSACGLHN-UHFFFAOYSA-N	283430	6-((4-(((5-chloro-1H-indazol-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- methylquinoline-8-carboxamide::US10023557, Example 82::US10266515, Example 82::US10308637, Example 82::US11021463, Example 82::US9611252, Example 82	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283430	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283430&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665290	378164759							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540284	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cc4cc[nH]c4cc3F)cc2c1)C(N)=O	InChI=1S/C27H22FN5O2/c1-15-6-19-7-16(9-22(26(29)34)25(19)32-13-15)8-21-11-18(3-4-30-21)27(35)33-14-20-10-17-2-5-31-24(17)12-23(20)28/h2-7,9-13,31H,8,14H2,1H3,(H2,29,34)(H,33,35)	UZTOCULVDVRYTA-UHFFFAOYSA-N	283431	6-((4-(((6-fluoro-1H-indol-5- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- methylquinoline-8-carboxamide::US10023557, Example 83::US10266515, Example 83::US10308637, Example 83::US11021463, Example 83::US9611252, Example 83	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283431	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283431&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665428	378164760							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540285	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2c1)C(O)=O	InChI=1S/C26H25N5O3/c1-14-6-19-8-17(10-21(26(33)34)24(19)29-12-14)9-20-11-18(4-5-28-20)25(32)30-13-22-15(2)7-23(27)31-16(22)3/h4-8,10-12H,9,13H2,1-3H3,(H2,27,31)(H,30,32)(H,33,34)	IDXZVLZJXGFXKF-UHFFFAOYSA-N	283432	6-((4-(((6-amino-2,4-dimethylpyridin-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- methylquinoline-8-carboxylic acid::US10023557, Example 84::US10266515, Example 84::US10308637, Example 84::US11021463, Example 84::US9611252, Example 84	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283432	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283432&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665404	378164761							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540286	Cc1cc(N)ncc1CNC(=O)c1ccnc(Cn2cc3cc(Cl)ccc3cc2=O)c1	InChI=1S/C23H20ClN5O2/c1-14-6-21(25)27-10-18(14)11-28-23(31)16-4-5-26-20(8-16)13-29-12-17-7-19(24)3-2-15(17)9-22(29)30/h2-10,12H,11,13H2,1H3,(H2,25,27)(H,28,31)	DNSFNVWZLXWEIP-UHFFFAOYSA-N	283433	N-((6-amino-4-methylpyridin-3-yl)methyl)-2- ((7-chloro-3-oxoisoquinolin-2(3H)- yl)methyl)isonicotinamide::US10023557, Example 85::US10266515, Example 85::US10308637, Example 85::US11021463, Example 85::US9611252, Example 85	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283433	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283433&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665165	378164762							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540287	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cn2cc3cc(Cl)ccc3cc2=O)c1	InChI=1S/C23H20ClN5O2/c1-14-17(3-5-21(25)28-14)11-27-23(31)16-6-7-26-20(9-16)13-29-12-18-8-19(24)4-2-15(18)10-22(29)30/h2-10,12H,11,13H2,1H3,(H2,25,28)(H,27,31)	BXRRZXRRYWPPRB-UHFFFAOYSA-N	283434	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((7-chloro-3-oxoisoquinolin-2(3H)- yl)methyl)isonicotinamide::US10023557, Example 86::US10266515, Example 86::US10308637, Example 86::US11021463, Example 86::US9611252, Example 86	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283434	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283434&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665384	378164763							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540288	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cn2cc3cc(Cl)ccc3cc2=O)c1	InChI=1S/C24H22ClN5O2/c1-14-7-22(26)29-15(2)21(14)11-28-24(32)17-5-6-27-20(9-17)13-30-12-18-8-19(25)4-3-16(18)10-23(30)31/h3-10,12H,11,13H2,1-2H3,(H2,26,29)(H,28,32)	IRSFVELJVAKOKE-UHFFFAOYSA-N	283435	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((7-chloro-3-oxoisoquinolin-2(3H)- yl)methyl)isonicotinamide::US10023557, Example 87::US10266515, Example 87::US10308637, Example 87::US11021463, Example 87::US9611252, Example 87	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283435	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283435&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665121	378164764							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540289	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1ccnc(Cn2cc3cc(Cl)ccc3cc2=O)c1	InChI=1S/C25H17Cl2FN4O2/c26-18-2-1-14-8-24(33)32(12-17(14)5-18)13-19-6-15(3-4-29-19)25(34)31-10-16-7-20-21(27)11-30-23(20)9-22(16)28/h1-9,11-12,30H,10,13H2,(H,31,34)	LIVKHBBLMAFTFP-UHFFFAOYSA-N	283436	2-((7-chloro-3-oxoisoquinolin-2(3H)-yl)methyl)- N-((3-chloro-6-fluoro-1H-indol-5- yl)methyl)isonicotinamide::US10023557, Example 88::US10266515, Example 88::US10308637, Example 88::US11021463, Example 88::US9611252, Example 88	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283436	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283436&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665351	378164765							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540290	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc(F)c3ncc(Cl)cc3c2)c1	InChI=1S/C24H21ClFN5O/c1-13-5-22(27)31-14(2)20(13)12-30-24(32)16-3-4-28-19(10-16)7-15-6-17-9-18(25)11-29-23(17)21(26)8-15/h3-6,8-11H,7,12H2,1-2H3,(H2,27,31)(H,30,32)	NJQUWZKNWYIFOW-UHFFFAOYSA-N	283437	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloro-8-fluoroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 89::US10266515, Example 89::US10308637, Example 89::US11021463, Example 89::US9611252, Example 89	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283437	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283437&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665263	378164766							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540291	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1ccnc(Cc2cc(F)c3ncc(Cl)cc3c2)c1	InChI=1S/C25H16Cl2F2N4O/c26-17-6-15-3-13(5-22(29)24(15)32-11-17)4-18-7-14(1-2-30-18)25(34)33-10-16-8-19-20(27)12-31-23(19)9-21(16)28/h1-3,5-9,11-12,31H,4,10H2,(H,33,34)	WZBGVJNIHVUBGP-UHFFFAOYSA-N	283438	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3-chloro-8-fluoroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 90::US10266515, Example 90::US10308637, Example 90::US11021463, Example 90::US9611252, Example 90	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283438	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283438&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665313	378164767							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540292	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2cc(F)c3ncc(Cl)cc3c2)c1	InChI=1S/C23H19ClFN5O/c1-13-16(2-3-21(26)30-13)11-29-23(31)15-4-5-27-19(10-15)7-14-6-17-9-18(24)12-28-22(17)20(25)8-14/h2-6,8-10,12H,7,11H2,1H3,(H2,26,30)(H,29,31)	JKVPCVWDMOMIMY-UHFFFAOYSA-N	283439	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-chloro-8-fluoroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 91::US10266515, Example 91::US10308637, Example 91::US11021463, Example 91::US9611252, Example 91	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283439	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283439&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665234	378164768							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540293	COC(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2c(C)cc(N)nc2C)cc2cc(Cl)cnc12	InChI=1S/C26H24ClN5O3/c1-14-6-23(28)32-15(2)22(14)13-31-25(33)17-4-5-29-20(11-17)8-16-7-18-10-19(27)12-30-24(18)21(9-16)26(34)35-3/h4-7,9-12H,8,13H2,1-3H3,(H2,28,32)(H,31,33)	YFEQLRSQCAMBNR-UHFFFAOYSA-N	283440	US10023557, Example 92::US10266515, Example 92::US10308637, Example 92::US11021463, Example 92::US9611252, Example 92::methyl 6-((4-(((6-amino-2,4-dimethylpyridin-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- chloroquinoline-8-carboxylate	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283440	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283440&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665210	378164769							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540294	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc(C(O)=O)c3ncc(Cl)cc3c2)c1	InChI=1S/C25H22ClN5O3/c1-13-5-22(27)31-14(2)21(13)12-30-24(32)16-3-4-28-19(10-16)7-15-6-17-9-18(26)11-29-23(17)20(8-15)25(33)34/h3-6,8-11H,7,12H2,1-2H3,(H2,27,31)(H,30,32)(H,33,34)	BVAYWMZNSZGAMT-UHFFFAOYSA-N	283441	6-((4-(((6-amino-2,4-dimethylpyridin-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- chloroquinoline-8-carboxylic acid::US10023557, Example 93::US10266515, Example 93::US10308637, Example 93::US11021463, Example 93::US9611252, Example 93	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283441	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283441&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665155	378164770							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540295	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc(CO)c3ncc(Cl)cc3c2)c1	InChI=1S/C25H24ClN5O2/c1-14-5-23(27)31-15(2)22(14)12-30-25(33)17-3-4-28-21(10-17)8-16-6-18-9-20(26)11-29-24(18)19(7-16)13-32/h3-7,9-11,32H,8,12-13H2,1-2H3,(H2,27,31)(H,30,33)	CDDJVGAEPTXXCL-UHFFFAOYSA-N	283442	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloro-8-(hydroxymethyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 94::US10266515, Example 94::US10308637, Example 94::US11021463, Example 94::US9611252, Example 94	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283442	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283442&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665190	378164771							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540296	COC(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2ccc(N)nc2C)cc2cc(Cl)cnc12	InChI=1S/C25H22ClN5O3/c1-14-17(3-4-22(27)31-14)12-30-24(32)16-5-6-28-20(11-16)8-15-7-18-10-19(26)13-29-23(18)21(9-15)25(33)34-2/h3-7,9-11,13H,8,12H2,1-2H3,(H2,27,31)(H,30,32)	JHWMKRJZPWMJLH-UHFFFAOYSA-N	283443	US10023557, Example 95::US10266515, Example 95::US10308637, Example 95::US11021463, Example 95::US9611252, Example 95::methyl 6-((4-(((6-amino-2-methylpyridin-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- chloroquinoline-8-carboxylate	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283443	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283443&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665172	378164772							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540297	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2cc(C(O)=O)c3ncc(Cl)cc3c2)c1	InChI=1S/C24H20ClN5O3/c1-13-16(2-3-21(26)30-13)11-29-23(31)15-4-5-27-19(10-15)7-14-6-17-9-18(25)12-28-22(17)20(8-14)24(32)33/h2-6,8-10,12H,7,11H2,1H3,(H2,26,30)(H,29,31)(H,32,33)	OWMRLFMYSUGJHS-UHFFFAOYSA-N	283444	6-((4-(((6-amino-2-methylpyridin-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- chloroquinoline-8-carboxylic acid::US10023557, Example 96::US10266515, Example 96::US10308637, Example 96::US11021463, Example 96::US9611252, Example 96	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283444	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283444&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665320	378164773							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540298	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2cc(CO)c3ncc(Cl)cc3c2)c1	InChI=1S/C24H22ClN5O2/c1-14-17(2-3-22(26)30-14)11-29-24(32)16-4-5-27-21(10-16)8-15-6-18-9-20(25)12-28-23(18)19(7-15)13-31/h2-7,9-10,12,31H,8,11,13H2,1H3,(H2,26,30)(H,29,32)	SCWQNZNCOWHKCU-UHFFFAOYSA-N	283445	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-chloro-8-(hydroxymethyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 97::US10266515, Example 97::US10308637, Example 97::US11021463, Example 97::US9611252, Example 97	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283445	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283445&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665282	378164774							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540299	Cc1cc(N)[n+]([O-])c(C)c1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C24H22ClN5O2/c1-14-7-23(26)30(32)15(2)21(14)13-29-24(31)17-5-6-27-20(11-17)9-16-3-4-22-18(8-16)10-19(25)12-28-22/h3-8,10-12H,9,13,26H2,1-2H3,(H,29,31)	JMNAJBKCXDWWFM-UHFFFAOYSA-N	283446	6-amino-3-((2-((3-chloroquinolin-6- yl)methyl)isonicotinamido)methyl)-2,4- dimethylpyridine 1-oxide::US10023557, Example 98::US10266515, Example 98::US10308637, Example 98::US11021463, Example 98::US9611252, Example 98	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283446	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283446&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665244	378164775							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540300	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3[n+]([O-])cc(Cl)cc3c2)c1	InChI=1S/C24H22ClN5O2/c1-14-7-23(26)29-15(2)21(14)12-28-24(31)17-5-6-27-20(11-17)9-16-3-4-22-18(8-16)10-19(25)13-30(22)32/h3-8,10-11,13H,9,12H2,1-2H3,(H2,26,29)(H,28,31)	XRSVMKZHXCTYQX-UHFFFAOYSA-N	283447	6-((4-(((6-amino-2,4-dimethylpyridin-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- chloroquinoline 1-oxide::US10023557, Example 99::US10266515, Example 99::US10308637, Example 99::US11021463, Example 99::US9611252, Example 99	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283447	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283447&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665346	378164776							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540301	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc(Cl)c3ncc(Cl)cc3c2)c1	InChI=1S/C24H21Cl2N5O/c1-13-5-22(27)31-14(2)20(13)12-30-24(32)16-3-4-28-19(10-16)7-15-6-17-9-18(25)11-29-23(17)21(26)8-15/h3-6,8-11H,7,12H2,1-2H3,(H2,27,31)(H,30,32)	HHXMWQGWYOIRGQ-UHFFFAOYSA-N	283448	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3,8-dichloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 100::US10266515, Example 100::US10308637, Example 100::US11021463, Example 100::US9611252, Example 100	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283448	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283448&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665316	378164777							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540302	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2cc(Cl)c3ncc(Cl)cc3c2)c1	InChI=1S/C23H19Cl2N5O/c1-13-16(2-3-21(26)30-13)11-29-23(31)15-4-5-27-19(10-15)7-14-6-17-9-18(24)12-28-22(17)20(25)8-14/h2-6,8-10,12H,7,11H2,1H3,(H2,26,30)(H,29,31)	LGBIYJSQIIGQJI-UHFFFAOYSA-N	283449	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3,8-dichloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 101::US10266515, Example 101::US10308637, Example 101::US11021463, Example 101::US9611252, Example 101	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283449	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283449&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665134	378164778							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540303	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2F)c1	InChI=1S/C24H21ClFN5O/c1-13-7-22(27)31-14(2)20(13)12-30-24(32)16-5-6-28-18(9-16)8-15-3-4-21-19(23(15)26)10-17(25)11-29-21/h3-7,9-11H,8,12H2,1-2H3,(H2,27,31)(H,30,32)	MDLFAZWEMPYOEY-UHFFFAOYSA-N	283450	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloro-5-fluoroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 102::US10266515, Example 102::US10308637, Example 102::US11021463, Example 102::US9611252, Example 102	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283450	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283450&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665170	378164779							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540304	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2F)c1	InChI=1S/C23H19ClFN5O/c1-13-16(3-5-21(26)30-13)11-29-23(31)15-6-7-27-18(9-15)8-14-2-4-20-19(22(14)25)10-17(24)12-28-20/h2-7,9-10,12H,8,11H2,1H3,(H2,26,30)(H,29,31)	CMOKBXIVBITBDZ-UHFFFAOYSA-N	283451	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-chloro-5-fluoroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 103::US10266515, Example 103::US10308637, Example 103::US11021463, Example 103::US9611252, Example 103	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283451	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283451&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665235	378164780							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540305	Cc1cc(cc(Cc2ccc3ncc(Cl)cc3c2)n1)C(=O)NCc1c(C)cc(N)nc1C	InChI=1S/C25H24ClN5O/c1-14-6-24(27)31-16(3)22(14)13-29-25(32)19-7-15(2)30-21(11-19)9-17-4-5-23-18(8-17)10-20(26)12-28-23/h4-8,10-12H,9,13H2,1-3H3,(H2,27,31)(H,29,32)	WDMJJASBQUYWJX-UHFFFAOYSA-N	283452	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloroquinolin-6-yl)methyl)-6- methylisonicotinamide::US10023557, Example 104::US10023557, Example 197::US10266515, Example 104::US10308637, Example 197::US11021463, Example 104::US9611252, Example 104	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283452	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283452&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665211	378164781							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540306	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(c1)-n1ncc2cc(Cl)ccc12	InChI=1S/C21H19ClN6O/c1-12-7-19(23)27-13(2)17(12)11-25-21(29)14-5-6-24-20(9-14)28-18-4-3-16(22)8-15(18)10-26-28/h3-10H,11H2,1-2H3,(H2,23,27)(H,25,29)	GWRZXFOABOEUJB-UHFFFAOYSA-N	283453	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((5-chloro-1H-indazol-1- yl)methyl)isonicotinamide::US10023557, Example 105	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283453	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283453&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126501503	378164782							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540307	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cn2cc3cc(Cl)ccc3n2)c1	InChI=1S/C22H21ClN6O/c1-13-7-21(24)27-14(2)19(13)10-26-22(30)15-5-6-25-18(9-15)12-29-11-16-8-17(23)3-4-20(16)28-29/h3-9,11H,10,12H2,1-2H3,(H2,24,27)(H,26,30)	JJKKHULUCHMWFC-UHFFFAOYSA-N	283454	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((5-chloro-2H-indazol-2- yl)methyl)isonicotinamide::US10023557, Example 106::US10023557, Example 107::US10023557, Example 199::US10266515, Example 107::US10308637, Example 199::US11021463, Example 106::US9611252, Example 106	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283454	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283454&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665275	378164783							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540308	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cn2cc3cc(Cl)ccc3n2)c1	InChI=1S/C22H21ClN6O/c1-13-7-21(24)27-14(2)19(13)10-26-22(30)15-5-6-25-18(9-15)12-29-11-16-8-17(23)3-4-20(16)28-29/h3-9,11H,10,12H2,1-2H3,(H2,24,27)(H,26,30)	JJKKHULUCHMWFC-UHFFFAOYSA-N	283454	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((5-chloro-2H-indazol-2- yl)methyl)isonicotinamide::US10023557, Example 106::US10023557, Example 107::US10023557, Example 199::US10266515, Example 107::US10308637, Example 199::US11021463, Example 106::US9611252, Example 106	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283454	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283454&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665275	378164783							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540309	Cc1ccc2n(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)ncc2c1	InChI=1S/C23H24N6O/c1-14-4-5-21-18(8-14)11-27-29(21)13-19-10-17(6-7-25-19)23(30)26-12-20-15(2)9-22(24)28-16(20)3/h4-11H,12-13H2,1-3H3,(H2,24,28)(H,26,30)	PJQHDAQZXYWCRS-UHFFFAOYSA-N	283456	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((5-methyl-1H-indazol-1- yl)methyl)isonicotinamide::US10023557, Example 108::US10266515, Example 108::US10308637, Example 108::US11021463, Example 108::US9611252, Example 108	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283456	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283456&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665436	378164784							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540310	Cc1ccc2nc(c(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)cc2c1)S(C)(=O)=O	InChI=1S/C27H22ClFN4O3S/c1-15-3-4-24-17(7-15)8-18(27(33-24)37(2,35)36)10-20-9-16(5-6-30-20)26(34)32-13-19-11-21-22(28)14-31-25(21)12-23(19)29/h3-9,11-12,14,31H,10,13H2,1-2H3,(H,32,34)	OXDNNQYYISTXOB-UHFFFAOYSA-N	283457	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((6-methyl-2-(methylsulfonyl)quinolin-3- yl)methyl)isonicotinamide::US10023557, Example 109::US10266515, Example 109::US10308637, Example 109::US11021463, Example 109::US9611252, Example 109	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283457	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283457&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213217	378164785							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540311	Cc1ccc2cc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)ccc2n1	InChI=1S/C26H20ClFN4O/c1-15-2-4-17-8-16(3-5-24(17)32-15)9-20-10-18(6-7-29-20)26(33)31-13-19-11-21-22(27)14-30-25(21)12-23(19)28/h2-8,10-12,14,30H,9,13H2,1H3,(H,31,33)	SQVVRWKBMIEHGU-UHFFFAOYSA-N	283458	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((2-methylquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 110::US10266515, Example 110::US10308637, Example 110::US11021463, Example 110::US9611252, Example 110	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283458	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283458&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212258	378164786							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540312	Cc1ccc2cc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)ccc2n1	InChI=1S/C27H23N5O/c1-17-2-5-21-12-18(4-7-25(21)32-17)14-23-15-22(9-10-29-23)27(33)31-16-19-3-6-24-20(13-19)8-11-30-26(24)28/h2-13,15H,14,16H2,1H3,(H2,28,30)(H,31,33)	BHHAKIOPTCXPSL-UHFFFAOYSA-N	283459	N-((1-aminoisoquinolin-6-yl)methyl)-2-((2- methylquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 111::US10266515, Example 111::US10308637, Example 111::US11021463, Example 111::US9611252, Example 111	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283459	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283459&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212697	378164787							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540313	Cc1ccc2cc(Cc3cc(ccn3)C(=O)NCc3ccc(N)nc3C)ccc2n1	InChI=1S/C24H23N5O/c1-15-3-5-18-11-17(4-7-22(18)28-15)12-21-13-19(9-10-26-21)24(30)27-14-20-6-8-23(25)29-16(20)2/h3-11,13H,12,14H2,1-2H3,(H2,25,29)(H,27,30)	XECXUFHBCFQVQM-UHFFFAOYSA-N	283460	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((2-methylquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 112::US10266515, Example 112::US10308637, Example 112::US11021463, Example 112::US9611252, Example 112	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283460	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283460&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212369	378164788							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540314	Cc1ccc2cc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)ccc2n1	InChI=1S/C25H25N5O/c1-15-10-24(26)30-17(3)22(15)14-28-25(31)20-8-9-27-21(13-20)12-18-5-7-23-19(11-18)6-4-16(2)29-23/h4-11,13H,12,14H2,1-3H3,(H2,26,30)(H,28,31)	SOGVYINZTNHWMJ-UHFFFAOYSA-N	283461	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((2-methylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 113::US10266515, Example 113::US10308637, Example 113::US11021463, Example 113::US9611252, Example 113	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283461	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283461&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212447	378164789							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540315	Cc1ccc2ncc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2c1	InChI=1S/C25H25N5O/c1-15-4-5-23-20(8-15)10-18(13-28-23)11-21-12-19(6-7-27-21)25(31)29-14-22-16(2)9-24(26)30-17(22)3/h4-10,12-13H,11,14H2,1-3H3,(H2,26,30)(H,29,31)	PERODSYFHIKGOQ-UHFFFAOYSA-N	283462	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((6-methylquinolin-3- yl)methyl)isonicotinamide::US10023557, Example 114::US10266515, Example 114::US10308637, Example 114::US11021463, Example 114::US9611252, Example 114	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283462	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283462&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212424	378164790							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540316	Cc1ccc2ncc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)cc2c1	InChI=1S/C27H23N5O/c1-17-2-5-25-22(10-17)12-19(16-31-25)13-23-14-21(7-8-29-23)27(33)32-15-18-3-4-24-20(11-18)6-9-30-26(24)28/h2-12,14,16H,13,15H2,1H3,(H2,28,30)(H,32,33)	YXYWWKCODFDZSQ-UHFFFAOYSA-N	283463	N-((1-aminoisoquinolin-6-yl)methyl)-2-((6- methylquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 115::US10266515, Example 115::US10308637, Example 115::US11021463, Example 115::US9611252, Example 115	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283463	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283463&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212341	378164791							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540317	Cc1ccc2ncc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)cc2c1	InChI=1S/C26H20ClFN4O/c1-15-2-3-24-18(6-15)7-16(12-30-24)8-20-9-17(4-5-29-20)26(33)32-13-19-10-21-22(27)14-31-25(21)11-23(19)28/h2-7,9-12,14,31H,8,13H2,1H3,(H,32,33)	HEFJFXWKPBYZLZ-UHFFFAOYSA-N	283464	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((6-methylquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 116::US10266515, Example 116::US10308637, Example 116::US11021463, Example 116::US9611252, Example 116	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283464	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283464&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212685	378164792							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540318	Cc1ccc2ncc(Cc3cc(ccn3)C(=O)NCc3ccc(N)nc3C)cc2c1	InChI=1S/C24H23N5O/c1-15-3-5-22-20(9-15)10-17(13-27-22)11-21-12-18(7-8-26-21)24(30)28-14-19-4-6-23(25)29-16(19)2/h3-10,12-13H,11,14H2,1-2H3,(H2,25,29)(H,28,30)	WNXNZZRXTORCMQ-UHFFFAOYSA-N	283465	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((6-methylquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 117::US10266515, Example 117::US10308637, Example 117::US11021463, Example 117::US9611252, Example 117	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283465	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283465&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212579	378164793							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540319	Nc1nccc2cc(CNC(=O)c3ccnc(Cc4cnc5ccc(F)cc5c4)c3)ccc12	InChI=1S/C26H20FN5O/c27-21-2-4-24-20(12-21)10-17(15-31-24)11-22-13-19(6-7-29-22)26(33)32-14-16-1-3-23-18(9-16)5-8-30-25(23)28/h1-10,12-13,15H,11,14H2,(H2,28,30)(H,32,33)	FEOOVYNQAJINSQ-UHFFFAOYSA-N	283466	N-((1-aminoisoquinolin-6-yl)methyl)-2-((6- fluoroquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 118::US10266515, Example 118::US10308637, Example 118::US11021463, Example 118::US9611252, Example 118	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283466	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283466&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212932	378164794							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540320	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cnc3ccc(F)cc3c2)c1	InChI=1S/C24H22FN5O/c1-14-7-23(26)30-15(2)21(14)13-29-24(31)17-5-6-27-20(11-17)9-16-8-18-10-19(25)3-4-22(18)28-12-16/h3-8,10-12H,9,13H2,1-2H3,(H2,26,30)(H,29,31)	VJYVCAQEIJFBMF-UHFFFAOYSA-N	283467	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((6-fluoroquinolin-3- yl)methyl)isonicotinamide::US10023557, Example 119::US10266515, Example 119::US10308637, Example 119::US11021463, Example 119::US9611252, Example 119	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283467	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283467&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212962	378164795							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540321	Fc1ccc2ncc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)cc2c1	InChI=1S/C25H17ClF2N4O/c26-21-13-31-24-10-22(28)17(9-20(21)24)12-32-25(33)15-3-4-29-19(8-15)6-14-5-16-7-18(27)1-2-23(16)30-11-14/h1-5,7-11,13,31H,6,12H2,(H,32,33)	PDPRSJXGOZQXDE-UHFFFAOYSA-N	283468	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((6-fluoroquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 120::US10266515, Example 120::US10308637, Example 120::US11021463, Example 120::US9611252, Example 120	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283468	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283468&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212861	378164796							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540322	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2cnc3ccc(F)cc3c2)c1	InChI=1S/C23H20FN5O/c1-14-17(2-5-22(25)29-14)13-28-23(30)16-6-7-26-20(11-16)9-15-8-18-10-19(24)3-4-21(18)27-12-15/h2-8,10-12H,9,13H2,1H3,(H2,25,29)(H,28,30)	HDWJBHJMHHEUTP-UHFFFAOYSA-N	283469	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((6-fluoroquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 121::US10266515, Example 121::US10308637, Example 121::US11021463, Example 121::US9611252, Example 121	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283469	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283469&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212359	378164797							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540323	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cnc3cc(F)ccc3c2)c1	InChI=1S/C24H22FN5O/c1-14-7-23(26)30-15(2)21(14)13-29-24(31)18-5-6-27-20(10-18)9-16-8-17-3-4-19(25)11-22(17)28-12-16/h3-8,10-12H,9,13H2,1-2H3,(H2,26,30)(H,29,31)	MWOHJBUVZJQGNX-UHFFFAOYSA-N	283470	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((7-fluoroquinolin-3- yl)methyl)isonicotinamide::US10023557, Example 122::US10266515, Example 122::US10308637, Example 122::US11021463, Example 122::US9611252, Example 122	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283470	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283470&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212621	378164798							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540324	Fc1ccc2cc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)cnc2c1	InChI=1S/C25H17ClF2N4O/c26-21-13-31-24-10-22(28)17(8-20(21)24)12-32-25(33)16-3-4-29-19(7-16)6-14-5-15-1-2-18(27)9-23(15)30-11-14/h1-5,7-11,13,31H,6,12H2,(H,32,33)	AMSTZJFOMLJWBY-UHFFFAOYSA-N	283471	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((7-fluoroquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 123::US10266515, Example 123::US10308637, Example 123::US11021463, Example 123::US9611252, Example 123	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283471	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283471&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212350	378164799							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540325	Nc1nccc2cc(CNC(=O)c3ccnc(Cc4cnc5cc(F)ccc5c4)c3)ccc12	InChI=1S/C26H20FN5O/c27-21-3-2-19-10-17(15-31-24(19)13-21)11-22-12-20(6-7-29-22)26(33)32-14-16-1-4-23-18(9-16)5-8-30-25(23)28/h1-10,12-13,15H,11,14H2,(H2,28,30)(H,32,33)	BBANODQRERYSMA-UHFFFAOYSA-N	283472	N-((1-aminoisoquinolin-6-yl)methyl)-2-((7- fluoroquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 124::US10266515, Example 124::US10308637, Example 124::US11021463, Example 124::US9611252, Example 124	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283472	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283472&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212446	378164800							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540326	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1ccnc(Cc2cnc3ccccc3c2)c1	InChI=1S/C25H18ClFN4O/c26-21-14-30-24-11-22(27)18(10-20(21)24)13-31-25(32)17-5-6-28-19(9-17)8-15-7-16-3-1-2-4-23(16)29-12-15/h1-7,9-12,14,30H,8,13H2,(H,31,32)	FYVVQNCFFZYQIZ-UHFFFAOYSA-N	283473	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- (quinolin-3-ylmethyl)isonicotinamide::US10023557, Example 125::US10266515, Example 125::US10308637, Example 125::US11021463, Example 125::US9611252, Example 125	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283473	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283473&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212449	378164801							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540327	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1ccnc(Cc2cnc3ccc(Cl)cc3c2)c1	InChI=1S/C25H17Cl2FN4O/c26-18-1-2-23-16(7-18)5-14(11-30-23)6-19-8-15(3-4-29-19)25(33)32-12-17-9-20-21(27)13-31-24(20)10-22(17)28/h1-5,7-11,13,31H,6,12H2,(H,32,33)	LRUSUFGKIZOKQY-UHFFFAOYSA-N	283474	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((6-chloroquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 126::US10266515, Example 126::US10308637, Example 126::US11021463, Example 126::US9611252, Example 126	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283474	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283474&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212638	378164802							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540328	Cc1ccc2ccc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)cc2n1	InChI=1S/C27H23N5O/c1-17-2-5-20-6-3-18(14-25(20)32-17)13-23-15-22(9-10-29-23)27(33)31-16-19-4-7-24-21(12-19)8-11-30-26(24)28/h2-12,14-15H,13,16H2,1H3,(H2,28,30)(H,31,33)	YUIGLCWKRLEJJV-UHFFFAOYSA-N	283475	N-((1-aminoisoquinolin-6-yl)methyl)-2-((2- methylquinolin-7-yl)methyl)isonicotinamide::US10023557, Example 127::US10266515, Example 127::US10308637, Example 127::US11021463, Example 127::US9611252, Example 127	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283475	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283475&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212220	378164803							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540329	Cc1ccc2ccc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)cc2n1	InChI=1S/C26H20ClFN4O/c1-15-2-4-17-5-3-16(9-24(17)32-15)8-20-10-18(6-7-29-20)26(33)31-13-19-11-21-22(27)14-30-25(21)12-23(19)28/h2-7,9-12,14,30H,8,13H2,1H3,(H,31,33)	ASHCCNPFZHFVAC-UHFFFAOYSA-N	283476	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((2-methylquinolin-7-yl)methyl)isonicotinamide::US10023557, Example 128::US10266515, Example 128::US10308637, Example 128::US11021463, Example 128::US9611252, Example 128	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283476	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283476&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212704	378164804							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540330	Cc1ccc2ccc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2n1	InChI=1S/C25H25N5O/c1-15-10-24(26)30-17(3)22(15)14-28-25(31)20-8-9-27-21(13-20)11-18-5-7-19-6-4-16(2)29-23(19)12-18/h4-10,12-13H,11,14H2,1-3H3,(H2,26,30)(H,28,31)	BOMAZLQSSNNLAL-UHFFFAOYSA-N	283477	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((2-methylquinolin-7- yl)methyl)isonicotinamide::US10023557, Example 129::US10266515, Example 129::US10308637, Example 129::US11021463, Example 129::US9611252, Example 129	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283477	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283477&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212507	378164805							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540331	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1ccnc(Cc2ccc3nc(ccc3c2)C#N)c1	InChI=1S/C26H17ClFN5O/c27-22-14-31-25-11-23(28)18(10-21(22)25)13-32-26(34)17-5-6-30-20(9-17)8-15-1-4-24-16(7-15)2-3-19(12-29)33-24/h1-7,9-11,14,31H,8,13H2,(H,32,34)	XHYLSPCHHJFGNQ-UHFFFAOYSA-N	283478	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((2-isocyanoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 130::US10266515, Example 130::US10308637, Example 130::US11021463, Example 130::US9611252, Example 130	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283478	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283478&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213085	378164806							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540332	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3nc(ccc3c2)C#N)c1	InChI=1S/C25H22N6O/c1-15-9-24(27)30-16(2)22(15)14-29-25(32)19-7-8-28-21(12-19)11-17-3-6-23-18(10-17)4-5-20(13-26)31-23/h3-10,12H,11,14H2,1-2H3,(H2,27,30)(H,29,32)	WCGZGKPBOPWGNC-UHFFFAOYSA-N	283479	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((2-isocyanoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 131::US10266515, Example 131::US10308637, Example 131::US9611252, Example 131	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283479	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283479&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212991	378164807							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540333	Cc1cc2cc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)ccc2cn1	InChI=1S/C27H23N5O/c1-17-10-23-11-18(2-4-22(23)16-31-17)13-24-14-21(7-8-29-24)27(33)32-15-19-3-5-25-20(12-19)6-9-30-26(25)28/h2-12,14,16H,13,15H2,1H3,(H2,28,30)(H,32,33)	KZGIIODXNPBNJO-UHFFFAOYSA-N	283480	N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- methylisoquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 132::US10266515, Example 132::US10308637, Example 132::US11021463, Example 132::US9611252, Example 132	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283480	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283480&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213018	378164808							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540334	Cc1cc2cc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)ccc2cn1	InChI=1S/C26H20ClFN4O/c1-15-6-19-7-16(2-3-18(19)12-30-15)8-21-9-17(4-5-29-21)26(33)32-13-20-10-22-23(27)14-31-25(22)11-24(20)28/h2-7,9-12,14,31H,8,13H2,1H3,(H,32,33)	KRFVOCRTZLYSJU-UHFFFAOYSA-N	283481	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3-methylisoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 133::US10266515, Example 133::US10308637, Example 133::US11021463, Example 133::US9611252, Example 133	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283481	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283481&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212795	378164809							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540335	CS(=O)(=O)c1ccc2cc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)ccc2n1	InChI=1S/C27H23N5O3S/c1-36(34,35)25-7-4-20-12-17(3-6-24(20)32-25)14-22-15-21(9-10-29-22)27(33)31-16-18-2-5-23-19(13-18)8-11-30-26(23)28/h2-13,15H,14,16H2,1H3,(H2,28,30)(H,31,33)	QZLYZRALGDJSAC-UHFFFAOYSA-N	283482	N-((1-aminoisoquinolin-6-yl)methyl)-2-((2- (methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 134::US10266515, Example 134::US10308637, Example 134::US11021463, Example 134::US9611252, Example 134	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283482	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283482&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212866	378164810							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540336	CS(=O)(=O)c1ccc2cc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)ccc2n1	InChI=1S/C26H20ClFN4O3S/c1-36(34,35)25-5-3-16-8-15(2-4-23(16)32-25)9-19-10-17(6-7-29-19)26(33)31-13-18-11-20-21(27)14-30-24(20)12-22(18)28/h2-8,10-12,14,30H,9,13H2,1H3,(H,31,33)	URHHGZRDZIHONJ-UHFFFAOYSA-N	283483	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((2-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 135::US10266515, Example 135::US10308637, Example 135::US11021463, Example 135::US9611252, Example 135	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283483	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283483&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212678	378164811							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540337	Nc1nccc2cc(CNC(=O)c3ccnc(Cc4ccc5nccc(C#N)c5c4)c3)ccc12	InChI=1S/C27H20N6O/c28-15-21-7-9-31-25-4-2-17(13-24(21)25)12-22-14-20(6-8-30-22)27(34)33-16-18-1-3-23-19(11-18)5-10-32-26(23)29/h1-11,13-14H,12,16H2,(H2,29,32)(H,33,34)	GWYUQVNAIHTMAT-UHFFFAOYSA-N	283484	N-((1-aminoisoquinolin-6-yl)methyl)-2-((4- cyanoquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 136::US10266515, Example 136::US10308637, Example 136::US11021463, Example 136::US9611252, Example 136	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283484	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283484&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213035	378164812							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540338	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1ccnc(Cc2ccc3nccc([N+]#[C-])c3c2)c1	InChI=1S/C26H17ClFN5O/c1-29-23-5-7-31-24-3-2-15(9-20(23)24)8-18-10-16(4-6-30-18)26(34)33-13-17-11-19-21(27)14-32-25(19)12-22(17)28/h2-7,9-12,14,32H,8,13H2,(H,33,34)	RDLBGCIBZMDBKB-UHFFFAOYSA-N	283485	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((4-cyanoquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 137::US9611252, Example 137	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283485	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283485&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			136215339	378164813							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540339	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3nccc([N+]#[C-])c3c2)c1	InChI=1S/C25H22N6O/c1-15-10-24(26)31-16(2)21(15)14-30-25(32)18-6-8-28-19(13-18)11-17-4-5-23-20(12-17)22(27-3)7-9-29-23/h4-10,12-13H,11,14H2,1-2H3,(H2,26,31)(H,30,32)	VOZLTLOQPVBEOD-UHFFFAOYSA-N	283486	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((4-cyanoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 138::US9611252, Example 138	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283486	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283486&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			136215340	378164814							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540340	Nc1nccc2cc(CNC(=O)c3ccnc(Cc4cnc5cc(Cl)ccc5c4)c3)ccc12	InChI=1S/C26H20ClN5O/c27-21-3-2-19-10-17(15-31-24(19)13-21)11-22-12-20(6-7-29-22)26(33)32-14-16-1-4-23-18(9-16)5-8-30-25(23)28/h1-10,12-13,15H,11,14H2,(H2,28,30)(H,32,33)	AIGLAHDLOIUXAW-UHFFFAOYSA-N	283487	N-((1-aminoisoquinolin-6-yl)methyl)-2-((7- chloroquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 139::US10266515, Example 139::US10308637, Example 139::US11021463, Example 139	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283487	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283487&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212540	378164815							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540341	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1ccnc(Cc2cnc3cc(Cl)ccc3c2)c1	InChI=1S/C25H17Cl2FN4O/c26-18-2-1-15-5-14(11-30-23(15)9-18)6-19-7-16(3-4-29-19)25(33)32-12-17-8-20-21(27)13-31-24(20)10-22(17)28/h1-5,7-11,13,31H,6,12H2,(H,32,33)	IKMVYXFFBLRHRM-UHFFFAOYSA-N	283488	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((7-chloroquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 140::US10266515, Example 140::US10308637, Example 140::US11021463, Example 140::US9611252, Example 140	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283488	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283488&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212776	378164816							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540342	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cnc3cc(Cl)ccc3c2)c1	InChI=1S/C24H22ClN5O/c1-14-7-23(26)30-15(2)21(14)13-29-24(31)18-5-6-27-20(10-18)9-16-8-17-3-4-19(25)11-22(17)28-12-16/h3-8,10-12H,9,13H2,1-2H3,(H2,26,30)(H,29,31)	CRTRNHYSRBELJZ-UHFFFAOYSA-N	283489	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((7-chloroquinolin-3- yl)methyl)isonicotinamide::US10023557, Example 141::US10266515, Example 141::US10308637, Example 141::US11021463, Example 141::US9611252, Example 141	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283489	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283489&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213050	378164817							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540343	Cc1cnc2ccc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)cc2c1	InChI=1S/C27H23N5O/c1-17-10-22-11-18(3-5-25(22)31-15-17)13-23-14-21(7-8-29-23)27(33)32-16-19-2-4-24-20(12-19)6-9-30-26(24)28/h2-12,14-15H,13,16H2,1H3,(H2,28,30)(H,32,33)	XPXFEZOWOODSMW-UHFFFAOYSA-N	283490	N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- methylquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 142::US10266515, Example 142::US10308637, Example 142::US11021463, Example 142::US9611252, Example 142	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283490	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283490&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212463	378164818							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540344	Cc1cnc2ccc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)cc2c1	InChI=1S/C26H20ClFN4O/c1-15-6-18-7-16(2-3-24(18)30-12-15)8-20-9-17(4-5-29-20)26(33)32-13-19-10-21-22(27)14-31-25(21)11-23(19)28/h2-7,9-12,14,31H,8,13H2,1H3,(H,32,33)	BAWQXCVTJNYXQW-UHFFFAOYSA-N	283491	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3-methylquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 143::US10266515, Example 143::US10308637, Example 143::US11021463, Example 143::US9611252, Example 143	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283491	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283491&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212764	378164819							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540345	Cc1cnc2ccc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2c1	InChI=1S/C25H25N5O/c1-15-8-20-10-18(4-5-23(20)28-13-15)11-21-12-19(6-7-27-21)25(31)29-14-22-16(2)9-24(26)30-17(22)3/h4-10,12-13H,11,14H2,1-3H3,(H2,26,30)(H,29,31)	BDBQXLZXRHXRJN-UHFFFAOYSA-N	283492	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-methylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 144::US10266515, Example 144::US10308637, Example 144::US11021463, Example 144::US9611252, Example 144	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283492	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283492&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212432	378164820							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540346	Cc1cc2cc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)ccc2cn1	InChI=1S/C25H25N5O/c1-15-8-24(26)30-17(3)23(15)14-29-25(31)19-6-7-27-22(12-19)11-18-4-5-20-13-28-16(2)9-21(20)10-18/h4-10,12-13H,11,14H2,1-3H3,(H2,26,30)(H,29,31)	IDPUQOZCEWQYLL-UHFFFAOYSA-N	283493	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-methylisoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 145::US10266515, Example 145::US10308637, Example 145::US11021463, Example 145::US9611252, Example 145	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283493	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283493&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212443	378164821							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540347	NCc1ccc2cc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)ccc2n1	InChI=1S/C27H24N6O/c28-15-22-4-3-20-11-17(2-6-25(20)33-22)13-23-14-21(8-9-30-23)27(34)32-16-18-1-5-24-19(12-18)7-10-31-26(24)29/h1-12,14H,13,15-16,28H2,(H2,29,31)(H,32,34)	NBXVVYPBTMZIFQ-UHFFFAOYSA-N	283494	N-((1-aminoisoquinolin-6-yl)methyl)-2-((2- (aminomethyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 146::US10266515, Example 146::US10308637, Example 146::US11021463, Example 146::US9611252, Example 146Biochemical	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283494	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283494&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212893	378164822							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540348	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc3cc(Cl)ccc3[nH]2)c1	InChI=1S/C23H22ClN5O/c1-13-7-22(25)28-14(2)20(13)12-27-23(30)15-5-6-26-18(9-15)11-19-10-16-8-17(24)3-4-21(16)29-19/h3-10,29H,11-12H2,1-2H3,(H2,25,28)(H,27,30)	FDAPFMHNHNNZCM-UHFFFAOYSA-N	283495	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((5-chloro-1H-indol-2- yl)methyl)isonicotinamide::US10023557, Example 147::US10308637, Example 147	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283495	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283495&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124181926	378164823							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540349	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc3cc(Cl)cnc3cn2)c1	InChI=1S/C23H21ClN6O/c1-13-5-22(25)30-14(2)20(13)11-29-23(31)15-3-4-26-18(7-15)9-19-8-16-6-17(24)10-28-21(16)12-27-19/h3-8,10,12H,9,11H2,1-2H3,(H2,25,30)(H,29,31)	DOFBPINSGHHTHL-UHFFFAOYSA-N	283496	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloro-1,7-naphthyridin-6- yl)methyl)isonicotinamide::US10023557, Example 148::US10308637, Example 148	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283496	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283496&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182428	378164824							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540350	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2cc3cc(Cl)cnc3cn2)c1	InChI=1S/C22H19ClN6O/c1-13-15(2-3-21(24)29-13)10-28-22(30)14-4-5-25-18(7-14)9-19-8-16-6-17(23)11-27-20(16)12-26-19/h2-8,11-12H,9-10H2,1H3,(H2,24,29)(H,28,30)	KXUGLTKYGLLMBT-UHFFFAOYSA-N	283497	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-chloro-1,7-naphthyridin-6- yl)methyl)isonicotinamide::US10023557, Example 149::US10308637, Example 149	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283497	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283497&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182483	378164825							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540351	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cnc3[nH]c(Cl)cc3c2)c1	InChI=1S/C22H21ClN6O/c1-12-5-20(24)28-13(2)18(12)11-27-22(30)15-3-4-25-17(8-15)7-14-6-16-9-19(23)29-21(16)26-10-14/h3-6,8-10H,7,11H2,1-2H3,(H2,24,28)(H,26,29)(H,27,30)	LBBPWLTWVVPJDU-UHFFFAOYSA-N	283498	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((2-chloro-1H-pyrrolo[2,3-b]pyridin-5- yl)methyl)isonicotinamide::US10023557, Example 150::US10308637, Example 150	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283498	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283498&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124181916	378164826							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540352	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc3cc(ccc3[nH]2)C(F)(F)F)c1	InChI=1S/C24H22F3N5O/c1-13-7-22(28)31-14(2)20(13)12-30-23(33)15-5-6-29-18(9-15)11-19-10-16-8-17(24(25,26)27)3-4-21(16)32-19/h3-10,32H,11-12H2,1-2H3,(H2,28,31)(H,30,33)	MAPGSKUWLDLVLP-UHFFFAOYSA-N	283499	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((5-(trifluoromethyl)-1H-indol-2- yl)methyl)isonicotinamide::US10023557, Example 151::US10308637, Example 151	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283499	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283499&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124181890	378164827							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540353	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cnc3[nH]c(cc3c2)C(F)(F)F)c1	InChI=1S/C23H21F3N6O/c1-12-5-20(27)31-13(2)18(12)11-30-22(33)15-3-4-28-17(8-15)7-14-6-16-9-19(23(24,25)26)32-21(16)29-10-14/h3-6,8-10H,7,11H2,1-2H3,(H2,27,31)(H,29,32)(H,30,33)	OSQCTZSKPWGQIJ-UHFFFAOYSA-N	283500	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((2-(trifluoromethyl)-1H-pyrrolo[2,3- b]pyridin-5-yl)methyl)isonicotinamide::US10023557, Example 152::US10308637, Example 152	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283500	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283500&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124181930	378164828							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540354	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc3cc(Cl)cn3cn2)c1	InChI=1S/C22H21ClN6O/c1-13-5-21(24)28-14(2)20(13)10-26-22(30)15-3-4-25-17(6-15)8-18-9-19-7-16(23)11-29(19)12-27-18/h3-7,9,11-12H,8,10H2,1-2H3,(H2,24,28)(H,26,30)	SQUKLLPOSXHIBK-UHFFFAOYSA-N	283501	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((6-chloropyrrolo [1,2-c]pyrimidin-3- yl)methyl)isonicotinamide::US10023557, Example 153::US10308637, Example 153	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283501	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283501&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124181891	378164829							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540355	Clc1ccc2nnc(CNC(=O)c3ccnc(Cc4ccc5ncc(Cl)cc5c4)c3)n2c1	InChI=1S/C23H16Cl2N6O/c24-17-2-4-21-29-30-22(31(21)13-17)12-28-23(32)15-5-6-26-19(10-15)8-14-1-3-20-16(7-14)9-18(25)11-27-20/h1-7,9-11,13H,8,12H2,(H,28,32)	MKOUWRINCHLWSP-UHFFFAOYSA-N	283503	N-((6-chloro-[1,2,4]triazolo[4,3-a]pyridin-3- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 154::US10308637, Example 154	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283503	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283503&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665341	378164831							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540356	Cc1ccn2nnc(CNC(=O)c3ccnc(Cc4ccc5ncc(Cl)cc5c4)c3)c2c1	InChI=1S/C24H19ClN6O/c1-15-5-7-31-23(8-15)22(29-30-31)14-28-24(32)17-4-6-26-20(12-17)10-16-2-3-21-18(9-16)11-19(25)13-27-21/h2-9,11-13H,10,14H2,1H3,(H,28,32)	GPLMABVCEUFRFE-UHFFFAOYSA-N	283504	2-((3-chloroquinolin-6-yl)methyl)-N-((5-methyl)- [1,2,3]triazolo[1,5-a]pyridin-3- yl)methyl)isonicotinamide::US10023557, Example 155::US10308637, Example 155	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283504	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283504&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182379	378164832							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540357	Cc1ccn2cnc(CNC(=O)c3ccnc(Cc4ccc5ncc(Cl)cc5c4)c3)c2c1	InChI=1S/C25H20ClN5O/c1-16-5-7-31-15-30-23(24(31)8-16)14-29-25(32)18-4-6-27-21(12-18)10-17-2-3-22-19(9-17)11-20(26)13-28-22/h2-9,11-13,15H,10,14H2,1H3,(H,29,32)	YCIACGKRXNLORD-UHFFFAOYSA-N	283505	2-((3-chloroquinolin-6-yl)methyl)-N-((7- methylimidazo[1,5-a]pyridin-1- yl)methyl0isonicotinamide::US10023557, Example 156::US10308637, Example 156	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283505	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283505&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126501507	378164833							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540358	Clc1ccc2ncc(CNC(=O)c3ccnc(Cc4ccc5ncc(Cl)cc5c4)c3)n2c1	InChI=1S/C24H17Cl2N5O/c25-18-2-4-23-29-12-21(31(23)14-18)13-30-24(32)16-5-6-27-20(10-16)8-15-1-3-22-17(7-15)9-19(26)11-28-22/h1-7,9-12,14H,8,13H2,(H,30,32)	QDENAUPMCRNUIE-UHFFFAOYSA-N	283506	N-((6-chloroimidazo[1,2-a]pyridin-3-yl)methyl)- 2-((3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 157::US10308637, Example 157	Plasma kallikrein			>10000					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283506	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283506&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665298	378164834							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540359	Cc1nc(CNC(=O)c2ccnc(Cc3ccc4ncc(Cl)cc4c3)c2)c2cc(C)ccn12	InChI=1S/C26H22ClN5O/c1-16-6-8-32-17(2)31-24(25(32)9-16)15-30-26(33)19-5-7-28-22(13-19)11-18-3-4-23-20(10-18)12-21(27)14-29-23/h3-10,12-14H,11,15H2,1-2H3,(H,30,33)	DSLFYWXOXHQCHX-UHFFFAOYSA-N	283507	2-((3-chloroquinolin-6-yl)methyl)-N-((3,7- dimethylimidazo[1,5-a]pyridin-1- yl)methyl)isonicotinamide::US10023557, Example 158::US10308637, Example 158	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283507	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283507&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124181951	378164835							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540360	Cc1nc(CNC(=O)c2ccnc(Cc3ccc4ncc(cc4c3)C(F)(F)F)c2)c2cc(C)ccn12	InChI=1S/C27H22F3N5O/c1-16-6-8-35-17(2)34-24(25(35)9-16)15-33-26(36)19-5-7-31-22(13-19)11-18-3-4-23-20(10-18)12-21(14-32-23)27(28,29)30/h3-10,12-14H,11,15H2,1-2H3,(H,33,36)	AZBCOCFKWZMQEJ-UHFFFAOYSA-N	283509	N-((3,7-dimethylimidazo[1,5-a]pyridin-1- yl)methyl)-2-((3-(trifluoromethyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 159::US10308637, Example 159	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283509	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283509&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182434	378164837							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540361	Cc1ccn2c(nc(CNC(=O)c3ccnc(Cc4ccc5ncc(Cl)cc5c4)c3)c2c1)C(F)(F)F	InChI=1S/C26H19ClF3N5O/c1-15-5-7-35-23(8-15)22(34-25(35)26(28,29)30)14-33-24(36)17-4-6-31-20(12-17)10-16-2-3-21-18(9-16)11-19(27)13-32-21/h2-9,11-13H,10,14H2,1H3,(H,33,36)	LHUPUBLCSFMDTJ-UHFFFAOYSA-N	283510	2-((3-chloroquinolin-6-yl)methyl)-N-((7-methyl- 3-(trifluoromethyl)imidazo[1,5-a]pyridin-1- yl)methyl)isonicotinamide::US10023557, Example 160::US10308637, Example 160	Plasma kallikrein			>10000					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283510	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283510&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182501	378164838							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540362	Cc1nc2NCCc2cc1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C25H22ClN5O/c1-15-20(10-17-4-7-28-24(17)31-15)13-30-25(32)18-5-6-27-22(12-18)9-16-2-3-23-19(8-16)11-21(26)14-29-23/h2-3,5-6,8,10-12,14H,4,7,9,13H2,1H3,(H,28,31)(H,30,32)	RUHSHSFQBWSFOU-UHFFFAOYSA-N	283511	2-((3-chloroquinolin-6-yl)methyl)-N-((6-methyl- 2,3-dihydro-1H-pyrrolo[2,3-b]pyridin-5- yl)methyl)isonicotinamide::US10023557, Example 161::US10308637, Example 161	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283511	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283511&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124181888	378164839							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540363	Cc1nc2NCCc2cc1CNC(=O)c1ccnc(Cc2ccc3ncc(cc3c2)C(F)(F)F)c1	InChI=1S/C26H22F3N5O/c1-15-20(10-17-4-7-31-24(17)34-15)13-33-25(35)18-5-6-30-22(12-18)9-16-2-3-23-19(8-16)11-21(14-32-23)26(27,28)29/h2-3,5-6,8,10-12,14H,4,7,9,13H2,1H3,(H,31,34)(H,33,35)	HZINCYNTSLFHIX-UHFFFAOYSA-N	283512	N-((6-methyl-2,3-dihydro-1H-pyrrolo[2,3- b]pyridin-5-yl)methyl)-2-((3- (trifluoromethyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 162::US10308637, Example 162	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283512	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283512&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182686	378164840							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540364	Cc1nc2CNCc2cc1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C25H22ClN5O/c1-15-19(8-20-11-27-14-24(20)31-15)12-30-25(32)17-4-5-28-22(10-17)7-16-2-3-23-18(6-16)9-21(26)13-29-23/h2-6,8-10,13,27H,7,11-12,14H2,1H3,(H,30,32)	XYTAMJWUOAYCTE-UHFFFAOYSA-N	283513	2-((3-chloroquinolin-6-yl)methyl)-N-((2-methyl- 6,7-dihydro-5H-pyrrolo[3,4-b]pyridin-3- yl)methyl)isonicotinamide::US10023557, Example 163::US10308637, Example 163	Plasma kallikrein			>10000					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283513	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283513&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182893	378164841							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540365	Cc1nc2CNCc2cc1CNC(=O)c1ccnc(Cc2ccc3ncc(cc3c2)C(F)(F)F)c1	InChI=1S/C26H22F3N5O/c1-15-19(8-20-11-30-14-24(20)34-15)12-33-25(35)17-4-5-31-22(10-17)7-16-2-3-23-18(6-16)9-21(13-32-23)26(27,28)29/h2-6,8-10,13,30H,7,11-12,14H2,1H3,(H,33,35)	NNOLLAGJCAHGSF-UHFFFAOYSA-N	283514	N-((2-methyl-6,7-dihydro-5H-pyrrolo[3,4- b]pyridin-3-yl)methyl)-2-((3- (trifluoromethyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 164::US10308637, Example 164	Plasma kallikrein			>10000					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283514	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283514&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124181957	378164842							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540366	Cc1nc(N)cc(c1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1)C(F)(F)F	InChI=1S/C24H19ClF3N5O/c1-13-19(20(24(26,27)28)10-22(29)33-13)12-32-23(34)15-4-5-30-18(9-15)7-14-2-3-21-16(6-14)8-17(25)11-31-21/h2-6,8-11H,7,12H2,1H3,(H2,29,33)(H,32,34)	MNOLIHFFGYKXGE-UHFFFAOYSA-N	283515	N-((6-amino-2-methyl-4- (trifluoromethyl)pyridin-3-yl)methyl)-2-((3- chloroquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 165::US10308637, Example 165	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283515	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283515&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124181873	378164843							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540367	COc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C24H22ClN5O2/c1-14-20(22(32-2)11-23(26)30-14)13-29-24(31)16-5-6-27-19(10-16)8-15-3-4-21-17(7-15)9-18(25)12-28-21/h3-7,9-12H,8,13H2,1-2H3,(H2,26,30)(H,29,31)	FTGGLYOMJRGSOC-UHFFFAOYSA-N	283517	N-((6-amino-4-methoxy-2-methylpyridin-3- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 166::US10308637, Example 166	Plasma kallikrein			>10000					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283517	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283517&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124181952	378164845							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540368	Cc1nc(N)cc(C#N)c1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C24H19ClN6O/c1-14-21(18(11-26)10-23(27)31-14)13-30-24(32)16-4-5-28-20(9-16)7-15-2-3-22-17(6-15)8-19(25)12-29-22/h2-6,8-10,12H,7,13H2,1H3,(H2,27,31)(H,30,32)	WLEBRIYBFAPAHX-UHFFFAOYSA-N	283518	N-((6-amino-4-cyano-2-methylpyridin-3- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 167::US10308637, Example 167	Plasma kallikrein			>10000					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283518	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283518&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124181927	378164846							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540369	NCc1ccc(CNC(=O)c2ccnc(Cc3ccc4ncc(Cl)cc4c3)c2)cc1	InChI=1S/C24H21ClN4O/c25-21-11-20-9-18(5-6-23(20)28-15-21)10-22-12-19(7-8-27-22)24(30)29-14-17-3-1-16(13-26)2-4-17/h1-9,11-12,15H,10,13-14,26H2,(H,29,30)	PCLWCWPEGAQJBO-UHFFFAOYSA-N	283519	N-(4-(aminomethyl)benzyl)-2-((3- chloroquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 168::US10308637, Example 168	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283519	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283519&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182505	378164847							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540370	NCc1ccc(CNC(=O)c2ccnc(Cc3ccc4ncc(Cl)cc4c3)c2)cn1	InChI=1S/C23H20ClN5O/c24-19-9-18-7-15(2-4-22(18)28-14-19)8-21-10-17(5-6-26-21)23(30)29-13-16-1-3-20(11-25)27-12-16/h1-7,9-10,12,14H,8,11,13,25H2,(H,29,30)	OQFFXAWHSVBXIC-UHFFFAOYSA-N	283520	N-((6-(aminomethyl)pyridin-3-yl)methyl)-2-((3- chloroquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 169::US10308637, Example 169	Plasma kallikrein			>10000					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283520	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283520&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182983	378164848							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540371	NCc1ccc(CNC(=O)c2ccnc(Cc3ccc4ncc(Cl)cc4c3)c2)nc1	InChI=1S/C23H20ClN5O/c24-19-9-18-7-15(2-4-22(18)28-13-19)8-21-10-17(5-6-26-21)23(30)29-14-20-3-1-16(11-25)12-27-20/h1-7,9-10,12-13H,8,11,14,25H2,(H,29,30)	MBSMBLMMJGTPGL-UHFFFAOYSA-N	283521	N-((5-(aminomethyl)pyridin-2-yl)methyl)-2-((3- chloroquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 170::US10308637, Example 170	Plasma kallikrein			>10000					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283521	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283521&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124181852	378164849							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540372	Cc1cc(CN)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C25H24ClN5O/c1-15-7-22(12-27)31-16(2)23(15)14-30-25(32)18-5-6-28-21(11-18)9-17-3-4-24-19(8-17)10-20(26)13-29-24/h3-8,10-11,13H,9,12,14,27H2,1-2H3,(H,30,32)	KRPYDVGDFIHKMK-UHFFFAOYSA-N	283522	N-((6-(aminomethyl)-2,4-dimethylpyridin-3- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 171::US10308637, Example 171	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283522	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283522&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182517	378164850							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540373	Cc1cc(CN)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3ncc(cc3c2)C(F)(F)F)c1	InChI=1S/C26H24F3N5O/c1-15-7-22(12-30)34-16(2)23(15)14-33-25(35)18-5-6-31-21(11-18)9-17-3-4-24-19(8-17)10-20(13-32-24)26(27,28)29/h3-8,10-11,13H,9,12,14,30H2,1-2H3,(H,33,35)	MCBPNFNZAWRTIW-UHFFFAOYSA-N	283523	N-((6-(aminomethyl)-2,4-dimethylpyridin-3- yl)methyl)-2-((3-(trifluoromethyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 172::US10308637, Example 172	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283523	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283523&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182577	378164851							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540374	CC(N)c1cc(C)c(CNC(=O)c2ccnc(Cc3ccc4ncc(Cl)cc4c3)c2)c(C)n1	InChI=1S/C26H26ClN5O/c1-15-8-25(16(2)28)32-17(3)23(15)14-31-26(33)19-6-7-29-22(12-19)10-18-4-5-24-20(9-18)11-21(27)13-30-24/h4-9,11-13,16H,10,14,28H2,1-3H3,(H,31,33)	JSFUQXSJDFWYQJ-UHFFFAOYSA-N	283524	N-((6-(1-aminoethyl)-2,4-dimethylpyridin-3- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 173::US10308637, Example 173	Plasma kallikrein			 5500					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283524	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283524&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182990	378164852							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540375	Cc1cc(nc(C)c1CNC(=O)c1ccnc(Cc2ccc3ncc(cc3c2)C(F)(F)F)c1)C(C)(C)O	InChI=1S/C28H27F3N4O2/c1-16-9-25(27(3,4)37)35-17(2)23(16)15-34-26(36)19-7-8-32-22(13-19)11-18-5-6-24-20(10-18)12-21(14-33-24)28(29,30)31/h5-10,12-14,37H,11,15H2,1-4H3,(H,34,36)	DAHHITKQTOHRMA-UHFFFAOYSA-N	283525	N-((6-(2-hydroxypropan-2-yl)-2,4- dimethylpyridin-3-yl)methyl)-2-((3- (trifluoromethyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 174::US10308637, Example 174	Plasma kallikrein			>10000					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283525	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283525&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124181972	378164853							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540376	Cc1nc2NCCc2c(C)c1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C26H24ClN5O/c1-15-22-6-8-29-25(22)32-16(2)23(15)14-31-26(33)18-5-7-28-21(12-18)10-17-3-4-24-19(9-17)11-20(27)13-30-24/h3-5,7,9,11-13H,6,8,10,14H2,1-2H3,(H,29,32)(H,31,33)	NCPDXDHJFNGUCT-UHFFFAOYSA-N	283526	2-((3-chloroquinolin-6-yl)methyl)-N-((4,6- dimethyl-2,3-dihydro-1H-pyrrolo[2,3-b]pyridin- 5-yl)methyl)isonicotinamide::US10023557, Example 175::US10308637, Example 175	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283526	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283526&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124181860	378164854							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540377	Cc1nc2NCCc2c(C)c1CNC(=O)c1ccnc(Cc2ccc3ncc(cc3c2)C(F)(F)F)c1	InChI=1S/C27H24F3N5O/c1-15-22-6-8-32-25(22)35-16(2)23(15)14-34-26(36)18-5-7-31-21(12-18)10-17-3-4-24-19(9-17)11-20(13-33-24)27(28,29)30/h3-5,7,9,11-13H,6,8,10,14H2,1-2H3,(H,32,35)(H,34,36)	VVONGBLBROSHAM-UHFFFAOYSA-N	283527	N-((4,6-dimethyl-2,3-dihydro-1H-pyrrolo[2,3- b]pyridin-5-yl)methyl)-2-((3- (trifluoromethyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 176::US10308637, Example 176	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283527	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283527&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182506	378164855							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540378	Cc1c(CNC(=O)c2ccnc(Cc3ccc4ncc(Cl)cc4c3)c2)ccc2c(N)nccc12	InChI=1S/C27H22ClN5O/c1-16-19(3-4-24-23(16)7-9-31-26(24)29)14-33-27(34)18-6-8-30-22(13-18)11-17-2-5-25-20(10-17)12-21(28)15-32-25/h2-10,12-13,15H,11,14H2,1H3,(H2,29,31)(H,33,34)	YXPTZYQGGAGCHI-UHFFFAOYSA-N	283528	N-((1-amino-5-methylisoquinolin-6-yl)methyl)- 2-((3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 177::US10308637, Example 177	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283528	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283528&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124181936	378164856							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540379	Nc1nccc2c(F)c(CNC(=O)c3ccnc(Cc4ccc5ncc(Cl)cc5c4)c3)ccc12	InChI=1S/C26H19ClFN5O/c27-19-11-18-9-15(1-4-23(18)32-14-19)10-20-12-16(5-7-30-20)26(34)33-13-17-2-3-22-21(24(17)28)6-8-31-25(22)29/h1-9,11-12,14H,10,13H2,(H2,29,31)(H,33,34)	FOHRMFWTCTZUPO-UHFFFAOYSA-N	283529	N-((1-amino-5-fluoroisoquinolin-6-yl)methyl)-2- ((3-chloroquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 178::US10308637, Example 178	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283529	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283529&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124181934	378164857							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540380	Nc1nccc2cc(CNC(=O)c3ccnc(Cc4ccc5ncc(Cl)cc5c4)c3)ccc12	InChI=1S/C26H20ClN5O/c27-21-12-20-9-16(2-4-24(20)31-15-21)11-22-13-19(6-7-29-22)26(33)32-14-17-1-3-23-18(10-17)5-8-30-25(23)28/h1-10,12-13,15H,11,14H2,(H2,28,30)(H,32,33)	WHHMKDFLRDNMQE-UHFFFAOYSA-N	283379	N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- chloroquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 179::US10023557, Example 31::US10266515, Example 31::US10308637, Example 179::US11021463, Example 31::US9611252, Example 31	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283379	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283379&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212700	378164708							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540381	Nc1nccc2cc(CNC(=O)c3ccnc(Cc4ccc5ncc(Cl)cc5c4)c3)c(F)cc12	InChI=1S/C26H19ClFN5O/c27-20-10-18-7-15(1-2-24(18)32-14-20)8-21-11-17(4-5-30-21)26(34)33-13-19-9-16-3-6-31-25(29)22(16)12-23(19)28/h1-7,9-12,14H,8,13H2,(H2,29,31)(H,33,34)	HCTXZEOGTFJACK-UHFFFAOYSA-N	283531	N-((1-amino-7-fluoroisoquinolin-6-yl)methyl)-2- ((3-chloroquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 180::US10308637, Example 180	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283531	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283531&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182533	378164858							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540382	Cc1cc2c(N)nccc2cc1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C27H22ClN5O/c1-16-8-24-18(4-7-31-26(24)29)11-21(16)14-33-27(34)19-5-6-30-23(13-19)10-17-2-3-25-20(9-17)12-22(28)15-32-25/h2-9,11-13,15H,10,14H2,1H3,(H2,29,31)(H,33,34)	MSEKTXXPPKABMW-UHFFFAOYSA-N	283532	N-((1-amino-7-methylisoquinolin-6-yl)methyl)- 2-((3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 181::US10308637, Example 181	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283532	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283532&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126501511	378164859							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540383	Nc1nccc2cc(CNC(=O)c3ccnc(Cc4ccc5ncc(cc5c4)C(F)(F)F)c3)c(F)cc12	InChI=1S/C27H19F4N5O/c28-23-12-22-16(3-6-34-25(22)32)9-19(23)13-36-26(37)17-4-5-33-21(11-17)8-15-1-2-24-18(7-15)10-20(14-35-24)27(29,30)31/h1-7,9-12,14H,8,13H2,(H2,32,34)(H,36,37)	PHBQHWAZPBJXLD-UHFFFAOYSA-N	283533	N-((1-amino-7-fluoroisoquinolin-6-yl)methyl)-2- ((3-(trifluoromethyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 182::US10308637, Example 182	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283533	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283533&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124183250	378164860							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540384	Cc1cc2c(N)nccc2cc1CNC(=O)c1ccnc(Cc2ccc3ncc(cc3c2)C(F)(F)F)c1	InChI=1S/C28H22F3N5O/c1-16-8-24-18(4-7-34-26(24)32)11-21(16)14-36-27(37)19-5-6-33-23(13-19)10-17-2-3-25-20(9-17)12-22(15-35-25)28(29,30)31/h2-9,11-13,15H,10,14H2,1H3,(H2,32,34)(H,36,37)	ANBJVFLQNRMXDF-UHFFFAOYSA-N	283534	N-((1-amino-7-methylisoquinolin-6-yl)methyl)- 2-((3-(trifluoromethyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 183::US10308637, Example 183	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283534	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283534&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182035	378164861							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540385	Cc1c(CNC(=O)c2ccnc(Cc3ccc4ncc(cc4c3)C(F)(F)F)c2)ccc2c(N)nccc12	InChI=1S/C28H22F3N5O/c1-16-19(3-4-24-23(16)7-9-34-26(24)32)14-36-27(37)18-6-8-33-22(13-18)11-17-2-5-25-20(10-17)12-21(15-35-25)28(29,30)31/h2-10,12-13,15H,11,14H2,1H3,(H2,32,34)(H,36,37)	ZNCHUSONBPLTLN-UHFFFAOYSA-N	283535	N-((1-amino-5-methylisoquinolion-6-yl)methyl)- 2-((3-(trifluoromethyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 184::US10308637, Example 184	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283535	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283535&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182981	378164862							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540386	FC(F)(F)c1ncc2ccc(CNC(=O)c3ccnc(Cc4ccc5ncc(Cl)cc5c4)c3)cn12	InChI=1S/C25H17ClF3N5O/c26-19-9-18-7-15(2-4-22(18)31-12-19)8-20-10-17(5-6-30-20)23(35)32-11-16-1-3-21-13-33-24(25(27,28)29)34(21)14-16/h1-7,9-10,12-14H,8,11H2,(H,32,35)	LNGDYVOAZUFPQF-UHFFFAOYSA-N	283536	2-((3-chloroquinolin-6-yl)methyl)-N-((3- (trifluoromethyl)imidazo[1,5-a]pyridin-6- yl)methyl)isonicotinamide::US10023557, Example 185::US10308637, Example 185	Plasma kallikrein			>10000					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283536	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283536&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124181937	378164863							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540387	Nc1nc(n2cc(CNC(=O)c3ccnc(Cc4ccc5ncc(Cl)cc5c4)c3)ccc12)C(F)(F)F	InChI=1S/C25H18ClF3N6O/c26-18-9-17-7-14(1-3-20(17)32-12-18)8-19-10-16(5-6-31-19)23(36)33-11-15-2-4-21-22(30)34-24(25(27,28)29)35(21)13-15/h1-7,9-10,12-13H,8,11,30H2,(H,33,36)	LHJQNHXTHBPWCV-UHFFFAOYSA-N	283537	N-((1-amino-3-(trifluoromethyl)imidazo[1,5- a]pyridin-6-yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 186::US10308637, Example 186	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283537	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283537&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124181933	378164864							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540388	Nc1ncc2cc(CNC(=O)c3ccnc(Cc4ccc5ncc(Cl)cc5c4)c3)ccn12	InChI=1S/C24H19ClN6O/c25-19-10-18-7-15(1-2-22(18)28-13-19)8-20-11-17(3-5-27-20)23(32)29-12-16-4-6-31-21(9-16)14-30-24(31)26/h1-7,9-11,13-14H,8,12H2,(H2,26,30)(H,29,32)	SRAMWKCEWIPKEV-UHFFFAOYSA-N	283538	N-((3-aminoimidazo[1,5-a]pyridin-7-yl)methyl)- 2-((3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 187::US10308637, Example 187	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283538	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283538&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665361	378164865							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540389	Cc1cc2cncn2cc1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C25H20ClN5O/c1-16-6-23-13-27-15-31(23)14-20(16)11-30-25(32)18-4-5-28-22(10-18)8-17-2-3-24-19(7-17)9-21(26)12-29-24/h2-7,9-10,12-15H,8,11H2,1H3,(H,30,32)	UUCUPCLUFRTRPJ-UHFFFAOYSA-N	283539	2-((3-chloroquinolin-6-yl)methyl)-N-((7- methylimidazo[1,5-a]pyridin-6- yl)methyl)isonicotinamide::US10023557, Example 188::US10308637, Example 188	Plasma kallikrein			>10000					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283539	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283539&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182984	378164866							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540390	Cc1c(CNC(=O)c2ccnc(Cc3ccc4ncc(Cl)cc4c3)c2)cnc2[nH]cc(Cl)c12	InChI=1S/C25H19Cl2N5O/c1-14-18(10-30-24-23(14)21(27)13-31-24)11-32-25(33)16-4-5-28-20(9-16)7-15-2-3-22-17(6-15)8-19(26)12-29-22/h2-6,8-10,12-13H,7,11H2,1H3,(H,30,31)(H,32,33)	BBDMTVSVTWJQRA-UHFFFAOYSA-N	283540	N-((3-chloro-4-methyl-1H-pyrrolo[2,3- b]pyridin-5-yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 189::US10308637, Example 189	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283540	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283540&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182537	378164867							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540391	Cc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C26H20Cl2N4O/c1-15-6-25-22(23(28)14-31-25)11-19(15)12-32-26(33)17-4-5-29-21(10-17)8-16-2-3-24-18(7-16)9-20(27)13-30-24/h2-7,9-11,13-14,31H,8,12H2,1H3,(H,32,33)	JBYRKKLGKRYYEB-UHFFFAOYSA-N	283541	N-((3-chloro-6-methyl-1H-indol-5-yl)methyl)-2- ((3-chloroquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 190::US10308637, Example 190	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283541	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283541&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182543	378164868							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540392	Cc1nc2[nH]cc(Cl)c2cc1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C25H19Cl2N5O/c1-14-18(10-21-22(27)13-30-24(21)32-14)11-31-25(33)16-4-5-28-20(9-16)7-15-2-3-23-17(6-15)8-19(26)12-29-23/h2-6,8-10,12-13H,7,11H2,1H3,(H,30,32)(H,31,33)	KTJINGFMFFVFCO-UHFFFAOYSA-N	283542	N-((3-chloro-6-methyl-1H-pyrrolo[2,3- b]pyridin-5-yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 191::US10308637, Example 191	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283542	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283542&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182560	378164869							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540393	Cc1nc2[nH]cc(Cl)c2c(C)c1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C26H21Cl2N5O/c1-14-21(15(2)33-25-24(14)22(28)13-31-25)12-32-26(34)17-5-6-29-20(10-17)8-16-3-4-23-18(7-16)9-19(27)11-30-23/h3-7,9-11,13H,8,12H2,1-2H3,(H,31,33)(H,32,34)	PMOGQHUXHONLRB-UHFFFAOYSA-N	283543	N-((3-chloro-4,5-dimethyl-1H-pyrrolo[2,3- b]pyridin-5-yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 192::US10308637, Example 192	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283543	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283543&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182568	378164870							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540394	CC(=O)Nc1cc(C)c(CNC(=O)c2ccnc(Cc3ccc4ncc(Cl)cc4c3)c2)c(C)n1	InChI=1S/C26H24ClN5O2/c1-15-8-25(32-17(3)33)31-16(2)23(15)14-30-26(34)19-6-7-28-22(12-19)10-18-4-5-24-20(9-18)11-21(27)13-29-24/h4-9,11-13H,10,14H2,1-3H3,(H,30,34)(H,31,32,33)	BEQCPIOVQMJEPZ-UHFFFAOYSA-N	283544	N-((6-acetamido-2,4-dimethylpyridin-3- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 193::US10308637, Example 193	Plasma kallikrein			 5500					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283544	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283544&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182092	378164871							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540395	Cc1cc(C)c(CNC(=O)c2ccnc(Cc3ccc4ncc(Cl)cc4c3)c2)c(C)n1	InChI=1S/C25H23ClN4O/c1-15-8-16(2)30-17(3)23(15)14-29-25(31)19-6-7-27-22(12-19)10-18-4-5-24-20(9-18)11-21(26)13-28-24/h4-9,11-13H,10,14H2,1-3H3,(H,29,31)	QLYAWHXDWLRBQZ-UHFFFAOYSA-N	283545	2-((3-chloroquinolin-6-yl)methyl)-N-((2,4,6- trimethylpyridin-3-yl)methyl)isonicotinamide::US10023557, Example 194::US10308637, Example 194	Plasma kallikrein			 5500					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283545	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283545&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124180699	378164872							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540396	Cc1nc2NCCCc2c(C)c1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C27H26ClN5O/c1-16-23-4-3-8-30-26(23)33-17(2)24(16)15-32-27(34)19-7-9-29-22(13-19)11-18-5-6-25-20(10-18)12-21(28)14-31-25/h5-7,9-10,12-14H,3-4,8,11,15H2,1-2H3,(H,30,33)(H,32,34)	RFVUWKWXYQQSGI-UHFFFAOYSA-N	283546	2-((3-chloroquinolin-6-yl)methyl)-N-((2,4- dimethyl-5,6,7,8-tetrahydro-1,8-naphthyridin-3- yl)methyl)isonicotinamide::US10023557, Example 195::US10308637, Example 195	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283546	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283546&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182091	378164873							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540397	Cc1cc(N)nc(C)c1CNC(=O)c1cc(Cc2ccc3ncc(Cl)cc3c2)nc(c1)-c1n[nH]c(=O)[nH]1	InChI=1S/C26H23ClN8O2/c1-13-5-23(28)31-14(2)20(13)12-30-25(36)17-9-19(32-22(10-17)24-33-26(37)35-34-24)7-15-3-4-21-16(6-15)8-18(27)11-29-21/h3-6,8-11H,7,12H2,1-2H3,(H2,28,31)(H,30,36)(H2,33,34,35,37)	VHVVKOARKJSETF-UHFFFAOYSA-N	283547	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloroquinolin-6-yl)methyl)-6-(5-oxo-4,5- dihydro-1H-1,2,4-triazol-3-yl)isonicotinamide::US10023557, Example 196::US10308637, Example 196	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283547	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283547&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			136215341	378164874							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540398	Cc1cc(cc(Cc2ccc3ncc(Cl)cc3c2)n1)C(=O)NCc1c(C)cc(N)nc1C	InChI=1S/C25H24ClN5O/c1-14-6-24(27)31-16(3)22(14)13-29-25(32)19-7-15(2)30-21(11-19)9-17-4-5-23-18(8-17)10-20(26)12-28-23/h4-8,10-12H,9,13H2,1-3H3,(H2,27,31)(H,29,32)	WDMJJASBQUYWJX-UHFFFAOYSA-N	283452	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloroquinolin-6-yl)methyl)-6- methylisonicotinamide::US10023557, Example 104::US10023557, Example 197::US10266515, Example 104::US10308637, Example 197::US11021463, Example 104::US9611252, Example 104	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283452	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283452&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665211	378164781							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540399	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cn2ncc3cc(Cl)ccc23)c1	InChI=1S/C22H21ClN6O/c1-13-7-21(24)28-14(2)19(13)11-26-22(30)15-5-6-25-18(9-15)12-29-20-4-3-17(23)8-16(20)10-27-29/h3-10H,11-12H2,1-2H3,(H2,24,28)(H,26,30)	VIIRLZCJMXLFHW-UHFFFAOYSA-N	283549	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((5-chloro-1H-indazol-1- yl)methyl)isonicotinamide::US10023557, Example 198::US10308637, Example 202::US11021463, Example 105::US9611252, Example 105	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283549	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283549&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665148	378164875							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540400	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cn2cc3cc(Cl)ccc3n2)c1	InChI=1S/C22H21ClN6O/c1-13-7-21(24)27-14(2)19(13)10-26-22(30)15-5-6-25-18(9-15)12-29-11-16-8-17(23)3-4-20(16)28-29/h3-9,11H,10,12H2,1-2H3,(H2,24,27)(H,26,30)	JJKKHULUCHMWFC-UHFFFAOYSA-N	283454	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((5-chloro-2H-indazol-2- yl)methyl)isonicotinamide::US10023557, Example 106::US10023557, Example 107::US10023557, Example 199::US10266515, Example 107::US10308637, Example 199::US11021463, Example 106::US9611252, Example 106	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283454	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283454&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665275	378164783							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540401	Cc1ccc2nn(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2c1	InChI=1S/C23H24N6O/c1-14-4-5-21-18(8-14)12-29(28-21)13-19-10-17(6-7-25-19)23(30)26-11-20-15(2)9-22(24)27-16(20)3/h4-10,12H,11,13H2,1-3H3,(H2,24,27)(H,26,30)	ZFEUOGPGKMODOZ-UHFFFAOYSA-N	283551	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((5-methyl-2H-indazol-2- yl)methyl)isonicotinamide::US10023557, Example 200::US10308637, Example 200::US11021463, Example 107::US9611252, Example 107	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283551	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283551&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665352	378164876							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540402	CC1=CC2C=NN(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)C2C=C1	InChI=1S/C23H26N6O/c1-14-4-5-21-18(8-14)11-27-29(21)13-19-10-17(6-7-25-19)23(30)26-12-20-15(2)9-22(24)28-16(20)3/h4-11,18,21H,12-13H2,1-3H3,(H2,24,28)(H,26,30)	MYDRSNUCNKLEQR-UHFFFAOYSA-N	283552	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((5-methyl-3a,7a-dihydro-1H-indazol-1- yl)methyl)isonicotinamide::US10023557, Example 201::US10308637, Example 201	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283552	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283552&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665255	378164877							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540403	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cn2ncc3cc(Cl)cnc23)c1	InChI=1S/C21H20ClN7O/c1-12-5-19(23)28-13(2)18(12)10-26-21(30)14-3-4-24-17(7-14)11-29-20-15(8-27-29)6-16(22)9-25-20/h3-9H,10-11H2,1-2H3,(H2,23,28)(H,26,30)	IQPUASRLQHZXNY-UHFFFAOYSA-N	283553	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((5-chloro-1H-pyrazolo[3,4-b]pyridin-1- yl)methyl)isonicotinamide::US10023557, Example 202	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283553	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283553&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182083	378164878							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540404	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cn2cc3cc(Cl)cnc3n2)c1	InChI=1S/C21H20ClN7O/c1-12-5-19(23)27-13(2)18(12)9-26-21(30)14-3-4-24-17(7-14)11-29-10-15-6-16(22)8-25-20(15)28-29/h3-8,10H,9,11H2,1-2H3,(H2,23,27)(H,26,30)	PXCMMEQZVRGOBR-UHFFFAOYSA-N	283554	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((5-chloro-2H-pyrazolo[3,4-b]pyridin-2- yl)methyl)isonicotinamide::US10023557, Example 203::US10308637, Example 203	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283554	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283554&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182547	378164879							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540405	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cnc3ncc(Cl)cc3c2)c1	InChI=1S/C23H21ClN6O/c1-13-5-21(25)30-14(2)20(13)12-29-23(31)16-3-4-26-19(9-16)7-15-6-17-8-18(24)11-28-22(17)27-10-15/h3-6,8-11H,7,12H2,1-2H3,(H2,25,30)(H,29,31)	ICJIUAHCHWDSAC-UHFFFAOYSA-N	283555	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((6-chloro-1,8-naphthyridin-3- yl)methyl)isonicotinamide::US10023557, Example 204::US10308637, Example 204	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283555	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283555&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124181948	378164880							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540406	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2cnc3ncc(Cl)cc3c2)c1	InChI=1S/C22H19ClN6O/c1-13-16(2-3-20(24)29-13)11-28-22(30)15-4-5-25-19(9-15)7-14-6-17-8-18(23)12-27-21(17)26-10-14/h2-6,8-10,12H,7,11H2,1H3,(H2,24,29)(H,28,30)	MFNSKEGLQYVDCO-UHFFFAOYSA-N	283556	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((6-chloro-1,8-naphthyridin-3- yl)methyl)isonicotinamide::US10023557, Example 205::US10308637, Example 205	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283556	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283556&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124183121	378164881							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540407	Clc1cnc2ccc(Cc3cc(ccn3)C(=O)NCc3ccc4ncc(Cl)cn34)cc2c1	InChI=1S/C24H17Cl2N5O/c25-18-9-17-7-15(1-3-22(17)28-11-18)8-20-10-16(5-6-27-20)24(32)30-13-21-2-4-23-29-12-19(26)14-31(21)23/h1-7,9-12,14H,8,13H2,(H,30,32)	SANNPVFFRUZMBW-UHFFFAOYSA-N	283557	N-((3-chloropyrrolo[1,2-a]pyrimidin-6- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 206::US10308637, Example 206	Plasma kallikrein			>10000					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283557	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283557&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665419	378164882							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540408	Cc1cc(N)nc(C)c1CNC(=O)c1cc(Cc2ccc3ncc(Cl)cc3c2)nc(c1)C#N	InChI=1S/C25H21ClN6O/c1-14-5-24(28)31-15(2)22(14)13-30-25(33)18-9-20(32-21(10-18)11-27)7-16-3-4-23-17(6-16)8-19(26)12-29-23/h3-6,8-10,12H,7,13H2,1-2H3,(H2,28,31)(H,30,33)	CWJVBELPNOXSMK-UHFFFAOYSA-N	283558	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloroquinolin-6-yl)methyl)-6- cyanoisonicotinamide::US10023557, Example 207::US10308637, Example 207	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283558	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283558&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124181913	378164883							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540409	Cc1cc(N)nc(C)c1CNC(=O)c1cc(Cc2ccc3ncc(Cl)cc3c2)nc(c1)C(N)=O	InChI=1S/C25H23ClN6O2/c1-13-5-23(27)31-14(2)20(13)12-30-25(34)17-9-19(32-22(10-17)24(28)33)7-15-3-4-21-16(6-15)8-18(26)11-29-21/h3-6,8-11H,7,12H2,1-2H3,(H2,27,31)(H2,28,33)(H,30,34)	APIQHIASTKZZSI-UHFFFAOYSA-N	283559	N4-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 6-((3-chloroquinolin-6-yl)methyl)pyridine-2,4- dicarboxamide::US10023557, Example 208::US10023557, Example 209::US10308637, Example 208	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283559	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283559&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182675	378164884							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540410	Cc1cc(N)nc(C)c1CNC(=O)c1cc(Cc2ccc3ncc(Cl)cc3c2)nc(c1)C(N)=O	InChI=1S/C25H23ClN6O2/c1-13-5-23(27)31-14(2)20(13)12-30-25(34)17-9-19(32-22(10-17)24(28)33)7-15-3-4-21-16(6-15)8-18(26)11-29-21/h3-6,8-11H,7,12H2,1-2H3,(H2,27,31)(H2,28,33)(H,30,34)	APIQHIASTKZZSI-UHFFFAOYSA-N	283559	N4-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 6-((3-chloroquinolin-6-yl)methyl)pyridine-2,4- dicarboxamide::US10023557, Example 208::US10023557, Example 209::US10308637, Example 208	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283559	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283559&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182675	378164884							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540411	Cc1cc(N)nc(C)c1CNC(=O)c1cc(Cc2ccc3ncc(Cl)cc3c2)nc(c1)C(C)(C)O	InChI=1S/C27H28ClN5O2/c1-15-7-25(29)32-16(2)22(15)14-31-26(34)19-11-21(33-24(12-19)27(3,4)35)9-17-5-6-23-18(8-17)10-20(28)13-30-23/h5-8,10-13,35H,9,14H2,1-4H3,(H2,29,32)(H,31,34)	KLVVQHRXXMNNPG-UHFFFAOYSA-N	283561	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloroquinolin-6-yl)methyl)-6-(2- hydroxypropan-2-yl)isonicotinamide::US10023557, Example 210::US10308637, Example 210	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283561	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283561&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182880	378164885							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540412	Cc1cc(N)nc(C)c1CNC(=O)c1cc(CN)nc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C25H25ClN6O/c1-14-5-24(28)31-15(2)22(14)13-30-25(33)18-9-20(32-21(10-18)11-27)7-16-3-4-23-17(6-16)8-19(26)12-29-23/h3-6,8-10,12H,7,11,13,27H2,1-2H3,(H2,28,31)(H,30,33)	WKUNOXOFANOVRL-UHFFFAOYSA-N	283562	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-(aminomethyl)-6-((3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 211::US10308637, Example 211	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283562	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283562&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124181929	378164886							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540413	Cc1cc(N)nc(C)c1CNC(=O)c1cc(CO)nc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C25H24ClN5O2/c1-14-5-24(27)30-15(2)22(14)12-29-25(33)18-9-20(31-21(10-18)13-32)7-16-3-4-23-17(6-16)8-19(26)11-28-23/h3-6,8-11,32H,7,12-13H2,1-2H3,(H2,27,30)(H,29,33)	CQRHLRRXAVLMJK-UHFFFAOYSA-N	283563	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloroquinolin-6-yl)methyl)-6- (hydroxymethyl)isonicotinamide::US10023557, Example 212::US10308637, Example 212	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283563	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283563&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124181946	378164887							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540414	Cc1cc(N)nc(C)c1CNC(=O)c1cc(CC#N)nc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C26H23ClN6O/c1-15-7-25(29)32-16(2)23(15)14-31-26(34)19-11-21(5-6-28)33-22(12-19)9-17-3-4-24-18(8-17)10-20(27)13-30-24/h3-4,7-8,10-13H,5,9,14H2,1-2H3,(H2,29,32)(H,31,34)	SGTIEOYDXRUOPQ-UHFFFAOYSA-N	283564	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloroquinolin-6-yl)methyl)-6- (cyanomethyl)isonicotinamide::US10023557, Example 213::US10308637, Example 213	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283564	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283564&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182548	378164888							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540415	Cc1cc(N)nc(C)c1CNC(=O)c1cc(CC(N)=O)nc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C26H25ClN6O2/c1-14-5-24(28)32-15(2)22(14)13-31-26(35)18-9-20(33-21(10-18)11-25(29)34)7-16-3-4-23-17(6-16)8-19(27)12-30-23/h3-6,8-10,12H,7,11,13H2,1-2H3,(H2,28,32)(H2,29,34)(H,31,35)	YAEFFBRTLWFBFV-UHFFFAOYSA-N	283565	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-(2-amino-2-oxoethyl)-6-((3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 214::US10308637, Example 214	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283565	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283565&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124181950	378164889							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540416	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc3cc(cnc3[nH]2)C(F)(F)F)c1	InChI=1S/C23H21F3N6O/c1-12-5-20(27)31-13(2)19(12)11-30-22(33)14-3-4-28-17(7-14)9-18-8-15-6-16(23(24,25)26)10-29-21(15)32-18/h3-8,10H,9,11H2,1-2H3,(H2,27,31)(H,29,32)(H,30,33)	SQKIYYNBNGHZOF-UHFFFAOYSA-N	283566	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((5-(trifluoromethyl)-1H-pyrrolo[2,3- b]pyridin-2-yl)methyl)isonicotinamide::US10023557, Example 215::US10308637, Example 215	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283566	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283566&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182012	378164890							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540417	Cc1nc(N)ccc1CNC(=O)c1cc(Cc2cnc3ncc(Cl)cc3c2)ncc1C#N	InChI=1S/C23H18ClN7O/c1-13-15(2-3-21(26)31-13)10-30-23(32)20-7-19(27-11-17(20)8-25)5-14-4-16-6-18(24)12-29-22(16)28-9-14/h2-4,6-7,9,11-12H,5,10H2,1H3,(H2,26,31)(H,30,32)	YJWAUBCYDYZIIG-UHFFFAOYSA-N	283567	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((6-chloro-1,8-naphthyridin-3-yl)methyl)-5- cyanoisonicotinamide::US10023557, Example 216::US10308637, Example 216	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283567	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283567&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182327	378164891							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540418	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc(N)c3ncc(Cl)cc3c2)c1	InChI=1S/C24H23ClN6O/c1-13-5-22(27)31-14(2)20(13)12-30-24(32)16-3-4-28-19(10-16)7-15-6-17-9-18(25)11-29-23(17)21(26)8-15/h3-6,8-11H,7,12,26H2,1-2H3,(H2,27,31)(H,30,32)	FCNWVPLZOZKABE-UHFFFAOYSA-N	283568	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((8-amino-3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 217::US10308637, Example 217	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283568	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283568&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182033	378164892							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540419	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2cc(N)c3ncc(Cl)cc3c2)c1	InChI=1S/C23H21ClN6O/c1-13-16(2-3-21(26)30-13)11-29-23(31)15-4-5-27-19(10-15)7-14-6-17-9-18(24)12-28-22(17)20(25)8-14/h2-6,8-10,12H,7,11,25H2,1H3,(H2,26,30)(H,29,31)	NONJMWYIKSDSMU-UHFFFAOYSA-N	283569	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((8-amino-3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 218::US10308637, Example 218	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283569	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283569&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124183342	378164893							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540420	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc(c3ncc(Cl)cc3c2)C(C)(C)O)c1	InChI=1S/C27H28ClN5O2/c1-15-7-24(29)33-16(2)22(15)14-32-26(34)18-5-6-30-21(12-18)9-17-8-19-11-20(28)13-31-25(19)23(10-17)27(3,4)35/h5-8,10-13,35H,9,14H2,1-4H3,(H2,29,33)(H,32,34)	CAMCXNZEUNOLQS-UHFFFAOYSA-N	283570	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloro-8-(2-hydroxypropan-2-yl)quinolin- 6-yl)methyl)isonicotinamide::US10023557, Example 219::US10308637, Example 219	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283570	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283570&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126501514	378164894							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540421	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2cc(c3ncc(Cl)cc3c2)C(C)(C)O)c1	InChI=1S/C26H26ClN5O2/c1-15-18(4-5-23(28)32-15)13-31-25(33)17-6-7-29-21(12-17)9-16-8-19-11-20(27)14-30-24(19)22(10-16)26(2,3)34/h4-8,10-12,14,34H,9,13H2,1-3H3,(H2,28,32)(H,31,33)	UKAZGEKVALJKKV-UHFFFAOYSA-N	283571	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-chloro-8-(2-hydroxypropan-2-yl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 220::US10308637, Example 220	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283571	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283571&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126501515	378164895							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540422	CC(C)(O)c1cc(Cc2cc(ccn2)C(=O)NCc2cc3c(Cl)c[nH]c3cc2F)cc2cc(Cl)cnc12	InChI=1S/C28H23Cl2FN4O2/c1-28(2,37)22-7-15(5-17-8-19(29)13-34-26(17)22)6-20-9-16(3-4-32-20)27(36)35-12-18-10-21-23(30)14-33-25(21)11-24(18)31/h3-5,7-11,13-14,33,37H,6,12H2,1-2H3,(H,35,36)	JTSSXAIYEHJPRT-UHFFFAOYSA-N	283572	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3-chloro-8-(2-hydroxypropan-2-yl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 221::US10308637, Example 221	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283572	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283572&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124183146	378164896							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540423	CC(C)(O)c1cc(Cc2cc(ccn2)C(=O)NCc2ccc3[nH]cc(Cl)c3c2F)cc2cc(Cl)cnc12	InChI=1S/C28H23Cl2FN4O2/c1-28(2,37)21-9-15(7-18-10-19(29)13-34-26(18)21)8-20-11-16(5-6-32-20)27(36)35-12-17-3-4-23-24(25(17)31)22(30)14-33-23/h3-7,9-11,13-14,33,37H,8,12H2,1-2H3,(H,35,36)	GMCQLRANWRPJLS-UHFFFAOYSA-N	283573	N-((3-chloro-4-fluoro-1H-indol-5-yl)methyl)-2- ((3-chloro-8-(2-hydroxypropan-2-yl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 222::US10308637, Example 222	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283573	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283573&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182922	378164897							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540424	CC(C)(O)c1cc(Cc2cc(ccn2)C(=O)NCc2cnc3[nH]cc(Cl)c3c2)cc2cc(Cl)cnc12	InChI=1S/C27H23Cl2N5O2/c1-27(2,36)22-8-15(5-18-9-19(28)13-31-24(18)22)6-20-10-17(3-4-30-20)26(35)34-12-16-7-21-23(29)14-33-25(21)32-11-16/h3-5,7-11,13-14,36H,6,12H2,1-2H3,(H,32,33)(H,34,35)	QMKHQGBBIIJGJC-UHFFFAOYSA-N	283575	N-((3-chloro-1H-pyrrolo[2,3-b]pyridin-5- yl)methyl)-2-((3-chloro-8-(2-hydroxypropan-2- yl)quinolin-6-yl)methyl)isonicotinamide::US10023557, Example 223::US10308637, Example 223	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283575	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283575&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182300	378164899							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540425	CC(C)(O)c1cc(Cc2cc(ccn2)C(=O)NCc2ccc3c(N)nccc3c2)cc2cc(Cl)cnc12	InChI=1S/C29H26ClN5O2/c1-29(2,37)25-12-18(10-21-13-22(30)16-34-26(21)25)11-23-14-20(6-7-32-23)28(36)35-15-17-3-4-24-19(9-17)5-8-33-27(24)31/h3-10,12-14,16,37H,11,15H2,1-2H3,(H2,31,33)(H,35,36)	APJPLXDNIOYUIA-UHFFFAOYSA-N	283576	N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- chloro-8-(2-hydroxypropan-2-yl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 224::US10308637, Example 224	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283576	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283576&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182897	378164900							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540426	CC(C)(O)c1cc(Cc2cc(ccn2)C(=O)NCc2n[nH]c3ccc(Cl)cc23)cc2cc(Cl)cnc12	InChI=1S/C27H23Cl2N5O2/c1-27(2,36)22-9-15(7-17-10-19(29)13-31-25(17)22)8-20-11-16(5-6-30-20)26(35)32-14-24-21-12-18(28)3-4-23(21)33-34-24/h3-7,9-13,36H,8,14H2,1-2H3,(H,32,35)(H,33,34)	FUJKDPLSFYNFOM-UHFFFAOYSA-N	283577	N-((5-chloro-1H-indazol-3-yl)methyl)-2-((3- chloro-8-(2-hydroxypropan-2-yl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 225::US10308637, Example 225	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283577	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283577&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124183147	378164901							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540427	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cnc3cc(F)c(Cl)cc3c2)c1	InChI=1S/C24H21ClFN5O/c1-13-5-23(27)31-14(2)19(13)12-30-24(32)16-3-4-28-18(8-16)7-15-6-17-9-20(25)21(26)10-22(17)29-11-15/h3-6,8-11H,7,12H2,1-2H3,(H2,27,31)(H,30,32)	DEFUWZJDNKPRKM-UHFFFAOYSA-N	283578	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((6-chloro-7-fluoroquinolin-3- yl)methyl)isonicotinamide::US10023557, Example 226::US10308637, Example 226	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283578	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283578&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182977	378164902							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540428	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2cnc3cc(F)c(Cl)cc3c2)c1	InChI=1S/C23H19ClFN5O/c1-13-16(2-3-22(26)30-13)12-29-23(31)15-4-5-27-18(8-15)7-14-6-17-9-19(24)20(25)10-21(17)28-11-14/h2-6,8-11H,7,12H2,1H3,(H2,26,30)(H,29,31)	RRLGVZCTFFZKPM-UHFFFAOYSA-N	283579	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((6-chloro-7-fluoroquinolin-3- yl)methyl)isonicotinamide::US10023557, Example 227::US10308637, Example 227	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283579	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283579&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124183141	378164903							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540429	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3ncc(cc3c2)C(F)(F)F)c1	InChI=1S/C25H22F3N5O/c1-14-7-23(29)33-15(2)21(14)13-32-24(34)17-5-6-30-20(11-17)9-16-3-4-22-18(8-16)10-19(12-31-22)25(26,27)28/h3-8,10-12H,9,13H2,1-2H3,(H2,29,33)(H,32,34)	OLFRKEDSESBYHU-UHFFFAOYSA-N	283580	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-(trifluoromethyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 228::US10308637, Example 228	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283580	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283580&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182807	378164904							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540430	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2ccc3ncc(cc3c2)C(F)(F)F)c1	InChI=1S/C24H20F3N5O/c1-14-17(3-5-22(28)32-14)12-31-23(33)16-6-7-29-20(11-16)9-15-2-4-21-18(8-15)10-19(13-30-21)24(25,26)27/h2-8,10-11,13H,9,12H2,1H3,(H2,28,32)(H,31,33)	ZQDRGIMYWHFSSC-UHFFFAOYSA-N	283581	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-(trifluoromethyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 229::US10308637, Example 229	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283581	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283581&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182888	378164905							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540431	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1ccnc(Cc2ccc3ncc(cc3c2)C(F)(F)F)c1	InChI=1S/C26H17ClF4N4O/c27-21-13-34-24-10-22(28)17(9-20(21)24)11-35-25(36)15-3-4-32-19(8-15)6-14-1-2-23-16(5-14)7-18(12-33-23)26(29,30)31/h1-5,7-10,12-13,34H,6,11H2,(H,35,36)	PKOZQSHURKITNU-UHFFFAOYSA-N	283582	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3-(trifluoromethyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 230	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283582	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283582&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124181944	378164906							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540432	FC(F)(F)c1cnc2ccc(Cc3cc(ccn3)C(=O)NCc3cnc4[nH]cc(Cl)c4c3)cc2c1	InChI=1S/C25H17ClF3N5O/c26-21-13-33-23-20(21)7-15(10-32-23)11-34-24(35)16-3-4-30-19(9-16)6-14-1-2-22-17(5-14)8-18(12-31-22)25(27,28)29/h1-5,7-10,12-13H,6,11H2,(H,32,33)(H,34,35)	AYANUSJKTXGYKD-UHFFFAOYSA-N	283583	N-((3-chloro-1H-pyrrolo[2,3-b]pyridin-5- yl)methyl)-2-((3-(trifluoromethyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 231::US10308637, Example 231	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283583	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283583&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124183181	378164907							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540433	Nc1nccc2cc(CNC(=O)c3ccnc(Cc4ccc5ncc(cc5c4)C(F)(F)F)c3)ccc12	InChI=1S/C27H20F3N5O/c28-27(29,30)21-12-20-9-16(2-4-24(20)34-15-21)11-22-13-19(6-7-32-22)26(36)35-14-17-1-3-23-18(10-17)5-8-33-25(23)31/h1-10,12-13,15H,11,14H2,(H2,31,33)(H,35,36)	AIYRZHRTMKXNDG-UHFFFAOYSA-N	283584	N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- (trifluoromethyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 232::US10308637, Example 232	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283584	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283584&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124183347	378164908							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540434	FC(F)(F)c1cnc2ccc(Cc3cc(ccn3)C(=O)NCc3n[nH]c4ccc(Cl)cc34)cc2c1	InChI=1S/C25H17ClF3N5O/c26-18-2-4-22-20(11-18)23(34-33-22)13-32-24(35)15-5-6-30-19(10-15)8-14-1-3-21-16(7-14)9-17(12-31-21)25(27,28)29/h1-7,9-12H,8,13H2,(H,32,35)(H,33,34)	FDMWBXWQINTDQC-UHFFFAOYSA-N	283585	N-((5-chloro-1H-indazol-3-yl)methyl)-2-((3- (trifluoromethyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 233::US10308637, Example 233	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283585	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283585&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182086	378164909							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540435	Fc1c(CNC(=O)c2ccnc(Cc3ccc4ncc(cc4c3)C(F)(F)F)c2)ccc2[nH]cc(Cl)c12	InChI=1S/C26H17ClF4N4O/c27-20-13-34-22-4-2-16(24(28)23(20)22)11-35-25(36)15-5-6-32-19(10-15)8-14-1-3-21-17(7-14)9-18(12-33-21)26(29,30)31/h1-7,9-10,12-13,34H,8,11H2,(H,35,36)	KBISFNIKCMKXCJ-UHFFFAOYSA-N	283586	N-((3-chloro-4-fluoro-1H-indol-5-yl)methyl)-2- ((3-(trifluoromethyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 234::US10308637, Example 234	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283586	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283586&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182878	378164910							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540436	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc(c3ncc(Cl)cc3c2)S(N)(=O)=O)c1	InChI=1S/C24H23ClN6O3S/c1-13-5-22(26)31-14(2)20(13)12-30-24(32)16-3-4-28-19(10-16)7-15-6-17-9-18(25)11-29-23(17)21(8-15)35(27,33)34/h3-6,8-11H,7,12H2,1-2H3,(H2,26,31)(H,30,32)(H2,27,33,34)	DKVANJKAPZQNAC-UHFFFAOYSA-N	283587	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloro-8-sulfamoylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 235::US10308637, Example 235	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283587	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283587&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182942	378164911							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540437	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2cc(c3ncc(Cl)cc3c2)S(N)(=O)=O)c1	InChI=1S/C23H21ClN6O3S/c1-13-16(2-3-21(25)30-13)11-29-23(31)15-4-5-27-19(10-15)7-14-6-17-9-18(24)12-28-22(17)20(8-14)34(26,32)33/h2-6,8-10,12H,7,11H2,1H3,(H2,25,30)(H,29,31)(H2,26,32,33)	YSBHUSXJGVVFNU-UHFFFAOYSA-N	283588	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-chloro-8-sulfamoylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 236::US10308637, Example 236	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283588	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283588&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126501516	378164912							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540438	CC(NC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1)c1ccc(N)nc1C	InChI=1S/C24H22ClN5O/c1-14-21(4-6-23(26)29-14)15(2)30-24(31)17-7-8-27-20(12-17)10-16-3-5-22-18(9-16)11-19(25)13-28-22/h3-9,11-13,15H,10H2,1-2H3,(H2,26,29)(H,30,31)	AZRDPBCNEVKBOW-UHFFFAOYSA-N	283589	N-(1-(6-amino-2-methylpyridin-3-yl)ethyl)-2- ((3-chloroquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 237::US10308637, Example 237	Plasma kallikrein			 5500					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283589	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283589&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182041	378164913							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540439	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3nc(C)c(Cl)cc3c2)c1	InChI=1S/C25H24ClN5O/c1-14-8-24(27)31-15(2)21(14)13-29-25(32)18-6-7-28-20(11-18)10-17-4-5-23-19(9-17)12-22(26)16(3)30-23/h4-9,11-12H,10,13H2,1-3H3,(H2,27,31)(H,29,32)	UWJAEYUDDOAGRL-UHFFFAOYSA-N	283590	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloro-2-methylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 238::US10308637, Example 238	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283590	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283590&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124183085	378164914							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540440	Cc1nc2ccc(Cc3cc(ccn3)C(=O)NCc3ccc(N)nc3C)cc2cc1Cl	InChI=1S/C24H22ClN5O/c1-14-18(4-6-23(26)30-14)13-28-24(31)17-7-8-27-20(11-17)10-16-3-5-22-19(9-16)12-21(25)15(2)29-22/h3-9,11-12H,10,13H2,1-2H3,(H2,26,30)(H,28,31)	AOYDVEJZPAPXAG-UHFFFAOYSA-N	283591	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-chloro-2-methylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 239::US10308637, Example 239	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283591	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283591&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124183192	378164915							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540441	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cccc(c2)-c2noc(=O)[nH]2)c1	InChI=1S/C23H22N6O3/c1-13-8-20(24)27-14(2)19(13)12-26-22(30)17-6-7-25-18(11-17)10-15-4-3-5-16(9-15)21-28-23(31)32-29-21/h3-9,11H,10,12H2,1-2H3,(H2,24,27)(H,26,30)(H,28,29,31)	QAAODUINVOHEBT-UHFFFAOYSA-N	283592	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-(3-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3- yl)benzyl)isonicotinamide::US10023557, Example 240::US10308637, Example 240	Plasma kallikrein			>10000					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283592	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283592&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			136215342	378164916							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540442	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc(CN)c3ncc(Cl)cc3c2)c1	InChI=1S/C25H25ClN6O/c1-14-5-23(28)32-15(2)22(14)13-31-25(33)17-3-4-29-21(10-17)8-16-6-18-9-20(26)12-30-24(18)19(7-16)11-27/h3-7,9-10,12H,8,11,13,27H2,1-2H3,(H2,28,32)(H,31,33)	RLEZQIDVARIXNS-UHFFFAOYSA-N	283593	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((8-(aminomethyl)-3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 241::US10308637, Example 241	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283593	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283593&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182089	378164917							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540443	COCCNc1ccc(CNC(=O)c2ccnc(Cc3ccc4ncc(Cl)cc4c3)c2)c(C)n1	InChI=1S/C26H26ClN5O2/c1-17-20(4-6-25(32-17)29-9-10-34-2)15-31-26(33)19-7-8-28-23(14-19)12-18-3-5-24-21(11-18)13-22(27)16-30-24/h3-8,11,13-14,16H,9-10,12,15H2,1-2H3,(H,29,32)(H,31,33)	MWUGCRIZPOMKMV-UHFFFAOYSA-N	283594	2-((3-chloroquinolin-6-yl)methyl)-N-((6-((2- methoxyethyl)amino)-2-methylpyridin-3- yl)methyl)isonicotinamide::US10023557, Example 242::US10308637, Example 242	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283594	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283594&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182006	378164918							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540444	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3ncc(cc3c2)C2CC2)c1	InChI=1S/C27H27N5O/c1-16-9-26(28)32-17(2)24(16)15-31-27(33)20-7-8-29-23(13-20)11-18-3-6-25-21(10-18)12-22(14-30-25)19-4-5-19/h3,6-10,12-14,19H,4-5,11,15H2,1-2H3,(H2,28,32)(H,31,33)	NXXNLEZZBXYGEX-UHFFFAOYSA-N	283595	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-cyclopropylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 243::US10308637, Example 243	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283595	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283595&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182364	378164919							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540445	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2ccc3ncc(cc3c2)C2CC2)c1	InChI=1S/C26H25N5O/c1-16-20(5-7-25(27)31-16)14-30-26(32)19-8-9-28-23(13-19)11-17-2-6-24-21(10-17)12-22(15-29-24)18-3-4-18/h2,5-10,12-13,15,18H,3-4,11,14H2,1H3,(H2,27,31)(H,30,32)	CESBXMOBCLQDDB-UHFFFAOYSA-N	283596	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-cyclopropylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 244::US10308637, Example 244	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283596	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283596&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182987	378164920							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540446	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1ccnc(Cc2ccc3ncc(cc3c2)C2CC2)c1	InChI=1S/C28H22ClFN4O/c29-24-15-33-27-12-25(30)21(11-23(24)27)14-34-28(35)18-5-6-31-22(10-18)8-16-1-4-26-19(7-16)9-20(13-32-26)17-2-3-17/h1,4-7,9-13,15,17,33H,2-3,8,14H2,(H,34,35)	PUSXIKSJCXOULP-UHFFFAOYSA-N	283597	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3-cyclopropylquinolin-6- yl)methyl0isonicotinamide::US10023557, Example 245::US10308637, Example 245	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283597	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283597&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124183090	378164921							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540447	Clc1c[nH]c2ncc(CNC(=O)c3ccnc(Cc4ccc5ncc(cc5c4)C4CC4)c3)cc12	InChI=1S/C27H22ClN5O/c28-24-15-32-26-23(24)9-17(12-31-26)13-33-27(34)19-5-6-29-22(11-19)8-16-1-4-25-20(7-16)10-21(14-30-25)18-2-3-18/h1,4-7,9-12,14-15,18H,2-3,8,13H2,(H,31,32)(H,33,34)	YRCSUWUDJJGADC-UHFFFAOYSA-N	283598	N-((3-chloro-1H-pyrrolo[2,3-b]pyridin-5- yl)methyl)-2-((3-cyclopropylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 246::US10308637, Example 246	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283598	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283598&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182143	378164922							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540448	Nc1nccc2cc(CNC(=O)c3ccnc(Cc4ccc5ncc(cc5c4)C4CC4)c3)ccc12	InChI=1S/C29H25N5O/c30-28-26-5-1-19(12-21(26)7-10-32-28)16-34-29(35)22-8-9-31-25(15-22)13-18-2-6-27-23(11-18)14-24(17-33-27)20-3-4-20/h1-2,5-12,14-15,17,20H,3-4,13,16H2,(H2,30,32)(H,34,35)	YXSSRVFBEYEKCJ-UHFFFAOYSA-N	283599	N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- cyclopropylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 247::US10308637, Example 247	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283599	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283599&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124183189	378164923							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540449	Fc1c(CNC(=O)c2ccnc(Cc3ccc4ncc(cc4c3)C3CC3)c2)ccc2[nH]cc(Cl)c12	InChI=1S/C28H22ClFN4O/c29-23-15-33-25-6-4-19(27(30)26(23)25)13-34-28(35)18-7-8-31-22(12-18)10-16-1-5-24-20(9-16)11-21(14-32-24)17-2-3-17/h1,4-9,11-12,14-15,17,33H,2-3,10,13H2,(H,34,35)	YEYBDCGTPYLKNH-UHFFFAOYSA-N	283600	N-((3-chloro-4-fluoro-1H-indol-5-yl)methyl)-2- ((3-cyclopropylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 248::US10308637, Example 248	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283600	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283600&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124183345	378164924							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540450	Clc1ccc2[nH]nc(CNC(=O)c3ccnc(Cc4ccc5ncc(cc5c4)C4CC4)c3)c2c1	InChI=1S/C27H22ClN5O/c28-21-4-6-25-23(13-21)26(33-32-25)15-31-27(34)18-7-8-29-22(12-18)10-16-1-5-24-19(9-16)11-20(14-30-24)17-2-3-17/h1,4-9,11-14,17H,2-3,10,15H2,(H,31,34)(H,32,33)	OWGSABVRUIXNJH-UHFFFAOYSA-N	283601	N-((5-chloro-1H-indazol-3-yl)methyl)-2-((3- cyclopropylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 249::US10308637, Example 249	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283601	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283601&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124183251	378164925							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540451	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3ncc(cc3c2)C(N)=O)c1	InChI=1S/C25H24N6O2/c1-14-7-23(26)31-15(2)21(14)13-30-25(33)17-5-6-28-20(11-17)9-16-3-4-22-18(8-16)10-19(12-29-22)24(27)32/h3-8,10-12H,9,13H2,1-2H3,(H2,26,31)(H2,27,32)(H,30,33)	ZZGXBFJZLKCYOO-UHFFFAOYSA-N	283602	6-((4-(((6-amino-2,4-dimethylpyridin-3- yl)methyl)carbamoyl)pyridin-2- yl)methyl)quinoline-3-carboxamide::US10023557, Example 250::US10308637, Example 250	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283602	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283602&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182381	378164926							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540452	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2ccc3ncc(cc3c2)C(N)=O)c1	InChI=1S/C24H22N6O2/c1-14-17(3-5-22(25)30-14)12-29-24(32)16-6-7-27-20(11-16)9-15-2-4-21-18(8-15)10-19(13-28-21)23(26)31/h2-8,10-11,13H,9,12H2,1H3,(H2,25,30)(H2,26,31)(H,29,32)	YHIGAVXEINDXPQ-UHFFFAOYSA-N	283603	6-((4-(((6-amino-2-methylpyridin-3- yl)methyl)carbamoyl)pyridin-2- yl)methyl)quinoline-3-carboxamide::US10023557, Example 251::US10308637, Example 251	Plasma kallikrein			 5500					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283603	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283603&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182166	378164927							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540453	Cc1nc(NCCO)ccc1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C25H24ClN5O2/c1-16-19(3-5-24(31-16)28-8-9-32)14-30-25(33)18-6-7-27-22(13-18)11-17-2-4-23-20(10-17)12-21(26)15-29-23/h2-7,10,12-13,15,32H,8-9,11,14H2,1H3,(H,28,31)(H,30,33)	ZIXOZJCGJNQMKX-UHFFFAOYSA-N	283604	2-((3-chloroquinolin-6-yl)methyl)-N-((6-((2- hydroxyethyl)amino)-2-methylpyridin-3- yl)methyl)isonicotinamide::US10023557, Example 252::US10308637, Example 252	Plasma kallikrein			>10000					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283604	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283604&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182160	378164928							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540454	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2cc(CN)c3ncc(Cl)cc3c2)c1	InChI=1S/C24H23ClN6O/c1-14-17(2-3-22(27)31-14)12-30-24(32)16-4-5-28-21(10-16)8-15-6-18-9-20(25)13-29-23(18)19(7-15)11-26/h2-7,9-10,13H,8,11-12,26H2,1H3,(H2,27,31)(H,30,32)	YVCBPKMPIZSYJL-UHFFFAOYSA-N	283606	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((8-(aminomethyl)-3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 253::US10308637, Example 253	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283606	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283606&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182139	378164930							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540455	CC(C)c1cnc2ccc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2c1	InChI=1S/C27H29N5O/c1-16(2)22-12-21-10-19(5-6-25(21)30-14-22)11-23-13-20(7-8-29-23)27(33)31-15-24-17(3)9-26(28)32-18(24)4/h5-10,12-14,16H,11,15H2,1-4H3,(H2,28,32)(H,31,33)	DIJRRFWNCLHEIN-UHFFFAOYSA-N	283607	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-isopropylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 254::US10308637, Example 254	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283607	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283607&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182291	378164931							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540456	CCCc1cnc2ccc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2c1	InChI=1S/C27H29N5O/c1-4-5-20-12-22-11-19(6-7-25(22)30-15-20)13-23-14-21(8-9-29-23)27(33)31-16-24-17(2)10-26(28)32-18(24)3/h6-12,14-15H,4-5,13,16H2,1-3H3,(H2,28,32)(H,31,33)	YBKWLMQUKCOEFW-UHFFFAOYSA-N	283608	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-propylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 255::US10308637, Example 255	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283608	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283608&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182380	378164932							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540457	Clc1cnc2ccc(Cc3cc(ccn3)C(=O)NCc3cnc4ncc(Cl)cn34)cc2c1	InChI=1S/C23H16Cl2N6O/c24-17-7-16-5-14(1-2-21(16)27-9-17)6-19-8-15(3-4-26-19)22(32)28-11-20-12-30-23-29-10-18(25)13-31(20)23/h1-5,7-10,12-13H,6,11H2,(H,28,32)	XQDDXYPQKRKBDF-UHFFFAOYSA-N	283609	N-((6-chloroimidazo[1,2-a]pyrimidin-3- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 256::US10308637, Example 256	Plasma kallikrein			>10000					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283609	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283609&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665343	378164933							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540458	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3ncc(CO)cc3c2)c1	InChI=1S/C25H25N5O2/c1-15-7-24(26)30-16(2)22(15)13-29-25(32)19-5-6-27-21(11-19)10-17-3-4-23-20(8-17)9-18(14-31)12-28-23/h3-9,11-12,31H,10,13-14H2,1-2H3,(H2,26,30)(H,29,32)	IMMXSQNITSNKGB-UHFFFAOYSA-N	283610	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-(hydroxymethyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 257::US10308637, Example 257	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283610	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283610&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124183145	378164934							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540459	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2ccc3ncc(CO)cc3c2)c1	InChI=1S/C24H23N5O2/c1-15-19(3-5-23(25)29-15)13-28-24(31)18-6-7-26-21(11-18)10-16-2-4-22-20(8-16)9-17(14-30)12-27-22/h2-9,11-12,30H,10,13-14H2,1H3,(H2,25,29)(H,28,31)	PPLCHDXBJPYXNY-UHFFFAOYSA-N	283611	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-(hydroxymethyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 258::US10308637, Example 258	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283611	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283611&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182250	378164935							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540460	Fc1cc2[nH]ccc2cc1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C25H18ClFN4O/c26-20-10-18-7-15(1-2-23(18)30-14-20)8-21-11-17(4-5-28-21)25(32)31-13-19-9-16-3-6-29-24(16)12-22(19)27/h1-7,9-12,14,29H,8,13H2,(H,31,32)	SVAFKWRLBOEKGD-UHFFFAOYSA-N	283389	2-((3-chloroquinolin-6-yl)methyl)-N-((6-fluoro- 1H-indol-5-yl)methyl)isonicotinamide::US10023557, Example 259::US10023557, Example 41::US10266515, Example 41::US10308637, Example 41::US11021463, Example 41::US9611252, Example 41	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283389	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283389&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665368	378164718							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540461	Fc1cc2[nH]ncc2cc1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C24H17ClFN5O/c25-19-8-16-5-14(1-2-22(16)28-13-19)6-20-9-15(3-4-27-20)24(32)29-11-17-7-18-12-30-31-23(18)10-21(17)26/h1-5,7-10,12-13H,6,11H2,(H,29,32)(H,30,31)	AUINKNGACHEZIV-UHFFFAOYSA-N	283380	2-((3-chloroquinolin-6-yl)methyl)-N-((6-fluoro- 1H-indazol-5-yl)methyl)isonicotinamide::US10023557, Example 260::US10023557, Example 32::US10266515, Example 32::US10308637, Example 32::US11021463, Example 32::US9611252, Example 32	Plasma kallikrein			 5500					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283380	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283380&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665325	378164709							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540462	Cc1n[nH]c2ccc(CNC(=O)c3ccnc(Cc4ccc5ncc(Cl)cc5c4)c3)cc12	InChI=1S/C25H20ClN5O/c1-15-22-10-17(3-5-24(22)31-30-15)13-29-25(32)18-6-7-27-21(12-18)9-16-2-4-23-19(8-16)11-20(26)14-28-23/h2-8,10-12,14H,9,13H2,1H3,(H,29,32)(H,30,31)	LZOVGKRNFVVKAA-UHFFFAOYSA-N	283614	2-((3-chloroquinolin-6-yl)methyl)-N-((3-methyl- 1H-indazol-5-yl)methyl)isonicotinamide::US10023557, Example 261::US10308637, Example 261	Plasma kallikrein			 5500					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283614	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283614&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182394	378164936							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540463	CC(O)c1cnc2ccc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2c1	InChI=1S/C26H27N5O2/c1-15-8-25(27)31-16(2)23(15)14-30-26(33)19-6-7-28-22(12-19)10-18-4-5-24-20(9-18)11-21(13-29-24)17(3)32/h4-9,11-13,17,32H,10,14H2,1-3H3,(H2,27,31)(H,30,33)	KFWQVOQZEKRWRS-UHFFFAOYSA-N	283615	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-(1-hydroxyethyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 262::US10308637, Example 262	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283615	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283615&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124183030	378164937							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540464	CC(O)c1cnc2ccc(Cc3cc(ccn3)C(=O)NCc3ccc(N)nc3C)cc2c1	InChI=1S/C25H25N5O2/c1-15-19(4-6-24(26)30-15)13-29-25(32)18-7-8-27-22(12-18)10-17-3-5-23-20(9-17)11-21(14-28-23)16(2)31/h3-9,11-12,14,16,31H,10,13H2,1-2H3,(H2,26,30)(H,29,32)	ARIDQNLHGPTVRV-UHFFFAOYSA-N	283616	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-(1-hydroxyethyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 263::US10308637, Example 263	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283616	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283616&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182411	378164938							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540465	COc1cnc2ccc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2c1	InChI=1S/C25H25N5O2/c1-15-8-24(26)30-16(2)22(15)14-29-25(31)18-6-7-27-20(11-18)10-17-4-5-23-19(9-17)12-21(32-3)13-28-23/h4-9,11-13H,10,14H2,1-3H3,(H2,26,30)(H,29,31)	RKVFEEITZZUJSF-UHFFFAOYSA-N	283617	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-methoxyquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 264::US10308637, Example 264	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283617	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283617&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182382	378164939							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540466	COc1cnc2ccc(Cc3cc(ccn3)C(=O)NCc3ccc(N)nc3C)cc2c1	InChI=1S/C24H23N5O2/c1-15-18(4-6-23(25)29-15)13-28-24(30)17-7-8-26-20(11-17)10-16-3-5-22-19(9-16)12-21(31-2)14-27-22/h3-9,11-12,14H,10,13H2,1-2H3,(H2,25,29)(H,28,30)	VHZPHVDESKYEIY-UHFFFAOYSA-N	283618	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-methoxyquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 265::US10308637, Example 265	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283618	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283618&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182235	378164940							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540467	Cc1n[nH]c2ncc(CNC(=O)c3ccnc(Cc4ccc5ncc(Cl)cc5c4)c3)cc12	InChI=1S/C24H19ClN6O/c1-14-21-8-16(11-28-23(21)31-30-14)12-29-24(32)17-4-5-26-20(10-17)7-15-2-3-22-18(6-15)9-19(25)13-27-22/h2-6,8-11,13H,7,12H2,1H3,(H,29,32)(H,28,30,31)	JLDJOBKZVVEOHL-UHFFFAOYSA-N	283619	2-((3-chloroquinolin-6-yl)methyl)-N-((3-methyl- 1H-pyrazolo[3,4-b]pyridin-5- yl)methyl)isonicotinamide::US10023557, Example 266::US10308637, Example 266	Plasma kallikrein			 5500					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283619	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283619&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124181931	378164941							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540468	FC(F)(F)c1n[nH]c2ccc(CNC(=O)c3ccnc(Cc4ccc5ncc(Cl)cc5c4)c3)cc12	InChI=1S/C25H17ClF3N5O/c26-18-10-17-7-14(1-3-21(17)31-13-18)8-19-11-16(5-6-30-19)24(35)32-12-15-2-4-22-20(9-15)23(34-33-22)25(27,28)29/h1-7,9-11,13H,8,12H2,(H,32,35)(H,33,34)	BRUDAKBQFBCDII-UHFFFAOYSA-N	283620	2-((3-chloroquinolin-6-yl)methyl)-N-((3- (trifluoromethyl)-1H-indazol-5- yl)methyl)isonicotinamide::US10023557, Example 267::US10308637, Example 267	Plasma kallikrein			 5500					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283620	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283620&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182937	378164942							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540469	Clc1ccc2[nH]cc(CNC(=O)c3ccnc(Cc4ccc5ncc(Cl)cc5c4)c3)c2c1	InChI=1S/C25H18Cl2N4O/c26-19-2-4-24-22(11-19)18(12-29-24)13-31-25(32)16-5-6-28-21(10-16)8-15-1-3-23-17(7-15)9-20(27)14-30-23/h1-7,9-12,14,29H,8,13H2,(H,31,32)	ZFIOIMARIIJADT-UHFFFAOYSA-N	283621	N-((5-chloro-1H-indol-3-yl)methyl)-2-((3- chloroquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 268::US10308637, Example 268	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283621	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283621&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124183130	378164943							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540470	Clc1cnc2[nH]cc(CNC(=O)c3ccnc(Cc4ccc5ncc(Cl)cc5c4)c3)c2c1	InChI=1S/C24H17Cl2N5O/c25-18-7-16-5-14(1-2-22(16)28-12-18)6-20-8-15(3-4-27-20)24(32)31-11-17-10-29-23-21(17)9-19(26)13-30-23/h1-5,7-10,12-13H,6,11H2,(H,29,30)(H,31,32)	PCVVGCGKNCLNOS-UHFFFAOYSA-N	283622	N-((5-chloro-1H-pyrrolo[2,3-b]pyridin-3- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 269::US10308637, Example 269	Plasma kallikrein			 5500					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283622	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283622&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182404	378164944							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540471	Cc1[nH]c2ccc(Cl)cc2c1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C26H20Cl2N4O/c1-15-23(22-12-19(27)3-5-25(22)32-15)14-31-26(33)17-6-7-29-21(11-17)9-16-2-4-24-18(8-16)10-20(28)13-30-24/h2-8,10-13,32H,9,14H2,1H3,(H,31,33)	CLLKJHGXNIIDCR-UHFFFAOYSA-N	283623	N-((5-chloro-2-methyl-1H-indol-3-yl)methyl)-2- ((3-chloroquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 270::US10308637, Example 270	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283623	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283623&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182303	378164945							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540472	FC(F)(F)c1n[nH]c2ncc(CNC(=O)c3ccnc(Cc4ccc5ncc(Cl)cc5c4)c3)cc12	InChI=1S/C24H16ClF3N6O/c25-17-8-16-5-13(1-2-20(16)30-12-17)6-18-9-15(3-4-29-18)23(35)32-11-14-7-19-21(24(26,27)28)33-34-22(19)31-10-14/h1-5,7-10,12H,6,11H2,(H,32,35)(H,31,33,34)	AWKURTHTBAHLFJ-UHFFFAOYSA-N	283624	2-((3-chloroquinolin-6-yl)methyl)-N-((3- (trifluoromethyl)-1H-pyrazolo[3,4-b]pyridin-5- yl)methyl)isonicotinamide::US10023557, Example 271::US10308637, Example 271	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283624	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283624&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124183323	378164946							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540473	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc(-c3nnn[nH]3)c3ncc(Cl)cc3c2)c1	InChI=1S/C25H22ClN9O/c1-13-5-22(27)31-14(2)21(13)12-30-25(36)16-3-4-28-19(10-16)7-15-6-17-9-18(26)11-29-23(17)20(8-15)24-32-34-35-33-24/h3-6,8-11H,7,12H2,1-2H3,(H2,27,31)(H,30,36)(H,32,33,34,35)	CHTXTYUXSQYZPG-UHFFFAOYSA-N	283625	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloro-8-(1H-tetrazol-5-yl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 272::US10308637, Example 272	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283625	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283625&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182986	378164947							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540474	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2cc(-c3nnn[nH]3)c3ncc(Cl)cc3c2)c1	InChI=1S/C24H20ClN9O/c1-13-16(2-3-21(26)30-13)11-29-24(35)15-4-5-27-19(10-15)7-14-6-17-9-18(25)12-28-22(17)20(8-14)23-31-33-34-32-23/h2-6,8-10,12H,7,11H2,1H3,(H2,26,30)(H,29,35)(H,31,32,33,34)	DCXQWYPQOMBAAM-UHFFFAOYSA-N	283626	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-chloro-8-(1H-tetrazol-5-yl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 273::US10308637, Example 273	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283626	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283626&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124183115	378164948							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540475	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(c1)C(=O)c1ccc2ncc(Cl)cc2c1	InChI=1S/C24H20ClN5O2/c1-13-7-22(26)30-14(2)19(13)12-29-24(32)16-5-6-27-21(10-16)23(31)15-3-4-20-17(8-15)9-18(25)11-28-20/h3-11H,12H2,1-2H3,(H2,26,30)(H,29,32)	ZUMUKHVVDXACCJ-UHFFFAOYSA-N	283627	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-(3-chloroquinoline-6-carbonyl)isonicotinamide::US10023557, Example 274::US10308637, Example 274	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283627	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283627&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182335	378164949							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540476	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(c1)C(O)c1ccc2ncc(Cl)cc2c1	InChI=1S/C24H22ClN5O2/c1-13-7-22(26)30-14(2)19(13)12-29-24(32)16-5-6-27-21(10-16)23(31)15-3-4-20-17(8-15)9-18(25)11-28-20/h3-11,23,31H,12H2,1-2H3,(H2,26,30)(H,29,32)	FZBWFJGOXURHDV-UHFFFAOYSA-N	283628	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloroquinolin-6- yl)(hydroxy)methyl)isonicotinamide::US10023557, Example 275::US10308637, Example 275	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283628	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283628&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182386	378164950							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540477	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(c1)C(N)c1ccc2ncc(Cl)cc2c1	InChI=1S/C24H23ClN6O/c1-13-7-22(26)31-14(2)19(13)12-30-24(32)16-5-6-28-21(10-16)23(27)15-3-4-20-17(8-15)9-18(25)11-29-20/h3-11,23H,12,27H2,1-2H3,(H2,26,31)(H,30,32)	YURFKDSCPCHWCH-UHFFFAOYSA-N	283629	2[Amino-(3-chloro-quinolin-6-yl)-methyl]-N- (6-amino-2,4-dimethyl-pyridin-3-ylmethyl)- isonicotinamide::US10023557, Example 276::US10308637, Example 276	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283629	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283629&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182336	378164951							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540478	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(c1)C(C)(O)c1ccc2ncc(Cl)cc2c1	InChI=1S/C25H24ClN5O2/c1-14-8-23(27)31-15(2)20(14)13-30-24(32)16-6-7-28-22(11-16)25(3,33)18-4-5-21-17(9-18)10-19(26)12-29-21/h4-12,33H,13H2,1-3H3,(H2,27,31)(H,30,32)	JTZWLDGXHLBJLE-UHFFFAOYSA-N	283630	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-(1-(3-chloroquinolin-6-yl)-1- hydroxyethyl)isonicotinamide::US10023557, Example 277::US10308637, Example 277	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283630	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283630&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182400	378164952							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540479	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3ncc(CC(F)F)cc3c2)c1	InChI=1S/C26H25F2N5O/c1-15-7-25(29)33-16(2)22(15)14-32-26(34)19-5-6-30-21(12-19)10-17-3-4-23-20(8-17)9-18(13-31-23)11-24(27)28/h3-9,12-13,24H,10-11,14H2,1-2H3,(H2,29,33)(H,32,34)	OVIYOYHDBWMVGM-UHFFFAOYSA-N	283631	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-(2,2-difluoroethyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 278::US10308637, Example 278	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283631	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283631&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182418	378164953							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540480	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2ccc3ncc(CC(F)F)cc3c2)c1	InChI=1S/C25H23F2N5O/c1-15-19(3-5-24(28)32-15)14-31-25(33)18-6-7-29-21(12-18)10-16-2-4-22-20(8-16)9-17(13-30-22)11-23(26)27/h2-9,12-13,23H,10-11,14H2,1H3,(H2,28,32)(H,31,33)	QFSMNAFQIHWMLY-UHFFFAOYSA-N	283632	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-(2,3-difluoroethyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 279::US10308637, Example 279	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283632	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283632&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182396	378164954							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540481	CCc1cnc2ccc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)cc2c1	InChI=1S/C27H22ClFN4O/c1-2-16-7-19-8-17(3-4-25(19)31-13-16)9-21-10-18(5-6-30-21)27(34)33-14-20-11-22-23(28)15-32-26(22)12-24(20)29/h3-8,10-13,15,32H,2,9,14H2,1H3,(H,33,34)	SRKDSXPWTVRRGC-UHFFFAOYSA-N	283633	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3-ethylquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 280::US10308637, Example 280	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283633	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283633&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124183131	378164955							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540482	CCc1cnc2ccc(Cc3cc(ccn3)C(=O)NCc3cnc4[nH]cc(Cl)c4c3)cc2c1	InChI=1S/C26H22ClN5O/c1-2-16-7-20-8-17(3-4-24(20)29-12-16)9-21-11-19(5-6-28-21)26(33)32-14-18-10-22-23(27)15-31-25(22)30-13-18/h3-8,10-13,15H,2,9,14H2,1H3,(H,30,31)(H,32,33)	LIPHAXJFMYSMMP-UHFFFAOYSA-N	283634	N-((3-chloro-1H-pyrrolo[2,3-b]pyridin-5- yl)methyl)-2-((3-ethylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 281::US10308637, Example 281	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283634	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283634&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124183144	378164956							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540483	CCc1cnc2ccc(Cc3cc(ccn3)C(=O)NCc3ccc4[nH]cc(Cl)c4c3F)cc2c1	InChI=1S/C27H22ClFN4O/c1-2-16-9-20-10-17(3-5-23(20)31-13-16)11-21-12-18(7-8-30-21)27(34)33-14-19-4-6-24-25(26(19)29)22(28)15-32-24/h3-10,12-13,15,32H,2,11,14H2,1H3,(H,33,34)	PETIZYZCCWGRAH-UHFFFAOYSA-N	283635	N-((3-chloro-4-fluoro-1H-indol-5-yl)methyl)-2- ((3-ethylquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 282::US10308637, Example 282	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283635	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283635&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182405	378164957							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540484	CCc1cnc2ccc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)cc2c1	InChI=1S/C28H25N5O/c1-2-18-11-23-12-19(4-6-26(23)32-16-18)14-24-15-22(8-9-30-24)28(34)33-17-20-3-5-25-21(13-20)7-10-31-27(25)29/h3-13,15-16H,2,14,17H2,1H3,(H2,29,31)(H,33,34)	IKKRHUSEAWLVJJ-UHFFFAOYSA-N	283636	N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- ethylquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 283::US10308637, Example 283	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283636	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283636&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124183163	378164958							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540485	CCc1cnc2ccc(Cc3cc(ccn3)C(=O)NCc3n[nH]c4ccc(Cl)cc34)cc2c1	InChI=1S/C26H22ClN5O/c1-2-16-9-19-10-17(3-5-23(19)29-14-16)11-21-12-18(7-8-28-21)26(33)30-15-25-22-13-20(27)4-6-24(22)31-32-25/h3-10,12-14H,2,11,15H2,1H3,(H,30,33)(H,31,32)	PNIMVVSWHBIUGP-UHFFFAOYSA-N	283637	N-((5-chloro-1H-indazol-3-yl)methyl)-2-((3- ethylquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 284::US10308637, Example 284	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283637	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283637&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124183149	378164959							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540486	CCc1cnc2ccc(Cc3cc(ccn3)C(=O)NCc3ccc(N)nc3C)cc2c1	InChI=1S/C25H25N5O/c1-3-17-10-21-11-18(4-6-23(21)28-14-17)12-22-13-19(8-9-27-22)25(31)29-15-20-5-7-24(26)30-16(20)2/h4-11,13-14H,3,12,15H2,1-2H3,(H2,26,30)(H,29,31)	OREPZDKJBZOUSC-UHFFFAOYSA-N	283638	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-ethylquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 285::US10308637, Example 285	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283638	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283638&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182421	378164960							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540487	CCc1cnc2ccc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2c1	InChI=1S/C26H27N5O/c1-4-18-10-21-11-19(5-6-24(21)29-14-18)12-22-13-20(7-8-28-22)26(32)30-15-23-16(2)9-25(27)31-17(23)3/h5-11,13-14H,4,12,15H2,1-3H3,(H2,27,31)(H,30,32)	WAXKFCXDFXHSDW-UHFFFAOYSA-N	283639	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-ethylquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 286::US10308637, Example 286	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283639	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283639&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124183333	378164961							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540488	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)cc2c1)S(N)(=O)=O	InChI=1S/C26H21ClFN5O3S/c1-14-4-17-5-15(7-24(37(29,35)36)25(17)32-11-14)6-19-8-16(2-3-30-19)26(34)33-12-18-9-20-21(27)13-31-23(20)10-22(18)28/h2-5,7-11,13,31H,6,12H2,1H3,(H,33,34)(H2,29,35,36)	FCBFPLGCTNIHRM-UHFFFAOYSA-N	283640	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3-methyl-8-sulfamoylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 287::US10308637, Example 287	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283640	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283640&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182369	378164962							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540489	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3n[nH]c4ccc(Cl)cc34)cc2c1)S(N)(=O)=O	InChI=1S/C25H21ClN6O3S/c1-14-6-17-7-15(9-23(36(27,34)35)24(17)29-12-14)8-19-10-16(4-5-28-19)25(33)30-13-22-20-11-18(26)2-3-21(20)31-32-22/h2-7,9-12H,8,13H2,1H3,(H,30,33)(H,31,32)(H2,27,34,35)	QAJVRULNMBOLEF-UHFFFAOYSA-N	283641	N-((5-chloro-1H-indazol-3-yl)methyl)-2-((3- methyl-8-sulfamoylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 288::US10308637, Example 288	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283641	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283641&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126501517	378164963							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540490	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)cc2c1)S(N)(=O)=O	InChI=1S/C27H24N6O3S/c1-16-8-21-10-18(12-24(37(29,35)36)25(21)32-14-16)11-22-13-20(5-6-30-22)27(34)33-15-17-2-3-23-19(9-17)4-7-31-26(23)28/h2-10,12-14H,11,15H2,1H3,(H2,28,31)(H,33,34)(H2,29,35,36)	ZLLFHJRJDPDQKT-UHFFFAOYSA-N	283642	N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- methyl-8-sulfamoylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 289::US10308637, Example 289	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283642	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283642&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665321	378164964							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540491	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3ccc4[nH]cc(Cl)c4c3F)cc2c1)S(N)(=O)=O	InChI=1S/C26H21ClFN5O3S/c1-14-6-18-7-15(9-22(37(29,35)36)25(18)32-11-14)8-19-10-16(4-5-30-19)26(34)33-12-17-2-3-21-23(24(17)28)20(27)13-31-21/h2-7,9-11,13,31H,8,12H2,1H3,(H,33,34)(H2,29,35,36)	ULXURFQBVYLUQN-UHFFFAOYSA-N	283643	N-((3-chloro-4-fluoro-1H-indol-5-yl)methyl)-2- ((3-methyl-8-sulfamoylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 290::US10308637, Example 290	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283643	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283643&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126501519	378164965							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540492	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cnc4[nH]cc(Cl)c4c3)cc2c1)S(N)(=O)=O	InChI=1S/C25H21ClN6O3S/c1-14-4-18-5-15(8-22(36(27,34)35)23(18)29-10-14)6-19-9-17(2-3-28-19)25(33)32-12-16-7-20-21(26)13-31-24(20)30-11-16/h2-5,7-11,13H,6,12H2,1H3,(H,30,31)(H,32,33)(H2,27,34,35)	MHMLWXMUMLUGIJ-UHFFFAOYSA-N	283644	N-((3-chloro-1H-pyrrolo[2,3-b]pyridin-5- yl)methyl)-2-((3-methyl-8-sulfamoylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 291::US10308637, Example 291	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283644	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283644&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126501518	378164966							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540493	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1ccnc(Cc2ccc3ncc(cc3c2)N2CCOCC2)c1	InChI=1S/C29H25ClFN5O2/c30-25-17-34-28-14-26(31)21(13-24(25)28)15-35-29(37)19-3-4-32-22(11-19)10-18-1-2-27-20(9-18)12-23(16-33-27)36-5-7-38-8-6-36/h1-4,9,11-14,16-17,34H,5-8,10,15H2,(H,35,37)	RLHAGNANFDZZBH-UHFFFAOYSA-N	283645	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3-morpholinoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 292::US10308637, Example 292	Plasma kallikrein			 5500					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283645	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283645&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124183338	378164967							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540494	Nc1nccc2cc(CNC(=O)c3ccnc(Cc4ccc5ncc(cc5c4)N4CCOCC4)c3)ccc12	InChI=1S/C30H28N6O2/c31-29-27-3-1-21(14-22(27)5-8-33-29)18-35-30(37)23-6-7-32-25(16-23)15-20-2-4-28-24(13-20)17-26(19-34-28)36-9-11-38-12-10-36/h1-8,13-14,16-17,19H,9-12,15,18H2,(H2,31,33)(H,35,37)	YXYUVCZDTRMHDB-UHFFFAOYSA-N	283647	N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- morpholinoquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 293::US10308637, Example 293	Plasma kallikrein			 5500					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283647	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283647&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124183241	378164969							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540495	Clc1c[nH]c2ncc(CNC(=O)c3ccnc(Cc4ccc5ncc(cc5c4)N4CCOCC4)c3)cc12	InChI=1S/C28H25ClN6O2/c29-25-17-33-27-24(25)11-19(14-32-27)15-34-28(36)20-3-4-30-22(12-20)10-18-1-2-26-21(9-18)13-23(16-31-26)35-5-7-37-8-6-35/h1-4,9,11-14,16-17H,5-8,10,15H2,(H,32,33)(H,34,36)	LNCPHKPUTABQKY-UHFFFAOYSA-N	283648	N-((3-chloro-1H-pyrrolo[2,3-b]pyridin-5- yl)methyl)-2-((3-morpholinoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 294::US10308637, Example 294	Plasma kallikrein			 5500					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283648	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283648&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182388	378164970							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540496	Clc1ccc2[nH]nc(CNC(=O)c3ccnc(Cc4ccc5ncc(cc5c4)N4CCOCC4)c3)c2c1	InChI=1S/C28H25ClN6O2/c29-21-2-4-26-24(15-21)27(34-33-26)17-32-28(36)19-5-6-30-22(13-19)12-18-1-3-25-20(11-18)14-23(16-31-25)35-7-9-37-10-8-35/h1-6,11,13-16H,7-10,12,17H2,(H,32,36)(H,33,34)	RINLSOSYWPWYLR-UHFFFAOYSA-N	283649	N-((5-chloro-1H-indazol-3-yl)methyl)-2-((3- morpholinoquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 295::US10308637, Example 295	Plasma kallikrein			 5500					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283649	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283649&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182413	378164971							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540497	COC(c1ccc2ncc(Cl)cc2c1)c1cc(ccn1)C(=O)NCc1c(C)cc(N)nc1C	InChI=1S/C25H24ClN5O2/c1-14-8-23(27)31-15(2)20(14)13-30-25(32)17-6-7-28-22(11-17)24(33-3)16-4-5-21-18(9-16)10-19(26)12-29-21/h4-12,24H,13H2,1-3H3,(H2,27,31)(H,30,32)	YMZIYTFRMDZUJW-UHFFFAOYSA-N	283650	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloroquinolin-6- yl)(methoxy)methyl)isonicotinamide::US10023557, Example 296::US10308637, Example 296	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283650	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283650&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124183159	378164972							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540498	Nc1cnc2ccc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)cc2c1	InChI=1S/C25H19ClFN5O/c26-21-13-31-24-10-22(27)17(9-20(21)24)11-32-25(33)15-3-4-29-19(8-15)6-14-1-2-23-16(5-14)7-18(28)12-30-23/h1-5,7-10,12-13,31H,6,11,28H2,(H,32,33)	OJKGBJDSLMQYOV-UHFFFAOYSA-N	283651	2-((3-aminoquinolin-6-yl)methyl)-N-((3-chloro- 6-fluoro-1H-indol-5-yl)methyl)isonicotinamide::US10023557, Example 297::US10308637, Example 297	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283651	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283651&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182420	378164973							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540499	Nc1cnc2ccc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)cc2c1	InChI=1S/C26H22N6O/c27-21-12-20-9-16(2-4-24(20)31-15-21)11-22-13-19(6-7-29-22)26(33)32-14-17-1-3-23-18(10-17)5-8-30-25(23)28/h1-10,12-13,15H,11,14,27H2,(H2,28,30)(H,32,33)	IKKAOLZAHXWOGL-UHFFFAOYSA-N	283652	N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- aminoquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 298::US10308637, Example 298	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283652	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283652&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124183165	378164974							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540500	Nc1cnc2ccc(Cc3cc(ccn3)C(=O)NCc3n[nH]c4ccc(Cl)cc34)cc2c1	InChI=1S/C24H19ClN6O/c25-17-2-4-22-20(11-17)23(31-30-22)13-29-24(32)15-5-6-27-19(10-15)8-14-1-3-21-16(7-14)9-18(26)12-28-21/h1-7,9-12H,8,13,26H2,(H,29,32)(H,30,31)	BIRKNFJCSZXTJR-UHFFFAOYSA-N	283653	2-((3-aminoquinolin-6-yl)methyl)-N-((5-chloro- 1H-indazol-3-yl)methyl)isonicotinamide::US10023557, Example 299::US10308637, Example 299	Plasma kallikrein			 5500					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283653	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283653&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182366	378164975							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540501	Nc1cnc2ccc(Cc3cc(ccn3)C(=O)NCc3cnc4[nH]cc(Cl)c4c3)cc2c1	InChI=1S/C24H19ClN6O/c25-21-13-30-23-20(21)7-15(10-29-23)11-31-24(32)16-3-4-27-19(9-16)6-14-1-2-22-17(5-14)8-18(26)12-28-22/h1-5,7-10,12-13H,6,11,26H2,(H,29,30)(H,31,32)	ADWKSPMSIUUGGA-UHFFFAOYSA-N	283654	2-((3-aminoquinolin-6-yl)methyl)-N-((3-chloro- 1H-pyrrolo[2,3-b]pyridin-5- yl)methyl)isonicotinamide::US10023557, Example 300::US10308637, Example 300	Plasma kallikrein			 5500					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283654	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283654&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124183334	378164976							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540502	Nc1cnc2ccc(Cc3cc(ccn3)C(=O)NCc3ccc4[nH]cc(Cl)c4c3F)cc2c1	InChI=1S/C25H19ClFN5O/c26-20-13-31-22-4-2-16(24(27)23(20)22)11-32-25(33)15-5-6-29-19(10-15)8-14-1-3-21-17(7-14)9-18(28)12-30-21/h1-7,9-10,12-13,31H,8,11,28H2,(H,32,33)	VDXDEJQPELHSLU-UHFFFAOYSA-N	283655	2-((3-aminoquinolin-6-yl)methyl)-N-((3-chloro- 4-fluoro-1H-indol-5-yl)methyl)isonicotinamide::US10023557, Example 301::US10308637, Example 301	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283655	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283655&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182348	378164977							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540503	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1ccnc(Cc2ccc3ncc(cc3c2)N2CCCCC2)c1	InChI=1S/C30H27ClFN5O/c31-26-18-35-29-15-27(32)22(14-25(26)29)16-36-30(38)20-6-7-33-23(12-20)11-19-4-5-28-21(10-19)13-24(17-34-28)37-8-2-1-3-9-37/h4-7,10,12-15,17-18,35H,1-3,8-9,11,16H2,(H,36,38)	AJOWBOSPRFMYLC-UHFFFAOYSA-N	283656	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3-(piperidin-1-yl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 302::US10308637, Example 302	Plasma kallikrein			 5500					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283656	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283656&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182454	378164978							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540504	Nc1nccc2cc(CNC(=O)c3ccnc(Cc4ccc5ncc(cc5c4)N4CCCCC4)c3)ccc12	InChI=1S/C31H30N6O/c32-30-28-6-4-22(15-23(28)8-11-34-30)19-36-31(38)24-9-10-33-26(17-24)16-21-5-7-29-25(14-21)18-27(20-35-29)37-12-2-1-3-13-37/h4-11,14-15,17-18,20H,1-3,12-13,16,19H2,(H2,32,34)(H,36,38)	CYJWRCPBQNZAPJ-UHFFFAOYSA-N	283657	N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- (piperidin-1-yl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 303::US10308637, Example 303	Plasma kallikrein			 5500					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283657	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283657&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124183365	378164979							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540505	Fc1c(CNC(=O)c2ccnc(Cc3ccc4ncc(cc4c3)N3CCCCC3)c2)ccc2[nH]cc(Cl)c12	InChI=1S/C30H27ClFN5O/c31-25-18-35-27-7-5-21(29(32)28(25)27)16-36-30(38)20-8-9-33-23(14-20)13-19-4-6-26-22(12-19)15-24(17-34-26)37-10-2-1-3-11-37/h4-9,12,14-15,17-18,35H,1-3,10-11,13,16H2,(H,36,38)	CFLPOTXWAYKWEV-UHFFFAOYSA-N	283658	N-((3-chloro-4-fluoro-1H-indol-5-yl)methyl)-2- ((3-(piperidin-1-yl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 305::US10308637, Example 305	Plasma kallikrein			>10000					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283658	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283658&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124183167	378164980							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540506	Clc1c[nH]c2ncc(CNC(=O)c3ccnc(Cc4ccc5ncc(cc5c4)N4CCCCC4)c3)cc12	InChI=1S/C29H27ClN6O/c30-26-18-34-28-25(26)12-20(15-33-28)16-35-29(37)21-6-7-31-23(13-21)11-19-4-5-27-22(10-19)14-24(17-32-27)36-8-2-1-3-9-36/h4-7,10,12-15,17-18H,1-3,8-9,11,16H2,(H,33,34)(H,35,37)	XETCHXVRJBOGIY-UHFFFAOYSA-N	283659	N-((3-chloro-1H-pyrrolo[2,3-b]pyridin-5- yl)methyl)-2-((3-(piperidin-1-yl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 306::US10308637, Example 306	Plasma kallikrein			 5500					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283659	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283659&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182440	378164981							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540507	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1ccnc(Cc2ccc3ncc(cc3c2)N2CCCC2)c1	InChI=1S/C29H25ClFN5O/c30-25-17-34-28-14-26(31)21(13-24(25)28)15-35-29(37)19-5-6-32-22(11-19)10-18-3-4-27-20(9-18)12-23(16-33-27)36-7-1-2-8-36/h3-6,9,11-14,16-17,34H,1-2,7-8,10,15H2,(H,35,37)	QXMYTSARCQSHKZ-UHFFFAOYSA-N	283660	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3-(pyrrolidin-1-yl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 307::US10308637, Example 307	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283660	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283660&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182377	378164982							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540508	Nc1nccc2cc(CNC(=O)c3ccnc(Cc4ccc5ncc(cc5c4)N4CCCC4)c3)ccc12	InChI=1S/C30H28N6O/c31-29-27-5-3-21(14-22(27)7-10-33-29)18-35-30(37)23-8-9-32-25(16-23)15-20-4-6-28-24(13-20)17-26(19-34-28)36-11-1-2-12-36/h3-10,13-14,16-17,19H,1-2,11-12,15,18H2,(H2,31,33)(H,35,37)	WZJCZLDUXMVVCO-UHFFFAOYSA-N	283661	N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- (pyrrolidin-1-yl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 308::US10308637, Example 308	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283661	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283661&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124183132	378164983							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540509	Clc1ccc2[nH]nc(CNC(=O)c3ccnc(Cc4ccc5ncc(cc5c4)N4CCCC4)c3)c2c1	InChI=1S/C28H25ClN6O/c29-21-4-6-26-24(15-21)27(34-33-26)17-32-28(36)19-7-8-30-22(13-19)12-18-3-5-25-20(11-18)14-23(16-31-25)35-9-1-2-10-35/h3-8,11,13-16H,1-2,9-10,12,17H2,(H,32,36)(H,33,34)	BXCYQVYUVRSMEO-UHFFFAOYSA-N	283662	N-((5-chloro-1H-indazol-3-yl)methyl)-2-((3- (pyrrolidin-1-yl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 309::US10308637, Example 309	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283662	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283662&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124183343	378164984							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540510	Clc1c[nH]c2ncc(CNC(=O)c3ccnc(Cc4ccc5ncc(cc5c4)N4CCCC4)c3)cc12	InChI=1S/C28H25ClN6O/c29-25-17-33-27-24(25)11-19(14-32-27)15-34-28(36)20-5-6-30-22(12-20)10-18-3-4-26-21(9-18)13-23(16-31-26)35-7-1-2-8-35/h3-6,9,11-14,16-17H,1-2,7-8,10,15H2,(H,32,33)(H,34,36)	CEPCFYXGKVUSIE-UHFFFAOYSA-N	283663	N-((3-chloro-1H-pyrrolo[2,3-b]pyridin-5- yl)methyl)-2-((3-(pyrrolidin-1-yl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 310::US10308637, Example 310	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283663	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283663&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182447	378164985							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540511	Fc1c(CNC(=O)c2ccnc(Cc3ccc4ncc(cc4c3)N3CCCC3)c2)ccc2[nH]cc(Cl)c12	InChI=1S/C29H25ClFN5O/c30-24-17-34-26-6-4-20(28(31)27(24)26)15-35-29(37)19-7-8-32-22(13-19)12-18-3-5-25-21(11-18)14-23(16-33-25)36-9-1-2-10-36/h3-8,11,13-14,16-17,34H,1-2,9-10,12,15H2,(H,35,37)	UDXKFAUNOZOTGY-UHFFFAOYSA-N	283664	N-((3-chloro-4-fluoro-1H-indol-5-yl)methyl)-2- ((3-(pyrrolidin-1-yl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 311::US10308637, Example 311	Plasma kallikrein			 550					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283664	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283664&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124183335	378164986							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540512	Clc1ccc2[nH]nc(CNC(=O)c3ccnc(Cc4ccc5ncc(cc5c4)N4CCNCC4)c3)c2c1	InChI=1S/C28H26ClN7O/c29-21-2-4-26-24(15-21)27(35-34-26)17-33-28(37)19-5-6-31-22(13-19)12-18-1-3-25-20(11-18)14-23(16-32-25)36-9-7-30-8-10-36/h1-6,11,13-16,30H,7-10,12,17H2,(H,33,37)(H,34,35)	SSJRLOMYWCCGLA-UHFFFAOYSA-N	283665	N-((5-chloro-1H-indazol-3-yl)methyl)-2-((3- (piperazin-1-yl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 312::US10308637, Example 312	Plasma kallikrein			 5500					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283665	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283665&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124183369	378164987							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540513	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1ccnc(Cc2ccc3ncc(cc3c2)N2CCNCC2)c1	InChI=1S/C29H26ClFN6O/c30-25-17-35-28-14-26(31)21(13-24(25)28)15-36-29(38)19-3-4-33-22(11-19)10-18-1-2-27-20(9-18)12-23(16-34-27)37-7-5-32-6-8-37/h1-4,9,11-14,16-17,32,35H,5-8,10,15H2,(H,36,38)	FPARTYUOMSHHEC-UHFFFAOYSA-N	283666	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3-(piperazin-1-yl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 313::US10308637, Example 313	Plasma kallikrein			 5500					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283666	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283666&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182466	378164988							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540514	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)cc2c1)C(C)(C)O	InChI=1S/C29H26ClFN4O2/c1-16-6-19-7-17(9-23(29(2,3)37)27(19)34-13-16)8-21-10-18(4-5-32-21)28(36)35-14-20-11-22-24(30)15-33-26(22)12-25(20)31/h4-7,9-13,15,33,37H,8,14H2,1-3H3,(H,35,36)	UCUOOADCSRGEKS-UHFFFAOYSA-N	283667	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((8-(2-hydroxypropan-2-yl)-3-methylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 314::US10308637, Example 314	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283667	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283667&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182080	378164989							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540515	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3ccc4[nH]cc(Cl)c4c3F)cc2c1)C(C)(C)O	InChI=1S/C29H26ClFN4O2/c1-16-8-20-9-17(11-22(29(2,3)37)27(20)34-13-16)10-21-12-18(6-7-32-21)28(36)35-14-19-4-5-24-25(26(19)31)23(30)15-33-24/h4-9,11-13,15,33,37H,10,14H2,1-3H3,(H,35,36)	NGUCAMUUAFWWSE-UHFFFAOYSA-N	283668	N-((3-chloro-4-fluoro-1H-indol-5-yl)methyl)-2- ((8-(2-hydroxypropan-2-yl)-3-methylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 315::US10308637, Example 315	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283668	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283668&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124183344	378164990							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540516	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cnc4[nH]cc(Cl)c4c3)cc2c1)C(C)(C)O	InChI=1S/C28H26ClN5O2/c1-16-6-20-7-17(10-23(28(2,3)36)25(20)31-12-16)8-21-11-19(4-5-30-21)27(35)34-14-18-9-22-24(29)15-33-26(22)32-13-18/h4-7,9-13,15,36H,8,14H2,1-3H3,(H,32,33)(H,34,35)	HJIORLPSRQEWBY-UHFFFAOYSA-N	283669	N-((3-chloro-1H-pyrrolo[2,3-b]pyridin-5- yl)methyl)-2-((8-(2-hydroxypropan-2-yl)-3- methylquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 316::US10308637, Example 316	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283669	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283669&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124183126	378164991							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540517	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3n[nH]c4ccc(Cl)cc34)cc2c1)C(C)(C)O	InChI=1S/C28H26ClN5O2/c1-16-8-19-9-17(11-23(28(2,3)36)26(19)31-14-16)10-21-12-18(6-7-30-21)27(35)32-15-25-22-13-20(29)4-5-24(22)33-34-25/h4-9,11-14,36H,10,15H2,1-3H3,(H,32,35)(H,33,34)	FYHVNMDJAWBBKJ-UHFFFAOYSA-N	283670	N-((5-chloro-1H-indazol-3-yl)methyl)-2-((8-(2- hydroxypropan-2-yl)-3-methylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 317::US10308637, Example 317	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283670	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283670&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124183370	378164992							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540518	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2c1)C(C)(C)O	InChI=1S/C28H31N5O2/c1-16-8-21-10-19(12-24(28(4,5)35)26(21)31-14-16)11-22-13-20(6-7-30-22)27(34)32-15-23-17(2)9-25(29)33-18(23)3/h6-10,12-14,35H,11,15H2,1-5H3,(H2,29,33)(H,32,34)	CCPFSMSMBYNPQC-UHFFFAOYSA-N	283671	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((8-(2-hydroxypropan-2-yl)-3-methylquinolin- 6-yl)methyl)isonicotinamide::US10023557, Example 318::US10308637, Example 318	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283671	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283671&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124183179	378164993							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540519	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)cc2c1)C(C)(C)O	InChI=1S/C30H29N5O2/c1-18-10-23-12-20(14-26(30(2,3)37)27(23)34-16-18)13-24-15-22(7-8-32-24)29(36)35-17-19-4-5-25-21(11-19)6-9-33-28(25)31/h4-12,14-16,37H,13,17H2,1-3H3,(H2,31,33)(H,35,36)	AJNSFFLHCZOATC-UHFFFAOYSA-N	283672	N-((1-aminoisoquinolin-6-yl)methyl)-2-((8-2- hydroxypropan-2-yl)-3-methylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 319::US10308637, Example 319	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283672	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283672&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182468	378164994							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540520	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1ccnc(Cc2ccc3ncc(cc3c2)N2CCC2)c1	InChI=1S/C28H23ClFN5O/c29-24-16-33-27-13-25(30)20(12-23(24)27)14-34-28(36)18-4-5-31-21(10-18)9-17-2-3-26-19(8-17)11-22(15-32-26)35-6-1-7-35/h2-5,8,10-13,15-16,33H,1,6-7,9,14H2,(H,34,36)	UVBHSNBVAWXQBJ-UHFFFAOYSA-N	283673	2-((3-(azetidin-1-yl)quinolin-6-yl)methyl)-N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)isonicotinamide::US10023557, Example 320::US10308637, Example 320	Plasma kallikrein			<100					7.5		US Patent		10.7270/Q2BZ6839		aid1795657	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283673	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283673&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182374	378164995							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540521	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2c1)S(C)(=O)=O	InChI=1S/C26H27N5O3S/c1-15-7-20-9-18(11-23(35(4,33)34)25(20)29-13-15)10-21-12-19(5-6-28-21)26(32)30-14-22-16(2)8-24(27)31-17(22)3/h5-9,11-13H,10,14H2,1-4H3,(H2,27,31)(H,30,32)	HXOKVKXTISERDZ-UHFFFAOYSA-N	283363	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-methyl-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 15::US10266515, Example 15::US10308637, Example 15::US11021463, Example 15::US9611252, Example 15	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283363	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283363&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213052	378164692							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540522	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)cc2c1)S(C)(=O)=O	InChI=1S/C28H25N5O3S/c1-17-9-22-11-19(13-25(37(2,35)36)26(22)32-15-17)12-23-14-21(6-7-30-23)28(34)33-16-18-3-4-24-20(10-18)5-8-31-27(24)29/h3-11,13-15H,12,16H2,1-2H3,(H2,29,31)(H,33,34)	AGLYWDINMJNVRE-UHFFFAOYSA-N	283364	N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- methyl-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 16::US10266515, Example 16::US10308637, Example 16::US11021463, Example 16::US9611252, Example 16	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283364	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283364&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665230	378164693							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540523	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)cc2c1)S(C)(=O)=O	InChI=1S/C27H22ClFN4O3S/c1-15-5-18-6-16(8-25(37(2,35)36)26(18)32-12-15)7-20-9-17(3-4-30-20)27(34)33-13-19-10-21-22(28)14-31-24(21)11-23(19)29/h3-6,8-12,14,31H,7,13H2,1-2H3,(H,33,34)	KNWYWDACHSZACS-UHFFFAOYSA-N	283365	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3-methyl-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 17::US10266515, Example 17::US10308637, Example 17::US11021463, Example 17::US9611252, Example 17	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283365	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283365&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213042	378164694							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540524	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cc4cc[nH]c4cc3F)cc2c1)S(C)(=O)=O	InChI=1S/C27H23FN4O3S/c1-16-7-20-8-17(10-25(36(2,34)35)26(20)31-14-16)9-22-12-19(4-5-29-22)27(33)32-15-21-11-18-3-6-30-24(18)13-23(21)28/h3-8,10-14,30H,9,15H2,1-2H3,(H,32,33)	JOIGNBGOTQEXSU-UHFFFAOYSA-N	283366	N-((6-fluoro-1H-indol-5-yl)methyl)-2-((3- methyl-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 18::US10266515, Example 18::US10308637, Example 18::US11021463, Example 18::US9611252, Example 18	Plasma kallikrein					 550					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283366	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283366&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665345	378164695							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540525	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3n[nH]c4ccc(Cl)cc34)cc2c1)S(C)(=O)=O	InChI=1S/C26H22ClN5O3S/c1-15-7-18-8-16(10-24(36(2,34)35)25(18)29-13-15)9-20-11-17(5-6-28-20)26(33)30-14-23-21-12-19(27)3-4-22(21)31-32-23/h3-8,10-13H,9,14H2,1-2H3,(H,30,33)(H,31,32)	INPUBOYBDZWEOS-UHFFFAOYSA-N	283368	N-((5-chloro-1H-indazol-3-yl)methyl)-2-((3- methyl-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 20::US10266515, Example 20::US10308637, Example 20::US11021463, Example 20::US9611252, Example 20	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283368	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283368&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665285	378164697							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540526	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3ccc4[nH]cc(Cl)c4c3F)cc2c1)S(C)(=O)=O	InChI=1S/C27H22ClFN4O3S/c1-15-7-19-8-16(10-23(37(2,35)36)26(19)32-12-15)9-20-11-17(5-6-30-20)27(34)33-13-18-3-4-22-24(25(18)29)21(28)14-31-22/h3-8,10-12,14,31H,9,13H2,1-2H3,(H,33,34)	RIPJTLFXOCXAJL-UHFFFAOYSA-N	283369	N-((3-chloro-4-fluoro-1H-indol-5-yl)methyl)-2- ((3-methyl-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 21::US10266515, Example 21::US10308637, Example 21::US11021463, Example 21::US9611252, Example 21	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283369	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283369&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213012	378164698							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540527	Nc1nccc2cc(CNC(=O)c3ccnc(Cc4ccc5ncc(Cl)cc5c4)c3)ccc12	InChI=1S/C26H20ClN5O/c27-21-12-20-9-16(2-4-24(20)31-15-21)11-22-13-19(6-7-29-22)26(33)32-14-17-1-3-23-18(10-17)5-8-30-25(23)28/h1-10,12-13,15H,11,14H2,(H2,28,30)(H,32,33)	WHHMKDFLRDNMQE-UHFFFAOYSA-N	283379	N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- chloroquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 179::US10023557, Example 31::US10266515, Example 31::US10308637, Example 179::US11021463, Example 31::US9611252, Example 31	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283379	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283379&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212700	378164708							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540528	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C25H17Cl2FN4O/c26-18-7-16-5-14(1-2-23(16)30-12-18)6-19-8-15(3-4-29-19)25(33)32-11-17-9-20-21(27)13-31-24(20)10-22(17)28/h1-5,7-10,12-13,31H,6,11H2,(H,32,33)	XZUNAOLBBRHEMP-UHFFFAOYSA-N	283381	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3-chloroquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 33::US10266515, Example 33::US10308637, Example 33::US11021463, Example 33::US9611252, Example 33	Plasma kallikrein					 550					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283381	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283381&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212875	378164710							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540529	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C23H20ClN5O/c1-14-17(3-5-22(25)29-14)12-28-23(30)16-6-7-26-20(11-16)9-15-2-4-21-18(8-15)10-19(24)13-27-21/h2-8,10-11,13H,9,12H2,1H3,(H2,25,29)(H,28,30)	ZGYIOYKVCAJRKO-UHFFFAOYSA-N	283382	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-chloroquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 34::US10266515, Example 39::US10308637, Example 39::US11021463, Example 39::US9611252, Example 39	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283382	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283382&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213054	378164711							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540530	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C24H22ClN5O/c1-14-7-23(26)30-15(2)21(14)13-29-24(31)17-5-6-27-20(11-17)9-16-3-4-22-18(8-16)10-19(25)12-28-22/h3-8,10-12H,9,13H2,1-2H3,(H2,26,30)(H,29,31)	BDLURRLRBKLEDL-UHFFFAOYSA-N	283383	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 35::US10266515, Example 35::US10308637, Example 35::US11021463, Example 35::US9611252, Example 35	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283383	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283383&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665163	378164712							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540531	Clc1c[nH]c2ncc(CNC(=O)c3ccnc(Cc4ccc5ncc(Cl)cc5c4)c3)cc12	InChI=1S/C24H17Cl2N5O/c25-18-8-17-5-14(1-2-22(17)28-12-18)6-19-9-16(3-4-27-19)24(32)31-11-15-7-20-21(26)13-30-23(20)29-10-15/h1-5,7-10,12-13H,6,11H2,(H,29,30)(H,31,32)	QFSDBAJWKWRDTA-UHFFFAOYSA-N	283386	N-((3-chloro-1H-pyrrolo[2,3-b]pyridin-5- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 38::US10266515, Example 38::US10308637, Example 38::US11021463, Example 38::US9611252, Example 38	Plasma kallikrein					 550					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283386	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283386&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665363	378164715							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540532	Fc1c(CNC(=O)c2ccnc(Cc3ccc4ncc(Cl)cc4c3)c2)ccc2[nH]cc(Cl)c12	InChI=1S/C25H17Cl2FN4O/c26-18-9-17-7-14(1-3-21(17)30-12-18)8-19-10-15(5-6-29-19)25(33)32-11-16-2-4-22-23(24(16)28)20(27)13-31-22/h1-7,9-10,12-13,31H,8,11H2,(H,32,33)	GVFULHFYDFFIFD-UHFFFAOYSA-N	283388	N-((3-chloro-4-fluoro-1H-indol-5-yl)methyl)-2- ((3-chloroquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 40::US10266515, Example 40::US10308637, Example 40::US11021463, Example 40::US9611252, Example 40	Plasma kallikrein					 550					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283388	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283388&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665357	378164717							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540533	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc(C#N)c3ncc(Cl)cc3c2)c1	InChI=1S/C25H21ClN6O/c1-14-5-23(28)32-15(2)22(14)13-31-25(33)17-3-4-29-21(10-17)8-16-6-18-9-20(26)12-30-24(18)19(7-16)11-27/h3-7,9-10,12H,8,13H2,1-2H3,(H2,28,32)(H,31,33)	VSKYRJRRAUSIED-UHFFFAOYSA-N	283398	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloro-8-cyanoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 50::US10266515, Example 50::US10308637, Example 50::US11021463, Example 50::US9611252, Example 50	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283398	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283398&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665177	378164727							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540534	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2cc(C#N)c3ncc(Cl)cc3c2)c1	InChI=1S/C24H19ClN6O/c1-14-17(2-3-22(27)31-14)12-30-24(32)16-4-5-28-21(10-16)8-15-6-18-9-20(25)13-29-23(18)19(7-15)11-26/h2-7,9-10,13H,8,12H2,1H3,(H2,27,31)(H,30,32)	FDKNUBSGWSPNRT-UHFFFAOYSA-N	283404	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-chloro-8-cyanoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 56::US10266515, Example 56::US10308637, Example 56::US11021463, Example 56::US9611252, Example 56	Plasma kallikrein					 550					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283404	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283404&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665146	378164733							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540535	Nc1nccc2cc(CNC(=O)c3ccnc(Cc4cc(C#N)c5ncc(Cl)cc5c4)c3)ccc12	InChI=1S/C27H19ClN6O/c28-22-11-20-8-17(9-21(13-29)25(20)33-15-22)10-23-12-19(4-5-31-23)27(35)34-14-16-1-2-24-18(7-16)3-6-32-26(24)30/h1-9,11-12,15H,10,14H2,(H2,30,32)(H,34,35)	IDTYIYATNJINLX-UHFFFAOYSA-N	283405	N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- chloro-8-cyanoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 57::US10266515, Example 57::US10308637, Example 57::US11021463, Example 57::US9611252, Example 57	Plasma kallikrein					 550					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283405	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283405&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665382	378164734							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540536	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc(C(N)=O)c3ncc(Cl)cc3c2)c1	InChI=1S/C25H23ClN6O2/c1-13-5-22(27)32-14(2)21(13)12-31-25(34)16-3-4-29-19(10-16)7-15-6-17-9-18(26)11-30-23(17)20(8-15)24(28)33/h3-6,8-11H,7,12H2,1-2H3,(H2,27,32)(H2,28,33)(H,31,34)	INWUNFFPSCFXCA-UHFFFAOYSA-N	283406	6-((4-(((6-amino-2,4-dimethylpyridin-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- chloroquinoline-8-carboxamide::US10023557, Example 58::US10266515, Example 58::US10308637, Example 58::US11021463, Example 58::US9611252, Example 58	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283406	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283406&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665386	378164735							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540537	NC(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2cc3c(Cl)c[nH]c3cc2F)cc2cc(Cl)cnc12	InChI=1S/C26H18Cl2FN5O2/c27-17-6-15-3-13(5-20(25(30)35)24(15)33-11-17)4-18-7-14(1-2-31-18)26(36)34-10-16-8-19-21(28)12-32-23(19)9-22(16)29/h1-3,5-9,11-12,32H,4,10H2,(H2,30,35)(H,34,36)	QMNRPOHMXWHKMB-UHFFFAOYSA-N	283407	3-chloro-6-((4-(((3-chloro-6-fluoro-1H-indol-5- yl)methyl)carbamoyl)pyridin-2- yl)methyl)quinoline-8-carboxamide::US10023557, Example 59::US10266515, Example 59::US11021463, Example 59::US9611252, Example 59	Plasma kallikrein					 550					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283407	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283407&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665413	378164736							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540538	NC(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2n[nH]c3ccc(Cl)cc23)cc2cc(Cl)cnc12	InChI=1S/C25H18Cl2N6O2/c26-16-1-2-21-19(10-16)22(33-32-21)12-31-25(35)14-3-4-29-18(9-14)6-13-5-15-8-17(27)11-30-23(15)20(7-13)24(28)34/h1-5,7-11H,6,12H2,(H2,28,34)(H,31,35)(H,32,33)	RTJGKEBRSSQCHQ-UHFFFAOYSA-N	283408	3-chloro-6-((4-(((5-chloro-1H-indazol-3- yl)methyl)carbamoyl)pyridin-2- yl)methyl)quinoline-8-carboxamide::US10023557, Example 60::US10266515, Example 60::US10308637, Example 60::US11021463, Example 60::US9611252, Example 60	Plasma kallikrein					 550					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283408	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283408&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665317	378164737							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540539	NC(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2cnc3[nH]cc(Cl)c3c2)cc2cc(Cl)cnc12	InChI=1S/C25H18Cl2N6O2/c26-17-7-16-3-13(5-20(23(28)34)22(16)30-11-17)4-18-8-15(1-2-29-18)25(35)33-10-14-6-19-21(27)12-32-24(19)31-9-14/h1-3,5-9,11-12H,4,10H2,(H2,28,34)(H,31,32)(H,33,35)	QHIFWJFJAOUBPC-UHFFFAOYSA-N	283409	3-chloro-6-((4-(((3-chloro-1H-pyrrolo[2,3- b]pyridin-5-yl)methyl)carbamoyl)pyridin-2- yl)methyl)quinoline-8-carboxamide::US10023557, Example 61::US10266515, Example 61::US10308637, Example 61::US11021463, Example 61::US9611252, Example 61	Plasma kallikrein					 550					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283409	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283409&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665370	378164738							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540540	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2cc(C(N)=O)c3ncc(Cl)cc3c2)c1	InChI=1S/C24H21ClN6O2/c1-13-16(2-3-21(26)31-13)11-30-24(33)15-4-5-28-19(10-15)7-14-6-17-9-18(25)12-29-22(17)20(8-14)23(27)32/h2-6,8-10,12H,7,11H2,1H3,(H2,26,31)(H2,27,32)(H,30,33)	WTBBASBLRSFZPD-UHFFFAOYSA-N	283410	6-((4-(((6-amino-2-methylpyridin-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- chloroquinoline-8-carboxamide::US10023557, Example 62::US10266515, Example 62::US10308637, Example 62::US11021463, Example 62::US9611252, Example 62	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283410	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283410&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665142	378164739							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540541	NC(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2ccc3c(N)nccc3c2)cc2cc(Cl)cnc12	InChI=1S/C27H21ClN6O2/c28-20-11-19-8-16(10-23(26(30)35)24(19)33-14-20)9-21-12-18(4-5-31-21)27(36)34-13-15-1-2-22-17(7-15)3-6-32-25(22)29/h1-8,10-12,14H,9,13H2,(H2,29,32)(H2,30,35)(H,34,36)	ZEVNHPCICZZSBU-UHFFFAOYSA-N	283412	6-((4-(((1-aminoisoquinolin-6- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- chloroquinoline-8-carboxamide::US10023557, Example 64::US10266515, Example 64::US10308637, Example 64::US11021463, Example 64::US9611252, Example 64	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283412	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283412&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665252	378164741							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540542	NC(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2ccc3[nH]cc(Cl)c3c2F)cc2cc(Cl)cnc12	InChI=1S/C26H18Cl2FN5O2/c27-17-8-16-5-13(7-19(25(30)35)24(16)33-11-17)6-18-9-14(3-4-31-18)26(36)34-10-15-1-2-21-22(23(15)29)20(28)12-32-21/h1-5,7-9,11-12,32H,6,10H2,(H2,30,35)(H,34,36)	PBEXDTRCFFOFDU-UHFFFAOYSA-N	283413	3-chloro-6-((4-(((3-chloro-4-fluoro-1H-indol-5- yl)methyl)carbamoyl)pyridin-2- yl)methyl)quinoline-8-carboxamide::US10023557, Example 65::US10266515, Example 65::US10308637, Example 65::US11021463, Example 65::US9611252, Example 65	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283413	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283413&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665414	378164742							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540543	NC(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2cc3cc[nH]c3cc2F)cc2cc(Cl)cnc12	InChI=1S/C26H19ClFN5O2/c27-19-9-17-5-14(7-21(25(29)34)24(17)32-13-19)6-20-10-16(2-3-30-20)26(35)33-12-18-8-15-1-4-31-23(15)11-22(18)28/h1-5,7-11,13,31H,6,12H2,(H2,29,34)(H,33,35)	ZDVUWSXSXIPPGM-UHFFFAOYSA-N	283414	3-chloro-6-((4-(((6-fluoro-1H-indol-5- yl)methyl)carbamoyl)pyridin-2- yl)methyl)quinoline-8-carboxamide::US10023557, Example 66::US10266515, Example 66::US10308637, Example 66::US11021463, Example 66::US9611252, Example 66	Plasma kallikrein					 550					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283414	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283414&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665192	378164743							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540544	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc(c3ncc(Cl)cc3c2)S(C)(=O)=O)c1	InChI=1S/C25H24ClN5O3S/c1-14-6-23(27)31-15(2)21(14)13-30-25(32)17-4-5-28-20(11-17)8-16-7-18-10-19(26)12-29-24(18)22(9-16)35(3,33)34/h4-7,9-12H,8,13H2,1-3H3,(H2,27,31)(H,30,32)	LOAAVKXHIOVCPQ-UHFFFAOYSA-N	283415	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloro-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 67::US10266515, Example 67::US10308637, Example 67::US11021463, Example 67::US9611252, Example 67	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283415	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283415&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213160	378164744							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540545	CS(=O)(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2cc3c(Cl)c[nH]c3cc2F)cc2cc(Cl)cnc12	InChI=1S/C26H19Cl2FN4O3S/c1-37(35,36)24-6-14(4-16-7-18(27)12-32-25(16)24)5-19-8-15(2-3-30-19)26(34)33-11-17-9-20-21(28)13-31-23(20)10-22(17)29/h2-4,6-10,12-13,31H,5,11H2,1H3,(H,33,34)	JHEOACUKXNFFDI-UHFFFAOYSA-N	283416	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3-chloro-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 68::US10266515, Example 68::US10308637, Example 68::US11021463, Example 68::US9611252, Example 68	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283416	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283416&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212213	378164745							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540546	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2cc(c3ncc(Cl)cc3c2)S(C)(=O)=O)c1	InChI=1S/C24H22ClN5O3S/c1-14-17(3-4-22(26)30-14)12-29-24(31)16-5-6-27-20(11-16)8-15-7-18-10-19(25)13-28-23(18)21(9-15)34(2,32)33/h3-7,9-11,13H,8,12H2,1-2H3,(H2,26,30)(H,29,31)	DAYVOWICNMKAHH-UHFFFAOYSA-N	283417	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-chloro-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 69::US10266515, Example 69::US10308637, Example 69::US11021463, Example 69::US9611252, Example 69	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283417	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283417&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665120	378164746							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540547	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2c1)C#N	InChI=1S/C26H24N6O/c1-15-6-20-8-18(9-21(12-27)25(20)30-13-15)10-22-11-19(4-5-29-22)26(33)31-14-23-16(2)7-24(28)32-17(23)3/h4-9,11,13H,10,14H2,1-3H3,(H2,28,32)(H,31,33)	FWOVJYZAXZFOSD-UHFFFAOYSA-N	283418	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((8-cyano-3-methylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 70::US10266515, Example 70::US10308637, Example 70::US11021463, Example 70::US9611252, Example 70	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283418	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283418&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665112	378164747							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540548	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)cc2c1)C#N	InChI=1S/C28H22N6O/c1-17-8-22-10-19(11-23(14-29)26(22)33-15-17)12-24-13-21(5-6-31-24)28(35)34-16-18-2-3-25-20(9-18)4-7-32-27(25)30/h2-11,13,15H,12,16H2,1H3,(H2,30,32)(H,34,35)	XJVZLICIUISDSM-UHFFFAOYSA-N	283419	N-((1-aminoisoquinolin-6-yl)methyl)-2-((8- cyano-3-methylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 71::US10266515, Example 71::US10308637, Example 71::US11021463, Example 71::US9611252, Example 71	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283419	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283419&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665353	378164748							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540549	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)cc2c1)C#N	InChI=1S/C27H19ClFN5O/c1-15-4-18-5-16(6-19(11-30)26(18)33-12-15)7-21-8-17(2-3-31-21)27(35)34-13-20-9-22-23(28)14-32-25(22)10-24(20)29/h2-6,8-10,12,14,32H,7,13H2,1H3,(H,34,35)	KVEDUIDZCUQFJJ-UHFFFAOYSA-N	283420	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((8-cyano-3-methylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 72::US10308637, Example 72::US11021463, Example 72::US9611252, Example 72	Plasma kallikrein					 550					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283420	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283420&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665256	378164749							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540550	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cnc4[nH]cc(Cl)c4c3)cc2c1)C#N	InChI=1S/C26H19ClN6O/c1-15-4-19-5-16(6-20(10-28)24(19)30-11-15)7-21-9-18(2-3-29-21)26(34)33-13-17-8-22-23(27)14-32-25(22)31-12-17/h2-6,8-9,11-12,14H,7,13H2,1H3,(H,31,32)(H,33,34)	DUPQBZNXOTZIFE-UHFFFAOYSA-N	283421	N-((3-chloro-1H-pyrrolo[2,3-b]pyridin-5- yl)methyl)-2-((8-cyano-3-methylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 73::US10266515, Example 73::US10308637, Example 73::US11021463, Example 73::US9611252, Example 73	Plasma kallikrein					 550					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283421	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283421&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665369	378164750							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540551	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2c1)C(N)=O	InChI=1S/C26H26N6O2/c1-14-6-19-8-17(10-21(25(28)33)24(19)30-12-14)9-20-11-18(4-5-29-20)26(34)31-13-22-15(2)7-23(27)32-16(22)3/h4-8,10-12H,9,13H2,1-3H3,(H2,27,32)(H2,28,33)(H,31,34)	OOWBJQXCALEAFC-UHFFFAOYSA-N	283425	6-((4-(((6-amino-2,4-dimethylpyridin-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- methylquinoline-8-carboxamide::US10023557, Example 77::US10266515, Example 77::US10308637, Example 77::US11021463, Example 77::US9611252, Example 77	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283425	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283425&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665125	378164754							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540552	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)cc2c1)C(N)=O	InChI=1S/C27H21ClFN5O2/c1-14-4-17-5-15(7-21(26(30)35)25(17)33-11-14)6-19-8-16(2-3-31-19)27(36)34-12-18-9-20-22(28)13-32-24(20)10-23(18)29/h2-5,7-11,13,32H,6,12H2,1H3,(H2,30,35)(H,34,36)	WETFPOPVXHIHFG-UHFFFAOYSA-N	283426	6-((4-(((3-chloro-6-fluoro-1H-indol-5- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- methylquinoline-8-carboxamide::US10023557, Example 78::US10266515, Example 78::US10308637, Example 78::US11021463, Example 78::US9611252, Example 78	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283426	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283426&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665427	378164755							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540553	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)cc2c1)C(N)=O	InChI=1S/C28H24N6O2/c1-16-8-21-10-18(12-24(27(30)35)25(21)33-14-16)11-22-13-20(5-6-31-22)28(36)34-15-17-2-3-23-19(9-17)4-7-32-26(23)29/h2-10,12-14H,11,15H2,1H3,(H2,29,32)(H2,30,35)(H,34,36)	AVMNYBKKWARJKT-UHFFFAOYSA-N	283427	6-((4-(((1-aminoisoquinolin-6- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- methylquinoline-8-carboxamide::US10023557, Example 79::US10266515, Example 79::US10308637, Example 79::US11021463, Example 79::US9611252, Example 79	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283427	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283427&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665123	378164756							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540554	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cnc4[nH]cc(Cl)c4c3)cc2c1)C(N)=O	InChI=1S/C26H21ClN6O2/c1-14-4-18-5-15(7-21(24(28)34)23(18)30-10-14)6-19-9-17(2-3-29-19)26(35)33-12-16-8-20-22(27)13-32-25(20)31-11-16/h2-5,7-11,13H,6,12H2,1H3,(H2,28,34)(H,31,32)(H,33,35)	CFJXZEDRAADQFI-UHFFFAOYSA-N	283428	6-((4-(((3-chloro-1H-pyrrolo[2,3-b]pyridin-5- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- methylquinoline-8-carboxamide::US10023557, Example 80::US10266515, Example 80::US10308637, Example 80::US11021463, Example 80::US9611252, Example 80	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283428	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283428&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665254	378164757							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540555	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3ccc4[nH]cc(Cl)c4c3F)cc2c1)C(N)=O	InChI=1S/C27H21ClFN5O2/c1-14-6-18-7-15(9-20(26(30)35)25(18)33-11-14)8-19-10-16(4-5-31-19)27(36)34-12-17-2-3-22-23(24(17)29)21(28)13-32-22/h2-7,9-11,13,32H,8,12H2,1H3,(H2,30,35)(H,34,36)	LJDMUPONZYUBTQ-UHFFFAOYSA-N	283429	6-((4-(((3-chloro-4-fluoro-1H-indol-5- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- methylquinoline-8-carboxamide::US10023557, Example 81::US10266515, Example 81::US10308637, Example 81::US11021463, Example 81::US9611252, Example 81	Plasma kallikrein					 550					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283429	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283429&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665251	378164758							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540556	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3n[nH]c4ccc(Cl)cc34)cc2c1)C(N)=O	InChI=1S/C26H21ClN6O2/c1-14-6-17-7-15(9-21(25(28)34)24(17)30-12-14)8-19-10-16(4-5-29-19)26(35)31-13-23-20-11-18(27)2-3-22(20)32-33-23/h2-7,9-12H,8,13H2,1H3,(H2,28,34)(H,31,35)(H,32,33)	KIVLLFJSACGLHN-UHFFFAOYSA-N	283430	6-((4-(((5-chloro-1H-indazol-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- methylquinoline-8-carboxamide::US10023557, Example 82::US10266515, Example 82::US10308637, Example 82::US11021463, Example 82::US9611252, Example 82	Plasma kallikrein					 550					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283430	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283430&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665290	378164759							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540557	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cc4cc[nH]c4cc3F)cc2c1)C(N)=O	InChI=1S/C27H22FN5O2/c1-15-6-19-7-16(9-22(26(29)34)25(19)32-13-15)8-21-11-18(3-4-30-21)27(35)33-14-20-10-17-2-5-31-24(17)12-23(20)28/h2-7,9-13,31H,8,14H2,1H3,(H2,29,34)(H,33,35)	UZTOCULVDVRYTA-UHFFFAOYSA-N	283431	6-((4-(((6-fluoro-1H-indol-5- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- methylquinoline-8-carboxamide::US10023557, Example 83::US10266515, Example 83::US10308637, Example 83::US11021463, Example 83::US9611252, Example 83	Plasma kallikrein					 550					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283431	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283431&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665428	378164760							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540558	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2c1)C(O)=O	InChI=1S/C26H25N5O3/c1-14-6-19-8-17(10-21(26(33)34)24(19)29-12-14)9-20-11-18(4-5-28-20)25(32)30-13-22-15(2)7-23(27)31-16(22)3/h4-8,10-12H,9,13H2,1-3H3,(H2,27,31)(H,30,32)(H,33,34)	IDXZVLZJXGFXKF-UHFFFAOYSA-N	283432	6-((4-(((6-amino-2,4-dimethylpyridin-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- methylquinoline-8-carboxylic acid::US10023557, Example 84::US10266515, Example 84::US10308637, Example 84::US11021463, Example 84::US9611252, Example 84	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283432	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283432&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665404	378164761							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540559	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc(F)c3ncc(Cl)cc3c2)c1	InChI=1S/C24H21ClFN5O/c1-13-5-22(27)31-14(2)20(13)12-30-24(32)16-3-4-28-19(10-16)7-15-6-17-9-18(25)11-29-23(17)21(26)8-15/h3-6,8-11H,7,12H2,1-2H3,(H2,27,31)(H,30,32)	NJQUWZKNWYIFOW-UHFFFAOYSA-N	283437	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloro-8-fluoroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 89::US10266515, Example 89::US10308637, Example 89::US11021463, Example 89::US9611252, Example 89	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283437	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283437&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665263	378164766							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540560	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2cc(F)c3ncc(Cl)cc3c2)c1	InChI=1S/C23H19ClFN5O/c1-13-16(2-3-21(26)30-13)11-29-23(31)15-4-5-27-19(10-15)7-14-6-17-9-18(24)12-28-22(17)20(25)8-14/h2-6,8-10,12H,7,11H2,1H3,(H2,26,30)(H,29,31)	JKVPCVWDMOMIMY-UHFFFAOYSA-N	283439	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-chloro-8-fluoroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 91::US10266515, Example 91::US10308637, Example 91::US11021463, Example 91::US9611252, Example 91	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283439	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283439&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665234	378164768							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540561	COC(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2c(C)cc(N)nc2C)cc2cc(Cl)cnc12	InChI=1S/C26H24ClN5O3/c1-14-6-23(28)32-15(2)22(14)13-31-25(33)17-4-5-29-20(11-17)8-16-7-18-10-19(27)12-30-24(18)21(9-16)26(34)35-3/h4-7,9-12H,8,13H2,1-3H3,(H2,28,32)(H,31,33)	YFEQLRSQCAMBNR-UHFFFAOYSA-N	283440	US10023557, Example 92::US10266515, Example 92::US10308637, Example 92::US11021463, Example 92::US9611252, Example 92::methyl 6-((4-(((6-amino-2,4-dimethylpyridin-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- chloroquinoline-8-carboxylate	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283440	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283440&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665210	378164769							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540562	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc(C(O)=O)c3ncc(Cl)cc3c2)c1	InChI=1S/C25H22ClN5O3/c1-13-5-22(27)31-14(2)21(13)12-30-24(32)16-3-4-28-19(10-16)7-15-6-17-9-18(26)11-29-23(17)20(8-15)25(33)34/h3-6,8-11H,7,12H2,1-2H3,(H2,27,31)(H,30,32)(H,33,34)	BVAYWMZNSZGAMT-UHFFFAOYSA-N	283441	6-((4-(((6-amino-2,4-dimethylpyridin-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- chloroquinoline-8-carboxylic acid::US10023557, Example 93::US10266515, Example 93::US10308637, Example 93::US11021463, Example 93::US9611252, Example 93	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283441	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283441&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665155	378164770							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540563	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2cc(CO)c3ncc(Cl)cc3c2)c1	InChI=1S/C24H22ClN5O2/c1-14-17(2-3-22(26)30-14)11-29-24(32)16-4-5-27-21(10-16)8-15-6-18-9-20(25)12-28-23(18)19(7-15)13-31/h2-7,9-10,12,31H,8,11,13H2,1H3,(H2,26,30)(H,29,32)	SCWQNZNCOWHKCU-UHFFFAOYSA-N	283445	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-chloro-8-(hydroxymethyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 97::US10266515, Example 97::US10308637, Example 97::US11021463, Example 97::US9611252, Example 97	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283445	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283445&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665282	378164774							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540564	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3[n+]([O-])cc(Cl)cc3c2)c1	InChI=1S/C24H22ClN5O2/c1-14-7-23(26)29-15(2)21(14)12-28-24(31)17-5-6-27-20(11-17)9-16-3-4-22-18(8-16)10-19(25)13-30(22)32/h3-8,10-11,13H,9,12H2,1-2H3,(H2,26,29)(H,28,31)	XRSVMKZHXCTYQX-UHFFFAOYSA-N	283447	6-((4-(((6-amino-2,4-dimethylpyridin-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- chloroquinoline 1-oxide::US10023557, Example 99::US10266515, Example 99::US10308637, Example 99::US11021463, Example 99::US9611252, Example 99	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283447	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283447&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665346	378164776							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540565	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc(Cl)c3ncc(Cl)cc3c2)c1	InChI=1S/C24H21Cl2N5O/c1-13-5-22(27)31-14(2)20(13)12-30-24(32)16-3-4-28-19(10-16)7-15-6-17-9-18(25)11-29-23(17)21(26)8-15/h3-6,8-11H,7,12H2,1-2H3,(H2,27,31)(H,30,32)	HHXMWQGWYOIRGQ-UHFFFAOYSA-N	283448	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3,8-dichloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 100::US10266515, Example 100::US10308637, Example 100::US11021463, Example 100::US9611252, Example 100	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283448	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283448&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665316	378164777							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540566	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2cc(Cl)c3ncc(Cl)cc3c2)c1	InChI=1S/C23H19Cl2N5O/c1-13-16(2-3-21(26)30-13)11-29-23(31)15-4-5-27-19(10-15)7-14-6-17-9-18(24)12-28-22(17)20(25)8-14/h2-6,8-10,12H,7,11H2,1H3,(H2,26,30)(H,29,31)	LGBIYJSQIIGQJI-UHFFFAOYSA-N	283449	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3,8-dichloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 101::US10266515, Example 101::US10308637, Example 101::US11021463, Example 101::US9611252, Example 101	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283449	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283449&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665134	378164778							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540567	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2F)c1	InChI=1S/C24H21ClFN5O/c1-13-7-22(27)31-14(2)20(13)12-30-24(32)16-5-6-28-18(9-16)8-15-3-4-21-19(23(15)26)10-17(25)11-29-21/h3-7,9-11H,8,12H2,1-2H3,(H2,27,31)(H,30,32)	MDLFAZWEMPYOEY-UHFFFAOYSA-N	283450	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloro-5-fluoroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 102::US10266515, Example 102::US10308637, Example 102::US11021463, Example 102::US9611252, Example 102	Plasma kallikrein					 550					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283450	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283450&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665170	378164779							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540568	Cc1cc(cc(Cc2ccc3ncc(Cl)cc3c2)n1)C(=O)NCc1c(C)cc(N)nc1C	InChI=1S/C25H24ClN5O/c1-14-6-24(27)31-16(3)22(14)13-29-25(32)19-7-15(2)30-21(11-19)9-17-4-5-23-18(8-17)10-20(26)12-28-23/h4-8,10-12H,9,13H2,1-3H3,(H2,27,31)(H,29,32)	WDMJJASBQUYWJX-UHFFFAOYSA-N	283452	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloroquinolin-6-yl)methyl)-6- methylisonicotinamide::US10023557, Example 104::US10023557, Example 197::US10266515, Example 104::US10308637, Example 197::US11021463, Example 104::US9611252, Example 104	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283452	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283452&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665211	378164781							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540569	Cc1ccc2cc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)ccc2n1	InChI=1S/C26H20ClFN4O/c1-15-2-4-17-8-16(3-5-24(17)32-15)9-20-10-18(6-7-29-20)26(33)31-13-19-11-21-22(27)14-30-25(21)12-23(19)28/h2-8,10-12,14,30H,9,13H2,1H3,(H,31,33)	SQVVRWKBMIEHGU-UHFFFAOYSA-N	283458	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((2-methylquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 110::US10266515, Example 110::US10308637, Example 110::US11021463, Example 110::US9611252, Example 110	Plasma kallikrein					 550					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283458	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283458&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212258	378164786							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540570	Cc1ccc2cc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)ccc2n1	InChI=1S/C27H23N5O/c1-17-2-5-21-12-18(4-7-25(21)32-17)14-23-15-22(9-10-29-23)27(33)31-16-19-3-6-24-20(13-19)8-11-30-26(24)28/h2-13,15H,14,16H2,1H3,(H2,28,30)(H,31,33)	BHHAKIOPTCXPSL-UHFFFAOYSA-N	283459	N-((1-aminoisoquinolin-6-yl)methyl)-2-((2- methylquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 111::US10266515, Example 111::US10308637, Example 111::US11021463, Example 111::US9611252, Example 111	Plasma kallikrein					 550					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283459	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283459&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212697	378164787							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540571	Cc1ccc2cc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)ccc2n1	InChI=1S/C25H25N5O/c1-15-10-24(26)30-17(3)22(15)14-28-25(31)20-8-9-27-21(13-20)12-18-5-7-23-19(11-18)6-4-16(2)29-23/h4-11,13H,12,14H2,1-3H3,(H2,26,30)(H,28,31)	SOGVYINZTNHWMJ-UHFFFAOYSA-N	283461	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((2-methylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 113::US10266515, Example 113::US10308637, Example 113::US11021463, Example 113::US9611252, Example 113	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283461	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283461&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212447	378164789							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540572	Cc1ccc2ncc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2c1	InChI=1S/C25H25N5O/c1-15-4-5-23-20(8-15)10-18(13-28-23)11-21-12-19(6-7-27-21)25(31)29-14-22-16(2)9-24(26)30-17(22)3/h4-10,12-13H,11,14H2,1-3H3,(H2,26,30)(H,29,31)	PERODSYFHIKGOQ-UHFFFAOYSA-N	283462	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((6-methylquinolin-3- yl)methyl)isonicotinamide::US10023557, Example 114::US10266515, Example 114::US10308637, Example 114::US11021463, Example 114::US9611252, Example 114	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283462	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283462&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212424	378164790							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540573	Cc1ccc2ncc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)cc2c1	InChI=1S/C27H23N5O/c1-17-2-5-25-22(10-17)12-19(16-31-25)13-23-14-21(7-8-29-23)27(33)32-15-18-3-4-24-20(11-18)6-9-30-26(24)28/h2-12,14,16H,13,15H2,1H3,(H2,28,30)(H,32,33)	YXYWWKCODFDZSQ-UHFFFAOYSA-N	283463	N-((1-aminoisoquinolin-6-yl)methyl)-2-((6- methylquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 115::US10266515, Example 115::US10308637, Example 115::US11021463, Example 115::US9611252, Example 115	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283463	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283463&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212341	378164791							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540574	Cc1ccc2ncc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)cc2c1	InChI=1S/C26H20ClFN4O/c1-15-2-3-24-18(6-15)7-16(12-30-24)8-20-9-17(4-5-29-20)26(33)32-13-19-10-21-22(27)14-31-25(21)11-23(19)28/h2-7,9-12,14,31H,8,13H2,1H3,(H,32,33)	HEFJFXWKPBYZLZ-UHFFFAOYSA-N	283464	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((6-methylquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 116::US10266515, Example 116::US10308637, Example 116::US11021463, Example 116::US9611252, Example 116	Plasma kallikrein					 550					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283464	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283464&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212685	378164792							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540575	Cc1ccc2ncc(Cc3cc(ccn3)C(=O)NCc3ccc(N)nc3C)cc2c1	InChI=1S/C24H23N5O/c1-15-3-5-22-20(9-15)10-17(13-27-22)11-21-12-18(7-8-26-21)24(30)28-14-19-4-6-23(25)29-16(19)2/h3-10,12-13H,11,14H2,1-2H3,(H2,25,29)(H,28,30)	WNXNZZRXTORCMQ-UHFFFAOYSA-N	283465	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((6-methylquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 117::US10266515, Example 117::US10308637, Example 117::US11021463, Example 117::US9611252, Example 117	Plasma kallikrein					 550					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283465	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283465&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212579	378164793							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540576	Nc1nccc2cc(CNC(=O)c3ccnc(Cc4cnc5ccc(F)cc5c4)c3)ccc12	InChI=1S/C26H20FN5O/c27-21-2-4-24-20(12-21)10-17(15-31-24)11-22-13-19(6-7-29-22)26(33)32-14-16-1-3-23-18(9-16)5-8-30-25(23)28/h1-10,12-13,15H,11,14H2,(H2,28,30)(H,32,33)	FEOOVYNQAJINSQ-UHFFFAOYSA-N	283466	N-((1-aminoisoquinolin-6-yl)methyl)-2-((6- fluoroquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 118::US10266515, Example 118::US10308637, Example 118::US11021463, Example 118::US9611252, Example 118	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283466	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283466&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212932	378164794							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540577	Cc1cc2cc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)ccc2cn1	InChI=1S/C27H23N5O/c1-17-10-23-11-18(2-4-22(23)16-31-17)13-24-14-21(7-8-29-24)27(33)32-15-19-3-5-25-20(12-19)6-9-30-26(25)28/h2-12,14,16H,13,15H2,1H3,(H2,28,30)(H,32,33)	KZGIIODXNPBNJO-UHFFFAOYSA-N	283480	N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- methylisoquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 132::US10266515, Example 132::US10308637, Example 132::US11021463, Example 132::US9611252, Example 132	Plasma kallikrein					 550					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283480	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283480&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213018	378164808							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540578	Cc1cnc2ccc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)cc2c1	InChI=1S/C27H23N5O/c1-17-10-22-11-18(3-5-25(22)31-15-17)13-23-14-21(7-8-29-23)27(33)32-16-19-2-4-24-20(12-19)6-9-30-26(24)28/h2-12,14-15H,13,16H2,1H3,(H2,28,30)(H,32,33)	XPXFEZOWOODSMW-UHFFFAOYSA-N	283490	N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- methylquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 142::US10266515, Example 142::US10308637, Example 142::US11021463, Example 142::US9611252, Example 142	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283490	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283490&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212463	378164818							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540579	Cc1cnc2ccc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)cc2c1	InChI=1S/C26H20ClFN4O/c1-15-6-18-7-16(2-3-24(18)30-12-15)8-20-9-17(4-5-29-20)26(33)32-13-19-10-21-22(27)14-31-25(21)11-23(19)28/h2-7,9-12,14,31H,8,13H2,1H3,(H,32,33)	BAWQXCVTJNYXQW-UHFFFAOYSA-N	283491	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3-methylquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 143::US10266515, Example 143::US10308637, Example 143::US11021463, Example 143::US9611252, Example 143	Plasma kallikrein					 550					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283491	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283491&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212764	378164819							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540580	Cc1cnc2ccc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2c1	InChI=1S/C25H25N5O/c1-15-8-20-10-18(4-5-23(20)28-13-15)11-21-12-19(6-7-27-21)25(31)29-14-22-16(2)9-24(26)30-17(22)3/h4-10,12-13H,11,14H2,1-3H3,(H2,26,30)(H,29,31)	BDBQXLZXRHXRJN-UHFFFAOYSA-N	283492	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-methylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 144::US10266515, Example 144::US10308637, Example 144::US11021463, Example 144::US9611252, Example 144	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283492	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283492&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212432	378164820							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540581	Cc1cc2cc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)ccc2cn1	InChI=1S/C25H25N5O/c1-15-8-24(26)30-17(3)23(15)14-29-25(31)19-6-7-27-22(12-19)11-18-4-5-20-13-28-16(2)9-21(20)10-18/h4-10,12-13H,11,14H2,1-3H3,(H2,26,30)(H,29,31)	IDPUQOZCEWQYLL-UHFFFAOYSA-N	283493	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-methylisoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 145::US10266515, Example 145::US10308637, Example 145::US11021463, Example 145::US9611252, Example 145	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283493	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283493&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212443	378164821							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540582	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc3cc(Cl)cnc3cn2)c1	InChI=1S/C23H21ClN6O/c1-13-5-22(25)30-14(2)20(13)11-29-23(31)15-3-4-26-18(7-15)9-19-8-16-6-17(24)10-28-21(16)12-27-19/h3-8,10,12H,9,11H2,1-2H3,(H2,25,30)(H,29,31)	DOFBPINSGHHTHL-UHFFFAOYSA-N	283496	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloro-1,7-naphthyridin-6- yl)methyl)isonicotinamide::US10023557, Example 148::US10308637, Example 148	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283496	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283496&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182428	378164824							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540583	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2cc3cc(Cl)cnc3cn2)c1	InChI=1S/C22H19ClN6O/c1-13-15(2-3-21(24)29-13)10-28-22(30)14-4-5-25-18(7-14)9-19-8-16-6-17(23)11-27-20(16)12-26-19/h2-8,11-12H,9-10H2,1H3,(H2,24,29)(H,28,30)	KXUGLTKYGLLMBT-UHFFFAOYSA-N	283497	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-chloro-1,7-naphthyridin-6- yl)methyl)isonicotinamide::US10023557, Example 149::US10308637, Example 149	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283497	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283497&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182483	378164825							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540584	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cnc3[nH]c(cc3c2)C(F)(F)F)c1	InChI=1S/C23H21F3N6O/c1-12-5-20(27)31-13(2)18(12)11-30-22(33)15-3-4-28-17(8-15)7-14-6-16-9-19(23(24,25)26)32-21(16)29-10-14/h3-6,8-10H,7,11H2,1-2H3,(H2,27,31)(H,29,32)(H,30,33)	OSQCTZSKPWGQIJ-UHFFFAOYSA-N	283500	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((2-(trifluoromethyl)-1H-pyrrolo[2,3- b]pyridin-5-yl)methyl)isonicotinamide::US10023557, Example 152::US10308637, Example 152	Plasma kallikrein					 550					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283500	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283500&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124181930	378164828							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540585	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc3cc(Cl)cn3cn2)c1	InChI=1S/C22H21ClN6O/c1-13-5-21(24)28-14(2)20(13)10-26-22(30)15-3-4-25-17(6-15)8-18-9-19-7-16(23)11-29(19)12-27-18/h3-7,9,11-12H,8,10H2,1-2H3,(H2,24,28)(H,26,30)	SQUKLLPOSXHIBK-UHFFFAOYSA-N	283501	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((6-chloropyrrolo [1,2-c]pyrimidin-3- yl)methyl)isonicotinamide::US10023557, Example 153::US10308637, Example 153	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283501	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283501&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124181891	378164829							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540586	Cc1ccn2cnc(CNC(=O)c3ccnc(Cc4ccc5ncc(Cl)cc5c4)c3)c2c1	InChI=1S/C25H20ClN5O/c1-16-5-7-31-15-30-23(24(31)8-16)14-29-25(32)18-4-6-27-21(12-18)10-17-2-3-22-19(9-17)11-20(26)13-28-22/h2-9,11-13,15H,10,14H2,1H3,(H,29,32)	YCIACGKRXNLORD-UHFFFAOYSA-N	283505	2-((3-chloroquinolin-6-yl)methyl)-N-((7- methylimidazo[1,5-a]pyridin-1- yl)methyl0isonicotinamide::US10023557, Example 156::US10308637, Example 156	Plasma kallikrein					 550					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283505	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283505&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126501507	378164833							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540587	Cc1cc(CN)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C25H24ClN5O/c1-15-7-22(12-27)31-16(2)23(15)14-30-25(32)18-5-6-28-21(11-18)9-17-3-4-24-19(8-17)10-20(26)13-29-24/h3-8,10-11,13H,9,12,14,27H2,1-2H3,(H,30,32)	KRPYDVGDFIHKMK-UHFFFAOYSA-N	283522	N-((6-(aminomethyl)-2,4-dimethylpyridin-3- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 171::US10308637, Example 171	Plasma kallikrein					 550					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283522	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283522&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182517	378164850							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540588	Cc1cc(CN)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3ncc(cc3c2)C(F)(F)F)c1	InChI=1S/C26H24F3N5O/c1-15-7-22(12-30)34-16(2)23(15)14-33-25(35)18-5-6-31-21(11-18)9-17-3-4-24-19(8-17)10-20(13-32-24)26(27,28)29/h3-8,10-11,13H,9,12,14,30H2,1-2H3,(H,33,35)	MCBPNFNZAWRTIW-UHFFFAOYSA-N	283523	N-((6-(aminomethyl)-2,4-dimethylpyridin-3- yl)methyl)-2-((3-(trifluoromethyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 172::US10308637, Example 172	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283523	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283523&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182577	378164851							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540589	Cc1nc2NCCc2c(C)c1CNC(=O)c1ccnc(Cc2ccc3ncc(cc3c2)C(F)(F)F)c1	InChI=1S/C27H24F3N5O/c1-15-22-6-8-32-25(22)35-16(2)23(15)14-34-26(36)18-5-7-31-21(12-18)10-17-3-4-24-19(9-17)11-20(13-33-24)27(28,29)30/h3-5,7,9,11-13H,6,8,10,14H2,1-2H3,(H,32,35)(H,34,36)	VVONGBLBROSHAM-UHFFFAOYSA-N	283527	N-((4,6-dimethyl-2,3-dihydro-1H-pyrrolo[2,3- b]pyridin-5-yl)methyl)-2-((3- (trifluoromethyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 176::US10308637, Example 176	Plasma kallikrein					 550					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283527	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283527&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182506	378164855							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540590	Cc1c(CNC(=O)c2ccnc(Cc3ccc4ncc(Cl)cc4c3)c2)ccc2c(N)nccc12	InChI=1S/C27H22ClN5O/c1-16-19(3-4-24-23(16)7-9-31-26(24)29)14-33-27(34)18-6-8-30-22(13-18)11-17-2-5-25-20(10-17)12-21(28)15-32-25/h2-10,12-13,15H,11,14H2,1H3,(H2,29,31)(H,33,34)	YXPTZYQGGAGCHI-UHFFFAOYSA-N	283528	N-((1-amino-5-methylisoquinolin-6-yl)methyl)- 2-((3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 177::US10308637, Example 177	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283528	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283528&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124181936	378164856							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540591	Nc1nccc2c(F)c(CNC(=O)c3ccnc(Cc4ccc5ncc(Cl)cc5c4)c3)ccc12	InChI=1S/C26H19ClFN5O/c27-19-11-18-9-15(1-4-23(18)32-14-19)10-20-12-16(5-7-30-20)26(34)33-13-17-2-3-22-21(24(17)28)6-8-31-25(22)29/h1-9,11-12,14H,10,13H2,(H2,29,31)(H,33,34)	FOHRMFWTCTZUPO-UHFFFAOYSA-N	283529	N-((1-amino-5-fluoroisoquinolin-6-yl)methyl)-2- ((3-chloroquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 178::US10308637, Example 178	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283529	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283529&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124181934	378164857							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540592	Nc1nccc2cc(CNC(=O)c3ccnc(Cc4ccc5ncc(Cl)cc5c4)c3)ccc12	InChI=1S/C26H20ClN5O/c27-21-12-20-9-16(2-4-24(20)31-15-21)11-22-13-19(6-7-29-22)26(33)32-14-17-1-3-23-18(10-17)5-8-30-25(23)28/h1-10,12-13,15H,11,14H2,(H2,28,30)(H,32,33)	WHHMKDFLRDNMQE-UHFFFAOYSA-N	283379	N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- chloroquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 179::US10023557, Example 31::US10266515, Example 31::US10308637, Example 179::US11021463, Example 31::US9611252, Example 31	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283379	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283379&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212700	378164708							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540593	Nc1nccc2cc(CNC(=O)c3ccnc(Cc4ccc5ncc(Cl)cc5c4)c3)c(F)cc12	InChI=1S/C26H19ClFN5O/c27-20-10-18-7-15(1-2-24(18)32-14-20)8-21-11-17(4-5-30-21)26(34)33-13-19-9-16-3-6-31-25(29)22(16)12-23(19)28/h1-7,9-12,14H,8,13H2,(H2,29,31)(H,33,34)	HCTXZEOGTFJACK-UHFFFAOYSA-N	283531	N-((1-amino-7-fluoroisoquinolin-6-yl)methyl)-2- ((3-chloroquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 180::US10308637, Example 180	Plasma kallikrein					 550					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283531	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283531&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182533	378164858							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540594	Cc1cc2c(N)nccc2cc1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C27H22ClN5O/c1-16-8-24-18(4-7-31-26(24)29)11-21(16)14-33-27(34)19-5-6-30-23(13-19)10-17-2-3-25-20(9-17)12-22(28)15-32-25/h2-9,11-13,15H,10,14H2,1H3,(H2,29,31)(H,33,34)	MSEKTXXPPKABMW-UHFFFAOYSA-N	283532	N-((1-amino-7-methylisoquinolin-6-yl)methyl)- 2-((3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 181::US10308637, Example 181	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283532	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283532&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126501511	378164859							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540595	Nc1nccc2cc(CNC(=O)c3ccnc(Cc4ccc5ncc(cc5c4)C(F)(F)F)c3)c(F)cc12	InChI=1S/C27H19F4N5O/c28-23-12-22-16(3-6-34-25(22)32)9-19(23)13-36-26(37)17-4-5-33-21(11-17)8-15-1-2-24-18(7-15)10-20(14-35-24)27(29,30)31/h1-7,9-12,14H,8,13H2,(H2,32,34)(H,36,37)	PHBQHWAZPBJXLD-UHFFFAOYSA-N	283533	N-((1-amino-7-fluoroisoquinolin-6-yl)methyl)-2- ((3-(trifluoromethyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 182::US10308637, Example 182	Plasma kallikrein					 550					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283533	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283533&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124183250	378164860							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540596	Cc1cc2c(N)nccc2cc1CNC(=O)c1ccnc(Cc2ccc3ncc(cc3c2)C(F)(F)F)c1	InChI=1S/C28H22F3N5O/c1-16-8-24-18(4-7-34-26(24)32)11-21(16)14-36-27(37)19-5-6-33-23(13-19)10-17-2-3-25-20(9-17)12-22(15-35-25)28(29,30)31/h2-9,11-13,15H,10,14H2,1H3,(H2,32,34)(H,36,37)	ANBJVFLQNRMXDF-UHFFFAOYSA-N	283534	N-((1-amino-7-methylisoquinolin-6-yl)methyl)- 2-((3-(trifluoromethyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 183::US10308637, Example 183	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283534	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283534&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182035	378164861							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540597	Cc1c(CNC(=O)c2ccnc(Cc3ccc4ncc(cc4c3)C(F)(F)F)c2)ccc2c(N)nccc12	InChI=1S/C28H22F3N5O/c1-16-19(3-4-24-23(16)7-9-34-26(24)32)14-36-27(37)18-6-8-33-22(13-18)11-17-2-5-25-20(10-17)12-21(15-35-25)28(29,30)31/h2-10,12-13,15H,11,14H2,1H3,(H2,32,34)(H,36,37)	ZNCHUSONBPLTLN-UHFFFAOYSA-N	283535	N-((1-amino-5-methylisoquinolion-6-yl)methyl)- 2-((3-(trifluoromethyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 184::US10308637, Example 184	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283535	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283535&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182981	378164862							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540598	Nc1nc(n2cc(CNC(=O)c3ccnc(Cc4ccc5ncc(Cl)cc5c4)c3)ccc12)C(F)(F)F	InChI=1S/C25H18ClF3N6O/c26-18-9-17-7-14(1-3-20(17)32-12-18)8-19-10-16(5-6-31-19)23(36)33-11-15-2-4-21-22(30)34-24(25(27,28)29)35(21)13-15/h1-7,9-10,12-13H,8,11,30H2,(H,33,36)	LHJQNHXTHBPWCV-UHFFFAOYSA-N	283537	N-((1-amino-3-(trifluoromethyl)imidazo[1,5- a]pyridin-6-yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 186::US10308637, Example 186	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283537	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283537&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124181933	378164864							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540599	Cc1cc(cc(Cc2ccc3ncc(Cl)cc3c2)n1)C(=O)NCc1c(C)cc(N)nc1C	InChI=1S/C25H24ClN5O/c1-14-6-24(27)31-16(3)22(14)13-29-25(32)19-7-15(2)30-21(11-19)9-17-4-5-23-18(8-17)10-20(26)12-28-23/h4-8,10-12H,9,13H2,1-3H3,(H2,27,31)(H,29,32)	WDMJJASBQUYWJX-UHFFFAOYSA-N	283452	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloroquinolin-6-yl)methyl)-6- methylisonicotinamide::US10023557, Example 104::US10023557, Example 197::US10266515, Example 104::US10308637, Example 197::US11021463, Example 104::US9611252, Example 104	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283452	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283452&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665211	378164781							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540600	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cnc3ncc(Cl)cc3c2)c1	InChI=1S/C23H21ClN6O/c1-13-5-21(25)30-14(2)20(13)12-29-23(31)16-3-4-26-19(9-16)7-15-6-17-8-18(24)11-28-22(17)27-10-15/h3-6,8-11H,7,12H2,1-2H3,(H2,25,30)(H,29,31)	ICJIUAHCHWDSAC-UHFFFAOYSA-N	283555	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((6-chloro-1,8-naphthyridin-3- yl)methyl)isonicotinamide::US10023557, Example 204::US10308637, Example 204	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283555	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283555&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124181948	378164880							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540601	Cc1cc(N)nc(C)c1CNC(=O)c1cc(Cc2ccc3ncc(Cl)cc3c2)nc(c1)C(N)=O	InChI=1S/C25H23ClN6O2/c1-13-5-23(27)31-14(2)20(13)12-30-25(34)17-9-19(32-22(10-17)24(28)33)7-15-3-4-21-16(6-15)8-18(26)11-29-21/h3-6,8-11H,7,12H2,1-2H3,(H2,27,31)(H2,28,33)(H,30,34)	APIQHIASTKZZSI-UHFFFAOYSA-N	283559	N4-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 6-((3-chloroquinolin-6-yl)methyl)pyridine-2,4- dicarboxamide::US10023557, Example 208::US10023557, Example 209::US10308637, Example 208	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283559	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283559&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182675	378164884							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540602	Cc1cc(N)nc(C)c1CNC(=O)c1cc(Cc2ccc3ncc(Cl)cc3c2)nc(c1)C(N)=O	InChI=1S/C25H23ClN6O2/c1-13-5-23(27)31-14(2)20(13)12-30-25(34)17-9-19(32-22(10-17)24(28)33)7-15-3-4-21-16(6-15)8-18(26)11-29-21/h3-6,8-11H,7,12H2,1-2H3,(H2,27,31)(H2,28,33)(H,30,34)	APIQHIASTKZZSI-UHFFFAOYSA-N	283559	N4-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 6-((3-chloroquinolin-6-yl)methyl)pyridine-2,4- dicarboxamide::US10023557, Example 208::US10023557, Example 209::US10308637, Example 208	Plasma kallikrein					 550					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283559	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283559&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182675	378164884							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540603	Cc1cc(N)nc(C)c1CNC(=O)c1cc(Cc2ccc3ncc(Cl)cc3c2)nc(c1)C(C)(C)O	InChI=1S/C27H28ClN5O2/c1-15-7-25(29)32-16(2)22(15)14-31-26(34)19-11-21(33-24(12-19)27(3,4)35)9-17-5-6-23-18(8-17)10-20(28)13-30-23/h5-8,10-13,35H,9,14H2,1-4H3,(H2,29,32)(H,31,34)	KLVVQHRXXMNNPG-UHFFFAOYSA-N	283561	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloroquinolin-6-yl)methyl)-6-(2- hydroxypropan-2-yl)isonicotinamide::US10023557, Example 210::US10308637, Example 210	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283561	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283561&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182880	378164885							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540604	Cc1cc(N)nc(C)c1CNC(=O)c1cc(CN)nc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C25H25ClN6O/c1-14-5-24(28)31-15(2)22(14)13-30-25(33)18-9-20(32-21(10-18)11-27)7-16-3-4-23-17(6-16)8-19(26)12-29-23/h3-6,8-10,12H,7,11,13,27H2,1-2H3,(H2,28,31)(H,30,33)	WKUNOXOFANOVRL-UHFFFAOYSA-N	283562	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-(aminomethyl)-6-((3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 211::US10308637, Example 211	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283562	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283562&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124181929	378164886							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540605	Cc1cc(N)nc(C)c1CNC(=O)c1cc(CO)nc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C25H24ClN5O2/c1-14-5-24(27)30-15(2)22(14)12-29-25(33)18-9-20(31-21(10-18)13-32)7-16-3-4-23-17(6-16)8-19(26)11-28-23/h3-6,8-11,32H,7,12-13H2,1-2H3,(H2,27,30)(H,29,33)	CQRHLRRXAVLMJK-UHFFFAOYSA-N	283563	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloroquinolin-6-yl)methyl)-6- (hydroxymethyl)isonicotinamide::US10023557, Example 212::US10308637, Example 212	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283563	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283563&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124181946	378164887							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540606	Cc1cc(N)nc(C)c1CNC(=O)c1cc(CC#N)nc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C26H23ClN6O/c1-15-7-25(29)32-16(2)23(15)14-31-26(34)19-11-21(5-6-28)33-22(12-19)9-17-3-4-24-18(8-17)10-20(27)13-30-24/h3-4,7-8,10-13H,5,9,14H2,1-2H3,(H2,29,32)(H,31,34)	SGTIEOYDXRUOPQ-UHFFFAOYSA-N	283564	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloroquinolin-6-yl)methyl)-6- (cyanomethyl)isonicotinamide::US10023557, Example 213::US10308637, Example 213	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283564	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283564&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182548	378164888							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540607	Cc1cc(N)nc(C)c1CNC(=O)c1cc(CC(N)=O)nc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C26H25ClN6O2/c1-14-5-24(28)32-15(2)22(14)13-31-26(35)18-9-20(33-21(10-18)11-25(29)34)7-16-3-4-23-17(6-16)8-19(27)12-30-23/h3-6,8-10,12H,7,11,13H2,1-2H3,(H2,28,32)(H2,29,34)(H,31,35)	YAEFFBRTLWFBFV-UHFFFAOYSA-N	283565	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-(2-amino-2-oxoethyl)-6-((3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 214::US10308637, Example 214	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283565	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283565&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124181950	378164889							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540608	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc3cc(cnc3[nH]2)C(F)(F)F)c1	InChI=1S/C23H21F3N6O/c1-12-5-20(27)31-13(2)19(12)11-30-22(33)14-3-4-28-17(7-14)9-18-8-15-6-16(23(24,25)26)10-29-21(15)32-18/h3-8,10H,9,11H2,1-2H3,(H2,27,31)(H,29,32)(H,30,33)	SQKIYYNBNGHZOF-UHFFFAOYSA-N	283566	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((5-(trifluoromethyl)-1H-pyrrolo[2,3- b]pyridin-2-yl)methyl)isonicotinamide::US10023557, Example 215::US10308637, Example 215	Plasma kallikrein					 550					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283566	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283566&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182012	378164890							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540609	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc(N)c3ncc(Cl)cc3c2)c1	InChI=1S/C24H23ClN6O/c1-13-5-22(27)31-14(2)20(13)12-30-24(32)16-3-4-28-19(10-16)7-15-6-17-9-18(25)11-29-23(17)21(26)8-15/h3-6,8-11H,7,12,26H2,1-2H3,(H2,27,31)(H,30,32)	FCNWVPLZOZKABE-UHFFFAOYSA-N	283568	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((8-amino-3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 217::US10308637, Example 217	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283568	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283568&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182033	378164892							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540610	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc(c3ncc(Cl)cc3c2)C(C)(C)O)c1	InChI=1S/C27H28ClN5O2/c1-15-7-24(29)33-16(2)22(15)14-32-26(34)18-5-6-30-21(12-18)9-17-8-19-11-20(28)13-31-25(19)23(10-17)27(3,4)35/h5-8,10-13,35H,9,14H2,1-4H3,(H2,29,33)(H,32,34)	CAMCXNZEUNOLQS-UHFFFAOYSA-N	283570	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloro-8-(2-hydroxypropan-2-yl)quinolin- 6-yl)methyl)isonicotinamide::US10023557, Example 219::US10308637, Example 219	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283570	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283570&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126501514	378164894							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540611	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2cc(c3ncc(Cl)cc3c2)C(C)(C)O)c1	InChI=1S/C26H26ClN5O2/c1-15-18(4-5-23(28)32-15)13-31-25(33)17-6-7-29-21(12-17)9-16-8-19-11-20(27)14-30-24(19)22(10-16)26(2,3)34/h4-8,10-12,14,34H,9,13H2,1-3H3,(H2,28,32)(H,31,33)	UKAZGEKVALJKKV-UHFFFAOYSA-N	283571	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-chloro-8-(2-hydroxypropan-2-yl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 220::US10308637, Example 220	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283571	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283571&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126501515	378164895							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540612	CC(C)(O)c1cc(Cc2cc(ccn2)C(=O)NCc2cc3c(Cl)c[nH]c3cc2F)cc2cc(Cl)cnc12	InChI=1S/C28H23Cl2FN4O2/c1-28(2,37)22-7-15(5-17-8-19(29)13-34-26(17)22)6-20-9-16(3-4-32-20)27(36)35-12-18-10-21-23(30)14-33-25(21)11-24(18)31/h3-5,7-11,13-14,33,37H,6,12H2,1-2H3,(H,35,36)	JTSSXAIYEHJPRT-UHFFFAOYSA-N	283572	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3-chloro-8-(2-hydroxypropan-2-yl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 221::US10308637, Example 221	Plasma kallikrein					 550					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283572	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283572&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124183146	378164896							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540613	CC(C)(O)c1cc(Cc2cc(ccn2)C(=O)NCc2ccc3[nH]cc(Cl)c3c2F)cc2cc(Cl)cnc12	InChI=1S/C28H23Cl2FN4O2/c1-28(2,37)21-9-15(7-18-10-19(29)13-34-26(18)21)8-20-11-16(5-6-32-20)27(36)35-12-17-3-4-23-24(25(17)31)22(30)14-33-23/h3-7,9-11,13-14,33,37H,8,12H2,1-2H3,(H,35,36)	GMCQLRANWRPJLS-UHFFFAOYSA-N	283573	N-((3-chloro-4-fluoro-1H-indol-5-yl)methyl)-2- ((3-chloro-8-(2-hydroxypropan-2-yl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 222::US10308637, Example 222	Plasma kallikrein					 550					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283573	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283573&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182922	378164897							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540614	CC(C)(O)c1cc(Cc2cc(ccn2)C(=O)NCc2cnc3[nH]cc(Cl)c3c2)cc2cc(Cl)cnc12	InChI=1S/C27H23Cl2N5O2/c1-27(2,36)22-8-15(5-18-9-19(28)13-31-24(18)22)6-20-10-17(3-4-30-20)26(35)34-12-16-7-21-23(29)14-33-25(21)32-11-16/h3-5,7-11,13-14,36H,6,12H2,1-2H3,(H,32,33)(H,34,35)	QMKHQGBBIIJGJC-UHFFFAOYSA-N	283575	N-((3-chloro-1H-pyrrolo[2,3-b]pyridin-5- yl)methyl)-2-((3-chloro-8-(2-hydroxypropan-2- yl)quinolin-6-yl)methyl)isonicotinamide::US10023557, Example 223::US10308637, Example 223	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283575	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283575&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182300	378164899							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540615	CC(C)(O)c1cc(Cc2cc(ccn2)C(=O)NCc2ccc3c(N)nccc3c2)cc2cc(Cl)cnc12	InChI=1S/C29H26ClN5O2/c1-29(2,37)25-12-18(10-21-13-22(30)16-34-26(21)25)11-23-14-20(6-7-32-23)28(36)35-15-17-3-4-24-19(9-17)5-8-33-27(24)31/h3-10,12-14,16,37H,11,15H2,1-2H3,(H2,31,33)(H,35,36)	APJPLXDNIOYUIA-UHFFFAOYSA-N	283576	N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- chloro-8-(2-hydroxypropan-2-yl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 224::US10308637, Example 224	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283576	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283576&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182897	378164900							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540616	CC(C)(O)c1cc(Cc2cc(ccn2)C(=O)NCc2n[nH]c3ccc(Cl)cc23)cc2cc(Cl)cnc12	InChI=1S/C27H23Cl2N5O2/c1-27(2,36)22-9-15(7-17-10-19(29)13-31-25(17)22)8-20-11-16(5-6-30-20)26(35)32-14-24-21-12-18(28)3-4-23(21)33-34-24/h3-7,9-13,36H,8,14H2,1-2H3,(H,32,35)(H,33,34)	FUJKDPLSFYNFOM-UHFFFAOYSA-N	283577	N-((5-chloro-1H-indazol-3-yl)methyl)-2-((3- chloro-8-(2-hydroxypropan-2-yl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 225::US10308637, Example 225	Plasma kallikrein					 550					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283577	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283577&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124183147	378164901							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540617	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cnc3cc(F)c(Cl)cc3c2)c1	InChI=1S/C24H21ClFN5O/c1-13-5-23(27)31-14(2)19(13)12-30-24(32)16-3-4-28-18(8-16)7-15-6-17-9-20(25)21(26)10-22(17)29-11-15/h3-6,8-11H,7,12H2,1-2H3,(H2,27,31)(H,30,32)	DEFUWZJDNKPRKM-UHFFFAOYSA-N	283578	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((6-chloro-7-fluoroquinolin-3- yl)methyl)isonicotinamide::US10023557, Example 226::US10308637, Example 226	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283578	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283578&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182977	378164902							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540618	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3ncc(cc3c2)C(F)(F)F)c1	InChI=1S/C25H22F3N5O/c1-14-7-23(29)33-15(2)21(14)13-32-24(34)17-5-6-30-20(11-17)9-16-3-4-22-18(8-16)10-19(12-31-22)25(26,27)28/h3-8,10-12H,9,13H2,1-2H3,(H2,29,33)(H,32,34)	OLFRKEDSESBYHU-UHFFFAOYSA-N	283580	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-(trifluoromethyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 228::US10308637, Example 228	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283580	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283580&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182807	378164904							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540619	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2ccc3ncc(cc3c2)C(F)(F)F)c1	InChI=1S/C24H20F3N5O/c1-14-17(3-5-22(28)32-14)12-31-23(33)16-6-7-29-20(11-16)9-15-2-4-21-18(8-15)10-19(13-30-21)24(25,26)27/h2-8,10-11,13H,9,12H2,1H3,(H2,28,32)(H,31,33)	ZQDRGIMYWHFSSC-UHFFFAOYSA-N	283581	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-(trifluoromethyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 229::US10308637, Example 229	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283581	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283581&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182888	378164905							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540620	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1ccnc(Cc2ccc3ncc(cc3c2)C(F)(F)F)c1	InChI=1S/C26H17ClF4N4O/c27-21-13-34-24-10-22(28)17(9-20(21)24)11-35-25(36)15-3-4-32-19(8-15)6-14-1-2-23-16(5-14)7-18(12-33-23)26(29,30)31/h1-5,7-10,12-13,34H,6,11H2,(H,35,36)	PKOZQSHURKITNU-UHFFFAOYSA-N	283582	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3-(trifluoromethyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 230	Plasma kallikrein					 550					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283582	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283582&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124181944	378164906							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540621	FC(F)(F)c1cnc2ccc(Cc3cc(ccn3)C(=O)NCc3cnc4[nH]cc(Cl)c4c3)cc2c1	InChI=1S/C25H17ClF3N5O/c26-21-13-33-23-20(21)7-15(10-32-23)11-34-24(35)16-3-4-30-19(9-16)6-14-1-2-22-17(5-14)8-18(12-31-22)25(27,28)29/h1-5,7-10,12-13H,6,11H2,(H,32,33)(H,34,35)	AYANUSJKTXGYKD-UHFFFAOYSA-N	283583	N-((3-chloro-1H-pyrrolo[2,3-b]pyridin-5- yl)methyl)-2-((3-(trifluoromethyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 231::US10308637, Example 231	Plasma kallikrein					 550					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283583	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283583&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124183181	378164907							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540622	Nc1nccc2cc(CNC(=O)c3ccnc(Cc4ccc5ncc(cc5c4)C(F)(F)F)c3)ccc12	InChI=1S/C27H20F3N5O/c28-27(29,30)21-12-20-9-16(2-4-24(20)34-15-21)11-22-13-19(6-7-32-22)26(36)35-14-17-1-3-23-18(10-17)5-8-33-25(23)31/h1-10,12-13,15H,11,14H2,(H2,31,33)(H,35,36)	AIYRZHRTMKXNDG-UHFFFAOYSA-N	283584	N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- (trifluoromethyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 232::US10308637, Example 232	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283584	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283584&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124183347	378164908							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540623	Fc1c(CNC(=O)c2ccnc(Cc3ccc4ncc(cc4c3)C(F)(F)F)c2)ccc2[nH]cc(Cl)c12	InChI=1S/C26H17ClF4N4O/c27-20-13-34-22-4-2-16(24(28)23(20)22)11-35-25(36)15-5-6-32-19(10-15)8-14-1-3-21-17(7-14)9-18(12-33-21)26(29,30)31/h1-7,9-10,12-13,34H,8,11H2,(H,35,36)	KBISFNIKCMKXCJ-UHFFFAOYSA-N	283586	N-((3-chloro-4-fluoro-1H-indol-5-yl)methyl)-2- ((3-(trifluoromethyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 234::US10308637, Example 234	Plasma kallikrein					 550					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283586	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283586&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182878	378164910							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540624	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc(c3ncc(Cl)cc3c2)S(N)(=O)=O)c1	InChI=1S/C24H23ClN6O3S/c1-13-5-22(26)31-14(2)20(13)12-30-24(32)16-3-4-28-19(10-16)7-15-6-17-9-18(25)11-29-23(17)21(8-15)35(27,33)34/h3-6,8-11H,7,12H2,1-2H3,(H2,26,31)(H,30,32)(H2,27,33,34)	DKVANJKAPZQNAC-UHFFFAOYSA-N	283587	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloro-8-sulfamoylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 235::US10308637, Example 235	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283587	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283587&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182942	378164911							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540625	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2cc(c3ncc(Cl)cc3c2)S(N)(=O)=O)c1	InChI=1S/C23H21ClN6O3S/c1-13-16(2-3-21(25)30-13)11-29-23(31)15-4-5-27-19(10-15)7-14-6-17-9-18(24)12-28-22(17)20(8-14)34(26,32)33/h2-6,8-10,12H,7,11H2,1H3,(H2,25,30)(H,29,31)(H2,26,32,33)	YSBHUSXJGVVFNU-UHFFFAOYSA-N	283588	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-chloro-8-sulfamoylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 236::US10308637, Example 236	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283588	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283588&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126501516	378164912							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540626	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3nc(C)c(Cl)cc3c2)c1	InChI=1S/C25H24ClN5O/c1-14-8-24(27)31-15(2)21(14)13-29-25(32)18-6-7-28-20(11-18)10-17-4-5-23-19(9-17)12-22(26)16(3)30-23/h4-9,11-12H,10,13H2,1-3H3,(H2,27,31)(H,29,32)	UWJAEYUDDOAGRL-UHFFFAOYSA-N	283590	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloro-2-methylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 238::US10308637, Example 238	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283590	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283590&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124183085	378164914							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540627	Cc1nc2ccc(Cc3cc(ccn3)C(=O)NCc3ccc(N)nc3C)cc2cc1Cl	InChI=1S/C24H22ClN5O/c1-14-18(4-6-23(26)30-14)13-28-24(31)17-7-8-27-20(11-17)10-16-3-5-22-19(9-16)12-21(25)15(2)29-22/h3-9,11-12H,10,13H2,1-2H3,(H2,26,30)(H,28,31)	AOYDVEJZPAPXAG-UHFFFAOYSA-N	283591	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-chloro-2-methylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 239::US10308637, Example 239	Plasma kallikrein					 550					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283591	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283591&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124183192	378164915							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540628	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc(CN)c3ncc(Cl)cc3c2)c1	InChI=1S/C25H25ClN6O/c1-14-5-23(28)32-15(2)22(14)13-31-25(33)17-3-4-29-21(10-17)8-16-6-18-9-20(26)12-30-24(18)19(7-16)11-27/h3-7,9-10,12H,8,11,13,27H2,1-2H3,(H2,28,32)(H,31,33)	RLEZQIDVARIXNS-UHFFFAOYSA-N	283593	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((8-(aminomethyl)-3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 241::US10308637, Example 241	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283593	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283593&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182089	378164917							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540629	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3ncc(cc3c2)C2CC2)c1	InChI=1S/C27H27N5O/c1-16-9-26(28)32-17(2)24(16)15-31-27(33)20-7-8-29-23(13-20)11-18-3-6-25-21(10-18)12-22(14-30-25)19-4-5-19/h3,6-10,12-14,19H,4-5,11,15H2,1-2H3,(H2,28,32)(H,31,33)	NXXNLEZZBXYGEX-UHFFFAOYSA-N	283595	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-cyclopropylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 243::US10308637, Example 243	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283595	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283595&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182364	378164919							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540630	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2ccc3ncc(cc3c2)C2CC2)c1	InChI=1S/C26H25N5O/c1-16-20(5-7-25(27)31-16)14-30-26(32)19-8-9-28-23(13-19)11-17-2-6-24-21(10-17)12-22(15-29-24)18-3-4-18/h2,5-10,12-13,15,18H,3-4,11,14H2,1H3,(H2,27,31)(H,30,32)	CESBXMOBCLQDDB-UHFFFAOYSA-N	283596	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-cyclopropylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 244::US10308637, Example 244	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283596	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283596&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182987	378164920							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540631	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1ccnc(Cc2ccc3ncc(cc3c2)C2CC2)c1	InChI=1S/C28H22ClFN4O/c29-24-15-33-27-12-25(30)21(11-23(24)27)14-34-28(35)18-5-6-31-22(10-18)8-16-1-4-26-19(7-16)9-20(13-32-26)17-2-3-17/h1,4-7,9-13,15,17,33H,2-3,8,14H2,(H,34,35)	PUSXIKSJCXOULP-UHFFFAOYSA-N	283597	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3-cyclopropylquinolin-6- yl)methyl0isonicotinamide::US10023557, Example 245::US10308637, Example 245	Plasma kallikrein					 550					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283597	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283597&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124183090	378164921							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540632	Clc1c[nH]c2ncc(CNC(=O)c3ccnc(Cc4ccc5ncc(cc5c4)C4CC4)c3)cc12	InChI=1S/C27H22ClN5O/c28-24-15-32-26-23(24)9-17(12-31-26)13-33-27(34)19-5-6-29-22(11-19)8-16-1-4-25-20(7-16)10-21(14-30-25)18-2-3-18/h1,4-7,9-12,14-15,18H,2-3,8,13H2,(H,31,32)(H,33,34)	YRCSUWUDJJGADC-UHFFFAOYSA-N	283598	N-((3-chloro-1H-pyrrolo[2,3-b]pyridin-5- yl)methyl)-2-((3-cyclopropylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 246::US10308637, Example 246	Plasma kallikrein					 550					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283598	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283598&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182143	378164922							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540633	Nc1nccc2cc(CNC(=O)c3ccnc(Cc4ccc5ncc(cc5c4)C4CC4)c3)ccc12	InChI=1S/C29H25N5O/c30-28-26-5-1-19(12-21(26)7-10-32-28)16-34-29(35)22-8-9-31-25(15-22)13-18-2-6-27-23(11-18)14-24(17-33-27)20-3-4-20/h1-2,5-12,14-15,17,20H,3-4,13,16H2,(H2,30,32)(H,34,35)	YXSSRVFBEYEKCJ-UHFFFAOYSA-N	283599	N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- cyclopropylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 247::US10308637, Example 247	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283599	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283599&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124183189	378164923							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540634	Fc1c(CNC(=O)c2ccnc(Cc3ccc4ncc(cc4c3)C3CC3)c2)ccc2[nH]cc(Cl)c12	InChI=1S/C28H22ClFN4O/c29-23-15-33-25-6-4-19(27(30)26(23)25)13-34-28(35)18-7-8-31-22(12-18)10-16-1-5-24-20(9-16)11-21(14-32-24)17-2-3-17/h1,4-9,11-12,14-15,17,33H,2-3,10,13H2,(H,34,35)	YEYBDCGTPYLKNH-UHFFFAOYSA-N	283600	N-((3-chloro-4-fluoro-1H-indol-5-yl)methyl)-2- ((3-cyclopropylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 248::US10308637, Example 248	Plasma kallikrein					 550					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283600	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283600&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124183345	378164924							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540635	Clc1ccc2[nH]nc(CNC(=O)c3ccnc(Cc4ccc5ncc(cc5c4)C4CC4)c3)c2c1	InChI=1S/C27H22ClN5O/c28-21-4-6-25-23(13-21)26(33-32-25)15-31-27(34)18-7-8-29-22(12-18)10-16-1-5-24-19(9-16)11-20(14-30-24)17-2-3-17/h1,4-9,11-14,17H,2-3,10,15H2,(H,31,34)(H,32,33)	OWGSABVRUIXNJH-UHFFFAOYSA-N	283601	N-((5-chloro-1H-indazol-3-yl)methyl)-2-((3- cyclopropylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 249::US10308637, Example 249	Plasma kallikrein					 550					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283601	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283601&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124183251	378164925							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540636	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2cc(CN)c3ncc(Cl)cc3c2)c1	InChI=1S/C24H23ClN6O/c1-14-17(2-3-22(27)31-14)12-30-24(32)16-4-5-28-21(10-16)8-15-6-18-9-20(25)13-29-23(18)19(7-15)11-26/h2-7,9-10,13H,8,11-12,26H2,1H3,(H2,27,31)(H,30,32)	YVCBPKMPIZSYJL-UHFFFAOYSA-N	283606	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((8-(aminomethyl)-3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 253::US10308637, Example 253	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283606	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283606&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182139	378164930							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540637	CC(C)c1cnc2ccc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2c1	InChI=1S/C27H29N5O/c1-16(2)22-12-21-10-19(5-6-25(21)30-14-22)11-23-13-20(7-8-29-23)27(33)31-15-24-17(3)9-26(28)32-18(24)4/h5-10,12-14,16H,11,15H2,1-4H3,(H2,28,32)(H,31,33)	DIJRRFWNCLHEIN-UHFFFAOYSA-N	283607	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-isopropylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 254::US10308637, Example 254	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283607	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283607&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182291	378164931							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540638	CCCc1cnc2ccc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2c1	InChI=1S/C27H29N5O/c1-4-5-20-12-22-11-19(6-7-25(22)30-15-20)13-23-14-21(8-9-29-23)27(33)31-16-24-17(2)10-26(28)32-18(24)3/h6-12,14-15H,4-5,13,16H2,1-3H3,(H2,28,32)(H,31,33)	YBKWLMQUKCOEFW-UHFFFAOYSA-N	283608	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-propylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 255::US10308637, Example 255	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283608	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283608&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182380	378164932							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540639	COc1cnc2ccc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2c1	InChI=1S/C25H25N5O2/c1-15-8-24(26)30-16(2)22(15)14-29-25(31)18-6-7-27-20(11-18)10-17-4-5-23-19(9-17)12-21(32-3)13-28-23/h4-9,11-13H,10,14H2,1-3H3,(H2,26,30)(H,29,31)	RKVFEEITZZUJSF-UHFFFAOYSA-N	283617	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-methoxyquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 264::US10308637, Example 264	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283617	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283617&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182382	378164939							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540640	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc(-c3nnn[nH]3)c3ncc(Cl)cc3c2)c1	InChI=1S/C25H22ClN9O/c1-13-5-22(27)31-14(2)21(13)12-30-25(36)16-3-4-28-19(10-16)7-15-6-17-9-18(26)11-29-23(17)20(8-15)24-32-34-35-33-24/h3-6,8-11H,7,12H2,1-2H3,(H2,27,31)(H,30,36)(H,32,33,34,35)	CHTXTYUXSQYZPG-UHFFFAOYSA-N	283625	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloro-8-(1H-tetrazol-5-yl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 272::US10308637, Example 272	Plasma kallikrein					 550					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283625	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283625&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182986	378164947							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540641	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(c1)C(O)c1ccc2ncc(Cl)cc2c1	InChI=1S/C24H22ClN5O2/c1-13-7-22(26)30-14(2)19(13)12-29-24(32)16-5-6-27-21(10-16)23(31)15-3-4-20-17(8-15)9-18(25)11-28-20/h3-11,23,31H,12H2,1-2H3,(H2,26,30)(H,29,32)	FZBWFJGOXURHDV-UHFFFAOYSA-N	283628	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloroquinolin-6- yl)(hydroxy)methyl)isonicotinamide::US10023557, Example 275::US10308637, Example 275	Plasma kallikrein					 550					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283628	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283628&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182386	378164950							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540642	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(c1)C(N)c1ccc2ncc(Cl)cc2c1	InChI=1S/C24H23ClN6O/c1-13-7-22(26)31-14(2)19(13)12-30-24(32)16-5-6-28-21(10-16)23(27)15-3-4-20-17(8-15)9-18(25)11-29-20/h3-11,23H,12,27H2,1-2H3,(H2,26,31)(H,30,32)	YURFKDSCPCHWCH-UHFFFAOYSA-N	283629	2[Amino-(3-chloro-quinolin-6-yl)-methyl]-N- (6-amino-2,4-dimethyl-pyridin-3-ylmethyl)- isonicotinamide::US10023557, Example 276::US10308637, Example 276	Plasma kallikrein					 550					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283629	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283629&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182336	378164951							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540643	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(c1)C(C)(O)c1ccc2ncc(Cl)cc2c1	InChI=1S/C25H24ClN5O2/c1-14-8-23(27)31-15(2)20(14)13-30-24(32)16-6-7-28-22(11-16)25(3,33)18-4-5-21-17(9-18)10-19(26)12-29-21/h4-12,33H,13H2,1-3H3,(H2,27,31)(H,30,32)	JTZWLDGXHLBJLE-UHFFFAOYSA-N	283630	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-(1-(3-chloroquinolin-6-yl)-1- hydroxyethyl)isonicotinamide::US10023557, Example 277::US10308637, Example 277	Plasma kallikrein					 550					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283630	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283630&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182400	378164952							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540644	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3ncc(CC(F)F)cc3c2)c1	InChI=1S/C26H25F2N5O/c1-15-7-25(29)33-16(2)22(15)14-32-26(34)19-5-6-30-21(12-19)10-17-3-4-23-20(8-17)9-18(13-31-23)11-24(27)28/h3-9,12-13,24H,10-11,14H2,1-2H3,(H2,29,33)(H,32,34)	OVIYOYHDBWMVGM-UHFFFAOYSA-N	283631	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-(2,2-difluoroethyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 278::US10308637, Example 278	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283631	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283631&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182418	378164953							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540645	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2ccc3ncc(CC(F)F)cc3c2)c1	InChI=1S/C25H23F2N5O/c1-15-19(3-5-24(28)32-15)14-31-25(33)18-6-7-29-21(12-18)10-16-2-4-22-20(8-16)9-17(13-30-22)11-23(26)27/h2-9,12-13,23H,10-11,14H2,1H3,(H2,28,32)(H,31,33)	QFSMNAFQIHWMLY-UHFFFAOYSA-N	283632	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-(2,3-difluoroethyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 279::US10308637, Example 279	Plasma kallikrein					 550					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283632	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283632&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182396	378164954							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540646	CCc1cnc2ccc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)cc2c1	InChI=1S/C28H25N5O/c1-2-18-11-23-12-19(4-6-26(23)32-16-18)14-24-15-22(8-9-30-24)28(34)33-17-20-3-5-25-21(13-20)7-10-31-27(25)29/h3-13,15-16H,2,14,17H2,1H3,(H2,29,31)(H,33,34)	IKKRHUSEAWLVJJ-UHFFFAOYSA-N	283636	N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- ethylquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 283::US10308637, Example 283	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283636	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283636&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124183163	378164958							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540647	CCc1cnc2ccc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2c1	InChI=1S/C26H27N5O/c1-4-18-10-21-11-19(5-6-24(21)29-14-18)12-22-13-20(7-8-28-22)26(32)30-15-23-16(2)9-25(27)31-17(23)3/h5-11,13-14H,4,12,15H2,1-3H3,(H2,27,31)(H,30,32)	WAXKFCXDFXHSDW-UHFFFAOYSA-N	283639	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-ethylquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 286::US10308637, Example 286	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283639	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283639&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124183333	378164961							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540648	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)cc2c1)S(N)(=O)=O	InChI=1S/C26H21ClFN5O3S/c1-14-4-17-5-15(7-24(37(29,35)36)25(17)32-11-14)6-19-8-16(2-3-30-19)26(34)33-12-18-9-20-21(27)13-31-23(20)10-22(18)28/h2-5,7-11,13,31H,6,12H2,1H3,(H,33,34)(H2,29,35,36)	FCBFPLGCTNIHRM-UHFFFAOYSA-N	283640	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3-methyl-8-sulfamoylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 287::US10308637, Example 287	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283640	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283640&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124182369	378164962							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540649	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3n[nH]c4ccc(Cl)cc34)cc2c1)S(N)(=O)=O	InChI=1S/C25H21ClN6O3S/c1-14-6-17-7-15(9-23(36(27,34)35)24(17)29-12-14)8-19-10-16(4-5-28-19)25(33)30-13-22-20-11-18(26)2-3-21(20)31-32-22/h2-7,9-12H,8,13H2,1H3,(H,30,33)(H,31,32)(H2,27,34,35)	QAJVRULNMBOLEF-UHFFFAOYSA-N	283641	N-((5-chloro-1H-indazol-3-yl)methyl)-2-((3- methyl-8-sulfamoylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 288::US10308637, Example 288	Plasma kallikrein					 550					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283641	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283641&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126501517	378164963							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540650	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)cc2c1)S(N)(=O)=O	InChI=1S/C27H24N6O3S/c1-16-8-21-10-18(12-24(37(29,35)36)25(21)32-14-16)11-22-13-20(5-6-30-22)27(34)33-15-17-2-3-23-19(9-17)4-7-31-26(23)28/h2-10,12-14H,11,15H2,1H3,(H2,28,31)(H,33,34)(H2,29,35,36)	ZLLFHJRJDPDQKT-UHFFFAOYSA-N	283642	N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- methyl-8-sulfamoylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 289::US10308637, Example 289	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283642	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283642&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665321	378164964							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540651	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3ccc4[nH]cc(Cl)c4c3F)cc2c1)S(N)(=O)=O	InChI=1S/C26H21ClFN5O3S/c1-14-6-18-7-15(9-22(37(29,35)36)25(18)32-11-14)8-19-10-16(4-5-30-19)26(34)33-12-17-2-3-21-23(24(17)28)20(27)13-31-21/h2-7,9-11,13,31H,8,12H2,1H3,(H,33,34)(H2,29,35,36)	ULXURFQBVYLUQN-UHFFFAOYSA-N	283643	N-((3-chloro-4-fluoro-1H-indol-5-yl)methyl)-2- ((3-methyl-8-sulfamoylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 290::US10308637, Example 290	Plasma kallikrein					 550					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283643	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283643&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126501519	378164965							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
540652	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cnc4[nH]cc(Cl)c4c3)cc2c1)S(N)(=O)=O	InChI=1S/C25H21ClN6O3S/c1-14-4-18-5-15(8-22(36(27,34)35)23(18)29-10-14)6-19-9-17(2-3-28-19)25(33)32-12-16-7-20-21(26)13-31-24(20)30-11-16/h2-5,7-11,13H,6,12H2,1H3,(H,30,31)(H,32,33)(H2,27,34,35)	MHMLWXMUMLUGIJ-UHFFFAOYSA-N	283644	N-((3-chloro-1H-pyrrolo[2,3-b]pyridin-5- yl)methyl)-2-((3-methyl-8-sulfamoylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 291::US10308637, Example 291	Plasma kallikrein					<100					US Patent		10.7270/Q2BZ6839		aid1795658	US10023557	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283644	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283644&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126501518	378164966							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
525086	COCCC(C(=O)Nc1ccc(s1)C(N)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C23H21ClN4O5S/c1-32-8-7-17(23(31)27-20-6-5-19(34-20)22(26)30)28-12-18(33-2)16(10-21(28)29)15-9-14(24)4-3-13(15)11-25/h3-6,9-10,12,17H,7-8H2,1-2H3,(H2,26,30)(H,27,31)	GOCYVYSSHSOPPN-UHFFFAOYSA-N	276767	US10071995, Example 1::US10071995, Example 8	Plasma kallikrein			 7.00					7.4	25.00 C	US Patent		10.7270/Q2H13429		aid1795531	US10071995	Rohrig, S; Jimenez Nunez, E; Schlemmer, K; Tersteegen, A; Teller, H; Hillisch, A; Heitmeier, S; Schmidt, MV; Stampfus, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=276767	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=276767&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118978142	378158429							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
525087	COCCC(C(=O)Nc1ccc(s1)C(N)=O)n1cc(Cl)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C22H18Cl2N4O4S/c1-32-7-6-17(22(31)27-19-5-4-18(33-19)21(26)30)28-11-16(24)15(9-20(28)29)14-8-13(23)3-2-12(14)10-25/h2-5,8-9,11,17H,6-7H2,1H3,(H2,26,30)(H,27,31)	FVYMEXYCTYXQIE-UHFFFAOYSA-N	276768	US10071995, Example 2	Plasma kallikrein			 26.0					7.4	25.00 C	US Patent		10.7270/Q2H13429		aid1795531	US10071995	Rohrig, S; Jimenez Nunez, E; Schlemmer, K; Tersteegen, A; Teller, H; Hillisch, A; Heitmeier, S; Schmidt, MV; Stampfus, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=276768	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=276768&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121242328	378158430							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
525088	COc1cn(C(Cc2ccccn2)C(=O)Nc2cc(F)c(s2)C(N)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C26H19ClFN5O4S/c1-37-21-13-33(23(34)10-18(21)17-8-15(27)6-5-14(17)12-29)20(9-16-4-2-3-7-31-16)26(36)32-22-11-19(28)24(38-22)25(30)35/h2-8,10-11,13,20H,9H2,1H3,(H2,30,35)(H,32,36)	OGOGYYKFZVHJBB-UHFFFAOYSA-N	276769	US10071995, Example 3	Plasma kallikrein			 34.0					7.4	25.00 C	US Patent		10.7270/Q2H13429		aid1795531	US10071995	Rohrig, S; Jimenez Nunez, E; Schlemmer, K; Tersteegen, A; Teller, H; Hillisch, A; Heitmeier, S; Schmidt, MV; Stampfus, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=276769	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=276769&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121243143	378158431							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
525089	COc1cn(C(Cc2ccncc2)C(=O)Nc2cc(F)c(s2)C(N)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C26H19ClFN5O4S/c1-37-21-13-33(23(34)10-18(21)17-9-16(27)3-2-15(17)12-29)20(8-14-4-6-31-7-5-14)26(36)32-22-11-19(28)24(38-22)25(30)35/h2-7,9-11,13,20H,8H2,1H3,(H2,30,35)(H,32,36)	NFRQLICWPZKLQL-UHFFFAOYSA-N	276770	US10071995, Example 4	Plasma kallikrein			 29.0					7.4	25.00 C	US Patent		10.7270/Q2H13429		aid1795531	US10071995	Rohrig, S; Jimenez Nunez, E; Schlemmer, K; Tersteegen, A; Teller, H; Hillisch, A; Heitmeier, S; Schmidt, MV; Stampfus, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=276770	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=276770&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121243126	378158432							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
525090	COc1cn(C(Cc2cccnc2)C(=O)Nc2cc(F)c(s2)C(N)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C26H19ClFN5O4S/c1-37-21-13-33(23(34)9-18(21)17-8-16(27)5-4-15(17)11-29)20(7-14-3-2-6-31-12-14)26(36)32-22-10-19(28)24(38-22)25(30)35/h2-6,8-10,12-13,20H,7H2,1H3,(H2,30,35)(H,32,36)	BMYLLTGHRWHCOP-UHFFFAOYSA-N	276771	US10071995, Example 5	Plasma kallikrein			 42.0					7.4	25.00 C	US Patent		10.7270/Q2H13429		aid1795531	US10071995	Rohrig, S; Jimenez Nunez, E; Schlemmer, K; Tersteegen, A; Teller, H; Hillisch, A; Heitmeier, S; Schmidt, MV; Stampfus, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=276771	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=276771&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121243135	378158433							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
525091	COc1cn(C(Cc2ccccn2)C(=O)Nc2cc(F)c(s2)C(N)=O)c(=O)cc1-c1cc(Cl)ccc1F	InChI=1S/C25H19ClF2N4O4S/c1-36-20-12-32(22(33)10-16(20)15-8-13(26)5-6-17(15)27)19(9-14-4-2-3-7-30-14)25(35)31-21-11-18(28)23(37-21)24(29)34/h2-8,10-12,19H,9H2,1H3,(H2,29,34)(H,31,35)	XEFXQUZIBHSGAK-UHFFFAOYSA-N	276772	US10071995, Example 6	Plasma kallikrein			 1200					7.4	25.00 C	US Patent		10.7270/Q2H13429		aid1795531	US10071995	Rohrig, S; Jimenez Nunez, E; Schlemmer, K; Tersteegen, A; Teller, H; Hillisch, A; Heitmeier, S; Schmidt, MV; Stampfus, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=276772	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=276772&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121243130	378158434							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
525092	COCCC(C(=O)Nc1ccc(s1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C23H20ClN3O6S/c1-32-8-7-17(22(29)26-20-6-5-19(34-20)23(30)31)27-12-18(33-2)16(10-21(27)28)15-9-14(24)4-3-13(15)11-25/h3-6,9-10,12,17H,7-8H2,1-2H3,(H,26,29)(H,30,31)	KUKXVSPOTPJXNA-UHFFFAOYSA-N	276773	5-({2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)-thiophene-2-carboxylic acid (racemate)::US10071995, Example 7	Plasma kallikrein			 3.00					7.4	25.00 C	US Patent		10.7270/Q2H13429		aid1795531	US10071995	Rohrig, S; Jimenez Nunez, E; Schlemmer, K; Tersteegen, A; Teller, H; Hillisch, A; Heitmeier, S; Schmidt, MV; Stampfus, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=276773	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=276773&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118978151	378158435							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
525093	COCCC(C(=O)Nc1ccc(s1)C(N)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C23H21ClN4O5S/c1-32-8-7-17(23(31)27-20-6-5-19(34-20)22(26)30)28-12-18(33-2)16(10-21(28)29)15-9-14(24)4-3-13(15)11-25/h3-6,9-10,12,17H,7-8H2,1-2H3,(H2,26,30)(H,27,31)	GOCYVYSSHSOPPN-UHFFFAOYSA-N	276767	US10071995, Example 1::US10071995, Example 8	Plasma kallikrein			 3.00					7.4	25.00 C	US Patent		10.7270/Q2H13429		aid1795531	US10071995	Rohrig, S; Jimenez Nunez, E; Schlemmer, K; Tersteegen, A; Teller, H; Hillisch, A; Heitmeier, S; Schmidt, MV; Stampfus, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=276767	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=276767&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118978142	378158429							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
525094	COCCC(C(=O)Nc1cc(F)c(s1)C(N)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C23H20ClFN4O5S/c1-33-6-5-17(23(32)28-19-9-16(25)21(35-19)22(27)31)29-11-18(34-2)15(8-20(29)30)14-7-13(24)4-3-12(14)10-26/h3-4,7-9,11,17H,5-6H2,1-2H3,(H2,27,31)(H,28,32)	UYQQPUYBTBCWTF-UHFFFAOYSA-N	276775	5-({2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)-3-fluorothiophene-2-carboxamide (racemate)::US10071995, Example 10::US10071995, Example 9	Plasma kallikrein			 54.0					7.4	25.00 C	US Patent		10.7270/Q2H13429		aid1795531	US10071995	Rohrig, S; Jimenez Nunez, E; Schlemmer, K; Tersteegen, A; Teller, H; Hillisch, A; Heitmeier, S; Schmidt, MV; Stampfus, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=276775	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=276775&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118978133	378158436							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
525095	COCCC(C(=O)Nc1cc(F)c(s1)C(N)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C23H20ClFN4O5S/c1-33-6-5-17(23(32)28-19-9-16(25)21(35-19)22(27)31)29-11-18(34-2)15(8-20(29)30)14-7-13(24)4-3-12(14)10-26/h3-4,7-9,11,17H,5-6H2,1-2H3,(H2,27,31)(H,28,32)	UYQQPUYBTBCWTF-UHFFFAOYSA-N	276775	5-({2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)-3-fluorothiophene-2-carboxamide (racemate)::US10071995, Example 10::US10071995, Example 9	Plasma kallikrein			 27.0					7.4	25.00 C	US Patent		10.7270/Q2H13429		aid1795531	US10071995	Rohrig, S; Jimenez Nunez, E; Schlemmer, K; Tersteegen, A; Teller, H; Hillisch, A; Heitmeier, S; Schmidt, MV; Stampfus, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=276775	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=276775&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118978133	378158436							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
525096	CNC(=O)c1ccc(NC(=O)C(CCOC)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2C#N)s1	InChI=1S/C24H23ClN4O5S/c1-27-24(32)20-6-7-21(35-20)28-23(31)18(8-9-33-2)29-13-19(34-3)17(11-22(29)30)16-10-15(25)5-4-14(16)12-26/h4-7,10-11,13,18H,8-9H2,1-3H3,(H,27,32)(H,28,31)	BIXGLCFSTUQYSC-UHFFFAOYSA-N	276777	5-({2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)-N-methylthiophene-2-carboxamide (racemate)::US10071995, Example 11::US10071995, Example 12	Plasma kallikrein			 4.60					7.4	25.00 C	US Patent		10.7270/Q2H13429		aid1795531	US10071995	Rohrig, S; Jimenez Nunez, E; Schlemmer, K; Tersteegen, A; Teller, H; Hillisch, A; Heitmeier, S; Schmidt, MV; Stampfus, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=276777	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=276777&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118978130	378158437							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
525097	CNC(=O)c1ccc(NC(=O)C(CCOC)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2C#N)s1	InChI=1S/C24H23ClN4O5S/c1-27-24(32)20-6-7-21(35-20)28-23(31)18(8-9-33-2)29-13-19(34-3)17(11-22(29)30)16-10-15(25)5-4-14(16)12-26/h4-7,10-11,13,18H,8-9H2,1-3H3,(H,27,32)(H,28,31)	BIXGLCFSTUQYSC-UHFFFAOYSA-N	276777	5-({2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)-N-methylthiophene-2-carboxamide (racemate)::US10071995, Example 11::US10071995, Example 12	Plasma kallikrein			 2.50					7.4	25.00 C	US Patent		10.7270/Q2H13429		aid1795531	US10071995	Rohrig, S; Jimenez Nunez, E; Schlemmer, K; Tersteegen, A; Teller, H; Hillisch, A; Heitmeier, S; Schmidt, MV; Stampfus, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=276777	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=276777&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118978130	378158437							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
525098	COc1cn(C(Cc2ccn(C)n2)C(=O)Nc2ccc(s2)C(N)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C25H21ClN6O4S/c1-31-8-7-16(30-31)10-19(25(35)29-22-6-5-21(37-22)24(28)34)32-13-20(36-2)18(11-23(32)33)17-9-15(26)4-3-14(17)12-27/h3-9,11,13,19H,10H2,1-2H3,(H2,28,34)(H,29,35)	XKHMCIMABQFRMZ-UHFFFAOYSA-N	276779	5-({2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-3-(1-methyl-1H-pyrazol-3-yl)propanoyl}amino)thiophene-2-carboxamide (racemate)::US10071995, Example 13::US10071995, Example 14	Plasma kallikrein			 4.10					7.4	25.00 C	US Patent		10.7270/Q2H13429		aid1795531	US10071995	Rohrig, S; Jimenez Nunez, E; Schlemmer, K; Tersteegen, A; Teller, H; Hillisch, A; Heitmeier, S; Schmidt, MV; Stampfus, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=276779	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=276779&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118978127	378158438							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
525099	COc1cn(C(Cc2ccn(C)n2)C(=O)Nc2ccc(s2)C(N)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C25H21ClN6O4S/c1-31-8-7-16(30-31)10-19(25(35)29-22-6-5-21(37-22)24(28)34)32-13-20(36-2)18(11-23(32)33)17-9-15(26)4-3-14(17)12-27/h3-9,11,13,19H,10H2,1-2H3,(H2,28,34)(H,29,35)	XKHMCIMABQFRMZ-UHFFFAOYSA-N	276779	5-({2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-3-(1-methyl-1H-pyrazol-3-yl)propanoyl}amino)thiophene-2-carboxamide (racemate)::US10071995, Example 13::US10071995, Example 14	Plasma kallikrein			 2.30					7.4	25.00 C	US Patent		10.7270/Q2H13429		aid1795531	US10071995	Rohrig, S; Jimenez Nunez, E; Schlemmer, K; Tersteegen, A; Teller, H; Hillisch, A; Heitmeier, S; Schmidt, MV; Stampfus, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=276779	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=276779&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118978127	378158438							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
525100	CNC(=O)c1ccc(NC(=O)C(Cc2ccn(C)n2)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2C#N)s1	InChI=1S/C26H23ClN6O4S/c1-29-26(36)22-6-7-23(38-22)30-25(35)20(11-17-8-9-32(2)31-17)33-14-21(37-3)19(12-24(33)34)18-10-16(27)5-4-15(18)13-28/h4-10,12,14,20H,11H2,1-3H3,(H,29,36)(H,30,35)	VZHZAANDMCCQRE-UHFFFAOYSA-N	276781	5-({2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-3-(1-methyl-1H-pyrazol-3-yl)propanoyl}amino)-N-methylthiophene-2-carboxamide (racemate)::US10071995, Example 15::US10071995, Example 16	Plasma kallikrein			 5.40					7.4	25.00 C	US Patent		10.7270/Q2H13429		aid1795531	US10071995	Rohrig, S; Jimenez Nunez, E; Schlemmer, K; Tersteegen, A; Teller, H; Hillisch, A; Heitmeier, S; Schmidt, MV; Stampfus, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=276781	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=276781&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118978139	378158439							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
525101	CNC(=O)c1ccc(NC(=O)C(Cc2ccn(C)n2)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2C#N)s1	InChI=1S/C26H23ClN6O4S/c1-29-26(36)22-6-7-23(38-22)30-25(35)20(11-17-8-9-32(2)31-17)33-14-21(37-3)19(12-24(33)34)18-10-16(27)5-4-15(18)13-28/h4-10,12,14,20H,11H2,1-3H3,(H,29,36)(H,30,35)	VZHZAANDMCCQRE-UHFFFAOYSA-N	276781	5-({2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-3-(1-methyl-1H-pyrazol-3-yl)propanoyl}amino)-N-methylthiophene-2-carboxamide (racemate)::US10071995, Example 15::US10071995, Example 16	Plasma kallikrein			 2.80					7.4	25.00 C	US Patent		10.7270/Q2H13429		aid1795531	US10071995	Rohrig, S; Jimenez Nunez, E; Schlemmer, K; Tersteegen, A; Teller, H; Hillisch, A; Heitmeier, S; Schmidt, MV; Stampfus, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=276781	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=276781&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118978139	378158439							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
525102	CNC(=O)c1ccc(NC(=O)C(Cc2cnco2)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2C#N)s1	InChI=1S/C25H20ClN5O5S/c1-28-25(34)21-5-6-22(37-21)30-24(33)19(8-16-11-29-13-36-16)31-12-20(35-2)18(9-23(31)32)17-7-15(26)4-3-14(17)10-27/h3-7,9,11-13,19H,8H2,1-2H3,(H,28,34)(H,30,33)	MWDYAWIVZRPCHQ-UHFFFAOYSA-N	276783	5-({2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-3-(1,3-oxazol-5-yl)-propanoyl}amino)-N-methylthiophene-2-carboxamide (racemate)::US10071995, Example 17	Plasma kallikrein			 6.20					7.4	25.00 C	US Patent		10.7270/Q2H13429		aid1795531	US10071995	Rohrig, S; Jimenez Nunez, E; Schlemmer, K; Tersteegen, A; Teller, H; Hillisch, A; Heitmeier, S; Schmidt, MV; Stampfus, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=276783	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=276783&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118978140	378158440							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
525103	COc1cn(C(Cc2ccccn2)C(=O)Nc2ccc(s2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C26H19ClN4O5S/c1-36-21-14-31(24(32)12-19(21)18-10-16(27)6-5-15(18)13-28)20(11-17-4-2-3-9-29-17)25(33)30-23-8-7-22(37-23)26(34)35/h2-10,12,14,20H,11H2,1H3,(H,30,33)(H,34,35)	LFFPKMZQMGFUFM-UHFFFAOYSA-N	276784	5-({2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-3-(pyridin-2-yl)propanoyl}-amino)thiophene-2-carboxylic acid (racemate)::US10071995, Example 18	Plasma kallikrein			 2.60					7.4	25.00 C	US Patent		10.7270/Q2H13429		aid1795531	US10071995	Rohrig, S; Jimenez Nunez, E; Schlemmer, K; Tersteegen, A; Teller, H; Hillisch, A; Heitmeier, S; Schmidt, MV; Stampfus, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=276784	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=276784&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118978141	378158441							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
525104	COCCC(C(=O)Nc1ccc(s1)C(O)=O)n1cc(Cl)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C22H17Cl2N3O5S/c1-32-7-6-17(21(29)26-19-5-4-18(33-19)22(30)31)27-11-16(24)15(9-20(27)28)14-8-13(23)3-2-12(14)10-25/h2-5,8-9,11,17H,6-7H2,1H3,(H,26,29)(H,30,31)	NOGZUPFUDRHOSR-UHFFFAOYSA-N	276785	5-({2-[5-Chloro-4-(5-chloro-2-cyanophenyl)-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)-thiophene-2-carboxylic acid (racemate)::US10071995, Example 19	Plasma kallikrein			 6.90					7.4	25.00 C	US Patent		10.7270/Q2H13429		aid1795531	US10071995	Rohrig, S; Jimenez Nunez, E; Schlemmer, K; Tersteegen, A; Teller, H; Hillisch, A; Heitmeier, S; Schmidt, MV; Stampfus, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=276785	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=276785&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118978143	378158442							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
525105	COCCC(C(=O)Nc1ccc(s1)C(N)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C23H21ClN4O5S/c1-32-8-7-17(23(31)27-20-6-5-19(34-20)22(26)30)28-12-18(33-2)16(10-21(28)29)15-9-14(24)4-3-13(15)11-25/h3-6,9-10,12,17H,7-8H2,1-2H3,(H2,26,30)(H,27,31)	GOCYVYSSHSOPPN-UHFFFAOYSA-N	276767	US10071995, Example 1::US10071995, Example 8	Plasma kallikrein			 3.00					7.4	25.00 C	US Patent		10.7270/Q2H13429		aid1795531	US10071995	Rohrig, S; Jimenez Nunez, E; Schlemmer, K; Tersteegen, A; Teller, H; Hillisch, A; Heitmeier, S; Schmidt, MV; Stampfus, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=276767	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=276767&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118978142	378158429							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
525106	COCCC(C(=O)Nc1ccc(s1)C(N)=O)n1cc(Cl)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C22H18Cl2N4O4S/c1-32-7-6-17(22(31)27-19-5-4-18(33-19)21(26)30)28-11-16(24)15(9-20(28)29)14-8-13(23)3-2-12(14)10-25/h2-5,8-9,11,17H,6-7H2,1H3,(H2,26,30)(H,27,31)	FVYMEXYCTYXQIE-UHFFFAOYSA-N	276768	US10071995, Example 2	Plasma kallikrein			 28.0					7.4	25.00 C	US Patent		10.7270/Q2H13429		aid1795531	US10071995	Rohrig, S; Jimenez Nunez, E; Schlemmer, K; Tersteegen, A; Teller, H; Hillisch, A; Heitmeier, S; Schmidt, MV; Stampfus, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=276768	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=276768&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121242328	378158430							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
525107	COc1cn(C(Cc2ccccn2)C(=O)Nc2cc(F)c(s2)C(N)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C26H19ClFN5O4S/c1-37-21-13-33(23(34)10-18(21)17-8-15(27)6-5-14(17)12-29)20(9-16-4-2-3-7-31-16)26(36)32-22-11-19(28)24(38-22)25(30)35/h2-8,10-11,13,20H,9H2,1H3,(H2,30,35)(H,32,36)	OGOGYYKFZVHJBB-UHFFFAOYSA-N	276769	US10071995, Example 3	Plasma kallikrein			 68.0					7.4	25.00 C	US Patent		10.7270/Q2H13429		aid1795531	US10071995	Rohrig, S; Jimenez Nunez, E; Schlemmer, K; Tersteegen, A; Teller, H; Hillisch, A; Heitmeier, S; Schmidt, MV; Stampfus, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=276769	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=276769&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121243143	378158431							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
525108	COc1cn(C(Cc2ccncc2)C(=O)Nc2cc(F)c(s2)C(N)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C26H19ClFN5O4S/c1-37-21-13-33(23(34)10-18(21)17-9-16(27)3-2-15(17)12-29)20(8-14-4-6-31-7-5-14)26(36)32-22-11-19(28)24(38-22)25(30)35/h2-7,9-11,13,20H,8H2,1H3,(H2,30,35)(H,32,36)	NFRQLICWPZKLQL-UHFFFAOYSA-N	276770	US10071995, Example 4	Plasma kallikrein			 36.0					7.4	25.00 C	US Patent		10.7270/Q2H13429		aid1795531	US10071995	Rohrig, S; Jimenez Nunez, E; Schlemmer, K; Tersteegen, A; Teller, H; Hillisch, A; Heitmeier, S; Schmidt, MV; Stampfus, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=276770	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=276770&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121243126	378158432							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
525109	COc1cn(C(Cc2cccnc2)C(=O)Nc2cc(F)c(s2)C(N)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C26H19ClFN5O4S/c1-37-21-13-33(23(34)9-18(21)17-8-16(27)5-4-15(17)11-29)20(7-14-3-2-6-31-12-14)26(36)32-22-10-19(28)24(38-22)25(30)35/h2-6,8-10,12-13,20H,7H2,1H3,(H2,30,35)(H,32,36)	BMYLLTGHRWHCOP-UHFFFAOYSA-N	276771	US10071995, Example 5	Plasma kallikrein			 38.0					7.4	25.00 C	US Patent		10.7270/Q2H13429		aid1795531	US10071995	Rohrig, S; Jimenez Nunez, E; Schlemmer, K; Tersteegen, A; Teller, H; Hillisch, A; Heitmeier, S; Schmidt, MV; Stampfus, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=276771	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=276771&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121243135	378158433							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
525110	COc1cn(C(Cc2ccccn2)C(=O)Nc2cc(F)c(s2)C(N)=O)c(=O)cc1-c1cc(Cl)ccc1F	InChI=1S/C25H19ClF2N4O4S/c1-36-20-12-32(22(33)10-16(20)15-8-13(26)5-6-17(15)27)19(9-14-4-2-3-7-30-14)25(35)31-21-11-18(28)23(37-21)24(29)34/h2-8,10-12,19H,9H2,1H3,(H2,29,34)(H,31,35)	XEFXQUZIBHSGAK-UHFFFAOYSA-N	276772	US10071995, Example 6	Plasma kallikrein			>10.00					7.4	25.00 C	US Patent		10.7270/Q2H13429		aid1795531	US10071995	Rohrig, S; Jimenez Nunez, E; Schlemmer, K; Tersteegen, A; Teller, H; Hillisch, A; Heitmeier, S; Schmidt, MV; Stampfus, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=276772	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=276772&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121243130	378158434							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
525111	COCCC(C(=O)Nc1ccc(s1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C23H20ClN3O6S/c1-32-8-7-17(22(29)26-20-6-5-19(34-20)23(30)31)27-12-18(33-2)16(10-21(27)28)15-9-14(24)4-3-13(15)11-25/h3-6,9-10,12,17H,7-8H2,1-2H3,(H,26,29)(H,30,31)	KUKXVSPOTPJXNA-UHFFFAOYSA-N	276773	5-({2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)-thiophene-2-carboxylic acid (racemate)::US10071995, Example 7	Plasma kallikrein			 7.60					7.4	25.00 C	US Patent		10.7270/Q2H13429		aid1795531	US10071995	Rohrig, S; Jimenez Nunez, E; Schlemmer, K; Tersteegen, A; Teller, H; Hillisch, A; Heitmeier, S; Schmidt, MV; Stampfus, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=276773	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=276773&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118978151	378158435							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
525112	COCCC(C(=O)Nc1ccc(s1)C(N)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C23H21ClN4O5S/c1-32-8-7-17(23(31)27-20-6-5-19(34-20)22(26)30)28-12-18(33-2)16(10-21(28)29)15-9-14(24)4-3-13(15)11-25/h3-6,9-10,12,17H,7-8H2,1-2H3,(H2,26,30)(H,27,31)	GOCYVYSSHSOPPN-UHFFFAOYSA-N	276767	US10071995, Example 1::US10071995, Example 8	Plasma kallikrein			 0.940					7.4	25.00 C	US Patent		10.7270/Q2H13429		aid1795531	US10071995	Rohrig, S; Jimenez Nunez, E; Schlemmer, K; Tersteegen, A; Teller, H; Hillisch, A; Heitmeier, S; Schmidt, MV; Stampfus, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=276767	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=276767&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118978142	378158429							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
525113	COCCC(C(=O)Nc1cc(F)c(s1)C(N)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C23H20ClFN4O5S/c1-33-6-5-17(23(32)28-19-9-16(25)21(35-19)22(27)31)29-11-18(34-2)15(8-20(29)30)14-7-13(24)4-3-12(14)10-26/h3-4,7-9,11,17H,5-6H2,1-2H3,(H2,27,31)(H,28,32)	UYQQPUYBTBCWTF-UHFFFAOYSA-N	276775	5-({2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)-3-fluorothiophene-2-carboxamide (racemate)::US10071995, Example 10::US10071995, Example 9	Plasma kallikrein			 100.0					7.4	25.00 C	US Patent		10.7270/Q2H13429		aid1795531	US10071995	Rohrig, S; Jimenez Nunez, E; Schlemmer, K; Tersteegen, A; Teller, H; Hillisch, A; Heitmeier, S; Schmidt, MV; Stampfus, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=276775	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=276775&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118978133	378158436							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
525114	COCCC(C(=O)Nc1cc(F)c(s1)C(N)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C23H20ClFN4O5S/c1-33-6-5-17(23(32)28-19-9-16(25)21(35-19)22(27)31)29-11-18(34-2)15(8-20(29)30)14-7-13(24)4-3-12(14)10-26/h3-4,7-9,11,17H,5-6H2,1-2H3,(H2,27,31)(H,28,32)	UYQQPUYBTBCWTF-UHFFFAOYSA-N	276775	5-({2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)-3-fluorothiophene-2-carboxamide (racemate)::US10071995, Example 10::US10071995, Example 9	Plasma kallikrein			 47.0					7.4	25.00 C	US Patent		10.7270/Q2H13429		aid1795531	US10071995	Rohrig, S; Jimenez Nunez, E; Schlemmer, K; Tersteegen, A; Teller, H; Hillisch, A; Heitmeier, S; Schmidt, MV; Stampfus, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=276775	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=276775&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118978133	378158436							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
525115	CNC(=O)c1ccc(NC(=O)C(CCOC)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2C#N)s1	InChI=1S/C24H23ClN4O5S/c1-27-24(32)20-6-7-21(35-20)28-23(31)18(8-9-33-2)29-13-19(34-3)17(11-22(29)30)16-10-15(25)5-4-14(16)12-26/h4-7,10-11,13,18H,8-9H2,1-3H3,(H,27,32)(H,28,31)	BIXGLCFSTUQYSC-UHFFFAOYSA-N	276777	5-({2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)-N-methylthiophene-2-carboxamide (racemate)::US10071995, Example 11::US10071995, Example 12	Plasma kallikrein			 2.70					7.4	25.00 C	US Patent		10.7270/Q2H13429		aid1795531	US10071995	Rohrig, S; Jimenez Nunez, E; Schlemmer, K; Tersteegen, A; Teller, H; Hillisch, A; Heitmeier, S; Schmidt, MV; Stampfus, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=276777	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=276777&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118978130	378158437							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
525116	CNC(=O)c1ccc(NC(=O)C(CCOC)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2C#N)s1	InChI=1S/C24H23ClN4O5S/c1-27-24(32)20-6-7-21(35-20)28-23(31)18(8-9-33-2)29-13-19(34-3)17(11-22(29)30)16-10-15(25)5-4-14(16)12-26/h4-7,10-11,13,18H,8-9H2,1-3H3,(H,27,32)(H,28,31)	BIXGLCFSTUQYSC-UHFFFAOYSA-N	276777	5-({2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)-N-methylthiophene-2-carboxamide (racemate)::US10071995, Example 11::US10071995, Example 12	Plasma kallikrein			 1.70					7.4	25.00 C	US Patent		10.7270/Q2H13429		aid1795531	US10071995	Rohrig, S; Jimenez Nunez, E; Schlemmer, K; Tersteegen, A; Teller, H; Hillisch, A; Heitmeier, S; Schmidt, MV; Stampfus, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=276777	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=276777&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118978130	378158437							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
525117	COc1cn(C(Cc2ccn(C)n2)C(=O)Nc2ccc(s2)C(N)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C25H21ClN6O4S/c1-31-8-7-16(30-31)10-19(25(35)29-22-6-5-21(37-22)24(28)34)32-13-20(36-2)18(11-23(32)33)17-9-15(26)4-3-14(17)12-27/h3-9,11,13,19H,10H2,1-2H3,(H2,28,34)(H,29,35)	XKHMCIMABQFRMZ-UHFFFAOYSA-N	276779	5-({2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-3-(1-methyl-1H-pyrazol-3-yl)propanoyl}amino)thiophene-2-carboxamide (racemate)::US10071995, Example 13::US10071995, Example 14	Plasma kallikrein			 2.20					7.4	25.00 C	US Patent		10.7270/Q2H13429		aid1795531	US10071995	Rohrig, S; Jimenez Nunez, E; Schlemmer, K; Tersteegen, A; Teller, H; Hillisch, A; Heitmeier, S; Schmidt, MV; Stampfus, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=276779	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=276779&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118978127	378158438							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
525118	COc1cn(C(Cc2ccn(C)n2)C(=O)Nc2ccc(s2)C(N)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C25H21ClN6O4S/c1-31-8-7-16(30-31)10-19(25(35)29-22-6-5-21(37-22)24(28)34)32-13-20(36-2)18(11-23(32)33)17-9-15(26)4-3-14(17)12-27/h3-9,11,13,19H,10H2,1-2H3,(H2,28,34)(H,29,35)	XKHMCIMABQFRMZ-UHFFFAOYSA-N	276779	5-({2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-3-(1-methyl-1H-pyrazol-3-yl)propanoyl}amino)thiophene-2-carboxamide (racemate)::US10071995, Example 13::US10071995, Example 14	Plasma kallikrein			 0.490					7.4	25.00 C	US Patent		10.7270/Q2H13429		aid1795531	US10071995	Rohrig, S; Jimenez Nunez, E; Schlemmer, K; Tersteegen, A; Teller, H; Hillisch, A; Heitmeier, S; Schmidt, MV; Stampfus, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=276779	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=276779&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118978127	378158438							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
525119	CNC(=O)c1ccc(NC(=O)C(Cc2ccn(C)n2)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2C#N)s1	InChI=1S/C26H23ClN6O4S/c1-29-26(36)22-6-7-23(38-22)30-25(35)20(11-17-8-9-32(2)31-17)33-14-21(37-3)19(12-24(33)34)18-10-16(27)5-4-15(18)13-28/h4-10,12,14,20H,11H2,1-3H3,(H,29,36)(H,30,35)	VZHZAANDMCCQRE-UHFFFAOYSA-N	276781	5-({2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-3-(1-methyl-1H-pyrazol-3-yl)propanoyl}amino)-N-methylthiophene-2-carboxamide (racemate)::US10071995, Example 15::US10071995, Example 16	Plasma kallikrein			 1.60					7.4	25.00 C	US Patent		10.7270/Q2H13429		aid1795531	US10071995	Rohrig, S; Jimenez Nunez, E; Schlemmer, K; Tersteegen, A; Teller, H; Hillisch, A; Heitmeier, S; Schmidt, MV; Stampfus, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=276781	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=276781&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118978139	378158439							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
525120	CNC(=O)c1ccc(NC(=O)C(Cc2ccn(C)n2)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2C#N)s1	InChI=1S/C26H23ClN6O4S/c1-29-26(36)22-6-7-23(38-22)30-25(35)20(11-17-8-9-32(2)31-17)33-14-21(37-3)19(12-24(33)34)18-10-16(27)5-4-15(18)13-28/h4-10,12,14,20H,11H2,1-3H3,(H,29,36)(H,30,35)	VZHZAANDMCCQRE-UHFFFAOYSA-N	276781	5-({2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-3-(1-methyl-1H-pyrazol-3-yl)propanoyl}amino)-N-methylthiophene-2-carboxamide (racemate)::US10071995, Example 15::US10071995, Example 16	Plasma kallikrein			 1.50					7.4	25.00 C	US Patent		10.7270/Q2H13429		aid1795531	US10071995	Rohrig, S; Jimenez Nunez, E; Schlemmer, K; Tersteegen, A; Teller, H; Hillisch, A; Heitmeier, S; Schmidt, MV; Stampfus, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=276781	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=276781&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118978139	378158439							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
525121	CNC(=O)c1ccc(NC(=O)C(Cc2cnco2)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2C#N)s1	InChI=1S/C25H20ClN5O5S/c1-28-25(34)21-5-6-22(37-21)30-24(33)19(8-16-11-29-13-36-16)31-12-20(35-2)18(9-23(31)32)17-7-15(26)4-3-14(17)10-27/h3-7,9,11-13,19H,8H2,1-2H3,(H,28,34)(H,30,33)	MWDYAWIVZRPCHQ-UHFFFAOYSA-N	276783	5-({2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-3-(1,3-oxazol-5-yl)-propanoyl}amino)-N-methylthiophene-2-carboxamide (racemate)::US10071995, Example 17	Plasma kallikrein			 2.70					7.4	25.00 C	US Patent		10.7270/Q2H13429		aid1795531	US10071995	Rohrig, S; Jimenez Nunez, E; Schlemmer, K; Tersteegen, A; Teller, H; Hillisch, A; Heitmeier, S; Schmidt, MV; Stampfus, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=276783	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=276783&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118978140	378158440							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
525122	COc1cn(C(Cc2ccccn2)C(=O)Nc2ccc(s2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C26H19ClN4O5S/c1-36-21-14-31(24(32)12-19(21)18-10-16(27)6-5-15(18)13-28)20(11-17-4-2-3-9-29-17)25(33)30-23-8-7-22(37-23)26(34)35/h2-10,12,14,20H,11H2,1H3,(H,30,33)(H,34,35)	LFFPKMZQMGFUFM-UHFFFAOYSA-N	276784	5-({2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-3-(pyridin-2-yl)propanoyl}-amino)thiophene-2-carboxylic acid (racemate)::US10071995, Example 18	Plasma kallikrein			 6.00					7.4	25.00 C	US Patent		10.7270/Q2H13429		aid1795531	US10071995	Rohrig, S; Jimenez Nunez, E; Schlemmer, K; Tersteegen, A; Teller, H; Hillisch, A; Heitmeier, S; Schmidt, MV; Stampfus, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=276784	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=276784&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118978141	378158441							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
525123	COCCC(C(=O)Nc1ccc(s1)C(O)=O)n1cc(Cl)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C22H17Cl2N3O5S/c1-32-7-6-17(21(29)26-19-5-4-18(33-19)22(30)31)27-11-16(24)15(9-20(27)28)14-8-13(23)3-2-12(14)10-25/h2-5,8-9,11,17H,6-7H2,1H3,(H,26,29)(H,30,31)	NOGZUPFUDRHOSR-UHFFFAOYSA-N	276785	5-({2-[5-Chloro-4-(5-chloro-2-cyanophenyl)-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)-thiophene-2-carboxylic acid (racemate)::US10071995, Example 19	Plasma kallikrein			 47.0					7.4	25.00 C	US Patent		10.7270/Q2H13429		aid1795531	US10071995	Rohrig, S; Jimenez Nunez, E; Schlemmer, K; Tersteegen, A; Teller, H; Hillisch, A; Heitmeier, S; Schmidt, MV; Stampfus, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=276785	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=276785&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118978143	378158442							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588167	NC(=N)c1ccc(CNC(=O)c2ccc3C4OC(c3c2)c2cc(C3CC3)c(cc42)C2CC2)cc1	InChI=1S/C29H27N3O2/c30-28(31)18-3-1-15(2-4-18)14-32-29(33)19-9-10-20-23(11-19)27-25-13-22(17-7-8-17)21(16-5-6-16)12-24(25)26(20)34-27/h1-4,9-13,16-17,26-27H,5-8,14H2,(H3,30,31)(H,32,33)	PATKGAJHNVAGIU-UHFFFAOYSA-N	306672	(+-)-N-[(4-carbamimidoyl- phenyl)methyl]-11,12- dicyclopropyl-15-oxatetracyclo [6.6.1.02,7.09,14]-pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 316	Plasma kallikrein			 4.90							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306672	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306672&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131995	381755371							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588168	Cc1cc2C3OC(c4cc(ccc34)C(=O)NCc3ccc(cc3)C(N)=N)c2cc1C	InChI=1S/C25H23N3O2/c1-13-9-19-20(10-14(13)2)23-21-11-17(7-8-18(21)22(19)30-23)25(29)28-12-15-3-5-16(6-4-15)24(26)27/h3-11,22-23H,12H2,1-2H3,(H3,26,27)(H,28,29)	GTZCVKZYBCHAEB-UHFFFAOYSA-N	306673	(+-)-N-[(4-carbamimidoylphenyl) methyl]-11,12-dimethyl-15- oxatetracyclo[6.6.1.02,7.09,14]- pentadeca-2,4,6,9(14),10,12- hexaene-4-carboxamide::US10144746, Compound 317	Plasma kallikrein			 28.8							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306673	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306673&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131996	381755372							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588169	CN1C(=O)c2cc3C4OC(c3cc2C1=O)c1cc(ccc41)C(=O)NCc1c(C)cc(N)nc1C	InChI=1S/C26H22N4O4/c1-11-6-21(27)29-12(2)20(11)10-28-24(31)13-4-5-14-15(7-13)23-17-9-19-18(8-16(17)22(14)34-23)25(32)30(3)26(19)33/h4-9,22-23H,10H2,1-3H3,(H2,27,29)(H,28,31)	XPZJZLILTNHDSC-UHFFFAOYSA-N	306674	(+-)-N-[(6-amino-2,4-dimethyl- pyridin-3-yl)methyl]-6- methyl-5,7-dioxo-18-oxa-6- azapentacyclo [9.6.1.02,10.04,8.012,14]octadeca- 2(10),3,8,12,14,16-hexaene- 14-carboxamide::US10144746, Compound 318	Plasma kallikrein			 17.4							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306674	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306674&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131997	381755373							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588170	COC(=O)c1cc2C3OC(c4cc(ccc34)C(=O)NCc3c(C)cc(N)nc3C)c2cc1C(=O)OC	InChI=1S/C27H25N3O6/c1-12-7-22(28)30-13(2)21(12)11-29-25(31)14-5-6-15-16(8-14)24-18-10-20(27(33)35-4)19(26(32)34-3)9-17(18)23(15)36-24/h5-10,23-24H,11H2,1-4H3,(H2,28,30)(H,29,31)	RTCIYAHXWGOQKR-UHFFFAOYSA-N	306675	(+-)-4,5-dimethyl 11-{[(6-amino- 2,4-dimethyl-pyridin-3- yl)methyl]carbamoyl}-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2(7),3,5,9,11,13- hexaene-4,5-dicarboxylate::US10144746, Compound 319	Plasma kallikrein			 2455							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306675	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306675&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131998	381755374							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588171	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc2c(O)nnc(O)c2cc31	InChI=1S/C25H21N5O4/c1-10-5-20(26)28-11(2)19(10)9-27-23(31)12-3-4-13-14(6-12)22-16-8-18-17(7-15(16)21(13)34-22)24(32)29-30-25(18)33/h3-8,21-22H,9H2,1-2H3,(H2,26,28)(H,27,31)(H,29,32)(H,30,33)	LTVPHEWBOGVINI-UHFFFAOYSA-N	306676	(+-)-N-[(6-amino-2,4-dimethyl- pyridin-3-yl)methyl]-5,8- dihydroxy-19-oxa-6,7- diazapentacyclo [10.6.1.02,11.04,9.013,18] nonadeca-2(11),3,5,7,9,13,15,17- octaene-15-carboxamide::US10144746, Compound 320	Plasma kallikrein			 10000							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306676	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306676&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124132001	381755375							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588172	CCc1cc2C3OC(c4cc(ccc34)C(=O)NCc3c(C)cc(N)nc3C)c2cc1-c1ccc(F)cc1F	InChI=1S/C31H27F2N3O2/c1-4-17-10-24-25(13-22(17)20-8-6-19(32)12-27(20)33)30-23-11-18(5-7-21(23)29(24)38-30)31(37)35-14-26-15(2)9-28(34)36-16(26)3/h5-13,29-30H,4,14H2,1-3H3,(H2,34,36)(H,35,37)	BLCRECLLKMSCAR-UHFFFAOYSA-N	306677	(+-)-N-[(6-amino-2,4-dimethyl- pyridin-3-yl)methyl]-12-(2,4- difluorophenyl)-11-ethyl-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9(14),10,12- hexaene-4-carboxamide and  (+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]-11- (2,4-difluorophenyl)-12- ethyl-15-oxatetracyclo [6.6.1.02,7.09,14]pentadeca- 2,4,6,9(14),10,12-hexaene-4- carboxamide::US10144746, Compound 321	Plasma kallikrein			 8.13							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306677	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306677&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131999	381755376							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588173	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(c(C=C)cc31)-c1ccc(F)cc1F	InChI=1S/C31H25F2N3O2/c1-4-17-10-24-25(13-22(17)20-8-6-19(32)12-27(20)33)30-23-11-18(5-7-21(23)29(24)38-30)31(37)35-14-26-15(2)9-28(34)36-16(26)3/h4-13,29-30H,1,14H2,2-3H3,(H2,34,36)(H,35,37)	JOLPUACDVQAJDV-UHFFFAOYSA-N	306678	(+-)-N-[(6-amino-2,4-dimethyl- pyridin-3-yl)methyl]-12-(2,4- difluorophenyl)-11-ethenyl-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide and (+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 11-(2,4-difluorophenyl)-12- ethenyl-15-oxatetraoyclo [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 322	Plasma kallikrein			 2.69							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306678	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306678&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124132000	381755377							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588174	Fc1ccc(c(F)c1)-c1ccc2[C@@H]3O[C@@H](c4cc(ccc34)C(=O)NCC3CNC3)c2c1	InChI=1S/C25H20F2N2O2/c26-16-3-6-17(22(27)9-16)14-1-4-18-20(7-14)24-21-8-15(2-5-19(21)23(18)31-24)25(30)29-12-13-10-28-11-13/h1-9,13,23-24,28H,10-12H2,(H,29,30)/t23-,24+/m0/s1	GRCZOGCXOADZKB-BJKOFHAPSA-N	306679	(1R,8S)-N-[(azetidin-3-yl) methyl]- 12-(2,4-difluorophenyl)- 15-oxatetracyclo [6.6.1.02,7.09,14]- pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 323	Plasma kallikrein			 100000							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306679	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306679&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124132004	381755378							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588175	Fc1ccc(c(F)c1)-c1ccc2[C@@H]3O[C@@H](c4cc(ccc34)C(=O)N[C@@H]3CCNC3)c2c1	InChI=1S/C25H20F2N2O2/c26-15-3-6-17(22(27)11-15)13-1-4-18-20(9-13)24-21-10-14(2-5-19(21)23(18)31-24)25(30)29-16-7-8-28-12-16/h1-6,9-11,16,23-24,28H,7-8,12H2,(H,29,30)/t16-,23+,24-/m1/s1	TZGWYVAZCPMNGX-QQTNTEGQSA-N	306680	(1R,8S)-12-(2,4-difluorophenyl)- N-[(3R)-pyrrolidin-3-yl]- 15-oxatetracyclo[6.6.1.02,7.09,14]- pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 324	Plasma kallikrein			 100000							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306680	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306680&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124132005	381755379							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588176	Fc1ccc(c(F)c1)-c1ccc2[C@@H]3O[C@@H](c4cc(ccc34)C(=O)N[C@H]3CCNC3)c2c1	InChI=1S/C25H20F2N2O2/c26-15-3-6-17(22(27)11-15)13-1-4-18-20(9-13)24-21-10-14(2-5-19(21)23(18)31-24)25(30)29-16-7-8-28-12-16/h1-6,9-11,16,23-24,28H,7-8,12H2,(H,29,30)/t16-,23-,24+/m0/s1	TZGWYVAZCPMNGX-VVMYJBMMSA-N	306681	(1R,8S)-12-(2,4-difluorophenyl)- N-[(3S)-pyrrolidin-3-yl]- 15-oxatetracyclo[6.6.1.02,7.09,14]- pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 325	Plasma kallikrein			 42658							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306681	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306681&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124132006	381755380							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588177	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(C#N)c(cc31)C#N	InChI=1S/C25H19N5O2/c1-12-5-22(28)30-13(2)21(12)11-29-25(31)14-3-4-17-18(6-14)24-20-8-16(10-27)15(9-26)7-19(20)23(17)32-24/h3-8,23-24H,11H2,1-2H3,(H2,28,30)(H,29,31)	ZEXACNNYSQKKBW-UHFFFAOYSA-N	306682	(+-)-N-((6-amino-2,4- dimethylpyridin-3-yl)methyl]- 11,12-dicyano-15-oxatetracyclo- [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 326	Plasma kallikrein			 851							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306682	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306682&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124132007	381755381							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588178	NC(=N)c1ccc(CNC(=O)c2ccc3[C@H]4O[C@H](c5cc(ccc45)C4CC4)c3c2)nc1	InChI=1S/C25H22N4O2/c26-24(27)16-3-6-17(28-11-16)12-29-25(30)15-5-8-19-21(10-15)23-20-9-14(13-1-2-13)4-7-18(20)22(19)31-23/h3-11,13,22-23H,1-2,12H2,(H3,26,27)(H,29,30)/t22-,23+/m0/s1	ISUGTEAPZOZSKJ-XZOQPEGZSA-N	306683	(1R,8S)-N-[(5- carbamimidoylpyridin-2-yl) methyl]-12- cyclopropyl-15-oxatetracyclo- [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 327	Plasma kallikrein			 427							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306683	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306683&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124132008	381755382							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588179	CC(C)c1ccc2[C@@H]3O[C@H](c2c1)c1cc(ccc31)C(=O)NCc1ccc(cc1)C(N)=N	InChI=1S/C26H25N3O2/c1-14(2)17-7-9-19-21(11-17)24-22-12-18(8-10-20(22)23(19)31-24)26(30)29-13-15-3-5-16(6-4-15)25(27)28/h3-12,14,23-24H,13H2,1-2H3,(H3,27,28)(H,29,30)/t23-,24+/m0/s1	YJMRCJUYBWQMGQ-BJKOFHAPSA-N	306684	(1R,8S)-N-[(4- carbamimidoylphenyl) methyl]-12-(propan-2- yl)-15-oxatetracyclo [6.6.1.02,7.09,14]-pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 328	Plasma kallikrein			 7.08							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306684	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306684&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124132009	381755383							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588180	NC(=N)c1ccc(CNC(=O)c2ccc3[C@H]4O[C@@H](c3c2)c2cc(ccc42)-c2ccc(F)cc2)c(F)c1	InChI=1S/C29H21F2N3O2/c30-20-7-3-15(4-8-20)16-5-9-21-23(11-16)27-24-12-18(6-10-22(24)26(21)36-27)29(35)34-14-19-2-1-17(28(32)33)13-25(19)31/h1-13,26-27H,14H2,(H3,32,33)(H,34,35)/t26-,27+/m0/s1	OSFMJFGBSHHRAI-RRPNLBNLSA-N	306685	(1R,8S)-N-[(4-carbamimidoyl- 2-fluorophenyl)-methyl]-12- (4-fluorophenyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13-hexaene- 4-carboxamide::US10144746, Compound 329	Plasma kallikrein			 1.000							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306685	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306685&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124132010	381755384							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588181	Cc1cc(cc(C)c1CNC(=O)c1ccc2[C@H]3O[C@H](c4cc(ccc34)C3CC3)c2c1)C(N)=N	InChI=1S/C28H27N3O2/c1-14-9-19(27(29)30)10-15(2)24(14)13-31-28(32)18-6-8-21-23(12-18)26-22-11-17(16-3-4-16)5-7-20(22)25(21)33-26/h5-12,16,25-26H,3-4,13H2,1-2H3,(H3,29,30)(H,31,32)/t25-,26+/m0/s1	SYSUACMAKJKASN-IZZNHLLZSA-N	306686	(1R,8S)-N-[(4-carbamimidoyl- 2,6-dimethyl-phenyl)methyl]- 12-cyclopropyl-15-oxatetracyclo [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 331	Plasma kallikrein			 1.000							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306686	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306686&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124132011	381755385							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588182	NC(=N)c1ccc(CNC(=O)c2ccc3[C@H]4O[C@@H](c3c2)c2cc(ccc42)-c2ccc(F)cc2F)nc1	InChI=1S/C28H20F2N4O2/c29-17-4-8-19(24(30)11-17)14-2-6-20-22(9-14)26-23-10-15(3-7-21(23)25(20)36-26)28(35)34-13-18-5-1-16(12-33-18)27(31)32/h1-12,25-26H,13H2,(H3,31,32)(H,34,35)/t25-,26+/m0/s1	ZJJYQWWFHJCYFB-IZZNHLLZSA-N	306687	(1R,8S)-N-[(5-carbamimidoyl- pyridin-2-yl)-methyl]-12-(2,4- difluorophenyl)-15-oxatetracyclo [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 332	Plasma kallikrein			 63.1							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306687	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306687&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124132012	381755386							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588183	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(C(N)=O)c(cc31)C#N	InChI=1S/C25H21N5O3/c1-11-5-21(27)30-12(2)20(11)10-29-25(32)13-3-4-15-17(6-13)23-19-8-16(24(28)31)14(9-26)7-18(19)22(15)33-23/h3-8,22-23H,10H2,1-2H3,(H2,27,30)(H2,28,31)(H,29,32)	ZXQSOYHNWOLCHG-UHFFFAOYSA-N	306688	(+-)-N4-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 11-cyano-15-oxatetracyclo- [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4,12- dicarboxamide and (+-)-N4-[(6- amino-2,4-dimethylpyridin-3- yl)methyl]-12-cyano-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4,11-dicarboxamide::US10144746, Compound 333	Plasma kallikrein			 2291							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306688	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306688&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124132013	381755387							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588184	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2c(c1)C1OC2(C)c2ccc(cc12)-c1ccc(F)cc1	InChI=1S/C30H26FN3O2/c1-16-12-27(32)34-17(2)24(16)15-33-29(35)20-7-11-26-23(14-20)28-22-13-19(18-4-8-21(31)9-5-18)6-10-25(22)30(26,3)36-28/h4-14,28H,15H2,1-3H3,(H2,32,34)(H,33,35)	BDPLFZSFMPSDJA-UHFFFAOYSA-N	306689	(+-)-N-[(6-amino-2,4-dimethyl- pyridin-3-yl)methyl]-12-(4- fluorophenyl)-8-methyl-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide (+-)-N- [(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 11-(4-fluorophenyl)-8-methyl- 15-oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 334	Plasma kallikrein			 2512							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306689	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306689&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124132015	381755388							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588185	COc1cc2C3OC(c2cc1OC)c1cc(ccc31)C(=O)NCc1c(C)cc(N)nc1C	InChI=1S/C25H25N3O4/c1-12-7-22(26)28-13(2)19(12)11-27-25(29)14-5-6-15-16(8-14)24-18-10-21(31-4)20(30-3)9-17(18)23(15)32-24/h5-10,23-24H,11H2,1-4H3,(H2,26,28)(H,27,29)	XVOASRFPZUXYHC-UHFFFAOYSA-N	306690	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 11,12-dimethoxy-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9(14),10,12- hexaene-4-carboxamide::US10144746, Compound 335	Plasma kallikrein			 1622							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306690	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306690&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124132017	381755389							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588186	NC(=N)c1cc(F)c(CNC(=O)c2ccc3[C@H]4O[C@H](c5cc(ccc45)N4CCS(=O)(=O)CC4)c3c2)c(F)c1	InChI=1S/C27H24F2N4O4S/c28-22-10-15(26(30)31)11-23(29)21(22)13-32-27(34)14-1-3-17-19(9-14)25-20-12-16(2-4-18(20)24(17)37-25)33-5-7-38(35,36)8-6-33/h1-4,9-12,24-25H,5-8,13H2,(H3,30,31)(H,32,34)/t24-,25+/m1/s1	XTPINWBFBVZCKT-RPBOFIJWSA-N	306691	(1S,8R)-N-[(4-carbamimidoyl- 2,6-difluoro-phenyl)methyl]- 12-(1,1-dioxo-1lambda6-thiomorpholin- 4-yl)-15-oxatetracyclo- [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 336	Plasma kallikrein			 5.01							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306691	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306691&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124132020	381755390							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588187	NC(=N)c1ccc(CNC(=O)c2ccc3[C@H]4O[C@H](c5cc(ccc45)N4CCS(=O)(=O)CC4)c3c2)cc1	InChI=1S/C27H26N4O4S/c28-26(29)17-3-1-16(2-4-17)15-30-27(32)18-5-7-20-22(13-18)25-23-14-19(6-8-21(23)24(20)35-25)31-9-11-36(33,34)12-10-31/h1-8,13-14,24-25H,9-12,15H2,(H3,28,29)(H,30,32)/t24-,25+/m1/s1	DXSLTOJZNMPEMA-RPBOFIJWSA-N	306692	(1S,8R)-N-[(4-carbamimidoyl- phenyl)methyl]-12-(1,1-dioxo- 1lambda6-thiomorpholin-4-yl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 337	Plasma kallikrein			 26.9							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306692	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306692&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124132019	381755391							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588188	COc1cc(CNC(=O)c2ccc3[C@H]4O[C@@H](c3c2)c2cc(ccc42)-c2ccc(F)cc2F)ccc1C(N)=N	InChI=1S/C30H23F2N3O3/c1-37-26-10-15(2-6-22(26)29(33)34)14-35-30(36)17-4-8-21-24(12-17)28-23-11-16(3-7-20(23)27(21)38-28)19-9-5-18(31)13-25(19)32/h2-13,27-28H,14H2,1H3,(H3,33,34)(H,35,36)/t27-,28+/m0/s1	ZCCYKYKIGXITPO-WUFINQPMSA-N	306693	(1R,8S)-N-[(4-carbamimidoyl- 3-methoxyphenyl)-methyl]- 12-(2,4-difluorophenyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 338	Plasma kallikrein			 5.89							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306693	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306693&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124132022	381755392							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588189	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2c(c1)C1(C)OC2(C)c2ccc(cc12)-c1ccc(F)cc1	InChI=1S/C31H28FN3O2/c1-17-13-28(33)35-18(2)23(17)16-34-29(36)21-8-12-25-27(15-21)31(4)26-14-20(19-5-9-22(32)10-6-19)7-11-24(26)30(25,3)37-31/h5-15H,16H2,1-4H3,(H2,33,35)(H,34,36)	OSNZWWSEVQUWFO-UHFFFAOYSA-N	306694	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 12-(4-fluorophenyl)-1,8- dimethyl-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide and (+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 11-(4-fluorophenyl)-1,8- dimethyl-15-oxatetracyclo [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 339	Plasma kallikrein			 100000							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306694	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306694&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124132021	381755393							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588190	Cc1cc(cc2C3OC(c4ccc(cc34)C(=O)NCc3c(C)cc(N)nc3C)c12)-c1ccc(F)cc1	InChI=1S/C30H26FN3O2/c1-15-11-26(32)34-17(3)25(15)14-33-30(35)19-6-9-22-23(12-19)28-24-13-20(18-4-7-21(31)8-5-18)10-16(2)27(24)29(22)36-28/h4-13,28-29H,14H2,1-3H3,(H2,32,34)(H,33,35)	DPSBISUQXKOWEV-UHFFFAOYSA-N	306695	(+-)-N-[(6-amino-2,4-dimethyl- pyridin-3-yl)methyl]-12-(4- fluorophenyl)-10-methyl-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9(14),10,12- hexaene-4-carboxamide and  (+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 11-(4-fluorophenyl)-13- methyl-15-oxatetracyclo [6.6.1.02,7.09,14]pentadeca- 2,4,6,9(14),10,12-hexaene-4- carboxamide::US10144746, Compound 340	Plasma kallikrein			 229							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306695	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306695&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124132027	381755394							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588191	Cc1cc(cc2C3OC(c4ccc(cc34)C(=O)NCc3ccc(cc3)C(N)=N)c12)-c1ccc(F)cc1	InChI=1S/C30H24FN3O2/c1-16-12-21(18-6-9-22(31)10-7-18)14-25-26(16)28-23-11-8-20(13-24(23)27(25)36-28)30(35)34-15-17-2-4-19(5-3-17)29(32)33/h2-14,27-28H,15H2,1H3,(H3,32,33)(H,34,35)	WBXOYELTYULMGO-UHFFFAOYSA-N	306696	(+-)-N-[(4-carbamimidoylphenyl) methyl]-12-(4- fluorophenyl)-10-methyl-15- oxatetracyclo- [6.6.1.02,7.09,14]pentadeca- 2,4,6,9(14),10,12-hexaene-4- carboxamide and (+-)-N-[(4- carbamimidoylphenyl)methyl]- 11-(4-fluorophenyl)-13-methyl- 15-oxatetracyclo- [6.6.1.02,7.09,14]pentadeca- 2,4,6,9(14),10,12-hexaene-4- carboxamide::US10144746, Compound 341	Plasma kallikrein			 7.08							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306696	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306696&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124132025	381755395							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588192	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c4cc5OCCOc5cc34)c2c1	InChI=1S/C25H23N3O4/c1-12-7-22(26)28-13(2)19(12)11-27-25(29)14-3-4-15-16(8-14)24-18-10-21-20(30-5-6-31-21)9-17(18)23(15)32-24/h3-4,7-10,23-24H,5-6,11H2,1-2H3,(H2,26,28)(H,27,29)	RHSFBANMFINCSI-UHFFFAOYSA-N	306697	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 5,8,19-trioxapentacyclo- [10.6.1.02,11.04,9.013,18]nonadeca- 2,4(9),10,13,15,17-hexaene- 15-carboxamide::US10144746, Compound 342	Plasma kallikrein			 550							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306697	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306697&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124132028	381755396							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588193	Fc1ccc(c(F)c1)-c1ccc2[C@@H]3O[C@@H](c4cc(ccc34)C(=O)NC3CCCNCC3)c2c1	InChI=1S/C27H24F2N2O2/c28-17-5-8-19(24(29)14-17)15-3-6-20-22(12-15)26-23-13-16(4-7-21(23)25(20)33-26)27(32)31-18-2-1-10-30-11-9-18/h3-8,12-14,18,25-26,30H,1-2,9-11H2,(H,31,32)/t18?,25-,26+/m0/s1	JWMLVXLNYQVTQX-XINCGQIGSA-N	306698	(1R,8S)-N-(azepan-4-yl)-12- (2,4-difluorophenyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 343	Plasma kallikrein			 100000							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306698	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306698&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124132029	381755397							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588194	CC12OC(C)(c3cc(ccc13)C(=O)NCc1ccc(cc1)C(N)=N)c1cc(ccc21)-c1ccc(F)cc1	InChI=1S/C31H26FN3O2/c1-30-24-13-9-21(19-7-11-23(32)12-8-19)15-26(24)31(2,37-30)27-16-22(10-14-25(27)30)29(36)35-17-18-3-5-20(6-4-18)28(33)34/h3-16H,17H2,1-2H3,(H3,33,34)(H,35,36)	BWERMWHMBQNMDZ-UHFFFAOYSA-N	306699	N-[(4-carbamimidoylphenyl) methyl]-12-(4-fluorophenyl)- 1,8-dimethyl-15-oxatetracyclo [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 344	Plasma kallikrein			 427							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306699	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306699&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124132030	381755398							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588195	Fc1ccc(c(F)c1)-c1ccc2[C@@H]3O[C@@H](c4cc(ccc34)C(=O)NC3CCNCC3)c2c1	InChI=1S/C26H22F2N2O2/c27-16-3-6-18(23(28)13-16)14-1-4-19-21(11-14)25-22-12-15(2-5-20(22)24(19)32-25)26(31)30-17-7-9-29-10-8-17/h1-6,11-13,17,24-25,29H,7-10H2,(H,30,31)/t24-,25+/m0/s1	GKFFGPQESAMEDS-LOSJGSFVSA-N	306700	(1R,8S)-12-(2,4-difluorophenyl)- N-(piperidin-4-yl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 345	Plasma kallikrein			 33884							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306700	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306700&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124132031	381755399							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588196	C[C@]12OC(c3cc(ccc13)C(=O)NCc1ccc(cc1)C(N)=N)c1cc(ccc21)-c1ccc(F)cc1	InChI=1S/C30H24FN3O2/c1-30-25-12-8-20(18-6-10-22(31)11-7-18)14-23(25)27(36-30)24-15-21(9-13-26(24)30)29(35)34-16-17-2-4-19(5-3-17)28(32)33/h2-15,27H,16H2,1H3,(H3,32,33)(H,34,35)/t27?,30-/m1/s1	YBZMUAJZMJUFFB-DINWUYGQSA-N	306701	(+-)-N-[(4-carbamimidoylphenyl) methyl]-12-(4- fluorophenyl)-8-methyl-15- oxatetracyclo- [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 346	Plasma kallikrein			 55.0							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306701	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306701&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137554694	381755400							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588197	Nc1cc(NC(=O)c2ccc3[C@H]4O[C@@H](c3c2)c2cc(ccc42)-c2ccc(F)cc2F)ccn1	InChI=1S/C26H17F2N3O2/c27-15-3-6-17(22(28)11-15)13-1-4-18-20(9-13)25-21-10-14(2-5-19(21)24(18)33-25)26(32)31-16-7-8-30-23(29)12-16/h1-12,24-25H,(H3,29,30,31,32)/t24-,25+/m0/s1	IRXVATNLUFNHFI-LOSJGSFVSA-N	306702	(1R,8S)-N-(2-aminopyridin- 4-yl)-12-(2,4-difluorophenyl)- 15-oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 347	Plasma kallikrein			 100000							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306702	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306702&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124132034	381755401							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588198	CCc1cc2[C@@H]3O[C@H](c2cc1CC)c1cc(ccc31)C(=O)NCc1ccc(cc1)C(N)=N	InChI=1S/C27H27N3O2/c1-3-16-11-22-23(12-17(16)4-2)25-21-13-19(9-10-20(21)24(22)32-25)27(31)30-14-15-5-7-18(8-6-15)26(28)29/h5-13,24-25H,3-4,14H2,1-2H3,(H3,28,29)(H,30,31)/t24-,25+/m1/s1	XROGSPJLCQLFQP-RPBOFIJWSA-N	306703	(1S,8R)-N-[(4- carbamimidoylphenyl) methyl]-11,12-diethyl- 15-oxatetracyclo [6.6.1.02,7.09,14] pentadeca- 2,4,6,9(14),10,12- hexaene-4-carboxamide::US10144746, Compound 392	Plasma kallikrein			 1.000							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306703	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306703&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124132071	381755402							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588199	Cc1cc(cc2C3OC(c12)c1c3cc(cc1F)C(=O)NCc1ccc(cc1)C(N)=N)-c1ccc(F)cc1	InChI=1S/C30H23F2N3O2/c1-15-10-19(17-6-8-21(31)9-7-17)11-22-25(15)28-26-23(27(22)37-28)12-20(13-24(26)32)30(36)35-14-16-2-4-18(5-3-16)29(33)34/h2-13,27-28H,14H2,1H3,(H3,33,34)(H,35,36)	SJUIOQOVYSVNHN-UHFFFAOYSA-N	306704	(+-)-N-[(4- carbamimidoylphenyl) methyl]-6-fluoro-12-(4- fluorophenyl)-10-methyl-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca- 2(7),3,5,9(14),10,12- hexaene-4-carboxamide::US10144746, Compound 396	Plasma kallikrein			 5.01							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306704	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306704&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124132074	381755403							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588200	Cc1cc(cc2C3OC(c12)c1c3cc(cc1F)C(=O)NCc1c(C)cc(N)nc1C)-c1ccc(F)cc1	InChI=1S/C30H25F2N3O2/c1-14-9-25(33)35-16(3)23(14)13-34-30(36)19-11-22-27(24(32)12-19)29-26-15(2)8-18(10-21(26)28(22)37-29)17-4-6-20(31)7-5-17/h4-12,28-29H,13H2,1-3H3,(H2,33,35)(H,34,36)	MIXKLOLTLDCLLR-UHFFFAOYSA-N	306705	(+-)-N-(6-amino-2,4- dimethylpyridin-3-yl) methyl]-6-fluoro- 12-(4-fluorophenyl)-10- methyl-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca- 2(7),3,5,9(14),10,12-hexaene- 4-carboxamide::US10144746, Compound 397	Plasma kallikrein			 20.0							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306705	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306705&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124132073	381755404							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588201	Cc1cc(cc2C3OC(c4cc(cc(F)c34)C(=O)NCc3c(C)cc(N)nc3C)c12)-c1ccc(F)cc1	InChI=1S/C30H25F2N3O2/c1-14-9-25(33)35-16(3)23(14)13-34-30(36)19-11-22-27(24(32)12-19)29-21-10-18(17-4-6-20(31)7-5-17)8-15(2)26(21)28(22)37-29/h4-12,28-29H,13H2,1-3H3,(H2,33,35)(H,34,36)	BEAADHDYJDYGEJ-UHFFFAOYSA-N	306706	N-[(6-amino-2,4-dimethyl- pyridin-3-yl)methyl]-6- fluoro-11- (4-fluorophenyl)-13-methyl-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9(14),10,12- hexaene-4-carboxamide::US10144746, Compound 398	Plasma kallikrein			 398							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306706	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306706&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124132075	381755405							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588202	NC(=N)c1ccc(CNC(=O)c2ccc3[C@@H]4O[C@H](c3c2)c2cc(C3CC3)c(cc42)C2CC2)cc1	InChI=1S/C29H27N3O2/c30-28(31)18-3-1-15(2-4-18)14-32-29(33)19-9-10-20-23(11-19)27-25-13-22(17-7-8-17)21(16-5-6-16)12-24(25)26(20)34-27/h1-4,9-13,16-17,26-27H,5-8,14H2,(H3,30,31)(H,32,33)/t26-,27+/m0/s1	PATKGAJHNVAGIU-RRPNLBNLSA-N	306707	(1R,8S)-N-[(4-carbamimidoyl- phenyl)methyl]-11,12- dicyclopropyl-15-oxatetracyclo [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 399	Plasma kallikrein			 100							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306707	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306707&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124132079	381755406							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588203	NC(=N)c1ccc(CNC(=O)c2ccc3[C@H]4O[C@@H](c3c2)c2cc(C3CC3)c(cc42)C2CC2)cc1	InChI=1S/C29H27N3O2/c30-28(31)18-3-1-15(2-4-18)14-32-29(33)19-9-10-20-23(11-19)27-25-13-22(17-7-8-17)21(16-5-6-16)12-24(25)26(20)34-27/h1-4,9-13,16-17,26-27H,5-8,14H2,(H3,30,31)(H,32,33)/t26-,27+/m1/s1	PATKGAJHNVAGIU-SXOMAYOGSA-N	306708	(1S,8R)-N-[(4-carbamimidoyl- phenyl)methyl]-11,12- dicyclopropyl-15- oxatetracyclo [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 400	Plasma kallikrein			 1.000							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306708	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306708&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124132076	381755407							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
582612	CCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc2c(cc1=O)-c1cc(Cl)ccc1CNC2=O	InChI=1S/C24H20ClN3O5/c1-2-20(23(31)27-16-7-4-13(5-8-16)24(32)33)28-12-19-18(10-21(28)29)17-9-15(25)6-3-14(17)11-26-22(19)30/h3-10,12,20H,2,11H2,1H3,(H,26,30)(H,27,31)(H,32,33)	SKGWZOVDJYWHAV-UHFFFAOYSA-N	303783	4-{[2-(10-Chloro-2,5-dioxo-2,5,6,7-tetrahydro-3H-pyrido[3,4-d][2]benzazepin-3-yl)butanoyl]amino}benzoic acid (Stereoisomer Mixture)::US10138236, Example 1	Plasma kallikrein			>10000							US Patent		10.7270/Q2445PH4		aid1796154	US10138236	Rohrig, S; Hillisch, A; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Schafer, M; Teller, H; Jimenez Nunez, E	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303783	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303783&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121247947	381752514							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
582613	CCC(C(=O)Nc1ccc(cc1)-c1noc(=O)[nH]1)n1cc2c(cc1=O)-c1cc(Cl)ccc1CNC2=O	InChI=1S/C25H20ClN5O5/c1-2-20(24(34)28-16-7-4-13(5-8-16)22-29-25(35)36-30-22)31-12-19-18(10-21(31)32)17-9-15(26)6-3-14(17)11-27-23(19)33/h3-10,12,20H,2,11H2,1H3,(H,27,33)(H,28,34)(H,29,30,35)	ISVJPGYUZXHMRW-UHFFFAOYSA-N	303784	2-(10-Chloro-2,5-dioxo-2,5,6,7-tetrahydro-3H-pyrido[3,4-d][2]benzazepin-3-yl)-N-[4-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)phenyl]butanamide (Stereoisomer Mixture)::US10138236, Example 2	Plasma kallikrein			 4900							US Patent		10.7270/Q2445PH4		aid1796154	US10138236	Rohrig, S; Hillisch, A; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Schafer, M; Teller, H; Jimenez Nunez, E	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303784	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303784&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137135831	381752515							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
582614	CCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc2c(cc1=O)-c1cc(Cl)ccc1C1(CC1)NC2=O	InChI=1S/C26H22ClN3O5/c1-2-21(24(33)28-16-6-3-14(4-7-16)25(34)35)30-13-19-17(12-22(30)31)18-11-15(27)5-8-20(18)26(9-10-26)29-23(19)32/h3-8,11-13,21H,2,9-10H2,1H3,(H,28,33)(H,29,32)(H,34,35)	KCGMSSQFQFMUQQ-UHFFFAOYSA-N	303785	4-{[2-(10&#8242;-Chloro-2&#8242;,5&#8242;-dioxo-5&#8242;,6&#8242;-dihydrospiro[cyclopropane-1,7&#8242;-pyrido[3,4-d][2]benzazepine]-3&#8242;(2&#8242;H)-yl)butanoyl]amino}benzoic acid (Stereoisomer Mixture)::US10138236, Example 3	Plasma kallikrein			>50000							US Patent		10.7270/Q2445PH4		aid1796154	US10138236	Rohrig, S; Hillisch, A; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Schafer, M; Teller, H; Jimenez Nunez, E	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303785	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303785&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121247954	381752516							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
582615	OC(=O)c1ccc(NC(=O)Cn2cc3c(cc2=O)-c2cc(Cl)ccc2CCNC3=O)cc1	InChI=1S/C23H18ClN3O5/c24-15-4-1-13-7-8-25-22(30)19-11-27(21(29)10-18(19)17(13)9-15)12-20(28)26-16-5-2-14(3-6-16)23(31)32/h1-6,9-11H,7-8,12H2,(H,25,30)(H,26,28)(H,31,32)	YHCVQIPIKWVWDD-UHFFFAOYSA-N	303786	4-{[(11-Chloro-2,5-dioxo-5,6,7,8-tetrahydropyrido[3,4-e][3]benzazocin-3(2H)-yl)acetyl]amino}benzoic acid::US10138236, Example 4	Plasma kallikrein			 18000							US Patent		10.7270/Q2445PH4		aid1796154	US10138236	Rohrig, S; Hillisch, A; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Schafer, M; Teller, H; Jimenez Nunez, E	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303786	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303786&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121248291	381752517							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
582616	Clc1ccc2CCNC(=O)c3cn(CC(=O)Nc4ccc(cc4)-c4noc(=O)[nH]4)c(=O)cc3-c2c1	InChI=1S/C24H18ClN5O5/c25-15-4-1-13-7-8-26-23(33)19-11-30(21(32)10-18(19)17(13)9-15)12-20(31)27-16-5-2-14(3-6-16)22-28-24(34)35-29-22/h1-6,9-11H,7-8,12H2,(H,26,33)(H,27,31)(H,28,29,34)	UPXBPQOTPKHXLR-UHFFFAOYSA-N	303787	2-(11-Chloro-2,5-dioxo-5,6,7,8-tetrahydropyrido[3,4-e][3]benzazocin-3(2H)-yl)-N-[4-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)phenyl]acetamide::US10138236, Example 5	Plasma kallikrein			 8300							US Patent		10.7270/Q2445PH4		aid1796154	US10138236	Rohrig, S; Hillisch, A; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Schafer, M; Teller, H; Jimenez Nunez, E	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303787	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303787&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137135834	381752518							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
582617	CCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc2c(cc1=O)-c1cc(Cl)ccc1CCNC2=O	InChI=1S/C25H22ClN3O5/c1-2-21(24(32)28-17-7-4-15(5-8-17)25(33)34)29-13-20-19(12-22(29)30)18-11-16(26)6-3-14(18)9-10-27-23(20)31/h3-8,11-13,21H,2,9-10H2,1H3,(H,27,31)(H,28,32)(H,33,34)	QTIMNPKDOKJHOR-UHFFFAOYSA-N	303788	4-{[2-(11-Chloro-2,5-dioxo-5,6,7,8-tetrahydropyrido[3,4-e][3]benzazocin-3(2H)-yl)butanoyl]amino}benzoic acid (Stereoisomer Mixture)::US10138236, Example 6	Plasma kallikrein			 1900							US Patent		10.7270/Q2445PH4		aid1796154	US10138236	Rohrig, S; Hillisch, A; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Schafer, M; Teller, H; Jimenez Nunez, E	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303788	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303788&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121247931	381752519							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
582618	CCC(C(=O)Nc1ccc(cc1)-c1noc(=O)[nH]1)n1cc2c(cc1=O)-c1cc(Cl)ccc1CCNC2=O	InChI=1S/C26H22ClN5O5/c1-2-21(25(35)29-17-7-4-15(5-8-17)23-30-26(36)37-31-23)32-13-20-19(12-22(32)33)18-11-16(27)6-3-14(18)9-10-28-24(20)34/h3-8,11-13,21H,2,9-10H2,1H3,(H,28,34)(H,29,35)(H,30,31,36)	JIKIDROQLCJHCV-UHFFFAOYSA-N	303789	2-(11-Chloro-2,5-dioxo-5,6,7,8-tetrahydropyrido[3,4-e][3]benzazocin-3(2H)-yl)-N-[4-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)phenyl]butanamide (Stereoisomer Mixture)::US10138236, Example 7	Plasma kallikrein			 3300							US Patent		10.7270/Q2445PH4		aid1796154	US10138236	Rohrig, S; Hillisch, A; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Schafer, M; Teller, H; Jimenez Nunez, E	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303789	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303789&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137135835	381752520							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
582619	CC(C)CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc2c(cc1=O)-c1cc(Cl)ccc1CCNC2=O	InChI=1S/C27H26ClN3O5/c1-15(2)11-23(26(34)30-19-7-4-17(5-8-19)27(35)36)31-14-22-21(13-24(31)32)20-12-18(28)6-3-16(20)9-10-29-25(22)33/h3-8,12-15,23H,9-11H2,1-2H3,(H,29,33)(H,30,34)(H,35,36)	NUGGTDIZDRCFKE-UHFFFAOYSA-N	303790	4-{[2-(11-Chloro-2,5-dioxo-5,6,7,8-tetrahydropyrido[3,4-e][3]benzazocin-3(2H)-yl)-4-methylpentanoyl]amino}benzoic acid (Stereoisomer Mixture)::US10138236, Example 8	Plasma kallikrein			 680							US Patent		10.7270/Q2445PH4		aid1796154	US10138236	Rohrig, S; Hillisch, A; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Schafer, M; Teller, H; Jimenez Nunez, E	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303790	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303790&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			130446977	381752521							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
582620	CC(C)CC(C(=O)Nc1ccc(cc1)-c1noc(=O)[nH]1)n1cc2c(cc1=O)-c1cc(Cl)ccc1CCNC2=O	InChI=1S/C28H26ClN5O5/c1-15(2)11-23(27(37)31-19-7-4-17(5-8-19)25-32-28(38)39-33-25)34-14-22-21(13-24(34)35)20-12-18(29)6-3-16(20)9-10-30-26(22)36/h3-8,12-15,23H,9-11H2,1-2H3,(H,30,36)(H,31,37)(H,32,33,38)	XMCVCGZQOZMSLX-UHFFFAOYSA-N	303791	2-(11-Chloro-2,5-dioxo-5,6,7,8-tetrahydropyrido[3,4-e][3]benzazocin-3(2H)-yl)-4-methyl-N-[4-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)phenyl]pentanamide (Stereoisomer Mixture)::US10138236, Example 9	Plasma kallikrein			 3800							US Patent		10.7270/Q2445PH4		aid1796154	US10138236	Rohrig, S; Hillisch, A; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Schafer, M; Teller, H; Jimenez Nunez, E	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303791	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303791&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137198183	381752522							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
582621	CCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc2c(cc1=O)-c1cc(Cl)ccc1CC1(CC1)NC2=O	InChI=1S/C27H24ClN3O5/c1-2-22(25(34)29-18-7-4-15(5-8-18)26(35)36)31-14-21-20(12-23(31)32)19-11-17(28)6-3-16(19)13-27(9-10-27)30-24(21)33/h3-8,11-12,14,22H,2,9-10,13H2,1H3,(H,29,34)(H,30,33)(H,35,36)	SLECLLUJAMLAFG-UHFFFAOYSA-N	303792	4-{[2-(11&#8242;-Chloro-2&#8242;,5&#8242;-dioxo-2&#8242;,5&#8242;,6&#8242;,8&#8242;-tetrahydro-3&#8242;H-spiro[cyclopropane-1,7&#8242;-pyrido[3,4-e][3]benzazocine]-3&#8242;-yl)butanoyl]amino}benzoic acid (Stereoisomer Mixture)::US10138236, Example 10	Plasma kallikrein			 2100							US Patent		10.7270/Q2445PH4		aid1796154	US10138236	Rohrig, S; Hillisch, A; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Schafer, M; Teller, H; Jimenez Nunez, E	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303792	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303792&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121248294	381752523							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
582622	CCC(C(=O)Nc1ccc(cc1)-c1noc(=O)[nH]1)n1cc2c(cc1=O)-c1cc(Cl)ccc1CC1(CC1)NC2=O	InChI=1S/C28H24ClN5O5/c1-2-22(26(37)30-18-7-4-15(5-8-18)24-31-27(38)39-33-24)34-14-21-20(12-23(34)35)19-11-17(29)6-3-16(19)13-28(9-10-28)32-25(21)36/h3-8,11-12,14,22H,2,9-10,13H2,1H3,(H,30,37)(H,32,36)(H,31,33,38)	ZUPOJXBRFRVQEB-UHFFFAOYSA-N	303793	2-(11&#8242;-Chloro-2&#8242;,5&#8242;-dioxo-2&#8242;,5&#8242;,6&#8242;,8&#8242;-tetrahydro-3&#8242;H-spiro[cyclopropane-1,7&#8242;-pyrido[3,4-e][3]benzazocine]-3&#8242;-yl)-N-[4-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)phenyl]butanamide (Stereoisomer Mixture)::US10138236, Example 11	Plasma kallikrein			 1700							US Patent		10.7270/Q2445PH4		aid1796154	US10138236	Rohrig, S; Hillisch, A; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Schafer, M; Teller, H; Jimenez Nunez, E	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303793	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303793&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137135832	381752524							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
582623	COCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc2c(cc1=O)-c1cc(Cl)ccc1CC1(CC1)NC2=O	InChI=1S/C28H26ClN3O6/c1-38-11-8-23(26(35)30-19-6-3-16(4-7-19)27(36)37)32-15-22-21(13-24(32)33)20-12-18(29)5-2-17(20)14-28(9-10-28)31-25(22)34/h2-7,12-13,15,23H,8-11,14H2,1H3,(H,30,35)(H,31,34)(H,36,37)	XQFUNGTWELOWHU-UHFFFAOYSA-N	303794	4-{[2-(11&#8242;-Chloro-2&#8242;,5&#8242;-dioxo-2&#8242;,5&#8242;,6&#8242;,8&#8242;-tetrahydro-3&#8242;H-spiro[cyclopropane-1,7&#8242;-pyrido[3,4-e][3]benzazocine]-3&#8242;-yl)-4-methoxybutanoyl]amino}benzoic acid (Stereoisomer Mixture)::US10138236, Example 12	Plasma kallikrein			 390							US Patent		10.7270/Q2445PH4		aid1796154	US10138236	Rohrig, S; Hillisch, A; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Schafer, M; Teller, H; Jimenez Nunez, E	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303794	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303794&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121247878	381752525							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
582624	COCCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc2c(cc1=O)-c1cc(Cl)ccc1CC1(CC1)NC2=O	InChI=1S/C28H26ClFN4O5/c1-39-9-6-23(27(38)32-17-4-5-18(25(31)36)22(30)11-17)34-14-21-20(12-24(34)35)19-10-16(29)3-2-15(19)13-28(7-8-28)33-26(21)37/h2-5,10-12,14,23H,6-9,13H2,1H3,(H2,31,36)(H,32,38)(H,33,37)	BPCDFQQYUDAWIS-UHFFFAOYSA-N	303795	4-{[2-(11&#8242;-Chloro-2&#8242;,5&#8242;-dioxo-2&#8242;,5&#8242;,6&#8242;,8&#8242;-tetrahydro-3&#8242;H-spiro[cyclopropane-1,7&#8242;-pyrido[3,4-e][3]benzazocine]-3&#8242;-yl)-4-methoxybutanoyl]amino}-2-fluorobenzamide (Stereoisomer Mixture)::US10138236, Example 13	Plasma kallikrein			 780							US Patent		10.7270/Q2445PH4		aid1796154	US10138236	Rohrig, S; Hillisch, A; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Schafer, M; Teller, H; Jimenez Nunez, E	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303795	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303795&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121247960	381752526							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
582625	COCCC(C(=O)Nc1ccc2[nH]c(=O)[nH]c2c1)n1cc2c(cc1=O)-c1cc(Cl)ccc1CC1(CC1)NC2=O	InChI=1S/C28H26ClN5O5/c1-39-9-6-23(26(37)30-17-4-5-21-22(11-17)32-27(38)31-21)34-14-20-19(12-24(34)35)18-10-16(29)3-2-15(18)13-28(7-8-28)33-25(20)36/h2-5,10-12,14,23H,6-9,13H2,1H3,(H,30,37)(H,33,36)(H2,31,32,38)	XTKDBGPBQRDAJF-UHFFFAOYSA-N	303796	2-(11&#8242;-Chloro-2&#8242;,5&#8242;-dioxo-2&#8242;,5&#8242;,6&#8242;,8&#8242;-tetrahydro-3&#8242;H-spiro[cyclopropane-1,7&#8242;-pyrido[3,4-e][3]benzazocine]-3&#8242;-yl)-4-methoxy-N-(2-oxo-2,3-dihydro-1H-benzimidazol-5-yl)butanamide (Stereoisomer Mixture)::US10138236, Example 14	Plasma kallikrein			 230							US Patent		10.7270/Q2445PH4		aid1796154	US10138236	Rohrig, S; Hillisch, A; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Schafer, M; Teller, H; Jimenez Nunez, E	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303796	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303796&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121248288	381752527							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
582626	COCCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc2c(cc1=O)-c1cc(Cl)ccc1CC1(CC1)NC2=O	InChI=1S/C29H28ClN5O4/c1-34-15-18-11-20(5-6-24(18)33-34)31-28(38)25(7-10-39-2)35-16-23-22(13-26(35)36)21-12-19(30)4-3-17(21)14-29(8-9-29)32-27(23)37/h3-6,11-13,15-16,25H,7-10,14H2,1-2H3,(H,31,38)(H,32,37)	KLDJEVDWFKQWAE-UHFFFAOYSA-N	303797	2-(11&#8242;-Chloro-2&#8242;,5&#8242;-dioxo-2&#8242;,5&#8242;,6&#8242;,8&#8242;-tetrahydro-3&#8242;H-spiro[cyclopropane-1,7&#8242;-pyrido[3,4-e][3]benzazocine]-3&#8242;-yl)-4-methoxy-N-(2-methyl-2H-indazol-5-yl)butanamide (Stereoisomer Mixture)::US10138236, Example 15	Plasma kallikrein			 240							US Patent		10.7270/Q2445PH4		aid1796154	US10138236	Rohrig, S; Hillisch, A; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Schafer, M; Teller, H; Jimenez Nunez, E	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303797	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303797&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121248295	381752528							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
582627	COCCC(C(=O)Nc1ccn2nccc2c1)n1cc2c(cc1=O)-c1cc(Cl)ccc1CC1(CC1)NC2=O	InChI=1S/C28H26ClN5O4/c1-38-11-6-24(27(37)31-19-5-10-34-20(13-19)4-9-30-34)33-16-23-22(14-25(33)35)21-12-18(29)3-2-17(21)15-28(7-8-28)32-26(23)36/h2-5,9-10,12-14,16,24H,6-8,11,15H2,1H3,(H,31,37)(H,32,36)	FJPYLKOGJOUMKM-UHFFFAOYSA-N	303798	2-(11&#8242;-Chloro-2&#8242;,5&#8242;-dioxo-2&#8242;,5&#8242;,6&#8242;,8&#8242;-tetrahydro-3&#8242;H-spiro[cyclopropane-1,7&#8242;-pyrido[3,4-e][3]benzazocine]-3&#8242;-yl)-4-methoxy-N-(pyrazolo[1,5-a]pyridin-5-yl)butanamide (Stereoisomer Mixture)::US10138236, Example 16	Plasma kallikrein			 210							US Patent		10.7270/Q2445PH4		aid1796154	US10138236	Rohrig, S; Hillisch, A; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Schafer, M; Teller, H; Jimenez Nunez, E	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303798	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303798&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121248130	381752529							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
582628	COCCC(C(=O)Nc1ccc2nccn2c1)n1cc2c(cc1=O)-c1cc(Cl)ccc1CC1(CC1)NC2=O	InChI=1S/C28H26ClN5O4/c1-38-11-6-23(27(37)31-19-4-5-24-30-9-10-33(24)15-19)34-16-22-21(13-25(34)35)20-12-18(29)3-2-17(20)14-28(7-8-28)32-26(22)36/h2-5,9-10,12-13,15-16,23H,6-8,11,14H2,1H3,(H,31,37)(H,32,36)	LJUIKBIWSCZQIA-UHFFFAOYSA-N	303799	2-(11&#8242;-Chloro-2&#8242;,5&#8242;-dioxo-2&#8242;,5&#8242;,6&#8242;,8&#8242;-tetrahydro-3&#8242;H-spiro[cyclopropane-1,7&#8242;-pyrido[3,4-e][3]benzazocine]-3&#8242;-yl)-N-(imidazo[1,2-a]pyridin-6-yl)-4-methoxybutanamide (Stereoisomer Mixture)::US10138236, Example 17	Plasma kallikrein			 1200							US Patent		10.7270/Q2445PH4		aid1796154	US10138236	Rohrig, S; Hillisch, A; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Schafer, M; Teller, H; Jimenez Nunez, E	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303799	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303799&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121247961	381752530							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
582629	COCCC(C(=O)Nc1ccc2[nH]ncc2c1)n1cc2c(cc1=O)-c1cc(Cl)ccc1CC1(CC1)NC2=O			303800	2-(11&#8242;-Chloro-2&#8242;,5&#8242;-dioxo-2&#8242;,5&#8242;,6&#8242;,8&#8242;-tetrahydro-3&#8242;H-spiro[cyclopropane-1,7&#8242;-pyrido[3,4-e][3]benzazocine]-3&#8242;-yl)-N-(1H-indazol-5-yl)-4-methoxybutanamide (Stereoisomer Mixture)::US10138236, Example 18	Plasma kallikrein			 330							US Patent		10.7270/Q2445PH4		aid1796154	US10138236	Rohrig, S; Hillisch, A; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Schafer, M; Teller, H; Jimenez Nunez, E	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303800	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303800&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121248129	381752531							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
582630	COCCC(C(=O)Nc1ccc2c(c1)[nH]n(C)c2=O)n1cc2c(cc1=O)-c1cc(Cl)ccc1CC1(CC1)NC2=O	InChI=1S/C29H28ClN5O5/c1-34-28(39)19-6-5-18(12-23(19)33-34)31-27(38)24(7-10-40-2)35-15-22-21(13-25(35)36)20-11-17(30)4-3-16(20)14-29(8-9-29)32-26(22)37/h3-6,11-13,15,24,33H,7-10,14H2,1-2H3,(H,31,38)(H,32,37)	DAQPCJFUMAFGPS-UHFFFAOYSA-N	303801	2-(11&#8242;-Chloro-2&#8242;,5&#8242;-dioxo-2&#8242;,5&#8242;,6&#8242;,8&#8242;-tetrahydro-3&#8242;H-spiro[cyclopropane-1,7&#8242;-pyrido[3,4-e][3]benzazocine]-3&#8242;-yl)-4-methoxy-N-(2-methyl-3-oxo-2,3-dihydro-1H-indazol-6-yl)butanamide (Stereoisomer Mixture)::US10138236, Example 19	Plasma kallikrein			 230							US Patent		10.7270/Q2445PH4		aid1796154	US10138236	Rohrig, S; Hillisch, A; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Schafer, M; Teller, H; Jimenez Nunez, E	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303801	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303801&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121247858	381752532							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
582631	COCCC(C(=O)Nc1ccc(nc1)C(O)=O)n1cc2c(cc1=O)-c1cc(Cl)ccc1CC1(CC1)NC2=O	InChI=1S/C27H25ClN4O6/c1-38-9-6-22(25(35)30-17-4-5-21(26(36)37)29-13-17)32-14-20-19(11-23(32)33)18-10-16(28)3-2-15(18)12-27(7-8-27)31-24(20)34/h2-5,10-11,13-14,22H,6-9,12H2,1H3,(H,30,35)(H,31,34)(H,36,37)	LAOPVJMWYLRSKK-UHFFFAOYSA-N	303802	5-{[2-(11&#8242;-Chloro-2&#8242;,5&#8242;-dioxo-2&#8242;,5&#8242;,6&#8242;,8&#8242;-tetrahydro-3&#8242;H-spiro[cyclopropane-1,7&#8242;-pyrido[3,4-e][3]benzazocine]-3&#8242;-yl)-4-methoxybutanoyl]amino}pyridine-2-carboxylic acid (Stereoisomer Mixture)::US10138236, Example 20	Plasma kallikrein			 4500							US Patent		10.7270/Q2445PH4		aid1796154	US10138236	Rohrig, S; Hillisch, A; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Schafer, M; Teller, H; Jimenez Nunez, E	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303802	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303802&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121247988	381752533							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
582632	COCCC(C(=O)Nc1ccc(nc1)C(N)=O)n1cc2c(cc1=O)-c1cc(Cl)ccc1CC1(CC1)NC2=O	InChI=1S/C27H26ClN5O5/c1-38-9-6-22(26(37)31-17-4-5-21(24(29)35)30-13-17)33-14-20-19(11-23(33)34)18-10-16(28)3-2-15(18)12-27(7-8-27)32-25(20)36/h2-5,10-11,13-14,22H,6-9,12H2,1H3,(H2,29,35)(H,31,37)(H,32,36)	MGDLVIVVZPLDNQ-UHFFFAOYSA-N	303803	5-{[2-(11&#8242;-Chloro-2&#8242;,5&#8242;-dioxo-2&#8242;,5&#8242;,6&#8242;,8&#8242;-tetrahydro-3&#8242;H-spiro[cyclopropane-1,7&#8242;-pyrido[3,4-e][3]benzazocine]-3&#8242;-yl)-4-methoxybutanoyl]amino}pyridine-2-carboxamide (Stereoisomer Mixture)::US10138236, Example 21	Plasma kallikrein			 910							US Patent		10.7270/Q2445PH4		aid1796154	US10138236	Rohrig, S; Hillisch, A; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Schafer, M; Teller, H; Jimenez Nunez, E	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303803	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303803&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121247879	381752534							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
582633	COCCC(C(=O)Nc1ccc(s1)C(O)=O)n1cc2c(cc1=O)-c1cc(Cl)ccc1CC1(CC1)NC2=O	InChI=1S/C26H24ClN3O6S/c1-36-9-6-19(24(33)28-21-5-4-20(37-21)25(34)35)30-13-18-17(11-22(30)31)16-10-15(27)3-2-14(16)12-26(7-8-26)29-23(18)32/h2-5,10-11,13,19H,6-9,12H2,1H3,(H,28,33)(H,29,32)(H,34,35)	SCDJLHAYCAFVMW-UHFFFAOYSA-N	303804	5-{[2-(11&#8242;-Chloro-2&#8242;,5&#8242;-dioxo-2&#8242;,5&#8242;,6&#8242;,8&#8242;-tetrahydro-3&#8242;H-spiro[cyclopropane-1,7&#8242;-pyrido[3,4-e][3]benzazocine]-3&#8242;-yl)-4-methoxybutanoyl]amino}thiophene-2-carboxylic acid (Stereoisomer Mixture)::US10138236, Example 22	Plasma kallikrein			 340							US Patent		10.7270/Q2445PH4		aid1796154	US10138236	Rohrig, S; Hillisch, A; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Schafer, M; Teller, H; Jimenez Nunez, E	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303804	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303804&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121247853	381752535							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
582634	COCCC(C(=O)Nc1cc(cs1)C(O)=O)n1cc2c(cc1=O)-c1cc(Cl)ccc1CC1(CC1)NC2=O	InChI=1S/C26H24ClN3O6S/c1-36-7-4-20(24(33)28-21-8-15(13-37-21)25(34)35)30-12-19-18(10-22(30)31)17-9-16(27)3-2-14(17)11-26(5-6-26)29-23(19)32/h2-3,8-10,12-13,20H,4-7,11H2,1H3,(H,28,33)(H,29,32)(H,34,35)	LVYYWTCICJFTHG-UHFFFAOYSA-N	303805	5-{[2-(11&#8242;-Chloro-2&#8242;,5&#8242;-dioxo-2&#8242;,5&#8242;,6&#8242;,8&#8242;-tetrahydro-3&#8242;H-spiro[cyclopropane-1,7&#8242;-pyrido[3,4-e][3]benzazocine]-3&#8242;-yl)-4-methoxybutanoyl]amino}thiophene-3-carboxylic acid (Stereoisomer Mixture)::US10138236, Example 23	Plasma kallikrein			 3900							US Patent		10.7270/Q2445PH4		aid1796154	US10138236	Rohrig, S; Hillisch, A; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Schafer, M; Teller, H; Jimenez Nunez, E	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303805	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303805&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121247825	381752536							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
582635	COCCC(C(=O)Nc1csc(c1)C(O)=O)n1cc2c(cc1=O)-c1cc(Cl)ccc1CC1(CC1)NC2=O	InChI=1S/C26H24ClN3O6S/c1-36-7-4-20(24(33)28-16-9-21(25(34)35)37-13-16)30-12-19-18(10-22(30)31)17-8-15(27)3-2-14(17)11-26(5-6-26)29-23(19)32/h2-3,8-10,12-13,20H,4-7,11H2,1H3,(H,28,33)(H,29,32)(H,34,35)	RLNDJWGABHXOKH-UHFFFAOYSA-N	303806	4-{[2-(11&#8242;-Chloro-2&#8242;,5&#8242;-dioxo-2&#8242;,5&#8242;,6&#8242;,8&#8242;-tetrahydro-3&#8242;H-spiro[cyclopropane-1,7&#8242;-pyrido[3,4-e][3]benzazocine]-3&#8242;-yl)-4-methoxybutanoyl]amino}thiophene-2-carboxylic acid (Stereoisomer Mixture)::US10138236, Example 24	Plasma kallikrein			 800							US Patent		10.7270/Q2445PH4		aid1796154	US10138236	Rohrig, S; Hillisch, A; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Schafer, M; Teller, H; Jimenez Nunez, E	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303806	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303806&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121247932	381752537							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
582636	CO[C@H]1CC[C@H](CC(C(=O)Nc2ccc(cc2)C(O)=O)n2cc3c(cc2=O)-c2cc(Cl)ccc2CC2(CC2)NC3=O)CC1	InChI=1S/C33H34ClN3O6/c1-43-24-10-2-19(3-11-24)14-28(31(40)35-23-8-5-20(6-9-23)32(41)42)37-18-27-26(16-29(37)38)25-15-22(34)7-4-21(25)17-33(12-13-33)36-30(27)39/h4-9,15-16,18-19,24,28H,2-3,10-14,17H2,1H3,(H,35,40)(H,36,39)(H,41,42)/t19-,24-,28?	QINUWAZYQLMKQU-UNKRNVDUSA-N	303807	4-{[2-(11&#8242;-Chloro-2&#8242;,5&#8242;-dioxo-2&#8242;,5&#8242;,6&#8242;,8&#8242;-tetrahydro-3&#8242;H-spiro[cyclopropane-1,7&#8242;-pyrido[3,4-e][3]benzazocine]-3&#8242;-yl)-3-(trans-4-methoxycyclohexyl)propanoyl]amino}benzoic acid (Stereoisomer Mixture)::US10138236, Example 25	Plasma kallikrein			 370							US Patent		10.7270/Q2445PH4		aid1796154	US10138236	Rohrig, S; Hillisch, A; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Schafer, M; Teller, H; Jimenez Nunez, E	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303807	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303807&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121248151	381752538							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
582637	CO[C@H]1CC[C@H](CC(C(=O)Nc2ccc(C(N)=O)c(F)c2)n2cc3c(cc2=O)-c2cc(Cl)ccc2CC2(CC2)NC3=O)CC1	InChI=1S/C33H34ClFN4O5/c1-44-22-7-2-18(3-8-22)12-28(32(43)37-21-6-9-23(30(36)41)27(35)14-21)39-17-26-25(15-29(39)40)24-13-20(34)5-4-19(24)16-33(10-11-33)38-31(26)42/h4-6,9,13-15,17-18,22,28H,2-3,7-8,10-12,16H2,1H3,(H2,36,41)(H,37,43)(H,38,42)/t18-,22-,28?	WBDFEEOUOGIVHD-PEGMDALASA-N	303808	4-{[2-(11&#8242;-Chloro-2&#8242;,5&#8242;-dioxo-2&#8242;,5&#8242;,6&#8242;,8&#8242;-tetrahydro-3&#8242;H-spiro[cyclopropane-1,7&#8242;-pyrido[3,4-e][3]benzazocine]-3&#8242;-yl)-3-(trans-4-methoxycyclohexyl)propanoyl]amino}-2-fluorobenzamide (Stereoisomer Mixture)::US10138236, Example 26	Plasma kallikrein			 740							US Patent		10.7270/Q2445PH4		aid1796154	US10138236	Rohrig, S; Hillisch, A; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Schafer, M; Teller, H; Jimenez Nunez, E	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303808	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303808&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121247818	381752539							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
582638	CO[C@H]1CC[C@H](CC(C(=O)Nc2ccc3[nH]c(=O)[nH]c3c2)n2cc3c(cc2=O)-c2cc(Cl)ccc2CC2(CC2)NC3=O)CC1	InChI=1S/C33H34ClN5O5/c1-44-22-7-2-18(3-8-22)12-28(31(42)35-21-6-9-26-27(14-21)37-32(43)36-26)39-17-25-24(15-29(39)40)23-13-20(34)5-4-19(23)16-33(10-11-33)38-30(25)41/h4-6,9,13-15,17-18,22,28H,2-3,7-8,10-12,16H2,1H3,(H,35,42)(H,38,41)(H2,36,37,43)/t18-,22-,28?	KKOUJTRQGUTRHQ-PEGMDALASA-N	303809	2-(11&#8242;-Chloro-2&#8242;,5&#8242;-dioxo-2&#8242;,5&#8242;,6&#8242;,8&#8242;-tetrahydro-3&#8242;H-spiro[cyclopropane-1,7&#8242;-pyrido[3,4-e][3]benzazocine]-3&#8242;-yl)-3-(trans-4-methoxycyclohexyl)-N-(2-oxo-2,3-dihydro-1H-benzimidazol-5-yl)propanamide (Stereoisomer Mixture)::US10138236, Example 27	Plasma kallikrein			 250							US Patent		10.7270/Q2445PH4		aid1796154	US10138236	Rohrig, S; Hillisch, A; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Schafer, M; Teller, H; Jimenez Nunez, E	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303809	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303809&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121247982	381752540							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
582639	OC(=O)c1ccc(NC(=O)C(Cc2ccccc2)n2cc3c(cc2=O)-c2cc(Cl)ccc2CC2(CC2)NC3=O)cc1	InChI=1S/C32H26ClN3O5/c33-22-9-6-21-17-32(12-13-32)35-29(38)26-18-36(28(37)16-25(26)24(21)15-22)27(14-19-4-2-1-3-5-19)30(39)34-23-10-7-20(8-11-23)31(40)41/h1-11,15-16,18,27H,12-14,17H2,(H,34,39)(H,35,38)(H,40,41)	IJIWFVZSETXIFG-UHFFFAOYSA-N	303810	4-{[2-(11&#8242;-Chloro-2&#8242;,5&#8242;-dioxo-2&#8242;,5&#8242;,6&#8242;,8&#8242;-tetrahydro-3&#8242;H-spiro[cyclopropane-1,7&#8242;-pyrido[3,4-e][3]benzazocine]-3&#8242;-yl)-3-phenylpropanoyl]amino}benzoic acid (Stereoisomer Mixture)::US10138236, Example 28	Plasma kallikrein			 55.0							US Patent		10.7270/Q2445PH4		aid1796154	US10138236	Rohrig, S; Hillisch, A; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Schafer, M; Teller, H; Jimenez Nunez, E	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303810	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303810&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121247962	381752541							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
582640	Clc1ccc2CC3(CC3)NC(=O)c3cn(C(Cc4ccccc4)C(=O)Nc4ccc5[nH]c(=O)[nH]c5c4)c(=O)cc3-c2c1	InChI=1S/C32H26ClN5O4/c33-20-7-6-19-16-32(10-11-32)37-29(40)24-17-38(28(39)15-23(24)22(19)13-20)27(12-18-4-2-1-3-5-18)30(41)34-21-8-9-25-26(14-21)36-31(42)35-25/h1-9,13-15,17,27H,10-12,16H2,(H,34,41)(H,37,40)(H2,35,36,42)	VUHILQGABHYBOA-UHFFFAOYSA-N	303811	2-(11&#8242;-Chloro-2&#8242;,5&#8242;-dioxo-2&#8242;,5&#8242;,6&#8242;,8&#8242;-tetrahydro-3&#8242;H-spiro[cyclopropane-1,7&#8242;-pyrido[3,4-e][3]benzazocine]-3&#8242;-yl)-N-(2-oxo-2,3-dihydro-1H-benzimidazol-5-yl)-3-phenylpropanamide (Stereoisomer Mixture)::US10138236, Example 29	Plasma kallikrein			 42.0							US Patent		10.7270/Q2445PH4		aid1796154	US10138236	Rohrig, S; Hillisch, A; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Schafer, M; Teller, H; Jimenez Nunez, E	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303811	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303811&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121247966	381752542							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
582641	Cn1cc2cc(NC(=O)C(Cc3ccccc3)n3cc4c(cc3=O)-c3cc(Cl)ccc3CC3(CC3)NC4=O)ccc2n1	InChI=1S/C33H28ClN5O3/c1-38-18-22-14-24(9-10-28(22)37-38)35-32(42)29(13-20-5-3-2-4-6-20)39-19-27-26(16-30(39)40)25-15-23(34)8-7-21(25)17-33(11-12-33)36-31(27)41/h2-10,14-16,18-19,29H,11-13,17H2,1H3,(H,35,42)(H,36,41)	NCOTWGDMTUCKSK-UHFFFAOYSA-N	303812	2-(11&#8242;-Chloro-2&#8242;,5&#8242;-dioxo-2&#8242;,5&#8242;,6&#8242;,8&#8242;-tetrahydro-3&#8242;H-spiro[cyclopropane-1,7&#8242;-pyrido[3,4-e][3]benzazocine]-3&#8242;-yl)-N-(2-methyl-2H-indazol-5-yl)-3-phenylpropanamide (Stereoisomer Mixture)::US10138236, Example 30	Plasma kallikrein			 45.0							US Patent		10.7270/Q2445PH4		aid1796154	US10138236	Rohrig, S; Hillisch, A; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Schafer, M; Teller, H; Jimenez Nunez, E	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303812	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303812&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121247985	381752543							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
582642	COCCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc2c(cc1=O)-c1cc(Cl)ccc1CC(CF)NC2=O	InChI=1S/C28H27ClFN5O4/c1-34-14-17-10-19(5-6-24(17)33-34)31-28(38)25(7-8-39-2)35-15-23-22(12-26(35)36)21-11-18(29)4-3-16(21)9-20(13-30)32-27(23)37/h3-6,10-12,14-15,20,25H,7-9,13H2,1-2H3,(H,31,38)(H,32,37)	WTECJQOPSGZRRS-UHFFFAOYSA-N	303813	2-[11-Chloro-7-(fluoromethyl)-2,5-dioxo-5,6,7,8-tetrahydropyrido[3,4-e][3]benzazocin-3(2H)-yl]-4-methoxy-N-(2-methyl-2H-indazol-5-yl)butanamide (Stereoisomer Mixture)::US10138236, Example 31	Plasma kallikrein			 42.0							US Patent		10.7270/Q2445PH4		aid1796154	US10138236	Rohrig, S; Hillisch, A; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Schafer, M; Teller, H; Jimenez Nunez, E	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303813	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303813&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121247976	381752544							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
582643	COCCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc2c(cc1=O)-c1cc(Cl)ccc1CC(CF)NC2=O	InChI=1S/C27H25ClF2N4O5/c1-39-7-6-23(27(38)32-16-4-5-18(25(31)36)22(30)10-16)34-13-21-20(11-24(34)35)19-9-15(28)3-2-14(19)8-17(12-29)33-26(21)37/h2-5,9-11,13,17,23H,6-8,12H2,1H3,(H2,31,36)(H,32,38)(H,33,37)	TUSKZVWLXAIZDG-UHFFFAOYSA-N	303814	4-({2-[11-Chloro-7-(fluoromethyl)-2,5-dioxo-5,6,7,8-tetrahydropyrido[3,4-e][3]benzazocin-3(2H)-yl]-4-methoxybutanoyl}amino)-2-fluorobenzamide (Stereoisomer Mixture)::US10138236, Example 32	Plasma kallikrein			 100.0							US Patent		10.7270/Q2445PH4		aid1796154	US10138236	Rohrig, S; Hillisch, A; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Schafer, M; Teller, H; Jimenez Nunez, E	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303814	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303814&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121247977	381752545							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
582644	COCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc2c(cc1=O)-c1cc(Cl)ccc1CC(CF)NC2=O	InChI=1S/C27H25ClFN3O6/c1-38-9-8-23(26(35)30-18-6-3-15(4-7-18)27(36)37)32-14-22-21(12-24(32)33)20-11-17(28)5-2-16(20)10-19(13-29)31-25(22)34/h2-7,11-12,14,19,23H,8-10,13H2,1H3,(H,30,35)(H,31,34)(H,36,37)	XPAARJWVQMOJHJ-UHFFFAOYSA-N	303815	4-({2-[11-Chloro-7-(fluoromethyl)-2,5-dioxo-5,6,7,8-tetrahydropyrido[3,4-e][3]benzazocin-3(2H)-yl]-4-methoxybutanoyl}amino)benzoic acid (Stereoisomer Mixture)::US10138236, Example 33	Plasma kallikrein			 97.0							US Patent		10.7270/Q2445PH4		aid1796154	US10138236	Rohrig, S; Hillisch, A; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Schafer, M; Teller, H; Jimenez Nunez, E	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303815	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303815&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121248128	381752546							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587854	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c4ccccc34)c2c1	InChI=1S/C23H21N3O2/c1-12-9-20(24)26-13(2)19(12)11-25-23(27)14-7-8-17-18(10-14)22-16-6-4-3-5-15(16)21(17)28-22/h3-10,21-22H,11H2,1-2H3,(H2,24,26)(H,25,27)	GCURZGWVFBYZHY-UHFFFAOYSA-N	306359	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]-15- oxatetracyclo[6.6.1.02,7.09,14]- pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 1	Plasma kallikrein			 6310							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306359	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306359&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131634	381755058							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587855	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3CC(C(=C3)c3coc4ccccc34)c2c1	InChI=1S/C28H25N3O2/c1-15-9-27(29)31-16(2)24(15)13-30-28(32)17-7-8-19-18-11-22(21(19)10-17)23(12-18)25-14-33-26-6-4-3-5-20(25)26/h3-10,12,14,18,22H,11,13H2,1-2H3,(H2,29,31)(H,30,32)	KHWLCTHVZHWTEH-UHFFFAOYSA-N	306360	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 10-(1-benzofuran-3-yl)tricycle- [6.2.1.02,7]undeca-2,4,6,9-tetraene- 4-carboxamide and (+-)-N- [(6-amino-2,4-dimethylpyridin-3- yl)methyl]-9-(1-benzofuran-3-yl) tricycle-[6.2.1.02,7]undeca- 2,4,6,9-tetraene-4-carboxamide::US10144746, Compound 2	Plasma kallikrein			 2512							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306360	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306360&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131629	381755059							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587856	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1ccccc1	InChI=1S/C29H25N3O2/c1-16-12-26(30)32-17(2)25(16)15-31-29(33)20-9-11-22-24(14-20)28-23-13-19(18-6-4-3-5-7-18)8-10-21(23)27(22)34-28/h3-14,27-28H,15H2,1-2H3,(H2,30,32)(H,31,33)	VELSJFVSMDCIDE-UHFFFAOYSA-N	306361	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]-12- phenyl-15-oxatetracyclo- [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide and N-[(6-amino-2,4- dimethyl-pyridin-3-yl)methyl]- 11-phenyl-15-oxatetra- cyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 3	Plasma kallikrein			 398							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306361	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306361&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131639	381755060							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587857	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(C=C3c3ccccc3)c2c1	InChI=1S/C25H23N3O2/c1-14-10-23(26)28-15(2)21(14)13-27-25(29)17-8-9-18-20(11-17)22-12-19(24(18)30-22)16-6-4-3-5-7-16/h3-12,22,24H,13H2,1-2H3,(H2,26,28)(H,27,29)	XZHNJVZEZQGMTP-UHFFFAOYSA-N	306362	(+-)-N-|(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 9-phenyl-11-oxatricyclo- [6.2.1.02,7]undeca-2,4,6,9- tetraene-4-carboxamide and (+-)-N-[(6-amino-2,4- dimethylpyridin-3- yl)methyl]-10-phenyl-11- oxatricyclo-[6.2.1.02,7]undeca- 2,4,6,9-tetraene-4-carboxamide::US10144746, Compound 4	Plasma kallikrein			 26303							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306362	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306362&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124124300	381755061							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587858	COc1ccc(Cl)c(CNC(=O)c2ccc3C4CC(C(=C4)c4coc5ccccc45)c3c2)c1F	InChI=1S/C28H21ClFNO3/c1-33-26-9-8-24(29)22(27(26)30)13-31-28(32)15-6-7-17-16-11-20(19(17)10-15)21(12-16)23-14-34-25-5-3-2-4-18(23)25/h2-10,12,14,16,20H,11,13H2,1H3,(H,31,32)	WHUMPFSRPHUNFU-UHFFFAOYSA-N	306363	(+-)-10-(1-benzofuran-3-yl)- N-[(6-chloro-2-fluoro-3- methoxyphenyl)methyl]tricycle- [6.2.1.02,7]undeca-2,4,6,9- tetraene-4-carboxamide and  (+-)-9-(1-benzofuran-3-yl)-N- [(6-chloro-2-fluoro-3- methoxyphenyl)methyl]tricycle- [6.2.1.02,7]undeca-2,4,6,9- tetraene-4-carboxamide::US10144746, Compound 5	Plasma kallikrein			 1000000							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306363	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306363&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131638	381755062							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587859	COc1ccc(F)c(CNC(=O)c2ccc3C4CC(C(=C4)c4coc5ccccc45)c3c2)c1F	InChI=1S/C28H21F2NO3/c1-33-26-9-8-24(29)22(27(26)30)13-31-28(32)15-6-7-17-16-11-20(19(17)10-15)21(12-16)23-14-34-25-5-3-2-4-18(23)25/h2-10,12,14,16,20H,11,13H2,1H3,(H,31,32)	GJUBTDNYKPUOJC-UHFFFAOYSA-N	306364	(+-)-10-(1-benzofuran-3-yl)-N- [(2,6-difluoro-3- methoxyphenyl)methyl]tricyclo- [6.2.1.02,7]undeca-2,4,6,9- tetraene-4-carboxamide and (+-)-9-(1-benzofuran-3-yl)-N- [(2,6-difluoro-3-methoxy- phenyl)methyl]tricyclo[6.2.1.02,7]- undeca-2,4,6,9-tetraene-4- carboxamide::US10144746, Compound 6	Plasma kallikrein			 1000000							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306364	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306364&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131641	381755063							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587860	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1ccc(F)cc1	InChI=1S/C29H24FN3O2/c1-15-11-26(31)33-16(2)25(15)14-32-29(34)19-6-10-22-24(13-19)28-23-12-18(5-9-21(23)27(22)35-28)17-3-7-20(30)8-4-17/h3-13,27-28H,14H2,1-2H3,(H2,31,33)(H,32,34)	VCXIRATVPKGBTD-UHFFFAOYSA-N	306365	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]-12-(4- fluorophenyl)-15-oxatetra- cyclo[6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide and (+-)-N-[(6-amino- 2,4-dimethylpyridin-3-yl)methyl]- 11-(4-fluorophenyl)-15- oxatetracyclo[6.6.1.02,7.09,14]- pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 7	Plasma kallikrein			 219							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306365	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306365&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131642	381755064							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587861	Clc1ccc2ccc(CNC(=O)c3ccc4C5CC(C(=C5)c5coc6ccccc56)c4c3)nc2c1	InChI=1S/C30H21ClN2O2/c31-20-8-5-17-6-9-21(33-28(17)14-20)15-32-30(34)18-7-10-22-19-12-25(24(22)11-18)26(13-19)27-16-35-29-4-2-1-3-23(27)29/h1-11,13-14,16,19,25H,12,15H2,(H,32,34)	PDFVLDURXIGXMH-UHFFFAOYSA-N	306366	(+-)-10-(1-benzofuran-3-yl)-N- [(7-chloroquinolin-2- yl)methyl]tricyclo[6.2.1.02,7] undeca-2,4,6,9-tetraene-4- carboxamide and (+-)-9- (1-benzofuran-3-yl)-N-[(7- chloroquinolin-2-yl)methyl] tricycle-[6.2.1.02,7]undeca- 2,4,6,9-tetraene-4-carboxamide::US10144746, Compound 8	Plasma kallikrein			 1000000							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306366	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306366&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124124076	381755065							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587862	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3CC(C(=C3)c3ccccc3)c2c1	InChI=1S/C26H25N3O/c1-15-10-25(27)29-16(2)24(15)14-28-26(30)18-8-9-20-19-12-21(17-6-4-3-5-7-17)23(13-19)22(20)11-18/h3-12,19,23H,13-14H2,1-2H3,(H2,27,29)(H,28,30)	QCEDUBHCNQOBMV-UHFFFAOYSA-N	306367	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]-10- phenyltricyclo[6.2.1.02,7]undeca- 2,4,6,9-tetraene-4- carboxamide and (+-)-N- [(6-amino-2,4-dimethylpyridin-3- yl)methyl]-9-phenyltricyclo [6.2.1.02,7]undeca-2,4,6,9- tetraene-4-carboxamide::US10144746, Compound 9	Plasma kallikrein			 12882							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306367	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306367&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124124136	381755066							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587863	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c4cc(Cn5cccn5)ccc34)c2c1	InChI=1S/C27H25N5O2/c1-15-10-24(28)31-16(2)23(15)13-29-27(33)18-5-7-20-22(12-18)26-21-11-17(14-32-9-3-8-30-32)4-6-19(21)25(20)34-26/h3-12,25-26H,13-14H2,1-2H3,(H2,28,31)(H,29,33)	MMUGDOUTRBTJAO-UHFFFAOYSA-N	306368	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 12-[(1H- pyrazol-1-yl)methyl]-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide (+-)-N- [(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 11-[(1H-pyrazol-1-yl)methyl]- 15-oxatetracyclo- [6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::BDBM306369::BDBM306370::US10144746, Compound 10	Plasma kallikrein			 17.4							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306368	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306368&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131645	381755067							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587864	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c4cc(Cn5cccn5)ccc34)c2c1	InChI=1S/C27H25N5O2/c1-15-10-24(28)31-16(2)23(15)13-29-27(33)18-5-7-20-22(12-18)26-21-11-17(14-32-9-3-8-30-32)4-6-19(21)25(20)34-26/h3-12,25-26H,13-14H2,1-2H3,(H2,28,31)(H,29,33)	MMUGDOUTRBTJAO-UHFFFAOYSA-N	306368	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 12-[(1H- pyrazol-1-yl)methyl]-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide (+-)-N- [(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 11-[(1H-pyrazol-1-yl)methyl]- 15-oxatetracyclo- [6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::BDBM306369::BDBM306370::US10144746, Compound 10	Plasma kallikrein			 23.4							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306368	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306368&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131645	381755067							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587865	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c4cc(Cn5cccn5)ccc34)c2c1	InChI=1S/C27H25N5O2/c1-15-10-24(28)31-16(2)23(15)13-29-27(33)18-5-7-20-22(12-18)26-21-11-17(14-32-9-3-8-30-32)4-6-19(21)25(20)34-26/h3-12,25-26H,13-14H2,1-2H3,(H2,28,31)(H,29,33)	MMUGDOUTRBTJAO-UHFFFAOYSA-N	306368	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 12-[(1H- pyrazol-1-yl)methyl]-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide (+-)-N- [(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 11-[(1H-pyrazol-1-yl)methyl]- 15-oxatetracyclo- [6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::BDBM306369::BDBM306370::US10144746, Compound 10	Plasma kallikrein			 51.3							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306368	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306368&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131645	381755067							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587866	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c4cc(CN5CCC=N5)ccc34)c2c1	InChI=1S/C27H27N5O2/c1-15-10-24(28)31-16(2)23(15)13-29-27(33)18-5-7-20-22(12-18)26-21-11-17(14-32-9-3-8-30-32)4-6-19(21)25(20)34-26/h4-8,10-12,25-26H,3,9,13-14H2,1-2H3,(H2,28,31)(H,29,33)	ATZLFBTZFGGWEB-UHFFFAOYSA-N	306371	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)- methyl]-12-[(1H- pyrazol-1-yl)(2H2)methyl]-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 13	Plasma kallikrein			 4.79							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306371	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306371&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137554673	381755070							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587867	COc1ccc(cn1)-c1ccc2C3OC(c4cc(ccc34)C(=O)NCc3c(C)cc(N)nc3C)c2c1	InChI=1S/C29H26N4O3/c1-15-10-25(30)33-16(2)24(15)14-32-29(34)18-5-8-21-23(12-18)28-22-11-17(4-7-20(22)27(21)36-28)19-6-9-26(35-3)31-13-19/h4-13,27-28H,14H2,1-3H3,(H2,30,33)(H,32,34)	CKCHXFRFGBYNSS-UHFFFAOYSA-N	306372	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl) methyl]-12-(6- methoxypyridin-3-yl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide and (+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 11-(6-methoxypyridin-3-yl)- 15-oxatetracyclo- [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 14	Plasma kallikrein			 186							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306372	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306372&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131650	381755071							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587868	Cc1noc(C)c1-c1ccc2C3OC(c4cc(ccc34)C(=O)NCc3c(C)cc(N)nc3C)c2c1	InChI=1S/C28H26N4O3/c1-13-9-24(29)31-14(2)23(13)12-30-28(33)18-6-8-20-22(11-18)27-21-10-17(5-7-19(21)26(20)34-27)25-15(3)32-35-16(25)4/h5-11,26-27H,12H2,1-4H3,(H2,29,31)(H,30,33)	VNXSBCBHZIJQGS-UHFFFAOYSA-N	306373	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 12-(3,5-dimethyl-1,2- oxazol-4-yl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide and  (+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 11-(3,5-dimethyl-1,2-oxazol- 4-yl)-15-oxatetracyclo [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 15	Plasma kallikrein			 1096							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306373	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306373&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131649	381755072							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587869	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3CC(C(=C3)c3ccccn3)c2c1	InChI=1S/C25H24N4O/c1-14-9-24(26)29-15(2)22(14)13-28-25(30)16-6-7-18-17-11-20(19(18)10-16)21(12-17)23-5-3-4-8-27-23/h3-10,12,17,20H,11,13H2,1-2H3,(H2,26,29)(H,28,30)	NLSKYUYHLSRTNU-UHFFFAOYSA-N	306374	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 10-(pyridin-2-yl)tricyclo [6.2.1.02,7]- undeca-2,4,6,9-tetraene-4- carboxamide and (+-)-N- [(6-amino-2,4- dimethylpyridin-3- yl)methyl]-9-(pyridin-2-yl) tricyclo [6.2.1.02,7]undeca-2,4,6,9- tetraene-4-carboxamide::US10144746, Compound 16	Plasma kallikrein			 14454							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306374	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306374&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124124309	381755073							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587870	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c4cc(ccc34)N3CC4CCC(C3)O4)c2c1	InChI=1S/C29H30N4O3/c1-15-9-26(30)32-16(2)25(15)12-31-29(34)17-3-7-21-23(10-17)28-24-11-18(4-8-22(24)27(21)36-28)33-13-19-5-6-20(14-33)35-19/h3-4,7-11,19-20,27-28H,5-6,12-14H2,1-2H3,(H2,30,32)(H,31,34)	QSFINUPOXAQLMQ-UHFFFAOYSA-N	306375	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 12-{8-oxa-3-azabicyclo[3.2.1] octan-3-yl}-15-oxatetracyclo [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide and (+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 11-{8-oxa-3-azabicyclo[3.2.1] octan-3-yl}-15-oxatetracyclo [6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 17	Plasma kallikrein			 437							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306375	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306375&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131653	381755074							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587871	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3CC(C(=C3)c3nccc4ccccc34)c2c1	InChI=1S/C29H26N4O/c1-16-11-27(30)33-17(2)26(16)15-32-29(34)19-7-8-21-20-13-24(23(21)12-19)25(14-20)28-22-6-4-3-5-18(22)9-10-31-28/h3-12,14,20,24H,13,15H2,1-2H3,(H2,30,33)(H,32,34)	MLUGFAOCGGBPBG-UHFFFAOYSA-N	306376	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]-10- (isoquinolin-1-yl)tricycle- [6.2.1.02,7] undeca-2,4,6,9-tetraene- 4-carboxamide and (+-)-N- [(6-amino-2,4-dimethyl- pyridin-3- yl)methyl]-9-(isoquinolin-1-yl) tricycle-[6.2.1.02,7]undeca- 2,4,6,9-tetraene-4-carboxamide::US10144746, Compound 18	Plasma kallikrein			 9772							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306376	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306376&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131655	381755075							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587872	CN1C2C=C(C1c1cc(ccc21)C(=O)NCc1c(C)cc(N)nc1C)c1ccccc1	InChI=1S/C26H26N4O/c1-15-11-24(27)29-16(2)22(15)14-28-26(31)18-9-10-19-21(12-18)25-20(13-23(19)30(25)3)17-7-5-4-6-8-17/h4-13,23,25H,14H2,1-3H3,(H2,27,29)(H,28,31)	ABYMXNVHYSYGIA-UHFFFAOYSA-N	306377	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl]methyl-11- methyl-10-phenyl-11-azatricyclo- [6.2.1.02,7]undeca-2,4,6,9- tetraene-4-carboxamide and (+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 11-methyl-9-phenyl-11- azatricyclo-[6.2.1.02,7]undeca- 2,4,6,9-tetraene-4-carboxamide::US10144746, Compound 19	Plasma kallikrein			 19055							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306377	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306377&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124124305	381755076							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587873	NCc1ccc(CNC(=O)c2ccc3C4OC(c3c2)c2cc(ccc42)-c2ccc(F)cc2)cc1	InChI=1S/C29H23FN2O2/c30-22-9-5-19(6-10-22)20-7-11-23-25(13-20)28-26-14-21(8-12-24(26)27(23)34-28)29(33)32-16-18-3-1-17(15-31)2-4-18/h1-14,27-28H,15-16,31H2,(H,32,33)	FGOVFOADQREPLY-UHFFFAOYSA-N	306378	(+-)-N-{[4-(aminomethyl) phenyl]methyl}-12-(4- fluorophenyl)-15-oxatetracyclo- [6.6.1.02,7.09,14]-pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide and (+-)-N-{[4- (aminomethyl)phenyl]methyl}- 11-(4-fluorophenyl)-15- oxatetracyclo-[6.6.1.02,7.09,14]- pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 20	Plasma kallikrein			 3467							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306378	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306378&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131657	381755077							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587874	COc1ccc(c(CNC(=O)c2ccc3C4OC(c3c2)c2cc(ccc42)-c2ccc(F)cc2)c1)-n1cnnn1	InChI=1S/C30H22FN5O3/c1-38-22-8-11-27(36-16-33-34-35-36)20(12-22)15-32-30(37)19-5-10-24-26(14-19)29-25-13-18(4-9-23(25)28(24)39-29)17-2-6-21(31)7-3-17/h2-14,16,28-29H,15H2,1H3,(H,32,37)	OOLDQVHHHUVWHQ-UHFFFAOYSA-N	306379	(+-)-12-(4-fluorophenyl)-N- {[5-methoxy-2-(1H-1,2,3,4- tetrazol-1-yl)phenyl]methyl}-15- oxatetracyclo[6.6.1.02,7.09,14] pentdeca-2,4,6,9,11,13- hexaene-4-carboxamide and  (+-)-11-(4-fluorophenyl)-N-{[5- methoxy-2-(1H-1,2,3,4-tetrazol- 1-yl)phenyl]methyl}-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 21	Plasma kallikrein			 1175							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306379	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306379&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131658	381755078							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587875	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1cccc(F)c1	InChI=1S/C29H24FN3O2/c1-15-10-26(31)33-16(2)25(15)14-32-29(34)19-7-9-22-24(13-19)28-23-12-18(6-8-21(23)27(22)35-28)17-4-3-5-20(30)11-17/h3-13,27-28H,14H2,1-2H3,(H2,31,33)(H,32,34)	MIRQUPOFONVQES-UHFFFAOYSA-N	306380	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 12-(3-fluorophenyl)-15- oxatetracyclo- [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide  and (+-)-N-[(6-amino- 2,4-dimethylpyridin-3-yl)methyl]- 11-(3-fluorophenyl)-15- oxatetracyclo[6.6.1.02,7.09,14]- pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 22	Plasma kallikrein			 331							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306380	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306380&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131661	381755079							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587876	CCOc1cc(c(F)cn1)-c1ccc2C3OC(c4cc(ccc34)C(=O)NCc3c(C)cc(N)nc3C)c2c1	InChI=1S/C30H27FN4O3/c1-4-37-27-12-21(25(31)14-33-27)17-5-7-19-22(10-17)29-23-11-18(6-8-20(23)28(19)38-29)30(36)34-13-24-15(2)9-26(32)35-16(24)3/h5-12,14,28-29H,4,13H2,1-3H3,(H2,32,35)(H,34,36)	HVDDKINKAVZUEX-UHFFFAOYSA-N	306381	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 12-(2-ethoxy-5-fluoropyridin- 4-yl)-15-oxatetracyclo [6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide and  (+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 11-(2-ethoxy-5-fluoropyridin- 4-yl)-15-oxatetra-cyclo [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 23	Plasma kallikrein			 550							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306381	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306381&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131662	381755080							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587877	CC(C)Oc1cc(c(F)cn1)-c1ccc2C3OC(c4cc(ccc34)C(=O)NCc3c(C)cc(N)nc3C)c2c1	InChI=1S/C31H29FN4O3/c1-15(2)38-28-12-22(26(32)14-34-28)18-5-7-20-23(10-18)30-24-11-19(6-8-21(24)29(20)39-30)31(37)35-13-25-16(3)9-27(33)36-17(25)4/h5-12,14-15,29-30H,13H2,1-4H3,(H2,33,36)(H,35,37)	UXKLSQDXUADECR-UHFFFAOYSA-N	306382	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)- methyl]-12-[5- fluoro-2-(propan-2-yloxy) pyridin-4-yl]-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide (+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl)-11-[5- fluoro-2-(propan-2-yloxy) pyridin-4-yl]-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 24	Plasma kallikrein			 1023							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306382	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306382&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131665	381755081							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587878	COc1ccc(Cl)c(CNC(=O)c2ccc3C4OC(c3c2)c2cc(ccc42)-c2ccco2)c1F	InChI=1S/C27H19ClFNO4/c1-32-23-9-8-21(28)20(24(23)29)13-30-27(31)15-5-7-17-19(12-15)26-18-11-14(22-3-2-10-33-22)4-6-16(18)25(17)34-26/h2-12,25-26H,13H2,1H3,(H,30,31)	AKZOGJDCQJUHCY-UHFFFAOYSA-N	306383	(+-)-N-[(6-chloro-2-fluoro-3- methoxyphenyl)methyl]-12- (furan-2-yl)-15-oxatetracyclo- [6.6.1.02,7.09,14]-pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide  and (+-)-N-[(6-chloro-2-fluoro-3- methoxyphenyl)methyl]-11- (furan-2-yl)-15-oxatetracyclo- [6.6.1.02,7.09,14]-pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 25	Plasma kallikrein			 33884							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306383	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306383&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131666	381755082							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587879	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1cc[c+]o1	InChI=1S/C27H21N3O3/c1-14-10-24(28)30-15(2)22(14)13-29-27(31)17-6-8-19-21(12-17)26-20-11-16(23-4-3-9-32-23)5-7-18(20)25(19)33-26/h3-8,10-12,25-26H,13H2,1-2H3,(H2-,28,29,30,31)/p+1	JRTGLBBQHODMMX-UHFFFAOYSA-O	306384	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]-12- (furan-2-yl)-15-oxatetracyclo- [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide and (+-)-N-[(6-amino- 2,4-dimethylpyridin-3-yl)methyl]- 11-(furan-2-yl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 26	Plasma kallikrein			 182							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306384	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306384&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137554674	381755083							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587880	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c4cc(Cn5cc(Br)cn5)ccc34)c2c1	InChI=1S/C27H24BrN5O2/c1-14-7-24(29)32-15(2)23(14)11-30-27(34)17-4-6-20-22(9-17)26-21-8-16(3-5-19(21)25(20)35-26)12-33-13-18(28)10-31-33/h3-10,13,25-26H,11-12H2,1-2H3,(H2,29,32)(H,30,34)	WYEFUAIPPITWKQ-UHFFFAOYSA-N	306385	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl) methyl]-12-[(4- bromo-1H-pyrazol-1-yl) methyl]-15- oxatetracyclo[6.6.1.02,7.09,14]- pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide and (+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]-11- [(4-bromo-1H-pyrazol-1- yl)methyl]-15-oxatetracyclo [6.6.1.02,7.09,14]-pentadeca-::US10144746, Compound 27	Plasma kallikrein			 24.0							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306385	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306385&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131671	381755084							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587881	COc1ccc(Cl)c(CNC(=O)c2ccc3C4OC(c3c2)c2cc(ccc42)-c2cccc(F)c2)c1F	InChI=1S/C29H20ClF2NO3/c1-35-25-10-9-24(30)23(26(25)32)14-33-29(34)17-6-8-20-22(13-17)28-21-12-16(5-7-19(21)27(20)36-28)15-3-2-4-18(31)11-15/h2-13,27-28H,14H2,1H3,(H,33,34)	KJANFAUDYAQPOI-UHFFFAOYSA-N	306386	(+-)-N-[(6-chloro-2-fluoro-3- methoxyphenyl)-methyl]-12-(3- fluorophenyl)-15-oxatetracyclo- [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide and (+-)-N-[(6-chloro- 2-fluoro-3-methoxyphenyl) methyl]- 11-(3-fluorophenyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 28	Plasma kallikrein			 1000000							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306386	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306386&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131673	381755085							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587882	NCc1ccc2CN(Cc2c1)C(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1ccc(F)cc1	InChI=1S/C30H23FN2O2/c31-23-7-3-18(4-8-23)19-5-9-24-26(12-19)29-27-13-20(6-10-25(27)28(24)35-29)30(34)33-15-21-2-1-17(14-32)11-22(21)16-33/h1-13,28-29H,14-16,32H2	RYNIQWLYTFIOBR-UHFFFAOYSA-N	306387	(+-)-{2-[12-(4-fluorophenyl)- 15-oxatetracyclo- [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carbonyl]-2,3-dihydro-1H-isoindol- 5-yl}methanamine and (+-)-{2-[11-(4-fluorophenyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carbonyl]-2,3-dihydro- 1H-isoindol-5- yl}methanamine::US10144746, Compound 29	Plasma kallikrein			 38905							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306387	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306387&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131675	381755086							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587883	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1ccccc1F	InChI=1S/C29H24FN3O2/c1-15-11-26(31)33-16(2)24(15)14-32-29(34)18-8-10-21-23(13-18)28-22-12-17(7-9-20(22)27(21)35-28)19-5-3-4-6-25(19)30/h3-13,27-28H,14H2,1-2H3,(H2,31,33)(H,32,34)	JOKIKVLIDHZPCQ-UHFFFAOYSA-N	306388	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)- methyl]-12-(2- fluorophenyl)-15-oxatetracyclo- [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide and (+-)-N-[(6-amino- 2,4-dimethylpyridin-3-yl)methyl]- 11-(2-fluoro-phenyl)-15- oxatetracyclo[6.6.1.02,7.09,14]- pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::BDBM306389::US10144746, Compound 30	Plasma kallikrein			 178							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306388	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306388&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131677	381755087							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587884	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1ccccc1F	InChI=1S/C29H24FN3O2/c1-15-11-26(31)33-16(2)24(15)14-32-29(34)18-8-10-21-23(13-18)28-22-12-17(7-9-20(22)27(21)35-28)19-5-3-4-6-25(19)30/h3-13,27-28H,14H2,1-2H3,(H2,31,33)(H,32,34)	JOKIKVLIDHZPCQ-UHFFFAOYSA-N	306388	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)- methyl]-12-(2- fluorophenyl)-15-oxatetracyclo- [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide and (+-)-N-[(6-amino- 2,4-dimethylpyridin-3-yl)methyl]- 11-(2-fluoro-phenyl)-15- oxatetracyclo[6.6.1.02,7.09,14]- pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::BDBM306389::US10144746, Compound 30	Plasma kallikrein			 123							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306388	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306388&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131677	381755087							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587885	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c4ccc(Cn5cccn5)cc34)c2c1	InChI=1S/C27H25N5O2/c1-15-10-24(28)31-16(2)23(15)13-29-27(33)18-5-7-20-22(12-18)26-19-6-4-17(11-21(19)25(20)34-26)14-32-9-3-8-30-32/h3-12,25-26H,13-14H2,1-2H3,(H2,28,31)(H,29,33)	SEIVEYBCZQWSOV-UHFFFAOYSA-N	306390	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]- 11-[(1H-pyrazol-1-yl)methyl]- 15-oxatetracyclo [6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 32	Plasma kallikrein			 87.1							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306390	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306390&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131646	381755089							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587886	Cc1cnn(Cc2ccc3C4OC(c3c2)c2cc(ccc42)C(=O)NCc2c(C)cc(N)nc2C)c1	InChI=1S/C28H27N5O2/c1-15-11-31-33(13-15)14-18-4-6-20-22(9-18)27-23-10-19(5-7-21(23)26(20)35-27)28(34)30-12-24-16(2)8-25(29)32-17(24)3/h4-11,13,26-27H,12,14H2,1-3H3,(H2,29,32)(H,30,34)	CPIXSFCYRWRGRW-UHFFFAOYSA-N	306391	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 12-[(4-methyl-1H-pyrazol-1- yl)methyl]-15- oxatetracyclo[6.6.1.02,7.09,14]- pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide and  (+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]-11- [(4-methyl-1H-pyrazol-1- yl)methyl]-15-oxatetracyclo [6.6.1.02,7.09,14]-pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 33	Plasma kallikrein			 11.0							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306391	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306391&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131679	381755090							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587887	Cc1cnn(Cc2ccc3C4OC(c3c2)c2cc(ccc42)C(=O)NCc2n[nH]c3ccc(Cl)cc23)c1			306392	(+-)-N-[(5-chloro-1H-indazol- 3-yl)methyl]-12-[(4-methyl- 1H-pyrazol-1-yl)methyl]-15- oxatetracyclo[6.6.1.02,7.09,14] pentedeca-2,4,6,9,11,13- hexaene-4-carboxamide  and (+-)-N-[(5-chloro- 1H-indazol-3-yl)methyl]- 11-[(4-methyl-1H-pyrazol-1-yl) methyl]-15-oxatetracyclo [6.6.1.02,7.09,14]- pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 34	Plasma kallikrein			 224							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306392	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306392&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131680	381755091							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587888	COc1c[c+]ccc1-c1ccc2C3OC(c4cc(ccc34)C(=O)NCc3c(C)cc(N)nc3C)c2c1	InChI=1S/C30H25N3O3/c1-16-12-27(31)33-17(2)25(16)15-32-30(34)19-9-11-22-24(14-19)29-23-13-18(8-10-21(23)28(22)36-29)20-6-4-5-7-26(20)35-3/h4,6-14,28-29H,15H2,1-3H3,(H2-,31,32,33,34)/p+1	NBXCUZOSKKAHED-UHFFFAOYSA-O	306393	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 12-(2-methoxypheny])-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide and (+-)-N-[(6-amino- 2,4-dimethylpyridin-3- yl)methyl]-11-(2-methoxy-phenyl)- 15-oxatetracyelo- [6.6.1.02,7.09,14]-pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 35	Plasma kallikrein			 407							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306393	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306393&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137554675	381755092							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587889	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1cccc2[nH]cnc12			306394	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 12-(1H-1,3-benzodiazol-4-yl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide and (+-)- N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 11-(1H-1,3-benzodiazol-4-yl)- 15-oxatetracyclo-[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 36	Plasma kallikrein			 339							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306394	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306394&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131687	381755093							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587890	COc1ccc(Cl)c(CNC(=O)c2ccc3C4OC(c3c2)c2cc(ccc42)-c2cccc3[nH]cnc23)c1F			306395	(+-)-12-(1H-1,3-benzodiazol- 4-yl)-N-[(6-chloro-2-fluoro-3 methoxyphenyl)methyl]-15- oxatetra-cyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13-hexaene-4- carboxamide and (+-)-11-(1H-1,3- benzodiazol-4-yl)-N-[(6- chloro-2-fluoro-3-methoxyphenyl) methyl]-15-oxatetracyclo- [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 37	Plasma kallikrein			 1000000							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306395	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306395&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131685	381755094							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587891	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1cccc2ncoc12	InChI=1S/C30H24N4O3/c1-15-10-26(31)34-16(2)24(15)13-32-30(35)18-7-9-21-23(12-18)28-22-11-17(6-8-20(22)27(21)37-28)19-4-3-5-25-29(19)36-14-33-25/h3-12,14,27-28H,13H2,1-2H3,(H2,31,34)(H,32,35)	YHFTYPOCEOOTSE-UHFFFAOYSA-N	306396	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]-12- (1,3-benzoxazol-7-yl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide and (+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 11-(1,3-benzoxazol-7-yl)-15- oxatetracyclo-[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 38	Plasma kallikrein			 525							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306396	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306396&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131690	381755095							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587892	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-n1ccccc1=O	InChI=1S/C28H24N4O3/c1-15-11-24(29)31-16(2)23(15)14-30-28(34)17-6-8-19-21(12-17)27-22-13-18(7-9-20(22)26(19)35-27)32-10-4-3-5-25(32)33/h3-13,26-27H,14H2,1-2H3,(H2,29,31)(H,30,34)	CFYMIDGIEMNDRD-UHFFFAOYSA-N	306397	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 12-(2-oxo-1,2- dihydropyridin-1-yl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide and  (+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 11-(2-oxo-1,2-dihydropyridin- 1-yl)-15-oxatetracyclo [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 39	Plasma kallikrein			 427							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306397	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306397&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131691	381755096							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587893	Nc1nccc2cc(CNC(=O)c3ccc4C5OC(c4c3)c3cc(ccc53)-c3cccc(F)c3)ccc12	InChI=1S/C31H22FN3O2/c32-22-3-1-2-18(13-22)19-5-8-24-26(14-19)29-27-15-21(6-9-25(27)28(24)37-29)31(36)35-16-17-4-7-23-20(12-17)10-11-34-30(23)33/h1-15,28-29H,16H2,(H2,33,34)(H,35,36)	YZEFKKCFUDTAJM-UHFFFAOYSA-N	306398	(+-)-N-[(1-aminoisoquinolin- 6-yl)methyl]-12-(2- fluorophenyl)-15-oxatetracyclo [6.6.1.02,7.09,14]-pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide and (+-)-N- [(1-aminoisoquinolin-6-yl) methyl]-11-(2-fluorophenyl)-15- oxatetracyclo-[6.6.1.02,7.09,14]- pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 40	Plasma kallikrein			 12023							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306398	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306398&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131693	381755097							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587894	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c4cc(CN5CCCC5)ccc34)c2c1	InChI=1S/C28H30N4O2/c1-16-11-25(29)31-17(2)24(16)14-30-28(33)19-6-8-21-23(13-19)27-22-12-18(15-32-9-3-4-10-32)5-7-20(22)26(21)34-27/h5-8,11-13,26-27H,3-4,9-10,14-15H2,1-2H3,(H2,29,31)(H,30,33)	KRTHCVKSHZXUOO-UHFFFAOYSA-N	306399	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]-12- [(pyrrolidin-1-yl)methyl]-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide and  (+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 11-[(pyrrolidin-1-yl)methyl]- 15-oxatetracyclo-[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 41	Plasma kallikrein			 132							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306399	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306399&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131696	381755098							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587895	COc1ccc(c(CNC(=O)c2ccc3C4OC(c5cc(Cn6nc(C)cc6C)ccc45)c3c2)c1)-n1cnnn1	InChI=1S/C30H27N7O3/c1-17-10-18(2)36(33-17)15-19-4-7-23-25(11-19)29-26-13-20(5-8-24(26)28(23)40-29)30(38)31-14-21-12-22(39-3)6-9-27(21)37-16-32-34-35-37/h4-13,16,28-29H,14-15H2,1-3H3,(H,31,38)	PQBHUXNKTDRFOT-UHFFFAOYSA-N	306400	(+-)-12-[(3,5-dimethyl-1H- pyrazol-1-yl)methyl]-N-{[5- methoxy-2-(1H-1,2,3,4-tetrazol- 1-yl(phenyl]methyl)-15- oxatetracyclo-[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide and (+-)- 11-[(3,5-dimethyl-1H- pyrazol-1-yl)methyl]-N-{[5- methoxy-2-(1H-1,2,3,4-tetrazol- 1-yl)phenyl]methyl}-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 42	Plasma kallikrein			 18.2							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306400	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306400&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131700	381755099							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587896	Cc1cc(C)n(Cc2ccc3C4OC(c3c2)c2cc(ccc42)C(=O)NCc2c(C)cc(N)nc2C)n1	InChI=1S/C29H29N5O2/c1-15-9-26(30)32-18(4)25(15)13-31-29(35)20-6-8-22-24(12-20)28-23-11-19(5-7-21(23)27(22)36-28)14-34-17(3)10-16(2)33-34/h5-12,27-28H,13-14H2,1-4H3,(H2,30,32)(H,31,35)	HFLNZILORROQPP-UHFFFAOYSA-N	306401	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 12-[(3,5-dimethyl-1H-pyrazol-1- yl]methyl-15- oxatetracyclo[6.6.1.02,7.09,14]- pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide and (+-)-N- [(6-amino-2,4- dimethylpyridin-3-yl)methyl]-11- [(3,5-dimethyl-1H-pyrazol- 1-yl)methyl]-15-oxatetracyclo [6.6.1.02,7.09,14]-pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 43	Plasma kallikrein			 17.0							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306401	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306401&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131698	381755100							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587897	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1cnccc1F	InChI=1S/C28H23FN4O2/c1-14-9-25(30)33-15(2)22(14)13-32-28(34)17-4-6-19-21(11-17)27-20-10-16(3-5-18(20)26(19)35-27)23-12-31-8-7-24(23)29/h3-12,26-27H,13H2,1-2H3,(H2,30,33)(H,32,34)	KSANKVNUQWQMTF-UHFFFAOYSA-N	306402	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 12-(4-fluoropyridin-3-yl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide and (+-)- N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]-11- (4-fluoropyridin-3-yl)-15- oxatetracyclo-[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 44	Plasma kallikrein			 178							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306402	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306402&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131701	381755101							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587898	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1cccc2ocnc12	InChI=1S/C30H24N4O3/c1-15-10-26(31)34-16(2)24(15)13-32-30(35)18-7-9-21-23(12-18)29-22-11-17(6-8-20(22)28(21)37-29)19-4-3-5-25-27(19)33-14-36-25/h3-12,14,28-29H,13H2,1-2H3,(H2,31,34)(H,32,35)	JGXYFNOCZSQOJQ-UHFFFAOYSA-N	306403	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 12-(1,3-benzoxazol-4-yl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13-hexaene-4- carboxamide and (+-)-N-[(6-amino- 2,4-dimethylpyridin-3- yl)methyl]-11-(1,3-benzoxazol- 4-yl)-15-oxatetracyclo [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 45	Plasma kallikrein			 95.5							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306403	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306403&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131703	381755102							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587899	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1c(F)cccc1F	InChI=1S/C29H23F2N3O2/c1-14-10-25(32)34-15(2)22(14)13-33-29(35)17-7-9-19-21(12-17)28-20-11-16(6-8-18(20)27(19)36-28)26-23(30)4-3-5-24(26)31/h3-12,27-28H,13H2,1-2H3,(H2,32,34)(H,33,35)	UXXZNMOFNAMQIS-UHFFFAOYSA-N	306404	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 12-(2,6-difluorophenyl)-15- oxatetra-cyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13-hexaene- 4-carboxamide and (+-)-N- [(6-amino- 2,4-dimethylpyridin-3-yl)methyl]- 11-(2,6-difluorophenyl)- 15-oxatetracyclo[6.6.1.02,7.09,14]- pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 46	Plasma kallikrein			 245							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306404	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306404&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131705	381755103							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587900	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1ccc(F)cc1F	InChI=1S/C29H23F2N3O2/c1-14-9-26(32)34-15(2)24(14)13-33-29(35)17-4-7-21-23(11-17)28-22-10-16(3-6-20(22)27(21)36-28)19-8-5-18(30)12-25(19)31/h3-12,27-28H,13H2,1-2H3,(H2,32,34)(H,33,35)	ULFZKTTWSDEBHE-UHFFFAOYSA-N	306405	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 12-(2,4-difluorophenyl)-15- oxatetra-cyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide  and (+-)-N-[(6-amino- 2,4-dimethylpyridin-3-yl)methyl]- 11-(2,4-difluoro-phenyl)- 15-oxatetracyclo[6.6.1.02,7.09,14]- pentadexa-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 47	Plasma kallikrein			 117							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306405	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306405&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131706	381755104							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587901	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(C4=C3CN(Cc3ccccc3)C4)c2c1	InChI=1S/C28H28N4O2/c1-16-10-25(29)31-17(2)22(16)12-30-28(33)19-8-9-20-21(11-19)27-24-15-32(14-23(24)26(20)34-27)13-18-6-4-3-5-7-18/h3-11,26-27H,12-15H2,1-2H3,(H2,29,31)(H,30,33)	LVDUBMISCNSRMA-UHFFFAOYSA-N	306406	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methy]-11- benzyl-14-oxa-11-azatetracyclo- [6.5.1.02,7.09,13]tetradeca- 2,4,6,9(13)-tetraene-4-carboxamide::US10144746, Compound 48	Plasma kallikrein			 13490							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306406	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306406&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131708	381755105							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587902	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1ccncc1F	InChI=1S/C28H23FN4O2/c1-14-9-25(30)33-15(2)23(14)12-32-28(34)17-4-6-20-22(11-17)27-21-10-16(3-5-19(21)26(20)35-27)18-7-8-31-13-24(18)29/h3-11,13,26-27H,12H2,1-2H3,(H2,30,33)(H,32,34)	LMKBEMQSCDRDMG-UHFFFAOYSA-N	306407	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 12-(3-fluoropyridin-4-yl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide and (+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 11-(3-fluoropyridin-4-yl)-15- oxatetracyclo-[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 49	Plasma kallikrein			 447							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306407	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306407&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131709	381755106							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587903	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c4cc(C[N]5(O)CCOCC5)ccc34)c2c1	InChI=1S/C28H31N4O4/c1-16-11-25(29)31-17(2)24(16)14-30-28(33)19-4-6-21-23(13-19)27-22-12-18(3-5-20(22)26(21)36-27)15-32(34)7-9-35-10-8-32/h3-6,11-13,26-27,34H,7-10,14-15H2,1-2H3,(H2,29,31)(H,30,33)	VQQSHHCCGZBYRC-UHFFFAOYSA-N	306408	(+-)-4-[(12-{[(6-amino-2,4- dimethylpyridin-3- yl)methyl]carbamoyl}-15- oxatetracyclo- [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaen-4- yl)methyl]morpholin-4-ium- 4-olate::US10144746, Compound 50	Plasma kallikrein			 3548							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306408	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306408&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124135727	381755107							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587904	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c4cc(Nc5ccn(C)n5)ccc34)c2c1	InChI=1S/C27H26N6O2/c1-14-10-23(28)30-15(2)22(14)13-29-27(34)16-4-6-18-20(11-16)26-21-12-17(5-7-19(21)25(18)35-26)31-24-8-9-33(3)32-24/h4-12,25-26H,13H2,1-3H3,(H2,28,30)(H,29,34)(H,31,32)	QOBJLFCESCMEDA-UHFFFAOYSA-N	306409	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]- 12-[(1-methyl-1H-pyrazol-3-yl) amino]-15-oxatetracyclo [6.6.1.02,7.09,14]-pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 51	Plasma kallikrein			 933							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306409	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306409&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131711	381755108							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587905	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c4ccc(Nc5ccn(C)n5)cc34)c2c1	InChI=1S/C27H26N6O2/c1-14-10-23(28)30-15(2)22(14)13-29-27(34)16-4-6-18-20(11-16)25-19-7-5-17(12-21(19)26(18)35-25)31-24-8-9-33(3)32-24/h4-12,25-26H,13H2,1-3H3,(H2,28,30)(H,29,34)(H,31,32)	BKGPEZIJYKWMIY-UHFFFAOYSA-N	306410	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 11-[(1-methyl-1H-pyrazol- 3-yl)amino]-15- oxatetracyclo[6.6.1.02,7.09,14]- pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 52	Plasma kallikrein			 1514							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306410	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306410&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124135682	381755109							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587906	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c4cc(Nc5ccnn5C)ccc34)c2c1	InChI=1S/C27H26N6O2/c1-14-10-23(28)31-15(2)22(14)13-29-27(34)16-4-6-18-20(11-16)26-21-12-17(5-7-19(21)25(18)35-26)32-24-8-9-30-33(24)3/h4-12,25-26,32H,13H2,1-3H3,(H2,28,31)(H,29,34)	HYNIRQNCWKOIPS-UHFFFAOYSA-N	306411	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 12-[(1-methyl-1H-pyrazol-5- yl)amino]-15-oxatetracyclo [6.6.1.02,7.09,14]-pentadeca- 2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 53	Plasma kallikrein			 23988							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306411	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306411&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131714	381755110							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587907	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c4ccc(Nc5ccnn5C)cc34)c2c1	InChI=1S/C27H26N6O2/c1-14-10-23(28)31-15(2)22(14)13-29-27(34)16-4-6-18-20(11-16)25-19-7-5-17(12-21(19)26(18)35-25)32-24-8-9-30-33(24)3/h4-12,25-26,32H,13H2,1-3H3,(H2,28,31)(H,29,34)	MOBICCQSALLBBS-UHFFFAOYSA-N	306412	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 11-[(1-methyl-1H-pyrazol-5- yl)amino]-15-oxatetracyclo [6.6.1.02,7.09,14]-pentadeca- 2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 54	Plasma kallikrein			 457							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306412	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306412&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124135684	381755111							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587908	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1cc(F)cc(F)c1	InChI=1S/C29H23F2N3O2/c1-14-7-26(32)34-15(2)25(14)13-33-29(35)17-4-6-22-24(11-17)28-23-10-16(3-5-21(23)27(22)36-28)18-8-19(30)12-20(31)9-18/h3-12,27-28H,13H2,1-2H3,(H2,32,34)(H,33,35)	IPPKDUKGRVRZBF-UHFFFAOYSA-N	306413	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 12-(3,5-difluorophenyl)-15- oxatetracyclo [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide  and (+-)-N-[(6-amino- 2,4-dimethylpyridin-3-yl) methyl]-11-(3,5- difluorophenyl)-15- oxatetracyclo-[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 55	Plasma kallikrein			 363							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306413	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306413&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131713	381755112							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587909	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1cccc(F)c1F	InChI=1S/C29H23F2N3O2/c1-14-10-25(32)34-15(2)23(14)13-33-29(35)17-7-9-20-22(12-17)28-21-11-16(6-8-19(21)27(20)36-28)18-4-3-5-24(30)26(18)31/h3-12,27-28H,13H2,1-2H3,(H2,32,34)(H,33,35)	NKHKKXOZEQKJKQ-UHFFFAOYSA-N	306414	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 12-(2,3-difluorophenyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide and (+-)-N-[(6-amino- 2,4-dimethylpyridin-3-yl) methyl]-11-(2,3- difluorophenyl)- 15-oxatetracyclo- [6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 56	Plasma kallikrein			 105							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306414	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306414&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131718	381755113							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587910	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1ccccc1Cl	InChI=1S/C29H24ClN3O2/c1-15-11-26(31)33-16(2)24(15)14-32-29(34)18-8-10-21-23(13-18)28-22-12-17(7-9-20(22)27(21)35-28)19-5-3-4-6-25(19)30/h3-13,27-28H,14H2,1-2H3,(H2,31,33)(H,32,34)	HJHIGXXOZGSIGW-UHFFFAOYSA-N	306415	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 12-(2-chlorophenyl)-15- oxatetra-cyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4- carboxamide  and (+-)-N-[(6-amino- 2,4-dimethylpyridin-3-yl) methyl]-11-(2-chloro- phenyl)-15-oxatetracyclo [6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 57	Plasma kallikrein			 2818							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306415	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306415&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131717	381755114							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587911	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1ccc(F)c(F)c1	InChI=1S/C29H23F2N3O2/c1-14-9-26(32)34-15(2)23(14)13-33-29(35)18-4-7-20-22(11-18)28-21-10-16(3-6-19(21)27(20)36-28)17-5-8-24(30)25(31)12-17/h3-12,27-28H,13H2,1-2H3,(H2,32,34)(H,33,35)	QODPAVRZKVKWCT-UHFFFAOYSA-N	306416	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 12-(3,4-difluorophenyl)-15- oxatetra-cyclo [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide and (+-)-N-[(6-amino- 2,4-dimethylpyridin-3-yl)methyl]- 11-(3,4-difluorophenyl)- 15-oxatetracyclo-[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 58	Plasma kallikrein			 398							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306416	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306416&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131719	381755115							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587912	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1ccccc1C(F)(F)F	InChI=1S/C30H24F3N3O2/c1-15-11-26(34)36-16(2)24(15)14-35-29(37)18-8-10-21-23(13-18)28-22-12-17(7-9-20(22)27(21)38-28)19-5-3-4-6-25(19)30(31,32)33/h3-13,27-28H,14H2,1-2H3,(H2,34,36)(H,35,37)	YNBAOPYTDQZTTA-UHFFFAOYSA-N	306417	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 12-[2-(trifluoromethyl)phenyl]- 15-oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide and  (+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 11-[2-(trifluoromethyl)phenyl]- 15-oxatetracyclo- [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 59	Plasma kallikrein			 1445							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306417	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306417&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131722	381755116							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587913	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1cc(Cl)ccc1F	InChI=1S/C29H23ClFN3O2/c1-14-9-26(32)34-15(2)24(14)13-33-29(35)17-4-7-20-23(11-17)28-22-10-16(3-6-19(22)27(20)36-28)21-12-18(30)5-8-25(21)31/h3-12,27-28H,13H2,1-2H3,(H2,32,34)(H,33,35)	TWJAMRVTYIOXLS-UHFFFAOYSA-N	306418	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 12-(5-chloro-2-fluorophenyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide and  (+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 11-(5-chloro-2-fluorophenyl)- 15-oxatetracyclo-[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 60	Plasma kallikrein			 490							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306418	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306418&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131733	381755117							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587914	Cc1ccc(F)c(c1)-c1ccc2C3OC(c4cc(ccc34)C(=O)NCc3c(C)cc(N)nc3C)c2c1	InChI=1S/C30H26FN3O2/c1-15-4-9-26(31)22(10-15)18-5-7-20-23(12-18)29-24-13-19(6-8-21(24)28(20)36-29)30(35)33-14-25-16(2)11-27(32)34-17(25)3/h4-13,28-29H,14H2,1-3H3,(H2,32,34)(H,33,35)	UBGLOKKXEDZTIL-UHFFFAOYSA-N	306419	(+-)-N-[(6-amino-2,4-dimethyl- pyridin-3-yl)methyl]-12-(2- fluoro-5-methylphenyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide and (+-)- N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]-11- (2-fluoro-5-methylphenyl)- 15-oxatetracyclo-[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 61	Plasma kallikrein			 1738							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306419	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306419&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131721	381755118							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587915	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1ccc(Cl)s1	InChI=1S/C27H22ClN3O2S/c1-13-9-24(29)31-14(2)21(13)12-30-27(32)16-4-6-18-20(11-16)26-19-10-15(22-7-8-23(28)34-22)3-5-17(19)25(18)33-26/h3-11,25-26H,12H2,1-2H3,(H2,29,31)(H,30,32)	CHSFRSKVCRLMGZ-UHFFFAOYSA-N	306420	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 12-(5-chlorothiophen-2-yl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide and  (+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]-11- (5-chlorothiophen-2-yl)- 15-oxatetracyclo-[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 62	Plasma kallikrein			 355							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306420	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306420&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131728	381755119							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587916	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c4cc(ccc34)N3CCN(CC3)C(=O)c3ccccc3)c2c1	InChI=1S/C34H33N5O3/c1-20-16-30(35)37-21(2)29(20)19-36-33(40)23-8-10-25-27(17-23)32-28-18-24(9-11-26(28)31(25)42-32)38-12-14-39(15-13-38)34(41)22-6-4-3-5-7-22/h3-11,16-18,31-32H,12-15,19H2,1-2H3,(H2,35,37)(H,36,40)	OKVDRTIQAUMZLU-UHFFFAOYSA-N	306421	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]- 12-(4-benzoylpiperazin-1-yl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide and (+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 11-(4-benzoylpiperazin-1-yl)- 15-oxatetracyclo-[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 63	Plasma kallikrein			 457							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306421	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306421&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131735	381755120							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587917	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c4ccc(cc34)N3CCN(CC3)C(=O)c3ccccc3)c2c1	InChI=1S/C34H33N5O3/c1-20-16-30(35)37-21(2)29(20)19-36-33(40)23-8-10-25-27(17-23)31-26-11-9-24(18-28(26)32(25)42-31)38-12-14-39(15-13-38)34(41)22-6-4-3-5-7-22/h3-11,16-18,31-32H,12-15,19H2,1-2H3,(H2,35,37)(H,36,40)	PMTXJUFWBQBMQW-UHFFFAOYSA-N	306422	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 11-(4-benzoylpiperazin-1-yl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 64	Plasma kallikrein			 282							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306422	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306422&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131730	381755121							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587918	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c4cc(Br)ccc34)c2c1	InChI=1S/C23H20BrN3O2/c1-11-7-20(25)27-12(2)19(11)10-26-23(28)13-3-5-15-17(8-13)22-18-9-14(24)4-6-16(18)21(15)29-22/h3-9,21-22H,10H2,1-2H3,(H2,25,27)(H,26,28)	SODWVFRCKUYKBM-UHFFFAOYSA-N	306423	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]- 12-bromo-15-oxatetracyclo- [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 65	Plasma kallikrein			 1000							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306423	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306423&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131738	381755122							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587919	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1ccc(O[CH2+])cc1F	InChI=1S/C30H24FN3O3/c1-15-10-27(32)34-16(2)25(15)14-33-30(35)18-5-8-22-24(12-18)29-23-11-17(4-7-21(23)28(22)37-29)20-9-6-19(36-3)13-26(20)31/h4-13,28-29H,3,14H2,1-2H3,(H2-,32,33,34,35)/p+1	HBBVPNFQXASPAA-UHFFFAOYSA-O	306424	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]- 12-(2-fluoro-4-methoxyphenyl)- 15-oxatetracyclo [6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide and  (+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 11-(2-fluoro-4- methoxyphenyl)-15-oxatetracyclo [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 66	Plasma kallikrein			 316							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306424	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306424&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137554676	381755123							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587920	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1ccc(cc1F)C#N	InChI=1S/C30H23FN4O2/c1-15-9-27(33)35-16(2)25(15)14-34-30(36)19-5-8-22-24(12-19)29-23-11-18(4-7-21(23)28(22)37-29)20-6-3-17(13-32)10-26(20)31/h3-12,28-29H,14H2,1-2H3,(H2,33,35)(H,34,36)	VDFZWPFLGLDBRY-UHFFFAOYSA-N	306425	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]- 12-(4-cyano-2-fluorophenyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide and (+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 11-(4-cyano-2-fluorophenyl)- 15-oxatetracyclo-[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 67	Plasma kallikrein			 269							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306425	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306425&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131736	381755124							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587921	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1ccc(F)cc1C#N	InChI=1S/C30H23FN4O2/c1-15-9-27(33)35-16(2)26(15)14-34-30(36)18-4-7-23-25(12-18)29-24-11-17(3-6-22(24)28(23)37-29)21-8-5-20(31)10-19(21)13-32/h3-12,28-29H,14H2,1-2H3,(H2,33,35)(H,34,36)	KCGYXMJGABIRNK-UHFFFAOYSA-N	306426	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 12-(2-cyano-4-fluorophenyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide and (+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 11-(2-cyano-4-fluorophenyl)- 15-oxatetracyclo-[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::BDBM306427::US10144746, Compound 68	Plasma kallikrein			 22.4							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306426	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306426&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131739	381755125							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587922	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1ccc(F)cc1C#N	InChI=1S/C30H23FN4O2/c1-15-9-27(33)35-16(2)26(15)14-34-30(36)18-4-7-23-25(12-18)29-24-11-17(3-6-22(24)28(23)37-29)21-8-5-20(31)10-19(21)13-32/h3-12,28-29H,14H2,1-2H3,(H2,33,35)(H,34,36)	KCGYXMJGABIRNK-UHFFFAOYSA-N	306426	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 12-(2-cyano-4-fluorophenyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide and (+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 11-(2-cyano-4-fluorophenyl)- 15-oxatetracyclo-[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::BDBM306427::US10144746, Compound 68	Plasma kallikrein			 6.31							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306426	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306426&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131739	381755125							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587923	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1cccc2OCOc12	InChI=1S/C30H25N3O4/c1-15-10-26(31)33-16(2)24(15)13-32-30(34)18-7-9-21-23(12-18)28-22-11-17(6-8-20(22)27(21)37-28)19-4-3-5-25-29(19)36-14-35-25/h3-12,27-28H,13-14H2,1-2H3,(H2,31,33)(H,32,34)	CNIVCTNGSVCRCV-UHFFFAOYSA-N	306428	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]- 12-(2H-1,3-benzodioxol-4-yl)- 15-oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 70	Plasma kallikrein			 269							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306428	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306428&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131737	381755127							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587924	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1ccccc1C(N)=O	InChI=1S/C30H26N4O3/c1-15-11-26(31)34-16(2)25(15)14-33-30(36)18-8-10-21-24(13-18)28-23-12-17(7-9-20(23)27(21)37-28)19-5-3-4-6-22(19)29(32)35/h3-13,27-28H,14H2,1-2H3,(H2,31,34)(H2,32,35)(H,33,36)	OJUPAGAMYPHVGS-UHFFFAOYSA-N	306429	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]- 12-(2-carbamoylphenyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide and  (+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 11-(2-carbamoylphenyl)-15- oxatetracydo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 71	Plasma kallikrein			 8128							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306429	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306429&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131740	381755128							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587925	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c4cc(Cc5cccc(c5)C#N)ccc34)c2c1	InChI=1S/C31H26N4O2/c1-17-10-28(33)35-18(2)27(17)16-34-31(36)22-7-9-24-26(14-22)30-25-13-20(6-8-23(25)29(24)37-30)11-19-4-3-5-21(12-19)15-32/h3-10,12-14,29-30H,11,16H2,1-2H3,(H2,33,35)(H,34,36)	XCWVHANIFJLDKH-UHFFFAOYSA-N	306430	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]- 12-[(3-cyanophenyl)methyl]-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide and  (+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 11-[(3-cyanophenyl)methyl]- 15-oxatetracyclo-[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 72	Plasma kallikrein			 2239							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306430	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306430&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131743	381755129							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587926	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c4cc(Nc5ccccc5F)ccc34)c2c1	InChI=1S/C29H25FN4O2/c1-15-11-26(31)33-16(2)23(15)14-32-29(35)17-7-9-19-21(12-17)28-22-13-18(8-10-20(22)27(19)36-28)34-25-6-4-3-5-24(25)30/h3-13,27-28,34H,14H2,1-2H3,(H2,31,33)(H,32,35)	QUCVQDXHGNPHLI-UHFFFAOYSA-N	306431	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 12-[(2-fluorophenyl)amino]-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide and (+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 11-[(2-fluorophenyl)amino]- 15-oxatetracyclo-[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 73	Plasma kallikrein			 5248							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306431	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306431&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131745	381755130							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587927	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c4cc(Nc5ncccc5F)ccc34)c2c1	InChI=1S/C28H24FN5O2/c1-14-10-24(30)33-15(2)22(14)13-32-28(35)16-5-7-18-20(11-16)26-21-12-17(6-8-19(21)25(18)36-26)34-27-23(29)4-3-9-31-27/h3-12,25-26H,13H2,1-2H3,(H2,30,33)(H,31,34)(H,32,35)	ZGOUFTUNPNNSOI-UHFFFAOYSA-N	306432	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 12-[(3-fluoropyridin-2-yl) amino]-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide and (+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 11-[(3-fluoropyridin-2- yl)amino]-15-oxatetra-cyclo [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 74	Plasma kallikrein			 3388							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306432	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306432&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131746	381755131							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587928	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c4cc(Oc5cccc(F)c5)ccc34)c2c1	InChI=1S/C29H24FN3O3/c1-15-10-26(31)33-16(2)25(15)14-32-29(34)17-6-8-21-23(11-17)28-24-13-20(7-9-22(24)27(21)36-28)35-19-5-3-4-18(30)12-19/h3-13,27-28H,14H2,1-2H3,(H2,31,33)(H,32,34)	TXJSALZVBMNHND-UHFFFAOYSA-N	306433	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]- 12-(3-fluorophenoxy)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13-hexaene- 4-carboxamide and (+-)-N-[(6- amino-2,4-dimethylpyridin- 3-yl)methyl]- 11-(3-fluorophenoxy)-15- oxatetracyclo-[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 75	Plasma kallikrein			 93.3							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306433	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306433&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131747	381755132							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587929	Cc1ccc(-c2ccc3C4OC(c5cc(ccc45)C(=O)NCc4c(C)cc(N)nc4C)c3c2)c(c1)C#N	InChI=1S/C31H26N4O2/c1-16-4-7-22(21(10-16)14-32)19-5-8-23-25(12-19)30-26-13-20(6-9-24(26)29(23)37-30)31(36)34-15-27-17(2)11-28(33)35-18(27)3/h4-13,29-30H,15H2,1-3H3,(H2,33,35)(H,34,36)	ZGFSEWSLLZZKLC-UHFFFAOYSA-N	306434	(+-)-N-[(6-amino)-2,4- dimethylpyridin-3-yl)-methyl]- 12-(2-cyano-4-methylphenyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide and (+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 11-(2-cyano-4-methylphenyl)- 15-oxatetracyclo-[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::BDBM306435::US10144746, Compound 76	Plasma kallikrein			 21.9							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306434	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306434&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131749	381755133							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587930	Cc1ccc(-c2ccc3C4OC(c5cc(ccc45)C(=O)NCc4c(C)cc(N)nc4C)c3c2)c(c1)C#N	InChI=1S/C31H26N4O2/c1-16-4-7-22(21(10-16)14-32)19-5-8-23-25(12-19)30-26-13-20(6-9-24(26)29(23)37-30)31(36)34-15-27-17(2)11-28(33)35-18(27)3/h4-13,29-30H,15H2,1-3H3,(H2,33,35)(H,34,36)	ZGFSEWSLLZZKLC-UHFFFAOYSA-N	306434	(+-)-N-[(6-amino)-2,4- dimethylpyridin-3-yl)-methyl]- 12-(2-cyano-4-methylphenyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide and (+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 11-(2-cyano-4-methylphenyl)- 15-oxatetracyclo-[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::BDBM306435::US10144746, Compound 76	Plasma kallikrein			 7.94							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306434	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306434&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131749	381755133							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587931	COc1ccc(-c2ccc3C4OC(c5cc(ccc45)C(=O)NCc4c(C)cc(N)nc4C)c3c2)c(c1)C#N	InChI=1S/C31H26N4O3/c1-16-10-28(33)35-17(2)27(16)15-34-31(36)19-5-8-24-26(13-19)30-25-12-18(4-7-23(25)29(24)38-30)22-9-6-21(37-3)11-20(22)14-32/h4-13,29-30H,15H2,1-3H3,(H2,33,35)(H,34,36)	ZVVNOOIWTZIQNF-UHFFFAOYSA-N	306436	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]- 12-(2-cyano-4-methoxyphenyl)- 15-oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 78	Plasma kallikrein			 257							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306436	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306436&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131751	381755135							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587932	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1ccccn1	InChI=1S/C28H24N4O2/c1-15-11-25(29)32-16(2)23(15)14-31-28(33)18-7-9-20-22(13-18)27-21-12-17(24-5-3-4-10-30-24)6-8-19(21)26(20)34-27/h3-13,26-27H,14H2,1-2H3,(H2,29,32)(H,31,33)	OQEXTCXZHQKLEN-UHFFFAOYSA-N	306437	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 12-(pyridin-2-yl)-15-oxatetra- cyclo[6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide and (+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 11-(pyridin-2-yl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 79	Plasma kallikrein			 339							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306437	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306437&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131756	381755136							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587933	COc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1ccc(F)cc1F	InChI=1S/C29H23F2N3O3/c1-14-23(25(36-2)12-26(32)34-14)13-33-29(35)16-4-7-20-22(10-16)28-21-9-15(3-6-19(21)27(20)37-28)18-8-5-17(30)11-24(18)31/h3-12,27-28H,13H2,1-2H3,(H2,32,34)(H,33,35)	AVYQCYKFKYQRPW-UHFFFAOYSA-N	306438	(+-)-N-[(6-amino-4-methoxy- 2-methylpyridin-3-yl)methyl]- 12-(2,4-difluorophenyl)-15- oxatetra-cyclo [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 80	Plasma kallikrein			 26.9							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306438	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306438&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131759	381755137							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587934	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1cccc2OCCOc12	InChI=1S/C31H27N3O4/c1-16-12-27(32)34-17(2)25(16)15-33-31(35)19-7-9-22-24(14-19)29-23-13-18(6-8-21(23)28(22)38-29)20-4-3-5-26-30(20)37-11-10-36-26/h3-9,12-14,28-29H,10-11,15H2,1-2H3,(H2,32,34)(H,33,35)	AWEATGYXIHCRBT-UHFFFAOYSA-N	306439	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]- 12-(2,3-dihydro-1,4-benzodioxin- 5-yl)-15-oxatetracyclo [6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide and (+-)-N-[(6-amino-2,4- (dimethylpyridin-3-yl)methyl]- 11-(2,3-dihydro-1,4- benzodioxin-5-yl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 81	Plasma kallikrein			 1585							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306439	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306439&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131753	381755138							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587935	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1ccccc1C#N	InChI=1S/C30H24N4O2/c1-16-11-27(32)34-17(2)26(16)15-33-30(35)19-8-10-23-25(13-19)29-24-12-18(7-9-22(24)28(23)36-29)21-6-4-3-5-20(21)14-31/h3-13,28-29H,15H2,1-2H3,(H2,32,34)(H,33,35)	QBBFEMRIWFYXLX-UHFFFAOYSA-N	306440	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]- 12-2-cyanophenyl)-15-oxatetra- cyclo[6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide and (+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 11-(2-cyanophenyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 82	Plasma kallikrein			 42.7							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306440	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306440&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131755	381755139							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587936	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c4cc(Cc5cnc(o5)-c5ccccc5)ccc34)c2c1	InChI=1S/C33H28N4O3/c1-18-12-29(34)37-19(2)28(18)17-35-32(38)22-9-11-25-27(15-22)31-26-14-20(8-10-24(26)30(25)40-31)13-23-16-36-33(39-23)21-6-4-3-5-7-21/h3-12,14-16,30-31H,13,17H2,1-2H3,(H2,34,37)(H,35,38)	IWVRXVXCRRVRSB-UHFFFAOYSA-N	306441	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]- 12-[(2-phenyl-1,3-oxazol-4-yl) methyl]-15-oxatetracyclo [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13- hexaene-4-carboxamide and  (+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]-11- [(2-phenyl-1,3-oxazol-4- yl)methyl]-15-oxatetracyclo [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 83	Plasma kallikrein			 2630							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306441	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306441&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131758	381755140							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587937	Cc1cccc(C#N)c1-c1ccc2C3OC(c4cc(ccc34)C(=O)NCc3c(C)cc(N)nc3C)c2c1	InChI=1S/C31H26N4O2/c1-16-5-4-6-21(14-32)28(16)19-7-9-22-24(12-19)30-25-13-20(8-10-23(25)29(22)37-30)31(36)34-15-26-17(2)11-27(33)35-18(26)3/h4-13,29-30H,15H2,1-3H3,(H2,33,35)(H,34,36)	XTZQQZJMJYVCLB-UHFFFAOYSA-N	306442	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]- 12-(2-cyano-6-methylphenyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide and (+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl]methyl]- 11-(2-cyano-6-methylphenyl)- 15-oxatetra-cyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 84	Plasma kallikrein			 178							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306442	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306442&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131762	381755141							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587938	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1ccc(OCC2CC2)nc1	InChI=1S/C32H30N4O3/c1-17-11-28(33)36-18(2)27(17)15-35-32(37)21-6-9-24-26(13-21)31-25-12-20(5-8-23(25)30(24)39-31)22-7-10-29(34-14-22)38-16-19-3-4-19/h5-14,19,30-31H,3-4,15-16H2,1-2H3,(H2,33,36)(H,35,37)	LYDSMBHZQBKBNN-UHFFFAOYSA-N	306443	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]- 12-[(6-(cyclopropylmethoxy) pyridin-3-yl]-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide  (+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 11-[6-(cyclopropylmethoxy) pyridin-3-yl]-15-oxatetra- cyclo[6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene- carboxamide::US10144746, Compound 85	Plasma kallikrein			 263							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306443	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306443&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131773	381755142							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587939	COc1cc(C)c(cn1)-c1ccc2C3OC(c4cc(ccc34)C(=O)NCc3c(C)cc(N)nc3C)c2c1	InChI=1S/C30H28N4O3/c1-15-9-26(31)34-17(3)24(15)13-33-30(35)19-6-8-21-23(12-19)29-22-11-18(5-7-20(22)28(21)37-29)25-14-32-27(36-4)10-16(25)2/h5-12,14,28-29H,13H2,1-4H3,(H2,31,34)(H,33,35)	QYLFICYRACDJLQ-UHFFFAOYSA-N	306444	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]- 12-[(6-methoxy-4-methylpyridin- 3-yl)-15-oxatetracyclo [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13- hexaene-4-carboxamide and (+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 11-(6-methoxy-4- methylpyridin-3-yl)-15-oxatetra- cyclo[6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 86	Plasma kallikrein			 389							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306444	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306444&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131766	381755143							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587940	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1ncccn1	InChI=1S/C27H23N5O2/c1-14-10-23(28)32-15(2)22(14)13-31-27(33)17-5-7-19-21(12-17)25-20-11-16(26-29-8-3-9-30-26)4-6-18(20)24(19)34-25/h3-12,24-25H,13H2,1-2H3,(H2,28,32)(H,31,33)	XCRNDCUTVHEQFA-UHFFFAOYSA-N	306445	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]- 12-(pyrimidin-2-yl)-15-oxatetra- cyclo[6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide and (+-)-N-[(6- amino-2,4-dimethylpyridin- yl)methyl]-11-(pyrimidin-2-yl)- 15-oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 87	Plasma kallikrein			 1585							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306445	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306445&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131764	381755144							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587941	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1ccccc1S(C)(=O)=O	InChI=1S/C30H27N3O4S/c1-16-12-27(31)33-17(2)25(16)15-32-30(34)19-9-11-22-24(14-19)29-23-13-18(8-10-21(23)28(22)37-29)20-6-4-5-7-26(20)38(3,35)36/h4-14,28-29H,15H2,1-3H3,(H2,31,33)(H,32,34)	IUWWZCGHDNMUBD-UHFFFAOYSA-N	306446	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)- methyl]-12-(2- methanesulfonylphenyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide and  (+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl) methyl]-11-(2- methanesulfonylphenyl)-15- oxatetra-cyclo [6.6.1.02,7.09,14]pentadeca- 2,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 88	Plasma kallikrein			 2692							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306446	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306446&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131768	381755145							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587942	CCOc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1ccc(F)cc1F	InChI=1S/C30H25F2N3O3/c1-3-37-26-13-27(33)35-15(2)24(26)14-34-30(36)17-5-8-21-23(11-17)29-22-10-16(4-7-20(22)28(21)38-29)19-9-6-18(31)12-25(19)32/h4-13,28-29H,3,14H2,1-2H3,(H2,33,35)(H,34,36)	OWMJTKXHYMFQTC-UHFFFAOYSA-N	306447	(+-)-N-[(6-amino-4-ethoxy-2- methylpyridin-3-yl)-methyl]- 12-(2,4-difluoropheny]-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide and (+-)-N-[(6-amino-4-ethoxy-2- methylpyridin-3-yl)methyl]-11- (2,4-difluorophenyl)-15- oxaletracyclo-[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 89	Plasma kallikrein			 33.9							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306447	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306447&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131769	381755146							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587943	CCOc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1cccc(F)c1F	InChI=1S/C30H25F2N3O3/c1-3-37-25-13-26(33)35-15(2)23(25)14-34-30(36)17-8-10-20-22(12-17)29-21-11-16(7-9-19(21)28(20)38-29)18-5-4-6-24(31)27(18)32/h4-13,28-29H,3,14H2,1-2H3,(H2,33,35)(H,34,36)	XGVUZMYGIQNMMN-UHFFFAOYSA-N	306448	(+-)-N-[(6-amino-4-ethoxy-2- methylpyridin-3-yl)methyl]-12- (2,3-difluorophenyl)-15-oxatetra- cyclo[6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4 carboxamide and (+-)-N- [(6-amino-4-ethoxy-2- methylpyridin-3-yl)methyl]-11- (2,3-difluorophenyl)-15- oxatetracyclo[6.6.1.02,7.09,14]- pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 90	Plasma kallikrein			 72.4							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306448	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306448&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131770	381755147							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587944	Cc1c2CNCc2cc(F)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1cccc(F)c1F	InChI=1S/C31H23F3N2O2/c1-15-24-13-35-12-18(24)11-27(33)25(15)14-36-31(37)17-6-8-21-23(10-17)30-22-9-16(5-7-20(22)29(21)38-30)19-3-2-4-26(32)28(19)34/h2-11,29-30,35H,12-14H2,1H3,(H,36,37)	DCFGHFXRLBZJRW-UHFFFAOYSA-N	306449	(+-)-12-(2,3-difluorophenyl)- N-[(6-fluoro-4-methyl-2,3- dihydro-1H-isoindol-5-yl)methyl]- 15-oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 91	Plasma kallikrein			 10000							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306449	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306449&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131774	381755148							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587945	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c4cc(Cc5cocn5)ccc34)c2c1	InChI=1S/C27H24N4O3/c1-14-7-24(28)31-15(2)23(14)11-29-27(32)17-4-6-20-22(10-17)26-21-9-16(8-18-12-33-13-30-18)3-5-19(21)25(20)34-26/h3-7,9-10,12-13,25-26H,8,11H2,1-2H3,(H2,28,31)(H,29,32)	XKVDBHPNVDLCFQ-UHFFFAOYSA-N	306450	(+-)-N-[(6-amino)-2,4- dimethylpyridin-3-yl)methyl]-12- [(1,3-oxazol-4-yl]methyl]-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide and (+-)- N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]-11- [(1,3-oxazol-4-yl)methyl]- 15-oxatetracyclo-[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 92	Plasma kallikrein			 155							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306450	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306450&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131775	381755149							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587946	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2[C@H]3O[C@@H](c2c1)c1cc(ccc31)-c1ccc(F)cc1F	InChI=1S/C29H23F2N3O2/c1-14-9-26(32)34-15(2)24(14)13-33-29(35)17-4-7-21-23(11-17)28-22-10-16(3-6-20(22)27(21)36-28)19-8-5-18(30)12-25(19)31/h3-12,27-28H,13H2,1-2H3,(H2,32,34)(H,33,35)/t27-,28+/m0/s1	ULFZKTTWSDEBHE-WUFINQPMSA-N	306451	(1R,8S)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]-12- (2,4-difluoropheny])-15-oxatetra- cyclol[6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 93	Plasma kallikrein			 18.6							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306451	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306451&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131606	381755150							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587947	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2[C@@H]3O[C@H](c2c1)c1cc(ccc31)-c1ccc(F)cc1F	InChI=1S/C29H23F2N3O2/c1-14-9-26(32)34-15(2)24(14)13-33-29(35)17-4-7-21-23(11-17)28-22-10-16(3-6-20(22)27(21)36-28)19-8-5-18(30)12-25(19)31/h3-12,27-28H,13H2,1-2H3,(H2,32,34)(H,33,35)/t27-,28+/m1/s1	ULFZKTTWSDEBHE-IZLXSDGUSA-N	306452	(1S,8R)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]- 12-(2,4-difluorophenyl)-15- oxatetracyclo- [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 94	Plasma kallikrein			 36308							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306452	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306452&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131781	381755151							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587948	Cc1ccc(o1)-c1ccc2C3OC(c4cc(ccc34)C(=O)NCc3c(C)cc(N)nc3C)c2c1	InChI=1S/C28H25N3O3/c1-14-10-25(29)31-16(3)23(14)13-30-28(32)18-6-8-20-22(12-18)27-21-11-17(24-9-4-15(2)33-24)5-7-19(21)26(20)34-27/h4-12,26-27H,13H2,1-3H3,(H2,29,31)(H,30,32)	DCJVFPWTKMBGJX-UHFFFAOYSA-N	306453	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]- 12-(5-methylfuran-2-yl)-15- oxatetra-cyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4- carboxamide and (+-)-N- [(6-amino-2,4-dimethylpyridin-3- yl)methyl]-11-(5-methylfuran-2-yl)- 15-oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 95	Plasma kallikrein			 457							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306453	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306453&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131779	381755152							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587949	Cc1cc(CN)cc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1ccc(F)cc1C#N	InChI=1S/C32H26FN3O2/c1-17-9-19(14-34)10-18(2)29(17)16-36-32(37)21-4-7-26-28(13-21)31-27-12-20(3-6-25(27)30(26)38-31)24-8-5-23(33)11-22(24)15-35/h3-13,30-31H,14,16,34H2,1-2H3,(H,36,37)	OXXGIFFIGXOATJ-UHFFFAOYSA-N	306454	(+-)-N-{[4-(aminomethyl)-2,6- dimethylphenyl]-methyl}-12- (2-cyano-4-fluorophenyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide and  (+-)-N-{[4-(aminomethyl)-2,6- dimethylphenyl]methyl}-11- (2-cyano-4-fluorophenyl)-15- oxatetracyclo-[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 96	Plasma kallikrein			 309							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306454	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306454&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131782	381755153							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587950	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c4cc(ccc34)N3CC4(COC4)C3)c2c1	InChI=1S/C28H28N4O3/c1-15-7-24(29)31-16(2)23(15)10-30-27(33)17-3-5-19-21(8-17)26-22-9-18(4-6-20(22)25(19)35-26)32-11-28(12-32)13-34-14-28/h3-9,25-26H,10-14H2,1-2H3,(H2,29,31)(H,30,33)	GSBHSQRFVNIHMK-UHFFFAOYSA-N	306455	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]- 12-{2-oxa-6-azaspiro[3.3]heptan- 6-yl}-15-oxatetracyclo [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide and (+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 11-{2-oxa-6-azaspiro[3.3]heptan- 6-yl}-15-oxatetracyclo [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13- hexaene-4-carboxanide::US10144746, Compound 97	Plasma kallikrein			 2239							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306455	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306455&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131784	381755154							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587951	Cc1c2CNCc2cc(F)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1ccc(F)cc1F	InChI=1S/C31H23F3N2O2/c1-15-25-13-35-12-18(25)10-27(33)26(15)14-36-31(37)17-3-6-22-24(9-17)30-23-8-16(2-5-21(23)29(22)38-30)20-7-4-19(32)11-28(20)34/h2-11,29-30,35H,12-14H2,1H3,(H,36,37)	SQCMOULPSRKTCF-UHFFFAOYSA-N	306456	(+-)-12-(2,4-difluorophenyl)-N- [(6-fluoro-4-methyl-2,3- dihydro-1H-isoindol-5-yl)methyl]- 15-oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 98	Plasma kallikrein			 102							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306456	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306456&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131786	381755155							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587952	Cc1cc2CNCc2c(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1ccc(F)cc1F	InChI=1S/C32H26F2N2O2/c1-16-9-20-13-35-14-28(20)17(2)27(16)15-36-32(37)19-4-7-24-26(11-19)31-25-10-18(3-6-23(25)30(24)38-31)22-8-5-21(33)12-29(22)34/h3-12,30-31,35H,13-15H2,1-2H3,(H,36,37)	XFHAFXAWRHFKJR-UHFFFAOYSA-N	306457	(+-)-12-(2.4-difluorophenyl)- N-[(4,6-dimethyl-2,3-dihydro- 1H-isoindol-5-yl)methyl]-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 99	Plasma kallikrein			 316							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306457	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306457&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131791	381755156							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587953	Cc1cc2CNCc2c(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1cccc(F)c1F	InChI=1S/C32H26F2N2O2/c1-16-10-20-13-35-14-27(20)17(2)26(16)15-36-32(37)19-7-9-23-25(12-19)31-24-11-18(6-8-22(24)30(23)38-31)21-4-3-5-28(33)29(21)34/h3-12,30-31,35H,13-15H2,1-2H3,(H,36,37)	XFMMZFIGFSCODG-UHFFFAOYSA-N	306458	(+-)-12-(2,3-difluorophenyl)- N-[(4,6-dimethyl-2,3-dihydro- 1H-isoindol-5-yl)methyl]-15- oxatetra-cyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 100	Plasma kallikrein			 6166							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306458	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306458&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135215170	381755157							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587954	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c4cc(ccc34)N3CCOCC3=O)c2c1	InChI=1S/C27H26N4O4/c1-14-9-23(28)30-15(2)22(14)12-29-27(33)16-3-5-18-20(10-16)26-21-11-17(4-6-19(21)25(18)35-26)31-7-8-34-13-24(31)32/h3-6,9-11,25-26H,7-8,12-13H2,1-2H3,(H2,28,30)(H,29,33)	LKPTUQXZIXBCID-UHFFFAOYSA-N	306459	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]- 12-(3-oxomorpholin-4-yl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide and  (+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 11-(3-oxomorpholin-4-yl)-15- oxatetracyclo-[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 101	Plasma kallikrein			 1585							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306459	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306459&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131787	381755158							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587955	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1ccc(cc1F)C(F)(F)F	InChI=1S/C30H23F4N3O2/c1-14-9-26(35)37-15(2)24(14)13-36-29(38)17-4-7-21-23(11-17)28-22-10-16(3-6-20(22)27(21)39-28)19-8-5-18(12-25(19)31)30(32,33)34/h3-12,27-28H,13H2,1-2H3,(H2,35,37)(H,36,38)	WQELMFWRQMYKFA-UHFFFAOYSA-N	306460	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 12-[2-fluoro-4-(trifluoromethyl)- phenyl]-15-oxatetracyclo [6.6.1.02,7.09,14]-pentadeca- 2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 102	Plasma kallikrein			 537							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306460	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306460&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131788	381755159							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587956	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1ccc(Cl)cc1C#N	InChI=1S/C30H23ClN4O2/c1-15-9-27(33)35-16(2)26(15)14-34-30(36)18-4-7-23-25(12-18)29-24-11-17(3-6-22(24)28(23)37-29)21-8-5-20(31)10-19(21)13-32/h3-12,28-29H,14H2,1-2H3,(H2,33,35)(H,34,36)	IZTZNFYCAUXHCR-UHFFFAOYSA-N	306461	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]- 12-(4-chloro-2-cyanophenyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 103	Plasma kallikrein			 8.91							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306461	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306461&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131793	381755160							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587957	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1ccc(F)c(F)c1F	InChI=1S/C29H22F3N3O2/c1-13-9-24(33)35-14(2)22(13)12-34-29(36)16-4-6-19-21(11-16)28-20-10-15(3-5-18(20)27(19)37-28)17-7-8-23(30)26(32)25(17)31/h3-11,27-28H,12H2,1-2H3,(H2,33,35)(H,34,36)	UJKMEDAFEFKAPX-UHFFFAOYSA-N	306462	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]- 12-(2,3,4-trifluorophenyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 104	Plasma kallikrein			 28.2							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306462	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306462&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131789	381755161							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587958	COc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1ccc(C)cc1C#N	InChI=1S/C31H26N4O3/c1-16-4-7-21(20(10-16)14-32)18-5-8-22-24(11-18)30-25-12-19(6-9-23(25)29(22)38-30)31(36)34-15-26-17(2)35-28(33)13-27(26)37-3/h4-13,29-30H,15H2,1-3H3,(H2,33,35)(H,34,36)	MRBTZQUTMGWMMI-UHFFFAOYSA-N	306463	(+-)-N-[(6-amino-4-methoxy- 2-methylpyridin-3-yl)methyl]- 12-(2-cyano-4-methylphenyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 105	Plasma kallikrein			 15.1							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306463	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306463&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131790	381755162							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587959	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1ccc(Cl)c(F)c1F	InChI=1S/C29H22ClF2N3O2/c1-13-9-24(33)35-14(2)22(13)12-34-29(36)16-4-6-19-21(11-16)28-20-10-15(3-5-18(20)27(19)37-28)17-7-8-23(30)26(32)25(17)31/h3-11,27-28H,12H2,1-2H3,(H2,33,35)(H,34,36)	GRSQCQRMJHEUMY-UHFFFAOYSA-N	306464	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]- 12-(4-chloro-2,3-difluorophenyl)- 15-oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 106	Plasma kallikrein			 22.9							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306464	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306464&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131796	381755163							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587960	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1nccs1	InChI=1S/C26H22N4O2S/c1-13-9-22(27)30-14(2)21(13)12-29-25(31)15-3-5-17-19(10-15)24-20-11-16(26-28-7-8-33-26)4-6-18(20)23(17)32-24/h3-11,23-24H,12H2,1-2H3,(H2,27,30)(H,29,31)	CBIVIIDJLFVPKK-UHFFFAOYSA-N	306465	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]- 12-(1,3-thiazol-2-yl)-15-oxatetra- cyclo[6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide  and (+-)-N-[(6-amino- 2,4-dimethylpyridin-3-yl)methyl]- 11-(1,3-thiazol-2-yl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 107	Plasma kallikrein			 741							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306465	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306465&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131795	381755164							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587961	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1ccc(F)c2OCOc12	InChI=1S/C30H24FN3O4/c1-14-9-25(32)34-15(2)23(14)12-33-30(35)17-4-6-20-22(11-17)27-21-10-16(3-5-19(21)26(20)38-27)18-7-8-24(31)29-28(18)36-13-37-29/h3-11,26-27H,12-13H2,1-2H3,(H2,32,34)(H,33,35)	WQRPFEGSVFCIKP-UHFFFAOYSA-N	306466	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]- 12-(7-fluoro-2H-1,3-benzodioxol- 4-yl)-15-oxatetracyclo [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 108	Plasma kallikrein			 25.7							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306466	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306466&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131798	381755165							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587962	COc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1ccc(Cl)c(F)c1F	InChI=1S/C29H22ClF2N3O3/c1-13-21(23(37-2)11-24(33)35-13)12-34-29(36)15-4-6-18-20(10-15)28-19-9-14(3-5-17(19)27(18)38-28)16-7-8-22(30)26(32)25(16)31/h3-11,27-28H,12H2,1-2H3,(H2,33,35)(H,34,36)	QRHYTBWDMJULJQ-UHFFFAOYSA-N	306467	(+-)-N-[(6-amino-4-methoxy- 2-methylpyridin-3-yl)methyl]- 12-(4-chloro-2,3-difluoropheny])- 15-oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 109	Plasma kallikrein			 25.7							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306467	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306467&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131794	381755166							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587963	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1ncccc1F	InChI=1S/C28H23FN4O2/c1-14-10-24(30)33-15(2)22(14)13-32-28(34)17-6-8-19-21(12-17)27-20-11-16(5-7-18(20)26(19)35-27)25-23(29)4-3-9-31-25/h3-12,26-27H,13H2,1-2H3,(H2,30,33)(H,32,34)	NQBFFYCRPPXZRU-UHFFFAOYSA-N	306468	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]- 12-(3-fluoropyridin-2-yl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 110	Plasma kallikrein			 162							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306468	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306468&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131799	381755167							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587964	CCOc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1c(C)cccc1F	InChI=1S/C31H28FN3O3/c1-4-37-26-14-27(33)35-17(3)24(26)15-34-31(36)19-9-11-21-23(13-19)30-22-12-18(8-10-20(22)29(21)38-30)28-16(2)6-5-7-25(28)32/h5-14,29-30H,4,15H2,1-3H3,(H2,33,35)(H,34,36)	DITTWLRCGZKKTG-UHFFFAOYSA-N	306469	(+-)-N-[(6-amino-4-ethoxy- 2-methylpyridin-3-yl)-methyl]- 12-(2-fluoro-6-methylphenyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 111	Plasma kallikrein			 123							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306469	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306469&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131800	381755168							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587965	Cc1cccc(F)c1-c1ccc2C3OC(c4cc(ccc34)C(=O)NCc3c(C)cc(N)nc3C)c2c1	InChI=1S/C30H26FN3O2/c1-15-5-4-6-25(31)27(15)18-7-9-20-22(12-18)29-23-13-19(8-10-21(23)28(20)36-29)30(35)33-14-24-16(2)11-26(32)34-17(24)3/h4-13,28-29H,14H2,1-3H3,(H2,32,34)(H,33,35)	KIYCBRYFAYUAJF-UHFFFAOYSA-N	306470	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]- 12-(2-fluoro-6-methylphenyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 112	Plasma kallikrein			 151							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306470	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306470&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131801	381755169							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587966	COc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1c(C)cccc1F	InChI=1S/C30H26FN3O3/c1-15-5-4-6-24(31)27(15)17-7-9-19-21(11-17)29-22-12-18(8-10-20(22)28(19)37-29)30(35)33-14-23-16(2)34-26(32)13-25(23)36-3/h4-13,28-29H,14H2,1-3H3,(H2,32,34)(H,33,35)	JKJYTJQZESMNBM-UHFFFAOYSA-N	306471	(+-)-N-[(6-amino-4-methoxy- 2-methylpyridin-3-yl)methyl]- 12-(2-fluoro-6-methylphenyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 113	Plasma kallikrein			 129							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306471	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306471&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131803	381755170							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587967	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c4cc(Oc5ccccc5C#N)ccc34)c2c1	InChI=1S/C30H24N4O3/c1-16-11-27(32)34-17(2)25(16)15-33-30(35)18-7-9-21-23(12-18)29-24-13-20(8-10-22(24)28(21)37-29)36-26-6-4-3-5-19(26)14-31/h3-13,28-29H,15H2,1-2H3,(H2,32,34)(H,33,35)	OSQNBVOJLIWPIL-UHFFFAOYSA-N	306472	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]- 12-(2-cyanophenoxy)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4- carboxamide::US10144746, Compound 114	Plasma kallikrein			 575							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306472	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306472&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131802	381755171							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587968	CN1C2c3ccc(cc3C1c1cc(ccc21)-c1ccc(F)cc1F)C(=O)NCc1c(C)cc(N)nc1C	InChI=1S/C30H26F2N4O/c1-15-10-27(33)35-16(2)25(15)14-34-30(37)18-5-8-22-24(12-18)29-23-11-17(4-7-21(23)28(22)36(29)3)20-9-6-19(31)13-26(20)32/h4-13,28-29H,14H2,1-3H3,(H2,33,35)(H,34,37)	JXCCZFMXEPLTDZ-UHFFFAOYSA-N	306473	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]- 12-(2,4-difluorophenyl)-15- methyl-15-azatetracyclo [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13- hexaene-4-carboxamide and (+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 11-(2,4-difluorophenyl)-15- methyl-15-azatetra-cyclo [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 115	Plasma kallikrein			 100000							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306473	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306473&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131804	381755172							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587969	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1ncc(F)cc1F	InChI=1S/C28H22F2N4O2/c1-13-7-24(31)34-14(2)22(13)12-33-28(35)16-4-6-19-21(9-16)27-20-8-15(3-5-18(20)26(19)36-27)25-23(30)10-17(29)11-32-25/h3-11,26-27H,12H2,1-2H3,(H2,31,34)(H,33,35)	YSEHKGYQUCYKDX-UHFFFAOYSA-N	306474	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]- 12-(3,5-difluoropyridin-2-yl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 116	Plasma kallikrein			 45.7							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306474	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306474&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131806	381755173							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587970	COc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c4cc(Cn5cccn5)ccc34)c2c1	InChI=1S/C27H25N5O3/c1-15-22(23(34-2)12-24(28)31-15)13-29-27(33)17-5-7-19-21(11-17)26-20-10-16(14-32-9-3-8-30-32)4-6-18(20)25(19)35-26/h3-12,25-26H,13-14H2,1-2H3,(H2,28,31)(H,29,33)	WBWIEECQYBCZOF-UHFFFAOYSA-N	306475	(+-)-N-[(6-amino-4-methoxy- 2-methylpyridin-3-yl)methyl]- 12-[(1H-pyrazol-1-yl)methyl]-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 117	Plasma kallikrein			 3.98							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306475	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306475&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131813	381755174							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587971	Cc1ccc(c(F)c1F)-c1ccc2C3OC(c4cc(ccc34)C(=O)NCc3c(C)cc(N)nc3C)c2c1	InChI=1S/C30H25F2N3O2/c1-14-4-7-19(27(32)26(14)31)17-5-8-20-22(11-17)29-23-12-18(6-9-21(23)28(20)37-29)30(36)34-13-24-15(2)10-25(33)35-16(24)3/h4-12,28-29H,13H2,1-3H3,(H2,33,35)(H,34,36)	CBWKKOGZYQEUEG-UHFFFAOYSA-N	306476	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]- 12-(2,3-difluoro-4- methylphenyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 118	Plasma kallikrein			 64.6							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306476	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306476&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131807	381755175							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587972	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1ccc(c(F)c1F)C(F)(F)F	InChI=1S/C30H22F5N3O2/c1-13-9-24(36)38-14(2)22(13)12-37-29(39)16-4-6-19-21(11-16)28-20-10-15(3-5-18(20)27(19)40-28)17-7-8-23(30(33,34)35)26(32)25(17)31/h3-11,27-28H,12H2,1-2H3,(H2,36,38)(H,37,39)	MKWJNZZKOGKFRH-UHFFFAOYSA-N	306477	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]- 12-[2,3-difluoro-4- (trifluoromethyl)-phenyl]-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 119	Plasma kallikrein			 427							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306477	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306477&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131808	381755176							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587973	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c4cc(Oc5ccc(F)cc5F)ccc34)c2c1	InChI=1S/C29H23F2N3O3/c1-14-9-26(32)34-15(2)23(14)13-33-29(35)16-3-6-19-21(10-16)28-22-12-18(5-7-20(22)27(19)37-28)36-25-8-4-17(30)11-24(25)31/h3-12,27-28H,13H2,1-2H3,(H2,32,34)(H,33,35)	IXTPLLAHETUGDH-UHFFFAOYSA-N	306478	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]- 12-(2,4-difluorophenoxy)-15- oxatetra-cyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 120	Plasma kallikrein			 676							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306478	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306478&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131809	381755177							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587974	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1ccc(F)c(c1)C(F)(F)F	InChI=1S/C30H23F4N3O2/c1-14-9-26(35)37-15(2)23(14)13-36-29(38)18-4-7-20-22(11-18)28-21-10-16(3-6-19(21)27(20)39-28)17-5-8-25(31)24(12-17)30(32,33)34/h3-12,27-28H,13H2,1-2H3,(H2,35,37)(H,36,38)	IPDRWCSRZZELEX-UHFFFAOYSA-N	306479	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]- 12-[4-fluoro-3-(trifluoromethyl) phenyl]-15-oxatetracyclo [6.6.1.02,7.09,14]pentdeca- 2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 121	Plasma kallikrein			 437							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306479	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306479&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131810	381755178							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587975	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c4cc(Oc5ccc(F)c(F)c5)ccc34)c2c1	InChI=1S/C29H23F2N3O3/c1-14-9-26(32)34-15(2)23(14)13-33-29(35)16-3-6-19-21(10-16)28-22-11-17(4-7-20(22)27(19)37-28)36-18-5-8-24(30)25(31)12-18/h3-12,27-28H,13H2,1-2H3,(H2,32,34)(H,33,35)	QNXPDQPIBVXEGL-UHFFFAOYSA-N	306480	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]- 12-(3,4-difluorophenoxy)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 122	Plasma kallikrein			 148							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306480	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306480&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131811	381755179							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587976	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1ccc2[nH]cnc2c1			306481	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]- 12-(1H-1,3-benzodiazol-5-yl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 123	Plasma kallikrein			 282							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306481	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306481&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131812	381755180							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587977	Cc1cc2CNCc2c(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1c(C)cccc1F	InChI=1S/C33H29FN2O2/c1-17-5-4-6-29(34)30(17)20-7-9-23-25(12-20)32-26-13-21(8-10-24(26)31(23)38-32)33(37)36-16-27-18(2)11-22-14-35-15-28(22)19(27)3/h4-13,31-32,35H,14-16H2,1-3H3,(H,36,37)	UXCYGNWBGDOBQP-UHFFFAOYSA-N	306482	(+-)-N-[(4,6-dimethyl-2,3-dihydro- 1H-isoindol-5-yl)methyl]- 12-(2-fluoro-6-methylphenyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 124	Plasma kallikrein			 11482							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306482	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306482&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131814	381755181							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587978	Cc1cc(CN)cc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1ccc(Cl)c(F)c1F	InChI=1S/C31H25ClF2N2O2/c1-15-9-17(13-35)10-16(2)25(15)14-36-31(37)19-4-6-22-24(12-19)30-23-11-18(3-5-21(23)29(22)38-30)20-7-8-26(32)28(34)27(20)33/h3-12,29-30H,13-14,35H2,1-2H3,(H,36,37)	WZCBRAFEBNNIEX-UHFFFAOYSA-N	306483	(+-)-N-{[4-(aminomethy])-2,6- dimethylphenyl]-methyl}-12- (4-chloro-2,3-difluorophenyl)-15- oxatetracyclo- [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 125	Plasma kallikrein			 661							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306483	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306483&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131815	381755182							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587979	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1ccccc1C#C	InChI=1S/C31H25N3O2/c1-4-19-7-5-6-8-22(19)20-9-11-23-25(14-20)30-26-15-21(10-12-24(26)29(23)36-30)31(35)33-16-27-17(2)13-28(32)34-18(27)3/h1,5-15,29-30H,16H2,2-3H3,(H2,32,34)(H,33,35)	QPWXUXQZXKVSDT-UHFFFAOYSA-N	306484	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]- 12-(2-ethynylphenyl)-15-oxatetra- cyclo[6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 126	Plasma kallikrein			 6310							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306484	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306484&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131816	381755183							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587980	COc1ccc(c(CNC(=O)c2ccc3C4OC(c3c2)c2cc(ccc42)-c2ccc(F)cc2F)c1)-n1cnnn1	InChI=1S/C30H21F2N5O3/c1-39-20-5-9-27(37-15-34-35-36-37)18(10-20)14-33-30(38)17-3-7-23-25(12-17)29-24-11-16(2-6-22(24)28(23)40-29)21-8-4-19(31)13-26(21)32/h2-13,15,28-29H,14H2,1H3,(H,33,38)	OHPASXPZMZKDSU-UHFFFAOYSA-N	306485	(+-)-12-(2,4-difluorophenyl)- N-{[5-methoxy-2-(1H-1,2,3,4- tetrazol-1-yl)phenyl]methyl}-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 127	Plasma kallikrein			 977							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306485	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306485&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131817	381755184							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587981	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1cccc(c1)S(C)(=O)=O	InChI=1S/C30H27N3O4S/c1-16-11-27(31)33-17(2)26(16)15-32-30(34)20-8-10-23-25(14-20)29-24-13-19(7-9-22(24)28(23)37-29)18-5-4-6-21(12-18)38(3,35)36/h4-14,28-29H,15H2,1-3H3,(H2,31,33)(H,32,34)	RZVXNSMZXGZCOL-UHFFFAOYSA-N	306486	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]- 12-(3-methanesulfonylphenyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13 hexaene-4-carboxamide::US10144746, Compound 128	Plasma kallikrein			 933							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306486	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306486&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131818	381755185							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587982	COc1ccc(c(CNC(=O)c2ccc3C4OC(c3c2)c2cc(ccc42)-c2ccc(F)cc2F)c1F)-n1cnnn1	InChI=1S/C30H20F3N5O3/c1-40-26-9-8-25(38-14-35-36-37-38)23(27(26)33)13-34-30(39)16-3-6-20-22(11-16)29-21-10-15(2-5-19(21)28(20)41-29)18-7-4-17(31)12-24(18)32/h2-12,14,28-29H,13H2,1H3,(H,34,39)	IKJCWTPPEKUQEV-UHFFFAOYSA-N	306487	(+-)-12-(2,4-difluorophenyl)-N- {[2-fluoro-3-methoxy-6-(1H- 1,2,3,4-tetrazol-1-yl)phenyl]- methyl}-15-oxatetracyclo [6.6.1.02,7.09,14]-pentadeca- 2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 129	Plasma kallikrein			 234							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306487	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306487&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131819	381755186							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587983	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2[C@H]3O[C@H](c4ccc(cc34)-c3ccccc3F)c2c1	InChI=1S/C29H24FN3O2/c1-15-11-26(31)33-16(2)24(15)14-32-29(34)18-8-10-21-23(13-18)28-20-9-7-17(12-22(20)27(21)35-28)19-5-3-4-6-25(19)30/h3-13,27-28H,14H2,1-2H3,(H2,31,33)(H,32,34)/t27-,28-/m1/s1	JQHWYZYKBOENHA-VSGBNLITSA-N	306488	(1R,8R)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]-11- (2-fluorophenyl)-15-oxatetracyclo- [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 130	Plasma kallikrein			 195							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306488	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306488&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131820	381755187							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587984	Cc1cc2CNCc2c(Cl)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1ccc(F)cc1F	InChI=1S/C31H23ClF2N2O2/c1-15-8-18-12-35-13-26(18)28(32)25(15)14-36-31(37)17-3-6-22-24(10-17)30-23-9-16(2-5-21(23)29(22)38-30)20-7-4-19(33)11-27(20)34/h2-11,29-30,35H,12-14H2,1H3,(H,36,37)	XUJRNJHVQOMRJB-UHFFFAOYSA-N	306489	(+-)-N[(4-chloro-6-methyl-2,3- dihydro-1H-isoindol-5- yl)methyl]-12-(2,4- difluoropheny])- 15-oxatetracyclo [6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 131	Plasma kallikrein			 7413							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306489	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306489&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131822	381755188							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587985	COc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c4cc(Cn5cc(C)cn5)ccc34)c2c1	InChI=1S/C28H27N5O3/c1-15-11-31-33(13-15)14-17-4-6-19-21(8-17)27-22-9-18(5-7-20(22)26(19)36-27)28(34)30-12-23-16(2)32-25(29)10-24(23)35-3/h4-11,13,26-27H,12,14H2,1-3H3,(H2,29,32)(H,30,34)	VGSWGVNTDAOLTK-UHFFFAOYSA-N	306490	(+-)-N-[(6-amino-4-methoxy-2- methylpyridin-3-yl)methyl]- 12-[(4-methyl-1H-pyrazol-1-yl)- methyl]-15- oxatetracyclo[6.6.1.02,7.09,14]- pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 132	Plasma kallikrein			 2.00							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306490	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306490&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131821	381755189							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587986	CCOc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c4cc(Cn5cccn5)ccc34)c2c1	InChI=1S/C28H27N5O3/c1-3-35-24-13-25(29)32-16(2)23(24)14-30-28(34)18-6-8-20-22(12-18)27-21-11-17(15-33-10-4-9-31-33)5-7-19(21)26(20)36-27/h4-13,26-27H,3,14-15H2,1-2H3,(H2,29,32)(H,30,34)	LVPGNNWUINXCRI-UHFFFAOYSA-N	306491	(+-)-N-[(6-amino-4-ethoxy-2- methylpyridin-3-yl)methyl]-12- [(1H-pyrazol-1-yl)methyl]-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 133	Plasma kallikrein			 11.0							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306491	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306491&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131823	381755190							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587987	CCOc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c4cc(Cn5cc(C)cn5)ccc34)c2c1	InChI=1S/C29H29N5O3/c1-4-36-25-11-26(30)33-17(3)24(25)13-31-29(35)19-6-8-21-23(10-19)28-22-9-18(5-7-20(22)27(21)37-28)15-34-14-16(2)12-32-34/h5-12,14,27-28H,4,13,15H2,1-3H3,(H2,30,33)(H,31,35)	HRNXFTSJGMRXGL-UHFFFAOYSA-N	306492	(+-)-N-[(6-amino-4-ethoxy-2- methylpyridin-3-yl)methyl]-12- [(4-methyl-1H-pyrazol- 1-yl)methyl]- 15-oxatetracyclo[6.6.1.02,7.09,14]- pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 134	Plasma kallikrein			 2.00							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306492	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306492&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131824	381755191							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587988	CCc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1ccc(F)cc1F	InChI=1S/C30H25F2N3O2/c1-3-16-12-27(33)35-15(2)25(16)14-34-30(36)18-5-8-22-24(11-18)29-23-10-17(4-7-21(23)28(22)37-29)20-9-6-19(31)13-26(20)32/h4-13,28-29H,3,14H2,1-2H3,(H2,33,35)(H,34,36)	NWHDVGYTIOZBKM-UHFFFAOYSA-N	306493	(+-)-N-[(6-amino-4-ethyl-2- methylpyridin-3-yl)methyl]-12- (2,4-difluorophenyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 135	Plasma kallikrein			 19.5							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306493	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306493&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131825	381755192							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587989	CCc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1ccc(C)cc1C#N	InChI=1S/C32H28N4O2/c1-4-19-14-29(34)36-18(3)28(19)16-35-32(37)21-7-10-25-27(13-21)31-26-12-20(6-9-24(26)30(25)38-31)23-8-5-17(2)11-22(23)15-33/h5-14,30-31H,4,16H2,1-3H3,(H2,34,36)(H,35,37)	WWQQLOVTRXFOTE-UHFFFAOYSA-N	306494	(+-)-N-[(6-amino-4-ethyl-2- methylpyridin-3-yl)methyl]-12- (2-cyano-4-methylphenyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 136	Plasma kallikrein			 3.98							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306494	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306494&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131826	381755193							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587990	Cc1ccc(-c2ccc3C4OC(c5cc(ccc45)C(=O)NCc4c(C)cc5CNCc5c4C)c3c2)c(c1)C#N	InChI=1S/C34H29N3O2/c1-18-4-7-25(23(10-18)14-35)21-5-8-26-28(12-21)33-29-13-22(6-9-27(29)32(26)39-33)34(38)37-17-30-19(2)11-24-15-36-16-31(24)20(30)3/h4-13,32-33,36H,15-17H2,1-3H3,(H,37,38)	KOJDQUKAZNSNSE-UHFFFAOYSA-N	306495	(+-)-12-(2-cyano-4-methylphenyl)- N-[(4,6-dimethyl-2,3- dihydro-1H-isoindol-5-yl) methyl]-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 137	Plasma kallikrein			 437							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306495	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306495&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131827	381755194							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587991	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2[C@H]3O[C@@H](c2c1)c1cc(ccc31)-c1ccc(F)c(F)c1F	InChI=1S/C29H22F3N3O2/c1-13-9-24(33)35-14(2)22(13)12-34-29(36)16-4-6-19-21(11-16)28-20-10-15(3-5-18(20)27(19)37-28)17-7-8-23(30)26(32)25(17)31/h3-11,27-28H,12H2,1-2H3,(H2,33,35)(H,34,36)/t27-,28+/m0/s1	UJKMEDAFEFKAPX-WUFINQPMSA-N	306496	(1R,8S)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]-12- (2,3,4-trifluorophenyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 138	Plasma kallikrein			 24.0							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306496	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306496&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131828	381755195							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587992	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2[C@H]3O[C@@H](c2c1)c1cc(ccc31)-c1ccc(Cl)cc1C#N	InChI=1S/C30H23ClN4O2/c1-15-9-27(33)35-16(2)26(15)14-34-30(36)18-4-7-23-25(12-18)29-24-11-17(3-6-22(24)28(23)37-29)21-8-5-20(31)10-19(21)13-32/h3-12,28-29H,14H2,1-2H3,(H2,33,35)(H,34,36)/t28-,29+/m0/s1	IZTZNFYCAUXHCR-URLMMPGGSA-N	306497	(1R,8S)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]-12- (4-chloro-2-cyanophenyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 139	Plasma kallikrein			 3.02							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306497	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306497&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131829	381755196							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587993	Cc1ccc(-c2ccc3[C@@H]4O[C@@H](c5cc(ccc45)C(=O)NCc4c(C)cc(N)nc4C)c3c2)c(c1)C#N	InChI=1S/C31H26N4O2/c1-16-4-7-22(21(10-16)14-32)19-5-8-23-25(12-19)30-26-13-20(6-9-24(26)29(23)37-30)31(36)34-15-27-17(2)11-28(33)35-18(27)3/h4-13,29-30H,15H2,1-3H3,(H2,33,35)(H,34,36)/t29-,30+/m0/s1	ZGFSEWSLLZZKLC-XZWHSSHBSA-N	306498	(1R,8S)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]-12- (2-cyano-4-methylphenyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 140	Plasma kallikrein			 5.01							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306498	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306498&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131830	381755197							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587994	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1c(C)cc(F)cc1F	InChI=1S/C30H25F2N3O2/c1-14-9-26(33)35-16(3)24(14)13-34-30(36)18-5-7-21-23(11-18)29-22-10-17(4-6-20(22)28(21)37-29)27-15(2)8-19(31)12-25(27)32/h4-12,28-29H,13H2,1-3H3,(H2,33,35)(H,34,36)	HGTYBUXPRGCKPZ-UHFFFAOYSA-N	306499	(+-)-N-[(6-amino-2,4- dimethlpyridin-3-yl)-methyl]- 12-(2,4-difluoro-6-methylphenyl)- 15-oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 141	Plasma kallikrein			 105							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306499	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306499&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131831	381755198							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587995	CCc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1c(C)cc(F)cc1F	InChI=1S/C31H27F2N3O2/c1-4-17-12-27(34)36-16(3)25(17)14-35-31(37)19-6-8-22-24(11-19)30-23-10-18(5-7-21(23)29(22)38-30)28-15(2)9-20(32)13-26(28)33/h5-13,29-30H,4,14H2,1-3H3,(H2,34,36)(H,35,37)	ZTKCXWWCVZLDQN-UHFFFAOYSA-N	306500	(+-)-N-[(6-amino-4-ethyl-2- methylpyridin-3-yl)-methyl]-12- (2,4-difluoro-6-methylphenyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 142	Plasma kallikrein			 1622							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306500	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306500&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131832	381755199							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587996	Cc1ccc(-c2ccc3C4OC(c5cc(ccc45)C(=O)NCc4c(F)cc5CNCc5c4C)c3c2)c(c1)C#N	InChI=1S/C33H26FN3O2/c1-17-3-6-23(21(9-17)13-35)19-4-7-24-26(10-19)32-27-11-20(5-8-25(27)31(24)39-32)33(38)37-16-29-18(2)28-15-36-14-22(28)12-30(29)34/h3-12,31-32,36H,14-16H2,1-2H3,(H,37,38)	WWEHZXPFTCNJMW-UHFFFAOYSA-N	306501	(+-)-12-(2-cyano-4-methylphenyl)- N-[(6-fluoro-4-methyl- 2,3-dihydro-1H-isoindol-5-yl) methyl]-15-oxatetracyclo [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 143	Plasma kallikrein			 288							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306501	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306501&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131833	381755200							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587997	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c4cc(Oc5cccnc5)ccc34)c2c1	InChI=1S/C28H24N4O3/c1-15-10-25(29)32-16(2)24(15)14-31-28(33)17-5-7-20-22(11-17)27-23-12-18(6-8-21(23)26(20)35-27)34-19-4-3-9-30-13-19/h3-13,26-27H,14H2,1-2H3,(H2,29,32)(H,31,33)	ICSSTDSAHQWYSU-UHFFFAOYSA-N	306502	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 12-(pyridin-3-yloxy)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 144	Plasma kallikrein			 6310							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306502	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306502&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131834	381755201							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587998	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2[C@H]3O[C@@H](c2c1)c1cc(ccc31)-c1ccc(Cl)c(F)c1F	InChI=1S/C29H22ClF2N3O2/c1-13-9-24(33)35-14(2)22(13)12-34-29(36)16-4-6-19-21(11-16)28-20-10-15(3-5-18(20)27(19)37-28)17-7-8-23(30)26(32)25(17)31/h3-11,27-28H,12H2,1-2H3,(H2,33,35)(H,34,36)/t27-,28+/m0/s1	GRSQCQRMJHEUMY-WUFINQPMSA-N	306503	(1R,8S)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]-12- (4-chloro-2,3-difluoropheny])- 15-oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 145	Plasma kallikrein			 17.4							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306503	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306503&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131836	381755202							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
587999	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1c(F)cc(F)cc1Cl	InChI=1S/C29H22ClF2N3O2/c1-13-7-25(33)35-14(2)22(13)12-34-29(36)16-4-6-19-21(9-16)28-20-8-15(3-5-18(20)27(19)37-28)26-23(30)10-17(31)11-24(26)32/h3-11,27-28H,12H2,1-2H3,(H2,33,35)(H,34,36)	CRJDVRNHGXAYMG-UHFFFAOYSA-N	306504	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]- 12-(2-chloro-4,6-difluorophenyl)- 15-oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 146	Plasma kallikrein			 148							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306504	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306504&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131835	381755203							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588000	Cc1cc(CN)cc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1ccc(F)cc1F	InChI=1S/C31H26F2N2O2/c1-16-9-18(14-34)10-17(2)27(16)15-35-31(36)20-4-7-24-26(12-20)30-25-11-19(3-6-23(25)29(24)37-30)22-8-5-21(32)13-28(22)33/h3-13,29-30H,14-15,34H2,1-2H3,(H,35,36)	WXQRDZKYSCJFMN-UHFFFAOYSA-N	306505	(+-)-N-{[4-(aminomethyl)-2,6- dimethylphenyl]-methyl}-12- (2,4-difluorophenyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 147	Plasma kallikrein			 372							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306505	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306505&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131837	381755204							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588001	Nc1nccc2c(CNC(=O)c3ccc4C5OC(c4c3)c3cc(ccc53)-c3ccc(F)cc3F)cccc12	InChI=1S/C31H21F2N3O2/c32-19-6-9-21(27(33)14-19)16-4-7-22-25(12-16)29-26-13-17(5-8-23(26)28(22)38-29)31(37)36-15-18-2-1-3-24-20(18)10-11-35-30(24)34/h1-14,28-29H,15H2,(H2,34,35)(H,36,37)	BWQAHIZWTXMOIQ-UHFFFAOYSA-N	306506	(+-)-N-[(1-aminoisoquinolin-5-yl) methyl]-12-(2,4- difluorophenyl)-15-oxatetracyclo [6.6.1.02,7.09,14]-pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 148	Plasma kallikrein			 85.1							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306506	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306506&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131838	381755205							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588002	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-n1ccc(=O)cc1	InChI=1S/C28H24N4O3/c1-15-11-25(29)31-16(2)24(15)14-30-28(34)17-3-5-20-22(12-17)27-23-13-18(4-6-21(23)26(20)35-27)32-9-7-19(33)8-10-32/h3-13,26-27H,14H2,1-2H3,(H2,29,31)(H,30,34)	CAYIVUXAAPKJFX-UHFFFAOYSA-N	306507	(+-)-N-[(6-amino-2,4- dimethylpyridin- 3-yl]-methyl]-12-(4- oxo-1,4-dihydropyridin-1-yl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 149	Plasma kallikrein			 5888							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306507	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306507&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131839	381755206							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588003	COc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1c(C)cc(F)cc1F	InChI=1S/C30H25F2N3O3/c1-14-8-18(31)11-24(32)27(14)16-4-6-19-21(9-16)29-22-10-17(5-7-20(22)28(19)38-29)30(36)34-13-23-15(2)35-26(33)12-25(23)37-3/h4-12,28-29H,13H2,1-3H3,(H2,33,35)(H,34,36)	RNMOCONXDOXVLD-UHFFFAOYSA-N	306508	(+-)-N-[(6-amino-4-methoxy-2- methylpyridin-3-yl)methyl]- 12-(2,4-difluoro-6-methylphenyl)- 15-oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 150	Plasma kallikrein			 34.7							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306508	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306508&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131840	381755207							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588004	CCOc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1c(C)cc(F)cc1F	InChI=1S/C31H27F2N3O3/c1-4-38-26-13-27(34)36-16(3)24(26)14-35-31(37)18-6-8-21-23(11-18)30-22-10-17(5-7-20(22)29(21)39-30)28-15(2)9-19(32)12-25(28)33/h5-13,29-30H,4,14H2,1-3H3,(H2,34,36)(H,35,37)	WWRKFNALWUICLH-UHFFFAOYSA-N	306509	(+-)-N-[(6-amino-4-ethoxy-2- methylpyridin-3-yl)-methyl]- 12-(2,4-difluoro-6-methylphenyl)- 15-oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 151	Plasma kallikrein			 195							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306509	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306509&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131841	381755208							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588005	COc1ccc(Oc2ccc3C4OC(c3c2)c2cc(ccc42)C(=O)NCc2c(C)cc(N)nc2C)cn1	InChI=1S/C29H26N4O4/c1-15-10-25(30)33-16(2)24(15)14-32-29(34)17-4-7-20-22(11-17)28-23-12-18(5-8-21(23)27(20)37-28)36-19-6-9-26(35-3)31-13-19/h4-13,27-28H,14H2,1-3H3,(H2,30,33)(H,32,34)	DSEHJFZXLKDONX-UHFFFAOYSA-N	306510	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]- 12-[(6-methoxypyridin-3-yl)oxy]- 15-(oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 152	Plasma kallikrein			 1259							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306510	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306510&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131842	381755209							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588006	Cc1cnn(Cc2ccc3C4OC(c3c2)c2cc(ccc42)C(=O)NCc2c(F)cc3CNCc3c2C)c1	InChI=1S/C30H27FN4O2/c1-16-10-34-35(14-16)15-18-3-5-21-23(7-18)29-24-8-19(4-6-22(24)28(21)37-29)30(36)33-13-26-17(2)25-12-32-11-20(25)9-27(26)31/h3-10,14,28-29,32H,11-13,15H2,1-2H3,(H,33,36)	KNHDCZPXKWZWMZ-UHFFFAOYSA-N	306511	(+-)-N-[(6-fluoro-4-methyl-2,3- dihydro-1H-isoindol-5- yl)methyl]-12-[(4-methyl-1H- pyrazol-1-yl)methyl]-15- oxatetracyclo[6.6.1.02,7.09,14]- pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 153	Plasma kallikrein			 204							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306511	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306511&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131844	381755210							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588007	Nc1nccc2ccc(CNC(=O)c3ccc4C5OC(c4c3)c3cc(ccc53)-c3ccc(F)cc3F)cc12	InChI=1S/C31H21F2N3O2/c32-20-5-8-21(27(33)14-20)18-3-6-22-25(12-18)29-26-13-19(4-7-23(26)28(22)38-29)31(37)36-15-16-1-2-17-9-10-35-30(34)24(17)11-16/h1-14,28-29H,15H2,(H2,34,35)(H,36,37)	HHOXCXLCVWPIKD-UHFFFAOYSA-N	306512	(+-)-N-[(1-aminoisoquinolin-7- yl)methyl]-12-(2,4- difluorophenyl)-15-oxatetracyclo [6.6.1.02,7.09,14]- pentadeca-2,4,6,9,11,13-hexaene- 4-carboxamide::US10144746, Compound 154	Plasma kallikrein			 3715							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306512	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306512&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131843	381755211							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588008	Nc1ncc(CNC(=O)c2ccc3C4OC(c3c2)c2cc(ccc42)-c2ccc(F)cc2F)c2ccccc12	InChI=1S/C31H21F2N3O2/c32-19-7-10-21(27(33)13-19)16-5-8-22-25(11-16)29-26-12-17(6-9-23(26)28(22)38-29)31(37)36-15-18-14-35-30(34)24-4-2-1-3-20(18)24/h1-14,28-29H,15H2,(H2,34,35)(H,36,37)	YRBOVYVYTPSIDE-UHFFFAOYSA-N	306513	(+-)-N-[(1-aminoisoquinolin-4- yl)methyl]-12-(2,4- difluorophenyl)-15-oxatetracyclo [6.6.1.02,7.09,14]- pentadeca-2,4,6,9,11,13-hexaene- 4-carboxamide::US10144746, Compound 155	Plasma kallikrein			 4074							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306513	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306513&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131845	381755212							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588009	Cc1ccc(C#N)c(c1)-c1ccc2C3OC(c4cc(ccc34)C(=O)NCc3c(C)cc(N)nc3C)c2c1	InChI=1S/C31H26N4O2/c1-16-4-5-21(14-32)24(10-16)19-6-8-22-25(12-19)30-26-13-20(7-9-23(26)29(22)37-30)31(36)34-15-27-17(2)11-28(33)35-18(27)3/h4-13,29-30H,15H2,1-3H3,(H2,33,35)(H,34,36)	LDXCGDUWYCAAIL-UHFFFAOYSA-N	306514	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]- 12-(2-cyano-5-methylphenyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 156	Plasma kallikrein			 93.3							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306514	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306514&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131846	381755213							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588010	Cc1ccc(-c2ccc3C4OC(c5cc(ccc45)C(=O)NCc4c(C)cc(N)nc4C)c3c2)c(n1)C#N	InChI=1S/C30H25N5O2/c1-15-10-27(32)35-17(3)25(15)14-33-30(36)19-6-9-22-24(12-19)29-23-11-18(5-8-21(23)28(22)37-29)20-7-4-16(2)34-26(20)13-31/h4-12,28-29H,14H2,1-3H3,(H2,32,35)(H,33,36)	HLQHGXZQQACGTI-UHFFFAOYSA-N	306515	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]- 12-(2-cyano-6-methylpyridin-3- yl)-15-oxatetracyclo [6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 157	Plasma kallikrein			 22.9							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306515	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306515&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131849	381755214							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588011	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1cccc(c1C#N)C(F)(F)F	InChI=1S/C31H23F3N4O2/c1-15-10-27(36)38-16(2)25(15)14-37-30(39)18-7-9-21-23(12-18)29-22-11-17(6-8-20(22)28(21)40-29)19-4-3-5-26(24(19)13-35)31(32,33)34/h3-12,28-29H,14H2,1-2H3,(H2,36,38)(H,37,39)	QIXFRSMUYKIMQD-UHFFFAOYSA-N	306516	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]- 12-[2-cyano-3-(trifluoromethyl) phenyl]-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 158	Plasma kallikrein			 112							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306516	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306516&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131847	381755215							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588012	Cc1cccc(Oc2ccc3C4OC(c3c2)c2cc(ccc42)C(=O)NCc2c(C)cc(N)nc2C)c1	InChI=1S/C30H27N3O3/c1-16-5-4-6-20(11-16)35-21-8-10-23-25(14-21)29-24-13-19(7-9-22(24)28(23)36-29)30(34)32-15-26-17(2)12-27(31)33-18(26)3/h4-14,28-29H,15H2,1-3H3,(H2,31,33)(H,32,34)	JTNDJBVVXZVONO-UHFFFAOYSA-N	306517	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]- 12-(3-methylphenoxy)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13-hexaene- 4-carboxamide::US10144746, Compound 159	Plasma kallikrein			 1862							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306517	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306517&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131848	381755216							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588013	Cc1c2CNCc2cc(F)c1CNC(=O)c1ccc2C3OC(c4cc(Cn5cccn5)ccc34)c2c1	InChI=1S/C29H25FN4O2/c1-16-24-13-31-12-19(24)11-26(30)25(16)14-32-29(35)18-4-6-21-23(10-18)28-22-9-17(15-34-8-2-7-33-34)3-5-20(22)27(21)36-28/h2-11,27-28,31H,12-15H2,1H3,(H,32,35)	QARMMBKZTBRBQD-UHFFFAOYSA-N	306518	(+-)-N-[(6-fluoro-4-methyl-2,3- dihydro-1H-isoindol-5- yl)methyl]-12-[(1H-pyrazol-1-yl) methyl]-15-oxatetracyclo [6.6.1.02,7.09,14]-pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 160	Plasma kallikrein			 120							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306518	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306518&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131850	381755217							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588014	Cc1cc2CNCc2c(C)c1CNC(=O)c1ccc2C3OC(c4cc(Cn5cccn5)ccc34)c2c1	InChI=1S/C30H28N4O2/c1-17-10-21-13-31-14-27(21)18(2)26(17)15-32-30(35)20-5-7-23-25(12-20)29-24-11-19(16-34-9-3-8-33-34)4-6-22(24)28(23)36-29/h3-12,28-29,31H,13-16H2,1-2H3,(H,32,35)	IKVOAGWGTKSLRC-UHFFFAOYSA-N	306519	(+-)-N-[(4,6-dimethyl-2,3-dihydro- 1H-isoindol-5-yl)methyl]- 12-[(1H-pyrazol-1-yl)methyl]-15- oxatetracyclo[6.6.1.02,7.09,14]- pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 161	Plasma kallikrein			 1288							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306519	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306519&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131851	381755218							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588015	Cc1cnn(Cc2ccc3C4OC(c3c2)c2cc(ccc42)C(=O)NCc2c(C)cc3CNCc3c2C)c1	InChI=1S/C31H30N4O2/c1-17-11-34-35(15-17)16-20-4-6-23-25(9-20)30-26-10-21(5-7-24(26)29(23)37-30)31(36)33-14-27-18(2)8-22-12-32-13-28(22)19(27)3/h4-11,15,29-30,32H,12-14,16H2,1-3H3,(H,33,36)	BOFORHNPOXPKFN-UHFFFAOYSA-N	306520	(+-)-N-[(4,6-dimethyl-2,3-dihydro- 1H-isoindol-5-yl)methyl]- 12-[(4-methyl-1H-pyrazol-1-yl) methyl]-15-oxatetracyclo [6.6.1.02,7.09,14]-pentadeca- 2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 162	Plasma kallikrein			 72.4							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306520	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306520&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131852	381755219							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588016	CCOc1cc(N)nc(C)c1CNC(=O)c1ccc2C3C(=O)NC(c2c1)c1cc(ccc31)-c1ccc(F)cc1F	InChI=1S/C31H26F2N4O3/c1-3-40-26-13-27(34)36-15(2)24(26)14-35-30(38)17-5-8-21-23(11-17)29-22-10-16(19-9-6-18(32)12-25(19)33)4-7-20(22)28(21)31(39)37-29/h4-13,28-29H,3,14H2,1-2H3,(H2,34,36)(H,35,38)(H,37,39)	KWISGOLWKBNZPT-UHFFFAOYSA-N	306521	(+-)-N-[(6-amino-4-ethoxy- 2-methylpyridin-3-yl)methyl]-12- (2,4-difluorophenyl)-16-oxo-15- azatetracyclo[6.6.1.02,7.09,14] hexadeca-2,4,6,9,11,13- hexaene-4-carboxamide and (+-)-N-[(6-amino-4-ethoxy-2- methylpyridin-3-yl)methyl]- 11-(2,4-difluorophenyl)-16-oxo- 15-azatetracyclo[6.6.1.02,7.09,14] hexadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 163	Plasma kallikrein			 776							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306521	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306521&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131853	381755220							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588017	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c4cc(Sc5ccccc5)ccc34)c2c1	InChI=1S/C29H25N3O2S/c1-16-12-26(30)32-17(2)25(16)15-31-29(33)18-8-10-21-23(13-18)28-24-14-20(9-11-22(24)27(21)34-28)35-19-6-4-3-5-7-19/h3-14,27-28H,15H2,1-2H3,(H2,30,32)(H,31,33)	QPLDUENSYDBZLC-UHFFFAOYSA-N	306522	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 12-(phenylsulfanyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide (+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]-11- (phenylsulfanyl)-15- oxatetracydo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 164	Plasma kallikrein			 138							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306522	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306522&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131856	381755221							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588018	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)S(=O)(=O)c1ccccc1	InChI=1S/C29H25N3O4S/c1-16-12-26(30)32-17(2)25(16)15-31-29(33)18-8-10-21-23(13-18)28-24-14-20(9-11-22(24)27(21)36-28)37(34,35)19-6-4-3-5-7-19/h3-14,27-28H,15H2,1-2H3,(H2,30,32)(H,31,33)	AMKDZYLEYYHWBL-UHFFFAOYSA-N	306523	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 12-(benzenesulfonyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide and (+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]-11- (benzenesulfonyl)-15- oxatetracyclo-[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 165	Plasma kallikrein			 1023							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306523	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306523&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131857	381755222							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588019	Cc1cc(CNC(=O)c2ccc3C4OC(c3c2)c2cc(ccc42)-c2ccc(F)cc2F)c(C)nc1N	InChI=1S/C29H23F2N3O2/c1-14-9-18(15(2)34-28(14)32)13-33-29(35)17-4-7-22-24(11-17)27-23-10-16(3-6-21(23)26(22)36-27)20-8-5-19(30)12-25(20)31/h3-12,26-27H,13H2,1-2H3,(H2,32,34)(H,33,35)	OXQHWGZFKIMQDH-UHFFFAOYSA-N	306524	(+-)-N-[(6-amino-2,5- dimethylpyridin-3-yl)-methyl]- 12-(2,4-difluorophenyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13-hexaene- 4-carboxamide::US10144746, Compound 166	Plasma kallikrein			 6761							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306524	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306524&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131859	381755223							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588020	COc1ccncc1-c1ccc2C3OC(c4cc(ccc34)C(=O)NCc3c(C)cc(N)nc3C)c2c1	InChI=1S/C29H26N4O3/c1-15-10-26(30)33-16(2)23(15)14-32-29(34)18-5-7-20-22(12-18)28-21-11-17(4-6-19(21)27(20)36-28)24-13-31-9-8-25(24)35-3/h4-13,27-28H,14H2,1-3H3,(H2,30,33)(H,32,34)	YKBUDTNGLMPEKR-UHFFFAOYSA-N	306525	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]- 12-(4-methoxypyridin-3-yl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 167	Plasma kallikrein			 115							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306525	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306525&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131860	381755224							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588021	Nc1cc(CNC(=O)c2ccc3C4OC(c3c2)c2cc(ccc42)-c2ccc(F)cc2F)ccn1	InChI=1S/C27H19F2N3O2/c28-17-3-6-18(23(29)12-17)15-1-4-19-21(10-15)26-22-11-16(2-5-20(22)25(19)34-26)27(33)32-13-14-7-8-31-24(30)9-14/h1-12,25-26H,13H2,(H2,30,31)(H,32,33)	UGISQNHZVSZBJQ-UHFFFAOYSA-N	306526	(+-)-N-[(2-aminopyridin-4-yl) methyl]- 12-(2,4-difluorophenyl)-15- oxatetracyclo[6.6.1.02,7.09,14]- pentadeca-2,4,6,9,11,13-hexaene- 4-carboxamide::US10144746, Compound 168	Plasma kallikrein			 19953							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306526	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306526&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131862	381755225							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588022	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1cc(F)c(F)cc1F	InChI=1S/C29H22F3N3O2/c1-13-7-26(33)35-14(2)22(13)12-34-29(36)16-4-6-18-21(9-16)28-20-8-15(3-5-17(20)27(18)37-28)19-10-24(31)25(32)11-23(19)30/h3-11,27-28H,12H2,1-2H3,(H2,33,35)(H,34,36)	KVNZSQYYJXXQCV-UHFFFAOYSA-N	306527	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)- methyl]-12- (2,4,5-trifluorophenyl)-15- oxatetra-cyclo [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 169	Plasma kallikrein			 34.7							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306527	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306527&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131861	381755226							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588023	NC(=N)c1ccc(CNC(=O)c2ccc3C4OC(c3c2)c2cc(ccc42)-c2ccc(F)cc2F)cc1	InChI=1S/C29H21F2N3O2/c30-19-7-10-20(25(31)13-19)17-5-8-21-23(11-17)27-24-12-18(6-9-22(24)26(21)36-27)29(35)34-14-15-1-3-16(4-2-15)28(32)33/h1-13,26-27H,14H2,(H3,32,33)(H,34,35)	AOLAUOFUQJVDKZ-UHFFFAOYSA-N	306528	(+-)-N-[(4-carbamimidoylphenyl) methyl]-12-(2,4- difluorophenyl)-15-oxatetracyclo [6.6.1.02,7.09,14]-pentadeca- 2,4,6,9,11,13-hexaene- 4-carboxamide::US10144746, Compound 170	Plasma kallikrein			 1.000							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306528	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306528&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131863	381755227							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588024	CCCc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1ccc(F)cc1F	InChI=1S/C31H27F2N3O2/c1-3-4-17-13-28(34)36-16(2)26(17)15-35-31(37)19-6-9-23-25(12-19)30-24-11-18(5-8-22(24)29(23)38-30)21-10-7-20(32)14-27(21)33/h5-14,29-30H,3-4,15H2,1-2H3,(H2,34,36)(H,35,37)	MFRYZBKKPKBOCH-UHFFFAOYSA-N	306529	(+-)-N-[(6-amino-2-methyl-4- propylpyridin-3-yl)methyl]-12 (2,4-difluorophenyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 172	Plasma kallikrein			 10.0							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306529	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306529&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131866	381755228							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588025	CC(C)c1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1ccc(F)cc1F	InChI=1S/C31H27F2N3O2/c1-15(2)23-13-28(34)36-16(3)26(23)14-35-31(37)18-5-8-22-25(11-18)30-24-10-17(4-7-21(24)29(22)38-30)20-9-6-19(32)12-27(20)33/h4-13,15,29-30H,14H2,1-3H3,(H2,34,36)(H,35,37)	JVTVTOMEUVTPTA-UHFFFAOYSA-N	306530	(+-)-N-{[6-amino-2-methyl-4- (propan-2-yl)pyridin-3- yl]methyl}-12-(2,4- difluorophenyl)-15-oxatetra- cyclo[6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 173	Plasma kallikrein			 3.02							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306530	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306530&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131867	381755229							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588026	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2[C@H]3O[C@@H](c2c1)c1cc(ccc31)-c1ccc(Cl)cc1F	InChI=1S/C29H23ClFN3O2/c1-14-9-26(32)34-15(2)24(14)13-33-29(35)17-4-7-21-23(11-17)28-22-10-16(3-6-20(22)27(21)36-28)19-8-5-18(30)12-25(19)31/h3-12,27-28H,13H2,1-2H3,(H2,32,34)(H,33,35)/t27-,28+/m0/s1	SBPZQSFSPZVTIN-WUFINQPMSA-N	306531	(1R,8S)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]- 12-(4-chloro-2- fluorophenyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 174	Plasma kallikrein			 46.8							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306531	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306531&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131868	381755230							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588027	Nc1ncc(CNC(=O)c2ccc3[C@H]4O[C@@H](c3c2)c2cc(ccc42)-c2ccccc2F)c2ccccc12	InChI=1S/C31H22FN3O2/c32-27-8-4-3-6-21(27)17-9-11-22-25(13-17)29-26-14-18(10-12-23(26)28(22)37-29)31(36)35-16-19-15-34-30(33)24-7-2-1-5-20(19)24/h1-15,28-29H,16H2,(H2,33,34)(H,35,36)/t28-,29+/m0/s1	BLYJQCUEQFRJBG-URLMMPGGSA-N	306532	(1R,8S)-N-[(1-aminoisoquinolin- 5-yl)methyl]-12-(2- fluorophenyl)-15-oxatetracyclo- [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 175	Plasma kallikrein			 55.0							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306532	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306532&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137554677	381755231							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588028	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2[C@H]3O[C@@H](c2c1)c1cc(ccc31)-c1ccc(F)cc1Cl	InChI=1S/C29H23ClFN3O2/c1-14-9-26(32)34-15(2)24(14)13-33-29(35)17-4-7-21-23(11-17)28-22-10-16(3-6-20(22)27(21)36-28)19-8-5-18(31)12-25(19)30/h3-12,27-28H,13H2,1-2H3,(H2,32,34)(H,33,35)/t27-,28+/m0/s1	ZZKWFWSXOORRCP-WUFINQPMSA-N	306533	(1R,8S)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]- 12-(2-chloro-4-fluorophenyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 176	Plasma kallikrein			 67.6							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306533	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306533&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131871	381755232							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588029	COc1ccc(c(F)n1)-c1ccc2[C@@H]3O[C@@H](c4cc(ccc34)C(=O)NCc3c(C)cc(N)nc3C)c2c1	InChI=1S/C29H25FN4O3/c1-14-10-24(31)33-15(2)23(14)13-32-29(35)17-5-7-20-22(12-17)27-21-11-16(4-6-19(21)26(20)37-27)18-8-9-25(36-3)34-28(18)30/h4-12,26-27H,13H2,1-3H3,(H2,31,33)(H,32,35)/t26-,27+/m0/s1	RPMALVGPATXMTH-RRPNLBNLSA-N	306534	(1R,8S)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]-12- (2-fluoro-6-methoxypyridin-3-yl)- 15-oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 177	Plasma kallikrein			 117							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306534	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306534&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131870	381755233							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588030	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2[C@H]3O[C@H](c4cc(Cn5cc(F)cn5)ccc34)c2c1	InChI=1S/C27H24FN5O2/c1-14-7-24(29)32-15(2)23(14)11-30-27(34)17-4-6-20-22(9-17)26-21-8-16(3-5-19(21)25(20)35-26)12-33-13-18(28)10-31-33/h3-10,13,25-26H,11-12H2,1-2H3,(H2,29,32)(H,30,34)/t25-,26+/m0/s1	MIQCYJCHVRGZCJ-IZZNHLLZSA-N	306535	(1R,8S)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]-12- [(4-fluoro-1H-pyrazol-1-yl)methyl]- 15-oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 178	Plasma kallikrein			 1.000							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306535	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306535&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131872	381755234							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588031	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2[C@H]3O[C@H](c4cc(Cn5cc(Cl)cn5)ccc34)c2c1	InChI=1S/C27H24ClN5O2/c1-14-7-24(29)32-15(2)23(14)11-30-27(34)17-4-6-20-22(9-17)26-21-8-16(3-5-19(21)25(20)35-26)12-33-13-18(28)10-31-33/h3-10,13,25-26H,11-12H2,1-2H3,(H2,29,32)(H,30,34)/t25-,26+/m0/s1	RCRDNPMWXUNXDS-IZZNHLLZSA-N	306536	(1R,8S)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]-12- [(4-chloro-1H-pyrazol-1-yl) methyl]-15-oxatetracyclo [6.6.1.02,7.09,14]-pentadeca- 2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 179	Plasma kallikrein			 1.000							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306536	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306536&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131873	381755235							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588032	Cc1nc(N)cc(C2CC2)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)-c1ccc(F)cc1F	InChI=1S/C31H25F2N3O2/c1-15-26(23(16-2-3-16)13-28(34)36-15)14-35-31(37)18-5-8-22-25(11-18)30-24-10-17(4-7-21(24)29(22)38-30)20-9-6-19(32)12-27(20)33/h4-13,16,29-30H,2-3,14H2,1H3,(H2,34,36)(H,35,37)	CDDBBNVGWDFWDK-UHFFFAOYSA-N	306537	(+-)-N-[(6-amino-4-cyclopropyl- 2-methylpyridin-3- yl)methyl]-12-(2,4-difluorophenyl)- 15-oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 180	Plasma kallikrein			 11.0							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306537	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306537&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131876	381755236							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588033	Cc1cnn(Cc2ccc3[C@@H]4O[C@H](c3c2)c2cc(ccc42)C(=O)NCc2c(C)cc(N)nc2C)c1	InChI=1S/C28H27N5O2/c1-15-11-31-33(13-15)14-18-4-6-20-22(9-18)27-23-10-19(5-7-21(23)26(20)35-27)28(34)30-12-24-16(2)8-25(29)32-17(24)3/h4-11,13,26-27H,12,14H2,1-3H3,(H2,29,32)(H,30,34)/t26-,27+/m0/s1	CPIXSFCYRWRGRW-RRPNLBNLSA-N	306538	(1R,8S)-N-[(6-amino-2,4- dimethylpyridin-3-yl)mehtyl]-12- [(4-methyl-1H-pyrazol-1-yl) methyl]-15-oxatetracyclo [6.6.1.02,7.09,14]-pentadeca- 2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 181	Plasma kallikrein			 1.000							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306538	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306538&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131874	381755237							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588034	Cc1nc(N)nc(C)c1CNC(=O)c1ccc2[C@H]3O[C@@H](c2c1)c1cc(ccc31)-c1ccc(F)cc1F	InChI=1S/C28H22F2N4O2/c1-13-23(14(2)34-28(31)33-13)12-32-27(35)16-4-7-20-22(10-16)26-21-9-15(3-6-19(21)25(20)36-26)18-8-5-17(29)11-24(18)30/h3-11,25-26H,12H2,1-2H3,(H,32,35)(H2,31,33,34)/t25-,26+/m0/s1	MDLXRCPVMMAUCB-IZZNHLLZSA-N	306539	(1R,8S)-N-[(2-amino-4,6- dimethylpyrimidin-5-yl)methyl]- 12-(2,4-difluorophenyl)-15- oxatetxacyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 182	Plasma kallikrein			 21380							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306539	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306539&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131875	381755238							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588035	CCc1cc(N)nc(C)c1CNC(=O)c1ccc2[C@H]3O[C@@H](c2c1)c1cc(ccc31)-c1ccc(F)cc1F	InChI=1S/C30H25F2N3O2/c1-3-16-12-27(33)35-15(2)25(16)14-34-30(36)18-5-8-22-24(11-18)29-23-10-17(4-7-21(23)28(22)37-29)20-9-6-19(31)13-26(20)32/h4-13,28-29H,3,14H2,1-2H3,(H2,33,35)(H,34,36)/t28-,29+/m0/s1	NWHDVGYTIOZBKM-URLMMPGGSA-N	306540	(1R,8S)-N-[(6-amino-ethyl-2- methylpyridin-3-yl)methyl]- 12-(2,4-difluorophenyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 183	Plasma kallikrein			 12.0							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306540	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306540&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131600	381755239							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588036	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2[C@H]3O[C@H](c4ccc(Oc5cccc(F)c5)cc34)c2c1	InChI=1S/C29H24FN3O3/c1-15-10-26(31)33-16(2)25(15)14-32-29(34)17-6-8-21-23(11-17)27-22-9-7-20(13-24(22)28(21)36-27)35-19-5-3-4-18(30)12-19/h3-13,27-28H,14H2,1-2H3,(H2,31,33)(H,32,34)/t27-,28-/m1/s1	DSOWPKOCACZHMO-VSGBNLITSA-N	306541	(1R,8R)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl- 11-(3-fluorophenoxy)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 184	Plasma kallikrein			 75.9							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306541	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306541&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131877	381755240							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588037	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2[C@H]3O[C@H](c4cc(Oc5ccn(C)n5)ccc34)c2c1	InChI=1S/C27H25N5O3/c1-14-10-23(28)30-15(2)22(14)13-29-27(33)16-4-6-18-20(11-16)26-21-12-17(5-7-19(21)25(18)35-26)34-24-8-9-32(3)31-24/h4-12,25-26H,13H2,1-3H3,(H2,28,30)(H,29,33)/t25-,26+/m1/s1	HFNQWCXRQZMPAL-FTJBHMTQSA-N	306542	(1S,8R)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]-12- [(1-methyl-1H-pyrazol-3-yl)oxy]- 15-oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 185	Plasma kallikrein			 2239							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306542	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306542&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131878	381755241							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588038	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2[C@H]3O[C@@H](c2c1)c1cc(ccc31)-n1n(C)ccc1=O	InChI=1S/C27H25N5O3/c1-14-10-23(28)30-15(2)22(14)13-29-27(34)16-4-6-18-20(11-16)26-21-12-17(5-7-19(21)25(18)35-26)32-24(33)8-9-31(32)3/h4-12,25-26H,13H2,1-3H3,(H2,28,30)(H,29,34)/t25-,26+/m1/s1	VPFGOQLJHZNAAC-FTJBHMTQSA-N	306543	(1S,8R)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl-12- (2-methyl-5-oxo-2,5-dihydro- 1H-pyrazol-1-yl)-15- oxatetracyclo[6.6.1.02,7.09,14]- pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 186	Plasma kallikrein			 1820							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306543	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306543&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131879	381755242							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588039	NC(=N)c1ccc(CNC(=O)c2ccc3[C@H]4O[C@@H](c3c2)c2cc(ccc42)-c2ccccc2F)cc1	InChI=1S/C29H22FN3O2/c30-25-4-2-1-3-20(25)18-9-11-21-23(13-18)27-24-14-19(10-12-22(24)26(21)35-27)29(34)33-15-16-5-7-17(8-6-16)28(31)32/h1-14,26-27H,15H2,(H3,31,32)(H,33,34)/t26-,27+/m0/s1	FVXWAVWDGCRVTP-RRPNLBNLSA-N	306544	(1R,8S)-N-[(4- carbamimidoylphenyl) methyl]-12-(2- fluorophenyl)-15- oxatetracyclo- [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 187	Plasma kallikrein			 1.74							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306544	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306544&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131881	381755243							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588040	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(ccc31)C(=O)c1ccccc1	InChI=1S/C30H25N3O3/c1-16-12-26(31)33-17(2)25(16)15-32-30(35)20-9-11-22-24(14-20)29-23-13-19(8-10-21(23)28(22)36-29)27(34)18-6-4-3-5-7-18/h3-14,28-29H,15H2,1-2H3,(H2,31,33)(H,32,35)	FZVLAIYJUFKRRY-UHFFFAOYSA-N	306545	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 12-benzoyl-15-oxatetracyclo- [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 188	Plasma kallikrein			 10.0							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306545	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306545&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131880	381755244							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588041	NC(=N)c1ccc(CNC(=O)c2ccc3C4OC(c3c2)c2cc(ccc42)-c2ccccc2)cc1	InChI=1S/C29H23N3O2/c30-28(31)19-8-6-17(7-9-19)16-32-29(33)21-11-13-23-25(15-21)27-24-14-20(18-4-2-1-3-5-18)10-12-22(24)26(23)34-27/h1-15,26-27H,16H2,(H3,30,31)(H,32,33)	DILNAPNTJIUWPL-UHFFFAOYSA-N	306546	(+-)-N-[(4-carbamimidoylphenyl) methyl]-12-phenyl-15- oxatetracyclo[6.6.1.02,7.09,14]- pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 189	Plasma kallikrein			 4.57							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306546	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306546&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131882	381755245							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588042	CN(C)C(=NC(=N)c1ccc(CNC(=O)c2ccc3C4OC(c3c2)c2cc(ccc42)-c2ccccc2)cc1)N(C)C	InChI=1S/C34H33N5O2/c1-38(2)34(39(3)4)37-32(35)23-12-10-21(11-13-23)20-36-33(40)25-15-17-27-29(19-25)31-28-18-24(22-8-6-5-7-9-22)14-16-26(28)30(27)41-31/h5-19,30-31,35H,20H2,1-4H3,(H,36,40)	WTOBZHOBTSLOKT-UHFFFAOYSA-N	306547	(+-)-N-{[4-({[bis(dimethylamino) methylidene]- amino}methanimidoyl)phenyl] methyl}-12-phenyl-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 190	Plasma kallikrein			 129							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306547	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306547&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131883	381755246							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588043	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2[C@H]3O[C@H](c4cc(Oc5cccc(F)c5)ccc34)c2c1	InChI=1S/C29H24FN3O3/c1-15-10-26(31)33-16(2)25(15)14-32-29(34)17-6-8-21-23(11-17)28-24-13-20(7-9-22(24)27(21)36-28)35-19-5-3-4-18(30)12-19/h3-13,27-28H,14H2,1-2H3,(H2,31,33)(H,32,34)/t27-,28+/m1/s1	TXJSALZVBMNHND-IZLXSDGUSA-N	306548	(1S,8R)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 12-(3-fluorophenoxy)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 191	Plasma kallikrein			 105							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306548	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306548&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131885	381755247							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588044	Cc1nc(N)cc(Cl)c1CNC(=O)c1ccc2[C@H]3O[C@@H](c2c1)c1cc(ccc31)-c1ccc(F)cc1F	InChI=1S/C28H20ClF2N3O2/c1-13-22(23(29)11-25(32)34-13)12-33-28(35)15-3-6-19-21(9-15)27-20-8-14(2-5-18(20)26(19)36-27)17-7-4-16(30)10-24(17)31/h2-11,26-27H,12H2,1H3,(H2,32,34)(H,33,35)/t26-,27+/m0/s1	CSUHFZGWGZKUOJ-RRPNLBNLSA-N	306549	(1R,8S)-N-[(6-amino-4-chloro- 2-methylpyridin-3- yl)methyl]-12-(2,4-difluorophenyl)- 15-oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 192	Plasma kallikrein			 977							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306549	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306549&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131626	381755248							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588045	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2[C@H]3O[C@@H](c2c1)c1cc(ccc31)C(=O)N1CC2CCC(C1)O2	InChI=1S/C30H30N4O4/c1-15-9-26(31)33-16(2)25(15)12-32-29(35)17-3-7-21-23(10-17)28-24-11-18(4-8-22(24)27(21)38-28)30(36)34-13-19-5-6-20(14-34)37-19/h3-4,7-11,19-20,27-28H,5-6,12-14H2,1-2H3,(H2,31,33)(H,32,35)/t19?,20?,27-,28+/m1/s1	UYDMOGQLHSIHMP-KNPRNWPSSA-N	306550	(1S,8R)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]- 12-{8-oxa-3-azabicyclo[3.2.1] octane-3-carbonyl}-15- oxatetracyclo[6.6.1.02,7.09,14]- pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 193	Plasma kallikrein			 1585							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306550	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306550&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131884	381755249							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588046	CN(C(=O)c1ccc2[C@@H]3O[C@@H](c4cc(ccc34)C(=O)NCc3c(C)cc(N)nc3C)c2c1)c1ccccc1	InChI=1S/C31H28N4O3/c1-17-13-27(32)34-18(2)26(17)16-33-30(36)19-9-11-22-24(14-19)29-25-15-20(10-12-23(25)28(22)38-29)31(37)35(3)21-7-5-4-6-8-21/h4-15,28-29H,16H2,1-3H3,(H2,32,34)(H,33,36)/t28-,29+/m1/s1	NAQPEFZAOVXXCT-WDYNHAJCSA-N	306551	(1S,8R)-N12-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- N4-methyl-N4-phenyl-15- oxatetra-cyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13-hexaene- 4,12-dicarboxamide::US10144746, Compound 194	Plasma kallikrein			 1660							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306551	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306551&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131886	381755250							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588047	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2[C@H]3O[C@@H](c2c1)c1cc(ccc31)C1=CC=CC=[N]1O	InChI=1S/C28H25N4O3/c1-15-11-25(29)31-16(2)23(15)14-30-28(33)18-7-9-20-22(13-18)27-21-12-17(6-8-19(21)26(20)35-27)24-5-3-4-10-32(24)34/h3-13,26-27,34H,14H2,1-2H3,(H2,29,31)(H,30,33)/t26-,27+/m0/s1	TWVCXCQSMATEFC-RRPNLBNLSA-N	306552	2-[(1R,8S)-12-{[(6-amino- 2,4-dimethylpyridin-3- yl)methyl]carbamoyl}-15- oxatetracyclo- [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaen-4- yl]pyridin-1-ium-1-olate::US10144746, Compound 195	Plasma kallikrein			 1047							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306552	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306552&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124135703	381755251							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588048	CN(C(=O)c1ccc2[C@@H]3O[C@@H](c4cc(ccc34)C(=O)NCc3c(C)cc(N)nc3C)c2c1)c1ccc(F)cc1	InChI=1S/C31H27FN4O3/c1-16-12-27(33)35-17(2)26(16)15-34-30(37)18-4-10-22-24(13-18)29-25-14-19(5-11-23(25)28(22)39-29)31(38)36(3)21-8-6-20(32)7-9-21/h4-14,28-29H,15H2,1-3H3,(H2,33,35)(H,34,37)/t28-,29+/m1/s1	RSEVWTVDCTZESL-WDYNHAJCSA-N	306553	(1S,8R)-N12-[(6-amino-2,4- dimethylypyridin-3-yl)methyl]- N4-(4-fluorophenyl)-N4-methyl- 15-oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4,12-dicarboxamide::US10144746, Compound 196	Plasma kallikrein			 4677							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306553	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306553&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131887	381755252							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588049	N\C(=N/O)c1ccc(CNC(=O)c2ccc3C4OC(c3c2)c2cc(ccc42)-c2ccc(F)cc2F)cc1F	InChI=1S/C29H20F3N3O3/c30-17-4-8-18(25(32)12-17)15-2-6-19-22(10-15)27-23-11-16(3-7-20(23)26(19)38-27)29(36)34-13-14-1-5-21(24(31)9-14)28(33)35-37/h1-12,26-27,37H,13H2,(H2,33,35)(H,34,36)	XZNVYPHPMCTEQH-UHFFFAOYSA-N	306554	(+-)-12-(2,4-difluorophenyl)-N- ({3-fluoro-4-[N'- hydroxycarbamimidoyl]phenyl} methyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 197	Plasma kallikrein			 100000							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306554	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306554&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137554678	381755253							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588050	NC(=N)c1ccc(CNC(=O)c2ccc3C4OC(c3c2)c2cc(ccc42)-c2ccc(F)cc2F)cc1F	InChI=1S/C29H20F3N3O2/c30-17-4-8-18(25(32)12-17)15-2-6-19-22(10-15)27-23-11-16(3-7-20(23)26(19)37-27)29(36)35-13-14-1-5-21(28(33)34)24(31)9-14/h1-12,26-27H,13H2,(H3,33,34)(H,35,36)	KMEXRHFMQQPGDD-UHFFFAOYSA-N	306555	(+-)-N-[(4-carbamimidoyl-3- fluorophenyl)methyl]-12-(2,4- difluorophenyl)-15-oxatetracyclo- [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 198	Plasma kallikrein			 20.9							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306555	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306555&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131889	381755254							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588051	Cc1cc(cc(C)c1CNC(=O)c1ccc2[C@H]3O[C@@H](c2c1)c1cc(ccc31)-c1ccc(F)cc1F)C(N)=N	InChI=1S/C31H25F2N3O2/c1-15-9-19(30(34)35)10-16(2)26(15)14-36-31(37)18-4-7-23-25(12-18)29-24-11-17(3-6-22(24)28(23)38-29)21-8-5-20(32)13-27(21)33/h3-13,28-29H,14H2,1-2H3,(H3,34,35)(H,36,37)/t28-,29+/m0/s1	IRWCDQSKKJYKSE-URLMMPGGSA-N	306556	(1R,8S)-N-[(4-carbamimidoyl- 2,6-dimethyl-phenyl)methyl]- 12-(2,4-difluorophenyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 199	Plasma kallikrein			 0.741							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306556	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306556&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131890	381755255							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588052	NC(=N)c1cccc(CNC(=O)c2ccc3[C@H]4O[C@@H](c3c2)c2cc(ccc42)-c2ccccc2F)c1	InChI=1S/C29H22FN3O2/c30-25-7-2-1-6-20(25)17-8-10-21-23(13-17)27-24-14-19(9-11-22(24)26(21)35-27)29(34)33-15-16-4-3-5-18(12-16)28(31)32/h1-14,26-27H,15H2,(H3,31,32)(H,33,34)/t26-,27+/m0/s1	NBFIIIUWLNOVLN-RRPNLBNLSA-N	306557	(1R,8S)-N-[(3- carbamimidoylphenyl) methyl]-12-(2- fluorophenyl)-15- oxatetracyclo- [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 200	Plasma kallikrein			 1230							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306557	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306557&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131891	381755256							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588053	NC(=N)c1ccc(CNC(=O)c2ccc3[C@H]4O[C@@H](c3c2)c2cc(ccc42)-c2ccc(F)cc2)cc1	InChI=1S/C29H22FN3O2/c30-21-9-5-17(6-10-21)19-7-11-22-24(13-19)27-25-14-20(8-12-23(25)26(22)35-27)29(34)33-15-16-1-3-18(4-2-16)28(31)32/h1-14,26-27H,15H2,(H3,31,32)(H,33,34)/t26-,27+/m0/s1	KHKRZZDBYZTAAZ-RRPNLBNLSA-N	306558	(1R,8S)-N-[(4- carbamimidoylphenyl) methyl]-12-(4- fluorophenyl)-15- oxatetracyclo- [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 201	Plasma kallikrein			 1.000							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306558	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306558&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131892	381755257							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588054	NC(=N)c1ccc(CNC(=O)c2ccc3[C@H]4O[C@@H](c3c2)c2cc(ccc42)-c2ccc(F)cc2F)cc1	InChI=1S/C29H21F2N3O2/c30-19-7-10-20(25(31)13-19)17-5-8-21-23(11-17)27-24-12-18(6-9-22(24)26(21)36-27)29(35)34-14-15-1-3-16(4-2-15)28(32)33/h1-13,26-27H,14H2,(H3,32,33)(H,34,35)/t26-,27+/m0/s1	AOLAUOFUQJVDKZ-RRPNLBNLSA-N	306559	(1R,8S)-N-[(4- carbamimidoylphenyl) methyl]-12-(2,4- difluorophenyl)-15- oxatetracyclo- [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 202	Plasma kallikrein			 1.000							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306559	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306559&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131620	381755258							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588055	N\C(=N\O)c1ccc(CNC(=O)c2ccc3[C@H]4O[C@@H](c3c2)c2cc(ccc42)-c2ccc(F)cc2F)cc1	InChI=1S/C29H21F2N3O3/c30-19-7-10-20(25(31)13-19)17-5-8-21-23(11-17)27-24-12-18(6-9-22(24)26(21)37-27)29(35)33-14-15-1-3-16(4-2-15)28(32)34-36/h1-13,26-27,36H,14H2,(H2,32,34)(H,33,35)/t26-,27+/m0/s1	DNFXHCVFEIYKKQ-RRPNLBNLSA-N	306560	(1R,8S)-12-(2,4- difluorophenyl)-N- {[4-(N''- hydroxycarbamimidoyl) phenyl]methyl}-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::BDBM306561::US10144746, Compound 203	Plasma kallikrein			 1047							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306560	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306560&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137554679	381755259							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588056	N\C(=N\O)c1ccc(CNC(=O)c2ccc3[C@H]4O[C@@H](c3c2)c2cc(ccc42)-c2ccc(F)cc2F)cc1	InChI=1S/C29H21F2N3O3/c30-19-7-10-20(25(31)13-19)17-5-8-21-23(11-17)27-24-12-18(6-9-22(24)26(21)37-27)29(35)33-14-15-1-3-16(4-2-15)28(32)34-36/h1-13,26-27,36H,14H2,(H2,32,34)(H,33,35)/t26-,27+/m0/s1	DNFXHCVFEIYKKQ-RRPNLBNLSA-N	306560	(1R,8S)-12-(2,4- difluorophenyl)-N- {[4-(N''- hydroxycarbamimidoyl) phenyl]methyl}-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::BDBM306561::US10144746, Compound 203	Plasma kallikrein			 933							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306560	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306560&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137554679	381755259							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588057	Nc1noc2cc(CNC(=O)c3ccc4[C@H]5O[C@@H](c4c3)c3cc(ccc53)-c3ccc(F)cc3F)ccc12	InChI=1S/C29H19F2N3O3/c30-17-4-8-18(24(31)12-17)15-2-6-19-22(10-15)27-23-11-16(3-7-20(23)26(19)36-27)29(35)33-13-14-1-5-21-25(9-14)37-34-28(21)32/h1-12,26-27H,13H2,(H2,32,34)(H,33,35)/t26-,27+/m0/s1	GISQUSLFJYYDAI-RRPNLBNLSA-N	306562	(1R,8S)-N-[(3-amino-1,2- benzoxazol-6-yl)-methyl]- 12-(2,4-difluorophenyl)- 15-oxatetracyclo [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 205	Plasma kallikrein			 1000							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306562	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306562&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131894	381755261							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588058	NC(=N)c1ccc(CNC(=O)c2ccc3[C@H]4O[C@H](c5cc(Br)ccc45)c3c2)cc1	InChI=1S/C23H18BrN3O2/c24-15-6-8-17-19(10-15)21-18-9-14(5-7-16(18)20(17)29-21)23(28)27-11-12-1-3-13(4-2-12)22(25)26/h1-10,20-21H,11H2,(H3,25,26)(H,27,28)/t20-,21+/m1/s1	ZWVCAUWPXIAVBW-RTWAWAEBSA-N	306563	(1S,8R)-12-bromo-N-[(4- carbamimidoyl-phenyl)methyl]- 15-oxatetracyclo[6.6.1.02,7.09,14]- pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 206	Plasma kallikrein			 37.2							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306563	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306563&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131895	381755262							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588059	Nc1n[nH]c2cc(CNC(=O)c3ccc4[C@H]5O[C@@H](c4c3)c3cc(ccc53)-c3ccc(F)cc3F)ccc12			306564	(1R,8S)-N-[(3-amino-1H- indazol-6-yl)methyl]-12-(2,4- difluorophenyl)-15-oxatetracyclo- [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 207	Plasma kallikrein			 4898							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306564	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306564&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131896	381755263							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588060	CC(C)c1cc(N)nc(C)c1CNC(=O)c1ccc2[C@H]3O[C@@H](c2c1)c1cc(ccc31)-c1ccc(F)cc1F	InChI=1S/C31H27F2N3O2/c1-15(2)23-13-28(34)36-16(3)26(23)14-35-31(37)18-5-8-22-25(11-18)30-24-10-17(4-7-21(24)29(22)38-30)20-9-6-19(32)12-27(20)33/h4-13,15,29-30H,14H2,1-3H3,(H2,34,36)(H,35,37)/t29-,30+/m0/s1	JVTVTOMEUVTPTA-XZWHSSHBSA-N	306565	(1R,8S)-N-{[6-amino-2-methyl- 4-(propan-2-yl)-pyridin-3- yl]methyl}-12-(2,4- difluorophenyl)- 15-oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 208	Plasma kallikrein			 1.000							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306565	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306565&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131607	381755264							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588061	CC(=O)N1C2c3ccc(cc3C1c1cc(ccc21)-c1ccc(F)cc1F)C(=O)NCc1c(C)cc(N)nc1C	InChI=1S/C31H26F2N4O2/c1-15-10-28(34)36-16(2)26(15)14-35-31(39)19-5-8-23-25(12-19)30-24-11-18(21-9-6-20(32)13-27(21)33)4-7-22(24)29(23)37(30)17(3)38/h4-13,29-30H,14H2,1-3H3,(H2,34,36)(H,35,39)	XDTJDQJALITUNM-UHFFFAOYSA-N	306566	(+-)-15-acetyl-N-[(6-amino-2,4- dimethylpyridin-3- yl)methyl]-12-(2,4-difluorophenyl)- 15-azatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide and  (+-)-15-acetyl-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 11-(2,4-difluorophenyl)-15- azatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 209	Plasma kallikrein			 3467							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306566	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306566&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131897	381755265							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588062	COC(=O)N1C2c3ccc(cc3C1c1cc(ccc21)-c1ccc(F)cc1F)C(=O)NCc1c(C)cc(N)nc1C	InChI=1S/C31H26F2N4O3/c1-15-10-27(34)36-16(2)25(15)14-35-30(38)18-5-8-22-24(12-18)29-23-11-17(20-9-6-19(32)13-26(20)33)4-7-21(23)28(22)37(29)31(39)40-3/h4-13,28-29H,14H2,1-3H3,(H2,34,36)(H,35,38)	IHSOWHOYZPFKGA-UHFFFAOYSA-N	306567	(+-)-methyl 4-{[(6-amino-2,4- dimethylpyridin-3- yl)methyl]carbamoyl}-12- (2,4-difluorophenyl)-15- azatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-15-carboxylate (+-)-methyl  4-{[(6-amino-2,4- dimethylpyridin-3-yl)methyl] carbamoyl}-11-(2,4- difluorophenyl)-15-azatetracyclo [6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13-hexaene- 15-carboxylate::US10144746, Compound 210	Plasma kallikrein			 13490							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306567	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306567&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131899	381755266							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588063	NC(=N)c1ccc(CNC(=O)c2ccc3[C@H]4O[C@@H](c3c2)c2cc(ccc42)-c2ccc(F)cc2F)cc1F	InChI=1S/C29H20F3N3O2/c30-17-4-8-18(25(32)12-17)15-2-6-19-22(10-15)27-23-11-16(3-7-20(23)26(19)37-27)29(36)35-13-14-1-5-21(28(33)34)24(31)9-14/h1-12,26-27H,13H2,(H3,33,34)(H,35,36)/t26-,27+/m0/s1	KMEXRHFMQQPGDD-RRPNLBNLSA-N	306568	(1R,8S)-N-[(4-carbamimidoyl-3- fluorophenyl)-methyl]-12- (2,4-difluorophenyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 211	Plasma kallikrein			 11.7							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306568	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306568&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131630	381755267							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588064	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2[C@H]3O[C@@H](c2c1)c1cc(ccc31)-c1cccnc1C	InChI=1S/C29H26N4O2/c1-15-11-26(30)33-17(3)25(15)14-32-29(34)19-7-9-22-24(13-19)28-23-12-18(6-8-21(23)27(22)35-28)20-5-4-10-31-16(20)2/h4-13,27-28H,14H2,1-3H3,(H2,30,33)(H,32,34)/t27-,28+/m0/s1	ZCXQLNXXRRWYEI-WUFINQPMSA-N	306569	(1R,8S)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-methyl]-12- (2-methylpyridin-3-yl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 212	Plasma kallikrein			 70.8							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306569	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306569&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131902	381755268							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588065	COc1ncccc1-c1ccc2[C@@H]3O[C@@H](c4cc(ccc34)C(=O)NCc3c(C)cc(N)nc3C)c2c1	InChI=1S/C29H26N4O3/c1-15-11-25(30)33-16(2)24(15)14-32-28(34)18-7-9-21-23(13-18)27-22-12-17(6-8-20(22)26(21)36-27)19-5-4-10-31-29(19)35-3/h4-13,26-27H,14H2,1-3H3,(H2,30,33)(H,32,34)/t26-,27+/m0/s1	SYBKQQKASBKWJT-RRPNLBNLSA-N	306570	(1R,8S)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]-12- (2-methoxypyridin-3-yl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 213	Plasma kallikrein			 676							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306570	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306570&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131901	381755269							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588066	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2[C@H]3O[C@@H](c2c1)c1cc(ccc31)C1=[N](O)C=C(F)C=C1	InChI=1S/C28H24FN4O3/c1-14-9-25(30)32-15(2)23(14)12-31-28(34)17-4-7-20-22(11-17)27-21-10-16(3-6-19(21)26(20)36-27)24-8-5-18(29)13-33(24)35/h3-11,13,26-27,35H,12H2,1-2H3,(H2,30,32)(H,31,34)/t26-,27+/m0/s1	SXYPCGHSWOFFSW-RRPNLBNLSA-N	306571	2-[(1R,8S)-12-{[(6-amino-2,4- dimethylpyridin-3- yl)methyl]carbamoyl}-15- oxatetracyclo- [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaen-4-yl]-5- fluoropyridin-1-ium-1-olate::US10144746, Compound 214	Plasma kallikrein			 83.2							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306571	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306571&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124135701	381755270							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588067	Cc1ccncc1-c1ccc2[C@@H]3O[C@@H](c4cc(ccc34)C(=O)NCc3c(C)cc(N)nc3C)c2c1	InChI=1S/C29H26N4O2/c1-15-8-9-31-13-25(15)18-4-6-20-22(11-18)28-23-12-19(5-7-21(23)27(20)35-28)29(34)32-14-24-16(2)10-26(30)33-17(24)3/h4-13,27-28H,14H2,1-3H3,(H2,30,33)(H,32,34)/t27-,28+/m0/s1	DHDBGKUQZWEAFV-WUFINQPMSA-N	306572	(1R,8S)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]-12- (4-methylpyridin-3-yl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 215	Plasma kallikrein			 79.4							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306572	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306572&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131903	381755271							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588068	Cc1ccc(-c2ccc3[C@@H]4O[C@@H](c5cc(ccc45)C(=O)NCc4cccc5c(N)nccc45)c3c2)c(c1)C#N	InChI=1S/C33H24N4O2/c1-18-5-8-23(22(13-18)16-34)19-6-9-25-28(14-19)31-29-15-20(7-10-26(29)30(25)39-31)33(38)37-17-21-3-2-4-27-24(21)11-12-36-32(27)35/h2-15,30-31H,17H2,1H3,(H2,35,36)(H,37,38)/t30-,31+/m0/s1	DFNKCPFYKPPJJA-IOWSJCHKSA-N	306573	(1R,8S)-N-[(l-aminoisoquinolin- 5-yl)methyl]-12-(2-cyano- 4-methylphenyl)-15-oxatetracyclo- [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 216	Plasma kallikrein			 15.8							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306573	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306573&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131904	381755272							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588069	NC(=N)c1ccc(CNC(=O)c2ccc3[C@H]4O[C@@H](c3c2)c2cc(ccc42)-c2ccc(Cl)s2)cc1	InChI=1S/C27H20ClN3O2S/c28-23-10-9-22(34-23)16-5-7-18-20(11-16)25-21-12-17(6-8-19(21)24(18)33-25)27(32)31-13-14-1-3-15(4-2-14)26(29)30/h1-12,24-25H,13H2,(H3,29,30)(H,31,32)/t24-,25+/m0/s1	MHQDMBCAMZUIKY-LOSJGSFVSA-N	306574	(1S,8R)-N-[(4- carbamimidoylphenyl)methyl]- 12-(5-chlorothiophen-2-yl)-15- oxatetracyclo- [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 217	Plasma kallikrein			 2.00							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306574	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306574&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131905	381755273							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588070	CN(c1ccc2[C@@H]3O[C@H](c2c1)c1cc(ccc31)C(=O)NCc1c(C)cc(N)nc1C)c1cccc(F)c1	InChI=1S/C30H27FN4O2/c1-16-11-27(32)34-17(2)26(16)15-33-30(36)18-7-9-22-24(12-18)29-25-14-21(8-10-23(25)28(22)37-29)35(3)20-6-4-5-19(31)13-20/h4-14,28-29H,15H2,1-3H3,(H2,32,34)(H,33,36)/t28-,29+/m1/s1	SCONHSOFBKFVGY-WDYNHAJCSA-N	306575	(1S,8R)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]-12- [(3-fluorophenyl)(methyl)amino]- 15-oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 218	Plasma kallikrein			 26.9							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306575	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306575&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131906	381755274							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588071	Cc1nc(N)cc(C=C)c1CNC(=O)c1ccc2[C@H]3O[C@@H](c2c1)c1cc(ccc31)-c1ccc(F)cc1F	InChI=1S/C30H23F2N3O2/c1-3-16-12-27(33)35-15(2)25(16)14-34-30(36)18-5-8-22-24(11-18)29-23-10-17(4-7-21(23)28(22)37-29)20-9-6-19(31)13-26(20)32/h3-13,28-29H,1,14H2,2H3,(H2,33,35)(H,34,36)/t28-,29+/m0/s1	IGDUNYZFDLOWEI-URLMMPGGSA-N	306576	(1R,8S)-N-[(6-amino-4-ethenyl- 2-methylpyridin-3- yl)methyl]-12-(2,4-difluorophenyl)- 15-oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 219	Plasma kallikrein			 17.0							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306576	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306576&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131907	381755275							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588072	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2[C@H]3O[C@@H](c2c1)c1cc(ccc31)C(=O)c1ccccc1	InChI=1S/C30H25N3O3/c1-16-12-26(31)33-17(2)25(16)15-32-30(35)20-9-11-22-24(14-20)29-23-13-19(8-10-21(23)28(22)36-29)27(34)18-6-4-3-5-7-18/h3-14,28-29H,15H2,1-2H3,(H2,31,33)(H,32,35)/t28-,29+/m0/s1	FZVLAIYJUFKRRY-URLMMPGGSA-N	306577	(1R,8S)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]-12- benzoyl-15-oxatetracyclo- [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 220	Plasma kallikrein			 12.0							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306577	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306577&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131908	381755276							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588073	Nc1ccc(cc1)C(=N)NC(=O)c1ccc2[C@H]3O[C@@H](c2c1)c1cc(ccc31)-c1ccc(F)cc1F	InChI=1S/C28H19F2N3O2/c29-17-5-10-19(24(30)13-17)15-3-8-20-22(11-15)26-23-12-16(4-9-21(23)25(20)35-26)28(34)33-27(32)14-1-6-18(31)7-2-14/h1-13,25-26H,31H2,(H2,32,33,34)/t25-,26+/m0/s1	WWYLGQDQNVSKTB-IZZNHLLZSA-N	306578	(1R,8S)-N-(4-aminobenzene- carboximidoyl)-12-(2,4- difluorophenyl)-15-oxatetracyclo- [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 221	Plasma kallikrein			 10000							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306578	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306578&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137554680	381755277							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588074	Cc1nc(N)cc(C2=CCOCC2)c1CNC(=O)c1ccc2[C@H]3O[C@@H](c2c1)c1cc(ccc31)-c1ccc(F)cc1F	InChI=1S/C33H27F2N3O3/c1-17-28(25(15-30(36)38-17)18-8-10-40-11-9-18)16-37-33(39)20-3-6-24-27(13-20)32-26-12-19(2-5-23(26)31(24)41-32)22-7-4-21(34)14-29(22)35/h2-8,12-15,31-32H,9-11,16H2,1H3,(H2,36,38)(H,37,39)/t31-,32+/m0/s1	CQSUFJNSJHLXEZ-AJQTZOPKSA-N	306579	(1R,8S)-N-{[6-amino-4-(3,6- dihydro-2H-pyran-4-yl)-2- methylpyridin-3-yl]methyl}- 12-(2,4-difluorophenyl)-15- oxatetracyclo[6.6.1.02,7.09,14]- pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 222	Plasma kallikrein			 28.2							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306579	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306579&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131909	381755278							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588075	Cc1ccc(o1)-c1ccc2[C@@H]3O[C@@H](c4cc(ccc34)C(=O)NCc3ccc(cc3)C(N)=N)c2c1	InChI=1S/C28H23N3O3/c1-15-2-11-24(33-15)18-7-9-20-22(12-18)26-23-13-19(8-10-21(23)25(20)34-26)28(32)31-14-16-3-5-17(6-4-16)27(29)30/h2-13,25-26H,14H2,1H3,(H3,29,30)(H,31,32)/t25-,26+/m0/s1	IFMKPBBZXHHMCG-IZZNHLLZSA-N	306580	(1R,8S)-N-[(4-carbamimidoyl- phenyl)methyl]-12-(5- methylfuran-2-yl)-15- oxatetracyclo-[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 223	Plasma kallikrein			 33.9							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306580	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306580&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131916	381755279							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588076	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2[C@H]3O[C@H](c4cc(Cn5ccccc5=O)ccc34)c2c1	InChI=1S/C29H26N4O3/c1-16-11-25(30)32-17(2)24(16)14-31-29(35)19-7-9-21-23(13-19)28-22-12-18(6-8-20(22)27(21)36-28)15-33-10-4-3-5-26(33)34/h3-13,27-28H,14-15H2,1-2H3,(H2,30,32)(H,31,35)/t27-,28+/m0/s1	XQTFRVXONVZEHH-WUFINQPMSA-N	306581	(1R,8S)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]-12- [(2-oxo-1,2-dihydropyridin-1- yl)methyl]-15- oxatetracyclo[6.6.1.02,7.09,14]- pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 224	Plasma kallikrein			 1.000							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306581	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306581&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131910	381755280							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588077	CO\N=C(\N)c1ccc(CNC(=O)c2ccc3[C@H]4O[C@@H](c3c2)c2cc(ccc42)-c2ccc(F)cc2F)cc1	InChI=1S/C30H23F2N3O3/c1-37-35-29(33)17-4-2-16(3-5-17)15-34-30(36)19-7-10-23-25(13-19)28-24-12-18(6-9-22(24)27(23)38-28)21-11-8-20(31)14-26(21)32/h2-14,27-28H,15H2,1H3,(H2,33,35)(H,34,36)/t27-,28+/m0/s1	FTUVPRBDNRZUAV-WUFINQPMSA-N	306582	(1R,8S)-12-(2,4-difluorophenyl)- N-{[4-(N'-methoxycarbamimidoyl) phenyl]methy]}-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 225	Plasma kallikrein			 10000							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306582	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306582&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137554681	381755281							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588078	Nc1nccc2c(CNC(=O)c3ccc4[C@H]5O[C@@H](c4c3)c3cc(ccc53)C(=O)c3ccccc3)cccc12	InChI=1S/C32H23N3O3/c33-31-25-8-4-7-21(22(25)13-14-34-31)17-35-32(37)20-10-12-24-27(16-20)30-26-15-19(9-11-23(26)29(24)38-30)28(36)18-5-2-1-3-6-18/h1-16,29-30H,17H2,(H2,33,34)(H,35,37)/t29-,30+/m0/s1	IKHQMTFBKRETSI-XZWHSSHBSA-N	306583	(1R,8S)-N-[(1-aminoisoquinolin- 5-yl)methyl]-12-benzoyl- 15-oxatetracyclo[6.6.1.02,7.09,14]- pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 226	Plasma kallikrein			 36.3							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306583	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306583&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131911	381755282							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588079	CC(=C)c1cc(N)nc(C)c1CNC(=O)c1ccc2[C@H]3O[C@@H](c2c1)c1cc(ccc31)-c1ccc(F)cc1F	InChI=1S/C31H25F2N3O2/c1-15(2)23-13-28(34)36-16(3)26(23)14-35-31(37)18-5-8-22-25(11-18)30-24-10-17(4-7-21(24)29(22)38-30)20-9-6-19(32)12-27(20)33/h4-13,29-30H,1,14H2,2-3H3,(H2,34,36)(H,35,37)/t29-,30+/m0/s1	SLCZINYQEVBAEW-XZWHSSHBSA-N	306584	(1R,8S)-N-{[6-amino-2-methyl- 4-(prop-1-en-2-yl)pyridin-3- yl]methyl}-12-(2,4-difluorophenyl)- 15-oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 227	Plasma kallikrein			 12.0							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306584	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306584&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131915	381755283							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588080	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2[C@H]3O[C@@H](c2c1)c1cc(ccc31)C(=O)c1cccc(F)c1	InChI=1S/C30H24FN3O3/c1-15-10-26(32)34-16(2)25(15)14-33-30(36)19-7-9-22-24(13-19)29-23-12-18(6-8-21(23)28(22)37-29)27(35)17-4-3-5-20(31)11-17/h3-13,28-29H,14H2,1-2H3,(H2,32,34)(H,33,36)/t28-,29+/m0/s1	MLVDNZXJZQEPSR-URLMMPGGSA-N	306585	(1R,8S)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 12-(3-fluorobenzoyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 228	Plasma kallikrein			 12.0							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306585	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306585&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131912	381755284							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588081	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2[C@H]3O[C@H](c4cc(NC(=O)c5ccccc5)ccc34)c2c1	InChI=1S/C30H26N4O3/c1-16-12-26(31)33-17(2)25(16)15-32-29(35)19-8-10-21-23(13-19)28-24-14-20(9-11-22(24)27(21)37-28)34-30(36)18-6-4-3-5-7-18/h3-14,27-28H,15H2,1-2H3,(H2,31,33)(H,32,35)(H,34,36)/t27-,28+/m1/s1	BKQDSZUUZPRYAK-IZLXSDGUSA-N	306586	(1S,8R)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 12-benzamido-15-oxatetracyclo- [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 229	Plasma kallikrein			 10000							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306586	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306586&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131919	381755285							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588082	CCN(c1ccc2[C@@H]3O[C@H](c2c1)c1cc(ccc31)C(=O)NCc1c(C)cc(N)nc1C)c1cccc(F)c1	InChI=1S/C31H29FN4O2/c1-4-36(21-7-5-6-20(32)14-21)22-9-11-24-26(15-22)30-25-13-19(8-10-23(25)29(24)38-30)31(37)34-16-27-17(2)12-28(33)35-18(27)3/h5-15,29-30H,4,16H2,1-3H3,(H2,33,35)(H,34,37)/t29-,30+/m1/s1	AWCJXSWNLHQKJN-IHLOFXLRSA-N	306587	(1S,8R)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]-12- [ethyl(3-fluorophenyl)amino]-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 230	Plasma kallikrein			 12.0							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306587	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306587&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131914	381755286							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588083	NC(=N)c1ccc(CNC(=O)c2ccc3[C@H]4O[C@H](c5cc(Oc6cccc(F)c6)ccc45)c3c2)cc1	InChI=1S/C29H22FN3O3/c30-19-2-1-3-20(13-19)35-21-9-11-23-25(14-21)27-24-12-18(8-10-22(24)26(23)36-27)29(34)33-15-16-4-6-17(7-5-16)28(31)32/h1-14,26-27H,15H2,(H3,31,32)(H,33,34)/t26-,27+/m1/s1	URKXUSWVFWQBIV-SXOMAYOGSA-N	306588	(1S,8R)-N-[(4-carbamimidoyl- phenyl)methyl]-12-(3- fluorophenoxy)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 231	Plasma kallikrein			 33.9							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306588	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306588&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131917	381755287							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588084	NC(=N)c1ccc(CNC(=O)c2ccc3[C@H]4O[C@H](c5cc(ccc45)N4CC5CCC(C4)O5)c3c2)cc1	InChI=1S/C29H28N4O3/c30-28(31)17-3-1-16(2-4-17)13-32-29(34)18-5-9-22-24(11-18)27-25-12-19(6-10-23(25)26(22)36-27)33-14-20-7-8-21(15-33)35-20/h1-6,9-12,20-21,26-27H,7-8,13-15H2,(H3,30,31)(H,32,34)/t20?,21?,26-,27+/m1/s1	DHELEDKJWZSBDS-OFJRGAFESA-N	306589	(1S,8R)-N-[(4-carbamimidoyl- phenyl)methyl]-12-{8-oxa-3- azabicyclo[3.2.1]octan-3-yl}- 15-oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 232	Plasma kallikrein			 38.9							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306589	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306589&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131918	381755288							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588085	CCc1ccc2[C@@H]3O[C@H](c2c1)c1cc(ccc31)C(=O)NCc1ccc(cc1)C(N)=N	InChI=1S/C25H23N3O2/c1-2-14-5-9-18-20(11-14)23-21-12-17(8-10-19(21)22(18)30-23)25(29)28-13-15-3-6-16(7-4-15)24(26)27/h3-12,22-23H,2,13H2,1H3,(H3,26,27)(H,28,29)/t22-,23+/m0/s1	ZIAUEHOPRDAJAE-XZOQPEGZSA-N	306590	(1R,8S)-N-[(4-carbamimidoyl- phenyl)methyl]-12-ethyl-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 233	Plasma kallikrein			 7.08							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306590	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306590&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131922	381755289							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588086	CCN(C(=O)c1ccccc1)c1ccc2[C@@H]3O[C@H](c2c1)c1cc(ccc31)C(=O)NCc1c(C)cc(N)nc1C	InChI=1S/C32H30N4O3/c1-4-36(32(38)20-8-6-5-7-9-20)22-11-13-24-26(16-22)30-25-15-21(10-12-23(25)29(24)39-30)31(37)34-17-27-18(2)14-28(33)35-19(27)3/h5-16,29-30H,4,17H2,1-3H3,(H2,33,35)(H,34,37)/t29-,30+/m1/s1	MGYJAFBEMVKUNF-IHLOFXLRSA-N	306591	(1S,8R)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 12-(N-ethylbenzamido)-15- oxatetacyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 234	Plasma kallikrein			 10000							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306591	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306591&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131920	381755290							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588087	CN1CCCN(Cc2ccc3[C@@H]4O[C@H](c3c2)c2cc(ccc42)C(=O)NCc2c(C)cc(N)nc2C)C1=O	InChI=1S/C29H31N5O3/c1-16-11-25(30)32-17(2)24(16)14-31-28(35)19-6-8-21-23(13-19)27-22-12-18(5-7-20(22)26(21)37-27)15-34-10-4-9-33(3)29(34)36/h5-8,11-13,26-27H,4,9-10,14-15H2,1-3H3,(H2,30,32)(H,31,35)/t26-,27+/m0/s1	HNNUCQVNYMTYNE-RRPNLBNLSA-N	306592	(1R,8S)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 12-[(3-methyl-2-oxo-1,3-diazinan- 1-yl)methyl]-15-oxatetracyclo [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 235	Plasma kallikrein			 12.9							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306592	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306592&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131921	381755291							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588088	NC(=N)c1ccc(CNC(=O)c2ccc3[C@H]4O[C@H](c5cc(ccc45)N4CCCC4)c3c2)cc1	InChI=1S/C27H26N4O2/c28-26(29)17-5-3-16(4-6-17)15-30-27(32)18-7-9-20-22(13-18)25-23-14-19(31-11-1-2-12-31)8-10-21(23)24(20)33-25/h3-10,13-14,24-25H,1-2,11-12,15H2,(H3,28,29)(H,30,32)/t24-,25+/m1/s1	AEPLPJDYVFDMKA-RPBOFIJWSA-N	306593	(1S,8R)-N-[(4-carbamimidoyl- phenyl)methyl]-12-(pyrrolidin- 1-yl)-15-oxatetracyclo [6.6.1.02,7.09,14]pentadeca- 2,4,6.9,11,13-hexaene-4- carboxamide::US10144746, Compound 236	Plasma kallikrein			 2.00							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306593	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306593&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131924	381755292							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588089	Nc1noc2c(CNC(=O)c3ccc4[C@H]5O[C@@H](c4c3)c3cc(ccc53)-c3ccccc3F)cccc12	InChI=1S/C29H20FN3O3/c30-24-7-2-1-5-18(24)15-8-10-19-22(12-15)27-23-13-16(9-11-20(23)26(19)35-27)29(34)32-14-17-4-3-6-21-25(17)36-33-28(21)31/h1-13,26-27H,14H2,(H2,31,33)(H,32,34)/t26-,27+/m0/s1	CDDXRWILMGEHCO-RRPNLBNLSA-N	306594	(1R,8S)-N-[(3-amino-1,2- benzoxazol-7-yl)-methyl]-12-(2- fluorophenyl)-15-oxatetracyclo- [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 237	Plasma kallikrein			 10000							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306594	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306594&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131923	381755293							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588090	NC(=N)c1ccc(CNC(=O)c2ccc3[C@H]4O[C@H](c5ccccc45)c3c2)cc1	InChI=1S/C23H19N3O2/c24-22(25)14-7-5-13(6-8-14)12-26-23(27)15-9-10-18-19(11-15)21-17-4-2-1-3-16(17)20(18)28-21/h1-11,20-21H,12H2,(H3,24,25)(H,26,27)/t20-,21+/m0/s1	GYYVIUNFPQMGSU-LEWJYISDSA-N	306595	(1R,8S)-N-[(4-carbamimidoyl- phenyl)methy]-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 238	Plasma kallikrein			 324							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306595	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306595&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131926	381755294							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588091	CCN(c1ccc2[C@@H]3O[C@H](c2c1)c1cc(ccc31)C(=O)NCc1c(C)cc(N)nc1C)c1ccccc1F	InChI=1S/C31H29FN4O2/c1-4-36(27-8-6-5-7-26(27)32)20-10-12-22-24(15-20)30-23-14-19(9-11-21(23)29(22)38-30)31(37)34-16-25-17(2)13-28(33)35-18(25)3/h5-15,29-30H,4,16H2,1-3H3,(H2,33,35)(H,34,37)/t29-,30+/m1/s1	SVGWNYXFOBPILM-IHLOFXLRSA-N	306596	(1S,8R)-N-[(6-amino-2,4- (dimethylpyridin-3-yl)methyl]-12- [ethyl(2-fluorophenyl)amino]-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 239	Plasma kallikrein			 234							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306596	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306596&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131925	381755295							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588092	CO\N=C(\N)c1ccc(CNC(=O)c2ccc3[C@H]4O[C@@H](c3c2)c2cc(ccc42)-c2ccccc2F)cc1	InChI=1S/C30H24FN3O3/c1-36-34-29(32)18-8-6-17(7-9-18)16-33-30(35)20-11-13-23-25(15-20)28-24-14-19(10-12-22(24)27(23)37-28)21-4-2-3-5-26(21)31/h2-15,27-28H,16H2,1H3,(H2,32,34)(H,33,35)/t27-,28+/m0/s1	HKANEXPIDFNLSA-WUFINQPMSA-N	306597	(1R,8S)-12-(2-fluorophenyl)- N-{[4-(N'-methoxy- carbamimidoyl)phenyl] methyl}-15-oxatetracyclo- [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 240	Plasma kallikrein			 100000							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306597	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306597&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137554682	381755296							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588093	CO\N=C(\N)c1ccc(CNC(=O)c2ccc3[C@H]4O[C@@H](c3c2)c2cc(ccc42)-c2ccc(F)cc2)cc1	InChI=1S/C30H24FN3O3/c1-36-34-29(32)19-4-2-17(3-5-19)16-33-30(35)21-9-13-24-26(15-21)28-25-14-20(8-12-23(25)27(24)37-28)18-6-10-22(31)11-7-18/h2-15,27-28H,16H2,1H3,(H2,32,34)(H,33,35)/t27-,28+/m0/s1	HJYFQHRERMBAGW-WUFINQPMSA-N	306598	(1R,8S)-12-(4-fluorophenyl)- N-{[4-(N'-methoxy-carbamimidoyl) pheny]methyl}-15-oxatetracyclo- [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 241	Plasma kallikrein			 100000							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306598	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306598&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137554683	381755297							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588094	Cc1c(N)ncc(CNC(=O)c2ccc3[C@H]4O[C@@H](c3c2)c2cc(ccc42)-c2ccccc2F)c1C	InChI=1S/C29H24FN3O2/c1-15-16(2)28(31)32-13-19(15)14-33-29(34)18-8-10-22-24(12-18)27-23-11-17(7-9-21(23)26(22)35-27)20-5-3-4-6-25(20)30/h3-13,26-27H,14H2,1-2H3,(H2,31,32)(H,33,34)/t26-,27+/m0/s1	BEEOHSLVGMNWSJ-RRPNLBNLSA-N	306599	(1R,8S)-N-[(6-amino-4,5- dimethylpyridin-3-yl)methyl]-12- (2-fluorophenyl)-15-oxatetra- cyclo[6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 242	Plasma kallikrein			 2754							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306599	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306599&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131928	381755298							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588095	CN(C(=O)c1ccccc1)c1ccc2[C@@H]3O[C@H](c2c1)c1cc(ccc31)C(=O)NCc1c(C)cc(N)nc1C	InChI=1S/C31H28N4O3/c1-17-13-27(32)34-18(2)26(17)16-33-30(36)20-9-11-22-24(14-20)29-25-15-21(10-12-23(25)28(22)38-29)35(3)31(37)19-7-5-4-6-8-19/h4-15,28-29H,16H2,1-3H3,(H2,32,34)(H,33,36)/t28-,29+/m1/s1	WWERJOFFZQITIU-WDYNHAJCSA-N	306600	(1S,8R)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]-12- (N-methylbenzamido)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 243	Plasma kallikrein			 1230							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306600	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306600&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131929	381755299							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588096	NC(=N)c1ccc(NC(=O)c2ccc3[C@H]4O[C@@H](c3c2)c2cc(ccc42)-c2ccc(F)cc2F)cc1	InChI=1S/C28H19F2N3O2/c29-17-5-10-19(24(30)13-17)15-3-8-20-22(11-15)26-23-12-16(4-9-21(23)25(20)35-26)28(34)33-18-6-1-14(2-7-18)27(31)32/h1-13,25-26H,(H3,31,32)(H,33,34)/t25-,26+/m0/s1	NNCZWJWYWCPHRS-IZZNHLLZSA-N	306601	(1R,8S)-N-(4-carbamimidoyl- phenyl)-12-(2,4- difluorophenyl)-15- oxatetracyclo[6.6.1.02,7.09,14]- pentadeca-2,4,6,9,11,13-hexaene- 4-carboxamide::US10144746, Compound 244	Plasma kallikrein			 10715							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306601	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306601&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131930	381755300							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588097	Nc1noc2ccc(NC(=O)c3ccc4[C@H]5O[C@@H](c4c3)c3cc(ccc53)-c3ccc(F)cc3F)cc12	InChI=1S/C28H17F2N3O3/c29-15-3-7-17(23(30)11-15)13-1-5-18-20(9-13)26-21-10-14(2-6-19(21)25(18)35-26)28(34)32-16-4-8-24-22(12-16)27(31)33-36-24/h1-12,25-26H,(H2,31,33)(H,32,34)/t25-,26+/m0/s1	ZCTNHUWWGQWDAS-IZZNHLLZSA-N	306602	(1R,8S)-N-(3-amino-1,2- benzoxazol-5-yl)-12-(2,4- difluorophenyl)-15-oxatetracyclo- [6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13-hexaene- 4-carboxamide::US10144746, Compound 245	Plasma kallikrein			 10000							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306602	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306602&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131931	381755301							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588098	Cc1nc(N)cc(c1CNC(=O)c1ccc2[C@H]3O[C@@H](c2c1)c1cc(ccc31)-c1ccc(F)cc1F)C(F)(F)F	InChI=1S/C29H20F5N3O2/c1-13-22(23(29(32,33)34)11-25(35)37-13)12-36-28(38)15-3-6-19-21(9-15)27-20-8-14(2-5-18(20)26(19)39-27)17-7-4-16(30)10-24(17)31/h2-11,26-27H,12H2,1H3,(H2,35,37)(H,36,38)/t26-,27+/m0/s1	KYTNFCHWFFKMLM-RRPNLBNLSA-N	306603	(1R,8S)-N-{[6-amino-2-methyl- 4-(trifluoro-methyl)pyridin- 3-yl]methyl}-12-(2,4- difluorophenyl)-15- oxatetracyclo[6.6.1.02,7.09,14]- pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 246	Plasma kallikrein			 10715							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306603	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306603&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131628	381755302							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588099	Cc1nc(N)cc(C2CCOCC2)c1CNC(=O)c1ccc2[C@H]3O[C@@H](c2c1)c1cc(ccc31)-c1ccc(F)cc1F	InChI=1S/C33H29F2N3O3/c1-17-28(25(15-30(36)38-17)18-8-10-40-11-9-18)16-37-33(39)20-3-6-24-27(13-20)32-26-12-19(2-5-23(26)31(24)41-32)22-7-4-21(34)14-29(22)35/h2-7,12-15,18,31-32H,8-11,16H2,1H3,(H2,36,38)(H,37,39)/t31-,32+/m0/s1	SGLCEUPAXRNQPL-AJQTZOPKSA-N	306604	(1R,8S)-N-{[6-amino-2-methyl-4- (oxan-4-yl)pyridin-3- yl]methyl)-12-(2,4- difluorophenyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 247	Plasma kallikrein			 5.01							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306604	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306604&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131933	381755303							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588100	CCc1cc(N)nc(CC)c1CNC(=O)c1ccc2[C@H]3O[C@@H](c2c1)c1cc(ccc31)-c1ccc(F)cc1F	InChI=1S/C31H27F2N3O2/c1-3-16-13-28(34)36-27(4-2)25(16)15-35-31(37)18-6-9-22-24(12-18)30-23-11-17(5-8-21(23)29(22)38-30)20-10-7-19(32)14-26(20)33/h5-14,29-30H,3-4,15H2,1-2H3,(H2,34,36)(H,35,37)/t29-,30+/m0/s1	BGDWJYALQRZTFT-XZWHSSHBSA-N	306605	(1R,8S)-N-[(6-amino-2,4- diethylpyridin-3-yl)methyl]-12- (2,4-difluorophenyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 248	Plasma kallikrein			 2570							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306605	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306605&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131932	381755304							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588101	CC(C)N(c1ccc2[C@@H]3O[C@H](c2c1)c1cc(ccc31)C(=O)NCc1c(C)cc(N)nc1C)c1cccc(F)c1	InChI=1S/C32H31FN4O2/c1-17(2)37(22-7-5-6-21(33)14-22)23-9-11-25-27(15-23)31-26-13-20(8-10-24(26)30(25)39-31)32(38)35-16-28-18(3)12-29(34)36-19(28)4/h5-15,17,30-31H,16H2,1-4H3,(H2,34,36)(H,35,38)/t30-,31+/m1/s1	VURFWJPALWDGGG-JSOSNVBQSA-N	306606	(1S,8R)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]-12- [(3-fluorophenyl)(propan-2-yl) amino]-15- oxatetracyclo[6.6.1.02,7.09,14]- pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 249	Plasma kallikrein			 93.3							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306606	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306606&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131934	381755305							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588102	CCCN(c1ccc2[C@@H]3O[C@H](c2c1)c1cc(ccc31)C(=O)NCc1c(C)cc(N)nc1C)c1cccc(F)c1	InChI=1S/C32H31FN4O2/c1-4-12-37(22-7-5-6-21(33)15-22)23-9-11-25-27(16-23)31-26-14-20(8-10-24(26)30(25)39-31)32(38)35-17-28-18(2)13-29(34)36-19(28)3/h5-11,13-16,30-31H,4,12,17H2,1-3H3,(H2,34,36)(H,35,38)/t30-,31+/m1/s1	SYGXSCXCDXGJHI-JSOSNVBQSA-N	306607	(1S,8R)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]-12- [(3-fluorophenyl)(propyl) amino]-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 250	Plasma kallikrein			 33.1							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306607	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306607&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131935	381755306							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588103	CO\N=C(\N)c1ccc(CNC(=O)c2ccc3[C@H]4O[C@@H](c3c2)c2cc(ccc42)-c2ccc(Cl)s2)cc1	InChI=1S/C28H22ClN3O3S/c1-34-32-27(30)16-4-2-15(3-5-16)14-31-28(33)18-7-9-20-22(13-18)26-21-12-17(23-10-11-24(29)36-23)6-8-19(21)25(20)35-26/h2-13,25-26H,14H2,1H3,(H2,30,32)(H,31,33)/t25-,26+/m0/s1	HVWLRGSZEYVDFG-IZZNHLLZSA-N	306608	(1S,8R)-12-(5-chlorothiophen- 2-yl)-N-({4-[N'- methoxycarbamimidoyl]phenyl} methyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 251	Plasma kallikrein			 100000							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306608	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306608&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137554684	381755307							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588104	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2[C@H]3O[C@@H](c2c1)c1cc(ccc31)-c1cn2ccccc2n1	InChI=1S/C30H25N5O2/c1-16-11-26(31)33-17(2)24(16)14-32-30(36)19-7-9-21-23(13-19)29-22-12-18(6-8-20(22)28(21)37-29)25-15-35-10-4-3-5-27(35)34-25/h3-13,15,28-29H,14H2,1-2H3,(H2,31,33)(H,32,36)/t28-,29+/m0/s1	SMSWUJJUQPYPPK-URLMMPGGSA-N	306609	(1R,8S)-N-[(6-amino-2,4- dimethylpyridin-3-y])methyl]- 12-{imidazo[1,2-a]pyridin-2- yl}-15-oxatetracyclo [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 252	Plasma kallikrein			 93.3							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306609	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306609&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131937	381755308							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588105	COc1ccc(CNC(=O)c2ccc3[C@H]4O[C@@H](c3c2)c2cc(ccc42)-c2ccccc2F)cc1	InChI=1S/C29H22FNO3/c1-33-20-10-6-17(7-11-20)16-31-29(32)19-9-13-23-25(15-19)28-24-14-18(8-12-22(24)27(23)34-28)21-4-2-3-5-26(21)30/h2-15,27-28H,16H2,1H3,(H,31,32)/t27-,28+/m0/s1	JPKWCXLFJMHLBZ-WUFINQPMSA-N	306610	(1R,8S)-12-(2-fluorophenyl)- N-[(4-methoxy- phenyl)methyl]-15- oxatetracyclo[6.6.1.02,7.09,14]- pentadeca-2,4,6,9,11,13-hexaene- 4-carboxamide::US10144746, Compound 253	Plasma kallikrein			 100000							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306610	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306610&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131938	381755309							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588106	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2[C@H]3O[C@H](c4cc(Cc5ccccc5)ccc34)c2c1	InChI=1S/C30H27N3O2/c1-17-12-27(31)33-18(2)26(17)16-32-30(34)21-9-11-23-25(15-21)29-24-14-20(8-10-22(24)28(23)35-29)13-19-6-4-3-5-7-19/h3-12,14-15,28-29H,13,16H2,1-2H3,(H2,31,33)(H,32,34)/t28-,29+/m0/s1	BPGBMFOWMCMBDZ-URLMMPGGSA-N	306611	(1R,8S)-N-[(6-amino-2,4- dimethylpyridin-3-yl) methyl]-12- benzyl-15-oxatetracyclo- [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 254	Plasma kallikrein			 19.1							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306611	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306611&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131939	381755310							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588107	CO\N=C(\N)c1cc(F)c(CNC(=O)c2ccc3[C@H]4O[C@@H](c3c2)c2cc(ccc42)-c2ccc(F)cc2F)c(F)c1	InChI=1S/C30H21F4N3O3/c1-39-37-29(35)16-10-24(32)23(25(33)11-16)13-36-30(38)15-3-6-20-22(9-15)28-21-8-14(2-5-19(21)27(20)40-28)18-7-4-17(31)12-26(18)34/h2-12,27-28H,13H2,1H3,(H2,35,37)(H,36,38)/t27-,28+/m0/s1	YNUYMQSQNXSQFG-WUFINQPMSA-N	306612	(1R,8S)-N-({2,6-difluoro- 4-[N'-methoxy- carbamimidoyl]phenyl}methyl)- 12-(2,4-difluorophenyl)-15- oxatetracyclo[6.6.1.02,7.09,14]- pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 255	Plasma kallikrein			 661							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306612	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306612&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137554685	381755311							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588108	NC(=N)c1cc(F)c(CNC(=O)c2ccc3[C@H]4O[C@@H](c3c2)c2cc(ccc42)-c2ccc(F)cc2F)c(F)c1	InChI=1S/C29H19F4N3O2/c30-16-3-6-17(25(33)11-16)13-1-4-18-20(7-13)27-21-8-14(2-5-19(21)26(18)38-27)29(37)36-12-22-23(31)9-15(28(34)35)10-24(22)32/h1-11,26-27H,12H2,(H3,34,35)(H,36,37)/t26-,27+/m0/s1	MHRZNRXBVWKSFH-RRPNLBNLSA-N	306613	(1R,8S)-N-[(4-carbamimidoyl- 2,6-difluoro-phenyl)methyl]- 12-(2,4-difluorophenyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 256	Plasma kallikrein			 0.759							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306613	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306613&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131633	381755312							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588109	Nc1cc(C2CC2)c(CNC(=O)c2ccc3[C@H]4O[C@@H](c3c2)c2cc(ccc42)-c2ccc(F)cc2F)c(n1)C1CC1	InChI=1S/C33H27F2N3O2/c34-20-7-10-21(28(35)13-20)18-5-8-22-25(11-18)32-26-12-19(6-9-23(26)31(22)40-32)33(39)37-15-27-24(16-1-2-16)14-29(36)38-30(27)17-3-4-17/h5-14,16-17,31-32H,1-4,15H2,(H2,36,38)(H,37,39)/t31-,32+/m0/s1	MIUWRWSERCPDJQ-AJQTZOPKSA-N	306614	(1R,8S)-N-[(6-amino-2,4- dicyclopropylpyridin-3- yl)methyl]-12-(2,4- difluorophenyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 257	Plasma kallikrein			 199526							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306614	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306614&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131941	381755313							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588110	NC(=N)c1cccc(NC(=O)c2ccc3[C@H]4O[C@@H](c3c2)c2cc(ccc42)-c2ccc(F)cc2F)c1	InChI=1S/C28H19F2N3O2/c29-17-6-9-19(24(30)13-17)14-4-7-20-22(11-14)26-23-12-16(5-8-21(23)25(20)35-26)28(34)33-18-3-1-2-15(10-18)27(31)32/h1-13,25-26H,(H3,31,32)(H,33,34)/t25-,26+/m0/s1	SBHSQYNDVOLYQR-IZZNHLLZSA-N	306615	(1R,8S)-N-(3- carbamimidoylphenyl)- 12-(2,4-difluorophenyl)-15- oxatetrayclo[6.6.1.02,7.09,14]- pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 258	Plasma kallikrein			 10000							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306615	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306615&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131942	381755314							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588111	NC(=N)c1ccc(CNC(=O)c2ccc3[C@H]4O[C@H](c5cc(ccc45)C4CC4)c3c2)cc1	InChI=1S/C26H23N3O2/c27-25(28)16-3-1-14(2-4-16)13-29-26(30)18-8-10-20-22(12-18)24-21-11-17(15-5-6-15)7-9-19(21)23(20)31-24/h1-4,7-12,15,23-24H,5-6,13H2,(H3,27,28)(H,29,30)/t23-,24+/m0/s1	ALJWHNMEZKCUCS-BJKOFHAPSA-N	306616	(1R,8S)-N-[(4- carbamimidoylphenyl) methyl]-12- cyclopropyl-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 259	Plasma kallikrein			 2.00							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306616	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306616&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131944	381755315							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588112	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2[C@H]3O[C@H](c4cc(ccc34)N(c3cccc(F)c3)S(C)(=O)=O)c2c1	InChI=1S/C30H27FN4O4S/c1-16-11-27(32)34-17(2)26(16)15-33-30(36)18-7-9-22-24(12-18)29-25-14-21(8-10-23(25)28(22)39-29)35(40(3,37)38)20-6-4-5-19(31)13-20/h4-14,28-29H,15H2,1-3H3,(H2,32,34)(H,33,36)/t28-,29+/m1/s1	QDYMNLNFJIQUGK-WDYNHAJCSA-N	306617	(1S,8R)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 12-[N-(3-fluorophenyl)methane- sulfonamido]-15- oxatetracyclo[6.6.1.02,7.09,14]- pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 260	Plasma kallikrein			 186							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306617	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306617&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131943	381755316							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588113	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3CCC(c2c1)c1cc(ccc31)-c1ccc(F)cc1F	InChI=1S/C31H27F2N3O/c1-16-11-30(34)36-17(2)28(16)15-35-31(37)19-4-7-24-22-9-10-25(27(24)13-19)26-12-18(3-6-23(22)26)21-8-5-20(32)14-29(21)33/h3-8,11-14,22,25H,9-10,15H2,1-2H3,(H2,34,36)(H,35,37)	XMTNKCZVMNCXFS-UHFFFAOYSA-N	306618	(+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl) methyl]-12-(2,4- difluorophenyl)tetracyclo- [6.6.1.02,7.09,14]hexadeca- 2,4,6,9,11,13-hexaene-4- carboxamide and (+-)-N-[(6- amino-2,4-dimethylpyridin- 3-yl)methyl]-11-(2,4- difluorophenyl)tetracyclo [6.6.1.02,7.09,14]hexadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 261	Plasma kallikrein			 479							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306618	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306618&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131945	381755317							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588114	CN(c1ccc2[C@@H]3O[C@H](c2c1)c1cc(ccc31)C(=O)NCc1c(C)cc(N)nc1C)c1cccc(Cl)c1	InChI=1S/C30H27ClN4O2/c1-16-11-27(32)34-17(2)26(16)15-33-30(36)18-7-9-22-24(12-18)29-25-14-21(8-10-23(25)28(22)37-29)35(3)20-6-4-5-19(31)13-20/h4-14,28-29H,15H2,1-3H3,(H2,32,34)(H,33,36)/t28-,29+/m1/s1	LWQBBMWVWPJJKI-WDYNHAJCSA-N	306619	(1S,8R)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 12-[(3-chlorophenyl) (methyl)amino]-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 262	Plasma kallikrein			 8.91							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306619	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306619&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131947	381755318							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588115	CN(c1ccc2[C@@H]3O[C@H](c2c1)c1cc(ccc31)C(=O)NCc1ccc(cc1)C(N)=N)c1cccc(Cl)c1	InChI=1S/C30H25ClN4O2/c1-35(21-4-2-3-20(31)14-21)22-10-12-24-26(15-22)28-25-13-19(9-11-23(25)27(24)37-28)30(36)34-16-17-5-7-18(8-6-17)29(32)33/h2-15,27-28H,16H2,1H3,(H3,32,33)(H,34,36)/t27-,28+/m1/s1	HISZJDSZTYNNBO-IZLXSDGUSA-N	306620	(1S,8R)-N-[(4-carbamimidoyl- phenyl)methyl]-12-[(3- chlorophenyl)(methyl)amino]- 15-oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 263	Plasma kallikrein			 1.000							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306620	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306620&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131949	381755319							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588116	COc1ccc(Cl)c(CNC(=N)c2ccc3[C@H]4O[C@@H](c3c2)c2cc(ccc42)-c2ccc(F)cc2F)c1F	InChI=1S/C29H20ClF3N2O2/c1-36-25-9-8-23(30)22(26(25)33)13-35-29(34)15-3-6-19-21(11-15)28-20-10-14(2-5-18(20)27(19)37-28)17-7-4-16(31)12-24(17)32/h2-12,27-28H,13H2,1H3,(H2,34,35)/t27-,28+/m0/s1	JGYAWBKUISCPEM-WUFINQPMSA-N	306621	(1R,8S)-N-[(6-chloro-2-fluoro- 3-methoxyphenyl)-methyl]- 12-(2,4-difluorophenyl)-15- oxatetrayclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboximidamide::US10144746, Compound 264	Plasma kallikrein			 2399							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306621	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306621&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131948	381755320							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588117	CC(C)c1cc(N)nc(C)c1CNC(=O)c1ccc2[C@H]3O[C@@H](c2c1)c1cc(ccc31)C1=C(F)C=[N](O)C=C1	InChI=1S/C30H28FN4O3/c1-15(2)22-12-27(32)34-16(3)25(22)13-33-30(36)18-5-7-21-24(11-18)29-23-10-17(4-6-20(23)28(21)38-29)19-8-9-35(37)14-26(19)31/h4-12,14-15,28-29,37H,13H2,1-3H3,(H2,32,34)(H,33,36)/t28-,29+/m0/s1	DKEKHSVMFNPQRP-URLMMPGGSA-N	306622	4-[(1R,8S)-12-({[6-amino- 2-methyl-4-(propan-2-yl)pyridin- 3-yl]methyl)carbamoyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaen-4-yl]-3-fluoropyridin- 1-ium-1-olate::US10144746, Compound 265	Plasma kallikrein			 91.2							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306622	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306622&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124135652	381755321							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588118	N\C(=N\O)c1cc(F)c(CNC(=O)c2ccc3[C@H]4O[C@@H](c3c2)c2cc(ccc42)-c2ccc(F)cc2F)c(F)c1	InChI=1S/C29H19F4N3O3/c30-16-3-6-17(25(33)11-16)13-1-4-18-20(7-13)27-21-8-14(2-5-19(21)26(18)39-27)29(37)35-12-22-23(31)9-15(10-24(22)32)28(34)36-38/h1-11,26-27,38H,12H2,(H2,34,36)(H,35,37)/t26-,27+/m0/s1	AIUZFWBLTIVTMX-RRPNLBNLSA-N	306623	(1R,8S)-N-({2,6-difluoro- 4-[N'-hydroxy- carbamimidoyl]phenyl} methyl)-12-(2,4-difluorophenyl)- 15-oxatetracyclo[6.6.1.02,7.09,14]- pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 266	Plasma kallikrein			 102							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306623	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306623&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137554686	381755322							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588119	Cc1nc(N)cc(C2=CCOC2)c1CNC(=O)c1ccc2[C@H]3O[C@@H](c2c1)c1cc(ccc31)-c1ccc(F)cc1F	InChI=1S/C32H25F2N3O3/c1-16-27(24(13-29(35)37-16)19-8-9-39-15-19)14-36-32(38)18-3-6-23-26(11-18)31-25-10-17(2-5-22(25)30(23)40-31)21-7-4-20(33)12-28(21)34/h2-8,10-13,30-31H,9,14-15H2,1H3,(H2,35,37)(H,36,38)/t30-,31+/m0/s1	UBWSOJISRSKQSF-IOWSJCHKSA-N	306624	(1R,8S)-N-{[6-amino-4- (2,5-dihydrofuran-3-yl)-2- methylpyridin-3-yl]methyl)- 12-(2,4-difluoro-phenyl)-15- oxatetracyclo[6.6.1.02,7.09,14]- pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 267	Plasma kallikrein			 97.7							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306624	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306624&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131950	381755323							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588120	NC(=N)c1ccc(CNC(=O)c2ccc3[C@H]4O[C@@H](c3c2)c2cc(ccc42)-c2ccc(F)cc2F)cn1	InChI=1S/C28H20F2N4O2/c29-17-4-7-18(23(30)11-17)15-2-5-19-21(9-15)26-22-10-16(3-6-20(22)25(19)36-26)28(35)34-13-14-1-8-24(27(31)32)33-12-14/h1-12,25-26H,13H2,(H3,31,32)(H,34,35)/t25-,26+/m0/s1	CQLIKLLIHOWWPO-IZZNHLLZSA-N	306625	(1R,8S)-N-[(6-carbamimidoyl- pyridin-3-yl)-methyl]-12-(2,4- difluorophenyl)-15-oxatetracyclo [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 268	Plasma kallikrein			 5.01							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306625	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306625&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131951	381755324							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588121	CCOC(=O)N=C(N)c1cc(F)c(CNC(=O)c2ccc3[C@H]4O[C@@H](c3c2)c2cc(ccc42)-c2ccc(F)cc2F)c(F)c1	InChI=1S/C32H23F4N3O4/c1-2-42-32(41)39-30(37)17-11-25(34)24(26(35)12-17)14-38-31(40)16-4-7-21-23(10-16)29-22-9-15(3-6-20(22)28(21)43-29)19-8-5-18(33)13-27(19)36/h3-13,28-29H,2,14H2,1H3,(H,38,40)(H2,37,39,41)/t28-,29+/m0/s1	MZPVQYCBJCADJY-URLMMPGGSA-N	306626	US10144746, Compound 269::ethyl N-[amino[4-({(1R,8S)- 12-(2,4-difluoro-phenyl)-15- oxatetracyclo[6.6.1.02,7.09,14]- pentadeca-2,4,6,9,11,13- hexaen-4-yl]formamido}- methyl)-3,5- difluorophenyl]methylidene]- carbamate	Plasma kallikrein			 1230							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306626	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306626&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137554687	381755325							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588122	Fc1ccc(c(F)c1)-c1ccc2[C@@H]3O[C@@H](c4cc(ccc34)C(=O)NCc3ccc(cc3)-c3noc(=O)[nH]3)c2c1			306627	(1R,8S)-12-(2,4-difluorophenyl)- N-{[4-(5-oxo-4,5-dihydro- 1,2,4-oxadiazol-3-yl)phenyl] methyl}-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 270	Plasma kallikrein			 100000							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306627	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306627&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137554688	381755326							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588123	NC(=N)c1ccc(CNC(=O)c2ccc3[C@H]4O[C@H](c5cc(ccc45)[N+]#[C-])c3c2)cc1	InChI=1S/C24H18N4O2/c1-27-16-7-9-18-20(11-16)22-19-10-15(6-8-17(19)21(18)30-22)24(29)28-12-13-2-4-14(5-3-13)23(25)26/h2-11,21-22H,12H2,(H3,25,26)(H,28,29)/t21-,22+/m1/s1	MIZCQBHGBIENOS-YADHBBJMSA-N	306628	(1R,8S)-N-[(4-carbamimidoyl- phenyl)methyl]-12-cyano-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 271	Plasma kallikrein			 138							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306628	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306628&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137554689	381755327							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588124	CO\N=C(\N)c1ccc(CNC(=O)c2ccc3[C@H]4O[C@H](c5cc(ccc45)C4CC4)c3c2)cc1	InChI=1S/C27H25N3O3/c1-32-30-26(28)17-4-2-15(3-5-17)14-29-27(31)19-9-11-21-23(13-19)25-22-12-18(16-6-7-16)8-10-20(22)24(21)33-25/h2-5,8-13,16,24-25H,6-7,14H2,1H3,(H2,28,30)(H,29,31)/t24-,25+/m0/s1	CMSWKHRALWNRQU-LOSJGSFVSA-N	306629	(1R,8S)-12-cyclopropyl-N- ({4-[N'-methoxy- carbamimidoyl]phenyl} methyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 272	Plasma kallikrein			 2455							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306629	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306629&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137554690	381755328							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588125	CCOC(=O)N=C(N)c1ccc(CNC(=O)c2ccc3[C@H]4O[C@@H](c3c2)c2cc(ccc42)-c2ccc(F)cc2F)cc1	InChI=1S/C32H25F2N3O4/c1-2-40-32(39)37-30(35)18-5-3-17(4-6-18)16-36-31(38)20-8-11-24-26(14-20)29-25-13-19(7-10-23(25)28(24)41-29)22-12-9-21(33)15-27(22)34/h3-15,28-29H,2,16H2,1H3,(H,36,38)(H2,35,37,39)/t28-,29+/m0/s1	PETLMZIRPGKZEA-URLMMPGGSA-N	306630	US10144746, Compound 273::ethyl N-[amino[4-({(1R,8S)- 12-(2,4-difluorophenyl)-15- oxatetracyclo[6.6.1.02,7.09,14]- pentadeca-2,4,6,9,11,13- hexaen-4-yl]formamido}- methyl)phenyl]methylidene] carbamate	Plasma kallikrein			 6026							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306630	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306630&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137554691	381755329							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588126	CO\N=C(\N)c1cc(F)c(CNC(=O)c2ccc3[C@H]4O[C@@H](c3c2)c2cc(ccc42)-c2nccs2)c(F)c1	InChI=1S/C27H20F2N4O3S/c1-35-33-25(30)15-10-21(28)20(22(29)11-15)12-32-26(34)13-2-4-16-18(8-13)24-19-9-14(27-31-6-7-37-27)3-5-17(19)23(16)36-24/h2-11,23-24H,12H2,1H3,(H2,30,33)(H,32,34)/t23-,24+/m1/s1	PGCICGFXMCXXPH-RPWUZVMVSA-N	306631	(1S,8R)-N-({2,6-difluoro-4- N'-methoxy- carbamimidoyl]phenyl}methyl)- 12-(1,3-thiazol-2-yl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 274	Plasma kallikrein			 1380							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306631	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306631&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137554692	381755330							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588127	NC(=N)c1cc(F)c(CNC(=O)c2ccc3[C@H]4O[C@@H](c3c2)c2cc(ccc42)-c2nccs2)c(F)c1	InChI=1S/C26H18F2N4O2S/c27-20-9-14(24(29)30)10-21(28)19(20)11-32-25(33)12-1-3-15-17(7-12)23-18-8-13(26-31-5-6-35-26)2-4-16(18)22(15)34-23/h1-10,22-23H,11H2,(H3,29,30)(H,32,33)/t22-,23+/m1/s1	GPQLYGNKNQSBGO-PKTZIBPZSA-N	306632	(1S,8R)-N-[(4-carbamimidoyl- 2,6-difluoro-phenyl)methyl]- 12-(1,3-thiazol-2-yl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 275	Plasma kallikrein			 2.00							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306632	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306632&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131957	381755331							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588128	N\C(=N\O)c1ccc(CNC(=O)c2ccc3[C@H]4O[C@@H](c3c2)c2cc(ccc42)-c2ccc(Cl)s2)cc1	InChI=1S/C27H20ClN3O3S/c28-23-10-9-22(35-23)16-5-7-18-20(11-16)25-21-12-17(6-8-19(21)24(18)34-25)27(32)30-13-14-1-3-15(4-2-14)26(29)31-33/h1-12,24-25,33H,13H2,(H2,29,31)(H,30,32)/t24-,25+/m0/s1	SWOBTKNHKLJIHA-LOSJGSFVSA-N	306633	(1S,8R)-12-(5-chlorothiophen- 2-yl)-N-{[4-(N'- hydroxycarbamimidoyl)phenyl] methyl}-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 276	Plasma kallikrein			 100000							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306633	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306633&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137554693	381755332							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588129	CC(C)(O)c1ccc2[C@@H]3O[C@@H](c4cc(ccc34)C(=O)NCc3ccc(cc3)C(N)=N)c2c1	InChI=1S/C26H25N3O3/c1-26(2,31)17-8-10-19-21(12-17)23-20-11-16(7-9-18(20)22(19)32-23)25(30)29-13-14-3-5-15(6-4-14)24(27)28/h3-12,22-23,31H,13H2,1-2H3,(H3,27,28)(H,29,30)/t22-,23+/m1/s1	IFLAJNOVITVTGC-PKTZIBPZSA-N	306634	(1R,8S)-N-[(4-carbamimidoyl- phenyl)methyl]-12-(2- hydroxypropan-2-yl)-15- oxatetracyclo- [6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4- carboxamide::US10144746, Compound 277	Plasma kallikrein			 35.5							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306634	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306634&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131958	381755333							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588130	Cc1nc(N)cc(C2CC2)c1CNC(=O)c1ccc2[C@H]3O[C@@H](c2c1)c1cc(ccc31)C1=C(F)C=[N](O)C=C1	InChI=1S/C30H26FN4O3/c1-15-25(22(16-2-3-16)12-27(32)34-15)13-33-30(36)18-5-7-21-24(11-18)29-23-10-17(4-6-20(23)28(21)38-29)19-8-9-35(37)14-26(19)31/h4-12,14,16,28-29,37H,2-3,13H2,1H3,(H2,32,34)(H,33,36)/t28-,29+/m0/s1	KSLBQOOTHMDCGN-URLMMPGGSA-N	306635	4-[(1R,8S)-12-{[(6-amino-4- cyclopropyl-2-methylpyridin-3- yl)methyl(carbamoyl}-15- oxatetrayclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13-  hexaen-4-yl]-3-fluoropyridin- 1-ium-1-olate::US10144746, Compound 278	Plasma kallikrein			 34.7							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306635	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306635&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124135730	381755334							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588131	Cc1ccc(o1)C(=O)c1ccc2[C@@H]3O[C@@H](c4cc(ccc34)C(=O)NCc3c(C)cc(N)nc3C)c2c1	InChI=1S/C29H25N3O4/c1-14-10-25(30)32-16(3)23(14)13-31-29(34)18-6-8-20-22(12-18)28-21-11-17(5-7-19(21)27(20)36-28)26(33)24-9-4-15(2)35-24/h4-12,27-28H,13H2,1-3H3,(H2,30,32)(H,31,34)/t27-,28+/m0/s1	VZULXQWMPLSCJC-WUFINQPMSA-N	306636	(1R,8S)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 12-(5-methylfuran-2-carbonyl)- 15-oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 279	Plasma kallikrein			 22.9							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306636	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306636&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131961	381755335							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588132	NC(=N)c1cc(F)c(CNC(=O)c2ccc3[C@H]4O[C@H](c5cc(ccc45)C4CC4)c3c2)c(F)c1	InChI=1S/C26H21F2N3O2/c27-21-9-15(25(29)30)10-22(28)20(21)11-31-26(32)14-4-6-17-19(8-14)24-18-7-13(12-1-2-12)3-5-16(18)23(17)33-24/h3-10,12,23-24H,1-2,11H2,(H3,29,30)(H,31,32)/t23-,24+/m0/s1	FAQRYUDXFCYVQK-BJKOFHAPSA-N	306637	(1R,8S)-N-[(4-carbamimidoyl- 2,6-difluoro-phenyl)methyl]- 12-cyclopropyl-15-oxatetracyclo [6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13-hexaene- 4-carboxamide::US10144746, Compound 280	Plasma kallikrein			 0.759							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306637	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306637&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131959	381755336							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588133	CC(F)(F)c1ccc2[C@@H]3O[C@@H](c4cc(ccc34)C(=O)NCc3ccc(cc3)C(N)=N)c2c1	InChI=1S/C25H21F2N3O2/c1-25(26,27)16-7-9-18-20(11-16)22-19-10-15(6-8-17(19)21(18)32-22)24(31)30-12-13-2-4-14(5-3-13)23(28)29/h2-11,21-22H,12H2,1H3,(H3,28,29)(H,30,31)/t21-,22+/m1/s1	PAKASIDMAICWFY-YADHBBJMSA-N	306638	(1S,8R)-N-[(4-carbamimidoyl- phenyl)methyl]-12-(1,1- difluoroethyl)-15-oxatetracyclo- [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 281	Plasma kallikrein			 10.0							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306638	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306638&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131960	381755337							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588134	Cc1cc(N)nc(C)c1CNC(=N)c1ccc2[C@H]3O[C@@H](c2c1)c1cc(ccc31)-c1ccc(F)cc1F	InChI=1S/C29H24F2N4O/c1-14-9-26(32)35-15(2)24(14)13-34-29(33)17-4-7-21-23(11-17)28-22-10-16(3-6-20(22)27(21)36-28)19-8-5-18(30)12-25(19)31/h3-12,27-28H,13H2,1-2H3,(H2,32,35)(H2,33,34)/t27-,28+/m0/s1	CJMGVVCDHMYCOH-WUFINQPMSA-N	306639	(1R,8S)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]-12- (2,4-difluorophenyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 282	Plasma kallikrein			 2951							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306639	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306639&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131966	381755338							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588135	Fc1ccc(c(F)c1)-c1ccc2[C@@H]3O[C@@H](c4cc(ccc34)C(=N)Nc3ccc(F)c(c3)C#N)c2c1	InChI=1S/C28H16F3N3O/c29-17-3-7-19(25(31)12-17)14-1-5-20-22(10-14)27-23-11-15(2-6-21(23)26(20)35-27)28(33)34-18-4-8-24(30)16(9-18)13-32/h1-12,26-27H,(H2,33,34)/t26-,27+/m0/s1	OZAHOURIRSSKIA-RRPNLBNLSA-N	306640	(1R,8S)-N-(3-cyano-4- fluorophenyl)-12-(2,4- difluorophenyl)-15-oxatetracyclo [6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13-hexaene- 4-carboximidamide::US10144746, Compound 283	Plasma kallikrein			 100000							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306640	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306640&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131967	381755339							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588136	CC(C)(F)c1ccc2[C@@H]3O[C@@H](c4cc(ccc34)C(=O)NCc3ccc(cc3)C(N)=N)c2c1	InChI=1S/C26H24FN3O2/c1-26(2,27)17-8-10-19-21(12-17)23-20-11-16(7-9-18(20)22(19)32-23)25(31)30-13-14-3-5-15(6-4-14)24(28)29/h3-12,22-23H,13H2,1-2H3,(H3,28,29)(H,30,31)/t22-,23+/m1/s1	RYCBNERCLXZHOG-PKTZIBPZSA-N	306641	(1S,8R)-N-[(4- carbamimidoylphenyl) methyl]-12-(2- fluoropropan-2-yl)-15- oxatetracyclo- [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 284	Plasma kallikrein			 6.31							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306641	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306641&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131962	381755340							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588137	CC(=C)c1ccc2[C@@H]3O[C@H](c2c1)c1cc(ccc31)C(=O)NCc1c(F)cc(cc1F)C(N)=N	InChI=1S/C26H21F2N3O2/c1-12(2)13-3-5-16-18(7-13)24-19-8-14(4-6-17(19)23(16)33-24)26(32)31-11-20-21(27)9-15(25(29)30)10-22(20)28/h3-10,23-24H,1,11H2,2H3,(H3,29,30)(H,31,32)/t23-,24+/m0/s1	MKRQBUJZVKUPFP-BJKOFHAPSA-N	306642	(1R,8S)-N-[(4-carbamimidoyl- 2,6-difluoro-phenyl)methyl]- 12-(prop-1-en-2-yl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,l3- hexaene-4-carboxamide::US10144746, Compound 285	Plasma kallikrein			 1.000							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306642	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306642&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131963	381755341							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588138	NC(=N)c1cc(F)c(CNC(=O)c2ccc3[C@H]4O[C@@H](c3c2)c2cc(ccc42)-n2cccn2)c(F)c1	InChI=1S/C26H19F2N5O2/c27-21-9-14(25(29)30)10-22(28)20(21)12-31-26(34)13-2-4-16-18(8-13)24-19-11-15(33-7-1-6-32-33)3-5-17(19)23(16)35-24/h1-11,23-24H,12H2,(H3,29,30)(H,31,34)/t23-,24+/m1/s1	GWKRUJSWYBMOMH-RPWUZVMVSA-N	306643	(1S,8R)-N-[(4-carbamimidoyl- 2,6-difluoro-phenyl)methyl]- 12-(1H-pyrazol-l-yl)15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 286	Plasma kallikrein			 2.45							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306643	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306643&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131964	381755342							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588139	Nc1cccc(NC(=O)c2ccc3[C@H]4O[C@@H](c3c2)c2cc(ccc42)-c2ccc(F)cc2F)c1	InChI=1S/C27H18F2N2O2/c28-16-6-9-19(24(29)12-16)14-4-7-20-22(10-14)26-23-11-15(5-8-21(23)25(20)33-26)27(32)31-18-3-1-2-17(30)13-18/h1-13,25-26H,30H2,(H,31,32)/t25-,26+/m0/s1	ZVINFYCGMDLOCV-IZZNHLLZSA-N	306644	(1R,8S)-N-(3-aminophenyl)-12- (2,4-difluoro-phenyl)-15- oxatetracyclo[6.6.1.02,7.09,14]- pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 287	Plasma kallikrein			 10000							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306644	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306644&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131965	381755343							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588140	Nc1ccc(NC(=O)c2ccc3[C@H]4O[C@@H](c3c2)c2cc(ccc42)-c2ccc(F)cc2F)cc1	InChI=1S/C27H18F2N2O2/c28-16-3-10-19(24(29)13-16)14-1-8-20-22(11-14)26-23-12-15(2-9-21(23)25(20)33-26)27(32)31-18-6-4-17(30)5-7-18/h1-13,25-26H,30H2,(H,31,32)/t25-,26+/m0/s1	NAJCZYSZQBUHSB-IZZNHLLZSA-N	306645	(1R,8S)-N-(4-aminophenyl)- 12-(2,4-difluoro-phenyl)-15- oxatetracyclo[6.6.1.02,7.09,14]- pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 288	Plasma kallikrein			 100000							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306645	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306645&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131970	381755344							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588141	CC(C)c1cc(N)nc(C)c1CNC(=O)c1ccc2[C@H]3O[C@@H](c2c1)c1cc(ccc31)C1=C(F)C=CC=[N]1O	InChI=1S/C30H28FN4O3/c1-15(2)21-13-26(32)34-16(3)24(21)14-33-30(36)18-7-9-20-23(12-18)29-22-11-17(6-8-19(22)28(20)38-29)27-25(31)5-4-10-35(27)37/h4-13,15,28-29,37H,14H2,1-3H3,(H2,32,34)(H,33,36)/t28-,29+/m0/s1	PBPBNFLCEJDVMI-URLMMPGGSA-N	306646	2-[(1R,8S)-12-({[6-amino-2- methyl-4-(propan-2-yl)pyridin- 3-yl]methyl}carbamoyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaen-4-yl]-3-fluoropyridin-1- ium-1-olate::US10144746, Compound 289	Plasma kallikrein			 123							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306646	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306646&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124135081	381755345							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588142	NC(=N)c1ccc(CNC(=O)c2ccc3[C@H]4O[C@@H](c3c2)c2cc(ccc42)-c2ccccc2F)c(F)c1	InChI=1S/C29H21F2N3O2/c30-24-4-2-1-3-19(24)15-7-9-20-22(11-15)27-23-12-17(8-10-21(23)26(20)36-27)29(35)34-14-18-6-5-16(28(32)33)13-25(18)31/h1-13,26-27H,14H2,(H3,32,33)(H,34,35)/t26-,27+/m0/s1	ILODSJIESOAMNC-RRPNLBNLSA-N	306647	(1R,8S)-N-[(4-carbamimidoyl- 2-fluorophenyl)-methyl]-12- (2-fluorophenyl)-15- oxatetracyclo [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 290	Plasma kallikrein			 1.000							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306647	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306647&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131968	381755346							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588143	NC(=N)c1ccc(CNC(=O)c2ccc3[C@H]4O[C@@H](c3c2)c2cc(ccc42)-c2ccc(F)cc2F)c(F)c1	InChI=1S/C29H20F3N3O2/c30-18-5-8-19(25(32)12-18)14-3-6-20-22(9-14)27-23-10-16(4-7-21(23)26(20)37-27)29(36)35-13-17-2-1-15(28(33)34)11-24(17)31/h1-12,26-27H,13H2,(H3,33,34)(H,35,36)/t26-,27+/m0/s1	FSPKTPDKYPESLT-RRPNLBNLSA-N	306648	(1R,8S)-N-[(4-carbamimidoyl- 2-fluorophenyl)-methyl]-12- (2,4-difluorophenyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 291	Plasma kallikrein			 1.000							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306648	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306648&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131969	381755347							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588144	NC(=O)c1cccc(CNC(=O)c2ccc3[C@H]4O[C@@H](c3c2)c2cc(ccc42)-c2ccc(F)cc2F)c1	InChI=1S/C29H20F2N2O3/c30-19-6-9-20(25(31)13-19)16-4-7-21-23(11-16)27-24-12-18(5-8-22(24)26(21)36-27)29(35)33-14-15-2-1-3-17(10-15)28(32)34/h1-13,26-27H,14H2,(H2,32,34)(H,33,35)/t26-,27+/m0/s1	XJIZSKAPCBEBGD-RRPNLBNLSA-N	306649	(1R,8S)-N-[(3-carbamoylphenyl methyl]-12-(2,4- difluorophenyl)-15-oxatetracyclo [6.6.1.02,7.09,14]-pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 292	Plasma kallikrein			 100000							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306649	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306649&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131971	381755348							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588145	Nc1nccc2c(CNC(=O)c3ccc4[C@H]5O[C@@H](c4c3)c3cc(ccc53)-c3ccccc3F)c(Cl)ccc12	InChI=1S/C31H21ClFN3O2/c32-26-10-9-22-19(11-12-35-30(22)34)25(26)15-36-31(37)17-6-8-21-24(14-17)29-23-13-16(5-7-20(23)28(21)38-29)18-3-1-2-4-27(18)33/h1-14,28-29H,15H2,(H2,34,35)(H,36,37)/t28-,29+/m0/s1	FEOAEQSPIWSFST-URLMMPGGSA-N	306650	(1R,8S)-N-[(1-amino-6- chloroisoquinolin-5-yl)methyl]- 12-(2-fluorophenyl)-15- oxatetracyclo [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 294	Plasma kallikrein			 20.9							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306650	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306650&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131972	381755349							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588146	Nc1nccc2cc(Cl)c(CNC(=O)c3ccc4[C@H]5O[C@@H](c4c3)c3cc(ccc53)-c3ccccc3F)cc12	InChI=1S/C31H21ClFN3O2/c32-26-14-17-9-10-35-30(34)23(17)13-19(26)15-36-31(37)18-6-8-22-25(12-18)29-24-11-16(5-7-21(24)28(22)38-29)20-3-1-2-4-27(20)33/h1-14,28-29H,15H2,(H2,34,35)(H,36,37)/t28-,29+/m0/s1	DOPIMMZBWXUVBS-URLMMPGGSA-N	306651	(1R,8S)-N-[(1-amino-6- chloroisoquinolin-7-yl)methyl]-12- (2-fluorophenyl)-15-oxatetracyclo [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 295	Plasma kallikrein			 10000							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306651	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306651&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131973	381755350							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588147	NC(=N)c1cc(F)c(CNC(=O)c2ccc3[C@H]4O[C@H](c5cc(CCC(F)(F)F)ccc45)c3c2)c(F)c1	InChI=1S/C26H20F5N3O2/c27-20-9-14(24(32)33)10-21(28)19(20)11-34-25(35)13-2-4-16-18(8-13)23-17-7-12(5-6-26(29,30)31)1-3-15(17)22(16)36-23/h1-4,7-10,22-23H,5-6,11H2,(H3,32,33)(H,34,35)/t22-,23+/m0/s1	WOSFAHWCDJJYHI-XZOQPEGZSA-N	306652	(1R,8S)-N-((4-carbamimidoyl- 2,6-difluorophenyl)methyl]- 12-(3,3,3-trifluoropropyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 296	Plasma kallikrein			 1.000							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306652	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306652&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124132102	381755351							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588148	NC(=N)c1cc(F)c(CNC(=O)c2ccc3[C@H]4O[C@@H](c3c2)c2cc(ccc42)-n2nccn2)c(F)c1	InChI=1S/C25H18F2N6O2/c26-20-8-13(24(28)29)9-21(27)19(20)11-30-25(34)12-1-3-15-17(7-12)23-18-10-14(33-31-5-6-32-33)2-4-16(18)22(15)35-23/h1-10,22-23H,11H2,(H3,28,29)(H,30,34)/t22-,23+/m1/s1	KQYRJJPKUJSGRO-PKTZIBPZSA-N	306653	(1S,8R)-N-[(4-carbamimidoyl- 2,6-difluoro-phenyl)methyl]- 12-(2H-1,2,3-triazol-2-yl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 297	Plasma kallikrein			 30.2							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306653	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306653&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131975	381755352							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588149	CC(C)c1ccc2[C@@H]3O[C@H](c2c1)c1cc(ccc31)C(=O)NCc1c(F)cc(cc1F)C(N)=N	InChI=1S/C26H23F2N3O2/c1-12(2)13-3-5-16-18(7-13)24-19-8-14(4-6-17(19)23(16)33-24)26(32)31-11-20-21(27)9-15(25(29)30)10-22(20)28/h3-10,12,23-24H,11H2,1-2H3,(H3,29,30)(H,31,32)/t23-,24+/m0/s1	MJSCDBLIGOTIAQ-BJKOFHAPSA-N	306654	(1R,8S)-N-[(4-carbamimidoyl- 2,6-difluoro-phenyl)methyl]- 12-(propan-2-yl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13-hexaene- 4-carboxamide::US10144746, Compound 298	Plasma kallikrein			 2.00							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306654	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306654&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131976	381755353							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588150	Cc1ccc2c(N)nccc2c1CNC(=O)c1ccc2[C@H]3O[C@@H](c2c1)c1cc(ccc31)-c1ccccc1F	InChI=1S/C32H24FN3O2/c1-17-6-9-24-21(12-13-35-31(24)34)27(17)16-36-32(37)19-8-11-23-26(15-19)30-25-14-18(7-10-22(25)29(23)38-30)20-4-2-3-5-28(20)33/h2-15,29-30H,16H2,1H3,(H2,34,35)(H,36,37)/t29-,30+/m0/s1	SHDGITCAZGNDRB-XZWHSSHBSA-N	306655	(1R,8S)-N-[(1-amino-6- methylisoquinolin-5-yl) methyl]-12- (2-fluorophenyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 299	Plasma kallikrein			 30.9							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306655	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306655&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131977	381755354							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588151	Cc1cc2ccnc(N)c2cc1CNC(=O)c1ccc2[C@H]3O[C@@H](c2c1)c1cc(ccc31)-c1ccccc1F	InChI=1S/C32H24FN3O2/c1-17-12-19-10-11-35-31(34)25(19)15-21(17)16-36-32(37)20-7-9-24-27(14-20)30-26-13-18(6-8-23(26)29(24)38-30)22-4-2-3-5-28(22)33/h2-15,29-30H,16H2,1H3,(H2,34,35)(H,36,37)/t29-,30+/m0/s1	CMXSCDCVECUPHS-XZWHSSHBSA-N	306656	(1R,8S)-N-[(1-amino-6- methylisoquinolin-7-yl) methyl]-12- (2-fluorophenyl)-15- oxatetracyclo [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 300	Plasma kallikrein			 3162							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306656	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306656&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131978	381755355							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588152	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(Br)c(Br)cc31	InChI=1S/C23H19Br2N3O2/c1-10-5-20(26)28-11(2)17(10)9-27-23(29)12-3-4-13-14(6-12)22-16-8-19(25)18(24)7-15(16)21(13)30-22/h3-8,21-22H,9H2,1-2H3,(H2,26,28)(H,27,29)	BOKRTWZGCXZKGM-UHFFFAOYSA-N	306657	N-[(6-amino-2,4-dimethylpyridin- 3-yl)methyl]-11,12- dibromo-15-oxatetracyclo [6.6.1.02,7.09,14]-pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 301	Plasma kallikrein			 389							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306657	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306657&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131979	381755356							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588153	NC(=N)c1ccc(CNC(=O)c2ccc3[C@H]4O[C@H](c5cc(ccc45)C4CC4)c3c2)c(F)c1	InChI=1S/C26H22FN3O2/c27-22-11-15(25(28)29)3-4-17(22)12-30-26(31)16-6-8-19-21(10-16)24-20-9-14(13-1-2-13)5-7-18(20)23(19)32-24/h3-11,13,23-24H,1-2,12H2,(H3,28,29)(H,30,31)/t23-,24+/m0/s1	HLQBNDDUQPDVLL-BJKOFHAPSA-N	306658	(1R,8S)-N-[(4-carbamimidoyl-2- fluorophenyl)-methyl]-12- cyclopropyl-15-oxatetracyclo- [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 302	Plasma kallikrein			 1.000							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306658	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306658&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131980	381755357							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588154	CCc1cc2C3OC(c2cc1CC)c1cc(ccc31)C(=O)NCc1c(C)cc(N)nc1C	InChI=1S/C27H29N3O2/c1-5-16-10-21-22(11-17(16)6-2)26-20-12-18(7-8-19(20)25(21)32-26)27(31)29-13-23-14(3)9-24(28)30-15(23)4/h7-12,25-26H,5-6,13H2,1-4H3,(H2,28,30)(H,29,31)	LKHRJDQHSFZXCI-UHFFFAOYSA-N	306659	(+-)-N-[(6-amino-2,4-dimethyl- pyridin-3-yl)methyl]-11,12- diethyl-15-oxatetracyclo [6.6.1.02,7.09,14]pentadeca- 2,4,6,9(14),10,12-hexaene-4- carboxamide::US10144746, Compound 303	Plasma kallikrein			 209							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306659	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306659&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131981	381755358							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588155	Nc1ccc(NC(=O)c2ccc3[C@H]4O[C@@H](c3c2)c2cc(ccc42)-c2ccc(F)cc2F)cn1	InChI=1S/C26H17F2N3O2/c27-15-3-7-17(22(28)11-15)13-1-5-18-20(9-13)25-21-10-14(2-6-19(21)24(18)33-25)26(32)31-16-4-8-23(29)30-12-16/h1-12,24-25H,(H2,29,30)(H,31,32)/t24-,25+/m0/s1	RDJJVSRRINGZCZ-LOSJGSFVSA-N	306660	(1R,8S)-N-(6-aminopyridin-3-yl)- 12-(2,4-difluorophenyl)- 15-oxatetracyclo[6.6.1.02,7.09,14]- pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 304	Plasma kallikrein			 10000							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306660	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306660&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131982	381755359							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588156	NC(=N)c1ccc(CNC(=O)c2ccc3[C@H]4O[C@@H](c3c2)c2cc(ccc42)-n2cccn2)cc1	InChI=1S/C26H21N5O2/c27-25(28)16-4-2-15(3-5-16)14-29-26(32)17-6-8-19-21(12-17)24-22-13-18(31-11-1-10-30-31)7-9-20(22)23(19)33-24/h1-13,23-24H,14H2,(H3,27,28)(H,29,32)/t23-,24+/m1/s1	ZVHSEPSHZYJWJE-RPWUZVMVSA-N	306661	(1S,8R)-N-[(4-carbamimidoyl- phenyl)methyl]-12-(1H- pyrazol-1-yl)-15-oxatetracyclo- [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 305	Plasma kallikrein			 8.91							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306661	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306661&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131983	381755360							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588157	Cc1cc(ccc1CNC(=O)c1ccc2[C@H]3O[C@@H](c2c1)c1cc(ccc31)-c1ccc(F)cc1F)C(N)=N	InChI=1S/C30H23F2N3O2/c1-15-10-17(29(33)34)2-3-19(15)14-35-30(36)18-5-8-23-25(12-18)28-24-11-16(4-7-22(24)27(23)37-28)21-9-6-20(31)13-26(21)32/h2-13,27-28H,14H2,1H3,(H3,33,34)(H,35,36)/t27-,28+/m0/s1	WACSXFFOGDZEBB-WUFINQPMSA-N	306662	(1R,8S)-N-[(4-carbamimidoyl- 2-methylpheny])-methyl]-12- (2,4-difluorophenyl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 306	Plasma kallikrein			 1.000							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306662	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306662&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131984	381755361							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588158	NC(=N)c1ccc(CNC(=O)c2ccc3[C@H]4O[C@H](c5cc(ccc45)N4CC(F)(F)C4)c3c2)cc1	InChI=1S/C26H22F2N4O2/c27-26(28)12-32(13-26)17-6-8-19-21(10-17)23-20-9-16(5-7-18(20)22(19)34-23)25(33)31-11-14-1-3-15(4-2-14)24(29)30/h1-10,22-23H,11-13H2,(H3,29,30)(H,31,33)/t22-,23+/m1/s1	XQVFEDUMLXBJFY-PKTZIBPZSA-N	306663	(1S,8R)-N-[(4-carbamimidoyl- phenyl)methyl]-12-(3,3- difluoroazetidin-1-yl)-15- oxatetracyclo- [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 307	Plasma kallikrein			 1.000							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306663	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306663&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131985	381755362							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588159	Cc1cc2C3OC(c2cc1C)c1cc(ccc31)C(=O)NCc1c(C)cc(N)nc1C	InChI=1S/C25H25N3O2/c1-12-7-18-19(8-13(12)2)24-20-10-16(5-6-17(20)23(18)30-24)25(29)27-11-21-14(3)9-22(26)28-15(21)4/h5-10,23-24H,11H2,1-4H3,(H2,26,28)(H,27,29)	JDMFMJOXINFZFV-UHFFFAOYSA-N	306664	(+-)-N-[(6-amino-2,4-dimethyl- pyridin-3-yl)methyl]-11,12- dimethyl-15-oxatetracyclo [6.6.1.02,7.09,14]pentadeca- 2,4,6,9(14),10,12-hexaene-4- carboxamide::US10144746, Compound 308	Plasma kallikrein			 224							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306664	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306664&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131986	381755363							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588160	Nc1ccnc(NC(=O)c2ccc3[C@H]4O[C@@H](c3c2)c2cc(ccc42)-c2ccc(F)cc2F)c1	InChI=1S/C26H17F2N3O2/c27-15-3-6-17(22(28)11-15)13-1-4-18-20(9-13)25-21-10-14(2-5-19(21)24(18)33-25)26(32)31-23-12-16(29)7-8-30-23/h1-12,24-25H,(H3,29,30,31,32)/t24-,25+/m0/s1	DYCCXODFUYQUNA-LOSJGSFVSA-N	306665	(1R,8S)-N-(4-aminopyridin- 2-yl)-12-(2,4-difluorophenyl)- 15-oxatetracyclo[6.6.1.02,7.09,14]- pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 309	Plasma kallikrein			 100000							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306665	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306665&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131987	381755364							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588161	Cc1cc2C3OC(c4cc(ccc34)C(=O)NCc3c(C)cc(N)nc3C)c2cc1-c1ccc(F)cc1F	InChI=1S/C30H25F2N3O2/c1-14-8-22-24(12-21(14)19-7-5-18(31)11-26(19)32)29-23-10-17(4-6-20(23)28(22)37-29)30(36)34-13-25-15(2)9-27(33)35-16(25)3/h4-12,28-29H,13H2,1-3H3,(H2,33,35)(H,34,36)	VHZGIFZSMLCLFW-UHFFFAOYSA-N	306666	(+-)-N-[(6-amino-2,4-dimethyl- pyridin-3-yl)methyl]-12-(2,4- difluorophenyl)-11-methyl-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9(14),10,12- hexaene-4-carboxamide and (+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]-11- (2,4-difluorophenyl)-12- methyl-15-oxatetracyclo [6.6.1.02,7.09,14]pentadeca- 2,4,6,9(14),10,12-hexaene-4- carboxamide::US10144746, Compound 310	Plasma kallikrein			 20.0							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306666	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306666&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131988	381755365							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588162	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(C2CC2)c(cc31)C1CC1	InChI=1S/C29H29N3O2/c1-14-9-26(30)32-15(2)25(14)13-31-29(33)18-7-8-19-22(10-18)28-24-12-21(17-5-6-17)20(16-3-4-16)11-23(24)27(19)34-28/h7-12,16-17,27-28H,3-6,13H2,1-2H3,(H2,30,32)(H,31,33)	XVJZWQSBZRYXPM-UHFFFAOYSA-N	306667	(+-)-N-[(6-amino-2,4-dimethyl- pyridin-3-yl)-methyl]-11,12- dicyclopropyl-15-oxatetracyclo [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 311	Plasma kallikrein			 32.4							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306667	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306667&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131990	381755366							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588163	Cc1cc(ccc1CNC(=O)c1ccc2[C@H]3O[C@@H](c2c1)c1cc(ccc31)-n1cccn1)C(N)=N	InChI=1S/C27H23N5O2/c1-15-11-16(26(28)29)3-4-18(15)14-30-27(33)17-5-7-20-22(12-17)25-23-13-19(32-10-2-9-31-32)6-8-21(23)24(20)34-25/h2-13,24-25H,14H2,1H3,(H3,28,29)(H,30,33)/t24-,25+/m1/s1	CNWLBDIQSZOXEO-RPBOFIJWSA-N	306668	(1S,8R)-N-[(4-carbamimidoyl-2- methylphenyl)-methyl]-12- (1H-pyrazol-1-yl)-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 312	Plasma kallikrein			 1.000							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306668	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306668&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131991	381755367							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588164	Fc1ccc(c(F)c1)-c1ccc2[C@@H]3O[C@@H](c4cc(ccc34)C(=O)NCC3CCNCC3)c2c1	InChI=1S/C27H24F2N2O2/c28-18-3-6-19(24(29)13-18)16-1-4-20-22(11-16)26-23-12-17(2-5-21(23)25(20)33-26)27(32)31-14-15-7-9-30-10-8-15/h1-6,11-13,15,25-26,30H,7-10,14H2,(H,31,32)/t25-,26+/m0/s1	MHRQNIJYMHLELG-IZZNHLLZSA-N	306669	(1R,8S)-12-(2,4- difluorophenyl)-N- [(piperidin-4-yl)methyl]- 15-oxatetracyclo[6.6.1.02,7.09,14]- pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 313	Plasma kallikrein			 47863							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306669	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306669&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131992	381755368							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588165	Cc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c2c1)c1cc(-c2ccccc2)c(cc31)-c1ccccc1	InChI=1S/C35H29N3O2/c1-20-15-32(36)38-21(2)31(20)19-37-35(39)24-13-14-25-28(16-24)34-30-18-27(23-11-7-4-8-12-23)26(17-29(30)33(25)40-34)22-9-5-3-6-10-22/h3-18,33-34H,19H2,1-2H3,(H2,36,38)(H,37,39)	VVOYBUFHTZCFOS-UHFFFAOYSA-N	306670	(+-)-N-[(6-amino-2,4-dimethyl- pyridin-3-yl)-methyl]-11,12- diphenyl-15-oxatetracyclo- [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 314	Plasma kallikrein			 871							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306670	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306670&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131993	381755369							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
588166	CCc1cc2C3OC(c2cc1CC)c1cc(ccc31)C(=O)NCc1ccc(cc1)C(N)=N	InChI=1S/C27H27N3O2/c1-3-16-11-22-23(12-17(16)4-2)25-21-13-19(9-10-20(21)24(22)32-25)27(31)30-14-15-5-7-18(8-6-15)26(28)29/h5-13,24-25H,3-4,14H2,1-2H3,(H3,28,29)(H,30,31)	XROGSPJLCQLFQP-UHFFFAOYSA-N	306671	(+-)-N-[(4-carbamimidoylphenyl) methyl]-11,12-diethyl-15- oxatetracyclo[6.6.1.02,7.09,14]- pentadeca-2,4,6,9(14),10,12- hexaene-4-carboxamide::US10144746, Compound 315	Plasma kallikrein			 1.82							US Patent		10.7270/Q2J38VNH		aid1796201	US10144746	Li, Z; Zancanella, M; Yu, C; Setti, LQ; Sham, H; Xu, Q; Yee, CW; Yu, M	Global Blood Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=306671	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=306671&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124131994	381755370							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583125	OC(=O)c1ccc(NC(=O)[C@@H](CC2CC2)c2ccc(c[n+]2[O-])-c2c(F)c(Cl)ccc2OC(F)F)cc1	InChI=1S/C25H20ClF3N2O5/c26-18-8-10-20(36-25(28)29)21(22(18)27)15-5-9-19(31(35)12-15)17(11-13-1-2-13)23(32)30-16-6-3-14(4-7-16)24(33)34/h3-10,12-13,17,25H,1-2,11H2,(H,30,32)(H,33,34)/t17-/m0/s1	KRBJCJHQECPFLG-KRWDZBQOSA-N	304092	(R)-2-(1-((4-carboxyphenyl)amino)-3-cyclopropyl-1-oxopropan-2-yl)-5-(3-chloro-6-(difluoromethoxy)-2-fluorophenyl)pyridine 1-oxide::BDBM304093::US10143681, Example 1	Plasma kallikrein			 79.0							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304092	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304092&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134261982	381752823							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583128	OC(=O)c1ccc(NC(=O)[C@H](CC2CCC2)c2ccc(c[n+]2[O-])-c2c(F)c(Cl)ccc2C(F)F)cc1	InChI=1S/C26H22ClF3N2O4/c27-20-10-9-18(24(29)30)22(23(20)28)16-6-11-21(32(36)13-16)19(12-14-2-1-3-14)25(33)31-17-7-4-15(5-8-17)26(34)35/h4-11,13-14,19,24H,1-3,12H2,(H,31,33)(H,34,35)/t19-/m1/s1	QELFRIHVHVRUFC-LJQANCHMSA-N	304095	(R)-2-(1-((4-Carboxyphenyl)amino)-3-cyclobutyl-1-oxopropan-2-yl)-5-(3-chloro-6-(difluoromethyl)-2-fluorophenyl)pyridine 1-oxide::US10143681, Example 4	Plasma kallikrein			 4.70							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304095	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304095&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134261992	381752826							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583132	OC(=O)c1ccc(NC(=O)C(CC2CC2)c2ccc(c[n+]2[O-])-c2cc(Cl)ccc2OC(F)F)cc1	InChI=1S/C25H21ClF2N2O5/c26-17-6-10-22(35-25(27)28)19(12-17)16-5-9-21(30(34)13-16)20(11-14-1-2-14)23(31)29-18-7-3-15(4-8-18)24(32)33/h3-10,12-14,20,25H,1-2,11H2,(H,29,31)(H,32,33)	YWZGOTWQFDUJLI-UHFFFAOYSA-N	304097	(S)- or (R)-4-[(2-{5-[5-chloro-2- (difluoromethoxy)phenyl]-1- oxidopyridin-2-yl}-3- cyclopropylpropanoyl)amino] benzoic acid::BDBM304098::US10143681, Example 6	Plasma kallikrein			 265							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304097	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304097&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134261889	381752828							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583135	CCOc1ccc(Cl)c(F)c1-c1ccc(C(CC2CC2)C(=O)Nc2ccc(cc2)C(O)=O)[n+]([O-])c1	InChI=1S/C26H24ClFN2O5/c1-2-35-22-12-10-20(27)24(28)23(22)17-7-11-21(30(34)14-17)19(13-15-3-4-15)25(31)29-18-8-5-16(6-9-18)26(32)33/h5-12,14-15,19H,2-4,13H2,1H3,(H,29,31)(H,32,33)	XSDMRJIEZPLQOG-UHFFFAOYSA-N	304099	(S)- or (R)-4-({2-[5-(3-chloro-6- ethoxy-2-fluorophenyl)-1- oxidopyridin-2-yl]-3- cyclopropylpropanoyl}amino) benzoic acid::BDBM304100::US10143681, Example 8	Plasma kallikrein			 857							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304099	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304099&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134261940	381752830							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583140	OC(=O)c1ccc(NC(=O)[C@H](CC2CC2)c2ccc(c[n+]2[O-])-c2c(F)c(Cl)ccc2OCC2CC2)cc1	InChI=1S/C28H26ClFN2O5/c29-22-10-12-24(37-15-17-3-4-17)25(26(22)30)19-7-11-23(32(36)14-19)21(13-16-1-2-16)27(33)31-20-8-5-18(6-9-20)28(34)35/h5-12,14,16-17,21H,1-4,13,15H2,(H,31,33)(H,34,35)/t21-/m1/s1	KSZYPGSZLPQUJD-OAQYLSRUSA-N	304104	(R)-4-[(2-{5-[3-chloro-6- (cyclopropylmethoxy)-2- fluorophenyl]-1-oxidopyridin-2- yl}-3- cyclopropylpropanoyl)amino] benzoic acid::US10143681, Example 13	Plasma kallikrein			 984							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304104	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304104&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137554349	381752835							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583143	OC(=O)c1ccc(NC(=O)C(CC2CCC2)c2ccc(c[n+]2[O-])-c2c(F)c(Cl)ccc2OC(F)F)cc1	InChI=1S/C26H22ClF3N2O5/c27-19-9-11-21(37-26(29)30)22(23(19)28)16-6-10-20(32(36)13-16)18(12-14-2-1-3-14)24(33)31-17-7-4-15(5-8-17)25(34)35/h4-11,13-14,18,26H,1-3,12H2,(H,31,33)(H,34,35)	SMVANVUZBHIRKH-UHFFFAOYSA-N	304105	(S)- or (R)-4-[(2-{5-[3-chloro-6- (difluoromethoxy)-2- fluorophenyl]-1-oxidopyridin-2- yl}-3- cyclobutylpropanoyl)amino] benzoic acid::BDBM304106::US10143681, Example 14	Plasma kallikrein			 20.0							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304105	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304105&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134261968	381752836							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583148	OC(=O)c1ccc(NC(=O)C(CC2CCCC2)c2ccc(c[n+]2[O-])-c2c(F)c(Cl)ccc2OC(F)F)cc1	InChI=1S/C27H24ClF3N2O5/c28-20-10-12-22(38-27(30)31)23(24(20)29)17-7-11-21(33(37)14-17)19(13-15-3-1-2-4-15)25(34)32-18-8-5-16(6-9-18)26(35)36/h5-12,14-15,19,27H,1-4,13H2,(H,32,34)(H,35,36)	WEDNVWIHKKHMLF-UHFFFAOYSA-N	304109	(S)- or (R)-4-[(2-{5-[3-chloro-6- (difluoromethoxy)-2- fluorophenyl]-1-oxidopyridin-2- yl}-3- cyclopentylpropanoyl)amino] benzoic acid::BDBM304110::US10143681, Example 18	Plasma kallikrein			 20.0							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304109	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304109&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134261903	381752839							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583153	OC(=O)c1ccc(NC(=O)[C@H](CC2CC2)c2ccc(c[n+]2[O-])-c2c(F)c(Cl)ccc2C(F)F)cc1	InChI=1S/C25H20ClF3N2O4/c26-19-9-8-17(23(28)29)21(22(19)27)15-5-10-20(31(35)12-15)18(11-13-1-2-13)24(32)30-16-6-3-14(4-7-16)25(33)34/h3-10,12-13,18,23H,1-2,11H2,(H,30,32)(H,33,34)/t18-/m1/s1	YTPAQVBXJDTTMW-GOSISDBHSA-N	304114	(R)-2-(1-((4-carboxyphenyl)amino)-3-cyclopropyl-1-oxopropan-2-yl)-5-(3-chloro-6-(difluoromethyl)-2-fluorophenyl)pyridine 1-oxide::US10143681, Example 23	Plasma kallikrein			 22.0							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304114	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304114&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134261848	381752844							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583156	OC(=O)c1ccc(NC(=O)C(CC2CC2)c2ccc(c[n+]2[O-])-c2cc(Cl)ccc2C(F)(F)F)cc1	InChI=1S/C25H20ClF3N2O4/c26-17-6-9-21(25(27,28)29)19(12-17)16-5-10-22(31(35)13-16)20(11-14-1-2-14)23(32)30-18-7-3-15(4-8-18)24(33)34/h3-10,12-14,20H,1-2,11H2,(H,30,32)(H,33,34)	QVXJUKANZPVSKU-UHFFFAOYSA-N	304115	(S)- or (R)-2-(1-((4- carboxyphenyl)amino)-3-cyclopropyl- 1-oxopropan-2-yl)-5-(5-chloro-2- (trifluoromethyl)phenyl)pyridine 1- oxide::BDBM304116::US10143681, Example 24	Plasma kallikrein			 756							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304115	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304115&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134261960	381752845							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583159	OC(=O)c1ccc(NC(=O)C(CC2CC2)c2ccc(c[n+]2[O-])-c2c(F)c(Cl)ccc2C(F)(F)F)cc1	InChI=1S/C25H19ClF4N2O4/c26-19-9-8-18(25(28,29)30)21(22(19)27)15-5-10-20(32(36)12-15)17(11-13-1-2-13)23(33)31-16-6-3-14(4-7-16)24(34)35/h3-10,12-13,17H,1-2,11H2,(H,31,33)(H,34,35)	JTLBWMORCYFFNN-UHFFFAOYSA-N	304117	(S)- or (R)-2-(1-((4- carboxyphenyl)amino)-3-cyclopropyl- 1-oxopropan-2-yl)-5-(3-chloro-2- fluoro-6- (trifluoromethyl)phenyl)pyridine 1- oxide::BDBM304118::US10143681, Example 26	Plasma kallikrein			 162							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304117	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304117&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134261894	381752847							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583162	OC(=O)c1ccc(NC(=O)C(CC2CC2)c2ccc(c[n+]2[O-])-c2cc(Cl)ccc2C(F)F)cc1	InChI=1S/C25H21ClF2N2O4/c26-17-6-9-19(23(27)28)20(12-17)16-5-10-22(30(34)13-16)21(11-14-1-2-14)24(31)29-18-7-3-15(4-8-18)25(32)33/h3-10,12-14,21,23H,1-2,11H2,(H,29,31)(H,32,33)	DEASBUXILZFEOO-UHFFFAOYSA-N	304119	(S)- or (R)-2-(1-((4- carboxyphenyl)amino)-3-cyclopropyl- 1-oxopropan-2-yl)-5-(5-chloro-2- (difluoromethyl)phenyl)pyridine 1- oxide::BDBM304120::US10143681, Example 28	Plasma kallikrein			 84.0							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304119	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304119&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134261888	381752849							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583164	OC(=O)c1ccc(NC(=O)C(CC2(CC2)C#N)c2ccc(c[n+]2[O-])-c2c(F)c(Cl)ccc2C(F)(F)F)cc1	InChI=1S/C26H18ClF4N3O4/c27-19-7-6-18(26(29,30)31)21(22(19)28)15-3-8-20(34(38)12-15)17(11-25(13-32)9-10-25)23(35)33-16-4-1-14(2-5-16)24(36)37/h1-8,12,17H,9-11H2,(H,33,35)(H,36,37)	IABKOYWFXCSAPK-UHFFFAOYSA-N	304121	2-(1-((4-carboxyphenyl)amino)-3-(1- cyanocyclopropyl)-1-oxopropan-2- yl)-5-(3-chloro-2-fluoro-6- (trifluoromethyl)phenyl)pyridine 1- oxide::US10143681, Example 30	Plasma kallikrein			 155							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304121	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304121&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134261918	381752851							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583166	OC(=O)c1ccc(NC(=O)C(CC2(CC2)C#N)c2ccc(c[n+]2[O-])-c2c(F)c(Cl)ccc2C(F)F)cc1	InChI=1S/C26H19ClF3N3O4/c27-19-7-6-17(23(29)30)21(22(19)28)15-3-8-20(33(37)12-15)18(11-26(13-31)9-10-26)24(34)32-16-4-1-14(2-5-16)25(35)36/h1-8,12,18,23H,9-11H2,(H,32,34)(H,35,36)	SKWZOYIDTMUKRB-UHFFFAOYSA-N	304122	2-(1-((4-carboxyphenyl)amino)-3-(1- cyanocyclopropyl)-1-oxopropan-2- yl)-5-(3-chloro-6-(difluoromethyl)-2- fluorophenyl)pyridine 1-oxide::US10143681, Example 31	Plasma kallikrein			 31.0							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304122	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304122&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134261973	381752852							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583169	OC(=O)c1ccc(NC(=O)[C@H](CC2CCC(=O)CC2)c2ccc(c[n+]2[O-])-c2c(F)c(Cl)ccc2OC(F)F)cc1	InChI=1S/C28H24ClF3N2O6/c29-21-10-12-23(40-28(31)32)24(25(21)30)17-5-11-22(34(39)14-17)20(13-15-1-8-19(35)9-2-15)26(36)33-18-6-3-16(4-7-18)27(37)38/h3-7,10-12,14-15,20,28H,1-2,8-9,13H2,(H,33,36)(H,37,38)/t20-/m1/s1	NKKYHDDBOFIQFZ-HXUWFJFHSA-N	304124	(R)-4-{[2-{5-[3-chloro-6-(difluoromethoxy)-2-fluorophenyl]-1-oxidopyridin-2-yl}-3-(4-oxocyclohexyl)propanoyl]amino}benzoic Acid::US10143681, Example 33	Plasma kallikrein			 81.0							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304124	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304124&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134261949	381752854							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583172	O[C@H]1CC[C@H](C[C@@H](C(=O)Nc2ccc(cc2)C(O)=O)c2ccc(c[n+]2[O-])-c2c(F)c(Cl)ccc2OC(F)F)CC1	InChI=1S/C28H26ClF3N2O6/c29-21-10-12-23(40-28(31)32)24(25(21)30)17-5-11-22(34(39)14-17)20(13-15-1-8-19(35)9-2-15)26(36)33-18-6-3-16(4-7-18)27(37)38/h3-7,10-12,14-15,19-20,28,35H,1-2,8-9,13H2,(H,33,36)(H,37,38)/t15-,19-,20-/m1/s1	WVAWTXJGGXPRFT-CDHQVMDDSA-N	304126	(R)-trans-4-{[2-{5-[3-chloro-6-(difluoromethoxy)-2-fluorophenyl]-1-oxidopyridin-2-yl}-3-(4-hydroxycyclohexyl)propanoyl]amino}benzoic Acid::US10143681, Example 35	Plasma kallikrein			 12.0							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304126	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304126&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134262099	381752856							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583175	O[C@H]1CC[C@H](CC(C(=O)Nc2ccc(cc2)C(O)=O)c2ccc(c[n+]2[O-])-c2c(F)c(Cl)ccc2C(F)F)CC1	InChI=1S/C28H26ClF3N2O5/c29-22-11-10-20(26(31)32)24(25(22)30)17-5-12-23(34(39)14-17)21(13-15-1-8-19(35)9-2-15)27(36)33-18-6-3-16(4-7-18)28(37)38/h3-7,10-12,14-15,19,21,26,35H,1-2,8-9,13H2,(H,33,36)(H,37,38)/t15-,19-,21?	AKWQVFJCPSUJBC-PRESFXJZSA-N	304127	(S)- or (R)-2-(1-((4- carboxyphenyl)amino)-3- ((1r,4r)-4-hydroxycyclohexyl)- 1-oxopropan-2-yl)-5-(3-chloro- 6-(difluoromethyl)-2- fluorophenyl)pyridine 1-oxide::BDBM304131::US10143681, Example 36	Plasma kallikrein			 5.70							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304127	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304127&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134261998	381752857							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583178	OC(=O)c1ccc(NC(=O)[C@H](CC2CCC(F)(F)CC2)c2ccc(c[n+]2[O-])-c2c(F)c(Cl)ccc2OC(F)F)cc1	InChI=1S/C28H24ClF5N2O5/c29-20-6-8-22(41-27(31)32)23(24(20)30)17-3-7-21(36(40)14-17)19(13-15-9-11-28(33,34)12-10-15)25(37)35-18-4-1-16(2-5-18)26(38)39/h1-8,14-15,19,27H,9-13H2,(H,35,37)(H,38,39)/t19-/m1/s1	FYTORULIARDUTO-LJQANCHMSA-N	304133	(R)-4-{[2-{5-[3-chloro-6-(difluoromethoxy)-2-fluorophenyl]-1-oxidopyridin-2-yl}-3-(4,4-difluorocyclohexyl)propanoyl]amino}benzoic Acid::US10143681, Example 39	Plasma kallikrein			 25.0							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304133	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304133&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134262157	381752863							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583180	C[C@@]1(O)CC[C@H](CC(C(=O)Nc2ccc(cc2)C(O)=O)c2ccc(c[n+]2[O-])-c2c(F)c(Cl)ccc2OC(F)F)CC1	InChI=1S/C29H28ClF3N2O6/c1-29(39)12-10-16(11-13-29)14-20(26(36)34-19-5-2-17(3-6-19)27(37)38)22-8-4-18(15-35(22)40)24-23(41-28(32)33)9-7-21(30)25(24)31/h2-9,15-16,20,28,39H,10-14H2,1H3,(H,34,36)(H,37,38)/t16-,20?,29+	PXYKTUTYSZAMSE-CVYQXTPRSA-N	304134	2-(1-((4- carboxyphenyl)amino)-3- ((1s,4s)-4-hydroxy-4- methylcyclohexyl)-1- oxopropan-2-yl)-5-(3-chloro- 6-(difluoromethoxy)-2- fluorophenyl)pyridine 1-oxide::US10143681, Example 40	Plasma kallikrein			 35.0							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304134	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304134&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134261970	381752864							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583184	C[C@]1(O)CC[C@H](CC(C(=O)Nc2ccc(cc2)C(O)=O)c2ccc(c[n+]2[O-])-c2c(F)c(Cl)ccc2OC(F)F)CC1	InChI=1S/C29H28ClF3N2O6/c1-29(39)12-10-16(11-13-29)14-20(26(36)34-19-5-2-17(3-6-19)27(37)38)22-8-4-18(15-35(22)40)24-23(41-28(32)33)9-7-21(30)25(24)31/h2-9,15-16,20,28,39H,10-14H2,1H3,(H,34,36)(H,37,38)/t16-,20?,29-	PXYKTUTYSZAMSE-XZWQZOJESA-N	304136	2-(1-((4- carboxyphenyl)amino)-3- ((1r,4r)-4-hydroxy-4- methylcyclohexyl)-1- oxopropan-2-yl)-5-(3-chloro- 6-(difluoromethoxy)-2- fluorophenyl)pyridine 1-oxide::BDBM304138::US10143681, Example 42	Plasma kallikrein			 20.0							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304136	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304136&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134261970	381752866							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583187	C[C@@]1(O)CC[C@H](CC(C(=O)Nc2ccc(cc2)C(O)=O)c2ccc(c[n+]2[O-])-c2c(F)c(Cl)ccc2C(F)F)CC1	InChI=1S/C29H28ClF3N2O5/c1-29(39)12-10-16(11-13-29)14-21(27(36)34-19-5-2-17(3-6-19)28(37)38)23-9-4-18(15-35(23)40)24-20(26(32)33)7-8-22(30)25(24)31/h2-9,15-16,21,26,39H,10-14H2,1H3,(H,34,36)(H,37,38)/t16-,21?,29+	ZWADCLCEAFKXOC-ZYBSQJPSSA-N	304139	2-(1-((4- carboxyphenyl)amino)-3- ((1s,4s)-4-hydroxy-4- methylcyclohexyl)-1- oxopropan-2-yl)-5-(3-chloro- 6-(difluoromethyl)-2- fluorophenyl)pyridine 1-oxide::BDBM304141::US10143681, Example 44	Plasma kallikrein			 12.0							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304139	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304139&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134262167	381752869							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583190	C[C@]1(O)CC[C@H](CC(C(=O)Nc2ccc(cc2)C(O)=O)c2ccc(c[n+]2[O-])-c2c(F)c(Cl)ccc2C(F)F)CC1	InChI=1S/C29H28ClF3N2O5/c1-29(39)12-10-16(11-13-29)14-21(27(36)34-19-5-2-17(3-6-19)28(37)38)23-9-4-18(15-35(23)40)24-20(26(32)33)7-8-22(30)25(24)31/h2-9,15-16,21,26,39H,10-14H2,1H3,(H,34,36)(H,37,38)/t16-,21?,29-	ZWADCLCEAFKXOC-LWAJIUGYSA-N	304142	2-(1-((4- carboxyphenyl)amino)-3- ((1r,4r)-4-hydroxy-4- methylcyclohexyl)-1- oxopropan-2-yl)-5-(3-chloro- 6-(difluoromethyl)-2- fluorophenyl)pyridine 1-oxide::BDBM304143::US10143681, Example 46	Plasma kallikrein			 20.0							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304142	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304142&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134262167	381752872							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583194	OC(=O)c1ccc(NC(=O)[C@H](CC2CC(F)(F)C2)c2ccc(c[n+]2[O-])-c2c(F)c(Cl)ccc2OC(F)F)cc1	InChI=1S/C26H20ClF5N2O5/c27-18-6-8-20(39-25(29)30)21(22(18)28)15-3-7-19(34(38)12-15)17(9-13-10-26(31,32)11-13)23(35)33-16-4-1-14(2-5-16)24(36)37/h1-8,12-13,17,25H,9-11H2,(H,33,35)(H,36,37)/t17-/m1/s1	BHJAKKAIHULLLP-QGZVFWFLSA-N	304147	(R)-2-(1-((4-carboxyphenyl)amino)-3-(3,3-difluorocyclobutyl)-1-oxopropan-2-yl)-5-(3-chloro-6-(difluoromethoxy)-2-fluorophenyl)pyridine 1-oxide::US10143681, Example 50	Plasma kallikrein			 47.0							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304147	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304147&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134262184	381752877							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583197	OC(=O)c1ccc(NC(=O)[C@H](CC23CC(C2)C3)c2ccc(c[n+]2[O-])-c2c(F)c(Cl)ccc2OC(F)F)cc1	InChI=1S/C27H22ClF3N2O5/c28-19-6-8-21(38-26(30)31)22(23(19)29)16-3-7-20(33(37)13-16)18(12-27-9-14(10-27)11-27)24(34)32-17-4-1-15(2-5-17)25(35)36/h1-8,13-14,18,26H,9-12H2,(H,32,34)(H,35,36)/t14?,18-,27?/m1/s1	MYUCKYTVMPEQIE-FXVQNQHISA-N	304149	(R)-4-[(3-bicyclo[1.1.1]pent-1-yl-2-{5-[3-chloro-6-(difluoromethoxy)-2-fluorophenyl]-1-oxidopyridin-2-yl}propanoyl)amino]benzoic Acid::US10143681, Example 52	Plasma kallikrein			 14.0							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304149	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304149&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134262153	381752879							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583201	C[C@H]1C[C@@H]1C[C@@H](C(=O)Nc1ccc(cc1)C(O)=O)c1ccc(c[n+]1[O-])-c1c(F)c(Cl)ccc1OC(F)F	InChI=1S/C26H22ClF3N2O5/c1-13-10-16(13)11-18(24(33)31-17-5-2-14(3-6-17)25(34)35)20-8-4-15(12-32(20)36)22-21(37-26(29)30)9-7-19(27)23(22)28/h2-9,12-13,16,18,26H,10-11H2,1H3,(H,31,33)(H,34,35)/t13-,16+,18+/m0/s1	CSPPCSXVVGHDSO-FDQGKXFDSA-N	304152	2-((R)-1-((4- carboxyphenyl)amino)-3- ((1R,2S)-2- methylcyclopropyl)-1- oxopropan-2-yl)-5-(3-chloro- 6-(difluoromethoxy)-2- fluorophenyl)pyridine 1- oxide::US10143681, Example 55	Plasma kallikrein			 21.0							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304152	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304152&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134261917	381752881							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583203	C[C@@H]1C[C@H]1C[C@@H](C(=O)Nc1ccc(cc1)C(O)=O)c1ccc(c[n+]1[O-])-c1c(F)c(Cl)ccc1OC(F)F	InChI=1S/C26H22ClF3N2O5/c1-13-10-16(13)11-18(24(33)31-17-5-2-14(3-6-17)25(34)35)20-8-4-15(12-32(20)36)22-21(37-26(29)30)9-7-19(27)23(22)28/h2-9,12-13,16,18,26H,10-11H2,1H3,(H,31,33)(H,34,35)/t13-,16+,18-/m1/s1	CSPPCSXVVGHDSO-RPVQJOFSSA-N	304153	2-((R)-1-((4- carboxyphenyl)amino)-3- ((1S,2R)-2- methylcyclopropyl)-1- oxopropan-2-yl)-5-(3-chloro- 6-(difluoromethoxy)-2- fluorophenyl)pyridine 1- oxide::US10143681, Example 56	Plasma kallikrein			 16.0							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304153	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304153&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134262045	381752882							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583210	CC1CC1C[C@@H](C(=O)Nc1ccc(cc1)C(O)=O)c1ccc(c[n+]1[O-])-c1c(F)c(Cl)ccc1C(F)F	InChI=1S/C26H22ClF3N2O4/c1-13-10-16(13)11-19(25(33)31-17-5-2-14(3-6-17)26(34)35)21-9-4-15(12-32(21)36)22-18(24(29)30)7-8-20(27)23(22)28/h2-9,12-13,16,19,24H,10-11H2,1H3,(H,31,33)(H,34,35)/t13?,16?,19-/m1/s1	KNUYTWQBCBAZFL-NSRCDFIJSA-N	304171	2-((2R)-1-((4- carboxyphenyl)amino)-3-(2- methylcyclopropyl)-1- oxopropan-2-yl)-5-(3-chloro-6- (difluoromethyl)-2- fluorophenyl)pyridine 1-oxide::US10143681, Example 62::US10143681, Example 63	Plasma kallikrein			 6.10							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304171	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304171&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134261987	381752897							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583212	CC1CC1C[C@@H](C(=O)Nc1ccc(cc1)C(O)=O)c1ccc(c[n+]1[O-])-c1c(F)c(Cl)ccc1C(F)F	InChI=1S/C26H22ClF3N2O4/c1-13-10-16(13)11-19(25(33)31-17-5-2-14(3-6-17)26(34)35)21-9-4-15(12-32(21)36)22-18(24(29)30)7-8-20(27)23(22)28/h2-9,12-13,16,19,24H,10-11H2,1H3,(H,31,33)(H,34,35)/t13?,16?,19-/m1/s1	KNUYTWQBCBAZFL-NSRCDFIJSA-N	304171	2-((2R)-1-((4- carboxyphenyl)amino)-3-(2- methylcyclopropyl)-1- oxopropan-2-yl)-5-(3-chloro-6- (difluoromethyl)-2- fluorophenyl)pyridine 1-oxide::US10143681, Example 62::US10143681, Example 63	Plasma kallikrein			 2.90							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304171	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304171&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134261987	381752897							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583215	CC1CC1C[C@@H](C(=O)Nc1ccc(cc1)C(O)=O)c1ccc(c[n+]1[O-])-c1c(F)c(Cl)ccc1C(F)(F)F	InChI=1S/C26H21ClF4N2O4/c1-13-10-16(13)11-18(24(34)32-17-5-2-14(3-6-17)25(35)36)21-9-4-15(12-33(21)37)22-19(26(29,30)31)7-8-20(27)23(22)28/h2-9,12-13,16,18H,10-11H2,1H3,(H,32,34)(H,35,36)/t13?,16?,18-/m1/s1	HXNUAZBSTFJGLY-PVCYVWKFSA-N	304174	2-((2R)-1-((4- carboxyphenyl)amino)-3-(2- methylcyclopropyl)-1- oxopropan-2-yl)-5-(3-chloro-2- fluoro-6- (trifluoromethyl)phenyl) pyridine 1-oxide::US10143681, Example 65	Plasma kallikrein			 51.0							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304174	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304174&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137554356	381752899							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583220	COc1cc([C@@H](CC2CC2)C(=O)Nc2ccc(cc2)C(O)=O)[n+]([O-])cc1-c1c(F)c(Cl)ccc1C(F)F	InChI=1S/C26H22ClF3N2O5/c1-37-21-11-20(32(36)12-18(21)22-16(24(29)30)8-9-19(27)23(22)28)17(10-13-2-3-13)25(33)31-15-6-4-14(5-7-15)26(34)35/h4-9,11-13,17,24H,2-3,10H2,1H3,(H,31,33)(H,34,35)/t17-/m1/s1	YVCFHVAJSFDIDX-QGZVFWFLSA-N	304178	(R)-2-(1-((4-carboxyphenyl)amino)-3-cyclopropyl-1-oxopropan-2-yl)-5-(3-chloro-6-(difluoromethyl)-2-fluorophenyl)-4-methoxypyridine 1-oxide::US10143681, Example 69	Plasma kallikrein			 42.0							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304178	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304178&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134261997	381752903							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583222	COc1cc(C(CC2CC2)C(=O)Nc2ccc(cc2)C(O)=O)[n+]([O-])cc1-c1c(F)c(Cl)ccc1OC(F)F	InChI=1S/C26H22ClF3N2O6/c1-37-21-11-19(32(36)12-17(21)22-20(38-26(29)30)9-8-18(27)23(22)28)16(10-13-2-3-13)24(33)31-15-6-4-14(5-7-15)25(34)35/h4-9,11-13,16,26H,2-3,10H2,1H3,(H,31,33)(H,34,35)	OUALKAWDVQPBGH-UHFFFAOYSA-N	304179	2-(1-((4-carboxyphenyl)amino)- 3-cyclopropyl-1-oxopropan-2- yl)-5-(3-chloro-6- (difluoromethoxy)-2- fluorophenyl)-4-methoxypyridine 1-oxide::BDBM304180::US10143681, Example 70	Plasma kallikrein			 3.30							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304179	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304179&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134262031	381752904							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583224	COc1cc(C(CC2CC2)C(=O)Nc2ccc(cc2)C(O)=O)[n+]([O-])cc1-c1c(F)c(Cl)ccc1OC(F)F	InChI=1S/C26H22ClF3N2O6/c1-37-21-11-19(32(36)12-17(21)22-20(38-26(29)30)9-8-18(27)23(22)28)16(10-13-2-3-13)24(33)31-15-6-4-14(5-7-15)25(34)35/h4-9,11-13,16,26H,2-3,10H2,1H3,(H,31,33)(H,34,35)	OUALKAWDVQPBGH-UHFFFAOYSA-N	304179	2-(1-((4-carboxyphenyl)amino)- 3-cyclopropyl-1-oxopropan-2- yl)-5-(3-chloro-6- (difluoromethoxy)-2- fluorophenyl)-4-methoxypyridine 1-oxide::BDBM304180::US10143681, Example 70	Plasma kallikrein			 11.0							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304179	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304179&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134262031	381752904							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583227	OC(=O)c1ccc(NC(=O)[C@H](CC2CC2)c2ccc(c[n+]2[O-])-c2c(F)c(Cl)ccc2OC(F)F)cc1F	InChI=1S/C25H19ClF4N2O5/c26-17-6-8-20(37-25(29)30)21(22(17)28)13-3-7-19(32(36)11-13)16(9-12-1-2-12)23(33)31-14-4-5-15(24(34)35)18(27)10-14/h3-8,10-12,16,25H,1-2,9H2,(H,31,33)(H,34,35)/t16-/m1/s1	LRECJFITXRQCOV-MRXNPFEDSA-N	304182	(R)-4-[(2-{5-[3-chloro-6-(difluoromethoxy)-2-fluorophenyl]-1-oxidopyridin-2-yl}-3-cyclopropylpropanoyl)amino]-2-fluorobenzoic Acid::US10143681, Example 73	Plasma kallikrein			 88.0							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304182	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304182&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134262024	381752907							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583229	CC1CC(CC(C(=O)Nc2ccc(cc2)C(O)=O)c2ccc(c[n+]2[O-])-c2c(F)c(Cl)ccc2C(F)(F)F)C1	InChI=1S/C27H23ClF4N2O4/c1-14-10-15(11-14)12-19(25(35)33-18-5-2-16(3-6-18)26(36)37)22-9-4-17(13-34(22)38)23-20(27(30,31)32)7-8-21(28)24(23)29/h2-9,13-15,19H,10-12H2,1H3,(H,33,35)(H,36,37)	DSFAAEBGZDLQIW-UHFFFAOYSA-N	304183	2-(1-((4- carboxyphenyl)amino)-3-(3- methylcyclobutyl)-1- oxopropan-2-yl)-5-(3- chloro-2-fluoro-6- (trifluoromethyl)phenyl) pyridine 1-oxide::US10143681, Example 74::US10143681, Example 75	Plasma kallikrein			 19.2							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304183	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304183&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137554359	381752908							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583231	CC1CC(CC(C(=O)Nc2ccc(cc2)C(O)=O)c2ccc(c[n+]2[O-])-c2c(F)c(Cl)ccc2C(F)(F)F)C1	InChI=1S/C27H23ClF4N2O4/c1-14-10-15(11-14)12-19(25(35)33-18-5-2-16(3-6-18)26(36)37)22-9-4-17(13-34(22)38)23-20(27(30,31)32)7-8-21(28)24(23)29/h2-9,13-15,19H,10-12H2,1H3,(H,33,35)(H,36,37)	DSFAAEBGZDLQIW-UHFFFAOYSA-N	304183	2-(1-((4- carboxyphenyl)amino)-3-(3- methylcyclobutyl)-1- oxopropan-2-yl)-5-(3- chloro-2-fluoro-6- (trifluoromethyl)phenyl) pyridine 1-oxide::US10143681, Example 74::US10143681, Example 75	Plasma kallikrein			 77.8							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304183	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304183&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137554359	381752908							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583233	OC(=O)c1ccc(NC(=O)C(CC2CC2(F)F)c2ccc(c[n+]2[O-])-c2c(F)c(Cl)ccc2C(F)F)cc1	InChI=1S/C25H18ClF5N2O4/c26-18-7-6-16(22(28)29)20(21(18)27)13-3-8-19(33(37)11-13)17(9-14-10-25(14,30)31)23(34)32-15-4-1-12(2-5-15)24(35)36/h1-8,11,14,17,22H,9-10H2,(H,32,34)(H,35,36)	SVGPLAPXCSQTJI-UHFFFAOYSA-N	304185	2-(1-((4- carboxyphenyl)amino)-3- (2,2-difluorocyclopropyl)-1- oxopropan-2-yl)-5-(3- chloro-6-(difluoromethyl)- 2-fluorophenyl)pyridine 1- oxide::BDBM304186::BDBM304187::BDBM304188::US10143681, Example 76	Plasma kallikrein			 14.5							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304185	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304185&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134261971	381752909							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583235	OC(=O)c1ccc(NC(=O)C(CC2CC2(F)F)c2ccc(c[n+]2[O-])-c2c(F)c(Cl)ccc2C(F)F)cc1	InChI=1S/C25H18ClF5N2O4/c26-18-7-6-16(22(28)29)20(21(18)27)13-3-8-19(33(37)11-13)17(9-14-10-25(14,30)31)23(34)32-15-4-1-12(2-5-15)24(35)36/h1-8,11,14,17,22H,9-10H2,(H,32,34)(H,35,36)	SVGPLAPXCSQTJI-UHFFFAOYSA-N	304185	2-(1-((4- carboxyphenyl)amino)-3- (2,2-difluorocyclopropyl)-1- oxopropan-2-yl)-5-(3- chloro-6-(difluoromethyl)- 2-fluorophenyl)pyridine 1- oxide::BDBM304186::BDBM304187::BDBM304188::US10143681, Example 76	Plasma kallikrein			 37.6							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304185	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304185&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134261971	381752909							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583240	OC(=O)c1ccc(NC(=O)C(CC2CC(F)C2)c2ccc(c[n+]2[O-])-c2c(F)c(Cl)ccc2C(F)F)cc1	InChI=1S/C26H21ClF4N2O4/c27-20-7-6-18(24(30)31)22(23(20)29)15-3-8-21(33(37)12-15)19(11-13-9-16(28)10-13)25(34)32-17-4-1-14(2-5-17)26(35)36/h1-8,12-13,16,19,24H,9-11H2,(H,32,34)(H,35,36)	FZRJFARUZQXZOZ-UHFFFAOYSA-N	304189	2-(1-((4- carboxyphenyl)amino)-3-(3- fluorocyclobutyl)-1- oxopropan-2-yl)-5-(3- chloro-6-(difluoromethyl)- 2-fluorophenyl)pyridine 1- oxide::BDBM304190::US10143681, Example 80	Plasma kallikrein			 8.40							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304189	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304189&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134261859	381752913							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583243	CC1(O)CC(CC(C(=O)Nc2ccc(cc2)C(O)=O)c2ccc(c[n+]2[O-])-c2c(F)c(Cl)ccc2C(F)F)C1	InChI=1S/C27H24ClF3N2O5/c1-27(37)11-14(12-27)10-19(25(34)32-17-5-2-15(3-6-17)26(35)36)21-9-4-16(13-33(21)38)22-18(24(30)31)7-8-20(28)23(22)29/h2-9,13-14,19,24,37H,10-12H2,1H3,(H,32,34)(H,35,36)	PGEJUVHVXIDCLU-UHFFFAOYSA-N	304191	2-(1-((4- carboxyphenyl)amino)-3-(3- hydroxy-3- methylcyclobutyl)-1- oxopropan-2-yl)-5-(3- chloro-6-(difluoromethyl)- 2-fluorophenyl)pyridine 1- oxide::US10143681, Example 82::US10143681, Example 83::US10143681, Example 84::US10143681, Example 85	Plasma kallikrein			 9.40							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304191	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304191&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134261928	381752915							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583246	CC1(O)CC(CC(C(=O)Nc2ccc(cc2)C(O)=O)c2ccc(c[n+]2[O-])-c2c(F)c(Cl)ccc2C(F)F)C1	InChI=1S/C27H24ClF3N2O5/c1-27(37)11-14(12-27)10-19(25(34)32-17-5-2-15(3-6-17)26(35)36)21-9-4-16(13-33(21)38)22-18(24(30)31)7-8-20(28)23(22)29/h2-9,13-14,19,24,37H,10-12H2,1H3,(H,32,34)(H,35,36)	PGEJUVHVXIDCLU-UHFFFAOYSA-N	304191	2-(1-((4- carboxyphenyl)amino)-3-(3- hydroxy-3- methylcyclobutyl)-1- oxopropan-2-yl)-5-(3- chloro-6-(difluoromethyl)- 2-fluorophenyl)pyridine 1- oxide::US10143681, Example 82::US10143681, Example 83::US10143681, Example 84::US10143681, Example 85	Plasma kallikrein			 38.0							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304191	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304191&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134261928	381752915							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583249	OC(=O)c1ccc(NC(=O)C(CC2CC2C(F)(F)F)c2ccc(c[n+]2[O-])-c2c(F)c(Cl)ccc2C(F)F)cc1	InChI=1S/C26H19ClF6N2O4/c27-19-7-6-16(23(29)30)21(22(19)28)13-3-8-20(35(39)11-13)17(9-14-10-18(14)26(31,32)33)24(36)34-15-4-1-12(2-5-15)25(37)38/h1-8,11,14,17-18,23H,9-10H2,(H,34,36)(H,37,38)	WBUMTRVFJVGNEX-UHFFFAOYSA-N	304195	2-(1-((4- carboxyphenyl)amino)-1- oxo-3-(2- (trifluoromethyl)cyclopropyl) propan-2-yl)-5-(3-chloro- 6-(difluoromethyl)-2- fluorophenyl)pyridine 1- oxide::BDBM304196::BDBM304197::US10143681, Example 86	Plasma kallikrein			 2.70							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304195	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304195&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137554360	381752916							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583251	OC(=O)c1ccc(NC(=O)C(CC2CC2C(F)(F)F)c2ccc(c[n+]2[O-])-c2c(F)c(Cl)ccc2C(F)F)cc1	InChI=1S/C26H19ClF6N2O4/c27-19-7-6-16(23(29)30)21(22(19)28)13-3-8-20(35(39)11-13)17(9-14-10-18(14)26(31,32)33)24(36)34-15-4-1-12(2-5-15)25(37)38/h1-8,11,14,17-18,23H,9-10H2,(H,34,36)(H,37,38)	WBUMTRVFJVGNEX-UHFFFAOYSA-N	304195	2-(1-((4- carboxyphenyl)amino)-1- oxo-3-(2- (trifluoromethyl)cyclopropyl) propan-2-yl)-5-(3-chloro- 6-(difluoromethyl)-2- fluorophenyl)pyridine 1- oxide::BDBM304196::BDBM304197::US10143681, Example 86	Plasma kallikrein			 3.60							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304195	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304195&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137554360	381752916							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583253	OC(=O)c1ccc(NC(=O)C(CC2CC2C(F)F)c2ccc(c[n+]2[O-])-c2c(F)c(Cl)ccc2C(F)F)cc1	InChI=1S/C26H20ClF5N2O4/c27-19-7-6-16(23(29)30)21(22(19)28)13-3-8-20(34(38)11-13)18(10-14-9-17(14)24(31)32)25(35)33-15-4-1-12(2-5-15)26(36)37/h1-8,11,14,17-18,23-24H,9-10H2,(H,33,35)(H,36,37)	CIBAUUPUKBYRIO-UHFFFAOYSA-N	304198	2-(1-((4- carboxyphenyl)amino)-3-(2- (difluoromethyl)cyclopropyl)- 1-oxopropan-2-yl)-5-(3- chloro-6-(difluoromethyl)- 2-fluorophenyl)pyridine-1- oxide::BDBM304199::US10143681, Example 89	Plasma kallikrein			 7.10							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304198	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304198&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134261907	381752919							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583255	OC(=O)c1ccc(NC(=O)C(CC2CC2C(F)F)c2ccc(c[n+]2[O-])-c2c(F)c(Cl)ccc2C(F)F)cc1	InChI=1S/C26H20ClF5N2O4/c27-19-7-6-16(23(29)30)21(22(19)28)13-3-8-20(34(38)11-13)18(10-14-9-17(14)24(31)32)25(35)33-15-4-1-12(2-5-15)26(36)37/h1-8,11,14,17-18,23-24H,9-10H2,(H,33,35)(H,36,37)	CIBAUUPUKBYRIO-UHFFFAOYSA-N	304198	2-(1-((4- carboxyphenyl)amino)-3-(2- (difluoromethyl)cyclopropyl)- 1-oxopropan-2-yl)-5-(3- chloro-6-(difluoromethyl)- 2-fluorophenyl)pyridine-1- oxide::BDBM304199::US10143681, Example 89	Plasma kallikrein			 5.30							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304198	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304198&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134261907	381752919							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583259	OC(=O)c1ccc(NC(=O)C(CC2CC2F)c2ccc(c[n+]2[O-])-c2c(F)c(Cl)ccc2C(F)F)cc1	InChI=1S/C25H19ClF4N2O4/c26-18-7-6-16(23(29)30)21(22(18)28)13-3-8-20(32(36)11-13)17(9-14-10-19(14)27)24(33)31-15-4-1-12(2-5-15)25(34)35/h1-8,11,14,17,19,23H,9-10H2,(H,31,33)(H,34,35)	PRDGTWINGHDYAQ-UHFFFAOYSA-N	304200	2-(1-((4- carboxyphenyl)amino)-3-(2- fluorocyclopropyl)-1- oxopropan-2-yl)-5-(3- chloro-6-(difluoromethyl)- 2-fluorophenyl)pyridine 1- oxide::BDBM304201::BDBM304202::US10143681, Example 91	Plasma kallikrein			 28.0							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304200	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304200&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134261924	381752921							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583261	OC(=O)c1ccc(NC(=O)C(CC2CC2CF)c2ccc(c[n+]2[O-])-c2c(F)c(Cl)ccc2C(F)F)cc1	InChI=1S/C26H21ClF4N2O4/c27-20-7-6-18(24(30)31)22(23(20)29)14-3-8-21(33(37)12-14)19(10-15-9-16(15)11-28)25(34)32-17-4-1-13(2-5-17)26(35)36/h1-8,12,15-16,19,24H,9-11H2,(H,32,34)(H,35,36)	NJNGYXSQUSGZGO-UHFFFAOYSA-N	304203	2-(1-((4- carboxyphenyl)amino)-3-(2- (fluoromethyl)cyclopropyl)- 1-oxopropan-2-yl)-5-(3- chloro-6-(difluoromethyl)- 2-fluorophenyl)pyridine 1- oxide::BDBM304204::BDBM304205::BDBM304206::US10143681, Example 94	Plasma kallikrein			 6.00							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304203	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304203&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134261948	381752924							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583263	OC(=O)c1ccc(NC(=O)C(CC2CC2CF)c2ccc(c[n+]2[O-])-c2c(F)c(Cl)ccc2C(F)F)cc1	InChI=1S/C26H21ClF4N2O4/c27-20-7-6-18(24(30)31)22(23(20)29)14-3-8-21(33(37)12-14)19(10-15-9-16(15)11-28)25(34)32-17-4-1-13(2-5-17)26(35)36/h1-8,12,15-16,19,24H,9-11H2,(H,32,34)(H,35,36)	NJNGYXSQUSGZGO-UHFFFAOYSA-N	304203	2-(1-((4- carboxyphenyl)amino)-3-(2- (fluoromethyl)cyclopropyl)- 1-oxopropan-2-yl)-5-(3- chloro-6-(difluoromethyl)- 2-fluorophenyl)pyridine 1- oxide::BDBM304204::BDBM304205::BDBM304206::US10143681, Example 94	Plasma kallikrein			 9.60							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304203	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304203&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134261948	381752924							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583267	CC1C(C)C1CC(C(=O)Nc1ccc(cc1)C(O)=O)c1ccc(c[n+]1[O-])-c1c(F)c(Cl)ccc1OC(F)F	InChI=1S/C27H24ClF3N2O5/c1-13-14(2)18(13)11-19(25(34)32-17-6-3-15(4-7-17)26(35)36)21-9-5-16(12-33(21)37)23-22(38-27(30)31)10-8-20(28)24(23)29/h3-10,12-14,18-19,27H,11H2,1-2H3,(H,32,34)(H,35,36)	GUCHYZAIJAAHRC-UHFFFAOYSA-N	304207	2-(1-((4- carboxyphenyl)amino)-3- (2,3-dimethylcyclopropyl)- 1-oxopropan-2-yl)-5-(3- chloro-6-(difluoromethoxy)- 2-fluorophenyl)pyridine 1- oxide::US10143681, Example 100::US10143681, Example 98::US10143681, Example 99	Plasma kallikrein			 11.3							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304207	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304207&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134262025	381752928							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583269	CC1C(C)C1CC(C(=O)Nc1ccc(cc1)C(O)=O)c1ccc(c[n+]1[O-])-c1c(F)c(Cl)ccc1OC(F)F	InChI=1S/C27H24ClF3N2O5/c1-13-14(2)18(13)11-19(25(34)32-17-6-3-15(4-7-17)26(35)36)21-9-5-16(12-33(21)37)23-22(38-27(30)31)10-8-20(28)24(23)29/h3-10,12-14,18-19,27H,11H2,1-2H3,(H,32,34)(H,35,36)	GUCHYZAIJAAHRC-UHFFFAOYSA-N	304207	2-(1-((4- carboxyphenyl)amino)-3- (2,3-dimethylcyclopropyl)- 1-oxopropan-2-yl)-5-(3- chloro-6-(difluoromethoxy)- 2-fluorophenyl)pyridine 1- oxide::US10143681, Example 100::US10143681, Example 98::US10143681, Example 99	Plasma kallikrein			 92.0							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304207	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304207&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134262025	381752928							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583273	OC(=O)c1ccc(NC(=O)C(CC2CC(F)C2)c2ccc(c[n+]2[O-])-c2c(F)c(Cl)ccc2OC(F)F)cc1	InChI=1S/C26H21ClF4N2O5/c27-19-6-8-21(38-26(30)31)22(23(19)29)15-3-7-20(33(37)12-15)18(11-13-9-16(28)10-13)24(34)32-17-4-1-14(2-5-17)25(35)36/h1-8,12-13,16,18,26H,9-11H2,(H,32,34)(H,35,36)	WXUVDQBEULMFNR-UHFFFAOYSA-N	304210	2-(1-((4- carboxyphenyl)amino)-3-(3- fluorocyclobutyl)-1- oxopropan-2-yl)-5-(3- chloro-6-(difluoromethoxy)- 2-fluorophenyl)pyridine 1- oxide::BDBM304211::US10143681, Example 101	Plasma kallikrein			 31.8							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304210	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304210&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134262004	381752929							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583277	CC1CCC1CC(C(=O)Nc1ccc(cc1)C(O)=O)c1ccc(c[n+]1[O-])-c1c(F)c(Cl)ccc1OC(F)F	InChI=1S/C27H24ClF3N2O5/c1-14-2-3-16(14)12-19(25(34)32-18-7-4-15(5-8-18)26(35)36)21-10-6-17(13-33(21)37)23-22(38-27(30)31)11-9-20(28)24(23)29/h4-11,13-14,16,19,27H,2-3,12H2,1H3,(H,32,34)(H,35,36)	XJVNYKZAWRFCKD-UHFFFAOYSA-N	304212	2-(1-((4- carboxyphenyl)amino)-3-(2- methylcyclobutyl)-1- oxopropan-2-yl)-5-(3- chloro-6-(difluoromethoxy)- 2-fluorophenyl)pyridine 1- oxide::US10143681, Example 103::US10143681, Example 104::US10143681, Example 105::US10143681, Example 106	Plasma kallikrein			 15.7							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304212	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304212&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134262078	381752931							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583279	CC1CCC1CC(C(=O)Nc1ccc(cc1)C(O)=O)c1ccc(c[n+]1[O-])-c1c(F)c(Cl)ccc1OC(F)F	InChI=1S/C27H24ClF3N2O5/c1-14-2-3-16(14)12-19(25(34)32-18-7-4-15(5-8-18)26(35)36)21-10-6-17(13-33(21)37)23-22(38-27(30)31)11-9-20(28)24(23)29/h4-11,13-14,16,19,27H,2-3,12H2,1H3,(H,32,34)(H,35,36)	XJVNYKZAWRFCKD-UHFFFAOYSA-N	304212	2-(1-((4- carboxyphenyl)amino)-3-(2- methylcyclobutyl)-1- oxopropan-2-yl)-5-(3- chloro-6-(difluoromethoxy)- 2-fluorophenyl)pyridine 1- oxide::US10143681, Example 103::US10143681, Example 104::US10143681, Example 105::US10143681, Example 106	Plasma kallikrein			 59.9							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304212	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304212&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134262078	381752931							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583281	OC(=O)c1ccc(NC(=O)C(CC2CC2C(F)(F)F)c2ccc(c[n+]2[O-])-c2c(F)c(Cl)ccc2OC(F)F)cc1	InChI=1S/C26H19ClF6N2O5/c27-18-6-8-20(40-25(29)30)21(22(18)28)13-3-7-19(35(39)11-13)16(9-14-10-17(14)26(31,32)33)23(36)34-15-4-1-12(2-5-15)24(37)38/h1-8,11,14,16-17,25H,9-10H2,(H,34,36)(H,37,38)	XAJRJEDITUHVJY-UHFFFAOYSA-N	304216	2-(1-((4- carboxyphenyl)amino)-1- oxo-3-(2- (trifluoromethyl)cyclopropyl) propan-2-yl)-5-(3-chloro- 6-(difluoromethoxy)-2- fluorophenyl)pyridine 1- oxide::BDBM304217::BDBM304218::BDBM304219::US10143681, Example 107	Plasma kallikrein			 24.2							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304216	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304216&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137554361	381752932							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583284	OC(=O)c1ccc(NC(=O)C(CC2CC2C(F)(F)F)c2ccc(c[n+]2[O-])-c2c(F)c(Cl)ccc2OC(F)F)cc1	InChI=1S/C26H19ClF6N2O5/c27-18-6-8-20(40-25(29)30)21(22(18)28)13-3-7-19(35(39)11-13)16(9-14-10-17(14)26(31,32)33)23(36)34-15-4-1-12(2-5-15)24(37)38/h1-8,11,14,16-17,25H,9-10H2,(H,34,36)(H,37,38)	XAJRJEDITUHVJY-UHFFFAOYSA-N	304216	2-(1-((4- carboxyphenyl)amino)-1- oxo-3-(2- (trifluoromethyl)cyclopropyl) propan-2-yl)-5-(3-chloro- 6-(difluoromethoxy)-2- fluorophenyl)pyridine 1- oxide::BDBM304217::BDBM304218::BDBM304219::US10143681, Example 107	Plasma kallikrein			 25.2							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304216	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304216&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137554361	381752932							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583288	CC1(C)CC1CC(C(=O)Nc1ccc(cc1)C(O)=O)c1ccc(c[n+]1[O-])-c1c(F)c(Cl)ccc1OC(F)F	InChI=1S/C27H24ClF3N2O5/c1-27(2)12-16(27)11-18(24(34)32-17-6-3-14(4-7-17)25(35)36)20-9-5-15(13-33(20)37)22-21(38-26(30)31)10-8-19(28)23(22)29/h3-10,13,16,18,26H,11-12H2,1-2H3,(H,32,34)(H,35,36)	RKEDHLUVEHVMLP-UHFFFAOYSA-N	304220	2-(1-((4- carboxyphenyl)amino)-3- (2,2-dimethylcyclopropyl)- 1-oxopropan-2-yl)-5-(3- chloro-6-(difluoromethoxy)- 2-fluorophenyl)pyridine 1- oxide::US10143681, Example 111::US10143681, Example 112	Plasma kallikrein			 21.3							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304220	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304220&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134262158	381752936							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583291	COC(=O)c1ccc(NC(=O)C(CC2CC2)c2ccc(c[n+]2[O-])-c2c(F)c(Cl)ccc2C(F)F)cc1	InChI=1S/C26H22ClF3N2O4/c1-36-26(34)15-4-7-17(8-5-15)31-25(33)19(12-14-2-3-14)21-11-6-16(13-32(21)35)22-18(24(29)30)9-10-20(27)23(22)28/h4-11,13-14,19,24H,2-3,12H2,1H3,(H,31,33)	GHKQLKHHVVATLP-UHFFFAOYSA-N	304222	5-(3-chloro-6- (difluoromethyl)-2- fluorophenyl)-2-(3- cyclopropyl-1-((4- (methoxycarbonyl)phenyl) amino)-1-oxopropan-2- yl)pyridine 1-oxide::BDBM304223::US10143681, Example 113	Plasma kallikrein			 201							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304222	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304222&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137554362	381752937							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583296	OC(=O)c1ccc(NC(=O)C(CC2CC2)c2ccc(c[n+]2[O-])-c2c(F)c(Cl)ccc2C(F)F)cc1F	InChI=1S/C25H19ClF4N2O4/c26-18-7-6-16(23(29)30)21(22(18)28)13-3-8-20(32(36)11-13)17(9-12-1-2-12)24(33)31-14-4-5-15(25(34)35)19(27)10-14/h3-8,10-12,17,23H,1-2,9H2,(H,31,33)(H,34,35)	JJPLFMNEWVLCNA-UHFFFAOYSA-N	304226	2-(1-((4-carboxy-3- fluorophenyl)amino)-3- cyclopropyl-1-oxopropan-2- yl)-5-(3-chloro-6- (difluoromethyl)-2- fluorophenyl)pyridine 1- oxide::BDBM304227::US10143681, Example 117	Plasma kallikrein			 14.6							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304226	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304226&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134261841	381752941							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583299	OC(=O)c1ccc(NC(=O)C(CC2CCC2)c2ccc(c[n+]2[O-])-c2c(F)c(Cl)ccc2C(F)F)cc1F	InChI=1S/C26H21ClF4N2O4/c27-19-8-7-17(24(30)31)22(23(19)29)14-4-9-21(33(37)12-14)18(10-13-2-1-3-13)25(34)32-15-5-6-16(26(35)36)20(28)11-15/h4-9,11-13,18,24H,1-3,10H2,(H,32,34)(H,35,36)	LHPWAHFZZCZBHC-UHFFFAOYSA-N	304228	2-(1-((4-carboxy-3- fluorophenyl)amino)-3- cyclobutyl-1-oxopropan-2- yl)-5-(3-chloro-6- (difluoromethyl)-2- fluorophenyl)pyridine 1- oxide::BDBM304229::US10143681, Example 119	Plasma kallikrein			 2.10							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304228	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304228&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134261966	381752943							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583302	Cc1cc(NC(=O)C(CC2CC2)c2ccc(c[n+]2[O-])-c2c(F)c(Cl)ccc2C(F)F)ccc1C(O)=O	InChI=1S/C26H22ClF3N2O4/c1-13-10-16(5-6-17(13)26(34)35)31-25(33)19(11-14-2-3-14)21-9-4-15(12-32(21)36)22-18(24(29)30)7-8-20(27)23(22)28/h4-10,12,14,19,24H,2-3,11H2,1H3,(H,31,33)(H,34,35)	PGJOTSZZDJNXMF-UHFFFAOYSA-N	304230	2-(1-((4-carboxy-3- methylphenyl)amino)-3- cyclopropyl-1-oxopropan-2- yl)-5-(3-chloro-6- (difluoromethyl)-2- fluorophenyl)pyridine 1- oxide::BDBM304231::US10143681, Example 121	Plasma kallikrein			 69.8							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304230	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304230&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134262011	381752945							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
583305	OC(=O)c1ccc(NC(=O)C(CC23CC(C2)C3)c2ccc(c[n+]2[O-])-c2c(F)c(Cl)ccc2C(F)F)cc1F	InChI=1S/C27H21ClF4N2O4/c28-19-5-4-17(24(31)32)22(23(19)30)14-1-6-21(34(38)12-14)18(11-27-8-13(9-27)10-27)25(35)33-15-2-3-16(26(36)37)20(29)7-15/h1-7,12-13,18,24H,8-11H2,(H,33,35)(H,36,37)	XSYGTWRAAARAFS-UHFFFAOYSA-N	304232	2-(3-(bicyclo[1.1.1]pentan- 1-yl)-1-((4-carboxy-3- fluorophenyl)amino)-1- oxopropan-2-yl)-5-(3- chloro-6-(difluoromethyl)- 2-fluorophenyl)pyridine 1- oxide::BDBM304233::US10143681, Example 123	Plasma kallikrein			 4.70							US Patent		10.7270/Q2348NG3		aid1796164	US10143681	Shen, D; Kuang, R; Kumar, P; Duffy, JL; Zhu, C; Ali, A; Yang, M; Debenham, JS	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304232	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304232&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134261847	381752947							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608419	CS(=O)(=O)c1ccc2ncc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)cc2c1	InChI=1S/C27H23N5O3S/c1-36(34,35)23-3-5-25-21(14-23)11-18(16-31-25)12-22-13-20(7-8-29-22)27(33)32-15-17-2-4-24-19(10-17)6-9-30-26(24)28/h2-11,13-14,16H,12,15H2,1H3,(H2,28,30)(H,32,33)	WYQOOVPHNNJHMZ-UHFFFAOYSA-N	283361	N-((1-aminoisoquinolin-6-yl)methyl)-2-((6- (methylsulfonyl)quinolin-3- yl)methyl)isonicotinamide::US10023557, Example 13::US10266515, Example 13::US10308637, Example 13::US11021463, Example 13::US9611252, Example 13	Plasma kallikrein			 550							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283361	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283361&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665105	378164690							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608420	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cnc3ccc(cc3c2)S(C)(=O)=O)c1	InChI=1S/C25H25N5O3S/c1-15-8-24(26)30-16(2)22(15)14-29-25(31)18-6-7-27-20(11-18)10-17-9-19-12-21(34(3,32)33)4-5-23(19)28-13-17/h4-9,11-13H,10,14H2,1-3H3,(H2,26,30)(H,29,31)	IISORMHFXQMHMH-UHFFFAOYSA-N	283362	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((6-(methylsulfonyl)quinolin-3- yl)methyl)isonicotinamide::US10023557, Example 14::US10266515, Example 14::US10308637, Example 14::US11021463, Example 14::US9611252, Example 14	Plasma kallikrein			 550							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283362	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283362&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665164	378164691							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608421	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2c1)S(C)(=O)=O	InChI=1S/C26H27N5O3S/c1-15-7-20-9-18(11-23(35(4,33)34)25(20)29-13-15)10-21-12-19(5-6-28-21)26(32)30-14-22-16(2)8-24(27)31-17(22)3/h5-9,11-13H,10,14H2,1-4H3,(H2,27,31)(H,30,32)	HXOKVKXTISERDZ-UHFFFAOYSA-N	283363	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-methyl-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 15::US10266515, Example 15::US10308637, Example 15::US11021463, Example 15::US9611252, Example 15	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283363	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283363&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213052	378164692							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608422	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)cc2c1)S(C)(=O)=O	InChI=1S/C28H25N5O3S/c1-17-9-22-11-19(13-25(37(2,35)36)26(22)32-15-17)12-23-14-21(6-7-30-23)28(34)33-16-18-3-4-24-20(10-18)5-8-31-27(24)29/h3-11,13-15H,12,16H2,1-2H3,(H2,29,31)(H,33,34)	AGLYWDINMJNVRE-UHFFFAOYSA-N	283364	N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- methyl-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 16::US10266515, Example 16::US10308637, Example 16::US11021463, Example 16::US9611252, Example 16	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283364	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283364&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665230	378164693							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608423	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)cc2c1)S(C)(=O)=O	InChI=1S/C27H22ClFN4O3S/c1-15-5-18-6-16(8-25(37(2,35)36)26(18)32-12-15)7-20-9-17(3-4-30-20)27(34)33-13-19-10-21-22(28)14-31-24(21)11-23(19)29/h3-6,8-12,14,31H,7,13H2,1-2H3,(H,33,34)	KNWYWDACHSZACS-UHFFFAOYSA-N	283365	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3-methyl-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 17::US10266515, Example 17::US10308637, Example 17::US11021463, Example 17::US9611252, Example 17	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283365	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283365&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213042	378164694							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608424	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cc4cc[nH]c4cc3F)cc2c1)S(C)(=O)=O	InChI=1S/C27H23FN4O3S/c1-16-7-20-8-17(10-25(36(2,34)35)26(20)31-14-16)9-22-12-19(4-5-29-22)27(33)32-15-21-11-18-3-6-30-24(18)13-23(21)28/h3-8,10-14,30H,9,15H2,1-2H3,(H,32,33)	JOIGNBGOTQEXSU-UHFFFAOYSA-N	283366	N-((6-fluoro-1H-indol-5-yl)methyl)-2-((3- methyl-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 18::US10266515, Example 18::US10308637, Example 18::US11021463, Example 18::US9611252, Example 18	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283366	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283366&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665345	378164695							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608425	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cnc4[nH]cc(Cl)c4c3)cc2c1)S(C)(=O)=O	InChI=1S/C26H22ClN5O3S/c1-15-5-19-6-16(9-23(36(2,34)35)24(19)29-11-15)7-20-10-18(3-4-28-20)26(33)32-13-17-8-21-22(27)14-31-25(21)30-12-17/h3-6,8-12,14H,7,13H2,1-2H3,(H,30,31)(H,32,33)	IIORZUFKRKFNHD-UHFFFAOYSA-N	283367	N-((3-chloro-1H-pyrrolo[2,3-b]pyridin-5- yl)methyl)-2-((3-methyl-8- (methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 19::US10266515, Example 19::US10308637, Example 19::US11021463, Example 19::US9611252, Example 19	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283367	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283367&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665214	378164696							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608426	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3n[nH]c4ccc(Cl)cc34)cc2c1)S(C)(=O)=O	InChI=1S/C26H22ClN5O3S/c1-15-7-18-8-16(10-24(36(2,34)35)25(18)29-13-15)9-20-11-17(5-6-28-20)26(33)30-14-23-21-12-19(27)3-4-22(21)31-32-23/h3-8,10-13H,9,14H2,1-2H3,(H,30,33)(H,31,32)	INPUBOYBDZWEOS-UHFFFAOYSA-N	283368	N-((5-chloro-1H-indazol-3-yl)methyl)-2-((3- methyl-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 20::US10266515, Example 20::US10308637, Example 20::US11021463, Example 20::US9611252, Example 20	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283368	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283368&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665285	378164697							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608427	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3ccc4[nH]cc(Cl)c4c3F)cc2c1)S(C)(=O)=O	InChI=1S/C27H22ClFN4O3S/c1-15-7-19-8-16(10-23(37(2,35)36)26(19)32-12-15)9-20-11-17(5-6-30-20)27(34)33-13-18-3-4-22-24(25(18)29)21(28)14-31-22/h3-8,10-12,14,31H,9,13H2,1-2H3,(H,33,34)	RIPJTLFXOCXAJL-UHFFFAOYSA-N	283369	N-((3-chloro-4-fluoro-1H-indol-5-yl)methyl)-2- ((3-methyl-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 21::US10266515, Example 21::US10308637, Example 21::US11021463, Example 21::US9611252, Example 21	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283369	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283369&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213012	378164698							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608428	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cn2ccc3c(Cl)cccc3c2=O)c1	InChI=1S/C24H22ClN5O2/c1-14-10-22(26)29-15(2)20(14)12-28-23(31)16-6-8-27-17(11-16)13-30-9-7-18-19(24(30)32)4-3-5-21(18)25/h3-11H,12-13H2,1-2H3,(H2,26,29)(H,28,31)	MEZFXRCCCIIGIW-UHFFFAOYSA-N	283370	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((5-chloro-1-oxoisoquinolin-2(1H)- yl)methyl)isonicotinamide::US10023557, Example 22::US10266515, Example 22::US10308637, Example 22::US11021463, Example 22::US9611252, Example 22	Plasma kallikrein			 550							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283370	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283370&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665187	378164699							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608429	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cn2ccc3cc(Cl)ccc3c2=O)c1	InChI=1S/C24H22ClN5O2/c1-14-9-22(26)29-15(2)21(14)12-28-23(31)17-5-7-27-19(11-17)13-30-8-6-16-10-18(25)3-4-20(16)24(30)32/h3-11H,12-13H2,1-2H3,(H2,26,29)(H,28,31)	AXAISOZEVYRCNQ-UHFFFAOYSA-N	283371	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((6-chloro-1-oxoisoquinolin-2(1H)- yl)methyl)isonicotinamide::US10023557, Example 23::US10266515, Example 23::US10308637, Example 23::US11021463, Example 23::US9611252, Example 23	Plasma kallikrein			 5500							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283371	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283371&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665258	378164700							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608430	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3[nH]cc(Cl)c3c2)c1	InChI=1S/C23H22ClN5O/c1-13-7-22(25)29-14(2)19(13)11-28-23(30)16-5-6-26-17(10-16)8-15-3-4-21-18(9-15)20(24)12-27-21/h3-7,9-10,12,27H,8,11H2,1-2H3,(H2,25,29)(H,28,30)	WGAUJZUEMJFDBD-UHFFFAOYSA-N	283372	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloro-1H-indol-5- yl)methyl)isonicotinamide::US10023557, Example 24::US10266515, Example 24::US10308637, Example 24::US11021463, Example 24::US9611252, Example 24	Plasma kallikrein			 550							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283372	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283372&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665371	378164701							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608431	Cc1c[nH]c2ccc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc12	InChI=1S/C24H25N5O/c1-14-8-23(25)29-16(3)21(14)13-28-24(30)18-6-7-26-19(11-18)9-17-4-5-22-20(10-17)15(2)12-27-22/h4-8,10-12,27H,9,13H2,1-3H3,(H2,25,29)(H,28,30)	POUWYQSQNNTBKE-UHFFFAOYSA-N	283373	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-methyl-1H-indol-5- yl)methyl)isonicotinamide::US10023557, Example 25::US10266515, Example 25::US10308637, Example 25::US11021463, Example 25::US9611252, Example 25	Plasma kallikrein			 550							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283373	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283373&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665395	378164702							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608432	Cc1nc(N)c(cc1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1)C#N	InChI=1S/C24H19ClN6O/c1-14-19(8-18(11-26)23(27)31-14)12-30-24(32)16-4-5-28-21(10-16)7-15-2-3-22-17(6-15)9-20(25)13-29-22/h2-6,8-10,13H,7,12H2,1H3,(H2,27,31)(H,30,32)	BSYAUMQSIQHPBV-UHFFFAOYSA-N	283374	N-((6-amino-5-cyano-2-methylpyridin-3- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 26::US10266515, Example 26::US10308637, Example 26::US11021463, Example 26::US9611252, Example 26	Plasma kallikrein			 5500							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283374	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283374&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665238	378164703							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608433	Cc1nc(N)c(cc1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1)C(N)=O	InChI=1S/C24H21ClN6O2/c1-13-17(10-20(23(27)32)22(26)31-13)11-30-24(33)15-4-5-28-19(9-15)7-14-2-3-21-16(6-14)8-18(25)12-29-21/h2-6,8-10,12H,7,11H2,1H3,(H2,26,31)(H2,27,32)(H,30,33)	AUZYMVREUCDBQL-UHFFFAOYSA-N	283375	2-amino-5-((2-((3-chloroquinolin-6- yl)methyl)isonicotinamido)methyl)-6- methylnicotinamide::US10023557, Example 27::US10266515, Example 27::US10308637, Example 27::US11021463, Example 27::US9611252, Example 27	Plasma kallikrein			>10000							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283375	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283375&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665169	378164704							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608434	Cc1nc(N)c(Cl)cc1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C23H19Cl2N5O/c1-13-17(10-20(25)22(26)30-13)11-29-23(31)15-4-5-27-19(9-15)7-14-2-3-21-16(6-14)8-18(24)12-28-21/h2-6,8-10,12H,7,11H2,1H3,(H2,26,30)(H,29,31)	QTDAMOULKXIHPX-UHFFFAOYSA-N	283376	N-((6-amino-5-chloro-2-methylpyridin-3- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 28::US10266515, Example 28::US10308637, Example 28::US11021463, Example 28::US9611252, Example 28	Plasma kallikrein			 5500							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283376	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283376&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665175	378164705							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608435	Cc1cc(N)ncc1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C23H20ClN5O/c1-14-6-22(25)28-11-18(14)12-29-23(30)16-4-5-26-20(10-16)8-15-2-3-21-17(7-15)9-19(24)13-27-21/h2-7,9-11,13H,8,12H2,1H3,(H2,25,28)(H,29,30)	VFDBWWVOFNVCCV-UHFFFAOYSA-N	283377	N-((6-amino-4-methylpyridin-3-yl)methyl)-2- ((3-chloroquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 29::US10266515, Example 29::US10308637, Example 29::US11021463, Example 29::US9611252, Example 29	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283377	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283377&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212275	378164706							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608436	Nc1ccc(CNC(=O)c2ccnc(Cc3ccc4ncc(Cl)cc4c3)c2)c(n1)C(F)(F)F	InChI=1S/C23H17ClF3N5O/c24-17-9-16-7-13(1-3-19(16)30-12-17)8-18-10-14(5-6-29-18)22(33)31-11-15-2-4-20(28)32-21(15)23(25,26)27/h1-7,9-10,12H,8,11H2,(H2,28,32)(H,31,33)	JQBVZTITQKTVTP-UHFFFAOYSA-N	283378	N-((6-amino-2-(trifluoromoethyl)pyridin-3- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 30::US10266515, Example 30::US10308637, Example 30::US11021463, Example 30::US9611252, Example 30	Plasma kallikrein			>10000							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283378	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283378&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665299	378164707							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608437	Nc1nccc2cc(CNC(=O)c3ccnc(Cc4ccc5ncc(Cl)cc5c4)c3)ccc12	InChI=1S/C26H20ClN5O/c27-21-12-20-9-16(2-4-24(20)31-15-21)11-22-13-19(6-7-29-22)26(33)32-14-17-1-3-23-18(10-17)5-8-30-25(23)28/h1-10,12-13,15H,11,14H2,(H2,28,30)(H,32,33)	WHHMKDFLRDNMQE-UHFFFAOYSA-N	283379	N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- chloroquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 179::US10023557, Example 31::US10266515, Example 31::US10308637, Example 179::US11021463, Example 31::US9611252, Example 31	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283379	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283379&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212700	378164708							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608438	Fc1cc2[nH]ncc2cc1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C24H17ClFN5O/c25-19-8-16-5-14(1-2-22(16)28-13-19)6-20-9-15(3-4-27-20)24(32)29-11-17-7-18-12-30-31-23(18)10-21(17)26/h1-5,7-10,12-13H,6,11H2,(H,29,32)(H,30,31)	AUINKNGACHEZIV-UHFFFAOYSA-N	283380	2-((3-chloroquinolin-6-yl)methyl)-N-((6-fluoro- 1H-indazol-5-yl)methyl)isonicotinamide::US10023557, Example 260::US10023557, Example 32::US10266515, Example 32::US10308637, Example 32::US11021463, Example 32::US9611252, Example 32	Plasma kallikrein			 5500							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283380	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283380&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665325	378164709							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608439	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C25H17Cl2FN4O/c26-18-7-16-5-14(1-2-23(16)30-12-18)6-19-8-15(3-4-29-19)25(33)32-11-17-9-20-21(27)13-31-24(20)10-22(17)28/h1-5,7-10,12-13,31H,6,11H2,(H,32,33)	XZUNAOLBBRHEMP-UHFFFAOYSA-N	283381	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3-chloroquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 33::US10266515, Example 33::US10308637, Example 33::US11021463, Example 33::US9611252, Example 33	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283381	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283381&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212875	378164710							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608440	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C23H20ClN5O/c1-14-17(3-5-22(25)29-14)12-28-23(30)16-6-7-26-20(11-16)9-15-2-4-21-18(8-15)10-19(24)13-27-21/h2-8,10-11,13H,9,12H2,1H3,(H2,25,29)(H,28,30)	ZGYIOYKVCAJRKO-UHFFFAOYSA-N	283382	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-chloroquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 34::US10266515, Example 39::US10308637, Example 39::US11021463, Example 39::US9611252, Example 39	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283382	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283382&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213054	378164711							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608441	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C24H22ClN5O/c1-14-7-23(26)30-15(2)21(14)13-29-24(31)17-5-6-27-20(11-17)9-16-3-4-22-18(8-16)10-19(25)12-28-22/h3-8,10-12H,9,13H2,1-2H3,(H2,26,30)(H,29,31)	BDLURRLRBKLEDL-UHFFFAOYSA-N	283383	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 35::US10266515, Example 35::US10308637, Example 35::US11021463, Example 35::US9611252, Example 35	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283383	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283383&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665163	378164712							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608442	Nc1noc2cc(CNC(=O)c3ccnc(Cc4ccc5ncc(Cl)cc5c4)c3)ccc12	InChI=1S/C24H18ClN5O2/c25-18-10-17-7-14(2-4-21(17)28-13-18)8-19-11-16(5-6-27-19)24(31)29-12-15-1-3-20-22(9-15)32-30-23(20)26/h1-7,9-11,13H,8,12H2,(H2,26,30)(H,29,31)	HNXHQCQPXRYRIC-UHFFFAOYSA-N	283384	N-((3-aminobenzo[d]isoxazol-6-yl)methyl)-2- ((3-chloroquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 36::US10266515, Example 36::US10308637, Example 36::US11021463, Example 36::US9611252, Example 36	Plasma kallikrein			 5500							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283384	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283384&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665141	378164713							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608443	Clc1ccc2[nH]nc(CNC(=O)c3ccnc(Cc4ccc5ncc(Cl)cc5c4)c3)c2c1	InChI=1S/C24H17Cl2N5O/c25-17-2-4-22-20(11-17)23(31-30-22)13-29-24(32)15-5-6-27-19(10-15)8-14-1-3-21-16(7-14)9-18(26)12-28-21/h1-7,9-12H,8,13H2,(H,29,32)(H,30,31)	YXHGJDJGKSPRKX-UHFFFAOYSA-N	283385	N-((5-chloro-1H-indazol-3-yl)methyl)-2-((3- chloroquinolin-6-yl)methyl)isonictotinamide::US10023557, Example 37::US10266515, Example 37::US10308637, Example 37::US11021463, Example 37::US9611252, Example 37	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283385	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283385&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212832	378164714							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608444	Clc1c[nH]c2ncc(CNC(=O)c3ccnc(Cc4ccc5ncc(Cl)cc5c4)c3)cc12	InChI=1S/C24H17Cl2N5O/c25-18-8-17-5-14(1-2-22(17)28-12-18)6-19-9-16(3-4-27-19)24(32)31-11-15-7-20-21(26)13-30-23(20)29-10-15/h1-5,7-10,12-13H,6,11H2,(H,29,30)(H,31,32)	QFSDBAJWKWRDTA-UHFFFAOYSA-N	283386	N-((3-chloro-1H-pyrrolo[2,3-b]pyridin-5- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 38::US10266515, Example 38::US10308637, Example 38::US11021463, Example 38::US9611252, Example 38	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283386	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283386&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665363	378164715							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608445	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C23H20ClN5O/c1-14-17(3-5-22(25)29-14)12-28-23(30)16-6-7-26-20(11-16)9-15-2-4-21-18(8-15)10-19(24)13-27-21/h2-8,10-11,13H,9,12H2,1H3,(H2,25,29)(H,28,30)	ZGYIOYKVCAJRKO-UHFFFAOYSA-N	283382	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-chloroquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 34::US10266515, Example 39::US10308637, Example 39::US11021463, Example 39::US9611252, Example 39	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283382	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283382&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213054	378164711							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608446	Fc1c(CNC(=O)c2ccnc(Cc3ccc4ncc(Cl)cc4c3)c2)ccc2[nH]cc(Cl)c12	InChI=1S/C25H17Cl2FN4O/c26-18-9-17-7-14(1-3-21(17)30-12-18)8-19-10-15(5-6-29-19)25(33)32-11-16-2-4-22-23(24(16)28)20(27)13-31-22/h1-7,9-10,12-13,31H,8,11H2,(H,32,33)	GVFULHFYDFFIFD-UHFFFAOYSA-N	283388	N-((3-chloro-4-fluoro-1H-indol-5-yl)methyl)-2- ((3-chloroquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 40::US10266515, Example 40::US10308637, Example 40::US11021463, Example 40::US9611252, Example 40	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283388	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283388&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665357	378164717							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608447	Fc1cc2[nH]ccc2cc1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C25H18ClFN4O/c26-20-10-18-7-15(1-2-23(18)30-14-20)8-21-11-17(4-5-28-21)25(32)31-13-19-9-16-3-6-29-24(16)12-22(19)27/h1-7,9-12,14,29H,8,13H2,(H,31,32)	SVAFKWRLBOEKGD-UHFFFAOYSA-N	283389	2-((3-chloroquinolin-6-yl)methyl)-N-((6-fluoro- 1H-indol-5-yl)methyl)isonicotinamide::US10023557, Example 259::US10023557, Example 41::US10266515, Example 41::US10308637, Example 41::US11021463, Example 41::US9611252, Example 41	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283389	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283389&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665368	378164718							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608448	CNc1ccc(CNC(=O)c2ccnc(Cc3ccc4ncc(Cl)cc4c3)c2)c(C)n1	InChI=1S/C24H22ClN5O/c1-15-18(4-6-23(26-2)30-15)13-29-24(31)17-7-8-27-21(12-17)10-16-3-5-22-19(9-16)11-20(25)14-28-22/h3-9,11-12,14H,10,13H2,1-2H3,(H,26,30)(H,29,31)	KRORJRNMSXNFRV-UHFFFAOYSA-N	283390	2-((3-chloroquinolin-6-yl)methyl)-N-((2-methyl- 6-(methylamino)pyridin-3- yl)methyl)isonicotinamide::US10023557, Example 42::US10266515, Example 42::US10308637, Example 42::US11021463, Example 42::US9611252, Example 42	Plasma kallikrein			 550							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283390	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283390&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665110	378164719							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608449	Nc1ccc(CNC(=O)c2ccnc(Cc3ccc4ncc(Cl)cc4c3)c2)c(n1)C1CC1	InChI=1S/C25H22ClN5O/c26-20-11-19-9-15(1-5-22(19)29-14-20)10-21-12-17(7-8-28-21)25(32)30-13-18-4-6-23(27)31-24(18)16-2-3-16/h1,4-9,11-12,14,16H,2-3,10,13H2,(H2,27,31)(H,30,32)	CZYMIYVLJPMDKR-UHFFFAOYSA-N	283391	N-((6-amino-2-cyclopropylpyridin-3-yl)methyl)- 2-((3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 43::US10266515, Example 43::US10308637, Example 43::US11021463, Example 43::US9611252, Example 43	Plasma kallikrein			 550							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283391	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283391&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665372	378164720							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608450	CN(C)c1ccc(CNC(=O)c2ccnc(Cc3ccc4ncc(Cl)cc4c3)c2)c(C)n1	InChI=1S/C25H24ClN5O/c1-16-19(5-7-24(30-16)31(2)3)14-29-25(32)18-8-9-27-22(13-18)11-17-4-6-23-20(10-17)12-21(26)15-28-23/h4-10,12-13,15H,11,14H2,1-3H3,(H,29,32)	RUFAAOLTGJTOMH-UHFFFAOYSA-N	283392	2-((3-chloroquinolin-6-yl)methyl)-N-((6- (dimethylamino)-2-methylpyridin-3- yl)methyl)isonicotinamide::US10023557, Example 44::US10266515, Example 44::US10308637, Example 44::US11021463, Example 44::US9611252, Example 44	Plasma kallikrein			>10000							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283392	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283392&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665107	378164721							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608451	NCc1ccc2cc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)ccc2n1	InChI=1S/C26H21ClFN5O/c27-22-14-31-25-11-23(28)18(10-21(22)25)13-32-26(34)17-5-6-30-20(9-17)8-15-1-4-24-16(7-15)2-3-19(12-29)33-24/h1-7,9-11,14,31H,8,12-13,29H2,(H,32,34)	JRFVVGICARMPKA-UHFFFAOYSA-N	283393	2-((2-(aminomethyl)quinolin-6-yl)methyl)-N- ((3-chloro-6-fluoro-1H-indol-5- yl)methyl)isonicotinamide::US10023557, Example 45::US10308637, Example 45::US11021463, Example 45::US9611252, Example 45	Plasma kallikrein			 550							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283393	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283393&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212391	378164722							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608452	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3nc(CN)ccc3c2)c1	InChI=1S/C25H26N6O/c1-15-9-24(27)30-16(2)22(15)14-29-25(32)19-7-8-28-21(12-19)11-17-3-6-23-18(10-17)4-5-20(13-26)31-23/h3-10,12H,11,13-14,26H2,1-2H3,(H2,27,30)(H,29,32)	VJXDXEYDWIAFJF-UHFFFAOYSA-N	283394	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((2-(aminomethyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 46::US10266515, Example 46::US10308637, Example 46::US11021463, Example 46::US9611252, Example 46	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283394	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283394&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212365	378164723							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608453	Cc1cnc2ccc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)noc4c3)cc2c1	InChI=1S/C25H21N5O2/c1-15-8-19-9-16(3-5-22(19)28-13-15)10-20-12-18(6-7-27-20)25(31)29-14-17-2-4-21-23(11-17)32-30-24(21)26/h2-9,11-13H,10,14H2,1H3,(H2,26,30)(H,29,31)	JIGUMEUDUOTSCV-UHFFFAOYSA-N	283395	N-((3-aminobenzo[d]isoxazol-6-yl)methyl)-2- ((3-methylquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 47::US10266515, Example 47::US10308637, Example 47::US11021463, Example 47::US9611252, Example 47	Plasma kallikrein			 5500							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283395	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283395&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212412	378164724							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608454	Cc1ccc2ncc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)noc4c3)cc2c1	InChI=1S/C25H21N5O2/c1-15-2-5-22-19(8-15)9-17(14-28-22)10-20-12-18(6-7-27-20)25(31)29-13-16-3-4-21-23(11-16)32-30-24(21)26/h2-9,11-12,14H,10,13H2,1H3,(H2,26,30)(H,29,31)	ZCNHTDLBGJQFLS-UHFFFAOYSA-N	283396	N-((3-aminobenzo[d]isoxazol-6-yl)methyl)-2- ((6-methylquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 48::US10266515, Example 48::US10308637, Example 48::US11021463, Example 48::US9611252, Example 48	Plasma kallikrein			>10000							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283396	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283396&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665294	378164725							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608455	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1ccnc(Cc2cc(C#N)c3ncc(Cl)cc3c2)c1	InChI=1S/C26H16Cl2FN5O/c27-19-6-16-3-14(4-17(10-30)25(16)33-12-19)5-20-7-15(1-2-31-20)26(35)34-11-18-8-21-22(28)13-32-24(21)9-23(18)29/h1-4,6-9,12-13,32H,5,11H2,(H,34,35)	GDWMEKXUNIOULX-UHFFFAOYSA-N	283397	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3-chloro-8-cyanoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 49::US10308637, Example 49::US11021463, Example 49::US9611252, Example 49	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283397	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283397&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665225	378164726							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608456	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc(C#N)c3ncc(Cl)cc3c2)c1	InChI=1S/C25H21ClN6O/c1-14-5-23(28)32-15(2)22(14)13-31-25(33)17-3-4-29-21(10-17)8-16-6-18-9-20(26)12-30-24(18)19(7-16)11-27/h3-7,9-10,12H,8,13H2,1-2H3,(H2,28,32)(H,31,33)	VSKYRJRRAUSIED-UHFFFAOYSA-N	283398	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloro-8-cyanoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 50::US10266515, Example 50::US10308637, Example 50::US11021463, Example 50::US9611252, Example 50	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283398	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283398&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665177	378164727							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608457	Fc1c(CNC(=O)c2ccnc(Cc3cc(C#N)c4ncc(Cl)cc4c3)c2)ccc2[nH]cc(Cl)c12	InChI=1S/C26H16Cl2FN5O/c27-19-8-17-5-14(6-18(10-30)25(17)33-12-19)7-20-9-15(3-4-31-20)26(35)34-11-16-1-2-22-23(24(16)29)21(28)13-32-22/h1-6,8-9,12-13,32H,7,11H2,(H,34,35)	RGFJCIZRNQJUFS-UHFFFAOYSA-N	283399	N-((3-chloro-4-fluoro-1H-indol-5-yl)methyl)-2- ((3-chloro-8-cyanoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 51::US10266515, Example 51::US10308637, Example 51::US11021463, Example 51::US9611252, Example 51	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283399	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283399&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665441	378164728							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608458	Fc1cc2[nH]ccc2cc1CNC(=O)c1ccnc(Cc2cc(C#N)c3ncc(Cl)cc3c2)c1	InChI=1S/C26H17ClFN5O/c27-21-9-18-5-15(6-19(12-29)25(18)32-14-21)7-22-10-17(2-3-30-22)26(34)33-13-20-8-16-1-4-31-24(16)11-23(20)28/h1-6,8-11,14,31H,7,13H2,(H,33,34)	DGMHYZXVTQSHTG-UHFFFAOYSA-N	283400	2-((3-chloro-8-cyanoquinolin-6-yl)methyl)-N- ((6-fluoro-1H-indol-5-yl)methyl)isonicotinamide::US10023557, Example 52::US10266515, Example 52::US10308637, Example 52::US11021463, Example 52::US9611252, Example 52	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283400	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283400&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665338	378164729							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608459	Cc1cc(N)ncc1CNC(=O)c1ccnc(Cc2cc(C#N)c3ncc(Cl)cc3c2)c1	InChI=1S/C24H19ClN6O/c1-14-4-22(27)29-11-19(14)12-31-24(32)16-2-3-28-21(9-16)7-15-5-17-8-20(25)13-30-23(17)18(6-15)10-26/h2-6,8-9,11,13H,7,12H2,1H3,(H2,27,29)(H,31,32)	WNDNOSDBRCNUAW-UHFFFAOYSA-N	283401	N-((6-amino-4-methylpyridin-3-yl)methyl)-2- ((3-chloro-8-cyanoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 53::US10266515, Example 53::US10308637, Example 53::US11021463, Example 53::US9611252, Example 53	Plasma kallikrein			 550							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283401	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283401&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665126	378164730							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608460	Clc1ccc2[nH]nc(CNC(=O)c3ccnc(Cc4cc(C#N)c5ncc(Cl)cc5c4)c3)c2c1	InChI=1S/C25H16Cl2N6O/c26-18-1-2-22-21(10-18)23(33-32-22)13-31-25(34)15-3-4-29-20(9-15)7-14-5-16-8-19(27)12-30-24(16)17(6-14)11-28/h1-6,8-10,12H,7,13H2,(H,31,34)(H,32,33)	KUYYPMPLUCLDIX-UHFFFAOYSA-N	283402	N-((5-chloro-1H-indazol-3-yl)methyl)-2-((3- chloro-8-cyanoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 54::US10266515, Example 54::US10308637, Example 54::US11021463, Example 54::US9611252, Example 54	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283402	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283402&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665197	378164731							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608461	Clc1c[nH]c2ncc(CNC(=O)c3ccnc(Cc4cc(C#N)c5ncc(Cl)cc5c4)c3)cc12	InChI=1S/C25H16Cl2N6O/c26-19-7-17-3-14(4-18(9-28)23(17)30-12-19)5-20-8-16(1-2-29-20)25(34)33-11-15-6-21-22(27)13-32-24(21)31-10-15/h1-4,6-8,10,12-13H,5,11H2,(H,31,32)(H,33,34)	DLZBPOOKWFQHBR-UHFFFAOYSA-N	283403	N-((3-chloro-1H-pyrrolo[2,3-b]pyridin-5- yl)methyl)-2-((3-chloro-8-cyanoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 55::US10266515, Example 55::US10308637, Example 55::US11021463, Example 55::US9611252, Example 55	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283403	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283403&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665328	378164732							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608462	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2cc(C#N)c3ncc(Cl)cc3c2)c1	InChI=1S/C24H19ClN6O/c1-14-17(2-3-22(27)31-14)12-30-24(32)16-4-5-28-21(10-16)8-15-6-18-9-20(25)13-29-23(18)19(7-15)11-26/h2-7,9-10,13H,8,12H2,1H3,(H2,27,31)(H,30,32)	FDKNUBSGWSPNRT-UHFFFAOYSA-N	283404	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-chloro-8-cyanoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 56::US10266515, Example 56::US10308637, Example 56::US11021463, Example 56::US9611252, Example 56	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283404	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283404&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665146	378164733							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608463	Nc1nccc2cc(CNC(=O)c3ccnc(Cc4cc(C#N)c5ncc(Cl)cc5c4)c3)ccc12	InChI=1S/C27H19ClN6O/c28-22-11-20-8-17(9-21(13-29)25(20)33-15-22)10-23-12-19(4-5-31-23)27(35)34-14-16-1-2-24-18(7-16)3-6-32-26(24)30/h1-9,11-12,15H,10,14H2,(H2,30,32)(H,34,35)	IDTYIYATNJINLX-UHFFFAOYSA-N	283405	N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- chloro-8-cyanoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 57::US10266515, Example 57::US10308637, Example 57::US11021463, Example 57::US9611252, Example 57	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283405	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283405&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665382	378164734							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608464	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc(C(N)=O)c3ncc(Cl)cc3c2)c1	InChI=1S/C25H23ClN6O2/c1-13-5-22(27)32-14(2)21(13)12-31-25(34)16-3-4-29-19(10-16)7-15-6-17-9-18(26)11-30-23(17)20(8-15)24(28)33/h3-6,8-11H,7,12H2,1-2H3,(H2,27,32)(H2,28,33)(H,31,34)	INWUNFFPSCFXCA-UHFFFAOYSA-N	283406	6-((4-(((6-amino-2,4-dimethylpyridin-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- chloroquinoline-8-carboxamide::US10023557, Example 58::US10266515, Example 58::US10308637, Example 58::US11021463, Example 58::US9611252, Example 58	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283406	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283406&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665386	378164735							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608465	NC(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2cc3c(Cl)c[nH]c3cc2F)cc2cc(Cl)cnc12	InChI=1S/C26H18Cl2FN5O2/c27-17-6-15-3-13(5-20(25(30)35)24(15)33-11-17)4-18-7-14(1-2-31-18)26(36)34-10-16-8-19-21(28)12-32-23(19)9-22(16)29/h1-3,5-9,11-12,32H,4,10H2,(H2,30,35)(H,34,36)	QMNRPOHMXWHKMB-UHFFFAOYSA-N	283407	3-chloro-6-((4-(((3-chloro-6-fluoro-1H-indol-5- yl)methyl)carbamoyl)pyridin-2- yl)methyl)quinoline-8-carboxamide::US10023557, Example 59::US10266515, Example 59::US11021463, Example 59::US9611252, Example 59	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283407	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283407&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665413	378164736							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608466	NC(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2n[nH]c3ccc(Cl)cc23)cc2cc(Cl)cnc12	InChI=1S/C25H18Cl2N6O2/c26-16-1-2-21-19(10-16)22(33-32-21)12-31-25(35)14-3-4-29-18(9-14)6-13-5-15-8-17(27)11-30-23(15)20(7-13)24(28)34/h1-5,7-11H,6,12H2,(H2,28,34)(H,31,35)(H,32,33)	RTJGKEBRSSQCHQ-UHFFFAOYSA-N	283408	3-chloro-6-((4-(((5-chloro-1H-indazol-3- yl)methyl)carbamoyl)pyridin-2- yl)methyl)quinoline-8-carboxamide::US10023557, Example 60::US10266515, Example 60::US10308637, Example 60::US11021463, Example 60::US9611252, Example 60	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283408	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283408&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665317	378164737							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608467	NC(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2cnc3[nH]cc(Cl)c3c2)cc2cc(Cl)cnc12	InChI=1S/C25H18Cl2N6O2/c26-17-7-16-3-13(5-20(23(28)34)22(16)30-11-17)4-18-8-15(1-2-29-18)25(35)33-10-14-6-19-21(27)12-32-24(19)31-9-14/h1-3,5-9,11-12H,4,10H2,(H2,28,34)(H,31,32)(H,33,35)	QHIFWJFJAOUBPC-UHFFFAOYSA-N	283409	3-chloro-6-((4-(((3-chloro-1H-pyrrolo[2,3- b]pyridin-5-yl)methyl)carbamoyl)pyridin-2- yl)methyl)quinoline-8-carboxamide::US10023557, Example 61::US10266515, Example 61::US10308637, Example 61::US11021463, Example 61::US9611252, Example 61	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283409	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283409&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665370	378164738							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608468	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2cc(C(N)=O)c3ncc(Cl)cc3c2)c1	InChI=1S/C24H21ClN6O2/c1-13-16(2-3-21(26)31-13)11-30-24(33)15-4-5-28-19(10-15)7-14-6-17-9-18(25)12-29-22(17)20(8-14)23(27)32/h2-6,8-10,12H,7,11H2,1H3,(H2,26,31)(H2,27,32)(H,30,33)	WTBBASBLRSFZPD-UHFFFAOYSA-N	283410	6-((4-(((6-amino-2-methylpyridin-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- chloroquinoline-8-carboxamide::US10023557, Example 62::US10266515, Example 62::US10308637, Example 62::US11021463, Example 62::US9611252, Example 62	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283410	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283410&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665142	378164739							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608469	Cc1cc(N)ncc1CNC(=O)c1ccnc(Cc2cc(C(N)=O)c3ncc(Cl)cc3c2)c1	InChI=1S/C24H21ClN6O2/c1-13-4-21(26)29-10-17(13)11-31-24(33)15-2-3-28-19(9-15)6-14-5-16-8-18(25)12-30-22(16)20(7-14)23(27)32/h2-5,7-10,12H,6,11H2,1H3,(H2,26,29)(H2,27,32)(H,31,33)	ZAZOBWBMBQVKFV-UHFFFAOYSA-N	283411	6-((4-(((6-amino-4-methylpyridin-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- chloroquinoline-8-carboxamide::US10023557, Example 63::US10266515, Example 63::US10308637, Example 63::US11021463, Example 63::US9611252, Example 63	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283411	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283411&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665130	378164740							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608470	NC(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2ccc3c(N)nccc3c2)cc2cc(Cl)cnc12	InChI=1S/C27H21ClN6O2/c28-20-11-19-8-16(10-23(26(30)35)24(19)33-14-20)9-21-12-18(4-5-31-21)27(36)34-13-15-1-2-22-17(7-15)3-6-32-25(22)29/h1-8,10-12,14H,9,13H2,(H2,29,32)(H2,30,35)(H,34,36)	ZEVNHPCICZZSBU-UHFFFAOYSA-N	283412	6-((4-(((1-aminoisoquinolin-6- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- chloroquinoline-8-carboxamide::US10023557, Example 64::US10266515, Example 64::US10308637, Example 64::US11021463, Example 64::US9611252, Example 64	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283412	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283412&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665252	378164741							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608471	NC(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2ccc3[nH]cc(Cl)c3c2F)cc2cc(Cl)cnc12	InChI=1S/C26H18Cl2FN5O2/c27-17-8-16-5-13(7-19(25(30)35)24(16)33-11-17)6-18-9-14(3-4-31-18)26(36)34-10-15-1-2-21-22(23(15)29)20(28)12-32-21/h1-5,7-9,11-12,32H,6,10H2,(H2,30,35)(H,34,36)	PBEXDTRCFFOFDU-UHFFFAOYSA-N	283413	3-chloro-6-((4-(((3-chloro-4-fluoro-1H-indol-5- yl)methyl)carbamoyl)pyridin-2- yl)methyl)quinoline-8-carboxamide::US10023557, Example 65::US10266515, Example 65::US10308637, Example 65::US11021463, Example 65::US9611252, Example 65	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283413	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283413&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665414	378164742							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608472	NC(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2cc3cc[nH]c3cc2F)cc2cc(Cl)cnc12	InChI=1S/C26H19ClFN5O2/c27-19-9-17-5-14(7-21(25(29)34)24(17)32-13-19)6-20-10-16(2-3-30-20)26(35)33-12-18-8-15-1-4-31-23(15)11-22(18)28/h1-5,7-11,13,31H,6,12H2,(H2,29,34)(H,33,35)	ZDVUWSXSXIPPGM-UHFFFAOYSA-N	283414	3-chloro-6-((4-(((6-fluoro-1H-indol-5- yl)methyl)carbamoyl)pyridin-2- yl)methyl)quinoline-8-carboxamide::US10023557, Example 66::US10266515, Example 66::US10308637, Example 66::US11021463, Example 66::US9611252, Example 66	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283414	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283414&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665192	378164743							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608473	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc(c3ncc(Cl)cc3c2)S(C)(=O)=O)c1	InChI=1S/C25H24ClN5O3S/c1-14-6-23(27)31-15(2)21(14)13-30-25(32)17-4-5-28-20(11-17)8-16-7-18-10-19(26)12-29-24(18)22(9-16)35(3,33)34/h4-7,9-12H,8,13H2,1-3H3,(H2,27,31)(H,30,32)	LOAAVKXHIOVCPQ-UHFFFAOYSA-N	283415	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloro-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 67::US10266515, Example 67::US10308637, Example 67::US11021463, Example 67::US9611252, Example 67	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283415	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283415&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213160	378164744							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608474	CS(=O)(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2cc3c(Cl)c[nH]c3cc2F)cc2cc(Cl)cnc12	InChI=1S/C26H19Cl2FN4O3S/c1-37(35,36)24-6-14(4-16-7-18(27)12-32-25(16)24)5-19-8-15(2-3-30-19)26(34)33-11-17-9-20-21(28)13-31-23(20)10-22(17)29/h2-4,6-10,12-13,31H,5,11H2,1H3,(H,33,34)	JHEOACUKXNFFDI-UHFFFAOYSA-N	283416	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3-chloro-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 68::US10266515, Example 68::US10308637, Example 68::US11021463, Example 68::US9611252, Example 68	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283416	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283416&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212213	378164745							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608475	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2cc(c3ncc(Cl)cc3c2)S(C)(=O)=O)c1	InChI=1S/C24H22ClN5O3S/c1-14-17(3-4-22(26)30-14)12-29-24(31)16-5-6-27-20(11-16)8-15-7-18-10-19(25)13-28-23(18)21(9-15)34(2,32)33/h3-7,9-11,13H,8,12H2,1-2H3,(H2,26,30)(H,29,31)	DAYVOWICNMKAHH-UHFFFAOYSA-N	283417	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-chloro-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 69::US10266515, Example 69::US10308637, Example 69::US11021463, Example 69::US9611252, Example 69	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283417	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283417&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665120	378164746							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608476	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2c1)C#N	InChI=1S/C26H24N6O/c1-15-6-20-8-18(9-21(12-27)25(20)30-13-15)10-22-11-19(4-5-29-22)26(33)31-14-23-16(2)7-24(28)32-17(23)3/h4-9,11,13H,10,14H2,1-3H3,(H2,28,32)(H,31,33)	FWOVJYZAXZFOSD-UHFFFAOYSA-N	283418	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((8-cyano-3-methylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 70::US10266515, Example 70::US10308637, Example 70::US11021463, Example 70::US9611252, Example 70	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283418	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283418&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665112	378164747							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608477	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)cc2c1)C#N	InChI=1S/C28H22N6O/c1-17-8-22-10-19(11-23(14-29)26(22)33-15-17)12-24-13-21(5-6-31-24)28(35)34-16-18-2-3-25-20(9-18)4-7-32-27(25)30/h2-11,13,15H,12,16H2,1H3,(H2,30,32)(H,34,35)	XJVZLICIUISDSM-UHFFFAOYSA-N	283419	N-((1-aminoisoquinolin-6-yl)methyl)-2-((8- cyano-3-methylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 71::US10266515, Example 71::US10308637, Example 71::US11021463, Example 71::US9611252, Example 71	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283419	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283419&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665353	378164748							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608478	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)cc2c1)C#N	InChI=1S/C27H19ClFN5O/c1-15-4-18-5-16(6-19(11-30)26(18)33-12-15)7-21-8-17(2-3-31-21)27(35)34-13-20-9-22-23(28)14-32-25(22)10-24(20)29/h2-6,8-10,12,14,32H,7,13H2,1H3,(H,34,35)	KVEDUIDZCUQFJJ-UHFFFAOYSA-N	283420	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((8-cyano-3-methylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 72::US10308637, Example 72::US11021463, Example 72::US9611252, Example 72	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283420	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283420&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665256	378164749							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608479	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cnc4[nH]cc(Cl)c4c3)cc2c1)C#N	InChI=1S/C26H19ClN6O/c1-15-4-19-5-16(6-20(10-28)24(19)30-11-15)7-21-9-18(2-3-29-21)26(34)33-13-17-8-22-23(27)14-32-25(22)31-12-17/h2-6,8-9,11-12,14H,7,13H2,1H3,(H,31,32)(H,33,34)	DUPQBZNXOTZIFE-UHFFFAOYSA-N	283421	N-((3-chloro-1H-pyrrolo[2,3-b]pyridin-5- yl)methyl)-2-((8-cyano-3-methylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 73::US10266515, Example 73::US10308637, Example 73::US11021463, Example 73::US9611252, Example 73	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283421	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283421&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665369	378164750							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608480	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3ccc4[nH]cc(Cl)c4c3F)cc2c1)C#N	InChI=1S/C27H19ClFN5O/c1-15-6-19-7-16(8-20(11-30)26(19)33-12-15)9-21-10-17(4-5-31-21)27(35)34-13-18-2-3-23-24(25(18)29)22(28)14-32-23/h2-8,10,12,14,32H,9,13H2,1H3,(H,34,35)	UJWAIKJCZKWWSO-UHFFFAOYSA-N	283422	N-((3-chloro-4-fluoro-1H-indol-5-yl)methyl)-2- ((8-cyano-3-methylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 74::US10266515, Example 74::US10308637, Example 74::US11021463, Example 74::US9611252, Example 74	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283422	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283422&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665323	378164751							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608481	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3n[nH]c4ccc(Cl)cc34)cc2c1)C#N	InChI=1S/C26H19ClN6O/c1-15-6-18-7-16(8-19(12-28)25(18)30-13-15)9-21-10-17(4-5-29-21)26(34)31-14-24-22-11-20(27)2-3-23(22)32-33-24/h2-8,10-11,13H,9,14H2,1H3,(H,31,34)(H,32,33)	SABOZYHOSJEBNR-UHFFFAOYSA-N	283423	N-((5-chloro-1H-indazol-3-yl)methyl)-2-((8- cyano-3-methylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 75::US10266515, Example 75::US10308637, Example 75::US11021463, Example 75::US9611252, Example 75	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283423	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283423&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665301	378164752							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608482	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cc4cc[nH]c4cc3F)cc2c1)C#N	InChI=1S/C27H20FN5O/c1-16-6-20-7-17(8-21(13-29)26(20)32-14-16)9-23-11-19(3-4-30-23)27(34)33-15-22-10-18-2-5-31-25(18)12-24(22)28/h2-8,10-12,14,31H,9,15H2,1H3,(H,33,34)	ZWLALZHUQUAZOX-UHFFFAOYSA-N	283424	2-((8-cyano-3-methylquinolin-6-yl)methyl)-N- ((6-fluoro-1H-indol-5-yl)methyl)isonicotinamide::US10023557, Example 76::US10266515, Example 76::US10308637, Example 76::US11021463, Example 76::US9611252, Example 76	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283424	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283424&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665344	378164753							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608483	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2c1)C(N)=O	InChI=1S/C26H26N6O2/c1-14-6-19-8-17(10-21(25(28)33)24(19)30-12-14)9-20-11-18(4-5-29-20)26(34)31-13-22-15(2)7-23(27)32-16(22)3/h4-8,10-12H,9,13H2,1-3H3,(H2,27,32)(H2,28,33)(H,31,34)	OOWBJQXCALEAFC-UHFFFAOYSA-N	283425	6-((4-(((6-amino-2,4-dimethylpyridin-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- methylquinoline-8-carboxamide::US10023557, Example 77::US10266515, Example 77::US10308637, Example 77::US11021463, Example 77::US9611252, Example 77	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283425	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283425&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665125	378164754							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608484	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)cc2c1)C(N)=O	InChI=1S/C27H21ClFN5O2/c1-14-4-17-5-15(7-21(26(30)35)25(17)33-11-14)6-19-8-16(2-3-31-19)27(36)34-12-18-9-20-22(28)13-32-24(20)10-23(18)29/h2-5,7-11,13,32H,6,12H2,1H3,(H2,30,35)(H,34,36)	WETFPOPVXHIHFG-UHFFFAOYSA-N	283426	6-((4-(((3-chloro-6-fluoro-1H-indol-5- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- methylquinoline-8-carboxamide::US10023557, Example 78::US10266515, Example 78::US10308637, Example 78::US11021463, Example 78::US9611252, Example 78	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283426	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283426&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665427	378164755							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608485	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)cc2c1)C(N)=O	InChI=1S/C28H24N6O2/c1-16-8-21-10-18(12-24(27(30)35)25(21)33-14-16)11-22-13-20(5-6-31-22)28(36)34-15-17-2-3-23-19(9-17)4-7-32-26(23)29/h2-10,12-14H,11,15H2,1H3,(H2,29,32)(H2,30,35)(H,34,36)	AVMNYBKKWARJKT-UHFFFAOYSA-N	283427	6-((4-(((1-aminoisoquinolin-6- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- methylquinoline-8-carboxamide::US10023557, Example 79::US10266515, Example 79::US10308637, Example 79::US11021463, Example 79::US9611252, Example 79	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283427	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283427&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665123	378164756							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608486	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cnc4[nH]cc(Cl)c4c3)cc2c1)C(N)=O	InChI=1S/C26H21ClN6O2/c1-14-4-18-5-15(7-21(24(28)34)23(18)30-10-14)6-19-9-17(2-3-29-19)26(35)33-12-16-8-20-22(27)13-32-25(20)31-11-16/h2-5,7-11,13H,6,12H2,1H3,(H2,28,34)(H,31,32)(H,33,35)	CFJXZEDRAADQFI-UHFFFAOYSA-N	283428	6-((4-(((3-chloro-1H-pyrrolo[2,3-b]pyridin-5- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- methylquinoline-8-carboxamide::US10023557, Example 80::US10266515, Example 80::US10308637, Example 80::US11021463, Example 80::US9611252, Example 80	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283428	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283428&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665254	378164757							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608487	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3ccc4[nH]cc(Cl)c4c3F)cc2c1)C(N)=O	InChI=1S/C27H21ClFN5O2/c1-14-6-18-7-15(9-20(26(30)35)25(18)33-11-14)8-19-10-16(4-5-31-19)27(36)34-12-17-2-3-22-23(24(17)29)21(28)13-32-22/h2-7,9-11,13,32H,8,12H2,1H3,(H2,30,35)(H,34,36)	LJDMUPONZYUBTQ-UHFFFAOYSA-N	283429	6-((4-(((3-chloro-4-fluoro-1H-indol-5- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- methylquinoline-8-carboxamide::US10023557, Example 81::US10266515, Example 81::US10308637, Example 81::US11021463, Example 81::US9611252, Example 81	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283429	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283429&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665251	378164758							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608488	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3n[nH]c4ccc(Cl)cc34)cc2c1)C(N)=O	InChI=1S/C26H21ClN6O2/c1-14-6-17-7-15(9-21(25(28)34)24(17)30-12-14)8-19-10-16(4-5-29-19)26(35)31-13-23-20-11-18(27)2-3-22(20)32-33-23/h2-7,9-12H,8,13H2,1H3,(H2,28,34)(H,31,35)(H,32,33)	KIVLLFJSACGLHN-UHFFFAOYSA-N	283430	6-((4-(((5-chloro-1H-indazol-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- methylquinoline-8-carboxamide::US10023557, Example 82::US10266515, Example 82::US10308637, Example 82::US11021463, Example 82::US9611252, Example 82	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283430	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283430&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665290	378164759							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608489	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cc4cc[nH]c4cc3F)cc2c1)C(N)=O	InChI=1S/C27H22FN5O2/c1-15-6-19-7-16(9-22(26(29)34)25(19)32-13-15)8-21-11-18(3-4-30-21)27(35)33-14-20-10-17-2-5-31-24(17)12-23(20)28/h2-7,9-13,31H,8,14H2,1H3,(H2,29,34)(H,33,35)	UZTOCULVDVRYTA-UHFFFAOYSA-N	283431	6-((4-(((6-fluoro-1H-indol-5- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- methylquinoline-8-carboxamide::US10023557, Example 83::US10266515, Example 83::US10308637, Example 83::US11021463, Example 83::US9611252, Example 83	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283431	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283431&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665428	378164760							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608490	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2c1)C(O)=O	InChI=1S/C26H25N5O3/c1-14-6-19-8-17(10-21(26(33)34)24(19)29-12-14)9-20-11-18(4-5-28-20)25(32)30-13-22-15(2)7-23(27)31-16(22)3/h4-8,10-12H,9,13H2,1-3H3,(H2,27,31)(H,30,32)(H,33,34)	IDXZVLZJXGFXKF-UHFFFAOYSA-N	283432	6-((4-(((6-amino-2,4-dimethylpyridin-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- methylquinoline-8-carboxylic acid::US10023557, Example 84::US10266515, Example 84::US10308637, Example 84::US11021463, Example 84::US9611252, Example 84	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283432	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283432&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665404	378164761							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608491	Cc1cc(N)ncc1CNC(=O)c1ccnc(Cn2cc3cc(Cl)ccc3cc2=O)c1	InChI=1S/C23H20ClN5O2/c1-14-6-21(25)27-10-18(14)11-28-23(31)16-4-5-26-20(8-16)13-29-12-17-7-19(24)3-2-15(17)9-22(29)30/h2-10,12H,11,13H2,1H3,(H2,25,27)(H,28,31)	DNSFNVWZLXWEIP-UHFFFAOYSA-N	283433	N-((6-amino-4-methylpyridin-3-yl)methyl)-2- ((7-chloro-3-oxoisoquinolin-2(3H)- yl)methyl)isonicotinamide::US10023557, Example 85::US10266515, Example 85::US10308637, Example 85::US11021463, Example 85::US9611252, Example 85	Plasma kallikrein			 550							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283433	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283433&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665165	378164762							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608492	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cn2cc3cc(Cl)ccc3cc2=O)c1	InChI=1S/C23H20ClN5O2/c1-14-17(3-5-21(25)28-14)11-27-23(31)16-6-7-26-20(9-16)13-29-12-18-8-19(24)4-2-15(18)10-22(29)30/h2-10,12H,11,13H2,1H3,(H2,25,28)(H,27,31)	BXRRZXRRYWPPRB-UHFFFAOYSA-N	283434	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((7-chloro-3-oxoisoquinolin-2(3H)- yl)methyl)isonicotinamide::US10023557, Example 86::US10266515, Example 86::US10308637, Example 86::US11021463, Example 86::US9611252, Example 86	Plasma kallikrein			 550							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283434	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283434&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665384	378164763							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608493	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cn2cc3cc(Cl)ccc3cc2=O)c1	InChI=1S/C24H22ClN5O2/c1-14-7-22(26)29-15(2)21(14)11-28-24(32)17-5-6-27-20(9-17)13-30-12-18-8-19(25)4-3-16(18)10-23(30)31/h3-10,12H,11,13H2,1-2H3,(H2,26,29)(H,28,32)	IRSFVELJVAKOKE-UHFFFAOYSA-N	283435	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((7-chloro-3-oxoisoquinolin-2(3H)- yl)methyl)isonicotinamide::US10023557, Example 87::US10266515, Example 87::US10308637, Example 87::US11021463, Example 87::US9611252, Example 87	Plasma kallikrein			 550							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283435	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283435&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665121	378164764							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608494	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1ccnc(Cn2cc3cc(Cl)ccc3cc2=O)c1	InChI=1S/C25H17Cl2FN4O2/c26-18-2-1-14-8-24(33)32(12-17(14)5-18)13-19-6-15(3-4-29-19)25(34)31-10-16-7-20-21(27)11-30-23(20)9-22(16)28/h1-9,11-12,30H,10,13H2,(H,31,34)	LIVKHBBLMAFTFP-UHFFFAOYSA-N	283436	2-((7-chloro-3-oxoisoquinolin-2(3H)-yl)methyl)- N-((3-chloro-6-fluoro-1H-indol-5- yl)methyl)isonicotinamide::US10023557, Example 88::US10266515, Example 88::US10308637, Example 88::US11021463, Example 88::US9611252, Example 88	Plasma kallikrein			 550							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283436	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283436&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665351	378164765							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608495	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc(F)c3ncc(Cl)cc3c2)c1	InChI=1S/C24H21ClFN5O/c1-13-5-22(27)31-14(2)20(13)12-30-24(32)16-3-4-28-19(10-16)7-15-6-17-9-18(25)11-29-23(17)21(26)8-15/h3-6,8-11H,7,12H2,1-2H3,(H2,27,31)(H,30,32)	NJQUWZKNWYIFOW-UHFFFAOYSA-N	283437	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloro-8-fluoroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 89::US10266515, Example 89::US10308637, Example 89::US11021463, Example 89::US9611252, Example 89	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283437	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283437&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665263	378164766							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608496	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1ccnc(Cc2cc(F)c3ncc(Cl)cc3c2)c1	InChI=1S/C25H16Cl2F2N4O/c26-17-6-15-3-13(5-22(29)24(15)32-11-17)4-18-7-14(1-2-30-18)25(34)33-10-16-8-19-20(27)12-31-23(19)9-21(16)28/h1-3,5-9,11-12,31H,4,10H2,(H,33,34)	WZBGVJNIHVUBGP-UHFFFAOYSA-N	283438	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3-chloro-8-fluoroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 90::US10266515, Example 90::US10308637, Example 90::US11021463, Example 90::US9611252, Example 90	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283438	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283438&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665313	378164767							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608497	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2cc(F)c3ncc(Cl)cc3c2)c1	InChI=1S/C23H19ClFN5O/c1-13-16(2-3-21(26)30-13)11-29-23(31)15-4-5-27-19(10-15)7-14-6-17-9-18(24)12-28-22(17)20(25)8-14/h2-6,8-10,12H,7,11H2,1H3,(H2,26,30)(H,29,31)	JKVPCVWDMOMIMY-UHFFFAOYSA-N	283439	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-chloro-8-fluoroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 91::US10266515, Example 91::US10308637, Example 91::US11021463, Example 91::US9611252, Example 91	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283439	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283439&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665234	378164768							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608498	COC(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2c(C)cc(N)nc2C)cc2cc(Cl)cnc12	InChI=1S/C26H24ClN5O3/c1-14-6-23(28)32-15(2)22(14)13-31-25(33)17-4-5-29-20(11-17)8-16-7-18-10-19(27)12-30-24(18)21(9-16)26(34)35-3/h4-7,9-12H,8,13H2,1-3H3,(H2,28,32)(H,31,33)	YFEQLRSQCAMBNR-UHFFFAOYSA-N	283440	US10023557, Example 92::US10266515, Example 92::US10308637, Example 92::US11021463, Example 92::US9611252, Example 92::methyl 6-((4-(((6-amino-2,4-dimethylpyridin-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- chloroquinoline-8-carboxylate	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283440	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283440&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665210	378164769							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608499	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc(C(O)=O)c3ncc(Cl)cc3c2)c1	InChI=1S/C25H22ClN5O3/c1-13-5-22(27)31-14(2)21(13)12-30-24(32)16-3-4-28-19(10-16)7-15-6-17-9-18(26)11-29-23(17)20(8-15)25(33)34/h3-6,8-11H,7,12H2,1-2H3,(H2,27,31)(H,30,32)(H,33,34)	BVAYWMZNSZGAMT-UHFFFAOYSA-N	283441	6-((4-(((6-amino-2,4-dimethylpyridin-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- chloroquinoline-8-carboxylic acid::US10023557, Example 93::US10266515, Example 93::US10308637, Example 93::US11021463, Example 93::US9611252, Example 93	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283441	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283441&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665155	378164770							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608500	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc(CO)c3ncc(Cl)cc3c2)c1	InChI=1S/C25H24ClN5O2/c1-14-5-23(27)31-15(2)22(14)12-30-25(33)17-3-4-28-21(10-17)8-16-6-18-9-20(26)11-29-24(18)19(7-16)13-32/h3-7,9-11,32H,8,12-13H2,1-2H3,(H2,27,31)(H,30,33)	CDDJVGAEPTXXCL-UHFFFAOYSA-N	283442	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloro-8-(hydroxymethyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 94::US10266515, Example 94::US10308637, Example 94::US11021463, Example 94::US9611252, Example 94	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283442	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283442&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665190	378164771							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608501	COC(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2ccc(N)nc2C)cc2cc(Cl)cnc12	InChI=1S/C25H22ClN5O3/c1-14-17(3-4-22(27)31-14)12-30-24(32)16-5-6-28-20(11-16)8-15-7-18-10-19(26)13-29-23(18)21(9-15)25(33)34-2/h3-7,9-11,13H,8,12H2,1-2H3,(H2,27,31)(H,30,32)	JHWMKRJZPWMJLH-UHFFFAOYSA-N	283443	US10023557, Example 95::US10266515, Example 95::US10308637, Example 95::US11021463, Example 95::US9611252, Example 95::methyl 6-((4-(((6-amino-2-methylpyridin-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- chloroquinoline-8-carboxylate	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283443	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283443&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665172	378164772							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608502	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2cc(C(O)=O)c3ncc(Cl)cc3c2)c1	InChI=1S/C24H20ClN5O3/c1-13-16(2-3-21(26)30-13)11-29-23(31)15-4-5-27-19(10-15)7-14-6-17-9-18(25)12-28-22(17)20(8-14)24(32)33/h2-6,8-10,12H,7,11H2,1H3,(H2,26,30)(H,29,31)(H,32,33)	OWMRLFMYSUGJHS-UHFFFAOYSA-N	283444	6-((4-(((6-amino-2-methylpyridin-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- chloroquinoline-8-carboxylic acid::US10023557, Example 96::US10266515, Example 96::US10308637, Example 96::US11021463, Example 96::US9611252, Example 96	Plasma kallikrein			 550							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283444	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283444&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665320	378164773							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608503	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2cc(CO)c3ncc(Cl)cc3c2)c1	InChI=1S/C24H22ClN5O2/c1-14-17(2-3-22(26)30-14)11-29-24(32)16-4-5-27-21(10-16)8-15-6-18-9-20(25)12-28-23(18)19(7-15)13-31/h2-7,9-10,12,31H,8,11,13H2,1H3,(H2,26,30)(H,29,32)	SCWQNZNCOWHKCU-UHFFFAOYSA-N	283445	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-chloro-8-(hydroxymethyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 97::US10266515, Example 97::US10308637, Example 97::US11021463, Example 97::US9611252, Example 97	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283445	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283445&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665282	378164774							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608504	Cc1cc(N)[n+]([O-])c(C)c1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C24H22ClN5O2/c1-14-7-23(26)30(32)15(2)21(14)13-29-24(31)17-5-6-27-20(11-17)9-16-3-4-22-18(8-16)10-19(25)12-28-22/h3-8,10-12H,9,13,26H2,1-2H3,(H,29,31)	JMNAJBKCXDWWFM-UHFFFAOYSA-N	283446	6-amino-3-((2-((3-chloroquinolin-6- yl)methyl)isonicotinamido)methyl)-2,4- dimethylpyridine 1-oxide::US10023557, Example 98::US10266515, Example 98::US10308637, Example 98::US11021463, Example 98::US9611252, Example 98	Plasma kallikrein			 550							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283446	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283446&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665244	378164775							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608505	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3[n+]([O-])cc(Cl)cc3c2)c1	InChI=1S/C24H22ClN5O2/c1-14-7-23(26)29-15(2)21(14)12-28-24(31)17-5-6-27-20(11-17)9-16-3-4-22-18(8-16)10-19(25)13-30(22)32/h3-8,10-11,13H,9,12H2,1-2H3,(H2,26,29)(H,28,31)	XRSVMKZHXCTYQX-UHFFFAOYSA-N	283447	6-((4-(((6-amino-2,4-dimethylpyridin-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- chloroquinoline 1-oxide::US10023557, Example 99::US10266515, Example 99::US10308637, Example 99::US11021463, Example 99::US9611252, Example 99	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283447	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283447&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665346	378164776							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608506	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc(Cl)c3ncc(Cl)cc3c2)c1	InChI=1S/C24H21Cl2N5O/c1-13-5-22(27)31-14(2)20(13)12-30-24(32)16-3-4-28-19(10-16)7-15-6-17-9-18(25)11-29-23(17)21(26)8-15/h3-6,8-11H,7,12H2,1-2H3,(H2,27,31)(H,30,32)	HHXMWQGWYOIRGQ-UHFFFAOYSA-N	283448	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3,8-dichloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 100::US10266515, Example 100::US10308637, Example 100::US11021463, Example 100::US9611252, Example 100	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283448	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283448&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665316	378164777							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608507	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2cc(Cl)c3ncc(Cl)cc3c2)c1	InChI=1S/C23H19Cl2N5O/c1-13-16(2-3-21(26)30-13)11-29-23(31)15-4-5-27-19(10-15)7-14-6-17-9-18(24)12-28-22(17)20(25)8-14/h2-6,8-10,12H,7,11H2,1H3,(H2,26,30)(H,29,31)	LGBIYJSQIIGQJI-UHFFFAOYSA-N	283449	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3,8-dichloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 101::US10266515, Example 101::US10308637, Example 101::US11021463, Example 101::US9611252, Example 101	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283449	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283449&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665134	378164778							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608508	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2F)c1	InChI=1S/C24H21ClFN5O/c1-13-7-22(27)31-14(2)20(13)12-30-24(32)16-5-6-28-18(9-16)8-15-3-4-21-19(23(15)26)10-17(25)11-29-21/h3-7,9-11H,8,12H2,1-2H3,(H2,27,31)(H,30,32)	MDLFAZWEMPYOEY-UHFFFAOYSA-N	283450	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloro-5-fluoroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 102::US10266515, Example 102::US10308637, Example 102::US11021463, Example 102::US9611252, Example 102	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283450	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283450&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665170	378164779							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608509	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2F)c1	InChI=1S/C23H19ClFN5O/c1-13-16(3-5-21(26)30-13)11-29-23(31)15-6-7-27-18(9-15)8-14-2-4-20-19(22(14)25)10-17(24)12-28-20/h2-7,9-10,12H,8,11H2,1H3,(H2,26,30)(H,29,31)	CMOKBXIVBITBDZ-UHFFFAOYSA-N	283451	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-chloro-5-fluoroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 103::US10266515, Example 103::US10308637, Example 103::US11021463, Example 103::US9611252, Example 103	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283451	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283451&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665235	378164780							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608510	Cc1cc(cc(Cc2ccc3ncc(Cl)cc3c2)n1)C(=O)NCc1c(C)cc(N)nc1C	InChI=1S/C25H24ClN5O/c1-14-6-24(27)31-16(3)22(14)13-29-25(32)19-7-15(2)30-21(11-19)9-17-4-5-23-18(8-17)10-20(26)12-28-23/h4-8,10-12H,9,13H2,1-3H3,(H2,27,31)(H,29,32)	WDMJJASBQUYWJX-UHFFFAOYSA-N	283452	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloroquinolin-6-yl)methyl)-6- methylisonicotinamide::US10023557, Example 104::US10023557, Example 197::US10266515, Example 104::US10308637, Example 197::US11021463, Example 104::US9611252, Example 104	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283452	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283452&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665211	378164781							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608511	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cn2ncc3cc(Cl)ccc23)c1	InChI=1S/C22H21ClN6O/c1-13-7-21(24)28-14(2)19(13)11-26-22(30)15-5-6-25-18(9-15)12-29-20-4-3-17(23)8-16(20)10-27-29/h3-10H,11-12H2,1-2H3,(H2,24,28)(H,26,30)	VIIRLZCJMXLFHW-UHFFFAOYSA-N	283549	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((5-chloro-1H-indazol-1- yl)methyl)isonicotinamide::US10023557, Example 198::US10308637, Example 202::US11021463, Example 105::US9611252, Example 105	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283549	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283549&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665148	378164875							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608512	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cn2cc3cc(Cl)ccc3n2)c1	InChI=1S/C22H21ClN6O/c1-13-7-21(24)27-14(2)19(13)10-26-22(30)15-5-6-25-18(9-15)12-29-11-16-8-17(23)3-4-20(16)28-29/h3-9,11H,10,12H2,1-2H3,(H2,24,27)(H,26,30)	JJKKHULUCHMWFC-UHFFFAOYSA-N	283454	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((5-chloro-2H-indazol-2- yl)methyl)isonicotinamide::US10023557, Example 106::US10023557, Example 107::US10023557, Example 199::US10266515, Example 107::US10308637, Example 199::US11021463, Example 106::US9611252, Example 106	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283454	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283454&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665275	378164783							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608513	Cc1ccc2nn(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2c1	InChI=1S/C23H24N6O/c1-14-4-5-21-18(8-14)12-29(28-21)13-19-10-17(6-7-25-19)23(30)26-11-20-15(2)9-22(24)27-16(20)3/h4-10,12H,11,13H2,1-3H3,(H2,24,27)(H,26,30)	ZFEUOGPGKMODOZ-UHFFFAOYSA-N	283551	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((5-methyl-2H-indazol-2- yl)methyl)isonicotinamide::US10023557, Example 200::US10308637, Example 200::US11021463, Example 107::US9611252, Example 107	Plasma kallikrein			 550							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283551	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283551&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665352	378164876							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608514	Cc1ccc2n(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)ncc2c1	InChI=1S/C23H24N6O/c1-14-4-5-21-18(8-14)11-27-29(21)13-19-10-17(6-7-25-19)23(30)26-12-20-15(2)9-22(24)28-16(20)3/h4-11H,12-13H2,1-3H3,(H2,24,28)(H,26,30)	PJQHDAQZXYWCRS-UHFFFAOYSA-N	283456	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((5-methyl-1H-indazol-1- yl)methyl)isonicotinamide::US10023557, Example 108::US10266515, Example 108::US10308637, Example 108::US11021463, Example 108::US9611252, Example 108	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283456	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283456&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665436	378164784							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608515	Cc1ccc2nc(c(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)cc2c1)S(C)(=O)=O	InChI=1S/C27H22ClFN4O3S/c1-15-3-4-24-17(7-15)8-18(27(33-24)37(2,35)36)10-20-9-16(5-6-30-20)26(34)32-13-19-11-21-22(28)14-31-25(21)12-23(19)29/h3-9,11-12,14,31H,10,13H2,1-2H3,(H,32,34)	OXDNNQYYISTXOB-UHFFFAOYSA-N	283457	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((6-methyl-2-(methylsulfonyl)quinolin-3- yl)methyl)isonicotinamide::US10023557, Example 109::US10266515, Example 109::US10308637, Example 109::US11021463, Example 109::US9611252, Example 109	Plasma kallikrein			 550							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283457	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283457&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213217	378164785							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608516	Cc1ccc2cc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)ccc2n1	InChI=1S/C26H20ClFN4O/c1-15-2-4-17-8-16(3-5-24(17)32-15)9-20-10-18(6-7-29-20)26(33)31-13-19-11-21-22(27)14-30-25(21)12-23(19)28/h2-8,10-12,14,30H,9,13H2,1H3,(H,31,33)	SQVVRWKBMIEHGU-UHFFFAOYSA-N	283458	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((2-methylquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 110::US10266515, Example 110::US10308637, Example 110::US11021463, Example 110::US9611252, Example 110	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283458	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283458&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212258	378164786							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608517	Cc1ccc2cc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)ccc2n1	InChI=1S/C27H23N5O/c1-17-2-5-21-12-18(4-7-25(21)32-17)14-23-15-22(9-10-29-23)27(33)31-16-19-3-6-24-20(13-19)8-11-30-26(24)28/h2-13,15H,14,16H2,1H3,(H2,28,30)(H,31,33)	BHHAKIOPTCXPSL-UHFFFAOYSA-N	283459	N-((1-aminoisoquinolin-6-yl)methyl)-2-((2- methylquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 111::US10266515, Example 111::US10308637, Example 111::US11021463, Example 111::US9611252, Example 111	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283459	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283459&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212697	378164787							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608518	Cc1ccc2cc(Cc3cc(ccn3)C(=O)NCc3ccc(N)nc3C)ccc2n1	InChI=1S/C24H23N5O/c1-15-3-5-18-11-17(4-7-22(18)28-15)12-21-13-19(9-10-26-21)24(30)27-14-20-6-8-23(25)29-16(20)2/h3-11,13H,12,14H2,1-2H3,(H2,25,29)(H,27,30)	XECXUFHBCFQVQM-UHFFFAOYSA-N	283460	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((2-methylquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 112::US10266515, Example 112::US10308637, Example 112::US11021463, Example 112::US9611252, Example 112	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283460	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283460&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212369	378164788							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608519	Cc1ccc2cc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)ccc2n1	InChI=1S/C25H25N5O/c1-15-10-24(26)30-17(3)22(15)14-28-25(31)20-8-9-27-21(13-20)12-18-5-7-23-19(11-18)6-4-16(2)29-23/h4-11,13H,12,14H2,1-3H3,(H2,26,30)(H,28,31)	SOGVYINZTNHWMJ-UHFFFAOYSA-N	283461	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((2-methylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 113::US10266515, Example 113::US10308637, Example 113::US11021463, Example 113::US9611252, Example 113	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283461	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283461&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212447	378164789							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608520	Cc1ccc2ncc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2c1	InChI=1S/C25H25N5O/c1-15-4-5-23-20(8-15)10-18(13-28-23)11-21-12-19(6-7-27-21)25(31)29-14-22-16(2)9-24(26)30-17(22)3/h4-10,12-13H,11,14H2,1-3H3,(H2,26,30)(H,29,31)	PERODSYFHIKGOQ-UHFFFAOYSA-N	283462	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((6-methylquinolin-3- yl)methyl)isonicotinamide::US10023557, Example 114::US10266515, Example 114::US10308637, Example 114::US11021463, Example 114::US9611252, Example 114	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283462	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283462&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212424	378164790							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608521	Cc1ccc2ncc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)cc2c1	InChI=1S/C27H23N5O/c1-17-2-5-25-22(10-17)12-19(16-31-25)13-23-14-21(7-8-29-23)27(33)32-15-18-3-4-24-20(11-18)6-9-30-26(24)28/h2-12,14,16H,13,15H2,1H3,(H2,28,30)(H,32,33)	YXYWWKCODFDZSQ-UHFFFAOYSA-N	283463	N-((1-aminoisoquinolin-6-yl)methyl)-2-((6- methylquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 115::US10266515, Example 115::US10308637, Example 115::US11021463, Example 115::US9611252, Example 115	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283463	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283463&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212341	378164791							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608522	Cc1ccc2ncc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)cc2c1	InChI=1S/C26H20ClFN4O/c1-15-2-3-24-18(6-15)7-16(12-30-24)8-20-9-17(4-5-29-20)26(33)32-13-19-10-21-22(27)14-31-25(21)11-23(19)28/h2-7,9-12,14,31H,8,13H2,1H3,(H,32,33)	HEFJFXWKPBYZLZ-UHFFFAOYSA-N	283464	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((6-methylquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 116::US10266515, Example 116::US10308637, Example 116::US11021463, Example 116::US9611252, Example 116	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283464	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283464&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212685	378164792							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608523	Cc1ccc2ncc(Cc3cc(ccn3)C(=O)NCc3ccc(N)nc3C)cc2c1	InChI=1S/C24H23N5O/c1-15-3-5-22-20(9-15)10-17(13-27-22)11-21-12-18(7-8-26-21)24(30)28-14-19-4-6-23(25)29-16(19)2/h3-10,12-13H,11,14H2,1-2H3,(H2,25,29)(H,28,30)	WNXNZZRXTORCMQ-UHFFFAOYSA-N	283465	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((6-methylquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 117::US10266515, Example 117::US10308637, Example 117::US11021463, Example 117::US9611252, Example 117	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283465	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283465&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212579	378164793							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608524	Nc1nccc2cc(CNC(=O)c3ccnc(Cc4cnc5ccc(F)cc5c4)c3)ccc12	InChI=1S/C26H20FN5O/c27-21-2-4-24-20(12-21)10-17(15-31-24)11-22-13-19(6-7-29-22)26(33)32-14-16-1-3-23-18(9-16)5-8-30-25(23)28/h1-10,12-13,15H,11,14H2,(H2,28,30)(H,32,33)	FEOOVYNQAJINSQ-UHFFFAOYSA-N	283466	N-((1-aminoisoquinolin-6-yl)methyl)-2-((6- fluoroquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 118::US10266515, Example 118::US10308637, Example 118::US11021463, Example 118::US9611252, Example 118	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283466	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283466&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212932	378164794							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608525	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cnc3ccc(F)cc3c2)c1	InChI=1S/C24H22FN5O/c1-14-7-23(26)30-15(2)21(14)13-29-24(31)17-5-6-27-20(11-17)9-16-8-18-10-19(25)3-4-22(18)28-12-16/h3-8,10-12H,9,13H2,1-2H3,(H2,26,30)(H,29,31)	VJYVCAQEIJFBMF-UHFFFAOYSA-N	283467	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((6-fluoroquinolin-3- yl)methyl)isonicotinamide::US10023557, Example 119::US10266515, Example 119::US10308637, Example 119::US11021463, Example 119::US9611252, Example 119	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283467	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283467&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212962	378164795							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608526	Fc1ccc2ncc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)cc2c1	InChI=1S/C25H17ClF2N4O/c26-21-13-31-24-10-22(28)17(9-20(21)24)12-32-25(33)15-3-4-29-19(8-15)6-14-5-16-7-18(27)1-2-23(16)30-11-14/h1-5,7-11,13,31H,6,12H2,(H,32,33)	PDPRSJXGOZQXDE-UHFFFAOYSA-N	283468	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((6-fluoroquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 120::US10266515, Example 120::US10308637, Example 120::US11021463, Example 120::US9611252, Example 120	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283468	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283468&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212861	378164796							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608527	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2cnc3ccc(F)cc3c2)c1	InChI=1S/C23H20FN5O/c1-14-17(2-5-22(25)29-14)13-28-23(30)16-6-7-26-20(11-16)9-15-8-18-10-19(24)3-4-21(18)27-12-15/h2-8,10-12H,9,13H2,1H3,(H2,25,29)(H,28,30)	HDWJBHJMHHEUTP-UHFFFAOYSA-N	283469	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((6-fluoroquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 121::US10266515, Example 121::US10308637, Example 121::US11021463, Example 121::US9611252, Example 121	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283469	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283469&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212359	378164797							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608528	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cnc3cc(F)ccc3c2)c1	InChI=1S/C24H22FN5O/c1-14-7-23(26)30-15(2)21(14)13-29-24(31)18-5-6-27-20(10-18)9-16-8-17-3-4-19(25)11-22(17)28-12-16/h3-8,10-12H,9,13H2,1-2H3,(H2,26,30)(H,29,31)	MWOHJBUVZJQGNX-UHFFFAOYSA-N	283470	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((7-fluoroquinolin-3- yl)methyl)isonicotinamide::US10023557, Example 122::US10266515, Example 122::US10308637, Example 122::US11021463, Example 122::US9611252, Example 122	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283470	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283470&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212621	378164798							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608529	Fc1ccc2cc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)cnc2c1	InChI=1S/C25H17ClF2N4O/c26-21-13-31-24-10-22(28)17(8-20(21)24)12-32-25(33)16-3-4-29-19(7-16)6-14-5-15-1-2-18(27)9-23(15)30-11-14/h1-5,7-11,13,31H,6,12H2,(H,32,33)	AMSTZJFOMLJWBY-UHFFFAOYSA-N	283471	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((7-fluoroquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 123::US10266515, Example 123::US10308637, Example 123::US11021463, Example 123::US9611252, Example 123	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283471	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283471&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212350	378164799							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608530	Nc1nccc2cc(CNC(=O)c3ccnc(Cc4cnc5cc(F)ccc5c4)c3)ccc12	InChI=1S/C26H20FN5O/c27-21-3-2-19-10-17(15-31-24(19)13-21)11-22-12-20(6-7-29-22)26(33)32-14-16-1-4-23-18(9-16)5-8-30-25(23)28/h1-10,12-13,15H,11,14H2,(H2,28,30)(H,32,33)	BBANODQRERYSMA-UHFFFAOYSA-N	283472	N-((1-aminoisoquinolin-6-yl)methyl)-2-((7- fluoroquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 124::US10266515, Example 124::US10308637, Example 124::US11021463, Example 124::US9611252, Example 124	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283472	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283472&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212446	378164800							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608531	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1ccnc(Cc2cnc3ccccc3c2)c1	InChI=1S/C25H18ClFN4O/c26-21-14-30-24-11-22(27)18(10-20(21)24)13-31-25(32)17-5-6-28-19(9-17)8-15-7-16-3-1-2-4-23(16)29-12-15/h1-7,9-12,14,30H,8,13H2,(H,31,32)	FYVVQNCFFZYQIZ-UHFFFAOYSA-N	283473	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- (quinolin-3-ylmethyl)isonicotinamide::US10023557, Example 125::US10266515, Example 125::US10308637, Example 125::US11021463, Example 125::US9611252, Example 125	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283473	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283473&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212449	378164801							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608532	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1ccnc(Cc2cnc3ccc(Cl)cc3c2)c1	InChI=1S/C25H17Cl2FN4O/c26-18-1-2-23-16(7-18)5-14(11-30-23)6-19-8-15(3-4-29-19)25(33)32-12-17-9-20-21(27)13-31-24(20)10-22(17)28/h1-5,7-11,13,31H,6,12H2,(H,32,33)	LRUSUFGKIZOKQY-UHFFFAOYSA-N	283474	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((6-chloroquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 126::US10266515, Example 126::US10308637, Example 126::US11021463, Example 126::US9611252, Example 126	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283474	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283474&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212638	378164802							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608533	Cc1ccc2ccc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)cc2n1	InChI=1S/C27H23N5O/c1-17-2-5-20-6-3-18(14-25(20)32-17)13-23-15-22(9-10-29-23)27(33)31-16-19-4-7-24-21(12-19)8-11-30-26(24)28/h2-12,14-15H,13,16H2,1H3,(H2,28,30)(H,31,33)	YUIGLCWKRLEJJV-UHFFFAOYSA-N	283475	N-((1-aminoisoquinolin-6-yl)methyl)-2-((2- methylquinolin-7-yl)methyl)isonicotinamide::US10023557, Example 127::US10266515, Example 127::US10308637, Example 127::US11021463, Example 127::US9611252, Example 127	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283475	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283475&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212220	378164803							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608534	Cc1ccc2ccc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)cc2n1	InChI=1S/C26H20ClFN4O/c1-15-2-4-17-5-3-16(9-24(17)32-15)8-20-10-18(6-7-29-20)26(33)31-13-19-11-21-22(27)14-30-25(21)12-23(19)28/h2-7,9-12,14,30H,8,13H2,1H3,(H,31,33)	ASHCCNPFZHFVAC-UHFFFAOYSA-N	283476	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((2-methylquinolin-7-yl)methyl)isonicotinamide::US10023557, Example 128::US10266515, Example 128::US10308637, Example 128::US11021463, Example 128::US9611252, Example 128	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283476	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283476&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212704	378164804							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608535	Cc1ccc2ccc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2n1	InChI=1S/C25H25N5O/c1-15-10-24(26)30-17(3)22(15)14-28-25(31)20-8-9-27-21(13-20)11-18-5-7-19-6-4-16(2)29-23(19)12-18/h4-10,12-13H,11,14H2,1-3H3,(H2,26,30)(H,28,31)	BOMAZLQSSNNLAL-UHFFFAOYSA-N	283477	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((2-methylquinolin-7- yl)methyl)isonicotinamide::US10023557, Example 129::US10266515, Example 129::US10308637, Example 129::US11021463, Example 129::US9611252, Example 129	Plasma kallikrein			 550							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283477	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283477&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212507	378164805							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608536	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1ccnc(Cc2ccc3nc(ccc3c2)C#N)c1	InChI=1S/C26H17ClFN5O/c27-22-14-31-25-11-23(28)18(10-21(22)25)13-32-26(34)17-5-6-30-20(9-17)8-15-1-4-24-16(7-15)2-3-19(12-29)33-24/h1-7,9-11,14,31H,8,13H2,(H,32,34)	XHYLSPCHHJFGNQ-UHFFFAOYSA-N	283478	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((2-isocyanoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 130::US10266515, Example 130::US10308637, Example 130::US11021463, Example 130::US9611252, Example 130	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283478	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283478&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213085	378164806							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608537	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3nc(ccc3c2)C#N)c1	InChI=1S/C25H22N6O/c1-15-9-24(27)30-16(2)22(15)14-29-25(32)19-7-8-28-21(12-19)11-17-3-6-23-18(10-17)4-5-20(13-26)31-23/h3-10,12H,11,14H2,1-2H3,(H2,27,30)(H,29,32)	WCGZGKPBOPWGNC-UHFFFAOYSA-N	283479	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((2-isocyanoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 131::US10266515, Example 131::US10308637, Example 131::US9611252, Example 131	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283479	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283479&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212991	378164807							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608538	Cc1cc2cc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)ccc2cn1	InChI=1S/C27H23N5O/c1-17-10-23-11-18(2-4-22(23)16-31-17)13-24-14-21(7-8-29-24)27(33)32-15-19-3-5-25-20(12-19)6-9-30-26(25)28/h2-12,14,16H,13,15H2,1H3,(H2,28,30)(H,32,33)	KZGIIODXNPBNJO-UHFFFAOYSA-N	283480	N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- methylisoquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 132::US10266515, Example 132::US10308637, Example 132::US11021463, Example 132::US9611252, Example 132	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283480	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283480&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213018	378164808							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608539	Cc1cc2cc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)ccc2cn1	InChI=1S/C26H20ClFN4O/c1-15-6-19-7-16(2-3-18(19)12-30-15)8-21-9-17(4-5-29-21)26(33)32-13-20-10-22-23(27)14-31-25(22)11-24(20)28/h2-7,9-12,14,31H,8,13H2,1H3,(H,32,33)	KRFVOCRTZLYSJU-UHFFFAOYSA-N	283481	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3-methylisoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 133::US10266515, Example 133::US10308637, Example 133::US11021463, Example 133::US9611252, Example 133	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283481	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283481&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212795	378164809							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608540	CS(=O)(=O)c1ccc2cc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)ccc2n1	InChI=1S/C27H23N5O3S/c1-36(34,35)25-7-4-20-12-17(3-6-24(20)32-25)14-22-15-21(9-10-29-22)27(33)31-16-18-2-5-23-19(13-18)8-11-30-26(23)28/h2-13,15H,14,16H2,1H3,(H2,28,30)(H,31,33)	QZLYZRALGDJSAC-UHFFFAOYSA-N	283482	N-((1-aminoisoquinolin-6-yl)methyl)-2-((2- (methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 134::US10266515, Example 134::US10308637, Example 134::US11021463, Example 134::US9611252, Example 134	Plasma kallikrein			 550							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283482	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283482&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212866	378164810							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608541	CS(=O)(=O)c1ccc2cc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)ccc2n1	InChI=1S/C26H20ClFN4O3S/c1-36(34,35)25-5-3-16-8-15(2-4-23(16)32-25)9-19-10-17(6-7-29-19)26(33)31-13-18-11-20-21(27)14-30-24(20)12-22(18)28/h2-8,10-12,14,30H,9,13H2,1H3,(H,31,33)	URHHGZRDZIHONJ-UHFFFAOYSA-N	283483	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((2-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 135::US10266515, Example 135::US10308637, Example 135::US11021463, Example 135::US9611252, Example 135	Plasma kallikrein			 550							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283483	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283483&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212678	378164811							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608542	Nc1nccc2cc(CNC(=O)c3ccnc(Cc4ccc5nccc(C#N)c5c4)c3)ccc12	InChI=1S/C27H20N6O/c28-15-21-7-9-31-25-4-2-17(13-24(21)25)12-22-14-20(6-8-30-22)27(34)33-16-18-1-3-23-19(11-18)5-10-32-26(23)29/h1-11,13-14H,12,16H2,(H2,29,32)(H,33,34)	GWYUQVNAIHTMAT-UHFFFAOYSA-N	283484	N-((1-aminoisoquinolin-6-yl)methyl)-2-((4- cyanoquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 136::US10266515, Example 136::US10308637, Example 136::US11021463, Example 136::US9611252, Example 136	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283484	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283484&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213035	378164812							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608543	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1ccnc(Cc2ccc3nccc([N+]#[C-])c3c2)c1	InChI=1S/C26H17ClFN5O/c1-29-23-5-7-31-24-3-2-15(9-20(23)24)8-18-10-16(4-6-30-18)26(34)33-13-17-11-19-21(27)14-32-25(19)12-22(17)28/h2-7,9-12,14,32H,8,13H2,(H,33,34)	RDLBGCIBZMDBKB-UHFFFAOYSA-N	283485	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((4-cyanoquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 137::US9611252, Example 137	Plasma kallikrein			 550							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283485	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283485&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			136215339	378164813							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608544	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3nccc([N+]#[C-])c3c2)c1	InChI=1S/C25H22N6O/c1-15-10-24(26)31-16(2)21(15)14-30-25(32)18-6-8-28-19(13-18)11-17-4-5-23-20(12-17)22(27-3)7-9-29-23/h4-10,12-13H,11,14H2,1-2H3,(H2,26,31)(H,30,32)	VOZLTLOQPVBEOD-UHFFFAOYSA-N	283486	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((4-cyanoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 138::US9611252, Example 138	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283486	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283486&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			136215340	378164814							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608545	Nc1nccc2cc(CNC(=O)c3ccnc(Cc4cnc5cc(ccc5c4)C#N)c3)ccc12	InChI=1S/C27H20N6O/c28-14-17-1-3-21-10-19(16-32-25(21)12-17)11-23-13-22(6-7-30-23)27(34)33-15-18-2-4-24-20(9-18)5-8-31-26(24)29/h1-10,12-13,16H,11,15H2,(H2,29,31)(H,33,34)	OLZHWXPPOPYAAI-UHFFFAOYSA-N	314643	N-((1-aminoisoquinolin-6-yl)methyl)-2-((7- chloroquinolin-3-yl)methyl)isonicotinamide::US9611252, Example 139	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314643	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314643&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121479584	383541476							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608546	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1ccnc(Cc2cnc3cc(Cl)ccc3c2)c1	InChI=1S/C25H17Cl2FN4O/c26-18-2-1-15-5-14(11-30-23(15)9-18)6-19-7-16(3-4-29-19)25(33)32-12-17-8-20-21(27)13-31-24(20)10-22(17)28/h1-5,7-11,13,31H,6,12H2,(H,32,33)	IKMVYXFFBLRHRM-UHFFFAOYSA-N	283488	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((7-chloroquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 140::US10266515, Example 140::US10308637, Example 140::US11021463, Example 140::US9611252, Example 140	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283488	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283488&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212776	378164816							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608547	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cnc3cc(Cl)ccc3c2)c1	InChI=1S/C24H22ClN5O/c1-14-7-23(26)30-15(2)21(14)13-29-24(31)18-5-6-27-20(10-18)9-16-8-17-3-4-19(25)11-22(17)28-12-16/h3-8,10-12H,9,13H2,1-2H3,(H2,26,30)(H,29,31)	CRTRNHYSRBELJZ-UHFFFAOYSA-N	283489	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((7-chloroquinolin-3- yl)methyl)isonicotinamide::US10023557, Example 141::US10266515, Example 141::US10308637, Example 141::US11021463, Example 141::US9611252, Example 141	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283489	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283489&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213050	378164817							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608548	Cc1cnc2ccc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)cc2c1	InChI=1S/C27H23N5O/c1-17-10-22-11-18(3-5-25(22)31-15-17)13-23-14-21(7-8-29-23)27(33)32-16-19-2-4-24-20(12-19)6-9-30-26(24)28/h2-12,14-15H,13,16H2,1H3,(H2,28,30)(H,32,33)	XPXFEZOWOODSMW-UHFFFAOYSA-N	283490	N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- methylquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 142::US10266515, Example 142::US10308637, Example 142::US11021463, Example 142::US9611252, Example 142	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283490	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283490&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212463	378164818							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608549	Cc1cnc2ccc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)cc2c1	InChI=1S/C26H20ClFN4O/c1-15-6-18-7-16(2-3-24(18)30-12-15)8-20-9-17(4-5-29-20)26(33)32-13-19-10-21-22(27)14-31-25(21)11-23(19)28/h2-7,9-12,14,31H,8,13H2,1H3,(H,32,33)	BAWQXCVTJNYXQW-UHFFFAOYSA-N	283491	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3-methylquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 143::US10266515, Example 143::US10308637, Example 143::US11021463, Example 143::US9611252, Example 143	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283491	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283491&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212764	378164819							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608550	Cc1cnc2ccc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2c1	InChI=1S/C25H25N5O/c1-15-8-20-10-18(4-5-23(20)28-13-15)11-21-12-19(6-7-27-21)25(31)29-14-22-16(2)9-24(26)30-17(22)3/h4-10,12-13H,11,14H2,1-3H3,(H2,26,30)(H,29,31)	BDBQXLZXRHXRJN-UHFFFAOYSA-N	283492	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-methylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 144::US10266515, Example 144::US10308637, Example 144::US11021463, Example 144::US9611252, Example 144	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283492	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283492&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212432	378164820							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608551	Cc1cc2cc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)ccc2cn1	InChI=1S/C25H25N5O/c1-15-8-24(26)30-17(3)23(15)14-29-25(31)19-6-7-27-22(12-19)11-18-4-5-20-13-28-16(2)9-21(20)10-18/h4-10,12-13H,11,14H2,1-3H3,(H2,26,30)(H,29,31)	IDPUQOZCEWQYLL-UHFFFAOYSA-N	283493	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-methylisoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 145::US10266515, Example 145::US10308637, Example 145::US11021463, Example 145::US9611252, Example 145	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283493	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283493&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212443	378164821							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608552	NCc1ccc2cc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)ccc2n1	InChI=1S/C27H24N6O/c28-15-22-4-3-20-11-17(2-6-25(20)33-22)13-23-14-21(8-9-30-23)27(34)32-16-18-1-5-24-19(12-18)7-10-31-26(24)29/h1-12,14H,13,15-16,28H2,(H2,29,31)(H,32,34)	NBXVVYPBTMZIFQ-UHFFFAOYSA-N	283494	N-((1-aminoisoquinolin-6-yl)methyl)-2-((2- (aminomethyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 146::US10266515, Example 146::US10308637, Example 146::US11021463, Example 146::US9611252, Example 146Biochemical	Plasma kallikrein			 550							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283494	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283494&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212893	378164822							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50678737	COC(=O)Nc1ccc2-c3c[nH]c(n3)[C@H](CCCCC(=O)Nc2c1)NC(=O)\C=C\c1cc(Cl)ccc1-n1cnnn1			47108	US10487086, Example 10::US11136327, Example 10::US8828983, 10::US8940720, 10::US9802939, 10	Plasma kallikrein		 70								ChEMBL	10.1021/acs.jmedchem.6b01460	10.7270/Q25D8V31	28085275			Corte, JR; Fang, T; Osuna, H; Pinto, DJ; Rossi, KA; Myers, JE; Sheriff, S; Lou, Z; Zheng, JJ; Harper, TW; Bozarth, JM; Wu, Y; Luettgen, JM; Seiffert, DA; Decicco, CP; Wexler, RR; Quan, ML	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=47108	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=47108&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	9EY	5Q0D	53341037	251973434							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608407	NC(=O)c1ccc2cc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)ccc2n1	InChI=1S/C26H19ClFN5O2/c27-20-13-31-24-11-21(28)17(10-19(20)24)12-32-26(35)16-5-6-30-18(9-16)8-14-1-3-22-15(7-14)2-4-23(33-22)25(29)34/h1-7,9-11,13,31H,8,12H2,(H2,29,34)(H,32,35)	QFADKPXVEQNUDC-UHFFFAOYSA-N	283349	6-((4-(((3-chloro-6-fluoro-1H-indol-5- yl)methyl)carbamoyl)pyridin-2- yl)methyl)quinoline-2-carboxamide::US10023557, Example 1::US10266515, Example 1::US10308637, Example 1::US11021463, Example 1::US9611252, Example 1	Plasma kallikrein			 550							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283349	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283349&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665333	378164678							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608408	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3nc(ccc3c2)C(N)=O)c1	InChI=1S/C25H24N6O2/c1-14-9-23(26)30-15(2)20(14)13-29-25(33)18-7-8-28-19(12-18)11-16-3-5-21-17(10-16)4-6-22(31-21)24(27)32/h3-10,12H,11,13H2,1-2H3,(H2,26,30)(H2,27,32)(H,29,33)	STXHTXUTWCUJHH-UHFFFAOYSA-N	283350	6-((4-(((6-amino-2,4-dimethylpyridin-3- yl)methyl)carbamoyl)pyridin-2- yl)methyl)quinoline-2-carboxamide::US10023557, Example 2::US10266515, Example 2::US10308637, Example 2::US11021463, Example 2::US9611252, Example 2	Plasma kallikrein			 550							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283350	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283350&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665160	378164679							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608409	Nc1nccc2cc(CNC(=O)c3ccnc(Cc4ccc5nc(ccc5c4)C#N)c3)ccc12	InChI=1S/C27H20N6O/c28-15-22-4-3-20-11-17(2-6-25(20)33-22)13-23-14-21(8-9-30-23)27(34)32-16-18-1-5-24-19(12-18)7-10-31-26(24)29/h1-12,14H,13,16H2,(H2,29,31)(H,32,34)	DMXHLBYRSDVDMO-UHFFFAOYSA-N	283351	N-((1-aminoisoquinolin-6-yl)methyl)-2-((2- cyanoquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 3::US10266515, Example 3::US10308637, Example 3::US11021463, Example 3::US9611252, Example 3	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283351	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283351&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665133	378164680							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608410	NC(=O)c1ccc2cc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)ccc2n1	InChI=1S/C27H22N6O2/c28-25-22-4-1-17(12-18(22)7-10-31-25)15-32-27(35)20-8-9-30-21(14-20)13-16-2-5-23-19(11-16)3-6-24(33-23)26(29)34/h1-12,14H,13,15H2,(H2,28,31)(H2,29,34)(H,32,35)	SPVRYWSSDGGGFK-UHFFFAOYSA-N	283352	6-((4-(((1-aminoisoquinolin-6- yl)methyl)carbamoyl)pyridin-2- yl)methyl)quinoline-2-carboxamide::US10023557, Example 4::US10266515, Example 4::US10308637, Example 4::US11021463, Example 4::US9611252, Example 4	Plasma kallikrein			 550							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283352	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283352&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665212	378164681							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608411	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1ccnc(Cc2ccc3ncc(cc3c2)C#N)c1	InChI=1S/C26H17ClFN5O/c27-22-14-32-25-10-23(28)19(9-21(22)25)13-33-26(34)17-3-4-30-20(8-17)7-15-1-2-24-18(5-15)6-16(11-29)12-31-24/h1-6,8-10,12,14,32H,7,13H2,(H,33,34)	UMGVLTPEGADZAJ-UHFFFAOYSA-N	283353	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3-cyanoquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 5::US10266515, Example 5::US10308637, Example 5::US11021463, Example 5::US9611252, Example 5	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283353	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283353&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665332	378164682							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608412	Nc1nccc2cc(CNC(=O)c3ccnc(Cc4ccc5ncc(cc5c4)C#N)c3)ccc12	InChI=1S/C27H20N6O/c28-14-19-11-22-9-17(2-4-25(22)32-16-19)12-23-13-21(6-7-30-23)27(34)33-15-18-1-3-24-20(10-18)5-8-31-26(24)29/h1-11,13,16H,12,15H2,(H2,29,31)(H,33,34)	KYRAMUYNXMHHJI-UHFFFAOYSA-N	283354	N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- cyanoquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 6::US10266515, Example 6::US10308637, Example 6::US11021463, Example 6::US9611252, Example 6	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283354	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283354&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665279	378164683							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608413	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3ncc(cc3c2)C#N)c1	InChI=1S/C25H22N6O/c1-15-7-24(27)31-16(2)22(15)14-30-25(32)19-5-6-28-21(11-19)10-17-3-4-23-20(8-17)9-18(12-26)13-29-23/h3-9,11,13H,10,14H2,1-2H3,(H2,27,31)(H,30,32)	CBKARQMZIQUSSI-UHFFFAOYSA-N	283355	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-cyanoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 7::US10266515, Example 7::US10308637, Example 7::US11021463, Example 7::US9611252, Example 7	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283355	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283355&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665185	378164684							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608414	Nc1nccc2cc(CNC(=O)c3ccnc(Cc4cnc5ccc(F)cc5n4)c3)ccc12	InChI=1S/C25H19FN6O/c26-18-2-4-22-23(11-18)32-20(14-30-22)12-19-10-17(6-7-28-19)25(33)31-13-15-1-3-21-16(9-15)5-8-29-24(21)27/h1-11,14H,12-13H2,(H2,27,29)(H,31,33)	NAEBTWZBUODUEA-UHFFFAOYSA-N	283356	N-((1-aminoisoquinolin-6-yl)methyl)-2-((7- fluoroquinoxalin-2-yl)methyl)isonicotinamide::US10023557, Example 8::US10266515, Example 8::US10308637, Example 8::US11021463, Example 8::US9611252, Example 8	Plasma kallikrein			 550							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283356	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283356&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665180	378164685							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608415	CC(=O)NCc1ccc2cc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)ccc2n1	InChI=1S/C28H23ClFN5O2/c1-16(36)32-14-21-4-3-18-8-17(2-5-26(18)35-21)9-22-10-19(6-7-31-22)28(37)34-13-20-11-23-24(29)15-33-27(23)12-25(20)30/h2-8,10-12,15,33H,9,13-14H2,1H3,(H,32,36)(H,34,37)	VKZVWMJENMIADE-UHFFFAOYSA-N	283357	2-((2-(acetamidomethyl)quinolin-6-yl)methyl)- N-((3-chloro-6-fluoro-1H-indol-5- yl)methyl)isonicotinamide::US10023557, Example 9::US10266515, Example 9::US10308637, Example 9::US11021463, Example 9::US9611252, Example 9	Plasma kallikrein			 550							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283357	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283357&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665193	378164686							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608416	CC(=O)NCc1ccc2cc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)ccc2n1	InChI=1S/C29H26N6O2/c1-18(36)33-17-24-5-4-22-12-19(3-7-27(22)35-24)14-25-15-23(9-10-31-25)29(37)34-16-20-2-6-26-21(13-20)8-11-32-28(26)30/h2-13,15H,14,16-17H2,1H3,(H2,30,32)(H,33,36)(H,34,37)	ZYSYOACDZZDUSZ-UHFFFAOYSA-N	283358	2-((2-(acetamidomethyl)quinolin-6-yl)methyl)- N-((1-aminoisoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 10::US10266515, Example 10::US10308637, Example 10::US11021463, Example 10::US9611252, Example 10	Plasma kallikrein			 550							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283358	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283358&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665233	378164687							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608417	CC(=O)NCc1ccc2cc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)ccc2n1	InChI=1S/C27H28N6O2/c1-16-10-26(28)32-17(2)24(16)15-31-27(35)21-8-9-29-23(13-21)12-19-4-7-25-20(11-19)5-6-22(33-25)14-30-18(3)34/h4-11,13H,12,14-15H2,1-3H3,(H2,28,32)(H,30,34)(H,31,35)	GCIYNSCGYKCNRO-UHFFFAOYSA-N	283359	2-((2-(acetamidomethyl)quinolin-6-yl)methyl)- N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)isonicotinamide::US10023557, Example 11::US10266515, Example 11::US10308637, Example 11::US11021463, Example 11::US9611252, Example 11	Plasma kallikrein			 550							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283359	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283359&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665205	378164688							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
608418	CS(=O)(=O)c1ccc2ncc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)cc2c1	InChI=1S/C26H20ClFN4O3S/c1-36(34,35)20-2-3-24-17(9-20)6-15(12-30-24)7-19-8-16(4-5-29-19)26(33)32-13-18-10-21-22(27)14-31-25(21)11-23(18)28/h2-6,8-12,14,31H,7,13H2,1H3,(H,32,33)	QNAPNSFSYRBKHH-UHFFFAOYSA-N	283360	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((6-(methylsulfonyl)quinolin-3- yl)methyl)isonicotinamide::US10023557, Example 12::US10266515, Example 12::US10308637, Example 12::US11021463, Example 12::US9611252, Example 12	Plasma kallikrein			<100							US Patent		10.7270/Q2930W8S		aid1796483	US9611252	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283360	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283360&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665393	378164689							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50677125	CC(C)C[C@@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]2CSCCC(=O)N3CN(CN(C3)C(=O)CCSC[C@H](NC(=O)[C@@H](N)CCNC(N)=N)C(=O)N[C@@H](Cc3ccc(F)cc3)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N3CCC[C@H]3C(=O)N2)C(=O)CCSC[C@H](NC(=O)[C@H](CCCNC(N)=N)NC1=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O	InChI=1S/C81H135FN32O18S3/c1-43(2)34-53-69(124)100-50(12-7-27-97-79(89)90)67(122)109-57(72(127)104-52(76(131)132)13-8-28-98-80(91)92)38-134-32-23-62(117)112-40-111-41-113(42-112)63(118)24-33-135-39-58(71(126)102-48(10-5-25-95-77(85)86)65(120)103-51(68(123)105-53)19-20-60(84)115)110-74(129)59-14-9-30-114(59)75(130)55(35-44(3)4)107-66(121)49(11-6-26-96-78(87)88)101-70(125)54(36-45-15-17-46(82)18-16-45)106-73(128)56(37-133-31-22-61(111)116)108-64(119)47(83)21-29-99-81(93)94/h15-18,43-44,47-59H,5-14,19-42,83H2,1-4H3,(H2,84,115)(H,100,124)(H,101,125)(H,102,126)(H,103,120)(H,104,127)(H,105,123)(H,106,128)(H,107,121)(H,108,119)(H,109,122)(H,110,129)(H,131,132)(H4,85,86,95)(H4,87,88,96)(H4,89,90,97)(H4,91,92,98)(H4,93,94,99)/t47-,48-,49-,50-,51-,52-,53-,54-,55-,56-,57-,58-,59-/m0/s1	SBHHAJOLSBKKBX-JWKNPDOPSA-N	50229738	CHEMBL4087027	Plasma kallikrein		 45100								ChEMBL	10.1021/acs.jmedchem.6b01548	10.7270/Q26D5W8V	28045547			Middendorp, SJ; Wilbs, J; Quarroz, C; Calzavarini, S; Angelillo-Scherrer, A; Heinis, C	Ecole Polytechnique F&#65533;d&#65533;rale de Lausanne (EPFL)	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50229738	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50229738&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137644829	383542846		CHEMBL4087027			C04026		1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755717	Nc1noc2cc(CNC(=O)c3ccnc(Cc4ccc5ncc(Cl)cc5c4)c3)ccc12	InChI=1S/C24H18ClN5O2/c25-18-10-17-7-14(2-4-21(17)28-13-18)8-19-11-16(5-6-27-19)24(31)29-12-15-1-3-20-22(9-15)32-30-23(20)26/h1-7,9-11,13H,8,12H2,(H2,26,30)(H,29,31)	HNXHQCQPXRYRIC-UHFFFAOYSA-N	283384	N-((3-aminobenzo[d]isoxazol-6-yl)methyl)-2- ((3-chloroquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 36::US10266515, Example 36::US10308637, Example 36::US11021463, Example 36::US9611252, Example 36	Plasma kallikrein			 26							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283384	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283384&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665141	378164713							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755718	Clc1ccc2[nH]nc(CNC(=O)c3ccnc(Cc4ccc5ncc(Cl)cc5c4)c3)c2c1	InChI=1S/C24H17Cl2N5O/c25-17-2-4-22-20(11-17)23(31-30-22)13-29-24(32)15-5-6-27-19(10-15)8-14-1-3-21-16(7-14)9-18(26)12-28-21/h1-7,9-12H,8,13H2,(H,29,32)(H,30,31)	YXHGJDJGKSPRKX-UHFFFAOYSA-N	283385	N-((5-chloro-1H-indazol-3-yl)methyl)-2-((3- chloroquinolin-6-yl)methyl)isonictotinamide::US10023557, Example 37::US10266515, Example 37::US10308637, Example 37::US11021463, Example 37::US9611252, Example 37	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283385	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283385&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212832	378164714							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755719	Clc1c[nH]c2ncc(CNC(=O)c3ccnc(Cc4ccc5ncc(Cl)cc5c4)c3)cc12	InChI=1S/C24H17Cl2N5O/c25-18-8-17-5-14(1-2-22(17)28-12-18)6-19-9-16(3-4-27-19)24(32)31-11-15-7-20-21(26)13-30-23(20)29-10-15/h1-5,7-10,12-13H,6,11H2,(H,29,30)(H,31,32)	QFSDBAJWKWRDTA-UHFFFAOYSA-N	283386	N-((3-chloro-1H-pyrrolo[2,3-b]pyridin-5- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 38::US10266515, Example 38::US10308637, Example 38::US11021463, Example 38::US9611252, Example 38	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283386	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283386&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665363	378164715							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755720	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C23H20ClN5O/c1-14-17(3-5-22(25)29-14)12-28-23(30)16-6-7-26-20(11-16)9-15-2-4-21-18(8-15)10-19(24)13-27-21/h2-8,10-11,13H,9,12H2,1H3,(H2,25,29)(H,28,30)	ZGYIOYKVCAJRKO-UHFFFAOYSA-N	283382	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-chloroquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 34::US10266515, Example 39::US10308637, Example 39::US11021463, Example 39::US9611252, Example 39	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283382	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283382&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213054	378164711							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755703	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cn2ccc3c(Cl)cccc3c2=O)c1	InChI=1S/C24H22ClN5O2/c1-14-10-22(26)29-15(2)20(14)12-28-23(31)16-6-8-27-17(11-16)13-30-9-7-18-19(24(30)32)4-3-5-21(18)25/h3-11H,12-13H2,1-2H3,(H2,26,29)(H,28,31)	MEZFXRCCCIIGIW-UHFFFAOYSA-N	283370	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((5-chloro-1-oxoisoquinolin-2(1H)- yl)methyl)isonicotinamide::US10023557, Example 22::US10266515, Example 22::US10308637, Example 22::US11021463, Example 22::US9611252, Example 22	Plasma kallikrein			 550							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283370	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283370&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665187	378164699							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755704	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cn2ccc3cc(Cl)ccc3c2=O)c1	InChI=1S/C24H22ClN5O2/c1-14-9-22(26)29-15(2)21(14)12-28-23(31)17-5-7-27-19(11-17)13-30-8-6-16-10-18(25)3-4-20(16)24(30)32/h3-11H,12-13H2,1-2H3,(H2,26,29)(H,28,31)	AXAISOZEVYRCNQ-UHFFFAOYSA-N	283371	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((6-chloro-1-oxoisoquinolin-2(1H)- yl)methyl)isonicotinamide::US10023557, Example 23::US10266515, Example 23::US10308637, Example 23::US11021463, Example 23::US9611252, Example 23	Plasma kallikrein			 26							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283371	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283371&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665258	378164700							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755705	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3[nH]cc(Cl)c3c2)c1	InChI=1S/C23H22ClN5O/c1-13-7-22(25)29-14(2)19(13)11-28-23(30)16-5-6-26-17(10-16)8-15-3-4-21-18(9-15)20(24)12-27-21/h3-7,9-10,12,27H,8,11H2,1-2H3,(H2,25,29)(H,28,30)	WGAUJZUEMJFDBD-UHFFFAOYSA-N	283372	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloro-1H-indol-5- yl)methyl)isonicotinamide::US10023557, Example 24::US10266515, Example 24::US10308637, Example 24::US11021463, Example 24::US9611252, Example 24	Plasma kallikrein			 550							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283372	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283372&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665371	378164701							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755706	Cc1c[nH]c2ccc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc12	InChI=1S/C24H25N5O/c1-14-8-23(25)29-16(3)21(14)13-28-24(30)18-6-7-26-19(11-18)9-17-4-5-22-20(10-17)15(2)12-27-22/h4-8,10-12,27H,9,13H2,1-3H3,(H2,25,29)(H,28,30)	POUWYQSQNNTBKE-UHFFFAOYSA-N	283373	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-methyl-1H-indol-5- yl)methyl)isonicotinamide::US10023557, Example 25::US10266515, Example 25::US10308637, Example 25::US11021463, Example 25::US9611252, Example 25	Plasma kallikrein			 550							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283373	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283373&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665395	378164702							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755707	Cc1nc(N)c(cc1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1)C#N	InChI=1S/C24H19ClN6O/c1-14-19(8-18(11-26)23(27)31-14)12-30-24(32)16-4-5-28-21(10-16)7-15-2-3-22-17(6-15)9-20(25)13-29-22/h2-6,8-10,13H,7,12H2,1H3,(H2,27,31)(H,30,32)	BSYAUMQSIQHPBV-UHFFFAOYSA-N	283374	N-((6-amino-5-cyano-2-methylpyridin-3- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 26::US10266515, Example 26::US10308637, Example 26::US11021463, Example 26::US9611252, Example 26	Plasma kallikrein			 26							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283374	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283374&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665238	378164703							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755708	Cc1nc(N)c(cc1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1)C(N)=O	InChI=1S/C24H21ClN6O2/c1-13-17(10-20(23(27)32)22(26)31-13)11-30-24(33)15-4-5-28-19(9-15)7-14-2-3-21-16(6-14)8-18(25)12-29-21/h2-6,8-10,12H,7,11H2,1H3,(H2,26,31)(H2,27,32)(H,30,33)	AUZYMVREUCDBQL-UHFFFAOYSA-N	283375	2-amino-5-((2-((3-chloroquinolin-6- yl)methyl)isonicotinamido)methyl)-6- methylnicotinamide::US10023557, Example 27::US10266515, Example 27::US10308637, Example 27::US11021463, Example 27::US9611252, Example 27	Plasma kallikrein			>10000							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283375	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283375&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665169	378164704							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755709	Cc1nc(N)c(Cl)cc1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C23H19Cl2N5O/c1-13-17(10-20(25)22(26)30-13)11-29-23(31)15-4-5-27-19(9-15)7-14-2-3-21-16(6-14)8-18(24)12-28-21/h2-6,8-10,12H,7,11H2,1H3,(H2,26,30)(H,29,31)	QTDAMOULKXIHPX-UHFFFAOYSA-N	283376	N-((6-amino-5-chloro-2-methylpyridin-3- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 28::US10266515, Example 28::US10308637, Example 28::US11021463, Example 28::US9611252, Example 28	Plasma kallikrein			 26							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283376	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283376&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665175	378164705							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755710	Cc1cc(N)ncc1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C23H20ClN5O/c1-14-6-22(25)28-11-18(14)12-29-23(30)16-4-5-26-20(10-16)8-15-2-3-21-17(7-15)9-19(24)13-27-21/h2-7,9-11,13H,8,12H2,1H3,(H2,25,28)(H,29,30)	VFDBWWVOFNVCCV-UHFFFAOYSA-N	283377	N-((6-amino-4-methylpyridin-3-yl)methyl)-2- ((3-chloroquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 29::US10266515, Example 29::US10308637, Example 29::US11021463, Example 29::US9611252, Example 29	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283377	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283377&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212275	378164706							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755711	Nc1ccc(CNC(=O)c2ccnc(Cc3ccc4ncc(Cl)cc4c3)c2)c(n1)C(F)(F)F	InChI=1S/C23H17ClF3N5O/c24-17-9-16-7-13(1-3-19(16)30-12-17)8-18-10-14(5-6-29-18)22(33)31-11-15-2-4-20(28)32-21(15)23(25,26)27/h1-7,9-10,12H,8,11H2,(H2,28,32)(H,31,33)	JQBVZTITQKTVTP-UHFFFAOYSA-N	283378	N-((6-amino-2-(trifluoromoethyl)pyridin-3- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 30::US10266515, Example 30::US10308637, Example 30::US11021463, Example 30::US9611252, Example 30	Plasma kallikrein			>10000							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283378	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283378&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665299	378164707							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755712	Nc1nccc2cc(CNC(=O)c3ccnc(Cc4ccc5ncc(Cl)cc5c4)c3)ccc12	InChI=1S/C26H20ClN5O/c27-21-12-20-9-16(2-4-24(20)31-15-21)11-22-13-19(6-7-29-22)26(33)32-14-17-1-3-23-18(10-17)5-8-30-25(23)28/h1-10,12-13,15H,11,14H2,(H2,28,30)(H,32,33)	WHHMKDFLRDNMQE-UHFFFAOYSA-N	283379	N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- chloroquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 179::US10023557, Example 31::US10266515, Example 31::US10308637, Example 179::US11021463, Example 31::US9611252, Example 31	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283379	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283379&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212700	378164708							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755713	Fc1cc2[nH]ncc2cc1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C24H17ClFN5O/c25-19-8-16-5-14(1-2-22(16)28-13-19)6-20-9-15(3-4-27-20)24(32)29-11-17-7-18-12-30-31-23(18)10-21(17)26/h1-5,7-10,12-13H,6,11H2,(H,29,32)(H,30,31)	AUINKNGACHEZIV-UHFFFAOYSA-N	283380	2-((3-chloroquinolin-6-yl)methyl)-N-((6-fluoro- 1H-indazol-5-yl)methyl)isonicotinamide::US10023557, Example 260::US10023557, Example 32::US10266515, Example 32::US10308637, Example 32::US11021463, Example 32::US9611252, Example 32	Plasma kallikrein			 26							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283380	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283380&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665325	378164709							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755714	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C25H17Cl2FN4O/c26-18-7-16-5-14(1-2-23(16)30-12-18)6-19-8-15(3-4-29-19)25(33)32-11-17-9-20-21(27)13-31-24(20)10-22(17)28/h1-5,7-10,12-13,31H,6,11H2,(H,32,33)	XZUNAOLBBRHEMP-UHFFFAOYSA-N	283381	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3-chloroquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 33::US10266515, Example 33::US10308637, Example 33::US11021463, Example 33::US9611252, Example 33	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283381	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283381&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212875	378164710							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755715	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C23H20ClN5O/c1-14-17(3-5-22(25)29-14)12-28-23(30)16-6-7-26-20(11-16)9-15-2-4-21-18(8-15)10-19(24)13-27-21/h2-8,10-11,13H,9,12H2,1H3,(H2,25,29)(H,28,30)	ZGYIOYKVCAJRKO-UHFFFAOYSA-N	283382	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-chloroquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 34::US10266515, Example 39::US10308637, Example 39::US11021463, Example 39::US9611252, Example 39	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283382	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283382&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213054	378164711							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755716	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C24H22ClN5O/c1-14-7-23(26)30-15(2)21(14)13-29-24(31)17-5-6-27-20(11-17)9-16-3-4-22-18(8-16)10-19(25)12-28-22/h3-8,10-12H,9,13H2,1-2H3,(H2,26,30)(H,29,31)	BDLURRLRBKLEDL-UHFFFAOYSA-N	283383	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 35::US10266515, Example 35::US10308637, Example 35::US11021463, Example 35::US9611252, Example 35	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283383	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283383&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665163	378164712							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50678696	COC(=O)Nc1ccc(cc1)-c1nc([nH]c1Cl)[C@H](Cc1ccccc1)NC(=O)\C=C\c1cc(Cl)ccc1-n1cnnn1			50063669	CHEMBL3398641	Plasma kallikrein		 519								ChEMBL	10.1021/acs.jmedchem.6b01460	10.7270/Q25D8V31	28085275			Corte, JR; Fang, T; Osuna, H; Pinto, DJ; Rossi, KA; Myers, JE; Sheriff, S; Lou, Z; Zheng, JJ; Harper, TW; Bozarth, JM; Wu, Y; Luettgen, JM; Seiffert, DA; Decicco, CP; Wexler, RR; Quan, ML	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50063669	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50063669&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			57976401	313071094		CHEMBL3398641					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50678702	COC(=O)Nc1ccc2-c3c[nH]c(n3)[C@H](C\C=C\CCC(=O)Nc2c1)NC(=O)\C=C\c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C28H26ClN9O4/c1-42-28(41)32-19-9-10-20-22(14-19)34-25(39)6-4-2-3-5-21(27-30-15-23(20)35-27)33-26(40)12-7-17-13-18(29)8-11-24(17)38-16-31-36-37-38/h2-3,7-16,21H,4-6H2,1H3,(H,30,35)(H,32,41)(H,33,40)(H,34,39)/b3-2+,12-7+/t21-/m0/s1	LCHKINZSWVDWJQ-XYWZPVONSA-N	50230322	CHEMBL4071545	Plasma kallikrein		 16								ChEMBL	10.1021/acs.jmedchem.6b01460	10.7270/Q25D8V31	28085275			Corte, JR; Fang, T; Osuna, H; Pinto, DJ; Rossi, KA; Myers, JE; Sheriff, S; Lou, Z; Zheng, JJ; Harper, TW; Bozarth, JM; Wu, Y; Luettgen, JM; Seiffert, DA; Decicco, CP; Wexler, RR; Quan, ML	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50230322	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50230322&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	7DS	5TKT	66744646	383543026		CHEMBL4071545					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755682	NC(=O)c1ccc2cc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)ccc2n1	InChI=1S/C26H19ClFN5O2/c27-20-13-31-24-11-21(28)17(10-19(20)24)12-32-26(35)16-5-6-30-18(9-16)8-14-1-3-22-15(7-14)2-4-23(33-22)25(29)34/h1-7,9-11,13,31H,8,12H2,(H2,29,34)(H,32,35)	QFADKPXVEQNUDC-UHFFFAOYSA-N	283349	6-((4-(((3-chloro-6-fluoro-1H-indol-5- yl)methyl)carbamoyl)pyridin-2- yl)methyl)quinoline-2-carboxamide::US10023557, Example 1::US10266515, Example 1::US10308637, Example 1::US11021463, Example 1::US9611252, Example 1	Plasma kallikrein			 550							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283349	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283349&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665333	378164678							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755683	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3nc(ccc3c2)C(N)=O)c1	InChI=1S/C25H24N6O2/c1-14-9-23(26)30-15(2)20(14)13-29-25(33)18-7-8-28-19(12-18)11-16-3-5-21-17(10-16)4-6-22(31-21)24(27)32/h3-10,12H,11,13H2,1-2H3,(H2,26,30)(H2,27,32)(H,29,33)	STXHTXUTWCUJHH-UHFFFAOYSA-N	283350	6-((4-(((6-amino-2,4-dimethylpyridin-3- yl)methyl)carbamoyl)pyridin-2- yl)methyl)quinoline-2-carboxamide::US10023557, Example 2::US10266515, Example 2::US10308637, Example 2::US11021463, Example 2::US9611252, Example 2	Plasma kallikrein			 550							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283350	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283350&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665160	378164679							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755684	Nc1nccc2cc(CNC(=O)c3ccnc(Cc4ccc5nc(ccc5c4)C#N)c3)ccc12	InChI=1S/C27H20N6O/c28-15-22-4-3-20-11-17(2-6-25(20)33-22)13-23-14-21(8-9-30-23)27(34)32-16-18-1-5-24-19(12-18)7-10-31-26(24)29/h1-12,14H,13,16H2,(H2,29,31)(H,32,34)	DMXHLBYRSDVDMO-UHFFFAOYSA-N	283351	N-((1-aminoisoquinolin-6-yl)methyl)-2-((2- cyanoquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 3::US10266515, Example 3::US10308637, Example 3::US11021463, Example 3::US9611252, Example 3	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283351	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283351&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665133	378164680							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755685	NC(=O)c1ccc2cc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)ccc2n1	InChI=1S/C27H22N6O2/c28-25-22-4-1-17(12-18(22)7-10-31-25)15-32-27(35)20-8-9-30-21(14-20)13-16-2-5-23-19(11-16)3-6-24(33-23)26(29)34/h1-12,14H,13,15H2,(H2,28,31)(H2,29,34)(H,32,35)	SPVRYWSSDGGGFK-UHFFFAOYSA-N	283352	6-((4-(((1-aminoisoquinolin-6- yl)methyl)carbamoyl)pyridin-2- yl)methyl)quinoline-2-carboxamide::US10023557, Example 4::US10266515, Example 4::US10308637, Example 4::US11021463, Example 4::US9611252, Example 4	Plasma kallikrein			 550							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283352	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283352&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665212	378164681							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755686	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1ccnc(Cc2ccc3ncc(cc3c2)C#N)c1	InChI=1S/C26H17ClFN5O/c27-22-14-32-25-10-23(28)19(9-21(22)25)13-33-26(34)17-3-4-30-20(8-17)7-15-1-2-24-18(5-15)6-16(11-29)12-31-24/h1-6,8-10,12,14,32H,7,13H2,(H,33,34)	UMGVLTPEGADZAJ-UHFFFAOYSA-N	283353	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3-cyanoquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 5::US10266515, Example 5::US10308637, Example 5::US11021463, Example 5::US9611252, Example 5	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283353	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283353&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665332	378164682							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755687	Nc1nccc2cc(CNC(=O)c3ccnc(Cc4ccc5ncc(cc5c4)C#N)c3)ccc12	InChI=1S/C27H20N6O/c28-14-19-11-22-9-17(2-4-25(22)32-16-19)12-23-13-21(6-7-30-23)27(34)33-15-18-1-3-24-20(10-18)5-8-31-26(24)29/h1-11,13,16H,12,15H2,(H2,29,31)(H,33,34)	KYRAMUYNXMHHJI-UHFFFAOYSA-N	283354	N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- cyanoquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 6::US10266515, Example 6::US10308637, Example 6::US11021463, Example 6::US9611252, Example 6	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283354	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283354&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665279	378164683							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755688	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3ncc(cc3c2)C#N)c1	InChI=1S/C25H22N6O/c1-15-7-24(27)31-16(2)22(15)14-30-25(32)19-5-6-28-21(11-19)10-17-3-4-23-20(8-17)9-18(12-26)13-29-23/h3-9,11,13H,10,14H2,1-2H3,(H2,27,31)(H,30,32)	CBKARQMZIQUSSI-UHFFFAOYSA-N	283355	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-cyanoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 7::US10266515, Example 7::US10308637, Example 7::US11021463, Example 7::US9611252, Example 7	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283355	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283355&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665185	378164684							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755689	Nc1nccc2cc(CNC(=O)c3ccnc(Cc4cnc5ccc(F)cc5n4)c3)ccc12	InChI=1S/C25H19FN6O/c26-18-2-4-22-23(11-18)32-20(14-30-22)12-19-10-17(6-7-28-19)25(33)31-13-15-1-3-21-16(9-15)5-8-29-24(21)27/h1-11,14H,12-13H2,(H2,27,29)(H,31,33)	NAEBTWZBUODUEA-UHFFFAOYSA-N	283356	N-((1-aminoisoquinolin-6-yl)methyl)-2-((7- fluoroquinoxalin-2-yl)methyl)isonicotinamide::US10023557, Example 8::US10266515, Example 8::US10308637, Example 8::US11021463, Example 8::US9611252, Example 8	Plasma kallikrein			 550							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283356	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283356&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665180	378164685							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755690	CC(=O)NCc1ccc2cc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)ccc2n1	InChI=1S/C28H23ClFN5O2/c1-16(36)32-14-21-4-3-18-8-17(2-5-26(18)35-21)9-22-10-19(6-7-31-22)28(37)34-13-20-11-23-24(29)15-33-27(23)12-25(20)30/h2-8,10-12,15,33H,9,13-14H2,1H3,(H,32,36)(H,34,37)	VKZVWMJENMIADE-UHFFFAOYSA-N	283357	2-((2-(acetamidomethyl)quinolin-6-yl)methyl)- N-((3-chloro-6-fluoro-1H-indol-5- yl)methyl)isonicotinamide::US10023557, Example 9::US10266515, Example 9::US10308637, Example 9::US11021463, Example 9::US9611252, Example 9	Plasma kallikrein			 550							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283357	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283357&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665193	378164686							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755691	CC(=O)NCc1ccc2cc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)ccc2n1	InChI=1S/C29H26N6O2/c1-18(36)33-17-24-5-4-22-12-19(3-7-27(22)35-24)14-25-15-23(9-10-31-25)29(37)34-16-20-2-6-26-21(13-20)8-11-32-28(26)30/h2-13,15H,14,16-17H2,1H3,(H2,30,32)(H,33,36)(H,34,37)	ZYSYOACDZZDUSZ-UHFFFAOYSA-N	283358	2-((2-(acetamidomethyl)quinolin-6-yl)methyl)- N-((1-aminoisoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 10::US10266515, Example 10::US10308637, Example 10::US11021463, Example 10::US9611252, Example 10	Plasma kallikrein			 550							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283358	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283358&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665233	378164687							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755692	CC(=O)NCc1ccc2cc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)ccc2n1	InChI=1S/C27H28N6O2/c1-16-10-26(28)32-17(2)24(16)15-31-27(35)21-8-9-29-23(13-21)12-19-4-7-25-20(11-19)5-6-22(33-25)14-30-18(3)34/h4-11,13H,12,14-15H2,1-3H3,(H2,28,32)(H,30,34)(H,31,35)	GCIYNSCGYKCNRO-UHFFFAOYSA-N	283359	2-((2-(acetamidomethyl)quinolin-6-yl)methyl)- N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)isonicotinamide::US10023557, Example 11::US10266515, Example 11::US10308637, Example 11::US11021463, Example 11::US9611252, Example 11	Plasma kallikrein			 550							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283359	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283359&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665205	378164688							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755693	CS(=O)(=O)c1ccc2ncc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)cc2c1	InChI=1S/C26H20ClFN4O3S/c1-36(34,35)20-2-3-24-17(9-20)6-15(12-30-24)7-19-8-16(4-5-29-19)26(33)32-13-18-10-21-22(27)14-31-25(21)11-23(18)28/h2-6,8-12,14,31H,7,13H2,1H3,(H,32,33)	QNAPNSFSYRBKHH-UHFFFAOYSA-N	283360	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((6-(methylsulfonyl)quinolin-3- yl)methyl)isonicotinamide::US10023557, Example 12::US10266515, Example 12::US10308637, Example 12::US11021463, Example 12::US9611252, Example 12	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283360	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283360&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665393	378164689							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755694	CS(=O)(=O)c1ccc2ncc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)cc2c1	InChI=1S/C27H23N5O3S/c1-36(34,35)23-3-5-25-21(14-23)11-18(16-31-25)12-22-13-20(7-8-29-22)27(33)32-15-17-2-4-24-19(10-17)6-9-30-26(24)28/h2-11,13-14,16H,12,15H2,1H3,(H2,28,30)(H,32,33)	WYQOOVPHNNJHMZ-UHFFFAOYSA-N	283361	N-((1-aminoisoquinolin-6-yl)methyl)-2-((6- (methylsulfonyl)quinolin-3- yl)methyl)isonicotinamide::US10023557, Example 13::US10266515, Example 13::US10308637, Example 13::US11021463, Example 13::US9611252, Example 13	Plasma kallikrein			 550							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283361	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283361&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665105	378164690							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755695	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cnc3ccc(cc3c2)S(C)(=O)=O)c1	InChI=1S/C25H25N5O3S/c1-15-8-24(26)30-16(2)22(15)14-29-25(31)18-6-7-27-20(11-18)10-17-9-19-12-21(34(3,32)33)4-5-23(19)28-13-17/h4-9,11-13H,10,14H2,1-3H3,(H2,26,30)(H,29,31)	IISORMHFXQMHMH-UHFFFAOYSA-N	283362	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((6-(methylsulfonyl)quinolin-3- yl)methyl)isonicotinamide::US10023557, Example 14::US10266515, Example 14::US10308637, Example 14::US11021463, Example 14::US9611252, Example 14	Plasma kallikrein			 550							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283362	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283362&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665164	378164691							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755696	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2c1)S(C)(=O)=O	InChI=1S/C26H27N5O3S/c1-15-7-20-9-18(11-23(35(4,33)34)25(20)29-13-15)10-21-12-19(5-6-28-21)26(32)30-14-22-16(2)8-24(27)31-17(22)3/h5-9,11-13H,10,14H2,1-4H3,(H2,27,31)(H,30,32)	HXOKVKXTISERDZ-UHFFFAOYSA-N	283363	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-methyl-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 15::US10266515, Example 15::US10308637, Example 15::US11021463, Example 15::US9611252, Example 15	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283363	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283363&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213052	378164692							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755697	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)cc2c1)S(C)(=O)=O	InChI=1S/C28H25N5O3S/c1-17-9-22-11-19(13-25(37(2,35)36)26(22)32-15-17)12-23-14-21(6-7-30-23)28(34)33-16-18-3-4-24-20(10-18)5-8-31-27(24)29/h3-11,13-15H,12,16H2,1-2H3,(H2,29,31)(H,33,34)	AGLYWDINMJNVRE-UHFFFAOYSA-N	283364	N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- methyl-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 16::US10266515, Example 16::US10308637, Example 16::US11021463, Example 16::US9611252, Example 16	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283364	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283364&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665230	378164693							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755698	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)cc2c1)S(C)(=O)=O	InChI=1S/C27H22ClFN4O3S/c1-15-5-18-6-16(8-25(37(2,35)36)26(18)32-12-15)7-20-9-17(3-4-30-20)27(34)33-13-19-10-21-22(28)14-31-24(21)11-23(19)29/h3-6,8-12,14,31H,7,13H2,1-2H3,(H,33,34)	KNWYWDACHSZACS-UHFFFAOYSA-N	283365	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3-methyl-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 17::US10266515, Example 17::US10308637, Example 17::US11021463, Example 17::US9611252, Example 17	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283365	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283365&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213042	378164694							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755699	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cc4cc[nH]c4cc3F)cc2c1)S(C)(=O)=O	InChI=1S/C27H23FN4O3S/c1-16-7-20-8-17(10-25(36(2,34)35)26(20)31-14-16)9-22-12-19(4-5-29-22)27(33)32-15-21-11-18-3-6-30-24(18)13-23(21)28/h3-8,10-14,30H,9,15H2,1-2H3,(H,32,33)	JOIGNBGOTQEXSU-UHFFFAOYSA-N	283366	N-((6-fluoro-1H-indol-5-yl)methyl)-2-((3- methyl-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 18::US10266515, Example 18::US10308637, Example 18::US11021463, Example 18::US9611252, Example 18	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283366	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283366&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665345	378164695							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755700	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cnc4[nH]cc(Cl)c4c3)cc2c1)S(C)(=O)=O	InChI=1S/C26H22ClN5O3S/c1-15-5-19-6-16(9-23(36(2,34)35)24(19)29-11-15)7-20-10-18(3-4-28-20)26(33)32-13-17-8-21-22(27)14-31-25(21)30-12-17/h3-6,8-12,14H,7,13H2,1-2H3,(H,30,31)(H,32,33)	IIORZUFKRKFNHD-UHFFFAOYSA-N	283367	N-((3-chloro-1H-pyrrolo[2,3-b]pyridin-5- yl)methyl)-2-((3-methyl-8- (methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 19::US10266515, Example 19::US10308637, Example 19::US11021463, Example 19::US9611252, Example 19	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283367	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283367&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665214	378164696							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755701	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3n[nH]c4ccc(Cl)cc34)cc2c1)S(C)(=O)=O	InChI=1S/C26H22ClN5O3S/c1-15-7-18-8-16(10-24(36(2,34)35)25(18)29-13-15)9-20-11-17(5-6-28-20)26(33)30-14-23-21-12-19(27)3-4-22(21)31-32-23/h3-8,10-13H,9,14H2,1-2H3,(H,30,33)(H,31,32)	INPUBOYBDZWEOS-UHFFFAOYSA-N	283368	N-((5-chloro-1H-indazol-3-yl)methyl)-2-((3- methyl-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 20::US10266515, Example 20::US10308637, Example 20::US11021463, Example 20::US9611252, Example 20	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283368	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283368&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665285	378164697							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662157	OC(=O)c1ccc(NC(=O)C2N(CCc3ccccc23)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C26H19ClFN5O4/c27-19-6-3-7-21(22(19)28)33-14-20(30-31-33)25(35)32-13-12-15-4-1-2-5-18(15)23(32)24(34)29-17-10-8-16(9-11-17)26(36)37/h1-11,14,23H,12-13H2,(H,29,34)(H,36,37)	HRLKIYSEPAYSAH-UHFFFAOYSA-N	335746	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 1	Plasma kallikrein		 20.8								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335746	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335746&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86298144	384987904							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662158	OC(=O)c1ccc(NC(=O)[C@H]2N(CCc3ccccc23)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C26H19ClFN5O4/c27-19-6-3-7-21(22(19)28)33-14-20(30-31-33)25(35)32-13-12-15-4-1-2-5-18(15)23(32)24(34)29-17-10-8-16(9-11-17)26(36)37/h1-11,14,23H,12-13H2,(H,29,34)(H,36,37)/t23-/m0/s1	HRLKIYSEPAYSAH-QHCPKHFHSA-N	335748	(S)-4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 3::US9738655, Example 4	Plasma kallikrein		 13.1								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335748	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335748&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602305	384987906							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662159	OC(=O)c1ccc(NC(=O)[C@H]2N(CCc3ccccc23)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C26H19ClFN5O4/c27-19-6-3-7-21(22(19)28)33-14-20(30-31-33)25(35)32-13-12-15-4-1-2-5-18(15)23(32)24(34)29-17-10-8-16(9-11-17)26(36)37/h1-11,14,23H,12-13H2,(H,29,34)(H,36,37)/t23-/m0/s1	HRLKIYSEPAYSAH-QHCPKHFHSA-N	335748	(S)-4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 3::US9738655, Example 4	Plasma kallikrein		 6.38								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335748	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335748&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602305	384987906							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662160	OC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3ccccc23)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C27H21ClFN3O5/c28-20-7-3-6-19(23(20)29)21-14-22(37-31-21)26(34)32-13-12-15-4-1-2-5-18(15)24(32)25(33)30-17-10-8-16(9-11-17)27(35)36/h1-11,22,24H,12-14H2,(H,30,33)(H,35,36)/t22-,24-/m1/s1	YPBHIZULGJULIC-ISKFKSNPSA-N	335750	4-((R)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 5	Plasma kallikrein		 1384								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335750	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335750&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602560	384987907							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662161	CN(C)CCNC(=O)c1ccc(cc1)-c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C37H33ClFN7O5/c1-44(2)20-18-40-34(47)23-11-9-22(10-12-23)26-5-3-6-28-27(26)17-19-45(33(28)35(48)41-25-15-13-24(14-16-25)37(50)51)36(49)30-21-46(43-42-30)31-8-4-7-29(38)32(31)39/h3-16,21,33H,17-20H2,1-2H3,(H,40,47)(H,41,48)(H,50,51)	QBESKCQOPGRWTA-UHFFFAOYSA-N	335751	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(4-((2-(dimethylamino)ethyl)carbamoyl)phenyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 6	Plasma kallikrein		 2.40								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335751	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335751&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86298354	384987908							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662162	CN(C)CCNC(=O)c1ccc(cc1)-c1cccc2C(N(CCc12)C(=O)c1nnn(c1C)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C38H35ClFN7O5/c1-22-33(43-44-47(22)31-9-5-8-30(39)32(31)40)37(50)46-20-18-28-27(23-10-12-24(13-11-23)35(48)41-19-21-45(2)3)6-4-7-29(28)34(46)36(49)42-26-16-14-25(15-17-26)38(51)52/h4-17,34H,18-21H2,1-3H3,(H,41,48)(H,42,49)(H,51,52)	WHXXBNXPFFJZMV-UHFFFAOYSA-N	335752	4-(2-(1-(3-Chloro-2-fluorophenyl)-5-methyl-1H-1,2,3-triazole-4-carbonyl)-5-(4-((2-(dimethylamino)ethyl)carbamoyl)phenyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 7	Plasma kallikrein		 29.9								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335752	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335752&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86298355	384987909							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662163	CN(C)CCNC(=O)c1ccc(cc1)-c1cccc2C(N(CCc12)C(=O)c1cnn(c1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C38H34ClFN6O5/c1-44(2)20-18-41-35(47)24-11-9-23(10-12-24)28-5-3-6-30-29(28)17-19-45(34(30)36(48)43-27-15-13-25(14-16-27)38(50)51)37(49)26-21-42-46(22-26)32-8-4-7-31(39)33(32)40/h3-16,21-22,34H,17-20H2,1-2H3,(H,41,47)(H,43,48)(H,50,51)	ASWKOTUOPISDTN-UHFFFAOYSA-N	335753	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-pyrazole-4-carbonyl)-5-(4-((2-(dimethylamino)ethyl)carbamoyl)phenyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 8	Plasma kallikrein		 3.37								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335753	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335753&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86298356	384987910							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662164	CN(C)C(=O)c1ccc(cc1)-c1cccc2C(N(CCc12)C(=O)c1nnn(c1C)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C36H30ClFN6O5/c1-20-31(40-41-44(20)29-9-5-8-28(37)30(29)38)35(47)43-19-18-26-25(21-10-12-22(13-11-21)34(46)42(2)3)6-4-7-27(26)32(43)33(45)39-24-16-14-23(15-17-24)36(48)49/h4-17,32H,18-19H2,1-3H3,(H,39,45)(H,48,49)	UTWSISMNNOGZOP-UHFFFAOYSA-N	335754	4-(2-(1-(3-Chloro-2-fluorophenyl)-5-methyl-1H-1,2,3-triazole-4-carbonyl)-5-(4-(dimethylcarbamoyl)phenyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 9	Plasma kallikrein		 72.9								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335754	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335754&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86298357	384987911							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662165	CN(C)CCNC(=O)c1ccc(cc1)-c1cccc2[C@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C37H33ClFN7O5/c1-44(2)20-18-40-34(47)23-11-9-22(10-12-23)26-5-3-6-28-27(26)17-19-45(33(28)35(48)41-25-15-13-24(14-16-25)37(50)51)36(49)30-21-46(43-42-30)31-8-4-7-29(38)32(31)39/h3-16,21,33H,17-20H2,1-2H3,(H,40,47)(H,41,48)(H,50,51)/t33-/m0/s1	QBESKCQOPGRWTA-XIFFEERXSA-N	335755	(S)-4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(4-((2-(dimethylamino)ethyl)carbamoyl)phenyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 10	Plasma kallikrein		 1.08								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335755	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335755&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86295514	384987912							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662166	CN(C)CCNC(=O)c1ccc(cc1)-c1cccc2[C@@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C37H33ClFN7O5/c1-44(2)20-18-40-34(47)23-11-9-22(10-12-23)26-5-3-6-28-27(26)17-19-45(33(28)35(48)41-25-15-13-24(14-16-25)37(50)51)36(49)30-21-46(43-42-30)31-8-4-7-29(38)32(31)39/h3-16,21,33H,17-20H2,1-2H3,(H,40,47)(H,41,48)(H,50,51)/t33-/m1/s1	QBESKCQOPGRWTA-MGBGTMOVSA-N	335756	(R)-4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(4-((2-(dimethylamino)ethyl)carbamoyl)phenyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid TFA salt::US9738655, Example 11	Plasma kallikrein		 1056								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335756	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335756&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86295305	384987913							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662167	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3-c2cncnc2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C30H21ClFN7O4/c31-23-5-2-6-25(26(23)32)39-15-24(36-37-39)29(41)38-12-11-21-20(18-13-33-16-34-14-18)3-1-4-22(21)27(38)28(40)35-19-9-7-17(8-10-19)30(42)43/h1-10,13-16,27H,11-12H2,(H,35,40)(H,42,43)	WNUYVQYWNLTYDS-UHFFFAOYSA-N	335757	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 12	Plasma kallikrein		 9.88								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335757	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335757&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86295306	384987914							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662168	OC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-c2cncnc2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C30H21ClFN7O4/c31-23-5-2-6-25(26(23)32)39-15-24(36-37-39)29(41)38-12-11-21-20(18-13-33-16-34-14-18)3-1-4-22(21)27(38)28(40)35-19-9-7-17(8-10-19)30(42)43/h1-10,13-16,27H,11-12H2,(H,35,40)(H,42,43)/t27-/m1/s1	WNUYVQYWNLTYDS-HHHXNRCGSA-N	335758	(R)-4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 13	Plasma kallikrein		 427								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335758	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335758&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626242	384987915							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662169	OC(=O)c1ccc(NC(=O)[C@H]2N(CCc3c2cccc3-c2cncnc2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C30H21ClFN7O4/c31-23-5-2-6-25(26(23)32)39-15-24(36-37-39)29(41)38-12-11-21-20(18-13-33-16-34-14-18)3-1-4-22(21)27(38)28(40)35-19-9-7-17(8-10-19)30(42)43/h1-10,13-16,27H,11-12H2,(H,35,40)(H,42,43)/t27-/m0/s1	WNUYVQYWNLTYDS-MHZLTWQESA-N	335759	(S)-4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 14	Plasma kallikrein		 6.27								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335759	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335759&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601612	384987916							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662170	OC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-c2ccc(nc2)C#N)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C32H21ClFN7O4/c33-25-5-2-6-27(28(25)34)41-17-26(38-39-41)31(43)40-14-13-23-22(19-9-12-21(15-35)36-16-19)3-1-4-24(23)29(40)30(42)37-20-10-7-18(8-11-20)32(44)45/h1-12,16-17,29H,13-14H2,(H,37,42)(H,44,45)/t29-/m1/s1	HETUUWMBFBHOTJ-GDLZYMKVSA-N	335760	(R)-4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(6-cyanopyridin-3-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 15	Plasma kallikrein		 219								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335760	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335760&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86295307	384987917							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662171	OC(=O)c1ccc(NC(=O)[C@H]2N(CCc3c2cccc3-c2ccc(nc2)C#N)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C32H21ClFN7O4/c33-25-5-2-6-27(28(25)34)41-17-26(38-39-41)31(43)40-14-13-23-22(19-9-12-21(15-35)36-16-19)3-1-4-24(23)29(40)30(42)37-20-10-7-18(8-11-20)32(44)45/h1-12,16-17,29H,13-14H2,(H,37,42)(H,44,45)/t29-/m0/s1	HETUUWMBFBHOTJ-LJAQVGFWSA-N	335761	(S)-4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(6-cyanopyridin-3-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 16	Plasma kallikrein		 4.55								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335761	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335761&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601910	384987918							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662172	OC(=O)c1ccc(NC(=O)[C@H]2N(CCc3c2cccc3-c2cncnc2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C31H23ClFN5O5/c32-24-6-2-5-23(27(24)33)25-13-26(43-37-25)30(40)38-12-11-21-20(18-14-34-16-35-15-18)3-1-4-22(21)28(38)29(39)36-19-9-7-17(8-10-19)31(41)42/h1-10,14-16,26,28H,11-13H2,(H,36,39)(H,41,42)/t26-,28+/m1/s1	DZCHJSRSEJTLGM-IAPPQJPRSA-N	335762	4-((S)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 17	Plasma kallikrein		 3.00								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335762	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335762&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86295308	384987919							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662173	OC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-c2cncnc2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C31H23ClFN5O5/c32-24-6-2-5-23(27(24)33)25-13-26(43-37-25)30(40)38-12-11-21-20(18-14-34-16-35-15-18)3-1-4-22(21)28(38)29(39)36-19-9-7-17(8-10-19)31(41)42/h1-10,14-16,26,28H,11-13H2,(H,36,39)(H,41,42)/t26-,28-/m1/s1	DZCHJSRSEJTLGM-IXCJQBJRSA-N	335763	4-((R)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 18	Plasma kallikrein		 892								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335763	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335763&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602165	384987920							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662174	CNC(=O)c1ccc(cn1)-c1cccc2[C@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H27ClFN5O6/c1-37-31(42)26-13-10-19(17-38-26)21-4-2-5-23-22(21)14-15-41(30(23)32(43)39-20-11-8-18(9-12-20)34(45)46)33(44)28-16-27(40-47-28)24-6-3-7-25(35)29(24)36/h2-13,17,28,30H,14-16H2,1H3,(H,37,42)(H,39,43)(H,45,46)/t28-,30+/m1/s1	RZCBNXHMENKKFK-DGPALRBDSA-N	335764	4-((S)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(6-(methylcarbamoyl)pyridin-3-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 19	Plasma kallikrein		 1.51								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335764	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335764&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601679	384987921							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662175	CNC(=O)c1ccc(cn1)-c1cccc2[C@@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H27ClFN5O6/c1-37-31(42)26-13-10-19(17-38-26)21-4-2-5-23-22(21)14-15-41(30(23)32(43)39-20-11-8-18(9-12-20)34(45)46)33(44)28-16-27(40-47-28)24-6-3-7-25(35)29(24)36/h2-13,17,28,30H,14-16H2,1H3,(H,37,42)(H,39,43)(H,45,46)/t28-,30-/m1/s1	RZCBNXHMENKKFK-PQHLKRTFSA-N	335765	4-((R)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(6-(methylcarbamoyl)pyridin-3-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 20	Plasma kallikrein		 840								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335765	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335765&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602054	384987922							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662176	OC(=O)c1ccc(NC(=O)[C@H]2N(CCc3c2cccc3-c2cncc(F)c2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C32H23ClF2N4O5/c33-25-6-2-5-24(28(25)35)26-14-27(44-38-26)31(41)39-12-11-22-21(18-13-19(34)16-36-15-18)3-1-4-23(22)29(39)30(40)37-20-9-7-17(8-10-20)32(42)43/h1-10,13,15-16,27,29H,11-12,14H2,(H,37,40)(H,42,43)/t27-,29+/m1/s1	WWPQQFMLZRWSKU-PXJZQJOASA-N	335766	4-((S)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(5-fluoropyridin-3-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 21	Plasma kallikrein		 9.60								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335766	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335766&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602235	384987923							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662177	OC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-c2cncc(F)c2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C32H23ClF2N4O5/c33-25-6-2-5-24(28(25)35)26-14-27(44-38-26)31(41)39-12-11-22-21(18-13-19(34)16-36-15-18)3-1-4-23(22)29(39)30(40)37-20-9-7-17(8-10-20)32(42)43/h1-10,13,15-16,27,29H,11-12,14H2,(H,37,40)(H,42,43)/t27-,29-/m1/s1	WWPQQFMLZRWSKU-XRKRLSELSA-N	335767	4-((R)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(5-fluoropyridin-3-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 22	Plasma kallikrein		 869								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335767	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335767&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601893	384987924							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662178	COc1cncc(c1)-c1cccc2[C@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H26ClFN4O6/c1-44-21-14-19(16-36-17-21)22-4-2-5-24-23(22)12-13-39(30(24)31(40)37-20-10-8-18(9-11-20)33(42)43)32(41)28-15-27(38-45-28)25-6-3-7-26(34)29(25)35/h2-11,14,16-17,28,30H,12-13,15H2,1H3,(H,37,40)(H,42,43)/t28-,30+/m1/s1	DQPLJHAOKDIZJN-DGPALRBDSA-N	335768	4-((S)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(5-methoxypyridin-3-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 23	Plasma kallikrein		 17.6								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335768	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335768&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602040	384987925							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662179	COc1cncc(c1)-c1cccc2[C@@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H26ClFN4O6/c1-44-21-14-19(16-36-17-21)22-4-2-5-24-23(22)12-13-39(30(24)31(40)37-20-10-8-18(9-11-20)33(42)43)32(41)28-15-27(38-45-28)25-6-3-7-26(34)29(25)35/h2-11,14,16-17,28,30H,12-13,15H2,1H3,(H,37,40)(H,42,43)/t28-,30-/m1/s1	DQPLJHAOKDIZJN-PQHLKRTFSA-N	335769	4-((R)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(5-methoxypyridin-3-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 24	Plasma kallikrein		 396								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335769	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335769&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601496	384987926							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662180	COC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-c2cncnc2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C31H23ClFN7O4/c1-44-31(43)18-8-10-20(11-9-18)36-29(41)28-23-5-2-4-21(19-14-34-17-35-15-19)22(23)12-13-39(28)30(42)25-16-40(38-37-25)26-7-3-6-24(32)27(26)33/h2-11,14-17,28H,12-13H2,1H3,(H,36,41)/t28-/m1/s1	WUUCSGOLHNCBKX-MUUNZHRXSA-N	335770	(R)-Methyl 4-(2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoate::US9738655, Example 25	Plasma kallikrein		>4340								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335770	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335770&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86295515	384987927							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662181	COC(=O)c1ccc(NC(=O)[C@H]2N(CCc3c2cccc3-c2cncnc2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C31H23ClFN7O4/c1-44-31(43)18-8-10-20(11-9-18)36-29(41)28-23-5-2-4-21(19-14-34-17-35-15-19)22(23)12-13-39(28)30(42)25-16-40(38-37-25)26-7-3-6-24(32)27(26)33/h2-11,14-17,28H,12-13H2,1H3,(H,36,41)/t28-/m0/s1	WUUCSGOLHNCBKX-NDEPHWFRSA-N	335771	(S)-Methyl 4-(2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoate::US9738655, Example 26	Plasma kallikrein		 62.0								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335771	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335771&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626327	384987928							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662182	CNC(=O)c1ccc(cn1)-c1cccc2[C@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(=O)OC	InChI=1S/C34H27ClFN7O5/c1-37-31(44)26-14-11-20(17-38-26)22-5-3-6-24-23(22)15-16-42(30(24)32(45)39-21-12-9-19(10-13-21)34(47)48-2)33(46)27-18-43(41-40-27)28-8-4-7-25(35)29(28)36/h3-14,17-18,30H,15-16H2,1-2H3,(H,37,44)(H,39,45)/t30-/m0/s1	CSJGZBYRICNEJG-PMERELPUSA-N	335772	(S)-Methyl 4-(2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(6-(methylcarbamoyl)pyridin-3-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoate, TFA salt::US9738655, Example 27	Plasma kallikrein		 46.8								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335772	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335772&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626355	384987929							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662183	COC(=O)c1ccc(NC(=O)[C@H]2N(CCc3c2cccc3-c2cncnc2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C32H25ClFN5O5/c1-43-32(42)18-8-10-20(11-9-18)37-30(40)29-23-5-2-4-21(19-15-35-17-36-16-19)22(23)12-13-39(29)31(41)27-14-26(38-44-27)24-6-3-7-25(33)28(24)34/h2-11,15-17,27,29H,12-14H2,1H3,(H,37,40)/t27-,29+/m1/s1	FAARZNRHKXNPTK-PXJZQJOASA-N	335773	Methyl 4-((S)-2-((R)-3-(3-chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoate::US9738655, Example 28	Plasma kallikrein		 55.8								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335773	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335773&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601981	384987930							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662184	COC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-c2cncnc2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C32H25ClFN5O5/c1-43-32(42)18-8-10-20(11-9-18)37-30(40)29-23-5-2-4-21(19-15-35-17-36-16-19)22(23)12-13-39(29)31(41)27-14-26(38-44-27)24-6-3-7-25(33)28(24)34/h2-11,15-17,27,29H,12-14H2,1H3,(H,37,40)/t27-,29-/m1/s1	FAARZNRHKXNPTK-XRKRLSELSA-N	335774	Methyl 4-((R)-2-((R)-3-(3-chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoate::US9738655, Example 29	Plasma kallikrein		 1200								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335774	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335774&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602065	384987931							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662185	COC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-c2cnc(N)nc2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C32H26ClFN6O5/c1-44-31(43)17-8-10-19(11-9-17)38-29(41)28-22-5-2-4-20(18-15-36-32(35)37-16-18)21(22)12-13-40(28)30(42)26-14-25(39-45-26)23-6-3-7-24(33)27(23)34/h2-11,15-16,26,28H,12-14H2,1H3,(H,38,41)(H2,35,36,37)/t26-,28-/m1/s1	PKWKUSFGPORMHY-IXCJQBJRSA-N	335775	4-(5-(2-aminopyrimidin-5- yl)-2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 30	Plasma kallikrein		 15.7								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335775	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335775&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			138752685	384987932							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662186	COC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-c2cnc(OC)nc2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C33H27ClFN5O6/c1-44-32(43)18-9-11-20(12-10-18)38-30(41)29-23-6-3-5-21(19-16-36-33(45-2)37-17-19)22(23)13-14-40(29)31(42)27-15-26(39-46-27)24-7-4-8-25(34)28(24)35/h3-12,16-17,27,29H,13-15H2,1-2H3,(H,38,41)/t27-,29-/m1/s1	BHULQGCNQYHAQM-XRKRLSELSA-N	335776	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(2- methoxypyrimidin-5-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 31	Plasma kallikrein		 19.9								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335776	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335776&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			138752686	384987933							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662187	COC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-c2cnc(nc2)C#N)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C33H24ClFN6O5/c1-45-33(44)18-8-10-20(11-9-18)39-31(42)30-23-5-2-4-21(19-16-37-28(15-36)38-17-19)22(23)12-13-41(30)32(43)27-14-26(40-46-27)24-6-3-7-25(34)29(24)35/h2-11,16-17,27,30H,12-14H2,1H3,(H,39,42)/t27-,30-/m1/s1	FDSLGCZUIUTCAB-POURPWNDSA-N	335777	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(2- cyanopyrimidin-5-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 32	Plasma kallikrein		 17.5								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335777	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335777&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			138752687	384987934							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662188	COC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-c2cccnc2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C33H26ClFN4O5/c1-43-33(42)19-10-12-21(13-11-19)37-31(40)30-24-7-2-6-22(20-5-4-15-36-18-20)23(24)14-16-39(30)32(41)28-17-27(38-44-28)25-8-3-9-26(34)29(25)35/h2-13,15,18,28,30H,14,16-17H2,1H3,(H,37,40)/t28-,30-/m1/s1	VMYPYDBRMJCEQI-PQHLKRTFSA-N	335778	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5- (pyridin-3-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 33	Plasma kallikrein		 9.54								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335778	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335778&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			138752688	384987935							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662189	COC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-c2cnc(O)nc2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C32H25ClFN5O6/c1-44-31(42)17-8-10-19(11-9-17)37-29(40)28-22-5-2-4-20(18-15-35-32(43)36-16-18)21(22)12-13-39(28)30(41)26-14-25(38-45-26)23-6-3-7-24(33)27(23)34/h2-11,15-16,26,28H,12-14H2,1H3,(H,37,40)(H,35,36,43)/t26-,28-/m1/s1	DNGPLVNRQZAENL-IXCJQBJRSA-N	335779	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(2- hydroxypyrimidin-5-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 34	Plasma kallikrein		 0.460								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335779	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335779&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			138752689	384987936							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662190	COC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-c2cncc(F)c2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C33H25ClF2N4O5/c1-44-33(43)18-8-10-21(11-9-18)38-31(41)30-24-5-2-4-22(19-14-20(35)17-37-16-19)23(24)12-13-40(30)32(42)28-15-27(39-45-28)25-6-3-7-26(34)29(25)36/h2-11,14,16-17,28,30H,12-13,15H2,1H3,(H,38,41)/t28-,30-/m1/s1	ITJJRCDKHPPSSS-PQHLKRTFSA-N	335780	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(5- fluoropyridin-3-yl)- 1.2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 35	Plasma kallikrein		 22.9								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335780	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335780&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			138752690	384987937							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662191	COC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-c2cncc(OC)c2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C34H28ClFN4O6/c1-44-22-15-20(17-37-18-22)23-5-3-6-25-24(23)13-14-40(31(25)32(41)38-21-11-9-19(10-12-21)34(43)45-2)33(42)29-16-28(39-46-29)26-7-4-8-27(35)30(26)36/h3-12,15,17-18,29,31H,13-14,16H2,1-2H3,(H,38,41)/t29-,31-/m1/s1	RLHOWYGHDLUQRW-BVRKHOPBSA-N	335781	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(5- methoxypyridin-3-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 36	Plasma kallikrein		 26.7								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335781	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335781&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			138752691	384987938							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662192	CNC(=O)c1cncc(c1)-c1cccc2[C@@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(=O)OC	InChI=1S/C35H29ClFN5O6/c1-38-32(43)21-15-20(17-39-18-21)23-5-3-6-25-24(23)13-14-42(31(25)33(44)40-22-11-9-19(10-12-22)35(46)47-2)34(45)29-16-28(41-48-29)26-7-4-8-27(36)30(26)37/h3-12,15,17-18,29,31H,13-14,16H2,1-2H3,(H,38,43)(H,40,44)/t29-,31-/m1/s1	BRCVBPCFQZEAOB-BVRKHOPBSA-N	335782	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(5- (methylcarbamoyl)pyridin- 3-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 37	Plasma kallikrein		 12.9								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335782	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335782&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			138752692	384987939							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662193	COC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-c2cncc(N)c2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C33H27ClFN5O5/c1-44-33(43)18-8-10-21(11-9-18)38-31(41)30-24-5-2-4-22(19-14-20(36)17-37-16-19)23(24)12-13-40(30)32(42)28-15-27(39-45-28)25-6-3-7-26(34)29(25)35/h2-11,14,16-17,28,30H,12-13,15,36H2,1H3,(H,38,41)/t28-,30-/m1/s1	XPDXBPGISHRRGJ-PQHLKRTFSA-N	335783	4-(5-(2-aminopyridin-4- yl)-2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  bis-TFA salt::US9738655, Example 38	Plasma kallikrein		 3.51								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335783	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335783&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			138752693	384987940							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662194	COC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-c2ccc(N)nc2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C33H27ClFN5O5/c1-44-33(43)18-8-11-20(12-9-18)38-31(41)30-23-5-2-4-21(19-10-13-28(36)37-17-19)22(23)14-15-40(30)32(42)27-16-26(39-45-27)24-6-3-7-25(34)29(24)35/h2-13,17,27,30H,14-16H2,1H3,(H2,36,37)(H,38,41)/t27-,30-/m1/s1	BCGVTAKTYPSRQS-POURPWNDSA-N	335784	4-(5-(6-aminopyridin-3- yl)-2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  bis-TFA salt::US9738655, Example 39	Plasma kallikrein		 2.63								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335784	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335784&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			138752694	384987941							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662195	COC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-c2ccc3CNCCc3c2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C37H32ClFN4O5/c1-47-37(46)21-10-12-25(13-11-21)41-35(44)34-28-5-2-4-26(23-8-9-24-20-40-16-14-22(24)18-23)27(28)15-17-43(34)36(45)32-19-31(42-48-32)29-6-3-7-30(38)33(29)39/h2-13,18,32,34,40H,14-17,19-20H2,1H3,(H,41,44)/t32-,34-/m1/s1	FENPKALJPSEIAL-ZFEZZJPFSA-N	335785	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)- 1,1',2,2',3,3',4,4'- octahydro-[5,6'- biisoquinoline]-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 40	Plasma kallikrein		 2.81								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335785	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335785&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			138752695	384987942							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662196	COC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-c2cn[nH]c2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1			335786	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5- (1H-pyrazol-4-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 41	Plasma kallikrein		 7.68								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335786	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335786&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			138752696	384987943							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662197	COC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-c2ccnn2C)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C32H27ClFN5O5/c1-38-26(13-15-35-38)21-5-3-6-22-20(21)14-16-39(29(22)30(40)36-19-11-9-18(10-12-19)32(42)43-2)31(41)27-17-25(37-44-27)23-7-4-8-24(33)28(23)34/h3-13,15,27,29H,14,16-17H2,1-2H3,(H,36,40)/t27-,29-/m1/s1	HPQUBGDPTRWPBQ-XRKRLSELSA-N	335787	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(1- methyl-1H-pyrazol-5-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 42	Plasma kallikrein		 13.1								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335787	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335787&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			138752697	384987944							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662198	COC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-c2ccn(C)n2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C32H27ClFN5O5/c1-38-15-14-25(36-38)21-5-3-6-22-20(21)13-16-39(29(22)30(40)35-19-11-9-18(10-12-19)32(42)43-2)31(41)27-17-26(37-44-27)23-7-4-8-24(33)28(23)34/h3-12,14-15,27,29H,13,16-17H2,1-2H3,(H,35,40)/t27-,29-/m1/s1	BRRKPQDJNOUSDE-XRKRLSELSA-N	335788	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(1- methyl-1H-pyrazol-3-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 43	Plasma kallikrein		 16.2								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335788	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335788&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			138752698	384987945							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662199	CNC(=O)c1ccc(cn1)-c1cccc2[C@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H25ClFN7O5/c1-36-30(43)25-13-10-19(16-37-25)21-4-2-5-23-22(21)14-15-41(29(23)31(44)38-20-11-8-18(9-12-20)33(46)47)32(45)26-17-42(40-39-26)27-7-3-6-24(34)28(27)35/h2-13,16-17,29H,14-15H2,1H3,(H,36,43)(H,38,44)(H,46,47)/t29-/m0/s1	MNYQVTQMJHBGTD-LJAQVGFWSA-N	335789	(S)-4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(6-(methylcarbamoyl)pyridin-3-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 44	Plasma kallikrein		 3.28								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335789	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335789&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86295516	384987946							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662200	CNC(=O)c1ccc(cn1)-c1cccc2[C@@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H25ClFN7O5/c1-36-30(43)25-13-10-19(16-37-25)21-4-2-5-23-22(21)14-15-41(29(23)31(44)38-20-11-8-18(9-12-20)33(46)47)32(45)26-17-42(40-39-26)27-7-3-6-24(34)28(27)35/h2-13,16-17,29H,14-15H2,1H3,(H,36,43)(H,38,44)(H,46,47)/t29-/m1/s1	MNYQVTQMJHBGTD-GDLZYMKVSA-N	335790	(R)-4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(6-(methylcarbamoyl)pyridin-3-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 45	Plasma kallikrein		 364								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335790	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335790&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602009	384987947							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662201	Nc1c(cnn1-c1cccc(Cl)c1F)C(=O)N1CCc2c(cccc2-c2cncnc2)C1C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C31H23ClFN7O4/c32-24-5-2-6-25(26(24)33)40-28(34)23(15-37-40)30(42)39-12-11-21-20(18-13-35-16-36-14-18)3-1-4-22(21)27(39)29(41)38-19-9-7-17(8-10-19)31(43)44/h1-10,13-16,27H,11-12,34H2,(H,38,41)(H,43,44)	DYZTYGBGDOZFGS-UHFFFAOYSA-N	335791	4-(2-(5-Amino-1-(3-chloro-2-fluorophenyl)-1H-pyrazole-4-carbonyl)-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 46	Plasma kallikrein		 50.1								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335791	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335791&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602105	384987948							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662202	CNC(=O)c1ccc(cn1)-c1cccc2C(N(CCc12)C(=O)c1cnn(c1N)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H27ClFN7O5/c1-38-31(44)26-13-10-19(16-39-26)21-4-2-5-23-22(21)14-15-42(29(23)32(45)41-20-11-8-18(9-12-20)34(47)48)33(46)24-17-40-43(30(24)37)27-7-3-6-25(35)28(27)36/h2-13,16-17,29H,14-15,37H2,1H3,(H,38,44)(H,41,45)(H,47,48)	JWUMGKLUPFRBEL-UHFFFAOYSA-N	335792	4-(2-(5-Amino-1-(3-chloro-2-fluorophenyl)-1H-pyrazole-4-carbonyl)-5-(6-(methylcarbamoyl)pyridin-3-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 47	Plasma kallikrein		 20.0								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335792	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335792&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86295517	384987949							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662203	CNC1CCN(CC1)c1cccc2[C@@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H31ClFN7O4/c1-35-20-12-15-39(16-13-20)26-6-2-4-23-22(26)14-17-40(29(23)30(42)36-21-10-8-19(9-11-21)32(44)45)31(43)25-18-41(38-37-25)27-7-3-5-24(33)28(27)34/h2-11,18,20,29,35H,12-17H2,1H3,(H,36,42)(H,44,45)/t29-/m1/s1	TZOHATLRQAUOQP-GDLZYMKVSA-N	335793	(R)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(4- (dimethylamino)piperidin-1- yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  bis-TFA salt::US9738655, Example 48	Plasma kallikrein		 452								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335793	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335793&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			130346376	384987950							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662204	CN(C)C1CCN(CC1)c1cccc2[C@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H33ClFN7O4/c1-39(2)22-13-16-40(17-14-22)27-7-3-5-24-23(27)15-18-41(30(24)31(43)36-21-11-9-20(10-12-21)33(45)46)32(44)26-19-42(38-37-26)28-8-4-6-25(34)29(28)35/h3-12,19,22,30H,13-18H2,1-2H3,(H,36,43)(H,45,46)/t30-/m0/s1	IRADZYNYESBTAE-PMERELPUSA-N	335794	(S)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(4- (dimethylamino)piperidin-1- yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  bis-TFA salt::US9738655, Example 49	Plasma kallikrein		 1.39								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335794	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335794&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348905	384987951							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662205	CN(C)C1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H34ClFN6O4/c1-39(2)24-13-16-40(17-14-24)28-7-3-5-26-25(28)15-18-41(31(26)32(43)38-23-11-9-21(10-12-23)34(45)46)33(44)22-19-37-42(20-22)29-8-4-6-27(35)30(29)36/h3-12,19-20,24,31H,13-18H2,1-2H3,(H,38,43)(H,45,46)	FBPUIWCXHWSFDU-UHFFFAOYSA-N	335795	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-pyrazole-4- carbonyl)-5-(4- (dimethylamino)piperidin-1- yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  bis-TFA salt::US9738655, Example 50	Plasma kallikrein		 4.94								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335795	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335795&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348819	384987952							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662206	CN(C)C1CCN(CC1)c1cccc2[C@@H](N(CCc12)C(=O)c1cnn(c1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H34ClFN6O4/c1-39(2)24-13-16-40(17-14-24)28-7-3-5-26-25(28)15-18-41(31(26)32(43)38-23-11-9-21(10-12-23)34(45)46)33(44)22-19-37-42(20-22)29-8-4-6-27(35)30(29)36/h3-12,19-20,24,31H,13-18H2,1-2H3,(H,38,43)(H,45,46)/t31-/m1/s1	FBPUIWCXHWSFDU-WJOKGBTCSA-N	335796	(R)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-pyrazole-4- carbonyl)-5-(4- (dimethylamino)piperidin-1- yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  bis-TFA salt::US9738655, Example 51	Plasma kallikrein		 340								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335796	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335796&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348873	384987953							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662207	CN(C)C1CCN(CC1)c1cccc2[C@H](N(CCc12)C(=O)c1cnn(c1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H34ClFN6O4/c1-39(2)24-13-16-40(17-14-24)28-7-3-5-26-25(28)15-18-41(31(26)32(43)38-23-11-9-21(10-12-23)34(45)46)33(44)22-19-37-42(20-22)29-8-4-6-27(35)30(29)36/h3-12,19-20,24,31H,13-18H2,1-2H3,(H,38,43)(H,45,46)/t31-/m0/s1	FBPUIWCXHWSFDU-HKBQPEDESA-N	335797	(S)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-pyrazole-4- carbonyl)-5-(4- (dimethylamino)piperidin-1- yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  bis-TFA salt::US9738655, Example 52	Plasma kallikrein		 1.79								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335797	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335797&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348857	384987954							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662208	CN(C)C1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(cn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H34ClFN6O4/c1-39(2)23-13-16-40(17-14-23)28-7-3-5-25-24(28)15-18-42(31(25)32(43)38-22-11-9-21(10-12-22)34(45)46)33(44)27-19-41(20-37-27)29-8-4-6-26(35)30(29)36/h3-12,19-20,23,31H,13-18H2,1-2H3,(H,38,43)(H,45,46)	TUTDFHYFDVWALK-UHFFFAOYSA-N	335799	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-imidazole- 4-carbonyl)-5-(4- (dimethylamino)piperidin-1- yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  bis-TFA salt::US9738655, Example 53	Plasma kallikrein		 1.21								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335799	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335799&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348865	384987956							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662209	CN(C)C1CCN(CC1)c1cccc2[C@@H](N(CCc12)C(=O)c1cn(cn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H34ClFN6O4/c1-39(2)23-13-16-40(17-14-23)28-7-3-5-25-24(28)15-18-42(31(25)32(43)38-22-11-9-21(10-12-22)34(45)46)33(44)27-19-41(20-37-27)29-8-4-6-26(35)30(29)36/h3-12,19-20,23,31H,13-18H2,1-2H3,(H,38,43)(H,45,46)/t31-/m1/s1	TUTDFHYFDVWALK-WJOKGBTCSA-N	335800	(R)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-imidazole- 4-carbonyl)-5-(4- (dimethylamino)piperidin-1- yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  bis-TFA salt::US9738655, Example 54	Plasma kallikrein		 50.4								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335800	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335800&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348863	384987957							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662210	CN(C)C1CCN(CC1)c1cccc2[C@H](N(CCc12)C(=O)c1cn(cn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H34ClFN6O4/c1-39(2)23-13-16-40(17-14-23)28-7-3-5-25-24(28)15-18-42(31(25)32(43)38-22-11-9-21(10-12-22)34(45)46)33(44)27-19-41(20-37-27)29-8-4-6-26(35)30(29)36/h3-12,19-20,23,31H,13-18H2,1-2H3,(H,38,43)(H,45,46)/t31-/m0/s1	TUTDFHYFDVWALK-HKBQPEDESA-N	335801	(S)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-imidazole- 4-carbonyl)-5-(4- (dimethylamino)piperidin-1- yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  bis-TFA salt::US9738655, Example 55	Plasma kallikrein		 0.920								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335801	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335801&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348942	384987958							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662211	CN(C)C(=O)C1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H33ClFN7O5/c1-40(2)32(45)20-13-16-41(17-14-20)27-7-3-5-24-23(27)15-18-42(30(24)31(44)37-22-11-9-21(10-12-22)34(47)48)33(46)26-19-43(39-38-26)28-8-4-6-25(35)29(28)36/h3-12,19-20,30H,13-18H2,1-2H3,(H,37,44)(H,47,48)	MGKYNQMITPWKCX-UHFFFAOYSA-N	335802	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(4- (dimethylcarbamoyl)piperidin- 1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 56	Plasma kallikrein		 5.60								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335802	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335802&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86295725	384987959							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662212	CN(C)C(=O)C1CCN(CC1)c1cccc2[C@@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H33ClFN7O5/c1-40(2)32(45)20-13-16-41(17-14-20)27-7-3-5-24-23(27)15-18-42(30(24)31(44)37-22-11-9-21(10-12-22)34(47)48)33(46)26-19-43(39-38-26)28-8-4-6-25(35)29(28)36/h3-12,19-20,30H,13-18H2,1-2H3,(H,37,44)(H,47,48)/t30-/m1/s1	MGKYNQMITPWKCX-SSEXGKCCSA-N	335803	(R)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(4- (dimethylcarbamoyl)piperidin- 1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 57	Plasma kallikrein		 276								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335803	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335803&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348973	384987960							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662213	CN(C)C(=O)C1CCN(CC1)c1cccc2[C@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H33ClFN7O5/c1-40(2)32(45)20-13-16-41(17-14-20)27-7-3-5-24-23(27)15-18-42(30(24)31(44)37-22-11-9-21(10-12-22)34(47)48)33(46)26-19-43(39-38-26)28-8-4-6-25(35)29(28)36/h3-12,19-20,30H,13-18H2,1-2H3,(H,37,44)(H,47,48)/t30-/m0/s1	MGKYNQMITPWKCX-PMERELPUSA-N	335804	(S)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(4- (dimethylcarbamoyl)piperidin- 1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 58	Plasma kallikrein		 3.24								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335804	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335804&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348922	384987961							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662214	CN(C)C(=O)C1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C35H34ClFN6O5/c1-40(2)33(45)21-13-16-41(17-14-21)28-7-3-5-26-25(28)15-18-42(31(26)32(44)39-24-11-9-22(10-12-24)35(47)48)34(46)23-19-38-43(20-23)29-8-4-6-27(36)30(29)37/h3-12,19-21,31H,13-18H2,1-2H3,(H,39,44)(H,47,48)	OSEVVJFCRIBXMR-UHFFFAOYSA-N	335805	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-pyrazole-4- carbonyl)-5-(4- (dimethylcarbamoyl)piperidin- 1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 59	Plasma kallikrein		 10.1								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335805	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335805&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86295726	384987962							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662215	CN(C)C(=O)C1CCN(CC1)c1cccc2[C@@H](N(CCc12)C(=O)c1cnn(c1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C35H34ClFN6O5/c1-40(2)33(45)21-13-16-41(17-14-21)28-7-3-5-26-25(28)15-18-42(31(26)32(44)39-24-11-9-22(10-12-24)35(47)48)34(46)23-19-38-43(20-23)29-8-4-6-27(36)30(29)37/h3-12,19-21,31H,13-18H2,1-2H3,(H,39,44)(H,47,48)/t31-/m1/s1	OSEVVJFCRIBXMR-WJOKGBTCSA-N	335806	(R)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-pyrazole-4- carbonyl)-5-(4- (dimethylcarbamoyl)piperidin- 1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 60	Plasma kallikrein		 698								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335806	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335806&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348889	384987963							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662216	CN(C)C(=O)C1CCN(CC1)c1cccc2[C@H](N(CCc12)C(=O)c1cnn(c1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C35H34ClFN6O5/c1-40(2)33(45)21-13-16-41(17-14-21)28-7-3-5-26-25(28)15-18-42(31(26)32(44)39-24-11-9-22(10-12-24)35(47)48)34(46)23-19-38-43(20-23)29-8-4-6-27(36)30(29)37/h3-12,19-21,31H,13-18H2,1-2H3,(H,39,44)(H,47,48)/t31-/m0/s1	OSEVVJFCRIBXMR-HKBQPEDESA-N	335807	(S)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-pyrazole-4- carbonyl)-5-(4- (dimethylcarbamoyl)piperidin- 1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 61	Plasma kallikrein		 5.89								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335807	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335807&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348844	384987964							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662217	CN(C)C(=O)C1CCN(CC1)c1cccc2[C@@H](N(CCc12)C(=O)c1cn(cn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C35H34ClFN6O5/c1-40(2)33(45)21-13-16-41(17-14-21)28-7-3-5-25-24(28)15-18-43(31(25)32(44)39-23-11-9-22(10-12-23)35(47)48)34(46)27-19-42(20-38-27)29-8-4-6-26(36)30(29)37/h3-12,19-21,31H,13-18H2,1-2H3,(H,39,44)(H,47,48)/t31-/m1/s1	DUQMUTYXYZUOHC-WJOKGBTCSA-N	335808	(R)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-imidazole- 4-carbonyl)-5-(4- (dimethylcarbamoyl)piperidin- 1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 62	Plasma kallikrein		 399								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335808	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335808&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348950	384987965							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662218	CN(C)C(=O)C1CCN(CC1)c1cccc2[C@H](N(CCc12)C(=O)c1cn(cn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C35H34ClFN6O5/c1-40(2)33(45)21-13-16-41(17-14-21)28-7-3-5-25-24(28)15-18-43(31(25)32(44)39-23-11-9-22(10-12-23)35(47)48)34(46)27-19-42(20-38-27)29-8-4-6-26(36)30(29)37/h3-12,19-21,31H,13-18H2,1-2H3,(H,39,44)(H,47,48)/t31-/m0/s1	DUQMUTYXYZUOHC-HKBQPEDESA-N	335809	(S)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-imidazole- 4-carbonyl)-5-(4- (dimethylcarbamoyl)piperidin- 1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 63	Plasma kallikrein		 2.71								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335809	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335809&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348854	384987966							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662219	CC(C)c1nnc2CN(CCn12)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H31ClFN9O4/c1-19(2)31-40-39-28-18-42(15-16-43(28)31)26-7-3-5-23-22(26)13-14-44(30(23)32(46)37-21-11-9-20(10-12-21)34(48)49)33(47)25-17-45(41-38-25)27-8-4-6-24(35)29(27)36/h3-12,17,19,30H,13-16,18H2,1-2H3,(H,37,46)(H,48,49)	NNFFYYPCMGFLPV-UHFFFAOYSA-N	335810	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(3- isopropyl-5,6-dihydro- [1,2,4]triazolo[4,3-a]pyrazin- 7(8H)-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 64	Plasma kallikrein		 4.70								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335810	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335810&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86295727	384987967							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662220	CC(C)c1nnc2CN(CCn12)c1cccc2[C@@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H31ClFN9O4/c1-19(2)31-40-39-28-18-42(15-16-43(28)31)26-7-3-5-23-22(26)13-14-44(30(23)32(46)37-21-11-9-20(10-12-21)34(48)49)33(47)25-17-45(41-38-25)27-8-4-6-24(35)29(27)36/h3-12,17,19,30H,13-16,18H2,1-2H3,(H,37,46)(H,48,49)/t30-/m1/s1	NNFFYYPCMGFLPV-SSEXGKCCSA-N	335811	(R)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(3- isopropyl-5,6-dihydro- [1,2,4]triazolo[4,3-a]pyrazin- 7(8H)-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboximido)benzoic acid,  TFA salt::US9738655, Example 65	Plasma kallikrein		 260								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335811	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335811&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348941	384987968							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662221	CC(C)c1nnc2CN(CCn12)c1cccc2[C@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H31ClFN9O4/c1-19(2)31-40-39-28-18-42(15-16-43(28)31)26-7-3-5-23-22(26)13-14-44(30(23)32(46)37-21-11-9-20(10-12-21)34(48)49)33(47)25-17-45(41-38-25)27-8-4-6-24(35)29(27)36/h3-12,17,19,30H,13-16,18H2,1-2H3,(H,37,46)(H,48,49)/t30-/m0/s1	NNFFYYPCMGFLPV-PMERELPUSA-N	335812	(S)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(3- isopropyl-5,6-dihydro- [1,2,4]triazolo[4,3-a]pyrazin- 7(8H)-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 66	Plasma kallikrein		 2.57								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335812	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335812&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348923	384987969							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662222	CC1(O)CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H30ClFN6O5/c1-32(45)13-16-38(17-14-32)25-6-2-4-22-21(25)12-15-39(28(22)29(41)35-20-10-8-19(9-11-20)31(43)44)30(42)24-18-40(37-36-24)26-7-3-5-23(33)27(26)34/h2-11,18,28,45H,12-17H2,1H3,(H,35,41)(H,43,44)	FIWQHMLLHCSPLW-UHFFFAOYSA-N	335813	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(4- hydroxy-4-methylpiperidin-1- yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 67	Plasma kallikrein		 7.17								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335813	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335813&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86295728	384987970							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662223	CC1(O)CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H31ClFN5O5/c1-33(45)13-16-38(17-14-33)26-6-2-4-24-23(26)12-15-39(29(24)30(41)37-22-10-8-20(9-11-22)32(43)44)31(42)21-18-36-40(19-21)27-7-3-5-25(34)28(27)35/h2-11,18-19,29,45H,12-17H2,1H3,(H,37,41)(H,43,44)	VEDPYHVUKWTDSO-UHFFFAOYSA-N	335814	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-pyrazole-4- carbonyl)-5-(4-hydroxy-4- methylpiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 68	Plasma kallikrein		 22.5								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335814	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335814&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348850	384987971							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662224	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3N2CCOCC2=O)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C30H24ClFN6O6/c31-21-4-2-6-24(26(21)32)38-15-22(34-35-38)29(41)37-12-11-19-20(3-1-5-23(19)36-13-14-44-16-25(36)39)27(37)28(40)33-18-9-7-17(8-10-18)30(42)43/h1-10,15,27H,11-14,16H2,(H,33,40)(H,42,43)	XTLAPAGGJSLEHW-UHFFFAOYSA-N	335815	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(3- oxomorpholino)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 69	Plasma kallikrein		 9.92								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335815	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335815&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348814	384987972							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662225	CN1CCN(c2cccc3C(N(CCc23)C(=O)c2cnn(c2)-c2cccc(Cl)c2F)C(=O)Nc2ccc(cc2)C(O)=O)C(=O)CC1	InChI=1S/C33H30ClFN6O5/c1-38-14-13-28(42)39(17-16-38)26-6-2-4-24-23(26)12-15-40(30(24)31(43)37-22-10-8-20(9-11-22)33(45)46)32(44)21-18-36-41(19-21)27-7-3-5-25(34)29(27)35/h2-11,18-19,30H,12-17H2,1H3,(H,37,43)(H,45,46)	XQFKNIZFWNFDAV-UHFFFAOYSA-N	335816	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-pyrazole-4- carbonyl)-5-(4-methyl-7-oxo- 1,4-diazepan-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 70	Plasma kallikrein		 11.5								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335816	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335816&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348891	384987973							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662226	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CN(C(=O)C1)c1c(F)ccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H33ClF2N4O6/c1-47-22-11-14-39(15-12-22)27-4-2-3-24-23(27)13-16-40(30(24)32(43)38-21-7-5-19(6-8-21)34(45)46)33(44)20-17-28(42)41(18-20)31-26(36)10-9-25(35)29(31)37/h2-10,20,22,30H,11-18H2,1H3,(H,38,43)(H,45,46)	MOURHNDDHSTRPL-UHFFFAOYSA-N	335817	4-(2-(1-(3-chloro-2,6- difluorophenyl)-5- oxopyrrolidine-3-carbonyl)-5- (4-methoxypiperidin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 71	Plasma kallikrein		>6000								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335817	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335817&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348809	384987974							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662227	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3N2CCC(CC2)N2CCCC2=O)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C35H33ClFN7O5/c36-26-5-2-7-29(31(26)37)44-20-27(39-40-44)34(47)43-19-15-24-25(32(43)33(46)38-22-11-9-21(10-12-22)35(48)49)4-1-6-28(24)41-17-13-23(14-18-41)42-16-3-8-30(42)45/h1-2,4-7,9-12,20,23,32H,3,8,13-19H2,(H,38,46)(H,48,49)	WQWGGABJZOMIBL-UHFFFAOYSA-N	335819	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(4-(2- oxopyrrolidin-1-yl)piperidin- 1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 72	Plasma kallikrein		 13.8								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335819	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335819&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348920	384987976							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662228	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3N2CCS(=O)(=O)CC2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C30H26ClFN6O6S/c31-22-4-2-6-25(26(22)32)38-17-23(34-35-38)29(40)37-12-11-20-21(3-1-5-24(20)36-13-15-45(43,44)16-14-36)27(37)28(39)33-19-9-7-18(8-10-19)30(41)42/h1-10,17,27H,11-16H2,(H,33,39)(H,41,42)	TZMZVJYUKWQYBS-UHFFFAOYSA-N	335820	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(1,1- dioxidothiomorpholino)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 73	Plasma kallikrein		 4.18								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335820	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335820&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348816	384987977							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662229	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3N2CCC(CC2)N2CCCC2=O)C(=O)c2cnn(c2)-c2cccc(Cl)c2F)cc1	InChI=1S/C36H34ClFN6O5/c37-28-5-2-7-30(32(28)38)44-21-23(20-39-44)35(47)43-19-15-26-27(33(43)34(46)40-24-11-9-22(10-12-24)36(48)49)4-1-6-29(26)41-17-13-25(14-18-41)42-16-3-8-31(42)45/h1-2,4-7,9-12,20-21,25,33H,3,8,13-19H2,(H,40,46)(H,48,49)	DUMHALQWYMKJRI-UHFFFAOYSA-N	335821	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-pyrazole-4- carbonyl)-5-(4-(2- oxopyrrolidin-1-yl)piperidin- 1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 74	Plasma kallikrein		 27.6								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335821	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335821&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348817	384987978							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662230	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3N2CCC3(CCC(=O)O3)CC2)C(=O)c2cnn(c2)-c2cccc(Cl)c2F)cc1	InChI=1S/C35H31ClFN5O6/c36-26-4-2-6-28(30(26)37)42-20-22(19-38-42)33(45)41-16-12-24-25(31(41)32(44)39-23-9-7-21(8-10-23)34(46)47)3-1-5-27(24)40-17-14-35(15-18-40)13-11-29(43)48-35/h1-10,19-20,31H,11-18H2,(H,39,44)(H,46,47)	KCJXOPXQHIVGOD-UHFFFAOYSA-N	335822	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-pyrazole-4- carbonyl)-5-(2-oxo-1-oxa-8- azaspiro[4.5]-decan-8-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 75	Plasma kallikrein		 25.8								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335822	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335822&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348802	384987979							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662231	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3N2CCC3(CCC(=O)O3)CC2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C34H30ClFN6O6/c35-24-4-2-6-27(29(24)36)42-19-25(38-39-42)32(45)41-16-12-22-23(30(41)31(44)37-21-9-7-20(8-10-21)33(46)47)3-1-5-26(22)40-17-14-34(15-18-40)13-11-28(43)48-34/h1-10,19,30H,11-18H2,(H,37,44)(H,46,47)	XPKQMZKAEDLRFG-UHFFFAOYSA-N	335823	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(2-oxo- 1-oxa-8-azaspiro[4.5]decan-8- yl)-1,2,3,4- tetrahydroisoquinoline-1- carboximido)benzoic acid,  TFA::US9738655, Example 76	Plasma kallikrein		 15.3								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335823	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335823&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348949	384987980							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662232	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3N2CCC3(CCC(=O)O3)CC2)C(=O)c2cn(cn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C35H31ClFN5O6/c36-25-4-2-6-28(30(25)37)41-19-26(38-20-41)33(45)42-16-12-23-24(31(42)32(44)39-22-9-7-21(8-10-22)34(46)47)3-1-5-27(23)40-17-14-35(15-18-40)13-11-29(43)48-35/h1-10,19-20,31H,11-18H2,(H,39,44)(H,46,47)	ZCFREWNYRKHFJI-UHFFFAOYSA-N	335824	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-imidazole- 4-carbonyl)-5-(2-oxo-1-oxa-8- azaspiro[4.5]decan-8-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 77	Plasma kallikrein		 7.96								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335824	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335824&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348904	384987981							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662233	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3N2CCCCC2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C31H28ClFN6O4/c32-23-7-5-9-26(27(23)33)39-18-24(35-36-39)30(41)38-17-14-21-22(6-4-8-25(21)37-15-2-1-3-16-37)28(38)29(40)34-20-12-10-19(11-13-20)31(42)43/h4-13,18,28H,1-3,14-17H2,(H,34,40)(H,42,43)	MMIGYNHOZGOKSR-UHFFFAOYSA-N	335825	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5- (piperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 78	Plasma kallikrein		 36.1								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335825	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335825&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348881	384987982							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662234	CN1CCN(C(=O)C1)c1cccc2[C@@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C31H27ClFN7O5/c1-37-14-15-38(26(41)17-37)24-6-2-4-21-20(24)12-13-39(28(21)29(42)34-19-10-8-18(9-11-19)31(44)45)30(43)23-16-40(36-35-23)25-7-3-5-22(32)27(25)33/h2-11,16,28H,12-15,17H2,1H3,(H,34,42)(H,44,45)/t28-/m1/s1	IJPZYJYAKOUZKY-MUUNZHRXSA-N	335826	(R)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(4- methyl-2-oxopiperazin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 79	Plasma kallikrein		 719								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335826	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335826&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348893	384987983							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662235	CN1CCN(C(=O)C1)c1cccc2[C@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C31H27ClFN7O5/c1-37-14-15-38(26(41)17-37)24-6-2-4-21-20(24)12-13-39(28(21)29(42)34-19-10-8-18(9-11-19)31(44)45)30(43)23-16-40(36-35-23)25-7-3-5-22(32)27(25)33/h2-11,16,28H,12-15,17H2,1H3,(H,34,42)(H,44,45)/t28-/m0/s1	IJPZYJYAKOUZKY-NDEPHWFRSA-N	335849	(S)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(4- methyl-2-oxopiprazin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  HCl::US9738655, Example 80	Plasma kallikrein		 6.37								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335849	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335849&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348974	384988006							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662236	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3N2CCCCC2=O)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C31H26ClFN6O5/c32-22-6-4-8-25(27(22)33)39-17-23(35-36-39)30(42)38-16-14-20-21(5-3-7-24(20)37-15-2-1-9-26(37)40)28(38)29(41)34-19-12-10-18(11-13-19)31(43)44/h3-8,10-13,17,28H,1-2,9,14-16H2,(H,34,41)(H,43,44)	YKRLXMNVDVQBIC-UHFFFAOYSA-N	335850	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(2- oxopiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 81	Plasma kallikrein		 20.7								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335850	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335850&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348836	384988007							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662237	CCOC1CN(C1)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C31H28ClFN6O5/c1-2-44-20-15-37(16-20)25-7-3-5-22-21(25)13-14-38(28(22)29(40)34-19-11-9-18(10-12-19)31(42)43)30(41)24-17-39(36-35-24)26-8-4-6-23(32)27(26)33/h3-12,17,20,28H,2,13-16H2,1H3,(H,34,40)(H,42,43)	MQJWOKRUYVLVHD-UHFFFAOYSA-N	335851	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(3- ethoxyazetidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 82	Plasma kallikrein		 23.1								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335851	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335851&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348875	384988008							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662238	COC1CN(C1)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C30H26ClFN6O5/c1-43-19-14-36(15-19)24-6-2-4-21-20(24)12-13-37(27(21)28(39)33-18-10-8-17(9-11-18)30(41)42)29(40)23-16-38(35-34-23)25-7-3-5-22(31)26(25)32/h2-11,16,19,27H,12-15H2,1H3,(H,33,39)(H,41,42)	MYNRGUFJJDMWTG-UHFFFAOYSA-N	335852	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(3- methoxyazetidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 83	Plasma kallikrein		 12.1								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335852	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335852&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348960	384988009							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662239	CO[C@@H]1CCN(C1)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C31H28ClFN6O5/c1-44-20-12-14-37(16-20)25-6-2-4-22-21(25)13-15-38(28(22)29(40)34-19-10-8-18(9-11-19)31(42)43)30(41)24-17-39(36-35-24)26-7-3-5-23(32)27(26)33/h2-11,17,20,28H,12-16H2,1H3,(H,34,40)(H,42,43)/t20-,28?/m1/s1	SJPWVCKRLGPILA-HFLPEKOISA-N	335853	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-((R)-3- methoxypyrrolidin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 84	Plasma kallikrein		 15.8								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335853	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335853&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348879	384988010							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662240	OC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C31H28ClFN6O5/c32-23-4-2-6-26(27(23)33)39-17-24(35-36-39)30(42)38-16-13-21-22(3-1-5-25(21)37-14-11-20(40)12-15-37)28(38)29(41)34-19-9-7-18(8-10-19)31(43)44/h1-10,17,20,28,40H,11-16H2,(H,34,41)(H,43,44)	PJWXABPIRATKKW-UHFFFAOYSA-N	335854	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(4- hydroxypiperidin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 85	Plasma kallikrein		 5.29								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335854	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335854&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348777	384988011							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662241	OC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3N2CCOCC2)C(=O)c2cnn(c2)-c2cccc(Cl)c2F)cc1	InChI=1S/C31H27ClFN5O5/c32-24-4-2-6-26(27(24)33)38-18-20(17-34-38)30(40)37-12-11-22-23(3-1-5-25(22)36-13-15-43-16-14-36)28(37)29(39)35-21-9-7-19(8-10-21)31(41)42/h1-10,17-18,28H,11-16H2,(H,35,39)(H,41,42)/t28-/m1/s1	AZMXBQFTTJWWIS-MUUNZHRXSA-N	335857	(R)-4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-pyrazole-4-carbonyl)-5-morpholino-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 88	Plasma kallikrein		 2085								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335857	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335857&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601721	384988014							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662242	OC(=O)c1ccc(NC(=O)[C@H]2N(CCc3c2cccc3N2CCOCC2)C(=O)c2cnn(c2)-c2cccc(Cl)c2F)cc1	InChI=1S/C31H27ClFN5O5/c32-24-4-2-6-26(27(24)33)38-18-20(17-34-38)30(40)37-12-11-22-23(3-1-5-25(22)36-13-15-43-16-14-36)28(37)29(39)35-21-9-7-19(8-10-21)31(41)42/h1-10,17-18,28H,11-16H2,(H,35,39)(H,41,42)/t28-/m0/s1	AZMXBQFTTJWWIS-NDEPHWFRSA-N	335858	(S)-4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-pyrazole-4-carbonyl)-5-morpholino-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 89	Plasma kallikrein		 11.4								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335858	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335858&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601534	384988015							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662243	OC(=O)c1ccc(NC(=O)[C@H]2N(CCc3c2cccc3N2CCOCC2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C30H26ClFN6O5/c31-22-4-2-6-25(26(22)32)38-17-23(34-35-38)29(40)37-12-11-20-21(3-1-5-24(20)36-13-15-43-16-14-36)27(37)28(39)33-19-9-7-18(8-10-19)30(41)42/h1-10,17,27H,11-16H2,(H,33,39)(H,41,42)/t27-/m0/s1	UCSKYPRDSCVAMS-MHZLTWQESA-N	335859	(S)-4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-morpholino-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 90	Plasma kallikrein		 5.37								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335859	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335859&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601974	384988016							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662244	OC(=O)c1ccc(NC(=O)[C@H]2N(CCc3c2cccc3N2CCOCC2)C(=O)c2cn(cn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C31H27ClFN5O5/c32-23-4-2-6-26(27(23)33)37-17-24(34-18-37)30(40)38-12-11-21-22(3-1-5-25(21)36-13-15-43-16-14-36)28(38)29(39)35-20-9-7-19(8-10-20)31(41)42/h1-10,17-18,28H,11-16H2,(H,35,39)(H,41,42)/t28-/m0/s1	DVLBZAYUFSXDAP-NDEPHWFRSA-N	335860	(S)-4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-imidazole-4-carbonyl)-5-morpholino-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 91	Plasma kallikrein		 3.84								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335860	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335860&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602090	384988017							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662245	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3N2CCC(CC2)N2CCCC2=O)C(=O)c2cn(cn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C36H34ClFN6O5/c37-27-5-2-7-30(32(27)38)42-20-28(39-21-42)35(47)44-19-15-25-26(33(44)34(46)40-23-11-9-22(10-12-23)36(48)49)4-1-6-29(25)41-17-13-24(14-18-41)43-16-3-8-31(43)45/h1-2,4-7,9-12,20-21,24,33H,3,8,13-19H2,(H,40,46)(H,48,49)	OHZPVCRHBZYZJT-UHFFFAOYSA-N	335861	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-imidazole-4-carbonyl)-5-(4-(2-oxopyrrolidin-1-yl)piperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 92	Plasma kallikrein		 5.60								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335861	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335861&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602164	384988018							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662246	CN(C)C1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)-c1ncco1	InChI=1S/C36H35ClFN7O3/c1-42(2)26-13-17-43(18-14-26)30-7-3-5-28-27(30)15-19-44(36(47)24-21-40-45(22-24)31-8-4-6-29(37)32(31)38)33(28)34(46)41-25-11-9-23(10-12-25)35-39-16-20-48-35/h3-12,16,20-22,26,33H,13-15,17-19H2,1-2H3,(H,41,46)	DJUCOOVKTPLJLE-UHFFFAOYSA-N	335862	2-(1-(3-Chloro-2-fluorophenyl)-1H-pyrazole-4-carbonyl)-5-(4-(dimethylamino)piperidin-1-yl)-N-(4-(oxazol-2-yl)phenyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, bis-TFA salt::US9738655, Example 93	Plasma kallikrein		 9.65								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335862	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335862&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602110	384988019							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662247	CCn1nnc(n1)-c1ccc(NC(=O)C2N(CCc3c2cccc3N2CCC(CC2)N(C)C)C(=O)c2cnn(c2)-c2cccc(Cl)c2F)cc1	InChI=1S/C36H38ClFN10O2/c1-4-48-42-34(41-43-48)23-11-13-25(14-12-23)40-35(49)33-28-7-5-9-30(45-18-15-26(16-19-45)44(2)3)27(28)17-20-46(33)36(50)24-21-39-47(22-24)31-10-6-8-29(37)32(31)38/h5-14,21-22,26,33H,4,15-20H2,1-3H3,(H,40,49)	RKJMKFUCSWGOSU-UHFFFAOYSA-N	335863	2-(1-(3-chloro 2-fluorophenyl)- 1H-pyrazole-4-carbonyl)-5-(4- (dimethylamino)piperidin-1-yl)- N-(4-(2-ethyl-2H-tetrazol-5- yl)phenyl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamide, TFA salt::US9738655, Example 94	Plasma kallikrein		 10.5								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335863	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335863&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348887	384988020							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662248	CN(C)C1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(OCC2CCCO2)cc1	InChI=1S/C38H42ClFN6O4/c1-43(2)27-15-18-44(19-16-27)33-9-3-7-31-30(33)17-20-45(38(48)25-22-41-46(23-25)34-10-4-8-32(39)35(34)40)36(31)37(47)42-26-11-13-28(14-12-26)50-24-29-6-5-21-49-29/h3-4,7-14,22-23,27,29,36H,5-6,15-21,24H2,1-2H3,(H,42,47)	RKRFJYCLJSOKBN-UHFFFAOYSA-N	335864	2-(1-(3-chloro-2-fluorophenyl)- 1H-pyrazole-4-carbonyl)-5-(4- (dimethylamino)piperidin-1-yl)- N-(4-((tetrahydrofuran-2- yl)methoxy)phenyl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamide, TFA salt::US9738655, Example 95	Plasma kallikrein		 16.9								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335864	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335864&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348781	384988021							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662249	CN(C)C1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(OC(F)F)cc1	InChI=1S/C34H34ClF3N6O3/c1-41(2)23-13-16-42(17-14-23)28-7-3-5-26-25(28)15-18-43(31(26)32(45)40-22-9-11-24(12-10-22)47-34(37)38)33(46)21-19-39-44(20-21)29-8-4-6-27(35)30(29)36/h3-12,19-20,23,31,34H,13-18H2,1-2H3,(H,40,45)	AUTKGNDQORIBBN-UHFFFAOYSA-N	335865	2-(1-(3-chloro-2-fluorophenyl)- 1H-pyrazole-4-carbonyl)-N-(4- (difluoromethoxy)phenyl)-5-(4- (dimethylamino)piperidin-1-yl)- 1,2,3,4-tetrahydroisoquinoline-1- carboxamide, TFA salt::US9738655, Example 96	Plasma kallikrein		 34.0								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335865	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335865&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348838	384988022							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662250	COc1ccc(NC(=O)C2N(CCc3c2cccc3N2CCC(CC2)N(C)C)C(=O)c2cnn(c2)-c2cccc(Cl)c2F)cc1	InChI=1S/C34H36ClFN6O3/c1-39(2)24-14-17-40(18-15-24)29-8-4-6-27-26(29)16-19-41(32(27)33(43)38-23-10-12-25(45-3)13-11-23)34(44)22-20-37-42(21-22)30-9-5-7-28(35)31(30)36/h4-13,20-21,24,32H,14-19H2,1-3H3,(H,38,43)	BYWCUUZBTKXTQC-UHFFFAOYSA-N	335866	2-(1-(3-chloro-2-fluorophenyl)- 1H-pyrazole-4-carbonyl)-5-(4- (dimethylamino)piperidin-1-yl)- N-(4-methoxyphenyl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamide, TFA salt::US9738655, Example 97	Plasma kallikrein		 21.7								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335866	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335866&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348861	384988023							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662251	CN(C)C1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)-c1noc(C)n1	InChI=1S/C35H35ClFN9O3/c1-21-38-33(41-49-21)22-10-12-23(13-11-22)39-34(47)32-26-6-4-8-29(44-17-14-24(15-18-44)43(2)3)25(26)16-19-45(32)35(48)28-20-46(42-40-28)30-9-5-7-27(36)31(30)37/h4-13,20,24,32H,14-19H2,1-3H3,(H,39,47)	PGRXFTCYMWPHKW-UHFFFAOYSA-N	335867	2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(4-(dimethylamino) piperidin-1-yl)-N-(4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, bis-TFA salt::US9738655, Example 98	Plasma kallikrein		 5.20								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335867	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335867&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601898	384988024							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662252	CN(C)C1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(N)=O	InChI=1S/C33H34ClFN8O3/c1-40(2)22-13-16-41(17-14-22)27-7-3-5-24-23(27)15-18-42(30(24)32(45)37-21-11-9-20(10-12-21)31(36)44)33(46)26-19-43(39-38-26)28-8-4-6-25(34)29(28)35/h3-12,19,22,30H,13-18H2,1-2H3,(H2,36,44)(H,37,45)	NMESXYFWTSUGKH-UHFFFAOYSA-N	335868	N-(4-Carbamoylphenyl)-2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(4-(dimethylamino)piperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, bis-TFA salt::US9738655, Example 99	Plasma kallikrein		 2.74								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335868	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335868&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602100	384988025							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662253	CN(C)C1CCN(CC1)c1cccc2[C@@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(N)=O	InChI=1S/C33H34ClFN8O3/c1-40(2)22-13-16-41(17-14-22)27-7-3-5-24-23(27)15-18-42(30(24)32(45)37-21-11-9-20(10-12-21)31(36)44)33(46)26-19-43(39-38-26)28-8-4-6-25(34)29(28)35/h3-12,19,22,30H,13-18H2,1-2H3,(H2,36,44)(H,37,45)/t30-/m1/s1	NMESXYFWTSUGKH-SSEXGKCCSA-N	335869	(R)-N-(4-Carbamoylphenyl)-2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(4-(dimethylamino)piperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, bis-TFA salt::US9738655, Example 100	Plasma kallikrein		 494								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335869	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335869&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601365	384988026							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662254	CN(C)C1CCN(CC1)c1cccc2[C@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(N)=O	InChI=1S/C33H34ClFN8O3/c1-40(2)22-13-16-41(17-14-22)27-7-3-5-24-23(27)15-18-42(30(24)32(45)37-21-11-9-20(10-12-21)31(36)44)33(46)26-19-43(39-38-26)28-8-4-6-25(34)29(28)35/h3-12,19,22,30H,13-18H2,1-2H3,(H2,36,44)(H,37,45)/t30-/m0/s1	NMESXYFWTSUGKH-PMERELPUSA-N	335870	(S)-N-(4-Carbamoylphenyl)-2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(4-(dimethylamino)piperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, bis-TFA salt::US9738655, Example 101	Plasma kallikrein		 1.75								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335870	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335870&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601517	384988027							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662255	CN(C)C1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)-c1cn[nH]c1			335871	N-(4-(1H-Pyrazol-4-yl)phenyl)-2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(4-(dimethylamino)piperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, bis-TFA salt::US9738655, Example 102	Plasma kallikrein		 1.39								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335871	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335871&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601936	384988028							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662256	CN(C)C1CCN(CC1)c1cccc2[C@@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)-c1cn[nH]c1			335872	(R)-N-(4-(1H-Pyrazol-4-yl)phenyl)-2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(4-(dimethylamino)piperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, bis-TFA salt::US9738655, Example 103	Plasma kallikrein		 34.0								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335872	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335872&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601934	384988029							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662257	CN(C)C1CCN(CC1)c1cccc2[C@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)-c1cn[nH]c1			335873	(S)-N-(4-(1H-Pyrazol-4-yl)phenyl)-2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(4-(dimethylamino)piperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, bis-TFA salt::US9738655, Example 104	Plasma kallikrein		 0.960								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335873	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335873&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602077	384988030							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662258	CN(C)C1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)-c1nnn[nH]1			335874	N-(4-(1H-Tetrazol-5-yl)phenyl)-2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(4-(dimethylamino)piperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, bis-TFA salt::US9738655, Example 105	Plasma kallikrein		 1.69								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335874	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335874&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601367	384988031							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662259	CN1CCC2(CCN(CC2)c2cccc3C(N(CCc23)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)C(=O)Nc2ccc(cc2)C(O)=O)C1=O	InChI=1S/C35H33ClFN7O5/c1-41-17-13-35(34(41)49)14-18-42(19-15-35)27-6-2-4-24-23(27)12-16-43(30(24)31(45)38-22-10-8-21(9-11-22)33(47)48)32(46)26-20-44(40-39-26)28-7-3-5-25(36)29(28)37/h2-11,20,30H,12-19H2,1H3,(H,38,45)(H,47,48)	LDBRXJJCOCLPDO-UHFFFAOYSA-N	335875	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(2-methyl-1-oxo-2,8-diazaspiro[4.5]decan-8-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 106	Plasma kallikrein		 7.58								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335875	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335875&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602434	384988032							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662260	CN1CCC2(CCN(CC2)c2cccc3C(N(CCc23)C(=O)c2cnn(c2)-c2cccc(Cl)c2F)C(=O)Nc2ccc(cc2)C(O)=O)C1=O	InChI=1S/C36H34ClFN6O5/c1-41-17-13-36(35(41)49)14-18-42(19-15-36)28-6-2-4-26-25(28)12-16-43(31(26)32(45)40-24-10-8-22(9-11-24)34(47)48)33(46)23-20-39-44(21-23)29-7-3-5-27(37)30(29)38/h2-11,20-21,31H,12-19H2,1H3,(H,40,45)(H,47,48)	IVMRSEGVRIIAGV-UHFFFAOYSA-N	335876	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-pyrazole-4-carbonyl)-5-(2-methyl-1-oxo-2,8-diazaspiro[4.5]decan-8-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 107	Plasma kallikrein		 12.5								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335876	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335876&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602252	384988033							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662261	OC(=O)c1ccc(NC(=O)C2N(CCc3c(cccc23)C#N)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C27H18ClFN6O4/c28-20-5-2-6-22(23(20)29)35-14-21(32-33-35)26(37)34-12-11-18-16(13-30)3-1-4-19(18)24(34)25(36)31-17-9-7-15(8-10-17)27(38)39/h1-10,14,24H,11-12H2,(H,31,36)(H,38,39)	RMICWTGTVHFVQN-UHFFFAOYSA-N	335877	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-cyano-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 108	Plasma kallikrein		 50.0								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335877	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335877&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602058	384988034							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662262	NCc1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C27H22ClFN6O4/c28-20-5-2-6-22(23(20)29)35-14-21(32-33-35)26(37)34-12-11-18-16(13-30)3-1-4-19(18)24(34)25(36)31-17-9-7-15(8-10-17)27(38)39/h1-10,14,24H,11-13,30H2,(H,31,36)(H,38,39)	YTULCQGNUIGFGU-UHFFFAOYSA-N	335878	4-(5-(Aminomethyl)-2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 109	Plasma kallikrein		 2.29								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335878	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335878&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602249	384988035							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662263	OC(=O)c1ccc(NC(=O)C2N(CCc3c(Br)cccc23)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C26H18BrClFN5O4/c27-18-4-1-3-17-16(18)11-12-33(23(17)24(35)30-15-9-7-14(8-10-15)26(37)38)25(36)20-13-34(32-31-20)21-6-2-5-19(28)22(21)29/h1-10,13,23H,11-12H2,(H,30,35)(H,37,38)	FTJKBBGXMSWJLV-UHFFFAOYSA-N	335879	4-(5-Bromo-2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 110	Plasma kallikrein		 23.0								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335879	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335879&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601996	384988036							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662264	OCCNc1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C28H24ClFN6O5/c29-20-4-2-6-23(24(20)30)36-15-22(33-34-36)27(39)35-13-11-18-19(3-1-5-21(18)31-12-14-37)25(35)26(38)32-17-9-7-16(8-10-17)28(40)41/h1-10,15,25,31,37H,11-14H2,(H,32,38)(H,40,41)	NYQZRXFSTDWBHC-UHFFFAOYSA-N	335880	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-((2-hydroxyethyl)amino)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 111	Plasma kallikrein		 5.60								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335880	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335880&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602499	384988037							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662265	OC(=O)c1ccc(NC(=O)C2N(CCc3c(OC4CCNCC4)cccc23)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C31H28ClFN6O5/c32-23-4-2-5-25(27(23)33)39-17-24(36-37-39)30(41)38-16-13-21-22(3-1-6-26(21)44-20-11-14-34-15-12-20)28(38)29(40)35-19-9-7-18(8-10-19)31(42)43/h1-10,17,20,28,34H,11-16H2,(H,35,40)(H,42,43)	DRTJXWBTRVZLSH-UHFFFAOYSA-N	335881	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(piperidin-4-yloxy)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 112	Plasma kallikrein		 3.16								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335881	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335881&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602076	384988038							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662266	OCCCOc1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C29H25ClFN5O6/c30-21-5-2-6-23(25(21)31)36-16-22(33-34-36)28(39)35-13-12-19-20(4-1-7-24(19)42-15-3-14-37)26(35)27(38)32-18-10-8-17(9-11-18)29(40)41/h1-2,4-11,16,26,37H,3,12-15H2,(H,32,38)(H,40,41)	ZKEMSABRIROBTJ-UHFFFAOYSA-N	335882	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(2-methoxyethoxy)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 113	Plasma kallikrein		 11.9								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335882	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335882&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			138752699	384988039							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662267	OCCCOc1cccc2[C@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C30H27ClFN3O7/c31-22-6-1-5-21(26(22)32)23-16-25(42-34-23)29(38)35-13-12-19-20(4-2-7-24(19)41-15-3-14-36)27(35)28(37)33-18-10-8-17(9-11-18)30(39)40/h1-2,4-11,25,27,36H,3,12-16H2,(H,33,37)(H,39,40)/t25-,27+/m1/s1	GQEFKPHQGKFWAI-VPUSJEBWSA-N	335883	4-((S)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(2-methoxyethoxy)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, and 4-((R)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(2-methoxyethoxy)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 114	Plasma kallikrein		 15.2								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335883	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335883&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			138752700	384988040							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662268	OCCCOc1cccc2[C@@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C30H27ClFN3O7/c31-22-6-1-5-21(26(22)32)23-16-25(42-34-23)29(38)35-13-12-19-20(4-2-7-24(19)41-15-3-14-36)27(35)28(37)33-18-10-8-17(9-11-18)30(39)40/h1-2,4-11,25,27,36H,3,12-16H2,(H,33,37)(H,39,40)/t25-,27-/m1/s1	GQEFKPHQGKFWAI-XNMGPUDCSA-N	335884	US9738655, Example 115	Plasma kallikrein		 61.3								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335884	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335884&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			138752701	384988041							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662269	CCOC(=O)Cc1ccc(NC(=O)C2N(CCc3c2cccc3-c2ccc(nc2)C(=O)NC)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C36H31ClFN7O5/c1-3-50-31(46)18-21-10-13-23(14-11-21)41-35(48)33-26-7-4-6-24(22-12-15-28(40-19-22)34(47)39-2)25(26)16-17-44(33)36(49)29-20-45(43-42-29)30-9-5-8-27(37)32(30)38/h4-15,19-20,33H,3,16-18H2,1-2H3,(H,39,47)(H,41,48)	RSPKBHVBCVXNMS-UHFFFAOYSA-N	335885	Ethyl 2-(4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(6-(methylcarbamoyl)pyridin-3-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)phenyl)acetate, TFA salt::US9738655, Example 116	Plasma kallikrein		 128								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335885	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335885&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626246	384988042							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662270	CNC(=O)c1ccc(cn1)-c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(CC(O)=O)cc1	InChI=1S/C34H27ClFN7O5/c1-37-32(46)26-13-10-20(17-38-26)22-4-2-5-24-23(22)14-15-42(31(24)33(47)39-21-11-8-19(9-12-21)16-29(44)45)34(48)27-18-43(41-40-27)28-7-3-6-25(35)30(28)36/h2-13,17-18,31H,14-16H2,1H3,(H,37,46)(H,39,47)(H,44,45)	PCKDHIDIRRZJKO-UHFFFAOYSA-N	335886	2-(4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(6-(methylcarbamoyl)pyridin-3-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)phenyl)acetic acid, TFA salt::US9738655, Example 117	Plasma kallikrein		 16.3								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335886	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335886&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626270	384988043					C03768		1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662271	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccccc1	InChI=1S/C31H30ClFN6O3/c1-42-21-13-16-37(17-14-21)26-11-5-9-23-22(26)15-18-38(29(23)30(40)34-20-7-3-2-4-8-20)31(41)25-19-39(36-35-25)27-12-6-10-24(32)28(27)33/h2-12,19,21,29H,13-18H2,1H3,(H,34,40)	OYJMUKCJZWQNIM-UHFFFAOYSA-N	335887	2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(4-methoxypiperidin-1-yl)-N-phenyl-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, TFA salt::US9738655, Example 118	Plasma kallikrein		 250								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335887	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335887&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602103	384988044							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662272	Fc1c(Cl)cccc1-n1cc(nn1)C(=O)N1CCc2c(Br)cccc2C1C(=O)Nc1ccccc1	InChI=1S/C25H18BrClFN5O2/c26-18-9-4-8-17-16(18)12-13-32(23(17)24(34)29-15-6-2-1-3-7-15)25(35)20-14-33(31-30-20)21-11-5-10-19(27)22(21)28/h1-11,14,23H,12-13H2,(H,29,34)	YQDIROVALXIHCO-UHFFFAOYSA-N	335888	5-Bromo-2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-N-phenyl-1,2,3,4-tetrahydroisoquinoline-1-carboxamide::US9738655, Example 119	Plasma kallikrein		 1104								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335888	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335888&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601337	384988045							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662273	OCc1ccc(NC(=O)C2N(CCc3c(Br)cccc23)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C26H20BrClFN5O3/c27-19-4-1-3-18-17(19)11-12-33(24(18)25(36)30-16-9-7-15(14-35)8-10-16)26(37)21-13-34(32-31-21)22-6-2-5-20(28)23(22)29/h1-10,13,24,35H,11-12,14H2,(H,30,36)	UVSSXHYWEKOUGV-UHFFFAOYSA-N	335889	5-Bromo-2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-N-(4-(hydroxymethyl)phenyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide::US9738655, Example 120	Plasma kallikrein		 517								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335889	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335889&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626330	384988046							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662274	COC1CCN(CC1)c1cccc2[C@@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(CO)cc1	InChI=1S/C32H32ClFN6O4/c1-44-22-12-15-38(16-13-22)27-6-2-4-24-23(27)14-17-39(30(24)31(42)35-21-10-8-20(19-41)9-11-21)32(43)26-18-40(37-36-26)28-7-3-5-25(33)29(28)34/h2-11,18,22,30,41H,12-17,19H2,1H3,(H,35,42)/t30-/m1/s1	IKSYNZROZSKPEA-SSEXGKCCSA-N	335890	(R)-2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-N-(4-(hydroxymethyl)phenyl)-5-(4-methoxypiperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide::US9738655, Example 121	Plasma kallikrein		 7896								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335890	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335890&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601941	384988047							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662275	COC1CCN(CC1)c1cccc2[C@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(CO)cc1	InChI=1S/C32H32ClFN6O4/c1-44-22-12-15-38(16-13-22)27-6-2-4-24-23(27)14-17-39(30(24)31(42)35-21-10-8-20(19-41)9-11-21)32(43)26-18-40(37-36-26)28-7-3-5-25(33)29(28)34/h2-11,18,22,30,41H,12-17,19H2,1H3,(H,35,42)/t30-/m0/s1	IKSYNZROZSKPEA-PMERELPUSA-N	335891	(S)-2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-N-(4-(hydroxymethyl)phenyl)-5-(4-methoxypiperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide::US9738655, Example 122	Plasma kallikrein		 99.8								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335891	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335891&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601458	384988048							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662276	OC(=O)c1ccc(NC(=O)C2N(CCc3c(OC4COC4)cccc23)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C29H23ClFN5O6/c30-21-4-2-5-23(25(21)31)36-13-22(33-34-36)28(38)35-12-11-19-20(3-1-6-24(19)42-18-14-41-15-18)26(35)27(37)32-17-9-7-16(8-10-17)29(39)40/h1-10,13,18,26H,11-12,14-15H2,(H,32,37)(H,39,40)	AMHCONOGPXXSHI-UHFFFAOYSA-N	335892	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(oxetan-3-yloxy)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 123	Plasma kallikrein		 21.1								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335892	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335892&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602453	384988049							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662277	CC1(COc2cccc3C(N(CCc23)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)C(=O)Nc2ccc(cc2)C(O)=O)COC1	InChI=1S/C31H27ClFN5O6/c1-31(15-43-16-31)17-44-25-7-2-4-21-20(25)12-13-37(27(21)28(39)34-19-10-8-18(9-11-19)30(41)42)29(40)23-14-38(36-35-23)24-6-3-5-22(32)26(24)33/h2-11,14,27H,12-13,15-17H2,1H3,(H,34,39)(H,41,42)	LEGCVLXVQJXNEL-UHFFFAOYSA-N	335893	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-((3-methyloxetan-3-yl)methoxy)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 124	Plasma kallikrein		 36.2								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335893	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335893&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626334	384988050							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662278	Fc1c(Cl)cccc1-n1cc(nn1)C(=O)N1CCc2c(cccc2-c2cncnc2)[C@@H]1C(=O)Nc1ccc2ncccc2c1	InChI=1S/C32H22ClFN8O2/c33-25-7-2-8-28(29(25)34)42-17-27(39-40-42)32(44)41-13-11-23-22(20-15-35-18-36-16-20)5-1-6-24(23)30(41)31(43)38-21-9-10-26-19(14-21)4-3-12-37-26/h1-10,12,14-18,30H,11,13H2,(H,38,43)/t30-/m1/s1	AOJOJDICJYHDFM-SSEXGKCCSA-N	335894	2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(pyrimidin-5-yl)-N-(quinolin-6-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, TFA salt::US9738655, Example 125	Plasma kallikrein		 54.1								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335894	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335894&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121357622	384988051							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662279	Fc1c(Cl)cccc1-n1cc(nn1)C(=O)N1CCc2c(cccc2-c2cncnc2)C1C(=O)Nc1ccc(cc1)-c1ncc[nH]1			335895	N-(4-(1H-imidazol-2-yl)phenyl)-2-(1- (3-chloro-2-fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(pyrimidin-5- yl)-1,2,3,4-tetrahy-droisoquinoline-1- carboxamide, TFA salt::US9738655, Example 126	Plasma kallikrein		 94.0								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335895	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335895&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348927	384988052							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662280	Fc1c(Cl)cccc1-n1cc(nn1)C(=O)N1CCc2c(cccc2-c2cncnc2)C1C(=O)Nc1ccc(cc1)-c1cc[nH]n1			335896	N-(4-(1H-pyrazol-3-yl)phenyl)-2-(1-(3- chloro-2-fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(pyrimidin-5- yl)-1,2,3,4-tetrahydroisoquinoline-1- carboxamide, TFA salt::US9738655, Example 127	Plasma kallikrein		 196								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335896	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335896&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348768	384988053							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662281	COC(=O)c1ccc2cc(NC(=O)C3N(CCc4c3cccc4-c3cncnc3)C(=O)c3cn(nn3)-c3cccc(Cl)c3F)ccc2n1	InChI=1S/C34H24ClFN8O4/c1-48-34(47)27-10-8-19-14-21(9-11-26(19)40-27)39-32(45)31-24-5-2-4-22(20-15-37-18-38-16-20)23(24)12-13-43(31)33(46)28-17-44(42-41-28)29-7-3-6-25(35)30(29)36/h2-11,14-18,31H,12-13H2,1H3,(H,39,45)	KIPVHPIVDXTMIZ-UHFFFAOYSA-N	335897	US9738655, Example 128::methyl 6-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3-triazole-4- carbonyl)-5-(pyrimidin-5-yl)-1,2,3,4- tetrahydroisoquinoline-1-carboxamido) quinoline-2-carboxylate, TFA salt	Plasma kallikrein		 65.3								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335897	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335897&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348964	384988054							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662282	OC(=O)c1ccc2cc(NC(=O)C3N(CCc4c3cccc4-c3cncnc3)C(=O)c3cn(nn3)-c3cccc(Cl)c3F)ccc2n1	InChI=1S/C33H22ClFN8O4/c34-24-5-2-6-28(29(24)35)43-16-27(40-41-43)32(45)42-12-11-22-21(19-14-36-17-37-15-19)3-1-4-23(22)30(42)31(44)38-20-8-10-25-18(13-20)7-9-26(39-25)33(46)47/h1-10,13-17,30H,11-12H2,(H,38,44)(H,46,47)	CBWGFRXFDKEMRZ-UHFFFAOYSA-N	335898	6-(2-(1-(3-chloro-2-fluorophenyl)-1H- 1,2,3-triazole-4-carbonyl)-5- (pyrimidin-5-yl)-1,2,3,4- tetrahydroisoquinoline-1-carboxamido) quinoline-2-carboxylic acid, TFA salt::US9738655, Example 129	Plasma kallikrein		 34.0								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335898	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335898&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348962	384988055							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662283	Fc1c(Cl)cccc1-n1cc(nn1)C(=O)N1CCc2c(cccc2-c2cncnc2)C1C(=O)Nc1ccc2cnccc2c1	InChI=1S/C32H22ClFN8O2/c33-26-5-2-6-28(29(26)34)42-17-27(39-40-42)32(44)41-12-10-24-23(21-15-36-18-37-16-21)3-1-4-25(24)30(41)31(43)38-22-8-7-20-14-35-11-9-19(20)13-22/h1-9,11,13-18,30H,10,12H2,(H,38,43)	JNENWLQOWWWAGJ-UHFFFAOYSA-N	335899	2-(1-(3-chloro-2-fluorophenyl)-1H- 1,2,3-triazol-4-carbonyl)-N- (isoquinolin-6-yl)-5-(pyrimidin-5-yl)- 1,2,3,4-tetrahydroisoquinoline-1- carboxamide, TFA salt::US9738655, Example 130	Plasma kallikrein		 126								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335899	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335899&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348762	384988056							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662284	Fc1c(Cl)cccc1-n1cc(nn1)C(=O)N1CCc2c(cccc2-c2cncnc2)C1C(=O)Nc1ccc(cc1)-c1ncn[nH]1			335900	N-(4-(1H-1,2,4-triazol-5-yl)phenyl)-2- (1-(3-chloro-2-fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(pyrimidin-5- yl)-1,2,3,4-tetrahydroisoquinoline-1- carboxamide, TFA salt::US9738655, Example 131	Plasma kallikrein		 60.3								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335900	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335900&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348776	384988057							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662285	COC(=O)[C@@H]1CC[C@@H](CC1)NC(=O)C1N(CCc2c1cccc2-c1cncnc1)C(=O)c1cn(nn1)-c1cccc(Cl)c1F	InChI=1S/C31H29ClFN7O4/c1-44-31(43)18-8-10-20(11-9-18)36-29(41)28-23-5-2-4-21(19-14-34-17-35-15-19)22(23)12-13-39(28)30(42)25-16-40(38-37-25)26-7-3-6-24(32)27(26)33/h2-7,14-18,20,28H,8-13H2,1H3,(H,36,41)/t18-,20+,28?	KRPMWHOIXWBEJN-NWNQRXDVSA-N	335901	(1R,4R)-methyl 4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3-triazole-4- carbonyl)-5-(pyrimidin-5-yl)-1,2,3,4- tetrahydroisoquinoline-1-carboxamido) cyclohexanecarboxylate::US9738655, Example 132	Plasma kallikrein		 1624								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335901	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335901&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348820	384988058							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662286	OC(=O)[C@@H]1CC[C@@H](CC1)NC(=O)C1N(CCc2c1cccc2-c1cncnc1)C(=O)c1cn(nn1)-c1cccc(Cl)c1F	InChI=1S/C30H27ClFN7O4/c31-23-5-2-6-25(26(23)32)39-15-24(36-37-39)29(41)38-12-11-21-20(18-13-33-16-34-14-18)3-1-4-22(21)27(38)28(40)35-19-9-7-17(8-10-19)30(42)43/h1-6,13-17,19,27H,7-12H2,(H,35,40)(H,42,43)/t17-,19+,27?	BKPBNEGPJBNSTD-MEXJIUHXSA-N	335902	(1R,4R)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3-triazole-4- carbonyl)-5-(pyrimidin-5-yl)-1,2,3,4- tetrahydroisoquinoline-1-carboxamido) cyclohexanecarboxylic acid::US9738655, Example 133	Plasma kallikrein		 750								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335902	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335902&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348874	384988059							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662287	Fc1c(Cl)cccc1C1=NO[C@H](C1)C(=O)N1CCc2c(cccc2-c2cncnc2)[C@H]1C(=O)Nc1ccc(cc1)-c1ncc[nH]1			335903	(1S)-N-(4-(1H-Imidazol-2-yl)phenyl)-2-(3-(3-chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, TFA salt, and (1R)-N-(4-(1H-Imidazol-2-yl)phenyl)-2-(3-(3-chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, TFA salt::US9738655, Example 134	Plasma kallikrein		 24.4								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335903	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335903&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602084	384988060							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662288	Fc1c(Cl)cccc1C1=NO[C@H](C1)C(=O)N1CCc2c(cccc2-c2cncnc2)[C@@H]1C(=O)Nc1ccc(cc1)-c1ncc[nH]1			335904	US9738655, Example 135	Plasma kallikrein		 399								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335904	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335904&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601929	384988061							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662289	Cc1c(ncn1-c1cccc(Cl)c1F)C(=O)N1CCc2c(cccc2-c2cncnc2)C1C(=O)Nc1ccc(cc1)-c1ncc[nH]1			335905	N-(4-(1H-Imidazol-2-yl)phenyl)-2-(1-(3-chloro-2-fluorophenyl)-5-methyl-1H-imidazole-4-carbonyl)-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, 2 TFA salt::US9738655, Example 136	Plasma kallikrein		 157								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335905	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335905&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601342	384988062							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662290	Fc1c(Cl)cccc1-n1cnc(c1)C(=O)N1CCc2c(cccc2-c2cncnc2)C1C(=O)Nc1ccc(cc1)-c1ncc[nH]1			335906	N-(4-(1H-Imidazol-2-yl)phenyl)-2-(1-(3-chloro-2-fluorophenyl)-1H-imidazole-4-carbonyl)-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, 2 TFA::US9738655, Example 137	Plasma kallikrein		 53.4								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335906	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335906&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601909	384988063							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662291	Fc1c(Cl)cccc1-n1cc(nn1)C(=O)N1CCc2c(cccc2-c2cncnc2)[C@H]1C(=O)Nc1ccc(cc1)-c1ncc[nH]1			335907	(S)-N-(4-(H-Imidazol-2-yl)phenyl)-2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, TFA salt, and (R)-N-(4-(1H-Imidazol-2-yl)phenyl)-2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, TFA salt::US9738655, Example 138	Plasma kallikrein		 25.9								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335907	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335907&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602016	384988064							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662292	Fc1c(Cl)cccc1-n1cc(nn1)C(=O)N1CCc2c(cccc2-c2cncnc2)[C@@H]1C(=O)Nc1ccc(cc1)-c1ncc[nH]1			335910	US9738655, Example 139	Plasma kallikrein		 16.5								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335910	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335910&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601485	384988067							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662293	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1nnn(c1C)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)-c1ncc[nH]1			335911	N-(4-(1H-Imidazol-2-yl)phenyl)-2-(1-(3-chloro-2-fluorophenyl)-5-methyl-1H-1,2,3-triazole-4-carbonyl)-5-(4-methoxypiperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, 2 TFA salt::US9738655, Example 140	Plasma kallikrein		 2371								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335911	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335911&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601331	384988068							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662294	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)-c1ncc[nH]1			335912	N-(4-(1H-Imidazol-2-yl)phenyl)-2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(4-methoxypiperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, 2 TFA::US9738655, Example 141	Plasma kallikrein		 161								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335912	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335912&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601344	384988069							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662295	COC(=O)C12CCC(CC1)(CC2)NC(=O)C1N(CCc2c1cccc2-c1cncnc1)C(=O)c1cn(nn1)-c1cccc(Cl)c1F	InChI=1S/C33H31ClFN7O4/c1-46-31(45)32-9-12-33(13-10-32,14-11-32)38-29(43)28-23-5-2-4-21(20-16-36-19-37-17-20)22(23)8-15-41(28)30(44)25-18-42(40-39-25)26-7-3-6-24(34)27(26)35/h2-7,16-19,28H,8-15H2,1H3,(H,38,43)	XUSXNGCEKZUXPA-UHFFFAOYSA-N	335913	Methyl 4-(2-{[1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazol-4-yl]carbonyl}-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-amido)bicyclo[2.2.2]octane-1-carboxylate, TFA salt::US9738655, Example 142	Plasma kallikrein		 426								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335913	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335913&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626226	384988070							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662296	OC(=O)C12CCC(CC1)(CC2)NC(=O)C1N(CCc2c1cccc2-c1cncnc1)C(=O)c1cn(nn1)-c1cccc(Cl)c1F	InChI=1S/C32H29ClFN7O4/c33-23-5-2-6-25(26(23)34)41-17-24(38-39-41)29(43)40-14-7-21-20(19-15-35-18-36-16-19)3-1-4-22(21)27(40)28(42)37-32-11-8-31(9-12-32,10-13-32)30(44)45/h1-6,15-18,27H,7-14H2,(H,37,42)(H,44,45)	PAUFAVZBDGYZEP-UHFFFAOYSA-N	335914	4-(2-{[1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazol-4-yl]carbonyl}-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-amido)bicyclo[2.2.2]octane-1-carboxylic acid, 1 TFA::US9738655, Example 143	Plasma kallikrein		 237								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335914	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335914&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626271	384988071							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662297	OC(=O)C12CCC(CC1)(CC2)NC(=O)[C@H]1N(CCc2c1cccc2-c1cncnc1)C(=O)c1cn(nn1)-c1cccc(Cl)c1F	InChI=1S/C32H29ClFN7O4/c33-23-5-2-6-25(26(23)34)41-17-24(38-39-41)29(43)40-14-7-21-20(19-15-35-18-36-16-19)3-1-4-22(21)27(40)28(42)37-32-11-8-31(9-12-32,10-13-32)30(44)45/h1-6,15-18,27H,7-14H2,(H,37,42)(H,44,45)/t27-,31?,32?/m0/s1	PAUFAVZBDGYZEP-ZHGDCFTFSA-N	335915	4-(2-{[1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazol-4-yl]carbonyl}-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-amido)bicyclo[2.2.2]octane-1-carboxylic acid, 1 TFA (enantiomer A), and 4-(2-{[1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazol-4-yl]carbonyl}-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-amido)bicyclo[2.2.2]octane-1-carboxylic acid, 1 TFA (enantiomer B)::US9738655, Example 144	Plasma kallikrein		 330								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335915	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335915&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			138752702	384988072							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662298	OC(=O)C12CCC(CC1)(CC2)NC(=O)[C@@H]1N(CCc2c1cccc2-c1cncnc1)C(=O)c1cn(nn1)-c1cccc(Cl)c1F	InChI=1S/C32H29ClFN7O4/c33-23-5-2-6-25(26(23)34)41-17-24(38-39-41)29(43)40-14-7-21-20(19-15-35-18-36-16-19)3-1-4-22(21)27(40)28(42)37-32-11-8-31(9-12-32,10-13-32)30(44)45/h1-6,15-18,27H,7-14H2,(H,37,42)(H,44,45)/t27-,31?,32?/m1/s1	PAUFAVZBDGYZEP-XJRVHGQPSA-N	335916	US9738655, Example 145	Plasma kallikrein		 252								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335916	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335916&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			138752703	384988073							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662299	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1sc(nc1C)-c1cccnc1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H33N5O5S/c1-20-29(44-31(35-20)22-5-4-15-34-19-22)32(40)38-18-14-25-26(6-3-7-27(25)37-16-12-24(43-2)13-17-37)28(38)30(39)36-23-10-8-21(9-11-23)33(41)42/h3-11,15,19,24,28H,12-14,16-18H2,1-2H3,(H,36,39)(H,41,42)	LLLXEIXZHFLWRN-UHFFFAOYSA-N	335917	4-(5-(4-methoxypiperidin-1- yl)-2-(4-methyl-2-(pyridin-3- yl)thiazole-5-carbonyl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 146	Plasma kallikrein		 2000								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335917	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335917&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626275	384988074							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662300	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cc(C)n(c1C)-c1ccc(Cl)cc1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C36H37ClN4O5/c1-22-21-31(23(2)41(22)27-13-9-25(37)10-14-27)35(43)40-20-17-29-30(5-4-6-32(29)39-18-15-28(46-3)16-19-39)33(40)34(42)38-26-11-7-24(8-12-26)36(44)45/h4-14,21,28,33H,15-20H2,1-3H3,(H,38,42)(H,44,45)	JUDGQBWJCBBMPL-UHFFFAOYSA-N	335918	4-(2-(1-(4-chlorophenyl)-2,5- dimethyl-1H-pyrrole-3- carbonyl)-5-(4- methoxypiperidin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 147	Plasma kallikrein		 6000								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335918	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335918&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626253	384988075							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662301	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cc(no1)-c1ccccc1Cl)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H31ClN4O6/c1-43-22-13-16-37(17-14-22)28-8-4-6-24-23(28)15-18-38(30(24)31(39)35-21-11-9-20(10-12-21)33(41)42)32(40)29-19-27(36-44-29)25-5-2-3-7-26(25)34/h2-12,19,22,30H,13-18H2,1H3,(H,35,39)(H,41,42)	FBWHUCZKOUXAFK-UHFFFAOYSA-N	335919	4-(2-(3-(2-chlorophenyl) isoxazole-5-carbonyl)-5-(4- methoxypiperidin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 148	Plasma kallikrein		 1250								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335919	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335919&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626257	384988076							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662302	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1C(F)(F)F)-c1cccc(Cl)c1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H31ClF3N5O5/c1-48-24-12-15-41(16-13-24)28-7-3-6-26-25(28)14-17-42(29(26)31(44)40-22-10-8-20(9-11-22)33(46)47)32(45)27-19-39-43(30(27)34(36,37)38)23-5-2-4-21(35)18-23/h2-11,18-19,24,29H,12-17H2,1H3,(H,40,44)(H,46,47)	UOAJSVQRAORWBH-UHFFFAOYSA-N	335921	4-(2-(1-(3-chlorophenyl)-5- (trifluoromethyl)-1H- pyrazole-4-carbonyl)-5-(4- methoxypiperidin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 150	Plasma kallikrein		 6000								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335921	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335921&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348851	384988078							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662303	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CCN(C1=O)c1cccc(Cl)c1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H35ClN4O6/c1-45-25-12-16-37(17-13-25)29-7-3-6-27-26(29)14-19-39(30(27)31(40)36-23-10-8-21(9-11-23)34(43)44)33(42)28-15-18-38(32(28)41)24-5-2-4-22(35)20-24/h2-11,20,25,28,30H,12-19H2,1H3,(H,36,40)(H,43,44)	HBNGEEKQCFDTBF-UHFFFAOYSA-N	336115	4-(2-(1-(3-chlorophenyl)-2- oxopyrrolidine-3-carbonyl)- 5-(4-methoxypiperidin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 151	Plasma kallikrein		 816								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336115	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336115&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626259	384988254							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662304	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cc(no1)-c1cccc(F)c1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H31FN4O6/c1-43-24-12-15-37(16-13-24)28-7-3-6-26-25(28)14-17-38(30(26)31(39)35-23-10-8-20(9-11-23)33(41)42)32(40)29-19-27(36-44-29)21-4-2-5-22(34)18-21/h2-11,18-19,24,30H,12-17H2,1H3,(H,35,39)(H,41,42)	CZQIYQUQRWMSNN-UHFFFAOYSA-N	335922	4-(2-(3-(3-fluorophenyl) isoxazole-5-carbonyl)-5-(4- methoxypiperidin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 152	Plasma kallikrein		 2516								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335922	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335922&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626254	384988079							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662305	COc1ncccc1-c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H24ClFN6O5/c1-45-30-23(7-4-15-35-30)20-5-2-6-22-21(20)14-16-39(28(22)29(41)36-19-12-10-18(11-13-19)32(43)44)31(42)25-17-40(38-37-25)26-9-3-8-24(33)27(26)34/h2-13,15,17,28H,14,16H2,1H3,(H,36,41)(H,43,44)	IGZAIPQOJHCWHB-UHFFFAOYSA-N	335924	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(2- methoxypyridin-3-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 153	Plasma kallikrein		 62.2								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335924	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335924&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626316	384988081							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662306	CN(C)Cc1ccc(cc1)-c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C35H30ClFN6O4/c1-41(2)19-21-9-11-22(12-10-21)25-5-3-6-27-26(25)17-18-42(32(27)33(44)38-24-15-13-23(14-16-24)35(46)47)34(45)29-20-43(40-39-29)30-8-4-7-28(36)31(30)37/h3-16,20,32H,17-19H2,1-2H3,(H,38,44)(H,46,47)	ZVZJRSQLHVSFCT-UHFFFAOYSA-N	335925	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(4- ((dimethylamino)methyl) phenyl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 154	Plasma kallikrein		 5.26								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335925	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335925&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626305	384988082							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662307	NS(=O)(=O)c1cccc(c1)-c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H24ClFN6O6S/c33-25-8-3-9-27(28(25)34)40-17-26(37-38-40)31(42)39-15-14-23-22(19-4-1-5-21(16-19)47(35,45)46)6-2-7-24(23)29(39)30(41)36-20-12-10-18(11-13-20)32(43)44/h1-13,16-17,29H,14-15H2,(H,36,41)(H,43,44)(H2,35,45,46)	WIFGOOCSSHFCOL-UHFFFAOYSA-N	335926	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(3- sulfamoylphenyl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 155	Plasma kallikrein		 23.9								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335926	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335926&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626308	384988083							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662308	Cn1ncc2cc(ccc12)-c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H25ClFN7O4/c1-41-28-13-10-20(16-21(28)17-37-41)23-4-2-5-25-24(23)14-15-42(31(25)32(44)38-22-11-8-19(9-12-22)34(46)47)33(45)27-18-43(40-39-27)29-7-3-6-26(35)30(29)36/h2-13,16-18,31H,14-15H2,1H3,(H,38,44)(H,46,47)	PEYSPUAISONHGJ-UHFFFAOYSA-N	335927	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(1- methyl-1H-indazol-5-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 156	Plasma kallikrein		 30.1								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335927	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335927&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626313	384988084							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662309	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3-c2ccc3OCOc3c2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C33H23ClFN5O6/c34-24-5-2-6-26(29(24)35)40-16-25(37-38-40)32(42)39-14-13-22-21(19-9-12-27-28(15-19)46-17-45-27)3-1-4-23(22)30(39)31(41)36-20-10-7-18(8-11-20)33(43)44/h1-12,15-16,30H,13-14,17H2,(H,36,41)(H,43,44)	YMKJYIGERWZMBD-UHFFFAOYSA-N	335928	4-(5-(benzo[d][1,3]dioxol-5- yl)-2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 157	Plasma kallikrein		 29.5								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335928	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335928&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626227	384988085							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662310	COc1nc(CO)ncc1-c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H25ClFN7O6/c1-47-30-22(14-35-26(16-42)37-30)19-4-2-5-21-20(19)12-13-40(28(21)29(43)36-18-10-8-17(9-11-18)32(45)46)31(44)24-15-41(39-38-24)25-7-3-6-23(33)27(25)34/h2-11,14-15,28,42H,12-13,16H2,1H3,(H,36,43)(H,45,46)	KEIUQGAQXZMPMF-UHFFFAOYSA-N	335929	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(2,4- dimethoxypyrimidin-5-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 158	Plasma kallikrein		 140								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335929	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335929&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			138752704	384988086							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662311	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3-c2cnoc2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C29H20ClFN6O5/c30-22-5-2-6-24(25(22)31)37-14-23(34-35-37)28(39)36-12-11-20-19(17-13-32-42-15-17)3-1-4-21(20)26(36)27(38)33-18-9-7-16(8-10-18)29(40)41/h1-10,13-15,26H,11-12H2,(H,33,38)(H,40,41)	KNHSJHYZPJNHQS-UHFFFAOYSA-N	335930	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5- (isoxazol-4-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 159	Plasma kallikrein		 21.9								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335930	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335930&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626229	384988087							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662312	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3-c2cccc3cc[nH]c23)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1			335931	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(1H- indol-7-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 160	Plasma kallikrein		 117								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335931	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335931&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626230	384988088							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662313	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3-c2ccc3cn[nH]c3c2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1			335932	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(1H- indazol-6-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 161	Plasma kallikrein		 2.46								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335932	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335932&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626374	384988089							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662314	Cn1cc2ccc(cc2n1)-c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H25ClFN7O4/c1-41-17-21-9-8-20(16-27(21)39-41)23-4-2-5-25-24(23)14-15-42(31(25)32(44)37-22-12-10-19(11-13-22)34(46)47)33(45)28-18-43(40-38-28)29-7-3-6-26(35)30(29)36/h2-13,16-18,31H,14-15H2,1H3,(H,37,44)(H,46,47)	KHUVYEDRWCEEIA-UHFFFAOYSA-N	335933	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(2- methyl-2H-indazol-6-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 162	Plasma kallikrein		 49.9								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335933	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335933&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626372	384988090							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662315	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc2N(C)C(=O)CCc2c1	InChI=1S/C35H35ClFN7O4/c1-41-28-11-10-22(19-21(28)9-12-31(41)45)38-34(46)33-25-5-3-7-29(42-16-13-23(48-2)14-17-42)24(25)15-18-43(33)35(47)27-20-44(40-39-27)30-8-4-6-26(36)32(30)37/h3-8,10-11,19-20,23,33H,9,12-18H2,1-2H3,(H,38,46)	BUBXPDDFAILUER-UHFFFAOYSA-N	335961	2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(4-methoxypiperidin-1-yl)-N-(1-methyl-2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, TFA salt::US9738655, Example 189	Plasma kallikrein		 540								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335961	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335961&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601819	384988118							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662316	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc2NC(=O)Cc2c1	InChI=1S/C33H31ClFN7O4/c1-46-21-10-13-40(14-11-21)27-6-2-4-23-22(27)12-15-41(31(23)32(44)36-20-8-9-25-19(16-20)17-29(43)37-25)33(45)26-18-42(39-38-26)28-7-3-5-24(34)30(28)35/h2-9,16,18,21,31H,10-15,17H2,1H3,(H,36,44)(H,37,43)	ITLFYSBJLLBJOI-UHFFFAOYSA-N	335962	2-(1-(3-Chloro-2-fluorophenyl)-1H-12,3-triazole-4-carbonyl)-5-(4-methoxypiperidin-1-yl)-N-(2-oxoindolin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, TFA salt::US9738655, Example 190	Plasma kallikrein		 163								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335962	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335962&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601759	384988119							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662317	CC(=O)Nc1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C28H22ClFN6O5/c1-15(37)31-21-6-2-4-19-18(21)12-13-35(25(19)26(38)32-17-10-8-16(9-11-17)28(40)41)27(39)22-14-36(34-33-22)23-7-3-5-20(29)24(23)30/h2-11,14,25H,12-13H2,1H3,(H,31,37)(H,32,38)(H,40,41)	DYDMJJDNJRSGGJ-UHFFFAOYSA-N	335963	4-(5-Acetamido-2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 191	Plasma kallikrein		 12.3								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335963	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335963&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626383	384988120							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662318	CN1CCC(CC1)NC(=O)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H31ClFN7O5/c1-40-15-12-21(13-16-40)36-30(43)24-5-2-4-23-22(24)14-17-41(29(23)31(44)37-20-10-8-19(9-11-20)33(46)47)32(45)26-18-42(39-38-26)27-7-3-6-25(34)28(27)35/h2-11,18,21,29H,12-17H2,1H3,(H,36,43)(H,37,44)(H,46,47)	LGQQAPCYXLKLHW-UHFFFAOYSA-N	335964	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-((1-methylpiperidin-4-yl)carbamoyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt.::US9738655, Example 192	Plasma kallikrein		 55.6								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335964	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335964&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602250	384988121							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662319	OC(=O)c1ccc(NC(=O)C2N(CCc3c(NC(=O)NC4CCCC4)cccc23)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C32H29ClFN7O5/c33-23-8-4-10-26(27(23)34)41-17-25(38-39-41)30(43)40-16-15-21-22(7-3-9-24(21)37-32(46)36-19-5-1-2-6-19)28(40)29(42)35-20-13-11-18(12-14-20)31(44)45/h3-4,7-14,17,19,28H,1-2,5-6,15-16H2,(H,35,42)(H,44,45)(H2,36,37,46)	LJVRVBNTOCCTEO-UHFFFAOYSA-N	335965	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(3-cyclopentylureido)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 193	Plasma kallikrein		 2.34								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335965	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335965&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601686	384988122							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662320	OC(=O)c1ccc(NC(=O)C2N(CCc3c(Cl)cccc23)C(=O)c2cn(nn2)C2CC=CC(Cl)=C2F)cc1	InChI=1S/C26H20Cl2FN5O4/c27-18-4-1-3-17-16(18)11-12-33(23(17)24(35)30-15-9-7-14(8-10-15)26(37)38)25(36)20-13-34(32-31-20)21-6-2-5-19(28)22(21)29/h1-5,7-10,13,21,23H,6,11-12H2,(H,30,35)(H,37,38)	WLTRHIYRFBTMJU-UHFFFAOYSA-N	335966	4-(5-Chloro-2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 194	Plasma kallikrein		 41.5								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335966	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335966&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121360915	384988123							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662321	OC(=O)c1ccc(NC(=O)C2N(CCc3c(F)cccc23)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C26H18ClF2N5O4/c27-18-4-2-6-21(22(18)29)34-13-20(31-32-34)25(36)33-12-11-16-17(3-1-5-19(16)28)23(33)24(35)30-15-9-7-14(8-10-15)26(37)38/h1-10,13,23H,11-12H2,(H,30,35)(H,37,38)	PKTQTDFJRKLUQK-UHFFFAOYSA-N	335967	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-fluoro-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 195	Plasma kallikrein		 30.9								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335967	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335967&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602022	384988124							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662322	O[C@H]1CCN(C1=O)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C30H24ClFN6O6/c31-20-4-2-6-23(25(20)32)38-15-21(34-35-38)28(41)37-13-11-18-19(3-1-5-22(18)36-14-12-24(39)29(36)42)26(37)27(40)33-17-9-7-16(8-10-17)30(43)44/h1-10,15,24,26,39H,11-14H2,(H,33,40)(H,43,44)/t24-,26?/m0/s1	QEZNFQPAVIEUBG-QSAPEBAKSA-N	335968	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-((S)-3-hydroxy-2-oxopyrrolidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 196	Plasma kallikrein		 11.9								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335968	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335968&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602162	384988125							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662323	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3N2CCN(CC(F)(F)F)CC2=O)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C32H26ClF4N7O5/c33-22-4-2-6-25(27(22)34)44-15-23(39-40-44)30(47)43-12-11-20-21(28(43)29(46)38-19-9-7-18(8-10-19)31(48)49)3-1-5-24(20)42-14-13-41(16-26(42)45)17-32(35,36)37/h1-10,15,28H,11-14,16-17H2,(H,38,46)(H,48,49)	CHOLKMVFUOCVEJ-UHFFFAOYSA-N	335969	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(2-oxo-4-(2,2,2-trifluoroethyl)piperazin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 197	Plasma kallikrein		 10.0								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335969	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335969&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602268	384988126							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662324	CN1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cc(no1)-c1cccc(Cl)c1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H30ClN5O5/c1-36-14-16-37(17-15-36)27-7-3-6-25-24(27)12-13-38(29(25)30(39)34-23-10-8-20(9-11-23)32(41)42)31(40)28-19-26(35-43-28)21-4-2-5-22(33)18-21/h2-11,18-19,29H,12-17H2,1H3,(H,34,39)(H,41,42)	HLDCZJMVJHEASJ-UHFFFAOYSA-N	335970	4-(2-(3-(3-chlorophenyl) isoxazole-5-carbonyl)-5- (4-methylpiperazin-1- yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 198	Plasma kallikrein		 122								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335970	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335970&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348948	384988127							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662325	CN1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(nc1C(F)(F)F)-c1cccc(Cl)c1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H30ClF3N6O4/c1-40-14-16-41(17-15-40)27-7-3-6-25-24(27)12-13-42(28(25)30(44)38-22-10-8-20(9-11-22)32(46)47)31(45)26-19-43(39-29(26)33(35,36)37)23-5-2-4-21(34)18-23/h2-11,18-19,28H,12-17H2,1H3,(H,38,44)(H,46,47)	GQXIFWCUUMUPDH-UHFFFAOYSA-N	335971	4-(2-(1-(3-chlorophenyl)- 3-(trifluoromethyl)-1H- pyrazole-4-carbonyl)-5- (4-methylpiperazin-1- yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 199	Plasma kallikrein		 6000								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335971	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335971&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348955	384988128							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662326	CN1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1)-c1cccc(Cl)c1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H31ClN6O4/c1-36-14-16-37(17-15-36)28-7-3-6-27-26(28)12-13-38(29(27)30(40)35-24-10-8-21(9-11-24)32(42)43)31(41)22-19-34-39(20-22)25-5-2-4-23(33)18-25/h2-11,18-20,29H,12-17H2,1H3,(H,35,40)(H,42,43)	LUIFJTITJHESQD-UHFFFAOYSA-N	335972	4-(2-(1-(3-chlorophenyl)- 1H-pyrazole-4-carbonyl)- 5-(4-methylpiperazin-1- yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 200	Plasma kallikrein		 10.7								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335972	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335972&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348951	384988129							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662327	CN1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C31H30ClN7O4/c1-36-14-16-37(17-15-36)27-7-3-6-25-24(27)12-13-38(28(25)29(40)33-22-10-8-20(9-11-22)31(42)43)30(41)26-19-39(35-34-26)23-5-2-4-21(32)18-23/h2-11,18-19,28H,12-17H2,1H3,(H,33,40)(H,42,43)	XMCZMUIHYCVFKG-UHFFFAOYSA-N	335973	4-(2-(1-(3-chlorophenyl)- 1H-1,2,3-triazole-4- carbonyl)-5-(4- methylpiperazin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 201	Plasma kallikrein		 4.21								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335973	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335973&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348790	384988130							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662328	CN1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H31ClFN5O5/c1-37-14-16-38(17-15-37)26-7-3-4-22-21(26)12-13-39(29(22)30(40)35-20-10-8-19(9-11-20)32(42)43)31(41)27-18-25(36-44-27)23-5-2-6-24(33)28(23)34/h2-11,27,29H,12-18H2,1H3,(H,35,40)(H,42,43)	VBRLSZRSHQMRBW-UHFFFAOYSA-N	335974	4-(2-(3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5- carbonyl)-5-(4- methylpiperazin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 202	Plasma kallikrein		 1.11								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335974	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335974&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348822	384988131							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662329	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3N2CCC(CC2)N2CCCC2)C(=O)C2CC(=NO2)c2cccc(Cl)c2)cc1	InChI=1S/C36H38ClN5O5/c37-25-6-3-5-24(21-25)30-22-32(47-39-30)35(44)42-20-15-28-29(33(42)34(43)38-26-11-9-23(10-12-26)36(45)46)7-4-8-31(28)41-18-13-27(14-19-41)40-16-1-2-17-40/h3-12,21,27,32-33H,1-2,13-20,22H2,(H,38,43)(H,45,46)	OCAQZKQTRAMKPI-UHFFFAOYSA-N	335975	4-(2-(3-(3-chlorophenyl)- 4,5-dihydroisoxazole-5- carbonyl)-5-(4-(pyrrolidin- 1-yl)piperidin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 203::US9738655, Example 204	Plasma kallikrein		 1.29								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335975	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335975&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348830	384988132							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662330	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3N2CCC(CC2)N2CCCC2)C(=O)C2CC(=NO2)c2cccc(Cl)c2)cc1	InChI=1S/C36H38ClN5O5/c37-25-6-3-5-24(21-25)30-22-32(47-39-30)35(44)42-20-15-28-29(33(42)34(43)38-26-11-9-23(10-12-26)36(45)46)7-4-8-31(28)41-18-13-27(14-19-41)40-16-1-2-17-40/h3-12,21,27,32-33H,1-2,13-20,22H2,(H,38,43)(H,45,46)	OCAQZKQTRAMKPI-UHFFFAOYSA-N	335975	4-(2-(3-(3-chlorophenyl)- 4,5-dihydroisoxazole-5- carbonyl)-5-(4-(pyrrolidin- 1-yl)piperidin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 203::US9738655, Example 204	Plasma kallikrein		 11.0								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335975	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335975&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348830	384988132							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662331	CN1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CC(=NO1)c1c(F)ccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H30ClF2N5O5/c1-38-13-15-39(16-14-38)25-4-2-3-21-20(25)11-12-40(29(21)30(41)36-19-7-5-18(6-8-19)32(43)44)31(42)26-17-24(37-45-26)27-23(34)10-9-22(33)28(27)35/h2-10,26,29H,11-17H2,1H3,(H,36,41)(H,43,44)	SMIFYFPYEXCOIX-UHFFFAOYSA-N	335977	4-(2-(3-(3-chloro-2,6- difluorophenyl)-4,5- dihydroisoxazole-5- carbonyl)-5-(4- methylpiperazin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 205	Plasma kallikrein		 0.640								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335977	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335977&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348800	384988133							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662332	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3N2CCC(CC2)N2CCCC2=O)C(=O)c2cn(nn2)-c2cccc(Cl)c2)cc1	InChI=1S/C35H34ClN7O5/c36-23-4-1-5-26(20-23)43-21-29(38-39-43)34(46)42-19-15-27-28(32(42)33(45)37-24-11-9-22(10-12-24)35(47)48)6-2-7-30(27)40-17-13-25(14-18-40)41-16-3-8-31(41)44/h1-2,4-7,9-12,20-21,25,32H,3,8,13-19H2,(H,37,45)(H,47,48)	HMYKACYTEVALQS-UHFFFAOYSA-N	335978	4-(2-(1-(3-chlorophenyl)- 1H-1,2,3-triazole-4- carbonyl)-5-(4-(2- oxopyrrolidin-1-yl) piperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 206	Plasma kallikrein		 68.1								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335978	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335978&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348862	384988134							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662333	OC(=O)c1ccc(NC(=O)[C@H]2N(CCc3c2cccc3N2CCC(CC2)N2CCCC2=O)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C36H35ClFN5O6/c37-27-6-1-5-26(32(27)38)28-20-30(49-40-28)35(46)43-19-15-24-25(33(43)34(45)39-22-11-9-21(10-12-22)36(47)48)4-2-7-29(24)41-17-13-23(14-18-41)42-16-3-8-31(42)44/h1-2,4-7,9-12,23,30,33H,3,8,13-20H2,(H,39,45)(H,47,48)/t30-,33+/m1/s1	BYIDDONUXSZNHZ-NDKRRWIDSA-N	335979	4-((S)-2-((R)-3-(3-chloro- 2-fluorophenyl)-4,5- dihydroisoxazole-5- carbonyl)-5-(4-(2- oxopyrrolidin-1- yl)piperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 207::US9738655, Example 208	Plasma kallikrein		 30.9								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335979	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335979&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348770	384988135							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662334	OC(=O)c1ccc(NC(=O)[C@H]2N(CCc3c2cccc3N2CCC(CC2)N2CCCC2=O)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C36H35ClFN5O6/c37-27-6-1-5-26(32(27)38)28-20-30(49-40-28)35(46)43-19-15-24-25(33(43)34(45)39-22-11-9-21(10-12-22)36(47)48)4-2-7-29(24)41-17-13-23(14-18-41)42-16-3-8-31(42)44/h1-2,4-7,9-12,23,30,33H,3,8,13-20H2,(H,39,45)(H,47,48)/t30-,33+/m1/s1	BYIDDONUXSZNHZ-NDKRRWIDSA-N	335979	4-((S)-2-((R)-3-(3-chloro- 2-fluorophenyl)-4,5- dihydroisoxazole-5- carbonyl)-5-(4-(2- oxopyrrolidin-1- yl)piperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 207::US9738655, Example 208	Plasma kallikrein		 447								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335979	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335979&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348770	384988135							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662335	CN1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnnn1-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C31H29ClFN7O4/c1-37-14-16-38(17-15-37)24-6-2-4-22-21(24)12-13-39(28(22)29(41)35-20-10-8-19(9-11-20)31(43)44)30(42)26-18-34-36-40(26)25-7-3-5-23(32)27(25)33/h2-11,18,28H,12-17H2,1H3,(H,35,41)(H,43,44)	YGAQJTUPCIZKHJ-UHFFFAOYSA-N	335981	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-5-carbonyl)-5-(4- methylpiperazin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 209	Plasma kallikrein		 491								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335981	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335981&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348957	384988136							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662336	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3N2CCC(CC2)N2CCCC2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C35H35ClFN7O4/c36-27-6-4-8-30(31(27)37)44-21-28(39-40-44)34(46)43-20-15-25-26(32(43)33(45)38-23-11-9-22(10-12-23)35(47)48)5-3-7-29(25)42-18-13-24(14-19-42)41-16-1-2-17-41/h3-12,21,24,32H,1-2,13-20H2,(H,38,45)(H,47,48)	SQPALEBBCZQRAK-UHFFFAOYSA-N	335982	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(4- (pyrrolidin-1-yl)piperidin- 1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 210	Plasma kallikrein		 1.34								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335982	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335982&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348842	384988137							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662337	CN1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C31H29ClFN7O4/c1-37-14-16-38(17-15-37)25-6-2-4-22-21(25)12-13-39(28(22)29(41)34-20-10-8-19(9-11-20)31(43)44)30(42)24-18-40(36-35-24)26-7-3-5-23(32)27(26)33/h2-11,18,28H,12-17H2,1H3,(H,34,41)(H,43,44)	POLUXRBRQBKZOB-UHFFFAOYSA-N	335984	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(4- methylpiperazin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 211	Plasma kallikrein		 0.520								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335984	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335984&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348915	384988139							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662338	CN1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1N)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H31ClFN7O4/c1-38-14-16-39(17-15-38)25-6-2-4-22-21(25)12-13-40(28(22)30(42)37-20-10-8-19(9-11-20)32(44)45)31(43)23-18-36-41(29(23)35)26-7-3-5-24(33)27(26)34/h2-11,18,28H,12-17,35H2,1H3,(H,37,42)(H,44,45)	NAHGIMDHYQSLEN-UHFFFAOYSA-N	335985	4-(2-(5-amino-1-(3-chloro- 2-fluorophenyl)-1H- pyrazole-4-carbonyl)-5-(4- methylpiperazin-1- yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 212	Plasma kallikrein		 2.89								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335985	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335985&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348847	384988140							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662339	Nc1c(cnn1-c1cccc(Cl)c1F)C(=O)N1CCc2c(cccc2N2CCC(CC2)N2CCCC2)C1C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C36H37ClFN7O4/c37-28-6-4-8-30(31(28)38)45-33(39)27(21-40-45)35(47)44-20-15-25-26(32(44)34(46)41-23-11-9-22(10-12-23)36(48)49)5-3-7-29(25)43-18-13-24(14-19-43)42-16-1-2-17-42/h3-12,21,24,32H,1-2,13-20,39H2,(H,41,46)(H,48,49)	ZZLZGWMCLXDEAX-UHFFFAOYSA-N	335987	4-(2-(5-amino-1-(3-chloro- 2-fluorophenyl)-1H- pyrazole-4-carbonyl)-5-(4- (pyrrolidin-1- yl)piperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, 3TFA salt::US9738655, Example 213	Plasma kallikrein		 12.2								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335987	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335987&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348876	384988142							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662340	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H30ClFN6O5/c1-45-21-12-15-38(16-13-21)26-6-2-4-23-22(26)14-17-39(29(23)30(41)35-20-10-8-19(9-11-20)32(43)44)31(42)25-18-40(37-36-25)27-7-3-5-24(33)28(27)34/h2-11,18,21,29H,12-17H2,1H3,(H,35,41)(H,43,44)	AVKKDSOYYJOTLE-UHFFFAOYSA-N	335989	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(4- methoxypiperidin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 215	Plasma kallikrein		 20.2								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335989	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335989&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348785	384988144							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662341	CN1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CC(=NO1)c1cccc(Cl)c1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H32ClN5O5/c1-36-14-16-37(17-15-36)27-7-3-6-25-24(27)12-13-38(29(25)30(39)34-23-10-8-20(9-11-23)32(41)42)31(40)28-19-26(35-43-28)21-4-2-5-22(33)18-21/h2-11,18,28-29H,12-17,19H2,1H3,(H,34,39)(H,41,42)	DXPRVTLHVRYGPT-UHFFFAOYSA-N	335990	4-(2-(3-(3-chlorophenyl)- 4,5-dihydroisoxazole-5- carbonyl)-5-(4- methylpiperazin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 216::US9738655, Example 217	Plasma kallikrein		 0.360								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335990	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335990&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348945	384988145							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662342	CN1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CC(=NO1)c1cccc(Cl)c1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H32ClN5O5/c1-36-14-16-37(17-15-36)27-7-3-6-25-24(27)12-13-38(29(25)30(39)34-23-10-8-20(9-11-23)32(41)42)31(40)28-19-26(35-43-28)21-4-2-5-22(33)18-21/h2-11,18,28-29H,12-17,19H2,1H3,(H,34,39)(H,41,42)	DXPRVTLHVRYGPT-UHFFFAOYSA-N	335990	4-(2-(3-(3-chlorophenyl)- 4,5-dihydroisoxazole-5- carbonyl)-5-(4- methylpiperazin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 216::US9738655, Example 217	Plasma kallikrein		 3.12								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335990	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335990&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348945	384988145							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662343	CCOC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3N2CCC(CC2)N2CCCC2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C37H39ClFN7O4/c1-2-50-37(49)24-11-13-25(14-12-24)40-35(47)34-28-7-5-9-31(44-20-15-26(16-21-44)43-18-3-4-19-43)27(28)17-22-45(34)36(48)30-23-46(42-41-30)32-10-6-8-29(38)33(32)39/h5-14,23,26,34H,2-4,15-22H2,1H3,(H,40,47)	OGIRXZYFCSDAHF-UHFFFAOYSA-N	335993	Ethyl 4-(2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(4-(pyrrolidin-1-yl)piperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoate, 2 TFA salt::US9738655, Example 219	Plasma kallikrein		 1.96								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335993	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335993&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601687	384988147							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662344	Cn1cc2C(N(CCc2n1)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C24H19ClFN7O4/c1-31-11-15-17(29-31)9-10-32(21(15)22(34)27-14-7-5-13(6-8-14)24(36)37)23(35)18-12-33(30-28-18)19-4-2-3-16(25)20(19)26/h2-8,11-12,21H,9-10H2,1H3,(H,27,34)(H,36,37)	PNBRHWUSMQXLGG-UHFFFAOYSA-N	335994	4-(5-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-2-methyl-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine-4-carboxamido)benzoic acid::US9738655, Example 220	Plasma kallikrein		 179								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335994	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335994&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601273	384988148							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662345	Cc1nn(C)c2CCN(C(C(=O)Nc3ccc(cc3)C(O)=O)c12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F	InChI=1S/C25H21ClFN7O4/c1-13-20-18(32(2)30-13)10-11-33(22(20)23(35)28-15-8-6-14(7-9-15)25(37)38)24(36)17-12-34(31-29-17)19-5-3-4-16(26)21(19)27/h3-9,12,22H,10-11H2,1-2H3,(H,28,35)(H,37,38)	LNKXXEMOPNVZGM-UHFFFAOYSA-N	335995	4-(5-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-1,3-dimethyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine-4-carboxamido)benzoic acid::US9738655, Example 221	Plasma kallikrein		 9.56								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335995	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335995&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602368	384988149							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662346	Cc1c2C(N(CCc2nn1C)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C25H21ClFN7O4/c1-13-20-17(30-32(13)2)10-11-33(22(20)23(35)28-15-8-6-14(7-9-15)25(37)38)24(36)18-12-34(31-29-18)19-5-3-4-16(26)21(19)27/h3-9,12,22H,10-11H2,1-2H3,(H,28,35)(H,37,38)	LPSATGNYPUSCRA-UHFFFAOYSA-N	335996	4-(5-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-2,3-dimethyl-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine-4-carboxamido)benzoic acid::US9738655, Example 222	Plasma kallikrein		 10.4								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335996	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335996&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602225	384988150							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662347	CC(C)c1nnc2C(N(CCn12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C25H22ClFN8O4/c1-13(2)21-30-31-22-20(23(36)28-15-8-6-14(7-9-15)25(38)39)33(10-11-34(21)22)24(37)17-12-35(32-29-17)18-5-3-4-16(26)19(18)27/h3-9,12-13,20H,10-11H2,1-2H3,(H,28,36)(H,38,39)	UNPXKQNGNGYHMC-UHFFFAOYSA-N	335997	4-(7-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-3-isopropyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine-8-carboxamido)benzoic acid::US9738655, Example 223	Plasma kallikrein		 3508								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335997	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335997&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348885	384988151							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662348	COC(C)(C)C1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C36H37ClFN5O5/c1-36(2,48-3)24-14-17-41(18-15-24)29-8-4-6-27-26(29)16-19-42(32(27)33(44)40-25-12-10-22(11-13-25)35(46)47)34(45)23-20-39-43(21-23)30-9-5-7-28(37)31(30)38/h4-13,20-21,24,32H,14-19H2,1-3H3,(H,40,44)(H,46,47)	KOIPMQRRUHXKHA-UHFFFAOYSA-N	335998	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-pyrazole-4-carbonyl)-5-(4-(2-methoxypropan-2-yl)piperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 224	Plasma kallikrein		 92.0								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335998	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335998&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602371	384988152							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662349	CC(CO)(CO)COC(C)(C)C1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C40H45ClFN5O7/c1-39(2,54-24-40(3,22-48)23-49)27-14-17-45(18-15-27)32-8-4-6-30-29(32)16-19-46(35(30)36(50)44-28-12-10-25(11-13-28)38(52)53)37(51)26-20-43-47(21-26)33-9-5-7-31(41)34(33)42/h4-13,20-21,27,35,48-49H,14-19,22-24H2,1-3H3,(H,44,50)(H,52,53)	LYLYQCQXDDERQN-UHFFFAOYSA-N	336000	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-pyrazole-4-carbonyl)-5-(4-(2-(3-hydroxy-2-(hydroxymethyl)-2-methylpropoxy)propan-2-yl)piperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 225	Plasma kallikrein		 48.8								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336000	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336000&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626341	384988154							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662350	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3N2CCN(CC2)C2COC2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C33H31ClFN7O5/c34-25-4-2-6-28(29(25)35)42-17-26(37-38-42)32(44)41-12-11-23-24(30(41)31(43)36-21-9-7-20(8-10-21)33(45)46)3-1-5-27(23)40-15-13-39(14-16-40)22-18-47-19-22/h1-10,17,22,30H,11-16,18-19H2,(H,36,43)(H,45,46)	OEFZJAZPDZGMHT-UHFFFAOYSA-N	336001	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(4-(oxetan-3-yl)piperazin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 226	Plasma kallikrein		 7.65								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336001	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336001&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602149	384988155							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662351	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3N2CCN(CC(F)(F)F)CC2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C32H28ClF4N7O4/c33-23-4-2-6-26(27(23)34)44-17-24(39-40-44)30(46)43-12-11-21-22(28(43)29(45)38-20-9-7-19(8-10-20)31(47)48)3-1-5-25(21)42-15-13-41(14-16-42)18-32(35,36)37/h1-10,17,28H,11-16,18H2,(H,38,45)(H,47,48)	HLCWXSMXMUHDBM-UHFFFAOYSA-N	336004	4-(2-(1-(3-Chloro-2 fluorophenyl) 1H 1,2,3 triazolo-4-carbonyl) 5 (4(2,2,2 trifluoroethyl)piperazin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 229	Plasma kallikrein		 124								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336004	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336004&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626281	384988158							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662352	OC(=O)c1ccc(NC(=O)[C@H]2N(CCc3c2cccc3N2CCN(CC(F)(F)F)CC2)C(=O)C2=NOC(C2)c2cccc(Cl)c2F)cc1	InChI=1S/C33H30ClF4N5O5/c34-24-5-1-4-23(28(24)35)27-17-25(40-48-27)31(45)43-12-11-21-22(29(43)30(44)39-20-9-7-19(8-10-20)32(46)47)3-2-6-26(21)42-15-13-41(14-16-42)18-33(36,37)38/h1-10,27,29H,11-18H2,(H,39,44)(H,46,47)/t27?,29-/m0/s1	NCKGZOIZIIDSIQ-ACEFPKFPSA-N	336005	4-((S)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(4-(2,2,2-trifluoroethyl)piperazin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 230	Plasma kallikrein		 12.3								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336005	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336005&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			138805702	384988159							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662353	OC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3N2CCN(CC(F)(F)F)CC2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C33H30ClF4N5O5/c34-24-5-1-4-23(28(24)35)25-17-27(48-40-25)31(45)43-12-11-21-22(29(43)30(44)39-20-9-7-19(8-10-20)32(46)47)3-2-6-26(21)42-15-13-41(14-16-42)18-33(36,37)38/h1-10,27,29H,11-18H2,(H,39,44)(H,46,47)/t27-,29-/m1/s1	OFIYZOXNLSDWIA-XRKRLSELSA-N	336006	4-((R)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(4-(2,2,2-trifluoroethyl)piperazin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 231	Plasma kallikrein		 1286								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336006	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336006&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626343	384988160							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662354	COC(=O)c1ccc(NC(=O)[C@H]2N(CCc3c2cccc3N2CCN(CC2)C2COC2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C35H35ClFN5O6/c1-46-35(45)21-8-10-22(11-9-21)38-33(43)32-25-4-3-7-29(41-16-14-40(15-17-41)23-19-47-20-23)24(25)12-13-42(32)34(44)30-18-28(39-48-30)26-5-2-6-27(36)31(26)37/h2-11,23,30,32H,12-20H2,1H3,(H,38,43)/t30-,32+/m1/s1	WYNQUZLUOKMEBB-BHYZAODMSA-N	336007	Methyl 4-((S)-2-((R)-3-(3-chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(4-(oxetan-3-yl)piperazin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoate, 2 TFA salt::US9738655, Example 232	Plasma kallikrein		 29.7								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336007	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336007&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602131	384988161							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662355	COC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3N2CCN(CC2)C2COC2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C35H35ClFN5O6/c1-46-35(45)21-8-10-22(11-9-21)38-33(43)32-25-4-3-7-29(41-16-14-40(15-17-41)23-19-47-20-23)24(25)12-13-42(32)34(44)30-18-28(39-48-30)26-5-2-6-27(36)31(26)37/h2-11,23,30,32H,12-20H2,1H3,(H,38,43)/t30-,32-/m1/s1	WYNQUZLUOKMEBB-XLJNKUFUSA-N	336008	Methyl 4-((R)-2-((R)-3-(3-chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(4-(oxetan-3-yl)piperazin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoate, 2 TFA salt::US9738655, Example 233	Plasma kallikrein		 16.5								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336008	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336008&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626342	384988162							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662356	OC(=O)c1ccc(NC(=O)[C@H]2N(CCc3c2cccc3N2CCC(CC2)C2COC2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C35H34ClFN4O6/c36-27-5-1-4-26(31(27)37)28-17-30(47-39-28)34(43)41-16-13-24-25(32(41)33(42)38-23-9-7-21(8-10-23)35(44)45)3-2-6-29(24)40-14-11-20(12-15-40)22-18-46-19-22/h1-10,20,22,30,32H,11-19H2,(H,38,42)(H,44,45)/t30-,32+/m1/s1	QWULNBLKJBJATC-BHYZAODMSA-N	336009	4-((1S)-2-(3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(4-(oxetan-3-yl)piperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 234	Plasma kallikrein		 26.9								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336009	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336009&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626284	384988163							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662357	COC1CCN(CC1)c1cccc2[C@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccccc1F	InChI=1S/C32H31ClF2N4O4/c1-42-19-12-15-38(16-13-19)27-11-5-6-21-20(27)14-17-39(30(21)31(40)36-25-10-3-2-9-24(25)34)32(41)28-18-26(37-43-28)22-7-4-8-23(33)29(22)35/h2-11,19,28,30H,12-18H2,1H3,(H,36,40)/t28-,30+/m1/s1	FBKZJUBYSKDARQ-DGPALRBDSA-N	336010	(S)-2-((R)-3-(3-chloro- 2-fluorophenyl)-4,5- dihydroisoxazole-5- carbonyl)- N-(2-fluorophenyl)-5- (4-methoxypiperidin- 1-yl)-1,2,3,4- tetrahydroisoquinoline- 1-carboxamide, TFA salt::US9738655, Example 235	Plasma kallikrein		 478								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336010	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336010&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348911	384988164							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662358	COC1CCN(CC1)c1cccc2[C@@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccccc1F	InChI=1S/C32H31ClF2N4O4/c1-42-19-12-15-38(16-13-19)27-11-5-6-21-20(27)14-17-39(30(21)31(40)36-25-10-3-2-9-24(25)34)32(41)28-18-26(37-43-28)22-7-4-8-23(33)29(22)35/h2-11,19,28,30H,12-18H2,1H3,(H,36,40)/t28-,30-/m1/s1	FBKZJUBYSKDARQ-PQHLKRTFSA-N	336011	(R)-2-((R)-3-(3-chloro- 2-fluorophenyl)-4,5- dihydroisoxazole-5- carbonyl)- N-(2-fluorophenyl)-5- (4-methoxypiperidin- 1-yl)-1,2,3,4- tetrahydroisoquinoline- 1-carboxamide, TFA salt::US9738655, Example 236	Plasma kallikrein		 172								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336011	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336011&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348975	384988165							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662359	COC1CCN(CC1)c1cccc2[C@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1cccc(F)c1	InChI=1S/C32H31ClF2N4O4/c1-42-21-11-14-38(15-12-21)27-10-4-7-23-22(27)13-16-39(30(23)31(40)36-20-6-2-5-19(34)17-20)32(41)28-18-26(37-43-28)24-8-3-9-25(33)29(24)35/h2-10,17,21,28,30H,11-16,18H2,1H3,(H,36,40)/t28-,30+/m1/s1	QVDOEOXJZQAZPB-DGPALRBDSA-N	336012	(S)-2-((R)-3-(3-chloro- 2-fluorophenyl)-4,5- dihydroisoxazole-5- carbonyl)- N-(3-fluorophenyl)-5- (4-methoxypiperidin- 1-yl)-1,2,3,4- tetrahydroisoquinoline- 1-carboxamide, TFA salt::US9738655, Example 237	Plasma kallikrein		 130								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336012	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336012&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348869	384988166							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662360	COC1CCN(CC1)c1cccc2[C@@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1cccc(F)c1	InChI=1S/C32H31ClF2N4O4/c1-42-21-11-14-38(15-12-21)27-10-4-7-23-22(27)13-16-39(30(23)31(40)36-20-6-2-5-19(34)17-20)32(41)28-18-26(37-43-28)24-8-3-9-25(33)29(24)35/h2-10,17,21,28,30H,11-16,18H2,1H3,(H,36,40)/t28-,30-/m1/s1	QVDOEOXJZQAZPB-PQHLKRTFSA-N	336013	(R)-2-((R)-3-(3-chloro- 2-fluorophenyl)-4,5- dihydroisoxazole-5- carbonyl)- N-(3-fluorophenyl)-5- (4-methoxypiperidin- 1-yl)-1,2,3,4- tetrahydroisoquinoline- 1-carboxamide, TFA salt::US9738655, Example 238	Plasma kallikrein		 172								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336013	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336013&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348871	384988167							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662361	COC1CCN(CC1)c1cccc2[C@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(F)cc1	InChI=1S/C32H31ClF2N4O4/c1-42-21-12-15-38(16-13-21)27-7-3-4-23-22(27)14-17-39(30(23)31(40)36-20-10-8-19(34)9-11-20)32(41)28-18-26(37-43-28)24-5-2-6-25(33)29(24)35/h2-11,21,28,30H,12-18H2,1H3,(H,36,40)/t28-,30+/m1/s1	XEUVRDLOIIIIHG-DGPALRBDSA-N	336014	(S)-2-((R)-3-(3-chloro- 2-fluorophenyl)-4,5- dihydroisoxazole-5- carbonyl)- N-(4-fluorophenyl)-5- (4-methoxypiperidin- 1-yl)-1,2,3,4- tetrahydroisoquinoline- 1-carboxamide, TFA salt::US9738655, Example 239	Plasma kallikrein		 84.8								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336014	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336014&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348952	384988168							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662362	COC1CCN(CC1)c1cccc2[C@@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(F)cc1	InChI=1S/C32H31ClF2N4O4/c1-42-21-12-15-38(16-13-21)27-7-3-4-23-22(27)14-17-39(30(23)31(40)36-20-10-8-19(34)9-11-20)32(41)28-18-26(37-43-28)24-5-2-6-25(33)29(24)35/h2-11,21,28,30H,12-18H2,1H3,(H,36,40)/t28-,30-/m1/s1	XEUVRDLOIIIIHG-PQHLKRTFSA-N	336015	(R)-2-((R)-3-(3-chloro- 2-fluorophenyl)-4,5- dihydroisoxazole-5- carbonyl)- N-(4-fluorophenyl)-5- (4-methoxypiperidin- 1-yl)-1,2,3,4- tetrahydroisoquinoline- 1-carboxamide, TFA salt::US9738655, Example 240	Plasma kallikrein		 172								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336015	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336015&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348765	384988169							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662363	COC1CCN(CC1)c1cccc2[C@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1cccnc1	InChI=1S/C31H31ClFN5O4/c1-41-20-10-14-37(15-11-20)26-9-3-6-22-21(26)12-16-38(29(22)30(39)35-19-5-4-13-34-18-19)31(40)27-17-25(36-42-27)23-7-2-8-24(32)28(23)33/h2-9,13,18,20,27,29H,10-12,14-17H2,1H3,(H,35,39)/t27-,29+/m1/s1	BKEBYDDMOGLBNQ-PXJZQJOASA-N	336016	(S)-2-((R)-3-(3-chloro- 2-fluorophenyl)-4,5- dihydroisoxazole-5- carbonyl)-5-(4- methoxypiperidin- 1-yl)-N- (pyridin-3-yl)-1,2,3,4- tetrahydroisoquinoline- 1-carboxamide, TFA salt::US9738655, Example 241	Plasma kallikrein		 66.7								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336016	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336016&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348835	384988170							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662364	COC1CCN(CC1)c1cccc2[C@@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1cccnc1	InChI=1S/C31H31ClFN5O4/c1-41-20-10-14-37(15-11-20)26-9-3-6-22-21(26)12-16-38(29(22)30(39)35-19-5-4-13-34-18-19)31(40)27-17-25(36-42-27)23-7-2-8-24(32)28(23)33/h2-9,13,18,20,27,29H,10-12,14-17H2,1H3,(H,35,39)/t27-,29-/m1/s1	BKEBYDDMOGLBNQ-XRKRLSELSA-N	336017	(R)-2-((R)-3-(3-chloro- 2-fluorophenyl)-4,5- dihydroisoxazole-5- carbonyl)-5-(4- methoxypiperidin- 1-yl)-N- (pyridin-3-yl)-1,2,3,4- tetrahydroisoquinoline- 1-carboxamide, TFA salt::US9738655, Example 242	Plasma kallikrein		 1230								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336017	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336017&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348810	384988171							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662365	COC1CCN(CC1)c1cccc2[C@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1F)C(O)=O	InChI=1S/C33H31ClF2N4O6/c1-45-19-10-13-39(14-11-19)27-7-3-4-21-20(27)12-15-40(30(21)31(41)37-25-9-8-18(33(43)44)16-24(25)35)32(42)28-17-26(38-46-28)22-5-2-6-23(34)29(22)36/h2-9,16,19,28,30H,10-15,17H2,1H3,(H,37,41)(H,43,44)/t28-,30+/m1/s1	BRVVKZBEEFTKFV-DGPALRBDSA-N	336018	4-((S)-2-((R)-3-(3- chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5- carbonyl)-5-(4- methoxypiperidin- 1-yl)-1,2,3,4- tetrahydroisoquinoline- 1-carboxamide)-3- fluorobenzoic acid, TFA salt::US9738655, Example 243	Plasma kallikrein		 37.6								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336018	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336018&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121360916	384988172							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662366	COC1CCN(CC1)c1cccc2[C@@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1F)C(O)=O	InChI=1S/C33H31ClF2N4O6/c1-45-19-10-13-39(14-11-19)27-7-3-4-21-20(27)12-15-40(30(21)31(41)37-25-9-8-18(33(43)44)16-24(25)35)32(42)28-17-26(38-46-28)22-5-2-6-23(34)29(22)36/h2-9,16,19,28,30H,10-15,17H2,1H3,(H,37,41)(H,43,44)/t28-,30-/m1/s1	BRVVKZBEEFTKFV-PQHLKRTFSA-N	336019	4-((R)-2-((R)-3-(3- chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5- carbonyl)-5-(4- methoxypiperidin- 1-yl)-1,2,3,4- tetrahydroisoquinoline- 1-carboxamido)-3- fluorobenzoic acid, TFA salt::US9738655, Example 244	Plasma kallikrein		 635								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336019	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336019&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348926	384988173							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662367	Cn1ncnc1-c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C29H22ClFN8O4/c1-37-26(32-15-33-37)20-5-2-4-19-18(20)12-13-38(25(19)27(40)34-17-10-8-16(9-11-17)29(42)43)28(41)22-14-39(36-35-22)23-7-3-6-21(30)24(23)31/h2-11,14-15,25H,12-13H2,1H3,(H,34,40)(H,42,43)	RMAYSVYLVSTKER-UHFFFAOYSA-N	336020	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(1-methyl-1H-1,2,4-triazol-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 245	Plasma kallikrein		 68.2								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336020	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336020&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602031	384988174							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662368	Cn1cnc(c1)-c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C30H23ClFN7O4/c1-37-14-23(33-16-37)20-4-2-5-21-19(20)12-13-38(27(21)28(40)34-18-10-8-17(9-11-18)30(42)43)29(41)24-15-39(36-35-24)25-7-3-6-22(31)26(25)32/h2-11,14-16,27H,12-13H2,1H3,(H,34,40)(H,42,43)	YIYZFYYPRWABJD-UHFFFAOYSA-N	336021	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(1-methyl-1H-imidazol-4-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 246	Plasma kallikrein		 29.7								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336021	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336021&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602346	384988175							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662369	OC(=O)c1ccc(NC(=O)[C@H]2N(CCc3c2cccc3-n2cnnc2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C29H22ClFN6O5/c30-21-5-1-4-20(25(21)31)22-13-24(42-35-22)28(39)37-12-11-18-19(3-2-6-23(18)36-14-32-33-15-36)26(37)27(38)34-17-9-7-16(8-10-17)29(40)41/h1-10,14-15,24,26H,11-13H2,(H,34,38)(H,40,41)/t24-,26+/m1/s1	VZRPGIGGABVQRY-RSXGOPAZSA-N	336022	4-((S)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(4H-1,2,4-triazol-4-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 247	Plasma kallikrein		 9.20								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336022	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336022&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602032	384988176							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662370	OC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-n2cnnc2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C29H22ClFN6O5/c30-21-5-1-4-20(25(21)31)22-13-24(42-35-22)28(39)37-12-11-18-19(3-2-6-23(18)36-14-32-33-15-36)26(37)27(38)34-17-9-7-16(8-10-17)29(40)41/h1-10,14-15,24,26H,11-13H2,(H,34,38)(H,40,41)/t24-,26-/m1/s1	VZRPGIGGABVQRY-AOYPEHQESA-N	336023	4-((R)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(4H-1,2,4-triazol-4-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 248	Plasma kallikrein		 83.2								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336023	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336023&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602179	384988177							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662371	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3-n2cnnc2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C28H20ClFN8O4/c29-20-4-2-6-23(24(20)30)38-13-21(34-35-38)27(40)37-12-11-18-19(3-1-5-22(18)36-14-31-32-15-36)25(37)26(39)33-17-9-7-16(8-10-17)28(41)42/h1-10,13-15,25H,11-12H2,(H,33,39)(H,41,42)	DVVGYZRXNJAFET-UHFFFAOYSA-N	336024	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(4H-1,2,4-triazol-4-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 249	Plasma kallikrein		 20.4								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336024	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336024&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602366	384988178							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662372	Cc1ncn(n1)-c1cccc2[C@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C30H24ClFN6O5/c1-16-33-15-38(35-16)24-7-3-4-20-19(24)12-13-37(27(20)28(39)34-18-10-8-17(9-11-18)30(41)42)29(40)25-14-23(36-43-25)21-5-2-6-22(31)26(21)32/h2-11,15,25,27H,12-14H2,1H3,(H,34,39)(H,41,42)/t25-,27+/m1/s1	DKXUHQBHEBTMRA-VPUSJEBWSA-N	336025	4-((S)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(3-methyl-1H-1,2,4-triazol-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 250	Plasma kallikrein		 6.80								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336025	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336025&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602048	384988179							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662373	Cc1ncn(n1)-c1cccc2[C@@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C30H24ClFN6O5/c1-16-33-15-38(35-16)24-7-3-4-20-19(24)12-13-37(27(20)28(39)34-18-10-8-17(9-11-18)30(41)42)29(40)25-14-23(36-43-25)21-5-2-6-22(31)26(21)32/h2-11,15,25,27H,12-14H2,1H3,(H,34,39)(H,41,42)/t25-,27-/m1/s1	DKXUHQBHEBTMRA-XNMGPUDCSA-N	336026	4-((R)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(3-methyl-1H-1,2,4-triazol-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 251	Plasma kallikrein		 601								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336026	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336026&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602070	384988180							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662374	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H31ClFN5O5/c1-45-23-12-15-38(16-13-23)27-6-2-4-25-24(27)14-17-39(30(25)31(41)37-22-10-8-20(9-11-22)33(43)44)32(42)21-18-36-40(19-21)28-7-3-5-26(34)29(28)35/h2-11,18-19,23,30H,12-17H2,1H3,(H,37,41)(H,43,44)	RWHNCKXIRHTDDM-UHFFFAOYSA-N	336027	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-pyrazole-4- carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 252	Plasma kallikrein		 42.8								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336027	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336027&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348805	384988181							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662375	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1nnn(c1C)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H32ClFN6O5/c1-19-29(37-38-41(19)27-8-4-6-25(34)28(27)35)32(43)40-18-15-23-24(5-3-7-26(23)39-16-13-22(46-2)14-17-39)30(40)31(42)36-21-11-9-20(10-12-21)33(44)45/h3-12,22,30H,13-18H2,1-2H3,(H,36,42)(H,44,45)	DWRSBCWFVOSCSL-UHFFFAOYSA-N	336028	4-(2-(1-(3-chloro-2- fluorophenyl)-5-methyl-1H- 1,2,3-triazole-4-cabonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 253	Plasma kallikrein		 156								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336028	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336028&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348977	384988182							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662376	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1c(F)ccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H29ClF2N6O5/c1-46-20-11-14-39(15-12-20)26-4-2-3-22-21(26)13-16-40(28(22)30(42)36-19-7-5-18(6-8-19)32(44)45)31(43)25-17-41(38-37-25)29-24(34)10-9-23(33)27(29)35/h2-10,17,20,28H,11-16H2,1H3,(H,36,42)(H,44,45)	BSVVTWVVLQCLSV-UHFFFAOYSA-N	336029	4-(2-(1-(3-chloro-2,6- difluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 254	Plasma kallikrein		 26.7								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336029	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336029&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348855	384988183							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662377	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CN(C(=O)C1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H34ClFN4O6/c1-46-23-12-15-38(16-13-23)27-6-2-4-25-24(27)14-17-39(31(25)32(42)37-22-10-8-20(9-11-22)34(44)45)33(43)21-18-29(41)40(19-21)28-7-3-5-26(35)30(28)36/h2-11,21,23,31H,12-19H2,1H3,(H,37,42)(H,44,45)	FVMSTJUBRSUZEY-UHFFFAOYSA-N	336030	4-(2-(1-(3-chloro-2- fluorophenyl)-5-oxopyrrolidine- 3-carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 255::US9738655, Example 260	Plasma kallikrein		 218								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336030	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336030&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348888	384988184							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662378	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CC(=NO1)c1c(F)ccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H31ClF2N4O6/c1-45-20-11-14-39(15-12-20)26-4-2-3-22-21(26)13-16-40(30(22)31(41)37-19-7-5-18(6-8-19)33(43)44)32(42)27-17-25(38-46-27)28-24(35)10-9-23(34)29(28)36/h2-10,20,27,30H,11-17H2,1H3,(H,37,41)(H,43,44)	STEFBFVBPIATQL-UHFFFAOYSA-N	336031	4-(2-(3-(3-chloro-2,6- difluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (4-methoxypiperidin-1-yl)- 1,2,3,4-tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 256::US9738655, Example 257	Plasma kallikrein		 198								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336031	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336031&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348852	384988185							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662379	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CC(=NO1)c1c(F)ccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H31ClF2N4O6/c1-45-20-11-14-39(15-12-20)26-4-2-3-22-21(26)13-16-40(30(22)31(41)37-19-7-5-18(6-8-19)33(43)44)32(42)27-17-25(38-46-27)28-24(35)10-9-23(34)29(28)36/h2-10,20,27,30H,11-17H2,1H3,(H,37,41)(H,43,44)	STEFBFVBPIATQL-UHFFFAOYSA-N	336031	4-(2-(3-(3-chloro-2,6- difluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (4-methoxypiperidin-1-yl)- 1,2,3,4-tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 256::US9738655, Example 257	Plasma kallikrein		 24.0								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336031	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336031&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348852	384988185							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662380	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CCN(C1)c1cccc(Cl)c1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H37ClN4O5/c1-44-27-13-17-37(18-14-27)30-7-3-6-29-28(30)15-19-39(31(29)32(40)36-25-10-8-22(9-11-25)34(42)43)33(41)23-12-16-38(21-23)26-5-2-4-24(35)20-26/h2-11,20,23,27,31H,12-19,21H2,1H3,(H,36,40)(H,42,43)	SDSUGQWNKGNWPZ-UHFFFAOYSA-N	336033	4-(2-(1-(3-chlorophenyl) pyrrolidine-3-carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 258::US9738655, Example 261	Plasma kallikrein		 1624								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336033	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336033&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348789	384988186							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662381	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1C)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H33ClFN5O5/c1-20-26(19-37-41(20)29-8-4-6-27(35)30(29)36)33(43)40-18-15-24-25(5-3-7-28(24)39-16-13-23(46-2)14-17-39)31(40)32(42)38-22-11-9-21(10-12-22)34(44)45/h3-12,19,23,31H,13-18H2,1-2H3,(H,38,42)(H,44,45)	UCDVYJZKTAJIGN-UHFFFAOYSA-N	336034	4-(2-(1-(3-chloro-2- fluorophenyl)-5-methyl-1H- pyrazole-4-carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 259	Plasma kallikrein		 77.9								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336034	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336034&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348864	384988187							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662382	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CN(C(=O)C1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H34ClFN4O6/c1-46-23-12-15-38(16-13-23)27-6-2-4-25-24(27)14-17-39(31(25)32(42)37-22-10-8-20(9-11-22)34(44)45)33(43)21-18-29(41)40(19-21)28-7-3-5-26(35)30(28)36/h2-11,21,23,31H,12-19H2,1H3,(H,37,42)(H,44,45)	FVMSTJUBRSUZEY-UHFFFAOYSA-N	336030	4-(2-(1-(3-chloro-2- fluorophenyl)-5-oxopyrrolidine- 3-carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 255::US9738655, Example 260	Plasma kallikrein		 4750								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336030	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336030&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348888	384988184							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662383	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CCN(C1)c1cccc(Cl)c1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H37ClN4O5/c1-44-27-13-17-37(18-14-27)30-7-3-6-29-28(30)15-19-39(31(29)32(40)36-25-10-8-22(9-11-25)34(42)43)33(41)23-12-16-38(21-23)26-5-2-4-24(35)20-26/h2-11,20,23,27,31H,12-19,21H2,1H3,(H,36,40)(H,42,43)	SDSUGQWNKGNWPZ-UHFFFAOYSA-N	336033	4-(2-(1-(3-chlorophenyl) pyrrolidine-3-carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 258::US9738655, Example 261	Plasma kallikrein		 891								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336033	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336033&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348789	384988186							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662384	CC(C)(O)C1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C35H36ClFN4O6/c1-35(2,46)21-13-16-40(17-14-21)28-8-4-5-24-23(28)15-18-41(31(24)32(42)38-22-11-9-20(10-12-22)34(44)45)33(43)29-19-27(39-47-29)25-6-3-7-26(36)30(25)37/h3-12,21,29,31,46H,13-19H2,1-2H3,(H,38,42)(H,44,45)	CBUOZCLOWILCLC-UHFFFAOYSA-N	336040	4-(2-(3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (4-(2-hydroxypropan-2- yl)piperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 262::US9738655, Example 263	Plasma kallikrein		 4.36								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336040	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336040&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348803	384988191							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662385	CC(C)(O)C1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C35H36ClFN4O6/c1-35(2,46)21-13-16-40(17-14-21)28-8-4-5-24-23(28)15-18-41(31(24)32(42)38-22-11-9-20(10-12-22)34(44)45)33(43)29-19-27(39-47-29)25-6-3-7-26(36)30(25)37/h3-12,21,29,31,46H,13-19H2,1-2H3,(H,38,42)(H,44,45)	CBUOZCLOWILCLC-UHFFFAOYSA-N	336040	4-(2-(3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (4-(2-hydroxypropan-2- yl)piperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 262::US9738655, Example 263	Plasma kallikrein		 68.1								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336040	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336040&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348803	384988191							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662386	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(nc1O)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H31ClFN5O6/c1-46-21-12-15-38(16-13-21)26-6-2-4-23-22(26)14-17-39(29(23)31(42)36-20-10-8-19(9-11-20)33(44)45)32(43)24-18-40(37-30(24)41)27-7-3-5-25(34)28(27)35/h2-11,18,21,29H,12-17H2,1H3,(H,36,42)(H,37,41)(H,44,45)	JHRMBOAVPWDUPH-UHFFFAOYSA-N	336042	4-(2-(1-(3-chloro-2- fluorophenyl)-3-hydroxy-1H- pyrazole-4-carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 264	Plasma kallikrein		 11.1								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336042	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336042&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348797	384988192							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662387	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cc(no1)-c1c(F)ccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H29ClF2N4O6/c1-45-20-11-14-39(15-12-20)26-4-2-3-22-21(26)13-16-40(30(22)31(41)37-19-7-5-18(6-8-19)33(43)44)32(42)27-17-25(38-46-27)28-24(35)10-9-23(34)29(28)36/h2-10,17,20,30H,11-16H2,1H3,(H,37,41)(H,43,44)	DPNLDCMWYAQGGL-UHFFFAOYSA-N	336043	4-(2-(3-(3-chloro-2,6- difluorophenyl)isoxazole-5- carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 265	Plasma kallikrein		 178								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336043	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336043&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348968	384988193							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662388	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1(C)CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H34ClFN4O6/c1-34(19-27(38-46-34)25-6-3-7-26(35)29(25)36)33(44)40-18-15-23-24(5-4-8-28(23)39-16-13-22(45-2)14-17-39)30(40)31(41)37-21-11-9-20(10-12-21)32(42)43/h3-12,22,30H,13-19H2,1-2H3,(H,37,41)(H,42,43)	FQAXKURWFFUWDN-UHFFFAOYSA-N	336044	4-(2-(3-(3-chloro-2- fluorophenyl)-5-methyl-4,5- dihydroisoxazole-5-carbonyl)-5- (4-methoxypiperidin-1-yl)- 1,2,3,4-tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 266::US9738655, Example 267	Plasma kallikrein		 687								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336044	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336044&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348791	384988194							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662389	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1(C)CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H34ClFN4O6/c1-34(19-27(38-46-34)25-6-3-7-26(35)29(25)36)33(44)40-18-15-23-24(5-4-8-28(23)39-16-13-22(45-2)14-17-39)30(40)31(41)37-21-11-9-20(10-12-21)32(42)43/h3-12,22,30H,13-19H2,1-2H3,(H,37,41)(H,42,43)	FQAXKURWFFUWDN-UHFFFAOYSA-N	336044	4-(2-(3-(3-chloro-2- fluorophenyl)-5-methyl-4,5- dihydroisoxazole-5-carbonyl)-5- (4-methoxypiperidin-1-yl)- 1,2,3,4-tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 266::US9738655, Example 267	Plasma kallikrein		 354								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336044	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336044&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348791	384988194							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662390	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cc(no1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H30ClFN4O6/c1-44-21-12-15-38(16-13-21)27-7-3-4-23-22(27)14-17-39(30(23)31(40)36-20-10-8-19(9-11-20)33(42)43)32(41)28-18-26(37-45-28)24-5-2-6-25(34)29(24)35/h2-11,18,21,30H,12-17H2,1H3,(H,36,40)(H,42,43)	FYOLOKHABDOZTA-UHFFFAOYSA-N	336046	4-(2-(3-(3-chloro-2- fluorophenyl)isoxazole-5- carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 268	Plasma kallikrein		 178								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336046	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336046&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348848	384988195							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662391	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cc(ns1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H30ClFN4O5S/c1-44-21-12-15-38(16-13-21)27-7-3-4-23-22(27)14-17-39(30(23)31(40)36-20-10-8-19(9-11-20)33(42)43)32(41)28-18-26(37-45-28)24-5-2-6-25(34)29(24)35/h2-11,18,21,30H,12-17H2,1H3,(H,36,40)(H,42,43)	ZBMLIFNYLFHWTC-UHFFFAOYSA-N	336047	4-(2-(3-(3-chloro-2- fluorophenyl)isothiazole-5- carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 269	Plasma kallikrein		 205								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336047	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336047&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348829	384988196							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662392	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnc(s1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H30ClFN4O5S/c1-44-21-12-15-38(16-13-21)26-7-3-4-23-22(26)14-17-39(29(23)30(40)37-20-10-8-19(9-11-20)33(42)43)32(41)27-18-36-31(45-27)24-5-2-6-25(34)28(24)35/h2-11,18,21,29H,12-17H2,1H3,(H,37,40)(H,42,43)	VPZJMGJFKCWLAF-UHFFFAOYSA-N	336048	4-(2-(2-(3-chloro-2- fluorophenyl)thiazole-5- carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 270	Plasma kallikrein		 269								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336048	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336048&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348782	384988197							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662393	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(cn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H31ClFN5O5/c1-45-22-12-15-38(16-13-22)27-6-2-4-24-23(27)14-17-40(30(24)31(41)37-21-10-8-20(9-11-21)33(43)44)32(42)26-18-39(19-36-26)28-7-3-5-25(34)29(28)35/h2-11,18-19,22,30H,12-17H2,1H3,(H,37,41)(H,43,44)	FBWNGNXFIOJJRU-UHFFFAOYSA-N	336049	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-imidazole-4- carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 271	Plasma kallikrein		 7.65								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336049	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336049&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348773	384988198							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662394	COC1CCN(CC1)c1cccc2[C@@H](N(CCc12)C(=O)c1cn(cn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H31ClFN5O5/c1-45-22-12-15-38(16-13-22)27-6-2-4-24-23(27)14-17-40(30(24)31(41)37-21-10-8-20(9-11-21)33(43)44)32(42)26-18-39(19-36-26)28-7-3-5-25(34)29(28)35/h2-11,18-19,22,30H,12-17H2,1H3,(H,37,41)(H,43,44)/t30-/m1/s1	FBWNGNXFIOJJRU-SSEXGKCCSA-N	336050	(R)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-imidazole-4- carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 272	Plasma kallikrein		 6000								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336050	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336050&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348867	384988199							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662395	COC1CCN(CC1)c1cccc2[C@H](N(CCc12)C(=O)c1cn(cn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H31ClFN5O5/c1-45-22-12-15-38(16-13-22)27-6-2-4-24-23(27)14-17-40(30(24)31(41)37-21-10-8-20(9-11-21)33(43)44)32(42)26-18-39(19-36-26)28-7-3-5-25(34)29(28)35/h2-11,18-19,22,30H,12-17H2,1H3,(H,37,41)(H,43,44)/t30-/m0/s1	FBWNGNXFIOJJRU-PMERELPUSA-N	336051	(S)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-imidazole-4- carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamide)benzoic acid, TFA salt::US9738655, Example 273	Plasma kallikrein		 7.65								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336051	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336051&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121360909	384988200							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662396	CN1CCN(CC1=O)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C31H27ClFN7O5/c1-37-14-15-38(17-26(37)41)24-6-2-4-21-20(24)12-13-39(28(21)29(42)34-19-10-8-18(9-11-19)31(44)45)30(43)23-16-40(36-35-23)25-7-3-5-22(32)27(25)33/h2-11,16,28H,12-15,17H2,1H3,(H,34,42)(H,44,45)	ZHBIFHSCHDUCTJ-UHFFFAOYSA-N	336052	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3-triazole- 4-carbonyl)-5-(4-methyl-3- oxopiperazin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 274	Plasma kallikrein		 4.87								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336052	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336052&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348843	384988201							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662397	COc1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C27H21ClFN5O5/c1-39-22-7-2-4-18-17(22)12-13-33(24(18)25(35)30-16-10-8-15(9-11-16)27(37)38)26(36)20-14-34(32-31-20)21-6-3-5-19(28)23(21)29/h2-11,14,24H,12-13H2,1H3,(H,30,35)(H,37,38)	LBKUAODILILVMN-UHFFFAOYSA-N	336053	4-(2-(1-(3-chloro-2- fluoroplienyl)-1H-1,2,3-triazole- 4-carbonyl)-5-methoxy-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 275	Plasma kallikrein		 11.8								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336053	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336053&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121360851	384988202							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662398	CN(C)C(=O)C1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C35H35ClFN5O6/c1-40(2)33(44)20-13-16-41(17-14-20)28-8-4-5-24-23(28)15-18-42(31(24)32(43)38-22-11-9-21(10-12-22)35(46)47)34(45)29-19-27(39-48-29)25-6-3-7-26(36)30(25)37/h3-12,20,29,31H,13-19H2,1-2H3,(H,38,43)(H,46,47)	KSKNDDJIIWDYJR-UHFFFAOYSA-N	336054	4-(2-(3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (4-(dimethylcarbamoyl) piperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 278::US9738655, Example 279	Plasma kallikrein		 1.98								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336054	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336054&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348906	384988203							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662399	CN(C)C(=O)C1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C35H35ClFN5O6/c1-40(2)33(44)20-13-16-41(17-14-20)28-8-4-5-24-23(28)15-18-42(31(24)32(43)38-22-11-9-21(10-12-22)35(46)47)34(45)29-19-27(39-48-29)25-6-3-7-26(36)30(25)37/h3-12,20,29,31H,13-19H2,1-2H3,(H,38,43)(H,46,47)	KSKNDDJIIWDYJR-UHFFFAOYSA-N	336054	4-(2-(3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (4-(dimethylcarbamoyl) piperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 278::US9738655, Example 279	Plasma kallikrein		 30.8								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336054	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336054&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348906	384988203							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662400	CN1CCN(CC1=O)c1cccc2C(N(CCc12)C(=O)C1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H29ClFN5O6/c1-37-14-15-38(17-27(37)40)25-7-3-4-21-20(25)12-13-39(29(21)30(41)35-19-10-8-18(9-11-19)32(43)44)31(42)26-16-24(36-45-26)22-5-2-6-23(33)28(22)34/h2-11,26,29H,12-17H2,1H3,(H,35,41)(H,43,44)	SRDPHAPHNIXEMB-UHFFFAOYSA-N	336056	4-(2-(3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (4-methyl-3-oxopiperazin-1-yl)- 1,2,3,4-tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 280::US9738655, Example 281::US9738655, Example 282::US9738655, Example 283	Plasma kallikrein		 283								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336056	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336056&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348900	384988204							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662401	CN1CCN(CC1=O)c1cccc2C(N(CCc12)C(=O)C1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H29ClFN5O6/c1-37-14-15-38(17-27(37)40)25-7-3-4-21-20(25)12-13-39(29(21)30(41)35-19-10-8-18(9-11-19)32(43)44)31(42)26-16-24(36-45-26)22-5-2-6-23(33)28(22)34/h2-11,26,29H,12-17H2,1H3,(H,35,41)(H,43,44)	SRDPHAPHNIXEMB-UHFFFAOYSA-N	336056	4-(2-(3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (4-methyl-3-oxopiperazin-1-yl)- 1,2,3,4-tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 280::US9738655, Example 281::US9738655, Example 282::US9738655, Example 283	Plasma kallikrein		 79.0								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336056	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336056&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348900	384988204							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662402	CN1CCN(CC1=O)c1cccc2C(N(CCc12)C(=O)C1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H29ClFN5O6/c1-37-14-15-38(17-27(37)40)25-7-3-4-21-20(25)12-13-39(29(21)30(41)35-19-10-8-18(9-11-19)32(43)44)31(42)26-16-24(36-45-26)22-5-2-6-23(33)28(22)34/h2-11,26,29H,12-17H2,1H3,(H,35,41)(H,43,44)	SRDPHAPHNIXEMB-UHFFFAOYSA-N	336056	4-(2-(3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (4-methyl-3-oxopiperazin-1-yl)- 1,2,3,4-tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 280::US9738655, Example 281::US9738655, Example 282::US9738655, Example 283	Plasma kallikrein		 1.87								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336056	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336056&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348900	384988204							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662403	CN1CCN(CC1=O)c1cccc2C(N(CCc12)C(=O)C1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H29ClFN5O6/c1-37-14-15-38(17-27(37)40)25-7-3-4-21-20(25)12-13-39(29(21)30(41)35-19-10-8-18(9-11-19)32(43)44)31(42)26-16-24(36-45-26)22-5-2-6-23(33)28(22)34/h2-11,26,29H,12-17H2,1H3,(H,35,41)(H,43,44)	SRDPHAPHNIXEMB-UHFFFAOYSA-N	336056	4-(2-(3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (4-methyl-3-oxopiperazin-1-yl)- 1,2,3,4-tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 280::US9738655, Example 281::US9738655, Example 282::US9738655, Example 283	Plasma kallikrein		 75.3								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336056	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336056&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348900	384988204							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662404	CN1CCN(CC1=O)c1cccc2C(N(CCc12)C(=O)c1cn(cn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H28ClFN6O5/c1-37-14-15-38(17-27(37)41)25-6-2-4-22-21(25)12-13-40(29(22)30(42)36-20-10-8-19(9-11-20)32(44)45)31(43)24-16-39(18-35-24)26-7-3-5-23(33)28(26)34/h2-11,16,18,29H,12-15,17H2,1H3,(H,36,42)(H,44,45)	HZAQQZFPWMLEIS-UHFFFAOYSA-N	336061	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-imidazole-4- carbonyl)-5-(4-methyl-3- oxopiperazin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 284	Plasma kallikrein		 6.25								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336061	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336061&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348764	384988206							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662405	COC1CCN(CC1)c1cccc2[C@H](N(CCc12)C(=O)c1cnn(c1N)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H32ClFN6O5/c1-46-21-12-15-39(16-13-21)26-6-2-4-23-22(26)14-17-40(29(23)31(42)38-20-10-8-19(9-11-20)33(44)45)32(43)24-18-37-41(30(24)36)27-7-3-5-25(34)28(27)35/h2-11,18,21,29H,12-17,36H2,1H3,(H,38,42)(H,44,45)/t29-/m0/s1	OERFGGVKNYUNRK-LJAQVGFWSA-N	336062	(S)-4-(2-(5-amino-1-(3-chloro-2- fluorophenyl)-1H-pyrazole-4- carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 285	Plasma kallikrein		 19.8								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336062	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336062&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348858	384988207							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662406	COC1CCN(CC1)c1cccc2[C@@H](N(CCc12)C(=O)c1cnn(c1N)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H32ClFN6O5/c1-46-21-12-15-39(16-13-21)26-6-2-4-23-22(26)14-17-40(29(23)31(42)38-20-10-8-19(9-11-20)33(44)45)32(43)24-18-37-41(30(24)36)27-7-3-5-25(34)28(27)35/h2-11,18,21,29H,12-17,36H2,1H3,(H,38,42)(H,44,45)/t29-/m1/s1	OERFGGVKNYUNRK-GDLZYMKVSA-N	336063	(R)-4-(2-(5-amino-1-(3-chloro-2- fluorophenyl)-1H-pyrazole-4- carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 286	Plasma kallikrein		 3286								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336063	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336063&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348884	384988208							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662407	CN1CCN(CC1=O)c1cccc2[C@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C31H27ClFN7O5/c1-37-14-15-38(17-26(37)41)24-6-2-4-21-20(24)12-13-39(28(21)29(42)34-19-10-8-18(9-11-19)31(44)45)30(43)23-16-40(36-35-23)25-7-3-5-22(32)27(25)33/h2-11,16,28H,12-15,17H2,1H3,(H,34,42)(H,44,45)/t28-/m0/s1	ZHBIFHSCHDUCTJ-NDEPHWFRSA-N	336064	(S)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3-triazole- 4-carbonyl)-5-(4-methyl-3- oxopiperizin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 287	Plasma kallikrein		 1.82								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336064	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336064&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121360859	384988209							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662408	CN1CCN(CC1=O)c1cccc2[C@@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C31H27ClFN7O5/c1-37-14-15-38(17-26(37)41)24-6-2-4-21-20(24)12-13-39(28(21)29(42)34-19-10-8-18(9-11-19)31(44)45)30(43)23-16-40(36-35-23)25-7-3-5-22(32)27(25)33/h2-11,16,28H,12-15,17H2,1H3,(H,34,42)(H,44,45)/t28-/m1/s1	ZHBIFHSCHDUCTJ-MUUNZHRXSA-N	336065	(R)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3-triazole- 4-carbonyl)-5-(4-methyl-3- oxopiperazin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 288	Plasma kallikrein		 824								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336065	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336065&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348969	384988210							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662409	OC(=O)c1ccc(NC(=O)[C@H]2N(CCc3c2cccc3N2CCOCC2=O)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C31H26ClFN4O7/c32-22-5-1-4-21(27(22)33)23-15-25(44-35-23)30(40)37-12-11-19-20(3-2-6-24(19)36-13-14-43-16-26(36)38)28(37)29(39)34-18-9-7-17(8-10-18)31(41)42/h1-10,25,28H,11-16H2,(H,34,39)(H,41,42)/t25-,28+/m1/s1	HUJNCDQHFCQWPY-NAKRPHOHSA-N	336066	4-((S)-2-((R)-3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (3-oxomorpholino)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,::US9738655, Example 289	Plasma kallikrein		 2.63								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336066	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336066&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348866	384988211							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662410	OC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3N2CCOCC2=O)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C31H26ClFN4O7/c32-22-5-1-4-21(27(22)33)23-15-25(44-35-23)30(40)37-12-11-19-20(3-2-6-24(19)36-13-14-43-16-26(36)38)28(37)29(39)34-18-9-7-17(8-10-18)31(41)42/h1-10,25,28H,11-16H2,(H,34,39)(H,41,42)/t25-,28-/m1/s1	HUJNCDQHFCQWPY-LEAFIULHSA-N	336067	4-((S)-2-((R)-3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (3-oxomorpholino)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 290	Plasma kallikrein		 101								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336067	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336067&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121360801	384988212							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662411	OC(=O)c1ccc(NC(=O)[C@H]2N(CCc3c2cccc3N2CCCCC2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C32H30ClFN4O5/c33-24-8-4-7-23(28(24)34)25-18-27(43-36-25)31(40)38-17-14-21-22(6-5-9-26(21)37-15-2-1-3-16-37)29(38)30(39)35-20-12-10-19(11-13-20)32(41)42/h4-13,27,29H,1-3,14-18H2,(H,35,39)(H,41,42)/t27-,29+/m1/s1	DZKVUSJHEHTSJV-PXJZQJOASA-N	336068	4-((S)-2-((R)-3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (piperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 291	Plasma kallikrein		 15.2								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336068	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336068&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348895	384988213							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662412	OC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3N2CCCCC2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C32H30ClFN4O5/c33-24-8-4-7-23(28(24)34)25-18-27(43-36-25)31(40)38-17-14-21-22(6-5-9-26(21)37-15-2-1-3-16-37)29(38)30(39)35-20-12-10-19(11-13-20)32(41)42/h4-13,27,29H,1-3,14-18H2,(H,35,39)(H,41,42)/t27-,29-/m1/s1	DZKVUSJHEHTSJV-XRKRLSELSA-N	336069	4-((R)-2-((R)-3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (piperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamide)benzoic acid, TFA salt::US9738655, Example 292	Plasma kallikrein		 758								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336069	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336069&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121360773	384988214							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662413	COc1cccc2[C@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C28H23ClFN3O6/c1-38-22-7-3-4-18-17(22)12-13-33(25(18)26(34)31-16-10-8-15(9-11-16)28(36)37)27(35)23-14-21(32-39-23)19-5-2-6-20(29)24(19)30/h2-11,23,25H,12-14H2,1H3,(H,31,34)(H,36,37)/t23-,25+/m1/s1	JMRJXBGKNVHKIB-NOZRDPDXSA-N	336070	4-((S)-2-((R)-3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- methoxy-1,2,3,4- tetrahydroisoquinoline-1- carboxamide)benzoic acid::US9738655, Example 293	Plasma kallikrein		 3.24								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336070	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336070&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121360914	384988215							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662414	COc1cccc2[C@@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C28H23ClFN3O6/c1-38-22-7-3-4-18-17(22)12-13-33(25(18)26(34)31-16-10-8-15(9-11-16)28(36)37)27(35)23-14-21(32-39-23)19-5-2-6-20(29)24(19)30/h2-11,23,25H,12-14H2,1H3,(H,31,34)(H,36,37)/t23-,25-/m1/s1	JMRJXBGKNVHKIB-ILBGXUMGSA-N	336071	4-((R)-2-((R)-3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- methoxy-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 294	Plasma kallikrein		 111								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336071	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336071&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348787	384988216							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662415	OC(=O)c1ccc(NC(=O)[C@H]2N(CCc3c2cccc3N2CCOCC2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C31H28ClFN4O6/c32-23-5-1-4-22(27(23)33)24-17-26(43-35-24)30(39)37-12-11-20-21(3-2-6-25(20)36-13-15-42-16-14-36)28(37)29(38)34-19-9-7-18(8-10-19)31(40)41/h1-10,26,28H,11-17H2,(H,34,38)(H,40,41)/t26-,28+/m1/s1	OUHGEEOLVXEYAO-IAPPQJPRSA-N	336072	4-((S)-2-((R)-3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- morpholino-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 295	Plasma kallikrein		 2.44								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336072	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336072&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348932	384988217							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662416	OC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3N2CCOCC2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C31H28ClFN4O6/c32-23-5-1-4-22(27(23)33)24-17-26(43-35-24)30(39)37-12-11-20-21(3-2-6-25(20)36-13-15-42-16-14-36)28(37)29(38)34-19-9-7-18(8-10-19)31(40)41/h1-10,26,28H,11-17H2,(H,34,38)(H,40,41)/t26-,28-/m1/s1	OUHGEEOLVXEYAO-IXCJQBJRSA-N	336073	4-((S)-2-((R)-3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- morpholino-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 296	Plasma kallikrein		 186								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336073	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336073&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121360852	384988218							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662417	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CC(=NO1)c1c(F)c(Cl)ccc1C(F)(F)F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H31ClF4N4O6/c1-48-20-11-14-42(15-12-20)26-4-2-3-22-21(26)13-16-43(30(22)31(44)40-19-7-5-18(6-8-19)33(46)47)32(45)27-17-25(41-49-27)28-23(34(37,38)39)9-10-24(35)29(28)36/h2-10,20,27,30H,11-17H2,1H3,(H,40,44)(H,46,47)	YCGVFCIHVNNBFQ-UHFFFAOYSA-N	336074	4-(2-(3-(3-chloro-2-fluoro-6- (trifluoromethyl)phenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (4-methoxypiperidin-1-yl)- 1,2,3,4-tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 297::US9738655, Example 298	Plasma kallikrein		 1281								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336074	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336074&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348831	384988219							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662418	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CC(=NO1)c1c(F)c(Cl)ccc1C(F)(F)F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H31ClF4N4O6/c1-48-20-11-14-42(15-12-20)26-4-2-3-22-21(26)13-16-43(30(22)31(44)40-19-7-5-18(6-8-19)33(46)47)32(45)27-17-25(41-49-27)28-23(34(37,38)39)9-10-24(35)29(28)36/h2-10,20,27,30H,11-17H2,1H3,(H,40,44)(H,46,47)	YCGVFCIHVNNBFQ-UHFFFAOYSA-N	336074	4-(2-(3-(3-chloro-2-fluoro-6- (trifluoromethyl)phenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (4-methoxypiperidin-1-yl)- 1,2,3,4-tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 297::US9738655, Example 298	Plasma kallikrein		 1010								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336074	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336074&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348831	384988219							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662419	CO[C@@H]1CCN(C1)c1cccc2[C@@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H30ClFN4O6/c1-43-20-12-14-37(17-20)26-7-3-4-22-21(26)13-15-38(29(22)30(39)35-19-10-8-18(9-11-19)32(41)42)31(40)27-16-25(36-44-27)23-5-2-6-24(33)28(23)34/h2-11,20,27,29H,12-17H2,1H3,(H,35,39)(H,41,42)/t20-,27-,29-/m1/s1	HRMKSRKSQRTIIL-VXLYDYDQSA-N	336076	4-((R)-2-((R)-3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- ((R)-3-methoxypyrrolidin-1-yl)- 1,2,3,4-tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 299	Plasma kallikrein		 316								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336076	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336076&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348839	384988220							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662420	CO[C@@H]1CCN(C1)c1cccc2[C@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H30ClFN4O6/c1-43-20-12-14-37(17-20)26-7-3-4-22-21(26)13-15-38(29(22)30(39)35-19-10-8-18(9-11-19)32(41)42)31(40)27-16-25(36-44-27)23-5-2-6-24(33)28(23)34/h2-11,20,27,29H,12-17H2,1H3,(H,35,39)(H,41,42)/t20-,27-,29+/m1/s1	HRMKSRKSQRTIIL-LEFTWQHSSA-N	336077	4-((S)-2-((R)-3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- ((R)-3-methoxypyrrolidin-1-yl)- 1,2,3,4-tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 300	Plasma kallikrein		 4.15								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336077	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336077&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348794	384988221							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662421	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H32ClFN4O6/c1-44-21-12-15-38(16-13-21)27-7-3-4-23-22(27)14-17-39(30(23)31(40)36-20-10-8-19(9-11-20)33(42)43)32(41)28-18-26(37-45-28)24-5-2-6-25(34)29(24)35/h2-11,21,28,30H,12-18H2,1H3,(H,36,40)(H,42,43)	BLFBDNXENKDPOA-UHFFFAOYSA-N	336080	4-(2-(3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (4-methoxypiperidin-1-yl)- 1,2,3,4-tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 303::US9738655, Example 304::US9738655, Example 305	Plasma kallikrein		 1963								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336080	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336080&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348793	384988224							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662422	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H32ClFN4O6/c1-44-21-12-15-38(16-13-21)27-7-3-4-23-22(27)14-17-39(30(23)31(40)36-20-10-8-19(9-11-20)33(42)43)32(41)28-18-26(37-45-28)24-5-2-6-25(34)29(24)35/h2-11,21,28,30H,12-18H2,1H3,(H,36,40)(H,42,43)	BLFBDNXENKDPOA-UHFFFAOYSA-N	336080	4-(2-(3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (4-methoxypiperidin-1-yl)- 1,2,3,4-tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 303::US9738655, Example 304::US9738655, Example 305	Plasma kallikrein		 232								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336080	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336080&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348793	384988224							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662423	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H32ClFN4O6/c1-44-21-12-15-38(16-13-21)27-7-3-4-23-22(27)14-17-39(30(23)31(40)36-20-10-8-19(9-11-20)33(42)43)32(41)28-18-26(37-45-28)24-5-2-6-25(34)29(24)35/h2-11,21,28,30H,12-18H2,1H3,(H,36,40)(H,42,43)	BLFBDNXENKDPOA-UHFFFAOYSA-N	336080	4-(2-(3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (4-methoxypiperidin-1-yl)- 1,2,3,4-tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 303::US9738655, Example 304::US9738655, Example 305	Plasma kallikrein		 31.7								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336080	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336080&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348793	384988224							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662424	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CCN(C1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H36ClFN4O5/c1-45-24-13-17-38(18-14-24)28-6-2-4-26-25(28)15-19-40(31(26)32(41)37-23-10-8-21(9-11-23)34(43)44)33(42)22-12-16-39(20-22)29-7-3-5-27(35)30(29)36/h2-11,22,24,31H,12-20H2,1H3,(H,37,41)(H,43,44)	XXEHXWAALBKPOQ-UHFFFAOYSA-N	336083	4-(2-(1-(3-Chloro-2-fluorophenyl)pyrrolidine-3-carbonyl) 5-(4-methoxypiperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 307::US9738655, Example 308	Plasma kallikrein		 593								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336083	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336083&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601967	384988225							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662425	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CCN(C1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H36ClFN4O5/c1-45-24-13-17-38(18-14-24)28-6-2-4-26-25(28)15-19-40(31(26)32(41)37-23-10-8-21(9-11-23)34(43)44)33(42)22-12-16-39(20-22)29-7-3-5-27(35)30(29)36/h2-11,22,24,31H,12-20H2,1H3,(H,37,41)(H,43,44)	XXEHXWAALBKPOQ-UHFFFAOYSA-N	336083	4-(2-(1-(3-Chloro-2-fluorophenyl)pyrrolidine-3-carbonyl) 5-(4-methoxypiperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 307::US9738655, Example 308	Plasma kallikrein		 79.7								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336083	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336083&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601967	384988225							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662426	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1N)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H32ClFN6O5/c1-46-21-12-15-39(16-13-21)26-6-2-4-23-22(26)14-17-40(29(23)31(42)38-20-10-8-19(9-11-20)33(44)45)32(43)24-18-37-41(30(24)36)27-7-3-5-25(34)28(27)35/h2-11,18,21,29H,12-17,36H2,1H3,(H,38,42)(H,44,45)	OERFGGVKNYUNRK-UHFFFAOYSA-N	336085	4-(2-(5-amino-1-(3-chloro-2- fluorophenyl)-1H-pyrazole-4- carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 309	Plasma kallikrein		 28.8								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336085	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336085&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348841	384988226							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662427	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1coc(n1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H30ClFN4O6/c1-44-21-12-15-38(16-13-21)27-7-3-4-23-22(27)14-17-39(29(23)30(40)36-20-10-8-19(9-11-20)33(42)43)32(41)26-18-45-31(37-26)24-5-2-6-25(34)28(24)35/h2-11,18,21,29H,12-17H2,1H3,(H,36,40)(H,42,43)	DSJQQMSCVFIBAC-UHFFFAOYSA-N	336086	4-(2-(2-(3-chloro-2- fluorophenyl)oxazole-4- carbonyl)-5-(4- methoxypiperidin-1-yl)- 1,2,3,4-tetrahydroisoquinoline- 1-carboxamido)benzoic acid, TFA salt::US9738655, Example 310	Plasma kallikrein		 610								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336086	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336086&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348778	384988227							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662428	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cc(n[nH]1)-c1cccc(Cl)c1)C(=O)Nc1ccc(cc1)C(O)=O			336087	4-(2-(3-(3-chlorophenyl)-1H- pyrazole-5-carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 311::US9738655, Example 316	Plasma kallikrein		 787								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336087	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336087&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			138752707	384988228							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662429	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(cn1)-c1c(F)ccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H30ClF2N5O5/c1-46-21-11-14-39(15-12-21)27-4-2-3-23-22(27)13-16-41(29(23)31(42)38-20-7-5-19(6-8-20)33(44)45)32(43)26-17-40(18-37-26)30-25(35)10-9-24(34)28(30)36/h2-10,17-18,21,29H,11-16H2,1H3,(H,38,42)(H,44,45)	NUPTVFLTOJMODJ-UHFFFAOYSA-N	336088	4-(2-(1-(3-chloro-2,6- difluorophenyl)-1H-imidazole- 4-carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 312	Plasma kallikrein		 27.3								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336088	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336088&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348774	384988229							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662430	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1N)-c1ccncc1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H33N7O5/c1-44-23-11-16-37(17-12-23)27-4-2-3-25-24(27)13-18-38(28(25)30(40)36-21-7-5-20(6-8-21)32(42)43)31(41)26-19-35-39(29(26)33)22-9-14-34-15-10-22/h2-10,14-15,19,23,28H,11-13,16-18,33H2,1H3,(H,36,40)(H,42,43)	MIVMVOVFTPYYTQ-UHFFFAOYSA-N	336089	4-(2-(5-amino-1-(pyridin-4-yl)- 1H-pyrazole-4-carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 313	Plasma kallikrein		 6000								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336089	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336089&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348806	384988230							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662431	COC1CCN(CC1)c1cccc2[C@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H30ClFN6O5/c1-45-21-12-15-38(16-13-21)26-6-2-4-23-22(26)14-17-39(29(23)30(41)35-20-10-8-19(9-11-20)32(43)44)31(42)25-18-40(37-36-25)27-7-3-5-24(33)28(27)34/h2-11,18,21,29H,12-17H2,1H3,(H,35,41)(H,43,44)/t29-/m0/s1	AVKKDSOYYJOTLE-LJAQVGFWSA-N	336090	(S)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3-triazole- 4-carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 314	Plasma kallikrein		 10.3								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336090	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336090&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348916	384988231							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662432	COC1CCN(CC1)c1cccc2[C@H](N(CCc12)C(=O)c1cnn(c1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H31ClFN5O5/c1-45-23-12-15-38(16-13-23)27-6-2-4-25-24(27)14-17-39(30(25)31(41)37-22-10-8-20(9-11-22)33(43)44)32(42)21-18-36-40(19-21)28-7-3-5-26(34)29(28)35/h2-11,18-19,23,30H,12-17H2,1H3,(H,37,41)(H,43,44)/t30-/m0/s1	RWHNCKXIRHTDDM-PMERELPUSA-N	336091	(S)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-pyrazole-4- carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 315	Plasma kallikrein		 19.6								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336091	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336091&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348804	384988232							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662433	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cc(n[nH]1)-c1cccc(Cl)c1)C(=O)Nc1ccc(cc1)C(O)=O			336087	4-(2-(3-(3-chlorophenyl)-1H- pyrazole-5-carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 311::US9738655, Example 316	Plasma kallikrein		 578								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336087	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336087&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			138752707	384988228							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662434	CN(C)C(=O)C1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1N)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C35H35ClFN7O5/c1-41(2)33(46)20-13-16-42(17-14-20)27-7-3-5-24-23(27)15-18-43(30(24)32(45)40-22-11-9-21(10-12-22)35(48)49)34(47)25-19-39-44(31(25)38)28-8-4-6-26(36)29(28)37/h3-12,19-20,30H,13-18,38H2,1-2H3,(H,40,45)(H,48,49)	LWVFYGGVTSBNPF-UHFFFAOYSA-N	336093	4-(2-(5-Amino-1-(3-chloro-2-fluorophenyl)-1H-pyrazole-4-carbonyl)-5-(4-(dimethylcarbamoyl)piperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 317	Plasma kallikrein		 41.1								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336093	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336093&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602265	384988233							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662435	CN1CCN(CC1=O)c1cccc2C(N(CCc12)C(=O)c1cnn(c1N)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H29ClFN7O5/c1-38-14-15-39(17-26(38)42)24-6-2-4-21-20(24)12-13-40(28(21)30(43)37-19-10-8-18(9-11-19)32(45)46)31(44)22-16-36-41(29(22)35)25-7-3-5-23(33)27(25)34/h2-11,16,28H,12-15,17,35H2,1H3,(H,37,43)(H,45,46)	KXECQFQEVMSQTL-UHFFFAOYSA-N	336094	4-(2-(5-Amino-1-(3-chloro-2-fluorophenyl)-1H-pyrazole-4-carbonyl)-5-(4-methyl-3-oxopiperazin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 318	Plasma kallikrein		 21.1								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336094	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336094&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601538	384988234							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662436	CN(C)CCOC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1N)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C36H39ClFN7O5/c1-42(2)19-20-50-24-13-16-43(17-14-24)29-7-3-5-26-25(29)15-18-44(32(26)34(46)41-23-11-9-22(10-12-23)36(48)49)35(47)27-21-40-45(33(27)39)30-8-4-6-28(37)31(30)38/h3-12,21,24,32H,13-20,39H2,1-2H3,(H,41,46)(H,48,49)	RLBBCCQWYWHBBU-UHFFFAOYSA-N	336095	4-(2-(3-Amino-1-(3-chloro-2-fluorophenyl)-1H-pyrazole-4-carbonyl)-5-(4-(2-(dimethylamino)ethoxy)piperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 319	Plasma kallikrein		 6.41								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336095	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336095&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602078	384988235							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662437	CN1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cncc(c1)-c1cccc(Cl)c1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H32ClN5O4/c1-38-14-16-39(17-15-38)30-7-3-6-29-28(30)12-13-40(31(29)32(41)37-27-10-8-22(9-11-27)34(43)44)33(42)25-18-24(20-36-21-25)23-4-2-5-26(35)19-23/h2-11,18-21,31H,12-17H2,1H3,(H,37,41)(H,43,44)	HPPADHZZFREPQU-UHFFFAOYSA-N	336096	4-(2-(5-(3-Chlorophenyl)nicotinoyl)-5-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 320	Plasma kallikrein		 124								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336096	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336096&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602034	384988236							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662438	CN1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cncc(c1)-c1ccccc1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H33N5O4/c1-37-16-18-38(19-17-37)30-9-5-8-29-28(30)14-15-39(31(29)32(40)36-27-12-10-24(11-13-27)34(42)43)33(41)26-20-25(21-35-22-26)23-6-3-2-4-7-23/h2-13,20-22,31H,14-19H2,1H3,(H,36,40)(H,42,43)	LOCAZELFDYLNGC-UHFFFAOYSA-N	336097	4-(5-(4-Methylpiperazin-1-yl)-2-(5-phenylnicotinoyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 321::US9738655, Example 326	Plasma kallikrein		 177								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336097	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336097&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601369	384988237							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662439	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1=NC=C[N](=C1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H32ClFN5O5/c1-46-23-12-16-39(17-13-23)28-6-2-4-25-24(28)14-18-41(31(25)32(42)38-22-10-8-21(9-11-22)34(44)45)33(43)27-20-40(19-15-37-27)29-7-3-5-26(35)30(29)36/h2-11,15,19-20,23,31H,12-14,16-18H2,1H3,(H,38,42)(H,44,45)	OLVDIBOPUAHCNU-UHFFFAOYSA-N	336098	4-(2-(4-(3-Chloro-2-fluorophenyl)picolinoyl)-5-(4-methoxypiperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 322	Plasma kallikrein		 138								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336098	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336098&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			138752708	384988238							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662440	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cncc(c1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C35H32ClFN4O5/c1-46-25-12-15-40(16-13-25)30-7-3-5-28-27(30)14-17-41(32(28)33(42)39-24-10-8-21(9-11-24)35(44)45)34(43)23-18-22(19-38-20-23)26-4-2-6-29(36)31(26)37/h2-11,18-20,25,32H,12-17H2,1H3,(H,39,42)(H,44,45)	YTLXZIUVYLFAJM-UHFFFAOYSA-N	336099	4-(2-(5-(3-Chloro-2-fluorophenyl)nicotinoyl)-5-(4-methoxypiperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 323	Plasma kallikrein		 99.2								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336099	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336099&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601670	384988239							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662441	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1ccnc(c1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C35H32ClFN4O5/c1-46-24-13-17-40(18-14-24)30-7-3-4-26-25(30)15-19-41(32(26)33(42)39-23-10-8-21(9-11-23)35(44)45)34(43)22-12-16-38-29(20-22)27-5-2-6-28(36)31(27)37/h2-12,16,20,24,32H,13-15,17-19H2,1H3,(H,39,42)(H,44,45)	IDTDQUJKOQHEEX-UHFFFAOYSA-N	336100	4-(2-(2-(3-Chloro-2-fluorophenyl)isonicotinoyl)-5-(4-methoxypiperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 324	Plasma kallikrein		 958								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336100	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336100&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602159	384988240							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662442	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cccc(n1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C35H32ClFN4O5/c1-46-23-15-18-40(19-16-23)30-10-3-5-25-24(30)17-20-41(32(25)33(42)38-22-13-11-21(12-14-22)35(44)45)34(43)29-9-4-8-28(39-29)26-6-2-7-27(36)31(26)37/h2-14,23,32H,15-20H2,1H3,(H,38,42)(H,44,45)	MOWBZALNHWFSAX-UHFFFAOYSA-N	336101	4-(2-(6-(3-Chloro-2-fluorophenyl)picolinoyl)-5-(4-methoxypiperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 325	Plasma kallikrein		 6000								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336101	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336101&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601512	384988241							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662443	CN1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cncc(c1)-c1ccccc1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H33N5O4/c1-37-16-18-38(19-17-37)30-9-5-8-29-28(30)14-15-39(31(29)32(40)36-27-12-10-24(11-13-27)34(42)43)33(41)26-20-25(21-35-22-26)23-6-3-2-4-7-23/h2-13,20-22,31H,14-19H2,1H3,(H,36,40)(H,42,43)	LOCAZELFDYLNGC-UHFFFAOYSA-N	336097	4-(5-(4-Methylpiperazin-1-yl)-2-(5-phenylnicotinoyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 321::US9738655, Example 326	Plasma kallikrein		 2000								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336097	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336097&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601369	384988237							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662444	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1)-c1ccnc(C)c1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H34N6O5/c1-21-18-25(10-14-34-21)39-20-23(19-35-39)32(41)38-17-13-27-28(4-3-5-29(27)37-15-11-26(44-2)12-16-37)30(38)31(40)36-24-8-6-22(7-9-24)33(42)43/h3-10,14,18-20,26,30H,11-13,15-17H2,1-2H3,(H,36,40)(H,42,43)	UKMKWFZGYUGHDQ-UHFFFAOYSA-N	336103	4-(5-(4-Methoxypiperidin-1-yl)-2-(1-(2-methylpyridin-4-yl)-1H-pyrazole-4-carbonyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 327	Plasma kallikrein		 6000								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336103	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336103&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602027	384988242							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662445	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1)-c1cc(Cl)ccn1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H31ClN6O5/c1-44-24-10-14-37(15-11-24)27-4-2-3-26-25(27)12-16-38(29(26)30(40)36-23-7-5-20(6-8-23)32(42)43)31(41)21-18-35-39(19-21)28-17-22(33)9-13-34-28/h2-9,13,17-19,24,29H,10-12,14-16H2,1H3,(H,36,40)(H,42,43)	UTRAREPQGBRVSK-UHFFFAOYSA-N	336104	4-(2-(1-(5-chloropyridin-3- yl)-1H-pyrazole-4-carbonyl)- 5-(4-methoxypiperidin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 328	Plasma kallikrein		 6000								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336104	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336104&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121357627	384988243							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662446	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1)-c1cccc(Cl)c1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H32ClN5O5/c1-44-26-12-15-37(16-13-26)29-7-3-6-28-27(29)14-17-38(30(28)31(40)36-24-10-8-21(9-11-24)33(42)43)32(41)22-19-35-39(20-22)25-5-2-4-23(34)18-25/h2-11,18-20,26,30H,12-17H2,1H3,(H,36,40)(H,42,43)	RESLNCPFDIUSRS-UHFFFAOYSA-N	336105	4-(2-(1-(3-chlorophenyl)-1H- pyrazole-4-carbonyl)-5-(4- methoxypiperidin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 329	Plasma kallikrein		 229								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336105	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336105&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626288	384988244							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662447	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1)-c1cccnc1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H32N6O5/c1-43-25-11-15-36(16-12-25)28-6-2-5-27-26(28)13-17-37(29(27)30(39)35-23-9-7-21(8-10-23)32(41)42)31(40)22-18-34-38(20-22)24-4-3-14-33-19-24/h2-10,14,18-20,25,29H,11-13,15-17H2,1H3,(H,35,39)(H,41,42)	CXGWBRHGBOMOMU-UHFFFAOYSA-N	336106	4-(5-(4-methoxypiperidin-1- yl)-2-(1-(pyridin-3-yl)-1H- pyrazolc-4-carbonyl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 330	Plasma kallikrein		 6000								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336106	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336106&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626289	384988245							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662448	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1)-c1ccc2nonc2c1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H31N7O6/c1-45-24-11-14-38(15-12-24)29-4-2-3-26-25(29)13-16-39(30(26)31(41)35-22-7-5-20(6-8-22)33(43)44)32(42)21-18-34-40(19-21)23-9-10-27-28(17-23)37-46-36-27/h2-10,17-19,24,30H,11-16H2,1H3,(H,35,41)(H,43,44)	LPIYTZNUEQITRK-UHFFFAOYSA-N	336107	4-(2-(1-(benzo[c][1,2,5] oxadiazol-5-yl)-1H-pyrazole- 4-carbonyl)-5-(4- methoxypiperidin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 331	Plasma kallikrein		 6000								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336107	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336107&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348853	384988246							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662449	CC(=C)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C29H23ClFN5O4/c1-16(2)19-5-3-6-21-20(19)13-14-35(26(21)27(37)32-18-11-9-17(10-12-18)29(39)40)28(38)23-15-36(34-33-23)24-8-4-7-22(30)25(24)31/h3-12,15,26H,1,13-14H2,2H3,(H,32,37)(H,39,40)	JCVXAUSYJPWAPW-UHFFFAOYSA-N	336108	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(prop-1-en-2-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 333	Plasma kallikrein		 61.3								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336108	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336108&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601361	384988247							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662450	Nc1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C26H20ClFN6O4/c27-18-4-2-6-21(22(18)28)34-13-20(31-32-34)25(36)33-12-11-16-17(3-1-5-19(16)29)23(33)24(35)30-15-9-7-14(8-10-15)26(37)38/h1-10,13,23H,11-12,29H2,(H,30,35)(H,37,38)	XWNDSMYHTNPVSM-UHFFFAOYSA-N	336109	4-(5-Amino-2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 334	Plasma kallikrein		 6.26								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336109	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336109&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602158	384988248							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662451	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(N)=O	InChI=1S/C32H31ClFN7O4/c1-45-21-12-15-39(16-13-21)26-6-2-4-23-22(26)14-17-40(29(23)31(43)36-20-10-8-19(9-11-20)30(35)42)32(44)25-18-41(38-37-25)27-7-3-5-24(33)28(27)34/h2-11,18,21,29H,12-17H2,1H3,(H2,35,42)(H,36,43)	QYVCEYOGBUMRBR-UHFFFAOYSA-N	336110	N-(4-Carbamoylphenyl)-2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(4-methoxypiperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, TFA salt::US9738655, Example 335	Plasma kallikrein		 96.9								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336110	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336110&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601484	384988249							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662452	CC(C)c1nnc2CN(CCn12)c1cccc2[C@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C35H33ClFN7O5/c1-19(2)32-40-39-29-18-42(15-16-43(29)32)27-8-4-5-23-22(27)13-14-44(31(23)33(45)38-21-11-9-20(10-12-21)35(47)48)34(46)28-17-26(41-49-28)24-6-3-7-25(36)30(24)37/h3-12,19,28,31H,13-18H2,1-2H3,(H,38,45)(H,47,48)/t28-,31+/m1/s1	PULGOHDYZKUKTQ-MVSFAKPFSA-N	336111	4-((S)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(3-isopropyl-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 336	Plasma kallikrein		 1.40								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336111	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336111&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626262	384988250							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662453	CC(C)c1nnc2CN(CCn12)c1cccc2[C@@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C35H33ClFN7O5/c1-19(2)32-40-39-29-18-42(15-16-43(29)32)27-8-4-5-23-22(27)13-14-44(31(23)33(45)38-21-11-9-20(10-12-21)35(47)48)34(46)28-17-26(41-49-28)24-6-3-7-25(36)30(24)37/h3-12,19,28,31H,13-18H2,1-2H3,(H,38,45)(H,47,48)/t28-,31-/m1/s1	PULGOHDYZKUKTQ-GRKNLSHJSA-N	336112	4-((R)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(3-isopropyl-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 337	Plasma kallikrein		 68.1								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336112	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336112&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626318	384988251							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662454	CC(C)c1nnc2CN(CCn12)c1cccc2[C@H](N(CCc12)C(=O)[C@@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C35H33ClFN7O5/c1-19(2)32-40-39-29-18-42(15-16-43(29)32)27-8-4-5-23-22(27)13-14-44(31(23)33(45)38-21-11-9-20(10-12-21)35(47)48)34(46)28-17-26(41-49-28)24-6-3-7-25(36)30(24)37/h3-12,19,28,31H,13-18H2,1-2H3,(H,38,45)(H,47,48)/t28-,31-/m0/s1	PULGOHDYZKUKTQ-IZEXYCQBSA-N	336116	4-((S)-2-((S)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(3-isopropyl-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 338	Plasma kallikrein		 251								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336116	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336116&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626232	384988255							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662455	CC(C)c1nnc2CN(CCn12)c1cccc2[C@@H](N(CCc12)C(=O)[C@@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C35H33ClFN7O5/c1-19(2)32-40-39-29-18-42(15-16-43(29)32)27-8-4-5-23-22(27)13-14-44(31(23)33(45)38-21-11-9-20(10-12-21)35(47)48)34(46)28-17-26(41-49-28)24-6-3-7-25(36)30(24)37/h3-12,19,28,31H,13-18H2,1-2H3,(H,38,45)(H,47,48)/t28-,31+/m0/s1	PULGOHDYZKUKTQ-QCENPCRXSA-N	336117	4-((R)-2-((S)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(3-isopropyl-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 339	Plasma kallikrein		 84.6								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336117	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336117&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626320	384988256							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662456	Cc1nnc2CN(CCn12)c1cccc2[C@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H29ClFN7O5/c1-18-37-38-28-17-40(14-15-41(18)28)26-7-3-4-22-21(26)12-13-42(30(22)31(43)36-20-10-8-19(9-11-20)33(45)46)32(44)27-16-25(39-47-27)23-5-2-6-24(34)29(23)35/h2-11,27,30H,12-17H2,1H3,(H,36,43)(H,45,46)/t27-,30+/m1/s1	QNQFMFYHIZXXRE-OFSOJUDTSA-N	336113	4-((S)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(3-methyl-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 340	Plasma kallikrein		 13.8								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336113	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336113&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626347	384988252							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662457	Cc1nnc2CN(CCn12)c1cccc2[C@@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H29ClFN7O5/c1-18-37-38-28-17-40(14-15-41(18)28)26-7-3-4-22-21(26)12-13-42(30(22)31(43)36-20-10-8-19(9-11-20)33(45)46)32(44)27-16-25(39-47-27)23-5-2-6-24(34)29(23)35/h2-11,27,30H,12-17H2,1H3,(H,36,43)(H,45,46)/t27-,30-/m1/s1	QNQFMFYHIZXXRE-POURPWNDSA-N	336114	4-((R)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(3-methyl-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 341	Plasma kallikrein		 46.9								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336114	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336114&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626234	384988253							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
662458	CC(C)c1nnc2CN(CCn12)c1cccc2[C@@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(F)cc1	InChI=1S/C34H32ClF2N7O3/c1-19(2)32-40-39-29-18-42(15-16-43(29)32)27-8-4-5-23-22(27)13-14-44(31(23)33(45)38-21-11-9-20(36)10-12-21)34(46)28-17-26(41-47-28)24-6-3-7-25(35)30(24)37/h3-12,19,28,31H,13-18H2,1-2H3,(H,38,45)/t28-,31-/m1/s1	CHAUNDCRDVOXQH-GRKNLSHJSA-N	336118	(R)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-N-(4-fluorophenyl)-5-(3-isopropyl-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, TFA salt::US9738655, Example 343	Plasma kallikrein		 114								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336118	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336118&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602061	384988257							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
674118	CCC(C(=O)Nc1cn2cc(ccc2n1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C25H20ClN5O5/c1-3-19(24(33)29-21-13-30-11-15(25(34)35)5-7-22(30)28-21)31-12-20(36-2)18(9-23(31)32)17-8-16(26)6-4-14(17)10-27/h4-9,11-13,19H,3H2,1-2H3,(H,29,33)(H,34,35)	JDNIAYIKSPVFEW-UHFFFAOYSA-N	341190	2-({2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]butanoyl}amino)imidazo[1,2-a]pyridine-6-carboxylic acid (racemate)::US9765070, Example 1	Plasma kallikrein			 140							US Patent		10.7270/Q25D8TZT		aid1797193	US9765070	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Teller, H; Jimenez Nunez, E; Schirok, H; Klar, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=341190	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=341190&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118054838	385211967							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
674119	CCC(C(=O)Nc1ccc2nc(cn2c1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C25H20ClN5O5/c1-3-20(24(33)28-16-6-7-22-29-19(25(34)35)12-30(22)11-16)31-13-21(36-2)18(9-23(31)32)17-8-15(26)5-4-14(17)10-27/h4-9,11-13,20H,3H2,1-2H3,(H,28,33)(H,34,35)	HKFLQFRUISEYHK-UHFFFAOYSA-N	341191	6-({2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]butanoyl}amino)imidazo[1,2-a]pyridine-2-carboxylic acid (racemate)::US9765070, Example 2	Plasma kallikrein			 16.0							US Patent		10.7270/Q25D8TZT		aid1797193	US9765070	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Teller, H; Jimenez Nunez, E; Schirok, H; Klar, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=341191	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=341191&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118054863	385211968							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
674120	CCC(C(=O)Nc1ccn2cc(nc2c1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C25H20ClN5O5/c1-3-20(24(33)28-16-6-7-30-12-19(25(34)35)29-22(30)9-16)31-13-21(36-2)18(10-23(31)32)17-8-15(26)5-4-14(17)11-27/h4-10,12-13,20H,3H2,1-2H3,(H,28,33)(H,34,35)	RVMRCKRREMQYBG-UHFFFAOYSA-N	341269	7-({2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]butanoyl}amino)imidazo[1,2-a]pyridine-2-carboxylic acid (racemate)::US9765070, Example 3	Plasma kallikrein			 13.0							US Patent		10.7270/Q25D8TZT		aid1797193	US9765070	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Teller, H; Jimenez Nunez, E; Schirok, H; Klar, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=341269	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=341269&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118054858	385212043							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
674121	CCC(C(=O)Nc1ccc2nccn2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C24H20ClN5O3/c1-3-20(24(32)28-17-6-7-22-27-8-9-29(22)13-17)30-14-21(33-2)19(11-23(30)31)18-10-16(25)5-4-15(18)12-26/h4-11,13-14,20H,3H2,1-2H3,(H,28,32)	ZADNRCIXROQDFP-UHFFFAOYSA-N	341274	2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-N-(imidazo[1,2-a]pyridin-6-yl)butanamide (racemate)::US9765070, Example 4	Plasma kallikrein			 44.0							US Patent		10.7270/Q25D8TZT		aid1797193	US9765070	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Teller, H; Jimenez Nunez, E; Schirok, H; Klar, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=341274	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=341274&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118051787	385212048							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
674122	COc1cn(C(CC2CCC2)C(=O)Nc2ccc3nc(cn3c2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C28H24ClN5O5/c1-39-24-15-34(26(35)11-21(24)20-10-18(29)6-5-17(20)12-30)23(9-16-3-2-4-16)27(36)31-19-7-8-25-32-22(28(37)38)14-33(25)13-19/h5-8,10-11,13-16,23H,2-4,9H2,1H3,(H,31,36)(H,37,38)	QPLOFYKBIFMXBX-UHFFFAOYSA-N	341277	6-({2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-3-cyclobutylpropanoyl}-amino)imidazo[1,2-a]pyridine-2-carboxylic acid (racemate)::US9765070, Example 5	Plasma kallikrein			 7.10							US Patent		10.7270/Q25D8TZT		aid1797193	US9765070	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Teller, H; Jimenez Nunez, E; Schirok, H; Klar, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=341277	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=341277&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118054855	385212050							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
674123	COc1cn(CC(=O)Nc2ccc3nc(cn3c2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C23H16ClN5O5/c1-34-19-11-29(22(31)7-17(19)16-6-14(24)3-2-13(16)8-25)12-21(30)26-15-4-5-20-27-18(23(32)33)10-28(20)9-15/h2-7,9-11H,12H2,1H3,(H,26,30)(H,32,33)	IPXQYASTYLYKCL-UHFFFAOYSA-N	341289	6-({[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]acetyl}amino)imidazo[1,2-a]pyridine-2-carboxylic acid::US9765070, Example 6	Plasma kallikrein			 61.0							US Patent		10.7270/Q25D8TZT		aid1797193	US9765070	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Teller, H; Jimenez Nunez, E; Schirok, H; Klar, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=341289	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=341289&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118054865	385212062							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
674124	CCC(C(=O)Nc1ccc2nc(cn2c1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1OC(F)F	InChI=1S/C25H21ClF2N4O6/c1-3-18(23(34)29-14-5-7-21-30-17(24(35)36)11-31(21)10-14)32-12-20(37-2)16(9-22(32)33)15-8-13(26)4-6-19(15)38-25(27)28/h4-12,18,25H,3H2,1-2H3,(H,29,34)(H,35,36)	GJLNJCSBJYJLIL-UHFFFAOYSA-N	341290	6-[(2-{4-[5-Chloro-2-(difluoromethoxy)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}butanoyl)amino]-imidazo[1,2-a]pyridine-2-carboxylic acid (racemate)::US9765070, Example 7	Plasma kallikrein			 150							US Patent		10.7270/Q25D8TZT		aid1797193	US9765070	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Teller, H; Jimenez Nunez, E; Schirok, H; Klar, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=341290	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=341290&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118054856	385212063							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
674125	COc1cn(C(C[C@@H]2CCCCO2)C(=O)Nc2ccc3nc(cn3c2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C29H26ClN5O6/c1-40-25-16-35(27(36)12-22(25)21-10-18(30)6-5-17(21)13-31)24(11-20-4-2-3-9-41-20)28(37)32-19-7-8-26-33-23(29(38)39)15-34(26)14-19/h5-8,10,12,14-16,20,24H,2-4,9,11H2,1H3,(H,32,37)(H,38,39)/t20-,24?/m0/s1	LLNQIULEMBGSKZ-QHELBMECSA-N	341292	6-({2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-3-[(2S)-tetrahydro-2H-pyran-2-yl]propanoyl}amino)imidazo[1,2-a]pyridine-2-carboxylic acid (mixture of enantiomerically pure diastereomers)::US9765070, Example 9	Plasma kallikrein			 4.80							US Patent		10.7270/Q25D8TZT		aid1797193	US9765070	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Teller, H; Jimenez Nunez, E; Schirok, H; Klar, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=341292	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=341292&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			122530840	385212065							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
674126	CCOC(=O)c1cnc2ccc(NC(=O)C(CCOC)n3cc(OC)c(cc3=O)-c3cc(Cl)ccc3C#N)cn12	InChI=1S/C28H26ClN5O6/c1-4-40-28(37)23-14-31-25-8-7-19(15-33(23)25)32-27(36)22(9-10-38-2)34-16-24(39-3)21(12-26(34)35)20-11-18(29)6-5-17(20)13-30/h5-8,11-12,14-16,22H,4,9-10H2,1-3H3,(H,32,36)	VVPIFAABYQQPKY-UHFFFAOYSA-N	341293	Ethyl 6-({2-[4-(5-chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)imidazo[1,2-a]pyridine-3-carboxylate (racemate)::US9765070, Example 10	Plasma kallikrein			 7.00							US Patent		10.7270/Q25D8TZT		aid1797193	US9765070	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Teller, H; Jimenez Nunez, E; Schirok, H; Klar, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=341293	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=341293&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118054866	385212066							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
674127	CCOC(=O)c1cn2ccc(NC(=O)C(CCOC)n3cc(OC)c(cc3=O)-c3cc(Cl)ccc3C#N)cc2n1	InChI=1S/C28H26ClN5O6/c1-4-40-28(37)22-15-33-9-7-19(12-25(33)32-22)31-27(36)23(8-10-38-2)34-16-24(39-3)21(13-26(34)35)20-11-18(29)6-5-17(20)14-30/h5-7,9,11-13,15-16,23H,4,8,10H2,1-3H3,(H,31,36)	VLNBINQYXHFUGN-UHFFFAOYSA-N	341294	Ethyl 7-({2-[4-(5-chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)imidazo[1,2-a]pyridine-2-carboxylate (racemate)::US9765070, Example 11	Plasma kallikrein			 5.00							US Patent		10.7270/Q25D8TZT		aid1797193	US9765070	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Teller, H; Jimenez Nunez, E; Schirok, H; Klar, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=341294	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=341294&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118054835	385212067							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
674128	COCCC(C(=O)Nc1ccn2cc(nc2c1)C(N)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C26H23ClN6O5/c1-37-8-6-21(26(36)30-17-5-7-32-13-20(25(29)35)31-23(32)10-17)33-14-22(38-2)19(11-24(33)34)18-9-16(27)4-3-15(18)12-28/h3-5,7,9-11,13-14,21H,6,8H2,1-2H3,(H2,29,35)(H,30,36)	YRUPTYVLRUXKLT-UHFFFAOYSA-N	341295	7-({2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)imidazo[1,2-a]pyridine-2-carboxamide (racemate)::US9765070, Example 12	Plasma kallikrein			 4.90							US Patent		10.7270/Q25D8TZT		aid1797193	US9765070	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Teller, H; Jimenez Nunez, E; Schirok, H; Klar, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=341295	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=341295&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118054864	385212068							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
674129	COCCC(C(=O)Nc1ccc2nccn2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C25H22ClN5O4/c1-34-10-7-21(25(33)29-18-5-6-23-28-8-9-30(23)14-18)31-15-22(35-2)20(12-24(31)32)19-11-17(26)4-3-16(19)13-27/h3-6,8-9,11-12,14-15,21H,7,10H2,1-2H3,(H,29,33)	WWGZYEFQIVMHGE-UHFFFAOYSA-N	341296	2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-N-(imidazo[1,2-a]pyridin-6-yl)-4-methoxybutanamide (racemate)::US9765070, Example 13	Plasma kallikrein			 13.0							US Patent		10.7270/Q25D8TZT		aid1797193	US9765070	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Teller, H; Jimenez Nunez, E; Schirok, H; Klar, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=341296	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=341296&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118054795	385212069							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
674130	COCCC(C(=O)Nc1ccc2nccn2c1)n1cc(Cl)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C24H19Cl2N5O3/c1-34-9-6-21(24(33)29-17-4-5-22-28-7-8-30(22)13-17)31-14-20(26)19(11-23(31)32)18-10-16(25)3-2-15(18)12-27/h2-5,7-8,10-11,13-14,21H,6,9H2,1H3,(H,29,33)	WUJLMAPJEXISQS-UHFFFAOYSA-N	341297	2-[5-Chloro-4-(5-chloro-2-cyanophenyl)-2-oxopyridin-1(2H)-yl]-N-(imidazo[1,2-a]pyridin-6-yl)-4-methoxybutanamide (racemate)::US9765070, Example 14	Plasma kallikrein			 65.0							US Patent		10.7270/Q25D8TZT		aid1797193	US9765070	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Teller, H; Jimenez Nunez, E; Schirok, H; Klar, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=341297	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=341297&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118054861	385212070							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
674131	COc1cn(C(CC2CCC2)C(=O)Nc2ccc3nccn3c2)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C27H24ClN5O3/c1-36-24-16-33(26(34)13-22(24)21-12-19(28)6-5-18(21)14-29)23(11-17-3-2-4-17)27(35)31-20-7-8-25-30-9-10-32(25)15-20/h5-10,12-13,15-17,23H,2-4,11H2,1H3,(H,31,35)	QBMVTFLFHVFJAP-UHFFFAOYSA-N	341298	2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-3-cyclobutyl-N-(imidazo[1,2-a]pyridin-6-yl)propanamide (racemate)::US9765070, Example 15	Plasma kallikrein			 31.0							US Patent		10.7270/Q25D8TZT		aid1797193	US9765070	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Teller, H; Jimenez Nunez, E; Schirok, H; Klar, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=341298	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=341298&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118054867	385212071							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
674132	COc1cn(C(C[C@H]2CC[C@H](O)CC2)C(=O)Nc2ccc3nccn3c2)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C29H28ClN5O4/c1-39-26-17-35(28(37)14-24(26)23-13-20(30)5-4-19(23)15-31)25(12-18-2-7-22(36)8-3-18)29(38)33-21-6-9-27-32-10-11-34(27)16-21/h4-6,9-11,13-14,16-18,22,25,36H,2-3,7-8,12H2,1H3,(H,33,38)/t18-,22-,25?	KTJTUSDFVHRIMF-OSEUUVDTSA-N	341299	2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-3-(trans-4-hydroxycyclohexyl)-N-(imidazo[1,2-a]pyridin-6-yl)propanamide (racemate)::US9765070, Example 16	Plasma kallikrein			 17.0							US Patent		10.7270/Q25D8TZT		aid1797193	US9765070	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Teller, H; Jimenez Nunez, E; Schirok, H; Klar, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=341299	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=341299&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118054869	385212072							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
674133	CCC(C(=O)Nc1ccc2ncc(Cl)n2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C24H19Cl2N5O3/c1-3-19(24(33)29-16-6-7-22-28-11-21(26)31(22)12-16)30-13-20(34-2)18(9-23(30)32)17-8-15(25)5-4-14(17)10-27/h4-9,11-13,19H,3H2,1-2H3,(H,29,33)	LGGDUJZWPDHZQK-UHFFFAOYSA-N	341300	2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-N-(3-chloroimidazo[1,2-a]pyridin-6-yl)butanamide (racemate)::US9765070, Example 17	Plasma kallikrein			 24.0							US Patent		10.7270/Q25D8TZT		aid1797193	US9765070	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Teller, H; Jimenez Nunez, E; Schirok, H; Klar, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=341300	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=341300&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118054846	385212073							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
674134	CCC(C(=O)Nc1ccc2nc(cn2c1)-c1ccc(F)cc1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C30H23ClFN5O3/c1-3-26(37-17-27(40-2)24(13-29(37)38)23-12-20(31)7-4-19(23)14-33)30(39)34-22-10-11-28-35-25(16-36(28)15-22)18-5-8-21(32)9-6-18/h4-13,15-17,26H,3H2,1-2H3,(H,34,39)	FOSCGLGAFGYBBL-UHFFFAOYSA-N	341301	2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-N-[2-(4-fluorophenyl)-imidazo[1,2-a]pyridin-6-yl]butanamide (racemate)::US9765070, Example 18	Plasma kallikrein			 130							US Patent		10.7270/Q25D8TZT		aid1797193	US9765070	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Teller, H; Jimenez Nunez, E; Schirok, H; Klar, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=341301	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=341301&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118054840	385212074							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
674135	COCCC(C(=O)Nc1ccc2nc(cn2c1)-c1ccc(F)cc1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C31H25ClFN5O4/c1-41-12-11-27(38-18-28(42-2)25(14-30(38)39)24-13-21(32)6-3-20(24)15-34)31(40)35-23-9-10-29-36-26(17-37(29)16-23)19-4-7-22(33)8-5-19/h3-10,13-14,16-18,27H,11-12H2,1-2H3,(H,35,40)	OYMWLNCQPGHRBO-UHFFFAOYSA-N	341302	2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-N-[2-(4-fluorophenyl)-imidazo[1,2-a]pyridin-6-yl]-4-methoxybutanamide (racemate)::US9765070, Example 19	Plasma kallikrein			 25.0							US Patent		10.7270/Q25D8TZT		aid1797193	US9765070	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Teller, H; Jimenez Nunez, E; Schirok, H; Klar, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=341302	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=341302&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118054901	385212075							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
674136	CCC(C(=O)Nc1ccc2nncn2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C23H19ClN6O3/c1-3-19(23(32)27-16-6-7-21-28-26-13-29(21)11-16)30-12-20(33-2)18(9-22(30)31)17-8-15(24)5-4-14(17)10-25/h4-9,11-13,19H,3H2,1-2H3,(H,27,32)	UGFDLQDEOQHJJU-UHFFFAOYSA-N	341303	2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-N-([1,2,4]triazolo[4,3-a]pyridin-6-yl)butanamide (racemate)::US9765070, Example 20	Plasma kallikrein			 23.0							US Patent		10.7270/Q25D8TZT		aid1797193	US9765070	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Teller, H; Jimenez Nunez, E; Schirok, H; Klar, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=341303	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=341303&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118054796	385212076							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
674137	COCCC(C(=O)Nc1ccc2nncn2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C24H21ClN6O4/c1-34-8-7-20(24(33)28-17-5-6-22-29-27-14-30(22)12-17)31-13-21(35-2)19(10-23(31)32)18-9-16(25)4-3-15(18)11-26/h3-6,9-10,12-14,20H,7-8H2,1-2H3,(H,28,33)	VWSZBXMMCLLXFO-UHFFFAOYSA-N	341304	2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxy-N-([1,2,4]triazolo[4,3-a]pyridin-6-yl)butanamide (racemate)::US9765070, Example 21	Plasma kallikrein			 8.00							US Patent		10.7270/Q25D8TZT		aid1797193	US9765070	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Teller, H; Jimenez Nunez, E; Schirok, H; Klar, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=341304	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=341304&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118054902	385212077							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
674138	COCCC(C(=O)Nc1ccc2nnc(C)n2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C25H23ClN6O4/c1-15-29-30-23-7-6-18(13-31(15)23)28-25(34)21(8-9-35-2)32-14-22(36-3)20(11-24(32)33)19-10-17(26)5-4-16(19)12-27/h4-7,10-11,13-14,21H,8-9H2,1-3H3,(H,28,34)	FRFVLJZLTVYZKB-UHFFFAOYSA-N	341305	2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxy-N-(3-methyl[1,2,4]triazolo[4,3-a]pyridin-6-yl)butanamide (racemate)::US9765070, Example 22	Plasma kallikrein			 8.30							US Patent		10.7270/Q25D8TZT		aid1797193	US9765070	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Teller, H; Jimenez Nunez, E; Schirok, H; Klar, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=341305	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=341305&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118054782	385212078							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
674139	CCc1nnc2ccc(NC(=O)C(CCOC)n3cc(OC)c(cc3=O)-c3cc(Cl)ccc3C#N)cn12	InChI=1S/C26H25ClN6O4/c1-4-23-30-31-24-8-7-18(14-33(23)24)29-26(35)21(9-10-36-2)32-15-22(37-3)20(12-25(32)34)19-11-17(27)6-5-16(19)13-28/h5-8,11-12,14-15,21H,4,9-10H2,1-3H3,(H,29,35)	FPJGVPXNXXXUKH-UHFFFAOYSA-N	341306	2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxy-N-(3-ethyl[1,2,4]triazolo[4,3-a]pyridin-6-yl)butanamide (racemate)::US9765070, Example 23	Plasma kallikrein			 13.0							US Patent		10.7270/Q25D8TZT		aid1797193	US9765070	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Teller, H; Jimenez Nunez, E; Schirok, H; Klar, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=341306	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=341306&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118054797	385212079							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
674140	CCCCc1nnc2ccc(NC(=O)C(CCOC)n3cc(OC)c(cc3=O)-c3cc(Cl)ccc3C#N)cn12	InChI=1S/C28H29ClN6O4/c1-4-5-6-25-32-33-26-10-9-20(16-35(25)26)31-28(37)23(11-12-38-2)34-17-24(39-3)22(14-27(34)36)21-13-19(29)8-7-18(21)15-30/h7-10,13-14,16-17,23H,4-6,11-12H2,1-3H3,(H,31,37)	RFWCJQGHDAKRMA-UHFFFAOYSA-N	341307	N-(3-Butyl[1,2,4]triazolo[4,3-a]pyridin-6-yl)-2-[4-(5-chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanamide (racemate)::US9765070, Example 24	Plasma kallikrein			 16.0							US Patent		10.7270/Q25D8TZT		aid1797193	US9765070	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Teller, H; Jimenez Nunez, E; Schirok, H; Klar, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=341307	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=341307&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118054871	385212080							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
674141	COCCC(C(=O)Nc1ccc2nnc(CN(C)C)n2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C27H28ClN7O4/c1-33(2)16-25-32-31-24-8-7-19(14-35(24)25)30-27(37)22(9-10-38-3)34-15-23(39-4)21(12-26(34)36)20-11-18(28)6-5-17(20)13-29/h5-8,11-12,14-15,22H,9-10,16H2,1-4H3,(H,30,37)	ZPAMDGZAOQSGLB-UHFFFAOYSA-N	341308	2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-N-{3-[(dimethylamino)-methyl][1,2,4]triazolo[4,3-a]pyridin-6-yl}-4-methoxybutanamide (racemate)::US9765070, Example 25	Plasma kallikrein			 23.0							US Patent		10.7270/Q25D8TZT		aid1797193	US9765070	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Teller, H; Jimenez Nunez, E; Schirok, H; Klar, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=341308	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=341308&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118054872	385212081							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
674142	COCCC(C(=O)Nc1ccc2nnc(CN3CCOCC3)n2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C29H30ClN7O5/c1-40-10-7-24(36-17-25(41-2)23(14-28(36)38)22-13-20(30)4-3-19(22)15-31)29(39)32-21-5-6-26-33-34-27(37(26)16-21)18-35-8-11-42-12-9-35/h3-6,13-14,16-17,24H,7-12,18H2,1-2H3,(H,32,39)	UJSFGKKVMPMPBW-UHFFFAOYSA-N	341309	2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxy-N-[3-(morpholin-4-ylmethyl)[1,2,4]triazolo[4,3-a]pyridin-6-yl]butanamide (racemate)::US9765070, Example 26	Plasma kallikrein			 12.0							US Patent		10.7270/Q25D8TZT		aid1797193	US9765070	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Teller, H; Jimenez Nunez, E; Schirok, H; Klar, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=341309	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=341309&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118054868	385212082							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
674143	COCCC(C(=O)Nc1ccc2cncn2c1)n1cc(Cl)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C24H19Cl2N5O3/c1-34-7-6-22(24(33)29-17-4-5-18-11-28-14-30(18)12-17)31-13-21(26)20(9-23(31)32)19-8-16(25)3-2-15(19)10-27/h2-5,8-9,11-14,22H,6-7H2,1H3,(H,29,33)	NURLNYIMYUHVQW-UHFFFAOYSA-N	341310	2-[5-Chloro-4-(5-chloro-2-cyanophenyl)-2-oxopyridin-1(2H)-yl]-N-(imidazo[1,5-a]pyridin-6-yl)-4-methoxybutanamide (racemate)::US9765070, Example 27	Plasma kallikrein			 50.0							US Patent		10.7270/Q25D8TZT		aid1797193	US9765070	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Teller, H; Jimenez Nunez, E; Schirok, H; Klar, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=341310	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=341310&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118054850	385212083							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
674144	COc1cn(C(Cc2ccccn2)C(=O)Nc2ccc3nccn3c2)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C28H21ClN6O3/c1-38-25-17-35(27(36)14-23(25)22-12-19(29)6-5-18(22)15-30)24(13-20-4-2-3-9-31-20)28(37)33-21-7-8-26-32-10-11-34(26)16-21/h2-12,14,16-17,24H,13H2,1H3,(H,33,37)	XPUMGIIZTYUOQT-UHFFFAOYSA-N	341311	2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-N-(imidazo[1,2-a]pyridin-6-yl)-3-(pyridin-2-yl)propanamide (racemate)::US9765070, Example 28	Plasma kallikrein			 8.80							US Patent		10.7270/Q25D8TZT		aid1797193	US9765070	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Teller, H; Jimenez Nunez, E; Schirok, H; Klar, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=341311	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=341311&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118054834	385212084							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
674145	COc1cn(C(Cc2cnco2)C(=O)Nc2ccc3nccn3c2)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C26H19ClN6O4/c1-36-23-14-33(25(34)10-21(23)20-8-17(27)3-2-16(20)11-28)22(9-19-12-29-15-37-19)26(35)31-18-4-5-24-30-6-7-32(24)13-18/h2-8,10,12-15,22H,9H2,1H3,(H,31,35)	SXEHENQWJCXCPF-UHFFFAOYSA-N	341312	2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-N-(imidazo[1,2-a]pyridin-6-yl)-3-(1,3-oxazol-5-yl)propanamide (racemate)::US9765070, Example 29	Plasma kallikrein			 11.0							US Patent		10.7270/Q25D8TZT		aid1797193	US9765070	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Teller, H; Jimenez Nunez, E; Schirok, H; Klar, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=341312	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=341312&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118054847	385212085							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
674146	Clc1ccc(C#N)c(c1)-c1cc(=O)n(cc1Cl)C(Cc1cnco1)C(=O)Nc1ccc2nccn2c1	InChI=1S/C25H16Cl2N6O3/c26-16-2-1-15(10-28)19(7-16)20-9-24(34)33(13-21(20)27)22(8-18-11-29-14-36-18)25(35)31-17-3-4-23-30-5-6-32(23)12-17/h1-7,9,11-14,22H,8H2,(H,31,35)	LNHRBAARNIAKDJ-UHFFFAOYSA-N	341313	2-[5-Chloro-4-(5-chloro-2-cyanophenyl)-2-oxopyridin-1(2H)-yl]-N-(imidazo[1,2-a]pyridin-6-yl)-3-(1,3-oxazol-5-yl)propanamide (racemate)::US9765070, Example 30	Plasma kallikrein			 120							US Patent		10.7270/Q25D8TZT		aid1797193	US9765070	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Teller, H; Jimenez Nunez, E; Schirok, H; Klar, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=341313	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=341313&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118054903	385212086							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
674147	FC(F)Oc1cn(C(Cc2cnco2)C(=O)Nc2ccc3nccn3c2)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C26H17ClF2N6O4/c27-16-2-1-15(10-30)19(7-16)20-9-24(36)35(13-22(20)39-26(28)29)21(8-18-11-31-14-38-18)25(37)33-17-3-4-23-32-5-6-34(23)12-17/h1-7,9,11-14,21,26H,8H2,(H,33,37)	UWSQGCJZIBJSGU-UHFFFAOYSA-N	341314	2-[4-(5-Chloro-2-cyanophenyl)-5-(difluoromethoxy)-2-oxopyridin-1(2H)-yl]-N-(imidazo[1,2-a]pyridin-6-yl)-3-(1,3-oxazol-5-yl)propanamide (racemate)::US9765070, Example 31	Plasma kallikrein			 970							US Patent		10.7270/Q25D8TZT		aid1797193	US9765070	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Teller, H; Jimenez Nunez, E; Schirok, H; Klar, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=341314	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=341314&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118054783	385212087							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
674148	COc1cn(C(Cc2cocn2)C(=O)Nc2ccc3nccn3c2)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C26H19ClN6O4/c1-36-23-13-33(25(34)10-21(23)20-8-17(27)3-2-16(20)11-28)22(9-19-14-37-15-30-19)26(35)31-18-4-5-24-29-6-7-32(24)12-18/h2-8,10,12-15,22H,9H2,1H3,(H,31,35)	MPOGRWXPOBZETN-UHFFFAOYSA-N	341315	2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-N-(imidazo[1,2-a]pyridin-6-yl)-3-(1,3-oxazol-4-yl)propanamide (racemate)::US9765070, Example 32	Plasma kallikrein			 36.0							US Patent		10.7270/Q25D8TZT		aid1797193	US9765070	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Teller, H; Jimenez Nunez, E; Schirok, H; Klar, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=341315	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=341315&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118054870	385212088							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
674149	Clc1ccc(C#N)c(c1)-c1cc(=O)n(cc1Cl)C(Cc1cocn1)C(=O)Nc1ccc2nccn2c1	InChI=1S/C25H16Cl2N6O3/c26-16-2-1-15(10-28)19(7-16)20-9-24(34)33(12-21(20)27)22(8-18-13-36-14-30-18)25(35)31-17-3-4-23-29-5-6-32(23)11-17/h1-7,9,11-14,22H,8H2,(H,31,35)	RMMLZVAGUQRCKX-UHFFFAOYSA-N	341316	2-[5-Chloro-4-(5-chloro-2-cyanophenyl)-2-oxopyridin-1(2H)-yl]-N-(imidazo[1,2-a]pyridin-6-yl)-3-(1,3-oxazol-4-yl)propanamide (racemate)::US9765070, Example 33	Plasma kallikrein			 250							US Patent		10.7270/Q25D8TZT		aid1797193	US9765070	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Teller, H; Jimenez Nunez, E; Schirok, H; Klar, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=341316	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=341316&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118054904	385212089							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
674150	CCC(C(=O)Nc1ccn2nccc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C24H20ClN5O3/c1-3-21(24(32)28-17-7-9-30-18(11-17)6-8-27-30)29-14-22(33-2)20(12-23(29)31)19-10-16(25)5-4-15(19)13-26/h4-12,14,21H,3H2,1-2H3,(H,28,32)	FAEMQZRJJSMJID-UHFFFAOYSA-N	341317	2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-N-(pyrazolo[1,5-a]pyridin-5-yl)butanamide (racemate)::US9765070, Example 34	Plasma kallikrein			 17.0							US Patent		10.7270/Q25D8TZT		aid1797193	US9765070	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Teller, H; Jimenez Nunez, E; Schirok, H; Klar, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=341317	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=341317&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118054784	385212090							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
674151	COCCC(C(=O)Nc1ccn2nccc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C25H22ClN5O4/c1-34-10-7-22(25(33)29-18-6-9-31-19(12-18)5-8-28-31)30-15-23(35-2)21(13-24(30)32)20-11-17(26)4-3-16(20)14-27/h3-6,8-9,11-13,15,22H,7,10H2,1-2H3,(H,29,33)	JREFSUNTZCXDKL-UHFFFAOYSA-N	341318	2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxy-N-(pyrazolo[1,5-a]pyridin-5-yl)butanamide (racemate)::US9765070, Example 35::US9765070, Example 36	Plasma kallikrein			 4.30							US Patent		10.7270/Q25D8TZT		aid1797193	US9765070	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Teller, H; Jimenez Nunez, E; Schirok, H; Klar, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=341318	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=341318&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			91755035	385212091							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
674152	COCCC(C(=O)Nc1ccn2nccc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C25H22ClN5O4/c1-34-10-7-22(25(33)29-18-6-9-31-19(12-18)5-8-28-31)30-15-23(35-2)21(13-24(30)32)20-11-17(26)4-3-16(20)14-27/h3-6,8-9,11-13,15,22H,7,10H2,1-2H3,(H,29,33)	JREFSUNTZCXDKL-UHFFFAOYSA-N	341318	2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxy-N-(pyrazolo[1,5-a]pyridin-5-yl)butanamide (racemate)::US9765070, Example 35::US9765070, Example 36	Plasma kallikrein			 3.20							US Patent		10.7270/Q25D8TZT		aid1797193	US9765070	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Teller, H; Jimenez Nunez, E; Schirok, H; Klar, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=341318	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=341318&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			91755035	385212091							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
674153	COCCC(C(=O)Nc1ccn2nccc2c1)n1cc(Cl)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C24H19Cl2N5O3/c1-34-9-6-22(24(33)29-17-5-8-31-18(11-17)4-7-28-31)30-14-21(26)20(12-23(30)32)19-10-16(25)3-2-15(19)13-27/h2-5,7-8,10-12,14,22H,6,9H2,1H3,(H,29,33)	XZFDILIFCBODQC-UHFFFAOYSA-N	341320	2-[5-Chloro-4-(5-chloro-2-cyanophenyl)-2-oxopyridin-1(2H)-yl]-4-methoxy-N-(pyrazolo[1,5-a]pyridin-5-yl)butanamide (racemate)::US9765070, Example 37::US9765070, Example 38	Plasma kallikrein			 65.0							US Patent		10.7270/Q25D8TZT		aid1797193	US9765070	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Teller, H; Jimenez Nunez, E; Schirok, H; Klar, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=341320	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=341320&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118054905	385212092							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
674154	COCCC(C(=O)Nc1ccn2nccc2c1)n1cc(Cl)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C24H19Cl2N5O3/c1-34-9-6-22(24(33)29-17-5-8-31-18(11-17)4-7-28-31)30-14-21(26)20(12-23(30)32)19-10-16(25)3-2-15(19)13-27/h2-5,7-8,10-12,14,22H,6,9H2,1H3,(H,29,33)	XZFDILIFCBODQC-UHFFFAOYSA-N	341320	2-[5-Chloro-4-(5-chloro-2-cyanophenyl)-2-oxopyridin-1(2H)-yl]-4-methoxy-N-(pyrazolo[1,5-a]pyridin-5-yl)butanamide (racemate)::US9765070, Example 37::US9765070, Example 38	Plasma kallikrein			 29.0							US Patent		10.7270/Q25D8TZT		aid1797193	US9765070	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Teller, H; Jimenez Nunez, E; Schirok, H; Klar, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=341320	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=341320&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118054905	385212092							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
674155	CCC(C(=O)Nc1ccn2nccc2c1)n1cc(C(O)=O)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C24H18ClN5O4/c1-2-21(23(32)28-16-6-8-30-17(10-16)5-7-27-30)29-13-20(24(33)34)19(11-22(29)31)18-9-15(25)4-3-14(18)12-26/h3-11,13,21H,2H2,1H3,(H,28,32)(H,33,34)	QGKUUYSHDCDVMQ-UHFFFAOYSA-N	341322	4-(5-Chloro-2-cyanophenyl)-6-oxo-1-[1-oxo-1-(pyrazol[1,5-a]pyridin-5-ylamino)butan-2-yl]-1,6-dihydropyridine-3-carboxylic acid (racemate)::US9765070, Example 39	Plasma kallikrein			 1800							US Patent		10.7270/Q25D8TZT		aid1797193	US9765070	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Teller, H; Jimenez Nunez, E; Schirok, H; Klar, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=341322	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=341322&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118051658	385212093							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
674156	CCC(C(=O)Nc1ccn2ncc(Cl)c2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C24H19Cl2N5O3/c1-3-20(24(33)29-16-6-7-31-21(9-16)19(26)12-28-31)30-13-22(34-2)18(10-23(30)32)17-8-15(25)5-4-14(17)11-27/h4-10,12-13,20H,3H2,1-2H3,(H,29,33)	YITCBZJHSBAOAD-UHFFFAOYSA-N	341323	2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-N-(3-chloropyrazolo[1,5-a]pyridin-5-yl)butanamide (racemate)::US9765070, Example 40	Plasma kallikrein			 51.0							US Patent		10.7270/Q25D8TZT		aid1797193	US9765070	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Teller, H; Jimenez Nunez, E; Schirok, H; Klar, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=341323	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=341323&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118054798	385212094							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
674157	COCCC(C(=O)Nc1ccn2ncc(Cl)c2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C25H21Cl2N5O4/c1-35-8-6-21(25(34)30-17-5-7-32-22(10-17)20(27)13-29-32)31-14-23(36-2)19(11-24(31)33)18-9-16(26)4-3-15(18)12-28/h3-5,7,9-11,13-14,21H,6,8H2,1-2H3,(H,30,34)	ULIBXHPBQUNUJM-UHFFFAOYSA-N	341324	2-[4-(5-Chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-N-(3-chloropyrazolo[1,5-a]pyridin-5-yl)-4-methoxybutanamide (racemate)::US9765070, Example 41	Plasma kallikrein			 11.0							US Patent		10.7270/Q25D8TZT		aid1797193	US9765070	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Teller, H; Jimenez Nunez, E; Schirok, H; Klar, J	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=341324	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=341324&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118054848	385212095							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50744290	NC(=O)n1cc(NC(=O)N2CCC[C@H]2C(=O)Nc2cccc(OC(F)(F)F)c2)c2ccccc12	InChI=1S/C22H20F3N5O4/c23-22(24,25)34-14-6-3-5-13(11-14)27-19(31)18-9-4-10-29(18)21(33)28-16-12-30(20(26)32)17-8-2-1-7-15(16)17/h1-3,5-8,11-12,18H,4,9-10H2,(H2,26,32)(H,27,31)(H,28,33)/t18-/m0/s1	GPEWMCZCFCZAEI-SFHVURJKSA-N	60517	US9085555, 124	Plasma kallikrein			>30000							ChEMBL	10.1021/acs.jmedchem.7b00425	10.7270/Q2TB195V	28621538			Lorthiois, E; Anderson, K; Vulpetti, A; Rogel, O; Cumin, F; Ostermann, N; Steinbacher, S; Mac Sweeney, A; Delgado, O; Liao, SM; Randl, S; Rüdisser, S; Dussauge, S; Fettis, K; Kieffer, L; de Erkenez, A; Yang, L; Hartwieg, C; Argikar, UA; La Bonte, LR; Newton, R; Kansara, V; Flohr, S; Hommel, U; Jaffee, B; Maibaum, J	Novartis Pharma AG	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=60517	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=60517&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	8RW	5NAR	68284084	313633343						ZINC02287367	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
661033	Nc1nccc2cc(CNc3nccc4n(Cc5csc(n5)-c5ccccc5)ccc34)ccc12	InChI=1S/C27H22N6S/c28-25-22-7-6-18(14-20(22)8-11-29-25)15-31-26-23-10-13-33(24(23)9-12-30-26)16-21-17-34-27(32-21)19-4-2-1-3-5-19/h1-14,17H,15-16H2,(H2,28,29)(H,30,31)	PRWSAIYLEUKOPE-UHFFFAOYSA-N	335736	6-{[1-(2-Phenyl-thiazol-4-ylmethyl)-1H-pyrrolo[3,2-c]-pyridin-4-ylamino]-methyl}-isoquinolin-1-ylamine::US9738641, 1	Plasma kallikrein			 6540							US Patent		10.7270/Q2M047K7		aid1797033	US9738641	Edwards, HJ; Evans, DM; Davie, RL; Rooker, DP; Hewison, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335736	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335736&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117890417	384987894							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
661034	Nc1nccc2cc(CNc3nccc4n(Cc5ccccc5)ccc34)ccc12	InChI=1S/C24H21N5/c25-23-20-7-6-18(14-19(20)8-11-26-23)15-28-24-21-10-13-29(22(21)9-12-27-24)16-17-4-2-1-3-5-17/h1-14H,15-16H2,(H2,25,26)(H,27,28)	XXHLWUGEDASFLJ-UHFFFAOYSA-N	335737	6-[(1-Benzyl-1H-pyrrolo[3,2-c]pyridin-4-ylamino)-methyl]-isoquinolin-1-ylamine::US9738641, 2	Plasma kallikrein			 28900							US Patent		10.7270/Q2M047K7		aid1797033	US9738641	Edwards, HJ; Evans, DM; Davie, RL; Rooker, DP; Hewison, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335737	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335737&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90647193	384987895							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
661035	O=c1ccccn1Cc1ccc(Cn2ccc3c(NCc4cnc5[nH]ccc5c4)nccc23)cc1	InChI=1S/C28H24N6O/c35-26-3-1-2-13-34(26)19-21-6-4-20(5-7-21)18-33-14-10-24-25(33)9-12-30-28(24)32-17-22-15-23-8-11-29-27(23)31-16-22/h1-16H,17-19H2,(H,29,31)(H,30,32)	KOTMMIHTHZXOHT-UHFFFAOYSA-N	335738	1-(4-{4-[(1H-Pyrrolo[2,3-b]pyridin-5-ylmethyl)-amino]-pyrrolo[3,2-c]pyridin-1-ylmethyl}-benzyl)-1H-pyridin-2-one::US9738641, 3	Plasma kallikrein			 5460							US Patent		10.7270/Q2M047K7		aid1797033	US9738641	Edwards, HJ; Evans, DM; Davie, RL; Rooker, DP; Hewison, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335738	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335738&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117890506	384987896							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
661036	C(Nc1nccc2n(Cc3csc(n3)-c3ccccc3)ccc12)c1cnc2[nH]ccc2c1	InChI=1S/C25H20N6S/c1-2-4-18(5-3-1)25-30-20(16-32-25)15-31-11-8-21-22(31)7-10-27-24(21)29-14-17-12-19-6-9-26-23(19)28-13-17/h1-13,16H,14-15H2,(H,26,28)(H,27,29)	ZQZFMVDDNFJRTA-UHFFFAOYSA-N	335739	US9738641, 4::[1-(2-Phenyl-thiazol-4-ylmethyl)-1H-pyrrolo[3,2-c]pyridin-4-yl]-(1H-pyrrolo[2,3-b]pyridin-5-ylmethyl)-amine	Plasma kallikrein			 5320							US Patent		10.7270/Q2M047K7		aid1797033	US9738641	Edwards, HJ; Evans, DM; Davie, RL; Rooker, DP; Hewison, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335739	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335739&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117890322	384987897							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
661037	NCc1ccc(CNc2nccc3n(CCCCc4ccccc4)ccc23)cc1	InChI=1S/C25H28N4/c26-18-21-9-11-22(12-10-21)19-28-25-23-14-17-29(24(23)13-15-27-25)16-5-4-8-20-6-2-1-3-7-20/h1-3,6-7,9-15,17H,4-5,8,16,18-19,26H2,(H,27,28)	JFHMDUALUMZCTL-UHFFFAOYSA-N	335740	(4-Aminomethyl-benzyl)-[1-(4-phenyl-butyl)-1H-pyrrolo[3,2-c]-pyridin-4-yl]-amine::US9738641, 5	Plasma kallikrein			 29000							US Patent		10.7270/Q2M047K7		aid1797033	US9738641	Edwards, HJ; Evans, DM; Davie, RL; Rooker, DP; Hewison, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335740	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335740&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117890516	384987898							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
661038	Cc1cc(CN)ccc1CNc1nccc2n(Cc3csc(n3)-c3ccccc3)ccc12	InChI=1S/C26H25N5S/c1-18-13-19(14-27)7-8-21(18)15-29-25-23-10-12-31(24(23)9-11-28-25)16-22-17-32-26(30-22)20-5-3-2-4-6-20/h2-13,17H,14-16,27H2,1H3,(H,28,29)	UPOGWTRXIGDVFH-UHFFFAOYSA-N	335741	(4-Aminomethyl-2-methyl-benzyl)-[1-(2-phenyl-thiazol-4-ylmethyl)-1H-pyrrolo[3,2-c]pyridin-4-yl]-amine::US9738641, 6	Plasma kallikrein			 8590							US Patent		10.7270/Q2M047K7		aid1797033	US9738641	Edwards, HJ; Evans, DM; Davie, RL; Rooker, DP; Hewison, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335741	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335741&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117890230	384987899							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
661039	NCc1ccc(CNc2nccc3n(Cc4ccc(Cn5ccccc5=O)cc4)ccc23)cc1	InChI=1S/C28H27N5O/c29-17-21-4-6-22(7-5-21)18-31-28-25-13-16-32(26(25)12-14-30-28)19-23-8-10-24(11-9-23)20-33-15-2-1-3-27(33)34/h1-16H,17-20,29H2,(H,30,31)	FPFNCSZYXPULRD-UHFFFAOYSA-N	335742	1-{4-[4-(4-Aminomethyl-benzylamino)-pyrrolo[3,2-c]pyridin-1-ylmethyl]-benzyl}-1H-pyridin-2-one::US9738641, 7	Plasma kallikrein			 5370							US Patent		10.7270/Q2M047K7		aid1797033	US9738641	Edwards, HJ; Evans, DM; Davie, RL; Rooker, DP; Hewison, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335742	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335742&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117890312	384987900							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
661040	Cc1cc(CN)ccc1CNc1nccc2n(Cc3ccc(Cn4ccccc4=O)cc3)ccc12	InChI=1S/C29H29N5O/c1-21-16-24(17-30)9-10-25(21)18-32-29-26-12-15-33(27(26)11-13-31-29)19-22-5-7-23(8-6-22)20-34-14-3-2-4-28(34)35/h2-16H,17-20,30H2,1H3,(H,31,32)	UJASRHWJAKFURS-UHFFFAOYSA-N	335743	1-{4-[4-(4-Aminomethyl-2-methyl-benzylamino)-pyrrolo[3,2-c]pyridin-1-ylmethyl]-benzyl}-1H-pyridin-2-one::US9738641, 8	Plasma kallikrein			 6300							US Patent		10.7270/Q2M047K7		aid1797033	US9738641	Edwards, HJ; Evans, DM; Davie, RL; Rooker, DP; Hewison, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335743	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335743&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117890428	384987901							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
661041	NCc1ccc(CNc2nccc3n(Cc4csc(n4)-c4ccccc4)ccc23)cc1	InChI=1S/C25H23N5S/c26-14-18-6-8-19(9-7-18)15-28-24-22-11-13-30(23(22)10-12-27-24)16-21-17-31-25(29-21)20-4-2-1-3-5-20/h1-13,17H,14-16,26H2,(H,27,28)	OCACJQIBMJEKIH-UHFFFAOYSA-N	335744	(4-Aminomethyl-benzyl)-[1-(2-phenyl-thiazol-4-ylmethyl)-1H-pyrrolo[3,2-c]pyridin-4-yl]-amine::US9738641, 9	Plasma kallikrein			 8100							US Patent		10.7270/Q2M047K7		aid1797033	US9738641	Edwards, HJ; Evans, DM; Davie, RL; Rooker, DP; Hewison, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335744	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335744&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117890203	384987902							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
661042	Cc1cnn(Cc2ccc(CN3CCOc4c(NCc5ccc6c(N)nccc6c5)ncnc34)cc2)c1	InChI=1S/C28H28N8O/c1-19-13-34-36(15-19)17-21-4-2-20(3-5-21)16-35-10-11-37-25-27(32-18-33-28(25)35)31-14-22-6-7-24-23(12-22)8-9-30-26(24)29/h2-9,12-13,15,18H,10-11,14,16-17H2,1H3,(H2,29,30)(H,31,32,33)	QJAPXRXDBNITPR-UHFFFAOYSA-N	335745	(1-Amino-isoquinolin-6-ylmethyl)-{8-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-4-yl}-amine::US9738641, 10	Plasma kallikrein			 20500							US Patent		10.7270/Q2M047K7		aid1797033	US9738641	Edwards, HJ; Evans, DM; Davie, RL; Rooker, DP; Hewison, SJ	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335745	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335745&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117890309	384987903							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716135	COc1cc(CN)ccc1CNC(=O)c1cc(C)n(Cc2csc(n2)-c2ccccc2)c1C	InChI=1S/C26H28N4O2S/c1-17-11-23(25(31)28-14-21-10-9-19(13-27)12-24(21)32-3)18(2)30(17)15-22-16-33-26(29-22)20-7-5-4-6-8-20/h4-12,16H,13-15,27H2,1-3H3,(H,28,31)	IBULPWHWUWJTMW-UHFFFAOYSA-N	186888	US9670157, 54 2,5-Dimethyl-1-(2-phenyl-thiazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-2-methoxy-benzylamide::US9834513, 54	Plasma kallikrein			 30.0							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186888	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186888&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290348	373987455							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716136	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1ccccc1	InChI=1S/C22H25N3O/c1-16-12-21(17(2)25(16)15-20-6-4-3-5-7-20)22(26)24-14-19-10-8-18(13-23)9-11-19/h3-12H,13-15,23H2,1-2H3,(H,24,26)	ZXWVKIBFYOVNCI-UHFFFAOYSA-N	362240	1-Benzyl-2,5-dimethyl-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 55	Plasma kallikrein			 3267							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=362240	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=362240&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716137	Cc1cc(C(=O)NCc2ccc(CN)cc2Cl)c(C)n1Cc1ccccc1	InChI=1S/C22H24ClN3O/c1-15-10-20(16(2)26(15)14-17-6-4-3-5-7-17)22(27)25-13-19-9-8-18(12-24)11-21(19)23/h3-11H,12-14,24H2,1-2H3,(H,25,27)	CEBWYTDSGYBBOG-UHFFFAOYSA-N	362241	1-Benzyl-2,5-dimethyl-1H-pyrrole-3-carboxylic acid 4-aminomethyl-2-chloro-benzylamide::US9834513, 56	Plasma kallikrein			 3856							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=362241	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=362241&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716138	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(-c2ccccc2)n1Cc1ccccc1	InChI=1S/C27H27N3O/c1-20-16-25(27(31)29-18-22-14-12-21(17-28)13-15-22)26(24-10-6-3-7-11-24)30(20)19-23-8-4-2-5-9-23/h2-16H,17-19,28H2,1H3,(H,29,31)	RKXLHVKAYMREQS-UHFFFAOYSA-N	186891	US9670157, 57 1-Benzyl-5-methyl-2-phenyl-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 57	Plasma kallikrein			 7178							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186891	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186891&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280195	373987458							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716139	CCOc1cccc(Cn2c(C)cc(C(=O)NCc3ccc(CN)cc3)c2C)c1	InChI=1S/C24H29N3O2/c1-4-29-22-7-5-6-21(13-22)16-27-17(2)12-23(18(27)3)24(28)26-15-20-10-8-19(14-25)9-11-20/h5-13H,4,14-16,25H2,1-3H3,(H,26,28)	OSOIQLFGFDLMQI-UHFFFAOYSA-N	186892	US9670157, 58 1-(3-Ethoxy-benzyl)-2,5-dimethyl-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 58	Plasma kallikrein			 4915							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186892	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186892&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280285	373987459							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716140	CCOc1ccc(Cn2c(C)cc(C(=O)NCc3ccc(CN)cc3)c2C)cc1	InChI=1S/C24H29N3O2/c1-4-29-22-11-9-21(10-12-22)16-27-17(2)13-23(18(27)3)24(28)26-15-20-7-5-19(14-25)6-8-20/h5-13H,4,14-16,25H2,1-3H3,(H,26,28)	DTHFKIRITMWVOZ-UHFFFAOYSA-N	186893	US9670157, 59 1-(4-Ethoxy-benzyl)-2,5-dimethyl-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 59	Plasma kallikrein			 2742							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186893	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186893&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280164	373987460							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716141	Cc1cc(C(=O)N(CN)Cc2ccccc2)c(C)n1Cc1ccc(OCc2ccccc2)cc1	InChI=1S/C29H31N3O2/c1-22-17-28(29(33)31(21-30)18-24-9-5-3-6-10-24)23(2)32(22)19-25-13-15-27(16-14-25)34-20-26-11-7-4-8-12-26/h3-17H,18-21,30H2,1-2H3	FNBAFFGIZYWHNC-UHFFFAOYSA-N	362245	1-(4-Benzyloxy-benzyl)-2,5-dimethyl-1H-pyrrole-3-carboxylic acid-aminomethyl-benzylamide::US9834513, 60	Plasma kallikrein			 3115							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=362245	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=362245&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716142	COc1ccc(Cn2c(C)cc(C(=O)N(CN)Cc3ccccc3)c2C)cc1	InChI=1S/C23H27N3O2/c1-17-13-22(23(27)25(16-24)14-19-7-5-4-6-8-19)18(2)26(17)15-20-9-11-21(28-3)12-10-20/h4-13H,14-16,24H2,1-3H3	RFFHAGIIRLGDCI-UHFFFAOYSA-N	362246	1-(4-Methoxy-benzyl)-2,5-dimethyl-1H-pyrrole-3-carboxylic acid-aminomethyl-benzylamide::US9834513, 61	Plasma kallikrein			 2990							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=362246	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=362246&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716143	Cc1cc(C(=O)N(CN)Cc2ccccc2)c(C)n1Cc1cccc(c1)C(N)=O	InChI=1S/C23H26N4O2/c1-16-11-21(23(29)26(15-24)13-18-7-4-3-5-8-18)17(2)27(16)14-19-9-6-10-20(12-19)22(25)28/h3-12H,13-15,24H2,1-2H3,(H2,25,28)	OVRBMNVKGVJSBO-UHFFFAOYSA-N	362247	1-(3-Carbamoyl-benzyl)-2,5-dimethyl-1H-pyrrole-3-carboxylic acid-aminomethyl-benzylamide::US9834513, 62	Plasma kallikrein			 6034							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=362247	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=362247&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716144	Cc1cc(C(=O)N(CN)Cc2ccccc2)c(C)n1Cc1ccc(cc1)C(N)=O	InChI=1S/C23H26N4O2/c1-16-12-21(23(29)26(15-24)13-18-6-4-3-5-7-18)17(2)27(16)14-19-8-10-20(11-9-19)22(25)28/h3-12H,13-15,24H2,1-2H3,(H2,25,28)	VYCMRSVXNCYATA-UHFFFAOYSA-N	362248	1-(4-Carbamoyl-benzyl)-2,5-dimethyl-1H-pyrrole-3-carboxylic acid-aminomethyl-benzylamide::US9834513, 63	Plasma kallikrein			 7338							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=362248	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=362248&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716145	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1cccc(c1)C#N	InChI=1S/C23H24N4O/c1-16-10-22(23(28)26-14-19-8-6-18(12-24)7-9-19)17(2)27(16)15-21-5-3-4-20(11-21)13-25/h3-11H,12,14-15,24H2,1-2H3,(H,26,28)	HZSKGFNWATXCGJ-UHFFFAOYSA-N	186898	US9670157, 64 1-(3-Cyano-benzyl)-2,5-dimethyl-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 64	Plasma kallikrein			 6253							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186898	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186898&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280205	373987465							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716146	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1ccc(cc1)C#N	InChI=1S/C23H24N4O/c1-16-11-22(23(28)26-14-20-7-3-18(12-24)4-8-20)17(2)27(16)15-21-9-5-19(13-25)6-10-21/h3-11H,12,14-15,24H2,1-2H3,(H,26,28)	PDWMJRDCYAVGDP-UHFFFAOYSA-N	186899	US9670157, 65 1-(4-Cyano-benzyl)-2,5-dimethyl-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 65	Plasma kallikrein			 4558							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186899	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186899&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280064	373987466							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716147	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1cccc(CN)c1	InChI=1S/C23H28N4O/c1-16-10-22(23(28)26-14-19-8-6-18(12-24)7-9-19)17(2)27(16)15-21-5-3-4-20(11-21)13-25/h3-11H,12-15,24-25H2,1-2H3,(H,26,28)	OPSYIFLJCDVWBB-UHFFFAOYSA-N	186900	US9670157, 66 1-(3-Aminomethyl-benzyl)-2,5-dimethyl-1H-pyrrole-3-carboxylicacid 4-aminomethyl-benzylamide::US9834513, 66	Plasma kallikrein			 5383							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186900	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186900&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280266	373987467							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716148	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1ccc(CN)cc1	InChI=1S/C23H28N4O/c1-16-11-22(23(28)26-14-20-7-3-18(12-24)4-8-20)17(2)27(16)15-21-9-5-19(13-25)6-10-21/h3-11H,12-15,24-25H2,1-2H3,(H,26,28)	HACVLVRJTRLUNN-UHFFFAOYSA-N	186901	US9670157, 67 1-(4-Aminomethyl-benzyl)-2,5-dimethyl-1H-pyrrole-3-carboxylicacid 4-aminomethyl-benzylamide::US9834513, 67	Plasma kallikrein			 3503							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186901	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186901&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280280	373987468							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716149	CC(=O)NCc1ccc(Cn2c(C)cc(C(=O)NCc3ccc(CN)cc3)c2C)cc1	InChI=1S/C25H30N4O2/c1-17-12-24(25(31)28-15-22-6-4-20(13-26)5-7-22)18(2)29(17)16-23-10-8-21(9-11-23)14-27-19(3)30/h4-12H,13-16,26H2,1-3H3,(H,27,30)(H,28,31)	HKSMDUNWNNKDFX-UHFFFAOYSA-N	362253	1-[4-(Acetylamino-methyl)-benzyl]-2,5-dimethyl-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 68	Plasma kallikrein			 2093							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=362253	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=362253&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716150	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1cccc(c1)-c1ccccc1	InChI=1S/C28H29N3O/c1-20-15-27(28(32)30-18-23-13-11-22(17-29)12-14-23)21(2)31(20)19-24-7-6-10-26(16-24)25-8-4-3-5-9-25/h3-16H,17-19,29H2,1-2H3,(H,30,32)	UPJXJSJQGXMKHH-UHFFFAOYSA-N	186903	US9670157, 69 1-Biphenyl-3-ylmethyl-2,5-dimethyl-1H-pyrrole-3-carboxylic acid4-aminomethyl-benzylamide::US9834513, 69	Plasma kallikrein			 689							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186903	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186903&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280297	373987470							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716151	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1ccc(cc1)-c1ccccc1	InChI=1S/C28H29N3O/c1-20-16-27(28(32)30-18-23-10-8-22(17-29)9-11-23)21(2)31(20)19-24-12-14-26(15-13-24)25-6-4-3-5-7-25/h3-16H,17-19,29H2,1-2H3,(H,30,32)	DRILYKUMENWWJU-UHFFFAOYSA-N	186904	US9670157, 70 1-Biphenyl-4-ylmethyl-2,5-dimethyl-1H-pyrrole-3-carboxylic acid4-aminomethyl-benzylamide::US9834513, 70	Plasma kallikrein			 4593							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186904	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186904&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280290	373987471							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716152	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1cccc(c1)-c1cccnc1	InChI=1S/C27H28N4O/c1-19-13-26(27(32)30-16-22-10-8-21(15-28)9-11-22)20(2)31(19)18-23-5-3-6-24(14-23)25-7-4-12-29-17-25/h3-14,17H,15-16,18,28H2,1-2H3,(H,30,32)	ZHSQJZFBBUWKBF-UHFFFAOYSA-N	186905	US9670157, 71 2,5-Dimethyl-1-(3-pyridin-3-yl-benzyl)-1H-pyrrole-3-carboxylicacid 4-aminomethyl-benzylamide::US9834513, 71	Plasma kallikrein			 702							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186905	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186905&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280260	373987472							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716153	Cc1cc(C(=O)NCc2ccc(C)cc2)c(C)n1Cc1cccc(c1)-c1ccncc1	InChI=1S/C27H27N3O/c1-19-7-9-22(10-8-19)17-29-27(31)26-15-20(2)30(21(26)3)18-23-5-4-6-25(16-23)24-11-13-28-14-12-24/h4-16H,17-18H2,1-3H3,(H,29,31)	GSLJDFDXVHKHBT-UHFFFAOYSA-N	362257	2,5-Dimethyl-1-(3-pyridin-4-yl-benzyl)-1H-pyrrole-3-carboxylicacid 4-aminomethyl-benzylamide::US9834513, 72	Plasma kallikrein			 3021							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=362257	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=362257&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716154	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1cccc(c1)N1CCOCC1	InChI=1S/C26H32N4O2/c1-19-14-25(26(31)28-17-22-8-6-21(16-27)7-9-22)20(2)30(19)18-23-4-3-5-24(15-23)29-10-12-32-13-11-29/h3-9,14-15H,10-13,16-18,27H2,1-2H3,(H,28,31)	OLCGTUICNZOAOJ-UHFFFAOYSA-N	186907	US9670157, 73 2,5-Dimethyl-1-(3-morpholin-4-yl-benzyl)-1H-pyrrole-3-carboxylicacid 4-aminomethyl-benzylamide::US9834513, 73	Plasma kallikrein			 7580							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186907	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186907&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280127	373987474							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716155	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1cccc(c1)N1CCCCC1	InChI=1S/C27H34N4O/c1-20-15-26(27(32)29-18-23-11-9-22(17-28)10-12-23)21(2)31(20)19-24-7-6-8-25(16-24)30-13-4-3-5-14-30/h6-12,15-16H,3-5,13-14,17-19,28H2,1-2H3,(H,29,32)	ITDCKEYZHSCEEN-UHFFFAOYSA-N	186908	US9670157, 74 2,5-Dimethyl-1-(3-piperidin-1-yl-benzyl)-1H-pyrrole-3-carboxylicacid 4-aminomethyl-benzylamide::US9834513, 74	Plasma kallikrein			 1584							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186908	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186908&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280213	373987475							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716156	Cc1cc(C(=O)NCc2ccc(CN)cc2)n(C)c1Cc1ccccc1	InChI=1S/C22H25N3O/c1-16-12-21(25(2)20(16)13-17-6-4-3-5-7-17)22(26)24-15-19-10-8-18(14-23)9-11-19/h3-12H,13-15,23H2,1-2H3,(H,24,26)	QKCMLEDBXHOENV-UHFFFAOYSA-N	186909	US9670157, 75 5-Benzyl-1,4-dimethyl-1H-pyrrole-2-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 75	Plasma kallikrein			 4499							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186909	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186909&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280304	373987476							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716157	Cc1cc([nH]c1Cc1ccccc1)C(=O)NCc1ccc(CN)cc1	InChI=1S/C21H23N3O/c1-15-11-20(24-19(15)12-16-5-3-2-4-6-16)21(25)23-14-18-9-7-17(13-22)8-10-18/h2-11,24H,12-14,22H2,1H3,(H,23,25)	GMYIVBMVEZAPCZ-UHFFFAOYSA-N	362261	5-Benzyl-4-methyl-1H-pyrrole-2-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 76	Plasma kallikrein			 8767							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=362261	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=362261&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716158	CCn1c(Cc2ccccc2)c(C)cc1C(=O)NCc1ccc(CN)cc1	InChI=1S/C23H27N3O/c1-3-26-21(14-18-7-5-4-6-8-18)17(2)13-22(26)23(27)25-16-20-11-9-19(15-24)10-12-20/h4-13H,3,14-16,24H2,1-2H3,(H,25,27)	SJUHCJNXJPBLHB-UHFFFAOYSA-N	186912	US9670157, 78 5-Benzyl-4-methyl-1-propyl-1H-pyrrole-2-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 77	Plasma kallikrein			 3722							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186912	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186912&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280100	373987479							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716159	CCCn1c(Cc2ccccc2)c(C)cc1C(=O)NCc1ccc(CN)cc1	InChI=1S/C24H29N3O/c1-3-13-27-22(15-19-7-5-4-6-8-19)18(2)14-23(27)24(28)26-17-21-11-9-20(16-25)10-12-21/h4-12,14H,3,13,15-17,25H2,1-2H3,(H,26,28)	TXFLOUBVCQUPIW-UHFFFAOYSA-N	186911	US9670157, 77 5-Benzyl-1-ethyl-4-methyl-1H-pyrrole-2-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 78	Plasma kallikrein			 4133							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186911	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186911&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280303	373987478							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716160	CC(C)NC(=O)c1ccc(Cn2cc(cn2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C23H27N5O2/c1-16(2)27-23(30)20-9-7-19(8-10-20)14-28-15-21(13-26-28)22(29)25-12-18-5-3-17(11-24)4-6-18/h3-10,13,15-16H,11-12,14,24H2,1-2H3,(H,25,29)(H,27,30)	GUERQUBALZWKPI-UHFFFAOYSA-N	186913	US9670157, 79 1-(4-Isopropylcarbamoyl-benzyl)-1H-pyrazole-4-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 79	Plasma kallikrein			 5546							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186913	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186913&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90281707	373987480							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716161	Cc1c(cnn1Cc1csc(n1)-c1ccccc1)C(=O)NCc1ccc(CN)cc1	InChI=1S/C23H23N5OS/c1-16-21(22(29)25-12-18-9-7-17(11-24)8-10-18)13-26-28(16)14-20-15-30-23(27-20)19-5-3-2-4-6-19/h2-10,13,15H,11-12,14,24H2,1H3,(H,25,29)	FFETVVLFKYPIEY-UHFFFAOYSA-N	186914	US9670157, 80 5-Methyl-1-(2-phenyl-thiazol-4-ylmethyl)-1H-pyrazole-4-carboxylicacid 4-aminomethyl-benzylamide::US9834513, 80	Plasma kallikrein			 2340							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186914	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186914&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280087	373987481							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716162	Cc1nn(Cc2csc(n2)-c2ccccc2)cc1C(=O)NCc1ccc(CN)cc1	InChI=1S/C23H23N5OS/c1-16-21(22(29)25-12-18-9-7-17(11-24)8-10-18)14-28(27-16)13-20-15-30-23(26-20)19-5-3-2-4-6-19/h2-10,14-15H,11-13,24H2,1H3,(H,25,29)	KJQLRTOJIBPKRC-UHFFFAOYSA-N	186915	US9670157, 81 3-Methyl-1-(2-phenyl-thiazol-4-ylmethyl)-1H-pyrazole-4-carboxylicacid 4-aminomethyl-benzylamide::US9834513, 81	Plasma kallikrein			 695							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186915	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186915&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280108	373987482							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716163	NCc1ccc(CNC(=O)c2cnn(Cc3csc(n3)-c3ccccc3)c2C(F)(F)F)cc1	InChI=1S/C23H20F3N5OS/c24-23(25,26)20-19(21(32)28-11-16-8-6-15(10-27)7-9-16)12-29-31(20)13-18-14-33-22(30-18)17-4-2-1-3-5-17/h1-9,12,14H,10-11,13,27H2,(H,28,32)	ZOGFWBZPASWNGT-UHFFFAOYSA-N	186916	US9670157, 82 1-(2-Phenyl-thiazol-4-ylmethyl)-5-trifluoromethyl-1H-pyrazole-4-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 82	Plasma kallikrein			 488							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186916	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186916&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280110	373987483							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716164	NCc1ccc(CNC(=O)c2cn(Cc3csc(n3)-c3ccccc3)nc2C(F)(F)F)cc1	InChI=1S/C23H20F3N5OS/c24-23(25,26)20-19(21(32)28-11-16-8-6-15(10-27)7-9-16)13-31(30-20)12-18-14-33-22(29-18)17-4-2-1-3-5-17/h1-9,13-14H,10-12,27H2,(H,28,32)	XKNWUHBAMSZYGY-UHFFFAOYSA-N	186917	US9670157, 83 1-(2-Phenyl-thiazol-4-ylmethyl)-3-trifluoromethyl-1H-pyrazole-4-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 83	Plasma kallikrein			 452							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186917	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186917&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280225	373987484							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716165	NCc1ccc(CNC(=O)c2cn(Cc3ccccc3)nc2-c2ccccc2)cc1	InChI=1S/C25H24N4O/c26-15-19-11-13-20(14-12-19)16-27-25(30)23-18-29(17-21-7-3-1-4-8-21)28-24(23)22-9-5-2-6-10-22/h1-14,18H,15-17,26H2,(H,27,30)	WADOCDNXVIYFEL-UHFFFAOYSA-N	186918	US9670157, 84 1-Benzyl-3-phenyl-1H-pyrazole-4-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 84	Plasma kallikrein			 8379							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186918	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186918&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280333	373987485							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716166	Cc1cnn(Cc2ccc(Cn3cc(cn3)C(=O)NCc3ccc(CN)cc3)cc2)c1	InChI=1S/C24H26N6O/c1-18-11-27-29(14-18)15-21-6-8-22(9-7-21)16-30-17-23(13-28-30)24(31)26-12-20-4-2-19(10-25)3-5-20/h2-9,11,13-14,17H,10,12,15-16,25H2,1H3,(H,26,31)	HPJLQUVYLPKVEH-UHFFFAOYSA-N	186919	US9670157, 85 1-[4-(4-Methyl-pyrazol-1-ylmethyl)-benzyl]-1H-pyrazole-4-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 85	Plasma kallikrein			 11.0							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186919	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186919&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290349	373987486							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716167	Cc1cc(C)n(Cc2ccc(Cn3cc(cn3)C(=O)NCc3ccc(CN)cc3)cc2)n1	InChI=1S/C25H28N6O/c1-18-11-19(2)31(29-18)16-23-9-7-22(8-10-23)15-30-17-24(14-28-30)25(32)27-13-21-5-3-20(12-26)4-6-21/h3-11,14,17H,12-13,15-16,26H2,1-2H3,(H,27,32)	BWBYPOROCPLNGV-UHFFFAOYSA-N	186920	US9670157, 86 1-[4-(3,5-Dimethyl-pyrazol-1-ylmethyl)-benzyl]-1H-pyrazole-4-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 86	Plasma kallikrein			 7.00							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186920	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186920&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290350	373987487							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716168	NCc1ccc(CNC(=O)c2cnn(Cc3ccc(cc3)C(=O)N3CCCCC3)c2)cc1	InChI=1S/C25H29N5O2/c26-14-19-4-6-20(7-5-19)15-27-24(31)23-16-28-30(18-23)17-21-8-10-22(11-9-21)25(32)29-12-2-1-3-13-29/h4-11,16,18H,1-3,12-15,17,26H2,(H,27,31)	VRVDDLVGBPHXNP-UHFFFAOYSA-N	186921	US9670157, 87 1-[4-(Piperidine-1-carbonyl)-benzyl]-1H-pyrazole-4-carboxylicacid 4-aminomethyl-benzylamide::US9834513, 87	Plasma kallikrein			 5480							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186921	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186921&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280091	373987488							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716169	NCc1ccc(CNC(=O)c2ncn(Cc3ccc(Oc4ccccc4)cc3)n2)cc1	InChI=1S/C24H23N5O2/c25-14-18-6-8-19(9-7-18)15-26-24(30)23-27-17-29(28-23)16-20-10-12-22(13-11-20)31-21-4-2-1-3-5-21/h1-13,17H,14-16,25H2,(H,26,30)	SGIOOJDXIKXIQM-UHFFFAOYSA-N	186946	US9670157, 88 1-(4-Phenoxy-benzyl)-1H-[1,2,4]triazole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 88	Plasma kallikrein			 6989							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186946	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186946&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280336	373987489							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716170	NC1(CC1)c1ccc(CNC(=O)c2cnn(Cc3ccc(Cn4ccccc4=O)cc3)c2)cc1	InChI=1S/C27H27N5O2/c28-27(12-13-27)24-10-8-20(9-11-24)15-29-26(34)23-16-30-32(19-23)18-22-6-4-21(5-7-22)17-31-14-2-1-3-25(31)33/h1-11,14,16,19H,12-13,15,17-18,28H2,(H,29,34)	MTPSFLBOMANTAH-UHFFFAOYSA-N	186947	US9670157, 89 1-[4-(2-Oxo-2H-pyridin-1-ylmethyl)-benzyl]-1H-pyrazole-4-carboxylic acid 4-(1-amino-cyclopropyl)-benzylamide::US9834513, 89	Plasma kallikrein			 226							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186947	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186947&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280105	373987490							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716171	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1ccc(Cn2ccccc2=O)cc1	InChI=1S/C28H30N4O2/c1-20-15-26(28(34)30-17-23-8-6-22(16-29)7-9-23)21(2)32(20)19-25-12-10-24(11-13-25)18-31-14-4-3-5-27(31)33/h3-15H,16-19,29H2,1-2H3,(H,30,34)	KVCQGKXGOOUPLT-UHFFFAOYSA-N	186948	US9670157, 90 2,5-Dimethyl-1-[4-(2-oxo-2H-pyridin-1-ylmethyl)-benzyl]-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 90	Plasma kallikrein			 114							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186948	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186948&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290351	373987491							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716172	Cc1cc(C(=O)NCc2ccc(CN)cc2C)c(C)n1Cc1ccc(Cn2ccccc2=O)cc1	InChI=1S/C29H32N4O2/c1-20-14-25(16-30)11-12-26(20)17-31-29(35)27-15-21(2)33(22(27)3)19-24-9-7-23(8-10-24)18-32-13-5-4-6-28(32)34/h4-15H,16-19,30H2,1-3H3,(H,31,35)	LJVGJJDTMUPYFI-UHFFFAOYSA-N	186949	US9670157, 91 2,5-Dimethyl-1-[4-(2-oxo-2H-pyridin-1-ylmethyl)-benzyl]-1H-pyrrole-3-carboxylic acid 4-aminomethyl-2-methyl-benzylamide::US9834513, 91	Plasma kallikrein			 29.0							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186949	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186949&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290390	373987492							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716173	CCn1c(Cc2ccc(Cn3ccccc3=O)cc2)c(C)cc1C(=O)NCc1ccc(CN)cc1C	InChI=1S/C30H34N4O2/c1-4-34-27(17-23-8-10-24(11-9-23)20-33-14-6-5-7-29(33)35)22(3)16-28(34)30(36)32-19-26-13-12-25(18-31)15-21(26)2/h5-16H,4,17-20,31H2,1-3H3,(H,32,36)	WERWYUINAJCXQE-UHFFFAOYSA-N	186950	US9670157, 92 1-Ethyl-4-methyl-5-[4-(2-oxo-2H-pyridin-1-ylmethyl)-benzyl]-1H-pyrrole-2-carboxylic acid 4-aminomethyl-2-methyl-benzylamide::US9834513, 92	Plasma kallikrein			 40.0							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186950	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186950&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290391	373987493							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716174	CCn1c(Cc2ccc(Cn3ccccc3=O)cc2)c(C)cc1C(=O)NCc1ccc(cc1)C1(N)CC1	InChI=1S/C31H34N4O2/c1-3-35-27(19-23-7-9-25(10-8-23)21-34-17-5-4-6-29(34)36)22(2)18-28(35)30(37)33-20-24-11-13-26(14-12-24)31(32)15-16-31/h4-14,17-18H,3,15-16,19-21,32H2,1-2H3,(H,33,37)	OGIRNMXNFGBTMG-UHFFFAOYSA-N	186951	US9670157, 93 1-Ethyl-4-methyl-5-[4-(2-oxo-2H-pyridin-1-ylmethyl)-benzyl]-1H-pyrrole-2-carboxylic acid 4-(1-amino-cyclopropyl)-benzylamide::US9834513, 93	Plasma kallikrein			 2845							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186951	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186951&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126614054	373987494							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716175	Cc1cc(C(=O)NCc2c(C)cc(CN)cc2C)c(C)n1Cc1ccc(Cn2ccccc2=O)cc1	InChI=1S/C30H34N4O2/c1-20-13-26(16-31)14-21(2)28(20)17-32-30(36)27-15-22(3)34(23(27)4)19-25-10-8-24(9-11-25)18-33-12-6-5-7-29(33)35/h5-15H,16-19,31H2,1-4H3,(H,32,36)	DNOYFEGEXZEIGB-UHFFFAOYSA-N	186952	US9670157, 94 2,5-Dimethyl-1-[4-(2-oxo-2H-pyridin-1-ylmethyl)-benzyl]-1H-pyrrole-3-carboxylic acid 4-aminomethyl-2,6-dimethyl-benzylamide::US9834513, 94	Plasma kallikrein			 11.0							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186952	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186952&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290392	373987495							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716176	CCn1c(Cc2ccc(Cn3ccccc3=O)cc2)c(C)cc1C(=O)NCc1c(C)cc(CN)cc1C	InChI=1S/C31H36N4O2/c1-5-35-28(17-24-9-11-25(12-10-24)20-34-13-7-6-8-30(34)36)23(4)16-29(35)31(37)33-19-27-21(2)14-26(18-32)15-22(27)3/h6-16H,5,17-20,32H2,1-4H3,(H,33,37)	ZQOCYURDVRRUQT-UHFFFAOYSA-N	362280	1-Ethyl-4-methyl-5-[4-(2-oxo-2H-pyridin-1-ylmethyl)-benzyl]-1H-pyrrole-2-carboxylic acid 4-aminomethyl-2,6-dimethyl-benzylamide::US9834513, 95	Plasma kallikrein			 16.0							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=362280	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=362280&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716177	Cc1cnn(Cc2ccc(Cn3c(C)cc(C(=O)NCc4ccc(CN)cc4)c3C)cc2)c1	InChI=1S/C27H31N5O/c1-19-14-30-31(16-19)17-24-8-10-25(11-9-24)18-32-20(2)12-26(21(32)3)27(33)29-15-23-6-4-22(13-28)5-7-23/h4-12,14,16H,13,15,17-18,28H2,1-3H3,(H,29,33)	ZQYKZHHAAMTVKK-UHFFFAOYSA-N	186955	US9670157, 96 2,5-Dimethyl-1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 96	Plasma kallikrein			 63.0							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186955	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186955&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290636	373987497							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716178	Cc1cnn(Cc2ccc(Cn3c(C)cc(C(=O)NCc4ccc(CN)cc4C)c3C)cc2)c1	InChI=1S/C28H33N5O/c1-19-14-31-32(16-19)17-23-5-7-24(8-6-23)18-33-21(3)12-27(22(33)4)28(34)30-15-26-10-9-25(13-29)11-20(26)2/h5-12,14,16H,13,15,17-18,29H2,1-4H3,(H,30,34)	PRNAVRPSAWUWHK-UHFFFAOYSA-N	186956	US9670157, 97 2,5-Dimethyl-1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-1H-pyrrole-3-carboxylic acid 4-aminomethyl-2-methyl-benzylamide::US9834513, 97	Plasma kallikrein			 28.0							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186956	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186956&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290394	373987498							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716179	Cc1cnn(Cc2ccc(Cn3c(C)cc(C(=O)NCc4ccc(cc4)C4(N)CC4)c3C)cc2)c1	InChI=1S/C29H33N5O/c1-20-15-32-33(17-20)18-24-4-6-25(7-5-24)19-34-21(2)14-27(22(34)3)28(35)31-16-23-8-10-26(11-9-23)29(30)12-13-29/h4-11,14-15,17H,12-13,16,18-19,30H2,1-3H3,(H,31,35)	ZGUGDENZORCLQB-UHFFFAOYSA-N	186958	US9670157, 98 2,5-Dimethyl-1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-1H-pyrrole-3-carboxylic acid 4-(1-amino-cyclopropyl)-benzylamide::US9834513, 98	Plasma kallikrein			 701							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186958	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186958&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126614077	373987499							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716180	CCn1c(cc(C)c1Cc1ccc(Cn2cc(C)cn2)cc1)C(=O)NCc1ccc(CN)cc1C	InChI=1S/C29H35N5O/c1-5-34-27(14-23-6-8-24(9-7-23)19-33-18-20(2)16-32-33)22(4)13-28(34)29(35)31-17-26-11-10-25(15-30)12-21(26)3/h6-13,16,18H,5,14-15,17,19,30H2,1-4H3,(H,31,35)	JWHKKHOUFUJOHR-UHFFFAOYSA-N	362284	1-Ethyl-4-methyl-5-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-1H-pyrrole-2-carboxylic acid 4-aminomethyl-2-methyl-benzylamide::US9834513, 99	Plasma kallikrein			 38.0							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=362284	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=362284&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716181	CCn1c(Cc2ccc(Cn3cc(C)cn3)cc2)c(C)cc1C(=O)NCc1ccc(cc1)C1(N)CC1	InChI=1S/C30H35N5O/c1-4-35-27(16-23-5-7-25(8-6-23)20-34-19-21(2)17-33-34)22(3)15-28(35)29(36)32-18-24-9-11-26(12-10-24)30(31)13-14-30/h5-12,15,17,19H,4,13-14,16,18,20,31H2,1-3H3,(H,32,36)	KSKMNCQBHLWUPL-UHFFFAOYSA-N	362285	1-Ethyl-4-methyl-5-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-1H-pyrrole-2-carboxylic acid 4-(1-amino-cyclopropyl)-benzylamide::US9834513, 100	Plasma kallikrein			 2321							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=362285	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=362285&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716182	Cc1cnn(Cc2ccc(Cn3c(C)cc(C(=O)NCc4c(C)cc(CN)cc4C)c3C)cc2)c1	InChI=1S/C29H35N5O/c1-19-14-32-33(16-19)17-24-6-8-25(9-7-24)18-34-22(4)12-27(23(34)5)29(35)31-15-28-20(2)10-26(13-30)11-21(28)3/h6-12,14,16H,13,15,17-18,30H2,1-5H3,(H,31,35)	CRSNMWANUJQZPT-UHFFFAOYSA-N	187087	US9670157, 101 2,5-Dimethyl-1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-1H-pyrrole-3-carboxylic acid 4-aminomethyl-2,6-dimethyl-benzylamide::US9834513, 101	Plasma kallikrein			 4.00							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=187087	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=187087&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290436	373987502							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716183	CCn1c(cc(C)c1Cc1ccc(Cn2cc(C)cn2)cc1)C(=O)NCc1c(C)cc(CN)cc1C	InChI=1S/C30H37N5O/c1-6-35-28(14-24-7-9-25(10-8-24)19-34-18-20(2)16-33-34)23(5)13-29(35)30(36)32-17-27-21(3)11-26(15-31)12-22(27)4/h7-13,16,18H,6,14-15,17,19,31H2,1-5H3,(H,32,36)	IJDZNHRRDCMJBE-UHFFFAOYSA-N	187088	US9670157, 102 1-Ethyl-4-methyl-5-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-1H-pyrrole-2-carboxylic acid 4-aminomethyl-2,6-dimethyl-benzylamide::US9834513, 102	Plasma kallikrein			 11.0							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=187088	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=187088&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290437	373987503							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716184	Cc1cnn(Cc2ccc(Cn3cc(cn3)C(=O)NCc3ccc(cc3)C3(N)CC3)cc2)c1	InChI=1S/C26H28N6O/c1-19-12-29-31(15-19)16-21-2-4-22(5-3-21)17-32-18-23(14-30-32)25(33)28-13-20-6-8-24(9-7-20)26(27)10-11-26/h2-9,12,14-15,18H,10-11,13,16-17,27H2,1H3,(H,28,33)	KPKAKVCRNPVDEF-UHFFFAOYSA-N	362288	1-[4-(4-Methyl-pyrazol-1-ylmethyl)-benzyl]-1H-pyrazole-4-carboxylic acid 4-(1-amino-cyclopropyl)-benzylamide::US9834513, 103	Plasma kallikrein			 694							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=362288	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=362288&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716185	Cc1cnn(Cc2ccc(Cn3cnc(c3)C(=O)NCc3ccc(CN)cc3)cc2)c1	InChI=1S/C24H26N6O/c1-18-11-28-30(13-18)15-22-8-6-21(7-9-22)14-29-16-23(27-17-29)24(31)26-12-20-4-2-19(10-25)3-5-20/h2-9,11,13,16-17H,10,12,14-15,25H2,1H3,(H,26,31)	XWRFLHKXCPPUJD-UHFFFAOYSA-N	187090	US9670157, 104 1-[4-(4-Methyl-pyrazol-1-ylmethyl)-benzyl]-1H-imidazole-4-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 104	Plasma kallikrein			 30.0							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=187090	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=187090&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290438	373987505							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716186	Cc1cnn(Cc2ccc(Cn3cnc(c3)C(=O)NCc3ccc(cc3)C3(N)CC3)cc2)c1	InChI=1S/C26H28N6O/c1-19-12-30-32(14-19)16-22-4-2-21(3-5-22)15-31-17-24(29-18-31)25(33)28-13-20-6-8-23(9-7-20)26(27)10-11-26/h2-9,12,14,17-18H,10-11,13,15-16,27H2,1H3,(H,28,33)	GGTIQPJNKCQXGL-UHFFFAOYSA-N	187091	US9670157, 105 1-[4-(4-Methyl-pyrazol-1-ylmethyl)-benzyl]-1H-imidazole-4-carboxylic acid 4-(1-amino-cyclopropyl)-benzylamide::US9834513, 105	Plasma kallikrein			 941							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=187091	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=187091&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126614033	373987506							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716187	Cc1cnn(Cc2ccc(Cn3cc(cn3)C(=O)NCc3ccc(CN)cc3C)cc2)c1	InChI=1S/C25H28N6O/c1-18-11-28-30(14-18)15-20-3-5-21(6-4-20)16-31-17-24(13-29-31)25(32)27-12-23-8-7-22(10-26)9-19(23)2/h3-9,11,13-14,17H,10,12,15-16,26H2,1-2H3,(H,27,32)	KMRPNZXNLYKBNI-UHFFFAOYSA-N	187092	US9670157, 106 1-[4-(4-Methyl-pyrazol-1-ylmethyl)-benzyl]-1H-pyrazole-4-carboxylic acid 4-aminomethyl-2-methyl-benzylamide::US9834513, 106	Plasma kallikrein			 2.00							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=187092	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=187092&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290439	373987507							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716188	Cc1cnn(Cc2ccc(Cn3cnc(c3)C(=O)NCc3ccc(CN)cc3C)cc2)c1	InChI=1S/C25H28N6O/c1-18-11-29-31(13-18)15-21-5-3-20(4-6-21)14-30-16-24(28-17-30)25(32)27-12-23-8-7-22(10-26)9-19(23)2/h3-9,11,13,16-17H,10,12,14-15,26H2,1-2H3,(H,27,32)	HNTAKOBIRREIDW-UHFFFAOYSA-N	187093	US9670157, 107 1-[4-(4-Methyl-pyrazol-1-ylmethyl)-benzyl]-1H-imidazole-4-carboxylic acid 4-aminomethyl-2-methyl-benzylamide::US9834513, 107	Plasma kallikrein			 3.00							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=187093	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=187093&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290440	373987508							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716189	Cc1cnn(Cc2ccc(Cn3cc(nn3)C(=O)NCc3ccc(CN)cc3)cc2)c1	InChI=1S/C23H25N7O/c1-17-11-26-29(13-17)14-20-6-8-21(9-7-20)15-30-16-22(27-28-30)23(31)25-12-19-4-2-18(10-24)3-5-19/h2-9,11,13,16H,10,12,14-15,24H2,1H3,(H,25,31)	QYIHBTUUQFBDIT-UHFFFAOYSA-N	187094	US9670157, 108 1-[4-(4-Methyl-pyrazol-1-ylmethyl)-benzyl]-1H-[1,2,3]triazole-4-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 108	Plasma kallikrein			 33.0							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=187094	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=187094&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290480	373987509							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716190	Cc1cnn(Cc2ccc(Cn3cc(nn3)C(=O)NCc3ccc(CN)cc3C)cc2)c1	InChI=1S/C24H27N7O/c1-17-11-27-30(13-17)14-19-3-5-20(6-4-19)15-31-16-23(28-29-31)24(32)26-12-22-8-7-21(10-25)9-18(22)2/h3-9,11,13,16H,10,12,14-15,25H2,1-2H3,(H,26,32)	YJGCZOIOIYXKFC-UHFFFAOYSA-N	187095	US9670157, 109 1-[4-(4-Methyl-pyrazol-1-ylmethyl)-benzyl]-1H-[1,2,3]triazole-4-carboxylic acid 4-aminomethyl-2-methyl-benzylamide::US9834513, 109	Plasma kallikrein			 5.00							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=187095	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=187095&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290481	373987510							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716191	Cc1cnn(Cc2ccc(Cn3cc(nn3)C(=O)NCc3ccc(cc3)C3(N)CC3)cc2)c1	InChI=1S/C25H27N7O/c1-18-12-28-31(14-18)15-20-2-4-21(5-3-20)16-32-17-23(29-30-32)24(33)27-13-19-6-8-22(9-7-19)25(26)10-11-25/h2-9,12,14,17H,10-11,13,15-16,26H2,1H3,(H,27,33)	QMDVOIRCHJYCMU-UHFFFAOYSA-N	187096	US9670157, 110 1-[4-(4-Methyl-pyrazol-1-ylmethyl)-benzyl]-1H-[1,2,3]triazole-4-carboxylic acid 4-(1-amino-cyclopropyl)-benzylamide::US9834513, 110	Plasma kallikrein			 2584							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=187096	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=187096&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126614036	373987511							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716192	Cc1cnn(Cc2ccc(Cn3cc(cn3)C(=O)NCc3c(C)cc(CN)cc3C)cc2)c1	InChI=1S/C26H30N6O/c1-18-11-29-31(14-18)15-21-4-6-22(7-5-21)16-32-17-24(12-30-32)26(33)28-13-25-19(2)8-23(10-27)9-20(25)3/h4-9,11-12,14,17H,10,13,15-16,27H2,1-3H3,(H,28,33)	NVKWHXBTNJQAIY-UHFFFAOYSA-N	187097	US9670157, 111 1-[4-(4-Methyl-pyrazol-1-ylmethyl)-benzyl]-1H-pyrazole-4-carboxylic acid 4-aminomethyl-2,6-dimethyl-benzylamide::US9670157, 115 5-Methyl-1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-1H-pyrazole-4-carboxylic acid 4-aminomethyl-2,6-dimethyl-benzylamide::US9834513, 111	Plasma kallikrein			 1.000							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=187097	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=187097&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290482	373987512							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716193	Cc1cnn(Cc2ccc(Cn3cnc(c3)C(=O)NCc3c(C)cc(CN)cc3C)cc2)c1	InChI=1S/C26H30N6O/c1-18-11-30-32(13-18)15-22-6-4-21(5-7-22)14-31-16-25(29-17-31)26(33)28-12-24-19(2)8-23(10-27)9-20(24)3/h4-9,11,13,16-17H,10,12,14-15,27H2,1-3H3,(H,28,33)	SEKJKDZFHSHSNB-UHFFFAOYSA-N	187098	US9670157, 112 1-[4-(4-Methyl-pyrazol-1-ylmethyl)-benzyl]-1H-imidazole-4-carboxylic acid 4-aminomethyl-2,6-dimethyl-benzylamide::US9834513, 112	Plasma kallikrein			 2.00							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=187098	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=187098&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290483	373987513							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716194	Cc1cnn(Cc2ccc(Cn3cc(nn3)C(=O)NCc3c(C)cc(CN)cc3C)cc2)c1	InChI=1S/C25H29N7O/c1-17-11-28-31(13-17)14-20-4-6-21(7-5-20)15-32-16-24(29-30-32)25(33)27-12-23-18(2)8-22(10-26)9-19(23)3/h4-9,11,13,16H,10,12,14-15,26H2,1-3H3,(H,27,33)	TWZMQQMXQBBUHW-UHFFFAOYSA-N	187099	US9670157, 113 1-[4-(4-Methyl-pyrazol-1-ylmethyl)-benzyl]-1H-[1,2,3]triazole-4-carboxylic acid 4-aminomethyl-2,6-dimethyl-benzylamide::US9834513, 113	Plasma kallikrein			 2.00							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=187099	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=187099&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290484	373987514							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716195	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4c(C)cc(CN)cc4C)c(C)n3)cc2)c1	InChI=1S/C27H32N6O/c1-18-12-30-32(14-18)15-22-5-7-23(8-6-22)16-33-17-26(21(4)31-33)27(34)29-13-25-19(2)9-24(11-28)10-20(25)3/h5-10,12,14,17H,11,13,15-16,28H2,1-4H3,(H,29,34)	PGMCAGSURRYVFE-UHFFFAOYSA-N	187100	US9670157, 114 3-Methyl-1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-1H-pyrazole-4-carboxylic acid 4-aminomethyl-2,6-dimethyl-benzylamide::US9834513, 114	Plasma kallikrein			 0.600							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=187100	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=187100&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126614028	373987515							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716196	Cc1cnn(Cc2ccc(Cn3ncc(C(=O)NCc4c(C)cc(CN)cc4C)c3C)cc2)c1	InChI=1S/C27H32N6O/c1-18-12-30-32(15-18)16-22-5-7-23(8-6-22)17-33-21(4)26(14-31-33)27(34)29-13-25-19(2)9-24(11-28)10-20(25)3/h5-10,12,14-15H,11,13,16-17,28H2,1-4H3,(H,29,34)	FKHUEKYDJMRASN-UHFFFAOYSA-N	362300	5-Methyl-1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-1H-pyrazole-4-carboxylic acid 4-aminomethyl-2,6-dimethyl-benzylamide::US9834513, 115	Plasma kallikrein			 8.00							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=362300	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=362300&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716197	Cc1cnn(Cc2ccc(Cn3nc(C)c(C(=O)NCc4c(C)cc(CN)cc4C)c3C)cc2)c1	InChI=1S/C28H34N6O/c1-18-13-31-33(15-18)16-23-6-8-24(9-7-23)17-34-22(5)27(21(4)32-34)28(35)30-14-26-19(2)10-25(12-29)11-20(26)3/h6-11,13,15H,12,14,16-17,29H2,1-5H3,(H,30,35)	QNIDRKXJPLTCKV-UHFFFAOYSA-N	187102	US9670157, 116 3,5-Dimethyl-1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-1H-pyrazole-4-carboxylic acid 4-aminomethyl-2,6-dimethyl-benzylamide::US9834513, 116	Plasma kallikrein			 11699							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=187102	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=187102&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126614044	373987516							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716198	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4ccc(CN)c(F)c4)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C25H24F4N6O/c1-16-10-32-34(12-16)13-17-2-4-18(5-3-17)14-35-15-21(23(33-35)25(27,28)29)24(36)31-11-19-6-7-20(9-30)22(26)8-19/h2-8,10,12,15H,9,11,13-14,30H2,1H3,(H,31,36)	KVZULUTYGQJNAW-UHFFFAOYSA-N	187103	US9670157, 117 1-[4-(4-Methyl-pyrazol-1-ylmethyl)-benzyl]-3-trifluoromethyl-1H-pyrazole-4-carboxylic acid 4-aminomethyl-3-fluoro-benzylamide::US9834513, 117	Plasma kallikrein			 51.0							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=187103	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=187103&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290528	373987517							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716199	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4c(C)cc(CN)cc4C)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C27H29F3N6O/c1-17-11-33-35(13-17)14-20-4-6-21(7-5-20)15-36-16-24(25(34-36)27(28,29)30)26(37)32-12-23-18(2)8-22(10-31)9-19(23)3/h4-9,11,13,16H,10,12,14-15,31H2,1-3H3,(H,32,37)	KODUDZPOXFRWEI-UHFFFAOYSA-N	187104	US9670157, 118 1-[4-(4-Methyl-pyrazol-1-ylmethyl)-benzyl]-3-trifluoromethyl-1H-pyrazole-4-carboxylic acid 4-aminomethyl-2,6-dimethyl-benzylamide::US9834513, 118	Plasma kallikrein			 1.000							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=187104	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=187104&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290529	373987518							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716200	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4ccc(CN)c(F)c4C)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C26H26F4N6O/c1-16-10-33-35(12-16)13-18-3-5-19(6-4-18)14-36-15-22(24(34-36)26(28,29)30)25(37)32-11-21-8-7-20(9-31)23(27)17(21)2/h3-8,10,12,15H,9,11,13-14,31H2,1-2H3,(H,32,37)	PKZHZUNPMZRBCV-UHFFFAOYSA-N	187105	US9670157, 119 1-[4-(4-Methyl-pyrazol-1-ylmethyl)-benzyl]-3-trifluoromethyl-1H-pyrazole-4-carboxylic acid 4-aminomethyl-3-fluoro-2-methyl-benzylamide::US9834513, 119	Plasma kallikrein			 9.00							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=187105	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=187105&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290530	373987519							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716201	CCn1c(cc(C)c1Cc1ccc(Cn2cc(C)cn2)cc1)C(=O)NCc1ccc(CN)cc1	InChI=1S/C28H33N5O/c1-4-33-26(14-22-5-11-25(12-6-22)19-32-18-20(2)16-31-32)21(3)13-27(33)28(34)30-17-24-9-7-23(15-29)8-10-24/h5-13,16,18H,4,14-15,17,19,29H2,1-3H3,(H,30,34)	APSRMPANLLTMGB-UHFFFAOYSA-N	187107	US9670157, 121 1-Ethyl-4-methyl-5-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-1H-pyrrole-2-carboxylic acid 4-aminomethyl-benzylamide::US9670157, 122 1-Ethyl-4-methyl-5-[4-(2-oxo-2H-pyridin-1-ylmethyl)-benzyl]-1H-pyrrole-2-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 121	Plasma kallikrein			 155							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=187107	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=187107&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290485	373987520							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716202	CCn1c(Cc2ccc(Cn3ccccc3=O)cc2)c(C)cc1C(=O)NCc1ccc(CN)cc1	InChI=1S/C29H32N4O2/c1-3-33-26(17-22-7-13-25(14-8-22)20-32-15-5-4-6-28(32)34)21(2)16-27(33)29(35)31-19-24-11-9-23(18-30)10-12-24/h4-16H,3,17-20,30H2,1-2H3,(H,31,35)	ULZKXPDTHIUETL-UHFFFAOYSA-N	187109	US9670157, 123 1-Ethyl-4-methyl-5-(2-phenyl-thiazol-4-ylmethyl)-1H-pyrrole-2-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 122	Plasma kallikrein			 151							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=187109	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=187109&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290526	373987521							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716203	CCn1c(Cc2csc(n2)-c2ccccc2)c(C)cc1C(=O)NCc1ccc(CN)cc1	InChI=1S/C26H28N4OS/c1-3-30-23(14-22-17-32-26(29-22)21-7-5-4-6-8-21)18(2)13-24(30)25(31)28-16-20-11-9-19(15-27)10-12-20/h4-13,17H,3,14-16,27H2,1-2H3,(H,28,31)	JLNWNHKTVXBIAM-UHFFFAOYSA-N	362307	1-Ethyl-4-methyl-5-(2-phenyl-thiazol-4-ylmethyl)-1H-pyrrole-2-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 123	Plasma kallikrein			 2149							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=362307	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=362307&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716204	Cc1nn(Cc2ccc3nc(C)ccc3c2)cc1C(=O)NCc1c(C)cc(CN)cc1C	InChI=1S/C26H29N5O/c1-16-9-21(12-27)10-17(2)23(16)13-28-26(32)24-15-31(30-19(24)4)14-20-6-8-25-22(11-20)7-5-18(3)29-25/h5-11,15H,12-14,27H2,1-4H3,(H,28,32)	NKFYMWBVMOGCMS-UHFFFAOYSA-N	187110	US9670157, 124 3-Methyl-1-(2-methyl-quinolin-6-ylmethyl)-1H-pyrazole-4-carboxylic acid 4-aminomethyl-2,6-dimethyl-benzylamide::US9834513, 124	Plasma kallikrein			 2.00							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=187110	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=187110&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290565	373987522							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716205	Cc1c(cnn1Cc1ccc2nc(C)ccc2c1)C(=O)NCc1c(C)cc(CN)cc1C	InChI=1S/C26H29N5O/c1-16-9-21(12-27)10-17(2)23(16)13-28-26(32)24-14-29-31(19(24)4)15-20-6-8-25-22(11-20)7-5-18(3)30-25/h5-11,14H,12-13,15,27H2,1-4H3,(H,28,32)	SVWVNWWLYZGNGT-UHFFFAOYSA-N	187111	US9670157, 125 5-Methyl-1-(2-methyl-quinolin-6-ylmethyl)-1H-pyrazole-4-carboxylic acid 4-aminomethyl-2,6-dimethyl-benzylamide::US9834513, 125	Plasma kallikrein			 3.00							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=187111	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=187111&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290566	373987523							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716206	Cc1ccc2cc(Cn3cc(C(=O)NCc4c(C)cc(CN)cc4C)c(n3)C(F)(F)F)ccc2n1	InChI=1S/C26H26F3N5O/c1-15-8-19(11-30)9-16(2)21(15)12-31-25(35)22-14-34(33-24(22)26(27,28)29)13-18-5-7-23-20(10-18)6-4-17(3)32-23/h4-10,14H,11-13,30H2,1-3H3,(H,31,35)	ASPQAQDFTSKEAM-UHFFFAOYSA-N	187112	US9670157, 126 1-(2-Methyl-quinolin-6-ylmethyl)-3-trifluoromethyl-1H-pyrazole-4-carboxylic acid 4-aminomethyl-2,6-dimethyl-benzylamide::US9834513, 126	Plasma kallikrein			 3.00							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=187112	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=187112&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290567	373987524							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716207	Cc1ccc2cc(Cn3ncc(C(=O)NCc4c(C)cc(CN)cc4C)c3C(F)(F)F)ccc2n1	InChI=1S/C26H26F3N5O/c1-15-8-19(11-30)9-16(2)21(15)12-31-25(35)22-13-32-34(24(22)26(27,28)29)14-18-5-7-23-20(10-18)6-4-17(3)33-23/h4-10,13H,11-12,14,30H2,1-3H3,(H,31,35)	VJTIBJURDVORHW-UHFFFAOYSA-N	187113	US9670157, 127 1-(2-Methyl-quinolin-6-ylmethyl)-5-trifluoromethyl-1H-pyrazole-4-carboxylic acid 4-aminomethyl-2,6-dimethyl-benzylamide::US9834513, 127	Plasma kallikrein			 731							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=187113	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=187113&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280088	373987525							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716208	Cc1cc(C(=O)NCc2c(C)cc(CN)cc2C)c(C)n1Cc1ccc2nc(C)ccc2c1	InChI=1S/C28H32N4O/c1-17-10-23(14-29)11-18(2)26(17)15-30-28(33)25-12-20(4)32(21(25)5)16-22-7-9-27-24(13-22)8-6-19(3)31-27/h6-13H,14-16,29H2,1-5H3,(H,30,33)	QQCDDUJPDRCOTN-UHFFFAOYSA-N	187114	US9670157, 128 2,5-Dimethyl-1-(2-methyl-quinolin-6-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-2,6-dimethyl-benzylamide::US9834513, 128	Plasma kallikrein			 934							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=187114	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=187114&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280273	373987526							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716209	Cc1cc(CN)cc(C)c1CNC(=O)c1cn(Cc2ccnc(c2)N2CCCC2)nc1C(F)(F)F	InChI=1S/C25H29F3N6O/c1-16-9-19(12-29)10-17(2)20(16)13-31-24(35)21-15-34(32-23(21)25(26,27)28)14-18-5-6-30-22(11-18)33-7-3-4-8-33/h5-6,9-11,15H,3-4,7-8,12-14,29H2,1-2H3,(H,31,35)	YWMLIFJICOBECK-UHFFFAOYSA-N	187115	US9670157, 129 1-(2-Pyrrolidin-1-yl-pyridin-4-ylmethyl)-3-trifluoromethyl-1H-pyrazole-4-carboxylic acid 4-aminomethyl-2,6-dimethyl-benzylamide::US9834513, 129	Plasma kallikrein			 24.0							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=187115	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=187115&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290568	373987527							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709480	Cc1cnn(Cc2ccc(Cc3cncc(c3)C(=O)NCc3ccc4c(N)nccc4c3)cc2)c1	InChI=1S/C28H26N6O/c1-19-13-33-34(17-19)18-21-4-2-20(3-5-21)10-23-12-25(16-30-14-23)28(35)32-15-22-6-7-26-24(11-22)8-9-31-27(26)29/h2-9,11-14,16-17H,10,15,18H2,1H3,(H2,29,31)(H,32,35)	XZGMSMZMNPUQHT-UHFFFAOYSA-N	359614	N-[(1-Aminoisoquinolin-6-yl)methyl]-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)pyridine-3-carboxamide::US10221161, Example 1::US11242333, Example 1	Plasma kallikrein			 3.86							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359614	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359614&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117889681	386399068							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709481	Cc1cnn(Cc2ccc(Cc3cncc(c3)C(=O)NCc3cnc4[nH]ccc4c3)cc2)c1	InChI=1S/C26H24N6O/c1-18-11-31-32(16-18)17-20-4-2-19(3-5-20)8-21-9-24(15-27-12-21)26(33)30-14-22-10-23-6-7-28-25(23)29-13-22/h2-7,9-13,15-16H,8,14,17H2,1H3,(H,28,29)(H,30,33)	JJUHBFMQMARLNX-UHFFFAOYSA-N	359615	5-({4-[(4-Methylpyrazol-1-yl)methyl]phenyl}methyl)-N-{7H-pyrrolo[2,3-b]pyridin-3-ylmethyl}pyridine-3-carboxamide::US10221161, Example 2::US11242333, Example 2	Plasma kallikrein			 216							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359615	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359615&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117889991	386399069							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709482	Cc1cnn(Cc2ccc(Cc3ccnc(c3)C(=O)NCc3ccc4c(N)nccc4c3)cc2)c1	InChI=1S/C28H26N6O/c1-19-15-33-34(17-19)18-21-4-2-20(3-5-21)12-22-8-10-30-26(14-22)28(35)32-16-23-6-7-25-24(13-23)9-11-31-27(25)29/h2-11,13-15,17H,12,16,18H2,1H3,(H2,29,31)(H,32,35)	DZDSGRZPTVIORQ-UHFFFAOYSA-N	359616	N-[(1-Aminoisoquinolin-6-yl)methyl]-4-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)pyridine-2-carboxamide::US10221161, Example 3::US11242333, Example 3	Plasma kallikrein			 159							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359616	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359616&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117889735	386399070							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709483	Cc1cnn(Cc2ccc(Cc3ccnc(c3)C(=O)NCc3cnc4[nH]ccc4c3)cc2)c1	InChI=1S/C26H24N6O/c1-18-13-31-32(16-18)17-20-4-2-19(3-5-20)10-21-6-8-27-24(12-21)26(33)30-15-22-11-23-7-9-28-25(23)29-14-22/h2-9,11-14,16H,10,15,17H2,1H3,(H,28,29)(H,30,33)	WRUWFRKMFQIBTK-UHFFFAOYSA-N	359617	4-({4-[(4-Methylpyrazol-1-yl)methyl]phenyl}methyl)-N-{7H-pyrrolo[2,3-b]pyridin-3-ylmethyl}pyridine-2-carboxamide::US10221161, Example 4::US11242333, Example 4	Plasma kallikrein			 6610							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359617	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359617&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121406191	386399071							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709484	Nc1nccc2cc(CNC(=O)c3ccc(=O)n(Cc4ccc(Cn5ccccc5=O)cc4)c3)ccc12	InChI=1S/C29H25N5O3/c30-28-25-10-8-22(15-23(25)12-13-31-28)16-32-29(37)24-9-11-27(36)34(19-24)18-21-6-4-20(5-7-21)17-33-14-2-1-3-26(33)35/h1-15,19H,16-18H2,(H2,30,31)(H,32,37)	UJFXLGBMZVPDMP-UHFFFAOYSA-N	359618	N-[(1-Aminoisoquinolin-6-yl)methyl]-6-oxo-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)pyridine-3-carboxamide::US10221161, Example 5::US11242333, Example 5	Plasma kallikrein			 24.7							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359618	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359618&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117907897	386399072							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709485	O=C(NCc1cnc2[nH]ccc2c1)c1ccc(=O)n(Cc2ccc(Cn3ccccc3=O)cc2)c1	InChI=1S/C27H23N5O3/c33-24-3-1-2-12-31(24)16-19-4-6-20(7-5-19)17-32-18-23(8-9-25(32)34)27(35)30-15-21-13-22-10-11-28-26(22)29-14-21/h1-14,18H,15-17H2,(H,28,29)(H,30,35)	LSSBHLFUNMHFAM-UHFFFAOYSA-N	359619	6-Oxo-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)-N-{7H-pyrrolo[2,3-b]pyridin-3-ylmethyl}pyridine-3-carboxamide::US10221161, Example 6::US11242333, Example 6	Plasma kallikrein			 580							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359619	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359619&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117907999	386399073							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709486	Cc1cnn(Cc2ccc(cc2)C(O)c2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)c1	InChI=1S/C28H26N6O2/c1-18-12-33-34(16-18)17-19-2-5-21(6-3-19)26(35)23-11-24(15-30-14-23)28(36)32-13-20-4-7-25-22(10-20)8-9-31-27(25)29/h2-12,14-16,26,35H,13,17H2,1H3,(H2,29,31)(H,32,36)	LJHHAYREDCAYJE-UHFFFAOYSA-N	359621	N-((1-Aminoisoquinolin-6-yl)methyl)-5-(hydroxy(4-((4-methyl-1H-pyrazol-1-yl)methyl)phenyl)methyl)nicotinamide::US10221161, Example 7::US11242333, Example 7	Plasma kallikrein			 35.3							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359621	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359621&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117890055	386399075							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709487	Cc1cnn(Cc2ccc(Cc3cc(ncn3)C(=O)NCc3ccc4c(N)nccc4c3)cc2)c1	InChI=1S/C27H25N7O/c1-18-13-33-34(15-18)16-20-4-2-19(3-5-20)11-23-12-25(32-17-31-23)27(35)30-14-21-6-7-24-22(10-21)8-9-29-26(24)28/h2-10,12-13,15,17H,11,14,16H2,1H3,(H2,28,29)(H,30,35)	YVWZOLYJJRHVHL-UHFFFAOYSA-N	359622	N-[(1-Aminoisoquinolin-6-yl)methyl]-6-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)pyrimidine-4-carboxamide::US10221161, Example 8::US11242333, Example 8	Plasma kallikrein			 119							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359622	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359622&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117890488	386399076							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709488	Cc1cnn(Cc2ccc(Cc3cncc(n3)C(=O)NCc3ccc4c(N)nccc4c3)cc2)c1	InChI=1S/C27H25N7O/c1-18-12-32-34(16-18)17-20-4-2-19(3-5-20)11-23-14-29-15-25(33-23)27(35)31-13-21-6-7-24-22(10-21)8-9-30-26(24)28/h2-10,12,14-16H,11,13,17H2,1H3,(H2,28,30)(H,31,35)	XNGKXROWONCSGX-UHFFFAOYSA-N	359623	N-[(1-Aminoisoquinolin-6-yl)methyl]-6-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)pyrazine-2-carboxamide::US10221161, Example 9::US11242333, Example 9	Plasma kallikrein			 30.8							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359623	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359623&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117890033	386399077							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709489	Cc1ccc2cc(Cc3cncc(n3)C(=O)NCc3ccc4c(N)nccc4c3)ccc2n1	InChI=1S/C26H22N6O/c1-16-2-5-20-10-17(4-7-23(20)31-16)12-21-14-28-15-24(32-21)26(33)30-13-18-3-6-22-19(11-18)8-9-29-25(22)27/h2-11,14-15H,12-13H2,1H3,(H2,27,29)(H,30,33)	CGNIOLXFEPYYHB-UHFFFAOYSA-N	359624	N-[(1-Aminoisoquinolin-6-yl)methyl]-6-[(2-methylquinolin-6-yl)methyl]pyrazine-2-carboxamide::US10221161, Example 10::US11242333, Example 10	Plasma kallikrein			 194							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359624	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359624&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117890082	386399078							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709490	Cc1cnn(Cc2ccc(Cc3cnnc(c3)C(=O)NCc3ccc4c(N)nccc4c3)cc2)c1	InChI=1S/C27H25N7O/c1-18-13-32-34(16-18)17-20-4-2-19(3-5-20)10-22-12-25(33-31-15-22)27(35)30-14-21-6-7-24-23(11-21)8-9-29-26(24)28/h2-9,11-13,15-16H,10,14,17H2,1H3,(H2,28,29)(H,30,35)	DDCNHPCNBRRWTO-UHFFFAOYSA-N	359625	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)pyridazine-3-carboxamide::US10221161, Example 11::US11242333, Example 11	Plasma kallikrein			 82.3							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359625	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359625&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117890119	386399079							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709491	Cc1cnn(Cc2ccc(Cc3cncc(c3)C(=O)NCc3c(C)nc4[nH]ccc(C)c34)cc2)c1	InChI=1S/C28H28N6O/c1-18-12-32-34(16-18)17-22-6-4-21(5-7-22)10-23-11-24(14-29-13-23)28(35)31-15-25-20(3)33-27-26(25)19(2)8-9-30-27/h4-9,11-14,16H,10,15,17H2,1-3H3,(H,30,33)(H,31,35)	ZBVFUONSGPAIOP-UHFFFAOYSA-N	359626	N-({2,4-Dimethyl-7H-pyrrolo[2,3-b]pyridin-3-yl}methyl)-5-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)pyridine-3-carboxamide::US10221161, Example 12	Plasma kallikrein			 244							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359626	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359626&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393177	386399080							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709492	Cc1nc2[nH]ccc(C)c2c1CNC(=O)c1cncc(Cc2ccc3nc(C)ccc3c2)c1	InChI=1S/C27H25N5O/c1-16-8-9-29-26-25(16)23(18(3)32-26)15-30-27(33)22-12-20(13-28-14-22)10-19-5-7-24-21(11-19)6-4-17(2)31-24/h4-9,11-14H,10,15H2,1-3H3,(H,29,32)(H,30,33)	MPEZSZKUEPIWCM-UHFFFAOYSA-N	359627	N-({2,4-Dimethyl-7H-pyrrolo[2,3-b]pyridin-3-yl}methyl)-5-[(2-methylquinolin-6-yl)methyl]pyridine-3-carboxamide::US10221161, Example 13	Plasma kallikrein			 923							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359627	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359627&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393186	386399081							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709493	Nc1nccc2cc(CNC(=O)c3ccc(=O)n(Cc4csc(n4)-c4ccccc4)c3)ccc12	InChI=1S/C26H21N5O2S/c27-24-22-8-6-17(12-19(22)10-11-28-24)13-29-25(33)20-7-9-23(32)31(14-20)15-21-16-34-26(30-21)18-4-2-1-3-5-18/h1-12,14,16H,13,15H2,(H2,27,28)(H,29,33)	TVMQOXCUTCHUPL-UHFFFAOYSA-N	359628	N-[(1-Aminoisoquinolin-6-yl)methyl]-6-oxo-1-[(2-phenyl-1,3-thiazol-4-yl)methyl]pyridine-3-carboxamide::US10221161, Example 14::US11242333, Example 14	Plasma kallikrein			 2670							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359628	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359628&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393161	386399082							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709494	Cc1cnn(Cc2ccc(Cn3cc(ccc3=O)C(=O)NCc3ccc4c(N)nccc4c3)cc2)c1	InChI=1S/C28H26N6O2/c1-19-13-32-34(15-19)17-21-4-2-20(3-5-21)16-33-18-24(7-9-26(33)35)28(36)31-14-22-6-8-25-23(12-22)10-11-30-27(25)29/h2-13,15,18H,14,16-17H2,1H3,(H2,29,30)(H,31,36)	JRVPVSFGNJKYLB-UHFFFAOYSA-N	359629	N-[(1-Aminoisoquinolin-6-yl)methyl]-1-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)-6-oxopyridine-3-carboxamide::US10221161, Example 15::US11242333, Example 15	Plasma kallikrein			 159							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359629	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359629&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117890144	386399083							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709495	Cc1ccc2cc(Cn3cc(ccc3=O)C(=O)NCc3ccc4c(N)nccc4c3)ccc2n1	InChI=1S/C27H23N5O2/c1-17-2-5-21-13-19(4-8-24(21)31-17)15-32-16-22(6-9-25(32)33)27(34)30-14-18-3-7-23-20(12-18)10-11-29-26(23)28/h2-13,16H,14-15H2,1H3,(H2,28,29)(H,30,34)	VRTRGFXOHVRQQQ-UHFFFAOYSA-N	359630	N-[(1-Aminoisoquinolin-6-yl)methyl]-1-[(2-methylquinolin-6-yl)methyl]-6-oxopyridine-3-carboxamide::US10221161, Example 16::US11242333, Example 16	Plasma kallikrein			 179							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359630	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359630&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393202	386399084							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709496	Cc1ccc2cc(Cc3cncc(c3)C(=O)NCc3ccc4c(N)nccc4c3)ccc2n1	InChI=1S/C27H23N5O/c1-17-2-5-22-11-18(4-7-25(22)32-17)10-20-13-23(16-29-14-20)27(33)31-15-19-3-6-24-21(12-19)8-9-30-26(24)28/h2-9,11-14,16H,10,15H2,1H3,(H2,28,30)(H,31,33)	YGGSTOCJVHLULA-UHFFFAOYSA-N	359631	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-[(2-methylquinolin-6-yl)methyl]pyridine-3-carboxamide::US10221161, Example 17::US11242333, Example 17	Plasma kallikrein			 27.5							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359631	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359631&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117890179	386399085							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709497	COc1ncc(cc1Cc1ccc2nc(C)ccc2c1)C(=O)NCc1ccc2c(N)nccc2c1	InChI=1S/C28H25N5O2/c1-17-3-6-21-11-18(5-8-25(21)33-17)12-22-14-23(16-32-28(22)35-2)27(34)31-15-19-4-7-24-20(13-19)9-10-30-26(24)29/h3-11,13-14,16H,12,15H2,1-2H3,(H2,29,30)(H,31,34)	RAXAJDWJQASKEB-UHFFFAOYSA-N	359632	N-[(1-Aminoisoquinolin-6-yl)methyl]-6-methoxy-5-[(2-methylquinolin-6-yl)methyl]pyridine-3-carboxamide::US10221161, Example 18::US11242333, Example 19	Plasma kallikrein			 702							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359632	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359632&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393219	386399086							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709498	COc1ncc(Cc2ccc3nc(C)ccc3c2)cc1C(=O)NCc1ccc2c(N)nccc2c1	InChI=1S/C28H25N5O2/c1-17-3-6-22-12-18(5-8-25(22)33-17)11-20-14-24(28(35-2)32-16-20)27(34)31-15-19-4-7-23-21(13-19)9-10-30-26(23)29/h3-10,12-14,16H,11,15H2,1-2H3,(H2,29,30)(H,31,34)	NTARKBOIYLKMIA-UHFFFAOYSA-N	359633	N-[(1-Aminoisoquinolin-6-yl)methyl]-2-methoxy-5-[(2-methylquinolin-6-yl)methyl]pyridine-3-carboxamide::US10221161, Example 19::US11242333, Example 18	Plasma kallikrein			 434							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359633	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359633&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393195	386399087							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709499	Cc1ccc2cc(Cc3c[nH]c(=O)c(c3)C(=O)NCc3ccc4c(N)nccc4c3)ccc2n1	InChI=1S/C27H23N5O2/c1-16-2-5-21-11-17(4-7-24(21)32-16)10-19-13-23(27(34)31-15-19)26(33)30-14-18-3-6-22-20(12-18)8-9-29-25(22)28/h2-9,11-13,15H,10,14H2,1H3,(H2,28,29)(H,30,33)(H,31,34)	BWDGDESETBEAIN-UHFFFAOYSA-N	359634	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-[(2-methylquinolin-6-yl)methyl]-2-oxo-1H-pyridine-3-carboxamide::US10221161, Example 20	Plasma kallikrein			 621							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359634	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359634&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139269071	386399088							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709500	CNc1ncc(cc1Cc1ccc2nc(C)ccc2c1)C(=O)NCc1ccc2c(N)nccc2c1	InChI=1S/C28H26N6O/c1-17-3-6-21-11-18(5-8-25(21)34-17)12-22-14-23(16-32-27(22)30-2)28(35)33-15-19-4-7-24-20(13-19)9-10-31-26(24)29/h3-11,13-14,16H,12,15H2,1-2H3,(H2,29,31)(H,30,32)(H,33,35)	VPCARFQYWNGPJW-UHFFFAOYSA-N	359635	N-[(1-Aminoisoquinolin-6-yl)methyl]-6-(methylamino)-5-[(2-methylquinolin-6-yl)methyl]pyridine-3-carboxamide::US10221161, Example 21	Plasma kallikrein			 53.3							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359635	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359635&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117889797	386399089							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709501	Cc1ccc2cc(Cc3cnc(C)c(c3)C(=O)NCc3ccc4c(N)nccc4c3)ccc2n1	InChI=1S/C28H25N5O/c1-17-3-6-23-12-19(5-8-26(23)33-17)11-21-14-25(18(2)31-16-21)28(34)32-15-20-4-7-24-22(13-20)9-10-30-27(24)29/h3-10,12-14,16H,11,15H2,1-2H3,(H2,29,30)(H,32,34)	FAQUHNMIVPDPJH-UHFFFAOYSA-N	359637	N-[(1-Aminoisoquinolin-6-yl)methyl]-2-methyl-5-[(2-methylquinolin-6-yl)methyl]pyridine-3-carboxamide::US10221161, Example 22	Plasma kallikrein			 104							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359637	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359637&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117890164	386399091							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709502	Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccccc4)c3)ccc12	InChI=1S/C23H20N4O/c24-22-21-7-6-17(11-19(21)8-9-26-22)14-27-23(28)20-12-18(13-25-15-20)10-16-4-2-1-3-5-16/h1-9,11-13,15H,10,14H2,(H2,24,26)(H,27,28)	HMNZKYMVBHQDLG-UHFFFAOYSA-N	359638	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-benzylpyridine-3-carboxamide::US10221161, Example 23::US11242333, Example 23	Plasma kallikrein			 40000							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359638	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359638&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117890433	386399092							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709503	Nc1nccc2cc(CNC(=O)c3cncc(Cc4csc(n4)-c4ccccc4)c3)ccc12	InChI=1S/C26H21N5OS/c27-24-23-7-6-17(10-20(23)8-9-29-24)14-30-25(32)21-11-18(13-28-15-21)12-22-16-33-26(31-22)19-4-2-1-3-5-19/h1-11,13,15-16H,12,14H2,(H2,27,29)(H,30,32)	ACVNKJMNWOONDL-UHFFFAOYSA-N	359639	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-[(2-phenyl-1,3-thiazol-4-yl)methyl]pyridine-3-carboxamide::US10221161, Example 24	Plasma kallikrein			 1710							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359639	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359639&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393158	386399093							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709504	COc1cccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)c1	InChI=1S/C24H22N4O2/c1-30-21-4-2-3-16(12-21)9-18-11-20(15-26-13-18)24(29)28-14-17-5-6-22-19(10-17)7-8-27-23(22)25/h2-8,10-13,15H,9,14H2,1H3,(H2,25,27)(H,28,29)	NHVPFJINKKJQSZ-UHFFFAOYSA-N	359640	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-[(3-methoxyphenyl)methyl]pyridine-3-carboxamide::US10221161, Example 25::US11242333, Example 25	Plasma kallikrein			 2640							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359640	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359640&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393160	386399094							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709505	COc1ccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)cc1	InChI=1S/C24H22N4O2/c1-30-21-5-2-16(3-6-21)10-18-12-20(15-26-13-18)24(29)28-14-17-4-7-22-19(11-17)8-9-27-23(22)25/h2-9,11-13,15H,10,14H2,1H3,(H2,25,27)(H,28,29)	RXDWASWWHDDTEG-UHFFFAOYSA-N	359641	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-[(4-methoxyphenyl)methyl]pyridine-3-carboxamide::US10221161, Example 26::US11242333, Example 26	Plasma kallikrein			 941							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359641	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359641&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393173	386399095							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709506	Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccc(cc4)-n4cccn4)c3)ccc12	InChI=1S/C26H22N6O/c27-25-24-7-4-19(13-21(24)8-10-29-25)16-30-26(33)22-14-20(15-28-17-22)12-18-2-5-23(6-3-18)32-11-1-9-31-32/h1-11,13-15,17H,12,16H2,(H2,27,29)(H,30,33)	MJHTYGXMZRJQOL-UHFFFAOYSA-N	359642	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[4-(pyrazol-1-yl)phenyl]methyl}pyridine-3-carboxamide::US10221161, Example 27::US11242333, Example 27	Plasma kallikrein			 1010							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359642	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359642&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393199	386399096							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709507	Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccc5ccncc5c4)c3)ccc12	InChI=1S/C26H21N5O/c27-25-24-4-2-18(11-21(24)6-8-30-25)14-31-26(32)23-12-19(13-29-16-23)9-17-1-3-20-5-7-28-15-22(20)10-17/h1-8,10-13,15-16H,9,14H2,(H2,27,30)(H,31,32)	QWPOIDBZQCSTHS-UHFFFAOYSA-N	359643	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-(isoquinolin-7-ylmethyl)pyridine-3-carboxamide::US10221161, Example 28::US11242333, Example 28	Plasma kallikrein			 1100							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359643	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359643&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393146	386399097							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709508	COc1ccccc1Cc1cncc(c1)C(=O)NCc1ccc2c(N)nccc2c1	InChI=1S/C24H22N4O2/c1-30-22-5-3-2-4-19(22)11-17-12-20(15-26-13-17)24(29)28-14-16-6-7-21-18(10-16)8-9-27-23(21)25/h2-10,12-13,15H,11,14H2,1H3,(H2,25,27)(H,28,29)	RJBICVKPFVWOFZ-UHFFFAOYSA-N	359644	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-[(2-methoxyphenyl)methyl]pyridine-3-carboxamide::US10221161, Example 29::US11242333, Example 29	Plasma kallikrein			 20200							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359644	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359644&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393216	386399098							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709509	Nc1nccc2cc(CNC(=O)c3cncc(Cc4cccc(c4)-n4cccn4)c3)ccc12	InChI=1S/C26H22N6O/c27-25-24-6-5-19(12-21(24)7-9-29-25)16-30-26(33)22-13-20(15-28-17-22)11-18-3-1-4-23(14-18)32-10-2-8-31-32/h1-10,12-15,17H,11,16H2,(H2,27,29)(H,30,33)	QCNNYPSWAPTRPO-UHFFFAOYSA-N	359645	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[3-(pyrazol-1-yl)phenyl]methyl}pyridine-3-carboxamide::US10221161, Example 30::US11242333, Example 30	Plasma kallikrein			 302							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359645	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359645&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393194	386399099							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709510	Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccc5ncccc5c4)c3)ccc12	InChI=1S/C26H21N5O/c27-25-23-5-3-18(12-20(23)7-9-30-25)15-31-26(32)22-13-19(14-28-16-22)10-17-4-6-24-21(11-17)2-1-8-29-24/h1-9,11-14,16H,10,15H2,(H2,27,30)(H,31,32)	XUTIWWYHRPIIGM-UHFFFAOYSA-N	359646	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-(quinolin-6-ylmethyl)pyridine-3-carboxamide::US10221161, Example 31::US11242333, Example 31	Plasma kallikrein			 144							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359646	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359646&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117889860	386399100							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709511	Nc1nccc2cc(CNC(=O)c3cncc(Cc4cccc(Cn5cccn5)c4)c3)ccc12	InChI=1S/C27H24N6O/c28-26-25-6-5-20(13-23(25)7-9-30-26)16-31-27(34)24-14-22(15-29-17-24)12-19-3-1-4-21(11-19)18-33-10-2-8-32-33/h1-11,13-15,17H,12,16,18H2,(H2,28,30)(H,31,34)	KXHZGAGGNIYIJJ-UHFFFAOYSA-N	359647	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[3-(pyrazol-1-ylmethyl)phenyl]methyl}pyridine-3-carboxamide::US10221161, Example 32::US11242333, Example 32	Plasma kallikrein			 237							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359647	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359647&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393182	386399101							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709512	COc1cc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)ccc1Cn1cc(C)cn1	InChI=1S/C29H28N6O2/c1-19-13-34-35(17-19)18-24-5-3-20(12-27(24)37-2)9-22-11-25(16-31-14-22)29(36)33-15-21-4-6-26-23(10-21)7-8-32-28(26)30/h3-8,10-14,16-17H,9,15,18H2,1-2H3,(H2,30,32)(H,33,36)	GTAQUAIETWGMKZ-UHFFFAOYSA-N	359648	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({3-methoxy-4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)pyridine-3-carboxamide::US10221161, Example 33::US11242333, Example 33	Plasma kallikrein			 17.1							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359648	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359648&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117889845	386399102							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709513	COCCOc1ccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)cc1	InChI=1S/C26H26N4O3/c1-32-10-11-33-23-5-2-18(3-6-23)12-20-14-22(17-28-15-20)26(31)30-16-19-4-7-24-21(13-19)8-9-29-25(24)27/h2-9,13-15,17H,10-12,16H2,1H3,(H2,27,29)(H,30,31)	VWAFTKDLCVIHNB-UHFFFAOYSA-N	359649	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[4-(2-methoxyethoxy)phenyl]methyl}pyridine-3-carboxamide::US10221161, Example 34::US11242333, Example 34	Plasma kallikrein			 1020							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359649	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359649&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393208	386399103							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709514	Nc1nccc2cc(CNC(=O)c3cncc(CN4CCN(CC4)S(=O)(=O)c4ccccc4)c3)ccc12	InChI=1S/C27H28N6O3S/c28-26-25-7-6-20(14-22(25)8-9-30-26)17-31-27(34)23-15-21(16-29-18-23)19-32-10-12-33(13-11-32)37(35,36)24-4-2-1-3-5-24/h1-9,14-16,18H,10-13,17,19H2,(H2,28,30)(H,31,34)	GSABBNCJRVLTCT-UHFFFAOYSA-N	359650	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[4-(benzenesulfonyl)piperazin-1-yl]methyl}pyridine-3-carboxamide::US10221161, Example 35::US11242333, Example 35	Plasma kallikrein			 3510							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359650	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359650&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393203	386399104							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709515	Nc1nccc2cc(CNC(=O)c3cncc(CN4CCN(CC4)C(=O)c4ccccc4)c3)ccc12	InChI=1S/C28H28N6O2/c29-26-25-7-6-20(14-23(25)8-9-31-26)17-32-27(35)24-15-21(16-30-18-24)19-33-10-12-34(13-11-33)28(36)22-4-2-1-3-5-22/h1-9,14-16,18H,10-13,17,19H2,(H2,29,31)(H,32,35)	QQISCDLIEFYLAP-UHFFFAOYSA-N	359651	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-[(4-benzoylpiperazin-1-yl)methyl]pyridine-3-carboxamide::US10221161, Example 36::US11242333, Example 36	Plasma kallikrein			 6650							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359651	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359651&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393205	386399105							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709516	Cc1cnn(CC2CCN(Cc3cncc(c3)C(=O)NCc3ccc4c(N)nccc4c3)CC2)c1	InChI=1S/C27H31N7O/c1-19-12-32-34(16-19)18-20-5-8-33(9-6-20)17-22-11-24(15-29-13-22)27(35)31-14-21-2-3-25-23(10-21)4-7-30-26(25)28/h2-4,7,10-13,15-16,20H,5-6,8-9,14,17-18H2,1H3,(H2,28,30)(H,31,35)	HYHCEUBNRXJNAP-UHFFFAOYSA-N	359652	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({4-[(4-methylpyrazol-1-yl)methyl]piperidin-1-yl}methyl)pyridine-3-carboxamide::US10221161, Example 37	Plasma kallikrein			 1180							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359652	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359652&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393163	386399106							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709517	CN1CCOc2cc(Cc3cncc(c3)C(=O)NCc3ccc4c(N)nccc4c3)ccc12	InChI=1S/C26H25N5O2/c1-31-8-9-33-24-13-17(3-5-23(24)31)10-19-12-21(16-28-14-19)26(32)30-15-18-2-4-22-20(11-18)6-7-29-25(22)27/h2-7,11-14,16H,8-10,15H2,1H3,(H2,27,29)(H,30,32)	JXTLOXNAUILARA-UHFFFAOYSA-N	359653	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-[(4-methyl-2,3-dihydro-1,4-benzoxazin-7-yl)methyl]pyridine-3-carboxamide::US10221161, Example 38::US11242333, Example 38	Plasma kallikrein			 107							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359653	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359653&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393147	386399107							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709518	Nc1nccc2cc(CNC(=O)c3cncc(CN4CCN(CC4)c4ccccc4)c3)ccc12	InChI=1S/C27H28N6O/c28-26-25-7-6-20(14-22(25)8-9-30-26)17-31-27(34)23-15-21(16-29-18-23)19-32-10-12-33(13-11-32)24-4-2-1-3-5-24/h1-9,14-16,18H,10-13,17,19H2,(H2,28,30)(H,31,34)	QNILJKZWSOSWNG-UHFFFAOYSA-N	359654	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-[(4-phenylpiperazin-1-yl)methyl]pyridine-3-carboxamide::US10221161, Example 39::US11242333, Example 39	Plasma kallikrein			 10000							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359654	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359654&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393150	386399108							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709519	Cc1cnn(CCOCc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)c1	InChI=1S/C23H24N6O2/c1-16-10-28-29(14-16)6-7-31-15-18-9-20(13-25-11-18)23(30)27-12-17-2-3-21-19(8-17)4-5-26-22(21)24/h2-5,8-11,13-14H,6-7,12,15H2,1H3,(H2,24,26)(H,27,30)	AZBQFJWLTSDFIL-UHFFFAOYSA-N	359655	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[2-(4-methylpyrazol-1-yl)ethoxy]methyl}pyridine-3-carboxamide::US10221161, Example 40::US11242333, Example 40	Plasma kallikrein			 127							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359655	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359655&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393171	386399109							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709520	Nc1nccc2cc(CNC(=O)c3cncc(CN4CCN(Cc5ccccc5)CC4)c3)ccc12	InChI=1S/C28H30N6O/c29-27-26-7-6-22(14-24(26)8-9-31-27)17-32-28(35)25-15-23(16-30-18-25)20-34-12-10-33(11-13-34)19-21-4-2-1-3-5-21/h1-9,14-16,18H,10-13,17,19-20H2,(H2,29,31)(H,32,35)	RIFRFZVMRBBMED-UHFFFAOYSA-N	359656	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-[(4-benzylpiperazin-1-yl)methyl]pyridine-3-carboxamide::US10221161, Example 41::US11242333, Example 41	Plasma kallikrein			 2750							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359656	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359656&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393218	386399110							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709521	COc1ccccc1CN1CCN(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)CC1	InChI=1S/C29H32N6O2/c1-37-27-5-3-2-4-24(27)20-35-12-10-34(11-13-35)19-22-15-25(18-31-16-22)29(36)33-17-21-6-7-26-23(14-21)8-9-32-28(26)30/h2-9,14-16,18H,10-13,17,19-20H2,1H3,(H2,30,32)(H,33,36)	UEKXUKONFSMUBQ-UHFFFAOYSA-N	359657	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({4-[(2-methoxyphenyl)methyl]piperazin-1-yl}methyl)pyridine-3-carboxamide::US10221161, Example 42::US11242333, Example 42	Plasma kallikrein			 1830							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359657	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359657&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393165	386399111							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709522	Nc1nccc2cc(CNC(=O)c3cncc(CN4CCN(CC5CCCC5)CC4)c3)ccc12	InChI=1S/C27H34N6O/c28-26-25-6-5-21(13-23(25)7-8-30-26)16-31-27(34)24-14-22(15-29-17-24)19-33-11-9-32(10-12-33)18-20-3-1-2-4-20/h5-8,13-15,17,20H,1-4,9-12,16,18-19H2,(H2,28,30)(H,31,34)	NZUKSQPPVVBORB-UHFFFAOYSA-N	359658	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[4-(cyclopentylmethyl)piperazin-1-yl]methyl}pyridine-3-carboxamide::US10221161, Example 43::US11242333, Example 43	Plasma kallikrein			 11000							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359658	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359658&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393157	386399112							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709523	Nc1nccc2cc(CNC(=O)c3cncc(CN4CCN(Cc5ccccc5F)CC4)c3)ccc12	InChI=1S/C28H29FN6O/c29-26-4-2-1-3-23(26)19-35-11-9-34(10-12-35)18-21-14-24(17-31-15-21)28(36)33-16-20-5-6-25-22(13-20)7-8-32-27(25)30/h1-8,13-15,17H,9-12,16,18-19H2,(H2,30,32)(H,33,36)	YQEBTDRANIJUMP-UHFFFAOYSA-N	359659	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({4-[(2-fluorophenyl)methyl]piperazin-1-yl}methyl)pyridine-3-carboxamide::US10221161, Example 44::US11242333, Example 44	Plasma kallikrein			 6790							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359659	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359659&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117889897	386399113							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709524	COc1ccc(CN2CCN(Cc3cncc(c3)C(=O)NCc3ccc4c(N)nccc4c3)CC2)cc1	InChI=1S/C29H32N6O2/c1-37-26-5-2-21(3-6-26)19-34-10-12-35(13-11-34)20-23-15-25(18-31-16-23)29(36)33-17-22-4-7-27-24(14-22)8-9-32-28(27)30/h2-9,14-16,18H,10-13,17,19-20H2,1H3,(H2,30,32)(H,33,36)	QDIVAMSJIHQKTJ-UHFFFAOYSA-N	359660	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({4-[(4-methoxyphenyl)methyl]piperazin-1-yl}methyl)pyridine-3-carboxamide::US10221161, Example 45	Plasma kallikrein			 33600							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359660	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359660&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393210	386399114							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709525	Nc1nccc2cc(CNC(=O)c3cncc(CN4CCN(Cc5cccc(F)c5)CC4)c3)ccc12	InChI=1S/C28H29FN6O/c29-25-3-1-2-21(14-25)18-34-8-10-35(11-9-34)19-22-13-24(17-31-15-22)28(36)33-16-20-4-5-26-23(12-20)6-7-32-27(26)30/h1-7,12-15,17H,8-11,16,18-19H2,(H2,30,32)(H,33,36)	JRLYQLXPWIQWEU-UHFFFAOYSA-N	359661	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({4-[(3-fluorophenyl)methyl]piperazin-1-yl}methyl)pyridine-3-carboxamide::US10221161, Example 46::US11242333, Example 46	Plasma kallikrein			 7510							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359661	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359661&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393221	386399115							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709526	Cn1cc(CN2CCN(Cc3cncc(c3)C(=O)NCc3ccc4c(N)nccc4c3)CC2)cn1	InChI=1S/C26H30N8O/c1-32-16-21(14-31-32)18-34-8-6-33(7-9-34)17-20-11-23(15-28-12-20)26(35)30-13-19-2-3-24-22(10-19)4-5-29-25(24)27/h2-5,10-12,14-16H,6-9,13,17-18H2,1H3,(H2,27,29)(H,30,35)	ACNMPVADOSTEOV-UHFFFAOYSA-N	359662	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({4-[(1-methylpyrazol-4-yl)methyl]piperazin-1-yl}methyl)pyridine-3-carboxamide::US10221161, Example 47::US11242333, Example 47	Plasma kallikrein			 40000							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359662	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359662&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393193	386399116							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709527	Nc1nccc2cc(CNC(=O)c3cncc(CN4CCN(Cc5ccc(F)cc5)CC4)c3)ccc12	InChI=1S/C28H29FN6O/c29-25-4-1-20(2-5-25)18-34-9-11-35(12-10-34)19-22-14-24(17-31-15-22)28(36)33-16-21-3-6-26-23(13-21)7-8-32-27(26)30/h1-8,13-15,17H,9-12,16,18-19H2,(H2,30,32)(H,33,36)	WFUMVGOBVWBOPI-UHFFFAOYSA-N	359663	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({4-[(4-fluorophenyl)methyl]piperazin-1-yl}methyl)pyridine-3-carboxamide::US10221161, Example 48::US11242333, Example 48	Plasma kallikrein			 21900							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359663	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359663&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393154	386399117							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709528	COc1cccc(CN2CCN(Cc3cncc(c3)C(=O)NCc3ccc4c(N)nccc4c3)CC2)c1	InChI=1S/C29H32N6O2/c1-37-26-4-2-3-22(15-26)19-34-9-11-35(12-10-34)20-23-14-25(18-31-16-23)29(36)33-17-21-5-6-27-24(13-21)7-8-32-28(27)30/h2-8,13-16,18H,9-12,17,19-20H2,1H3,(H2,30,32)(H,33,36)	ZCPQVTBQVQZWBJ-UHFFFAOYSA-N	359664	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({4-[(3-methoxyphenyl)methyl]piperazin-1-yl}methyl)pyridine-3-carboxamide::US10221161, Example 49::US11242333, Example 49	Plasma kallikrein			 6990							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359664	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359664&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393176	386399118							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709529	Nc1nccc2cc(CNC(=O)c3cncc(CN4CCN(CCCc5ccccc5)CC4)c3)ccc12	InChI=1S/C30H34N6O/c31-29-28-9-8-24(17-26(28)10-11-33-29)20-34-30(37)27-18-25(19-32-21-27)22-36-15-13-35(14-16-36)12-4-7-23-5-2-1-3-6-23/h1-3,5-6,8-11,17-19,21H,4,7,12-16,20,22H2,(H2,31,33)(H,34,37)	WZRBBDWAJNKRJJ-UHFFFAOYSA-N	359665	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[4-(3-phenylpropyl)piperazin-1-yl]methyl}pyridine-3-carboxamide::US10221161, Example 50::US11242333, Example 50	Plasma kallikrein			 10000							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359665	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359665&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393207	386399119							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709530	Nc1nccc2cc(CNC(=O)c3cncc(CN4CCN(CCc5ccccc5)CC4)c3)ccc12	InChI=1S/C29H32N6O/c30-28-27-7-6-23(16-25(27)8-10-32-28)19-33-29(36)26-17-24(18-31-20-26)21-35-14-12-34(13-15-35)11-9-22-4-2-1-3-5-22/h1-8,10,16-18,20H,9,11-15,19,21H2,(H2,30,32)(H,33,36)	WOKOXMNRFZLCOD-UHFFFAOYSA-N	359666	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[4-(2-phenylethyl)piperazin-1-yl]methyl}pyridine-3-carboxamide::US10221161, Example 51::US11242333, Example 51	Plasma kallikrein			 8110							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359666	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359666&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393152	386399120							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709531	Nc1nccc2cc(CNC(=O)c3cncc(CN4CCN(CC(O)=O)CC4)c3)ccc12	InChI=1S/C23H26N6O3/c24-22-20-2-1-16(9-18(20)3-4-26-22)12-27-23(32)19-10-17(11-25-13-19)14-28-5-7-29(8-6-28)15-21(30)31/h1-4,9-11,13H,5-8,12,14-15H2,(H2,24,26)(H,27,32)(H,30,31)	FCGIVIRGUFMPIA-UHFFFAOYSA-N	359667	US10221161, Example 52::US11242333, Example 52::{4-[(5-{[(1-Aminoisoquinolin-6-yl)methyl]carbamoyl}pyridin-3-yl)methyl]piperazin-1-yl}acetic acid	Plasma kallikrein			 10000							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359667	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359667&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393192	386399121							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709532	Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccc(nc4)N4CCCC4=O)c3)ccc12	InChI=1S/C26H24N6O2/c27-25-22-5-3-18(11-20(22)7-8-29-25)15-31-26(34)21-12-19(13-28-16-21)10-17-4-6-23(30-14-17)32-9-1-2-24(32)33/h3-8,11-14,16H,1-2,9-10,15H2,(H2,27,29)(H,31,34)	FGWAAFZCRVTFKI-UHFFFAOYSA-N	359668	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[6-(2-oxopyrrolidin-1-yl)pyridin-3-yl]methyl}pyridine-3-carboxamide::US10221161, Example 53::US11242333, Example 53	Plasma kallikrein			 200							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359668	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359668&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393215	386399122							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709533	Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccc(F)nc4)c3)ccc12	InChI=1S/C22H18FN5O/c23-20-4-2-14(11-27-20)7-16-9-18(13-25-10-16)22(29)28-12-15-1-3-19-17(8-15)5-6-26-21(19)24/h1-6,8-11,13H,7,12H2,(H2,24,26)(H,28,29)	MNWMUSUGAZXLAF-UHFFFAOYSA-N	359669	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-[(6-fluoropyridin-3-yl)methyl]pyridine-3-carboxamide::US10221161, Example 54::US11242333, Example 54	Plasma kallikrein			 14600							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359669	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359669&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393149	386399123							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709534	Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccc(nc4)N4CCCC4)c3)ccc12	InChI=1S/C26H26N6O/c27-25-23-5-3-19(12-21(23)7-8-29-25)16-31-26(33)22-13-20(14-28-17-22)11-18-4-6-24(30-15-18)32-9-1-2-10-32/h3-8,12-15,17H,1-2,9-11,16H2,(H2,27,29)(H,31,33)	YHNLOIFSKXIOLI-UHFFFAOYSA-N	359670	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[6-(pyrrolidin-1-yl)pyridin-3-yl]methyl}pyridine-3-carboxamide::US10221161, Example 55::US11242333, Example 55	Plasma kallikrein			 103							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359670	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359670&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393159	386399124							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709535	Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccc(nc4)N4CCCCC4)c3)ccc12	InChI=1S/C27H28N6O/c28-26-24-6-4-20(13-22(24)8-9-30-26)17-32-27(34)23-14-21(15-29-18-23)12-19-5-7-25(31-16-19)33-10-2-1-3-11-33/h4-9,13-16,18H,1-3,10-12,17H2,(H2,28,30)(H,32,34)	HSRMSOFBIDEBQY-UHFFFAOYSA-N	359671	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[6-(piperidin-1-yl)pyridin-3-yl]methyl}pyridine-3-carboxamide::US10221161, Example 56::US11242333, Example 56	Plasma kallikrein			 313							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359671	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359671&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393162	386399125							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709536	Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccc(nc4)N4CCC(F)(F)C4)c3)ccc12	InChI=1S/C26H24F2N6O/c27-26(28)6-8-34(16-26)23-4-2-17(13-32-23)9-19-11-21(15-30-12-19)25(35)33-14-18-1-3-22-20(10-18)5-7-31-24(22)29/h1-5,7,10-13,15H,6,8-9,14,16H2,(H2,29,31)(H,33,35)	SQHRXWHUJDTTGU-UHFFFAOYSA-N	359672	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[6-(3,3-difluoropyrrolidin-1-yl)pyridin-3-yl]methyl}pyridine-3-carboxamide::US10221161, Example 57::US11242333, Example 57	Plasma kallikrein			 240							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359672	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359672&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393204	386399126							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709537	CC1CCCN1c1ccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)cn1	InChI=1S/C27H28N6O/c1-18-3-2-10-33(18)25-7-5-19(15-31-25)11-21-13-23(17-29-14-21)27(34)32-16-20-4-6-24-22(12-20)8-9-30-26(24)28/h4-9,12-15,17-18H,2-3,10-11,16H2,1H3,(H2,28,30)(H,32,34)	HCKCTEYBXXLMKG-UHFFFAOYSA-N	359673	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[6-(2-methylpyrrolidin-1-yl)pyridin-3-yl]methyl}pyridine-3-carboxamide::US10221161, Example 58::US11242333, Example 58	Plasma kallikrein			 153							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359673	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359673&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393156	386399127							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709538	Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccc(nc4)N4CCC(O)C4)c3)ccc12	InChI=1S/C26H26N6O2/c27-25-23-3-1-18(10-20(23)5-7-29-25)14-31-26(34)21-11-19(12-28-15-21)9-17-2-4-24(30-13-17)32-8-6-22(33)16-32/h1-5,7,10-13,15,22,33H,6,8-9,14,16H2,(H2,27,29)(H,31,34)	WRPGPMLIUGFQRG-UHFFFAOYSA-N	359674	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[6-(3-hydroxypyrrolidin-1-yl)pyridin-3-yl]methyl}pyridine-3-carboxamide::US10221161, Example 59::US11242333, Example 59	Plasma kallikrein			 417							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359674	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359674&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393196	386399128							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709539	Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccc(nc4)N4CCC(F)C4)c3)ccc12	InChI=1S/C26H25FN6O/c27-22-6-8-33(16-22)24-4-2-17(13-31-24)9-19-11-21(15-29-12-19)26(34)32-14-18-1-3-23-20(10-18)5-7-30-25(23)28/h1-5,7,10-13,15,22H,6,8-9,14,16H2,(H2,28,30)(H,32,34)	ADLMVMMMJBJZMR-UHFFFAOYSA-N	359675	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[6-(3-fluoropyrrolidin-1-yl)pyridin-3-yl]methyl}pyridine-3-carboxamide::US10221161, Example 60::US11242333, Example 60	Plasma kallikrein			 137							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359675	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359675&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393183	386399129							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709540	CC1CCN(C1)c1ccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)cn1	InChI=1S/C27H28N6O/c1-18-7-9-33(17-18)25-5-3-19(14-31-25)10-21-12-23(16-29-13-21)27(34)32-15-20-2-4-24-22(11-20)6-8-30-26(24)28/h2-6,8,11-14,16,18H,7,9-10,15,17H2,1H3,(H2,28,30)(H,32,34)	ALWCYCHCLNSCIN-UHFFFAOYSA-N	359676	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[6-(3-methylpyrrolidin-1-yl)pyridin-3-yl]methyl}pyridine-3-carboxamide::US10221161, Example 61::US11242333, Example 61	Plasma kallikrein			 137							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359676	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359676&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393187	386399130							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709541	COC1CCN(C1)c1ccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)cn1	InChI=1S/C27H28N6O2/c1-35-23-7-9-33(17-23)25-5-3-18(14-31-25)10-20-12-22(16-29-13-20)27(34)32-15-19-2-4-24-21(11-19)6-8-30-26(24)28/h2-6,8,11-14,16,23H,7,9-10,15,17H2,1H3,(H2,28,30)(H,32,34)	QKSNHFIMZOACNT-UHFFFAOYSA-N	359677	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[6-(3-methoxypyrrolidin-1-yl)pyridin-3-yl]methyl}pyridine-3-carboxamide::US10221161, Example 62::US11242333, Example 62	Plasma kallikrein			 255							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359677	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359677&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393214	386399131							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709542	Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccc(nc4)N4CCOCC4)c3)ccc12	InChI=1S/C26H26N6O2/c27-25-23-3-1-19(12-21(23)5-6-29-25)16-31-26(33)22-13-20(14-28-17-22)11-18-2-4-24(30-15-18)32-7-9-34-10-8-32/h1-6,12-15,17H,7-11,16H2,(H2,27,29)(H,31,33)	GCDCEQPKZBSJCH-UHFFFAOYSA-N	359678	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[6-(morpholin-4-yl)pyridin-3-yl]methyl}pyridine-3-carboxamide::US10221161, Example 63::US11242333, Example 63	Plasma kallikrein			 432							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359678	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359678&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393185	386399132							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709543	CN1CCN(CC1)c1ccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)cn1	InChI=1S/C27H29N7O/c1-33-8-10-34(11-9-33)25-5-3-19(16-31-25)12-21-14-23(18-29-15-21)27(35)32-17-20-2-4-24-22(13-20)6-7-30-26(24)28/h2-7,13-16,18H,8-12,17H2,1H3,(H2,28,30)(H,32,35)	AYIZOVVOLGYDQH-UHFFFAOYSA-N	359679	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[6-(4-methylpiperazin-1-yl)pyridin-3-yl]methyl}pyridine-3-carboxamide::US10221161, Example 64::US11242333, Example 64	Plasma kallikrein			 610							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359679	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359679&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393166	386399133							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709544	CC1(C)CCCN1c1ccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)cn1	InChI=1S/C28H30N6O/c1-28(2)9-3-11-34(28)25-7-5-19(16-32-25)12-21-14-23(18-30-15-21)27(35)33-17-20-4-6-24-22(13-20)8-10-31-26(24)29/h4-8,10,13-16,18H,3,9,11-12,17H2,1-2H3,(H2,29,31)(H,33,35)	NUHVLIFKBURDJA-UHFFFAOYSA-N	359680	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[6-(2,2-dimethylpyrrolidin-1-yl)pyridin-3-yl]methyl}pyridine-3-carboxamide::US10221161, Example 65::US11242333, Example 65	Plasma kallikrein			 131							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359680	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359680&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393179	386399134							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709545	CCN(CC)c1ccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)cn1	InChI=1S/C26H28N6O/c1-3-32(4-2)24-8-6-18(15-30-24)11-20-13-22(17-28-14-20)26(33)31-16-19-5-7-23-21(12-19)9-10-29-25(23)27/h5-10,12-15,17H,3-4,11,16H2,1-2H3,(H2,27,29)(H,31,33)	RRHDPDBRJHCVGS-UHFFFAOYSA-N	359681	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[6-(diethylamino)pyridin-3-yl]methyl}pyridine-3-carboxamide::US10221161, Example 66	Plasma kallikrein			 52.7							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359681	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359681&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393197	386399135							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709546	Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccc(nc4)N4CCCC4CO)c3)ccc12	InChI=1S/C27H28N6O2/c28-26-24-5-3-19(11-21(24)7-8-30-26)15-32-27(35)22-12-20(13-29-16-22)10-18-4-6-25(31-14-18)33-9-1-2-23(33)17-34/h3-8,11-14,16,23,34H,1-2,9-10,15,17H2,(H2,28,30)(H,32,35)	CDKBTMZPQXYCQA-UHFFFAOYSA-N	359682	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({6-[2-(hydroxymethyl)pyrrolidin-1-yl]pyridin-3-yl}methyl)pyridine-3-carboxamide::US10221161, Example 67::US11242333, Example 67	Plasma kallikrein			 73.3							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359682	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359682&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393174	386399136							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709547	CN(C)C1CCN(C1)c1ccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)cn1	InChI=1S/C28H31N7O/c1-34(2)24-8-10-35(18-24)26-6-4-19(15-32-26)11-21-13-23(17-30-14-21)28(36)33-16-20-3-5-25-22(12-20)7-9-31-27(25)29/h3-7,9,12-15,17,24H,8,10-11,16,18H2,1-2H3,(H2,29,31)(H,33,36)	SPGWHUUKFWWSEI-UHFFFAOYSA-N	359683	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({6-[3-(dimethylamino)pyrrolidin-1-yl]pyridin-3-yl}methyl)pyridine-3-carboxamide::US10221161, Example 68::US10221161, Example 69	Plasma kallikrein			 375							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359683	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359683&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393169	386399137							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709548	CN(C)C1CCN(C1)c1ccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)cn1	InChI=1S/C28H31N7O/c1-34(2)24-8-10-35(18-24)26-6-4-19(15-32-26)11-21-13-23(17-30-14-21)28(36)33-16-20-3-5-25-22(12-20)7-9-31-27(25)29/h3-7,9,12-15,17,24H,8,10-11,16,18H2,1-2H3,(H2,29,31)(H,33,36)	SPGWHUUKFWWSEI-UHFFFAOYSA-N	359683	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({6-[3-(dimethylamino)pyrrolidin-1-yl]pyridin-3-yl}methyl)pyridine-3-carboxamide::US10221161, Example 68::US10221161, Example 69	Plasma kallikrein			 579							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359683	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359683&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393169	386399137							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709549	CC(C)Oc1ccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)cn1	InChI=1S/C25H25N5O2/c1-16(2)32-23-6-4-17(13-29-23)9-19-11-21(15-27-12-19)25(31)30-14-18-3-5-22-20(10-18)7-8-28-24(22)26/h3-8,10-13,15-16H,9,14H2,1-2H3,(H2,26,28)(H,30,31)	YKHQYVOPIDSSDX-UHFFFAOYSA-N	359686	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-[(6-isopropoxypyridin-3-yl)methyl]pyridine-3-carboxamide::US10221161, Example 70::US11242333, Example 70	Plasma kallikrein			 1740							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359686	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359686&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393155	386399139							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709550	Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccc(nc4)N4CCC(CO)C4)c3)ccc12	InChI=1S/C27H28N6O2/c28-26-24-3-1-19(10-22(24)5-7-30-26)14-32-27(35)23-11-21(12-29-15-23)9-18-2-4-25(31-13-18)33-8-6-20(16-33)17-34/h1-5,7,10-13,15,20,34H,6,8-9,14,16-17H2,(H2,28,30)(H,32,35)	YHDQKRLULDVQCF-UHFFFAOYSA-N	359687	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({6-[3-(hydroxymethyl)pyrrolidin-1-yl]pyridin-3-yl}methyl)pyridine-3-carboxamide::US10221161, Example 71::US11242333, Example 71	Plasma kallikrein			 306							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359687	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359687&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393164	386399140							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709551	CCOC(=O)C1CCN(C1)c1ccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)cn1	InChI=1S/C29H30N6O3/c1-2-38-29(37)23-8-10-35(18-23)26-6-4-19(15-33-26)11-21-13-24(17-31-14-21)28(36)34-16-20-3-5-25-22(12-20)7-9-32-27(25)30/h3-7,9,12-15,17,23H,2,8,10-11,16,18H2,1H3,(H2,30,32)(H,34,36)	JLRATSDYYSCALN-UHFFFAOYSA-N	359688	Ethyl 1-{5-[(5-{[(1-aminoisoquinolin-6-yl)methyl]carbamoyl}pyridin-3-yl)methyl]pyridin-2-yl}pyrrolidine-3-carboxylate::US10221161, Example 72	Plasma kallikrein			 860							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359688	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359688&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393190	386399141							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709552	CC(C)N(C)c1ccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)cn1	InChI=1S/C26H28N6O/c1-17(2)32(3)24-7-5-18(14-30-24)10-20-12-22(16-28-13-20)26(33)31-15-19-4-6-23-21(11-19)8-9-29-25(23)27/h4-9,11-14,16-17H,10,15H2,1-3H3,(H2,27,29)(H,31,33)	QHAUWEJXKZUUPP-UHFFFAOYSA-N	359689	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({6-[isopropyl(methyl)amino]pyridin-3-yl}methyl)pyridine-3-carboxamide::US10221161, Example 73::US11242333, Example 73	Plasma kallikrein			 51.1							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359689	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359689&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393184	386399142							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709553	CC1(C)CCN(C1)c1ccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)cn1	InChI=1S/C28H30N6O/c1-28(2)8-10-34(18-28)25-6-4-19(15-32-25)11-21-13-23(17-30-14-21)27(35)33-16-20-3-5-24-22(12-20)7-9-31-26(24)29/h3-7,9,12-15,17H,8,10-11,16,18H2,1-2H3,(H2,29,31)(H,33,35)	ZLDDWJIJDXHGIU-UHFFFAOYSA-N	359692	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[6-(3,3-dimethylpyrrolidin-1-yl)pyridin-3-yl]methyl}pyridine-3-carboxamide::US10221161, Example 74::US11242333, Example 74	Plasma kallikrein			 83.1							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359692	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359692&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393206	386399145							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709554	Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccc(nc4)N4CCC(C4)C(O)=O)c3)ccc12	InChI=1S/C27H26N6O3/c28-25-23-3-1-18(10-20(23)5-7-30-25)14-32-26(34)22-11-19(12-29-15-22)9-17-2-4-24(31-13-17)33-8-6-21(16-33)27(35)36/h1-5,7,10-13,15,21H,6,8-9,14,16H2,(H2,28,30)(H,32,34)(H,35,36)	SAVRWXYQJVOYRM-UHFFFAOYSA-N	359693	1-{5-[(5-{[(1-Aminoisoquinolin-6-yl)methyl]carbamoyl}pyridin-3-yl)methyl]pyridin-2-yl}pyrrolidine-3-carboxylic acid::US10221161, Example 75::US11242333, Example 75	Plasma kallikrein			 6120							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359693	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359693&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393191	386399146							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709555	Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccnc(c4)N4CCCC4=O)c3)ccc12	InChI=1S/C26H24N6O2/c27-25-22-4-3-18(11-20(22)6-8-30-25)15-31-26(34)21-12-19(14-28-16-21)10-17-5-7-29-23(13-17)32-9-1-2-24(32)33/h3-8,11-14,16H,1-2,9-10,15H2,(H2,27,30)(H,31,34)	DWTKEQLXPBZTEF-UHFFFAOYSA-N	359694	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[2-(2-oxopyrrolidin-1-yl)pyridin-4-yl]methyl}pyridine-3-carboxamide::US10221161, Example 76::US11242333, Example 76	Plasma kallikrein			 242							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359694	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359694&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393217	386399147							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709556	Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccnc(c4)N4CCCC4)c3)ccc12	InChI=1S/C26H26N6O/c27-25-23-4-3-19(12-21(23)6-8-30-25)16-31-26(33)22-13-20(15-28-17-22)11-18-5-7-29-24(14-18)32-9-1-2-10-32/h3-8,12-15,17H,1-2,9-11,16H2,(H2,27,30)(H,31,33)	OKYNKPFZSOLVQE-UHFFFAOYSA-N	359695	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[2-(pyrrolidin-1-yl)pyridin-4-yl]methyl}pyridine-3-carboxamide::US10221161, Example 77::US11242333, Example 77	Plasma kallikrein			 37.7							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359695	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359695&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117890050	386399148							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709557	Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccnc(c4)N4CCCCC4)c3)ccc12	InChI=1S/C27H28N6O/c28-26-24-5-4-20(13-22(24)7-9-31-26)17-32-27(34)23-14-21(16-29-18-23)12-19-6-8-30-25(15-19)33-10-2-1-3-11-33/h4-9,13-16,18H,1-3,10-12,17H2,(H2,28,31)(H,32,34)	RJFGZABUVYSVKX-UHFFFAOYSA-N	359696	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[2-(piperidin-1-yl)pyridin-4-yl]methyl}pyridine-3-carboxamide::US10221161, Example 78::US11242333, Example 78	Plasma kallikrein			 164							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359696	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359696&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393189	386399149							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709558	CC1CCCN1c1cc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)ccn1	InChI=1S/C27H28N6O/c1-18-3-2-10-33(18)25-14-19(6-8-30-25)11-21-13-23(17-29-15-21)27(34)32-16-20-4-5-24-22(12-20)7-9-31-26(24)28/h4-9,12-15,17-18H,2-3,10-11,16H2,1H3,(H2,28,31)(H,32,34)	QJOGYBUMALCINT-UHFFFAOYSA-N	359697	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[2-(2-methylpyrrolidin-1-yl)pyridin-4-yl]methyl}pyridine-3-carboxamide::US10221161, Example 79::US11242333, Example 79	Plasma kallikrein			 155							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359697	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359697&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393170	386399150							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709559	Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccnc(c4)N4CCC(F)(F)C4)c3)ccc12	InChI=1S/C26H24F2N6O/c27-26(28)5-8-34(16-26)23-12-17(3-6-31-23)9-19-11-21(15-30-13-19)25(35)33-14-18-1-2-22-20(10-18)4-7-32-24(22)29/h1-4,6-7,10-13,15H,5,8-9,14,16H2,(H2,29,32)(H,33,35)	OTPILUCJJKOWPU-UHFFFAOYSA-N	359698	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[2-(3,3-difluoropyrrolidin-1-yl)pyridin-4-yl]methyl}pyridine-3-carboxamide::US10221161, Example 80::US11242333, Example 80	Plasma kallikrein			 88.5							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359698	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359698&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393213	386399151							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709560	Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccnc(c4)N4CCC(O)C4)c3)ccc12	InChI=1S/C26H26N6O2/c27-25-23-2-1-18(10-20(23)4-7-30-25)14-31-26(34)21-11-19(13-28-15-21)9-17-3-6-29-24(12-17)32-8-5-22(33)16-32/h1-4,6-7,10-13,15,22,33H,5,8-9,14,16H2,(H2,27,30)(H,31,34)	PSHMRDARMQOLRC-UHFFFAOYSA-N	359699	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[2-(3-hydroxypyrrolidin-1-yl)pyridin-4-yl]methyl}pyridine-3-carboxamide::US10221161, Example 81::US11242333, Example 81	Plasma kallikrein			 674							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359699	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359699&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393153	386399152							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709561	Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccnc(c4)N4CCC(F)C4)c3)ccc12	InChI=1S/C26H25FN6O/c27-22-5-8-33(16-22)24-12-17(3-6-30-24)9-19-11-21(15-29-13-19)26(34)32-14-18-1-2-23-20(10-18)4-7-31-25(23)28/h1-4,6-7,10-13,15,22H,5,8-9,14,16H2,(H2,28,31)(H,32,34)	UOVPCOMKDUSQBG-UHFFFAOYSA-N	359700	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[2-(3-fluoropyrrolidin-1-yl)pyridin-4-yl]methyl}pyridine-3-carboxamide::US10221161, Example 82::US11242333, Example 82	Plasma kallikrein			 67.8							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359700	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359700&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393198	386399153							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709562	CC1CCN(C1)c1cc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)ccn1	InChI=1S/C27H28N6O/c1-18-6-9-33(17-18)25-13-19(4-7-30-25)10-21-12-23(16-29-14-21)27(34)32-15-20-2-3-24-22(11-20)5-8-31-26(24)28/h2-5,7-8,11-14,16,18H,6,9-10,15,17H2,1H3,(H2,28,31)(H,32,34)	BDDHAZOVAFLCQY-UHFFFAOYSA-N	359701	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[2-(3-methylpyrrolidin-1-yl)pyridin-4-yl]methyl}pyridine-3-carboxamide::US10221161, Example 83::US11242333, Example 83	Plasma kallikrein			 106							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359701	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359701&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393220	386399154							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709563	CC1(C)CCCN1c1cc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)ccn1	InChI=1S/C28H30N6O/c1-28(2)8-3-11-34(28)25-15-19(6-9-31-25)12-21-14-23(18-30-16-21)27(35)33-17-20-4-5-24-22(13-20)7-10-32-26(24)29/h4-7,9-10,13-16,18H,3,8,11-12,17H2,1-2H3,(H2,29,32)(H,33,35)	UUAUDGVZIJLYSI-UHFFFAOYSA-N	359702	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[2-(2,2-dimethylpyrrolidin-1-yl)pyridin-4-yl]methyl}pyridine-3-carboxamide::US10221161, Example 84::US11242333, Example 84	Plasma kallikrein			 683							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359702	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359702&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393211	386399155							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709564	Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccnc(c4)N4CCOCC4)c3)ccc12	InChI=1S/C26H26N6O2/c27-25-23-2-1-19(12-21(23)4-6-30-25)16-31-26(33)22-13-20(15-28-17-22)11-18-3-5-29-24(14-18)32-7-9-34-10-8-32/h1-6,12-15,17H,7-11,16H2,(H2,27,30)(H,31,33)	WDTKDHOKUXYDRS-UHFFFAOYSA-N	359703	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[2-(morpholin-4-yl)pyridin-4-yl]methyl}pyridine-3-carboxamide::US10221161, Example 85::US11242333, Example 85	Plasma kallikrein			 1670							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359703	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359703&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393148	386399156							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709565	CN1CCN(CC1)c1cc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)ccn1	InChI=1S/C27H29N7O/c1-33-8-10-34(11-9-33)25-15-19(4-6-30-25)12-21-14-23(18-29-16-21)27(35)32-17-20-2-3-24-22(13-20)5-7-31-26(24)28/h2-7,13-16,18H,8-12,17H2,1H3,(H2,28,31)(H,32,35)	CCWAWYXGGKGFJT-UHFFFAOYSA-N	359704	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[2-(4-methylpiperazin-1-yl)pyridin-4-yl]methyl}pyridine-3-carboxamide::US10221161, Example 86::US11242333, Example 86	Plasma kallikrein			 395							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359704	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359704&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393188	386399157							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709566	CCN(CC)c1cc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)ccn1	InChI=1S/C26H28N6O/c1-3-32(4-2)24-14-18(7-9-29-24)11-20-13-22(17-28-15-20)26(33)31-16-19-5-6-23-21(12-19)8-10-30-25(23)27/h5-10,12-15,17H,3-4,11,16H2,1-2H3,(H2,27,30)(H,31,33)	BSYLXGAPHBOLPP-UHFFFAOYSA-N	359705	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[2-(diethylamino)pyridin-4-yl]methyl}pyridine-3-carboxamide::US10221161, Example 87::US11242333, Example 87	Plasma kallikrein			 358							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359705	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359705&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393200	386399158							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709567	COC1CCN(C1)c1cc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)ccn1	InChI=1S/C27H28N6O2/c1-35-23-6-9-33(17-23)25-13-18(4-7-30-25)10-20-12-22(16-29-14-20)27(34)32-15-19-2-3-24-21(11-19)5-8-31-26(24)28/h2-5,7-8,11-14,16,23H,6,9-10,15,17H2,1H3,(H2,28,31)(H,32,34)	AGESLAHMMMUCOA-UHFFFAOYSA-N	359706	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[2-(3-methoxypyrrolidin-1-yl)pyridin-4-yl]methyl}pyridine-3-carboxamide::US10221161, Example 88::US11242333, Example 92	Plasma kallikrein			 234							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359706	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359706&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393167	386399159							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709568	Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccnc(c4)N4CCCC4CO)c3)ccc12	InChI=1S/C27H28N6O2/c28-26-24-4-3-19(11-21(24)6-8-31-26)15-32-27(35)22-12-20(14-29-16-22)10-18-5-7-30-25(13-18)33-9-1-2-23(33)17-34/h3-8,11-14,16,23,34H,1-2,9-10,15,17H2,(H2,28,31)(H,32,35)	YEGMXIRGBOBRED-UHFFFAOYSA-N	359707	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({2-[2-(hydroxymethyl)pyrrolidin-1-yl]pyridin-4-yl}methyl)pyridine-3-carboxamide::US10221161, Example 89::US11242333, Example 89	Plasma kallikrein			 104							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359707	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359707&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117889851	386399160							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709569	CN(C)C1CCN(C1)c1cc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)ccn1	InChI=1S/C28H31N7O/c1-34(2)24-7-10-35(18-24)26-14-19(5-8-31-26)11-21-13-23(17-30-15-21)28(36)33-16-20-3-4-25-22(12-20)6-9-32-27(25)29/h3-6,8-9,12-15,17,24H,7,10-11,16,18H2,1-2H3,(H2,29,32)(H,33,36)	QLBNBADVDGUZLM-UHFFFAOYSA-N	359708	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({2-[3-(dimethylamino)pyrrolidin-1-yl]pyridin-4-yl}methyl)pyridine-3-carboxamide::US10221161, Example 90::US10221161, Example 91	Plasma kallikrein			 1550							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359708	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359708&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393168	386399161							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709570	CN(C)C1CCN(C1)c1cc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)ccn1	InChI=1S/C28H31N7O/c1-34(2)24-7-10-35(18-24)26-14-19(5-8-31-26)11-21-13-23(17-30-15-21)28(36)33-16-20-3-4-25-22(12-20)6-9-32-27(25)29/h3-6,8-9,12-15,17,24H,7,10-11,16,18H2,1-2H3,(H2,29,32)(H,33,36)	QLBNBADVDGUZLM-UHFFFAOYSA-N	359708	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({2-[3-(dimethylamino)pyrrolidin-1-yl]pyridin-4-yl}methyl)pyridine-3-carboxamide::US10221161, Example 90::US10221161, Example 91	Plasma kallikrein			 1710							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359708	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359708&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393168	386399161							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709571	Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccnc(c4)N4CCC(CO)C4)c3)ccc12	InChI=1S/C27H28N6O2/c28-26-24-2-1-19(10-22(24)4-7-31-26)14-32-27(35)23-11-21(13-29-15-23)9-18-3-6-30-25(12-18)33-8-5-20(16-33)17-34/h1-4,6-7,10-13,15,20,34H,5,8-9,14,16-17H2,(H2,28,31)(H,32,35)	KXOHCDTXIZSUSX-UHFFFAOYSA-N	359710	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({2-[3-(hydroxymethyl)pyrrolidin-1-yl]pyridin-4-yl}methyl)pyridine-3-carboxamide::US10221161, Example 92	Plasma kallikrein			 355							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359710	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359710&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393201	386399162							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709572	Cc1cnn(Cc2ccc(Cc3cncc(c3)C(=O)NCc3ccc(CN)cc3C)cc2)c1	InChI=1S/C27H29N5O/c1-19-13-31-32(17-19)18-22-5-3-21(4-6-22)10-24-11-26(15-29-14-24)27(33)30-16-25-8-7-23(12-28)9-20(25)2/h3-9,11,13-15,17H,10,12,16,18,28H2,1-2H3,(H,30,33)	JKTKKPCPPHYQER-UHFFFAOYSA-N	359711	N-{[4-(Aminomethyl)-2-methylphenyl]methyl}-5-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)pyridine-3-carboxamide::US10221161, Example 93	Plasma kallikrein			 14.4							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359711	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359711&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117889648	386399163							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709573	Cc1cnn(Cc2ccc(Cc3cncc(c3)C(=O)NCc3c(C)cc(CN)cc3C)cc2)c1	InChI=1S/C28H31N5O/c1-19-13-32-33(17-19)18-23-6-4-22(5-7-23)10-25-11-26(15-30-14-25)28(34)31-16-27-20(2)8-24(12-29)9-21(27)3/h4-9,11,13-15,17H,10,12,16,18,29H2,1-3H3,(H,31,34)	QWAPEEDIDSKKLU-UHFFFAOYSA-N	359712	N-{[4-(Aminomethyl)-2,6-dimethylphenyl]methyl}-5-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)pyridine-3-carboxamide::US10221161, Example 94	Plasma kallikrein			 7.47							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359712	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359712&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117889922	386399164							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709574	Cc1cnn(Cc2ccc(Cc3cncc(n3)C(=O)NCc3c(C)cc(CN)cc3C)cc2)c1	InChI=1S/C27H30N6O/c1-18-12-31-33(16-18)17-22-6-4-21(5-7-22)10-24-13-29-15-26(32-24)27(34)30-14-25-19(2)8-23(11-28)9-20(25)3/h4-9,12-13,15-16H,10-11,14,17,28H2,1-3H3,(H,30,34)	QDRGMOCPSUXWFS-UHFFFAOYSA-N	359713	N-{[4-(Aminomethyl)-2,6-dimethylphenyl]methyl}-6-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)pyrazine-2-carboxamide::US10221161, Example 95::US11242333, Example 95	Plasma kallikrein			 53.6							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359713	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359713&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117889949	386399165							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
709575	Cc1cnn(Cc2ccc(Cc3cncc(c3)C(=O)NCc3ccc(CN)c(F)c3)cc2)c1	InChI=1S/C26H26FN5O/c1-18-12-31-32(16-18)17-20-4-2-19(3-5-20)8-22-9-24(15-29-13-22)26(33)30-14-21-6-7-23(11-28)25(27)10-21/h2-7,9-10,12-13,15-16H,8,11,14,17,28H2,1H3,(H,30,33)	IZERGKYBLGUDKW-UHFFFAOYSA-N	359714	N-{[4-(Aminomethyl)-3-fluorophenyl]methyl}-5-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)pyridine-3-carboxamide::US10221161, Example 96	Plasma kallikrein			 365							US Patent		10.7270/Q23B62DG		aid1797758	US10221161	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359714	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359714&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393212	386399166							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716085	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1csc(n1)-c1ccccc1	InChI=1S/C25H26N4OS/c1-17-12-23(24(30)27-14-20-10-8-19(13-26)9-11-20)18(2)29(17)15-22-16-31-25(28-22)21-6-4-3-5-7-21/h3-12,16H,13-15,26H2,1-2H3,(H,27,30)	SJVAITNWGSDKNM-UHFFFAOYSA-N	186835	US9670157, 1 2,5-Dimethyl-1-(2-phenyl-thiazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 1	Plasma kallikrein			 63.0							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186835	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186835&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290252	373987407							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716086	Cc1cc(C(=O)NCc2ccc(CN)cc2C)c(C)n1Cc1csc(n1)-c1ccccc1	InChI=1S/C26H28N4OS/c1-17-11-20(13-27)9-10-22(17)14-28-25(31)24-12-18(2)30(19(24)3)15-23-16-32-26(29-23)21-7-5-4-6-8-21/h4-12,16H,13-15,27H2,1-3H3,(H,28,31)	LRLXLIQZQCBDLR-UHFFFAOYSA-N	186836	US9670157, 2 2,5-Dimethyl-1-(2-phenyl-thiazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-2-methyl-benzylamide::US9834513, 2	Plasma kallikrein			 15.0							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186836	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186836&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290253	373987408							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716087	Cc1cc(C(=O)NCc2c(C)cc(CN)cc2C)c(C)n1Cc1csc(n1)-c1ccccc1	InChI=1S/C27H30N4OS/c1-17-10-21(13-28)11-18(2)25(17)14-29-26(32)24-12-19(3)31(20(24)4)15-23-16-33-27(30-23)22-8-6-5-7-9-22/h5-12,16H,13-15,28H2,1-4H3,(H,29,32)	XFFLHTLNQQRHNA-UHFFFAOYSA-N	186837	US9670157, 3 2,5-Dimethyl-1-(2-phenyl-thiazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-2,6-dimethyl-benzylamide::US9834513, 3	Plasma kallikrein			 6.00							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186837	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186837&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290254	373987409							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716088	Cc1cc(C(=O)NCc2ccc(cc2)C2(N)CC2)c(C)n1Cc1csc(n1)-c1ccccc1	InChI=1S/C27H28N4OS/c1-18-14-24(25(32)29-15-20-8-10-22(11-9-20)27(28)12-13-27)19(2)31(18)16-23-17-33-26(30-23)21-6-4-3-5-7-21/h3-11,14,17H,12-13,15-16,28H2,1-2H3,(H,29,32)	JDDOXSIDIBNPSA-UHFFFAOYSA-N	186838	US9670157, 4 2,5-Dimethyl-1-(2-phenyl-thiazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-(1-amino-cyclopropyl)-benzylamide::US9834513, 4	Plasma kallikrein			 121							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186838	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186838&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290298	373987410							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716089	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1csc(c1)-c1cccnc1	InChI=1S/C25H26N4OS/c1-17-10-23(25(30)28-13-20-7-5-19(12-26)6-8-20)18(2)29(17)15-21-11-24(31-16-21)22-4-3-9-27-14-22/h3-11,14,16H,12-13,15,26H2,1-2H3,(H,28,30)	UIJXPAQBXCMOQM-UHFFFAOYSA-N	186842	US9670157, 19 2,5-Dimethyl-1-(5-methyl-2-phenyl-oxazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9670157, 8 2,5-Dimethyl-1-(5-pyridin-3-yl-thiophen-3-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 8	Plasma kallikrein			 348							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186842	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186842&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280284	373987411							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716090	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1cc(cs1)-c1ccccc1	InChI=1S/C26H27N3OS/c1-18-12-25(26(30)28-15-21-10-8-20(14-27)9-11-21)19(2)29(18)16-24-13-23(17-31-24)22-6-4-3-5-7-22/h3-13,17H,14-16,27H2,1-2H3,(H,28,30)	WZOQSONUCUVTNE-UHFFFAOYSA-N	362189	2,5-Dimethyl-1-(4-phenyl-thiophen-2-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 9	Plasma kallikrein			 543							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=362189	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=362189&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716091	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1csc(c1)-c1ccccc1	InChI=1S/C26H27N3OS/c1-18-12-24(26(30)28-15-21-10-8-20(14-27)9-11-21)19(2)29(18)16-22-13-25(31-17-22)23-6-4-3-5-7-23/h3-13,17H,14-16,27H2,1-2H3,(H,28,30)	AKTNRYFLMYWXLM-UHFFFAOYSA-N	186844	US9670157, 10 2,5-Dimethyl-1-(5-phenyl-thiophen-3-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 10	Plasma kallikrein			 571							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186844	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186844&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280153	373987413							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716092	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1cc(no1)-c1ccccc1	InChI=1S/C25H26N4O2/c1-17-12-23(25(30)27-15-20-10-8-19(14-26)9-11-20)18(2)29(17)16-22-13-24(28-31-22)21-6-4-3-5-7-21/h3-13H,14-16,26H2,1-2H3,(H,27,30)	NQJSPLMQDLYQOM-UHFFFAOYSA-N	186845	US9670157, 11 2,5-Dimethyl-1-(3-phenyl-isoxazol-5-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 11	Plasma kallikrein			 2419							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186845	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186845&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280287	373987414							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716093	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1nc2ccccc2s1	InChI=1S/C23H24N4OS/c1-15-11-19(23(28)25-13-18-9-7-17(12-24)8-10-18)16(2)27(15)14-22-26-20-5-3-4-6-21(20)29-22/h3-11H,12-14,24H2,1-2H3,(H,25,28)	CUWABYMPFZECKG-UHFFFAOYSA-N	186846	US9670157, 12 1-Benzothiazol-2-ylmethyl-2,5-dimethyl-1H-pyrrole-3-carboxylicacid 4-aminomethyl-benzylamide::US9834513, 12	Plasma kallikrein			 5119							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186846	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186846&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280357	373987415							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716094	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1cc(cs1)-c1cccnc1	InChI=1S/C25H26N4OS/c1-17-10-24(25(30)28-13-20-7-5-19(12-26)6-8-20)18(2)29(17)15-23-11-22(16-31-23)21-4-3-9-27-14-21/h3-11,14,16H,12-13,15,26H2,1-2H3,(H,28,30)	PGWYTVSRTREBIS-UHFFFAOYSA-N	186843	US9670157, 13 2,5-Dimethyl-1-(4-pyridin-3-yl-thiophen-2-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9670157, 9 2,5-Dimethyl-1-(4-phenyl-thiophen-2-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 13	Plasma kallikrein			 2383							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186843	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186843&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280182	373987412							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716095	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1cc(cs1)-c1ccncc1	InChI=1S/C25H26N4OS/c1-17-11-24(25(30)28-14-20-5-3-19(13-26)4-6-20)18(2)29(17)15-23-12-22(16-31-23)21-7-9-27-10-8-21/h3-12,16H,13-15,26H2,1-2H3,(H,28,30)	FFHGQGZOGJPGRM-UHFFFAOYSA-N	186848	US9670157, 14 2,5-Dimethyl-1-(4-pyridin-4-yl-thiophen-2-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 14	Plasma kallikrein			 2295							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186848	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186848&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280263	373987416							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716096	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1cccc(n1)N1CCOCC1	InChI=1S/C25H31N5O2/c1-18-14-23(25(31)27-16-21-8-6-20(15-26)7-9-21)19(2)30(18)17-22-4-3-5-24(28-22)29-10-12-32-13-11-29/h3-9,14H,10-13,15-17,26H2,1-2H3,(H,27,31)	UUXDGEGFHRYLQP-UHFFFAOYSA-N	186849	US9670157, 15 2,5-Dimethyl-1-(6-morpholin-4-yl-pyridin-2-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 15	Plasma kallikrein			 5694							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186849	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186849&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280313	373987417							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716097	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1cccc(n1)-c1ccccc1	InChI=1S/C27H28N4O/c1-19-15-25(27(32)29-17-22-13-11-21(16-28)12-14-22)20(2)31(19)18-24-9-6-10-26(30-24)23-7-4-3-5-8-23/h3-15H,16-18,28H2,1-2H3,(H,29,32)	ANTXTTKCONNLSC-UHFFFAOYSA-N	186850	US9670157, 16 2,5-Dimethyl-1-(6-phenyl-pyridin-2-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 16	Plasma kallikrein			 186							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186850	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186850&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290299	373987418							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716098	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1cccc(n1)-c1cccnc1	InChI=1S/C26H27N5O/c1-18-13-24(26(32)29-15-21-10-8-20(14-27)9-11-21)19(2)31(18)17-23-6-3-7-25(30-23)22-5-4-12-28-16-22/h3-13,16H,14-15,17,27H2,1-2H3,(H,29,32)	PBAAHHAGMWJRRK-UHFFFAOYSA-N	186851	US9670157, 17 1-[2,3&#8242;]Bipyridinyl-6-ylmethyl-2,5-dimethyl-1H-pyrrole-3-carboxylicacid 4-aminomethyl-benzylamide::US9834513, 17	Plasma kallikrein			 492							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186851	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186851&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280261	373987419							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716099	Cc1c(NC(=O)c2ccccc2)c(C(O)=O)c(C)n1Cc1coc(n1)-c1ccccc1	InChI=1S/C24H21N3O4/c1-15-20(24(29)30)21(26-22(28)17-9-5-3-6-10-17)16(2)27(15)13-19-14-31-23(25-19)18-11-7-4-8-12-18/h3-12,14H,13H2,1-2H3,(H,26,28)(H,29,30)	AKOBILZCRBHSFG-UHFFFAOYSA-N	362203	2,5-Methyl-1-(2-phenyl-oxazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 18	Plasma kallikrein			 435							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=362203	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=362203&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716100	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1nc(oc1C)-c1ccccc1	InChI=1S/C26H28N4O2/c1-17-13-23(25(31)28-15-21-11-9-20(14-27)10-12-21)18(2)30(17)16-24-19(3)32-26(29-24)22-7-5-4-6-8-22/h4-13H,14-16,27H2,1-3H3,(H,28,31)	GBMCJVKROFUGFO-UHFFFAOYSA-N	186852	US9670157, 18 2,5-Methyl-1-(2-phenyl-oxazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 19	Plasma kallikrein			 768							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186852	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186852&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280165	373987420							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716101	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1cccs1	InChI=1S/C20H23N3OS/c1-14-10-19(15(2)23(14)13-18-4-3-9-25-18)20(24)22-12-17-7-5-16(11-21)6-8-17/h3-10H,11-13,21H2,1-2H3,(H,22,24)	ZMXSBHQMBIJZCD-UHFFFAOYSA-N	186854	US9670157, 20 2,5-Dimethyl-1-thiophen-2-ylmethyl-1H-pyrrole-3-carboxylic acid4-amidomethyl-benzylamide::US9834513, 20	Plasma kallikrein			 4947							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186854	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186854&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90281198	373987421							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716102	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1ccc(s1)-c1ccncc1	InChI=1S/C25H26N4OS/c1-17-13-23(25(30)28-15-20-5-3-19(14-26)4-6-20)18(2)29(17)16-22-7-8-24(31-22)21-9-11-27-12-10-21/h3-13H,14-16,26H2,1-2H3,(H,28,30)	ZQAPVJHUJUFJAE-UHFFFAOYSA-N	362206	2,5-Dimethyl-1-(5-pyridin-4-yl-thiophen-2-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 21	Plasma kallikrein			 4522							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=362206	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=362206&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716103	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1ccc(s1)-c1ccccc1	InChI=1S/C26H27N3OS/c1-18-14-24(26(30)28-16-21-10-8-20(15-27)9-11-21)19(2)29(18)17-23-12-13-25(31-23)22-6-4-3-5-7-22/h3-14H,15-17,27H2,1-2H3,(H,28,30)	SEOPPKFHBLYACK-UHFFFAOYSA-N	186856	US9670157, 22 2,5-Dimethyl-1-(5-phenyl-thiophen-2-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 22	Plasma kallikrein			 3269							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186856	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186856&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280292	373987423							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716104	Cc1nc(cs1)-c1ccc(Cn2c(C)cc(C(=O)NCc3ccc(CN)cc3)c2C)s1	InChI=1S/C24H26N4OS2/c1-15-10-21(24(29)26-12-19-6-4-18(11-25)5-7-19)16(2)28(15)13-20-8-9-23(31-20)22-14-30-17(3)27-22/h4-10,14H,11-13,25H2,1-3H3,(H,26,29)	ZSZFPNYSEHIILX-UHFFFAOYSA-N	186857	US9670157, 23 2,5-Dimethyl-1-[5-(2-methyl-thiazol-4-yl)-thiophen-2-ylmethyl]-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 23	Plasma kallikrein			 1596							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186857	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186857&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126614087	373987424							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716105	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(-c2ccccc2)n1Cc1csc(n1)-c1ccccc1	InChI=1S/C30H28N4OS/c1-21-16-27(29(35)32-18-23-14-12-22(17-31)13-15-23)28(24-8-4-2-5-9-24)34(21)19-26-20-36-30(33-26)25-10-6-3-7-11-25/h2-16,20H,17-19,31H2,1H3,(H,32,35)	FKVKXCNSLJKHHC-UHFFFAOYSA-N	362209	5-Methyl-2-phenyl-1-(2-phenyl-thiazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 24	Plasma kallikrein			 431							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=362209	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=362209&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716106	Cc1c(ccn1Cc1csc(n1)-c1ccccc1)C(=O)NCc1ccc(CN)cc1	InChI=1S/C24H24N4OS/c1-17-22(23(29)26-14-19-9-7-18(13-25)8-10-19)11-12-28(17)15-21-16-30-24(27-21)20-5-3-2-4-6-20/h2-12,16H,13-15,25H2,1H3,(H,26,29)	FJXDRICPCAOHJX-UHFFFAOYSA-N	362210	2-Methyl-1-(2-phenyl-thiazol-4-ylmethyl)-1H-pyrrole-3-carboxylicacid 4-aminomethyl-benzylamide::US9834513, 25	Plasma kallikrein			 1327							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=362210	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=362210&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716107	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1csc(n1)-c1cccs1	InChI=1S/C23H24N4OS2/c1-15-10-20(22(28)25-12-18-7-5-17(11-24)6-8-18)16(2)27(15)13-19-14-30-23(26-19)21-4-3-9-29-21/h3-10,14H,11-13,24H2,1-2H3,(H,25,28)	VHJPNQYKEKNZTP-UHFFFAOYSA-N	186860	US9670157, 26 2,5-Dimethyl-1-[2-(2-thienyl)-thiazol-4-ylmethyl]-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 26	Plasma kallikrein			 437							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186860	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186860&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280075	373987427							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716108	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1csc(n1)-c1cccc(Cl)c1	InChI=1S/C25H25ClN4OS/c1-16-10-23(24(31)28-13-19-8-6-18(12-27)7-9-19)17(2)30(16)14-22-15-32-25(29-22)20-4-3-5-21(26)11-20/h3-11,15H,12-14,27H2,1-2H3,(H,28,31)	MVOBCBLLGMUFLX-UHFFFAOYSA-N	186861	US9670157, 27 2,5-Dimethyl-1-[2-(3-chlorophenyl)-thiazol-4-ylmethyl]-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 27	Plasma kallikrein			 848							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186861	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186861&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280111	373987428							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716109	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1csc(n1)-c1ccc(Cl)cc1	InChI=1S/C25H25ClN4OS/c1-16-11-23(24(31)28-13-19-5-3-18(12-27)4-6-19)17(2)30(16)14-22-15-32-25(29-22)20-7-9-21(26)10-8-20/h3-11,15H,12-14,27H2,1-2H3,(H,28,31)	GOXMUZWIQWXYSI-UHFFFAOYSA-N	186862	US9670157, 28 2,5-Dimethyl-1-[2-(4-chlorophenyl)-thiazol-4-ylmethyl]-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 28	Plasma kallikrein			 1326							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186862	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186862&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280224	373987429							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716110	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1csc(n1)-c1cccc(F)c1	InChI=1S/C25H25FN4OS/c1-16-10-23(24(31)28-13-19-8-6-18(12-27)7-9-19)17(2)30(16)14-22-15-32-25(29-22)20-4-3-5-21(26)11-20/h3-11,15H,12-14,27H2,1-2H3,(H,28,31)	RGTMXBFSDAULGX-UHFFFAOYSA-N	186863	US9670157, 29 1-[2-(3-Fluoro-phenyl)-thiazol-4-ylmethyl]-2,5-dimethyl-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 29	Plasma kallikrein			 140							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186863	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186863&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280151	373987430							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716111	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1csc(n1)-c1cccc(C)c1	InChI=1S/C26H28N4OS/c1-17-5-4-6-22(11-17)26-29-23(16-32-26)15-30-18(2)12-24(19(30)3)25(31)28-14-21-9-7-20(13-27)8-10-21/h4-12,16H,13-15,27H2,1-3H3,(H,28,31)	LOLRGICQBGBJJG-UHFFFAOYSA-N	186864	US9670157, 30 2,5-Dimethyl-1-(2-m-tolyl-thiazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 30	Plasma kallikrein			 773							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186864	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186864&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280383	373987431							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716112	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1csc(n1)-c1cccnc1	InChI=1S/C24H25N5OS/c1-16-10-22(23(30)27-12-19-7-5-18(11-25)6-8-19)17(2)29(16)14-21-15-31-24(28-21)20-4-3-9-26-13-20/h3-10,13,15H,11-12,14,25H2,1-2H3,(H,27,30)	CWVNAOJNXQJVGV-UHFFFAOYSA-N	186865	US9670157, 31 2,5-Dimethyl-1-(2-pyridin-3-yl-thiazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 31	Plasma kallikrein			 251							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186865	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186865&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280099	373987432							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716113	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1csc(n1)-c1ccncc1	InChI=1S/C24H25N5OS/c1-16-11-22(23(30)27-13-19-5-3-18(12-25)4-6-19)17(2)29(16)14-21-15-31-24(28-21)20-7-9-26-10-8-20/h3-11,15H,12-14,25H2,1-2H3,(H,27,30)	ROUDVONQVMIJDR-UHFFFAOYSA-N	186866	US9670157, 32 2,5-Dimethyl-1-(2-pyridin-4-yl-thiazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 32	Plasma kallikrein			 732							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186866	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186866&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280388	373987433							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716114	COc1cccc(c1)C(c1cscn1)n1c(C)cc(C(=O)NCc2ccc(CN)cc2)c1C	InChI=1S/C26H28N4O2S/c1-17-11-23(26(31)28-14-20-9-7-19(13-27)8-10-20)18(2)30(17)25(24-15-33-16-29-24)21-5-4-6-22(12-21)32-3/h4-12,15-16,25H,13-14,27H2,1-3H3,(H,28,31)	QXSNCMLQENMZBO-UHFFFAOYSA-N	362218	2,5-Dimethyl-1-(3-methoxyphenyl-thiazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 33	Plasma kallikrein			 919							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=362218	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=362218&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716115	COc1ccc(cc1)C(c1cscn1)n1c(C)cc(C(=O)NCc2ccc(CN)cc2)c1C	InChI=1S/C26H28N4O2S/c1-17-12-23(26(31)28-14-20-6-4-19(13-27)5-7-20)18(2)30(17)25(24-15-33-16-29-24)21-8-10-22(32-3)11-9-21/h4-12,15-16,25H,13-14,27H2,1-3H3,(H,28,31)	BKLWJWXUTVBPJJ-UHFFFAOYSA-N	362219	2,5-Dimethyl-1-(4-methoxyphenyl-thiazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 34	Plasma kallikrein			 3599							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=362219	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=362219&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716116	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1csc(n1)-c1ccc(C)cc1	InChI=1S/C26H28N4OS/c1-17-4-10-22(11-5-17)26-29-23(16-32-26)15-30-18(2)12-24(19(30)3)25(31)28-14-21-8-6-20(13-27)7-9-21/h4-12,16H,13-15,27H2,1-3H3,(H,28,31)	RDXOSTLWPPAKRM-UHFFFAOYSA-N	186869	US9670157, 35 2,5-Dimethyl-1-(2-p-tolyl-thiazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 35	Plasma kallikrein			 2100							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186869	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186869&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280376	373987436							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716117	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1csc(n1)-c1ccccn1	InChI=1S/C24H25N5OS/c1-16-11-21(23(30)27-13-19-8-6-18(12-25)7-9-19)17(2)29(16)14-20-15-31-24(28-20)22-5-3-4-10-26-22/h3-11,15H,12-14,25H2,1-2H3,(H,27,30)	CUZADIYTJRHRIY-UHFFFAOYSA-N	186870	US9670157, 36 2,5-Dimethyl-1-(2-pyridin-2-yl-thiazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 36	Plasma kallikrein			 203							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186870	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186870&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280150	373987437							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716118	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1csc(n1)-c1ccsc1	InChI=1S/C23H24N4OS2/c1-15-9-21(22(28)25-11-18-5-3-17(10-24)4-6-18)16(2)27(15)12-20-14-30-23(26-20)19-7-8-29-13-19/h3-9,13-14H,10-12,24H2,1-2H3,(H,25,28)	NJTXQIBROXFAJJ-UHFFFAOYSA-N	186871	US9670157, 37 2,5-Dimethyl-1-(2-thiophen-3-yl-thiazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 37	Plasma kallikrein			 170							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186871	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186871&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290301	373987438							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716119	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1csc(Cc2ccccc2)n1	InChI=1S/C26H28N4OS/c1-18-12-24(26(31)28-15-22-10-8-21(14-27)9-11-22)19(2)30(18)16-23-17-32-25(29-23)13-20-6-4-3-5-7-20/h3-12,17H,13-16,27H2,1-2H3,(H,28,31)	KWYMDWISISCNQW-UHFFFAOYSA-N	186872	US9670157, 38 1-(2-Benzyl-thiazol-4-ylmethyl)-2,5-dimethyl-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 38	Plasma kallikrein			 2311							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186872	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186872&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280246	373987439							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716120	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1csc(n1)-c1ccoc1	InChI=1S/C23H24N4O2S/c1-15-9-21(22(28)25-11-18-5-3-17(10-24)4-6-18)16(2)27(15)12-20-14-30-23(26-20)19-7-8-29-13-19/h3-9,13-14H,10-12,24H2,1-2H3,(H,25,28)	CWTXPXXJXGMCNG-UHFFFAOYSA-N	362224	2,5-Dimethyl-1-(2-furan-3-yl-thiazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 39	Plasma kallikrein			 1092							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=362224	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=362224&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716121	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1csc(n1)-c1cnccn1	InChI=1S/C23H24N6OS/c1-15-9-20(22(30)27-11-18-5-3-17(10-24)4-6-18)16(2)29(15)13-19-14-31-23(28-19)21-12-25-7-8-26-21/h3-9,12,14H,10-11,13,24H2,1-2H3,(H,27,30)	GEUSEXYWZZDBQX-UHFFFAOYSA-N	186874	US9670157, 40 2,5-Dimethyl-1-(2-pyrazin-2-yl-thiazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 40	Plasma kallikrein			 1661							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186874	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186874&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280229	373987441							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716122	CCOc1ccc(cc1)-c1nc(Cn2c(C)cc(C(=O)NCc3ccc(CN)cc3)c2C)cs1	InChI=1S/C27H30N4O2S/c1-4-33-24-11-9-22(10-12-24)27-30-23(17-34-27)16-31-18(2)13-25(19(31)3)26(32)29-15-21-7-5-20(14-28)6-8-21/h5-13,17H,4,14-16,28H2,1-3H3,(H,29,32)	DJNXGSWGJXAIJL-UHFFFAOYSA-N	186875	US9670157, 41 1-[2-(4-Ethoxy-phenyl)-thiazol-4-ylmethyl]-2,5-dimethyl-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 41	Plasma kallikrein			 4704							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186875	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186875&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126614035	373987442							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716123	C[C@@H](NC(=O)c1cc(C)n(Cc2csc(n2)-c2ccccc2)c1C)c1ccc(CN)cc1	InChI=1S/C26H28N4OS/c1-17-13-24(25(31)28-18(2)21-11-9-20(14-27)10-12-21)19(3)30(17)15-23-16-32-26(29-23)22-7-5-4-6-8-22/h4-13,16,18H,14-15,27H2,1-3H3,(H,28,31)/t18-/m1/s1	SGSHRWGTUUKPRK-GOSISDBHSA-N	362227	2,5-Dimethyl-1-(2-phenyl-thiazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid [(R)-1-(4-aminomethyl-phenyl)-ethyl]-amide::US9834513, 42	Plasma kallikrein			 953							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=362227	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=362227&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716124	Cc1cc(C(=O)NCc2ccc(CN)nc2)c(C)n1Cc1csc(n1)-c1ccccc1	InChI=1S/C24H25N5OS/c1-16-10-22(23(30)27-13-18-8-9-20(11-25)26-12-18)17(2)29(16)14-21-15-31-24(28-21)19-6-4-3-5-7-19/h3-10,12,15H,11,13-14,25H2,1-2H3,(H,27,30)	SMPAEILCYAFKDO-UHFFFAOYSA-N	186877	US9670157, 43 2,5-Dimethyl-1-(2-phenyl-thiazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid (6-aminomethyl-pyridin-3-ylmethyl)-amide::US9834513, 43	Plasma kallikrein			 196							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186877	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186877&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290302	373987444							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716125	Cc1cc(C(=O)NCc2ccc(CN)nc2)c(C)n1Cc1csc(n1)-c1cccc(F)c1	InChI=1S/C24H24FN5OS/c1-15-8-22(23(31)28-12-17-6-7-20(10-26)27-11-17)16(2)30(15)13-21-14-32-24(29-21)18-4-3-5-19(25)9-18/h3-9,11,14H,10,12-13,26H2,1-2H3,(H,28,31)	LNJDJWSMFMSGEH-UHFFFAOYSA-N	186878	US9670157, 44 1-[2-(3-Fluoro-phenyl)-thiazol-4-ylmethyl]-2,5-dimethyl-1H-pyrrole-3-carboxylic acid (6-aminomethyl-pyridin-3-ylmethyl)-amide::US9834513, 44	Plasma kallikrein			 355							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186878	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186878&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134128249	373987445							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716126	Cc1cc(C(=O)NCc2ccc(CN)c(F)c2)c(C)n1Cc1csc(n1)-c1ccccc1	InChI=1S/C25H25FN4OS/c1-16-10-22(24(31)28-13-18-8-9-20(12-27)23(26)11-18)17(2)30(16)14-21-15-32-25(29-21)19-6-4-3-5-7-19/h3-11,15H,12-14,27H2,1-2H3,(H,28,31)	ICSBZJSGYBSVLI-UHFFFAOYSA-N	186879	US9670157, 45 2,5-Dimethyl-1-(2-phenyl-thiazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-3-fluoro-benzylamide::US9834513, 45	Plasma kallikrein			 135							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186879	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186879&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			76285426	373987446							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716127	Cc1cc(C(=O)NCc2ccc(CN)c(C)c2)c(C)n1Cc1csc(n1)-c1ccccc1	InChI=1S/C26H28N4OS/c1-17-11-20(9-10-22(17)13-27)14-28-25(31)24-12-18(2)30(19(24)3)15-23-16-32-26(29-23)21-7-5-4-6-8-21/h4-12,16H,13-15,27H2,1-3H3,(H,28,31)	SYWALHZYILGMMA-UHFFFAOYSA-N	186880	US9670157, 46 2,5-Dimethyl-1-(2-phenyl-thiazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-3-methyl-benzylamide::US9834513, 46	Plasma kallikrein			 1164							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186880	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186880&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280311	373987447							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716128	Cc1cc(C(=O)NCc2ccc(CN)cc2F)c(C)n1Cc1csc(n1)-c1ccccc1	InChI=1S/C25H25FN4OS/c1-16-10-22(24(31)28-13-20-9-8-18(12-27)11-23(20)26)17(2)30(16)14-21-15-32-25(29-21)19-6-4-3-5-7-19/h3-11,15H,12-14,27H2,1-2H3,(H,28,31)	UNKAHMHMAXWBRJ-UHFFFAOYSA-N	186881	US9670157, 47 2,5-Dimethyl-1-(2-phenyl-thiazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-2-fluoro-benzylamide::US9834513, 47	Plasma kallikrein			 74.0							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186881	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186881&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290303	373987448							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716129	C[C@@H](N)c1ccc(CNC(=O)c2cc(C)n(Cc3csc(n3)-c3ccccc3)c2C)cc1	InChI=1S/C26H28N4OS/c1-17-13-24(25(31)28-14-20-9-11-21(12-10-20)18(2)27)19(3)30(17)15-23-16-32-26(29-23)22-7-5-4-6-8-22/h4-13,16,18H,14-15,27H2,1-3H3,(H,28,31)/t18-/m1/s1	IQRYOMJGXFGGCX-GOSISDBHSA-N	362233	2,5-Dimethyl-1-(2-phenyl-thiazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-((R)-1-amino-ethyl)-benzylamide::US9834513, 48	Plasma kallikrein			 624							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=362233	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=362233&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716130	Cc1cc(C(=O)NCc2ccc(CN)cc2Cl)c(C)n1Cc1csc(n1)-c1ccccc1	InChI=1S/C25H25ClN4OS/c1-16-10-22(24(31)28-13-20-9-8-18(12-27)11-23(20)26)17(2)30(16)14-21-15-32-25(29-21)19-6-4-3-5-7-19/h3-11,15H,12-14,27H2,1-2H3,(H,28,31)	LXZGTPFYSZITPH-UHFFFAOYSA-N	186883	US9670157, 49 2,5-Dimethyl-1-(2-phenyl-thiazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-2-chloro-benzylamide::US9834513, 49	Plasma kallikrein			 89.0							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186883	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186883&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290346	373987450							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716131	Cc1cc(C(=O)NCc2ccc(CN)cc2C(F)(F)F)c(C)n1Cc1csc(n1)-c1ccccc1	InChI=1S/C26H25F3N4OS/c1-16-10-22(24(34)31-13-20-9-8-18(12-30)11-23(20)26(27,28)29)17(2)33(16)14-21-15-35-25(32-21)19-6-4-3-5-7-19/h3-11,15H,12-14,30H2,1-2H3,(H,31,34)	GSVROUVRXWFULX-UHFFFAOYSA-N	186884	US9670157, 50 2,5-Dimethyl-1-(2-phenyl-thiazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-2-trifluoromethyl-benzylamide::US9834513, 50	Plasma kallikrein			 56.0							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186884	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186884&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290347	373987451							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716132	C[C@H](N)c1ccc(CNC(=O)c2cc(C)n(Cc3csc(n3)-c3ccccc3)c2C)cc1	InChI=1S/C26H28N4OS/c1-17-13-24(25(31)28-14-20-9-11-21(12-10-20)18(2)27)19(3)30(17)15-23-16-32-26(29-23)22-7-5-4-6-8-22/h4-13,16,18H,14-15,27H2,1-3H3,(H,28,31)/t18-/m0/s1	IQRYOMJGXFGGCX-SFHVURJKSA-N	362236	2,5-Dimethyl-1-(2-phenyl-thiazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid-4-((S)-1-amino-ethyl)-benzylamide::US9834513, 51	Plasma kallikrein			 341							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=362236	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=362236&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716133	Cc1cc(C(=O)NC2(CC2)c2ccc(CN)cc2)c(C)n1Cc1csc(n1)-c1ccccc1	InChI=1S/C27H28N4OS/c1-18-14-24(25(32)30-27(12-13-27)22-10-8-20(15-28)9-11-22)19(2)31(18)16-23-17-33-26(29-23)21-6-4-3-5-7-21/h3-11,14,17H,12-13,15-16,28H2,1-2H3,(H,30,32)	DSUFTYRAXNTLED-UHFFFAOYSA-N	186886	US9670157, 52 2,5-Dimethyl-1-(2-phenyl-thiazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid [1-(4-aminomethyl-phenyl)-cyclopropyl]-amide::US9834513, 52	Plasma kallikrein			 475							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186886	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186886&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134128252	373987453							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
716134	COc1cc(CNC(=O)c2cc(C)n(Cc3csc(n3)-c3ccccc3)c2C)ccc1CN	InChI=1S/C26H28N4O2S/c1-17-11-23(25(31)28-14-19-9-10-21(13-27)24(12-19)32-3)18(2)30(17)15-22-16-33-26(29-22)20-7-5-4-6-8-20/h4-12,16H,13-15,27H2,1-3H3,(H,28,31)	MAGFCMDPSMQSNK-UHFFFAOYSA-N	186887	US9670157, 53 2,5-Dimethyl-1-(2-phenyl-thiazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-3-methoxy-benzylamide::US9834513, 53	Plasma kallikrein			 677							US Patent		10.7270/Q2348NPS		aid1797872	US9834513	Allan, CE; Batt, AR; Davie, RL; Edwards, HJ; Evans, DM; Pethen, SJ	Kalvista Pharmceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186887	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186887&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126614069	373987454							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710905	CC(C(=O)Nc1ccc(cc1)-c1nnn[nH]1)n1ccc(cc1=O)-c1cc(Cl)ccc1C#N			246096	US10183932, Example 1::US9434690, 1::US9822102, Example 1	Plasma kallikrein			 600							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246096	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246096&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622715	341103945							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710906	COCc1n[nH]c(n1)-c1ccc(NC(=O)C(C)n2ccc(cc2=O)-c2cc(Cl)ccc2C#N)cc1			246098	US9434690, 3::US9822102, Example 3	Plasma kallikrein			 650							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246098	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246098&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118877955	341103947							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710907	CC(C(=O)Nc1ccc(cc1)-c1ncc[nH]1)n1ccc(cc1=O)-c1cc(Cl)ccc1C#N			246099	US10183932, Example 4::US9434690, 4::US9822102, Example 4	Plasma kallikrein			 590							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246099	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246099&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622607	341103948							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710908	CC(C(=O)Nc1ccc(cc1)-c1c[nH]cn1)n1ccc(cc1=O)-c1cc(Cl)ccc1C#N			246100	US10183932, Example 5::US9434690, 5::US9822102, Example 5	Plasma kallikrein			 330							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246100	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246100&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86297545	341103949							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710909	CC(C(=O)Nc1ccc(cc1)-c1c[nH]c(n1)C(F)(F)F)n1ccc(cc1=O)-c1cc(Cl)ccc1C#N			246101	US10183932, Example 6::US9434690, 6::US9822102, Example 6	Plasma kallikrein			 640							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246101	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246101&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622723	341103950							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710910	CC(C(=O)Nc1ccc(cc1)-c1cc(=O)[nH][nH]1)n1ccc(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C24H16ClN5O3/c1-14(24(33)27-19-6-3-15(4-7-19)21-12-22(31)29-28-21)30-9-8-16(10-23(30)32)20-11-18(25)5-2-17(20)13-26/h2-12,14H,1H3,(H,27,33)	MHOPKDGSPNBRDE-UHFFFAOYSA-N	246102	US10183932, Example 7::US9434690, 7::US9822102, Example 7	Plasma kallikrein			 220							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246102	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246102&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			129626901	341103951							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710911	CC(C(=O)Nc1ccc(cc1)-c1noc(=O)[nH]1)n1ccc(cc1=O)-c1cc(Cl)ccc1C#N			246103	US10183932, Example 8::US9434690, 8::US9822102, Example 8	Plasma kallikrein			 490							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246103	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246103&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			129626902	341103952							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710912	CC(C(=O)Nc1ccc(cc1)C(O)=O)n1ccc(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C22H16ClN3O4/c1-13(21(28)25-18-6-3-14(4-7-18)22(29)30)26-9-8-15(10-20(26)27)19-11-17(23)5-2-16(19)12-24/h2-11,13H,1H3,(H,25,28)(H,29,30)	IVAMXDIDNRHTRD-UHFFFAOYSA-N	246104	US10183932, Example 9::US9434690, 9::US9822102, Example 9	Plasma kallikrein			 840							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246104	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246104&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622737	341103953							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710913	CC(C(=O)Nc1ccc2c(c1)[nH]n(C)c2=O)n1ccc(cc1=O)-c1cc(Cl)ccc1C#N			246112	US10183932, Example 17::US9434690, 17::US9822102, Example 17	Plasma kallikrein			 630							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246112	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246112&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			129626903	341103961							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710914	CC(C(=O)Nc1ccc2nc[nH]c2c1)n1ccc(cc1=O)-c1cc(Cl)ccc1C#N			246113	US10183932, Example 18::US9434690, 18::US9822102, Example 18	Plasma kallikrein			 490							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246113	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246113&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86297342	341103962							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710915	CCC(C(=O)Nc1ccc(cc1)-c1nnn[nH]1)n1ccc(cc1=O)-c1cc(Cl)ccc1C#N			246114	US10183932, Example 21::US9434690, 19::US9434690, 20::US9434690, 21::US9822102, Example 21	Plasma kallikrein			 120							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246114	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246114&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622611	341103963							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710916	CC(C)C(C(=O)Nc1ccc(cc1)-c1nnn[nH]1)n1ccc(cc1=O)-c1cc(Cl)ccc1C#N			246117	US10183932, Example 22::US9434690, 22::US9822102, Example 22	Plasma kallikrein			 595							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246117	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246117&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622744	341103964							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710917	CCCCC(C(=O)Nc1ccc(cc1)-c1nnn[nH]1)n1ccc(cc1=O)-c1cc(Cl)ccc1C#N			246118	US10183932, Example 23::US9434690, 23::US9822102, Example 23	Plasma kallikrein			 520							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246118	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246118&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622898	341103965							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710918	Clc1ccc(C#N)c(c1)-c1ccn(C(Cc2ccccc2)C(=O)Nc2ccc(cc2)-c2nnn[nH]2)c(=O)c1			246121	US10183932, Example 26::US9434690, 26::US9822102, Example 26	Plasma kallikrein			 67.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246121	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246121&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			129626904	341103968							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710919	OC(=O)c1ccc(NC(=O)C(Cc2ccccn2)n2ccc(cc2=O)-c2cc(Cl)ccc2C(F)(F)F)cc1	InChI=1S/C27H19ClF3N3O4/c28-18-6-9-22(27(29,30)31)21(14-18)17-10-12-34(24(35)13-17)23(15-20-3-1-2-11-32-20)25(36)33-19-7-4-16(5-8-19)26(37)38/h1-14,23H,15H2,(H,33,36)(H,37,38)	CKFCLGOBAUZLCA-UHFFFAOYSA-N	246122	US10183932, Example 27::US9434690, 27::US9822102, Example 27	Plasma kallikrein			 780							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246122	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246122&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622905	341103969							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710920	OC(=O)c1ccc(NC(=O)C(Cc2cccnc2)n2ccc(cc2=O)-c2cc(Cl)ccc2C(F)(F)F)cc1	InChI=1S/C27H19ClF3N3O4/c28-19-5-8-22(27(29,30)31)21(14-19)18-9-11-34(24(35)13-18)23(12-16-2-1-10-32-15-16)25(36)33-20-6-3-17(4-7-20)26(37)38/h1-11,13-15,23H,12H2,(H,33,36)(H,37,38)	LODANOLKNFDNSD-UHFFFAOYSA-N	246123	US10183932, Example 28::US9434690, 28::US9822102, Example 28	Plasma kallikrein			 570							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246123	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246123&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622612	341103970							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710921	OC(=O)c1ccc(NC(=O)C(Cc2cccnc2)n2ccc(cc2=O)-c2cc(Cl)ccc2Br)cc1	InChI=1S/C26H19BrClN3O4/c27-22-8-5-19(28)14-21(22)18-9-11-31(24(32)13-18)23(12-16-2-1-10-29-15-16)25(33)30-20-6-3-17(4-7-20)26(34)35/h1-11,13-15,23H,12H2,(H,30,33)(H,34,35)	FJLLPUNDAQQFCD-UHFFFAOYSA-N	246124	US10183932, Example 29::US9434690, 29::US9822102, Example 29	Plasma kallikrein			 350							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246124	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246124&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622939	341103971							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710922	OC(=O)c1ccc(NC(=O)C(Cc2ccncc2)n2ccc(cc2=O)-c2cc(Cl)ccc2C(F)(F)F)cc1	InChI=1S/C27H19ClF3N3O4/c28-19-3-6-22(27(29,30)31)21(15-19)18-9-12-34(24(35)14-18)23(13-16-7-10-32-11-8-16)25(36)33-20-4-1-17(2-5-20)26(37)38/h1-12,14-15,23H,13H2,(H,33,36)(H,37,38)	VOEMZDCOWSMTBH-UHFFFAOYSA-N	246125	US10183932, Example 32::US9434690, 30::US9434690, 31::US9434690, 32::US9822102, Example 32	Plasma kallikrein			 620							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246125	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246125&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622752	341103972							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710923	OC(=O)c1ccc(NC(=O)C(Cc2ccncc2)n2ccc(cc2=O)-c2cc(Cl)ccc2C(F)(F)F)cc1	InChI=1S/C27H19ClF3N3O4/c28-19-3-6-22(27(29,30)31)21(15-19)18-9-12-34(24(35)14-18)23(13-16-7-10-32-11-8-16)25(36)33-20-4-1-17(2-5-20)26(37)38/h1-12,14-15,23H,13H2,(H,33,36)(H,37,38)	VOEMZDCOWSMTBH-UHFFFAOYSA-N	246125	US10183932, Example 32::US9434690, 30::US9434690, 31::US9434690, 32::US9822102, Example 32	Plasma kallikrein			 800							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246125	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246125&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622752	341103972							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710924	OC(=O)c1ccc(NC(=O)C(Cc2ccncc2)n2ccc(cc2=O)-c2cc(Cl)ccc2Br)cc1	InChI=1S/C26H19BrClN3O4/c27-22-6-3-19(28)15-21(22)18-9-12-31(24(32)14-18)23(13-16-7-10-29-11-8-16)25(33)30-20-4-1-17(2-5-20)26(34)35/h1-12,14-15,23H,13H2,(H,30,33)(H,34,35)	NBSDLGUPVWYUGD-UHFFFAOYSA-N	246128	US10183932, Example 33::US9434690, 33::US9822102, Example 33	Plasma kallikrein			 320							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246128	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246128&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622617	341103973							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710925	CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(F)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C22H15ClFN3O4/c1-12(21(29)26-16-6-3-13(4-7-16)22(30)31)27-11-19(24)18(9-20(27)28)17-8-15(23)5-2-14(17)10-25/h2-9,11-12H,1H3,(H,26,29)(H,30,31)	BFAOKCDIFBZLTD-UHFFFAOYSA-N	246129	US10183932, Example 34::US9434690, 34::US9822102, Example 34	Plasma kallikrein			 310							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246129	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246129&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622987	341103974							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710926	CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(Cl)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C22H15Cl2N3O4/c1-12(21(29)26-16-6-3-13(4-7-16)22(30)31)27-11-19(24)18(9-20(27)28)17-8-15(23)5-2-14(17)10-25/h2-9,11-12H,1H3,(H,26,29)(H,30,31)	MYLKJUSMRUADNT-UHFFFAOYSA-N	246130	US10183932, Example 37::US9434690, 35::US9434690, 36::US9434690, 37::US9822102, Example 37	Plasma kallikrein			 510							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246130	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246130&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622690	341103975							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710927	CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(Cl)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C22H15Cl2N3O4/c1-12(21(29)26-16-6-3-13(4-7-16)22(30)31)27-11-19(24)18(9-20(27)28)17-8-15(23)5-2-14(17)10-25/h2-9,11-12H,1H3,(H,26,29)(H,30,31)	MYLKJUSMRUADNT-UHFFFAOYSA-N	246130	US10183932, Example 37::US9434690, 35::US9434690, 36::US9434690, 37::US9822102, Example 37	Plasma kallikrein			 275							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246130	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246130&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622690	341103975							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710928	CC(C(=O)Nc1ccc(C(O)=O)c(F)c1)n1cc(Cl)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C22H14Cl2FN3O4/c1-11(21(30)27-14-4-5-15(22(31)32)19(25)7-14)28-10-18(24)17(8-20(28)29)16-6-13(23)3-2-12(16)9-26/h2-8,10-11H,1H3,(H,27,30)(H,31,32)	IAFAJANRVZTTGY-UHFFFAOYSA-N	246135	US10183932, Example 40::US9434690, 40::US9822102, Example 40	Plasma kallikrein			 550							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246135	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246135&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622831	341103978							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710929	CC(C(=O)Nc1ccc(cc1)-c1nc(n[nH]1)C(F)(F)F)n1cc(Cl)c(cc1=O)-c1cc(Cl)ccc1C#N			246136	US10183932, Example 41::US9434690, 41::US9822102, Example 41	Plasma kallikrein			 1600							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246136	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246136&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622989	341103979							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710930	CC(C(=O)Nc1ccc(cc1)-c1cc(=O)[nH][nH]1)n1cc(Cl)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C24H15Cl2N5O3/c1-13(24(34)28-17-6-3-14(4-7-17)21-10-22(32)30-29-21)31-12-20(26)19(9-23(31)33)18-8-16(25)5-2-15(18)11-27/h2-10,12-13H,1H3,(H,28,34)	AXABJGPJVKQRBN-UHFFFAOYSA-N	246137	US10183932, Example 42::US9434690, 42::US9822102, Example 42	Plasma kallikrein			 110							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246137	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246137&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			129626905	341103980							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710931	CC(C(=O)Nc1ccc(cc1)-c1cnc[nH]1)n1cc(Cl)c(cc1=O)-c1cc(Cl)ccc1C#N			246138	US10183932, Example 43::US9434690, 43::US9822102, Example 43	Plasma kallikrein			 230							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246138	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246138&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622610	341103981							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710932	CC(C(=O)Nc1ccc2nc([nH]c2c1)C(F)(F)F)n1cc(Cl)c(cc1=O)-c1cc(Cl)ccc1C#N			246139	US10183932, Example 44::US9434690, 44::US9822102, Example 44	Plasma kallikrein			 140							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246139	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246139&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622619	341103982							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710933	OC(=O)c1ccc(NC(=O)C(CC2CC2)n2cc(Cl)c(cc2=O)-c2cc(Cl)ccc2C#N)cc1	InChI=1S/C25H19Cl2N3O4/c26-17-6-3-16(12-28)19(10-17)20-11-23(31)30(13-21(20)27)22(9-14-1-2-14)24(32)29-18-7-4-15(5-8-18)25(33)34/h3-8,10-11,13-14,22H,1-2,9H2,(H,29,32)(H,33,34)	APZJTXHPPDAWRM-UHFFFAOYSA-N	246140	US10183932, Example 47::US9434690, 45::US9434690, 46::US9434690, 47::US9822102, Example 47	Plasma kallikrein			 200							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246140	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246140&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622732	341103983							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710934	OC(=O)c1ccc(NC(=O)C(CC2CC2)n2cc(Cl)c(cc2=O)-c2cc(Cl)ccc2C#N)cc1	InChI=1S/C25H19Cl2N3O4/c26-17-6-3-16(12-28)19(10-17)20-11-23(31)30(13-21(20)27)22(9-14-1-2-14)24(32)29-18-7-4-15(5-8-18)25(33)34/h3-8,10-11,13-14,22H,1-2,9H2,(H,29,32)(H,33,34)	APZJTXHPPDAWRM-UHFFFAOYSA-N	246140	US10183932, Example 47::US9434690, 45::US9434690, 46::US9434690, 47::US9822102, Example 47	Plasma kallikrein			 150							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246140	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246140&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622732	341103983							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710935	COc1cn(C(C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C23H18ClN3O5/c1-13(22(29)26-17-7-4-14(5-8-17)23(30)31)27-12-20(32-2)19(10-21(27)28)18-9-16(24)6-3-15(18)11-25/h3-10,12-13H,1-2H3,(H,26,29)(H,30,31)	MPSQYCLTAAEIDL-UHFFFAOYSA-N	246150	US10183932, Example 57::US9434690, 55::US9434690, 56::US9434690, 57::US9822102, Example 57	Plasma kallikrein			 31.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246150	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246150&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622624	341103991							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710936	COc1cn(C(C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C23H18ClN3O5/c1-13(22(29)26-17-7-4-14(5-8-17)23(30)31)27-12-20(32-2)19(10-21(27)28)18-9-16(24)6-3-15(18)11-25/h3-10,12-13H,1-2H3,(H,26,29)(H,30,31)	MPSQYCLTAAEIDL-UHFFFAOYSA-N	246150	US10183932, Example 57::US9434690, 55::US9434690, 56::US9434690, 57::US9822102, Example 57	Plasma kallikrein			 17.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246150	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246150&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622624	341103991							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710937	COc1cn(C(C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1[N+]([O-])=O	InChI=1S/C22H18ClN3O7/c1-12(21(28)24-15-6-3-13(4-7-15)22(29)30)25-11-19(33-2)17(10-20(25)27)16-9-14(23)5-8-18(16)26(31)32/h3-12H,1-2H3,(H,24,28)(H,29,30)	PTHBJYOJADPDRP-UHFFFAOYSA-N	246153	US10183932, Example 58::US9434690, 58::US9822102, Example 58	Plasma kallikrein			 46.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246153	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246153&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86297546	341103992							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710938	COc1cn(C(CC2CC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C26H22ClN3O5/c1-35-23-14-30(24(31)12-21(23)20-11-18(27)7-4-17(20)13-28)22(10-15-2-3-15)25(32)29-19-8-5-16(6-9-19)26(33)34/h4-9,11-12,14-15,22H,2-3,10H2,1H3,(H,29,32)(H,33,34)	YEOQEAASRZWJNV-UHFFFAOYSA-N	246154	US10183932, Example 60::US9434690, 59::US9434690, 60::US9822102, Example 60	Plasma kallikrein			 15.5							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246154	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246154&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622901	341103993							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710939	COc1cn(C(CC#C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C25H18ClN3O5/c1-3-4-21(24(31)28-18-9-6-15(7-10-18)25(32)33)29-14-22(34-2)20(12-23(29)30)19-11-17(26)8-5-16(19)13-27/h1,5-12,14,21H,4H2,2H3,(H,28,31)(H,32,33)	BVJKTUAUDCSIJC-UHFFFAOYSA-N	246156	US10183932, Example 61::US9434690, 61::US9822102, Example 61	Plasma kallikrein			 29.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246156	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246156&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622828	341103994							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710940	COc1cn(C(CC(C)C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C26H24ClN3O5/c1-15(2)10-22(25(32)29-19-8-5-16(6-9-19)26(33)34)30-14-23(35-3)21(12-24(30)31)20-11-18(27)7-4-17(20)13-28/h4-9,11-12,14-15,22H,10H2,1-3H3,(H,29,32)(H,33,34)	PDLAMRDOLIUATC-UHFFFAOYSA-N	246158	US10183932, Example 65::US9434690, 63::US9434690, 64::US9434690, 65::US9822102, Example 65	Plasma kallikrein			 67.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246158	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246158&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622627	341103996							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710941	COc1cn(C(CC(C)C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C26H24ClN3O5/c1-15(2)10-22(25(32)29-19-8-5-16(6-9-19)26(33)34)30-14-23(35-3)21(12-24(30)31)20-11-18(27)7-4-17(20)13-28/h4-9,11-12,14-15,22H,10H2,1-3H3,(H,29,32)(H,33,34)	PDLAMRDOLIUATC-UHFFFAOYSA-N	246158	US10183932, Example 65::US9434690, 63::US9434690, 64::US9434690, 65::US9822102, Example 65	Plasma kallikrein			 25.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246158	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246158&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622627	341103996							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710942	CCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C24H20ClN3O5/c1-3-20(23(30)27-17-8-5-14(6-9-17)24(31)32)28-13-21(33-2)19(11-22(28)29)18-10-16(25)7-4-15(18)12-26/h4-11,13,20H,3H2,1-2H3,(H,27,30)(H,31,32)	HUXWVMXMMHUYLB-UHFFFAOYSA-N	246161	US10183932, Example 140::US9434690, 140::US9434690, 66::US9434690, 67::US9434690, 68::US9822102, Example 140	Plasma kallikrein			 31.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246161	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246161&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622754	341103997							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710943	CCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C24H20ClN3O5/c1-3-20(23(30)27-17-8-5-14(6-9-17)24(31)32)28-13-21(33-2)19(11-22(28)29)18-10-16(25)7-4-15(18)12-26/h4-11,13,20H,3H2,1-2H3,(H,27,30)(H,31,32)	HUXWVMXMMHUYLB-UHFFFAOYSA-N	246161	US10183932, Example 140::US9434690, 140::US9434690, 66::US9434690, 67::US9434690, 68::US9822102, Example 140	Plasma kallikrein			 14.5							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246161	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246161&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622754	341103997							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710944	CCC(C(=O)Nc1ccc(cc1)-c1cc(=O)[nH][nH]1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C26H20ClN5O4/c1-3-22(26(35)29-18-8-5-15(6-9-18)21-12-24(33)31-30-21)32-14-23(36-2)20(11-25(32)34)19-10-17(27)7-4-16(19)13-28/h4-12,14,22H,3H2,1-2H3,(H,29,35)	UBQSSKXXBQWBRF-UHFFFAOYSA-N	246164	US10183932, Example 69::US9434690, 69::US9822102, Example 69	Plasma kallikrein			 11.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246164	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246164&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			129626907	341103998							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710945	CCC(C(=O)Nc1ccc2c(c1)[nH]n(C)c2=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N			246165	US10183932, Example 70::US9434690, 70::US9822102, Example 70	Plasma kallikrein			 16.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246165	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246165&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			129626908	341103999							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710946	CCC(C(=O)Nc1ccc2[nH]c(=O)[nH]c2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C24H18ClN5O4/c1-3-20(23(32)27-15-6-7-18-19(9-15)29-24(33)28-18)30-12-21(34-2)17(10-22(30)31)16-8-14(25)5-4-13(16)11-26/h4-10,12,20H,3H2,1-2H3,(H,27,32)	MYCQSHUBJLXZMN-UHFFFAOYSA-N	246166	US10183932, Example 71::US9434690, 71::US9822102, Example 71	Plasma kallikrein			 17.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246166	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246166&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			129626909	341104000							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710947	CCC(C(=O)Nc1ccc(cc1)-c1c[nH]c(=O)o1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N			246167	US10183932, Example 72::US9434690, 72::US9822102, Example 72	Plasma kallikrein			 29.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246167	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246167&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622993	341104001							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710948	CCC(C(=O)Nc1ccc2nc([nH]c2c1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N			246168	US10183932, Example 73::US9434690, 73::US9822102, Example 73	Plasma kallikrein			 16.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246168	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246168&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622919	341104002							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710949	CCC(C(=O)Nc1ccc2cc([nH]c2c1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N			246169	US10183932, Example 74::US9434690, 74::US9822102, Example 74	Plasma kallikrein			 10.00							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246169	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246169&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622760	341104003							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710950	CCC(C(=O)Nc1ccc2[nH]c(cc2c1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N			246170	US10183932, Example 75::US9434690, 75::US9822102, Example 75	Plasma kallikrein			 28.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246170	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246170&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622951	341104004							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710951	COCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C25H22ClN3O6/c1-34-10-9-21(24(31)28-18-7-4-15(5-8-18)25(32)33)29-14-22(35-2)20(12-23(29)30)19-11-17(26)6-3-16(19)13-27/h3-8,11-12,14,21H,9-10H2,1-2H3,(H,28,31)(H,32,33)	XAYFQGTYMRMPAS-UHFFFAOYSA-N	246171	US10183932, Example 78::US9434690, 76::US9434690, 77::US9434690, 78::US9822102, Example 78	Plasma kallikrein			 12.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246171	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246171&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86297748	341104005							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710952	COCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C25H22ClN3O6/c1-34-10-9-21(24(31)28-18-7-4-15(5-8-18)25(32)33)29-14-22(35-2)20(12-23(29)30)19-11-17(26)6-3-16(19)13-27/h3-8,11-12,14,21H,9-10H2,1-2H3,(H,28,31)(H,32,33)	XAYFQGTYMRMPAS-UHFFFAOYSA-N	246171	US10183932, Example 78::US9434690, 76::US9434690, 77::US9434690, 78::US9822102, Example 78	Plasma kallikrein			 4.10							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246171	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246171&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86297748	341104005							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710953	CO[C@@H](C)CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C26H24ClN3O6/c1-15(35-2)10-22(25(32)29-19-8-5-16(6-9-19)26(33)34)30-14-23(36-3)21(12-24(30)31)20-11-18(27)7-4-17(20)13-28/h4-9,11-12,14-15,22H,10H2,1-3H3,(H,29,32)(H,33,34)/t15-,22?/m0/s1	DYNSAJCVHKUDFF-UEDXYCIISA-N	246174	US10183932, Example 81::US9434690, 79::US9434690, 80::US9434690, 81::US9822102, Example 81	Plasma kallikrein			 15.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246174	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246174&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118877945	341104006							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710954	CO[C@@H](C)CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C26H24ClN3O6/c1-15(35-2)10-22(25(32)29-19-8-5-16(6-9-19)26(33)34)30-14-23(36-3)21(12-24(30)31)20-11-18(27)7-4-17(20)13-28/h4-9,11-12,14-15,22H,10H2,1-3H3,(H,29,32)(H,33,34)/t15-,22?/m0/s1	DYNSAJCVHKUDFF-UEDXYCIISA-N	246174	US10183932, Example 81::US9434690, 79::US9434690, 80::US9434690, 81::US9822102, Example 81	Plasma kallikrein			 7.60							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246174	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246174&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118877945	341104006							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710955	CO[C@H](C)CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C26H24ClN3O6/c1-15(35-2)10-22(25(32)29-19-8-5-16(6-9-19)26(33)34)30-14-23(36-3)21(12-24(30)31)20-11-18(27)7-4-17(20)13-28/h4-9,11-12,14-15,22H,10H2,1-3H3,(H,29,32)(H,33,34)/t15-,22?/m1/s1	DYNSAJCVHKUDFF-JGHKVMFLSA-N	246177	US10183932, Example 83::US9434690, 82::US9434690, 83::US9822102, Example 83	Plasma kallikrein			 45.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246177	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246177&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118877889	341104007							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710956	CO[C@H](C)CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C26H24ClN3O6/c1-15(35-2)10-22(25(32)29-19-8-5-16(6-9-19)26(33)34)30-14-23(36-3)21(12-24(30)31)20-11-18(27)7-4-17(20)13-28/h4-9,11-12,14-15,22H,10H2,1-3H3,(H,29,32)(H,33,34)/t15-,22?/m1/s1	DYNSAJCVHKUDFF-JGHKVMFLSA-N	246177	US10183932, Example 83::US9434690, 82::US9434690, 83::US9822102, Example 83	Plasma kallikrein			 15.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246177	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246177&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118877889	341104007							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710957	COc1cn(C(C[C@H]2CCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C27H24ClN3O6/c1-36-24-15-31(25(32)13-22(24)21-11-18(28)7-4-17(21)14-29)23(12-20-3-2-10-37-20)26(33)30-19-8-5-16(6-9-19)27(34)35/h4-9,11,13,15,20,23H,2-3,10,12H2,1H3,(H,30,33)(H,34,35)/t20-,23?/m1/s1	AETBCOOBUYAHJM-PPUHSXQSSA-N	246179	US10183932, Example 86::US9434690, 84::US9434690, 85::US9434690, 86::US9822102, Example 86	Plasma kallikrein			 40.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246179	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246179&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622620	341104008							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710958	COc1cn(C(C[C@H]2CCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C27H24ClN3O6/c1-36-24-15-31(25(32)13-22(24)21-11-18(28)7-4-17(21)14-29)23(12-20-3-2-10-37-20)26(33)30-19-8-5-16(6-9-19)27(34)35/h4-9,11,13,15,20,23H,2-3,10,12H2,1H3,(H,30,33)(H,34,35)/t20-,23?/m1/s1	AETBCOOBUYAHJM-PPUHSXQSSA-N	246179	US10183932, Example 86::US9434690, 84::US9434690, 85::US9434690, 86::US9822102, Example 86	Plasma kallikrein			 16.5							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246179	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246179&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622620	341104008							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710959	COc1cn(C(C[C@@H]2CCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C27H24ClN3O6/c1-36-24-15-31(25(32)13-22(24)21-11-18(28)7-4-17(21)14-29)23(12-20-3-2-10-37-20)26(33)30-19-8-5-16(6-9-19)27(34)35/h4-9,11,13,15,20,23H,2-3,10,12H2,1H3,(H,30,33)(H,34,35)/t20-,23?/m0/s1	AETBCOOBUYAHJM-AJZOCDQUSA-N	246182	US10183932, Example 89::US9434690, 87::US9434690, 88::US9434690, 89::US9822102, Example 89	Plasma kallikrein			 14.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246182	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246182&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118877947	341104009							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710960	COc1cn(C(C[C@@H]2CCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C27H24ClN3O6/c1-36-24-15-31(25(32)13-22(24)21-11-18(28)7-4-17(21)14-29)23(12-20-3-2-10-37-20)26(33)30-19-8-5-16(6-9-19)27(34)35/h4-9,11,13,15,20,23H,2-3,10,12H2,1H3,(H,30,33)(H,34,35)/t20-,23?/m0/s1	AETBCOOBUYAHJM-AJZOCDQUSA-N	246182	US10183932, Example 89::US9434690, 87::US9434690, 88::US9434690, 89::US9822102, Example 89	Plasma kallikrein			 7.90							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246182	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246182&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118877947	341104009							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710961	COc1cn(C(C[C@@H]2CCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C27H24ClN3O6/c1-36-24-15-31(25(32)13-22(24)21-11-18(28)7-4-17(21)14-29)23(12-20-3-2-10-37-20)26(33)30-19-8-5-16(6-9-19)27(34)35/h4-9,11,13,15,20,23H,2-3,10,12H2,1H3,(H,30,33)(H,34,35)/t20-,23?/m0/s1	AETBCOOBUYAHJM-AJZOCDQUSA-N	246182	US10183932, Example 89::US9434690, 87::US9434690, 88::US9434690, 89::US9822102, Example 89	Plasma kallikrein			 850							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246182	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246182&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118877947	341104009							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710962	COc1cn(C(CC2CCOC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C27H24ClN3O6/c1-36-24-14-31(25(32)12-22(24)21-11-19(28)5-2-18(21)13-29)23(10-16-8-9-37-15-16)26(33)30-20-6-3-17(4-7-20)27(34)35/h2-7,11-12,14,16,23H,8-10,15H2,1H3,(H,30,33)(H,34,35)	UPJPTNTVAMVKSD-UHFFFAOYSA-N	246185	US10183932, Example 93::US9434690, 90::US9434690, 91::US9434690, 92::US9434690, 93::US9822102, Example 93	Plasma kallikrein			 54.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246185	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246185&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86297749	341104010							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710963	COc1cn(C(CC2CCOC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C27H24ClN3O6/c1-36-24-14-31(25(32)12-22(24)21-11-19(28)5-2-18(21)13-29)23(10-16-8-9-37-15-16)26(33)30-20-6-3-17(4-7-20)27(34)35/h2-7,11-12,14,16,23H,8-10,15H2,1H3,(H,30,33)(H,34,35)	UPJPTNTVAMVKSD-UHFFFAOYSA-N	246185	US10183932, Example 93::US9434690, 90::US9434690, 91::US9434690, 92::US9434690, 93::US9822102, Example 93	Plasma kallikrein			 35.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246185	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246185&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86297749	341104010							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710964	COc1cn(C(CC2CCOC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C27H24ClN3O6/c1-36-24-14-31(25(32)12-22(24)21-11-19(28)5-2-18(21)13-29)23(10-16-8-9-37-15-16)26(33)30-20-6-3-17(4-7-20)27(34)35/h2-7,11-12,14,16,23H,8-10,15H2,1H3,(H,30,33)(H,34,35)	UPJPTNTVAMVKSD-UHFFFAOYSA-N	246185	US10183932, Example 93::US9434690, 90::US9434690, 91::US9434690, 92::US9434690, 93::US9822102, Example 93	Plasma kallikrein			 18.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246185	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246185&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86297749	341104010							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710965	COc1cn(C(CC2CCOCC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C28H26ClN3O6/c1-37-25-16-32(26(33)14-23(25)22-13-20(29)5-2-19(22)15-30)24(12-17-8-10-38-11-9-17)27(34)31-21-6-3-18(4-7-21)28(35)36/h2-7,13-14,16-17,24H,8-12H2,1H3,(H,31,34)(H,35,36)	BMRPDPXXIHCBMO-UHFFFAOYSA-N	246189	US10183932, Example 96::US9434690, 94::US9434690, 95::US9434690, 96::US9822102, Example 96	Plasma kallikrein			 48.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246189	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246189&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86297750	341104011							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710966	COc1cn(C(CC2CCOCC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C28H26ClN3O6/c1-37-25-16-32(26(33)14-23(25)22-13-20(29)5-2-19(22)15-30)24(12-17-8-10-38-11-9-17)27(34)31-21-6-3-18(4-7-21)28(35)36/h2-7,13-14,16-17,24H,8-12H2,1H3,(H,31,34)(H,35,36)	BMRPDPXXIHCBMO-UHFFFAOYSA-N	246189	US10183932, Example 96::US9434690, 94::US9434690, 95::US9434690, 96::US9822102, Example 96	Plasma kallikrein			 19.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246189	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246189&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86297750	341104011							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710967	COc1cn(C(CC2CCCOC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C28H26ClN3O6/c1-37-25-15-32(26(33)13-23(25)22-12-20(29)7-4-19(22)14-30)24(11-17-3-2-10-38-16-17)27(34)31-21-8-5-18(6-9-21)28(35)36/h4-9,12-13,15,17,24H,2-3,10-11,16H2,1H3,(H,31,34)(H,35,36)	SNVIVXDTJLCEGY-UHFFFAOYSA-N	246192	US10183932, Example 100::US9434690, 100::US9434690, 97::US9434690, 98::US9434690, 99::US9822102, Example 100	Plasma kallikrein			 26.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246192	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246192&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622761	341104012							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710968	COc1cn(C(CC2CCCOC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C28H26ClN3O6/c1-37-25-15-32(26(33)13-23(25)22-12-20(29)7-4-19(22)14-30)24(11-17-3-2-10-38-16-17)27(34)31-21-8-5-18(6-9-21)28(35)36/h4-9,12-13,15,17,24H,2-3,10-11,16H2,1H3,(H,31,34)(H,35,36)	SNVIVXDTJLCEGY-UHFFFAOYSA-N	246192	US10183932, Example 100::US9434690, 100::US9434690, 97::US9434690, 98::US9434690, 99::US9822102, Example 100	Plasma kallikrein			 15.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246192	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246192&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622761	341104012							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710969	COc1cn(C(CC2CCCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C28H26ClN3O6/c1-37-25-16-32(26(33)14-23(25)22-12-19(29)8-5-18(22)15-30)24(13-21-4-2-3-11-38-21)27(34)31-20-9-6-17(7-10-20)28(35)36/h5-10,12,14,16,21,24H,2-4,11,13H2,1H3,(H,31,34)(H,35,36)	WVQIDDPAQZTNTF-UHFFFAOYSA-N	246196	US10183932, Example 105::US9434690, 101::US9434690, 102::US9434690, 103::US9434690, 104::US9434690, 105::US9822102, Example 105	Plasma kallikrein			 19.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246196	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246196&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622618	341104013							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710970	COc1cn(C(CC2CCCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C28H26ClN3O6/c1-37-25-16-32(26(33)14-23(25)22-12-19(29)8-5-18(22)15-30)24(13-21-4-2-3-11-38-21)27(34)31-20-9-6-17(7-10-20)28(35)36/h5-10,12,14,16,21,24H,2-4,11,13H2,1H3,(H,31,34)(H,35,36)	WVQIDDPAQZTNTF-UHFFFAOYSA-N	246196	US10183932, Example 105::US9434690, 101::US9434690, 102::US9434690, 103::US9434690, 104::US9434690, 105::US9822102, Example 105	Plasma kallikrein			 5.90							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246196	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246196&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622618	341104013							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710971	COc1cn(C(CC2CCCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C28H26ClN3O6/c1-37-25-16-32(26(33)14-23(25)22-12-19(29)8-5-18(22)15-30)24(13-21-4-2-3-11-38-21)27(34)31-20-9-6-17(7-10-20)28(35)36/h5-10,12,14,16,21,24H,2-4,11,13H2,1H3,(H,31,34)(H,35,36)	WVQIDDPAQZTNTF-UHFFFAOYSA-N	246196	US10183932, Example 105::US9434690, 101::US9434690, 102::US9434690, 103::US9434690, 104::US9434690, 105::US9822102, Example 105	Plasma kallikrein			 67.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246196	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246196&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622618	341104013							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710972	COc1cn(C(CC2CCCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C28H26ClN3O6/c1-37-25-16-32(26(33)14-23(25)22-12-19(29)8-5-18(22)15-30)24(13-21-4-2-3-11-38-21)27(34)31-20-9-6-17(7-10-20)28(35)36/h5-10,12,14,16,21,24H,2-4,11,13H2,1H3,(H,31,34)(H,35,36)	WVQIDDPAQZTNTF-UHFFFAOYSA-N	246196	US10183932, Example 105::US9434690, 101::US9434690, 102::US9434690, 103::US9434690, 104::US9434690, 105::US9822102, Example 105	Plasma kallikrein			 13.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246196	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246196&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622618	341104013							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710973	COc1cn(C(CC2COCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C27H24ClN3O7/c1-36-24-14-31(25(32)12-22(24)21-10-18(28)5-2-17(21)13-29)23(11-20-15-37-8-9-38-20)26(33)30-19-6-3-16(4-7-19)27(34)35/h2-7,10,12,14,20,23H,8-9,11,15H2,1H3,(H,30,33)(H,34,35)	BHLQGSGEFNRQIY-UHFFFAOYSA-N	246201	US10183932, Example 106::US9434690, 106::US9822102, Example 106	Plasma kallikrein			 21.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246201	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246201&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622773	341104014							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710974	COc1cn(C(CCF)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C24H19ClFN3O5/c1-34-21-13-29(22(30)11-19(21)18-10-16(25)5-2-15(18)12-27)20(8-9-26)23(31)28-17-6-3-14(4-7-17)24(32)33/h2-7,10-11,13,20H,8-9H2,1H3,(H,28,31)(H,32,33)	UUJSOQRGXUGTOX-UHFFFAOYSA-N	246202	US10183932, Example 107::US9434690, 107::US9822102, Example 107	Plasma kallikrein			 56.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246202	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246202&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86297751	341104015							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710975	COc1cn(C(CC(F)F)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C24H18ClF2N3O5/c1-35-20-12-30(22(31)9-18(20)17-8-15(25)5-2-14(17)11-28)19(10-21(26)27)23(32)29-16-6-3-13(4-7-16)24(33)34/h2-9,12,19,21H,10H2,1H3,(H,29,32)(H,33,34)	MGICMZBKNIZMHA-UHFFFAOYSA-N	246203	US10183932, Example 108::US9434690, 108::US9822102, Example 108	Plasma kallikrein			 59.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246203	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246203&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622933	341104016							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710976	COc1cn(C(CC(F)(F)F)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C24H17ClF3N3O5/c1-36-20-12-31(21(32)9-18(20)17-8-15(25)5-2-14(17)11-29)19(10-24(26,27)28)22(33)30-16-6-3-13(4-7-16)23(34)35/h2-9,12,19H,10H2,1H3,(H,30,33)(H,34,35)	JTNKIBBMWHFHLA-UHFFFAOYSA-N	246204	US10183932, Example 109::US9434690, 109::US9822102, Example 109	Plasma kallikrein			 220							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246204	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246204&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622628	341104017							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710977	COc1cn(C(CC(C)F)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C25H21ClFN3O5/c1-14(27)9-21(24(32)29-18-7-4-15(5-8-18)25(33)34)30-13-22(35-2)20(11-23(30)31)19-10-17(26)6-3-16(19)12-28/h3-8,10-11,13-14,21H,9H2,1-2H3,(H,29,32)(H,33,34)	ZQIKHBBWQGREQS-UHFFFAOYSA-N	246205	US10183932, Example 110::US9434690, 110::US9822102, Example 110	Plasma kallikrein			 78.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246205	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246205&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86297752	341104018							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710978	COc1cn(C(CC(C)C(F)(F)F)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C26H21ClF3N3O5/c1-14(26(28,29)30)9-21(24(35)32-18-7-4-15(5-8-18)25(36)37)33-13-22(38-2)20(11-23(33)34)19-10-17(27)6-3-16(19)12-31/h3-8,10-11,13-14,21H,9H2,1-2H3,(H,32,35)(H,36,37)	BHOCMFJOQHDNNX-UHFFFAOYSA-N	246206	US10183932, Example 111::US9434690, 111::US9822102, Example 111	Plasma kallikrein			 220							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246206	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246206&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117623008	341104019							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710979	COc1cn(C(CC(C)(C)C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C27H26ClN3O5/c1-27(2,3)13-22(25(33)30-19-9-6-16(7-10-19)26(34)35)31-15-23(36-4)21(12-24(31)32)20-11-18(28)8-5-17(20)14-29/h5-12,15,22H,13H2,1-4H3,(H,30,33)(H,34,35)	JQVBPYPYIBVMCC-UHFFFAOYSA-N	246207	US10183932, Example 112::US9434690, 112::US9822102, Example 112	Plasma kallikrein			 200							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246207	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246207&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86297948	341104020							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710980	COc1cn(C(CC2CC2(F)F)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C26H20ClF2N3O5/c1-37-22-13-32(23(33)10-20(22)19-9-17(27)5-2-15(19)12-30)21(8-16-11-26(16,28)29)24(34)31-18-6-3-14(4-7-18)25(35)36/h2-7,9-10,13,16,21H,8,11H2,1H3,(H,31,34)(H,35,36)	PPOMRFJZWPHFPA-UHFFFAOYSA-N	246208	US10183932, Example 115::US9434690, 113::US9434690, 114::US9434690, 115::US9822102, Example 115	Plasma kallikrein			 39.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246208	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246208&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86297949	341104021							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710981	COc1cn(C(CC2CC2(F)F)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C26H20ClF2N3O5/c1-37-22-13-32(23(33)10-20(22)19-9-17(27)5-2-15(19)12-30)21(8-16-11-26(16,28)29)24(34)31-18-6-3-14(4-7-18)25(35)36/h2-7,9-10,13,16,21H,8,11H2,1H3,(H,31,34)(H,35,36)	PPOMRFJZWPHFPA-UHFFFAOYSA-N	246208	US10183932, Example 115::US9434690, 113::US9434690, 114::US9434690, 115::US9822102, Example 115	Plasma kallikrein			 16.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246208	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246208&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86297949	341104021							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710982	COc1cn(C(CC2(C)CC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C27H24ClN3O5/c1-27(9-10-27)13-22(25(33)30-19-7-4-16(5-8-19)26(34)35)31-15-23(36-2)21(12-24(31)32)20-11-18(28)6-3-17(20)14-29/h3-8,11-12,15,22H,9-10,13H2,1-2H3,(H,30,33)(H,34,35)	DCFGHORVDDAJPY-UHFFFAOYSA-N	246211	US10183932, Example 116::US9434690, 116::US9822102, Example 116	Plasma kallikrein			 11.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246211	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246211&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622788	341104022							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710983	COc1cn(C(CC2CCC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C27H24ClN3O5/c1-36-24-15-31(25(32)13-22(24)21-12-19(28)8-5-18(21)14-29)23(11-16-3-2-4-16)26(33)30-20-9-6-17(7-10-20)27(34)35/h5-10,12-13,15-16,23H,2-4,11H2,1H3,(H,30,33)(H,34,35)	BXIDJSNINHKLLQ-UHFFFAOYSA-N	246212	US10183932, Example 117::US9434690, 117::US9822102, Example 117	Plasma kallikrein			 12.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246212	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246212&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86297950	341104023							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710984	CCOC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C24H20ClN3O6/c1-3-34-23(22(30)27-17-8-5-14(6-9-17)24(31)32)28-13-20(33-2)19(11-21(28)29)18-10-16(25)7-4-15(18)12-26/h4-11,13,23H,3H2,1-2H3,(H,27,30)(H,31,32)	MUNUHSGUPNMRDO-UHFFFAOYSA-N	246213	US10183932, Example 118::US9434690, 118::US9822102, Example 118	Plasma kallikrein			 210							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246213	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246213&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117623009	341104024							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710985	COc1cn(CC(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C22H16ClN3O5/c1-31-19-11-26(12-20(27)25-16-6-3-13(4-7-16)22(29)30)21(28)9-18(19)17-8-15(23)5-2-14(17)10-24/h2-9,11H,12H2,1H3,(H,25,27)(H,29,30)	SAHCVGAZLPRNEE-UHFFFAOYSA-N	246214	US10183932, Example 119::US9434690, 119::US9822102, Example 119	Plasma kallikrein			 200							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246214	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246214&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622872	341104025							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710986	COc1cn(C(C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1Br	InChI=1S/C22H18BrClN2O5/c1-12(21(28)25-15-6-3-13(4-7-15)22(29)30)26-11-19(31-2)17(10-20(26)27)16-9-14(24)5-8-18(16)23/h3-12H,1-2H3,(H,25,28)(H,29,30)	BZZDCJXMIRUBDL-UHFFFAOYSA-N	246216	US10183932, Example 121::US9434690, 121::US9822102, Example 121	Plasma kallikrein			 220							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246216	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246216&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86297951	341104027							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710987	COc1cn(C(C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C	InChI=1S/C23H21ClN2O5/c1-13-4-7-16(24)10-18(13)19-11-21(27)26(12-20(19)31-3)14(2)22(28)25-17-8-5-15(6-9-17)23(29)30/h4-12,14H,1-3H3,(H,25,28)(H,29,30)	CVTZPKKDPIRSKS-UHFFFAOYSA-N	246217	US10183932, Example 122::US9434690, 122::US9822102, Example 122	Plasma kallikrein			 700							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246217	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246217&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622769	341104028							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710988	COc1cn(C(C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C(F)(F)F	InChI=1S/C23H18ClF3N2O5/c1-12(21(31)28-15-6-3-13(4-7-15)22(32)33)29-11-19(34-2)17(10-20(29)30)16-9-14(24)5-8-18(16)23(25,26)27/h3-12H,1-2H3,(H,28,31)(H,32,33)	AHLPDNRPHFMHAO-UHFFFAOYSA-N	246218	US10183932, Example 123::US9434690, 123::US9822102, Example 123	Plasma kallikrein			 1100							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246218	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246218&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622932	341104029							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710989	CCC(CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N)OC	InChI=1S/C27H26ClN3O6/c1-4-20(36-2)12-23(26(33)30-19-9-6-16(7-10-19)27(34)35)31-15-24(37-3)22(13-25(31)32)21-11-18(28)8-5-17(21)14-29/h5-11,13,15,20,23H,4,12H2,1-3H3,(H,30,33)(H,34,35)	NWTLKQWFPQKMLC-UHFFFAOYSA-N	246220	US10183932, Example 144::US9434690, 125::US9434690, 141::US9434690, 142::US9434690, 143::US9434690, 144::US9822102, Example 144	Plasma kallikrein			 23.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246220	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246220&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86297952	341104031							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710990	COc1cn(C(CCO)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C24H20ClN3O6/c1-34-21-13-28(22(30)11-19(21)18-10-16(25)5-2-15(18)12-26)20(8-9-29)23(31)27-17-6-3-14(4-7-17)24(32)33/h2-7,10-11,13,20,29H,8-9H2,1H3,(H,27,31)(H,32,33)	BKTRHZIMQRNWEQ-UHFFFAOYSA-N	246221	US10183932, Example 126::US9434690, 126::US9822102, Example 126	Plasma kallikrein			 64.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246221	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246221&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622878	341104032							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710991	COc1cn(C(C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1OC(F)F	InChI=1S/C23H19ClF2N2O6/c1-12(21(30)27-15-6-3-13(4-7-15)22(31)32)28-11-19(33-2)17(10-20(28)29)16-9-14(24)5-8-18(16)34-23(25)26/h3-12,23H,1-2H3,(H,27,30)(H,31,32)	YRKPZRMKWAQTNS-UHFFFAOYSA-N	246222	US10183932, Example 127::US9434690, 127::US9822102, Example 127	Plasma kallikrein			 160							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246222	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246222&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622893	341104033							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710992	CCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1OC(F)F	InChI=1S/C24H21ClF2N2O6/c1-3-18(22(31)28-15-7-4-13(5-8-15)23(32)33)29-12-20(34-2)17(11-21(29)30)16-10-14(25)6-9-19(16)35-24(26)27/h4-12,18,24H,3H2,1-2H3,(H,28,31)(H,32,33)	BGDFMSJIOCVRBT-UHFFFAOYSA-N	246223	US10183932, Example 128::US9434690, 128::US9822102, Example 128	Plasma kallikrein			 180							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246223	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246223&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622790	341104034							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710993	CCOc1cn(C(C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C24H20ClN3O5/c1-3-33-21-13-28(14(2)23(30)27-18-8-5-15(6-9-18)24(31)32)22(29)11-20(21)19-10-17(25)7-4-16(19)12-26/h4-11,13-14H,3H2,1-2H3,(H,27,30)(H,31,32)	MHLRUCJOXJQBOK-UHFFFAOYSA-N	246224	US10183932, Example 129::US9434690, 129::US9822102, Example 129	Plasma kallikrein			 390							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246224	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246224&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622947	341104035							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710994	CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC(F)F)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C23H16ClF2N3O5/c1-12(21(31)28-16-6-3-13(4-7-16)22(32)33)29-11-19(34-23(25)26)18(9-20(29)30)17-8-15(24)5-2-14(17)10-27/h2-9,11-12,23H,1H3,(H,28,31)(H,32,33)	XEVLNKRJTMYBIC-UHFFFAOYSA-N	246225	US10183932, Example 130::US9434690, 130::US9822102, Example 130	Plasma kallikrein			 1300							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246225	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246225&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622897	341104036							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710995	COc1cn(C(CC2CCC(O)CC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C29H28ClN3O6/c1-39-26-16-33(27(35)14-24(26)23-13-20(30)7-4-19(23)15-31)25(12-17-2-10-22(34)11-3-17)28(36)32-21-8-5-18(6-9-21)29(37)38/h4-9,13-14,16-17,22,25,34H,2-3,10-12H2,1H3,(H,32,36)(H,37,38)	CJNBXUGWBBVSDD-UHFFFAOYSA-N	246227	US10183932, Example 135::US9434690, 132::US9434690, 133::US9434690, 134::US9434690, 135::US9822102, Example 135	Plasma kallikrein			 18.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246227	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246227&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86298154	341104038							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710996	COc1cn(C(CC2CCC(O)CC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C29H28ClN3O6/c1-39-26-16-33(27(35)14-24(26)23-13-20(30)7-4-19(23)15-31)25(12-17-2-10-22(34)11-3-17)28(36)32-21-8-5-18(6-9-21)29(37)38/h4-9,13-14,16-17,22,25,34H,2-3,10-12H2,1H3,(H,32,36)(H,37,38)	CJNBXUGWBBVSDD-UHFFFAOYSA-N	246227	US10183932, Example 135::US9434690, 132::US9434690, 133::US9434690, 134::US9434690, 135::US9822102, Example 135	Plasma kallikrein			 5.80							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246227	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246227&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86298154	341104038							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710997	COc1cn(C(CC2CCC(O)CC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C29H28ClN3O6/c1-39-26-16-33(27(35)14-24(26)23-13-20(30)7-4-19(23)15-31)25(12-17-2-10-22(34)11-3-17)28(36)32-21-8-5-18(6-9-21)29(37)38/h4-9,13-14,16-17,22,25,34H,2-3,10-12H2,1H3,(H,32,36)(H,37,38)	CJNBXUGWBBVSDD-UHFFFAOYSA-N	246227	US10183932, Example 135::US9434690, 132::US9434690, 133::US9434690, 134::US9434690, 135::US9822102, Example 135	Plasma kallikrein			 19.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246227	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246227&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86298154	341104038							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710998	COc1cn(C(CCOC(F)(F)F)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C25H19ClF3N3O6/c1-37-21-13-32(22(33)11-19(21)18-10-16(26)5-2-15(18)12-30)20(8-9-38-25(27,28)29)23(34)31-17-6-3-14(4-7-17)24(35)36/h2-7,10-11,13,20H,8-9H2,1H3,(H,31,34)(H,35,36)	YNXCWDXRPDZZLO-UHFFFAOYSA-N	246231	US10183932, Example 138::US9434690, 136::US9434690, 137::US9434690, 138::US9822102, Example 138	Plasma kallikrein			 9.40							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246231	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246231&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622873	341104039							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
710999	COc1cn(C(CCOC(F)(F)F)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C25H19ClF3N3O6/c1-37-21-13-32(22(33)11-19(21)18-10-16(26)5-2-15(18)12-30)20(8-9-38-25(27,28)29)23(34)31-17-6-3-14(4-7-17)24(35)36/h2-7,10-11,13,20H,8-9H2,1H3,(H,31,34)(H,35,36)	YNXCWDXRPDZZLO-UHFFFAOYSA-N	246231	US10183932, Example 138::US9434690, 136::US9434690, 137::US9434690, 138::US9822102, Example 138	Plasma kallikrein			 6.50							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246231	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246231&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622873	341104039							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711000	CCC1(CC(C(=O)Nc2ccc(cc2)-c2noc(=O)[nH]2)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2C#N)COC1			246234	US10183932, Example 139::US9434690, 139::US9822102, Example 139	Plasma kallikrein			 9.40							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246234	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246234&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			129626910	341104040							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711001	CCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C24H20ClN3O5/c1-3-20(23(30)27-17-8-5-14(6-9-17)24(31)32)28-13-21(33-2)19(11-22(28)29)18-10-16(25)7-4-15(18)12-26/h4-11,13,20H,3H2,1-2H3,(H,27,30)(H,31,32)	HUXWVMXMMHUYLB-UHFFFAOYSA-N	246161	US10183932, Example 140::US9434690, 140::US9434690, 66::US9434690, 67::US9434690, 68::US9822102, Example 140	Plasma kallikrein			 32.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246161	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246161&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622754	341103997							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711002	CCC(CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N)OC	InChI=1S/C27H26ClN3O6/c1-4-20(36-2)12-23(26(33)30-19-9-6-16(7-10-19)27(34)35)31-15-24(37-3)22(13-25(31)32)21-11-18(28)8-5-17(21)14-29/h5-11,13,15,20,23H,4,12H2,1-3H3,(H,30,33)(H,34,35)	NWTLKQWFPQKMLC-UHFFFAOYSA-N	246220	US10183932, Example 144::US9434690, 125::US9434690, 141::US9434690, 142::US9434690, 143::US9434690, 144::US9822102, Example 144	Plasma kallikrein			 1600							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246220	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246220&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86297952	341104031							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711003	CCC(CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N)OC	InChI=1S/C27H26ClN3O6/c1-4-20(36-2)12-23(26(33)30-19-9-6-16(7-10-19)27(34)35)31-15-24(37-3)22(13-25(31)32)21-11-18(28)8-5-17(21)14-29/h5-11,13,15,20,23H,4,12H2,1-3H3,(H,30,33)(H,34,35)	NWTLKQWFPQKMLC-UHFFFAOYSA-N	246220	US10183932, Example 144::US9434690, 125::US9434690, 141::US9434690, 142::US9434690, 143::US9434690, 144::US9822102, Example 144	Plasma kallikrein			 18.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246220	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246220&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86297952	341104031							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711004	CCC(CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N)OC	InChI=1S/C27H26ClN3O6/c1-4-20(36-2)12-23(26(33)30-19-9-6-16(7-10-19)27(34)35)31-15-24(37-3)22(13-25(31)32)21-11-18(28)8-5-17(21)14-29/h5-11,13,15,20,23H,4,12H2,1-3H3,(H,30,33)(H,34,35)	NWTLKQWFPQKMLC-UHFFFAOYSA-N	246220	US10183932, Example 144::US9434690, 125::US9434690, 141::US9434690, 142::US9434690, 143::US9434690, 144::US9822102, Example 144	Plasma kallikrein			 4.60							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246220	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246220&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86297952	341104031							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711005	CCC(CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N)OC	InChI=1S/C27H26ClN3O6/c1-4-20(36-2)12-23(26(33)30-19-9-6-16(7-10-19)27(34)35)31-15-24(37-3)22(13-25(31)32)21-11-18(28)8-5-17(21)14-29/h5-11,13,15,20,23H,4,12H2,1-3H3,(H,30,33)(H,34,35)	NWTLKQWFPQKMLC-UHFFFAOYSA-N	246220	US10183932, Example 144::US9434690, 125::US9434690, 141::US9434690, 142::US9434690, 143::US9434690, 144::US9822102, Example 144	Plasma kallikrein			 1000							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246220	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246220&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86297952	341104031							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711006	COc1cn(C(CC2(CC2)C(F)(F)F)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C27H21ClF3N3O5/c1-39-22-14-34(23(35)11-20(22)19-10-17(28)5-2-16(19)13-32)21(12-26(8-9-26)27(29,30)31)24(36)33-18-6-3-15(4-7-18)25(37)38/h2-7,10-11,14,21H,8-9,12H2,1H3,(H,33,36)(H,37,38)	PNSIVGGUCOLACI-UHFFFAOYSA-N	246239	US10183932, Example 147::US9434690, 145::US9434690, 146::US9434690, 147::US9822102, Example 147	Plasma kallikrein			 98.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246239	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246239&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86298155	341104041							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711007	COc1cn(C(CC2(CC2)C(F)(F)F)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C27H21ClF3N3O5/c1-39-22-14-34(23(35)11-20(22)19-10-17(28)5-2-16(19)13-32)21(12-26(8-9-26)27(29,30)31)24(36)33-18-6-3-15(4-7-18)25(37)38/h2-7,10-11,14,21H,8-9,12H2,1H3,(H,33,36)(H,37,38)	PNSIVGGUCOLACI-UHFFFAOYSA-N	246239	US10183932, Example 147::US9434690, 145::US9434690, 146::US9434690, 147::US9822102, Example 147	Plasma kallikrein			 1500							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246239	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246239&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86298155	341104041							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711008	COc1cn(C(CC2(CC2)C(F)(F)F)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C27H21ClF3N3O5/c1-39-22-14-34(23(35)11-20(22)19-10-17(28)5-2-16(19)13-32)21(12-26(8-9-26)27(29,30)31)24(36)33-18-6-3-15(4-7-18)25(37)38/h2-7,10-11,14,21H,8-9,12H2,1H3,(H,33,36)(H,37,38)	PNSIVGGUCOLACI-UHFFFAOYSA-N	246239	US10183932, Example 147::US9434690, 145::US9434690, 146::US9434690, 147::US9822102, Example 147	Plasma kallikrein			 70.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246239	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246239&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86298155	341104041							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711009	COc1cn(C(CC2(CCC2)C(F)(F)F)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C28H23ClF3N3O5/c1-40-23-15-35(24(36)12-21(23)20-11-18(29)6-3-17(20)14-33)22(13-27(9-2-10-27)28(30,31)32)25(37)34-19-7-4-16(5-8-19)26(38)39/h3-8,11-12,15,22H,2,9-10,13H2,1H3,(H,34,37)(H,38,39)	NNYYRFPFZSEPNY-UHFFFAOYSA-N	246242	US10183932, Example 148::US9434690, 148::US9822102, Example 148	Plasma kallikrein			 430							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246242	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246242&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117623022	341104042							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711010	COc1cn(C(CC2CC(F)(F)C2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C27H22ClF2N3O5/c1-38-23-14-33(24(34)10-21(23)20-9-18(28)5-2-17(20)13-31)22(8-15-11-27(29,30)12-15)25(35)32-19-6-3-16(4-7-19)26(36)37/h2-7,9-10,14-15,22H,8,11-12H2,1H3,(H,32,35)(H,36,37)	IIHVYKJYWMUBJC-UHFFFAOYSA-N	246243	US10183932, Example 149::US9434690, 149::US9822102, Example 149	Plasma kallikrein			 27.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246243	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246243&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622900	341104043							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711011	COc1cn(C(CC2(C)COC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C27H24ClN3O6/c1-27(14-37-15-27)11-22(25(33)30-19-7-4-16(5-8-19)26(34)35)31-13-23(36-2)21(10-24(31)32)20-9-18(28)6-3-17(20)12-29/h3-10,13,22H,11,14-15H2,1-2H3,(H,30,33)(H,34,35)	UCSCLOQQIVMMIJ-UHFFFAOYSA-N	246244	US10183932, Example 150::US9434690, 150::US9822102, Example 150	Plasma kallikrein			 18.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246244	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246244&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622630	341104044							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711012	COc1cn(C(CC2(C)CCOCC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C29H28ClN3O6/c1-29(9-11-39-12-10-29)15-24(27(35)32-21-7-4-18(5-8-21)28(36)37)33-17-25(38-2)23(14-26(33)34)22-13-20(30)6-3-19(22)16-31/h3-8,13-14,17,24H,9-12,15H2,1-2H3,(H,32,35)(H,36,37)	PAESNLCGOZMSMT-UHFFFAOYSA-N	246245	US10183932, Example 151::US9434690, 151::US9822102, Example 151	Plasma kallikrein			 110							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246245	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246245&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117623020	341104045							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711013	CO[C@@H]1CC[C@H](CC(C(=O)Nc2ccc(cc2)C(O)=O)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2C#N)CC1	InChI=1S/C30H30ClN3O6/c1-39-23-11-3-18(4-12-23)13-26(29(36)33-22-9-6-19(7-10-22)30(37)38)34-17-27(40-2)25(15-28(34)35)24-14-21(31)8-5-20(24)16-32/h5-10,14-15,17-18,23,26H,3-4,11-13H2,1-2H3,(H,33,36)(H,37,38)/t18-,23+,26?	LARGKTWCHAEXEF-CIGLETDBSA-N	246246	US10183932, Example 154::US9434690, 152::US9434690, 153::US9434690, 154::US9822102, Example 154	Plasma kallikrein			 75.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246246	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246246&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622774	341104046							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711014	CO[C@@H]1CC[C@H](CC(C(=O)Nc2ccc(cc2)C(O)=O)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2C#N)CC1	InChI=1S/C30H30ClN3O6/c1-39-23-11-3-18(4-12-23)13-26(29(36)33-22-9-6-19(7-10-22)30(37)38)34-17-27(40-2)25(15-28(34)35)24-14-21(31)8-5-20(24)16-32/h5-10,14-15,17-18,23,26H,3-4,11-13H2,1-2H3,(H,33,36)(H,37,38)/t18-,23+,26?	LARGKTWCHAEXEF-CIGLETDBSA-N	246246	US10183932, Example 154::US9434690, 152::US9434690, 153::US9434690, 154::US9822102, Example 154	Plasma kallikrein			 45.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246246	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246246&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622774	341104046							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711015	CO[C@H]1CC[C@H](CC(C(=O)Nc2ccc(cc2)C(O)=O)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2C#N)CC1	InChI=1S/C30H30ClN3O6/c1-39-23-11-3-18(4-12-23)13-26(29(36)33-22-9-6-19(7-10-22)30(37)38)34-17-27(40-2)25(15-28(34)35)24-14-21(31)8-5-20(24)16-32/h5-10,14-15,17-18,23,26H,3-4,11-13H2,1-2H3,(H,33,36)(H,37,38)/t18-,23-,26?	LARGKTWCHAEXEF-QDTYANCNSA-N	246249	US10183932, Example 157::US9434690, 155::US9434690, 156::US9434690, 157::US9822102, Example 157	Plasma kallikrein			 10.00							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246249	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246249&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622774	341104047							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711016	CO[C@H]1CC[C@H](CC(C(=O)Nc2ccc(cc2)C(O)=O)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2C#N)CC1	InChI=1S/C30H30ClN3O6/c1-39-23-11-3-18(4-12-23)13-26(29(36)33-22-9-6-19(7-10-22)30(37)38)34-17-27(40-2)25(15-28(34)35)24-14-21(31)8-5-20(24)16-32/h5-10,14-15,17-18,23,26H,3-4,11-13H2,1-2H3,(H,33,36)(H,37,38)/t18-,23-,26?	LARGKTWCHAEXEF-QDTYANCNSA-N	246249	US10183932, Example 157::US9434690, 155::US9434690, 156::US9434690, 157::US9822102, Example 157	Plasma kallikrein			 5.20							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246249	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246249&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622774	341104047							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711017	COc1cn(C(CC2CCC2)C(=O)Nc2ccc(cc2)-c2c[nH]c(=O)o2)c(=O)cc1-c1cc(Cl)ccc1C#N			246252	US10183932, Example 158::US9434690, 158::US9822102, Example 158	Plasma kallikrein			 29.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246252	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246252&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622778	341104048							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711018	COc1cn(C(CC2CCC2)C(=O)Nc2ccc3c(c2)[nH]n(C)c3=O)c(=O)cc1-c1cc(Cl)ccc1C#N			246253	US10183932, Example 159::US9434690, 159::US9822102, Example 159	Plasma kallikrein			 16.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246253	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246253&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			129626911	341104049							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711019	COc1cn(C(C(C)C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C25H22ClN3O5/c1-14(2)23(24(31)28-18-8-5-15(6-9-18)25(32)33)29-13-21(34-3)20(11-22(29)30)19-10-17(26)7-4-16(19)12-27/h4-11,13-14,23H,1-3H3,(H,28,31)(H,32,33)	SGNRWMZAJNVPLX-UHFFFAOYSA-N	246254	US10183932, Example 160::US9434690, 160::US9822102, Example 160	Plasma kallikrein			 240							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246254	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246254&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622781	341104050							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711020	COc1cn(C(C(C)C)C(=O)Nc2ccc(C(O)=O)c(C)c2)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C26H24ClN3O5/c1-14(2)24(25(32)29-18-7-8-19(26(33)34)15(3)9-18)30-13-22(35-4)21(11-23(30)31)20-10-17(27)6-5-16(20)12-28/h5-11,13-14,24H,1-4H3,(H,29,32)(H,33,34)	ZYWDBAHJEMNANX-UHFFFAOYSA-N	246255	US10183932, Example 161::US9434690, 161::US9822102, Example 161	Plasma kallikrein			 1500							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246255	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246255&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622965	341104051							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711021	COc1cn(C(C(C)C)C(=O)Nc2ccc3nc([nH]c3c2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N			246256	US10183932, Example 162::US9434690, 162::US9822102, Example 162	Plasma kallikrein			 250							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246256	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246256&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622907	341104052							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711022	COCCC(C(=O)Nc1ccc2[nH]c(=O)[nH]c2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C25H20ClN5O5/c1-35-8-7-21(24(33)28-16-5-6-19-20(10-16)30-25(34)29-19)31-13-22(36-2)18(11-23(31)32)17-9-15(26)4-3-14(17)12-27/h3-6,9-11,13,21H,7-8H2,1-2H3,(H,28,33)	LVYGLUYPTDVDIW-UHFFFAOYSA-N	246257	US10183932, Example 163::US9434690, 163::US9822102, Example 163	Plasma kallikrein			 3.60							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246257	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246257&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			129626912	341104053							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711023	COCCC(C(=O)Nc1ccc2c(c1)[nH][nH]c2=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C25H20ClN5O5/c1-35-8-7-21(25(34)28-16-5-6-17-20(10-16)29-30-24(17)33)31-13-22(36-2)19(11-23(31)32)18-9-15(26)4-3-14(18)12-27/h3-6,9-11,13,21H,7-8H2,1-2H3,(H,28,34)	LSOXVFXTZIMGBB-UHFFFAOYSA-N	246258	US10183932, Example 164::US9434690, 164::US9822102, Example 164	Plasma kallikrein			 1.90							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246258	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246258&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			129626913	341104054							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711024	COCCC(C(=O)Nc1ccc2c(c1)[nH]n(C)c2=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N			246259	US10183932, Example 165::US9434690, 165::US9822102, Example 165	Plasma kallikrein			 8.20							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246259	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246259&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			129626914	341104055							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711025	COCCC(C(=O)Nc1ccc2[nH]ncc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N			246260	US10183932, Example 166::US9434690, 166::US9822102, Example 166	Plasma kallikrein			 6.30							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246260	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246260&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			129626915	341104056							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711026	COCCC(C(=O)Nc1ccc2[nH]nc(Cl)c2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N			246261	US10183932, Example 167::US9434690, 167::US9822102, Example 167	Plasma kallikrein			 8.40							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246261	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246261&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			129626916	341104057							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711027	COCCC(C(=O)Nc1ccc2cc([nH]c2c1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N			246262	US10183932, Example 168::US9434690, 168::US9822102, Example 168	Plasma kallikrein			 3.10							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246262	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246262&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622955	341104058							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711028	COCCC(C(=O)Nc1cc2[nH]c(cc2cc1OC)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N			246263	US10183932, Example 169::US9434690, 169::US9822102, Example 169	Plasma kallikrein			 54.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246263	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246263&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622918	341104059							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711029	CC(C)CC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(Cl)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C25H21Cl2N3O4/c1-14(2)9-22(24(32)29-18-7-4-15(5-8-18)25(33)34)30-13-21(27)20(11-23(30)31)19-10-17(26)6-3-16(19)12-28/h3-8,10-11,13-14,22H,9H2,1-2H3,(H,29,32)(H,33,34)	AMIQZUOXODCISO-UHFFFAOYSA-N	246264	US10183932, Example 170::US9434690, 170::US9822102, Example 170	Plasma kallikrein			 670							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246264	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246264&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622957	341104060							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711030	OC(=O)c1ccc(NC(=O)C(CCOC(F)(F)F)n2cc(Cl)c(cc2=O)-c2cc(Cl)ccc2C#N)cc1	InChI=1S/C24H16Cl2F3N3O5/c25-15-4-1-14(11-30)17(9-15)18-10-21(33)32(12-19(18)26)20(7-8-37-24(27,28)29)22(34)31-16-5-2-13(3-6-16)23(35)36/h1-6,9-10,12,20H,7-8H2,(H,31,34)(H,35,36)	AHPKGYGFEFPFAF-UHFFFAOYSA-N	246265	US10183932, Example 171::US9434690, 171::US9822102, Example 171	Plasma kallikrein			 89.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246265	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246265&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622783	341104061							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711031	COc1cn(C(CC(C)C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1OC(F)F	InChI=1S/C26H25ClF2N2O6/c1-14(2)10-20(24(33)30-17-7-4-15(5-8-17)25(34)35)31-13-22(36-3)19(12-23(31)32)18-11-16(27)6-9-21(18)37-26(28)29/h4-9,11-14,20,26H,10H2,1-3H3,(H,30,33)(H,34,35)	PONZAFSAZRCPMW-UHFFFAOYSA-N	246266	US10183932, Example 172::US9434690, 172::US9822102, Example 172	Plasma kallikrein			 360							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246266	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246266&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117623021	341104062							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711032	COCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1OC(F)F	InChI=1S/C25H23ClF2N2O7/c1-35-10-9-19(23(32)29-16-6-3-14(4-7-16)24(33)34)30-13-21(36-2)18(12-22(30)31)17-11-15(26)5-8-20(17)37-25(27)28/h3-8,11-13,19,25H,9-10H2,1-2H3,(H,29,32)(H,33,34)	BRLSWNMQGWOZIZ-UHFFFAOYSA-N	246267	US10183932, Example 173::US9434690, 173::US9822102, Example 173	Plasma kallikrein			 54.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246267	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246267&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622938	341104063							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711033	COCCC(C(=O)Nc1ccc2c(c1)[nH]n(C)c2=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1OC(F)F			246268	US10183932, Example 174::US9434690, 174::US9822102, Example 174	Plasma kallikrein			 28.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246268	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246268&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			129626917	341104064							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711034	COCCC(C(=O)Nc1ccc2[nH]c(=O)[nH]c2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1OC(F)F	InChI=1S/C25H21ClF2N4O6/c1-36-8-7-19(23(34)29-14-4-5-17-18(10-14)31-25(35)30-17)32-12-21(37-2)16(11-22(32)33)15-9-13(26)3-6-20(15)38-24(27)28/h3-6,9-12,19,24H,7-8H2,1-2H3,(H,29,34)	NKCAKTVAUQJXMR-UHFFFAOYSA-N	246269	US10183932, Example 175::US9434690, 175::US9822102, Example 175	Plasma kallikrein			 20.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246269	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246269&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			129626918	341104065							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711035	COc1cn(C(CCOC(F)(F)F)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1OC(F)F	InChI=1S/C25H20ClF5N2O7/c1-38-20-12-33(21(34)11-17(20)16-10-14(26)4-7-19(16)40-24(27)28)18(8-9-39-25(29,30)31)22(35)32-15-5-2-13(3-6-15)23(36)37/h2-7,10-12,18,24H,8-9H2,1H3,(H,32,35)(H,36,37)	MQEMRRKVUTYPQR-UHFFFAOYSA-N	246270	US10183932, Example 176::US9434690, 176::US9822102, Example 176	Plasma kallikrein			 58.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246270	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246270&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622904	341104066							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711036	COc1cn(C(C[C@H]2CCCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1OC(F)F	InChI=1S/C28H27ClF2N2O7/c1-38-24-15-33(25(34)14-21(24)20-12-17(29)7-10-23(20)40-28(30)31)22(13-19-4-2-3-11-39-19)26(35)32-18-8-5-16(6-9-18)27(36)37/h5-10,12,14-15,19,22,28H,2-4,11,13H2,1H3,(H,32,35)(H,36,37)/t19-,22?/m1/s1	OTYWURKUSAPCDC-LCQOSCCDSA-N	246271	US10183932, Example 177::US9434690, 177::US9822102, Example 177	Plasma kallikrein			 120							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246271	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246271&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622940	341104067							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711037	CCC(C(=O)Nc1ccc(C(O)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C24H19ClFN3O5/c1-3-20(23(31)28-15-6-7-16(24(32)33)19(26)9-15)29-12-21(34-2)18(10-22(29)30)17-8-14(25)5-4-13(17)11-27/h4-10,12,20H,3H2,1-2H3,(H,28,31)(H,32,33)	LRTKHAKNKDKNGN-UHFFFAOYSA-N	246272	US10183932, Example 179::US9434690, 178::US9434690, 179::US9822102, Example 179	Plasma kallikrein			 33.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246272	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246272&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622926	341104068							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711038	CCC(C(=O)Nc1ccc(C(O)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C24H19ClFN3O5/c1-3-20(23(31)28-15-6-7-16(24(32)33)19(26)9-15)29-12-21(34-2)18(10-22(29)30)17-8-14(25)5-4-13(17)11-27/h4-10,12,20H,3H2,1-2H3,(H,28,31)(H,32,33)	LRTKHAKNKDKNGN-UHFFFAOYSA-N	246272	US10183932, Example 179::US9434690, 178::US9434690, 179::US9822102, Example 179	Plasma kallikrein			 24.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246272	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246272&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622926	341104068							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711039	CCC(C(=O)Nc1ccc(cc1F)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C24H19ClFN3O5/c1-3-20(23(31)28-19-7-5-13(24(32)33)8-18(19)26)29-12-21(34-2)17(10-22(29)30)16-9-15(25)6-4-14(16)11-27/h4-10,12,20H,3H2,1-2H3,(H,28,31)(H,32,33)	JXWVATDLTXDPIQ-UHFFFAOYSA-N	246274	US10183932, Example 181::US9434690, 180::US9434690, 181::US9822102, Example 181	Plasma kallikrein			 78.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246274	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246274&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622633	341104069							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711040	CCC(C(=O)Nc1ccc(cc1F)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C24H19ClFN3O5/c1-3-20(23(31)28-19-7-5-13(24(32)33)8-18(19)26)29-12-21(34-2)17(10-22(29)30)16-9-15(25)6-4-14(16)11-27/h4-10,12,20H,3H2,1-2H3,(H,28,31)(H,32,33)	JXWVATDLTXDPIQ-UHFFFAOYSA-N	246274	US10183932, Example 181::US9434690, 180::US9434690, 181::US9822102, Example 181	Plasma kallikrein			 45.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246274	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246274&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622633	341104069							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711041	CCC(C(=O)Nc1cc(F)c(cc1F)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C24H18ClF2N3O5/c1-3-20(23(32)29-19-9-17(26)16(24(33)34)7-18(19)27)30-11-21(35-2)15(8-22(30)31)14-6-13(25)5-4-12(14)10-28/h4-9,11,20H,3H2,1-2H3,(H,29,32)(H,33,34)	ZVXCULUAQHRZBD-UHFFFAOYSA-N	246276	US10183932, Example 183::US9434690, 182::US9434690, 183::US9822102, Example 183	Plasma kallikrein			 130							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246276	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246276&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622968	341104070							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711042	CCC(C(=O)Nc1cc(F)c(cc1F)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C24H18ClF2N3O5/c1-3-20(23(32)29-19-9-17(26)16(24(33)34)7-18(19)27)30-11-21(35-2)15(8-22(30)31)14-6-13(25)5-4-12(14)10-28/h4-9,11,20H,3H2,1-2H3,(H,29,32)(H,33,34)	ZVXCULUAQHRZBD-UHFFFAOYSA-N	246276	US10183932, Example 183::US9434690, 182::US9434690, 183::US9822102, Example 183	Plasma kallikrein			 62.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246276	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246276&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622968	341104070							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711043	CCC(C(=O)Nc1ccc(C(O)=O)c(F)c1F)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C24H18ClF2N3O5/c1-3-18(23(32)29-17-7-6-14(24(33)34)21(26)22(17)27)30-11-19(35-2)16(9-20(30)31)15-8-13(25)5-4-12(15)10-28/h4-9,11,18H,3H2,1-2H3,(H,29,32)(H,33,34)	BSTJIMFCDNVZGR-UHFFFAOYSA-N	246278	US10183932, Example 184::US9434690, 184::US9822102, Example 184	Plasma kallikrein			 110							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246278	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246278&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622631	341104071							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711044	CCC(C(=O)Nc1cc(F)c(C(O)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C24H18ClF2N3O5/c1-3-19(23(32)29-14-7-17(26)22(24(33)34)18(27)8-14)30-11-20(35-2)16(9-21(30)31)15-6-13(25)5-4-12(15)10-28/h4-9,11,19H,3H2,1-2H3,(H,29,32)(H,33,34)	UALXRLIAFKMVEE-UHFFFAOYSA-N	246279	US10183932, Example 185::US9434690, 185::US9822102, Example 185	Plasma kallikrein			 40.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246279	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246279&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622950	341104072							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711045	CCC(C(=O)Nc1ccc(cc1)-c1nsc(=O)[nH]1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N			246280	US10183932, Example 187::US9434690, 186::US9434690, 187::US9822102, Example 187	Plasma kallikrein			 31.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246280	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246280&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			129626919	341104073							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711046	CCC(C(=O)Nc1ccc(cc1)-c1nsc(=O)[nH]1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N			246280	US10183932, Example 187::US9434690, 186::US9434690, 187::US9822102, Example 187	Plasma kallikrein			 14.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246280	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246280&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			129626919	341104073							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711047	CCC(C(=O)Nc1ccc(cc1)-c1noc(=S)[nH]1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N			246282	US10183932, Example 188::US9434690, 188::US9822102, Example 188	Plasma kallikrein			 31.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246282	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246282&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			129626920	341104074							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711048	CCC(C(=O)Nc1ccc(cc1)-c1ncco1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C26H21ClN4O4/c1-3-22(25(33)30-19-8-5-16(6-9-19)26-29-10-11-35-26)31-15-23(34-2)21(13-24(31)32)20-12-18(27)7-4-17(20)14-28/h4-13,15,22H,3H2,1-2H3,(H,30,33)	WOVKYOZMJFJOLI-UHFFFAOYSA-N	246283	US10183932, Example 189::US9434690, 189::US9822102, Example 189	Plasma kallikrein			 63.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246283	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246283&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622969	341104075							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711049	CCC(C(=O)Nc1ccc(cc1)-c1ncon1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C25H20ClN5O4/c1-3-21(25(33)29-18-8-5-15(6-9-18)24-28-14-35-30-24)31-13-22(34-2)20(11-23(31)32)19-10-17(26)7-4-16(19)12-27/h4-11,13-14,21H,3H2,1-2H3,(H,29,33)	JIVAXRBOSDSXCF-UHFFFAOYSA-N	246284	US10183932, Example 190::US9434690, 190::US9822102, Example 190	Plasma kallikrein			 35.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246284	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246284&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117623031	341104076							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711050	CCC(C(=O)Nc1ccc(cc1)-c1nnc(C)o1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C26H22ClN5O4/c1-4-22(25(34)29-19-9-6-16(7-10-19)26-31-30-15(2)36-26)32-14-23(35-3)21(12-24(32)33)20-11-18(27)8-5-17(20)13-28/h5-12,14,22H,4H2,1-3H3,(H,29,34)	IWJPZYSOUYLTNJ-UHFFFAOYSA-N	246285	US10183932, Example 191::US9434690, 191::US9822102, Example 191	Plasma kallikrein			 35.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246285	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246285&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622798	341104077							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711051	CCC(C(=O)Nc1ccc(cc1)-c1nnc([nH]1)C(F)(F)C(F)(F)C(=O)OC)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N			246286	US10183932, Example 192::US9434690, 192::US9822102, Example 192	Plasma kallikrein			 61.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246286	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246286&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622636	341104078							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711052	CCC(C(=O)Nc1ccc(cc1)-c1nnc([nH]1)C(F)(F)C(F)(F)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N			246287	US10183932, Example 193::US9434690, 193::US9822102, Example 193	Plasma kallikrein			 46.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246287	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246287&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622923	341104079							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711053	CCC(C(=O)Nc1cc(F)c2c(c1)[nH][nH]c2=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C24H17ClFN5O4/c1-3-19(23(33)28-14-7-17(26)22-18(8-14)29-30-24(22)34)31-11-20(35-2)16(9-21(31)32)15-6-13(25)5-4-12(15)10-27/h4-9,11,19H,3H2,1-2H3,(H,28,33)	GKSXPUJAHJCWDQ-UHFFFAOYSA-N	246288	US10183932, Example 194::US9434690, 194::US9822102, Example 194	Plasma kallikrein			 6.30							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246288	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246288&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			129626921	341104080							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711054	CCC(C(=O)Nc1ccc2c(n[nH]c2c1)C(F)(F)F)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N			246289	US10183932, Example 195::US9434690, 195::US9822102, Example 195	Plasma kallikrein			 59.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246289	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246289&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118877926	341104081							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711055	CCC(C(=O)Nc1ccc2[nH]nc(Cl)c2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N			246290	US10183932, Example 196::US9434690, 196::US9822102, Example 196	Plasma kallikrein			 21.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246290	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246290&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622966	341104082							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711056	CCC(C(=O)Nc1ccc2[nH]ncc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C#N			246291	US10183932, Example 197::US9434690, 197::US9822102, Example 197	Plasma kallikrein			 10.00							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246291	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246291&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622970	341104083							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711057	COc1cn(C(CC2CCS(=O)(=O)CC2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C28H26ClN3O7S/c1-39-25-16-32(26(33)14-23(25)22-13-20(29)5-2-19(22)15-30)24(12-17-8-10-40(37,38)11-9-17)27(34)31-21-6-3-18(4-7-21)28(35)36/h2-7,13-14,16-17,24H,8-12H2,1H3,(H,31,34)(H,35,36)	PDHWFIGBHMGYOO-UHFFFAOYSA-N	246292	US10183932, Example 198::US9434690, 198::US9822102, Example 198	Plasma kallikrein			 39.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246292	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246292&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622799	341104084							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711058	COc1cn(C(C[C@@H]2CCCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1OC(F)F	InChI=1S/C28H27ClF2N2O7/c1-38-24-15-33(25(34)14-21(24)20-12-17(29)7-10-23(20)40-28(30)31)22(13-19-4-2-3-11-39-19)26(35)32-18-8-5-16(6-9-18)27(36)37/h5-10,12,14-15,19,22,28H,2-4,11,13H2,1H3,(H,32,35)(H,36,37)/t19-,22?/m0/s1	OTYWURKUSAPCDC-YDNXMHBPSA-N	246293	US10183932, Example 199::US9434690, 199::US9822102, Example 199	Plasma kallikrein			 34.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246293	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246293&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622782	341104085							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711059	OC(=O)c1ccc(NC(=O)C(C[C@@H]2CCCCO2)n2cc(Cl)c(cc2=O)-c2cc(Cl)ccc2C#N)cc1	InChI=1S/C27H23Cl2N3O5/c28-18-7-4-17(14-30)21(11-18)22-13-25(33)32(15-23(22)29)24(12-20-3-1-2-10-37-20)26(34)31-19-8-5-16(6-9-19)27(35)36/h4-9,11,13,15,20,24H,1-3,10,12H2,(H,31,34)(H,35,36)/t20-,24?/m0/s1	KBFYCDAOFYYRQQ-QHELBMECSA-N	246296	US10183932, Example 202::US9434690, 202::US9822102, Example 202	Plasma kallikrein			 82.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246296	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246296&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622964	341104086							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
711060	COCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(Cl)c(cc1=O)-c1cc(Cl)ccc1C#N	InChI=1S/C24H19Cl2N3O5/c1-34-9-8-21(23(31)28-17-6-3-14(4-7-17)24(32)33)29-13-20(26)19(11-22(29)30)18-10-16(25)5-2-15(18)12-27/h2-7,10-11,13,21H,8-9H2,1H3,(H,28,31)(H,32,33)	YWIBKDIZKZBHGC-UHFFFAOYSA-N	246299	US10183932, Example 205::US9434690, 205::US9822102, Example 205	Plasma kallikrein			 68.0							US Patent		10.7270/Q2FN18G5		aid1797772	US9822102	Rohrig, S; Hillisch, A; Strassburger, J; Heitmeier, S; Schmidt, MV; Schlemmer, K; Tersteegen, A; Buchmuller, A; Gerdes, C; Schafer, M; Kinzel, T; Teller, H; Schirok, H; Klar, J; Nunez, EJ	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246299	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=246299&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117622796	341104087							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50761402	CN1Cc2cc(NC(=O)OCCc3c(C)cc(cc3C)[C@@H](Nc3ccc4cc[nH]c(=O)c4c3)C1=O)ccc2S(=O)(=O)C1CC1	InChI=1S/C33H34N4O6S/c1-19-14-22-15-20(2)27(19)11-13-43-33(40)36-24-6-9-29(44(41,42)26-7-8-26)23(16-24)18-37(3)32(39)30(22)35-25-5-4-21-10-12-34-31(38)28(21)17-25/h4-6,9-10,12,14-17,26,30,35H,7-8,11,13,18H2,1-3H3,(H,34,38)(H,36,40)/t30-/m1/s1	YJTFTQFUZXRAGN-SSEXGKCCSA-N	50242359	CHEMBL4083729	Plasma kallikrein		>10000								ChEMBL	10.1016/j.bmcl.2017.04.008	10.7270/Q29P3420	28460818			Wurtz, NR; Parkhurst, BL; DeLucca, I; Glunz, PW; Jiang, W; Zhang, X; Cheney, DL; Bozarth, JM; Rendina, AR; Wei, A; Harper, T; Luettgen, JM; Wu, Y; Wong, PC; Seiffert, DA; Wexler, RR; Priestley, ES	Bristol-Myers Squibb Research and Development	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50242359	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50242359&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			59315536	386402486		CHEMBL4083729					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50761403	CCc1cc2ccc1CCOC(=O)Nc1ccc(c(CN(C)C(=O)[C@@H]2Nc2cccc(c2)C(N)=O)c1)S(=O)(=O)C(C)C	InChI=1S/C31H36N4O6S/c1-5-20-15-22-10-9-21(20)13-14-41-31(38)34-26-11-12-27(42(39,40)19(2)3)24(17-26)18-35(4)30(37)28(22)33-25-8-6-7-23(16-25)29(32)36/h6-12,15-17,19,28,33H,5,13-14,18H2,1-4H3,(H2,32,36)(H,34,38)/t28-/m1/s1	KZSYSYPLRUUKEU-MUUNZHRXSA-N	50242360	CHEMBL4069575	Plasma kallikrein		>10000								ChEMBL	10.1016/j.bmcl.2017.04.008	10.7270/Q29P3420	28460818			Wurtz, NR; Parkhurst, BL; DeLucca, I; Glunz, PW; Jiang, W; Zhang, X; Cheney, DL; Bozarth, JM; Rendina, AR; Wei, A; Harper, T; Luettgen, JM; Wu, Y; Wong, PC; Seiffert, DA; Wexler, RR; Priestley, ES	Bristol-Myers Squibb Research and Development	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50242360	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50242360&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	82J	5U6J	57842830	386402487		CHEMBL4069575					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50806663	CC(C)C[C@@H]1NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2cnc[nH]2)NC[C@H](C)NC(=O)[C@@H]2CSCc3cc(CSC[C@H](NC1=O)C(O)=O)cc(CSC[C@H](NC(C)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N2)c3	InChI=1S/C76H105N19O19S3/c1-40(2)22-53-67(105)94-60(75(113)114)38-117-35-47-24-45-23-46(25-47)34-116-37-59(71(109)84-41(3)30-82-52(28-48-31-80-39-83-48)66(104)87-51(18-19-62(77)99)65(103)89-55(29-63(100)101)69(107)88-53)93-64(102)50(12-8-20-81-76(78)79)86-68(106)54(26-44-14-16-49(98)17-15-44)90-73(111)61-13-9-21-95(61)74(112)56(27-43-10-6-5-7-11-43)91-70(108)57(32-96)92-72(110)58(36-115-33-45)85-42(4)97/h5-7,10-11,14-17,23-25,31,39-41,50-61,82,96,98H,8-9,12-13,18-22,26-30,32-38H2,1-4H3,(H2,77,99)(H,80,83)(H,84,109)(H,85,97)(H,86,106)(H,87,104)(H,88,107)(H,89,103)(H,90,111)(H,91,108)(H,92,110)(H,93,102)(H,94,105)(H,100,101)(H,113,114)(H4,78,79,81)/t41-,50-,51-,52-,53-,54-,55-,56-,57-,58-,59-,60-,61-/m0/s1	OXQUBXCLKKQRCE-GEIPQBTESA-N	50256263	CHEMBL4088185	Plasma kallikrein		 1.3								ChEMBL	10.1021/acs.jmedchem.7b01625	10.7270/Q2862JW6	29517911			Teufel, DP; Bennett, G; Harrison, H; van Rietschoten, K; Pavan, S; Stace, C; Le Floch, F; Van Bergen, T; Vermassen, E; Barbeaux, P; Hu, TT; Feyen, JHM; Vanhove, M	Bicycle Therapeutics Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50256263	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50256263&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137642984	402360662							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50806664	CC(C)C[C@@H]1NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CSCc3cc(CSC[C@H](NC1=O)C(O)=O)cc(CSC[C@H](NC(C)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c4ccccc14)C(=O)N1CCC1C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCNC(N)=N)C(=O)N2)c3	InChI=1S/C75H106N20O19S3/c1-37(2)19-50-65(104)89-52(25-45-28-79-36-82-45)67(106)86-49(14-15-60(76)98)64(103)90-53(26-61(99)100)68(107)87-51(20-38(3)4)66(105)94-58(74(113)114)35-117-32-43-22-41-21-42(23-43)31-116-34-57(71(110)88-50)93-63(102)48(13-9-10-17-80-75(77)78)85-62(101)39(5)83-72(111)59-16-18-95(59)73(112)54(24-44-27-81-47-12-8-7-11-46(44)47)91-69(108)55(29-96)92-70(109)56(33-115-30-41)84-40(6)97/h7-8,11-12,21-23,27-28,36-39,48-59,81,96H,9-10,13-20,24-26,29-35H2,1-6H3,(H2,76,98)(H,79,82)(H,83,111)(H,84,97)(H,85,101)(H,86,106)(H,87,107)(H,88,110)(H,89,104)(H,90,103)(H,91,108)(H,92,109)(H,93,102)(H,94,105)(H,99,100)(H,113,114)(H4,77,78,80)/t39-,48-,49-,50-,51-,52-,53-,54-,55-,56-,57-,58-,59?/m0/s1	BZKNNTULLXYXIY-PMRUMLPOSA-N	50256264	CHEMBL4099333	Plasma kallikrein		 0.140000								ChEMBL	10.1021/acs.jmedchem.7b01625	10.7270/Q2862JW6	29517911			Teufel, DP; Bennett, G; Harrison, H; van Rietschoten, K; Pavan, S; Stace, C; Le Floch, F; Van Bergen, T; Vermassen, E; Barbeaux, P; Hu, TT; Feyen, JHM; Vanhove, M	Bicycle Therapeutics Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50256264	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50256264&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137661862	402360663							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50806667	CC(C)C[C@@H]1NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CSCc3cc(CSC[C@H](NC1=O)C(O)=O)cc(CSC[C@H](NC(C)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c4ccccc14)C(=O)N1CCC1C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N2)c3	InChI=1S/C74H104N20O19S3/c1-36(2)18-49-64(103)88-51(24-44-27-78-35-81-44)66(105)85-48(13-14-59(75)97)63(102)89-52(25-60(98)99)67(106)86-50(19-37(3)4)65(104)93-57(73(112)113)34-116-31-42-21-40-20-41(22-42)30-115-33-56(70(109)87-49)92-62(101)47(12-9-16-79-74(76)77)84-61(100)38(5)82-71(110)58-15-17-94(58)72(111)53(23-43-26-80-46-11-8-7-10-45(43)46)90-68(107)54(28-95)91-69(108)55(32-114-29-40)83-39(6)96/h7-8,10-11,20-22,26-27,35-38,47-58,80,95H,9,12-19,23-25,28-34H2,1-6H3,(H2,75,97)(H,78,81)(H,82,110)(H,83,96)(H,84,100)(H,85,105)(H,86,106)(H,87,109)(H,88,103)(H,89,102)(H,90,107)(H,91,108)(H,92,101)(H,93,104)(H,98,99)(H,112,113)(H4,76,77,79)/t38-,47-,48-,49-,50-,51-,52-,53-,54-,55-,56-,57-,58?/m0/s1	DIBSXNVNMXRIJU-RVSJRZBLSA-N	50256265	CHEMBL4089486	Plasma kallikrein		 0.060000								ChEMBL	10.1021/acs.jmedchem.7b01625	10.7270/Q2862JW6	29517911			Teufel, DP; Bennett, G; Harrison, H; van Rietschoten, K; Pavan, S; Stace, C; Le Floch, F; Van Bergen, T; Vermassen, E; Barbeaux, P; Hu, TT; Feyen, JHM; Vanhove, M	Bicycle Therapeutics Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50256265	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50256265&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137643031	402360664							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50806722	CC(C)C[C@@H]1NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2cnc[nH]2)NC[C@H](C)NC(=O)[C@H]2CSCc3cc(CSC[C@H](NC1=O)C(O)=O)cc(CSC[C@H](NC(C)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCNC(N)=N)C(=O)N2)c3	InChI=1S/C76H105N19O19S3/c1-40(2)22-53-67(105)94-60(75(113)114)38-117-35-47-24-45-23-46(25-47)34-116-37-59(71(109)84-41(3)30-82-52(28-48-31-80-39-83-48)66(104)87-51(17-18-62(77)99)65(103)89-55(29-63(100)101)69(107)88-53)93-64(102)50(12-8-9-20-81-76(78)79)86-68(106)54(26-44-13-15-49(98)16-14-44)90-73(111)61-19-21-95(61)74(112)56(27-43-10-6-5-7-11-43)91-70(108)57(32-96)92-72(110)58(36-115-33-45)85-42(4)97/h5-7,10-11,13-16,23-25,31,39-41,50-61,82,96,98H,8-9,12,17-22,26-30,32-38H2,1-4H3,(H2,77,99)(H,80,83)(H,84,109)(H,85,97)(H,86,106)(H,87,104)(H,88,107)(H,89,103)(H,90,111)(H,91,108)(H,92,110)(H,93,102)(H,94,105)(H,100,101)(H,113,114)(H4,78,79,81)/t41-,50-,51-,52-,53-,54-,55-,56-,57-,58-,59+,60-,61?/m0/s1	NWSILYZBKZBZOH-SOPRAFLKSA-N	50256260	CHEMBL4094403	Plasma kallikrein		 0.360000								ChEMBL	10.1021/acs.jmedchem.7b01625	10.7270/Q2862JW6	29517911			Teufel, DP; Bennett, G; Harrison, H; van Rietschoten, K; Pavan, S; Stace, C; Le Floch, F; Van Bergen, T; Vermassen, E; Barbeaux, P; Hu, TT; Feyen, JHM; Vanhove, M	Bicycle Therapeutics Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50256260	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50256260&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137654508	402360659							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50806723	CC(C)C[C@@H]1NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CSCc3cc(CSC[C@H](NC1=O)C(O)=O)cc(CSC[C@H](NC(C)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N2)c3	InChI=1S/C79H109N19O20S3/c1-41(2)23-53-68(107)91-56(30-49-32-83-40-85-49)71(110)88-52(19-20-64(80)102)67(106)92-57(31-65(103)104)72(111)89-54(24-42(3)4)69(108)97-62(78(117)118)39-121-36-48-26-46-25-47(27-48)35-120-38-61(75(114)90-53)96-66(105)51(13-9-21-84-79(81)82)87-70(109)55(28-45-15-17-50(101)18-16-45)93-76(115)63-14-10-22-98(63)77(116)58(29-44-11-7-6-8-12-44)94-73(112)59(33-99)95-74(113)60(37-119-34-46)86-43(5)100/h6-8,11-12,15-18,25-27,32,40-42,51-63,99,101H,9-10,13-14,19-24,28-31,33-39H2,1-5H3,(H2,80,102)(H,83,85)(H,86,100)(H,87,109)(H,88,110)(H,89,111)(H,90,114)(H,91,107)(H,92,106)(H,93,115)(H,94,112)(H,95,113)(H,96,105)(H,97,108)(H,103,104)(H,117,118)(H4,81,82,84)/t51-,52-,53-,54-,55-,56-,57-,58-,59-,60-,61-,62-,63-/m0/s1	BCUWGYPJFIUZCG-DPZPEPSFSA-N	50256276	CHEMBL4079260	Plasma kallikrein		 0.390000								ChEMBL	10.1021/acs.jmedchem.7b01625	10.7270/Q2862JW6	29517911			Teufel, DP; Bennett, G; Harrison, H; van Rietschoten, K; Pavan, S; Stace, C; Le Floch, F; Van Bergen, T; Vermassen, E; Barbeaux, P; Hu, TT; Feyen, JHM; Vanhove, M	Bicycle Therapeutics Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50256276	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50256276&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137651057	104107834							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50806724	CC(C)C[C@@H]1NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CSCc3cc(CSC[C@H](NC1=O)C(O)=O)cc(CSC[C@H](NC(C)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c4ccccc14)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N2)c3	InChI=1S/C75H106N20O19S3/c1-37(2)19-50-65(104)89-52(25-45-28-79-36-82-45)67(106)86-49(15-16-60(76)98)64(103)90-53(26-61(99)100)68(107)87-51(20-38(3)4)66(105)94-58(74(113)114)35-117-32-43-22-41-21-42(23-43)31-116-34-57(71(110)88-50)93-63(102)48(13-9-17-80-75(77)78)85-62(101)39(5)83-72(111)59-14-10-18-95(59)73(112)54(24-44-27-81-47-12-8-7-11-46(44)47)91-69(108)55(29-96)92-70(109)56(33-115-30-41)84-40(6)97/h7-8,11-12,21-23,27-28,36-39,48-59,81,96H,9-10,13-20,24-26,29-35H2,1-6H3,(H2,76,98)(H,79,82)(H,83,111)(H,84,97)(H,85,101)(H,86,106)(H,87,107)(H,88,110)(H,89,104)(H,90,103)(H,91,108)(H,92,109)(H,93,102)(H,94,105)(H,99,100)(H,113,114)(H4,77,78,80)/t39-,48-,49-,50-,51-,52-,53-,54-,55-,56-,57-,58-,59-/m0/s1	WFQVKZPGCMLABB-SQNZOHODSA-N	50256277	CHEMBL4093698	Plasma kallikrein		 0.150000								ChEMBL	10.1021/acs.jmedchem.7b01625	10.7270/Q2862JW6	29517911			Teufel, DP; Bennett, G; Harrison, H; van Rietschoten, K; Pavan, S; Stace, C; Le Floch, F; Van Bergen, T; Vermassen, E; Barbeaux, P; Hu, TT; Feyen, JHM; Vanhove, M	Bicycle Therapeutics Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50256277	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50256277&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137655401	104107835							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50806727	CC(C)C[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSCc3cc(CSC[C@@H](NC1=O)C(=O)N[C@@H](C)C(=O)N(C)CC(=O)N(C)CC(=O)N(C)CC(=O)N[C@H](CCCNC(N)=N)C(=O)N[C@H](CCCNC(N)=N)C(O)=O)cc(CSC[C@H](NC(C)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c4ccccc14)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c4ccccc14)C(=O)N2)c3	InChI=1S/C117H160N32O28S3/c1-59(2)37-78-100(161)141-86(105(166)129-60(3)111(172)146(9)52-95(156)145(8)51-94(155)144(7)50-93(154)132-76(27-16-32-124-116(120)121)98(159)133-77(115(176)177)28-17-33-125-117(122)123)57-179-54-65-38-64-39-66(40-65)55-180-58-87(114(175)149-36-20-31-90(149)109(170)137-79(41-67-47-126-73-24-13-10-21-70(67)73)101(162)135-83(46-96(157)158)99(160)130-61(4)112(173)147-34-18-29-88(147)107(168)136-78)142-103(164)80(42-68-48-127-74-25-14-11-22-71(68)74)138-108(169)89-30-19-35-148(89)113(174)84(45-92(119)153)140-102(163)81(43-69-49-128-75-26-15-12-23-72(69)75)139-110(171)97(62(5)150)143-104(165)82(44-91(118)152)134-106(167)85(56-178-53-64)131-63(6)151/h10-15,21-26,38-40,47-49,59-62,76-90,97,126-128,150H,16-20,27-37,41-46,50-58H2,1-9H3,(H2,118,152)(H2,119,153)(H,129,166)(H,130,160)(H,131,151)(H,132,154)(H,133,159)(H,134,167)(H,135,162)(H,136,168)(H,137,170)(H,138,169)(H,139,171)(H,140,163)(H,141,161)(H,142,164)(H,143,165)(H,157,158)(H,176,177)(H4,120,121,124)(H4,122,123,125)/t60-,61-,62+,76+,77+,78-,79-,80-,81-,82-,83-,84-,85-,86+,87-,88-,89-,90-,97-/m0/s1	OHOYFNPMBCNOTR-QFZQKJJLSA-N	50256261	CHEMBL4059991	Plasma kallikrein		 3.0								ChEMBL	10.1021/acs.jmedchem.7b01625	10.7270/Q2862JW6	29517911			Teufel, DP; Bennett, G; Harrison, H; van Rietschoten, K; Pavan, S; Stace, C; Le Floch, F; Van Bergen, T; Vermassen, E; Barbeaux, P; Hu, TT; Feyen, JHM; Vanhove, M	Bicycle Therapeutics Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50256261	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50256261&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137637214	402360660							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50806729	CC(C)C[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSCc3cc(CSC[C@H](NC1=O)C(=O)N[C@@H](C)C(O)=O)cc(CSC[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c4ccccc14)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c4ccccc14)C(=O)N2)c3	InChI=1S/C97H124N22O23S3/c1-47(2)28-64-83(127)114-71(88(132)105-50(5)97(141)142)44-143-41-52-29-53-31-54(30-52)43-145-46-73(96(140)119-27-15-24-76(119)92(136)109-65(32-55-38-101-61-19-10-7-16-58(55)61)84(128)107-69(37-79(123)124)82(126)104-49(4)94(138)117-25-13-22-74(117)90(134)108-64)115-86(130)66(33-56-39-102-62-20-11-8-17-59(56)62)110-91(135)75-23-14-26-118(75)95(139)70(36-78(100)122)112-85(129)67(34-57-40-103-63-21-12-9-18-60(57)63)111-93(137)80(51(6)120)116-87(131)68(35-77(99)121)106-89(133)72(45-144-42-53)113-81(125)48(3)98/h7-12,16-21,29-31,38-40,47-51,64-76,80,101-103,120H,13-15,22-28,32-37,41-46,98H2,1-6H3,(H2,99,121)(H2,100,122)(H,104,126)(H,105,132)(H,106,133)(H,107,128)(H,108,134)(H,109,136)(H,110,135)(H,111,137)(H,112,129)(H,113,125)(H,114,127)(H,115,130)(H,116,131)(H,123,124)(H,141,142)/t48-,49-,50-,51+,64-,65-,66-,67-,68-,69-,70-,71-,72-,73-,74-,75-,76-,80-/m0/s1	SXVQAILPCKZLEI-OFFIONHRSA-N	50256284	CHEMBL4075544	Plasma kallikrein		 2.3								ChEMBL	10.1021/acs.jmedchem.7b01625	10.7270/Q2862JW6	29517911			Teufel, DP; Bennett, G; Harrison, H; van Rietschoten, K; Pavan, S; Stace, C; Le Floch, F; Van Bergen, T; Vermassen, E; Barbeaux, P; Hu, TT; Feyen, JHM; Vanhove, M	Bicycle Therapeutics Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50256284	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50256284&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137649699	402360666					C03803		1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50806791	CC(C)C[C@@H]1NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CSCc3cc(CSC[C@H](NC1=O)C(O)=O)cc(CSC[C@H](NC(C)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCNC(N)=N)C(=O)N2)c3	InChI=1S/C79H109N19O20S3/c1-41(2)23-53-68(107)91-56(30-49-32-83-40-85-49)71(110)88-52(18-19-64(80)102)67(106)92-57(31-65(103)104)72(111)89-54(24-42(3)4)69(108)97-62(78(117)118)39-121-36-48-26-46-25-47(27-48)35-120-38-61(75(114)90-53)96-66(105)51(13-9-10-21-84-79(81)82)87-70(109)55(28-45-14-16-50(101)17-15-45)93-76(115)63-20-22-98(63)77(116)58(29-44-11-7-6-8-12-44)94-73(112)59(33-99)95-74(113)60(37-119-34-46)86-43(5)100/h6-8,11-12,14-17,25-27,32,40-42,51-63,99,101H,9-10,13,18-24,28-31,33-39H2,1-5H3,(H2,80,102)(H,83,85)(H,86,100)(H,87,109)(H,88,110)(H,89,111)(H,90,114)(H,91,107)(H,92,106)(H,93,115)(H,94,112)(H,95,113)(H,96,105)(H,97,108)(H,103,104)(H,117,118)(H4,81,82,84)/t51-,52-,53-,54-,55-,56-,57-,58-,59-,60-,61-,62-,63?/m0/s1	BSBXOIWTBKCTIX-OOENKDQZSA-N	50256286	CHEMBL4076199	Plasma kallikrein		 0.210000								ChEMBL	10.1021/acs.jmedchem.7b01625	10.7270/Q2862JW6	29517911			Teufel, DP; Bennett, G; Harrison, H; van Rietschoten, K; Pavan, S; Stace, C; Le Floch, F; Van Bergen, T; Vermassen, E; Barbeaux, P; Hu, TT; Feyen, JHM; Vanhove, M	Bicycle Therapeutics Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50256286	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50256286&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137651852	402360668							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50806792	CC(C)C[C@@H]1NC(=O)[C@@H]2CSCc3cc(CSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc4cnc[nH]4)NC1=O)C(O)=O)cc(CSC[C@H](NC(C)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c4ccccc14)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCNC(N)=N)C(=O)N2)c3	InChI=1S/C76H108N20O19S3/c1-38(2)20-51-66(105)90-53(26-46-29-80-37-83-46)68(107)87-50(16-17-61(77)99)65(104)91-54(27-62(100)101)69(108)88-52(21-39(3)4)67(106)95-59(75(114)115)36-118-33-44-23-42-22-43(24-44)32-117-35-58(72(111)89-51)94-64(103)49(14-9-10-18-81-76(78)79)86-63(102)40(5)84-73(112)60-15-11-19-96(60)74(113)55(25-45-28-82-48-13-8-7-12-47(45)48)92-70(109)56(30-97)93-71(110)57(34-116-31-42)85-41(6)98/h7-8,12-13,22-24,28-29,37-40,49-60,82,97H,9-11,14-21,25-27,30-36H2,1-6H3,(H2,77,99)(H,80,83)(H,84,112)(H,85,98)(H,86,102)(H,87,107)(H,88,108)(H,89,111)(H,90,105)(H,91,104)(H,92,109)(H,93,110)(H,94,103)(H,95,106)(H,100,101)(H,114,115)(H4,78,79,81)/t40-,49-,50-,51-,52-,53-,54-,55-,56-,57-,58-,59-,60-/m0/s1	LUSQSQGAIDVUNP-DMIGJDTBSA-N	50256287	CHEMBL4105318	Plasma kallikrein		 2.1								ChEMBL	10.1021/acs.jmedchem.7b01625	10.7270/Q2862JW6	29517911			Teufel, DP; Bennett, G; Harrison, H; van Rietschoten, K; Pavan, S; Stace, C; Le Floch, F; Van Bergen, T; Vermassen, E; Barbeaux, P; Hu, TT; Feyen, JHM; Vanhove, M	Bicycle Therapeutics Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50256287	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50256287&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137657674	402360669							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50806799	CC[C@H](C)[C@@H]1NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](NC(=O)[C@@H]2CSCc3cc(CSC[C@H](NC1=O)C(=O)N[C@@H](C)C(=O)N(C)CC(=O)N(C)CC(=O)N(C)CC(=O)N[C@H](CCCNC(N)=N)C(=O)N[C@H](CCCNC(N)=N)C(O)=O)cc(CSC[C@H](NC(C)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCNC(N)=N)C(=O)N2)c3)C(C)C	InChI=1S/C114H161N29O28S3/c1-10-62(4)94-107(166)136-85(101(160)124-63(5)108(167)141(9)53-91(151)140(8)52-90(150)139(7)51-89(149)126-75(22-16-39-122-113(117)118)95(154)128-77(111(170)171)23-17-40-123-114(119)120)59-173-56-70-43-69-44-71(45-70)57-174-60-86(103(162)137-93(61(2)3)106(165)131-79(47-67-27-33-73(147)34-28-67)98(157)132-82(49-68-29-35-74(148)36-30-68)109(168)142-41-18-24-87(142)104(163)130-80(50-92(152)153)99(158)138-94)135-96(155)76(21-14-15-38-121-112(115)116)127-97(156)78(46-66-25-31-72(146)32-26-66)129-105(164)88-37-42-143(88)110(169)81(48-65-19-12-11-13-20-65)133-100(159)83(54-144)134-102(161)84(58-172-55-69)125-64(6)145/h11-13,19-20,25-36,43-45,61-63,75-88,93-94,144,146-148H,10,14-18,21-24,37-42,46-60H2,1-9H3,(H,124,160)(H,125,145)(H,126,149)(H,127,156)(H,128,154)(H,129,164)(H,130,163)(H,131,165)(H,132,157)(H,133,159)(H,134,161)(H,135,155)(H,136,166)(H,137,162)(H,138,158)(H,152,153)(H,170,171)(H4,115,116,121)(H4,117,118,122)(H4,119,120,123)/t62-,63-,75+,76-,77+,78-,79-,80-,81-,82-,83-,84-,85-,86-,87-,88?,93-,94-/m0/s1	CUGMKURPXUMGSV-PHOGTTDVSA-N	50256262	CHEMBL4070056	Plasma kallikrein		 0.250000								ChEMBL	10.1021/acs.jmedchem.7b01625	10.7270/Q2862JW6	29517911			Teufel, DP; Bennett, G; Harrison, H; van Rietschoten, K; Pavan, S; Stace, C; Le Floch, F; Van Bergen, T; Vermassen, E; Barbeaux, P; Hu, TT; Feyen, JHM; Vanhove, M	Bicycle Therapeutics Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50256262	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50256262&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137639385	402360661							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50806800	CC(C)C[C@@H]1NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CSCc3cc(CSC[C@H](NC1=O)C(=O)N[C@@H](C)C(O)=O)cc(CSC[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c4ccccc14)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N2)c3	InChI=1S/C79H114N22O20S3/c1-38(2)20-52-68(110)94-54(26-47-29-84-37-87-47)70(112)91-51(16-17-62(81)103)67(109)95-55(27-63(104)105)71(113)92-53(21-39(3)4)69(111)100-58(73(115)89-42(7)78(120)121)34-122-31-43-22-44-24-45(23-43)33-124-36-60(74(116)93-52)99-66(108)50(14-10-18-85-79(82)83)90-65(107)41(6)88-76(118)61-15-11-19-101(61)77(119)56(25-46-28-86-49-13-9-8-12-48(46)49)96-72(114)57(30-102)97-75(117)59(35-123-32-44)98-64(106)40(5)80/h8-9,12-13,22-24,28-29,37-42,50-61,86,102H,10-11,14-21,25-27,30-36,80H2,1-7H3,(H2,81,103)(H,84,87)(H,88,118)(H,89,115)(H,90,107)(H,91,112)(H,92,113)(H,93,116)(H,94,110)(H,95,109)(H,96,114)(H,97,117)(H,98,106)(H,99,108)(H,100,111)(H,104,105)(H,120,121)(H4,82,83,85)/t40-,41-,42-,50-,51-,52-,53-,54-,55-,56-,57-,58-,59-,60-,61-/m0/s1	UUIVCDRHADWAMH-VYYVOJDASA-N	50256283	CHEMBL4079711	Plasma kallikrein		 0.070000								ChEMBL	10.1021/acs.jmedchem.7b01625	10.7270/Q2862JW6	29517911			Teufel, DP; Bennett, G; Harrison, H; van Rietschoten, K; Pavan, S; Stace, C; Le Floch, F; Van Bergen, T; Vermassen, E; Barbeaux, P; Hu, TT; Feyen, JHM; Vanhove, M	Bicycle Therapeutics Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50256283	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50256283&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137651042	402360665					C03803		1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50806801	CC[C@H](C)[C@@H]1NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](NC(=O)[C@@H]2CSCc3cc(CSC[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc4ccccc4)C(=O)N4CCC[C@H]4C(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N2)cc(CSC[C@H](NC1=O)C(=O)N[C@@H](C)C(O)=O)c3)C(C)C	InChI=1S/C99H132N22O24S3/c1-7-52(4)81-95(141)117-72(89(135)106-54(6)98(144)145)48-146-45-59-35-60-37-61(36-59)47-148-50-74(91(137)118-80(51(2)3)94(140)112-66(39-57-24-28-62(122)29-25-57)85(131)113-71(41-58-26-30-63(123)31-27-58)97(143)121-34-16-23-76(121)93(139)111-69(44-79(126)127)88(134)119-81)116-83(129)64(21-14-32-105-99(103)104)107-84(130)65(38-55-17-10-8-11-18-55)110-92(138)75-22-15-33-120(75)96(142)70(40-56-19-12-9-13-20-56)114-87(133)68(43-78(102)125)108-86(132)67(42-77(101)124)109-90(136)73(49-147-46-60)115-82(128)53(5)100/h8-13,17-20,24-31,35-37,51-54,64-76,80-81,122-123H,7,14-16,21-23,32-34,38-50,100H2,1-6H3,(H2,101,124)(H2,102,125)(H,106,135)(H,107,130)(H,108,132)(H,109,136)(H,110,138)(H,111,139)(H,112,140)(H,113,131)(H,114,133)(H,115,128)(H,116,129)(H,117,141)(H,118,137)(H,119,134)(H,126,127)(H,144,145)(H4,103,104,105)/t52-,53-,54-,64-,65-,66-,67-,68-,69-,70-,71-,72-,73-,74-,75-,76-,80-,81-/m0/s1	MTQMXGQOCFMRJO-FWQFGMEYSA-N	50256288	CHEMBL4085408	Plasma kallikrein		 0.440000								ChEMBL	10.1021/acs.jmedchem.7b01625	10.7270/Q2862JW6	29517911			Teufel, DP; Bennett, G; Harrison, H; van Rietschoten, K; Pavan, S; Stace, C; Le Floch, F; Van Bergen, T; Vermassen, E; Barbeaux, P; Hu, TT; Feyen, JHM; Vanhove, M	Bicycle Therapeutics Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50256288	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50256288&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137646822	402360670					C03803		1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50784323	CN1CCN(C(=O)C1)c1cccc2[C@H](N(CCc12)C(=O)\C=C\c1c(F)c(Cl)ccc1-n1cnnn1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H28ClFN8O5/c1-39-15-16-40(28(44)17-39)25-4-2-3-22-21(25)13-14-41(30(22)31(45)36-20-7-5-19(6-8-20)32(46)47)27(43)12-9-23-26(42-18-35-37-38-42)11-10-24(33)29(23)34/h2-12,18,30H,13-17H2,1H3,(H,36,45)(H,46,47)/b12-9+/t30-/m0/s1	WYFCZWSWFGJODV-MIANJLSGSA-N	349975	(S,E)-4-(2-(3-(3-chloro-2-fluoro-6-(1H-tetrazol-1-yl)phenyl)acryloyl)-5-(4-methyl-2-oxopiperazin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US10208021, Example 184	Plasma kallikrein		 310								ChEMBL	10.1021/acs.jmedchem.7b01171	10.7270/Q2K64MHN	29077405			Pinto, DJP; Orwat, MJ; Smith, LM; Quan, ML; Lam, PYS; Rossi, KA; Apedo, A; Bozarth, JM; Wu, Y; Zheng, JJ; Xin, B; Toussaint, N; Stetsko, P; Gudmundsson, O; Maxwell, B; Crain, EJ; Wong, PC; Lou, Z; Harper, TW; Chacko, SA; Myers, JE; Sheriff, S; Zhang, H; Hou, X; Mathur, A; Seiffert, DA; Wexler, RR; Luettgen, JM; Ewing, WR	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349975	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349975&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71548883	386051723							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755702	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3ccc4[nH]cc(Cl)c4c3F)cc2c1)S(C)(=O)=O	InChI=1S/C27H22ClFN4O3S/c1-15-7-19-8-16(10-23(37(2,35)36)26(19)32-12-15)9-20-11-17(5-6-30-20)27(34)33-13-18-3-4-22-24(25(18)29)21(28)14-31-22/h3-8,10-12,14,31H,9,13H2,1-2H3,(H,33,34)	RIPJTLFXOCXAJL-UHFFFAOYSA-N	283369	N-((3-chloro-4-fluoro-1H-indol-5-yl)methyl)-2- ((3-methyl-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 21::US10266515, Example 21::US10308637, Example 21::US11021463, Example 21::US9611252, Example 21	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283369	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283369&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213012	378164698							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755721	Fc1c(CNC(=O)c2ccnc(Cc3ccc4ncc(Cl)cc4c3)c2)ccc2[nH]cc(Cl)c12	InChI=1S/C25H17Cl2FN4O/c26-18-9-17-7-14(1-3-21(17)30-12-18)8-19-10-15(5-6-29-19)25(33)32-11-16-2-4-22-23(24(16)28)20(27)13-31-22/h1-7,9-10,12-13,31H,8,11H2,(H,32,33)	GVFULHFYDFFIFD-UHFFFAOYSA-N	283388	N-((3-chloro-4-fluoro-1H-indol-5-yl)methyl)-2- ((3-chloroquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 40::US10266515, Example 40::US10308637, Example 40::US11021463, Example 40::US9611252, Example 40	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283388	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283388&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665357	378164717							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779279	CC1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(Cl)ccc2C(F)(F)F)c2cc(ccn2)-c2ccc(cc2NC1=O)C(O)=O	InChI=1S/C31H26ClF4N3O4/c1-16-3-2-4-25(24-13-17(9-11-37-24)20-6-5-19(30(42)43)14-23(20)38-29(16)41)39-12-10-18(15-26(39)40)27-21(31(34,35)36)7-8-22(32)28(27)33/h5-9,11,13-16,25H,2-4,10,12H2,1H3,(H,38,41)(H,42,43)/t16?,25-/m0/s1	MXNBAKPXIVRTNV-JIKORUOASA-N	241474	US9409908, 106::US9951071, Example 106	Plasma kallikrein		 890								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241474	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241474&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060487	341093789							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779280	CC1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(cc2NC1=O)C(N)=O	InChI=1S/C30H27ClF2N4O3/c1-16-3-2-4-25(37-12-10-18(15-26(37)38)27-22(32)8-7-21(31)28(27)33)24-13-17(9-11-35-24)20-6-5-19(29(34)39)14-23(20)36-30(16)40/h5-9,11,13-16,25H,2-4,10,12H2,1H3,(H2,34,39)(H,36,40)/t16?,25-/m0/s1	WDKWHOHDPBEVOR-JIKORUOASA-N	241475	US9409908, 107::US9951071, Example 107	Plasma kallikrein		 88.0								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241475	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241475&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060346	341093790							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779281	CC1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(Cl)ccc2C(F)(F)F)c2cc(ccn2)-c2ccc(cc2NC1=O)C(N)=O	InChI=1S/C31H27ClF4N4O3/c1-16-3-2-4-25(24-13-17(9-11-38-24)20-6-5-19(29(37)42)14-23(20)39-30(16)43)40-12-10-18(15-26(40)41)27-21(31(34,35)36)7-8-22(32)28(27)33/h5-9,11,13-16,25H,2-4,10,12H2,1H3,(H2,37,42)(H,39,43)/t16?,25-/m0/s1	HCTAXDGSXWTQSI-JIKORUOASA-N	241476	US9409908, 108::US9951071, Example 108	Plasma kallikrein		 29.0								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241476	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241476&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060522	341093791							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779282	CC1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(cc2NC1=O)C#N	InChI=1S/C30H25ClF2N4O2/c1-17-3-2-4-26(37-12-10-20(15-27(37)38)28-23(32)8-7-22(31)29(28)33)25-14-19(9-11-35-25)21-6-5-18(16-34)13-24(21)36-30(17)39/h5-9,11,13-15,17,26H,2-4,10,12H2,1H3,(H,36,39)/t17?,26-/m0/s1	BKSCSZWESYMLPD-KKFPZRRJSA-N	241391	US9409908, 109::US9409908, 23::US9951071, Example 109	Plasma kallikrein		 40.0								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241391	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241391&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060433	341093706							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779283	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3cc(Cl)ccc3C)c3cc-2ccn3)c1	InChI=1S/C32H33ClN4O4/c1-19-7-8-23(33)17-26(19)22-12-14-37(30(38)16-22)29-6-4-5-20(2)31(39)36-27-18-24(35-32(40)41-3)9-10-25(27)21-11-13-34-28(29)15-21/h7-11,13,15-18,20,29H,4-6,12,14H2,1-3H3,(H,35,40)(H,36,39)/t20-,29+/m1/s1	KMNWQMKSCBCXNX-OLILMLBXSA-N	241478	US9409908, 110::US9951071, Example 110	Plasma kallikrein		 3.91								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241478	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241478&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060378	341093792							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779284	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)ccc(C)c3F)c3cc-2ccn3)c1	InChI=1S/C32H32F2N4O4/c1-18-7-10-24(33)29(30(18)34)21-12-14-38(28(39)16-21)27-6-4-5-19(2)31(40)37-25-17-22(36-32(41)42-3)8-9-23(25)20-11-13-35-26(27)15-20/h7-11,13,15-17,19,27H,4-6,12,14H2,1-3H3,(H,36,41)(H,37,40)/t19-,27+/m1/s1	QNXVSHDBEGAVAR-WINIVTDRSA-N	241479	US9409908, 111::US9951071, Example 111	Plasma kallikrein		 3.25								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241479	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241479&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060596	341093793							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779285	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3cccc(C)c3F)c3cc-2ccn3)c1	InChI=1S/C32H33FN4O4/c1-19-6-4-8-25(30(19)33)22-13-15-37(29(38)17-22)28-9-5-7-20(2)31(39)36-26-18-23(35-32(40)41-3)10-11-24(26)21-12-14-34-27(28)16-21/h4,6,8,10-12,14,16-18,20,28H,5,7,9,13,15H2,1-3H3,(H,35,40)(H,36,39)/t20-,28+/m1/s1	VABZDZOISVDIRI-NGOKVRLYSA-N	241480	US9409908, 112::US9951071, Example 112	Plasma kallikrein		 6.44								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241480	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241480&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060385	341093794							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779286	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3cc(C)ccc3F)c3cc-2ccn3)c1	InChI=1S/C32H33FN4O4/c1-19-7-10-26(33)25(15-19)22-12-14-37(30(38)17-22)29-6-4-5-20(2)31(39)36-27-18-23(35-32(40)41-3)8-9-24(27)21-11-13-34-28(29)16-21/h7-11,13,15-18,20,29H,4-6,12,14H2,1-3H3,(H,35,40)(H,36,39)/t20-,29+/m1/s1	MXRDZXPUYIWTCH-OLILMLBXSA-N	241481	US9409908, 113::US9951071, Example 113	Plasma kallikrein		 15.6								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241481	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241481&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060464	341093795							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779287	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3cccc(C)c3C)c3cc-2ccn3)c1	InChI=1S/C33H36N4O4/c1-20-7-5-9-26(22(20)3)24-14-16-37(31(38)18-24)30-10-6-8-21(2)32(39)36-28-19-25(35-33(40)41-4)11-12-27(28)23-13-15-34-29(30)17-23/h5,7,9,11-13,15,17-19,21,30H,6,8,10,14,16H2,1-4H3,(H,35,40)(H,36,39)/t21-,30+/m1/s1	FMPJBVHOCLIHLL-DFXYEROKSA-N	241482	US9409908, 114::US9951071, Example 114	Plasma kallikrein		 143								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241482	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241482&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060564	341093796							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779288	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3cccc(OC)c3F)c3cc-2ccn3)c1	InChI=1S/C32H33FN4O5/c1-19-6-4-8-27(37-15-13-21(17-29(37)38)24-7-5-9-28(41-2)30(24)33)26-16-20(12-14-34-26)23-11-10-22(35-32(40)42-3)18-25(23)36-31(19)39/h5,7,9-12,14,16-19,27H,4,6,8,13,15H2,1-3H3,(H,35,40)(H,36,39)/t19-,27+/m1/s1	QGKFVNQGQIVBFN-WINIVTDRSA-N	241483	US9409908, 115::US9951071, Example 115	Plasma kallikrein		 362								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241483	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241483&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060477	341093797							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779289	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3ccccc3OC)c3cc-2ccn3)c1	InChI=1S/C32H34N4O5/c1-20-7-6-9-28(36-16-14-22(18-30(36)37)25-8-4-5-10-29(25)40-2)27-17-21(13-15-33-27)24-12-11-23(34-32(39)41-3)19-26(24)35-31(20)38/h4-5,8,10-13,15,17-20,28H,6-7,9,14,16H2,1-3H3,(H,34,39)(H,35,38)/t20-,28+/m1/s1	NRQMSCAXOVOPLH-NGOKVRLYSA-N	241484	US9409908, 116::US9951071, Example 116	Plasma kallikrein		 739								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241484	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241484&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060557	341093798							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779290	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3ccc(OC)cc3)c3cc-2ccn3)c1	InChI=1S/C32H34N4O5/c1-20-5-4-6-29(36-16-14-22(18-30(36)37)21-7-10-25(40-2)11-8-21)28-17-23(13-15-33-28)26-12-9-24(34-32(39)41-3)19-27(26)35-31(20)38/h7-13,15,17-20,29H,4-6,14,16H2,1-3H3,(H,34,39)(H,35,38)/t20-,29+/m1/s1	XNPLCUMDJXLFEW-OLILMLBXSA-N	241485	US9409908, 117::US9951071, Example 117	Plasma kallikrein		>13020								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241485	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241485&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060586	341093799							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779291	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3cccc(Cl)c3OC)c3cc-2ccn3)c1	InChI=1S/C32H33ClN4O5/c1-19-6-4-9-28(37-15-13-21(17-29(37)38)24-7-5-8-25(33)30(24)41-2)27-16-20(12-14-34-27)23-11-10-22(35-32(40)42-3)18-26(23)36-31(19)39/h5,7-8,10-12,14,16-19,28H,4,6,9,13,15H2,1-3H3,(H,35,40)(H,36,39)/t19-,28+/m1/s1	GJWIXJQSUJTPHG-GDJIYFAZSA-N	241486	US9409908, 118::US9951071, Example 118	Plasma kallikrein		 2027								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241486	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241486&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060525	341093800							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779292	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3cccc(OC)c3)c3cc-2ccn3)c1	InChI=1S/C32H34N4O5/c1-20-6-4-9-29(36-15-13-22(18-30(36)37)21-7-5-8-25(16-21)40-2)28-17-23(12-14-33-28)26-11-10-24(34-32(39)41-3)19-27(26)35-31(20)38/h5,7-8,10-12,14,16-20,29H,4,6,9,13,15H2,1-3H3,(H,34,39)(H,35,38)/t20-,29+/m1/s1	BURCJSBKPJCHNP-OLILMLBXSA-N	241487	US9409908, 119::US9951071, Example 119	Plasma kallikrein		 534								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241487	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241487&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060484	341093801							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779293	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3cccc(Cl)c3C)c3cc-2ccn3)c1	InChI=1S/C32H33ClN4O4/c1-19-6-4-9-29(37-15-13-22(17-30(37)38)24-7-5-8-26(33)20(24)2)28-16-21(12-14-34-28)25-11-10-23(35-32(40)41-3)18-27(25)36-31(19)39/h5,7-8,10-12,14,16-19,29H,4,6,9,13,15H2,1-3H3,(H,35,40)(H,36,39)/t19-,29+/m1/s1	WZNODWFKHIBNND-XBBWARJSSA-N	241488	US9409908, 120::US9951071, Example 120	Plasma kallikrein		 187								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241488	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241488&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060587	341093802							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779294	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3cc(Cl)ccc3OC)c3cc-2ccn3)c1	InChI=1S/C32H33ClN4O5/c1-19-5-4-6-28(37-14-12-21(16-30(37)38)25-17-22(33)7-10-29(25)41-2)27-15-20(11-13-34-27)24-9-8-23(35-32(40)42-3)18-26(24)36-31(19)39/h7-11,13,15-19,28H,4-6,12,14H2,1-3H3,(H,35,40)(H,36,39)/t19-,28+/m1/s1	DYPKGMLWFCORQB-GDJIYFAZSA-N	241489	US9409908, 121::US9951071, Example 121	Plasma kallikrein		 39.3								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241489	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241489&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060589	341093803							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779295	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3ccc(OC)c(Cl)c3)c3cc-2ccn3)c1	InChI=1S/C32H33ClN4O5/c1-19-5-4-6-28(37-14-12-21(17-30(37)38)20-7-10-29(41-2)25(33)15-20)27-16-22(11-13-34-27)24-9-8-23(35-32(40)42-3)18-26(24)36-31(19)39/h7-11,13,15-19,28H,4-6,12,14H2,1-3H3,(H,35,40)(H,36,39)/t19-,28+/m1/s1	QFXGUOYKINAAEP-GDJIYFAZSA-N	241490	US9409908, 122::US9951071, Example 122	Plasma kallikrein		 9318								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241490	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241490&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060374	341093804							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779296	COC(=O)Nc1ccc-2c(NC(=O)C(C)(O)CCC[C@H](N3CCC(=CC3=O)c3c(F)ccc(Cl)c3F)c3cc-2ccn3)c1	InChI=1S/C31H29ClF2N4O5/c1-31(42)11-3-4-25(38-13-10-18(15-26(38)39)27-22(33)8-7-21(32)28(27)34)24-14-17(9-12-35-24)20-6-5-19(36-30(41)43-2)16-23(20)37-29(31)40/h5-9,12,14-16,25,42H,3-4,10-11,13H2,1-2H3,(H,36,41)(H,37,40)/t25-,31?/m0/s1	WTXJOYYHXJPKFK-ZGAORZAOSA-N	241491	US9409908, 123::US9409908, 124::US9951071, Example 123	Plasma kallikrein		 26.1								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241491	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241491&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060543	341093805							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779297	COC(=O)Nc1ccc-2c(NC(=O)[C@@](C)(O)CCC[C@H](N3CCC(=CC3=O)c3c(F)ccc(Cl)c3F)c3cc-2ccn3)c1	InChI=1S/C31H29ClF2N4O5/c1-31(42)11-3-4-25(38-13-10-18(15-26(38)39)27-22(33)8-7-21(32)28(27)34)24-14-17(9-12-35-24)20-6-5-19(36-30(41)43-2)16-23(20)37-29(31)40/h5-9,12,14-16,25,42H,3-4,10-11,13H2,1-2H3,(H,36,41)(H,37,40)/t25-,31-/m0/s1	WTXJOYYHXJPKFK-FKAPRUDGSA-N	390106	US9951071, Example 124	Plasma kallikrein		 483								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=390106	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=390106&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			146011682	404958687							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779298	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(NC3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3O)cc2NC1=O	InChI=1S/C35H37ClF2N4O7/c1-17-3-2-4-26(42-12-10-19(14-28(42)44)29-23(37)8-7-22(36)30(29)38)25-13-18(9-11-39-25)21-6-5-20(15-24(21)41-34(17)48)40-35-33(47)32(46)31(45)27(16-43)49-35/h5-9,11,13-15,17,26-27,31-33,35,40,43,45-47H,2-4,10,12,16H2,1H3,(H,41,48)/t17-,26+,27-,31-,32+,33+,35?/m1/s1	IKJOOTAXPJZGLI-NZHWWQFHSA-N	241493	US9409908, 125::US9951071, Example 125	Plasma kallikrein		 11.6								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241493	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241493&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060594	341093806							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779299	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(NC3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)cc2NC1=O	InChI=1S/C35H37ClF2N4O7/c1-17-3-2-4-26(42-12-10-19(14-28(42)44)29-23(37)8-7-22(36)30(29)38)25-13-18(9-11-39-25)21-6-5-20(15-24(21)41-34(17)48)40-35-33(47)32(46)31(45)27(16-43)49-35/h5-9,11,13-15,17,26-27,31-33,35,40,43,45-47H,2-4,10,12,16H2,1H3,(H,41,48)/t17-,26+,27-,31-,32+,33-,35?/m1/s1	IKJOOTAXPJZGLI-KKHJKUPUSA-N	241494	US9409908, 126::US9951071, Example 126	Plasma kallikrein		 37.6								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241494	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241494&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060493	341093807							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779300	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(NC3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3N)cc2NC1=O	InChI=1S/C35H38ClF2N5O6/c1-17-3-2-4-26(43-12-10-19(14-28(43)45)29-23(37)8-7-22(36)30(29)38)25-13-18(9-11-40-25)21-6-5-20(15-24(21)42-34(17)48)41-35-31(39)33(47)32(46)27(16-44)49-35/h5-9,11,13-15,17,26-27,31-33,35,41,44,46-47H,2-4,10,12,16,39H2,1H3,(H,42,48)/t17-,26+,27-,31+,32-,33-,35?/m1/s1	SITZZDVPGOZBMP-IQBWVKGISA-N	241495	US9409908, 127::US9951071, Example 127	Plasma kallikrein		 9.97								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241495	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241495&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			122443679	341093808							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779301	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(NC3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)cc2NC1=O	InChI=1S/C35H35ClF2N4O8/c1-16-3-2-4-25(42-12-10-18(14-26(42)43)27-22(37)8-7-21(36)28(27)38)24-13-17(9-11-39-24)20-6-5-19(15-23(20)41-33(16)47)40-34-31(46)29(44)30(45)32(50-34)35(48)49/h5-9,11,13-16,25,29-32,34,40,44-46H,2-4,10,12H2,1H3,(H,41,47)(H,48,49)/t16-,25+,29+,30+,31-,32+,34?/m1/s1	VWHKOZYYJGJUSB-QUIQRVKYSA-N	241496	US9409908, 128::US9951071, Example 128	Plasma kallikrein		 25.5								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241496	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241496&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060406	341093809							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779302	CO[C@H]1[C@H](O)[C@@H](CO)OC(Nc2ccc-3c(NC(=O)[C@H](C)CCC[C@H](N4CCC(=CC4=O)c4c(F)ccc(Cl)c4F)c4cc-3ccn4)c2)[C@@H]1O	InChI=1S/C36H39ClF2N4O7/c1-18-4-3-5-27(43-13-11-20(15-29(43)45)30-24(38)9-8-23(37)31(30)39)26-14-19(10-12-40-26)22-7-6-21(16-25(22)42-35(18)48)41-36-33(47)34(49-2)32(46)28(17-44)50-36/h6-10,12,14-16,18,27-28,32-34,36,41,44,46-47H,3-5,11,13,17H2,1-2H3,(H,42,48)/t18-,27+,28-,32-,33-,34+,36?/m1/s1	QRZWBLRZWNFZEW-RXKREALZSA-N	241497	US9409908, 129::US9951071, Example 129	Plasma kallikrein		 21.7								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241497	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241497&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060402	341093810							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779303	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(NC3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3NC(C)=O)cc2NC1=O	InChI=1S/C37H40ClF2N5O7/c1-18-4-3-5-28(45-13-11-21(15-30(45)48)31-25(39)9-8-24(38)32(31)40)27-14-20(10-12-41-27)23-7-6-22(16-26(23)44-36(18)51)43-37-33(42-19(2)47)35(50)34(49)29(17-46)52-37/h6-10,12,14-16,18,28-29,33-35,37,43,46,49-50H,3-5,11,13,17H2,1-2H3,(H,42,47)(H,44,51)/t18-,28+,29-,33+,34-,35-,37?/m1/s1	KOIOMLLRGBAMQW-ADUISHHQSA-N	241498	US9409908, 130::US9951071, Example 130	Plasma kallikrein		 26.5								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241498	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241498&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			122443678	341093811							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779304	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(NC3O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]3O)cc2NC1=O	InChI=1S/C35H37ClF2N4O7/c1-17-3-2-4-26(42-12-10-19(14-28(42)44)29-23(37)8-7-22(36)30(29)38)25-13-18(9-11-39-25)21-6-5-20(15-24(21)41-34(17)48)40-35-33(47)32(46)31(45)27(16-43)49-35/h5-9,11,13-15,17,26-27,31-33,35,40,43,45-47H,2-4,10,12,16H2,1H3,(H,41,48)/t17-,26+,27+,31+,32-,33+,35?/m1/s1	IKJOOTAXPJZGLI-ZXGJDRJESA-N	241499	US9409908, 131::US9951071, Example 131	Plasma kallikrein		 20.8								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241499	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241499&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060376	341093812							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779305	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(NC3O[C@H](CO)[C@@H](O)[C@@H](O)[C@H]3NC(=O)OC(C)(C)C)cc2NC1=O	InChI=1S/C40H46ClF2N5O8/c1-20-6-5-7-29(48-15-13-22(17-31(48)50)32-26(42)11-10-25(41)33(32)43)28-16-21(12-14-44-28)24-9-8-23(18-27(24)46-37(20)53)45-38-34(47-39(54)56-40(2,3)4)36(52)35(51)30(19-49)55-38/h8-12,14,16-18,20,29-30,34-36,38,45,49,51-52H,5-7,13,15,19H2,1-4H3,(H,46,53)(H,47,54)/t20-,29+,30-,34-,35-,36+,38?/m1/s1	CUMIMQRZHBVFHF-FODBMTDKSA-N	241500	US9409908, 132::US9951071, Example 132	Plasma kallikrein		 17.3								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241500	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241500&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			122443681	341093813							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779306	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(NC3O[C@H](CO)[C@@H](O[C@H]4O[C@H](CO)[C@@H](O[C@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O)cc2NC1=O	InChI=1S/C47H57ClF2N4O17/c1-19-3-2-4-28(54-12-10-21(14-32(54)58)33-25(49)8-7-24(48)34(33)50)27-13-20(9-11-51-27)23-6-5-22(15-26(23)53-44(19)66)52-45-39(63)37(61)42(30(17-56)67-45)70-47-41(65)38(62)43(31(18-57)69-47)71-46-40(64)36(60)35(59)29(16-55)68-46/h5-9,11,13-15,19,28-31,35-43,45-47,52,55-57,59-65H,2-4,10,12,16-18H2,1H3,(H,53,66)/t19-,28+,29-,30-,31-,35-,36+,37-,38-,39-,40-,41-,42-,43-,45?,46-,47-/m1/s1	LENBBWGIXLGPPR-DAKYFYASSA-N	241501	US9409908, 133::US9951071, Example 133	Plasma kallikrein		 12.6								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241501	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241501&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			122466887	341093814					C01140		1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779307	COC(=O)[C@H]1OC(Nc2ccc-3c(NC(=O)[C@H](C)CCC[C@H](N4CCC(=CC4=O)c4c(F)ccc(Cl)c4F)c4cc-3ccn4)c2)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O	InChI=1S/C42H43ClF2N4O11/c1-20-7-6-8-32(49-16-14-25(18-33(49)53)34-29(44)12-11-28(43)35(34)45)31-17-24(13-15-46-31)27-10-9-26(19-30(27)48-40(20)54)47-41-38(59-23(4)52)36(57-21(2)50)37(58-22(3)51)39(60-41)42(55)56-5/h9-13,15,17-20,32,36-39,41,47H,6-8,14,16H2,1-5H3,(H,48,54)/t20-,32+,36+,37+,38-,39+,41?/m1/s1	NGYYEMLUUNCVGC-LDGUVKFUSA-N	241502	US9409908, 134::US9951071, Example 134	Plasma kallikrein		 192								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241502	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241502&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			122466885	341093815							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779308	COC(=O)Nc1ccc2-c3nc([nH]c3Cl)[C@H](CCC[C@@H](C)C(=O)Nc2c1)N1CCC(=CC1=O)c1c(F)ccc(Cl)c1F			241503	US9409908, 135::US9951071, Example 135	Plasma kallikrein		 0.560								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241503	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241503&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060560	341093816							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779309	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)C(=O)CC[C@H](N3CCC(=CC3=O)c3c(F)ccc(Cl)c3F)c3cc-2ccn3)c1	InChI=1S/C31H27ClF2N4O5/c1-16-26(39)8-7-25(38-12-10-18(14-27(38)40)28-22(33)6-5-21(32)29(28)34)24-13-17(9-11-35-24)20-4-3-19(36-31(42)43-2)15-23(20)37-30(16)41/h3-6,9,11,13-16,25H,7-8,10,12H2,1-2H3,(H,36,42)(H,37,41)/t16-,25+/m1/s1	YLFZHPYQZPGMGB-CPJLOUKISA-N	241504	US9409908, 136::US9951071, Example 136	Plasma kallikrein		 118								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241504	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241504&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060599	341093817							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779310	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2cc(Br)ccc2NC1=O	InChI=1S/C29H25BrClF2N3O2/c1-16-3-2-4-25(36-12-10-18(14-26(36)37)27-22(32)7-6-21(31)28(27)33)24-13-17(9-11-34-24)20-15-19(30)5-8-23(20)35-29(16)38/h5-9,11,13-16,25H,2-4,10,12H2,1H3,(H,35,38)/t16-,25+/m1/s1	AEJIUIRHFAEGHI-CPJLOUKISA-N	241505	US9409908, 137::US9951071, Example 137	Plasma kallikrein		 91.3								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241505	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241505&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060447	341093818							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779311	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2cc(ccc2NC1=O)C#N	InChI=1S/C30H25ClF2N4O2/c1-17-3-2-4-26(37-12-10-20(15-27(37)38)28-23(32)7-6-22(31)29(28)33)25-14-19(9-11-35-25)21-13-18(16-34)5-8-24(21)36-30(17)39/h5-9,11,13-15,17,26H,2-4,10,12H2,1H3,(H,36,39)/t17-,26+/m1/s1	OQVHPCHZBPUBCJ-QUGAMOGWSA-N	241506	US9409908, 138::US9951071, Example 138	Plasma kallikrein		 31.7								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241506	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241506&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060503	341093819							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779312	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(C#N)c2F)c2cc(ccn2)-c2cc(ccc2NC1=O)C#N	InChI=1S/C31H25F2N5O2/c1-18-3-2-4-27(38-12-10-21(15-28(38)39)29-24(32)7-6-22(17-35)30(29)33)26-14-20(9-11-36-26)23-13-19(16-34)5-8-25(23)37-31(18)40/h5-9,11,13-15,18,27H,2-4,10,12H2,1H3,(H,37,40)/t18-,27+/m1/s1	MFZYQWVLTUKKTJ-CLYVBNDRSA-N	241507	US9409908, 139::US9951071, Example 139	Plasma kallikrein		 6046								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241507	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241507&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060504	341093820							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779313	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2cc(ccc2NC1=O)-c1nn[nH]n1			241508	US9409908, 140::US9951071, Example 140	Plasma kallikrein		 28.7								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241508	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241508&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060372	341093821							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779314	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2cc(C)ccc2NC1=O	InChI=1S/C30H28ClF2N3O2/c1-17-6-9-24-21(14-17)19-10-12-34-25(15-19)26(5-3-4-18(2)30(38)35-24)36-13-11-20(16-27(36)37)28-23(32)8-7-22(31)29(28)33/h6-10,12,14-16,18,26H,3-5,11,13H2,1-2H3,(H,35,38)/t18-,26+/m1/s1	BNZCCWRWIPSVFG-DWXRJYCRSA-N	241509	US9409908, 141::US9951071, Example 141	Plasma kallikrein		 123								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241509	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241509&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060593	341093822							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779315	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CC=C(CC3=O)c3c(F)ccc(Cl)c3F)c3cc-2ccn3)c1	InChI=1S/C31H29ClF2N4O4/c1-17-4-3-5-26(38-13-11-19(15-27(38)39)28-23(33)9-8-22(32)29(28)34)25-14-18(10-12-35-25)21-7-6-20(36-31(41)42-2)16-24(21)37-30(17)40/h6-12,14,16-17,26H,3-5,13,15H2,1-2H3,(H,36,41)(H,37,40)/t17-,26+/m1/s1	DGSNYQOOWLOGKI-QUGAMOGWSA-N	241510	US9409908, 142::US9951071, Example 142	Plasma kallikrein		 7.76								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241510	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241510&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060479	341093823							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779316	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2cc(F)c(N)cc2NC1=O	InChI=1S/C29H26ClF3N4O2/c1-15-3-2-4-25(37-10-8-17(12-26(37)38)27-20(31)6-5-19(30)28(27)33)24-11-16(7-9-35-24)18-13-21(32)22(34)14-23(18)36-29(15)39/h5-7,9,11-15,25H,2-4,8,10,34H2,1H3,(H,36,39)/t15-,25+/m1/s1	LIFWZDTWISKRBJ-BZQUYTCOSA-N	241511	US9409908, 143::US9951071, Example 143	Plasma kallikrein		 3.38								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241511	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241511&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060600	341093824							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779317	COC(=O)c1ccc2NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)ccc(Cl)c3F)c3cc(ccn3)-c2c1	InChI=1S/C31H28ClF2N3O4/c1-17-4-3-5-26(37-13-11-19(16-27(37)38)28-23(33)8-7-22(32)29(28)34)25-15-18(10-12-35-25)21-14-20(31(40)41-2)6-9-24(21)36-30(17)39/h6-10,12,14-17,26H,3-5,11,13H2,1-2H3,(H,36,39)/t17-,26+/m1/s1	DGDPVCXANRRSLR-QUGAMOGWSA-N	241512	US9409908, 144::US9951071, Example 144	Plasma kallikrein		 108								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241512	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241512&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060597	341093825							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779318	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2cc(F)ccc2NC1=O	InChI=1S/C29H25ClF3N3O2/c1-16-3-2-4-25(36-12-10-18(14-26(36)37)27-22(32)7-6-21(30)28(27)33)24-13-17(9-11-34-24)20-15-19(31)5-8-23(20)35-29(16)38/h5-9,11,13-16,25H,2-4,10,12H2,1H3,(H,35,38)/t16-,25+/m1/s1	RUOAINJRKCJLQF-CPJLOUKISA-N	241513	US9409908, 145::US9951071, Example 145	Plasma kallikrein		 28.0								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241513	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241513&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060395	341093826							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779319	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2cc(ccc2NC1=O)C(O)=O	InChI=1S/C30H26ClF2N3O4/c1-16-3-2-4-25(36-12-10-18(15-26(36)37)27-22(32)7-6-21(31)28(27)33)24-14-17(9-11-34-24)20-13-19(30(39)40)5-8-23(20)35-29(16)38/h5-9,11,13-16,25H,2-4,10,12H2,1H3,(H,35,38)(H,39,40)/t16-,25+/m1/s1	LWMFRBAXSOWUDH-CPJLOUKISA-N	241514	US9409908, 146::US9951071, Example 146	Plasma kallikrein		 56.5								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241514	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241514&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060416	341093827							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779320	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(Br)ccc(Cl)c2F)c2cc(ccn2)-c2cc(F)ccc2NC1=O	InChI=1S/C29H25BrClF2N3O2/c1-16-3-2-4-25(36-12-10-18(14-26(36)37)27-21(30)6-7-22(31)28(27)33)24-13-17(9-11-34-24)20-15-19(32)5-8-23(20)35-29(16)38/h5-9,11,13-16,25H,2-4,10,12H2,1H3,(H,35,38)/t16-,25+/m1/s1	OBSGJFCIYCQJEU-CPJLOUKISA-N	241515	US9409908, 147::US9951071, Example 147	Plasma kallikrein		 7.51								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241515	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241515&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060523	341093828							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779321	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2cc(CO)ccc2NC1=O	InChI=1S/C30H28ClF2N3O3/c1-17-3-2-4-26(36-12-10-20(15-27(36)38)28-23(32)7-6-22(31)29(28)33)25-14-19(9-11-34-25)21-13-18(16-37)5-8-24(21)35-30(17)39/h5-9,11,13-15,17,26,37H,2-4,10,12,16H2,1H3,(H,35,39)/t17-,26+/m1/s1	NNLOEPDADGZRFE-QUGAMOGWSA-N	241516	US9409908, 148::US9951071, Example 148	Plasma kallikrein		 118								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241516	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241516&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060496	341093829							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779322	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(CO)cc2NC1=O	InChI=1S/C30H28ClF2N3O3/c1-17-3-2-4-26(36-12-10-20(15-27(36)38)28-23(32)8-7-22(31)29(28)33)25-14-19(9-11-34-25)21-6-5-18(16-37)13-24(21)35-30(17)39/h5-9,11,13-15,17,26,37H,2-4,10,12,16H2,1H3,(H,35,39)/t17-,26+/m1/s1	NMONIMGTMZNNBY-QUGAMOGWSA-N	241517	US9409908, 149::US9951071, Example 149	Plasma kallikrein		 22.6								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241517	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241517&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060588	341093830							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779323	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(Cl)ccc2C#N)c2cc(ccn2)-c2cc(F)ccc2NC1=O	InChI=1S/C30H25ClF2N4O2/c1-17-3-2-4-26(25-13-18(9-11-35-25)22-15-21(32)6-8-24(22)36-30(17)39)37-12-10-19(14-27(37)38)28-20(16-34)5-7-23(31)29(28)33/h5-9,11,13-15,17,26H,2-4,10,12H2,1H3,(H,36,39)/t17-,26+/m1/s1	HWKYPMGUMIKDKT-QUGAMOGWSA-N	241518	US9409908, 150::US9951071, Example 150	Plasma kallikrein		 2.27								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241518	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241518&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060526	341093831							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779324	COC(=O)Nc1ccc2-c3nc([nH]c3C)[C@H](CCC[C@@H](C)C(=O)Nc2c1)N1CCC(=CC1=O)c1cccc(Cl)c1F			241519	US9409908, 151::US9951071, Example 151	Plasma kallikrein		 23.8								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241519	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241519&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060389	341093832							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779325	COC(=O)Nc1ccc2-c3ccnc(c3)[C@H](CCCCCNC(=O)c2c1)N1CCC(=CC1=O)c1c(F)ccc(Cl)c1F	InChI=1S/C31H29ClF2N4O4/c1-42-31(41)37-20-6-7-21-18-10-13-35-25(15-18)26(5-3-2-4-12-36-30(40)22(21)17-20)38-14-11-19(16-27(38)39)28-24(33)9-8-23(32)29(28)34/h6-10,13,15-17,26H,2-5,11-12,14H2,1H3,(H,36,40)(H,37,41)/t26-/m0/s1	HSFYNSBFBKRIIH-SANMLTNESA-N	241520	US9409908, 152::US9951071, Example 152	Plasma kallikrein		 24.3								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241520	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241520&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060469	341093833							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779326	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)C3CCCC(C)C3)c3cc-2ccn3)c1	InChI=1S/C32H40N4O4/c1-20-6-4-8-22(16-20)23-13-15-36(30(37)18-23)29-9-5-7-21(2)31(38)35-27-19-25(34-32(39)40-3)10-11-26(27)24-12-14-33-28(29)17-24/h10-12,14,17-22,29H,4-9,13,15-16H2,1-3H3,(H,34,39)(H,35,38)/t20?,21-,22?,29+/m1/s1	NTRPAMBLEXVPQJ-BELJIYFPSA-N	241521	BDBM241596::US9409908, 153::US9409908, 159::US9409908, 218::US9409908, 225::US9951071, Example 225	Plasma kallikrein		 21.2								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241521	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241521&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060429	341093834							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779327	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3ccnc(N)c3)c3cc-2ccn3)c1	InChI=1S/C30H32N6O4/c1-18-4-3-5-26(36-13-10-20(16-28(36)37)19-8-12-33-27(31)15-19)25-14-21(9-11-32-25)23-7-6-22(34-30(39)40-2)17-24(23)35-29(18)38/h6-9,11-12,14-18,26H,3-5,10,13H2,1-2H3,(H2,31,33)(H,34,39)(H,35,38)/t18-,26+/m1/s1	RMRRVQDJORWNCJ-DWXRJYCRSA-N	241522	US9409908, 154::US9951071, Example 154	Plasma kallikrein		 118								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241522	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241522&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060489	341093835							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779328	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)C3CCNCC3)c3cc-2ccn3)c1	InChI=1S/C30H37N5O4/c1-19-4-3-5-27(35-15-11-21(17-28(35)36)20-8-12-31-13-9-20)26-16-22(10-14-32-26)24-7-6-23(33-30(38)39-2)18-25(24)34-29(19)37/h6-7,10,14,16-20,27,31H,3-5,8-9,11-13,15H2,1-2H3,(H,33,38)(H,34,37)/t19-,27+/m1/s1	LEQIDBQAUYONLV-WINIVTDRSA-N	241523	US9409908, 155::US9951071, Example 155	Plasma kallikrein		 199								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241523	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241523&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060508	341093836							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779329	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3ccnc(Cl)c3)c3cc-2ccn3)c1	InChI=1S/C30H30ClN5O4/c1-18-4-3-5-26(36-13-10-20(16-28(36)37)19-8-12-33-27(31)15-19)25-14-21(9-11-32-25)23-7-6-22(34-30(39)40-2)17-24(23)35-29(18)38/h6-9,11-12,14-18,26H,3-5,10,13H2,1-2H3,(H,34,39)(H,35,38)/t18-,26+/m1/s1	RVFWLEJQHJVOBX-DWXRJYCRSA-N	241524	US9409908, 156::US9951071, Example 156	Plasma kallikrein		 3249								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241524	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241524&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060575	341093837							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779330	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3cccc(Cl)n3)c3cc-2ccn3)c1	InChI=1S/C30H30ClN5O4/c1-18-5-3-7-26(36-14-12-20(16-28(36)37)23-6-4-8-27(31)34-23)25-15-19(11-13-32-25)22-10-9-21(33-30(39)40-2)17-24(22)35-29(18)38/h4,6,8-11,13,15-18,26H,3,5,7,12,14H2,1-2H3,(H,33,39)(H,35,38)/t18-,26+/m1/s1	MXTYQFYCUOGQNN-DWXRJYCRSA-N	241525	US9409908, 157::US9951071, Example 157	Plasma kallikrein		 108								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241525	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241525&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060501	341093838							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779331	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)C3CCCCN3C)c3cc-2ccn3)c1	InChI=1S/C31H39N5O4/c1-20-7-6-9-28(36-16-13-22(18-29(36)37)27-8-4-5-15-35(27)2)26-17-21(12-14-32-26)24-11-10-23(33-31(39)40-3)19-25(24)34-30(20)38/h10-12,14,17-20,27-28H,4-9,13,15-16H2,1-3H3,(H,33,39)(H,34,38)/t20-,27?,28+/m1/s1	IJBHJOXFQYQUMY-VDHQWJSESA-N	241526	US9409908, 158::US9951071, Example 158	Plasma kallikrein		 10900								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241526	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241526&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060584	341093839							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779332	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)C3CCCC(C)C3)c3cc-2ccn3)c1	InChI=1S/C32H40N4O4/c1-20-6-4-8-22(16-20)23-13-15-36(30(37)18-23)29-9-5-7-21(2)31(38)35-27-19-25(34-32(39)40-3)10-11-26(27)24-12-14-33-28(29)17-24/h10-12,14,17-22,29H,4-9,13,15-16H2,1-3H3,(H,34,39)(H,35,38)/t20?,21-,22?,29+/m1/s1	NTRPAMBLEXVPQJ-BELJIYFPSA-N	241521	BDBM241596::US9409908, 153::US9409908, 159::US9409908, 218::US9409908, 225::US9951071, Example 225	Plasma kallikrein		 58.9								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241521	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241521&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060429	341093834							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779333	COC(=O)Nc1ccc2-c3nc([nH]c3C)[C@H](CCC[C@@H](C)C(=O)Nc2c1)N1CCC(=CC1=O)c1c(F)ccc(Cl)c1F			241528	US9409908, 160::US9951071, Example 160	Plasma kallikrein		 2.00								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241528	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241528&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060520	341093840							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779334	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)c(Cl)ccc3Br)c3cccc-2c3)c1	InChI=1S/C32H30BrClFN3O4/c1-18-5-3-8-27(38-14-13-21(16-28(38)39)29-24(33)11-12-25(34)30(29)35)20-7-4-6-19(15-20)23-10-9-22(36-32(41)42-2)17-26(23)37-31(18)40/h4,6-7,9-12,15-18,27H,3,5,8,13-14H2,1-2H3,(H,36,41)(H,37,40)/t18-,27+/m1/s1	YPAISRDCVKHFMI-CLYVBNDRSA-N	241529	US9409908, 161::US9951071, Example 161	Plasma kallikrein		 21.6								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241529	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241529&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060605	341093841							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779335	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cccc(c2)-c2ccccc2NC1=O	InChI=1S/C30H27ClF2N2O2/c1-18-6-4-11-26(20-8-5-7-19(16-20)22-9-2-3-10-25(22)34-30(18)37)35-15-14-21(17-27(35)36)28-24(32)13-12-23(31)29(28)33/h2-3,5,7-10,12-13,16-18,26H,4,6,11,14-15H2,1H3,(H,34,37)/t18-,26+/m1/s1	SXZFGGAOSJYHKQ-DWXRJYCRSA-N	241530	US9409908, 162::US9951071, Example 162	Plasma kallikrein		 125								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241530	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241530&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060601	341093842							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779336	COC(=O)c1ccc2NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)c(Cl)ccc3Br)c3cccc(c3)-c2c1	InChI=1S/C32H29BrClFN2O4/c1-18-5-3-8-27(37-14-13-21(17-28(37)38)29-24(33)10-11-25(34)30(29)35)20-7-4-6-19(15-20)23-16-22(32(40)41-2)9-12-26(23)36-31(18)39/h4,6-7,9-12,15-18,27H,3,5,8,13-14H2,1-2H3,(H,36,39)/t18-,27+/m1/s1	BSNSKODJGQKGRG-CLYVBNDRSA-N	241531	US9409908, 163::US9409908, 176::US9951071, Example 176	Plasma kallikrein		 224								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241531	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241531&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060611	341093843							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779337	COC(=O)c1ccc2NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)ccc(Cl)c3F)c3cccc(c3)-c2c1	InChI=1S/C32H29ClF2N2O4/c1-18-5-3-8-27(37-14-13-21(17-28(37)38)29-25(34)11-10-24(33)30(29)35)20-7-4-6-19(15-20)23-16-22(32(40)41-2)9-12-26(23)36-31(18)39/h4,6-7,9-12,15-18,27H,3,5,8,13-14H2,1-2H3,(H,36,39)/t18-,27+/m1/s1	PQMIPRJGMKRLRT-CLYVBNDRSA-N	241532	US9409908, 164::US9409908, 174::US9951071, Example 174	Plasma kallikrein		 442								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241532	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241532&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060592	341093844							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779338	COC(=O)c1ccc2NC(=O)[C@H](C)CCC[C@@H](N3CCC(=CC3=O)c3c(F)ccc(Cl)c3F)c3cccc(c3)-c2c1	InChI=1S/C32H29ClF2N2O4/c1-18-5-3-8-27(37-14-13-21(17-28(37)38)29-25(34)11-10-24(33)30(29)35)20-7-4-6-19(15-20)23-16-22(32(40)41-2)9-12-26(23)36-31(18)39/h4,6-7,9-12,15-18,27H,3,5,8,13-14H2,1-2H3,(H,36,39)/t18-,27-/m1/s1	PQMIPRJGMKRLRT-DNOBIOAJSA-N	241533	US9409908, 165::US9951071, Example 165	Plasma kallikrein		 9471								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241533	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241533&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060412	341093845							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779339	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cccc(c2)-c2cc(ccc2NC1=O)C(O)=O	InChI=1S/C31H27ClF2N2O4/c1-17-4-2-7-26(36-13-12-20(16-27(36)37)28-24(33)10-9-23(32)29(28)34)19-6-3-5-18(14-19)22-15-21(31(39)40)8-11-25(22)35-30(17)38/h3,5-6,8-11,14-17,26H,2,4,7,12-13H2,1H3,(H,35,38)(H,39,40)/t17-,26+/m1/s1	VNKIWRSSMQDOEY-QUGAMOGWSA-N	241534	US9409908, 166::US9951071, Example 166	Plasma kallikrein		 113								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241534	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241534&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060540	341093846							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779340	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(Cl)ccc2Br)c2cccc(c2)-c2cc(ccc2NC1=O)C(O)=O	InChI=1S/C31H27BrClFN2O4/c1-17-4-2-7-26(36-13-12-20(16-27(36)37)28-23(32)9-10-24(33)29(28)34)19-6-3-5-18(14-19)22-15-21(31(39)40)8-11-25(22)35-30(17)38/h3,5-6,8-11,14-17,26H,2,4,7,12-13H2,1H3,(H,35,38)(H,39,40)/t17-,26+/m1/s1	AMKLNLCMEAFCLA-QUGAMOGWSA-N	241535	US9409908, 167::US9951071, Example 167	Plasma kallikrein		 20.1								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241535	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241535&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060613	341093847							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779341	COC(=O)c1ccc2NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)c(ccc3C#N)C#N)c3cccc(c3)-c2c1	InChI=1S/C34H29FN4O4/c1-20-5-3-8-29(39-14-13-23(17-30(39)40)31-25(18-36)9-10-26(19-37)32(31)35)22-7-4-6-21(15-22)27-16-24(34(42)43-2)11-12-28(27)38-33(20)41/h4,6-7,9-12,15-17,20,29H,3,5,8,13-14H2,1-2H3,(H,38,41)/t20-,29+/m1/s1	UVLCKUPXQUONLR-OLILMLBXSA-N	241536	US9409908, 168::US9951071, Example 168	Plasma kallikrein		 1916								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241536	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241536&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060517	341093848							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779342	COC(=O)c1ccc2NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3cccc(Cl)c3F)c3cccc(c3)-c2c1	InChI=1S/C32H30ClFN2O4/c1-19-6-3-11-28(36-15-14-21(18-29(36)37)24-9-5-10-26(33)30(24)34)22-8-4-7-20(16-22)25-17-23(32(39)40-2)12-13-27(25)35-31(19)38/h4-5,7-10,12-13,16-19,28H,3,6,11,14-15H2,1-2H3,(H,35,38)/t19-,28+/m1/s1	WJFXOEOEEZYWCV-GDJIYFAZSA-N	241537	US9409908, 169::US9951071, Example 169	Plasma kallikrein		 768								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241537	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241537&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060486	341093849							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779343	COC(=O)c1ccc2NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)c(Cl)ccc3C#N)c3cccc(c3)-c2c1	InChI=1S/C33H29ClFN3O4/c1-19-5-3-8-28(38-14-13-22(17-29(38)39)30-24(18-36)9-11-26(34)31(30)35)21-7-4-6-20(15-21)25-16-23(33(41)42-2)10-12-27(25)37-32(19)40/h4,6-7,9-12,15-17,19,28H,3,5,8,13-14H2,1-2H3,(H,37,40)/t19-,28+/m1/s1	QENGYZQWMBJJRV-GDJIYFAZSA-N	241538	US9409908, 170::US9951071, Example 170	Plasma kallikrein		 7.73								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241538	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241538&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060590	341093850							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779344	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)c(Cl)ccc3C(C)=O)c3cccc-2c3)c1	InChI=1S/C34H33ClFN3O5/c1-19-6-4-9-29(39-15-14-23(17-30(39)41)31-25(20(2)40)12-13-27(35)32(31)36)22-8-5-7-21(16-22)26-11-10-24(37-34(43)44-3)18-28(26)38-33(19)42/h5,7-8,10-13,16-19,29H,4,6,9,14-15H2,1-3H3,(H,37,43)(H,38,42)/t19-,29+/m1/s1	XTUFVXUJJQAYGD-XBBWARJSSA-N	241539	US9409908, 171::US9951071, Example 171	Plasma kallikrein		 8.87								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241539	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241539&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060524	341093851							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779345	COC(=O)c1ccc2NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)ccc(Cl)c3F)c3cccc(c3)-c2c1	InChI=1S/C32H29ClF2N2O4/c1-18-5-3-8-27(37-14-13-21(17-28(37)38)29-25(34)11-10-24(33)30(29)35)20-7-4-6-19(15-20)23-16-22(32(40)41-2)9-12-26(23)36-31(18)39/h4,6-7,9-12,15-18,27H,3,5,8,13-14H2,1-2H3,(H,36,39)/t18-,27+/m1/s1	PQMIPRJGMKRLRT-CLYVBNDRSA-N	241532	US9409908, 164::US9409908, 174::US9951071, Example 174	Plasma kallikrein		 1398								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241532	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241532&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060592	341093844							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779346	COC(=O)c1ccc2NC(=O)[C@H](C)CCC[C@@H](N3CCC(=CC3=O)c3c(F)c(Cl)ccc3Br)c3cccc(c3)-c2c1	InChI=1S/C32H29BrClFN2O4/c1-18-5-3-8-27(37-14-13-21(17-28(37)38)29-24(33)10-11-25(34)30(29)35)20-7-4-6-19(15-20)23-16-22(32(40)41-2)9-12-26(23)36-31(18)39/h4,6-7,9-12,15-18,27H,3,5,8,13-14H2,1-2H3,(H,36,39)/t18-,27-/m1/s1	BSNSKODJGQKGRG-DNOBIOAJSA-N	241543	US9409908, 175::US9951071, Example 175	Plasma kallikrein		 3809								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241543	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241543&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060617	341093854							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779347	COC(=O)c1ccc2NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)c(Cl)ccc3Br)c3cccc(c3)-c2c1	InChI=1S/C32H29BrClFN2O4/c1-18-5-3-8-27(37-14-13-21(17-28(37)38)29-24(33)10-11-25(34)30(29)35)20-7-4-6-19(15-20)23-16-22(32(40)41-2)9-12-26(23)36-31(18)39/h4,6-7,9-12,15-18,27H,3,5,8,13-14H2,1-2H3,(H,36,39)/t18-,27+/m1/s1	BSNSKODJGQKGRG-CLYVBNDRSA-N	241531	US9409908, 163::US9409908, 176::US9951071, Example 176	Plasma kallikrein		 523								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241531	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241531&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060611	341093843							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779348	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CC(C)C(=CC3=O)c3c(F)ccc(Cl)c3F)c3cc-2ccn3)c1	InChI=1S/C32H31ClF2N4O4/c1-17-5-4-6-27(39-16-18(2)22(15-28(39)40)29-24(34)10-9-23(33)30(29)35)26-13-19(11-12-36-26)21-8-7-20(37-32(42)43-3)14-25(21)38-31(17)41/h7-15,17-18,27H,4-6,16H2,1-3H3,(H,37,42)(H,38,41)/t17-,18?,27+/m1/s1	NPKCSHLGQLVUNO-ILPYMAIGSA-N	241441	US9409908, 177::US9409908, 178::US9409908, 73::US9951071, Example 73	Plasma kallikrein		 4.02								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241441	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241441&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060513	341093756							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779349	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CC(C)C(=CC3=O)c3c(F)ccc(Cl)c3F)c3cc-2ccn3)c1	InChI=1S/C32H31ClF2N4O4/c1-17-5-4-6-27(39-16-18(2)22(15-28(39)40)29-24(34)10-9-23(33)30(29)35)26-13-19(11-12-36-26)21-8-7-20(37-32(42)43-3)14-25(21)38-31(17)41/h7-15,17-18,27H,4-6,16H2,1-3H3,(H,37,42)(H,38,41)/t17-,18?,27+/m1/s1	NPKCSHLGQLVUNO-ILPYMAIGSA-N	241441	US9409908, 177::US9409908, 178::US9409908, 73::US9951071, Example 73	Plasma kallikrein		 5.68								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241441	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241441&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060513	341093756							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779350	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(Cl)ccc2NC(=O)C(F)(F)F)c2cc(ccn2)-c2ccccc2NC1=O	InChI=1S/C31H27ClF4N4O3/c1-17-5-4-8-25(24-15-18(11-13-37-24)20-6-2-3-7-22(20)38-29(17)42)40-14-12-19(16-26(40)41)27-23(10-9-21(32)28(27)33)39-30(43)31(34,35)36/h2-3,6-7,9-11,13,15-17,25H,4-5,8,12,14H2,1H3,(H,38,42)(H,39,43)/t17-,25+/m1/s1	ORFSGGJRUOCUTD-NSYGIPOTSA-N	241547	US9409908, 179::US9951071, Example 179	Plasma kallikrein		 50.1								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241547	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241547&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060492	341093855							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779351	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)C(F)CC[C@H](N3CCC(=CC3=O)c3c(F)ccc(Cl)c3F)c3cc-2ccn3)c1	InChI=1S/C31H28ClF3N4O4/c1-16-22(33)7-8-26(39-12-10-18(14-27(39)40)28-23(34)6-5-21(32)29(28)35)25-13-17(9-11-36-25)20-4-3-19(37-31(42)43-2)15-24(20)38-30(16)41/h3-6,9,11,13-16,22,26H,7-8,10,12H2,1-2H3,(H,37,42)(H,38,41)/t16-,22?,26+/m1/s1	QMJWWNVVTLEZIW-ALZQUROESA-N	390162	Methyl N-[(10S,14S)-14-[4-(3-chloro-2,6-difluorophenyl)-6-oxo-1,2,3,6-tetrahydropyridin-1-yl]-11-fluoro-10-methyl-9-oxo-8,16-diazatricyclo[13.3.1.02,7]nonadeca-1(19),2::US9951071, Example 180	Plasma kallikrein		 2.42								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=390162	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=390162&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060607	404958743							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779352	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)c(Cl)ccc3C#C)c3cc-2ccn3)c1	InChI=1S/C33H30ClFN4O4/c1-4-20-8-11-25(34)31(35)30(20)22-13-15-39(29(40)17-22)28-7-5-6-19(2)32(41)38-26-18-23(37-33(42)43-3)9-10-24(26)21-12-14-36-27(28)16-21/h1,8-12,14,16-19,28H,5-7,13,15H2,2-3H3,(H,37,42)(H,38,41)/t19-,28+/m1/s1	QYWRPJPBRRCNJD-GDJIYFAZSA-N	241549	US9409908, 181::US9951071, Example 181	Plasma kallikrein		 3.29								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241549	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241549&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060531	341093857							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779353	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)c(Cl)ccc3-c3c[nH]nn3)c3cc-2ccn3)c1			241550	US9409908, 182::US9951071, Example 182	Plasma kallikrein		 14.3								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241550	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241550&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060498	341093858							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779354	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(Cl)ccc2NC(C)=O)c2cc(ccn2)-c2ccccc2NC1=O	InChI=1S/C31H30ClFN4O3/c1-18-6-5-9-27(26-16-20(12-14-34-26)22-7-3-4-8-24(22)36-31(18)40)37-15-13-21(17-28(37)39)29-25(35-19(2)38)11-10-23(32)30(29)33/h3-4,7-8,10-12,14,16-18,27H,5-6,9,13,15H2,1-2H3,(H,35,38)(H,36,40)/t18-,27+/m1/s1	WTYSEXAPGLRBCV-CLYVBNDRSA-N	241551	US9409908, 183::US9951071, Example 183	Plasma kallikrein		 297								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241551	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241551&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060536	341093859							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779355	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(Cl)ccc2-n2cnnn2)c2cc(ccn2)-c2cc(F)ccc2NC1=O	InChI=1S/C30H26ClF2N7O2/c1-17-3-2-4-25(24-13-18(9-11-34-24)21-15-20(32)5-7-23(21)36-30(17)42)39-12-10-19(14-27(39)41)28-26(40-16-35-37-38-40)8-6-22(31)29(28)33/h5-9,11,13-17,25H,2-4,10,12H2,1H3,(H,36,42)/t17-,25+/m1/s1	BBDIEHHRWQGMIS-NSYGIPOTSA-N	241552	US9409908, 184::US9951071, Example 184	Plasma kallikrein		 2.51								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241552	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241552&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060538	341093860							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779356	C[C@@H]1CCC[C@@H](c2cc(ccn2)-c2ccncc2NC1=O)n1ccc(cc1=O)-c1c(F)ccc(Cl)c1F	InChI=1S/C28H23ClF2N4O2/c1-16-3-2-4-24(22-13-17(7-11-33-22)19-8-10-32-15-23(19)34-28(16)37)35-12-9-18(14-25(35)36)26-21(30)6-5-20(29)27(26)31/h5-16,24H,2-4H2,1H3,(H,34,37)/t16-,24+/m1/s1	XWDREXKZCICPNC-GYCJOSAFSA-N	390167	(10R,14S)-14-[4-(3-chloro-2,6-difluorophenyl)-2-oxo-1,2-dihydropyridin-1-yl]-10-methyl-5,8,16-triazatricyclo[13.3.1.02,7]nonadeca-1(19),2::US9951071, Example 185	Plasma kallikrein		 47.4								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=390167	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=390167&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060401	404958747							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779357	COC(=O)c1ccc2NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)c(Cl)ccc3C(F)(F)F)c3cc(ccn3)-c2c1	InChI=1S/C32H28ClF4N3O4/c1-17-4-3-5-26(40-13-11-19(16-27(40)41)28-22(32(35,36)37)7-8-23(33)29(28)34)25-15-18(10-12-38-25)21-14-20(31(43)44-2)6-9-24(21)39-30(17)42/h6-10,12,14-17,26H,3-5,11,13H2,1-2H3,(H,39,42)/t17-,26+/m1/s1	KGBUFRIXAWSHKU-QUGAMOGWSA-N	241554	US9409908, 186::US9951071, Example 186	Plasma kallikrein		 60.5								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241554	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241554&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060544	341093861							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779358	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(Cl)ccc2C(F)(F)F)c2cc(ccn2)-c2cc(ccc2NC1=O)C(O)=O	InChI=1S/C31H26ClF4N3O4/c1-16-3-2-4-25(24-14-17(9-11-37-24)20-13-19(30(42)43)5-8-23(20)38-29(16)41)39-12-10-18(15-26(39)40)27-21(31(34,35)36)6-7-22(32)28(27)33/h5-9,11,13-16,25H,2-4,10,12H2,1H3,(H,38,41)(H,42,43)/t16-,25+/m1/s1	OUXKGHOTTHIOQL-CPJLOUKISA-N	241555	US9409908, 187::US9951071, Example 187	Plasma kallikrein		 17.4								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241555	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241555&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060491	341093862							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779359	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2cc(Cl)ccc2-n2ccnn2)c2cc(ccn2)-c2cc(F)ccc2NC1=O	InChI=1S/C31H28ClFN6O2/c1-19-3-2-4-29(27-15-20(9-11-34-27)24-18-23(33)6-7-26(24)36-31(19)41)38-13-10-21(16-30(38)40)25-17-22(32)5-8-28(25)39-14-12-35-37-39/h5-9,11-12,14-19,29H,2-4,10,13H2,1H3,(H,36,41)/t19-,29+/m1/s1	NUAGLWKIGCGSTL-XBBWARJSSA-N	241556	US9409908, 188::US9951071, Example 188	Plasma kallikrein		 23.2								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241556	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241556&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060622	341093863							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779360	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2cc(Cl)ccc2-n2ccnn2)c2cc(ccn2)-c2ccccc2NC1=O	InChI=1S/C31H29ClN6O2/c1-20-5-4-8-29(27-17-21(11-13-33-27)24-6-2-3-7-26(24)35-31(20)40)37-15-12-22(18-30(37)39)25-19-23(32)9-10-28(25)38-16-14-34-36-38/h2-3,6-7,9-11,13-14,16-20,29H,4-5,8,12,15H2,1H3,(H,35,40)/t20-,29+/m1/s1	IOMDGXNOZMTGIL-OLILMLBXSA-N	241557	US9409908, 189::US9951071, Example 189	Plasma kallikrein		 40.4								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241557	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241557&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060618	341093864							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779361	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)ccc(Br)c3F)c3cc-2ccn3)c1	InChI=1S/C31H29BrF2N4O4/c1-17-4-3-5-26(38-13-11-19(15-27(38)39)28-23(33)9-8-22(32)29(28)34)25-14-18(10-12-35-25)21-7-6-20(36-31(41)42-2)16-24(21)37-30(17)40/h6-10,12,14-17,26H,3-5,11,13H2,1-2H3,(H,36,41)(H,37,40)/t17-,26+/m1/s1	IMCXJEIDVWMIBG-QUGAMOGWSA-N	241558	US9409908, 190::US9951071, Example 190	Plasma kallikrein		 1.11								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241558	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241558&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060603	341093865							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779362	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)c(Cl)ccc3C(C)=O)c3cc(F)cc-2c3)c1	InChI=1S/C34H32ClF2N3O5/c1-18-5-4-6-29(40-12-11-20(16-30(40)42)31-25(19(2)41)9-10-27(35)32(31)37)22-13-21(14-23(36)15-22)26-8-7-24(38-34(44)45-3)17-28(26)39-33(18)43/h7-10,13-18,29H,4-6,11-12H2,1-3H3,(H,38,44)(H,39,43)/t18-,29+/m1/s1	WKGAFUMVYFTGCQ-LBEKAKSKSA-N	241559	US9409908, 191::US9951071, Example 191	Plasma kallikrein		 19.2								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241559	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241559&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060515	341093866							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779363	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(NC(N)=N)cc2NC1=O	InChI=1S/C30H29ClF2N6O2/c1-16-3-2-4-25(39-12-10-18(14-26(39)40)27-22(32)8-7-21(31)28(27)33)24-13-17(9-11-36-24)20-6-5-19(37-30(34)35)15-23(20)38-29(16)41/h5-9,11,13-16,25H,2-4,10,12H2,1H3,(H,38,41)(H4,34,35,37)/t16-,25+/m1/s1	BWKUSQPAEGPWQY-CPJLOUKISA-N	241560	US9409908, 192::US9951071, Example 192	Plasma kallikrein		 182								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241560	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241560&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060545	341093867							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779364	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2cc(Br)c(N)cc2NC1=O	InChI=1S/C29H26BrClF2N4O2/c1-15-3-2-4-25(37-10-8-17(12-26(37)38)27-21(32)6-5-20(31)28(27)33)24-11-16(7-9-35-24)18-13-19(30)22(34)14-23(18)36-29(15)39/h5-7,9,11-15,25H,2-4,8,10,34H2,1H3,(H,36,39)/t15-,25+/m1/s1	DZZRWRHLIZMWFJ-BZQUYTCOSA-N	241561	US9409908, 193::US9951071, Example 193	Plasma kallikrein		 3.91								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241561	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241561&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060511	341093868							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779365	COC(=O)Nc1ccc2-c3ccnc(c3)[C@H](CCCC(C)NC(=O)c2c1)N1CCC(=CC1=O)c1c(F)ccc(Cl)c1F	InChI=1S/C31H29ClF2N4O4/c1-17-4-3-5-26(38-13-11-19(15-27(38)39)28-24(33)9-8-23(32)29(28)34)25-14-18(10-12-35-25)21-7-6-20(37-31(41)42-2)16-22(21)30(40)36-17/h6-10,12,14-17,26H,3-5,11,13H2,1-2H3,(H,36,40)(H,37,41)/t17?,26-/m0/s1	JORBAAKNOUMANA-KKFPZRRJSA-N	390176	Methyl N-[(14S)-14-[4-(3-chloro-2,6-difluorophenyl)-6-oxo-1,2,3,6-tetrahydropyridin-1-yl]-10-methyl-8-oxo-9,16-diazatricyclo[13.3.1.02,7]nonadeca-1(19),2::US9951071, Example 194	Plasma kallikrein		 310								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=390176	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=390176&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060556	404958756							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779366	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(Nc3cccnc3)cc2NC1=O	InChI=1S/C34H30ClF2N5O2/c1-20-4-2-6-30(42-15-12-22(17-31(42)43)32-27(36)10-9-26(35)33(32)37)29-16-21(11-14-39-29)25-8-7-23(18-28(25)41-34(20)44)40-24-5-3-13-38-19-24/h3,5,7-11,13-14,16-20,30,40H,2,4,6,12,15H2,1H3,(H,41,44)/t20-,30+/m1/s1	OCWLBXWNNDGCER-KEEVHDRGSA-N	241563	US9409908, 195::US9951071, Example 195	Plasma kallikrein		 2.96								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241563	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241563&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060548	341093870							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779367	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(Nc3cccnn3)cc2NC1=O	InChI=1S/C33H29ClF2N6O2/c1-19-4-2-5-28(42-15-12-21(17-30(42)43)31-25(35)10-9-24(34)32(31)36)27-16-20(11-14-37-27)23-8-7-22(18-26(23)40-33(19)44)39-29-6-3-13-38-41-29/h3,6-11,13-14,16-19,28H,2,4-5,12,15H2,1H3,(H,39,41)(H,40,44)/t19-,28+/m1/s1	QWMGKGHSOYXEJP-GDJIYFAZSA-N	241564	US9409908, 196::US9951071, Example 196	Plasma kallikrein		 1.52								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241564	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241564&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060616	341093871							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779368	COC(=O)c1cc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)ccc(Cl)c3F)c3cc-2ccn3)cc1N	InChI=1S/C31H29ClF2N4O4/c1-16-4-3-5-26(38-11-9-18(13-27(38)39)28-22(33)7-6-21(32)29(28)34)25-12-17(8-10-36-25)19-14-20(31(41)42-2)23(35)15-24(19)37-30(16)40/h6-8,10,12-16,26H,3-5,9,11,35H2,1-2H3,(H,37,40)/t16-,26+/m1/s1	KZXNHUNTABHMLN-DXPJPUQTSA-N	241565	US9409908, 197::US9951071, Example 197	Plasma kallikrein		 4.83								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241565	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241565&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060620	341093872							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779369	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2cc(C(O)=O)c(N)cc2NC1=O	InChI=1S/C30H27ClF2N4O4/c1-15-3-2-4-25(37-10-8-17(12-26(37)38)27-21(32)6-5-20(31)28(27)33)24-11-16(7-9-35-24)18-13-19(30(40)41)22(34)14-23(18)36-29(15)39/h5-7,9,11-15,25H,2-4,8,10,34H2,1H3,(H,36,39)(H,40,41)/t15-,25+/m1/s1	RDKBQIHAKHPESW-BZQUYTCOSA-N	241566	US9409908, 198::US9951071, Example 198	Plasma kallikrein		 1.000								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241566	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241566&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060514	341093873							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779370	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2cc3c(O)cc(=O)[nH]c3cc2NC1=O			241567	US9409908, 199::US9951071, Example 199	Plasma kallikrein		 1.79								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241567	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241567&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			129625767	341093874							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779371	C[C@@H]1CCC[C@@H](c2cc(ccn2)-c2c(F)cccc2NC1=O)n1ccc(cc1=O)-c1c(F)ccc(Cl)c1F	InChI=1S/C29H23ClF3N3O2/c1-16-4-2-7-24(36-13-11-18(15-25(36)37)27-21(32)9-8-19(30)28(27)33)23-14-17(10-12-34-23)26-20(31)5-3-6-22(26)35-29(16)38/h3,5-6,8-16,24H,2,4,7H2,1H3,(H,35,38)/t16-,24+/m1/s1	IWFAEMIVPFQUEI-GYCJOSAFSA-N	241568	US9409908, 200::US9951071, Example 200	Plasma kallikrein		 28.7								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241568	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241568&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060553	341093875							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779372	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2c(F)cc(F)cc2NC1=O	InChI=1S/C29H24ClF4N3O2/c1-15-3-2-4-24(37-10-8-17(12-25(37)38)27-20(32)6-5-19(30)28(27)34)22-11-16(7-9-35-22)26-21(33)13-18(31)14-23(26)36-29(15)39/h5-7,9,11-15,24H,2-4,8,10H2,1H3,(H,36,39)/t15-,24+/m1/s1	KPESKXMOJFJEFE-MYYSRTQBSA-N	241569	US9409908, 201::US9951071, Example 201	Plasma kallikrein		 105								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241569	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241569&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060639	341093876							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779373	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(Br)ccc(Cl)c2F)c2cc(ccn2)-c2c(F)cc(F)cc2NC1=O	InChI=1S/C29H24BrClF3N3O2/c1-15-3-2-4-24(37-10-8-17(12-25(37)38)26-19(30)5-6-20(31)28(26)34)22-11-16(7-9-35-22)27-21(33)13-18(32)14-23(27)36-29(15)39/h5-7,9,11-15,24H,2-4,8,10H2,1H3,(H,36,39)/t15-,24+/m1/s1	DSYKFFMSBGSONK-MYYSRTQBSA-N	241570	US9409908, 202::US9951071, Example 202	Plasma kallikrein		 30.1								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241570	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241570&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060494	341093877							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779374	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2c(F)c(F)ccc2NC1=O	InChI=1S/C29H24ClF4N3O2/c1-15-3-2-4-23(37-12-10-17(14-24(37)38)25-19(31)6-5-18(30)27(25)33)22-13-16(9-11-35-22)26-21(36-29(15)39)8-7-20(32)28(26)34/h5-9,11,13-15,23H,2-4,10,12H2,1H3,(H,36,39)/t15-,23+/m1/s1	FHTHEOCGYPFYBM-CMJOXMDJSA-N	241571	US9409908, 203::US9951071, Example 203	Plasma kallikrein		 44.0								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241571	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241571&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060602	341093878							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779375	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(Br)ccc(Cl)c2F)c2cc(ccn2)-c2c(F)c(F)ccc2NC1=O	InChI=1S/C29H24BrClF3N3O2/c1-15-3-2-4-23(37-12-10-17(14-24(37)38)25-18(30)5-6-19(31)27(25)33)22-13-16(9-11-35-22)26-21(36-29(15)39)8-7-20(32)28(26)34/h5-9,11,13-15,23H,2-4,10,12H2,1H3,(H,36,39)/t15-,23+/m1/s1	TXRMRQKQNYNOAW-CMJOXMDJSA-N	241572	US9409908, 204::US9951071, Example 204	Plasma kallikrein		 16.0								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241572	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241572&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060539	341093879							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779376	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2cc(F)c(F)cc2NC1=O	InChI=1S/C29H24ClF4N3O2/c1-15-3-2-4-25(37-10-8-17(12-26(37)38)27-20(31)6-5-19(30)28(27)34)24-11-16(7-9-35-24)18-13-21(32)22(33)14-23(18)36-29(15)39/h5-7,9,11-15,25H,2-4,8,10H2,1H3,(H,36,39)/t15-,25+/m1/s1	SOEFIQITYNWYLZ-BZQUYTCOSA-N	241573	US9409908, 205::US9951071, Example 205	Plasma kallikrein		 88.4								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241573	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241573&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060621	341093880							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779377	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(Br)ccc(Cl)c2F)c2cc(ccn2)-c2cc(F)c(F)cc2NC1=O	InChI=1S/C29H24BrClF3N3O2/c1-15-3-2-4-25(37-10-8-17(12-26(37)38)27-19(30)5-6-20(31)28(27)34)24-11-16(7-9-35-24)18-13-21(32)22(33)14-23(18)36-29(15)39/h5-7,9,11-15,25H,2-4,8,10H2,1H3,(H,36,39)/t15-,25+/m1/s1	VTBXUUQDJAJGJV-BZQUYTCOSA-N	241574	US9409908, 206::US9951071, Example 206	Plasma kallikrein		 27.5								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241574	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241574&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060428	341093881							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779378	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(Cl)ccc2C#N)c2cc(ccn2)-c2c(F)cc(F)cc2NC1=O	InChI=1S/C30H24ClF3N4O2/c1-16-3-2-4-25(38-10-8-18(12-26(38)39)27-19(15-35)5-6-21(31)29(27)34)23-11-17(7-9-36-23)28-22(33)13-20(32)14-24(28)37-30(16)40/h5-7,9,11-14,16,25H,2-4,8,10H2,1H3,(H,37,40)/t16-,25+/m1/s1	UUUYIBUJURRXLR-CPJLOUKISA-N	241575	US9409908, 207::US9951071, Example 207	Plasma kallikrein		 5.80								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241575	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241575&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060555	341093882							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779379	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(Cl)ccc2C#N)c2cc(ccn2)-c2c(F)c(F)ccc2NC1=O	InChI=1S/C30H24ClF3N4O2/c1-16-3-2-4-24(38-12-10-18(14-25(38)39)26-19(15-35)5-6-20(31)28(26)33)23-13-17(9-11-36-23)27-22(37-30(16)40)8-7-21(32)29(27)34/h5-9,11,13-14,16,24H,2-4,10,12H2,1H3,(H,37,40)/t16-,24+/m1/s1	DUPDRBCVCXMPPE-GYCJOSAFSA-N	241576	US9409908, 208::US9951071, Example 208	Plasma kallikrein		 3.10								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241576	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241576&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060604	341093883							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779380	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(ccc2C#N)C#N)c2cc(ccn2)-c2c(F)c(F)ccc2NC1=O	InChI=1S/C31H24F3N5O2/c1-17-3-2-4-25(24-13-18(9-11-37-24)28-23(38-31(17)41)8-7-22(32)30(28)34)39-12-10-19(14-26(39)40)27-20(15-35)5-6-21(16-36)29(27)33/h5-9,11,13-14,17,25H,2-4,10,12H2,1H3,(H,38,41)/t17-,25+/m1/s1	FDTVUOVYASYRLD-NSYGIPOTSA-N	241577	US9409908, 209::US9951071, Example 209	Plasma kallikrein		 457								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241577	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241577&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060512	341093884							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779381	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(ccc2C#N)C#N)c2cc(ccn2)-c2cc(F)c(F)cc2NC1=O	InChI=1S/C31H24F3N5O2/c1-17-3-2-4-27(26-11-18(7-9-37-26)22-13-23(32)24(33)14-25(22)38-31(17)41)39-10-8-19(12-28(39)40)29-20(15-35)5-6-21(16-36)30(29)34/h5-7,9,11-14,17,27H,2-4,8,10H2,1H3,(H,38,41)/t17-,27+/m1/s1	LLKMMHWUWOEVMR-CRYYWNKWSA-N	241578	US9409908, 210::US9951071, Example 210	Plasma kallikrein		 1200								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241578	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241578&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060623	341093885							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779382	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(Cl)ccc2C#N)c2cc(ccn2)-c2cc(F)c(F)cc2NC1=O	InChI=1S/C30H24ClF3N4O2/c1-16-3-2-4-26(38-10-8-18(12-27(38)39)28-19(15-35)5-6-21(31)29(28)34)25-11-17(7-9-36-25)20-13-22(32)23(33)14-24(20)37-30(16)40/h5-7,9,11-14,16,26H,2-4,8,10H2,1H3,(H,37,40)/t16-,26+/m1/s1	GTMQLRVEOBBFGO-DXPJPUQTSA-N	241579	US9409908, 211::US9951071, Example 211	Plasma kallikrein		 6.46								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241579	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241579&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060566	341093886							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779383	C[C@@H]1CCC[C@@H](c2cc(ccn2)-c2c(F)cc(F)cc2NC1=O)n1ccc(cc1=O)-c1cccc(Cl)c1F	InChI=1S/C29H23ClF3N3O2/c1-16-4-2-7-25(36-11-9-17(13-26(36)37)20-5-3-6-21(30)28(20)33)23-12-18(8-10-34-23)27-22(32)14-19(31)15-24(27)35-29(16)38/h3,5-6,8-16,25H,2,4,7H2,1H3,(H,35,38)/t16-,25+/m1/s1	ZPJLQXFNQCVGJK-CPJLOUKISA-N	241580	US9409908, 212::US9951071, Example 212	Plasma kallikrein		 286								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241580	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241580&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060449	341093887							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779384	COC(=O)c1cccc2NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)ccc(Cl)c3F)c3cc(ccn3)-c12	InChI=1S/C31H28ClF2N3O4/c1-17-5-3-8-25(37-14-12-19(16-26(37)38)28-22(33)10-9-21(32)29(28)34)24-15-18(11-13-35-24)27-20(31(40)41-2)6-4-7-23(27)36-30(17)39/h4,6-7,9-11,13,15-17,25H,3,5,8,12,14H2,1-2H3,(H,36,39)/t17-,25+/m1/s1	CXESAZISLSPVSR-NSYGIPOTSA-N	241581	US9409908, 213::US9951071, Example 213	Plasma kallikrein		 3370								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241581	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241581&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060624	341093888							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779385	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2c(NC1=O)cccc2C(O)=O	InChI=1S/C30H26ClF2N3O4/c1-16-4-2-7-24(36-13-11-18(15-25(36)37)27-21(32)9-8-20(31)28(27)33)23-14-17(10-12-34-23)26-19(30(39)40)5-3-6-22(26)35-29(16)38/h3,5-6,8-10,12,14-16,24H,2,4,7,11,13H2,1H3,(H,35,38)(H,39,40)/t16-,24+/m1/s1	OROOHDNCDLETBU-GYCJOSAFSA-N	241582	US9409908, 214::US9951071, Example 214	Plasma kallikrein		>13020								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241582	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241582&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060629	341093889							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779386	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(Cl)ccc2-n2cnnn2)c2cc(ccn2)-c2cc(F)c(F)cc2NC1=O	InChI=1S/C30H25ClF3N7O2/c1-16-3-2-4-25(24-11-17(7-9-35-24)19-13-21(32)22(33)14-23(19)37-30(16)43)40-10-8-18(12-27(40)42)28-26(41-15-36-38-39-41)6-5-20(31)29(28)34/h5-7,9,11-16,25H,2-4,8,10H2,1H3,(H,37,43)/t16-,25+/m1/s1	JKKGBKZFKPXHDS-CPJLOUKISA-N	241583	US9409908, 215::US9951071, Example 215	Plasma kallikrein		 3.61								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241583	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241583&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060551	341093890							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779387	COC(=O)Nc1ccc2-c3ccnc(c3)[C@H](C\C=C\CCNC(=O)c2c1)N1CCC(=CC1=O)c1c(F)ccc(Cl)c1F	InChI=1S/C31H27ClF2N4O4/c1-42-31(41)37-20-6-7-21-18-10-13-35-25(15-18)26(5-3-2-4-12-36-30(40)22(21)17-20)38-14-11-19(16-27(38)39)28-24(33)9-8-23(32)29(28)34/h2-3,6-10,13,15-17,26H,4-5,11-12,14H2,1H3,(H,36,40)(H,37,41)/b3-2+/t26-/m0/s1	YWQXBKNISYYIMA-HPHQOREJSA-N	241584	US9409908, 216::US9951071, Example 216	Plasma kallikrein		 212								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241584	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241584&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060552	341093891							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779388	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2c(NC1=O)cccc2C#N	InChI=1S/C30H25ClF2N4O2/c1-17-4-2-7-25(37-13-11-19(15-26(37)38)28-22(32)9-8-21(31)29(28)33)24-14-18(10-12-35-24)27-20(16-34)5-3-6-23(27)36-30(17)39/h3,5-6,8-10,12,14-15,17,25H,2,4,7,11,13H2,1H3,(H,36,39)/t17-,25+/m1/s1	VPKWFQMGARBSGB-NSYGIPOTSA-N	390199	(10R,14S)-14-[4-(3-chloro-2,6-difluorophenyl)-6-oxo-1,2,3,6-tetrahydropyridin-1-yl]-10-methyl-9-oxo-8,16-diazatricyclo[13.3.1.02,7]nonadeca-1(19),2::US9951071, Example 217	Plasma kallikrein		 154								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=390199	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=390199&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060432	404958779							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779389	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)C3CCCC(C)C3)c3cc-2ccn3)c1	InChI=1S/C32H40N4O4/c1-20-6-4-8-22(16-20)23-13-15-36(30(37)18-23)29-9-5-7-21(2)31(38)35-27-19-25(34-32(39)40-3)10-11-26(27)24-12-14-33-28(29)17-24/h10-12,14,17-22,29H,4-9,13,15-16H2,1-3H3,(H,34,39)(H,35,38)/t20?,21-,22?,29+/m1/s1	NTRPAMBLEXVPQJ-BELJIYFPSA-N	241521	BDBM241596::US9409908, 153::US9409908, 159::US9409908, 218::US9409908, 225::US9951071, Example 225	Plasma kallikrein		 378								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241521	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241521&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060429	341093834							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779390	COC(=O)Nc1ccc-2c(NC(=O)CCCCC[C@H](N3CCC(=CC3=O)c3c(F)ccc(Cl)c3F)c3cc-2ccn3)c1	InChI=1S/C31H29ClF2N4O4/c1-42-31(41)36-20-7-8-21-18-11-13-35-25(15-18)26(5-3-2-4-6-27(39)37-24(21)17-20)38-14-12-19(16-28(38)40)29-23(33)10-9-22(32)30(29)34/h7-11,13,15-17,26H,2-6,12,14H2,1H3,(H,36,41)(H,37,39)/t26-/m0/s1	QGEHSULTCOSTKP-SANMLTNESA-N	241587	US9409908, 219::US9951071, Example 219	Plasma kallikrein		 6.85								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241587	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241587&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060521	341093893							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779391	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2nc(c(C)[nH]2)-c2ccccc2NC1=O			241588	US9409908, 220::US9951071, Example 220	Plasma kallikrein		 50.2								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241588	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241588&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060434	341093894							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779392	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2cn[nH]c2NC1=O			241589	US9409908, 221::US9951071, Example 221	Plasma kallikrein		 1317								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241589	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241589&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060532	341093895							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779393	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-n2nc(cc2NC1=O)C(O)=O	InChI=1S/C27H24ClF2N5O4/c1-14-3-2-4-21(34-10-8-15(11-23(34)36)24-18(29)6-5-17(28)25(24)30)19-12-16(7-9-31-19)35-22(32-26(14)37)13-20(33-35)27(38)39/h5-7,9,11-14,21H,2-4,8,10H2,1H3,(H,32,37)(H,38,39)/t14-,21+/m1/s1	NPHHNMJIOHQPCH-SZNDQCEHSA-N	241590	US9409908, 222::US9951071, Example 222	Plasma kallikrein		 501								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241590	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241590&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060636	341093896							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779394	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-n2nc(cc2NC1=O)C1CC1	InChI=1S/C29H28ClF2N5O2/c1-16-3-2-4-24(36-12-10-18(13-26(36)38)27-21(31)8-7-20(30)28(27)32)23-14-19(9-11-33-23)37-25(34-29(16)39)15-22(35-37)17-5-6-17/h7-9,11,13-17,24H,2-6,10,12H2,1H3,(H,34,39)/t16-,24+/m1/s1	ZSIJVOIVCNQFGT-GYCJOSAFSA-N	241591	US9409908, 223::US9951071, Example 223	Plasma kallikrein		 146								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241591	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241591&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060518	341093897							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779395	COC(=O)Nc1cc2NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)ccc(Cl)c3F)c3cc(ccn3)-n2n1	InChI=1S/C28H27ClF2N6O4/c1-15-4-3-5-21(36-11-9-16(12-24(36)38)25-19(30)7-6-18(29)26(25)31)20-13-17(8-10-32-20)37-23(34-27(15)39)14-22(35-37)33-28(40)41-2/h6-8,10,12-15,21H,3-5,9,11H2,1-2H3,(H,34,39)(H,33,35,40)/t15-,21+/m1/s1	XVHYFJOHASTAFQ-VFNWGFHPSA-N	241592	US9409908, 224::US9951071, Example 224	Plasma kallikrein		 271								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241592	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241592&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060497	341093898							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779396	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)C3CCCC(C)C3)c3cc-2ccn3)c1	InChI=1S/C32H40N4O4/c1-20-6-4-8-22(16-20)23-13-15-36(30(37)18-23)29-9-5-7-21(2)31(38)35-27-19-25(34-32(39)40-3)10-11-26(27)24-12-14-33-28(29)17-24/h10-12,14,17-22,29H,4-9,13,15-16H2,1-3H3,(H,34,39)(H,35,38)/t20?,21-,22?,29+/m1/s1	NTRPAMBLEXVPQJ-BELJIYFPSA-N	241521	BDBM241596::US9409908, 153::US9409908, 159::US9409908, 218::US9409908, 225::US9951071, Example 225	Plasma kallikrein		 95.5								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241521	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241521&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060429	341093834							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779397	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)C3CCCC(C)C3)c3cc-2ccn3)c1	InChI=1S/C32H40N4O4/c1-20-6-4-8-22(16-20)23-13-15-36(30(37)18-23)29-9-5-7-21(2)31(38)35-27-19-25(34-32(39)40-3)10-11-26(27)24-12-14-33-28(29)17-24/h10-12,14,17-22,29H,4-9,13,15-16H2,1-3H3,(H,34,39)(H,35,38)/t20?,21-,22?,29+/m1/s1	NTRPAMBLEXVPQJ-BELJIYFPSA-N	390208	US9951071, Example 226	Plasma kallikrein		 165								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=390208	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=390208&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060429	404958787							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779398	COC(=O)Nc1ccc2-c3nc([nH]c3-c3cncnc3)[C@H](CCC[C@@H](C)C(=O)Nc2c1)N1CCC(=CC1=O)c1c(F)ccc(Cl)c1F	InChI=1S/C33H30ClF2N7O4/c1-17-4-3-5-25(43-11-10-18(12-26(43)44)27-23(35)9-8-22(34)28(27)36)31-41-29(19-14-37-16-38-15-19)30(42-31)21-7-6-20(39-33(46)47-2)13-24(21)40-32(17)45/h6-9,12-17,25H,3-5,10-11H2,1-2H3,(H,39,46)(H,40,45)(H,41,42)/t17-,25+/m1/s1	UPJJSWVFWUIVGU-NSYGIPOTSA-N	390210	US9951071, Example 227	Plasma kallikrein		 3.90								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=390210	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=390210&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060619	404958789							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779181	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)c(Cl)ccc3OC)c3cc-2ccn3)c1	InChI=1S/C32H32ClFN4O5/c1-18-5-4-6-26(38-14-12-20(16-28(38)39)29-27(42-2)10-9-23(33)30(29)34)25-15-19(11-13-35-25)22-8-7-21(36-32(41)43-3)17-24(22)37-31(18)40/h7-11,13,15-18,26H,4-6,12,14H2,1-3H3,(H,36,41)(H,37,40)/t18-,26+/m1/s1	NVKNABMCMNHCSO-DWXRJYCRSA-N	241369	US9409908, 1::US9951071, Example 1	Plasma kallikrein		 10.00								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241369	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241369&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			73052833	341093684							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779182	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(C)ccc(Cl)c3F)c3cc-2ccn3)c1	InChI=1S/C32H32ClFN4O4/c1-18-7-10-24(33)30(34)29(18)21-12-14-38(28(39)16-21)27-6-4-5-19(2)31(40)37-25-17-22(36-32(41)42-3)8-9-23(25)20-11-13-35-26(27)15-20/h7-11,13,15-17,19,27H,4-6,12,14H2,1-3H3,(H,36,41)(H,37,40)/t19-,27+/m1/s1	VZCFMFWKMXXTFA-WINIVTDRSA-N	241370	US9409908, 2::US9951071, Example 2	Plasma kallikrein		 5.00								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241370	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241370&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			73052989	341093685							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779183	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)c(Cl)ccc3C#N)c3cc-2ccn3)c1	InChI=1S/C32H29ClFN5O4/c1-18-4-3-5-27(39-13-11-20(15-28(39)40)29-21(17-35)6-9-24(33)30(29)34)26-14-19(10-12-36-26)23-8-7-22(37-32(42)43-2)16-25(23)38-31(18)41/h6-10,12,14-16,18,27H,3-5,11,13H2,1-2H3,(H,37,42)(H,38,41)/t18-,27+/m1/s1	WSDKNZUBTLXSPM-CLYVBNDRSA-N	241371	US9409908, 3::US9951071, Example 3	Plasma kallikrein		 1.000								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241371	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241371&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			72792440	341093686							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779184	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)cccc3C#N)c3cc-2ccn3)c1	InChI=1S/C32H30FN5O4/c1-19-5-3-8-28(38-14-12-21(16-29(38)39)30-22(18-34)6-4-7-25(30)33)27-15-20(11-13-35-27)24-10-9-23(36-32(41)42-2)17-26(24)37-31(19)40/h4,6-7,9-11,13,15-17,19,28H,3,5,8,12,14H2,1-2H3,(H,36,41)(H,37,40)/t19-,28+/m1/s1	HLWOCEXYCJLWGO-GDJIYFAZSA-N	241372	US9409908, 4::US9951071, Example 4	Plasma kallikrein		 1.000								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241372	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241372&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			73053131	341093687							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779185	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3nccc(Cl)c3F)c3cc-2cc(OC)n3)c1	InChI=1S/C31H31ClFN5O5/c1-17-5-4-6-25(38-12-10-18(15-27(38)39)29-28(33)22(32)9-11-34-29)24-13-19(14-26(36-24)42-2)21-8-7-20(35-31(41)43-3)16-23(21)37-30(17)40/h7-9,11,13-17,25H,4-6,10,12H2,1-3H3,(H,35,41)(H,37,40)/t17-,25+/m1/s1	IEVMGHWIRRVDRB-NSYGIPOTSA-N	241373	US9409908, 5::US9951071, Example 5	Plasma kallikrein		 3.00								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241373	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241373&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			73052988	341093688							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779186	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3nccc(Cl)c3OC)c3cc-2cc(OC)n3)c1	InChI=1S/C32H34ClN5O6/c1-18-6-5-7-26(38-13-11-19(16-28(38)39)29-30(43-3)23(33)10-12-34-29)25-14-20(15-27(36-25)42-2)22-9-8-21(35-32(41)44-4)17-24(22)37-31(18)40/h8-10,12,14-18,26H,5-7,11,13H2,1-4H3,(H,35,41)(H,37,40)/t18-,26+/m1/s1	YRVVTNRXDLFTOG-DWXRJYCRSA-N	241374	US9409908, 6::US9951071, Example 6	Plasma kallikrein		 303								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241374	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241374&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			73053132	341093689							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779187	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)c(ccc3C#N)C#N)c3cc-2cc(OC)n3)c1	InChI=1S/C34H31FN6O5/c1-19-5-4-6-28(41-12-11-20(15-30(41)42)31-21(17-36)7-8-22(18-37)32(31)35)27-13-23(14-29(39-27)45-2)25-10-9-24(38-34(44)46-3)16-26(25)40-33(19)43/h7-10,13-16,19,28H,4-6,11-12H2,1-3H3,(H,38,44)(H,40,43)/t19-,28+/m1/s1	FJMCAFXMYKYZAO-GDJIYFAZSA-N	241375	US9409908, 7::US9951071, Example 7	Plasma kallikrein		 10.00								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241375	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241375&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			73053133	341093690							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779188	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(ccc4c(N)n[nH]c34)C#N)c3cc-2cc(OC)n3)c1			241376	US9409908, 8::US9951071, Example 8	Plasma kallikrein		 173								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241376	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241376&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			73053134	341093691							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779189	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(ccc4c(N)noc34)C#N)c3cc-2cc(OC)n3)c1	InChI=1S/C34H33N7O6/c1-18-5-4-6-27(41-12-11-19(15-29(41)42)30-20(17-35)7-9-24-31(30)47-40-32(24)36)26-13-21(14-28(38-26)45-2)23-10-8-22(37-34(44)46-3)16-25(23)39-33(18)43/h7-10,13-16,18,27H,4-6,11-12H2,1-3H3,(H2,36,40)(H,37,44)(H,39,43)/t18-,27+/m1/s1	ZWUUYRIAOVUGDT-CLYVBNDRSA-N	241377	US9409908, 9::US9951071, Example 9	Plasma kallikrein		 46.0								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241377	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241377&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			73053279	341093692							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779190	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3nccc(Cl)c3F)c3cc-2ccn3)c1	InChI=1S/C30H29ClFN5O4/c1-17-4-3-5-25(37-13-10-19(15-26(37)38)28-27(32)22(31)9-12-34-28)24-14-18(8-11-33-24)21-7-6-20(35-30(40)41-2)16-23(21)36-29(17)39/h6-9,11-12,14-17,25H,3-5,10,13H2,1-2H3,(H,35,40)(H,36,39)/t17-,25+/m1/s1	XXPYQZDZFMYLHR-NSYGIPOTSA-N	241378	US9409908, 10::US9951071, Example 10	Plasma kallikrein		 1.000								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241378	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241378&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118236087	341093693							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779191	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@@H](c3cc-2ccn3)n2ncc(cc2=O)-c2c(F)ccc(Cl)c2F)c1	InChI=1S/C30H26ClF2N5O4/c1-16-4-3-5-25(38-26(39)13-18(15-35-38)27-22(32)9-8-21(31)28(27)33)24-12-17(10-11-34-24)20-7-6-19(36-30(41)42-2)14-23(20)37-29(16)40/h6-16,25H,3-5H2,1-2H3,(H,36,41)(H,37,40)/t16-,25+/m1/s1	HXEKGJHLQWBYKJ-CPJLOUKISA-N	241379	US9409908, 11::US9951071, Example 11	Plasma kallikrein		 14.0								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241379	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241379&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060516	341093694							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779192	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(N)cc2NC1=O	InChI=1S/C29H27ClF2N4O2/c1-16-3-2-4-25(36-12-10-18(14-26(36)37)27-22(31)8-7-21(30)28(27)32)24-13-17(9-11-34-24)20-6-5-19(33)15-23(20)35-29(16)38/h5-9,11,13-16,25H,2-4,10,12,33H2,1H3,(H,35,38)/t16-,25+/m1/s1	VSUYWTSSABVZTL-CPJLOUKISA-N	241380	US9409908, 12::US9951071, Example 12	Plasma kallikrein		 1.000								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241380	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241380&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			73053281	341093695							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779193	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccccc2NC1=O	InChI=1S/C29H26ClF2N3O2/c1-17-5-4-8-25(24-15-18(11-13-33-24)20-6-2-3-7-23(20)34-29(17)37)35-14-12-19(16-26(35)36)27-22(31)10-9-21(30)28(27)32/h2-3,6-7,9-11,13,15-17,25H,4-5,8,12,14H2,1H3,(H,34,37)/t17-,25+/m1/s1	UZTAEKUHQOCYGB-NSYGIPOTSA-N	241381	US9409908, 13::US9951071, Example 13	Plasma kallikrein		 8.00								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241381	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241381&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			73053282	341093696							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779194	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(F)cc2NC1=O	InChI=1S/C29H25ClF3N3O2/c1-16-3-2-4-25(36-12-10-18(14-26(36)37)27-22(32)8-7-21(30)28(27)33)24-13-17(9-11-34-24)20-6-5-19(31)15-23(20)35-29(16)38/h5-9,11,13-16,25H,2-4,10,12H2,1H3,(H,35,38)/t16-,25+/m1/s1	MNAHWSVGTPZXHY-CPJLOUKISA-N	241382	US9409908, 14::US9951071, Example 14	Plasma kallikrein		 25.0								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241382	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241382&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			73053283	341093697							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779195	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(Cl)cc2NC1=O	InChI=1S/C29H25Cl2F2N3O2/c1-16-3-2-4-25(36-12-10-18(14-26(36)37)27-22(32)8-7-21(31)28(27)33)24-13-17(9-11-34-24)20-6-5-19(30)15-23(20)35-29(16)38/h5-9,11,13-16,25H,2-4,10,12H2,1H3,(H,35,38)/t16-,25+/m1/s1	RPJZNKIGALAKBZ-CPJLOUKISA-N	241383	US9409908, 15::US9951071, Example 15	Plasma kallikrein		 77.0								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241383	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241383&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			73050939	341093698							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779196	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(Nc3ncccn3)cc2NC1=O	InChI=1S/C33H29ClF2N6O2/c1-19-4-2-5-28(42-15-11-21(17-29(42)43)30-25(35)9-8-24(34)31(30)36)27-16-20(10-14-37-27)23-7-6-22(18-26(23)41-32(19)44)40-33-38-12-3-13-39-33/h3,6-10,12-14,16-19,28H,2,4-5,11,15H2,1H3,(H,41,44)(H,38,39,40)/t19-,28+/m1/s1	SEYYELZSACSHCW-GDJIYFAZSA-N	241384	US9409908, 16::US9951071, Example 16	Plasma kallikrein		 1.000								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241384	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241384&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			73050940	341093699							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779197	COc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)ccc(Cl)c3F)c3cc-2ccn3)c1	InChI=1S/C30H28ClF2N3O3/c1-17-4-3-5-26(36-13-11-19(15-27(36)37)28-23(32)9-8-22(31)29(28)33)25-14-18(10-12-34-25)21-7-6-20(39-2)16-24(21)35-30(17)38/h6-10,12,14-17,26H,3-5,11,13H2,1-2H3,(H,35,38)/t17-,26+/m1/s1	BFURPWNKSPOHBU-QUGAMOGWSA-N	241385	US9409908, 17::US9951071, Example 17	Plasma kallikrein		 114								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241385	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241385&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			73050941	341093700							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779198	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(O)cc2NC1=O	InChI=1S/C29H26ClF2N3O3/c1-16-3-2-4-25(35-12-10-18(14-26(35)37)27-22(31)8-7-21(30)28(27)32)24-13-17(9-11-33-24)20-6-5-19(36)15-23(20)34-29(16)38/h5-9,11,13-16,25,36H,2-4,10,12H2,1H3,(H,34,38)/t16-,25+/m1/s1	YDTFCSKLISVNDE-CPJLOUKISA-N	241386	US9409908, 18::US9951071, Example 18	Plasma kallikrein		 4.00								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241386	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241386&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060431	341093701							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779199	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2cc(Cl)c(O)cc2NC1=O	InChI=1S/C29H25Cl2F2N3O3/c1-15-3-2-4-24(36-10-8-17(12-26(36)38)27-21(32)6-5-19(30)28(27)33)23-11-16(7-9-34-23)18-13-20(31)25(37)14-22(18)35-29(15)39/h5-7,9,11-15,24,37H,2-4,8,10H2,1H3,(H,35,39)/t15-,24+/m1/s1	RPNKMAIYDGDARV-MYYSRTQBSA-N	241387	US9409908, 19::US9951071, Example 19	Plasma kallikrein		 52.0								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241387	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241387&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			73050942	341093702							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779200	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2cc(Cl)c(O)c(Cl)c2NC1=O	InChI=1S/C29H24Cl3F2N3O3/c1-14-3-2-4-22(37-10-8-16(12-23(37)38)24-20(33)6-5-18(30)26(24)34)21-11-15(7-9-35-21)17-13-19(31)28(39)25(32)27(17)36-29(14)40/h5-7,9,11-14,22,39H,2-4,8,10H2,1H3,(H,36,40)/t14-,22+/m1/s1	CCYMFXPYIKCNFP-PEBXRYMYSA-N	241388	US9409908, 20::US9951071, Example 20	Plasma kallikrein		 973								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241388	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241388&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060427	341093703							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779201	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(Nc3nnc(C)o3)cc2NC1=O	InChI=1S/C32H29ClF2N6O3/c1-17-4-3-5-27(41-13-11-20(15-28(41)42)29-24(34)9-8-23(33)30(29)35)26-14-19(10-12-36-26)22-7-6-21(16-25(22)38-31(17)43)37-32-40-39-18(2)44-32/h6-10,12,14-17,27H,3-5,11,13H2,1-2H3,(H,37,40)(H,38,43)/t17-,27+/m1/s1	WNNVCOPVUBHDRW-CRYYWNKWSA-N	241389	US9409908, 21::US9951071, Example 21	Plasma kallikrein		 1.000								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241389	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241389&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			73051092	341093704							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779202	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CC(=O)C[C@H](N3CCC(=CC3=O)c3c(F)ccc(Cl)c3F)c3cc-2ccn3)c1	InChI=1S/C31H27ClF2N4O5/c1-16-11-20(39)15-26(38-10-8-18(13-27(38)40)28-23(33)6-5-22(32)29(28)34)25-12-17(7-9-35-25)21-4-3-19(36-31(42)43-2)14-24(21)37-30(16)41/h3-7,9,12-14,16,26H,8,10-11,15H2,1-2H3,(H,36,42)(H,37,41)/t16-,26+/m1/s1	JMHUINMWXFHURP-DXPJPUQTSA-N	241390	US9409908, 22::US9951071, Example 22	Plasma kallikrein		 352								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241390	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241390&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			89955508	341093705							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779203	COC(=O)Nc1ccc2-c3ccnc(c3)[C@H](CCCCNC(=O)c2c1)N1CCC(=CC1=O)c1c(F)ccc(Cl)c1F	InChI=1S/C30H27ClF2N4O4/c1-41-30(40)36-19-5-6-20-17-9-12-34-24(14-17)25(4-2-3-11-35-29(39)21(20)16-19)37-13-10-18(15-26(37)38)27-23(32)8-7-22(31)28(27)33/h5-9,12,14-16,25H,2-4,10-11,13H2,1H3,(H,35,39)(H,36,40)/t25-/m0/s1	WLTAHYDRUHDZHH-VWLOTQADSA-N	241392	US9409908, 24::US9951071, Example 24	Plasma kallikrein		 214								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241392	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241392&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060422	341093707							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779204	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)c(Cl)ccc3C(F)(F)F)c3cc-2ccn3)c1	InChI=1S/C32H29ClF4N4O4/c1-17-4-3-5-26(41-13-11-19(15-27(41)42)28-22(32(35,36)37)8-9-23(33)29(28)34)25-14-18(10-12-38-25)21-7-6-20(39-31(44)45-2)16-24(21)40-30(17)43/h6-10,12,14-17,26H,3-5,11,13H2,1-2H3,(H,39,44)(H,40,43)/t17-,26+/m1/s1	XSTSJEFWXNDBQO-QUGAMOGWSA-N	241393	US9409908, 25::US9951071, Example 25	Plasma kallikrein		 12.0								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241393	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241393&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060388	341093708							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779205	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)c(Cl)ccc3C#N)c3cc-2cc(OC)n3)c1	InChI=1S/C33H31ClFN5O5/c1-18-5-4-6-27(40-12-11-19(15-29(40)41)30-20(17-36)7-10-24(34)31(30)35)26-13-21(14-28(38-26)44-2)23-9-8-22(37-33(43)45-3)16-25(23)39-32(18)42/h7-10,13-16,18,27H,4-6,11-12H2,1-3H3,(H,37,43)(H,39,42)/t18-,27+/m1/s1	QUNVBYGAKUPYEF-CLYVBNDRSA-N	241394	US9409908, 26::US9951071, Example 26	Plasma kallikrein		 1.000								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241394	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241394&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060527	341093709							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779206	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(NC(=O)OC(C)(C)C)cc2NC1=O	InChI=1S/C34H35ClF2N4O4/c1-19-6-5-7-28(41-15-13-21(17-29(41)42)30-25(36)11-10-24(35)31(30)37)27-16-20(12-14-38-27)23-9-8-22(18-26(23)40-32(19)43)39-33(44)45-34(2,3)4/h8-12,14,16-19,28H,5-7,13,15H2,1-4H3,(H,39,44)(H,40,43)/t19-,28+/m1/s1	MYVHXAZVOPYYRI-GDJIYFAZSA-N	390009	US9951071, Example 27::tert-Butyl N-[(10R,14S)-14-[4-(3-chloro-2,6-difluorophenyl)-6-oxo-1,2,3,6-tetrahydropyridin-1-yl]-10-methyl-9-oxo-8,16-diazatricyclo[13.3.1.02,7]nonadeca-1(18),2,4,6,15	Plasma kallikrein		 15.0								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=390009	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=390009&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060392	404958591							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779207	CC1CCC[C@H](N2CCC(=CC2=O)c2c(Br)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(cc2NC1=O)C(O)=O	InChI=1S/C30H26BrClFN3O4/c1-16-3-2-4-25(36-12-10-18(15-26(36)37)27-21(31)7-8-22(32)28(27)33)24-13-17(9-11-34-24)20-6-5-19(30(39)40)14-23(20)35-29(16)38/h5-9,11,13-16,25H,2-4,10,12H2,1H3,(H,35,38)(H,39,40)/t16?,25-/m0/s1	NSUXTCLEARCMHH-JIKORUOASA-N	390010	(14S)-14-[4-(6-Bromo-3-chloro-2-fluorophenyl)-6-oxo-1,2,3,6-tetrahydropyridin-1-yl]-10-methyl-9-oxo-8,16-diazatricyclo[13.3.1.02,7]nonadeca-1(19),2::US9951071, Example 28	Plasma kallikrein		 196								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=390010	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=390010&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060542	404958592							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779208	CC1CCC[C@H](N2CCC(=CC2=O)c2c(Br)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(cc2NC1=O)C(N)=O	InChI=1S/C30H27BrClFN4O3/c1-16-3-2-4-25(37-12-10-18(15-26(37)38)27-21(31)7-8-22(32)28(27)33)24-13-17(9-11-35-24)20-6-5-19(29(34)39)14-23(20)36-30(16)40/h5-9,11,13-16,25H,2-4,10,12H2,1H3,(H2,34,39)(H,36,40)/t16?,25-/m0/s1	GZIWAJRNQSUBEG-JIKORUOASA-N	390011	(14S)-14-[4-(6-Bromo-3-chloro-2-fluorophenyl)-6-oxo-1,2,3,6-tetrahydropyridin-1-yl]-10-methyl-9-oxo-8,16-diazatricyclo[13.3.1.02,7]nonadeca-1(19),2::US9951071, Example 29	Plasma kallikrein		 3.00								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=390011	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=390011&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060534	404958593							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779209	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)c(Cl)ccc3C#N)c3cc-2cc(=O)[nH]3)c1			241398	US9409908, 30::US9951071, Example 30	Plasma kallikrein		 3.00								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241398	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241398&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			129625765	341093713							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779210	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)c(Cl)ccc3OC(F)F)c3ccnc-2c3)c1	InChI=1S/C32H30ClF3N4O5/c1-17-4-3-5-25(40-13-11-19(15-27(40)41)28-26(45-31(35)36)9-8-22(33)29(28)34)18-10-12-37-23(14-18)21-7-6-20(38-32(43)44-2)16-24(21)39-30(17)42/h6-10,12,14-17,25,31H,3-5,11,13H2,1-2H3,(H,38,43)(H,39,42)/t17-,25+/m1/s1	WUPABZDGAQQKAU-NSYGIPOTSA-N	241399	US9409908, 31::US9951071, Example 31	Plasma kallikrein		 3.00								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241399	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241399&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060356	341093714							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779211	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)c(Cl)ccc3OC(F)F)c3cc-2ccn3)c1	InChI=1S/C32H30ClF3N4O5/c1-17-4-3-5-25(40-13-11-19(15-27(40)41)28-26(45-31(35)36)9-8-22(33)29(28)34)24-14-18(10-12-37-24)21-7-6-20(38-32(43)44-2)16-23(21)39-30(17)42/h6-10,12,14-17,25,31H,3-5,11,13H2,1-2H3,(H,38,43)(H,39,42)/t17-,25+/m1/s1	MWSHJNLPNRIIFT-NSYGIPOTSA-N	241400	US9409908, 32::US9951071, Example 32	Plasma kallikrein		 6.00								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241400	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241400&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060350	341093715							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779212	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(Cl)ccc2C#N)c2cc(ccn2)-c2ccc(cc2NC1=O)C(N)=O	InChI=1S/C31H27ClFN5O3/c1-17-3-2-4-26(38-12-10-19(15-27(38)39)28-21(16-34)6-8-23(32)29(28)33)25-13-18(9-11-36-25)22-7-5-20(30(35)40)14-24(22)37-31(17)41/h5-9,11,13-15,17,26H,2-4,10,12H2,1H3,(H2,35,40)(H,37,41)/t17-,26+/m1/s1	AKZWUAZVOXSXOH-QUGAMOGWSA-N	390015	(10R,14S)-14-[4-(3-Chloro-6-cyano-2-fluorophenyl)-6-oxo-1,2,3,6-tetrahydropyridin-1-yl]-10-methyl-9-oxo-8,16-diazatricyclo[13.3.1.02,7]nonadeca-1::US9951071, Example 33	Plasma kallikrein		 3.00								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=390015	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=390015&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060362	404958597							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779213	CC1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(Cl)ccc2C(C)=O)c2cc(ccn2)-c2ccc(cc2NC1=O)C(N)=O	InChI=1S/C32H30ClFN4O4/c1-17-4-3-5-27(38-13-11-20(16-28(38)40)29-22(18(2)39)8-9-24(33)30(29)34)26-14-19(10-12-36-26)23-7-6-21(31(35)41)15-25(23)37-32(17)42/h6-10,12,14-17,27H,3-5,11,13H2,1-2H3,(H2,35,41)(H,37,42)/t17?,27-/m0/s1	NPYVUTHLJTXPCZ-LYTHVRBOSA-N	241402	US9409908, 34::US9951071, Example 34	Plasma kallikrein		 15.0								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241402	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241402&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060546	341093717							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779214	CC1CCC[C@H](N2CCC(=CC2=O)c2cccc(Cl)c2F)c2cc(ccn2)-c2ccc(cc2NC1=O)C(N)=O	InChI=1S/C30H28ClFN4O3/c1-17-4-2-7-26(36-13-11-19(16-27(36)37)22-5-3-6-23(31)28(22)32)25-14-18(10-12-34-25)21-9-8-20(29(33)38)15-24(21)35-30(17)39/h3,5-6,8-10,12,14-17,26H,2,4,7,11,13H2,1H3,(H2,33,38)(H,35,39)/t17?,26-/m0/s1	UUGIAJZFMUNAQO-KKFPZRRJSA-N	241403	US9409908, 35::US9951071, Example 35	Plasma kallikrein		 26.0								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241403	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241403&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060550	341093718							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779215	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3cc(Cl)ccc3C(F)(F)F)c3cc-2ccn3)c1	InChI=1S/C32H30ClF3N4O4/c1-18-4-3-5-28(40-13-11-20(15-29(40)41)24-16-21(33)6-9-25(24)32(34,35)36)27-14-19(10-12-37-27)23-8-7-22(38-31(43)44-2)17-26(23)39-30(18)42/h6-10,12,14-18,28H,3-5,11,13H2,1-2H3,(H,38,43)(H,39,42)/t18-,28+/m1/s1	YGFGZLKRXRBORE-WRHNGFHOSA-N	241404	US9409908, 36::US9951071, Example 36	Plasma kallikrein		 8.00								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241404	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241404&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060451	341093719							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779216	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2ccnc(c2)-c2ccc(Nc3nnc(C)o3)cc2NC1=O	InChI=1S/C32H29ClF2N6O3/c1-17-4-3-5-27(41-13-11-20(15-28(41)42)29-24(34)9-8-23(33)30(29)35)19-10-12-36-25(14-19)22-7-6-21(16-26(22)38-31(17)43)37-32-40-39-18(2)44-32/h6-10,12,14-17,27H,3-5,11,13H2,1-2H3,(H,37,40)(H,38,43)/t17-,27+/m1/s1	WIOGTPFOPDWSIT-CRYYWNKWSA-N	241405	US9409908, 37::US9951071, Example 37	Plasma kallikrein		 1.000								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241405	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241405&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060444	341093720							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779217	CC1CCC[C@H](N2CCC(=CC2=O)c2c(Br)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(cc2NC1=O)-c1nnc[nH]1			241406	US9409908, 38::US9951071, Example 38	Plasma kallikrein		 6.00								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241406	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241406&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060547	341093721							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779218	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(Nc3nnc(o3)C3CC3)cc2NC1=O	InChI=1S/C34H31ClF2N6O3/c1-18-3-2-4-28(43-14-12-21(16-29(43)44)30-25(36)10-9-24(35)31(30)37)27-15-20(11-13-38-27)23-8-7-22(17-26(23)40-32(18)45)39-34-42-41-33(46-34)19-5-6-19/h7-11,13,15-19,28H,2-6,12,14H2,1H3,(H,39,42)(H,40,45)/t18-,28+/m1/s1	XRRSNWWFDKBFCV-WRHNGFHOSA-N	241407	US9409908, 39::US9951071, Example 39	Plasma kallikrein		 2.00								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241407	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241407&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060448	341093722							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779219	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(Nc3nnc(CC#N)o3)cc2NC1=O	InChI=1S/C33H28ClF2N7O3/c1-18-3-2-4-27(43-14-11-20(16-29(43)44)30-24(35)8-7-23(34)31(30)36)26-15-19(10-13-38-26)22-6-5-21(17-25(22)40-32(18)45)39-33-42-41-28(46-33)9-12-37/h5-8,10,13,15-18,27H,2-4,9,11,14H2,1H3,(H,39,42)(H,40,45)/t18-,27+/m1/s1	KJPOONPDKYPIKE-CLYVBNDRSA-N	241408	US9409908, 40::US9951071, Example 40	Plasma kallikrein		 4.00								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241408	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241408&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060450	341093723							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779220	COCc1nnc(Nc2ccc-3c(NC(=O)[C@H](C)CCC[C@H](N4CCC(=CC4=O)c4c(F)ccc(Cl)c4F)c4cc-3ccn4)c2)o1	InChI=1S/C33H31ClF2N6O4/c1-18-4-3-5-27(42-13-11-20(15-29(42)43)30-24(35)9-8-23(34)31(30)36)26-14-19(10-12-37-26)22-7-6-21(16-25(22)39-32(18)44)38-33-41-40-28(46-33)17-45-2/h6-10,12,14-16,18,27H,3-5,11,13,17H2,1-2H3,(H,38,41)(H,39,44)/t18-,27+/m1/s1	YCPIFMNZNHRZMY-CLYVBNDRSA-N	241409	US9409908, 41::US9951071, Example 41	Plasma kallikrein		 2.00								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241409	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241409&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118236062	341093724							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779221	CCOC(=O)Cc1nnc(Nc2ccc-3c(NC(=O)[C@H](C)CCC[C@H](N4CCC(=CC4=O)c4c(F)ccc(Cl)c4F)c4cc-3ccn4)c2)o1	InChI=1S/C35H33ClF2N6O5/c1-3-48-31(46)18-29-42-43-35(49-29)40-22-7-8-23-20-11-13-39-27(15-20)28(6-4-5-19(2)34(47)41-26(23)17-22)44-14-12-21(16-30(44)45)32-25(37)10-9-24(36)33(32)38/h7-11,13,15-17,19,28H,3-6,12,14,18H2,1-2H3,(H,40,43)(H,41,47)/t19-,28+/m1/s1	LRJDBUKQKSAXJD-GDJIYFAZSA-N	241410	US9409908, 42::US9951071, Example 42	Plasma kallikrein		 2.00								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241410	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241410&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118236118	341093725							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779222	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(Br)ccc(Cl)c2F)c2cc(ccn2)-c2ccccc2NC1=O	InChI=1S/C29H26BrClFN3O2/c1-17-5-4-8-25(24-15-18(11-13-33-24)20-6-2-3-7-23(20)34-29(17)37)35-14-12-19(16-26(35)36)27-21(30)9-10-22(31)28(27)32/h2-3,6-7,9-11,13,15-17,25H,4-5,8,12,14H2,1H3,(H,34,37)/t17-,25+/m1/s1	MUMWTBPFGOZRHX-NSYGIPOTSA-N	241413	US9409908, 45::US9951071, Example 45	Plasma kallikrein		 7.00								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241413	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241413&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060445	341093728							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779223	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(ccc2C#N)C#N)c2cc(ccn2)-c2ccccc2NC1=O	InChI=1S/C31H26FN5O2/c1-19-5-4-8-27(26-15-20(11-13-35-26)24-6-2-3-7-25(24)36-31(19)39)37-14-12-21(16-28(37)38)29-22(17-33)9-10-23(18-34)30(29)32/h2-3,6-7,9-11,13,15-16,19,27H,4-5,8,12,14H2,1H3,(H,36,39)/t19-,27+/m1/s1	IGRHHNIJWDUEGX-WINIVTDRSA-N	241414	US9409908, 46::US9951071, Example 46	Plasma kallikrein		 669								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241414	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241414&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060442	341093729							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779224	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2cccc(Cl)c2F)c2cc(ccn2)-c2ccccc2NC1=O	InChI=1S/C29H27ClFN3O2/c1-18-6-4-11-26(34-15-13-20(17-27(34)35)22-8-5-9-23(30)28(22)31)25-16-19(12-14-32-25)21-7-2-3-10-24(21)33-29(18)36/h2-3,5,7-10,12,14,16-18,26H,4,6,11,13,15H2,1H3,(H,33,36)/t18-,26+/m1/s1	CIECXKZOQDYMLR-DWXRJYCRSA-N	241415	US9409908, 47::US9951071, Example 47	Plasma kallikrein		 66.0								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241415	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241415&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060474	341093730							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779225	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(Cl)ccc2C(C)=O)c2cc(ccn2)-c2ccccc2NC1=O	InChI=1S/C31H29ClFN3O3/c1-18-6-5-9-27(26-16-20(12-14-34-26)23-7-3-4-8-25(23)35-31(18)39)36-15-13-21(17-28(36)38)29-22(19(2)37)10-11-24(32)30(29)33/h3-4,7-8,10-12,14,16-18,27H,5-6,9,13,15H2,1-2H3,(H,35,39)/t18-,27+/m1/s1	KZFXDGGAQOKLCK-CLYVBNDRSA-N	241416	US9409908, 48::US9951071, Example 48	Plasma kallikrein		 49.0								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241416	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241416&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060344	341093731							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779226	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(Cl)ccc2C#N)c2cc(ccn2)-c2ccccc2NC1=O	InChI=1S/C30H26ClFN4O2/c1-18-5-4-8-26(25-15-19(11-13-34-25)22-6-2-3-7-24(22)35-30(18)38)36-14-12-20(16-27(36)37)28-21(17-33)9-10-23(31)29(28)32/h2-3,6-7,9-11,13,15-16,18,26H,4-5,8,12,14H2,1H3,(H,35,38)/t18-,26+/m1/s1	BYCWLOQDZYMODR-DWXRJYCRSA-N	241417	US9409908, 49::US9951071, Example 49	Plasma kallikrein		 3.00								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241417	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241417&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060478	341093732							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779227	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)cccc2C#N)c2cc(ccn2)-c2ccccc2NC1=O	InChI=1S/C30H27FN4O2/c1-19-6-4-11-27(26-16-20(12-14-33-26)23-8-2-3-10-25(23)34-30(19)37)35-15-13-21(17-28(35)36)29-22(18-32)7-5-9-24(29)31/h2-3,5,7-10,12,14,16-17,19,27H,4,6,11,13,15H2,1H3,(H,34,37)/t19-,27+/m1/s1	SPRNNBTVEOFNCO-WINIVTDRSA-N	241418	US9409908, 50::US9951071, Example 50	Plasma kallikrein		 130								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241418	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241418&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060533	341093733							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779228	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(C)ccc(Cl)c2F)c2cc(ccn2)-c2ccccc2NC1=O	InChI=1S/C30H29ClFN3O2/c1-18-10-11-23(31)29(32)28(18)21-13-15-35(27(36)17-21)26-9-5-6-19(2)30(37)34-24-8-4-3-7-22(24)20-12-14-33-25(26)16-20/h3-4,7-8,10-12,14,16-17,19,26H,5-6,9,13,15H2,1-2H3,(H,34,37)/t19-,26+/m1/s1	JDSFHGPELLRDCN-BCHFMIIMSA-N	241419	US9409908, 51::US9951071, Example 51	Plasma kallikrein		 38.0								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241419	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241419&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060480	341093734							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779229	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(Cl)ccc2C2CC2)c2cc(ccn2)-c2ccccc2NC1=O	InChI=1S/C32H31ClFN3O2/c1-19-5-4-8-28(27-17-21(13-15-35-27)23-6-2-3-7-26(23)36-32(19)39)37-16-14-22(18-29(37)38)30-24(20-9-10-20)11-12-25(33)31(30)34/h2-3,6-7,11-13,15,17-20,28H,4-5,8-10,14,16H2,1H3,(H,36,39)/t19-,28+/m1/s1	HSEAXCFUYVIPDA-GDJIYFAZSA-N	241420	US9409908, 52::US9951071, Example 52	Plasma kallikrein		 193								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241420	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241420&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060360	341093735							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779230	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(NC(=O)OCCOC(C)(C)C)cc2NC1=O	InChI=1S/C36H39ClF2N4O5/c1-21-6-5-7-30(43-15-13-23(19-31(43)44)32-27(38)11-10-26(37)33(32)39)29-18-22(12-14-40-29)25-9-8-24(20-28(25)42-34(21)45)41-35(46)47-16-17-48-36(2,3)4/h8-12,14,18-21,30H,5-7,13,15-17H2,1-4H3,(H,41,46)(H,42,45)/t21-,30+/m1/s1	URTZZBQNKCNCOJ-DFXYEROKSA-N	241421	US9409908, 53::US9951071, Example 53	Plasma kallikrein		 2.00								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241421	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241421&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060558	341093736							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779231	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(NC(=O)OCCO)cc2NC1=O	InChI=1S/C32H31ClF2N4O5/c1-18-3-2-4-27(39-12-10-20(16-28(39)41)29-24(34)8-7-23(33)30(29)35)26-15-19(9-11-36-26)22-6-5-21(17-25(22)38-31(18)42)37-32(43)44-14-13-40/h5-9,11,15-18,27,40H,2-4,10,12-14H2,1H3,(H,37,43)(H,38,42)/t18-,27+/m1/s1	BAQBTVHTGIAQPV-CLYVBNDRSA-N	241422	US9409908, 54::US9951071, Example 54	Plasma kallikrein		 1.000								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241422	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241422&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060475	341093737							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779232	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(Cl)ccc2-c2cn[nH]c2)c2cc(ccn2)-c2ccccc2NC1=O			241423	US9409908, 55::US9951071, Example 55	Plasma kallikrein		 19.0								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241423	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241423&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060488	341093738							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779233	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(Cl)ccc2-c2ccncc2)c2cc(ccn2)-c2ccccc2NC1=O	InChI=1S/C34H30ClFN4O2/c1-21-5-4-8-30(29-19-23(13-17-38-29)25-6-2-3-7-28(25)39-34(21)42)40-18-14-24(20-31(40)41)32-26(9-10-27(35)33(32)36)22-11-15-37-16-12-22/h2-3,6-7,9-13,15-17,19-21,30H,4-5,8,14,18H2,1H3,(H,39,42)/t21-,30+/m1/s1	GHPODOFIYRAVAI-DFXYEROKSA-N	241424	US9409908, 56::US9951071, Example 56	Plasma kallikrein		 137								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241424	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241424&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060499	341093739							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779234	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(Cl)ccc2-c2ccccc2)c2cc(ccn2)-c2ccccc2NC1=O	InChI=1S/C35H31ClFN3O2/c1-22-8-7-13-31(30-20-24(16-18-38-30)26-11-5-6-12-29(26)39-35(22)42)40-19-17-25(21-32(40)41)33-27(14-15-28(36)34(33)37)23-9-3-2-4-10-23/h2-6,9-12,14-16,18,20-22,31H,7-8,13,17,19H2,1H3,(H,39,42)/t22-,31+/m1/s1	GRKZZDPEPPSASR-UVDDSOTQSA-N	241425	US9409908, 57::US9951071, Example 57	Plasma kallikrein		 351								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241425	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241425&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060541	341093740							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779235	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(Cl)ccc2-c2cccnc2)c2cc(ccn2)-c2ccccc2NC1=O	InChI=1S/C34H30ClFN4O2/c1-21-6-4-10-30(29-18-22(13-16-38-29)25-8-2-3-9-28(25)39-34(21)42)40-17-14-23(19-31(40)41)32-26(11-12-27(35)33(32)36)24-7-5-15-37-20-24/h2-3,5,7-9,11-13,15-16,18-21,30H,4,6,10,14,17H2,1H3,(H,39,42)/t21-,30+/m1/s1	VKSXRXMDAQLCIZ-DFXYEROKSA-N	241426	US9409908, 58::US9951071, Example 58	Plasma kallikrein		 179								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241426	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241426&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060463	341093741							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779236	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(Cl)ccc2-c2cnn(C)c2)c2cc(ccn2)-c2ccccc2NC1=O	InChI=1S/C33H31ClFN5O2/c1-20-6-5-9-29(28-16-21(12-14-36-28)24-7-3-4-8-27(24)38-33(20)42)40-15-13-22(17-30(40)41)31-25(10-11-26(34)32(31)35)23-18-37-39(2)19-23/h3-4,7-8,10-12,14,16-20,29H,5-6,9,13,15H2,1-2H3,(H,38,42)/t20-,29+/m1/s1	IRQQHHGYQUYTOU-OLILMLBXSA-N	241427	US9409908, 59::US9951071, Example 59	Plasma kallikrein		 68.0								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241427	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241427&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060404	341093742							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779237	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(Cl)ccc2-c2cn(C)nc2C)c2cc(ccn2)-c2ccccc2NC1=O	InChI=1S/C34H33ClFN5O2/c1-20-7-6-10-30(29-17-22(13-15-37-29)24-8-4-5-9-28(24)38-34(20)43)41-16-14-23(18-31(41)42)32-25(11-12-27(35)33(32)36)26-19-40(3)39-21(26)2/h4-5,8-9,11-13,15,17-20,30H,6-7,10,14,16H2,1-3H3,(H,38,43)/t20-,30+/m1/s1	CMVGISXWABZZHF-KEEVHDRGSA-N	241428	US9409908, 60::US9951071, Example 60	Plasma kallikrein		 1090								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241428	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241428&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060495	341093743							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779238	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2cc(I)c(N)cc2NC1=O	InChI=1S/C29H26ClF2IN4O2/c1-15-3-2-4-25(37-10-8-17(12-26(37)38)27-20(31)6-5-19(30)28(27)32)24-11-16(7-9-35-24)18-13-21(33)22(34)14-23(18)36-29(15)39/h5-7,9,11-15,25H,2-4,8,10,34H2,1H3,(H,36,39)/t15-,25+/m1/s1	FEZYZPVXOKHVHG-BZQUYTCOSA-N	241429	US9409908, 61::US9951071, Example 61	Plasma kallikrein		 7.00								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241429	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241429&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118236110	341093744							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779239	COC(=O)Nc1cc2NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)ccc(Cl)c3F)c3cc(ccn3)-c2cc1I	InChI=1S/C31H28ClF2IN4O4/c1-16-4-3-5-26(39-11-9-18(13-27(39)40)28-21(33)7-6-20(32)29(28)34)25-12-17(8-10-36-25)19-14-22(35)24(38-31(42)43-2)15-23(19)37-30(16)41/h6-8,10,12-16,26H,3-5,9,11H2,1-2H3,(H,37,41)(H,38,42)/t16-,26+/m1/s1	RGLBUVNDXXCFGZ-DXPJPUQTSA-N	241430	US9409908, 62::US9951071, Example 62	Plasma kallikrein		 1095								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241430	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241430&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060461	341093745							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779240	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(NC(=S)NC(C)=O)cc2NC1=O	InChI=1S/C32H30ClF2N5O3S/c1-17-4-3-5-27(40-13-11-20(15-28(40)42)29-24(34)9-8-23(33)30(29)35)26-14-19(10-12-36-26)22-7-6-21(16-25(22)39-31(17)43)38-32(44)37-18(2)41/h6-10,12,14-17,27H,3-5,11,13H2,1-2H3,(H,39,43)(H2,37,38,41,44)/t17-,27+/m1/s1	CMZZDHRYQQNSPO-CRYYWNKWSA-N	241431	US9409908, 63::US9951071, Example 63	Plasma kallikrein		 48.0								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241431	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241431&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060500	341093746							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779241	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=C(C)C3=O)c3c(F)ccc(Cl)c3F)c3cc-2ccn3)c1	InChI=1S/C32H31ClF2N4O4/c1-17-5-4-6-27(39-14-12-21(18(2)31(39)41)28-24(34)10-9-23(33)29(28)35)26-15-19(11-13-36-26)22-8-7-20(37-32(42)43-3)16-25(22)38-30(17)40/h7-11,13,15-17,27H,4-6,12,14H2,1-3H3,(H,37,42)(H,38,40)/t17-,27+/m1/s1	VUZOUHVXCSHECJ-CRYYWNKWSA-N	241432	US9409908, 64::US9951071, Example 64	Plasma kallikrein		 171								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241432	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241432&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060554	341093747							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779242	C[C@@H]1CCC[C@@H](c2cc(ccn2)-c2ccccc2NC1=O)n1ccc(cc1=O)-c1cccc(Cl)c1F	InChI=1S/C29H25ClFN3O2/c1-18-6-4-11-26(34-15-13-20(17-27(34)35)22-8-5-9-23(30)28(22)31)25-16-19(12-14-32-25)21-7-2-3-10-24(21)33-29(18)36/h2-3,5,7-10,12-18,26H,4,6,11H2,1H3,(H,33,36)/t18-,26+/m1/s1	DMHPUWZFOHKVNM-DWXRJYCRSA-N	241433	US9409908, 65::US9951071, Example 65	Plasma kallikrein		 53.0								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241433	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241433&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060559	341093748							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779243	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(N)ccc(Cl)c2F)c2cc(ccn2)-c2ccccc2NC1=O	InChI=1S/C29H28ClFN4O2/c1-17-5-4-8-25(24-15-18(11-13-33-24)20-6-2-3-7-23(20)34-29(17)37)35-14-12-19(16-26(35)36)27-22(32)10-9-21(30)28(27)31/h2-3,6-7,9-11,13,15-17,25H,4-5,8,12,14,32H2,1H3,(H,34,37)/t17-,25+/m1/s1	RBNWLYPYPBBIBI-NSYGIPOTSA-N	241434	US9409908, 66::US9951071, Example 66	Plasma kallikrein		 45.0								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241434	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241434&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060358	341093749							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779244	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(Cl)ccc2C(F)(F)F)c2cc(ccn2)-c2ccccc2NC1=O	InChI=1S/C30H26ClF4N3O2/c1-17-5-4-8-25(24-15-18(11-13-36-24)20-6-2-3-7-23(20)37-29(17)40)38-14-12-19(16-26(38)39)27-21(30(33,34)35)9-10-22(31)28(27)32/h2-3,6-7,9-11,13,15-17,25H,4-5,8,12,14H2,1H3,(H,37,40)/t17-,25+/m1/s1	SPQJJBABLHIVSF-NSYGIPOTSA-N	241435	US9409908, 67::US9951071, Example 67	Plasma kallikrein		 19.0								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241435	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241435&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060403	341093750							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779245	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(Cl)ccc2-n2cnnn2)c2cc(ccn2)-c2ccccc2NC1=O	InChI=1S/C30H27ClFN7O2/c1-18-5-4-8-25(24-15-19(11-13-33-24)21-6-2-3-7-23(21)35-30(18)41)38-14-12-20(16-27(38)40)28-26(39-17-34-36-37-39)10-9-22(31)29(28)32/h2-3,6-7,9-11,13,15-18,25H,4-5,8,12,14H2,1H3,(H,35,41)/t18-,25+/m1/s1	JSZAYFVPBHXVCY-CJAUYULYSA-N	241436	US9409908, 68::US9951071, Example 68	Plasma kallikrein		 3.00								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241436	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241436&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060476	341093751							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779246	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(Br)cc2NC1=O	InChI=1S/C29H25BrClF2N3O2/c1-16-3-2-4-25(36-12-10-18(14-26(36)37)27-22(32)8-7-21(31)28(27)33)24-13-17(9-11-34-24)20-6-5-19(30)15-23(20)35-29(16)38/h5-9,11,13-16,25H,2-4,10,12H2,1H3,(H,35,38)/t16-,25+/m1/s1	DAYSEIQDDXRVTA-CPJLOUKISA-N	241437	US9409908, 69::US9951071, Example 69	Plasma kallikrein		 338								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241437	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241437&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060481	341093752							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779247	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(cc[n+]2[O-])-c2ccc(N)cc2NC1=O	InChI=1S/C29H27ClF2N4O3/c1-16-3-2-4-24(35-11-9-18(14-26(35)37)27-22(31)8-7-21(30)28(27)32)25-13-17(10-12-36(25)39)20-6-5-19(33)15-23(20)34-29(16)38/h5-8,10,12-16,24H,2-4,9,11,33H2,1H3,(H,34,38)/t16-,24+/m1/s1	SKANAQYYDPFGRP-GYCJOSAFSA-N	241438	US9409908, 70::US9951071, Example 70	Plasma kallikrein		 18.0								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241438	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241438&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118236100	341093753							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779248	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2cc(Cl)ccc2-n2cncn2)c2cc(ccn2)-c2ccccc2NC1=O	InChI=1S/C31H29ClN6O2/c1-20-5-4-8-29(27-15-21(11-13-34-27)24-6-2-3-7-26(24)36-31(20)40)37-14-12-22(16-30(37)39)25-17-23(32)9-10-28(25)38-19-33-18-35-38/h2-3,6-7,9-11,13,15-20,29H,4-5,8,12,14H2,1H3,(H,36,40)/t20-,29+/m1/s1	WOYLVPNPEGMMRB-OLILMLBXSA-N	241439	US9409908, 71::US9951071, Example 71	Plasma kallikrein		 60.0								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241439	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241439&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060367	341093754							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779249	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccncc2NC1=O	InChI=1S/C28H25ClF2N4O2/c1-16-3-2-4-24(22-13-17(7-11-33-22)19-8-10-32-15-23(19)34-28(16)37)35-12-9-18(14-25(35)36)26-21(30)6-5-20(29)27(26)31/h5-8,10-11,13-16,24H,2-4,9,12H2,1H3,(H,34,37)/t16-,24+/m1/s1	XYICNNPOQLZANR-GYCJOSAFSA-N	241440	US9409908, 185::US9409908, 72::US9951071, Example 72	Plasma kallikrein		 19.0								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241440	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241440&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060363	341093755							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779250	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CC(C)C(=CC3=O)c3c(F)ccc(Cl)c3F)c3cc-2ccn3)c1	InChI=1S/C32H31ClF2N4O4/c1-17-5-4-6-27(39-16-18(2)22(15-28(39)40)29-24(34)10-9-23(33)30(29)35)26-13-19(11-12-36-26)21-8-7-20(37-32(42)43-3)14-25(21)38-31(17)41/h7-15,17-18,27H,4-6,16H2,1-3H3,(H,37,42)(H,38,41)/t17-,18?,27+/m1/s1	NPKCSHLGQLVUNO-ILPYMAIGSA-N	241441	US9409908, 177::US9409908, 178::US9409908, 73::US9951071, Example 73	Plasma kallikrein		 6.00								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241441	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241441&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060513	341093756							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779251	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2cc(Cl)ccc2-n2cnc(C)n2)c2cc(ccn2)-c2ccccc2NC1=O	InChI=1S/C32H31ClN6O2/c1-20-6-5-9-30(28-16-22(12-14-34-28)25-7-3-4-8-27(25)36-32(20)41)38-15-13-23(17-31(38)40)26-18-24(33)10-11-29(26)39-19-35-21(2)37-39/h3-4,7-8,10-12,14,16-20,30H,5-6,9,13,15H2,1-2H3,(H,36,41)/t20-,30+/m1/s1	ANAMVZJDWRVIRM-KEEVHDRGSA-N	241442	US9409908, 74::US9951071, Example 74	Plasma kallikrein		 238								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241442	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241442&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060425	341093757							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779252	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(NC(C)=O)cc2NC1=O	InChI=1S/C31H29ClF2N4O3/c1-17-4-3-5-27(38-13-11-20(15-28(38)40)29-24(33)9-8-23(32)30(29)34)26-14-19(10-12-35-26)22-7-6-21(36-18(2)39)16-25(22)37-31(17)41/h6-10,12,14-17,27H,3-5,11,13H2,1-2H3,(H,36,39)(H,37,41)/t17-,27+/m1/s1	FSWZRDMSLCEJGG-CRYYWNKWSA-N	241443	US9409908, 75::US9951071, Example 75	Plasma kallikrein		 4.00								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241443	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241443&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060529	341093758							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779253	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(NS(C)(=O)=O)cc2NC1=O	InChI=1S/C30H29ClF2N4O4S/c1-17-4-3-5-26(37-13-11-19(15-27(37)38)28-23(32)9-8-22(31)29(28)33)25-14-18(10-12-34-25)21-7-6-20(36-42(2,40)41)16-24(21)35-30(17)39/h6-10,12,14-17,26,36H,3-5,11,13H2,1-2H3,(H,35,39)/t17-,26+/m1/s1	XXVLKIDHEHHRBJ-QUGAMOGWSA-N	241444	US9409908, 76::US9951071, Example 76	Plasma kallikrein		 15.0								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241444	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241444&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060573	341093759							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779254	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)\C=C\C[C@H](N3CCC(=CC3=O)c3c(F)ccc(Cl)c3F)c3cc-2ccn3)c1	InChI=1S/C31H27ClF2N4O4/c1-17-4-3-5-26(38-13-11-19(15-27(38)39)28-23(33)9-8-22(32)29(28)34)25-14-18(10-12-35-25)21-7-6-20(36-31(41)42-2)16-24(21)37-30(17)40/h3-4,6-10,12,14-17,26H,5,11,13H2,1-2H3,(H,36,41)(H,37,40)/b4-3+/t17-,26+/m1/s1	QCWKHDNSZZEEOE-NZCDSGJISA-N	241445	US9409908, 77::US9951071, Example 77	Plasma kallikrein		 67.0								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241445	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241445&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060436	341093760							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779255	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@@H](c3cc-2ccn3)n2ncc(cc2=O)-c2c(F)c(Cl)ccc2Br)c1	InChI=1S/C30H26BrClFN5O4/c1-16-4-3-5-25(38-26(39)13-18(15-35-38)27-21(31)8-9-22(32)28(27)33)24-12-17(10-11-34-24)20-7-6-19(36-30(41)42-2)14-23(20)37-29(16)40/h6-16,25H,3-5H2,1-2H3,(H,36,41)(H,37,40)/t16-,25+/m1/s1	NEHLLAYKPWEYRL-CPJLOUKISA-N	241446	US9409908, 78::US9951071, Example 78	Plasma kallikrein		 5.00								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241446	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241446&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060583	341093761							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779256	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@@H](c3cc-2ccn3)n2ncc(cc2=O)-c2c(F)c(Cl)ccc2C#N)c1	InChI=1S/C31H26ClFN6O4/c1-17-4-3-5-26(39-27(40)13-20(16-36-39)28-19(15-34)6-9-23(32)29(28)33)25-12-18(10-11-35-25)22-8-7-21(37-31(42)43-2)14-24(22)38-30(17)41/h6-14,16-17,26H,3-5H2,1-2H3,(H,37,42)(H,38,41)/t17-,26+/m1/s1	SUNUOUSWUILJOO-QUGAMOGWSA-N	241447	US9409908, 79::US9951071, Example 79	Plasma kallikrein		 3.00								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241447	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241447&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060505	341093762							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779257	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2c(F)cccc2NC1=O	InChI=1S/C29H25ClF3N3O2/c1-16-4-2-7-24(36-13-11-18(15-25(36)37)27-21(32)9-8-19(30)28(27)33)23-14-17(10-12-34-23)26-20(31)5-3-6-22(26)35-29(16)38/h3,5-6,8-10,12,14-16,24H,2,4,7,11,13H2,1H3,(H,35,38)/t16-,24+/m1/s1	MTXDKYJYHRVQFC-GYCJOSAFSA-N	241448	US9409908, 80::US9951071, Example 80	Plasma kallikrein		 38.0								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241448	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241448&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060509	341093763							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779258	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2cc3ccc(=O)[nH]c3cc2NC1=O			241449	US9409908, 81::US9951071, Example 81	Plasma kallikrein		 1.000								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241449	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241449&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			129625766	341093764							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779259	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2cc(\C=C/C(O)=O)c(N)cc2NC1=O	InChI=1S/C32H29ClF2N4O4/c1-17-3-2-4-27(39-12-10-20(15-28(39)40)30-23(34)7-6-22(33)31(30)35)26-14-18(9-11-37-26)21-13-19(5-8-29(41)42)24(36)16-25(21)38-32(17)43/h5-9,11,13-17,27H,2-4,10,12,36H2,1H3,(H,38,43)(H,41,42)/b8-5-/t17-,27+/m1/s1	XKWQQMINHXZTDQ-XVRNRBCSSA-N	241450	US9409908, 82::US9951071, Example 82	Plasma kallikrein		 22.0								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241450	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241450&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060537	341093765							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779260	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2cc3c(C(O)=O)c(C)[nH]c3cc2NC1=O			241451	US9409908, 83::US9951071, Example 83	Plasma kallikrein		 7.00								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241451	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241451&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060510	341093766							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779261	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2cc3CC(=O)Nc3cc2NC1=O	InChI=1S/C31H27ClF2N4O3/c1-16-3-2-4-26(38-10-8-18(14-28(38)40)29-22(33)6-5-21(32)30(29)34)25-12-17(7-9-35-25)20-11-19-13-27(39)36-23(19)15-24(20)37-31(16)41/h5-7,9,11-12,14-16,26H,2-4,8,10,13H2,1H3,(H,36,39)(H,37,41)/t16-,26+/m1/s1	KLNQZPSOKNUSPH-DXPJPUQTSA-N	241452	US9409908, 84::US9951071, Example 84	Plasma kallikrein		 16.0								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241452	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241452&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060471	341093767							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779262	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2cc3cc(C)[nH]c3cc2NC1=O			241453	US9409908, 85::US9951071, Example 85	Plasma kallikrein		 47.0								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241453	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241453&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060409	341093768							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779263	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2cc3CCC(=O)Nc3cc2NC1=O	InChI=1S/C32H29ClF2N4O3/c1-17-3-2-4-27(39-12-10-20(15-29(39)41)30-23(34)7-6-22(33)31(30)35)26-14-18(9-11-36-26)21-13-19-5-8-28(40)37-24(19)16-25(21)38-32(17)42/h6-7,9,11,13-17,27H,2-5,8,10,12H2,1H3,(H,37,40)(H,38,42)/t17-,27+/m1/s1	BPYVSZXRXGLXFP-CRYYWNKWSA-N	241454	US9409908, 86::US9951071, Example 86	Plasma kallikrein		 1.000								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241454	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241454&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060483	341093769							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779264	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(NC(=O)CC(=O)OC(C)(C)C)cc2NC1=O	InChI=1S/C36H37ClF2N4O5/c1-20-6-5-7-29(43-15-13-22(17-31(43)45)33-26(38)11-10-25(37)34(33)39)28-16-21(12-14-40-28)24-9-8-23(18-27(24)42-35(20)47)41-30(44)19-32(46)48-36(2,3)4/h8-12,14,16-18,20,29H,5-7,13,15,19H2,1-4H3,(H,41,44)(H,42,47)/t20-,29+/m1/s1	NZUBFOCJZIJKEH-OLILMLBXSA-N	241455	US9409908, 87::US9951071, Example 87	Plasma kallikrein		 63.0								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241455	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241455&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060438	341093770							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779265	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(Nc3ccccn3)cc2NC1=O	InChI=1S/C34H30ClF2N5O2/c1-20-5-4-6-29(42-16-13-22(18-31(42)43)32-26(36)11-10-25(35)33(32)37)28-17-21(12-15-38-28)24-9-8-23(19-27(24)41-34(20)44)40-30-7-2-3-14-39-30/h2-3,7-12,14-15,17-20,29H,4-6,13,16H2,1H3,(H,39,40)(H,41,44)/t20-,29+/m1/s1	QMPSRRLYDPGUKS-OLILMLBXSA-N	241456	US9409908, 88::US9951071, Example 88	Plasma kallikrein		 5.00								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241456	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241456&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060502	341093771							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779266	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(Nc3ccncc3)cc2NC1=O	InChI=1S/C34H30ClF2N5O2/c1-20-3-2-4-30(42-16-12-22(18-31(42)43)32-27(36)8-7-26(35)33(32)37)29-17-21(9-15-39-29)25-6-5-24(19-28(25)41-34(20)44)40-23-10-13-38-14-11-23/h5-11,13-15,17-20,30H,2-4,12,16H2,1H3,(H,38,40)(H,41,44)/t20-,30+/m1/s1	BHHIIHJGDBVRNZ-KEEVHDRGSA-N	241457	US9409908, 89::US9951071, Example 89	Plasma kallikrein		 5.00								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241457	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241457&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060455	341093772							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779267	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(Nc3ccncn3)cc2NC1=O	InChI=1S/C33H29ClF2N6O2/c1-19-3-2-4-28(42-14-11-21(16-30(42)43)31-25(35)8-7-24(34)32(31)36)27-15-20(9-13-38-27)23-6-5-22(17-26(23)41-33(19)44)40-29-10-12-37-18-39-29/h5-10,12-13,15-19,28H,2-4,11,14H2,1H3,(H,41,44)(H,37,39,40)/t19-,28+/m1/s1	MOLMATGEEFSJHI-GDJIYFAZSA-N	241458	US9409908, 90::US9951071, Example 90	Plasma kallikrein		 4.00								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241458	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241458&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060528	341093773							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779268	C[C@@H]1CCC[C@@H](c2cc(ccn2)-c2ccc(N)cc2NC1=O)n1ccc(cc1=O)-c1c(F)ccc(Cl)c1F	InChI=1S/C29H25ClF2N4O2/c1-16-3-2-4-25(36-12-10-18(14-26(36)37)27-22(31)8-7-21(30)28(27)32)24-13-17(9-11-34-24)20-6-5-19(33)15-23(20)35-29(16)38/h5-16,25H,2-4,33H2,1H3,(H,35,38)/t16-,25+/m1/s1	QFJLWQWOKYLTEQ-CPJLOUKISA-N	241459	US9409908, 91::US9951071, Example 91	Plasma kallikrein		 3.00								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241459	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241459&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060507	341093774							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779269	C[C@@H]1CCC[C@@H](c2cc(ccn2)-c2ccc(Nc3ncccn3)cc2NC1=O)n1ccc(cc1=O)-c1c(F)ccc(Cl)c1F	InChI=1S/C33H27ClF2N6O2/c1-19-4-2-5-28(42-15-11-21(17-29(42)43)30-25(35)9-8-24(34)31(30)36)27-16-20(10-14-37-27)23-7-6-22(18-26(23)41-32(19)44)40-33-38-12-3-13-39-33/h3,6-19,28H,2,4-5H2,1H3,(H,41,44)(H,38,39,40)/t19-,28+/m1/s1	ONIHHUWDVFUCAR-GDJIYFAZSA-N	241460	US9409908, 92::US9951071, Example 92	Plasma kallikrein		 3.00								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241460	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241460&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060453	341093775							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779270	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(Nc3cnccn3)cc2NC1=O	InChI=1S/C33H29ClF2N6O2/c1-19-3-2-4-28(42-14-10-21(16-30(42)43)31-25(35)8-7-24(34)32(31)36)27-15-20(9-11-38-27)23-6-5-22(17-26(23)41-33(19)44)40-29-18-37-12-13-39-29/h5-9,11-13,15-19,28H,2-4,10,14H2,1H3,(H,39,40)(H,41,44)/t19-,28+/m1/s1	KKQBOZNOYSOFLO-GDJIYFAZSA-N	241461	US9409908, 93::US9951071, Example 93	Plasma kallikrein		 3.00								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241461	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241461&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060482	341093776							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779271	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CC(=CC3=O)c3c(Br)ccc(Cl)c3F)c3cc-2ccn3)c1	InChI=1S/C30H27BrClFN4O4/c1-16-4-3-5-25(37-15-18(13-26(37)38)27-21(31)8-9-22(32)28(27)33)24-12-17(10-11-34-24)20-7-6-19(35-30(40)41-2)14-23(20)36-29(16)39/h6-14,16,25H,3-5,15H2,1-2H3,(H,35,40)(H,36,39)/t16-,25+/m1/s1	XHXHYSLQUPGOGY-CPJLOUKISA-N	390076	Methyl N-[(10R,14S)-14-[4-(6-bromo-3-chloro-2-fluorophenyl)-2-oxo-2,5-dihydro-1H-pyrrol-1-yl]-10-methyl-9-oxo-8,16-diazatricyclo[13.3.1.02,7]nonadeca-1(19),2::US9951071, Example 94	Plasma kallikrein		 1027								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=390076	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=390076&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060485	404958658							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779272	CC(C)[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccccc2NC1=O	InChI=1S/C31H30ClF2N3O2/c1-18(2)21-7-5-9-27(26-16-19(12-14-35-26)22-6-3-4-8-25(22)36-31(21)39)37-15-13-20(17-28(37)38)29-24(33)11-10-23(32)30(29)34/h3-4,6,8,10-12,14,16-18,21,27H,5,7,9,13,15H2,1-2H3,(H,36,39)/t21-,27-/m0/s1	JPRPVMXGMBRZJQ-IDISGSTGSA-N	241463	US9409908, 95::US9951071, Example 95	Plasma kallikrein		 107								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241463	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241463&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060582	341093778							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779273	CC(C)[C@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccccc2NC1=O	InChI=1S/C31H30ClF2N3O2/c1-18(2)21-7-5-9-27(26-16-19(12-14-35-26)22-6-3-4-8-25(22)36-31(21)39)37-15-13-20(17-28(37)38)29-24(33)11-10-23(32)30(29)34/h3-4,6,8,10-12,14,16-18,21,27H,5,7,9,13,15H2,1-2H3,(H,36,39)/t21-,27+/m1/s1	JPRPVMXGMBRZJQ-ZBLYBZFDSA-N	241464	US9409908, 96::US9951071, Example 96	Plasma kallikrein		 1968								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241464	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241464&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060371	341093779							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779274	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)C3CCCCC3)c3cc-2ccn3)c1	InChI=1S/C31H38N4O4/c1-20-7-6-10-28(35-16-14-22(18-29(35)36)21-8-4-3-5-9-21)27-17-23(13-15-32-27)25-12-11-24(33-31(38)39-2)19-26(25)34-30(20)37/h11-13,15,17-21,28H,3-10,14,16H2,1-2H3,(H,33,38)(H,34,37)/t20-,28+/m1/s1	WKTKDNDIPWKADW-NGOKVRLYSA-N	241466	US9409908, 98::US9951071, Example 98	Plasma kallikrein		 36.0								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241466	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241466&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060519	341093781							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779275	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3cncc(Cl)c3)c3cc-2ccn3)c1	InChI=1S/C30H30ClN5O4/c1-18-4-3-5-27(36-11-9-19(14-28(36)37)21-12-22(31)17-32-16-21)26-13-20(8-10-33-26)24-7-6-23(34-30(39)40-2)15-25(24)35-29(18)38/h6-8,10,12-18,27H,3-5,9,11H2,1-2H3,(H,34,39)(H,35,38)/t18-,27+/m1/s1	OQSIAGIBPDNVSD-CLYVBNDRSA-N	241467	US9409908, 99::US9951071, Example 99	Plasma kallikrein		 2402								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241467	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241467&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060370	341093782							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779276	CC(C)[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)c(Cl)ccc2-n2cnnn2)c2cc(ccn2)-c2ccccc2NC1=O	InChI=1S/C32H31ClFN7O2/c1-19(2)22-7-5-9-27(26-16-20(12-14-35-26)23-6-3-4-8-25(23)37-32(22)43)40-15-13-21(17-29(40)42)30-28(41-18-36-38-39-41)11-10-24(33)31(30)34/h3-4,6,8,10-12,14,16-19,22,27H,5,7,9,13,15H2,1-2H3,(H,37,43)/t22-,27-/m0/s1	OWBNSFCRELNSPK-CUNXSJBXSA-N	241468	US9409908, 100::US9951071, Example 100	Plasma kallikrein		 4.00								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241468	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241468&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060373	341093783							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779277	C[C@@H]1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(Nc3nnc(o3)-c3ccco3)cc2NC1=O	InChI=1S/C35H29ClF2N6O4/c1-19-4-2-5-28(44-14-12-21(17-30(44)45)31-25(37)10-9-24(36)32(31)38)27-16-20(11-13-39-27)23-8-7-22(18-26(23)41-33(19)46)40-35-43-42-34(48-35)29-6-3-15-47-29/h3,6-11,13,15-19,28H,2,4-5,12,14H2,1H3,(H,40,43)(H,41,46)/t19-,28+/m1/s1	SLEPXNVLHDFXGN-GDJIYFAZSA-N	241471	US9409908, 103::US9951071, Example 103	Plasma kallikrein		 13.0								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241471	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241471&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060585	341093786							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
779278	CC1CCC[C@H](N2CCC(=CC2=O)c2c(F)ccc(Cl)c2F)c2cc(ccn2)-c2ccc(cc2NC1=O)C(O)=O	InChI=1S/C30H26ClF2N3O4/c1-16-3-2-4-25(36-12-10-18(15-26(36)37)27-22(32)8-7-21(31)28(27)33)24-13-17(9-11-34-24)20-6-5-19(30(39)40)14-23(20)35-29(16)38/h5-9,11,13-16,25H,2-4,10,12H2,1H3,(H,35,38)(H,39,40)/t16?,25-/m0/s1	UKWDMAVKJJGCDP-JIKORUOASA-N	241473	US9409908, 105::US9951071, Example 105	Plasma kallikrein		 3920								US Patent		10.7270/Q2R78HKQ		aid1798804	US9951071	Yang, W; Corte, JR; Gilligan, PJ; Pinto, DJ; Ewing, WR; Dilger, AK; Wang, Y; Fang, T; Pabbisetty, KB; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241473	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=241473&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90060437	341093788							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784517	Cc1cc(N)nc(C)c1CNC(=O)c1ccn(Cc2ccc3ncc(Cl)cc3c2)n1	InChI=1S/C22H21ClN6O/c1-13-7-21(24)27-14(2)18(13)11-26-22(30)20-5-6-29(28-20)12-15-3-4-19-16(8-15)9-17(23)10-25-19/h3-10H,11-12H2,1-2H3,(H2,24,27)(H,26,30)	VKIAGBWYTANQQQ-UHFFFAOYSA-N	392515	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-1H-pyrazole-3- carboxamide::US10301284, Example 1::US10781200, Example 1	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392515	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392515&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178166	404960845							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784518	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C22H21ClN6O/c1-13-5-21(24)28-14(2)19(13)10-26-22(30)17-8-27-29(12-17)11-15-3-4-20-16(6-15)7-18(23)9-25-20/h3-9,12H,10-11H2,1-2H3,(H2,24,28)(H,26,30)	KEVAKJMOXFNJON-UHFFFAOYSA-N	392516	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)-1-((3-chloroquinolin-6-yl)methyl)-1H-pyrazole-4-carboxamide::US10301284, Example 2::US10781200, Example 2	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392516	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392516&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081249	404960846							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784519	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)cn1	InChI=1S/C22H21ClN6O/c1-13-5-21(24)28-14(2)18(13)9-26-22(30)20-11-29(12-27-20)10-15-3-4-19-16(6-15)7-17(23)8-25-19/h3-8,11-12H,9-10H2,1-2H3,(H2,24,28)(H,26,30)	IYSVYKDNXSZWIU-UHFFFAOYSA-N	392517	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-1H-imidazole-4- carboxamide::US10301284, Example 3::US10781200, Example 3	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392517	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392517&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178766	404960847							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784520	Cc1cc(N)nc(C)c1CNC(=O)c1ncn(Cc2ccc3ncc(Cl)cc3c2)n1	InChI=1S/C21H20ClN7O/c1-12-5-19(23)27-13(2)17(12)9-25-21(30)20-26-11-29(28-20)10-14-3-4-18-15(6-14)7-16(22)8-24-18/h3-8,11H,9-10H2,1-2H3,(H2,23,27)(H,25,30)	ACDFLJFTAQVDFE-UHFFFAOYSA-N	392518	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-1H-1,2,4-triazole-3- carboxamide::US10301284, Example 4::US10781200, Example 4	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392518	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392518&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178767	404960848							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784521	Cc1cc(N)nc(C)c1CNC(=O)c1cnc(Cc2ccc3ncc(Cl)cc3c2)[nH]1	InChI=1S/C22H21ClN6O/c1-12-5-20(24)28-13(2)17(12)10-27-22(30)19-11-26-21(29-19)7-14-3-4-18-15(6-14)8-16(23)9-25-18/h3-6,8-9,11H,7,10H2,1-2H3,(H2,24,28)(H,26,29)(H,27,30)	HEBXTXYICXOMQA-UHFFFAOYSA-N	392519	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)-1H-imidazole-5- carboxamide::US10301284, Example 5::US10781200, Example 5	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392519	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392519&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178458	404960849							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784522	Cc1cc(N)nc(C)c1CNC(=O)c1nc(Cc2ccc3ncc(Cl)cc3c2)no1	InChI=1S/C21H19ClN6O2/c1-11-5-18(23)26-12(2)16(11)10-25-20(29)21-27-19(28-30-21)7-13-3-4-17-14(6-13)8-15(22)9-24-17/h3-6,8-9H,7,10H2,1-2H3,(H2,23,26)(H,25,29)	XIDDFVXNDJDMCJ-UHFFFAOYSA-N	392520	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-3-((3-chloroquinolin-6- yl)methyl)-1,2,4-oxadiazole-5- carboxamide::US10301284, Example 6::US10781200, Example 6	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392520	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392520&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178676	404960850							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784523	Cc1cc(N)nc(C)c1CNC(=O)c1noc(Cc2ccc3ncc(Cl)cc3c2)n1	InChI=1S/C21H19ClN6O2/c1-11-5-18(23)26-12(2)16(11)10-25-21(29)20-27-19(30-28-20)7-13-3-4-17-14(6-13)8-15(22)9-24-17/h3-6,8-9H,7,10H2,1-2H3,(H2,23,26)(H,25,29)	UQVCTRRWOSYTKA-UHFFFAOYSA-N	392521	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-5-((3-chloroquinolin-6- yl)methyl)-1,2,4-oxadiazole-3- carboxamide::US10301284, Example 7::US10781200, Example 7	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392521	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392521&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178180	404960851							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784524	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)c2cccnc12	InChI=1S/C26H23ClN6O/c1-15-8-24(28)32-16(2)20(15)12-31-26(34)21-14-33(23-4-3-7-29-25(21)23)13-17-5-6-22-18(9-17)10-19(27)11-30-22/h3-11,14H,12-13H2,1-2H3,(H2,28,32)(H,31,34)	KDELRJSGFBTOGO-UHFFFAOYSA-N	392522	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-1H-pyrrolo[3,2-b]pyridine- 3-carboxamide::US10301284, Example 8::US10781200, Example 8	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392522	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392522&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178464	404960852							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784525	Cc1cc(N)nc(C)c1CNC(=O)c1nc(Cc2ccc3ncc(Cl)cc3c2)n2ccccc12	InChI=1S/C26H23ClN6O/c1-15-9-23(28)31-16(2)20(15)14-30-26(34)25-22-5-3-4-8-33(22)24(32-25)11-17-6-7-21-18(10-17)12-19(27)13-29-21/h3-10,12-13H,11,14H2,1-2H3,(H2,28,31)(H,30,34)	SWRWGJKWQQWOOV-UHFFFAOYSA-N	392523	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-3-((3-chloroquinolin-6- yl)methyl)imidazo[1,5-a]pyridine-1- carboxamide::US10301284, Example 9::US10781200, Example 9	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392523	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392523&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178190	404960853							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784526	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)nn1	InChI=1S/C21H20ClN7O/c1-12-5-20(23)26-13(2)17(12)9-25-21(30)19-11-29(28-27-19)10-14-3-4-18-15(6-14)7-16(22)8-24-18/h3-8,11H,9-10H2,1-2H3,(H2,23,26)(H,25,30)	AHPGCVRPNQBODS-UHFFFAOYSA-N	392524	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-1H-1,2,3-triazole-4- carboxamide::US10301284, Example 10::US10781200, Example 10	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392524	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392524&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134177973	404960854							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784527	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)c2ccccc12	InChI=1S/C27H24ClN5O/c1-16-9-26(29)32-17(2)22(16)13-31-27(34)23-15-33(25-6-4-3-5-21(23)25)14-18-7-8-24-19(10-18)11-20(28)12-30-24/h3-12,15H,13-14H2,1-2H3,(H2,29,32)(H,31,34)	SJQDIMSVWPPDAT-UHFFFAOYSA-N	392525	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-1H-indole-3-carboxamide::US10301284, Example 11::US10781200, Example 11	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392525	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392525&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178472	404960855							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784528	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)c2ncccc12	InChI=1S/C26H23ClN6O/c1-15-8-24(28)32-16(2)21(15)12-31-26(34)22-14-33(25-20(22)4-3-7-29-25)13-17-5-6-23-18(9-17)10-19(27)11-30-23/h3-11,14H,12-13H2,1-2H3,(H2,28,32)(H,31,34)	KAHFCXDBNMIWGS-UHFFFAOYSA-N	392526	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-1H-pyrrolo[2,3-b]pyridine- 3-carboxamide::US10301284, Example 12::US10781200, Example 12	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392526	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392526&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178194	404960856							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784529	Cc1cc(N)nc(C)c1CNC(=O)c1nn(Cc2ccc3ncc(Cl)cc3c2)c2ccccc12	InChI=1S/C26H23ClN6O/c1-15-9-24(28)31-16(2)21(15)13-30-26(34)25-20-5-3-4-6-23(20)33(32-25)14-17-7-8-22-18(10-17)11-19(27)12-29-22/h3-12H,13-14H2,1-2H3,(H2,28,31)(H,30,34)	VQICXQYHCMJZFJ-UHFFFAOYSA-N	392527	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-1H-indazole-3- carboxamide::US10301284, Example 13::US10781200, Example 13	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392527	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392527&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134177977	404960857							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784530	Cc1cc(N)nc(C)c1CNC(=O)c1n(Cc2ccc3ncc(Cl)cc3c2)nc2ccccc12	InChI=1S/C26H23ClN6O/c1-15-9-24(28)31-16(2)21(15)13-30-26(34)25-20-5-3-4-6-23(20)32-33(25)14-17-7-8-22-18(10-17)11-19(27)12-29-22/h3-12H,13-14H2,1-2H3,(H2,28,31)(H,30,34)	ORCDLEWLNKYCIX-UHFFFAOYSA-N	392528	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)-2H-indazole-3- carboxamide::US10301284, Example 14::US10781200, Example 14	Plasma kallikrein			>10000							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392528	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392528&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178680	404960858							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784531	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)nc1C(F)(F)F	InChI=1S/C23H20ClF3N6O/c1-12-5-20(28)31-13(2)17(12)9-30-22(34)18-11-33(32-21(18)23(25,26)27)10-14-3-4-19-15(6-14)7-16(24)8-29-19/h3-8,11H,9-10H2,1-2H3,(H2,28,31)(H,30,34)	IMIXVMUJVUBYFQ-UHFFFAOYSA-N	392529	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-3-(trifluoromethyl)-1H- pyrazole-4-carboxamide::US10301284, Example 15	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392529	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392529&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134177981	404960859							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784532	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)c2cnccc12	InChI=1S/C26H23ClN6O/c1-15-7-25(28)32-16(2)21(15)11-31-26(34)22-14-33(24-12-29-6-5-20(22)24)13-17-3-4-23-18(8-17)9-19(27)10-30-23/h3-10,12,14H,11,13H2,1-2H3,(H2,28,32)(H,31,34)	ALARXHMGODKARD-UHFFFAOYSA-N	392530	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-1H-pyrrolo[2,3-c]pyridine- 3-carboxamide::US10301284, Example 16::US10781200, Example 16	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392530	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392530&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178685	404960860							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784533	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)nc1N	InChI=1S/C22H22ClN7O/c1-12-5-20(24)28-13(2)17(12)9-27-22(31)18-11-30(29-21(18)25)10-14-3-4-19-15(6-14)7-16(23)8-26-19/h3-8,11H,9-10H2,1-2H3,(H2,24,28)(H2,25,29)(H,27,31)	HGONQWUUMOMYLI-UHFFFAOYSA-N	392531	3-amino-N-((6-amino-2,4- dimethylpyridin-3-yl)methyl)-1-((3- chloroquinolin-6-yl)methyl)-1H- pyrazole-4-carboxamide::US10301284, Example 17::US10781200, Example 17	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392531	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392531&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134177986	404960861							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784534	Cc1cc(N)nc(C)c1CNC(=O)c1nn(Cc2ccc3ncc(Cl)cc3c2)cc1[N+]([O-])=O	InChI=1S/C22H20ClN7O3/c1-12-5-20(24)27-13(2)17(12)9-26-22(31)21-19(30(32)33)11-29(28-21)10-14-3-4-18-15(6-14)7-16(23)8-25-18/h3-8,11H,9-10H2,1-2H3,(H2,24,27)(H,26,31)	XSIQQKKUXKCPCC-UHFFFAOYSA-N	392532	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-4-nitro-1H-pyrazole-3- carboxamide::US10301284, Example 18::US10781200, Example 18	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392532	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392532&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134177990	404960862							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784535	CC(=O)Nc1cn(Cc2ccc3ncc(Cl)cc3c2)nc1C(=O)NCc1c(C)cc(N)nc1C	InChI=1S/C24H24ClN7O2/c1-13-6-22(26)29-14(2)19(13)10-28-24(34)23-21(30-15(3)33)12-32(31-23)11-16-4-5-20-17(7-16)8-18(25)9-27-20/h4-9,12H,10-11H2,1-3H3,(H2,26,29)(H,28,34)(H,30,33)	BNAQXULXFFGAMA-UHFFFAOYSA-N	392533	4-acetamido-N-((6-amino-2,4- dimethylpyridin-3-yl)methyl)-1-((3- chloroquinolin-6-yl)methyl)-1H- pyrazole-3-carboxamide::US10301284, Example 19::US10781200, Example 19	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392533	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392533&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178487	404960863							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784536	Cc1cc(N)nc(C)c1CNC(=O)c1nc(N)n(Cc2ccc3ncc(Cl)cc3c2)n1	InChI=1S/C21H21ClN8O/c1-11-5-18(23)27-12(2)16(11)9-26-20(31)19-28-21(24)30(29-19)10-13-3-4-17-14(6-13)7-15(22)8-25-17/h3-8H,9-10H2,1-2H3,(H2,23,27)(H,26,31)(H2,24,28,29)	WDBBZFSOOMIEDT-UHFFFAOYSA-N	392534	5-amino-N-((6-amino-2,4- dimethylpyridin-3-yl)methyl)-1-((3- chloroquinolin-6-yl)methyl)-1H-1,2,4- triazole-3-carboxamide::US10301284, Example 20::US10781200, Example 20	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392534	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392534&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178488	404960864							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784537	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc3ncc(Cl)cc3c2)n1	InChI=1S/C21H20ClN7O/c1-12-5-20(23)27-13(2)17(12)9-25-21(30)19-10-26-29(28-19)11-14-3-4-18-15(6-14)7-16(22)8-24-18/h3-8,10H,9,11H2,1-2H3,(H2,23,27)(H,25,30)	UNBNQKMBDWSTOT-UHFFFAOYSA-N	392535	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)-2H-1,2,3-triazole-4- carboxamide::US10301284, Example 21::US10781200, Example 21	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392535	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392535&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178483	404960865							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784538	Cc1cc(N)nc(C)c1CNC(=O)c1nn(Cc2ccc3ncc(Cl)cc3c2)cc1C(F)(F)F	InChI=1S/C23H20ClF3N6O/c1-12-5-20(28)31-13(2)17(12)9-30-22(34)21-18(23(25,26)27)11-33(32-21)10-14-3-4-19-15(6-14)7-16(24)8-29-19/h3-8,11H,9-10H2,1-2H3,(H2,28,31)(H,30,34)	XFWLVBACPMNBMP-UHFFFAOYSA-N	392536	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-4-(trifluoromethyl)-1H- pyrazole-3-carboxamide::US10301284, Example 22::US10781200, Example 22	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392536	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392536&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178489	404960866							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784539	Cc1cc(N)nc(C)c1CNC(=O)c1nc(Cc2ccc3ncc(Cl)cc3c2)c2ccccn12	InChI=1S/C26H23ClN6O/c1-15-9-24(28)31-16(2)20(15)14-30-26(34)25-32-22(23-5-3-4-8-33(23)25)11-17-6-7-21-18(10-17)12-19(27)13-29-21/h3-10,12-13H,11,14H2,1-2H3,(H2,28,31)(H,30,34)	PMJMPOLQHRXHNS-UHFFFAOYSA-N	392537	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)imidazo[1,5-a]pyridine-3- carboxamide::US10301284, Example 23::US10781200, Example 23	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392537	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392537&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178211	404960867							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784540	Cc1cc(N)nc(C)c1CNC(=O)c1nn(Cc2ccc3ncc(Cl)cc3c2)cc1N	InChI=1S/C22H22ClN7O/c1-12-5-20(25)28-13(2)17(12)9-27-22(31)21-18(24)11-30(29-21)10-14-3-4-19-15(6-14)7-16(23)8-26-19/h3-8,11H,9-10,24H2,1-2H3,(H2,25,28)(H,27,31)	RAEHGJMOKLSBEU-UHFFFAOYSA-N	392538	4-amino-N-((6-amino-2,4- dimethylpyridin-3-yl)methyl)-1-((3- chloroquinolin-6-yl)methyl)-1H- pyrazole-3-carboxamide::US10301284, Example 24::US10781200, Example 24	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392538	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392538&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			138658473	404960868							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784541	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)nc1C#N	InChI=1S/C23H20ClN7O/c1-13-5-22(26)29-14(2)18(13)10-28-23(32)19-12-31(30-21(19)8-25)11-15-3-4-20-16(6-15)7-17(24)9-27-20/h3-7,9,12H,10-11H2,1-2H3,(H2,26,29)(H,28,32)	BCORIVPXZDAOIN-UHFFFAOYSA-N	392539	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-3-cyano-1H-pyrazole-4- carboxamide::US10301284, Example 25::US10781200, Example 25	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392539	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392539&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178214	404960869							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784542	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)nc1C(N)=O	InChI=1S/C23H22ClN7O2/c1-12-5-20(25)29-13(2)17(12)9-28-23(33)18-11-31(30-21(18)22(26)32)10-14-3-4-19-15(6-14)7-16(24)8-27-19/h3-8,11H,9-10H2,1-2H3,(H2,25,29)(H2,26,32)(H,28,33)	NDNGLLNCMHYNID-UHFFFAOYSA-N	392540	N4-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-1H-pyrazole-3,4- dicarboxamide::US10301284, Example 26::US10781200, Example 26	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392540	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392540&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178498	404960870							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784543	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)nc1CN	InChI=1S/C23H24ClN7O/c1-13-5-22(26)29-14(2)18(13)10-28-23(32)19-12-31(30-21(19)8-25)11-15-3-4-20-16(6-15)7-17(24)9-27-20/h3-7,9,12H,8,10-11,25H2,1-2H3,(H2,26,29)(H,28,32)	MTEWYIIDBDKBQW-UHFFFAOYSA-N	392541	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-3-(aminomethyl)-1-((3- chloroquinolin-6-yl)methyl)-1H- pyrazole-4-carboxamide::US10301284, Example 27::US10781200, Example 27	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392541	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392541&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178786	404960871							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784544	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)c(N)n1	InChI=1S/C22H22ClN7O/c1-12-5-20(24)28-13(2)17(12)9-27-21(31)19-11-30(22(25)29-19)10-14-3-4-18-15(6-14)7-16(23)8-26-18/h3-8,11H,9-10H2,1-2H3,(H2,24,28)(H2,25,29)(H,27,31)	SKQOIDQWNDVKDS-UHFFFAOYSA-N	392542	2-amino-N-((6-amino-2,4- dimethylpyridin-3-yl)methyl)-1-((3- chloroquinolin-6-yl)methyl)-1H- imidazole-4-carboxamide::US10301284, Example 28::US10781200, Example 28	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392542	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392542&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134177999	404960872							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784545	Cc1cc(N)nc(C)c1CNC(=O)c1coc(Cc2ccc3ncc(Cl)cc3c2)n1	InChI=1S/C22H20ClN5O2/c1-12-5-20(24)27-13(2)17(12)10-26-22(29)19-11-30-21(28-19)7-14-3-4-18-15(6-14)8-16(23)9-25-18/h3-6,8-9,11H,7,10H2,1-2H3,(H2,24,27)(H,26,29)	KBEIDEIEYCSPQD-UHFFFAOYSA-N	392543	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)oxazole-4-carboxamide::US10301284, Example 29::US10781200, Example 29	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392543	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392543&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178511	404960873							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784546	Cc1cc(N)nc(C)c1CNC(=O)c1nnc(Cc2ccc3ncc(Cl)cc3c2)o1	InChI=1S/C21H19ClN6O2/c1-11-5-18(23)26-12(2)16(11)10-25-20(29)21-28-27-19(30-21)7-13-3-4-17-14(6-13)8-15(22)9-24-17/h3-6,8-9H,7,10H2,1-2H3,(H2,23,26)(H,25,29)	YKVZBHZTIGFTLW-UHFFFAOYSA-N	392544	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-5-((3-chloroquinolin-6- yl)methyl)-1,3,4-oxadiazole-2- carboxamide::US10301284, Example 30::US10781200, Example 30	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392544	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392544&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178225	404960874							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784547	Cc1cc(N)nc(C)c1CNC(=O)c1ncc(Cc2ccc3ncc(Cl)cc3c2)o1	InChI=1S/C22H20ClN5O2/c1-12-5-20(24)28-13(2)18(12)11-26-21(29)22-27-10-17(30-22)7-14-3-4-19-15(6-14)8-16(23)9-25-19/h3-6,8-10H,7,11H2,1-2H3,(H2,24,28)(H,26,29)	GJNCWMJQWUCZEU-UHFFFAOYSA-N	392545	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-5-((3-chloroquinolin-6- yl)methyl)oxazole-2-carboxamide::US10301284, Example 31::US10781200, Example 31	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392545	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392545&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178003	404960875							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784548	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)c2ncncc12	InChI=1S/C25H22ClN7O/c1-14-5-23(27)32-15(2)19(14)10-30-25(34)21-12-33(24-20(21)9-28-13-31-24)11-16-3-4-22-17(6-16)7-18(26)8-29-22/h3-9,12-13H,10-11H2,1-2H3,(H2,27,32)(H,30,34)	KMELJRSHOBKADN-UHFFFAOYSA-N	392546	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-7-((3-chloroquinolin-6- yl)methyl)-7H-pyrrolo[2,3- d]pyrimidine-5-carboxamide::US10301284, Example 32::US10781200, Example 32	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392546	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392546&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178005	404960876							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784549	Cc1cc(N)nc(C)c1CNC(=O)c1nn(Cc2ccc3ncc(Cl)cc3c2)c2cccc(N)c12	InChI=1S/C26H24ClN7O/c1-14-8-23(29)32-15(2)19(14)12-31-26(35)25-24-20(28)4-3-5-22(24)34(33-25)13-16-6-7-21-17(9-16)10-18(27)11-30-21/h3-11H,12-13,28H2,1-2H3,(H2,29,32)(H,31,35)	NZUOVEDIDJEFJS-UHFFFAOYSA-N	392547	4-amino-N-((6-amino-2,4- dimethylpyridin-3-yl)methyl)-1-((3- chloroquinolin-6-yl)methyl)-1H- indazole-3-carboxamide::US10301284, Example 33::US10781200, Example 33	Plasma kallikrein			 550							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392547	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392547&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178009	404960877							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784550	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)c2ncnc(N)c12	InChI=1S/C25H23ClN8O/c1-13-5-21(27)33-14(2)18(13)9-30-25(35)19-11-34(24-22(19)23(28)31-12-32-24)10-15-3-4-20-16(6-15)7-17(26)8-29-20/h3-8,11-12H,9-10H2,1-2H3,(H2,27,33)(H,30,35)(H2,28,31,32)	KGPFROBTQTWIBZ-UHFFFAOYSA-N	392548	4-amino-N-((6-amino-2,4- dimethylpyridin-3-yl)methyl)-7-((3- chloroquinolin-6-yl)methyl)-7H- pyrrolo[2,3-d]pyrimidine-5- carboxamide::US10301284, Example 34::US10781200, Example 34	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392548	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392548&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178018	404960878							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784551	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)c2ccncc12	InChI=1S/C26H23ClN6O/c1-15-7-25(28)32-16(2)20(15)12-31-26(34)22-14-33(24-5-6-29-11-21(22)24)13-17-3-4-23-18(8-17)9-19(27)10-30-23/h3-11,14H,12-13H2,1-2H3,(H2,28,32)(H,31,34)	FWLAEBZLRADQOV-UHFFFAOYSA-N	392549	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-1H-pyrrolo[3,2-c]pyridine- 3-carboxamide::US10301284, Example 35::US10781200, Example 35	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392549	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392549&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178507	404960879							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784552	Cc1cc(N)nc(C)c1CNC(=O)c1nn(Cc2ccc3ncc(Cl)cc3c2)cc1C#N	InChI=1S/C23H20ClN7O/c1-13-5-21(26)29-14(2)19(13)10-28-23(32)22-17(8-25)12-31(30-22)11-15-3-4-20-16(6-15)7-18(24)9-27-20/h3-7,9,12H,10-11H2,1-2H3,(H2,26,29)(H,28,32)	HZGAZHPWZQRQKR-UHFFFAOYSA-N	392550	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-4-cyano-1H-pyrazole-3- carboxamide::US10301284, Example 36::US10781200, Example 36	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392550	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392550&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178518	404960880							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784553	Cc1cc(N)nc(C)c1CNC(=O)c1oc(Cc2ccc3ncc(Cl)cc3c2)nc1C(F)(F)F	InChI=1S/C23H19ClF3N5O2/c1-11-5-18(28)31-12(2)16(11)10-30-22(33)20-21(23(25,26)27)32-19(34-20)7-13-3-4-17-14(6-13)8-15(24)9-29-17/h3-6,8-9H,7,10H2,1-2H3,(H2,28,31)(H,30,33)	JDNRBENRMDAUBB-UHFFFAOYSA-N	392551	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)-4-(trifluoromethyl)oxazole- 5-carboxamide::US10301284, Example 37::US10781200, Example 37	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392551	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392551&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178522	404960881							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784554	Cc1nn(Cc2ccc3ncc(Cl)cc3c2)cc1C(=O)NCc1c(C)cc(N)nc1C	InChI=1S/C23H23ClN6O/c1-13-6-22(25)28-14(2)19(13)10-27-23(31)20-12-30(29-15(20)3)11-16-4-5-21-17(7-16)8-18(24)9-26-21/h4-9,12H,10-11H2,1-3H3,(H2,25,28)(H,27,31)	NOHQPKSFPNEIFR-UHFFFAOYSA-N	392552	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-3-methyl-1H-pyrazole-4- carboxamide::US10301284, Example 38::US10781200, Example 38	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392552	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392552&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178248	404960882							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784555	COc1nn(Cc2ccc3ncc(Cl)cc3c2)cc1C(=O)NCc1c(C)cc(N)nc1C	InChI=1S/C23H23ClN6O2/c1-13-6-21(25)28-14(2)18(13)10-27-22(31)19-12-30(29-23(19)32-3)11-15-4-5-20-16(7-15)8-17(24)9-26-20/h4-9,12H,10-11H2,1-3H3,(H2,25,28)(H,27,31)	IGEIBYRPRHIVMF-UHFFFAOYSA-N	392553	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-3-methoxy-1H-pyrazole-4- carboxamide::US10301284, Example 39::US10781200, Example 39	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392553	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392553&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178536	404960883							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784556	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc3ncc(Cl)cc3c2)c1C#N	InChI=1S/C23H20ClN7O/c1-13-5-22(26)30-14(2)18(13)10-28-23(32)19-11-29-31(21(19)8-25)12-15-3-4-20-16(6-15)7-17(24)9-27-20/h3-7,9,11H,10,12H2,1-2H3,(H2,26,30)(H,28,32)	JDHSXDQGXRVALU-UHFFFAOYSA-N	392554	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-5-cyano-1H-pyrazole-4- carboxamide::US10301284, Example 40::US10781200, Example 40	Plasma kallikrein			 5500							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392554	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392554&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178249	404960884							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784557	Cc1cc(N)nc(C)c1CNC(=O)c1ncc(Cc2ccc3ncc(Cl)cc3c2)[nH]1	InChI=1S/C22H21ClN6O/c1-12-5-20(24)28-13(2)18(12)11-27-22(30)21-26-10-17(29-21)7-14-3-4-19-15(6-14)8-16(23)9-25-19/h3-6,8-10H,7,11H2,1-2H3,(H2,24,28)(H,26,29)(H,27,30)	IJVOWAQEKPWMPD-UHFFFAOYSA-N	392555	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-5-((3-chloroquinolin-6- yl)methyl)-1H-imidazole-2- carboxamide::US10301284, Example 41::US10781200, Example 41	Plasma kallikrein			 550							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392555	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392555&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178259	404960885							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784558	Clc1ccc2[nH]nc(CNC(=O)c3nnc(Cc4ccc5ncc(Cl)cc5c4)o3)c2c1	InChI=1S/C21H14Cl2N6O2/c22-13-2-4-17-15(8-13)18(27-26-17)10-25-20(30)21-29-28-19(31-21)6-11-1-3-16-12(5-11)7-14(23)9-24-16/h1-5,7-9H,6,10H2,(H,25,30)(H,26,27)	ASSSRESORCJQOR-UHFFFAOYSA-N	392556	N-((5-chloro-1H-indazol-3-yl)methyl)- 5-((3-chloroquinolin-6-yl)methyl)- 1,3,4-oxadiazole-2-carboxamide::US10301284, Example 42::US10781200, Example 42	Plasma kallikrein			 550							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392556	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392556&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178025	404960886							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784559	Fc1c(CNC(=O)c2nnc(Cc3ccc4ncc(Cl)cc4c3)o2)ccc2[nH]cc(Cl)c12	InChI=1S/C22H14Cl2FN5O2/c23-14-7-13-5-11(1-3-16(13)26-9-14)6-18-29-30-22(32-18)21(31)28-8-12-2-4-17-19(20(12)25)15(24)10-27-17/h1-5,7,9-10,27H,6,8H2,(H,28,31)	SZCHJWPFNIABFS-UHFFFAOYSA-N	392557	N-((3-chloro-4-fluoro-1H-indol-5- yl)methyl)-5-((3-chloroquinolin-6- yl)methyl)-1,3,4-oxadiazole-2- carboxamide::US10301284, Example 43	Plasma kallikrein			 550							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392557	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392557&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178261	404960887							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784560	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1nnc(Cc2ccc3ncc(Cl)cc3c2)o1	InChI=1S/C22H14Cl2FN5O2/c23-14-5-12-3-11(1-2-18(12)26-9-14)4-20-29-30-22(32-20)21(31)28-8-13-6-15-16(24)10-27-19(15)7-17(13)25/h1-3,5-7,9-10,27H,4,8H2,(H,28,31)	PPYGRAMAIMBPCH-UHFFFAOYSA-N	392558	N-((3-chloro-6-fluoro-1H-indol-5- yl)methyl)-5-((3-chloroquinolin-6- yl)methyl)-1,3,4-oxadiazole-2- carboxamide::US10301284, Example 44::US10781200, Example 44	Plasma kallikrein			 550							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392558	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392558&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178028	404960888							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784561	Clc1c[nH]c2ncc(CNC(=O)c3nnc(Cc4ccc5ncc(Cl)cc5c4)o3)cc12	InChI=1S/C21H14Cl2N6O2/c22-14-6-13-3-11(1-2-17(13)24-9-14)5-18-28-29-21(31-18)20(30)27-8-12-4-15-16(23)10-26-19(15)25-7-12/h1-4,6-7,9-10H,5,8H2,(H,25,26)(H,27,30)	ASIUEMSWDSFJCK-UHFFFAOYSA-N	392559	N-((3-chloro-1H-pyrrolo[2,3- b]pyridin-5-yl)methyl)-5-((3- chloroquinolin-6-yl)methyl)-1,3,4- oxadiazole-2-carboxamide::US10301284, Example 45::US10781200, Example 45	Plasma kallikrein			 550							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392559	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392559&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178553	404960889							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784562	Nc1nccc2cc(CNC(=O)c3nnc(Cc4ccc5ncc(Cl)cc5c4)o3)ccc12	InChI=1S/C23H17ClN6O2/c24-17-10-16-7-13(2-4-19(16)27-12-17)9-20-29-30-23(32-20)22(31)28-11-14-1-3-18-15(8-14)5-6-26-21(18)25/h1-8,10,12H,9,11H2,(H2,25,26)(H,28,31)	AACZHUCCAHCXNO-UHFFFAOYSA-N	392560	N-((1-aminoisoquinolin-6-yl)methyl)- 5-((3-chloroquinolin-6-yl)methyl)- 1,3,4-oxadiazole-2-carboxamide::US10301284, Example 46::US10781200, Example 46	Plasma kallikrein			 550							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392560	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392560&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178534	404960890							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784563	Fc1c(CNC(=O)c2cn(Cc3ccc4ncc(Cl)cc4c3)nc2C#N)ccc2[nH]cc(Cl)c12	InChI=1S/C24H15Cl2FN6O/c25-16-6-15-5-13(1-3-19(15)29-9-16)11-33-12-17(21(7-28)32-33)24(34)31-8-14-2-4-20-22(23(14)27)18(26)10-30-20/h1-6,9-10,12,30H,8,11H2,(H,31,34)	QQWUMTHJFCYDCM-UHFFFAOYSA-N	392561	N-((3-chloro-4-fluoro-1H-indol-5- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-3-cyano-1H-pyrazole-4- carboxamide::US10301284, Example 47::US10781200, Example 47	Plasma kallikrein			 550							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392561	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392561&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178740	404960891							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784564	Clc1ccc2[nH]nc(CNC(=O)c3cn(Cc4ccc5ncc(Cl)cc5c4)nc3C#N)c2c1	InChI=1S/C23H15Cl2N7O/c24-15-2-4-20-17(7-15)22(30-29-20)10-28-23(33)18-12-32(31-21(18)8-26)11-13-1-3-19-14(5-13)6-16(25)9-27-19/h1-7,9,12H,10-11H2,(H,28,33)(H,29,30)	SEMGAPGVYHRCIB-UHFFFAOYSA-N	392562	N-((5-chloro-1H-indazol-3-yl)methyl)- 1-((3-chloroquinolin-6-yl)methyl)-3- cyano-1H-pyrazole-4-carboxamide::US10301284, Example 48::US10781200, Example 48	Plasma kallikrein			 550							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392562	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392562&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178029	404960892							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784565	Nc1nccc2cc(CNC(=O)c3cn(Cc4ccc5ncc(Cl)cc5c4)nc3C#N)ccc12	InChI=1S/C25H18ClN7O/c26-19-9-18-8-16(2-4-22(18)30-12-19)13-33-14-21(23(10-27)32-33)25(34)31-11-15-1-3-20-17(7-15)5-6-29-24(20)28/h1-9,12,14H,11,13H2,(H2,28,29)(H,31,34)	LNXYHPIIXNZTBP-UHFFFAOYSA-N	392563	N-((1-aminoisoquinolin-6-yl)methyl)- 1-((3-chloroquinolin-6-yl)methyl)-3- cyano-1H-pyrazole-4-carboxamide::US10301284, Example 49::US10781200, Example 49	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392563	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392563&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178279	404960893							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784566	Clc1c[nH]c2ncc(CNC(=O)c3cn(Cc4ccc5ncc(Cl)cc5c4)nc3C#N)cc12	InChI=1S/C23H15Cl2N7O/c24-16-5-15-3-13(1-2-20(15)27-9-16)11-32-12-18(21(6-26)31-32)23(33)30-8-14-4-17-19(25)10-29-22(17)28-7-14/h1-5,7,9-10,12H,8,11H2,(H,28,29)(H,30,33)	WUPSQPWFFJCKGX-UHFFFAOYSA-N	392564	N-((3-chloro-1H-pyrrolo[2,3- b]pyridin-5-yl)methyl)-1-((3- chloroquinolin-6-yl)methyl)-3-cyano- 1H-pyrazole-4-carboxamide::US10301284, Example 50::US10781200, Example 50	Plasma kallikrein			 550							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392564	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392564&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178555	404960894							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784567	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)nc1C#N	InChI=1S/C24H15Cl2FN6O/c25-16-4-14-3-13(1-2-21(14)29-9-16)11-33-12-18(23(7-28)32-33)24(34)31-8-15-5-17-19(26)10-30-22(17)6-20(15)27/h1-6,9-10,12,30H,8,11H2,(H,31,34)	RHVPFAANQBLDPZ-UHFFFAOYSA-N	392565	N-((3-chloro-6-fluoro-1H-indol-5- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-3-cyano-1H-pyrazole-4- carboxamide::US10301284, Example 51::US10781200, Example 51	Plasma kallikrein			 550							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392565	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392565&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178282	404960895							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784568	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2cc(F)c3ncc(Cl)cc3c2)nc1C#N	InChI=1S/C23H19ClFN7O/c1-12-3-21(27)30-13(2)17(12)9-29-23(33)18-11-32(31-20(18)7-26)10-14-4-15-6-16(24)8-28-22(15)19(25)5-14/h3-6,8,11H,9-10H2,1-2H3,(H2,27,30)(H,29,33)	RXZGWIZLIKYBPD-UHFFFAOYSA-N	392566	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloro-8- fluoroquinolin-6-yl)methyl)-3-cyano- 1H-pyrazole-4-carboxamide::US10301284, Example 52::US10781200, Example 52	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392566	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392566&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178556	404960896							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784569	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1cn(Cc2cc(F)c3ncc(Cl)cc3c2)nc1C#N	InChI=1S/C24H14Cl2F2N6O/c25-15-3-13-1-12(2-20(28)23(13)31-8-15)10-34-11-17(22(6-29)33-34)24(35)32-7-14-4-16-18(26)9-30-21(16)5-19(14)27/h1-5,8-9,11,30H,7,10H2,(H,32,35)	OOXUSHJPYMHNBL-UHFFFAOYSA-N	392567	N-((3-chloro-6-fluoro-1H-indol-5- yl)methyl)-1-((3-chloro-8- fluoroquinolin-6-yl)methyl)-3-cyano- 1H-pyrazole-4-carboxamide::US10301284, Example 53::US10781200, Example 53	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392567	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392567&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178552	404960897							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784570	Nc1nccc2cc(CNC(=O)c3cn(Cc4cc(F)c5ncc(Cl)cc5c4)nc3C#N)ccc12	InChI=1S/C25H17ClFN7O/c26-18-8-17-6-15(7-21(27)23(17)31-11-18)12-34-13-20(22(9-28)33-34)25(35)32-10-14-1-2-19-16(5-14)3-4-30-24(19)29/h1-8,11,13H,10,12H2,(H2,29,30)(H,32,35)	TTYKYHQSIRGSBH-UHFFFAOYSA-N	392568	N-((1-aminoisoquinolin-6-yl)methyl)- 1-((3-chloro-8-fluoroquinolin-6- yl)methyl)-3-cyano-1H-pyrazole-4- carboxamide::US10301284, Example 54::US10781200, Example 54	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392568	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392568&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178037	404960898							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784571	Fc1cc(Cn2cc(C(=O)NCc3n[nH]c4ccc(Cl)cc34)c(n2)C#N)cc2cc(Cl)cnc12	InChI=1S/C23H14Cl2FN7O/c24-14-1-2-19-16(6-14)21(31-30-19)9-29-23(34)17-11-33(32-20(17)7-27)10-12-3-13-5-15(25)8-28-22(13)18(26)4-12/h1-6,8,11H,9-10H2,(H,29,34)(H,30,31)	FZQKNWVIDPCNAL-UHFFFAOYSA-N	392569	N-((5-chloro-1H-indazol-3-yl)methyl)- 1-((3-chloro-8-fluoroquinolin-6- yl)methyl)-3-cyano-1H-pyrazole-4- carboxamide::US10301284, Example 55::US10781200, Example 55	Plasma kallikrein			 550							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392569	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392569&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178038	404960899							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784572	Fc1cc(Cn2cc(C(=O)NCc3cnc4[nH]cc(Cl)c4c3)c(n2)C#N)cc2cc(Cl)cnc12	InChI=1S/C23H14Cl2FN7O/c24-15-4-14-1-12(3-19(26)21(14)28-8-15)10-33-11-17(20(5-27)32-33)23(34)31-7-13-2-16-18(25)9-30-22(16)29-6-13/h1-4,6,8-9,11H,7,10H2,(H,29,30)(H,31,34)	SDEPGTROUDXDFT-UHFFFAOYSA-N	392570	N-((3-chloro-1H-pyrrolo[2,3- b]pyridin-5-yl)methyl)-1-((3-chloro-8- fluoroquinolin-6-yl)methyl)-3-cyano- 1H-pyrazole-4-carboxamide::US10301284, Example 56::US10781200, Example 56	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392570	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392570&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178288	404960900							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784573	Fc1cc(Cn2cc(C(=O)NCc3ccc4[nH]cc(Cl)c4c3F)c(n2)C#N)cc2cc(Cl)cnc12	InChI=1S/C24H14Cl2F2N6O/c25-15-5-14-3-12(4-18(27)23(14)31-8-15)10-34-11-16(20(6-29)33-34)24(35)32-7-13-1-2-19-21(22(13)28)17(26)9-30-19/h1-5,8-9,11,30H,7,10H2,(H,32,35)	OMIWTSNONUWZIQ-UHFFFAOYSA-N	392571	N-((3-chloro-4-fluoro-1H-indol-5- yl)methyl)-1-((3-chloro-8- fluoroquinolin-6-yl)methyl)-3-cyano- 1H-pyrazole-4-carboxamide::US10301284, Example 57::US10781200, Example 57	Plasma kallikrein			 550							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392571	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392571&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178041	404960901							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784574	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2cc(c3ncc(Cl)cc3c2)C(C)(C)O)nc1C#N	InChI=1S/C26H26ClN7O2/c1-14-5-23(29)32-15(2)19(14)11-31-25(35)20-13-34(33-22(20)9-28)12-16-6-17-8-18(27)10-30-24(17)21(7-16)26(3,4)36/h5-8,10,13,36H,11-12H2,1-4H3,(H2,29,32)(H,31,35)	JBHSVGYJIWWDJV-UHFFFAOYSA-N	392572	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloro-8-(2- hydroxypropan-2-yl)quinolin-6- yl)methyl)-3-cyano-1H-pyrazole-4- carboxamide::US10301284, Example 58::US10781200, Example 58	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392572	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392572&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178742	404960902							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784575	CC(C)(O)c1cc(Cn2cc(C(=O)NCc3ccc4c(N)nccc4c3)c(n2)C#N)cc2cc(Cl)cnc12	InChI=1S/C28H24ClN7O2/c1-28(2,38)23-9-17(8-19-10-20(29)13-33-25(19)23)14-36-15-22(24(11-30)35-36)27(37)34-12-16-3-4-21-18(7-16)5-6-32-26(21)31/h3-10,13,15,38H,12,14H2,1-2H3,(H2,31,32)(H,34,37)	JFMWDYUDNMXWSX-UHFFFAOYSA-N	392573	N-((1-aminoisoquinolin-6-yl)methyl)- 1-((3-chloro-8-(2-hydroxypropan-2- yl)quinolin-6-yl)methyl)-3-cyano-1H- pyrazole-4-carboxamide::US10301284, Example 59::US10781200, Example 59	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392573	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392573&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178292	404960903							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784576	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2cc(c3ncc(Cl)cc3c2)S(N)(=O)=O)nc1C#N	InChI=1S/C23H21ClN8O3S/c1-12-3-21(26)30-13(2)17(12)9-29-23(33)18-11-32(31-19(18)7-25)10-14-4-15-6-16(24)8-28-22(15)20(5-14)36(27,34)35/h3-6,8,11H,9-10H2,1-2H3,(H2,26,30)(H,29,33)(H2,27,34,35)	JWZVQMGFSBRWLR-UHFFFAOYSA-N	392574	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloro-8- sulfamoylquinolin-6-yl)methyl)-3- cyano-1H-pyrazole-4-carboxamide::US10301284, Example 60::US10781200, Example 60	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392574	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392574&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178828	404960904							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784577	Cc1cnc2c(cc(Cn3cc(C(=O)NCc4c(C)cc(N)nc4C)c(n3)C#N)cc2c1)S(C)(=O)=O	InChI=1S/C25H25N7O3S/c1-14-5-18-7-17(8-22(36(4,34)35)24(18)28-10-14)12-32-13-20(21(9-26)31-32)25(33)29-11-19-15(2)6-23(27)30-16(19)3/h5-8,10,13H,11-12H2,1-4H3,(H2,27,30)(H,29,33)	XPRAOLSTLRFCRV-UHFFFAOYSA-N	392575	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-3-cyano-1-((3-methyl-8- (methylsulfonyl)quinolin-6- yl)methyl)-1H-pyrazole-4- carboxamide::US10301284, Example 61::US10781200, Example 61	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392575	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392575&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135354631	404960905							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784578	Cc1cnc2c(cc(Cn3cc(C(=O)NCc4c(C)cc(N)nc4C)c(n3)C#N)cc2c1)C#N	InChI=1S/C25H22N8O/c1-14-4-18-6-17(7-19(8-26)24(18)29-10-14)12-33-13-21(22(9-27)32-33)25(34)30-11-20-15(2)5-23(28)31-16(20)3/h4-7,10,13H,11-12H2,1-3H3,(H2,28,31)(H,30,34)	PPOODUNSOSWLJJ-UHFFFAOYSA-N	392576	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-3-cyano-1-((8-cyano-3- methylquinolin-6-yl)methyl)-1H- pyrazole-4-carboxamide::US10301284, Example 62::US10781200, Example 62	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392576	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392576&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178052	404960906							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784579	Cc1cnc2c(cc(Cn3cc(C(=O)NCc4c(C)cc(N)nc4C)c(n3)C(N)=O)cc2c1)C#N	InChI=1S/C25H24N8O2/c1-13-4-17-6-16(7-18(8-26)22(17)29-9-13)11-33-12-20(23(32-33)24(28)34)25(35)30-10-19-14(2)5-21(27)31-15(19)3/h4-7,9,12H,10-11H2,1-3H3,(H2,27,31)(H2,28,34)(H,30,35)	KOPPRFDMDJZZCZ-UHFFFAOYSA-N	392577	N4-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((8-cyano-3- methylquinolin-6-yl)methyl)-1H- pyrazole-3,4-dicarboxamide::US10301284, Example 63::US10781200, Example 63	Plasma kallikrein			 550							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392577	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392577&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178300	404960907							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784580	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(cc3c2)C2CC2)nc1C#N	InChI=1S/C26H25N7O/c1-15-7-25(28)31-16(2)21(15)12-30-26(34)22-14-33(32-24(22)10-27)13-17-3-6-23-19(8-17)9-20(11-29-23)18-4-5-18/h3,6-9,11,14,18H,4-5,12-13H2,1-2H3,(H2,28,31)(H,30,34)	NXWBCYNOFIKWBT-UHFFFAOYSA-N	392578	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-3-cyano-1-((3- cyclopropylquinolin-6-yl)methyl)-1H- pyrazole-4-carboxamide::US10301284, Example 65::US10781200, Example 65	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392578	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392578&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178747	404960908							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784581	Cc1nc(N)ccc1CNC(=O)c1cn(Cc2ccc3ncc(cc3c2)C2CC2)nc1C#N	InChI=1S/C25H23N7O/c1-15-18(5-7-24(27)30-15)11-29-25(33)21-14-32(31-23(21)10-26)13-16-2-6-22-19(8-16)9-20(12-28-22)17-3-4-17/h2,5-9,12,14,17H,3-4,11,13H2,1H3,(H2,27,30)(H,29,33)	XNBQSYYTSSLVFF-UHFFFAOYSA-N	392579	N-((6-amino-2-methylpyridin-3- yl)methyl)-3-cyano-1-((3- cyclopropylquinolin-6-yl)methyl)-1H- pyrazole-4-carboxamide::US10301284, Example 66::US10781200, Example 66	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392579	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392579&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178748	404960909							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784582	Cc1cnc2c(cc(Cn3ncc(C(=O)NCc4c(C)cc(N)nc4C)c3C#N)cc2c1)C(C)(C)O	InChI=1S/C27H29N7O2/c1-15-6-19-8-18(9-22(27(4,5)36)25(19)30-11-15)14-34-23(10-28)21(13-32-34)26(35)31-12-20-16(2)7-24(29)33-17(20)3/h6-9,11,13,36H,12,14H2,1-5H3,(H2,29,33)(H,31,35)	VGEXEBFWUMODSQ-UHFFFAOYSA-N	392580	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-5-cyano-1-((8-(2- hydroxypropan-2-yl)-3- methylquinolin-6-yl)methyl)-1H- pyrazole-4-carboxamide::US10301284, Example 67::US10781200, Example 67	Plasma kallikrein			 5500							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392580	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392580&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178836	404960910							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784583	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2cc(c3ncc(Cl)cc3c2)S(C)(=O)=O)nc1C#N	InChI=1S/C24H22ClN7O3S/c1-13-4-22(27)30-14(2)18(13)10-29-24(33)19-12-32(31-20(19)8-26)11-15-5-16-7-17(25)9-28-23(16)21(6-15)36(3,34)35/h4-7,9,12H,10-11H2,1-3H3,(H2,27,30)(H,29,33)	LCBLUFJTGZMWMW-UHFFFAOYSA-N	392581	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloro-8- (methylsulfonyl)quinolin-6- yl)methyl)-3-cyano-1H-pyrazole-4- carboxamide::US10301284, Example 68::US10781200, Example 68	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392581	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392581&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178301	404960911							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784584	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2cc(C#N)c3ncc(Cl)cc3c2)nc1C#N	InChI=1S/C24H19ClN8O/c1-13-3-22(28)31-14(2)19(13)10-30-24(34)20-12-33(32-21(20)8-27)11-15-4-16-6-18(25)9-29-23(16)17(5-15)7-26/h3-6,9,12H,10-11H2,1-2H3,(H2,28,31)(H,30,34)	ABUOKOXGYGWPDU-UHFFFAOYSA-N	392582	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloro-8- cyanoquinolin-6-yl)methyl)-3-cyano- 1H-pyrazole-4-carboxamide::US10301284, Example 69::US10781200, Example 69	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392582	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392582&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178753	404960912							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784585	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2cc(F)c3ncc(Cl)cc3c2)c1C#N	InChI=1S/C23H19ClFN7O/c1-12-3-21(27)31-13(2)17(12)9-29-23(33)18-10-30-32(20(18)7-26)11-14-4-15-6-16(24)8-28-22(15)19(25)5-14/h3-6,8,10H,9,11H2,1-2H3,(H2,27,31)(H,29,33)	AFIKLFDLPMFODS-UHFFFAOYSA-N	392583	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloro-8- fluoroquinolin-6-yl)methyl)-5-cyano- 1H-pyrazole-4-carboxamide::US10301284, Example 70::US10781200, Example 70	Plasma kallikrein			>10000							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392583	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392583&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178574	404960913							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784586	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2cc(F)c3ncc(Cl)cc3c2)c1C(N)=O	InChI=1S/C23H21ClFN7O2/c1-11-3-19(26)31-12(2)16(11)8-29-23(34)17-9-30-32(21(17)22(27)33)10-13-4-14-6-15(24)7-28-20(14)18(25)5-13/h3-7,9H,8,10H2,1-2H3,(H2,26,31)(H2,27,33)(H,29,34)	PYXFFFNKKGJNLF-UHFFFAOYSA-N	392584	N4-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloro-8- fluoroquinolin-6-yl)methyl)-1H- pyrazole-4,5-dicarboxamide::US10301284, Example 71::US10781200, Example 71	Plasma kallikrein			>10000							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392584	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392584&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178754	404960914							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784587	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2cc(C(N)=O)c3ncc(Cl)cc3c2)nc1C#N	InChI=1S/C24H21ClN8O2/c1-12-3-21(27)31-13(2)18(12)9-30-24(35)19-11-33(32-20(19)7-26)10-14-4-15-6-16(25)8-29-22(15)17(5-14)23(28)34/h3-6,8,11H,9-10H2,1-2H3,(H2,27,31)(H2,28,34)(H,30,35)	LXGUFOWDTCMHRM-UHFFFAOYSA-N	392585	6-((4-(((6-amino-2,4-dimethylpyridin- 3-yl)methyl)carbamoyl)-3-cyano-1H- pyrazol-1-yl)methyl)-3- chloroquinoline-8-carboxamide::US10301284, Example 72::US10781200, Example 72	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392585	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392585&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178607	404960915							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784588	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(cc3c2)C(F)(F)F)nc1C#N	InChI=1S/C24H20F3N7O/c1-13-5-22(29)32-14(2)18(13)10-31-23(35)19-12-34(33-21(19)8-28)11-15-3-4-20-16(6-15)7-17(9-30-20)24(25,26)27/h3-7,9,12H,10-11H2,1-2H3,(H2,29,32)(H,31,35)	AFPHIOZWMKEEPJ-UHFFFAOYSA-N	392586	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-3-cyano-1-((3- (trifluoromethyl)quinolin-6- yl)methyl)-1H-pyrazole-4- carboxamide::US10301284, Example 73::US10781200, Example 73	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392586	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392586&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178580	404960916							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784589	Cc1nc(N)ccc1CNC(=O)c1cn(Cc2ccc3ncc(cc3c2)C(F)(F)F)nc1C#N	InChI=1S/C23H18F3N7O/c1-13-15(3-5-21(28)31-13)9-30-22(34)18-12-33(32-20(18)8-27)11-14-2-4-19-16(6-14)7-17(10-29-19)23(24,25)26/h2-7,10,12H,9,11H2,1H3,(H2,28,31)(H,30,34)	HSOXCLRPEGJBFZ-UHFFFAOYSA-N	392587	N-((6-amino-2-methylpyridin-3- yl)methyl)-3-cyano-1-((3- (trifluoromethyl)quinolin-6- yl)methyl)-1H-pyrazole-4- carboxamide::US10301284, Example 74::US10781200, Example 74	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392587	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392587&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178612	404960917							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784590	Cc1cc(N)nc(C)c1CNC(=O)c1nnc(Cc2cc(F)c3ncc(Cl)cc3c2)o1	InChI=1S/C21H18ClFN6O2/c1-10-3-17(24)27-11(2)15(10)9-26-20(30)21-29-28-18(31-21)6-12-4-13-7-14(22)8-25-19(13)16(23)5-12/h3-5,7-8H,6,9H2,1-2H3,(H2,24,27)(H,26,30)	FZYUVHFBIXMQNM-UHFFFAOYSA-N	392588	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-5-((3-chloro-8- fluoroquinolin-6-yl)methyl)-1,3,4- oxadiazole-2-carboxamide::US10301284, Example 75::US10781200, Example 75	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392588	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392588&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178316	404960918							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784591	Cc1cc(N)nc(C)c1CNC(=O)c1nn(Cc2ccc3ncc(Cl)cc3c2)c2ccnc(C#N)c12	InChI=1S/C26H21ClN8O/c1-14-7-23(29)33-15(2)19(14)12-32-26(36)25-24-21(10-28)30-6-5-22(24)35(34-25)13-16-3-4-20-17(8-16)9-18(27)11-31-20/h3-9,11H,12-13H2,1-2H3,(H2,29,33)(H,32,36)	NXUPLLOGEOCWIG-UHFFFAOYSA-N	392589	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-4-cyano-1H-pyrazolo[4,3- c]pyridine-3-carboxamide::US10301284, Example 76::US10781200, Example 76	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392589	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392589&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178075	404960919							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784592	Cc1nc(N)ccc1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)nc1C#N	InChI=1S/C22H18ClN7O/c1-13-15(3-5-21(25)28-13)9-27-22(31)18-12-30(29-20(18)8-24)11-14-2-4-19-16(6-14)7-17(23)10-26-19/h2-7,10,12H,9,11H2,1H3,(H2,25,28)(H,27,31)	OMXOVARZDRTMGD-UHFFFAOYSA-N	392590	N-((6-amino-2-methylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-3-cyano-1H-pyrazole-4- carboxamide::US10301284, Example 77::US10781200, Example 77	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392590	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392590&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178076	404960920							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784593	Cc1cnc2c(cc(Cn3cc(C(=O)NCc4c(C)cc(N)nc4C)c(n3)C#N)cc2c1)C(N)=O	InChI=1S/C25H24N8O2/c1-13-4-17-6-16(7-18(24(28)34)23(17)29-9-13)11-33-12-20(21(8-26)32-33)25(35)30-10-19-14(2)5-22(27)31-15(19)3/h4-7,9,12H,10-11H2,1-3H3,(H2,27,31)(H2,28,34)(H,30,35)	KWOBNPHUEXOCGN-UHFFFAOYSA-N	392591	6-((4-(((6-amino-2,4-dimethylpyridin- 3-yl)methyl)carbamoyl)-3-cyano-1H- pyrazol-1-yl)methyl)-3- methylquinoline-8-carboxamide::US10301284, Example 78::US10781200, Example 78	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392591	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392591&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178624	404960921							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784594	Cc1nc(N)ccc1CNC(=O)c1nnc(Cc2ccc3ncc(Cl)cc3c2)o1	InChI=1S/C20H17ClN6O2/c1-11-13(3-5-17(22)25-11)9-24-19(28)20-27-26-18(29-20)7-12-2-4-16-14(6-12)8-15(21)10-23-16/h2-6,8,10H,7,9H2,1H3,(H2,22,25)(H,24,28)	AQHZJJWUYYGRQM-UHFFFAOYSA-N	392592	N-((6-amino-2-methylpyridin-3- yl)methyl)-5-((3-chloroquinolin-6- yl)methyl)-1,3,4-oxadiazole-2- carboxamide::US10301284, Example 79::US10781200, Example 79	Plasma kallikrein			 550							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392592	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392592&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178763	404960922							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784595	Cc1cc(N)nc(C)c1CNC(=O)c1cnc(o1)C(=O)c1ccc2ncc(Cl)cc2c1	InChI=1S/C22H18ClN5O3/c1-11-5-19(24)28-12(2)16(11)9-26-21(30)18-10-27-22(31-18)20(29)13-3-4-17-14(6-13)7-15(23)8-25-17/h3-8,10H,9H2,1-2H3,(H2,24,28)(H,26,30)	GTELKVRQDBZNKH-UHFFFAOYSA-N	392593	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-2-(3-chloroquinoline-6- carbonyl)oxazole-5-carboxamide::US10301284, Example 80::US10781200, Example 80	Plasma kallikrein			>10000							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392593	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392593&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178255	404960923							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784596	Cc1cnc2ccc(Cn3cc(C(=O)NCc4c(C)cc(N)nc4C)c(n3)C#N)cc2c1	InChI=1S/C24H23N7O/c1-14-6-18-8-17(4-5-21(18)27-10-14)12-31-13-20(22(9-25)30-31)24(32)28-11-19-15(2)7-23(26)29-16(19)3/h4-8,10,13H,11-12H2,1-3H3,(H2,26,29)(H,28,32)	RJJTWNPAAKOFGC-UHFFFAOYSA-N	392594	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-3-cyano-1-((3- methylquinolin-6-yl)methyl)-1H- pyrazole-4-carboxamide::US10301284, Example 81::US10781200, Example 81	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392594	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392594&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178770	404960924							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784597	Cc1cnc2ccc(Cn3cc(C(=O)NCc4ccc(N)nc4C)c(n3)C#N)cc2c1	InChI=1S/C23H21N7O/c1-14-7-18-8-16(3-5-20(18)26-10-14)12-30-13-19(21(9-24)29-30)23(31)27-11-17-4-6-22(25)28-15(17)2/h3-8,10,13H,11-12H2,1-2H3,(H2,25,28)(H,27,31)	VLKMZUJBTBGDEX-UHFFFAOYSA-N	392595	N-((6-amino-2-methylpyridin-3- yl)methyl)-3-cyano-1-((3- methylquinolin-6-yl)methyl)-1H- pyrazole-4-carboxamide::US10301284, Example 82::US10781200, Example 82	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392595	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392595&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178090	404960925							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784598	Cc1nc(N)ccc1CNC(=O)c1coc(Cc2ccc3ncc(Cl)cc3c2)n1	InChI=1S/C21H18ClN5O2/c1-12-14(3-5-19(23)26-12)9-25-21(28)18-11-29-20(27-18)7-13-2-4-17-15(6-13)8-16(22)10-24-17/h2-6,8,10-11H,7,9H2,1H3,(H2,23,26)(H,25,28)	STTJLBAGARXCNC-UHFFFAOYSA-N	392596	N-((6-amino-2-methylpyridin-3- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)oxazole-4-carboxamide::US10301284, Example 83::US10781200, Example 83	Plasma kallikrein			 550							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392596	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392596&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178093	404960926							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784599	Cc1nc(N)ccc1CNC(=O)c1ncc(Cc2ccc3ncc(Cl)cc3c2)o1	InChI=1S/C21H18ClN5O2/c1-12-14(3-5-19(23)27-12)9-25-20(28)21-26-11-17(29-21)7-13-2-4-18-15(6-13)8-16(22)10-24-18/h2-6,8,10-11H,7,9H2,1H3,(H2,23,27)(H,25,28)	DVQVQRZIBKJHBQ-UHFFFAOYSA-N	392597	N-((6-amino-2-methylpyridin-3- yl)methyl)-5-((3-chloroquinolin-6- yl)methyl)oxazole-2-carboxamide::US10301284, Example 84::US10781200, Example 84	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392597	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392597&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178094	404960927							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784600	Cc1nn(Cc2ccc3ncc(Cl)cc3c2)cc1C(=O)NCc1ccc(N)nc1C	InChI=1S/C22H21ClN6O/c1-13-16(4-6-21(24)27-13)9-26-22(30)19-12-29(28-14(19)2)11-15-3-5-20-17(7-15)8-18(23)10-25-20/h3-8,10,12H,9,11H2,1-2H3,(H2,24,27)(H,26,30)	VMLILBWSDVWDGN-UHFFFAOYSA-N	392598	N-((6-amino-2-methylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-3-methyl-1H-pyrazole-4- carboxamide::US10301284, Example 85::US10781200, Example 85	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392598	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392598&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178243	404960928							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784601	Cc1cc(N)nc(C)c1CNC(=O)c1nnc(Cc2cc(c3ncc(Cl)cc3c2)C(C)(C)O)o1	InChI=1S/C24H25ClN6O3/c1-12-5-19(26)29-13(2)17(12)11-28-22(32)23-31-30-20(34-23)8-14-6-15-9-16(25)10-27-21(15)18(7-14)24(3,4)33/h5-7,9-10,33H,8,11H2,1-4H3,(H2,26,29)(H,28,32)	XOKNJAVPHRBBRO-UHFFFAOYSA-N	392599	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-5-((3-chloro-8-(2- hydroxypropan-2-yl)quinolin-6- yl)methyl)-1,3,4-oxadiazole-2- carboxamide::US10301284, Example 86::US10781200, Example 86	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392599	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392599&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178326	404960929							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784602	Cc1cc(N)nc(C)c1CNC(=O)c1oc(Cc2ccc3ncc(Cl)cc3c2)nc1C#N	InChI=1S/C23H19ClN6O2/c1-12-5-20(26)29-13(2)17(12)11-28-23(31)22-19(9-25)30-21(32-22)7-14-3-4-18-15(6-14)8-16(24)10-27-18/h3-6,8,10H,7,11H2,1-2H3,(H2,26,29)(H,28,31)	KUUZATFFKQICAR-UHFFFAOYSA-N	392600	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)-4-cyanooxazole-5- carboxamide::US10301284, Example 87::US10781200, Example 87	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392600	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392600&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178781	404960930							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784603	Cc1nc(N)ccc1CNC(=O)c1oc(Cc2ccc3ncc(Cl)cc3c2)nc1C#N	InChI=1S/C22H17ClN6O2/c1-12-14(3-5-19(25)28-12)10-27-22(30)21-18(9-24)29-20(31-21)7-13-2-4-17-15(6-13)8-16(23)11-26-17/h2-6,8,11H,7,10H2,1H3,(H2,25,28)(H,27,30)	IYMMAGWPLVXHAE-UHFFFAOYSA-N	392601	N-((6-amino-2-methylpyridin-3- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)-4-cyanooxazole-5- carboxamide::US10301284, Example 88::US10781200, Example 88	Plasma kallikrein			 550							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392601	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392601&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178599	404960931							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784604	Cc1cc(N)nc(C)c1CNC(=O)c1cnc(Cc2ccc3ncc(Cl)cc3c2)o1	InChI=1S/C22H20ClN5O2/c1-12-5-20(24)28-13(2)17(12)10-27-22(29)19-11-26-21(30-19)7-14-3-4-18-15(6-14)8-16(23)9-25-18/h3-6,8-9,11H,7,10H2,1-2H3,(H2,24,28)(H,27,29)	BWAYCGGQOLRABV-UHFFFAOYSA-N	392602	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)oxazole-5-carboxamide::US10301284, Example 114::US10301284, Example 89::US10781200, Example 114	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392602	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392602&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178172	404960932							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784605	Cc1nc(N)ccc1CNC(=O)c1cnc(Cc2ccc3ncc(Cl)cc3c2)o1	InChI=1S/C21H18ClN5O2/c1-12-14(3-5-19(23)27-12)9-26-21(28)18-11-25-20(29-18)7-13-2-4-17-15(6-13)8-16(22)10-24-17/h2-6,8,10-11H,7,9H2,1H3,(H2,23,27)(H,26,28)	IDSATTJBDHIOKY-UHFFFAOYSA-N	392603	N-((6-amino-2-methylpyridin-3- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)oxazole-5-carboxamide::US10301284, Example 90::US10781200, Example 90	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392603	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392603&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178649	404960933							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784606	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)nc1C(F)F	InChI=1S/C23H21ClF2N6O/c1-12-5-20(27)30-13(2)17(12)9-29-23(33)18-11-32(31-21(18)22(25)26)10-14-3-4-19-15(6-14)7-16(24)8-28-19/h3-8,11,22H,9-10H2,1-2H3,(H2,27,30)(H,29,33)	LWOLUSSBTVYQPC-UHFFFAOYSA-N	392604	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-3-(difluoromethyl)-1H- pyrazole-4-carboxamide::US10301284, Example 91::US10781200, Example 91	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392604	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392604&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178601	404960934							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784607	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)nc1CO	InChI=1S/C23H23ClN6O2/c1-13-5-22(25)28-14(2)18(13)9-27-23(32)19-11-30(29-21(19)12-31)10-15-3-4-20-16(6-15)7-17(24)8-26-20/h3-8,11,31H,9-10,12H2,1-2H3,(H2,25,28)(H,27,32)	UEIKIRKDOQZEPL-UHFFFAOYSA-N	392605	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-3-(hydroxymethyl)-1H- pyrazole-4-carboxamide::US10301284, Example 92::US10781200, Example 92	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392605	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392605&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134177821	404960935							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784608	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)nc1CF	InChI=1S/C23H22ClFN6O/c1-13-5-22(26)29-14(2)18(13)10-28-23(32)19-12-31(30-21(19)8-25)11-15-3-4-20-16(6-15)7-17(24)9-27-20/h3-7,9,12H,8,10-11H2,1-2H3,(H2,26,29)(H,28,32)	MZZKZOACNKDJAF-UHFFFAOYSA-N	392606	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-3-(fluoromethyl)-1H- pyrazole-4-carboxamide::US10301284, Example 93::US10781200, Example 93	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392606	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392606&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178792	404960936							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784609	CC(O)c1nn(Cc2ccc3ncc(Cl)cc3c2)cc1C(=O)NCc1c(C)cc(N)nc1C	InChI=1S/C24H25ClN6O2/c1-13-6-22(26)29-14(2)19(13)10-28-24(33)20-12-31(30-23(20)15(3)32)11-16-4-5-21-17(7-16)8-18(25)9-27-21/h4-9,12,15,32H,10-11H2,1-3H3,(H2,26,29)(H,28,33)	AIXXOQKKNALNFF-UHFFFAOYSA-N	392607	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-3-(1-hydroxyethyl)-1H- pyrazole-4-carboxamide::US10301284, Example 94::US10781200, Example 94	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392607	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392607&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178108	404960937							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784610	Cc1cc(N)nc(C)c1CNC(=O)c1nn(Cc2ccc3ncc(Cl)cc3c2)nc1C#N	InChI=1S/C22H19ClN8O/c1-12-5-20(25)28-13(2)17(12)10-27-22(32)21-19(8-24)29-31(30-21)11-14-3-4-18-15(6-14)7-16(23)9-26-18/h3-7,9H,10-11H2,1-2H3,(H2,25,28)(H,27,32)	BGBQIVACHOGRQL-UHFFFAOYSA-N	392608	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)-5-cyano-2H-1,2,3-triazole- 4-carboxamide::US10301284, Example 95::US10781200, Example 95	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392608	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392608&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178112	404960938							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784611	Cc1cc(N)nc(C)c1CNC(=O)c1nnc(Cc2ccc3ncc(Cl)cc3c2)[nH]1	InChI=1S/C21H20ClN7O/c1-11-5-18(23)26-12(2)16(11)10-25-21(30)20-27-19(28-29-20)7-13-3-4-17-14(6-13)8-15(22)9-24-17/h3-6,8-9H,7,10H2,1-2H3,(H2,23,26)(H,25,30)(H,27,28,29)	GWZNHJDQNSQXBV-UHFFFAOYSA-N	392609	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-5-((3-chloroquinolin-6- yl)methyl)-4H-1,2,4-triazole-3- carboxamide::US10301284, Example 96::US10781200, Example 96	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392609	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392609&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178628	404960939							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784612	Cc1nc(N)ccc1CNC(=O)c1nnc(Cc2ccc3ncc(Cl)cc3c2)[nH]1	InChI=1S/C20H18ClN7O/c1-11-13(3-5-17(22)25-11)9-24-20(29)19-26-18(27-28-19)7-12-2-4-16-14(6-12)8-15(21)10-23-16/h2-6,8,10H,7,9H2,1H3,(H2,22,25)(H,24,29)(H,26,27,28)	LALNGWBKLQSSFH-UHFFFAOYSA-N	392610	N-((6-amino-2-methylpyridin-3- yl)methyl)-5-((3-chloroquinolin-6- yl)methyl)-4H-1,2,4-triazole-3- carboxamide::US10301284, Example 97::US10781200, Example 97	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392610	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392610&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134177935	404960940							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784613	Cc1cc(N)nc(C)c1CNC(=O)c1nnc(Cc2ccc3ncc(Cl)cc3c2)n1C	InChI=1S/C22H22ClN7O/c1-12-6-19(24)27-13(2)17(12)11-26-22(31)21-29-28-20(30(21)3)8-14-4-5-18-15(7-14)9-16(23)10-25-18/h4-7,9-10H,8,11H2,1-3H3,(H2,24,27)(H,26,31)	KNFHNBUOVPFSSJ-UHFFFAOYSA-N	392611	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-5-((3-chloroquinolin-6- yl)methyl)-4-methyl-4H-1,2,4-triazole- 3-carboxamide::US10301284, Example 98::US10781200, Example 98	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392611	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392611&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178115	404960941							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784614	Cc1cc(N)nc(C)c1CNC(=O)c1nc(Cc2ccc3ncc(Cl)cc3c2)nn1C	InChI=1S/C22H22ClN7O/c1-12-6-19(24)27-13(2)17(12)11-26-22(31)21-28-20(29-30(21)3)8-14-4-5-18-15(7-14)9-16(23)10-25-18/h4-7,9-10H,8,11H2,1-3H3,(H2,24,27)(H,26,31)	WYXVZAJMHRAVCY-UHFFFAOYSA-N	392612	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-3-((3-chloroquinolin-6- yl)methyl)-1-methyl-1H-1,2,4-triazole- 5-carboxamide::US10301284, Example 99::US10781200, Example 99	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392612	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392612&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178430	404960942							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784615	Cc1cc(N)nc(C)c1CNC(=O)c1nc(Br)n(Cc2ccc3ncc(Cl)cc3c2)n1	InChI=1S/C21H19BrClN7O/c1-11-5-18(24)27-12(2)16(11)9-26-20(31)19-28-21(22)30(29-19)10-13-3-4-17-14(6-13)7-15(23)8-25-17/h3-8H,9-10H2,1-2H3,(H2,24,27)(H,26,31)	CAYHJZWPQZWFHQ-UHFFFAOYSA-N	392613	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-5-bromo-1-((3- chloroquinolin-6-yl)methyl)-1H-1,2,4- triazole-3-carboxamide::US10301284, Example 100::US10781200, Example 100	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392613	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392613&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178441	404960943							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784616	Cc1cc(N)nc(C)c1CNC(=O)c1nc(C#N)n(Cc2ccc3ncc(Cl)cc3c2)n1	InChI=1S/C22H19ClN8O/c1-12-5-19(25)28-13(2)17(12)10-27-22(32)21-29-20(8-24)31(30-21)11-14-3-4-18-15(6-14)7-16(23)9-26-18/h3-7,9H,10-11H2,1-2H3,(H2,25,28)(H,27,32)	LUQXRLODCNWAOB-UHFFFAOYSA-N	392614	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-5-cyano-1H-1,2,4-triazole- 3-carboxamide::US10301284, Example 101::US10301284, Example 107::US10781200, Example 108	Plasma kallikrein			>10000							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392614	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392614&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178440	404960944							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784617	COC(=O)c1nc(nn1Cc1ccc2ncc(Cl)cc2c1)C(=O)NCc1c(C)cc(N)nc1C	InChI=1S/C23H22ClN7O3/c1-12-6-19(25)28-13(2)17(12)10-27-22(32)20-29-21(23(33)34-3)31(30-20)11-14-4-5-18-15(7-14)8-16(24)9-26-18/h4-9H,10-11H2,1-3H3,(H2,25,28)(H,27,32)	PDBYDGASNRJXIH-UHFFFAOYSA-N	392615	US10301284, Example 102::US10781200, Example 102::methyl 3-(((6-amino-2,4- dimethylpyridin-3- yl)methyl)carbamoyl)-1-((3- chloroquinolin-6-yl)methyl)-1H-1,2,4- triazole-5-carboxylate	Plasma kallikrein			>10000							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392615	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392615&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178456	404960945							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784618	Cc1cc(N)nc(C)c1CNC(=O)c1c[nH]c(Cc2ccc3ncc(Cl)cc3c2)n1	InChI=1S/C22H21ClN6O/c1-12-5-20(24)28-13(2)17(12)10-27-22(30)19-11-26-21(29-19)7-14-3-4-18-15(6-14)8-16(23)9-25-18/h3-6,8-9,11H,7,10H2,1-2H3,(H2,24,28)(H,26,29)(H,27,30)	HEBXTXYICXOMQA-UHFFFAOYSA-N	392616	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)-1H-imidazole-4- carboxamide::US10301284, Example 103::US10781200, Example 103	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392616	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392616&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178458	404960946							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784619	Cc1cc(N)nc(C)c1CNC(=O)c1cn(C)c(Cc2ccc3ncc(Cl)cc3c2)n1	InChI=1S/C23H23ClN6O/c1-13-6-21(25)28-14(2)18(13)11-27-23(31)20-12-30(3)22(29-20)8-15-4-5-19-16(7-15)9-17(24)10-26-19/h4-7,9-10,12H,8,11H2,1-3H3,(H2,25,28)(H,27,31)	UPEWXEYBWGKXKU-UHFFFAOYSA-N	392617	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)-1-methyl-1H-imidazole-4- carboxamide::US10301284, Example 104::US10781200, Example 104	Plasma kallikrein			>10000							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392617	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392617&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178455	404960947							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784620	Cc1cc(N)nc(C)c1CNC(=O)c1cnc(Cc2ccc3ncc(Cl)cc3c2)n1C	InChI=1S/C23H23ClN6O/c1-13-6-21(25)29-14(2)18(13)11-28-23(31)20-12-27-22(30(20)3)8-15-4-5-19-16(7-15)9-17(24)10-26-19/h4-7,9-10,12H,8,11H2,1-3H3,(H2,25,29)(H,28,31)	JKDTYUNBKGFNIV-UHFFFAOYSA-N	392618	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)-1-methyl-1H-imidazole-5- carboxamide::US10301284, Example 105::US10781200, Example 105	Plasma kallikrein			 5500							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392618	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392618&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134177927	404960948							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784621	Cc1cc(N)nc(C)c1CNC(=O)c1[nH]c(Cc2ccc3ncc(Cl)cc3c2)nc1Br	InChI=1S/C22H20BrClN6O/c1-11-5-18(25)28-12(2)16(11)10-27-22(31)20-21(23)30-19(29-20)7-13-3-4-17-14(6-13)8-15(24)9-26-17/h3-6,8-9H,7,10H2,1-2H3,(H2,25,28)(H,27,31)(H,29,30)	XEFKTWYRQYYWNW-UHFFFAOYSA-N	392619	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-4-bromo-2-((3- chloroquinolin-6-yl)methyl)-1H- imidazole-5-carboxamide::US10301284, Example 106::US10781200, Example 106	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392619	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392619&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178120	404960949							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784622	Cc1cc(N)nc(C)c1CNC(=O)c1nc(C#N)n(Cc2ccc3ncc(Cl)cc3c2)n1	InChI=1S/C22H19ClN8O/c1-12-5-19(25)28-13(2)17(12)10-27-22(32)21-29-20(8-24)31(30-21)11-14-3-4-18-15(6-14)7-16(23)9-26-18/h3-7,9H,10-11H2,1-2H3,(H2,25,28)(H,27,32)	LUQXRLODCNWAOB-UHFFFAOYSA-N	392614	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-5-cyano-1H-1,2,4-triazole- 3-carboxamide::US10301284, Example 101::US10301284, Example 107::US10781200, Example 108	Plasma kallikrein			 550							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392614	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392614&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178440	404960944							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784623	Cc1cc(N)nc(C)c1CNC(=O)c1cc(C#N)n(Cc2ccc3ncc(Cl)cc3c2)n1	InChI=1S/C23H20ClN7O/c1-13-5-22(26)29-14(2)19(13)11-28-23(32)21-8-18(9-25)31(30-21)12-15-3-4-20-16(6-15)7-17(24)10-27-20/h3-8,10H,11-12H2,1-2H3,(H2,26,29)(H,28,32)	SHLOCLXTJRSXMR-UHFFFAOYSA-N	392621	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-5-cyano-1H-pyrazole-3- carboxamide::US10301284, Example 108	Plasma kallikrein			 550							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392621	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392621&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134177940	404960950							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784624	Cc1cc(N)nc(C)c1CNC(=O)c1cc(nn1Cc1ccc2ncc(Cl)cc2c1)C#N	InChI=1S/C23H20ClN7O/c1-13-5-22(26)29-14(2)19(13)11-28-23(32)21-8-18(9-25)30-31(21)12-15-3-4-20-16(6-15)7-17(24)10-27-20/h3-8,10H,11-12H2,1-2H3,(H2,26,29)(H,28,32)	CFWIUGJZUJJTDD-UHFFFAOYSA-N	392622	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-3-cyano-1H-pyrazole-5- carboxamide::US10301284, Example 109::US10781200, Example 109	Plasma kallikrein			>10000							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392622	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392622&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178125	404960951							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784625	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)c(CO)n1	InChI=1S/C23H23ClN6O2/c1-13-5-21(25)28-14(2)18(13)9-27-23(32)20-11-30(22(12-31)29-20)10-15-3-4-19-16(6-15)7-17(24)8-26-19/h3-8,11,31H,9-10,12H2,1-2H3,(H2,25,28)(H,27,32)	JDLJMUVSMCYMMH-UHFFFAOYSA-N	392623	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-2-(hydroxymethyl)-1H- imidazole-4-carboxamide::US10301284, Example 110::US10781200, Example 110	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392623	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392623&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178434	404960952							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784626	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)c(n1)C(O)=O	InChI=1S/C23H21ClN6O3/c1-12-5-20(25)28-13(2)17(12)9-27-22(31)19-11-30(21(29-19)23(32)33)10-14-3-4-18-15(6-14)7-16(24)8-26-18/h3-8,11H,9-10H2,1-2H3,(H2,25,28)(H,27,31)(H,32,33)	YCRVBUXHOFRAEK-UHFFFAOYSA-N	392624	N4-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-1H-imidazole-2,4- dicarboxamide::US10301284, Example 111	Plasma kallikrein			 550							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392624	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392624&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			138658478	404960953							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784627	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)c(CN)n1	InChI=1S/C23H24ClN7O/c1-13-5-21(26)29-14(2)18(13)10-28-23(32)20-12-31(22(8-25)30-20)11-15-3-4-19-16(6-15)7-17(24)9-27-19/h3-7,9,12H,8,10-11,25H2,1-2H3,(H2,26,29)(H,28,32)	UMSUITBTAXIOKI-UHFFFAOYSA-N	392625	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-2-(aminomethyl)-1-((3- chloroquinolin-6-yl)methyl)-1H- imidazole-4-carboxamide::US10301284, Example 112::US10781200, Example 112	Plasma kallikrein			 550							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392625	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392625&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178616	404960954							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784628	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)c(n1)C#N	InChI=1S/C23H20ClN7O/c1-13-5-21(26)29-14(2)18(13)10-28-23(32)20-12-31(22(8-25)30-20)11-15-3-4-19-16(6-15)7-17(24)9-27-19/h3-7,9,12H,10-11H2,1-2H3,(H2,26,29)(H,28,32)	QRFIOVQERIMLRW-UHFFFAOYSA-N	392626	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-2-cyano-1H-imidazole-4- carboxamide::US10301284, Example 113::US10781200, Example 113	Plasma kallikrein			 550							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392626	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392626&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178350	404960955							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784629	Cc1cc(N)nc(C)c1CNC(=O)c1cnc(Cc2ccc3ncc(Cl)cc3c2)o1	InChI=1S/C22H20ClN5O2/c1-12-5-20(24)28-13(2)17(12)10-27-22(29)19-11-26-21(30-19)7-14-3-4-18-15(6-14)8-16(23)9-25-18/h3-6,8-9,11H,7,10H2,1-2H3,(H2,24,28)(H,27,29)	BWAYCGGQOLRABV-UHFFFAOYSA-N	392602	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)oxazole-5-carboxamide::US10301284, Example 114::US10301284, Example 89::US10781200, Example 114	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392602	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392602&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178172	404960932							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784630	Cc1cc(N)nc(C)c1CNC(=O)c1nn(Cc2ccc3ncc(Cl)cc3c2)nc1C(F)(F)F	InChI=1S/C22H19ClF3N7O/c1-11-5-18(27)30-12(2)16(11)9-29-21(34)19-20(22(24,25)26)32-33(31-19)10-13-3-4-17-14(6-13)7-15(23)8-28-17/h3-8H,9-10H2,1-2H3,(H2,27,30)(H,29,34)	QVJZSLPTEPTTJN-UHFFFAOYSA-N	392628	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)-5-(trifluoromethyl)-2H- 1,2,3-triazole-4-carboxamide::US10301284, Example 115::US10781200, Example 115	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392628	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392628&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178693	404960956							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784631	Cc1cc(N)nc(C)c1CNC(=O)c1cc(n(Cc2ccc3ncc(Cl)cc3c2)n1)C(F)(F)F	InChI=1S/C23H20ClF3N6O/c1-12-5-21(28)31-13(2)17(12)10-30-22(34)19-8-20(23(25,26)27)33(32-19)11-14-3-4-18-15(6-14)7-16(24)9-29-18/h3-9H,10-11H2,1-2H3,(H2,28,31)(H,30,34)	DDSXVVAYYHCPAS-UHFFFAOYSA-N	392629	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-5-(trifluoromethyl)-1H- pyrazole-3-carboxamide::US10301284, Example 116::US10781200, Example 116	Plasma kallikrein			 5500							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392629	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392629&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178640	404960957							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784632	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)c2cnc(Cl)cc12	InChI=1S/C26H22Cl2N6O/c1-14-5-25(29)33-15(2)20(14)10-32-26(35)21-13-34(23-11-31-24(28)8-19(21)23)12-16-3-4-22-17(6-16)7-18(27)9-30-22/h3-9,11,13H,10,12H2,1-2H3,(H2,29,33)(H,32,35)	VSUOKEQGVUESPJ-UHFFFAOYSA-N	392630	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-5-chloro-1-((3- chloroquinolin-6-yl)methyl)-1H- pyrrolo[2,3-c]pyridine-3-carboxamide::US10301284, Example 117::US10781200, Example 117	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392630	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392630&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178358	404960958							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784633	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)c2cc[nH]c(=O)c12	InChI=1S/C26H23ClN6O2/c1-14-7-23(28)32-15(2)19(14)11-31-25(34)20-13-33(22-5-6-29-26(35)24(20)22)12-16-3-4-21-17(8-16)9-18(27)10-30-21/h3-10,13H,11-12H2,1-2H3,(H2,28,32)(H,29,35)(H,31,34)	ILKWFMJGGDAPRD-UHFFFAOYSA-N	392631	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-4-oxo-4,5-dihydro-1H- pyrrolo[3,2-c]pyridine-3-carboxamide::US10301284, Example 118::US10781200, Example 118	Plasma kallikrein			>10000							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392631	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392631&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			146012335	404960959							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784634	Cc1cc(N)nc(C)c1CNC(=O)c1nn(Cc2ccc3ncc(Cl)cc3c2)c2ccnc(Cl)c12	InChI=1S/C25H21Cl2N7O/c1-13-7-21(28)32-14(2)18(13)11-31-25(35)23-22-20(5-6-29-24(22)27)34(33-23)12-15-3-4-19-16(8-15)9-17(26)10-30-19/h3-10H,11-12H2,1-2H3,(H2,28,32)(H,31,35)	YVVUSFNKWIJDRO-UHFFFAOYSA-N	392632	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-4-chloro-1-((3- chloroquinolin-6-yl)methyl)-1H- pyrazolo[4,3-c]pyridine-3- carboxamide::US10301284, Example 119::US10781200, Example 119	Plasma kallikrein			 550							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392632	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392632&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178824	404960960							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784635	Cc1cc(N)nc(C)c1CNC(=O)c1nn(Cc2ccc3ncc(Cl)cc3c2)c2cc[nH]c(=O)c12	InChI=1S/C25H22ClN7O2/c1-13-7-21(27)31-14(2)18(13)11-30-25(35)23-22-20(5-6-28-24(22)34)33(32-23)12-15-3-4-19-16(8-15)9-17(26)10-29-19/h3-10H,11-12H2,1-2H3,(H2,27,31)(H,28,34)(H,30,35)	JGZHQZLALCTIAI-UHFFFAOYSA-N	392633	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-4-oxo-4,5-dihydro-1H- pyrazolo[4,3-c]pyridine-3- carboxamide::US10301284, Example 120::US10781200, Example 120	Plasma kallikrein			 5500							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392633	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392633&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			146012336	404960961							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784636	COc1cc2c(cn(Cc3ccc4ncc(Cl)cc4c3)c2cn1)C(=O)NCc1c(C)cc(N)nc1C	InChI=1S/C27H25ClN6O2/c1-15-6-25(29)33-16(2)21(15)11-32-27(35)22-14-34(24-12-31-26(36-3)9-20(22)24)13-17-4-5-23-18(7-17)8-19(28)10-30-23/h4-10,12,14H,11,13H2,1-3H3,(H2,29,33)(H,32,35)	LWJZROFHXJWOKM-UHFFFAOYSA-N	392634	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-5-methoxy-1H-pyrrolo[2,3- c]pyridine-3-carboxamide::US10301284, Example 121::US10781200, Example 121	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392634	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392634&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134177829	404960962							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784637	COc1cc2c(nn(Cc3ccc4ncc(Cl)cc4c3)c2cn1)C(=O)NCc1c(C)cc(N)nc1C	InChI=1S/C26H24ClN7O2/c1-14-6-23(28)32-15(2)20(14)11-31-26(35)25-19-9-24(36-3)30-12-22(19)34(33-25)13-16-4-5-21-17(7-16)8-18(27)10-29-21/h4-10,12H,11,13H2,1-3H3,(H2,28,32)(H,31,35)	PSAXJTGHLNJLPE-UHFFFAOYSA-N	392635	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-5-methoxy-1H- pyrazolo[3,4-c]pyridine-3- carboxamide::US10301284, Example 122::US10781200, Example 122	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392635	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392635&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178921	404960963							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784638	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)c2cncc(C#N)c12	InChI=1S/C27H22ClN7O/c1-15-5-25(30)34-16(2)21(15)11-33-27(36)22-14-35(24-12-31-9-19(8-29)26(22)24)13-17-3-4-23-18(6-17)7-20(28)10-32-23/h3-7,9-10,12,14H,11,13H2,1-2H3,(H2,30,34)(H,33,36)	SSGRYFOBYQPFKP-UHFFFAOYSA-N	392636	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-4-cyano-1H-pyrrolo[2,3- c]pyridine-3-carboxamide::US10301284, Example 123::US10781200, Example 123	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392636	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392636&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178629	404960964							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784639	Cc1cc(N)nc(C)c1CNC(=O)c1nn(Cc2ccc3ncc(Cl)cc3c2)c2c[nH]c(=O)cc12	InChI=1S/C25H22ClN7O2/c1-13-5-22(27)31-14(2)19(13)10-30-25(35)24-18-8-23(34)29-11-21(18)33(32-24)12-15-3-4-20-16(6-15)7-17(26)9-28-20/h3-9,11H,10,12H2,1-2H3,(H2,27,31)(H,29,34)(H,30,35)	IBWIDFNSDDXQSS-UHFFFAOYSA-N	392637	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-5-oxo-5,6-dihydro-1H- pyrazolo[3,4-c]pyridine-3- carboxamide::US10301284, Example 124::US10781200, Example 124	Plasma kallikrein			 550							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392637	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392637&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			146012337	404960965							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784640	Cc1nc(N)ccc1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)c2ccc(=O)[nH]c12	InChI=1S/C25H21ClN6O2/c1-14-16(3-6-22(27)30-14)10-29-25(34)19-13-32(21-5-7-23(33)31-24(19)21)12-15-2-4-20-17(8-15)9-18(26)11-28-20/h2-9,11,13H,10,12H2,1H3,(H2,27,30)(H,29,34)(H,31,33)	IWDBVKCJUBGXNQ-UHFFFAOYSA-N	392638	N-((6-amino-2-methylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-5-oxo-4,5-dihydro-1H- pyrrolo[3,2-b]pyridine-3-carboxamide::US10301284, Example 125::US10781200, Example 125	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392638	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392638&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			146012338	404960966							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784641	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)c2ccc(=O)[nH]c12	InChI=1S/C26H23ClN6O2/c1-14-7-23(28)31-15(2)19(14)11-30-26(35)20-13-33(22-5-6-24(34)32-25(20)22)12-16-3-4-21-17(8-16)9-18(27)10-29-21/h3-10,13H,11-12H2,1-2H3,(H2,28,31)(H,30,35)(H,32,34)	ZSIYFIYIEHIJSA-UHFFFAOYSA-N	392639	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-5-oxo-4,5-dihydro-1H- pyrrolo[3,2-b]pyridine-3-carboxamide::US10301284, Example 126::US10781200, Example 126	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392639	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392639&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			146012339	404960967							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784642	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)c2nccc(C#N)c12	InChI=1S/C27H22ClN7O/c1-15-7-24(30)34-16(2)21(15)12-33-27(36)22-14-35(26-25(22)18(10-29)5-6-31-26)13-17-3-4-23-19(8-17)9-20(28)11-32-23/h3-9,11,14H,12-13H2,1-2H3,(H2,30,34)(H,33,36)	HFIDVVPXOSGIDQ-UHFFFAOYSA-N	392640	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-4-cyano-1H-pyrrolo[2,3- b]pyridine-3-carboxamide::US10301284, Example 127::US10781200, Example 127	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392640	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392640&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178151	404960968							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784643	COc1ccc2n(Cc3ccc4ncc(Cl)cc4c3)cc(C(=O)NCc3c(C)cc(N)nc3C)c2n1	InChI=1S/C27H25ClN6O2/c1-15-8-24(29)32-16(2)20(15)12-31-27(35)21-14-34(23-6-7-25(36-3)33-26(21)23)13-17-4-5-22-18(9-17)10-19(28)11-30-22/h4-11,14H,12-13H2,1-3H3,(H2,29,32)(H,31,35)	VWMBRYCYRNXPCV-UHFFFAOYSA-N	392641	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-5-methoxy-1H-pyrrolo[3,2- b]pyridine-3-carboxamide::US10301284, Example 128::US10781200, Example 128	Plasma kallikrein			 5500							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392641	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392641&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178707	404960969							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784644	Cc1cc(N)nc(C)c1CNC(=O)c1nn(Cc2ccc3ncc(Cl)cc3c2)c2cncc(C#N)c12	InChI=1S/C26H21ClN8O/c1-14-5-23(29)33-15(2)20(14)11-32-26(36)25-24-18(8-28)9-30-12-22(24)35(34-25)13-16-3-4-21-17(6-16)7-19(27)10-31-21/h3-7,9-10,12H,11,13H2,1-2H3,(H2,29,33)(H,32,36)	DOYCANBVVULGAM-UHFFFAOYSA-N	392642	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-4-cyano-1H-pyrazolo[3,4- c]pyridine-3-carboxamide::US10301284, Example 129::US10781200, Example 129	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392642	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392642&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178160	404960970							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784645	Cc1cc(N)nc(C)c1CNC(=O)c1nn(Cc2ccc3ncc(Cl)cc3c2)c2cnc(cc12)C#N	InChI=1S/C26H21ClN8O/c1-14-5-24(29)33-15(2)21(14)11-32-26(36)25-20-8-19(9-28)30-12-23(20)35(34-25)13-16-3-4-22-17(6-16)7-18(27)10-31-22/h3-8,10,12H,11,13H2,1-2H3,(H2,29,33)(H,32,36)	UQNSZONADWWBQT-UHFFFAOYSA-N	392643	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-5-cyano-1H-pyrazolo[3,4- c]pyridine-3-carboxamide::US10301284, Example 130::US10781200, Example 130	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392643	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392643&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178150	404960971							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784646	COc1ncnc2n(Cc3ccc4ncc(Cl)cc4c3)cc(C(=O)NCc3c(C)cc(N)nc3C)c12	InChI=1S/C26H24ClN7O2/c1-14-6-22(28)33-15(2)19(14)10-30-25(35)20-12-34(24-23(20)26(36-3)32-13-31-24)11-16-4-5-21-17(7-16)8-18(27)9-29-21/h4-9,12-13H,10-11H2,1-3H3,(H2,28,33)(H,30,35)	CBZIOLZYDJEJLE-UHFFFAOYSA-N	392644	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-7-((3-chloroquinolin-6- yl)methyl)-4-methoxy-7H-pyrrolo[2,3- d]pyrimidine-5-carboxamide::US10301284, Example 131::US10781200, Example 131	Plasma kallikrein			 550							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392644	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392644&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178648	404960972							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784647	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)c2nc[nH]c(=O)c12	InChI=1S/C25H22ClN7O2/c1-13-5-21(27)32-14(2)18(13)9-29-24(34)19-11-33(23-22(19)25(35)31-12-30-23)10-15-3-4-20-16(6-15)7-17(26)8-28-20/h3-8,11-12H,9-10H2,1-2H3,(H2,27,32)(H,29,34)(H,30,31,35)	ZHYZSRYMWVTPNS-UHFFFAOYSA-N	392645	BDBM463686::N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-7-((3-chloroquinolin-6- yl)methyl)-4-oxo-4,7-dihydro-3H- pyrrolo[2,3-d]pyrimidine-5- carboxamide::US10301284, Example 132	Plasma kallikrein			>10000							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392645	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392645&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			146012340	404960973							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784648	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)c2ccnc(C#N)c12	InChI=1S/C27H22ClN7O/c1-15-7-25(30)34-16(2)20(15)12-33-27(36)21-14-35(24-5-6-31-23(10-29)26(21)24)13-17-3-4-22-18(8-17)9-19(28)11-32-22/h3-9,11,14H,12-13H2,1-2H3,(H2,30,34)(H,33,36)	FBWMCRMTDWAWGR-UHFFFAOYSA-N	392646	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-4-cyano-1H-pyrrolo[3,2- c]pyridine-3-carboxamide::US10301284, Example 133::US10781200, Example 133	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392646	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392646&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178831	404960974							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784649	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)c2cnc(cc12)C#N	InChI=1S/C27H22ClN7O/c1-15-5-26(30)34-16(2)22(15)11-33-27(36)23-14-35(25-12-31-20(9-29)8-21(23)25)13-17-3-4-24-18(6-17)7-19(28)10-32-24/h3-8,10,12,14H,11,13H2,1-2H3,(H2,30,34)(H,33,36)	ZZZYLKQDEHLLEY-UHFFFAOYSA-N	392647	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-5-cyano-1H-pyrrolo[2,3- c]pyridine-3-carboxamide::US10301284, Example 134::US10781200, Example 134	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392647	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392647&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178983	404960975							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784650	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)c2ncc(cc12)C#N	InChI=1S/C27H22ClN7O/c1-15-5-25(30)34-16(2)22(15)12-33-27(36)23-14-35(26-21(23)7-18(9-29)10-32-26)13-17-3-4-24-19(6-17)8-20(28)11-31-24/h3-8,10-11,14H,12-13H2,1-2H3,(H2,30,34)(H,33,36)	XUQVNZYJNNIDSK-UHFFFAOYSA-N	392648	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-5-cyano-1H-pyrrolo[2,3- b]pyridine-3-carboxamide::US10301284, Example 135::US10781200, Example 135	Plasma kallikrein			 550							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392648	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392648&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134177819	404960976							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784651	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)c2ncnc(C#N)c12	InChI=1S/C26H21ClN8O/c1-14-5-23(29)34-15(2)19(14)10-31-26(36)20-12-35(25-24(20)22(8-28)32-13-33-25)11-16-3-4-21-17(6-16)7-18(27)9-30-21/h3-7,9,12-13H,10-11H2,1-2H3,(H2,29,34)(H,31,36)	JEVRMRCQEQRXPS-UHFFFAOYSA-N	392649	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-7-((3-chloroquinolin-6- yl)methyl)-4-cyano-7H-pyrrolo[2,3- d]pyrimidine-5-carboxamide::US10301284, Example 136::US10781200, Example 136	Plasma kallikrein			 550							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392649	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392649&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178388	404960977							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784652	COc1ccc2n(Cc3ccc4ncc(Cl)cc4c3)nc(C(=O)NCc3c(C)cc(N)nc3C)c2n1	InChI=1S/C26H24ClN7O2/c1-14-8-22(28)31-15(2)19(14)12-30-26(35)25-24-21(6-7-23(32-24)36-3)34(33-25)13-16-4-5-20-17(9-16)10-18(27)11-29-20/h4-11H,12-13H2,1-3H3,(H2,28,31)(H,30,35)	ZSWVBLZEEQRHJX-UHFFFAOYSA-N	392650	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-5-methoxy-1H- pyrazolo[4,3-b]pyridine-3- carboxamide::US10301284, Example 137::US10781200, Example 137	Plasma kallikrein			 550							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392650	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392650&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178404	404960978							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784653	Cc1cc(N)nc(C)c1CNC(=O)c1nn(Cc2ccc3ncc(Cl)cc3c2)c2ccc(=O)[nH]c12	InChI=1S/C25H22ClN7O2/c1-13-7-21(27)30-14(2)18(13)11-29-25(35)24-23-20(5-6-22(34)31-23)33(32-24)12-15-3-4-19-16(8-15)9-17(26)10-28-19/h3-10H,11-12H2,1-2H3,(H2,27,30)(H,29,35)(H,31,34)	MSXCHOPMBMEYQZ-UHFFFAOYSA-N	392651	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-5-oxo-4,5-dihydro-1H- pyrazolo[4,3-b]pyridine-3- carboxamide::US10301284, Example 138::US10781200, Example 138	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392651	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392651&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			146012341	404960979							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784654	Cc1nc(N)ccc1CNC(=O)c1nn(Cc2ccc3ncc(Cl)cc3c2)c2ccc(=O)[nH]c12	InChI=1S/C24H20ClN7O2/c1-13-15(3-6-20(26)29-13)10-28-24(34)23-22-19(5-7-21(33)30-22)32(31-23)12-14-2-4-18-16(8-14)9-17(25)11-27-18/h2-9,11H,10,12H2,1H3,(H2,26,29)(H,28,34)(H,30,33)	SUSGOGCPZRQBIA-UHFFFAOYSA-N	392652	N-((6-amino-2-methylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-5-oxo-4,5-dihydro-1H- pyrazolo[4,3-b]pyridine-3- carboxamide::US10301284, Example 139::US10781200, Example 139	Plasma kallikrein			<100							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392652	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392652&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			146012342	404960980							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784655	Cc1cc(N)nc(C)c1CNC(=O)c1n(Cc2ccc3ncc(Cl)cc3c2)nc2cccc(N)c12	InChI=1S/C26H24ClN7O/c1-14-8-23(29)32-15(2)19(14)12-31-26(35)25-24-20(28)4-3-5-22(24)33-34(25)13-16-6-7-21-17(9-16)10-18(27)11-30-21/h3-11H,12-13,28H2,1-2H3,(H2,29,32)(H,31,35)	VXICWXMHAZNFJG-UHFFFAOYSA-N	392653	4-amino-N-((6-amino-2,4- dimethylpyridin-3-yl)methyl)-2-((3- chloroquinolin-6-yl)methyl)-2H- indazole-3-carboxamide::US10301284, Example 140::US10781200, Example 140	Plasma kallikrein			>10000							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392653	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392653&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			138658600	404960981							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784656	Cc1cc(N)nc(C)c1CNC(=O)c1c(nnn1Cc1ccc2ncc(Cl)cc2c1)C(F)(F)F	InChI=1S/C22H19ClF3N7O/c1-11-5-18(27)30-12(2)16(11)9-29-21(34)19-20(22(24,25)26)31-32-33(19)10-13-3-4-17-14(6-13)7-15(23)8-28-17/h3-8H,9-10H2,1-2H3,(H2,27,30)(H,29,34)	YRRIRNYGGYIAHF-UHFFFAOYSA-N	392654	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-4-(trifluoromethyl)-1H- 1,2,3-triazole-5-carboxamide::US10301284, Example 141::US10781200, Example 141	Plasma kallikrein			>10000							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392654	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392654&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178148	404960982							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
784657	CCOC(=O)c1nc(nn1Cc1ccc2ncc(Cl)cc2c1)C(=O)NCc1c(C)cc(N)nc1C	InChI=1S/C24H24ClN7O3/c1-4-35-24(34)22-30-21(23(33)28-11-18-13(2)7-20(26)29-14(18)3)31-32(22)12-15-5-6-19-16(8-15)9-17(25)10-27-19/h5-10H,4,11-12H2,1-3H3,(H2,26,29)(H,28,33)	FCYBAWFLNBGASR-UHFFFAOYSA-N	392655	US10301284, Example 142::US10781200, Example 142::ethyl 3-(((6-amino-2,4- dimethylpyridin-3- yl)methyl)carbamoyl)-1-((3- chloroquinolin-6-yl)methyl)-1H-1,2,4- triazole-5-carboxylate	Plasma kallikrein			>10000							US Patent		10.7270/Q2CV4M2H		aid1798896	US10301284	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392655	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392655&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135354644	404960983							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755846	NC(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2cc3c(Cl)c[nH]c3cc2F)cc2cc(Cl)cnc12	InChI=1S/C26H18Cl2FN5O2/c27-17-6-15-3-13(5-20(25(30)35)24(15)33-11-17)4-18-7-14(1-2-31-18)26(36)34-10-16-8-19-21(28)12-32-23(19)9-22(16)29/h1-3,5-9,11-12,32H,4,10H2,(H2,30,35)(H,34,36)	QMNRPOHMXWHKMB-UHFFFAOYSA-N	283407	3-chloro-6-((4-(((3-chloro-6-fluoro-1H-indol-5- yl)methyl)carbamoyl)pyridin-2- yl)methyl)quinoline-8-carboxamide::US10023557, Example 59::US10266515, Example 59::US11021463, Example 59::US9611252, Example 59	Plasma kallikrein					 550					US Patent		10.7270/Q2J968P7		aid1798385	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283407	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283407&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665413	378164736							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755847	NC(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2n[nH]c3ccc(Cl)cc23)cc2cc(Cl)cnc12	InChI=1S/C25H18Cl2N6O2/c26-16-1-2-21-19(10-16)22(33-32-21)12-31-25(35)14-3-4-29-18(9-14)6-13-5-15-8-17(27)11-30-23(15)20(7-13)24(28)34/h1-5,7-11H,6,12H2,(H2,28,34)(H,31,35)(H,32,33)	RTJGKEBRSSQCHQ-UHFFFAOYSA-N	283408	3-chloro-6-((4-(((5-chloro-1H-indazol-3- yl)methyl)carbamoyl)pyridin-2- yl)methyl)quinoline-8-carboxamide::US10023557, Example 60::US10266515, Example 60::US10308637, Example 60::US11021463, Example 60::US9611252, Example 60	Plasma kallikrein					 550					US Patent		10.7270/Q2J968P7		aid1798385	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283408	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283408&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665317	378164737							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755848	NC(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2cnc3[nH]cc(Cl)c3c2)cc2cc(Cl)cnc12	InChI=1S/C25H18Cl2N6O2/c26-17-7-16-3-13(5-20(23(28)34)22(16)30-11-17)4-18-8-15(1-2-29-18)25(35)33-10-14-6-19-21(27)12-32-24(19)31-9-14/h1-3,5-9,11-12H,4,10H2,(H2,28,34)(H,31,32)(H,33,35)	QHIFWJFJAOUBPC-UHFFFAOYSA-N	283409	3-chloro-6-((4-(((3-chloro-1H-pyrrolo[2,3- b]pyridin-5-yl)methyl)carbamoyl)pyridin-2- yl)methyl)quinoline-8-carboxamide::US10023557, Example 61::US10266515, Example 61::US10308637, Example 61::US11021463, Example 61::US9611252, Example 61	Plasma kallikrein					 550					US Patent		10.7270/Q2J968P7		aid1798385	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283409	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283409&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665370	378164738							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755849	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2cc(C(N)=O)c3ncc(Cl)cc3c2)c1	InChI=1S/C24H21ClN6O2/c1-13-16(2-3-21(26)31-13)11-30-24(33)15-4-5-28-19(10-15)7-14-6-17-9-18(25)12-29-22(17)20(8-14)23(27)32/h2-6,8-10,12H,7,11H2,1H3,(H2,26,31)(H2,27,32)(H,30,33)	WTBBASBLRSFZPD-UHFFFAOYSA-N	283410	6-((4-(((6-amino-2-methylpyridin-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- chloroquinoline-8-carboxamide::US10023557, Example 62::US10266515, Example 62::US10308637, Example 62::US11021463, Example 62::US9611252, Example 62	Plasma kallikrein					<100					US Patent		10.7270/Q2J968P7		aid1798385	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283410	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283410&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665142	378164739							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755850	NC(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2ccc3c(N)nccc3c2)cc2cc(Cl)cnc12	InChI=1S/C27H21ClN6O2/c28-20-11-19-8-16(10-23(26(30)35)24(19)33-14-20)9-21-12-18(4-5-31-21)27(36)34-13-15-1-2-22-17(7-15)3-6-32-25(22)29/h1-8,10-12,14H,9,13H2,(H2,29,32)(H2,30,35)(H,34,36)	ZEVNHPCICZZSBU-UHFFFAOYSA-N	283412	6-((4-(((1-aminoisoquinolin-6- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- chloroquinoline-8-carboxamide::US10023557, Example 64::US10266515, Example 64::US10308637, Example 64::US11021463, Example 64::US9611252, Example 64	Plasma kallikrein					<100					US Patent		10.7270/Q2J968P7		aid1798385	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283412	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283412&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665252	378164741							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755851	NC(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2ccc3[nH]cc(Cl)c3c2F)cc2cc(Cl)cnc12	InChI=1S/C26H18Cl2FN5O2/c27-17-8-16-5-13(7-19(25(30)35)24(16)33-11-17)6-18-9-14(3-4-31-18)26(36)34-10-15-1-2-21-22(23(15)29)20(28)12-32-21/h1-5,7-9,11-12,32H,6,10H2,(H2,30,35)(H,34,36)	PBEXDTRCFFOFDU-UHFFFAOYSA-N	283413	3-chloro-6-((4-(((3-chloro-4-fluoro-1H-indol-5- yl)methyl)carbamoyl)pyridin-2- yl)methyl)quinoline-8-carboxamide::US10023557, Example 65::US10266515, Example 65::US10308637, Example 65::US11021463, Example 65::US9611252, Example 65	Plasma kallikrein					<100					US Patent		10.7270/Q2J968P7		aid1798385	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283413	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283413&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665414	378164742							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755852	NC(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2cc3cc[nH]c3cc2F)cc2cc(Cl)cnc12	InChI=1S/C26H19ClFN5O2/c27-19-9-17-5-14(7-21(25(29)34)24(17)32-13-19)6-20-10-16(2-3-30-20)26(35)33-12-18-8-15-1-4-31-23(15)11-22(18)28/h1-5,7-11,13,31H,6,12H2,(H2,29,34)(H,33,35)	ZDVUWSXSXIPPGM-UHFFFAOYSA-N	283414	3-chloro-6-((4-(((6-fluoro-1H-indol-5- yl)methyl)carbamoyl)pyridin-2- yl)methyl)quinoline-8-carboxamide::US10023557, Example 66::US10266515, Example 66::US10308637, Example 66::US11021463, Example 66::US9611252, Example 66	Plasma kallikrein					 550					US Patent		10.7270/Q2J968P7		aid1798385	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283414	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283414&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665192	378164743							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755853	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc(c3ncc(Cl)cc3c2)S(C)(=O)=O)c1	InChI=1S/C25H24ClN5O3S/c1-14-6-23(27)31-15(2)21(14)13-30-25(32)17-4-5-28-20(11-17)8-16-7-18-10-19(26)12-29-24(18)22(9-16)35(3,33)34/h4-7,9-12H,8,13H2,1-3H3,(H2,27,31)(H,30,32)	LOAAVKXHIOVCPQ-UHFFFAOYSA-N	283415	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloro-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 67::US10266515, Example 67::US10308637, Example 67::US11021463, Example 67::US9611252, Example 67	Plasma kallikrein					<100					US Patent		10.7270/Q2J968P7		aid1798385	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283415	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283415&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213160	378164744							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755854	CS(=O)(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2cc3c(Cl)c[nH]c3cc2F)cc2cc(Cl)cnc12	InChI=1S/C26H19Cl2FN4O3S/c1-37(35,36)24-6-14(4-16-7-18(27)12-32-25(16)24)5-19-8-15(2-3-30-19)26(34)33-11-17-9-20-21(28)13-31-23(20)10-22(17)29/h2-4,6-10,12-13,31H,5,11H2,1H3,(H,33,34)	JHEOACUKXNFFDI-UHFFFAOYSA-N	283416	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3-chloro-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 68::US10266515, Example 68::US10308637, Example 68::US11021463, Example 68::US9611252, Example 68	Plasma kallikrein					<100					US Patent		10.7270/Q2J968P7		aid1798385	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283416	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283416&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212213	378164745							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755855	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2cc(c3ncc(Cl)cc3c2)S(C)(=O)=O)c1	InChI=1S/C24H22ClN5O3S/c1-14-17(3-4-22(26)30-14)12-29-24(31)16-5-6-27-20(11-16)8-15-7-18-10-19(25)13-28-23(18)21(9-15)34(2,32)33/h3-7,9-11,13H,8,12H2,1-2H3,(H2,26,30)(H,29,31)	DAYVOWICNMKAHH-UHFFFAOYSA-N	283417	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-chloro-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 69::US10266515, Example 69::US10308637, Example 69::US11021463, Example 69::US9611252, Example 69	Plasma kallikrein					<100					US Patent		10.7270/Q2J968P7		aid1798385	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283417	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283417&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665120	378164746							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755856	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2c1)C#N	InChI=1S/C26H24N6O/c1-15-6-20-8-18(9-21(12-27)25(20)30-13-15)10-22-11-19(4-5-29-22)26(33)31-14-23-16(2)7-24(28)32-17(23)3/h4-9,11,13H,10,14H2,1-3H3,(H2,28,32)(H,31,33)	FWOVJYZAXZFOSD-UHFFFAOYSA-N	283418	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((8-cyano-3-methylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 70::US10266515, Example 70::US10308637, Example 70::US11021463, Example 70::US9611252, Example 70	Plasma kallikrein					<100					US Patent		10.7270/Q2J968P7		aid1798385	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283418	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283418&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665112	378164747							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755857	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)cc2c1)C#N	InChI=1S/C28H22N6O/c1-17-8-22-10-19(11-23(14-29)26(22)33-15-17)12-24-13-21(5-6-31-24)28(35)34-16-18-2-3-25-20(9-18)4-7-32-27(25)30/h2-11,13,15H,12,16H2,1H3,(H2,30,32)(H,34,35)	XJVZLICIUISDSM-UHFFFAOYSA-N	283419	N-((1-aminoisoquinolin-6-yl)methyl)-2-((8- cyano-3-methylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 71::US10266515, Example 71::US10308637, Example 71::US11021463, Example 71::US9611252, Example 71	Plasma kallikrein					<100					US Patent		10.7270/Q2J968P7		aid1798385	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283419	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283419&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665353	378164748							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755858	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3ccc4[nH]cc(Cl)c4c3)cc2c1)C#N	InChI=1S/C27H20ClN5O/c1-16-6-20-7-18(8-21(12-29)26(20)32-13-16)9-22-11-19(4-5-30-22)27(34)33-14-17-2-3-25-23(10-17)24(28)15-31-25/h2-8,10-11,13,15,31H,9,14H2,1H3,(H,33,34)	XBDGHTYURFXKEM-UHFFFAOYSA-N	377943	N-((3-chloro-6-fluoro-1H-indol-5- yl)methyl)-2-((8-cyano-3-methylquinolin-6- yl)methyl)isonicotinamide::US10266515, Example 72	Plasma kallikrein					 550					US Patent		10.7270/Q2J968P7		aid1798385	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=377943	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=377943&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118668724	404346877							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755859	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cnc4[nH]cc(Cl)c4c3)cc2c1)C#N	InChI=1S/C26H19ClN6O/c1-15-4-19-5-16(6-20(10-28)24(19)30-11-15)7-21-9-18(2-3-29-21)26(34)33-13-17-8-22-23(27)14-32-25(22)31-12-17/h2-6,8-9,11-12,14H,7,13H2,1H3,(H,31,32)(H,33,34)	DUPQBZNXOTZIFE-UHFFFAOYSA-N	283421	N-((3-chloro-1H-pyrrolo[2,3-b]pyridin-5- yl)methyl)-2-((8-cyano-3-methylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 73::US10266515, Example 73::US10308637, Example 73::US11021463, Example 73::US9611252, Example 73	Plasma kallikrein					 550					US Patent		10.7270/Q2J968P7		aid1798385	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283421	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283421&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665369	378164750							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755860	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2c1)C(N)=O	InChI=1S/C26H26N6O2/c1-14-6-19-8-17(10-21(25(28)33)24(19)30-12-14)9-20-11-18(4-5-29-20)26(34)31-13-22-15(2)7-23(27)32-16(22)3/h4-8,10-12H,9,13H2,1-3H3,(H2,27,32)(H2,28,33)(H,31,34)	OOWBJQXCALEAFC-UHFFFAOYSA-N	283425	6-((4-(((6-amino-2,4-dimethylpyridin-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- methylquinoline-8-carboxamide::US10023557, Example 77::US10266515, Example 77::US10308637, Example 77::US11021463, Example 77::US9611252, Example 77	Plasma kallikrein					<100					US Patent		10.7270/Q2J968P7		aid1798385	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283425	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283425&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665125	378164754							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755861	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)cc2c1)C(N)=O	InChI=1S/C27H21ClFN5O2/c1-14-4-17-5-15(7-21(26(30)35)25(17)33-11-14)6-19-8-16(2-3-31-19)27(36)34-12-18-9-20-22(28)13-32-24(20)10-23(18)29/h2-5,7-11,13,32H,6,12H2,1H3,(H2,30,35)(H,34,36)	WETFPOPVXHIHFG-UHFFFAOYSA-N	283426	6-((4-(((3-chloro-6-fluoro-1H-indol-5- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- methylquinoline-8-carboxamide::US10023557, Example 78::US10266515, Example 78::US10308637, Example 78::US11021463, Example 78::US9611252, Example 78	Plasma kallikrein					<100					US Patent		10.7270/Q2J968P7		aid1798385	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283426	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283426&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665427	378164755							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755862	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)cc2c1)C(N)=O	InChI=1S/C28H24N6O2/c1-16-8-21-10-18(12-24(27(30)35)25(21)33-14-16)11-22-13-20(5-6-31-22)28(36)34-15-17-2-3-23-19(9-17)4-7-32-26(23)29/h2-10,12-14H,11,15H2,1H3,(H2,29,32)(H2,30,35)(H,34,36)	AVMNYBKKWARJKT-UHFFFAOYSA-N	283427	6-((4-(((1-aminoisoquinolin-6- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- methylquinoline-8-carboxamide::US10023557, Example 79::US10266515, Example 79::US10308637, Example 79::US11021463, Example 79::US9611252, Example 79	Plasma kallikrein					<100					US Patent		10.7270/Q2J968P7		aid1798385	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283427	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283427&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665123	378164756							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755863	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cnc4[nH]cc(Cl)c4c3)cc2c1)C(N)=O	InChI=1S/C26H21ClN6O2/c1-14-4-18-5-15(7-21(24(28)34)23(18)30-10-14)6-19-9-17(2-3-29-19)26(35)33-12-16-8-20-22(27)13-32-25(20)31-11-16/h2-5,7-11,13H,6,12H2,1H3,(H2,28,34)(H,31,32)(H,33,35)	CFJXZEDRAADQFI-UHFFFAOYSA-N	283428	6-((4-(((3-chloro-1H-pyrrolo[2,3-b]pyridin-5- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- methylquinoline-8-carboxamide::US10023557, Example 80::US10266515, Example 80::US10308637, Example 80::US11021463, Example 80::US9611252, Example 80	Plasma kallikrein					<100					US Patent		10.7270/Q2J968P7		aid1798385	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283428	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283428&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665254	378164757							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755864	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3ccc4[nH]cc(Cl)c4c3F)cc2c1)C(N)=O	InChI=1S/C27H21ClFN5O2/c1-14-6-18-7-15(9-20(26(30)35)25(18)33-11-14)8-19-10-16(4-5-31-19)27(36)34-12-17-2-3-22-23(24(17)29)21(28)13-32-22/h2-7,9-11,13,32H,8,12H2,1H3,(H2,30,35)(H,34,36)	LJDMUPONZYUBTQ-UHFFFAOYSA-N	283429	6-((4-(((3-chloro-4-fluoro-1H-indol-5- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- methylquinoline-8-carboxamide::US10023557, Example 81::US10266515, Example 81::US10308637, Example 81::US11021463, Example 81::US9611252, Example 81	Plasma kallikrein					 550					US Patent		10.7270/Q2J968P7		aid1798385	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283429	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283429&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665251	378164758							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755865	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3n[nH]c4ccc(Cl)cc34)cc2c1)C(N)=O	InChI=1S/C26H21ClN6O2/c1-14-6-17-7-15(9-21(25(28)34)24(17)30-12-14)8-19-10-16(4-5-29-19)26(35)31-13-23-20-11-18(27)2-3-22(20)32-33-23/h2-7,9-12H,8,13H2,1H3,(H2,28,34)(H,31,35)(H,32,33)	KIVLLFJSACGLHN-UHFFFAOYSA-N	283430	6-((4-(((5-chloro-1H-indazol-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- methylquinoline-8-carboxamide::US10023557, Example 82::US10266515, Example 82::US10308637, Example 82::US11021463, Example 82::US9611252, Example 82	Plasma kallikrein					 550					US Patent		10.7270/Q2J968P7		aid1798385	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283430	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283430&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665290	378164759							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755866	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cc4cc[nH]c4cc3F)cc2c1)C(N)=O	InChI=1S/C27H22FN5O2/c1-15-6-19-7-16(9-22(26(29)34)25(19)32-13-15)8-21-11-18(3-4-30-21)27(35)33-14-20-10-17-2-5-31-24(17)12-23(20)28/h2-7,9-13,31H,8,14H2,1H3,(H2,29,34)(H,33,35)	UZTOCULVDVRYTA-UHFFFAOYSA-N	283431	6-((4-(((6-fluoro-1H-indol-5- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- methylquinoline-8-carboxamide::US10023557, Example 83::US10266515, Example 83::US10308637, Example 83::US11021463, Example 83::US9611252, Example 83	Plasma kallikrein					 550					US Patent		10.7270/Q2J968P7		aid1798385	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283431	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283431&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665428	378164760							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755867	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2c1)C(O)=O	InChI=1S/C26H25N5O3/c1-14-6-19-8-17(10-21(26(33)34)24(19)29-12-14)9-20-11-18(4-5-28-20)25(32)30-13-22-15(2)7-23(27)31-16(22)3/h4-8,10-12H,9,13H2,1-3H3,(H2,27,31)(H,30,32)(H,33,34)	IDXZVLZJXGFXKF-UHFFFAOYSA-N	283432	6-((4-(((6-amino-2,4-dimethylpyridin-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- methylquinoline-8-carboxylic acid::US10023557, Example 84::US10266515, Example 84::US10308637, Example 84::US11021463, Example 84::US9611252, Example 84	Plasma kallikrein					<100					US Patent		10.7270/Q2J968P7		aid1798385	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283432	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283432&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665404	378164761							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755868	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc(F)c3ncc(Cl)cc3c2)c1	InChI=1S/C24H21ClFN5O/c1-13-5-22(27)31-14(2)20(13)12-30-24(32)16-3-4-28-19(10-16)7-15-6-17-9-18(25)11-29-23(17)21(26)8-15/h3-6,8-11H,7,12H2,1-2H3,(H2,27,31)(H,30,32)	NJQUWZKNWYIFOW-UHFFFAOYSA-N	283437	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloro-8-fluoroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 89::US10266515, Example 89::US10308637, Example 89::US11021463, Example 89::US9611252, Example 89	Plasma kallikrein					<100					US Patent		10.7270/Q2J968P7		aid1798385	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283437	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283437&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665263	378164766							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755869	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2cc(F)c3ncc(Cl)cc3c2)c1	InChI=1S/C23H19ClFN5O/c1-13-16(2-3-21(26)30-13)11-29-23(31)15-4-5-27-19(10-15)7-14-6-17-9-18(24)12-28-22(17)20(25)8-14/h2-6,8-10,12H,7,11H2,1H3,(H2,26,30)(H,29,31)	JKVPCVWDMOMIMY-UHFFFAOYSA-N	283439	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-chloro-8-fluoroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 91::US10266515, Example 91::US10308637, Example 91::US11021463, Example 91::US9611252, Example 91	Plasma kallikrein					<100					US Patent		10.7270/Q2J968P7		aid1798385	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283439	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283439&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665234	378164768							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755870	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc(Cl)c3ncc(Cl)cc3c2)c1	InChI=1S/C24H21Cl2N5O/c1-13-5-22(27)31-14(2)20(13)12-30-24(32)16-3-4-28-19(10-16)7-15-6-17-9-18(25)11-29-23(17)21(26)8-15/h3-6,8-11H,7,12H2,1-2H3,(H2,27,31)(H,30,32)	HHXMWQGWYOIRGQ-UHFFFAOYSA-N	283448	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3,8-dichloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 100::US10266515, Example 100::US10308637, Example 100::US11021463, Example 100::US9611252, Example 100	Plasma kallikrein					<100					US Patent		10.7270/Q2J968P7		aid1798385	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283448	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283448&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665316	378164777							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755871	Cc1ccc2cc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)ccc2n1	InChI=1S/C26H20ClFN4O/c1-15-2-4-17-8-16(3-5-24(17)32-15)9-20-10-18(6-7-29-20)26(33)31-13-19-11-21-22(27)14-30-25(21)12-23(19)28/h2-8,10-12,14,30H,9,13H2,1H3,(H,31,33)	SQVVRWKBMIEHGU-UHFFFAOYSA-N	283458	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((2-methylquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 110::US10266515, Example 110::US10308637, Example 110::US11021463, Example 110::US9611252, Example 110	Plasma kallikrein					 550					US Patent		10.7270/Q2J968P7		aid1798385	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283458	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283458&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212258	378164786							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755872	Cc1ccc2cc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)ccc2n1	InChI=1S/C27H23N5O/c1-17-2-5-21-12-18(4-7-25(21)32-17)14-23-15-22(9-10-29-23)27(33)31-16-19-3-6-24-20(13-19)8-11-30-26(24)28/h2-13,15H,14,16H2,1H3,(H2,28,30)(H,31,33)	BHHAKIOPTCXPSL-UHFFFAOYSA-N	283459	N-((1-aminoisoquinolin-6-yl)methyl)-2-((2- methylquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 111::US10266515, Example 111::US10308637, Example 111::US11021463, Example 111::US9611252, Example 111	Plasma kallikrein					 550					US Patent		10.7270/Q2J968P7		aid1798385	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283459	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283459&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212697	378164787							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755873	Cc1ccc2cc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)ccc2n1	InChI=1S/C25H25N5O/c1-15-10-24(26)30-17(3)22(15)14-28-25(31)20-8-9-27-21(13-20)12-18-5-7-23-19(11-18)6-4-16(2)29-23/h4-11,13H,12,14H2,1-3H3,(H2,26,30)(H,28,31)	SOGVYINZTNHWMJ-UHFFFAOYSA-N	283461	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((2-methylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 113::US10266515, Example 113::US10308637, Example 113::US11021463, Example 113::US9611252, Example 113	Plasma kallikrein					<100					US Patent		10.7270/Q2J968P7		aid1798385	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283461	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283461&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212447	378164789							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755874	Cc1ccc2ncc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2c1	InChI=1S/C25H25N5O/c1-15-4-5-23-20(8-15)10-18(13-28-23)11-21-12-19(6-7-27-21)25(31)29-14-22-16(2)9-24(26)30-17(22)3/h4-10,12-13H,11,14H2,1-3H3,(H2,26,30)(H,29,31)	PERODSYFHIKGOQ-UHFFFAOYSA-N	283462	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((6-methylquinolin-3- yl)methyl)isonicotinamide::US10023557, Example 114::US10266515, Example 114::US10308637, Example 114::US11021463, Example 114::US9611252, Example 114	Plasma kallikrein					<100					US Patent		10.7270/Q2J968P7		aid1798385	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283462	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283462&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212424	378164790							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755875	Cc1ccc2ncc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)cc2c1	InChI=1S/C27H23N5O/c1-17-2-5-25-22(10-17)12-19(16-31-25)13-23-14-21(7-8-29-23)27(33)32-15-18-3-4-24-20(11-18)6-9-30-26(24)28/h2-12,14,16H,13,15H2,1H3,(H2,28,30)(H,32,33)	YXYWWKCODFDZSQ-UHFFFAOYSA-N	283463	N-((1-aminoisoquinolin-6-yl)methyl)-2-((6- methylquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 115::US10266515, Example 115::US10308637, Example 115::US11021463, Example 115::US9611252, Example 115	Plasma kallikrein					<100					US Patent		10.7270/Q2J968P7		aid1798385	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283463	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283463&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212341	378164791							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755876	Cc1ccc2ncc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)cc2c1	InChI=1S/C26H20ClFN4O/c1-15-2-3-24-18(6-15)7-16(12-30-24)8-20-9-17(4-5-29-20)26(33)32-13-19-10-21-22(27)14-31-25(21)11-23(19)28/h2-7,9-12,14,31H,8,13H2,1H3,(H,32,33)	HEFJFXWKPBYZLZ-UHFFFAOYSA-N	283464	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((6-methylquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 116::US10266515, Example 116::US10308637, Example 116::US11021463, Example 116::US9611252, Example 116	Plasma kallikrein					 550					US Patent		10.7270/Q2J968P7		aid1798385	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283464	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283464&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212685	378164792							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755877	Cc1ccc2ncc(Cc3cc(ccn3)C(=O)NCc3ccc(N)nc3C)cc2c1	InChI=1S/C24H23N5O/c1-15-3-5-22-20(9-15)10-17(13-27-22)11-21-12-18(7-8-26-21)24(30)28-14-19-4-6-23(25)29-16(19)2/h3-10,12-13H,11,14H2,1-2H3,(H2,25,29)(H,28,30)	WNXNZZRXTORCMQ-UHFFFAOYSA-N	283465	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((6-methylquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 117::US10266515, Example 117::US10308637, Example 117::US11021463, Example 117::US9611252, Example 117	Plasma kallikrein					 550					US Patent		10.7270/Q2J968P7		aid1798385	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283465	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283465&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212579	378164793							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755878	Nc1nccc2cc(CNC(=O)c3ccnc(Cc4cnc5ccc(F)cc5c4)c3)ccc12	InChI=1S/C26H20FN5O/c27-21-2-4-24-20(12-21)10-17(15-31-24)11-22-13-19(6-7-29-22)26(33)32-14-16-1-3-23-18(9-16)5-8-30-25(23)28/h1-10,12-13,15H,11,14H2,(H2,28,30)(H,32,33)	FEOOVYNQAJINSQ-UHFFFAOYSA-N	283466	N-((1-aminoisoquinolin-6-yl)methyl)-2-((6- fluoroquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 118::US10266515, Example 118::US10308637, Example 118::US11021463, Example 118::US9611252, Example 118	Plasma kallikrein					<100					US Patent		10.7270/Q2J968P7		aid1798385	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283466	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283466&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212932	378164794							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755879	Cc1cc2cc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)ccc2cn1	InChI=1S/C27H23N5O/c1-17-10-23-11-18(2-4-22(23)16-31-17)13-24-14-21(7-8-29-24)27(33)32-15-19-3-5-25-20(12-19)6-9-30-26(25)28/h2-12,14,16H,13,15H2,1H3,(H2,28,30)(H,32,33)	KZGIIODXNPBNJO-UHFFFAOYSA-N	283480	N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- methylisoquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 132::US10266515, Example 132::US10308637, Example 132::US11021463, Example 132::US9611252, Example 132	Plasma kallikrein					 550					US Patent		10.7270/Q2J968P7		aid1798385	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283480	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283480&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213018	378164808							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755880	Cc1cnc2ccc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)cc2c1	InChI=1S/C27H23N5O/c1-17-10-22-11-18(3-5-25(22)31-15-17)13-23-14-21(7-8-29-23)27(33)32-16-19-2-4-24-20(12-19)6-9-30-26(24)28/h2-12,14-15H,13,16H2,1H3,(H2,28,30)(H,32,33)	XPXFEZOWOODSMW-UHFFFAOYSA-N	283490	N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- methylquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 142::US10266515, Example 142::US10308637, Example 142::US11021463, Example 142::US9611252, Example 142	Plasma kallikrein					<100					US Patent		10.7270/Q2J968P7		aid1798385	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283490	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283490&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212463	378164818							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755881	Cc1cnc2ccc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)cc2c1	InChI=1S/C26H20ClFN4O/c1-15-6-18-7-16(2-3-24(18)30-12-15)8-20-9-17(4-5-29-20)26(33)32-13-19-10-21-22(27)14-31-25(21)11-23(19)28/h2-7,9-12,14,31H,8,13H2,1H3,(H,32,33)	BAWQXCVTJNYXQW-UHFFFAOYSA-N	283491	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3-methylquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 143::US10266515, Example 143::US10308637, Example 143::US11021463, Example 143::US9611252, Example 143	Plasma kallikrein					 550					US Patent		10.7270/Q2J968P7		aid1798385	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283491	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283491&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212764	378164819							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755882	Cc1cnc2ccc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2c1	InChI=1S/C25H25N5O/c1-15-8-20-10-18(4-5-23(20)28-13-15)11-21-12-19(6-7-27-21)25(31)29-14-22-16(2)9-24(26)30-17(22)3/h4-10,12-13H,11,14H2,1-3H3,(H2,26,30)(H,29,31)	BDBQXLZXRHXRJN-UHFFFAOYSA-N	283492	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-methylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 144::US10266515, Example 144::US10308637, Example 144::US11021463, Example 144::US9611252, Example 144	Plasma kallikrein					<100					US Patent		10.7270/Q2J968P7		aid1798385	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283492	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283492&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212432	378164820							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755883	Cc1cc2cc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)ccc2cn1	InChI=1S/C25H25N5O/c1-15-8-24(26)30-17(3)23(15)14-29-25(31)19-6-7-27-22(12-19)11-18-4-5-20-13-28-16(2)9-21(20)10-18/h4-10,12-13H,11,14H2,1-3H3,(H2,26,30)(H,29,31)	IDPUQOZCEWQYLL-UHFFFAOYSA-N	283493	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-methylisoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 145::US10266515, Example 145::US10308637, Example 145::US11021463, Example 145::US9611252, Example 145	Plasma kallikrein					<100					US Patent		10.7270/Q2J968P7		aid1798385	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283493	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283493&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212443	378164821							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755722	Fc1cc2[nH]ccc2cc1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C25H18ClFN4O/c26-20-10-18-7-15(1-2-23(18)30-14-20)8-21-11-17(4-5-28-21)25(32)31-13-19-9-16-3-6-29-24(16)12-22(19)27/h1-7,9-12,14,29H,8,13H2,(H,31,32)	SVAFKWRLBOEKGD-UHFFFAOYSA-N	283389	2-((3-chloroquinolin-6-yl)methyl)-N-((6-fluoro- 1H-indol-5-yl)methyl)isonicotinamide::US10023557, Example 259::US10023557, Example 41::US10266515, Example 41::US10308637, Example 41::US11021463, Example 41::US9611252, Example 41	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283389	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283389&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665368	378164718							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755723	CNc1ccc(CNC(=O)c2ccnc(Cc3ccc4ncc(Cl)cc4c3)c2)c(C)n1	InChI=1S/C24H22ClN5O/c1-15-18(4-6-23(26-2)30-15)13-29-24(31)17-7-8-27-21(12-17)10-16-3-5-22-19(9-16)11-20(25)14-28-22/h3-9,11-12,14H,10,13H2,1-2H3,(H,26,30)(H,29,31)	KRORJRNMSXNFRV-UHFFFAOYSA-N	283390	2-((3-chloroquinolin-6-yl)methyl)-N-((2-methyl- 6-(methylamino)pyridin-3- yl)methyl)isonicotinamide::US10023557, Example 42::US10266515, Example 42::US10308637, Example 42::US11021463, Example 42::US9611252, Example 42	Plasma kallikrein			 550							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283390	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283390&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665110	378164719							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755724	Nc1ccc(CNC(=O)c2ccnc(Cc3ccc4ncc(Cl)cc4c3)c2)c(n1)C1CC1	InChI=1S/C25H22ClN5O/c26-20-11-19-9-15(1-5-22(19)29-14-20)10-21-12-17(7-8-28-21)25(32)30-13-18-4-6-23(27)31-24(18)16-2-3-16/h1,4-9,11-12,14,16H,2-3,10,13H2,(H2,27,31)(H,30,32)	CZYMIYVLJPMDKR-UHFFFAOYSA-N	283391	N-((6-amino-2-cyclopropylpyridin-3-yl)methyl)- 2-((3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 43::US10266515, Example 43::US10308637, Example 43::US11021463, Example 43::US9611252, Example 43	Plasma kallikrein			 550							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283391	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283391&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665372	378164720							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755725	CN(C)c1ccc(CNC(=O)c2ccnc(Cc3ccc4ncc(Cl)cc4c3)c2)c(C)n1	InChI=1S/C25H24ClN5O/c1-16-19(5-7-24(30-16)31(2)3)14-29-25(32)18-8-9-27-22(13-18)11-17-4-6-23-20(10-17)12-21(26)15-28-23/h4-10,12-13,15H,11,14H2,1-3H3,(H,29,32)	RUFAAOLTGJTOMH-UHFFFAOYSA-N	283392	2-((3-chloroquinolin-6-yl)methyl)-N-((6- (dimethylamino)-2-methylpyridin-3- yl)methyl)isonicotinamide::US10023557, Example 44::US10266515, Example 44::US10308637, Example 44::US11021463, Example 44::US9611252, Example 44	Plasma kallikrein			>10000							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283392	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283392&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665107	378164721							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755726	NCc1ccc2cc(Cc3cc(ccn3)C(=O)NCc3ccc(N\C=C\Cl)cc3F)ccc2n1	InChI=1S/C26H23ClFN5O/c27-8-10-31-21-4-3-20(24(28)14-21)16-32-26(34)19-7-9-30-23(13-19)12-17-1-6-25-18(11-17)2-5-22(15-29)33-25/h1-11,13-14,31H,12,15-16,29H2,(H,32,34)/b10-8+	JVGOZTCBHNKVEW-CSKARUKUSA-N	377916	2-((2-(aminomethyl)quinolin-6-yl)methyl)- N-((3-chloro-6-fluoro-1H-indol-5- yl)methyl)isonicotinamide::US10266515, Example 45	Plasma kallikrein			 550							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=377916	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=377916&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135131629	404346850							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755727	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3nc(CN)ccc3c2)c1	InChI=1S/C25H26N6O/c1-15-9-24(27)30-16(2)22(15)14-29-25(32)19-7-8-28-21(12-19)11-17-3-6-23-18(10-17)4-5-20(13-26)31-23/h3-10,12H,11,13-14,26H2,1-2H3,(H2,27,30)(H,29,32)	VJXDXEYDWIAFJF-UHFFFAOYSA-N	283394	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((2-(aminomethyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 46::US10266515, Example 46::US10308637, Example 46::US11021463, Example 46::US9611252, Example 46	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283394	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283394&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212365	378164723							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755728	Cc1cnc2ccc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)noc4c3)cc2c1	InChI=1S/C25H21N5O2/c1-15-8-19-9-16(3-5-22(19)28-13-15)10-20-12-18(6-7-27-20)25(31)29-14-17-2-4-21-23(11-17)32-30-24(21)26/h2-9,11-13H,10,14H2,1H3,(H2,26,30)(H,29,31)	JIGUMEUDUOTSCV-UHFFFAOYSA-N	283395	N-((3-aminobenzo[d]isoxazol-6-yl)methyl)-2- ((3-methylquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 47::US10266515, Example 47::US10308637, Example 47::US11021463, Example 47::US9611252, Example 47	Plasma kallikrein			 26							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283395	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283395&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212412	378164724							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755729	Cc1ccc2ncc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)noc4c3)cc2c1	InChI=1S/C25H21N5O2/c1-15-2-5-22-19(8-15)9-17(14-28-22)10-20-12-18(6-7-27-20)25(31)29-13-16-3-4-21-23(11-16)32-30-24(21)26/h2-9,11-12,14H,10,13H2,1H3,(H2,26,30)(H,29,31)	ZCNHTDLBGJQFLS-UHFFFAOYSA-N	283396	N-((3-aminobenzo[d]isoxazol-6-yl)methyl)-2- ((6-methylquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 48::US10266515, Example 48::US10308637, Example 48::US11021463, Example 48::US9611252, Example 48	Plasma kallikrein			>10000							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283396	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283396&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665294	378164725							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755730	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1ccnc(Cc2cc(C#N)c3ccc(Cl)cc3c2)c1	InChI=1S/C27H17Cl2FN4O/c28-20-1-2-22-17(8-20)5-15(6-18(22)12-31)7-21-9-16(3-4-32-21)27(35)34-13-19-10-23-24(29)14-33-26(23)11-25(19)30/h1-6,8-11,14,33H,7,13H2,(H,34,35)	LAGIQPIPYAXKJV-UHFFFAOYSA-N	377920	N-((3-chloro-6-fluoro-1H-indol-5- yl)methyl)-2-((3-chloro-8-cyanoquinolin-6- yl)methyl)isonicotinamide::US10266515, Example 49	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=377920	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=377920&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135131548	404346854							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755731	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc(C#N)c3ncc(Cl)cc3c2)c1	InChI=1S/C25H21ClN6O/c1-14-5-23(28)32-15(2)22(14)13-31-25(33)17-3-4-29-21(10-17)8-16-6-18-9-20(26)12-30-24(18)19(7-16)11-27/h3-7,9-10,12H,8,13H2,1-2H3,(H2,28,32)(H,31,33)	VSKYRJRRAUSIED-UHFFFAOYSA-N	283398	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloro-8-cyanoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 50::US10266515, Example 50::US10308637, Example 50::US11021463, Example 50::US9611252, Example 50	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283398	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283398&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665177	378164727							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755732	Fc1c(CNC(=O)c2ccnc(Cc3cc(C#N)c4ncc(Cl)cc4c3)c2)ccc2[nH]cc(Cl)c12	InChI=1S/C26H16Cl2FN5O/c27-19-8-17-5-14(6-18(10-30)25(17)33-12-19)7-20-9-15(3-4-31-20)26(35)34-11-16-1-2-22-23(24(16)29)21(28)13-32-22/h1-6,8-9,12-13,32H,7,11H2,(H,34,35)	RGFJCIZRNQJUFS-UHFFFAOYSA-N	283399	N-((3-chloro-4-fluoro-1H-indol-5-yl)methyl)-2- ((3-chloro-8-cyanoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 51::US10266515, Example 51::US10308637, Example 51::US11021463, Example 51::US9611252, Example 51	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283399	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283399&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665441	378164728							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755733	Fc1cc2[nH]ccc2cc1CNC(=O)c1ccnc(Cc2cc(C#N)c3ncc(Cl)cc3c2)c1	InChI=1S/C26H17ClFN5O/c27-21-9-18-5-15(6-19(12-29)25(18)32-14-21)7-22-10-17(2-3-30-22)26(34)33-13-20-8-16-1-4-31-24(16)11-23(20)28/h1-6,8-11,14,31H,7,13H2,(H,33,34)	DGMHYZXVTQSHTG-UHFFFAOYSA-N	283400	2-((3-chloro-8-cyanoquinolin-6-yl)methyl)-N- ((6-fluoro-1H-indol-5-yl)methyl)isonicotinamide::US10023557, Example 52::US10266515, Example 52::US10308637, Example 52::US11021463, Example 52::US9611252, Example 52	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283400	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283400&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665338	378164729							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755734	Cc1cc(N)ncc1CNC(=O)c1ccnc(Cc2cc(C#N)c3ncc(Cl)cc3c2)c1	InChI=1S/C24H19ClN6O/c1-14-4-22(27)29-11-19(14)12-31-24(32)16-2-3-28-21(9-16)7-15-5-17-8-20(25)13-30-23(17)18(6-15)10-26/h2-6,8-9,11,13H,7,12H2,1H3,(H2,27,29)(H,31,32)	WNDNOSDBRCNUAW-UHFFFAOYSA-N	283401	N-((6-amino-4-methylpyridin-3-yl)methyl)-2- ((3-chloro-8-cyanoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 53::US10266515, Example 53::US10308637, Example 53::US11021463, Example 53::US9611252, Example 53	Plasma kallikrein			 550							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283401	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283401&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665126	378164730							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755735	Clc1ccc2[nH]nc(CNC(=O)c3ccnc(Cc4cc(C#N)c5ncc(Cl)cc5c4)c3)c2c1	InChI=1S/C25H16Cl2N6O/c26-18-1-2-22-21(10-18)23(33-32-22)13-31-25(34)15-3-4-29-20(9-15)7-14-5-16-8-19(27)12-30-24(16)17(6-14)11-28/h1-6,8-10,12H,7,13H2,(H,31,34)(H,32,33)	KUYYPMPLUCLDIX-UHFFFAOYSA-N	283402	N-((5-chloro-1H-indazol-3-yl)methyl)-2-((3- chloro-8-cyanoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 54::US10266515, Example 54::US10308637, Example 54::US11021463, Example 54::US9611252, Example 54	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283402	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283402&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665197	378164731							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755736	Clc1c[nH]c2ncc(CNC(=O)c3ccnc(Cc4cc(C#N)c5ncc(Cl)cc5c4)c3)cc12	InChI=1S/C25H16Cl2N6O/c26-19-7-17-3-14(4-18(9-28)23(17)30-12-19)5-20-8-16(1-2-29-20)25(34)33-11-15-6-21-22(27)13-32-24(21)31-10-15/h1-4,6-8,10,12-13H,5,11H2,(H,31,32)(H,33,34)	DLZBPOOKWFQHBR-UHFFFAOYSA-N	283403	N-((3-chloro-1H-pyrrolo[2,3-b]pyridin-5- yl)methyl)-2-((3-chloro-8-cyanoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 55::US10266515, Example 55::US10308637, Example 55::US11021463, Example 55::US9611252, Example 55	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283403	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283403&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665328	378164732							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755737	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2cc(C#N)c3ncc(Cl)cc3c2)c1	InChI=1S/C24H19ClN6O/c1-14-17(2-3-22(27)31-14)12-30-24(32)16-4-5-28-21(10-16)8-15-6-18-9-20(25)13-29-23(18)19(7-15)11-26/h2-7,9-10,13H,8,12H2,1H3,(H2,27,31)(H,30,32)	FDKNUBSGWSPNRT-UHFFFAOYSA-N	283404	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-chloro-8-cyanoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 56::US10266515, Example 56::US10308637, Example 56::US11021463, Example 56::US9611252, Example 56	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283404	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283404&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665146	378164733							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755738	Nc1nccc2cc(CNC(=O)c3ccnc(Cc4cc(C#N)c5ncc(Cl)cc5c4)c3)ccc12	InChI=1S/C27H19ClN6O/c28-22-11-20-8-17(9-21(13-29)25(20)33-15-22)10-23-12-19(4-5-31-23)27(35)34-14-16-1-2-24-18(7-16)3-6-32-26(24)30/h1-9,11-12,15H,10,14H2,(H2,30,32)(H,34,35)	IDTYIYATNJINLX-UHFFFAOYSA-N	283405	N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- chloro-8-cyanoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 57::US10266515, Example 57::US10308637, Example 57::US11021463, Example 57::US9611252, Example 57	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283405	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283405&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665382	378164734							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755739	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc(C(N)=O)c3ncc(Cl)cc3c2)c1	InChI=1S/C25H23ClN6O2/c1-13-5-22(27)32-14(2)21(13)12-31-25(34)16-3-4-29-19(10-16)7-15-6-17-9-18(26)11-30-23(17)20(8-15)24(28)33/h3-6,8-11H,7,12H2,1-2H3,(H2,27,32)(H2,28,33)(H,31,34)	INWUNFFPSCFXCA-UHFFFAOYSA-N	283406	6-((4-(((6-amino-2,4-dimethylpyridin-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- chloroquinoline-8-carboxamide::US10023557, Example 58::US10266515, Example 58::US10308637, Example 58::US11021463, Example 58::US9611252, Example 58	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283406	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283406&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665386	378164735							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755740	NC(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2cc3c(Cl)c[nH]c3cc2F)cc2cc(Cl)cnc12	InChI=1S/C26H18Cl2FN5O2/c27-17-6-15-3-13(5-20(25(30)35)24(15)33-11-17)4-18-7-14(1-2-31-18)26(36)34-10-16-8-19-21(28)12-32-23(19)9-22(16)29/h1-3,5-9,11-12,32H,4,10H2,(H2,30,35)(H,34,36)	QMNRPOHMXWHKMB-UHFFFAOYSA-N	283407	3-chloro-6-((4-(((3-chloro-6-fluoro-1H-indol-5- yl)methyl)carbamoyl)pyridin-2- yl)methyl)quinoline-8-carboxamide::US10023557, Example 59::US10266515, Example 59::US11021463, Example 59::US9611252, Example 59	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283407	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283407&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665413	378164736							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755741	NC(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2n[nH]c3ccc(Cl)cc23)cc2cc(Cl)cnc12	InChI=1S/C25H18Cl2N6O2/c26-16-1-2-21-19(10-16)22(33-32-21)12-31-25(35)14-3-4-29-18(9-14)6-13-5-15-8-17(27)11-30-23(15)20(7-13)24(28)34/h1-5,7-11H,6,12H2,(H2,28,34)(H,31,35)(H,32,33)	RTJGKEBRSSQCHQ-UHFFFAOYSA-N	283408	3-chloro-6-((4-(((5-chloro-1H-indazol-3- yl)methyl)carbamoyl)pyridin-2- yl)methyl)quinoline-8-carboxamide::US10023557, Example 60::US10266515, Example 60::US10308637, Example 60::US11021463, Example 60::US9611252, Example 60	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283408	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283408&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665317	378164737							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755742	NC(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2cnc3[nH]cc(Cl)c3c2)cc2cc(Cl)cnc12	InChI=1S/C25H18Cl2N6O2/c26-17-7-16-3-13(5-20(23(28)34)22(16)30-11-17)4-18-8-15(1-2-29-18)25(35)33-10-14-6-19-21(27)12-32-24(19)31-9-14/h1-3,5-9,11-12H,4,10H2,(H2,28,34)(H,31,32)(H,33,35)	QHIFWJFJAOUBPC-UHFFFAOYSA-N	283409	3-chloro-6-((4-(((3-chloro-1H-pyrrolo[2,3- b]pyridin-5-yl)methyl)carbamoyl)pyridin-2- yl)methyl)quinoline-8-carboxamide::US10023557, Example 61::US10266515, Example 61::US10308637, Example 61::US11021463, Example 61::US9611252, Example 61	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283409	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283409&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665370	378164738							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755743	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2cc(C(N)=O)c3ncc(Cl)cc3c2)c1	InChI=1S/C24H21ClN6O2/c1-13-16(2-3-21(26)31-13)11-30-24(33)15-4-5-28-19(10-15)7-14-6-17-9-18(25)12-29-22(17)20(8-14)23(27)32/h2-6,8-10,12H,7,11H2,1H3,(H2,26,31)(H2,27,32)(H,30,33)	WTBBASBLRSFZPD-UHFFFAOYSA-N	283410	6-((4-(((6-amino-2-methylpyridin-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- chloroquinoline-8-carboxamide::US10023557, Example 62::US10266515, Example 62::US10308637, Example 62::US11021463, Example 62::US9611252, Example 62	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283410	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283410&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665142	378164739							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755744	Cc1cc(N)ncc1CNC(=O)c1ccnc(Cc2cc(C(N)=O)c3ncc(Cl)cc3c2)c1	InChI=1S/C24H21ClN6O2/c1-13-4-21(26)29-10-17(13)11-31-24(33)15-2-3-28-19(9-15)6-14-5-16-8-18(25)12-30-22(16)20(7-14)23(27)32/h2-5,7-10,12H,6,11H2,1H3,(H2,26,29)(H2,27,32)(H,31,33)	ZAZOBWBMBQVKFV-UHFFFAOYSA-N	283411	6-((4-(((6-amino-4-methylpyridin-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- chloroquinoline-8-carboxamide::US10023557, Example 63::US10266515, Example 63::US10308637, Example 63::US11021463, Example 63::US9611252, Example 63	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283411	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283411&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665130	378164740							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755745	NC(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2ccc3c(N)nccc3c2)cc2cc(Cl)cnc12	InChI=1S/C27H21ClN6O2/c28-20-11-19-8-16(10-23(26(30)35)24(19)33-14-20)9-21-12-18(4-5-31-21)27(36)34-13-15-1-2-22-17(7-15)3-6-32-25(22)29/h1-8,10-12,14H,9,13H2,(H2,29,32)(H2,30,35)(H,34,36)	ZEVNHPCICZZSBU-UHFFFAOYSA-N	283412	6-((4-(((1-aminoisoquinolin-6- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- chloroquinoline-8-carboxamide::US10023557, Example 64::US10266515, Example 64::US10308637, Example 64::US11021463, Example 64::US9611252, Example 64	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283412	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283412&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665252	378164741							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755746	NC(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2ccc3[nH]cc(Cl)c3c2F)cc2cc(Cl)cnc12	InChI=1S/C26H18Cl2FN5O2/c27-17-8-16-5-13(7-19(25(30)35)24(16)33-11-17)6-18-9-14(3-4-31-18)26(36)34-10-15-1-2-21-22(23(15)29)20(28)12-32-21/h1-5,7-9,11-12,32H,6,10H2,(H2,30,35)(H,34,36)	PBEXDTRCFFOFDU-UHFFFAOYSA-N	283413	3-chloro-6-((4-(((3-chloro-4-fluoro-1H-indol-5- yl)methyl)carbamoyl)pyridin-2- yl)methyl)quinoline-8-carboxamide::US10023557, Example 65::US10266515, Example 65::US10308637, Example 65::US11021463, Example 65::US9611252, Example 65	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283413	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283413&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665414	378164742							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755747	NC(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2cc3cc[nH]c3cc2F)cc2cc(Cl)cnc12	InChI=1S/C26H19ClFN5O2/c27-19-9-17-5-14(7-21(25(29)34)24(17)32-13-19)6-20-10-16(2-3-30-20)26(35)33-12-18-8-15-1-4-31-23(15)11-22(18)28/h1-5,7-11,13,31H,6,12H2,(H2,29,34)(H,33,35)	ZDVUWSXSXIPPGM-UHFFFAOYSA-N	283414	3-chloro-6-((4-(((6-fluoro-1H-indol-5- yl)methyl)carbamoyl)pyridin-2- yl)methyl)quinoline-8-carboxamide::US10023557, Example 66::US10266515, Example 66::US10308637, Example 66::US11021463, Example 66::US9611252, Example 66	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283414	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283414&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665192	378164743							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755748	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc(c3ncc(Cl)cc3c2)S(C)(=O)=O)c1	InChI=1S/C25H24ClN5O3S/c1-14-6-23(27)31-15(2)21(14)13-30-25(32)17-4-5-28-20(11-17)8-16-7-18-10-19(26)12-29-24(18)22(9-16)35(3,33)34/h4-7,9-12H,8,13H2,1-3H3,(H2,27,31)(H,30,32)	LOAAVKXHIOVCPQ-UHFFFAOYSA-N	283415	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloro-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 67::US10266515, Example 67::US10308637, Example 67::US11021463, Example 67::US9611252, Example 67	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283415	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283415&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213160	378164744							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755749	CS(=O)(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2cc3c(Cl)c[nH]c3cc2F)cc2cc(Cl)cnc12	InChI=1S/C26H19Cl2FN4O3S/c1-37(35,36)24-6-14(4-16-7-18(27)12-32-25(16)24)5-19-8-15(2-3-30-19)26(34)33-11-17-9-20-21(28)13-31-23(20)10-22(17)29/h2-4,6-10,12-13,31H,5,11H2,1H3,(H,33,34)	JHEOACUKXNFFDI-UHFFFAOYSA-N	283416	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3-chloro-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 68::US10266515, Example 68::US10308637, Example 68::US11021463, Example 68::US9611252, Example 68	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283416	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283416&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212213	378164745							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755750	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2cc(c3ncc(Cl)cc3c2)S(C)(=O)=O)c1	InChI=1S/C24H22ClN5O3S/c1-14-17(3-4-22(26)30-14)12-29-24(31)16-5-6-27-20(11-16)8-15-7-18-10-19(25)13-28-23(18)21(9-15)34(2,32)33/h3-7,9-11,13H,8,12H2,1-2H3,(H2,26,30)(H,29,31)	DAYVOWICNMKAHH-UHFFFAOYSA-N	283417	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-chloro-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 69::US10266515, Example 69::US10308637, Example 69::US11021463, Example 69::US9611252, Example 69	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283417	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283417&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665120	378164746							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755751	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2c1)C#N	InChI=1S/C26H24N6O/c1-15-6-20-8-18(9-21(12-27)25(20)30-13-15)10-22-11-19(4-5-29-22)26(33)31-14-23-16(2)7-24(28)32-17(23)3/h4-9,11,13H,10,14H2,1-3H3,(H2,28,32)(H,31,33)	FWOVJYZAXZFOSD-UHFFFAOYSA-N	283418	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((8-cyano-3-methylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 70::US10266515, Example 70::US10308637, Example 70::US11021463, Example 70::US9611252, Example 70	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283418	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283418&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665112	378164747							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755752	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)cc2c1)C#N	InChI=1S/C28H22N6O/c1-17-8-22-10-19(11-23(14-29)26(22)33-15-17)12-24-13-21(5-6-31-24)28(35)34-16-18-2-3-25-20(9-18)4-7-32-27(25)30/h2-11,13,15H,12,16H2,1H3,(H2,30,32)(H,34,35)	XJVZLICIUISDSM-UHFFFAOYSA-N	283419	N-((1-aminoisoquinolin-6-yl)methyl)-2-((8- cyano-3-methylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 71::US10266515, Example 71::US10308637, Example 71::US11021463, Example 71::US9611252, Example 71	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283419	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283419&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665353	378164748							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755753	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3ccc4[nH]cc(Cl)c4c3)cc2c1)C#N	InChI=1S/C27H20ClN5O/c1-16-6-20-7-18(8-21(12-29)26(20)32-13-16)9-22-11-19(4-5-30-22)27(34)33-14-17-2-3-25-23(10-17)24(28)15-31-25/h2-8,10-11,13,15,31H,9,14H2,1H3,(H,33,34)	XBDGHTYURFXKEM-UHFFFAOYSA-N	377943	N-((3-chloro-6-fluoro-1H-indol-5- yl)methyl)-2-((8-cyano-3-methylquinolin-6- yl)methyl)isonicotinamide::US10266515, Example 72	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=377943	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=377943&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118668724	404346877							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755754	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cnc4[nH]cc(Cl)c4c3)cc2c1)C#N	InChI=1S/C26H19ClN6O/c1-15-4-19-5-16(6-20(10-28)24(19)30-11-15)7-21-9-18(2-3-29-21)26(34)33-13-17-8-22-23(27)14-32-25(22)31-12-17/h2-6,8-9,11-12,14H,7,13H2,1H3,(H,31,32)(H,33,34)	DUPQBZNXOTZIFE-UHFFFAOYSA-N	283421	N-((3-chloro-1H-pyrrolo[2,3-b]pyridin-5- yl)methyl)-2-((8-cyano-3-methylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 73::US10266515, Example 73::US10308637, Example 73::US11021463, Example 73::US9611252, Example 73	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283421	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283421&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665369	378164750							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755755	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3ccc4[nH]cc(Cl)c4c3F)cc2c1)C#N	InChI=1S/C27H19ClFN5O/c1-15-6-19-7-16(8-20(11-30)26(19)33-12-15)9-21-10-17(4-5-31-21)27(35)34-13-18-2-3-23-24(25(18)29)22(28)14-32-23/h2-8,10,12,14,32H,9,13H2,1H3,(H,34,35)	UJWAIKJCZKWWSO-UHFFFAOYSA-N	283422	N-((3-chloro-4-fluoro-1H-indol-5-yl)methyl)-2- ((8-cyano-3-methylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 74::US10266515, Example 74::US10308637, Example 74::US11021463, Example 74::US9611252, Example 74	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283422	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283422&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665323	378164751							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755756	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3n[nH]c4ccc(Cl)cc34)cc2c1)C#N	InChI=1S/C26H19ClN6O/c1-15-6-18-7-16(8-19(12-28)25(18)30-13-15)9-21-10-17(4-5-29-21)26(34)31-14-24-22-11-20(27)2-3-23(22)32-33-24/h2-8,10-11,13H,9,14H2,1H3,(H,31,34)(H,32,33)	SABOZYHOSJEBNR-UHFFFAOYSA-N	283423	N-((5-chloro-1H-indazol-3-yl)methyl)-2-((8- cyano-3-methylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 75::US10266515, Example 75::US10308637, Example 75::US11021463, Example 75::US9611252, Example 75	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283423	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283423&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665301	378164752							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755757	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cc4cc[nH]c4cc3F)cc2c1)C#N	InChI=1S/C27H20FN5O/c1-16-6-20-7-17(8-21(13-29)26(20)32-14-16)9-23-11-19(3-4-30-23)27(34)33-15-22-10-18-2-5-31-25(18)12-24(22)28/h2-8,10-12,14,31H,9,15H2,1H3,(H,33,34)	ZWLALZHUQUAZOX-UHFFFAOYSA-N	283424	2-((8-cyano-3-methylquinolin-6-yl)methyl)-N- ((6-fluoro-1H-indol-5-yl)methyl)isonicotinamide::US10023557, Example 76::US10266515, Example 76::US10308637, Example 76::US11021463, Example 76::US9611252, Example 76	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283424	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283424&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665344	378164753							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755758	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2c1)C(N)=O	InChI=1S/C26H26N6O2/c1-14-6-19-8-17(10-21(25(28)33)24(19)30-12-14)9-20-11-18(4-5-29-20)26(34)31-13-22-15(2)7-23(27)32-16(22)3/h4-8,10-12H,9,13H2,1-3H3,(H2,27,32)(H2,28,33)(H,31,34)	OOWBJQXCALEAFC-UHFFFAOYSA-N	283425	6-((4-(((6-amino-2,4-dimethylpyridin-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- methylquinoline-8-carboxamide::US10023557, Example 77::US10266515, Example 77::US10308637, Example 77::US11021463, Example 77::US9611252, Example 77	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283425	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283425&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665125	378164754							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755759	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)cc2c1)C(N)=O	InChI=1S/C27H21ClFN5O2/c1-14-4-17-5-15(7-21(26(30)35)25(17)33-11-14)6-19-8-16(2-3-31-19)27(36)34-12-18-9-20-22(28)13-32-24(20)10-23(18)29/h2-5,7-11,13,32H,6,12H2,1H3,(H2,30,35)(H,34,36)	WETFPOPVXHIHFG-UHFFFAOYSA-N	283426	6-((4-(((3-chloro-6-fluoro-1H-indol-5- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- methylquinoline-8-carboxamide::US10023557, Example 78::US10266515, Example 78::US10308637, Example 78::US11021463, Example 78::US9611252, Example 78	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283426	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283426&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665427	378164755							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755760	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)cc2c1)C(N)=O	InChI=1S/C28H24N6O2/c1-16-8-21-10-18(12-24(27(30)35)25(21)33-14-16)11-22-13-20(5-6-31-22)28(36)34-15-17-2-3-23-19(9-17)4-7-32-26(23)29/h2-10,12-14H,11,15H2,1H3,(H2,29,32)(H2,30,35)(H,34,36)	AVMNYBKKWARJKT-UHFFFAOYSA-N	283427	6-((4-(((1-aminoisoquinolin-6- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- methylquinoline-8-carboxamide::US10023557, Example 79::US10266515, Example 79::US10308637, Example 79::US11021463, Example 79::US9611252, Example 79	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283427	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283427&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665123	378164756							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755761	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cnc4[nH]cc(Cl)c4c3)cc2c1)C(N)=O	InChI=1S/C26H21ClN6O2/c1-14-4-18-5-15(7-21(24(28)34)23(18)30-10-14)6-19-9-17(2-3-29-19)26(35)33-12-16-8-20-22(27)13-32-25(20)31-11-16/h2-5,7-11,13H,6,12H2,1H3,(H2,28,34)(H,31,32)(H,33,35)	CFJXZEDRAADQFI-UHFFFAOYSA-N	283428	6-((4-(((3-chloro-1H-pyrrolo[2,3-b]pyridin-5- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- methylquinoline-8-carboxamide::US10023557, Example 80::US10266515, Example 80::US10308637, Example 80::US11021463, Example 80::US9611252, Example 80	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283428	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283428&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665254	378164757							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755762	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3ccc4[nH]cc(Cl)c4c3F)cc2c1)C(N)=O	InChI=1S/C27H21ClFN5O2/c1-14-6-18-7-15(9-20(26(30)35)25(18)33-11-14)8-19-10-16(4-5-31-19)27(36)34-12-17-2-3-22-23(24(17)29)21(28)13-32-22/h2-7,9-11,13,32H,8,12H2,1H3,(H2,30,35)(H,34,36)	LJDMUPONZYUBTQ-UHFFFAOYSA-N	283429	6-((4-(((3-chloro-4-fluoro-1H-indol-5- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- methylquinoline-8-carboxamide::US10023557, Example 81::US10266515, Example 81::US10308637, Example 81::US11021463, Example 81::US9611252, Example 81	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283429	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283429&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665251	378164758							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755763	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3n[nH]c4ccc(Cl)cc34)cc2c1)C(N)=O	InChI=1S/C26H21ClN6O2/c1-14-6-17-7-15(9-21(25(28)34)24(17)30-12-14)8-19-10-16(4-5-29-19)26(35)31-13-23-20-11-18(27)2-3-22(20)32-33-23/h2-7,9-12H,8,13H2,1H3,(H2,28,34)(H,31,35)(H,32,33)	KIVLLFJSACGLHN-UHFFFAOYSA-N	283430	6-((4-(((5-chloro-1H-indazol-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- methylquinoline-8-carboxamide::US10023557, Example 82::US10266515, Example 82::US10308637, Example 82::US11021463, Example 82::US9611252, Example 82	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283430	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283430&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665290	378164759							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755764	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cc4cc[nH]c4cc3F)cc2c1)C(N)=O	InChI=1S/C27H22FN5O2/c1-15-6-19-7-16(9-22(26(29)34)25(19)32-13-15)8-21-11-18(3-4-30-21)27(35)33-14-20-10-17-2-5-31-24(17)12-23(20)28/h2-7,9-13,31H,8,14H2,1H3,(H2,29,34)(H,33,35)	UZTOCULVDVRYTA-UHFFFAOYSA-N	283431	6-((4-(((6-fluoro-1H-indol-5- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- methylquinoline-8-carboxamide::US10023557, Example 83::US10266515, Example 83::US10308637, Example 83::US11021463, Example 83::US9611252, Example 83	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283431	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283431&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665428	378164760							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755765	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2c1)C(O)=O	InChI=1S/C26H25N5O3/c1-14-6-19-8-17(10-21(26(33)34)24(19)29-12-14)9-20-11-18(4-5-28-20)25(32)30-13-22-15(2)7-23(27)31-16(22)3/h4-8,10-12H,9,13H2,1-3H3,(H2,27,31)(H,30,32)(H,33,34)	IDXZVLZJXGFXKF-UHFFFAOYSA-N	283432	6-((4-(((6-amino-2,4-dimethylpyridin-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- methylquinoline-8-carboxylic acid::US10023557, Example 84::US10266515, Example 84::US10308637, Example 84::US11021463, Example 84::US9611252, Example 84	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283432	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283432&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665404	378164761							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755766	Cc1cc(N)ncc1CNC(=O)c1ccnc(Cn2cc3cc(Cl)ccc3cc2=O)c1	InChI=1S/C23H20ClN5O2/c1-14-6-21(25)27-10-18(14)11-28-23(31)16-4-5-26-20(8-16)13-29-12-17-7-19(24)3-2-15(17)9-22(29)30/h2-10,12H,11,13H2,1H3,(H2,25,27)(H,28,31)	DNSFNVWZLXWEIP-UHFFFAOYSA-N	283433	N-((6-amino-4-methylpyridin-3-yl)methyl)-2- ((7-chloro-3-oxoisoquinolin-2(3H)- yl)methyl)isonicotinamide::US10023557, Example 85::US10266515, Example 85::US10308637, Example 85::US11021463, Example 85::US9611252, Example 85	Plasma kallikrein			 550							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283433	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283433&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665165	378164762							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755767	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cn2cc3cc(Cl)ccc3cc2=O)c1	InChI=1S/C23H20ClN5O2/c1-14-17(3-5-21(25)28-14)11-27-23(31)16-6-7-26-20(9-16)13-29-12-18-8-19(24)4-2-15(18)10-22(29)30/h2-10,12H,11,13H2,1H3,(H2,25,28)(H,27,31)	BXRRZXRRYWPPRB-UHFFFAOYSA-N	283434	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((7-chloro-3-oxoisoquinolin-2(3H)- yl)methyl)isonicotinamide::US10023557, Example 86::US10266515, Example 86::US10308637, Example 86::US11021463, Example 86::US9611252, Example 86	Plasma kallikrein			 550							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283434	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283434&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665384	378164763							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755768	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cn2cc3cc(Cl)ccc3cc2=O)c1	InChI=1S/C24H22ClN5O2/c1-14-7-22(26)29-15(2)21(14)11-28-24(32)17-5-6-27-20(9-17)13-30-12-18-8-19(25)4-3-16(18)10-23(30)31/h3-10,12H,11,13H2,1-2H3,(H2,26,29)(H,28,32)	IRSFVELJVAKOKE-UHFFFAOYSA-N	283435	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((7-chloro-3-oxoisoquinolin-2(3H)- yl)methyl)isonicotinamide::US10023557, Example 87::US10266515, Example 87::US10308637, Example 87::US11021463, Example 87::US9611252, Example 87	Plasma kallikrein			 550							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283435	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283435&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665121	378164764							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755769	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1ccnc(Cn2cc3cc(Cl)ccc3cc2=O)c1	InChI=1S/C25H17Cl2FN4O2/c26-18-2-1-14-8-24(33)32(12-17(14)5-18)13-19-6-15(3-4-29-19)25(34)31-10-16-7-20-21(27)11-30-23(20)9-22(16)28/h1-9,11-12,30H,10,13H2,(H,31,34)	LIVKHBBLMAFTFP-UHFFFAOYSA-N	283436	2-((7-chloro-3-oxoisoquinolin-2(3H)-yl)methyl)- N-((3-chloro-6-fluoro-1H-indol-5- yl)methyl)isonicotinamide::US10023557, Example 88::US10266515, Example 88::US10308637, Example 88::US11021463, Example 88::US9611252, Example 88	Plasma kallikrein			 550							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283436	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283436&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665351	378164765							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755770	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc(F)c3ncc(Cl)cc3c2)c1	InChI=1S/C24H21ClFN5O/c1-13-5-22(27)31-14(2)20(13)12-30-24(32)16-3-4-28-19(10-16)7-15-6-17-9-18(25)11-29-23(17)21(26)8-15/h3-6,8-11H,7,12H2,1-2H3,(H2,27,31)(H,30,32)	NJQUWZKNWYIFOW-UHFFFAOYSA-N	283437	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloro-8-fluoroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 89::US10266515, Example 89::US10308637, Example 89::US11021463, Example 89::US9611252, Example 89	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283437	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283437&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665263	378164766							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755771	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1ccnc(Cc2cc(F)c3ncc(Cl)cc3c2)c1	InChI=1S/C25H16Cl2F2N4O/c26-17-6-15-3-13(5-22(29)24(15)32-11-17)4-18-7-14(1-2-30-18)25(34)33-10-16-8-19-20(27)12-31-23(19)9-21(16)28/h1-3,5-9,11-12,31H,4,10H2,(H,33,34)	WZBGVJNIHVUBGP-UHFFFAOYSA-N	283438	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3-chloro-8-fluoroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 90::US10266515, Example 90::US10308637, Example 90::US11021463, Example 90::US9611252, Example 90	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283438	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283438&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665313	378164767							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755772	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2cc(F)c3ncc(Cl)cc3c2)c1	InChI=1S/C23H19ClFN5O/c1-13-16(2-3-21(26)30-13)11-29-23(31)15-4-5-27-19(10-15)7-14-6-17-9-18(24)12-28-22(17)20(25)8-14/h2-6,8-10,12H,7,11H2,1H3,(H2,26,30)(H,29,31)	JKVPCVWDMOMIMY-UHFFFAOYSA-N	283439	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-chloro-8-fluoroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 91::US10266515, Example 91::US10308637, Example 91::US11021463, Example 91::US9611252, Example 91	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283439	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283439&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665234	378164768							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755773	COC(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2c(C)cc(N)nc2C)cc2cc(Cl)cnc12	InChI=1S/C26H24ClN5O3/c1-14-6-23(28)32-15(2)22(14)13-31-25(33)17-4-5-29-20(11-17)8-16-7-18-10-19(27)12-30-24(18)21(9-16)26(34)35-3/h4-7,9-12H,8,13H2,1-3H3,(H2,28,32)(H,31,33)	YFEQLRSQCAMBNR-UHFFFAOYSA-N	283440	US10023557, Example 92::US10266515, Example 92::US10308637, Example 92::US11021463, Example 92::US9611252, Example 92::methyl 6-((4-(((6-amino-2,4-dimethylpyridin-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- chloroquinoline-8-carboxylate	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283440	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283440&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665210	378164769							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755774	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc(C(O)=O)c3ncc(Cl)cc3c2)c1	InChI=1S/C25H22ClN5O3/c1-13-5-22(27)31-14(2)21(13)12-30-24(32)16-3-4-28-19(10-16)7-15-6-17-9-18(26)11-29-23(17)20(8-15)25(33)34/h3-6,8-11H,7,12H2,1-2H3,(H2,27,31)(H,30,32)(H,33,34)	BVAYWMZNSZGAMT-UHFFFAOYSA-N	283441	6-((4-(((6-amino-2,4-dimethylpyridin-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- chloroquinoline-8-carboxylic acid::US10023557, Example 93::US10266515, Example 93::US10308637, Example 93::US11021463, Example 93::US9611252, Example 93	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283441	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283441&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665155	378164770							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755775	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc(CO)c3ncc(Cl)cc3c2)c1	InChI=1S/C25H24ClN5O2/c1-14-5-23(27)31-15(2)22(14)12-30-25(33)17-3-4-28-21(10-17)8-16-6-18-9-20(26)11-29-24(18)19(7-16)13-32/h3-7,9-11,32H,8,12-13H2,1-2H3,(H2,27,31)(H,30,33)	CDDJVGAEPTXXCL-UHFFFAOYSA-N	283442	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloro-8-(hydroxymethyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 94::US10266515, Example 94::US10308637, Example 94::US11021463, Example 94::US9611252, Example 94	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283442	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283442&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665190	378164771							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755776	COC(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2ccc(N)nc2C)cc2cc(Cl)cnc12	InChI=1S/C25H22ClN5O3/c1-14-17(3-4-22(27)31-14)12-30-24(32)16-5-6-28-20(11-16)8-15-7-18-10-19(26)13-29-23(18)21(9-15)25(33)34-2/h3-7,9-11,13H,8,12H2,1-2H3,(H2,27,31)(H,30,32)	JHWMKRJZPWMJLH-UHFFFAOYSA-N	283443	US10023557, Example 95::US10266515, Example 95::US10308637, Example 95::US11021463, Example 95::US9611252, Example 95::methyl 6-((4-(((6-amino-2-methylpyridin-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- chloroquinoline-8-carboxylate	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283443	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283443&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665172	378164772							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755777	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2cc(C(O)=O)c3ncc(Cl)cc3c2)c1	InChI=1S/C24H20ClN5O3/c1-13-16(2-3-21(26)30-13)11-29-23(31)15-4-5-27-19(10-15)7-14-6-17-9-18(25)12-28-22(17)20(8-14)24(32)33/h2-6,8-10,12H,7,11H2,1H3,(H2,26,30)(H,29,31)(H,32,33)	OWMRLFMYSUGJHS-UHFFFAOYSA-N	283444	6-((4-(((6-amino-2-methylpyridin-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- chloroquinoline-8-carboxylic acid::US10023557, Example 96::US10266515, Example 96::US10308637, Example 96::US11021463, Example 96::US9611252, Example 96	Plasma kallikrein			 550							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283444	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283444&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665320	378164773							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755778	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2cc(CO)c3ncc(Cl)cc3c2)c1	InChI=1S/C24H22ClN5O2/c1-14-17(2-3-22(26)30-14)11-29-24(32)16-4-5-27-21(10-16)8-15-6-18-9-20(25)12-28-23(18)19(7-15)13-31/h2-7,9-10,12,31H,8,11,13H2,1H3,(H2,26,30)(H,29,32)	SCWQNZNCOWHKCU-UHFFFAOYSA-N	283445	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-chloro-8-(hydroxymethyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 97::US10266515, Example 97::US10308637, Example 97::US11021463, Example 97::US9611252, Example 97	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283445	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283445&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665282	378164774							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755779	Cc1cc(N)[n+]([O-])c(C)c1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C24H22ClN5O2/c1-14-7-23(26)30(32)15(2)21(14)13-29-24(31)17-5-6-27-20(11-17)9-16-3-4-22-18(8-16)10-19(25)12-28-22/h3-8,10-12H,9,13,26H2,1-2H3,(H,29,31)	JMNAJBKCXDWWFM-UHFFFAOYSA-N	283446	6-amino-3-((2-((3-chloroquinolin-6- yl)methyl)isonicotinamido)methyl)-2,4- dimethylpyridine 1-oxide::US10023557, Example 98::US10266515, Example 98::US10308637, Example 98::US11021463, Example 98::US9611252, Example 98	Plasma kallikrein			 550							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283446	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283446&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665244	378164775							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755780	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3[n+]([O-])cc(Cl)cc3c2)c1	InChI=1S/C24H22ClN5O2/c1-14-7-23(26)29-15(2)21(14)12-28-24(31)17-5-6-27-20(11-17)9-16-3-4-22-18(8-16)10-19(25)13-30(22)32/h3-8,10-11,13H,9,12H2,1-2H3,(H2,26,29)(H,28,31)	XRSVMKZHXCTYQX-UHFFFAOYSA-N	283447	6-((4-(((6-amino-2,4-dimethylpyridin-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- chloroquinoline 1-oxide::US10023557, Example 99::US10266515, Example 99::US10308637, Example 99::US11021463, Example 99::US9611252, Example 99	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283447	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283447&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665346	378164776							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755781	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc(Cl)c3ncc(Cl)cc3c2)c1	InChI=1S/C24H21Cl2N5O/c1-13-5-22(27)31-14(2)20(13)12-30-24(32)16-3-4-28-19(10-16)7-15-6-17-9-18(25)11-29-23(17)21(26)8-15/h3-6,8-11H,7,12H2,1-2H3,(H2,27,31)(H,30,32)	HHXMWQGWYOIRGQ-UHFFFAOYSA-N	283448	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3,8-dichloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 100::US10266515, Example 100::US10308637, Example 100::US11021463, Example 100::US9611252, Example 100	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283448	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283448&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665316	378164777							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755782	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2cc(Cl)c3ncc(Cl)cc3c2)c1	InChI=1S/C23H19Cl2N5O/c1-13-16(2-3-21(26)30-13)11-29-23(31)15-4-5-27-19(10-15)7-14-6-17-9-18(24)12-28-22(17)20(25)8-14/h2-6,8-10,12H,7,11H2,1H3,(H2,26,30)(H,29,31)	LGBIYJSQIIGQJI-UHFFFAOYSA-N	283449	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3,8-dichloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 101::US10266515, Example 101::US10308637, Example 101::US11021463, Example 101::US9611252, Example 101	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283449	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283449&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665134	378164778							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755783	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2F)c1	InChI=1S/C24H21ClFN5O/c1-13-7-22(27)31-14(2)20(13)12-30-24(32)16-5-6-28-18(9-16)8-15-3-4-21-19(23(15)26)10-17(25)11-29-21/h3-7,9-11H,8,12H2,1-2H3,(H2,27,31)(H,30,32)	MDLFAZWEMPYOEY-UHFFFAOYSA-N	283450	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloro-5-fluoroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 102::US10266515, Example 102::US10308637, Example 102::US11021463, Example 102::US9611252, Example 102	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283450	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283450&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665170	378164779							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755784	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2F)c1	InChI=1S/C23H19ClFN5O/c1-13-16(3-5-21(26)30-13)11-29-23(31)15-6-7-27-18(9-15)8-14-2-4-20-19(22(14)25)10-17(24)12-28-20/h2-7,9-10,12H,8,11H2,1H3,(H2,26,30)(H,29,31)	CMOKBXIVBITBDZ-UHFFFAOYSA-N	283451	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-chloro-5-fluoroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 103::US10266515, Example 103::US10308637, Example 103::US11021463, Example 103::US9611252, Example 103	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283451	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283451&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665235	378164780							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755785	Cc1cc(cc(Cc2ccc3ncc(Cl)cc3c2)n1)C(=O)NCc1c(C)cc(N)nc1C	InChI=1S/C25H24ClN5O/c1-14-6-24(27)31-16(3)22(14)13-29-25(32)19-7-15(2)30-21(11-19)9-17-4-5-23-18(8-17)10-20(26)12-28-23/h4-8,10-12H,9,13H2,1-3H3,(H2,27,31)(H,29,32)	WDMJJASBQUYWJX-UHFFFAOYSA-N	283452	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloroquinolin-6-yl)methyl)-6- methylisonicotinamide::US10023557, Example 104::US10023557, Example 197::US10266515, Example 104::US10308637, Example 197::US11021463, Example 104::US9611252, Example 104	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283452	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283452&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665211	378164781							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755786	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cn2ccc3cc(Cl)ccc23)c1	InChI=1S/C23H22ClN5O/c1-14-9-22(25)28-15(2)20(14)12-27-23(30)17-5-7-26-19(11-17)13-29-8-6-16-10-18(24)3-4-21(16)29/h3-11H,12-13H2,1-2H3,(H2,25,28)(H,27,30)	SHEVSFKZVQPYGB-UHFFFAOYSA-N	377976	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-2-((5-chloro-1H-indazol-1- yl)methyl)isonicotinamide::US10266515, Example 105	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=377976	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=377976&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135131502	404346910							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755787	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cn2cc3cc(Cl)ccc3n2)c1	InChI=1S/C22H21ClN6O/c1-13-7-21(24)27-14(2)19(13)10-26-22(30)15-5-6-25-18(9-15)12-29-11-16-8-17(23)3-4-20(16)28-29/h3-9,11H,10,12H2,1-2H3,(H2,24,27)(H,26,30)	JJKKHULUCHMWFC-UHFFFAOYSA-N	283454	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((5-chloro-2H-indazol-2- yl)methyl)isonicotinamide::US10023557, Example 106::US10023557, Example 107::US10023557, Example 199::US10266515, Example 107::US10308637, Example 199::US11021463, Example 106::US9611252, Example 106	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283454	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283454&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665275	378164783							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755788	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cn2cc3cc(Cl)ccc3n2)c1	InChI=1S/C22H21ClN6O/c1-13-7-21(24)27-14(2)19(13)10-26-22(30)15-5-6-25-18(9-15)12-29-11-16-8-17(23)3-4-20(16)28-29/h3-9,11H,10,12H2,1-2H3,(H2,24,27)(H,26,30)	JJKKHULUCHMWFC-UHFFFAOYSA-N	283454	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((5-chloro-2H-indazol-2- yl)methyl)isonicotinamide::US10023557, Example 106::US10023557, Example 107::US10023557, Example 199::US10266515, Example 107::US10308637, Example 199::US11021463, Example 106::US9611252, Example 106	Plasma kallikrein			 550							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283454	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283454&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665275	378164783							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755789	Cc1ccc2n(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)ncc2c1	InChI=1S/C23H24N6O/c1-14-4-5-21-18(8-14)11-27-29(21)13-19-10-17(6-7-25-19)23(30)26-12-20-15(2)9-22(24)28-16(20)3/h4-11H,12-13H2,1-3H3,(H2,24,28)(H,26,30)	PJQHDAQZXYWCRS-UHFFFAOYSA-N	283456	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((5-methyl-1H-indazol-1- yl)methyl)isonicotinamide::US10023557, Example 108::US10266515, Example 108::US10308637, Example 108::US11021463, Example 108::US9611252, Example 108	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283456	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283456&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665436	378164784							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755790	Cc1ccc2nc(c(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)cc2c1)S(C)(=O)=O	InChI=1S/C27H22ClFN4O3S/c1-15-3-4-24-17(7-15)8-18(27(33-24)37(2,35)36)10-20-9-16(5-6-30-20)26(34)32-13-19-11-21-22(28)14-31-25(21)12-23(19)29/h3-9,11-12,14,31H,10,13H2,1-2H3,(H,32,34)	OXDNNQYYISTXOB-UHFFFAOYSA-N	283457	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((6-methyl-2-(methylsulfonyl)quinolin-3- yl)methyl)isonicotinamide::US10023557, Example 109::US10266515, Example 109::US10308637, Example 109::US11021463, Example 109::US9611252, Example 109	Plasma kallikrein			 550							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283457	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283457&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213217	378164785							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755791	Cc1ccc2cc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)ccc2n1	InChI=1S/C26H20ClFN4O/c1-15-2-4-17-8-16(3-5-24(17)32-15)9-20-10-18(6-7-29-20)26(33)31-13-19-11-21-22(27)14-30-25(21)12-23(19)28/h2-8,10-12,14,30H,9,13H2,1H3,(H,31,33)	SQVVRWKBMIEHGU-UHFFFAOYSA-N	283458	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((2-methylquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 110::US10266515, Example 110::US10308637, Example 110::US11021463, Example 110::US9611252, Example 110	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283458	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283458&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212258	378164786							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755792	Cc1ccc2cc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)ccc2n1	InChI=1S/C27H23N5O/c1-17-2-5-21-12-18(4-7-25(21)32-17)14-23-15-22(9-10-29-23)27(33)31-16-19-3-6-24-20(13-19)8-11-30-26(24)28/h2-13,15H,14,16H2,1H3,(H2,28,30)(H,31,33)	BHHAKIOPTCXPSL-UHFFFAOYSA-N	283459	N-((1-aminoisoquinolin-6-yl)methyl)-2-((2- methylquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 111::US10266515, Example 111::US10308637, Example 111::US11021463, Example 111::US9611252, Example 111	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283459	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283459&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212697	378164787							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755793	Cc1ccc2cc(Cc3cc(ccn3)C(=O)NCc3ccc(N)nc3C)ccc2n1	InChI=1S/C24H23N5O/c1-15-3-5-18-11-17(4-7-22(18)28-15)12-21-13-19(9-10-26-21)24(30)27-14-20-6-8-23(25)29-16(20)2/h3-11,13H,12,14H2,1-2H3,(H2,25,29)(H,27,30)	XECXUFHBCFQVQM-UHFFFAOYSA-N	283460	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((2-methylquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 112::US10266515, Example 112::US10308637, Example 112::US11021463, Example 112::US9611252, Example 112	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283460	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283460&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212369	378164788							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755794	Cc1ccc2cc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)ccc2n1	InChI=1S/C25H25N5O/c1-15-10-24(26)30-17(3)22(15)14-28-25(31)20-8-9-27-21(13-20)12-18-5-7-23-19(11-18)6-4-16(2)29-23/h4-11,13H,12,14H2,1-3H3,(H2,26,30)(H,28,31)	SOGVYINZTNHWMJ-UHFFFAOYSA-N	283461	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((2-methylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 113::US10266515, Example 113::US10308637, Example 113::US11021463, Example 113::US9611252, Example 113	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283461	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283461&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212447	378164789							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755795	Cc1ccc2ncc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2c1	InChI=1S/C25H25N5O/c1-15-4-5-23-20(8-15)10-18(13-28-23)11-21-12-19(6-7-27-21)25(31)29-14-22-16(2)9-24(26)30-17(22)3/h4-10,12-13H,11,14H2,1-3H3,(H2,26,30)(H,29,31)	PERODSYFHIKGOQ-UHFFFAOYSA-N	283462	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((6-methylquinolin-3- yl)methyl)isonicotinamide::US10023557, Example 114::US10266515, Example 114::US10308637, Example 114::US11021463, Example 114::US9611252, Example 114	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283462	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283462&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212424	378164790							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755796	Cc1ccc2ncc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)cc2c1	InChI=1S/C27H23N5O/c1-17-2-5-25-22(10-17)12-19(16-31-25)13-23-14-21(7-8-29-23)27(33)32-15-18-3-4-24-20(11-18)6-9-30-26(24)28/h2-12,14,16H,13,15H2,1H3,(H2,28,30)(H,32,33)	YXYWWKCODFDZSQ-UHFFFAOYSA-N	283463	N-((1-aminoisoquinolin-6-yl)methyl)-2-((6- methylquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 115::US10266515, Example 115::US10308637, Example 115::US11021463, Example 115::US9611252, Example 115	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283463	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283463&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212341	378164791							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755797	Cc1ccc2ncc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)cc2c1	InChI=1S/C26H20ClFN4O/c1-15-2-3-24-18(6-15)7-16(12-30-24)8-20-9-17(4-5-29-20)26(33)32-13-19-10-21-22(27)14-31-25(21)11-23(19)28/h2-7,9-12,14,31H,8,13H2,1H3,(H,32,33)	HEFJFXWKPBYZLZ-UHFFFAOYSA-N	283464	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((6-methylquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 116::US10266515, Example 116::US10308637, Example 116::US11021463, Example 116::US9611252, Example 116	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283464	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283464&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212685	378164792							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755798	Cc1ccc2ncc(Cc3cc(ccn3)C(=O)NCc3ccc(N)nc3C)cc2c1	InChI=1S/C24H23N5O/c1-15-3-5-22-20(9-15)10-17(13-27-22)11-21-12-18(7-8-26-21)24(30)28-14-19-4-6-23(25)29-16(19)2/h3-10,12-13H,11,14H2,1-2H3,(H2,25,29)(H,28,30)	WNXNZZRXTORCMQ-UHFFFAOYSA-N	283465	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((6-methylquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 117::US10266515, Example 117::US10308637, Example 117::US11021463, Example 117::US9611252, Example 117	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283465	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283465&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212579	378164793							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755799	Nc1nccc2cc(CNC(=O)c3ccnc(Cc4cnc5ccc(F)cc5c4)c3)ccc12	InChI=1S/C26H20FN5O/c27-21-2-4-24-20(12-21)10-17(15-31-24)11-22-13-19(6-7-29-22)26(33)32-14-16-1-3-23-18(9-16)5-8-30-25(23)28/h1-10,12-13,15H,11,14H2,(H2,28,30)(H,32,33)	FEOOVYNQAJINSQ-UHFFFAOYSA-N	283466	N-((1-aminoisoquinolin-6-yl)methyl)-2-((6- fluoroquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 118::US10266515, Example 118::US10308637, Example 118::US11021463, Example 118::US9611252, Example 118	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283466	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283466&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212932	378164794							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755800	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cnc3ccc(F)cc3c2)c1	InChI=1S/C24H22FN5O/c1-14-7-23(26)30-15(2)21(14)13-29-24(31)17-5-6-27-20(11-17)9-16-8-18-10-19(25)3-4-22(18)28-12-16/h3-8,10-12H,9,13H2,1-2H3,(H2,26,30)(H,29,31)	VJYVCAQEIJFBMF-UHFFFAOYSA-N	283467	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((6-fluoroquinolin-3- yl)methyl)isonicotinamide::US10023557, Example 119::US10266515, Example 119::US10308637, Example 119::US11021463, Example 119::US9611252, Example 119	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283467	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283467&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212962	378164795							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755801	Fc1ccc2ncc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)cc2c1	InChI=1S/C25H17ClF2N4O/c26-21-13-31-24-10-22(28)17(9-20(21)24)12-32-25(33)15-3-4-29-19(8-15)6-14-5-16-7-18(27)1-2-23(16)30-11-14/h1-5,7-11,13,31H,6,12H2,(H,32,33)	PDPRSJXGOZQXDE-UHFFFAOYSA-N	283468	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((6-fluoroquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 120::US10266515, Example 120::US10308637, Example 120::US11021463, Example 120::US9611252, Example 120	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283468	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283468&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212861	378164796							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755802	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2cnc3ccc(F)cc3c2)c1	InChI=1S/C23H20FN5O/c1-14-17(2-5-22(25)29-14)13-28-23(30)16-6-7-26-20(11-16)9-15-8-18-10-19(24)3-4-21(18)27-12-15/h2-8,10-12H,9,13H2,1H3,(H2,25,29)(H,28,30)	HDWJBHJMHHEUTP-UHFFFAOYSA-N	283469	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((6-fluoroquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 121::US10266515, Example 121::US10308637, Example 121::US11021463, Example 121::US9611252, Example 121	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283469	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283469&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212359	378164797							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755803	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cnc3cc(F)ccc3c2)c1	InChI=1S/C24H22FN5O/c1-14-7-23(26)30-15(2)21(14)13-29-24(31)18-5-6-27-20(10-18)9-16-8-17-3-4-19(25)11-22(17)28-12-16/h3-8,10-12H,9,13H2,1-2H3,(H2,26,30)(H,29,31)	MWOHJBUVZJQGNX-UHFFFAOYSA-N	283470	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((7-fluoroquinolin-3- yl)methyl)isonicotinamide::US10023557, Example 122::US10266515, Example 122::US10308637, Example 122::US11021463, Example 122::US9611252, Example 122	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283470	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283470&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212621	378164798							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755804	Fc1ccc2cc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)cnc2c1	InChI=1S/C25H17ClF2N4O/c26-21-13-31-24-10-22(28)17(8-20(21)24)12-32-25(33)16-3-4-29-19(7-16)6-14-5-15-1-2-18(27)9-23(15)30-11-14/h1-5,7-11,13,31H,6,12H2,(H,32,33)	AMSTZJFOMLJWBY-UHFFFAOYSA-N	283471	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((7-fluoroquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 123::US10266515, Example 123::US10308637, Example 123::US11021463, Example 123::US9611252, Example 123	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283471	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283471&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212350	378164799							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755805	Nc1nccc2cc(CNC(=O)c3ccnc(Cc4cnc5cc(F)ccc5c4)c3)ccc12	InChI=1S/C26H20FN5O/c27-21-3-2-19-10-17(15-31-24(19)13-21)11-22-12-20(6-7-29-22)26(33)32-14-16-1-4-23-18(9-16)5-8-30-25(23)28/h1-10,12-13,15H,11,14H2,(H2,28,30)(H,32,33)	BBANODQRERYSMA-UHFFFAOYSA-N	283472	N-((1-aminoisoquinolin-6-yl)methyl)-2-((7- fluoroquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 124::US10266515, Example 124::US10308637, Example 124::US11021463, Example 124::US9611252, Example 124	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283472	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283472&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212446	378164800							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755806	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1ccnc(Cc2cnc3ccccc3c2)c1	InChI=1S/C25H18ClFN4O/c26-21-14-30-24-11-22(27)18(10-20(21)24)13-31-25(32)17-5-6-28-19(9-17)8-15-7-16-3-1-2-4-23(16)29-12-15/h1-7,9-12,14,30H,8,13H2,(H,31,32)	FYVVQNCFFZYQIZ-UHFFFAOYSA-N	283473	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- (quinolin-3-ylmethyl)isonicotinamide::US10023557, Example 125::US10266515, Example 125::US10308637, Example 125::US11021463, Example 125::US9611252, Example 125	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283473	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283473&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212449	378164801							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755807	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1ccnc(Cc2cnc3ccc(Cl)cc3c2)c1	InChI=1S/C25H17Cl2FN4O/c26-18-1-2-23-16(7-18)5-14(11-30-23)6-19-8-15(3-4-29-19)25(33)32-12-17-9-20-21(27)13-31-24(20)10-22(17)28/h1-5,7-11,13,31H,6,12H2,(H,32,33)	LRUSUFGKIZOKQY-UHFFFAOYSA-N	283474	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((6-chloroquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 126::US10266515, Example 126::US10308637, Example 126::US11021463, Example 126::US9611252, Example 126	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283474	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283474&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212638	378164802							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755808	Cc1ccc2ccc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)cc2n1	InChI=1S/C27H23N5O/c1-17-2-5-20-6-3-18(14-25(20)32-17)13-23-15-22(9-10-29-23)27(33)31-16-19-4-7-24-21(12-19)8-11-30-26(24)28/h2-12,14-15H,13,16H2,1H3,(H2,28,30)(H,31,33)	YUIGLCWKRLEJJV-UHFFFAOYSA-N	283475	N-((1-aminoisoquinolin-6-yl)methyl)-2-((2- methylquinolin-7-yl)methyl)isonicotinamide::US10023557, Example 127::US10266515, Example 127::US10308637, Example 127::US11021463, Example 127::US9611252, Example 127	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283475	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283475&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212220	378164803							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755809	Cc1ccc2ccc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)cc2n1	InChI=1S/C26H20ClFN4O/c1-15-2-4-17-5-3-16(9-24(17)32-15)8-20-10-18(6-7-29-20)26(33)31-13-19-11-21-22(27)14-30-25(21)12-23(19)28/h2-7,9-12,14,30H,8,13H2,1H3,(H,31,33)	ASHCCNPFZHFVAC-UHFFFAOYSA-N	283476	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((2-methylquinolin-7-yl)methyl)isonicotinamide::US10023557, Example 128::US10266515, Example 128::US10308637, Example 128::US11021463, Example 128::US9611252, Example 128	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283476	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283476&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212704	378164804							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755810	Cc1ccc2ccc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2n1	InChI=1S/C25H25N5O/c1-15-10-24(26)30-17(3)22(15)14-28-25(31)20-8-9-27-21(13-20)11-18-5-7-19-6-4-16(2)29-23(19)12-18/h4-10,12-13H,11,14H2,1-3H3,(H2,26,30)(H,28,31)	BOMAZLQSSNNLAL-UHFFFAOYSA-N	283477	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((2-methylquinolin-7- yl)methyl)isonicotinamide::US10023557, Example 129::US10266515, Example 129::US10308637, Example 129::US11021463, Example 129::US9611252, Example 129	Plasma kallikrein			 550							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283477	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283477&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212507	378164805							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755811	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1ccnc(Cc2ccc3nc(ccc3c2)C#N)c1	InChI=1S/C26H17ClFN5O/c27-22-14-31-25-11-23(28)18(10-21(22)25)13-32-26(34)17-5-6-30-20(9-17)8-15-1-4-24-16(7-15)2-3-19(12-29)33-24/h1-7,9-11,14,31H,8,13H2,(H,32,34)	XHYLSPCHHJFGNQ-UHFFFAOYSA-N	283478	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((2-isocyanoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 130::US10266515, Example 130::US10308637, Example 130::US11021463, Example 130::US9611252, Example 130	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283478	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283478&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213085	378164806							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755812	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3nc(ccc3c2)C#N)c1	InChI=1S/C25H22N6O/c1-15-9-24(27)30-16(2)22(15)14-29-25(32)19-7-8-28-21(12-19)11-17-3-6-23-18(10-17)4-5-20(13-26)31-23/h3-10,12H,11,14H2,1-2H3,(H2,27,30)(H,29,32)	WCGZGKPBOPWGNC-UHFFFAOYSA-N	283479	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((2-isocyanoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 131::US10266515, Example 131::US10308637, Example 131::US9611252, Example 131	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283479	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283479&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212991	378164807							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755813	Cc1cc2cc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)ccc2cn1	InChI=1S/C27H23N5O/c1-17-10-23-11-18(2-4-22(23)16-31-17)13-24-14-21(7-8-29-24)27(33)32-15-19-3-5-25-20(12-19)6-9-30-26(25)28/h2-12,14,16H,13,15H2,1H3,(H2,28,30)(H,32,33)	KZGIIODXNPBNJO-UHFFFAOYSA-N	283480	N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- methylisoquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 132::US10266515, Example 132::US10308637, Example 132::US11021463, Example 132::US9611252, Example 132	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283480	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283480&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213018	378164808							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755814	Cc1cc2cc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)ccc2cn1	InChI=1S/C26H20ClFN4O/c1-15-6-19-7-16(2-3-18(19)12-30-15)8-21-9-17(4-5-29-21)26(33)32-13-20-10-22-23(27)14-31-25(22)11-24(20)28/h2-7,9-12,14,31H,8,13H2,1H3,(H,32,33)	KRFVOCRTZLYSJU-UHFFFAOYSA-N	283481	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3-methylisoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 133::US10266515, Example 133::US10308637, Example 133::US11021463, Example 133::US9611252, Example 133	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283481	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283481&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212795	378164809							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755815	CS(=O)(=O)c1ccc2cc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)ccc2n1	InChI=1S/C27H23N5O3S/c1-36(34,35)25-7-4-20-12-17(3-6-24(20)32-25)14-22-15-21(9-10-29-22)27(33)31-16-18-2-5-23-19(13-18)8-11-30-26(23)28/h2-13,15H,14,16H2,1H3,(H2,28,30)(H,31,33)	QZLYZRALGDJSAC-UHFFFAOYSA-N	283482	N-((1-aminoisoquinolin-6-yl)methyl)-2-((2- (methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 134::US10266515, Example 134::US10308637, Example 134::US11021463, Example 134::US9611252, Example 134	Plasma kallikrein			 550							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283482	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283482&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212866	378164810							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755816	CS(=O)(=O)c1ccc2cc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)ccc2n1	InChI=1S/C26H20ClFN4O3S/c1-36(34,35)25-5-3-16-8-15(2-4-23(16)32-25)9-19-10-17(6-7-29-19)26(33)31-13-18-11-20-21(27)14-30-24(20)12-22(18)28/h2-8,10-12,14,30H,9,13H2,1H3,(H,31,33)	URHHGZRDZIHONJ-UHFFFAOYSA-N	283483	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((2-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 135::US10266515, Example 135::US10308637, Example 135::US11021463, Example 135::US9611252, Example 135	Plasma kallikrein			 550							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283483	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283483&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212678	378164811							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755817	Nc1nccc2cc(CNC(=O)c3ccnc(Cc4ccc5nccc(C#N)c5c4)c3)ccc12	InChI=1S/C27H20N6O/c28-15-21-7-9-31-25-4-2-17(13-24(21)25)12-22-14-20(6-8-30-22)27(34)33-16-18-1-3-23-19(11-18)5-10-32-26(23)29/h1-11,13-14H,12,16H2,(H2,29,32)(H,33,34)	GWYUQVNAIHTMAT-UHFFFAOYSA-N	283484	N-((1-aminoisoquinolin-6-yl)methyl)-2-((4- cyanoquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 136::US10266515, Example 136::US10308637, Example 136::US11021463, Example 136::US9611252, Example 136	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283484	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283484&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213035	378164812							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755818	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1ccnc(Cc2ccc3nccc(C#N)c3c2)c1	InChI=1S/C26H17ClFN5O/c27-22-14-32-25-11-23(28)18(10-21(22)25)13-33-26(34)16-3-5-30-19(9-16)7-15-1-2-24-20(8-15)17(12-29)4-6-31-24/h1-6,8-11,14,32H,7,13H2,(H,33,34)	NHUNQBFMIZILLQ-UHFFFAOYSA-N	378008	N-((3-chloro-6-fluoro-1H-indol-5- yl)methyl)-2-((4-cyanoquinolin-6- yl)methyl)isonicotinamide::US10266515, Example 137::US10308637, Example 137::US11021463, Example 137	Plasma kallikrein			 550							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378008	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378008&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213256	404346942							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755819	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3nccc(C#N)c3c2)c1	InChI=1S/C25H22N6O/c1-15-9-24(27)31-16(2)22(15)14-30-25(32)18-5-7-28-20(12-18)10-17-3-4-23-21(11-17)19(13-26)6-8-29-23/h3-9,11-12H,10,14H2,1-2H3,(H2,27,31)(H,30,32)	GBSCHYJOECITNK-UHFFFAOYSA-N	378009	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-2-((4-cyanoquinolin-6- yl)methyl)isonicotinamide::US10266515, Example 138::US10308637, Example 138::US11021463, Example 138	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378009	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378009&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212566	404346943							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755820	Nc1nccc2cc(CNC(=O)c3ccnc(Cc4cnc5cc(Cl)ccc5c4)c3)ccc12	InChI=1S/C26H20ClN5O/c27-21-3-2-19-10-17(15-31-24(19)13-21)11-22-12-20(6-7-29-22)26(33)32-14-16-1-4-23-18(9-16)5-8-30-25(23)28/h1-10,12-13,15H,11,14H2,(H2,28,30)(H,32,33)	AIGLAHDLOIUXAW-UHFFFAOYSA-N	283487	N-((1-aminoisoquinolin-6-yl)methyl)-2-((7- chloroquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 139::US10266515, Example 139::US10308637, Example 139::US11021463, Example 139	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283487	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283487&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212540	378164815							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755821	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1ccnc(Cc2cnc3cc(Cl)ccc3c2)c1	InChI=1S/C25H17Cl2FN4O/c26-18-2-1-15-5-14(11-30-23(15)9-18)6-19-7-16(3-4-29-19)25(33)32-12-17-8-20-21(27)13-31-24(20)10-22(17)28/h1-5,7-11,13,31H,6,12H2,(H,32,33)	IKMVYXFFBLRHRM-UHFFFAOYSA-N	283488	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((7-chloroquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 140::US10266515, Example 140::US10308637, Example 140::US11021463, Example 140::US9611252, Example 140	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283488	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283488&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212776	378164816							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755822	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cnc3cc(Cl)ccc3c2)c1	InChI=1S/C24H22ClN5O/c1-14-7-23(26)30-15(2)21(14)13-29-24(31)18-5-6-27-20(10-18)9-16-8-17-3-4-19(25)11-22(17)28-12-16/h3-8,10-12H,9,13H2,1-2H3,(H2,26,30)(H,29,31)	CRTRNHYSRBELJZ-UHFFFAOYSA-N	283489	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((7-chloroquinolin-3- yl)methyl)isonicotinamide::US10023557, Example 141::US10266515, Example 141::US10308637, Example 141::US11021463, Example 141::US9611252, Example 141	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283489	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283489&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213050	378164817							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755823	Cc1cnc2ccc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)cc2c1	InChI=1S/C27H23N5O/c1-17-10-22-11-18(3-5-25(22)31-15-17)13-23-14-21(7-8-29-23)27(33)32-16-19-2-4-24-20(12-19)6-9-30-26(24)28/h2-12,14-15H,13,16H2,1H3,(H2,28,30)(H,32,33)	XPXFEZOWOODSMW-UHFFFAOYSA-N	283490	N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- methylquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 142::US10266515, Example 142::US10308637, Example 142::US11021463, Example 142::US9611252, Example 142	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283490	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283490&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212463	378164818							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755824	Cc1cnc2ccc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)cc2c1	InChI=1S/C26H20ClFN4O/c1-15-6-18-7-16(2-3-24(18)30-12-15)8-20-9-17(4-5-29-20)26(33)32-13-19-10-21-22(27)14-31-25(21)11-23(19)28/h2-7,9-12,14,31H,8,13H2,1H3,(H,32,33)	BAWQXCVTJNYXQW-UHFFFAOYSA-N	283491	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3-methylquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 143::US10266515, Example 143::US10308637, Example 143::US11021463, Example 143::US9611252, Example 143	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283491	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283491&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212764	378164819							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755825	Cc1cnc2ccc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2c1	InChI=1S/C25H25N5O/c1-15-8-20-10-18(4-5-23(20)28-13-15)11-21-12-19(6-7-27-21)25(31)29-14-22-16(2)9-24(26)30-17(22)3/h4-10,12-13H,11,14H2,1-3H3,(H2,26,30)(H,29,31)	BDBQXLZXRHXRJN-UHFFFAOYSA-N	283492	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-methylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 144::US10266515, Example 144::US10308637, Example 144::US11021463, Example 144::US9611252, Example 144	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283492	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283492&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212432	378164820							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755826	Cc1cc2cc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)ccc2cn1	InChI=1S/C25H25N5O/c1-15-8-24(26)30-17(3)23(15)14-29-25(31)19-6-7-27-22(12-19)11-18-4-5-20-13-28-16(2)9-21(20)10-18/h4-10,12-13H,11,14H2,1-3H3,(H2,26,30)(H,29,31)	IDPUQOZCEWQYLL-UHFFFAOYSA-N	283493	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-methylisoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 145::US10266515, Example 145::US10308637, Example 145::US11021463, Example 145::US9611252, Example 145	Plasma kallikrein			<100							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283493	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283493&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212443	378164821							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755827	NCc1ccc2cc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)ccc2n1	InChI=1S/C27H24N6O/c28-15-22-4-3-20-11-17(2-6-25(20)33-22)13-23-14-21(8-9-30-23)27(34)32-16-18-1-5-24-19(12-18)7-10-31-26(24)29/h1-12,14H,13,15-16,28H2,(H2,29,31)(H,32,34)	NBXVVYPBTMZIFQ-UHFFFAOYSA-N	283494	N-((1-aminoisoquinolin-6-yl)methyl)-2-((2- (aminomethyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 146::US10266515, Example 146::US10308637, Example 146::US11021463, Example 146::US9611252, Example 146Biochemical	Plasma kallikrein			 550							US Patent		10.7270/Q2J968P7		aid1798384	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283494	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283494&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212893	378164822							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755828	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2c1)S(C)(=O)=O	InChI=1S/C26H27N5O3S/c1-15-7-20-9-18(11-23(35(4,33)34)25(20)29-13-15)10-21-12-19(5-6-28-21)26(32)30-14-22-16(2)8-24(27)31-17(22)3/h5-9,11-13H,10,14H2,1-4H3,(H2,27,31)(H,30,32)	HXOKVKXTISERDZ-UHFFFAOYSA-N	283363	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-methyl-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 15::US10266515, Example 15::US10308637, Example 15::US11021463, Example 15::US9611252, Example 15	Plasma kallikrein					<100					US Patent		10.7270/Q2J968P7		aid1798385	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283363	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283363&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213052	378164692							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755829	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)cc2c1)S(C)(=O)=O	InChI=1S/C28H25N5O3S/c1-17-9-22-11-19(13-25(37(2,35)36)26(22)32-15-17)12-23-14-21(6-7-30-23)28(34)33-16-18-3-4-24-20(10-18)5-8-31-27(24)29/h3-11,13-15H,12,16H2,1-2H3,(H2,29,31)(H,33,34)	AGLYWDINMJNVRE-UHFFFAOYSA-N	283364	N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- methyl-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 16::US10266515, Example 16::US10308637, Example 16::US11021463, Example 16::US9611252, Example 16	Plasma kallikrein					<100					US Patent		10.7270/Q2J968P7		aid1798385	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283364	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283364&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665230	378164693							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755830	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)cc2c1)S(C)(=O)=O	InChI=1S/C27H22ClFN4O3S/c1-15-5-18-6-16(8-25(37(2,35)36)26(18)32-12-15)7-20-9-17(3-4-30-20)27(34)33-13-19-10-21-22(28)14-31-24(21)11-23(19)29/h3-6,8-12,14,31H,7,13H2,1-2H3,(H,33,34)	KNWYWDACHSZACS-UHFFFAOYSA-N	283365	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3-methyl-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 17::US10266515, Example 17::US10308637, Example 17::US11021463, Example 17::US9611252, Example 17	Plasma kallikrein					<100					US Patent		10.7270/Q2J968P7		aid1798385	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283365	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283365&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213042	378164694							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755831	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cc4cc[nH]c4cc3F)cc2c1)S(C)(=O)=O	InChI=1S/C27H23FN4O3S/c1-16-7-20-8-17(10-25(36(2,34)35)26(20)31-14-16)9-22-12-19(4-5-29-22)27(33)32-15-21-11-18-3-6-30-24(18)13-23(21)28/h3-8,10-14,30H,9,15H2,1-2H3,(H,32,33)	JOIGNBGOTQEXSU-UHFFFAOYSA-N	283366	N-((6-fluoro-1H-indol-5-yl)methyl)-2-((3- methyl-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 18::US10266515, Example 18::US10308637, Example 18::US11021463, Example 18::US9611252, Example 18	Plasma kallikrein					 550					US Patent		10.7270/Q2J968P7		aid1798385	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283366	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283366&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665345	378164695							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755832	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cnc4[nH]cc(Cl)c4c3)cc2c1)S(C)(=O)=O	InChI=1S/C26H22ClN5O3S/c1-15-5-19-6-16(9-23(36(2,34)35)24(19)29-11-15)7-20-10-18(3-4-28-20)26(33)32-13-17-8-21-22(27)14-31-25(21)30-12-17/h3-6,8-12,14H,7,13H2,1-2H3,(H,30,31)(H,32,33)	IIORZUFKRKFNHD-UHFFFAOYSA-N	283367	N-((3-chloro-1H-pyrrolo[2,3-b]pyridin-5- yl)methyl)-2-((3-methyl-8- (methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 19::US10266515, Example 19::US10308637, Example 19::US11021463, Example 19::US9611252, Example 19	Plasma kallikrein					<100					US Patent		10.7270/Q2J968P7		aid1798385	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283367	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283367&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665214	378164696							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755833	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3n[nH]c4ccc(Cl)cc34)cc2c1)S(C)(=O)=O	InChI=1S/C26H22ClN5O3S/c1-15-7-18-8-16(10-24(36(2,34)35)25(18)29-13-15)9-20-11-17(5-6-28-20)26(33)30-14-23-21-12-19(27)3-4-22(21)31-32-23/h3-8,10-13H,9,14H2,1-2H3,(H,30,33)(H,31,32)	INPUBOYBDZWEOS-UHFFFAOYSA-N	283368	N-((5-chloro-1H-indazol-3-yl)methyl)-2-((3- methyl-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 20::US10266515, Example 20::US10308637, Example 20::US11021463, Example 20::US9611252, Example 20	Plasma kallikrein					<100					US Patent		10.7270/Q2J968P7		aid1798385	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283368	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283368&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665285	378164697							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755834	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3ccc4[nH]cc(Cl)c4c3F)cc2c1)S(C)(=O)=O	InChI=1S/C27H22ClFN4O3S/c1-15-7-19-8-16(10-23(37(2,35)36)26(19)32-12-15)9-20-11-17(5-6-30-20)27(34)33-13-18-3-4-22-24(25(18)29)21(28)14-31-22/h3-8,10-12,14,31H,9,13H2,1-2H3,(H,33,34)	RIPJTLFXOCXAJL-UHFFFAOYSA-N	283369	N-((3-chloro-4-fluoro-1H-indol-5-yl)methyl)-2- ((3-methyl-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 21::US10266515, Example 21::US10308637, Example 21::US11021463, Example 21::US9611252, Example 21	Plasma kallikrein					<100					US Patent		10.7270/Q2J968P7		aid1798385	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283369	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283369&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213012	378164698							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755835	Nc1nccc2cc(CNC(=O)c3ccnc(Cc4ccc5ncc(Cl)cc5c4)c3)ccc12	InChI=1S/C26H20ClN5O/c27-21-12-20-9-16(2-4-24(20)31-15-21)11-22-13-19(6-7-29-22)26(33)32-14-17-1-3-23-18(10-17)5-8-30-25(23)28/h1-10,12-13,15H,11,14H2,(H2,28,30)(H,32,33)	WHHMKDFLRDNMQE-UHFFFAOYSA-N	283379	N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- chloroquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 179::US10023557, Example 31::US10266515, Example 31::US10308637, Example 179::US11021463, Example 31::US9611252, Example 31	Plasma kallikrein					<100					US Patent		10.7270/Q2J968P7		aid1798385	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283379	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283379&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212700	378164708							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755836	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C25H17Cl2FN4O/c26-18-7-16-5-14(1-2-23(16)30-12-18)6-19-8-15(3-4-29-19)25(33)32-11-17-9-20-21(27)13-31-24(20)10-22(17)28/h1-5,7-10,12-13,31H,6,11H2,(H,32,33)	XZUNAOLBBRHEMP-UHFFFAOYSA-N	283381	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3-chloroquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 33::US10266515, Example 33::US10308637, Example 33::US11021463, Example 33::US9611252, Example 33	Plasma kallikrein					 550					US Patent		10.7270/Q2J968P7		aid1798385	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283381	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283381&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212875	378164710							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755837	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C23H20ClN5O/c1-14-17(3-5-22(25)29-14)12-28-23(30)16-6-7-26-20(11-16)9-15-2-4-21-18(8-15)10-19(24)13-27-21/h2-8,10-11,13H,9,12H2,1H3,(H2,25,29)(H,28,30)	ZGYIOYKVCAJRKO-UHFFFAOYSA-N	283382	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-chloroquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 34::US10266515, Example 39::US10308637, Example 39::US11021463, Example 39::US9611252, Example 39	Plasma kallikrein					<100					US Patent		10.7270/Q2J968P7		aid1798385	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283382	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283382&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213054	378164711							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755838	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C24H22ClN5O/c1-14-7-23(26)30-15(2)21(14)13-29-24(31)17-5-6-27-20(11-17)9-16-3-4-22-18(8-16)10-19(25)12-28-22/h3-8,10-12H,9,13H2,1-2H3,(H2,26,30)(H,29,31)	BDLURRLRBKLEDL-UHFFFAOYSA-N	283383	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 35::US10266515, Example 35::US10308637, Example 35::US11021463, Example 35::US9611252, Example 35	Plasma kallikrein					<100					US Patent		10.7270/Q2J968P7		aid1798385	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283383	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283383&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665163	378164712							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755839	Clc1c[nH]c2ncc(CNC(=O)c3ccnc(Cc4ccc5ncc(Cl)cc5c4)c3)cc12	InChI=1S/C24H17Cl2N5O/c25-18-8-17-5-14(1-2-22(17)28-12-18)6-19-9-16(3-4-27-19)24(32)31-11-15-7-20-21(26)13-30-23(20)29-10-15/h1-5,7-10,12-13H,6,11H2,(H,29,30)(H,31,32)	QFSDBAJWKWRDTA-UHFFFAOYSA-N	283386	N-((3-chloro-1H-pyrrolo[2,3-b]pyridin-5- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 38::US10266515, Example 38::US10308637, Example 38::US11021463, Example 38::US9611252, Example 38	Plasma kallikrein					 550					US Patent		10.7270/Q2J968P7		aid1798385	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283386	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283386&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665363	378164715							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755840	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C23H20ClN5O/c1-14-17(3-5-22(25)29-14)12-28-23(30)16-6-7-26-20(11-16)9-15-2-4-21-18(8-15)10-19(24)13-27-21/h2-8,10-11,13H,9,12H2,1H3,(H2,25,29)(H,28,30)	ZGYIOYKVCAJRKO-UHFFFAOYSA-N	283382	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-chloroquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 34::US10266515, Example 39::US10308637, Example 39::US11021463, Example 39::US9611252, Example 39	Plasma kallikrein					<100					US Patent		10.7270/Q2J968P7		aid1798385	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283382	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283382&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213054	378164711							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755841	Fc1c(CNC(=O)c2ccnc(Cc3ccc4ncc(Cl)cc4c3)c2)ccc2[nH]cc(Cl)c12	InChI=1S/C25H17Cl2FN4O/c26-18-9-17-7-14(1-3-21(17)30-12-18)8-19-10-15(5-6-29-19)25(33)32-11-16-2-4-22-23(24(16)28)20(27)13-31-22/h1-7,9-10,12-13,31H,8,11H2,(H,32,33)	GVFULHFYDFFIFD-UHFFFAOYSA-N	283388	N-((3-chloro-4-fluoro-1H-indol-5-yl)methyl)-2- ((3-chloroquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 40::US10266515, Example 40::US10308637, Example 40::US11021463, Example 40::US9611252, Example 40	Plasma kallikrein					 550					US Patent		10.7270/Q2J968P7		aid1798385	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283388	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283388&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665357	378164717							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755842	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc(C#N)c3ncc(Cl)cc3c2)c1	InChI=1S/C25H21ClN6O/c1-14-5-23(28)32-15(2)22(14)13-31-25(33)17-3-4-29-21(10-17)8-16-6-18-9-20(26)12-30-24(18)19(7-16)11-27/h3-7,9-10,12H,8,13H2,1-2H3,(H2,28,32)(H,31,33)	VSKYRJRRAUSIED-UHFFFAOYSA-N	283398	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloro-8-cyanoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 50::US10266515, Example 50::US10308637, Example 50::US11021463, Example 50::US9611252, Example 50	Plasma kallikrein					<100					US Patent		10.7270/Q2J968P7		aid1798385	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283398	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283398&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665177	378164727							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755843	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2cc(C#N)c3ncc(Cl)cc3c2)c1	InChI=1S/C24H19ClN6O/c1-14-17(2-3-22(27)31-14)12-30-24(32)16-4-5-28-21(10-16)8-15-6-18-9-20(25)13-29-23(18)19(7-15)11-26/h2-7,9-10,13H,8,12H2,1H3,(H2,27,31)(H,30,32)	FDKNUBSGWSPNRT-UHFFFAOYSA-N	283404	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-chloro-8-cyanoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 56::US10266515, Example 56::US10308637, Example 56::US11021463, Example 56::US9611252, Example 56	Plasma kallikrein					 550					US Patent		10.7270/Q2J968P7		aid1798385	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283404	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283404&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665146	378164733							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755844	Nc1nccc2cc(CNC(=O)c3ccnc(Cc4cc(C#N)c5ncc(Cl)cc5c4)c3)ccc12	InChI=1S/C27H19ClN6O/c28-22-11-20-8-17(9-21(13-29)25(20)33-15-22)10-23-12-19(4-5-31-23)27(35)34-14-16-1-2-24-18(7-16)3-6-32-26(24)30/h1-9,11-12,15H,10,14H2,(H2,30,32)(H,34,35)	IDTYIYATNJINLX-UHFFFAOYSA-N	283405	N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- chloro-8-cyanoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 57::US10266515, Example 57::US10308637, Example 57::US11021463, Example 57::US9611252, Example 57	Plasma kallikrein					 550					US Patent		10.7270/Q2J968P7		aid1798385	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283405	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283405&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665382	378164734							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
755845	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc(C(N)=O)c3ncc(Cl)cc3c2)c1	InChI=1S/C25H23ClN6O2/c1-13-5-22(27)32-14(2)21(13)12-31-25(34)16-3-4-29-19(10-16)7-15-6-17-9-18(26)11-30-23(17)20(8-15)24(28)33/h3-6,8-11H,7,12H2,1-2H3,(H2,27,32)(H2,28,33)(H,31,34)	INWUNFFPSCFXCA-UHFFFAOYSA-N	283406	6-((4-(((6-amino-2,4-dimethylpyridin-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- chloroquinoline-8-carboxamide::US10023557, Example 58::US10266515, Example 58::US10308637, Example 58::US11021463, Example 58::US9611252, Example 58	Plasma kallikrein					<100					US Patent		10.7270/Q2J968P7		aid1798385	US10266515	McDonald, A; Qian, S	LIFESCI PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283406	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283406&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665386	378164735							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835547	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(n1)C#N)C(F)(F)F	InChI=1S/C30H27F4N7O/c31-23-10-9-20(29(37,12-11-18-7-8-18)26-6-2-4-21(17-36)38-26)14-24(23)39-28(42)25-15-27(30(32,33)34)40-41(25)22-5-1-3-19(13-22)16-35/h1-6,9-10,13-15,18H,7-8,11-12,16,35,37H2,(H,39,42)	UYAYDZPBNCJYMZ-UHFFFAOYSA-N	417008	(+)-N-(5-(1-amino-1-(6-cyanopyridin-2-yl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 220f::US10633345, Compound 220f::US10689346, Compound 220f::US11203574, Compound 220f::US11230530, Compound 220f::US11685721, Compound 220f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417008	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417008&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355858	433916919							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835548	CC(C)(C)[S@@](=O)NC(CCC1CC1)(c1cccnc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(c2)C(N)=N)C(F)(F)F)c1	InChI=1S/C33H35F4N7O2S/c1-31(2,3)47(46)43-32(14-13-20-9-10-20,23-7-5-15-40-19-23)22-11-12-25(34)26(17-22)41-30(45)27-18-28(33(35,36)37)42-44(27)24-8-4-6-21(16-24)29(38)39/h4-8,11-12,15-20,43H,9-10,13-14H2,1-3H3,(H3,38,39)(H,41,45)/t32?,47-/m1/s1	ORCJXCNQCCWVHD-HKYIEPEJSA-N	417009	1-(3-carbamimidoylphenyl)-N-(5-((+-)-3-cyclopropyl-1-((R)-1,1-dimethylethylsulfinamido)-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 238c::US10633345, Compound 238c::US10689346, Compound 238c::US11203574, Compound 238c::US11230530, Compound 238c::US11685721, Compound 238c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417009	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417009&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355741	433916920							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835549	Nc1nccc2ccc(cc12)-n1nc(cc1C(F)(F)F)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1	InChI=1S/C31H27F4N7O/c32-24-6-4-21(30(37,11-7-18-1-2-18)20-9-12-38-13-10-20)15-25(24)40-29(43)26-17-27(31(33,34)35)42(41-26)22-5-3-19-8-14-39-28(36)23(19)16-22/h3-6,8-10,12-18H,1-2,7,11,37H2,(H2,36,39)(H,40,43)	JTQCWLVRCRAKSI-UHFFFAOYSA-N	417010	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-4-yl)propyl)-2-fluorophenyl)-1-(1-aminoisoquinolin-7-yl)-5-(trifluoromethyl)-1H-pyrazole-3-carboxamide::US10329260, Compound 268g::US10633345, Compound 268g::US10689346, Compound 268g::US11203574, Compound 268g::US11230530, Compound 268g::US11685721, Compound 268g	Plasma kallikrein		 75.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417010	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417010&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356088	433916921							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835550	Nc1ncnc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H25F4N7O/c31-22-10-8-19(27(36-15-17-6-7-17)18-4-2-1-3-5-18)12-24(22)39-29(42)25-14-26(30(32,33)34)40-41(25)20-9-11-23-21(13-20)28(35)38-16-37-23/h1-5,8-14,16-17,27,36H,6-7,15H2,(H,39,42)(H2,35,37,38)	NOYPEPJWHRTGGG-UHFFFAOYSA-N	417011	1-(4-aminoquinazolin-6-yl)-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 224b::US10329260, Compound 226a::US10633345, Compound 226a::US10689346, Compound 226a::US11203574, Compound 226a::US11230530, Compound 226a::US11685721, Compound 226a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417011	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417011&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665806	433916922							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835551	NC(=N)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C31H27F4N7O/c32-24-11-10-22(30(39,13-12-18-4-5-18)21-8-6-19(17-36)7-9-21)15-25(24)40-29(43)26-16-27(31(33,34)35)41-42(26)23-3-1-2-20(14-23)28(37)38/h1-3,6-11,14-16,18H,4-5,12-13,39H2,(H3,37,38)(H,40,43)	QLTPSVVBRYJDCX-UHFFFAOYSA-N	417012	(+)-N-(5-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-carbamimidoylphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 241a::US10633345, Compound 241a::US10689346, Compound 241a::US11192861, Compound 241a::US11230530, Compound 241a::US11685721, Compound 241a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417012	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417012&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665936	433916923							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835552	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccccc1=O)C(F)(F)F	InChI=1S/C31H26F4N6O2/c32-23-10-8-20(25(11-6-18-4-5-18)40-14-2-1-3-28(40)42)15-24(23)38-30(43)26-17-27(31(33,34)35)39-41(26)21-9-7-19-12-13-37-29(36)22(19)16-21/h1-3,7-10,12-18,25H,4-6,11H2,(H2,36,37)(H,38,43)	GNDQLXKOPYFGBP-UHFFFAOYSA-N	417013	1-(1-aminoisoquinolin-7-yl)-N-(5-(3-cyclopropyl-1-(2-oxopyridin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 258g::US10633345, Compound 258g::US10689346, Compound 258g::US11203574, Compound 258g::US11230530, Compound 258g::US11685721, Compound 258g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417013	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417013&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355895	433916924							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835553	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C(N)=O)C(F)(F)F	InChI=1S/C31H30F4N6O2/c32-24-10-9-22(30(38,12-11-18-7-8-18)21-5-2-4-20(14-21)28(37)42)15-25(24)39-29(43)26-16-27(31(33,34)35)40-41(26)23-6-1-3-19(13-23)17-36/h1-6,9-10,13-16,18H,7-8,11-12,17,36,38H2,(H2,37,42)(H,39,43)	DYGHBBDYRMOWAC-UHFFFAOYSA-N	417014	(+-)-N-(5-(1-amino-1-(3-carbamoylphenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 225a::US10633345, Compound 225a::US10689346, Compound 225a::US11203574, Compound 225a::US11230530, Compound 225a::US11685721, Compound 225a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417014	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417014&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665606	433916925							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835554	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C31H28F4N6O/c32-25-10-9-23(30(38,12-11-19-7-8-19)22-5-1-3-20(13-22)17-36)15-26(25)39-29(42)27-16-28(31(33,34)35)40-41(27)24-6-2-4-21(14-24)18-37/h1-6,9-10,13-16,19H,7-8,11-12,18,37-38H2,(H,39,42)	ZBDDMFBNDOEVJT-UHFFFAOYSA-N	417015	(+-)-N-(5-(1-amino-1-(3-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 215d	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417015	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417015&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665709	433916926							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835555	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)[C@H](CCC1CC1)n1ccccc1=O)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-11-10-20(24(12-9-18-7-8-18)37-13-2-1-6-27(37)39)15-23(22)35-28(40)25-16-26(29(31,32)33)36-38(25)21-5-3-4-19(14-21)17-34/h1-6,10-11,13-16,18,24H,7-9,12,17,34H2,(H,35,40)/t24-/m0/s1	OFQQGSYWUFBMPP-DEOSSOPVSA-N	417016	(+)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(2-oxopyridin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (248k), (+-)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(2-oxopyridin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 248l	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417016	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417016&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			154584234	433916927							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835556	Nc1ncnc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H25F4N7O/c31-22-10-8-19(27(36-15-17-6-7-17)18-4-2-1-3-5-18)12-24(22)39-29(42)25-14-26(30(32,33)34)40-41(25)20-9-11-23-21(13-20)28(35)38-16-37-23/h1-5,8-14,16-17,27,36H,6-7,15H2,(H,39,42)(H2,35,37,38)	NOYPEPJWHRTGGG-UHFFFAOYSA-N	417011	1-(4-aminoquinazolin-6-yl)-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 224b::US10329260, Compound 226a::US10633345, Compound 226a::US10689346, Compound 226a::US11203574, Compound 226a::US11230530, Compound 226a::US11685721, Compound 226a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417011	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417011&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665806	433916922							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835557	NC(=N)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H27F4N7O/c30-22-9-8-19(28(36,11-10-17-6-7-17)20-4-2-12-37-16-20)14-23(22)38-27(41)24-15-25(29(31,32)33)39-40(24)21-5-1-3-18(13-21)26(34)35/h1-5,8-9,12-17H,6-7,10-11,36H2,(H3,34,35)(H,38,41)	JBCZLPFSSAYNEJ-UHFFFAOYSA-N	417018	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-1-(3-carbamimidoylphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 238d::US10633345, Compound 238d::US10689346, Compound 238d::US11192861, Compound 238d::US11230530, Compound 238d::US11685721, Compound 238d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417018	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417018&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355839	433916928							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835558	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)[C@@H](CCC1CC1)n1ccccc1=O)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-11-10-20(24(12-9-18-7-8-18)37-13-2-1-6-27(37)39)15-23(22)35-28(40)25-16-26(29(31,32)33)36-38(25)21-5-3-4-19(14-21)17-34/h1-6,10-11,13-16,18,24H,7-9,12,17,34H2,(H,35,40)/t24-/m1/s1	OFQQGSYWUFBMPP-XMMPIXPASA-N	417019	(+)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(2-oxopyridin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (248k)::US10329260, Compound 248k	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417019	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417019&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			154584235	433916929							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835559	NC(=N)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)[C@@H](NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N6O/c30-22-12-11-19(26(36-16-17-9-10-17)18-5-2-1-3-6-18)14-23(22)37-28(40)24-15-25(29(31,32)33)38-39(24)21-8-4-7-20(13-21)27(34)35/h1-8,11-15,17,26,36H,9-10,16H2,(H3,34,35)(H,37,40)/t26-/m0/s1	HUIANTFJQLRTEM-SANMLTNESA-N	417020	HCl salt of (+-)-1-(3-carbamimidoylphenyl)-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 227d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417020	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417020&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			154584236	433916930							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835560	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(nc1)C(N)=O)C(F)(F)F	InChI=1S/C30H29F4N7O2/c31-22-8-6-19(29(37,11-10-17-4-5-17)20-7-9-23(27(36)42)38-16-20)13-24(22)39-28(43)25-14-26(30(32,33)34)40-41(25)21-3-1-2-18(12-21)15-35/h1-3,6-9,12-14,16-17H,4-5,10-11,15,35,37H2,(H2,36,42)(H,39,43)	IQWHGFSUUIEJQU-UHFFFAOYSA-N	417021	(+)-5-(1-amino-1-(3-(1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamido)-4-fluorophenyl)-3-cyclopropylpropyl)picolinamide::US10329260, Compound 221i::US10633345, Compound 221i::US10689346, Compound 221i::US11203574, Compound 221i::US11230530, Compound 221i::US11685721, Compound 221i	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417021	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417021&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665782	433916931							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835561	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C30H25F4N7O/c31-23-6-4-20(27(38-16-17-1-2-17)19-7-10-36-11-8-19)13-24(23)39-29(42)25-15-26(30(32,33)34)40-41(25)21-5-3-18-9-12-37-28(35)22(18)14-21/h3-15,17,27,38H,1-2,16H2,(H2,35,37)(H,39,42)	UQWHIYYZYLIMKJ-UHFFFAOYSA-N	417022	(+)-1-(1-aminoisoquinolin-7-yl)-N-(5-((cyclopropylmethylamino)(pyridin-4-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 264g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417022	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417022&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355979	433916932							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835562	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C(N)=O)C(F)(F)F	InChI=1S/C31H30F4N6O2/c32-24-11-10-22(30(38,13-12-18-4-5-18)21-8-6-20(7-9-21)28(37)42)15-25(24)39-29(43)26-16-27(31(33,34)35)40-41(26)23-3-1-2-19(14-23)17-36/h1-3,6-11,14-16,18H,4-5,12-13,17,36,38H2,(H2,37,42)(H,39,43)	HZQICPCUMLWHPZ-UHFFFAOYSA-N	417023	(+)-N-(5-(1-amino-1-(4-carbamoylphenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 228a::US10633345, Compound 228a::US10689346, Compound 228a::US11203574, Compound 228a::US11230530, Compound 228a::US11685721, Compound 228a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417023	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417023&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665484	433916933							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835563	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-23-7-6-21(28(35,11-8-18-4-5-18)20-9-12-36-13-10-20)15-24(23)37-27(40)25-16-26(29(31,32)33)38-39(25)22-3-1-2-19(14-22)17-34/h1-3,6-7,9-10,12-16,18H,4-5,8,11,17,34-35H2,(H,37,40)	AGVFYPDLNPHKER-UHFFFAOYSA-N	417024	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-4-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 216d::US10633345, Compound 217d::US10689346, Compound 217d::US11192861, Compound 217d::US11230530, Compound 217d::US11685721, Compound 217d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417024	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417024&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665723	433916934							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835564	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)N1CCCCC1=O)C(F)(F)F	InChI=1S/C29H31F4N5O2/c30-22-11-10-20(24(12-9-18-7-8-18)37-13-2-1-6-27(37)39)15-23(22)35-28(40)25-16-26(29(31,32)33)36-38(25)21-5-3-4-19(14-21)17-34/h3-5,10-11,14-16,18,24H,1-2,6-9,12-13,17,34H2,(H,35,40)	BPULHNPIKAHCAG-UHFFFAOYSA-N	417025	(+)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(2-oxopiperidin-1-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 261k::US10633345, Compound 261k::US10689346, Compound 261k::US11203574, Compound 261k::US11230530, Compound 261k::US11685721, Compound 261k	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417025	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417025&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123312183	433916935							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835565	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(N)=O	InChI=1S/C29H29FN6O2/c30-23-12-11-21(27(33-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)34-29(38)26-15-25(28(32)37)35-36(26)22-8-4-5-19(13-22)16-31/h1-8,11-15,18,27,33H,9-10,16-17,31H2,(H2,32,37)(H,34,38)	UMNCVWUVWBVXCX-UHFFFAOYSA-N	417026	(+-)-1-(3-(aminomethyl)phenyl)-N5-(5-((cyclopropylmethylamino)-(phenyl)methyl)-2-fluorophenyl)-1H-pyrazole-3,5-dicarboxamide::US10329260, Compound 229i::US10633345, Compound 229i::US10689346, Compound 229i::US11203574, Compound 229i::US11230530, Compound 229i::US11685721, Compound 229i	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417026	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417026&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665747	433916936							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835566	CC(C)(C)[S@@](=O)NC(CCC1CC1)(c1cccnc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C33H36F4N6O2S/c1-31(2,3)46(45)42-32(14-13-21-9-10-21,24-7-5-15-39-20-24)23-11-12-26(34)27(17-23)40-30(44)28-18-29(33(35,36)37)41-43(28)25-8-4-6-22(16-25)19-38/h4-8,11-12,15-18,20-21,42H,9-10,13-14,19,38H2,1-3H3,(H,40,44)/t32?,46-/m1/s1	LAOWFCURFGDGCT-ODZHGNIVSA-N	417027	1-(3-(aminomethyl)phenyl)-N-(5-((+-)-3-cyclopropyl-1-((R)-1,1-dimethylethylsulfinamido)-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 243a::US10633345, Compound 243a::US10689346, Compound 243a::US11203574, Compound 243a::US11230530, Compound 243a::US11685721, Compound 243a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417027	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417027&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665825	433916937							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835567	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccncc1=O)C(F)(F)F	InChI=1S/C30H25F4N7O2/c31-22-7-5-19(24(8-3-17-1-2-17)40-12-11-36-16-27(40)42)13-23(22)38-29(43)25-15-26(30(32,33)34)39-41(25)20-6-4-18-9-10-37-28(35)21(18)14-20/h4-7,9-17,24H,1-3,8H2,(H2,35,37)(H,38,43)	RGAKSJSQGQBUGG-UHFFFAOYSA-N	417028	1-(1-aminoisoquinolin-7-yl)-N-(5-(3-cyclopropyl-1-(2-oxopyrazin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 259d::US10633345, Compound 259d::US10689346, Compound 259d::US11203574, Compound 259d::US11230530, Compound 259d::US11685721, Compound 259d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417028	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417028&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355792	433916938							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835568	NC(=O)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H25F4N5O2/c30-22-12-11-19(26(35-16-17-9-10-17)18-5-2-1-3-6-18)14-23(22)36-28(40)24-15-25(29(31,32)33)37-38(24)21-8-4-7-20(13-21)27(34)39/h1-8,11-15,17,26,35H,9-10,16H2,(H2,34,39)(H,36,40)	JMSFBJDWVQAENA-UHFFFAOYSA-N	417029	(+-)-1-(3-carbamoylphenyl)-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 230a::US10633345, Compound 230a::US10689346, Compound 230a::US11203574, Compound 230a::US11230530, Compound 230a::US11685721, Compound 230a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417029	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417029&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665857	433916939							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835569	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-23-7-6-21(28(35,11-8-18-4-5-18)20-9-12-36-13-10-20)15-24(23)37-27(40)25-16-26(29(31,32)33)38-39(25)22-3-1-2-19(14-22)17-34/h1-3,6-7,9-10,12-16,18H,4-5,8,11,17,34-35H2,(H,37,40)	AGVFYPDLNPHKER-UHFFFAOYSA-N	417030	(+-)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-4-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 217d	Plasma kallikrein		 75.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417030	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417030&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665723	433916940							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835570	Cc1cc(ccn1)C(N)(CCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F4N6O/c1-18-13-22(10-12-37-18)29(36,11-9-19-5-6-19)21-7-8-24(31)25(15-21)38-28(41)26-16-27(30(32,33)34)39-40(26)23-4-2-3-20(14-23)17-35/h2-4,7-8,10,12-16,19H,5-6,9,11,17,35-36H2,1H3,(H,38,41)	PYONXWOUVYIBRU-UHFFFAOYSA-N	417031	(+)-N-(5-(1-amino-3-cyclopropyl-1-(2-methylpyridin-4-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 266j::US10633345, Compound 266j::US10689346, Compound 266j::US11203574, Compound 266j::US11230530, Compound 266j::US11685721, Compound 266j	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417031	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417031&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665585	433916941							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835572	CCNCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C31H31F4N5O/c1-2-36-18-21-7-6-10-24(15-21)40-27(17-28(39-40)31(33,34)35)30(41)38-26-16-23(13-14-25(26)32)29(37-19-20-11-12-20)22-8-4-3-5-9-22/h3-10,13-17,20,29,36-37H,2,11-12,18-19H2,1H3,(H,38,41)	RBEFOPDBDLERKF-UHFFFAOYSA-N	417033	(+-)-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-1-(3-((ethylamino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 270a::US10633345, Compound 270a::US10689346, Compound 270a::US11203574, Compound 270a::US11230530, Compound 270a::US11685721, Compound 270a	Plasma kallikrein		 75.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417033	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417033&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665791	433916943							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835571	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccc(=O)[nH]c1=O)C(F)(F)F			417032	1-(1-aminoisoquinolin-7-yl)-N-(5-(3-cyclopropyl-1-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 269b::US10633345, Compound 269b::US10689346, Compound 269b::US11203574, Compound 269b::US11230530, Compound 269b::US11685721, Compound 269b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417032	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417032&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			154584237	433916942							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835290	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1Cl)C(O)c1ccccc1)C(F)(F)F	InChI=1S/C25H20ClF3N4O2/c26-19-10-9-17(23(34)16-6-2-1-3-7-16)12-20(19)31-24(35)21-13-22(25(27,28)29)32-33(21)18-8-4-5-15(11-18)14-30/h1-13,23,34H,14,30H2,(H,31,35)	RYPOCSQZGRAPIF-UHFFFAOYSA-N	416738	1-(3-(aminomethyl)phenyl)-N-(2-chloro-5-(hydroxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 33f::US10633345, Compound 33f::US10689346, Compound 33f::US11203574, Compound 33f::US11230530, Compound 33f::US11685721, Compound 33f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416738	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416738&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665810	433916652							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835291	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)N(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H28F3N5O/c30-29(31,32)27-18-26(37(35-27)25-11-4-6-21(16-25)19-33)28(38)34-22-7-5-10-24(17-22)36(15-14-20-12-13-20)23-8-2-1-3-9-23/h1-11,16-18,20H,12-15,19,33H2,(H,34,38)	BPUAEVGWEFCIEW-UHFFFAOYSA-N	416739	1-(3-(aminomethyl)phenyl)-N-(3-((2-cyclopropylethyl)(phenyl)amino)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 87f::US10633345, Compound 87f::US10689346, Compound 87f::US11203574, Compound 87f::US11230530, Compound 87f::US11685721, Compound 87f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416739	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416739&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665744	433916653							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835292	CCOC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C27H25F3N4O2/c1-2-36-25(19-9-4-3-5-10-19)20-11-7-12-21(15-20)32-26(35)23-16-24(27(28,29)30)33-34(23)22-13-6-8-18(14-22)17-31/h3-16,25H,2,17,31H2,1H3,(H,32,35)	NWRGIGNKIBZYEM-UHFFFAOYSA-N	416740	1-(3-(aminomethyl)phenyl)-N-(3-(ethoxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18g::US10633345, Compound 18g::US10689346, Compound 18g::US11203574, Compound 18g::US11230530, Compound 18g::US11685721, Compound 18g	Plasma kallikrein		 75.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416740	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416740&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356270	433916654							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835293	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)c1ccccc1)C(F)(F)F	InChI=1S/C25H20F4N4O2/c26-19-10-9-17(23(34)16-6-2-1-3-7-16)12-20(19)31-24(35)21-13-22(25(27,28)29)32-33(21)18-8-4-5-15(11-18)14-30/h1-13,23,34H,14,30H2,(H,31,35)	SUGJHCONPCVXKJ-UHFFFAOYSA-N	416741	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-5-(hydroxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 34d::US10633345, Compound 34d::US10689346, Compound 34d::US11203574, Compound 34d::US11230530, Compound 34d::US11685721, Compound 34d	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416741	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416741&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665740	433916655							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835294	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(C(NCC2CC2)c2ccccc2)c1F)C(F)(F)F	InChI=1S/C29H27F4N5O/c30-26-22(27(35-17-18-12-13-18)20-7-2-1-3-8-20)10-5-11-23(26)36-28(39)24-15-25(29(31,32)33)37-38(24)21-9-4-6-19(14-21)16-34/h1-11,14-15,18,27,35H,12-13,16-17,34H2,(H,36,39)	YDBPNMJFMRHCIG-UHFFFAOYSA-N	416742	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 88b::US10633345, Compound 88b::US10689346, Compound 88b::US11203574, Compound 88b::US11230530, Compound 88b::US11685721, Compound 88b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416742	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416742&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123349010	433916656							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835295	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(=O)c1ccccc1)C(F)(F)F	InChI=1S/C25H19F3N4O2/c26-25(27,28)22-14-21(32(31-22)20-11-4-6-16(12-20)15-29)24(34)30-19-10-5-9-18(13-19)23(33)17-7-2-1-3-8-17/h1-14H,15,29H2,(H,30,34)	ZRVRSUVIXBEHIJ-UHFFFAOYSA-N	416743	1-(3-(aminomethyl)phenyl)-N-(3-benzoylphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 22b::US10633345, Compound 22b::US10689346, Compound 22b::US11203574, Compound 22b::US11230530, Compound 22b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416743	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416743&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355917	433916657							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835296	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(C(O)c2ccccc2)c1F)C(F)(F)F	InChI=1S/C25H20F4N4O2/c26-22-18(23(34)16-7-2-1-3-8-16)10-5-11-19(22)31-24(35)20-13-21(25(27,28)29)32-33(20)17-9-4-6-15(12-17)14-30/h1-13,23,34H,14,30H2,(H,31,35)	DENXCWXVTOPLRK-UHFFFAOYSA-N	416744	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-3-(hydroxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 35g::US10633345, Compound 35g::US10689346, Compound 35g::US11203574, Compound 35g::US11230530, Compound 35g::US11685721, Compound 35g	Plasma kallikrein		 75.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416744	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416744&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355965	433916658							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835297	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1nccs1)C(F)(F)F	InChI=1S/C26H24F3N5O2S/c27-26(28,29)22-13-21(34(33-22)20-6-1-3-17(11-20)14-30)24(35)32-19-5-2-4-18(12-19)23(25-31-9-10-37-25)36-15-16-7-8-16/h1-6,9-13,16,23H,7-8,14-15,30H2,(H,32,35)	FKPORVMTXYTRPN-UHFFFAOYSA-N	416745	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(thiazol-2-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 82f::US10633345, Compound 82f::US10689346, Compound 82f::US11203574, Compound 82f::US11230530, Compound 82f::US11685721, Compound 82f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416745	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416745&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355763	433916659							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835298	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(Oc2ccccc2)c1F)C(F)(F)F	InChI=1S/C24H18F4N4O2/c25-22-18(10-5-11-20(22)34-17-8-2-1-3-9-17)30-23(33)19-13-21(24(26,27)28)31-32(19)16-7-4-6-15(12-16)14-29/h1-13H,14,29H2,(H,30,33)	VUYMCUFLTORTFW-UHFFFAOYSA-N	416746	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-3-phenoxyphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 23c::US10633345, Compound 23c::US10689346, Compound 23c::US11203574, Compound 23c::US11230530, Compound 23c::US11685721, Compound 23c	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416746	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416746&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665745	433916660							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835299	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-23-12-11-21(27(39-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)35-28(38)25-15-26(29(31,32)33)36-37(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27H,9-10,16-17,34H2,(H,35,38)	HIMJVDQVZQMIPM-UHFFFAOYSA-N	416747	1-(3-(Aminomethyl)phenyl)-N-(5-((cyclopropylmethoxy)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 34c::US10633345, Compound 34c::US10689346, Compound 34c::US11203574, Compound 37a::US11230530, Compound 37a::US11685721, Compound 34c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416747	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416747&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355729	433916661							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835300	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C28H27F3N6O/c29-28(30,31)25-15-24(37(36-25)22-8-3-5-19(13-22)16-32)27(38)35-21-7-4-6-20(14-21)26(34-17-18-10-11-18)23-9-1-2-12-33-23/h1-9,12-15,18,26,34H,10-11,16-17,32H2,(H,35,38)	UTXGSCUKCKWESJ-UHFFFAOYSA-N	416748	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(pyridin-2-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 83c::US10633345, Compound 83c::US10689346, Compound 83c::US11203574, Compound 83c::US11230530, Compound 83c::US11685721, Compound 83c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416748	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416748&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355952	433916662							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835301	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(Oc2ccccc2)ccc1F)C(F)(F)F	InChI=1S/C24H18F4N4O2/c25-19-10-9-18(34-17-7-2-1-3-8-17)12-20(19)30-23(33)21-13-22(24(26,27)28)31-32(21)16-6-4-5-15(11-16)14-29/h1-13H,14,29H2,(H,30,33)	RDALDQDNCYVLAM-UHFFFAOYSA-N	416749	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-5-phenoxyphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 24c::US10633345, Compound 24c::US10689346, Compound 24c::US11203574, Compound 24c::US11230530, Compound 24c::US11685721, Compound 24c	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416749	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416749&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356123	433916663							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835302	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)c1ccccc1)C(F)(F)F	InChI=1S/C25H21F3N4O2/c26-25(27,28)22-14-21(32(31-22)20-11-4-6-16(12-20)15-29)24(34)30-19-10-5-9-18(13-19)23(33)17-7-2-1-3-8-17/h1-14,23,33H,15,29H2,(H,30,34)	RTXOPDIFOPLOGN-UHFFFAOYSA-N	416750	US10329260, Compound 18e	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416750	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416750&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126689238	433916664							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835303	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F3N4O2/c31-30(32,33)27-18-26(37(36-27)25-11-4-6-21(16-25)19-34)28(38)35-24-10-5-9-23(17-24)29(39,15-14-20-12-13-20)22-7-2-1-3-8-22/h1-11,16-18,20,39H,12-15,19,34H2,(H,35,38)	DCGYPXFSNPCKGX-UHFFFAOYSA-N	416751	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 46g::US10633345, Compound 46g::US10689346, Compound 46g::US11203574, Compound 46i::US11230530, Compound 46i::US11685721, Compound 46g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416751	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416751&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355790	433916665							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835304	CCOC(c1ccccc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C27H24F4N4O2/c1-2-37-25(18-8-4-3-5-9-18)19-11-12-21(28)22(14-19)33-26(36)23-15-24(27(29,30)31)34-35(23)20-10-6-7-17(13-20)16-32/h3-15,25H,2,16,32H2,1H3,(H,33,36)	YVBRMUSUELCGNA-UHFFFAOYSA-N	416752	1-(3-(aminomethyl)phenyl)-N-(5-(ethoxy(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 25b::US10633345, Compound 25b::US10689346, Compound 25b::US11203574, Compound 25b::US11230530, Compound 25b::US11685721, Compound 25b	Plasma kallikrein		 75.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416752	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416752&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665520	433916666							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835305	CC(C)[C@H](N)C(=O)OC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O3/c1-18(2)26(35)29(40)41-27(20-9-4-3-5-10-20)21-11-7-12-22(15-21)36-28(39)24-16-25(30(31,32)33)37-38(24)23-13-6-8-19(14-23)17-34/h3-16,18,26-27H,17,34-35H2,1-2H3,(H,36,39)/t26-,27?/m0/s1	OQCWFOUCOSAWQU-QBHOUYDASA-N	416753	(2S)-(3-(1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamido)phenyl)(phenyl)methyl 2-amino-3-methylbutanoate::US10329260, Compound 81c::US10633345, Compound 81c::US10689346, Compound 81c::US11203574, Compound 81c::US11230530, Compound 81c::US11685721, Compound 81c	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416753	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416753&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355992	433916667					C03317		1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835306	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)[C@](N)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-22-10-9-20(28(35,12-11-18-7-8-18)25-6-1-2-13-36-25)15-23(22)37-27(40)24-16-26(29(31,32)33)38-39(24)21-5-3-4-19(14-21)17-34/h1-6,9-10,13-16,18H,7-8,11-12,17,34-35H2,(H,37,40)/t28-/m1/s1	IFWBAIGKQKRJGJ-MUUNZHRXSA-N	416754	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carb oxamide::US10329260, Compound 205f::US10633345, Compound 205e::US11203574, Compound 205f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416754	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416754&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			146207235	433916668							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835307	COC(c1ccccc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C26H22F4N4O2/c1-36-24(17-7-3-2-4-8-17)18-10-11-20(27)21(13-18)32-25(35)22-14-23(26(28,29)30)33-34(22)19-9-5-6-16(12-19)15-31/h2-14,24H,15,31H2,1H3,(H,32,35)	AJQPEPSKLFPFIU-UHFFFAOYSA-N	416755	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-5-(methoxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 25c::US10633345, Compound 25c::US10689346, Compound 25c::US11203574, Compound 25c::US11230530, Compound 25c::US11685721, Compound 25c	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416755	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416755&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126666045	433916669							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835308	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CC#N)c1ccccc1)C(F)(F)F	InChI=1S/C27H22F3N5O/c28-27(29,30)25-16-24(35(34-25)22-11-4-6-18(14-22)17-32)26(36)33-21-10-5-9-20(15-21)23(12-13-31)19-7-2-1-3-8-19/h1-11,14-16,23H,12,17,32H2,(H,33,36)	AUPCAIQBGWQVBR-UHFFFAOYSA-N	416756	1-(3-(aminomethyl)phenyl)-N-(3-(2-cyano-1-phenylethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 39e::US10633345, Compound 39e::US10689346, Compound 39e::US11203574, Compound 39e::US11230530, Compound 39e::US11685721, Compound 39e	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416756	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416756&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126666023	433916670							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835309	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CCC1CC1)n1ccnc1)C(F)(F)F	InChI=1S/C27H27F3N6O/c28-27(29,30)25-15-24(36(34-25)22-6-1-3-19(13-22)16-31)26(37)33-21-5-2-4-20(14-21)23(10-9-18-7-8-18)35-12-11-32-17-35/h1-6,11-15,17-18,23H,7-10,16,31H2,(H,33,37)	UPEDWOJFQGRWOZ-UHFFFAOYSA-N	416757	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-(1H-imidazol-1-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 89g::US10633345, Compound 89g::US10689346, Compound 89g::US11203574, Compound 89g::US11230530, Compound 89g::US11685721, Compound 89g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416757	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416757&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665540	433916671							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835310	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(Cc2ccccc2)ccc1F)C(F)(F)F	InChI=1S/C25H20F4N4O/c26-20-10-9-17(11-16-5-2-1-3-6-16)13-21(20)31-24(34)22-14-23(25(27,28)29)32-33(22)19-8-4-7-18(12-19)15-30/h1-10,12-14H,11,15,30H2,(H,31,34)	PFWDQKVXCJEZES-UHFFFAOYSA-N	416758	1-(3-(aminomethyl)phenyl)-N-(5-benzyl-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 26f::US10633345, Compound 26f::US10689346, Compound 26f::US11203574, Compound 26f::US11230530, Compound 26f::US11685721, Compound 26f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416758	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416758&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355900	433916672							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835311	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CC(N)=O)c1ccccc1)C(F)(F)F	InChI=1S/C27H24F3N5O2/c28-27(29,30)24-15-23(35(34-24)21-11-4-6-17(12-21)16-31)26(37)33-20-10-5-9-19(13-20)22(14-25(32)36)18-7-2-1-3-8-18/h1-13,15,22H,14,16,31H2,(H2,32,36)(H,33,37)	KDXRDWIYPXSJST-UHFFFAOYSA-N	416759	N-(3-(3-amino-3-oxo-1-phenylpropyl)phenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 40b::US10633345, Compound 40b::US10689346, Compound 40b::US11203574, Compound 40b::US11230530, Compound 40b::US11685721, Compound 40b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416759	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416759&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665680	433916673							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835312	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(=C\CC1CC1)\c1ccccc1)C(F)(F)F	InChI=1S/C30H27F3N4O/c31-30(32,33)28-18-27(37(36-28)25-11-4-6-21(16-25)19-34)29(38)35-24-10-5-9-23(17-24)26(15-14-20-12-13-20)22-7-2-1-3-8-22/h1-11,15-18,20H,12-14,19,34H2,(H,35,38)/b26-15+	VKLRLOSKQDEQAH-CVKSISIWSA-N	416760	(E/Z)-1-(3-(Aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-phenylprop-1-enyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide hydrochloride::US10329260, Compound 91a::US11203574, Compound 91a::US11685721, Compound 91a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416760	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416760&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			153066367	433916674							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835313	CC(C)COC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C29H29F3N4O2/c1-19(2)18-38-27(21-9-4-3-5-10-21)22-11-7-12-23(15-22)34-28(37)25-16-26(29(30,31)32)35-36(25)24-13-6-8-20(14-24)17-33/h3-16,19,27H,17-18,33H2,1-2H3,(H,34,37)	FMSXMXLNUZXXSC-UHFFFAOYSA-N	416762	1-(3-(aminomethyl)phenyl)-N-(3-(isobutoxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18i::US10633345, Compound 18i::US10689346, Compound 18i::US11203574, Compound 18i::US11230530, Compound 18i::US11685721, Compound 18i	Plasma kallikrein		 75.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416762	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416762&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356257	433916676							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835314	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(Cc2ccccc2NCC2CC2)c1)C(F)(F)F	InChI=1S/C29H28F3N5O/c30-29(31,32)27-16-26(37(36-27)24-9-4-6-21(15-24)17-33)28(38)35-23-8-3-5-20(14-23)13-22-7-1-2-10-25(22)34-18-19-11-12-19/h1-10,14-16,19,34H,11-13,17-18,33H2,(H,35,38)	PECONQSWBUWDBN-UHFFFAOYSA-N	416763	1-(3-(Aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(phenyl) methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 41e::US11685721, Compound 41e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416763	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416763&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			154584212	433916677							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835315	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C28H27F3N6O/c29-28(30,31)25-15-24(37(36-25)23-6-1-3-19(13-23)16-32)27(38)35-22-5-2-4-21(14-22)26(34-17-18-7-8-18)20-9-11-33-12-10-20/h1-6,9-15,18,26,34H,7-8,16-17,32H2,(H,35,38)	VXJYGPKEYKOJCQ-UHFFFAOYSA-N	416764	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(pyridin-4-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 86g::US10633345, Compound 86g::US10689346, Compound 86g::US11203574, Compound 86g::US11230530, Compound 86g::US11685721, Compound 86g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416764	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416764&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355880	433916678							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835316	CCCOC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C28H27F3N4O2/c1-2-14-37-26(20-9-4-3-5-10-20)21-11-7-12-22(16-21)33-27(36)24-17-25(28(29,30)31)34-35(24)23-13-6-8-19(15-23)18-32/h3-13,15-17,26H,2,14,18,32H2,1H3,(H,33,36)	ODVQLXVRAUDBCL-UHFFFAOYSA-N	416765	1-(3-(aminomethyl)phenyl)-N-(3-(phenyl(propoxy)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18h::US10633345, Compound 18k::US10689346, Compound 18h::US11203574, Compound 18h::US11230530, Compound 18h::US11685721, Compound 18h	Plasma kallikrein		 75.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416765	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416765&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665753	433916679							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835317	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F3N4O2/c31-30(32,33)27-18-26(37(36-27)25-11-4-6-21(16-25)19-34)29(38)35-24-10-5-9-23(17-24)28(22-7-2-1-3-8-22)39-15-14-20-12-13-20/h1-11,16-18,20,28H,12-15,19,34H2,(H,35,38)	WCAGCVGZCBBZDT-UHFFFAOYSA-N	416766	1-(3-(aminomethyl)phenyl)-N-(3-((2-cyclopropylethoxy)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 74a::US10689346, Compound 74a::US11203574, Compound 74a::US11230530, Compound 74a::US11685721, Compound 74a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416766	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416766&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665775	433916680							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835318	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-17-24(37(36-26)23-8-3-5-20(15-23)18-33)27(38)35-22-7-4-6-21(16-22)28(39,13-12-19-10-11-19)25-9-1-2-14-34-25/h1-9,14-17,19,39H,10-13,18,33H2,(H,35,38)	BAOACYBKKSTHLE-UHFFFAOYSA-N	416767	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 45g::US10633345, Compound 45g::US10689346, Compound 45g::US11203574, Compound 45g::US11230530, Compound 45g::US11685721, Compound 45g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416767	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416767&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665639	433916681							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835319	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(=O)Nc1ccccc1)C(F)(F)F	InChI=1S/C25H20F3N5O2/c26-25(27,28)22-14-21(33(32-22)20-11-4-6-16(12-20)15-29)24(35)31-19-10-5-7-17(13-19)23(34)30-18-8-2-1-3-9-18/h1-14H,15,29H2,(H,30,34)(H,31,35)	HDBCJKHEPGEJHK-UHFFFAOYSA-N	416768	1-(3-(aminomethyl)phenyl)-N-(3-(phenylcarbamoyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 21e::US10633345, Compound 21e::US10689346, Compound 21e::US11203574, Compound 21e::US11230530, Compound 21e::US11685721, Compound 21e	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416768	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416768&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665523	433916682							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835320	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CCC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F3N4O2/c31-30(32,33)27-17-26(37(36-27)25-14-5-9-21(15-25)18-34)29(38)35-24-13-6-12-23(16-24)28(22-10-2-1-3-11-22)39-19-20-7-4-8-20/h1-3,5-6,9-17,20,28H,4,7-8,18-19,34H2,(H,35,38)	KBAGRISCOGFVJB-UHFFFAOYSA-N	416769	1-(3-(aminomethyl)phenyl)-N-(3-((cyclobutylmethoxy)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 75a::US10633345, Compound 75a::US10689346, Compound 75a::US11203574, Compound 75a::US11230530, Compound 75a::US11685721, Compound 75a	Plasma kallikrein		 75.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416769	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416769&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665761	433916683							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835321	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-16-25(37(36-26)24-8-1-4-20(14-24)17-33)27(38)35-23-7-2-5-21(15-23)28(39,12-11-19-9-10-19)22-6-3-13-34-18-22/h1-8,13-16,18-19,39H,9-12,17,33H2,(H,35,38)	AOCZEQQKIIWUBU-UHFFFAOYSA-N	416770	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 47f::US10633345, Compound 47f::US10689346, Compound 47f::US11203574, Compound 47g::US11230530, Compound 47h::US11685721, Compound 47f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416770	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416770&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355766	433916684							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835322	CCCCOC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C29H29F3N4O2/c1-2-3-15-38-27(21-10-5-4-6-11-21)22-12-8-13-23(17-22)34-28(37)25-18-26(29(30,31)32)35-36(25)24-14-7-9-20(16-24)19-33/h4-14,16-18,27H,2-3,15,19,33H2,1H3,(H,34,37)	PKUIOUWZEKKIOY-UHFFFAOYSA-N	416772	1-(3-(aminomethyl)phenyl)-N-(3-(butoxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18j::US10633345, Compound 18j::US10689346, Compound 18j::US11203574, Compound 18j::US11230530, Compound 18j::US11685721, Compound 18j	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416772	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416772&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356140	433916686							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835323	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F4N5O/c30-23-12-11-21(27(35-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27,35H,9-10,16-17,34H2,(H,36,39)	MCLZOCFEIKBMBA-UHFFFAOYSA-N	416773	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 38d::US10633345, Compound 38d::US10689346, Compound 42a::US11203574, Compound 42a::US11230530, Compound 42a::US11685721, Compound 38d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416773	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416773&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356124	433916687							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835324	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-17-25(37(36-26)24-6-1-3-20(15-24)18-33)27(38)35-23-5-2-4-22(16-23)28(39,12-9-19-7-8-19)21-10-13-34-14-11-21/h1-6,10-11,13-17,19,39H,7-9,12,18,33H2,(H,35,38)	HEXYKZQZIBBLLM-UHFFFAOYSA-N	416774	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-(pyridin-4-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 92g::US10633345, Compound 92g::US10689346, Compound 92g::US11203574, Compound 92g::US11230530, Compound 92g::US11685721, Compound 92g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416774	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416774&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355890	433916688							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835325	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F3N4O2/c30-29(31,32)26-16-25(36(35-26)24-11-4-6-20(14-24)17-33)28(37)34-23-10-5-9-22(15-23)27(38-18-19-12-13-19)21-7-2-1-3-8-21/h1-11,14-16,19,27H,12-13,17-18,33H2,(H,34,37)	PEZVPVUPSJXZCH-UHFFFAOYSA-N	416775	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18k::US10633345, Compound 74a::US10689346, Compound 165e::US11203574, Compound 165e::US11230530, Compound 165e::US11685721, Compound 18k	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416775	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416775&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			91884591	433916689							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835326	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1ccc(F)c(c1)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-24-12-11-21(14-23(24)27(39-17-18-9-10-18)20-6-2-1-3-7-20)35-28(38)25-15-26(29(31,32)33)36-37(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27H,9-10,16-17,34H2,(H,35,38)	SMAPKFCZNNYDET-UHFFFAOYSA-N	416776	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)-4-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 76h::US10633345, Compound 76h::US10689346, Compound 76h::US11203574, Compound 76h::US11230530, Compound 76h::US11685721, Compound 76h	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416776	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416776&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356199	433916690							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835327	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cn[nH]c1)C(F)(F)F			416777	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(1H-pyrazol-4-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 84h::US10633345, Compound 84h::US10689346, Compound 84h::US11203574, Compound 84h::US11230530, Compound 84h::US11685721, Compound 84h	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416777	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416777&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			154584214	433916691							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835329	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(C(OCC2CC2)c2ccccc2)c1F)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-26-22(27(39-17-18-12-13-18)20-7-2-1-3-8-20)10-5-11-23(26)35-28(38)24-15-25(29(31,32)33)36-37(24)21-9-4-6-19(14-21)16-34/h1-11,14-15,18,27H,12-13,16-17,34H2,(H,35,38)	OCYVMBLZCJPYSX-UHFFFAOYSA-N	416779	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 36d::US10633345, Compound 36d::US10689346, Compound 36d::US11203574, Compound 36d::US11230530, Compound 36d::US11685721, Compound 36d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416779	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416779&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356266	433916693							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835330	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1nccs1)C(F)(F)F	InChI=1S/C26H25F3N6OS/c27-26(28,29)22-13-21(35(34-22)20-6-1-3-17(11-20)14-30)24(36)33-19-5-2-4-18(12-19)23(25-31-9-10-37-25)32-15-16-7-8-16/h1-6,9-13,16,23,32H,7-8,14-15,30H2,(H,33,36)	BPCHTFOGBGFGRD-UHFFFAOYSA-N	416780	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(thiazol-2-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 85c::US10633345, Compound 85c::US10689346, Compound 85c::US11203574, Compound 85c::US11230530, Compound 85c::US11685721, Compound 85c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416780	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416780&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355975	433916694							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835331	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CCC1CC1)N1CCOCC1)C(F)(F)F	InChI=1S/C28H32F3N5O2/c29-28(30,31)26-17-25(36(34-26)23-6-1-3-20(15-23)18-32)27(37)33-22-5-2-4-21(16-22)24(10-9-19-7-8-19)35-11-13-38-14-12-35/h1-6,15-17,19,24H,7-14,18,32H2,(H,33,37)	JPSOHZUNYZMZBS-UHFFFAOYSA-N	416781	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-morpholinopropyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 93b::US10633345, Compound 93b::US10689346, Compound 93b::US11203574, Compound 93b::US11230530, Compound 93b::US11685721, Compound 93b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416781	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416781&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665612	433916695							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835328	CCCN(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C27H26F3N5O/c1-2-14-34(21-10-4-3-5-11-21)22-12-7-9-20(16-22)32-26(36)24-17-25(27(28,29)30)33-35(24)23-13-6-8-19(15-23)18-31/h3-13,15-17H,2,14,18,31H2,1H3,(H,32,36)	IKJCTSPODFFZCP-UHFFFAOYSA-N	416778	1-(3-(aminomethyl)phenyl)-N-(3-(phenyl(propyl)amino)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 27f::US10633345, Compound 27f::US10689346, Compound 27f::US11203574, Compound 27f::US11230530, Compound 27f::US11685721, Compound 27f	Plasma kallikrein		 75.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416778	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416778&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356135	433916692							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835332	COc1cccc(c1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O2/c1-40-25-10-4-7-22(15-25)28(35-18-19-11-12-19)21-6-3-8-23(14-21)36-29(39)26-16-27(30(31,32)33)37-38(26)24-9-2-5-20(13-24)17-34/h2-10,13-16,19,28,35H,11-12,17-18,34H2,1H3,(H,36,39)	DMSXJIPDGRICQW-UHFFFAOYSA-N	416782	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(3-methoxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 109f::US10633345, Compound 109f::US10689346, Compound 109f::US11203574, Compound 109f::US11230530, Compound 109f::US11685721, Compound 109f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416782	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416782&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356265	433916696							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835333	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc2ccccc2c1)C(F)(F)F	InChI=1S/C33H30F3N5O/c34-33(35,36)30-18-29(41(40-30)28-10-3-5-22(15-28)19-37)32(42)39-27-9-4-8-25(17-27)31(38-20-21-11-12-21)26-14-13-23-6-1-2-7-24(23)16-26/h1-10,13-18,21,31,38H,11-12,19-20,37H2,(H,39,42)	QCSULFNIDZTXJZ-UHFFFAOYSA-N	416783	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic acid {3-[(cyclopropylmethyl-amino)-naphthalen-2-yl-methyl]-phenyl}-amide::US10329260, Compound 128g::US10633345, Compound 128g::US10689346, Compound 128g::US11203574, Compound 128g::US11230530, Compound 128g::US11685721, Compound 128g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416783	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416783&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665786	433916697							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835334	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H26F4N6O/c29-22-9-8-19(26(35-15-17-6-7-17)20-4-2-10-34-16-20)12-23(22)36-27(39)24-13-25(28(30,31)32)37-38(24)21-5-1-3-18(11-21)14-33/h1-5,8-13,16-17,26,35H,6-7,14-15,33H2,(H,36,39)	SECDZDWRLPONSX-UHFFFAOYSA-N	416784	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(pyridin-3-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 94b::US10633345, Compound 94b::US10689346, Compound 94b::US11203574, Compound 94b::US11230530, Compound 94b::US11685721, Compound 94b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416784	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416784&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355774	433916698							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835335	Cc1cccc(c1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O/c1-19-5-2-7-22(13-19)28(35-18-20-11-12-20)23-8-4-9-24(15-23)36-29(39)26-16-27(30(31,32)33)37-38(26)25-10-3-6-21(14-25)17-34/h2-10,13-16,20,28,35H,11-12,17-18,34H2,1H3,(H,36,39)	ADKXWAHEFSGGQB-UHFFFAOYSA-N	416785	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(m-tolyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 110f::US10633345, Compound 110f::US10689346, Compound 110f::US11203574, Compound 110f::US11230530, Compound 110f::US11685721, Compound 110f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416785	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416785&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123875262	433916699							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835336	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc2ccccc12)C(F)(F)F	InChI=1S/C33H30F3N5O/c34-33(35,36)30-18-29(41(40-30)26-11-3-6-22(16-26)19-37)32(42)39-25-10-4-9-24(17-25)31(38-20-21-14-15-21)28-13-5-8-23-7-1-2-12-27(23)28/h1-13,16-18,21,31,38H,14-15,19-20,37H2,(H,39,42)	NFYBGLSBONMUGA-UHFFFAOYSA-N	416786	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic acid {3-[(cyclopropylmethyl-amino)-naphthalen-1-yl-methyl]-phenyl}-amide::US10329260, Compound 129f::US10633345, Compound 129f::US10689346, Compound 129f::US11203574, Compound 129f::US11230530, Compound 129f::US11685721, Compound 129f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416786	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416786&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356190	433916700							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835337	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(Cc2ccccc2NCC2CC2)cc(c1)C1CC1)C(F)(F)F	InChI=1S/C32H32F3N5O/c33-32(34,35)30-17-29(40(39-30)27-6-3-4-21(15-27)18-36)31(41)38-26-14-22(13-25(16-26)23-10-11-23)12-24-5-1-2-7-28(24)37-19-20-8-9-20/h1-7,13-17,20,23,37H,8-12,18-19,36H2,(H,38,41)	YGERAFNXGPIXIA-UHFFFAOYSA-N	416787	1-(3-(aminomethyl)phenyl)-N-(3-cyclopropyl-5-((cyclopropylmethylamino)(phenyl) methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 95i	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416787	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416787&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			154584215	433916701							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835338	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc(c1)C(F)(F)F)C(F)(F)F	InChI=1S/C30H27F6N5O/c31-29(32,33)22-7-2-5-20(13-22)27(38-17-18-10-11-18)21-6-3-8-23(14-21)39-28(42)25-15-26(30(34,35)36)40-41(25)24-9-1-4-19(12-24)16-37/h1-9,12-15,18,27,38H,10-11,16-17,37H2,(H,39,42)	FZSHDRVSVGSKOF-UHFFFAOYSA-N	416788	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(3-(trifluoromethyl) phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 111f::US10633345, Compound 111f::US10689346, Compound 111f::US11203574, Compound 111f::US11230530, Compound 111f::US11685721, Compound 111f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416788	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416788&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355816	433916702							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835339	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccc(N)cc1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-23-11-8-20(27(36-16-17-4-5-17)19-6-9-21(35)10-7-19)13-24(23)37-28(40)25-14-26(29(31,32)33)38-39(25)22-3-1-2-18(12-22)15-34/h1-3,6-14,17,27,36H,4-5,15-16,34-35H2,(H,37,40)	QTGVDKNDDSXZLM-UHFFFAOYSA-N	416789	1-(3-(aminomethyl)phenyl)-N-(5-((4-aminophenyl)(cyclopropylmethylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 130g::US10633345, Compound 130g::US10689346, Compound 130g::US11203574, Compound 130g::US11230530, Compound 130g::US11685721, Compound 130g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416789	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416789&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665503	433916703							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835340	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1Cl)C(NCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H26ClF3N6O/c29-22-9-8-19(26(35-15-17-6-7-17)20-4-2-10-34-16-20)12-23(22)36-27(39)24-13-25(28(30,31)32)37-38(24)21-5-1-3-18(11-21)14-33/h1-5,8-13,16-17,26,35H,6-7,14-15,33H2,(H,36,39)	DCRDGEJSCMQMFA-UHFFFAOYSA-N	416790	1-(3-(Aminomethyl)phenyl)-N-(2-chloro-5-((cyclopropylmethylamino)(pyridin-3-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 96f::US10633345, Compound 96f::US10689346, Compound 96f::US11203574, Compound 96f::US11230530, Compound 96f::US11685721, Compound 96f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416790	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416790&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355757	433916704							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835341	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(cc1)S(N)(=O)=O)C(F)(F)F	InChI=1S/C29H29F3N6O3S/c30-29(31,32)26-15-25(38(37-26)23-6-1-3-19(13-23)16-33)28(39)36-22-5-2-4-21(14-22)27(35-17-18-7-8-18)20-9-11-24(12-10-20)42(34,40)41/h1-6,9-15,18,27,35H,7-8,16-17,33H2,(H,36,39)(H2,34,40,41)	BGEXZQITRMVFRR-UHFFFAOYSA-N	416791	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(4-sulfamoylphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 112g::US10633345, Compound 112g::US10689346, Compound 112g::US11203574, Compound 112g::US11230530, Compound 112g::US11685721, Compound 112g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416791	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416791&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355780	433916705							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835342	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-23-10-9-20(27(36-16-17-7-8-17)19-4-2-5-21(35)12-19)13-24(23)37-28(40)25-14-26(29(31,32)33)38-39(25)22-6-1-3-18(11-22)15-34/h1-6,9-14,17,27,36H,7-8,15-16,34-35H2,(H,37,40)	HJMCNZIVUWWSBV-UHFFFAOYSA-N	416792	1-(3-(aminomethyl)phenyl)-N-(5-((3-aminophenyl)(cyclopropylmethylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 131b::US10633345, Compound 131b::US10689346, Compound 131b::US11203574, Compound 131b::US11230530, Compound 131b::US11685721, Compound 131b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416792	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416792&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665555	433916706							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835343	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H25F4N5O2/c29-22-9-8-19(26(39-16-17-6-7-17)20-4-2-10-34-15-20)12-23(22)35-27(38)24-13-25(28(30,31)32)36-37(24)21-5-1-3-18(11-21)14-33/h1-5,8-13,15,17,26H,6-7,14,16,33H2,(H,35,38)	CNAFOXQNPWSINI-UHFFFAOYSA-N	416794	Racemic 1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethoxy)(pyridin-3-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 48f::US10633345, Compound 48f::US10689346, Compound 48f::US11203574, Compound 48g::US11230530, Compound 48h::US11685721, Compound 48f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416794	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416794&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355617	433916708							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835344	CS(=O)(=O)c1ccc(cc1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O3S/c1-42(40,41)25-12-10-21(11-13-25)28(35-18-19-8-9-19)22-5-3-6-23(15-22)36-29(39)26-16-27(30(31,32)33)37-38(26)24-7-2-4-20(14-24)17-34/h2-7,10-16,19,28,35H,8-9,17-18,34H2,1H3,(H,36,39)	UTLDYOFVUPHYMX-UHFFFAOYSA-N	416795	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(4-(methylsulfonyl)phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 113f::US10633345, Compound 113f::US10689346, Compound 113f::US11203574, Compound 113f::US11230530, Compound 113f::US11685721, Compound 113f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416795	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416795&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355808	433916709							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835345	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C28H26F4N6O/c29-22-7-6-20(26(35-16-17-4-5-17)19-8-10-34-11-9-19)13-23(22)36-27(39)24-14-25(28(30,31)32)37-38(24)21-3-1-2-18(12-21)15-33/h1-3,6-14,17,26,35H,4-5,15-16,33H2,(H,36,39)	JHXYEKYRIWFSRY-UHFFFAOYSA-N	416796	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(pyridin-4-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 132f::US10633345, Compound 132f::US10689346, Compound 132f::US11203574, Compound 132f::US11230530, Compound 132f::US11685721, Compound 132f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416796	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416796&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665438	433916710							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835346	CN1CCc2c(C1)ccc(NC(=O)c1cc(nn1-c1cccc(CN)c1)C(F)(F)F)c2F	InChI=1S/C22H21F4N5O/c1-30-8-7-16-14(12-30)5-6-17(20(16)23)28-21(32)18-10-19(22(24,25)26)29-31(18)15-4-2-3-13(9-15)11-27/h2-6,9-10H,7-8,11-12,27H2,1H3,(H,28,32)	XRSKJTRQFAFTLA-UHFFFAOYSA-N	416797	1-(3-(aminomethyl)phenyl)-N-(5-fluoro-2-methyl-1,2,3,4-tetrahydroisoquinolin-6-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 164e::US10633345, Compound 164e::US10689346, Compound 164e::US11203574, Compound 164e::US11230530, Compound 164e::US11685721, Compound 164e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416797	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416797&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665488	433916711							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835347	CS(=O)(=O)c1cccc(c1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O3S/c1-42(40,41)25-10-4-7-22(15-25)28(35-18-19-11-12-19)21-6-3-8-23(14-21)36-29(39)26-16-27(30(31,32)33)37-38(26)24-9-2-5-20(13-24)17-34/h2-10,13-16,19,28,35H,11-12,17-18,34H2,1H3,(H,36,39)	VJYAFYNZRBTGFW-UHFFFAOYSA-N	416798	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(3-(methylsulfonyl)phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 114f::US10633345, Compound 114f::US10689346, Compound 114f::US11203574, Compound 114f::US11230530, Compound 114f::US11685721, Compound 114f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416798	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416798&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665780	433916712							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835348	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(cc1)-c1ccccc1)C(F)(F)F	InChI=1S/C35H32F3N5O/c36-35(37,38)32-20-31(43(42-32)30-11-4-6-24(18-30)21-39)34(44)41-29-10-5-9-28(19-29)33(40-22-23-12-13-23)27-16-14-26(15-17-27)25-7-2-1-3-8-25/h1-11,14-20,23,33,40H,12-13,21-22,39H2,(H,41,44)	SZCMOETVRNQDRC-UHFFFAOYSA-N	416799	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic Acid {3-[biphenyl-4-yl-(cyclopropylmethyl-amino)-methyl]-phenyl}-amide::US10329260, Compound 133g::US10633345, Compound 133g::US10689346, Compound 133g::US11203574, Compound 133g::US11230530, Compound 133g::US11685721, Compound 133g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416799	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416799&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665928	433916713							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835349	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(F)cc(c1)C(O)c1ccccc1)C(F)(F)F	InChI=1S/C25H20F4N4O2/c26-18-10-17(23(34)16-6-2-1-3-7-16)11-19(12-18)31-24(35)21-13-22(25(27,28)29)32-33(21)20-8-4-5-15(9-20)14-30/h1-13,23,34H,14,30H2,(H,31,35)	WOQUHGPQEUKGPZ-UHFFFAOYSA-N	416800	1-(3-(aminomethyl)phenyl)-N-(3-fluoro-5-(hydroxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 97f::US10633345, Compound 97f::US10689346, Compound 97f::US11203574, Compound 97f::US11230530, Compound 97f::US11685721, Compound 97f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416800	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416800&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355887	433916714							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835350	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(Cc2ccccc2NC(=O)C2CC2)c1)C(F)(F)F	InChI=1S/C29H26F3N5O2/c30-29(31,32)26-16-25(37(36-26)23-9-4-6-19(15-23)17-33)28(39)34-22-8-3-5-18(14-22)13-21-7-1-2-10-24(21)35-27(38)20-11-12-20/h1-10,14-16,20H,11-13,17,33H2,(H,34,39)(H,35,38)	PMOFKIUBYLIJEG-UHFFFAOYSA-N	416803	1-(3-(aminomethyl)phenyl)-N-(3-(cyclopropanecarboxamido(phenyl) methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 115e	Plasma kallikrein		 75.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416803	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416803&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			154584219	433916717							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835351	COc1ccc2cc(ccc2c1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H32F3N5O2/c1-44-29-13-12-23-15-26(11-10-24(23)17-29)32(39-20-21-8-9-21)25-5-3-6-27(16-25)40-33(43)30-18-31(34(35,36)37)41-42(30)28-7-2-4-22(14-28)19-38/h2-7,10-18,21,32,39H,8-9,19-20,38H2,1H3,(H,40,43)	YJEVEVIVXGFKBA-UHFFFAOYSA-N	416804	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic Acid {3-[(cyclopropylmethyl-amino)-(6-methoxy-naphthalen-2-yl)-methyl]-phenyl}-amide::US10329260, Compound 134f::US10633345, Compound 134f::US10689346, Compound 134f::US11203574, Compound 134f::US11230530, Compound 134f::US11685721, Compound 134f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416804	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416804&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356181	433916718							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835352	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CCC1CC1)N1CCCC1)C(F)(F)F	InChI=1S/C28H32F3N5O/c29-28(30,31)26-17-25(36(34-26)23-8-3-5-20(15-23)18-32)27(37)33-22-7-4-6-21(16-22)24(12-11-19-9-10-19)35-13-1-2-14-35/h3-8,15-17,19,24H,1-2,9-14,18,32H2,(H,33,37)	LGRABUBILIXIOO-UHFFFAOYSA-N	416805	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-(pyrrolidin-1-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 98b::US11685721, Compound 98b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416805	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416805&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123509304	433916719							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835353	CCc1cccc(c1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C31H32F3N5O/c1-2-20-6-3-8-23(14-20)29(36-19-21-12-13-21)24-9-5-10-25(16-24)37-30(40)27-17-28(31(32,33)34)38-39(27)26-11-4-7-22(15-26)18-35/h3-11,14-17,21,29,36H,2,12-13,18-19,35H2,1H3,(H,37,40)	YUWQOWXTNOVILU-UHFFFAOYSA-N	416807	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(3-ethylphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 116e::US10633345, Compound 116e::US10689346, Compound 116e::US11203574, Compound 116e::US11230530, Compound 116e::US11685721, Compound 116e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416807	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416807&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123342870	433916721							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835354	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(O)cc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-25(37(36-26)23-6-1-3-19(13-23)16-33)28(39)35-22-5-2-4-21(14-22)27(34-17-18-7-8-18)20-9-11-24(38)12-10-20/h1-6,9-15,18,27,34,38H,7-8,16-17,33H2,(H,35,39)	GDUMJZLASJIDFD-UHFFFAOYSA-N	416808	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(4-hydroxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 135c::US10633345, Compound 135c::US10689346, Compound 135c::US11203574, Compound 135c::US11230530, Compound 135c::US11685721, Compound 135c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416808	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416808&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355747	433916722							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835355	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CNC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-16-25(37(36-26)24-11-4-6-19(14-24)17-33)27(38)35-23-10-5-9-21(15-23)28(39,18-34-22-12-13-22)20-7-2-1-3-8-20/h1-11,14-16,22,34,39H,12-13,17-18,33H2,(H,35,38)	WTFGPUOPMMMRIY-UHFFFAOYSA-N	416809	1-(3-(aminomethyl)phenyl)-N-(3-(2-(cyclopropylamino)-1-hydroxy-1-phenylethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 99g::US10633345, Compound 99g::US10689346, Compound 99g::US11203574, Compound 99g::US11230530, Compound 99g::US11685721, Compound 99g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416809	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416809&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355899	433916723							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835356	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1F)C(F)(F)F	InChI=1S/C29H27F4N5O/c30-24-10-2-1-9-23(24)27(35-17-18-11-12-18)20-6-4-7-21(14-20)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-3-5-19(13-22)16-34/h1-10,13-15,18,27,35H,11-12,16-17,34H2,(H,36,39)	XNBKWIREUIHXKI-UHFFFAOYSA-N	416810	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2-fluorophenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 117e::US10329260, Compound 119e::US10633345, Compound 117e::US10689346, Compound 117e::US11203574, Compound 117e::US11230530, Compound 117e::US11685721, Compound 117e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416810	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416810&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123243852	433916724							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835357	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(Cc2ccc(O)cc2)c1)C(F)(F)F	InChI=1S/C25H21F3N4O2/c26-25(27,28)23-14-22(32(31-23)20-6-2-4-18(13-20)15-29)24(34)30-19-5-1-3-17(12-19)11-16-7-9-21(33)10-8-16/h1-10,12-14,33H,11,15,29H2,(H,30,34)	OPPQXCJMBFITBL-UHFFFAOYSA-N	416811	1-(3-(Aminomethyl)phenyl)-N-(3-(4-hydroxybenzyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 136a::US10633345, Compound 136a::US10689346, Compound 136a::US11203574, Compound 136a::US11230530, Compound 136a::US11685721, Compound 136a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416811	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416811&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356271	433916725							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835358	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C28H26F4N6O/c29-21-10-9-19(26(35-16-17-7-8-17)22-6-1-2-11-34-22)13-23(21)36-27(39)24-14-25(28(30,31)32)37-38(24)20-5-3-4-18(12-20)15-33/h1-6,9-14,17,26,35H,7-8,15-16,33H2,(H,36,39)	NHHQSQFDXMXIJU-UHFFFAOYSA-N	416812	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(pyridin-2-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 100e::US10633345, Compound 100e::US10689346, Compound 100e::US11203574, Compound 100e::US11230530, Compound 100e::US11685721, Compound 100e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416812	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416812&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356158	433916726							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835359	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1c2ccccc2c(Cl)c2ccccc12)C(F)(F)F	InChI=1S/C37H31ClF3N5O/c38-34-29-13-3-1-11-27(29)33(28-12-2-4-14-30(28)34)35(43-21-22-15-16-22)24-8-6-9-25(18-24)44-36(47)31-19-32(37(39,40)41)45-46(31)26-10-5-7-23(17-26)20-42/h1-14,17-19,22,35,43H,15-16,20-21,42H2,(H,44,47)	WNAKJZQMCRSZKD-UHFFFAOYSA-N	416813	1-(3-(aminomethyl)phenyl)-N-(3-((10-chloroanthracen-9-yl)(cyclopropylmethylamino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 118f::US10633345, Compound 118f::US10689346, Compound 118f::US11203574, Compound 118f::US11230530, Compound 118f::US11685721, Compound 118f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416813	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416813&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355872	433916727							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835360	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc(O)c1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-25(37(36-26)23-8-1-4-19(12-23)16-33)28(39)35-22-7-2-5-20(13-22)27(34-17-18-10-11-18)21-6-3-9-24(38)14-21/h1-9,12-15,18,27,34,38H,10-11,16-17,33H2,(H,35,39)	WNKOEKOISOIHSR-UHFFFAOYSA-N	416814	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(3-hydroxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 137a::US10633345, Compound 137a::US10689346, Compound 137a::US11203574, Compound 137a::US11230530, Compound 137a::US11685721, Compound 137a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416814	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416814&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355922	433916728							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835361	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1nccs1)C(F)(F)F	InChI=1S/C26H24F4N6OS/c27-19-7-6-17(23(25-32-8-9-38-25)33-14-15-4-5-15)11-20(19)34-24(37)21-12-22(26(28,29)30)35-36(21)18-3-1-2-16(10-18)13-31/h1-3,6-12,15,23,33H,4-5,13-14,31H2,(H,34,37)	FBQBHRBLNRXXHC-UHFFFAOYSA-N	416815	1-(3-(Aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(thiazol-2-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 101e::US10633345, Compound 101e::US10689346, Compound 101e::US11203574, Compound 101e::US11230530, Compound 101e::US11685721, Compound 101e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416815	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416815&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355606	433916729							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835362	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1F)C(F)(F)F	InChI=1S/C29H27F4N5O/c30-24-10-2-1-9-23(24)27(35-17-18-11-12-18)20-6-4-7-21(14-20)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-3-5-19(13-22)16-34/h1-10,13-15,18,27,35H,11-12,16-17,34H2,(H,36,39)	XNBKWIREUIHXKI-UHFFFAOYSA-N	416810	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2-fluorophenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 117e::US10329260, Compound 119e::US10633345, Compound 117e::US10689346, Compound 117e::US11203574, Compound 117e::US11230530, Compound 117e::US11685721, Compound 117e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416810	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416810&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123243852	433916724							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835363	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(Cc2cccc(O)c2)c1)C(F)(F)F	InChI=1S/C25H21F3N4O2/c26-25(27,28)23-14-22(32(31-23)20-8-2-6-18(12-20)15-29)24(34)30-19-7-1-4-16(11-19)10-17-5-3-9-21(33)13-17/h1-9,11-14,33H,10,15,29H2,(H,30,34)	SDKHQNOIRDBHTG-UHFFFAOYSA-N	416820	1-(3-(aminomethyl)phenyl)-N-(3-(3-hydroxybenzyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 137b::US10633345, Compound 137b::US10689346, Compound 137b::US11203574, Compound 137b::US11230530, Compound 137b::US11685721, Compound 137b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416820	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416820&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665628	433916733							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835364	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H29F3N6O/c30-29(31,32)26-15-25(38(37-26)24-9-1-4-19(12-24)16-33)28(39)36-23-8-3-6-21(14-23)27(35-17-18-10-11-18)20-5-2-7-22(34)13-20/h1-9,12-15,18,27,35H,10-11,16-17,33-34H2,(H,36,39)	JHOLOXZJFLDOCM-UHFFFAOYSA-N	416821	1-(3-(aminomethyl)phenyl)-N-(3-((3-aminophenyl)(cyclopropylmethylamino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 102b::US11192861, Compound 102b::US11685721, Compound 102b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416821	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416821&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665659	433916734							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835365	CC(C)c1ccc(cc1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C32H34F3N5O/c1-20(2)23-11-13-24(14-12-23)30(37-19-21-9-10-21)25-6-4-7-26(16-25)38-31(41)28-17-29(32(33,34)35)39-40(28)27-8-3-5-22(15-27)18-36/h3-8,11-17,20-21,30,37H,9-10,18-19,36H2,1-2H3,(H,38,41)	BFUXJPJTVQBLMT-UHFFFAOYSA-N	416823	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(4-isopropylphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 120e::US10633345, Compound 120e::US10689346, Compound 120e::US11203574, Compound 120e::US11230530, Compound 120e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416823	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416823&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355943	433916736							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835366	CC(=O)Nc1ccc(cc1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C31H31F3N6O2/c1-19(41)37-24-12-10-22(11-13-24)29(36-18-20-8-9-20)23-5-3-6-25(15-23)38-30(42)27-16-28(31(32,33)34)39-40(27)26-7-2-4-21(14-26)17-35/h2-7,10-16,20,29,36H,8-9,17-18,35H2,1H3,(H,37,41)(H,38,42)	JDALRNHKHTYPON-UHFFFAOYSA-N	416827	N-(3-((4-acetamidophenyl)(cyclopropylmethylamino)methyl)phenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 138f::US10633345, Compound 138f::US10689346, Compound 138f::US11203574, Compound 138f::US11230530, Compound 138f::US11685721, Compound 138f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416827	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416827&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355810	433916740							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835367	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CCC1CC1)c1cc[nH]c1)C(F)(F)F			416828	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-(1H-pyrrol-3-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 103b::US10633345, Compound 103b::US10689346, Compound 103b::US11203574, Compound 103b::US11230530, Compound 103b::US11685721, Compound 103b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416828	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416828&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355898	433916741							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835413	CCC(CO)NC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C29H30F3N5O2/c1-2-22(18-38)34-27(20-9-4-3-5-10-20)21-11-7-12-23(15-21)35-28(39)25-16-26(29(30,31)32)36-37(25)24-13-6-8-19(14-24)17-33/h3-16,22,27,34,38H,2,17-18,33H2,1H3,(H,35,39)	KIDPOTSBLNZGML-UHFFFAOYSA-N	416874	1-(3-(aminomethyl)phenyl)-N-(3-(((1-hydroxybutan-2-yl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 168b::US10633345, Compound 168b::US10689346, Compound 168b::US11192861, Compound 168b::US11230530, Compound 168b::US11685721, Compound 168b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416874	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416874&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356215	433916787							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835411	CC(C)(C)CNC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H32F3N5O/c1-29(2,3)19-35-27(21-10-5-4-6-11-21)22-12-8-13-23(16-22)36-28(39)25-17-26(30(31,32)33)37-38(25)24-14-7-9-20(15-24)18-34/h4-17,27,35H,18-19,34H2,1-3H3,(H,36,39)	NWBNOBGYJRWWRK-UHFFFAOYSA-N	416872	1-(3-(Aminomethyl)phenyl)-N-(3-((neopentylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 187b::US10633345, Compound 187b::US10689346, Compound 187b::US11203574, Compound 187b::US11230530, Compound 187b::US11685721, Compound 187b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416872	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416872&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124028296	433916785							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835412	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccc(cc1)C(N)=O)C(F)(F)F	InChI=1S/C30H28F4N6O2/c31-23-11-10-21(27(37-16-17-4-5-17)19-6-8-20(9-7-19)28(36)41)13-24(23)38-29(42)25-14-26(30(32,33)34)39-40(25)22-3-1-2-18(12-22)15-35/h1-3,6-14,17,27,37H,4-5,15-16,35H2,(H2,36,41)(H,38,42)	AHHWWBRXILLXFU-UHFFFAOYSA-N	416873	1-(3-(aminomethyl)phenyl)-N-(5-((4-carbamoylphenyl)(cyclopropylmethylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 153b::US10633345, Compound 153b::US10689346, Compound 153b::US11203574, Compound 153b::US11230530, Compound 153b::US11685721, Compound 153b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416873	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416873&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355991	433916786							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835414	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NC1CCC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H28F3N5O/c30-29(31,32)26-17-25(37(36-26)24-14-4-7-19(15-24)18-33)28(38)35-23-13-5-10-21(16-23)27(34-22-11-6-12-22)20-8-2-1-3-9-20/h1-5,7-10,13-17,22,27,34H,6,11-12,18,33H2,(H,35,38)	UCFAODSDUNDTFF-UHFFFAOYSA-N	416875	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclobutylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 188b::US10633345, Compound 188b::US10689346, Compound 188b::US11203574, Compound 188b::US11230530, Compound 188b::US11685721, Compound 188b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416875	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416875&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123435501	433916788							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835415	COc1cccc(C(NCC2CC2)c2cccc(NC(=O)c3cc(nn3-c3cccc(CN)c3)C(F)(F)F)c2)c1O	InChI=1S/C30H30F3N5O3/c1-41-25-10-4-9-23(28(25)39)27(35-17-18-11-12-18)20-6-3-7-21(14-20)36-29(40)24-15-26(30(31,32)33)37-38(24)22-8-2-5-19(13-22)16-34/h2-10,13-15,18,27,35,39H,11-12,16-17,34H2,1H3,(H,36,40)	KCIFFUCEHRXTLF-UHFFFAOYSA-N	416876	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2-hydroxy-3-methoxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 151g::US10633345, Compound 151g::US10689346, Compound 151g::US11203574, Compound 151g::US11230530, Compound 151g::US11685721, Compound 151g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416876	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416876&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356165	433916789							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835416	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(N1CCCC1CO)c1ccccc1)C(F)(F)F	InChI=1S/C30H30F3N5O2/c31-30(32,33)27-17-26(38(36-27)24-12-4-7-20(15-24)18-34)29(40)35-23-11-5-10-22(16-23)28(21-8-2-1-3-9-21)37-14-6-13-25(37)19-39/h1-5,7-12,15-17,25,28,39H,6,13-14,18-19,34H2,(H,35,40)	BNZLGFQHSKUMEG-UHFFFAOYSA-N	416877	1-(3-(aminomethyl)phenyl)-N-(3-((2-(hydroxymethyl)pyrrolidin-1-yl)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 169b::US10633345, Compound 169b::US10689346, Compound 169b::US11203574, Compound 169b::US11230530, Compound 169b::US11685721, Compound 169b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416877	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416877&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356128	433916790							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835417	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCc1ccc(N)cc1)c1ccccc1)C(F)(F)F	InChI=1S/C32H29F3N6O/c33-32(34,35)29-18-28(41(40-29)27-11-4-6-22(16-27)19-36)31(42)39-26-10-5-9-24(17-26)30(23-7-2-1-3-8-23)38-20-21-12-14-25(37)15-13-21/h1-18,30,38H,19-20,36-37H2,(H,39,42)	BKOBJSLLJPHJRR-UHFFFAOYSA-N	416878	N-(3-(((4-Aminobenzyl)amino)(phenyl)methyl)phenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 189b::US10633345, Compound 189b::US10689346, Compound 189b::US11203574, Compound 189b::US11230530, Compound 189b::US11685721, Compound 189b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416878	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416878&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665871	433916791							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835418	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C30H27F3N6O/c31-30(32,33)27-15-26(39(38-27)25-9-2-5-21(13-25)17-35)29(40)37-24-8-3-7-23(14-24)28(36-18-19-10-11-19)22-6-1-4-20(12-22)16-34/h1-9,12-15,19,28,36H,10-11,17-18,35H2,(H,37,40)	VQJJJCIJWBDLSJ-UHFFFAOYSA-N	416879	1-(3-(aminomethyl)phenyl)-N-(3-((3-cyanophenyl)(cyclopropylmethyl amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 152d::US10633345, Compound 152d::US10689346, Compound 152d::US11203574, Compound 152d::US11230530, Compound 152d::US11685721, Compound 152d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416879	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416879&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356166	433916792							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835419	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(N1CCC(O)C1)c1ccccc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-16-25(37(35-26)23-11-4-6-19(14-23)17-33)28(39)34-22-10-5-9-21(15-22)27(20-7-2-1-3-8-20)36-13-12-24(38)18-36/h1-11,14-16,24,27,38H,12-13,17-18,33H2,(H,34,39)	FPAZEZULJGBLCM-UHFFFAOYSA-N	416880	1-(3-(aminomethyl)phenyl)-N-(3-((3-hydroxypyrrolidin-1-yl)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 170b::US10633345, Compound 170b::US10689346, Compound 170b::US11192861, Compound 170b::US11230530, Compound 170b::US11685721, Compound 170b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416880	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416880&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355902	433916793							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835420	CSCCNC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C28H28F3N5OS/c1-38-14-13-33-26(20-8-3-2-4-9-20)21-10-6-11-22(16-21)34-27(37)24-17-25(28(29,30)31)35-36(24)23-12-5-7-19(15-23)18-32/h2-12,15-17,26,33H,13-14,18,32H2,1H3,(H,34,37)	GMRUHWVMBSEBQV-UHFFFAOYSA-N	416881	1-(3-(aminomethyl)phenyl)-N-(3-(((2-(methylthio)ethyl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 190b::US10633345, Compound 190b::US10689346, Compound 190b::US11203574, Compound 190b::US11230530, Compound 190b::US11685721, Compound 190b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416881	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416881&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665913	433916794							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835421	COc1ccc(C(NCC2CC2)c2cccc(NC(=O)c3cc(nn3-c3cccc(CN)c3)C(F)(F)F)c2)c2ccccc12	InChI=1S/C34H32F3N5O2/c1-44-30-15-14-28(26-10-2-3-11-27(26)30)32(39-20-21-12-13-21)23-7-5-8-24(17-23)40-33(43)29-18-31(34(35,36)37)41-42(29)25-9-4-6-22(16-25)19-38/h2-11,14-18,21,32,39H,12-13,19-20,38H2,1H3,(H,40,43)	YOBACLFKAGKOLX-UHFFFAOYSA-N	416882	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(4-methoxynaphthalen-1-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 154e::US10633345, Compound 154e::US10689346, Compound 154e::US11203574, Compound 154e::US11230530, Compound 154e::US11685721, Compound 154e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416882	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416882&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665632	433916795							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835422	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NC1CCCCCC1)c1ccccc1)C(F)(F)F	InChI=1S/C32H34F3N5O/c33-32(34,35)29-20-28(40(39-29)27-17-8-10-22(18-27)21-36)31(41)38-26-16-9-13-24(19-26)30(23-11-4-3-5-12-23)37-25-14-6-1-2-7-15-25/h3-5,8-13,16-20,25,30,37H,1-2,6-7,14-15,21,36H2,(H,38,41)	DQWBWUNYPIEFTF-UHFFFAOYSA-N	416883	1-(3-(aminomethyl)phenyl)-N-(3-((cycloheptylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 171b::US10633345, Compound 171b::US10689346, Compound 171b::US11203574, Compound 171b::US11230530, Compound 171b::US11685721, Compound 171b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416883	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416883&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356134	433916796							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835423	Cc1ccccc1C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O/c1-19-6-2-3-11-25(19)28(35-18-20-12-13-20)22-8-5-9-23(15-22)36-29(39)26-16-27(30(31,32)33)37-38(26)24-10-4-7-21(14-24)17-34/h2-11,14-16,20,28,35H,12-13,17-18,34H2,1H3,(H,36,39)	NQOSRSVLDYDVDI-UHFFFAOYSA-N	416884	1-(3-(Aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(o-tolyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 193f::US10633345, Compound 193f::US10689346, Compound 193f::US11203574, Compound 193f::US11230530, Compound 193f::US11685721, Compound 193f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416884	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416884&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355753	433916797							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835424	NCc1cccc(c1)C(NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F4N6O/c31-24-10-9-22(28(37-17-18-7-8-18)21-5-1-3-19(11-21)15-35)13-25(24)38-29(41)26-14-27(30(32,33)34)39-40(26)23-6-2-4-20(12-23)16-36/h1-6,9-14,18,28,37H,7-8,15-17,35-36H2,(H,38,41)	PIDHZVXEDSCGNA-UHFFFAOYSA-N	416885	1-(3-(aminomethyl)phenyl)-N-(5-((3-(aminomethyl)phenyl)(cyclopropylmethylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 155c::US10633345, Compound 155c::US10689346, Compound 155c::US11203574, Compound 155c::US11230530, Compound 155c::US11685721, Compound 155c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416885	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416885&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355611	433916798							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835425	CCCCCNC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H32F3N5O/c1-2-3-7-16-35-28(22-11-5-4-6-12-22)23-13-9-14-24(18-23)36-29(39)26-19-27(30(31,32)33)37-38(26)25-15-8-10-21(17-25)20-34/h4-6,8-15,17-19,28,35H,2-3,7,16,20,34H2,1H3,(H,36,39)	LIINXFZWPJSNHF-UHFFFAOYSA-N	416886	1-(3-(Aminomethyl)phenyl)-N-(3-((pentylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 172b::US10633345, Compound 172b::US10689346, Compound 172b::US11203574, Compound 172b::US11230530, Compound 172b::US11685721, Compound 172b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416886	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416886&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355915	433916799							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835426	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCCCO)c1ccccc1)C(F)(F)F	InChI=1S/C28H28F3N5O2/c29-28(30,31)25-17-24(36(35-25)23-12-4-7-19(15-23)18-32)27(38)34-22-11-5-10-21(16-22)26(33-13-6-14-37)20-8-2-1-3-9-20/h1-5,7-12,15-17,26,33,37H,6,13-14,18,32H2,(H,34,38)	YSEURYDLGGVADI-UHFFFAOYSA-N	416887	1-(3-(Aminomethyl)phenyl)-N-(3-(((3-hydroxypropyl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 191b::US10633345, Compound 191b::US10689346, Compound 191b::US11203574, Compound 191b::US11230530, Compound 191b::US11685721, Compound 191b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416887	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416887&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665847	433916800							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835427	COC(CCC1CC1)(c1cccnc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O2/c1-40-29(13-12-20-10-11-20,23-7-4-14-35-19-23)22-6-3-8-24(16-22)36-28(39)26-17-27(30(31,32)33)37-38(26)25-9-2-5-21(15-25)18-34/h2-9,14-17,19-20H,10-13,18,34H2,1H3,(H,36,39)	HEQLXMARFGMGBQ-UHFFFAOYSA-N	416888	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-methoxy-1-(pyridin-3-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 156c::US10633345, Compound 156c::US10689346, Compound 156c::US11203574, Compound 156c::US11230530, Compound 156c::US11685721, Compound 156c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416888	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416888&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355759	433916801							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835428	CC(CO)NC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C28H28F3N5O2/c1-18(17-37)33-26(20-8-3-2-4-9-20)21-10-6-11-22(14-21)34-27(38)24-15-25(28(29,30)31)35-36(24)23-12-5-7-19(13-23)16-32/h2-15,18,26,33,37H,16-17,32H2,1H3,(H,34,38)	HGDYIKLNDBPRGN-UHFFFAOYSA-N	416889	1-(3-(aminomethyl)phenyl)-N-(3-(((1-hydroxypropan-2-yl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 173b::US10633345, Compound 173b::US10689346, Compound 173b::US11203574, Compound 173b::US11230530, Compound 173b::US11685721, Compound 173b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416889	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416889&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355997	433916802							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835429	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc(F)c1)C(F)(F)F	InChI=1S/C29H27F4N5O/c30-22-7-2-5-20(13-22)27(35-17-18-10-11-18)21-6-3-8-23(14-21)36-28(39)25-15-26(29(31,32)33)37-38(25)24-9-1-4-19(12-24)16-34/h1-9,12-15,18,27,35H,10-11,16-17,34H2,(H,36,39)	FVMNYLZQOFMPFE-UHFFFAOYSA-N	416890	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(3-fluorophenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 195f::US10633345, Compound 195f::US10689346, Compound 195f::US11203574, Compound 195f::US11230530, Compound 195f::US11685721, Compound 195f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416890	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416890&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665561	433916803							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835430	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C30H26F4N6O/c31-24-10-9-22(28(37-17-18-7-8-18)21-5-1-3-19(11-21)15-35)13-25(24)38-29(41)26-14-27(30(32,33)34)39-40(26)23-6-2-4-20(12-23)16-36/h1-6,9-14,18,28,37H,7-8,16-17,36H2,(H,38,41)	UXNXMBYCBRBRFD-UHFFFAOYSA-N	416891	1-(3-(aminomethyl)phenyl)-N-(5-((3-cyanophenyl)(cyclopropyl-methylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 54e::US11685721, Compound 70b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416891	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416891&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	0RI	7N7X	118355809	433916804							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835431	CC(C)(CO)NC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C29H30F3N5O2/c1-28(2,18-38)35-26(20-9-4-3-5-10-20)21-11-7-12-22(15-21)34-27(39)24-16-25(29(30,31)32)36-37(24)23-13-6-8-19(14-23)17-33/h3-16,26,35,38H,17-18,33H2,1-2H3,(H,34,39)	JPSBLISQAZCRFK-UHFFFAOYSA-N	416892	1-(3-(aminomethyl)phenyl)-N-(3-(((1-hydroxy-2-methylpropan-2-yl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 174b::US10633345, Compound 174b::US10689346, Compound 174b::US11203574, Compound 174b::US11230530, Compound 174b::US11685721, Compound 174b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416892	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416892&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665949	433916805							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835432	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(F)cc1F)C(F)(F)F	InChI=1S/C29H26F5N5O/c30-20-9-10-23(24(31)13-20)27(36-16-17-7-8-17)19-4-2-5-21(12-19)37-28(40)25-14-26(29(32,33)34)38-39(25)22-6-1-3-18(11-22)15-35/h1-6,9-14,17,27,36H,7-8,15-16,35H2,(H,37,40)	QIBXOBBXVAEMNW-UHFFFAOYSA-N	416893	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2,4-difluorophenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 196f::US10633345, Compound 196f::US10689346, Compound 196f::US11203574, Compound 196f::US11230530, Compound 196f::US11685721, Compound 196f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416893	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416893&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665453	433916806							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835433	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C30H25F4N5O2/c31-24-11-10-22(28(41-17-19-4-5-19)21-8-6-18(15-35)7-9-21)13-25(24)37-29(40)26-14-27(30(32,33)34)38-39(26)23-3-1-2-20(12-23)16-36/h1-3,6-14,19,28H,4-5,16-17,36H2,(H,37,40)	WXFHQCUXOOXGLO-UHFFFAOYSA-N	416894	1-(3-(aminomethyl)phenyl)-N-(5-((4-cyanophenyl)(cyclopropylmethoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 55b::US10633345, Compound 73b::US10689346, Compound 55b::US11203574, Compound 73b::US11230530, Compound 73b::US11685721, Compound 73b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416894	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416894&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665569	433916807							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835434	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CCCO1)c1ccccc1)C(F)(F)F	InChI=1S/C30H30F3N5O2/c31-30(32,33)27-17-26(38(37-27)24-12-4-7-20(15-24)18-34)29(39)36-23-11-5-10-22(16-23)28(21-8-2-1-3-9-21)35-19-25-13-6-14-40-25/h1-5,7-12,15-17,25,28,35H,6,13-14,18-19,34H2,(H,36,39)	SIOCTSAXUSNOCO-UHFFFAOYSA-N	416895	1-(3-(aminomethyl)phenyl)-N-(3-(phenyl(((tetrahydrofuran-2-yl)methyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 175b::US10633345, Compound 175b::US10689346, Compound 175b::US11203574, Compound 175b::US11230530, Compound 175b::US11685721, Compound 175b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416895	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416895&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355976	433916808							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835435	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cc(F)ccc1F)C(F)(F)F	InChI=1S/C29H26F5N5O/c30-20-9-10-24(31)23(13-20)27(36-16-17-7-8-17)19-4-2-5-21(12-19)37-28(40)25-14-26(29(32,33)34)38-39(25)22-6-1-3-18(11-22)15-35/h1-6,9-14,17,27,36H,7-8,15-16,35H2,(H,37,40)	DGRITJGAWATINU-UHFFFAOYSA-N	416896	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2,5-difluorophenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 197f::US10633345, Compound 197f::US10689346, Compound 197f::US11203574, Compound 197f::US11230530, Compound 197f::US11685721, Compound 197f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416896	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416896&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665599	433916809							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835436	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-9-8-20(28(40,11-10-18-6-7-18)21-4-2-12-35-17-21)14-24(23)36-27(39)25-15-26(29(31,32)33)37-38(25)22-5-1-3-19(13-22)16-34/h1-5,8-9,12-15,17-18,40H,6-7,10-11,16,34H2,(H,36,39)	VCHFZCHUEHQXSZ-UHFFFAOYSA-N	416897	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 58c::US10633345, Compound 67b::US10689346, Compound 67b::US11203574, Compound 67b::US11230530, Compound 67b::US11685721, Compound 67b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416897	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416897&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355889	433916810							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835437	CC(C)CCNC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H32F3N5O/c1-20(2)14-15-35-28(22-9-4-3-5-10-22)23-11-7-12-24(17-23)36-29(39)26-18-27(30(31,32)33)37-38(26)25-13-6-8-21(16-25)19-34/h3-13,16-18,20,28,35H,14-15,19,34H2,1-2H3,(H,36,39)	WPCVSFNABLNPTN-UHFFFAOYSA-N	416898	1-(3-(aminomethyl)phenyl)-N-(3-((isopentylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 176b::US10633345, Compound 176b::US10689346, Compound 176b::US11203574, Compound 176b::US11230530, Compound 176b::US11685721, Compound 176b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416898	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416898&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665776	433916811							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835438	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1c(F)cccc1F)C(F)(F)F	InChI=1S/C29H26F5N5O/c30-22-8-3-9-23(31)26(22)27(36-16-17-10-11-17)19-5-2-6-20(13-19)37-28(40)24-14-25(29(32,33)34)38-39(24)21-7-1-4-18(12-21)15-35/h1-9,12-14,17,27,36H,10-11,15-16,35H2,(H,37,40)	OHXCNQRJQHLAER-UHFFFAOYSA-N	416899	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2,6-difluorophenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 198f::US10633345, Compound 198f::US10689346, Compound 198f::US11203574, Compound 198f::US11230530, Compound 198f::US11685721, Compound 198f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416899	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416899&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665643	433916812							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835439	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C30H25F4N5O2/c31-24-10-9-22(28(41-17-18-7-8-18)21-5-1-3-19(11-21)15-35)13-25(24)37-29(40)26-14-27(30(32,33)34)38-39(26)23-6-2-4-20(12-23)16-36/h1-6,9-14,18,28H,7-8,16-17,36H2,(H,37,40)	LSXFYXGKZDVRTL-UHFFFAOYSA-N	416900	1-(3-(aminomethyl)phenyl)-N-(5-((3-cyanophenyl)(cyclopropyl-methoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 56c::US10633345, Compound 72d::US10689346, Compound 56c::US11203574, Compound 72d::US11230530, Compound 72d::US11685721, Compound 72d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416900	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416900&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356211	433916813							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835440	CCC(C)CNC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H32F3N5O/c1-3-20(2)19-35-28(22-10-5-4-6-11-22)23-12-8-13-24(16-23)36-29(39)26-17-27(30(31,32)33)37-38(26)25-14-7-9-21(15-25)18-34/h4-17,20,28,35H,3,18-19,34H2,1-2H3,(H,36,39)	ZCSNRDNUIRVYLS-UHFFFAOYSA-N	416901	1-(3-(Aminomethyl)phenyl)-N-(3-(((2-methylbutyl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 177b::US10633345, Compound 177b::US10689346, Compound 177b::US11203574, Compound 177b::US11230530, Compound 177b::US11685721, Compound 177b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416901	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416901&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665478	433916814							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835441	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1Cl)C(F)(F)F	InChI=1S/C29H27ClF3N5O/c30-24-10-2-1-9-23(24)27(35-17-18-11-12-18)20-6-4-7-21(14-20)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-3-5-19(13-22)16-34/h1-10,13-15,18,27,35H,11-12,16-17,34H2,(H,36,39)	UQMCUIGBQDUSLW-UHFFFAOYSA-N	416902	1-(3-(aminomethyl)phenyl)-N-(3-((2-chlorophenyl)((cyclopropylmethyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 194f::US10329260, Compound 199f::US10633345, Compound 199f::US10689346, Compound 199f::US11203574, Compound 199f::US11230530, Compound 199f::US11685721, Compound 199f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416902	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416902&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356220	433916815							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835442	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H28F4N4O2/c31-24-12-11-22(29(40,14-13-19-9-10-19)21-6-2-1-3-7-21)16-25(24)36-28(39)26-17-27(30(32,33)34)37-38(26)23-8-4-5-20(15-23)18-35/h1-8,11-12,15-17,19,40H,9-10,13-14,18,35H2,(H,36,39)	NIWMWYNGSALJGG-UHFFFAOYSA-N	416903	Racemic 1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 68c::US10633345, Compound 68e::US10689346, Compound 68c::US11203574, Compound 68e::US11230530, Compound 68e::US11685721, Compound 68e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416903	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416903&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355758	433916816							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835443	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(N(CCO)CCO)c1ccccc1)C(F)(F)F	InChI=1S/C29H30F3N5O3/c30-29(31,32)26-18-25(37(35-26)24-11-4-6-20(16-24)19-33)28(40)34-23-10-5-9-22(17-23)27(21-7-2-1-3-8-21)36(12-14-38)13-15-39/h1-11,16-18,27,38-39H,12-15,19,33H2,(H,34,40)	HFRFNKSEVVNXFK-UHFFFAOYSA-N	416904	1-(3-(aminomethyl)phenyl)-N-(3-((bis(2-hydroxyethyl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 178b::US10633345, Compound 178b::US10689346, Compound 178b::US11203574, Compound 178b::US11230530, Compound 178b::US11685721, Compound 178b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416904	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416904&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355913	433916817							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835444	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1Cl)C(F)(F)F	InChI=1S/C29H27ClF3N5O/c30-24-10-2-1-9-23(24)27(35-17-18-11-12-18)20-6-4-7-21(14-20)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-3-5-19(13-22)16-34/h1-10,13-15,18,27,35H,11-12,16-17,34H2,(H,36,39)	UQMCUIGBQDUSLW-UHFFFAOYSA-N	416902	1-(3-(aminomethyl)phenyl)-N-(3-((2-chlorophenyl)((cyclopropylmethyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 194f::US10329260, Compound 199f::US10633345, Compound 199f::US10689346, Compound 199f::US11203574, Compound 199f::US11230530, Compound 199f::US11685721, Compound 199f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416902	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416902&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356220	433916815							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835445	COc1ccc2ccccc2c1C(NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H31F4N5O2/c1-45-29-14-12-22-6-2-3-8-25(22)31(29)32(40-19-20-9-10-20)23-11-13-26(35)27(16-23)41-33(44)28-17-30(34(36,37)38)42-43(28)24-7-4-5-21(15-24)18-39/h2-8,11-17,20,32,40H,9-10,18-19,39H2,1H3,(H,41,44)	AYMFYNZEWAELBE-UHFFFAOYSA-N	416906	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(2-methoxynaphthalen-1-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide dihydrochloride::US10329260, Compound 61e::US10633345, Compound 63b::US10689346, Compound 61e::US11203574, Compound 63b::US11230530, Compound 63b::US11685721, Compound 63b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416906	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416906&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355591	433916818							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835446	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCc1cccnc1)c1ccccc1)C(F)(F)F	InChI=1S/C31H27F3N6O/c32-31(33,34)28-17-27(40(39-28)26-13-4-7-21(15-26)18-35)30(41)38-25-12-5-11-24(16-25)29(23-9-2-1-3-10-23)37-20-22-8-6-14-36-19-22/h1-17,19,29,37H,18,20,35H2,(H,38,41)	HIJVXEVWORHKBX-UHFFFAOYSA-N	416907	1-(3-(Aminomethyl)phenyl)-N-(3-(phenyl((pyridin-3-ylmethyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 179b::US10633345, Compound 179b::US10689346, Compound 179b::US11203574, Compound 179b::US11230530, Compound 179b::US11685721, Compound 179b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416907	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416907&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665526	433916819							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835447	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(Cl)cc1Cl)C(F)(F)F	InChI=1S/C29H26Cl2F3N5O/c30-20-9-10-23(24(31)13-20)27(36-16-17-7-8-17)19-4-2-5-21(12-19)37-28(40)25-14-26(29(32,33)34)38-39(25)22-6-1-3-18(11-22)15-35/h1-6,9-14,17,27,36H,7-8,15-16,35H2,(H,37,40)	CXLXHJIZVQBZJV-UHFFFAOYSA-N	416908	1-(3-(aminomethyl)phenyl)-N-(3-((2,4-dichlorophenyl)((cyclopropylmethyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 200f::US10633345, Compound 200f::US10689346, Compound 200f::US11203574, Compound 200f::US11230530, Compound 200f::US11685721, Compound 200f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416908	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416908&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126688969	433916820							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835448	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-10-9-20(28(40,12-11-18-7-8-18)25-6-1-2-13-35-25)15-23(22)36-27(39)24-16-26(29(31,32)33)37-38(24)21-5-3-4-19(14-21)17-34/h1-6,9-10,13-16,18,40H,7-8,11-12,17,34H2,(H,36,39)	XXMBQXWQIGCREG-UHFFFAOYSA-N	416909	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 59c::US10633345, Compound 69b::US10689346, Compound 59c::US11203574, Compound 69b::US11230530, Compound 69b::US11685721, Compound 69b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416909	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416909&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356067	433916821							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835449	CCCCNC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C29H30F3N5O/c1-2-3-15-34-27(21-10-5-4-6-11-21)22-12-8-13-23(17-22)35-28(38)25-18-26(29(30,31)32)36-37(25)24-14-7-9-20(16-24)19-33/h4-14,16-18,27,34H,2-3,15,19,33H2,1H3,(H,35,38)	IJFOMNKWJBCMSK-UHFFFAOYSA-N	416910	1-(3-(Aminomethyl)phenyl)-N-(3-((butylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 180b::US10633345, Compound 180b::US10689346, Compound 180b::US11203574, Compound 180b::US11230530, Compound 180b::US11685721, Compound 180b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416910	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416910&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665986	433916822							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835450	Cc1ccc(C(NCC2CC2)c2cccc(NC(=O)c3cc(nn3-c3cccc(CN)c3)C(F)(F)F)c2)c(C)c1	InChI=1S/C31H32F3N5O/c1-19-9-12-26(20(2)13-19)29(36-18-21-10-11-21)23-6-4-7-24(15-23)37-30(40)27-16-28(31(32,33)34)38-39(27)25-8-3-5-22(14-25)17-35/h3-9,12-16,21,29,36H,10-11,17-18,35H2,1-2H3,(H,37,40)	PPHLPILJSQAZAY-UHFFFAOYSA-N	416911	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2,4-dimethylphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 201f::US10689346, Compound 201f::US11192861, Compound 201f::US11230530, Compound 201f::US11685721, Compound 201f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416911	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416911&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665576	433916823							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835451	Cc1ccc(C)c(c1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C31H32F3N5O/c1-19-9-10-20(2)26(13-19)29(36-18-21-11-12-21)23-6-4-7-24(15-23)37-30(40)27-16-28(31(32,33)34)38-39(27)25-8-3-5-22(14-25)17-35/h3-10,13-16,21,29,36H,11-12,17-18,35H2,1-2H3,(H,37,40)	NFGQIHGOUUFZHN-UHFFFAOYSA-N	416912	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2,5-dimethylphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 202f::US10633345, Compound 202f::US10689346, Compound 202f::US11203574, Compound 202f::US11230530, Compound 202f::US11685721, Compound 202f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416912	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416912&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665510	433916824							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835452	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F3N4O2/c30-29(31,32)26-16-25(36(35-26)24-11-4-6-20(14-24)17-33)28(37)34-23-10-5-9-22(15-23)27(38-18-19-12-13-19)21-7-2-1-3-8-21/h1-11,14-16,19,27H,12-13,17-18,33H2,(H,34,37)	PEZVPVUPSJXZCH-UHFFFAOYSA-N	416913	(+)-1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 166e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416913	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416913&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			91884591	433916825							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835453	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F4N5O/c30-23-12-11-21(27(35-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27,35H,9-10,16-17,34H2,(H,36,39)	MCLZOCFEIKBMBA-UHFFFAOYSA-N	416914	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 42b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416914	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416914&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356124	433916826							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835454	CC(C)(C)c1ccc(cc1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C33H36F3N5O/c1-32(2,3)25-14-12-23(13-15-25)30(38-20-21-10-11-21)24-7-5-8-26(17-24)39-31(42)28-18-29(33(34,35)36)40-41(28)27-9-4-6-22(16-27)19-37/h4-9,12-18,21,30,38H,10-11,19-20,37H2,1-3H3,(H,39,42)	OVDVNIYCGDTOJR-UHFFFAOYSA-N	416915	1-(3-(aminomethyl)phenyl)-N-(3-((4-(tert-butyl)phenyl)((cyclopropylmethyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 203f::US10633345, Compound 203f::US10689346, Compound 203f::US11203574, Compound 203f::US11230530, Compound 203f::US11685721, Compound 203f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416915	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416915&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665458	433916827							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835455	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F3N4O2/c30-29(31,32)26-16-25(36(35-26)24-11-4-6-20(14-24)17-33)28(37)34-23-10-5-9-22(15-23)27(38-18-19-12-13-19)21-7-2-1-3-8-21/h1-11,14-16,19,27H,12-13,17-18,33H2,(H,34,37)	PEZVPVUPSJXZCH-UHFFFAOYSA-N	416916	(+-)-1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 165e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416916	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416916&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			91884591	433916828							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835456	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F4N5O/c30-23-12-11-21(27(35-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27,35H,9-10,16-17,34H2,(H,36,39)	MCLZOCFEIKBMBA-UHFFFAOYSA-N	416917	(+)-1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 42a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416917	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416917&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356124	433916829							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835457	OC(CCC1CC1)(c1ccc(F)c(NC(=O)c2cc(nn2-c2ccc(Cl)cc2)C(F)(F)F)c1)c1ccccn1	InChI=1S/C28H23ClF4N4O2/c29-19-7-9-20(10-8-19)37-23(16-25(36-37)28(31,32)33)26(38)35-22-15-18(6-11-21(22)30)27(39,13-12-17-4-5-17)24-3-1-2-14-34-24/h1-3,6-11,14-17,39H,4-5,12-13H2,(H,35,38)	QWPFRWIQIFPXCC-UHFFFAOYSA-N	416918	1-(4-chlorophenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 157a::US10633345, Compound 157a::US10689346, Compound 157a::US11203574, Compound 157a::US11230530, Compound 157a::US11685721, Compound 157a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416918	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416918&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665679	433916830							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835458	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(N)cc1)C(F)(F)F	InChI=1S/C29H29F3N6O/c30-29(31,32)26-15-25(38(37-26)24-6-1-3-19(13-24)16-33)28(39)36-23-5-2-4-21(14-23)27(35-17-18-7-8-18)20-9-11-22(34)12-10-20/h1-6,9-15,18,27,35H,7-8,16-17,33-34H2,(H,36,39)	XDCYYWMSVYTRMZ-UHFFFAOYSA-N	416919	(+)-1-(3-(aminomethyl)phenyl)-N-(3-((4-aminophenyl)(cyclopropylmethyl-amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 50g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416919	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416919&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355587	433916831							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835459	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-9-8-20(28(40,11-10-18-6-7-18)21-4-2-12-35-17-21)14-24(23)36-27(39)25-15-26(29(31,32)33)37-38(25)22-5-1-3-19(13-22)16-34/h1-5,8-9,12-15,17-18,40H,6-7,10-11,16,34H2,(H,36,39)	VCHFZCHUEHQXSZ-UHFFFAOYSA-N	416920	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 67a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416920	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416920&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355889	433916832							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835460	OC(CCC1CC1)(c1ccc(F)c(NC(=O)c2cc(nn2-c2ccc3cc(Cl)ccc3c2)C(F)(F)F)c1)c1ccccn1	InChI=1S/C32H25ClF4N4O2/c33-23-9-6-21-16-24(10-7-20(21)15-23)41-27(18-29(40-41)32(35,36)37)30(42)39-26-17-22(8-11-25(26)34)31(43,13-12-19-4-5-19)28-3-1-2-14-38-28/h1-3,6-11,14-19,43H,4-5,12-13H2,(H,39,42)	XTIXOVGIMHWYOB-UHFFFAOYSA-N	416921	1-(6-chloronaphthalen-2-yl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 158a::US10633345, Compound 158a::US10689346, Compound 158a::US11203574, Compound 158a::US11230530, Compound 158a::US11685721, Compound 158a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416921	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416921&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355937	433916833							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835461	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(N)cc1)C(F)(F)F	InChI=1S/C29H29F3N6O/c30-29(31,32)26-15-25(38(37-26)24-6-1-3-19(13-24)16-33)28(39)36-23-5-2-4-21(14-23)27(35-17-18-7-8-18)20-9-11-22(34)12-10-20/h1-6,9-15,18,27,35H,7-8,16-17,33-34H2,(H,36,39)	XDCYYWMSVYTRMZ-UHFFFAOYSA-N	416922	(+-)-1-(3-(aminomethyl)phenyl)-N-(3-((4-aminophenyl)(cyclopropylmethyl-amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 50h	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416922	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416922&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355587	433916834							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835462	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-9-8-20(28(40,11-10-18-6-7-18)21-4-2-12-35-17-21)14-24(23)36-27(39)25-15-26(29(31,32)33)37-38(25)22-5-1-3-19(13-22)16-34/h1-5,8-9,12-15,17-18,40H,6-7,10-11,16,34H2,(H,36,39)	VCHFZCHUEHQXSZ-UHFFFAOYSA-N	416923	(+)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 67b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416923	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416923&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355889	433916835							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835463	OC(CCC1CC1)(c1ccc(F)c(NC(=O)c2cc(nn2-c2ccc(Cl)cn2)C(F)(F)F)c1)c1ccccn1	InChI=1S/C27H22ClF4N5O2/c28-18-7-9-24(34-15-18)37-21(14-23(36-37)27(30,31)32)25(38)35-20-13-17(6-8-19(20)29)26(39,11-10-16-4-5-16)22-3-1-2-12-33-22/h1-3,6-9,12-16,39H,4-5,10-11H2,(H,35,38)	HMQODPUNPWDVSN-UHFFFAOYSA-N	416924	1-(5-chloropyridin-2-yl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 159a::US10633345, Compound 159a::US10689346, Compound 159a::US11203574, Compound 159a::US11230530, Compound 159a::US11685721, Compound 159a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416924	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416924&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355989	433916836							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835464	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C28H26F3N5O2/c29-28(30,31)25-15-24(36(35-25)22-8-3-5-19(13-22)16-32)27(37)34-21-7-4-6-20(14-21)26(38-17-18-10-11-18)23-9-1-2-12-33-23/h1-9,12-15,18,26H,10-11,16-17,32H2,(H,34,37)	UBQUVYTUKOFUOF-UHFFFAOYSA-N	416925	(+-)-1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(pyridin-2-yl)methyl)-phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 43g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416925	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416925&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355947	433916837							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835484	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)Oc1ccccn1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-11-10-20(25(12-9-18-7-8-18)40-27-6-1-2-13-35-27)15-23(22)36-28(39)24-16-26(29(31,32)33)37-38(24)21-5-3-4-19(14-21)17-34/h1-6,10-11,13-16,18,25H,7-9,12,17,34H2,(H,36,39)	NLWJKTCXFARQOW-UHFFFAOYSA-N	416945	US10329260, Compound 250c::US10633345, Compound 250c::US11192861, Compound 250c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416945	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416945&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126689760	433916857							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835485	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F3N4O2/c31-30(32,33)27-18-26(37(36-27)25-11-4-6-21(16-25)19-34)28(38)35-24-10-5-9-23(17-24)29(39,15-14-20-12-13-20)22-7-2-1-3-8-22/h1-11,16-18,20,39H,12-15,19,34H2,(H,35,38)	DCGYPXFSNPCKGX-UHFFFAOYSA-N	416946	(+-)-1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 46i	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416946	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416946&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355790	433916858							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835486	COc1ccc2ccccc2c1C(NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H31F4N5O2/c1-45-29-14-12-22-6-2-3-8-25(22)31(29)32(40-19-20-9-10-20)23-11-13-26(35)27(16-23)41-33(44)28-17-30(34(36,37)38)42-43(28)24-7-4-5-21(15-24)18-39/h2-8,11-17,20,32,40H,9-10,18-19,39H2,1H3,(H,41,44)	AYMFYNZEWAELBE-UHFFFAOYSA-N	416947	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(2-methoxynaphthalen-1-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (63a), (+)-1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(2-methoxynaphthalen-1-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 63b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416947	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416947&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355591	433916859							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835487	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(=CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H26F4N4O/c31-25-14-12-22(24(13-11-19-9-10-19)21-6-2-1-3-7-21)16-26(25)36-29(39)27-17-28(30(32,33)34)37-38(27)23-8-4-5-20(15-23)18-35/h1-8,12-17,19H,9-11,18,35H2,(H,36,39)/b24-13-	BAAJKWZPAGFHDE-CFRMEGHHSA-N	416948	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-phenylprop-1-enyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 252c::US10633345, Compound 252c::US10689346, Compound 252c::US11203574, Compound 252c::US11230530, Compound 252c::US11685721, Compound 252c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416948	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416948&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			140777564	433916860							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835488	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H25F4N5O2/c29-22-9-8-19(26(39-16-17-6-7-17)20-4-2-10-34-15-20)12-23(22)35-27(38)24-13-25(28(30,31)32)36-37(24)21-5-1-3-18(11-21)14-33/h1-5,8-13,15,17,26H,6-7,14,16,33H2,(H,35,38)	CNAFOXQNPWSINI-UHFFFAOYSA-N	416949	(+)-1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethoxy)(pyridin-3-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 48g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416949	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416949&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355617	433916861							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835489	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C30H25F4N5O2/c31-24-11-10-22(28(41-17-19-4-5-19)21-8-6-18(15-35)7-9-21)13-25(24)37-29(40)26-14-27(30(32,33)34)38-39(26)23-3-1-2-20(12-23)16-36/h1-3,6-14,19,28H,4-5,16-17,36H2,(H,37,40)	WXFHQCUXOOXGLO-UHFFFAOYSA-N	416950	(+)-1-(3-(aminomethyl)phenyl)-N-(5-((4-cyanophenyl)(cyclopropylmethoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 73a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416950	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416950&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665569	433916862							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835490	CN1CCCN(CC1)C(CCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H36F4N6O/c1-38-12-3-13-39(15-14-38)26(11-8-20-6-7-20)22-9-10-24(31)25(17-22)36-29(41)27-18-28(30(32,33)34)37-40(27)23-5-2-4-21(16-23)19-35/h2,4-5,9-10,16-18,20,26H,3,6-8,11-15,19,35H2,1H3,(H,36,41)	WXRMFESIILBOBA-UHFFFAOYSA-N	416951	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(4-methyl-1,4-diazepan-1-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 251e::US10633345, Compound 251e::US10689346, Compound 251e::US11203574, Compound 251e::US11230530, Compound 251e::US11685721, Compound 251e	Plasma kallikrein		 75.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416951	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416951&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355664	433916863							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835491	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H25F4N5O2/c29-22-9-8-19(26(39-16-17-6-7-17)20-4-2-10-34-15-20)12-23(22)35-27(38)24-13-25(28(30,31)32)36-37(24)21-5-1-3-18(11-21)14-33/h1-5,8-13,15,17,26H,6-7,14,16,33H2,(H,35,38)	CNAFOXQNPWSINI-UHFFFAOYSA-N	416952	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethoxy)(pyridin-3-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 48h	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416952	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416952&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355617	433916864							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835492	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C30H25F4N5O2/c31-24-11-10-22(28(41-17-19-4-5-19)21-8-6-18(15-35)7-9-21)13-25(24)37-29(40)26-14-27(30(32,33)34)38-39(26)23-3-1-2-20(12-23)16-36/h1-3,6-14,19,28H,4-5,16-17,36H2,(H,37,40)	WXFHQCUXOOXGLO-UHFFFAOYSA-N	416953	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-((4-cyanophenyl)(cyclopropylmethoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 73b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416953	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416953&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665569	433916865							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835493	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)N1C(=O)CCC1=O)C(F)(F)F	InChI=1S/C28H27F4N5O3/c29-20-8-7-18(22(9-6-16-4-5-16)36-25(38)10-11-26(36)39)13-21(20)34-27(40)23-14-24(28(30,31)32)35-37(23)19-3-1-2-17(12-19)15-33/h1-3,7-8,12-14,16,22H,4-6,9-11,15,33H2,(H,34,40)	ZAWTZVLCOQSDBX-UHFFFAOYSA-N	416954	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(2,5-dioxopyrrolidin-1-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 260b::US10633345, Compound 260b::US10689346, Compound 260b::US11203574, Compound 260b::US11230530, Compound 260b::US11685721, Compound 260b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416954	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416954&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665563	433916866							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835494	COc1ccc2ccccc2c1C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H32F3N5O2/c1-44-29-15-14-23-7-2-3-11-27(23)31(29)32(39-20-21-12-13-21)24-8-5-9-25(17-24)40-33(43)28-18-30(34(35,36)37)41-42(28)26-10-4-6-22(16-26)19-38/h2-11,14-18,21,32,39H,12-13,19-20,38H2,1H3,(H,40,43)	XVOUQCJHWNZPKF-UHFFFAOYSA-N	416955	(+-)-1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2-methoxynaphthalen-1-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 51g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416955	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416955&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356155	433916867							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835495	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C30H25F4N5O2/c31-24-10-9-22(28(41-17-18-7-8-18)21-5-1-3-19(11-21)15-35)13-25(24)37-29(40)26-14-27(30(32,33)34)38-39(26)23-6-2-4-20(12-23)16-36/h1-6,9-14,18,28H,7-8,16-17,36H2,(H,37,40)	LSXFYXGKZDVRTL-UHFFFAOYSA-N	416956	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-((3-cyanophenyl)(cyclopropylmethoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 72c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416956	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416956&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356211	433916868							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835496	CS(=O)(=O)NC(CCC1CC1)(c1ccncc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2ccc3ccnc(N)c3c2)C(F)(F)F)c1	InChI=1S/C32H29F4N7O3S/c1-47(45,46)42-31(12-8-19-2-3-19,21-10-13-38-14-11-21)22-5-7-25(33)26(16-22)40-30(44)27-18-28(32(34,35)36)41-43(27)23-6-4-20-9-15-39-29(37)24(20)17-23/h4-7,9-11,13-19,42H,2-3,8,12H2,1H3,(H2,37,39)(H,40,44)	WOIASLBXHIHYRY-UHFFFAOYSA-N	416957	(+-)-1-(1-aminoisoquinolin-7-yl)-N-(5-(3-cyclopropyl-1-(methylsulfonamido)-1-(pyridin-4-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 262f::US10633345, Compound 262f::US10689346, Compound 262f::US11192861, Compound 262f::US11230530, Compound 262f::US11685721, Compound 262f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416957	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416957&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355636	433916869							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835497	COc1ccc2ccccc2c1C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H32F3N5O2/c1-44-29-15-14-23-7-2-3-11-27(23)31(29)32(39-20-21-12-13-21)24-8-5-9-25(17-24)40-33(43)28-18-30(34(35,36)37)41-42(28)26-10-4-6-22(16-26)19-38/h2-11,14-18,21,32,39H,12-13,19-20,38H2,1H3,(H,40,43)	XVOUQCJHWNZPKF-UHFFFAOYSA-N	416958	(+)-1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2-methoxynaphthalen-1-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 51h	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416958	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416958&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356155	433916870							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835368	Cc1ccc(cc1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O/c1-19-8-12-22(13-9-19)28(35-18-20-10-11-20)23-5-3-6-24(15-23)36-29(39)26-16-27(30(31,32)33)37-38(26)25-7-2-4-21(14-25)17-34/h2-9,12-16,20,28,35H,10-11,17-18,34H2,1H3,(H,36,39)	HRCLMMKOPKWJGF-UHFFFAOYSA-N	416829	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(p-tolyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 122g::US10633345, Compound 122g::US10689346, Compound 122g::US11203574, Compound 122g::US11230530, Compound 122g::US11685721, Compound 122g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416829	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416829&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355867	433916742							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835369	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C30H26F4N6O/c31-24-11-10-22(28(37-17-19-4-5-19)21-8-6-18(15-35)7-9-21)13-25(24)38-29(41)26-14-27(30(32,33)34)39-40(26)23-3-1-2-20(12-23)16-36/h1-3,6-14,19,28,37H,4-5,16-17,36H2,(H,38,41)	GLPWOIBPISJWCH-UHFFFAOYSA-N	416830	1-(3-(aminomethyl)phenyl)-N-(5-((4-cyanophenyl)(cyclopropyl-methylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 52h::US11685721, Compound 71b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416830	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416830&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355582	433916743							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835370	Cn1cc(cn1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C27H28F3N7O/c1-36-16-20(15-33-36)25(32-14-17-8-9-17)19-5-3-6-21(11-19)34-26(38)23-12-24(27(28,29)30)35-37(23)22-7-2-4-18(10-22)13-31/h2-7,10-12,15-17,25,32H,8-9,13-14,31H2,1H3,(H,34,38)	GHANDLPUFXRHQK-UHFFFAOYSA-N	416831	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(1-methyl-1H-pyrazol-4-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 104f::US10633345, Compound 104f::US10689346, Compound 104f::US11203574, Compound 104f::US11230530, Compound 104f::US11685721, Compound 104f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416831	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416831&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356100	433916744							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835371	CS(=O)(=O)c1ccccc1C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O3S/c1-42(40,41)26-11-3-2-10-24(26)28(35-18-19-12-13-19)21-7-5-8-22(15-21)36-29(39)25-16-27(30(31,32)33)37-38(25)23-9-4-6-20(14-23)17-34/h2-11,14-16,19,28,35H,12-13,17-18,34H2,1H3,(H,36,39)	XEAXHMDONDJJBQ-UHFFFAOYSA-N	416832	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2-(methylsulfonyl)phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 121f::US10633345, Compound 121f::US10689346, Compound 121f::US11203574, Compound 121f::US11230530, Compound 121f::US11685721, Compound 121f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416832	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416832&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665701	433916745							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835372	NCc1ccc(cc1)C(NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F4N6O/c31-24-11-10-22(28(37-17-19-4-5-19)21-8-6-18(15-35)7-9-21)13-25(24)38-29(41)26-14-27(30(32,33)34)39-40(26)23-3-1-2-20(12-23)16-36/h1-3,6-14,19,28,37H,4-5,15-17,35-36H2,(H,38,41)	AYTAHYJWZGLMOI-UHFFFAOYSA-N	416833	1-(3-(aminomethyl)phenyl)-N-(5-((4-(aminomethyl)phenyl)(cyclopropylmethylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 139b::US11685721, Compound 139b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416833	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416833&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665498	433916746							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835373	COc1ccc(cc1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O2/c1-40-25-12-10-21(11-13-25)28(35-18-19-8-9-19)22-5-3-6-23(15-22)36-29(39)26-16-27(30(31,32)33)37-38(26)24-7-2-4-20(14-24)17-34/h2-7,10-16,19,28,35H,8-9,17-18,34H2,1H3,(H,36,39)	NTRWDZUFVXMYGD-UHFFFAOYSA-N	416834	1-(3-(Aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(4-methoxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 105g::US10633345, Compound 105g::US10689346, Compound 105g::US11203574, Compound 105g::US11230530, Compound 105g::US11685721, Compound 105g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416834	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416834&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665521	433916747							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835374	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(CN(CC2CC2)c2ccc(OCc3ccccc3)cc2)c1)C(F)(F)F	InChI=1S/C36H34F3N5O2/c37-36(38,39)34-20-33(44(42-34)31-11-5-8-27(19-31)21-40)35(45)41-29-10-4-9-28(18-29)23-43(22-25-12-13-25)30-14-16-32(17-15-30)46-24-26-6-2-1-3-7-26/h1-11,14-20,25H,12-13,21-24,40H2,(H,41,45)	BDKFTABMYPATOF-UHFFFAOYSA-N	416835	1-(3-(Aminomethyl)phenyl)-N-(3-((4-(benzyloxy)phenyl)(cyclopropylmethylamino) methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 123g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416835	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416835&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			154584224	433916748							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835375	Cc1cccc(c1)C(NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H29F4N5O/c1-18-4-2-6-21(12-18)28(36-17-19-8-9-19)22-10-11-24(31)25(14-22)37-29(40)26-15-27(30(32,33)34)38-39(26)23-7-3-5-20(13-23)16-35/h2-7,10-15,19,28,36H,8-9,16-17,35H2,1H3,(H,37,40)	DWXIBXKRESUYFO-UHFFFAOYSA-N	416836	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(m-tolyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 140e::US10633345, Compound 140e::US10689346, Compound 140e::US11203574, Compound 140e::US11230530, Compound 140e::US11685721, Compound 140e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416836	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416836&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356147	433916749							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835376	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1O)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-24(37(36-26)22-8-3-5-19(13-22)16-33)28(39)35-21-7-4-6-20(14-21)27(34-17-18-11-12-18)23-9-1-2-10-25(23)38/h1-10,13-15,18,27,34,38H,11-12,16-17,33H2,(H,35,39)	PCNDJIQOMLHSEK-UHFFFAOYSA-N	416837	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2-hydroxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 49h::US10633345, Compound 49h::US10689346, Compound 49h::US11203574, Compound 49j::US11230530, Compound 49j::US11685721, Compound 49h	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416837	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416837&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355733	433916750							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835377	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc(OC(F)(F)F)c1)C(F)(F)F	InChI=1S/C30H27F6N5O2/c31-29(32,33)26-15-25(41(40-26)23-8-1-4-19(12-23)16-37)28(42)39-22-7-2-5-20(13-22)27(38-17-18-10-11-18)21-6-3-9-24(14-21)43-30(34,35)36/h1-9,12-15,18,27,38H,10-11,16-17,37H2,(H,39,42)	IVEYKJBEIIJLCR-UHFFFAOYSA-N	416838	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(3-(trifluoromethoxy) phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 124f::US10633345, Compound 124f::US10689346, Compound 124f::US11203574, Compound 124f::US11230530, Compound 124f::US11685721, Compound 124f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416838	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416838&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665809	433916751							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835378	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C1OC(=O)Nc2ccccc12)C(F)(F)F	InChI=1S/C26H20F3N5O3/c27-26(28,29)22-13-21(34(33-22)18-8-3-5-15(11-18)14-30)24(35)31-17-7-4-6-16(12-17)23-19-9-1-2-10-20(19)32-25(36)37-23/h1-13,23H,14,30H2,(H,31,35)(H,32,36)	LRCHTKOMIAYQHX-UHFFFAOYSA-N	416839	1-(3-(aminomethyl)phenyl)-N-(3-(2-oxo-2,4-dihydro-1H-benzo[d][1,3]oxazin-4-yl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 167f::US10633345, Compound 167f::US10689346, Compound 167f::US11203574, Compound 167f::US11230530, Compound 167f::US11685721, Compound 167f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416839	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416839&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665868	433916752							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835379	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1OCc1ccccc1)C(F)(F)F	InChI=1S/C36H34F3N5O2/c37-36(38,39)33-20-31(44(43-33)29-13-6-10-26(18-29)21-40)35(45)42-28-12-7-11-27(19-28)34(41-22-24-16-17-24)30-14-4-5-15-32(30)46-23-25-8-2-1-3-9-25/h1-15,18-20,24,34,41H,16-17,21-23,40H2,(H,42,45)	XAZZTVOUWUHFIG-UHFFFAOYSA-N	416840	1-(3-(aminomethyl)phenyl)-N-(3-((2-(benzyloxy)phenyl)(cyclopropylmethyl amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 106a::US10633345, Compound 106a::US10689346, Compound 106a::US11203574, Compound 106a::US11230530, Compound 106a::US11685721, Compound 106a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416840	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416840&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356273	433916753							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835380	COc1ccc2ccccc2c1C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H32F3N5O2/c1-44-29-15-14-23-7-2-3-11-27(23)31(29)32(39-20-21-12-13-21)24-8-5-9-25(17-24)40-33(43)28-18-30(34(35,36)37)41-42(28)26-10-4-6-22(16-26)19-38/h2-11,14-18,21,32,39H,12-13,19-20,38H2,1H3,(H,40,43)	XVOUQCJHWNZPKF-UHFFFAOYSA-N	416841	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2-methoxynaphthalen-1-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 51f::US10633345, Compound 51f::US10689346, Compound 51f::US11203574, Compound 51h::US11230530, Compound 51h::US11685721, Compound 51f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416841	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416841&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356155	433916754							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835381	COc1cccc(c1)C(NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H29F4N5O2/c1-41-23-7-3-5-20(13-23)28(36-17-18-8-9-18)21-10-11-24(31)25(14-21)37-29(40)26-15-27(30(32,33)34)38-39(26)22-6-2-4-19(12-22)16-35/h2-7,10-15,18,28,36H,8-9,16-17,35H2,1H3,(H,37,40)	MRNMVRANILFBMK-UHFFFAOYSA-N	416842	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(3-methoxyphenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 141e::US10633345, Compound 141e::US10689346, Compound 141e::US11203574, Compound 141e::US11230530, Compound 141e::US11685721, Compound 142f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416842	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416842&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355803	433916755							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835382	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(N)cc1)C(F)(F)F	InChI=1S/C29H29F3N6O/c30-29(31,32)26-15-25(38(37-26)24-6-1-3-19(13-24)16-33)28(39)36-23-5-2-4-21(14-23)27(35-17-18-7-8-18)20-9-11-22(34)12-10-20/h1-6,9-15,18,27,35H,7-8,16-17,33-34H2,(H,36,39)	XDCYYWMSVYTRMZ-UHFFFAOYSA-N	416843	1-(3-(aminomethyl)phenyl)-N-(3-((4-aminophenyl)(cyclopropylmethyl-amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 50f::US10633345, Compound 50f::US10689346, Compound 50h::US11203574, Compound 50h::US11230530, Compound 50h::US11685721, Compound 50f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416843	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416843&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355587	433916756							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835383	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cc2ccccc2c2ccccc12)C(F)(F)F	InChI=1S/C37H32F3N5O/c38-37(39,40)34-20-33(45(44-34)28-11-5-7-24(17-28)21-41)36(46)43-27-10-6-9-26(18-27)35(42-22-23-15-16-23)32-19-25-8-1-2-12-29(25)30-13-3-4-14-31(30)32/h1-14,17-20,23,35,42H,15-16,21-22,41H2,(H,43,46)	OZXXGJIBGVGMMV-UHFFFAOYSA-N	416844	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic acid {3-[(cyclopropylmethyl-amino)-phenanthren-9-yl-methyl]-phenyl}-amide::US10329260, Compound 125g::US10633345, Compound 125g::US10689346, Compound 125g::US11203574, Compound 125g::US11230530, Compound 125g::US11685721, Compound 125g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416844	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416844&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665609	433916757							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835384	COc1ccc(cc1)C(NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H29F4N5O2/c1-41-23-10-7-20(8-11-23)28(36-17-18-5-6-18)21-9-12-24(31)25(14-21)37-29(40)26-15-27(30(32,33)34)38-39(26)22-4-2-3-19(13-22)16-35/h2-4,7-15,18,28,36H,5-6,16-17,35H2,1H3,(H,37,40)	GWNRXEFJAQDBCM-UHFFFAOYSA-N	416845	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(4-methoxyphenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 142f::US10633345, Compound 142f::US10689346, Compound 142f::US11203574, Compound 142f::US11230530, Compound 142f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416845	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416845&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355909	433916758							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835385	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(CN(CC2CC2)c2cccc(OCc3ccccc3)c2)c1)C(F)(F)F	InChI=1S/C36H34F3N5O2/c37-36(38,39)34-20-33(44(42-34)31-13-5-9-27(18-31)21-40)35(45)41-29-11-4-10-28(17-29)23-43(22-25-15-16-25)30-12-6-14-32(19-30)46-24-26-7-2-1-3-8-26/h1-14,17-20,25H,15-16,21-24,40H2,(H,41,45)	XJANGLQOUFSJAS-UHFFFAOYSA-N	416846	1-(3-(Aminomethyl)phenyl)-N-(3-((3-(benzyloxy)phenyl)(cyclopropylmethylamino) methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 107f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416846	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416846&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			154584225	433916759							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835386	CN(C)c1ccc(C(NCC2CC2)c2cccc(NC(=O)c3cc(nn3-c3cccc(CN)c3)C(F)(F)F)c2)c2ccccc12	InChI=1S/C35H35F3N6O/c1-43(2)30-16-15-29(27-11-3-4-12-28(27)30)33(40-21-22-13-14-22)24-8-6-9-25(18-24)41-34(45)31-19-32(35(36,37)38)42-44(31)26-10-5-7-23(17-26)20-39/h3-12,15-19,22,33,40H,13-14,20-21,39H2,1-2H3,(H,41,45)	IQAVMSNXUBZMCB-UHFFFAOYSA-N	416847	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic acid {3-[(cyclopropylmethyl-amino)-(4-dimethylamino-naphthalen-1-yl)-methyl]-phenyl}-amide::US10329260, Compound 126g::US10633345, Compound 126g::US10689346, Compound 126g::US11203574, Compound 126g::US11230530, Compound 126g::US11685721, Compound 126g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416847	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416847&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355601	433916760							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835387	Cc1cc(C(=O)Nc2cccc(c2)C(NCC2CC2)c2ccccc2)n(n1)-c1cccc(CN)c1	InChI=1S/C29H31N5O/c1-20-15-27(34(33-20)26-12-5-7-22(16-26)18-30)29(35)32-25-11-6-10-24(17-25)28(31-19-21-13-14-21)23-8-3-2-4-9-23/h2-12,15-17,21,28,31H,13-14,18-19,30H2,1H3,(H,32,35)	GPDBDHGXUBYWPY-UHFFFAOYSA-N	416848	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(phenyl)methyl)phenyl)-3-methyl-1H-pyrazole-5-carboxamid::US10329260, Compound 143l::US10633345, Compound 143l::US10689346, Compound 143l::US11203574, Compound 143l::US11230530, Compound 143l::US11685721, Compound 143l	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416848	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416848&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356139	433916761							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835498	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C30H25F4N5O2/c31-24-10-9-22(28(41-17-18-7-8-18)21-5-1-3-19(11-21)15-35)13-25(24)37-29(40)26-14-27(30(32,33)34)38-39(26)23-6-2-4-20(12-23)16-36/h1-6,9-14,18,28H,7-8,16-17,36H2,(H,37,40)	LSXFYXGKZDVRTL-UHFFFAOYSA-N	416959	(+)-1-(3-(aminomethyl)phenyl)-N-(5-((3-cyanophenyl)(cyclopropylmethoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 72d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416959	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416959&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356211	433916871							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835499	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccc(=O)[nH]c1=O)C(F)(F)F			416960	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 263d::US10633345, Compound 263d::US10689346, Compound 263d::US11203574, Compound 263d::US11230530, Compound 263d::US11685721, Compound 263d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416960	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416960&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			154584232	433916872							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835500	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-25(37(36-26)24-9-1-4-19(12-24)16-33)28(38)35-23-8-3-6-21(14-23)27(39-17-18-10-11-18)20-5-2-7-22(34)13-20/h1-9,12-15,18,27H,10-11,16-17,33-34H2,(H,35,38)	FPQYUIIRVBKUDH-UHFFFAOYSA-N	416961	(+-)-1-(3-(aminomethyl)phenyl)-N-(3-((3-aminophenyl)(cyclopropyl-methoxy)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 64a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416961	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416961&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355845	433916873							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835501	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1O)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-11-10-19(27(35-16-17-8-9-17)21-6-1-2-7-25(21)39)13-23(22)36-28(40)24-14-26(29(31,32)33)37-38(24)20-5-3-4-18(12-20)15-34/h1-7,10-14,17,27,35,39H,8-9,15-16,34H2,(H,36,40)	CKWWRAGQIQAYTL-UHFFFAOYSA-N	416962	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(2-hydroxyphenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 66a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416962	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416962&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665480	433916874							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835502	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1ccc(cc1F)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-23-14-21(27(39-17-18-9-10-18)20-6-2-1-3-7-20)11-12-24(23)35-28(38)25-15-26(29(31,32)33)36-37(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27H,9-10,16-17,34H2,(H,35,38)	HBXVQXKJLUQKAE-UHFFFAOYSA-N	416963	1-(3-(aminomethyl)phenyl)-N-(4-((cyclopropylmethoxy)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 15g::US10633345, Compound 15g::US10689346, Compound 15g::US11203574, Compound 15g::US11230530, Compound 15g::US11685721, Compound 15g	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416963	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416963&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355605	433916875							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835503	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-25(37(36-26)24-9-1-4-19(12-24)16-33)28(38)35-23-8-3-6-21(14-23)27(39-17-18-10-11-18)20-5-2-7-22(34)13-20/h1-9,12-15,18,27H,10-11,16-17,33-34H2,(H,35,38)	FPQYUIIRVBKUDH-UHFFFAOYSA-N	416964	(+)-1-(3-(aminomethyl)phenyl)-N-(3-((3-aminophenyl)(cyclopropyl-methoxy)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 64b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416964	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416964&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355845	433916876							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835504	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1O)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-11-10-19(27(35-16-17-8-9-17)21-6-1-2-7-25(21)39)13-23(22)36-28(40)24-14-26(29(31,32)33)37-38(24)20-5-3-4-18(12-20)15-34/h1-7,10-14,17,27,35,39H,8-9,15-16,34H2,(H,36,40)	CKWWRAGQIQAYTL-UHFFFAOYSA-N	416965	(+)-1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(2-hydroxyphenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 66b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416965	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416965&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665480	433916877							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835505	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1ccc(cc1F)C(O)c1ccccc1)C(F)(F)F	InChI=1S/C25H20F4N4O2/c26-19-12-17(23(34)16-6-2-1-3-7-16)9-10-20(19)31-24(35)21-13-22(25(27,28)29)32-33(21)18-8-4-5-15(11-18)14-30/h1-13,23,34H,14,30H2,(H,31,35)	WVBOXESRKOBMTK-UHFFFAOYSA-N	416966	1-(3-(Aminomethyl)phenyl)-N-(2-fluoro-4-(hydroxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 16b::US10633345, Compound 16b::US10689346, Compound 16b::US11203574, Compound 16b::US11230530, Compound 16b::US11685721, Compound 16b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416966	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416966&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665483	433916878							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835506	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1O)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-24(37(36-26)22-8-3-5-19(13-22)16-33)28(39)35-21-7-4-6-20(14-21)27(34-17-18-11-12-18)23-9-1-2-10-25(23)38/h1-10,13-15,18,27,34,38H,11-12,16-17,33H2,(H,35,39)	PCNDJIQOMLHSEK-UHFFFAOYSA-N	416967	(+)-1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2-hydroxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 49i	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416967	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416967&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355733	433916879							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835507	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-23-12-11-21(27(39-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)35-28(38)25-15-26(29(31,32)33)36-37(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27H,9-10,16-17,34H2,(H,35,38)	HIMJVDQVZQMIPM-UHFFFAOYSA-N	416968	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethoxy)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 37b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416968	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416968&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355729	433916880							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835508	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1c(F)cccc1C(O)c1ccccc1)C(F)(F)F	InChI=1S/C25H20F4N4O2/c26-19-11-5-10-18(23(34)16-7-2-1-3-8-16)22(19)31-24(35)20-13-21(25(27,28)29)32-33(20)17-9-4-6-15(12-17)14-30/h1-13,23,34H,14,30H2,(H,31,35)	PIMJYQUHLMMZIO-UHFFFAOYSA-N	416969	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-6-(hydroxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 90f::US10633345, Compound 90f::US10689346, Compound 90f::US11203574, Compound 90f::US11230530, Compound 90f::US11685721, Compound 90f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416969	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416969&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356272	433916881							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835509	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1O)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-24(37(36-26)22-8-3-5-19(13-22)16-33)28(39)35-21-7-4-6-20(14-21)27(34-17-18-11-12-18)23-9-1-2-10-25(23)38/h1-10,13-15,18,27,34,38H,11-12,16-17,33H2,(H,35,39)	PCNDJIQOMLHSEK-UHFFFAOYSA-N	416970	(+-)-1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2-hydroxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 49j	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416970	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416970&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355733	433916882							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835510	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-23-12-11-21(27(39-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)35-28(38)25-15-26(29(31,32)33)36-37(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27H,9-10,16-17,34H2,(H,35,38)	HIMJVDQVZQMIPM-UHFFFAOYSA-N	416971	(+)-1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethoxy)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 37a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416971	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416971&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355729	433916883							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835511	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N(CC1CC1)CC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C33H33F4N5O/c34-27-14-13-25(31(24-6-2-1-3-7-24)41(19-21-9-10-21)20-22-11-12-22)16-28(27)39-32(43)29-17-30(33(35,36)37)40-42(29)26-8-4-5-23(15-26)18-38/h1-8,13-17,21-22,31H,9-12,18-20,38H2,(H,39,43)	FVEYNTAGBBDICV-UHFFFAOYSA-N	416972	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-((bis(cyclopropylmethyl)amino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 206d::US10633345, Compound 206d::US10689346, Compound 206d::US11203574, Compound 206d::US11230530, Compound 206d::US11685721, Compound 206d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416972	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416972&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355791	433916884							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835512	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C#N)C(N)=O	InChI=1S/C31H30FN7O2/c32-25-11-10-23(31(36,13-12-19-4-5-19)22-8-6-20(17-33)7-9-22)15-26(25)37-30(41)28-16-27(29(35)40)38-39(28)24-3-1-2-21(14-24)18-34/h1-3,6-11,14-16,19H,4-5,12-13,18,34,36H2,(H2,35,40)(H,37,41)	BCLQAOJZVSDWEP-UHFFFAOYSA-N	416973	(+)-N5-(5-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-1H-pyrazole-3,5-dicarboxamide::US10329260, Compound 231d::US10633345, Compound 231d::US10689346, Compound 231d::US11203574, Compound 231d::US11230530, Compound 231d::US11685721, Compound 231d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416973	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416973&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665708	433916885							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835513	CC(C)(C)C(=O)NC(CCC1CC1)(c1cccnc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H36F4N6O2/c1-32(2,3)31(46)42-33(14-13-21-9-10-21,24-7-5-15-40-20-24)23-11-12-26(35)27(17-23)41-30(45)28-18-29(34(36,37)38)43-44(28)25-8-4-6-22(16-25)19-39/h4-8,11-12,15-18,20-21H,9-10,13-14,19,39H2,1-3H3,(H,41,45)(H,42,46)	QDJVSPVHYSLBHH-UHFFFAOYSA-N	416974	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-pivalamido-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 244g::US10689346, Compound 244g::US11203574, Compound 244g::US11230530, Compound 244g::US11685721, Compound 244g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416974	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416974&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665924	433916886							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835514	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-22-10-9-20(28(35,12-11-18-7-8-18)25-6-1-2-13-36-25)15-23(22)37-27(40)24-16-26(29(31,32)33)38-39(24)21-5-3-4-19(14-21)17-34/h1-6,9-10,13-16,18H,7-8,11-12,17,34-35H2,(H,37,40)	IFWBAIGKQKRJGJ-UHFFFAOYSA-N	416975	(+-)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 205d::US10633345, Compound 205c::US10689346, Compound 205e::US11203574, Compound 205e::US11230530, Compound 205e::US11685721, Compound 205f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416975	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416975&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665627	433916887							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835515	ONC(=N)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N6O2/c30-22-12-11-19(26(35-16-17-9-10-17)18-5-2-1-3-6-18)14-23(22)36-28(40)24-15-25(29(31,32)33)37-39(24)21-8-4-7-20(13-21)27(34)38-41/h1-8,11-15,17,26,35,41H,9-10,16H2,(H2,34,38)(H,36,40)	RKUBSDCTAQRJEX-UHFFFAOYSA-N	416976	(+-)-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-1-(3-(N-hydroxycarbamimidoyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 232a::US10633345, Compound 232a::US10689346, Compound 232a::US11203574, Compound 232a::US11230530, Compound 232a::US11685721, Compound 232a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416976	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416976&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665466	433916888							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835516	CC(=O)NC(CCC1CC1)(c1cccnc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C31H30F4N6O2/c1-19(42)39-30(12-11-20-7-8-20,23-5-3-13-37-18-23)22-9-10-25(32)26(15-22)38-29(43)27-16-28(31(33,34)35)40-41(27)24-6-2-4-21(14-24)17-36/h2-6,9-10,13-16,18,20H,7-8,11-12,17,36H2,1H3,(H,38,43)(H,39,42)	NXVHVPBDWBOZQI-UHFFFAOYSA-N	416977	(+-)-N-(5-(1-acetamido-3-cyclopropyl-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 244h::US10633345, Compound 244h::US10689346, Compound 244h::US11203574, Compound 244h::US11230530, Compound 244h::US11685721, Compound 244h	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416977	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416977&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355894	433916889							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835517	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-22-10-9-20(28(35,12-11-18-7-8-18)25-6-1-2-13-36-25)15-23(22)37-27(40)24-16-26(29(31,32)33)38-39(24)21-5-3-4-19(14-21)17-34/h1-6,9-10,13-16,18H,7-8,11-12,17,34-35H2,(H,37,40)	IFWBAIGKQKRJGJ-UHFFFAOYSA-N	416978	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 205e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416978	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416978&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665627	433916890							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835518	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(O)=O	InChI=1S/C29H28FN5O3/c30-23-12-11-21(27(32-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)33-28(36)26-15-25(29(37)38)34-35(26)22-8-4-5-19(13-22)16-31/h1-8,11-15,18,27,32H,9-10,16-17,31H2,(H,33,36)(H,37,38)	XPAISISGRLZRHF-UHFFFAOYSA-N	416979	(+)-1-(3-(aminomethyl)phenyl)-5-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenylcarbamoyl)-1H-pyrazole-3-carboxylic acid::US10329260, Compound 246f::US10633345, Compound 246f::US10689346, Compound 246f::US11203574, Compound 246f::US11230530, Compound 246f::US11685721, Compound 246f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416979	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416979&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356041	433916891							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835519	CCC(=O)NC(CCC1CC1)(c1cccnc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C32H32F4N6O2/c1-2-29(43)40-31(13-12-20-8-9-20,23-6-4-14-38-19-23)22-10-11-25(33)26(16-22)39-30(44)27-17-28(32(34,35)36)41-42(27)24-7-3-5-21(15-24)18-37/h3-7,10-11,14-17,19-20H,2,8-9,12-13,18,37H2,1H3,(H,39,44)(H,40,43)	VLEWWVBFKVHAND-UHFFFAOYSA-N	416980	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-propionamido-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 244i::US10633345, Compound 244i::US10689346, Compound 244i::US11203574, Compound 244i::US11230530, Compound 244j::US11685721, Compound 244i	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416980	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416980&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665945	433916892							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835520	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-23-9-8-20(28(35,11-10-18-6-7-18)21-4-2-12-36-17-21)14-24(23)37-27(40)25-15-26(29(31,32)33)38-39(25)22-5-1-3-19(13-22)16-34/h1-5,8-9,12-15,17-18H,6-7,10-11,16,34-35H2,(H,37,40)	QXMQDWOYOXVOQZ-UHFFFAOYSA-N	416981	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 208d::US10633345, Compound 209d::US10689346, Compound 209d::US11203574, Compound 209d::US11230530, Compound 209d::US11685721, Compound 209d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416981	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416981&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355646	433916893							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835521	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C#N)C#N	InChI=1S/C31H28FN7O/c32-27-11-10-24(31(36,13-12-20-4-5-20)23-8-6-21(17-33)7-9-23)15-28(27)37-30(40)29-16-25(19-35)38-39(29)26-3-1-2-22(14-26)18-34/h1-3,6-11,14-16,20H,4-5,12-13,18,34,36H2,(H,37,40)	SWSSXIJHEDUEIQ-UHFFFAOYSA-N	416982	(+)-N-(5-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-cyano-1H-pyrazole-5-carboxamide::US10329260, Compound 234d::US10633345, Compound 234d::US10689346, Compound 234d::US11203574, Compound 234d::US11230530, Compound 234d::US11685721, Compound 234d	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416982	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416982&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356248	433916894							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835522	CC(C)C(=O)NC(CCC1CC1)(c1cccnc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C33H34F4N6O2/c1-20(2)30(44)41-32(13-12-21-8-9-21,24-6-4-14-39-19-24)23-10-11-26(34)27(16-23)40-31(45)28-17-29(33(35,36)37)42-43(28)25-7-3-5-22(15-25)18-38/h3-7,10-11,14-17,19-21H,8-9,12-13,18,38H2,1-2H3,(H,40,45)(H,41,44)	POAUUALSNYEBRU-UHFFFAOYSA-N	416983	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-isobutyramido-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 244j::US10633345, Compound 244j::US10689346, Compound 244j::US11203574, Compound 244j::US11685721, Compound 244j	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416983	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416983&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356184	433916895							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835523	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-23-9-8-20(28(35,11-10-18-6-7-18)21-4-2-12-36-17-21)14-24(23)37-27(40)25-15-26(29(31,32)33)38-39(25)22-5-1-3-19(13-22)16-34/h1-5,8-9,12-15,17-18H,6-7,10-11,16,34-35H2,(H,37,40)	QXMQDWOYOXVOQZ-UHFFFAOYSA-N	416984	(+-)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 209d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416984	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416984&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355646	433916896							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835524	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)[C@@H](NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C31H26F4N6O/c32-24-11-9-21(28(38-17-18-6-7-18)20-4-2-1-3-5-20)14-25(24)39-30(42)26-16-27(31(33,34)35)40-41(26)22-10-8-19-12-13-37-29(36)23(19)15-22/h1-5,8-16,18,28,38H,6-7,17H2,(H2,36,37)(H,39,42)/t28-/m0/s1	OUKVDAXUKVLTKB-NDEPHWFRSA-N	416985	(&#8722;)-1-(1-aminoisoquinolin-7-yl)-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 235g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416985	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416985&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			154584233	433916897							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835525	CC(C)CC(=O)NC(CCC1CC1)(c1cccnc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H36F4N6O2/c1-21(2)15-31(45)42-33(13-12-22-8-9-22,25-6-4-14-40-20-25)24-10-11-27(35)28(17-24)41-32(46)29-18-30(34(36,37)38)43-44(29)26-7-3-5-23(16-26)19-39/h3-7,10-11,14,16-18,20-22H,8-9,12-13,15,19,39H2,1-2H3,(H,41,46)(H,42,45)	WIIQCCUTLYCVOE-UHFFFAOYSA-N	416986	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(3-methylbutanamido)-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 244k::US10633345, Compound 244k::US10689346, Compound 244k::US11203574, Compound 244k::US11230530, Compound 244k::US11685721, Compound 244k	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416986	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416986&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665507	433916898							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835526	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F4N5O/c31-24-12-11-22(29(36,14-13-19-9-10-19)21-6-2-1-3-7-21)16-25(24)37-28(40)26-17-27(30(32,33)34)38-39(26)23-8-4-5-20(15-23)18-35/h1-8,11-12,15-17,19H,9-10,13-14,18,35-36H2,(H,37,40)	NQFNNZJJOCPZCP-UHFFFAOYSA-N	416987	(+-)-N-(5-(1-amino-3-cyclopropyl-1-phenylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 210d::US10633345, Compound 211d::US10689346, Compound 211d::US11203574, Compound 211d::US11230530, Compound 211d::US11685721, Compound 211d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416987	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416987&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355764	433916899							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835527	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(N)(CCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C31H29F3N6O/c32-31(33,34)28-17-27(40(39-28)26-6-1-3-22(15-26)19-36)29(41)38-25-5-2-4-24(16-25)30(37,14-13-20-7-8-20)23-11-9-21(18-35)10-12-23/h1-6,9-12,15-17,20H,7-8,13-14,19,36-37H2,(H,38,41)	WPWCLOAAAHRQMG-UHFFFAOYSA-N	416988	(+)-N-(3-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)phenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 218c::US10633345, Compound 218c::US10689346, Compound 218c::US11203574, Compound 218c::US11230530, Compound 218c::US11685721, Compound 218c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416988	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416988&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356070	433916900							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835528	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C31H27F4N7O/c32-24-6-4-21(30(37,11-7-18-1-2-18)20-9-12-38-13-10-20)15-25(24)40-29(43)26-17-27(31(33,34)35)41-42(26)22-5-3-19-8-14-39-28(36)23(19)16-22/h3-6,8-10,12-18H,1-2,7,11,37H2,(H2,36,39)(H,40,43)	BGYDOWYGLFEYGE-UHFFFAOYSA-N	416989	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-4-yl)propyl)-2-fluorophenyl)-1-(1-aminoisoquinolin-7-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 253e::US10633345, Compound 253e::US10689346, Compound 253e::US11203574, Compound 253e::US11230530, Compound 253e::US11685721, Compound 253e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416989	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416989&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665703	433916901							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835529	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F4N5O/c31-24-12-11-22(29(36,14-13-19-9-10-19)21-6-2-1-3-7-21)16-25(24)37-28(40)26-17-27(30(32,33)34)38-39(26)23-8-4-5-20(15-23)18-35/h1-8,11-12,15-17,19H,9-10,13-14,18,35-36H2,(H,37,40)	NQFNNZJJOCPZCP-UHFFFAOYSA-N	416990	(+)-N-(5-(1-amino-3-cyclopropyl-1-phenylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 211d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416990	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416990&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355764	433916902							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835530	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(N)(CCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C31H29F3N6O/c32-31(33,34)28-17-27(40(39-28)26-9-2-5-22(15-26)19-36)29(41)38-25-8-3-7-24(16-25)30(37,13-12-20-10-11-20)23-6-1-4-21(14-23)18-35/h1-9,14-17,20H,10-13,19,36-37H2,(H,38,41)	JHGXWQQOSIGIHO-UHFFFAOYSA-N	416991	(+)-N-(3-(1-amino-1-(3-cyanophenyl)-3-cyclopropylpropyl)phenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 219c::US10633345, Compound 219c::US10689346, Compound 219c::US11203574, Compound 219c::US11230530, Compound 219c::US11685721, Compound 219c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416991	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416991&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355760	433916903							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835531	CS(=O)(=O)NC(CCC1CC1)(c1ccncc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F4N6O3S/c1-44(42,43)39-29(12-9-19-5-6-19,21-10-13-36-14-11-21)22-7-8-24(31)25(16-22)37-28(41)26-17-27(30(32,33)34)38-40(26)23-4-2-3-20(15-23)18-35/h2-4,7-8,10-11,13-17,19,39H,5-6,9,12,18,35H2,1H3,(H,37,41)	SFWRGGJAWAJGGN-UHFFFAOYSA-N	416992	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(methylsulfonamido)-1-(pyridin-4-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 245c::US10633345, Compound 245c::US10689346, Compound 245c::US11203574, Compound 245c::US11230530, Compound 245c::US11685721, Compound 245c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416992	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416992&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355707	433916904							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835532	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C31H28F4N6O/c32-25-11-10-23(30(38,13-12-19-4-5-19)22-8-6-20(17-36)7-9-22)15-26(25)39-29(42)27-16-28(31(33,34)35)40-41(27)24-3-1-2-21(14-24)18-37/h1-3,6-11,14-16,19H,4-5,12-13,18,37-38H2,(H,39,42)	JCBKPNPCGNTAQN-UHFFFAOYSA-N	416993	(+)-N-(5-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 212g::US10633345, Compound 213d::US10689346, Compound 213d::US11203574, Compound 213d::US11230530, Compound 213d::US11685721, Compound 213d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416993	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416993&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356170	433916905							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835388	NCc1cccc(c1)N(CC1CC1)Cc1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H31F3N6O/c31-30(32,33)28-15-27(39(37-28)26-9-3-5-22(14-26)17-35)29(40)36-24-7-1-6-23(12-24)19-38(18-20-10-11-20)25-8-2-4-21(13-25)16-34/h1-9,12-15,20H,10-11,16-19,34-35H2,(H,36,40)	KWKGWXUNXWXADH-UHFFFAOYSA-N	416849	1-(3-(Aminomethyl)phenyl)-N-(3-((3-(aminomethyl)phenyl)(cyclopropylmethylamino) methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 108e::US11685721, Compound 108e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416849	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416849&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			154584226	433916762							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835389	CCCOc1ccc(cc1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C32H34F3N5O2/c1-2-15-42-27-13-11-23(12-14-27)30(37-20-21-9-10-21)24-6-4-7-25(17-24)38-31(41)28-18-29(32(33,34)35)39-40(28)26-8-3-5-22(16-26)19-36/h3-8,11-14,16-18,21,30,37H,2,9-10,15,19-20,36H2,1H3,(H,38,41)	BSIABEDKJHMBRX-UHFFFAOYSA-N	416850	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic acid {3-[(cyclopropylmethyl-amino)-(4-propoxy-phenyl)-methyl]-phenyl}-amide::US10329260, Compound 127f::US10633345, Compound 127f::US10689346, Compound 127f::US11203574, Compound 127f::US11230530, Compound 127f::US11685721, Compound 127f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416850	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416850&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356061	433916763							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835390	CC(C)NC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C28H28F3N5O/c1-18(2)33-26(20-9-4-3-5-10-20)21-11-7-12-22(15-21)34-27(37)24-16-25(28(29,30)31)35-36(24)23-13-6-8-19(14-23)17-32/h3-16,18,26,33H,17,32H2,1-2H3,(H,34,37)	XNDGACONQUBLGK-UHFFFAOYSA-N	416851	1-(3-(Aminomethyl)phenyl)-N-(3-((isopropylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 144d::US10633345, Compound 144d::US10689346, Compound 144d::US11203574, Compound 144d::US11230530, Compound 144d::US11685721, Compound 144d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416851	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416851&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355596	433916764							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835391	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCCO)c1ccccc1)C(F)(F)F	InChI=1S/C27H26F3N5O2/c28-27(29,30)24-16-23(35(34-24)22-11-4-6-18(14-22)17-31)26(37)33-21-10-5-9-20(15-21)25(32-12-13-36)19-7-2-1-3-8-19/h1-11,14-16,25,32,36H,12-13,17,31H2,(H,33,37)	MMNKSYPQOFLCSY-UHFFFAOYSA-N	416852	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic acid {3-[(2-hydroxy-ethylamino)-phenyl-methyl]-phenyl}-amide::US10329260, Compound 145c::US10633345, Compound 145c::US10689346, Compound 145c::US11203574, Compound 145c::US11230530, Compound 145c::US11685721, Compound 145c	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416852	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416852&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123569320	433916765							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835392	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-10-9-20(27(40-16-17-7-8-17)19-4-2-5-21(35)12-19)13-24(23)36-28(39)25-14-26(29(31,32)33)37-38(25)22-6-1-3-18(11-22)15-34/h1-6,9-14,17,27H,7-8,15-16,34-35H2,(H,36,39)	GBDDXSAKQKODCG-UHFFFAOYSA-N	416853	1-(3-(aminomethyl)phenyl)-N-(5-((3-aminophenyl)(cyclopropylmethoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 57e::US10633345, Compound 65b::US10689346, Compound 65b::US11203574, Compound 65a::US11230530, Compound 65b::US11685721, Compound 57e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416853	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416853&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355865	433916766							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835393	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(N[C@H]1CC[C@H](O)CC1)c1ccccc1)C(F)(F)F	InChI=1S/C31H32F3N5O2/c32-31(33,34)28-18-27(39(38-28)25-11-4-6-20(16-25)19-35)30(41)37-24-10-5-9-22(17-24)29(21-7-2-1-3-8-21)36-23-12-14-26(40)15-13-23/h1-11,16-18,23,26,29,36,40H,12-15,19,35H2,(H,37,41)/t23-,26-,29?	QCYULPRIJNBHAA-APJPSQSRSA-N	416854	1-(3-(Aminomethyl)phenyl)-N-(3-((((trans)-4-hydroxycyclohexyl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 181b::US10633345, Compound 181b::US10689346, Compound 181b::US11203574, Compound 181b::US11230530, Compound 181b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416854	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416854&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665446	433916767							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835394	Cc1cc(C(=O)Nc2cccc(c2)C(NCC2CC2)c2cc(O)ccc2O)n(n1)-c1cccc(CN)c1	InChI=1S/C29H31N5O3/c1-18-12-26(34(33-18)23-7-2-4-20(13-23)16-30)29(37)32-22-6-3-5-21(14-22)28(31-17-19-8-9-19)25-15-24(35)10-11-27(25)36/h2-7,10-15,19,28,31,35-36H,8-9,16-17,30H2,1H3,(H,32,37)	LPEUWRVJEWZQCO-UHFFFAOYSA-N	416855	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2,5-dihydroxyphenyl)methyl) phenyl)-3-methyl-1H-pyrazole-5-carboxamide::US10329260, Compound 146g::US10633345, Compound 146g::US10689346, Compound 146g::US11203574, Compound 146g::US11230530, Compound 146g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416855	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416855&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356064	433916768							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835395	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1O)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-11-10-19(27(35-16-17-8-9-17)21-6-1-2-7-25(21)39)13-23(22)36-28(40)24-14-26(29(31,32)33)37-38(24)20-5-3-4-18(12-20)15-34/h1-7,10-14,17,27,35,39H,8-9,15-16,34H2,(H,36,40)	CKWWRAGQIQAYTL-UHFFFAOYSA-N	416856	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(2-hydroxyphenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 60e::US10633345, Compound 66b::US10689346, Compound 60e::US11203574, Compound 66b::US11230530, Compound 66b::US11685721, Compound 60e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416856	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416856&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665480	433916769							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835396	CC(O)CNC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C28H28F3N5O2/c1-18(37)17-33-26(20-8-3-2-4-9-20)21-10-6-11-22(14-21)34-27(38)24-15-25(28(29,30)31)35-36(24)23-12-5-7-19(13-23)16-32/h2-15,18,26,33,37H,16-17,32H2,1H3,(H,34,38)	XWEXCUNXVFBKNX-UHFFFAOYSA-N	416857	1-(3-(aminomethyl)phenyl)-N-(3-(((2-hydroxypropyl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 182b::US10633345, Compound 182b::US10689346, Compound 182b::US11203574, Compound 182b::US11230530, Compound 182b::US11685721, Compound 182b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416857	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416857&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355690	433916770							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835397	CC(=O)Nc1ccc(cc1)C(OCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C31H30F3N5O3/c1-19(40)36-24-12-10-22(11-13-24)29(42-18-20-8-9-20)23-5-3-6-25(15-23)37-30(41)27-16-28(31(32,33)34)38-39(27)26-7-2-4-21(14-26)17-35/h2-7,10-16,20,29H,8-9,17-18,35H2,1H3,(H,36,40)(H,37,41)	AETJNKBVQDZIDV-UHFFFAOYSA-N	416858	N-(3-((4-acetamidophenyl)(cyclopropylmethoxy)methyl)phenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 147e::US10633345, Compound 147e::US10689346, Compound 147e::US11203574, Compound 147e::US11230530, Compound 147e::US11685721, Compound 147e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416858	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416858&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355828	433916771							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835398	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)[C@@H](NCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C30H26F4N6O/c31-24-11-10-22(28(37-17-19-4-5-19)21-8-6-18(15-35)7-9-21)13-25(24)38-29(41)26-14-27(30(32,33)34)39-40(26)23-3-1-2-20(12-23)16-36/h1-3,6-14,19,28,37H,4-5,16-17,36H2,(H,38,41)/t28-/m0/s1	GLPWOIBPISJWCH-NDEPHWFRSA-N	416859	US10329260, Compound 71a::chiral isomer-1 1-(3-(aminomethyl)phenyl)-N-(5-((4-cyanophenyl)(cyclopropyl-methylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416859	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416859&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			154584227	433916772							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835399	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCCCn1ccnc1)c1ccccc1)C(F)(F)F	InChI=1S/C31H30F3N7O/c32-31(33,34)28-19-27(41(39-28)26-12-4-7-22(17-26)20-35)30(42)38-25-11-5-10-24(18-25)29(23-8-2-1-3-9-23)37-13-6-15-40-16-14-36-21-40/h1-5,7-12,14,16-19,21,29,37H,6,13,15,20,35H2,(H,38,42)	XJDJXHWYZLFIJY-UHFFFAOYSA-N	416860	N-(3-(((3-(1H-Imidazol-1-yl)propyl)amino)(phenyl)methyl)phenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 183b::US10633345, Compound 183b::US10689346, Compound 183b::US11203574, Compound 183b::US11230530, Compound 183b::US11685721, Compound 183b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416860	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416860&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665638	433916773							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835533	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C(N)=O)C#N	InChI=1S/C31H30FN7O2/c32-26-11-10-23(31(36,13-12-19-4-5-19)22-8-6-21(7-9-22)29(35)40)15-27(26)37-30(41)28-16-24(18-34)38-39(28)25-3-1-2-20(14-25)17-33/h1-3,6-11,14-16,19H,4-5,12-13,17,33,36H2,(H2,35,40)(H,37,41)	KLZOEGIZCNFTHC-UHFFFAOYSA-N	416994	(-)-N-(5-(1-amino-1-(4-carbamoylphenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-cyano-1H-pyrazole-5-carboxamide::US10329260, Compound 239d::US10633345, Compound 239c::US10689346, Compound 239d::US11203574, Compound 239d::US11685721, Compound 239d	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416994	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416994&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356225	433916906							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835534	CN(C(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)c2cc(nn2-c2ccc3ccnc(N)c3c2)C(F)(F)F)c1)C1CC1	InChI=1S/C32H25F4N7O/c1-42(22-8-9-22)29(20-4-2-3-18(13-20)17-37)21-6-10-25(33)26(14-21)40-31(44)27-16-28(32(34,35)36)41-43(27)23-7-5-19-11-12-39-30(38)24(19)15-23/h2-7,10-16,22,29H,8-9H2,1H3,(H2,38,39)(H,40,44)	UKFKVRZKIXONGS-UHFFFAOYSA-N	416995	(+)-1-(1-aminoisoquinolin-7-yl)-N-(5-((3-cyanophenyl)(cyclopropyl methylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 257b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416995	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416995&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665470	433916907							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835535	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C31H28F4N6O/c32-25-10-9-23(30(38,12-11-19-7-8-19)22-5-1-3-20(13-22)17-36)15-26(25)39-29(42)27-16-28(31(33,34)35)40-41(27)24-6-2-4-21(14-24)18-37/h1-6,9-10,13-16,19H,7-8,11-12,18,37-38H2,(H,39,42)	ZBDDMFBNDOEVJT-UHFFFAOYSA-N	416996	(+)-N-(5-(1-amino-1-(3-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 214g::US10633345, Compound 215d::US10689346, Compound 215d::US11203574, Compound 215d::US11230530, Compound 215d::US11685721, Compound 215d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416996	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416996&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665709	433916908							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835536	NC(=O)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C31H26F4N6O2/c32-24-10-9-22(30(38,12-11-18-7-8-18)21-5-1-3-19(13-21)17-36)15-25(24)39-29(43)26-16-27(31(33,34)35)40-41(26)23-6-2-4-20(14-23)28(37)42/h1-6,9-10,13-16,18H,7-8,11-12,38H2,(H2,37,42)(H,39,43)	MJBRNYICMOSPEH-UHFFFAOYSA-N	416997	(+-)-N-(5-(1-amino-1-(3-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-carbamoylphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 267c::US10633345, Compound 267c::US10689346, Compound 267c::US11203574, Compound 267c::US11230530, Compound 267c::US11685721, Compound 267c	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416997	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416997&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665760	433916909							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835537	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C33H27F4N7O/c34-26-10-8-23(32(40,13-11-19-1-2-19)22-6-3-20(18-38)4-7-22)15-27(26)42-31(45)28-17-29(33(35,36)37)43-44(28)24-9-5-21-12-14-41-30(39)25(21)16-24/h3-10,12,14-17,19H,1-2,11,13,40H2,(H2,39,41)(H,42,45)	QUIZETAQJOZQJA-UHFFFAOYSA-N	416998	(+)-N-(5-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(1-aminoisoquinolin-7-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 254c::US10633345, Compound 254c::US10689346, Compound 254c::US11203574, Compound 254c::US11230530, Compound 254c::US11685721, Compound 254c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416998	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416998&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665477	433916910							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835538	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C31H28F4N6O/c32-25-11-10-23(30(38,13-12-19-4-5-19)22-8-6-20(17-36)7-9-22)15-26(25)39-29(42)27-16-28(31(33,34)35)40-41(27)24-3-1-2-21(14-24)18-37/h1-3,6-11,14-16,19H,4-5,12-13,18,37-38H2,(H,39,42)	JCBKPNPCGNTAQN-UHFFFAOYSA-N	416999	(+-)-N-(5-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 213d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416999	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416999&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356170	433916911							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835539	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C#N	InChI=1S/C29H27FN6O/c30-25-12-11-22(28(33-18-19-9-10-19)21-6-2-1-3-7-21)14-26(25)34-29(37)27-15-23(17-32)35-36(27)24-8-4-5-20(13-24)16-31/h1-8,11-15,19,28,33H,9-10,16,18,31H2,(H,34,37)	OBANZZDEWOCPST-UHFFFAOYSA-N	417000	(+-)-1-(3-(aminomethyl)phenyl)-3-cyano-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 240b::US10633345, Compound 240b::US10689346, Compound 240b::US11203574, Compound 240b::US11230530, Compound 240b::US11685721, Compound 240b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417000	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417000&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355661	433916912							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835540	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C32H28F4N6O/c33-25-11-9-22(31(38,14-12-19-6-7-19)21-4-2-1-3-5-21)16-26(25)40-30(43)27-18-28(32(34,35)36)41-42(27)23-10-8-20-13-15-39-29(37)24(20)17-23/h1-5,8-11,13,15-19H,6-7,12,14,38H2,(H2,37,39)(H,40,43)	SUIQVQQNEUOJQB-UHFFFAOYSA-N	417001	(+)-N-(5-(1-amino-3-cyclopropyl-1-phenylpropyl)-2-fluorophenyl)-1-(1-aminoisoquinolin-7-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 255a::US10633345, Compound 255a::US10689346, Compound 255a::US11203574, Compound 255a::US11230530, Compound 255a::US11685721, Compound 255a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417001	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417001&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356059	433916913							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835541	Nc1noc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H24F4N6O2/c30-21-10-8-18(26(35-15-16-6-7-16)17-4-2-1-3-5-17)12-22(21)36-28(40)23-14-25(29(31,32)33)37-39(23)19-9-11-24-20(13-19)27(34)38-41-24/h1-5,8-14,16,26,35H,6-7,15H2,(H2,34,38)(H,36,40)	QWKNFIFTTXOPHF-UHFFFAOYSA-N	417002	(+-)-1-(3-aminobenzo[d]isoxazol-5-yl)-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 222k::US10329260, Compound 223f::US10633345, Compound 223f::US10689346, Compound 223f::US11203574, Compound 223f::US11230530, Compound 223f::US11685721, Compound 223f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417002	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417002&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123289526	433916914							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835542	NC(=N)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C30H25F4N7O/c31-23-10-9-20(27(38-16-17-7-8-17)19-4-1-3-18(11-19)15-35)13-24(23)39-29(42)25-14-26(30(32,33)34)40-41(25)22-6-2-5-21(12-22)28(36)37/h1-6,9-14,17,27,38H,7-8,16H2,(H3,36,37)(H,39,42)	VIRFLKJDRZOSPM-UHFFFAOYSA-N	417003	(+)-1-(3-carbamimidoylphenyl)-N-(5-((3-cyanophenyl)(cyclopropylmethylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 236h::US10633345, Compound 236h::US10689346, Compound 236h::US11203574, Compound 236h::US11230530, Compound 236h::US11685721, Compound 236h	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417003	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417003&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665908	433916915							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835543	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C30H25F4N7O/c31-23-6-4-20(27(38-16-17-1-2-17)19-7-10-36-11-8-19)13-24(23)39-29(42)25-15-26(30(32,33)34)40-41(25)21-5-3-18-9-12-37-28(35)22(18)14-21/h3-15,17,27,38H,1-2,16H2,(H2,35,37)(H,39,42)	UQWHIYYZYLIMKJ-UHFFFAOYSA-N	417004	(+-)-1-(1-aminoisoquinolin-7-yl)-N-(5-((cyclopropylmethylamino)(pyridin-4-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 265d::US10633345, Compound 264g::US10689346, Compound 264g::US11203574, Compound 264g::US11230530, Compound 264g::US11685721, Compound 264g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417004	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417004&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355979	433916916							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835544	Nc1noc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H24F4N6O2/c30-21-10-8-18(26(35-15-16-6-7-16)17-4-2-1-3-5-17)12-22(21)36-28(40)23-14-25(29(31,32)33)37-39(23)19-9-11-24-20(13-19)27(34)38-41-24/h1-5,8-14,16,26,35H,6-7,15H2,(H2,34,38)(H,36,40)	QWKNFIFTTXOPHF-UHFFFAOYSA-N	417002	(+-)-1-(3-aminobenzo[d]isoxazol-5-yl)-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 222k::US10329260, Compound 223f::US10633345, Compound 223f::US10689346, Compound 223f::US11203574, Compound 223f::US11230530, Compound 223f::US11685721, Compound 223f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417002	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417002&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123289526	433916914							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835545	NC(=N)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C31H27F4N7O/c32-24-10-9-22(30(39,12-11-18-7-8-18)21-5-1-3-19(13-21)17-36)15-25(24)40-29(43)26-16-27(31(33,34)35)41-42(26)23-6-2-4-20(14-23)28(37)38/h1-6,9-10,13-16,18H,7-8,11-12,39H2,(H3,37,38)(H,40,43)	BZRUVEYOOHPOOF-UHFFFAOYSA-N	417006	(+)-N-(5-(1-amino-1-(3-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-carbamimidoylphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 237a::US10633345, Compound 237a::US10689346, Compound 237a::US11192861, Compound 237a::US11230530, Compound 237a::US11685721, Compound 237a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417006	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417006&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356202	433916917							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835546	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C33H27F4N7O/c34-26-9-7-23(32(40,12-10-19-4-5-19)22-3-1-2-20(14-22)18-38)15-27(26)42-31(45)28-17-29(33(35,36)37)43-44(28)24-8-6-21-11-13-41-30(39)25(21)16-24/h1-3,6-9,11,13-17,19H,4-5,10,12,40H2,(H2,39,41)(H,42,45)	MNAPHYKXZOGSTD-UHFFFAOYSA-N	417007	(+)-N-(5-(1-amino-1-(3-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(1-aminoisoquinolin-7-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 256a::US10633345, Compound 256a::US10689346, Compound 256a::US11203574, Compound 256a::US11230530, Compound 256a::US11685721, Compound 256a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417007	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417007&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665459	433916918							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835400	COc1ccc2ccccc2c1C(OCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H31F3N4O3/c1-43-29-15-14-23-7-2-3-11-27(23)31(29)32(44-20-21-12-13-21)24-8-5-9-25(17-24)39-33(42)28-18-30(34(35,36)37)40-41(28)26-10-4-6-22(16-26)19-38/h2-11,14-18,21,32H,12-13,19-20,38H2,1H3,(H,39,42)	YJZQWEYZTCABEY-UHFFFAOYSA-N	416861	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(2-methoxynaphthalen-1-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 148b::US10633345, Compound 148b::US10689346, Compound 148b::US11203574, Compound 148b::US11230530, Compound 148b::US11685721, Compound 148b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416861	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416861&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665874	433916774							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835401	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)[C@H](NCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C30H26F4N6O/c31-24-11-10-22(28(37-17-19-4-5-19)21-8-6-18(15-35)7-9-21)13-25(24)38-29(41)26-14-27(30(32,33)34)39-40(26)23-3-1-2-20(12-23)16-36/h1-3,6-14,19,28,37H,4-5,16-17,36H2,(H,38,41)/t28-/m1/s1	GLPWOIBPISJWCH-MUUNZHRXSA-N	416862	US10329260, Compound 71b::chiral isomer-2 1-(3-(aminomethyl)phenyl)-N-(5-((4-cyanophenyl)(cyclopropyl-methylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416862	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416862&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			154584228	433916775							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835402	CN(C)C(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C27H26F3N5O/c1-34(2)25(19-9-4-3-5-10-19)20-11-7-12-21(15-20)32-26(36)23-16-24(27(28,29)30)33-35(23)22-13-6-8-18(14-22)17-31/h3-16,25H,17,31H2,1-2H3,(H,32,36)	BIAJBXPGRHVMIB-UHFFFAOYSA-N	416863	1-(3-(Aminomethyl)phenyl)-N-(3-((dimethylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 184b::US10633345, Compound 184b::US10689346, Compound 184b::US11203574, Compound 184b::US11230530, Compound 184b::US11685721, Compound 184b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416863	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416863&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356007	433916776							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835403	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccc(O)cc1)C(F)(F)F	InChI=1S/C29H27F3N4O3/c30-29(31,32)26-15-25(36(35-26)23-6-1-3-19(13-23)16-33)28(38)34-22-5-2-4-21(14-22)27(39-17-18-7-8-18)20-9-11-24(37)12-10-20/h1-6,9-15,18,27,37H,7-8,16-17,33H2,(H,34,38)	WIBHWKLQWUWRRF-UHFFFAOYSA-N	416864	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(4-hydroxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 149b::US10633345, Compound 149b::US10689346, Compound 149b::US11203574, Compound 149b::US11230530, Compound 149b::US11685721, Compound 149b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416864	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416864&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665542	433916777							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835404	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)[C@H](OCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-10-9-20(27(40-16-17-7-8-17)19-4-2-5-21(35)12-19)13-24(23)36-28(39)25-14-26(29(31,32)33)37-38(25)22-6-1-3-18(11-22)15-34/h1-6,9-14,17,27H,7-8,15-16,34-35H2,(H,36,39)/t27-/m1/s1	GBDDXSAKQKODCG-HHHXNRCGSA-N	416865	US10329260, Compound 65a::chiral isomer-1 1-(3-(aminomethyl)phenyl)-N-(5-((3-aminophenyl)(cyclopropylmethoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416865	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416865&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			154584229	433916778							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835405	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NC1CCCCC1)c1ccccc1)C(F)(F)F	InChI=1S/C31H32F3N5O/c32-31(33,34)28-19-27(39(38-28)26-16-7-9-21(17-26)20-35)30(40)37-25-15-8-12-23(18-25)29(22-10-3-1-4-11-22)36-24-13-5-2-6-14-24/h1,3-4,7-12,15-19,24,29,36H,2,5-6,13-14,20,35H2,(H,37,40)	MXMWHPZXCVOSEY-UHFFFAOYSA-N	416866	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclohexylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 185b::US10633345, Compound 185b::US10689346, Compound 185b::US11203574, Compound 185b::US11230530, Compound 185b::US11685721, Compound 185b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416866	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416866&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356164	433916779							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835406	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-25(37(36-26)24-9-1-4-19(12-24)16-33)28(38)35-23-8-3-6-21(14-23)27(39-17-18-10-11-18)20-5-2-7-22(34)13-20/h1-9,12-15,18,27H,10-11,16-17,33-34H2,(H,35,38)	FPQYUIIRVBKUDH-UHFFFAOYSA-N	416867	1-(3-(aminomethyl)phenyl)-N-(3-((3-aminophenyl)(cyclopropyl-methoxy)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 53f::US10633345, Compound 53f::US10689346, Compound 53f::US11203574, Compound 64b::US11230530, Compound 64b::US11685721, Compound 49j	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416867	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416867&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355845	433916780							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835407	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)[C@@H](OCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-10-9-20(27(40-16-17-7-8-17)19-4-2-5-21(35)12-19)13-24(23)36-28(39)25-14-26(29(31,32)33)37-38(25)22-6-1-3-18(11-22)15-34/h1-6,9-14,17,27H,7-8,15-16,34-35H2,(H,36,39)/t27-/m0/s1	GBDDXSAKQKODCG-MHZLTWQESA-N	416868	US10329260, Compound 65b::chiral isomer-2 1-(3-(aminomethyl)phenyl)-N-(5-((3-aminophenyl)(cyclopropylmethoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416868	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416868&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			154584230	433916781							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835408	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCc1ccncc1)c1ccccc1)C(F)(F)F	InChI=1S/C31H27F3N6O/c32-31(33,34)28-18-27(40(39-28)26-11-4-6-22(16-26)19-35)30(41)38-25-10-5-9-24(17-25)29(23-7-2-1-3-8-23)37-20-21-12-14-36-15-13-21/h1-18,29,37H,19-20,35H2,(H,38,41)	PXKQYONQBKMAKS-UHFFFAOYSA-N	416869	1-(3-(Aminomethyl)phenyl)-N-(3-(phenyl((pyridin-4-ylmethyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 186b::US10633345, Compound 186b::US10689346, Compound 186b::US11203574, Compound 186b::US11230530, Compound 186b::US11685721, Compound 186b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416869	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416869&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665494	433916782							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835409	Cc1cc(C(=O)Nc2cccc(c2)C(NCC2CC2)c2cccc(O)c2O)n(n1)-c1cccc(CN)c1	InChI=1S/C29H31N5O3/c1-18-13-25(34(33-18)23-8-2-5-20(14-23)16-30)29(37)32-22-7-3-6-21(15-22)27(31-17-19-11-12-19)24-9-4-10-26(35)28(24)36/h2-10,13-15,19,27,31,35-36H,11-12,16-17,30H2,1H3,(H,32,37)	VPKURNQNFXHFDB-UHFFFAOYSA-N	416870	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2,3-dihydroxyphenyl)methyl)phenyl)-3-methyl-1H-pyrazole-5-carboxamide::US10329260, Compound 150f::US10633345, Compound 150f::US10689346, Compound 150f::US11203574, Compound 150f::US11230530, Compound 150f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416870	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416870&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355949	433916783							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835410	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc2OCOc12)C(F)(F)F	InChI=1S/C30H28F3N5O3/c31-30(32,33)26-14-24(38(37-26)22-7-1-4-19(12-22)15-34)29(39)36-21-6-2-5-20(13-21)27(35-16-18-10-11-18)23-8-3-9-25-28(23)41-17-40-25/h1-9,12-14,18,27,35H,10-11,15-17,34H2,(H,36,39)	FVRZDZZJKCSOIR-UHFFFAOYSA-N	416871	1-(3-(aminomethyl)phenyl)-N-(3-(benzo[d][1,3]dioxol-4-yl(cyclopropylmethylamino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 192f::US10633345, Compound 192f::US10689346, Compound 192f::US11203574, Compound 192f::US11230530, Compound 192f::US11685721, Compound 192f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416871	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416871&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665720	433916784							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835465	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C30H26F4N6O/c31-24-10-9-22(28(37-17-18-7-8-18)21-5-1-3-19(11-21)15-35)13-25(24)38-29(41)26-14-27(30(32,33)34)39-40(26)23-6-2-4-20(12-23)16-36/h1-6,9-14,18,28,37H,7-8,16-17,36H2,(H,38,41)	UXNXMBYCBRBRFD-UHFFFAOYSA-N	416926	(+)-1-(3-(aminomethyl)phenyl)-N-(5-((3-cyanophenyl)(cyclopropyl-methylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 70a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416926	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416926&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	0RI	7N7X	118355809	433916838							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835466	COc1ccc(cc1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H26F4N4O3/c1-40-21-10-8-20(9-11-21)37-24(17-26(36-37)29(31,32)33)27(38)35-23-16-19(7-12-22(23)30)28(39,14-13-18-5-6-18)25-4-2-3-15-34-25/h2-4,7-12,15-18,39H,5-6,13-14H2,1H3,(H,35,38)	YTPYYUUEYRYYOR-UHFFFAOYSA-N	416927	N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-1-(4-methoxyphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 160a::US10633345, Compound 160a::US10689346, Compound 160a::US11203574, Compound 160a::US11230530, Compound 160a::US11685721, Compound 160a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416927	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416927&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665840	433916839							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835467	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C28H26F3N5O2/c29-28(30,31)25-15-24(36(35-25)22-8-3-5-19(13-22)16-32)27(37)34-21-7-4-6-20(14-21)26(38-17-18-10-11-18)23-9-1-2-12-33-23/h1-9,12-15,18,26H,10-11,16-17,32H2,(H,34,37)	UBQUVYTUKOFUOF-UHFFFAOYSA-N	416928	(+)-1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(pyridin-2-yl)methyl)-phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 43h	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416928	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416928&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355947	433916840							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835468	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C30H26F4N6O/c31-24-10-9-22(28(37-17-18-7-8-18)21-5-1-3-19(11-21)15-35)13-25(24)38-29(41)26-14-27(30(32,33)34)39-40(26)23-6-2-4-20(12-23)16-36/h1-6,9-14,18,28,37H,7-8,16-17,36H2,(H,38,41)	UXNXMBYCBRBRFD-UHFFFAOYSA-N	416929	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-((3-cyanophenyl)(cyclopropyl-methylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 70b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416929	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416929&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	0RI	7N7X	118355809	433916841							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835469	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(O)c(Br)c1)C(F)(F)F	InChI=1S/C29H27BrF3N5O2/c30-23-13-20(9-10-25(23)39)27(35-16-17-7-8-17)19-4-2-5-21(12-19)36-28(40)24-14-26(29(31,32)33)37-38(24)22-6-1-3-18(11-22)15-34/h1-6,9-14,17,27,35,39H,7-8,15-16,34H2,(H,36,40)	VZKYGMDBRSVHHT-UHFFFAOYSA-N	416930	1-(3-(Aminomethyl)phenyl)-N-(3-((3-bromo-4-hydroxyphenyl)(cyclopropylmethylamino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 207j::US10633345, Compound 207j::US10689346, Compound 207j::US11203574, Compound 207j::US11230530, Compound 207j::US11685721, Compound 207j	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416930	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416930&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665574	433916842							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835470	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H26F3N5O2/c29-28(30,31)25-14-24(36(35-25)23-8-1-4-19(12-23)15-32)27(37)34-22-7-2-5-20(13-22)26(38-17-18-9-10-18)21-6-3-11-33-16-21/h1-8,11-14,16,18,26H,9-10,15,17,32H2,(H,34,37)	SHFRWTHPPCXLER-UHFFFAOYSA-N	416931	(+)-1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(pyridin-3-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 44d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416931	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416931&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355578	433916843							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835471	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-10-9-20(28(40,12-11-18-7-8-18)25-6-1-2-13-35-25)15-23(22)36-27(39)24-16-26(29(31,32)33)37-38(24)21-5-3-4-19(14-21)17-34/h1-6,9-10,13-16,18,40H,7-8,11-12,17,34H2,(H,36,39)	XXMBQXWQIGCREG-UHFFFAOYSA-N	416932	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 69a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416932	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416932&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356067	433916844							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835472	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CCC1CC1)n1ccccc1=O)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-17-25(37(35-26)23-8-3-5-20(15-23)18-33)28(39)34-22-7-4-6-21(16-22)24(13-12-19-10-11-19)36-14-2-1-9-27(36)38/h1-9,14-17,19,24H,10-13,18,33H2,(H,34,39)	OGNFHFCMBSJJNJ-UHFFFAOYSA-N	416933	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-(2-oxopyridin-1(2H)-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 247c::US10633345, Compound 247c::US10689346, Compound 247c::US11203574, Compound 247c::US11230530, Compound 247c::US11685721, Compound 247c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416933	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416933&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356133	433916845							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835473	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H26F3N5O2/c29-28(30,31)25-14-24(36(35-25)23-8-1-4-19(12-23)15-32)27(37)34-22-7-2-5-20(13-22)26(38-17-18-9-10-18)21-6-3-11-33-16-21/h1-8,11-14,16,18,26H,9-10,15,17,32H2,(H,34,37)	SHFRWTHPPCXLER-UHFFFAOYSA-N	416934	(+-)-1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(pyridin-3-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 44e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416934	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416934&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355578	433916846							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835474	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-10-9-20(28(40,12-11-18-7-8-18)25-6-1-2-13-35-25)15-23(22)36-27(39)24-16-26(29(31,32)33)37-38(24)21-5-3-4-19(14-21)17-34/h1-6,9-10,13-16,18,40H,7-8,11-12,17,34H2,(H,36,39)	XXMBQXWQIGCREG-UHFFFAOYSA-N	416935	(+)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 69b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416935	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416935&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356067	433916847							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835475	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CCC1CC1)N1CCCC1=O)C(F)(F)F	InChI=1S/C28H30F3N5O2/c29-28(30,31)25-16-24(36(34-25)22-7-1-4-19(14-22)17-32)27(38)33-21-6-2-5-20(15-21)23(12-11-18-9-10-18)35-13-3-8-26(35)37/h1-2,4-7,14-16,18,23H,3,8-13,17,32H2,(H,33,38)	LEZWAIIPWSOOAE-UHFFFAOYSA-N	416936	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-(2-oxopyrrolidin-1-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 247e::US10633345, Compound 247e::US10689346, Compound 247e::US11203574, Compound 247e::US11230530, Compound 247e::US11685721, Compound 247e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416936	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416936&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665605	433916848							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835476	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-16-25(37(36-26)24-8-1-4-20(14-24)17-33)27(38)35-23-7-2-5-21(15-23)28(39,12-11-19-9-10-19)22-6-3-13-34-18-22/h1-8,13-16,18-19,39H,9-12,17,33H2,(H,35,38)	AOCZEQQKIIWUBU-UHFFFAOYSA-N	416937	(+-)-1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 47g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416937	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416937&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355766	433916849							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835477	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H28F4N4O2/c31-24-12-11-22(29(40,14-13-19-9-10-19)21-6-2-1-3-7-21)16-25(24)36-28(39)26-17-27(30(32,33)34)37-38(26)23-8-4-5-20(15-23)18-35/h1-8,11-12,15-17,19,40H,9-10,13-14,18,35H2,(H,36,39)	NIWMWYNGSALJGG-UHFFFAOYSA-N	416938	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 68d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416938	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416938&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355758	433916850							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835478	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccccc1=O)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-11-10-20(24(12-9-18-7-8-18)37-13-2-1-6-27(37)39)15-23(22)35-28(40)25-16-26(29(31,32)33)36-38(25)21-5-3-4-19(14-21)17-34/h1-6,10-11,13-16,18,24H,7-9,12,17,34H2,(H,35,40)	OFQQGSYWUFBMPP-UHFFFAOYSA-N	416939	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(2-oxopyridin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 248j::US10633345, Compound 248k::US10689346, Compound 248k::US11203574, Compound 248k::US11230530, Compound 248k::US11685721, Compound 248k	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416939	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416939&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355727	433916851							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835479	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-16-25(37(36-26)24-8-1-4-20(14-24)17-33)27(38)35-23-7-2-5-21(15-23)28(39,12-11-19-9-10-19)22-6-3-13-34-18-22/h1-8,13-16,18-19,39H,9-12,17,33H2,(H,35,38)	AOCZEQQKIIWUBU-UHFFFAOYSA-N	416940	(+)-1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 47h	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416940	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416940&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355766	433916852							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835480	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H28F4N4O2/c31-24-12-11-22(29(40,14-13-19-9-10-19)21-6-2-1-3-7-21)16-25(24)36-28(39)26-17-27(30(32,33)34)37-38(26)23-8-4-5-20(15-23)18-35/h1-8,11-12,15-17,19,40H,9-10,13-14,18,35H2,(H,36,39)	NIWMWYNGSALJGG-UHFFFAOYSA-N	416941	(+)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 68e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416941	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416941&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355758	433916853							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835481	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccncc1=O)C(F)(F)F	InChI=1S/C28H26F4N6O2/c29-21-8-7-19(23(9-6-17-4-5-17)37-11-10-34-16-26(37)39)13-22(21)35-27(40)24-14-25(28(30,31)32)36-38(24)20-3-1-2-18(12-20)15-33/h1-3,7-8,10-14,16-17,23H,4-6,9,15,33H2,(H,35,40)	GLPOCDKMIDNWGE-UHFFFAOYSA-N	416942	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(2-oxopyrazin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 249b::US10633345, Compound 249b::US10689346, Compound 249b::US11203574, Compound 249b::US11230530, Compound 249b::US11685721, Compound 249b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416942	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416942&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665736	433916854							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835482	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F3N4O2/c31-30(32,33)27-18-26(37(36-27)25-11-4-6-21(16-25)19-34)28(38)35-24-10-5-9-23(17-24)29(39,15-14-20-12-13-20)22-7-2-1-3-8-22/h1-11,16-18,20,39H,12-15,19,34H2,(H,35,38)	DCGYPXFSNPCKGX-UHFFFAOYSA-N	416943	(+)-1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 46h	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416943	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416943&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355790	433916855							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835483	COc1ccc2ccccc2c1[C@@H](NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H31F4N5O2/c1-45-29-14-12-22-6-2-3-8-25(22)31(29)32(40-19-20-9-10-20)23-11-13-26(35)27(16-23)41-33(44)28-17-30(34(36,37)38)42-43(28)24-7-4-5-21(15-24)18-39/h2-8,11-17,20,32,40H,9-10,18-19,39H2,1H3,(H,41,44)/t32-/m0/s1	AYMFYNZEWAELBE-YTTGMZPUSA-N	416944	(&#8722;)-1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(2-methoxynaphthalen-1-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 63a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416944	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416944&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			154584231	433916856							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
788096	COC(=O)Nc1ccc(cc1)-c1cccc(c1)C(Cc1ccccc1)c1ccc(c[n+]1[O-])-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C34H27ClN6O3/c1-44-34(42)37-29-14-10-24(11-15-29)25-8-5-9-26(19-25)30(18-23-6-3-2-4-7-23)33-16-12-27(21-41(33)43)31-20-28(35)13-17-32(31)40-22-36-38-39-40/h2-17,19-22,30H,18H2,1H3,(H,37,42)	DQMXVKZVAVGVDA-UHFFFAOYSA-N	394128	US9975874, Example 1::US9975874, Example 2::US9975874, Example 3	Plasma kallikrein			 24.4							US Patent		10.7270/Q2M61NK4		aid1798992	US9975874	Mertz, E; Edmondson, SD; Hruza, A; He, J; So, S; Ali, A; Gao, Y	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=394128	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=394128&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118695844	405264238							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
788099	COC(=O)Nc1ccc(cc1)-c1cccc(c1)C(Cc1ccccc1)c1ccc(c[n+]1[O-])-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C34H27ClN6O3/c1-44-34(42)37-29-14-10-24(11-15-29)25-8-5-9-26(19-25)30(18-23-6-3-2-4-7-23)33-16-12-27(21-41(33)43)31-20-28(35)13-17-32(31)40-22-36-38-39-40/h2-17,19-22,30H,18H2,1H3,(H,37,42)	DQMXVKZVAVGVDA-UHFFFAOYSA-N	394128	US9975874, Example 1::US9975874, Example 2::US9975874, Example 3	Plasma kallikrein			 34.3							US Patent		10.7270/Q2M61NK4		aid1798992	US9975874	Mertz, E; Edmondson, SD; Hruza, A; He, J; So, S; Ali, A; Gao, Y	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=394128	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=394128&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118695844	405264238							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
788101	CS(=O)(=O)c1ccc(cc1)-c1cccc(c1)C(Cc1ccccc1)c1ccc(c[n+]1[O-])-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C33H26ClN5O3S/c1-43(41,42)29-14-10-24(11-15-29)25-8-5-9-26(19-25)30(18-23-6-3-2-4-7-23)33-16-12-27(21-39(33)40)31-20-28(34)13-17-32(31)38-22-35-36-37-38/h2-17,19-22,30H,18H2,1H3	UYKJEZDHLCBKRB-UHFFFAOYSA-N	394131	US9975874, Example 4	Plasma kallikrein			 4663							US Patent		10.7270/Q2M61NK4		aid1798992	US9975874	Mertz, E; Edmondson, SD; Hruza, A; He, J; So, S; Ali, A; Gao, Y	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=394131	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=394131&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118860159	405264239							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
788104	CS(=O)(=O)c1ccc(cc1)-c1cccc(c1)[C@H](Cc1ccccc1)c1ccc(c[n+]1[O-])-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C33H26ClN5O3S/c1-43(41,42)29-14-10-24(11-15-29)25-8-5-9-26(19-25)30(18-23-6-3-2-4-7-23)33-16-12-27(21-39(33)40)31-20-28(34)13-17-32(31)38-22-35-36-37-38/h2-17,19-22,30H,18H2,1H3/t30-/m0/s1	UYKJEZDHLCBKRB-PMERELPUSA-N	394133	US9975874, Example 6	Plasma kallikrein			 1112							US Patent		10.7270/Q2M61NK4		aid1798992	US9975874	Mertz, E; Edmondson, SD; Hruza, A; He, J; So, S; Ali, A; Gao, Y	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=394133	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=394133&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118860165	405264241							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
788106	OC(=O)c1cccc(c1)-c1cccc(c1)C(Cc1ccccc1)c1ccc(c[n+]1[O-])-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C33H24ClN5O3/c34-28-13-15-31(38-21-35-36-37-38)30(19-28)27-12-14-32(39(42)20-27)29(16-22-6-2-1-3-7-22)25-10-4-8-23(17-25)24-9-5-11-26(18-24)33(40)41/h1-15,17-21,29H,16H2,(H,40,41)	QHEYZCXINSRRGF-UHFFFAOYSA-N	394134	US9975874, Example 7	Plasma kallikrein			 77.7							US Patent		10.7270/Q2M61NK4		aid1798992	US9975874	Mertz, E; Edmondson, SD; Hruza, A; He, J; So, S; Ali, A; Gao, Y	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=394134	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=394134&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118859665	405264242							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
788108	OC(=O)c1cccc(c1)-c1cccc(c1)[C@@H](Cc1ccccc1)c1ccc(c[n+]1[O-])-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C33H24ClN5O3/c34-28-13-15-31(38-21-35-36-37-38)30(19-28)27-12-14-32(39(42)20-27)29(16-22-6-2-1-3-7-22)25-10-4-8-23(17-25)24-9-5-11-26(18-24)33(40)41/h1-15,17-21,29H,16H2,(H,40,41)/t29-/m1/s1	QHEYZCXINSRRGF-GDLZYMKVSA-N	394135	US9975874, Example 8	Plasma kallikrein			 6921							US Patent		10.7270/Q2M61NK4		aid1798992	US9975874	Mertz, E; Edmondson, SD; Hruza, A; He, J; So, S; Ali, A; Gao, Y	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=394135	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=394135&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118859668	405264243							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
788110	OC(=O)c1cccc(c1)-c1cccc(c1)[C@H](Cc1ccccc1)c1ccc(c[n+]1[O-])-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C33H24ClN5O3/c34-28-13-15-31(38-21-35-36-37-38)30(19-28)27-12-14-32(39(42)20-27)29(16-22-6-2-1-3-7-22)25-10-4-8-23(17-25)24-9-5-11-26(18-24)33(40)41/h1-15,17-21,29H,16H2,(H,40,41)/t29-/m0/s1	QHEYZCXINSRRGF-LJAQVGFWSA-N	394136	US9975874, Example 9	Plasma kallikrein			 24.9							US Patent		10.7270/Q2M61NK4		aid1798992	US9975874	Mertz, E; Edmondson, SD; Hruza, A; He, J; So, S; Ali, A; Gao, Y	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=394136	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=394136&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118859647	405264244							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
788112	OC(=O)c1ccc(cc1)-c1cccc(c1)C(Cc1ccccc1)c1ccc(c[n+]1[O-])-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C33H24ClN5O3/c34-28-14-16-31(38-21-35-36-37-38)30(19-28)27-13-15-32(39(42)20-27)29(17-22-5-2-1-3-6-22)26-8-4-7-25(18-26)23-9-11-24(12-10-23)33(40)41/h1-16,18-21,29H,17H2,(H,40,41)	HFSPXAUCIUBDST-UHFFFAOYSA-N	394137	US9975874, Example 10::US9975874, Example 11::US9975874, Example 12	Plasma kallikrein			 705							US Patent		10.7270/Q2M61NK4		aid1798992	US9975874	Mertz, E; Edmondson, SD; Hruza, A; He, J; So, S; Ali, A; Gao, Y	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=394137	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=394137&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118859635	405264245							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
788114	OC(=O)c1ccc(cc1)-c1cccc(c1)C(Cc1ccccc1)c1ccc(c[n+]1[O-])-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C33H24ClN5O3/c34-28-14-16-31(38-21-35-36-37-38)30(19-28)27-13-15-32(39(42)20-27)29(17-22-5-2-1-3-6-22)26-8-4-7-25(18-26)23-9-11-24(12-10-23)33(40)41/h1-16,18-21,29H,17H2,(H,40,41)	HFSPXAUCIUBDST-UHFFFAOYSA-N	394137	US9975874, Example 10::US9975874, Example 11::US9975874, Example 12	Plasma kallikrein			 276							US Patent		10.7270/Q2M61NK4		aid1798992	US9975874	Mertz, E; Edmondson, SD; Hruza, A; He, J; So, S; Ali, A; Gao, Y	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=394137	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=394137&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118859635	405264245							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
788117	OC(=O)c1cccc(c1)-c1cc(F)cc(c1)C(Cc1ccccc1)c1ccc(c[n+]1[O-])-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C33H23ClFN5O3/c34-27-10-12-31(39-20-36-37-38-39)30(18-27)24-9-11-32(40(43)19-24)29(13-21-5-2-1-3-6-21)26-15-25(16-28(35)17-26)22-7-4-8-23(14-22)33(41)42/h1-12,14-20,29H,13H2,(H,41,42)	IVAAKCWYCWMCGX-UHFFFAOYSA-N	394140	US9975874, Example 13	Plasma kallikrein			 12.0							US Patent		10.7270/Q2M61NK4		aid1798992	US9975874	Mertz, E; Edmondson, SD; Hruza, A; He, J; So, S; Ali, A; Gao, Y	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=394140	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=394140&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118859633	405264246							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
788119	OC(=O)c1cccc(c1)-c1cc(F)cc(c1)[C@H](Cc1ccccc1)c1ccc(c[n+]1[O-])-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C33H23ClFN5O3/c34-27-10-12-31(39-20-36-37-38-39)30(18-27)24-9-11-32(40(43)19-24)29(13-21-5-2-1-3-6-21)26-15-25(16-28(35)17-26)22-7-4-8-23(14-22)33(41)42/h1-12,14-20,29H,13H2,(H,41,42)/t29-/m0/s1	IVAAKCWYCWMCGX-LJAQVGFWSA-N	394141	US9975874, Example 14	Plasma kallikrein			 19.1							US Patent		10.7270/Q2M61NK4		aid1798992	US9975874	Mertz, E; Edmondson, SD; Hruza, A; He, J; So, S; Ali, A; Gao, Y	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=394141	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=394141&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118859670	405264247							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
788122	NC(=O)c1cccc(c1)-c1cc(F)cc(c1)[C@H](Cc1ccccc1)c1ccc(c[n+]1[O-])-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C33H24ClFN6O2/c34-27-10-12-31(40-20-37-38-39-40)30(18-27)24-9-11-32(41(43)19-24)29(13-21-5-2-1-3-6-21)26-15-25(16-28(35)17-26)22-7-4-8-23(14-22)33(36)42/h1-12,14-20,29H,13H2,(H2,36,42)/t29-/m0/s1	XKXRNAFNZJXZGA-LJAQVGFWSA-N	394143	US9975874, Example 16	Plasma kallikrein			 178							US Patent		10.7270/Q2M61NK4		aid1798992	US9975874	Mertz, E; Edmondson, SD; Hruza, A; He, J; So, S; Ali, A; Gao, Y	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=394143	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=394143&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118859644	405264249							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
788124	OC(=O)c1cccc(c1)-c1cccc(c1)C(CC1CC1)c1ccc(c[n+]1[O-])-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C30H24ClN5O3/c31-25-10-12-28(35-18-32-33-34-35)27(16-25)24-9-11-29(36(39)17-24)26(13-19-7-8-19)22-5-1-3-20(14-22)21-4-2-6-23(15-21)30(37)38/h1-6,9-12,14-19,26H,7-8,13H2,(H,37,38)	MUXIQACANPTWNF-UHFFFAOYSA-N	394144	US9975874, Example 17::US9975874, Example 18::US9975874, Example 19	Plasma kallikrein			 543							US Patent		10.7270/Q2M61NK4		aid1798992	US9975874	Mertz, E; Edmondson, SD; Hruza, A; He, J; So, S; Ali, A; Gao, Y	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=394144	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=394144&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118859634	405264250							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
788126	OC(=O)c1cccc(c1)-c1cccc(c1)C(CC1CC1)c1ccc(c[n+]1[O-])-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C30H24ClN5O3/c31-25-10-12-28(35-18-32-33-34-35)27(16-25)24-9-11-29(36(39)17-24)26(13-19-7-8-19)22-5-1-3-20(14-22)21-4-2-6-23(15-21)30(37)38/h1-6,9-12,14-19,26H,7-8,13H2,(H,37,38)	MUXIQACANPTWNF-UHFFFAOYSA-N	394144	US9975874, Example 17::US9975874, Example 18::US9975874, Example 19	Plasma kallikrein			 250							US Patent		10.7270/Q2M61NK4		aid1798992	US9975874	Mertz, E; Edmondson, SD; Hruza, A; He, J; So, S; Ali, A; Gao, Y	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=394144	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=394144&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118859634	405264250							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
788130	CNC(=O)N1CCC(CC1)c1cccc(c1)C(Cc1ccccc1)c1ccc(c[n+]1[O-])-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C33H32ClN7O2/c1-35-33(42)39-16-14-24(15-17-39)25-8-5-9-26(19-25)29(18-23-6-3-2-4-7-23)32-12-10-27(21-41(32)43)30-20-28(34)11-13-31(30)40-22-36-37-38-40/h2-13,19-22,24,29H,14-18H2,1H3,(H,35,42)	GTBLDFWQINEPEV-UHFFFAOYSA-N	394148	4-[3-(1-{5-[5- chloro-2-(1H- tetrazol-1- yl)phenyl]-1- oxidopyridin- 2-yl}-2- phenylethyl) phenyl]-N- methyl piperidine- 1-carboxamide::US9975874, Example 21::US9975874, Example 24	Plasma kallikrein			 496							US Patent		10.7270/Q2M61NK4		aid1798992	US9975874	Mertz, E; Edmondson, SD; Hruza, A; He, J; So, S; Ali, A; Gao, Y	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=394148	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=394148&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118695881	405264252							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
788132	CS(=O)(=O)N1CCC(CC1)c1cccc(c1)C(Cc1ccccc1)c1ccc(c[n+]1[O-])-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C32H31ClN6O3S/c1-43(41,42)37-16-14-24(15-17-37)25-8-5-9-26(19-25)29(18-23-6-3-2-4-7-23)32-12-10-27(21-39(32)40)30-20-28(33)11-13-31(30)38-22-34-35-36-38/h2-13,19-22,24,29H,14-18H2,1H3	RFWROHBSGCEZDU-UHFFFAOYSA-N	394149	5-[5-chloro-2- (1H-tetrazol- 1-yl)phenyl]- 2-(1-{3-[1- (methylsulfonyl) piperidin-4- yl]phenyl}-2- phenylethyl) pyridine 1- oxide::US9975874, Example 22	Plasma kallikrein			 1038							US Patent		10.7270/Q2M61NK4		aid1798992	US9975874	Mertz, E; Edmondson, SD; Hruza, A; He, J; So, S; Ali, A; Gao, Y	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=394149	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=394149&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118860198	405264253							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
788135	CNC(=O)N1CCC(CC1)c1cccc(c1)C(Cc1ccccc1)c1ccc(c[n+]1[O-])-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C33H32ClN7O2/c1-35-33(42)39-16-14-24(15-17-39)25-8-5-9-26(19-25)29(18-23-6-3-2-4-7-23)32-12-10-27(21-41(32)43)30-20-28(34)11-13-31(30)40-22-36-37-38-40/h2-13,19-22,24,29H,14-18H2,1H3,(H,35,42)	GTBLDFWQINEPEV-UHFFFAOYSA-N	394148	4-[3-(1-{5-[5- chloro-2-(1H- tetrazol-1- yl)phenyl]-1- oxidopyridin- 2-yl}-2- phenylethyl) phenyl]-N- methyl piperidine- 1-carboxamide::US9975874, Example 21::US9975874, Example 24	Plasma kallikrein			 714							US Patent		10.7270/Q2M61NK4		aid1798992	US9975874	Mertz, E; Edmondson, SD; Hruza, A; He, J; So, S; Ali, A; Gao, Y	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=394148	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=394148&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118695881	405264252							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
788140	CCNC(=O)N1CCC(CC1)c1cccc(c1)[C@H](Cc1ccccc1)c1ccc(c[n+]1[O-])-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C34H34ClN7O2/c1-2-36-34(43)40-17-15-25(16-18-40)26-9-6-10-27(20-26)30(19-24-7-4-3-5-8-24)33-13-11-28(22-42(33)44)31-21-29(35)12-14-32(31)41-23-37-38-39-41/h3-14,20-23,25,30H,2,15-19H2,1H3,(H,36,43)/t30-/m0/s1	RFMWHQBDEPXWHU-PMERELPUSA-N	394155	4-{3-[(1S)-1- {5-[5-chloro-2- (1H-tetrazol- 1-yl)phenyl]- 1- oxidopyridin- 2-yl}-2- phenylethyl] phenyl}-N- ethylpiperidine-1- carboxamide::US9975874, Example 28	Plasma kallikrein			 271							US Patent		10.7270/Q2M61NK4		aid1798992	US9975874	Mertz, E; Edmondson, SD; Hruza, A; He, J; So, S; Ali, A; Gao, Y	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=394155	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=394155&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118859631	405264258							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
788142	FC1(F)CC1C(=O)N1CCC(CC1)c1cccc(c1)[C@H](Cc1ccccc1)c1ccc(c[nH+]1)-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C35H31ClF2N6O/c36-28-10-12-33(44-22-40-41-42-44)30(19-28)27-9-11-32(39-21-27)29(17-23-5-2-1-3-6-23)26-8-4-7-25(18-26)24-13-15-43(16-14-24)34(45)31-20-35(31,37)38/h1-12,18-19,21-22,24,29,31H,13-17,20H2/p+1/t29-,31?/m0/s1	GPBLBSGWNANDAH-QHSFNAQHSA-O	394156	5-[5-chloro-2- (1H-tetrazol- 1-yl)phenyl]- 2-[(1S)-1-(3- {1-[(2,2- difluoro- cyclopropyl) carbonyl] piperidin-4- yl}phenyl)-2- phenylethyl] pyridine 1- oxide::US9975874, Example 30	Plasma kallikrein			 820							US Patent		10.7270/Q2M61NK4		aid1798992	US9975874	Mertz, E; Edmondson, SD; Hruza, A; He, J; So, S; Ali, A; Gao, Y	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=394156	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=394156&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			140807218	405264259							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
788144	Clc1ccc(c(c1)-c1ccc([nH+]c1)[C@@H](Cc1ccccc1)c1cccc(c1)C1CCN(CC1)C(=O)C1CCCO1)-n1cnnn1	InChI=1S/C36H35ClN6O2/c37-30-12-14-34(43-24-39-40-41-43)32(22-30)29-11-13-33(38-23-29)31(20-25-6-2-1-3-7-25)28-9-4-8-27(21-28)26-15-17-42(18-16-26)36(44)35-10-5-19-45-35/h1-4,6-9,11-14,21-24,26,31,35H,5,10,15-20H2/p+1/t31-,35?/m0/s1	BGHNTLQJRAHOQI-MWGAKABSSA-O	394157	5-[5-chloro-2- (1H-tetrazol- 1-yl)phenyl]- 2-[(1S)-2- phenyl-1-{3- [1- (tetrahydrofuran- 2- ylcarbonyl) piperidin-4- yl]phenyl}ethyl] pyridine 1- oxide::US9975874, Example 31	Plasma kallikrein			 336							US Patent		10.7270/Q2M61NK4		aid1798992	US9975874	Mertz, E; Edmondson, SD; Hruza, A; He, J; So, S; Ali, A; Gao, Y	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=394157	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=394157&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			140807210	405264260							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
788146	Clc1ccc(c(c1)-c1ccc([nH+]c1)[C@@H](Cc1ccccc1)c1cccc(c1)C1CCN(CC1)C(=O)C1CC(=O)C1)-n1cnnn1	InChI=1S/C36H33ClN6O2/c37-30-10-12-35(43-23-39-40-41-43)33(21-30)28-9-11-34(38-22-28)32(17-24-5-2-1-3-6-24)27-8-4-7-26(18-27)25-13-15-42(16-14-25)36(45)29-19-31(44)20-29/h1-12,18,21-23,25,29,32H,13-17,19-20H2/p+1/t32-/m0/s1	QUSNISKZXOJQDZ-YTTGMZPUSA-O	394158	3-[(4-{3-[(1S)- 1-{5-[5-chloro- 2-(1H- tetrazol-1- yl)phenyl]-1- oxidopyridin- 2-yl}-2- phenylethyl] phenyl} piperidin- 1- yl)carbonyl] cyclobutanone::US9975874, Example 32	Plasma kallikrein			 324							US Patent		10.7270/Q2M61NK4		aid1798992	US9975874	Mertz, E; Edmondson, SD; Hruza, A; He, J; So, S; Ali, A; Gao, Y	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=394158	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=394158&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			140807217	405264261							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
788148	COCCC(=O)N1CCC(CC1)c1cccc(c1)[C@H](Cc1ccccc1)c1ccc(c[nH+]1)-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C35H35ClN6O2/c1-44-19-16-35(43)41-17-14-26(15-18-41)27-8-5-9-28(21-27)31(20-25-6-3-2-4-7-25)33-12-10-29(23-37-33)32-22-30(36)11-13-34(32)42-24-38-39-40-42/h2-13,21-24,26,31H,14-20H2,1H3/p+1/t31-/m0/s1	BLTANBDUBMLEEC-HKBQPEDESA-O	394159	5-[5-chloro-2- (1H-tetrazol- 1-yl)phenyl]- 2-[(1S)-1-{3- [1-(3- methoxy- propanoyl) piperidin- 4-yl]phenyl}- 2- phenylethyl] pyridine 1- oxide::US9975874, Example 33	Plasma kallikrein			 376							US Patent		10.7270/Q2M61NK4		aid1798992	US9975874	Mertz, E; Edmondson, SD; Hruza, A; He, J; So, S; Ali, A; Gao, Y	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=394159	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=394159&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			140807208	405264262							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
788150	Clc1ccc(c(c1)-c1ccc([nH+]c1)[C@@H](Cc1ccccc1)c1cccc(c1)C1CCN(CC1)C(=O)C1CC1)-n1cnnn1	InChI=1S/C35H33ClN6O/c36-30-12-14-34(42-23-38-39-40-42)32(21-30)29-11-13-33(37-22-29)31(19-24-5-2-1-3-6-24)28-8-4-7-27(20-28)25-15-17-41(18-16-25)35(43)26-9-10-26/h1-8,11-14,20-23,25-26,31H,9-10,15-19H2/p+1/t31-/m0/s1	WRCNMRGKEQDAPN-HKBQPEDESA-O	394160	5-[5-chloro-2- (1H-tetrazol- 1-yl)phenyl]- 2-[(1S)-1-{3- [1- (cyclopropyl- carbonyl) piperidin- 4- yl]phenyl}-2- phenylethyl] pyridine 1- oxide::US9975874, Example 34	Plasma kallikrein			 371							US Patent		10.7270/Q2M61NK4		aid1798992	US9975874	Mertz, E; Edmondson, SD; Hruza, A; He, J; So, S; Ali, A; Gao, Y	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=394160	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=394160&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			140807215	405264263							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
788152	Clc1ccc(c(c1)-c1ccc([nH+]c1)[C@@H](Cc1ccccc1)c1cccc(c1)C1CCN(CC1)C(=O)C1CCO1)-n1cnnn1	InChI=1S/C35H33ClN6O2/c36-29-10-12-33(42-23-38-39-40-42)31(21-29)28-9-11-32(37-22-28)30(19-24-5-2-1-3-6-24)27-8-4-7-26(20-27)25-13-16-41(17-14-25)35(43)34-15-18-44-34/h1-12,20-23,25,30,34H,13-19H2/p+1/t30-,34?/m0/s1	FGNYZFBGTYKJNE-LUWJBUJKSA-O	394161	5-[5-chloro-2- (1H-tetrazol- 1-yl)phenyl]- 2-[(1S)-1-{3- [1-(oxetan-2- ylcarbonyl) piperidin-4- yl]phenyl}-2- phenylethyl] pyridine 1- oxide::US9975874, Example 35	Plasma kallikrein			 403							US Patent		10.7270/Q2M61NK4		aid1798992	US9975874	Mertz, E; Edmondson, SD; Hruza, A; He, J; So, S; Ali, A; Gao, Y	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=394161	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=394161&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			140807213	405264264							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
788154	COCC(=O)N1CCC(CC1)c1cccc(c1)[C@H](Cc1ccccc1)c1ccc(c[nH+]1)-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C34H33ClN6O2/c1-43-22-34(42)40-16-14-25(15-17-40)26-8-5-9-27(19-26)30(18-24-6-3-2-4-7-24)32-12-10-28(21-36-32)31-20-29(35)11-13-33(31)41-23-37-38-39-41/h2-13,19-21,23,25,30H,14-18,22H2,1H3/p+1/t30-/m0/s1	PAGWGMZEDZMTDN-PMERELPUSA-O	394162	5-[5-chloro-2- (1H-tetrazol- 1-yl)phenyl]- 2-[(1S)-1-{3- [1- (methoxyacetyl) piperidin-4- yl]phenyl}-2- phenylethyl] pyridine 1- oxide::US9975874, Example 36	Plasma kallikrein			 382							US Patent		10.7270/Q2M61NK4		aid1798992	US9975874	Mertz, E; Edmondson, SD; Hruza, A; He, J; So, S; Ali, A; Gao, Y	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=394162	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=394162&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			140807214	405264265							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
788156	FC(F)C(=O)N1CCC(CC1)c1cccc(c1)[C@H](Cc1ccccc1)c1ccc(c[nH+]1)-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C33H29ClF2N6O/c34-27-10-12-31(42-21-38-39-40-42)29(19-27)26-9-11-30(37-20-26)28(17-22-5-2-1-3-6-22)25-8-4-7-24(18-25)23-13-15-41(16-14-23)33(43)32(35)36/h1-12,18-21,23,28,32H,13-17H2/p+1/t28-/m0/s1	JAYFHKUDAMZMCZ-NDEPHWFRSA-O	394163	5-[5-chloro-2-  (1H-tetrazol- 1-yl)phenyl]- 2-[(1S)-1-{3- [1- (difluoroacetyl) piperidin-4- yl]phenyl}-2- phenylethyl] pyridine 1- oxide::US9975874, Example 37	Plasma kallikrein			 536							US Patent		10.7270/Q2M61NK4		aid1798992	US9975874	Mertz, E; Edmondson, SD; Hruza, A; He, J; So, S; Ali, A; Gao, Y	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=394163	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=394163&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			140807211	405264266							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
788158	FCC(=O)N1CCC(CC1)c1cccc(c1)[C@H](Cc1ccccc1)c1ccc(c[nH+]1)-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C33H30ClFN6O/c34-28-10-12-32(41-22-37-38-39-41)30(19-28)27-9-11-31(36-21-27)29(17-23-5-2-1-3-6-23)26-8-4-7-25(18-26)24-13-15-40(16-14-24)33(42)20-35/h1-12,18-19,21-22,24,29H,13-17,20H2/p+1/t29-/m0/s1	GCPPPUXXKSPSRQ-LJAQVGFWSA-O	394164	5-[5-chloro-2- (1H-tetrazol- 1-yl)phenyl]- 2-[(1S)-1-{3- [1- (fluoroacetyl) piperidin-4- yl]phenyl}-2- phenylethyl] pyridine 1- oxide::US9975874, Example 38	Plasma kallikrein			 322							US Patent		10.7270/Q2M61NK4		aid1798992	US9975874	Mertz, E; Edmondson, SD; Hruza, A; He, J; So, S; Ali, A; Gao, Y	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=394164	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=394164&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			140807219	405264267							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
788160	NC(=O)C(=O)N1CCC(CC1)c1cccc(c1)[C@H](Cc1ccccc1)c1ccc(c[nH+]1)-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C33H30ClN7O2/c34-27-10-12-31(41-21-37-38-39-41)29(19-27)26-9-11-30(36-20-26)28(17-22-5-2-1-3-6-22)25-8-4-7-24(18-25)23-13-15-40(16-14-23)33(43)32(35)42/h1-12,18-21,23,28H,13-17H2,(H2,35,42)/p+1/t28-/m0/s1	AWMPYUUFUKVZBE-NDEPHWFRSA-O	394165	2-(4-{3-[(1S)- 1-{5-[5-chloro- 2-(1H- tetrazol-1- yl)phenyl]-1- oxidopyridin- 2-yl}-2- phenylethyl] phenyl} piperidin- 1-yl)-2- oxoacetamide::US9975874, Example 39	Plasma kallikrein			 113							US Patent		10.7270/Q2M61NK4		aid1798992	US9975874	Mertz, E; Edmondson, SD; Hruza, A; He, J; So, S; Ali, A; Gao, Y	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=394165	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=394165&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			140807206	405264268							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
788162	[O-][n+]1cc(ccc1[C@@H](Cc1ccccc1)c1cccc(c1)C1CCN(CC1)C(=O)C1COC1)-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C35H33ClN6O3/c36-30-10-12-33(41-23-37-38-39-41)32(19-30)28-9-11-34(42(44)20-28)31(17-24-5-2-1-3-6-24)27-8-4-7-26(18-27)25-13-15-40(16-14-25)35(43)29-21-45-22-29/h1-12,18-20,23,25,29,31H,13-17,21-22H2/t31-/m0/s1	CJHJTTSPDLFDGO-HKBQPEDESA-N	394166	5-[5-chloro-2- (1H-tetrazol- 1-yl)phenyl]- 2-(1S)-1-{3- [1-(oxetan-3- ylcarbonyl) piperidin-4- yl]phenyl}-2- phenylethyl] pyridine 1- oxide::US9975874, Example 40	Plasma kallikrein			 413							US Patent		10.7270/Q2M61NK4		aid1798992	US9975874	Mertz, E; Edmondson, SD; Hruza, A; He, J; So, S; Ali, A; Gao, Y	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=394166	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=394166&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118859658	405264269							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
788168	COCCOC(=O)N1CCC(CC1)c1cccc(c1)[C@H](Cc1ccccc1)c1ccc(c[n+]1[O-])-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C35H35ClN6O4/c1-45-18-19-46-35(43)40-16-14-26(15-17-40)27-8-5-9-28(21-27)31(20-25-6-3-2-4-7-25)34-12-10-29(23-42(34)44)32-22-30(36)11-13-33(32)41-24-37-38-39-41/h2-13,21-24,26,31H,14-20H2,1H3/t31-/m0/s1	OTFTVKZHSYWZGH-HKBQPEDESA-N	394171	2-methoxyethyl 4-{3-[(1S)-1- {5-[5-chloro-2- (1H-tetrazol- 1-yl)phenyl]-1- 1-  oxidopyridin- 2-yl}-2- phenylethyl] phenyl} piperidine- 1- carboxylate::US9975874, Example 45	Plasma kallikrein			 659							US Patent		10.7270/Q2M61NK4		aid1798992	US9975874	Mertz, E; Edmondson, SD; Hruza, A; He, J; So, S; Ali, A; Gao, Y	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=394171	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=394171&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118859833	405264274							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
788171	[O-][n+]1cc(ccc1[C@@H](Cc1ccccc1)c1cccc(c1)C1CCN(CC1)C(=O)NC1CCCC1)-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C37H38ClN7O2/c38-31-14-16-35(44-25-39-41-42-44)34(23-31)30-13-15-36(45(47)24-30)33(21-26-7-2-1-3-8-26)29-10-6-9-28(22-29)27-17-19-43(20-18-27)37(46)40-32-11-4-5-12-32/h1-3,6-10,13-16,22-25,27,32-33H,4-5,11-12,17-21H2,(H,40,46)/t33-/m0/s1	JHNLKEAMRZHHJO-XIFFEERXSA-N	394173	4-{3-[(1S)-1- {5-[5-chloro-2- (1H-tetrazol- 1-yl)phenyl]-1- oxidopyridin- 2-yl}-2- phenylethyl] phenyl}-N- cyclopentyl piperidine-1- carboxamide::US9975874, Example 47	Plasma kallikrein			 879							US Patent		10.7270/Q2M61NK4		aid1798992	US9975874	Mertz, E; Edmondson, SD; Hruza, A; He, J; So, S; Ali, A; Gao, Y	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=394173	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=394173&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118859865	405264276							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
788174	[O-][n+]1cc(ccc1[C@@H](Cc1ccccc1)c1cccc(c1)C1CCN(CC1)C(=O)NC1CCOC1)-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C36H36ClN7O3/c37-30-10-12-34(43-24-38-40-41-43)33(21-30)29-9-11-35(44(46)22-29)32(19-25-5-2-1-3-6-25)28-8-4-7-27(20-28)26-13-16-42(17-14-26)36(45)39-31-15-18-47-23-31/h1-12,20-22,24,26,31-32H,13-19,23H2,(H,39,45)/t31?,32-/m0/s1	IVLHGJVYHNUUFI-JYUUXGOASA-N	394175	4-{3-[(1S)-1-  {5-[5-chloro-2- (1H-tetrazol- 1-yl)phenyl]- 1- oxidopyridin- 2-yl}-2- phenylethyl] phenyl}-N- (tetrahydrofuran- 3- yl)piperidine- 1- carboxamide::US9975874, Example 49	Plasma kallikrein			 414							US Patent		10.7270/Q2M61NK4		aid1798992	US9975874	Mertz, E; Edmondson, SD; Hruza, A; He, J; So, S; Ali, A; Gao, Y	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=394175	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=394175&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118859862	405264278							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
788176	[O-][n+]1cc(ccc1[C@@H](Cc1ccccc1)c1cccc(c1)C1CCN(CC1)C(=O)NC1CC=CC1)-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C37H36ClN7O2/c38-31-14-16-35(44-25-39-41-42-44)34(23-31)30-13-15-36(45(47)24-30)33(21-26-7-2-1-3-8-26)29-10-6-9-28(22-29)27-17-19-43(20-18-27)37(46)40-32-11-4-5-12-32/h1-10,13-16,22-25,27,32-33H,11-12,17-21H2,(H,40,46)/t33-/m0/s1	GILUFDJPLAOOLN-XIFFEERXSA-N	394176	4-{3-[(1S)-1- {5-[5-chloro-2- (1H-tetrazol- 1-yl)phenyl]- oxidopyridin- 2-yl}-2- phenylethyl] phenyl}-N- cyclopent-3- en-1-ylpiperidine- 1- carboxamide::US9975874, Example 50	Plasma kallikrein			 696							US Patent		10.7270/Q2M61NK4		aid1798992	US9975874	Mertz, E; Edmondson, SD; Hruza, A; He, J; So, S; Ali, A; Gao, Y	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=394176	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=394176&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118859662	405264279							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
788178	[O-][n+]1cc(ccc1[C@@H](Cc1ccccc1)c1cccc(c1)C1CCN(CC1)C(=O)NC1CCC1)-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C36H36ClN7O2/c37-30-13-15-34(43-24-38-40-41-43)33(22-30)29-12-14-35(44(46)23-29)32(20-25-6-2-1-3-7-25)28-9-4-8-27(21-28)26-16-18-42(19-17-26)36(45)39-31-10-5-11-31/h1-4,6-9,12-15,21-24,26,31-32H,5,10-11,16-20H2,(H,39,45)/t32-/m0/s1	KQEDBMOYOKTGPZ-YTTGMZPUSA-N	394177	4-{3-[(1S)-1- {5-[5-chloro-2- (1H-tetrazol- 1-yl)phenyl]- 1- oxidopyridin- 2-yl}-2- phenylethyl] phenyl}-N- cyclobutyl piperidine-1- carboxamide::US9975874, Example 51	Plasma kallikrein			 614							US Patent		10.7270/Q2M61NK4		aid1798992	US9975874	Mertz, E; Edmondson, SD; Hruza, A; He, J; So, S; Ali, A; Gao, Y	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=394177	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=394177&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118859684	405264280							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
788180	[O-][n+]1cc(ccc1[C@@H](Cc1ccccc1)c1cccc(c1)C1CCN(CC1)C(=O)NCC1CCOC1)-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C37H38ClN7O3/c38-32-10-12-35(44-25-40-41-42-44)34(21-32)31-9-11-36(45(47)23-31)33(19-26-5-2-1-3-6-26)30-8-4-7-29(20-30)28-13-16-43(17-14-28)37(46)39-22-27-15-18-48-24-27/h1-12,20-21,23,25,27-28,33H,13-19,22,24H2,(H,39,46)/t27?,33-/m0/s1	AWFWGPTVUBFPHC-UWPPNVRMSA-N	394178	4-{3-[(1S)-1- {5-[5-chloro-2- (1H-tetrazol- 1-yl)phenyl]- 1- oxidopyridin- 2-yl}-2- phenylethyl] phenyl}-N- (tetrahydrofuran- 3-ylmethyl) piperidine-1- carboxamide::US9975874, Example 52	Plasma kallikrein			 384							US Patent		10.7270/Q2M61NK4		aid1798992	US9975874	Mertz, E; Edmondson, SD; Hruza, A; He, J; So, S; Ali, A; Gao, Y	Merck Sharp & Dohme Corp	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=394178	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=394178&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118859866	405264281							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50907319	Cc1cnn(Cc2ccc(Cn3nc(cc3C(F)(F)F)C(=O)N[C@@H]3CCc4c3ccnc4N)cc2)c1	InChI=1S/C25H24F3N7O/c1-15-11-31-34(12-15)13-16-2-4-17(5-3-16)14-35-22(25(26,27)28)10-21(33-35)24(36)32-20-7-6-19-18(20)8-9-30-23(19)29/h2-5,8-12,20H,6-7,13-14H2,1H3,(H2,29,30)(H,32,36)/t20-/m1/s1	UPTLTLUEWPYSAJ-HXUWFJFHSA-N	50271123	CHEMBL4128218	Plasma kallikrein			 1.000000							ChEMBL	10.1021/acsmedchemlett.7b00253	10.7270/Q2ZK5K5B	28835783			Abdel-Magid, AF	Therachem Research Medilab (India) Pvt. Ltd.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50271123	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50271123&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			145962597	405255719							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50907320	C[C@H]1CCN(C1)c1ccc(Cn2cc(cn2)C(=O)N[C@@H]2CCc3nc(N)ccc23)cn1	InChI=1S/C23H27N7O/c1-15-8-9-29(12-15)22-7-2-16(10-25-22)13-30-14-17(11-26-30)23(31)28-20-5-4-19-18(20)3-6-21(24)27-19/h2-3,6-7,10-11,14-15,20H,4-5,8-9,12-13H2,1H3,(H2,24,27)(H,28,31)/t15-,20+/m0/s1	VBXFERGVTGHWOF-MGPUTAFESA-N	50271124	CHEMBL4126836::US10399961, Example 13	Plasma kallikrein			 19							ChEMBL	10.1021/acsmedchemlett.7b00253	10.7270/Q2ZK5K5B	28835783			Abdel-Magid, AF	Therachem Research Medilab (India) Pvt. Ltd.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50271124	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50271124&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			129103439	405255720							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50907321	Cc1cc(N)nc2CCC(NC(=O)c3cnn(Cc4ccc(Cn5ccccc5=O)cc4)c3)c12	InChI=1S/C26H26N6O2/c1-17-12-23(27)29-21-9-10-22(25(17)21)30-26(34)20-13-28-32(16-20)15-19-7-5-18(6-8-19)14-31-11-3-2-4-24(31)33/h2-8,11-13,16,22H,9-10,14-15H2,1H3,(H2,27,29)(H,30,34)	OGCXJXOXGMNRHG-UHFFFAOYSA-N	50271125	CHEMBL4128066	Plasma kallikrein			 4.0							ChEMBL	10.1021/acsmedchemlett.7b00253	10.7270/Q2ZK5K5B	28835783			Abdel-Magid, AF	Therachem Research Medilab (India) Pvt. Ltd.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50271125	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50271125&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			129103433	405255721							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50907322	Nc1ccc2C(CCc2n1)NC(=O)c1cnn(Cc2ccc(Cn3ccccc3=O)cc2)c1	InChI=1S/C25H24N6O2/c26-23-11-8-20-21(28-23)9-10-22(20)29-25(33)19-13-27-31(16-19)15-18-6-4-17(5-7-18)14-30-12-2-1-3-24(30)32/h1-8,11-13,16,22H,9-10,14-15H2,(H2,26,28)(H,29,33)	GAHSGTPDISUWPL-UHFFFAOYSA-N	50271136	CHEMBL4129492	Plasma kallikrein			 9.0							ChEMBL	10.1021/acsmedchemlett.7b00253	10.7270/Q2ZK5K5B	28835783			Abdel-Magid, AF	Therachem Research Medilab (India) Pvt. Ltd.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50271136	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50271136&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			129103630	405255722							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50907323	Cc1ccc2cc(Cn3cc(nn3)C(=O)NC3CCCc4nc(N)ccc34)ccc2n1	InChI=1S/C23H23N7O/c1-14-5-7-16-11-15(6-9-18(16)25-14)12-30-13-21(28-29-30)23(31)27-20-4-2-3-19-17(20)8-10-22(24)26-19/h5-11,13,20H,2-4,12H2,1H3,(H2,24,26)(H,27,31)	BFOWXSOUPPGYKF-UHFFFAOYSA-N	50271137	CHEMBL4126194	Plasma kallikrein			 900							ChEMBL	10.1021/acsmedchemlett.7b00253	10.7270/Q2ZK5K5B	28835783			Abdel-Magid, AF	Therachem Research Medilab (India) Pvt. Ltd.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50271137	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50271137&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			129103576	405255723							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50907324	Cc1ccc2cc(Cn3cc(nn3)C(=O)N[C@H]3CCc4nc(N)ccc34)ccc2n1	InChI=1S/C22H21N7O/c1-13-2-4-15-10-14(3-6-17(15)24-13)11-29-12-20(27-28-29)22(30)26-19-8-7-18-16(19)5-9-21(23)25-18/h2-6,9-10,12,19H,7-8,11H2,1H3,(H2,23,25)(H,26,30)/t19-/m0/s1	DIWKOOBICROCPL-IBGZPJMESA-N	50271139	CHEMBL4129444	Plasma kallikrein			 1900							ChEMBL	10.1021/acsmedchemlett.7b00253	10.7270/Q2ZK5K5B	28835783			Abdel-Magid, AF	Therachem Research Medilab (India) Pvt. Ltd.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50271139	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50271139&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			145963085	104116099						ZINC40951401	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
811482	C[C@@H]1CCC[C@@H](c2cc(ccn2)-c2c(NC1=O)cnn2C(F)F)n1cnc(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C28H23Cl2F2N9O2/c1-15-3-2-4-23(20-9-16(7-8-33-20)26-21(36-27(15)43)12-35-41(26)28(31)32)39-14-34-19(11-25(39)42)18-10-17(29)5-6-22(18)40-13-24(30)37-38-40/h5-15,23,28H,2-4H2,1H3,(H,36,43)/t15-,23+/m1/s1	FSWFYCYPTDLKON-CMJOXMDJSA-N	247411	US10336754, Example 353::US11053247, Example 353::US9453018, 353	Plasma kallikrein		 28.0								US Patent		10.7270/Q2474D6F		aid1803706	US10336754	Dilger, AK; Corte, JR; De Lucca, I; Fang, T; Yang, W; Wang, Y; Pabbisetty, KB; Ewing, WR; Zhu, Y; Wexler, RR; Pinto, DJ; Orwat, MJ; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=247411	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=247411&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	YXG	7MBO	131635534	346541954							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
811483	C[C@@H]1CCC[C@@H](c2cc(ccn2)-c2nn(cc2NC1=O)-c1cccnc1)n1cnc(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C32H26Cl2N10O2/c1-19-4-2-6-28(42-18-37-24(14-30(42)45)23-13-21(33)7-8-27(23)44-17-29(34)39-41-44)25-12-20(9-11-36-25)31-26(38-32(19)46)16-43(40-31)22-5-3-10-35-15-22/h3,5,7-19,28H,2,4,6H2,1H3,(H,38,46)/t19-,28+/m1/s1	ASWFFXNYMLHVMO-GDJIYFAZSA-N	247412	US10336754, Example 354::US11053247, Example 354::US9453018, 354	Plasma kallikrein		 10.00								US Patent		10.7270/Q2474D6F		aid1803706	US10336754	Dilger, AK; Corte, JR; De Lucca, I; Fang, T; Yang, W; Wang, Y; Pabbisetty, KB; Ewing, WR; Zhu, Y; Wexler, RR; Pinto, DJ; Orwat, MJ; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=247412	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=247412&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			131635535	346541955							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
811484	C[C@@H]1CCC[C@@H](c2ccnc(c2)-c2c(NC1=O)cnn2C)n1cnc(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C28H25Cl2N9O2/c1-16-4-3-5-23(17-8-9-31-21(10-17)27-22(34-28(16)41)13-33-37(27)2)38-15-32-20(12-26(38)40)19-11-18(29)6-7-24(19)39-14-25(30)35-36-39/h6-16,23H,3-5H2,1-2H3,(H,34,41)/t16-,23+/m1/s1	PYWPRMLFPPPQRF-MWTRTKDXSA-N	247413	US10336754, Example 363::US11053247, Example 363::US9453018, 362::US9453018, 363	Plasma kallikrein		 23.0								US Patent		10.7270/Q2474D6F		aid1803706	US10336754	Dilger, AK; Corte, JR; De Lucca, I; Fang, T; Yang, W; Wang, Y; Pabbisetty, KB; Ewing, WR; Zhu, Y; Wexler, RR; Pinto, DJ; Orwat, MJ; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=247413	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=247413&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			131635536	346541956							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
811485	C[C@@H]1CCC[C@@H](c2ccnc(c2)-c2c(NC1=O)cnn2C)n1cnc(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C28H25Cl2N9O2/c1-16-4-3-5-23(17-8-9-31-21(10-17)27-22(34-28(16)41)13-33-37(27)2)38-15-32-20(12-26(38)40)19-11-18(29)6-7-24(19)39-14-25(30)35-36-39/h6-16,23H,3-5H2,1-2H3,(H,34,41)/t16-,23+/m1/s1	PYWPRMLFPPPQRF-MWTRTKDXSA-N	247413	US10336754, Example 363::US11053247, Example 363::US9453018, 362::US9453018, 363	Plasma kallikrein		 22.0								US Patent		10.7270/Q2474D6F		aid1803706	US10336754	Dilger, AK; Corte, JR; De Lucca, I; Fang, T; Yang, W; Wang, Y; Pabbisetty, KB; Ewing, WR; Zhu, Y; Wexler, RR; Pinto, DJ; Orwat, MJ; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=247413	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=247413&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			131635536	346541956							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
811486	C[C@@H]1CCC[C@@H](c2cc(ccn2)-c2c(NC1=O)cnn2C)n1cnc(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)(F)F	InChI=1S/C29H25ClF3N9O2/c1-16-4-3-5-24(21-10-17(8-9-34-21)27-22(37-28(16)44)13-36-40(27)2)41-15-35-20(12-26(41)43)19-11-18(30)6-7-23(19)42-14-25(38-39-42)29(31,32)33/h6-16,24H,3-5H2,1-2H3,(H,37,44)/t16-,24+/m1/s1	SDMTXZKAASAJMI-GYCJOSAFSA-N	247414	US10336754, Example 368::US11053247, Example 368::US9453018, 367::US9453018, 368	Plasma kallikrein		 24.0								US Patent		10.7270/Q2474D6F		aid1803706	US10336754	Dilger, AK; Corte, JR; De Lucca, I; Fang, T; Yang, W; Wang, Y; Pabbisetty, KB; Ewing, WR; Zhu, Y; Wexler, RR; Pinto, DJ; Orwat, MJ; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=247414	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=247414&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			131635537	346541957							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
811487	C[C@@H]1CCC[C@@H](c2cc(ccn2)-c2c(NC1=O)cnn2C)n1cnc(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)(F)F	InChI=1S/C29H25ClF3N9O2/c1-16-4-3-5-24(21-10-17(8-9-34-21)27-22(37-28(16)44)13-36-40(27)2)41-15-35-20(12-26(41)43)19-11-18(30)6-7-23(19)42-14-25(38-39-42)29(31,32)33/h6-16,24H,3-5H2,1-2H3,(H,37,44)/t16-,24+/m1/s1	SDMTXZKAASAJMI-GYCJOSAFSA-N	247414	US10336754, Example 368::US11053247, Example 368::US9453018, 367::US9453018, 368	Plasma kallikrein		 32.0								US Patent		10.7270/Q2474D6F		aid1803706	US10336754	Dilger, AK; Corte, JR; De Lucca, I; Fang, T; Yang, W; Wang, Y; Pabbisetty, KB; Ewing, WR; Zhu, Y; Wexler, RR; Pinto, DJ; Orwat, MJ; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=247414	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=247414&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			131635537	346541957							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
811488	C[C@@H]1CCC[C@@H](c2cc(ccn2)-c2c(NC1=O)cnn2C(F)F)n1cnc(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)(F)F	InChI=1S/C29H23ClF5N9O2/c1-15-3-2-4-23(20-9-16(7-8-36-20)26-21(39-27(15)46)12-38-44(26)28(31)32)42-14-37-19(11-25(42)45)18-10-17(30)5-6-22(18)43-13-24(40-41-43)29(33,34)35/h5-15,23,28H,2-4H2,1H3,(H,39,46)/t15-,23+/m1/s1	OEFZCPJFLZPAHN-CMJOXMDJSA-N	247416	US10336754, Example 369::US11053247, Example 369::US9453018, 369	Plasma kallikrein		 33.0								US Patent		10.7270/Q2474D6F		aid1803706	US10336754	Dilger, AK; Corte, JR; De Lucca, I; Fang, T; Yang, W; Wang, Y; Pabbisetty, KB; Ewing, WR; Zhu, Y; Wexler, RR; Pinto, DJ; Orwat, MJ; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=247416	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=247416&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			131635538	346541958							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
811489	C[C@@H]1CCC[C@@H](c2ccnc(c2)-c2c(NC1=O)cnn2C)n1cnc(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)(F)F	InChI=1S/C29H25ClF3N9O2/c1-16-4-3-5-23(17-8-9-34-21(10-17)27-22(37-28(16)44)13-36-40(27)2)41-15-35-20(12-26(41)43)19-11-18(30)6-7-24(19)42-14-25(38-39-42)29(31,32)33/h6-16,23H,3-5H2,1-2H3,(H,37,44)/t16-,23+/m1/s1	FQRJWJILLRZDIQ-MWTRTKDXSA-N	247417	US10336754, Example 371::US11053247, Example 371::US9453018, 370::US9453018, 371	Plasma kallikrein		 17.0								US Patent		10.7270/Q2474D6F		aid1803706	US10336754	Dilger, AK; Corte, JR; De Lucca, I; Fang, T; Yang, W; Wang, Y; Pabbisetty, KB; Ewing, WR; Zhu, Y; Wexler, RR; Pinto, DJ; Orwat, MJ; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=247417	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=247417&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			131635539	346541959							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
811490	C[C@@H]1CCC[C@@H](c2ccnc(c2)-c2c(NC1=O)cnn2C)n1cnc(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)(F)F	InChI=1S/C29H25ClF3N9O2/c1-16-4-3-5-23(17-8-9-34-21(10-17)27-22(37-28(16)44)13-36-40(27)2)41-15-35-20(12-26(41)43)19-11-18(30)6-7-24(19)42-14-25(38-39-42)29(31,32)33/h6-16,23H,3-5H2,1-2H3,(H,37,44)/t16-,23+/m1/s1	FQRJWJILLRZDIQ-MWTRTKDXSA-N	247417	US10336754, Example 371::US11053247, Example 371::US9453018, 370::US9453018, 371	Plasma kallikrein		 19.0								US Patent		10.7270/Q2474D6F		aid1803706	US10336754	Dilger, AK; Corte, JR; De Lucca, I; Fang, T; Yang, W; Wang, Y; Pabbisetty, KB; Ewing, WR; Zhu, Y; Wexler, RR; Pinto, DJ; Orwat, MJ; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=247417	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=247417&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			131635539	346541959							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
811491	C[C@@H]1CCC[C@@H](c2ccnc(c2)-c2c(NC1=O)cnn2C)n1cnc(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(O)=O	InChI=1S/C29H26ClN9O4/c1-16-4-3-5-24(17-8-9-31-21(10-17)27-22(34-28(16)41)13-33-37(27)2)38-15-32-20(12-26(38)40)19-11-18(30)6-7-25(19)39-14-23(29(42)43)35-36-39/h6-16,24H,3-5H2,1-2H3,(H,34,41)(H,42,43)/t16-,24+/m1/s1	ZEUDFUNISLCCKE-GYCJOSAFSA-N	247418	US10336754, Example 372::US11053247, Example 372::US9453018, 372	Plasma kallikrein		 35.0								US Patent		10.7270/Q2474D6F		aid1803706	US10336754	Dilger, AK; Corte, JR; De Lucca, I; Fang, T; Yang, W; Wang, Y; Pabbisetty, KB; Ewing, WR; Zhu, Y; Wexler, RR; Pinto, DJ; Orwat, MJ; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=247418	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=247418&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			131635540	346541960							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
811492	C[C@@H]1CCC[C@@H](c2cc(ccn2)-c2c(NC1=O)cnn2C)n1cnc(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(O)=O	InChI=1S/C29H26ClN9O4/c1-16-4-3-5-25(21-10-17(8-9-31-21)27-22(34-28(16)41)13-33-37(27)2)38-15-32-20(12-26(38)40)19-11-18(30)6-7-24(19)39-14-23(29(42)43)35-36-39/h6-16,25H,3-5H2,1-2H3,(H,34,41)(H,42,43)/t16-,25+/m1/s1	MLTHDTRXOVPWLH-CPJLOUKISA-N	247419	US10336754, Example 373::US11053247, Example 373::US9453018, 373	Plasma kallikrein		 37.0								US Patent		10.7270/Q2474D6F		aid1803706	US10336754	Dilger, AK; Corte, JR; De Lucca, I; Fang, T; Yang, W; Wang, Y; Pabbisetty, KB; Ewing, WR; Zhu, Y; Wexler, RR; Pinto, DJ; Orwat, MJ; Smith, II, LM	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=247419	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=247419&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			131635541	346541961							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825895	CCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(o1)C(F)F	InChI=1S/C26H21ClF3N5O5/c1-3-19(24(38)32-13-5-7-15(23(31)37)18(28)9-13)35-11-20(39-2)17(10-21(35)36)16-8-12(27)4-6-14(16)25-33-34-26(40-25)22(29)30/h4-11,19,22H,3H2,1-2H3,(H2,31,37)(H,32,38)	GELPZCSNZJPUPR-UHFFFAOYSA-N	413763	4-({2-[4-{5-Chloro-2-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanoyl}amino)-2-fluorobenzamide (Racemate)::US10421742, Example 156::US11180471, Example 160	Plasma kallikrein			 170							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413763	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413763&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205925	433913866							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825896	CCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(o1)C(F)F	InChI=1S/C27H23ClF2N6O4/c1-4-21(25(38)31-16-6-8-20-14(9-16)12-35(2)34-20)36-13-22(39-3)19(11-23(36)37)18-10-15(28)5-7-17(18)26-32-33-27(40-26)24(29)30/h5-13,21,24H,4H2,1-3H3,(H,31,38)	HUAFIQJRZLYLOU-UHFFFAOYSA-N	413764	2-[4-{5-Chloro-2-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 157::US11180471, Example 157	Plasma kallikrein			 65.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413764	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413764&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205941	433913867							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825897	CCC(C(=O)Nc1ccc2nccnc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(o1)C(F)F	InChI=1S/C27H21ClF2N6O4/c1-3-21(25(38)33-15-5-7-19-20(11-15)32-9-8-31-19)36-13-22(39-2)18(12-23(36)37)17-10-14(28)4-6-16(17)26-34-35-27(40-26)24(29)30/h4-13,21,24H,3H2,1-2H3,(H,33,38)	ZXOWUCFZXVCGPI-UHFFFAOYSA-N	413765	N-(Quinoxalin-6-yl)-2-[4-{5-chloro-2-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanamide (Racemate)::US10421742, Example 158::US11180471, Example 158	Plasma kallikrein			 32.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413765	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413765&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205104	433913868							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825898	CCC(C(=O)Nc1ccc(C(=O)NC)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(o1)C(F)F	InChI=1S/C27H23ClF3N5O5/c1-4-20(25(39)33-14-6-8-16(19(29)10-14)24(38)32-2)36-12-21(40-3)18(11-22(36)37)17-9-13(28)5-7-15(17)26-34-35-27(41-26)23(30)31/h5-12,20,23H,4H2,1-3H3,(H,32,38)(H,33,39)	XEUUKFFBCFEEHJ-UHFFFAOYSA-N	413766	4-({2-[4-{5-Chloro-2-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanoyl}amino)-2-fluoro-N-methylbenzamide (Racemate)::US10421742, Example 159::US11180471, Example 159	Plasma kallikrein			 230							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413766	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413766&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205157	433913869							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825899	CCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C26H22ClF3N6O4/c1-3-20(26(39)32-14-5-6-15(25(31)38)18(28)9-14)35-12-22(40-2)17(10-23(35)37)16-8-13(27)4-7-21(16)36-11-19(24(29)30)33-34-36/h4-12,20,24H,3H2,1-2H3,(H2,31,38)(H,32,39)	OETZVLILMHLZTG-UHFFFAOYSA-N	413767	4-({2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanoyl}amino)-2-fluorobenzamide (Racemate)::US10421742, Example 160::US11180471, Example 230	Plasma kallikrein			 18.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413767	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413767&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205282	433913870							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825900	CC[C@@H](C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C26H22ClF3N6O4/c1-3-20(26(39)32-14-5-6-15(25(31)38)18(28)9-14)35-12-22(40-2)17(10-23(35)37)16-8-13(27)4-7-21(16)36-11-19(24(29)30)33-34-36/h4-12,20,24H,3H2,1-2H3,(H2,31,38)(H,32,39)/t20-/m0/s1	OETZVLILMHLZTG-FQEVSTJZSA-N	413768	4-({(2S)-2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanoyl}amino)-2-fluorobenzamide (Enantiomer 2)::US10421742, Example 161::US11180471, Example 161	Plasma kallikrein			 14.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413768	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413768&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205281	433913871							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825901	CCC(C(=O)Nc1ccc2nccnc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C27H22ClF2N7O3/c1-3-22(27(39)33-16-5-6-19-20(11-16)32-9-8-31-19)36-14-24(40-2)18(12-25(36)38)17-10-15(28)4-7-23(17)37-13-21(26(29)30)34-35-37/h4-14,22,26H,3H2,1-2H3,(H,33,39)	OEMBYSUFEIJUEQ-UHFFFAOYSA-N	413769	N-(Quinoxalin-6-yl)-2-[4-{5-chloro-2-[4-(difluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanamide (Racemate)::US10421742, Example 162::US11180471, Example 162	Plasma kallikrein			 5.90							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413769	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413769&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205522	433913872							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825902	CC[C@@H](C(=O)Nc1ccc2nccnc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C27H22ClF2N7O3/c1-3-22(27(39)33-16-5-6-19-20(11-16)32-9-8-31-19)36-14-24(40-2)18(12-25(36)38)17-10-15(28)4-7-23(17)37-13-21(26(29)30)34-35-37/h4-14,22,26H,3H2,1-2H3,(H,33,39)/t22-/m0/s1	OEMBYSUFEIJUEQ-QFIPXVFZSA-N	413770	N-(Quinoxalin-6-yl)-(2S)-2-[4-{5-chloro-2-[4-(difluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanamide (Enantiomer 2)::US10421742, Example 163::US11180471, Example 163	Plasma kallikrein			 1.70							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413770	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413770&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205521	433913873							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825903	CCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C27H24ClF2N7O3/c1-4-22(27(39)31-17-6-7-20-15(9-17)12-35(2)33-20)36-14-24(40-3)19(11-25(36)38)18-10-16(28)5-8-23(18)37-13-21(26(29)30)32-34-37/h5-14,22,26H,4H2,1-3H3,(H,31,39)	UAHXABWWDRJQRK-UHFFFAOYSA-N	413771	2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 164::US11180471, Example 164	Plasma kallikrein			 8.20							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413771	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413771&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205536	433913874							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825904	CC[C@@H](C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C27H24ClF2N7O3/c1-4-22(27(39)31-17-6-7-20-15(9-17)12-35(2)33-20)36-14-24(40-3)19(11-25(36)38)18-10-16(28)5-8-23(18)37-13-21(26(29)30)32-34-37/h5-14,22,26H,4H2,1-3H3,(H,31,39)/t22-/m0/s1	UAHXABWWDRJQRK-QFIPXVFZSA-N	413772	(2S)-2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-N-(2-methyl-2H-indazol-5-yl)butanamide (Enantiomer 2)::US10421742, Example 165	Plasma kallikrein			 3.20							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413772	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413772&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205534	433913875							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825905	CCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C26H22ClF2N5O5/c1-3-20(25(36)30-16-7-4-14(5-8-16)26(37)38)33-13-22(39-2)18(11-23(33)35)17-10-15(27)6-9-21(17)34-12-19(24(28)29)31-32-34/h4-13,20,24H,3H2,1-2H3,(H,30,36)(H,37,38)	NNJGQRMOKIHSCI-UHFFFAOYSA-N	413773	4-({2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanoyl}amino)benzoic acid (Racemate)::US10421742, Example 166::US11180471, Example 166	Plasma kallikrein			 20.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413773	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413773&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205919	433913876							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825906	CCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C26H23Cl2N7O3/c1-4-21(26(37)29-17-6-7-20-15(9-17)12-33(2)31-20)34-13-23(38-3)19(11-25(34)36)18-10-16(27)5-8-22(18)35-14-24(28)30-32-35/h5-14,21H,4H2,1-3H3,(H,29,37)	QBWXHIMIUSZAOP-UHFFFAOYSA-N	413774	2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 167::US10421742, Example 225::US11180471, Example 225	Plasma kallikrein			 6.30							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413774	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413774&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205467	433913877							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825907	CC[C@@H](C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C26H23Cl2N7O3/c1-4-21(26(37)29-17-6-7-20-15(9-17)12-33(2)31-20)34-13-23(38-3)19(11-25(34)36)18-10-16(27)5-8-22(18)35-14-24(28)30-32-35/h5-14,21H,4H2,1-3H3,(H,29,37)/t21-/m0/s1	QBWXHIMIUSZAOP-NRFANRHFSA-N	413775	(2S)-2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(2-methyl-2H-indazol-5-yl)butanamide (Enantiomer 2)::US10421742, Example 168	Plasma kallikrein			 2.10							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413775	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413775&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135206046	433913878							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825908	CCC(C(=O)Nc1ccc2nccnc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C26H21Cl2N7O3/c1-3-21(26(37)31-16-5-6-19-20(11-16)30-9-8-29-19)34-13-23(38-2)18(12-25(34)36)17-10-15(27)4-7-22(17)35-14-24(28)32-33-35/h4-14,21H,3H2,1-2H3,(H,31,37)	QWJAHBCIMJSNPO-UHFFFAOYSA-N	413776	N-(Quinoxalin-6-yl)-2-{4-[5-chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}butanamide (Racemate)::US10421742, Example 169::US11180471, Example 169	Plasma kallikrein			 3.80							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413776	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413776&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205827	433913879							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825909	CC[C@@H](C(=O)Nc1ccc2nccnc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C26H21Cl2N7O3/c1-3-21(26(37)31-16-5-6-19-20(11-16)30-9-8-29-19)34-13-23(38-2)18(12-25(34)36)17-10-15(27)4-7-22(17)35-14-24(28)32-33-35/h4-14,21H,3H2,1-2H3,(H,31,37)/t21-/m0/s1	QWJAHBCIMJSNPO-NRFANRHFSA-N	413777	N-(Quinoxalin-6-yl)-(2S)-2-{4-[5-chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}butanamide (Enantiomer 2)::US10421742, Example 170::US11180471, Example 170	Plasma kallikrein			 1.50							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413777	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413777&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135206028	433913880							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825910	CCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C25H21Cl2FN6O4/c1-3-19(25(37)30-14-5-6-15(24(29)36)18(28)9-14)33-11-21(38-2)17(10-23(33)35)16-8-13(26)4-7-20(16)34-12-22(27)31-32-34/h4-12,19H,3H2,1-2H3,(H2,29,36)(H,30,37)	FPAKZDLGEHHCTC-UHFFFAOYSA-N	413778	4-[(2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}butanoyl)amino]-2-fluorobenzamide (Racemate)::US10421742, Example 171::US11180471, Example 171	Plasma kallikrein			 9.60							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413778	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413778&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205799	433913881							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825911	CC[C@@H](C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C25H23ClN8O3/c1-4-21(25(36)28-17-6-7-20-15(9-17)12-32(2)29-20)33-13-23(37-3)19(11-24(33)35)18-10-16(26)5-8-22(18)34-14-27-30-31-34/h5-14,21H,4H2,1-3H3,(H,28,36)/t21-/m0/s1	IQNORUMXNDXEIL-NRFANRHFSA-N	413779	2-{4-[5-Chloro-2-(1H-tetrazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-(2H)-yl}-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 172	Plasma kallikrein			 1.70							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413779	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413779&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135211561	433913882							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825912	COc1cn(C(CC2CCC2)C(=O)Nc2ccc3nccnc3c2)c(=O)cc1-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C29H25Cl2N7O3/c1-41-26-15-37(28(39)14-21(26)20-12-18(30)5-8-24(20)38-16-27(31)35-36-38)25(11-17-3-2-4-17)29(40)34-19-6-7-22-23(13-19)33-10-9-32-22/h5-10,12-17,25H,2-4,11H2,1H3,(H,34,40)	MZJDBIVMBJLQSX-UHFFFAOYSA-N	413780	N-(Quinoxalin-6-yl)-2-{4-[5-chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-3-cyclobutylpropanamide (Racemate)::US10421742, Example 173::US11180471, Example 173	Plasma kallikrein			 5.90							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413780	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413780&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135206019	433913883							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825913	CCC(C(=O)Nc1ccc(nc1)C(N)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1cc(on1)C(F)F	InChI=1S/C26H22ClF2N5O5/c1-3-20(26(37)32-14-5-7-18(25(30)36)31-11-14)34-12-22(38-2)17(9-23(34)35)16-8-13(27)4-6-15(16)19-10-21(24(28)29)39-33-19/h4-12,20,24H,3H2,1-2H3,(H2,30,36)(H,32,37)	CFZRHXMVQOAQBA-UHFFFAOYSA-N	413781	5-({2-[4-{5-Chloro-2-[5-(difluoromethyl)-1,2-oxazol-3-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanoyl}amino)pyridine-2-carboxamide (Racemate)::US10421742, Example 174::US11180471, Example 174	Plasma kallikrein			 15.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413781	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413781&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205546	433913884							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825914	CCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1cc(on1)C(F)F	InChI=1S/C27H22ClF3N4O5/c1-3-21(27(38)33-14-5-7-16(26(32)37)19(29)9-14)35-12-23(39-2)18(10-24(35)36)17-8-13(28)4-6-15(17)20-11-22(25(30)31)40-34-20/h4-12,21,25H,3H2,1-2H3,(H2,32,37)(H,33,38)	WJQZEXDXRMYEAJ-UHFFFAOYSA-N	413782	4-({2-[4-{5-Chloro-2-[5-(difluoromethyl)-1,2-oxazol-3-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanoyl}amino)-2-fluorobenzamide (Racemate)::US10421742, Example 175::US11180471, Example 175	Plasma kallikrein			 38.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413782	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413782&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205744	433913885							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825915	CCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1cc(on1)C(F)F	InChI=1S/C28H24ClF2N5O4/c1-4-23(28(38)32-17-6-8-21-15(9-17)13-35(2)33-21)36-14-25(39-3)20(11-26(36)37)19-10-16(29)5-7-18(19)22-12-24(27(30)31)40-34-22/h5-14,23,27H,4H2,1-3H3,(H,32,38)	YPTNTTHZSPASJM-UHFFFAOYSA-N	413783	2-[4-{5-Chloro-2-[5-(difluoromethyl)-1,2-oxazol-3-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 176::US11180471, Example 176	Plasma kallikrein			 14.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413783	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413783&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205796	433913886							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825916	CCC(C(=O)Nc1ccc(C(=O)NC)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1cc(on1)C(F)F	InChI=1S/C28H24ClF3N4O5/c1-4-22(28(39)34-15-6-8-17(20(30)10-15)27(38)33-2)36-13-24(40-3)19(11-25(36)37)18-9-14(29)5-7-16(18)21-12-23(26(31)32)41-35-21/h5-13,22,26H,4H2,1-3H3,(H,33,38)(H,34,39)	GWQBOPAUXMQWRD-UHFFFAOYSA-N	413784	4-({2-[4-{5-Chloro-2-[5-(difluoromethyl)-1,2-oxazol-3-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanoyl}amino)-2-fluoro-N-methylbenzamide (Racemate)::US10421742, Example 177::US11180471, Example 177	Plasma kallikrein			 43.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413784	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413784&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205630	433913887							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825917	CCC(C(=O)Nc1ccc2nccnc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1cc(on1)C(F)F	InChI=1S/C28H22ClF2N5O4/c1-3-23(28(38)34-16-5-7-20-22(11-16)33-9-8-32-20)36-14-25(39-2)19(12-26(36)37)18-10-15(29)4-6-17(18)21-13-24(27(30)31)40-35-21/h4-14,23,27H,3H2,1-2H3,(H,34,38)	VCYPQGRHNOEINV-UHFFFAOYSA-N	413785	N-(Quinoxalin-6-yl)-2-[4-{5-chloro-2-[5-(difluoromethyl)-1,2-oxazol-3-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanamide (Racemate)::US10421742, Example 178::US11180471, Example 178	Plasma kallikrein			 24.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413785	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413785&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205450	433913888							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825918	COc1cn(C(CCOC(C)(C)C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C1=NOCC1	InChI=1S/C30H32ClN3O7/c1-30(2,3)40-13-12-25(28(36)32-20-8-5-18(6-9-20)29(37)38)34-17-26(39-4)23(16-27(34)35)22-15-19(31)7-10-21(22)24-11-14-41-33-24/h5-10,15-17,25H,11-14H2,1-4H3,(H,32,36)(H,37,38)	IZEONOSVIATBHE-UHFFFAOYSA-N	413786	4-[(4-tert-Butoxy-2-{4-[5-chloro-2-(4,5-dihydro-1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}butanoyl)amino]benzoic acid (Racemate)::US10421742, Example 179::US11180471, Example 179	Plasma kallikrein			 260							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413786	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413786&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205653	433913889							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825919	COCC[C@@H](C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1cnn(c1)C(F)F	InChI=1S/C28H25ClF2N4O6/c1-40-10-9-23(26(37)33-19-6-3-16(4-7-19)27(38)39)34-15-24(41-2)22(12-25(34)36)21-11-18(29)5-8-20(21)17-13-32-35(14-17)28(30)31/h3-8,11-15,23,28H,9-10H2,1-2H3,(H,33,37)(H,38,39)/t23-/m0/s1	KPDQGYYQHYCMAC-QHCPKHFHSA-N	413787	4-({(2S)-2-[4-{5-Chloro-2-[1-(difluoromethyl)-1H-pyrazol-4-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)benzoic acid (Enantiomer 2)::US10421742, Example 180::US11180471, Example 180	Plasma kallikrein			 71.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413787	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413787&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205723	433913890							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825920	COCC[C@@H](C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(o1)C(F)(F)F	InChI=1S/C27H22ClF4N5O6/c1-41-8-7-20(24(40)34-14-4-6-16(23(33)39)19(29)10-14)37-12-21(42-2)18(11-22(37)38)17-9-13(28)3-5-15(17)25-35-36-26(43-25)27(30,31)32/h3-6,9-12,20H,7-8H2,1-2H3,(H2,33,39)(H,34,40)/t20-/m0/s1	FGIRAZNDJOPUAW-FQEVSTJZSA-N	413788	4-({(2S)-2-[4-{5-Chloro-2-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)-2-fluorobenzamide (Enantiomer 2)::US10421742, Example 181::US11180471, Example 181	Plasma kallikrein			 31.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413788	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413788&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205816	433913891							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825921	CCC[C@@H](C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C27H24ClF3N6O4/c1-3-4-22(27(40)33-15-6-7-16(26(32)39)19(29)10-15)36-13-23(41-2)18(11-24(36)38)17-9-14(28)5-8-21(17)37-12-20(25(30)31)34-35-37/h5-13,22,25H,3-4H2,1-2H3,(H2,32,39)(H,33,40)/t22-/m0/s1	WZUXJAUBKKDABN-QFIPXVFZSA-N	413789	4-({(2S)-2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]pentanoyl}amino)-2-fluorobenzamide (Enantiomer 2)::US10421742, Example 182::US11180471, Example 182	Plasma kallikrein			 19.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413789	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413789&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205866	433913892							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825922	CCC[C@@H](C(=O)Nc1ccc(nc1)C(=O)NC)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C27H26ClF2N7O4/c1-4-5-22(27(40)33-16-7-8-19(32-12-16)26(39)31-2)36-14-23(41-3)18(11-24(36)38)17-10-15(28)6-9-21(17)37-13-20(25(29)30)34-35-37/h6-14,22,25H,4-5H2,1-3H3,(H,31,39)(H,33,40)/t22-/m0/s1	ZZXQOEFXCPENDW-QFIPXVFZSA-N	413790	5-({(2S)-2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]pentanoyl}amino)-N-methylpyridine-2-carboxamide (Enantiomer 2)::US10421742, Example 183::US11180471, Example 183	Plasma kallikrein			 9.60							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413790	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413790&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205807	433913893							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825923	COc1cn(C(C)C(=O)Nc2ccc(C(N)=O)c(F)c2)c(=O)cc1-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C24H19Cl2FN6O4/c1-12(24(36)29-14-4-5-15(23(28)35)18(27)8-14)32-10-20(37-2)17(9-22(32)34)16-7-13(25)3-6-19(16)33-11-21(26)30-31-33/h3-12H,1-2H3,(H2,28,35)(H,29,36)	QGNJMTPKSKWTBQ-UHFFFAOYSA-N	413791	4-[(2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}propanoyl)amino]-2-fluorobenzamide (Racemate)::US10421742, Example 184::US11180471, Example 184	Plasma kallikrein			 9.00							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413791	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413791&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205405	433913894							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825924	COc1cn(C(C)C(=O)Nc2ccc3nccnc3c2)c(=O)cc1-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C25H19Cl2N7O3/c1-14(25(36)30-16-4-5-19-20(10-16)29-8-7-28-19)33-12-22(37-2)18(11-24(33)35)17-9-15(26)3-6-21(17)34-13-23(27)31-32-34/h3-14H,1-2H3,(H,30,36)	BJLPPNMAKGCMOT-UHFFFAOYSA-N	413792	N-(Quinoxalin-6-yl)-2-{4-[5-chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}propanamide (Racemate)::US10421742, Example 185::US11180471, Example 185	Plasma kallikrein			 1.50							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413792	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413792&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205724	433913895							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825925	COc1cn(C(C)C(=O)Nc2ccc3nn(C)cc3c2)c(=O)cc1-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C25H21Cl2N7O3/c1-14(25(36)28-17-5-6-20-15(8-17)11-32(2)30-20)33-12-22(37-3)19(10-24(33)35)18-9-16(26)4-7-21(18)34-13-23(27)29-31-34/h4-14H,1-3H3,(H,28,36)	GBMNOBITEYOELC-UHFFFAOYSA-N	413793	2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(2-methyl-2H-indazol-5-yl)propanamide (Racemate)::US10421742, Example 186::US11180471, Example 186	Plasma kallikrein			 3.00							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413793	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413793&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205501	433913896							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825926	COc1cn(CC(=O)Nc2ccc3nn(C)cc3c2)c(=O)cc1-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C23H19ClN8O3/c1-30-10-14-7-16(4-5-19(14)27-30)26-22(33)12-31-11-21(35-2)18(9-23(31)34)17-8-15(24)3-6-20(17)32-13-25-28-29-32/h3-11,13H,12H2,1-2H3,(H,26,33)	OGFVUXQMVAVOQF-UHFFFAOYSA-N	413794	2-{4-[5-Chloro-2-(1H-tetrazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(2-methyl-2H-indazol-5-yl)acetamide::US10421742, Example 187::US11180471, Example 187	Plasma kallikrein			 2.70							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413794	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413794&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205510	433913897							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825927	CNC(=O)c1ccc(NC(=O)Cn2cc(OC)c(cc2=O)-c2cc(Cl)ccc2-n2cnnn2)cn1	InChI=1S/C22H19ClN8O4/c1-24-22(34)17-5-4-14(9-25-17)27-20(32)11-30-10-19(35-2)16(8-21(30)33)15-7-13(23)3-6-18(15)31-12-26-28-29-31/h3-10,12H,11H2,1-2H3,(H,24,34)(H,27,32)	MPORBPNHVULGJP-UHFFFAOYSA-N	413795	5-[({4-[5-Chloro-2-(1H-tetrazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}acetyl)amino]-N-methylpyridine-2-carboxamide::US10421742, Example 188::US11180471, Example 188	Plasma kallikrein			 5.40							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413795	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413795&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205086	433913898							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825928	COc1cn(CC(=O)Nc2ccc3nccnc3c2)c(=O)cc1-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C23H17ClN8O3/c1-35-21-11-31(12-22(33)28-15-3-4-18-19(9-15)26-7-6-25-18)23(34)10-17(21)16-8-14(24)2-5-20(16)32-13-27-29-30-32/h2-11,13H,12H2,1H3,(H,28,33)	GOCDCIBQPRFDPL-UHFFFAOYSA-N	413796	N-(Quinoxalin-6-yl)-2-{4-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}acetamide::US10421742, Example 189::US11180471, Example 189	Plasma kallikrein			 1.000							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413796	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413796&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205044	433913899							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825929	COc1cn(CC(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C22H17ClN6O5/c1-34-19-10-28(11-20(30)25-15-5-2-13(3-6-15)22(32)33)21(31)9-17(19)16-8-14(23)4-7-18(16)29-12-24-26-27-29/h2-10,12H,11H2,1H3,(H,25,30)(H,32,33)	KWIOAPQMNXFJOI-UHFFFAOYSA-N	413797	4-[({4-[5-Chloro-2-(1H-tetrazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}acetyl)amino]benzoic acid::US10421742, Example 190::US11180471, Example 190	Plasma kallikrein			 9.40							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413797	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413797&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205876	433913900							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825930	COc1cn(CC(=O)Nc2ccc(C(N)=O)c(F)c2)c(=O)cc1-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C22H17ClFN7O4/c1-35-19-9-30(10-20(32)27-13-3-4-14(22(25)34)17(24)7-13)21(33)8-16(19)15-6-12(23)2-5-18(15)31-11-26-28-29-31/h2-9,11H,10H2,1H3,(H2,25,34)(H,27,32)	NEENJQHZEIXZHZ-UHFFFAOYSA-N	413798	4-[({4-[5-Chloro-2-(1H-tetrazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}acetyl)amino]-2-fluorobenzamide::US10421742, Example 191::US11180471, Example 191	Plasma kallikrein			 7.90							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413798	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413798&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205431	433913901							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825931	CCC(C(=O)Nc1ccc(nc1)C(N)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(s1)C(F)F	InChI=1S/C25H21ClF2N6O4S/c1-3-18(23(37)31-13-5-7-17(22(29)36)30-10-13)34-11-19(38-2)16(9-20(34)35)15-8-12(26)4-6-14(15)24-32-33-25(39-24)21(27)28/h4-11,18,21H,3H2,1-2H3,(H2,29,36)(H,31,37)	UMNQYPPSVMIHGW-UHFFFAOYSA-N	413799	5-({2-[4-{5-Chloro-2-[5-(difluoromethyl)-1,3,4-thiadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanoyl}amino)pyridine-2-carboxamide (Racemate)::US10421742, Example 192::US11180471, Example 192	Plasma kallikrein			 32.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413799	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413799&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205370	433913902							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825932	CCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(s1)C(F)F	InChI=1S/C26H21ClF3N5O4S/c1-3-19(24(38)32-13-5-7-15(23(31)37)18(28)9-13)35-11-20(39-2)17(10-21(35)36)16-8-12(27)4-6-14(16)25-33-34-26(40-25)22(29)30/h4-11,19,22H,3H2,1-2H3,(H2,31,37)(H,32,38)	CTFVRNUYERRNLZ-UHFFFAOYSA-N	413800	4-({2-[4-{5-Chloro-2-[5-(difluoromethyl)-1,3,4-thiadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanoyl}amino)-2-fluorobenzamide (Racemate)::US10421742, Example 193::US11180471, Example 193	Plasma kallikrein			 56.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413800	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413800&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205721	433913903							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825933	CCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(s1)C(F)F	InChI=1S/C27H23ClF2N6O3S/c1-4-21(25(38)31-16-6-8-20-14(9-16)12-35(2)34-20)36-13-22(39-3)19(11-23(36)37)18-10-15(28)5-7-17(18)26-32-33-27(40-26)24(29)30/h5-13,21,24H,4H2,1-3H3,(H,31,38)	DFCBCYSQFOUFPJ-UHFFFAOYSA-N	413801	2-[4-{5-Chloro-2-[5-(difluoroethyl)-1,3,4-thiadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 194::US11180471, Example 194	Plasma kallikrein			 23.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413801	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413801&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135211537	433913904							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825934	CCC(C(=O)Nc1ccc(C(=O)NC)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(s1)C(F)F	InChI=1S/C27H23ClF3N5O4S/c1-4-20(25(39)33-14-6-8-16(19(29)10-14)24(38)32-2)36-12-21(40-3)18(11-22(36)37)17-9-13(28)5-7-15(17)26-34-35-27(41-26)23(30)31/h5-12,20,23H,4H2,1-3H3,(H,32,38)(H,33,39)	DPAIONDPIWYBAL-UHFFFAOYSA-N	413802	4-({2-[4-{5-Chloro-2-[5-(difluoromethyl)-1,3,4-thiadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanoyl}amino)-2-fluoro-N-methylbenzamide (Racemate)::US10421742, Example 195::US11180471, Example 195	Plasma kallikrein			 72.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413802	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413802&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205747	433913905							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825935	CCC(C(=O)Nc1ccc2nccnc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(s1)C(F)F	InChI=1S/C27H21ClF2N6O3S/c1-3-21(25(38)33-15-5-7-19-20(11-15)32-9-8-31-19)36-13-22(39-2)18(12-23(36)37)17-10-14(28)4-6-16(17)26-34-35-27(40-26)24(29)30/h4-13,21,24H,3H2,1-2H3,(H,33,38)	CVGKJPRJDXNZKV-UHFFFAOYSA-N	413803	2-[4-{5-Chloro-2-[5-(difluoromethyl)-1,3,4-thiadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-N-(quinoxalin-6-yl)butanamide (Racemate)::US10421742, Example 196::US11180471, Example 196	Plasma kallikrein			 11.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413803	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413803&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135211531	433913906							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825936	CCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1cc(on1)C(F)(F)F	InChI=1S/C27H21ClF4N4O5/c1-3-21(26(39)34-14-5-7-16(25(33)38)19(29)9-14)36-12-22(40-2)18(10-24(36)37)17-8-13(28)4-6-15(17)20-11-23(41-35-20)27(30,31)32/h4-12,21H,3H2,1-2H3,(H2,33,38)(H,34,39)	VMJCKYNXJRHMKZ-UHFFFAOYSA-N	413804	4-({2-[4-{5-Chloro-2-[5-(trifluoromethyl)-1,2-oxazol-3-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanoyl}amino)-2-fluorobenzamide (Racemate)::US10421742, Example 197::US11180471, Example 197	Plasma kallikrein			 34.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413804	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413804&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135206067	433913907							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825937	CCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1cc(on1)C(F)(F)F	InChI=1S/C28H23ClF3N5O4/c1-4-23(27(39)33-17-6-8-21-15(9-17)13-36(2)34-21)37-14-24(40-3)20(11-26(37)38)19-10-16(29)5-7-18(19)22-12-25(41-35-22)28(30,31)32/h5-14,23H,4H2,1-3H3,(H,33,39)	KLVMLPOMRPNVJU-UHFFFAOYSA-N	413805	2-[4-{5-Chloro-2-[5-(trifluoromethyl)-1,2-oxazol-3-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 198::US11180471, Example 198	Plasma kallikrein			 20.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413805	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413805&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205719	433913908							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51119530	NC(=N)NC(=O)c1nc(Cl)c(nc1N)N1CCCCCC1	InChI=1S/C12H18ClN7O/c13-8-10(20-5-3-1-2-4-6-20)18-9(14)7(17-8)11(21)19-12(15)16/h1-6H2,(H2,14,18)(H4,15,16,19,21)	RQQJJXVETXFINY-UHFFFAOYSA-N	81818	CAS_1794::CHEMBL1909810::HMA::NSC_1794	Plasma kallikrein			>50000							ChEMBL	10.1021/acs.jmedchem.8b00838	10.7270/Q2QF8WH4	30130401			Buckley, BJ; Aboelela, A; Minaei, E; Jiang, LX; Xu, Z; Ali, U; Fildes, K; Cheung, CY; Cook, SM; Johnson, DC; Bachovchin, DA; Cook, GM; Apte, M; Huang, M; Ranson, M; Kelso, MJ	University of Wollongong	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=81818	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=81818&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			1794	131342392		CHEMBL1909810		1192		ZINC03871091	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51119533	NC(=N)NC(=O)c1nc(-c2cc3c(F)cccc3o2)c(nc1N)N1CCCCCC1	InChI=1S/C20H22FN7O2/c21-12-6-5-7-13-11(12)10-14(30-13)15-18(28-8-3-1-2-4-9-28)26-17(22)16(25-15)19(29)27-20(23)24/h5-7,10H,1-4,8-9H2,(H2,22,26)(H4,23,24,27,29)	ITMHCPYYAUUUAC-UHFFFAOYSA-N	50459055	CHEMBL4207715	Plasma kallikrein			 16700							ChEMBL	10.1021/acs.jmedchem.8b00838	10.7270/Q2QF8WH4	30130401			Buckley, BJ; Aboelela, A; Minaei, E; Jiang, LX; Xu, Z; Ali, U; Fildes, K; Cheung, CY; Cook, SM; Johnson, DC; Bachovchin, DA; Cook, GM; Apte, M; Huang, M; Ranson, M; Kelso, MJ	University of Wollongong	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50459055	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50459055&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	09I	5ZC5	146029523	433926320							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825938	CCC(C(=O)Nc1ccc2nc([NH3+])ccc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C27H23Cl2N7O3/c1-3-21(27(38)31-17-6-7-20-15(10-17)4-9-25(30)32-20)35-13-23(39-2)19(12-26(35)37)18-11-16(28)5-8-22(18)36-14-24(29)33-34-36/h4-14,21H,3H2,1-2H3,(H2,30,32)(H,31,38)/p+1	UOFFBMYRFFCNLY-UHFFFAOYSA-O	413806	6-[(2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}butanoyl)amino]quinolin-2-aminium formate (Racemate)::US10421742, Example 199::US11180471, Example 199	Plasma kallikrein			 3.60							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413806	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413806&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			152948432	433913909							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825939	CCC(C(=O)Nc1ccc2ncc(C)nc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C27H23Cl2N7O3/c1-4-22(27(38)32-17-6-7-20-21(10-17)31-15(2)12-30-20)35-13-24(39-3)19(11-26(35)37)18-9-16(28)5-8-23(18)36-14-25(29)33-34-36/h5-14,22H,4H2,1-3H3,(H,32,38)	SADGBXCCQGIXDH-UHFFFAOYSA-N	413807	2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(3-methylquinoxalin-6-yl)butanamide (Racemate)::US10421742, Example 200::US11180471, Example 200	Plasma kallikrein			 2.40							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413807	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413807&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205297	433913910							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825940	CC[C@@H](C(=O)Nc1ccc2ncc(C)nc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C27H23Cl2N7O3/c1-4-22(27(38)32-17-6-7-20-21(10-17)31-15(2)12-30-20)35-13-24(39-3)19(11-26(35)37)18-9-16(28)5-8-23(18)36-14-25(29)33-34-36/h5-14,22H,4H2,1-3H3,(H,32,38)/t22-/m0/s1	SADGBXCCQGIXDH-QFIPXVFZSA-N	413808	(S)-2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(3-methylquinoxalin-6-yl)butanamide (Enantiomer 2)::US10421742, Example 201::US11180471, Example 201	Plasma kallikrein			 2.20							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413808	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413808&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205797	433913911							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825941	CCC[C@@H](C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C26H23Cl2FN6O4/c1-3-4-21(26(38)31-15-6-7-16(25(30)37)19(29)10-15)34-12-22(39-2)18(11-24(34)36)17-9-14(27)5-8-20(17)35-13-23(28)32-33-35/h5-13,21H,3-4H2,1-2H3,(H2,30,37)(H,31,38)/t21-/m0/s1	KQZYQOJQXJGZMI-NRFANRHFSA-N	413809	4-{[(2S)-2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}pentanoyl]amino}-2-fluorobenzamide (Enantiomer 2)::US10421742, Example 202::US11180471, Example 202	Plasma kallikrein			 9.80							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413809	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413809&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205777	433913912							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825942	CCC(C(=O)Nc1ccc2ncc(nc2c1)C(F)(F)F)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C27H20Cl2F3N7O3/c1-3-20(26(41)34-15-5-6-18-19(9-15)35-23(11-33-18)27(30,31)32)38-12-22(42-2)17(10-25(38)40)16-8-14(28)4-7-21(16)39-13-24(29)36-37-39/h4-13,20H,3H2,1-2H3,(H,34,41)	ZIDSWWLSQTUOIZ-UHFFFAOYSA-N	413810	2-{4-[5-Chloro-2-(4-chloro-1H-H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-[3-(trifluoromethyl)quinoxalin-6-yl]butanamide (Racemate)::US10421742, Example 203::US10421742, Example 205::US11180471, Example 203	Plasma kallikrein			 29.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413810	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413810&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135211523	433913913							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825943	CCC(C(=O)Nc1ccc2nc(cnc2c1)C(F)(F)F)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C27H20Cl2F3N7O3/c1-3-20(26(41)34-15-5-6-18-19(9-15)33-11-23(35-18)27(30,31)32)38-12-22(42-2)17(10-25(38)40)16-8-14(28)4-7-21(16)39-13-24(29)36-37-39/h4-13,20H,3H2,1-2H3,(H,34,41)	AGDBQILBKXGVMA-UHFFFAOYSA-N	413811	2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-[2-(trifluoromethyl)quinoxalin-6-yl]butanamide (Racemate)::US10421742, Example 204::US10421742, Example 206::US11180471, Example 204	Plasma kallikrein			 10.00							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413811	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413811&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205251	433913914							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825944	CCC(C(=O)Nc1ccc2ncc(nc2c1)C(F)(F)F)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C27H20Cl2F3N7O3/c1-3-20(26(41)34-15-5-6-18-19(9-15)35-23(11-33-18)27(30,31)32)38-12-22(42-2)17(10-25(38)40)16-8-14(28)4-7-21(16)39-13-24(29)36-37-39/h4-13,20H,3H2,1-2H3,(H,34,41)	ZIDSWWLSQTUOIZ-UHFFFAOYSA-N	413810	2-{4-[5-Chloro-2-(4-chloro-1H-H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-[3-(trifluoromethyl)quinoxalin-6-yl]butanamide (Racemate)::US10421742, Example 203::US10421742, Example 205::US11180471, Example 203	Plasma kallikrein			 47.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413810	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413810&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135211523	433913913							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825945	CCC(C(=O)Nc1ccc2nc(cnc2c1)C(F)(F)F)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C27H20Cl2F3N7O3/c1-3-20(26(41)34-15-5-6-18-19(9-15)33-11-23(35-18)27(30,31)32)38-12-22(42-2)17(10-25(38)40)16-8-14(28)4-7-21(16)39-13-24(29)36-37-39/h4-13,20H,3H2,1-2H3,(H,34,41)	AGDBQILBKXGVMA-UHFFFAOYSA-N	413811	2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-[2-(trifluoromethyl)quinoxalin-6-yl]butanamide (Racemate)::US10421742, Example 204::US10421742, Example 206::US11180471, Example 204	Plasma kallikrein			 24.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413811	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413811&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205251	433913914							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825946	CCC(C(=O)Nc1ccc2cnncc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C26H21Cl2N7O3/c1-3-21(26(37)31-18-6-4-15-11-29-30-12-16(15)8-18)34-13-23(38-2)20(10-25(34)36)19-9-17(27)5-7-22(19)35-14-24(28)32-33-35/h4-14,21H,3H2,1-2H3,(H,31,37)	UENKHDMGQRVXOA-UHFFFAOYSA-N	413814	2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(phthalazin-6-yl)butanamide (Racemate)::US10421742, Example 207::US10421742, Example 208::US11180471, Example 207	Plasma kallikrein			 3.50							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413814	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413814&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205592	433913915							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825947	CCC(C(=O)Nc1ccc2cnncc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C26H21Cl2N7O3/c1-3-21(26(37)31-18-6-4-15-11-29-30-12-16(15)8-18)34-13-23(38-2)20(10-25(34)36)19-9-17(27)5-7-22(19)35-14-24(28)32-33-35/h4-14,21H,3H2,1-2H3,(H,31,37)	UENKHDMGQRVXOA-UHFFFAOYSA-N	413814	2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(phthalazin-6-yl)butanamide (Racemate)::US10421742, Example 207::US10421742, Example 208::US11180471, Example 207	Plasma kallikrein			 4.40							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413814	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413814&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205592	433913915							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825948	CCC(C(=O)Nc1ccc2nn(cc2c1)C(F)F)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C27H22ClF4N7O3/c1-3-21(26(41)33-16-5-6-19-14(8-16)11-39(35-19)27(31)32)37-13-23(42-2)18(10-24(37)40)17-9-15(28)4-7-22(17)38-12-20(25(29)30)34-36-38/h4-13,21,25,27H,3H2,1-2H3,(H,33,41)	METWKYXLYOAEDA-UHFFFAOYSA-N	413816	2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-N-[2-(difluoromethyl)-2H-indazol-5-yl]butanamide (Racemate)::US10421742, Example 209::US11180471, Example 209	Plasma kallikrein			 9.10							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413816	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413816&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205934	433913916							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825949	CC[C@@H](C(=O)Nc1ccc2nn(cc2c1)C(F)F)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C27H22ClF4N7O3/c1-3-21(26(41)33-16-5-6-19-14(8-16)11-39(35-19)27(31)32)37-13-23(42-2)18(10-24(37)40)17-9-15(28)4-7-22(17)38-12-20(25(29)30)34-36-38/h4-13,21,25,27H,3H2,1-2H3,(H,33,41)/t21-/m0/s1	METWKYXLYOAEDA-NRFANRHFSA-N	413817	(2S)-2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-N-[2-(difluoromethyl)-2H-indazol-5-yl]butanamide (Enantiomer 2)::US10421742, Example 210::US11180471, Example 210	Plasma kallikrein			 3.50							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413817	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413817&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135206066	433913917							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825950	CCC(C(=O)Nc1ccc2nn(cc2c1)C(F)F)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C26H21Cl2F2N7O3/c1-3-20(25(39)31-16-5-6-19-14(8-16)11-37(33-19)26(29)30)35-12-22(40-2)18(10-24(35)38)17-9-15(27)4-7-21(17)36-13-23(28)32-34-36/h4-13,20,26H,3H2,1-2H3,(H,31,39)	ZXSDTWYIYKNDSR-UHFFFAOYSA-N	413818	2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-[2-(difluoromethyl)-2H-indazol-5-yl]butanamide (Racemate)::US10421742, Example 211::US11180471, Example 211	Plasma kallikrein			 5.40							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413818	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413818&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135204866	433913918							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825951	CC[C@@H](C(=O)Nc1ccc2nn(cc2c1)C(F)F)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C26H21Cl2F2N7O3/c1-3-20(25(39)31-16-5-6-19-14(8-16)11-37(33-19)26(29)30)35-12-22(40-2)18(10-24(35)38)17-9-15(27)4-7-21(17)36-13-23(28)32-34-36/h4-13,20,26H,3H2,1-2H3,(H,31,39)/t20-/m0/s1	ZXSDTWYIYKNDSR-FQEVSTJZSA-N	413819	(2S)-2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-[2-(difluoromethyl)-2H-indazol-5-yl]butanamide (Enantiomer 2)::US10421742, Example 212::US11180471, Example 212	Plasma kallikrein			 1.50							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413819	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413819&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135206089	433913919							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825952	CCC(C(=O)Nc1ccc2nn(CC3CC3)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C29H27Cl2N7O3/c1-3-24(29(40)32-20-7-8-23-18(10-20)14-36(34-23)13-17-4-5-17)37-15-26(41-2)22(12-28(37)39)21-11-19(30)6-9-25(21)38-16-27(31)33-35-38/h6-12,14-17,24H,3-5,13H2,1-2H3,(H,32,40)	TXLDRSXSUKQIEC-UHFFFAOYSA-N	413820	2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-[2-(cyclopropylmethyl)-2H-indazol-5-yl]butanamide (Racemate)::US10421742, Example 213::US11180471, Example 213	Plasma kallikrein			 12.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413820	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413820&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135206022	433913920							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825953	COc1cn(C(CC(F)F)C(=O)Nc2ccc(C(N)=O)c(F)c2)c(=O)cc1-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C25H19Cl2F3N6O4/c1-40-20-10-35(19(9-22(29)30)25(39)32-13-3-4-14(24(31)38)17(28)7-13)23(37)8-16(20)15-6-12(26)2-5-18(15)36-11-21(27)33-34-36/h2-8,10-11,19,22H,9H2,1H3,(H2,31,38)(H,32,39)	VICLFWRBPGESJU-UHFFFAOYSA-N	413821	4-[(2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4,4-difluorobutanoyl)amino]-2-fluorobenzamide (Racemate)::US10421742, Example 214::US11180471, Example 214	Plasma kallikrein			 21.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413821	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413821&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135206005	433913921							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825954	CCC(C(=O)Nc1ccc(nc1)C(=O)NC)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(s1)C(F)(F)F	InChI=1S/C26H22ClF3N6O4S/c1-4-19(23(39)33-14-6-8-18(32-11-14)22(38)31-2)36-12-20(40-3)17(10-21(36)37)16-9-13(27)5-7-15(16)24-34-35-25(41-24)26(28,29)30/h5-12,19H,4H2,1-3H3,(H,31,38)(H,33,39)	MTUVSPCBSRPPFH-UHFFFAOYSA-N	413822	5-({2-[4-{5-Chloro-2-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanoyl}amino)-N-methylpyridine-2-carboxamide (Racemate)::US10421742, Example 215::US11180471, Example 215	Plasma kallikrein			 20.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413822	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413822&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205910	433913922							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825955	COc1cn(C(CC(F)F)C(=O)Nc2ccc3nn(cc3c2)C(F)F)c(=O)cc1-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C26H19Cl2F4N7O3/c1-42-21-11-37(24(40)8-17(21)16-7-14(27)2-5-19(16)38-12-22(28)34-36-38)20(9-23(29)30)25(41)33-15-3-4-18-13(6-15)10-39(35-18)26(31)32/h2-8,10-12,20,23,26H,9H2,1H3,(H,33,41)	RTIMPDQMXMBUMW-UHFFFAOYSA-N	413823	2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-[2-(difluoromethyl)-2H-indazol-5-yl]-4,4-difluorobutanamide (Racemate)::US10421742, Example 216::US11180471, Example 216	Plasma kallikrein			 10.00							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413823	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413823&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135204789	433913923							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825956	COc1cn(C(CC(F)F)C(=O)Nc2ccc3nccnc3c2)c(=O)cc1-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C26H19Cl2F2N7O3/c1-40-22-12-36(21(11-24(29)30)26(39)33-15-3-4-18-19(9-15)32-7-6-31-18)25(38)10-17(22)16-8-14(27)2-5-20(16)37-13-23(28)34-35-37/h2-10,12-13,21,24H,11H2,1H3,(H,33,39)	SATGRGDFTKEDOC-UHFFFAOYSA-N	413824	2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4,4-difluoro-N-(quinoxalin-6-yl)butanamide (Racemate)::US10421742, Example 217::US11180471, Example 217	Plasma kallikrein			 4.90							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413824	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413824&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205462	433913924							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825957	COc1cn(C(CC(F)F)C(=O)Nc2ccc3nn(C)cc3c2)c(=O)cc1-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C26H21Cl2F2N7O3/c1-35-11-14-7-16(4-5-19(14)33-35)31-26(39)21(10-24(29)30)36-12-22(40-2)18(9-25(36)38)17-8-15(27)3-6-20(17)37-13-23(28)32-34-37/h3-9,11-13,21,24H,10H2,1-2H3,(H,31,39)	SVTFEVREYQHXOM-UHFFFAOYSA-N	413825	2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4,4-difluoro-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 218::US11180471, Example 218	Plasma kallikrein			 10.00							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413825	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413825&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205201	433913925							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825958	CCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(s1)C(F)(F)F	InChI=1S/C26H20ClF4N5O4S/c1-3-19(23(39)33-13-5-7-15(22(32)38)18(28)9-13)36-11-20(40-2)17(10-21(36)37)16-8-12(27)4-6-14(16)24-34-35-25(41-24)26(29,30)31/h4-11,19H,3H2,1-2H3,(H2,32,38)(H,33,39)	XRCANQJWEYJRNE-UHFFFAOYSA-N	413826	4-({2-[4-{5-Chloro-2-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanoyl}amino)-2-fluorobenzamide (Racemate)::US10421742, Example 219::US11180471, Example 219	Plasma kallikrein			 43.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413826	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413826&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205452	433913926							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825959	CCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(s1)C(F)(F)F	InChI=1S/C27H22ClF3N6O3S/c1-4-21(24(39)32-16-6-8-20-14(9-16)12-36(2)35-20)37-13-22(40-3)19(11-23(37)38)18-10-15(28)5-7-17(18)25-33-34-26(41-25)27(29,30)31/h5-13,21H,4H2,1-3H3,(H,32,39)	HCRLZPHBOLGRPG-UHFFFAOYSA-N	413827	2-[4-{5-Chloro-2-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 220::US11180471, Example 220	Plasma kallikrein			 14.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413827	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413827&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135206083	433913927							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825960	CCC(C(=O)Nc1ccc2nc(C)cnc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C27H23Cl2N7O3/c1-4-22(27(38)32-17-6-7-20-21(10-17)30-12-15(2)31-20)35-13-24(39-3)19(11-26(35)37)18-9-16(28)5-8-23(18)36-14-25(29)33-34-36/h5-14,22H,4H2,1-3H3,(H,32,38)	NINJGBVHUFUANQ-UHFFFAOYSA-N	413828	2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(2-methylquinoxalin-6-yl)butanamide (Racemate)::US10421742, Example 221::US11180471, Example 221	Plasma kallikrein			 2.80							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413828	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413828&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205262	433913928							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825961	CCC(C(=O)Nc1ccc2nc(C)c(C)nc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C28H25Cl2N7O3/c1-5-23(28(39)33-18-7-8-21-22(11-18)32-16(3)15(2)31-21)36-13-25(40-4)20(12-27(36)38)19-10-17(29)6-9-24(19)37-14-26(30)34-35-37/h6-14,23H,5H2,1-4H3,(H,33,39)	PQLJHTCQQFICKU-UHFFFAOYSA-N	413829	2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(2,3-dimethylquinoxalin-6-yl)butanamide (Racemate)::US10421742, Example 222::US11180471, Example 222	Plasma kallikrein			 2.40							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413829	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413829&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205457	433913929							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825962	CCC(C(=O)Nc1ccc2ncccc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C27H22Cl2N6O3/c1-3-22(27(37)31-18-7-8-21-16(11-18)5-4-10-30-21)34-14-24(38-2)20(13-26(34)36)19-12-17(28)6-9-23(19)35-15-25(29)32-33-35/h4-15,22H,3H2,1-2H3,(H,31,37)	FTLCKEYXULODRH-UHFFFAOYSA-N	413830	2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(quinolin-6-yl)butanamide (Racemate)::US10421742, Example 223::US11180471, Example 223	Plasma kallikrein			 3.60							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413830	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413830&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135211524	433913930							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825963	CCC(C(=O)Nc1ccc2cccnc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C27H22Cl2N6O3/c1-3-22(27(37)31-18-8-6-16-5-4-10-30-21(16)12-18)34-14-24(38-2)20(13-26(34)36)19-11-17(28)7-9-23(19)35-15-25(29)32-33-35/h4-15,22H,3H2,1-2H3,(H,31,37)	FQMWRNFRVKBREN-UHFFFAOYSA-N	413831	2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(quinolin-7-yl)butanamide (Racemate)::US10421742, Example 224::US11180471, Example 224	Plasma kallikrein			 4.60							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413831	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413831&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205567	433913931							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825964	CCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C26H23Cl2N7O3/c1-4-21(26(37)29-17-6-7-20-15(9-17)12-33(2)31-20)34-13-23(38-3)19(11-25(34)36)18-10-16(27)5-8-22(18)35-14-24(28)30-32-35/h5-14,21H,4H2,1-3H3,(H,29,37)	QBWXHIMIUSZAOP-UHFFFAOYSA-N	413774	2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 167::US10421742, Example 225::US11180471, Example 225	Plasma kallikrein			 3.50							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413774	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413774&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205467	433913877							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825965	CCC(C(=O)Nc1ccc2nn(CC(F)F)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C27H23Cl2F2N7O3/c1-3-21(27(40)32-17-5-6-20-15(8-17)11-36(34-20)14-25(30)31)37-12-23(41-2)19(10-26(37)39)18-9-16(28)4-7-22(18)38-13-24(29)33-35-38/h4-13,21,25H,3,14H2,1-2H3,(H,32,40)	GTOBEZUWBRGMLK-UHFFFAOYSA-N	413833	2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-[2-(2,2-difluoroethyl)-2H-indazol-5-yl]butanamide (Racemate)::US10421742, Example 226::US11180471, Example 226	Plasma kallikrein			 6.00							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413833	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413833&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205643	433913932							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825966	CCC(C(=O)Nc1ccc2nn(CC(F)(F)F)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C27H22Cl2F3N7O3/c1-3-21(26(41)33-17-5-6-20-15(8-17)11-37(35-20)14-27(30,31)32)38-12-23(42-2)19(10-25(38)40)18-9-16(28)4-7-22(18)39-13-24(29)34-36-39/h4-13,21H,3,14H2,1-2H3,(H,33,41)	DBBPDYZRKMIZOJ-UHFFFAOYSA-N	413834	2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-[2-(2,2,2-trifluoroethyl)-2H-indazol-5-yl]butanamide (Racemate)::US10421742, Example 227::US11180471, Example 227	Plasma kallikrein			 6.00							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413834	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413834&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135204990	433913933							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825967	CCC(C(=O)Nc1ccc2nc(C)ccc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C28H24Cl2N6O3/c1-4-23(28(38)32-19-8-9-22-17(11-19)6-5-16(2)31-22)35-14-25(39-3)21(13-27(35)37)20-12-18(29)7-10-24(20)36-15-26(30)33-34-36/h5-15,23H,4H2,1-3H3,(H,32,38)	AZYMEDAZJNOBLR-UHFFFAOYSA-N	413835	2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(2-methylquinolin-6-yl)butanamide (Racemate)::US10421742, Example 228::US11180471, Example 228	Plasma kallikrein			 2.90							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413835	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413835&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205176	433913934							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825968	CCC(C(=O)Nc1ccc2nc(C)ccc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C29H25ClF2N6O3/c1-4-24(29(40)34-19-8-9-22-17(11-19)6-5-16(2)33-22)37-15-26(41-3)21(13-27(37)39)20-12-18(30)7-10-25(20)38-14-23(28(31)32)35-36-38/h5-15,24,28H,4H2,1-3H3,(H,34,40)	FVOIRKKFLDCVKH-UHFFFAOYSA-N	413836	2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-N-(2-methylquinolin-6-yl)butanamide (Racemate)::US10421742, Example 229::US11180471, Example 229	Plasma kallikrein			 3.90							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413836	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413836&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205284	433913935							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825969	COc1cn(C(C)C(=O)Nc2ccc(C(N)=O)c(F)c2)c(=O)cc1-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C25H20ClF3N6O4/c1-12(25(38)31-14-4-5-15(24(30)37)18(27)8-14)34-11-21(39-2)17(9-22(34)36)16-7-13(26)3-6-20(16)35-10-19(23(28)29)32-33-35/h3-12,23H,1-2H3,(H2,30,37)(H,31,38)	JVCAULOQATWKKF-UHFFFAOYSA-N	413837	4-({2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]propanoyl}amino)-2-fluorobenzamide (Racemate)::US10421742, Example 230	Plasma kallikrein			 17.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413837	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413837&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135204687	433913936							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825970	CCC[C@@H](C(=O)Nc1ccc2nccnc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C28H24ClF2N7O3/c1-3-4-24(28(40)34-17-6-7-20-21(12-17)33-10-9-32-20)37-15-25(41-2)19(13-26(37)39)18-11-16(29)5-8-23(18)38-14-22(27(30)31)35-36-38/h5-15,24,27H,3-4H2,1-2H3,(H,34,40)/t24-/m0/s1	NKCIMLZZOJBOGZ-DEOSSOPVSA-N	413838	(2S)-2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-N-(quinoxalin-6-yl)pentanamide (Enantiomer 2)::US10421742, Example 231::US11180471, Example 231	Plasma kallikrein			 3.30							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413838	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413838&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135204967	433913937							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825971	CCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)(F)F	InChI=1S/C27H23ClF3N7O3/c1-4-21(26(40)32-17-6-7-20-15(9-17)12-36(2)34-20)37-13-23(41-3)19(11-25(37)39)18-10-16(28)5-8-22(18)38-14-24(33-35-38)27(29,30)31/h5-14,21H,4H2,1-3H3,(H,32,40)	YXQQDNTZJAXMNL-UHFFFAOYSA-N	413839	2-[4-{5-Chloro-2-[4-(trifluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 232::US11180471, Example 232	Plasma kallikrein			 5.20							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413839	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413839&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205554	433913938							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825972	CC[C@@H](C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)(F)F	InChI=1S/C27H23ClF3N7O3/c1-4-21(26(40)32-17-6-7-20-15(9-17)12-36(2)34-20)37-13-23(41-3)19(11-25(37)39)18-10-16(28)5-8-22(18)38-14-24(33-35-38)27(29,30)31/h5-14,21H,4H2,1-3H3,(H,32,40)/t21-/m0/s1	YXQQDNTZJAXMNL-NRFANRHFSA-N	413840	(2S)-2-[4-{5-Chloro-2-[4-(trifluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-N-(2-methyl-2H-indazol-5-yl)butanamide (Enantiomer 2)::US10421742, Example 233::US11180471, Example 233	Plasma kallikrein			 3.50							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413840	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413840&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205553	433913939							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825973	CCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)(F)F	InChI=1S/C26H21ClF4N6O4/c1-3-19(25(40)33-14-5-6-15(24(32)39)18(28)9-14)36-11-21(41-2)17(10-23(36)38)16-8-13(27)4-7-20(16)37-12-22(34-35-37)26(29,30)31/h4-12,19H,3H2,1-2H3,(H2,32,39)(H,33,40)	XYWIPYBIIRTJMM-UHFFFAOYSA-N	413841	4-({2-[4-{5-Chloro-2-[4-(trifluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanoyl}amino)-2-fluorobenzamide (Racemate)::US10421742, Example 234::US11180471, Example 234	Plasma kallikrein			 14.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413841	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413841&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205380	433913940							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825974	CC[C@@H](C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)(F)F	InChI=1S/C26H21ClF4N6O4/c1-3-19(25(40)33-14-5-6-15(24(32)39)18(28)9-14)36-11-21(41-2)17(10-23(36)38)16-8-13(27)4-7-20(16)37-12-22(34-35-37)26(29,30)31/h4-12,19H,3H2,1-2H3,(H2,32,39)(H,33,40)/t19-/m0/s1	XYWIPYBIIRTJMM-IBGZPJMESA-N	413842	4-({(2S)-2-[4-{5-Chloro-2-[4-(trifluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanoyl}amino)-2-fluorobenzamide (Enantiomer 2)::US10421742, Example 235::US11180471, Example 235	Plasma kallikrein			 5.70							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413842	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413842&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135206011	433913941							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825975	CCC(C(=O)Nc1ccc2nc(C)c(C)nc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)(F)F	InChI=1S/C29H25ClF3N7O3/c1-5-23(28(42)36-18-7-8-21-22(11-18)35-16(3)15(2)34-21)39-13-25(43-4)20(12-27(39)41)19-10-17(30)6-9-24(19)40-14-26(37-38-40)29(31,32)33/h6-14,23H,5H2,1-4H3,(H,36,42)	UDQDURKQOJZYOA-UHFFFAOYSA-N	413843	2-[4-{5-Chloro-2-[4-(trifluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-N-(2,3-dimethylquinoxalin-6-yl)butanamide (Racemate)::US10421742, Example 236::US11180471, Example 236	Plasma kallikrein			 5.80							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413843	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413843&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205535	433913942							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825976	CC[C@@H](C(=O)Nc1ccc2nc(C)c(C)nc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)(F)F	InChI=1S/C29H25ClF3N7O3/c1-5-23(28(42)36-18-7-8-21-22(11-18)35-16(3)15(2)34-21)39-13-25(43-4)20(12-27(39)41)19-10-17(30)6-9-24(19)40-14-26(37-38-40)29(31,32)33/h6-14,23H,5H2,1-4H3,(H,36,42)/t23-/m0/s1	UDQDURKQOJZYOA-QHCPKHFHSA-N	413844	(2S)-2-[4-{5-Chloro-2-[4-(trifluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-N-(2,3-dimethylquinoxalin-6-yl)butanamide (Enantiomer 2)::US10421742, Example 237::US11180471, Example 237	Plasma kallikrein			 2.40							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413844	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413844&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205533	433913943							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825977	CCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1cnc(o1)C(F)F	InChI=1S/C27H22ClF2N3O6/c1-3-20(25(35)32-16-7-4-14(5-8-16)27(36)37)33-13-22(38-2)19(11-23(33)34)18-10-15(28)6-9-17(18)21-12-31-26(39-21)24(29)30/h4-13,20,24H,3H2,1-2H3,(H,32,35)(H,36,37)	QFFBKCKFGNVYBW-UHFFFAOYSA-N	413845	4-({2-[4-{5-Chloro-2-[2-(difluoromethyl)-1,3-oxazol-5-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanoyl}amino)benzoic acid (Racemate)::US10421742, Example 238::US11180471, Example 238	Plasma kallikrein			 850							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413845	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413845&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205970	433913944							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825978	COc1cn(C(C)C(=O)Nc2ccc(C(N)=O)c(F)c2)c(=O)cc1-c1cc(Cl)ccc1-n1cc(nn1)C(F)(F)F	InChI=1S/C25H19ClF4N6O4/c1-12(24(39)32-14-4-5-15(23(31)38)18(27)8-14)35-10-20(40-2)17(9-22(35)37)16-7-13(26)3-6-19(16)36-11-21(33-34-36)25(28,29)30/h3-12H,1-2H3,(H2,31,38)(H,32,39)	SNUMNATTXKTJQD-UHFFFAOYSA-N	413846	4-({2-[4-{5-Chloro-2-[4-(trifluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]propanoyl}amino)-2-fluorobenzamide (Racemate)::US10421742, Example 239::US11180471, Example 239	Plasma kallikrein			 6.90							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413846	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413846&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205033	433913945							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825979	COc1cn([C@@H](C)C(=O)Nc2ccc(C(N)=O)c(F)c2)c(=O)cc1-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C24H19Cl2FN6O4/c1-12(24(36)29-14-4-5-15(23(28)35)18(27)8-14)32-10-20(37-2)17(9-22(32)34)16-7-13(25)3-6-19(16)33-11-21(26)30-31-33/h3-12H,1-2H3,(H2,28,35)(H,29,36)/t12-/m0/s1	QGNJMTPKSKWTBQ-LBPRGKRZSA-N	413847	4-{[(2S)-2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}propanoyl]amino}-2-fluorobenzamide (Enantiomer 2)::US10421742, Example 240::US11180471, Example 240	Plasma kallikrein			 3.50							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413847	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413847&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205642	433913946							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825980	COc1cn([C@@H](C)C(=O)Nc2ccc(C(N)=O)c(F)c2)c(=O)cc1-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C25H20ClF3N6O4/c1-12(25(38)31-14-4-5-15(24(30)37)18(27)8-14)34-11-21(39-2)17(9-22(34)36)16-7-13(26)3-6-20(16)35-10-19(23(28)29)32-33-35/h3-12,23H,1-2H3,(H2,30,37)(H,31,38)/t12-/m0/s1	JVCAULOQATWKKF-LBPRGKRZSA-N	413848	4-({(2S)-2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]propanoyl}amino)-2-fluorobenzamide (Enantiomer 2)::US10421742, Example 241::US11180471, Example 241	Plasma kallikrein			 6.00							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413848	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413848&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205975	433913947							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825981	CC[C@@H](C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C25H21Cl2FN6O4/c1-3-19(25(37)30-14-5-6-15(24(29)36)18(28)9-14)33-11-21(38-2)17(10-23(33)35)16-8-13(26)4-7-20(16)34-12-22(27)31-32-34/h4-12,19H,3H2,1-2H3,(H2,29,36)(H,30,37)/t19-/m0/s1	FPAKZDLGEHHCTC-IBGZPJMESA-N	413849	4-{[(2S)-2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}butanoyl]amino}-2-fluorobenzamide (Enantiomer 2)::US10421742, Example 242::US11180471, Example 242	Plasma kallikrein			 5.40							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413849	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413849&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205798	433913948							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825982	CC[C@@H](C(=O)Nc1ccc2nc(C)ccc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C29H25ClF2N6O3/c1-4-24(29(40)34-19-8-9-22-17(11-19)6-5-16(2)33-22)37-15-26(41-3)21(13-27(37)39)20-12-18(30)7-10-25(20)38-14-23(28(31)32)35-36-38/h5-15,24,28H,4H2,1-3H3,(H,34,40)/t24-/m0/s1	FVOIRKKFLDCVKH-DEOSSOPVSA-N	413850	(2S)-2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-N-(2-methylquinolin-6-yl)butanamide (Enantiomer 2)::US10421742, Example 243::US11180471, Example 243	Plasma kallikrein			 1.70							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413850	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413850&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205377	433913949							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825983	CC[C@@H](C(=O)Nc1ccc2nc(C)ccc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C28H24Cl2N6O3/c1-4-23(28(38)32-19-8-9-22-17(11-19)6-5-16(2)31-22)35-14-25(39-3)21(13-27(35)37)20-12-18(29)7-10-24(20)36-15-26(30)33-34-36/h5-15,23H,4H2,1-3H3,(H,32,38)/t23-/m0/s1	AZYMEDAZJNOBLR-QHCPKHFHSA-N	413851	(2S)-2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(2-methylquinolin-6-yl)butanamide (Enantiomer 2)::US10421742, Example 244::US11180471, Example 244	Plasma kallikrein			 1.40							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413851	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413851&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205851	433913950							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825984	CCC(C(=O)Nc1ccc2nn(C)c(C)c2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C27H25Cl2N7O3/c1-5-22(27(38)30-17-7-8-21-18(11-17)15(2)34(3)32-21)35-13-24(39-4)20(12-26(35)37)19-10-16(28)6-9-23(19)36-14-25(29)31-33-36/h6-14,22H,5H2,1-4H3,(H,30,38)	SBXOMGIKOINZME-UHFFFAOYSA-N	413852	2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(2,3-dimethyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 245::US11180471, Example 245	Plasma kallikrein			 5.80							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413852	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413852&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205409	433913951							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825985	CCC(C(=O)Nc1ccc2nn(C)c(C)c2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)(F)F	InChI=1S/C28H25ClF3N7O3/c1-5-22(27(41)33-17-7-8-21-18(11-17)15(2)37(3)35-21)38-13-24(42-4)20(12-26(38)40)19-10-16(29)6-9-23(19)39-14-25(34-36-39)28(30,31)32/h6-14,22H,5H2,1-4H3,(H,33,41)	MKSVLCRJUVAEQS-UHFFFAOYSA-N	413853	2-[4-{5-Chloro-2-[4-(trifluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-N-(2,3-dimethyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 246::US11180471, Example 246	Plasma kallikrein			 7.80							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413853	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413853&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205407	433913952							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825986	CCC(C(=O)Nc1ccc2nc(ccc2c1)C(F)(F)F)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C28H21Cl2F3N6O3/c1-3-21(27(41)34-17-6-7-20-15(10-17)4-9-24(35-20)28(31,32)33)38-13-23(42-2)19(12-26(38)40)18-11-16(29)5-8-22(18)39-14-25(30)36-37-39/h4-14,21H,3H2,1-2H3,(H,34,41)	SEVBXRKORJAERT-UHFFFAOYSA-N	413854	2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-[2-(trifluoromethyl)quinolin-6-yl]butanamide (Racemate)::US10421742, Example 247::US11180471, Example 247	Plasma kallikrein			 17.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413854	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413854&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205363	433913953							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825987	CCC(C(=O)Nc1ccc2nc(ccc2c1)C(F)(F)F)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C29H22ClF5N6O3/c1-3-22(28(43)36-17-6-7-20-15(10-17)4-9-25(37-20)29(33,34)35)40-14-24(44-2)19(12-26(40)42)18-11-16(30)5-8-23(18)41-13-21(27(31)32)38-39-41/h4-14,22,27H,3H2,1-2H3,(H,36,43)	SDQAOZYYHXEPNT-UHFFFAOYSA-N	413855	2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-N-[2-(trifluoromethyl)quinolin-6-yl]butanamide (Racemate)::US10421742, Example 248::US11180471, Example 248	Plasma kallikrein			 21.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413855	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413855&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205958	433913954							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825988	CCC(C(=O)Nc1ccc2nn(C)nc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C25H22Cl2N8O3/c1-4-20(25(37)28-15-6-7-18-19(10-15)31-33(2)30-18)34-12-22(38-3)17(11-24(34)36)16-9-14(26)5-8-21(16)35-13-23(27)29-32-35/h5-13,20H,4H2,1-3H3,(H,28,37)	LZHGUODYTWJFHC-UHFFFAOYSA-N	413856	2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(2-methyl-2H-benzotriazol-5-yl)butanamide (Racemate)::US10421742, Example 249::US11180471, Example 249	Plasma kallikrein			 7.60							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413856	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413856&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205352	433913955							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825989	CCC(C(=O)Nc1ccc2nn(CC)nc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C26H24Cl2N8O3/c1-4-21(26(38)29-16-7-8-19-20(11-16)32-36(5-2)31-19)34-13-23(39-3)18(12-25(34)37)17-10-15(27)6-9-22(17)35-14-24(28)30-33-35/h6-14,21H,4-5H2,1-3H3,(H,29,38)	IACDYBNAKZUROA-UHFFFAOYSA-N	413857	2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(2-ethyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 250	Plasma kallikrein			 4.70							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413857	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413857&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135211533	433913956							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825990	COc1cn([C@@H](C)C(=O)Nc2ccc(C(N)=O)c(F)c2)c(=O)cc1-c1cc(Cl)ccc1-n1cc(nn1)C(F)(F)F	InChI=1S/C25H19ClF4N6O4/c1-12(24(39)32-14-4-5-15(23(31)38)18(27)8-14)35-10-20(40-2)17(9-22(35)37)16-7-13(26)3-6-19(16)36-11-21(33-34-36)25(28,29)30/h3-12H,1-2H3,(H2,31,38)(H,32,39)/t12-/m0/s1	SNUMNATTXKTJQD-LBPRGKRZSA-N	413858	4-({(2S)-2-[4-{5-Chloro-2-[4-(trifluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]propanoyl}amino)-2-fluorobenzamide (Enantiomer 2)::US10421742, Example 251::US11180471, Example 251	Plasma kallikrein			 4.60							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413858	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413858&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205940	433913957							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825991	CCC(C(=O)Nc1ccc2nc(ccc2c1)C#N)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C29H22ClF2N7O3/c1-3-24(29(41)35-18-7-8-22-16(10-18)4-6-19(13-33)34-22)38-15-26(42-2)21(12-27(38)40)20-11-17(30)5-9-25(20)39-14-23(28(31)32)36-37-39/h4-12,14-15,24,28H,3H2,1-2H3,(H,35,41)	DERODARCDQXYDI-UHFFFAOYSA-N	413859	2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-N-(2-cyanoquinolin-6-yl)butanamide (Racemate)::US10421742, Example 252::US11180471, Example 252	Plasma kallikrein			 11.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413859	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413859&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205841	433913958							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825992	CCC(C(=O)Nc1ccc2nc(ccc2c1)C#N)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C28H21Cl2N7O3/c1-3-23(28(39)33-18-7-8-22-16(10-18)4-6-19(13-31)32-22)36-14-25(40-2)21(12-27(36)38)20-11-17(29)5-9-24(20)37-15-26(30)34-35-37/h4-12,14-15,23H,3H2,1-2H3,(H,33,39)	QCAYWCRUVAGYIH-UHFFFAOYSA-N	413860	2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(2-cyanoquinolin-6-yl)butanamide (Racemate)::US10421742, Example 253::US11180471, Example 253	Plasma kallikrein			 6.80							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413860	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413860&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135211506	433913959							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825993	CCC(C(=O)Nc1ccc2nn(CCO)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C27H25Cl2N7O4/c1-3-22(27(39)30-18-5-6-21-16(10-18)13-34(32-21)8-9-37)35-14-24(40-2)20(12-26(35)38)19-11-17(28)4-7-23(19)36-15-25(29)31-33-36/h4-7,10-15,22,37H,3,8-9H2,1-2H3,(H,30,39)	CJLPNFNSEYZOKO-UHFFFAOYSA-N	413861	2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-[2-(2-hydroxyethyl)-2H-indazol-5-yl]butanamide (Racemate)::US10421742, Example 254::US11180471, Example 254	Plasma kallikrein			 3.50							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413861	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413861&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205337	433913960							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825994	CCC(C(=O)Nc1ccc2nn(CCO)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C28H26ClF2N7O4/c1-3-23(28(41)32-18-5-6-21-16(10-18)13-36(34-21)8-9-39)37-15-25(42-2)20(12-26(37)40)19-11-17(29)4-7-24(19)38-14-22(27(30)31)33-35-38/h4-7,10-15,23,27,39H,3,8-9H2,1-2H3,(H,32,41)	ZWZWZPJQIZBWFH-UHFFFAOYSA-N	413862	2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-N-[2-(2-hydroxyethyl)-2H-indazol-5-yl]butanamide (Racemate)::US10421742, Example 255::US11180471, Example 255	Plasma kallikrein			 8.90							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413862	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413862&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205193	433913961							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825995	CCC(C(=O)Nc1ccc2[nH]nc(c2c1)C(F)(F)F)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1			413863	2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-[3-(trifluoromethyl)-1H-indazol-5-yl]butanamide (Racemate)::US10421742, Example 256::US11180471, Example 256	Plasma kallikrein			 17.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413863	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413863&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205900	433913962							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51119570	COc1ncc(cn1)-c1nc(C(=O)NC(N)=N)c(N)nc1N1CCCCCC1	InChI=1S/C17H23N9O2/c1-28-17-21-8-10(9-22-17)11-14(26-6-4-2-3-5-7-26)24-13(18)12(23-11)15(27)25-16(19)20/h8-9H,2-7H2,1H3,(H2,18,24)(H4,19,20,25,27)	WREBDSFOSWCPIS-UHFFFAOYSA-N	50459059	CHEMBL4217043	Plasma kallikrein			>50000							ChEMBL	10.1021/acs.jmedchem.8b00838	10.7270/Q2QF8WH4	30130401			Buckley, BJ; Aboelela, A; Minaei, E; Jiang, LX; Xu, Z; Ali, U; Fildes, K; Cheung, CY; Cook, SM; Johnson, DC; Bachovchin, DA; Cook, GM; Apte, M; Huang, M; Ranson, M; Kelso, MJ	University of Wollongong	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50459059	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50459059&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	30I	5ZAH	135393474	433926324							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51119594	NC(=N)NC(=O)c1nc(-c2cc3ccccc3o2)c(nc1N)N1CCCCCC1	InChI=1S/C20H23N7O2/c21-17-16(19(28)26-20(22)23)24-15(14-11-12-7-3-4-8-13(12)29-14)18(25-17)27-9-5-1-2-6-10-27/h3-4,7-8,11H,1-2,5-6,9-10H2,(H2,21,25)(H4,22,23,26,28)	FSPGYSVEHLETQR-UHFFFAOYSA-N	50459054	CHEMBL4213248	Plasma kallikrein			 11300							ChEMBL	10.1021/acs.jmedchem.8b00838	10.7270/Q2QF8WH4	30130401			Buckley, BJ; Aboelela, A; Minaei, E; Jiang, LX; Xu, Z; Ali, U; Fildes, K; Cheung, CY; Cook, SM; Johnson, DC; Bachovchin, DA; Cook, GM; Apte, M; Huang, M; Ranson, M; Kelso, MJ	University of Wollongong	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50459054	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50459054&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	50I	5ZA9,6L05	135393470	433926319							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825996	COc1cn([C@@H](CC(F)F)C(=O)Nc2ccc3nccnc3c2)c(=O)cc1-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C26H19Cl2F2N7O3/c1-40-22-12-36(21(11-24(29)30)26(39)33-15-3-4-18-19(9-15)32-7-6-31-18)25(38)10-17(22)16-8-14(27)2-5-20(16)37-13-23(28)34-35-37/h2-10,12-13,21,24H,11H2,1H3,(H,33,39)/t21-/m0/s1	SATGRGDFTKEDOC-NRFANRHFSA-N	413864	(2S)-2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4,4-difluoro-N-(quinoxalin-6-yl)butanamide (Enantiomer 2)::US10421742, Example 257::US11180471, Example 257	Plasma kallikrein			 2.70							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413864	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413864&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205541	433913963							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825997	CCCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)(F)F	InChI=1S/C27H23ClF4N6O4/c1-3-4-21(26(41)34-15-6-7-16(25(33)40)19(29)10-15)37-12-22(42-2)18(11-24(37)39)17-9-14(28)5-8-20(17)38-13-23(35-36-38)27(30,31)32/h5-13,21H,3-4H2,1-2H3,(H2,33,40)(H,34,41)	FQRNHVWJUMYDQS-UHFFFAOYSA-N	413865	4-({2-[4-{5-Chloro-2-[4-(trifluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]pentanoyl}amino)-2-fluorobenzamide (Racemate)::US10421742, Example 258::US11180471, Example 258	Plasma kallikrein			 34.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413865	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413865&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205430	433913964							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825740	COc1cn(C(CCOC(C)(C)C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1-c1cnco1	InChI=1S/C30H30ClN3O7/c1-30(2,3)41-12-11-24(28(36)33-20-8-5-18(6-9-20)29(37)38)34-16-26(39-4)23(14-27(34)35)22-13-19(31)7-10-21(22)25-15-32-17-40-25/h5-10,13-17,24H,11-12H2,1-4H3,(H,33,36)(H,37,38)	WPCCHOKPWHOVEL-UHFFFAOYSA-N	413602	4-[(4-tert-Butoxy-2-{4-[5-chloro-2-(1,3-oxazol-5-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}butanoyl)amino]benzoic acid (Racemate)::US10421742, Example 1::US11180471, Example 1	Plasma kallikrein			 41.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413602	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413602&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205829	433913710							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825741	COc1cn(C(CCOC(C)(C)C)C(=O)Nc2ccc3nn(C)cc3c2)c(=O)cc1-c1cc(Cl)ccc1-c1cnco1	InChI=1S/C31H32ClN5O5/c1-31(2,3)42-11-10-26(30(39)34-21-7-9-25-19(12-21)16-36(4)35-25)37-17-28(40-5)24(14-29(37)38)23-13-20(32)6-8-22(23)27-15-33-18-41-27/h6-9,12-18,26H,10-11H2,1-5H3,(H,34,39)	XCQGMIZGIJYINH-UHFFFAOYSA-N	413603	4-tert-Butoxy-2-{4-[5-chloro-2-(1,3-oxazol-5-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 2::US11180471, Example 2	Plasma kallikrein			 29.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413603	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413603&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205678	433913711							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825742	CCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1cnco1	InChI=1S/C26H22ClN3O6/c1-3-21(25(32)29-17-7-4-15(5-8-17)26(33)34)30-13-23(35-2)20(11-24(30)31)19-10-16(27)6-9-18(19)22-12-28-14-36-22/h4-14,21H,3H2,1-2H3,(H,29,32)(H,33,34)	IXCUXZHAJIAIIU-UHFFFAOYSA-N	413604	4-[(2-{4-[5-Chloro-2-(1,3-oxazol-5-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}butanoyl)amino]benzoic acid (Racemate)::US10421742, Example 3::US11180471, Example 3	Plasma kallikrein			 110							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413604	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413604&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205676	433913712							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825743	COc1cn(C(CCOC(F)(F)F)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1-c1cnco1	InChI=1S/C27H21ClF3N3O7/c1-39-23-13-34(24(35)11-20(23)19-10-16(28)4-7-18(19)22-12-32-14-40-22)21(8-9-41-27(29,30)31)25(36)33-17-5-2-15(3-6-17)26(37)38/h2-7,10-14,21H,8-9H2,1H3,(H,33,36)(H,37,38)	BNAZVDSXUSMSQR-UHFFFAOYSA-N	413605	4-{[2-{4-[5-Chloro-2-(1,3-oxazol-5-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-(trifluoromethoxy)butanoyl]amino}benzoic acid (Racemate)::US10421742, Example 4::US11180471, Example 4	Plasma kallikrein			 53.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413605	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413605&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135204648	433913713							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825744	COc1cn(C(C[C@@H]2CCCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1-c1cnco1	InChI=1S/C30H28ClN3O7/c1-39-27-16-34(28(35)14-24(27)23-12-19(31)7-10-22(23)26-15-32-17-41-26)25(13-21-4-2-3-11-40-21)29(36)33-20-8-5-18(6-9-20)30(37)38/h5-10,12,14-17,21,25H,2-4,11,13H2,1H3,(H,33,36)(H,37,38)/t21-,25?/m0/s1	DIXCLZVJKSCYHJ-BWDMCYIDSA-N	413608	4-[(2-{4-[5-Chloro-2-(1,3-oxazol-5-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-3-[(2S)-tetrahydro-2H-pyran-2-yl]propanoyl)amino]benzoic acid (Mixture of Enantiomerically Pure Diastereomers)::US10421742, Example 5::US11180471, Example 5	Plasma kallikrein			 53.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413608	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413608&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205983	433913716							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825745	COCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1cnco1	InChI=1S/C27H24ClN3O7/c1-36-10-9-22(26(33)30-18-6-3-16(4-7-18)27(34)35)31-14-24(37-2)21(12-25(31)32)20-11-17(28)5-8-19(20)23-13-29-15-38-23/h3-8,11-15,22H,9-10H2,1-2H3,(H,30,33)(H,34,35)	SEWAOULYQTXIQF-UHFFFAOYSA-N	413609	4-[(2-{4-[5-Chloro-2-(1,3-oxazol-5-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxy-butanoyl)amino]benzoic acid (Racemate)::US10421742, Example 6::US11180471, Example 6	Plasma kallikrein			 31.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413609	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413609&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135204684	433913717							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825746	COCC[C@@H](C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1cnco1	InChI=1S/C27H24ClN3O7/c1-36-10-9-22(26(33)30-18-6-3-16(4-7-18)27(34)35)31-14-24(37-2)21(12-25(31)32)20-11-17(28)5-8-19(20)23-13-29-15-38-23/h3-8,11-15,22H,9-10H2,1-2H3,(H,30,33)(H,34,35)/t22-/m0/s1	SEWAOULYQTXIQF-QFIPXVFZSA-N	413610	4-{[(2S)-2-{4-[5-Chloro-2-(1,3-oxazol-5-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxybutanoyl]amino}benzoic acid (Enantiomer 2)::US10421742, Example 7::US11180471, Example 7	Plasma kallikrein			 13.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413610	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413610&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205514	433913718							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825747	COCCC(C(=O)Nc1ccc(s1)C(=O)NC1CC1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1cnco1	InChI=1S/C28H27ClN4O6S/c1-37-10-9-21(27(35)32-25-8-7-24(40-25)28(36)31-17-4-5-17)33-14-23(38-2)20(12-26(33)34)19-11-16(29)3-6-18(19)22-13-30-15-39-22/h3,6-8,11-15,17,21H,4-5,9-10H2,1-2H3,(H,31,36)(H,32,35)	QJNOMWVCKLXXGM-UHFFFAOYSA-N	413612	5-[(2-{4-[5-Chloro-2-(1,3-oxazol-5-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxybutanoyl)amino]-N-cyclopropylthiophen-2-carboxamide (Racemate)::US10421742, Example 8::US11180471, Example 8	Plasma kallikrein			 21.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413612	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413612&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205789	433913720							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825748	COCCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1cnco1	InChI=1S/C28H26ClN5O5/c1-33-14-17-10-19(5-7-23(17)32-33)31-28(36)24(8-9-37-2)34-15-26(38-3)22(12-27(34)35)21-11-18(29)4-6-20(21)25-13-30-16-39-25/h4-7,10-16,24H,8-9H2,1-3H3,(H,31,36)	NAFNAAZYCZFUNR-UHFFFAOYSA-N	413613	2-{4-[5-Chloro-2-(1,3-oxazol-5-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxy-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 9::US11180471, Example 9	Plasma kallikrein			 11.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413613	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413613&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205704	433913721							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825749	CNC(=O)c1ccc(NC(=O)C(CCOC)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2-c2cnco2)cn1	InChI=1S/C27H26ClN5O6/c1-29-26(35)21-7-5-17(12-31-21)32-27(36)22(8-9-37-2)33-14-24(38-3)20(11-25(33)34)19-10-16(28)4-6-18(19)23-13-30-15-39-23/h4-7,10-15,22H,8-9H2,1-3H3,(H,29,35)(H,32,36)	BVTWDIIYCUBXNG-UHFFFAOYSA-N	413614	5-[(2-{4-[5-Chloro-2-(1,3-oxazol-5-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxybutanoyl)amino]-N-methylpyridine-2-carboxamide (Racemate)::US10421742, Example 10::US11180471, Example 10	Plasma kallikrein			 21.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413614	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413614&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205982	433913722							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825750	COCCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1cnco1	InChI=1S/C27H24ClFN4O6/c1-37-8-7-22(27(36)32-16-4-6-18(26(30)35)21(29)10-16)33-13-24(38-2)20(11-25(33)34)19-9-15(28)3-5-17(19)23-12-31-14-39-23/h3-6,9-14,22H,7-8H2,1-2H3,(H2,30,35)(H,32,36)	IQJRZUBQZPMNPH-UHFFFAOYSA-N	413615	4-[(2-{4-[5-Chloro-2-(1,3-oxazol-5-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxybutanoyl)amino]-2-fluorobenzamide (Racemate)::US10421742, Example 11::US11180471, Example 11	Plasma kallikrein			 19.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413615	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413615&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205451	433913723							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825751	COCCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C1=NOCC1	InChI=1S/C28H28ClN5O5/c1-33-15-17-12-19(5-7-23(17)31-33)30-28(36)25(9-10-37-2)34-16-26(38-3)22(14-27(34)35)21-13-18(29)4-6-20(21)24-8-11-39-32-24/h4-7,12-16,25H,8-11H2,1-3H3,(H,30,36)	NMQHQLHZXFJBKV-UHFFFAOYSA-N	413616	2-{4-[5-Chloro-2-(4,5-dihydro-1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxy-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 12::US11180471, Example 12	Plasma kallikrein			 34.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413616	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413616&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135204747	433913724							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825752	COCC[C@@H](C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C1=NOCC1	InChI=1S/C28H28ClN5O5/c1-33-15-17-12-19(5-7-23(17)31-33)30-28(36)25(9-10-37-2)34-16-26(38-3)22(14-27(34)35)21-13-18(29)4-6-20(21)24-8-11-39-32-24/h4-7,12-16,25H,8-11H2,1-3H3,(H,30,36)/t25-/m0/s1	NMQHQLHZXFJBKV-VWLOTQADSA-N	413617	(2S)-2-{4-[5-Chloro-2-(4,5-dihydro-1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxy-N-(2-methyl-2H-indazol-5-yl)butanamide (Enantiomer 2)::US10421742, Example 13::US11180471, Example 13	Plasma kallikrein			 34.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413617	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413617&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205289	433913725							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825753	COCCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C1=NOCC1	InChI=1S/C27H26ClFN4O6/c1-37-9-8-23(27(36)31-16-4-6-18(26(30)35)21(29)12-16)33-14-24(38-2)20(13-25(33)34)19-11-15(28)3-5-17(19)22-7-10-39-32-22/h3-6,11-14,23H,7-10H2,1-2H3,(H2,30,35)(H,31,36)	DABAFGKGZQBJDK-UHFFFAOYSA-N	413618	4-[(2-{4-[5-Chloro-2-(4,5-dihydro-1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxybutanoyl)amino]-2-fluorobenzamide (Racemate)::US10421742, Example 14::US11180471, Example 14	Plasma kallikrein			 85.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413618	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413618&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205928	433913726							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825754	COCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C1=NOCC1	InChI=1S/C27H26ClN3O7/c1-36-11-10-23(26(33)29-18-6-3-16(4-7-18)27(34)35)31-15-24(37-2)21(14-25(31)32)20-13-17(28)5-8-19(20)22-9-12-38-30-22/h3-8,13-15,23H,9-12H2,1-2H3,(H,29,33)(H,34,35)	LOUUMSPZPZILMW-UHFFFAOYSA-N	413620	4-[(2-{4-[5-Chloro-2-(4,5-dihydro-1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxybutanoyl)amino]benzoic acid (Racemate)::US10421742, Example 15::US11180471, Example 15	Plasma kallikrein			 85.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413620	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413620&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205416	433913727							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825755	CNC(=O)c1ccc(NC(=O)C(CCOC)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2C2=NOCC2)cc1F	InChI=1S/C28H28ClFN4O6/c1-31-27(36)19-7-5-17(13-22(19)30)32-28(37)24(9-10-38-2)34-15-25(39-3)21(14-26(34)35)20-12-16(29)4-6-18(20)23-8-11-40-33-23/h4-7,12-15,24H,8-11H2,1-3H3,(H,31,36)(H,32,37)	JFECOVHUSFKCIW-UHFFFAOYSA-N	413622	4-[(2-{4-[5-Chloro-2-(4,5-dihydro-1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxybutanoyl)amino]-2-fluoro-N-methylbenzamide (Racemate)::US10421742, Example 16::US11180471, Example 16	Plasma kallikrein			 99.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413622	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413622&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205842	433913728							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825756	COCCC(C(=O)Nc1ccc(nc1)C(N)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C1=NOCCO1	InChI=1S/C26H26ClN5O7/c1-36-8-7-21(25(35)30-16-4-6-20(24(28)34)29-13-16)32-14-22(37-2)19(12-23(32)33)18-11-15(27)3-5-17(18)26-31-39-10-9-38-26/h3-6,11-14,21H,7-10H2,1-2H3,(H2,28,34)(H,30,35)	KGGJSEUIYZFMSZ-UHFFFAOYSA-N	413623	5-[(2-{4-[5-Chloro-2-(5,6-dihydro-1,4,2-dioxazin-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxybutanoyl)amino]pyridine-2-carboxamide (Racemate)::US10421742, Example 17::US11180471, Example 17	Plasma kallikrein			 500							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413623	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413623&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205954	433913729							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825757	COCCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C1=NOCCO1	InChI=1S/C28H28ClN5O6/c1-33-15-17-12-19(5-7-23(17)31-33)30-27(36)24(8-9-37-2)34-16-25(38-3)22(14-26(34)35)21-13-18(29)4-6-20(21)28-32-40-11-10-39-28/h4-7,12-16,24H,8-11H2,1-3H3,(H,30,36)	RGUMZXDJADTTSV-UHFFFAOYSA-N	413624	2-{4-[5-Chloro-2-(5,6-dihydro-1,4,2-dioxazin-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxy-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 18::US11180471, Example 18	Plasma kallikrein			 150							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413624	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413624&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205290	433913730							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825758	COCCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C26H25ClN8O4/c1-33-13-16-10-18(5-6-21(16)30-33)29-26(37)23(8-9-38-2)34-14-24(39-3)20(12-25(34)36)19-11-17(27)4-7-22(19)35-15-28-31-32-35/h4-7,10-15,23H,8-9H2,1-3H3,(H,29,37)	UUIHUWPHJJSKFX-UHFFFAOYSA-N	413625	2-{4-[5-Chloro-2-(1H-tetrazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxy-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 19::US11180471, Example 19	Plasma kallikrein			 1.10							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413625	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413625&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205820	433913731							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825759	COCCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C25H23ClFN7O5/c1-38-8-7-21(25(37)30-15-4-5-16(24(28)36)19(27)10-15)33-12-22(39-2)18(11-23(33)35)17-9-14(26)3-6-20(17)34-13-29-31-32-34/h3-6,9-13,21H,7-8H2,1-2H3,(H2,28,36)(H,30,37)	IICMIKXBIINPOO-UHFFFAOYSA-N	413626	4-[(2-{4-[5-Chloro-2-(1H-tetrazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxy-butanoyl)amino]-2-fluorobenzamide (Racemate)::US10421742, Example 20::US11180471, Example 20	Plasma kallikrein			 1.40							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413626	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413626&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205703	433913732							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825760	COCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1ccnc1	InChI=1S/C27H25ClN4O6/c1-37-12-9-23(26(34)30-19-6-3-17(4-7-19)27(35)36)32-15-24(38-2)21(14-25(32)33)20-13-18(28)5-8-22(20)31-11-10-29-16-31/h3-8,10-11,13-16,23H,9,12H2,1-2H3,(H,30,34)(H,35,36)	QAOJLVDDEDCBPJ-UHFFFAOYSA-N	413627	4-[(2-{4-[5-Chloro-2-(1H-imidazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxy-butanoyl)amino]benzoic acid (Racemate)::US10421742, Example 21::US11180471, Example 21	Plasma kallikrein			 69.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413627	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413627&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205879	433913733							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825761	COCCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1ccnc1	InChI=1S/C27H25ClFN5O5/c1-38-10-7-23(27(37)32-17-4-5-18(26(30)36)21(29)12-17)34-14-24(39-2)20(13-25(34)35)19-11-16(28)3-6-22(19)33-9-8-31-15-33/h3-6,8-9,11-15,23H,7,10H2,1-2H3,(H2,30,36)(H,32,37)	NHVDXTRNBLJMKL-UHFFFAOYSA-N	413628	4-[(2-{4-[5-Chloro-2-(1H-imidazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxy-butanoyl)amino]-2-fluorobenzamide (Racemate)::US10421742, Example 22::US11180471, Example 22	Plasma kallikrein			 31.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413628	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413628&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205815	433913734							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825762	COCCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1ccnc1	InChI=1S/C28H27ClN6O4/c1-33-15-18-12-20(5-6-23(18)32-33)31-28(37)25(8-11-38-2)35-16-26(39-3)22(14-27(35)36)21-13-19(29)4-7-24(21)34-10-9-30-17-34/h4-7,9-10,12-17,25H,8,11H2,1-3H3,(H,31,37)	HEMONLHVVQNSEO-UHFFFAOYSA-N	413629	2-{4-[5-Chloro-2-(1H-imidazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1 (2f)-yl}-4-methoxy-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 23::US11180471, Example 23	Plasma kallikrein			 12.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413629	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413629&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205442	433913735							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825763	COCCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1cocn1	InChI=1S/C27H24ClFN4O6/c1-37-8-7-23(27(36)32-16-4-6-18(26(30)35)21(29)10-16)33-12-24(38-2)20(11-25(33)34)19-9-15(28)3-5-17(19)22-13-39-14-31-22/h3-6,9-14,23H,7-8H2,1-2H3,(H2,30,35)(H,32,36)	WWYXXZQZSPIQLH-UHFFFAOYSA-N	413630	4-[(2-{4-[5-Chloro-2-(1,3-oxazol-4-yl)phenyl]-5-methoxy-2-oxopyridin-1 (2N)-yl}-4-methoxybutanoyl)amino]-2-fluorobenzamide (Racemate)::US10421742, Example 24::US11180471, Example 24	Plasma kallikrein			 360							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413630	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413630&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135211514	433913736							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825764	COCCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1cocn1	InChI=1S/C28H26ClN5O5/c1-33-13-17-10-19(5-7-23(17)32-33)31-28(36)25(8-9-37-2)34-14-26(38-3)22(12-27(34)35)21-11-18(29)4-6-20(21)24-15-39-16-30-24/h4-7,10-16,25H,8-9H2,1-3H3,(H,31,36)	LMABFZNOSCTFBL-UHFFFAOYSA-N	413631	2-{4-[5-Chloro-2-(1,3-oxazol-4-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxy-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 25::US11180471, Example 25	Plasma kallikrein			 170							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413631	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413631&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135206017	433913737							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825765	COCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1cocn1	InChI=1S/C27H24ClN3O7/c1-36-10-9-23(26(33)30-18-6-3-16(4-7-18)27(34)35)31-13-24(37-2)21(12-25(31)32)20-11-17(28)5-8-19(20)22-14-38-15-29-22/h3-8,11-15,23H,9-10H2,1-2H3,(H,30,33)(H,34,35)	DDOXVBZTTPBKNS-UHFFFAOYSA-N	413632	4-[(2-{4-[5-Chloro-2-(1,3-oxazol-4-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxybutanoyl)amino]benzoic acid (Racemate)::US10421742, Example 26::US11180471, Example 26	Plasma kallikrein			 510							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413632	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413632&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205923	433913738							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825766	COCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnco1	InChI=1S/C26H23ClN4O7/c1-36-10-9-21(24(33)29-17-6-3-15(4-7-17)26(34)35)31-13-22(37-2)20(12-23(31)32)19-11-16(27)5-8-18(19)25-30-28-14-38-25/h3-8,11-14,21H,9-10H2,1-2H3,(H,29,33)(H,34,35)	QIURUUZJCMOSSC-UHFFFAOYSA-N	413633	4-[(2-{4-[5-Chloro-2-(1,3,4-oxadiazol-2-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxybutanoyl)amino]benzoic acid (Racemate)::US10421742, Example 27::US11180471, Example 27	Plasma kallikrein			 18.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413633	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413633&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205873	433913739							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825767	COCCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnco1	InChI=1S/C26H23ClFN5O6/c1-37-8-7-21(25(36)31-15-4-6-17(24(29)35)20(28)10-15)33-12-22(38-2)19(11-23(33)34)18-9-14(27)3-5-16(18)26-32-30-13-39-26/h3-6,9-13,21H,7-8H2,1-2H3,(H2,29,35)(H,31,36)	UISHCWSATBUTQA-UHFFFAOYSA-N	413634	4-[(2-{4-[5-Chloro-2-(1,3,4-oxadiazol-2-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxybutanoyl)amino]-2-fluorobenzamide (Racemate)::US10421742, Example 28::US11180471, Example 28	Plasma kallikrein			 20.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413634	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413634&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205855	433913740							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825768	CNC(=O)c1ccc(NC(=O)C(CCOC)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2-n2cc(F)cn2)cn1	InChI=1S/C27H26ClFN6O5/c1-30-26(37)21-6-5-18(13-31-21)33-27(38)23(8-9-39-2)34-15-24(40-3)20(11-25(34)36)19-10-16(28)4-7-22(19)35-14-17(29)12-32-35/h4-7,10-15,23H,8-9H2,1-3H3,(H,30,37)(H,33,38)	VTZPJMDYPXOBMS-UHFFFAOYSA-N	413635	5-[(2-{4-[5-Chloro-2-(4-fluoro-1H-pyrazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2N)-yl}-4-methoxybutanoyl)amino]-N-methylpyridine-2-carboxamide (Racemate)::US10421742, Example 29::US11180471, Example 29	Plasma kallikrein			 870							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413635	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413635&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135211518	433913741							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825769	COCCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnco1	InChI=1S/C27H25ClN6O5/c1-33-13-16-10-18(5-7-22(16)32-33)30-26(36)23(8-9-37-2)34-14-24(38-3)21(12-25(34)35)20-11-17(28)4-6-19(20)27-31-29-15-39-27/h4-7,10-15,23H,8-9H2,1-3H3,(H,30,36)	VWKPWXZBFLVGCL-UHFFFAOYSA-N	413636	2-{4-[5-Chloro-2-(1,3,4-oxadiazol-2-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxy-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 30::US11180471, Example 30	Plasma kallikrein			 11.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413636	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413636&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205971	433913742							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825770	COc1cn(C(CC2COCCO2)C(=O)Nc2ccc3nccnc3c2)c(=O)cc1-c1cc(Cl)ccc1C1=NOCC1	InChI=1S/C30H28ClN5O6/c1-39-28-16-36(29(37)15-23(28)22-12-18(31)2-4-21(22)24-6-9-42-35-24)27(14-20-17-40-10-11-41-20)30(38)34-19-3-5-25-26(13-19)33-8-7-32-25/h2-5,7-8,12-13,15-16,20,27H,6,9-11,14,17H2,1H3,(H,34,38)	GRVRMTKUMARYRR-UHFFFAOYSA-N	413637	N-(Quinoxalin-6-yl)-2-{4-[5-chloro-2-(4,5-dihydro-1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-3-(1,4-dioxan-2-yl)propanamide (Diastereomer Mixture)::US10421742, Example 31::US11180471, Example 31	Plasma kallikrein			 21.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413637	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413637&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205330	433913743							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825771	COc1cn(C(CC2COCCO2)C(=O)Nc2ccc3nn(C)cc3c2)c(=O)cc1-c1cc(Cl)ccc1C1=NOCC1	InChI=1S/C30H30ClN5O6/c1-35-15-18-11-20(4-6-25(18)33-35)32-30(38)27(13-21-17-40-9-10-41-21)36-16-28(39-2)24(14-29(36)37)23-12-19(31)3-5-22(23)26-7-8-42-34-26/h3-6,11-12,14-16,21,27H,7-10,13,17H2,1-2H3,(H,32,38)	NOYWIPLIXQSLPY-UHFFFAOYSA-N	413638	2-{4-[5-Chloro-2-(4,5-dihydro-1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-3-(1,4-dioxan-2-yl)-N-(2-methyl-2H-indazol-5-yl)propanamide (Diastereomer Mixture)::US10421742, Example 32::US11180471, Example 32	Plasma kallikrein			 51.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413638	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413638&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205291	433913744							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825772	COc1cn(C(CC2COCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C1=NOCC1	InChI=1S/C29H28ClN3O8/c1-38-26-15-33(27(34)14-23(26)22-12-18(30)4-7-21(22)24-8-9-41-32-24)25(13-20-16-39-10-11-40-20)28(35)31-19-5-2-17(3-6-19)29(36)37/h2-7,12,14-15,20,25H,8-11,13,16H2,1H3,(H,31,35)(H,36,37)	DVWWRIVKJVUPDO-UHFFFAOYSA-N	413639	4-{[2-{4-[5-Chloro-2-(4,5-dihydro-1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-3-(1,4-dioxan-2-yl)propanoyl]amino}benzoic acid (Diastereomer Mixture)::US10421742, Example 33::US11180471, Example 33	Plasma kallikrein			 170							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413639	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413639&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205538	433913745							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825773	CNC(=O)c1ccc(NC(=O)C(CC2COCCO2)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2C2=NOCC2)cn1	InChI=1S/C29H30ClN5O7/c1-31-28(37)24-6-4-18(14-32-24)33-29(38)25(12-19-16-40-9-10-41-19)35-15-26(39-2)22(13-27(35)36)21-11-17(30)3-5-20(21)23-7-8-42-34-23/h3-6,11,13-15,19,25H,7-10,12,16H2,1-2H3,(H,31,37)(H,33,38)	DEFNAUKAAWHGKT-UHFFFAOYSA-N	413640	5-{[2-{4-[5-Chloro-2-(4,5-dihydro-1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-3-(1,4-dioxan-2-yl)propanoyl]amino}-N-methylpyridine-2-carboxamide (Diastereomer Mixture)::US10421742, Example 34::US11180471, Example 34	Plasma kallikrein			 140							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413640	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413640&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205531	433913746							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825774	COc1cn(C(C[C@@H]2CCCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C1=NOCC1	InChI=1S/C30H30ClN3O7/c1-39-27-17-34(28(35)16-24(27)23-14-19(31)7-10-22(23)25-11-13-41-33-25)26(15-21-4-2-3-12-40-21)29(36)32-20-8-5-18(6-9-20)30(37)38/h5-10,14,16-17,21,26H,2-4,11-13,15H2,1H3,(H,32,36)(H,37,38)/t21-,26?/m0/s1	DSSYHGODIQPLGT-GVNKFJBHSA-N	413641	4-[(2-{4-[5-Chloro-2-(4,5-dihydro-1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-3-[(2S)-tetrahydro-2H-pyran-2-yl]propanoyl)amino]benzoic acid (Diastereomer Mixture)::US10421742, Example 35::US10421742, Example 36::US11180471, Example 36	Plasma kallikrein			 83.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413641	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413641&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205730	433913747							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825775	COc1cn(C(C[C@@H]2CCCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C1=NOCC1	InChI=1S/C30H30ClN3O7/c1-39-27-17-34(28(35)16-24(27)23-14-19(31)7-10-22(23)25-11-13-41-33-25)26(15-21-4-2-3-12-40-21)29(36)32-20-8-5-18(6-9-20)30(37)38/h5-10,14,16-17,21,26H,2-4,11-13,15H2,1H3,(H,32,36)(H,37,38)/t21-,26?/m0/s1	DSSYHGODIQPLGT-GVNKFJBHSA-N	413641	4-[(2-{4-[5-Chloro-2-(4,5-dihydro-1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-3-[(2S)-tetrahydro-2H-pyran-2-yl]propanoyl)amino]benzoic acid (Diastereomer Mixture)::US10421742, Example 35::US10421742, Example 36::US11180471, Example 36	Plasma kallikrein			 96.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413641	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413641&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205730	433913747							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825776	CNC(=O)c1ccc(NC(=O)C(C[C@@H]2CCCCO2)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2C2=NOCC2)cn1	InChI=1S/C30H32ClN5O6/c1-32-29(38)25-9-7-19(16-33-25)34-30(39)26(14-20-5-3-4-11-41-20)36-17-27(40-2)23(15-28(36)37)22-13-18(31)6-8-21(22)24-10-12-42-35-24/h6-9,13,15-17,20,26H,3-5,10-12,14H2,1-2H3,(H,32,38)(H,34,39)/t20-,26?/m0/s1	YJLNILRUWJVMCG-DQUNLGLBSA-N	413643	5-[(2-{4-[5-Chloro-2-(4,5-dihydro-1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-3-[(2S)-tetrahydro-2H-pyran-2-yl]propanoyl)amino]-N-methylpyridine-2-carboxamide (Diastereomer Mixture)::US10421742, Example 37::US11180471, Example 37	Plasma kallikrein			 100.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413643	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413643&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205449	433913748							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825777	COc1cn(C(C[C@@H]2CCCCO2)C(=O)Nc2ccc3nn(C)cc3c2)c(=O)cc1-c1cc(Cl)ccc1C1=NOCC1	InChI=1S/C31H32ClN5O5/c1-36-17-19-13-21(7-9-26(19)34-36)33-31(39)28(15-22-5-3-4-11-41-22)37-18-29(40-2)25(16-30(37)38)24-14-20(32)6-8-23(24)27-10-12-42-35-27/h6-9,13-14,16-18,22,28H,3-5,10-12,15H2,1-2H3,(H,33,39)/t22-,28?/m0/s1	LNIZEAPOEAZWLH-XYXHBKGXSA-N	413644	2-{4-[5-Chloro-2-(4,5-dihydro-1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(2-methyl-2H-indazol-5-yl)-3-[(2S)-tetrahydro-2H-pyran-2-yl]propanamide (Diastereomer Mixture)::US10421742, Example 38::US11180471, Example 38	Plasma kallikrein			 46.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413644	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413644&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205844	433913749							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825778	COc1cn(C(C[C@H]2CCCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C1=NOCC1	InChI=1S/C30H30ClN3O7/c1-39-27-17-34(28(35)16-24(27)23-14-19(31)7-10-22(23)25-11-13-41-33-25)26(15-21-4-2-3-12-40-21)29(36)32-20-8-5-18(6-9-20)30(37)38/h5-10,14,16-17,21,26H,2-4,11-13,15H2,1H3,(H,32,36)(H,37,38)/t21-,26?/m1/s1	DSSYHGODIQPLGT-OSMGYRLQSA-N	413645	4-[(2-{4-[5-Chloro-2-(4,5-dihydro-1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-3-[(2R)-tetrahydro-2H-pyran-2-yl]propanoyl)amino]benzoic acid (Diastereomer Mixture)::US10421742, Example 39::US11180471, Example 39	Plasma kallikrein			 570							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413645	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413645&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205996	433913750							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825779	COc1cn(C(C[C@H]2CCCCO2)C(=O)Nc2ccc3nn(C)cc3c2)c(=O)cc1-c1cc(Cl)ccc1C1=NOCC1	InChI=1S/C31H32ClN5O5/c1-36-17-19-13-21(7-9-26(19)34-36)33-31(39)28(15-22-5-3-4-11-41-22)37-18-29(40-2)25(16-30(37)38)24-14-20(32)6-8-23(24)27-10-12-42-35-27/h6-9,13-14,16-18,22,28H,3-5,10-12,15H2,1-2H3,(H,33,39)/t22-,28?/m1/s1	LNIZEAPOEAZWLH-WZOMIXFGSA-N	413646	2-{4-[5-Chloro-2-(4,5-dihydro-1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(2-methyl-2H-indazol-5-yl)-3-[(2R)-tetrahydro-2H-pyran-2-yl]propanamide (Diastereomer Mixture)::US10421742, Example 40::US11180471, Example 40	Plasma kallikrein			 130							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413646	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413646&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205645	433913751							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825780	COc1cn(C(C[C@H]2CCCCO2)C(=O)Nc2ccc(C(N)=O)c(F)c2)c(=O)cc1-c1cc(Cl)ccc1C1=NOCC1	InChI=1S/C30H30ClFN4O6/c1-40-27-16-36(28(37)15-23(27)22-12-17(31)5-7-20(22)25-9-11-42-35-25)26(14-19-4-2-3-10-41-19)30(39)34-18-6-8-21(29(33)38)24(32)13-18/h5-8,12-13,15-16,19,26H,2-4,9-11,14H2,1H3,(H2,33,38)(H,34,39)/t19-,26?/m1/s1	BKMNWKMPOGYRQA-ICCFGIFFSA-N	413647	4-[(2-{4-[5-Chloro-2-(4,5-dihydro-1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-3-[(2R)-tetrahydro-2H-pyran-2-yl]propanoyl)amino]-2-fluorobenzamide (Diastereomer Mixture)::US10421742, Example 41::US11180471, Example 41	Plasma kallikrein			 220							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413647	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413647&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205771	433913752							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825781	CNC(=O)c1ccc(NC(=O)C(CCOC)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2-c2ccon2)cn1	InChI=1S/C27H26ClN5O6/c1-29-26(35)22-7-5-17(14-30-22)31-27(36)23(9-10-37-2)33-15-24(38-3)20(13-25(33)34)19-12-16(28)4-6-18(19)21-8-11-39-32-21/h4-8,11-15,23H,9-10H2,1-3H3,(H,29,35)(H,31,36)	DGUWRYFZSHPSRF-UHFFFAOYSA-N	413648	5-[(2-{4-[5-Chloro-2-(1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxybutanoyl)amino]-N-methylpyridin-2-carboxamide (Racemate)::US10421742, Example 42::US11180471, Example 42	Plasma kallikrein			 24.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413648	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413648&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135206087	433913753							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825782	COCCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1ccon1	InChI=1S/C28H26ClN5O5/c1-33-15-17-12-19(5-7-23(17)31-33)30-28(36)25(9-10-37-2)34-16-26(38-3)22(14-27(34)35)21-13-18(29)4-6-20(21)24-8-11-39-32-24/h4-8,11-16,25H,9-10H2,1-3H3,(H,30,36)	MQPMEUJFEVBLRJ-UHFFFAOYSA-N	413649	2-{4-[5-Chloro-2-(1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxy-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 43::US11180471, Example 43	Plasma kallikrein			 18.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413649	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413649&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135206020	433913754							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825783	CNC(=O)c1ccc(NC(=O)C(CCOC(C)(C)C)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2-c2ccon2)cn1	InChI=1S/C30H32ClN5O6/c1-30(2,3)41-12-11-25(29(39)34-19-7-9-24(33-16-19)28(38)32-4)36-17-26(40-5)22(15-27(36)37)21-14-18(31)6-8-20(21)23-10-13-42-35-23/h6-10,13-17,25H,11-12H2,1-5H3,(H,32,38)(H,34,39)	XQIJVKWEUWNLCF-UHFFFAOYSA-N	413650	5-[(4-tert-Butoxy-2-{4-[5-chloro-2-(1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}butanoyl)amino]-N-methylpyridine-2-carboxamide (Racemate)::US10421742, Example 44::US11180471, Example 44	Plasma kallikrein			 18.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413650	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413650&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205942	433913755							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825784	COc1cn(C(CCOC(C)(C)C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1-c1ccon1	InChI=1S/C30H30ClN3O7/c1-30(2,3)40-13-12-25(28(36)32-20-8-5-18(6-9-20)29(37)38)34-17-26(39-4)23(16-27(34)35)22-15-19(31)7-10-21(22)24-11-14-41-33-24/h5-11,14-17,25H,12-13H2,1-4H3,(H,32,36)(H,37,38)	XVQJXIHGEMVIBL-UHFFFAOYSA-N	413651	4-[(4-tert-Butoxy-2-{4-[5-chloro-2-(1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}butanoyl)amino]benzoic acid (Racemate)::US10421742, Example 45::US11180471, Example 45	Plasma kallikrein			 28.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413651	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413651&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205454	433913756							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825785	COc1cn([C@@H](CCOC(C)(C)C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1-c1ccon1	InChI=1S/C30H30ClN3O7/c1-30(2,3)40-13-12-25(28(36)32-20-8-5-18(6-9-20)29(37)38)34-17-26(39-4)23(16-27(34)35)22-15-19(31)7-10-21(22)24-11-14-41-33-24/h5-11,14-17,25H,12-13H2,1-4H3,(H,32,36)(H,37,38)/t25-/m0/s1	XVQJXIHGEMVIBL-VWLOTQADSA-N	413652	4-{[(2S)-4-tert-Butoxy-2-{4-[5-chloro-2-(1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}butanoyl]amino}benzoic acid (Enantiomer 2)::US10421742, Example 46::US11180471, Example 46	Plasma kallikrein			 15.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413652	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413652&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205453	433913757							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825786	COc1cn(C(C[C@@H]2CCCCO2)C(=O)Nc2ccc3nccnc3c2)c(=O)cc1-c1cc(Cl)ccc1-c1ccon1	InChI=1S/C31H28ClN5O5/c1-40-29-18-37(30(38)17-24(29)23-14-19(32)5-7-22(23)25-9-13-42-36-25)28(16-21-4-2-3-12-41-21)31(39)35-20-6-8-26-27(15-20)34-11-10-33-26/h5-11,13-15,17-18,21,28H,2-4,12,16H2,1H3,(H,35,39)/t21-,28?/m0/s1	QHFRLRVXSRUUOC-QDLLFRBVSA-N	413653	N-(Quinoxalin-6-yl)-2-{4-[5-chloro-2-(1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-3-[(2S)-tetrahydro-2H-pyran-2-yl]propanamide (Diastereomer Mixture)::US10421742, Example 47::US11180471, Example 47	Plasma kallikrein			 25.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413653	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413653&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205254	433913758							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825787	COc1cn(C(C[C@@H]2CCCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1-c1ccon1	InChI=1S/C30H28ClN3O7/c1-39-27-17-34(28(35)16-24(27)23-14-19(31)7-10-22(23)25-11-13-41-33-25)26(15-21-4-2-3-12-40-21)29(36)32-20-8-5-18(6-9-20)30(37)38/h5-11,13-14,16-17,21,26H,2-4,12,15H2,1H3,(H,32,36)(H,37,38)/t21-,26?/m0/s1	RTTPBBKILQCFGH-GVNKFJBHSA-N	413654	4-[(2-{4-[5-Chloro-2-(1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-3-[(2S)-tetrahydro-2H-pyran-2-yl]propanoyl)amino]benzoic acid (Diastereomer Mixture)::US10421742, Example 48::US10421742, Example 49::US11180471, Example 49	Plasma kallikrein			 49.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413654	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413654&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205526	433913759							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825788	COc1cn(C(C[C@@H]2CCCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1-c1ccon1	InChI=1S/C30H28ClN3O7/c1-39-27-17-34(28(35)16-24(27)23-14-19(31)7-10-22(23)25-11-13-41-33-25)26(15-21-4-2-3-12-40-21)29(36)32-20-8-5-18(6-9-20)30(37)38/h5-11,13-14,16-17,21,26H,2-4,12,15H2,1H3,(H,32,36)(H,37,38)/t21-,26?/m0/s1	RTTPBBKILQCFGH-GVNKFJBHSA-N	413654	4-[(2-{4-[5-Chloro-2-(1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-3-[(2S)-tetrahydro-2H-pyran-2-yl]propanoyl)amino]benzoic acid (Diastereomer Mixture)::US10421742, Example 48::US10421742, Example 49::US11180471, Example 49	Plasma kallikrein			 17.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413654	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413654&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205526	433913759							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825789	COCCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnc(F)c1	InChI=1S/C28H26ClFN6O4/c1-34-13-17-10-19(5-6-22(17)33-34)32-28(38)24(8-9-39-2)36-14-25(40-3)21(12-27(36)37)20-11-18(29)4-7-23(20)35-15-26(30)31-16-35/h4-7,10-16,24H,8-9H2,1-3H3,(H,32,38)	XXIIEASKYLNDLZ-UHFFFAOYSA-N	413656	2-{4-[5-Chloro-2-(4-fluoro-1H-imidazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxy-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 50::US11180471, Example 50	Plasma kallikrein			 95.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413656	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413656&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135206014	433913760							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825790	COCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnc(F)c1	InChI=1S/C27H24ClFN4O6/c1-38-10-9-22(26(35)31-18-6-3-16(4-7-18)27(36)37)33-13-23(39-2)20(12-25(33)34)19-11-17(28)5-8-21(19)32-14-24(29)30-15-32/h3-8,11-15,22H,9-10H2,1-2H3,(H,31,35)(H,36,37)	LQOPQTHAZLUPRF-UHFFFAOYSA-N	413657	4-[(2-{4-[5-Chloro-2-(4-fluoro-1H-imidazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxybutanoyl)amino]benzoic acid (Racemate)::US10421742, Example 51::US11180471, Example 51	Plasma kallikrein			 56.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413657	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413657&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205822	433913761							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825791	COCCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnc(Cl)c1	InChI=1S/C28H26Cl2N6O4/c1-34-13-17-10-19(5-6-22(17)33-34)32-28(38)24(8-9-39-2)36-14-25(40-3)21(12-27(36)37)20-11-18(29)4-7-23(20)35-15-26(30)31-16-35/h4-7,10-16,24H,8-9H2,1-3H3,(H,32,38)	VHDZGIZYASTKPK-UHFFFAOYSA-N	413658	2-{4-[5-Chloro-2-(4-chloro-1H-imidazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxy-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 52::US11180471, Example 52	Plasma kallikrein			 19.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413658	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413658&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205518	433913762							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825792	COCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnc(Cl)c1	InChI=1S/C27H24Cl2N4O6/c1-38-10-9-22(26(35)31-18-6-3-16(4-7-18)27(36)37)33-13-23(39-2)20(12-25(33)34)19-11-17(28)5-8-21(19)32-14-24(29)30-15-32/h3-8,11-15,22H,9-10H2,1-2H3,(H,31,35)(H,36,37)	ATCFLROFGUZFNA-UHFFFAOYSA-N	413659	4-[(2-{4-[5-Chloro-2-(4-chloro-1H-imidazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxybutanoyl)amino]benzoic acid (Racemate)::US10421742, Example 53::US11180471, Example 53	Plasma kallikrein			 37.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413659	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413659&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135206033	433913763							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825793	CNC(=O)c1ccc(NC(=O)C(CCOC)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2-n2cnc(Cl)c2)cn1	InChI=1S/C27H26Cl2N6O5/c1-30-26(37)20-6-5-17(12-31-20)33-27(38)22(8-9-39-2)35-13-23(40-3)19(11-25(35)36)18-10-16(28)4-7-21(18)34-14-24(29)32-15-34/h4-7,10-15,22H,8-9H2,1-3H3,(H,30,37)(H,33,38)	ILXCPIBUCWIAMK-UHFFFAOYSA-N	413660	5-[(2-{4-[5-Chloro-2-(4-chloro-1H-imidazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxybutanoyl)amino]-N-methylpyridine-2-carboxamide (Racemate)::US10421742, Example 54::US11180471, Example 54	Plasma kallikrein			 44.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413660	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413660&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135206034	433913764							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825794	COCCC(C(=O)Nc1ccc2nccnc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnc(Cl)c1	InChI=1S/C28H24Cl2N6O4/c1-39-10-7-24(28(38)34-18-4-5-21-22(12-18)32-9-8-31-21)36-14-25(40-2)20(13-27(36)37)19-11-17(29)3-6-23(19)35-15-26(30)33-16-35/h3-6,8-9,11-16,24H,7,10H2,1-2H3,(H,34,38)	FCJJBIBALYUNQH-UHFFFAOYSA-N	413661	N-(Quinoxalin-6-yl)-2-{4-[5-chloro-2-(4-chloro-1H-imidazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxybutanamide (Racemate)::US10421742, Example 55::US11180471, Example 55	Plasma kallikrein			 12.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413661	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413661&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205710	433913765							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825795	COCCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnnc1	InChI=1S/C26H24ClFN6O5/c1-38-8-7-22(26(37)32-16-4-5-17(25(29)36)20(28)10-16)34-12-23(39-2)19(11-24(34)35)18-9-15(27)3-6-21(18)33-13-30-31-14-33/h3-6,9-14,22H,7-8H2,1-2H3,(H2,29,36)(H,32,37)	YIFQLPJMHMOWFU-UHFFFAOYSA-N	413662	4-[(2-{4-[5-Chloro-2-(4H-1,2,4-triazol-4-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxybutanoyl)amino]-2-fluorobenzamide (Racemate)::US10421742, Example 56::US11180471, Example 56	Plasma kallikrein			 26.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413662	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413662&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205108	433913766							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825796	COCCC(C(=O)Nc1ccc2nccnc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnnc1	InChI=1S/C27H24ClN7O4/c1-38-10-7-24(27(37)33-18-4-5-21-22(12-18)30-9-8-29-21)35-14-25(39-2)20(13-26(35)36)19-11-17(28)3-6-23(19)34-15-31-32-16-34/h3-6,8-9,11-16,24H,7,10H2,1-2H3,(H,33,37)	QEUZUPMZRYSKJR-UHFFFAOYSA-N	413663	N-(Quinoxalin-6-yl)-2-{4-[5-chloro-2-(4H-1,2,4-triazol-4-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxybutanamide (Racemate)::US10421742, Example 57::US11180471, Example 57	Plasma kallikrein			 8.70							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413663	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413663&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205805	433913767							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825797	COCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnnc1	InChI=1S/C26H24ClN5O6/c1-37-10-9-22(25(34)30-18-6-3-16(4-7-18)26(35)36)32-13-23(38-2)20(12-24(32)33)19-11-17(27)5-8-21(19)31-14-28-29-15-31/h3-8,11-15,22H,9-10H2,1-2H3,(H,30,34)(H,35,36)	BABSEGOQVMFTTL-UHFFFAOYSA-N	413664	4-[(2-{4-[5-Chloro-2-(4H-1,2,4-triazol-4-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxybutanoyl)amino]benzoic acid (Racemate)::US10421742, Example 58::US11180471, Example 58	Plasma kallikrein			 47.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413664	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413664&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205192	433913768							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825798	COCCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnnc1	InChI=1S/C27H26ClN7O4/c1-33-13-17-10-19(5-6-22(17)32-33)31-27(37)24(8-9-38-2)35-14-25(39-3)21(12-26(35)36)20-11-18(28)4-7-23(20)34-15-29-30-16-34/h4-7,10-16,24H,8-9H2,1-3H3,(H,31,37)	FGCCTMXHTZVEGP-UHFFFAOYSA-N	413665	2-{4-[5-Chloro-2-(4H-1,2,4-triazol-4-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxy-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 59::US11180471, Example 59	Plasma kallikrein			 15.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413665	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413665&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135206021	433913769							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825799	CCCC(C(=O)Nc1ccc2nccnc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C28H24ClF2N7O3/c1-3-4-24(28(40)34-17-6-7-20-21(12-17)33-10-9-32-20)37-15-25(41-2)19(13-26(37)39)18-11-16(29)5-8-23(18)38-14-22(27(30)31)35-36-38/h5-15,24,27H,3-4H2,1-2H3,(H,34,40)	NKCIMLZZOJBOGZ-UHFFFAOYSA-N	413666	N-(Quinoxalin-6-yl)-2-[4-{5-chloro-2-[4-(difluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]pentanamide (Racemate)::US10421742, Example 60	Plasma kallikrein			 6.60							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413666	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413666&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135204968	433913770							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825800	COCCC(C(=O)Nc1ccc2nccnc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnc(c1)C(F)F	InChI=1S/C29H25ClF2N6O4/c1-41-10-7-25(29(40)36-18-4-5-21-22(12-18)34-9-8-33-21)38-15-26(42-2)20(13-27(38)39)19-11-17(30)3-6-24(19)37-14-23(28(31)32)35-16-37/h3-6,8-9,11-16,25,28H,7,10H2,1-2H3,(H,36,40)	JXACRAOKHLGFCC-UHFFFAOYSA-N	413667	N-(Quinoxalin-6-yl)-2-[4-{5-chloro-2-[4-(difluoromethyl)-1H-imidazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanamide (Racemate)::US10421742, Example 61::US11180471, Example 61	Plasma kallikrein			 15.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413667	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413667&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205843	433913771							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825801	COCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnc(c1)C(F)F	InChI=1S/C28H25ClF2N4O6/c1-40-10-9-23(27(37)33-18-6-3-16(4-7-18)28(38)39)35-14-24(41-2)20(12-25(35)36)19-11-17(29)5-8-22(19)34-13-21(26(30)31)32-15-34/h3-8,11-15,23,26H,9-10H2,1-2H3,(H,33,37)(H,38,39)	RXURALNQBFWKQS-UHFFFAOYSA-N	413668	4-({2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-imidazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)benzoic acid (Racemate)::US10421742, Example 62::US11180471, Example 62	Plasma kallikrein			 140							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413668	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413668&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205732	433913772							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825802	COCCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnc(c1)C(F)F	InChI=1S/C28H25ClF3N5O5/c1-41-8-7-23(28(40)35-16-4-5-17(27(33)39)20(30)10-16)37-13-24(42-2)19(11-25(37)38)18-9-15(29)3-6-22(18)36-12-21(26(31)32)34-14-36/h3-6,9-14,23,26H,7-8H2,1-2H3,(H2,33,39)(H,35,40)	LOOFPSIULDNXTC-UHFFFAOYSA-N	413669	4-({2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-imidazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)-2-fluorobenzamide (Racemate)::US10421742, Example 63::US11180471, Example 63	Plasma kallikrein			 170							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413669	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413669&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205511	433913773							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825803	COCCC(C(=O)Nc1ccc(nc1)C(N)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnc(c1)C(F)F	InChI=1S/C27H25ClF2N6O5/c1-40-8-7-22(27(39)34-16-4-5-19(26(31)38)32-11-16)36-13-23(41-2)18(10-24(36)37)17-9-15(28)3-6-21(17)35-12-20(25(29)30)33-14-35/h3-6,9-14,22,25H,7-8H2,1-2H3,(H2,31,38)(H,34,39)	SRNOHCLEBDLQNM-UHFFFAOYSA-N	413670	5-({2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-imidazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)pyridine-2-carboxamide (Racemate)::US10421742, Example 64::US11180471, Example 64	Plasma kallikrein			 180							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413670	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413670&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205917	433913774							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825804	CNC(=O)c1ccc(NC(=O)C(CCOC)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2-n2cnc(c2)C(F)F)cn1	InChI=1S/C28H27ClF2N6O5/c1-32-27(39)20-6-5-17(12-33-20)35-28(40)23(8-9-41-2)37-14-24(42-3)19(11-25(37)38)18-10-16(29)4-7-22(18)36-13-21(26(30)31)34-15-36/h4-7,10-15,23,26H,8-9H2,1-3H3,(H,32,39)(H,35,40)	BZGWCVVHLRMNJS-UHFFFAOYSA-N	413671	5-({2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-imidazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)-N-methylpyridine-2-carboxamide (Racemate)::US10421742, Example 65::US11180471, Example 65	Plasma kallikrein			 93.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413671	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413671&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135211501	433913775							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825805	COCCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnc(c1)C(F)F	InChI=1S/C29H27ClF2N6O4/c1-36-13-17-10-19(5-6-22(17)35-36)34-29(40)25(8-9-41-2)38-15-26(42-3)21(12-27(38)39)20-11-18(30)4-7-24(20)37-14-23(28(31)32)33-16-37/h4-7,10-16,25,28H,8-9H2,1-3H3,(H,34,40)	RVACDGDJWAWWGJ-UHFFFAOYSA-N	413672	2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-imidazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxy-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 66::US11180471, Example 66	Plasma kallikrein			 43.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413672	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413672&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135211559	433913776							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825806	COCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1cc(C)no1	InChI=1S/C28H26ClN3O7/c1-16-12-24(39-31-16)20-9-6-18(29)13-21(20)22-14-26(33)32(15-25(22)38-3)23(10-11-37-2)27(34)30-19-7-4-17(5-8-19)28(35)36/h4-9,12-15,23H,10-11H2,1-3H3,(H,30,34)(H,35,36)	KHIKDAHZRTYQLP-UHFFFAOYSA-N	413673	4-[(2-{4-[5-Chloro-2-(3-methyl-1,2-oxazol-5-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxybutanoyl)amino]benzoic acid (Racemate)::US10421742, Example 67::US11180471, Example 67	Plasma kallikrein			 45.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413673	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413673&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205834	433913777							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825807	COCCC(C(=O)Nc1ccc(nc1)C(N)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1cc(C)no1	InChI=1S/C27H26ClN5O6/c1-15-10-23(39-32-15)18-6-4-16(28)11-19(18)20-12-25(34)33(14-24(20)38-3)22(8-9-37-2)27(36)31-17-5-7-21(26(29)35)30-13-17/h4-7,10-14,22H,8-9H2,1-3H3,(H2,29,35)(H,31,36)	MJTYRMTXTRTXFO-UHFFFAOYSA-N	413674	5-[(2-{4-[5-Chloro-2-(3-methyl-1,2-oxazol-5-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxybutanoyl)amino]pyridine-2-carboxamide (Racemate)::US10421742, Example 68::US11180471, Example 68	Plasma kallikrein			 51.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413674	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413674&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205583	433913778							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825808	COCCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1cc(C)no1	InChI=1S/C28H26ClFN4O6/c1-15-10-24(40-33-15)18-6-4-16(29)11-20(18)21-13-26(35)34(14-25(21)39-3)23(8-9-38-2)28(37)32-17-5-7-19(27(31)36)22(30)12-17/h4-7,10-14,23H,8-9H2,1-3H3,(H2,31,36)(H,32,37)	IOKBSWHNAJFKBB-UHFFFAOYSA-N	413675	4-[(2-{4-[5-Chloro-2-(3-methyl-1,2-oxazol-5-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxybutanoyl)amino]-2-fluorobenzamide (Racemate)::US10421742, Example 69::US11180471, Example 69	Plasma kallikrein			 58.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413675	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413675&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205883	433913779							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825809	COCCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1cc(Cl)no1	InChI=1S/C28H25Cl2N5O5/c1-34-14-16-10-18(5-7-22(16)32-34)31-28(37)23(8-9-38-2)35-15-25(39-3)21(12-27(35)36)20-11-17(29)4-6-19(20)24-13-26(30)33-40-24/h4-7,10-15,23H,8-9H2,1-3H3,(H,31,37)	KOOPULMUYDUHAS-UHFFFAOYSA-N	413676	2-{4-[5-Chloro-2-(3-methyl-1,2-oxazol-5-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxy-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 70	Plasma kallikrein			 21.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413676	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413676&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135211513	433913780							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825810	CNC(=O)c1ccc(NC(=O)C(CCOC)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2-c2cc(C)no2)cn1	InChI=1S/C28H28ClN5O6/c1-16-11-24(40-33-16)19-7-5-17(29)12-20(19)21-13-26(35)34(15-25(21)39-4)23(9-10-38-3)28(37)32-18-6-8-22(31-14-18)27(36)30-2/h5-8,11-15,23H,9-10H2,1-4H3,(H,30,36)(H,32,37)	ROFGROGQJVVGAV-UHFFFAOYSA-N	413677	5-[(2-{4-[5-Chloro-2-(3-methyl-1,2-oxazol-5-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxybutanoyl)amino]-N-methylpyridine-2-carboxamide (Racemate)::US10421742, Example 71::US11180471, Example 71	Plasma kallikrein			 35.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413677	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413677&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205793	433913781							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825811	COCCC(C(=O)Nc1ccc2nccnc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1cc(C)no1	InChI=1S/C29H26ClN5O5/c1-17-12-26(40-34-17)20-6-4-18(30)13-21(20)22-15-28(36)35(16-27(22)39-3)25(8-11-38-2)29(37)33-19-5-7-23-24(14-19)32-10-9-31-23/h4-7,9-10,12-16,25H,8,11H2,1-3H3,(H,33,37)	BOMMICKHAGJNKQ-UHFFFAOYSA-N	413678	N-(Quinoxalin-6-yl)-2-{4-[5-chloro-2-(3-methyl-1,2-oxazol-5-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxybutanamide (Racemate)::US10421742, Example 72::US11180471, Example 72	Plasma kallikrein			 18.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413678	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413678&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205700	433913782							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825812	COCCC(C(=O)Nc1ccc(nc1)C(N)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(o1)C(F)(F)F	InChI=1S/C26H22ClF3N6O6/c1-40-8-7-19(23(39)33-14-4-6-18(22(31)38)32-11-14)36-12-20(41-2)17(10-21(36)37)16-9-13(27)3-5-15(16)24-34-35-25(42-24)26(28,29)30/h3-6,9-12,19H,7-8H2,1-2H3,(H2,31,38)(H,33,39)	LICUUHCNECQSQW-UHFFFAOYSA-N	413679	5-({2-[4-{5-Chloro-2-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)pyridine-2-carboxamide (Racemate)::US10421742, Example 73::US11180471, Example 73	Plasma kallikrein			 110							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413679	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413679&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205765	433913783							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825813	COCCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(o1)C(F)(F)F	InChI=1S/C27H22ClF4N5O6/c1-41-8-7-20(24(40)34-14-4-6-16(23(33)39)19(29)10-14)37-12-21(42-2)18(11-22(37)38)17-9-13(28)3-5-15(17)25-35-36-26(43-25)27(30,31)32/h3-6,9-12,20H,7-8H2,1-2H3,(H2,33,39)(H,34,40)	FGIRAZNDJOPUAW-UHFFFAOYSA-N	413680	4-({2-[4-{5-Chloro-2-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)-2-fluorobenzamide (Racemate)::US10421742, Example 74::US11180471, Example 74	Plasma kallikrein			 98.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413680	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413680&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205473	433913784							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825814	COCCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(o1)C(F)(F)F	InChI=1S/C28H24ClF3N6O5/c1-37-13-15-10-17(5-7-21(15)36-37)33-25(40)22(8-9-41-2)38-14-23(42-3)20(12-24(38)39)19-11-16(29)4-6-18(19)26-34-35-27(43-26)28(30,31)32/h4-7,10-14,22H,8-9H2,1-3H3,(H,33,40)	YOTPLZPCUXHOMZ-UHFFFAOYSA-N	413681	2-[4-{5-Chloro-2-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxy-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 75::US11180471, Example 75	Plasma kallikrein			 28.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413681	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413681&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205440	433913785							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825815	COCC[C@@H](C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(o1)C(F)(F)F	InChI=1S/C28H24ClF3N6O5/c1-37-13-15-10-17(5-7-21(15)36-37)33-25(40)22(8-9-41-2)38-14-23(42-3)20(12-24(38)39)19-11-16(29)4-6-18(19)26-34-35-27(43-26)28(30,31)32/h4-7,10-14,22H,8-9H2,1-3H3,(H,33,40)/t22-/m0/s1	YOTPLZPCUXHOMZ-QFIPXVFZSA-N	413682	(2S)-2-[4-{5-Chloro-2-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxy-N-(2-methyl-2H-indazol-5-yl)butanamide (Enantiomer 2)::US10421742, Example 76::US11180471, Example 76	Plasma kallikrein			 23.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413682	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413682&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205552	433913786							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825816	CNC(=O)c1ccc(NC(=O)C(CCOC)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2-c2nnc(o2)C(F)(F)F)cn1	InChI=1S/C27H24ClF3N6O6/c1-32-23(39)19-7-5-15(12-33-19)34-24(40)20(8-9-41-2)37-13-21(42-3)18(11-22(37)38)17-10-14(28)4-6-16(17)25-35-36-26(43-25)27(29,30)31/h4-7,10-13,20H,8-9H2,1-3H3,(H,32,39)(H,34,40)	NUOFQPYZYCWJHB-UHFFFAOYSA-N	413683	5-({2-[4-{5-Chloro-2-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)-N-methylpyridine-2-carboxamide (Racemate)::US10421742, Example 77::US11180471, Example 77	Plasma kallikrein			 47.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413683	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413683&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135206080	433913787							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825817	COCCC(C(=O)Nc1ccc2nccnc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(o1)C(F)(F)F	InChI=1S/C28H22ClF3N6O5/c1-41-10-7-22(25(40)35-16-4-6-20-21(12-16)34-9-8-33-20)38-14-23(42-2)19(13-24(38)39)18-11-15(29)3-5-17(18)26-36-37-27(43-26)28(30,31)32/h3-6,8-9,11-14,22H,7,10H2,1-2H3,(H,35,40)	RLFXIFOZOPMNCY-UHFFFAOYSA-N	413684	N-(Quinoxalin-6-yl)-2-[4-{5-chloro-2-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanamide (Racemate)::US10421742, Example 78::US11180471, Example 78	Plasma kallikrein			 14.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413684	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413684&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205675	433913788							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825818	COCC[C@@H](C(=O)Nc1ccc2nccnc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(o1)C(F)(F)F	InChI=1S/C28H22ClF3N6O5/c1-41-10-7-22(25(40)35-16-4-6-20-21(12-16)34-9-8-33-20)38-14-23(42-2)19(13-24(38)39)18-11-15(29)3-5-17(18)26-36-37-27(43-26)28(30,31)32/h3-6,8-9,11-14,22H,7,10H2,1-2H3,(H,35,40)/t22-/m0/s1	RLFXIFOZOPMNCY-QFIPXVFZSA-N	413685	N-(Quinoxalin-6-yl)-(2S)-2-[4-{5-chloro-2-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanamide (Enantiomer 2)::US10421742, Example 79::US11180471, Example 79	Plasma kallikrein			 9.80							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413685	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413685&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205803	433913789							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825819	COCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(o1)C(F)F	InChI=1S/C27H23ClF2N4O7/c1-39-10-9-20(24(36)31-16-6-3-14(4-7-16)27(37)38)34-13-21(40-2)19(12-22(34)35)18-11-15(28)5-8-17(18)25-32-33-26(41-25)23(29)30/h3-8,11-13,20,23H,9-10H2,1-2H3,(H,31,36)(H,37,38)	XNHWHTYAEJBBSE-UHFFFAOYSA-N	413686	4-({2-[4-{5-Chloro-2-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)benzoic acid (Racemate)::US10421742, Example 80::US11180471, Example 80	Plasma kallikrein			 78.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413686	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413686&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205800	433913790							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825820	COCCC(C(=O)Nc1ccc(nc1)C(N)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(o1)C(F)F	InChI=1S/C26H23ClF2N6O6/c1-39-8-7-19(24(38)32-14-4-6-18(23(30)37)31-11-14)35-12-20(40-2)17(10-21(35)36)16-9-13(27)3-5-15(16)25-33-34-26(41-25)22(28)29/h3-6,9-12,19,22H,7-8H2,1-2H3,(H2,30,37)(H,32,38)	MDWVKPVBVQCTPE-UHFFFAOYSA-N	413687	5-({2-[4-{5-Chloro-2-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)pyridine-2-carboxamide (Racemate)::US10421742, Example 81::US11180471, Example 81	Plasma kallikrein			 100.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413687	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413687&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135206035	433913791							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825821	COCCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(o1)C(F)F	InChI=1S/C27H23ClF3N5O6/c1-40-8-7-20(25(39)33-14-4-6-16(24(32)38)19(29)10-14)36-12-21(41-2)18(11-22(36)37)17-9-13(28)3-5-15(17)26-34-35-27(42-26)23(30)31/h3-6,9-12,20,23H,7-8H2,1-2H3,(H2,32,38)(H,33,39)	ZFLRJTQBCYIFEA-UHFFFAOYSA-N	413688	4-({2-[4-{5-Chloro-2-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)-2-fluorobenzamide (Racemate)::US10421742, Example 82::US11180471, Example 82	Plasma kallikrein			 67.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413688	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413688&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205342	433913792							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825822	COCCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(o1)C(F)F	InChI=1S/C28H25ClF2N6O5/c1-36-13-15-10-17(5-7-21(15)35-36)32-26(39)22(8-9-40-2)37-14-23(41-3)20(12-24(37)38)19-11-16(29)4-6-18(19)27-33-34-28(42-27)25(30)31/h4-7,10-14,22,25H,8-9H2,1-3H3,(H,32,39)	OYMYFSRVCJZGAS-UHFFFAOYSA-N	413689	2-[4-{5-Chloro-2-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxy-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 83::US11180471, Example 83	Plasma kallikrein			 21.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413689	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413689&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205398	433913793							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825823	CNC(=O)c1ccc(NC(=O)C(CCOC)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2-c2nnc(o2)C(F)F)cn1	InChI=1S/C27H25ClF2N6O6/c1-31-24(38)19-7-5-15(12-32-19)33-25(39)20(8-9-40-2)36-13-21(41-3)18(11-22(36)37)17-10-14(28)4-6-16(17)26-34-35-27(42-26)23(29)30/h4-7,10-13,20,23H,8-9H2,1-3H3,(H,31,38)(H,33,39)	HOPVUQHXIRDKQQ-UHFFFAOYSA-N	413690	5-({2-[4-{5-Chloro-2-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)-N-methylpyridine-2-carboxamide (Racemate)::US10421742, Example 84::US11180471, Example 84	Plasma kallikrein			 49.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413690	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413690&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205828	433913794							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825824	COCCC(C(=O)Nc1ccc2nccnc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(o1)C(F)F	InChI=1S/C28H23ClF2N6O5/c1-40-10-7-22(26(39)34-16-4-6-20-21(12-16)33-9-8-32-20)37-14-23(41-2)19(13-24(37)38)18-11-15(29)3-5-17(18)27-35-36-28(42-27)25(30)31/h3-6,8-9,11-14,22,25H,7,10H2,1-2H3,(H,34,39)	XQGAAZGSIZFZJH-UHFFFAOYSA-N	413691	N-(Quinoxalin-6-yl)-2-[4-{5-chloro-2-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanamide (Racemate)::US10421742, Example 85::US11180471, Example 85	Plasma kallikrein			 9.60							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413691	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413691&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205474	433913795							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825825	COCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1cnn(c1)C(F)F	InChI=1S/C28H25ClF2N4O6/c1-40-10-9-23(26(37)33-19-6-3-16(4-7-19)27(38)39)34-15-24(41-2)22(12-25(34)36)21-11-18(29)5-8-20(21)17-13-32-35(14-17)28(30)31/h3-8,11-15,23,28H,9-10H2,1-2H3,(H,33,37)(H,38,39)	KPDQGYYQHYCMAC-UHFFFAOYSA-N	413692	4-({2-[4-{5-Chloro-2-[1-(difluoromethyl)-1H-pyrazol-4-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)benzoic acid (Racemate)::US10421742, Example 86::US11180471, Example 86	Plasma kallikrein			 88.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413692	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413692&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205712	433913796							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825826	COCCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1cnn(c1)C(F)F	InChI=1S/C29H27ClF2N6O4/c1-36-14-17-10-20(5-7-24(17)35-36)34-28(40)25(8-9-41-2)37-16-26(42-3)23(12-27(37)39)22-11-19(30)4-6-21(22)18-13-33-38(15-18)29(31)32/h4-7,10-16,25,29H,8-9H2,1-3H3,(H,34,40)	FLLYAGGTZNJKNW-UHFFFAOYSA-N	413693	2-[4-{5-Chloro-2-[1-(difluoromethyl)-1H-pyrazol-4-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxy-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 87::US11180471, Example 87	Plasma kallikrein			 41.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413693	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413693&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205794	433913797							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825827	COCCC(C(=O)Nc1ccc(nc1)C(N)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1cnn(c1)C(F)F	InChI=1S/C27H25ClF2N6O5/c1-40-8-7-22(26(39)34-17-4-6-21(25(31)38)32-12-17)35-14-23(41-2)20(10-24(35)37)19-9-16(28)3-5-18(19)15-11-33-36(13-15)27(29)30/h3-6,9-14,22,27H,7-8H2,1-2H3,(H2,31,38)(H,34,39)	ZDGFODUVDKHNBN-UHFFFAOYSA-N	413694	5-({2-[4-{5-Chloro-2-[1-(difluoromethyl)-1H-pyrazol-4-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)pyridine-2-carboxamide (Racemate)::US10421742, Example 88::US11180471, Example 88	Plasma kallikrein			 110							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413694	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413694&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205957	433913798							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825828	COCCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nc(C)no1	InChI=1S/C27H25ClFN5O6/c1-14-31-27(40-33-14)17-6-4-15(28)10-19(17)20-12-24(35)34(13-23(20)39-3)22(8-9-38-2)26(37)32-16-5-7-18(25(30)36)21(29)11-16/h4-7,10-13,22H,8-9H2,1-3H3,(H2,30,36)(H,32,37)	KXEKQPUKVUVDQB-UHFFFAOYSA-N	413695	4-[(2-{4-[5-Chloro-2-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxybutanoyl)amino]-2-fluorobenzamide (Racemate)::US10421742, Example 89::US11180471, Example 89	Plasma kallikrein			 58.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413695	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413695&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205626	433913799							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825829	COCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nc(C)no1	InChI=1S/C27H25ClN4O7/c1-15-29-26(39-31-15)19-9-6-17(28)12-20(19)21-13-24(33)32(14-23(21)38-3)22(10-11-37-2)25(34)30-18-7-4-16(5-8-18)27(35)36/h4-9,12-14,22H,10-11H2,1-3H3,(H,30,34)(H,35,36)	NOYZMHMPNZKENJ-UHFFFAOYSA-N	413696	4-[(2-{4-[5-Chloro-2-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxybutanoyl)amino]benzoic acid (Racemate)::US10421742, Example 90::US11180471, Example 90	Plasma kallikrein			 54.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413696	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413696&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205964	433913800							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825830	COCCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nc(C)no1	InChI=1S/C28H27ClN6O5/c1-16-30-28(40-33-16)20-7-5-18(29)12-21(20)22-13-26(36)35(15-25(22)39-4)24(9-10-38-3)27(37)31-19-6-8-23-17(11-19)14-34(2)32-23/h5-8,11-15,24H,9-10H2,1-4H3,(H,31,37)	AKPADQIFUKNACD-UHFFFAOYSA-N	413697	2-{4-[5-Chloro-2-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxy-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 91::US11180471, Example 91	Plasma kallikrein			 25.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413697	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413697&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135204923	433913801							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825831	COc1cn(C(CCOC(C)(C)C)C(=O)Nc2ccc3nccnc3c2)c(=O)cc1-c1cc(Cl)ccc1-c1nc(C)no1	InChI=1S/C31H31ClN6O5/c1-18-35-30(43-37-18)21-8-6-19(32)14-22(21)23-16-28(39)38(17-27(23)41-5)26(10-13-42-31(2,3)4)29(40)36-20-7-9-24-25(15-20)34-12-11-33-24/h6-9,11-12,14-17,26H,10,13H2,1-5H3,(H,36,40)	WHJFAHUWUMDVIH-UHFFFAOYSA-N	413699	4-tert-Butoxy-N-(quinoxalin-6-yl)-2-{4-[5-chloro-2-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}butanamide (Racemate)::US10421742, Example 92::US11180471, Example 92	Plasma kallikrein			 24.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413699	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413699&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205417	433913802							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825832	COc1cn(C(CCOC(C)(C)C)C(=O)Nc2ccc(C(N)=O)c(F)c2)c(=O)cc1-c1cc(Cl)ccc1-c1nc(C)no1	InChI=1S/C30H31ClFN5O6/c1-16-34-29(43-36-16)19-8-6-17(31)12-21(19)22-14-26(38)37(15-25(22)41-5)24(10-11-42-30(2,3)4)28(40)35-18-7-9-20(27(33)39)23(32)13-18/h6-9,12-15,24H,10-11H2,1-5H3,(H2,33,39)(H,35,40)	NZUPFRNOGBEVPO-UHFFFAOYSA-N	413700	4-[(4-tert-Butoxy-2-{4-[5-chloro-2-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}butanoyl)amino]-2-fluorobenzamide (Racemate)::US10421742, Example 93::US11180471, Example 93	Plasma kallikrein			 87.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413700	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413700&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205738	433913803							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825833	COc1cn(C(CCOC(C)(C)C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1-c1nc(C)no1	InChI=1S/C30H31ClN4O7/c1-17-32-28(42-34-17)21-11-8-19(31)14-22(21)23-15-26(36)35(16-25(23)40-5)24(12-13-41-30(2,3)4)27(37)33-20-9-6-18(7-10-20)29(38)39/h6-11,14-16,24H,12-13H2,1-5H3,(H,33,37)(H,38,39)	ZWRNKDXMIOGALM-UHFFFAOYSA-N	413701	4-[(4-tert-Butoxy-2-{4-[5-chloro-2-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}butanoyl)amino]benzoic acid (Racemate)::US10421742, Example 94::US11180471, Example 94	Plasma kallikrein			 40.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413701	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413701&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205935	433913804							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825834	COc1cn(C(CCOC(C)(C)C)C(=O)Nc2ccc3nn(C)cc3c2)c(=O)cc1-c1cc(Cl)ccc1-c1nc(C)no1	InChI=1S/C31H33ClN6O5/c1-18-33-30(43-36-18)22-9-7-20(32)14-23(22)24-15-28(39)38(17-27(24)41-6)26(11-12-42-31(2,3)4)29(40)34-21-8-10-25-19(13-21)16-37(5)35-25/h7-10,13-17,26H,11-12H2,1-6H3,(H,34,40)	QVRAHCXUFLLOFP-UHFFFAOYSA-N	413702	4-tert-Butoxy-2-{4-[5-chloro-2-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 95::US11180471, Example 95	Plasma kallikrein			 51.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413702	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413702&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205986	433913805							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825835	COCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1cnn(CC(F)(F)F)c1	InChI=1S/C29H26ClF3N4O6/c1-42-10-9-24(27(39)35-20-6-3-17(4-7-20)28(40)41)37-15-25(43-2)23(12-26(37)38)22-11-19(30)5-8-21(22)18-13-34-36(14-18)16-29(31,32)33/h3-8,11-15,24H,9-10,16H2,1-2H3,(H,35,39)(H,40,41)	RUCWELAAUNKPGR-UHFFFAOYSA-N	413703	4-({2-[4-{5-Chloro-2-[1-(2,2,2-trifluoroethyl)-1H-pyrazol-4-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)benzoic acid (Racemate)::US10421742, Example 96::US11180471, Example 96	Plasma kallikrein			 230							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413703	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413703&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135211517	433913806							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825836	CNC(=O)c1ccc(NC(=O)C(CCOC)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2-c2cnn(CC(F)(F)F)c2)cn1	InChI=1S/C29H28ClF3N6O5/c1-34-27(41)23-7-5-19(13-35-23)37-28(42)24(8-9-43-2)39-15-25(44-3)22(11-26(39)40)21-10-18(30)4-6-20(21)17-12-36-38(14-17)16-29(31,32)33/h4-7,10-15,24H,8-9,16H2,1-3H3,(H,34,41)(H,37,42)	BSBZPHKWOOZTDV-UHFFFAOYSA-N	413704	5-({2-[4-{5-Chloro-2-[1-(2,2,2-trifluoroethyl)-1H-pyrazol-4-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)-N-methylpyridine-2-carboxamide (Racemate)::US10421742, Example 97::US11180471, Example 97	Plasma kallikrein			 190							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413704	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413704&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135211552	433913807							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825837	COCCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1cnn(CC(F)(F)F)c1	InChI=1S/C30H28ClF3N6O4/c1-38-14-18-10-21(5-7-25(18)37-38)36-29(42)26(8-9-43-2)40-16-27(44-3)24(12-28(40)41)23-11-20(31)4-6-22(23)19-13-35-39(15-19)17-30(32,33)34/h4-7,10-16,26H,8-9,17H2,1-3H3,(H,36,42)	SSDUONDHEXQWQO-UHFFFAOYSA-N	413705	2-[4-{5-Chloro-2-[1-(2,2,2-trifluoroethyl)-1H-pyrazol-4-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxy-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 98::US11180471, Example 98	Plasma kallikrein			 100.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413705	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413705&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205464	433913808							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825838	COCCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C27H25Cl2N7O4/c1-34-13-16-10-18(5-6-21(16)32-34)30-27(38)23(8-9-39-2)35-14-24(40-3)20(12-26(35)37)19-11-17(28)4-7-22(19)36-15-25(29)31-33-36/h4-7,10-15,23H,8-9H2,1-3H3,(H,30,38)	HQFBMTXLTXVRAL-UHFFFAOYSA-N	413706	2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxy-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 99::US11180471, Example 99	Plasma kallikrein			 3.20							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413706	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413706&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205773	433913809							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825839	COCCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C26H23Cl2FN6O5/c1-39-8-7-21(26(38)31-15-4-5-16(25(30)37)19(29)10-15)34-12-22(40-2)18(11-24(34)36)17-9-14(27)3-6-20(17)35-13-23(28)32-33-35/h3-6,9-13,21H,7-8H2,1-2H3,(H2,30,37)(H,31,38)	AITUBRIGGLTKMQ-UHFFFAOYSA-N	413707	4-[(2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxybutanoyl)amino]-2-fluorobenzamide (Racemate)::US10421742, Example 100::US11180471, Example 100	Plasma kallikrein			 5.00							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413707	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413707&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135206029	433913810							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825840	COCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C26H23Cl2N5O6/c1-38-10-9-21(25(35)29-17-6-3-15(4-7-17)26(36)37)32-13-22(39-2)19(12-24(32)34)18-11-16(27)5-8-20(18)33-14-23(28)30-31-33/h3-8,11-14,21H,9-10H2,1-2H3,(H,29,35)(H,36,37)	WCANIIANZRELQI-UHFFFAOYSA-N	413708	4-[(2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxybutanoyl)amino]benzoic acid (Racemate)::US10421742, Example 101::US11180471, Example 101	Plasma kallikrein			 6.00							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413708	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413708&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205978	433913811							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825841	COc1cn(C(CCOC(C)(C)C)C(=O)Nc2ccc(C(N)=O)c(F)c2)c(=O)cc1-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C29H29Cl2FN6O5/c1-29(2,3)43-10-9-23(28(41)34-17-6-7-18(27(33)40)21(32)12-17)37-14-24(42-4)20(13-26(37)39)19-11-16(30)5-8-22(19)38-15-25(31)35-36-38/h5-8,11-15,23H,9-10H2,1-4H3,(H2,33,40)(H,34,41)	JFTPUCJHGXFNAL-UHFFFAOYSA-N	413709	4-[(4-tert-Butoxy-2-{4-[5-chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}butanoyl)amino]-2-fluorobenzamide (Racemate)::US10421742, Example 102::US11180471, Example 102	Plasma kallikrein			 4.40							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413709	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413709&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205886	433913812							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825842	COc1cn(C(CCOC(C)(C)C)C(=O)Nc2ccc3nn(C)cc3c2)c(=O)cc1-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C30H31Cl2N7O4/c1-30(2,3)43-11-10-25(29(41)33-20-7-8-23-18(12-20)15-37(4)35-23)38-16-26(42-5)22(14-28(38)40)21-13-19(31)6-9-24(21)39-17-27(32)34-36-39/h6-9,12-17,25H,10-11H2,1-5H3,(H,33,41)	ZAKSQHPNZWUBFJ-UHFFFAOYSA-N	413710	4-tert-Butoxy-2-{4-[5-chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 103::US11180471, Example 103	Plasma kallikrein			 4.30							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413710	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413710&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205159	433913813							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825843	CCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnc(F)c1	InChI=1S/C27H24ClFN4O5/c1-3-4-22(26(35)31-18-8-5-16(6-9-18)27(36)37)33-13-23(38-2)20(12-25(33)34)19-11-17(28)7-10-21(19)32-14-24(29)30-15-32/h5-15,22H,3-4H2,1-2H3,(H,31,35)(H,36,37)	UEDRHDRNPGYCFA-UHFFFAOYSA-N	413711	4-{[2-{4-[5-Chloro-2-(4-fluoro-1H-imidazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}pentanoyl]amino}benzoic acid (Racemate)::US10421742, Example 104::US11180471, Example 104	Plasma kallikrein			 250							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413711	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413711&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205818	433913814							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825844	CCCC(C(=O)Nc1ccc2nccnc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnc(F)c1	InChI=1S/C28H24ClFN6O3/c1-3-4-24(28(38)34-18-6-7-21-22(12-18)32-10-9-31-21)36-14-25(39-2)20(13-27(36)37)19-11-17(29)5-8-23(19)35-15-26(30)33-16-35/h5-16,24H,3-4H2,1-2H3,(H,34,38)	ZJEBCRXBTDTSDY-UHFFFAOYSA-N	413712	N-(Quinoxalin-6-yl)-2-{4-[5-chloro-2-(4-fluoro-1H-imidazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}pentanamide (Racemate)::US10421742, Example 105::US11180471, Example 105	Plasma kallikrein			 47.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413712	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413712&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205899	433913815							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825845	CCCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnc(F)c1	InChI=1S/C28H26ClFN6O3/c1-4-5-24(28(38)32-19-7-8-22-17(10-19)13-34(2)33-22)36-14-25(39-3)21(12-27(36)37)20-11-18(29)6-9-23(20)35-15-26(30)31-16-35/h6-16,24H,4-5H2,1-3H3,(H,32,38)	ZFHCCWVEIZPKIK-UHFFFAOYSA-N	413713	2-{4-[5-Chloro-2-(4-fluoro-1H-imidazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(2-methyl-2H-indazol-5-yl)pentanamide (Racemate)::US10421742, Example 106::US11180471, Example 106	Plasma kallikrein			 85.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413713	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413713&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205875	433913816							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825846	CCCC(C(=O)Nc1ccc(nc1)C(N)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnc(Cl)c1	InChI=1S/C26H24Cl2N6O4/c1-3-4-21(26(37)32-16-6-7-19(25(29)36)30-11-16)34-12-22(38-2)18(10-24(34)35)17-9-15(27)5-8-20(17)33-13-23(28)31-14-33/h5-14,21H,3-4H2,1-2H3,(H2,29,36)(H,32,37)	ZZSYBTPQPYGNKT-UHFFFAOYSA-N	413714	5-{[2-{4-[5-Chloro-2-(4-chloro-1H-imidazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}pentanoyl]amino}pyridine-2-carboxamide (Racemate)::US10421742, Example 107::US11180471, Example 107	Plasma kallikrein			 200							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413714	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413714&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205208	433913817							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825847	CCCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnc(Cl)c1	InChI=1S/C28H26Cl2N6O3/c1-4-5-24(28(38)32-19-7-8-22-17(10-19)13-34(2)33-22)36-14-25(39-3)21(12-27(36)37)20-11-18(29)6-9-23(20)35-15-26(30)31-16-35/h6-16,24H,4-5H2,1-3H3,(H,32,38)	GJZFNUOEHXFLPK-UHFFFAOYSA-N	413715	2-{4-[5-Chloro-2-(4-chloro-1H-imidazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(2-methyl-2H-indazol-5-yl)pentanamide (Racemate)::US10421742, Example 108::US11180471, Example 108	Plasma kallikrein			 67.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413715	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413715&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205633	433913818							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825848	CCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnc(Cl)c1	InChI=1S/C27H24Cl2N4O5/c1-3-4-22(26(35)31-18-8-5-16(6-9-18)27(36)37)33-13-23(38-2)20(12-25(33)34)19-11-17(28)7-10-21(19)32-14-24(29)30-15-32/h5-15,22H,3-4H2,1-2H3,(H,31,35)(H,36,37)	PYCOXKADFBYSOX-UHFFFAOYSA-N	413716	4-{[2-{4-[5-Chloro-2-(4-chloro-1H-imidazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}pentanoyl]amino}benzoic acid (Racemate)::US10421742, Example 109::US11180471, Example 109	Plasma kallikrein			 180							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413716	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413716&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205936	433913819							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825849	COCCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnc(c1)C(F)(F)F	InChI=1S/C28H24ClF4N5O5/c1-42-8-7-22(27(41)36-16-4-5-17(26(34)40)20(30)10-16)38-12-23(43-2)19(11-25(38)39)18-9-15(29)3-6-21(18)37-13-24(35-14-37)28(31,32)33/h3-6,9-14,22H,7-8H2,1-2H3,(H2,34,40)(H,36,41)	NDZYZAAAWXQARZ-UHFFFAOYSA-N	413717	4-({2-[4-{5-Chloro-2-[4-(trifluoromethyl)-1H-imidazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)-2-fluorobenzamide (Racemate)::US10421742, Example 110::US11180471, Example 110	Plasma kallikrein			 330							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413717	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413717&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205099	433913820							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825850	COCCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnc(c1)C(F)(F)F	InChI=1S/C29H26ClF3N6O4/c1-37-13-17-10-19(5-6-22(17)36-37)35-28(41)24(8-9-42-2)39-14-25(43-3)21(12-27(39)40)20-11-18(30)4-7-23(20)38-15-26(34-16-38)29(31,32)33/h4-7,10-16,24H,8-9H2,1-3H3,(H,35,41)	MCUQCQLBAAKRPX-UHFFFAOYSA-N	413718	2-[4-{5-Chloro-2-[4-(trifluoromethyl)-1H-imidazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxy-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 111::US11180471, Example 111	Plasma kallikrein			 120							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413718	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413718&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205640	433913821							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825851	CCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C25H23ClN6O5/c1-3-4-21(24(34)28-17-8-5-15(6-9-17)25(35)36)31-13-22(37-2)19(12-23(31)33)18-11-16(26)7-10-20(18)32-14-27-29-30-32/h5-14,21H,3-4H2,1-2H3,(H,28,34)(H,35,36)	KXLAWRVDSZAFKG-UHFFFAOYSA-N	413719	4-{[2-{4-[5-Chloro-2-(1H-tetrazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}pentanoyl]amino}benzoic acid (Racemate)::US10421742, Example 112::US11180471, Example 112	Plasma kallikrein			 2.90							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413719	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413719&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205582	433913822							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825852	CCCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C25H23ClFN7O4/c1-3-4-21(25(37)30-15-6-7-16(24(28)36)19(27)10-15)33-12-22(38-2)18(11-23(33)35)17-9-14(26)5-8-20(17)34-13-29-31-32-34/h5-13,21H,3-4H2,1-2H3,(H2,28,36)(H,30,37)	CZWHJSKWMSOPRC-UHFFFAOYSA-N	413720	4-{[2-{4-[5-Chloro-2-(1H-tetrazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}pentanoyl]amino}-2-fluorobenzamide (Racemate)::US10421742, Example 113::US11180471, Example 113	Plasma kallikrein			 3.70							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413720	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413720&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205931	433913823							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825853	CCC[C@@H](C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C25H23ClFN7O4/c1-3-4-21(25(37)30-15-6-7-16(24(28)36)19(27)10-15)33-12-22(38-2)18(11-23(33)35)17-9-14(26)5-8-20(17)34-13-29-31-32-34/h5-13,21H,3-4H2,1-2H3,(H2,28,36)(H,30,37)/t21-/m0/s1	CZWHJSKWMSOPRC-NRFANRHFSA-N	413721	4-{[(2S)-2-{4-[5-Chloro-2-(1H-tetrazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}pentanoyl]amino}-2-fluorobenzamide (Enantiomer 1)::US10421742, Example 114::US11180471, Example 114	Plasma kallikrein			 1.30							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413721	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413721&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205929	433913824							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825854	CCCC(C(=O)Nc1ccc(nc1)C(N)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C24H23ClN8O4/c1-3-4-20(24(36)29-15-6-7-18(23(26)35)27-11-15)32-12-21(37-2)17(10-22(32)34)16-9-14(25)5-8-19(16)33-13-28-30-31-33/h5-13,20H,3-4H2,1-2H3,(H2,26,35)(H,29,36)	AWLPKPUSDZNVQR-UHFFFAOYSA-N	413722	5-{[2-{4-[5-Chloro-2-(1H-tetrazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}pentanoyl]amino}pyridine-2-carboxamide (Racemate)::US10421742, Example 115::US11180471, Example 115	Plasma kallikrein			 1.90							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413722	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413722&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205390	433913825							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825855	CCCC(C(=O)Nc1ccc(nc1)C(=O)NC)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C25H25ClN8O4/c1-4-5-21(25(37)30-16-7-8-19(28-12-16)24(36)27-2)33-13-22(38-3)18(11-23(33)35)17-10-15(26)6-9-20(17)34-14-29-31-32-34/h6-14,21H,4-5H2,1-3H3,(H,27,36)(H,30,37)	NZYSNSQHJHYDEI-UHFFFAOYSA-N	413723	5-{[2-{4-[5-Chloro-2-(1H-tetrazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}pentanoyl]-amino}-N-methylpyridine-2-carboxamide (Racemate)::US10421742, Example 116::US11180471, Example 116	Plasma kallikrein			 1.80							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413723	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413723&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205823	433913826							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825856	CCCC(C(=O)Nc1ccc2nccnc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C26H23ClN8O3/c1-3-4-23(26(37)31-17-6-7-20-21(12-17)29-10-9-28-20)34-14-24(38-2)19(13-25(34)36)18-11-16(27)5-8-22(18)35-15-30-32-33-35/h5-15,23H,3-4H2,1-2H3,(H,31,37)	BSNRZZUTVDCZAA-UHFFFAOYSA-N	413724	N-(Quinoxalin-6-yl)-2-{4-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}pentanamide (Racemate)::US10421742, Example 117::US11180471, Example 117	Plasma kallikrein			 0.970							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413724	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413724&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205052	433913827							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825857	CCC[C@@H](C(=O)Nc1ccc2nccnc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C26H23ClN8O3/c1-3-4-23(26(37)31-17-6-7-20-21(12-17)29-10-9-28-20)34-14-24(38-2)19(13-25(34)36)18-11-16(27)5-8-22(18)35-15-30-32-33-35/h5-15,23H,3-4H2,1-2H3,(H,31,37)/t23-/m0/s1	BSNRZZUTVDCZAA-QHCPKHFHSA-N	413725	N-(Quinoxalin-6-yl)-(2S)-2-{4-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}pentanamide (Enantiomer 2)::US10421742, Example 118::US11180471, Example 118	Plasma kallikrein			 0.570							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413725	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413725&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135211528	433913828							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825858	CCCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C26H25ClN8O3/c1-4-5-23(26(37)29-18-7-8-21-16(10-18)13-33(2)30-21)34-14-24(38-3)20(12-25(34)36)19-11-17(27)6-9-22(19)35-15-28-31-32-35/h6-15,23H,4-5H2,1-3H3,(H,29,37)	DROSFHKHAAIBHD-UHFFFAOYSA-N	413726	2-{4-[5-Chloro-2-(1H-tetrazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(2-methyl-2H-indazol-5-yl)pentanamide (Racemate)::US10421742, Example 119::US11180471, Example 119	Plasma kallikrein			 1.10							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413726	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413726&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135204930	433913829							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825859	CCC[C@@H](C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C26H25ClN8O3/c1-4-5-23(26(37)29-18-7-8-21-16(10-18)13-33(2)30-21)34-14-24(38-3)20(12-25(34)36)19-11-17(27)6-9-22(19)35-15-28-31-32-35/h6-15,23H,4-5H2,1-3H3,(H,29,37)/t23-/m0/s1	DROSFHKHAAIBHD-QHCPKHFHSA-N	413727	(2S)-2-{4-[5-Chloro-2-(1H-tetrazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(2-methyl-2H-indazol-5-yl)pentanamide (Enantiomer 2)::US10421742, Example 120::US11180471, Example 120	Plasma kallikrein			 0.780							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413727	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413727&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135204928	433913830							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825860	CCCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C27H24ClF3N6O4/c1-3-4-22(27(40)33-15-6-7-16(26(32)39)19(29)10-15)36-13-23(41-2)18(11-24(36)38)17-9-14(28)5-8-21(17)37-12-20(25(30)31)34-35-37/h5-13,22,25H,3-4H2,1-2H3,(H2,32,39)(H,33,40)	WZUXJAUBKKDABN-UHFFFAOYSA-N	413728	4-({2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]pentanoyl}amino)-2-fluorobenzamide (Racemate)::US10421742, Example 121::US11180471, Example 121	Plasma kallikrein			 39.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413728	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413728&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205311	433913831							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825861	CCCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C28H26ClF2N7O3/c1-4-5-24(28(40)32-18-7-8-21-16(10-18)13-36(2)34-21)37-15-25(41-3)20(12-26(37)39)19-11-17(29)6-9-23(19)38-14-22(27(30)31)33-35-38/h6-15,24,27H,4-5H2,1-3H3,(H,32,40)	TZKJUKFMINMKSP-UHFFFAOYSA-N	413729	2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-N-(2-methyl-2H-indazol-5-yl)pentanamide (Racemate)::US10421742, Example 122::US11180471, Example 122	Plasma kallikrein			 16.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413729	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413729&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205690	433913832							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825862	CCC[C@@H](C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C28H26ClF2N7O3/c1-4-5-24(28(40)32-18-7-8-21-16(10-18)13-36(2)34-21)37-15-25(41-3)20(12-26(37)39)19-11-17(29)6-9-23(19)38-14-22(27(30)31)33-35-38/h6-15,24,27H,4-5H2,1-3H3,(H,32,40)/t24-/m0/s1	TZKJUKFMINMKSP-DEOSSOPVSA-N	413730	(2S)-2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-N-(2-methyl-2H-indazol-5-yl)pentanamide (Enantiomer 2)::US10421742, Example 123::US11180471, Example 123	Plasma kallikrein			 4.50							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413730	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413730&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205688	433913833							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825863	CCCC(C(=O)Nc1ccc(nc1)C(=O)NC)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C27H26ClF2N7O4/c1-4-5-22(27(40)33-16-7-8-19(32-12-16)26(39)31-2)36-14-23(41-3)18(11-24(36)38)17-10-15(28)6-9-21(17)37-13-20(25(29)30)34-35-37/h6-14,22,25H,4-5H2,1-3H3,(H,31,39)(H,33,40)	ZZXQOEFXCPENDW-UHFFFAOYSA-N	413731	5-({2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]pentanoyl}amino)-N-methylpyridine-2-carboxamide (Racemate)::US10421742, Example 124::US11180471, Example 124	Plasma kallikrein			 24.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413731	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413731&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135204627	433913834							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825864	CCCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C26H23Cl2FN6O4/c1-3-4-21(26(38)31-15-6-7-16(25(30)37)19(29)10-15)34-12-22(39-2)18(11-24(34)36)17-9-14(27)5-8-20(17)35-13-23(28)32-33-35/h5-13,21H,3-4H2,1-2H3,(H2,30,37)(H,31,38)	KQZYQOJQXJGZMI-UHFFFAOYSA-N	413732	4-{[2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}pentanoyl]amino}-2-fluorobenzamide (Racemate)::US10421742, Example 125::US11180471, Example 125	Plasma kallikrein			 13.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413732	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413732&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135204823	433913835							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825865	CCCC(C(=O)Nc1ccc2nccnc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C27H23Cl2N7O3/c1-3-4-23(27(38)32-17-6-7-20-21(12-17)31-10-9-30-20)35-14-24(39-2)19(13-26(35)37)18-11-16(28)5-8-22(18)36-15-25(29)33-34-36/h5-15,23H,3-4H2,1-2H3,(H,32,38)	AJXCDVGDMKCSJV-UHFFFAOYSA-N	413733	N-(Quinoxalin-6-yl)-2-{4-[5-chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}pentanamide (Racemate)::US10421742, Example 126::US11180471, Example 126	Plasma kallikrein			 3.80							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413733	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413733&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135204993	433913836							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825866	CCCC(C(=O)Nc1ccc(nc1)C(=O)NC)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C26H25Cl2N7O4/c1-4-5-21(26(38)31-16-7-8-19(30-12-16)25(37)29-2)34-13-22(39-3)18(11-24(34)36)17-10-15(27)6-9-20(17)35-14-23(28)32-33-35/h6-14,21H,4-5H2,1-3H3,(H,29,37)(H,31,38)	RMNQUVGQJWBXRY-UHFFFAOYSA-N	413734	5-{[2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}pentanoyl]amino}-N-methylpyridine-2-carboxamide (Racemate)::US10421742, Example 127::US11180471, Example 127	Plasma kallikrein			 7.50							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413734	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413734&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205374	433913837							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825867	CCC[C@@H](C(=O)Nc1ccc(nc1)C(=O)NC)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C26H25Cl2N7O4/c1-4-5-21(26(38)31-16-7-8-19(30-12-16)25(37)29-2)34-13-22(39-3)18(11-24(34)36)17-10-15(27)6-9-20(17)35-14-23(28)32-33-35/h6-14,21H,4-5H2,1-3H3,(H,29,37)(H,31,38)/t21-/m0/s1	RMNQUVGQJWBXRY-NRFANRHFSA-N	413735	5-{[(2S)-2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}pentanoyl]amino}-N-methylpyridine-2-carboxamide (Enantiomer 2)::US10421742, Example 128::US11180471, Example 128	Plasma kallikrein			 4.60							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413735	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413735&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205795	433913838							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825868	CCCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C27H25Cl2N7O3/c1-4-5-23(27(38)30-18-7-8-21-16(10-18)13-34(2)32-21)35-14-24(39-3)20(12-26(35)37)19-11-17(28)6-9-22(19)36-15-25(29)31-33-36/h6-15,23H,4-5H2,1-3H3,(H,30,38)	XMGACJAVDNSYFS-UHFFFAOYSA-N	413736	2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(2-methyl-2H-indazol-5-yl)pentanamide (Racemate)::US10421742, Example 129::US11180471, Example 129	Plasma kallikrein			 6.80							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413736	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413736&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205483	433913839							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825869	CCC[C@@H](C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C27H25Cl2N7O3/c1-4-5-23(27(38)30-18-7-8-21-16(10-18)13-34(2)32-21)35-14-24(39-3)20(12-26(35)37)19-11-17(28)6-9-22(19)36-15-25(29)31-33-36/h6-15,23H,4-5H2,1-3H3,(H,30,38)/t23-/m0/s1	XMGACJAVDNSYFS-QHCPKHFHSA-N	413737	(2S)-2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(2-methyl-2H-indazol-5-yl)pentanamide (Enantiomer 2)::US10421742, Example 130::US11180471, Example 130	Plasma kallikrein			 3.10							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413737	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413737&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205651	433913840							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825870	CCCC(C(=O)Nc1ccc(nc1)C(=O)NC)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C1=NOCC1	InChI=1S/C27H28ClN5O5/c1-4-5-23(27(36)31-17-7-9-22(30-14-17)26(35)29-2)33-15-24(37-3)20(13-25(33)34)19-12-16(28)6-8-18(19)21-10-11-38-32-21/h6-9,12-15,23H,4-5,10-11H2,1-3H3,(H,29,35)(H,31,36)	FVMMOGSUTBHAJT-UHFFFAOYSA-N	413738	5-{[2-{4-[5-Chloro-2-(4,5-dihydro-1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}pentanoyl]amino}-N-methylpyridine-2-carboxamide (Racemate)::US10421742, Example 131::US11180471, Example 131	Plasma kallikrein			 250							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413738	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413738&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205781	433913841							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825871	CCCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C1=NOCC1	InChI=1S/C28H28ClN5O4/c1-4-5-25(28(36)30-19-7-9-23-17(12-19)15-33(2)31-23)34-16-26(37-3)22(14-27(34)35)21-13-18(29)6-8-20(21)24-10-11-38-32-24/h6-9,12-16,25H,4-5,10-11H2,1-3H3,(H,30,36)	GGCCNKNGPKYJET-UHFFFAOYSA-N	413739	2-{4-[5-Chloro-2-(4,5-dihydro-1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(2-methyl-2H-indazol-5-yl)pentanamide (Racemate)::US10421742, Example 132::US11180471, Example 132	Plasma kallikrein			 110							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413739	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413739&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205590	433913842							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825872	CCCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C1=NOCC1	InChI=1S/C27H26ClFN4O5/c1-3-4-23(27(36)31-16-6-8-18(26(30)35)21(29)12-16)33-14-24(37-2)20(13-25(33)34)19-11-15(28)5-7-17(19)22-9-10-38-32-22/h5-8,11-14,23H,3-4,9-10H2,1-2H3,(H2,30,35)(H,31,36)	CACLNVKPTHLQAL-UHFFFAOYSA-N	413740	4-{[2-{4-[5-Chloro-2-(4,5-dihydro-1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}pentanoyl]amino}-2-fluorobenzamide (Racemate)::US10421742, Example 133::US11180471, Example 133	Plasma kallikrein			 460							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413740	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413740&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135211499	433913843							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825873	CCCC(C(=O)Nc1ccc2nccnc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C1=NOCC1	InChI=1S/C28H26ClN5O4/c1-3-4-25(28(36)32-18-6-8-23-24(14-18)31-11-10-30-23)34-16-26(37-2)21(15-27(34)35)20-13-17(29)5-7-19(20)22-9-12-38-33-22/h5-8,10-11,13-16,25H,3-4,9,12H2,1-2H3,(H,32,36)	QYYKJTWIVWXLBD-UHFFFAOYSA-N	413741	N-(Quinoxalin-6-yl)-2-{4-[5-chloro-2-(4,5-dihydro-1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}pentanamide (Racemate)::US10421742, Example 134::US11180471, Example 134	Plasma kallikrein			 45.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413741	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413741&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135204822	433913844							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825874	CCCC(C(=O)Nc1ccc(nc1)C(N)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C1=NOCC1	InChI=1S/C26H26ClN5O5/c1-3-4-22(26(35)30-16-6-8-21(25(28)34)29-13-16)32-14-23(36-2)19(12-24(32)33)18-11-15(27)5-7-17(18)20-9-10-37-31-20/h5-8,11-14,22H,3-4,9-10H2,1-2H3,(H2,28,34)(H,30,35)	WRJUZVZDXJUFIS-UHFFFAOYSA-N	413742	5-{[2-{4-[5-Chloro-2-(4,5-dihydro-1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}pentanoyl]amino}pyridine-2-carboxamide (Racemate)::US10421742, Example 135::US11180471, Example 135	Plasma kallikrein			 380							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413742	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413742&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205806	433913845							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825875	CCCCC(C(=O)Nc1ccc(nc1)C(N)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C25H25ClN8O4/c1-3-4-5-21(25(37)30-16-7-8-19(24(27)36)28-12-16)33-13-22(38-2)18(11-23(33)35)17-10-15(26)6-9-20(17)34-14-29-31-32-34/h6-14,21H,3-5H2,1-2H3,(H2,27,36)(H,30,37)	ZIAUCGPBMPJNBL-UHFFFAOYSA-N	413743	5-{[2-{4-[5-Chloro-2-(1H-tetrazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}hexanoyl]amino}pyridine-2-carboxamide (Racemate)::US10421742, Example 136::US11180471, Example 136	Plasma kallikrein			 2.50							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413743	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413743&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205668	433913846							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825876	CCCCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C26H25ClFN7O4/c1-3-4-5-22(26(38)31-16-7-8-17(25(29)37)20(28)11-16)34-13-23(39-2)19(12-24(34)36)18-10-15(27)6-9-21(18)35-14-30-32-33-35/h6-14,22H,3-5H2,1-2H3,(H2,29,37)(H,31,38)	VQBUYPWHWZACJN-UHFFFAOYSA-N	413744	4-{[2-{4-[5-Chloro-2-(1H-tetrazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}hexanoyl]amino}-2-fluorobenzamide (Racemate)::US10421742, Example 137::US11180471, Example 137	Plasma kallikrein			 2.10							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413744	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413744&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205878	433913847							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825877	CCCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C26H25ClN6O5/c1-3-4-5-22(25(35)29-18-9-6-16(7-10-18)26(36)37)32-14-23(38-2)20(13-24(32)34)19-12-17(27)8-11-21(19)33-15-28-30-31-33/h6-15,22H,3-5H2,1-2H3,(H,29,35)(H,36,37)	FCSAYDZPMDLFSN-UHFFFAOYSA-N	413745	4-{[2-{4-[5-Chloro-2-(1H-tetrazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}hexanoyl]amino}benzoic acid (Racemate)::US10421742, Example 138::US11180471, Example 138	Plasma kallikrein			 1.80							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413745	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413745&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205666	433913848							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825878	CCCCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C27H27ClN8O3/c1-4-5-6-24(27(38)30-19-8-9-22-17(11-19)14-34(2)31-22)35-15-25(39-3)21(13-26(35)37)20-12-18(28)7-10-23(20)36-16-29-32-33-36/h7-16,24H,4-6H2,1-3H3,(H,30,38)	GTVFMNZALGQANW-UHFFFAOYSA-N	413746	2-{4-[5-Chloro-2-(1H-tetrazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(2-methyl-2H-indazol-5-yl)hexanamide (Racemate)::US10421742, Example 139::US11180471, Example 139	Plasma kallikrein			 1.000							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413746	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413746&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205025	433913849							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825879	CCCCC(C(=O)Nc1ccc2nccnc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C27H25ClN8O3/c1-3-4-5-24(27(38)32-18-7-8-21-22(13-18)30-11-10-29-21)35-15-25(39-2)20(14-26(35)37)19-12-17(28)6-9-23(19)36-16-31-33-34-36/h6-16,24H,3-5H2,1-2H3,(H,32,38)	DVTLDIPPLKDTBX-UHFFFAOYSA-N	413747	N-(Quinoxalin-6-yl)-2-{4-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}hexanamide (Racemate)::US10421742, Example 140::US11180471, Example 140	Plasma kallikrein			 1.50							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413747	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413747&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205988	433913850							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51123151	COC(=O)Nc1ccc(cc1)-c1cc(nnc1Cl)[C@H](Cc1ccccc1)NC(=O)\C=C\c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C30H24Cl2N8O3/c1-43-30(42)34-23-11-7-20(8-12-23)24-17-26(36-37-29(24)32)25(15-19-5-3-2-4-6-19)35-28(41)14-9-21-16-22(31)10-13-27(21)40-18-33-38-39-40/h2-14,16-18,25H,15H2,1H3,(H,34,42)(H,35,41)/b14-9+/t25-/m0/s1	KNIIBCIANRMVRA-SXAZAVRTSA-N	50460457	CHEMBL4227743	Plasma kallikrein		>6000								ChEMBL	10.1016/j.bmcl.2018.02.049	10.7270/Q2DJ5J7H	29501396			Hu, Z; Wang, C; Han, W; Rossi, KA; Bozarth, JM; Wu, Y; Sheriff, S; Myers, JE; Luettgen, JM; Seiffert, DA; Wexler, RR; Quan, ML	Bristol-Myers Squibb Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50460457	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50460457&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			88582319	433927722							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51123152	COC(=O)Nc1ccc(cc1)-c1cc([C@H](Cc2ccccc2)NC(=O)\C=C\c2cc(Cl)ccc2-n2cnnn2)c(Cl)nn1	InChI=1S/C30H24Cl2N8O3/c1-43-30(42)34-23-11-7-20(8-12-23)25-17-24(29(32)37-36-25)26(15-19-5-3-2-4-6-19)35-28(41)14-9-21-16-22(31)10-13-27(21)40-18-33-38-39-40/h2-14,16-18,26H,15H2,1H3,(H,34,42)(H,35,41)/b14-9+/t26-/m0/s1	KWZZDFIUKWTKDC-BULTVDLSSA-N	50460462	CHEMBL4226897	Plasma kallikrein		 192								ChEMBL	10.1016/j.bmcl.2018.02.049	10.7270/Q2DJ5J7H	29501396			Hu, Z; Wang, C; Han, W; Rossi, KA; Bozarth, JM; Wu, Y; Sheriff, S; Myers, JE; Luettgen, JM; Seiffert, DA; Wexler, RR; Quan, ML	Bristol-Myers Squibb Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50460462	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50460462&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			145970642	433927727							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51123161	COC(=O)Nc1ccc(cc1)-c1cc(nnc1C)[C@H](Cc1ccccc1)NC(=O)\C=C\c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C31H27ClN8O3/c1-20-26(22-8-12-25(13-9-22)34-31(42)43-2)18-28(37-36-20)27(16-21-6-4-3-5-7-21)35-30(41)15-10-23-17-24(32)11-14-29(23)40-19-33-38-39-40/h3-15,17-19,27H,16H2,1-2H3,(H,34,42)(H,35,41)/b15-10+/t27-/m0/s1	ARGAWPOUZMCKAP-ZOYLIWTNSA-N	50460468	CHEMBL4226631	Plasma kallikrein		 1370								ChEMBL	10.1016/j.bmcl.2018.02.049	10.7270/Q2DJ5J7H	29501396			Hu, Z; Wang, C; Han, W; Rossi, KA; Bozarth, JM; Wu, Y; Sheriff, S; Myers, JE; Luettgen, JM; Seiffert, DA; Wexler, RR; Quan, ML	Bristol-Myers Squibb Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50460468	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50460468&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			70253788	433927733							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51123179	COC(=O)Nc1ccc(cc1)-c1cnnc(c1)[C@H](Cc1ccccc1)NC(=O)\C=C\c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C30H25ClN8O3/c1-42-30(41)34-25-11-7-21(8-12-25)23-17-27(36-32-18-23)26(15-20-5-3-2-4-6-20)35-29(40)14-9-22-16-24(31)10-13-28(22)39-19-33-37-38-39/h2-14,16-19,26H,15H2,1H3,(H,34,41)(H,35,40)/b14-9+/t26-/m0/s1	VQGKRPKUGUYGOV-BULTVDLSSA-N	50460459	CHEMBL4228006	Plasma kallikrein		 268								ChEMBL	10.1016/j.bmcl.2018.02.049	10.7270/Q2DJ5J7H	29501396			Hu, Z; Wang, C; Han, W; Rossi, KA; Bozarth, JM; Wu, Y; Sheriff, S; Myers, JE; Luettgen, JM; Seiffert, DA; Wexler, RR; Quan, ML	Bristol-Myers Squibb Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50460459	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50460459&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			70252985	433927724							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825880	CCCCC(C(=O)Nc1ccc(nc1)C(=O)NC)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C26H27ClN8O4/c1-4-5-6-22(26(38)31-17-8-9-20(29-13-17)25(37)28-2)34-14-23(39-3)19(12-24(34)36)18-11-16(27)7-10-21(18)35-15-30-32-33-35/h7-15,22H,4-6H2,1-3H3,(H,28,37)(H,31,38)	ORRIMSVBDDRCMC-UHFFFAOYSA-N	413748	5-{[2-{4-[5-Chloro-2-(1H-tetrazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}hexanoyl]amino}-N-methylpyridine-2-carboxamide (Racemate)::US10421742, Example 141::US11180471, Example 141	Plasma kallikrein			 1.40							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413748	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413748&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205579	433913851							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825881	CCCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C28H26ClF2N5O5/c1-3-4-5-23(27(38)32-18-9-6-16(7-10-18)28(39)40)35-15-24(41-2)20(13-25(35)37)19-12-17(29)8-11-22(19)36-14-21(26(30)31)33-34-36/h6-15,23,26H,3-5H2,1-2H3,(H,32,38)(H,39,40)	PSPFOZLTTSZDFP-UHFFFAOYSA-N	413749	4-({2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]hexanoyl}amino)benzoic acid (Racemate)::US10421742, Example 142::US11180471, Example 142	Plasma kallikrein			 11.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413749	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413749&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135204833	433913852							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825882	CCCCC(C(=O)Nc1ccc(nc1)C(N)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C27H26ClF2N7O4/c1-3-4-5-22(27(40)33-16-7-8-19(26(31)39)32-12-16)36-14-23(41-2)18(11-24(36)38)17-10-15(28)6-9-21(17)37-13-20(25(29)30)34-35-37/h6-14,22,25H,3-5H2,1-2H3,(H2,31,39)(H,33,40)	JSHWYUYKRGKALM-UHFFFAOYSA-N	413750	5-({2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]hexanoyl}amino)pyridine-2-carboxamide (Racemate)::US10421742, Example 143::US11180471, Example 143	Plasma kallikrein			 21.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413750	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413750&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205512	433913853							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825883	CCCCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C28H26ClF3N6O4/c1-3-4-5-23(28(41)34-16-7-8-17(27(33)40)20(30)11-16)37-14-24(42-2)19(12-25(37)39)18-10-15(29)6-9-22(18)38-13-21(26(31)32)35-36-38/h6-14,23,26H,3-5H2,1-2H3,(H2,33,40)(H,34,41)	HGCFEYDNSXOVOU-UHFFFAOYSA-N	413751	4-({2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]hexanoyl}amino)-2-fluorobenzamide (Racemate)::US10421742, Example 144::US11180471, Example 144	Plasma kallikrein			 30.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413751	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413751&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205069	433913854							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825884	CCCCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C29H28ClF2N7O3/c1-4-5-6-25(29(41)33-19-8-9-22-17(11-19)14-37(2)35-22)38-16-26(42-3)21(13-27(38)40)20-12-18(30)7-10-24(20)39-15-23(28(31)32)34-36-39/h7-16,25,28H,4-6H2,1-3H3,(H,33,41)	OUOIBTWZEMQDJD-UHFFFAOYSA-N	413752	2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-N-(2-methyl-2H-indazol-5-yl)hexanamide (Racemate)::US10421742, Example 145::US11180471, Example 145	Plasma kallikrein			 7.30							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413752	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413752&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205547	433913855							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825885	CCCCC(C(=O)Nc1ccc2nccnc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C29H26ClF2N7O3/c1-3-4-5-25(29(41)35-18-7-8-21-22(13-18)34-11-10-33-21)38-16-26(42-2)20(14-27(38)40)19-12-17(30)6-9-24(19)39-15-23(28(31)32)36-37-39/h6-16,25,28H,3-5H2,1-2H3,(H,35,41)	YGFSDBVKNXCHFA-UHFFFAOYSA-N	413753	N-(Quinoxalin-6-yl)-2-[4-{5-chloro-2-[4-(difluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]hexanamide (Racemate)::US10421742, Example 146::US11180471, Example 146	Plasma kallikrein			 5.60							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413753	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413753&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205951	433913856							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825886	CCCCC(C(=O)Nc1ccc(nc1)C(=O)NC)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C28H28ClF2N7O4/c1-4-5-6-23(28(41)34-17-8-9-20(33-13-17)27(40)32-2)37-15-24(42-3)19(12-25(37)39)18-11-16(29)7-10-22(18)38-14-21(26(30)31)35-36-38/h7-15,23,26H,4-6H2,1-3H3,(H,32,40)(H,34,41)	LATWNRFJRFBWAT-UHFFFAOYSA-N	413754	5-({2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]hexanoyl}amino)-N-methylpyridine-2-carboxamide (Racemate)::US10421742, Example 147::US11180471, Example 147	Plasma kallikrein			 13.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413754	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413754&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135206088	433913857							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825887	CCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(o1)C(F)(F)F	InChI=1S/C26H20ClF3N4O6/c1-3-19(22(36)31-15-7-4-13(5-8-15)24(37)38)34-12-20(39-2)18(11-21(34)35)17-10-14(27)6-9-16(17)23-32-33-25(40-23)26(28,29)30/h4-12,19H,3H2,1-2H3,(H,31,36)(H,37,38)	QIVMZHNMVQBPGT-UHFFFAOYSA-N	413755	4-({2-[4-{5-Chloro-2-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanoyl}amino)benzoic acid (Racemate)::US10421742, Example 148::US11180471, Example 148	Plasma kallikrein			 200							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413755	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413755&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205817	433913858							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825888	CCC(C(=O)Nc1ccc(nc1)C(N)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(o1)C(F)(F)F	InChI=1S/C25H20ClF3N6O5/c1-3-18(22(38)32-13-5-7-17(21(30)37)31-10-13)35-11-19(39-2)16(9-20(35)36)15-8-12(26)4-6-14(15)23-33-34-24(40-23)25(27,28)29/h4-11,18H,3H2,1-2H3,(H2,30,37)(H,32,38)	IQJSIJCMDLKBFX-UHFFFAOYSA-N	413756	5-({2-[4-{5-Chloro-2-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanoyl}amino)pyridine-2-carboxamide (Racemate)::US10421742, Example 149::US11180471, Example 149	Plasma kallikrein			 210							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413756	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413756&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135206048	433913859							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825889	CCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(o1)C(F)(F)F	InChI=1S/C26H20ClF4N5O5/c1-3-19(23(39)33-13-5-7-15(22(32)38)18(28)9-13)36-11-20(40-2)17(10-21(36)37)16-8-12(27)4-6-14(16)24-34-35-25(41-24)26(29,30)31/h4-11,19H,3H2,1-2H3,(H2,32,38)(H,33,39)	UHOHRXOOGVHYED-UHFFFAOYSA-N	413757	4-({2-[4-{5-Chloro-2-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanoyl}amino)-2-fluorobenzamide (Racemate)::US10421742, Example 150::US11180471, Example 150	Plasma kallikrein			 210							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413757	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413757&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205709	433913860							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825890	CCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(o1)C(F)(F)F	InChI=1S/C27H22ClF3N6O4/c1-4-21(24(39)32-16-6-8-20-14(9-16)12-36(2)35-20)37-13-22(40-3)19(11-23(37)38)18-10-15(28)5-7-17(18)25-33-34-26(41-25)27(29,30)31/h5-13,21H,4H2,1-3H3,(H,32,39)	HHSBQKYCPNEOQX-UHFFFAOYSA-N	413758	2-[4-{5-Chloro-2-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 151::US11180471, Example 151	Plasma kallikrein			 71.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413758	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413758&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205384	433913861							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825891	CCC(C(=O)Nc1ccc2nccnc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(o1)C(F)(F)F	InChI=1S/C27H20ClF3N6O4/c1-3-21(24(39)34-15-5-7-19-20(11-15)33-9-8-32-19)37-13-22(40-2)18(12-23(37)38)17-10-14(28)4-6-16(17)25-35-36-26(41-25)27(29,30)31/h4-13,21H,3H2,1-2H3,(H,34,39)	OLLLLNYOIWPNPJ-UHFFFAOYSA-N	413759	N-(Quinoxalin-6-yl)-2-[4-{5-chloro-2-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanamide (Racemate)::US10421742, Example 152::US11180471, Example 152	Plasma kallikrein			 40.0							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413759	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413759&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205969	433913862							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825892	CCC(C(=O)Nc1ccc(C(=O)NC)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(o1)C(F)(F)F	InChI=1S/C27H22ClF4N5O5/c1-4-20(24(40)34-14-6-8-16(19(29)10-14)23(39)33-2)37-12-21(41-3)18(11-22(37)38)17-9-13(28)5-7-15(17)25-35-36-26(42-25)27(30,31)32/h5-12,20H,4H2,1-3H3,(H,33,39)(H,34,40)	DLRRJLUTWALOOR-UHFFFAOYSA-N	413760	4-({2-[4-{5-Chloro-2-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanoyl}amino)-2-fluoro-N-methylbenzamide (Racemate)::US10421742, Example 153::US11180471, Example 153	Plasma kallikrein			 270							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413760	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413760&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135204746	433913863							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825893	CCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(o1)C(F)F	InChI=1S/C26H21ClF2N4O6/c1-3-19(23(35)30-15-7-4-13(5-8-15)26(36)37)33-12-20(38-2)18(11-21(33)34)17-10-14(27)6-9-16(17)24-31-32-25(39-24)22(28)29/h4-12,19,22H,3H2,1-2H3,(H,30,35)(H,36,37)	ARBVSWGIQYWRFI-UHFFFAOYSA-N	413761	4-({2-[4-{5-Chloro-2-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanoyl}amino)benzoic acid (Racemate)::US10421742, Example 154::US11180471, Example 154	Plasma kallikrein			 170							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413761	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413761&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205186	433913864							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
825894	CCC(C(=O)Nc1ccc(nc1)C(N)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(o1)C(F)F	InChI=1S/C25H21ClF2N6O5/c1-3-18(23(37)31-13-5-7-17(22(29)36)30-10-13)34-11-19(38-2)16(9-20(34)35)15-8-12(26)4-6-14(15)24-32-33-25(39-24)21(27)28/h4-11,18,21H,3H2,1-2H3,(H2,29,36)(H,31,37)	MXCXAGMMMBQTPS-UHFFFAOYSA-N	413762	5-({2-[4-{5-Chloro-2-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanoyl}amino)pyridine-2-carboxamide (Racemate)::US10421742, Example 155::US11180471, Example 155	Plasma kallikrein			 140							US Patent		10.7270/Q26M3967		aid1803835	US10421742	Jimenez Nunez, E; Ackerstaff, J; Rohrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfus, J; Ellerbrock, P; Meibom, D; Lang, D	BAYER PHARMA AKTIENGESELLSCHAFT	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413762	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413762&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205309	433913865							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
822384	Cc1ccc2cc(Cn3cc(nn3)C(=O)NC3CCCc4nc(Cl)ccc34)ccc2n1	InChI=1S/C23H21ClN6O/c1-14-5-7-16-11-15(6-9-18(16)25-14)12-30-13-21(28-29-30)23(31)27-20-4-2-3-19-17(20)8-10-22(24)26-19/h5-11,13,20H,2-4,12H2,1H3,(H,27,31)	IRDYSCISPDGSNH-UHFFFAOYSA-N	412357	1-(2-Methyl-quinolin-6-ylmethyl)-1H-[1,2,3]triazole-4-carboxylic acid (2-amino-5,6,7,8-tetrahydro-quinolin-5-yl)-amide::US10399961, Example 1	Plasma kallikrein			 900							US Patent		10.7270/Q22Z17X8		aid1803793	US10399961	Frattini, S; Bakker, R; Giovannini, R; Hamprecht, D; Lingard, I; Pautsch, A; Wellenzohn, B	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=412357	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=412357&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
822385	Nc1nccc2CCC(NC(=O)c3cn(Cc4ccc(Cn5cccn5)cc4)nn3)c12	InChI=1S/C22H22N8O/c23-21-20-17(8-10-24-21)6-7-18(20)26-22(31)19-14-30(28-27-19)13-16-4-2-15(3-5-16)12-29-11-1-9-25-29/h1-5,8-11,14,18H,6-7,12-13H2,(H2,23,24)(H,26,31)	BAZJOBLYOILXCF-UHFFFAOYSA-N	412358	1-(4-Pyrazol-1-ylmethyl-benzyl)-1H-[1,2,3]triazole-4-carboxylic acid (1-amino-6,7-dihydro-5H-[2]pyrindin-7-yl)-amide::US10399961, Example 2	Plasma kallikrein			 600							US Patent		10.7270/Q22Z17X8		aid1803793	US10399961	Frattini, S; Bakker, R; Giovannini, R; Hamprecht, D; Lingard, I; Pautsch, A; Wellenzohn, B	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=412358	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=412358&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
822386	Nc1ccc2C(CCc2n1)NC(=O)c1cn(Cc2ccc(cc2)C(F)c2ccon2)nn1	InChI=1S/C22H20FN7O2/c23-21(18-9-10-32-28-18)14-3-1-13(2-4-14)11-30-12-19(27-29-30)22(31)26-17-7-6-16-15(17)5-8-20(24)25-16/h1-5,8-10,12,17,21H,6-7,11H2,(H2,24,25)(H,26,31)	SRPFSQFHTWHXEQ-UHFFFAOYSA-N	412359	US10399961, Example 3	Plasma kallikrein			 5500							US Patent		10.7270/Q22Z17X8		aid1803793	US10399961	Frattini, S; Bakker, R; Giovannini, R; Hamprecht, D; Lingard, I; Pautsch, A; Wellenzohn, B	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=412359	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=412359&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
822387	Nc1cc2CCC(NC(=O)c3cn(Cc4ccc(Cn5cccn5)cc4)nn3)c2cn1	InChI=1S/C22H22N8O/c23-21-10-17-6-7-19(18(17)11-24-21)26-22(31)20-14-30(28-27-20)13-16-4-2-15(3-5-16)12-29-9-1-8-25-29/h1-5,8-11,14,19H,6-7,12-13H2,(H2,23,24)(H,26,31)	CSEXJDBYVWHNCY-UHFFFAOYSA-N	412360	US10399961, Example 4	Plasma kallikrein			 790							US Patent		10.7270/Q22Z17X8		aid1803793	US10399961	Frattini, S; Bakker, R; Giovannini, R; Hamprecht, D; Lingard, I; Pautsch, A; Wellenzohn, B	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=412360	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=412360&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
822388	Nc1ccc2C(CCc2n1)NC(=O)c1cn(Cc2ccc(Cn3ccccc3=O)cc2)nn1	InChI=1S/C24H23N7O2/c25-22-11-8-18-19(26-22)9-10-20(18)27-24(33)21-15-31(29-28-21)14-17-6-4-16(5-7-17)13-30-12-2-1-3-23(30)32/h1-8,11-12,15,20H,9-10,13-14H2,(H2,25,26)(H,27,33)	WKZOGGQVVZDFQR-UHFFFAOYSA-N	412361	US10399961, Example 5	Plasma kallikrein			 9.00							US Patent		10.7270/Q22Z17X8		aid1803793	US10399961	Frattini, S; Bakker, R; Giovannini, R; Hamprecht, D; Lingard, I; Pautsch, A; Wellenzohn, B	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=412361	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=412361&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
822389	Nc1ccc2C(CCc2n1)NC(=O)c1cnn(Cc2ccc(Cn3cccn3)cc2)c1	InChI=1S/C23H23N7O/c24-22-9-6-19-20(27-22)7-8-21(19)28-23(31)18-12-26-30(15-18)14-17-4-2-16(3-5-17)13-29-11-1-10-25-29/h1-6,9-12,15,21H,7-8,13-14H2,(H2,24,27)(H,28,31)	NFVVIKJQOBFYOZ-UHFFFAOYSA-N	412362	US10399961, Example 6	Plasma kallikrein			 32.0							US Patent		10.7270/Q22Z17X8		aid1803793	US10399961	Frattini, S; Bakker, R; Giovannini, R; Hamprecht, D; Lingard, I; Pautsch, A; Wellenzohn, B	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=412362	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=412362&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
822390	Cc1ccc2cc(Cn3cc(nn3)C(=O)NC3CCc4nc(N)ccc34)ccc2n1	InChI=1S/C22H21N7O/c1-13-2-4-15-10-14(3-6-17(15)24-13)11-29-12-20(27-28-29)22(30)26-19-8-7-18-16(19)5-9-21(23)25-18/h2-6,9-10,12,19H,7-8,11H2,1H3,(H2,23,25)(H,26,30)	DIWKOOBICROCPL-UHFFFAOYSA-N	412363	US10399961, Example 7	Plasma kallikrein			 910							US Patent		10.7270/Q22Z17X8		aid1803793	US10399961	Frattini, S; Bakker, R; Giovannini, R; Hamprecht, D; Lingard, I; Pautsch, A; Wellenzohn, B	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=412363	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=412363&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
822391	Cc1cc(N)nc2CCC(NC(=O)c3cn(Cc4ccc(Cn5ccccc5=O)cc4)nn3)c12	InChI=1S/C25H25N7O2/c1-16-12-22(26)27-19-9-10-20(24(16)19)28-25(34)21-15-32(30-29-21)14-18-7-5-17(6-8-18)13-31-11-3-2-4-23(31)33/h2-8,11-12,15,20H,9-10,13-14H2,1H3,(H2,26,27)(H,28,34)	UZGQNEPUORSINM-UHFFFAOYSA-N	412364	US10399961, Example 8	Plasma kallikrein			 4.00							US Patent		10.7270/Q22Z17X8		aid1803793	US10399961	Frattini, S; Bakker, R; Giovannini, R; Hamprecht, D; Lingard, I; Pautsch, A; Wellenzohn, B	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=412364	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=412364&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
822392	CC(C)(O)c1cccn(Cc2ccc(Cn3cc(nn3)C(=O)NC3CCc4nc(N)ccc34)cc2)c1=O	InChI=1S/C27H29N7O3/c1-27(2,37)20-4-3-13-33(26(20)36)14-17-5-7-18(8-6-17)15-34-16-23(31-32-34)25(35)30-22-11-10-21-19(22)9-12-24(28)29-21/h3-9,12-13,16,22,37H,10-11,14-15H2,1-2H3,(H2,28,29)(H,30,35)	UNBADXUMSDUIPF-UHFFFAOYSA-N	412365	US10399961, Example 9	Plasma kallikrein			 560							US Patent		10.7270/Q22Z17X8		aid1803793	US10399961	Frattini, S; Bakker, R; Giovannini, R; Hamprecht, D; Lingard, I; Pautsch, A; Wellenzohn, B	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=412365	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=412365&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
822393	Cc1ccc2cc(Cn3cc(nn3)C(=O)N[C@H]3CCc4c3ccnc4N)ccc2n1	InChI=1S/C22H21N7O/c1-13-2-4-15-10-14(3-6-18(15)25-13)11-29-12-20(27-28-29)22(30)26-19-7-5-17-16(19)8-9-24-21(17)23/h2-4,6,8-10,12,19H,5,7,11H2,1H3,(H2,23,24)(H,26,30)/t19-/m0/s1	YXBFGZDLXYEGII-IBGZPJMESA-N	412366	US10399961, Example 11	Plasma kallikrein			 1900							US Patent		10.7270/Q22Z17X8		aid1803793	US10399961	Frattini, S; Bakker, R; Giovannini, R; Hamprecht, D; Lingard, I; Pautsch, A; Wellenzohn, B	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=412366	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=412366&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
822394	Cc1ccc2cc(Cn3cc(nn3)C(=O)N[C@@H]3CCc4c3ccnc4N)ccc2n1	InChI=1S/C22H21N7O/c1-13-2-4-15-10-14(3-6-18(15)25-13)11-29-12-20(27-28-29)22(30)26-19-7-5-17-16(19)8-9-24-21(17)23/h2-4,6,8-10,12,19H,5,7,11H2,1H3,(H2,23,24)(H,26,30)/t19-/m1/s1	YXBFGZDLXYEGII-LJQANCHMSA-N	412367	US10399961, Example 12	Plasma kallikrein			 36.0							US Patent		10.7270/Q22Z17X8		aid1803793	US10399961	Frattini, S; Bakker, R; Giovannini, R; Hamprecht, D; Lingard, I; Pautsch, A; Wellenzohn, B	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=412367	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=412367&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
822395	C[C@H]1CCN(C1)c1ccc(Cn2cc(cn2)C(=O)N[C@@H]2CCc3nc(N)ccc23)cn1	InChI=1S/C23H27N7O/c1-15-8-9-29(12-15)22-7-2-16(10-25-22)13-30-14-17(11-26-30)23(31)28-20-5-4-19-18(20)3-6-21(24)27-19/h2-3,6-7,10-11,14-15,20H,4-5,8-9,12-13H2,1H3,(H2,24,27)(H,28,31)/t15-,20+/m0/s1	VBXFERGVTGHWOF-MGPUTAFESA-N	50271124	CHEMBL4126836::US10399961, Example 13	Plasma kallikrein			 19.0							US Patent		10.7270/Q22Z17X8		aid1803793	US10399961	Frattini, S; Bakker, R; Giovannini, R; Hamprecht, D; Lingard, I; Pautsch, A; Wellenzohn, B	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50271124	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50271124&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			129103439	405255720							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
822396	C[C@H]1CCN(C1)c1ccc(Cn2cc(C(=O)N[C@@H]3CCc4nc(N)ccc34)c(n2)C(F)(F)F)cn1	InChI=1S/C24H26F3N7O/c1-14-8-9-33(11-14)21-7-2-15(10-29-21)12-34-13-17(22(32-34)24(25,26)27)23(35)31-19-5-4-18-16(19)3-6-20(28)30-18/h2-3,6-7,10,13-14,19H,4-5,8-9,11-12H2,1H3,(H2,28,30)(H,31,35)/t14-,19+/m0/s1	IYWOLFDPAKKHGW-IFXJQAMLSA-N	412369	US10399961, Example 14	Plasma kallikrein			 40.0							US Patent		10.7270/Q22Z17X8		aid1803793	US10399961	Frattini, S; Bakker, R; Giovannini, R; Hamprecht, D; Lingard, I; Pautsch, A; Wellenzohn, B	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=412369	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=412369&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
822397	Cc1cnn(Cc2ccc(Cn3cc(C(=O)N[C@@H]4CCc5c4ccnc5N)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C25H24F3N7O/c1-15-10-31-34(11-15)12-16-2-4-17(5-3-16)13-35-14-20(22(33-35)25(26,27)28)24(36)32-21-7-6-19-18(21)8-9-30-23(19)29/h2-5,8-11,14,21H,6-7,12-13H2,1H3,(H2,29,30)(H,32,36)/t21-/m1/s1	KBJLKCOIGIUVBO-OAQYLSRUSA-N	412370	US10399961, Example 15	Plasma kallikrein			 1.000							US Patent		10.7270/Q22Z17X8		aid1803793	US10399961	Frattini, S; Bakker, R; Giovannini, R; Hamprecht, D; Lingard, I; Pautsch, A; Wellenzohn, B	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=412370	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=412370&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
822398	Cc1cnn(Cc2ccc(Cn3cc(C(=O)N[C@@H]4CCc5nc(N)ccc45)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C25H24F3N7O/c1-15-10-30-34(11-15)12-16-2-4-17(5-3-16)13-35-14-19(23(33-35)25(26,27)28)24(36)32-21-8-7-20-18(21)6-9-22(29)31-20/h2-6,9-11,14,21H,7-8,12-13H2,1H3,(H2,29,31)(H,32,36)/t21-/m1/s1	GYYMWPJBNBSMIW-OAQYLSRUSA-N	412371	US10399961, Example 16	Plasma kallikrein			 18.0							US Patent		10.7270/Q22Z17X8		aid1803793	US10399961	Frattini, S; Bakker, R; Giovannini, R; Hamprecht, D; Lingard, I; Pautsch, A; Wellenzohn, B	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=412371	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=412371&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816325	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(OC)cc(OC)c1	InChI=1S/C28H30N4O5/c1-35-19-26-25(28(34)29-15-22-12-23(36-2)14-24(13-22)37-3)18-32(30-26)17-21-9-7-20(8-10-21)16-31-11-5-4-6-27(31)33/h4-14,18H,15-17,19H2,1-3H3,(H,29,34)	BKELALJCIHUNCS-UHFFFAOYSA-N	408665	N-(3,5-Dimethoxybenzyl)-3-(methoxymethyl)-1-(4-((2-oxopyridin-1(2H)-yl)methyl)benzyl)-1H-pyrazole-4-carboxamide::US10364238, Example 1::US11001578, Example 1::US11084809, Example 1::US11198691, Example 1	Plasma kallikrein			 698							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408665	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408665&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364994	406799299							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816327	COc1cccc(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2N)c1F	InChI=1S/C25H24FN5O3/c1-34-21-6-4-5-19(23(21)26)13-28-25(33)20-16-31(29-24(20)27)15-18-10-8-17(9-11-18)14-30-12-3-2-7-22(30)32/h2-12,16H,13-15H2,1H3,(H2,27,29)(H,28,33)	HICYNMRHZGAFMT-UHFFFAOYSA-N	408666	3-Amino-1-[4-(2-oxo-2H-pyridin-1-ylmethyl)-benzyl]-1H-pyrazole-4-carboxylic acid 2-fluoro-3-methoxy-benzylamide::US10364238, Example 2::US11001578, Example 2::US11084809, Example 2::US11198691, Example 2	Plasma kallikrein			 8.70							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408666	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408666&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365045	406799300							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816329	COCc1nn(Cc2cnc3cc(Cl)ccc3c2)cc1C(=O)NCc1cccc(OC)c1F	InChI=1S/C24H22ClFN4O3/c1-32-14-21-19(24(31)28-11-17-4-3-5-22(33-2)23(17)26)13-30(29-21)12-15-8-16-6-7-18(25)9-20(16)27-10-15/h3-10,13H,11-12,14H2,1-2H3,(H,28,31)	WPIUJKAYUGBTDW-UHFFFAOYSA-N	408667	1-(7-Chloro-quinolin-3-ylmethyl)-3-methoxymethyl-1H-pyrazole-4-carboxylic acid 2-fluoro-3-methoxy-benzylamide::US10364238, Example 3::US11001578, Example 3::US11084809, Example 3::US11198691, Example 3	Plasma kallikrein			 2580							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408667	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408667&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365013	406799301							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816331	COc1cccc(CNC(=O)c2cn(Cc3ccc(Cn4cc(C)cn4)cc3)nc2C(F)(F)F)c1F	InChI=1S/C25H23F4N5O2/c1-16-10-31-33(12-16)13-17-6-8-18(9-7-17)14-34-15-20(23(32-34)25(27,28)29)24(35)30-11-19-4-3-5-21(36-2)22(19)26/h3-10,12,15H,11,13-14H2,1-2H3,(H,30,35)	QZMZZOCEJPCAIJ-UHFFFAOYSA-N	408668	N-[(2-fluoro-3-methoxyphenyl)methyl]-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide::US10364238, Example 4::US11001578, Example 4::US11084809, Example 4::US11198691, Example 4	Plasma kallikrein			 136							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408668	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408668&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365107	406799302							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816333	COc1cccc(CNC(=O)c2cn(Cc3ccc(Cn4cc(C)cn4)cc3)nc2C(F)(F)F)c1	InChI=1S/C25H24F3N5O2/c1-17-11-30-32(13-17)14-18-6-8-19(9-7-18)15-33-16-22(23(31-33)25(26,27)28)24(34)29-12-20-4-3-5-21(10-20)35-2/h3-11,13,16H,12,14-15H2,1-2H3,(H,29,34)	JLGLPBSVAUHGOI-UHFFFAOYSA-N	408671	N-[(3-methoxyphenyl)methyl]-1-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)-3- (trifluoromethyl)pyrazole-4-carboxamide ::US10364238, Example 5::US11001578, Example 5::US11084809, Example 5::US11198691, Example 5	Plasma kallikrein			 364							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408671	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408671&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365083	406799304							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816335	CCOc1cccc(CNC(=O)c2cn(Cc3ccc(Cn4cc(C)cn4)cc3)nc2C(F)(F)F)c1	InChI=1S/C26H26F3N5O2/c1-3-36-22-6-4-5-21(11-22)13-30-25(35)23-17-34(32-24(23)26(27,28)29)16-20-9-7-19(8-10-20)15-33-14-18(2)12-31-33/h4-12,14,17H,3,13,15-16H2,1-2H3,(H,30,35)	UJVJDICDWMSCMO-UHFFFAOYSA-N	408672	N-[(3-ethoxyphenyl)methyl]-1-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)-3- (trifluoromethyl)pyrazole-4-carboxamide::US10364238, Example 6::US11001578, Example 6::US11084809, Example 6::US11198691, Example 6	Plasma kallikrein			 2360							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408672	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408672&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365014	406799305							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816337	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4cccc(OC(F)(F)F)c4)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C25H21F6N5O2/c1-16-10-33-35(12-16)13-17-5-7-18(8-6-17)14-36-15-21(22(34-36)24(26,27)28)23(37)32-11-19-3-2-4-20(9-19)38-25(29,30)31/h2-10,12,15H,11,13-14H2,1H3,(H,32,37)	IWQRRWVFCUYKBA-UHFFFAOYSA-N	408674	1-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)-N-{[3- (trifluoromethoxy)phenyl]methyl}-3-(trifluoromethyl)pyrazole-4-carboxamide ::US10364238, Example 7::US11001578, Example 7::US11084809, Example 7::US11198691, Example 7	Plasma kallikrein			>10000							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408674	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408674&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365116	406799307							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816339	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4ccc(C)cc4)c(n3)C(F)F)cc2)c1	InChI=1S/C25H25F2N5O/c1-17-3-5-19(6-4-17)12-28-25(33)22-16-32(30-23(22)24(26)27)15-21-9-7-20(8-10-21)14-31-13-18(2)11-29-31/h3-11,13,16,24H,12,14-15H2,1-2H3,(H,28,33)	RUQCLTICFVRTIS-UHFFFAOYSA-N	408676	N-[(4-methylphenyl)methyl]-1-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)-3- (trifluoromethyl)pyrazole-4-carboxamide ::US10364238, Example 8	Plasma kallikrein			 539							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408676	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408676&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			146676851	406799309							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816341	COc1ccc(F)c(CNC(=O)c2cn(Cc3ccc(Cn4cc(C)cn4)cc3)nc2C(F)(F)F)c1	InChI=1S/C25H23F4N5O2/c1-16-10-31-33(12-16)13-17-3-5-18(6-4-17)14-34-15-21(23(32-34)25(27,28)29)24(35)30-11-19-9-20(36-2)7-8-22(19)26/h3-10,12,15H,11,13-14H2,1-2H3,(H,30,35)	HQJUOFQTROTCAB-UHFFFAOYSA-N	408678	N-[(2-fluoro-5-methoxyphenyl)methyl]-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide ::US10364238, Example 9::US11001578, Example 9::US11084809, Example 9::US11198691, Example 9	Plasma kallikrein			 239							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408678	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408678&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365002	406799311							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816343	COc1ccc(CNC(=O)c2cn(Cc3ccc(Cn4cc(C)cn4)cc3)nc2C(F)(F)F)c(OC)c1	InChI=1S/C26H26F3N5O3/c1-17-11-31-33(13-17)14-18-4-6-19(7-5-18)15-34-16-22(24(32-34)26(27,28)29)25(35)30-12-20-8-9-21(36-2)10-23(20)37-3/h4-11,13,16H,12,14-15H2,1-3H3,(H,30,35)	CXDMHDUCUCLAEV-UHFFFAOYSA-N	408681	N-[(2,4-dimethoxyphenyl)methyl]-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide ::US10364238, Example 10::US11001578, Example 10::US11084809, Example 10::US11198691, Example 10	Plasma kallikrein			 1270							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408681	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408681&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365034	406799314							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816345	COc1cc(F)c(CNC(=O)c2cn(Cc3ccc(Cn4cc(C)cn4)cc3)nc2C(F)(F)F)c(F)c1	InChI=1S/C25H22F5N5O2/c1-15-9-32-34(11-15)12-16-3-5-17(6-4-16)13-35-14-20(23(33-35)25(28,29)30)24(36)31-10-19-21(26)7-18(37-2)8-22(19)27/h3-9,11,14H,10,12-13H2,1-2H3,(H,31,36)	HRWXHWAUCMAPKJ-UHFFFAOYSA-N	408683	 N-[(2,6-difluoro-4-methoxyphenyl)methyl]-1-({4-[(4-methylpyrazol-1- yl)methyl]pheny}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide::US10364238, Example 11::US11001578, Example 11::US11084809, Example 11::US11198691, Example 11	Plasma kallikrein			 456							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408683	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408683&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365073	406799316							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816347	COc1ccc(CNC(=O)c2cn(Cc3ccc(Cn4cc(C)cn4)cc3)nc2C(F)(F)F)c(c1)C(F)(F)F	InChI=1S/C26H23F6N5O2/c1-16-10-34-36(12-16)13-17-3-5-18(6-4-17)14-37-15-21(23(35-37)26(30,31)32)24(38)33-11-19-7-8-20(39-2)9-22(19)25(27,28)29/h3-10,12,15H,11,13-14H2,1-2H3,(H,33,38)	UJRPEIINPALAES-UHFFFAOYSA-N	408685	N-{[4-methoxy-2-(trifluoromethyl)phenyl]methyl}-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide ::US10364238, Example 12::US11001578, Example 12::US11084809, Example 12::US11198691, Example 12	Plasma kallikrein			 746							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408685	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408685&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365025	406799318							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816349	Cc1cn(Cc2c(F)cccc2F)nc1Cc1ccc(CNC(=O)c2c[nH]nc2C(F)(F)F)cc1	InChI=1S/C24H20F5N5O/c1-14-12-34(13-18-19(25)3-2-4-20(18)26)33-21(14)9-15-5-7-16(8-6-15)10-30-23(35)17-11-31-32-22(17)24(27,28)29/h2-8,11-12H,9-10,13H2,1H3,(H,30,35)(H,31,32)	ACQZFDIAYFYJLE-UHFFFAOYSA-N	408686	N-[(2,6-difluorophenyl)methyl]-1-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)-::US10364238, Example 13	Plasma kallikrein			 439							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408686	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408686&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			146676857	406799319							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816351	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4c(F)cccc4Cl)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C24H20ClF4N5O/c1-15-9-31-33(11-15)12-16-5-7-17(8-6-16)13-34-14-19(22(32-34)24(27,28)29)23(35)30-10-18-20(25)3-2-4-21(18)26/h2-9,11,14H,10,12-13H2,1H3,(H,30,35)	UCUUHDDHAAXSSH-UHFFFAOYSA-N	408689	N-[(2-chloro-6-fluorophenyl)methyl]-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide ::US10364238, Example 14::US11001578, Example 14::US11084809, Example 14::US11198691, Example 14	Plasma kallikrein			 514							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408689	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408689&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365058	406799322							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816353	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4c(F)cccc4C(F)(F)F)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C25H20F7N5O/c1-15-9-34-36(11-15)12-16-5-7-17(8-6-16)13-37-14-19(22(35-37)25(30,31)32)23(38)33-10-18-20(24(27,28)29)3-2-4-21(18)26/h2-9,11,14H,10,12-13H2,1H3,(H,33,38)	MRFKCVIKSCVIEK-UHFFFAOYSA-N	408691	N-{[2-fluoro-6-(trifluoromethyl)phenyl]methyl}-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide::US10364238, Example 15::US11001578, Example 15::US11084809, Example 15::US11198691, Example 15	Plasma kallikrein			 219							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408691	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408691&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365041	406799324							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816355	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4c(F)cc(Cl)cc4F)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C24H19ClF5N5O/c1-14-8-32-34(10-14)11-15-2-4-16(5-3-15)12-35-13-19(22(33-35)24(28,29)30)23(36)31-9-18-20(26)6-17(25)7-21(18)27/h2-8,10,13H,9,11-12H2,1H3,(H,31,36)	SXIKFYGPUGSYOC-UHFFFAOYSA-N	408692	N-[(4-chloro-2,6-difluorophenyl)methyl]-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide ::US10364238, Example 16::US11001578, Example 16::US11084809, Example 16::US11198691, Example 16	Plasma kallikrein			 263							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408692	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408692&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365003	406799325							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816357	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4ccc(Cl)cc4F)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C24H20ClF4N5O/c1-15-9-31-33(11-15)12-16-2-4-17(5-3-16)13-34-14-20(22(32-34)24(27,28)29)23(35)30-10-18-6-7-19(25)8-21(18)26/h2-9,11,14H,10,12-13H2,1H3,(H,30,35)	MPXDOEQMYFYSIT-UHFFFAOYSA-N	408693	 N-[(4-chloro-2-fluorophenyl)methyl]-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide ::US10364238, Example 17::US11001578, Example 17::US11084809, Example 17::US11198691, Example 17	Plasma kallikrein			 865							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408693	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408693&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365130	406799326							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816359	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4c(F)ccc(Cl)c4F)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C24H19ClF5N5O/c1-14-8-32-34(10-14)11-15-2-4-16(5-3-15)12-35-13-18(22(33-35)24(28,29)30)23(36)31-9-17-20(26)7-6-19(25)21(17)27/h2-8,10,13H,9,11-12H2,1H3,(H,31,36)	HNSAKACOONQHKG-UHFFFAOYSA-N	408694	N-[(3-chloro-2,6-difluorophenyl)methyl]-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide::US10364238, Example 18::US11001578, Example 18::US11084809, Example 18::US11198691, Example 18	Plasma kallikrein			 373							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408694	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408694&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365160	406799327							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816361	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4cccc(Cl)c4F)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C24H20ClF4N5O/c1-15-9-31-33(11-15)12-16-5-7-17(8-6-16)13-34-14-19(22(32-34)24(27,28)29)23(35)30-10-18-3-2-4-20(25)21(18)26/h2-9,11,14H,10,12-13H2,1H3,(H,30,35)	RFRZBYFPHZMTPR-UHFFFAOYSA-N	408695	N-[(3-chloro-2-fluorophenyl)methyl]-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide::US10364238, Example 19::US11001578, Example 19::US11084809, Example 19::US11198691, Example 19	Plasma kallikrein			 1130							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408695	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408695&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365137	406799328							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816363	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4cc(Cl)ccc4F)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C24H20ClF4N5O/c1-15-9-31-33(11-15)12-16-2-4-17(5-3-16)13-34-14-20(22(32-34)24(27,28)29)23(35)30-10-18-8-19(25)6-7-21(18)26/h2-9,11,14H,10,12-13H2,1H3,(H,30,35)	VQSXMSNNAGMGCB-UHFFFAOYSA-N	408696	N-[(5-chloro-2-fluorophenyl)methyl]-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide ::US10364238, Example 20::US11001578, Example 20::US11084809, Example 20::US11198691, Example 20	Plasma kallikrein			 740							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408696	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408696&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365077	406799329							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816365	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4c(F)c(Cl)ccc4C(F)(F)F)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C25H19ClF7N5O/c1-14-8-35-37(10-14)11-15-2-4-16(5-3-15)12-38-13-18(22(36-38)25(31,32)33)23(39)34-9-17-19(24(28,29)30)6-7-20(26)21(17)27/h2-8,10,13H,9,11-12H2,1H3,(H,34,39)	KVPLENMFVKIMRG-UHFFFAOYSA-N	408697	 N-{[3-chloro-2-fluoro-6-(trifluoromethyl)phenyl]methyl}-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide ::US10364238, Example 21::US11001578, Example 21::US11084809, Example 21::US11198691, Example 21	Plasma kallikrein			 257							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408697	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408697&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365161	406799330							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816367	Cc1cn(Cc2c(Cl)cccc2Cl)nc1Cc1ccc(CNC(=O)c2c[nH]nc2C(F)(F)F)cc1	InChI=1S/C24H20Cl2F3N5O/c1-14-12-34(13-18-19(25)3-2-4-20(18)26)33-21(14)9-15-5-7-16(8-6-15)10-30-23(35)17-11-31-32-22(17)24(27,28)29/h2-8,11-12H,9-10,13H2,1H3,(H,30,35)(H,31,32)	XCHFPFYKIASENJ-UHFFFAOYSA-N	408698	N-[(2,6-dichlorophenyl)methyl]-1-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)-::US10364238, Example 22	Plasma kallikrein			 1350							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408698	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408698&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			146676860	406799331							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816369	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4cc(Cl)ccc4C(F)(F)F)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C25H20ClF6N5O/c1-15-9-34-36(11-15)12-16-2-4-17(5-3-16)13-37-14-20(22(35-37)25(30,31)32)23(38)33-10-18-8-19(26)6-7-21(18)24(27,28)29/h2-9,11,14H,10,12-13H2,1H3,(H,33,38)	JUBFFEWNQIXKCQ-UHFFFAOYSA-N	408699	 N-{[5-chloro-2-(trifluoromethyl)phenyl]methyl}-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide ::US10364238, Example 23::US11001578, Example 23::US11084809, Example 23::US11198691, Example 23	Plasma kallikrein			 1060							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408699	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408699&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365020	406799332							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816371	Cc1cn(Cc2ccc(C)cc2C)nc1Cc1ccc(CNC(=O)c2c[nH]nc2C(F)(F)F)cc1	InChI=1S/C26H26F3N5O/c1-16-4-9-21(17(2)10-16)15-34-14-18(3)23(33-34)11-19-5-7-20(8-6-19)12-30-25(35)22-13-31-32-24(22)26(27,28)29/h4-10,13-14H,11-12,15H2,1-3H3,(H,30,35)(H,31,32)	BLKGJBZKNQMYPX-UHFFFAOYSA-N	408700	 N-[(2,4-dimethylphenyl)methyl]-1-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)- 3-(trifluoromethyl)pyrazole-4-carboxamide ::US10364238, Example 24	Plasma kallikrein			 717							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408700	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408700&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			146676861	406799333							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816373	Cc1cn(Cc2c(C)cccc2C)nc1Cc1ccc(CNC(=O)c2c[nH]nc2C(F)(F)F)cc1	InChI=1S/C26H26F3N5O/c1-16-5-4-6-17(2)22(16)15-34-14-18(3)23(33-34)11-19-7-9-20(10-8-19)12-30-25(35)21-13-31-32-24(21)26(27,28)29/h4-10,13-14H,11-12,15H2,1-3H3,(H,30,35)(H,31,32)	ILSHRYGCRCCJDS-UHFFFAOYSA-N	408704	N-[(2,6-dimethylphenyl)methyl]-1-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)-::US10364238, Example 25	Plasma kallikrein			 1840							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408704	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408704&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			146676864	406799337							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816375	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4c(C)cc(C)cc4C)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C27H28F3N5O/c1-17-9-19(3)23(20(4)10-17)12-31-26(36)24-16-35(33-25(24)27(28,29)30)15-22-7-5-21(6-8-22)14-34-13-18(2)11-32-34/h5-11,13,16H,12,14-15H2,1-4H3,(H,31,36)	YRBWCDOHOBNJLH-UHFFFAOYSA-N	408705	 1-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)-3-(trifluoromethyl)-N-[(2,4,6- trimethylphenyl)methyl]pyrazole-4-carboxamide::US10364238, Example 26::US11001578, Example 26::US11084809, Example 26::US11198691, Example 26	Plasma kallikrein			 1340							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408705	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408705&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365037	406799338							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816377	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4cccc(F)c4C)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C25H23F4N5O/c1-16-10-31-33(12-16)13-18-6-8-19(9-7-18)14-34-15-21(23(32-34)25(27,28)29)24(35)30-11-20-4-3-5-22(26)17(20)2/h3-10,12,15H,11,13-14H2,1-2H3,(H,30,35)	VMUDSUQWHSSZHZ-UHFFFAOYSA-N	408707	N-[(3-fluoro-2-methylphenyl)methyl]-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide ::US10364238, Example 27::US11001578, Example 27::US11084809, Example 27::US11198691, Example 27	Plasma kallikrein			>10000							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408707	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408707&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365082	406799340							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816379	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4ccc(C)cc4F)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C25H23F4N5O/c1-16-3-8-20(22(26)9-16)11-30-24(35)21-15-34(32-23(21)25(27,28)29)14-19-6-4-18(5-7-19)13-33-12-17(2)10-31-33/h3-10,12,15H,11,13-14H2,1-2H3,(H,30,35)	OAWJOZMRPBQRIM-UHFFFAOYSA-N	408708	N-[(2-fluoro-4-methylphenyl)methyl]-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide ::US10364238, Example 28::US11001578, Example 28::US11084809, Example 28::US11198691, Example 28	Plasma kallikrein			 280							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408708	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408708&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365048	406799341							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816381	Cc1cn(Cc2ncccc2F)nc1Cc1ccc(CNC(=O)c2c[nH]nc2C(F)(F)F)cc1	InChI=1S/C23H20F4N6O/c1-14-12-33(13-20-18(24)3-2-8-28-20)32-19(14)9-15-4-6-16(7-5-15)10-29-22(34)17-11-30-31-21(17)23(25,26)27/h2-8,11-12H,9-10,13H2,1H3,(H,29,34)(H,30,31)	BPJSUYYXJWLHOA-UHFFFAOYSA-N	408709	N-[(3-fluoropyridin-2-yl)methyl]-1-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)- 3-(trifluoromethyl)pyrazole-4-carboxamide ::US10364238, Example 29	Plasma kallikrein			 2190							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408709	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408709&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			146676866	406799342							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816383	Cc1cn(Cc2cc(Cl)ccn2)nc1Cc1ccc(CNC(=O)c2c[nH]nc2C(F)(F)F)cc1	InChI=1S/C23H20ClF3N6O/c1-14-12-33(13-18-9-17(24)6-7-28-18)32-20(14)8-15-2-4-16(5-3-15)10-29-22(34)19-11-30-31-21(19)23(25,26)27/h2-7,9,11-12H,8,10,13H2,1H3,(H,29,34)(H,30,31)	JCKZSHJKBNQGCC-UHFFFAOYSA-N	408710	-[(4-chloropyridin-2-yl)methyl]-1-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)- 3-(trifluoromethyl)pyrazole-4-carboxamide ::US10364238, Example 30	Plasma kallikrein			 915							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408710	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408710&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			146676867	406799343							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816385	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cnccc1C(F)(F)F	InChI=1S/C26H24F3N5O3/c1-37-17-23-21(25(36)31-13-20-12-30-10-9-22(20)26(27,28)29)16-34(32-23)15-19-7-5-18(6-8-19)14-33-11-3-2-4-24(33)35/h2-12,16H,13-15,17H2,1H3,(H,31,36)	ZHJJZIGZXRDDHP-UHFFFAOYSA-N	408711	3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)-N-{[4- (trifluoromethyl)pyridin-3-yl]methyl}pyrazole-4-carboxamide ::US10364238, Example 31::US10364238, Example 37::US11001578, Example 37::US11084809, Example 37::US11198691, Example 37	Plasma kallikrein			 392							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408711	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408711&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365063	406799344							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816387	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1ccc(C)nc1	InChI=1S/C26H27N5O3/c1-19-6-7-22(13-27-19)14-28-26(33)23-17-31(29-24(23)18-34-2)16-21-10-8-20(9-11-21)15-30-12-4-3-5-25(30)32/h3-13,17H,14-16,18H2,1-2H3,(H,28,33)	IKFHJYIVYYFDCA-UHFFFAOYSA-N	408712	3-(methoxymethyl)-N-[(6-methylpyridin-3-yl)methyl]-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 32::US10364238, Example 39::US11001578, Example 39::US11084809, Example 39::US11198691, Example 39	Plasma kallikrein			 7870							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408712	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408712&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365092	406799345							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816389	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cccnc1C(F)(F)F	InChI=1S/C26H24F3N5O3/c1-37-17-22-21(25(36)31-13-20-5-4-11-30-24(20)26(27,28)29)16-34(32-22)15-19-9-7-18(8-10-19)14-33-12-3-2-6-23(33)35/h2-12,16H,13-15,17H2,1H3,(H,31,36)	ULAOQOFMZICMAA-UHFFFAOYSA-N	408713	 3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)-N-{[2- (trifluoromethyl)pyridin-3-yl]methyl}pyrazole-4-carboxamide::US10364238, Example 36::US11001578, Example 36::US11084809, Example 36::US11198691, Example 36	Plasma kallikrein			 4170							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408713	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408713&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365101	406799346							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816391	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cnccc1C(F)(F)F	InChI=1S/C26H24F3N5O3/c1-37-17-23-21(25(36)31-13-20-12-30-10-9-22(20)26(27,28)29)16-34(32-23)15-19-7-5-18(6-8-19)14-33-11-3-2-4-24(33)35/h2-12,16H,13-15,17H2,1H3,(H,31,36)	ZHJJZIGZXRDDHP-UHFFFAOYSA-N	408711	3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)-N-{[4- (trifluoromethyl)pyridin-3-yl]methyl}pyrazole-4-carboxamide ::US10364238, Example 31::US10364238, Example 37::US11001578, Example 37::US11084809, Example 37::US11198691, Example 37	Plasma kallikrein			 392							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408711	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408711&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365063	406799344							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816393	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1ccc(C)nc1	InChI=1S/C26H27N5O3/c1-19-6-7-22(13-27-19)14-28-26(33)23-17-31(29-24(23)18-34-2)16-21-10-8-20(9-11-21)15-30-12-4-3-5-25(30)32/h3-13,17H,14-16,18H2,1-2H3,(H,28,33)	IKFHJYIVYYFDCA-UHFFFAOYSA-N	408712	3-(methoxymethyl)-N-[(6-methylpyridin-3-yl)methyl]-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 32::US10364238, Example 39::US11001578, Example 39::US11084809, Example 39::US11198691, Example 39	Plasma kallikrein			 7870							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408712	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408712&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365092	406799345							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816395	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cccc(OC)n1	InChI=1S/C26H27N5O4/c1-34-18-23-22(26(33)27-14-21-6-5-7-24(28-21)35-2)17-31(29-23)16-20-11-9-19(10-12-20)15-30-13-4-3-8-25(30)32/h3-13,17H,14-16,18H2,1-2H3,(H,27,33)	XOCSKLGONWNPHT-UHFFFAOYSA-N	408716	3-(methoxymethyl)-N-[(6-methoxypyridin-2-yl)methyl]-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 40::US11001578, Example 40::US11084809, Example 40::US11198691, Example 40	Plasma kallikrein			 3700							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408716	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408716&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365155	406799347							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816397	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1nccc(OC)c1F	InChI=1S/C26H26FN5O4/c1-35-17-22-20(26(34)29-13-21-25(27)23(36-2)10-11-28-21)16-32(30-22)15-19-8-6-18(7-9-19)14-31-12-4-3-5-24(31)33/h3-12,16H,13-15,17H2,1-2H3,(H,29,34)	KGMPDQIYDKKXRD-UHFFFAOYSA-N	408717	 N-[(3-fluoro-4-methoxypyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin- 1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 41::US10730874, Example 00397::US11001578, Example 41::US11084809, Example 41::US11198691, Example 41::US11352356, Table II.3::US11584735, Example 41 of WO2016/083820	Plasma kallikrein			 3.30							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408717	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408717&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365142	406799348							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816399	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1nc(OC)ccc1F	InChI=1S/C26H26FN5O4/c1-35-17-23-20(26(34)28-13-22-21(27)10-11-24(29-22)36-2)16-32(30-23)15-19-8-6-18(7-9-19)14-31-12-4-3-5-25(31)33/h3-12,16H,13-15,17H2,1-2H3,(H,28,34)	KQSCQCAZZHSOOR-UHFFFAOYSA-N	408718	N-[(3-fluoro-6-methoxypyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin- 1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 42::US11001578, Example 42::US11084809, Example 42::US11198691, Example 42	Plasma kallikrein			 831							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408718	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408718&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365159	406799349							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816401	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1csc2ccc(Cl)cc12	InChI=1S/C28H25ClN4O3S/c1-36-17-25-24(28(35)30-13-21-18-37-26-10-9-22(29)12-23(21)26)16-33(31-25)15-20-7-5-19(6-8-20)14-32-11-3-2-4-27(32)34/h2-12,16,18H,13-15,17H2,1H3,(H,30,35)	TZULTWISCDFBIR-UHFFFAOYSA-N	408719	N-[(5-chloro-1-benzothiophen-3-yl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin- 1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 45::US11001578, Example 45::US11084809, Example 45::US11198691, Example 45	Plasma kallikrein			 144							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408719	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408719&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365070	406799350							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816403	COCc1nn(Cc2ccc(nc2)N2CCCC2)cc1C(=O)NCc1csc2ccc(Cl)cc12	InChI=1S/C25H26ClN5O2S/c1-33-15-22-21(25(32)28-12-18-16-34-23-6-5-19(26)10-20(18)23)14-31(29-22)13-17-4-7-24(27-11-17)30-8-2-3-9-30/h4-7,10-11,14,16H,2-3,8-9,12-13,15H2,1H3,(H,28,32)	WMNGADNOQNFZIE-UHFFFAOYSA-N	408720	N-[(5-chloro-1-benzothiophen-3-yl)methyl]-3-(methoxymethyl)-1-{[6-(pyrrolidin-1-::US10364238, Example 46::US11001578, Example 46::US11084809, Example 46::US11198691, Example 46	Plasma kallikrein			 2400							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408720	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408720&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365148	406799351							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816405	COCc1nn(Cc2ccc(Cn3cc(C)cn3)cc2)cc1C(=O)NCc1csc2ccc(Cl)cc12	InChI=1S/C27H26ClN5O2S/c1-18-10-30-32(12-18)13-19-3-5-20(6-4-19)14-33-15-24(25(31-33)16-35-2)27(34)29-11-21-17-36-26-8-7-22(28)9-23(21)26/h3-10,12,15,17H,11,13-14,16H2,1-2H3,(H,29,34)	OVCXPEFSYYWEMX-UHFFFAOYSA-N	408725	 N-[(5-chloro-1-benzothiophen-3-yl)methyl]-3-(methoxymethyl)-1-({4-[(4- methylpyrazol-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 47::US11001578, Example 47::US11084809, Example 47::US11198691, Example 47	Plasma kallikrein			 753							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408725	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408725&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365059	406799356							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816407	NC(=O)c1ccccc1CNC(=O)c1cn(Cc2ccc(Cn3ccccc3=O)cc2)nc1C1CC1	InChI=1S/C28H27N5O3/c29-27(35)23-6-2-1-5-22(23)15-30-28(36)24-18-33(31-26(24)21-12-13-21)17-20-10-8-19(9-11-20)16-32-14-4-3-7-25(32)34/h1-11,14,18,21H,12-13,15-17H2,(H2,29,35)(H,30,36)	KOYPCAXNSUCYIL-UHFFFAOYSA-N	408726	N-[(2-carbamoylphenyl)methyl]-3-cyclopropyl-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 48::US11001578, Example 48::US11084809, Example 48::US11198691, Example 48	Plasma kallikrein			 647							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408726	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408726&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365021	406799357							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816409	NC(=O)c1cccc(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2C2CC2)c1	InChI=1S/C28H27N5O3/c29-27(35)23-5-3-4-21(14-23)15-30-28(36)24-18-33(31-26(24)22-11-12-22)17-20-9-7-19(8-10-20)16-32-13-2-1-6-25(32)34/h1-10,13-14,18,22H,11-12,15-17H2,(H2,29,35)(H,30,36)	GLBUGHLBAAXCAZ-UHFFFAOYSA-N	408727	 N-[(3-carbamoylphenyl)methyl]-3-cyclopropyl-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide   ::US10364238, Example 49::US11001578, Example 49::US11084809, Example 49::US11198691, Example 49	Plasma kallikrein			 5450							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408727	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408727&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365022	406799358							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816411	NC(=O)c1ccc(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2C2CC2)cc1	InChI=1S/C28H27N5O3/c29-27(35)23-10-8-19(9-11-23)15-30-28(36)24-18-33(31-26(24)22-12-13-22)17-21-6-4-20(5-7-21)16-32-14-2-1-3-25(32)34/h1-11,14,18,22H,12-13,15-17H2,(H2,29,35)(H,30,36)	XDXGOIDNTUZASE-UHFFFAOYSA-N	408730	N-[(4-carbamoylphenyl)methyl]-3-cyclopropyl-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 50::US11001578, Example 50::US11084809, Example 50::US11198691, Example 50	Plasma kallikrein			 1800							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408730	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408730&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365075	406799361							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816413	Fc1cccc(c1CNC(=O)c1cn(Cc2ccc(Cn3ccccc3=O)cc2)nc1C(F)(F)F)C(F)(F)F	InChI=1S/C26H19F7N4O2/c27-21-5-3-4-20(25(28,29)30)18(21)12-34-24(39)19-15-37(35-23(19)26(31,32)33)14-17-9-7-16(8-10-17)13-36-11-2-1-6-22(36)38/h1-11,15H,12-14H2,(H,34,39)	ASCUMAURKSBUPS-UHFFFAOYSA-N	408732	 N-{[2-fluoro-6-(trifluoromethyl)phenyl]methyl}-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide::US10364238, Example 51::US11001578, Example 51::US11084809, Example 51::US11198691, Example 51	Plasma kallikrein			 48.9							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408732	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408732&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365085	406799363							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816415	COc1cccc(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2C2CC2)c1F	InChI=1S/C28H27FN4O3/c1-36-24-6-4-5-22(26(24)29)15-30-28(35)23-18-33(31-27(23)21-12-13-21)17-20-10-8-19(9-11-20)16-32-14-3-2-7-25(32)34/h2-11,14,18,21H,12-13,15-17H2,1H3,(H,30,35)	NFLOZDGNLCLQAJ-UHFFFAOYSA-N	408733	 3-cyclopropyl-N-[(2-fluoro-3-methoxyphenyl)methyl]-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 52::US11001578, Example 52::US11084809, Example 52::US11198691, Example 52	Plasma kallikrein			 23.3							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408733	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408733&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365123	406799364							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816417	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cccc(OC)c1F	InChI=1S/C27H27FN4O4/c1-35-18-23-22(27(34)29-14-21-6-5-7-24(36-2)26(21)28)17-32(30-23)16-20-11-9-19(10-12-20)15-31-13-4-3-8-25(31)33/h3-13,17H,14-16,18H2,1-2H3,(H,29,34)	MLCDWARNPOODOL-UHFFFAOYSA-N	408734	 N-[(2-fluoro-3-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US10364238, Example 53::US11001578, Example 53::US11084809, Example 53::US11198691, Example 53	Plasma kallikrein			 20.2							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408734	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408734&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365056	406799365							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816419	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(OC)ccc(OC)c1F	InChI=1S/C28H29FN4O5/c1-36-18-23-22(28(35)30-14-21-24(37-2)11-12-25(38-3)27(21)29)17-33(31-23)16-20-9-7-19(8-10-20)15-32-13-5-4-6-26(32)34/h4-13,17H,14-16,18H2,1-3H3,(H,30,35)	TVHOOPXMFWZGQK-UHFFFAOYSA-N	408736	 N-[(2-fluoro-3,6-dimethoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin- 1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 54::US11001578, Example 54::US11084809, Example 54::US11198691, Example 54	Plasma kallikrein			 2.10							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408736	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408736&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365119	406799367							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816421	Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1ccc(OC(F)(F)F)cc1	InChI=1S/C25H22F3N5O3/c26-25(27,28)36-20-10-8-17(9-11-20)13-30-24(35)21-16-33(31-23(21)29)15-19-6-4-18(5-7-19)14-32-12-2-1-3-22(32)34/h1-12,16H,13-15H2,(H2,29,31)(H,30,35)	KRHKQKBRWFYZPN-UHFFFAOYSA-N	408737	3-amino-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)-N-{[4- (trifluoromethoxy)phenyl]methyl}pyrazole-4-carboxamide ::US10364238, Example 58::US11001578, Example 58::US11084809, Example 58::US11198691, Example 58	Plasma kallikrein			 5780							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408737	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408737&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365068	406799368							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816423	COc1cccc(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2N(C)C)c1F	InChI=1S/C27H28FN5O3/c1-31(2)26-22(27(35)29-15-21-7-6-8-23(36-3)25(21)28)18-33(30-26)17-20-12-10-19(11-13-20)16-32-14-5-4-9-24(32)34/h4-14,18H,15-17H2,1-3H3,(H,29,35)	OMUPFLKDHHROJU-UHFFFAOYSA-N	408738	 3-(dimethylamino)-N-[(2-fluoro-3-methoxyphenyl)methyl]-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 59::US11001578, Example 59::US11084809, Example 59::US11198691, Example 59	Plasma kallikrein			 73.4							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408738	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408738&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365158	406799369							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816425	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1ccccc1F	InChI=1S/C26H25FN4O3/c1-34-18-24-22(26(33)28-14-21-6-2-3-7-23(21)27)17-31(29-24)16-20-11-9-19(10-12-20)15-30-13-5-4-8-25(30)32/h2-13,17H,14-16,18H2,1H3,(H,28,33)	OMZXAEPYOCEHIS-UHFFFAOYSA-N	408740	N-[(2-fluorophenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 62::US11001578, Example 62::US11084809, Example 62::US11198691, Example 62	Plasma kallikrein			 572							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408740	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408740&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365055	406799371							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816427	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1ccccc1C(F)(F)F	InChI=1S/C27H25F3N4O3/c1-37-18-24-22(26(36)31-14-21-6-2-3-7-23(21)27(28,29)30)17-34(32-24)16-20-11-9-19(10-12-20)15-33-13-5-4-8-25(33)35/h2-13,17H,14-16,18H2,1H3,(H,31,36)	ZLZZEINFXWKIBR-UHFFFAOYSA-N	408742	 3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)-N-{[2- (trifluoromethyl)phenyl]methyl}pyrazole-4-carboxamide::US10364238, Example 63::US11001578, Example 63::US11084809, Example 63::US11198691, Example 63	Plasma kallikrein			 342							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408742	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408742&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365012	406799373							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816429	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(OC)ccc1F	InChI=1S/C27H27FN4O4/c1-35-18-25-23(27(34)29-14-21-13-22(36-2)10-11-24(21)28)17-32(30-25)16-20-8-6-19(7-9-20)15-31-12-4-3-5-26(31)33/h3-13,17H,14-16,18H2,1-2H3,(H,29,34)	NKTZDNHYVJSOOU-UHFFFAOYSA-N	408744	 N-[(2-fluoro-5-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US10364238, Example 64::US11001578, Example 64::US11084809, Example 64::US11198691, Example 64	Plasma kallikrein			 35.2							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408744	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408744&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365036	406799375							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816431	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1ccc(C)cc1F	InChI=1S/C27H27FN4O3/c1-19-6-11-22(24(28)13-19)14-29-27(34)23-17-32(30-25(23)18-35-2)16-21-9-7-20(8-10-21)15-31-12-4-3-5-26(31)33/h3-13,17H,14-16,18H2,1-2H3,(H,29,34)	XRBNFAVKAJTXOR-UHFFFAOYSA-N	408745	 N-[(2-fluoro-4-methylphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 65::US11001578, Example 65::US11084809, Example 65::US11198691, Example 65	Plasma kallikrein			 43.3							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408745	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408745&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365028	406799376							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816433	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(F)ccc(OC)c1F	InChI=1S/C27H26F2N4O4/c1-36-17-23-21(27(35)30-13-20-22(28)10-11-24(37-2)26(20)29)16-33(31-23)15-19-8-6-18(7-9-19)14-32-12-4-3-5-25(32)34/h3-12,16H,13-15,17H2,1-2H3,(H,30,35)	PIYDGHWVVUCTNS-UHFFFAOYSA-N	408746	 N-[(2,6-difluoro-3-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin- 1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US10364238, Example 66::US10730874, Example 00395::US11001578, Example 66::US11084809, Example 66::US11198691, Example 66::US11352356, Table II.1	Plasma kallikrein			 4.60							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408746	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408746&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365096	406799377							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816435	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(Cl)cc(OC)c1	InChI=1S/C27H27ClN4O4/c1-35-18-25-24(27(34)29-14-21-11-22(28)13-23(12-21)36-2)17-32(30-25)16-20-8-6-19(7-9-20)15-31-10-4-3-5-26(31)33/h3-13,17H,14-16,18H2,1-2H3,(H,29,34)	OABPMYGSJQVQPN-UHFFFAOYSA-N	408747	 N-[(3-chloro-5-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 67::US11001578, Example 67::US11084809, Example 67::US11198691, Example 67	Plasma kallikrein			 393							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408747	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408747&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365024	406799378							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816437	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1ccccc1C(F)F	InChI=1S/C27H26F2N4O3/c1-36-18-24-23(27(35)30-14-21-6-2-3-7-22(21)26(28)29)17-33(31-24)16-20-11-9-19(10-12-20)15-32-13-5-4-8-25(32)34/h2-13,17,26H,14-16,18H2,1H3,(H,30,35)	GEFVFTYILHWIGO-UHFFFAOYSA-N	408749	 N-{[2-(difluoromethyl)phenyl]methyl}-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 68::US11001578, Example 68::US11084809, Example 68::US11198691, Example 68	Plasma kallikrein			 81.1							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408749	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408749&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365084	406799380							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816439	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cccc(OC)c1C(F)F	InChI=1S/C28H28F2N4O4/c1-37-18-23-22(28(36)31-14-21-6-5-7-24(38-2)26(21)27(29)30)17-34(32-23)16-20-11-9-19(10-12-20)15-33-13-4-3-8-25(33)35/h3-13,17,27H,14-16,18H2,1-2H3,(H,31,36)	PTXDNBVAMADNIH-UHFFFAOYSA-N	408750	N-{[2-(difluoromethyl)-3-methoxyphenyl]methyl}-3-(methoxymethyl)-1-({4-[(2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 69::US11001578, Example 69::US11084809, Example 69::US11198691, Example 69	Plasma kallikrein			 16.8							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408750	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408750&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365140	406799381							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816441	Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(F)cccc1C(F)(F)F	InChI=1S/C25H21F4N5O2/c26-21-5-3-4-20(25(27,28)29)18(21)12-31-24(36)19-15-34(32-23(19)30)14-17-9-7-16(8-10-17)13-33-11-2-1-6-22(33)35/h1-11,15H,12-14H2,(H2,30,32)(H,31,36)	ZRDGSEIHHBOARU-UHFFFAOYSA-N	408753	 3-amino-N-{[2-fluoro-6-(trifluoromethyl)phenyl]methyl}-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 70::US11001578, Example 70::US11084809, Example 70::US11198691, Example 70	Plasma kallikrein			 26.7							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408753	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408753&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365067	406799384							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816443	COc1cccc(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2NC(C)=O)c1F	InChI=1S/C27H26FN5O4/c1-18(34)30-26-22(27(36)29-14-21-6-5-7-23(37-2)25(21)28)17-33(31-26)16-20-11-9-19(10-12-20)15-32-13-4-3-8-24(32)35/h3-13,17H,14-16H2,1-2H3,(H,29,36)(H,30,31,34)	JJEXYMJFQVLENB-UHFFFAOYSA-N	408755	 3-acetamido-N-[(2-fluoro-3-methoxyphenyl)methyl]-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 71::US11001578, Example 71::US11084809, Example 71::US11198691, Example 71	Plasma kallikrein			 300							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408755	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408755&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365125	406799386							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816445	COc1cccc(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2N(C)C(C)=O)c1F	InChI=1S/C28H28FN5O4/c1-19(35)32(2)27-23(28(37)30-15-22-7-6-8-24(38-3)26(22)29)18-34(31-27)17-21-12-10-20(11-13-21)16-33-14-5-4-9-25(33)36/h4-14,18H,15-17H2,1-3H3,(H,30,37)	QWMQDDAFZVHSLS-UHFFFAOYSA-N	408756	N-[(2-fluoro-3-methoxyphenyl)methyl]-3-(N-methylacetamido)-1-({4-[(2-oxopyridin- 1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 72::US11001578, Example 72::US11084809, Example 72::US11198691, Example 72	Plasma kallikrein			 6610							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408756	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408756&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365011	406799387							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816447	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(F)ccc(Cl)c1F	InChI=1S/C26H23ClF2N4O3/c1-36-16-23-20(26(35)30-12-19-22(28)10-9-21(27)25(19)29)15-33(31-23)14-18-7-5-17(6-8-18)13-32-11-3-2-4-24(32)34/h2-11,15H,12-14,16H2,1H3,(H,30,35)	ZHIGUNZKTJKAFE-UHFFFAOYSA-N	408757	 N-[(3-chloro-2,6-difluorophenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 73::US11001578, Example 73::US11084809, Example 73::US11198691, Example 73	Plasma kallikrein			 120							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408757	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408757&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365124	406799388							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816449	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(Cl)ccc1C#N	InChI=1S/C27H24ClN5O3/c1-36-18-25-24(27(35)30-14-22-12-23(28)10-9-21(22)13-29)17-33(31-25)16-20-7-5-19(6-8-20)15-32-11-3-2-4-26(32)34/h2-12,17H,14-16,18H2,1H3,(H,30,35)	AQJYHYPGWCFTGU-UHFFFAOYSA-N	408759	N-[(5-chloro-2-cyanophenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 76::US11001578, Example 76::US11084809, Example 76::US11198691, Example 76	Plasma kallikrein			 28.3							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408759	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408759&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365097	406799390							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816451	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(F)c(OC)ccc1C#N	InChI=1S/C28H26FN5O4/c1-37-18-24-23(28(36)31-14-22-21(13-30)10-11-25(38-2)27(22)29)17-34(32-24)16-20-8-6-19(7-9-20)15-33-12-4-3-5-26(33)35/h3-12,17H,14-16,18H2,1-2H3,(H,31,36)	SPXOTFDBWDBJRN-UHFFFAOYSA-N	408768	N-[(6-cyano-2-fluoro-3-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-::US10364238, Example 77::US10730874, Example 00398::US11001578, Example 77::US11084809, Example 77::US11198691, Example 77::US11352356, Table II.4	Plasma kallikrein			 0.600							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408768	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408768&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365006	406799399							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816453	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cccc(OC)c1C(F)(F)F	InChI=1S/C28H27F3N4O4/c1-38-18-23-22(27(37)32-14-21-6-5-7-24(39-2)26(21)28(29,30)31)17-35(33-23)16-20-11-9-19(10-12-20)15-34-13-4-3-8-25(34)36/h3-13,17H,14-16,18H2,1-2H3,(H,32,37)	LSXBZEBSXFDZEZ-UHFFFAOYSA-N	408769	 N-{[3-methoxy-2-(trifluoromethyl)phenyl]methyl}-3-(methoxymethyl)-1-({4-[(2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 78::US11001578, Example 78::US11084809, Example 78::US11198691, Example 78	Plasma kallikrein			 612							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408769	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408769&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365105	406799400							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816455	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(OC)ccc1C(F)(F)F	InChI=1S/C28H27F3N4O4/c1-38-18-25-23(27(37)32-14-21-13-22(39-2)10-11-24(21)28(29,30)31)17-35(33-25)16-20-8-6-19(7-9-20)15-34-12-4-3-5-26(34)36/h3-13,17H,14-16,18H2,1-2H3,(H,32,37)	FKGBWMYRUOPIHY-UHFFFAOYSA-N	408770	 N-{[5-methoxy-2-(trifluoromethyl)phenyl]methyl}-3-(methoxymethyl)-1-({4-[(2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 79::US11001578, Example 79::US11084809, Example 79::US11198691, Example 79	Plasma kallikrein			 14.7							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408770	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408770&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365060	406799401							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816457	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(F)cccc1C(F)F	InChI=1S/C27H25F3N4O3/c1-37-17-24-22(27(36)31-13-21-20(26(29)30)5-4-6-23(21)28)16-34(32-24)15-19-10-8-18(9-11-19)14-33-12-3-2-7-25(33)35/h2-12,16,26H,13-15,17H2,1H3,(H,31,36)	BZFADXUGNHDNKB-UHFFFAOYSA-N	408772	 N-{[2-(difluoromethyl)-6-fluorophenyl]methyl}-3-(methoxymethyl)-1-({4-[(2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 80::US11001578, Example 80::US11084809, Example 80::US11198691, Example 80	Plasma kallikrein			 20.4							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408772	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408772&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365145	406799403							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816459	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(OC)ccc1C(F)F	InChI=1S/C28H28F2N4O4/c1-37-18-25-24(28(36)31-14-21-13-22(38-2)10-11-23(21)27(29)30)17-34(32-25)16-20-8-6-19(7-9-20)15-33-12-4-3-5-26(33)35/h3-13,17,27H,14-16,18H2,1-2H3,(H,31,36)	IBBPTWWPBCQANZ-UHFFFAOYSA-N	408773	 N-{[2-(difluoromethyl)-5-methoxyphenyl]methyl}-3-(methoxymethyl)-1-({4-[(2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 81::US11001578, Example 81::US11084809, Example 81::US11198691, Example 81	Plasma kallikrein			 2.30							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408773	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408773&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365102	406799404							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816461	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(F)ccc(OC)c1C(F)F	InChI=1S/C28H27F3N4O4/c1-38-17-23-21(28(37)32-13-20-22(29)10-11-24(39-2)26(20)27(30)31)16-35(33-23)15-19-8-6-18(7-9-19)14-34-12-4-3-5-25(34)36/h3-12,16,27H,13-15,17H2,1-2H3,(H,32,37)	FDDKVGBGYLYHDV-UHFFFAOYSA-N	408775	 N-{[2-(difluoromethyl)-6-fluoro-3-methoxyphenyl]methyl}-3-(methoxymethyl)-1-({4- [(2-oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 83::US11001578, Example 83::US11084809, Example 83::US11198691, Example 83	Plasma kallikrein			 6.80							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408775	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408775&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365138	406799406							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816463	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(F)cccc1C(N)=O	InChI=1S/C27H26FN5O4/c1-37-17-24-22(27(36)30-13-21-20(26(29)35)5-4-6-23(21)28)16-33(31-24)15-19-10-8-18(9-11-19)14-32-12-3-2-7-25(32)34/h2-12,16H,13-15,17H2,1H3,(H2,29,35)(H,30,36)	PQVWIESRTSEZPB-UHFFFAOYSA-N	408778	 N-[(2-carbamoyl-6-fluorophenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 85::US11001578, Example 85::US11084809, Example 85::US11198691, Example 85	Plasma kallikrein			 79.2							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408778	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408778&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365001	406799409							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816465	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(OC)ccc1C(N)=O	InChI=1S/C28H29N5O5/c1-37-18-25-24(28(36)30-14-21-13-22(38-2)10-11-23(21)27(29)35)17-33(31-25)16-20-8-6-19(7-9-20)15-32-12-4-3-5-26(32)34/h3-13,17H,14-16,18H2,1-2H3,(H2,29,35)(H,30,36)	VTFAEOJNECOMFY-UHFFFAOYSA-N	408779	N-[(2-carbamoyl-5-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin- 1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 86::US11001578, Example 86::US11084809, Example 86::US11198691, Example 86	Plasma kallikrein			 8.70							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408779	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408779&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365131	406799410							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816467	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1ccccc1C(O)=O	InChI=1S/C27H26N4O5/c1-36-18-24-23(26(33)28-14-21-6-2-3-7-22(21)27(34)35)17-31(29-24)16-20-11-9-19(10-12-20)15-30-13-5-4-8-25(30)32/h2-13,17H,14-16,18H2,1H3,(H,28,33)(H,34,35)	MCBMZYKZJXHUKZ-UHFFFAOYSA-N	408780	 2-({[3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)pyrazol-4- yl]formamido}methyl)benzoic acid ::US10364238, Example 87::US11001578, Example 87::US11084809, Example 87::US11198691, Example 87	Plasma kallikrein			>10000							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408780	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408780&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365095	406799411							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816469	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cccc(OC(F)F)c1F	InChI=1S/C27H25F3N4O4/c1-37-17-22-21(26(36)31-13-20-5-4-6-23(25(20)28)38-27(29)30)16-34(32-22)15-19-10-8-18(9-11-19)14-33-12-3-2-7-24(33)35/h2-12,16,27H,13-15,17H2,1H3,(H,31,36)	CMNOMOOEIDZWNA-UHFFFAOYSA-N	408781	 N-{[3-(difluoromethoxy)-2-fluorophenyl]methyl}-3-(methoxymethyl)-1-({4-[(2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 90::US11001578, Example 90::US11084809, Example 90::US11198691, Example 90	Plasma kallikrein			 154							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408781	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408781&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365051	406799412							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816471	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cccc(OC(F)F)c1	InChI=1S/C27H26F2N4O4/c1-36-18-24-23(26(35)30-14-21-5-4-6-22(13-21)37-27(28)29)17-33(31-24)16-20-10-8-19(9-11-20)15-32-12-3-2-7-25(32)34/h2-13,17,27H,14-16,18H2,1H3,(H,30,35)	ZLXXVTBIWCEPEY-UHFFFAOYSA-N	408782	 N-{[3-(difluoromethoxy)phenyl]methyl}-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 91::US11001578, Example 91::US11084809, Example 91::US11198691, Example 91	Plasma kallikrein			 523							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408782	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408782&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365090	406799413							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816473	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(F)cccc1OC(F)F	InChI=1S/C27H25F3N4O4/c1-37-17-23-21(26(36)31-13-20-22(28)5-4-6-24(20)38-27(29)30)16-34(32-23)15-19-10-8-18(9-11-19)14-33-12-3-2-7-25(33)35/h2-12,16,27H,13-15,17H2,1H3,(H,31,36)	MKZIFUOKFBQCJL-UHFFFAOYSA-N	408783	N-{[2-(difluoromethoxy)-6-fluorophenyl]methyl}-3-(methoxymethyl)-1-({4-[(2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 92::US11001578, Example 92::US11084809, Example 92::US11198691, Example 92	Plasma kallikrein			 16.0							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408783	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408783&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365108	406799414							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816475	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(F)ccc1F	InChI=1S/C26H24F2N4O3/c1-35-17-24-22(26(34)29-13-20-12-21(27)9-10-23(20)28)16-32(30-24)15-19-7-5-18(6-8-19)14-31-11-3-2-4-25(31)33/h2-12,16H,13-15,17H2,1H3,(H,29,34)	XQLOPLZHIJLNDB-UHFFFAOYSA-N	408784	 N-[(2,5-difluorophenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US10364238, Example 94::US11001578, Example 94::US11084809, Example 94::US11198691, Example 94	Plasma kallikrein			 780							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408784	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408784&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365078	406799415							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816477	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(F)cc(OC)c1	InChI=1S/C27H27FN4O4/c1-35-18-25-24(27(34)29-14-21-11-22(28)13-23(12-21)36-2)17-32(30-25)16-20-8-6-19(7-9-20)15-31-10-4-3-5-26(31)33/h3-13,17H,14-16,18H2,1-2H3,(H,29,34)	AYOVCXXHHIWMRN-UHFFFAOYSA-N	408786	N-[(3-fluoro-5-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 95::US11001578, Example 95::US11084809, Example 95::US11198691, Example 95	Plasma kallikrein			 308							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408786	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408786&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365039	406799417							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816479	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(F)cc(OC)c1F	InChI=1S/C27H26F2N4O4/c1-36-17-23-22(27(35)30-13-20-11-21(28)12-24(37-2)26(20)29)16-33(31-23)15-19-8-6-18(7-9-19)14-32-10-4-3-5-25(32)34/h3-12,16H,13-15,17H2,1-2H3,(H,30,35)	FKXBPOXUNOOPGU-UHFFFAOYSA-N	408787	N-[(2,5-difluoro-3-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin- 1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 96::US11001578, Example 96::US11084809, Example 96::US11198691, Example 96	Plasma kallikrein			 75.0							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408787	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408787&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365093	406799418							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816481	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(C)cccc1F	InChI=1S/C27H27FN4O3/c1-19-6-5-7-24(28)22(19)14-29-27(34)23-17-32(30-25(23)18-35-2)16-21-11-9-20(10-12-21)15-31-13-4-3-8-26(31)33/h3-13,17H,14-16,18H2,1-2H3,(H,29,34)	NLVINHRIZCLAQG-UHFFFAOYSA-N	408788	 N-[(2-fluoro-6-methylphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US10364238, Example 97::US11001578, Example 97::US11084809, Example 97::US11198691, Example 97	Plasma kallikrein			 153							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408788	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408788&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365111	406799419							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816483	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(Cl)ccc(O)c1F	InChI=1S/C26H24ClFN4O4/c1-36-16-22-20(26(35)29-12-19-21(27)9-10-23(33)25(19)28)15-32(30-22)14-18-7-5-17(6-8-18)13-31-11-3-2-4-24(31)34/h2-11,15,33H,12-14,16H2,1H3,(H,29,35)	MWEHEDAJHMYHGM-UHFFFAOYSA-N	408789	N-[(6-chloro-2-fluoro-3-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 99	Plasma kallikrein			 6.40							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408789	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408789&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			146676885	406799420							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816485	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cccc(O)c1F	InChI=1S/C26H25FN4O4/c1-35-17-22-21(26(34)28-13-20-5-4-6-23(32)25(20)27)16-31(29-22)15-19-10-8-18(9-11-19)14-30-12-3-2-7-24(30)33/h2-12,16,32H,13-15,17H2,1H3,(H,28,34)	JFAWWGDJBCGIDJ-UHFFFAOYSA-N	408790	N-[(2-fluoro-3-hydroxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 129::US11001578, Example 129::US11084809, Example 129::US11198691, Example 129	Plasma kallikrein			 437							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408790	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408790&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365133	406799421							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816487	Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cccc(O)c1F	InChI=1S/C24H22FN5O3/c25-22-18(4-3-5-20(22)31)12-27-24(33)19-15-30(28-23(19)26)14-17-9-7-16(8-10-17)13-29-11-2-1-6-21(29)32/h1-11,15,31H,12-14H2,(H2,26,28)(H,27,33)	OOXKEXDZGXUAST-UHFFFAOYSA-N	408792	 3-amino-N-[(2-fluoro-3-hydroxyphenyl)methyl]-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 130::US11001578, Example 130::US11084809, Example 130::US11198691, Example 130	Plasma kallikrein			 174							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408792	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408792&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365044	406799423							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816489	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1ccccc1C(=O)OC	InChI=1S/C28H28N4O5/c1-36-19-25-24(27(34)29-15-22-7-3-4-8-23(22)28(35)37-2)18-32(30-25)17-21-12-10-20(11-13-21)16-31-14-6-5-9-26(31)33/h3-14,18H,15-17,19H2,1-2H3,(H,29,34)	CLMIQCGDYIVGMD-UHFFFAOYSA-N	408793	 methyl 2-({[3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazol-4-yl]formamido}methyl)benzoate::US10364238, Example 131::US11001578, Example 131::US11084809, Example 131::US11198691, Example 131	Plasma kallikrein			 1510							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408793	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408793&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364999	406799424							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816491	CCc1cccc(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2COC)c1F	InChI=1S/C28H29FN4O3/c1-3-22-7-6-8-23(27(22)29)15-30-28(35)24-18-33(31-25(24)19-36-2)17-21-12-10-20(11-13-21)16-32-14-5-4-9-26(32)34/h4-14,18H,3,15-17,19H2,1-2H3,(H,30,35)	TVACIVBKATZGQV-UHFFFAOYSA-N	408794	 N-[(3-ethyl-2-fluorophenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 132::US11001578, Example 132::US11084809, Example 132::US11198691, Example 132	Plasma kallikrein			 135							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408794	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408794&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365023	406799425							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816493	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cccc(OC)c1	InChI=1S/C27H28N4O4/c1-34-19-25-24(27(33)28-15-22-6-5-7-23(14-22)35-2)18-31(29-25)17-21-11-9-20(10-12-21)16-30-13-4-3-8-26(30)32/h3-14,18H,15-17,19H2,1-2H3,(H,28,33)	YDHZFMPDUQUAJM-UHFFFAOYSA-N	408795	 3-(methoxymethyl)-N-[(3-methoxyphenyl)methyl]-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 133::US11001578, Example 133::US11084809, Example 133::US11198691, Example 133	Plasma kallikrein			 90.2							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408795	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408795&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365129	406799426							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816495	COCc1nn(Cc2ccc(Cn3ccncc3=O)cc2)cc1C(=O)NCc1cccc(OC)c1F	InChI=1S/C26H26FN5O4/c1-35-17-22-21(26(34)29-12-20-4-3-5-23(36-2)25(20)27)16-32(30-22)15-19-8-6-18(7-9-19)14-31-11-10-28-13-24(31)33/h3-11,13,16H,12,14-15,17H2,1-2H3,(H,29,34)	QNPXQCIYWHCURP-UHFFFAOYSA-N	408796	 N-[(2-fluoro-3-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyrazin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 104::US11001578, Example 104::US11084809, Example 104::US11198691, Example 104	Plasma kallikrein			 691							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408796	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408796&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365146	406799427							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816497	COCc1nn(Cc2ccc(Cn3ccc(C)cc3=O)cc2)cc1C(=O)NCc1c(F)ccc(OC)c1F	InChI=1S/C28H28F2N4O4/c1-18-10-11-33(26(35)12-18)14-19-4-6-20(7-5-19)15-34-16-22(24(32-34)17-37-2)28(36)31-13-21-23(29)8-9-25(38-3)27(21)30/h4-12,16H,13-15,17H2,1-3H3,(H,31,36)	BKTJDPOLKWOBHW-UHFFFAOYSA-N	408797	N-[(2,6-difluoro-3-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(4-methyl-2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US10364238, Example 106::US11001578, Example 106::US11084809, Example 106::US11198691, Example 106	Plasma kallikrein			 140							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408797	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408797&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365091	406799428							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816499	COCc1nn(Cc2ccc(Cn3cc(F)ccc3=O)cc2)cc1C(=O)NCc1c(F)ccc(OC)c1F	InChI=1S/C27H25F3N4O4/c1-37-16-23-21(27(36)31-11-20-22(29)8-9-24(38-2)26(20)30)15-34(32-23)13-18-5-3-17(4-6-18)12-33-14-19(28)7-10-25(33)35/h3-10,14-15H,11-13,16H2,1-2H3,(H,31,36)	JRSJFSJQRZMHDN-UHFFFAOYSA-N	408798	 N-[(2,6-difluoro-3-methoxyphenyl)methyl]-1-({4-[(5-fluoro-2-oxopyridin-1- yl)methyl]phenyl}methyl)-3-(methoxymethyl)pyrazole-4-carboxamide::US10364238, Example 108::US11001578, Example 108::US11084809, Example 108::US11198691, Example 108	Plasma kallikrein			 5.50							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408798	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408798&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365114	406799429							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816501	CCOc1ccn(Cc2ccc(Cn3cc(C(=O)NCc4c(F)ccc(OC)c4F)c(COC)n3)cc2)c(=O)c1	InChI=1S/C29H30F2N4O5/c1-4-40-21-11-12-34(27(36)13-21)15-19-5-7-20(8-6-19)16-35-17-23(25(33-35)18-38-2)29(37)32-14-22-24(30)9-10-26(39-3)28(22)31/h5-13,17H,4,14-16,18H2,1-3H3,(H,32,37)	MMGSTVOIQROITG-UHFFFAOYSA-N	408799	N-[(2,6-difluoro-3-methoxyphenyl)methyl]-1-({4-[(4-ethoxy-2-oxopyridin-1- yl)methyl]phenyl}methyl)-3-(methoxymethyl)pyrazole-4-carboxamide ::US10364238, Example 109::US11001578, Example 109::US11084809, Example 109::US11198691, Example 109	Plasma kallikrein			 2980							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408799	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408799&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364997	406799430							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816503	COc1cccc(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)c(C)n2)c1F	InChI=1S/C26H25FN4O3/c1-18-29-22(26(33)28-14-21-6-5-7-23(34-2)25(21)27)17-31(18)16-20-11-9-19(10-12-20)15-30-13-4-3-8-24(30)32/h3-13,17H,14-16H2,1-2H3,(H,28,33)	XCBLTBHUJNNESG-UHFFFAOYSA-N	408801	 N-[(2-fluoro-3-methoxyphenyl)methyl]-2-methyl-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)imidazole-4-carboxamide ::US10364238, Example 121::US11001578, Example 121::US11084809, Example 121::US11198691, Example 121	Plasma kallikrein			 43.9							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408801	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408801&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365087	406799432							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816505	COc1cccc(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)c(n2)C(F)(F)F)c1F	InChI=1S/C26H22F4N4O3/c1-37-21-6-4-5-19(23(21)27)13-31-24(36)20-16-34(25(32-20)26(28,29)30)15-18-10-8-17(9-11-18)14-33-12-3-2-7-22(33)35/h2-12,16H,13-15H2,1H3,(H,31,36)	UZZGYTADFHNIGM-UHFFFAOYSA-N	408803	 N-[(2-fluoro-3-methoxyphenyl)methyl]-1-({4-[(2-oxopyrldin-1- yl)methyl]phenyl}methyl)-2-(trifluoromethyl)imidazole-4-carboxamide ::US10364238, Example 124::US11001578, Example 124::US11084809, Example 124::US11198691, Example 124	Plasma kallikrein			 191							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408803	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408803&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365057	406799434							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816507	COc1cccc(CNC(=O)c2cn(Cc3ccc(nc3)N3CCCC3)nc2C(F)(F)F)c1F	InChI=1S/C23H23F4N5O2/c1-34-18-6-4-5-16(20(18)24)12-29-22(33)17-14-32(30-21(17)23(25,26)27)13-15-7-8-19(28-11-15)31-9-2-3-10-31/h4-8,11,14H,2-3,9-10,12-13H2,1H3,(H,29,33)	CWABZPWKGAMQLS-UHFFFAOYSA-N	408804	N-[(2-fluoro-3-methoxyphenyl)methyl]-1-{[6-(pyrrolidin-1-yl)pyridin-3-yl]methyl}-3- (trifluoromethyl)pyrazole-4-carboxamide::US10364238, Example 126::US11001578, Example 126::US11084809, Example 126::US11180484, Reference Example G	Plasma kallikrein			 742							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408804	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408804&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365050	406799435							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816509	CN1CC(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2N)Oc2cc(Cl)ccc12	InChI=1S/C27H27ClN6O3/c1-32-16-21(37-24-12-20(28)9-10-23(24)32)13-30-27(36)22-17-34(31-26(22)29)15-19-7-5-18(6-8-19)14-33-11-3-2-4-25(33)35/h2-12,17,21H,13-16H2,1H3,(H2,29,31)(H,30,36)	BZQHROALKROIIJ-UHFFFAOYSA-N	408805	 3-amino-N-[(7-chloro-4-methyl-2,3-dihydro-1,4-benzoxazin-2-yl)methyl]-1-({4-[(2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 139::US11001578, Example 139::US11084809, Example 139::US11198691, Example 139	Plasma kallikrein			 64.7							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408805	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408805&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365007	406799436							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
816511	Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCC1CNc2ccc(Cl)cc2O1	InChI=1S/C26H25ClN6O3/c27-19-8-9-22-23(11-19)36-20(12-29-22)13-30-26(35)21-16-33(31-25(21)28)15-18-6-4-17(5-7-18)14-32-10-2-1-3-24(32)34/h1-11,16,20,29H,12-15H2,(H2,28,31)(H,30,35)	PIQXYEUIEZKEKB-UHFFFAOYSA-N	408806	3-amino-N-[(7-chloro-3,4-dihydro-2H-1,4-benzoxazin-2-yl)methyl]-1-({4-[(2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 140::US11001578, Example 140::US11084809, Example 140::US11198691, Example 140	Plasma kallikrein			 10.6							US Patent		10.7270/Q2J968QP		aid1803731	US10364238	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408806	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408806&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365122	406799437							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51126796	NCc1cccc(C[C@H](NC(=O)[C@@H](CCCc2ccccc2)NS(=O)(=O)Cc2cccc(c2)C(O)=O)C(=O)Cc2ccc(cc2)C(N)=N)c1	InChI=1S/C37H41N5O6S/c38-23-28-11-4-10-27(19-28)21-33(34(43)22-26-15-17-30(18-16-26)35(39)40)41-36(44)32(14-6-9-25-7-2-1-3-8-25)42-49(47,48)24-29-12-5-13-31(20-29)37(45)46/h1-5,7-8,10-13,15-20,32-33,42H,6,9,14,21-24,38H2,(H3,39,40)(H,41,44)(H,45,46)/t32-,33+/m1/s1	HEKNEXYMJKVOGQ-SAIUNTKASA-N	50462133	CHEMBL4238882	Plasma kallikrein		 0.020000								ChEMBL	10.1021/acs.jmedchem.7b00772	10.7270/Q2C2502H	29072911			Fischer, PM	University of Nottingham	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50462133	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50462133&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			145982984	433929398							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835271	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc2CCNCc2cc1F)C(F)(F)F	InChI=1S/C21H19F4N5O/c22-16-7-14-11-27-5-4-13(14)8-17(16)28-20(31)18-9-19(21(23,24)25)29-30(18)15-3-1-2-12(6-15)10-26/h1-3,6-9,27H,4-5,10-11,26H2,(H,28,31)	XCBOZBQFIYATFU-UHFFFAOYSA-N	416716	1-(3-(aminomethyl)phenyl)-N-(7-fluoro-1,2,3,4-tetrahydroisoquinolin-6-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 161e::US10633345, Compound 161e::US10689346, Compound 161e::US11203574, Compound 161e::US11230530, Compound 161e::US11685721, Compound 161e	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416716	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416716&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356276	433916630							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835272	CN(Cc1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1)c1ccccc1	InChI=1S/C26H24F3N5O/c1-33(21-10-3-2-4-11-21)17-19-8-5-9-20(13-19)31-25(35)23-15-24(26(27,28)29)32-34(23)22-12-6-7-18(14-22)16-30/h2-15H,16-17,30H2,1H3,(H,31,35)	IEARPKHOKPOLCS-UHFFFAOYSA-N	416717	1-(3-(aminomethyl)phenyl)-N-(3-((methyl(phenyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 28f::US10633345, Compound 28f::US10689346, Compound 28f::US11203574, Compound 28f::US11230530, Compound 28f::US11685721, Compound 28f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416717	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416717&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665676	433916631							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835273	CCCN(c1ccccc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C27H25F4N5O/c1-2-13-35(19-8-4-3-5-9-19)20-11-12-22(28)23(15-20)33-26(37)24-16-25(27(29,30)31)34-36(24)21-10-6-7-18(14-21)17-32/h3-12,14-16H,2,13,17,32H2,1H3,(H,33,37)	NZQCKHUBEMVLQD-UHFFFAOYSA-N	416718	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-5-(phenyl(propyl)amino)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 77e::US10633345, Compound 77e::US10689346, Compound 77e::US11203574, Compound 77e::US11230530, Compound 77e::US11685721, Compound 77e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416718	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416718&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665730	433916632							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835274	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1ccc2CNCCc2c1F)C(F)(F)F	InChI=1S/C21H19F4N5O/c22-19-15-6-7-27-11-13(15)4-5-16(19)28-20(31)17-9-18(21(23,24)25)29-30(17)14-3-1-2-12(8-14)10-26/h1-5,8-9,27H,6-7,10-11,26H2,(H,28,31)	RYNJWLCYWDTYKF-UHFFFAOYSA-N	416719	1-(3-(aminomethyl)phenyl)-N-(5-fluoro-1,2,3,4-tetrahydroisoquinolin-6-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 162c::US10633345, Compound 162c::US10689346, Compound 162c::US11203574, Compound 162c::US11230530, Compound 162c::US11685721, Compound 162c	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416719	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416719&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665528	433916633							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835275	CCCN(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1F	InChI=1S/C27H25F4N5O/c1-2-14-35(19-9-4-3-5-10-19)22-13-7-12-21(25(22)28)33-26(37)23-16-24(27(29,30)31)34-36(23)20-11-6-8-18(15-20)17-32/h3-13,15-16H,2,14,17,32H2,1H3,(H,33,37)	SDFZIQBGIDPGAP-UHFFFAOYSA-N	416720	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-3-(phenyl(propyl)amino)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 29e::US10633345, Compound 29e::US10689346, Compound 29e::US11203574, Compound 29e::US11230530, Compound 29e::US11685721, Compound 29e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416720	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416720&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355654	433916634							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835276	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C28H26F3N5O2/c29-28(30,31)25-15-24(36(35-25)22-8-3-5-19(13-22)16-32)27(37)34-21-7-4-6-20(14-21)26(38-17-18-10-11-18)23-9-1-2-12-33-23/h1-9,12-15,18,26H,10-11,16-17,32H2,(H,34,37)	UBQUVYTUKOFUOF-UHFFFAOYSA-N	416721	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(pyridin-2-yl)methyl)-phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 43f::US10633345, Compound 43f::US10689346, Compound 43g::US11203574, Compound 43h::US11230530, Compound 43h::US11685721, Compound 43f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416721	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416721&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355947	433916635							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835277	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc2CNCCc2cc1F)C(F)(F)F	InChI=1S/C21H19F4N5O/c22-16-7-13-4-5-27-11-14(13)8-17(16)28-20(31)18-9-19(21(23,24)25)29-30(18)15-3-1-2-12(6-15)10-26/h1-3,6-9,27H,4-5,10-11,26H2,(H,28,31)	APLBFUXJEQDPBH-UHFFFAOYSA-N	416722	1-(3-(aminomethyl)phenyl)-N-(6-fluoro-1,2,3,4-tetrahydroisoquinolin-7-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 163g::US10633345, Compound 163g::US10689346, Compound 163g::US11203574, Compound 163g::US11230530, Compound 163g::US11685721, Compound 163g	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416722	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416722&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355616	433916636							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835278	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(Cn2ccnc2)ccc1F)C(F)(F)F	InChI=1S/C22H18F4N6O/c23-17-5-4-15(12-31-7-6-28-13-31)9-18(17)29-21(33)19-10-20(22(24,25)26)30-32(19)16-3-1-2-14(8-16)11-27/h1-10,13H,11-12,27H2,(H,29,33)	FOWNNAMOGPFGSS-UHFFFAOYSA-N	416723	N-(5-((1H-imidazol-1-yl)methyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 30g::US10633345, Compound 30g::US10689346, Compound 30g::US11203574, Compound 30g::US11230530, Compound 30g::US11685721, Compound 30g	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416723	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416723&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356018	433916637							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835279	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H26F3N5O2/c29-28(30,31)25-14-24(36(35-25)23-8-1-4-19(12-23)15-32)27(37)34-22-7-2-5-20(13-22)26(38-17-18-9-10-18)21-6-3-11-33-16-21/h1-8,11-14,16,18,26H,9-10,15,17,32H2,(H,34,37)	SHFRWTHPPCXLER-UHFFFAOYSA-N	416725	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(pyridin-3-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 44c::US10633345, Compound 44c::US10689346, Compound 44c::US11203574, Compound 44d::US11230530, Compound 44e::US11685721, Compound 44c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416725	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416725&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355578	433916639							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835280	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(Nc2ccccc2)c1)C(F)(F)F	InChI=1S/C24H20F3N5O/c25-24(26,27)22-14-21(32(31-22)20-11-4-6-16(12-20)15-28)23(33)30-19-10-5-9-18(13-19)29-17-7-2-1-3-8-17/h1-14,29H,15,28H2,(H,30,33)	BURYUTYBSGJGCF-UHFFFAOYSA-N	416728	1-(3-(aminomethyl)phenyl)-N-(3-(phenylamino)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 17d::US10689346, Compound 17d::US11203574, Compound 17d::US11230530, Compound 17d::US11685721, Compound 17d	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416728	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416728&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665499	433916642							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835281	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)c1cccnc1)C(F)(F)F	InChI=1S/C24H20F3N5O2/c25-24(26,27)21-12-20(32(31-21)19-8-1-4-15(10-19)13-28)23(34)30-18-7-2-5-16(11-18)22(33)17-6-3-9-29-14-17/h1-12,14,22,33H,13,28H2,(H,30,34)	ZKOHYLRGOQBIFH-UHFFFAOYSA-N	416729	1-(3-(aminomethyl)phenyl)-N-(3-(hydroxy(pyridin-3-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 31f::US10633345, Compound 31f::US10689346, Compound 31f::US11203574, Compound 31f::US11230530, Compound 31f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416729	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416729&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665970	433916643							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835282	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F3N4O/c31-30(32,33)28-18-27(37(36-28)25-11-4-6-21(16-25)19-34)29(38)35-24-10-5-9-23(17-24)26(15-14-20-12-13-20)22-7-2-1-3-8-22/h1-11,16-18,20,26H,12-15,19,34H2,(H,35,38)	LVGPKQXQIQRVCT-UHFFFAOYSA-N	416730	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-phenylpropyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 78d::US10633345, Compound 78d::US10689346, Compound 78d::US11203574, Compound 78d::US11230530, Compound 78d::US11685721, Compound 78d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416730	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416730&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665672	433916644							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835283	COC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C26H23F3N4O2/c1-35-24(18-8-3-2-4-9-18)19-10-6-11-20(14-19)31-25(34)22-15-23(26(27,28)29)32-33(22)21-12-5-7-17(13-21)16-30/h2-15,24H,16,30H2,1H3,(H,31,34)	XNHGZPIIDJTQKO-UHFFFAOYSA-N	416731	1-(3-(aminomethyl)phenyl)-N-(3-(methoxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18f::US10633345, Compound 18f::US10689346, Compound 18f::US11203574, Compound 18f::US11230530, Compound 18e::US11685721, Compound 18f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416731	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416731&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665801	433916645							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835284	CCCCC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C29H29F3N4O/c1-2-3-15-25(21-10-5-4-6-11-21)22-12-8-13-23(17-22)34-28(37)26-18-27(29(30,31)32)35-36(26)24-14-7-9-20(16-24)19-33/h4-14,16-18,25H,2-3,15,19,33H2,1H3,(H,34,37)	PEZPMDJZISDDKH-UHFFFAOYSA-N	416732	1-(3-(aminomethyl)phenyl)-N-(3-(1-phenylpentyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 32f::US10633345, Compound 32f::US10689346, Compound 32f::US11203574, Compound 32f::US11230530, Compound 32f::US11685721, Compound 32f	Plasma kallikrein		 75.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416732	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416732&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356224	433916646							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835285	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H27F3N6O/c29-28(30,31)25-14-24(37(36-25)23-8-1-4-19(12-23)15-32)27(38)35-22-7-2-5-20(13-22)26(34-16-18-9-10-18)21-6-3-11-33-17-21/h1-8,11-14,17-18,26,34H,9-10,15-16,32H2,(H,35,38)	KSDPGGAAGHTRLB-UHFFFAOYSA-N	416733	1-(3-(Aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(pyridin-3-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 79f::US10633345, Compound 79f::US10689346, Compound 79f::US11203574, Compound 79f::US11230530, Compound 79f::US11685721, Compound 79f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416733	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416733&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356066	433916647							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835286	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(Cc2ccccc2)c1)C(F)(F)F	InChI=1S/C25H21F3N4O/c26-25(27,28)23-15-22(32(31-23)21-11-5-9-19(14-21)16-29)24(33)30-20-10-4-8-18(13-20)12-17-6-2-1-3-7-17/h1-11,13-15H,12,16,29H2,(H,30,33)	GVRJCFWHVBXPLW-UHFFFAOYSA-N	416734	1-(3-(aminomethyl)phenyl)-N-(3-benzylphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 19d::US10633345, Compound 19d::US10689346, Compound 19d::US11203574, Compound 19d::US11230530, Compound 19d::US11685721, Compound 19d	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416734	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416734&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355715	433916648							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835287	CCOC(c1ccccc1)c1ccc(Cl)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C27H24ClF3N4O2/c1-2-37-25(18-8-4-3-5-9-18)19-11-12-21(28)22(14-19)33-26(36)23-15-24(27(29,30)31)34-35(23)20-10-6-7-17(13-20)16-32/h3-15,25H,2,16,32H2,1H3,(H,33,36)	XUCZWPPXZIMXPF-UHFFFAOYSA-N	416735	1-(3-(aminomethyl)phenyl)-N-(2-chloro-5-(ethoxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 33e::US10633345, Compound 33e::US10689346, Compound 33e::US11203574, Compound 33e::US11230530, Compound 33e::US11685721, Compound 33e	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416735	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416735&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665706	433916649							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835288	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(F)cc(c1)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-22-12-21(27(39-17-18-9-10-18)20-6-2-1-3-7-20)13-23(14-22)35-28(38)25-15-26(29(31,32)33)36-37(25)24-8-4-5-19(11-24)16-34/h1-8,11-15,18,27H,9-10,16-17,34H2,(H,35,38)	CECISELXZFBKBA-UHFFFAOYSA-N	416736	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)-5-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 80h::US10633345, Compound 80h::US10689346, Compound 80h::US11203574, Compound 80h::US11230530, Compound 80h::US11685721, Compound 80h	Plasma kallikrein		 25.1								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416736	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416736&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356068	433916650							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50806390	CC(C)C[C@@H]1NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2cnc[nH]2)NC[C@H](C)NC(=O)[C@H]2CSCc3cc(CSC[C@H](NC1=O)C(O)=O)cc(CSC[C@H](NC(C)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCNC(N)=N)C(=O)N2)c3	InChI=1S/C76H105N19O19S3/c1-40(2)22-53-67(105)94-60(75(113)114)38-117-35-47-24-45-23-46(25-47)34-116-37-59(71(109)84-41(3)30-82-52(28-48-31-80-39-83-48)66(104)87-51(17-18-62(77)99)65(103)89-55(29-63(100)101)69(107)88-53)93-64(102)50(12-8-9-20-81-76(78)79)86-68(106)54(26-44-13-15-49(98)16-14-44)90-73(111)61-19-21-95(61)74(112)56(27-43-10-6-5-7-11-43)91-70(108)57(32-96)92-72(110)58(36-115-33-45)85-42(4)97/h5-7,10-11,13-16,23-25,31,39-41,50-61,82,96,98H,8-9,12,17-22,26-30,32-38H2,1-4H3,(H2,77,99)(H,80,83)(H,84,109)(H,85,97)(H,86,106)(H,87,104)(H,88,107)(H,89,103)(H,90,111)(H,91,108)(H,92,110)(H,93,102)(H,94,105)(H,100,101)(H,113,114)(H4,78,79,81)/t41-,50-,51-,52-,53-,54-,55-,56-,57-,58-,59+,60-,61?/m0/s1	NWSILYZBKZBZOH-SOPRAFLKSA-N	50256260	CHEMBL4094403	Plasma kallikrein			 120							ChEMBL	10.1021/acs.jmedchem.7b01625	10.7270/Q2862JW6	29517911			Teufel, DP; Bennett, G; Harrison, H; van Rietschoten, K; Pavan, S; Stace, C; Le Floch, F; Van Bergen, T; Vermassen, E; Barbeaux, P; Hu, TT; Feyen, JHM; Vanhove, M	Bicycle Therapeutics Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50256260	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50256260&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137654508	402360659							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50806763	CC(C)C[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSCc3cc(CSC[C@@H](NC1=O)C(=O)N[C@@H](C)C(=O)N(C)CC(=O)N(C)CC(=O)N(C)CC(=O)N[C@H](CCCNC(N)=N)C(=O)N[C@H](CCCNC(N)=N)C(O)=O)cc(CSC[C@H](NC(C)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c4ccccc14)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c4ccccc14)C(=O)N2)c3	InChI=1S/C117H160N32O28S3/c1-59(2)37-78-100(161)141-86(105(166)129-60(3)111(172)146(9)52-95(156)145(8)51-94(155)144(7)50-93(154)132-76(27-16-32-124-116(120)121)98(159)133-77(115(176)177)28-17-33-125-117(122)123)57-179-54-65-38-64-39-66(40-65)55-180-58-87(114(175)149-36-20-31-90(149)109(170)137-79(41-67-47-126-73-24-13-10-21-70(67)73)101(162)135-83(46-96(157)158)99(160)130-61(4)112(173)147-34-18-29-88(147)107(168)136-78)142-103(164)80(42-68-48-127-74-25-14-11-22-71(68)74)138-108(169)89-30-19-35-148(89)113(174)84(45-92(119)153)140-102(163)81(43-69-49-128-75-26-15-12-23-72(69)75)139-110(171)97(62(5)150)143-104(165)82(44-91(118)152)134-106(167)85(56-178-53-64)131-63(6)151/h10-15,21-26,38-40,47-49,59-62,76-90,97,126-128,150H,16-20,27-37,41-46,50-58H2,1-9H3,(H2,118,152)(H2,119,153)(H,129,166)(H,130,160)(H,131,151)(H,132,154)(H,133,159)(H,134,167)(H,135,162)(H,136,168)(H,137,170)(H,138,169)(H,139,171)(H,140,163)(H,141,161)(H,142,164)(H,143,165)(H,157,158)(H,176,177)(H4,120,121,124)(H4,122,123,125)/t60-,61-,62+,76+,77+,78-,79-,80-,81-,82-,83-,84-,85-,86+,87-,88-,89-,90-,97-/m0/s1	OHOYFNPMBCNOTR-QFZQKJJLSA-N	50256261	CHEMBL4059991	Plasma kallikrein			 790							ChEMBL	10.1021/acs.jmedchem.7b01625	10.7270/Q2862JW6	29517911			Teufel, DP; Bennett, G; Harrison, H; van Rietschoten, K; Pavan, S; Stace, C; Le Floch, F; Van Bergen, T; Vermassen, E; Barbeaux, P; Hu, TT; Feyen, JHM; Vanhove, M	Bicycle Therapeutics Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50256261	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50256261&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137637214	402360660							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50806765	CC(C)C[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSCc3cc(CSC[C@@H](NC1=O)C(=O)N[C@@H](C)C(=O)N(C)CC(=O)N(C)CC(=O)N(C)CC(=O)N[C@H](CCCNC(N)=N)C(=O)N[C@H](CCCNC(N)=N)C(O)=O)cc(CSC[C@H](NC(C)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c4ccccc14)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c4ccccc14)C(=O)N2)c3	InChI=1S/C117H160N32O28S3/c1-59(2)37-78-100(161)141-86(105(166)129-60(3)111(172)146(9)52-95(156)145(8)51-94(155)144(7)50-93(154)132-76(27-16-32-124-116(120)121)98(159)133-77(115(176)177)28-17-33-125-117(122)123)57-179-54-65-38-64-39-66(40-65)55-180-58-87(114(175)149-36-20-31-90(149)109(170)137-79(41-67-47-126-73-24-13-10-21-70(67)73)101(162)135-83(46-96(157)158)99(160)130-61(4)112(173)147-34-18-29-88(147)107(168)136-78)142-103(164)80(42-68-48-127-74-25-14-11-22-71(68)74)138-108(169)89-30-19-35-148(89)113(174)84(45-92(119)153)140-102(163)81(43-69-49-128-75-26-15-12-23-72(69)75)139-110(171)97(62(5)150)143-104(165)82(44-91(118)152)134-106(167)85(56-178-53-64)131-63(6)151/h10-15,21-26,38-40,47-49,59-62,76-90,97,126-128,150H,16-20,27-37,41-46,50-58H2,1-9H3,(H2,118,152)(H2,119,153)(H,129,166)(H,130,160)(H,131,151)(H,132,154)(H,133,159)(H,134,167)(H,135,162)(H,136,168)(H,137,170)(H,138,169)(H,139,171)(H,140,163)(H,141,161)(H,142,164)(H,143,165)(H,157,158)(H,176,177)(H4,120,121,124)(H4,122,123,125)/t60-,61-,62+,76+,77+,78-,79-,80-,81-,82-,83-,84-,85-,86+,87-,88-,89-,90-,97-/m0/s1	OHOYFNPMBCNOTR-QFZQKJJLSA-N	50256261	CHEMBL4059991	Plasma kallikrein			 27							ChEMBL	10.1021/acs.jmedchem.7b01625	10.7270/Q2862JW6	29517911			Teufel, DP; Bennett, G; Harrison, H; van Rietschoten, K; Pavan, S; Stace, C; Le Floch, F; Van Bergen, T; Vermassen, E; Barbeaux, P; Hu, TT; Feyen, JHM; Vanhove, M	Bicycle Therapeutics Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50256261	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50256261&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137637214	402360660							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50806797	CC(C)C[C@@H]1NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2cnc[nH]2)NC[C@H](C)NC(=O)[C@H]2CSCc3cc(CSC[C@H](NC1=O)C(O)=O)cc(CSC[C@H](NC(C)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCNC(N)=N)C(=O)N2)c3	InChI=1S/C76H105N19O19S3/c1-40(2)22-53-67(105)94-60(75(113)114)38-117-35-47-24-45-23-46(25-47)34-116-37-59(71(109)84-41(3)30-82-52(28-48-31-80-39-83-48)66(104)87-51(17-18-62(77)99)65(103)89-55(29-63(100)101)69(107)88-53)93-64(102)50(12-8-9-20-81-76(78)79)86-68(106)54(26-44-13-15-49(98)16-14-44)90-73(111)61-19-21-95(61)74(112)56(27-43-10-6-5-7-11-43)91-70(108)57(32-96)92-72(110)58(36-115-33-45)85-42(4)97/h5-7,10-11,13-16,23-25,31,39-41,50-61,82,96,98H,8-9,12,17-22,26-30,32-38H2,1-4H3,(H2,77,99)(H,80,83)(H,84,109)(H,85,97)(H,86,106)(H,87,104)(H,88,107)(H,89,103)(H,90,111)(H,91,108)(H,92,110)(H,93,102)(H,94,105)(H,100,101)(H,113,114)(H4,78,79,81)/t41-,50-,51-,52-,53-,54-,55-,56-,57-,58-,59+,60-,61?/m0/s1	NWSILYZBKZBZOH-SOPRAFLKSA-N	50256260	CHEMBL4094403	Plasma kallikrein			 6							ChEMBL	10.1021/acs.jmedchem.7b01625	10.7270/Q2862JW6	29517911			Teufel, DP; Bennett, G; Harrison, H; van Rietschoten, K; Pavan, S; Stace, C; Le Floch, F; Van Bergen, T; Vermassen, E; Barbeaux, P; Hu, TT; Feyen, JHM; Vanhove, M	Bicycle Therapeutics Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50256260	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50256260&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137654508	402360659							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
835289	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(Oc2ccccc2)c1)C(F)(F)F	InChI=1S/C24H19F3N4O2/c25-24(26,27)22-14-21(31(30-22)18-8-4-6-16(12-18)15-28)23(32)29-17-7-5-11-20(13-17)33-19-9-2-1-3-10-19/h1-14H,15,28H2,(H,29,32)	CMENISUXWPWEPE-UHFFFAOYSA-N	416737	1-(3-(aminomethyl)phenyl)-N-(3-phenoxyphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 20d::US10689346, Compound 20d::US11203574, Compound 20d::US11230530, Compound 20d::US11685721, Compound 20d	Plasma kallikrein		>100.0								US Patent		10.7270/Q2R78HM5		aid1803903	US10329260	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416737	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416737&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665805	433916651							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878850	O[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cc1)C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1	InChI=1S/C29H30ClFN4O3/c30-21-9-11-22(12-10-21)33-29(38)35-17-23(36)15-26(35)28(37)34-25-14-20(8-13-24(25)31)27(32-16-18-6-7-18)19-4-2-1-3-5-19/h1-5,8-14,18,23,26-27,32,36H,6-7,15-17H2,(H,33,38)(H,34,37)/t23-,26-,27?/m1/s1	HBBZGIHYHHTCAB-UTZIHYNGSA-N	433366	US10562850, Compound 1p::US10562850, Compound 3a::US11066360, Compound 3a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433366	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433366&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135281863	438642299							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
853834	Cc1nc(ccc1Cn1cc(cn1)C(=O)N[C@@H]1CCc2c1ccnc2N)N1CC2CC2C1	InChI=1S/C24H27N7O/c1-14-15(2-5-22(28-14)30-10-16-8-17(16)11-30)12-31-13-18(9-27-31)24(32)29-21-4-3-20-19(21)6-7-26-23(20)25/h2,5-7,9,13,16-17,21H,3-4,8,10-12H2,1H3,(H2,25,26)(H,29,32)/t16?,17?,21-/m1/s1	YILAMRTXZFQLRL-MYKUNDNFSA-N	423169	N-[(5R)-1-Amino-5H,6H,7H-cyclopenta[c]pyridin-5-yl]-1-[(6-{3-azabicyclo[3.1.0]hexan-3-yl}-2-methylpyridin-3-yl)methyl]-1H-pyrazole-4-carboxamide::US10501440, Example 1	Plasma kallikrein		 0.300								US Patent		10.7270/Q2QR50JS		aid1804038	US10501440	Frattini, S; Lingard, I; Hamprecht, DW; Bakker, RA; Eckhardt, M; Gollner, A; Hehn, JP; Langkopf, E; Wagner, H; Wellenzohn, B; Wiedenmayer, D	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=423169	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=423169&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135362341	434148977							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
853835	Cc1cc2[C@@H](CCc2c(N)n1)NC(=O)c1cnn(Cc2ccc(nc2C)N2CC3CC3C2)c1	InChI=1S/C25H29N7O/c1-14-7-21-20(24(26)28-14)4-5-22(21)30-25(33)19-9-27-32(13-19)12-16-3-6-23(29-15(16)2)31-10-17-8-18(17)11-31/h3,6-7,9,13,17-18,22H,4-5,8,10-12H2,1-2H3,(H2,26,28)(H,30,33)/t17?,18?,22-/m1/s1	UJFRMUZADUJJKJ-RWWKDMOOSA-N	423170	US10501440, Example 2	Plasma kallikrein		 0.300								US Patent		10.7270/Q2QR50JS		aid1804038	US10501440	Frattini, S; Lingard, I; Hamprecht, DW; Bakker, RA; Eckhardt, M; Gollner, A; Hehn, JP; Langkopf, E; Wagner, H; Wellenzohn, B; Wiedenmayer, D	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=423170	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=423170&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			140932749	434148978							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
853836	Cc1nn(Cc2ccc(nc2C)N2CC3CC3C2)cc1C(=O)N[C@@H]1CCc2c1ccnc2N	InChI=1S/C25H29N7O/c1-14-16(3-6-23(28-14)31-10-17-9-18(17)11-31)12-32-13-21(15(2)30-32)25(33)29-22-5-4-20-19(22)7-8-27-24(20)26/h3,6-8,13,17-18,22H,4-5,9-12H2,1-2H3,(H2,26,27)(H,29,33)/t17?,18?,22-/m1/s1	YNFHLIKBRGHMLO-RWWKDMOOSA-N	423171	US10501440, Example 3	Plasma kallikrein		 0.300								US Patent		10.7270/Q2QR50JS		aid1804038	US10501440	Frattini, S; Lingard, I; Hamprecht, DW; Bakker, RA; Eckhardt, M; Gollner, A; Hehn, JP; Langkopf, E; Wagner, H; Wellenzohn, B; Wiedenmayer, D	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=423171	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=423171&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			140932721	434148979							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
853837	Cc1nc(ccc1Cn1cc(C(=O)N[C@@H]2CCc3c2ccnc3N)c(n1)C(F)(F)F)N1CC2CC2C1	InChI=1S/C25H26F3N7O/c1-13-14(2-5-21(31-13)34-9-15-8-16(15)10-34)11-35-12-19(22(33-35)25(26,27)28)24(36)32-20-4-3-18-17(20)6-7-30-23(18)29/h2,5-7,12,15-16,20H,3-4,8-11H2,1H3,(H2,29,30)(H,32,36)/t15?,16?,20-/m1/s1	REBSMAGUIWGBJY-ALLBUHFWSA-N	423173	US10501440, Example 4	Plasma kallikrein		 0.400								US Patent		10.7270/Q2QR50JS		aid1804038	US10501440	Frattini, S; Lingard, I; Hamprecht, DW; Bakker, RA; Eckhardt, M; Gollner, A; Hehn, JP; Langkopf, E; Wagner, H; Wellenzohn, B; Wiedenmayer, D	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=423173	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=423173&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			140932742	434148981							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
853838	Cc1nc(ccc1Cn1cc(nn1)C(=O)N[C@@H]1CCc2c1ccnc2N)N1CC2CC2C1	InChI=1S/C23H26N8O/c1-13-14(2-5-21(26-13)30-9-15-8-16(15)10-30)11-31-12-20(28-29-31)23(32)27-19-4-3-18-17(19)6-7-25-22(18)24/h2,5-7,12,15-16,19H,3-4,8-11H2,1H3,(H2,24,25)(H,27,32)/t15?,16?,19-/m1/s1	IGXXMLUUXMAVLM-LADRWXRNSA-N	423174	US10501440, Example 5	Plasma kallikrein		 0.400								US Patent		10.7270/Q2QR50JS		aid1804038	US10501440	Frattini, S; Lingard, I; Hamprecht, DW; Bakker, RA; Eckhardt, M; Gollner, A; Hehn, JP; Langkopf, E; Wagner, H; Wellenzohn, B; Wiedenmayer, D	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=423174	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=423174&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			140932743	434148982							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
853839	Cc1nc(ccc1Cn1cc(C(=O)N[C@@H]2CCc3c2ccnc3N)c(n1)C(F)(F)F)N1CC2C(C1)C2(F)F	InChI=1S/C25H24F5N7O/c1-12-13(2-5-20(33-12)36-10-17-18(11-36)24(17,26)27)8-37-9-16(21(35-37)25(28,29)30)23(38)34-19-4-3-15-14(19)6-7-32-22(15)31/h2,5-7,9,17-19H,3-4,8,10-11H2,1H3,(H2,31,32)(H,34,38)/t17?,18?,19-/m1/s1	QLCURGKHEDHWIR-CTWPCTMYSA-N	423176	US10501440, Example 7	Plasma kallikrein		 1.90								US Patent		10.7270/Q2QR50JS		aid1804038	US10501440	Frattini, S; Lingard, I; Hamprecht, DW; Bakker, RA; Eckhardt, M; Gollner, A; Hehn, JP; Langkopf, E; Wagner, H; Wellenzohn, B; Wiedenmayer, D	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=423176	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=423176&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			140932745	434148984							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
853840	Cc1nc(ccc1Cn1cc(cn1)C(=O)N[C@@H]1CCc2c1ccnc2N)N1CC2C(C1)C2(F)F	InChI=1S/C24H25F2N7O/c1-13-14(2-5-21(30-13)32-11-18-19(12-32)24(18,25)26)9-33-10-15(8-29-33)23(34)31-20-4-3-17-16(20)6-7-28-22(17)27/h2,5-8,10,18-20H,3-4,9,11-12H2,1H3,(H2,27,28)(H,31,34)/t18?,19?,20-/m1/s1	JECFULPDSRFDSJ-SOAGJPPSSA-N	423179	N-[(5R)-1-Amino-5H,6H,7H-cyclopenta[c]pyridin-5-yl]-1-[(6-{6,6-difluoro-3-azabicyclo[3.1.0]hexan-3-yl}-2-methylpyridin-3-yl)methyl]-1H-pyrazole-4-carboxamide::US10501440, Example 9	Plasma kallikrein		 0.400								US Patent		10.7270/Q2QR50JS		aid1804038	US10501440	Frattini, S; Lingard, I; Hamprecht, DW; Bakker, RA; Eckhardt, M; Gollner, A; Hehn, JP; Langkopf, E; Wagner, H; Wellenzohn, B; Wiedenmayer, D	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=423179	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=423179&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			140932736	434148987							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
853841	Cc1cc2[C@@H](CCc2c(N)n1)NC(=O)c1cnn(Cc2ccc(nc2C)N2CC3C(C2)C3(F)F)c1	InChI=1S/C25H27F2N7O/c1-13-7-18-17(23(28)30-13)4-5-21(18)32-24(35)16-8-29-34(10-16)9-15-3-6-22(31-14(15)2)33-11-19-20(12-33)25(19,26)27/h3,6-8,10,19-21H,4-5,9,11-12H2,1-2H3,(H2,28,30)(H,32,35)/t19?,20?,21-/m1/s1	RBEJFEBBRUQTOB-XVAXZDLZSA-N	423180	N-[(5R)-1-Amino-3-methyl-5H,6H,7H-cyclopenta[c]pyridin-5-yl]-1-[(6-{6,6-difluoro-3-azabicyclo[3.1.0]hexan-3-yl}-2-methylpyridin-3-yl)methyl]-1H-pyrazole-4-carboxamide::US10501440, Example 10	Plasma kallikrein		 0.400								US Patent		10.7270/Q2QR50JS		aid1804038	US10501440	Frattini, S; Lingard, I; Hamprecht, DW; Bakker, RA; Eckhardt, M; Gollner, A; Hehn, JP; Langkopf, E; Wagner, H; Wellenzohn, B; Wiedenmayer, D	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=423180	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=423180&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135362185	434148988							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
853842	Cc1nc(ncc1Cn1cc(cn1)C(=O)N[C@@H]1CCc2c1ccnc2N)N1CC2CC2C1	InChI=1S/C23H26N8O/c1-13-16(7-26-23(28-13)30-9-14-6-15(14)10-30)11-31-12-17(8-27-31)22(32)29-20-3-2-19-18(20)4-5-25-21(19)24/h4-5,7-8,12,14-15,20H,2-3,6,9-11H2,1H3,(H2,24,25)(H,29,32)/t14?,15?,20-/m1/s1	GSSGILAXRWXBFU-NODKNVJMSA-N	423181	US10501440, Example 11	Plasma kallikrein		 1.50								US Patent		10.7270/Q2QR50JS		aid1804038	US10501440	Frattini, S; Lingard, I; Hamprecht, DW; Bakker, RA; Eckhardt, M; Gollner, A; Hehn, JP; Langkopf, E; Wagner, H; Wellenzohn, B; Wiedenmayer, D	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=423181	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=423181&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			140932746	434148989							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
853843	Cc1nc(ccc1Cn1cc(cn1)C(=O)N[C@@H]1CCc2c1ccnc2N)N1C[C@H]2[C@@H](CO)[C@H]2C1	InChI=1S/C25H29N7O2/c1-14-15(2-5-23(29-14)31-11-19-20(12-31)21(19)13-33)9-32-10-16(8-28-32)25(34)30-22-4-3-18-17(22)6-7-27-24(18)26/h2,5-8,10,19-22,33H,3-4,9,11-13H2,1H3,(H2,26,27)(H,30,34)/t19-,20+,21-,22-/m1/s1	RFORMPIXYBXGPO-CIAFKFPVSA-N	423182	US10501440, Example 12	Plasma kallikrein		 0.600								US Patent		10.7270/Q2QR50JS		aid1804038	US10501440	Frattini, S; Lingard, I; Hamprecht, DW; Bakker, RA; Eckhardt, M; Gollner, A; Hehn, JP; Langkopf, E; Wagner, H; Wellenzohn, B; Wiedenmayer, D	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=423182	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=423182&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			140932698	434148990							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
853844	COc1ccc(CNc2nccc3[C@@H](CCc23)NC(=O)c2cnn(Cc3ccc(nc3C)N3C[C@H]4[C@@H](C3)[C@H]4C#N)c2)c(OC)c1	InChI=1S/C34H36N8O3/c1-20-22(5-9-32(39-20)41-18-28-27(13-35)29(28)19-41)16-42-17-23(15-38-42)34(43)40-30-8-7-26-25(30)10-11-36-33(26)37-14-21-4-6-24(44-2)12-31(21)45-3/h4-6,9-12,15,17,27-30H,7-8,14,16,18-19H2,1-3H3,(H,36,37)(H,40,43)/t27-,28+,29-,30-/m1/s1	TWMGUIMYGMKACB-GOGZTAQTSA-N	423183	N-[(5R)-1-Amino-5H,6H,7H-cyclopenta[c]pyridin-5-yl]-1-({6-[(1R,5S,6R)-6-cyano-3-azabicyclo[3.1.0]hexan-3-yl]-2-methylpyridin-3-yl}methyl)-1H-pyrazole-4-carboxamide::US10501440, Example 13	Plasma kallikrein		 0.300								US Patent		10.7270/Q2QR50JS		aid1804038	US10501440	Frattini, S; Lingard, I; Hamprecht, DW; Bakker, RA; Eckhardt, M; Gollner, A; Hehn, JP; Langkopf, E; Wagner, H; Wellenzohn, B; Wiedenmayer, D	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=423183	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=423183&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			140932709	434148991							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
853845	Cc1nc(ccc1Cn1cc(cn1)C(=O)N[C@@H]1CCc2c1ccnc2N)N1CCC2(CC2)C1	InChI=1S/C25H29N7O/c1-16-17(2-5-22(29-16)31-11-9-25(15-31)7-8-25)13-32-14-18(12-28-32)24(33)30-21-4-3-20-19(21)6-10-27-23(20)26/h2,5-6,10,12,14,21H,3-4,7-9,11,13,15H2,1H3,(H2,26,27)(H,30,33)/t21-/m1/s1	OJWJKJUSXXWQSJ-OAQYLSRUSA-N	423184	US10501440, Example 14	Plasma kallikrein		 1.10								US Patent		10.7270/Q2QR50JS		aid1804038	US10501440	Frattini, S; Lingard, I; Hamprecht, DW; Bakker, RA; Eckhardt, M; Gollner, A; Hehn, JP; Langkopf, E; Wagner, H; Wellenzohn, B; Wiedenmayer, D	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=423184	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=423184&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			140932748	434148992							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
853846	COc1ccc(CNc2nc(C)cc3[C@@H](CCc23)NC(=O)c2cn(Cc3ccc(nc3C)N3CC4CC4C3)nc2C)c(OC)c1	InChI=1S/C35H41N7O3/c1-20-12-29-28(34(37-20)36-15-23-6-8-27(44-4)14-32(23)45-5)9-10-31(29)39-35(43)30-19-42(40-22(30)3)18-24-7-11-33(38-21(24)2)41-16-25-13-26(25)17-41/h6-8,11-12,14,19,25-26,31H,9-10,13,15-18H2,1-5H3,(H,36,37)(H,39,43)/t25?,26?,31-/m1/s1	PQXOFAKBCRDHCR-FJGWTWLBSA-N	423185	N-[(5R)-1-Amino-3-methyl-5H,6H,7H-cyclopenta[c]pyridin-5-yl]-1-[(6-{3-azabicyclo[3.1.0]hexan-3-yl}-2-methylpyridin-3-yl)methyl]-3-methyl-1H-pyrazole-4-carboxamide::US10501440, Example 15	Plasma kallikrein		 0.400								US Patent		10.7270/Q2QR50JS		aid1804038	US10501440	Frattini, S; Lingard, I; Hamprecht, DW; Bakker, RA; Eckhardt, M; Gollner, A; Hehn, JP; Langkopf, E; Wagner, H; Wellenzohn, B; Wiedenmayer, D	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=423185	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=423185&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			140932754	434148993							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
853847	Cc1nc(ncc1Cn1cc(nn1)C(=O)N[C@@H]1CCc2c1ccnc2N)N1CC2CC2C1	InChI=1S/C22H25N9O/c1-12-15(7-25-22(26-12)30-8-13-6-14(13)9-30)10-31-11-19(28-29-31)21(32)27-18-3-2-17-16(18)4-5-24-20(17)23/h4-5,7,11,13-14,18H,2-3,6,8-10H2,1H3,(H2,23,24)(H,27,32)/t13?,14?,18-/m1/s1	CTCYVDUTJJZGMM-WTNGLUPJSA-N	423186	N-[(5R)-1-Amino-5H,6H,7H-cyclopenta[c]pyridin-5-yl]-1-[(2-{3-azabicyclo[3.1.0]hexan-3-yl}-4-methylpyrimidin-5-yl)methyl]-1H-1,2,3-triazole-4-carboxamide::US10501440, Example 16	Plasma kallikrein		 2.20								US Patent		10.7270/Q2QR50JS		aid1804038	US10501440	Frattini, S; Lingard, I; Hamprecht, DW; Bakker, RA; Eckhardt, M; Gollner, A; Hehn, JP; Langkopf, E; Wagner, H; Wellenzohn, B; Wiedenmayer, D	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=423186	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=423186&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135362347	434148994							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
853848	Cc1cc2[C@@H](CCc2c(N)n1)NC(=O)c1cnn(Cc2cnc(nc2C)N2CC3CC3C2)c1	InChI=1S/C24H28N8O/c1-13-5-20-19(22(25)28-13)3-4-21(20)30-23(33)18-8-27-32(12-18)11-17-7-26-24(29-14(17)2)31-9-15-6-16(15)10-31/h5,7-8,12,15-16,21H,3-4,6,9-11H2,1-2H3,(H2,25,28)(H,30,33)/t15?,16?,21-/m1/s1	UOJJXXFVJMLSSH-CPAJTMIGSA-N	423187	N-[(5R)-1-Amino-3-methyl-5H,6H,7H-cyclopenta[c]pyridin-5-yl]-1-[(2-{3-azabicyclo[3.1.0]hexan-3-yl}-4-methylpyrimidin-5-yl)methyl]-1H-pyrazole-4-carboxamide::US10501440, Example 17	Plasma kallikrein		 0.500								US Patent		10.7270/Q2QR50JS		aid1804038	US10501440	Frattini, S; Lingard, I; Hamprecht, DW; Bakker, RA; Eckhardt, M; Gollner, A; Hehn, JP; Langkopf, E; Wagner, H; Wellenzohn, B; Wiedenmayer, D	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=423187	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=423187&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			140932713	434148995							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
853849	Cc1cc2[C@@H](CCc2c(N)n1)NC(=O)c1cn(Cc2cnc(nc2C)N2CC3CC3C2)nn1	InChI=1S/C23H27N9O/c1-12-5-18-17(21(24)26-12)3-4-19(18)28-22(33)20-11-32(30-29-20)10-16-7-25-23(27-13(16)2)31-8-14-6-15(14)9-31/h5,7,11,14-15,19H,3-4,6,8-10H2,1-2H3,(H2,24,26)(H,28,33)/t14?,15?,19-/m1/s1	XDBBPZMNZIKLHM-JFIBYHEFSA-N	423188	N-[(5R)-1-Amino-3-methyl-5H,6H,7H-cyclopenta[c]pyridin-5-yl]-1-[(2-{3-azabicyclo[3.1.0]hexan-3-yl}-4-methylpyrimidin-5-yl)methyl]-1H-1,2,3-triazole-4-carboxamide::US10501440, Example 18	Plasma kallikrein		 0.500								US Patent		10.7270/Q2QR50JS		aid1804038	US10501440	Frattini, S; Lingard, I; Hamprecht, DW; Bakker, RA; Eckhardt, M; Gollner, A; Hehn, JP; Langkopf, E; Wagner, H; Wellenzohn, B; Wiedenmayer, D	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=423188	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=423188&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135362177	434148996							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51214668	CC(C)C[C@@H]1NC(=O)[C@H](C)NC(=O)[C@H](CC2CCN(CC2)C(N)=N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC1=O)C(O)=O	InChI=1S/C58H85N17O11S2/c1-31(2)24-41-51(80)72-44(27-36-28-65-39-15-9-8-14-37(36)39)53(82)73-45(56(85)86)30-88-87-29-38(59)55(84)75-21-11-17-46(75)54(83)67-33(4)47(76)68-40(16-10-20-64-57(60)61)49(78)70-43(25-34-12-6-5-7-13-34)52(81)71-42(50(79)66-32(3)48(77)69-41)26-35-18-22-74(23-19-35)58(62)63/h5-9,12-15,28,31-33,35,38,40-46,65H,10-11,16-27,29-30,59H2,1-4H3,(H3,62,63)(H,66,79)(H,67,83)(H,68,76)(H,69,77)(H,70,78)(H,71,81)(H,72,80)(H,73,82)(H,85,86)(H4,60,61,64)/t32-,33-,38-,40-,41-,42-,43-,44-,45-,46-/m0/s1	OHKHDWZCCRSLRV-GAHVENFSSA-N	50499238	CHEMBL3735263	Plasma kallikrein				 3.0						ChEMBL	10.1021/acs.jmedchem.5b01128	10.7270/Q2XK8JH7	26536069			Xu, P; Xu, M; Jiang, L; Yang, Q; Luo, Z; Dauter, Z; Huang, M; Andreasen, PA	Aarhus University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50499238	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50499238&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			127037264	433911139							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51214670	CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC2CCN(CC2)C(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC1=O)C(O)=O	InChI=1S/C54H77N13O16S2/c1-27(2)19-35-45(74)63-39(23-43(71)72)49(78)65-41(53(82)83)26-85-84-25-34(55)52(81)67-16-4-5-42(67)51(80)58-28(3)44(73)59-36(20-29-6-10-32(69)11-7-29)48(77)64-40(24-68)50(79)62-38(22-31-14-17-66(18-15-31)54(56)57)47(76)61-37(46(75)60-35)21-30-8-12-33(70)13-9-30/h6-13,27-28,31,34-42,68-70H,4-5,14-26,55H2,1-3H3,(H3,56,57)(H,58,80)(H,59,73)(H,60,75)(H,61,76)(H,62,79)(H,63,74)(H,64,77)(H,65,78)(H,71,72)(H,82,83)/t28-,34-,35-,36-,37-,38-,39-,40-,41-,42-/m0/s1	WRGPIGGAVZQKSB-ZSEJDYQNSA-N	50499240	CHEMBL3735080	Plasma kallikrein		 938								ChEMBL	10.1021/acs.jmedchem.5b01128	10.7270/Q2XK8JH7	26536069			Xu, P; Xu, M; Jiang, L; Yang, Q; Luo, Z; Dauter, Z; Huang, M; Andreasen, PA	Aarhus University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50499240	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50499240&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			127037469	433911141							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51214671	CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC2CCN(CC2)C(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC1=O)C(O)=O	InChI=1S/C54H77N13O16S2/c1-27(2)19-35-45(74)63-39(23-43(71)72)49(78)65-41(53(82)83)26-85-84-25-34(55)52(81)67-16-4-5-42(67)51(80)58-28(3)44(73)59-36(20-29-6-10-32(69)11-7-29)48(77)64-40(24-68)50(79)62-38(22-31-14-17-66(18-15-31)54(56)57)47(76)61-37(46(75)60-35)21-30-8-12-33(70)13-9-30/h6-13,27-28,31,34-42,68-70H,4-5,14-26,55H2,1-3H3,(H3,56,57)(H,58,80)(H,59,73)(H,60,75)(H,61,76)(H,62,79)(H,63,74)(H,64,77)(H,65,78)(H,71,72)(H,82,83)/t28-,34-,35-,36-,37-,38-,39-,40-,41-,42-/m0/s1	WRGPIGGAVZQKSB-ZSEJDYQNSA-N	50499240	CHEMBL3735080	Plasma kallikrein		 136								ChEMBL	10.1021/acs.jmedchem.5b01128	10.7270/Q2XK8JH7	26536069			Xu, P; Xu, M; Jiang, L; Yang, Q; Luo, Z; Dauter, Z; Huang, M; Andreasen, PA	Aarhus University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50499240	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50499240&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			127037469	433911141							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51214673	CC(C)C[C@@H]1NC(=O)[C@H](C)NC(=O)[C@H](CC2CCN(CC2)C(N)=N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC1=O)C(O)=O	InChI=1S/C58H85N17O11S2/c1-31(2)24-41-51(80)72-44(27-36-28-65-39-15-9-8-14-37(36)39)53(82)73-45(56(85)86)30-88-87-29-38(59)55(84)75-21-11-17-46(75)54(83)67-33(4)47(76)68-40(16-10-20-64-57(60)61)49(78)70-43(25-34-12-6-5-7-13-34)52(81)71-42(50(79)66-32(3)48(77)69-41)26-35-18-22-74(23-19-35)58(62)63/h5-9,12-15,28,31-33,35,38,40-46,65H,10-11,16-27,29-30,59H2,1-4H3,(H3,62,63)(H,66,79)(H,67,83)(H,68,76)(H,69,77)(H,70,78)(H,71,81)(H,72,80)(H,73,82)(H,85,86)(H4,60,61,64)/t32-,33-,38-,40-,41-,42-,43-,44-,45-,46-/m0/s1	OHKHDWZCCRSLRV-GAHVENFSSA-N	50499238	CHEMBL3735263	Plasma kallikrein		 14								ChEMBL	10.1021/acs.jmedchem.5b01128	10.7270/Q2XK8JH7	26536069			Xu, P; Xu, M; Jiang, L; Yang, Q; Luo, Z; Dauter, Z; Huang, M; Andreasen, PA	Aarhus University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50499238	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50499238&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			127037264	433911139							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51214686	CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC2CCN(CC2)C(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC1=O)C(O)=O	InChI=1S/C54H77N13O16S2/c1-27(2)19-35-45(74)63-39(23-43(71)72)49(78)65-41(53(82)83)26-85-84-25-34(55)52(81)67-16-4-5-42(67)51(80)58-28(3)44(73)59-36(20-29-6-10-32(69)11-7-29)48(77)64-40(24-68)50(79)62-38(22-31-14-17-66(18-15-31)54(56)57)47(76)61-37(46(75)60-35)21-30-8-12-33(70)13-9-30/h6-13,27-28,31,34-42,68-70H,4-5,14-26,55H2,1-3H3,(H3,56,57)(H,58,80)(H,59,73)(H,60,75)(H,61,76)(H,62,79)(H,63,74)(H,64,77)(H,65,78)(H,71,72)(H,82,83)/t28-,34-,35-,36-,37-,38-,39-,40-,41-,42-/m0/s1	WRGPIGGAVZQKSB-ZSEJDYQNSA-N	50499240	CHEMBL3735080	Plasma kallikrein		 907								ChEMBL	10.1021/acs.jmedchem.5b01128	10.7270/Q2XK8JH7	26536069			Xu, P; Xu, M; Jiang, L; Yang, Q; Luo, Z; Dauter, Z; Huang, M; Andreasen, PA	Aarhus University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50499240	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50499240&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			127037469	433911141							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51214687	CC(C)C[C@@H]1NC(=O)[C@H](C)NC(=O)[C@H](CC2CCN(CC2)C(N)=N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC1=O)C(O)=O	InChI=1S/C58H85N17O11S2/c1-31(2)24-41-51(80)72-44(27-36-28-65-39-15-9-8-14-37(36)39)53(82)73-45(56(85)86)30-88-87-29-38(59)55(84)75-21-11-17-46(75)54(83)67-33(4)47(76)68-40(16-10-20-64-57(60)61)49(78)70-43(25-34-12-6-5-7-13-34)52(81)71-42(50(79)66-32(3)48(77)69-41)26-35-18-22-74(23-19-35)58(62)63/h5-9,12-15,28,31-33,35,38,40-46,65H,10-11,16-27,29-30,59H2,1-4H3,(H3,62,63)(H,66,79)(H,67,83)(H,68,76)(H,69,77)(H,70,78)(H,71,81)(H,72,80)(H,73,82)(H,85,86)(H4,60,61,64)/t32-,33-,38-,40-,41-,42-,43-,44-,45-,46-/m0/s1	OHKHDWZCCRSLRV-GAHVENFSSA-N	50499238	CHEMBL3735263	Plasma kallikrein		 32								ChEMBL	10.1021/acs.jmedchem.5b01128	10.7270/Q2XK8JH7	26536069			Xu, P; Xu, M; Jiang, L; Yang, Q; Luo, Z; Dauter, Z; Huang, M; Andreasen, PA	Aarhus University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50499238	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50499238&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			127037264	433911139							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51214688	CC(C)C[C@@H]1NC(=O)[C@H](C)NC(=O)[C@H](CC2CCN(CC2)C(N)=N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC1=O)C(O)=O	InChI=1S/C58H85N17O11S2/c1-31(2)24-41-51(80)72-44(27-36-28-65-39-15-9-8-14-37(36)39)53(82)73-45(56(85)86)30-88-87-29-38(59)55(84)75-21-11-17-46(75)54(83)67-33(4)47(76)68-40(16-10-20-64-57(60)61)49(78)70-43(25-34-12-6-5-7-13-34)52(81)71-42(50(79)66-32(3)48(77)69-41)26-35-18-22-74(23-19-35)58(62)63/h5-9,12-15,28,31-33,35,38,40-46,65H,10-11,16-27,29-30,59H2,1-4H3,(H3,62,63)(H,66,79)(H,67,83)(H,68,76)(H,69,77)(H,70,78)(H,71,81)(H,72,80)(H,73,82)(H,85,86)(H4,60,61,64)/t32-,33-,38-,40-,41-,42-,43-,44-,45-,46-/m0/s1	OHKHDWZCCRSLRV-GAHVENFSSA-N	50499238	CHEMBL3735263	Plasma kallikrein		 166								ChEMBL	10.1021/acs.jmedchem.5b01128	10.7270/Q2XK8JH7	26536069			Xu, P; Xu, M; Jiang, L; Yang, Q; Luo, Z; Dauter, Z; Huang, M; Andreasen, PA	Aarhus University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50499238	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50499238&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			127037264	433911139							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51214689	CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC2CCN(CC2)C(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC1=O)C(O)=O	InChI=1S/C54H77N13O16S2/c1-27(2)19-35-45(74)63-39(23-43(71)72)49(78)65-41(53(82)83)26-85-84-25-34(55)52(81)67-16-4-5-42(67)51(80)58-28(3)44(73)59-36(20-29-6-10-32(69)11-7-29)48(77)64-40(24-68)50(79)62-38(22-31-14-17-66(18-15-31)54(56)57)47(76)61-37(46(75)60-35)21-30-8-12-33(70)13-9-30/h6-13,27-28,31,34-42,68-70H,4-5,14-26,55H2,1-3H3,(H3,56,57)(H,58,80)(H,59,73)(H,60,75)(H,61,76)(H,62,79)(H,63,74)(H,64,77)(H,65,78)(H,71,72)(H,82,83)/t28-,34-,35-,36-,37-,38-,39-,40-,41-,42-/m0/s1	WRGPIGGAVZQKSB-ZSEJDYQNSA-N	50499240	CHEMBL3735080	Plasma kallikrein				 737						ChEMBL	10.1021/acs.jmedchem.5b01128	10.7270/Q2XK8JH7	26536069			Xu, P; Xu, M; Jiang, L; Yang, Q; Luo, Z; Dauter, Z; Huang, M; Andreasen, PA	Aarhus University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50499240	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50499240&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			127037469	433911141							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51214690	CC(C)C[C@@H]1NC(=O)[C@H](C)NC(=O)[C@H](CC2CCN(CC2)C(N)=N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](N)CSSC[C@@H](NC(=O)[C@H](CCCCNC(C)=O)NC1=O)C(O)=O	InChI=1S/C55H89N17O12S2/c1-30(2)25-39-49(79)66-37(15-9-10-20-61-33(5)73)47(77)70-42(53(83)84)29-86-85-28-36(56)52(82)72-22-12-17-43(72)51(81)64-32(4)44(74)65-38(16-11-21-62-54(57)58)46(76)68-41(26-34-13-7-6-8-14-34)50(80)69-40(48(78)63-31(3)45(75)67-39)27-35-18-23-71(24-19-35)55(59)60/h6-8,13-14,30-32,35-43H,9-12,15-29,56H2,1-5H3,(H3,59,60)(H,61,73)(H,63,78)(H,64,81)(H,65,74)(H,66,79)(H,67,75)(H,68,76)(H,69,80)(H,70,77)(H,83,84)(H4,57,58,62)/t31-,32-,36-,37-,38-,39-,40-,41-,42+,43-/m0/s1	KERRERRJNCDROY-FPUIQZHASA-N	50499242	CHEMBL3736473	Plasma kallikrein		 64								ChEMBL	10.1021/acs.jmedchem.5b01128	10.7270/Q2XK8JH7	26536069			Xu, P; Xu, M; Jiang, L; Yang, Q; Luo, Z; Dauter, Z; Huang, M; Andreasen, PA	Aarhus University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50499242	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50499242&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			127035685	433911143							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51214692	CC(C)C[C@@H]1NC(=O)[C@H](C)NC(=O)[C@H](CC2CCN(CC2)C(N)=N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC1=O)C(O)=O	InChI=1S/C58H85N17O11S2/c1-31(2)24-41-51(80)72-44(27-36-28-65-39-15-9-8-14-37(36)39)53(82)73-45(56(85)86)30-88-87-29-38(59)55(84)75-21-11-17-46(75)54(83)67-33(4)47(76)68-40(16-10-20-64-57(60)61)49(78)70-43(25-34-12-6-5-7-13-34)52(81)71-42(50(79)66-32(3)48(77)69-41)26-35-18-22-74(23-19-35)58(62)63/h5-9,12-15,28,31-33,35,38,40-46,65H,10-11,16-27,29-30,59H2,1-4H3,(H3,62,63)(H,66,79)(H,67,83)(H,68,76)(H,69,77)(H,70,78)(H,71,81)(H,72,80)(H,73,82)(H,85,86)(H4,60,61,64)/t32-,33-,38-,40-,41-,42-,43-,44-,45-,46-/m0/s1	OHKHDWZCCRSLRV-GAHVENFSSA-N	50499238	CHEMBL3735263	Plasma kallikrein		 54								ChEMBL	10.1021/acs.jmedchem.5b01128	10.7270/Q2XK8JH7	26536069			Xu, P; Xu, M; Jiang, L; Yang, Q; Luo, Z; Dauter, Z; Huang, M; Andreasen, PA	Aarhus University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50499238	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50499238&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			127037264	433911139							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51214695	CC(C)C[C@@H]1NC(=O)[C@H](C)NC(=O)[C@H](CC2CCN(CC2)C(N)=N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](Cc2ccccc2)NC1=O)C(O)=O	InChI=1S/C59H91N17O11S2/c1-34(2)28-42-52(81)73-45(30-37-16-8-5-9-17-37)54(83)74-46(57(86)87)33-89-88-32-39(61)56(85)76-25-13-20-47(76)55(84)69-40(18-10-11-23-60)49(78)68-41(19-12-24-66-58(62)63)50(79)71-44(29-36-14-6-4-7-15-36)53(82)72-43(51(80)67-35(3)48(77)70-42)31-38-21-26-75(27-22-38)59(64)65/h4-9,14-17,34-35,38-47H,10-13,18-33,60-61H2,1-3H3,(H3,64,65)(H,67,80)(H,68,78)(H,69,84)(H,70,77)(H,71,79)(H,72,82)(H,73,81)(H,74,83)(H,86,87)(H4,62,63,66)/t35-,39-,40-,41-,42-,43-,44-,45-,46-,47-/m0/s1	LECDADCSAFKFQE-LEXUIDAJSA-N	50499237	CHEMBL3735217	Plasma kallikrein		 22								ChEMBL	10.1021/acs.jmedchem.5b01128	10.7270/Q2XK8JH7	26536069			Xu, P; Xu, M; Jiang, L; Yang, Q; Luo, Z; Dauter, Z; Huang, M; Andreasen, PA	Aarhus University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50499237	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50499237&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			127035672	433911138							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51214719	CC(C)C[C@@H]1NC(=O)[C@H](C)NC(=O)[C@H](CC2CCN(CC2)C(N)=N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](Cc2ccccc2)NC1=O)C(O)=O	InChI=1S/C56H84N16O11S2/c1-31(2)25-39-49(77)69-42(27-35-15-9-6-10-16-35)51(79)70-43(54(82)83)30-85-84-29-37(57)53(81)72-22-12-18-44(72)52(80)64-33(4)45(73)65-38(17-11-21-62-55(58)59)47(75)67-41(26-34-13-7-5-8-14-34)50(78)68-40(48(76)63-32(3)46(74)66-39)28-36-19-23-71(24-20-36)56(60)61/h5-10,13-16,31-33,36-44H,11-12,17-30,57H2,1-4H3,(H3,60,61)(H,63,76)(H,64,80)(H,65,73)(H,66,74)(H,67,75)(H,68,78)(H,69,77)(H,70,79)(H,82,83)(H4,58,59,62)/t32-,33-,37-,38-,39-,40-,41-,42-,43-,44-/m0/s1	DAZKRYLEGWSBDU-RSOQHMFVSA-N	50499241	CHEMBL3735513	Plasma kallikrein		 8.0								ChEMBL	10.1021/acs.jmedchem.5b01128	10.7270/Q2XK8JH7	26536069			Xu, P; Xu, M; Jiang, L; Yang, Q; Luo, Z; Dauter, Z; Huang, M; Andreasen, PA	Aarhus University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50499241	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50499241&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			127036086	433911142							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51214732	CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC1=O)C(O)=O	InChI=1S/C51H73N13O16S2/c1-25(2)18-33-43(72)61-36(21-40(68)69)46(75)63-38(50(79)80)24-82-81-23-31(52)49(78)64-17-5-7-39(64)48(77)56-26(3)41(70)58-34(19-27-8-12-29(66)13-9-27)45(74)62-37(22-65)47(76)57-32(6-4-16-55-51(53)54)42(71)60-35(44(73)59-33)20-28-10-14-30(67)15-11-28/h8-15,25-26,31-39,65-67H,4-7,16-24,52H2,1-3H3,(H,56,77)(H,57,76)(H,58,70)(H,59,73)(H,60,71)(H,61,72)(H,62,74)(H,63,75)(H,68,69)(H,79,80)(H4,53,54,55)/t26-,31-,32-,33-,34-,35-,36-,37-,38-,39-/m0/s1	RTBBZNOSANWPBI-ZPJKPQIISA-N	50499239	CHEMBL3734777	Plasma kallikrein				>1000000						ChEMBL	10.1021/acs.jmedchem.5b01128	10.7270/Q2XK8JH7	26536069			Xu, P; Xu, M; Jiang, L; Yang, Q; Luo, Z; Dauter, Z; Huang, M; Andreasen, PA	Aarhus University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50499239	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50499239&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			101862198	433911140							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51214733	CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC2CCN(CC2)C(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC1=O)C(O)=O	InChI=1S/C54H77N13O16S2/c1-27(2)19-35-45(74)63-39(23-43(71)72)49(78)65-41(53(82)83)26-85-84-25-34(55)52(81)67-16-4-5-42(67)51(80)58-28(3)44(73)59-36(20-29-6-10-32(69)11-7-29)48(77)64-40(24-68)50(79)62-38(22-31-14-17-66(18-15-31)54(56)57)47(76)61-37(46(75)60-35)21-30-8-12-33(70)13-9-30/h6-13,27-28,31,34-42,68-70H,4-5,14-26,55H2,1-3H3,(H3,56,57)(H,58,80)(H,59,73)(H,60,75)(H,61,76)(H,62,79)(H,63,74)(H,64,77)(H,65,78)(H,71,72)(H,82,83)/t28-,34-,35-,36-,37-,38-,39-,40-,41-,42-/m0/s1	WRGPIGGAVZQKSB-ZSEJDYQNSA-N	50499240	CHEMBL3735080	Plasma kallikrein		 1694								ChEMBL	10.1021/acs.jmedchem.5b01128	10.7270/Q2XK8JH7	26536069			Xu, P; Xu, M; Jiang, L; Yang, Q; Luo, Z; Dauter, Z; Huang, M; Andreasen, PA	Aarhus University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50499240	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50499240&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			127037469	433911141							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51214739	CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC2CCN(CC2)C(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC1=O)C(O)=O	InChI=1S/C54H77N13O16S2/c1-27(2)19-35-45(74)63-39(23-43(71)72)49(78)65-41(53(82)83)26-85-84-25-34(55)52(81)67-16-4-5-42(67)51(80)58-28(3)44(73)59-36(20-29-6-10-32(69)11-7-29)48(77)64-40(24-68)50(79)62-38(22-31-14-17-66(18-15-31)54(56)57)47(76)61-37(46(75)60-35)21-30-8-12-33(70)13-9-30/h6-13,27-28,31,34-42,68-70H,4-5,14-26,55H2,1-3H3,(H3,56,57)(H,58,80)(H,59,73)(H,60,75)(H,61,76)(H,62,79)(H,63,74)(H,64,77)(H,65,78)(H,71,72)(H,82,83)/t28-,34-,35-,36-,37-,38-,39-,40-,41-,42-/m0/s1	WRGPIGGAVZQKSB-ZSEJDYQNSA-N	50499240	CHEMBL3735080	Plasma kallikrein		 1580								ChEMBL	10.1021/acs.jmedchem.5b01128	10.7270/Q2XK8JH7	26536069			Xu, P; Xu, M; Jiang, L; Yang, Q; Luo, Z; Dauter, Z; Huang, M; Andreasen, PA	Aarhus University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50499240	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50499240&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			127037469	433911141							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51214740	CC(C)C[C@@H]1NC(=O)[C@H](C)NC(=O)[C@H](CC2CCN(CC2)C(N)=N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC1=O)C(O)=O	InChI=1S/C58H85N17O11S2/c1-31(2)24-41-51(80)72-44(27-36-28-65-39-15-9-8-14-37(36)39)53(82)73-45(56(85)86)30-88-87-29-38(59)55(84)75-21-11-17-46(75)54(83)67-33(4)47(76)68-40(16-10-20-64-57(60)61)49(78)70-43(25-34-12-6-5-7-13-34)52(81)71-42(50(79)66-32(3)48(77)69-41)26-35-18-22-74(23-19-35)58(62)63/h5-9,12-15,28,31-33,35,38,40-46,65H,10-11,16-27,29-30,59H2,1-4H3,(H3,62,63)(H,66,79)(H,67,83)(H,68,76)(H,69,77)(H,70,78)(H,71,81)(H,72,80)(H,73,82)(H,85,86)(H4,60,61,64)/t32-,33-,38-,40-,41-,42-,43-,44-,45-,46-/m0/s1	OHKHDWZCCRSLRV-GAHVENFSSA-N	50499238	CHEMBL3735263	Plasma kallikrein		 9.9								ChEMBL	10.1021/acs.jmedchem.5b01128	10.7270/Q2XK8JH7	26536069			Xu, P; Xu, M; Jiang, L; Yang, Q; Luo, Z; Dauter, Z; Huang, M; Andreasen, PA	Aarhus University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50499238	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50499238&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			127037264	433911139							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51214748	CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC1=O)C(O)=O	InChI=1S/C51H73N13O16S2/c1-25(2)18-33-43(72)61-36(21-40(68)69)46(75)63-38(50(79)80)24-82-81-23-31(52)49(78)64-17-5-7-39(64)48(77)56-26(3)41(70)58-34(19-27-8-12-29(66)13-9-27)45(74)62-37(22-65)47(76)57-32(6-4-16-55-51(53)54)42(71)60-35(44(73)59-33)20-28-10-14-30(67)15-11-28/h8-15,25-26,31-39,65-67H,4-7,16-24,52H2,1-3H3,(H,56,77)(H,57,76)(H,58,70)(H,59,73)(H,60,71)(H,61,72)(H,62,74)(H,63,75)(H,68,69)(H,79,80)(H4,53,54,55)/t26-,31-,32-,33-,34-,35-,36-,37-,38-,39-/m0/s1	RTBBZNOSANWPBI-ZPJKPQIISA-N	50499239	CHEMBL3734777	Plasma kallikrein		>1000000								ChEMBL	10.1021/acs.jmedchem.5b01128	10.7270/Q2XK8JH7	26536069			Xu, P; Xu, M; Jiang, L; Yang, Q; Luo, Z; Dauter, Z; Huang, M; Andreasen, PA	Aarhus University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50499239	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50499239&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			101862198	433911140							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51216445	CCCCNC(=O)c1ccn2c(NCc3ccc(NC(N)=N)cc3)cnc2c1	InChI=1S/C20H25N7O/c1-2-3-9-23-19(28)15-8-10-27-17(11-15)25-13-18(27)24-12-14-4-6-16(7-5-14)26-20(21)22/h4-8,10-11,13,24H,2-3,9,12H2,1H3,(H,23,28)(H4,21,22,26)	BEACCZKINFJRSI-UHFFFAOYSA-N	50499900	CHEMBL3740183	Plasma kallikrein			>100000							ChEMBL	10.1021/acs.jmedchem.5b01171	10.7270/Q241713M	26575094			Gladysz, R; Adriaenssens, Y; De Winter, H; Joossens, J; Lambeir, AM; Augustyns, K; Van der Veken, P	University of Antwerp (UA)	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50499900	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50499900&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			127041472	433911801							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51216459	NC(=N)c1ccc(\C=C2\N=C(OC2=O)c2ccccc2)cc1	InChI=1S/C17H13N3O2/c18-15(19)12-8-6-11(7-9-12)10-14-17(21)22-16(20-14)13-4-2-1-3-5-13/h1-10H,(H3,18,19)/b14-10+	JBHISGPWLXASFE-GXDHUFHOSA-N	50363655	CHEMBL1945236	Plasma kallikrein			 1340							ChEMBL	10.1021/acs.jmedchem.5b01171	10.7270/Q241713M	26575094			Gladysz, R; Adriaenssens, Y; De Winter, H; Joossens, J; Lambeir, AM; Augustyns, K; Van der Veken, P	University of Antwerp (UA)	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50363655	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50363655&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			16220264	136967717		CHEMBL1945236				ZINC06733270	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51216484	CCOC(=O)c1ccc(OC(=O)CCCCCNC(N)=N)cc1	InChI=1S/C16H23N3O4/c1-2-22-15(21)12-7-9-13(10-8-12)23-14(20)6-4-3-5-11-19-16(17)18/h7-10H,2-6,11H2,1H3,(H4,17,18,19)	YKGYIDJEEQRWQH-UHFFFAOYSA-N	50104435	4-(6-Guanidino-hexanoyloxy)-benzoic acid ethyl ester::CHEMBL87563	Plasma kallikrein			 1350							ChEMBL	10.1021/acs.jmedchem.5b01171	10.7270/Q241713M	26575094			Gladysz, R; Adriaenssens, Y; De Winter, H; Joossens, J; Lambeir, AM; Augustyns, K; Van der Veken, P	University of Antwerp (UA)	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50104435	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50104435&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			3447	104000374		CHEMBL87563				ZINC13118883	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896143	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C30H27F3N6O/c31-30(32,33)27-15-26(39(38-27)25-9-2-5-21(13-25)17-35)29(40)37-24-8-3-7-23(14-24)28(36-18-19-10-11-19)22-6-1-4-20(12-22)16-34/h1-9,12-15,19,28,36H,10-11,17-18,35H2,(H,37,40)	VQJJJCIJWBDLSJ-UHFFFAOYSA-N	416879	1-(3-(aminomethyl)phenyl)-N-(3-((3-cyanophenyl)(cyclopropylmethyl amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 152d::US10633345, Compound 152d::US10689346, Compound 152d::US11203574, Compound 152d::US11230530, Compound 152d::US11685721, Compound 152d	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416879	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416879&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356166	433916792							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896144	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(N1CCC(O)C1)c1ccccc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-16-25(37(35-26)23-11-4-6-19(14-23)17-33)28(39)34-22-10-5-9-21(15-22)27(20-7-2-1-3-8-20)36-13-12-24(38)18-36/h1-11,14-16,24,27,38H,12-13,17-18,33H2,(H,34,39)	FPAZEZULJGBLCM-UHFFFAOYSA-N	416880	1-(3-(aminomethyl)phenyl)-N-(3-((3-hydroxypyrrolidin-1-yl)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 170b::US10633345, Compound 170b::US10689346, Compound 170b::US11192861, Compound 170b::US11230530, Compound 170b::US11685721, Compound 170b	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416880	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416880&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355902	433916793							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896145	CSCCNC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C28H28F3N5OS/c1-38-14-13-33-26(20-8-3-2-4-9-20)21-10-6-11-22(16-21)34-27(37)24-17-25(28(29,30)31)35-36(24)23-12-5-7-19(15-23)18-32/h2-12,15-17,26,33H,13-14,18,32H2,1H3,(H,34,37)	GMRUHWVMBSEBQV-UHFFFAOYSA-N	416881	1-(3-(aminomethyl)phenyl)-N-(3-(((2-(methylthio)ethyl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 190b::US10633345, Compound 190b::US10689346, Compound 190b::US11203574, Compound 190b::US11230530, Compound 190b::US11685721, Compound 190b	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416881	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416881&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665913	433916794							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896146	COc1ccc(C(NCC2CC2)c2cccc(NC(=O)c3cc(nn3-c3cccc(CN)c3)C(F)(F)F)c2)c2ccccc12	InChI=1S/C34H32F3N5O2/c1-44-30-15-14-28(26-10-2-3-11-27(26)30)32(39-20-21-12-13-21)23-7-5-8-24(17-23)40-33(43)29-18-31(34(35,36)37)41-42(29)25-9-4-6-22(16-25)19-38/h2-11,14-18,21,32,39H,12-13,19-20,38H2,1H3,(H,40,43)	YOBACLFKAGKOLX-UHFFFAOYSA-N	416882	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(4-methoxynaphthalen-1-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 154e::US10633345, Compound 154e::US10689346, Compound 154e::US11203574, Compound 154e::US11230530, Compound 154e::US11685721, Compound 154e	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416882	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416882&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665632	433916795							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896147	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NC1CCCCCC1)c1ccccc1)C(F)(F)F	InChI=1S/C32H34F3N5O/c33-32(34,35)29-20-28(40(39-29)27-17-8-10-22(18-27)21-36)31(41)38-26-16-9-13-24(19-26)30(23-11-4-3-5-12-23)37-25-14-6-1-2-7-15-25/h3-5,8-13,16-20,25,30,37H,1-2,6-7,14-15,21,36H2,(H,38,41)	DQWBWUNYPIEFTF-UHFFFAOYSA-N	416883	1-(3-(aminomethyl)phenyl)-N-(3-((cycloheptylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 171b::US10633345, Compound 171b::US10689346, Compound 171b::US11203574, Compound 171b::US11230530, Compound 171b::US11685721, Compound 171b	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416883	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416883&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356134	433916796							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896148	Cc1ccccc1C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O/c1-19-6-2-3-11-25(19)28(35-18-20-12-13-20)22-8-5-9-23(15-22)36-29(39)26-16-27(30(31,32)33)37-38(26)24-10-4-7-21(14-24)17-34/h2-11,14-16,20,28,35H,12-13,17-18,34H2,1H3,(H,36,39)	NQOSRSVLDYDVDI-UHFFFAOYSA-N	416884	1-(3-(Aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(o-tolyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 193f::US10633345, Compound 193f::US10689346, Compound 193f::US11203574, Compound 193f::US11230530, Compound 193f::US11685721, Compound 193f	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416884	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416884&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355753	433916797							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896149	NCc1cccc(c1)C(NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F4N6O/c31-24-10-9-22(28(37-17-18-7-8-18)21-5-1-3-19(11-21)15-35)13-25(24)38-29(41)26-14-27(30(32,33)34)39-40(26)23-6-2-4-20(12-23)16-36/h1-6,9-14,18,28,37H,7-8,15-17,35-36H2,(H,38,41)	PIDHZVXEDSCGNA-UHFFFAOYSA-N	416885	1-(3-(aminomethyl)phenyl)-N-(5-((3-(aminomethyl)phenyl)(cyclopropylmethylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 155c::US10633345, Compound 155c::US10689346, Compound 155c::US11203574, Compound 155c::US11230530, Compound 155c::US11685721, Compound 155c	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416885	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416885&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355611	433916798							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896150	CCCCCNC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H32F3N5O/c1-2-3-7-16-35-28(22-11-5-4-6-12-22)23-13-9-14-24(18-23)36-29(39)26-19-27(30(31,32)33)37-38(26)25-15-8-10-21(17-25)20-34/h4-6,8-15,17-19,28,35H,2-3,7,16,20,34H2,1H3,(H,36,39)	LIINXFZWPJSNHF-UHFFFAOYSA-N	416886	1-(3-(Aminomethyl)phenyl)-N-(3-((pentylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 172b::US10633345, Compound 172b::US10689346, Compound 172b::US11203574, Compound 172b::US11230530, Compound 172b::US11685721, Compound 172b	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416886	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416886&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355915	433916799							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896151	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCCCO)c1ccccc1)C(F)(F)F	InChI=1S/C28H28F3N5O2/c29-28(30,31)25-17-24(36(35-25)23-12-4-7-19(15-23)18-32)27(38)34-22-11-5-10-21(16-22)26(33-13-6-14-37)20-8-2-1-3-9-20/h1-5,7-12,15-17,26,33,37H,6,13-14,18,32H2,(H,34,38)	YSEURYDLGGVADI-UHFFFAOYSA-N	416887	1-(3-(Aminomethyl)phenyl)-N-(3-(((3-hydroxypropyl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 191b::US10633345, Compound 191b::US10689346, Compound 191b::US11203574, Compound 191b::US11230530, Compound 191b::US11685721, Compound 191b	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416887	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416887&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665847	433916800							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896152	COC(CCC1CC1)(c1cccnc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O2/c1-40-29(13-12-20-10-11-20,23-7-4-14-35-19-23)22-6-3-8-24(16-22)36-28(39)26-17-27(30(31,32)33)37-38(26)25-9-2-5-21(15-25)18-34/h2-9,14-17,19-20H,10-13,18,34H2,1H3,(H,36,39)	HEQLXMARFGMGBQ-UHFFFAOYSA-N	416888	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-methoxy-1-(pyridin-3-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 156c::US10633345, Compound 156c::US10689346, Compound 156c::US11203574, Compound 156c::US11230530, Compound 156c::US11685721, Compound 156c	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416888	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416888&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355759	433916801							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896153	CC(CO)NC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C28H28F3N5O2/c1-18(17-37)33-26(20-8-3-2-4-9-20)21-10-6-11-22(14-21)34-27(38)24-15-25(28(29,30)31)35-36(24)23-12-5-7-19(13-23)16-32/h2-15,18,26,33,37H,16-17,32H2,1H3,(H,34,38)	HGDYIKLNDBPRGN-UHFFFAOYSA-N	416889	1-(3-(aminomethyl)phenyl)-N-(3-(((1-hydroxypropan-2-yl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 173b::US10633345, Compound 173b::US10689346, Compound 173b::US11203574, Compound 173b::US11230530, Compound 173b::US11685721, Compound 173b	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416889	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416889&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355997	433916802							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896154	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc(F)c1)C(F)(F)F	InChI=1S/C29H27F4N5O/c30-22-7-2-5-20(13-22)27(35-17-18-10-11-18)21-6-3-8-23(14-21)36-28(39)25-15-26(29(31,32)33)37-38(25)24-9-1-4-19(12-24)16-34/h1-9,12-15,18,27,35H,10-11,16-17,34H2,(H,36,39)	FVMNYLZQOFMPFE-UHFFFAOYSA-N	416890	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(3-fluorophenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 195f::US10633345, Compound 195f::US10689346, Compound 195f::US11203574, Compound 195f::US11230530, Compound 195f::US11685721, Compound 195f	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416890	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416890&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665561	433916803							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896155	CN(C(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1)C1CC1	InChI=1S/C30H26F4N6O/c1-39(22-9-10-22)28(20-6-2-4-18(12-20)16-35)21-8-11-24(31)25(14-21)37-29(41)26-15-27(30(32,33)34)38-40(26)23-7-3-5-19(13-23)17-36/h2-8,11-15,22,28H,9-10,17,36H2,1H3,(H,37,41)	LONUELZOBAIWEW-UHFFFAOYSA-N	439471	US10633345, Compound 54e::US10633345, Compound 70a::US10633345, Compound 70b::US10689346, Compound 70a::US11203574, Compound 70b::US11230530, Compound 70b	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439471	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439471&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355805	439661023							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896156	CC(C)(CO)NC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C29H30F3N5O2/c1-28(2,18-38)35-26(20-9-4-3-5-10-20)21-11-7-12-22(15-21)34-27(39)24-16-25(29(30,31)32)36-37(24)23-13-6-8-19(14-23)17-33/h3-16,26,35,38H,17-18,33H2,1-2H3,(H,34,39)	JPSBLISQAZCRFK-UHFFFAOYSA-N	416892	1-(3-(aminomethyl)phenyl)-N-(3-(((1-hydroxy-2-methylpropan-2-yl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 174b::US10633345, Compound 174b::US10689346, Compound 174b::US11203574, Compound 174b::US11230530, Compound 174b::US11685721, Compound 174b	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416892	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416892&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665949	433916805							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896157	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(F)cc1F)C(F)(F)F	InChI=1S/C29H26F5N5O/c30-20-9-10-23(24(31)13-20)27(36-16-17-7-8-17)19-4-2-5-21(12-19)37-28(40)25-14-26(29(32,33)34)38-39(25)22-6-1-3-18(11-22)15-35/h1-6,9-14,17,27,36H,7-8,15-16,35H2,(H,37,40)	QIBXOBBXVAEMNW-UHFFFAOYSA-N	416893	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2,4-difluorophenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 196f::US10633345, Compound 196f::US10689346, Compound 196f::US11203574, Compound 196f::US11230530, Compound 196f::US11685721, Compound 196f	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416893	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416893&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665453	433916806							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896158	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C30H25F4N5O2/c31-24-11-10-22(28(41-17-19-4-5-19)21-8-6-18(15-35)7-9-21)13-25(24)37-29(40)26-14-27(30(32,33)34)38-39(26)23-3-1-2-20(12-23)16-36/h1-3,6-14,19,28H,4-5,16-17,36H2,(H,37,40)	WXFHQCUXOOXGLO-UHFFFAOYSA-N	416894	1-(3-(aminomethyl)phenyl)-N-(5-((4-cyanophenyl)(cyclopropylmethoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 55b::US10633345, Compound 73b::US10689346, Compound 55b::US11203574, Compound 73b::US11230530, Compound 73b::US11685721, Compound 73b	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416894	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416894&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665569	433916807							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896159	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CCCO1)c1ccccc1)C(F)(F)F	InChI=1S/C30H30F3N5O2/c31-30(32,33)27-17-26(38(37-27)24-12-4-7-20(15-24)18-34)29(39)36-23-11-5-10-22(16-23)28(21-8-2-1-3-9-21)35-19-25-13-6-14-40-25/h1-5,7-12,15-17,25,28,35H,6,13-14,18-19,34H2,(H,36,39)	SIOCTSAXUSNOCO-UHFFFAOYSA-N	416895	1-(3-(aminomethyl)phenyl)-N-(3-(phenyl(((tetrahydrofuran-2-yl)methyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 175b::US10633345, Compound 175b::US10689346, Compound 175b::US11203574, Compound 175b::US11230530, Compound 175b::US11685721, Compound 175b	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416895	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416895&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355976	433916808							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896160	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cc(F)ccc1F)C(F)(F)F	InChI=1S/C29H26F5N5O/c30-20-9-10-24(31)23(13-20)27(36-16-17-7-8-17)19-4-2-5-21(12-19)37-28(40)25-14-26(29(32,33)34)38-39(25)22-6-1-3-18(11-22)15-35/h1-6,9-14,17,27,36H,7-8,15-16,35H2,(H,37,40)	DGRITJGAWATINU-UHFFFAOYSA-N	416896	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2,5-difluorophenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 197f::US10633345, Compound 197f::US10689346, Compound 197f::US11203574, Compound 197f::US11230530, Compound 197f::US11685721, Compound 197f	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416896	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416896&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665599	433916809							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896161	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-9-8-20(28(40,11-10-18-6-7-18)21-4-2-12-35-17-21)14-24(23)36-27(39)25-15-26(29(31,32)33)37-38(25)22-5-1-3-19(13-22)16-34/h1-5,8-9,12-15,17-18,40H,6-7,10-11,16,34H2,(H,36,39)	VCHFZCHUEHQXSZ-UHFFFAOYSA-N	416897	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 58c::US10633345, Compound 67b::US10689346, Compound 67b::US11203574, Compound 67b::US11230530, Compound 67b::US11685721, Compound 67b	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416897	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416897&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355889	433916810							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896162	CC(C)CCNC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H32F3N5O/c1-20(2)14-15-35-28(22-9-4-3-5-10-22)23-11-7-12-24(17-23)36-29(39)26-18-27(30(31,32)33)37-38(26)25-13-6-8-21(16-25)19-34/h3-13,16-18,20,28,35H,14-15,19,34H2,1-2H3,(H,36,39)	WPCVSFNABLNPTN-UHFFFAOYSA-N	416898	1-(3-(aminomethyl)phenyl)-N-(3-((isopentylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 176b::US10633345, Compound 176b::US10689346, Compound 176b::US11203574, Compound 176b::US11230530, Compound 176b::US11685721, Compound 176b	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416898	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416898&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665776	433916811							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896163	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1c(F)cccc1F)C(F)(F)F	InChI=1S/C29H26F5N5O/c30-22-8-3-9-23(31)26(22)27(36-16-17-10-11-17)19-5-2-6-20(13-19)37-28(40)24-14-25(29(32,33)34)38-39(24)21-7-1-4-18(12-21)15-35/h1-9,12-14,17,27,36H,10-11,15-16,35H2,(H,37,40)	OHXCNQRJQHLAER-UHFFFAOYSA-N	416899	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2,6-difluorophenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 198f::US10633345, Compound 198f::US10689346, Compound 198f::US11203574, Compound 198f::US11230530, Compound 198f::US11685721, Compound 198f	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416899	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416899&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665643	433916812							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896164	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C30H25F4N5O2/c31-24-10-9-22(28(41-17-18-7-8-18)21-5-1-3-19(11-21)15-35)13-25(24)37-29(40)26-14-27(30(32,33)34)38-39(26)23-6-2-4-20(12-23)16-36/h1-6,9-14,18,28H,7-8,16-17,36H2,(H,37,40)	LSXFYXGKZDVRTL-UHFFFAOYSA-N	416900	1-(3-(aminomethyl)phenyl)-N-(5-((3-cyanophenyl)(cyclopropyl-methoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 56c::US10633345, Compound 72d::US10689346, Compound 56c::US11203574, Compound 72d::US11230530, Compound 72d::US11685721, Compound 72d	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416900	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416900&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356211	433916813							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896165	CCC(C)CNC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H32F3N5O/c1-3-20(2)19-35-28(22-10-5-4-6-11-22)23-12-8-13-24(16-23)36-29(39)26-17-27(30(31,32)33)37-38(26)25-14-7-9-21(15-25)18-34/h4-17,20,28,35H,3,18-19,34H2,1-2H3,(H,36,39)	ZCSNRDNUIRVYLS-UHFFFAOYSA-N	416901	1-(3-(Aminomethyl)phenyl)-N-(3-(((2-methylbutyl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 177b::US10633345, Compound 177b::US10689346, Compound 177b::US11203574, Compound 177b::US11230530, Compound 177b::US11685721, Compound 177b	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416901	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416901&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665478	433916814							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896166	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1Cl)C(F)(F)F	InChI=1S/C29H27ClF3N5O/c30-24-10-2-1-9-23(24)27(35-17-18-11-12-18)20-6-4-7-21(14-20)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-3-5-19(13-22)16-34/h1-10,13-15,18,27,35H,11-12,16-17,34H2,(H,36,39)	UQMCUIGBQDUSLW-UHFFFAOYSA-N	416902	1-(3-(aminomethyl)phenyl)-N-(3-((2-chlorophenyl)((cyclopropylmethyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 194f::US10329260, Compound 199f::US10633345, Compound 199f::US10689346, Compound 199f::US11203574, Compound 199f::US11230530, Compound 199f::US11685721, Compound 199f	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416902	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416902&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356220	433916815							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896167	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H28F4N4O2/c31-24-12-11-22(29(40,14-13-19-9-10-19)21-6-2-1-3-7-21)16-25(24)36-28(39)26-17-27(30(32,33)34)37-38(26)23-8-4-5-20(15-23)18-35/h1-8,11-12,15-17,19,40H,9-10,13-14,18,35H2,(H,36,39)	NIWMWYNGSALJGG-UHFFFAOYSA-N	416903	Racemic 1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 68c::US10633345, Compound 68e::US10689346, Compound 68c::US11203574, Compound 68e::US11230530, Compound 68e::US11685721, Compound 68e	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416903	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416903&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355758	433916816							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896168	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(N(CCO)CCO)c1ccccc1)C(F)(F)F	InChI=1S/C29H30F3N5O3/c30-29(31,32)26-18-25(37(35-26)24-11-4-6-20(16-24)19-33)28(40)34-23-10-5-9-22(17-23)27(21-7-2-1-3-8-21)36(12-14-38)13-15-39/h1-11,16-18,27,38-39H,12-15,19,33H2,(H,34,40)	HFRFNKSEVVNXFK-UHFFFAOYSA-N	416904	1-(3-(aminomethyl)phenyl)-N-(3-((bis(2-hydroxyethyl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 178b::US10633345, Compound 178b::US10689346, Compound 178b::US11203574, Compound 178b::US11230530, Compound 178b::US11685721, Compound 178b	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416904	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416904&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355913	433916817							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896169	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1Cl)C(F)(F)F	InChI=1S/C29H27ClF3N5O/c30-24-10-2-1-9-23(24)27(35-17-18-11-12-18)20-6-4-7-21(14-20)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-3-5-19(13-22)16-34/h1-10,13-15,18,27,35H,11-12,16-17,34H2,(H,36,39)	UQMCUIGBQDUSLW-UHFFFAOYSA-N	416902	1-(3-(aminomethyl)phenyl)-N-(3-((2-chlorophenyl)((cyclopropylmethyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 194f::US10329260, Compound 199f::US10633345, Compound 199f::US10689346, Compound 199f::US11203574, Compound 199f::US11230530, Compound 199f::US11685721, Compound 199f	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416902	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416902&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356220	433916815							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896170	COc1ccc2ccccc2c1C(NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H31F4N5O2/c1-45-29-14-12-22-6-2-3-8-25(22)31(29)32(40-19-20-9-10-20)23-11-13-26(35)27(16-23)41-33(44)28-17-30(34(36,37)38)42-43(28)24-7-4-5-21(15-24)18-39/h2-8,11-17,20,32,40H,9-10,18-19,39H2,1H3,(H,41,44)	AYMFYNZEWAELBE-UHFFFAOYSA-N	416906	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(2-methoxynaphthalen-1-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide dihydrochloride::US10329260, Compound 61e::US10633345, Compound 63b::US10689346, Compound 61e::US11203574, Compound 63b::US11230530, Compound 63b::US11685721, Compound 63b	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416906	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416906&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355591	433916818							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896171	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCc1cccnc1)c1ccccc1)C(F)(F)F	InChI=1S/C31H27F3N6O/c32-31(33,34)28-17-27(40(39-28)26-13-4-7-21(15-26)18-35)30(41)38-25-12-5-11-24(16-25)29(23-9-2-1-3-10-23)37-20-22-8-6-14-36-19-22/h1-17,19,29,37H,18,20,35H2,(H,38,41)	HIJVXEVWORHKBX-UHFFFAOYSA-N	416907	1-(3-(Aminomethyl)phenyl)-N-(3-(phenyl((pyridin-3-ylmethyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 179b::US10633345, Compound 179b::US10689346, Compound 179b::US11203574, Compound 179b::US11230530, Compound 179b::US11685721, Compound 179b	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416907	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416907&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665526	433916819							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896172	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(Cl)cc1Cl)C(F)(F)F	InChI=1S/C29H26Cl2F3N5O/c30-20-9-10-23(24(31)13-20)27(36-16-17-7-8-17)19-4-2-5-21(12-19)37-28(40)25-14-26(29(32,33)34)38-39(25)22-6-1-3-18(11-22)15-35/h1-6,9-14,17,27,36H,7-8,15-16,35H2,(H,37,40)	CXLXHJIZVQBZJV-UHFFFAOYSA-N	416908	1-(3-(aminomethyl)phenyl)-N-(3-((2,4-dichlorophenyl)((cyclopropylmethyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 200f::US10633345, Compound 200f::US10689346, Compound 200f::US11203574, Compound 200f::US11230530, Compound 200f::US11685721, Compound 200f	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416908	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416908&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126688969	433916820							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896173	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-10-9-20(28(40,12-11-18-7-8-18)25-6-1-2-13-35-25)15-23(22)36-27(39)24-16-26(29(31,32)33)37-38(24)21-5-3-4-19(14-21)17-34/h1-6,9-10,13-16,18,40H,7-8,11-12,17,34H2,(H,36,39)	XXMBQXWQIGCREG-UHFFFAOYSA-N	416909	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 59c::US10633345, Compound 69b::US10689346, Compound 59c::US11203574, Compound 69b::US11230530, Compound 69b::US11685721, Compound 69b	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416909	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416909&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356067	433916821							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896174	CCCCNC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C29H30F3N5O/c1-2-3-15-34-27(21-10-5-4-6-11-21)22-12-8-13-23(17-22)35-28(38)25-18-26(29(30,31)32)36-37(25)24-14-7-9-20(16-24)19-33/h4-14,16-18,27,34H,2-3,15,19,33H2,1H3,(H,35,38)	IJFOMNKWJBCMSK-UHFFFAOYSA-N	416910	1-(3-(Aminomethyl)phenyl)-N-(3-((butylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 180b::US10633345, Compound 180b::US10689346, Compound 180b::US11203574, Compound 180b::US11230530, Compound 180b::US11685721, Compound 180b	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416910	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416910&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665986	433916822							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896175	Cc1ccc(C(NCCC2CC2)c2cccc(NC(=O)c3cc(nn3-c3cccc(CN)c3)C(F)(F)F)c2)c(C)c1	InChI=1S/C32H34F3N5O/c1-20-9-12-27(21(2)15-20)30(37-14-13-22-10-11-22)24-6-4-7-25(17-24)38-31(41)28-18-29(32(33,34)35)39-40(28)26-8-3-5-23(16-26)19-36/h3-9,12,15-18,22,30,37H,10-11,13-14,19,36H2,1-2H3,(H,38,41)	YLZKZSSJTOEPKE-UHFFFAOYSA-N	439493	US10633345, Compound 201f	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439493	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439493&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137355381	439661045							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896176	Cc1ccc(C)c(c1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C31H32F3N5O/c1-19-9-10-20(2)26(13-19)29(36-18-21-11-12-21)23-6-4-7-24(15-23)37-30(40)27-16-28(31(32,33)34)38-39(27)25-8-3-5-22(14-25)17-35/h3-10,13-16,21,29,36H,11-12,17-18,35H2,1-2H3,(H,37,40)	NFGQIHGOUUFZHN-UHFFFAOYSA-N	416912	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2,5-dimethylphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 202f::US10633345, Compound 202f::US10689346, Compound 202f::US11203574, Compound 202f::US11230530, Compound 202f::US11685721, Compound 202f	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416912	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416912&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665510	433916824							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896177	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F3N4O2/c30-29(31,32)26-16-25(36(35-26)24-11-4-6-20(14-24)17-33)28(37)34-23-10-5-9-22(15-23)27(38-18-19-12-13-19)21-7-2-1-3-8-21/h1-11,14-16,19,27H,12-13,17-18,33H2,(H,34,37)	PEZVPVUPSJXZCH-UHFFFAOYSA-N	416775	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18k::US10633345, Compound 74a::US10689346, Compound 165e::US11203574, Compound 165e::US11230530, Compound 165e::US11685721, Compound 18k	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416775	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416775&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			91884591	433916689							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896178	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F4N5O/c30-23-12-11-21(27(35-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27,35H,9-10,16-17,34H2,(H,36,39)	MCLZOCFEIKBMBA-UHFFFAOYSA-N	416773	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 38d::US10633345, Compound 38d::US10689346, Compound 42a::US11203574, Compound 42a::US11230530, Compound 42a::US11685721, Compound 38d	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416773	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416773&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356124	433916687							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896179	CC(C)(C)c1ccc(cc1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C33H36F3N5O/c1-32(2,3)25-14-12-23(13-15-25)30(38-20-21-10-11-21)24-7-5-8-26(17-24)39-31(42)28-18-29(33(34,35)36)40-41(28)27-9-4-6-22(16-27)19-37/h4-9,12-18,21,30,38H,10-11,19-20,37H2,1-3H3,(H,39,42)	OVDVNIYCGDTOJR-UHFFFAOYSA-N	416915	1-(3-(aminomethyl)phenyl)-N-(3-((4-(tert-butyl)phenyl)((cyclopropylmethyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 203f::US10633345, Compound 203f::US10689346, Compound 203f::US11203574, Compound 203f::US11230530, Compound 203f::US11685721, Compound 203f	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416915	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416915&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665458	433916827							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896180	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F3N4O2/c30-29(31,32)26-16-25(36(35-26)24-11-4-6-20(14-24)17-33)28(37)34-23-10-5-9-22(15-23)27(38-18-19-12-13-19)21-7-2-1-3-8-21/h1-11,14-16,19,27H,12-13,17-18,33H2,(H,34,37)	PEZVPVUPSJXZCH-UHFFFAOYSA-N	416775	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18k::US10633345, Compound 74a::US10689346, Compound 165e::US11203574, Compound 165e::US11230530, Compound 165e::US11685721, Compound 18k	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416775	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416775&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			91884591	433916689							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896181	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F4N5O/c30-23-12-11-21(27(35-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27,35H,9-10,16-17,34H2,(H,36,39)	MCLZOCFEIKBMBA-UHFFFAOYSA-N	416773	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 38d::US10633345, Compound 38d::US10689346, Compound 42a::US11203574, Compound 42a::US11230530, Compound 42a::US11685721, Compound 38d	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416773	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416773&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356124	433916687							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896182	OC(CCC1CC1)(c1ccc(F)c(NC(=O)c2cc(nn2-c2ccc(Cl)cc2)C(F)(F)F)c1)c1ccccn1	InChI=1S/C28H23ClF4N4O2/c29-19-7-9-20(10-8-19)37-23(16-25(36-37)28(31,32)33)26(38)35-22-15-18(6-11-21(22)30)27(39,13-12-17-4-5-17)24-3-1-2-14-34-24/h1-3,6-11,14-17,39H,4-5,12-13H2,(H,35,38)	QWPFRWIQIFPXCC-UHFFFAOYSA-N	416918	1-(4-chlorophenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 157a::US10633345, Compound 157a::US10689346, Compound 157a::US11203574, Compound 157a::US11230530, Compound 157a::US11685721, Compound 157a	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416918	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416918&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665679	433916830							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896183	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(N)cc1)C(F)(F)F	InChI=1S/C29H29F3N6O/c30-29(31,32)26-15-25(38(37-26)24-6-1-3-19(13-24)16-33)28(39)36-23-5-2-4-21(14-23)27(35-17-18-7-8-18)20-9-11-22(34)12-10-20/h1-6,9-15,18,27,35H,7-8,16-17,33-34H2,(H,36,39)	XDCYYWMSVYTRMZ-UHFFFAOYSA-N	416843	1-(3-(aminomethyl)phenyl)-N-(3-((4-aminophenyl)(cyclopropylmethyl-amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 50f::US10633345, Compound 50f::US10689346, Compound 50h::US11203574, Compound 50h::US11230530, Compound 50h::US11685721, Compound 50f	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416843	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416843&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355587	433916756							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896184	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-9-8-20(28(40,11-10-18-6-7-18)21-4-2-12-35-17-21)14-24(23)36-27(39)25-15-26(29(31,32)33)37-38(25)22-5-1-3-19(13-22)16-34/h1-5,8-9,12-15,17-18,40H,6-7,10-11,16,34H2,(H,36,39)	VCHFZCHUEHQXSZ-UHFFFAOYSA-N	416897	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 58c::US10633345, Compound 67b::US10689346, Compound 67b::US11203574, Compound 67b::US11230530, Compound 67b::US11685721, Compound 67b	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416897	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416897&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355889	433916810							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896185	OC(CCC1CC1)(c1ccc(F)c(NC(=O)c2cc(nn2-c2ccc3cc(Cl)ccc3c2)C(F)(F)F)c1)c1ccccn1	InChI=1S/C32H25ClF4N4O2/c33-23-9-6-21-16-24(10-7-20(21)15-23)41-27(18-29(40-41)32(35,36)37)30(42)39-26-17-22(8-11-25(26)34)31(43,13-12-19-4-5-19)28-3-1-2-14-38-28/h1-3,6-11,14-19,43H,4-5,12-13H2,(H,39,42)	XTIXOVGIMHWYOB-UHFFFAOYSA-N	416921	1-(6-chloronaphthalen-2-yl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 158a::US10633345, Compound 158a::US10689346, Compound 158a::US11203574, Compound 158a::US11230530, Compound 158a::US11685721, Compound 158a	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416921	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416921&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355937	433916833							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896186	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(N)cc1)C(F)(F)F	InChI=1S/C29H29F3N6O/c30-29(31,32)26-15-25(38(37-26)24-6-1-3-19(13-24)16-33)28(39)36-23-5-2-4-21(14-23)27(35-17-18-7-8-18)20-9-11-22(34)12-10-20/h1-6,9-15,18,27,35H,7-8,16-17,33-34H2,(H,36,39)	XDCYYWMSVYTRMZ-UHFFFAOYSA-N	416843	1-(3-(aminomethyl)phenyl)-N-(3-((4-aminophenyl)(cyclopropylmethyl-amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 50f::US10633345, Compound 50f::US10689346, Compound 50h::US11203574, Compound 50h::US11230530, Compound 50h::US11685721, Compound 50f	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416843	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416843&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355587	433916756							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896187	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-9-8-20(28(40,11-10-18-6-7-18)21-4-2-12-35-17-21)14-24(23)36-27(39)25-15-26(29(31,32)33)37-38(25)22-5-1-3-19(13-22)16-34/h1-5,8-9,12-15,17-18,40H,6-7,10-11,16,34H2,(H,36,39)	VCHFZCHUEHQXSZ-UHFFFAOYSA-N	416897	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 58c::US10633345, Compound 67b::US10689346, Compound 67b::US11203574, Compound 67b::US11230530, Compound 67b::US11685721, Compound 67b	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416897	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416897&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355889	433916810							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896188	OC(CCC1CC1)(c1ccc(F)c(NC(=O)c2cc(nn2-c2ccc(Cl)cn2)C(F)(F)F)c1)c1ccccn1	InChI=1S/C27H22ClF4N5O2/c28-18-7-9-24(34-15-18)37-21(14-23(36-37)27(30,31)32)25(38)35-20-13-17(6-8-19(20)29)26(39,11-10-16-4-5-16)22-3-1-2-12-33-22/h1-3,6-9,12-16,39H,4-5,10-11H2,(H,35,38)	HMQODPUNPWDVSN-UHFFFAOYSA-N	416924	1-(5-chloropyridin-2-yl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 159a::US10633345, Compound 159a::US10689346, Compound 159a::US11203574, Compound 159a::US11230530, Compound 159a::US11685721, Compound 159a	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416924	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416924&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355989	433916836							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896189	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C28H26F3N5O2/c29-28(30,31)25-15-24(36(35-25)22-8-3-5-19(13-22)16-32)27(37)34-21-7-4-6-20(14-21)26(38-17-18-10-11-18)23-9-1-2-12-33-23/h1-9,12-15,18,26H,10-11,16-17,32H2,(H,34,37)	UBQUVYTUKOFUOF-UHFFFAOYSA-N	416721	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(pyridin-2-yl)methyl)-phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 43f::US10633345, Compound 43f::US10689346, Compound 43g::US11203574, Compound 43h::US11230530, Compound 43h::US11685721, Compound 43f	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416721	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416721&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355947	433916635							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896190	CN(C(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1)C1CC1	InChI=1S/C30H26F4N6O/c1-39(22-9-10-22)28(20-6-2-4-18(12-20)16-35)21-8-11-24(31)25(14-21)37-29(41)26-15-27(30(32,33)34)38-40(26)23-7-3-5-19(13-23)17-36/h2-8,11-15,22,28H,9-10,17,36H2,1H3,(H,37,41)	LONUELZOBAIWEW-UHFFFAOYSA-N	439471	US10633345, Compound 54e::US10633345, Compound 70a::US10633345, Compound 70b::US10689346, Compound 70a::US11203574, Compound 70b::US11230530, Compound 70b	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439471	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439471&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355805	439661023							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896191	COc1ccc(cc1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H26F4N4O3/c1-40-21-10-8-20(9-11-21)37-24(17-26(36-37)29(31,32)33)27(38)35-23-16-19(7-12-22(23)30)28(39,14-13-18-5-6-18)25-4-2-3-15-34-25/h2-4,7-12,15-18,39H,5-6,13-14H2,1H3,(H,35,38)	YTPYYUUEYRYYOR-UHFFFAOYSA-N	416927	N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-1-(4-methoxyphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 160a::US10633345, Compound 160a::US10689346, Compound 160a::US11203574, Compound 160a::US11230530, Compound 160a::US11685721, Compound 160a	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416927	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416927&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665840	433916839							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896192	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C28H26F3N5O2/c29-28(30,31)25-15-24(36(35-25)22-8-3-5-19(13-22)16-32)27(37)34-21-7-4-6-20(14-21)26(38-17-18-10-11-18)23-9-1-2-12-33-23/h1-9,12-15,18,26H,10-11,16-17,32H2,(H,34,37)	UBQUVYTUKOFUOF-UHFFFAOYSA-N	416721	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(pyridin-2-yl)methyl)-phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 43f::US10633345, Compound 43f::US10689346, Compound 43g::US11203574, Compound 43h::US11230530, Compound 43h::US11685721, Compound 43f	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416721	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416721&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355947	433916635							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896193	CN(C(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1)C1CC1	InChI=1S/C30H26F4N6O/c1-39(22-9-10-22)28(20-6-2-4-18(12-20)16-35)21-8-11-24(31)25(14-21)37-29(41)26-15-27(30(32,33)34)38-40(26)23-7-3-5-19(13-23)17-36/h2-8,11-15,22,28H,9-10,17,36H2,1H3,(H,37,41)	LONUELZOBAIWEW-UHFFFAOYSA-N	439471	US10633345, Compound 54e::US10633345, Compound 70a::US10633345, Compound 70b::US10689346, Compound 70a::US11203574, Compound 70b::US11230530, Compound 70b	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439471	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439471&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355805	439661023							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896194	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(O)c(Br)c1)C(F)(F)F	InChI=1S/C29H27BrF3N5O2/c30-23-13-20(9-10-25(23)39)27(35-16-17-7-8-17)19-4-2-5-21(12-19)36-28(40)24-14-26(29(31,32)33)37-38(24)22-6-1-3-18(11-22)15-34/h1-6,9-14,17,27,35,39H,7-8,15-16,34H2,(H,36,40)	VZKYGMDBRSVHHT-UHFFFAOYSA-N	416930	1-(3-(Aminomethyl)phenyl)-N-(3-((3-bromo-4-hydroxyphenyl)(cyclopropylmethylamino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 207j::US10633345, Compound 207j::US10689346, Compound 207j::US11203574, Compound 207j::US11230530, Compound 207j::US11685721, Compound 207j	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416930	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416930&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665574	433916842							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896195	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H26F3N5O2/c29-28(30,31)25-14-24(36(35-25)23-8-1-4-19(12-23)15-32)27(37)34-22-7-2-5-20(13-22)26(38-17-18-9-10-18)21-6-3-11-33-16-21/h1-8,11-14,16,18,26H,9-10,15,17,32H2,(H,34,37)	SHFRWTHPPCXLER-UHFFFAOYSA-N	416725	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(pyridin-3-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 44c::US10633345, Compound 44c::US10689346, Compound 44c::US11203574, Compound 44d::US11230530, Compound 44e::US11685721, Compound 44c	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416725	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416725&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355578	433916639							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896196	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-10-9-20(28(40,12-11-18-7-8-18)25-6-1-2-13-35-25)15-23(22)36-27(39)24-16-26(29(31,32)33)37-38(24)21-5-3-4-19(14-21)17-34/h1-6,9-10,13-16,18,40H,7-8,11-12,17,34H2,(H,36,39)	XXMBQXWQIGCREG-UHFFFAOYSA-N	416909	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 59c::US10633345, Compound 69b::US10689346, Compound 59c::US11203574, Compound 69b::US11230530, Compound 69b::US11685721, Compound 69b	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416909	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416909&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356067	433916821							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896197	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CCC1CC1)n1ccccc1=O)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-17-25(37(35-26)23-8-3-5-20(15-23)18-33)28(39)34-22-7-4-6-21(16-22)24(13-12-19-10-11-19)36-14-2-1-9-27(36)38/h1-9,14-17,19,24H,10-13,18,33H2,(H,34,39)	OGNFHFCMBSJJNJ-UHFFFAOYSA-N	416933	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-(2-oxopyridin-1(2H)-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 247c::US10633345, Compound 247c::US10689346, Compound 247c::US11203574, Compound 247c::US11230530, Compound 247c::US11685721, Compound 247c	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416933	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416933&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356133	433916845							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896198	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H26F3N5O2/c29-28(30,31)25-14-24(36(35-25)23-8-1-4-19(12-23)15-32)27(37)34-22-7-2-5-20(13-22)26(38-17-18-9-10-18)21-6-3-11-33-16-21/h1-8,11-14,16,18,26H,9-10,15,17,32H2,(H,34,37)	SHFRWTHPPCXLER-UHFFFAOYSA-N	416725	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(pyridin-3-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 44c::US10633345, Compound 44c::US10689346, Compound 44c::US11203574, Compound 44d::US11230530, Compound 44e::US11685721, Compound 44c	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416725	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416725&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355578	433916639							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896199	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-10-9-20(28(40,12-11-18-7-8-18)25-6-1-2-13-35-25)15-23(22)36-27(39)24-16-26(29(31,32)33)37-38(24)21-5-3-4-19(14-21)17-34/h1-6,9-10,13-16,18,40H,7-8,11-12,17,34H2,(H,36,39)	XXMBQXWQIGCREG-UHFFFAOYSA-N	416909	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 59c::US10633345, Compound 69b::US10689346, Compound 59c::US11203574, Compound 69b::US11230530, Compound 69b::US11685721, Compound 69b	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416909	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416909&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356067	433916821							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896200	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CCC1CC1)N1CCCC1=O)C(F)(F)F	InChI=1S/C28H30F3N5O2/c29-28(30,31)25-16-24(36(34-25)22-7-1-4-19(14-22)17-32)27(38)33-21-6-2-5-20(15-21)23(12-11-18-9-10-18)35-13-3-8-26(35)37/h1-2,4-7,14-16,18,23H,3,8-13,17,32H2,(H,33,38)	LEZWAIIPWSOOAE-UHFFFAOYSA-N	416936	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-(2-oxopyrrolidin-1-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 247e::US10633345, Compound 247e::US10689346, Compound 247e::US11203574, Compound 247e::US11230530, Compound 247e::US11685721, Compound 247e	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416936	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416936&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665605	433916848							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896201	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-16-25(37(36-26)24-8-1-4-20(14-24)17-33)27(38)35-23-7-2-5-21(15-23)28(39,12-11-19-9-10-19)22-6-3-13-34-18-22/h1-8,13-16,18-19,39H,9-12,17,33H2,(H,35,38)	AOCZEQQKIIWUBU-UHFFFAOYSA-N	416770	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 47f::US10633345, Compound 47f::US10689346, Compound 47f::US11203574, Compound 47g::US11230530, Compound 47h::US11685721, Compound 47f	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416770	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416770&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355766	433916684							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896202	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H28F4N4O2/c31-24-12-11-22(29(40,14-13-19-9-10-19)21-6-2-1-3-7-21)16-25(24)36-28(39)26-17-27(30(32,33)34)37-38(26)23-8-4-5-20(15-23)18-35/h1-8,11-12,15-17,19,40H,9-10,13-14,18,35H2,(H,36,39)	NIWMWYNGSALJGG-UHFFFAOYSA-N	416903	Racemic 1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 68c::US10633345, Compound 68e::US10689346, Compound 68c::US11203574, Compound 68e::US11230530, Compound 68e::US11685721, Compound 68e	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416903	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416903&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355758	433916816							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896203	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccccc1=O)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-11-10-20(24(12-9-18-7-8-18)37-13-2-1-6-27(37)39)15-23(22)35-28(40)25-16-26(29(31,32)33)36-38(25)21-5-3-4-19(14-21)17-34/h1-6,10-11,13-16,18,24H,7-9,12,17,34H2,(H,35,40)	OFQQGSYWUFBMPP-UHFFFAOYSA-N	416939	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(2-oxopyridin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 248j::US10633345, Compound 248k::US10689346, Compound 248k::US11203574, Compound 248k::US11230530, Compound 248k::US11685721, Compound 248k	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416939	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416939&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355727	433916851							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896204	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-16-25(37(36-26)24-8-1-4-20(14-24)17-33)27(38)35-23-7-2-5-21(15-23)28(39,12-11-19-9-10-19)22-6-3-13-34-18-22/h1-8,13-16,18-19,39H,9-12,17,33H2,(H,35,38)	AOCZEQQKIIWUBU-UHFFFAOYSA-N	416770	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 47f::US10633345, Compound 47f::US10689346, Compound 47f::US11203574, Compound 47g::US11230530, Compound 47h::US11685721, Compound 47f	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416770	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416770&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355766	433916684							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896205	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H28F4N4O2/c31-24-12-11-22(29(40,14-13-19-9-10-19)21-6-2-1-3-7-21)16-25(24)36-28(39)26-17-27(30(32,33)34)37-38(26)23-8-4-5-20(15-23)18-35/h1-8,11-12,15-17,19,40H,9-10,13-14,18,35H2,(H,36,39)	NIWMWYNGSALJGG-UHFFFAOYSA-N	416903	Racemic 1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 68c::US10633345, Compound 68e::US10689346, Compound 68c::US11203574, Compound 68e::US11230530, Compound 68e::US11685721, Compound 68e	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416903	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416903&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355758	433916816							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896206	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccncc1=O)C(F)(F)F	InChI=1S/C28H26F4N6O2/c29-21-8-7-19(23(9-6-17-4-5-17)37-11-10-34-16-26(37)39)13-22(21)35-27(40)24-14-25(28(30,31)32)36-38(24)20-3-1-2-18(12-20)15-33/h1-3,7-8,10-14,16-17,23H,4-6,9,15,33H2,(H,35,40)	GLPOCDKMIDNWGE-UHFFFAOYSA-N	416942	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(2-oxopyrazin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 249b::US10633345, Compound 249b::US10689346, Compound 249b::US11203574, Compound 249b::US11230530, Compound 249b::US11685721, Compound 249b	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416942	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416942&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665736	433916854							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896207	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F3N4O2/c31-30(32,33)27-18-26(37(36-27)25-11-4-6-21(16-25)19-34)28(38)35-24-10-5-9-23(17-24)29(39,15-14-20-12-13-20)22-7-2-1-3-8-22/h1-11,16-18,20,39H,12-15,19,34H2,(H,35,38)	DCGYPXFSNPCKGX-UHFFFAOYSA-N	416751	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 46g::US10633345, Compound 46g::US10689346, Compound 46g::US11203574, Compound 46i::US11230530, Compound 46i::US11685721, Compound 46g	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416751	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416751&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355790	433916665							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896208	COc1ccc2ccccc2c1C(NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H31F4N5O2/c1-45-29-14-12-22-6-2-3-8-25(22)31(29)32(40-19-20-9-10-20)23-11-13-26(35)27(16-23)41-33(44)28-17-30(34(36,37)38)42-43(28)24-7-4-5-21(15-24)18-39/h2-8,11-17,20,32,40H,9-10,18-19,39H2,1H3,(H,41,44)	AYMFYNZEWAELBE-UHFFFAOYSA-N	416906	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(2-methoxynaphthalen-1-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide dihydrochloride::US10329260, Compound 61e::US10633345, Compound 63b::US10689346, Compound 61e::US11203574, Compound 63b::US11230530, Compound 63b::US11685721, Compound 63b	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416906	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416906&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355591	433916818							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896209	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)Oc1ccccn1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-11-10-20(25(12-9-18-7-8-18)40-27-6-1-2-13-35-27)15-23(22)36-28(39)24-16-26(29(31,32)33)37-38(24)21-5-3-4-19(14-21)17-34/h1-6,10-11,13-16,18,25H,7-9,12,17,34H2,(H,36,39)	NLWJKTCXFARQOW-UHFFFAOYSA-N	416945	US10329260, Compound 250c::US10633345, Compound 250c::US11192861, Compound 250c	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416945	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416945&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126689760	433916857							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896210	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F3N4O2/c31-30(32,33)27-18-26(37(36-27)25-11-4-6-21(16-25)19-34)28(38)35-24-10-5-9-23(17-24)29(39,15-14-20-12-13-20)22-7-2-1-3-8-22/h1-11,16-18,20,39H,12-15,19,34H2,(H,35,38)	DCGYPXFSNPCKGX-UHFFFAOYSA-N	416751	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 46g::US10633345, Compound 46g::US10689346, Compound 46g::US11203574, Compound 46i::US11230530, Compound 46i::US11685721, Compound 46g	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416751	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416751&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355790	433916665							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896211	COc1ccc2ccccc2c1C(NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H31F4N5O2/c1-45-29-14-12-22-6-2-3-8-25(22)31(29)32(40-19-20-9-10-20)23-11-13-26(35)27(16-23)41-33(44)28-17-30(34(36,37)38)42-43(28)24-7-4-5-21(15-24)18-39/h2-8,11-17,20,32,40H,9-10,18-19,39H2,1H3,(H,41,44)	AYMFYNZEWAELBE-UHFFFAOYSA-N	416906	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(2-methoxynaphthalen-1-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide dihydrochloride::US10329260, Compound 61e::US10633345, Compound 63b::US10689346, Compound 61e::US11203574, Compound 63b::US11230530, Compound 63b::US11685721, Compound 63b	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416906	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416906&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355591	433916818							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896212	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(=CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H26F4N4O/c31-25-14-12-22(24(13-11-19-9-10-19)21-6-2-1-3-7-21)16-26(25)36-29(39)27-17-28(30(32,33)34)37-38(27)23-8-4-5-20(15-23)18-35/h1-8,12-17,19H,9-11,18,35H2,(H,36,39)/b24-13-	BAAJKWZPAGFHDE-CFRMEGHHSA-N	416948	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-phenylprop-1-enyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 252c::US10633345, Compound 252c::US10689346, Compound 252c::US11203574, Compound 252c::US11230530, Compound 252c::US11685721, Compound 252c	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416948	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416948&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			140777564	433916860							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896213	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H25F4N5O2/c29-22-9-8-19(26(39-16-17-6-7-17)20-4-2-10-34-15-20)12-23(22)35-27(38)24-13-25(28(30,31)32)36-37(24)21-5-1-3-18(11-21)14-33/h1-5,8-13,15,17,26H,6-7,14,16,33H2,(H,35,38)	CNAFOXQNPWSINI-UHFFFAOYSA-N	416794	Racemic 1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethoxy)(pyridin-3-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 48f::US10633345, Compound 48f::US10689346, Compound 48f::US11203574, Compound 48g::US11230530, Compound 48h::US11685721, Compound 48f	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416794	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416794&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355617	433916708							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896214	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C30H25F4N5O2/c31-24-11-10-22(28(41-17-19-4-5-19)21-8-6-18(15-35)7-9-21)13-25(24)37-29(40)26-14-27(30(32,33)34)38-39(26)23-3-1-2-20(12-23)16-36/h1-3,6-14,19,28H,4-5,16-17,36H2,(H,37,40)	WXFHQCUXOOXGLO-UHFFFAOYSA-N	416894	1-(3-(aminomethyl)phenyl)-N-(5-((4-cyanophenyl)(cyclopropylmethoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 55b::US10633345, Compound 73b::US10689346, Compound 55b::US11203574, Compound 73b::US11230530, Compound 73b::US11685721, Compound 73b	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416894	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416894&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665569	433916807							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896215	CN1CCCN(CC1)C(CCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H36F4N6O/c1-38-12-3-13-39(15-14-38)26(11-8-20-6-7-20)22-9-10-24(31)25(17-22)36-29(41)27-18-28(30(32,33)34)37-40(27)23-5-2-4-21(16-23)19-35/h2,4-5,9-10,16-18,20,26H,3,6-8,11-15,19,35H2,1H3,(H,36,41)	WXRMFESIILBOBA-UHFFFAOYSA-N	416951	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(4-methyl-1,4-diazepan-1-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 251e::US10633345, Compound 251e::US10689346, Compound 251e::US11203574, Compound 251e::US11230530, Compound 251e::US11685721, Compound 251e	Plasma kallikrein		>75.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416951	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416951&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355664	433916863							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896216	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H25F4N5O2/c29-22-9-8-19(26(39-16-17-6-7-17)20-4-2-10-34-15-20)12-23(22)35-27(38)24-13-25(28(30,31)32)36-37(24)21-5-1-3-18(11-21)14-33/h1-5,8-13,15,17,26H,6-7,14,16,33H2,(H,35,38)	CNAFOXQNPWSINI-UHFFFAOYSA-N	416794	Racemic 1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethoxy)(pyridin-3-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 48f::US10633345, Compound 48f::US10689346, Compound 48f::US11203574, Compound 48g::US11230530, Compound 48h::US11685721, Compound 48f	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416794	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416794&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355617	433916708							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896217	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C30H25F4N5O2/c31-24-11-10-22(28(41-17-19-4-5-19)21-8-6-18(15-35)7-9-21)13-25(24)37-29(40)26-14-27(30(32,33)34)38-39(26)23-3-1-2-20(12-23)16-36/h1-3,6-14,19,28H,4-5,16-17,36H2,(H,37,40)	WXFHQCUXOOXGLO-UHFFFAOYSA-N	416894	1-(3-(aminomethyl)phenyl)-N-(5-((4-cyanophenyl)(cyclopropylmethoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 55b::US10633345, Compound 73b::US10689346, Compound 55b::US11203574, Compound 73b::US11230530, Compound 73b::US11685721, Compound 73b	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416894	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416894&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665569	433916807							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896218	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)N1C(=O)CCC1=O)C(F)(F)F	InChI=1S/C28H27F4N5O3/c29-20-8-7-18(22(9-6-16-4-5-16)36-25(38)10-11-26(36)39)13-21(20)34-27(40)23-14-24(28(30,31)32)35-37(23)19-3-1-2-17(12-19)15-33/h1-3,7-8,12-14,16,22H,4-6,9-11,15,33H2,(H,34,40)	ZAWTZVLCOQSDBX-UHFFFAOYSA-N	416954	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(2,5-dioxopyrrolidin-1-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 260b::US10633345, Compound 260b::US10689346, Compound 260b::US11203574, Compound 260b::US11230530, Compound 260b::US11685721, Compound 260b	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416954	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416954&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665563	433916866							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896219	COc1ccc2ccccc2c1C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H32F3N5O2/c1-44-29-15-14-23-7-2-3-11-27(23)31(29)32(39-20-21-12-13-21)24-8-5-9-25(17-24)40-33(43)28-18-30(34(35,36)37)41-42(28)26-10-4-6-22(16-26)19-38/h2-11,14-18,21,32,39H,12-13,19-20,38H2,1H3,(H,40,43)	XVOUQCJHWNZPKF-UHFFFAOYSA-N	416841	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2-methoxynaphthalen-1-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 51f::US10633345, Compound 51f::US10689346, Compound 51f::US11203574, Compound 51h::US11230530, Compound 51h::US11685721, Compound 51f	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416841	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416841&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356155	433916754							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896220	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C30H25F4N5O2/c31-24-10-9-22(28(41-17-18-7-8-18)21-5-1-3-19(11-21)15-35)13-25(24)37-29(40)26-14-27(30(32,33)34)38-39(26)23-6-2-4-20(12-23)16-36/h1-6,9-14,18,28H,7-8,16-17,36H2,(H,37,40)	LSXFYXGKZDVRTL-UHFFFAOYSA-N	416900	1-(3-(aminomethyl)phenyl)-N-(5-((3-cyanophenyl)(cyclopropyl-methoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 56c::US10633345, Compound 72d::US10689346, Compound 56c::US11203574, Compound 72d::US11230530, Compound 72d::US11685721, Compound 72d	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416900	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416900&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356211	433916813							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896221	CS(=O)(=O)NC(CCC1CC1)(c1ccncc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2ccc3ccnc(N)c3c2)C(F)(F)F)c1	InChI=1S/C32H29F4N7O3S/c1-47(45,46)42-31(12-8-19-2-3-19,21-10-13-38-14-11-21)22-5-7-25(33)26(16-22)40-30(44)27-18-28(32(34,35)36)41-43(27)23-6-4-20-9-15-39-29(37)24(20)17-23/h4-7,9-11,13-19,42H,2-3,8,12H2,1H3,(H2,37,39)(H,40,44)	WOIASLBXHIHYRY-UHFFFAOYSA-N	416957	(+-)-1-(1-aminoisoquinolin-7-yl)-N-(5-(3-cyclopropyl-1-(methylsulfonamido)-1-(pyridin-4-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 262f::US10633345, Compound 262f::US10689346, Compound 262f::US11192861, Compound 262f::US11230530, Compound 262f::US11685721, Compound 262f	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416957	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416957&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355636	433916869							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896222	COc1ccc2ccccc2c1C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H32F3N5O2/c1-44-29-15-14-23-7-2-3-11-27(23)31(29)32(39-20-21-12-13-21)24-8-5-9-25(17-24)40-33(43)28-18-30(34(35,36)37)41-42(28)26-10-4-6-22(16-26)19-38/h2-11,14-18,21,32,39H,12-13,19-20,38H2,1H3,(H,40,43)	XVOUQCJHWNZPKF-UHFFFAOYSA-N	416841	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2-methoxynaphthalen-1-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 51f::US10633345, Compound 51f::US10689346, Compound 51f::US11203574, Compound 51h::US11230530, Compound 51h::US11685721, Compound 51f	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416841	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416841&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356155	433916754							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896223	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C30H25F4N5O2/c31-24-10-9-22(28(41-17-18-7-8-18)21-5-1-3-19(11-21)15-35)13-25(24)37-29(40)26-14-27(30(32,33)34)38-39(26)23-6-2-4-20(12-23)16-36/h1-6,9-14,18,28H,7-8,16-17,36H2,(H,37,40)	LSXFYXGKZDVRTL-UHFFFAOYSA-N	416900	1-(3-(aminomethyl)phenyl)-N-(5-((3-cyanophenyl)(cyclopropyl-methoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 56c::US10633345, Compound 72d::US10689346, Compound 56c::US11203574, Compound 72d::US11230530, Compound 72d::US11685721, Compound 72d	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416900	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416900&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356211	433916813							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896224	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccc(=O)[nH]c1=O)C(F)(F)F			416960	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 263d::US10633345, Compound 263d::US10689346, Compound 263d::US11203574, Compound 263d::US11230530, Compound 263d::US11685721, Compound 263d	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416960	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416960&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			154584232	433916872							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896225	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-25(37(36-26)24-9-1-4-19(12-24)16-33)28(38)35-23-8-3-6-21(14-23)27(39-17-18-10-11-18)20-5-2-7-22(34)13-20/h1-9,12-15,18,27H,10-11,16-17,33-34H2,(H,35,38)	FPQYUIIRVBKUDH-UHFFFAOYSA-N	416867	1-(3-(aminomethyl)phenyl)-N-(3-((3-aminophenyl)(cyclopropyl-methoxy)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 53f::US10633345, Compound 53f::US10689346, Compound 53f::US11203574, Compound 64b::US11230530, Compound 64b::US11685721, Compound 49j	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416867	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416867&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355845	433916780							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896226	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1O)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-11-10-19(27(35-16-17-8-9-17)21-6-1-2-7-25(21)39)13-23(22)36-28(40)24-14-26(29(31,32)33)37-38(24)20-5-3-4-18(12-20)15-34/h1-7,10-14,17,27,35,39H,8-9,15-16,34H2,(H,36,40)	CKWWRAGQIQAYTL-UHFFFAOYSA-N	416856	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(2-hydroxyphenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 60e::US10633345, Compound 66b::US10689346, Compound 60e::US11203574, Compound 66b::US11230530, Compound 66b::US11685721, Compound 60e	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416856	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416856&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665480	433916769							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896227	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1ccc(cc1F)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-23-14-21(27(39-17-18-9-10-18)20-6-2-1-3-7-20)11-12-24(23)35-28(38)25-15-26(29(31,32)33)36-37(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27H,9-10,16-17,34H2,(H,35,38)	HBXVQXKJLUQKAE-UHFFFAOYSA-N	416963	1-(3-(aminomethyl)phenyl)-N-(4-((cyclopropylmethoxy)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 15g::US10633345, Compound 15g::US10689346, Compound 15g::US11203574, Compound 15g::US11230530, Compound 15g::US11685721, Compound 15g	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416963	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416963&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355605	433916875							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896228	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-25(37(36-26)24-9-1-4-19(12-24)16-33)28(38)35-23-8-3-6-21(14-23)27(39-17-18-10-11-18)20-5-2-7-22(34)13-20/h1-9,12-15,18,27H,10-11,16-17,33-34H2,(H,35,38)	FPQYUIIRVBKUDH-UHFFFAOYSA-N	416867	1-(3-(aminomethyl)phenyl)-N-(3-((3-aminophenyl)(cyclopropyl-methoxy)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 53f::US10633345, Compound 53f::US10689346, Compound 53f::US11203574, Compound 64b::US11230530, Compound 64b::US11685721, Compound 49j	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416867	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416867&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355845	433916780							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896229	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1O)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-11-10-19(27(35-16-17-8-9-17)21-6-1-2-7-25(21)39)13-23(22)36-28(40)24-14-26(29(31,32)33)37-38(24)20-5-3-4-18(12-20)15-34/h1-7,10-14,17,27,35,39H,8-9,15-16,34H2,(H,36,40)	CKWWRAGQIQAYTL-UHFFFAOYSA-N	416856	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(2-hydroxyphenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 60e::US10633345, Compound 66b::US10689346, Compound 60e::US11203574, Compound 66b::US11230530, Compound 66b::US11685721, Compound 60e	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416856	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416856&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665480	433916769							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896230	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1ccc(cc1F)C(O)c1ccccc1)C(F)(F)F	InChI=1S/C25H20F4N4O2/c26-19-12-17(23(34)16-6-2-1-3-7-16)9-10-20(19)31-24(35)21-13-22(25(27,28)29)32-33(21)18-8-4-5-15(11-18)14-30/h1-13,23,34H,14,30H2,(H,31,35)	WVBOXESRKOBMTK-UHFFFAOYSA-N	416966	1-(3-(Aminomethyl)phenyl)-N-(2-fluoro-4-(hydroxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 16b::US10633345, Compound 16b::US10689346, Compound 16b::US11203574, Compound 16b::US11230530, Compound 16b::US11685721, Compound 16b	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416966	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416966&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665483	433916878							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896231	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1O)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-24(37(36-26)22-8-3-5-19(13-22)16-33)28(39)35-21-7-4-6-20(14-21)27(34-17-18-11-12-18)23-9-1-2-10-25(23)38/h1-10,13-15,18,27,34,38H,11-12,16-17,33H2,(H,35,39)	PCNDJIQOMLHSEK-UHFFFAOYSA-N	416837	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2-hydroxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 49h::US10633345, Compound 49h::US10689346, Compound 49h::US11203574, Compound 49j::US11230530, Compound 49j::US11685721, Compound 49h	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416837	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416837&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355733	433916750							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896232	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-23-12-11-21(27(39-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)35-28(38)25-15-26(29(31,32)33)36-37(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27H,9-10,16-17,34H2,(H,35,38)	HIMJVDQVZQMIPM-UHFFFAOYSA-N	416747	1-(3-(Aminomethyl)phenyl)-N-(5-((cyclopropylmethoxy)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 34c::US10633345, Compound 34c::US10689346, Compound 34c::US11203574, Compound 37a::US11230530, Compound 37a::US11685721, Compound 34c	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416747	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416747&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355729	433916661							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896233	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1c(F)cccc1C(O)c1ccccc1)C(F)(F)F	InChI=1S/C25H20F4N4O2/c26-19-11-5-10-18(23(34)16-7-2-1-3-8-16)22(19)31-24(35)20-13-21(25(27,28)29)32-33(20)17-9-4-6-15(12-17)14-30/h1-13,23,34H,14,30H2,(H,31,35)	PIMJYQUHLMMZIO-UHFFFAOYSA-N	416969	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-6-(hydroxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 90f::US10633345, Compound 90f::US10689346, Compound 90f::US11203574, Compound 90f::US11230530, Compound 90f::US11685721, Compound 90f	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416969	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416969&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356272	433916881							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896234	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1O)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-24(37(36-26)22-8-3-5-19(13-22)16-33)28(39)35-21-7-4-6-20(14-21)27(34-17-18-11-12-18)23-9-1-2-10-25(23)38/h1-10,13-15,18,27,34,38H,11-12,16-17,33H2,(H,35,39)	PCNDJIQOMLHSEK-UHFFFAOYSA-N	416837	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2-hydroxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 49h::US10633345, Compound 49h::US10689346, Compound 49h::US11203574, Compound 49j::US11230530, Compound 49j::US11685721, Compound 49h	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416837	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416837&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355733	433916750							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896235	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-23-12-11-21(27(39-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)35-28(38)25-15-26(29(31,32)33)36-37(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27H,9-10,16-17,34H2,(H,35,38)	HIMJVDQVZQMIPM-UHFFFAOYSA-N	416747	1-(3-(Aminomethyl)phenyl)-N-(5-((cyclopropylmethoxy)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 34c::US10633345, Compound 34c::US10689346, Compound 34c::US11203574, Compound 37a::US11230530, Compound 37a::US11685721, Compound 34c	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416747	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416747&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355729	433916661							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896236	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N(CC1CC1)CC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C33H33F4N5O/c34-27-14-13-25(31(24-6-2-1-3-7-24)41(19-21-9-10-21)20-22-11-12-22)16-28(27)39-32(43)29-17-30(33(35,36)37)40-42(29)26-8-4-5-23(15-26)18-38/h1-8,13-17,21-22,31H,9-12,18-20,38H2,(H,39,43)	FVEYNTAGBBDICV-UHFFFAOYSA-N	416972	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-((bis(cyclopropylmethyl)amino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 206d::US10633345, Compound 206d::US10689346, Compound 206d::US11203574, Compound 206d::US11230530, Compound 206d::US11685721, Compound 206d	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416972	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416972&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355791	433916884							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896237	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C#N)C(N)=O	InChI=1S/C31H30FN7O2/c32-25-11-10-23(31(36,13-12-19-4-5-19)22-8-6-20(17-33)7-9-22)15-26(25)37-30(41)28-16-27(29(35)40)38-39(28)24-3-1-2-21(14-24)18-34/h1-3,6-11,14-16,19H,4-5,12-13,18,34,36H2,(H2,35,40)(H,37,41)	BCLQAOJZVSDWEP-UHFFFAOYSA-N	416973	(+)-N5-(5-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-1H-pyrazole-3,5-dicarboxamide::US10329260, Compound 231d::US10633345, Compound 231d::US10689346, Compound 231d::US11203574, Compound 231d::US11230530, Compound 231d::US11685721, Compound 231d	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416973	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416973&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665708	433916885							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896238	CC(C)(C)C(=O)NC(CC(C1CC1)c1cccnc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H36F4N6O2/c1-33(2,3)32(46)42-27(16-25(21-9-10-21)23-7-5-13-40-19-23)22-11-12-26(35)28(15-22)41-31(45)29-17-30(34(36,37)38)43-44(29)24-8-4-6-20(14-24)18-39/h4-8,11-15,17,19,21,25,27H,9-10,16,18,39H2,1-3H3,(H,41,45)(H,42,46)	LKWABQLBDBHXHD-UHFFFAOYSA-N	439557	US10633345, Compound 244g	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439557	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439557&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			150954847	439661105							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896239	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)[C@@](N)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-22-10-9-20(28(35,12-11-18-7-8-18)25-6-1-2-13-36-25)15-23(22)37-27(40)24-16-26(29(31,32)33)38-39(24)21-5-3-4-19(14-21)17-34/h1-6,9-10,13-16,18H,7-8,11-12,17,34-35H2,(H,37,40)/t28-/m0/s1	IFWBAIGKQKRJGJ-NDEPHWFRSA-N	439558	US10633345, Compound 205d	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439558	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439558&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155295686	439661106							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896240	ONC(=N)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N6O2/c30-22-12-11-19(26(35-16-17-9-10-17)18-5-2-1-3-6-18)14-23(22)36-28(40)24-15-25(29(31,32)33)37-39(24)21-8-4-7-20(13-21)27(34)38-41/h1-8,11-15,17,26,35,41H,9-10,16H2,(H2,34,38)(H,36,40)	RKUBSDCTAQRJEX-UHFFFAOYSA-N	416976	(+-)-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-1-(3-(N-hydroxycarbamimidoyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 232a::US10633345, Compound 232a::US10689346, Compound 232a::US11203574, Compound 232a::US11230530, Compound 232a::US11685721, Compound 232a	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416976	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416976&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665466	433916888							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896241	CC(=O)NC(CCC1CC1)(c1cccnc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C31H30F4N6O2/c1-19(42)39-30(12-11-20-7-8-20,23-5-3-13-37-18-23)22-9-10-25(32)26(15-22)38-29(43)27-16-28(31(33,34)35)40-41(27)24-6-2-4-21(14-24)17-36/h2-6,9-10,13-16,18,20H,7-8,11-12,17,36H2,1H3,(H,38,43)(H,39,42)	NXVHVPBDWBOZQI-UHFFFAOYSA-N	416977	(+-)-N-(5-(1-acetamido-3-cyclopropyl-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 244h::US10633345, Compound 244h::US10689346, Compound 244h::US11203574, Compound 244h::US11230530, Compound 244h::US11685721, Compound 244h	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416977	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416977&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355894	433916889							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896242	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)[C@](N)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-22-10-9-20(28(35,12-11-18-7-8-18)25-6-1-2-13-36-25)15-23(22)37-27(40)24-16-26(29(31,32)33)38-39(24)21-5-3-4-19(14-21)17-34/h1-6,9-10,13-16,18H,7-8,11-12,17,34-35H2,(H,37,40)/t28-/m1/s1	IFWBAIGKQKRJGJ-MUUNZHRXSA-N	416754	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carb oxamide::US10329260, Compound 205f::US10633345, Compound 205e::US11203574, Compound 205f	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416754	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416754&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			146207235	433916668							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896243	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(O)=O	InChI=1S/C29H28FN5O3/c30-23-12-11-21(27(32-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)33-28(36)26-15-25(29(37)38)34-35(26)22-8-4-5-19(13-22)16-31/h1-8,11-15,18,27,32H,9-10,16-17,31H2,(H,33,36)(H,37,38)	XPAISISGRLZRHF-UHFFFAOYSA-N	416979	(+)-1-(3-(aminomethyl)phenyl)-5-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenylcarbamoyl)-1H-pyrazole-3-carboxylic acid::US10329260, Compound 246f::US10633345, Compound 246f::US10689346, Compound 246f::US11203574, Compound 246f::US11230530, Compound 246f::US11685721, Compound 246f	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416979	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416979&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356041	433916891							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896244	CCC(=O)NC(CCC1CC1)(c1cccnc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C32H32F4N6O2/c1-2-29(43)40-31(13-12-20-8-9-20,23-6-4-14-38-19-23)22-10-11-25(33)26(16-22)39-30(44)27-17-28(32(34,35)36)41-42(27)24-7-3-5-21(15-24)18-37/h3-7,10-11,14-17,19-20H,2,8-9,12-13,18,37H2,1H3,(H,39,44)(H,40,43)	VLEWWVBFKVHAND-UHFFFAOYSA-N	416980	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-propionamido-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 244i::US10633345, Compound 244i::US10689346, Compound 244i::US11203574, Compound 244i::US11230530, Compound 244j::US11685721, Compound 244i	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416980	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416980&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665945	433916892							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896245	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-23-9-8-20(28(35,11-10-18-6-7-18)21-4-2-12-36-17-21)14-24(23)37-27(40)25-15-26(29(31,32)33)38-39(25)22-5-1-3-19(13-22)16-34/h1-5,8-9,12-15,17-18H,6-7,10-11,16,34-35H2,(H,37,40)	QXMQDWOYOXVOQZ-UHFFFAOYSA-N	416981	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 208d::US10633345, Compound 209d::US10689346, Compound 209d::US11203574, Compound 209d::US11230530, Compound 209d::US11685721, Compound 209d	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416981	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416981&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355646	433916893							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896246	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C#N)C#N	InChI=1S/C31H28FN7O/c32-27-11-10-24(31(36,13-12-20-4-5-20)23-8-6-21(17-33)7-9-23)15-28(27)37-30(40)29-16-25(19-35)38-39(29)26-3-1-2-22(14-26)18-34/h1-3,6-11,14-16,20H,4-5,12-13,18,34,36H2,(H,37,40)	SWSSXIJHEDUEIQ-UHFFFAOYSA-N	416982	(+)-N-(5-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-cyano-1H-pyrazole-5-carboxamide::US10329260, Compound 234d::US10633345, Compound 234d::US10689346, Compound 234d::US11203574, Compound 234d::US11230530, Compound 234d::US11685721, Compound 234d	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416982	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416982&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356248	433916894							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896247	CC(C)C(=O)NC(CCC1CC1)(c1cccnc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C33H34F4N6O2/c1-20(2)30(44)41-32(13-12-21-8-9-21,24-6-4-14-39-19-24)23-10-11-26(34)27(16-23)40-31(45)28-17-29(33(35,36)37)42-43(28)25-7-3-5-22(15-25)18-38/h3-7,10-11,14-17,19-21H,8-9,12-13,18,38H2,1-2H3,(H,40,45)(H,41,44)	POAUUALSNYEBRU-UHFFFAOYSA-N	416983	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-isobutyramido-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 244j::US10633345, Compound 244j::US10689346, Compound 244j::US11203574, Compound 244j::US11685721, Compound 244j	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416983	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416983&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356184	433916895							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896248	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-23-9-8-20(28(35,11-10-18-6-7-18)21-4-2-12-36-17-21)14-24(23)37-27(40)25-15-26(29(31,32)33)38-39(25)22-5-1-3-19(13-22)16-34/h1-5,8-9,12-15,17-18H,6-7,10-11,16,34-35H2,(H,37,40)	QXMQDWOYOXVOQZ-UHFFFAOYSA-N	416981	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 208d::US10633345, Compound 209d::US10689346, Compound 209d::US11203574, Compound 209d::US11230530, Compound 209d::US11685721, Compound 209d	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416981	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416981&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355646	433916893							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896249	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C31H26F4N6O/c32-24-11-9-21(28(38-17-18-6-7-18)20-4-2-1-3-5-20)14-25(24)39-30(42)26-16-27(31(33,34)35)40-41(26)22-10-8-19-12-13-37-29(36)23(19)15-22/h1-5,8-16,18,28,38H,6-7,17H2,(H2,36,37)(H,39,42)	OUKVDAXUKVLTKB-UHFFFAOYSA-N	439568	US10633345, Compound 235g::US10689346, Compound 235g::US11192861, Compound 235g	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439568	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439568&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665742	439661116							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896250	CC(C)CC(=O)NC(CCC1CC1)(c1cccnc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H36F4N6O2/c1-21(2)15-31(45)42-33(13-12-22-8-9-22,25-6-4-14-40-20-25)24-10-11-27(35)28(17-24)41-32(46)29-18-30(34(36,37)38)43-44(29)26-7-3-5-23(16-26)19-39/h3-7,10-11,14,16-18,20-22H,8-9,12-13,15,19,39H2,1-2H3,(H,41,46)(H,42,45)	WIIQCCUTLYCVOE-UHFFFAOYSA-N	416986	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(3-methylbutanamido)-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 244k::US10633345, Compound 244k::US10689346, Compound 244k::US11203574, Compound 244k::US11230530, Compound 244k::US11685721, Compound 244k	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416986	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416986&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665507	433916898							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896251	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F4N5O/c31-24-12-11-22(29(36,14-13-19-9-10-19)21-6-2-1-3-7-21)16-25(24)37-28(40)26-17-27(30(32,33)34)38-39(26)23-8-4-5-20(15-23)18-35/h1-8,11-12,15-17,19H,9-10,13-14,18,35-36H2,(H,37,40)	NQFNNZJJOCPZCP-UHFFFAOYSA-N	416987	(+-)-N-(5-(1-amino-3-cyclopropyl-1-phenylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 210d::US10633345, Compound 211d::US10689346, Compound 211d::US11203574, Compound 211d::US11230530, Compound 211d::US11685721, Compound 211d	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416987	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416987&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355764	433916899							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896252	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(N)(CCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C31H29F3N6O/c32-31(33,34)28-17-27(40(39-28)26-6-1-3-22(15-26)19-36)29(41)38-25-5-2-4-24(16-25)30(37,14-13-20-7-8-20)23-11-9-21(18-35)10-12-23/h1-6,9-12,15-17,20H,7-8,13-14,19,36-37H2,(H,38,41)	WPWCLOAAAHRQMG-UHFFFAOYSA-N	416988	(+)-N-(3-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)phenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 218c::US10633345, Compound 218c::US10689346, Compound 218c::US11203574, Compound 218c::US11230530, Compound 218c::US11685721, Compound 218c	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416988	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416988&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356070	433916900							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896253	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C31H27F4N7O/c32-24-6-4-21(30(37,11-7-18-1-2-18)20-9-12-38-13-10-20)15-25(24)40-29(43)26-17-27(31(33,34)35)41-42(26)22-5-3-19-8-14-39-28(36)23(19)16-22/h3-6,8-10,12-18H,1-2,7,11,37H2,(H2,36,39)(H,40,43)	BGYDOWYGLFEYGE-UHFFFAOYSA-N	416989	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-4-yl)propyl)-2-fluorophenyl)-1-(1-aminoisoquinolin-7-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 253e::US10633345, Compound 253e::US10689346, Compound 253e::US11203574, Compound 253e::US11230530, Compound 253e::US11685721, Compound 253e	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416989	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416989&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665703	433916901							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896254	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F4N5O/c31-24-12-11-22(29(36,14-13-19-9-10-19)21-6-2-1-3-7-21)16-25(24)37-28(40)26-17-27(30(32,33)34)38-39(26)23-8-4-5-20(15-23)18-35/h1-8,11-12,15-17,19H,9-10,13-14,18,35-36H2,(H,37,40)	NQFNNZJJOCPZCP-UHFFFAOYSA-N	416987	(+-)-N-(5-(1-amino-3-cyclopropyl-1-phenylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 210d::US10633345, Compound 211d::US10689346, Compound 211d::US11203574, Compound 211d::US11230530, Compound 211d::US11685721, Compound 211d	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416987	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416987&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355764	433916899							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896255	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(N)(CCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C31H29F3N6O/c32-31(33,34)28-17-27(40(39-28)26-9-2-5-22(15-26)19-36)29(41)38-25-8-3-7-24(16-25)30(37,13-12-20-10-11-20)23-6-1-4-21(14-23)18-35/h1-9,14-17,20H,10-13,19,36-37H2,(H,38,41)	JHGXWQQOSIGIHO-UHFFFAOYSA-N	416991	(+)-N-(3-(1-amino-1-(3-cyanophenyl)-3-cyclopropylpropyl)phenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 219c::US10633345, Compound 219c::US10689346, Compound 219c::US11203574, Compound 219c::US11230530, Compound 219c::US11685721, Compound 219c	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416991	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416991&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355760	433916903							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896256	CS(=O)(=O)NC(CCC1CC1)(c1ccncc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F4N6O3S/c1-44(42,43)39-29(12-9-19-5-6-19,21-10-13-36-14-11-21)22-7-8-24(31)25(16-22)37-28(41)26-17-27(30(32,33)34)38-40(26)23-4-2-3-20(15-23)18-35/h2-4,7-8,10-11,13-17,19,39H,5-6,9,12,18,35H2,1H3,(H,37,41)	SFWRGGJAWAJGGN-UHFFFAOYSA-N	416992	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(methylsulfonamido)-1-(pyridin-4-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 245c::US10633345, Compound 245c::US10689346, Compound 245c::US11203574, Compound 245c::US11230530, Compound 245c::US11685721, Compound 245c	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416992	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416992&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355707	433916904							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896257	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C31H28F4N6O/c32-25-11-10-23(30(38,13-12-19-4-5-19)22-8-6-20(17-36)7-9-22)15-26(25)39-29(42)27-16-28(31(33,34)35)40-41(27)24-3-1-2-21(14-24)18-37/h1-3,6-11,14-16,19H,4-5,12-13,18,37-38H2,(H,39,42)	JCBKPNPCGNTAQN-UHFFFAOYSA-N	416993	(+)-N-(5-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 212g::US10633345, Compound 213d::US10689346, Compound 213d::US11203574, Compound 213d::US11230530, Compound 213d::US11685721, Compound 213d	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416993	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416993&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356170	433916905							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896258	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C(N)=O)C#N	InChI=1S/C31H30FN7O2/c32-26-11-10-23(31(36,13-12-19-4-5-19)22-8-6-21(7-9-22)29(35)40)15-27(26)37-30(41)28-16-24(18-34)38-39(28)25-3-1-2-20(14-25)17-33/h1-3,6-11,14-16,19H,4-5,12-13,17,33,36H2,(H2,35,40)(H,37,41)	KLZOEGIZCNFTHC-UHFFFAOYSA-N	416994	(-)-N-(5-(1-amino-1-(4-carbamoylphenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-cyano-1H-pyrazole-5-carboxamide::US10329260, Compound 239d::US10633345, Compound 239c::US10689346, Compound 239d::US11203574, Compound 239d::US11685721, Compound 239d	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416994	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416994&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356225	433916906							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896259	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C32H25F4N7O/c33-25-9-7-22(29(40-17-18-4-5-18)21-3-1-2-19(12-21)16-37)13-26(25)41-31(44)27-15-28(32(34,35)36)42-43(27)23-8-6-20-10-11-39-30(38)24(20)14-23/h1-3,6-15,18,29,40H,4-5,17H2,(H2,38,39)(H,41,44)	PQPAZBKFVDKERF-UHFFFAOYSA-N	439578	US10633345, Compound 257b::US10689346, Compound 257b::US11203574, Compound 257b::US11230530, Compound 257b::US11685721, Compound 257b	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439578	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439578&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665471	439661126							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896260	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C31H28F4N6O/c32-25-10-9-23(30(38,12-11-19-7-8-19)22-5-1-3-20(13-22)17-36)15-26(25)39-29(42)27-16-28(31(33,34)35)40-41(27)24-6-2-4-21(14-24)18-37/h1-6,9-10,13-16,19H,7-8,11-12,18,37-38H2,(H,39,42)	ZBDDMFBNDOEVJT-UHFFFAOYSA-N	416996	(+)-N-(5-(1-amino-1-(3-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 214g::US10633345, Compound 215d::US10689346, Compound 215d::US11203574, Compound 215d::US11230530, Compound 215d::US11685721, Compound 215d	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416996	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416996&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665709	433916908							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896261	NC(=O)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C31H26F4N6O2/c32-24-10-9-22(30(38,12-11-18-7-8-18)21-5-1-3-19(13-21)17-36)15-25(24)39-29(43)26-16-27(31(33,34)35)40-41(26)23-6-2-4-20(14-23)28(37)42/h1-6,9-10,13-16,18H,7-8,11-12,38H2,(H2,37,42)(H,39,43)	MJBRNYICMOSPEH-UHFFFAOYSA-N	416997	(+-)-N-(5-(1-amino-1-(3-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-carbamoylphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 267c::US10633345, Compound 267c::US10689346, Compound 267c::US11203574, Compound 267c::US11230530, Compound 267c::US11685721, Compound 267c	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416997	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416997&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665760	433916909							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896262	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C33H27F4N7O/c34-26-10-8-23(32(40,13-11-19-1-2-19)22-6-3-20(18-38)4-7-22)15-27(26)42-31(45)28-17-29(33(35,36)37)43-44(28)24-9-5-21-12-14-41-30(39)25(21)16-24/h3-10,12,14-17,19H,1-2,11,13,40H2,(H2,39,41)(H,42,45)	QUIZETAQJOZQJA-UHFFFAOYSA-N	416998	(+)-N-(5-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(1-aminoisoquinolin-7-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 254c::US10633345, Compound 254c::US10689346, Compound 254c::US11203574, Compound 254c::US11230530, Compound 254c::US11685721, Compound 254c	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416998	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416998&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665477	433916910							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896263	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C31H28F4N6O/c32-25-11-10-23(30(38,13-12-19-4-5-19)22-8-6-20(17-36)7-9-22)15-26(25)39-29(42)27-16-28(31(33,34)35)40-41(27)24-3-1-2-21(14-24)18-37/h1-3,6-11,14-16,19H,4-5,12-13,18,37-38H2,(H,39,42)	JCBKPNPCGNTAQN-UHFFFAOYSA-N	416993	(+)-N-(5-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 212g::US10633345, Compound 213d::US10689346, Compound 213d::US11203574, Compound 213d::US11230530, Compound 213d::US11685721, Compound 213d	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416993	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416993&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356170	433916905							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896264	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C#N	InChI=1S/C29H27FN6O/c30-25-12-11-22(28(33-18-19-9-10-19)21-6-2-1-3-7-21)14-26(25)34-29(37)27-15-23(17-32)35-36(27)24-8-4-5-20(13-24)16-31/h1-8,11-15,19,28,33H,9-10,16,18,31H2,(H,34,37)	OBANZZDEWOCPST-UHFFFAOYSA-N	417000	(+-)-1-(3-(aminomethyl)phenyl)-3-cyano-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 240b::US10633345, Compound 240b::US10689346, Compound 240b::US11203574, Compound 240b::US11230530, Compound 240b::US11685721, Compound 240b	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417000	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417000&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355661	433916912							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896265	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C32H28F4N6O/c33-25-11-9-22(31(38,14-12-19-6-7-19)21-4-2-1-3-5-21)16-26(25)40-30(43)27-18-28(32(34,35)36)41-42(27)23-10-8-20-13-15-39-29(37)24(20)17-23/h1-5,8-11,13,15-19H,6-7,12,14,38H2,(H2,37,39)(H,40,43)	SUIQVQQNEUOJQB-UHFFFAOYSA-N	417001	(+)-N-(5-(1-amino-3-cyclopropyl-1-phenylpropyl)-2-fluorophenyl)-1-(1-aminoisoquinolin-7-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 255a::US10633345, Compound 255a::US10689346, Compound 255a::US11203574, Compound 255a::US11230530, Compound 255a::US11685721, Compound 255a	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417001	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417001&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356059	433916913							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896266	Nc1noc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H24F4N6O2/c30-21-10-8-18(26(35-15-16-6-7-16)17-4-2-1-3-5-17)12-22(21)36-28(40)23-14-25(29(31,32)33)37-39(23)19-9-11-24-20(13-19)27(34)38-41-24/h1-5,8-14,16,26,35H,6-7,15H2,(H2,34,38)(H,36,40)	QWKNFIFTTXOPHF-UHFFFAOYSA-N	417002	(+-)-1-(3-aminobenzo[d]isoxazol-5-yl)-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 222k::US10329260, Compound 223f::US10633345, Compound 223f::US10689346, Compound 223f::US11203574, Compound 223f::US11230530, Compound 223f::US11685721, Compound 223f	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417002	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417002&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123289526	433916914							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896267	NC(=N)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C30H25F4N7O/c31-23-10-9-20(27(38-16-17-7-8-17)19-4-1-3-18(11-19)15-35)13-24(23)39-29(42)25-14-26(30(32,33)34)40-41(25)22-6-2-5-21(12-22)28(36)37/h1-6,9-14,17,27,38H,7-8,16H2,(H3,36,37)(H,39,42)	VIRFLKJDRZOSPM-UHFFFAOYSA-N	417003	(+)-1-(3-carbamimidoylphenyl)-N-(5-((3-cyanophenyl)(cyclopropylmethylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 236h::US10633345, Compound 236h::US10689346, Compound 236h::US11203574, Compound 236h::US11230530, Compound 236h::US11685721, Compound 236h	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417003	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417003&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665908	433916915							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896268	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C30H25F4N7O/c31-23-6-4-20(27(38-16-17-1-2-17)19-7-10-36-11-8-19)13-24(23)39-29(42)25-15-26(30(32,33)34)40-41(25)21-5-3-18-9-12-37-28(35)22(18)14-21/h3-15,17,27,38H,1-2,16H2,(H2,35,37)(H,39,42)	UQWHIYYZYLIMKJ-UHFFFAOYSA-N	417004	(+-)-1-(1-aminoisoquinolin-7-yl)-N-(5-((cyclopropylmethylamino)(pyridin-4-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 265d::US10633345, Compound 264g::US10689346, Compound 264g::US11203574, Compound 264g::US11230530, Compound 264g::US11685721, Compound 264g	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417004	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417004&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355979	433916916							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896269	Nc1noc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H24F4N6O2/c30-21-10-8-18(26(35-15-16-6-7-16)17-4-2-1-3-5-17)12-22(21)36-28(40)23-14-25(29(31,32)33)37-39(23)19-9-11-24-20(13-19)27(34)38-41-24/h1-5,8-14,16,26,35H,6-7,15H2,(H2,34,38)(H,36,40)	QWKNFIFTTXOPHF-UHFFFAOYSA-N	417002	(+-)-1-(3-aminobenzo[d]isoxazol-5-yl)-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 222k::US10329260, Compound 223f::US10633345, Compound 223f::US10689346, Compound 223f::US11203574, Compound 223f::US11230530, Compound 223f::US11685721, Compound 223f	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417002	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417002&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123289526	433916914							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896270	NC(=N)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C31H27F4N7O/c32-24-10-9-22(30(39,12-11-18-7-8-18)21-5-1-3-19(13-21)17-36)15-25(24)40-29(43)26-16-27(31(33,34)35)41-42(26)23-6-2-4-20(14-23)28(37)38/h1-6,9-10,13-16,18H,7-8,11-12,39H2,(H3,37,38)(H,40,43)	BZRUVEYOOHPOOF-UHFFFAOYSA-N	417006	(+)-N-(5-(1-amino-1-(3-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-carbamimidoylphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 237a::US10633345, Compound 237a::US10689346, Compound 237a::US11192861, Compound 237a::US11230530, Compound 237a::US11685721, Compound 237a	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417006	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417006&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356202	433916917							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896271	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C33H27F4N7O/c34-26-9-7-23(32(40,12-10-19-4-5-19)22-3-1-2-20(14-22)18-38)15-27(26)42-31(45)28-17-29(33(35,36)37)43-44(28)24-8-6-21-11-13-41-30(39)25(21)16-24/h1-3,6-9,11,13-17,19H,4-5,10,12,40H2,(H2,39,41)(H,42,45)	MNAPHYKXZOGSTD-UHFFFAOYSA-N	417007	(+)-N-(5-(1-amino-1-(3-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(1-aminoisoquinolin-7-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 256a::US10633345, Compound 256a::US10689346, Compound 256a::US11203574, Compound 256a::US11230530, Compound 256a::US11685721, Compound 256a	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417007	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417007&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665459	433916918							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896272	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(n1)C#N)C(F)(F)F	InChI=1S/C30H27F4N7O/c31-23-10-9-20(29(37,12-11-18-7-8-18)26-6-2-4-21(17-36)38-26)14-24(23)39-28(42)25-15-27(30(32,33)34)40-41(25)22-5-1-3-19(13-22)16-35/h1-6,9-10,13-15,18H,7-8,11-12,16,35,37H2,(H,39,42)	UYAYDZPBNCJYMZ-UHFFFAOYSA-N	417008	(+)-N-(5-(1-amino-1-(6-cyanopyridin-2-yl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 220f::US10633345, Compound 220f::US10689346, Compound 220f::US11203574, Compound 220f::US11230530, Compound 220f::US11685721, Compound 220f	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417008	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417008&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355858	433916919							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896273	CC(C)(C)[S@@](=O)NC(CCC1CC1)(c1cccnc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(c2)C(N)=N)C(F)(F)F)c1	InChI=1S/C33H35F4N7O2S/c1-31(2,3)47(46)43-32(14-13-20-9-10-20,23-7-5-15-40-19-23)22-11-12-25(34)26(17-22)41-30(45)27-18-28(33(35,36)37)42-44(27)24-8-4-6-21(16-24)29(38)39/h4-8,11-12,15-20,43H,9-10,13-14H2,1-3H3,(H3,38,39)(H,41,45)/t32?,47-/m1/s1	ORCJXCNQCCWVHD-HKYIEPEJSA-N	417009	1-(3-carbamimidoylphenyl)-N-(5-((+-)-3-cyclopropyl-1-((R)-1,1-dimethylethylsulfinamido)-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 238c::US10633345, Compound 238c::US10689346, Compound 238c::US11203574, Compound 238c::US11230530, Compound 238c::US11685721, Compound 238c	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417009	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417009&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355741	433916920							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896274	Nc1nccc2ccc(cc12)-n1nc(cc1C(F)(F)F)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1	InChI=1S/C31H27F4N7O/c32-24-6-4-21(30(37,11-7-18-1-2-18)20-9-12-38-13-10-20)15-25(24)40-29(43)26-17-27(31(33,34)35)42(41-26)22-5-3-19-8-14-39-28(36)23(19)16-22/h3-6,8-10,12-18H,1-2,7,11,37H2,(H2,36,39)(H,40,43)	JTQCWLVRCRAKSI-UHFFFAOYSA-N	417010	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-4-yl)propyl)-2-fluorophenyl)-1-(1-aminoisoquinolin-7-yl)-5-(trifluoromethyl)-1H-pyrazole-3-carboxamide::US10329260, Compound 268g::US10633345, Compound 268g::US10689346, Compound 268g::US11203574, Compound 268g::US11230530, Compound 268g::US11685721, Compound 268g	Plasma kallikrein		>75.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417010	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417010&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356088	433916921							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896275	Nc1n[nH]c2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F			439594	US10633345, Compound 224b::US10689346, Compound 224b::US11203574, Compound 224b::US11230530, Compound 224b	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439594	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439594&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155295687	439661142							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896276	NC(=N)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C31H27F4N7O/c32-24-11-10-22(30(39,13-12-18-4-5-18)21-8-6-19(17-36)7-9-21)15-25(24)40-29(43)26-16-27(31(33,34)35)41-42(26)23-3-1-2-20(14-23)28(37)38/h1-3,6-11,14-16,18H,4-5,12-13,39H2,(H3,37,38)(H,40,43)	QLTPSVVBRYJDCX-UHFFFAOYSA-N	417012	(+)-N-(5-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-carbamimidoylphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 241a::US10633345, Compound 241a::US10689346, Compound 241a::US11192861, Compound 241a::US11230530, Compound 241a::US11685721, Compound 241a	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417012	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417012&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665936	433916923							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896277	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccccc1=O)C(F)(F)F	InChI=1S/C31H26F4N6O2/c32-23-10-8-20(25(11-6-18-4-5-18)40-14-2-1-3-28(40)42)15-24(23)38-30(43)26-17-27(31(33,34)35)39-41(26)21-9-7-19-12-13-37-29(36)22(19)16-21/h1-3,7-10,12-18,25H,4-6,11H2,(H2,36,37)(H,38,43)	GNDQLXKOPYFGBP-UHFFFAOYSA-N	417013	1-(1-aminoisoquinolin-7-yl)-N-(5-(3-cyclopropyl-1-(2-oxopyridin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 258g::US10633345, Compound 258g::US10689346, Compound 258g::US11203574, Compound 258g::US11230530, Compound 258g::US11685721, Compound 258g	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417013	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417013&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355895	433916924							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896278	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C(N)=O)C(F)(F)F	InChI=1S/C31H30F4N6O2/c32-24-10-9-22(30(38,12-11-18-7-8-18)21-5-2-4-20(14-21)28(37)42)15-25(24)39-29(43)26-16-27(31(33,34)35)40-41(26)23-6-1-3-19(13-23)17-36/h1-6,9-10,13-16,18H,7-8,11-12,17,36,38H2,(H2,37,42)(H,39,43)	DYGHBBDYRMOWAC-UHFFFAOYSA-N	417014	(+-)-N-(5-(1-amino-1-(3-carbamoylphenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 225a::US10633345, Compound 225a::US10689346, Compound 225a::US11203574, Compound 225a::US11230530, Compound 225a::US11685721, Compound 225a	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417014	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417014&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665606	433916925							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896279	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C31H28F4N6O/c32-25-10-9-23(30(38,12-11-19-7-8-19)22-5-1-3-20(13-22)17-36)15-26(25)39-29(42)27-16-28(31(33,34)35)40-41(27)24-6-2-4-21(14-24)18-37/h1-6,9-10,13-16,19H,7-8,11-12,18,37-38H2,(H,39,42)	ZBDDMFBNDOEVJT-UHFFFAOYSA-N	416996	(+)-N-(5-(1-amino-1-(3-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 214g::US10633345, Compound 215d::US10689346, Compound 215d::US11203574, Compound 215d::US11230530, Compound 215d::US11685721, Compound 215d	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416996	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416996&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665709	433916908							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896280	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccccc1=O)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-11-10-20(24(12-9-18-7-8-18)37-13-2-1-6-27(37)39)15-23(22)35-28(40)25-16-26(29(31,32)33)36-38(25)21-5-3-4-19(14-21)17-34/h1-6,10-11,13-16,18,24H,7-9,12,17,34H2,(H,35,40)	OFQQGSYWUFBMPP-UHFFFAOYSA-N	416939	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(2-oxopyridin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 248j::US10633345, Compound 248k::US10689346, Compound 248k::US11203574, Compound 248k::US11230530, Compound 248k::US11685721, Compound 248k	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416939	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416939&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355727	433916851							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896281	Nc1ncnc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H25F4N7O/c31-22-10-8-19(27(36-15-17-6-7-17)18-4-2-1-3-5-18)12-24(22)39-29(42)25-14-26(30(32,33)34)40-41(25)20-9-11-23-21(13-20)28(35)38-16-37-23/h1-5,8-14,16-17,27,36H,6-7,15H2,(H,39,42)(H2,35,37,38)	NOYPEPJWHRTGGG-UHFFFAOYSA-N	417011	1-(4-aminoquinazolin-6-yl)-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 224b::US10329260, Compound 226a::US10633345, Compound 226a::US10689346, Compound 226a::US11203574, Compound 226a::US11230530, Compound 226a::US11685721, Compound 226a	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417011	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417011&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665806	433916922							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896282	NC(=N)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H27F4N7O/c30-22-9-8-19(28(36,11-10-17-6-7-17)20-4-2-12-37-16-20)14-23(22)38-27(41)24-15-25(29(31,32)33)39-40(24)21-5-1-3-18(13-21)26(34)35/h1-5,8-9,12-17H,6-7,10-11,36H2,(H3,34,35)(H,38,41)	JBCZLPFSSAYNEJ-UHFFFAOYSA-N	417018	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-1-(3-carbamimidoylphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 238d::US10633345, Compound 238d::US10689346, Compound 238d::US11192861, Compound 238d::US11230530, Compound 238d::US11685721, Compound 238d	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417018	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417018&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355839	433916928							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896283	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccccc1=O)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-11-10-20(24(12-9-18-7-8-18)37-13-2-1-6-27(37)39)15-23(22)35-28(40)25-16-26(29(31,32)33)36-38(25)21-5-3-4-19(14-21)17-34/h1-6,10-11,13-16,18,24H,7-9,12,17,34H2,(H,35,40)	OFQQGSYWUFBMPP-UHFFFAOYSA-N	416939	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(2-oxopyridin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 248j::US10633345, Compound 248k::US10689346, Compound 248k::US11203574, Compound 248k::US11230530, Compound 248k::US11685721, Compound 248k	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416939	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416939&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355727	433916851							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896284	NC(=N)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N6O/c30-22-12-11-19(26(36-16-17-9-10-17)18-5-2-1-3-6-18)14-23(22)37-28(40)24-15-25(29(31,32)33)38-39(24)21-8-4-7-20(13-21)27(34)35/h1-8,11-15,17,26,36H,9-10,16H2,(H3,34,35)(H,37,40)	HUIANTFJQLRTEM-UHFFFAOYSA-N	439603	US10633345, Compound 227d::US10689346, Compound 227d::US11203574, Compound 227d::US11230530, Compound 227d::US11685721, Compound 227d	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439603	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439603&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356162	439661151							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896285	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(nc1)C(N)=O)C(F)(F)F	InChI=1S/C30H29F4N7O2/c31-22-8-6-19(29(37,11-10-17-4-5-17)20-7-9-23(27(36)42)38-16-20)13-24(22)39-28(43)25-14-26(30(32,33)34)40-41(25)21-3-1-2-18(12-21)15-35/h1-3,6-9,12-14,16-17H,4-5,10-11,15,35,37H2,(H2,36,42)(H,39,43)	IQWHGFSUUIEJQU-UHFFFAOYSA-N	417021	(+)-5-(1-amino-1-(3-(1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamido)-4-fluorophenyl)-3-cyclopropylpropyl)picolinamide::US10329260, Compound 221i::US10633345, Compound 221i::US10689346, Compound 221i::US11203574, Compound 221i::US11230530, Compound 221i::US11685721, Compound 221i	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417021	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417021&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665782	433916931							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896286	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C30H25F4N7O/c31-23-6-4-20(27(38-16-17-1-2-17)19-7-10-36-11-8-19)13-24(23)39-29(42)25-15-26(30(32,33)34)40-41(25)21-5-3-18-9-12-37-28(35)22(18)14-21/h3-15,17,27,38H,1-2,16H2,(H2,35,37)(H,39,42)	UQWHIYYZYLIMKJ-UHFFFAOYSA-N	417004	(+-)-1-(1-aminoisoquinolin-7-yl)-N-(5-((cyclopropylmethylamino)(pyridin-4-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 265d::US10633345, Compound 264g::US10689346, Compound 264g::US11203574, Compound 264g::US11230530, Compound 264g::US11685721, Compound 264g	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417004	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417004&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355979	433916916							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896287	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C(N)=O)C(F)(F)F	InChI=1S/C31H30F4N6O2/c32-24-11-10-22(30(38,13-12-18-4-5-18)21-8-6-20(7-9-21)28(37)42)15-25(24)39-29(43)26-16-27(31(33,34)35)40-41(26)23-3-1-2-19(14-23)17-36/h1-3,6-11,14-16,18H,4-5,12-13,17,36,38H2,(H2,37,42)(H,39,43)	HZQICPCUMLWHPZ-UHFFFAOYSA-N	417023	(+)-N-(5-(1-amino-1-(4-carbamoylphenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 228a::US10633345, Compound 228a::US10689346, Compound 228a::US11203574, Compound 228a::US11230530, Compound 228a::US11685721, Compound 228a	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417023	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417023&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665484	433916933							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896288	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-23-7-6-21(28(35,11-8-18-4-5-18)20-9-12-36-13-10-20)15-24(23)37-27(40)25-16-26(29(31,32)33)38-39(25)22-3-1-2-19(14-22)17-34/h1-3,6-7,9-10,12-16,18H,4-5,8,11,17,34-35H2,(H,37,40)	AGVFYPDLNPHKER-UHFFFAOYSA-N	417024	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-4-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 216d::US10633345, Compound 217d::US10689346, Compound 217d::US11192861, Compound 217d::US11230530, Compound 217d::US11685721, Compound 217d	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417024	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417024&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665723	433916934							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896289	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)N1CCCCC1=O)C(F)(F)F	InChI=1S/C29H31F4N5O2/c30-22-11-10-20(24(12-9-18-7-8-18)37-13-2-1-6-27(37)39)15-23(22)35-28(40)25-16-26(29(31,32)33)36-38(25)21-5-3-4-19(14-21)17-34/h3-5,10-11,14-16,18,24H,1-2,6-9,12-13,17,34H2,(H,35,40)	BPULHNPIKAHCAG-UHFFFAOYSA-N	417025	(+)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(2-oxopiperidin-1-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 261k::US10633345, Compound 261k::US10689346, Compound 261k::US11203574, Compound 261k::US11230530, Compound 261k::US11685721, Compound 261k	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417025	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417025&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123312183	433916935							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896290	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(N)=O	InChI=1S/C29H29FN6O2/c30-23-12-11-21(27(33-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)34-29(38)26-15-25(28(32)37)35-36(26)22-8-4-5-19(13-22)16-31/h1-8,11-15,18,27,33H,9-10,16-17,31H2,(H2,32,37)(H,34,38)	UMNCVWUVWBVXCX-UHFFFAOYSA-N	417026	(+-)-1-(3-(aminomethyl)phenyl)-N5-(5-((cyclopropylmethylamino)-(phenyl)methyl)-2-fluorophenyl)-1H-pyrazole-3,5-dicarboxamide::US10329260, Compound 229i::US10633345, Compound 229i::US10689346, Compound 229i::US11203574, Compound 229i::US11230530, Compound 229i::US11685721, Compound 229i	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417026	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417026&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665747	433916936							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896291	CC(C)(C)[S@@](=O)NC(CCC1CC1)(c1cccnc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C33H36F4N6O2S/c1-31(2,3)46(45)42-32(14-13-21-9-10-21,24-7-5-15-39-20-24)23-11-12-26(34)27(17-23)40-30(44)28-18-29(33(35,36)37)41-43(28)25-8-4-6-22(16-25)19-38/h4-8,11-12,15-18,20-21,42H,9-10,13-14,19,38H2,1-3H3,(H,40,44)/t32?,46-/m1/s1	LAOWFCURFGDGCT-ODZHGNIVSA-N	417027	1-(3-(aminomethyl)phenyl)-N-(5-((+-)-3-cyclopropyl-1-((R)-1,1-dimethylethylsulfinamido)-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 243a::US10633345, Compound 243a::US10689346, Compound 243a::US11203574, Compound 243a::US11230530, Compound 243a::US11685721, Compound 243a	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417027	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417027&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665825	433916937							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896292	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccncc1=O)C(F)(F)F	InChI=1S/C30H25F4N7O2/c31-22-7-5-19(24(8-3-17-1-2-17)40-12-11-36-16-27(40)42)13-23(22)38-29(43)25-15-26(30(32,33)34)39-41(25)20-6-4-18-9-10-37-28(35)21(18)14-20/h4-7,9-17,24H,1-3,8H2,(H2,35,37)(H,38,43)	RGAKSJSQGQBUGG-UHFFFAOYSA-N	417028	1-(1-aminoisoquinolin-7-yl)-N-(5-(3-cyclopropyl-1-(2-oxopyrazin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 259d::US10633345, Compound 259d::US10689346, Compound 259d::US11203574, Compound 259d::US11230530, Compound 259d::US11685721, Compound 259d	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417028	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417028&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355792	433916938							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896293	NC(=O)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H25F4N5O2/c30-22-12-11-19(26(35-16-17-9-10-17)18-5-2-1-3-6-18)14-23(22)36-28(40)24-15-25(29(31,32)33)37-38(24)21-8-4-7-20(13-21)27(34)39/h1-8,11-15,17,26,35H,9-10,16H2,(H2,34,39)(H,36,40)	JMSFBJDWVQAENA-UHFFFAOYSA-N	417029	(+-)-1-(3-carbamoylphenyl)-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 230a::US10633345, Compound 230a::US10689346, Compound 230a::US11203574, Compound 230a::US11230530, Compound 230a::US11685721, Compound 230a	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417029	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417029&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665857	433916939							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896294	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-23-7-6-21(28(35,11-8-18-4-5-18)20-9-12-36-13-10-20)15-24(23)37-27(40)25-16-26(29(31,32)33)38-39(25)22-3-1-2-19(14-22)17-34/h1-3,6-7,9-10,12-16,18H,4-5,8,11,17,34-35H2,(H,37,40)	AGVFYPDLNPHKER-UHFFFAOYSA-N	417024	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-4-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 216d::US10633345, Compound 217d::US10689346, Compound 217d::US11192861, Compound 217d::US11230530, Compound 217d::US11685721, Compound 217d	Plasma kallikrein		>75.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417024	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417024&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665723	433916934							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896295	Cc1cc(ccn1)C(N)(CCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F4N6O/c1-18-13-22(10-12-37-18)29(36,11-9-19-5-6-19)21-7-8-24(31)25(15-21)38-28(41)26-16-27(30(32,33)34)39-40(26)23-4-2-3-20(14-23)17-35/h2-4,7-8,10,12-16,19H,5-6,9,11,17,35-36H2,1H3,(H,38,41)	PYONXWOUVYIBRU-UHFFFAOYSA-N	417031	(+)-N-(5-(1-amino-3-cyclopropyl-1-(2-methylpyridin-4-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 266j::US10633345, Compound 266j::US10689346, Compound 266j::US11203574, Compound 266j::US11230530, Compound 266j::US11685721, Compound 266j	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417031	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417031&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665585	433916941							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896296	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccc(=O)[nH]c1=O)C(F)(F)F			417032	1-(1-aminoisoquinolin-7-yl)-N-(5-(3-cyclopropyl-1-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 269b::US10633345, Compound 269b::US10689346, Compound 269b::US11203574, Compound 269b::US11230530, Compound 269b::US11685721, Compound 269b	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417032	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417032&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			154584237	433916942							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896297	CCNCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C31H31F4N5O/c1-2-36-18-21-7-6-10-24(15-21)40-27(17-28(39-40)31(33,34)35)30(41)38-26-16-23(13-14-25(26)32)29(37-19-20-11-12-20)22-8-4-3-5-9-22/h3-10,13-17,20,29,36-37H,2,11-12,18-19H2,1H3,(H,38,41)	RBEFOPDBDLERKF-UHFFFAOYSA-N	417033	(+-)-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-1-(3-((ethylamino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 270a::US10633345, Compound 270a::US10689346, Compound 270a::US11203574, Compound 270a::US11230530, Compound 270a::US11685721, Compound 270a	Plasma kallikrein		>75.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417033	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417033&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665791	433916943							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
895996	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc2CCNCc2cc1F)C(F)(F)F	InChI=1S/C21H19F4N5O/c22-16-7-14-11-27-5-4-13(14)8-17(16)28-20(31)18-9-19(21(23,24)25)29-30(18)15-3-1-2-12(6-15)10-26/h1-3,6-9,27H,4-5,10-11,26H2,(H,28,31)	XCBOZBQFIYATFU-UHFFFAOYSA-N	416716	1-(3-(aminomethyl)phenyl)-N-(7-fluoro-1,2,3,4-tetrahydroisoquinolin-6-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 161e::US10633345, Compound 161e::US10689346, Compound 161e::US11203574, Compound 161e::US11230530, Compound 161e::US11685721, Compound 161e	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416716	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416716&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356276	433916630							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
895997	CN(Cc1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1)c1ccccc1	InChI=1S/C26H24F3N5O/c1-33(21-10-3-2-4-11-21)17-19-8-5-9-20(13-19)31-25(35)23-15-24(26(27,28)29)32-34(23)22-12-6-7-18(14-22)16-30/h2-15H,16-17,30H2,1H3,(H,31,35)	IEARPKHOKPOLCS-UHFFFAOYSA-N	416717	1-(3-(aminomethyl)phenyl)-N-(3-((methyl(phenyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 28f::US10633345, Compound 28f::US10689346, Compound 28f::US11203574, Compound 28f::US11230530, Compound 28f::US11685721, Compound 28f	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416717	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416717&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665676	433916631							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
895998	CCCN(c1ccccc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C27H25F4N5O/c1-2-13-35(19-8-4-3-5-9-19)20-11-12-22(28)23(15-20)33-26(37)24-16-25(27(29,30)31)34-36(24)21-10-6-7-18(14-21)17-32/h3-12,14-16H,2,13,17,32H2,1H3,(H,33,37)	NZQCKHUBEMVLQD-UHFFFAOYSA-N	416718	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-5-(phenyl(propyl)amino)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 77e::US10633345, Compound 77e::US10689346, Compound 77e::US11203574, Compound 77e::US11230530, Compound 77e::US11685721, Compound 77e	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416718	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416718&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665730	433916632							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
895999	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1ccc2CNCCc2c1F)C(F)(F)F	InChI=1S/C21H19F4N5O/c22-19-15-6-7-27-11-13(15)4-5-16(19)28-20(31)17-9-18(21(23,24)25)29-30(17)14-3-1-2-12(8-14)10-26/h1-5,8-9,27H,6-7,10-11,26H2,(H,28,31)	RYNJWLCYWDTYKF-UHFFFAOYSA-N	416719	1-(3-(aminomethyl)phenyl)-N-(5-fluoro-1,2,3,4-tetrahydroisoquinolin-6-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 162c::US10633345, Compound 162c::US10689346, Compound 162c::US11203574, Compound 162c::US11230530, Compound 162c::US11685721, Compound 162c	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416719	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416719&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665528	433916633							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896000	CCCN(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1F	InChI=1S/C27H25F4N5O/c1-2-14-35(19-9-4-3-5-10-19)22-13-7-12-21(25(22)28)33-26(37)23-16-24(27(29,30)31)34-36(23)20-11-6-8-18(15-20)17-32/h3-13,15-16H,2,14,17,32H2,1H3,(H,33,37)	SDFZIQBGIDPGAP-UHFFFAOYSA-N	416720	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-3-(phenyl(propyl)amino)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 29e::US10633345, Compound 29e::US10689346, Compound 29e::US11203574, Compound 29e::US11230530, Compound 29e::US11685721, Compound 29e	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416720	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416720&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355654	433916634							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896001	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C28H26F3N5O2/c29-28(30,31)25-15-24(36(35-25)22-8-3-5-19(13-22)16-32)27(37)34-21-7-4-6-20(14-21)26(38-17-18-10-11-18)23-9-1-2-12-33-23/h1-9,12-15,18,26H,10-11,16-17,32H2,(H,34,37)	UBQUVYTUKOFUOF-UHFFFAOYSA-N	416721	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(pyridin-2-yl)methyl)-phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 43f::US10633345, Compound 43f::US10689346, Compound 43g::US11203574, Compound 43h::US11230530, Compound 43h::US11685721, Compound 43f	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416721	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416721&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355947	433916635							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896002	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc2CNCCc2cc1F)C(F)(F)F	InChI=1S/C21H19F4N5O/c22-16-7-13-4-5-27-11-14(13)8-17(16)28-20(31)18-9-19(21(23,24)25)29-30(18)15-3-1-2-12(6-15)10-26/h1-3,6-9,27H,4-5,10-11,26H2,(H,28,31)	APLBFUXJEQDPBH-UHFFFAOYSA-N	416722	1-(3-(aminomethyl)phenyl)-N-(6-fluoro-1,2,3,4-tetrahydroisoquinolin-7-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 163g::US10633345, Compound 163g::US10689346, Compound 163g::US11203574, Compound 163g::US11230530, Compound 163g::US11685721, Compound 163g	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416722	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416722&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355616	433916636							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896003	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(Cn2ccnc2)ccc1F)C(F)(F)F	InChI=1S/C22H18F4N6O/c23-17-5-4-15(12-31-7-6-28-13-31)9-18(17)29-21(33)19-10-20(22(24,25)26)30-32(19)16-3-1-2-14(8-16)11-27/h1-10,13H,11-12,27H2,(H,29,33)	FOWNNAMOGPFGSS-UHFFFAOYSA-N	416723	N-(5-((1H-imidazol-1-yl)methyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 30g::US10633345, Compound 30g::US10689346, Compound 30g::US11203574, Compound 30g::US11230530, Compound 30g::US11685721, Compound 30g	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416723	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416723&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356018	433916637							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896004	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H26F3N5O2/c29-28(30,31)25-14-24(36(35-25)23-8-1-4-19(12-23)15-32)27(37)34-22-7-2-5-20(13-22)26(38-17-18-9-10-18)21-6-3-11-33-16-21/h1-8,11-14,16,18,26H,9-10,15,17,32H2,(H,34,37)	SHFRWTHPPCXLER-UHFFFAOYSA-N	416725	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(pyridin-3-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 44c::US10633345, Compound 44c::US10689346, Compound 44c::US11203574, Compound 44d::US11230530, Compound 44e::US11685721, Compound 44c	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416725	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416725&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355578	433916639							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896005	Fc1ccccc1C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(c2)C#N)C(F)(F)F)c1	InChI=1S/C29H23F4N5O/c30-24-10-2-1-9-23(24)27(35-17-18-11-12-18)20-6-4-7-21(14-20)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-3-5-19(13-22)16-34/h1-10,13-15,18,27,35H,11-12,17H2,(H,36,39)	FNFLJTHHDSXOBP-UHFFFAOYSA-N	439311	US10633345, Compound 17d	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439311	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439311&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126689745	439660869							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896006	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)c1cccnc1)C(F)(F)F	InChI=1S/C24H20F3N5O2/c25-24(26,27)21-12-20(32(31-21)19-8-1-4-15(10-19)13-28)23(34)30-18-7-2-5-16(11-18)22(33)17-6-3-9-29-14-17/h1-12,14,22,33H,13,28H2,(H,30,34)	ZKOHYLRGOQBIFH-UHFFFAOYSA-N	416729	1-(3-(aminomethyl)phenyl)-N-(3-(hydroxy(pyridin-3-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 31f::US10633345, Compound 31f::US10689346, Compound 31f::US11203574, Compound 31f::US11230530, Compound 31f	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416729	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416729&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665970	433916643							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896007	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F3N4O/c31-30(32,33)28-18-27(37(36-28)25-11-4-6-21(16-25)19-34)29(38)35-24-10-5-9-23(17-24)26(15-14-20-12-13-20)22-7-2-1-3-8-22/h1-11,16-18,20,26H,12-15,19,34H2,(H,35,38)	LVGPKQXQIQRVCT-UHFFFAOYSA-N	416730	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-phenylpropyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 78d::US10633345, Compound 78d::US10689346, Compound 78d::US11203574, Compound 78d::US11230530, Compound 78d::US11685721, Compound 78d	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416730	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416730&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665672	433916644							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896008	COC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C26H23F3N4O2/c1-35-24(18-8-3-2-4-9-18)19-10-6-11-20(14-19)31-25(34)22-15-23(26(27,28)29)32-33(22)21-12-5-7-17(13-21)16-30/h2-15,24H,16,30H2,1H3,(H,31,34)	XNHGZPIIDJTQKO-UHFFFAOYSA-N	416731	1-(3-(aminomethyl)phenyl)-N-(3-(methoxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18f::US10633345, Compound 18f::US10689346, Compound 18f::US11203574, Compound 18f::US11230530, Compound 18e::US11685721, Compound 18f	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416731	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416731&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665801	433916645							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896009	CCCCC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C29H29F3N4O/c1-2-3-15-25(21-10-5-4-6-11-21)22-12-8-13-23(17-22)34-28(37)26-18-27(29(30,31)32)35-36(26)24-14-7-9-20(16-24)19-33/h4-14,16-18,25H,2-3,15,19,33H2,1H3,(H,34,37)	PEZPMDJZISDDKH-UHFFFAOYSA-N	416732	1-(3-(aminomethyl)phenyl)-N-(3-(1-phenylpentyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 32f::US10633345, Compound 32f::US10689346, Compound 32f::US11203574, Compound 32f::US11230530, Compound 32f::US11685721, Compound 32f	Plasma kallikrein		>75.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416732	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416732&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356224	433916646							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896010	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H27F3N6O/c29-28(30,31)25-14-24(37(36-25)23-8-1-4-19(12-23)15-32)27(38)35-22-7-2-5-20(13-22)26(34-16-18-9-10-18)21-6-3-11-33-17-21/h1-8,11-14,17-18,26,34H,9-10,15-16,32H2,(H,35,38)	KSDPGGAAGHTRLB-UHFFFAOYSA-N	416733	1-(3-(Aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(pyridin-3-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 79f::US10633345, Compound 79f::US10689346, Compound 79f::US11203574, Compound 79f::US11230530, Compound 79f::US11685721, Compound 79f	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416733	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416733&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356066	433916647							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896011	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(Cc2ccccc2)c1)C(F)(F)F	InChI=1S/C25H21F3N4O/c26-25(27,28)23-15-22(32(31-23)21-11-5-9-19(14-21)16-29)24(33)30-20-10-4-8-18(13-20)12-17-6-2-1-3-7-17/h1-11,13-15H,12,16,29H2,(H,30,33)	GVRJCFWHVBXPLW-UHFFFAOYSA-N	416734	1-(3-(aminomethyl)phenyl)-N-(3-benzylphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 19d::US10633345, Compound 19d::US10689346, Compound 19d::US11203574, Compound 19d::US11230530, Compound 19d::US11685721, Compound 19d	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416734	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416734&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355715	433916648							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896012	CCOC(c1ccccc1)c1ccc(Cl)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C27H24ClF3N4O2/c1-2-37-25(18-8-4-3-5-9-18)19-11-12-21(28)22(14-19)33-26(36)23-15-24(27(29,30)31)34-35(23)20-10-6-7-17(13-20)16-32/h3-15,25H,2,16,32H2,1H3,(H,33,36)	XUCZWPPXZIMXPF-UHFFFAOYSA-N	416735	1-(3-(aminomethyl)phenyl)-N-(2-chloro-5-(ethoxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 33e::US10633345, Compound 33e::US10689346, Compound 33e::US11203574, Compound 33e::US11230530, Compound 33e::US11685721, Compound 33e	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416735	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416735&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665706	433916649							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896013	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(F)cc(c1)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-22-12-21(27(39-17-18-9-10-18)20-6-2-1-3-7-20)13-23(14-22)35-28(38)25-15-26(29(31,32)33)36-37(25)24-8-4-5-19(11-24)16-34/h1-8,11-15,18,27H,9-10,16-17,34H2,(H,35,38)	CECISELXZFBKBA-UHFFFAOYSA-N	416736	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)-5-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 80h::US10633345, Compound 80h::US10689346, Compound 80h::US11203574, Compound 80h::US11230530, Compound 80h::US11685721, Compound 80h	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416736	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416736&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356068	433916650							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896014	CC(C)c1ccc(cc1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(c2)C#N)C(F)(F)F)c1	InChI=1S/C32H30F3N5O/c1-20(2)23-11-13-24(14-12-23)30(37-19-21-9-10-21)25-6-4-7-26(16-25)38-31(41)28-17-29(32(33,34)35)39-40(28)27-8-3-5-22(15-27)18-36/h3-8,11-17,20-21,30,37H,9-10,19H2,1-2H3,(H,38,41)	PYHXQCOIBCBYEA-UHFFFAOYSA-N	439320	US10633345, Compound 20d	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439320	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439320&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665491	439660878							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896015	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1Cl)C(O)c1ccccc1)C(F)(F)F	InChI=1S/C25H20ClF3N4O2/c26-19-10-9-17(23(34)16-6-2-1-3-7-16)12-20(19)31-24(35)21-13-22(25(27,28)29)32-33(21)18-8-4-5-15(11-18)14-30/h1-13,23,34H,14,30H2,(H,31,35)	RYPOCSQZGRAPIF-UHFFFAOYSA-N	416738	1-(3-(aminomethyl)phenyl)-N-(2-chloro-5-(hydroxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 33f::US10633345, Compound 33f::US10689346, Compound 33f::US11203574, Compound 33f::US11230530, Compound 33f::US11685721, Compound 33f	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416738	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416738&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665810	433916652							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896016	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)N(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H28F3N5O/c30-29(31,32)27-18-26(37(35-27)25-11-4-6-21(16-25)19-33)28(38)34-22-7-5-10-24(17-22)36(15-14-20-12-13-20)23-8-2-1-3-9-23/h1-11,16-18,20H,12-15,19,33H2,(H,34,38)	BPUAEVGWEFCIEW-UHFFFAOYSA-N	416739	1-(3-(aminomethyl)phenyl)-N-(3-((2-cyclopropylethyl)(phenyl)amino)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 87f::US10633345, Compound 87f::US10689346, Compound 87f::US11203574, Compound 87f::US11230530, Compound 87f::US11685721, Compound 87f	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416739	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416739&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665744	433916653							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896017	CCOC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C27H25F3N4O2/c1-2-36-25(19-9-4-3-5-10-19)20-11-7-12-21(15-20)32-26(35)23-16-24(27(28,29)30)33-34(23)22-13-6-8-18(14-22)17-31/h3-16,25H,2,17,31H2,1H3,(H,32,35)	NWRGIGNKIBZYEM-UHFFFAOYSA-N	416740	1-(3-(aminomethyl)phenyl)-N-(3-(ethoxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18g::US10633345, Compound 18g::US10689346, Compound 18g::US11203574, Compound 18g::US11230530, Compound 18g::US11685721, Compound 18g	Plasma kallikrein		>75.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416740	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416740&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356270	433916654							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896018	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)c1ccccc1)C(F)(F)F	InChI=1S/C25H20F4N4O2/c26-19-10-9-17(23(34)16-6-2-1-3-7-16)12-20(19)31-24(35)21-13-22(25(27,28)29)32-33(21)18-8-4-5-15(11-18)14-30/h1-13,23,34H,14,30H2,(H,31,35)	SUGJHCONPCVXKJ-UHFFFAOYSA-N	416741	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-5-(hydroxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 34d::US10633345, Compound 34d::US10689346, Compound 34d::US11203574, Compound 34d::US11230530, Compound 34d::US11685721, Compound 34d	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416741	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416741&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665740	433916655							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896019	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(C(NCC2CC2)c2ccccc2)c1F)C(F)(F)F	InChI=1S/C29H27F4N5O/c30-26-22(27(35-17-18-12-13-18)20-7-2-1-3-8-20)10-5-11-23(26)36-28(39)24-15-25(29(31,32)33)37-38(24)21-9-4-6-19(14-21)16-34/h1-11,14-15,18,27,35H,12-13,16-17,34H2,(H,36,39)	YDBPNMJFMRHCIG-UHFFFAOYSA-N	416742	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 88b::US10633345, Compound 88b::US10689346, Compound 88b::US11203574, Compound 88b::US11230530, Compound 88b::US11685721, Compound 88b	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416742	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416742&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123349010	433916656							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896020	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(=O)c1ccccc1)C(F)(F)F	InChI=1S/C25H19F3N4O2/c26-25(27,28)22-14-21(32(31-22)20-11-4-6-16(12-20)15-29)24(34)30-19-10-5-9-18(13-19)23(33)17-7-2-1-3-8-17/h1-14H,15,29H2,(H,30,34)	ZRVRSUVIXBEHIJ-UHFFFAOYSA-N	416743	1-(3-(aminomethyl)phenyl)-N-(3-benzoylphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 22b::US10633345, Compound 22b::US10689346, Compound 22b::US11203574, Compound 22b::US11230530, Compound 22b	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416743	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416743&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355917	433916657							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896021	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(C(O)c2ccccc2)c1F)C(F)(F)F	InChI=1S/C25H20F4N4O2/c26-22-18(23(34)16-7-2-1-3-8-16)10-5-11-19(22)31-24(35)20-13-21(25(27,28)29)32-33(20)17-9-4-6-15(12-17)14-30/h1-13,23,34H,14,30H2,(H,31,35)	DENXCWXVTOPLRK-UHFFFAOYSA-N	416744	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-3-(hydroxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 35g::US10633345, Compound 35g::US10689346, Compound 35g::US11203574, Compound 35g::US11230530, Compound 35g::US11685721, Compound 35g	Plasma kallikrein		>75.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416744	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416744&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355965	433916658							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896022	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1nccs1)C(F)(F)F	InChI=1S/C26H24F3N5O2S/c27-26(28,29)22-13-21(34(33-22)20-6-1-3-17(11-20)14-30)24(35)32-19-5-2-4-18(12-19)23(25-31-9-10-37-25)36-15-16-7-8-16/h1-6,9-13,16,23H,7-8,14-15,30H2,(H,32,35)	FKPORVMTXYTRPN-UHFFFAOYSA-N	416745	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(thiazol-2-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 82f::US10633345, Compound 82f::US10689346, Compound 82f::US11203574, Compound 82f::US11230530, Compound 82f::US11685721, Compound 82f	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416745	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416745&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355763	433916659							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896023	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(Oc2ccccc2)c1F)C(F)(F)F	InChI=1S/C24H18F4N4O2/c25-22-18(10-5-11-20(22)34-17-8-2-1-3-9-17)30-23(33)19-13-21(24(26,27)28)31-32(19)16-7-4-6-15(12-16)14-29/h1-13H,14,29H2,(H,30,33)	VUYMCUFLTORTFW-UHFFFAOYSA-N	416746	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-3-phenoxyphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 23c::US10633345, Compound 23c::US10689346, Compound 23c::US11203574, Compound 23c::US11230530, Compound 23c::US11685721, Compound 23c	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416746	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416746&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665745	433916660							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896024	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-23-12-11-21(27(39-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)35-28(38)25-15-26(29(31,32)33)36-37(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27H,9-10,16-17,34H2,(H,35,38)	HIMJVDQVZQMIPM-UHFFFAOYSA-N	416747	1-(3-(Aminomethyl)phenyl)-N-(5-((cyclopropylmethoxy)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 34c::US10633345, Compound 34c::US10689346, Compound 34c::US11203574, Compound 37a::US11230530, Compound 37a::US11685721, Compound 34c	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416747	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416747&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355729	433916661							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896025	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C28H27F3N6O/c29-28(30,31)25-15-24(37(36-25)22-8-3-5-19(13-22)16-32)27(38)35-21-7-4-6-20(14-21)26(34-17-18-10-11-18)23-9-1-2-12-33-23/h1-9,12-15,18,26,34H,10-11,16-17,32H2,(H,35,38)	UTXGSCUKCKWESJ-UHFFFAOYSA-N	416748	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(pyridin-2-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 83c::US10633345, Compound 83c::US10689346, Compound 83c::US11203574, Compound 83c::US11230530, Compound 83c::US11685721, Compound 83c	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416748	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416748&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355952	433916662							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896026	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(Oc2ccccc2)ccc1F)C(F)(F)F	InChI=1S/C24H18F4N4O2/c25-19-10-9-18(34-17-7-2-1-3-8-17)12-20(19)30-23(33)21-13-22(24(26,27)28)31-32(21)16-6-4-5-15(11-16)14-29/h1-13H,14,29H2,(H,30,33)	RDALDQDNCYVLAM-UHFFFAOYSA-N	416749	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-5-phenoxyphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 24c::US10633345, Compound 24c::US10689346, Compound 24c::US11203574, Compound 24c::US11230530, Compound 24c::US11685721, Compound 24c	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416749	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416749&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356123	433916663							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896027	FC(F)(F)c1cc(C(=O)Nc2cccc(c2)C(=O)c2ccccc2)n(n1)-c1cccc(c1)C#N	InChI=1S/C25H15F3N4O2/c26-25(27,28)22-14-21(32(31-22)20-11-4-6-16(12-20)15-29)24(34)30-19-10-5-9-18(13-19)23(33)17-7-2-1-3-8-17/h1-14H,(H,30,34)	BHKYENHRJMAGRJ-UHFFFAOYSA-N	439334	US10633345, Compound 18e	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439334	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439334&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665688	439660892							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896028	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F3N4O2/c31-30(32,33)27-18-26(37(36-27)25-11-4-6-21(16-25)19-34)28(38)35-24-10-5-9-23(17-24)29(39,15-14-20-12-13-20)22-7-2-1-3-8-22/h1-11,16-18,20,39H,12-15,19,34H2,(H,35,38)	DCGYPXFSNPCKGX-UHFFFAOYSA-N	416751	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 46g::US10633345, Compound 46g::US10689346, Compound 46g::US11203574, Compound 46i::US11230530, Compound 46i::US11685721, Compound 46g	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416751	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416751&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355790	433916665							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896029	CCOC(c1ccccc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C27H24F4N4O2/c1-2-37-25(18-8-4-3-5-9-18)19-11-12-21(28)22(14-19)33-26(36)23-15-24(27(29,30)31)34-35(23)20-10-6-7-17(13-20)16-32/h3-15,25H,2,16,32H2,1H3,(H,33,36)	YVBRMUSUELCGNA-UHFFFAOYSA-N	416752	1-(3-(aminomethyl)phenyl)-N-(5-(ethoxy(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 25b::US10633345, Compound 25b::US10689346, Compound 25b::US11203574, Compound 25b::US11230530, Compound 25b::US11685721, Compound 25b	Plasma kallikrein		>75.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416752	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416752&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665520	433916666							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896030	CC(C)[C@H](N)C(=O)OC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O3/c1-18(2)26(35)29(40)41-27(20-9-4-3-5-10-20)21-11-7-12-22(15-21)36-28(39)24-16-25(30(31,32)33)37-38(24)23-13-6-8-19(14-23)17-34/h3-16,18,26-27H,17,34-35H2,1-2H3,(H,36,39)/t26-,27?/m0/s1	OQCWFOUCOSAWQU-QBHOUYDASA-N	416753	(2S)-(3-(1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamido)phenyl)(phenyl)methyl 2-amino-3-methylbutanoate::US10329260, Compound 81c::US10633345, Compound 81c::US10689346, Compound 81c::US11203574, Compound 81c::US11230530, Compound 81c::US11685721, Compound 81c	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416753	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416753&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355992	433916667					C03317		1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896031	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-22-10-9-20(28(35,12-11-18-7-8-18)25-6-1-2-13-36-25)15-23(22)37-27(40)24-16-26(29(31,32)33)38-39(24)21-5-3-4-19(14-21)17-34/h1-6,9-10,13-16,18H,7-8,11-12,17,34-35H2,(H,37,40)	IFWBAIGKQKRJGJ-UHFFFAOYSA-N	416975	(+-)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 205d::US10633345, Compound 205c::US10689346, Compound 205e::US11203574, Compound 205e::US11230530, Compound 205e::US11685721, Compound 205f	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416975	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416975&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665627	433916887							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896032	COC(c1ccccc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C26H22F4N4O2/c1-36-24(17-7-3-2-4-8-17)18-10-11-20(27)21(13-18)32-25(35)22-14-23(26(28,29)30)33-34(22)19-9-5-6-16(12-19)15-31/h2-14,24H,15,31H2,1H3,(H,32,35)	AJQPEPSKLFPFIU-UHFFFAOYSA-N	416755	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-5-(methoxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 25c::US10633345, Compound 25c::US10689346, Compound 25c::US11203574, Compound 25c::US11230530, Compound 25c::US11685721, Compound 25c	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416755	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416755&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126666045	433916669							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896033	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CC#N)c1ccccc1)C(F)(F)F	InChI=1S/C27H22F3N5O/c28-27(29,30)25-16-24(35(34-25)22-11-4-6-18(14-22)17-32)26(36)33-21-10-5-9-20(15-21)23(12-13-31)19-7-2-1-3-8-19/h1-11,14-16,23H,12,17,32H2,(H,33,36)	AUPCAIQBGWQVBR-UHFFFAOYSA-N	416756	1-(3-(aminomethyl)phenyl)-N-(3-(2-cyano-1-phenylethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 39e::US10633345, Compound 39e::US10689346, Compound 39e::US11203574, Compound 39e::US11230530, Compound 39e::US11685721, Compound 39e	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416756	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416756&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126666023	433916670							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896034	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CCC1CC1)n1ccnc1)C(F)(F)F	InChI=1S/C27H27F3N6O/c28-27(29,30)25-15-24(36(34-25)22-6-1-3-19(13-22)16-31)26(37)33-21-5-2-4-20(14-21)23(10-9-18-7-8-18)35-12-11-32-17-35/h1-6,11-15,17-18,23H,7-10,16,31H2,(H,33,37)	UPEDWOJFQGRWOZ-UHFFFAOYSA-N	416757	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-(1H-imidazol-1-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 89g::US10633345, Compound 89g::US10689346, Compound 89g::US11203574, Compound 89g::US11230530, Compound 89g::US11685721, Compound 89g	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416757	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416757&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665540	433916671							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896035	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(Cc2ccccc2)ccc1F)C(F)(F)F	InChI=1S/C25H20F4N4O/c26-20-10-9-17(11-16-5-2-1-3-6-16)13-21(20)31-24(34)22-14-23(25(27,28)29)32-33(22)19-8-4-7-18(12-19)15-30/h1-10,12-14H,11,15,30H2,(H,31,34)	PFWDQKVXCJEZES-UHFFFAOYSA-N	416758	1-(3-(aminomethyl)phenyl)-N-(5-benzyl-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 26f::US10633345, Compound 26f::US10689346, Compound 26f::US11203574, Compound 26f::US11230530, Compound 26f::US11685721, Compound 26f	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416758	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416758&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355900	433916672							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896036	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CC(N)=O)c1ccccc1)C(F)(F)F	InChI=1S/C27H24F3N5O2/c28-27(29,30)24-15-23(35(34-24)21-11-4-6-17(12-21)16-31)26(37)33-20-10-5-9-19(13-20)22(14-25(32)36)18-7-2-1-3-8-18/h1-13,15,22H,14,16,31H2,(H2,32,36)(H,33,37)	KDXRDWIYPXSJST-UHFFFAOYSA-N	416759	N-(3-(3-amino-3-oxo-1-phenylpropyl)phenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 40b::US10633345, Compound 40b::US10689346, Compound 40b::US11203574, Compound 40b::US11230530, Compound 40b::US11685721, Compound 40b	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416759	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416759&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665680	433916673							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896037	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(=CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H27F3N4O/c31-30(32,33)28-18-27(37(36-28)25-11-4-6-21(16-25)19-34)29(38)35-24-10-5-9-23(17-24)26(15-14-20-12-13-20)22-7-2-1-3-8-22/h1-11,15-18,20H,12-14,19,34H2,(H,35,38)/b26-15+	VKLRLOSKQDEQAH-CVKSISIWSA-N	439345	US10633345, Compound 91a::US10689346, Compound 91a::US11192861, Compound 91a::US11230530, Compound 91a	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439345	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439345&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			153066367	439660903							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896038	CC(C)COC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C29H29F3N4O2/c1-19(2)18-38-27(21-9-4-3-5-10-21)22-11-7-12-23(15-22)34-28(37)25-16-26(29(30,31)32)35-36(25)24-13-6-8-20(14-24)17-33/h3-16,19,27H,17-18,33H2,1-2H3,(H,34,37)	FMSXMXLNUZXXSC-UHFFFAOYSA-N	416762	1-(3-(aminomethyl)phenyl)-N-(3-(isobutoxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18i::US10633345, Compound 18i::US10689346, Compound 18i::US11203574, Compound 18i::US11230530, Compound 18i::US11685721, Compound 18i	Plasma kallikrein		>75.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416762	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416762&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356257	433916676							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896039	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H28F3N5O/c30-29(31,32)26-16-25(37(36-26)24-11-4-6-20(14-24)17-33)28(38)35-23-10-5-9-22(15-23)27(34-18-19-12-13-19)21-7-2-1-3-8-21/h1-11,14-16,19,27,34H,12-13,17-18,33H2,(H,35,38)	QZQLNMURVWFZTC-UHFFFAOYSA-N	439347	US10633345, Compound 41e::US10689346, Compound 41e::US11203574, Compound 41e::US11230530, Compound 41e	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439347	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439347&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665751	439660905							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896040	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C28H27F3N6O/c29-28(30,31)25-15-24(37(36-25)23-6-1-3-19(13-23)16-32)27(38)35-22-5-2-4-21(14-22)26(34-17-18-7-8-18)20-9-11-33-12-10-20/h1-6,9-15,18,26,34H,7-8,16-17,32H2,(H,35,38)	VXJYGPKEYKOJCQ-UHFFFAOYSA-N	416764	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(pyridin-4-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 86g::US10633345, Compound 86g::US10689346, Compound 86g::US11203574, Compound 86g::US11230530, Compound 86g::US11685721, Compound 86g	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416764	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416764&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355880	433916678							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896041	CCCOC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C28H27F3N4O2/c1-2-14-37-26(20-9-4-3-5-10-20)21-11-7-12-22(16-21)33-27(36)24-17-25(28(29,30)31)34-35(24)23-13-6-8-19(15-23)18-32/h3-13,15-17,26H,2,14,18,32H2,1H3,(H,33,36)	ODVQLXVRAUDBCL-UHFFFAOYSA-N	416765	1-(3-(aminomethyl)phenyl)-N-(3-(phenyl(propoxy)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18h::US10633345, Compound 18k::US10689346, Compound 18h::US11203574, Compound 18h::US11230530, Compound 18h::US11685721, Compound 18h	Plasma kallikrein		>75.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416765	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416765&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665753	433916679							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896042	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F3N4O2/c30-29(31,32)26-16-25(36(35-26)24-11-4-6-20(14-24)17-33)28(37)34-23-10-5-9-22(15-23)27(38-18-19-12-13-19)21-7-2-1-3-8-21/h1-11,14-16,19,27H,12-13,17-18,33H2,(H,34,37)	PEZVPVUPSJXZCH-UHFFFAOYSA-N	416775	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18k::US10633345, Compound 74a::US10689346, Compound 165e::US11203574, Compound 165e::US11230530, Compound 165e::US11685721, Compound 18k	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416775	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416775&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			91884591	433916689							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896043	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-17-24(37(36-26)23-8-3-5-20(15-23)18-33)27(38)35-22-7-4-6-21(16-22)28(39,13-12-19-10-11-19)25-9-1-2-14-34-25/h1-9,14-17,19,39H,10-13,18,33H2,(H,35,38)	BAOACYBKKSTHLE-UHFFFAOYSA-N	416767	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 45g::US10633345, Compound 45g::US10689346, Compound 45g::US11203574, Compound 45g::US11230530, Compound 45g::US11685721, Compound 45g	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416767	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416767&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665639	433916681							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896044	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(=O)Nc1ccccc1)C(F)(F)F	InChI=1S/C25H20F3N5O2/c26-25(27,28)22-14-21(33(32-22)20-11-4-6-16(12-20)15-29)24(35)31-19-10-5-7-17(13-19)23(34)30-18-8-2-1-3-9-18/h1-14H,15,29H2,(H,30,34)(H,31,35)	HDBCJKHEPGEJHK-UHFFFAOYSA-N	416768	1-(3-(aminomethyl)phenyl)-N-(3-(phenylcarbamoyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 21e::US10633345, Compound 21e::US10689346, Compound 21e::US11203574, Compound 21e::US11230530, Compound 21e::US11685721, Compound 21e	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416768	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416768&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665523	433916682							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896045	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CCC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F3N4O2/c31-30(32,33)27-17-26(37(36-27)25-14-5-9-21(15-25)18-34)29(38)35-24-13-6-12-23(16-24)28(22-10-2-1-3-11-22)39-19-20-7-4-8-20/h1-3,5-6,9-17,20,28H,4,7-8,18-19,34H2,(H,35,38)	KBAGRISCOGFVJB-UHFFFAOYSA-N	416769	1-(3-(aminomethyl)phenyl)-N-(3-((cyclobutylmethoxy)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 75a::US10633345, Compound 75a::US10689346, Compound 75a::US11203574, Compound 75a::US11230530, Compound 75a::US11685721, Compound 75a	Plasma kallikrein		>75.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416769	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416769&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665761	433916683							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896046	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-16-25(37(36-26)24-8-1-4-20(14-24)17-33)27(38)35-23-7-2-5-21(15-23)28(39,12-11-19-9-10-19)22-6-3-13-34-18-22/h1-8,13-16,18-19,39H,9-12,17,33H2,(H,35,38)	AOCZEQQKIIWUBU-UHFFFAOYSA-N	416770	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 47f::US10633345, Compound 47f::US10689346, Compound 47f::US11203574, Compound 47g::US11230530, Compound 47h::US11685721, Compound 47f	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416770	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416770&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355766	433916684							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896047	CCCCOC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C29H29F3N4O2/c1-2-3-15-38-27(21-10-5-4-6-11-21)22-12-8-13-23(17-22)34-28(37)25-18-26(29(30,31)32)35-36(25)24-14-7-9-20(16-24)19-33/h4-14,16-18,27H,2-3,15,19,33H2,1H3,(H,34,37)	PKUIOUWZEKKIOY-UHFFFAOYSA-N	416772	1-(3-(aminomethyl)phenyl)-N-(3-(butoxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18j::US10633345, Compound 18j::US10689346, Compound 18j::US11203574, Compound 18j::US11230530, Compound 18j::US11685721, Compound 18j	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416772	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416772&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356140	433916686							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896048	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F4N5O/c30-23-12-11-21(27(35-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27,35H,9-10,16-17,34H2,(H,36,39)	MCLZOCFEIKBMBA-UHFFFAOYSA-N	416773	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 38d::US10633345, Compound 38d::US10689346, Compound 42a::US11203574, Compound 42a::US11230530, Compound 42a::US11685721, Compound 38d	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416773	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416773&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356124	433916687							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896049	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-17-25(37(36-26)24-6-1-3-20(15-24)18-33)27(38)35-23-5-2-4-22(16-23)28(39,12-9-19-7-8-19)21-10-13-34-14-11-21/h1-6,10-11,13-17,19,39H,7-9,12,18,33H2,(H,35,38)	HEXYKZQZIBBLLM-UHFFFAOYSA-N	416774	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-(pyridin-4-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 92g::US10633345, Compound 92g::US10689346, Compound 92g::US11203574, Compound 92g::US11230530, Compound 92g::US11685721, Compound 92g	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416774	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416774&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355890	433916688							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896050	CCCOC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C28H27F3N4O2/c1-2-14-37-26(20-9-4-3-5-10-20)21-11-7-12-22(16-21)33-27(36)24-17-25(28(29,30)31)34-35(24)23-13-6-8-19(15-23)18-32/h3-13,15-17,26H,2,14,18,32H2,1H3,(H,33,36)	ODVQLXVRAUDBCL-UHFFFAOYSA-N	416765	1-(3-(aminomethyl)phenyl)-N-(3-(phenyl(propoxy)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18h::US10633345, Compound 18k::US10689346, Compound 18h::US11203574, Compound 18h::US11230530, Compound 18h::US11685721, Compound 18h	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416765	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416765&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665753	433916679							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896051	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1ccc(F)c(c1)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-24-12-11-21(14-23(24)27(39-17-18-9-10-18)20-6-2-1-3-7-20)35-28(38)25-15-26(29(31,32)33)36-37(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27H,9-10,16-17,34H2,(H,35,38)	SMAPKFCZNNYDET-UHFFFAOYSA-N	416776	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)-4-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 76h::US10633345, Compound 76h::US10689346, Compound 76h::US11203574, Compound 76h::US11230530, Compound 76h::US11685721, Compound 76h	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416776	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416776&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356199	433916690							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896052	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cn[nH]c1)C(F)(F)F			416777	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(1H-pyrazol-4-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 84h::US10633345, Compound 84h::US10689346, Compound 84h::US11203574, Compound 84h::US11230530, Compound 84h::US11685721, Compound 84h	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416777	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416777&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			154584214	433916691							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896053	CCCN(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C27H26F3N5O/c1-2-14-34(21-10-4-3-5-11-21)22-12-7-9-20(16-22)32-26(36)24-17-25(27(28,29)30)33-35(24)23-13-6-8-19(15-23)18-31/h3-13,15-17H,2,14,18,31H2,1H3,(H,32,36)	IKJCTSPODFFZCP-UHFFFAOYSA-N	416778	1-(3-(aminomethyl)phenyl)-N-(3-(phenyl(propyl)amino)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 27f::US10633345, Compound 27f::US10689346, Compound 27f::US11203574, Compound 27f::US11230530, Compound 27f::US11685721, Compound 27f	Plasma kallikrein		>75.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416778	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416778&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356135	433916692							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896054	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(C(OCC2CC2)c2ccccc2)c1F)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-26-22(27(39-17-18-12-13-18)20-7-2-1-3-8-20)10-5-11-23(26)35-28(38)24-15-25(29(31,32)33)36-37(24)21-9-4-6-19(14-21)16-34/h1-11,14-15,18,27H,12-13,16-17,34H2,(H,35,38)	OCYVMBLZCJPYSX-UHFFFAOYSA-N	416779	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 36d::US10633345, Compound 36d::US10689346, Compound 36d::US11203574, Compound 36d::US11230530, Compound 36d::US11685721, Compound 36d	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416779	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416779&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356266	433916693							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896055	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1nccs1)C(F)(F)F	InChI=1S/C26H25F3N6OS/c27-26(28,29)22-13-21(35(34-22)20-6-1-3-17(11-20)14-30)24(36)33-19-5-2-4-18(12-19)23(25-31-9-10-37-25)32-15-16-7-8-16/h1-6,9-13,16,23,32H,7-8,14-15,30H2,(H,33,36)	BPCHTFOGBGFGRD-UHFFFAOYSA-N	416780	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(thiazol-2-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 85c::US10633345, Compound 85c::US10689346, Compound 85c::US11203574, Compound 85c::US11230530, Compound 85c::US11685721, Compound 85c	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416780	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416780&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355975	433916694							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896056	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CCC1CC1)N1CCOCC1)C(F)(F)F	InChI=1S/C28H32F3N5O2/c29-28(30,31)26-17-25(36(34-26)23-6-1-3-20(15-23)18-32)27(37)33-22-5-2-4-21(16-22)24(10-9-19-7-8-19)35-11-13-38-14-12-35/h1-6,15-17,19,24H,7-14,18,32H2,(H,33,37)	JPSOHZUNYZMZBS-UHFFFAOYSA-N	416781	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-morpholinopropyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 93b::US10633345, Compound 93b::US10689346, Compound 93b::US11203574, Compound 93b::US11230530, Compound 93b::US11685721, Compound 93b	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416781	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416781&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665612	433916695							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896057	COc1cccc(c1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O2/c1-40-25-10-4-7-22(15-25)28(35-18-19-11-12-19)21-6-3-8-23(14-21)36-29(39)26-16-27(30(31,32)33)37-38(26)24-9-2-5-20(13-24)17-34/h2-10,13-16,19,28,35H,11-12,17-18,34H2,1H3,(H,36,39)	DMSXJIPDGRICQW-UHFFFAOYSA-N	416782	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(3-methoxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 109f::US10633345, Compound 109f::US10689346, Compound 109f::US11203574, Compound 109f::US11230530, Compound 109f::US11685721, Compound 109f	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416782	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416782&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356265	433916696							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896058	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc2ccccc2c1)C(F)(F)F	InChI=1S/C33H30F3N5O/c34-33(35,36)30-18-29(41(40-30)28-10-3-5-22(15-28)19-37)32(42)39-27-9-4-8-25(17-27)31(38-20-21-11-12-21)26-14-13-23-6-1-2-7-24(23)16-26/h1-10,13-18,21,31,38H,11-12,19-20,37H2,(H,39,42)	QCSULFNIDZTXJZ-UHFFFAOYSA-N	416783	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic acid {3-[(cyclopropylmethyl-amino)-naphthalen-2-yl-methyl]-phenyl}-amide::US10329260, Compound 128g::US10633345, Compound 128g::US10689346, Compound 128g::US11203574, Compound 128g::US11230530, Compound 128g::US11685721, Compound 128g	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416783	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416783&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665786	433916697							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896059	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H26F4N6O/c29-22-9-8-19(26(35-15-17-6-7-17)20-4-2-10-34-16-20)12-23(22)36-27(39)24-13-25(28(30,31)32)37-38(24)21-5-1-3-18(11-21)14-33/h1-5,8-13,16-17,26,35H,6-7,14-15,33H2,(H,36,39)	SECDZDWRLPONSX-UHFFFAOYSA-N	416784	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(pyridin-3-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 94b::US10633345, Compound 94b::US10689346, Compound 94b::US11203574, Compound 94b::US11230530, Compound 94b::US11685721, Compound 94b	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416784	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416784&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355774	433916698							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896060	Cc1cccc(c1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O/c1-19-5-2-7-22(13-19)28(35-18-20-11-12-20)23-8-4-9-24(15-23)36-29(39)26-16-27(30(31,32)33)37-38(26)25-10-3-6-21(14-25)17-34/h2-10,13-16,20,28,35H,11-12,17-18,34H2,1H3,(H,36,39)	ADKXWAHEFSGGQB-UHFFFAOYSA-N	416785	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(m-tolyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 110f::US10633345, Compound 110f::US10689346, Compound 110f::US11203574, Compound 110f::US11230530, Compound 110f::US11685721, Compound 110f	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416785	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416785&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123875262	433916699							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896061	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc2ccccc12)C(F)(F)F	InChI=1S/C33H30F3N5O/c34-33(35,36)30-18-29(41(40-30)26-11-3-6-22(16-26)19-37)32(42)39-25-10-4-9-24(17-25)31(38-20-21-14-15-21)28-13-5-8-23-7-1-2-12-27(23)28/h1-13,16-18,21,31,38H,14-15,19-20,37H2,(H,39,42)	NFYBGLSBONMUGA-UHFFFAOYSA-N	416786	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic acid {3-[(cyclopropylmethyl-amino)-naphthalen-1-yl-methyl]-phenyl}-amide::US10329260, Compound 129f::US10633345, Compound 129f::US10689346, Compound 129f::US11203574, Compound 129f::US11230530, Compound 129f::US11685721, Compound 129f	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416786	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416786&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356190	433916700							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896062	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(cc(c1)C1CC1)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C32H32F3N5O/c33-32(34,35)29-17-28(40(39-29)27-8-4-5-21(13-27)18-36)31(41)38-26-15-24(22-11-12-22)14-25(16-26)30(37-19-20-9-10-20)23-6-2-1-3-7-23/h1-8,13-17,20,22,30,37H,9-12,18-19,36H2,(H,38,41)	TXFPQXDVPCBKSX-UHFFFAOYSA-N	439372	US10633345, Compound 95i::US10689346, Compound 95i::US11203574, Compound 95i::US11230530, Compound 95i::US11685721, Compound 95i	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439372	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439372&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665927	439660930							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896063	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc(c1)C(F)(F)F)C(F)(F)F	InChI=1S/C30H27F6N5O/c31-29(32,33)22-7-2-5-20(13-22)27(38-17-18-10-11-18)21-6-3-8-23(14-21)39-28(42)25-15-26(30(34,35)36)40-41(25)24-9-1-4-19(12-24)16-37/h1-9,12-15,18,27,38H,10-11,16-17,37H2,(H,39,42)	FZSHDRVSVGSKOF-UHFFFAOYSA-N	416788	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(3-(trifluoromethyl) phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 111f::US10633345, Compound 111f::US10689346, Compound 111f::US11203574, Compound 111f::US11230530, Compound 111f::US11685721, Compound 111f	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416788	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416788&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355816	433916702							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896064	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccc(N)cc1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-23-11-8-20(27(36-16-17-4-5-17)19-6-9-21(35)10-7-19)13-24(23)37-28(40)25-14-26(29(31,32)33)38-39(25)22-3-1-2-18(12-22)15-34/h1-3,6-14,17,27,36H,4-5,15-16,34-35H2,(H,37,40)	QTGVDKNDDSXZLM-UHFFFAOYSA-N	416789	1-(3-(aminomethyl)phenyl)-N-(5-((4-aminophenyl)(cyclopropylmethylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 130g::US10633345, Compound 130g::US10689346, Compound 130g::US11203574, Compound 130g::US11230530, Compound 130g::US11685721, Compound 130g	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416789	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416789&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665503	433916703							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896065	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1Cl)C(NCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H26ClF3N6O/c29-22-9-8-19(26(35-15-17-6-7-17)20-4-2-10-34-16-20)12-23(22)36-27(39)24-13-25(28(30,31)32)37-38(24)21-5-1-3-18(11-21)14-33/h1-5,8-13,16-17,26,35H,6-7,14-15,33H2,(H,36,39)	DCRDGEJSCMQMFA-UHFFFAOYSA-N	416790	1-(3-(Aminomethyl)phenyl)-N-(2-chloro-5-((cyclopropylmethylamino)(pyridin-3-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 96f::US10633345, Compound 96f::US10689346, Compound 96f::US11203574, Compound 96f::US11230530, Compound 96f::US11685721, Compound 96f	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416790	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416790&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355757	433916704							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896066	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(cc1)S(N)(=O)=O)C(F)(F)F	InChI=1S/C29H29F3N6O3S/c30-29(31,32)26-15-25(38(37-26)23-6-1-3-19(13-23)16-33)28(39)36-22-5-2-4-21(14-22)27(35-17-18-7-8-18)20-9-11-24(12-10-20)42(34,40)41/h1-6,9-15,18,27,35H,7-8,16-17,33H2,(H,36,39)(H2,34,40,41)	BGEXZQITRMVFRR-UHFFFAOYSA-N	416791	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(4-sulfamoylphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 112g::US10633345, Compound 112g::US10689346, Compound 112g::US11203574, Compound 112g::US11230530, Compound 112g::US11685721, Compound 112g	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416791	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416791&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355780	433916705							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896067	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-23-10-9-20(27(36-16-17-7-8-17)19-4-2-5-21(35)12-19)13-24(23)37-28(40)25-14-26(29(31,32)33)38-39(25)22-6-1-3-18(11-22)15-34/h1-6,9-14,17,27,36H,7-8,15-16,34-35H2,(H,37,40)	HJMCNZIVUWWSBV-UHFFFAOYSA-N	416792	1-(3-(aminomethyl)phenyl)-N-(5-((3-aminophenyl)(cyclopropylmethylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 131b::US10633345, Compound 131b::US10689346, Compound 131b::US11203574, Compound 131b::US11230530, Compound 131b::US11685721, Compound 131b	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416792	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416792&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665555	433916706							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896068	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H25F4N5O2/c29-22-9-8-19(26(39-16-17-6-7-17)20-4-2-10-34-15-20)12-23(22)35-27(38)24-13-25(28(30,31)32)36-37(24)21-5-1-3-18(11-21)14-33/h1-5,8-13,15,17,26H,6-7,14,16,33H2,(H,35,38)	CNAFOXQNPWSINI-UHFFFAOYSA-N	416794	Racemic 1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethoxy)(pyridin-3-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 48f::US10633345, Compound 48f::US10689346, Compound 48f::US11203574, Compound 48g::US11230530, Compound 48h::US11685721, Compound 48f	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416794	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416794&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355617	433916708							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896069	CS(=O)(=O)c1ccc(cc1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O3S/c1-42(40,41)25-12-10-21(11-13-25)28(35-18-19-8-9-19)22-5-3-6-23(15-22)36-29(39)26-16-27(30(31,32)33)37-38(26)24-7-2-4-20(14-24)17-34/h2-7,10-16,19,28,35H,8-9,17-18,34H2,1H3,(H,36,39)	UTLDYOFVUPHYMX-UHFFFAOYSA-N	416795	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(4-(methylsulfonyl)phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 113f::US10633345, Compound 113f::US10689346, Compound 113f::US11203574, Compound 113f::US11230530, Compound 113f::US11685721, Compound 113f	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416795	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416795&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355808	433916709							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896070	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C28H26F4N6O/c29-22-7-6-20(26(35-16-17-4-5-17)19-8-10-34-11-9-19)13-23(22)36-27(39)24-14-25(28(30,31)32)37-38(24)21-3-1-2-18(12-21)15-33/h1-3,6-14,17,26,35H,4-5,15-16,33H2,(H,36,39)	JHXYEKYRIWFSRY-UHFFFAOYSA-N	416796	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(pyridin-4-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 132f::US10633345, Compound 132f::US10689346, Compound 132f::US11203574, Compound 132f::US11230530, Compound 132f::US11685721, Compound 132f	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416796	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416796&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665438	433916710							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896071	CN1CCc2c(C1)ccc(NC(=O)c1cc(nn1-c1cccc(CN)c1)C(F)(F)F)c2F	InChI=1S/C22H21F4N5O/c1-30-8-7-16-14(12-30)5-6-17(20(16)23)28-21(32)18-10-19(22(24,25)26)29-31(18)15-4-2-3-13(9-15)11-27/h2-6,9-10H,7-8,11-12,27H2,1H3,(H,28,32)	XRSKJTRQFAFTLA-UHFFFAOYSA-N	416797	1-(3-(aminomethyl)phenyl)-N-(5-fluoro-2-methyl-1,2,3,4-tetrahydroisoquinolin-6-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 164e::US10633345, Compound 164e::US10689346, Compound 164e::US11203574, Compound 164e::US11230530, Compound 164e::US11685721, Compound 164e	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416797	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416797&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665488	433916711							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896072	CS(=O)(=O)c1cccc(c1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O3S/c1-42(40,41)25-10-4-7-22(15-25)28(35-18-19-11-12-19)21-6-3-8-23(14-21)36-29(39)26-16-27(30(31,32)33)37-38(26)24-9-2-5-20(13-24)17-34/h2-10,13-16,19,28,35H,11-12,17-18,34H2,1H3,(H,36,39)	VJYAFYNZRBTGFW-UHFFFAOYSA-N	416798	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(3-(methylsulfonyl)phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 114f::US10633345, Compound 114f::US10689346, Compound 114f::US11203574, Compound 114f::US11230530, Compound 114f::US11685721, Compound 114f	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416798	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416798&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665780	433916712							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896073	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(cc1)-c1ccccc1)C(F)(F)F	InChI=1S/C35H32F3N5O/c36-35(37,38)32-20-31(43(42-32)30-11-4-6-24(18-30)21-39)34(44)41-29-10-5-9-28(19-29)33(40-22-23-12-13-23)27-16-14-26(15-17-27)25-7-2-1-3-8-25/h1-11,14-20,23,33,40H,12-13,21-22,39H2,(H,41,44)	SZCMOETVRNQDRC-UHFFFAOYSA-N	416799	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic Acid {3-[biphenyl-4-yl-(cyclopropylmethyl-amino)-methyl]-phenyl}-amide::US10329260, Compound 133g::US10633345, Compound 133g::US10689346, Compound 133g::US11203574, Compound 133g::US11230530, Compound 133g::US11685721, Compound 133g	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416799	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416799&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665928	433916713							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896074	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(F)cc(c1)C(O)c1ccccc1)C(F)(F)F	InChI=1S/C25H20F4N4O2/c26-18-10-17(23(34)16-6-2-1-3-7-16)11-19(12-18)31-24(35)21-13-22(25(27,28)29)32-33(21)20-8-4-5-15(9-20)14-30/h1-13,23,34H,14,30H2,(H,31,35)	WOQUHGPQEUKGPZ-UHFFFAOYSA-N	416800	1-(3-(aminomethyl)phenyl)-N-(3-fluoro-5-(hydroxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 97f::US10633345, Compound 97f::US10689346, Compound 97f::US11203574, Compound 97f::US11230530, Compound 97f::US11685721, Compound 97f	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416800	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416800&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355887	433916714							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896075	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NC(=O)C1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F3N5O2/c30-29(31,32)25-16-24(37(36-25)23-11-4-6-18(14-23)17-33)28(39)34-22-10-5-9-21(15-22)26(19-7-2-1-3-8-19)35-27(38)20-12-13-20/h1-11,14-16,20,26H,12-13,17,33H2,(H,34,39)(H,35,38)	JNPDNCCSYJLXEM-UHFFFAOYSA-N	439388	US10633345, Compound 115e::US10689346, Compound 115e::US11203574, Compound 115e::US11230530, Compound 115e::US11685721, Compound 115e	Plasma kallikrein		>75.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439388	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439388&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665512	439660946							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896076	COc1ccc2cc(ccc2c1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H32F3N5O2/c1-44-29-13-12-23-15-26(11-10-24(23)17-29)32(39-20-21-8-9-21)25-5-3-6-27(16-25)40-33(43)30-18-31(34(35,36)37)41-42(30)28-7-2-4-22(14-28)19-38/h2-7,10-18,21,32,39H,8-9,19-20,38H2,1H3,(H,40,43)	YJEVEVIVXGFKBA-UHFFFAOYSA-N	416804	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic Acid {3-[(cyclopropylmethyl-amino)-(6-methoxy-naphthalen-2-yl)-methyl]-phenyl}-amide::US10329260, Compound 134f::US10633345, Compound 134f::US10689346, Compound 134f::US11203574, Compound 134f::US11230530, Compound 134f::US11685721, Compound 134f	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416804	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416804&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356181	433916718							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896077	FC(F)(F)c1cc(C(=O)Nc2cccc(c2)C(CCC2CC2)N2CCCC2)n(n1)-c1cccc(c1)C#N	InChI=1S/C28H28F3N5O/c29-28(30,31)26-17-25(36(34-26)23-8-3-5-20(15-23)18-32)27(37)33-22-7-4-6-21(16-22)24(12-11-19-9-10-19)35-13-1-2-14-35/h3-8,15-17,19,24H,1-2,9-14H2,(H,33,37)	MJYCRZLDCMJLHR-UHFFFAOYSA-N	439390	US10633345, Compound 98b::US10689346, Compound 98b::US11203574, Compound 98b::US11230530, Compound 98b	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439390	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439390&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355716	439660948							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896078	CCc1cccc(c1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C31H32F3N5O/c1-2-20-6-3-8-23(14-20)29(36-19-21-12-13-21)24-9-5-10-25(16-24)37-30(40)27-17-28(31(32,33)34)38-39(27)26-11-4-7-22(15-26)18-35/h3-11,14-17,21,29,36H,2,12-13,18-19,35H2,1H3,(H,37,40)	YUWQOWXTNOVILU-UHFFFAOYSA-N	416807	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(3-ethylphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 116e::US10633345, Compound 116e::US10689346, Compound 116e::US11203574, Compound 116e::US11230530, Compound 116e::US11685721, Compound 116e	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416807	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416807&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123342870	433916721							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896079	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(O)cc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-25(37(36-26)23-6-1-3-19(13-23)16-33)28(39)35-22-5-2-4-21(14-22)27(34-17-18-7-8-18)20-9-11-24(38)12-10-20/h1-6,9-15,18,27,34,38H,7-8,16-17,33H2,(H,35,39)	GDUMJZLASJIDFD-UHFFFAOYSA-N	416808	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(4-hydroxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 135c::US10633345, Compound 135c::US10689346, Compound 135c::US11203574, Compound 135c::US11230530, Compound 135c::US11685721, Compound 135c	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416808	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416808&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355747	433916722							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896080	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CNC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-16-25(37(36-26)24-11-4-6-19(14-24)17-33)27(38)35-23-10-5-9-21(15-23)28(39,18-34-22-12-13-22)20-7-2-1-3-8-20/h1-11,14-16,22,34,39H,12-13,17-18,33H2,(H,35,38)	WTFGPUOPMMMRIY-UHFFFAOYSA-N	416809	1-(3-(aminomethyl)phenyl)-N-(3-(2-(cyclopropylamino)-1-hydroxy-1-phenylethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 99g::US10633345, Compound 99g::US10689346, Compound 99g::US11203574, Compound 99g::US11230530, Compound 99g::US11685721, Compound 99g	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416809	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416809&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355899	433916723							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896081	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1F)C(F)(F)F	InChI=1S/C29H27F4N5O/c30-24-10-2-1-9-23(24)27(35-17-18-11-12-18)20-6-4-7-21(14-20)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-3-5-19(13-22)16-34/h1-10,13-15,18,27,35H,11-12,16-17,34H2,(H,36,39)	XNBKWIREUIHXKI-UHFFFAOYSA-N	416810	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2-fluorophenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 117e::US10329260, Compound 119e::US10633345, Compound 117e::US10689346, Compound 117e::US11203574, Compound 117e::US11230530, Compound 117e::US11685721, Compound 117e	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416810	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416810&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123243852	433916724							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896082	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(Cc2ccc(O)cc2)c1)C(F)(F)F	InChI=1S/C25H21F3N4O2/c26-25(27,28)23-14-22(32(31-23)20-6-2-4-18(13-20)15-29)24(34)30-19-5-1-3-17(12-19)11-16-7-9-21(33)10-8-16/h1-10,12-14,33H,11,15,29H2,(H,30,34)	OPPQXCJMBFITBL-UHFFFAOYSA-N	416811	1-(3-(Aminomethyl)phenyl)-N-(3-(4-hydroxybenzyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 136a::US10633345, Compound 136a::US10689346, Compound 136a::US11203574, Compound 136a::US11230530, Compound 136a::US11685721, Compound 136a	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416811	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416811&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356271	433916725							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896083	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C28H26F4N6O/c29-21-10-9-19(26(35-16-17-7-8-17)22-6-1-2-11-34-22)13-23(21)36-27(39)24-14-25(28(30,31)32)37-38(24)20-5-3-4-18(12-20)15-33/h1-6,9-14,17,26,35H,7-8,15-16,33H2,(H,36,39)	NHHQSQFDXMXIJU-UHFFFAOYSA-N	416812	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(pyridin-2-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 100e::US10633345, Compound 100e::US10689346, Compound 100e::US11203574, Compound 100e::US11230530, Compound 100e::US11685721, Compound 100e	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416812	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416812&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356158	433916726							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896084	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1c2ccccc2c(Cl)c2ccccc12)C(F)(F)F	InChI=1S/C37H31ClF3N5O/c38-34-29-13-3-1-11-27(29)33(28-12-2-4-14-30(28)34)35(43-21-22-15-16-22)24-8-6-9-25(18-24)44-36(47)31-19-32(37(39,40)41)45-46(31)26-10-5-7-23(17-26)20-42/h1-14,17-19,22,35,43H,15-16,20-21,42H2,(H,44,47)	WNAKJZQMCRSZKD-UHFFFAOYSA-N	416813	1-(3-(aminomethyl)phenyl)-N-(3-((10-chloroanthracen-9-yl)(cyclopropylmethylamino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 118f::US10633345, Compound 118f::US10689346, Compound 118f::US11203574, Compound 118f::US11230530, Compound 118f::US11685721, Compound 118f	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416813	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416813&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355872	433916727							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896085	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc(O)c1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-25(37(36-26)23-8-1-4-19(12-23)16-33)28(39)35-22-7-2-5-20(13-22)27(34-17-18-10-11-18)21-6-3-9-24(38)14-21/h1-9,12-15,18,27,34,38H,10-11,16-17,33H2,(H,35,39)	WNKOEKOISOIHSR-UHFFFAOYSA-N	416814	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(3-hydroxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 137a::US10633345, Compound 137a::US10689346, Compound 137a::US11203574, Compound 137a::US11230530, Compound 137a::US11685721, Compound 137a	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416814	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416814&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355922	433916728							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896086	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1nccs1)C(F)(F)F	InChI=1S/C26H24F4N6OS/c27-19-7-6-17(23(25-32-8-9-38-25)33-14-15-4-5-15)11-20(19)34-24(37)21-12-22(26(28,29)30)35-36(21)18-3-1-2-16(10-18)13-31/h1-3,6-12,15,23,33H,4-5,13-14,31H2,(H,34,37)	FBQBHRBLNRXXHC-UHFFFAOYSA-N	416815	1-(3-(Aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(thiazol-2-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 101e::US10633345, Compound 101e::US10689346, Compound 101e::US11203574, Compound 101e::US11230530, Compound 101e::US11685721, Compound 101e	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416815	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416815&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355606	433916729							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896087	COc1ccccc1C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O2/c1-40-26-11-3-2-10-24(26)28(35-18-19-12-13-19)21-7-5-8-22(15-21)36-29(39)25-16-27(30(31,32)33)37-38(25)23-9-4-6-20(14-23)17-34/h2-11,14-16,19,28,35H,12-13,17-18,34H2,1H3,(H,36,39)	DAKZTBMQWXCVFA-UHFFFAOYSA-N	439400	US10633345, Compound 119e::US10689346, Compound 119e::US11203574, Compound 119e::US11230530, Compound 119e::US11685721, Compound 120e	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439400	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439400&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665475	439660958							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896088	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(Cc2cccc(O)c2)c1)C(F)(F)F	InChI=1S/C25H21F3N4O2/c26-25(27,28)23-14-22(32(31-23)20-8-2-6-18(12-20)15-29)24(34)30-19-7-1-4-16(11-19)10-17-5-3-9-21(33)13-17/h1-9,11-14,33H,10,15,29H2,(H,30,34)	SDKHQNOIRDBHTG-UHFFFAOYSA-N	416820	1-(3-(aminomethyl)phenyl)-N-(3-(3-hydroxybenzyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 137b::US10633345, Compound 137b::US10689346, Compound 137b::US11203574, Compound 137b::US11230530, Compound 137b::US11685721, Compound 137b	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416820	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416820&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665628	433916733							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896089	CN(C(c1cccc(N)c1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1)C1CC1	InChI=1S/C29H29F3N6O/c1-37(23-11-12-23)27(19-6-3-8-21(34)14-19)20-7-4-9-22(15-20)35-28(39)25-16-26(29(30,31)32)36-38(25)24-10-2-5-18(13-24)17-33/h2-10,13-16,23,27H,11-12,17,33-34H2,1H3,(H,35,39)	UUQWENBOKMRZFC-UHFFFAOYSA-N	439402	US10633345, Compound 102b::US10689346, Compound 102b::US11203574, Compound 102b::US11230530, Compound 102b	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439402	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439402&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665661	439660960							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896090	CC(C)c1ccc(cc1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C32H34F3N5O/c1-20(2)23-11-13-24(14-12-23)30(37-19-21-9-10-21)25-6-4-7-26(16-25)38-31(41)28-17-29(32(33,34)35)39-40(28)27-8-3-5-22(15-27)18-36/h3-8,11-17,20-21,30,37H,9-10,18-19,36H2,1-2H3,(H,38,41)	BFUXJPJTVQBLMT-UHFFFAOYSA-N	416823	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(4-isopropylphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 120e::US10633345, Compound 120e::US10689346, Compound 120e::US11203574, Compound 120e::US11230530, Compound 120e	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416823	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416823&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355943	433916736							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896091	CC(=O)Nc1ccc(cc1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C31H31F3N6O2/c1-19(41)37-24-12-10-22(11-13-24)29(36-18-20-8-9-20)23-5-3-6-25(15-23)38-30(42)27-16-28(31(32,33)34)39-40(27)26-7-2-4-21(14-26)17-35/h2-7,10-16,20,29,36H,8-9,17-18,35H2,1H3,(H,37,41)(H,38,42)	JDALRNHKHTYPON-UHFFFAOYSA-N	416827	N-(3-((4-acetamidophenyl)(cyclopropylmethylamino)methyl)phenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 138f::US10633345, Compound 138f::US10689346, Compound 138f::US11203574, Compound 138f::US11230530, Compound 138f::US11685721, Compound 138f	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416827	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416827&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355810	433916740							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896092	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CCC1CC1)c1cc[nH]c1)C(F)(F)F			416828	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-(1H-pyrrol-3-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 103b::US10633345, Compound 103b::US10689346, Compound 103b::US11203574, Compound 103b::US11230530, Compound 103b::US11685721, Compound 103b	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416828	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416828&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355898	433916741							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896093	Cc1ccc(cc1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O/c1-19-8-12-22(13-9-19)28(35-18-20-10-11-20)23-5-3-6-24(15-23)36-29(39)26-16-27(30(31,32)33)37-38(26)25-7-2-4-21(14-25)17-34/h2-9,12-16,20,28,35H,10-11,17-18,34H2,1H3,(H,36,39)	HRCLMMKOPKWJGF-UHFFFAOYSA-N	416829	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(p-tolyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 122g::US10633345, Compound 122g::US10689346, Compound 122g::US11203574, Compound 122g::US11230530, Compound 122g::US11685721, Compound 122g	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416829	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416829&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355867	433916742							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896094	CN(C(c1ccc(cc1)C#N)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1)C1CC1	InChI=1S/C30H26F4N6O/c1-39(22-10-11-22)28(20-7-5-18(16-35)6-8-20)21-9-12-24(31)25(14-21)37-29(41)26-15-27(30(32,33)34)38-40(26)23-4-2-3-19(13-23)17-36/h2-9,12-15,22,28H,10-11,17,36H2,1H3,(H,37,41)	BZIYYSLZWQNWBF-UHFFFAOYSA-N	439407	US10633345, Compound 52h::US10633345, Compound 71a::US10633345, Compound 71b::US10689346, Compound 71b::US11203574, Compound 71a::US11230530, Compound 71b	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439407	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439407&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355581	439660965							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896095	Cn1cc(cn1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C27H28F3N7O/c1-36-16-20(15-33-36)25(32-14-17-8-9-17)19-5-3-6-21(11-19)34-26(38)23-12-24(27(28,29)30)35-37(23)22-7-2-4-18(10-22)13-31/h2-7,10-12,15-17,25,32H,8-9,13-14,31H2,1H3,(H,34,38)	GHANDLPUFXRHQK-UHFFFAOYSA-N	416831	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(1-methyl-1H-pyrazol-4-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 104f::US10633345, Compound 104f::US10689346, Compound 104f::US11203574, Compound 104f::US11230530, Compound 104f::US11685721, Compound 104f	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416831	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416831&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356100	433916744							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896096	CS(=O)(=O)c1ccccc1C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O3S/c1-42(40,41)26-11-3-2-10-24(26)28(35-18-19-12-13-19)21-7-5-8-22(15-21)36-29(39)25-16-27(30(31,32)33)37-38(25)23-9-4-6-20(14-23)17-34/h2-11,14-16,19,28,35H,12-13,17-18,34H2,1H3,(H,36,39)	XEAXHMDONDJJBQ-UHFFFAOYSA-N	416832	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2-(methylsulfonyl)phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 121f::US10633345, Compound 121f::US10689346, Compound 121f::US11203574, Compound 121f::US11230530, Compound 121f::US11685721, Compound 121f	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416832	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416832&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665701	433916745							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896097	CN(C(c1ccc(CN)cc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1)C1CC1	InChI=1S/C30H30F4N6O/c1-39(22-10-11-22)28(20-7-5-18(16-35)6-8-20)21-9-12-24(31)25(14-21)37-29(41)26-15-27(30(32,33)34)38-40(26)23-4-2-3-19(13-23)17-36/h2-9,12-15,22,28H,10-11,16-17,35-36H2,1H3,(H,37,41)	REFXZSDKKDUEPN-UHFFFAOYSA-N	439410	US10633345, Compound 139b::US10689346, Compound 139b::US11203574, Compound 139b::US11230530, Compound 139b	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439410	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439410&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665496	439660968							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896098	COc1ccc(cc1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O2/c1-40-25-12-10-21(11-13-25)28(35-18-19-8-9-19)22-5-3-6-23(15-22)36-29(39)26-16-27(30(31,32)33)37-38(26)24-7-2-4-20(14-24)17-34/h2-7,10-16,19,28,35H,8-9,17-18,34H2,1H3,(H,36,39)	NTRWDZUFVXMYGD-UHFFFAOYSA-N	416834	1-(3-(Aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(4-methoxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 105g::US10633345, Compound 105g::US10689346, Compound 105g::US11203574, Compound 105g::US11230530, Compound 105g::US11685721, Compound 105g	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416834	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416834&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665521	433916747							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896099	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(OCc2ccccc2)cc1)C(F)(F)F	InChI=1S/C36H34F3N5O2/c37-36(38,39)33-20-32(44(43-33)30-11-4-8-26(18-30)21-40)35(45)42-29-10-5-9-28(19-29)34(41-22-24-12-13-24)27-14-16-31(17-15-27)46-23-25-6-2-1-3-7-25/h1-11,14-20,24,34,41H,12-13,21-23,40H2,(H,42,45)	AKMGFHNAHQDIKU-UHFFFAOYSA-N	439412	US10633345, Compound 123g::US10689346, Compound 123g::US11203574, Compound 123g::US11230530, Compound 123g::US11685721, Compound 107f	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439412	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439412&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665739	439660970							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896100	Cc1cccc(c1)C(NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H29F4N5O/c1-18-4-2-6-21(12-18)28(36-17-19-8-9-19)22-10-11-24(31)25(14-22)37-29(40)26-15-27(30(32,33)34)38-39(26)23-7-3-5-20(13-23)16-35/h2-7,10-15,19,28,36H,8-9,16-17,35H2,1H3,(H,37,40)	DWXIBXKRESUYFO-UHFFFAOYSA-N	416836	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(m-tolyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 140e::US10633345, Compound 140e::US10689346, Compound 140e::US11203574, Compound 140e::US11230530, Compound 140e::US11685721, Compound 140e	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416836	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416836&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356147	433916749							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896101	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1O)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-24(37(36-26)22-8-3-5-19(13-22)16-33)28(39)35-21-7-4-6-20(14-21)27(34-17-18-11-12-18)23-9-1-2-10-25(23)38/h1-10,13-15,18,27,34,38H,11-12,16-17,33H2,(H,35,39)	PCNDJIQOMLHSEK-UHFFFAOYSA-N	416837	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2-hydroxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 49h::US10633345, Compound 49h::US10689346, Compound 49h::US11203574, Compound 49j::US11230530, Compound 49j::US11685721, Compound 49h	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416837	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416837&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355733	433916750							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896102	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc(OC(F)(F)F)c1)C(F)(F)F	InChI=1S/C30H27F6N5O2/c31-29(32,33)26-15-25(41(40-26)23-8-1-4-19(12-23)16-37)28(42)39-22-7-2-5-20(13-22)27(38-17-18-10-11-18)21-6-3-9-24(14-21)43-30(34,35)36/h1-9,12-15,18,27,38H,10-11,16-17,37H2,(H,39,42)	IVEYKJBEIIJLCR-UHFFFAOYSA-N	416838	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(3-(trifluoromethoxy) phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 124f::US10633345, Compound 124f::US10689346, Compound 124f::US11203574, Compound 124f::US11230530, Compound 124f::US11685721, Compound 124f	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416838	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416838&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665809	433916751							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896103	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C1OC(=O)Nc2ccccc12)C(F)(F)F	InChI=1S/C26H20F3N5O3/c27-26(28,29)22-13-21(34(33-22)18-8-3-5-15(11-18)14-30)24(35)31-17-7-4-6-16(12-17)23-19-9-1-2-10-20(19)32-25(36)37-23/h1-13,23H,14,30H2,(H,31,35)(H,32,36)	LRCHTKOMIAYQHX-UHFFFAOYSA-N	416839	1-(3-(aminomethyl)phenyl)-N-(3-(2-oxo-2,4-dihydro-1H-benzo[d][1,3]oxazin-4-yl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 167f::US10633345, Compound 167f::US10689346, Compound 167f::US11203574, Compound 167f::US11230530, Compound 167f::US11685721, Compound 167f	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416839	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416839&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665868	433916752							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896104	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1OCc1ccccc1)C(F)(F)F	InChI=1S/C36H34F3N5O2/c37-36(38,39)33-20-31(44(43-33)29-13-6-10-26(18-29)21-40)35(45)42-28-12-7-11-27(19-28)34(41-22-24-16-17-24)30-14-4-5-15-32(30)46-23-25-8-2-1-3-9-25/h1-15,18-20,24,34,41H,16-17,21-23,40H2,(H,42,45)	XAZZTVOUWUHFIG-UHFFFAOYSA-N	416840	1-(3-(aminomethyl)phenyl)-N-(3-((2-(benzyloxy)phenyl)(cyclopropylmethyl amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 106a::US10633345, Compound 106a::US10689346, Compound 106a::US11203574, Compound 106a::US11230530, Compound 106a::US11685721, Compound 106a	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416840	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416840&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356273	433916753							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896105	COc1ccc2ccccc2c1C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H32F3N5O2/c1-44-29-15-14-23-7-2-3-11-27(23)31(29)32(39-20-21-12-13-21)24-8-5-9-25(17-24)40-33(43)28-18-30(34(35,36)37)41-42(28)26-10-4-6-22(16-26)19-38/h2-11,14-18,21,32,39H,12-13,19-20,38H2,1H3,(H,40,43)	XVOUQCJHWNZPKF-UHFFFAOYSA-N	416841	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2-methoxynaphthalen-1-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 51f::US10633345, Compound 51f::US10689346, Compound 51f::US11203574, Compound 51h::US11230530, Compound 51h::US11685721, Compound 51f	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416841	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416841&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356155	433916754							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896106	COc1cccc(c1)C(NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H29F4N5O2/c1-41-23-7-3-5-20(13-23)28(36-17-18-8-9-18)21-10-11-24(31)25(14-21)37-29(40)26-15-27(30(32,33)34)38-39(26)22-6-2-4-19(12-22)16-35/h2-7,10-15,18,28,36H,8-9,16-17,35H2,1H3,(H,37,40)	MRNMVRANILFBMK-UHFFFAOYSA-N	416842	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(3-methoxyphenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 141e::US10633345, Compound 141e::US10689346, Compound 141e::US11203574, Compound 141e::US11230530, Compound 141e::US11685721, Compound 142f	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416842	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416842&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355803	433916755							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896107	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(N)cc1)C(F)(F)F	InChI=1S/C29H29F3N6O/c30-29(31,32)26-15-25(38(37-26)24-6-1-3-19(13-24)16-33)28(39)36-23-5-2-4-21(14-23)27(35-17-18-7-8-18)20-9-11-22(34)12-10-20/h1-6,9-15,18,27,35H,7-8,16-17,33-34H2,(H,36,39)	XDCYYWMSVYTRMZ-UHFFFAOYSA-N	416843	1-(3-(aminomethyl)phenyl)-N-(3-((4-aminophenyl)(cyclopropylmethyl-amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 50f::US10633345, Compound 50f::US10689346, Compound 50h::US11203574, Compound 50h::US11230530, Compound 50h::US11685721, Compound 50f	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416843	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416843&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355587	433916756							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896108	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cc2ccccc2c2ccccc12)C(F)(F)F	InChI=1S/C37H32F3N5O/c38-37(39,40)34-20-33(45(44-34)28-11-5-7-24(17-28)21-41)36(46)43-27-10-6-9-26(18-27)35(42-22-23-15-16-23)32-19-25-8-1-2-12-29(25)30-13-3-4-14-31(30)32/h1-14,17-20,23,35,42H,15-16,21-22,41H2,(H,43,46)	OZXXGJIBGVGMMV-UHFFFAOYSA-N	416844	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic acid {3-[(cyclopropylmethyl-amino)-phenanthren-9-yl-methyl]-phenyl}-amide::US10329260, Compound 125g::US10633345, Compound 125g::US10689346, Compound 125g::US11203574, Compound 125g::US11230530, Compound 125g::US11685721, Compound 125g	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416844	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416844&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665609	433916757							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896109	COc1ccc(cc1)C(NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H29F4N5O2/c1-41-23-10-7-20(8-11-23)28(36-17-18-5-6-18)21-9-12-24(31)25(14-21)37-29(40)26-15-27(30(32,33)34)38-39(26)22-4-2-3-19(13-22)16-35/h2-4,7-15,18,28,36H,5-6,16-17,35H2,1H3,(H,37,40)	GWNRXEFJAQDBCM-UHFFFAOYSA-N	416845	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(4-methoxyphenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 142f::US10633345, Compound 142f::US10689346, Compound 142f::US11203574, Compound 142f::US11230530, Compound 142f	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416845	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416845&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355909	433916758							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896110	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc(OCc2ccccc2)c1)C(F)(F)F	InChI=1S/C36H34F3N5O2/c37-36(38,39)33-20-32(44(43-33)30-13-4-9-26(17-30)21-40)35(45)42-29-12-5-10-27(18-29)34(41-22-24-15-16-24)28-11-6-14-31(19-28)46-23-25-7-2-1-3-8-25/h1-14,17-20,24,34,41H,15-16,21-23,40H2,(H,42,45)	VWRITWGTGWRWCP-UHFFFAOYSA-N	439423	US10633345, Compound 107f::US11203574, Compound 107f::US11230530, Compound 107f	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439423	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439423&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665642	439660981							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896111	CN(C)c1ccc(C(NCC2CC2)c2cccc(NC(=O)c3cc(nn3-c3cccc(CN)c3)C(F)(F)F)c2)c2ccccc12	InChI=1S/C35H35F3N6O/c1-43(2)30-16-15-29(27-11-3-4-12-28(27)30)33(40-21-22-13-14-22)24-8-6-9-25(18-24)41-34(45)31-19-32(35(36,37)38)42-44(31)26-10-5-7-23(17-26)20-39/h3-12,15-19,22,33,40H,13-14,20-21,39H2,1-2H3,(H,41,45)	IQAVMSNXUBZMCB-UHFFFAOYSA-N	416847	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic acid {3-[(cyclopropylmethyl-amino)-(4-dimethylamino-naphthalen-1-yl)-methyl]-phenyl}-amide::US10329260, Compound 126g::US10633345, Compound 126g::US10689346, Compound 126g::US11203574, Compound 126g::US11230530, Compound 126g::US11685721, Compound 126g	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416847	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416847&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355601	433916760							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896112	Cc1cc(C(=O)Nc2cccc(c2)C(NCC2CC2)c2ccccc2)n(n1)-c1cccc(CN)c1	InChI=1S/C29H31N5O/c1-20-15-27(34(33-20)26-12-5-7-22(16-26)18-30)29(35)32-25-11-6-10-24(17-25)28(31-19-21-13-14-21)23-8-3-2-4-9-23/h2-12,15-17,21,28,31H,13-14,18-19,30H2,1H3,(H,32,35)	GPDBDHGXUBYWPY-UHFFFAOYSA-N	416848	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(phenyl)methyl)phenyl)-3-methyl-1H-pyrazole-5-carboxamid::US10329260, Compound 143l::US10633345, Compound 143l::US10689346, Compound 143l::US11203574, Compound 143l::US11230530, Compound 143l::US11685721, Compound 143l	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416848	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416848&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356139	433916761							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896113	NCc1cccc(c1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H31F3N6O/c31-30(32,33)27-15-26(39(38-27)25-9-2-5-21(13-25)17-35)29(40)37-24-8-3-7-23(14-24)28(36-18-19-10-11-19)22-6-1-4-20(12-22)16-34/h1-9,12-15,19,28,36H,10-11,16-18,34-35H2,(H,37,40)	CBXMVQRWSKIMMQ-UHFFFAOYSA-N	439426	US10633345, Compound 108e::US10689346, Compound 108e::US11203574, Compound 108e::US11230530, Compound 108e	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439426	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439426&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665469	439660984							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896114	CCCOc1ccc(cc1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C32H34F3N5O2/c1-2-15-42-27-13-11-23(12-14-27)30(37-20-21-9-10-21)24-6-4-7-25(17-24)38-31(41)28-18-29(32(33,34)35)39-40(28)26-8-3-5-22(16-26)19-36/h3-8,11-14,16-18,21,30,37H,2,9-10,15,19-20,36H2,1H3,(H,38,41)	BSIABEDKJHMBRX-UHFFFAOYSA-N	416850	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic acid {3-[(cyclopropylmethyl-amino)-(4-propoxy-phenyl)-methyl]-phenyl}-amide::US10329260, Compound 127f::US10633345, Compound 127f::US10689346, Compound 127f::US11203574, Compound 127f::US11230530, Compound 127f::US11685721, Compound 127f	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416850	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416850&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356061	433916763							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896115	CC(C)NC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C28H28F3N5O/c1-18(2)33-26(20-9-4-3-5-10-20)21-11-7-12-22(15-21)34-27(37)24-16-25(28(29,30)31)35-36(24)23-13-6-8-19(14-23)17-32/h3-16,18,26,33H,17,32H2,1-2H3,(H,34,37)	XNDGACONQUBLGK-UHFFFAOYSA-N	416851	1-(3-(Aminomethyl)phenyl)-N-(3-((isopropylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 144d::US10633345, Compound 144d::US10689346, Compound 144d::US11203574, Compound 144d::US11230530, Compound 144d::US11685721, Compound 144d	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416851	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416851&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355596	433916764							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896116	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCCO)c1ccccc1)C(F)(F)F	InChI=1S/C27H26F3N5O2/c28-27(29,30)24-16-23(35(34-24)22-11-4-6-18(14-22)17-31)26(37)33-21-10-5-9-20(15-21)25(32-12-13-36)19-7-2-1-3-8-19/h1-11,14-16,25,32,36H,12-13,17,31H2,(H,33,37)	MMNKSYPQOFLCSY-UHFFFAOYSA-N	416852	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic acid {3-[(2-hydroxy-ethylamino)-phenyl-methyl]-phenyl}-amide::US10329260, Compound 145c::US10633345, Compound 145c::US10689346, Compound 145c::US11203574, Compound 145c::US11230530, Compound 145c::US11685721, Compound 145c	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416852	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416852&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123569320	433916765							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896117	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-10-9-20(27(40-16-17-7-8-17)19-4-2-5-21(35)12-19)13-24(23)36-28(39)25-14-26(29(31,32)33)37-38(25)22-6-1-3-18(11-22)15-34/h1-6,9-14,17,27H,7-8,15-16,34-35H2,(H,36,39)	GBDDXSAKQKODCG-UHFFFAOYSA-N	416853	1-(3-(aminomethyl)phenyl)-N-(5-((3-aminophenyl)(cyclopropylmethoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 57e::US10633345, Compound 65b::US10689346, Compound 65b::US11203574, Compound 65a::US11230530, Compound 65b::US11685721, Compound 57e	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416853	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416853&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355865	433916766							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896118	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(N[C@H]1CC[C@H](O)CC1)c1ccccc1)C(F)(F)F	InChI=1S/C31H32F3N5O2/c32-31(33,34)28-18-27(39(38-28)25-11-4-6-20(16-25)19-35)30(41)37-24-10-5-9-22(17-24)29(21-7-2-1-3-8-21)36-23-12-14-26(40)15-13-23/h1-11,16-18,23,26,29,36,40H,12-15,19,35H2,(H,37,41)/t23-,26-,29?	QCYULPRIJNBHAA-APJPSQSRSA-N	416854	1-(3-(Aminomethyl)phenyl)-N-(3-((((trans)-4-hydroxycyclohexyl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 181b::US10633345, Compound 181b::US10689346, Compound 181b::US11203574, Compound 181b::US11230530, Compound 181b	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416854	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416854&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665446	433916767							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896119	Cc1cc(C(=O)Nc2cccc(c2)C(NCC2CC2)c2cc(O)ccc2O)n(n1)-c1cccc(CN)c1	InChI=1S/C29H31N5O3/c1-18-12-26(34(33-18)23-7-2-4-20(13-23)16-30)29(37)32-22-6-3-5-21(14-22)28(31-17-19-8-9-19)25-15-24(35)10-11-27(25)36/h2-7,10-15,19,28,31,35-36H,8-9,16-17,30H2,1H3,(H,32,37)	LPEUWRVJEWZQCO-UHFFFAOYSA-N	416855	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2,5-dihydroxyphenyl)methyl) phenyl)-3-methyl-1H-pyrazole-5-carboxamide::US10329260, Compound 146g::US10633345, Compound 146g::US10689346, Compound 146g::US11203574, Compound 146g::US11230530, Compound 146g	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416855	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416855&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356064	433916768							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896120	Cc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1O)C(F)(F)F	InChI=1S/C29H26F4N4O2/c1-17-5-4-6-20(13-17)37-24(15-26(36-37)29(31,32)33)28(39)35-23-14-19(11-12-22(23)30)27(34-16-18-9-10-18)21-7-2-3-8-25(21)38/h2-8,11-15,18,27,34,38H,9-10,16H2,1H3,(H,35,39)	LQHOUXMPIPWXII-UHFFFAOYSA-N	439433	US10633345, Compound 60e	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439433	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439433&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155295684	439660991							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896121	CC(O)CNC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C28H28F3N5O2/c1-18(37)17-33-26(20-8-3-2-4-9-20)21-10-6-11-22(14-21)34-27(38)24-15-25(28(29,30)31)35-36(24)23-12-5-7-19(13-23)16-32/h2-15,18,26,33,37H,16-17,32H2,1H3,(H,34,38)	XWEXCUNXVFBKNX-UHFFFAOYSA-N	416857	1-(3-(aminomethyl)phenyl)-N-(3-(((2-hydroxypropyl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 182b::US10633345, Compound 182b::US10689346, Compound 182b::US11203574, Compound 182b::US11230530, Compound 182b::US11685721, Compound 182b	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416857	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416857&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355690	433916770							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896122	CC(=O)Nc1ccc(cc1)C(OCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C31H30F3N5O3/c1-19(40)36-24-12-10-22(11-13-24)29(42-18-20-8-9-20)23-5-3-6-25(15-23)37-30(41)27-16-28(31(32,33)34)38-39(27)26-7-2-4-21(14-26)17-35/h2-7,10-16,20,29H,8-9,17-18,35H2,1H3,(H,36,40)(H,37,41)	AETJNKBVQDZIDV-UHFFFAOYSA-N	416858	N-(3-((4-acetamidophenyl)(cyclopropylmethoxy)methyl)phenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 147e::US10633345, Compound 147e::US10689346, Compound 147e::US11203574, Compound 147e::US11230530, Compound 147e::US11685721, Compound 147e	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416858	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416858&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355828	433916771							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896123	CN(C(c1ccc(cc1)C#N)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1)C1CC1	InChI=1S/C30H26F4N6O/c1-39(22-10-11-22)28(20-7-5-18(16-35)6-8-20)21-9-12-24(31)25(14-21)37-29(41)26-15-27(30(32,33)34)38-40(26)23-4-2-3-19(13-23)17-36/h2-9,12-15,22,28H,10-11,17,36H2,1H3,(H,37,41)	BZIYYSLZWQNWBF-UHFFFAOYSA-N	439407	US10633345, Compound 52h::US10633345, Compound 71a::US10633345, Compound 71b::US10689346, Compound 71b::US11203574, Compound 71a::US11230530, Compound 71b	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439407	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439407&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355581	439660965							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896124	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCCCn1ccnc1)c1ccccc1)C(F)(F)F	InChI=1S/C31H30F3N7O/c32-31(33,34)28-19-27(41(39-28)26-12-4-7-22(17-26)20-35)30(42)38-25-11-5-10-24(18-25)29(23-8-2-1-3-9-23)37-13-6-15-40-16-14-36-21-40/h1-5,7-12,14,16-19,21,29,37H,6,13,15,20,35H2,(H,38,42)	XJDJXHWYZLFIJY-UHFFFAOYSA-N	416860	N-(3-(((3-(1H-Imidazol-1-yl)propyl)amino)(phenyl)methyl)phenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 183b::US10633345, Compound 183b::US10689346, Compound 183b::US11203574, Compound 183b::US11230530, Compound 183b::US11685721, Compound 183b	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416860	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416860&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665638	433916773							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896125	COc1ccc2ccccc2c1C(OCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H31F3N4O3/c1-43-29-15-14-23-7-2-3-11-27(23)31(29)32(44-20-21-12-13-21)24-8-5-9-25(17-24)39-33(42)28-18-30(34(35,36)37)40-41(28)26-10-4-6-22(16-26)19-38/h2-11,14-18,21,32H,12-13,19-20,38H2,1H3,(H,39,42)	YJZQWEYZTCABEY-UHFFFAOYSA-N	416861	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(2-methoxynaphthalen-1-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 148b::US10633345, Compound 148b::US10689346, Compound 148b::US11203574, Compound 148b::US11230530, Compound 148b::US11685721, Compound 148b	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416861	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416861&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665874	433916774							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896126	CN(C(c1ccc(cc1)C#N)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1)C1CC1	InChI=1S/C30H26F4N6O/c1-39(22-10-11-22)28(20-7-5-18(16-35)6-8-20)21-9-12-24(31)25(14-21)37-29(41)26-15-27(30(32,33)34)38-40(26)23-4-2-3-19(13-23)17-36/h2-9,12-15,22,28H,10-11,17,36H2,1H3,(H,37,41)	BZIYYSLZWQNWBF-UHFFFAOYSA-N	439407	US10633345, Compound 52h::US10633345, Compound 71a::US10633345, Compound 71b::US10689346, Compound 71b::US11203574, Compound 71a::US11230530, Compound 71b	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439407	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439407&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355581	439660965							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896127	CN(C)C(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C27H26F3N5O/c1-34(2)25(19-9-4-3-5-10-19)20-11-7-12-21(15-20)32-26(36)23-16-24(27(28,29)30)33-35(23)22-13-6-8-18(14-22)17-31/h3-16,25H,17,31H2,1-2H3,(H,32,36)	BIAJBXPGRHVMIB-UHFFFAOYSA-N	416863	1-(3-(Aminomethyl)phenyl)-N-(3-((dimethylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 184b::US10633345, Compound 184b::US10689346, Compound 184b::US11203574, Compound 184b::US11230530, Compound 184b::US11685721, Compound 184b	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416863	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416863&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356007	433916776							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896128	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccc(O)cc1)C(F)(F)F	InChI=1S/C29H27F3N4O3/c30-29(31,32)26-15-25(36(35-26)23-6-1-3-19(13-23)16-33)28(38)34-22-5-2-4-21(14-22)27(39-17-18-7-8-18)20-9-11-24(37)12-10-20/h1-6,9-15,18,27,37H,7-8,16-17,33H2,(H,34,38)	WIBHWKLQWUWRRF-UHFFFAOYSA-N	416864	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(4-hydroxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 149b::US10633345, Compound 149b::US10689346, Compound 149b::US11203574, Compound 149b::US11230530, Compound 149b::US11685721, Compound 149b	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416864	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416864&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665542	433916777							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896129	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-10-9-20(27(40-16-17-7-8-17)19-4-2-5-21(35)12-19)13-24(23)36-28(39)25-14-26(29(31,32)33)37-38(25)22-6-1-3-18(11-22)15-34/h1-6,9-14,17,27H,7-8,15-16,34-35H2,(H,36,39)	GBDDXSAKQKODCG-UHFFFAOYSA-N	416853	1-(3-(aminomethyl)phenyl)-N-(5-((3-aminophenyl)(cyclopropylmethoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 57e::US10633345, Compound 65b::US10689346, Compound 65b::US11203574, Compound 65a::US11230530, Compound 65b::US11685721, Compound 57e	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416853	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416853&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355865	433916766							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896130	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NC1CCCCC1)c1ccccc1)C(F)(F)F	InChI=1S/C31H32F3N5O/c32-31(33,34)28-19-27(39(38-28)26-16-7-9-21(17-26)20-35)30(40)37-25-15-8-12-23(18-25)29(22-10-3-1-4-11-22)36-24-13-5-2-6-14-24/h1,3-4,7-12,15-19,24,29,36H,2,5-6,13-14,20,35H2,(H,37,40)	MXMWHPZXCVOSEY-UHFFFAOYSA-N	416866	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclohexylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 185b::US10633345, Compound 185b::US10689346, Compound 185b::US11203574, Compound 185b::US11230530, Compound 185b::US11685721, Compound 185b	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416866	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416866&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356164	433916779							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896131	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-25(37(36-26)24-9-1-4-19(12-24)16-33)28(38)35-23-8-3-6-21(14-23)27(39-17-18-10-11-18)20-5-2-7-22(34)13-20/h1-9,12-15,18,27H,10-11,16-17,33-34H2,(H,35,38)	FPQYUIIRVBKUDH-UHFFFAOYSA-N	416867	1-(3-(aminomethyl)phenyl)-N-(3-((3-aminophenyl)(cyclopropyl-methoxy)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 53f::US10633345, Compound 53f::US10689346, Compound 53f::US11203574, Compound 64b::US11230530, Compound 64b::US11685721, Compound 49j	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416867	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416867&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355845	433916780							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896132	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-10-9-20(27(40-16-17-7-8-17)19-4-2-5-21(35)12-19)13-24(23)36-28(39)25-14-26(29(31,32)33)37-38(25)22-6-1-3-18(11-22)15-34/h1-6,9-14,17,27H,7-8,15-16,34-35H2,(H,36,39)	GBDDXSAKQKODCG-UHFFFAOYSA-N	416853	1-(3-(aminomethyl)phenyl)-N-(5-((3-aminophenyl)(cyclopropylmethoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 57e::US10633345, Compound 65b::US10689346, Compound 65b::US11203574, Compound 65a::US11230530, Compound 65b::US11685721, Compound 57e	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416853	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416853&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355865	433916766							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896133	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCc1ccncc1)c1ccccc1)C(F)(F)F	InChI=1S/C31H27F3N6O/c32-31(33,34)28-18-27(40(39-28)26-11-4-6-22(16-26)19-35)30(41)38-25-10-5-9-24(17-25)29(23-7-2-1-3-8-23)37-20-21-12-14-36-15-13-21/h1-18,29,37H,19-20,35H2,(H,38,41)	PXKQYONQBKMAKS-UHFFFAOYSA-N	416869	1-(3-(Aminomethyl)phenyl)-N-(3-(phenyl((pyridin-4-ylmethyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 186b::US10633345, Compound 186b::US10689346, Compound 186b::US11203574, Compound 186b::US11230530, Compound 186b::US11685721, Compound 186b	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416869	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416869&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665494	433916782							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896134	Cc1cc(C(=O)Nc2cccc(c2)C(NCC2CC2)c2cccc(O)c2O)n(n1)-c1cccc(CN)c1	InChI=1S/C29H31N5O3/c1-18-13-25(34(33-18)23-8-2-5-20(14-23)16-30)29(37)32-22-7-3-6-21(15-22)27(31-17-19-11-12-19)24-9-4-10-26(35)28(24)36/h2-10,13-15,19,27,31,35-36H,11-12,16-17,30H2,1H3,(H,32,37)	VPKURNQNFXHFDB-UHFFFAOYSA-N	416870	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2,3-dihydroxyphenyl)methyl)phenyl)-3-methyl-1H-pyrazole-5-carboxamide::US10329260, Compound 150f::US10633345, Compound 150f::US10689346, Compound 150f::US11203574, Compound 150f::US11230530, Compound 150f	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416870	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416870&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355949	433916783							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896135	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc2OCOc12)C(F)(F)F	InChI=1S/C30H28F3N5O3/c31-30(32,33)26-14-24(38(37-26)22-7-1-4-19(12-22)15-34)29(39)36-21-6-2-5-20(13-21)27(35-16-18-10-11-18)23-8-3-9-25-28(23)41-17-40-25/h1-9,12-14,18,27,35H,10-11,15-17,34H2,(H,36,39)	FVRZDZZJKCSOIR-UHFFFAOYSA-N	416871	1-(3-(aminomethyl)phenyl)-N-(3-(benzo[d][1,3]dioxol-4-yl(cyclopropylmethylamino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 192f::US10633345, Compound 192f::US10689346, Compound 192f::US11203574, Compound 192f::US11230530, Compound 192f::US11685721, Compound 192f	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416871	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416871&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665720	433916784							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896136	CC(C)(C)CNC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H32F3N5O/c1-29(2,3)19-35-27(21-10-5-4-6-11-21)22-12-8-13-23(16-22)36-28(39)25-17-26(30(31,32)33)37-38(25)24-14-7-9-20(15-24)18-34/h4-17,27,35H,18-19,34H2,1-3H3,(H,36,39)	NWBNOBGYJRWWRK-UHFFFAOYSA-N	416872	1-(3-(Aminomethyl)phenyl)-N-(3-((neopentylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 187b::US10633345, Compound 187b::US10689346, Compound 187b::US11203574, Compound 187b::US11230530, Compound 187b::US11685721, Compound 187b	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416872	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416872&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124028296	433916785							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896137	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccc(cc1)C(N)=O)C(F)(F)F	InChI=1S/C30H28F4N6O2/c31-23-11-10-21(27(37-16-17-4-5-17)19-6-8-20(9-7-19)28(36)41)13-24(23)38-29(42)25-14-26(30(32,33)34)39-40(25)22-3-1-2-18(12-22)15-35/h1-3,6-14,17,27,37H,4-5,15-16,35H2,(H2,36,41)(H,38,42)	AHHWWBRXILLXFU-UHFFFAOYSA-N	416873	1-(3-(aminomethyl)phenyl)-N-(5-((4-carbamoylphenyl)(cyclopropylmethylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 153b::US10633345, Compound 153b::US10689346, Compound 153b::US11203574, Compound 153b::US11230530, Compound 153b::US11685721, Compound 153b	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416873	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416873&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355991	433916786							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896138	CCC(CO)NC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C29H30F3N5O2/c1-2-22(18-38)34-27(20-9-4-3-5-10-20)21-11-7-12-23(15-21)35-28(39)25-16-26(29(30,31)32)36-37(25)24-13-6-8-19(14-24)17-33/h3-16,22,27,34,38H,2,17-18,33H2,1H3,(H,35,39)	KIDPOTSBLNZGML-UHFFFAOYSA-N	416874	1-(3-(aminomethyl)phenyl)-N-(3-(((1-hydroxybutan-2-yl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 168b::US10633345, Compound 168b::US10689346, Compound 168b::US11192861, Compound 168b::US11230530, Compound 168b::US11685721, Compound 168b	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416874	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416874&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356215	433916787							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896139	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NC1CCC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H28F3N5O/c30-29(31,32)26-17-25(37(36-26)24-14-4-7-19(15-24)18-33)28(38)35-23-13-5-10-21(16-23)27(34-22-11-6-12-22)20-8-2-1-3-9-20/h1-5,7-10,13-17,22,27,34H,6,11-12,18,33H2,(H,35,38)	UCFAODSDUNDTFF-UHFFFAOYSA-N	416875	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclobutylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 188b::US10633345, Compound 188b::US10689346, Compound 188b::US11203574, Compound 188b::US11230530, Compound 188b::US11685721, Compound 188b	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416875	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416875&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123435501	433916788							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896140	COc1cccc(C(NCC2CC2)c2cccc(NC(=O)c3cc(nn3-c3cccc(CN)c3)C(F)(F)F)c2)c1O	InChI=1S/C30H30F3N5O3/c1-41-25-10-4-9-23(28(25)39)27(35-17-18-11-12-18)20-6-3-7-21(14-20)36-29(40)24-15-26(30(31,32)33)37-38(24)22-8-2-5-19(13-22)16-34/h2-10,13-15,18,27,35,39H,11-12,16-17,34H2,1H3,(H,36,40)	KCIFFUCEHRXTLF-UHFFFAOYSA-N	416876	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2-hydroxy-3-methoxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 151g::US10633345, Compound 151g::US10689346, Compound 151g::US11203574, Compound 151g::US11230530, Compound 151g::US11685721, Compound 151g	Plasma kallikrein		 25.1								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416876	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416876&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356165	433916789							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896141	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(N1CCCC1CO)c1ccccc1)C(F)(F)F	InChI=1S/C30H30F3N5O2/c31-30(32,33)27-17-26(38(36-27)24-12-4-7-20(15-24)18-34)29(40)35-23-11-5-10-22(16-23)28(21-8-2-1-3-9-21)37-14-6-13-25(37)19-39/h1-5,7-12,15-17,25,28,39H,6,13-14,18-19,34H2,(H,35,40)	BNZLGFQHSKUMEG-UHFFFAOYSA-N	416877	1-(3-(aminomethyl)phenyl)-N-(3-((2-(hydroxymethyl)pyrrolidin-1-yl)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 169b::US10633345, Compound 169b::US10689346, Compound 169b::US11203574, Compound 169b::US11230530, Compound 169b::US11685721, Compound 169b	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416877	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416877&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356128	433916790							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
896142	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCc1ccc(N)cc1)c1ccccc1)C(F)(F)F	InChI=1S/C32H29F3N6O/c33-32(34,35)29-18-28(41(40-29)27-11-4-6-22(16-27)19-36)31(42)39-26-10-5-9-24(17-26)30(23-7-2-1-3-8-23)38-20-21-12-14-25(37)15-13-21/h1-18,30,38H,19-20,36-37H2,(H,39,42)	BKOBJSLLJPHJRR-UHFFFAOYSA-N	416878	N-(3-(((4-Aminobenzyl)amino)(phenyl)methyl)phenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 189b::US10633345, Compound 189b::US10689346, Compound 189b::US11203574, Compound 189b::US11230530, Compound 189b::US11685721, Compound 189b	Plasma kallikrein		>100.0								US Patent		10.7270/Q26Q218G		aid1804367	US10633345	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416878	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416878&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665871	433916791							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878851	CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cc1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N	InChI=1S/C32H33ClFN5O3/c1-42-26-17-29(39(19-26)31(41)37-25-10-8-24(33)9-11-25)30(40)38-28-16-23(7-12-27(28)34)32(36,14-13-20-5-6-20)22-4-2-3-21(15-22)18-35/h2-4,7-12,15-16,20,26,29H,5-6,13-14,17,19,36H2,1H3,(H,37,41)(H,38,40)/t26-,29-,32?/m1/s1	YTGQPSYAWGTQEE-IYGDAUFUSA-N	433367	US10562850, Compound 17b::US11066360, Compound 17b	Plasma kallikrein		 75.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433367	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433367&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359623	438642300							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878852	CC(C)(C)[S@](=O)NC(CCC1CC1)(c1ccc(F)c(NC(=O)[C@H]2C[C@@H](O)CN2C(=O)Nc2ccc(Cl)cc2)c1)c1ccccn1	InChI=1S/C33H39ClFN5O4S/c1-32(2,3)45(44)39-33(16-15-21-7-8-21,29-6-4-5-17-36-29)22-9-14-26(35)27(18-22)38-30(42)28-19-25(41)20-40(28)31(43)37-24-12-10-23(34)11-13-24/h4-6,9-14,17-18,21,25,28,39,41H,7-8,15-16,19-20H2,1-3H3,(H,37,43)(H,38,42)/t25-,28-,33?,45+/m1/s1	JEVCIJSWWNTRIA-SMAHILNNSA-N	433368	US10562850, Compound 61b::US11066360, Compound 61b	Plasma kallikrein		<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433368	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433368&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			145750145	438642301							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878853	O[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cc1)C(=O)Nc1ccccc1F	InChI=1S/C18H17ClFN3O3/c19-11-5-7-12(8-6-11)21-18(26)23-10-13(24)9-16(23)17(25)22-15-4-2-1-3-14(15)20/h1-8,13,16,24H,9-10H2,(H,21,26)(H,22,25)/t13-,16-/m1/s1	YIUKCJACECLDEF-CZUORRHYSA-N	433369	US10562850, Compound 2a::US11066360, Compound 2a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433369	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433369&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359279	438642302							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878854	CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N	InChI=1S/C31H32ClFN6O3/c1-42-24-15-27(39(18-24)30(41)38-28-10-8-23(32)17-36-28)29(40)37-26-14-22(7-9-25(26)33)31(35,12-11-19-5-6-19)21-4-2-3-20(13-21)16-34/h2-4,7-10,13-14,17,19,24,27H,5-6,11-12,15,18,35H2,1H3,(H,37,40)(H,36,38,41)/t24-,27-,31?/m1/s1	XHEUJDABOZVRIR-QPLSPKJVSA-N	433370	US10562850, Compound 18b::US11066360, Compound 18b	Plasma kallikrein		<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433370	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433370&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359297	438642303							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878855	O[C@@]1(C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cc1)C(=O)Nc1cc(ccc1F)C(CCC1CC1)(NC(=O)Nc1ccc(Cl)cc1)c1cccc(c1)C#N)c1ccccc1	InChI=1S/C44H39Cl2FN6O4/c45-33-12-16-35(17-13-33)49-41(55)52-44(22-21-28-9-10-28,31-8-4-5-29(23-31)26-48)32-11-20-37(47)38(24-32)51-40(54)39-25-43(57,30-6-2-1-3-7-30)27-53(39)42(56)50-36-18-14-34(46)15-19-36/h1-8,11-20,23-24,28,39,57H,9-10,21-22,25,27H2,(H,50,56)(H,51,54)(H2,49,52,55)/t39-,43-,44?/m1/s1	UCADJOBQLTWIBK-TVHZFVKUSA-N	433371	US10562850, Compound 30b::US11066360, Compound 30b	Plasma kallikrein		 75.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433371	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433371&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359527	438642304							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878856	O[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cc1)C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1	InChI=1S/C29H30ClFN4O3/c30-21-9-11-22(12-10-21)33-29(38)35-17-23(36)15-26(35)28(37)34-25-14-20(8-13-24(25)31)27(32-16-18-6-7-18)19-4-2-1-3-5-19/h1-5,8-14,18,23,26-27,32,36H,6-7,15-17H2,(H,33,38)(H,34,37)/t23-,26-,27?/m1/s1	HBBZGIHYHHTCAB-UTZIHYNGSA-N	433366	US10562850, Compound 1p::US10562850, Compound 3a::US11066360, Compound 3a	Plasma kallikrein		 75.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433366	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433366&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135281863	438642299							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878857	CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(CCC1CC1)(N[S@](=O)C(C)(C)C)c1cccc(c1)C#N	InChI=1S/C35H40ClFN6O4S/c1-34(2,3)48(46)42-35(15-14-22-8-9-22,24-7-5-6-23(16-24)19-38)25-10-12-28(37)29(17-25)40-32(44)30-18-27(47-4)21-43(30)33(45)41-31-13-11-26(36)20-39-31/h5-7,10-13,16-17,20,22,27,30,42H,8-9,14-15,18,21H2,1-4H3,(H,40,44)(H,39,41,45)/t27-,30-,35?,48-/m1/s1	VAASFQVGQYBRMC-BEGVHSJBSA-N	433373	US10562850, Compound 18a::US11066360, Compound 18a	Plasma kallikrein		<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433373	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433373&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			145750015	438642305							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878858	NC(CCC1CC1)(c1ccc(F)c(NC(=O)[C@H]2C[C@@H](O)CN2C(=O)Nc2ccc(Cl)cn2)c1)c1ccccn1	InChI=1S/C28H30ClFN6O3/c29-19-7-9-25(33-15-19)35-27(39)36-16-20(37)14-23(36)26(38)34-22-13-18(6-8-21(22)30)28(31,11-10-17-4-5-17)24-3-1-2-12-32-24/h1-3,6-9,12-13,15,17,20,23,37H,4-5,10-11,14,16,31H2,(H,34,38)(H,33,35,39)/t20-,23-,28?/m1/s1	KXFZKEZPEDQJMM-JLGCCPRNSA-N	433374	US10562850, Compound 62c::US11066360, Compound 62c	Plasma kallikrein		<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433374	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433374&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359241	438642306							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878859	NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2C[C@@H](O)CN2C(=O)Nc2ccc(Cl)cc2)c1	InChI=1S/C31H31ClFN5O3/c32-23-7-9-24(10-8-23)36-30(41)38-18-25(39)16-28(38)29(40)37-27-15-22(6-11-26(27)33)31(35,13-12-19-4-5-19)21-3-1-2-20(14-21)17-34/h1-3,6-11,14-15,19,25,28,39H,4-5,12-13,16,18,35H2,(H,36,41)(H,37,40)/t25-,28-,31?/m1/s1	ZSOTVUHHWYEFAC-JADDJLNISA-N	433375	US10562850, Compound 4g::US11066360, Compound 4g	Plasma kallikrein		 75.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433375	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433375&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359354	438642307							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878860	N[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cc1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N	InChI=1S/C31H32ClFN6O2/c32-23-7-9-25(10-8-23)37-30(41)39-18-24(35)16-28(39)29(40)38-27-15-22(6-11-26(27)33)31(36,13-12-19-4-5-19)21-3-1-2-20(14-21)17-34/h1-3,6-11,14-15,19,24,28H,4-5,12-13,16,18,35-36H2,(H,37,41)(H,38,40)/t24-,28-,31?/m1/s1	TXDNHUJHLZWLQW-LLAOLMGESA-N	433376	US10562850, Compound 19c::US11066360, Compound 19c	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433376	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433376&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359601	438642308							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878861	NC(CCC1CC1)(c1ccc(cc1)C#N)c1ccc(F)c(NC(=O)[C@H]2C[C@@H](O)CN2C(=O)Nc2ccc(Cl)cc2)c1	InChI=1S/C31H31ClFN5O3/c32-23-8-10-24(11-9-23)36-30(41)38-18-25(39)16-28(38)29(40)37-27-15-22(7-12-26(27)33)31(35,14-13-19-1-2-19)21-5-3-20(17-34)4-6-21/h3-12,15,19,25,28,39H,1-2,13-14,16,18,35H2,(H,36,41)(H,37,40)/t25-,28-,31?/m1/s1	NNIFNVSICNCVCW-JADDJLNISA-N	433377	US10562850, Compound 63g::US11066360, Compound 63g	Plasma kallikrein		 75.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433377	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433377&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359504	438642309							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878862	NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)Nc2ccc(Cl)cc2)c1	InChI=1S/C31H31ClFN5O3/c32-23-7-9-24(10-8-23)36-30(41)38-18-25(39)16-28(38)29(40)37-27-15-22(6-11-26(27)33)31(35,13-12-19-4-5-19)21-3-1-2-20(14-21)17-34/h1-3,6-11,14-15,19,25,28,39H,4-5,12-13,16,18,35H2,(H,36,41)(H,37,40)/t25-,28+,31?/m1/s1	ZSOTVUHHWYEFAC-LHPFXVGBSA-N	433378	US10562850, Compound 5e::US11066360, Compound 5e	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433378	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433378&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135281905	438642310					C04398		1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878863	N[C@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cc1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N	InChI=1S/C31H32ClFN6O2/c32-23-7-9-25(10-8-23)37-30(41)39-18-24(35)16-28(39)29(40)38-27-15-22(6-11-26(27)33)31(36,13-12-19-4-5-19)21-3-1-2-20(14-21)17-34/h1-3,6-11,14-15,19,24,28H,4-5,12-13,16,18,35-36H2,(H,37,41)(H,38,40)/t24-,28+,31?/m0/s1	TXDNHUJHLZWLQW-MPAODNJVSA-N	433379	US10562850, Compound 33d::US11066360, Compound 33d	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433379	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433379&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359561	438642311							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878864	NC(CCC1CC1)(c1cccnc1)c1ccc(F)c(NC(=O)[C@H]2C[C@@H](O)CN2C(=O)Nc2ccc(Cl)cc2)c1	InChI=1S/C29H31ClFN5O3/c30-21-6-8-22(9-7-21)34-28(39)36-17-23(37)15-26(36)27(38)35-25-14-19(5-10-24(25)31)29(32,12-11-18-3-4-18)20-2-1-13-33-16-20/h1-2,5-10,13-14,16,18,23,26,37H,3-4,11-12,15,17,32H2,(H,34,39)(H,35,38)/t23-,26-,29?/m1/s1	GXRAZUOSZNNHEA-XATCSJPRSA-N	433382	US10562850, Compound 64g::US11066360, Compound 64g	Plasma kallikrein		<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433382	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433382&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359617	438642314							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878865	CO[C@@H]1C[C@H](N(C1)C(=O)N(C)c1ccc(Cl)cc1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N	InChI=1S/C33H35ClFN5O3/c1-39(26-11-9-25(34)10-12-26)32(42)40-20-27(43-2)18-30(40)31(41)38-29-17-24(8-13-28(29)35)33(37,15-14-21-6-7-21)23-5-3-4-22(16-23)19-36/h3-5,8-13,16-17,21,27,30H,6-7,14-15,18,20,37H2,1-2H3,(H,38,41)/t27-,30+,33?/m1/s1	FPWZXKOIXOEUQB-RDJZJCQLSA-N	433383	US10562850, Compound 6f::US11066360, Compound 6f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433383	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433383&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359365	438642315							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878866	NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2CC(=O)CN2C(=O)Nc2ccc(Cl)cc2)c1	InChI=1S/C31H29ClFN5O3/c32-23-7-9-24(10-8-23)36-30(41)38-18-25(39)16-28(38)29(40)37-27-15-22(6-11-26(27)33)31(35,13-12-19-4-5-19)21-3-1-2-20(14-21)17-34/h1-3,6-11,14-15,19,28H,4-5,12-13,16,18,35H2,(H,36,41)(H,37,40)/t28-,31?/m1/s1	QMSQFJCSTHFEIQ-ZZTVPSNHSA-N	433384	US10562850, Compound 20b::US11066360, Compound 20b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433384	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433384&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359348	438642316							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878867	CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cc1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccn1	InChI=1S/C30H33ClFN5O3/c1-40-23-17-26(37(18-23)29(39)35-22-10-8-21(31)9-11-22)28(38)36-25-16-20(7-12-24(25)32)30(33,14-13-19-5-6-19)27-4-2-3-15-34-27/h2-4,7-12,15-16,19,23,26H,5-6,13-14,17-18,33H2,1H3,(H,35,39)(H,36,38)/t23-,26-,30?/m1/s1	VXUMWJIENCDFKX-JRSXUWQBSA-N	433385	US10562850, Compound 65b::US11066360, Compound 65b	Plasma kallikrein		<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433385	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433385&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359647	438642317							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878868	CO[C@@H]1C[C@@H](N(C1)C(=O)N(C)c1ccc(Cl)cc1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N	InChI=1S/C33H35ClFN5O3/c1-39(26-11-9-25(34)10-12-26)32(42)40-20-27(43-2)18-30(40)31(41)38-29-17-24(8-13-28(29)35)33(37,15-14-21-6-7-21)23-5-3-4-22(16-23)19-36/h3-5,8-13,16-17,21,27,30H,6-7,14-15,18,20,37H2,1-2H3,(H,38,41)/t27-,30-,33?/m1/s1	FPWZXKOIXOEUQB-QDZZTBPHSA-N	433386	US10562850, Compound 6e::US11066360, Compound 6e	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433386	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433386&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359618	438642318							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878869	NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2C[C@@H](O)CN2C(=O)Nc2ccccc2)c1	InChI=1S/C31H32FN5O3/c32-26-12-11-23(31(34,14-13-20-9-10-20)22-6-4-5-21(15-22)18-33)16-27(26)36-29(39)28-17-25(38)19-37(28)30(40)35-24-7-2-1-3-8-24/h1-8,11-12,15-16,20,25,28,38H,9-10,13-14,17,19,34H2,(H,35,40)(H,36,39)/t25-,28-,31?/m1/s1	BHZFWFPHPBCYRY-JADDJLNISA-N	433387	US10562850, Compound 21d::US11066360, Compound 21d	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433387	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433387&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359590	438642319							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878870	CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccn1	InChI=1S/C29H32ClFN6O3/c1-40-21-15-24(37(17-21)28(39)36-26-10-8-20(30)16-34-26)27(38)35-23-14-19(7-9-22(23)31)29(32,12-11-18-5-6-18)25-4-2-3-13-33-25/h2-4,7-10,13-14,16,18,21,24H,5-6,11-12,15,17,32H2,1H3,(H,35,38)(H,34,36,39)/t21-,24-,29?/m1/s1	HMKGSFLIMYOEKX-ZORXERLGSA-N	433388	BDBM433391::US10562850, Compound 36d::US10562850, Compound 37d::US11066360, Compound 37d	Plasma kallikrein		<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433388	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433388&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359283	438642320							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878871	NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2CCCN2C(=O)Nc2ccc(Cl)cc2)c1	InChI=1S/C31H31ClFN5O2/c32-24-9-11-25(12-10-24)36-30(40)38-16-2-5-28(38)29(39)37-27-18-23(8-13-26(27)33)31(35,15-14-20-6-7-20)22-4-1-3-21(17-22)19-34/h1,3-4,8-13,17-18,20,28H,2,5-7,14-16,35H2,(H,36,40)(H,37,39)/t28-,31?/m1/s1	LISQDGOQHUHLHR-ZZTVPSNHSA-N	433389	US10562850, Compound 7c::US11066360, Compound 7c	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433389	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433389&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359645	438642321							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878872	Cc1ccc(NC(=O)N2C[C@H](O)C[C@@H]2C(=O)Nc2cc(ccc2F)C(N)(CCC2CC2)c2cccc(c2)C#N)cc1	InChI=1S/C32H34FN5O3/c1-20-5-10-25(11-6-20)36-31(41)38-19-26(39)17-29(38)30(40)37-28-16-24(9-12-27(28)33)32(35,14-13-21-7-8-21)23-4-2-3-22(15-23)18-34/h2-6,9-12,15-16,21,26,29,39H,7-8,13-14,17,19,35H2,1H3,(H,36,41)(H,37,40)/t26-,29-,32?/m1/s1	IWZUFFQUBYJSIV-IYGDAUFUSA-N	433390	US10562850, Compound 22b::US11066360, Compound 22b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433390	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433390&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359621	438642322							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878873	CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccn1	InChI=1S/C29H32ClFN6O3/c1-40-21-15-24(37(17-21)28(39)36-26-10-8-20(30)16-34-26)27(38)35-23-14-19(7-9-22(23)31)29(32,12-11-18-5-6-18)25-4-2-3-13-33-25/h2-4,7-10,13-14,16,18,21,24H,5-6,11-12,15,17,32H2,1H3,(H,35,38)(H,34,36,39)/t21-,24-,29?/m1/s1	HMKGSFLIMYOEKX-ZORXERLGSA-N	433388	BDBM433391::US10562850, Compound 36d::US10562850, Compound 37d::US11066360, Compound 37d	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433388	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433388&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359283	438642320							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878874	NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@@H]2CCCN2C(=O)Nc2ccc(Cl)cc2)c1	InChI=1S/C31H31ClFN5O2/c32-24-9-11-25(12-10-24)36-30(40)38-16-2-5-28(38)29(39)37-27-18-23(8-13-26(27)33)31(35,15-14-20-6-7-20)22-4-1-3-21(17-22)19-34/h1,3-4,8-13,17-18,20,28H,2,5-7,14-16,35H2,(H,36,40)(H,37,39)/t28-,31?/m0/s1	LISQDGOQHUHLHR-NPHAVVRNSA-N	433392	US10562850, Compound 8c::US11066360, Compound 8c	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433392	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433392&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359611	438642323							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878875	NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2C[C@@H](O)CN2C(=O)Nc2ccc(Br)cc2)c1	InChI=1S/C31H31BrFN5O3/c32-23-7-9-24(10-8-23)36-30(41)38-18-25(39)16-28(38)29(40)37-27-15-22(6-11-26(27)33)31(35,13-12-19-4-5-19)21-3-1-2-20(14-21)17-34/h1-3,6-11,14-15,19,25,28,39H,4-5,12-13,16,18,35H2,(H,36,41)(H,37,40)/t25-,28-,31?/m1/s1	LKZRDRGVMHMUQQ-JADDJLNISA-N	433393	US10562850, Compound 23b::US11066360, Compound 23b	Plasma kallikrein		 75.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433393	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433393&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135281908	438642324							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878876	NC(CCC1CC1)(c1ccc(F)c(NC(=O)[C@H]2C[C@@](O)(CN2C(=O)Nc2ccc(Cl)cc2)c2ccccc2)c1)c1ccccn1	InChI=1S/C35H35ClFN5O3/c36-26-12-14-27(15-13-26)40-33(44)42-22-34(45,24-6-2-1-3-7-24)21-30(42)32(43)41-29-20-25(11-16-28(29)37)35(38,18-17-23-9-10-23)31-8-4-5-19-39-31/h1-8,11-16,19-20,23,30,45H,9-10,17-18,21-22,38H2,(H,40,44)(H,41,43)/t30-,34-,35?/m1/s1	QSEWLZJVGPKOAW-WELJHWQCSA-N	433394	US10562850, Compound 31i::US11066360, Compound 31i	Plasma kallikrein		<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433394	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433394&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359587	438642325							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878877	NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2C[C@H](O)CN2C(=O)Nc2ccc(Cl)cc2)c1	InChI=1S/C31H31ClFN5O3/c32-23-7-9-24(10-8-23)36-30(41)38-18-25(39)16-28(38)29(40)37-27-15-22(6-11-26(27)33)31(35,13-12-19-4-5-19)21-3-1-2-20(14-21)17-34/h1-3,6-11,14-15,19,25,28,39H,4-5,12-13,16,18,35H2,(H,36,41)(H,37,40)/t25-,28+,31?/m0/s1	ZSOTVUHHWYEFAC-RKPVUUMKSA-N	433395	US10562850, Compound 9c::US11066360, Compound 9c	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433395	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433395&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359482	438642326							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878878	NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2C[C@@H](O)CN2C(=O)Nc2ccc(F)cc2)c1	InChI=1S/C31H31F2N5O3/c32-23-7-9-24(10-8-23)36-30(41)38-18-25(39)16-28(38)29(40)37-27-15-22(6-11-26(27)33)31(35,13-12-19-4-5-19)21-3-1-2-20(14-21)17-34/h1-3,6-11,14-15,19,25,28,39H,4-5,12-13,16,18,35H2,(H,36,41)(H,37,40)/t25-,28-,31?/m1/s1	CEXKWMHOXZZHFS-JADDJLNISA-N	433396	US10562850, Compound 24b::US11066360, Compound 24b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433396	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433396&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359547	438642327							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878879	NC(CCC1CC1)(c1ccc(F)c(NC(=O)[C@H]2C[C@@](O)(CN2C(=O)Nc2ccc(Cl)cn2)c2ccccc2)c1)c1ccccn1	InChI=1S/C34H34ClFN6O3/c35-25-12-14-30(39-20-25)41-32(44)42-21-33(45,23-6-2-1-3-7-23)19-28(42)31(43)40-27-18-24(11-13-26(27)36)34(37,16-15-22-9-10-22)29-8-4-5-17-38-29/h1-8,11-14,17-18,20,22,28,45H,9-10,15-16,19,21,37H2,(H,40,43)(H,39,41,44)/t28-,33-,34?/m1/s1	CSRIYPJRLBVGQK-WHGMDWNTSA-N	433397	US10562850, Compound 32a::US11066360, Compound 32a	Plasma kallikrein		<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433397	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433397&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359570	438642328							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878880	NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@@H]2C[C@H](O)CN2C(=O)Nc2ccc(Cl)cc2)c1	InChI=1S/C31H31ClFN5O3/c32-23-7-9-24(10-8-23)36-30(41)38-18-25(39)16-28(38)29(40)37-27-15-22(6-11-26(27)33)31(35,13-12-19-4-5-19)21-3-1-2-20(14-21)17-34/h1-3,6-11,14-15,19,25,28,39H,4-5,12-13,16,18,35H2,(H,36,41)(H,37,40)/t25-,28-,31?/m0/s1	ZSOTVUHHWYEFAC-RXKSKBTASA-N	433398	US10562850, Compound 10c::US11066360, Compound 10c	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433398	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433398&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359568	438642329							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878881	NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2C[C@@H](O)CN2C(=O)Nc2ccc(cc2)[N+]([O-])=O)c1	InChI=1S/C31H31FN6O5/c32-26-11-6-22(31(34,13-12-19-4-5-19)21-3-1-2-20(14-21)17-33)15-27(26)36-29(40)28-16-25(39)18-37(28)30(41)35-23-7-9-24(10-8-23)38(42)43/h1-3,6-11,14-15,19,25,28,39H,4-5,12-13,16,18,34H2,(H,35,41)(H,36,40)/t25-,28-,31?/m1/s1	GOFUDLSJSSMFGH-JADDJLNISA-N	433399	US10562850, Compound 25b::US11066360, Compound 25b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433399	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433399&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359649	438642330					C02125		1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878882	O[C@@]1(C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(CCC1CC1)(NC(=O)Nc1ccc(Cl)cn1)c1ccccn1)c1ccccc1	InChI=1S/C40H37Cl2FN8O4/c41-28-12-15-34(45-22-28)48-37(53)50-40(18-17-25-9-10-25,33-8-4-5-19-44-33)27-11-14-30(43)31(20-27)47-36(52)32-21-39(55,26-6-2-1-3-7-26)24-51(32)38(54)49-35-16-13-29(42)23-46-35/h1-8,11-16,19-20,22-23,25,32,55H,9-10,17-18,21,24H2,(H,47,52)(H,46,49,54)(H2,45,48,50,53)/t32-,39-,40?/m1/s1	LHPFAIGHMVQELS-HLYQHIASSA-N	433400	US10562850, Compound 32b::US11066360, Compound 32b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433400	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433400&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359518	438642331							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878883	CO[C@H]1C[C@H](N(C1)C(=O)Nc1ccc(Cl)cc1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N	InChI=1S/C32H33ClFN5O3/c1-42-26-17-29(39(19-26)31(41)37-25-10-8-24(33)9-11-25)30(40)38-28-16-23(7-12-27(28)34)32(36,14-13-20-5-6-20)22-4-2-3-21(15-22)18-35/h2-4,7-12,15-16,20,26,29H,5-6,13-14,17,19,36H2,1H3,(H,37,41)(H,38,40)/t26-,29-,32?/m0/s1	YTGQPSYAWGTQEE-RCESYNESSA-N	433401	US10562850, Compound 11e::US11066360, Compound 11e	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433401	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433401&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135281907	438642332							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878884	NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2C[C@@H](O)CN2C(=O)Nc2cccc3ccccc23)c1	InChI=1S/C35H34FN5O3/c36-29-14-13-26(35(38,16-15-22-11-12-22)25-8-3-5-23(17-25)20-37)18-31(29)39-33(43)32-19-27(42)21-41(32)34(44)40-30-10-4-7-24-6-1-2-9-28(24)30/h1-10,13-14,17-18,22,27,32,42H,11-12,15-16,19,21,38H2,(H,39,43)(H,40,44)/t27-,32-,35?/m1/s1	XADXZHLGEJHMKA-GCMUPQKQSA-N	433402	US10562850, Compound 26b::US11066360, Compound 26b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433402	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433402&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359610	438642333							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878885	CO[C@@]1(C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cc1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccn1)c1ccccc1	InChI=1S/C36H37ClFN5O3/c1-46-35(25-7-3-2-4-8-25)22-31(43(23-35)34(45)41-28-15-13-27(37)14-16-28)33(44)42-30-21-26(12-17-29(30)38)36(39,19-18-24-10-11-24)32-9-5-6-20-40-32/h2-9,12-17,20-21,24,31H,10-11,18-19,22-23,39H2,1H3,(H,41,45)(H,42,44)/t31-,35-,36?/m1/s1	CVMRJSNJZIDFBV-HKGUWHNTSA-N	433403	US10562850, Compound 34d::US11066360, Compound 34d	Plasma kallikrein		<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433403	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433403&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359339	438642334							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878886	NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2CCCN2C(=O)Nc2ccc(Cl)cn2)c1	InChI=1S/C30H30ClFN6O2/c31-23-9-11-27(35-18-23)37-29(40)38-14-2-5-26(38)28(39)36-25-16-22(8-10-24(25)32)30(34,13-12-19-6-7-19)21-4-1-3-20(15-21)17-33/h1,3-4,8-11,15-16,18-19,26H,2,5-7,12-14,34H2,(H,36,39)(H,35,37,40)/t26-,30?/m1/s1	BHUHPYWDKYISKX-FIQOPJFZSA-N	433404	US10562850, Compound 13e::US11066360, Compound 13e	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433404	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433404&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135281909	438642335							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878887	NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2C[C@@H](O)CN2C(=O)Nc2ccc(cc2)C(F)(F)F)c1	InChI=1S/C32H31F4N5O3/c33-26-11-8-23(31(38,13-12-19-4-5-19)22-3-1-2-20(14-22)17-37)15-27(26)40-29(43)28-16-25(42)18-41(28)30(44)39-24-9-6-21(7-10-24)32(34,35)36/h1-3,6-11,14-15,19,25,28,42H,4-5,12-13,16,18,38H2,(H,39,44)(H,40,43)/t25-,28-,31?/m1/s1	XJHRLFBDDQULDZ-JADDJLNISA-N	433405	US10562850, Compound 27b::US11066360, Compound 27b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433405	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433405&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359579	438642336							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878888	CO[C@@]1(C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccn1)c1ccccc1	InChI=1S/C35H36ClFN6O3/c1-46-34(24-7-3-2-4-8-24)20-29(43(22-34)33(45)42-31-15-13-26(36)21-40-31)32(44)41-28-19-25(12-14-27(28)37)35(38,17-16-23-10-11-23)30-9-5-6-18-39-30/h2-9,12-15,18-19,21,23,29H,10-11,16-17,20,22,38H2,1H3,(H,41,44)(H,40,42,45)/t29-,34-,35?/m1/s1	JDWCFHUHWOPMOA-QKKDUPNPSA-N	433406	US10562850, Compound 35a::US11066360, Compound 35a	Plasma kallikrein		 75.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433406	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433406&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359597	438642337							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878889	NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2C[C@@H](O)CN2C(=O)Nc2ccc(Cl)cn2)c1	InChI=1S/C30H30ClFN6O3/c31-22-7-9-27(35-16-22)37-29(41)38-17-23(39)14-26(38)28(40)36-25-13-21(6-8-24(25)32)30(34,11-10-18-4-5-18)20-3-1-2-19(12-20)15-33/h1-3,6-9,12-13,16,18,23,26,39H,4-5,10-11,14,17,34H2,(H,36,40)(H,35,37,41)/t23-,26-,30?/m1/s1	SXTWVJSROGJKOX-JRSXUWQBSA-N	433407	US10562850, Compound 14h::US11066360, Compound 14h	Plasma kallikrein		<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433407	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433407&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359350	438642338							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878890	Nc1ccc(NC(=O)N2C[C@H](O)C[C@@H]2C(=O)Nc2cc(ccc2F)C(N)(CCC2CC2)c2cccc(c2)C#N)cc1	InChI=1S/C31H33FN6O3/c32-26-11-6-22(31(35,13-12-19-4-5-19)21-3-1-2-20(14-21)17-33)15-27(26)37-29(40)28-16-25(39)18-38(28)30(41)36-24-9-7-23(34)8-10-24/h1-3,6-11,14-15,19,25,28,39H,4-5,12-13,16,18,34-35H2,(H,36,41)(H,37,40)/t25-,28-,31?/m1/s1	XAOKWPPAZPSJST-JADDJLNISA-N	433408	US10562850, Compound 28b::US11066360, Compound 28b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433408	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433408&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135281910	438642339							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878891	CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(CCC1CC1)(N[S@](=O)C(C)(C)C)c1ccccc1	InChI=1S/C34H41ClFN5O4S/c1-33(2,3)46(44)40-34(17-16-22-10-11-22,23-8-6-5-7-9-23)24-12-14-27(36)28(18-24)38-31(42)29-19-26(45-4)21-41(29)32(43)39-30-15-13-25(35)20-37-30/h5-9,12-15,18,20,22,26,29,40H,10-11,16-17,19,21H2,1-4H3,(H,38,42)(H,37,39,43)/t26-,29-,34?,46-/m1/s1	QAXCQTYVFNJQHP-CUFRGZMTSA-N	433409	US10562850, Compound 66c::US11066360, Compound 66c	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433409	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433409&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			145750157	438642340							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878892	CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(cc1)C#N)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N	InChI=1S/C33H33FN6O3/c1-43-27-17-30(40(20-27)32(42)38-26-10-7-22(18-35)8-11-26)31(41)39-29-16-25(9-12-28(29)34)33(37,14-13-21-5-6-21)24-4-2-3-23(15-24)19-36/h2-4,7-12,15-16,21,27,30H,5-6,13-14,17,20,37H2,1H3,(H,38,42)(H,39,41)/t27-,30-,33?/m1/s1	XJUMLAKVFMNIFB-QDZZTBPHSA-N	433411	US10562850, Compound 15f::US11066360, Compound 15f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433411	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433411&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359523	438642342							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878893	NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2C[C@@](O)(CN2C(=O)Nc2ccc(Cl)cn2)c2ccccc2)c1	InChI=1S/C36H34ClFN6O3/c37-28-12-14-32(41-21-28)43-34(46)44-22-35(47,25-6-2-1-3-7-25)19-31(44)33(45)42-30-18-27(11-13-29(30)38)36(40,16-15-23-9-10-23)26-8-4-5-24(17-26)20-39/h1-8,11-14,17-18,21,23,31,47H,9-10,15-16,19,22,40H2,(H,42,45)(H,41,43,46)/t31-,35-,36?/m1/s1	HWYAZMPNKGJCSA-HKGUWHNTSA-N	433412	US10562850, Compound 29e::US11066360, Compound 29e	Plasma kallikrein		<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433412	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433412&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359341	438642343							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878894	CC(C)(C)[S@@](=O)NC(CCC1CC1)(c1ccncc1)c1ccc(F)c(NC(=O)[C@H]2C[C@@H](O)CN2C(=O)Nc2ccc(Cl)cc2)c1	InChI=1S/C33H39ClFN5O4S/c1-32(2,3)45(44)39-33(15-12-21-4-5-21,22-13-16-36-17-14-22)23-6-11-27(35)28(18-23)38-30(42)29-19-26(41)20-40(29)31(43)37-25-9-7-24(34)8-10-25/h6-11,13-14,16-18,21,26,29,39,41H,4-5,12,15,19-20H2,1-3H3,(H,37,43)(H,38,42)/t26-,29-,33?,45-/m1/s1	QQLAJCNDSPMTIP-WZPBTREFSA-N	433413	US10562850, Compound 68a::US11066360, Compound 68a	Plasma kallikrein		<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433413	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433413&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359286	438642344							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878895	CC(=O)O[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N	InChI=1S/C32H32ClFN6O4/c1-19(41)44-25-15-28(40(18-25)31(43)39-29-10-8-24(33)17-37-29)30(42)38-27-14-23(7-9-26(27)34)32(36,12-11-20-5-6-20)22-4-2-3-21(13-22)16-35/h2-4,7-10,13-14,17,20,25,28H,5-6,11-12,15,18,36H2,1H3,(H,38,42)(H,37,39,43)/t25-,28-,32?/m1/s1	SNYRVQXDQOVDKK-OHCGPUKPSA-N	433414	US10562850, Compound 14g::US11066360, Compound 14g	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433414	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433414&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359520	438642345							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878896	NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2C[C@@](O)(CN2C(=O)Nc2ccc(Cl)cc2)c2ccccc2)c1	InChI=1S/C37H35ClFN5O3/c38-29-12-14-30(15-13-29)42-35(46)44-23-36(47,26-6-2-1-3-7-26)21-33(44)34(45)43-32-20-28(11-16-31(32)39)37(41,18-17-24-9-10-24)27-8-4-5-25(19-27)22-40/h1-8,11-16,19-20,24,33,47H,9-10,17-18,21,23,41H2,(H,42,46)(H,43,45)/t33-,36-,37?/m1/s1	BUDMXNKNTXVVSL-OJLDNJJMSA-N	433415	US10562850, Compound 30a::US11066360, Compound 30a	Plasma kallikrein		<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433415	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433415&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359662	438642346							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878897	NC(CCC1CC1)(c1ccncc1)c1ccc(F)c(NC(=O)[C@H]2C[C@@H](O)CN2C(=O)Nc2ccc(Cl)cc2)c1	InChI=1S/C29H31ClFN5O3/c30-21-4-6-22(7-5-21)34-28(39)36-17-23(37)16-26(36)27(38)35-25-15-20(3-8-24(25)31)29(32,12-9-18-1-2-18)19-10-13-33-14-11-19/h3-8,10-11,13-15,18,23,26,37H,1-2,9,12,16-17,32H2,(H,34,39)(H,35,38)/t23-,26-,29?/m1/s1	KWYZMIIVFJJBEL-XATCSJPRSA-N	433416	US10562850, Compound 69a::US11066360, Compound 69a	Plasma kallikrein		<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433416	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433416&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359521	438642347							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878899	O[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cc1)C(=O)Nc1cc(ccc1F)[C@H](NCC1CC1)c1cccc(c1)C#N	InChI=1S/C30H29ClFN5O3/c31-22-7-9-23(10-8-22)35-30(40)37-17-24(38)14-27(37)29(39)36-26-13-21(6-11-25(26)32)28(34-16-18-4-5-18)20-3-1-2-19(12-20)15-33/h1-3,6-13,18,24,27-28,34,38H,4-5,14,16-17H2,(H,35,40)(H,36,39)/t24-,27-,28-/m1/s1	SQGKFOGUTRWMGA-RYRVMRHHSA-N	433417	US10562850, Compound 60a::US11066360, Compound 60a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433417	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433417&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359582	438642348							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878900	NC(CCC1CC1)(c1ccncc1)c1ccc(F)c(NC(=O)[C@H]2C[C@@H](O)CN2C(=O)Nc2ccc(Cl)cn2)c1	InChI=1S/C28H30ClFN6O3/c29-20-4-6-25(33-15-20)35-27(39)36-16-21(37)14-24(36)26(38)34-23-13-19(3-5-22(23)30)28(31,10-7-17-1-2-17)18-8-11-32-12-9-18/h3-6,8-9,11-13,15,17,21,24,37H,1-2,7,10,14,16,31H2,(H,34,38)(H,33,35,39)/t21-,24-,28?/m1/s1	HQGRGSNARPYLCN-OWWYDEOISA-N	433418	US10562850, Compound 72c::US11066360, Compound 72c	Plasma kallikrein		<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433418	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433418&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359595	438642349							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878901	CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1	InChI=1S/C29H32ClFN6O3/c1-40-22-15-25(37(17-22)28(39)36-26-7-5-21(30)16-34-26)27(38)35-24-14-20(4-6-23(24)31)29(32,11-8-18-2-3-18)19-9-12-33-13-10-19/h4-7,9-10,12-14,16,18,22,25H,2-3,8,11,15,17,32H2,1H3,(H,35,38)(H,34,36,39)/t22-,25-,29?/m1/s1	VGGJBRJWCKLWRW-LKXBVVHWSA-N	433419	US10562850, Compound 70c::US11066360, Compound 70c	Plasma kallikrein		<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433419	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433419&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359295	438642350							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878902	CO[C@@H]1C[C@@H](N(C1)C(=O)Cc1ccc(Cl)cc1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1	InChI=1S/C31H34ClFN4O3/c1-40-25-18-28(37(19-25)29(38)16-21-4-7-24(32)8-5-21)30(39)36-27-17-23(6-9-26(27)33)31(34,13-10-20-2-3-20)22-11-14-35-15-12-22/h4-9,11-12,14-15,17,20,25,28H,2-3,10,13,16,18-19,34H2,1H3,(H,36,39)/t25-,28-,31?/m1/s1	DHVCRRDPZVVRDO-JADDJLNISA-N	433420	US10562850, Compound 76e::US11066360, Compound 76e	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433420	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433420&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359516	438642351							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878903	CC(C)(C)[S@@](=O)NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@@H]2C[C@H](O)CN2C(=O)Nc2ccc(Cl)cc2)c1	InChI=1S/C35H39ClFN5O4S/c1-34(2,3)47(46)41-35(16-15-22-7-8-22,24-6-4-5-23(17-24)20-38)25-9-14-29(37)30(18-25)40-32(44)31-19-28(43)21-42(31)33(45)39-27-12-10-26(36)11-13-27/h4-6,9-14,17-18,22,28,31,41,43H,7-8,15-16,19,21H2,1-3H3,(H,39,45)(H,40,44)/t28-,31-,35?,47+/m0/s1	MJBIFAIWKFMNPW-GVNGFNKKSA-N	433421	US10562850, Compound 10b::US11066360, Compound 10b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433421	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433421&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			145750013	438642352							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878904	CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cc1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1	InChI=1S/C30H33ClFN5O3/c1-40-24-17-27(37(18-24)29(39)35-23-7-5-22(31)6-8-23)28(38)36-26-16-21(4-9-25(26)32)30(33,13-10-19-2-3-19)20-11-14-34-15-12-20/h4-9,11-12,14-16,19,24,27H,2-3,10,13,17-18,33H2,1H3,(H,35,39)(H,36,38)/t24-,27-,30?/m1/s1	SAMYKJCENRVZAI-CPBGAKQSSA-N	433422	US10562850, Compound 71a::US11066360, Compound 71a	Plasma kallikrein		<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433422	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433422&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359598	438642353							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878905	CCO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(CCC1CC1)(NS(C)(=O)=O)c1ccncc1	InChI=1S/C31H36ClFN6O5S/c1-3-44-24-17-27(39(19-24)30(41)37-28-9-7-23(32)18-35-28)29(40)36-26-16-22(6-8-25(26)33)31(38-45(2,42)43,13-10-20-4-5-20)21-11-14-34-15-12-21/h6-9,11-12,14-16,18,20,24,27,38H,3-5,10,13,17,19H2,1-2H3,(H,36,40)(H,35,37,41)/t24-,27-,31?/m1/s1	WFRSAFQXIIEVRI-QPLSPKJVSA-N	433423	US10562850, Compound 55a::US11066360, Compound 55a	Plasma kallikrein		<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433423	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433423&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359384	438642354							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878906	CC(C)(C)[S@@](=O)NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2C[C@@H](O)CN2C(=O)Nc2ccc(Cl)cc2)c1	InChI=1S/C35H39ClFN5O4S/c1-34(2,3)47(46)41-35(16-15-22-7-8-22,24-6-4-5-23(17-24)20-38)25-9-14-29(37)30(18-25)40-32(44)31-19-28(43)21-42(31)33(45)39-27-12-10-26(36)11-13-27/h4-6,9-14,17-18,22,28,31,41,43H,7-8,15-16,19,21H2,1-3H3,(H,39,45)(H,40,44)/t28-,31-,35?,47-/m1/s1	MJBIFAIWKFMNPW-ZQUSZWJISA-N	433424	US10562850, Compound 4f::US11066360, Compound 4f	Plasma kallikrein		 75.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433424	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433424&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			145750195	438642355							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878907	CCNC(CCC1CC1)(c1ccccc1)c1ccc(F)c(NC(=O)[C@H]2C[C@H](CN2C(=O)Nc2ccc(Cl)cn2)OC)c1	InChI=1S/C32H37ClFN5O3/c1-3-36-32(16-15-21-9-10-21,22-7-5-4-6-8-22)23-11-13-26(34)27(17-23)37-30(40)28-18-25(42-2)20-39(28)31(41)38-29-14-12-24(33)19-35-29/h4-8,11-14,17,19,21,25,28,36H,3,9-10,15-16,18,20H2,1-2H3,(H,37,40)(H,35,38,41)/t25-,28-,32?/m1/s1	LUJTUEOORDUTPD-OHCGPUKPSA-N	433425	US10562850, Compound 67b::US11066360, Compound 67b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433425	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433425&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359524	438642356							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878908	CCO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(CCC1CC1)(NC(C)=O)c1ccncc1	InChI=1S/C32H36ClFN6O4/c1-3-44-25-17-28(40(19-25)31(43)38-29-9-7-24(33)18-36-29)30(42)37-27-16-23(6-8-26(27)34)32(39-20(2)41,13-10-21-4-5-21)22-11-14-35-15-12-22/h6-9,11-12,14-16,18,21,25,28H,3-5,10,13,17,19H2,1-2H3,(H,37,42)(H,39,41)(H,36,38,43)/t25-,28-,32?/m1/s1	PBUISDDGSOCZAC-OHCGPUKPSA-N	433426	US10562850, Compound 56a::US11066360, Compound 56a	Plasma kallikrein		<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433426	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433426&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359338	438642357							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878909	CC(C)(C)[S@@](=O)NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2C[C@H](O)CN2C(=O)Nc2ccc(Cl)cc2)c1	InChI=1S/C35H39ClFN5O4S/c1-34(2,3)47(46)41-35(16-15-22-7-8-22,24-6-4-5-23(17-24)20-38)25-9-14-29(37)30(18-25)40-32(44)31-19-28(43)21-42(31)33(45)39-27-12-10-26(36)11-13-27/h4-6,9-14,17-18,22,28,31,41,43H,7-8,15-16,19,21H2,1-3H3,(H,39,45)(H,40,44)/t28-,31+,35?,47+/m0/s1	MJBIFAIWKFMNPW-CVFBLIOSSA-N	433427	US10562850, Compound 9b::US11066360, Compound 9b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433427	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433427&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			145750116	438642358							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878910	CCC1(O)C[C@@H](N(C1)C(=O)OC(C)(C)C)C(=O)Nc1cc(ccc1F)C(CCC1CC1)(N[S@@](=O)C(C)(C)C)c1ccccn1	InChI=1S/C33H47FN4O5S/c1-8-32(41)20-26(38(21-32)29(40)43-30(2,3)4)28(39)36-25-19-23(14-15-24(25)34)33(17-16-22-12-13-22,27-11-9-10-18-35-27)37-44(42)31(5,6)7/h9-11,14-15,18-19,22,26,37,41H,8,12-13,16-17,20-21H2,1-7H3,(H,36,39)/t26-,32?,33?,44+/m1/s1	LFTPBCWVQLYAOS-PAOCNZHCSA-N	433428	US10562850, Compound 38d::US11066360, Compound 38d	Plasma kallikrein		<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433428	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433428&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			145750041	438642359							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878911	CCNC(CCC1CC1)(c1ccncc1)c1ccc(F)c(NC(=O)[C@H]2C[C@H](CN2C(=O)Nc2ccc(Cl)cn2)OC)c1	InChI=1S/C31H36ClFN6O3/c1-3-36-31(13-10-20-4-5-20,21-11-14-34-15-12-21)22-6-8-25(33)26(16-22)37-29(40)27-17-24(42-2)19-39(27)30(41)38-28-9-7-23(32)18-35-28/h6-9,11-12,14-16,18,20,24,27,36H,3-5,10,13,17,19H2,1-2H3,(H,37,40)(H,35,38,41)/t24-,27-,31?/m1/s1	QJDWRBFXQVIGMO-QPLSPKJVSA-N	433429	US10562850, Compound 77a::US11066360, Compound 77a	Plasma kallikrein		<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433429	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433429&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359543	438642360							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878912	CO[C@H]1C[C@H](N(C1)C(=O)Nc1ccc(Cl)cc1)C(=O)Nc1cc(ccc1F)C(CCC1CC1)(N[S@](=O)C(C)(C)C)c1cccc(c1)C#N	InChI=1S/C36H41ClFN5O4S/c1-35(2,3)48(46)42-36(17-16-23-8-9-23,25-7-5-6-24(18-25)21-39)26-10-15-30(38)31(19-26)41-33(44)32-20-29(47-4)22-43(32)34(45)40-28-13-11-27(37)12-14-28/h5-7,10-15,18-19,23,29,32,42H,8-9,16-17,20,22H2,1-4H3,(H,40,45)(H,41,44)/t29-,32-,36?,48+/m0/s1	FHFCUESMMUURQU-AITDCACWSA-N	433430	US10562850, Compound 11d::US11066360, Compound 11d	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433430	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433430&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359327	438642361							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878913	NC(CCC1CC1)(c1ccncc1)c1ccc(F)c(NC(=O)[C@H]2C[C@@](O)(CN2C(=O)Nc2ccc(Cl)cn2)c2ccccc2)c1	InChI=1S/C34H34ClFN6O3/c35-26-9-11-30(39-20-26)41-32(44)42-21-33(45,23-4-2-1-3-5-23)19-29(42)31(43)40-28-18-25(8-10-27(28)36)34(37,15-12-22-6-7-22)24-13-16-38-17-14-24/h1-5,8-11,13-14,16-18,20,22,29,45H,6-7,12,15,19,21,37H2,(H,40,43)(H,39,41,44)/t29-,33-,34?/m1/s1	FRTGSCXDLYWPRX-KLPUMSTOSA-N	433431	US10562850, Compound 39h::US11066360, Compound 39h	Plasma kallikrein		<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433431	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433431&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359380	438642362							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878914	CO[C@@]1(C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C30H31ClF4N6O3/c1-44-28(30(33,34)35)15-24(41(17-28)27(43)40-25-7-5-21(31)16-38-25)26(42)39-23-14-20(4-6-22(23)32)29(36,11-8-18-2-3-18)19-9-12-37-13-10-19/h4-7,9-10,12-14,16,18,24H,2-3,8,11,15,17,36H2,1H3,(H,39,42)(H,38,40,43)/t24-,28-,29?/m1/s1	LTSHZLULDHEDGR-KWPCEPOYSA-N	433432	US10562850, Compound 57d::US11066360, Compound 57d	Plasma kallikrein		<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433432	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433432&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359642	438642363							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878915	CC(C)(C)[S@@](=O)NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2CCCN2C(=O)OCc2ccccc2)c1	InChI=1S/C36H41FN4O4S/c1-35(2,3)46(44)40-36(19-18-25-14-15-25,28-12-7-11-27(21-28)23-38)29-16-17-30(37)31(22-29)39-33(42)32-13-8-20-41(32)34(43)45-24-26-9-5-4-6-10-26/h4-7,9-12,16-17,21-22,25,32,40H,8,13-15,18-20,24H2,1-3H3,(H,39,42)/t32-,36?,46-/m1/s1	QQQBZZFKCABGOT-BJXIDKMJSA-N	433433	US10562850, Compound 12b::US11066360, Compound 12b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433433	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433433&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			145750178	438642364							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878916	NC(CCC1CC1)(c1ccncc1)c1ccc(F)c(NC(=O)[C@H]2C[C@@](O)(CN2C(=O)Nc2ccc(Cl)cc2)c2ccccc2)c1	InChI=1S/C35H35ClFN5O3/c36-27-9-11-28(12-10-27)40-33(44)42-22-34(45,24-4-2-1-3-5-24)21-31(42)32(43)41-30-20-26(8-13-29(30)37)35(38,17-14-23-6-7-23)25-15-18-39-19-16-25/h1-5,8-13,15-16,18-20,23,31,45H,6-7,14,17,21-22,38H2,(H,40,44)(H,41,43)/t31-,34-,35?/m1/s1	XGAOCKOVDHHBDP-XUTBDEIESA-N	433434	US10562850, Compound 40a::US11066360, Compound 40a	Plasma kallikrein		<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433434	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433434&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359646	438642365							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878917	CNC(CCC1CC1)(c1ccncc1)c1ccc(F)c(NC(=O)[C@H]2C[C@@](O)(CN2C(=O)Nc2ccc(Cl)cn2)c2ccccc2)c1	InChI=1S/C35H36ClFN6O3/c1-38-35(16-13-23-7-8-23,25-14-17-39-18-15-25)26-9-11-28(37)29(19-26)41-32(44)30-20-34(46,24-5-3-2-4-6-24)22-43(30)33(45)42-31-12-10-27(36)21-40-31/h2-6,9-12,14-15,17-19,21,23,30,38,46H,7-8,13,16,20,22H2,1H3,(H,41,44)(H,40,42,45)/t30-,34-,35?/m1/s1	BQQGWVYCWOCVBA-WELJHWQCSA-N	433435	US10562850, Compound 41a::US11066360, Compound 41a	Plasma kallikrein		<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433435	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433435&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359385	438642366							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878918	CC(C)(C)[S@@](=O)NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2C[C@@H](O)CN2C(=O)Nc2ccc(cc2)C(F)(F)F)c1	InChI=1S/C36H39F4N5O4S/c1-34(2,3)50(49)44-35(16-15-22-7-8-22,25-6-4-5-23(17-25)20-41)26-11-14-29(37)30(18-26)43-32(47)31-19-28(46)21-45(31)33(48)42-27-12-9-24(10-13-27)36(38,39)40/h4-6,9-14,17-18,22,28,31,44,46H,7-8,15-16,19,21H2,1-3H3,(H,42,48)(H,43,47)/t28-,31-,35?,50-/m1/s1	LTFUBQNOSSPCKY-VGEWIOIYSA-N	433436	US10562850, Compound 27a::US11066360, Compound 27a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433436	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433436&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			141522419	438642367							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878919	NC(CCC1CC1)(c1ccncc1)c1ccc(F)c(NC(=O)[C@H]2C[C@@H](CN2C(=O)Nc2ccc(Cl)cn2)c2ccccc2)c1	InChI=1S/C34H34ClFN6O2/c35-27-9-11-31(39-20-27)41-33(44)42-21-24(23-4-2-1-3-5-23)18-30(42)32(43)40-29-19-26(8-10-28(29)36)34(37,15-12-22-6-7-22)25-13-16-38-17-14-25/h1-5,8-11,13-14,16-17,19-20,22,24,30H,6-7,12,15,18,21,37H2,(H,40,43)(H,39,41,44)/t24-,30+,34?/m0/s1	DYWQLBIPOOGHBX-DDNXYRJESA-N	433438	US10562850, Compound 47d::US11066360, Compound 47d	Plasma kallikrein		 75.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433438	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433438&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359360	438642369							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878920	CCO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1cccc(c1)C#N	InChI=1S/C31H32ClFN6O3/c1-2-42-24-14-27(39(18-24)31(41)38-28-11-9-23(32)17-35-28)30(40)37-26-13-22(8-10-25(26)33)29(36-16-19-6-7-19)21-5-3-4-20(12-21)15-34/h3-5,8-13,17,19,24,27,29,36H,2,6-7,14,16,18H2,1H3,(H,37,40)(H,35,38,41)/t24-,27-,29?/m1/s1	GBDNLKBWBYVNQM-MPXLCVCVSA-N	433439	US10562850, Compound 58j::US11066360, Compound 58j	Plasma kallikrein		<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433439	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433439&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359574	438642370							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878921	NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2C[C@@](O)(CN2)c2ccccc2)c1	InChI=1S/C30H31FN4O2/c31-25-12-11-24(30(33,14-13-20-9-10-20)23-8-4-5-21(15-23)18-32)16-26(25)35-28(36)27-17-29(37,19-34-27)22-6-2-1-3-7-22/h1-8,11-12,15-16,20,27,34,37H,9-10,13-14,17,19,33H2,(H,35,36)/t27-,29-,30?/m1/s1	JALINIFPYUQJSU-MODKJIOJSA-N	433440	US10562850, Compound 29d::US11066360, Compound 29d	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433440	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433440&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359296	438642371							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878922	C[C@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1	InChI=1S/C29H32ClFN6O2/c1-18-14-25(37(17-18)28(39)36-26-7-5-22(30)16-34-26)27(38)35-24-15-21(4-6-23(24)31)29(32,11-8-19-2-3-19)20-9-12-33-13-10-20/h4-7,9-10,12-13,15-16,18-19,25H,2-3,8,11,14,17,32H2,1H3,(H,35,38)(H,34,36,39)/t18-,25+,29?/m0/s1	VKZOYNOIAPSODG-MEPMZUDESA-N	433441	US10562850, Compound 48d::US11066360, Compound 48d	Plasma kallikrein		<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433441	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433441&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359603	438642372							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878923	NC(CCC1CC1)(c1ccncc1)c1ccc(F)c(NC(=O)[C@H]2C[C@@](O)(CN2C(=O)Nc2ccc(Cl)cn2)C2CC2)c1	InChI=1S/C31H34ClFN6O3/c32-23-6-8-27(36-17-23)38-29(41)39-18-30(42,20-3-4-20)16-26(39)28(40)37-25-15-22(5-7-24(25)33)31(34,12-9-19-1-2-19)21-10-13-35-14-11-21/h5-8,10-11,13-15,17,19-20,26,42H,1-4,9,12,16,18,34H2,(H,37,40)(H,36,38,41)/t26-,30-,31?/m1/s1	NPTYSNQRJNJEBG-FIWLTRSASA-N	433443	US10562850, Compound 59d::US11066360, Compound 59d	Plasma kallikrein		<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433443	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433443&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359499	438642374							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878924	CC(C)(C)[S@@](=O)NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2C[C@@H](CN2C(=O)Nc2ccc(Cl)cc2)N=[N+]=[N-])c1	InChI=1S/C35H38ClFN8O3S/c1-34(2,3)49(48)43-35(16-15-22-7-8-22,24-6-4-5-23(17-24)20-38)25-9-14-29(37)30(18-25)41-32(46)31-19-28(42-44-39)21-45(31)33(47)40-27-12-10-26(36)11-13-27/h4-6,9-14,17-18,22,28,31,43H,7-8,15-16,19,21H2,1-3H3,(H,40,47)(H,41,46)/t28-,31+,35?,49+/m0/s1	DDAHRDRLWWWJFX-IOQIPRRTSA-N	433444	US10562850, Compound 33b::US11066360, Compound 33b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433444	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433444&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			145750144	438642375							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878925	C[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1	InChI=1S/C29H32ClFN6O2/c1-18-14-25(37(17-18)28(39)36-26-7-5-22(30)16-34-26)27(38)35-24-15-21(4-6-23(24)31)29(32,11-8-19-2-3-19)20-9-12-33-13-10-20/h4-7,9-10,12-13,15-16,18-19,25H,2-3,8,11,14,17,32H2,1H3,(H,35,38)(H,34,36,39)/t18-,25-,29?/m1/s1	VKZOYNOIAPSODG-OYRGDXRMSA-N	433445	US10562850, Compound 49d::US11066360, Compound 49d	Plasma kallikrein		 75.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433445	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433445&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359583	438642376							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878926	CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(CCC1CC1)N1CCCCC1=O	InChI=1S/C29H35ClFN5O4/c1-40-21-15-25(36(17-21)29(39)34-26-12-9-20(30)16-32-26)28(38)33-23-14-19(8-10-22(23)31)24(11-7-18-5-6-18)35-13-3-2-4-27(35)37/h8-10,12,14,16,18,21,24-25H,2-7,11,13,15,17H2,1H3,(H,33,38)(H,32,34,39)/t21-,24?,25-/m1/s1	UWRIUUXMKXAKLB-TYIXABJVSA-N	433446	US10562850, Compound 44e::US11066360, Compound 44e	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433446	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433446&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359289	438642377							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878927	CO[C@@]1(C[C@@H](N(C1)C(=O)OC(C)(C)C)C(=O)Nc1cc(ccc1F)C(CCC1CC1)(N[S@@](=O)C(C)(C)C)c1ccccn1)c1ccccc1	InChI=1S/C38H49FN4O5S/c1-35(2,3)48-34(45)43-25-37(47-7,27-13-9-8-10-14-27)24-31(43)33(44)41-30-23-28(18-19-29(30)39)38(21-20-26-16-17-26,32-15-11-12-22-40-32)42-49(46)36(4,5)6/h8-15,18-19,22-23,26,31,42H,16-17,20-21,24-25H2,1-7H3,(H,41,44)/t31-,37-,38?,49+/m1/s1	WSLPEHAMZHBFSH-DQCGMSCASA-N	433447	US10562850, Compound 34b::US11066360, Compound 34b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433447	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433447&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			145750087	438642378							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878928	CCCO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1	InChI=1S/C31H36ClFN6O3/c1-2-15-42-24-17-27(39(19-24)30(41)38-28-8-6-23(32)18-36-28)29(40)37-26-16-22(5-7-25(26)33)31(34,12-9-20-3-4-20)21-10-13-35-14-11-21/h5-8,10-11,13-14,16,18,20,24,27H,2-4,9,12,15,17,19,34H2,1H3,(H,37,40)(H,36,38,41)/t24-,27-,31?/m1/s1	STHHQVRGMGLOTE-QPLSPKJVSA-N	433448	US10562850, Compound 52d::US11066360, Compound 52d	Plasma kallikrein		<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433448	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433448&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359656	438642379							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878929	CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccccc1=O	InChI=1S/C29H31ClFN5O4/c1-40-21-15-25(36(17-21)29(39)34-26-12-9-20(30)16-32-26)28(38)33-23-14-19(8-10-22(23)31)24(11-7-18-5-6-18)35-13-3-2-4-27(35)37/h2-4,8-10,12-14,16,18,21,24-25H,5-7,11,15,17H2,1H3,(H,33,38)(H,32,34,39)/t21-,24?,25-/m1/s1	XUORFTPJFLKHSK-TYIXABJVSA-N	433449	US10562850, Compound 42l::US10562850, Compound 43m::US11066360, Compound 43m	Plasma kallikrein		 75.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433449	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433449&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359367	438642380							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878930	CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)s1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1	InChI=1S/C28H31ClFN5O3S/c1-38-20-15-23(35(16-20)27(37)34-25-7-6-24(29)39-25)26(36)33-22-14-19(4-5-21(22)30)28(31,11-8-17-2-3-17)18-9-12-32-13-10-18/h4-7,9-10,12-14,17,20,23H,2-3,8,11,15-16,31H2,1H3,(H,33,36)(H,34,37)/t20-,23-,28?/m1/s1	VSBGZUFFBZVRNX-JLGCCPRNSA-N	433450	US10562850, Compound 81h::US11066360, Compound 81h	Plasma kallikrein		<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433450	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433450&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359293	438642381							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878931	NC(CCC1CC1)(c1ccncc1)c1ccc(F)c(NC(=O)[C@H]2CC(F)(F)CN2C(=O)Nc2ccc(Cl)cn2)c1	InChI=1S/C28H28ClF3N6O2/c29-20-4-6-24(35-15-20)37-26(40)38-16-27(31,32)14-23(38)25(39)36-22-13-19(3-5-21(22)30)28(33,10-7-17-1-2-17)18-8-11-34-12-9-18/h3-6,8-9,11-13,15,17,23H,1-2,7,10,14,16,33H2,(H,36,39)(H,35,37,40)/t23-,28?/m1/s1	MXPGAAAGVICXGQ-YFIOFSHDSA-N	433451	US10562850, Compound 53d::US11066360, Compound 53d	Plasma kallikrein		<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433451	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433451&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359378	438642382							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878932	CO[C@@]1(C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1)c1ccccc1	InChI=1S/C35H36ClFN6O3/c1-46-34(24-5-3-2-4-6-24)20-30(43(22-34)33(45)42-31-12-10-27(36)21-40-31)32(44)41-29-19-26(9-11-28(29)37)35(38,16-13-23-7-8-23)25-14-17-39-18-15-25/h2-6,9-12,14-15,17-19,21,23,30H,7-8,13,16,20,22,38H2,1H3,(H,41,44)(H,40,42,45)/t30-,34-,35?/m1/s1	OHOVUWGMVUKSAR-WELJHWQCSA-N	433452	US10562850, Compound 45c::US11066360, Compound 45c	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433452	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433452&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359481	438642383							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878933	CNC(CCC1CC1)(c1ccnc(C)c1)c1ccc(F)c(NC(=O)[C@H]2C[C@H](CN2C(=O)Nc2ccc(Cl)cn2)OC)c1	InChI=1S/C31H36ClFN6O3/c1-19-14-22(11-13-35-19)31(34-2,12-10-20-4-5-20)21-6-8-25(33)26(15-21)37-29(40)27-16-24(42-3)18-39(27)30(41)38-28-9-7-23(32)17-36-28/h6-9,11,13-15,17,20,24,27,34H,4-5,10,12,16,18H2,1-3H3,(H,37,40)(H,36,38,41)/t24-,27-,31?/m1/s1	XOXPJMACNDGQNW-QPLSPKJVSA-N	433453	US10562850, Compound 79a::US11066360, Compound 79a	Plasma kallikrein		<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433453	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433453&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359239	438642384							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878934	CCO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1	InChI=1S/C30H34ClFN6O3/c1-2-41-23-16-26(38(18-23)29(40)37-27-8-6-22(31)17-35-27)28(39)36-25-15-21(5-7-24(25)32)30(33,12-9-19-3-4-19)20-10-13-34-14-11-20/h5-8,10-11,13-15,17,19,23,26H,2-4,9,12,16,18,33H2,1H3,(H,36,39)(H,35,37,40)/t23-,26-,30?/m1/s1	ZLNHEWKEIZHPQN-JRSXUWQBSA-N	433454	US10562850, Compound 51b::US11066360, Compound 51b	Plasma kallikrein		<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433454	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433454&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359548	438642385							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878935	CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccnc(C)c1	InChI=1S/C30H34ClFN6O3/c1-18-13-21(10-12-34-18)30(33,11-9-19-3-4-19)20-5-7-24(32)25(14-20)36-28(39)26-15-23(41-2)17-38(26)29(40)37-27-8-6-22(31)16-35-27/h5-8,10,12-14,16,19,23,26H,3-4,9,11,15,17,33H2,1-2H3,(H,36,39)(H,35,37,40)/t23-,26-,30?/m1/s1	LPEGODAKCBEEGJ-JRSXUWQBSA-N	433455	US10562850, Compound 46k::US11066360, Compound 46k	Plasma kallikrein		<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433455	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433455&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359589	438642386							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878936	CCNC(CCC1CC1)(c1ccnc(C)c1)c1ccc(F)c(NC(=O)[C@H]2C[C@H](CN2C(=O)Nc2ccc(Cl)cn2)OC)c1	InChI=1S/C32H38ClFN6O3/c1-4-37-32(13-11-21-5-6-21,23-12-14-35-20(2)15-23)22-7-9-26(34)27(16-22)38-30(41)28-17-25(43-3)19-40(28)31(42)39-29-10-8-24(33)18-36-29/h7-10,12,14-16,18,21,25,28,37H,4-6,11,13,17,19H2,1-3H3,(H,38,41)(H,36,39,42)/t25-,28-,32?/m1/s1	GNWSEMQWKUFLTO-OHCGPUKPSA-N	433456	US10562850, Compound 78a::US11066360, Compound 78a	Plasma kallikrein		<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433456	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433456&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359318	438642387							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878937	CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(CCC1CC1)(NC(C)=O)c1ccncc1	InChI=1S/C31H34ClFN6O4/c1-19(40)38-31(12-9-20-3-4-20,21-10-13-34-14-11-21)22-5-7-25(33)26(15-22)36-29(41)27-16-24(43-2)18-39(27)30(42)37-28-8-6-23(32)17-35-28/h5-8,10-11,13-15,17,20,24,27H,3-4,9,12,16,18H2,1-2H3,(H,36,41)(H,38,40)(H,35,37,42)/t24-,27-,31?/m1/s1	YDKUZDQMWDWMAQ-QPLSPKJVSA-N	433457	US10562850, Compound 73a::US11066360, Compound 73a	Plasma kallikrein		<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433457	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433457&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359571	438642388							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878938	CC(C)(C)[S@@](=O)NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)Nc2ccc(Cl)cc2)c1	InChI=1S/C35H39ClFN5O4S/c1-34(2,3)47(46)41-35(16-15-22-7-8-22,24-6-4-5-23(17-24)20-38)25-9-14-29(37)30(18-25)40-32(44)31-19-28(43)21-42(31)33(45)39-27-12-10-26(36)11-13-27/h4-6,9-14,17-18,22,28,31,41,43H,7-8,15-16,19,21H2,1-3H3,(H,39,45)(H,40,44)/t28-,31+,35?,47-/m1/s1	MJBIFAIWKFMNPW-JMDKQSTQSA-N	433458	US10562850, Compound 5d::US11066360, Compound 5d	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433458	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433458&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			145750036	438642389					C04398		1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878939	NC(CCC1CC1)(c1ccncc1)c1ccc(F)c(NC(=O)[C@H]2C[C@H]3C[C@H]3N2)c1	InChI=1S/C23H27FN4O/c24-18-4-3-17(13-20(18)28-22(29)21-12-15-11-19(15)27-21)23(25,8-5-14-1-2-14)16-6-9-26-10-7-16/h3-4,6-7,9-10,13-15,19,21,27H,1-2,5,8,11-12,25H2,(H,28,29)/t15-,19-,21-,23?/m1/s1	NFWCRWGBHZCTPQ-PUJXVWCHSA-N	433459	US10562850, Compound 80c::US11066360, Compound 80c	Plasma kallikrein		 75.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433459	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433459&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359660	438642390							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878940	CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(CCC1CC1)(NS(C)(=O)=O)c1ccncc1	InChI=1S/C30H34ClFN6O5S/c1-43-23-16-26(38(18-23)29(40)36-27-8-6-22(31)17-34-27)28(39)35-25-15-21(5-7-24(25)32)30(37-44(2,41)42,12-9-19-3-4-19)20-10-13-33-14-11-20/h5-8,10-11,13-15,17,19,23,26,37H,3-4,9,12,16,18H2,1-2H3,(H,35,39)(H,34,36,40)/t23-,26-,30?/m1/s1	QWHRSMIIATYYJL-JRSXUWQBSA-N	433460	US10562850, Compound 74a::US11066360, Compound 74a	Plasma kallikrein		<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433460	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433460&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359654	438642391							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878941	CO[C@@H]1C[C@H](N(C1)C(=O)N(C)c1ccc(Cl)cc1)C(=O)Nc1cc(ccc1F)C(CCC1CC1)(N[S@](=O)C(C)(C)C)c1cccc(c1)C#N	InChI=1S/C37H43ClFN5O4S/c1-36(2,3)49(47)42-37(18-17-24-9-10-24,26-8-6-7-25(19-26)22-40)27-11-16-31(39)32(20-27)41-34(45)33-21-30(48-5)23-44(33)35(46)43(4)29-14-12-28(38)13-15-29/h6-8,11-16,19-20,24,30,33,42H,9-10,17-18,21,23H2,1-5H3,(H,41,45)/t30-,33+,37?,49-/m1/s1	QHCSTFXYRQGZKO-PCMIATBVSA-N	433461	US10562850, Compound 6d::US11066360, Compound 6d	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433461	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433461&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359575	438642392							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878942	CO[C@@H]1C[C@@H](N(C1)C(=O)c1ccc2cc[nH]c2c1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1	InChI=1S/C32H34FN5O3/c1-41-25-18-29(38(19-25)31(40)22-5-4-21-9-15-36-27(21)16-22)30(39)37-28-17-24(6-7-26(28)33)32(34,12-8-20-2-3-20)23-10-13-35-14-11-23/h4-7,9-11,13-17,20,25,29,36H,2-3,8,12,18-19,34H2,1H3,(H,37,39)/t25-,29-,32?/m1/s1	MPOMDZOLMQUDDS-UCGPOHEZSA-N	433462	US10562850, Compound 82a::US11066360, Compound 82a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433462	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433462&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135281871	438642393							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878943	NC(CCC1CC1)(c1ccncc1)c1ccc(F)c(NC(=O)[C@H]2C[C@@](O)(CN2C(=O)Nc2ccc(Cl)cn2)C(F)(F)F)c1	InChI=1S/C29H29ClF4N6O3/c30-20-4-6-24(37-15-20)39-26(42)40-16-27(43,29(32,33)34)14-23(40)25(41)38-22-13-19(3-5-21(22)31)28(35,10-7-17-1-2-17)18-8-11-36-12-9-18/h3-6,8-9,11-13,15,17,23,43H,1-2,7,10,14,16,35H2,(H,38,41)(H,37,39,42)/t23-,27-,28?/m1/s1	VGCFWQXZFXYVKN-AFJRLBRLSA-N	433463	US10562850, Compound 54g::US11066360, Compound 54g	Plasma kallikrein		<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433463	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433463&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359502	438642394							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878944	CO[C@@H]1C[C@@H](N(C1)C(=O)N(C)c1ccc(Cl)cc1)C(=O)Nc1cc(ccc1F)C(CCC1CC1)(N[S@](=O)C(C)(C)C)c1cccc(c1)C#N	InChI=1S/C37H43ClFN5O4S/c1-36(2,3)49(47)42-37(18-17-24-9-10-24,26-8-6-7-25(19-26)22-40)27-11-16-31(39)32(20-27)41-34(45)33-21-30(48-5)23-44(33)35(46)43(4)29-14-12-28(38)13-15-29/h6-8,11-16,19-20,24,30,33,42H,9-10,17-18,21,23H2,1-5H3,(H,41,45)/t30-,33-,37?,49-/m1/s1	QHCSTFXYRQGZKO-VVHKCOIQSA-N	433464	US10562850, Compound 6c::US11066360, Compound 6c	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433464	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433464&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			145750114	438642395							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878945	CO[C@@H]1C[C@@H](N(C1)C(=O)c1ccc2c(Cl)c[nH]c2c1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1	InChI=1S/C32H33ClFN5O3/c1-42-23-16-29(39(18-23)31(41)20-4-6-24-25(33)17-37-27(24)14-20)30(40)38-28-15-22(5-7-26(28)34)32(35,11-8-19-2-3-19)21-9-12-36-13-10-21/h4-7,9-10,12-15,17,19,23,29,37H,2-3,8,11,16,18,35H2,1H3,(H,38,40)/t23-,29-,32?/m1/s1	WCQRTVWTSVWTGK-ULZFTAANSA-N	433465	US10562850, Compound 83a::US11066360, Compound 83a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433465	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433465&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135281889	438642396							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878946	CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccccc1=O	InChI=1S/C29H31ClFN5O4/c1-40-21-15-25(36(17-21)29(39)34-26-12-9-20(30)16-32-26)28(38)33-23-14-19(8-10-22(23)31)24(11-7-18-5-6-18)35-13-3-2-4-27(35)37/h2-4,8-10,12-14,16,18,21,24-25H,5-7,11,15,17H2,1H3,(H,33,38)(H,32,34,39)/t21-,24?,25-/m1/s1	XUORFTPJFLKHSK-TYIXABJVSA-N	433449	US10562850, Compound 42l::US10562850, Compound 43m::US11066360, Compound 43m	Plasma kallikrein		<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433449	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433449&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359367	438642380							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878947	CC(C)(C)[S@@](=O)NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2CCCN2C(=O)Nc2ccc(Cl)cc2)c1	InChI=1S/C35H39ClFN5O3S/c1-34(2,3)46(45)41-35(18-17-23-9-10-23,25-7-4-6-24(20-25)22-38)26-11-16-29(37)30(21-26)40-32(43)31-8-5-19-42(31)33(44)39-28-14-12-27(36)13-15-28/h4,6-7,11-16,20-21,23,31,41H,5,8-10,17-19H2,1-3H3,(H,39,44)(H,40,43)/t31-,35?,46-/m1/s1	QMMABOBRWWOXDM-BLQLWLDUSA-N	433467	US10562850, Compound 7b::US11066360, Compound 7b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433467	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433467&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			145750056	438642397							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878948	CO[C@@H]1C[C@@H](N(C1)C(=O)c1ccc(Cl)c(N)c1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1	InChI=1S/C30H33ClFN5O3/c1-40-22-16-27(37(17-22)29(39)19-4-6-23(31)25(33)14-19)28(38)36-26-15-21(5-7-24(26)32)30(34,11-8-18-2-3-18)20-9-12-35-13-10-20/h4-7,9-10,12-15,18,22,27H,2-3,8,11,16-17,33-34H2,1H3,(H,36,38)/t22-,27-,30?/m1/s1	SUBHSHKRDIKUKN-MPCSXZBSSA-N	433468	US10562850, Compound 84a::US11066360, Compound 84a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433468	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433468&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135281821	438642398							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878949	CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cccc(c1)C(N)(CCC1CC1)c1ccncc1	InChI=1S/C29H33ClN6O3/c1-39-24-16-25(36(18-24)28(38)35-26-8-7-22(30)17-33-26)27(37)34-23-4-2-3-21(15-23)29(31,12-9-19-5-6-19)20-10-13-32-14-11-20/h2-4,7-8,10-11,13-15,17,19,24-25H,5-6,9,12,16,18,31H2,1H3,(H,34,37)(H,33,35,38)/t24-,25-,29?/m1/s1	NBIGEYRETZSFJW-COJIHYBUSA-N	433469	US10562850, Compound 75e::US11066360, Compound 75e	Plasma kallikrein		<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433469	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433469&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359567	438642399							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878950	CC(C)(C)[S@@](=O)NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@@H]2CCCN2C(=O)Nc2ccc(Cl)cc2)c1	InChI=1S/C35H39ClFN5O3S/c1-34(2,3)46(45)41-35(18-17-23-9-10-23,25-7-4-6-24(20-25)22-38)26-11-16-29(37)30(21-26)40-32(43)31-8-5-19-42(31)33(44)39-28-14-12-27(36)13-15-28/h4,6-7,11-16,20-21,23,31,41H,5,8-10,17-19H2,1-3H3,(H,39,44)(H,40,43)/t31-,35?,46+/m0/s1	QMMABOBRWWOXDM-GFRNEHCDSA-N	433470	US10562850, Compound 8b::US11066360, Compound 8b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433470	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433470&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			145750194	438642400							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878951	CO[C@@H]1C[C@@H](N(C1)C(=O)c1ccc(F)c(N)c1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1	InChI=1S/C30H33F2N5O3/c1-40-22-16-27(37(17-22)29(39)19-4-6-23(31)25(33)14-19)28(38)36-26-15-21(5-7-24(26)32)30(34,11-8-18-2-3-18)20-9-12-35-13-10-20/h4-7,9-10,12-15,18,22,27H,2-3,8,11,16-17,33-34H2,1H3,(H,36,38)/t22-,27-,30?/m1/s1	YLALVSNPTPTFII-MPCSXZBSSA-N	433471	US10562850, Compound 85a::US11066360, Compound 85a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433471	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433471&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135281882	438642401							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878952	CO[C@@H]1C[C@@H](N(C1)C(=O)c1cccc(c1)C#N)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1	InChI=1S/C31H32FN5O3/c1-40-25-17-28(37(19-25)30(39)22-4-2-3-21(15-22)18-33)29(38)36-27-16-24(7-8-26(27)32)31(34,12-9-20-5-6-20)23-10-13-35-14-11-23/h2-4,7-8,10-11,13-16,20,25,28H,5-6,9,12,17,19,34H2,1H3,(H,36,38)/t25-,28-,31?/m1/s1	IYLXYRHOQVZYRJ-JADDJLNISA-N	433472	US10562850, Compound 86a::US11066360, Compound 86a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433472	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433472&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135281782	438642402							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
878953	CO[C@@H]1C[C@@H](N(C1)S(=O)(=O)c1cccc2c(Cl)cccc12)C(=O)Nc1cc(ccc1F)C(CCC1CC1)(N[S@](=O)C(C)(C)C)c1ccncc1	InChI=1S/C37H42ClFN4O5S2/c1-36(2,3)49(45)42-37(18-15-24-11-12-24,25-16-19-40-20-17-25)26-13-14-31(39)32(21-26)41-35(44)33-22-27(48-4)23-43(33)50(46,47)34-10-6-7-28-29(34)8-5-9-30(28)38/h5-10,13-14,16-17,19-21,24,27,33,42H,11-12,15,18,22-23H2,1-4H3,(H,41,44)/t27-,33-,37?,49-/m1/s1	HNTKROBOBZDWET-MYCXRTHGSA-N	433473	US10562850, Compound 87b::US11066360, Compound 87b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433473	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433473&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			145750019	438642403							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136255	CC1(C)CCCN1c1ccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)cn1	InChI=1S/C28H30N6O/c1-28(2)9-3-11-34(28)25-7-5-19(16-32-25)12-21-14-23(18-30-15-21)27(35)33-17-20-4-6-24-22(13-20)8-10-31-26(24)29/h4-8,10,13-16,18H,3,9,11-12,17H2,1-2H3,(H2,29,31)(H,33,35)	NUHVLIFKBURDJA-UHFFFAOYSA-N	359680	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[6-(2,2-dimethylpyrrolidin-1-yl)pyridin-3-yl]methyl}pyridine-3-carboxamide::US10221161, Example 65::US11242333, Example 65	Plasma kallikrein			 131							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359680	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359680&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393179	386399134							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136256	CN(C)c1ccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)cn1	InChI=1S/C24H24N6O/c1-30(2)22-6-4-16(13-28-22)9-18-11-20(15-26-12-18)24(31)29-14-17-3-5-21-19(10-17)7-8-27-23(21)25/h3-8,10-13,15H,9,14H2,1-2H3,(H2,25,27)(H,29,31)	OOGPOIMLTCOJDQ-UHFFFAOYSA-N	535951	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[6-(diethylamino)pyridin-3-::US11242333, Example 66	Plasma kallikrein			 52.7							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535951	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535951&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163407717	464921132							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136257	Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccc(nc4)N4CCCC4CO)c3)ccc12	InChI=1S/C27H28N6O2/c28-26-24-5-3-19(11-21(24)7-8-30-26)15-32-27(35)22-12-20(13-29-16-22)10-18-4-6-25(31-14-18)33-9-1-2-23(33)17-34/h3-8,11-14,16,23,34H,1-2,9-10,15,17H2,(H2,28,30)(H,32,35)	CDKBTMZPQXYCQA-UHFFFAOYSA-N	359682	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({6-[2-(hydroxymethyl)pyrrolidin-1-yl]pyridin-3-yl}methyl)pyridine-3-carboxamide::US10221161, Example 67::US11242333, Example 67	Plasma kallikrein			 73.3							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359682	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359682&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393174	386399136							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136258	CC(C)[C@@H]1CCN(C1)c1ccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)cn1	InChI=1S/C29H32N6O/c1-19(2)24-8-10-35(18-24)27-6-4-20(15-33-27)11-22-13-25(17-31-14-22)29(36)34-16-21-3-5-26-23(12-21)7-9-32-28(26)30/h3-7,9,12-15,17,19,24H,8,10-11,16,18H2,1-2H3,(H2,30,32)(H,34,36)/t24-/m1/s1	PCHUAPQHDMIHKN-XMMPIXPASA-N	535953	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({6-[3-(dimethylamino)pyrrolidin-::US11242333, Example 68	Plasma kallikrein			 375							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535953	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535953&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163407719	464921134							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136259	CC(C)[C@H]1CCN(C1)c1ccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)cn1	InChI=1S/C29H32N6O/c1-19(2)24-8-10-35(18-24)27-6-4-20(15-33-27)11-22-13-25(17-31-14-22)29(36)34-16-21-3-5-26-23(12-21)7-9-32-28(26)30/h3-7,9,12-15,17,19,24H,8,10-11,16,18H2,1-2H3,(H2,30,32)(H,34,36)/t24-/m0/s1	PCHUAPQHDMIHKN-DEOSSOPVSA-N	535954	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({6-[3-(dimethylamino)pyrrolidin-::US11242333, Example 69	Plasma kallikrein			 579							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535954	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535954&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163407720	464921135							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136260	CC(C)Oc1ccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)cn1	InChI=1S/C25H25N5O2/c1-16(2)32-23-6-4-17(13-29-23)9-19-11-21(15-27-12-19)25(31)30-14-18-3-5-22-20(10-18)7-8-28-24(22)26/h3-8,10-13,15-16H,9,14H2,1-2H3,(H2,26,28)(H,30,31)	YKHQYVOPIDSSDX-UHFFFAOYSA-N	359686	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-[(6-isopropoxypyridin-3-yl)methyl]pyridine-3-carboxamide::US10221161, Example 70::US11242333, Example 70	Plasma kallikrein			 1740							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359686	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359686&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393155	386399139							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136261	Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccc(nc4)N4CCC(CO)C4)c3)ccc12	InChI=1S/C27H28N6O2/c28-26-24-3-1-19(10-22(24)5-7-30-26)14-32-27(35)23-11-21(12-29-15-23)9-18-2-4-25(31-13-18)33-8-6-20(16-33)17-34/h1-5,7,10-13,15,20,34H,6,8-9,14,16-17H2,(H2,28,30)(H,32,35)	YHDQKRLULDVQCF-UHFFFAOYSA-N	359687	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({6-[3-(hydroxymethyl)pyrrolidin-1-yl]pyridin-3-yl}methyl)pyridine-3-carboxamide::US10221161, Example 71::US11242333, Example 71	Plasma kallikrein			 306							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359687	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359687&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393164	386399140							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136262	CCC(=O)C1CCN(C1)c1ccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)cn1	InChI=1S/C29H30N6O2/c1-2-26(36)23-8-10-35(18-23)27-6-4-19(15-33-27)11-21-13-24(17-31-14-21)29(37)34-16-20-3-5-25-22(12-20)7-9-32-28(25)30/h3-7,9,12-15,17,23H,2,8,10-11,16,18H2,1H3,(H2,30,32)(H,34,37)	JABWZDXBQGNXIT-UHFFFAOYSA-N	535957	Ethyl 1-{5-[(5-{[(1-aminoisoquinolin-6-yl)methyl]carbamoyl}pyridin-3-::US11242333, Example 72	Plasma kallikrein			 860							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535957	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535957&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163407722	464921138							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136191	Cc1cnn(Cc2ccc(Cc3cncc(c3)C(=O)NCc3ccc4c(N)nccc4c3)cc2)c1	InChI=1S/C28H26N6O/c1-19-13-33-34(17-19)18-21-4-2-20(3-5-21)10-23-12-25(16-30-14-23)28(35)32-15-22-6-7-26-24(11-22)8-9-31-27(26)29/h2-9,11-14,16-17H,10,15,18H2,1H3,(H2,29,31)(H,32,35)	XZGMSMZMNPUQHT-UHFFFAOYSA-N	359614	N-[(1-Aminoisoquinolin-6-yl)methyl]-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)pyridine-3-carboxamide::US10221161, Example 1::US11242333, Example 1	Plasma kallikrein			 3.86							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359614	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359614&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117889681	386399068							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136192	Cc1cnn(Cc2ccc(Cc3cncc(c3)C(=O)NCc3cnc4[nH]ccc4c3)cc2)c1	InChI=1S/C26H24N6O/c1-18-11-31-32(16-18)17-20-4-2-19(3-5-20)8-21-9-24(15-27-12-21)26(33)30-14-22-10-23-6-7-28-25(23)29-13-22/h2-7,9-13,15-16H,8,14,17H2,1H3,(H,28,29)(H,30,33)	JJUHBFMQMARLNX-UHFFFAOYSA-N	359615	5-({4-[(4-Methylpyrazol-1-yl)methyl]phenyl}methyl)-N-{7H-pyrrolo[2,3-b]pyridin-3-ylmethyl}pyridine-3-carboxamide::US10221161, Example 2::US11242333, Example 2	Plasma kallikrein			 216							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359615	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359615&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117889991	386399069							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136193	Cc1cnn(Cc2ccc(Cc3ccnc(c3)C(=O)NCc3ccc4c(N)nccc4c3)cc2)c1	InChI=1S/C28H26N6O/c1-19-15-33-34(17-19)18-21-4-2-20(3-5-21)12-22-8-10-30-26(14-22)28(35)32-16-23-6-7-25-24(13-23)9-11-31-27(25)29/h2-11,13-15,17H,12,16,18H2,1H3,(H2,29,31)(H,32,35)	DZDSGRZPTVIORQ-UHFFFAOYSA-N	359616	N-[(1-Aminoisoquinolin-6-yl)methyl]-4-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)pyridine-2-carboxamide::US10221161, Example 3::US11242333, Example 3	Plasma kallikrein			 159							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359616	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359616&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117889735	386399070							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136194	Cc1cnn(Cc2ccc(Cc3ccnc(c3)C(=O)NCc3cnc4[nH]ccc4c3)cc2)c1	InChI=1S/C26H24N6O/c1-18-13-31-32(16-18)17-20-4-2-19(3-5-20)10-21-6-8-27-24(12-21)26(33)30-15-22-11-23-7-9-28-25(23)29-14-22/h2-9,11-14,16H,10,15,17H2,1H3,(H,28,29)(H,30,33)	WRUWFRKMFQIBTK-UHFFFAOYSA-N	359617	4-({4-[(4-Methylpyrazol-1-yl)methyl]phenyl}methyl)-N-{7H-pyrrolo[2,3-b]pyridin-3-ylmethyl}pyridine-2-carboxamide::US10221161, Example 4::US11242333, Example 4	Plasma kallikrein			 6610							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359617	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359617&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121406191	386399071							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136195	Nc1nccc2cc(CNC(=O)c3ccc(=O)n(Cc4ccc(Cn5ccccc5=O)cc4)c3)ccc12	InChI=1S/C29H25N5O3/c30-28-25-10-8-22(15-23(25)12-13-31-28)16-32-29(37)24-9-11-27(36)34(19-24)18-21-6-4-20(5-7-21)17-33-14-2-1-3-26(33)35/h1-15,19H,16-18H2,(H2,30,31)(H,32,37)	UJFXLGBMZVPDMP-UHFFFAOYSA-N	359618	N-[(1-Aminoisoquinolin-6-yl)methyl]-6-oxo-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)pyridine-3-carboxamide::US10221161, Example 5::US11242333, Example 5	Plasma kallikrein			 24.7							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359618	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359618&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117907897	386399072							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136196	O=C(NCc1cnc2[nH]ccc2c1)c1ccc(=O)n(Cc2ccc(Cn3ccccc3=O)cc2)c1	InChI=1S/C27H23N5O3/c33-24-3-1-2-12-31(24)16-19-4-6-20(7-5-19)17-32-18-23(8-9-25(32)34)27(35)30-15-21-13-22-10-11-28-26(22)29-14-21/h1-14,18H,15-17H2,(H,28,29)(H,30,35)	LSSBHLFUNMHFAM-UHFFFAOYSA-N	359619	6-Oxo-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)-N-{7H-pyrrolo[2,3-b]pyridin-3-ylmethyl}pyridine-3-carboxamide::US10221161, Example 6::US11242333, Example 6	Plasma kallikrein			 580							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359619	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359619&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117907999	386399073							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136197	Cc1cnn(Cc2ccc(cc2)C(O)c2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)c1	InChI=1S/C28H26N6O2/c1-18-12-33-34(16-18)17-19-2-5-21(6-3-19)26(35)23-11-24(15-30-14-23)28(36)32-13-20-4-7-25-22(10-20)8-9-31-27(25)29/h2-12,14-16,26,35H,13,17H2,1H3,(H2,29,31)(H,32,36)	LJHHAYREDCAYJE-UHFFFAOYSA-N	359621	N-((1-Aminoisoquinolin-6-yl)methyl)-5-(hydroxy(4-((4-methyl-1H-pyrazol-1-yl)methyl)phenyl)methyl)nicotinamide::US10221161, Example 7::US11242333, Example 7	Plasma kallikrein			 35.3							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359621	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359621&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117890055	386399075							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136198	Cc1cnn(Cc2ccc(Cc3cc(ncn3)C(=O)NCc3ccc4c(N)nccc4c3)cc2)c1	InChI=1S/C27H25N7O/c1-18-13-33-34(15-18)16-20-4-2-19(3-5-20)11-23-12-25(32-17-31-23)27(35)30-14-21-6-7-24-22(10-21)8-9-29-26(24)28/h2-10,12-13,15,17H,11,14,16H2,1H3,(H2,28,29)(H,30,35)	YVWZOLYJJRHVHL-UHFFFAOYSA-N	359622	N-[(1-Aminoisoquinolin-6-yl)methyl]-6-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)pyrimidine-4-carboxamide::US10221161, Example 8::US11242333, Example 8	Plasma kallikrein			 119							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359622	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359622&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117890488	386399076							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136199	Cc1cnn(Cc2ccc(Cc3cncc(n3)C(=O)NCc3ccc4c(N)nccc4c3)cc2)c1	InChI=1S/C27H25N7O/c1-18-12-32-34(16-18)17-20-4-2-19(3-5-20)11-23-14-29-15-25(33-23)27(35)31-13-21-6-7-24-22(10-21)8-9-30-26(24)28/h2-10,12,14-16H,11,13,17H2,1H3,(H2,28,30)(H,31,35)	XNGKXROWONCSGX-UHFFFAOYSA-N	359623	N-[(1-Aminoisoquinolin-6-yl)methyl]-6-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)pyrazine-2-carboxamide::US10221161, Example 9::US11242333, Example 9	Plasma kallikrein			 30.8							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359623	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359623&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117890033	386399077							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136200	Cc1ccc2cc(Cc3cncc(n3)C(=O)NCc3ccc4c(N)nccc4c3)ccc2n1	InChI=1S/C26H22N6O/c1-16-2-5-20-10-17(4-7-23(20)31-16)12-21-14-28-15-24(32-21)26(33)30-13-18-3-6-22-19(11-18)8-9-29-25(22)27/h2-11,14-15H,12-13H2,1H3,(H2,27,29)(H,30,33)	CGNIOLXFEPYYHB-UHFFFAOYSA-N	359624	N-[(1-Aminoisoquinolin-6-yl)methyl]-6-[(2-methylquinolin-6-yl)methyl]pyrazine-2-carboxamide::US10221161, Example 10::US11242333, Example 10	Plasma kallikrein			 194							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359624	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359624&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117890082	386399078							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136201	Cc1cnn(Cc2ccc(Cc3cnnc(c3)C(=O)NCc3ccc4c(N)nccc4c3)cc2)c1	InChI=1S/C27H25N7O/c1-18-13-32-34(16-18)17-20-4-2-19(3-5-20)10-22-12-25(33-31-15-22)27(35)30-14-21-6-7-24-23(11-21)8-9-29-26(24)28/h2-9,11-13,15-16H,10,14,17H2,1H3,(H2,28,29)(H,30,35)	DDCNHPCNBRRWTO-UHFFFAOYSA-N	359625	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)pyridazine-3-carboxamide::US10221161, Example 11::US11242333, Example 11	Plasma kallikrein			 82.3							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359625	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359625&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117890119	386399079							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136202	Cc1cnn(Cc2ccc(Cc3cncc(c3)C(=O)NCc3c(C)nc4[nH]ccc4c3C)cc2)c1	InChI=1S/C28H28N6O/c1-18-12-32-34(16-18)17-22-6-4-21(5-7-22)10-23-11-24(14-29-13-23)28(35)31-15-26-19(2)25-8-9-30-27(25)33-20(26)3/h4-9,11-14,16H,10,15,17H2,1-3H3,(H,30,33)(H,31,35)	PGNWGBYTLDFGKD-UHFFFAOYSA-N	535897	N-({2,4-Dimethyl-7H-pyrrolo[2,3-b]pyridin-3-yl}methyl)-5-({4-[(4-::US11242333, Example 12	Plasma kallikrein			 244							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535897	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535897&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163407703	464921079							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136203	Cc1ccc2cc(Cc3cncc(c3)C(=O)NCc3c(C)nc4[nH]ccc4c3C)ccc2n1	InChI=1S/C27H25N5O/c1-16-4-6-21-11-19(5-7-25(21)31-16)10-20-12-22(14-28-13-20)27(33)30-15-24-17(2)23-8-9-29-26(23)32-18(24)3/h4-9,11-14H,10,15H2,1-3H3,(H,29,32)(H,30,33)	LGHSOUBTKFLVOU-UHFFFAOYSA-N	535898	N-({2,4-Dimethyl-7H-pyrrolo[2,3-b]pyridin-3-yl}methyl)-5-[(2-::US11242333, Example 13	Plasma kallikrein			 923							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535898	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535898&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163407704	464921080							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136204	Nc1nccc2cc(CNC(=O)c3ccc(=O)n(Cc4csc(n4)-c4ccccc4)c3)ccc12	InChI=1S/C26H21N5O2S/c27-24-22-8-6-17(12-19(22)10-11-28-24)13-29-25(33)20-7-9-23(32)31(14-20)15-21-16-34-26(30-21)18-4-2-1-3-5-18/h1-12,14,16H,13,15H2,(H2,27,28)(H,29,33)	TVMQOXCUTCHUPL-UHFFFAOYSA-N	359628	N-[(1-Aminoisoquinolin-6-yl)methyl]-6-oxo-1-[(2-phenyl-1,3-thiazol-4-yl)methyl]pyridine-3-carboxamide::US10221161, Example 14::US11242333, Example 14	Plasma kallikrein			 2670							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359628	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359628&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393161	386399082							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136205	Cc1cnn(Cc2ccc(Cn3cc(ccc3=O)C(=O)NCc3ccc4c(N)nccc4c3)cc2)c1	InChI=1S/C28H26N6O2/c1-19-13-32-34(15-19)17-21-4-2-20(3-5-21)16-33-18-24(7-9-26(33)35)28(36)31-14-22-6-8-25-23(12-22)10-11-30-27(25)29/h2-13,15,18H,14,16-17H2,1H3,(H2,29,30)(H,31,36)	JRVPVSFGNJKYLB-UHFFFAOYSA-N	359629	N-[(1-Aminoisoquinolin-6-yl)methyl]-1-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)-6-oxopyridine-3-carboxamide::US10221161, Example 15::US11242333, Example 15	Plasma kallikrein			 159							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359629	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359629&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117890144	386399083							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136206	Cc1ccc2cc(Cn3cc(ccc3=O)C(=O)NCc3ccc4c(N)nccc4c3)ccc2n1	InChI=1S/C27H23N5O2/c1-17-2-5-21-13-19(4-8-24(21)31-17)15-32-16-22(6-9-25(32)33)27(34)30-14-18-3-7-23-20(12-18)10-11-29-26(23)28/h2-13,16H,14-15H2,1H3,(H2,28,29)(H,30,34)	VRTRGFXOHVRQQQ-UHFFFAOYSA-N	359630	N-[(1-Aminoisoquinolin-6-yl)methyl]-1-[(2-methylquinolin-6-yl)methyl]-6-oxopyridine-3-carboxamide::US10221161, Example 16::US11242333, Example 16	Plasma kallikrein			 179							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359630	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359630&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393202	386399084							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136207	Cc1ccc2cc(Cc3cncc(c3)C(=O)NCc3ccc4c(N)nccc4c3)ccc2n1	InChI=1S/C27H23N5O/c1-17-2-5-22-11-18(4-7-25(22)32-17)10-20-13-23(16-29-14-20)27(33)31-15-19-3-6-24-21(12-19)8-9-30-26(24)28/h2-9,11-14,16H,10,15H2,1H3,(H2,28,30)(H,31,33)	YGGSTOCJVHLULA-UHFFFAOYSA-N	359631	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-[(2-methylquinolin-6-yl)methyl]pyridine-3-carboxamide::US10221161, Example 17::US11242333, Example 17	Plasma kallikrein			 27.5							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359631	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359631&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117890179	386399085							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136208	COc1ncc(Cc2ccc3nc(C)ccc3c2)cc1C(=O)NCc1ccc2c(N)nccc2c1	InChI=1S/C28H25N5O2/c1-17-3-6-22-12-18(5-8-25(22)33-17)11-20-14-24(28(35-2)32-16-20)27(34)31-15-19-4-7-23-21(13-19)9-10-30-26(23)29/h3-10,12-14,16H,11,15H2,1-2H3,(H2,29,30)(H,31,34)	NTARKBOIYLKMIA-UHFFFAOYSA-N	359633	N-[(1-Aminoisoquinolin-6-yl)methyl]-2-methoxy-5-[(2-methylquinolin-6-yl)methyl]pyridine-3-carboxamide::US10221161, Example 19::US11242333, Example 18	Plasma kallikrein			 702							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359633	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359633&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393195	386399087							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136209	COc1ncc(cc1Cc1ccc2nc(C)ccc2c1)C(=O)NCc1ccc2c(N)nccc2c1	InChI=1S/C28H25N5O2/c1-17-3-6-21-11-18(5-8-25(21)33-17)12-22-14-23(16-32-28(22)35-2)27(34)31-15-19-4-7-24-20(13-19)9-10-30-26(24)29/h3-11,13-14,16H,12,15H2,1-2H3,(H2,29,30)(H,31,34)	RAXAJDWJQASKEB-UHFFFAOYSA-N	359632	N-[(1-Aminoisoquinolin-6-yl)methyl]-6-methoxy-5-[(2-methylquinolin-6-yl)methyl]pyridine-3-carboxamide::US10221161, Example 18::US11242333, Example 19	Plasma kallikrein			 434							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359632	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359632&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393219	386399086							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136210	Cc1ccc2cc(Cc3cc(cnc3O)C(=O)NCc3ccc4c(N)nccc4c3)ccc2n1	InChI=1S/C27H23N5O2/c1-16-2-5-20-10-17(4-7-24(20)32-16)11-21-13-22(15-31-26(21)33)27(34)30-14-18-3-6-23-19(12-18)8-9-29-25(23)28/h2-10,12-13,15H,11,14H2,1H3,(H2,28,29)(H,30,34)(H,31,33)	QJIHREWEXODGLE-UHFFFAOYSA-N	535905	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-[(2-methylquinolin-6-::US11242333, Example 20	Plasma kallikrein			 621							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535905	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535905&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163407705	464921087							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136211	CNc1ncc(Cc2ccc3nc(C)ccc3c2)cc1C(=O)NCc1ccc2c(N)nccc2c1	InChI=1S/C28H26N6O/c1-17-3-6-22-12-18(5-8-25(22)34-17)11-20-14-24(27(30-2)32-16-20)28(35)33-15-19-4-7-23-21(13-19)9-10-31-26(23)29/h3-10,12-14,16H,11,15H2,1-2H3,(H2,29,31)(H,30,32)(H,33,35)	APWVVRPKDPLSQW-UHFFFAOYSA-N	535906	N-[(1-Aminoisoquinolin-6-yl)methyl]-6-(methylamino)-5-[(2-::US11242333, Example 21	Plasma kallikrein			 53.3							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535906	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535906&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163407706	464921088							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136212	Cc1ccc2cc(Cc3cc(cnc3C)C(=O)NCc3ccc4c(N)nccc4c3)ccc2n1	InChI=1S/C28H25N5O/c1-17-3-6-22-11-19(5-8-26(22)33-17)12-23-14-24(16-31-18(23)2)28(34)32-15-20-4-7-25-21(13-20)9-10-30-27(25)29/h3-11,13-14,16H,12,15H2,1-2H3,(H2,29,30)(H,32,34)	AOPWXUUWEMUVOB-UHFFFAOYSA-N	535907	N-[(1-Aminoisoquinolin-6-yl)methyl]-2-methyl-5-[(2-methylquinolin-6-::US11242333, Example 22	Plasma kallikrein			 104							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535907	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535907&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163407707	464921089							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136213	Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccccc4)c3)ccc12	InChI=1S/C23H20N4O/c24-22-21-7-6-17(11-19(21)8-9-26-22)14-27-23(28)20-12-18(13-25-15-20)10-16-4-2-1-3-5-16/h1-9,11-13,15H,10,14H2,(H2,24,26)(H,27,28)	HMNZKYMVBHQDLG-UHFFFAOYSA-N	359638	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-benzylpyridine-3-carboxamide::US10221161, Example 23::US11242333, Example 23	Plasma kallikrein			 40000							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359638	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359638&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117890433	386399092							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136214	Nc1nccc2cc(CNC(=O)c3cncc(CC4CSC(=N4)c4ccccc4)c3)ccc12	InChI=1S/C26H23N5OS/c27-24-23-7-6-17(10-20(23)8-9-29-24)14-30-25(32)21-11-18(13-28-15-21)12-22-16-33-26(31-22)19-4-2-1-3-5-19/h1-11,13,15,22H,12,14,16H2,(H2,27,29)(H,30,32)	ZOVPGCGIJUFIDU-UHFFFAOYSA-N	535909	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-[(2-phenyl-1,3-thiazol-4-::US11242333, Example 24	Plasma kallikrein			 1710							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535909	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535909&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163407708	464921091							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136215	COc1cccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)c1	InChI=1S/C24H22N4O2/c1-30-21-4-2-3-16(12-21)9-18-11-20(15-26-13-18)24(29)28-14-17-5-6-22-19(10-17)7-8-27-23(22)25/h2-8,10-13,15H,9,14H2,1H3,(H2,25,27)(H,28,29)	NHVPFJINKKJQSZ-UHFFFAOYSA-N	359640	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-[(3-methoxyphenyl)methyl]pyridine-3-carboxamide::US10221161, Example 25::US11242333, Example 25	Plasma kallikrein			 2640							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359640	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359640&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393160	386399094							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136216	COc1ccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)cc1	InChI=1S/C24H22N4O2/c1-30-21-5-2-16(3-6-21)10-18-12-20(15-26-13-18)24(29)28-14-17-4-7-22-19(11-17)8-9-27-23(22)25/h2-9,11-13,15H,10,14H2,1H3,(H2,25,27)(H,28,29)	RXDWASWWHDDTEG-UHFFFAOYSA-N	359641	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-[(4-methoxyphenyl)methyl]pyridine-3-carboxamide::US10221161, Example 26::US11242333, Example 26	Plasma kallikrein			 941							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359641	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359641&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393173	386399095							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136217	Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccc(cc4)-n4cccn4)c3)ccc12	InChI=1S/C26H22N6O/c27-25-24-7-4-19(13-21(24)8-10-29-25)16-30-26(33)22-14-20(15-28-17-22)12-18-2-5-23(6-3-18)32-11-1-9-31-32/h1-11,13-15,17H,12,16H2,(H2,27,29)(H,30,33)	MJHTYGXMZRJQOL-UHFFFAOYSA-N	359642	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[4-(pyrazol-1-yl)phenyl]methyl}pyridine-3-carboxamide::US10221161, Example 27::US11242333, Example 27	Plasma kallikrein			 1010							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359642	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359642&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393199	386399096							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136218	Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccc5ccncc5c4)c3)ccc12	InChI=1S/C26H21N5O/c27-25-24-4-2-18(11-21(24)6-8-30-25)14-31-26(32)23-12-19(13-29-16-23)9-17-1-3-20-5-7-28-15-22(20)10-17/h1-8,10-13,15-16H,9,14H2,(H2,27,30)(H,31,32)	QWPOIDBZQCSTHS-UHFFFAOYSA-N	359643	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-(isoquinolin-7-ylmethyl)pyridine-3-carboxamide::US10221161, Example 28::US11242333, Example 28	Plasma kallikrein			 1100							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359643	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359643&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393146	386399097							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136219	COc1ccccc1Cc1cncc(c1)C(=O)NCc1ccc2c(N)nccc2c1	InChI=1S/C24H22N4O2/c1-30-22-5-3-2-4-19(22)11-17-12-20(15-26-13-17)24(29)28-14-16-6-7-21-18(10-16)8-9-27-23(21)25/h2-10,12-13,15H,11,14H2,1H3,(H2,25,27)(H,28,29)	RJBICVKPFVWOFZ-UHFFFAOYSA-N	359644	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-[(2-methoxyphenyl)methyl]pyridine-3-carboxamide::US10221161, Example 29::US11242333, Example 29	Plasma kallikrein			 20200							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359644	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359644&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393216	386399098							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136220	Nc1nccc2cc(CNC(=O)c3cncc(Cc4cccc(c4)-n4cccn4)c3)ccc12	InChI=1S/C26H22N6O/c27-25-24-6-5-19(12-21(24)7-9-29-25)16-30-26(33)22-13-20(15-28-17-22)11-18-3-1-4-23(14-18)32-10-2-8-31-32/h1-10,12-15,17H,11,16H2,(H2,27,29)(H,30,33)	QCNNYPSWAPTRPO-UHFFFAOYSA-N	359645	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[3-(pyrazol-1-yl)phenyl]methyl}pyridine-3-carboxamide::US10221161, Example 30::US11242333, Example 30	Plasma kallikrein			 302							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359645	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359645&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393194	386399099							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136221	Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccc5ncccc5c4)c3)ccc12	InChI=1S/C26H21N5O/c27-25-23-5-3-18(12-20(23)7-9-30-25)15-31-26(32)22-13-19(14-28-16-22)10-17-4-6-24-21(11-17)2-1-8-29-24/h1-9,11-14,16H,10,15H2,(H2,27,30)(H,31,32)	XUTIWWYHRPIIGM-UHFFFAOYSA-N	359646	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-(quinolin-6-ylmethyl)pyridine-3-carboxamide::US10221161, Example 31::US11242333, Example 31	Plasma kallikrein			 144							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359646	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359646&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117889860	386399100							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136222	Nc1nccc2cc(CNC(=O)c3cncc(Cc4cccc(Cn5cccn5)c4)c3)ccc12	InChI=1S/C27H24N6O/c28-26-25-6-5-20(13-23(25)7-9-30-26)16-31-27(34)24-14-22(15-29-17-24)12-19-3-1-4-21(11-19)18-33-10-2-8-32-33/h1-11,13-15,17H,12,16,18H2,(H2,28,30)(H,31,34)	KXHZGAGGNIYIJJ-UHFFFAOYSA-N	359647	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[3-(pyrazol-1-ylmethyl)phenyl]methyl}pyridine-3-carboxamide::US10221161, Example 32::US11242333, Example 32	Plasma kallikrein			 237							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359647	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359647&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393182	386399101							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136223	COc1cc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)ccc1Cn1cc(C)cn1	InChI=1S/C29H28N6O2/c1-19-13-34-35(17-19)18-24-5-3-20(12-27(24)37-2)9-22-11-25(16-31-14-22)29(36)33-15-21-4-6-26-23(10-21)7-8-32-28(26)30/h3-8,10-14,16-17H,9,15,18H2,1-2H3,(H2,30,32)(H,33,36)	GTAQUAIETWGMKZ-UHFFFAOYSA-N	359648	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({3-methoxy-4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)pyridine-3-carboxamide::US10221161, Example 33::US11242333, Example 33	Plasma kallikrein			 17.1							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359648	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359648&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117889845	386399102							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136224	COCCOc1ccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)cc1	InChI=1S/C26H26N4O3/c1-32-10-11-33-23-5-2-18(3-6-23)12-20-14-22(17-28-15-20)26(31)30-16-19-4-7-24-21(13-19)8-9-29-25(24)27/h2-9,13-15,17H,10-12,16H2,1H3,(H2,27,29)(H,30,31)	VWAFTKDLCVIHNB-UHFFFAOYSA-N	359649	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[4-(2-methoxyethoxy)phenyl]methyl}pyridine-3-carboxamide::US10221161, Example 34::US11242333, Example 34	Plasma kallikrein			 1020							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359649	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359649&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393208	386399103							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136225	Nc1nccc2cc(CNC(=O)c3cncc(CN4CCN(CC4)S(=O)(=O)c4ccccc4)c3)ccc12	InChI=1S/C27H28N6O3S/c28-26-25-7-6-20(14-22(25)8-9-30-26)17-31-27(34)23-15-21(16-29-18-23)19-32-10-12-33(13-11-32)37(35,36)24-4-2-1-3-5-24/h1-9,14-16,18H,10-13,17,19H2,(H2,28,30)(H,31,34)	GSABBNCJRVLTCT-UHFFFAOYSA-N	359650	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[4-(benzenesulfonyl)piperazin-1-yl]methyl}pyridine-3-carboxamide::US10221161, Example 35::US11242333, Example 35	Plasma kallikrein			 3510							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359650	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359650&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393203	386399104							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136226	Nc1nccc2cc(CNC(=O)c3cncc(CN4CCN(CC4)C(=O)c4ccccc4)c3)ccc12	InChI=1S/C28H28N6O2/c29-26-25-7-6-20(14-23(25)8-9-31-26)17-32-27(35)24-15-21(16-30-18-24)19-33-10-12-34(13-11-33)28(36)22-4-2-1-3-5-22/h1-9,14-16,18H,10-13,17,19H2,(H2,29,31)(H,32,35)	QQISCDLIEFYLAP-UHFFFAOYSA-N	359651	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-[(4-benzoylpiperazin-1-yl)methyl]pyridine-3-carboxamide::US10221161, Example 36::US11242333, Example 36	Plasma kallikrein			 6650							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359651	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359651&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393205	386399105							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136227	Cn1cc(CC2CCN(Cc3cncc(c3)C(=O)NCc3ccc4c(N)nccc4c3)CC2)cn1	InChI=1S/C27H31N7O/c1-33-17-21(15-32-33)10-19-5-8-34(9-6-19)18-22-12-24(16-29-13-22)27(35)31-14-20-2-3-25-23(11-20)4-7-30-26(25)28/h2-4,7,11-13,15-17,19H,5-6,8-10,14,18H2,1H3,(H2,28,30)(H,31,35)	XLLOULXMPWEUCW-UHFFFAOYSA-N	535922	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({4-[(4-methylpyrazol-1-::US11242333, Example 37	Plasma kallikrein			 1180							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535922	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535922&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163407709	464921104							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136228	CN1CCOc2cc(Cc3cncc(c3)C(=O)NCc3ccc4c(N)nccc4c3)ccc12	InChI=1S/C26H25N5O2/c1-31-8-9-33-24-13-17(3-5-23(24)31)10-19-12-21(16-28-14-19)26(32)30-15-18-2-4-22-20(11-18)6-7-29-25(22)27/h2-7,11-14,16H,8-10,15H2,1H3,(H2,27,29)(H,30,32)	JXTLOXNAUILARA-UHFFFAOYSA-N	359653	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-[(4-methyl-2,3-dihydro-1,4-benzoxazin-7-yl)methyl]pyridine-3-carboxamide::US10221161, Example 38::US11242333, Example 38	Plasma kallikrein			 107							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359653	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359653&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393147	386399107							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136229	Nc1nccc2cc(CNC(=O)c3cncc(CN4CCN(CC4)c4ccccc4)c3)ccc12	InChI=1S/C27H28N6O/c28-26-25-7-6-20(14-22(25)8-9-30-26)17-31-27(34)23-15-21(16-29-18-23)19-32-10-12-33(13-11-32)24-4-2-1-3-5-24/h1-9,14-16,18H,10-13,17,19H2,(H2,28,30)(H,31,34)	QNILJKZWSOSWNG-UHFFFAOYSA-N	359654	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-[(4-phenylpiperazin-1-yl)methyl]pyridine-3-carboxamide::US10221161, Example 39::US11242333, Example 39	Plasma kallikrein			 10000							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359654	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359654&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393150	386399108							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136230	Cc1cnn(CCOCc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)c1	InChI=1S/C23H24N6O2/c1-16-10-28-29(14-16)6-7-31-15-18-9-20(13-25-11-18)23(30)27-12-17-2-3-21-19(8-17)4-5-26-22(21)24/h2-5,8-11,13-14H,6-7,12,15H2,1H3,(H2,24,26)(H,27,30)	AZBQFJWLTSDFIL-UHFFFAOYSA-N	359655	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[2-(4-methylpyrazol-1-yl)ethoxy]methyl}pyridine-3-carboxamide::US10221161, Example 40::US11242333, Example 40	Plasma kallikrein			 127							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359655	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359655&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393171	386399109							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136231	Nc1nccc2cc(CNC(=O)c3cncc(CN4CCN(Cc5ccccc5)CC4)c3)ccc12	InChI=1S/C28H30N6O/c29-27-26-7-6-22(14-24(26)8-9-31-27)17-32-28(35)25-15-23(16-30-18-25)20-34-12-10-33(11-13-34)19-21-4-2-1-3-5-21/h1-9,14-16,18H,10-13,17,19-20H2,(H2,29,31)(H,32,35)	RIFRFZVMRBBMED-UHFFFAOYSA-N	359656	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-[(4-benzylpiperazin-1-yl)methyl]pyridine-3-carboxamide::US10221161, Example 41::US11242333, Example 41	Plasma kallikrein			 2750							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359656	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359656&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393218	386399110							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136232	COc1ccccc1CN1CCN(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)CC1	InChI=1S/C29H32N6O2/c1-37-27-5-3-2-4-24(27)20-35-12-10-34(11-13-35)19-22-15-25(18-31-16-22)29(36)33-17-21-6-7-26-23(14-21)8-9-32-28(26)30/h2-9,14-16,18H,10-13,17,19-20H2,1H3,(H2,30,32)(H,33,36)	UEKXUKONFSMUBQ-UHFFFAOYSA-N	359657	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({4-[(2-methoxyphenyl)methyl]piperazin-1-yl}methyl)pyridine-3-carboxamide::US10221161, Example 42::US11242333, Example 42	Plasma kallikrein			 1830							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359657	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359657&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393165	386399111							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136233	Nc1nccc2cc(CNC(=O)c3cncc(CN4CCN(CC5CCCC5)CC4)c3)ccc12	InChI=1S/C27H34N6O/c28-26-25-6-5-21(13-23(25)7-8-30-26)16-31-27(34)24-14-22(15-29-17-24)19-33-11-9-32(10-12-33)18-20-3-1-2-4-20/h5-8,13-15,17,20H,1-4,9-12,16,18-19H2,(H2,28,30)(H,31,34)	NZUKSQPPVVBORB-UHFFFAOYSA-N	359658	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[4-(cyclopentylmethyl)piperazin-1-yl]methyl}pyridine-3-carboxamide::US10221161, Example 43::US11242333, Example 43	Plasma kallikrein			 11000							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359658	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359658&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393157	386399112							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136234	Nc1nccc2cc(CNC(=O)c3cncc(CN4CCN(Cc5ccccc5F)CC4)c3)ccc12	InChI=1S/C28H29FN6O/c29-26-4-2-1-3-23(26)19-35-11-9-34(10-12-35)18-21-14-24(17-31-15-21)28(36)33-16-20-5-6-25-22(13-20)7-8-32-27(25)30/h1-8,13-15,17H,9-12,16,18-19H2,(H2,30,32)(H,33,36)	YQEBTDRANIJUMP-UHFFFAOYSA-N	359659	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({4-[(2-fluorophenyl)methyl]piperazin-1-yl}methyl)pyridine-3-carboxamide::US10221161, Example 44::US11242333, Example 44	Plasma kallikrein			 6790							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359659	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359659&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117889897	386399113							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136235	CCc1ccc(CN2CCN(Cc3cncc(c3)C(=O)NCc3ccc4c(N)nccc4c3)CC2)cc1	InChI=1S/C30H34N6O/c1-2-22-3-5-23(6-4-22)20-35-11-13-36(14-12-35)21-25-16-27(19-32-17-25)30(37)34-18-24-7-8-28-26(15-24)9-10-33-29(28)31/h3-10,15-17,19H,2,11-14,18,20-21H2,1H3,(H2,31,33)(H,34,37)	DTHSGCZIOYPCHE-UHFFFAOYSA-N	535930	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({4-[(4-::US11242333, Example 45	Plasma kallikrein			 33600							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535930	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535930&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163407710	464921112							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136236	Nc1nccc2cc(CNC(=O)c3cncc(CN4CCN(Cc5cccc(F)c5)CC4)c3)ccc12	InChI=1S/C28H29FN6O/c29-25-3-1-2-21(14-25)18-34-8-10-35(11-9-34)19-22-13-24(17-31-15-22)28(36)33-16-20-4-5-26-23(12-20)6-7-32-27(26)30/h1-7,12-15,17H,8-11,16,18-19H2,(H2,30,32)(H,33,36)	JRLYQLXPWIQWEU-UHFFFAOYSA-N	359661	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({4-[(3-fluorophenyl)methyl]piperazin-1-yl}methyl)pyridine-3-carboxamide::US10221161, Example 46::US11242333, Example 46	Plasma kallikrein			 7510							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359661	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359661&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393221	386399115							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136237	Cn1cc(CN2CCN(Cc3cncc(c3)C(=O)NCc3ccc4c(N)nccc4c3)CC2)cn1	InChI=1S/C26H30N8O/c1-32-16-21(14-31-32)18-34-8-6-33(7-9-34)17-20-11-23(15-28-12-20)26(35)30-13-19-2-3-24-22(10-19)4-5-29-25(24)27/h2-5,10-12,14-16H,6-9,13,17-18H2,1H3,(H2,27,29)(H,30,35)	ACNMPVADOSTEOV-UHFFFAOYSA-N	359662	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({4-[(1-methylpyrazol-4-yl)methyl]piperazin-1-yl}methyl)pyridine-3-carboxamide::US10221161, Example 47::US11242333, Example 47	Plasma kallikrein			 40000							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359662	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359662&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393193	386399116							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136238	Nc1nccc2cc(CNC(=O)c3cncc(CN4CCN(Cc5ccc(F)cc5)CC4)c3)ccc12	InChI=1S/C28H29FN6O/c29-25-4-1-20(2-5-25)18-34-9-11-35(12-10-34)19-22-14-24(17-31-15-22)28(36)33-16-21-3-6-26-23(13-21)7-8-32-27(26)30/h1-8,13-15,17H,9-12,16,18-19H2,(H2,30,32)(H,33,36)	WFUMVGOBVWBOPI-UHFFFAOYSA-N	359663	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({4-[(4-fluorophenyl)methyl]piperazin-1-yl}methyl)pyridine-3-carboxamide::US10221161, Example 48::US11242333, Example 48	Plasma kallikrein			 21900							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359663	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359663&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393154	386399117							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136239	COc1cccc(CN2CCN(Cc3cncc(c3)C(=O)NCc3ccc4c(N)nccc4c3)CC2)c1	InChI=1S/C29H32N6O2/c1-37-26-4-2-3-22(15-26)19-34-9-11-35(12-10-34)20-23-14-25(18-31-16-23)29(36)33-17-21-5-6-27-24(13-21)7-8-32-28(27)30/h2-8,13-16,18H,9-12,17,19-20H2,1H3,(H2,30,32)(H,33,36)	ZCPQVTBQVQZWBJ-UHFFFAOYSA-N	359664	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({4-[(3-methoxyphenyl)methyl]piperazin-1-yl}methyl)pyridine-3-carboxamide::US10221161, Example 49::US11242333, Example 49	Plasma kallikrein			 6990							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359664	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359664&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393176	386399118							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136240	Nc1nccc2cc(CNC(=O)c3cncc(CN4CCN(CCCc5ccccc5)CC4)c3)ccc12	InChI=1S/C30H34N6O/c31-29-28-9-8-24(17-26(28)10-11-33-29)20-34-30(37)27-18-25(19-32-21-27)22-36-15-13-35(14-16-36)12-4-7-23-5-2-1-3-6-23/h1-3,5-6,8-11,17-19,21H,4,7,12-16,20,22H2,(H2,31,33)(H,34,37)	WZRBBDWAJNKRJJ-UHFFFAOYSA-N	359665	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[4-(3-phenylpropyl)piperazin-1-yl]methyl}pyridine-3-carboxamide::US10221161, Example 50::US11242333, Example 50	Plasma kallikrein			 10000							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359665	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359665&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393207	386399119							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136241	Nc1nccc2cc(CNC(=O)c3cncc(CN4CCN(CCc5ccccc5)CC4)c3)ccc12	InChI=1S/C29H32N6O/c30-28-27-7-6-23(16-25(27)8-10-32-28)19-33-29(36)26-17-24(18-31-20-26)21-35-14-12-34(13-15-35)11-9-22-4-2-1-3-5-22/h1-8,10,16-18,20H,9,11-15,19,21H2,(H2,30,32)(H,33,36)	WOKOXMNRFZLCOD-UHFFFAOYSA-N	359666	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[4-(2-phenylethyl)piperazin-1-yl]methyl}pyridine-3-carboxamide::US10221161, Example 51::US11242333, Example 51	Plasma kallikrein			 8110							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359666	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359666&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393152	386399120							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136242	Nc1nccc2cc(CNC(=O)c3cncc(CN4CCN(CC(O)=O)CC4)c3)ccc12	InChI=1S/C23H26N6O3/c24-22-20-2-1-16(9-18(20)3-4-26-22)12-27-23(32)19-10-17(11-25-13-19)14-28-5-7-29(8-6-28)15-21(30)31/h1-4,9-11,13H,5-8,12,14-15H2,(H2,24,26)(H,27,32)(H,30,31)	FCGIVIRGUFMPIA-UHFFFAOYSA-N	359667	US10221161, Example 52::US11242333, Example 52::{4-[(5-{[(1-Aminoisoquinolin-6-yl)methyl]carbamoyl}pyridin-3-yl)methyl]piperazin-1-yl}acetic acid	Plasma kallikrein			 10000							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359667	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359667&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393192	386399121							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136243	Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccc(nc4)N4CCCC4=O)c3)ccc12	InChI=1S/C26H24N6O2/c27-25-22-5-3-18(11-20(22)7-8-29-25)15-31-26(34)21-12-19(13-28-16-21)10-17-4-6-23(30-14-17)32-9-1-2-24(32)33/h3-8,11-14,16H,1-2,9-10,15H2,(H2,27,29)(H,31,34)	FGWAAFZCRVTFKI-UHFFFAOYSA-N	359668	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[6-(2-oxopyrrolidin-1-yl)pyridin-3-yl]methyl}pyridine-3-carboxamide::US10221161, Example 53::US11242333, Example 53	Plasma kallikrein			 200							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359668	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359668&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393215	386399122							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136244	Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccc(F)nc4)c3)ccc12	InChI=1S/C22H18FN5O/c23-20-4-2-14(11-27-20)7-16-9-18(13-25-10-16)22(29)28-12-15-1-3-19-17(8-15)5-6-26-21(19)24/h1-6,8-11,13H,7,12H2,(H2,24,26)(H,28,29)	MNWMUSUGAZXLAF-UHFFFAOYSA-N	359669	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-[(6-fluoropyridin-3-yl)methyl]pyridine-3-carboxamide::US10221161, Example 54::US11242333, Example 54	Plasma kallikrein			 14600							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359669	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359669&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393149	386399123							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136245	Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccc(nc4)N4CCCC4)c3)ccc12	InChI=1S/C26H26N6O/c27-25-23-5-3-19(12-21(23)7-8-29-25)16-31-26(33)22-13-20(14-28-17-22)11-18-4-6-24(30-15-18)32-9-1-2-10-32/h3-8,12-15,17H,1-2,9-11,16H2,(H2,27,29)(H,31,33)	YHNLOIFSKXIOLI-UHFFFAOYSA-N	359670	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[6-(pyrrolidin-1-yl)pyridin-3-yl]methyl}pyridine-3-carboxamide::US10221161, Example 55::US11242333, Example 55	Plasma kallikrein			 103							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359670	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359670&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393159	386399124							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136246	Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccc(nc4)N4CCCCC4)c3)ccc12	InChI=1S/C27H28N6O/c28-26-24-6-4-20(13-22(24)8-9-30-26)17-32-27(34)23-14-21(15-29-18-23)12-19-5-7-25(31-16-19)33-10-2-1-3-11-33/h4-9,13-16,18H,1-3,10-12,17H2,(H2,28,30)(H,32,34)	HSRMSOFBIDEBQY-UHFFFAOYSA-N	359671	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[6-(piperidin-1-yl)pyridin-3-yl]methyl}pyridine-3-carboxamide::US10221161, Example 56::US11242333, Example 56	Plasma kallikrein			 313							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359671	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359671&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393162	386399125							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136247	Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccc(nc4)N4CCC(F)(F)C4)c3)ccc12	InChI=1S/C26H24F2N6O/c27-26(28)6-8-34(16-26)23-4-2-17(13-32-23)9-19-11-21(15-30-12-19)25(35)33-14-18-1-3-22-20(10-18)5-7-31-24(22)29/h1-5,7,10-13,15H,6,8-9,14,16H2,(H2,29,31)(H,33,35)	SQHRXWHUJDTTGU-UHFFFAOYSA-N	359672	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[6-(3,3-difluoropyrrolidin-1-yl)pyridin-3-yl]methyl}pyridine-3-carboxamide::US10221161, Example 57::US11242333, Example 57	Plasma kallikrein			 240							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359672	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359672&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393204	386399126							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136248	CC1CCCN1c1ccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)cn1	InChI=1S/C27H28N6O/c1-18-3-2-10-33(18)25-7-5-19(15-31-25)11-21-13-23(17-29-14-21)27(34)32-16-20-4-6-24-22(12-20)8-9-30-26(24)28/h4-9,12-15,17-18H,2-3,10-11,16H2,1H3,(H2,28,30)(H,32,34)	HCKCTEYBXXLMKG-UHFFFAOYSA-N	359673	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[6-(2-methylpyrrolidin-1-yl)pyridin-3-yl]methyl}pyridine-3-carboxamide::US10221161, Example 58::US11242333, Example 58	Plasma kallikrein			 153							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359673	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359673&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393156	386399127							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136249	Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccc(nc4)N4CCC(O)C4)c3)ccc12	InChI=1S/C26H26N6O2/c27-25-23-3-1-18(10-20(23)5-7-29-25)14-31-26(34)21-11-19(12-28-15-21)9-17-2-4-24(30-13-17)32-8-6-22(33)16-32/h1-5,7,10-13,15,22,33H,6,8-9,14,16H2,(H2,27,29)(H,31,34)	WRPGPMLIUGFQRG-UHFFFAOYSA-N	359674	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[6-(3-hydroxypyrrolidin-1-yl)pyridin-3-yl]methyl}pyridine-3-carboxamide::US10221161, Example 59::US11242333, Example 59	Plasma kallikrein			 417							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359674	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359674&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393196	386399128							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136250	Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccc(nc4)N4CCC(F)C4)c3)ccc12	InChI=1S/C26H25FN6O/c27-22-6-8-33(16-22)24-4-2-17(13-31-24)9-19-11-21(15-29-12-19)26(34)32-14-18-1-3-23-20(10-18)5-7-30-25(23)28/h1-5,7,10-13,15,22H,6,8-9,14,16H2,(H2,28,30)(H,32,34)	ADLMVMMMJBJZMR-UHFFFAOYSA-N	359675	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[6-(3-fluoropyrrolidin-1-yl)pyridin-3-yl]methyl}pyridine-3-carboxamide::US10221161, Example 60::US11242333, Example 60	Plasma kallikrein			 137							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359675	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359675&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393183	386399129							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136251	CC1CCN(C1)c1ccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)cn1	InChI=1S/C27H28N6O/c1-18-7-9-33(17-18)25-5-3-19(14-31-25)10-21-12-23(16-29-13-21)27(34)32-15-20-2-4-24-22(11-20)6-8-30-26(24)28/h2-6,8,11-14,16,18H,7,9-10,15,17H2,1H3,(H2,28,30)(H,32,34)	ALWCYCHCLNSCIN-UHFFFAOYSA-N	359676	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[6-(3-methylpyrrolidin-1-yl)pyridin-3-yl]methyl}pyridine-3-carboxamide::US10221161, Example 61::US11242333, Example 61	Plasma kallikrein			 137							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359676	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359676&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393187	386399130							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136252	COC1CCN(C1)c1ccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)cn1	InChI=1S/C27H28N6O2/c1-35-23-7-9-33(17-23)25-5-3-18(14-31-25)10-20-12-22(16-29-13-20)27(34)32-15-19-2-4-24-21(11-19)6-8-30-26(24)28/h2-6,8,11-14,16,23H,7,9-10,15,17H2,1H3,(H2,28,30)(H,32,34)	QKSNHFIMZOACNT-UHFFFAOYSA-N	359677	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[6-(3-methoxypyrrolidin-1-yl)pyridin-3-yl]methyl}pyridine-3-carboxamide::US10221161, Example 62::US11242333, Example 62	Plasma kallikrein			 255							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359677	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359677&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393214	386399131							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136253	Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccc(nc4)N4CCOCC4)c3)ccc12	InChI=1S/C26H26N6O2/c27-25-23-3-1-19(12-21(23)5-6-29-25)16-31-26(33)22-13-20(14-28-17-22)11-18-2-4-24(30-15-18)32-7-9-34-10-8-32/h1-6,12-15,17H,7-11,16H2,(H2,27,29)(H,31,33)	GCDCEQPKZBSJCH-UHFFFAOYSA-N	359678	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[6-(morpholin-4-yl)pyridin-3-yl]methyl}pyridine-3-carboxamide::US10221161, Example 63::US11242333, Example 63	Plasma kallikrein			 432							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359678	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359678&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393185	386399132							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136254	CN1CCN(CC1)c1ccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)cn1	InChI=1S/C27H29N7O/c1-33-8-10-34(11-9-33)25-5-3-19(16-31-25)12-21-14-23(18-29-15-21)27(35)32-17-20-2-4-24-22(13-20)6-7-30-26(24)28/h2-7,13-16,18H,8-12,17H2,1H3,(H2,28,30)(H,32,35)	AYIZOVVOLGYDQH-UHFFFAOYSA-N	359679	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[6-(4-methylpiperazin-1-yl)pyridin-3-yl]methyl}pyridine-3-carboxamide::US10221161, Example 64::US11242333, Example 64	Plasma kallikrein			 610							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359679	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359679&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393166	386399133							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
917968	Cc1[nH]nc2[C@@H](CCc12)NC(=O)c1cnn(Cc2ccc(nc2C)N2CCCC2)c1			448401	N-[(6R)-3-Methyl-2H,4H,5H,6H-cyclopenta[c]pyrazol-6-yl]-1-{[2-methyl-6-(pyrrolidin-1-yl)pyridin-3-::US10695334, Example 52	Plasma kallikrein		 1.000								US Patent		10.7270/Q2VT1W4K		aid1804527	US10695334	Eckhardt, M; Gollner, A; Langkopf, E; Wagner, H; Wiedenmayer, D	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=448401	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=448401&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
917969	Cc1c2CC[C@@H](NC(=O)c3cnn(Cc4ccc(F)nc4C)c3)c2nn1COCC[Si](C)(C)C	InChI=1S/C24H33FN6O2Si/c1-16-18(6-9-22(25)27-16)13-30-14-19(12-26-30)24(32)28-21-8-7-20-17(2)31(29-23(20)21)15-33-10-11-34(3,4)5/h6,9,12,14,21H,7-8,10-11,13,15H2,1-5H3,(H,28,32)/t21-/m1/s1	BZOPKNBZYRMPLV-OAQYLSRUSA-N	448402	1-[(6-{2-Azaspiro[3.31]heptan-2-yl}-2-methylpyridin-3-yl)methyl]-N-[(6R)-3-methyl-2H,4H,5H,6H- cyclopenta[c]pyrazol-6-yl]-1H-pyrazole-4-::US10695334, Example 54	Plasma kallikrein		 1.000								US Patent		10.7270/Q2VT1W4K		aid1804527	US10695334	Eckhardt, M; Gollner, A; Langkopf, E; Wagner, H; Wiedenmayer, D	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=448402	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=448402&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
917970	Cc1[nH]nc2[C@@H](CCc12)NC(=O)c1cnn(Cc2ccc(nc2C)N2CC(C)(C)C2)c1			448403	1-{[6-(3,3-Dimethylazetidin-1-yl)-2-methylpyridin-3-yl]methyl}-N-[(6R)-3-methyl-2H,4H,5H,6H-::US10695334, Example 67	Plasma kallikrein		 1.000								US Patent		10.7270/Q2VT1W4K		aid1804527	US10695334	Eckhardt, M; Gollner, A; Langkopf, E; Wagner, H; Wiedenmayer, D	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=448403	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=448403&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
917971	Cc1[nH]nc2[C@@H](CCc12)NC(=O)c1cnn(Cc2ccc(nc2C)N2CCC(C)(C2)C#N)c1			448404	1-{[6-(3-Cyano-3-methylpyrrolidin-1-yl)-2-methylpyridin-3-yl]methyl}-N-[(6R)-3-methyl-::US10695334, Example 71	Plasma kallikrein		 1.000								US Patent		10.7270/Q2VT1W4K		aid1804527	US10695334	Eckhardt, M; Gollner, A; Langkopf, E; Wagner, H; Wiedenmayer, D	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=448404	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=448404&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
917972	Cc1[nH]nc2[C@@H](CCc12)NC(=O)c1cnn(Cc2ccc(nc2C)N2CC(C)(F)C2)c1			448405	1-{[6-(3-Fluoro-3-methylazetidin-1-yl)-2-methylpyridin-3-yl]methyl}-N-[(6R)-3-methyl-::US10695334, Example 77	Plasma kallikrein		 4.00								US Patent		10.7270/Q2VT1W4K		aid1804527	US10695334	Eckhardt, M; Gollner, A; Langkopf, E; Wagner, H; Wiedenmayer, D	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=448405	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=448405&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
917973	Cc1c2CC[C@@H](NC(=O)c3cn(Cc4cnc(nc4C)N4CC5CC5C4)nn3)c2nn1COCC[Si](C)(C)C	InChI=1S/C27H39N9O2Si/c1-17-21(11-28-27(29-17)34-12-19-10-20(19)13-34)14-35-15-24(31-33-35)26(37)30-23-7-6-22-18(2)36(32-25(22)23)16-38-8-9-39(3,4)5/h11,15,19-20,23H,6-10,12-14,16H2,1-5H3,(H,30,37)/t19?,20?,23-/m1/s1	LXWFSNVUCGMOGD-YABDQXBESA-N	448406	1-[(2-{3-Azabicyclo[3.1.0]hexan-3-yl}-4-methylpyrimidin-5-yl)methyl]-N-[(6R)-3-methyl-1H,4H,5H,6H- cyclopenta[c]pyrazol-6-yl]-1H-1,2,3-triazole-4-carboxamide::US10695334, Example 87	Plasma kallikrein		 1.000								US Patent		10.7270/Q2VT1W4K		aid1804527	US10695334	Eckhardt, M; Gollner, A; Langkopf, E; Wagner, H; Wiedenmayer, D	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=448406	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=448406&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
917974	Cc1[nH]nc2[C@@H](CCc12)NC(=O)c1cn(Cc2ccc(nc2C)N2CC3CC3C2)c(n1)C1CC1			448407	1-[(6-{3-Azabicyclo[3.1.0]hexan-3-yl}-2-methyl-::US10695334, Example 96	Plasma kallikrein		 1.000								US Patent		10.7270/Q2VT1W4K		aid1804527	US10695334	Eckhardt, M; Gollner, A; Langkopf, E; Wagner, H; Wiedenmayer, D	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=448407	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=448407&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
917975	Cc1nc(cn1Cc1ccc(nc1C)N1CC2CC2C1)C(=O)NC1CCc2c(C)[nH]nc12			448408	1-[(6-(3-Azabicyclo[3.1.0]hexan-3-yl}-2-methyl-::US10695334, Example 97	Plasma kallikrein		 1.000								US Patent		10.7270/Q2VT1W4K		aid1804527	US10695334	Eckhardt, M; Gollner, A; Langkopf, E; Wagner, H; Wiedenmayer, D	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=448408	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=448408&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
917976	Cc1[nH]nc2[C@@H](CCc12)NC(=O)c1cn(Cc2ccc(nc2C)N2CC3CC3C2)c(n1)C(F)(F)F			448409	1-[(6-{3-Azabicyclo[3.1.0]hexan-3-yl}-2-methyl-::US10695334, Example 98	Plasma kallikrein		 6.00								US Patent		10.7270/Q2VT1W4K		aid1804527	US10695334	Eckhardt, M; Gollner, A; Langkopf, E; Wagner, H; Wiedenmayer, D	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=448409	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=448409&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
917977	Cc1[nH]nc2[C@@H](CCc12)NC(=O)c1cn(Cc2c(C)cc(nc2C)N2C[C@H]3[C@@H](CO)[C@H]3C2)cn1			448410	1-({6-[(1R,5S,6S)-6-(Hydroxymethyl)-3-aza-::US10695334, Example 99	Plasma kallikrein		 1.000								US Patent		10.7270/Q2VT1W4K		aid1804527	US10695334	Eckhardt, M; Gollner, A; Langkopf, E; Wagner, H; Wiedenmayer, D	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=448410	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=448410&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
917978	C[C@@H]1[C@@H]2CN(C[C@H]12)c1ccc(Cn2cnc(c2)C(=O)N[C@@H]2CCc3c(C)[nH]nc23)c(C)n1			448411	N-[(6R)-3-Methyl-2H,4H,5H,6H-cyclopenta[c]-::US10695334, Example 100	Plasma kallikrein		 0.800								US Patent		10.7270/Q2VT1W4K		aid1804527	US10695334	Eckhardt, M; Gollner, A; Langkopf, E; Wagner, H; Wiedenmayer, D	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=448411	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=448411&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
917979	C[C@@H]1[C@@H]2CN(C[C@H]12)c1ncc(Cn2cnc(c2)C(=O)N[C@@H]2CCc3c(C)[nH]nc23)c(C)n1			448412	1-({4-Methyl-2-[(1R,5S,6R)-6-methyl-3-::US10695334, Example 101	Plasma kallikrein		 2.00								US Patent		10.7270/Q2VT1W4K		aid1804527	US10695334	Eckhardt, M; Gollner, A; Langkopf, E; Wagner, H; Wiedenmayer, D	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=448412	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=448412&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
917980	Cc1[nH]nc2[C@@H](CCc12)NC(=O)c1cn(Cc2ccc(nc2C)N2CC3CC3C2)c(Cl)n1			448413	1-[(6-{3-Azabicyclo[3.1.0]hexan-3-yl}-2-methyl-::US10695334, Example 102	Plasma kallikrein		 4.00								US Patent		10.7270/Q2VT1W4K		aid1804527	US10695334	Eckhardt, M; Gollner, A; Langkopf, E; Wagner, H; Wiedenmayer, D	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=448413	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=448413&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51258682	Cl.Cl.COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](NC(=O)c3ncn(c3C)-c3cccc(Cl)c3F)c3cc-2ccn3)c1	InChI=1S/C31H30ClFN6O4.2ClH/c1-17-6-4-8-23(37-30(41)28-18(2)39(16-35-28)26-9-5-7-22(32)27(26)33)25-14-19(12-13-34-25)21-11-10-20(36-31(42)43-3)15-24(21)38-29(17)40;;/h5,7,9-17,23H,4,6,8H2,1-3H3,(H,36,42)(H,37,41)(H,38,40);2*1H/t17-,23+;;/m1../s1	GRFBPSQUHXGFOO-VQRJTFEDSA-N	50514432	CHEMBL4438385	Plasma kallikrein		 6.3								ChEMBL	10.1021/acs.jmedchem.9b01768	10.7270/Q2J67M9S	31833761			Corte, JR; Pinto, DJP; Fang, T; Osuna, H; Yang, W; Wang, Y; Lai, A; Clark, CG; Sun, JH; Rampulla, R; Mathur, A; Kaspady, M; Neithnadka, PR; Li, YC; Rossi, KA; Myers, JE; Sheriff, S; Lou, Z; Harper, TW; Huang, C; Zheng, JJ; Bozarth, JM; Wu, Y; Wong, PC; Crain, EJ; Seiffert, DA; Luettgen, JM; Lam, PYS; Wexler, RR; Ewing, WR	Bristol-Myers Squibb Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514432	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514432&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155512946	440723014							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
917943	Cc1n[nH]c2C(CCc12)NC(=O)c1cnn(Cc2ccc(nc2C)N2CC3CC3C2)c1			448320	1-[(6-{3-Azabicyclo[3.1.0]hexan-3-yl}-2-methylpyridin-3-yl)methyl]-N-{3-methyl-1H,4H,5H,6H-cyclopenta[c]pyrazol-6-yl}-1H-pyrazole-4-carboxamide::US10695334, Example 1	Plasma kallikrein		 1.000								US Patent		10.7270/Q2VT1W4K		aid1804527	US10695334	Eckhardt, M; Gollner, A; Langkopf, E; Wagner, H; Wiedenmayer, D	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=448320	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=448320&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
917944	Cc1n[nH]c2[C@@H](CCc12)NC(=O)c1cnn(Cc2ccc(nc2C)N2CC3CC3C2)c1			448376	1-[(6-{3-Azabicyclo[3.1.0]hexan-3-yl}-2-methylpyridin-3-yl)methyl]-N-[(6R)-3-methyl-1H,4H,5H,6H- cyclopenta[c]pyrazol-6-yl]-1H-pyrazole-4-carboxamide::US10695334, Example 3	Plasma kallikrein		 0.500								US Patent		10.7270/Q2VT1W4K		aid1804527	US10695334	Eckhardt, M; Gollner, A; Langkopf, E; Wagner, H; Wiedenmayer, D	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=448376	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=448376&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
917945	Cc1n[nH]c2[C@@H](CCc12)NC(=O)c1cnn(Cc2ccc(nc2C)N2CC3C(C2)C3(F)F)c1			448377	1-[(6-{6,6-Difluoro-3-azabicyclo[3.1.0]hexan-3-yl}-2-methylpyridin-3-yl)methyl]-N-[(6R)-3-methyl-1H,4H,5H,6H-cyclopenta[c]pyrazol-6-yl]-1H-pyrazole-4-carboxamide::US10695334, Example 5	Plasma kallikrein		 0.300								US Patent		10.7270/Q2VT1W4K		aid1804527	US10695334	Eckhardt, M; Gollner, A; Langkopf, E; Wagner, H; Wiedenmayer, D	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=448377	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=448377&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
917946	Cc1n[nH]c2[C@@H](CCc12)NC(=O)c1cc(Cc2ccc(nc2C)N2CC3CC3C2)cs1			448378	4-[(6-{3-Azabicyclo[3.1.0]hexan-3-yl}-2-methylpyridin-3-yl)methyl]-N-[(6R)-3-methyl-1H,4H,5H,6H- cyclopenta[c]pyrazol-6-yl]thiophene-2-carboxamide::US10695334, Example 6	Plasma kallikrein		 0.500								US Patent		10.7270/Q2VT1W4K		aid1804527	US10695334	Eckhardt, M; Gollner, A; Langkopf, E; Wagner, H; Wiedenmayer, D	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=448378	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=448378&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
917947	Cc1nc(ccc1Cc1cc(C(O)=O)n(COCC[Si](C)(C)C)c1)N1CC2CC2C1	InChI=1S/C23H33N3O3Si/c1-16-18(5-6-22(24-16)25-13-19-11-20(19)14-25)9-17-10-21(23(27)28)26(12-17)15-29-7-8-30(2,3)4/h5-6,10,12,19-20H,7-9,11,13-15H2,1-4H3,(H,27,28)	BPFQHQGUCMVTKA-UHFFFAOYSA-N	448379	4-[(6-{3-Azabicyclo[3.1.0]hexan-3-yl}-2-methylpyridin-3-yl)methyl]-N-[(6R)-3-methyl-1H,4H,5H,6H- cyclopenta[c]pyrazol-6-yl]-1H-pyrrole-2-carboxamide::US10695334, Example 7	Plasma kallikrein		 0.700								US Patent		10.7270/Q2VT1W4K		aid1804527	US10695334	Eckhardt, M; Gollner, A; Langkopf, E; Wagner, H; Wiedenmayer, D	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=448379	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=448379&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
917948	Cc1n[nH]c2[C@@H](CCc12)NC(=O)c1cc(Cc2ccc(nc2C)N2CC3CC3C2)c(s1)C#N			448380	4-[(6-{3-Azabicyclo[3.1.0]hexan-3-yl}-2-methylpyridin-3-yl)methyl]-5-cyano-N-[(6R)-3-methyl-1H,4H,5H,6H-cyclopenta[c]pyrazol-6-yl]thiophene-2-carboxamide::US10695334, Example 8	Plasma kallikrein		 3.00								US Patent		10.7270/Q2VT1W4K		aid1804527	US10695334	Eckhardt, M; Gollner, A; Langkopf, E; Wagner, H; Wiedenmayer, D	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=448380	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=448380&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
917949	Cc1n[nH]c2[C@@H](CCc12)NC(=O)c1nnn(Cc2ccc(nc2C)N2CC3CC3C2)n1			448381	2-[(6-{3-Azabicyclo[3.1.0]hexan-3-yl}-2-methylpyridin-3-yl)methyl]-N-[(6R)-3-methyl-1H,4H,5H,6H- cyclopenta[c]pyrazol-6-yl]-2H-1,2,3,4-tetrazole-5-carboxamide::US10695334, Example 9	Plasma kallikrein		 5.00								US Patent		10.7270/Q2VT1W4K		aid1804527	US10695334	Eckhardt, M; Gollner, A; Langkopf, E; Wagner, H; Wiedenmayer, D	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=448381	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=448381&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
917950	Cc1n[nH]c2[C@@H](CCc12)NC(=O)c1cnn(Cc2ccc(nc2C)N2CC3(CC3)C2)c1			448382	1-[(6-{5-azaspiro[2.3]hexan-5-yl}-2-methylpyridin-3-ylmethyl]-N-[(6R)-3-methyl-1H,4H,5H,6H- cyclopenta[c]pyrazol-6-yl]-1H-pyrazole-4-carboxamide::US10695334, Example 11	Plasma kallikrein		 0.400								US Patent		10.7270/Q2VT1W4K		aid1804527	US10695334	Eckhardt, M; Gollner, A; Langkopf, E; Wagner, H; Wiedenmayer, D	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=448382	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=448382&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
917951	Cc1n[nH]c2[C@@H](CCc12)NC(=O)c1cn(Cc2ccc(nc2C)N2CC3CC3C2)nc1Cl			448383	1-[(6-{3-Azabicyclo[3.1.0]hexan-3-yl}-2-methylpyridin-3-yl)methyl]-3-chloro-N-[(6R)-3-methyl-1H,4H,5H,6H-cyclopenta[c]pyrazol-6-yl]-1H-pyrazole-4-carboxamide::US10695334, Example 12	Plasma kallikrein		 2.00								US Patent		10.7270/Q2VT1W4K		aid1804527	US10695334	Eckhardt, M; Gollner, A; Langkopf, E; Wagner, H; Wiedenmayer, D	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=448383	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=448383&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
917952	Cc1n[nH]c2[C@@H](CCc12)NC(=O)c1cn(Cc2ccc(nc2C)N2CC3C(C2)C3(F)F)c2ncncc12			448384	7-[(6-{6,6-Difluoro-3-azabicyclo[3.1.0]hexan-3-yl}-::US10695334, Example 13	Plasma kallikrein		 0.100								US Patent		10.7270/Q2VT1W4K		aid1804527	US10695334	Eckhardt, M; Gollner, A; Langkopf, E; Wagner, H; Wiedenmayer, D	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=448384	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=448384&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
917953	Cc1n[nH]c2[C@@H](CCc12)NC(=O)c1cn(Cc2ccc(nc2C)N2CC3CC3C2)nc1C(F)F			448385	1-[(6-{3-Azabicyclo[3.1.0]hexan-3-yl}-2-methyl-::US10695334, Example 14	Plasma kallikrein		 0.100								US Patent		10.7270/Q2VT1W4K		aid1804527	US10695334	Eckhardt, M; Gollner, A; Langkopf, E; Wagner, H; Wiedenmayer, D	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=448385	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=448385&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
917954	COCc1nn(Cc2ccc(nc2C)N2CC3C(C2)C3(F)F)cc1C(=O)N[C@@H]1CCc2c(C)n[nH]c12			448386	1-[(6-{6,6-Difluoro-3-azabicyclo[3.1.0]hexan-3-yl}-::US10695334, Example 15	Plasma kallikrein		 0.100								US Patent		10.7270/Q2VT1W4K		aid1804527	US10695334	Eckhardt, M; Gollner, A; Langkopf, E; Wagner, H; Wiedenmayer, D	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=448386	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=448386&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
917955	COCc1nn(Cc2ccc(nc2C)N2CC3CC3C2)cc1C(=O)N[C@@H]1CCc2c(C)n[nH]c12			448387	1-[(6-{3-Azabicyclo[3.1.0]hexan-3-yl}-2-methyl-::US10695334, Example 16	Plasma kallikrein		 0.100								US Patent		10.7270/Q2VT1W4K		aid1804527	US10695334	Eckhardt, M; Gollner, A; Langkopf, E; Wagner, H; Wiedenmayer, D	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=448387	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=448387&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
917956	Cc1n[nH]c2[C@@H](CCc12)NC(=O)c1cn(Cc2ccc(nc2C)N2CC3CC3C2)c2ncncc12			448388	7-[(6-{3-Azabicyclo[3.1.0]hexan-3-yl}-2-methyl-::US10695334, Example 17	Plasma kallikrein		 0.100								US Patent		10.7270/Q2VT1W4K		aid1804527	US10695334	Eckhardt, M; Gollner, A; Langkopf, E; Wagner, H; Wiedenmayer, D	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=448388	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=448388&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
917957	Cc1nn(Cc2ccc(nc2C)N2CC3C(C2)C3(F)F)cc1C(=O)N[C@@H]1CCc2c(C)n[nH]c12			448390	1-[(6-{6,6-Difluoro-3-azabicyclo[3.1.0]hexan-3-yl}-::US10695334, Example 18	Plasma kallikrein		 0.100								US Patent		10.7270/Q2VT1W4K		aid1804527	US10695334	Eckhardt, M; Gollner, A; Langkopf, E; Wagner, H; Wiedenmayer, D	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=448390	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=448390&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
917958	Cc1nn(Cc2ccc(nc2C)N2CC3CC3C2)cc1C(=O)N[C@@H]1CCc2c(C)n[nH]c12			448391	1-[(6-{3-Azabicyclo[3.1.0]hexan-3-yl}-2-methyl-::US10695334, Example 19	Plasma kallikrein		 0.300								US Patent		10.7270/Q2VT1W4K		aid1804527	US10695334	Eckhardt, M; Gollner, A; Langkopf, E; Wagner, H; Wiedenmayer, D	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=448391	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=448391&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
917959	COc1nn(Cc2ccc(nc2C)N2CC3CC3C2)cc1C(=O)N[C@@H]1CCc2c(C)n[nH]c12			448392	1-[(6-{3-Azabicyclo[3.1.0]hexan-3-yl}-2-methyl-::US10695334, Example 20	Plasma kallikrein		 0.200								US Patent		10.7270/Q2VT1W4K		aid1804527	US10695334	Eckhardt, M; Gollner, A; Langkopf, E; Wagner, H; Wiedenmayer, D	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=448392	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=448392&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
917960	Cc1n[nH]c2[C@@H](CCc12)NC(=O)c1cn(Cc2cnc(nc2C)N2CC3C(C2)C3(F)F)c2ncncc12			448393	7-[(2-{6,6-Difluoro-3-azabicyclo[3.1.0]hexan-3-yl}-::US10695334, Example 21	Plasma kallikrein		 0.100								US Patent		10.7270/Q2VT1W4K		aid1804527	US10695334	Eckhardt, M; Gollner, A; Langkopf, E; Wagner, H; Wiedenmayer, D	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=448393	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=448393&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
917961	COCc1nn(Cc2ccc(nc2C)N2CC3(CC3)C2)cc1C(=O)N[C@@H]1CCc2c(C)n[nH]c12			448394	1-[(6-{5-Azaspiro[2.3]hexan-5-yl}-2-methylpyridin-::US10695334, Example 22	Plasma kallikrein		 0.100								US Patent		10.7270/Q2VT1W4K		aid1804527	US10695334	Eckhardt, M; Gollner, A; Langkopf, E; Wagner, H; Wiedenmayer, D	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=448394	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=448394&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
917962	Cc1n[nH]c2[C@@H](CCc12)NC(=O)c1cn(Cc2cnc(nc2C)N2CC3CC3C2)c2ncncc12			448395	7-[(2-{3-Azabicyclo[3.1.0]hexan-3-yl}-4-methyl-::US10695334, Example 23	Plasma kallikrein		 0.300								US Patent		10.7270/Q2VT1W4K		aid1804527	US10695334	Eckhardt, M; Gollner, A; Langkopf, E; Wagner, H; Wiedenmayer, D	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=448395	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=448395&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
917963	Cc1[nH]nc2[C@@H](CCc12)NC(=O)c1cnn(Cc2ccc(nc2C)N2CCC(C)(C)C2)c1			448396	1{[6-(3,3-Dimethylpyrrolidin-1-yl)-2-methylpyridin-3-yl]methyl}-N-[(6R)-3-methyl-2H,4H,5H,6H-::US10695334, Example 35	Plasma kallikrein		 0.900								US Patent		10.7270/Q2VT1W4K		aid1804527	US10695334	Eckhardt, M; Gollner, A; Langkopf, E; Wagner, H; Wiedenmayer, D	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=448396	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=448396&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
917964	Cc1[nH]nc2[C@@H](CCc12)NC(=O)c1cnn(Cc2ccc(nc2C)N2CCC3(CCC3)C2)c1			448397	1-[(6-{6-Azaspiro[3.4]octan-6-yl}-2-methylpyridin-3-yl)methyl]-N-[(6R)-3-methyl-2H,4H,5H,6H-::US10695334, Example 36	Plasma kallikrein		 1.000								US Patent		10.7270/Q2VT1W4K		aid1804527	US10695334	Eckhardt, M; Gollner, A; Langkopf, E; Wagner, H; Wiedenmayer, D	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=448397	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=448397&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
917965	Cc1[nH]nc2[C@@H](CCc12)NC(=O)c1cnn(Cc2ccc(nc2C)N2CCC(F)(F)C2)c1			448398	1-{[6-(3,3-Difluoropyrrolidin-1-yl)-2-methylpyridin-3-yl]methyl}-N-[(6R)-3-methyl-2H,4H,5H,6H-::US10695334, Example 37	Plasma kallikrein		 2.00								US Patent		10.7270/Q2VT1W4K		aid1804527	US10695334	Eckhardt, M; Gollner, A; Langkopf, E; Wagner, H; Wiedenmayer, D	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=448398	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=448398&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
917966	Cc1[nH]nc2[C@@H](CCc12)NC(=O)c1cnn(Cc2ccc(nc2C)N2CCC(C2)C(F)F)c1			448399	1-({6-[3-(Difluoromethyl)pyrrolidin-1-yl]-2-methylpyridin-3-yl}methyl)-N-[(6R)-3-methyl-2H,4H,5H,6H-::US10695334, Example 46	Plasma kallikrein		 1.000								US Patent		10.7270/Q2VT1W4K		aid1804527	US10695334	Eckhardt, M; Gollner, A; Langkopf, E; Wagner, H; Wiedenmayer, D	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=448399	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=448399&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
917967	C[C@@H]1[C@@H]2CN(C[C@H]12)c1ccc(Cn2cc(cn2)C(=O)N[C@@H]2CCc3c(C)[nH]nc23)c(C)n1			448400	N-[(6R)-3-Methyl-2H,4H,5H,6H-cyclopenta[c]pyrazol-6-yl]-1-({2-methyl-6-[(1R,5S,6S)-6-methyl-3-::US10695334, Example 47	Plasma kallikrein		 0.400								US Patent		10.7270/Q2VT1W4K		aid1804527	US10695334	Eckhardt, M; Gollner, A; Langkopf, E; Wagner, H; Wiedenmayer, D	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=448400	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=448400&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
917981	Cc1[nH]nc2[C@@H](CCc12)NC(=O)c1cn(Cc2ccc(nc2)N2CC3CC3C2)cn1			448414	1-[(6-{3-Azabicyclo[3.1.0]hexan-3-yl}pyridin-3-yl)-::US10695334, Example 103	Plasma kallikrein		 3.00								US Patent		10.7270/Q2VT1W4K		aid1804527	US10695334	Eckhardt, M; Gollner, A; Langkopf, E; Wagner, H; Wiedenmayer, D	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=448414	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=448414&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
917982	Cc1[nH]nc2[C@@H](CCc12)NC(=O)c1cn(Cc2ccc(nc2)N2CC3(CC3)C2)cn1			448415	1-[(6-{5-Azaspiro[2.3]hexan-5-yl}pyridin-3-yl)-::US10695334, Example 104	Plasma kallikrein		 3.00								US Patent		10.7270/Q2VT1W4K		aid1804527	US10695334	Eckhardt, M; Gollner, A; Langkopf, E; Wagner, H; Wiedenmayer, D	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=448415	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=448415&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
917983	Cc1[nH]nc2C(CCc12)NC(=O)c1cn(Cc2ccc(nc2C#N)N2CC3CC3C2)cn1			448416	1-[(6-{3-Azabicyclo[3.1.0]hexan-3-yl}-2-cyano-::US10695334, Example 105	Plasma kallikrein		 1.000								US Patent		10.7270/Q2VT1W4K		aid1804527	US10695334	Eckhardt, M; Gollner, A; Langkopf, E; Wagner, H; Wiedenmayer, D	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=448416	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=448416&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
917984	COC(=O)c1ccc2n(Cc3ccc(nc3C)N3CC4CC4C3)cc(C(=O)N[C@@H]3CCc4c(C)n(COCC[Si](C)(C)C)nc34)c2c1	InChI=1S/C36H46N6O4Si/c1-22-25(8-12-33(37-22)41-18-26-15-27(26)19-41)17-40-20-30(29-16-24(36(44)45-3)7-11-32(29)40)35(43)38-31-10-9-28-23(2)42(39-34(28)31)21-46-13-14-47(4,5)6/h7-8,11-12,16,20,26-27,31H,9-10,13-15,17-19,21H2,1-6H3,(H,38,43)/t26?,27?,31-/m1/s1	DLXGKYRJWVKYSS-ZGPWAXATSA-N	448417	1-[(6-{3-Azabicyclo[3.1.0]hexan-3-yl}-2-methylpyridin-3-yl)methyl]-3-{[(6R)-3-methyl-2H,4H,5H,6H-cyclopenta[c]pyrazol-6-yl]carbamoyl}-1H-indole-5-carboxylic acid::US10695334, Example 108	Plasma kallikrein		 6.00								US Patent		10.7270/Q2VT1W4K		aid1804527	US10695334	Eckhardt, M; Gollner, A; Langkopf, E; Wagner, H; Wiedenmayer, D	Boehringer Ingelheim International GmbH	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=448417	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=448417&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51229177	CCOC(=O)[C@]1(C)CCC[C@@]2(C)[C@@H]3CC[C@@]4(C)C[C@@]3(C\C4=N/OCc3ccsc3)CC[C@H]12	InChI=1S/C27H39NO3S/c1-5-30-23(29)26(4)11-6-10-25(3)20(26)8-13-27-15-22(24(2,18-27)12-7-21(25)27)28-31-16-19-9-14-32-17-19/h9,14,17,20-21H,5-8,10-13,15-16,18H2,1-4H3/b28-22+/t20-,21-,24-,25+,26+,27-/m0/s1	BYWYOMPEDCPVLV-UZDFUANBSA-N	50504369	CHEMBL4439549	Plasma kallikrein		 2205								ChEMBL	10.1016/j.ejmech.2019.111722	10.7270/Q2891943	31563807			Chen, P; Zhang, D; Li, M; Wu, Q; Lam, YPY; Guo, Y; Chen, C; Bai, N; Malhotra, S; Li, W; O'Connor, PB; Fu, H	Peking University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50504369	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50504369&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155513907	440712954							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51229188	CCOC(=O)[C@]1(C)CCC[C@@]2(C)[C@@H]3CC[C@@]4(C)C[C@@]3(C\C4=N/OCC3(C)COC3)CC[C@H]12	InChI=1S/C27H43NO4/c1-6-31-22(29)26(5)11-7-10-25(4)19(26)9-13-27-14-21(24(3,15-27)12-8-20(25)27)28-32-18-23(2)16-30-17-23/h19-20H,6-18H2,1-5H3/b28-21+/t19-,20-,24-,25+,26+,27-/m0/s1	MKKNODUCOLIUJT-DPZKWCDVSA-N	50504368	CHEMBL4435573	Plasma kallikrein		 277								ChEMBL	10.1016/j.ejmech.2019.111722	10.7270/Q2891943	31563807			Chen, P; Zhang, D; Li, M; Wu, Q; Lam, YPY; Guo, Y; Chen, C; Bai, N; Malhotra, S; Li, W; O'Connor, PB; Fu, H	Peking University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50504368	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50504368&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155511394	440712953							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51240264	CC[C@H](C)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]4CCCN4C(=O)[C@@H]4CSSC[C@H](NC(=O)[C@H](Cc5ccc(O)cc5)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC1=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N4)NC(=O)[C@@H](NC3=O)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N2	InChI=1S/C136H220N46O44S6/c1-10-66(7)105-130(223)170-77(43-64(3)4)118(211)164-72(23-12-15-35-137)113(206)162-73(24-13-16-36-138)116(209)174-87-59-228-229-60-88-125(218)161-71(26-18-38-147-134(141)142)108(201)150-50-97(190)158-79(45-94(140)187)109(202)151-51-96(189)157-78(44-69-31-33-70(186)34-32-69)119(212)173-86-58-227-231-62-90(176-121(214)82(48-103(198)199)169-123(216)85(57-185)171-120(213)81(47-102(196)197)168-115(208)76(28-20-40-149-136(145)146)163-114(207)75(165-124(87)217)27-19-39-148-135(143)144)132(225)181-41-21-29-92(181)127(220)155-49-95(188)156-68(9)107(200)172-89(126(219)180-106(67(8)11-2)131(224)175-88)61-230-232-63-91(133(226)182-42-22-30-93(182)128(221)166-74(117(210)179-105)25-14-17-37-139)177-129(222)104(65(5)6)178-100(193)54-152-110(203)80(46-101(194)195)167-122(215)84(56-184)160-99(192)52-153-111(204)83(55-183)159-98(191)53-154-112(86)205/h31-34,64-68,71-93,104-106,183-186H,10-30,35-63,137-139H2,1-9H3,(H2,140,187)(H,150,201)(H,151,202)(H,152,203)(H,153,204)(H,154,205)(H,155,220)(H,156,188)(H,157,189)(H,158,190)(H,159,191)(H,160,192)(H,161,218)(H,162,206)(H,163,207)(H,164,211)(H,165,217)(H,166,221)(H,167,215)(H,168,208)(H,169,216)(H,170,223)(H,171,213)(H,172,200)(H,173,212)(H,174,209)(H,175,224)(H,176,214)(H,177,222)(H,178,193)(H,179,210)(H,180,219)(H,194,195)(H,196,197)(H,198,199)(H4,141,142,147)(H4,143,144,148)(H4,145,146,149)/t66-,67-,68-,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,104-,105-,106-/m0/s1	WBFBQDAAAKLBHB-ONJFZGEYSA-N	50507483	CHEMBL4530379	Plasma kallikrein		>10000								ChEMBL	10.1021/acsmedchemlett.8b00422	10.7270/Q2Q81HCD	30613336			Swedberg, JE; Ghani, HA; Harris, JM; de Veer, SJ; Craik, DJ	The University of Queensland	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50507483	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50507483&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155545897	440716068							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51240273	CC[C@H](C)[C@@H]1NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]4CCCN4C(=O)[C@@H]4CSSC[C@H](NC(=O)[C@H](Cc5ccc(O)cc5)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC1=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N4)NC(=O)[C@@H](NC3=O)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N2	InChI=1S/C142H224N50O46S6/c1-8-68(5)110-136(236)182-81(44-67(3)4)124(224)176-75(24-13-15-37-143)118(218)173-76(25-14-16-38-144)121(221)186-92-62-240-242-64-94-133(233)172-74(26-17-39-155-139(147)148)113(213)161-54-104(203)169-84(47-99(146)198)114(214)162-55-103(202)168-83(46-72-31-33-73(196)34-32-72)125(225)185-91-61-239-244-66-96(189-128(228)87(50-109(210)211)181-130(230)90(60-195)183-127(227)86(49-108(208)209)180-120(220)78(28-19-41-157-141(151)152)174-119(219)77(177-131(92)231)27-18-40-156-140(149)150)138(238)192-43-21-30-97(192)135(235)165-53-101(200)166-70(7)112(212)184-95(134(234)191-111(69(6)9-2)137(237)188-94)65-243-241-63-93(132(232)178-80(35-36-98(145)197)122(222)175-79(123(223)190-110)29-20-42-158-142(153)154)187-126(226)82(45-71-22-11-10-12-23-71)167-102(201)52-159-100(199)51-160-115(215)85(48-107(206)207)179-129(229)89(59-194)171-106(205)56-163-116(216)88(58-193)170-105(204)57-164-117(91)217/h10-12,22-23,31-34,67-70,74-97,110-111,193-196H,8-9,13-21,24-30,35-66,143-144H2,1-7H3,(H2,145,197)(H2,146,198)(H,159,199)(H,160,215)(H,161,213)(H,162,214)(H,163,216)(H,164,217)(H,165,235)(H,166,200)(H,167,201)(H,168,202)(H,169,203)(H,170,204)(H,171,205)(H,172,233)(H,173,218)(H,174,219)(H,175,222)(H,176,224)(H,177,231)(H,178,232)(H,179,229)(H,180,220)(H,181,230)(H,182,236)(H,183,227)(H,184,212)(H,185,225)(H,186,221)(H,187,226)(H,188,237)(H,189,228)(H,190,223)(H,191,234)(H,206,207)(H,208,209)(H,210,211)(H4,147,148,155)(H4,149,150,156)(H4,151,152,157)(H4,153,154,158)/t68-,69-,70-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,110-,111-/m0/s1	WONGRAWCJSVHOJ-GYRZNHFHSA-N	50507481	CHEMBL4564063	Plasma kallikrein		>10000								ChEMBL	10.1021/acsmedchemlett.8b00422	10.7270/Q2Q81HCD	30613336			Swedberg, JE; Ghani, HA; Harris, JM; de Veer, SJ; Craik, DJ	The University of Queensland	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50507481	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50507481&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155559920	440716066							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51240277	CC[C@H](C)[C@@H]1NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]4CCCN4C(=O)[C@@H]4CSSC[C@H](NC(=O)[C@H](Cc5ccc(O)cc5)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC1=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N4)NC(=O)[C@@H](NC3=O)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N2	InChI=1S/C138H208N44O50S6/c1-8-63(5)109-135(230)172-76(39-62(3)4)123(218)166-71(26-31-93(140)187)118(213)165-75(30-35-97(144)191)121(216)176-87-57-234-236-59-89-132(227)162-69(19-13-14-36-139)112(207)151-49-103(197)159-79(42-98(145)192)113(208)152-50-102(196)158-78(41-67-22-24-68(186)25-23-67)124(219)175-86-56-233-238-61-91(179-127(222)82(45-108(204)205)171-129(224)85(55-185)173-126(221)81(44-107(202)203)170-120(215)74(29-34-96(143)190)164-119(214)73(168-130(87)225)28-33-95(142)189)137(232)182-38-16-21-92(182)134(229)155-48-100(194)156-65(7)111(206)174-90(133(228)181-110(64(6)9-2)136(231)178-89)60-237-235-58-88(131(226)167-72(27-32-94(141)188)117(212)163-70(122(217)180-109)20-15-37-148-138(146)147)177-125(220)77(40-66-17-11-10-12-18-66)157-101(195)47-149-99(193)46-150-114(209)80(43-106(200)201)169-128(223)84(54-184)161-105(199)51-153-115(210)83(53-183)160-104(198)52-154-116(86)211/h10-12,17-18,22-25,62-65,69-92,109-110,183-186H,8-9,13-16,19-21,26-61,139H2,1-7H3,(H2,140,187)(H2,141,188)(H2,142,189)(H2,143,190)(H2,144,191)(H2,145,192)(H,149,193)(H,150,209)(H,151,207)(H,152,208)(H,153,210)(H,154,211)(H,155,229)(H,156,194)(H,157,195)(H,158,196)(H,159,197)(H,160,198)(H,161,199)(H,162,227)(H,163,212)(H,164,214)(H,165,213)(H,166,218)(H,167,226)(H,168,225)(H,169,223)(H,170,215)(H,171,224)(H,172,230)(H,173,221)(H,174,206)(H,175,219)(H,176,216)(H,177,220)(H,178,231)(H,179,222)(H,180,217)(H,181,228)(H,200,201)(H,202,203)(H,204,205)(H4,146,147,148)/t63-,64-,65-,69-,70-,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,109-,110-/m0/s1	KHTRPJFHQNRISN-SUQRTAHISA-N	50507482	CHEMBL4531700	Plasma kallikrein		>10000								ChEMBL	10.1021/acsmedchemlett.8b00422	10.7270/Q2Q81HCD	30613336			Swedberg, JE; Ghani, HA; Harris, JM; de Veer, SJ; Craik, DJ	The University of Queensland	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50507482	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50507482&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155546346	440716067							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51257810	NC(=N)c1ccc(CNC(=O)[C@H](CCC2CCNCC2)NC(=O)[C@@H](CCC2CCN(CC2)C(=O)C2CC2)NS(=O)(=O)Cc2ccccc2)cc1	InChI=1S/C37H53N7O5S/c38-34(39)30-10-6-28(7-11-30)24-41-35(45)32(14-8-26-16-20-40-21-17-26)42-36(46)33(43-50(48,49)25-29-4-2-1-3-5-29)15-9-27-18-22-44(23-19-27)37(47)31-12-13-31/h1-7,10-11,26-27,31-33,40,43H,8-9,12-25H2,(H3,38,39)(H,41,45)(H,42,46)/t32-,33+/m0/s1	DIFGLRSYVDIDJS-JHOUSYSJSA-N	108098	US8598206, Table 6, 7	Plasma kallikrein		 0.300000								ChEMBL	10.1021/acs.jmedchem.9b01060	10.7270/Q2VQ361P	31658420			Steinmetzer, T; Pilgram, O; Wenzel, BM; Wiedemeyer, SJA	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=108098	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=108098&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			53345968	186524968							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51257839	Cc1cc2c(cc1-c1ccc(C[C@H](NC(=O)[C@H]3CC[C@H](CN)CC3)C(=O)Nc3cc(Cl)c4[nH]c(=O)[nH]c4c3)cc1)[nH]cc(C(O)=O)c2=O	InChI=1S/C35H35ClN6O6/c1-17-10-24-27(38-16-25(31(24)43)34(46)47)14-23(17)20-6-2-18(3-7-20)11-29(40-32(44)21-8-4-19(15-37)5-9-21)33(45)39-22-12-26(36)30-28(13-22)41-35(48)42-30/h2-3,6-7,10,12-14,16,19,21,29H,4-5,8-9,11,15,37H2,1H3,(H,38,43)(H,39,45)(H,40,44)(H,46,47)(H2,41,42,48)/t19-,21-,29-/m0/s1	MRERGFSFJIIPPV-ZIEGJXHLSA-N	50514078	CHEMBL4582882	Plasma kallikrein			 0.700000							ChEMBL	10.1021/acs.jmedchem.9b01060	10.7270/Q2VQ361P	31658420			Steinmetzer, T; Pilgram, O; Wenzel, BM; Wiedemeyer, SJA	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514078	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514078&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			122550417	440722660							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51257847	NCc1cccc(C[C@H](NC(=O)[C@@H](CCCc2ccccc2)NS(=O)(=O)Cc2cccc(c2)C(O)=O)C(=O)NCc2ccc(cc2)C(N)=N)c1	InChI=1S/C37H42N6O6S/c38-22-28-11-4-10-27(19-28)21-33(35(44)41-23-26-15-17-30(18-16-26)34(39)40)42-36(45)32(14-6-9-25-7-2-1-3-8-25)43-50(48,49)24-29-12-5-13-31(20-29)37(46)47/h1-5,7-8,10-13,15-20,32-33,43H,6,9,14,21-24,38H2,(H3,39,40)(H,41,44)(H,42,45)(H,46,47)/t32-,33+/m1/s1	BHQDUYVBGREBCB-SAIUNTKASA-N	50514081	CHEMBL4471466	Plasma kallikrein		 0.019000								ChEMBL	10.1021/acs.jmedchem.9b01060	10.7270/Q2VQ361P	31658420			Steinmetzer, T; Pilgram, O; Wenzel, BM; Wiedemeyer, SJA	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514081	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514081&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			70306716	440722663							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51257851	NC(=N)c1ccc(CNC(=O)[C@H](CCc2ccncc2)NC(=O)[C@@H](CCCc2ccccc2)NS(=O)(=O)Cc2ccccc2)cc1	InChI=1S/C35H40N6O4S/c36-33(37)30-17-14-28(15-18-30)24-39-34(42)31(19-16-27-20-22-38-23-21-27)40-35(43)32(13-7-12-26-8-3-1-4-9-26)41-46(44,45)25-29-10-5-2-6-11-29/h1-6,8-11,14-15,17-18,20-23,31-32,41H,7,12-13,16,19,24-25H2,(H3,36,37)(H,39,42)(H,40,43)/t31-,32+/m0/s1	OUGUMFKJMHXPKT-AJQTZOPKSA-N	50514082	CHEMBL4462811	Plasma kallikrein		 0.600000								ChEMBL	10.1021/acs.jmedchem.9b01060	10.7270/Q2VQ361P	31658420			Steinmetzer, T; Pilgram, O; Wenzel, BM; Wiedemeyer, SJA	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514082	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514082&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155529536	440722664							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51257858	NC(=N)c1ccc(CNC(=O)[C@H](CCC2CCNCC2)NC(=O)[C@@H](CCC2CCNCC2)NS(=O)(=O)Cc2ccccc2)cc1	InChI=1S/C33H49N7O4S/c34-31(35)28-10-6-26(7-11-28)22-38-32(41)29(12-8-24-14-18-36-19-15-24)39-33(42)30(13-9-25-16-20-37-21-17-25)40-45(43,44)23-27-4-2-1-3-5-27/h1-7,10-11,24-25,29-30,36-37,40H,8-9,12-23H2,(H3,34,35)(H,38,41)(H,39,42)/t29-,30+/m0/s1	ZTJVQQCXGUIYTL-XZWHSSHBSA-N	108101	US8598206, Table 6, 10	Plasma kallikrein		 7.5								ChEMBL	10.1021/acs.jmedchem.9b01060	10.7270/Q2VQ361P	31658420			Steinmetzer, T; Pilgram, O; Wenzel, BM; Wiedemeyer, SJA	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=108101	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=108101&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			53346181	186524971							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51257871	CNC(=O)c1ccc(NC(=O)[C@H](Cc2ccc(cc2)-c2cc3[nH]cc(C(O)=O)c(=O)c3cc2C)NC(=O)[C@H]2CC[C@H](CN)CC2)cc1Cl	InChI=1S/C36H38ClN5O6/c1-19-13-27-30(40-18-28(32(27)43)36(47)48)16-26(19)22-7-3-20(4-8-22)14-31(42-33(44)23-9-5-21(17-38)6-10-23)35(46)41-24-11-12-25(29(37)15-24)34(45)39-2/h3-4,7-8,11-13,15-16,18,21,23,31H,5-6,9-10,14,17,38H2,1-2H3,(H,39,45)(H,40,43)(H,41,46)(H,42,44)(H,47,48)/t21-,23-,31-/m0/s1	LCMPWMFTZAUSIJ-KOVHPOKXSA-N	50514077	CHEMBL4475211	Plasma kallikrein			 8.5							ChEMBL	10.1021/acs.jmedchem.9b01060	10.7270/Q2VQ361P	31658420			Steinmetzer, T; Pilgram, O; Wenzel, BM; Wiedemeyer, SJA	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514077	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514077&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			122550396	440722659							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51257872	CC(C)c1nc2cc(C)c(cc2[nH]1)-c1ccc(C[C@H](NC(=O)[C@H]2CC[C@H](CN)CC2)C(=O)Nc2ccc(cc2)-c2nnc([nH]2)C(F)(F)C(F)(F)C(O)=O)cc1	InChI=1S/C39H42F4N8O4/c1-20(2)32-46-29-16-21(3)28(18-30(29)47-32)24-8-4-22(5-9-24)17-31(48-34(52)26-10-6-23(19-44)7-11-26)35(53)45-27-14-12-25(13-15-27)33-49-36(51-50-33)38(40,41)39(42,43)37(54)55/h4-5,8-9,12-16,18,20,23,26,31H,6-7,10-11,17,19,44H2,1-3H3,(H,45,53)(H,46,47)(H,48,52)(H,54,55)(H,49,50,51)/t23-,26-,31-/m0/s1	DNNZYGQJIKJSHH-NEEWURRISA-N	50514079	CHEMBL4449958	Plasma kallikrein			 7.2							ChEMBL	10.1021/acs.jmedchem.9b01060	10.7270/Q2VQ361P	31658420			Steinmetzer, T; Pilgram, O; Wenzel, BM; Wiedemeyer, SJA	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514079	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514079&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117986603	440722661							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51257875	NC(=N)c1ccc(CNC(=O)[C@H](CCC2CCNCC2)NC(=O)[C@@H](CCCc2ccccc2)NS(=O)(=O)Cc2ccccc2)cc1	InChI=1S/C35H46N6O4S/c36-33(37)30-17-14-28(15-18-30)24-39-34(42)31(19-16-27-20-22-38-23-21-27)40-35(43)32(13-7-12-26-8-3-1-4-9-26)41-46(44,45)25-29-10-5-2-6-11-29/h1-6,8-11,14-15,17-18,27,31-32,38,41H,7,12-13,16,19-25H2,(H3,36,37)(H,39,42)(H,40,43)/t31-,32+/m0/s1	MCDKKKIUEGNSPK-AJQTZOPKSA-N	108110	US8598206, Table 6, 19	Plasma kallikrein		 1.5								ChEMBL	10.1021/acs.jmedchem.9b01060	10.7270/Q2VQ361P	31658420			Steinmetzer, T; Pilgram, O; Wenzel, BM; Wiedemeyer, SJA	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=108110	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=108110&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			53345652	186524980							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51257887	CC(C)c1nc2nc(C)c(cc2[nH]1)-c1ccc(C[C@H](NC(=O)[C@H]2CC[C@H](CN)CC2)C(=O)Nc2ccc(cc2)-c2nnc([nH]2)C(F)(F)C(F)(F)C(O)=O)cc1	InChI=1S/C38H41F4N9O4/c1-19(2)30-46-28-17-27(20(3)44-32(28)48-30)23-8-4-21(5-9-23)16-29(47-33(52)25-10-6-22(18-43)7-11-25)34(53)45-26-14-12-24(13-15-26)31-49-35(51-50-31)37(39,40)38(41,42)36(54)55/h4-5,8-9,12-15,17,19,22,25,29H,6-7,10-11,16,18,43H2,1-3H3,(H,45,53)(H,47,52)(H,54,55)(H,44,46,48)(H,49,50,51)/t22-,25-,29-/m0/s1	ZJYAXUISSVXYQC-HTLVZCCDSA-N	50514063	CHEMBL4447001	Plasma kallikrein			 1.7							ChEMBL	10.1021/acs.jmedchem.9b01060	10.7270/Q2VQ361P	31658420			Steinmetzer, T; Pilgram, O; Wenzel, BM; Wiedemeyer, SJA	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514063	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514063&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			122551266	440722645							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51257901	NCc1cccc(C[C@H](NC(=O)[C@@H](Cc2ccc3ccccc3c2)NS(=O)(=O)Cc2ccccc2)C(=O)NCc2ccc(cc2)C(N)=N)c1	InChI=1S/C38H40N6O4S/c39-23-30-10-6-9-28(19-30)21-34(37(45)42-24-26-13-17-32(18-14-26)36(40)41)43-38(46)35(44-49(47,48)25-27-7-2-1-3-8-27)22-29-15-16-31-11-4-5-12-33(31)20-29/h1-20,34-35,44H,21-25,39H2,(H3,40,41)(H,42,45)(H,43,46)/t34-,35+/m0/s1	XGUFEENWPFGFKD-OIDHKYIRSA-N	50514086	CHEMBL4524734	Plasma kallikrein		 0.100000								ChEMBL	10.1021/acs.jmedchem.9b01060	10.7270/Q2VQ361P	31658420			Steinmetzer, T; Pilgram, O; Wenzel, BM; Wiedemeyer, SJA	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514086	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514086&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			24984725	440722668							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51269151	CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CSSC[C@H](NC1=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N2	InChI=1S/C72H107N19O18S2/c1-3-40(2)58-68(106)87-52-39-111-110-38-51(86-60(98)44(19-11-29-77-72(75)76)79-56(94)36-78-59(97)48(35-57(95)96)83-66(104)53-20-12-30-89(53)70(108)49(84-65(52)103)34-41-15-5-4-6-16-41)64(102)82-47(33-42-23-25-43(93)26-24-42)62(100)80-45(17-7-9-27-73)61(99)85-50(37-92)63(101)81-46(18-8-10-28-74)69(107)91-32-14-22-55(91)71(109)90-31-13-21-54(90)67(105)88-58/h4-6,15-16,23-26,40,44-55,58,92-93H,3,7-14,17-22,27-39,73-74H2,1-2H3,(H,78,97)(H,79,94)(H,80,100)(H,81,101)(H,82,102)(H,83,104)(H,84,103)(H,85,99)(H,86,98)(H,87,106)(H,88,105)(H,95,96)(H4,75,76,77)/t40-,44-,45-,46-,47-,48-,49-,50-,51-,52-,53-,54-,55-,58-/m0/s1	NMQUIMIHINHOMQ-FROOAQRNSA-N	50518240	CHEMBL4439523	Plasma kallikrein		>50000								ChEMBL	10.1021/acs.jmedchem.8b01139	10.7270/Q2MS3X3S	30520638			Swedberg, JE; Wu, G; Mahatmanto, T; Durek, T; Caradoc-Davies, TT; Whisstock, JC; Law, RHP; Craik, DJ	The University of Queensland	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50518240	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50518240&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155514020	440726822							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51269152	CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CSSC[C@H](NC1=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N2	InChI=1S/C72H107N21O18S2/c1-3-39(2)57-67(108)89-51-38-113-112-37-50(88-59(100)43(17-9-27-78-71(74)75)81-55(96)35-80-58(99)47(34-56(97)98)85-65(106)52-19-11-29-91(52)69(110)48(86-64(51)105)33-40-14-5-4-6-15-40)63(104)84-46(32-41-22-24-42(95)25-23-41)61(102)82-44(16-7-8-26-73)60(101)87-49(36-94)62(103)83-45(18-10-28-79-72(76)77)68(109)93-31-13-21-54(93)70(111)92-30-12-20-53(92)66(107)90-57/h4-6,14-15,22-25,39,43-54,57,94-95H,3,7-13,16-21,26-38,73H2,1-2H3,(H,80,99)(H,81,96)(H,82,102)(H,83,103)(H,84,104)(H,85,106)(H,86,105)(H,87,101)(H,88,100)(H,89,108)(H,90,107)(H,97,98)(H4,74,75,78)(H4,76,77,79)/t39-,43-,44-,45-,46-,47-,48-,49-,50-,51-,52-,53-,54-,57-/m0/s1	QNIDBHORVMQSDP-UFUSHNEESA-N	50518241	CHEMBL4569923	Plasma kallikrein		>50000								ChEMBL	10.1021/acs.jmedchem.8b01139	10.7270/Q2MS3X3S	30520638			Swedberg, JE; Wu, G; Mahatmanto, T; Durek, T; Caradoc-Davies, TT; Whisstock, JC; Law, RHP; Craik, DJ	The University of Queensland	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50518241	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50518241&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155551858	440726823							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51269158	CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CSSC[C@H](NC1=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N2)[C@@H](C)CC	InChI=1S/C72H106N18O18S2/c1-5-39(3)57-68(105)85-51-38-110-109-37-50(84-60(97)44(19-12-28-76-72(74)75)78-55(93)35-77-59(96)47(34-56(94)95)81-66(103)52-20-13-29-88(52)69(106)48(82-65(51)102)33-41-16-8-7-9-17-41)64(101)80-46(32-42-23-25-43(92)26-24-42)62(99)79-45(18-10-11-27-73)61(98)83-49(36-91)63(100)87-58(40(4)6-2)71(108)90-31-15-22-54(90)70(107)89-30-14-21-53(89)67(104)86-57/h7-9,16-17,23-26,39-40,44-54,57-58,91-92H,5-6,10-15,18-22,27-38,73H2,1-4H3,(H,77,96)(H,78,93)(H,79,99)(H,80,101)(H,81,103)(H,82,102)(H,83,98)(H,84,97)(H,85,105)(H,86,104)(H,87,100)(H,94,95)(H4,74,75,76)/t39-,40-,44-,45-,46-,47-,48-,49-,50-,51-,52-,53-,54-,57-,58-/m0/s1	LIELEUWQJRVBAG-IEBOQBBFSA-N	50518249	CHEMBL4588827	Plasma kallikrein		 32000								ChEMBL	10.1021/acs.jmedchem.8b01139	10.7270/Q2MS3X3S	30520638			Swedberg, JE; Wu, G; Mahatmanto, T; Durek, T; Caradoc-Davies, TT; Whisstock, JC; Law, RHP; Craik, DJ	The University of Queensland	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50518249	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50518249&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155567613	440726831							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915438	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C28H26F3N5O2/c29-28(30,31)25-15-24(36(35-25)22-8-3-5-19(13-22)16-32)27(37)34-21-7-4-6-20(14-21)26(38-17-18-10-11-18)23-9-1-2-12-33-23/h1-9,12-15,18,26H,10-11,16-17,32H2,(H,34,37)	UBQUVYTUKOFUOF-UHFFFAOYSA-N	416721	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(pyridin-2-yl)methyl)-phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 43f::US10633345, Compound 43f::US10689346, Compound 43g::US11203574, Compound 43h::US11230530, Compound 43h::US11685721, Compound 43f	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416721	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416721&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355947	433916635							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915439	CN(C(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1)C1CC1	InChI=1S/C30H26F4N6O/c1-39(22-9-10-22)28(20-6-2-4-18(12-20)16-35)21-8-11-24(31)25(14-21)37-29(41)26-15-27(30(32,33)34)38-40(26)23-7-3-5-19(13-23)17-36/h2-8,11-15,22,28H,9-10,17,36H2,1H3,(H,37,41)	LONUELZOBAIWEW-UHFFFAOYSA-N	439471	US10633345, Compound 54e::US10633345, Compound 70a::US10633345, Compound 70b::US10689346, Compound 70a::US11203574, Compound 70b::US11230530, Compound 70b	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439471	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439471&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355805	439661023							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915440	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(O)c(Br)c1)C(F)(F)F	InChI=1S/C29H27BrF3N5O2/c30-23-13-20(9-10-25(23)39)27(35-16-17-7-8-17)19-4-2-5-21(12-19)36-28(40)24-14-26(29(31,32)33)37-38(24)22-6-1-3-18(11-22)15-34/h1-6,9-14,17,27,35,39H,7-8,15-16,34H2,(H,36,40)	VZKYGMDBRSVHHT-UHFFFAOYSA-N	416930	1-(3-(Aminomethyl)phenyl)-N-(3-((3-bromo-4-hydroxyphenyl)(cyclopropylmethylamino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 207j::US10633345, Compound 207j::US10689346, Compound 207j::US11203574, Compound 207j::US11230530, Compound 207j::US11685721, Compound 207j	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416930	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416930&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665574	433916842							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915441	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H26F3N5O2/c29-28(30,31)25-14-24(36(35-25)23-8-1-4-19(12-23)15-32)27(37)34-22-7-2-5-20(13-22)26(38-17-18-9-10-18)21-6-3-11-33-16-21/h1-8,11-14,16,18,26H,9-10,15,17,32H2,(H,34,37)	SHFRWTHPPCXLER-UHFFFAOYSA-N	416725	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(pyridin-3-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 44c::US10633345, Compound 44c::US10689346, Compound 44c::US11203574, Compound 44d::US11230530, Compound 44e::US11685721, Compound 44c	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416725	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416725&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355578	433916639							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915442	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-10-9-20(28(40,12-11-18-7-8-18)25-6-1-2-13-35-25)15-23(22)36-27(39)24-16-26(29(31,32)33)37-38(24)21-5-3-4-19(14-21)17-34/h1-6,9-10,13-16,18,40H,7-8,11-12,17,34H2,(H,36,39)	XXMBQXWQIGCREG-UHFFFAOYSA-N	416909	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 59c::US10633345, Compound 69b::US10689346, Compound 59c::US11203574, Compound 69b::US11230530, Compound 69b::US11685721, Compound 69b	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416909	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416909&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356067	433916821							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915443	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CCC1CC1)n1ccccc1=O)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-17-25(37(35-26)23-8-3-5-20(15-23)18-33)28(39)34-22-7-4-6-21(16-22)24(13-12-19-10-11-19)36-14-2-1-9-27(36)38/h1-9,14-17,19,24H,10-13,18,33H2,(H,34,39)	OGNFHFCMBSJJNJ-UHFFFAOYSA-N	416933	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-(2-oxopyridin-1(2H)-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 247c::US10633345, Compound 247c::US10689346, Compound 247c::US11203574, Compound 247c::US11230530, Compound 247c::US11685721, Compound 247c	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416933	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416933&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356133	433916845							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915444	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H26F3N5O2/c29-28(30,31)25-14-24(36(35-25)23-8-1-4-19(12-23)15-32)27(37)34-22-7-2-5-20(13-22)26(38-17-18-9-10-18)21-6-3-11-33-16-21/h1-8,11-14,16,18,26H,9-10,15,17,32H2,(H,34,37)	SHFRWTHPPCXLER-UHFFFAOYSA-N	416725	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(pyridin-3-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 44c::US10633345, Compound 44c::US10689346, Compound 44c::US11203574, Compound 44d::US11230530, Compound 44e::US11685721, Compound 44c	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416725	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416725&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355578	433916639							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915445	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-10-9-20(28(40,12-11-18-7-8-18)25-6-1-2-13-35-25)15-23(22)36-27(39)24-16-26(29(31,32)33)37-38(24)21-5-3-4-19(14-21)17-34/h1-6,9-10,13-16,18,40H,7-8,11-12,17,34H2,(H,36,39)	XXMBQXWQIGCREG-UHFFFAOYSA-N	416909	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 59c::US10633345, Compound 69b::US10689346, Compound 59c::US11203574, Compound 69b::US11230530, Compound 69b::US11685721, Compound 69b	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416909	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416909&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356067	433916821							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915446	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CCC1CC1)N1CCCC1=O)C(F)(F)F	InChI=1S/C28H30F3N5O2/c29-28(30,31)25-16-24(36(34-25)22-7-1-4-19(14-22)17-32)27(38)33-21-6-2-5-20(15-21)23(12-11-18-9-10-18)35-13-3-8-26(35)37/h1-2,4-7,14-16,18,23H,3,8-13,17,32H2,(H,33,38)	LEZWAIIPWSOOAE-UHFFFAOYSA-N	416936	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-(2-oxopyrrolidin-1-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 247e::US10633345, Compound 247e::US10689346, Compound 247e::US11203574, Compound 247e::US11230530, Compound 247e::US11685721, Compound 247e	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416936	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416936&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665605	433916848							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915447	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-16-25(37(36-26)24-8-1-4-20(14-24)17-33)27(38)35-23-7-2-5-21(15-23)28(39,12-11-19-9-10-19)22-6-3-13-34-18-22/h1-8,13-16,18-19,39H,9-12,17,33H2,(H,35,38)	AOCZEQQKIIWUBU-UHFFFAOYSA-N	416770	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 47f::US10633345, Compound 47f::US10689346, Compound 47f::US11203574, Compound 47g::US11230530, Compound 47h::US11685721, Compound 47f	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416770	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416770&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355766	433916684							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915448	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H28F4N4O2/c31-24-12-11-22(29(40,14-13-19-9-10-19)21-6-2-1-3-7-21)16-25(24)36-28(39)26-17-27(30(32,33)34)37-38(26)23-8-4-5-20(15-23)18-35/h1-8,11-12,15-17,19,40H,9-10,13-14,18,35H2,(H,36,39)	NIWMWYNGSALJGG-UHFFFAOYSA-N	416903	Racemic 1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 68c::US10633345, Compound 68e::US10689346, Compound 68c::US11203574, Compound 68e::US11230530, Compound 68e::US11685721, Compound 68e	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416903	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416903&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355758	433916816							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915449	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccccc1=O)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-11-10-20(24(12-9-18-7-8-18)37-13-2-1-6-27(37)39)15-23(22)35-28(40)25-16-26(29(31,32)33)36-38(25)21-5-3-4-19(14-21)17-34/h1-6,10-11,13-16,18,24H,7-9,12,17,34H2,(H,35,40)	OFQQGSYWUFBMPP-UHFFFAOYSA-N	416939	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(2-oxopyridin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 248j::US10633345, Compound 248k::US10689346, Compound 248k::US11203574, Compound 248k::US11230530, Compound 248k::US11685721, Compound 248k	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416939	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416939&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355727	433916851							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915450	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-16-25(37(36-26)24-8-1-4-20(14-24)17-33)27(38)35-23-7-2-5-21(15-23)28(39,12-11-19-9-10-19)22-6-3-13-34-18-22/h1-8,13-16,18-19,39H,9-12,17,33H2,(H,35,38)	AOCZEQQKIIWUBU-UHFFFAOYSA-N	416770	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 47f::US10633345, Compound 47f::US10689346, Compound 47f::US11203574, Compound 47g::US11230530, Compound 47h::US11685721, Compound 47f	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416770	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416770&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355766	433916684							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915451	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H28F4N4O2/c31-24-12-11-22(29(40,14-13-19-9-10-19)21-6-2-1-3-7-21)16-25(24)36-28(39)26-17-27(30(32,33)34)37-38(26)23-8-4-5-20(15-23)18-35/h1-8,11-12,15-17,19,40H,9-10,13-14,18,35H2,(H,36,39)	NIWMWYNGSALJGG-UHFFFAOYSA-N	416903	Racemic 1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 68c::US10633345, Compound 68e::US10689346, Compound 68c::US11203574, Compound 68e::US11230530, Compound 68e::US11685721, Compound 68e	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416903	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416903&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355758	433916816							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915452	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccncc1=O)C(F)(F)F	InChI=1S/C28H26F4N6O2/c29-21-8-7-19(23(9-6-17-4-5-17)37-11-10-34-16-26(37)39)13-22(21)35-27(40)24-14-25(28(30,31)32)36-38(24)20-3-1-2-18(12-20)15-33/h1-3,7-8,10-14,16-17,23H,4-6,9,15,33H2,(H,35,40)	GLPOCDKMIDNWGE-UHFFFAOYSA-N	416942	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(2-oxopyrazin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 249b::US10633345, Compound 249b::US10689346, Compound 249b::US11203574, Compound 249b::US11230530, Compound 249b::US11685721, Compound 249b	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416942	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416942&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665736	433916854							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915453	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F3N4O2/c31-30(32,33)27-18-26(37(36-27)25-11-4-6-21(16-25)19-34)28(38)35-24-10-5-9-23(17-24)29(39,15-14-20-12-13-20)22-7-2-1-3-8-22/h1-11,16-18,20,39H,12-15,19,34H2,(H,35,38)	DCGYPXFSNPCKGX-UHFFFAOYSA-N	416751	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 46g::US10633345, Compound 46g::US10689346, Compound 46g::US11203574, Compound 46i::US11230530, Compound 46i::US11685721, Compound 46g	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416751	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416751&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355790	433916665							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915454	COc1ccc2ccccc2c1C(NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H31F4N5O2/c1-45-29-14-12-22-6-2-3-8-25(22)31(29)32(40-19-20-9-10-20)23-11-13-26(35)27(16-23)41-33(44)28-17-30(34(36,37)38)42-43(28)24-7-4-5-21(15-24)18-39/h2-8,11-17,20,32,40H,9-10,18-19,39H2,1H3,(H,41,44)	AYMFYNZEWAELBE-UHFFFAOYSA-N	416906	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(2-methoxynaphthalen-1-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide dihydrochloride::US10329260, Compound 61e::US10633345, Compound 63b::US10689346, Compound 61e::US11203574, Compound 63b::US11230530, Compound 63b::US11685721, Compound 63b	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416906	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416906&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355591	433916818							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915455	Fc1ccc(cc1NC(=O)c1cc(nn1-c1cccc(c1)C#N)C(F)(F)F)C(CCC1CC1)Oc1ccccn1	InChI=1S/C29H23F4N5O2/c30-22-11-10-20(25(12-9-18-7-8-18)40-27-6-1-2-13-35-27)15-23(22)36-28(39)24-16-26(29(31,32)33)37-38(24)21-5-3-4-19(14-21)17-34/h1-6,10-11,13-16,18,25H,7-9,12H2,(H,36,39)	SGHCSSRTSJXCIZ-UHFFFAOYSA-N	447737	US10689346, Compound 250c::US11203574, Compound 250c::US11230530, Compound 250c::US11685721, Compound 250c	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=447737	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=447737&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355856	440709842							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915456	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F3N4O2/c31-30(32,33)27-18-26(37(36-27)25-11-4-6-21(16-25)19-34)28(38)35-24-10-5-9-23(17-24)29(39,15-14-20-12-13-20)22-7-2-1-3-8-22/h1-11,16-18,20,39H,12-15,19,34H2,(H,35,38)	DCGYPXFSNPCKGX-UHFFFAOYSA-N	416751	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 46g::US10633345, Compound 46g::US10689346, Compound 46g::US11203574, Compound 46i::US11230530, Compound 46i::US11685721, Compound 46g	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416751	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416751&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355790	433916665							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915457	COc1ccc2ccccc2c1C(NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H31F4N5O2/c1-45-29-14-12-22-6-2-3-8-25(22)31(29)32(40-19-20-9-10-20)23-11-13-26(35)27(16-23)41-33(44)28-17-30(34(36,37)38)42-43(28)24-7-4-5-21(15-24)18-39/h2-8,11-17,20,32,40H,9-10,18-19,39H2,1H3,(H,41,44)	AYMFYNZEWAELBE-UHFFFAOYSA-N	416906	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(2-methoxynaphthalen-1-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide dihydrochloride::US10329260, Compound 61e::US10633345, Compound 63b::US10689346, Compound 61e::US11203574, Compound 63b::US11230530, Compound 63b::US11685721, Compound 63b	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416906	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416906&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355591	433916818							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915458	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(=CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H26F4N4O/c31-25-14-12-22(24(13-11-19-9-10-19)21-6-2-1-3-7-21)16-26(25)36-29(39)27-17-28(30(32,33)34)37-38(27)23-8-4-5-20(15-23)18-35/h1-8,12-17,19H,9-11,18,35H2,(H,36,39)/b24-13-	BAAJKWZPAGFHDE-CFRMEGHHSA-N	416948	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-phenylprop-1-enyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 252c::US10633345, Compound 252c::US10689346, Compound 252c::US11203574, Compound 252c::US11230530, Compound 252c::US11685721, Compound 252c	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416948	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416948&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			140777564	433916860							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915459	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H25F4N5O2/c29-22-9-8-19(26(39-16-17-6-7-17)20-4-2-10-34-15-20)12-23(22)35-27(38)24-13-25(28(30,31)32)36-37(24)21-5-1-3-18(11-21)14-33/h1-5,8-13,15,17,26H,6-7,14,16,33H2,(H,35,38)	CNAFOXQNPWSINI-UHFFFAOYSA-N	416794	Racemic 1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethoxy)(pyridin-3-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 48f::US10633345, Compound 48f::US10689346, Compound 48f::US11203574, Compound 48g::US11230530, Compound 48h::US11685721, Compound 48f	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416794	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416794&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355617	433916708							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915460	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C30H25F4N5O2/c31-24-11-10-22(28(41-17-19-4-5-19)21-8-6-18(15-35)7-9-21)13-25(24)37-29(40)26-14-27(30(32,33)34)38-39(26)23-3-1-2-20(12-23)16-36/h1-3,6-14,19,28H,4-5,16-17,36H2,(H,37,40)	WXFHQCUXOOXGLO-UHFFFAOYSA-N	416894	1-(3-(aminomethyl)phenyl)-N-(5-((4-cyanophenyl)(cyclopropylmethoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 55b::US10633345, Compound 73b::US10689346, Compound 55b::US11203574, Compound 73b::US11230530, Compound 73b::US11685721, Compound 73b	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416894	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416894&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665569	433916807							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915461	CN1CCCN(CC1)C(CCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H36F4N6O/c1-38-12-3-13-39(15-14-38)26(11-8-20-6-7-20)22-9-10-24(31)25(17-22)36-29(41)27-18-28(30(32,33)34)37-40(27)23-5-2-4-21(16-23)19-35/h2,4-5,9-10,16-18,20,26H,3,6-8,11-15,19,35H2,1H3,(H,36,41)	WXRMFESIILBOBA-UHFFFAOYSA-N	416951	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(4-methyl-1,4-diazepan-1-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 251e::US10633345, Compound 251e::US10689346, Compound 251e::US11203574, Compound 251e::US11230530, Compound 251e::US11685721, Compound 251e	Plasma kallikrein		>75.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416951	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416951&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355664	433916863							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915462	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H25F4N5O2/c29-22-9-8-19(26(39-16-17-6-7-17)20-4-2-10-34-15-20)12-23(22)35-27(38)24-13-25(28(30,31)32)36-37(24)21-5-1-3-18(11-21)14-33/h1-5,8-13,15,17,26H,6-7,14,16,33H2,(H,35,38)	CNAFOXQNPWSINI-UHFFFAOYSA-N	416794	Racemic 1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethoxy)(pyridin-3-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 48f::US10633345, Compound 48f::US10689346, Compound 48f::US11203574, Compound 48g::US11230530, Compound 48h::US11685721, Compound 48f	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416794	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416794&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355617	433916708							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915463	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C30H25F4N5O2/c31-24-11-10-22(28(41-17-19-4-5-19)21-8-6-18(15-35)7-9-21)13-25(24)37-29(40)26-14-27(30(32,33)34)38-39(26)23-3-1-2-20(12-23)16-36/h1-3,6-14,19,28H,4-5,16-17,36H2,(H,37,40)	WXFHQCUXOOXGLO-UHFFFAOYSA-N	416894	1-(3-(aminomethyl)phenyl)-N-(5-((4-cyanophenyl)(cyclopropylmethoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 55b::US10633345, Compound 73b::US10689346, Compound 55b::US11203574, Compound 73b::US11230530, Compound 73b::US11685721, Compound 73b	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416894	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416894&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665569	433916807							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915464	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)N1C(=O)CCC1=O)C(F)(F)F	InChI=1S/C28H27F4N5O3/c29-20-8-7-18(22(9-6-16-4-5-16)36-25(38)10-11-26(36)39)13-21(20)34-27(40)23-14-24(28(30,31)32)35-37(23)19-3-1-2-17(12-19)15-33/h1-3,7-8,12-14,16,22H,4-6,9-11,15,33H2,(H,34,40)	ZAWTZVLCOQSDBX-UHFFFAOYSA-N	416954	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(2,5-dioxopyrrolidin-1-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 260b::US10633345, Compound 260b::US10689346, Compound 260b::US11203574, Compound 260b::US11230530, Compound 260b::US11685721, Compound 260b	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416954	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416954&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665563	433916866							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915465	COc1ccc2ccccc2c1C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H32F3N5O2/c1-44-29-15-14-23-7-2-3-11-27(23)31(29)32(39-20-21-12-13-21)24-8-5-9-25(17-24)40-33(43)28-18-30(34(35,36)37)41-42(28)26-10-4-6-22(16-26)19-38/h2-11,14-18,21,32,39H,12-13,19-20,38H2,1H3,(H,40,43)	XVOUQCJHWNZPKF-UHFFFAOYSA-N	416841	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2-methoxynaphthalen-1-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 51f::US10633345, Compound 51f::US10689346, Compound 51f::US11203574, Compound 51h::US11230530, Compound 51h::US11685721, Compound 51f	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416841	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416841&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356155	433916754							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915466	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C30H25F4N5O2/c31-24-10-9-22(28(41-17-18-7-8-18)21-5-1-3-19(11-21)15-35)13-25(24)37-29(40)26-14-27(30(32,33)34)38-39(26)23-6-2-4-20(12-23)16-36/h1-6,9-14,18,28H,7-8,16-17,36H2,(H,37,40)	LSXFYXGKZDVRTL-UHFFFAOYSA-N	416900	1-(3-(aminomethyl)phenyl)-N-(5-((3-cyanophenyl)(cyclopropyl-methoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 56c::US10633345, Compound 72d::US10689346, Compound 56c::US11203574, Compound 72d::US11230530, Compound 72d::US11685721, Compound 72d	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416900	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416900&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356211	433916813							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915467	CS(=O)(=O)NC(CCC1CC1)(c1ccncc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2ccc3ccnc(N)c3c2)C(F)(F)F)c1	InChI=1S/C32H29F4N7O3S/c1-47(45,46)42-31(12-8-19-2-3-19,21-10-13-38-14-11-21)22-5-7-25(33)26(16-22)40-30(44)27-18-28(32(34,35)36)41-43(27)23-6-4-20-9-15-39-29(37)24(20)17-23/h4-7,9-11,13-19,42H,2-3,8,12H2,1H3,(H2,37,39)(H,40,44)	WOIASLBXHIHYRY-UHFFFAOYSA-N	416957	(+-)-1-(1-aminoisoquinolin-7-yl)-N-(5-(3-cyclopropyl-1-(methylsulfonamido)-1-(pyridin-4-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 262f::US10633345, Compound 262f::US10689346, Compound 262f::US11192861, Compound 262f::US11230530, Compound 262f::US11685721, Compound 262f	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416957	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416957&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355636	433916869							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915468	COc1ccc2ccccc2c1C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H32F3N5O2/c1-44-29-15-14-23-7-2-3-11-27(23)31(29)32(39-20-21-12-13-21)24-8-5-9-25(17-24)40-33(43)28-18-30(34(35,36)37)41-42(28)26-10-4-6-22(16-26)19-38/h2-11,14-18,21,32,39H,12-13,19-20,38H2,1H3,(H,40,43)	XVOUQCJHWNZPKF-UHFFFAOYSA-N	416841	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2-methoxynaphthalen-1-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 51f::US10633345, Compound 51f::US10689346, Compound 51f::US11203574, Compound 51h::US11230530, Compound 51h::US11685721, Compound 51f	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416841	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416841&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356155	433916754							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915469	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C30H25F4N5O2/c31-24-10-9-22(28(41-17-18-7-8-18)21-5-1-3-19(11-21)15-35)13-25(24)37-29(40)26-14-27(30(32,33)34)38-39(26)23-6-2-4-20(12-23)16-36/h1-6,9-14,18,28H,7-8,16-17,36H2,(H,37,40)	LSXFYXGKZDVRTL-UHFFFAOYSA-N	416900	1-(3-(aminomethyl)phenyl)-N-(5-((3-cyanophenyl)(cyclopropyl-methoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 56c::US10633345, Compound 72d::US10689346, Compound 56c::US11203574, Compound 72d::US11230530, Compound 72d::US11685721, Compound 72d	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416900	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416900&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356211	433916813							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915470	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccc(=O)[nH]c1=O)C(F)(F)F			416960	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 263d::US10633345, Compound 263d::US10689346, Compound 263d::US11203574, Compound 263d::US11230530, Compound 263d::US11685721, Compound 263d	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416960	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416960&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			154584232	433916872							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915471	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-25(37(36-26)24-9-1-4-19(12-24)16-33)28(38)35-23-8-3-6-21(14-23)27(39-17-18-10-11-18)20-5-2-7-22(34)13-20/h1-9,12-15,18,27H,10-11,16-17,33-34H2,(H,35,38)	FPQYUIIRVBKUDH-UHFFFAOYSA-N	416867	1-(3-(aminomethyl)phenyl)-N-(3-((3-aminophenyl)(cyclopropyl-methoxy)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 53f::US10633345, Compound 53f::US10689346, Compound 53f::US11203574, Compound 64b::US11230530, Compound 64b::US11685721, Compound 49j	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416867	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416867&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355845	433916780							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915472	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1O)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-11-10-19(27(35-16-17-8-9-17)21-6-1-2-7-25(21)39)13-23(22)36-28(40)24-14-26(29(31,32)33)37-38(24)20-5-3-4-18(12-20)15-34/h1-7,10-14,17,27,35,39H,8-9,15-16,34H2,(H,36,40)	CKWWRAGQIQAYTL-UHFFFAOYSA-N	416856	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(2-hydroxyphenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 60e::US10633345, Compound 66b::US10689346, Compound 60e::US11203574, Compound 66b::US11230530, Compound 66b::US11685721, Compound 60e	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416856	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416856&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665480	433916769							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915473	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1ccc(cc1F)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-23-14-21(27(39-17-18-9-10-18)20-6-2-1-3-7-20)11-12-24(23)35-28(38)25-15-26(29(31,32)33)36-37(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27H,9-10,16-17,34H2,(H,35,38)	HBXVQXKJLUQKAE-UHFFFAOYSA-N	416963	1-(3-(aminomethyl)phenyl)-N-(4-((cyclopropylmethoxy)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 15g::US10633345, Compound 15g::US10689346, Compound 15g::US11203574, Compound 15g::US11230530, Compound 15g::US11685721, Compound 15g	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416963	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416963&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355605	433916875							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915474	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-25(37(36-26)24-9-1-4-19(12-24)16-33)28(38)35-23-8-3-6-21(14-23)27(39-17-18-10-11-18)20-5-2-7-22(34)13-20/h1-9,12-15,18,27H,10-11,16-17,33-34H2,(H,35,38)	FPQYUIIRVBKUDH-UHFFFAOYSA-N	416867	1-(3-(aminomethyl)phenyl)-N-(3-((3-aminophenyl)(cyclopropyl-methoxy)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 53f::US10633345, Compound 53f::US10689346, Compound 53f::US11203574, Compound 64b::US11230530, Compound 64b::US11685721, Compound 49j	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416867	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416867&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355845	433916780							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915475	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1O)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-11-10-19(27(35-16-17-8-9-17)21-6-1-2-7-25(21)39)13-23(22)36-28(40)24-14-26(29(31,32)33)37-38(24)20-5-3-4-18(12-20)15-34/h1-7,10-14,17,27,35,39H,8-9,15-16,34H2,(H,36,40)	CKWWRAGQIQAYTL-UHFFFAOYSA-N	416856	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(2-hydroxyphenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 60e::US10633345, Compound 66b::US10689346, Compound 60e::US11203574, Compound 66b::US11230530, Compound 66b::US11685721, Compound 60e	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416856	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416856&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665480	433916769							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915476	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1ccc(cc1F)C(O)c1ccccc1)C(F)(F)F	InChI=1S/C25H20F4N4O2/c26-19-12-17(23(34)16-6-2-1-3-7-16)9-10-20(19)31-24(35)21-13-22(25(27,28)29)32-33(21)18-8-4-5-15(11-18)14-30/h1-13,23,34H,14,30H2,(H,31,35)	WVBOXESRKOBMTK-UHFFFAOYSA-N	416966	1-(3-(Aminomethyl)phenyl)-N-(2-fluoro-4-(hydroxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 16b::US10633345, Compound 16b::US10689346, Compound 16b::US11203574, Compound 16b::US11230530, Compound 16b::US11685721, Compound 16b	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416966	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416966&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665483	433916878							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915477	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1O)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-24(37(36-26)22-8-3-5-19(13-22)16-33)28(39)35-21-7-4-6-20(14-21)27(34-17-18-11-12-18)23-9-1-2-10-25(23)38/h1-10,13-15,18,27,34,38H,11-12,16-17,33H2,(H,35,39)	PCNDJIQOMLHSEK-UHFFFAOYSA-N	416837	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2-hydroxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 49h::US10633345, Compound 49h::US10689346, Compound 49h::US11203574, Compound 49j::US11230530, Compound 49j::US11685721, Compound 49h	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416837	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416837&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355733	433916750							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915478	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-23-12-11-21(27(39-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)35-28(38)25-15-26(29(31,32)33)36-37(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27H,9-10,16-17,34H2,(H,35,38)	HIMJVDQVZQMIPM-UHFFFAOYSA-N	416747	1-(3-(Aminomethyl)phenyl)-N-(5-((cyclopropylmethoxy)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 34c::US10633345, Compound 34c::US10689346, Compound 34c::US11203574, Compound 37a::US11230530, Compound 37a::US11685721, Compound 34c	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416747	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416747&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355729	433916661							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915479	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1c(F)cccc1C(O)c1ccccc1)C(F)(F)F	InChI=1S/C25H20F4N4O2/c26-19-11-5-10-18(23(34)16-7-2-1-3-8-16)22(19)31-24(35)20-13-21(25(27,28)29)32-33(20)17-9-4-6-15(12-17)14-30/h1-13,23,34H,14,30H2,(H,31,35)	PIMJYQUHLMMZIO-UHFFFAOYSA-N	416969	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-6-(hydroxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 90f::US10633345, Compound 90f::US10689346, Compound 90f::US11203574, Compound 90f::US11230530, Compound 90f::US11685721, Compound 90f	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416969	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416969&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356272	433916881							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915480	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1O)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-24(37(36-26)22-8-3-5-19(13-22)16-33)28(39)35-21-7-4-6-20(14-21)27(34-17-18-11-12-18)23-9-1-2-10-25(23)38/h1-10,13-15,18,27,34,38H,11-12,16-17,33H2,(H,35,39)	PCNDJIQOMLHSEK-UHFFFAOYSA-N	416837	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2-hydroxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 49h::US10633345, Compound 49h::US10689346, Compound 49h::US11203574, Compound 49j::US11230530, Compound 49j::US11685721, Compound 49h	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416837	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416837&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355733	433916750							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915481	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-23-12-11-21(27(39-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)35-28(38)25-15-26(29(31,32)33)36-37(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27H,9-10,16-17,34H2,(H,35,38)	HIMJVDQVZQMIPM-UHFFFAOYSA-N	416747	1-(3-(Aminomethyl)phenyl)-N-(5-((cyclopropylmethoxy)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 34c::US10633345, Compound 34c::US10689346, Compound 34c::US11203574, Compound 37a::US11230530, Compound 37a::US11685721, Compound 34c	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416747	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416747&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355729	433916661							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915482	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N(CC1CC1)CC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C33H33F4N5O/c34-27-14-13-25(31(24-6-2-1-3-7-24)41(19-21-9-10-21)20-22-11-12-22)16-28(27)39-32(43)29-17-30(33(35,36)37)40-42(29)26-8-4-5-23(15-26)18-38/h1-8,13-17,21-22,31H,9-12,18-20,38H2,(H,39,43)	FVEYNTAGBBDICV-UHFFFAOYSA-N	416972	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-((bis(cyclopropylmethyl)amino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 206d::US10633345, Compound 206d::US10689346, Compound 206d::US11203574, Compound 206d::US11230530, Compound 206d::US11685721, Compound 206d	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416972	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416972&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355791	433916884							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915483	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C#N)C(N)=O	InChI=1S/C31H30FN7O2/c32-25-11-10-23(31(36,13-12-19-4-5-19)22-8-6-20(17-33)7-9-22)15-26(25)37-30(41)28-16-27(29(35)40)38-39(28)24-3-1-2-21(14-24)18-34/h1-3,6-11,14-16,19H,4-5,12-13,18,34,36H2,(H2,35,40)(H,37,41)	BCLQAOJZVSDWEP-UHFFFAOYSA-N	416973	(+)-N5-(5-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-1H-pyrazole-3,5-dicarboxamide::US10329260, Compound 231d::US10633345, Compound 231d::US10689346, Compound 231d::US11203574, Compound 231d::US11230530, Compound 231d::US11685721, Compound 231d	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416973	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416973&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665708	433916885							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915484	CC(C)(C)C(=O)NC(CCC1CC1)(c1cccnc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H36F4N6O2/c1-32(2,3)31(46)42-33(14-13-21-9-10-21,24-7-5-15-40-20-24)23-11-12-26(35)27(17-23)41-30(45)28-18-29(34(36,37)38)43-44(28)25-8-4-6-22(16-25)19-39/h4-8,11-12,15-18,20-21H,9-10,13-14,19,39H2,1-3H3,(H,41,45)(H,42,46)	QDJVSPVHYSLBHH-UHFFFAOYSA-N	416974	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-pivalamido-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 244g::US10689346, Compound 244g::US11203574, Compound 244g::US11230530, Compound 244g::US11685721, Compound 244g	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416974	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416974&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665924	433916886							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915485	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-22-10-9-20(28(35,12-11-18-7-8-18)25-6-1-2-13-36-25)15-23(22)37-27(40)24-16-26(29(31,32)33)38-39(24)21-5-3-4-19(14-21)17-34/h1-6,9-10,13-16,18H,7-8,11-12,17,34-35H2,(H,37,40)	IFWBAIGKQKRJGJ-UHFFFAOYSA-N	416975	(+-)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 205d::US10633345, Compound 205c::US10689346, Compound 205e::US11203574, Compound 205e::US11230530, Compound 205e::US11685721, Compound 205f	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416975	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416975&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665627	433916887							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915486	ONC(=N)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N6O2/c30-22-12-11-19(26(35-16-17-9-10-17)18-5-2-1-3-6-18)14-23(22)36-28(40)24-15-25(29(31,32)33)37-39(24)21-8-4-7-20(13-21)27(34)38-41/h1-8,11-15,17,26,35,41H,9-10,16H2,(H2,34,38)(H,36,40)	RKUBSDCTAQRJEX-UHFFFAOYSA-N	416976	(+-)-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-1-(3-(N-hydroxycarbamimidoyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 232a::US10633345, Compound 232a::US10689346, Compound 232a::US11203574, Compound 232a::US11230530, Compound 232a::US11685721, Compound 232a	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416976	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416976&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665466	433916888							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915487	CC(=O)NC(CCC1CC1)(c1cccnc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C31H30F4N6O2/c1-19(42)39-30(12-11-20-7-8-20,23-5-3-13-37-18-23)22-9-10-25(32)26(15-22)38-29(43)27-16-28(31(33,34)35)40-41(27)24-6-2-4-21(14-24)17-36/h2-6,9-10,13-16,18,20H,7-8,11-12,17,36H2,1H3,(H,38,43)(H,39,42)	NXVHVPBDWBOZQI-UHFFFAOYSA-N	416977	(+-)-N-(5-(1-acetamido-3-cyclopropyl-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 244h::US10633345, Compound 244h::US10689346, Compound 244h::US11203574, Compound 244h::US11230530, Compound 244h::US11685721, Compound 244h	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416977	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416977&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355894	433916889							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915488	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-22-10-9-20(28(35,12-11-18-7-8-18)25-6-1-2-13-36-25)15-23(22)37-27(40)24-16-26(29(31,32)33)38-39(24)21-5-3-4-19(14-21)17-34/h1-6,9-10,13-16,18H,7-8,11-12,17,34-35H2,(H,37,40)	IFWBAIGKQKRJGJ-UHFFFAOYSA-N	416975	(+-)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 205d::US10633345, Compound 205c::US10689346, Compound 205e::US11203574, Compound 205e::US11230530, Compound 205e::US11685721, Compound 205f	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416975	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416975&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665627	433916887							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915489	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(O)=O	InChI=1S/C29H28FN5O3/c30-23-12-11-21(27(32-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)33-28(36)26-15-25(29(37)38)34-35(26)22-8-4-5-19(13-22)16-31/h1-8,11-15,18,27,32H,9-10,16-17,31H2,(H,33,36)(H,37,38)	XPAISISGRLZRHF-UHFFFAOYSA-N	416979	(+)-1-(3-(aminomethyl)phenyl)-5-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenylcarbamoyl)-1H-pyrazole-3-carboxylic acid::US10329260, Compound 246f::US10633345, Compound 246f::US10689346, Compound 246f::US11203574, Compound 246f::US11230530, Compound 246f::US11685721, Compound 246f	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416979	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416979&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356041	433916891							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915490	CCC(=O)NC(CCC1CC1)(c1cccnc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C32H32F4N6O2/c1-2-29(43)40-31(13-12-20-8-9-20,23-6-4-14-38-19-23)22-10-11-25(33)26(16-22)39-30(44)27-17-28(32(34,35)36)41-42(27)24-7-3-5-21(15-24)18-37/h3-7,10-11,14-17,19-20H,2,8-9,12-13,18,37H2,1H3,(H,39,44)(H,40,43)	VLEWWVBFKVHAND-UHFFFAOYSA-N	416980	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-propionamido-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 244i::US10633345, Compound 244i::US10689346, Compound 244i::US11203574, Compound 244i::US11230530, Compound 244j::US11685721, Compound 244i	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416980	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416980&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665945	433916892							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915491	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-23-9-8-20(28(35,11-10-18-6-7-18)21-4-2-12-36-17-21)14-24(23)37-27(40)25-15-26(29(31,32)33)38-39(25)22-5-1-3-19(13-22)16-34/h1-5,8-9,12-15,17-18H,6-7,10-11,16,34-35H2,(H,37,40)	QXMQDWOYOXVOQZ-UHFFFAOYSA-N	416981	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 208d::US10633345, Compound 209d::US10689346, Compound 209d::US11203574, Compound 209d::US11230530, Compound 209d::US11685721, Compound 209d	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416981	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416981&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355646	433916893							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915492	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C#N)C#N	InChI=1S/C31H28FN7O/c32-27-11-10-24(31(36,13-12-20-4-5-20)23-8-6-21(17-33)7-9-23)15-28(27)37-30(40)29-16-25(19-35)38-39(29)26-3-1-2-22(14-26)18-34/h1-3,6-11,14-16,20H,4-5,12-13,18,34,36H2,(H,37,40)	SWSSXIJHEDUEIQ-UHFFFAOYSA-N	416982	(+)-N-(5-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-cyano-1H-pyrazole-5-carboxamide::US10329260, Compound 234d::US10633345, Compound 234d::US10689346, Compound 234d::US11203574, Compound 234d::US11230530, Compound 234d::US11685721, Compound 234d	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416982	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416982&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356248	433916894							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915493	CC(C)C(=O)NC(CCC1CC1)(c1cccnc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C33H34F4N6O2/c1-20(2)30(44)41-32(13-12-21-8-9-21,24-6-4-14-39-19-24)23-10-11-26(34)27(16-23)40-31(45)28-17-29(33(35,36)37)42-43(28)25-7-3-5-22(15-25)18-38/h3-7,10-11,14-17,19-21H,8-9,12-13,18,38H2,1-2H3,(H,40,45)(H,41,44)	POAUUALSNYEBRU-UHFFFAOYSA-N	416983	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-isobutyramido-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 244j::US10633345, Compound 244j::US10689346, Compound 244j::US11203574, Compound 244j::US11685721, Compound 244j	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416983	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416983&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356184	433916895							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915494	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-23-9-8-20(28(35,11-10-18-6-7-18)21-4-2-12-36-17-21)14-24(23)37-27(40)25-15-26(29(31,32)33)38-39(25)22-5-1-3-19(13-22)16-34/h1-5,8-9,12-15,17-18H,6-7,10-11,16,34-35H2,(H,37,40)	QXMQDWOYOXVOQZ-UHFFFAOYSA-N	416981	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 208d::US10633345, Compound 209d::US10689346, Compound 209d::US11203574, Compound 209d::US11230530, Compound 209d::US11685721, Compound 209d	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416981	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416981&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355646	433916893							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915495	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C31H26F4N6O/c32-24-11-9-21(28(38-17-18-6-7-18)20-4-2-1-3-5-20)14-25(24)39-30(42)26-16-27(31(33,34)35)40-41(26)22-10-8-19-12-13-37-29(36)23(19)15-22/h1-5,8-16,18,28,38H,6-7,17H2,(H2,36,37)(H,39,42)	OUKVDAXUKVLTKB-UHFFFAOYSA-N	439568	US10633345, Compound 235g::US10689346, Compound 235g::US11192861, Compound 235g	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439568	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439568&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665742	439661116							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915496	CC(C)CC(=O)NC(CCC1CC1)(c1cccnc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H36F4N6O2/c1-21(2)15-31(45)42-33(13-12-22-8-9-22,25-6-4-14-40-20-25)24-10-11-27(35)28(17-24)41-32(46)29-18-30(34(36,37)38)43-44(29)26-7-3-5-23(16-26)19-39/h3-7,10-11,14,16-18,20-22H,8-9,12-13,15,19,39H2,1-2H3,(H,41,46)(H,42,45)	WIIQCCUTLYCVOE-UHFFFAOYSA-N	416986	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(3-methylbutanamido)-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 244k::US10633345, Compound 244k::US10689346, Compound 244k::US11203574, Compound 244k::US11230530, Compound 244k::US11685721, Compound 244k	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416986	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416986&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665507	433916898							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915497	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F4N5O/c31-24-12-11-22(29(36,14-13-19-9-10-19)21-6-2-1-3-7-21)16-25(24)37-28(40)26-17-27(30(32,33)34)38-39(26)23-8-4-5-20(15-23)18-35/h1-8,11-12,15-17,19H,9-10,13-14,18,35-36H2,(H,37,40)	NQFNNZJJOCPZCP-UHFFFAOYSA-N	416987	(+-)-N-(5-(1-amino-3-cyclopropyl-1-phenylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 210d::US10633345, Compound 211d::US10689346, Compound 211d::US11203574, Compound 211d::US11230530, Compound 211d::US11685721, Compound 211d	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416987	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416987&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355764	433916899							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915498	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(N)(CCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C31H29F3N6O/c32-31(33,34)28-17-27(40(39-28)26-6-1-3-22(15-26)19-36)29(41)38-25-5-2-4-24(16-25)30(37,14-13-20-7-8-20)23-11-9-21(18-35)10-12-23/h1-6,9-12,15-17,20H,7-8,13-14,19,36-37H2,(H,38,41)	WPWCLOAAAHRQMG-UHFFFAOYSA-N	416988	(+)-N-(3-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)phenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 218c::US10633345, Compound 218c::US10689346, Compound 218c::US11203574, Compound 218c::US11230530, Compound 218c::US11685721, Compound 218c	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416988	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416988&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356070	433916900							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915499	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C31H27F4N7O/c32-24-6-4-21(30(37,11-7-18-1-2-18)20-9-12-38-13-10-20)15-25(24)40-29(43)26-17-27(31(33,34)35)41-42(26)22-5-3-19-8-14-39-28(36)23(19)16-22/h3-6,8-10,12-18H,1-2,7,11,37H2,(H2,36,39)(H,40,43)	BGYDOWYGLFEYGE-UHFFFAOYSA-N	416989	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-4-yl)propyl)-2-fluorophenyl)-1-(1-aminoisoquinolin-7-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 253e::US10633345, Compound 253e::US10689346, Compound 253e::US11203574, Compound 253e::US11230530, Compound 253e::US11685721, Compound 253e	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416989	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416989&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665703	433916901							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915500	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F4N5O/c31-24-12-11-22(29(36,14-13-19-9-10-19)21-6-2-1-3-7-21)16-25(24)37-28(40)26-17-27(30(32,33)34)38-39(26)23-8-4-5-20(15-23)18-35/h1-8,11-12,15-17,19H,9-10,13-14,18,35-36H2,(H,37,40)	NQFNNZJJOCPZCP-UHFFFAOYSA-N	416987	(+-)-N-(5-(1-amino-3-cyclopropyl-1-phenylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 210d::US10633345, Compound 211d::US10689346, Compound 211d::US11203574, Compound 211d::US11230530, Compound 211d::US11685721, Compound 211d	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416987	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416987&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355764	433916899							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915501	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(N)(CCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C31H29F3N6O/c32-31(33,34)28-17-27(40(39-28)26-9-2-5-22(15-26)19-36)29(41)38-25-8-3-7-24(16-25)30(37,13-12-20-10-11-20)23-6-1-4-21(14-23)18-35/h1-9,14-17,20H,10-13,19,36-37H2,(H,38,41)	JHGXWQQOSIGIHO-UHFFFAOYSA-N	416991	(+)-N-(3-(1-amino-1-(3-cyanophenyl)-3-cyclopropylpropyl)phenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 219c::US10633345, Compound 219c::US10689346, Compound 219c::US11203574, Compound 219c::US11230530, Compound 219c::US11685721, Compound 219c	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416991	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416991&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355760	433916903							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915502	CS(=O)(=O)NC(CCC1CC1)(c1ccncc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F4N6O3S/c1-44(42,43)39-29(12-9-19-5-6-19,21-10-13-36-14-11-21)22-7-8-24(31)25(16-22)37-28(41)26-17-27(30(32,33)34)38-40(26)23-4-2-3-20(15-23)18-35/h2-4,7-8,10-11,13-17,19,39H,5-6,9,12,18,35H2,1H3,(H,37,41)	SFWRGGJAWAJGGN-UHFFFAOYSA-N	416992	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(methylsulfonamido)-1-(pyridin-4-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 245c::US10633345, Compound 245c::US10689346, Compound 245c::US11203574, Compound 245c::US11230530, Compound 245c::US11685721, Compound 245c	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416992	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416992&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355707	433916904							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915503	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C31H28F4N6O/c32-25-11-10-23(30(38,13-12-19-4-5-19)22-8-6-20(17-36)7-9-22)15-26(25)39-29(42)27-16-28(31(33,34)35)40-41(27)24-3-1-2-21(14-24)18-37/h1-3,6-11,14-16,19H,4-5,12-13,18,37-38H2,(H,39,42)	JCBKPNPCGNTAQN-UHFFFAOYSA-N	416993	(+)-N-(5-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 212g::US10633345, Compound 213d::US10689346, Compound 213d::US11203574, Compound 213d::US11230530, Compound 213d::US11685721, Compound 213d	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416993	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416993&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356170	433916905							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915504	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C(N)=O)C#N	InChI=1S/C31H30FN7O2/c32-26-11-10-23(31(36,13-12-19-4-5-19)22-8-6-21(7-9-22)29(35)40)15-27(26)37-30(41)28-16-24(18-34)38-39(28)25-3-1-2-20(14-25)17-33/h1-3,6-11,14-16,19H,4-5,12-13,17,33,36H2,(H2,35,40)(H,37,41)	KLZOEGIZCNFTHC-UHFFFAOYSA-N	416994	(-)-N-(5-(1-amino-1-(4-carbamoylphenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-cyano-1H-pyrazole-5-carboxamide::US10329260, Compound 239d::US10633345, Compound 239c::US10689346, Compound 239d::US11203574, Compound 239d::US11685721, Compound 239d	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416994	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416994&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356225	433916906							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915505	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C32H25F4N7O/c33-25-9-7-22(29(40-17-18-4-5-18)21-3-1-2-19(12-21)16-37)13-26(25)41-31(44)27-15-28(32(34,35)36)42-43(27)23-8-6-20-10-11-39-30(38)24(20)14-23/h1-3,6-15,18,29,40H,4-5,17H2,(H2,38,39)(H,41,44)	PQPAZBKFVDKERF-UHFFFAOYSA-N	439578	US10633345, Compound 257b::US10689346, Compound 257b::US11203574, Compound 257b::US11230530, Compound 257b::US11685721, Compound 257b	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439578	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439578&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665471	439661126							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915506	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C31H28F4N6O/c32-25-10-9-23(30(38,12-11-19-7-8-19)22-5-1-3-20(13-22)17-36)15-26(25)39-29(42)27-16-28(31(33,34)35)40-41(27)24-6-2-4-21(14-24)18-37/h1-6,9-10,13-16,19H,7-8,11-12,18,37-38H2,(H,39,42)	ZBDDMFBNDOEVJT-UHFFFAOYSA-N	416996	(+)-N-(5-(1-amino-1-(3-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 214g::US10633345, Compound 215d::US10689346, Compound 215d::US11203574, Compound 215d::US11230530, Compound 215d::US11685721, Compound 215d	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416996	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416996&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665709	433916908							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915507	NC(=O)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C31H26F4N6O2/c32-24-10-9-22(30(38,12-11-18-7-8-18)21-5-1-3-19(13-21)17-36)15-25(24)39-29(43)26-16-27(31(33,34)35)40-41(26)23-6-2-4-20(14-23)28(37)42/h1-6,9-10,13-16,18H,7-8,11-12,38H2,(H2,37,42)(H,39,43)	MJBRNYICMOSPEH-UHFFFAOYSA-N	416997	(+-)-N-(5-(1-amino-1-(3-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-carbamoylphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 267c::US10633345, Compound 267c::US10689346, Compound 267c::US11203574, Compound 267c::US11230530, Compound 267c::US11685721, Compound 267c	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416997	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416997&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665760	433916909							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915508	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C33H27F4N7O/c34-26-10-8-23(32(40,13-11-19-1-2-19)22-6-3-20(18-38)4-7-22)15-27(26)42-31(45)28-17-29(33(35,36)37)43-44(28)24-9-5-21-12-14-41-30(39)25(21)16-24/h3-10,12,14-17,19H,1-2,11,13,40H2,(H2,39,41)(H,42,45)	QUIZETAQJOZQJA-UHFFFAOYSA-N	416998	(+)-N-(5-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(1-aminoisoquinolin-7-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 254c::US10633345, Compound 254c::US10689346, Compound 254c::US11203574, Compound 254c::US11230530, Compound 254c::US11685721, Compound 254c	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416998	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416998&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665477	433916910							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915509	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C31H28F4N6O/c32-25-11-10-23(30(38,13-12-19-4-5-19)22-8-6-20(17-36)7-9-22)15-26(25)39-29(42)27-16-28(31(33,34)35)40-41(27)24-3-1-2-21(14-24)18-37/h1-3,6-11,14-16,19H,4-5,12-13,18,37-38H2,(H,39,42)	JCBKPNPCGNTAQN-UHFFFAOYSA-N	416993	(+)-N-(5-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 212g::US10633345, Compound 213d::US10689346, Compound 213d::US11203574, Compound 213d::US11230530, Compound 213d::US11685721, Compound 213d	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416993	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416993&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356170	433916905							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915510	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C#N	InChI=1S/C29H27FN6O/c30-25-12-11-22(28(33-18-19-9-10-19)21-6-2-1-3-7-21)14-26(25)34-29(37)27-15-23(17-32)35-36(27)24-8-4-5-20(13-24)16-31/h1-8,11-15,19,28,33H,9-10,16,18,31H2,(H,34,37)	OBANZZDEWOCPST-UHFFFAOYSA-N	417000	(+-)-1-(3-(aminomethyl)phenyl)-3-cyano-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 240b::US10633345, Compound 240b::US10689346, Compound 240b::US11203574, Compound 240b::US11230530, Compound 240b::US11685721, Compound 240b	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417000	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417000&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355661	433916912							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915511	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C32H28F4N6O/c33-25-11-9-22(31(38,14-12-19-6-7-19)21-4-2-1-3-5-21)16-26(25)40-30(43)27-18-28(32(34,35)36)41-42(27)23-10-8-20-13-15-39-29(37)24(20)17-23/h1-5,8-11,13,15-19H,6-7,12,14,38H2,(H2,37,39)(H,40,43)	SUIQVQQNEUOJQB-UHFFFAOYSA-N	417001	(+)-N-(5-(1-amino-3-cyclopropyl-1-phenylpropyl)-2-fluorophenyl)-1-(1-aminoisoquinolin-7-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 255a::US10633345, Compound 255a::US10689346, Compound 255a::US11203574, Compound 255a::US11230530, Compound 255a::US11685721, Compound 255a	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417001	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417001&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356059	433916913							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915512	Nc1noc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H24F4N6O2/c30-21-10-8-18(26(35-15-16-6-7-16)17-4-2-1-3-5-17)12-22(21)36-28(40)23-14-25(29(31,32)33)37-39(23)19-9-11-24-20(13-19)27(34)38-41-24/h1-5,8-14,16,26,35H,6-7,15H2,(H2,34,38)(H,36,40)	QWKNFIFTTXOPHF-UHFFFAOYSA-N	417002	(+-)-1-(3-aminobenzo[d]isoxazol-5-yl)-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 222k::US10329260, Compound 223f::US10633345, Compound 223f::US10689346, Compound 223f::US11203574, Compound 223f::US11230530, Compound 223f::US11685721, Compound 223f	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417002	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417002&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123289526	433916914							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915513	NC(=N)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C30H25F4N7O/c31-23-10-9-20(27(38-16-17-7-8-17)19-4-1-3-18(11-19)15-35)13-24(23)39-29(42)25-14-26(30(32,33)34)40-41(25)22-6-2-5-21(12-22)28(36)37/h1-6,9-14,17,27,38H,7-8,16H2,(H3,36,37)(H,39,42)	VIRFLKJDRZOSPM-UHFFFAOYSA-N	417003	(+)-1-(3-carbamimidoylphenyl)-N-(5-((3-cyanophenyl)(cyclopropylmethylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 236h::US10633345, Compound 236h::US10689346, Compound 236h::US11203574, Compound 236h::US11230530, Compound 236h::US11685721, Compound 236h	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417003	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417003&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665908	433916915							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915514	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C30H25F4N7O/c31-23-6-4-20(27(38-16-17-1-2-17)19-7-10-36-11-8-19)13-24(23)39-29(42)25-15-26(30(32,33)34)40-41(25)21-5-3-18-9-12-37-28(35)22(18)14-21/h3-15,17,27,38H,1-2,16H2,(H2,35,37)(H,39,42)	UQWHIYYZYLIMKJ-UHFFFAOYSA-N	417004	(+-)-1-(1-aminoisoquinolin-7-yl)-N-(5-((cyclopropylmethylamino)(pyridin-4-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 265d::US10633345, Compound 264g::US10689346, Compound 264g::US11203574, Compound 264g::US11230530, Compound 264g::US11685721, Compound 264g	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417004	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417004&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355979	433916916							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915515	Nc1noc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H24F4N6O2/c30-21-10-8-18(26(35-15-16-6-7-16)17-4-2-1-3-5-17)12-22(21)36-28(40)23-14-25(29(31,32)33)37-39(23)19-9-11-24-20(13-19)27(34)38-41-24/h1-5,8-14,16,26,35H,6-7,15H2,(H2,34,38)(H,36,40)	QWKNFIFTTXOPHF-UHFFFAOYSA-N	417002	(+-)-1-(3-aminobenzo[d]isoxazol-5-yl)-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 222k::US10329260, Compound 223f::US10633345, Compound 223f::US10689346, Compound 223f::US11203574, Compound 223f::US11230530, Compound 223f::US11685721, Compound 223f	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417002	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417002&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123289526	433916914							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915516	NC(=N)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C31H27F4N7O/c32-24-10-9-22(30(39,12-11-18-7-8-18)21-5-1-3-19(13-21)17-36)15-25(24)40-29(43)26-16-27(31(33,34)35)41-42(26)23-6-2-4-20(14-23)28(37)38/h1-6,9-10,13-16,18H,7-8,11-12,39H2,(H3,37,38)(H,40,43)	BZRUVEYOOHPOOF-UHFFFAOYSA-N	417006	(+)-N-(5-(1-amino-1-(3-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-carbamimidoylphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 237a::US10633345, Compound 237a::US10689346, Compound 237a::US11192861, Compound 237a::US11230530, Compound 237a::US11685721, Compound 237a	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417006	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417006&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356202	433916917							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915517	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C33H27F4N7O/c34-26-9-7-23(32(40,12-10-19-4-5-19)22-3-1-2-20(14-22)18-38)15-27(26)42-31(45)28-17-29(33(35,36)37)43-44(28)24-8-6-21-11-13-41-30(39)25(21)16-24/h1-3,6-9,11,13-17,19H,4-5,10,12,40H2,(H2,39,41)(H,42,45)	MNAPHYKXZOGSTD-UHFFFAOYSA-N	417007	(+)-N-(5-(1-amino-1-(3-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(1-aminoisoquinolin-7-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 256a::US10633345, Compound 256a::US10689346, Compound 256a::US11203574, Compound 256a::US11230530, Compound 256a::US11685721, Compound 256a	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417007	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417007&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665459	433916918							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915518	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(n1)C#N)C(F)(F)F	InChI=1S/C30H27F4N7O/c31-23-10-9-20(29(37,12-11-18-7-8-18)26-6-2-4-21(17-36)38-26)14-24(23)39-28(42)25-15-27(30(32,33)34)40-41(25)22-5-1-3-19(13-22)16-35/h1-6,9-10,13-15,18H,7-8,11-12,16,35,37H2,(H,39,42)	UYAYDZPBNCJYMZ-UHFFFAOYSA-N	417008	(+)-N-(5-(1-amino-1-(6-cyanopyridin-2-yl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 220f::US10633345, Compound 220f::US10689346, Compound 220f::US11203574, Compound 220f::US11230530, Compound 220f::US11685721, Compound 220f	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417008	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417008&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355858	433916919							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915519	CC(C)(C)[S@@](=O)NC(CCC1CC1)(c1cccnc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(c2)C(N)=N)C(F)(F)F)c1	InChI=1S/C33H35F4N7O2S/c1-31(2,3)47(46)43-32(14-13-20-9-10-20,23-7-5-15-40-19-23)22-11-12-25(34)26(17-22)41-30(45)27-18-28(33(35,36)37)42-44(27)24-8-4-6-21(16-24)29(38)39/h4-8,11-12,15-20,43H,9-10,13-14H2,1-3H3,(H3,38,39)(H,41,45)/t32?,47-/m1/s1	ORCJXCNQCCWVHD-HKYIEPEJSA-N	417009	1-(3-carbamimidoylphenyl)-N-(5-((+-)-3-cyclopropyl-1-((R)-1,1-dimethylethylsulfinamido)-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 238c::US10633345, Compound 238c::US10689346, Compound 238c::US11203574, Compound 238c::US11230530, Compound 238c::US11685721, Compound 238c	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417009	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417009&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355741	433916920							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915520	Nc1nccc2ccc(cc12)-n1nc(cc1C(F)(F)F)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1	InChI=1S/C31H27F4N7O/c32-24-6-4-21(30(37,11-7-18-1-2-18)20-9-12-38-13-10-20)15-25(24)40-29(43)26-17-27(31(33,34)35)42(41-26)22-5-3-19-8-14-39-28(36)23(19)16-22/h3-6,8-10,12-18H,1-2,7,11,37H2,(H2,36,39)(H,40,43)	JTQCWLVRCRAKSI-UHFFFAOYSA-N	417010	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-4-yl)propyl)-2-fluorophenyl)-1-(1-aminoisoquinolin-7-yl)-5-(trifluoromethyl)-1H-pyrazole-3-carboxamide::US10329260, Compound 268g::US10633345, Compound 268g::US10689346, Compound 268g::US11203574, Compound 268g::US11230530, Compound 268g::US11685721, Compound 268g	Plasma kallikrein		>75.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417010	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417010&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356088	433916921							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915521	Nc1n[nH]c2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F			439594	US10633345, Compound 224b::US10689346, Compound 224b::US11203574, Compound 224b::US11230530, Compound 224b	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439594	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439594&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155295687	439661142							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915522	NC(=N)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C31H27F4N7O/c32-24-11-10-22(30(39,13-12-18-4-5-18)21-8-6-19(17-36)7-9-21)15-25(24)40-29(43)26-16-27(31(33,34)35)41-42(26)23-3-1-2-20(14-23)28(37)38/h1-3,6-11,14-16,18H,4-5,12-13,39H2,(H3,37,38)(H,40,43)	QLTPSVVBRYJDCX-UHFFFAOYSA-N	417012	(+)-N-(5-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-carbamimidoylphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 241a::US10633345, Compound 241a::US10689346, Compound 241a::US11192861, Compound 241a::US11230530, Compound 241a::US11685721, Compound 241a	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417012	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417012&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665936	433916923							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915523	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccccc1=O)C(F)(F)F	InChI=1S/C31H26F4N6O2/c32-23-10-8-20(25(11-6-18-4-5-18)40-14-2-1-3-28(40)42)15-24(23)38-30(43)26-17-27(31(33,34)35)39-41(26)21-9-7-19-12-13-37-29(36)22(19)16-21/h1-3,7-10,12-18,25H,4-6,11H2,(H2,36,37)(H,38,43)	GNDQLXKOPYFGBP-UHFFFAOYSA-N	417013	1-(1-aminoisoquinolin-7-yl)-N-(5-(3-cyclopropyl-1-(2-oxopyridin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 258g::US10633345, Compound 258g::US10689346, Compound 258g::US11203574, Compound 258g::US11230530, Compound 258g::US11685721, Compound 258g	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417013	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417013&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355895	433916924							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915524	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C(N)=O)C(F)(F)F	InChI=1S/C31H30F4N6O2/c32-24-10-9-22(30(38,12-11-18-7-8-18)21-5-2-4-20(14-21)28(37)42)15-25(24)39-29(43)26-16-27(31(33,34)35)40-41(26)23-6-1-3-19(13-23)17-36/h1-6,9-10,13-16,18H,7-8,11-12,17,36,38H2,(H2,37,42)(H,39,43)	DYGHBBDYRMOWAC-UHFFFAOYSA-N	417014	(+-)-N-(5-(1-amino-1-(3-carbamoylphenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 225a::US10633345, Compound 225a::US10689346, Compound 225a::US11203574, Compound 225a::US11230530, Compound 225a::US11685721, Compound 225a	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417014	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417014&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665606	433916925							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915525	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C31H28F4N6O/c32-25-10-9-23(30(38,12-11-19-7-8-19)22-5-1-3-20(13-22)17-36)15-26(25)39-29(42)27-16-28(31(33,34)35)40-41(27)24-6-2-4-21(14-24)18-37/h1-6,9-10,13-16,19H,7-8,11-12,18,37-38H2,(H,39,42)	ZBDDMFBNDOEVJT-UHFFFAOYSA-N	416996	(+)-N-(5-(1-amino-1-(3-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 214g::US10633345, Compound 215d::US10689346, Compound 215d::US11203574, Compound 215d::US11230530, Compound 215d::US11685721, Compound 215d	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416996	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416996&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665709	433916908							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915526	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccccc1=O)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-11-10-20(24(12-9-18-7-8-18)37-13-2-1-6-27(37)39)15-23(22)35-28(40)25-16-26(29(31,32)33)36-38(25)21-5-3-4-19(14-21)17-34/h1-6,10-11,13-16,18,24H,7-9,12,17,34H2,(H,35,40)	OFQQGSYWUFBMPP-UHFFFAOYSA-N	416939	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(2-oxopyridin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 248j::US10633345, Compound 248k::US10689346, Compound 248k::US11203574, Compound 248k::US11230530, Compound 248k::US11685721, Compound 248k	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416939	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416939&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355727	433916851							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915527	Nc1ncnc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H25F4N7O/c31-22-10-8-19(27(36-15-17-6-7-17)18-4-2-1-3-5-18)12-24(22)39-29(42)25-14-26(30(32,33)34)40-41(25)20-9-11-23-21(13-20)28(35)38-16-37-23/h1-5,8-14,16-17,27,36H,6-7,15H2,(H,39,42)(H2,35,37,38)	NOYPEPJWHRTGGG-UHFFFAOYSA-N	417011	1-(4-aminoquinazolin-6-yl)-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 224b::US10329260, Compound 226a::US10633345, Compound 226a::US10689346, Compound 226a::US11203574, Compound 226a::US11230530, Compound 226a::US11685721, Compound 226a	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417011	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417011&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665806	433916922							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915528	NC(=N)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H27F4N7O/c30-22-9-8-19(28(36,11-10-17-6-7-17)20-4-2-12-37-16-20)14-23(22)38-27(41)24-15-25(29(31,32)33)39-40(24)21-5-1-3-18(13-21)26(34)35/h1-5,8-9,12-17H,6-7,10-11,36H2,(H3,34,35)(H,38,41)	JBCZLPFSSAYNEJ-UHFFFAOYSA-N	417018	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-1-(3-carbamimidoylphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 238d::US10633345, Compound 238d::US10689346, Compound 238d::US11192861, Compound 238d::US11230530, Compound 238d::US11685721, Compound 238d	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417018	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417018&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355839	433916928							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915529	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccccc1=O)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-11-10-20(24(12-9-18-7-8-18)37-13-2-1-6-27(37)39)15-23(22)35-28(40)25-16-26(29(31,32)33)36-38(25)21-5-3-4-19(14-21)17-34/h1-6,10-11,13-16,18,24H,7-9,12,17,34H2,(H,35,40)	OFQQGSYWUFBMPP-UHFFFAOYSA-N	416939	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(2-oxopyridin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 248j::US10633345, Compound 248k::US10689346, Compound 248k::US11203574, Compound 248k::US11230530, Compound 248k::US11685721, Compound 248k	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416939	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416939&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355727	433916851							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915530	NC(=N)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N6O/c30-22-12-11-19(26(36-16-17-9-10-17)18-5-2-1-3-6-18)14-23(22)37-28(40)24-15-25(29(31,32)33)38-39(24)21-8-4-7-20(13-21)27(34)35/h1-8,11-15,17,26,36H,9-10,16H2,(H3,34,35)(H,37,40)	HUIANTFJQLRTEM-UHFFFAOYSA-N	439603	US10633345, Compound 227d::US10689346, Compound 227d::US11203574, Compound 227d::US11230530, Compound 227d::US11685721, Compound 227d	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439603	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439603&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356162	439661151							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915531	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(nc1)C(N)=O)C(F)(F)F	InChI=1S/C30H29F4N7O2/c31-22-8-6-19(29(37,11-10-17-4-5-17)20-7-9-23(27(36)42)38-16-20)13-24(22)39-28(43)25-14-26(30(32,33)34)40-41(25)21-3-1-2-18(12-21)15-35/h1-3,6-9,12-14,16-17H,4-5,10-11,15,35,37H2,(H2,36,42)(H,39,43)	IQWHGFSUUIEJQU-UHFFFAOYSA-N	417021	(+)-5-(1-amino-1-(3-(1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamido)-4-fluorophenyl)-3-cyclopropylpropyl)picolinamide::US10329260, Compound 221i::US10633345, Compound 221i::US10689346, Compound 221i::US11203574, Compound 221i::US11230530, Compound 221i::US11685721, Compound 221i	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417021	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417021&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665782	433916931							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915532	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C30H25F4N7O/c31-23-6-4-20(27(38-16-17-1-2-17)19-7-10-36-11-8-19)13-24(23)39-29(42)25-15-26(30(32,33)34)40-41(25)21-5-3-18-9-12-37-28(35)22(18)14-21/h3-15,17,27,38H,1-2,16H2,(H2,35,37)(H,39,42)	UQWHIYYZYLIMKJ-UHFFFAOYSA-N	417004	(+-)-1-(1-aminoisoquinolin-7-yl)-N-(5-((cyclopropylmethylamino)(pyridin-4-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 265d::US10633345, Compound 264g::US10689346, Compound 264g::US11203574, Compound 264g::US11230530, Compound 264g::US11685721, Compound 264g	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417004	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417004&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355979	433916916							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915533	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C(N)=O)C(F)(F)F	InChI=1S/C31H30F4N6O2/c32-24-11-10-22(30(38,13-12-18-4-5-18)21-8-6-20(7-9-21)28(37)42)15-25(24)39-29(43)26-16-27(31(33,34)35)40-41(26)23-3-1-2-19(14-23)17-36/h1-3,6-11,14-16,18H,4-5,12-13,17,36,38H2,(H2,37,42)(H,39,43)	HZQICPCUMLWHPZ-UHFFFAOYSA-N	417023	(+)-N-(5-(1-amino-1-(4-carbamoylphenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 228a::US10633345, Compound 228a::US10689346, Compound 228a::US11203574, Compound 228a::US11230530, Compound 228a::US11685721, Compound 228a	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417023	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417023&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665484	433916933							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915534	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-23-7-6-21(28(35,11-8-18-4-5-18)20-9-12-36-13-10-20)15-24(23)37-27(40)25-16-26(29(31,32)33)38-39(25)22-3-1-2-19(14-22)17-34/h1-3,6-7,9-10,12-16,18H,4-5,8,11,17,34-35H2,(H,37,40)	AGVFYPDLNPHKER-UHFFFAOYSA-N	417024	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-4-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 216d::US10633345, Compound 217d::US10689346, Compound 217d::US11192861, Compound 217d::US11230530, Compound 217d::US11685721, Compound 217d	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417024	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417024&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665723	433916934							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915535	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)N1CCCCC1=O)C(F)(F)F	InChI=1S/C29H31F4N5O2/c30-22-11-10-20(24(12-9-18-7-8-18)37-13-2-1-6-27(37)39)15-23(22)35-28(40)25-16-26(29(31,32)33)36-38(25)21-5-3-4-19(14-21)17-34/h3-5,10-11,14-16,18,24H,1-2,6-9,12-13,17,34H2,(H,35,40)	BPULHNPIKAHCAG-UHFFFAOYSA-N	417025	(+)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(2-oxopiperidin-1-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 261k::US10633345, Compound 261k::US10689346, Compound 261k::US11203574, Compound 261k::US11230530, Compound 261k::US11685721, Compound 261k	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417025	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417025&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123312183	433916935							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915536	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(N)=O	InChI=1S/C29H29FN6O2/c30-23-12-11-21(27(33-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)34-29(38)26-15-25(28(32)37)35-36(26)22-8-4-5-19(13-22)16-31/h1-8,11-15,18,27,33H,9-10,16-17,31H2,(H2,32,37)(H,34,38)	UMNCVWUVWBVXCX-UHFFFAOYSA-N	417026	(+-)-1-(3-(aminomethyl)phenyl)-N5-(5-((cyclopropylmethylamino)-(phenyl)methyl)-2-fluorophenyl)-1H-pyrazole-3,5-dicarboxamide::US10329260, Compound 229i::US10633345, Compound 229i::US10689346, Compound 229i::US11203574, Compound 229i::US11230530, Compound 229i::US11685721, Compound 229i	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417026	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417026&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665747	433916936							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915537	CC(C)(C)[S@@](=O)NC(CCC1CC1)(c1cccnc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C33H36F4N6O2S/c1-31(2,3)46(45)42-32(14-13-21-9-10-21,24-7-5-15-39-20-24)23-11-12-26(34)27(17-23)40-30(44)28-18-29(33(35,36)37)41-43(28)25-8-4-6-22(16-25)19-38/h4-8,11-12,15-18,20-21,42H,9-10,13-14,19,38H2,1-3H3,(H,40,44)/t32?,46-/m1/s1	LAOWFCURFGDGCT-ODZHGNIVSA-N	417027	1-(3-(aminomethyl)phenyl)-N-(5-((+-)-3-cyclopropyl-1-((R)-1,1-dimethylethylsulfinamido)-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 243a::US10633345, Compound 243a::US10689346, Compound 243a::US11203574, Compound 243a::US11230530, Compound 243a::US11685721, Compound 243a	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417027	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417027&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665825	433916937							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915538	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccncc1=O)C(F)(F)F	InChI=1S/C30H25F4N7O2/c31-22-7-5-19(24(8-3-17-1-2-17)40-12-11-36-16-27(40)42)13-23(22)38-29(43)25-15-26(30(32,33)34)39-41(25)20-6-4-18-9-10-37-28(35)21(18)14-20/h4-7,9-17,24H,1-3,8H2,(H2,35,37)(H,38,43)	RGAKSJSQGQBUGG-UHFFFAOYSA-N	417028	1-(1-aminoisoquinolin-7-yl)-N-(5-(3-cyclopropyl-1-(2-oxopyrazin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 259d::US10633345, Compound 259d::US10689346, Compound 259d::US11203574, Compound 259d::US11230530, Compound 259d::US11685721, Compound 259d	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417028	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417028&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355792	433916938							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915539	NC(=O)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H25F4N5O2/c30-22-12-11-19(26(35-16-17-9-10-17)18-5-2-1-3-6-18)14-23(22)36-28(40)24-15-25(29(31,32)33)37-38(24)21-8-4-7-20(13-21)27(34)39/h1-8,11-15,17,26,35H,9-10,16H2,(H2,34,39)(H,36,40)	JMSFBJDWVQAENA-UHFFFAOYSA-N	417029	(+-)-1-(3-carbamoylphenyl)-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 230a::US10633345, Compound 230a::US10689346, Compound 230a::US11203574, Compound 230a::US11230530, Compound 230a::US11685721, Compound 230a	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417029	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417029&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665857	433916939							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915540	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-23-7-6-21(28(35,11-8-18-4-5-18)20-9-12-36-13-10-20)15-24(23)37-27(40)25-16-26(29(31,32)33)38-39(25)22-3-1-2-19(14-22)17-34/h1-3,6-7,9-10,12-16,18H,4-5,8,11,17,34-35H2,(H,37,40)	AGVFYPDLNPHKER-UHFFFAOYSA-N	417024	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-4-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 216d::US10633345, Compound 217d::US10689346, Compound 217d::US11192861, Compound 217d::US11230530, Compound 217d::US11685721, Compound 217d	Plasma kallikrein		>75.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417024	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417024&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665723	433916934							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915541	Cc1cc(ccn1)C(N)(CCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F4N6O/c1-18-13-22(10-12-37-18)29(36,11-9-19-5-6-19)21-7-8-24(31)25(15-21)38-28(41)26-16-27(30(32,33)34)39-40(26)23-4-2-3-20(14-23)17-35/h2-4,7-8,10,12-16,19H,5-6,9,11,17,35-36H2,1H3,(H,38,41)	PYONXWOUVYIBRU-UHFFFAOYSA-N	417031	(+)-N-(5-(1-amino-3-cyclopropyl-1-(2-methylpyridin-4-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 266j::US10633345, Compound 266j::US10689346, Compound 266j::US11203574, Compound 266j::US11230530, Compound 266j::US11685721, Compound 266j	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417031	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417031&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665585	433916941							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915542	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccc(=O)[nH]c1=O)C(F)(F)F			417032	1-(1-aminoisoquinolin-7-yl)-N-(5-(3-cyclopropyl-1-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 269b::US10633345, Compound 269b::US10689346, Compound 269b::US11203574, Compound 269b::US11230530, Compound 269b::US11685721, Compound 269b	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417032	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417032&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			154584237	433916942							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915543	CCNCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C31H31F4N5O/c1-2-36-18-21-7-6-10-24(15-21)40-27(17-28(39-40)31(33,34)35)30(41)38-26-16-23(13-14-25(26)32)29(37-19-20-11-12-20)22-8-4-3-5-9-22/h3-10,13-17,20,29,36-37H,2,11-12,18-19H2,1H3,(H,38,41)	RBEFOPDBDLERKF-UHFFFAOYSA-N	417033	(+-)-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-1-(3-((ethylamino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 270a::US10633345, Compound 270a::US10689346, Compound 270a::US11203574, Compound 270a::US11230530, Compound 270a::US11685721, Compound 270a	Plasma kallikrein		>75.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417033	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417033&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665791	433916943							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51275761	CC(C)C[C@@H]1NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSCc3cc(CSC[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N2)cc(CSC[C@H](NC1=O)C(=O)NCC(O)=O)c3	InChI=1S/C81H120N24O26S3/c1-38(2)22-49-71(123)103-55(67(119)90-30-63(114)115)35-132-32-43-23-44-25-45(24-43)34-134-37-57(79(131)105-21-11-16-58(105)78(130)92-41(5)66(118)97-52(28-61(110)111)74(126)95-48(17-18-60(108)109)68(120)91-40(4)65(117)96-49)104-73(125)51(27-59(83)107)99-70(122)47(15-10-20-89-81(86)87)93-72(124)50(26-42-12-7-6-8-13-42)98-69(121)46(14-9-19-88-80(84)85)94-75(127)53(29-62(112)113)100-76(128)54(31-106)101-77(129)56(36-133-33-44)102-64(116)39(3)82/h6-8,12-13,23-25,38-41,46-58,106H,9-11,14-22,26-37,82H2,1-5H3,(H2,83,107)(H,90,119)(H,91,120)(H,92,130)(H,93,124)(H,94,127)(H,95,126)(H,96,117)(H,97,118)(H,98,121)(H,99,122)(H,100,128)(H,101,129)(H,102,116)(H,103,123)(H,104,125)(H,108,109)(H,110,111)(H,112,113)(H,114,115)(H4,84,85,88)(H4,86,87,89)/t39-,40-,41-,46-,47-,48-,49-,50-,51-,52-,53-,54-,55-,56-,57-,58-/m0/s1	GTNHZOBIFWBTFR-KRHMNGOQSA-N	50520630	CHEMBL4533247	Plasma kallikrein				 20						ChEMBL	10.1021/acs.jmedchem.8b00378	10.7270/Q2N301BF	29851477			Valeur, E; Jimonet, P	AstraZeneca	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50520630	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50520630&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155547271	440729212					C03803		1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915242	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc2CCNCc2cc1F)C(F)(F)F	InChI=1S/C21H19F4N5O/c22-16-7-14-11-27-5-4-13(14)8-17(16)28-20(31)18-9-19(21(23,24)25)29-30(18)15-3-1-2-12(6-15)10-26/h1-3,6-9,27H,4-5,10-11,26H2,(H,28,31)	XCBOZBQFIYATFU-UHFFFAOYSA-N	416716	1-(3-(aminomethyl)phenyl)-N-(7-fluoro-1,2,3,4-tetrahydroisoquinolin-6-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 161e::US10633345, Compound 161e::US10689346, Compound 161e::US11203574, Compound 161e::US11230530, Compound 161e::US11685721, Compound 161e	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416716	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416716&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356276	433916630							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915243	CN(Cc1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1)c1ccccc1	InChI=1S/C26H24F3N5O/c1-33(21-10-3-2-4-11-21)17-19-8-5-9-20(13-19)31-25(35)23-15-24(26(27,28)29)32-34(23)22-12-6-7-18(14-22)16-30/h2-15H,16-17,30H2,1H3,(H,31,35)	IEARPKHOKPOLCS-UHFFFAOYSA-N	416717	1-(3-(aminomethyl)phenyl)-N-(3-((methyl(phenyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 28f::US10633345, Compound 28f::US10689346, Compound 28f::US11203574, Compound 28f::US11230530, Compound 28f::US11685721, Compound 28f	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416717	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416717&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665676	433916631							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915244	CCCN(c1ccccc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C27H25F4N5O/c1-2-13-35(19-8-4-3-5-9-19)20-11-12-22(28)23(15-20)33-26(37)24-16-25(27(29,30)31)34-36(24)21-10-6-7-18(14-21)17-32/h3-12,14-16H,2,13,17,32H2,1H3,(H,33,37)	NZQCKHUBEMVLQD-UHFFFAOYSA-N	416718	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-5-(phenyl(propyl)amino)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 77e::US10633345, Compound 77e::US10689346, Compound 77e::US11203574, Compound 77e::US11230530, Compound 77e::US11685721, Compound 77e	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416718	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416718&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665730	433916632							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915245	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1ccc2CNCCc2c1F)C(F)(F)F	InChI=1S/C21H19F4N5O/c22-19-15-6-7-27-11-13(15)4-5-16(19)28-20(31)17-9-18(21(23,24)25)29-30(17)14-3-1-2-12(8-14)10-26/h1-5,8-9,27H,6-7,10-11,26H2,(H,28,31)	RYNJWLCYWDTYKF-UHFFFAOYSA-N	416719	1-(3-(aminomethyl)phenyl)-N-(5-fluoro-1,2,3,4-tetrahydroisoquinolin-6-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 162c::US10633345, Compound 162c::US10689346, Compound 162c::US11203574, Compound 162c::US11230530, Compound 162c::US11685721, Compound 162c	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416719	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416719&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665528	433916633							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915246	CCCN(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1F	InChI=1S/C27H25F4N5O/c1-2-14-35(19-9-4-3-5-10-19)22-13-7-12-21(25(22)28)33-26(37)23-16-24(27(29,30)31)34-36(23)20-11-6-8-18(15-20)17-32/h3-13,15-16H,2,14,17,32H2,1H3,(H,33,37)	SDFZIQBGIDPGAP-UHFFFAOYSA-N	416720	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-3-(phenyl(propyl)amino)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 29e::US10633345, Compound 29e::US10689346, Compound 29e::US11203574, Compound 29e::US11230530, Compound 29e::US11685721, Compound 29e	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416720	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416720&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355654	433916634							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915247	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C28H26F3N5O2/c29-28(30,31)25-15-24(36(35-25)22-8-3-5-19(13-22)16-32)27(37)34-21-7-4-6-20(14-21)26(38-17-18-10-11-18)23-9-1-2-12-33-23/h1-9,12-15,18,26H,10-11,16-17,32H2,(H,34,37)	UBQUVYTUKOFUOF-UHFFFAOYSA-N	416721	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(pyridin-2-yl)methyl)-phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 43f::US10633345, Compound 43f::US10689346, Compound 43g::US11203574, Compound 43h::US11230530, Compound 43h::US11685721, Compound 43f	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416721	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416721&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355947	433916635							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915248	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc2CNCCc2cc1F)C(F)(F)F	InChI=1S/C21H19F4N5O/c22-16-7-13-4-5-27-11-14(13)8-17(16)28-20(31)18-9-19(21(23,24)25)29-30(18)15-3-1-2-12(6-15)10-26/h1-3,6-9,27H,4-5,10-11,26H2,(H,28,31)	APLBFUXJEQDPBH-UHFFFAOYSA-N	416722	1-(3-(aminomethyl)phenyl)-N-(6-fluoro-1,2,3,4-tetrahydroisoquinolin-7-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 163g::US10633345, Compound 163g::US10689346, Compound 163g::US11203574, Compound 163g::US11230530, Compound 163g::US11685721, Compound 163g	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416722	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416722&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355616	433916636							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915249	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(Cn2ccnc2)ccc1F)C(F)(F)F	InChI=1S/C22H18F4N6O/c23-17-5-4-15(12-31-7-6-28-13-31)9-18(17)29-21(33)19-10-20(22(24,25)26)30-32(19)16-3-1-2-14(8-16)11-27/h1-10,13H,11-12,27H2,(H,29,33)	FOWNNAMOGPFGSS-UHFFFAOYSA-N	416723	N-(5-((1H-imidazol-1-yl)methyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 30g::US10633345, Compound 30g::US10689346, Compound 30g::US11203574, Compound 30g::US11230530, Compound 30g::US11685721, Compound 30g	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416723	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416723&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356018	433916637							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915250	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H26F3N5O2/c29-28(30,31)25-14-24(36(35-25)23-8-1-4-19(12-23)15-32)27(37)34-22-7-2-5-20(13-22)26(38-17-18-9-10-18)21-6-3-11-33-16-21/h1-8,11-14,16,18,26H,9-10,15,17,32H2,(H,34,37)	SHFRWTHPPCXLER-UHFFFAOYSA-N	416725	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(pyridin-3-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 44c::US10633345, Compound 44c::US10689346, Compound 44c::US11203574, Compound 44d::US11230530, Compound 44e::US11685721, Compound 44c	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416725	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416725&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355578	433916639							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915251	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(Nc2ccccc2)c1)C(F)(F)F	InChI=1S/C24H20F3N5O/c25-24(26,27)22-14-21(32(31-22)20-11-4-6-16(12-20)15-28)23(33)30-19-10-5-9-18(13-19)29-17-7-2-1-3-8-17/h1-14,29H,15,28H2,(H,30,33)	BURYUTYBSGJGCF-UHFFFAOYSA-N	416728	1-(3-(aminomethyl)phenyl)-N-(3-(phenylamino)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 17d::US10689346, Compound 17d::US11203574, Compound 17d::US11230530, Compound 17d::US11685721, Compound 17d	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416728	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416728&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665499	433916642							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915252	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)c1cccnc1)C(F)(F)F	InChI=1S/C24H20F3N5O2/c25-24(26,27)21-12-20(32(31-21)19-8-1-4-15(10-19)13-28)23(34)30-18-7-2-5-16(11-18)22(33)17-6-3-9-29-14-17/h1-12,14,22,33H,13,28H2,(H,30,34)	ZKOHYLRGOQBIFH-UHFFFAOYSA-N	416729	1-(3-(aminomethyl)phenyl)-N-(3-(hydroxy(pyridin-3-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 31f::US10633345, Compound 31f::US10689346, Compound 31f::US11203574, Compound 31f::US11230530, Compound 31f	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416729	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416729&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665970	433916643							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915253	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F3N4O/c31-30(32,33)28-18-27(37(36-28)25-11-4-6-21(16-25)19-34)29(38)35-24-10-5-9-23(17-24)26(15-14-20-12-13-20)22-7-2-1-3-8-22/h1-11,16-18,20,26H,12-15,19,34H2,(H,35,38)	LVGPKQXQIQRVCT-UHFFFAOYSA-N	416730	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-phenylpropyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 78d::US10633345, Compound 78d::US10689346, Compound 78d::US11203574, Compound 78d::US11230530, Compound 78d::US11685721, Compound 78d	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416730	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416730&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665672	433916644							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915254	COC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C26H23F3N4O2/c1-35-24(18-8-3-2-4-9-18)19-10-6-11-20(14-19)31-25(34)22-15-23(26(27,28)29)32-33(22)21-12-5-7-17(13-21)16-30/h2-15,24H,16,30H2,1H3,(H,31,34)	XNHGZPIIDJTQKO-UHFFFAOYSA-N	416731	1-(3-(aminomethyl)phenyl)-N-(3-(methoxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18f::US10633345, Compound 18f::US10689346, Compound 18f::US11203574, Compound 18f::US11230530, Compound 18e::US11685721, Compound 18f	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416731	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416731&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665801	433916645							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915255	CCCCC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C29H29F3N4O/c1-2-3-15-25(21-10-5-4-6-11-21)22-12-8-13-23(17-22)34-28(37)26-18-27(29(30,31)32)35-36(26)24-14-7-9-20(16-24)19-33/h4-14,16-18,25H,2-3,15,19,33H2,1H3,(H,34,37)	PEZPMDJZISDDKH-UHFFFAOYSA-N	416732	1-(3-(aminomethyl)phenyl)-N-(3-(1-phenylpentyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 32f::US10633345, Compound 32f::US10689346, Compound 32f::US11203574, Compound 32f::US11230530, Compound 32f::US11685721, Compound 32f	Plasma kallikrein		>75.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416732	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416732&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356224	433916646							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915256	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H27F3N6O/c29-28(30,31)25-14-24(37(36-25)23-8-1-4-19(12-23)15-32)27(38)35-22-7-2-5-20(13-22)26(34-16-18-9-10-18)21-6-3-11-33-17-21/h1-8,11-14,17-18,26,34H,9-10,15-16,32H2,(H,35,38)	KSDPGGAAGHTRLB-UHFFFAOYSA-N	416733	1-(3-(Aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(pyridin-3-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 79f::US10633345, Compound 79f::US10689346, Compound 79f::US11203574, Compound 79f::US11230530, Compound 79f::US11685721, Compound 79f	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416733	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416733&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356066	433916647							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915257	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(Cc2ccccc2)c1)C(F)(F)F	InChI=1S/C25H21F3N4O/c26-25(27,28)23-15-22(32(31-23)21-11-5-9-19(14-21)16-29)24(33)30-20-10-4-8-18(13-20)12-17-6-2-1-3-7-17/h1-11,13-15H,12,16,29H2,(H,30,33)	GVRJCFWHVBXPLW-UHFFFAOYSA-N	416734	1-(3-(aminomethyl)phenyl)-N-(3-benzylphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 19d::US10633345, Compound 19d::US10689346, Compound 19d::US11203574, Compound 19d::US11230530, Compound 19d::US11685721, Compound 19d	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416734	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416734&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355715	433916648							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915258	CCOC(c1ccccc1)c1ccc(Cl)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C27H24ClF3N4O2/c1-2-37-25(18-8-4-3-5-9-18)19-11-12-21(28)22(14-19)33-26(36)23-15-24(27(29,30)31)34-35(23)20-10-6-7-17(13-20)16-32/h3-15,25H,2,16,32H2,1H3,(H,33,36)	XUCZWPPXZIMXPF-UHFFFAOYSA-N	416735	1-(3-(aminomethyl)phenyl)-N-(2-chloro-5-(ethoxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 33e::US10633345, Compound 33e::US10689346, Compound 33e::US11203574, Compound 33e::US11230530, Compound 33e::US11685721, Compound 33e	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416735	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416735&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665706	433916649							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915259	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(F)cc(c1)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-22-12-21(27(39-17-18-9-10-18)20-6-2-1-3-7-20)13-23(14-22)35-28(38)25-15-26(29(31,32)33)36-37(25)24-8-4-5-19(11-24)16-34/h1-8,11-15,18,27H,9-10,16-17,34H2,(H,35,38)	CECISELXZFBKBA-UHFFFAOYSA-N	416736	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)-5-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 80h::US10633345, Compound 80h::US10689346, Compound 80h::US11203574, Compound 80h::US11230530, Compound 80h::US11685721, Compound 80h	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416736	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416736&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356068	433916650							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915260	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(Oc2ccccc2)c1)C(F)(F)F	InChI=1S/C24H19F3N4O2/c25-24(26,27)22-14-21(31(30-22)18-8-4-6-16(12-18)15-28)23(32)29-17-7-5-11-20(13-17)33-19-9-2-1-3-10-19/h1-14H,15,28H2,(H,29,32)	CMENISUXWPWEPE-UHFFFAOYSA-N	416737	1-(3-(aminomethyl)phenyl)-N-(3-phenoxyphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 20d::US10689346, Compound 20d::US11203574, Compound 20d::US11230530, Compound 20d::US11685721, Compound 20d	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416737	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416737&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665805	433916651							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915261	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1Cl)C(O)c1ccccc1)C(F)(F)F	InChI=1S/C25H20ClF3N4O2/c26-19-10-9-17(23(34)16-6-2-1-3-7-16)12-20(19)31-24(35)21-13-22(25(27,28)29)32-33(21)18-8-4-5-15(11-18)14-30/h1-13,23,34H,14,30H2,(H,31,35)	RYPOCSQZGRAPIF-UHFFFAOYSA-N	416738	1-(3-(aminomethyl)phenyl)-N-(2-chloro-5-(hydroxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 33f::US10633345, Compound 33f::US10689346, Compound 33f::US11203574, Compound 33f::US11230530, Compound 33f::US11685721, Compound 33f	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416738	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416738&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665810	433916652							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915262	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)N(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H28F3N5O/c30-29(31,32)27-18-26(37(35-27)25-11-4-6-21(16-25)19-33)28(38)34-22-7-5-10-24(17-22)36(15-14-20-12-13-20)23-8-2-1-3-9-23/h1-11,16-18,20H,12-15,19,33H2,(H,34,38)	BPUAEVGWEFCIEW-UHFFFAOYSA-N	416739	1-(3-(aminomethyl)phenyl)-N-(3-((2-cyclopropylethyl)(phenyl)amino)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 87f::US10633345, Compound 87f::US10689346, Compound 87f::US11203574, Compound 87f::US11230530, Compound 87f::US11685721, Compound 87f	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416739	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416739&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665744	433916653							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915263	CCOC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C27H25F3N4O2/c1-2-36-25(19-9-4-3-5-10-19)20-11-7-12-21(15-20)32-26(35)23-16-24(27(28,29)30)33-34(23)22-13-6-8-18(14-22)17-31/h3-16,25H,2,17,31H2,1H3,(H,32,35)	NWRGIGNKIBZYEM-UHFFFAOYSA-N	416740	1-(3-(aminomethyl)phenyl)-N-(3-(ethoxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18g::US10633345, Compound 18g::US10689346, Compound 18g::US11203574, Compound 18g::US11230530, Compound 18g::US11685721, Compound 18g	Plasma kallikrein		>75.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416740	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416740&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356270	433916654							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915264	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)c1ccccc1)C(F)(F)F	InChI=1S/C25H20F4N4O2/c26-19-10-9-17(23(34)16-6-2-1-3-7-16)12-20(19)31-24(35)21-13-22(25(27,28)29)32-33(21)18-8-4-5-15(11-18)14-30/h1-13,23,34H,14,30H2,(H,31,35)	SUGJHCONPCVXKJ-UHFFFAOYSA-N	416741	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-5-(hydroxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 34d::US10633345, Compound 34d::US10689346, Compound 34d::US11203574, Compound 34d::US11230530, Compound 34d::US11685721, Compound 34d	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416741	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416741&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665740	433916655							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915265	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(C(NCC2CC2)c2ccccc2)c1F)C(F)(F)F	InChI=1S/C29H27F4N5O/c30-26-22(27(35-17-18-12-13-18)20-7-2-1-3-8-20)10-5-11-23(26)36-28(39)24-15-25(29(31,32)33)37-38(24)21-9-4-6-19(14-21)16-34/h1-11,14-15,18,27,35H,12-13,16-17,34H2,(H,36,39)	YDBPNMJFMRHCIG-UHFFFAOYSA-N	416742	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 88b::US10633345, Compound 88b::US10689346, Compound 88b::US11203574, Compound 88b::US11230530, Compound 88b::US11685721, Compound 88b	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416742	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416742&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123349010	433916656							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915266	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(=O)c1ccccc1)C(F)(F)F	InChI=1S/C25H19F3N4O2/c26-25(27,28)22-14-21(32(31-22)20-11-4-6-16(12-20)15-29)24(34)30-19-10-5-9-18(13-19)23(33)17-7-2-1-3-8-17/h1-14H,15,29H2,(H,30,34)	ZRVRSUVIXBEHIJ-UHFFFAOYSA-N	416743	1-(3-(aminomethyl)phenyl)-N-(3-benzoylphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 22b::US10633345, Compound 22b::US10689346, Compound 22b::US11203574, Compound 22b::US11230530, Compound 22b	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416743	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416743&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355917	433916657							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915267	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(C(O)c2ccccc2)c1F)C(F)(F)F	InChI=1S/C25H20F4N4O2/c26-22-18(23(34)16-7-2-1-3-8-16)10-5-11-19(22)31-24(35)20-13-21(25(27,28)29)32-33(20)17-9-4-6-15(12-17)14-30/h1-13,23,34H,14,30H2,(H,31,35)	DENXCWXVTOPLRK-UHFFFAOYSA-N	416744	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-3-(hydroxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 35g::US10633345, Compound 35g::US10689346, Compound 35g::US11203574, Compound 35g::US11230530, Compound 35g::US11685721, Compound 35g	Plasma kallikrein		>75.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416744	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416744&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355965	433916658							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915268	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1nccs1)C(F)(F)F	InChI=1S/C26H24F3N5O2S/c27-26(28,29)22-13-21(34(33-22)20-6-1-3-17(11-20)14-30)24(35)32-19-5-2-4-18(12-19)23(25-31-9-10-37-25)36-15-16-7-8-16/h1-6,9-13,16,23H,7-8,14-15,30H2,(H,32,35)	FKPORVMTXYTRPN-UHFFFAOYSA-N	416745	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(thiazol-2-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 82f::US10633345, Compound 82f::US10689346, Compound 82f::US11203574, Compound 82f::US11230530, Compound 82f::US11685721, Compound 82f	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416745	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416745&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355763	433916659							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915269	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(Oc2ccccc2)c1F)C(F)(F)F	InChI=1S/C24H18F4N4O2/c25-22-18(10-5-11-20(22)34-17-8-2-1-3-9-17)30-23(33)19-13-21(24(26,27)28)31-32(19)16-7-4-6-15(12-16)14-29/h1-13H,14,29H2,(H,30,33)	VUYMCUFLTORTFW-UHFFFAOYSA-N	416746	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-3-phenoxyphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 23c::US10633345, Compound 23c::US10689346, Compound 23c::US11203574, Compound 23c::US11230530, Compound 23c::US11685721, Compound 23c	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416746	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416746&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665745	433916660							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915270	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-23-12-11-21(27(39-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)35-28(38)25-15-26(29(31,32)33)36-37(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27H,9-10,16-17,34H2,(H,35,38)	HIMJVDQVZQMIPM-UHFFFAOYSA-N	416747	1-(3-(Aminomethyl)phenyl)-N-(5-((cyclopropylmethoxy)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 34c::US10633345, Compound 34c::US10689346, Compound 34c::US11203574, Compound 37a::US11230530, Compound 37a::US11685721, Compound 34c	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416747	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416747&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355729	433916661							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915271	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C28H27F3N6O/c29-28(30,31)25-15-24(37(36-25)22-8-3-5-19(13-22)16-32)27(38)35-21-7-4-6-20(14-21)26(34-17-18-10-11-18)23-9-1-2-12-33-23/h1-9,12-15,18,26,34H,10-11,16-17,32H2,(H,35,38)	UTXGSCUKCKWESJ-UHFFFAOYSA-N	416748	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(pyridin-2-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 83c::US10633345, Compound 83c::US10689346, Compound 83c::US11203574, Compound 83c::US11230530, Compound 83c::US11685721, Compound 83c	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416748	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416748&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355952	433916662							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915272	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(Oc2ccccc2)ccc1F)C(F)(F)F	InChI=1S/C24H18F4N4O2/c25-19-10-9-18(34-17-7-2-1-3-8-17)12-20(19)30-23(33)21-13-22(24(26,27)28)31-32(21)16-6-4-5-15(11-16)14-29/h1-13H,14,29H2,(H,30,33)	RDALDQDNCYVLAM-UHFFFAOYSA-N	416749	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-5-phenoxyphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 24c::US10633345, Compound 24c::US10689346, Compound 24c::US11203574, Compound 24c::US11230530, Compound 24c::US11685721, Compound 24c	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416749	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416749&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356123	433916663							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915273	CC(c1ccccc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C26H22F4N4O/c1-16(18-7-3-2-4-8-18)19-10-11-21(27)22(13-19)32-25(35)23-14-24(26(28,29)30)33-34(23)20-9-5-6-17(12-20)15-31/h2-14,16H,15,31H2,1H3,(H,32,35)	MJZIDCFCPYDNMT-UHFFFAOYSA-N	447495	US10689346, Compound 18e	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=447495	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=447495&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155803027	440709605							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915274	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F3N4O2/c31-30(32,33)27-18-26(37(36-27)25-11-4-6-21(16-25)19-34)28(38)35-24-10-5-9-23(17-24)29(39,15-14-20-12-13-20)22-7-2-1-3-8-22/h1-11,16-18,20,39H,12-15,19,34H2,(H,35,38)	DCGYPXFSNPCKGX-UHFFFAOYSA-N	416751	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 46g::US10633345, Compound 46g::US10689346, Compound 46g::US11203574, Compound 46i::US11230530, Compound 46i::US11685721, Compound 46g	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416751	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416751&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355790	433916665							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915275	CCOC(c1ccccc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C27H24F4N4O2/c1-2-37-25(18-8-4-3-5-9-18)19-11-12-21(28)22(14-19)33-26(36)23-15-24(27(29,30)31)34-35(23)20-10-6-7-17(13-20)16-32/h3-15,25H,2,16,32H2,1H3,(H,33,36)	YVBRMUSUELCGNA-UHFFFAOYSA-N	416752	1-(3-(aminomethyl)phenyl)-N-(5-(ethoxy(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 25b::US10633345, Compound 25b::US10689346, Compound 25b::US11203574, Compound 25b::US11230530, Compound 25b::US11685721, Compound 25b	Plasma kallikrein		>75.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416752	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416752&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665520	433916666							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915276	CC(C)[C@H](N)C(=O)OC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O3/c1-18(2)26(35)29(40)41-27(20-9-4-3-5-10-20)21-11-7-12-22(15-21)36-28(39)24-16-25(30(31,32)33)37-38(24)23-13-6-8-19(14-23)17-34/h3-16,18,26-27H,17,34-35H2,1-2H3,(H,36,39)/t26-,27?/m0/s1	OQCWFOUCOSAWQU-QBHOUYDASA-N	416753	(2S)-(3-(1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamido)phenyl)(phenyl)methyl 2-amino-3-methylbutanoate::US10329260, Compound 81c::US10633345, Compound 81c::US10689346, Compound 81c::US11203574, Compound 81c::US11230530, Compound 81c::US11685721, Compound 81c	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416753	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416753&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355992	433916667					C03317		1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915277	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C28H26F4N6O/c29-21-10-9-19(26(35-16-17-7-8-17)22-6-1-2-11-34-22)13-23(21)36-27(39)24-14-25(28(30,31)32)37-38(24)20-5-3-4-18(12-20)15-33/h1-6,9-14,17,26,35H,7-8,15-16,33H2,(H,36,39)	NHHQSQFDXMXIJU-UHFFFAOYSA-N	416812	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(pyridin-2-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 100e::US10633345, Compound 100e::US10689346, Compound 100e::US11203574, Compound 100e::US11230530, Compound 100e::US11685721, Compound 100e	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416812	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416812&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356158	433916726							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915278	COC(c1ccccc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C26H22F4N4O2/c1-36-24(17-7-3-2-4-8-17)18-10-11-20(27)21(13-18)32-25(35)22-14-23(26(28,29)30)33-34(22)19-9-5-6-16(12-19)15-31/h2-14,24H,15,31H2,1H3,(H,32,35)	AJQPEPSKLFPFIU-UHFFFAOYSA-N	416755	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-5-(methoxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 25c::US10633345, Compound 25c::US10689346, Compound 25c::US11203574, Compound 25c::US11230530, Compound 25c::US11685721, Compound 25c	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416755	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416755&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126666045	433916669							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915279	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CC#N)c1ccccc1)C(F)(F)F	InChI=1S/C27H22F3N5O/c28-27(29,30)25-16-24(35(34-25)22-11-4-6-18(14-22)17-32)26(36)33-21-10-5-9-20(15-21)23(12-13-31)19-7-2-1-3-8-19/h1-11,14-16,23H,12,17,32H2,(H,33,36)	AUPCAIQBGWQVBR-UHFFFAOYSA-N	416756	1-(3-(aminomethyl)phenyl)-N-(3-(2-cyano-1-phenylethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 39e::US10633345, Compound 39e::US10689346, Compound 39e::US11203574, Compound 39e::US11230530, Compound 39e::US11685721, Compound 39e	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416756	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416756&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126666023	433916670							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915280	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CCC1CC1)n1ccnc1)C(F)(F)F	InChI=1S/C27H27F3N6O/c28-27(29,30)25-15-24(36(34-25)22-6-1-3-19(13-22)16-31)26(37)33-21-5-2-4-20(14-21)23(10-9-18-7-8-18)35-12-11-32-17-35/h1-6,11-15,17-18,23H,7-10,16,31H2,(H,33,37)	UPEDWOJFQGRWOZ-UHFFFAOYSA-N	416757	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-(1H-imidazol-1-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 89g::US10633345, Compound 89g::US10689346, Compound 89g::US11203574, Compound 89g::US11230530, Compound 89g::US11685721, Compound 89g	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416757	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416757&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665540	433916671							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915281	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(Cc2ccccc2)ccc1F)C(F)(F)F	InChI=1S/C25H20F4N4O/c26-20-10-9-17(11-16-5-2-1-3-6-16)13-21(20)31-24(34)22-14-23(25(27,28)29)32-33(22)19-8-4-7-18(12-19)15-30/h1-10,12-14H,11,15,30H2,(H,31,34)	PFWDQKVXCJEZES-UHFFFAOYSA-N	416758	1-(3-(aminomethyl)phenyl)-N-(5-benzyl-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 26f::US10633345, Compound 26f::US10689346, Compound 26f::US11203574, Compound 26f::US11230530, Compound 26f::US11685721, Compound 26f	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416758	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416758&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355900	433916672							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915282	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CC(N)=O)c1ccccc1)C(F)(F)F	InChI=1S/C27H24F3N5O2/c28-27(29,30)24-15-23(35(34-24)21-11-4-6-17(12-21)16-31)26(37)33-20-10-5-9-19(13-20)22(14-25(32)36)18-7-2-1-3-8-18/h1-13,15,22H,14,16,31H2,(H2,32,36)(H,33,37)	KDXRDWIYPXSJST-UHFFFAOYSA-N	416759	N-(3-(3-amino-3-oxo-1-phenylpropyl)phenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 40b::US10633345, Compound 40b::US10689346, Compound 40b::US11203574, Compound 40b::US11230530, Compound 40b::US11685721, Compound 40b	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416759	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416759&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665680	433916673							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915283	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(=CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H27F3N4O/c31-30(32,33)28-18-27(37(36-28)25-11-4-6-21(16-25)19-34)29(38)35-24-10-5-9-23(17-24)26(15-14-20-12-13-20)22-7-2-1-3-8-22/h1-11,15-18,20H,12-14,19,34H2,(H,35,38)/b26-15+	VKLRLOSKQDEQAH-CVKSISIWSA-N	439345	US10633345, Compound 91a::US10689346, Compound 91a::US11192861, Compound 91a::US11230530, Compound 91a	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439345	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439345&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			153066367	439660903							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915284	CC(C)COC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C29H29F3N4O2/c1-19(2)18-38-27(21-9-4-3-5-10-21)22-11-7-12-23(15-22)34-28(37)25-16-26(29(30,31)32)35-36(25)24-13-6-8-20(14-24)17-33/h3-16,19,27H,17-18,33H2,1-2H3,(H,34,37)	FMSXMXLNUZXXSC-UHFFFAOYSA-N	416762	1-(3-(aminomethyl)phenyl)-N-(3-(isobutoxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18i::US10633345, Compound 18i::US10689346, Compound 18i::US11203574, Compound 18i::US11230530, Compound 18i::US11685721, Compound 18i	Plasma kallikrein		>75.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416762	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416762&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356257	433916676							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915285	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H28F3N5O/c30-29(31,32)26-16-25(37(36-26)24-11-4-6-20(14-24)17-33)28(38)35-23-10-5-9-22(15-23)27(34-18-19-12-13-19)21-7-2-1-3-8-21/h1-11,14-16,19,27,34H,12-13,17-18,33H2,(H,35,38)	QZQLNMURVWFZTC-UHFFFAOYSA-N	439347	US10633345, Compound 41e::US10689346, Compound 41e::US11203574, Compound 41e::US11230530, Compound 41e	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439347	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439347&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665751	439660905							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915286	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C28H27F3N6O/c29-28(30,31)25-15-24(37(36-25)23-6-1-3-19(13-23)16-32)27(38)35-22-5-2-4-21(14-22)26(34-17-18-7-8-18)20-9-11-33-12-10-20/h1-6,9-15,18,26,34H,7-8,16-17,32H2,(H,35,38)	VXJYGPKEYKOJCQ-UHFFFAOYSA-N	416764	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(pyridin-4-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 86g::US10633345, Compound 86g::US10689346, Compound 86g::US11203574, Compound 86g::US11230530, Compound 86g::US11685721, Compound 86g	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416764	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416764&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355880	433916678							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915287	CCCOC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C28H27F3N4O2/c1-2-14-37-26(20-9-4-3-5-10-20)21-11-7-12-22(16-21)33-27(36)24-17-25(28(29,30)31)34-35(24)23-13-6-8-19(15-23)18-32/h3-13,15-17,26H,2,14,18,32H2,1H3,(H,33,36)	ODVQLXVRAUDBCL-UHFFFAOYSA-N	416765	1-(3-(aminomethyl)phenyl)-N-(3-(phenyl(propoxy)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18h::US10633345, Compound 18k::US10689346, Compound 18h::US11203574, Compound 18h::US11230530, Compound 18h::US11685721, Compound 18h	Plasma kallikrein		>75.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416765	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416765&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665753	433916679							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915288	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F3N4O2/c31-30(32,33)27-18-26(37(36-27)25-11-4-6-21(16-25)19-34)29(38)35-24-10-5-9-23(17-24)28(22-7-2-1-3-8-22)39-15-14-20-12-13-20/h1-11,16-18,20,28H,12-15,19,34H2,(H,35,38)	WCAGCVGZCBBZDT-UHFFFAOYSA-N	416766	1-(3-(aminomethyl)phenyl)-N-(3-((2-cyclopropylethoxy)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 74a::US10689346, Compound 74a::US11203574, Compound 74a::US11230530, Compound 74a::US11685721, Compound 74a	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416766	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416766&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665775	433916680							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915289	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-17-24(37(36-26)23-8-3-5-20(15-23)18-33)27(38)35-22-7-4-6-21(16-22)28(39,13-12-19-10-11-19)25-9-1-2-14-34-25/h1-9,14-17,19,39H,10-13,18,33H2,(H,35,38)	BAOACYBKKSTHLE-UHFFFAOYSA-N	416767	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 45g::US10633345, Compound 45g::US10689346, Compound 45g::US11203574, Compound 45g::US11230530, Compound 45g::US11685721, Compound 45g	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416767	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416767&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665639	433916681							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915290	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(=O)Nc1ccccc1)C(F)(F)F	InChI=1S/C25H20F3N5O2/c26-25(27,28)22-14-21(33(32-22)20-11-4-6-16(12-20)15-29)24(35)31-19-10-5-7-17(13-19)23(34)30-18-8-2-1-3-9-18/h1-14H,15,29H2,(H,30,34)(H,31,35)	HDBCJKHEPGEJHK-UHFFFAOYSA-N	416768	1-(3-(aminomethyl)phenyl)-N-(3-(phenylcarbamoyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 21e::US10633345, Compound 21e::US10689346, Compound 21e::US11203574, Compound 21e::US11230530, Compound 21e::US11685721, Compound 21e	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416768	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416768&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665523	433916682							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915291	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CCC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F3N4O2/c31-30(32,33)27-17-26(37(36-27)25-14-5-9-21(15-25)18-34)29(38)35-24-13-6-12-23(16-24)28(22-10-2-1-3-11-22)39-19-20-7-4-8-20/h1-3,5-6,9-17,20,28H,4,7-8,18-19,34H2,(H,35,38)	KBAGRISCOGFVJB-UHFFFAOYSA-N	416769	1-(3-(aminomethyl)phenyl)-N-(3-((cyclobutylmethoxy)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 75a::US10633345, Compound 75a::US10689346, Compound 75a::US11203574, Compound 75a::US11230530, Compound 75a::US11685721, Compound 75a	Plasma kallikrein		>75.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416769	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416769&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665761	433916683							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915292	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-16-25(37(36-26)24-8-1-4-20(14-24)17-33)27(38)35-23-7-2-5-21(15-23)28(39,12-11-19-9-10-19)22-6-3-13-34-18-22/h1-8,13-16,18-19,39H,9-12,17,33H2,(H,35,38)	AOCZEQQKIIWUBU-UHFFFAOYSA-N	416770	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 47f::US10633345, Compound 47f::US10689346, Compound 47f::US11203574, Compound 47g::US11230530, Compound 47h::US11685721, Compound 47f	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416770	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416770&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355766	433916684							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915293	CCCCOC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C29H29F3N4O2/c1-2-3-15-38-27(21-10-5-4-6-11-21)22-12-8-13-23(17-22)34-28(37)25-18-26(29(30,31)32)35-36(25)24-14-7-9-20(16-24)19-33/h4-14,16-18,27H,2-3,15,19,33H2,1H3,(H,34,37)	PKUIOUWZEKKIOY-UHFFFAOYSA-N	416772	1-(3-(aminomethyl)phenyl)-N-(3-(butoxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18j::US10633345, Compound 18j::US10689346, Compound 18j::US11203574, Compound 18j::US11230530, Compound 18j::US11685721, Compound 18j	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416772	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416772&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356140	433916686							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915294	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F4N5O/c30-23-12-11-21(27(35-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27,35H,9-10,16-17,34H2,(H,36,39)	MCLZOCFEIKBMBA-UHFFFAOYSA-N	416773	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 38d::US10633345, Compound 38d::US10689346, Compound 42a::US11203574, Compound 42a::US11230530, Compound 42a::US11685721, Compound 38d	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416773	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416773&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356124	433916687							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915295	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-17-25(37(36-26)24-6-1-3-20(15-24)18-33)27(38)35-23-5-2-4-22(16-23)28(39,12-9-19-7-8-19)21-10-13-34-14-11-21/h1-6,10-11,13-17,19,39H,7-9,12,18,33H2,(H,35,38)	HEXYKZQZIBBLLM-UHFFFAOYSA-N	416774	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-(pyridin-4-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 92g::US10633345, Compound 92g::US10689346, Compound 92g::US11203574, Compound 92g::US11230530, Compound 92g::US11685721, Compound 92g	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416774	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416774&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355890	433916688							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915296	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F3N4O2/c30-29(31,32)26-16-25(36(35-26)24-11-4-6-20(14-24)17-33)28(37)34-23-10-5-9-22(15-23)27(38-18-19-12-13-19)21-7-2-1-3-8-21/h1-11,14-16,19,27H,12-13,17-18,33H2,(H,34,37)	PEZVPVUPSJXZCH-UHFFFAOYSA-N	416775	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18k::US10633345, Compound 74a::US10689346, Compound 165e::US11203574, Compound 165e::US11230530, Compound 165e::US11685721, Compound 18k	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416775	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416775&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			91884591	433916689							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915297	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1ccc(F)c(c1)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-24-12-11-21(14-23(24)27(39-17-18-9-10-18)20-6-2-1-3-7-20)35-28(38)25-15-26(29(31,32)33)36-37(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27H,9-10,16-17,34H2,(H,35,38)	SMAPKFCZNNYDET-UHFFFAOYSA-N	416776	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)-4-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 76h::US10633345, Compound 76h::US10689346, Compound 76h::US11203574, Compound 76h::US11230530, Compound 76h::US11685721, Compound 76h	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416776	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416776&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356199	433916690							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915298	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cn[nH]c1)C(F)(F)F			416777	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(1H-pyrazol-4-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 84h::US10633345, Compound 84h::US10689346, Compound 84h::US11203574, Compound 84h::US11230530, Compound 84h::US11685721, Compound 84h	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416777	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416777&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			154584214	433916691							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915299	CCCN(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C27H26F3N5O/c1-2-14-34(21-10-4-3-5-11-21)22-12-7-9-20(16-22)32-26(36)24-17-25(27(28,29)30)33-35(24)23-13-6-8-19(15-23)18-31/h3-13,15-17H,2,14,18,31H2,1H3,(H,32,36)	IKJCTSPODFFZCP-UHFFFAOYSA-N	416778	1-(3-(aminomethyl)phenyl)-N-(3-(phenyl(propyl)amino)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 27f::US10633345, Compound 27f::US10689346, Compound 27f::US11203574, Compound 27f::US11230530, Compound 27f::US11685721, Compound 27f	Plasma kallikrein		>75.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416778	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416778&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356135	433916692							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915300	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(C(OCC2CC2)c2ccccc2)c1F)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-26-22(27(39-17-18-12-13-18)20-7-2-1-3-8-20)10-5-11-23(26)35-28(38)24-15-25(29(31,32)33)36-37(24)21-9-4-6-19(14-21)16-34/h1-11,14-15,18,27H,12-13,16-17,34H2,(H,35,38)	OCYVMBLZCJPYSX-UHFFFAOYSA-N	416779	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 36d::US10633345, Compound 36d::US10689346, Compound 36d::US11203574, Compound 36d::US11230530, Compound 36d::US11685721, Compound 36d	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416779	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416779&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356266	433916693							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915301	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1nccs1)C(F)(F)F	InChI=1S/C26H25F3N6OS/c27-26(28,29)22-13-21(35(34-22)20-6-1-3-17(11-20)14-30)24(36)33-19-5-2-4-18(12-19)23(25-31-9-10-37-25)32-15-16-7-8-16/h1-6,9-13,16,23,32H,7-8,14-15,30H2,(H,33,36)	BPCHTFOGBGFGRD-UHFFFAOYSA-N	416780	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(thiazol-2-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 85c::US10633345, Compound 85c::US10689346, Compound 85c::US11203574, Compound 85c::US11230530, Compound 85c::US11685721, Compound 85c	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416780	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416780&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355975	433916694							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915302	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CCC1CC1)N1CCOCC1)C(F)(F)F	InChI=1S/C28H32F3N5O2/c29-28(30,31)26-17-25(36(34-26)23-6-1-3-20(15-23)18-32)27(37)33-22-5-2-4-21(16-22)24(10-9-19-7-8-19)35-11-13-38-14-12-35/h1-6,15-17,19,24H,7-14,18,32H2,(H,33,37)	JPSOHZUNYZMZBS-UHFFFAOYSA-N	416781	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-morpholinopropyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 93b::US10633345, Compound 93b::US10689346, Compound 93b::US11203574, Compound 93b::US11230530, Compound 93b::US11685721, Compound 93b	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416781	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416781&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665612	433916695							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915303	COc1cccc(c1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O2/c1-40-25-10-4-7-22(15-25)28(35-18-19-11-12-19)21-6-3-8-23(14-21)36-29(39)26-16-27(30(31,32)33)37-38(26)24-9-2-5-20(13-24)17-34/h2-10,13-16,19,28,35H,11-12,17-18,34H2,1H3,(H,36,39)	DMSXJIPDGRICQW-UHFFFAOYSA-N	416782	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(3-methoxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 109f::US10633345, Compound 109f::US10689346, Compound 109f::US11203574, Compound 109f::US11230530, Compound 109f::US11685721, Compound 109f	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416782	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416782&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356265	433916696							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915304	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc2ccccc2c1)C(F)(F)F	InChI=1S/C33H30F3N5O/c34-33(35,36)30-18-29(41(40-30)28-10-3-5-22(15-28)19-37)32(42)39-27-9-4-8-25(17-27)31(38-20-21-11-12-21)26-14-13-23-6-1-2-7-24(23)16-26/h1-10,13-18,21,31,38H,11-12,19-20,37H2,(H,39,42)	QCSULFNIDZTXJZ-UHFFFAOYSA-N	416783	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic acid {3-[(cyclopropylmethyl-amino)-naphthalen-2-yl-methyl]-phenyl}-amide::US10329260, Compound 128g::US10633345, Compound 128g::US10689346, Compound 128g::US11203574, Compound 128g::US11230530, Compound 128g::US11685721, Compound 128g	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416783	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416783&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665786	433916697							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915305	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H26F4N6O/c29-22-9-8-19(26(35-15-17-6-7-17)20-4-2-10-34-16-20)12-23(22)36-27(39)24-13-25(28(30,31)32)37-38(24)21-5-1-3-18(11-21)14-33/h1-5,8-13,16-17,26,35H,6-7,14-15,33H2,(H,36,39)	SECDZDWRLPONSX-UHFFFAOYSA-N	416784	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(pyridin-3-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 94b::US10633345, Compound 94b::US10689346, Compound 94b::US11203574, Compound 94b::US11230530, Compound 94b::US11685721, Compound 94b	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416784	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416784&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355774	433916698							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915306	Cc1cccc(c1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O/c1-19-5-2-7-22(13-19)28(35-18-20-11-12-20)23-8-4-9-24(15-23)36-29(39)26-16-27(30(31,32)33)37-38(26)25-10-3-6-21(14-25)17-34/h2-10,13-16,20,28,35H,11-12,17-18,34H2,1H3,(H,36,39)	ADKXWAHEFSGGQB-UHFFFAOYSA-N	416785	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(m-tolyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 110f::US10633345, Compound 110f::US10689346, Compound 110f::US11203574, Compound 110f::US11230530, Compound 110f::US11685721, Compound 110f	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416785	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416785&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123875262	433916699							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915307	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc2ccccc12)C(F)(F)F	InChI=1S/C33H30F3N5O/c34-33(35,36)30-18-29(41(40-30)26-11-3-6-22(16-26)19-37)32(42)39-25-10-4-9-24(17-25)31(38-20-21-14-15-21)28-13-5-8-23-7-1-2-12-27(23)28/h1-13,16-18,21,31,38H,14-15,19-20,37H2,(H,39,42)	NFYBGLSBONMUGA-UHFFFAOYSA-N	416786	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic acid {3-[(cyclopropylmethyl-amino)-naphthalen-1-yl-methyl]-phenyl}-amide::US10329260, Compound 129f::US10633345, Compound 129f::US10689346, Compound 129f::US11203574, Compound 129f::US11230530, Compound 129f::US11685721, Compound 129f	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416786	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416786&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356190	433916700							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915308	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(cc(c1)C1CC1)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C32H32F3N5O/c33-32(34,35)29-17-28(40(39-29)27-8-4-5-21(13-27)18-36)31(41)38-26-15-24(22-11-12-22)14-25(16-26)30(37-19-20-9-10-20)23-6-2-1-3-7-23/h1-8,13-17,20,22,30,37H,9-12,18-19,36H2,(H,38,41)	TXFPQXDVPCBKSX-UHFFFAOYSA-N	439372	US10633345, Compound 95i::US10689346, Compound 95i::US11203574, Compound 95i::US11230530, Compound 95i::US11685721, Compound 95i	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439372	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439372&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665927	439660930							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915309	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc(c1)C(F)(F)F)C(F)(F)F	InChI=1S/C30H27F6N5O/c31-29(32,33)22-7-2-5-20(13-22)27(38-17-18-10-11-18)21-6-3-8-23(14-21)39-28(42)25-15-26(30(34,35)36)40-41(25)24-9-1-4-19(12-24)16-37/h1-9,12-15,18,27,38H,10-11,16-17,37H2,(H,39,42)	FZSHDRVSVGSKOF-UHFFFAOYSA-N	416788	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(3-(trifluoromethyl) phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 111f::US10633345, Compound 111f::US10689346, Compound 111f::US11203574, Compound 111f::US11230530, Compound 111f::US11685721, Compound 111f	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416788	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416788&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355816	433916702							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915310	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccc(N)cc1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-23-11-8-20(27(36-16-17-4-5-17)19-6-9-21(35)10-7-19)13-24(23)37-28(40)25-14-26(29(31,32)33)38-39(25)22-3-1-2-18(12-22)15-34/h1-3,6-14,17,27,36H,4-5,15-16,34-35H2,(H,37,40)	QTGVDKNDDSXZLM-UHFFFAOYSA-N	416789	1-(3-(aminomethyl)phenyl)-N-(5-((4-aminophenyl)(cyclopropylmethylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 130g::US10633345, Compound 130g::US10689346, Compound 130g::US11203574, Compound 130g::US11230530, Compound 130g::US11685721, Compound 130g	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416789	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416789&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665503	433916703							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915311	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1Cl)C(NCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H26ClF3N6O/c29-22-9-8-19(26(35-15-17-6-7-17)20-4-2-10-34-16-20)12-23(22)36-27(39)24-13-25(28(30,31)32)37-38(24)21-5-1-3-18(11-21)14-33/h1-5,8-13,16-17,26,35H,6-7,14-15,33H2,(H,36,39)	DCRDGEJSCMQMFA-UHFFFAOYSA-N	416790	1-(3-(Aminomethyl)phenyl)-N-(2-chloro-5-((cyclopropylmethylamino)(pyridin-3-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 96f::US10633345, Compound 96f::US10689346, Compound 96f::US11203574, Compound 96f::US11230530, Compound 96f::US11685721, Compound 96f	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416790	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416790&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355757	433916704							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915312	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(cc1)S(N)(=O)=O)C(F)(F)F	InChI=1S/C29H29F3N6O3S/c30-29(31,32)26-15-25(38(37-26)23-6-1-3-19(13-23)16-33)28(39)36-22-5-2-4-21(14-22)27(35-17-18-7-8-18)20-9-11-24(12-10-20)42(34,40)41/h1-6,9-15,18,27,35H,7-8,16-17,33H2,(H,36,39)(H2,34,40,41)	BGEXZQITRMVFRR-UHFFFAOYSA-N	416791	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(4-sulfamoylphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 112g::US10633345, Compound 112g::US10689346, Compound 112g::US11203574, Compound 112g::US11230530, Compound 112g::US11685721, Compound 112g	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416791	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416791&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355780	433916705							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915313	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-23-10-9-20(27(36-16-17-7-8-17)19-4-2-5-21(35)12-19)13-24(23)37-28(40)25-14-26(29(31,32)33)38-39(25)22-6-1-3-18(11-22)15-34/h1-6,9-14,17,27,36H,7-8,15-16,34-35H2,(H,37,40)	HJMCNZIVUWWSBV-UHFFFAOYSA-N	416792	1-(3-(aminomethyl)phenyl)-N-(5-((3-aminophenyl)(cyclopropylmethylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 131b::US10633345, Compound 131b::US10689346, Compound 131b::US11203574, Compound 131b::US11230530, Compound 131b::US11685721, Compound 131b	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416792	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416792&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665555	433916706							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915314	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H25F4N5O2/c29-22-9-8-19(26(39-16-17-6-7-17)20-4-2-10-34-15-20)12-23(22)35-27(38)24-13-25(28(30,31)32)36-37(24)21-5-1-3-18(11-21)14-33/h1-5,8-13,15,17,26H,6-7,14,16,33H2,(H,35,38)	CNAFOXQNPWSINI-UHFFFAOYSA-N	416794	Racemic 1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethoxy)(pyridin-3-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 48f::US10633345, Compound 48f::US10689346, Compound 48f::US11203574, Compound 48g::US11230530, Compound 48h::US11685721, Compound 48f	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416794	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416794&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355617	433916708							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915315	CS(=O)(=O)c1ccc(cc1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O3S/c1-42(40,41)25-12-10-21(11-13-25)28(35-18-19-8-9-19)22-5-3-6-23(15-22)36-29(39)26-16-27(30(31,32)33)37-38(26)24-7-2-4-20(14-24)17-34/h2-7,10-16,19,28,35H,8-9,17-18,34H2,1H3,(H,36,39)	UTLDYOFVUPHYMX-UHFFFAOYSA-N	416795	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(4-(methylsulfonyl)phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 113f::US10633345, Compound 113f::US10689346, Compound 113f::US11203574, Compound 113f::US11230530, Compound 113f::US11685721, Compound 113f	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416795	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416795&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355808	433916709							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915316	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C28H26F4N6O/c29-22-7-6-20(26(35-16-17-4-5-17)19-8-10-34-11-9-19)13-23(22)36-27(39)24-14-25(28(30,31)32)37-38(24)21-3-1-2-18(12-21)15-33/h1-3,6-14,17,26,35H,4-5,15-16,33H2,(H,36,39)	JHXYEKYRIWFSRY-UHFFFAOYSA-N	416796	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(pyridin-4-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 132f::US10633345, Compound 132f::US10689346, Compound 132f::US11203574, Compound 132f::US11230530, Compound 132f::US11685721, Compound 132f	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416796	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416796&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665438	433916710							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915317	CN1CCc2c(C1)ccc(NC(=O)c1cc(nn1-c1cccc(CN)c1)C(F)(F)F)c2F	InChI=1S/C22H21F4N5O/c1-30-8-7-16-14(12-30)5-6-17(20(16)23)28-21(32)18-10-19(22(24,25)26)29-31(18)15-4-2-3-13(9-15)11-27/h2-6,9-10H,7-8,11-12,27H2,1H3,(H,28,32)	XRSKJTRQFAFTLA-UHFFFAOYSA-N	416797	1-(3-(aminomethyl)phenyl)-N-(5-fluoro-2-methyl-1,2,3,4-tetrahydroisoquinolin-6-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 164e::US10633345, Compound 164e::US10689346, Compound 164e::US11203574, Compound 164e::US11230530, Compound 164e::US11685721, Compound 164e	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416797	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416797&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665488	433916711							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915318	CS(=O)(=O)c1cccc(c1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O3S/c1-42(40,41)25-10-4-7-22(15-25)28(35-18-19-11-12-19)21-6-3-8-23(14-21)36-29(39)26-16-27(30(31,32)33)37-38(26)24-9-2-5-20(13-24)17-34/h2-10,13-16,19,28,35H,11-12,17-18,34H2,1H3,(H,36,39)	VJYAFYNZRBTGFW-UHFFFAOYSA-N	416798	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(3-(methylsulfonyl)phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 114f::US10633345, Compound 114f::US10689346, Compound 114f::US11203574, Compound 114f::US11230530, Compound 114f::US11685721, Compound 114f	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416798	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416798&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665780	433916712							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915319	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(cc1)-c1ccccc1)C(F)(F)F	InChI=1S/C35H32F3N5O/c36-35(37,38)32-20-31(43(42-32)30-11-4-6-24(18-30)21-39)34(44)41-29-10-5-9-28(19-29)33(40-22-23-12-13-23)27-16-14-26(15-17-27)25-7-2-1-3-8-25/h1-11,14-20,23,33,40H,12-13,21-22,39H2,(H,41,44)	SZCMOETVRNQDRC-UHFFFAOYSA-N	416799	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic Acid {3-[biphenyl-4-yl-(cyclopropylmethyl-amino)-methyl]-phenyl}-amide::US10329260, Compound 133g::US10633345, Compound 133g::US10689346, Compound 133g::US11203574, Compound 133g::US11230530, Compound 133g::US11685721, Compound 133g	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416799	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416799&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665928	433916713							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915320	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(F)cc(c1)C(O)c1ccccc1)C(F)(F)F	InChI=1S/C25H20F4N4O2/c26-18-10-17(23(34)16-6-2-1-3-7-16)11-19(12-18)31-24(35)21-13-22(25(27,28)29)32-33(21)20-8-4-5-15(9-20)14-30/h1-13,23,34H,14,30H2,(H,31,35)	WOQUHGPQEUKGPZ-UHFFFAOYSA-N	416800	1-(3-(aminomethyl)phenyl)-N-(3-fluoro-5-(hydroxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 97f::US10633345, Compound 97f::US10689346, Compound 97f::US11203574, Compound 97f::US11230530, Compound 97f::US11685721, Compound 97f	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416800	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416800&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355887	433916714							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915321	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NC(=O)C1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F3N5O2/c30-29(31,32)25-16-24(37(36-25)23-11-4-6-18(14-23)17-33)28(39)34-22-10-5-9-21(15-22)26(19-7-2-1-3-8-19)35-27(38)20-12-13-20/h1-11,14-16,20,26H,12-13,17,33H2,(H,34,39)(H,35,38)	JNPDNCCSYJLXEM-UHFFFAOYSA-N	439388	US10633345, Compound 115e::US10689346, Compound 115e::US11203574, Compound 115e::US11230530, Compound 115e::US11685721, Compound 115e	Plasma kallikrein		>75.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439388	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439388&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665512	439660946							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915322	COc1ccc2cc(ccc2c1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H32F3N5O2/c1-44-29-13-12-23-15-26(11-10-24(23)17-29)32(39-20-21-8-9-21)25-5-3-6-27(16-25)40-33(43)30-18-31(34(35,36)37)41-42(30)28-7-2-4-22(14-28)19-38/h2-7,10-18,21,32,39H,8-9,19-20,38H2,1H3,(H,40,43)	YJEVEVIVXGFKBA-UHFFFAOYSA-N	416804	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic Acid {3-[(cyclopropylmethyl-amino)-(6-methoxy-naphthalen-2-yl)-methyl]-phenyl}-amide::US10329260, Compound 134f::US10633345, Compound 134f::US10689346, Compound 134f::US11203574, Compound 134f::US11230530, Compound 134f::US11685721, Compound 134f	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416804	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416804&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356181	433916718							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915323	FC(F)(F)c1cc(C(=O)Nc2cccc(c2)C(CCC2CC2)N2CCCC2)n(n1)-c1cccc(c1)C#N	InChI=1S/C28H28F3N5O/c29-28(30,31)26-17-25(36(34-26)23-8-3-5-20(15-23)18-32)27(37)33-22-7-4-6-21(16-22)24(12-11-19-9-10-19)35-13-1-2-14-35/h3-8,15-17,19,24H,1-2,9-14H2,(H,33,37)	MJYCRZLDCMJLHR-UHFFFAOYSA-N	439390	US10633345, Compound 98b::US10689346, Compound 98b::US11203574, Compound 98b::US11230530, Compound 98b	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439390	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439390&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355716	439660948							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915324	CCc1cccc(c1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C31H32F3N5O/c1-2-20-6-3-8-23(14-20)29(36-19-21-12-13-21)24-9-5-10-25(16-24)37-30(40)27-17-28(31(32,33)34)38-39(27)26-11-4-7-22(15-26)18-35/h3-11,14-17,21,29,36H,2,12-13,18-19,35H2,1H3,(H,37,40)	YUWQOWXTNOVILU-UHFFFAOYSA-N	416807	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(3-ethylphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 116e::US10633345, Compound 116e::US10689346, Compound 116e::US11203574, Compound 116e::US11230530, Compound 116e::US11685721, Compound 116e	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416807	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416807&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123342870	433916721							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915325	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(O)cc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-25(37(36-26)23-6-1-3-19(13-23)16-33)28(39)35-22-5-2-4-21(14-22)27(34-17-18-7-8-18)20-9-11-24(38)12-10-20/h1-6,9-15,18,27,34,38H,7-8,16-17,33H2,(H,35,39)	GDUMJZLASJIDFD-UHFFFAOYSA-N	416808	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(4-hydroxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 135c::US10633345, Compound 135c::US10689346, Compound 135c::US11203574, Compound 135c::US11230530, Compound 135c::US11685721, Compound 135c	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416808	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416808&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355747	433916722							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915326	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CNC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-16-25(37(36-26)24-11-4-6-19(14-24)17-33)27(38)35-23-10-5-9-21(15-23)28(39,18-34-22-12-13-22)20-7-2-1-3-8-20/h1-11,14-16,22,34,39H,12-13,17-18,33H2,(H,35,38)	WTFGPUOPMMMRIY-UHFFFAOYSA-N	416809	1-(3-(aminomethyl)phenyl)-N-(3-(2-(cyclopropylamino)-1-hydroxy-1-phenylethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 99g::US10633345, Compound 99g::US10689346, Compound 99g::US11203574, Compound 99g::US11230530, Compound 99g::US11685721, Compound 99g	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416809	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416809&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355899	433916723							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915327	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1F)C(F)(F)F	InChI=1S/C29H27F4N5O/c30-24-10-2-1-9-23(24)27(35-17-18-11-12-18)20-6-4-7-21(14-20)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-3-5-19(13-22)16-34/h1-10,13-15,18,27,35H,11-12,16-17,34H2,(H,36,39)	XNBKWIREUIHXKI-UHFFFAOYSA-N	416810	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2-fluorophenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 117e::US10329260, Compound 119e::US10633345, Compound 117e::US10689346, Compound 117e::US11203574, Compound 117e::US11230530, Compound 117e::US11685721, Compound 117e	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416810	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416810&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123243852	433916724							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915328	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(Cc2ccc(O)cc2)c1)C(F)(F)F	InChI=1S/C25H21F3N4O2/c26-25(27,28)23-14-22(32(31-23)20-6-2-4-18(13-20)15-29)24(34)30-19-5-1-3-17(12-19)11-16-7-9-21(33)10-8-16/h1-10,12-14,33H,11,15,29H2,(H,30,34)	OPPQXCJMBFITBL-UHFFFAOYSA-N	416811	1-(3-(Aminomethyl)phenyl)-N-(3-(4-hydroxybenzyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 136a::US10633345, Compound 136a::US10689346, Compound 136a::US11203574, Compound 136a::US11230530, Compound 136a::US11685721, Compound 136a	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416811	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416811&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356271	433916725							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915329	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C28H26F4N6O/c29-21-10-9-19(26(35-16-17-7-8-17)22-6-1-2-11-34-22)13-23(21)36-27(39)24-14-25(28(30,31)32)37-38(24)20-5-3-4-18(12-20)15-33/h1-6,9-14,17,26,35H,7-8,15-16,33H2,(H,36,39)	NHHQSQFDXMXIJU-UHFFFAOYSA-N	416812	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(pyridin-2-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 100e::US10633345, Compound 100e::US10689346, Compound 100e::US11203574, Compound 100e::US11230530, Compound 100e::US11685721, Compound 100e	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416812	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416812&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356158	433916726							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915330	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1c2ccccc2c(Cl)c2ccccc12)C(F)(F)F	InChI=1S/C37H31ClF3N5O/c38-34-29-13-3-1-11-27(29)33(28-12-2-4-14-30(28)34)35(43-21-22-15-16-22)24-8-6-9-25(18-24)44-36(47)31-19-32(37(39,40)41)45-46(31)26-10-5-7-23(17-26)20-42/h1-14,17-19,22,35,43H,15-16,20-21,42H2,(H,44,47)	WNAKJZQMCRSZKD-UHFFFAOYSA-N	416813	1-(3-(aminomethyl)phenyl)-N-(3-((10-chloroanthracen-9-yl)(cyclopropylmethylamino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 118f::US10633345, Compound 118f::US10689346, Compound 118f::US11203574, Compound 118f::US11230530, Compound 118f::US11685721, Compound 118f	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416813	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416813&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355872	433916727							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915331	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc(O)c1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-25(37(36-26)23-8-1-4-19(12-23)16-33)28(39)35-22-7-2-5-20(13-22)27(34-17-18-10-11-18)21-6-3-9-24(38)14-21/h1-9,12-15,18,27,34,38H,10-11,16-17,33H2,(H,35,39)	WNKOEKOISOIHSR-UHFFFAOYSA-N	416814	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(3-hydroxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 137a::US10633345, Compound 137a::US10689346, Compound 137a::US11203574, Compound 137a::US11230530, Compound 137a::US11685721, Compound 137a	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416814	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416814&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355922	433916728							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915332	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1nccs1)C(F)(F)F	InChI=1S/C26H24F4N6OS/c27-19-7-6-17(23(25-32-8-9-38-25)33-14-15-4-5-15)11-20(19)34-24(37)21-12-22(26(28,29)30)35-36(21)18-3-1-2-16(10-18)13-31/h1-3,6-12,15,23,33H,4-5,13-14,31H2,(H,34,37)	FBQBHRBLNRXXHC-UHFFFAOYSA-N	416815	1-(3-(Aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(thiazol-2-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 101e::US10633345, Compound 101e::US10689346, Compound 101e::US11203574, Compound 101e::US11230530, Compound 101e::US11685721, Compound 101e	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416815	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416815&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355606	433916729							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915333	COc1ccccc1C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O2/c1-40-26-11-3-2-10-24(26)28(35-18-19-12-13-19)21-7-5-8-22(15-21)36-29(39)25-16-27(30(31,32)33)37-38(25)23-9-4-6-20(14-23)17-34/h2-11,14-16,19,28,35H,12-13,17-18,34H2,1H3,(H,36,39)	DAKZTBMQWXCVFA-UHFFFAOYSA-N	439400	US10633345, Compound 119e::US10689346, Compound 119e::US11203574, Compound 119e::US11230530, Compound 119e::US11685721, Compound 120e	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439400	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439400&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665475	439660958							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915334	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(Cc2cccc(O)c2)c1)C(F)(F)F	InChI=1S/C25H21F3N4O2/c26-25(27,28)23-14-22(32(31-23)20-8-2-6-18(12-20)15-29)24(34)30-19-7-1-4-16(11-19)10-17-5-3-9-21(33)13-17/h1-9,11-14,33H,10,15,29H2,(H,30,34)	SDKHQNOIRDBHTG-UHFFFAOYSA-N	416820	1-(3-(aminomethyl)phenyl)-N-(3-(3-hydroxybenzyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 137b::US10633345, Compound 137b::US10689346, Compound 137b::US11203574, Compound 137b::US11230530, Compound 137b::US11685721, Compound 137b	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416820	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416820&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665628	433916733							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915335	CN(C(c1cccc(N)c1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1)C1CC1	InChI=1S/C29H29F3N6O/c1-37(23-11-12-23)27(19-6-3-8-21(34)14-19)20-7-4-9-22(15-20)35-28(39)25-16-26(29(30,31)32)36-38(25)24-10-2-5-18(13-24)17-33/h2-10,13-16,23,27H,11-12,17,33-34H2,1H3,(H,35,39)	UUQWENBOKMRZFC-UHFFFAOYSA-N	439402	US10633345, Compound 102b::US10689346, Compound 102b::US11203574, Compound 102b::US11230530, Compound 102b	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439402	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439402&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665661	439660960							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915336	CC(C)c1ccc(cc1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C32H34F3N5O/c1-20(2)23-11-13-24(14-12-23)30(37-19-21-9-10-21)25-6-4-7-26(16-25)38-31(41)28-17-29(32(33,34)35)39-40(28)27-8-3-5-22(15-27)18-36/h3-8,11-17,20-21,30,37H,9-10,18-19,36H2,1-2H3,(H,38,41)	BFUXJPJTVQBLMT-UHFFFAOYSA-N	416823	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(4-isopropylphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 120e::US10633345, Compound 120e::US10689346, Compound 120e::US11203574, Compound 120e::US11230530, Compound 120e	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416823	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416823&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355943	433916736							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915337	CC(=O)Nc1ccc(cc1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C31H31F3N6O2/c1-19(41)37-24-12-10-22(11-13-24)29(36-18-20-8-9-20)23-5-3-6-25(15-23)38-30(42)27-16-28(31(32,33)34)39-40(27)26-7-2-4-21(14-26)17-35/h2-7,10-16,20,29,36H,8-9,17-18,35H2,1H3,(H,37,41)(H,38,42)	JDALRNHKHTYPON-UHFFFAOYSA-N	416827	N-(3-((4-acetamidophenyl)(cyclopropylmethylamino)methyl)phenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 138f::US10633345, Compound 138f::US10689346, Compound 138f::US11203574, Compound 138f::US11230530, Compound 138f::US11685721, Compound 138f	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416827	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416827&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355810	433916740							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915338	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CCC1CC1)c1cc[nH]c1)C(F)(F)F			416828	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-(1H-pyrrol-3-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 103b::US10633345, Compound 103b::US10689346, Compound 103b::US11203574, Compound 103b::US11230530, Compound 103b::US11685721, Compound 103b	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416828	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416828&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355898	433916741							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915339	Cc1ccc(cc1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O/c1-19-8-12-22(13-9-19)28(35-18-20-10-11-20)23-5-3-6-24(15-23)36-29(39)26-16-27(30(31,32)33)37-38(26)25-7-2-4-21(14-25)17-34/h2-9,12-16,20,28,35H,10-11,17-18,34H2,1H3,(H,36,39)	HRCLMMKOPKWJGF-UHFFFAOYSA-N	416829	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(p-tolyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 122g::US10633345, Compound 122g::US10689346, Compound 122g::US11203574, Compound 122g::US11230530, Compound 122g::US11685721, Compound 122g	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416829	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416829&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355867	433916742							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915340	CN(C(c1ccc(cc1)C#N)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1)C1CC1	InChI=1S/C30H26F4N6O/c1-39(22-10-11-22)28(20-7-5-18(16-35)6-8-20)21-9-12-24(31)25(14-21)37-29(41)26-15-27(30(32,33)34)38-40(26)23-4-2-3-19(13-23)17-36/h2-9,12-15,22,28H,10-11,17,36H2,1H3,(H,37,41)	BZIYYSLZWQNWBF-UHFFFAOYSA-N	439407	US10633345, Compound 52h::US10633345, Compound 71a::US10633345, Compound 71b::US10689346, Compound 71b::US11203574, Compound 71a::US11230530, Compound 71b	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439407	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439407&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355581	439660965							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915341	Cn1cc(cn1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C27H28F3N7O/c1-36-16-20(15-33-36)25(32-14-17-8-9-17)19-5-3-6-21(11-19)34-26(38)23-12-24(27(28,29)30)35-37(23)22-7-2-4-18(10-22)13-31/h2-7,10-12,15-17,25,32H,8-9,13-14,31H2,1H3,(H,34,38)	GHANDLPUFXRHQK-UHFFFAOYSA-N	416831	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(1-methyl-1H-pyrazol-4-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 104f::US10633345, Compound 104f::US10689346, Compound 104f::US11203574, Compound 104f::US11230530, Compound 104f::US11685721, Compound 104f	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416831	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416831&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356100	433916744							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915342	CS(=O)(=O)c1ccccc1C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O3S/c1-42(40,41)26-11-3-2-10-24(26)28(35-18-19-12-13-19)21-7-5-8-22(15-21)36-29(39)25-16-27(30(31,32)33)37-38(25)23-9-4-6-20(14-23)17-34/h2-11,14-16,19,28,35H,12-13,17-18,34H2,1H3,(H,36,39)	XEAXHMDONDJJBQ-UHFFFAOYSA-N	416832	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2-(methylsulfonyl)phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 121f::US10633345, Compound 121f::US10689346, Compound 121f::US11203574, Compound 121f::US11230530, Compound 121f::US11685721, Compound 121f	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416832	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416832&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665701	433916745							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915343	CN(C(c1ccc(CN)cc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1)C1CC1	InChI=1S/C30H30F4N6O/c1-39(22-10-11-22)28(20-7-5-18(16-35)6-8-20)21-9-12-24(31)25(14-21)37-29(41)26-15-27(30(32,33)34)38-40(26)23-4-2-3-19(13-23)17-36/h2-9,12-15,22,28H,10-11,16-17,35-36H2,1H3,(H,37,41)	REFXZSDKKDUEPN-UHFFFAOYSA-N	439410	US10633345, Compound 139b::US10689346, Compound 139b::US11203574, Compound 139b::US11230530, Compound 139b	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439410	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439410&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665496	439660968							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915344	COc1ccc(cc1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O2/c1-40-25-12-10-21(11-13-25)28(35-18-19-8-9-19)22-5-3-6-23(15-22)36-29(39)26-16-27(30(31,32)33)37-38(26)24-7-2-4-20(14-24)17-34/h2-7,10-16,19,28,35H,8-9,17-18,34H2,1H3,(H,36,39)	NTRWDZUFVXMYGD-UHFFFAOYSA-N	416834	1-(3-(Aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(4-methoxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 105g::US10633345, Compound 105g::US10689346, Compound 105g::US11203574, Compound 105g::US11230530, Compound 105g::US11685721, Compound 105g	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416834	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416834&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665521	433916747							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915345	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(OCc2ccccc2)cc1)C(F)(F)F	InChI=1S/C36H34F3N5O2/c37-36(38,39)33-20-32(44(43-33)30-11-4-8-26(18-30)21-40)35(45)42-29-10-5-9-28(19-29)34(41-22-24-12-13-24)27-14-16-31(17-15-27)46-23-25-6-2-1-3-7-25/h1-11,14-20,24,34,41H,12-13,21-23,40H2,(H,42,45)	AKMGFHNAHQDIKU-UHFFFAOYSA-N	439412	US10633345, Compound 123g::US10689346, Compound 123g::US11203574, Compound 123g::US11230530, Compound 123g::US11685721, Compound 107f	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439412	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439412&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665739	439660970							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915346	Cc1cccc(c1)C(NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H29F4N5O/c1-18-4-2-6-21(12-18)28(36-17-19-8-9-19)22-10-11-24(31)25(14-22)37-29(40)26-15-27(30(32,33)34)38-39(26)23-7-3-5-20(13-23)16-35/h2-7,10-15,19,28,36H,8-9,16-17,35H2,1H3,(H,37,40)	DWXIBXKRESUYFO-UHFFFAOYSA-N	416836	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(m-tolyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 140e::US10633345, Compound 140e::US10689346, Compound 140e::US11203574, Compound 140e::US11230530, Compound 140e::US11685721, Compound 140e	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416836	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416836&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356147	433916749							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915347	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1O)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-24(37(36-26)22-8-3-5-19(13-22)16-33)28(39)35-21-7-4-6-20(14-21)27(34-17-18-11-12-18)23-9-1-2-10-25(23)38/h1-10,13-15,18,27,34,38H,11-12,16-17,33H2,(H,35,39)	PCNDJIQOMLHSEK-UHFFFAOYSA-N	416837	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2-hydroxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 49h::US10633345, Compound 49h::US10689346, Compound 49h::US11203574, Compound 49j::US11230530, Compound 49j::US11685721, Compound 49h	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416837	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416837&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355733	433916750							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915348	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc(OC(F)(F)F)c1)C(F)(F)F	InChI=1S/C30H27F6N5O2/c31-29(32,33)26-15-25(41(40-26)23-8-1-4-19(12-23)16-37)28(42)39-22-7-2-5-20(13-22)27(38-17-18-10-11-18)21-6-3-9-24(14-21)43-30(34,35)36/h1-9,12-15,18,27,38H,10-11,16-17,37H2,(H,39,42)	IVEYKJBEIIJLCR-UHFFFAOYSA-N	416838	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(3-(trifluoromethoxy) phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 124f::US10633345, Compound 124f::US10689346, Compound 124f::US11203574, Compound 124f::US11230530, Compound 124f::US11685721, Compound 124f	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416838	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416838&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665809	433916751							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915349	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C1OC(=O)Nc2ccccc12)C(F)(F)F	InChI=1S/C26H20F3N5O3/c27-26(28,29)22-13-21(34(33-22)18-8-3-5-15(11-18)14-30)24(35)31-17-7-4-6-16(12-17)23-19-9-1-2-10-20(19)32-25(36)37-23/h1-13,23H,14,30H2,(H,31,35)(H,32,36)	LRCHTKOMIAYQHX-UHFFFAOYSA-N	416839	1-(3-(aminomethyl)phenyl)-N-(3-(2-oxo-2,4-dihydro-1H-benzo[d][1,3]oxazin-4-yl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 167f::US10633345, Compound 167f::US10689346, Compound 167f::US11203574, Compound 167f::US11230530, Compound 167f::US11685721, Compound 167f	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416839	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416839&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665868	433916752							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915350	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1OCc1ccccc1)C(F)(F)F	InChI=1S/C36H34F3N5O2/c37-36(38,39)33-20-31(44(43-33)29-13-6-10-26(18-29)21-40)35(45)42-28-12-7-11-27(19-28)34(41-22-24-16-17-24)30-14-4-5-15-32(30)46-23-25-8-2-1-3-9-25/h1-15,18-20,24,34,41H,16-17,21-23,40H2,(H,42,45)	XAZZTVOUWUHFIG-UHFFFAOYSA-N	416840	1-(3-(aminomethyl)phenyl)-N-(3-((2-(benzyloxy)phenyl)(cyclopropylmethyl amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 106a::US10633345, Compound 106a::US10689346, Compound 106a::US11203574, Compound 106a::US11230530, Compound 106a::US11685721, Compound 106a	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416840	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416840&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356273	433916753							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915351	COc1ccc2ccccc2c1C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H32F3N5O2/c1-44-29-15-14-23-7-2-3-11-27(23)31(29)32(39-20-21-12-13-21)24-8-5-9-25(17-24)40-33(43)28-18-30(34(35,36)37)41-42(28)26-10-4-6-22(16-26)19-38/h2-11,14-18,21,32,39H,12-13,19-20,38H2,1H3,(H,40,43)	XVOUQCJHWNZPKF-UHFFFAOYSA-N	416841	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2-methoxynaphthalen-1-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 51f::US10633345, Compound 51f::US10689346, Compound 51f::US11203574, Compound 51h::US11230530, Compound 51h::US11685721, Compound 51f	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416841	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416841&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356155	433916754							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915352	COc1cccc(c1)C(NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H29F4N5O2/c1-41-23-7-3-5-20(13-23)28(36-17-18-8-9-18)21-10-11-24(31)25(14-21)37-29(40)26-15-27(30(32,33)34)38-39(26)22-6-2-4-19(12-22)16-35/h2-7,10-15,18,28,36H,8-9,16-17,35H2,1H3,(H,37,40)	MRNMVRANILFBMK-UHFFFAOYSA-N	416842	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(3-methoxyphenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 141e::US10633345, Compound 141e::US10689346, Compound 141e::US11203574, Compound 141e::US11230530, Compound 141e::US11685721, Compound 142f	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416842	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416842&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355803	433916755							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915353	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(N)cc1)C(F)(F)F	InChI=1S/C29H29F3N6O/c30-29(31,32)26-15-25(38(37-26)24-6-1-3-19(13-24)16-33)28(39)36-23-5-2-4-21(14-23)27(35-17-18-7-8-18)20-9-11-22(34)12-10-20/h1-6,9-15,18,27,35H,7-8,16-17,33-34H2,(H,36,39)	XDCYYWMSVYTRMZ-UHFFFAOYSA-N	416843	1-(3-(aminomethyl)phenyl)-N-(3-((4-aminophenyl)(cyclopropylmethyl-amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 50f::US10633345, Compound 50f::US10689346, Compound 50h::US11203574, Compound 50h::US11230530, Compound 50h::US11685721, Compound 50f	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416843	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416843&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355587	433916756							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915354	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cc2ccccc2c2ccccc12)C(F)(F)F	InChI=1S/C37H32F3N5O/c38-37(39,40)34-20-33(45(44-34)28-11-5-7-24(17-28)21-41)36(46)43-27-10-6-9-26(18-27)35(42-22-23-15-16-23)32-19-25-8-1-2-12-29(25)30-13-3-4-14-31(30)32/h1-14,17-20,23,35,42H,15-16,21-22,41H2,(H,43,46)	OZXXGJIBGVGMMV-UHFFFAOYSA-N	416844	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic acid {3-[(cyclopropylmethyl-amino)-phenanthren-9-yl-methyl]-phenyl}-amide::US10329260, Compound 125g::US10633345, Compound 125g::US10689346, Compound 125g::US11203574, Compound 125g::US11230530, Compound 125g::US11685721, Compound 125g	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416844	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416844&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665609	433916757							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915355	COc1ccc(cc1)C(NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H29F4N5O2/c1-41-23-10-7-20(8-11-23)28(36-17-18-5-6-18)21-9-12-24(31)25(14-21)37-29(40)26-15-27(30(32,33)34)38-39(26)22-4-2-3-19(13-22)16-35/h2-4,7-15,18,28,36H,5-6,16-17,35H2,1H3,(H,37,40)	GWNRXEFJAQDBCM-UHFFFAOYSA-N	416845	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(4-methoxyphenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 142f::US10633345, Compound 142f::US10689346, Compound 142f::US11203574, Compound 142f::US11230530, Compound 142f	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416845	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416845&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355909	433916758							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915356	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc(OCc2ccccc2)c1)C(F)F	InChI=1S/C36H35F2N5O2/c37-35(38)32-20-33(43(42-32)30-13-4-9-26(17-30)21-39)36(44)41-29-12-5-10-27(18-29)34(40-22-24-15-16-24)28-11-6-14-31(19-28)45-23-25-7-2-1-3-8-25/h1-14,17-20,24,34-35,40H,15-16,21-23,39H2,(H,41,44)	LWOWROIEELPOJZ-UHFFFAOYSA-N	447602	US10689346, Compound 107f	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=447602	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=447602&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155803045	440709709							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915357	CN(C)c1ccc(C(NCC2CC2)c2cccc(NC(=O)c3cc(nn3-c3cccc(CN)c3)C(F)(F)F)c2)c2ccccc12	InChI=1S/C35H35F3N6O/c1-43(2)30-16-15-29(27-11-3-4-12-28(27)30)33(40-21-22-13-14-22)24-8-6-9-25(18-24)41-34(45)31-19-32(35(36,37)38)42-44(31)26-10-5-7-23(17-26)20-39/h3-12,15-19,22,33,40H,13-14,20-21,39H2,1-2H3,(H,41,45)	IQAVMSNXUBZMCB-UHFFFAOYSA-N	416847	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic acid {3-[(cyclopropylmethyl-amino)-(4-dimethylamino-naphthalen-1-yl)-methyl]-phenyl}-amide::US10329260, Compound 126g::US10633345, Compound 126g::US10689346, Compound 126g::US11203574, Compound 126g::US11230530, Compound 126g::US11685721, Compound 126g	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416847	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416847&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355601	433916760							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915358	Cc1cc(C(=O)Nc2cccc(c2)C(NCC2CC2)c2ccccc2)n(n1)-c1cccc(CN)c1	InChI=1S/C29H31N5O/c1-20-15-27(34(33-20)26-12-5-7-22(16-26)18-30)29(35)32-25-11-6-10-24(17-25)28(31-19-21-13-14-21)23-8-3-2-4-9-23/h2-12,15-17,21,28,31H,13-14,18-19,30H2,1H3,(H,32,35)	GPDBDHGXUBYWPY-UHFFFAOYSA-N	416848	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(phenyl)methyl)phenyl)-3-methyl-1H-pyrazole-5-carboxamid::US10329260, Compound 143l::US10633345, Compound 143l::US10689346, Compound 143l::US11203574, Compound 143l::US11230530, Compound 143l::US11685721, Compound 143l	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416848	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416848&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356139	433916761							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915359	NCc1cccc(c1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H31F3N6O/c31-30(32,33)27-15-26(39(38-27)25-9-2-5-21(13-25)17-35)29(40)37-24-8-3-7-23(14-24)28(36-18-19-10-11-19)22-6-1-4-20(12-22)16-34/h1-9,12-15,19,28,36H,10-11,16-18,34-35H2,(H,37,40)	CBXMVQRWSKIMMQ-UHFFFAOYSA-N	439426	US10633345, Compound 108e::US10689346, Compound 108e::US11203574, Compound 108e::US11230530, Compound 108e	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439426	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439426&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665469	439660984							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915360	CCCOc1ccc(cc1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C32H34F3N5O2/c1-2-15-42-27-13-11-23(12-14-27)30(37-20-21-9-10-21)24-6-4-7-25(17-24)38-31(41)28-18-29(32(33,34)35)39-40(28)26-8-3-5-22(16-26)19-36/h3-8,11-14,16-18,21,30,37H,2,9-10,15,19-20,36H2,1H3,(H,38,41)	BSIABEDKJHMBRX-UHFFFAOYSA-N	416850	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic acid {3-[(cyclopropylmethyl-amino)-(4-propoxy-phenyl)-methyl]-phenyl}-amide::US10329260, Compound 127f::US10633345, Compound 127f::US10689346, Compound 127f::US11203574, Compound 127f::US11230530, Compound 127f::US11685721, Compound 127f	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416850	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416850&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356061	433916763							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915361	CC(C)NC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C28H28F3N5O/c1-18(2)33-26(20-9-4-3-5-10-20)21-11-7-12-22(15-21)34-27(37)24-16-25(28(29,30)31)35-36(24)23-13-6-8-19(14-23)17-32/h3-16,18,26,33H,17,32H2,1-2H3,(H,34,37)	XNDGACONQUBLGK-UHFFFAOYSA-N	416851	1-(3-(Aminomethyl)phenyl)-N-(3-((isopropylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 144d::US10633345, Compound 144d::US10689346, Compound 144d::US11203574, Compound 144d::US11230530, Compound 144d::US11685721, Compound 144d	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416851	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416851&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355596	433916764							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915362	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCCO)c1ccccc1)C(F)(F)F	InChI=1S/C27H26F3N5O2/c28-27(29,30)24-16-23(35(34-24)22-11-4-6-18(14-22)17-31)26(37)33-21-10-5-9-20(15-21)25(32-12-13-36)19-7-2-1-3-8-19/h1-11,14-16,25,32,36H,12-13,17,31H2,(H,33,37)	MMNKSYPQOFLCSY-UHFFFAOYSA-N	416852	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic acid {3-[(2-hydroxy-ethylamino)-phenyl-methyl]-phenyl}-amide::US10329260, Compound 145c::US10633345, Compound 145c::US10689346, Compound 145c::US11203574, Compound 145c::US11230530, Compound 145c::US11685721, Compound 145c	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416852	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416852&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123569320	433916765							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915363	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-10-9-20(27(40-16-17-7-8-17)19-4-2-5-21(35)12-19)13-24(23)36-28(39)25-14-26(29(31,32)33)37-38(25)22-6-1-3-18(11-22)15-34/h1-6,9-14,17,27H,7-8,15-16,34-35H2,(H,36,39)	GBDDXSAKQKODCG-UHFFFAOYSA-N	416853	1-(3-(aminomethyl)phenyl)-N-(5-((3-aminophenyl)(cyclopropylmethoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 57e::US10633345, Compound 65b::US10689346, Compound 65b::US11203574, Compound 65a::US11230530, Compound 65b::US11685721, Compound 57e	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416853	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416853&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355865	433916766							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915364	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(N[C@H]1CC[C@H](O)CC1)c1ccccc1)C(F)(F)F	InChI=1S/C31H32F3N5O2/c32-31(33,34)28-18-27(39(38-28)25-11-4-6-20(16-25)19-35)30(41)37-24-10-5-9-22(17-24)29(21-7-2-1-3-8-21)36-23-12-14-26(40)15-13-23/h1-11,16-18,23,26,29,36,40H,12-15,19,35H2,(H,37,41)/t23-,26-,29?	QCYULPRIJNBHAA-APJPSQSRSA-N	416854	1-(3-(Aminomethyl)phenyl)-N-(3-((((trans)-4-hydroxycyclohexyl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 181b::US10633345, Compound 181b::US10689346, Compound 181b::US11203574, Compound 181b::US11230530, Compound 181b	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416854	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416854&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665446	433916767							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915365	Cc1cc(C(=O)Nc2cccc(c2)C(NCC2CC2)c2cc(O)ccc2O)n(n1)-c1cccc(CN)c1	InChI=1S/C29H31N5O3/c1-18-12-26(34(33-18)23-7-2-4-20(13-23)16-30)29(37)32-22-6-3-5-21(14-22)28(31-17-19-8-9-19)25-15-24(35)10-11-27(25)36/h2-7,10-15,19,28,31,35-36H,8-9,16-17,30H2,1H3,(H,32,37)	LPEUWRVJEWZQCO-UHFFFAOYSA-N	416855	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2,5-dihydroxyphenyl)methyl) phenyl)-3-methyl-1H-pyrazole-5-carboxamide::US10329260, Compound 146g::US10633345, Compound 146g::US10689346, Compound 146g::US11203574, Compound 146g::US11230530, Compound 146g	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416855	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416855&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356064	433916768							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915366	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1O)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-11-10-19(27(35-16-17-8-9-17)21-6-1-2-7-25(21)39)13-23(22)36-28(40)24-14-26(29(31,32)33)37-38(24)20-5-3-4-18(12-20)15-34/h1-7,10-14,17,27,35,39H,8-9,15-16,34H2,(H,36,40)	CKWWRAGQIQAYTL-UHFFFAOYSA-N	416856	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(2-hydroxyphenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 60e::US10633345, Compound 66b::US10689346, Compound 60e::US11203574, Compound 66b::US11230530, Compound 66b::US11685721, Compound 60e	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416856	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416856&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665480	433916769							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915367	CC(O)CNC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C28H28F3N5O2/c1-18(37)17-33-26(20-8-3-2-4-9-20)21-10-6-11-22(14-21)34-27(38)24-15-25(28(29,30)31)35-36(24)23-12-5-7-19(13-23)16-32/h2-15,18,26,33,37H,16-17,32H2,1H3,(H,34,38)	XWEXCUNXVFBKNX-UHFFFAOYSA-N	416857	1-(3-(aminomethyl)phenyl)-N-(3-(((2-hydroxypropyl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 182b::US10633345, Compound 182b::US10689346, Compound 182b::US11203574, Compound 182b::US11230530, Compound 182b::US11685721, Compound 182b	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416857	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416857&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355690	433916770							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915368	CC(=O)Nc1ccc(cc1)C(OCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C31H30F3N5O3/c1-19(40)36-24-12-10-22(11-13-24)29(42-18-20-8-9-20)23-5-3-6-25(15-23)37-30(41)27-16-28(31(32,33)34)38-39(27)26-7-2-4-21(14-26)17-35/h2-7,10-16,20,29H,8-9,17-18,35H2,1H3,(H,36,40)(H,37,41)	AETJNKBVQDZIDV-UHFFFAOYSA-N	416858	N-(3-((4-acetamidophenyl)(cyclopropylmethoxy)methyl)phenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 147e::US10633345, Compound 147e::US10689346, Compound 147e::US11203574, Compound 147e::US11230530, Compound 147e::US11685721, Compound 147e	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416858	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416858&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355828	433916771							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915369	CN(C(c1ccc(cc1)C#N)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1)C1CC1	InChI=1S/C30H26F4N6O/c1-39(22-10-11-22)28(20-7-5-18(16-35)6-8-20)21-9-12-24(31)25(14-21)37-29(41)26-15-27(30(32,33)34)38-40(26)23-4-2-3-19(13-23)17-36/h2-9,12-15,22,28H,10-11,17,36H2,1H3,(H,37,41)	BZIYYSLZWQNWBF-UHFFFAOYSA-N	439407	US10633345, Compound 52h::US10633345, Compound 71a::US10633345, Compound 71b::US10689346, Compound 71b::US11203574, Compound 71a::US11230530, Compound 71b	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439407	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439407&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355581	439660965							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915370	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCCCn1ccnc1)c1ccccc1)C(F)(F)F	InChI=1S/C31H30F3N7O/c32-31(33,34)28-19-27(41(39-28)26-12-4-7-22(17-26)20-35)30(42)38-25-11-5-10-24(18-25)29(23-8-2-1-3-9-23)37-13-6-15-40-16-14-36-21-40/h1-5,7-12,14,16-19,21,29,37H,6,13,15,20,35H2,(H,38,42)	XJDJXHWYZLFIJY-UHFFFAOYSA-N	416860	N-(3-(((3-(1H-Imidazol-1-yl)propyl)amino)(phenyl)methyl)phenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 183b::US10633345, Compound 183b::US10689346, Compound 183b::US11203574, Compound 183b::US11230530, Compound 183b::US11685721, Compound 183b	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416860	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416860&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665638	433916773							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915371	COc1ccc2ccccc2c1C(OCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H31F3N4O3/c1-43-29-15-14-23-7-2-3-11-27(23)31(29)32(44-20-21-12-13-21)24-8-5-9-25(17-24)39-33(42)28-18-30(34(35,36)37)40-41(28)26-10-4-6-22(16-26)19-38/h2-11,14-18,21,32H,12-13,19-20,38H2,1H3,(H,39,42)	YJZQWEYZTCABEY-UHFFFAOYSA-N	416861	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(2-methoxynaphthalen-1-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 148b::US10633345, Compound 148b::US10689346, Compound 148b::US11203574, Compound 148b::US11230530, Compound 148b::US11685721, Compound 148b	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416861	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416861&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665874	433916774							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915372	CN(C(c1ccc(cc1)C#N)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1)C1CC1	InChI=1S/C30H26F4N6O/c1-39(22-10-11-22)28(20-7-5-18(16-35)6-8-20)21-9-12-24(31)25(14-21)37-29(41)26-15-27(30(32,33)34)38-40(26)23-4-2-3-19(13-23)17-36/h2-9,12-15,22,28H,10-11,17,36H2,1H3,(H,37,41)	BZIYYSLZWQNWBF-UHFFFAOYSA-N	439407	US10633345, Compound 52h::US10633345, Compound 71a::US10633345, Compound 71b::US10689346, Compound 71b::US11203574, Compound 71a::US11230530, Compound 71b	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439407	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439407&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355581	439660965							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915373	CN(C)C(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C27H26F3N5O/c1-34(2)25(19-9-4-3-5-10-19)20-11-7-12-21(15-20)32-26(36)23-16-24(27(28,29)30)33-35(23)22-13-6-8-18(14-22)17-31/h3-16,25H,17,31H2,1-2H3,(H,32,36)	BIAJBXPGRHVMIB-UHFFFAOYSA-N	416863	1-(3-(Aminomethyl)phenyl)-N-(3-((dimethylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 184b::US10633345, Compound 184b::US10689346, Compound 184b::US11203574, Compound 184b::US11230530, Compound 184b::US11685721, Compound 184b	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416863	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416863&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356007	433916776							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915374	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccc(O)cc1)C(F)(F)F	InChI=1S/C29H27F3N4O3/c30-29(31,32)26-15-25(36(35-26)23-6-1-3-19(13-23)16-33)28(38)34-22-5-2-4-21(14-22)27(39-17-18-7-8-18)20-9-11-24(37)12-10-20/h1-6,9-15,18,27,37H,7-8,16-17,33H2,(H,34,38)	WIBHWKLQWUWRRF-UHFFFAOYSA-N	416864	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(4-hydroxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 149b::US10633345, Compound 149b::US10689346, Compound 149b::US11203574, Compound 149b::US11230530, Compound 149b::US11685721, Compound 149b	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416864	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416864&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665542	433916777							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915375	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-10-9-20(27(40-16-17-7-8-17)19-4-2-5-21(35)12-19)13-24(23)36-28(39)25-14-26(29(31,32)33)37-38(25)22-6-1-3-18(11-22)15-34/h1-6,9-14,17,27H,7-8,15-16,34-35H2,(H,36,39)	GBDDXSAKQKODCG-UHFFFAOYSA-N	416853	1-(3-(aminomethyl)phenyl)-N-(5-((3-aminophenyl)(cyclopropylmethoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 57e::US10633345, Compound 65b::US10689346, Compound 65b::US11203574, Compound 65a::US11230530, Compound 65b::US11685721, Compound 57e	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416853	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416853&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355865	433916766							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915376	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NC1CCCCC1)c1ccccc1)C(F)(F)F	InChI=1S/C31H32F3N5O/c32-31(33,34)28-19-27(39(38-28)26-16-7-9-21(17-26)20-35)30(40)37-25-15-8-12-23(18-25)29(22-10-3-1-4-11-22)36-24-13-5-2-6-14-24/h1,3-4,7-12,15-19,24,29,36H,2,5-6,13-14,20,35H2,(H,37,40)	MXMWHPZXCVOSEY-UHFFFAOYSA-N	416866	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclohexylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 185b::US10633345, Compound 185b::US10689346, Compound 185b::US11203574, Compound 185b::US11230530, Compound 185b::US11685721, Compound 185b	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416866	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416866&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356164	433916779							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915377	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-25(37(36-26)24-9-1-4-19(12-24)16-33)28(38)35-23-8-3-6-21(14-23)27(39-17-18-10-11-18)20-5-2-7-22(34)13-20/h1-9,12-15,18,27H,10-11,16-17,33-34H2,(H,35,38)	FPQYUIIRVBKUDH-UHFFFAOYSA-N	416867	1-(3-(aminomethyl)phenyl)-N-(3-((3-aminophenyl)(cyclopropyl-methoxy)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 53f::US10633345, Compound 53f::US10689346, Compound 53f::US11203574, Compound 64b::US11230530, Compound 64b::US11685721, Compound 49j	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416867	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416867&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355845	433916780							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915378	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-10-9-20(27(40-16-17-7-8-17)19-4-2-5-21(35)12-19)13-24(23)36-28(39)25-14-26(29(31,32)33)37-38(25)22-6-1-3-18(11-22)15-34/h1-6,9-14,17,27H,7-8,15-16,34-35H2,(H,36,39)	GBDDXSAKQKODCG-UHFFFAOYSA-N	416853	1-(3-(aminomethyl)phenyl)-N-(5-((3-aminophenyl)(cyclopropylmethoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 57e::US10633345, Compound 65b::US10689346, Compound 65b::US11203574, Compound 65a::US11230530, Compound 65b::US11685721, Compound 57e	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416853	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416853&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355865	433916766							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915379	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCc1ccncc1)c1ccccc1)C(F)(F)F	InChI=1S/C31H27F3N6O/c32-31(33,34)28-18-27(40(39-28)26-11-4-6-22(16-26)19-35)30(41)38-25-10-5-9-24(17-25)29(23-7-2-1-3-8-23)37-20-21-12-14-36-15-13-21/h1-18,29,37H,19-20,35H2,(H,38,41)	PXKQYONQBKMAKS-UHFFFAOYSA-N	416869	1-(3-(Aminomethyl)phenyl)-N-(3-(phenyl((pyridin-4-ylmethyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 186b::US10633345, Compound 186b::US10689346, Compound 186b::US11203574, Compound 186b::US11230530, Compound 186b::US11685721, Compound 186b	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416869	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416869&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665494	433916782							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915380	Cc1cc(C(=O)Nc2cccc(c2)C(NCC2CC2)c2cccc(O)c2O)n(n1)-c1cccc(CN)c1	InChI=1S/C29H31N5O3/c1-18-13-25(34(33-18)23-8-2-5-20(14-23)16-30)29(37)32-22-7-3-6-21(15-22)27(31-17-19-11-12-19)24-9-4-10-26(35)28(24)36/h2-10,13-15,19,27,31,35-36H,11-12,16-17,30H2,1H3,(H,32,37)	VPKURNQNFXHFDB-UHFFFAOYSA-N	416870	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2,3-dihydroxyphenyl)methyl)phenyl)-3-methyl-1H-pyrazole-5-carboxamide::US10329260, Compound 150f::US10633345, Compound 150f::US10689346, Compound 150f::US11203574, Compound 150f::US11230530, Compound 150f	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416870	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416870&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355949	433916783							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915381	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc2OCOc12)C(F)(F)F	InChI=1S/C30H28F3N5O3/c31-30(32,33)26-14-24(38(37-26)22-7-1-4-19(12-22)15-34)29(39)36-21-6-2-5-20(13-21)27(35-16-18-10-11-18)23-8-3-9-25-28(23)41-17-40-25/h1-9,12-14,18,27,35H,10-11,15-17,34H2,(H,36,39)	FVRZDZZJKCSOIR-UHFFFAOYSA-N	416871	1-(3-(aminomethyl)phenyl)-N-(3-(benzo[d][1,3]dioxol-4-yl(cyclopropylmethylamino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 192f::US10633345, Compound 192f::US10689346, Compound 192f::US11203574, Compound 192f::US11230530, Compound 192f::US11685721, Compound 192f	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416871	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416871&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665720	433916784							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915382	CC(C)(C)CNC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H32F3N5O/c1-29(2,3)19-35-27(21-10-5-4-6-11-21)22-12-8-13-23(16-22)36-28(39)25-17-26(30(31,32)33)37-38(25)24-14-7-9-20(15-24)18-34/h4-17,27,35H,18-19,34H2,1-3H3,(H,36,39)	NWBNOBGYJRWWRK-UHFFFAOYSA-N	416872	1-(3-(Aminomethyl)phenyl)-N-(3-((neopentylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 187b::US10633345, Compound 187b::US10689346, Compound 187b::US11203574, Compound 187b::US11230530, Compound 187b::US11685721, Compound 187b	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416872	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416872&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124028296	433916785							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915383	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccc(cc1)C(N)=O)C(F)(F)F	InChI=1S/C30H28F4N6O2/c31-23-11-10-21(27(37-16-17-4-5-17)19-6-8-20(9-7-19)28(36)41)13-24(23)38-29(42)25-14-26(30(32,33)34)39-40(25)22-3-1-2-18(12-22)15-35/h1-3,6-14,17,27,37H,4-5,15-16,35H2,(H2,36,41)(H,38,42)	AHHWWBRXILLXFU-UHFFFAOYSA-N	416873	1-(3-(aminomethyl)phenyl)-N-(5-((4-carbamoylphenyl)(cyclopropylmethylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 153b::US10633345, Compound 153b::US10689346, Compound 153b::US11203574, Compound 153b::US11230530, Compound 153b::US11685721, Compound 153b	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416873	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416873&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355991	433916786							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915384	CCC(CO)NC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C29H30F3N5O2/c1-2-22(18-38)34-27(20-9-4-3-5-10-20)21-11-7-12-23(15-21)35-28(39)25-16-26(29(30,31)32)36-37(25)24-13-6-8-19(14-24)17-33/h3-16,22,27,34,38H,2,17-18,33H2,1H3,(H,35,39)	KIDPOTSBLNZGML-UHFFFAOYSA-N	416874	1-(3-(aminomethyl)phenyl)-N-(3-(((1-hydroxybutan-2-yl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 168b::US10633345, Compound 168b::US10689346, Compound 168b::US11192861, Compound 168b::US11230530, Compound 168b::US11685721, Compound 168b	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416874	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416874&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356215	433916787							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915385	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NC1CCC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H28F3N5O/c30-29(31,32)26-17-25(37(36-26)24-14-4-7-19(15-24)18-33)28(38)35-23-13-5-10-21(16-23)27(34-22-11-6-12-22)20-8-2-1-3-9-20/h1-5,7-10,13-17,22,27,34H,6,11-12,18,33H2,(H,35,38)	UCFAODSDUNDTFF-UHFFFAOYSA-N	416875	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclobutylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 188b::US10633345, Compound 188b::US10689346, Compound 188b::US11203574, Compound 188b::US11230530, Compound 188b::US11685721, Compound 188b	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416875	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416875&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123435501	433916788							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915386	COc1cccc(C(NCC2CC2)c2cccc(NC(=O)c3cc(nn3-c3cccc(CN)c3)C(F)(F)F)c2)c1O	InChI=1S/C30H30F3N5O3/c1-41-25-10-4-9-23(28(25)39)27(35-17-18-11-12-18)20-6-3-7-21(14-20)36-29(40)24-15-26(30(31,32)33)37-38(24)22-8-2-5-19(13-22)16-34/h2-10,13-15,18,27,35,39H,11-12,16-17,34H2,1H3,(H,36,40)	KCIFFUCEHRXTLF-UHFFFAOYSA-N	416876	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2-hydroxy-3-methoxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 151g::US10633345, Compound 151g::US10689346, Compound 151g::US11203574, Compound 151g::US11230530, Compound 151g::US11685721, Compound 151g	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416876	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416876&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356165	433916789							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915387	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(N1CCCC1CO)c1ccccc1)C(F)(F)F	InChI=1S/C30H30F3N5O2/c31-30(32,33)27-17-26(38(36-27)24-12-4-7-20(15-24)18-34)29(40)35-23-11-5-10-22(16-23)28(21-8-2-1-3-9-21)37-14-6-13-25(37)19-39/h1-5,7-12,15-17,25,28,39H,6,13-14,18-19,34H2,(H,35,40)	BNZLGFQHSKUMEG-UHFFFAOYSA-N	416877	1-(3-(aminomethyl)phenyl)-N-(3-((2-(hydroxymethyl)pyrrolidin-1-yl)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 169b::US10633345, Compound 169b::US10689346, Compound 169b::US11203574, Compound 169b::US11230530, Compound 169b::US11685721, Compound 169b	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416877	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416877&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356128	433916790							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915388	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCc1ccc(N)cc1)c1ccccc1)C(F)(F)F	InChI=1S/C32H29F3N6O/c33-32(34,35)29-18-28(41(40-29)27-11-4-6-22(16-27)19-36)31(42)39-26-10-5-9-24(17-26)30(23-7-2-1-3-8-23)38-20-21-12-14-25(37)15-13-21/h1-18,30,38H,19-20,36-37H2,(H,39,42)	BKOBJSLLJPHJRR-UHFFFAOYSA-N	416878	N-(3-(((4-Aminobenzyl)amino)(phenyl)methyl)phenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 189b::US10633345, Compound 189b::US10689346, Compound 189b::US11203574, Compound 189b::US11230530, Compound 189b::US11685721, Compound 189b	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416878	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416878&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665871	433916791							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915389	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C30H27F3N6O/c31-30(32,33)27-15-26(39(38-27)25-9-2-5-21(13-25)17-35)29(40)37-24-8-3-7-23(14-24)28(36-18-19-10-11-19)22-6-1-4-20(12-22)16-34/h1-9,12-15,19,28,36H,10-11,17-18,35H2,(H,37,40)	VQJJJCIJWBDLSJ-UHFFFAOYSA-N	416879	1-(3-(aminomethyl)phenyl)-N-(3-((3-cyanophenyl)(cyclopropylmethyl amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 152d::US10633345, Compound 152d::US10689346, Compound 152d::US11203574, Compound 152d::US11230530, Compound 152d::US11685721, Compound 152d	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416879	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416879&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356166	433916792							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915390	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(N1CCC(O)C1)c1ccccc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-16-25(37(35-26)23-11-4-6-19(14-23)17-33)28(39)34-22-10-5-9-21(15-22)27(20-7-2-1-3-8-20)36-13-12-24(38)18-36/h1-11,14-16,24,27,38H,12-13,17-18,33H2,(H,34,39)	FPAZEZULJGBLCM-UHFFFAOYSA-N	416880	1-(3-(aminomethyl)phenyl)-N-(3-((3-hydroxypyrrolidin-1-yl)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 170b::US10633345, Compound 170b::US10689346, Compound 170b::US11192861, Compound 170b::US11230530, Compound 170b::US11685721, Compound 170b	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416880	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416880&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355902	433916793							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915391	CSCCNC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C28H28F3N5OS/c1-38-14-13-33-26(20-8-3-2-4-9-20)21-10-6-11-22(16-21)34-27(37)24-17-25(28(29,30)31)35-36(24)23-12-5-7-19(15-23)18-32/h2-12,15-17,26,33H,13-14,18,32H2,1H3,(H,34,37)	GMRUHWVMBSEBQV-UHFFFAOYSA-N	416881	1-(3-(aminomethyl)phenyl)-N-(3-(((2-(methylthio)ethyl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 190b::US10633345, Compound 190b::US10689346, Compound 190b::US11203574, Compound 190b::US11230530, Compound 190b::US11685721, Compound 190b	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416881	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416881&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665913	433916794							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915392	COc1ccc(C(NCC2CC2)c2cccc(NC(=O)c3cc(nn3-c3cccc(CN)c3)C(F)(F)F)c2)c2ccccc12	InChI=1S/C34H32F3N5O2/c1-44-30-15-14-28(26-10-2-3-11-27(26)30)32(39-20-21-12-13-21)23-7-5-8-24(17-23)40-33(43)29-18-31(34(35,36)37)41-42(29)25-9-4-6-22(16-25)19-38/h2-11,14-18,21,32,39H,12-13,19-20,38H2,1H3,(H,40,43)	YOBACLFKAGKOLX-UHFFFAOYSA-N	416882	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(4-methoxynaphthalen-1-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 154e::US10633345, Compound 154e::US10689346, Compound 154e::US11203574, Compound 154e::US11230530, Compound 154e::US11685721, Compound 154e	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416882	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416882&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665632	433916795							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915393	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NC1CCCCCC1)c1ccccc1)C(F)(F)F	InChI=1S/C32H34F3N5O/c33-32(34,35)29-20-28(40(39-29)27-17-8-10-22(18-27)21-36)31(41)38-26-16-9-13-24(19-26)30(23-11-4-3-5-12-23)37-25-14-6-1-2-7-15-25/h3-5,8-13,16-20,25,30,37H,1-2,6-7,14-15,21,36H2,(H,38,41)	DQWBWUNYPIEFTF-UHFFFAOYSA-N	416883	1-(3-(aminomethyl)phenyl)-N-(3-((cycloheptylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 171b::US10633345, Compound 171b::US10689346, Compound 171b::US11203574, Compound 171b::US11230530, Compound 171b::US11685721, Compound 171b	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416883	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416883&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356134	433916796							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915394	Cc1ccccc1C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O/c1-19-6-2-3-11-25(19)28(35-18-20-12-13-20)22-8-5-9-23(15-22)36-29(39)26-16-27(30(31,32)33)37-38(26)24-10-4-7-21(14-24)17-34/h2-11,14-16,20,28,35H,12-13,17-18,34H2,1H3,(H,36,39)	NQOSRSVLDYDVDI-UHFFFAOYSA-N	416884	1-(3-(Aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(o-tolyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 193f::US10633345, Compound 193f::US10689346, Compound 193f::US11203574, Compound 193f::US11230530, Compound 193f::US11685721, Compound 193f	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416884	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416884&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355753	433916797							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915395	NCc1cccc(c1)C(NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F4N6O/c31-24-10-9-22(28(37-17-18-7-8-18)21-5-1-3-19(11-21)15-35)13-25(24)38-29(41)26-14-27(30(32,33)34)39-40(26)23-6-2-4-20(12-23)16-36/h1-6,9-14,18,28,37H,7-8,15-17,35-36H2,(H,38,41)	PIDHZVXEDSCGNA-UHFFFAOYSA-N	416885	1-(3-(aminomethyl)phenyl)-N-(5-((3-(aminomethyl)phenyl)(cyclopropylmethylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 155c::US10633345, Compound 155c::US10689346, Compound 155c::US11203574, Compound 155c::US11230530, Compound 155c::US11685721, Compound 155c	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416885	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416885&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355611	433916798							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915396	CCCCCNC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H32F3N5O/c1-2-3-7-16-35-28(22-11-5-4-6-12-22)23-13-9-14-24(18-23)36-29(39)26-19-27(30(31,32)33)37-38(26)25-15-8-10-21(17-25)20-34/h4-6,8-15,17-19,28,35H,2-3,7,16,20,34H2,1H3,(H,36,39)	LIINXFZWPJSNHF-UHFFFAOYSA-N	416886	1-(3-(Aminomethyl)phenyl)-N-(3-((pentylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 172b::US10633345, Compound 172b::US10689346, Compound 172b::US11203574, Compound 172b::US11230530, Compound 172b::US11685721, Compound 172b	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416886	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416886&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355915	433916799							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915397	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCCCO)c1ccccc1)C(F)(F)F	InChI=1S/C28H28F3N5O2/c29-28(30,31)25-17-24(36(35-25)23-12-4-7-19(15-23)18-32)27(38)34-22-11-5-10-21(16-22)26(33-13-6-14-37)20-8-2-1-3-9-20/h1-5,7-12,15-17,26,33,37H,6,13-14,18,32H2,(H,34,38)	YSEURYDLGGVADI-UHFFFAOYSA-N	416887	1-(3-(Aminomethyl)phenyl)-N-(3-(((3-hydroxypropyl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 191b::US10633345, Compound 191b::US10689346, Compound 191b::US11203574, Compound 191b::US11230530, Compound 191b::US11685721, Compound 191b	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416887	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416887&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665847	433916800							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915398	COC(CCC1CC1)(c1cccnc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O2/c1-40-29(13-12-20-10-11-20,23-7-4-14-35-19-23)22-6-3-8-24(16-22)36-28(39)26-17-27(30(31,32)33)37-38(26)25-9-2-5-21(15-25)18-34/h2-9,14-17,19-20H,10-13,18,34H2,1H3,(H,36,39)	HEQLXMARFGMGBQ-UHFFFAOYSA-N	416888	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-methoxy-1-(pyridin-3-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 156c::US10633345, Compound 156c::US10689346, Compound 156c::US11203574, Compound 156c::US11230530, Compound 156c::US11685721, Compound 156c	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416888	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416888&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355759	433916801							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915399	CC(CO)NC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C28H28F3N5O2/c1-18(17-37)33-26(20-8-3-2-4-9-20)21-10-6-11-22(14-21)34-27(38)24-15-25(28(29,30)31)35-36(24)23-12-5-7-19(13-23)16-32/h2-15,18,26,33,37H,16-17,32H2,1H3,(H,34,38)	HGDYIKLNDBPRGN-UHFFFAOYSA-N	416889	1-(3-(aminomethyl)phenyl)-N-(3-(((1-hydroxypropan-2-yl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 173b::US10633345, Compound 173b::US10689346, Compound 173b::US11203574, Compound 173b::US11230530, Compound 173b::US11685721, Compound 173b	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416889	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416889&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355997	433916802							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915400	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc(F)c1)C(F)(F)F	InChI=1S/C29H27F4N5O/c30-22-7-2-5-20(13-22)27(35-17-18-10-11-18)21-6-3-8-23(14-21)36-28(39)25-15-26(29(31,32)33)37-38(25)24-9-1-4-19(12-24)16-34/h1-9,12-15,18,27,35H,10-11,16-17,34H2,(H,36,39)	FVMNYLZQOFMPFE-UHFFFAOYSA-N	416890	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(3-fluorophenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 195f::US10633345, Compound 195f::US10689346, Compound 195f::US11203574, Compound 195f::US11230530, Compound 195f::US11685721, Compound 195f	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416890	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416890&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665561	433916803							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915401	CN(C(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1)C1CC1	InChI=1S/C30H26F4N6O/c1-39(22-9-10-22)28(20-6-2-4-18(12-20)16-35)21-8-11-24(31)25(14-21)37-29(41)26-15-27(30(32,33)34)38-40(26)23-7-3-5-19(13-23)17-36/h2-8,11-15,22,28H,9-10,17,36H2,1H3,(H,37,41)	LONUELZOBAIWEW-UHFFFAOYSA-N	439471	US10633345, Compound 54e::US10633345, Compound 70a::US10633345, Compound 70b::US10689346, Compound 70a::US11203574, Compound 70b::US11230530, Compound 70b	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439471	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439471&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355805	439661023							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915402	CC(C)(CO)NC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C29H30F3N5O2/c1-28(2,18-38)35-26(20-9-4-3-5-10-20)21-11-7-12-22(15-21)34-27(39)24-16-25(29(30,31)32)36-37(24)23-13-6-8-19(14-23)17-33/h3-16,26,35,38H,17-18,33H2,1-2H3,(H,34,39)	JPSBLISQAZCRFK-UHFFFAOYSA-N	416892	1-(3-(aminomethyl)phenyl)-N-(3-(((1-hydroxy-2-methylpropan-2-yl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 174b::US10633345, Compound 174b::US10689346, Compound 174b::US11203574, Compound 174b::US11230530, Compound 174b::US11685721, Compound 174b	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416892	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416892&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665949	433916805							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915403	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(F)cc1F)C(F)(F)F	InChI=1S/C29H26F5N5O/c30-20-9-10-23(24(31)13-20)27(36-16-17-7-8-17)19-4-2-5-21(12-19)37-28(40)25-14-26(29(32,33)34)38-39(25)22-6-1-3-18(11-22)15-35/h1-6,9-14,17,27,36H,7-8,15-16,35H2,(H,37,40)	QIBXOBBXVAEMNW-UHFFFAOYSA-N	416893	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2,4-difluorophenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 196f::US10633345, Compound 196f::US10689346, Compound 196f::US11203574, Compound 196f::US11230530, Compound 196f::US11685721, Compound 196f	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416893	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416893&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665453	433916806							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915404	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C30H25F4N5O2/c31-24-11-10-22(28(41-17-19-4-5-19)21-8-6-18(15-35)7-9-21)13-25(24)37-29(40)26-14-27(30(32,33)34)38-39(26)23-3-1-2-20(12-23)16-36/h1-3,6-14,19,28H,4-5,16-17,36H2,(H,37,40)	WXFHQCUXOOXGLO-UHFFFAOYSA-N	416894	1-(3-(aminomethyl)phenyl)-N-(5-((4-cyanophenyl)(cyclopropylmethoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 55b::US10633345, Compound 73b::US10689346, Compound 55b::US11203574, Compound 73b::US11230530, Compound 73b::US11685721, Compound 73b	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416894	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416894&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665569	433916807							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915405	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CCCO1)c1ccccc1)C(F)(F)F	InChI=1S/C30H30F3N5O2/c31-30(32,33)27-17-26(38(37-27)24-12-4-7-20(15-24)18-34)29(39)36-23-11-5-10-22(16-23)28(21-8-2-1-3-9-21)35-19-25-13-6-14-40-25/h1-5,7-12,15-17,25,28,35H,6,13-14,18-19,34H2,(H,36,39)	SIOCTSAXUSNOCO-UHFFFAOYSA-N	416895	1-(3-(aminomethyl)phenyl)-N-(3-(phenyl(((tetrahydrofuran-2-yl)methyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 175b::US10633345, Compound 175b::US10689346, Compound 175b::US11203574, Compound 175b::US11230530, Compound 175b::US11685721, Compound 175b	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416895	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416895&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355976	433916808							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915406	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cc(F)ccc1F)C(F)(F)F	InChI=1S/C29H26F5N5O/c30-20-9-10-24(31)23(13-20)27(36-16-17-7-8-17)19-4-2-5-21(12-19)37-28(40)25-14-26(29(32,33)34)38-39(25)22-6-1-3-18(11-22)15-35/h1-6,9-14,17,27,36H,7-8,15-16,35H2,(H,37,40)	DGRITJGAWATINU-UHFFFAOYSA-N	416896	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2,5-difluorophenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 197f::US10633345, Compound 197f::US10689346, Compound 197f::US11203574, Compound 197f::US11230530, Compound 197f::US11685721, Compound 197f	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416896	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416896&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665599	433916809							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915407	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-9-8-20(28(40,11-10-18-6-7-18)21-4-2-12-35-17-21)14-24(23)36-27(39)25-15-26(29(31,32)33)37-38(25)22-5-1-3-19(13-22)16-34/h1-5,8-9,12-15,17-18,40H,6-7,10-11,16,34H2,(H,36,39)	VCHFZCHUEHQXSZ-UHFFFAOYSA-N	416897	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 58c::US10633345, Compound 67b::US10689346, Compound 67b::US11203574, Compound 67b::US11230530, Compound 67b::US11685721, Compound 67b	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416897	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416897&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355889	433916810							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915408	CC(C)CCNC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H32F3N5O/c1-20(2)14-15-35-28(22-9-4-3-5-10-22)23-11-7-12-24(17-23)36-29(39)26-18-27(30(31,32)33)37-38(26)25-13-6-8-21(16-25)19-34/h3-13,16-18,20,28,35H,14-15,19,34H2,1-2H3,(H,36,39)	WPCVSFNABLNPTN-UHFFFAOYSA-N	416898	1-(3-(aminomethyl)phenyl)-N-(3-((isopentylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 176b::US10633345, Compound 176b::US10689346, Compound 176b::US11203574, Compound 176b::US11230530, Compound 176b::US11685721, Compound 176b	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416898	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416898&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665776	433916811							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915409	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1c(F)cccc1F)C(F)(F)F	InChI=1S/C29H26F5N5O/c30-22-8-3-9-23(31)26(22)27(36-16-17-10-11-17)19-5-2-6-20(13-19)37-28(40)24-14-25(29(32,33)34)38-39(24)21-7-1-4-18(12-21)15-35/h1-9,12-14,17,27,36H,10-11,15-16,35H2,(H,37,40)	OHXCNQRJQHLAER-UHFFFAOYSA-N	416899	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2,6-difluorophenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 198f::US10633345, Compound 198f::US10689346, Compound 198f::US11203574, Compound 198f::US11230530, Compound 198f::US11685721, Compound 198f	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416899	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416899&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665643	433916812							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915410	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C30H25F4N5O2/c31-24-10-9-22(28(41-17-18-7-8-18)21-5-1-3-19(11-21)15-35)13-25(24)37-29(40)26-14-27(30(32,33)34)38-39(26)23-6-2-4-20(12-23)16-36/h1-6,9-14,18,28H,7-8,16-17,36H2,(H,37,40)	LSXFYXGKZDVRTL-UHFFFAOYSA-N	416900	1-(3-(aminomethyl)phenyl)-N-(5-((3-cyanophenyl)(cyclopropyl-methoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 56c::US10633345, Compound 72d::US10689346, Compound 56c::US11203574, Compound 72d::US11230530, Compound 72d::US11685721, Compound 72d	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416900	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416900&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356211	433916813							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915411	CCC(C)CNC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H32F3N5O/c1-3-20(2)19-35-28(22-10-5-4-6-11-22)23-12-8-13-24(16-23)36-29(39)26-17-27(30(31,32)33)37-38(26)25-14-7-9-21(15-25)18-34/h4-17,20,28,35H,3,18-19,34H2,1-2H3,(H,36,39)	ZCSNRDNUIRVYLS-UHFFFAOYSA-N	416901	1-(3-(Aminomethyl)phenyl)-N-(3-(((2-methylbutyl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 177b::US10633345, Compound 177b::US10689346, Compound 177b::US11203574, Compound 177b::US11230530, Compound 177b::US11685721, Compound 177b	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416901	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416901&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665478	433916814							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915412	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1Cl)C(F)(F)F	InChI=1S/C29H27ClF3N5O/c30-24-10-2-1-9-23(24)27(35-17-18-11-12-18)20-6-4-7-21(14-20)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-3-5-19(13-22)16-34/h1-10,13-15,18,27,35H,11-12,16-17,34H2,(H,36,39)	UQMCUIGBQDUSLW-UHFFFAOYSA-N	416902	1-(3-(aminomethyl)phenyl)-N-(3-((2-chlorophenyl)((cyclopropylmethyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 194f::US10329260, Compound 199f::US10633345, Compound 199f::US10689346, Compound 199f::US11203574, Compound 199f::US11230530, Compound 199f::US11685721, Compound 199f	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416902	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416902&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356220	433916815							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915413	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H28F4N4O2/c31-24-12-11-22(29(40,14-13-19-9-10-19)21-6-2-1-3-7-21)16-25(24)36-28(39)26-17-27(30(32,33)34)37-38(26)23-8-4-5-20(15-23)18-35/h1-8,11-12,15-17,19,40H,9-10,13-14,18,35H2,(H,36,39)	NIWMWYNGSALJGG-UHFFFAOYSA-N	416903	Racemic 1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 68c::US10633345, Compound 68e::US10689346, Compound 68c::US11203574, Compound 68e::US11230530, Compound 68e::US11685721, Compound 68e	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416903	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416903&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355758	433916816							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915414	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(N(CCO)CCO)c1ccccc1)C(F)(F)F	InChI=1S/C29H30F3N5O3/c30-29(31,32)26-18-25(37(35-26)24-11-4-6-20(16-24)19-33)28(40)34-23-10-5-9-22(17-23)27(21-7-2-1-3-8-21)36(12-14-38)13-15-39/h1-11,16-18,27,38-39H,12-15,19,33H2,(H,34,40)	HFRFNKSEVVNXFK-UHFFFAOYSA-N	416904	1-(3-(aminomethyl)phenyl)-N-(3-((bis(2-hydroxyethyl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 178b::US10633345, Compound 178b::US10689346, Compound 178b::US11203574, Compound 178b::US11230530, Compound 178b::US11685721, Compound 178b	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416904	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416904&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355913	433916817							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915415	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1Cl)C(F)(F)F	InChI=1S/C29H27ClF3N5O/c30-24-10-2-1-9-23(24)27(35-17-18-11-12-18)20-6-4-7-21(14-20)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-3-5-19(13-22)16-34/h1-10,13-15,18,27,35H,11-12,16-17,34H2,(H,36,39)	UQMCUIGBQDUSLW-UHFFFAOYSA-N	416902	1-(3-(aminomethyl)phenyl)-N-(3-((2-chlorophenyl)((cyclopropylmethyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 194f::US10329260, Compound 199f::US10633345, Compound 199f::US10689346, Compound 199f::US11203574, Compound 199f::US11230530, Compound 199f::US11685721, Compound 199f	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416902	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416902&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356220	433916815							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915416	COc1ccc2ccccc2c1C(NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H31F4N5O2/c1-45-29-14-12-22-6-2-3-8-25(22)31(29)32(40-19-20-9-10-20)23-11-13-26(35)27(16-23)41-33(44)28-17-30(34(36,37)38)42-43(28)24-7-4-5-21(15-24)18-39/h2-8,11-17,20,32,40H,9-10,18-19,39H2,1H3,(H,41,44)	AYMFYNZEWAELBE-UHFFFAOYSA-N	416906	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(2-methoxynaphthalen-1-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide dihydrochloride::US10329260, Compound 61e::US10633345, Compound 63b::US10689346, Compound 61e::US11203574, Compound 63b::US11230530, Compound 63b::US11685721, Compound 63b	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416906	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416906&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355591	433916818							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915417	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCc1cccnc1)c1ccccc1)C(F)(F)F	InChI=1S/C31H27F3N6O/c32-31(33,34)28-17-27(40(39-28)26-13-4-7-21(15-26)18-35)30(41)38-25-12-5-11-24(16-25)29(23-9-2-1-3-10-23)37-20-22-8-6-14-36-19-22/h1-17,19,29,37H,18,20,35H2,(H,38,41)	HIJVXEVWORHKBX-UHFFFAOYSA-N	416907	1-(3-(Aminomethyl)phenyl)-N-(3-(phenyl((pyridin-3-ylmethyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 179b::US10633345, Compound 179b::US10689346, Compound 179b::US11203574, Compound 179b::US11230530, Compound 179b::US11685721, Compound 179b	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416907	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416907&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665526	433916819							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915418	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(Cl)cc1Cl)C(F)(F)F	InChI=1S/C29H26Cl2F3N5O/c30-20-9-10-23(24(31)13-20)27(36-16-17-7-8-17)19-4-2-5-21(12-19)37-28(40)25-14-26(29(32,33)34)38-39(25)22-6-1-3-18(11-22)15-35/h1-6,9-14,17,27,36H,7-8,15-16,35H2,(H,37,40)	CXLXHJIZVQBZJV-UHFFFAOYSA-N	416908	1-(3-(aminomethyl)phenyl)-N-(3-((2,4-dichlorophenyl)((cyclopropylmethyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 200f::US10633345, Compound 200f::US10689346, Compound 200f::US11203574, Compound 200f::US11230530, Compound 200f::US11685721, Compound 200f	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416908	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416908&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126688969	433916820							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915419	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-10-9-20(28(40,12-11-18-7-8-18)25-6-1-2-13-35-25)15-23(22)36-27(39)24-16-26(29(31,32)33)37-38(24)21-5-3-4-19(14-21)17-34/h1-6,9-10,13-16,18,40H,7-8,11-12,17,34H2,(H,36,39)	XXMBQXWQIGCREG-UHFFFAOYSA-N	416909	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 59c::US10633345, Compound 69b::US10689346, Compound 59c::US11203574, Compound 69b::US11230530, Compound 69b::US11685721, Compound 69b	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416909	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416909&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356067	433916821							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915420	CCCCNC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C29H30F3N5O/c1-2-3-15-34-27(21-10-5-4-6-11-21)22-12-8-13-23(17-22)35-28(38)25-18-26(29(30,31)32)36-37(25)24-14-7-9-20(16-24)19-33/h4-14,16-18,27,34H,2-3,15,19,33H2,1H3,(H,35,38)	IJFOMNKWJBCMSK-UHFFFAOYSA-N	416910	1-(3-(Aminomethyl)phenyl)-N-(3-((butylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 180b::US10633345, Compound 180b::US10689346, Compound 180b::US11203574, Compound 180b::US11230530, Compound 180b::US11685721, Compound 180b	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416910	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416910&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665986	433916822							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915421	Cc1ccc(C(NCC2CC2)c2cccc(NC(=O)c3cc(nn3-c3cccc(CN)c3)C(F)(F)F)c2)c(C)c1	InChI=1S/C31H32F3N5O/c1-19-9-12-26(20(2)13-19)29(36-18-21-10-11-21)23-6-4-7-24(15-23)37-30(40)27-16-28(31(32,33)34)38-39(27)25-8-3-5-22(14-25)17-35/h3-9,12-16,21,29,36H,10-11,17-18,35H2,1-2H3,(H,37,40)	PPHLPILJSQAZAY-UHFFFAOYSA-N	416911	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2,4-dimethylphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 201f::US10689346, Compound 201f::US11192861, Compound 201f::US11230530, Compound 201f::US11685721, Compound 201f	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416911	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416911&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665576	433916823							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915422	Cc1ccc(C)c(c1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C31H32F3N5O/c1-19-9-10-20(2)26(13-19)29(36-18-21-11-12-21)23-6-4-7-24(15-23)37-30(40)27-16-28(31(32,33)34)38-39(27)25-8-3-5-22(14-25)17-35/h3-10,13-16,21,29,36H,11-12,17-18,35H2,1-2H3,(H,37,40)	NFGQIHGOUUFZHN-UHFFFAOYSA-N	416912	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2,5-dimethylphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 202f::US10633345, Compound 202f::US10689346, Compound 202f::US11203574, Compound 202f::US11230530, Compound 202f::US11685721, Compound 202f	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416912	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416912&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665510	433916824							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915423	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F3N4O2/c30-29(31,32)26-16-25(36(35-26)24-11-4-6-20(14-24)17-33)28(37)34-23-10-5-9-22(15-23)27(38-18-19-12-13-19)21-7-2-1-3-8-21/h1-11,14-16,19,27H,12-13,17-18,33H2,(H,34,37)	PEZVPVUPSJXZCH-UHFFFAOYSA-N	416775	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18k::US10633345, Compound 74a::US10689346, Compound 165e::US11203574, Compound 165e::US11230530, Compound 165e::US11685721, Compound 18k	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416775	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416775&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			91884591	433916689							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915424	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F4N5O/c30-23-12-11-21(27(35-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27,35H,9-10,16-17,34H2,(H,36,39)	MCLZOCFEIKBMBA-UHFFFAOYSA-N	416773	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 38d::US10633345, Compound 38d::US10689346, Compound 42a::US11203574, Compound 42a::US11230530, Compound 42a::US11685721, Compound 38d	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416773	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416773&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356124	433916687							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915425	CC(C)(C)c1ccc(cc1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C33H36F3N5O/c1-32(2,3)25-14-12-23(13-15-25)30(38-20-21-10-11-21)24-7-5-8-26(17-24)39-31(42)28-18-29(33(34,35)36)40-41(28)27-9-4-6-22(16-27)19-37/h4-9,12-18,21,30,38H,10-11,19-20,37H2,1-3H3,(H,39,42)	OVDVNIYCGDTOJR-UHFFFAOYSA-N	416915	1-(3-(aminomethyl)phenyl)-N-(3-((4-(tert-butyl)phenyl)((cyclopropylmethyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 203f::US10633345, Compound 203f::US10689346, Compound 203f::US11203574, Compound 203f::US11230530, Compound 203f::US11685721, Compound 203f	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416915	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416915&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665458	433916827							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915426	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F3N4O2/c30-29(31,32)26-16-25(36(35-26)24-11-4-6-20(14-24)17-33)28(37)34-23-10-5-9-22(15-23)27(38-18-19-12-13-19)21-7-2-1-3-8-21/h1-11,14-16,19,27H,12-13,17-18,33H2,(H,34,37)	PEZVPVUPSJXZCH-UHFFFAOYSA-N	416775	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18k::US10633345, Compound 74a::US10689346, Compound 165e::US11203574, Compound 165e::US11230530, Compound 165e::US11685721, Compound 18k	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416775	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416775&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			91884591	433916689							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915427	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F4N5O/c30-23-12-11-21(27(35-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27,35H,9-10,16-17,34H2,(H,36,39)	MCLZOCFEIKBMBA-UHFFFAOYSA-N	416773	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 38d::US10633345, Compound 38d::US10689346, Compound 42a::US11203574, Compound 42a::US11230530, Compound 42a::US11685721, Compound 38d	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416773	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416773&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356124	433916687							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915428	OC(CCC1CC1)(c1ccc(F)c(NC(=O)c2cc(nn2-c2ccc(Cl)cc2)C(F)(F)F)c1)c1ccccn1	InChI=1S/C28H23ClF4N4O2/c29-19-7-9-20(10-8-19)37-23(16-25(36-37)28(31,32)33)26(38)35-22-15-18(6-11-21(22)30)27(39,13-12-17-4-5-17)24-3-1-2-14-34-24/h1-3,6-11,14-17,39H,4-5,12-13H2,(H,35,38)	QWPFRWIQIFPXCC-UHFFFAOYSA-N	416918	1-(4-chlorophenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 157a::US10633345, Compound 157a::US10689346, Compound 157a::US11203574, Compound 157a::US11230530, Compound 157a::US11685721, Compound 157a	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416918	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416918&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665679	433916830							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915429	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(N)cc1)C(F)(F)F	InChI=1S/C29H29F3N6O/c30-29(31,32)26-15-25(38(37-26)24-6-1-3-19(13-24)16-33)28(39)36-23-5-2-4-21(14-23)27(35-17-18-7-8-18)20-9-11-22(34)12-10-20/h1-6,9-15,18,27,35H,7-8,16-17,33-34H2,(H,36,39)	XDCYYWMSVYTRMZ-UHFFFAOYSA-N	416843	1-(3-(aminomethyl)phenyl)-N-(3-((4-aminophenyl)(cyclopropylmethyl-amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 50f::US10633345, Compound 50f::US10689346, Compound 50h::US11203574, Compound 50h::US11230530, Compound 50h::US11685721, Compound 50f	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416843	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416843&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355587	433916756							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915430	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-9-8-20(28(40,11-10-18-6-7-18)21-4-2-12-35-17-21)14-24(23)36-27(39)25-15-26(29(31,32)33)37-38(25)22-5-1-3-19(13-22)16-34/h1-5,8-9,12-15,17-18,40H,6-7,10-11,16,34H2,(H,36,39)	VCHFZCHUEHQXSZ-UHFFFAOYSA-N	416897	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 58c::US10633345, Compound 67b::US10689346, Compound 67b::US11203574, Compound 67b::US11230530, Compound 67b::US11685721, Compound 67b	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416897	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416897&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355889	433916810							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915431	OC(CCC1CC1)(c1ccc(F)c(NC(=O)c2cc(nn2-c2ccc3cc(Cl)ccc3c2)C(F)(F)F)c1)c1ccccn1	InChI=1S/C32H25ClF4N4O2/c33-23-9-6-21-16-24(10-7-20(21)15-23)41-27(18-29(40-41)32(35,36)37)30(42)39-26-17-22(8-11-25(26)34)31(43,13-12-19-4-5-19)28-3-1-2-14-38-28/h1-3,6-11,14-19,43H,4-5,12-13H2,(H,39,42)	XTIXOVGIMHWYOB-UHFFFAOYSA-N	416921	1-(6-chloronaphthalen-2-yl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 158a::US10633345, Compound 158a::US10689346, Compound 158a::US11203574, Compound 158a::US11230530, Compound 158a::US11685721, Compound 158a	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416921	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416921&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355937	433916833							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915432	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(N)cc1)C(F)(F)F	InChI=1S/C29H29F3N6O/c30-29(31,32)26-15-25(38(37-26)24-6-1-3-19(13-24)16-33)28(39)36-23-5-2-4-21(14-23)27(35-17-18-7-8-18)20-9-11-22(34)12-10-20/h1-6,9-15,18,27,35H,7-8,16-17,33-34H2,(H,36,39)	XDCYYWMSVYTRMZ-UHFFFAOYSA-N	416843	1-(3-(aminomethyl)phenyl)-N-(3-((4-aminophenyl)(cyclopropylmethyl-amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 50f::US10633345, Compound 50f::US10689346, Compound 50h::US11203574, Compound 50h::US11230530, Compound 50h::US11685721, Compound 50f	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416843	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416843&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355587	433916756							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915433	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-9-8-20(28(40,11-10-18-6-7-18)21-4-2-12-35-17-21)14-24(23)36-27(39)25-15-26(29(31,32)33)37-38(25)22-5-1-3-19(13-22)16-34/h1-5,8-9,12-15,17-18,40H,6-7,10-11,16,34H2,(H,36,39)	VCHFZCHUEHQXSZ-UHFFFAOYSA-N	416897	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 58c::US10633345, Compound 67b::US10689346, Compound 67b::US11203574, Compound 67b::US11230530, Compound 67b::US11685721, Compound 67b	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416897	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416897&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355889	433916810							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915434	OC(CCC1CC1)(c1ccc(F)c(NC(=O)c2cc(nn2-c2ccc(Cl)cn2)C(F)(F)F)c1)c1ccccn1	InChI=1S/C27H22ClF4N5O2/c28-18-7-9-24(34-15-18)37-21(14-23(36-37)27(30,31)32)25(38)35-20-13-17(6-8-19(20)29)26(39,11-10-16-4-5-16)22-3-1-2-12-33-22/h1-3,6-9,12-16,39H,4-5,10-11H2,(H,35,38)	HMQODPUNPWDVSN-UHFFFAOYSA-N	416924	1-(5-chloropyridin-2-yl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 159a::US10633345, Compound 159a::US10689346, Compound 159a::US11203574, Compound 159a::US11230530, Compound 159a::US11685721, Compound 159a	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416924	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416924&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355989	433916836							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915435	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C28H26F3N5O2/c29-28(30,31)25-15-24(36(35-25)22-8-3-5-19(13-22)16-32)27(37)34-21-7-4-6-20(14-21)26(38-17-18-10-11-18)23-9-1-2-12-33-23/h1-9,12-15,18,26H,10-11,16-17,32H2,(H,34,37)	UBQUVYTUKOFUOF-UHFFFAOYSA-N	416721	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(pyridin-2-yl)methyl)-phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 43f::US10633345, Compound 43f::US10689346, Compound 43g::US11203574, Compound 43h::US11230530, Compound 43h::US11685721, Compound 43f	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416721	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416721&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355947	433916635							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915436	CN(C(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1)C1CC1	InChI=1S/C30H26F4N6O/c1-39(22-9-10-22)28(20-6-2-4-18(12-20)16-35)21-8-11-24(31)25(14-21)37-29(41)26-15-27(30(32,33)34)38-40(26)23-7-3-5-19(13-23)17-36/h2-8,11-15,22,28H,9-10,17,36H2,1H3,(H,37,41)	LONUELZOBAIWEW-UHFFFAOYSA-N	439471	US10633345, Compound 54e::US10633345, Compound 70a::US10633345, Compound 70b::US10689346, Compound 70a::US11203574, Compound 70b::US11230530, Compound 70b	Plasma kallikrein		 25.1								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439471	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439471&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355805	439661023							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
915437	COc1ccc(cc1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H26F4N4O3/c1-40-21-10-8-20(9-11-21)37-24(17-26(36-37)29(31,32)33)27(38)35-23-16-19(7-12-22(23)30)28(39,14-13-18-5-6-18)25-4-2-3-15-34-25/h2-4,7-12,15-18,39H,5-6,13-14H2,1H3,(H,35,38)	YTPYYUUEYRYYOR-UHFFFAOYSA-N	416927	N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-1-(4-methoxyphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 160a::US10633345, Compound 160a::US10689346, Compound 160a::US11203574, Compound 160a::US11230530, Compound 160a::US11685721, Compound 160a	Plasma kallikrein		>100.0								US Patent		10.7270/Q22J6FXH		aid1804499	US10689346	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416927	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416927&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665840	433916839							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51280280	NC(=N)c1ccc(NCc2nc(c[nH]2)-c2ccccc2)cc1OCc1cccnc1	InChI=1S/C23H22N6O/c24-23(25)19-9-8-18(11-21(19)30-15-16-5-4-10-26-12-16)27-14-22-28-13-20(29-22)17-6-2-1-3-7-17/h1-13,27H,14-15H2,(H3,24,25)(H,28,29)	ZDLCAMFQMDNCSU-UHFFFAOYSA-N	50522493	CHEMBL4530083	Plasma kallikrein			 6310							ChEMBL	10.1016/j.bmcl.2019.04.022	10.7270/Q24F1V4V	31005442			Walker, AL; Bingham, RP; Edgar, EV; Ferrie, A; Holmes, DS; Liddle, J; Polyakova, O; Rella, M; Smith, KJ; Thorpe, JH; Wang, Y; White, GV; Young, RJ; Hovnanian, A	GlaxoSmithKline R&D	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50522493	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50522493&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			138115400	440731075							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51310789	CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CSSC[C@H](NC(=O)CNC1=O)C(N)=O)NC(C)=O	InChI=1S/C51H74N14O14S2/c1-5-26(2)41-49(78)56-22-40(70)59-37(42(52)71)24-80-81-25-38(58-28(4)67)50(79)65-19-7-9-39(65)48(77)57-27(3)43(72)61-34(20-29-10-14-31(68)15-11-29)45(74)63-36(23-66)47(76)60-33(8-6-18-55-51(53)54)44(73)62-35(46(75)64-41)21-30-12-16-32(69)17-13-30/h10-17,26-27,33-39,41,66,68-69H,5-9,18-25H2,1-4H3,(H2,52,71)(H,56,78)(H,57,77)(H,58,67)(H,59,70)(H,60,76)(H,61,72)(H,62,73)(H,63,74)(H,64,75)(H4,53,54,55)/t26-,27-,33-,34-,35-,36-,37-,38-,39-,41-/m0/s1	AHNRRYUUVBEIKK-HRWHNLGZSA-N	50531926	CHEMBL4550668	Plasma kallikrein		>25000								ChEMBL	10.1021/acs.jmedchem.8b01908	10.7270/Q24F1V6R	30707839			Wang, D; Yang, Y; Jiang, L; Wang, Y; Li, J; Andreasen, PA; Chen, Z; Huang, M; Xu, P	Chinese Academy of Sciences	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50531926	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50531926&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155555208	440740508							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51310790	CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC1=O)C(N)=O)NC(C)=O	InChI=1S/C53H76N14O16S2/c1-26(2)19-34-46(77)64-37(22-42(72)73)49(80)66-39(43(54)74)24-84-85-25-40(59-28(4)69)52(83)67-18-6-8-41(67)51(82)58-27(3)44(75)61-35(20-29-9-13-31(70)14-10-29)48(79)65-38(23-68)50(81)60-33(7-5-17-57-53(55)56)45(76)63-36(47(78)62-34)21-30-11-15-32(71)16-12-30/h9-16,26-27,33-41,68,70-71H,5-8,17-25H2,1-4H3,(H2,54,74)(H,58,82)(H,59,69)(H,60,81)(H,61,75)(H,62,78)(H,63,76)(H,64,77)(H,65,79)(H,66,80)(H,72,73)(H4,55,56,57)/t27-,33-,34-,35-,36-,37-,38-,39-,40-,41-/m0/s1	CJDDQXAFRANGRP-SUMWPZCCSA-N	50531925	CHEMBL4522772	Plasma kallikrein		>25000								ChEMBL	10.1021/acs.jmedchem.8b01908	10.7270/Q24F1V6R	30707839			Wang, D; Yang, Y; Jiang, L; Wang, Y; Li, J; Andreasen, PA; Chen, Z; Huang, M; Xu, P	Chinese Academy of Sciences	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50531925	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50531925&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155543617	440740507							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51310817	CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](N)CSSC[C@H](NC(=O)CNC1=O)C(O)=O	InChI=1S/C49H71N13O14S2/c1-4-25(2)39-46(73)54-21-38(66)56-36(48(75)76)24-78-77-23-31(50)47(74)62-18-6-8-37(62)45(72)55-26(3)40(67)58-33(19-27-9-13-29(64)14-10-27)42(69)60-35(22-63)44(71)57-32(7-5-17-53-49(51)52)41(68)59-34(43(70)61-39)20-28-11-15-30(65)16-12-28/h9-16,25-26,31-37,39,63-65H,4-8,17-24,50H2,1-3H3,(H,54,73)(H,55,72)(H,56,66)(H,57,71)(H,58,67)(H,59,68)(H,60,69)(H,61,70)(H,75,76)(H4,51,52,53)/t25-,26-,31-,32-,33-,34-,35-,36-,37-,39-/m0/s1	CCJVUWLRIGMAMZ-SZLYCLTDSA-N	50531924	CHEMBL4464577	Plasma kallikrein		>25000								ChEMBL	10.1021/acs.jmedchem.8b01908	10.7270/Q24F1V6R	30707839			Wang, D; Yang, Y; Jiang, L; Wang, Y; Li, J; Andreasen, PA; Chen, Z; Huang, M; Xu, P	Chinese Academy of Sciences	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50531924	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50531924&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155530642	440740506							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51312654	OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3ccc(NC(=O)CCN4CCN(CC4)CCC(=O)Nc4ccc(C[C@@H](NS(=O)(=O)c5ccccc5)C(=O)N2)cc4)cc3)cc1	InChI=1S/C42H49N9O6S.3C2HF3O2/c43-40(44)32-12-6-31(7-13-32)28-45-41(54)36-26-29-8-14-33(15-9-29)46-38(52)18-20-50-22-24-51(25-23-50)21-19-39(53)47-34-16-10-30(11-17-34)27-37(42(55)48-36)49-58(56,57)35-4-2-1-3-5-35;3*3-2(4,5)1(6)7/h1-17,36-37,49H,18-28H2,(H3,43,44)(H,45,54)(H,46,52)(H,47,53)(H,48,55);3*(H,6,7)/t36-,37+;;;/m0.../s1	GUZDUMGZMCJBMI-JYFAEEROSA-N	50532387	CHEMBL4476141	Plasma kallikrein		 800								ChEMBL	10.1021/acs.jmedchem.6b00606	10.7270/Q2377D5T	27280436			Hinkes, S; Wuttke, A; Saupe, SM; Ivanova, T; Wagner, S; Knörlein, A; Heine, A; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50532387	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50532387&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155538439	440740969							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51312667	OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3ccc(NC(=O)CCN4CCN(CC4)CCC(=O)Nc4ccc(C[C@@H](NS(=O)(=O)c5ccccc5)C(=O)N2)cc4)cc3)cc1	InChI=1S/C42H49N9O6S.3C2HF3O2/c43-40(44)32-12-6-31(7-13-32)28-45-41(54)36-26-29-8-14-33(15-9-29)46-38(52)18-20-50-22-24-51(25-23-50)21-19-39(53)47-34-16-10-30(11-17-34)27-37(42(55)48-36)49-58(56,57)35-4-2-1-3-5-35;3*3-2(4,5)1(6)7/h1-17,36-37,49H,18-28H2,(H3,43,44)(H,45,54)(H,46,52)(H,47,53)(H,48,55);3*(H,6,7)/t36-,37+;;;/m0.../s1	GUZDUMGZMCJBMI-JYFAEEROSA-N	50532387	CHEMBL4476141	Plasma kallikrein		 800								ChEMBL	10.1021/acs.jmedchem.6b00606	10.7270/Q2377D5T	27280436			Hinkes, S; Wuttke, A; Saupe, SM; Ivanova, T; Wagner, S; Knörlein, A; Heine, A; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50532387	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50532387&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155538439	440740969							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51312686	OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.N[C@@H]1Cc2ccc(NC(=O)CN3CCN(CC3)CC(=O)Nc3ccc(C[C@H](NC1=O)C(=O)NCc1ccc(cc1)C(N)=N)cc3)cc2	InChI=1S/C34H41N9O4.4C2HF3O2/c35-28-17-22-3-9-26(10-4-22)39-30(44)20-42-13-15-43(16-14-42)21-31(45)40-27-11-5-23(6-12-27)18-29(41-33(28)46)34(47)38-19-24-1-7-25(8-2-24)32(36)37;4*3-2(4,5)1(6)7/h1-12,28-29H,13-21,35H2,(H3,36,37)(H,38,47)(H,39,44)(H,40,45)(H,41,46);4*(H,6,7)/t28-,29+;;;;/m1..../s1	SBMBEEAHLHJZTA-HEPJRUFNSA-N	50532388	CHEMBL4441722	Plasma kallikrein		 9090								ChEMBL	10.1021/acs.jmedchem.6b00606	10.7270/Q2377D5T	27280436			Hinkes, S; Wuttke, A; Saupe, SM; Ivanova, T; Wagner, S; Knörlein, A; Heine, A; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50532388	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50532388&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155515624	440740970							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51312689	OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.NCCCCNC(=O)[C@@H]1Cc2ccc(NC(=O)CCN3CCN(CC3)CCC(=O)Nc3ccc(C[C@@H](NS(=O)(=O)NC4CCCCC4)C(=O)N1)cc3)cc2	InChI=1S/C38H57N9O6S.3C2HF3O2/c39-18-4-5-19-40-37(50)33-26-28-8-12-30(13-9-28)41-35(48)16-20-46-22-24-47(25-23-46)21-17-36(49)42-31-14-10-29(11-15-31)27-34(38(51)43-33)45-54(52,53)44-32-6-2-1-3-7-32;3*3-2(4,5)1(6)7/h8-15,32-34,44-45H,1-7,16-27,39H2,(H,40,50)(H,41,48)(H,42,49)(H,43,51);3*(H,6,7)/t33-,34+;;;/m0.../s1	IIDGVCJTMDUJRC-MDCYEDDYSA-N	50532393	CHEMBL4583612	Plasma kallikrein		 64397								ChEMBL	10.1021/acs.jmedchem.6b00606	10.7270/Q2377D5T	27280436			Hinkes, S; Wuttke, A; Saupe, SM; Ivanova, T; Wagner, S; Knörlein, A; Heine, A; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50532393	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50532393&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155561904	440740975							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51312695	OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3ccc(NC(=O)CN4CCN(CC4)CC(=O)Nc4ccc(C[C@@H](NC(=O)CCc5ccccc5)C(=O)N2)cc4)cc3)cc1	InChI=1S/C43H49N9O5.2C2HF3O2/c44-41(45)33-13-6-32(7-14-33)26-46-42(56)36-24-30-8-15-34(16-9-30)47-39(54)27-51-20-22-52(23-21-51)28-40(55)48-35-17-10-31(11-18-35)25-37(43(57)50-36)49-38(53)19-12-29-4-2-1-3-5-29;2*3-2(4,5)1(6)7/h1-11,13-18,36-37H,12,19-28H2,(H3,44,45)(H,46,56)(H,47,54)(H,48,55)(H,49,53)(H,50,57);2*(H,6,7)/t36-,37+;;/m0../s1	MQDLMPVZWKXFOG-NYZPMSFKSA-N	50532385	CHEMBL4577240	Plasma kallikrein		 8246								ChEMBL	10.1021/acs.jmedchem.6b00606	10.7270/Q2377D5T	27280436			Hinkes, S; Wuttke, A; Saupe, SM; Ivanova, T; Wagner, S; Knörlein, A; Heine, A; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50532385	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50532385&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155554082	440740967							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51312700	OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3ccc(NC(=O)CN4CCN(CC4)CC(=O)Nc4ccc(C[C@@H](NC(=O)CCCc5ccccc5)C(=O)N2)cc4)cc3)cc1	InChI=1S/C44H51N9O5.3C2HF3O2/c45-42(46)34-15-9-33(10-16-34)27-47-43(57)37-25-31-11-17-35(18-12-31)48-40(55)28-52-21-23-53(24-22-52)29-41(56)49-36-19-13-32(14-20-36)26-38(44(58)51-37)50-39(54)8-4-7-30-5-2-1-3-6-30;3*3-2(4,5)1(6)7/h1-3,5-6,9-20,37-38H,4,7-8,21-29H2,(H3,45,46)(H,47,57)(H,48,55)(H,49,56)(H,50,54)(H,51,58);3*(H,6,7)/t37-,38+;;;/m0.../s1	TZQOMXRPJOCMPP-BYQQZPSGSA-N	50532399	CHEMBL4444049	Plasma kallikrein		 12550								ChEMBL	10.1021/acs.jmedchem.6b00606	10.7270/Q2377D5T	27280436			Hinkes, S; Wuttke, A; Saupe, SM; Ivanova, T; Wagner, S; Knörlein, A; Heine, A; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50532399	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50532399&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155517054	440740981							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51312701	OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3ccc(NC(=O)CCN4CCN(CC4)CCC(=O)Nc4ccc(C[C@@H](NC(=O)Cc5ccccc5)C(=O)N2)cc4)cc3)cc1	InChI=1S/C44H51N9O5.3C2HF3O2/c45-42(46)34-12-6-33(7-13-34)29-47-43(57)37-26-31-8-14-35(15-9-31)48-39(54)18-20-52-22-24-53(25-23-52)21-19-40(55)49-36-16-10-32(11-17-36)27-38(44(58)51-37)50-41(56)28-30-4-2-1-3-5-30;3*3-2(4,5)1(6)7/h1-17,37-38H,18-29H2,(H3,45,46)(H,47,57)(H,48,54)(H,49,55)(H,50,56)(H,51,58);3*(H,6,7)/t37-,38+;;;/m0.../s1	KSEAMKRYDHJDFB-BYQQZPSGSA-N	50532396	CHEMBL4519782	Plasma kallikrein		 7920								ChEMBL	10.1021/acs.jmedchem.6b00606	10.7270/Q2377D5T	27280436			Hinkes, S; Wuttke, A; Saupe, SM; Ivanova, T; Wagner, S; Knörlein, A; Heine, A; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50532396	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50532396&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155542229	440740978							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51312702	OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3ccc(NC(=O)CN4CCN(CC4)CC(=O)Nc4ccc(C[C@@H](NC(=O)Cc5ccccc5)C(=O)N2)cc4)cc3)cc1	InChI=1S/C42H47N9O5.2C2HF3O2/c43-40(44)32-12-6-31(7-13-32)25-45-41(55)35-22-29-8-14-33(15-9-29)46-38(53)26-50-18-20-51(21-19-50)27-39(54)47-34-16-10-30(11-17-34)23-36(42(56)49-35)48-37(52)24-28-4-2-1-3-5-28;2*3-2(4,5)1(6)7/h1-17,35-36H,18-27H2,(H3,43,44)(H,45,55)(H,46,53)(H,47,54)(H,48,52)(H,49,56);2*(H,6,7)/t35-,36+;;/m0../s1	SOOWAQPZCMMZQQ-RXMGXJPNSA-N	50532400	CHEMBL4549153	Plasma kallikrein		 7270								ChEMBL	10.1021/acs.jmedchem.6b00606	10.7270/Q2377D5T	27280436			Hinkes, S; Wuttke, A; Saupe, SM; Ivanova, T; Wagner, S; Knörlein, A; Heine, A; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50532400	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50532400&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155548907	440740982							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51312703	OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.COC(=O)N[C@@H]1Cc2ccc(NC(=O)CCN3CCN(CC3)CCC(=O)Nc3ccc(C[C@H](NC1=O)C(=O)NCc1ccc(cc1)C(N)=N)cc3)cc2	InChI=1S/C38H47N9O6.3C2HF3O2/c1-53-38(52)45-32-23-26-6-12-30(13-7-26)43-34(49)15-17-47-20-18-46(19-21-47)16-14-33(48)42-29-10-4-25(5-11-29)22-31(44-37(32)51)36(50)41-24-27-2-8-28(9-3-27)35(39)40;3*3-2(4,5)1(6)7/h2-13,31-32H,14-24H2,1H3,(H3,39,40)(H,41,50)(H,42,48)(H,43,49)(H,44,51)(H,45,52);3*(H,6,7)/t31-,32+;;;/m0.../s1	MDWMQNUVZXFTRT-ORZGUCGRSA-N	50532401	CHEMBL4515955	Plasma kallikrein		 7245								ChEMBL	10.1021/acs.jmedchem.6b00606	10.7270/Q2377D5T	27280436			Hinkes, S; Wuttke, A; Saupe, SM; Ivanova, T; Wagner, S; Knörlein, A; Heine, A; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50532401	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50532401&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155540148	440740983							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51312704	OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3ccc(NC(=O)CCN4CCN(CC4)CCC(=O)Nc4ccc(C[C@@H](NC=O)C(=O)N2)cc4)cc3)cc1	InChI=1S/C37H45N9O5.3C2HF3O2/c38-35(39)28-7-1-27(2-8-28)23-40-36(50)32-22-26-5-11-30(12-6-26)43-34(49)14-16-46-19-17-45(18-20-46)15-13-33(48)42-29-9-3-25(4-10-29)21-31(41-24-47)37(51)44-32;3*3-2(4,5)1(6)7/h1-12,24,31-32H,13-23H2,(H3,38,39)(H,40,50)(H,41,47)(H,42,48)(H,43,49)(H,44,51);3*(H,6,7)/t31-,32+;;;/m1.../s1	KRGVGXOQWKCFDW-HYPLIVHBSA-N	50532397	CHEMBL4476627	Plasma kallikrein		 3865								ChEMBL	10.1021/acs.jmedchem.6b00606	10.7270/Q2377D5T	27280436			Hinkes, S; Wuttke, A; Saupe, SM; Ivanova, T; Wagner, S; Knörlein, A; Heine, A; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50532397	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50532397&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155538514	440740979							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51312705	OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.N[C@@H]1Cc2ccc(NC(=O)CCN3CCN(CC3)CCC(=O)Nc3ccc(C[C@H](NC1=O)C(=O)NCc1ccc(cc1)C(N)=N)cc3)cc2	InChI=1S/C36H45N9O4.4C2HF3O2/c37-30-21-24-3-9-28(10-4-24)41-32(46)13-15-44-17-19-45(20-18-44)16-14-33(47)42-29-11-5-25(6-12-29)22-31(43-35(30)48)36(49)40-23-26-1-7-27(8-2-26)34(38)39;4*3-2(4,5)1(6)7/h1-12,30-31H,13-23,37H2,(H3,38,39)(H,40,49)(H,41,46)(H,42,47)(H,43,48);4*(H,6,7)/t30-,31+;;;;/m1..../s1	SXCYORRQBGIHCT-NTNLIPOVSA-N	50532395	CHEMBL4547050	Plasma kallikrein		 24500								ChEMBL	10.1021/acs.jmedchem.6b00606	10.7270/Q2377D5T	27280436			Hinkes, S; Wuttke, A; Saupe, SM; Ivanova, T; Wagner, S; Knörlein, A; Heine, A; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50532395	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50532395&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155552651	440740977							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51312717	OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.CCCCS(=O)(=O)N[C@@H]1Cc2ccc(NC(=O)CCN3CCN(CC3)CCC(=O)Nc3ccc(C[C@H](NC1=O)C(=O)NCc1ccc(cc1)C(N)=N)cc3)cc2	InChI=1S/C40H53N9O6S.3C2HF3O2/c1-2-3-24-56(54,55)47-35-26-29-8-14-33(15-9-29)45-37(51)17-19-49-22-20-48(21-23-49)18-16-36(50)44-32-12-6-28(7-13-32)25-34(46-40(35)53)39(52)43-27-30-4-10-31(11-5-30)38(41)42;3*3-2(4,5)1(6)7/h4-15,34-35,47H,2-3,16-27H2,1H3,(H3,41,42)(H,43,52)(H,44,50)(H,45,51)(H,46,53);3*(H,6,7)/t34-,35+;;;/m0.../s1	CVYCWIYEJYWSJB-GXPAHXHVSA-N	50532391	CHEMBL4591922	Plasma kallikrein		 701								ChEMBL	10.1021/acs.jmedchem.6b00606	10.7270/Q2377D5T	27280436			Hinkes, S; Wuttke, A; Saupe, SM; Ivanova, T; Wagner, S; Knörlein, A; Heine, A; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50532391	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50532391&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155568484	440740973							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51312718	OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3ccc(NC(=O)CN4CCN(CC4)CC(=O)Nc4ccc(C[C@@H](NS(=O)(=O)c5ccccc5)C(=O)N2)cc4)cc3)cc1	InChI=1S/C40H45N9O6S.3C2HF3O2/c41-38(42)30-12-6-29(7-13-30)24-43-39(52)34-22-27-8-14-31(15-9-27)44-36(50)25-48-18-20-49(21-19-48)26-37(51)45-32-16-10-28(11-17-32)23-35(40(53)46-34)47-56(54,55)33-4-2-1-3-5-33;3*3-2(4,5)1(6)7/h1-17,34-35,47H,18-26H2,(H3,41,42)(H,43,52)(H,44,50)(H,45,51)(H,46,53);3*(H,6,7)/t34-,35+;;;/m0.../s1	KTEFKNQNVXYIRI-GXPAHXHVSA-N	50532383	CHEMBL4571212	Plasma kallikrein		 540								ChEMBL	10.1021/acs.jmedchem.6b00606	10.7270/Q2377D5T	27280436			Hinkes, S; Wuttke, A; Saupe, SM; Ivanova, T; Wagner, S; Knörlein, A; Heine, A; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50532383	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50532383&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155562968	440740965							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51312719	OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3ccc(NC(=O)CN4CCN(CC4)CC(=O)Nc4ccc(C[C@@H](NS(=O)(=O)NC5CCCCC5)C(=O)N2)cc4)cc3)cc1	InChI=1S/C40H52N10O6S.3C2HF3O2/c41-38(42)30-12-6-29(7-13-30)24-43-39(53)34-22-27-8-14-31(15-9-27)44-36(51)25-49-18-20-50(21-19-49)26-37(52)45-32-16-10-28(11-17-32)23-35(40(54)46-34)48-57(55,56)47-33-4-2-1-3-5-33;3*3-2(4,5)1(6)7/h6-17,33-35,47-48H,1-5,18-26H2,(H3,41,42)(H,43,53)(H,44,51)(H,45,52)(H,46,54);3*(H,6,7)/t34-,35+;;;/m0.../s1	KMNGCOQBSMCHCQ-GXPAHXHVSA-N	50532398	CHEMBL4454130	Plasma kallikrein		 319								ChEMBL	10.1021/acs.jmedchem.6b00606	10.7270/Q2377D5T	27280436			Hinkes, S; Wuttke, A; Saupe, SM; Ivanova, T; Wagner, S; Knörlein, A; Heine, A; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50532398	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50532398&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155523885	440740980							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51312720	OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.CN(C)S(=O)(=O)N[C@@H]1Cc2ccc(NC(=O)CN3CCN(CC3)CC(=O)Nc3ccc(C[C@H](NC1=O)C(=O)NCc1ccc(cc1)C(N)=N)cc3)cc2	InChI=1S/C36H46N10O6S.3C2HF3O2/c1-44(2)53(51,52)43-31-20-25-7-13-29(14-8-25)41-33(48)23-46-17-15-45(16-18-46)22-32(47)40-28-11-5-24(6-12-28)19-30(42-36(31)50)35(49)39-21-26-3-9-27(10-4-26)34(37)38;3*3-2(4,5)1(6)7/h3-14,30-31,43H,15-23H2,1-2H3,(H3,37,38)(H,39,49)(H,40,47)(H,41,48)(H,42,50);3*(H,6,7)/t30-,31+;;;/m0.../s1	MQNIOWXLEYXPOK-SALRHSCXSA-N	50532402	CHEMBL4466850	Plasma kallikrein		 12000								ChEMBL	10.1021/acs.jmedchem.6b00606	10.7270/Q2377D5T	27280436			Hinkes, S; Wuttke, A; Saupe, SM; Ivanova, T; Wagner, S; Knörlein, A; Heine, A; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50532402	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50532402&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155531991	440740984							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51312721	OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.NC(=N)NCCCCNC(=O)[C@@H]1Cc2ccc(NC(=O)CCN3CCN(CC3)CCC(=O)Nc3ccc(C[C@@H](NS(=O)(=O)NC4CCCCC4)C(=O)N1)cc3)cc2	InChI=1S/C39H59N11O6S.3C2HF3O2/c40-39(41)43-19-5-4-18-42-37(53)33-26-28-8-12-30(13-9-28)44-35(51)16-20-49-22-24-50(25-23-49)21-17-36(52)45-31-14-10-29(11-15-31)27-34(38(54)46-33)48-57(55,56)47-32-6-2-1-3-7-32;3*3-2(4,5)1(6)7/h8-15,32-34,47-48H,1-7,16-27H2,(H,42,53)(H,44,51)(H,45,52)(H,46,54)(H4,40,41,43);3*(H,6,7)/t33-,34+;;;/m0.../s1	OYDZYOXSRLAULW-MDCYEDDYSA-N	50532404	CHEMBL4443405	Plasma kallikrein		 10390								ChEMBL	10.1021/acs.jmedchem.6b00606	10.7270/Q2377D5T	27280436			Hinkes, S; Wuttke, A; Saupe, SM; Ivanova, T; Wagner, S; Knörlein, A; Heine, A; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50532404	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50532404&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155516565	440740986							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51312722	OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.NCc1ccc(CNC(=O)[C@@H]2Cc3ccc(NC(=O)CCN4CCN(CC4)CCC(=O)Nc4ccc(C[C@@H](NS(=O)(=O)c5ccccc5)C(=O)N2)cc4)cc3)cc1	InChI=1S/C42H50N8O6S.3C2HF3O2/c43-28-32-6-8-33(9-7-32)29-44-41(53)37-26-30-10-14-34(15-11-30)45-39(51)18-20-49-22-24-50(25-23-49)21-19-40(52)46-35-16-12-31(13-17-35)27-38(42(54)47-37)48-57(55,56)36-4-2-1-3-5-36;3*3-2(4,5)1(6)7/h1-17,37-38,48H,18-29,43H2,(H,44,53)(H,45,51)(H,46,52)(H,47,54);3*(H,6,7)/t37-,38+;;;/m0.../s1	HVEXWDUPQQGDSO-BYQQZPSGSA-N	50532384	CHEMBL4560508	Plasma kallikrein		 48690								ChEMBL	10.1021/acs.jmedchem.6b00606	10.7270/Q2377D5T	27280436			Hinkes, S; Wuttke, A; Saupe, SM; Ivanova, T; Wagner, S; Knörlein, A; Heine, A; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50532384	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50532384&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155558368	440740966							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51312723	CC(C)(C)OC(=O)N[C@@H]1Cc2ccc(NC(=O)CCN3CCN(CC3)CCC(=O)Nc3ccc(C[C@H](NC1=O)C(=O)NCc1ccc(CN)cc1)cc3)cc2	InChI=1S/C41H54N8O6/c1-41(2,3)55-40(54)47-35-25-29-10-14-33(15-11-29)45-37(51)17-19-49-22-20-48(21-23-49)18-16-36(50)44-32-12-8-28(9-13-32)24-34(46-39(35)53)38(52)43-27-31-6-4-30(26-42)5-7-31/h4-15,34-35H,16-27,42H2,1-3H3,(H,43,52)(H,44,50)(H,45,51)(H,46,53)(H,47,54)/t34-,35+/m0/s1	RPWFDWLGCJYSML-OIDHKYIRSA-N	50532390	CHEMBL4472791	Plasma kallikrein		>100000								ChEMBL	10.1021/acs.jmedchem.6b00606	10.7270/Q2377D5T	27280436			Hinkes, S; Wuttke, A; Saupe, SM; Ivanova, T; Wagner, S; Knörlein, A; Heine, A; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50532390	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50532390&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155535907	440740972							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51312823	OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3ccc(NC(=O)CN4CCN(CC4)CC(=O)Nc4ccc(C[C@@H](NC(=O)CCCc5ccccc5)C(=O)N2)cc4)cc3)cc1	InChI=1S/C44H51N9O5.3C2HF3O2/c45-42(46)34-15-9-33(10-16-34)27-47-43(57)37-25-31-11-17-35(18-12-31)48-40(55)28-52-21-23-53(24-22-52)29-41(56)49-36-19-13-32(14-20-36)26-38(44(58)51-37)50-39(54)8-4-7-30-5-2-1-3-6-30;3*3-2(4,5)1(6)7/h1-3,5-6,9-20,37-38H,4,7-8,21-29H2,(H3,45,46)(H,47,57)(H,48,55)(H,49,56)(H,50,54)(H,51,58);3*(H,6,7)/t37-,38+;;;/m0.../s1	TZQOMXRPJOCMPP-BYQQZPSGSA-N	50532399	CHEMBL4444049	Plasma kallikrein		 12550								ChEMBL	10.1021/acs.jmedchem.6b00606	10.7270/Q2377D5T	27280436			Hinkes, S; Wuttke, A; Saupe, SM; Ivanova, T; Wagner, S; Knörlein, A; Heine, A; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50532399	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50532399&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155517054	440740981							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51312824	OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3ccc(NC(=O)CCN4CCN(CC4)CCC(=O)Nc4ccc(C[C@@H](NC(=O)Cc5ccccc5)C(=O)N2)cc4)cc3)cc1	InChI=1S/C44H51N9O5.3C2HF3O2/c45-42(46)34-12-6-33(7-13-34)29-47-43(57)37-26-31-8-14-35(15-9-31)48-39(54)18-20-52-22-24-53(25-23-52)21-19-40(55)49-36-16-10-32(11-17-36)27-38(44(58)51-37)50-41(56)28-30-4-2-1-3-5-30;3*3-2(4,5)1(6)7/h1-17,37-38H,18-29H2,(H3,45,46)(H,47,57)(H,48,54)(H,49,55)(H,50,56)(H,51,58);3*(H,6,7)/t37-,38+;;;/m0.../s1	KSEAMKRYDHJDFB-BYQQZPSGSA-N	50532396	CHEMBL4519782	Plasma kallikrein		 7920								ChEMBL	10.1021/acs.jmedchem.6b00606	10.7270/Q2377D5T	27280436			Hinkes, S; Wuttke, A; Saupe, SM; Ivanova, T; Wagner, S; Knörlein, A; Heine, A; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50532396	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50532396&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155542229	440740978							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51312825	OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3ccc(NC(=O)CN4CCN(CC4)CC(=O)Nc4ccc(C[C@@H](NC(=O)Cc5ccccc5)C(=O)N2)cc4)cc3)cc1	InChI=1S/C42H47N9O5.2C2HF3O2/c43-40(44)32-12-6-31(7-13-32)25-45-41(55)35-22-29-8-14-33(15-9-29)46-38(53)26-50-18-20-51(21-19-50)27-39(54)47-34-16-10-30(11-17-34)23-36(42(56)49-35)48-37(52)24-28-4-2-1-3-5-28;2*3-2(4,5)1(6)7/h1-17,35-36H,18-27H2,(H3,43,44)(H,45,55)(H,46,53)(H,47,54)(H,48,52)(H,49,56);2*(H,6,7)/t35-,36+;;/m0../s1	SOOWAQPZCMMZQQ-RXMGXJPNSA-N	50532400	CHEMBL4549153	Plasma kallikrein		 7270								ChEMBL	10.1021/acs.jmedchem.6b00606	10.7270/Q2377D5T	27280436			Hinkes, S; Wuttke, A; Saupe, SM; Ivanova, T; Wagner, S; Knörlein, A; Heine, A; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50532400	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50532400&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155548907	440740982							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51312826	OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.COC(=O)N[C@@H]1Cc2ccc(NC(=O)CCN3CCN(CC3)CCC(=O)Nc3ccc(C[C@H](NC1=O)C(=O)NCc1ccc(cc1)C(N)=N)cc3)cc2	InChI=1S/C38H47N9O6.3C2HF3O2/c1-53-38(52)45-32-23-26-6-12-30(13-7-26)43-34(49)15-17-47-20-18-46(19-21-47)16-14-33(48)42-29-10-4-25(5-11-29)22-31(44-37(32)51)36(50)41-24-27-2-8-28(9-3-27)35(39)40;3*3-2(4,5)1(6)7/h2-13,31-32H,14-24H2,1H3,(H3,39,40)(H,41,50)(H,42,48)(H,43,49)(H,44,51)(H,45,52);3*(H,6,7)/t31-,32+;;;/m0.../s1	MDWMQNUVZXFTRT-ORZGUCGRSA-N	50532401	CHEMBL4515955	Plasma kallikrein		 7245								ChEMBL	10.1021/acs.jmedchem.6b00606	10.7270/Q2377D5T	27280436			Hinkes, S; Wuttke, A; Saupe, SM; Ivanova, T; Wagner, S; Knörlein, A; Heine, A; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50532401	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50532401&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155540148	440740983							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51312827	OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3ccc(NC(=O)CCN4CCN(CC4)CCC(=O)Nc4ccc(C[C@@H](NC=O)C(=O)N2)cc4)cc3)cc1	InChI=1S/C37H45N9O5.3C2HF3O2/c38-35(39)28-7-1-27(2-8-28)23-40-36(50)32-22-26-5-11-30(12-6-26)43-34(49)14-16-46-19-17-45(18-20-46)15-13-33(48)42-29-9-3-25(4-10-29)21-31(41-24-47)37(51)44-32;3*3-2(4,5)1(6)7/h1-12,24,31-32H,13-23H2,(H3,38,39)(H,40,50)(H,41,47)(H,42,48)(H,43,49)(H,44,51);3*(H,6,7)/t31-,32+;;;/m1.../s1	KRGVGXOQWKCFDW-HYPLIVHBSA-N	50532397	CHEMBL4476627	Plasma kallikrein		 3865								ChEMBL	10.1021/acs.jmedchem.6b00606	10.7270/Q2377D5T	27280436			Hinkes, S; Wuttke, A; Saupe, SM; Ivanova, T; Wagner, S; Knörlein, A; Heine, A; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50532397	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50532397&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155538514	440740979							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51312828	OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.N[C@@H]1Cc2ccc(NC(=O)CCN3CCN(CC3)CCC(=O)Nc3ccc(C[C@H](NC1=O)C(=O)NCc1ccc(cc1)C(N)=N)cc3)cc2	InChI=1S/C36H45N9O4.4C2HF3O2/c37-30-21-24-3-9-28(10-4-24)41-32(46)13-15-44-17-19-45(20-18-44)16-14-33(47)42-29-11-5-25(6-12-29)22-31(43-35(30)48)36(49)40-23-26-1-7-27(8-2-26)34(38)39;4*3-2(4,5)1(6)7/h1-12,30-31H,13-23,37H2,(H3,38,39)(H,40,49)(H,41,46)(H,42,47)(H,43,48);4*(H,6,7)/t30-,31+;;;;/m1..../s1	SXCYORRQBGIHCT-NTNLIPOVSA-N	50532395	CHEMBL4547050	Plasma kallikrein		 24500								ChEMBL	10.1021/acs.jmedchem.6b00606	10.7270/Q2377D5T	27280436			Hinkes, S; Wuttke, A; Saupe, SM; Ivanova, T; Wagner, S; Knörlein, A; Heine, A; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50532395	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50532395&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155552651	440740977							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51312840	OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.CCCCS(=O)(=O)N[C@@H]1Cc2ccc(NC(=O)CCN3CCN(CC3)CCC(=O)Nc3ccc(C[C@H](NC1=O)C(=O)NCc1ccc(cc1)C(N)=N)cc3)cc2	InChI=1S/C40H53N9O6S.3C2HF3O2/c1-2-3-24-56(54,55)47-35-26-29-8-14-33(15-9-29)45-37(51)17-19-49-22-20-48(21-23-49)18-16-36(50)44-32-12-6-28(7-13-32)25-34(46-40(35)53)39(52)43-27-30-4-10-31(11-5-30)38(41)42;3*3-2(4,5)1(6)7/h4-15,34-35,47H,2-3,16-27H2,1H3,(H3,41,42)(H,43,52)(H,44,50)(H,45,51)(H,46,53);3*(H,6,7)/t34-,35+;;;/m0.../s1	CVYCWIYEJYWSJB-GXPAHXHVSA-N	50532391	CHEMBL4591922	Plasma kallikrein		 701								ChEMBL	10.1021/acs.jmedchem.6b00606	10.7270/Q2377D5T	27280436			Hinkes, S; Wuttke, A; Saupe, SM; Ivanova, T; Wagner, S; Knörlein, A; Heine, A; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50532391	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50532391&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155568484	440740973							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51312841	OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3ccc(NC(=O)CN4CCN(CC4)CC(=O)Nc4ccc(C[C@@H](NS(=O)(=O)c5ccccc5)C(=O)N2)cc4)cc3)cc1	InChI=1S/C40H45N9O6S.3C2HF3O2/c41-38(42)30-12-6-29(7-13-30)24-43-39(52)34-22-27-8-14-31(15-9-27)44-36(50)25-48-18-20-49(21-19-48)26-37(51)45-32-16-10-28(11-17-32)23-35(40(53)46-34)47-56(54,55)33-4-2-1-3-5-33;3*3-2(4,5)1(6)7/h1-17,34-35,47H,18-26H2,(H3,41,42)(H,43,52)(H,44,50)(H,45,51)(H,46,53);3*(H,6,7)/t34-,35+;;;/m0.../s1	KTEFKNQNVXYIRI-GXPAHXHVSA-N	50532383	CHEMBL4571212	Plasma kallikrein		 540								ChEMBL	10.1021/acs.jmedchem.6b00606	10.7270/Q2377D5T	27280436			Hinkes, S; Wuttke, A; Saupe, SM; Ivanova, T; Wagner, S; Knörlein, A; Heine, A; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50532383	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50532383&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155562968	440740965							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51312842	OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3ccc(NC(=O)CN4CCN(CC4)CC(=O)Nc4ccc(C[C@@H](NS(=O)(=O)NC5CCCCC5)C(=O)N2)cc4)cc3)cc1	InChI=1S/C40H52N10O6S.3C2HF3O2/c41-38(42)30-12-6-29(7-13-30)24-43-39(53)34-22-27-8-14-31(15-9-27)44-36(51)25-49-18-20-50(21-19-49)26-37(52)45-32-16-10-28(11-17-32)23-35(40(54)46-34)48-57(55,56)47-33-4-2-1-3-5-33;3*3-2(4,5)1(6)7/h6-17,33-35,47-48H,1-5,18-26H2,(H3,41,42)(H,43,53)(H,44,51)(H,45,52)(H,46,54);3*(H,6,7)/t34-,35+;;;/m0.../s1	KMNGCOQBSMCHCQ-GXPAHXHVSA-N	50532398	CHEMBL4454130	Plasma kallikrein		 319								ChEMBL	10.1021/acs.jmedchem.6b00606	10.7270/Q2377D5T	27280436			Hinkes, S; Wuttke, A; Saupe, SM; Ivanova, T; Wagner, S; Knörlein, A; Heine, A; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50532398	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50532398&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155523885	440740980							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51312843	OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.CN(C)S(=O)(=O)N[C@@H]1Cc2ccc(NC(=O)CN3CCN(CC3)CC(=O)Nc3ccc(C[C@H](NC1=O)C(=O)NCc1ccc(cc1)C(N)=N)cc3)cc2	InChI=1S/C36H46N10O6S.3C2HF3O2/c1-44(2)53(51,52)43-31-20-25-7-13-29(14-8-25)41-33(48)23-46-17-15-45(16-18-46)22-32(47)40-28-11-5-24(6-12-28)19-30(42-36(31)50)35(49)39-21-26-3-9-27(10-4-26)34(37)38;3*3-2(4,5)1(6)7/h3-14,30-31,43H,15-23H2,1-2H3,(H3,37,38)(H,39,49)(H,40,47)(H,41,48)(H,42,50);3*(H,6,7)/t30-,31+;;;/m0.../s1	MQNIOWXLEYXPOK-SALRHSCXSA-N	50532402	CHEMBL4466850	Plasma kallikrein		 12000								ChEMBL	10.1021/acs.jmedchem.6b00606	10.7270/Q2377D5T	27280436			Hinkes, S; Wuttke, A; Saupe, SM; Ivanova, T; Wagner, S; Knörlein, A; Heine, A; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50532402	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50532402&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155531991	440740984							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51312844	OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.NC(=N)NCCCCNC(=O)[C@@H]1Cc2ccc(NC(=O)CCN3CCN(CC3)CCC(=O)Nc3ccc(C[C@@H](NS(=O)(=O)NC4CCCCC4)C(=O)N1)cc3)cc2	InChI=1S/C39H59N11O6S.3C2HF3O2/c40-39(41)43-19-5-4-18-42-37(53)33-26-28-8-12-30(13-9-28)44-35(51)16-20-49-22-24-50(25-23-49)21-17-36(52)45-31-14-10-29(11-15-31)27-34(38(54)46-33)48-57(55,56)47-32-6-2-1-3-7-32;3*3-2(4,5)1(6)7/h8-15,32-34,47-48H,1-7,16-27H2,(H,42,53)(H,44,51)(H,45,52)(H,46,54)(H4,40,41,43);3*(H,6,7)/t33-,34+;;;/m0.../s1	OYDZYOXSRLAULW-MDCYEDDYSA-N	50532404	CHEMBL4443405	Plasma kallikrein		 10390								ChEMBL	10.1021/acs.jmedchem.6b00606	10.7270/Q2377D5T	27280436			Hinkes, S; Wuttke, A; Saupe, SM; Ivanova, T; Wagner, S; Knörlein, A; Heine, A; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50532404	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50532404&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155516565	440740986							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51312845	OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.NCc1ccc(CNC(=O)[C@@H]2Cc3ccc(NC(=O)CCN4CCN(CC4)CCC(=O)Nc4ccc(C[C@@H](NS(=O)(=O)c5ccccc5)C(=O)N2)cc4)cc3)cc1	InChI=1S/C42H50N8O6S.3C2HF3O2/c43-28-32-6-8-33(9-7-32)29-44-41(53)37-26-30-10-14-34(15-11-30)45-39(51)18-20-49-22-24-50(25-23-49)21-19-40(52)46-35-16-12-31(13-17-35)27-38(42(54)47-37)48-57(55,56)36-4-2-1-3-5-36;3*3-2(4,5)1(6)7/h1-17,37-38,48H,18-29,43H2,(H,44,53)(H,45,51)(H,46,52)(H,47,54);3*(H,6,7)/t37-,38+;;;/m0.../s1	HVEXWDUPQQGDSO-BYQQZPSGSA-N	50532384	CHEMBL4560508	Plasma kallikrein		 48690								ChEMBL	10.1021/acs.jmedchem.6b00606	10.7270/Q2377D5T	27280436			Hinkes, S; Wuttke, A; Saupe, SM; Ivanova, T; Wagner, S; Knörlein, A; Heine, A; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50532384	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50532384&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155558368	440740966							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51312846	CC(C)(C)OC(=O)N[C@@H]1Cc2ccc(NC(=O)CCN3CCN(CC3)CCC(=O)Nc3ccc(C[C@H](NC1=O)C(=O)NCc1ccc(CN)cc1)cc3)cc2	InChI=1S/C41H54N8O6/c1-41(2,3)55-40(54)47-35-25-29-10-14-33(15-11-29)45-37(51)17-19-49-22-20-48(21-23-49)18-16-36(50)44-32-12-8-28(9-13-32)24-34(46-39(35)53)38(52)43-27-31-6-4-30(26-42)5-7-31/h4-15,34-35H,16-27,42H2,1-3H3,(H,43,52)(H,44,50)(H,45,51)(H,46,53)(H,47,54)/t34-,35+/m0/s1	RPWFDWLGCJYSML-OIDHKYIRSA-N	50532390	CHEMBL4472791	Plasma kallikrein		>100000								ChEMBL	10.1021/acs.jmedchem.6b00606	10.7270/Q2377D5T	27280436			Hinkes, S; Wuttke, A; Saupe, SM; Ivanova, T; Wagner, S; Knörlein, A; Heine, A; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50532390	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50532390&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155535907	440740972							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51312871	NCc1cccc(C[C@H](NC(=O)[C@@H](CCCc2ccccc2)NS(=O)(=O)Cc2cccc(c2)C(O)=O)C(=O)NCc2ccc(cc2)C(N)=N)c1	InChI=1S/C37H42N6O6S/c38-22-28-11-4-10-27(19-28)21-33(35(44)41-23-26-15-17-30(18-16-26)34(39)40)42-36(45)32(14-6-9-25-7-2-1-3-8-25)43-50(48,49)24-29-12-5-13-31(20-29)37(46)47/h1-5,7-8,10-13,15-20,32-33,43H,6,9,14,21-24,38H2,(H3,39,40)(H,41,44)(H,42,45)(H,46,47)/t32-,33+/m1/s1	BHQDUYVBGREBCB-SAIUNTKASA-N	50514081	CHEMBL4471466	Plasma kallikrein		 0.019000								ChEMBL	10.1021/acs.jmedchem.6b00606	10.7270/Q2377D5T	27280436			Hinkes, S; Wuttke, A; Saupe, SM; Ivanova, T; Wagner, S; Knörlein, A; Heine, A; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514081	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514081&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			70306716	440722663							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51312892	OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3ccc(NC(=O)CCN4CCN(CC4)CCC(=O)Nc4ccc(C[C@@H](NC(=O)CCc5ccccc5)C(=O)N2)cc4)cc3)cc1	InChI=1S/C45H53N9O5.3C2HF3O2/c46-43(47)35-13-6-34(7-14-35)30-48-44(58)38-28-32-8-15-36(16-9-32)49-41(56)20-22-53-24-26-54(27-25-53)23-21-42(57)50-37-17-10-33(11-18-37)29-39(45(59)52-38)51-40(55)19-12-31-4-2-1-3-5-31;3*3-2(4,5)1(6)7/h1-11,13-18,38-39H,12,19-30H2,(H3,46,47)(H,48,58)(H,49,56)(H,50,57)(H,51,55)(H,52,59);3*(H,6,7)/t38-,39+;;;/m0.../s1	RRUCNIDBIJSCKU-LOTBSJHJSA-N	50532405	CHEMBL4441842	Plasma kallikrein		 7405								ChEMBL	10.1021/acs.jmedchem.6b00606	10.7270/Q2377D5T	27280436			Hinkes, S; Wuttke, A; Saupe, SM; Ivanova, T; Wagner, S; Knörlein, A; Heine, A; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50532405	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50532405&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155515728	440740987							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51312893	OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3ccc(NC(=O)CCN4CCN(CC4)CCC(=O)Nc4ccc(C[C@@H](NC(=O)OCc5ccccc5)C(=O)N2)cc4)cc3)cc1	InChI=1S/C44H51N9O6.3C2HF3O2/c45-41(46)34-12-6-32(7-13-34)28-47-42(56)37-26-30-8-14-35(15-9-30)48-39(54)18-20-52-22-24-53(25-23-52)21-19-40(55)49-36-16-10-31(11-17-36)27-38(43(57)50-37)51-44(58)59-29-33-4-2-1-3-5-33;3*3-2(4,5)1(6)7/h1-17,37-38H,18-29H2,(H3,45,46)(H,47,56)(H,48,54)(H,49,55)(H,50,57)(H,51,58);3*(H,6,7)/t37-,38+;;;/m0.../s1	WAKHSGZPGZIDOP-BYQQZPSGSA-N	50532406	CHEMBL4545331	Plasma kallikrein		 6950								ChEMBL	10.1021/acs.jmedchem.6b00606	10.7270/Q2377D5T	27280436			Hinkes, S; Wuttke, A; Saupe, SM; Ivanova, T; Wagner, S; Knörlein, A; Heine, A; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50532406	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50532406&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155553129	440740988							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51312899	OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3ccc(NC(=O)CCN4CCN(CC4)CCC(=O)Nc4ccc(C[C@@H](NC(=O)CCCc5ccccc5)C(=O)N2)cc4)cc3)cc1	InChI=1S/C46H55N9O5.3C2HF3O2/c47-44(48)36-15-9-35(10-16-36)31-49-45(59)39-29-33-11-17-37(18-12-33)50-42(57)21-23-54-25-27-55(28-26-54)24-22-43(58)51-38-19-13-34(14-20-38)30-40(46(60)53-39)52-41(56)8-4-7-32-5-2-1-3-6-32;3*3-2(4,5)1(6)7/h1-3,5-6,9-20,39-40H,4,7-8,21-31H2,(H3,47,48)(H,49,59)(H,50,57)(H,51,58)(H,52,56)(H,53,60);3*(H,6,7)/t39-,40+;;;/m0.../s1	QELHFWJQCDDNQW-CQAYMILNSA-N	50532403	CHEMBL4466116	Plasma kallikrein		 10470								ChEMBL	10.1021/acs.jmedchem.6b00606	10.7270/Q2377D5T	27280436			Hinkes, S; Wuttke, A; Saupe, SM; Ivanova, T; Wagner, S; Knörlein, A; Heine, A; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50532403	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50532403&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155531811	440740985							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51312900	OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3ccc(NC(=O)CCN4CCN(CC4)CCC(=O)Nc4ccc(C[C@@H](NS(=O)(=O)NC5CCCCC5)C(=O)N2)cc4)cc3)cc1	InChI=1S/C42H56N10O6S.3C2HF3O2/c43-40(44)32-12-6-31(7-13-32)28-45-41(55)36-26-29-8-14-33(15-9-29)46-38(53)18-20-51-22-24-52(25-23-51)21-19-39(54)47-34-16-10-30(11-17-34)27-37(42(56)48-36)50-59(57,58)49-35-4-2-1-3-5-35;3*3-2(4,5)1(6)7/h6-17,35-37,49-50H,1-5,18-28H2,(H3,43,44)(H,45,55)(H,46,53)(H,47,54)(H,48,56);3*(H,6,7)/t36-,37+;;;/m0.../s1	RAJUTZRXBLKGIB-JYFAEEROSA-N	50532389	CHEMBL4458743	Plasma kallikrein		 600								ChEMBL	10.1021/acs.jmedchem.6b00606	10.7270/Q2377D5T	27280436			Hinkes, S; Wuttke, A; Saupe, SM; Ivanova, T; Wagner, S; Knörlein, A; Heine, A; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50532389	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50532389&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155527010	440740971							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51312901	OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.NCc1ccc(CNC(=O)[C@@H]2Cc3ccc(NC(=O)CCN4CCN(CC4)CCC(=O)Nc4ccc(C[C@@H](NS(=O)(=O)Cc5ccccc5)C(=O)N2)cc4)cc3)cc1	InChI=1S/C43H52N8O6S.3C2HF3O2/c44-28-33-6-8-34(9-7-33)29-45-42(54)38-26-31-10-14-36(15-11-31)46-40(52)18-20-50-22-24-51(25-23-50)21-19-41(53)47-37-16-12-32(13-17-37)27-39(43(55)48-38)49-58(56,57)30-35-4-2-1-3-5-35;3*3-2(4,5)1(6)7/h1-17,38-39,49H,18-30,44H2,(H,45,54)(H,46,52)(H,47,53)(H,48,55);3*(H,6,7)/t38-,39+;;;/m0.../s1	QLOXVUFMRHNZGS-LOTBSJHJSA-N	50532392	CHEMBL4437656	Plasma kallikrein		 6380								ChEMBL	10.1021/acs.jmedchem.6b00606	10.7270/Q2377D5T	27280436			Hinkes, S; Wuttke, A; Saupe, SM; Ivanova, T; Wagner, S; Knörlein, A; Heine, A; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50532392	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50532392&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155512709	440740974							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51312903	NCc1cccc(C[C@H](NC(=O)[C@@H](CCCc2ccccc2)NS(=O)(=O)Cc2cccc(c2)C(O)=O)C(=O)NCc2ccc(cc2)C(N)=N)c1	InChI=1S/C37H42N6O6S/c38-22-28-11-4-10-27(19-28)21-33(35(44)41-23-26-15-17-30(18-16-26)34(39)40)42-36(45)32(14-6-9-25-7-2-1-3-8-25)43-50(48,49)24-29-12-5-13-31(20-29)37(46)47/h1-5,7-8,10-13,15-20,32-33,43H,6,9,14,21-24,38H2,(H3,39,40)(H,41,44)(H,42,45)(H,46,47)/t32-,33+/m1/s1	BHQDUYVBGREBCB-SAIUNTKASA-N	50514081	CHEMBL4471466	Plasma kallikrein		 0.019000								ChEMBL	10.1021/acs.jmedchem.6b00606	10.7270/Q2377D5T	27280436			Hinkes, S; Wuttke, A; Saupe, SM; Ivanova, T; Wagner, S; Knörlein, A; Heine, A; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514081	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514081&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			70306716	440722663							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51312921	OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3ccc(NC(=O)CN4CCN(CC4)CC(=O)Nc4ccc(C[C@@H](NC(=O)OCc5ccccc5)C(=O)N2)cc4)cc3)cc1	InChI=1S/C42H47N9O6.3C2HF3O2/c43-39(44)32-12-6-30(7-13-32)24-45-40(54)35-22-28-8-14-33(15-9-28)46-37(52)25-50-18-20-51(21-19-50)26-38(53)47-34-16-10-29(11-17-34)23-36(41(55)48-35)49-42(56)57-27-31-4-2-1-3-5-31;3*3-2(4,5)1(6)7/h1-17,35-36H,18-27H2,(H3,43,44)(H,45,54)(H,46,52)(H,47,53)(H,48,55)(H,49,56);3*(H,6,7)/t35-,36+;;;/m0.../s1	VVGWFOCDEJJLPJ-VMYQRNJMSA-N	50532386	CHEMBL4458773	Plasma kallikrein		 4640								ChEMBL	10.1021/acs.jmedchem.6b00606	10.7270/Q2377D5T	27280436			Hinkes, S; Wuttke, A; Saupe, SM; Ivanova, T; Wagner, S; Knörlein, A; Heine, A; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50532386	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50532386&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155526377	440740968							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51312924	OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.NCc1ccc(CNC(=O)[C@@H]2Cc3ccc(NC(=O)CCN4CCN(CC4)CCC(=O)Nc4ccc(C[C@@H](NS(=O)(=O)NC5CCCCC5)C(=O)N2)cc4)cc3)cc1	InChI=1S/C42H57N9O6S.3C2HF3O2/c43-28-32-6-8-33(9-7-32)29-44-41(54)37-26-30-10-14-34(15-11-30)45-39(52)18-20-50-22-24-51(25-23-50)21-19-40(53)46-35-16-12-31(13-17-35)27-38(42(55)47-37)49-58(56,57)48-36-4-2-1-3-5-36;3*3-2(4,5)1(6)7/h6-17,36-38,48-49H,1-5,18-29,43H2,(H,44,54)(H,45,52)(H,46,53)(H,47,55);3*(H,6,7)/t37-,38+;;;/m0.../s1	YZYLLDBQOGKMNX-BYQQZPSGSA-N	50532394	CHEMBL4553652	Plasma kallikrein		 43190								ChEMBL	10.1021/acs.jmedchem.6b00606	10.7270/Q2377D5T	27280436			Hinkes, S; Wuttke, A; Saupe, SM; Ivanova, T; Wagner, S; Knörlein, A; Heine, A; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50532394	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50532394&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155510375	440740976							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51312925	OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3ccc(NC(=O)CN4CCN(CC4)CC(=O)Nc4ccc(C[C@@H](NC(=O)OCc5ccccc5)C(=O)N2)cc4)cc3)cc1	InChI=1S/C42H47N9O6.3C2HF3O2/c43-39(44)32-12-6-30(7-13-32)24-45-40(54)35-22-28-8-14-33(15-9-28)46-37(52)25-50-18-20-51(21-19-50)26-38(53)47-34-16-10-29(11-17-34)23-36(41(55)48-35)49-42(56)57-27-31-4-2-1-3-5-31;3*3-2(4,5)1(6)7/h1-17,35-36H,18-27H2,(H3,43,44)(H,45,54)(H,46,52)(H,47,53)(H,48,55)(H,49,56);3*(H,6,7)/t35-,36+;;;/m0.../s1	VVGWFOCDEJJLPJ-VMYQRNJMSA-N	50532386	CHEMBL4458773	Plasma kallikrein		 4640								ChEMBL	10.1021/acs.jmedchem.6b00606	10.7270/Q2377D5T	27280436			Hinkes, S; Wuttke, A; Saupe, SM; Ivanova, T; Wagner, S; Knörlein, A; Heine, A; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50532386	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50532386&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155526377	440740968							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51312928	OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.NCc1ccc(CNC(=O)[C@@H]2Cc3ccc(NC(=O)CCN4CCN(CC4)CCC(=O)Nc4ccc(C[C@@H](NS(=O)(=O)NC5CCCCC5)C(=O)N2)cc4)cc3)cc1	InChI=1S/C42H57N9O6S.3C2HF3O2/c43-28-32-6-8-33(9-7-32)29-44-41(54)37-26-30-10-14-34(15-11-30)45-39(52)18-20-50-22-24-51(25-23-50)21-19-40(53)46-35-16-12-31(13-17-35)27-38(42(55)47-37)49-58(56,57)48-36-4-2-1-3-5-36;3*3-2(4,5)1(6)7/h6-17,36-38,48-49H,1-5,18-29,43H2,(H,44,54)(H,45,52)(H,46,53)(H,47,55);3*(H,6,7)/t37-,38+;;;/m0.../s1	YZYLLDBQOGKMNX-BYQQZPSGSA-N	50532394	CHEMBL4553652	Plasma kallikrein		 43190								ChEMBL	10.1021/acs.jmedchem.6b00606	10.7270/Q2377D5T	27280436			Hinkes, S; Wuttke, A; Saupe, SM; Ivanova, T; Wagner, S; Knörlein, A; Heine, A; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50532394	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50532394&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155510375	440740976							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51312935	OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3ccc(NC(=O)CCN4CCN(CC4)CCC(=O)Nc4ccc(C[C@@H](NC(=O)CCc5ccccc5)C(=O)N2)cc4)cc3)cc1	InChI=1S/C45H53N9O5.3C2HF3O2/c46-43(47)35-13-6-34(7-14-35)30-48-44(58)38-28-32-8-15-36(16-9-32)49-41(56)20-22-53-24-26-54(27-25-53)23-21-42(57)50-37-17-10-33(11-18-37)29-39(45(59)52-38)51-40(55)19-12-31-4-2-1-3-5-31;3*3-2(4,5)1(6)7/h1-11,13-18,38-39H,12,19-30H2,(H3,46,47)(H,48,58)(H,49,56)(H,50,57)(H,51,55)(H,52,59);3*(H,6,7)/t38-,39+;;;/m0.../s1	RRUCNIDBIJSCKU-LOTBSJHJSA-N	50532405	CHEMBL4441842	Plasma kallikrein		 7405								ChEMBL	10.1021/acs.jmedchem.6b00606	10.7270/Q2377D5T	27280436			Hinkes, S; Wuttke, A; Saupe, SM; Ivanova, T; Wagner, S; Knörlein, A; Heine, A; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50532405	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50532405&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155515728	440740987							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51312936	OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3ccc(NC(=O)CCN4CCN(CC4)CCC(=O)Nc4ccc(C[C@@H](NC(=O)OCc5ccccc5)C(=O)N2)cc4)cc3)cc1	InChI=1S/C44H51N9O6.3C2HF3O2/c45-41(46)34-12-6-32(7-13-34)28-47-42(56)37-26-30-8-14-35(15-9-30)48-39(54)18-20-52-22-24-53(25-23-52)21-19-40(55)49-36-16-10-31(11-17-36)27-38(43(57)50-37)51-44(58)59-29-33-4-2-1-3-5-33;3*3-2(4,5)1(6)7/h1-17,37-38H,18-29H2,(H3,45,46)(H,47,56)(H,48,54)(H,49,55)(H,50,57)(H,51,58);3*(H,6,7)/t37-,38+;;;/m0.../s1	WAKHSGZPGZIDOP-BYQQZPSGSA-N	50532406	CHEMBL4545331	Plasma kallikrein		 6950								ChEMBL	10.1021/acs.jmedchem.6b00606	10.7270/Q2377D5T	27280436			Hinkes, S; Wuttke, A; Saupe, SM; Ivanova, T; Wagner, S; Knörlein, A; Heine, A; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50532406	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50532406&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155553129	440740988							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51312942	OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3ccc(NC(=O)CCN4CCN(CC4)CCC(=O)Nc4ccc(C[C@@H](NC(=O)CCCc5ccccc5)C(=O)N2)cc4)cc3)cc1	InChI=1S/C46H55N9O5.3C2HF3O2/c47-44(48)36-15-9-35(10-16-36)31-49-45(59)39-29-33-11-17-37(18-12-33)50-42(57)21-23-54-25-27-55(28-26-54)24-22-43(58)51-38-19-13-34(14-20-38)30-40(46(60)53-39)52-41(56)8-4-7-32-5-2-1-3-6-32;3*3-2(4,5)1(6)7/h1-3,5-6,9-20,39-40H,4,7-8,21-31H2,(H3,47,48)(H,49,59)(H,50,57)(H,51,58)(H,52,56)(H,53,60);3*(H,6,7)/t39-,40+;;;/m0.../s1	QELHFWJQCDDNQW-CQAYMILNSA-N	50532403	CHEMBL4466116	Plasma kallikrein		 10470								ChEMBL	10.1021/acs.jmedchem.6b00606	10.7270/Q2377D5T	27280436			Hinkes, S; Wuttke, A; Saupe, SM; Ivanova, T; Wagner, S; Knörlein, A; Heine, A; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50532403	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50532403&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155531811	440740985							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51312943	OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3ccc(NC(=O)CCN4CCN(CC4)CCC(=O)Nc4ccc(C[C@@H](NS(=O)(=O)NC5CCCCC5)C(=O)N2)cc4)cc3)cc1	InChI=1S/C42H56N10O6S.3C2HF3O2/c43-40(44)32-12-6-31(7-13-32)28-45-41(55)36-26-29-8-14-33(15-9-29)46-38(53)18-20-51-22-24-52(25-23-51)21-19-39(54)47-34-16-10-30(11-17-34)27-37(42(56)48-36)50-59(57,58)49-35-4-2-1-3-5-35;3*3-2(4,5)1(6)7/h6-17,35-37,49-50H,1-5,18-28H2,(H3,43,44)(H,45,55)(H,46,53)(H,47,54)(H,48,56);3*(H,6,7)/t36-,37+;;;/m0.../s1	RAJUTZRXBLKGIB-JYFAEEROSA-N	50532389	CHEMBL4458743	Plasma kallikrein		 600								ChEMBL	10.1021/acs.jmedchem.6b00606	10.7270/Q2377D5T	27280436			Hinkes, S; Wuttke, A; Saupe, SM; Ivanova, T; Wagner, S; Knörlein, A; Heine, A; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50532389	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50532389&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155527010	440740971							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51312944	OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.NCc1ccc(CNC(=O)[C@@H]2Cc3ccc(NC(=O)CCN4CCN(CC4)CCC(=O)Nc4ccc(C[C@@H](NS(=O)(=O)Cc5ccccc5)C(=O)N2)cc4)cc3)cc1	InChI=1S/C43H52N8O6S.3C2HF3O2/c44-28-33-6-8-34(9-7-33)29-45-42(54)38-26-31-10-14-36(15-11-31)46-40(52)18-20-50-22-24-51(25-23-50)21-19-41(53)47-37-16-12-32(13-17-37)27-39(43(55)48-38)49-58(56,57)30-35-4-2-1-3-5-35;3*3-2(4,5)1(6)7/h1-17,38-39,49H,18-30,44H2,(H,45,54)(H,46,52)(H,47,53)(H,48,55);3*(H,6,7)/t38-,39+;;;/m0.../s1	QLOXVUFMRHNZGS-LOTBSJHJSA-N	50532392	CHEMBL4437656	Plasma kallikrein		 6380								ChEMBL	10.1021/acs.jmedchem.6b00606	10.7270/Q2377D5T	27280436			Hinkes, S; Wuttke, A; Saupe, SM; Ivanova, T; Wagner, S; Knörlein, A; Heine, A; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50532392	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50532392&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155512709	440740974							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51312946	OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.NC(=N)c1ccc(CNC(=O)[C@@H]2Cc3ccc(NC(=O)CN4CCN(CC4)CC(=O)Nc4ccc(C[C@@H](NC(=O)CCc5ccccc5)C(=O)N2)cc4)cc3)cc1	InChI=1S/C43H49N9O5.2C2HF3O2/c44-41(45)33-13-6-32(7-14-33)26-46-42(56)36-24-30-8-15-34(16-9-30)47-39(54)27-51-20-22-52(23-21-51)28-40(55)48-35-17-10-31(11-18-35)25-37(43(57)50-36)49-38(53)19-12-29-4-2-1-3-5-29;2*3-2(4,5)1(6)7/h1-11,13-18,36-37H,12,19-28H2,(H3,44,45)(H,46,56)(H,47,54)(H,48,55)(H,49,53)(H,50,57);2*(H,6,7)/t36-,37+;;/m0../s1	MQDLMPVZWKXFOG-NYZPMSFKSA-N	50532385	CHEMBL4577240	Plasma kallikrein		 8246								ChEMBL	10.1021/acs.jmedchem.6b00606	10.7270/Q2377D5T	27280436			Hinkes, S; Wuttke, A; Saupe, SM; Ivanova, T; Wagner, S; Knörlein, A; Heine, A; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50532385	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50532385&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155554082	440740967							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51312950	OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.N[C@@H]1Cc2ccc(NC(=O)CN3CCN(CC3)CC(=O)Nc3ccc(C[C@H](NC1=O)C(=O)NCc1ccc(cc1)C(N)=N)cc3)cc2	InChI=1S/C34H41N9O4.4C2HF3O2/c35-28-17-22-3-9-26(10-4-22)39-30(44)20-42-13-15-43(16-14-42)21-31(45)40-27-11-5-23(6-12-27)18-29(41-33(28)46)34(47)38-19-24-1-7-25(8-2-24)32(36)37;4*3-2(4,5)1(6)7/h1-12,28-29H,13-21,35H2,(H3,36,37)(H,38,47)(H,39,44)(H,40,45)(H,41,46);4*(H,6,7)/t28-,29+;;;;/m1..../s1	SBMBEEAHLHJZTA-HEPJRUFNSA-N	50532388	CHEMBL4441722	Plasma kallikrein		 9090								ChEMBL	10.1021/acs.jmedchem.6b00606	10.7270/Q2377D5T	27280436			Hinkes, S; Wuttke, A; Saupe, SM; Ivanova, T; Wagner, S; Knörlein, A; Heine, A; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50532388	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50532388&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155515624	440740970							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51312951	OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.NCCCCNC(=O)[C@@H]1Cc2ccc(NC(=O)CCN3CCN(CC3)CCC(=O)Nc3ccc(C[C@@H](NS(=O)(=O)NC4CCCCC4)C(=O)N1)cc3)cc2	InChI=1S/C38H57N9O6S.3C2HF3O2/c39-18-4-5-19-40-37(50)33-26-28-8-12-30(13-9-28)41-35(48)16-20-46-22-24-47(25-23-46)21-17-36(49)42-31-14-10-29(11-15-31)27-34(38(51)43-33)45-54(52,53)44-32-6-2-1-3-7-32;3*3-2(4,5)1(6)7/h8-15,32-34,44-45H,1-7,16-27,39H2,(H,40,50)(H,41,48)(H,42,49)(H,43,51);3*(H,6,7)/t33-,34+;;;/m0.../s1	IIDGVCJTMDUJRC-MDCYEDDYSA-N	50532393	CHEMBL4583612	Plasma kallikrein		 64397								ChEMBL	10.1021/acs.jmedchem.6b00606	10.7270/Q2377D5T	27280436			Hinkes, S; Wuttke, A; Saupe, SM; Ivanova, T; Wagner, S; Knörlein, A; Heine, A; Klebe, G; Steinmetzer, T	Philipps University Marburg	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50532393	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50532393&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155561904	440740975							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51318070	CC[C@H](C)[C@@H]1NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@@H](CSSC[C@H]2NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]3CCCN3C(=O)[C@@H]3CSSC[C@@H](NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC1=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N3)NC(=O)[C@@H](NC2=O)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)CN	InChI=1S/C136H222N50O48S6/c1-8-63(5)104-129(230)174-75(39-62(3)4)117(218)169-69(19-10-12-32-137)111(212)167-70(20-11-13-33-138)114(215)180-86-57-236-238-59-88-125(226)166-68(21-14-34-150-133(142)143)107(208)155-48-98(198)163-77(41-93(141)193)108(209)156-49-97(197)162-76(40-66-26-28-67(191)29-27-66)118(219)179-85(110(211)158-51-99(199)164-81(52-187)109(210)157-50-100(200)165-82(53-188)121(222)175-80(132(233)234)44-103(205)206)56-235-240-61-90(183-120(221)79(43-102(203)204)173-123(224)84(55-190)176-119(220)78(42-101(201)202)172-113(214)72(23-16-36-152-135(146)147)168-112(213)71(171-124(86)225)22-15-35-151-134(144)145)131(232)186-38-18-25-91(186)128(229)159-47-95(195)160-65(7)106(207)178-89(127(228)185-105(64(6)9-2)130(231)182-88)60-239-237-58-87(181-115(216)74(30-31-92(140)192)161-96(196)46-154-94(194)45-139)126(227)177-83(54-189)122(223)170-73(116(217)184-104)24-17-37-153-136(148)149/h26-29,62-65,68-91,104-105,187-191H,8-25,30-61,137-139H2,1-7H3,(H2,140,192)(H2,141,193)(H,154,194)(H,155,208)(H,156,209)(H,157,210)(H,158,211)(H,159,229)(H,160,195)(H,161,196)(H,162,197)(H,163,198)(H,164,199)(H,165,200)(H,166,226)(H,167,212)(H,168,213)(H,169,218)(H,170,223)(H,171,225)(H,172,214)(H,173,224)(H,174,230)(H,175,222)(H,176,220)(H,177,227)(H,178,207)(H,179,219)(H,180,215)(H,181,216)(H,182,231)(H,183,221)(H,184,217)(H,185,228)(H,201,202)(H,203,204)(H,205,206)(H,233,234)(H4,142,143,150)(H4,144,145,151)(H4,146,147,152)(H4,148,149,153)/t63-,64-,65-,68-,69-,70-,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,85+,86-,87+,88-,89+,90-,91-,104-,105-/m0/s1	LCMSWGVHKJDKHX-ZFWCQMGFSA-N	50533534	CHEMBL4446504	Plasma kallikrein		>10000								ChEMBL	10.1021/acs.jmedchem.6b00557	10.7270/Q29G5R98	27434175			Swedberg, JE; Mahatmanto, T; Abdul Ghani, H; de Veer, SJ; Schroeder, CI; Harris, JM; Craik, DJ	The University of Queensland	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533534	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533534&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155518671	440742116					C02715		1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51318097	CC[C@H](C)[C@@H]1NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](CSSC[C@H]2NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]3CCCN3C(=O)[C@@H]3CSSC[C@@H](NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC1=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N3)NC(=O)[C@@H](NC2=O)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)CN	InChI=1S/C142H226N50O47S6/c1-8-68(5)110-135(235)181-81(44-67(3)4)123(223)175-75(24-13-15-37-143)117(217)173-76(25-14-16-38-144)120(220)186-92-62-241-243-64-94-131(231)172-74(26-17-39-156-139(148)149)113(213)161-54-104(203)169-84(47-99(147)198)114(214)162-55-103(202)168-82(46-72-31-33-73(196)34-32-72)124(224)185-91(116(216)164-57-105(204)170-88(58-193)115(215)163-56-106(205)171-89(59-194)128(228)182-87(138(238)239)50-109(210)211)61-240-245-66-96(189-127(227)86(49-108(208)209)180-129(229)90(60-195)183-126(226)85(48-107(206)207)179-119(219)78(28-19-41-158-141(152)153)174-118(218)77(177-130(92)230)27-18-40-157-140(150)151)137(237)192-43-21-30-97(192)134(234)165-53-101(200)166-70(7)112(212)184-95(133(233)191-111(69(6)9-2)136(236)188-94)65-244-242-63-93(187-121(221)80(35-36-98(146)197)167-102(201)52-160-100(199)51-145)132(232)178-83(45-71-22-11-10-12-23-71)125(225)176-79(122(222)190-110)29-20-42-159-142(154)155/h10-12,22-23,31-34,67-70,74-97,110-111,193-196H,8-9,13-21,24-30,35-66,143-145H2,1-7H3,(H2,146,197)(H2,147,198)(H,160,199)(H,161,213)(H,162,214)(H,163,215)(H,164,216)(H,165,234)(H,166,200)(H,167,201)(H,168,202)(H,169,203)(H,170,204)(H,171,205)(H,172,231)(H,173,217)(H,174,218)(H,175,223)(H,176,225)(H,177,230)(H,178,232)(H,179,219)(H,180,229)(H,181,235)(H,182,228)(H,183,226)(H,184,212)(H,185,224)(H,186,220)(H,187,221)(H,188,236)(H,189,227)(H,190,222)(H,191,233)(H,206,207)(H,208,209)(H,210,211)(H,238,239)(H4,148,149,156)(H4,150,151,157)(H4,152,153,158)(H4,154,155,159)/t68-,69-,70-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91+,92-,93+,94-,95+,96-,97-,110-,111-/m0/s1	OOSAWCAECZEMCW-DJKXKCNZSA-N	50533535	CHEMBL4440685	Plasma kallikrein		>10000								ChEMBL	10.1021/acs.jmedchem.6b00557	10.7270/Q29G5R98	27434175			Swedberg, JE; Mahatmanto, T; Abdul Ghani, H; de Veer, SJ; Schroeder, CI; Harris, JM; Craik, DJ	The University of Queensland	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533535	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533535&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155514640	440742117					C02715		1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51318098	CC[C@H](C)[C@@H]1NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](CSSC[C@H]2NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]3CCCN3C(=O)[C@@H]3CSSC[C@@H](NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc4c[nH]c5ccccc45)NC1=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N3)NC(=O)[C@@H](NC2=O)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)CN	InChI=1S/C147H225N51O47S6/c1-6-70(3)115-140(241)187-88(48-75-54-165-78-25-12-11-24-77(75)78)130(231)181-80(26-13-15-39-148)122(223)179-81(27-14-16-40-149)125(226)192-97-65-247-249-67-99-136(237)178-79(28-17-41-161-144(153)154)118(219)167-57-109(209)175-89(49-104(152)204)119(220)168-58-108(208)174-86(47-74-33-35-76(202)36-34-74)128(229)191-96(121(222)170-60-110(210)176-93(61-199)120(221)169-59-111(211)177-94(62-200)133(234)188-92(143(244)245)52-114(216)217)64-246-251-69-101(195-132(233)91(51-113(214)215)186-134(235)95(63-201)189-131(232)90(50-112(212)213)185-124(225)83(30-19-43-163-146(157)158)180-123(224)82(183-135(97)236)29-18-42-162-145(155)156)142(243)198-45-21-32-102(198)139(240)171-56-106(206)172-72(5)117(218)190-100(138(239)197-116(71(4)7-2)141(242)194-99)68-250-248-66-98(193-126(227)85(37-38-103(151)203)173-107(207)55-166-105(205)53-150)137(238)184-87(46-73-22-9-8-10-23-73)129(230)182-84(127(228)196-115)31-20-44-164-147(159)160/h8-12,22-25,33-36,54,70-72,79-102,115-116,165,199-202H,6-7,13-21,26-32,37-53,55-69,148-150H2,1-5H3,(H2,151,203)(H2,152,204)(H,166,205)(H,167,219)(H,168,220)(H,169,221)(H,170,222)(H,171,240)(H,172,206)(H,173,207)(H,174,208)(H,175,209)(H,176,210)(H,177,211)(H,178,237)(H,179,223)(H,180,224)(H,181,231)(H,182,230)(H,183,236)(H,184,238)(H,185,225)(H,186,235)(H,187,241)(H,188,234)(H,189,232)(H,190,218)(H,191,229)(H,192,226)(H,193,227)(H,194,242)(H,195,233)(H,196,228)(H,197,239)(H,212,213)(H,214,215)(H,216,217)(H,244,245)(H4,153,154,161)(H4,155,156,162)(H4,157,158,163)(H4,159,160,164)/t70-,71-,72-,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96+,97-,98+,99-,100+,101-,102-,115-,116-/m0/s1	OPNKQHQUGQXDBT-DDFJWNRVSA-N	50533533	CHEMBL4449980	Plasma kallikrein		>10000								ChEMBL	10.1021/acs.jmedchem.6b00557	10.7270/Q29G5R98	27434175			Swedberg, JE; Mahatmanto, T; Abdul Ghani, H; de Veer, SJ; Schroeder, CI; Harris, JM; Craik, DJ	The University of Queensland	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533533	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533533&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155520916	440742115					C02715		1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51318099	CC[C@H](C)[C@@H]1NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](CSSC[C@H]2NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]3CCCN3C(=O)[C@@H]3CSSC[C@@H](NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc4c[nH]c5ccccc45)NC1=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N3)NC(=O)[C@@H](NC2=O)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN	InChI=1S/C151H234N52O47S6/c1-6-73(3)118-144(246)192-92(52-78-57-170-82-28-12-11-26-80(78)82)134(236)186-84(29-14-17-43-153)126(228)184-85(30-15-18-44-154)129(231)197-101-68-252-254-70-103-140(242)183-83(31-19-45-166-148(158)159)122(224)172-60-112(213)180-93(53-108(157)209)123(225)173-61-111(212)179-90(51-77-36-38-79(207)39-37-77)132(234)196-100(125(227)175-63-113(214)181-97(64-204)124(226)174-62-114(215)182-98(65-205)137(239)193-96(147(249)250)56-117(220)221)67-251-256-72-105(200-136(238)95(55-116(218)219)191-138(240)99(66-206)194-135(237)94(54-115(216)217)190-128(230)87(33-21-47-168-150(162)163)185-127(229)86(188-139(101)241)32-20-46-167-149(160)161)146(248)203-49-23-35-106(203)143(245)176-58-109(210)177-75(5)120(222)195-104(142(244)202-119(74(4)7-2)145(247)199-103)71-255-253-69-102(198-130(232)89(40-41-107(156)208)178-110(211)59-171-121(223)81(155)27-13-16-42-152)141(243)189-91(50-76-24-9-8-10-25-76)133(235)187-88(131(233)201-118)34-22-48-169-151(164)165/h8-12,24-26,28,36-39,57,73-75,81,83-106,118-119,170,204-207H,6-7,13-23,27,29-35,40-56,58-72,152-155H2,1-5H3,(H2,156,208)(H2,157,209)(H,171,223)(H,172,224)(H,173,225)(H,174,226)(H,175,227)(H,176,245)(H,177,210)(H,178,211)(H,179,212)(H,180,213)(H,181,214)(H,182,215)(H,183,242)(H,184,228)(H,185,229)(H,186,236)(H,187,235)(H,188,241)(H,189,243)(H,190,230)(H,191,240)(H,192,246)(H,193,239)(H,194,237)(H,195,222)(H,196,234)(H,197,231)(H,198,232)(H,199,247)(H,200,238)(H,201,233)(H,202,244)(H,216,217)(H,218,219)(H,220,221)(H,249,250)(H4,158,159,166)(H4,160,161,167)(H4,162,163,168)(H4,164,165,169)/t73-,74-,75-,81-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100+,101-,102+,103-,104+,105-,106-,118-,119-/m0/s1	JEBHEQAGJNWHLB-OOUDVJKPSA-N	50533537	CHEMBL4590811	Plasma kallikrein		>50000								ChEMBL	10.1021/acs.jmedchem.6b00557	10.7270/Q29G5R98	27434175			Swedberg, JE; Mahatmanto, T; Abdul Ghani, H; de Veer, SJ; Schroeder, CI; Harris, JM; Craik, DJ	The University of Queensland	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533537	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533537&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155568406	440742119					C02715		1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51318116	CC[C@H](C)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](CSSC[C@H]2NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]3CCCN3C(=O)[C@@H]3CSSC[C@@H](NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC1=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N3)NC(=O)[C@@H](NC2=O)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O)NC(=O)[C@@H](NC(=O)CNC(=O)CN)C(C)C	InChI=1S/C138H225N47O46S6/c1-10-67(7)107-131(226)172-78(43-65(3)4)119(214)167-73(23-12-15-35-139)114(209)165-74(24-13-16-36-140)117(212)177-88-60-233-234-61-89-126(221)164-72(26-18-38-150-136(144)145)110(205)154-52-99(194)161-80(45-95(143)190)111(206)155-53-98(193)160-79(44-70-31-33-71(189)34-32-70)120(215)176-87(113(208)157-55-100(195)162-84(56-186)112(207)156-54-101(196)163-85(57-187)123(218)173-83(135(230)231)48-105(202)203)59-232-236-63-91(179-122(217)82(47-104(200)201)171-124(219)86(58-188)174-121(216)81(46-103(198)199)170-116(211)77(28-20-40-152-138(148)149)166-115(210)76(168-125(88)220)27-19-39-151-137(146)147)133(228)184-41-21-29-93(184)128(223)158-51-97(192)159-69(9)109(204)175-90(127(222)183-108(68(8)11-2)132(227)178-89)62-235-237-64-92(180-130(225)106(66(5)6)181-102(197)50-153-96(191)49-142)134(229)185-42-22-30-94(185)129(224)169-75(118(213)182-107)25-14-17-37-141/h31-34,65-69,72-94,106-108,186-189H,10-30,35-64,139-142H2,1-9H3,(H2,143,190)(H,153,191)(H,154,205)(H,155,206)(H,156,207)(H,157,208)(H,158,223)(H,159,192)(H,160,193)(H,161,194)(H,162,195)(H,163,196)(H,164,221)(H,165,209)(H,166,210)(H,167,214)(H,168,220)(H,169,224)(H,170,211)(H,171,219)(H,172,226)(H,173,218)(H,174,216)(H,175,204)(H,176,215)(H,177,212)(H,178,227)(H,179,217)(H,180,225)(H,181,197)(H,182,213)(H,183,222)(H,198,199)(H,200,201)(H,202,203)(H,230,231)(H4,144,145,150)(H4,146,147,151)(H4,148,149,152)/t67-,68-,69-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,87+,88-,89-,90+,91-,92+,93-,94-,106-,107-,108-/m0/s1	IWNWXPRWSFWNMU-GYSAZADJSA-N	50533536	CHEMBL4483694	Plasma kallikrein		>10000								ChEMBL	10.1021/acs.jmedchem.6b00557	10.7270/Q29G5R98	27434175			Swedberg, JE; Mahatmanto, T; Abdul Ghani, H; de Veer, SJ; Schroeder, CI; Harris, JM; Craik, DJ	The University of Queensland	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533536	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533536&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155540666	440742118					C02715		1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51298712	NC(=N)NC(=O)c1nc(-c2cc3ccccc3o2)c(N)nc1N	InChI=1S/C14H13N7O2/c15-11-9(8-5-6-3-1-2-4-7(6)23-8)19-10(12(16)20-11)13(22)21-14(17)18/h1-5H,(H4,15,16,20)(H4,17,18,21,22)	ZKLNPUKNSARQMG-UHFFFAOYSA-N	50529246	CHEMBL4473654	Plasma kallikrein			>50000							ChEMBL	10.1016/j.bmcl.2019.126753	10.7270/Q2BV7M3S	31679971			Buckley, BJ; Majed, H; Aboelela, A; Minaei, E; Jiang, L; Fildes, K; Cheung, CY; Johnson, D; Bachovchin, D; Cook, GM; Huang, M; Ranson, M; Kelso, MJ	University of Wollongong	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50529246	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50529246&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	9XF	6AG9	139030452	440737828							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51298713	NC(=N)NC(=O)c1nc(Cl)c(N)nc1N	InChI=1S/C6H8ClN7O/c7-2-4(9)13-3(8)1(12-2)5(15)14-6(10)11/h(H4,8,9,13)(H4,10,11,14,15)	XSDQTOBWRPYKKA-UHFFFAOYSA-N	16173	3,5-diamino-6-chloro-N-(diaminomethylene)pyrazinamide;hydrochloride::3,5-diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide::Amiloride::Amipramidin::CHEMBL945	Plasma kallikrein			>50000							ChEMBL	10.1016/j.bmcl.2019.126753	10.7270/Q2BV7M3S	31679971			Buckley, BJ; Majed, H; Aboelela, A; Minaei, E; Jiang, L; Fildes, K; Cheung, CY; Johnson, D; Bachovchin, D; Cook, GM; Huang, M; Ranson, M; Kelso, MJ	University of Wollongong	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16173	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=16173&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	AMR	4NTX,1F5L	16231	46516430	2639	CHEMBL945		2421	C06821	ZINC04340269	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51290018	Cl.NC(=N)c1ccc(CC2OB(O)c3ccccc23)cc1OCc1cccnc1	InChI=1S/C21H20BN3O3.ClH/c23-21(24)17-8-7-14(10-19(17)27-13-15-4-3-9-25-12-15)11-20-16-5-1-2-6-18(16)22(26)28-20;/h1-10,12,20,26H,11,13H2,(H3,23,24);1H	HPYATRFIYRCQMP-UHFFFAOYSA-N	50525903	CHEMBL4436048	Plasma kallikrein			 79							ChEMBL	10.1016/j.bmcl.2019.126675	10.7270/Q2571GG1	31521475			Walker, AL; Denis, A; Bingham, RP; Bouillot, A; Edgar, EV; Ferrie, A; Holmes, DS; Laroze, A; Liddle, J; Fouchet, MH; Moquette, A; Nassau, P; Pearce, AC; Polyakova, O; Smith, KJ; Thomas, P; Thorpe, JH; Trottet, L; Wang, Y; Hovnanian, A	GlaxoSmithKline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50525903	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50525903&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155511554	440734485							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51290045	Cl.NC(=N)c1ccc(cc1OCc1cccnc1)C1Cc2ccccc2B(O)O1	InChI=1S/C21H20BN3O3.ClH/c23-21(24)17-8-7-16(11-20(17)27-13-14-4-3-9-25-12-14)19-10-15-5-1-2-6-18(15)22(26)28-19;/h1-9,11-12,19,26H,10,13H2,(H3,23,24);1H	KRVQMQVYRRLIIY-UHFFFAOYSA-N	50525917	CHEMBL4579813	Plasma kallikrein			 100							ChEMBL	10.1016/j.bmcl.2019.126675	10.7270/Q2571GG1	31521475			Walker, AL; Denis, A; Bingham, RP; Bouillot, A; Edgar, EV; Ferrie, A; Holmes, DS; Laroze, A; Liddle, J; Fouchet, MH; Moquette, A; Nassau, P; Pearce, AC; Polyakova, O; Smith, KJ; Thomas, P; Thorpe, JH; Trottet, L; Wang, Y; Hovnanian, A	GlaxoSmithKline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50525917	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50525917&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155565537	440734499							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51290046	Cl.Cc1cccc2CC(OB(O)c12)c1ccc(C(N)=N)c(OCc2cccnc2)c1	InChI=1S/C22H22BN3O3.ClH/c1-14-4-2-6-17-11-19(29-23(27)21(14)17)16-7-8-18(22(24)25)20(10-16)28-13-15-5-3-9-26-12-15;/h2-10,12,19,27H,11,13H2,1H3,(H3,24,25);1H	LQXAUZRGEUWLRB-UHFFFAOYSA-N	50525900	CHEMBL4460168	Plasma kallikrein			 79							ChEMBL	10.1016/j.bmcl.2019.126675	10.7270/Q2571GG1	31521475			Walker, AL; Denis, A; Bingham, RP; Bouillot, A; Edgar, EV; Ferrie, A; Holmes, DS; Laroze, A; Liddle, J; Fouchet, MH; Moquette, A; Nassau, P; Pearce, AC; Polyakova, O; Smith, KJ; Thomas, P; Thorpe, JH; Trottet, L; Wang, Y; Hovnanian, A	GlaxoSmithKline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50525900	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50525900&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155527998	440734482							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51290047	Cl.NC(=N)c1ccc(cc1OCc1cccnc1)C1Cc2ccc(F)cc2B(O)O1	InChI=1S/C21H19BFN3O3.ClH/c23-16-5-3-14-8-19(29-22(27)18(14)10-16)15-4-6-17(21(24)25)20(9-15)28-12-13-2-1-7-26-11-13;/h1-7,9-11,19,27H,8,12H2,(H3,24,25);1H	QCFQPLRYJXIOOO-UHFFFAOYSA-N	50525913	CHEMBL4464120	Plasma kallikrein			 794							ChEMBL	10.1016/j.bmcl.2019.126675	10.7270/Q2571GG1	31521475			Walker, AL; Denis, A; Bingham, RP; Bouillot, A; Edgar, EV; Ferrie, A; Holmes, DS; Laroze, A; Liddle, J; Fouchet, MH; Moquette, A; Nassau, P; Pearce, AC; Polyakova, O; Smith, KJ; Thomas, P; Thorpe, JH; Trottet, L; Wang, Y; Hovnanian, A	GlaxoSmithKline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50525913	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50525913&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155530095	440734495							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51290048	Cl.NC(=N)c1ccc(CC2OB(O)c3cc(ccc23)C(F)(F)F)cc1OCc1cccnc1	InChI=1S/C22H19BF3N3O3.ClH/c24-22(25,26)15-4-6-16-18(10-15)23(30)32-20(16)9-13-3-5-17(21(27)28)19(8-13)31-12-14-2-1-7-29-11-14;/h1-8,10-11,20,30H,9,12H2,(H3,27,28);1H	SJWIYNDYLDXFMU-UHFFFAOYSA-N	50525918	CHEMBL4473069	Plasma kallikrein			 200							ChEMBL	10.1016/j.bmcl.2019.126675	10.7270/Q2571GG1	31521475			Walker, AL; Denis, A; Bingham, RP; Bouillot, A; Edgar, EV; Ferrie, A; Holmes, DS; Laroze, A; Liddle, J; Fouchet, MH; Moquette, A; Nassau, P; Pearce, AC; Polyakova, O; Smith, KJ; Thomas, P; Thorpe, JH; Trottet, L; Wang, Y; Hovnanian, A	GlaxoSmithKline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50525918	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50525918&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155536142	440734500							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51290049	Cl.NC(=N)c1ccc(cc1OCc1cccnc1)[C@H]1Cc2ccc(cc2B(O)O1)C(F)(F)F	InChI=1S/C22H19BF3N3O3.ClH/c24-22(25,26)16-5-3-14-8-19(32-23(30)18(14)10-16)15-4-6-17(21(27)28)20(9-15)31-12-13-2-1-7-29-11-13;/h1-7,9-11,19,30H,8,12H2,(H3,27,28);1H/t19-;/m1./s1	DFCWVDGZBOIYOG-FSRHSHDFSA-N	50525914	CHEMBL4558285	Plasma kallikrein			 20							ChEMBL	10.1016/j.bmcl.2019.126675	10.7270/Q2571GG1	31521475			Walker, AL; Denis, A; Bingham, RP; Bouillot, A; Edgar, EV; Ferrie, A; Holmes, DS; Laroze, A; Liddle, J; Fouchet, MH; Moquette, A; Nassau, P; Pearce, AC; Polyakova, O; Smith, KJ; Thomas, P; Thorpe, JH; Trottet, L; Wang, Y; Hovnanian, A	GlaxoSmithKline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50525914	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50525914&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155557718	440734496							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51290050	Cl.NC(=N)c1ccc(cc1OCc1cccnc1)[C@@H]1Cc2ccc(cc2B(O)O1)C(F)(F)F	InChI=1S/C22H19BF3N3O3.ClH/c24-22(25,26)16-5-3-14-8-19(32-23(30)18(14)10-16)15-4-6-17(21(27)28)20(9-15)31-12-13-2-1-7-29-11-13;/h1-7,9-11,19,30H,8,12H2,(H3,27,28);1H/t19-;/m0./s1	DFCWVDGZBOIYOG-FYZYNONXSA-N	50525899	CHEMBL4465265	Plasma kallikrein			 398							ChEMBL	10.1016/j.bmcl.2019.126675	10.7270/Q2571GG1	31521475			Walker, AL; Denis, A; Bingham, RP; Bouillot, A; Edgar, EV; Ferrie, A; Holmes, DS; Laroze, A; Liddle, J; Fouchet, MH; Moquette, A; Nassau, P; Pearce, AC; Polyakova, O; Smith, KJ; Thomas, P; Thorpe, JH; Trottet, L; Wang, Y; Hovnanian, A	GlaxoSmithKline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50525899	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50525899&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155531023	440734481							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51290120	Cl.NC(=N)c1ccc(cc1OCc1cccnc1)C1Cc2ccc(cc2B(O)O1)C(F)(F)F	InChI=1S/C22H19BF3N3O3.ClH/c24-22(25,26)16-5-3-14-8-19(32-23(30)18(14)10-16)15-4-6-17(21(27)28)20(9-15)31-12-13-2-1-7-29-11-13;/h1-7,9-11,19,30H,8,12H2,(H3,27,28);1H	DFCWVDGZBOIYOG-UHFFFAOYSA-N	50525895	CHEMBL4447752	Plasma kallikrein			 10.0							ChEMBL	10.1016/j.bmcl.2019.126675	10.7270/Q2571GG1	31521475			Walker, AL; Denis, A; Bingham, RP; Bouillot, A; Edgar, EV; Ferrie, A; Holmes, DS; Laroze, A; Liddle, J; Fouchet, MH; Moquette, A; Nassau, P; Pearce, AC; Polyakova, O; Smith, KJ; Thomas, P; Thorpe, JH; Trottet, L; Wang, Y; Hovnanian, A	GlaxoSmithKline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50525895	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50525895&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155519661	440734477							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51290121	Cl.COc1ccc2B(O)OC(Cc3ccc(C(N)=N)c(OCc4cccnc4)c3)c2c1	InChI=1S/C22H22BN3O4.ClH/c1-28-16-5-7-19-18(11-16)21(30-23(19)27)10-14-4-6-17(22(24)25)20(9-14)29-13-15-3-2-8-26-12-15;/h2-9,11-12,21,27H,10,13H2,1H3,(H3,24,25);1H	CZCQHLKWYANBTR-UHFFFAOYSA-N	50525902	CHEMBL4547455	Plasma kallikrein			 1259							ChEMBL	10.1016/j.bmcl.2019.126675	10.7270/Q2571GG1	31521475			Walker, AL; Denis, A; Bingham, RP; Bouillot, A; Edgar, EV; Ferrie, A; Holmes, DS; Laroze, A; Liddle, J; Fouchet, MH; Moquette, A; Nassau, P; Pearce, AC; Polyakova, O; Smith, KJ; Thomas, P; Thorpe, JH; Trottet, L; Wang, Y; Hovnanian, A	GlaxoSmithKline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50525902	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50525902&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155553630	440734484							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51290155	Cl.NC(=N)c1ccc(cc1OCc1cccc(Cl)c1)C1Cc2ccccc2B(O)O1	InChI=1S/C22H20BClN2O3.ClH/c24-17-6-3-4-14(10-17)13-28-21-12-16(8-9-18(21)22(25)26)20-11-15-5-1-2-7-19(15)23(27)29-20;/h1-10,12,20,27H,11,13H2,(H3,25,26);1H	DJRBTAGYIUUURP-UHFFFAOYSA-N	50525905	CHEMBL4517343	Plasma kallikrein			 5.0							ChEMBL	10.1016/j.bmcl.2019.126675	10.7270/Q2571GG1	31521475			Walker, AL; Denis, A; Bingham, RP; Bouillot, A; Edgar, EV; Ferrie, A; Holmes, DS; Laroze, A; Liddle, J; Fouchet, MH; Moquette, A; Nassau, P; Pearce, AC; Polyakova, O; Smith, KJ; Thomas, P; Thorpe, JH; Trottet, L; Wang, Y; Hovnanian, A	GlaxoSmithKline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50525905	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50525905&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155540964	440734487							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51290172	Cl.NC(=N)c1ccc(CC2OB(O)c3cc(F)ccc23)cc1OCc1cccnc1	InChI=1S/C21H19BFN3O3.ClH/c23-15-4-6-16-18(10-15)22(27)29-20(16)9-13-3-5-17(21(24)25)19(8-13)28-12-14-2-1-7-26-11-14;/h1-8,10-11,20,27H,9,12H2,(H3,24,25);1H	AICRPMXGMYJQHU-UHFFFAOYSA-N	50525912	CHEMBL4543039	Plasma kallikrein			 79							ChEMBL	10.1016/j.bmcl.2019.126675	10.7270/Q2571GG1	31521475			Walker, AL; Denis, A; Bingham, RP; Bouillot, A; Edgar, EV; Ferrie, A; Holmes, DS; Laroze, A; Liddle, J; Fouchet, MH; Moquette, A; Nassau, P; Pearce, AC; Polyakova, O; Smith, KJ; Thomas, P; Thorpe, JH; Trottet, L; Wang, Y; Hovnanian, A	GlaxoSmithKline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50525912	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50525912&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155551892	440734494							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51290180	Cl.NC(=N)c1ccc(CC2OB(O)c3ccc(F)cc23)cc1OCc1cccnc1	InChI=1S/C21H19BFN3O3.ClH/c23-15-4-6-18-17(10-15)20(29-22(18)27)9-13-3-5-16(21(24)25)19(8-13)28-12-14-2-1-7-26-11-14;/h1-8,10-11,20,27H,9,12H2,(H3,24,25);1H	MDPKHZAASWAWDT-UHFFFAOYSA-N	50525901	CHEMBL4448315	Plasma kallikrein			 794							ChEMBL	10.1016/j.bmcl.2019.126675	10.7270/Q2571GG1	31521475			Walker, AL; Denis, A; Bingham, RP; Bouillot, A; Edgar, EV; Ferrie, A; Holmes, DS; Laroze, A; Liddle, J; Fouchet, MH; Moquette, A; Nassau, P; Pearce, AC; Polyakova, O; Smith, KJ; Thomas, P; Thorpe, JH; Trottet, L; Wang, Y; Hovnanian, A	GlaxoSmithKline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50525901	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50525901&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155519676	440734483							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51290192	Cl.NC(=N)c1ccc(cc1OCc1ccccc1Cl)C1Cc2ccccc2B(O)O1	InChI=1S/C22H20BClN2O3.ClH/c24-19-8-4-2-6-16(19)13-28-21-12-15(9-10-17(21)22(25)26)20-11-14-5-1-3-7-18(14)23(27)29-20;/h1-10,12,20,27H,11,13H2,(H3,25,26);1H	QPOQVIOUNBPFAY-UHFFFAOYSA-N	50525911	CHEMBL4535907	Plasma kallikrein			 50							ChEMBL	10.1016/j.bmcl.2019.126675	10.7270/Q2571GG1	31521475			Walker, AL; Denis, A; Bingham, RP; Bouillot, A; Edgar, EV; Ferrie, A; Holmes, DS; Laroze, A; Liddle, J; Fouchet, MH; Moquette, A; Nassau, P; Pearce, AC; Polyakova, O; Smith, KJ; Thomas, P; Thorpe, JH; Trottet, L; Wang, Y; Hovnanian, A	GlaxoSmithKline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50525911	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50525911&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155547962	440734493							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51290193	Cl.Cc1ccc2B(O)OC(Cc3ccc(C(N)=N)c(OCc4cccnc4)c3)c2c1	InChI=1S/C22H22BN3O3.ClH/c1-14-4-7-19-18(9-14)21(29-23(19)27)11-15-5-6-17(22(24)25)20(10-15)28-13-16-3-2-8-26-12-16;/h2-10,12,21,27H,11,13H2,1H3,(H3,24,25);1H	BSZJZZYFEGDCDY-UHFFFAOYSA-N	50525897	CHEMBL4536142	Plasma kallikrein			 794							ChEMBL	10.1016/j.bmcl.2019.126675	10.7270/Q2571GG1	31521475			Walker, AL; Denis, A; Bingham, RP; Bouillot, A; Edgar, EV; Ferrie, A; Holmes, DS; Laroze, A; Liddle, J; Fouchet, MH; Moquette, A; Nassau, P; Pearce, AC; Polyakova, O; Smith, KJ; Thomas, P; Thorpe, JH; Trottet, L; Wang, Y; Hovnanian, A	GlaxoSmithKline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50525897	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50525897&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155548371	440734479							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51290208	Cl.NC(=N)c1ccc(cc1OCc1cccnc1)C1Cc2cc(Cl)c(F)cc2B(O)O1	InChI=1S/C21H18BClFN3O3.ClH/c23-17-6-14-8-19(30-22(28)16(14)9-18(17)24)13-3-4-15(21(25)26)20(7-13)29-11-12-2-1-5-27-10-12;/h1-7,9-10,19,28H,8,11H2,(H3,25,26);1H	LYGOCJOSRHVHRY-UHFFFAOYSA-N	50525904	CHEMBL4461533	Plasma kallikrein			 200							ChEMBL	10.1016/j.bmcl.2019.126675	10.7270/Q2571GG1	31521475			Walker, AL; Denis, A; Bingham, RP; Bouillot, A; Edgar, EV; Ferrie, A; Holmes, DS; Laroze, A; Liddle, J; Fouchet, MH; Moquette, A; Nassau, P; Pearce, AC; Polyakova, O; Smith, KJ; Thomas, P; Thorpe, JH; Trottet, L; Wang, Y; Hovnanian, A	GlaxoSmithKline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50525904	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50525904&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155528639	440734486							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935522	CC(C)(Cc1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1)C(O)=O	InChI=1S/C27H26ClFN8O3/c1-27(2,26(39)40)8-16-7-17(15-3-4-15)10-36-11-18(32-24(16)36)12-37-13-21(33-34-37)25(38)30-9-20-23-22(29)19(28)5-6-35(23)14-31-20/h5-7,10-11,13-15H,3-4,8-9,12H2,1-2H3,(H,30,38)(H,39,40)	WUNYVCBTCIBICM-UHFFFAOYSA-N	455188	US10730874, Compound I-206::US11352356, Compound I-206	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455188	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455188&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487663	440971014							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935523	CCOC(=O)COc1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C26H24ClFN8O4/c1-2-39-22(37)13-40-21-7-16(15-3-4-15)9-35-10-17(31-25(21)35)11-36-12-20(32-33-36)26(38)29-8-19-24-23(28)18(27)5-6-34(24)14-30-19/h5-7,9-10,12,14-15H,2-4,8,11,13H2,1H3,(H,29,38)	FWUDJTOFXCGHCR-UHFFFAOYSA-N	455189	US10730874, Compound I-207::US11352356, Compound I-207	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455189	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455189&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487470	440971015							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935524	OC(=O)COc1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C24H20ClFN8O4/c25-16-3-4-32-12-28-17(22(32)21(16)26)6-27-24(37)18-10-34(31-30-18)9-15-8-33-7-14(13-1-2-13)5-19(23(33)29-15)38-11-20(35)36/h3-5,7-8,10,12-13H,1-2,6,9,11H2,(H,27,37)(H,35,36)	LOQCZJXILCLEOY-UHFFFAOYSA-N	455190	US10730874, Compound I-208::US11352356, Compound I-208	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455190	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455190&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487408	471695250							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935525	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cc5ncc(cn5n4)C4CC4)nn3)c12	InChI=1S/C21H17ClFN9O/c22-15-3-4-30-11-26-16(20(30)19(15)23)7-25-21(33)17-10-31(29-27-17)9-14-5-18-24-6-13(12-1-2-12)8-32(18)28-14/h3-6,8,10-12H,1-2,7,9H2,(H,25,33)	BMMPQMYYBFRCDP-UHFFFAOYSA-N	455191	US10730874, Compound I-209::US11352356, Compound I-209	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455191	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455191&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487537	440971016							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935526	OC(=O)c1nnc(Cc2cc(cn3cc(Cn4cc(nn4)C(=O)NCc4cn5c(F)c(Cl)ccc5n4)nc23)C2CC2)o1	InChI=1S/C26H20ClFN10O4/c27-18-3-4-20-30-16(11-38(20)22(18)28)7-29-24(39)19-12-37(35-32-19)10-17-9-36-8-15(13-1-2-13)5-14(23(36)31-17)6-21-33-34-25(42-21)26(40)41/h3-5,8-9,11-13H,1-2,6-7,10H2,(H,29,39)(H,40,41)	BMCVXVOXDQSAET-UHFFFAOYSA-N	455192	US10730874, Compound I-210a	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455192	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455192&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155883679	440971017							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935527	Fc1c(Cl)ccc2nc(CNC(=O)c3cn(Cc4cn5cc(cc(Cc6nnco6)c5n4)C4CC4)nn3)cn12	InChI=1S/C25H20ClFN10O2/c26-19-3-4-21-30-17(11-37(21)23(19)27)7-28-25(38)20-12-36(34-32-20)10-18-9-35-8-16(14-1-2-14)5-15(24(35)31-18)6-22-33-29-13-39-22/h3-5,8-9,11-14H,1-2,6-7,10H2,(H,28,38)	UUINXAZEXLAYBL-UHFFFAOYSA-N	455193	US10730874, Compound I-210b	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455193	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455193&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155883680	440971018							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935528	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4nc5ccc(cc5c4C(F)(F)F)C4CC4)nn3)c12	InChI=1S/C24H18ClF4N7O/c25-15-5-6-35-11-31-17(22(35)21(15)26)8-30-23(37)19-10-36(34-33-19)9-18-20(24(27,28)29)14-7-13(12-1-2-12)3-4-16(14)32-18/h3-7,10-12,32H,1-2,8-9H2,(H,30,37)	KTGRBLHYUSEPRF-UHFFFAOYSA-N	455194	US10730874, Compound I-211::US11352356, Compound I-211	Plasma kallikrein					 55					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455194	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455194&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487759	440971019							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935529	CC(C)(Oc1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1)C(O)=O	InChI=1S/C26H24ClFN8O4/c1-26(2,25(38)39)40-20-7-15(14-3-4-14)9-35-10-16(31-23(20)35)11-36-12-19(32-33-36)24(37)29-8-18-22-21(28)17(27)5-6-34(22)13-30-18/h5-7,9-10,12-14H,3-4,8,11H2,1-2H3,(H,29,37)(H,38,39)	DREDWHZESUFRNK-UHFFFAOYSA-N	455195	US10730874, Compound I-212	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455195	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455195&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488099	440971020							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935530	CC(F)c1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C24H21ClF2N8O/c1-13(26)17-6-15(14-2-3-14)8-34-9-16(30-23(17)34)10-35-11-20(31-32-35)24(36)28-7-19-22-21(27)18(25)4-5-33(22)12-29-19/h4-6,8-9,11-14H,2-3,7,10H2,1H3,(H,28,36)	CEHRHYFXIRSYSG-UHFFFAOYSA-N	455196	US10730874, Compound I-213::US11352356, Compound I-213	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455196	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455196&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487908	440971021							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935531	Fc1c(Cl)ccn2cnc(CNC(=O)c3cnn(Cc4cn5cc(cc(Cc6nnco6)c5n4)C4CC4)c3)c12	InChI=1S/C26H21ClFN9O2/c27-20-3-4-35-13-30-21(24(35)23(20)28)8-29-26(38)18-7-32-37(10-18)12-19-11-36-9-17(15-1-2-15)5-16(25(36)33-19)6-22-34-31-14-39-22/h3-5,7,9-11,13-15H,1-2,6,8,12H2,(H,29,38)	QBAIWYMONSAABV-UHFFFAOYSA-N	455197	US10730874, Compound I-214::US11352356, Compound I-214	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455197	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455197&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487917	440971022							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935532	Fc1c(Cl)ccn2cnc(CNC(=O)c3cnn(Cc4cn5cc(cc(C6COC6)c5n4)C4CC4)c3)c12	InChI=1S/C26H23ClFN7O2/c27-21-3-4-33-14-30-22(24(33)23(21)28)7-29-26(36)17-6-31-35(9-17)11-19-10-34-8-16(15-1-2-15)5-20(25(34)32-19)18-12-37-13-18/h3-6,8-10,14-15,18H,1-2,7,11-13H2,(H,29,36)	GRVCFXZFAOPZNJ-UHFFFAOYSA-N	455198	US10730874, Compound I-215::US11352356, Compound I-215	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455198	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455198&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488057	440971023							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935533	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(cc(N6CCOC6=O)c5n4)C4CC4)nn3)c12	InChI=1S/C25H21ClFN9O3/c26-17-3-4-33-13-29-18(22(33)21(17)27)8-28-24(37)19-12-35(32-31-19)11-16-10-34-9-15(14-1-2-14)7-20(23(34)30-16)36-5-6-39-25(36)38/h3-4,7,9-10,12-14H,1-2,5-6,8,11H2,(H,28,37)	QOZPQJGJKRLSPV-UHFFFAOYSA-N	455199	US10730874, Compound I-216::US11352356, Compound I-216	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455199	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455199&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488328	440971024							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935534	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5ccc(cc5n4)C4CC4)nn3)c12	InChI=1S/C22H18ClFN8O/c23-16-4-6-31-12-26-17(21(31)20(16)24)8-25-22(33)18-11-32(29-28-18)10-15-9-30-5-3-14(13-1-2-13)7-19(30)27-15/h3-7,9,11-13H,1-2,8,10H2,(H,25,33)	DDGRQLLUWRVEGP-UHFFFAOYSA-N	455200	US10730874, Compound I-217::US11352356, Compound I-148	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455200	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455200&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155180310	440971025							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935535	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cc5cc(ccc5s4)C4CC4)nn3)c12	InChI=1S/C23H18ClFN6OS/c24-17-5-6-30-12-27-18(22(30)21(17)25)9-26-23(32)19-11-31(29-28-19)10-16-8-15-7-14(13-1-2-13)3-4-20(15)33-16/h3-8,11-13H,1-2,9-10H2,(H,26,32)	MOPFCOIADXHEFH-UHFFFAOYSA-N	455201	US10730874, Compound I-218::US11352356, Compound I-218	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455201	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455201&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488039	440971026							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935536	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cc5ccc(cc5o4)C4CC4)nn3)c12	InChI=1S/C23H18ClFN6O2/c24-17-5-6-30-12-27-18(22(30)21(17)25)9-26-23(32)19-11-31(29-28-19)10-16-7-15-4-3-14(13-1-2-13)8-20(15)33-16/h3-8,11-13H,1-2,9-10H2,(H,26,32)	SSLSXHUJUZXTRN-UHFFFAOYSA-N	455202	US10730874, Compound I-219::US11352356, Compound I-219	Plasma kallikrein					 55					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455202	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455202&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487787	440971027							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935537	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(cc(-n6cccn6)c5n4)C4CC4)nn3)c12	InChI=1S/C25H20ClFN10O/c26-18-4-7-34-14-29-19(23(34)22(18)27)9-28-25(38)20-13-36(33-32-20)12-17-11-35-10-16(15-2-3-15)8-21(24(35)31-17)37-6-1-5-30-37/h1,4-8,10-11,13-15H,2-3,9,12H2,(H,28,38)	YPEIDQJFIUQZSH-UHFFFAOYSA-N	455203	US10730874, Compound I-220::US11352356, Compound I-220	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455203	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455203&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487971	440971028							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935538	CCOc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(cc(CC6(CCCC6)C(O)=O)c5n4)C4CC4)nn3)c12	InChI=1S/C31H33ClN8O4/c1-2-44-27-23(32)7-10-38-18-34-24(26(27)38)13-33-29(41)25-17-40(37-36-25)16-22-15-39-14-21(19-5-6-19)11-20(28(39)35-22)12-31(30(42)43)8-3-4-9-31/h7,10-11,14-15,17-19H,2-6,8-9,12-13,16H2,1H3,(H,33,41)(H,42,43)	ZAKHZOFIGIZBQD-UHFFFAOYSA-N	455204	US10730874, Compound I-221a::US10730874, Compound I-221b::US10730874, Compound I-221c::US11352356, Compound I-221c	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455204	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455204&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487912	440971029							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935539	CCOc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(cc(CC6(CCCC6)C(O)=O)c5n4)C4CC4)nn3)c12	InChI=1S/C31H33ClN8O4/c1-2-44-27-23(32)7-10-38-18-34-24(26(27)38)13-33-29(41)25-17-40(37-36-25)16-22-15-39-14-21(19-5-6-19)11-20(28(39)35-22)12-31(30(42)43)8-3-4-9-31/h7,10-11,14-15,17-19H,2-6,8-9,12-13,16H2,1H3,(H,33,41)(H,42,43)	ZAKHZOFIGIZBQD-UHFFFAOYSA-N	455204	US10730874, Compound I-221a::US10730874, Compound I-221b::US10730874, Compound I-221c::US11352356, Compound I-221c	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455204	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455204&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487912	440971029							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935540	CCOc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(cc(CC6(CCCC6)C(O)=O)c5n4)C4CC4)nn3)c12	InChI=1S/C31H33ClN8O4/c1-2-44-27-23(32)7-10-38-18-34-24(26(27)38)13-33-29(41)25-17-40(37-36-25)16-22-15-39-14-21(19-5-6-19)11-20(28(39)35-22)12-31(30(42)43)8-3-4-9-31/h7,10-11,14-15,17-19H,2-6,8-9,12-13,16H2,1H3,(H,33,41)(H,42,43)	ZAKHZOFIGIZBQD-UHFFFAOYSA-N	455204	US10730874, Compound I-221a::US10730874, Compound I-221b::US10730874, Compound I-221c::US11352356, Compound I-221c	Plasma kallikrein					 55					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455204	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455204&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487912	440971029							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935541	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(CC4=CC5C=CC(Cl)=CC5N4)nn3)c12	InChI=1S/C20H16Cl2FN7O/c21-12-2-1-11-5-13(26-15(11)6-12)8-30-9-17(27-28-30)20(31)24-7-16-19-18(23)14(22)3-4-29(19)10-25-16/h1-6,9-11,15,26H,7-8H2,(H,24,31)	NDRDRRJEBJSGFG-UHFFFAOYSA-N	455207	US10730874, Compound I-222	Plasma kallikrein					 1050					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455207	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455207&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139505324	440971030							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935542	CCOC(=O)C(C)(C)Oc1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C28H28ClFN8O4/c1-4-41-27(40)28(2,3)42-22-9-17(16-5-6-16)11-37-12-18(33-25(22)37)13-38-14-21(34-35-38)26(39)31-10-20-24-23(30)19(29)7-8-36(24)15-32-20/h7-9,11-12,14-16H,4-6,10,13H2,1-3H3,(H,31,39)	MZULJSVETYOZBO-UHFFFAOYSA-N	455208	US10730874, Compound I-223::US11352356, Compound I-223	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455208	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455208&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487764	440971031							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935543	COC(=O)C(F)(Cc1cc(cn2cc(Cn3cc(nn3)C(=O)OC(C)(C)C)nc12)C1CC1)C(=O)OC	InChI=1S/C24H28FN5O6/c1-23(2,3)36-20(31)18-13-30(28-27-18)12-17-11-29-10-16(14-6-7-14)8-15(19(29)26-17)9-24(25,21(32)34-4)22(33)35-5/h8,10-11,13-14H,6-7,9,12H2,1-5H3	SHJTYGZHVISFOM-UHFFFAOYSA-N	455209	US10730874, Compound I-224a::US10730874, Compound I-224b	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455209	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455209&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487458	440971032							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935544	COC(=O)C(F)(Cc1cc(cn2cc(Cn3cc(nn3)C(=O)OC(C)(C)C)nc12)C1CC1)C(=O)OC	InChI=1S/C24H28FN5O6/c1-23(2,3)36-20(31)18-13-30(28-27-18)12-17-11-29-10-16(14-6-7-14)8-15(19(29)26-17)9-24(25,21(32)34-4)22(33)35-5/h8,10-11,13-14H,6-7,9,12H2,1-5H3	SHJTYGZHVISFOM-UHFFFAOYSA-N	455209	US10730874, Compound I-224a::US10730874, Compound I-224b	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455209	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455209&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487458	440971032							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935545	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(cc(-c6cnoc6)c5n4)C4CC4)nn3)c12	InChI=1S/C25H19ClFN9O2/c26-19-3-4-34-13-29-20(23(34)22(19)27)7-28-25(37)21-11-36(33-32-21)10-17-9-35-8-15(14-1-2-14)5-18(24(35)31-17)16-6-30-38-12-16/h3-6,8-9,11-14H,1-2,7,10H2,(H,28,37)	AFGPDDAXHBLMJY-UHFFFAOYSA-N	455211	US10730874, Compound I-225::US11352356, Compound I-225	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455211	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455211&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487456	440971033							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935546	OC(=O)c1cn(cn1)-c1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C26H20ClFN10O3/c27-17-3-4-35-12-30-18(23(35)22(17)28)6-29-25(39)19-11-38(34-33-19)9-16-8-36-7-15(14-1-2-14)5-21(24(36)32-16)37-10-20(26(40)41)31-13-37/h3-5,7-8,10-14H,1-2,6,9H2,(H,29,39)(H,40,41)	UTYNLOXXNUTIPN-UHFFFAOYSA-N	455212	US10730874, Compound I-226::US11352356, Compound I-226	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455212	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455212&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487562	440971034							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935547	CCOC(=O)CC(NC(=O)c1cn(Cc2cn3cc(ccc3n2)C2CC2)nn1)c1ncn2ccc(Cl)c(F)c12	InChI=1S/C26H24ClFN8O3/c1-2-39-22(37)9-19(24-25-23(28)18(27)7-8-34(25)14-29-24)31-26(38)20-13-36(33-32-20)12-17-11-35-10-16(15-3-4-15)5-6-21(35)30-17/h5-8,10-11,13-15,19H,2-4,9,12H2,1H3,(H,31,38)	YSAFBPWVBACDTD-UHFFFAOYSA-N	455213	US10730874, Compound I-227a	Plasma kallikrein					 55					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455213	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455213&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155883681	440971035							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935548	OC(=O)CC(NC(=O)c1cn(Cc2cn3cc(ccc3n2)C2CC2)nn1)c1ncn2ccc(Cl)c(F)c12	InChI=1S/C24H20ClFN8O3/c25-16-5-6-32-12-27-22(23(32)21(16)26)17(7-20(35)36)29-24(37)18-11-34(31-30-18)10-15-9-33-8-14(13-1-2-13)3-4-19(33)28-15/h3-6,8-9,11-13,17H,1-2,7,10H2,(H,29,37)(H,35,36)	ZKQQNXGQJQBXIJ-UHFFFAOYSA-N	455214	US10730874, Compound I-227b	Plasma kallikrein					 1050					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455214	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455214&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155883682	440971036							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935549	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(cc(C#C)c5n4)C4CC4)nn3)c12	InChI=1S/C24H18ClFN8O/c1-2-14-7-16(15-3-4-15)9-33-10-17(29-23(14)33)11-34-12-20(30-31-34)24(35)27-8-19-22-21(26)18(25)5-6-32(22)13-28-19/h1,5-7,9-10,12-13,15H,3-4,8,11H2,(H,27,35)	MAYHRVBMCWJNCC-UHFFFAOYSA-N	455215	US10730874, Compound I-228::US11352356, Compound I-228	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455215	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455215&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487642	440971037							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935550	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cc5ccc(cc5s4)C4CC4)nn3)c12	InChI=1S/C23H18ClFN6OS/c24-17-5-6-30-12-27-18(22(30)21(17)25)9-26-23(32)19-11-31(29-28-19)10-16-7-15-4-3-14(13-1-2-13)8-20(15)33-16/h3-8,11-13H,1-2,9-10H2,(H,26,32)	ZOEACGAPJNATPL-UHFFFAOYSA-N	455216	US10730874, Compound I-229::US11352356, Compound I-229	Plasma kallikrein					 55					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455216	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455216&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487274	440971038							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935551	OC(=O)c1cnn(c1)-c1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C26H20ClFN10O3/c27-18-3-4-35-13-30-19(23(35)22(18)28)7-29-25(39)20-12-37(34-33-20)11-17-10-36-8-15(14-1-2-14)5-21(24(36)32-17)38-9-16(6-31-38)26(40)41/h3-6,8-10,12-14H,1-2,7,11H2,(H,29,39)(H,40,41)	OOLFMSUVCWWWRI-UHFFFAOYSA-N	455217	US10730874, Compound I-230	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455217	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455217&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487654	440971039							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935552	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cc5cc(cc(n5n4)C(F)(F)F)C4CC4)nn3)c12	InChI=1S/C23H17ClF4N8O/c24-16-3-4-34-11-30-17(21(34)20(16)25)8-29-22(37)18-10-35(33-31-18)9-14-7-15-5-13(12-1-2-12)6-19(23(26,27)28)36(15)32-14/h3-7,10-12H,1-2,8-9H2,(H,29,37)	OEAPVMVSQWGEDQ-UHFFFAOYSA-N	455218	US10730874, Compound I-231::US11352356, Compound I-231	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455218	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455218&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488389	440971040							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935553	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cc5cc(ccc5[nH]4)C4CC4)nn3)c12	InChI=1S/C23H19ClFN7O/c24-17-5-6-31-12-27-19(22(31)21(17)25)9-26-23(33)20-11-32(30-29-20)10-16-8-15-7-14(13-1-2-13)3-4-18(15)28-16/h3-8,11-13,28H,1-2,9-10H2,(H,26,33)	XJVYSSFMEXUMCC-UHFFFAOYSA-N	455219	US10730874, Compound I-232::US11352356, Compound I-232	Plasma kallikrein					 55					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455219	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455219&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488084	440971041							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935554	Cn1c(Cn2cc(nn2)C(=O)NCc2ncn3ccc(Cl)c(F)c23)cc2cc(ccc12)C1CC1	InChI=1S/C24H21ClFN7O/c1-31-17(9-16-8-15(14-2-3-14)4-5-21(16)31)11-33-12-20(29-30-33)24(34)27-10-19-23-22(26)18(25)6-7-32(23)13-28-19/h4-9,12-14H,2-3,10-11H2,1H3,(H,27,34)	DDGPUUXNVFDGHE-UHFFFAOYSA-N	455220	US10730874, Compound I-233::US11352356, Compound I-233	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455220	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455220&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487417	440971042							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935555	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cc5ccc(Cl)cc5s4)nn3)c12	InChI=1S/C20H13Cl2FN6OS/c21-12-2-1-11-5-13(31-17(11)6-12)8-29-9-16(26-27-29)20(30)24-7-15-19-18(23)14(22)3-4-28(19)10-25-15/h1-6,9-10H,7-8H2,(H,24,30)	UDQXMMRHILVFQM-UHFFFAOYSA-N	455221	US10730874, Compound I-234::US11352356, Compound I-234	Plasma kallikrein					 55					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455221	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455221&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487622	440971043							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935556	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cc5ccc(cc5[nH]4)C4CC4)nn3)c12	InChI=1S/C23H19ClFN7O/c24-17-5-6-31-12-27-19(22(31)21(17)25)9-26-23(33)20-11-32(30-29-20)10-16-7-15-4-3-14(13-1-2-13)8-18(15)28-16/h3-8,11-13,28H,1-2,9-10H2,(H,26,33)	QYHIARHHDXPSGM-UHFFFAOYSA-N	455222	US10730874, Compound I-235::US11352356, Compound I-235	Plasma kallikrein					 1050					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455222	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455222&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488015	440971044							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935557	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4nc5cc(ccc5[nH]4)C4CC4)nn3)c12	InChI=1S/C22H18ClFN8O/c23-14-5-6-31-11-26-17(21(31)20(14)24)8-25-22(33)18-9-32(30-29-18)10-19-27-15-4-3-13(12-1-2-12)7-16(15)28-19/h3-7,9,11-12H,1-2,8,10H2,(H,25,33)(H,27,28)	SHIXYCBIXKHBFS-UHFFFAOYSA-N	455223	US10730874, Compound I-236::US11352356, Compound I-236	Plasma kallikrein					 55					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455223	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455223&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488305	440971045							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935558	CC(C)(Cc1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1)C(O)=O	InChI=1S/C28H27ClFN7O3/c1-28(2,27(39)40)8-17-7-18(16-3-4-16)11-36-13-20(34-25(17)36)14-37-12-19(9-33-37)26(38)31-10-22-24-23(30)21(29)5-6-35(24)15-32-22/h5-7,9,11-13,15-16H,3-4,8,10,14H2,1-2H3,(H,31,38)(H,39,40)	HJMRZQSPPGPLHS-UHFFFAOYSA-N	455224	US10730874, Compound I-237::US11352356, Compound I-237	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455224	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455224&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139490610	440971046							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935559	CC(C)(Cc1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1)c1nn[nH]n1	InChI=1S/C28H27ClFN11O/c1-28(2,27-35-37-38-36-27)8-17-7-18(16-3-4-16)11-40-13-20(34-25(17)40)14-41-12-19(9-33-41)26(42)31-10-22-24-23(30)21(29)5-6-39(24)15-32-22/h5-7,9,11-13,15-16H,3-4,8,10,14H2,1-2H3,(H,31,42)(H,35,36,37,38)	SCCRXLRICSMLTR-UHFFFAOYSA-N	455225	US10730874, Compound I-238::US11352356, Compound I-238	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455225	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455225&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487855	440971047							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935560	Fc1cc2nc(Cn3cc(nn3)C(=O)OCc3ncn4ccc(Cl)c(F)c34)cn2cc1C1CC1	InChI=1S/C22H16ClF2N7O2/c23-15-3-4-30-11-26-18(21(30)20(15)25)10-34-22(33)17-9-32(29-28-17)7-13-6-31-8-14(12-1-2-12)16(24)5-19(31)27-13/h3-6,8-9,11-12H,1-2,7,10H2	SDJSFAPPNYFXTA-UHFFFAOYSA-N	455226	US10730874, Compound I-239	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455226	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455226&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139505265	440971048							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935561	Fc1c(Cn2cc(nn2)C(=O)NCc2ncn3ccc(Cl)c(F)c23)nc2ccc(cn12)C1CC1	InChI=1S/C22H17ClF2N8O/c23-14-5-6-31-11-27-15(20(31)19(14)24)7-26-22(34)17-10-32(30-29-17)9-16-21(25)33-8-13(12-1-2-12)3-4-18(33)28-16/h3-6,8,10-12H,1-2,7,9H2,(H,26,34)	FIYCBKFNXUXFBP-UHFFFAOYSA-N	455227	US10730874, Compound I-240::US11352356, Compound I-240	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455227	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455227&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488052	440971049							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935562	CCOC(=O)C(C)(C)C(O)c1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C29H30ClFN8O4/c1-4-43-28(42)29(2,3)25(40)19-9-17(16-5-6-16)11-38-12-18(34-26(19)38)13-39-14-22(35-36-39)27(41)32-10-21-24-23(31)20(30)7-8-37(24)15-33-21/h7-9,11-12,14-16,25,40H,4-6,10,13H2,1-3H3,(H,32,41)	NFXYWWHOOYWZPT-UHFFFAOYSA-N	455228	US10730874, Compound I-241a::US11352356, Compound I-241a	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455228	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455228&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487636	440971050							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935563	CC(C)(C(O)c1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1)C(O)=O	InChI=1S/C27H26ClFN8O4/c1-27(2,26(40)41)23(38)17-7-15(14-3-4-14)9-36-10-16(32-24(17)36)11-37-12-20(33-34-37)25(39)30-8-19-22-21(29)18(28)5-6-35(22)13-31-19/h5-7,9-10,12-14,23,38H,3-4,8,11H2,1-2H3,(H,30,39)(H,40,41)	OZZKRVWVWFHSDG-UHFFFAOYSA-N	455229	US10730874, Compound I-241b::US11352356, Compound I-241b	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455229	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455229&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487275	440971051							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935564	CCn1ncn(-c2cc(cn3cc(Cn4cc(nn4)C(=O)NCc4ncn5ccc(Cl)c(F)c45)nc23)C2CC2)c(=O)c1=O	InChI=1S/C27H23ClFN11O3/c1-2-40-27(43)26(42)39(14-32-40)21-7-16(15-3-4-15)9-37-10-17(33-24(21)37)11-38-12-20(34-35-38)25(41)30-8-19-23-22(29)18(28)5-6-36(23)13-31-19/h5-7,9-10,12-15H,2-4,8,11H2,1H3,(H,30,41)	XPDLVYUDGVDSQA-UHFFFAOYSA-N	455230	US10730874, Compound I-242::US11352356, Compound I-242	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455230	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455230&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155883683	440971052							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935565	Fc1c(Cl)ccn2cnc(CNC(=O)c3nnc(o3)C(F)(F)c3cn4cc(ccc4n3)C3CC3)c12	InChI=1S/C22H15ClF3N7O2/c23-13-5-6-32-10-28-14(18(32)17(13)24)7-27-19(34)20-30-31-21(35-20)22(25,26)15-9-33-8-12(11-1-2-11)3-4-16(33)29-15/h3-6,8-11H,1-2,7H2,(H,27,34)	OLBRMLDSQFMHGN-UHFFFAOYSA-N	455231	US10730874, Compound I-243::US11352356, Compound I-243	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455231	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455231&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488297	440971053							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935566	COC(=O)Cn1c(Cn2cc(nn2)C(=O)NCc2ncn3ccc(Cl)c(F)c23)cc2cc(ccc12)C1CC1	InChI=1S/C26H23ClFN7O3/c1-38-23(36)13-35-18(9-17-8-16(15-2-3-15)4-5-22(17)35)11-34-12-21(31-32-34)26(37)29-10-20-25-24(28)19(27)6-7-33(25)14-30-20/h4-9,12,14-15H,2-3,10-11,13H2,1H3,(H,29,37)	CARKALGDYODXNI-UHFFFAOYSA-N	455232	US10730874, Compound I-244::US11352356, Compound I-244	Plasma kallikrein					 55					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455232	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455232&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488148	440971054							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935567	CCOC(=O)C(C)Cc1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C28H28ClFN8O3/c1-3-41-28(40)16(2)8-18-9-19(17-4-5-17)11-37-12-20(33-26(18)37)13-38-14-23(34-35-38)27(39)31-10-22-25-24(30)21(29)6-7-36(25)15-32-22/h6-7,9,11-12,14-17H,3-5,8,10,13H2,1-2H3,(H,31,39)	DWFQWYQWENUHKB-UHFFFAOYSA-N	455233	US10730874, Compound I-245a::US11352356, Compound I-245a	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455233	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455233&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488291	440971055							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935568	CC(Cc1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1)C(O)=O	InChI=1S/C26H24ClFN8O3/c1-14(26(38)39)6-16-7-17(15-2-3-15)9-35-10-18(31-24(16)35)11-36-12-21(32-33-36)25(37)29-8-20-23-22(28)19(27)4-5-34(23)13-30-20/h4-5,7,9-10,12-15H,2-3,6,8,11H2,1H3,(H,29,37)(H,38,39)	SKNDRGROUPZYJA-UHFFFAOYSA-N	455234	US10730874, Compound I-245b::US11352356, Compound I-245b	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455234	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455234&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488269	440971056							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935569	OC(=O)Cn1c(Cn2cc(nn2)C(=O)NCc2ncn3ccc(Cl)c(F)c23)cc2cc(ccc12)C1CC1	InChI=1S/C25H21ClFN7O3/c26-18-5-6-32-13-29-19(24(32)23(18)27)9-28-25(37)20-11-33(31-30-20)10-17-8-16-7-15(14-1-2-14)3-4-21(16)34(17)12-22(35)36/h3-8,11,13-14H,1-2,9-10,12H2,(H,28,37)(H,35,36)	YMRXVMCXMGDLPL-UHFFFAOYSA-N	455235	US10730874, Compound I-246::US11352356, Compound I-246	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455235	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455235&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488221	471695251							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935570	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(cc(-n6cn[nH]c(=O)c6=O)c5n4)C4CC4)nn3)c12	InChI=1S/C25H19ClFN11O3/c26-16-3-4-35-11-29-17(21(35)20(16)27)6-28-23(39)18-10-37(34-32-18)9-15-8-36-7-14(13-1-2-13)5-19(22(36)31-15)38-12-30-33-24(40)25(38)41/h3-5,7-8,10-13H,1-2,6,9H2,(H,28,39)(H,33,40)	NFRQQTRYGIYGMO-UHFFFAOYSA-N	455236	US10730874, Compound I-247::US11352356, Compound I-247	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455236	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455236&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155883684	440971057							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935571	CCOC(=O)c1nncn1-c1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C27H23ClFN11O3/c1-2-43-27(42)25-35-32-14-40(25)21-7-16(15-3-4-15)9-38-10-17(33-24(21)38)11-39-12-20(34-36-39)26(41)30-8-19-23-22(29)18(28)5-6-37(23)13-31-19/h5-7,9-10,12-15H,2-4,8,11H2,1H3,(H,30,41)	NDOLKRIZGJGJOH-UHFFFAOYSA-N	455237	US10730874, Compound I-248::US11352356, Compound I-248	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455237	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455237&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487829	440971058							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935572	Cc1nncn1-c1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C25H21ClFN11O/c1-14-32-30-13-38(14)21-6-16(15-2-3-15)8-36-9-17(31-24(21)36)10-37-11-20(33-34-37)25(39)28-7-19-23-22(27)18(26)4-5-35(23)12-29-19/h4-6,8-9,11-13,15H,2-3,7,10H2,1H3,(H,28,39)	YCJBZBXZGIDXDX-UHFFFAOYSA-N	455238	US10730874, Compound I-249::US11352356, Compound I-249	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455238	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455238&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488147	440971059							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935573	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(cc(N6CC7(COC7)C6)c5n4)C4CC4)nn3)c12	InChI=1S/C27H25ClFN9O2/c28-19-3-4-35-15-31-20(24(35)23(19)29)6-30-26(39)21-10-38(34-33-21)9-18-8-36-7-17(16-1-2-16)5-22(25(36)32-18)37-11-27(12-37)13-40-14-27/h3-5,7-8,10,15-16H,1-2,6,9,11-14H2,(H,30,39)	AWWPNDXFOZUTGX-UHFFFAOYSA-N	455239	US10730874, Compound I-250::US11352356, Compound I-250	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455239	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455239&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487839	440971060							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935574	OC(=O)CCn1c(Cn2cc(nn2)C(=O)NCc2ncn3ccc(Cl)c(F)c23)cc2cc(ccc12)C1CC1	InChI=1S/C26H23ClFN7O3/c27-19-5-7-33-14-30-20(25(33)24(19)28)11-29-26(38)21-13-34(32-31-21)12-18-10-17-9-16(15-1-2-15)3-4-22(17)35(18)8-6-23(36)37/h3-5,7,9-10,13-15H,1-2,6,8,11-12H2,(H,29,38)(H,36,37)	VOMPCERFIBJDSW-UHFFFAOYSA-N	455240	US10730874, Compound I-251a::US11352356, Compound I-251b	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455240	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455240&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487926	440971061							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935575	CCOC(=O)CCn1c(Cn2cc(nn2)C(=O)NCc2ncn3ccc(Cl)c(F)c23)cc2cc(ccc12)C1CC1	InChI=1S/C28H27ClFN7O3/c1-2-40-25(38)8-10-37-20(12-19-11-18(17-3-4-17)5-6-24(19)37)14-36-15-23(33-34-36)28(39)31-13-22-27-26(30)21(29)7-9-35(27)16-32-22/h5-7,9,11-12,15-17H,2-4,8,10,13-14H2,1H3,(H,31,39)	XFPMNJNQDSEDHM-UHFFFAOYSA-N	455241	US10730874, Compound I-251b::US11352356, Compound I-251a	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455241	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455241&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488113	440971062							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935576	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4nc5ccc(cc5s4)C4CC4)nn3)c12	InChI=1S/C22H17ClFN7OS/c23-14-5-6-30-11-26-16(21(30)20(14)24)8-25-22(32)17-9-31(29-28-17)10-19-27-15-4-3-13(12-1-2-12)7-18(15)33-19/h3-7,9,11-12H,1-2,8,10H2,(H,25,32)	QFQJJMPYEJONGW-UHFFFAOYSA-N	455242	US10730874, Compound I-252::US11352356, Compound I-252	Plasma kallikrein					 55					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455242	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455242&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487897	440971063							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935577	Cc1nnc(C)n1-c1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C26H23ClFN11O/c1-14-32-33-15(2)39(14)22-7-17(16-3-4-16)9-37-10-18(31-25(22)37)11-38-12-21(34-35-38)26(40)29-8-20-24-23(28)19(27)5-6-36(24)13-30-20/h5-7,9-10,12-13,16H,3-4,8,11H2,1-2H3,(H,29,40)	PCZUSEDWBDEHIR-UHFFFAOYSA-N	455243	US10730874, Compound I-253::US11352356, Compound I-253	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455243	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455243&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487874	440971064							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935578	COC(=O)c1ccc(cc1)-n1c(Cn2cc(nn2)C(=O)NCc2ncn3ccc(Cl)c(F)c23)cc2cc(ccc12)C1CC1	InChI=1S/C31H25ClFN7O3/c1-43-31(42)19-4-7-22(8-5-19)40-23(13-21-12-20(18-2-3-18)6-9-27(21)40)15-39-16-26(36-37-39)30(41)34-14-25-29-28(33)24(32)10-11-38(29)17-35-25/h4-13,16-18H,2-3,14-15H2,1H3,(H,34,41)	VPHHTERWGSFUGV-UHFFFAOYSA-N	455244	US10730874, Compound I-254::US11352356, Compound I-254	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455244	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455244&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487835	440971065							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935579	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4nc5cc(cc(Cl)n5n4)C4CC4)nn3)c12	InChI=1S/C21H16Cl2FN9O/c22-13-3-4-31-10-26-14(20(31)19(13)24)7-25-21(34)15-8-32(30-28-15)9-17-27-18-6-12(11-1-2-11)5-16(23)33(18)29-17/h3-6,8,10-11H,1-2,7,9H2,(H,25,34)	NZPWPFJMHGOWNW-UHFFFAOYSA-N	455245	US10730874, Compound I-255::US11352356, Compound I-255	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455245	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455245&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487813	440971066							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935580	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cc5ccc(cn5c4)C4CC4)nn3)c12	InChI=1S/C23H19ClFN7O/c24-18-5-6-30-13-27-19(22(30)21(18)25)8-26-23(33)20-12-32(29-28-20)10-14-7-17-4-3-16(15-1-2-15)11-31(17)9-14/h3-7,9,11-13,15H,1-2,8,10H2,(H,26,33)	MORSAJTYBNUHRL-UHFFFAOYSA-N	455246	US10730874, Compound I-256::US11352356, Compound I-256	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455246	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455246&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488295	440971067							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935581	Cc1ncc(s1)-c1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C26H21ClFN9OS/c1-14-29-8-22(39-14)18-6-16(15-2-3-15)9-36-10-17(32-25(18)36)11-37-12-21(33-34-37)26(38)30-7-20-24-23(28)19(27)4-5-35(24)13-31-20/h4-6,8-10,12-13,15H,2-3,7,11H2,1H3,(H,30,38)	WTMMADILQWOTEV-UHFFFAOYSA-N	455247	US10730874, Compound I-257::US11352356, Compound I-257	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455247	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455247&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487513	440971068							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935582	Cc1ncn(n1)C1=CC(=CC2C=C(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)C=C12)C1CC1	InChI=1S/C27H23ClFN9O/c1-15-31-14-38(34-15)24-9-18(17-2-3-17)8-19-6-16(7-20(19)24)11-37-12-23(33-35-37)27(39)30-10-22-26-25(29)21(28)4-5-36(26)13-32-22/h4-9,12-14,17,19H,2-3,10-11H2,1H3,(H,30,39)	WVLSLVKXOFSQHX-UHFFFAOYSA-N	455248	US10730874, Compound I-258	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455248	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455248&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139505052	440971069							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935583	OC(=O)c1ccc(cc1)-n1c(Cn2cc(nn2)C(=O)NCc2ncn3ccc(Cl)c(F)c23)cc2cc(ccc12)C1CC1	InChI=1S/C30H23ClFN7O3/c31-23-9-10-37-16-34-24(28(37)27(23)32)13-33-29(40)25-15-38(36-35-25)14-22-12-20-11-19(17-1-2-17)5-8-26(20)39(22)21-6-3-18(4-7-21)30(41)42/h3-12,15-17H,1-2,13-14H2,(H,33,40)(H,41,42)	HMQMBBYTPJFINU-UHFFFAOYSA-N	455249	US10730874, Compound I-259::US11352356, Compound I-259	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455249	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455249&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487713	471695252							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935584	CCOC(=O)c1nc(cn1Cc1cn2cc(ccc2n1)C1CC1)C(=O)NCc1ncn2ccc(Cl)c(F)c12	InChI=1S/C26H23ClFN7O3/c1-2-38-26(37)24-32-20(25(36)29-9-19-23-22(28)18(27)7-8-33(23)14-30-19)13-35(24)12-17-11-34-10-16(15-3-4-15)5-6-21(34)31-17/h5-8,10-11,13-15H,2-4,9,12H2,1H3,(H,29,36)	MQMYUXQXYJPBOV-UHFFFAOYSA-N	455250	US10730874, Compound I-260::US11352356, Compound I-260	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455250	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455250&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488252	440971070							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935585	OC(=O)c1nc(cn1Cc1cn2cc(ccc2n1)C1CC1)C(=O)NCc1ncn2ccc(Cl)c(F)c12	InChI=1S/C24H19ClFN7O3/c25-16-5-6-31-12-28-17(21(31)20(16)26)7-27-23(34)18-11-33(22(30-18)24(35)36)10-15-9-32-8-14(13-1-2-13)3-4-19(32)29-15/h3-6,8-9,11-13H,1-2,7,10H2,(H,27,34)(H,35,36)	QRIAWBAEIRHTDP-UHFFFAOYSA-N	455251	BDBM455263::US10730874, Compound I-261::US11352356, Compound I-261	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455251	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455251&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487725	471695253							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935586	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cc5cc(cc(N6CCCC6=O)n5n4)C4CC4)nn3)c12	InChI=1S/C26H23ClFN9O2/c27-19-5-7-34-14-30-20(25(34)24(19)28)11-29-26(39)21-13-35(33-31-21)12-17-10-18-8-16(15-3-4-15)9-22(37(18)32-17)36-6-1-2-23(36)38/h5,7-10,13-15H,1-4,6,11-12H2,(H,29,39)	VNYUOYWQIICEJF-UHFFFAOYSA-N	455252	US10730874, Compound I-262::US11352356, Compound I-262	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455252	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455252&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488322	440971071							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935587	CC(C)(C)OC(=O)c1ncc(s1)-c1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C30H27ClFN9O3S/c1-30(2,3)44-29(43)28-34-10-23(45-28)19-8-17(16-4-5-16)11-40-12-18(36-26(19)40)13-41-14-22(37-38-41)27(42)33-9-21-25-24(32)20(31)6-7-39(25)15-35-21/h6-8,10-12,14-16H,4-5,9,13H2,1-3H3,(H,33,42)	JPYUVYSRLHACRV-UHFFFAOYSA-N	455253	US10730874, Compound I-263	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455253	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455253&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487854	440971072							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935588	CCOC(=O)C1CN(CCO1)c1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C29H29ClFN9O4/c1-2-43-29(42)24-15-37(7-8-44-24)23-9-18(17-3-4-17)11-39-12-19(34-27(23)39)13-40-14-22(35-36-40)28(41)32-10-21-26-25(31)20(30)5-6-38(26)16-33-21/h5-6,9,11-12,14,16-17,24H,2-4,7-8,10,13,15H2,1H3,(H,32,41)	DEVJROQFYQYNDL-UHFFFAOYSA-N	455254	US10730874, Compound I-264	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455254	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455254&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487777	440971073							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935589	COC(=O)C1CN(C1)c1cc(nn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C26H24ClFN10O3/c1-41-26(40)15-8-36(9-15)21-6-18(14-2-3-14)33-38-11-16(31-24(21)38)10-37-12-20(32-34-37)25(39)29-7-19-23-22(28)17(27)4-5-35(23)13-30-19/h4-6,11-15H,2-3,7-10H2,1H3,(H,29,39)	WCUZZJJIYBJJMV-UHFFFAOYSA-N	455255	US10730874, Compound I-265a::US11352356, Compound I-265a	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455255	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455255&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487530	440971074							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935590	OC(=O)C1CN(C1)c1cc(nn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C25H22ClFN10O3/c26-16-3-4-34-12-29-18(22(34)21(16)27)6-28-24(38)19-11-36(33-31-19)9-15-10-37-23(30-15)20(5-17(32-37)13-1-2-13)35-7-14(8-35)25(39)40/h3-5,10-14H,1-2,6-9H2,(H,28,38)(H,39,40)	VVBVZHUNSUIZJA-UHFFFAOYSA-N	455256	US10730874, Compound I-265b::US11352356, Compound I-265b	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455256	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455256&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488072	440971075							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935591	COC(=O)C1CCN(C1)c1cc(nn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C27H26ClFN10O3/c1-42-27(41)16-4-6-36(10-16)22-8-19(15-2-3-15)34-39-12-17(32-25(22)39)11-38-13-21(33-35-38)26(40)30-9-20-24-23(29)18(28)5-7-37(24)14-31-20/h5,7-8,12-16H,2-4,6,9-11H2,1H3,(H,30,40)	DPTXWIJTPPUXFX-UHFFFAOYSA-N	455257	US10730874, Compound I-266::US11352356, Compound I-266	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455257	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455257&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487566	440971076							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935592	OC(=O)C1CCN(C1)c1cc(nn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C26H24ClFN10O3/c27-17-4-6-36-13-30-19(23(36)22(17)28)8-29-25(39)20-12-37(34-32-20)10-16-11-38-24(31-16)21(7-18(33-38)14-1-2-14)35-5-3-15(9-35)26(40)41/h4,6-7,11-15H,1-3,5,8-10H2,(H,29,39)(H,40,41)	SUNUKMYKABZUNE-UHFFFAOYSA-N	455258	US10730874, Compound I-267::US11352356, Compound I-267	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455258	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455258&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487317	471695254							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935593	CCOC(=O)c1c(Cn2cc(nn2)C(=O)NCc2ncn3ccc(Cl)c(F)c23)cc2ccc(cn12)C1CC1	InChI=1S/C26H23ClFN7O3/c1-2-38-26(37)23-17(9-18-6-5-16(12-35(18)23)15-3-4-15)11-34-13-21(31-32-34)25(36)29-10-20-24-22(28)19(27)7-8-33(24)14-30-20/h5-9,12-15H,2-4,10-11H2,1H3,(H,29,36)	JDFNPHKJAYAIDT-UHFFFAOYSA-N	455259	US10730874, Compound I-268::US11352356, Compound I-268	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455259	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455259&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487790	440971077							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935594	Cc1c(C)c2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)ccc2n1C	InChI=1S/C23H21ClFN7O/c1-13-14(2)30(3)20-5-4-15(8-16(13)20)10-32-11-19(28-29-32)23(33)26-9-18-22-21(25)17(24)6-7-31(22)12-27-18/h4-8,11-12H,9-10H2,1-3H3,(H,26,33)	XYYCBPGDXBGUAX-UHFFFAOYSA-N	455260	US10730874, Compound I-269::US11352356, Compound I-269	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455260	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455260&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488107	440971078							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935595	COC(=O)c1cc(cn1Cc1cn2cc(ccc2n1)C1CC1)C(=O)NCc1ncn2ccc(Cl)c(F)c12	InChI=1S/C26H22ClFN6O3/c1-37-26(36)21-8-17(25(35)29-9-20-24-23(28)19(27)6-7-32(24)14-30-20)11-33(21)12-18-13-34-10-16(15-2-3-15)4-5-22(34)31-18/h4-8,10-11,13-15H,2-3,9,12H2,1H3,(H,29,35)	GFWSTLBWNVUUNX-UHFFFAOYSA-N	455261	US10730874, Compound I-270a::US11352356, Compound I-270a	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455261	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455261&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487457	440971079							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935596	OC(=O)c1cc(cn1Cc1cn2cc(ccc2n1)C1CC1)C(=O)NCc1ncn2ccc(Cl)c(F)c12	InChI=1S/C25H20ClFN6O3/c26-18-5-6-31-13-29-19(23(31)22(18)27)8-28-24(34)16-7-20(25(35)36)32(10-16)11-17-12-33-9-15(14-1-2-14)3-4-21(33)30-17/h3-7,9-10,12-14H,1-2,8,11H2,(H,28,34)(H,35,36)	PUBUNCLOYXZPKC-UHFFFAOYSA-N	455262	US10730874, Compound I-270b::US11352356, Compound I-270b	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455262	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455262&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488190	440971080							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935597	OC(=O)c1nc(cn1Cc1cn2cc(ccc2n1)C1CC1)C(=O)NCc1ncn2ccc(Cl)c(F)c12	InChI=1S/C24H19ClFN7O3/c25-16-5-6-31-12-28-17(21(31)20(16)26)7-27-23(34)18-11-33(22(30-18)24(35)36)10-15-9-32-8-14(13-1-2-13)3-4-19(32)29-15/h3-6,8-9,11-13H,1-2,7,10H2,(H,27,34)(H,35,36)	QRIAWBAEIRHTDP-UHFFFAOYSA-N	455251	BDBM455263::US10730874, Compound I-261::US11352356, Compound I-261	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455251	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455251&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487725	471695253							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935598	OCC1(COC1)C(O)c1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C27H26ClFN8O4/c28-19-3-4-35-14-31-20(23(35)22(19)29)6-30-26(40)21-10-37(34-33-21)9-17-8-36-7-16(15-1-2-15)5-18(25(36)32-17)24(39)27(11-38)12-41-13-27/h3-5,7-8,10,14-15,24,38-39H,1-2,6,9,11-13H2,(H,30,40)	XPNJNFZYPYATBN-UHFFFAOYSA-N	455264	BDBM455265::US10730874, Compound I-272	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455264	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455264&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487524	440971082							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935599	OCC1(COC1)C(O)c1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C27H26ClFN8O4/c28-19-3-4-35-14-31-20(23(35)22(19)29)6-30-26(40)21-10-37(34-33-21)9-17-8-36-7-16(15-1-2-15)5-18(25(36)32-17)24(39)27(11-38)12-41-13-27/h3-5,7-8,10,14-15,24,38-39H,1-2,6,9,11-13H2,(H,30,40)	XPNJNFZYPYATBN-UHFFFAOYSA-N	455264	BDBM455265::US10730874, Compound I-272	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455264	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455264&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487524	440971082							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935600	OC(=O)c1c(Cn2cc(nn2)C(=O)NCc2ncn3ccc(Cl)c(F)c23)[nH]c2cc(ccc12)C1CC1	InChI=1S/C24H19ClFN7O3/c25-15-5-6-32-11-28-17(22(32)21(15)26)8-27-23(34)19-10-33(31-30-19)9-18-20(24(35)36)14-4-3-13(12-1-2-12)7-16(14)29-18/h3-7,10-12,29H,1-2,8-9H2,(H,27,34)(H,35,36)	SRZVOUXOYHHDQR-UHFFFAOYSA-N	455266	BDBM455275::US10730874, Compound I-274	Plasma kallikrein					 1050					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455266	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455266&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487810	440971084							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935601	NC(=O)c1cc(Cn2cc(nn2)C(=O)NCc2ncn3ccc(Cl)c(F)c23)cc2cc(cnc12)C1CC1	InChI=1S/C25H20ClFN8O2/c26-18-3-4-34-12-31-19(23(34)21(18)27)9-30-25(37)20-11-35(33-32-20)10-13-5-15-7-16(14-1-2-14)8-29-22(15)17(6-13)24(28)36/h3-8,11-12,14H,1-2,9-10H2,(H2,28,36)(H,30,37)	BILHIKZWAIIMIU-UHFFFAOYSA-N	455267	US10730874, Compound I-275::US11352356, Compound I-275	Plasma kallikrein					 55					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455267	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455267&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487815	440971085							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935602	Fc1c(Cl)ccn2cnc(CNC(=O)c3ccn(Cc4cn5cc(ccc5n4)C4CC4)c3)c12	InChI=1S/C24H20ClFN6O/c25-19-6-8-31-14-28-20(23(31)22(19)26)9-27-24(33)17-5-7-30(10-17)12-18-13-32-11-16(15-1-2-15)3-4-21(32)29-18/h3-8,10-11,13-15H,1-2,9,12H2,(H,27,33)	AMUWISREKFTEKP-UHFFFAOYSA-N	455268	US10730874, Compound I-276::US11352356, Compound I-276	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455268	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455268&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487661	440971086							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935603	Fc1cn2cnc(CNC(=O)c3cn(Cc4cn5cc(ccc5n4)C4CC4)nn3)c2cc1Cl	InChI=1S/C22H18ClFN8O/c23-16-5-20-18(26-12-31(20)10-17(16)24)6-25-22(33)19-11-32(29-28-19)9-15-8-30-7-14(13-1-2-13)3-4-21(30)27-15/h3-5,7-8,10-13H,1-2,6,9H2,(H,25,33)	BZKHXEZUKFAFOG-UHFFFAOYSA-N	455269	US10730874, Compound I-277::US11352356, Compound I-277	Plasma kallikrein					 55					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455269	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455269&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487411	440971087							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935604	CC(NC(=O)c1cn(nn1)C(C)c1cn2cc(ccc2n1)C1CC1)c1ncn2ccc(Cl)c(F)c12	InChI=1S/C24H22ClFN8O/c1-13(22-23-21(26)17(25)7-8-32(23)12-27-22)28-24(35)19-11-34(31-30-19)14(2)18-10-33-9-16(15-3-4-15)5-6-20(33)29-18/h5-15H,3-4H2,1-2H3,(H,28,35)	GRUPCZYPBIIPSA-UHFFFAOYSA-N	455270	US10730874, Compound I-278::US11352356, Compound I-278	Plasma kallikrein					 1050					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455270	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455270&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488380	440971088							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935605	OC(C1COC1)c1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C26H24ClFN8O3/c27-19-3-4-34-13-30-20(23(34)22(19)28)6-29-26(38)21-10-36(33-32-21)9-17-8-35-7-15(14-1-2-14)5-18(25(35)31-17)24(37)16-11-39-12-16/h3-5,7-8,10,13-14,16,24,37H,1-2,6,9,11-12H2,(H,29,38)	ANJUXYVWPPFEHI-UHFFFAOYSA-N	455271	US10730874, Compound I-279::US11352356, Compound I-279	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455271	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455271&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487354	440971089							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935606	CC(NC(=O)c1cn(Cc2cn3cc(cc(C(O)C4COC4)c3n2)C2CC2)nn1)c1ncn2ccc(Cl)c(F)c12	InChI=1S/C27H26ClFN8O3/c1-14(23-24-22(29)20(28)4-5-35(24)13-30-23)31-27(39)21-10-37(34-33-21)9-18-8-36-7-16(15-2-3-15)6-19(26(36)32-18)25(38)17-11-40-12-17/h4-8,10,13-15,17,25,38H,2-3,9,11-12H2,1H3,(H,31,39)	VLWOOFCIHAHAPJ-UHFFFAOYSA-N	455272	US10730874, Compound I-280::US11352356, Compound I-280	Plasma kallikrein					 55					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455272	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455272&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487320	440971090							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935607	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(cc(CS(=O)(=O)NCC(F)(F)F)c5n4)C4CC4)nn3)c12	InChI=1S/C25H22ClF4N9O3S/c26-18-3-4-37-13-32-19(22(37)21(18)27)6-31-24(40)20-10-39(36-35-20)9-17-8-38-7-15(14-1-2-14)5-16(23(38)34-17)11-43(41,42)33-12-25(28,29)30/h3-5,7-8,10,13-14,33H,1-2,6,9,11-12H2,(H,31,40)	JCBINPZGFRKSJU-UHFFFAOYSA-N	455273	US10730874, Compound I-281::US11352356, Compound I-281	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455273	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455273&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487999	440971091							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935608	Fc1c(Cl)ccn2cnc(CNC(=O)c3cnn(Cc4nc5ccccn5n4)c3)c12	InChI=1S/C19H14ClFN8O/c20-13-4-6-27-11-23-14(18(27)17(13)21)8-22-19(30)12-7-24-28(9-12)10-15-25-16-3-1-2-5-29(16)26-15/h1-7,9,11H,8,10H2,(H,22,30)	CULJZVGPACAFDQ-UHFFFAOYSA-N	455274	US10730874, Compound I-282::US11352356, Compound I-282	Plasma kallikrein					 1050					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455274	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455274&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487976	440971092							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935609	OC(=O)c1c(Cn2cc(nn2)C(=O)NCc2ncn3ccc(Cl)c(F)c23)[nH]c2cc(ccc12)C1CC1	InChI=1S/C24H19ClFN7O3/c25-15-5-6-32-11-28-17(22(32)21(15)26)8-27-23(34)19-10-33(31-30-19)9-18-20(24(35)36)14-4-3-13(12-1-2-12)7-16(14)29-18/h3-7,10-12,29H,1-2,8-9H2,(H,27,34)(H,35,36)	SRZVOUXOYHHDQR-UHFFFAOYSA-N	455266	BDBM455275::US10730874, Compound I-274	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455266	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455266&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487810	440971084							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935610	Fc1c(Cl)ccn2cnc(CNC(=O)c3cnn(Cc4cn5ccccc5n4)c3)c12	InChI=1S/C20H15ClFN7O/c21-15-4-6-28-12-24-16(19(28)18(15)22)8-23-20(30)13-7-25-29(9-13)11-14-10-27-5-2-1-3-17(27)26-14/h1-7,9-10,12H,8,11H2,(H,23,30)	SRXDUMJRVNFNCU-UHFFFAOYSA-N	455276	US10730874, Compound I-284::US11352356, Compound I-284	Plasma kallikrein					 55					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455276	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455276&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488050	440971094							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935611	Fc1c(Cl)ccn2cnc(CNC(=O)c3cnn(Cc4cn5ncccc5n4)c3)c12	InChI=1S/C19H14ClFN8O/c20-14-3-5-27-11-23-15(18(27)17(14)21)7-22-19(30)12-6-25-28(8-12)9-13-10-29-16(26-13)2-1-4-24-29/h1-6,8,10-11H,7,9H2,(H,22,30)	MMPYVAQWIZLLEO-UHFFFAOYSA-N	455277	US10730874, Compound I-285::US11352356, Compound I-285	Plasma kallikrein					 55					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455277	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455277&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488226	440971095							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935612	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5ccccc5n4)nn3)c12	InChI=1S/C19H14ClFN8O/c20-13-4-6-28-11-23-14(18(28)17(13)21)7-22-19(30)15-10-29(26-25-15)9-12-8-27-5-2-1-3-16(27)24-12/h1-6,8,10-11H,7,9H2,(H,22,30)	MWMIWGWQBRCKCE-UHFFFAOYSA-N	455278	US10730874, Compound I-286::US11352356, Compound I-286	Plasma kallikrein					 55					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455278	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455278&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488043	440971096							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935613	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4nc5ccccn5n4)nn3)c12	InChI=1S/C18H13ClFN9O/c19-11-4-6-27-10-22-12(17(27)16(11)20)7-21-18(30)13-8-28(26-24-13)9-14-23-15-3-1-2-5-29(15)25-14/h1-6,8,10H,7,9H2,(H,21,30)	PHYWGECHSHCECS-UHFFFAOYSA-N	455279	US10730874, Compound I-287::US11352356, Compound I-287	Plasma kallikrein					 1050					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455279	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455279&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487736	440971097							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935614	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5nc(ccc5n4)C4CC4)cn3)c12	InChI=1S/C22H18ClFN8O/c23-15-5-6-31-12-27-17(21(31)20(15)24)7-25-22(33)18-10-30(11-26-18)8-14-9-32-19(28-14)4-3-16(29-32)13-1-2-13/h3-6,9-13H,1-2,7-8H2,(H,25,33)	ZYERBHNUHACZNF-UHFFFAOYSA-N	455280	US10730874, Compound I-288::US11352356, Compound I-288	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455280	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455280&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487740	440971098							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935615	Fc1c(Cl)ccn2cnc(CNC(=O)c3nnn(Cc4cn5nc(ccc5n4)C4CC4)n3)c12	InChI=1S/C20H16ClFN10O/c21-13-5-6-30-10-24-15(18(30)17(13)22)7-23-20(33)19-26-29-32(28-19)9-12-8-31-16(25-12)4-3-14(27-31)11-1-2-11/h3-6,8,10-11H,1-2,7,9H2,(H,23,33)	KJQMWGXATUXRIG-UHFFFAOYSA-N	455281	US10730874, Compound I-289::US11352356, Compound I-289	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455281	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455281&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488098	440971099							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935616	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5ncccc5n4)nn3)c12	InChI=1S/C18H13ClFN9O/c19-12-3-5-27-10-22-13(17(27)16(12)20)6-21-18(30)14-9-28(26-25-14)7-11-8-29-15(24-11)2-1-4-23-29/h1-5,8-10H,6-7H2,(H,21,30)	HWFRTGURAIEHHD-UHFFFAOYSA-N	455282	US10730874, Compound I-290::US11352356, Compound I-290	Plasma kallikrein					 55					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455282	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455282&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488117	440971100							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935617	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5ncccc5n4)cn3)c12	InChI=1S/C19H14ClFN8O/c20-13-3-5-28-11-24-14(18(28)17(13)21)6-22-19(30)15-9-27(10-23-15)7-12-8-29-16(26-12)2-1-4-25-29/h1-5,8-11H,6-7H2,(H,22,30)	FRQGCIVYEOXBAC-UHFFFAOYSA-N	455283	US10730874, Compound I-291::US11352356, Compound I-291	Plasma kallikrein					 55					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455283	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455283&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487958	440971101							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935618	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4ccc5nccnc5c4)nn3)c12	InChI=1S/C20H14ClFN8O/c21-13-3-6-29-11-26-16(19(29)18(13)22)8-25-20(31)17-10-30(28-27-17)9-12-1-2-14-15(7-12)24-5-4-23-14/h1-7,10-11H,8-9H2,(H,25,31)	IRUVVDHVOONSKW-UHFFFAOYSA-N	455284	US10730874, Compound I-292::US11352356, Compound I-292	Plasma kallikrein					 55					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455284	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455284&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488306	440971102							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935619	Fc1c(Cl)ccn2cnc(CNC(=O)c3cnn(Cc4ccc5nccnc5c4)c3)c12	InChI=1S/C21H15ClFN7O/c22-15-3-6-29-12-27-18(20(29)19(15)23)9-26-21(31)14-8-28-30(11-14)10-13-1-2-16-17(7-13)25-5-4-24-16/h1-8,11-12H,9-10H2,(H,26,31)	SREFSAFODKMNJQ-UHFFFAOYSA-N	455285	US10730874, Compound I-293::US11352356, Compound I-293	Plasma kallikrein					 55					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455285	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455285&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487828	440971103							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935620	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5cccc(-n6cnnc6)c5n4)nn3)c12	InChI=1S/C21H15ClFN11O/c22-14-3-5-32-10-25-15(19(32)18(14)23)6-24-21(35)16-9-34(30-29-16)8-13-7-31-4-1-2-17(20(31)28-13)33-11-26-27-12-33/h1-5,7,9-12H,6,8H2,(H,24,35)	KDHNRYZHFAOACS-UHFFFAOYSA-N	455286	US10730874, Compound I-294	Plasma kallikrein					 55					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455286	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455286&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155883685	440971104							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935621	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5nc(cc(CN6CCCC6)c5n4)C4CC4)nn3)c12	InChI=1S/C26H26ClFN10O/c27-19-5-8-36-15-30-21(24(36)23(19)28)10-29-26(39)22-14-37(34-32-22)12-18-13-38-25(31-18)17(11-35-6-1-2-7-35)9-20(33-38)16-3-4-16/h5,8-9,13-16H,1-4,6-7,10-12H2,(H,29,39)	SFWYTHFTKMIAFA-UHFFFAOYSA-N	455287	US10730874, Compound I-295	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455287	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455287&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139505216	440971105							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935622	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5nccc(CC6COC6)c5n4)nn3)c12	InChI=1S/C22H19ClFN9O2/c23-16-2-4-31-12-26-17(20(31)19(16)24)6-25-22(34)18-9-32(30-29-18)7-15-8-33-21(28-15)14(1-3-27-33)5-13-10-35-11-13/h1-4,8-9,12-13H,5-7,10-11H2,(H,25,34)	RWKYQXBUKBZISL-UHFFFAOYSA-N	455288	US10730874, Compound I-296::US11352356, Compound I-296	Plasma kallikrein					 55					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455288	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455288&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488094	440971106							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935623	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5ccccc5n4)cn3)c12	InChI=1S/C20H15ClFN7O/c21-14-4-6-29-12-25-15(19(29)18(14)22)7-23-20(30)16-10-27(11-24-16)8-13-9-28-5-2-1-3-17(28)26-13/h1-6,9-12H,7-8H2,(H,23,30)	AKFHCJZOAMDYLL-UHFFFAOYSA-N	455289	US10730874, Compound I-297::US11352356, Compound I-297	Plasma kallikrein					 55					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455289	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455289&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487675	440971107							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935624	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(cc(CCl)c5n4)C4CC4)nn3)c12	InChI=1S/C23H19Cl2FN8O/c24-6-14-5-15(13-1-2-13)8-33-9-16(29-22(14)33)10-34-11-19(30-31-34)23(35)27-7-18-21-20(26)17(25)3-4-32(21)12-28-18/h3-5,8-9,11-13H,1-2,6-7,10H2,(H,27,35)	WVLVEOWLNFQILV-UHFFFAOYSA-N	455290	US10730874, Compound I-298	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455290	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455290&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488080	440971108							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935625	CN(C)CCOCc1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C27H29ClFN9O2/c1-35(2)7-8-40-15-19-9-18(17-3-4-17)11-37-12-20(32-26(19)37)13-38-14-23(33-34-38)27(39)30-10-22-25-24(29)21(28)5-6-36(25)16-31-22/h5-6,9,11-12,14,16-17H,3-4,7-8,10,13,15H2,1-2H3,(H,30,39)	OGFDUILZJFFLLO-UHFFFAOYSA-N	455291	US10730874, Compound I-299::US11352356, Compound I-299	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455291	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455291&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487528	440971109							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935626	OC(CNCc1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1)C(F)(F)F	InChI=1S/C26H24ClF4N9O2/c27-18-3-4-38-13-34-19(23(38)22(18)28)7-33-25(42)20-12-40(37-36-20)11-17-10-39-9-16(14-1-2-14)5-15(24(39)35-17)6-32-8-21(41)26(29,30)31/h3-5,9-10,12-14,21,32,41H,1-2,6-8,11H2,(H,33,42)	CXKXYHXYEORTFI-UHFFFAOYSA-N	455292	US10730874, Compound I-300::US11352356, Compound I-300	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455292	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455292&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488172	440971110							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935627	OCCOCc1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C25H24ClFN8O3/c26-19-3-4-33-14-29-20(23(33)22(19)27)8-28-25(37)21-12-35(32-31-21)11-18-10-34-9-16(15-1-2-15)7-17(24(34)30-18)13-38-6-5-36/h3-4,7,9-10,12,14-15,36H,1-2,5-6,8,11,13H2,(H,28,37)	WMQJOMVTUTVWNE-UHFFFAOYSA-N	455293	US10730874, Compound I-301	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455293	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455293&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487620	440971111							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935628	NCCOCc1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C25H25ClFN9O2/c26-19-3-5-34-14-30-20(23(34)22(19)27)8-29-25(37)21-12-36(33-32-21)11-18-10-35-9-16(15-1-2-15)7-17(24(35)31-18)13-38-6-4-28/h3,5,7,9-10,12,14-15H,1-2,4,6,8,11,13,28H2,(H,29,37)	TUWOREDOEDMEIO-UHFFFAOYSA-N	455294	US10730874, Compound I-302	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455294	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455294&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487545	440971112							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935629	Brc1ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(ccc5n4)C4CC4)nn3)c2c1	InChI=1S/C22H19BrN8O/c23-16-5-6-29-13-25-18(20(29)7-16)8-24-22(32)19-12-31(28-27-19)11-17-10-30-9-15(14-1-2-14)3-4-21(30)26-17/h3-7,9-10,12-14H,1-2,8,11H2,(H,24,32)	YXGYCECUXYIXEZ-UHFFFAOYSA-N	455295	US10730874, Compound I-303::US11352356, Compound I-303	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455295	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455295&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487532	440971113							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935630	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(F)ccc(OC)c1F	InChI=1S/C27H26F2N4O4/c1-36-17-23-21(27(35)30-13-20-22(28)10-11-24(37-2)26(20)29)16-33(31-23)15-19-8-6-18(7-9-19)14-32-12-4-3-5-25(32)34/h3-12,16H,13-15,17H2,1-2H3,(H,30,35)	PIYDGHWVVUCTNS-UHFFFAOYSA-N	408746	 N-[(2,6-difluoro-3-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin- 1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US10364238, Example 66::US10730874, Example 00395::US11001578, Example 66::US11084809, Example 66::US11198691, Example 66::US11352356, Table II.1	Plasma kallikrein					 55					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408746	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408746&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365096	406799377							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935631	COCc1nn(Cc2ccc(nc2)N2CCCC2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cnnn1	InChI=1S/C25H28FN9O3/c1-37-15-20-19(14-34(30-20)13-17-5-8-23(27-11-17)33-9-3-4-10-33)25(36)28-12-18-21(35-16-29-31-32-35)6-7-22(38-2)24(18)26/h5-8,11,14,16H,3-4,9-10,12-13,15H2,1-2H3,(H,28,36)	DGIRMJAUTLUPMU-UHFFFAOYSA-N	455297	US10730874, Compound TABLE II.2::US11180484, Example 77::US11352356, Table II.2	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455297	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455297&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301849	440971115							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935632	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1nccc(OC)c1F	InChI=1S/C26H26FN5O4/c1-35-17-22-20(26(34)29-13-21-25(27)23(36-2)10-11-28-21)16-32(30-22)15-19-8-6-18(7-9-19)14-31-12-4-3-5-24(31)33/h3-12,16H,13-15,17H2,1-2H3,(H,29,34)	KGMPDQIYDKKXRD-UHFFFAOYSA-N	408717	 N-[(3-fluoro-4-methoxypyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin- 1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 41::US10730874, Example 00397::US11001578, Example 41::US11084809, Example 41::US11198691, Example 41::US11352356, Table II.3::US11584735, Example 41 of WO2016/083820	Plasma kallikrein					 55					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408717	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408717&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365142	406799348							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935633	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(F)c(OC)ccc1C#N	InChI=1S/C28H26FN5O4/c1-37-18-24-23(28(36)31-14-22-21(13-30)10-11-25(38-2)27(22)29)17-34(32-24)16-20-8-6-19(7-9-20)15-33-12-4-3-5-26(33)35/h3-12,17H,14-16,18H2,1-2H3,(H,31,36)	SPXOTFDBWDBJRN-UHFFFAOYSA-N	408768	N-[(6-cyano-2-fluoro-3-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-::US10364238, Example 77::US10730874, Example 00398::US11001578, Example 77::US11084809, Example 77::US11198691, Example 77::US11352356, Table II.4	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408768	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408768&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365006	406799399							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935634	Clc1ccn2cnc(CNC(=O)c3ccnc(Cc4ccc5ncc(Cl)cc5c4)c3)c2c1	InChI=1S/C24H17Cl2N5O/c25-18-4-6-31-14-30-22(23(31)11-18)13-29-24(32)16-3-5-27-20(10-16)8-15-1-2-21-17(7-15)9-19(26)12-28-21/h1-7,9-12,14H,8,13H2,(H,29,32)	XLKFBGCZLDPHJM-UHFFFAOYSA-N	454918	US10730874, Compound I-3::US10730874, Compound TABLE II.5::US11352356, Table II.5	Plasma kallikrein					 55					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=454918	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=454918&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665434	440970771							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935635	Clc1ccc2snc(CNC(=O)c3cnn(Cc4cn5cc(ccc5n4)C4CC4)c3)c2c1	InChI=1S/C23H19ClN6OS/c24-17-4-5-21-19(7-17)20(28-32-21)9-25-23(31)16-8-26-30(11-16)13-18-12-29-10-15(14-1-2-14)3-6-22(29)27-18/h3-8,10-12,14H,1-2,9,13H2,(H,25,31)	YSGNQMRGFQGWKZ-UHFFFAOYSA-N	455301	US10730874, Compound TABLE II.6::US11352356, Table II.6	Plasma kallikrein					 55					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455301	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455301&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139505217	440971118							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935636	Clc1ccc2nnc(CNC(=O)c3cnn(Cc4cn5cc(ccc5n4)C4CC4)c3)n2c1	InChI=1S/C22H19ClN8O/c23-17-4-6-20-27-28-21(31(20)11-17)8-24-22(32)16-7-25-30(10-16)13-18-12-29-9-15(14-1-2-14)3-5-19(29)26-18/h3-7,9-12,14H,1-2,8,13H2,(H,24,32)	QJZJZWMAEPTLGJ-UHFFFAOYSA-N	455302	US10730874, Compound TABLE II.7::US11352356, Table II.7	Plasma kallikrein					 1050					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455302	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455302&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139498761	440971119							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935637	Cc1ccc2nc(Cn3cc(cn3)C(=O)NCc3cnc4ccc(Cl)cn34)cn2c1	InChI=1S/C21H18ClN7O/c1-14-2-4-20-26-17(12-27(20)9-14)13-28-10-15(6-25-28)21(30)24-8-18-7-23-19-5-3-16(22)11-29(18)19/h2-7,9-12H,8,13H2,1H3,(H,24,30)	QIDFCLVUNHZLNM-UHFFFAOYSA-N	455303	US10730874, Compound TABLE II.8	Plasma kallikrein					 1050					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455303	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455303&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139504866	440971120							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935638	O=C(NCc1ncn2ccc(cc12)C1CC1)c1cnn(Cc2cn3cc(ccc3n2)C2CC2)c1	InChI=1S/C26H25N7O/c34-26(27-11-23-24-9-19(17-1-2-17)7-8-31(24)16-28-23)21-10-29-33(13-21)15-22-14-32-12-20(18-3-4-18)5-6-25(32)30-22/h5-10,12-14,16-18H,1-4,11,15H2,(H,27,34)	BRSPMWXQBHDJIL-UHFFFAOYSA-N	455304	US10730874, Compound TABLE II.9::US11352356, Table II.9	Plasma kallikrein					 1050					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455304	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455304&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487423	440971121							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935311	Clc1ccn2cnc(CNC(=O)c3cnn(Cc4ccc5ncc(Cl)cc5c4)c3)c2c1	InChI=1S/C22H16Cl2N6O/c23-17-3-4-29-13-27-20(21(29)7-17)10-26-22(31)16-8-28-30(12-16)11-14-1-2-19-15(5-14)6-18(24)9-25-19/h1-9,12-13H,10-11H2,(H,26,31)	YGHYRKGNWWNBNH-UHFFFAOYSA-N	454840	US10730874, Compound I-1::US11352356, Compound I-1	Plasma kallikrein					 55					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=454840	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=454840&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487760	440970693							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935312	Clc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5cc(ccc5n4)C4CC4)c3)c2c1	InChI=1S/C23H20ClN7O/c24-18-5-6-29-14-26-20(21(29)7-18)9-25-23(32)17-8-27-31(11-17)13-19-12-30-10-16(15-1-2-15)3-4-22(30)28-19/h3-8,10-12,14-15H,1-2,9,13H2,(H,25,32)	JKVSCXTZILFUPG-UHFFFAOYSA-N	454849	US10730874, Compound I-147::US10730874, Compound I-2::US10730874, Compound I-90::US11352356, Compound I-90	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=454849	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=454849&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488035	440970702							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935313	Clc1ccn2cnc(CNC(=O)c3ccnc(Cc4ccc5ncc(Cl)cc5c4)c3)c2c1	InChI=1S/C24H17Cl2N5O/c25-18-4-6-31-14-30-22(23(31)11-18)13-29-24(32)16-3-5-27-20(10-16)8-15-1-2-21-17(7-15)9-19(26)12-28-21/h1-7,9-12,14H,8,13H2,(H,29,32)	XLKFBGCZLDPHJM-UHFFFAOYSA-N	454918	US10730874, Compound I-3::US10730874, Compound TABLE II.5::US11352356, Table II.5	Plasma kallikrein					 55					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=454918	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=454918&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665434	440970771							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935314	Cc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5cc(ccc5n4)C4CC4)c3)c2c1	InChI=1S/C24H23N7O/c1-16-6-7-29-15-26-21(22(29)8-16)10-25-24(32)19-9-27-31(12-19)14-20-13-30-11-18(17-2-3-17)4-5-23(30)28-20/h4-9,11-13,15,17H,2-3,10,14H2,1H3,(H,25,32)	HNSDVTIBNOEEFK-UHFFFAOYSA-N	454941	US10730874, Compound I-4::US11352356, Compound I-4	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=454941	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=454941&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487581	440970794							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935315	Brc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5cc(ccc5n4)C4CC4)c3)c2c1	InChI=1S/C23H20BrN7O/c24-18-5-6-29-14-26-20(21(29)7-18)9-25-23(32)17-8-27-31(11-17)13-19-12-30-10-16(15-1-2-15)3-4-22(30)28-19/h3-8,10-12,14-15H,1-2,9,13H2,(H,25,32)	ZEWKVFDLIOUNBA-UHFFFAOYSA-N	454966	US10730874, Compound I-5::US11352356, Compound I-5	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=454966	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=454966&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488150	440970816							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935316	Clc1ccn2cnc(CNC(=O)c3cnn(Cc4nc5ccc(cc5n4)C4CC4)c3)c2c1			454982	US10730874, Compound I-6	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=454982	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=454982&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155883671	440970831							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935317	Cc1c(Cl)ccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)cn12	InChI=1S/C21H17Cl2N7O/c1-13-17(23)2-3-20-27-16(11-30(13)20)10-29-9-14(7-26-29)21(31)24-8-18-19-6-15(22)4-5-28(19)12-25-18/h2-7,9,11-12H,8,10H2,1H3,(H,24,31)	OVKNWFRJGTWLTL-UHFFFAOYSA-N	454983	US10730874, Compound I-7::US11352356, Compound I-7	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=454983	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=454983&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488222	440970832							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935318	CC(C)c1ccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)cn2c1	InChI=1S/C23H22ClN7O/c1-15(2)16-3-4-22-28-19(12-30(22)10-16)13-31-11-17(8-27-31)23(32)25-9-20-21-7-18(24)5-6-29(21)14-26-20/h3-8,10-12,14-15H,9,13H2,1-2H3,(H,25,32)	ZMTCXNYHBDKYAR-UHFFFAOYSA-N	454984	US10730874, Compound I-8::US11352356, Compound I-8	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=454984	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=454984&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488249	440970833							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935319	Cc1cccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)cn12	InChI=1S/C21H18ClN7O/c1-14-3-2-4-20-26-17(12-29(14)20)11-28-10-15(8-25-28)21(30)23-9-18-19-7-16(22)5-6-27(19)13-24-18/h2-8,10,12-13H,9,11H2,1H3,(H,23,30)	OYBHCKSHQPCSPX-UHFFFAOYSA-N	454985	US10730874, Compound I-9::US11352356, Compound I-9	Plasma kallikrein					 55					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=454985	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=454985&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488146	440970834							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935320	CC1(CC1)c1ccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)cn2c1	InChI=1S/C24H22ClN7O/c1-24(5-6-24)17-2-3-22-29-19(13-31(22)12-17)14-32-11-16(9-28-32)23(33)26-10-20-21-8-18(25)4-7-30(21)15-27-20/h2-4,7-9,11-13,15H,5-6,10,14H2,1H3,(H,26,33)	DFLQTEKKEFGFLD-UHFFFAOYSA-N	454986	US10730874, Compound I-10::US11352356, Compound I-10	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=454986	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=454986&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487939	440970835							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935321	Clc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5nc(Cl)ccc5n4)c3)c2c1	InChI=1S/C19H14Cl2N8O/c20-13-3-4-27-11-23-15(16(27)5-13)7-22-19(30)12-6-24-28(8-12)9-14-10-29-18(25-14)2-1-17(21)26-29/h1-6,8,10-11H,7,9H2,(H,22,30)	VFINYKRXVHQPRI-UHFFFAOYSA-N	454987	US10730874, Compound I-11	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=454987	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=454987&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139498685	440970836							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935322	COc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5cc(ccc5n4)C4CC4)c3)c2c1	InChI=1S/C24H23N7O2/c1-33-20-6-7-29-15-26-21(22(29)8-20)10-25-24(32)18-9-27-31(12-18)14-19-13-30-11-17(16-2-3-16)4-5-23(30)28-19/h4-9,11-13,15-16H,2-3,10,14H2,1H3,(H,25,32)	UFXKBHFDBHKOPJ-UHFFFAOYSA-N	454988	US10730874, Compound I-12	Plasma kallikrein					 55					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=454988	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=454988&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155883672	440970837							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935323	Cc1c(ccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)cn12)C1CC1	InChI=1S/C24H22ClN7O/c1-15-20(16-2-3-16)4-5-23-29-19(13-32(15)23)12-31-11-17(9-28-31)24(33)26-10-21-22-8-18(25)6-7-30(22)14-27-21/h4-9,11,13-14,16H,2-3,10,12H2,1H3,(H,26,33)	FNFAWTYTWKPAIM-UHFFFAOYSA-N	454989	US10730874, Compound I-13::US11352356, Compound I-13	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=454989	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=454989&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487289	440970838							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935324	Cc1c(ccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Br)cc34)cn12)C1CC1	InChI=1S/C24H22BrN7O/c1-15-20(16-2-3-16)4-5-23-29-19(13-32(15)23)12-31-11-17(9-28-31)24(33)26-10-21-22-8-18(25)6-7-30(22)14-27-21/h4-9,11,13-14,16H,2-3,10,12H2,1H3,(H,26,33)	AYZDCCSRKYCBED-UHFFFAOYSA-N	454990	US10730874, Compound I-14::US11352356, Compound I-14	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=454990	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=454990&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487307	440970839							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935325	Clc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5nc(ccc5n4)C4CC4)c3)c2c1	InChI=1S/C22H19ClN8O/c23-16-5-6-29-13-25-19(20(29)7-16)9-24-22(32)15-8-26-30(10-15)11-17-12-31-21(27-17)4-3-18(28-31)14-1-2-14/h3-8,10,12-14H,1-2,9,11H2,(H,24,32)	ODQXINWZNJUUAM-UHFFFAOYSA-N	454991	US10730874, Compound I-15::US11352356, Compound I-15	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=454991	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=454991&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488083	440970840							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935326	Cc1cc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)cn2cc1C1CC1	InChI=1S/C24H22ClN7O/c1-15-6-23-29-19(11-31(23)13-20(15)16-2-3-16)12-32-10-17(8-28-32)24(33)26-9-21-22-7-18(25)4-5-30(22)14-27-21/h4-8,10-11,13-14,16H,2-3,9,12H2,1H3,(H,26,33)	BBISFGDBAJOETE-UHFFFAOYSA-N	454992	US10730874, Compound I-16::US11352356, Compound I-16	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=454992	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=454992&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487602	440970841							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935327	Cc1cc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Br)cc34)cn2cc1C1CC1	InChI=1S/C24H22BrN7O/c1-15-6-23-29-19(11-31(23)13-20(15)16-2-3-16)12-32-10-17(8-28-32)24(33)26-9-21-22-7-18(25)4-5-30(22)14-27-21/h4-8,10-11,13-14,16H,2-3,9,12H2,1H3,(H,26,33)	IPYAFLZZLOACBG-UHFFFAOYSA-N	454993	US10730874, Compound I-17::US11352356, Compound I-17	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=454993	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=454993&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487685	440970842							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935328	FC(F)(F)c1ccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)cn2c1	InChI=1S/C21H15ClF3N7O/c22-15-3-4-30-12-27-17(18(30)5-15)7-26-20(33)13-6-28-32(8-13)11-16-10-31-9-14(21(23,24)25)1-2-19(31)29-16/h1-6,8-10,12H,7,11H2,(H,26,33)	PKNOZGCFVCKNLS-UHFFFAOYSA-N	454994	US10730874, Compound I-18::US11352356, Compound I-18	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=454994	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=454994&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488258	440970843							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935329	FC(F)(F)c1ccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Br)cc34)cn2c1	InChI=1S/C21H15BrF3N7O/c22-15-3-4-30-12-27-17(18(30)5-15)7-26-20(33)13-6-28-32(8-13)11-16-10-31-9-14(21(23,24)25)1-2-19(31)29-16/h1-6,8-10,12H,7,11H2,(H,26,33)	JVZOYIDCIORJAQ-UHFFFAOYSA-N	454995	US10730874, Compound I-19::US11352356, Compound I-19	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=454995	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=454995&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487786	440970844							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935330	Fc1cc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Br)cc34)cn2cc1C1CC1	InChI=1S/C23H19BrFN7O/c24-16-3-4-30-13-27-20(21(30)5-16)8-26-23(33)15-7-28-32(9-15)11-17-10-31-12-18(14-1-2-14)19(25)6-22(31)29-17/h3-7,9-10,12-14H,1-2,8,11H2,(H,26,33)	VCUYOJBHLIHSGT-UHFFFAOYSA-N	454996	US10730874, Compound I-20::US11352356, Compound I-20	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=454996	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=454996&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488070	440970845							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935331	Fc1cc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)cn2cc1C1CC1	InChI=1S/C23H19ClFN7O/c24-16-3-4-30-13-27-20(21(30)5-16)8-26-23(33)15-7-28-32(9-15)11-17-10-31-12-18(14-1-2-14)19(25)6-22(31)29-17/h3-7,9-10,12-14H,1-2,8,11H2,(H,26,33)	DRUARKVXTOYYNC-UHFFFAOYSA-N	454997	US10730874, Compound I-21	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=454997	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=454997&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488223	440970846							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935332	Clc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5c(cccc5n4)C4CC4)c3)c2c1	InChI=1S/C23H20ClN7O/c24-17-6-7-29-14-26-19(21(29)8-17)10-25-23(32)16-9-27-30(11-16)12-18-13-31-20(15-4-5-15)2-1-3-22(31)28-18/h1-3,6-9,11,13-15H,4-5,10,12H2,(H,25,32)	LFLIKARDRACBNG-UHFFFAOYSA-N	454998	US10730874, Compound I-22::US11352356, Compound I-22	Plasma kallikrein					 1050					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=454998	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=454998&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487693	440970847							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935333	Clc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5c(Cl)c(ccc5n4)C4CC4)c3)c2c1	InChI=1S/C23H19Cl2N7O/c24-16-5-6-30-13-27-19(20(30)7-16)9-26-23(33)15-8-28-31(10-15)11-17-12-32-21(29-17)4-3-18(22(32)25)14-1-2-14/h3-8,10,12-14H,1-2,9,11H2,(H,26,33)	YDIWPUMFVBGXGH-UHFFFAOYSA-N	454999	US10730874, Compound I-23::US11352356, Compound I-23	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=454999	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=454999&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487827	440970848							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935334	Clc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5cc(C6CC6)c(Cl)cc5n4)c3)c2c1	InChI=1S/C23H19Cl2N7O/c24-16-3-4-30-13-27-20(21(30)5-16)8-26-23(33)15-7-28-32(9-15)11-17-10-31-12-18(14-1-2-14)19(25)6-22(31)29-17/h3-7,9-10,12-14H,1-2,8,11H2,(H,26,33)	AEZJESJNGNUNDT-UHFFFAOYSA-N	455000	US10730874, Compound I-24::US11352356, Compound I-24	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455000	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455000&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487875	440970849							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935335	Clc1cc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Br)cc34)cn2cc1C1CC1	InChI=1S/C23H19BrClN7O/c24-16-3-4-30-13-27-20(21(30)5-16)8-26-23(33)15-7-28-32(9-15)11-17-10-31-12-18(14-1-2-14)19(25)6-22(31)29-17/h3-7,9-10,12-14H,1-2,8,11H2,(H,26,33)	BQNJPCRXWFWFFQ-UHFFFAOYSA-N	455001	US10730874, Compound I-25::US11352356, Compound I-25	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455001	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455001&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487393	440970850							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935336	Cc1ccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Br)cc34)cn2c1C	InChI=1S/C22H20BrN7O/c1-14-3-4-21-27-18(12-30(21)15(14)2)11-29-10-16(8-26-29)22(31)24-9-19-20-7-17(23)5-6-28(20)13-25-19/h3-8,10,12-13H,9,11H2,1-2H3,(H,24,31)	MGRDBYAJBXASLN-UHFFFAOYSA-N	455002	US10730874, Compound I-26::US11352356, Compound I-26	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455002	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455002&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487504	440970851							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935337	Clc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5c(Br)cccc5n4)c3)c2c1	InChI=1S/C20H15BrClN7O/c21-18-2-1-3-19-26-15(11-29(18)19)10-28-9-13(7-25-28)20(30)23-8-16-17-6-14(22)4-5-27(17)12-24-16/h1-7,9,11-12H,8,10H2,(H,23,30)	OSQSMINIULXMEH-UHFFFAOYSA-N	455003	US10730874, Compound I-27::US11352356, Compound I-27	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455003	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455003&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487803	440970852							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935338	Cc1cc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)cn2cc1Br	InChI=1S/C21H17BrClN7O/c1-13-4-20-27-16(9-29(20)11-17(13)22)10-30-8-14(6-26-30)21(31)24-7-18-19-5-15(23)2-3-28(19)12-25-18/h2-6,8-9,11-12H,7,10H2,1H3,(H,24,31)	KLHWAUVVXAOLFR-UHFFFAOYSA-N	455004	BDBM557366::US10730874, Compound I-28	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455004	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455004&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487751	440970853							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935339	Clc1ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(ccc5n4)C4CC4)c4cccnc34)c2c1	InChI=1S/C27H22ClN7O/c28-19-7-9-33-16-31-22(24(33)10-19)11-30-27(36)21-15-34(23-2-1-8-29-26(21)23)13-20-14-35-12-18(17-3-4-17)5-6-25(35)32-20/h1-2,5-10,12,14-17H,3-4,11,13H2,(H,30,36)	KFUIEEVEXJQKAG-UHFFFAOYSA-N	455005	US10730874, Compound I-29::US11352356, Compound I-29	Plasma kallikrein					 55					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455005	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455005&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487433	440970854							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935340	Brc1ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(ccc5n4)C4CC4)c4cccnc34)c2c1	InChI=1S/C27H22BrN7O/c28-19-7-9-33-16-31-22(24(33)10-19)11-30-27(36)21-15-34(23-2-1-8-29-26(21)23)13-20-14-35-12-18(17-3-4-17)5-6-25(35)32-20/h1-2,5-10,12,14-17H,3-4,11,13H2,(H,30,36)	ZDVFFTJYLKRXRU-UHFFFAOYSA-N	455006	US10730874, Compound I-30::US11352356, Compound I-30	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455006	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455006&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487916	440970855							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935341	COCc1nn(Cc2cn3cc(ccc3n2)C2CC2)cc1C(=O)NCc1ncn2ccc(Cl)cc12	InChI=1S/C25H24ClN7O2/c1-35-14-22-20(25(34)27-9-21-23-8-18(26)6-7-31(23)15-28-21)13-33(30-22)12-19-11-32-10-17(16-2-3-16)4-5-24(32)29-19/h4-8,10-11,13,15-16H,2-3,9,12,14H2,1H3,(H,27,34)	WNOWDWICFGNCLL-UHFFFAOYSA-N	455007	US10730874, Compound I-31::US10730874, Compound I-61::US11352356, Compound I-31	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455007	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455007&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488337	440970856							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935342	COCc1c(cnn1Cc1cn2cc(ccc2n1)C1CC1)C(=O)NCc1ncn2ccc(Cl)cc12	InChI=1S/C25H24ClN7O2/c1-35-14-23-20(25(34)27-10-21-22-8-18(26)6-7-31(22)15-28-21)9-29-33(23)13-19-12-32-11-17(16-2-3-16)4-5-24(32)30-19/h4-9,11-12,15-16H,2-3,10,13-14H2,1H3,(H,27,34)	JPBUEVOVRBEMTD-UHFFFAOYSA-N	455008	US10730874, Compound I-32::US11352356, Compound I-32	Plasma kallikrein					 55					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455008	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455008&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488264	440970857							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935343	Cc1ccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)c(Cl)c34)cn2c1	InChI=1S/C21H17Cl2N7O/c1-13-2-3-18-27-15(10-29(18)8-13)11-30-9-14(6-26-30)21(31)24-7-17-20-19(23)16(22)4-5-28(20)12-25-17/h2-6,8-10,12H,7,11H2,1H3,(H,24,31)	SLJAHBLTOHFKQU-UHFFFAOYSA-N	455009	US10730874, Compound I-33::US11352356, Compound I-33	Plasma kallikrein					 55					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455009	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455009&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487580	440970858							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935344	CCc1c(Cl)ccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)cn12	InChI=1S/C22H19Cl2N7O/c1-2-19-17(24)3-4-21-28-16(12-31(19)21)11-30-10-14(8-27-30)22(32)25-9-18-20-7-15(23)5-6-29(20)13-26-18/h3-8,10,12-13H,2,9,11H2,1H3,(H,25,32)	WAIAUTRIETUDII-UHFFFAOYSA-N	455010	US10730874, Compound I-34::US11352356, Compound I-34	Plasma kallikrein					 55					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455010	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455010&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488106	440970859							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935345	Cc1ccc2nc(Cn3cc(cn3)C(=O)NCc3cn4c(C)c(Cl)ccc4n3)cn2c1	InChI=1S/C22H20ClN7O/c1-14-3-5-20-27-18(11-28(20)9-14)12-29-10-16(7-25-29)22(31)24-8-17-13-30-15(2)19(23)4-6-21(30)26-17/h3-7,9-11,13H,8,12H2,1-2H3,(H,24,31)	LWPSVEYWMMXPHV-UHFFFAOYSA-N	455011	US10730874, Compound I-35	Plasma kallikrein					 1050					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455011	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455011&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155883673	440970860							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935346	Clc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5cc(Br)c(Cl)cc5n4)c3)c2c1	InChI=1S/C20H14BrCl2N7O/c21-15-10-29-8-14(27-19(29)4-16(15)23)9-30-7-12(5-26-30)20(31)24-6-17-18-3-13(22)1-2-28(18)11-25-17/h1-5,7-8,10-11H,6,9H2,(H,24,31)	PUPGCOZXHNDRHN-UHFFFAOYSA-N	455012	US10730874, Compound I-36	Plasma kallikrein					 55					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455012	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455012&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488413	440970861							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935347	Clc1cc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Br)cc34)cn2cc1Br	InChI=1S/C20H14Br2ClN7O/c21-13-1-2-28-11-25-17(18(28)3-13)6-24-20(31)12-5-26-30(7-12)9-14-8-29-10-15(22)16(23)4-19(29)27-14/h1-5,7-8,10-11H,6,9H2,(H,24,31)	UDFPEIWDWQLTKO-UHFFFAOYSA-N	455013	US10730874, Compound I-37	Plasma kallikrein					 55					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455013	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455013&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487531	440970862							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935348	Clc1ccn2cnc(CNC(=O)c3cnc(Cc4cn5cc(ccc5n4)C4CC4)s3)c2c1	InChI=1S/C23H19ClN6OS/c24-16-5-6-29-13-27-18(19(29)7-16)9-26-23(31)20-10-25-22(32-20)8-17-12-30-11-15(14-1-2-14)3-4-21(30)28-17/h3-7,10-14H,1-2,8-9H2,(H,26,31)	VTKXCXJDWRUNQV-UHFFFAOYSA-N	455014	US10730874, Compound I-38::US11352356, Compound I-38	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455014	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455014&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487746	440970863							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935349	Clc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5c(Cl)c(Br)ccc5n4)c3)c2c1	InChI=1S/C20H14BrCl2N7O/c21-15-1-2-18-27-14(10-30(18)19(15)23)9-29-8-12(6-26-29)20(31)24-7-16-17-5-13(22)3-4-28(17)11-25-16/h1-6,8,10-11H,7,9H2,(H,24,31)	HBCOBHHFOHXVIF-UHFFFAOYSA-N	455015	US10730874, Compound I-39::US11352356, Compound I-39	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455015	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455015&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487436	440970864							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935350	Clc1c(Br)ccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Br)cc34)cn12	InChI=1S/C20H14Br2ClN7O/c21-13-3-4-28-11-25-16(17(28)5-13)7-24-20(31)12-6-26-29(8-12)9-14-10-30-18(27-14)2-1-15(22)19(30)23/h1-6,8,10-11H,7,9H2,(H,24,31)	CSEMVCMVMSEKBC-UHFFFAOYSA-N	455016	US10730874, Compound I-40::US11352356, Compound I-40	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455016	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455016&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487481	440970865							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935351	CC1(C)CC1c1ccn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc2c1	InChI=1S/C25H24ClN7O/c1-25(2)9-20(25)16-3-5-31-13-19(30-23(31)7-16)14-33-12-17(10-29-33)24(34)27-11-21-22-8-18(26)4-6-32(22)15-28-21/h3-8,10,12-13,15,20H,9,11,14H2,1-2H3,(H,27,34)	AAIHMXYLJZEEAD-UHFFFAOYSA-N	455017	US10730874, Compound I-41	Plasma kallikrein					 55					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455017	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455017&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487779	440970866							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935352	CC(C)=Cc1ccn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc2c1	InChI=1S/C24H22ClN7O/c1-16(2)7-17-3-5-30-13-20(29-23(30)8-17)14-32-12-18(10-28-32)24(33)26-11-21-22-9-19(25)4-6-31(22)15-27-21/h3-10,12-13,15H,11,14H2,1-2H3,(H,26,33)	UIWDXCWEYCXVFE-UHFFFAOYSA-N	455018	US10730874, Compound I-42	Plasma kallikrein					 55					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455018	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455018&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487792	440970867							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935353	CC1CC1c1ccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)cn2c1	InChI=1S/C24H22ClN7O/c1-15-6-20(15)16-2-3-23-29-19(12-31(23)10-16)13-32-11-17(8-28-32)24(33)26-9-21-22-7-18(25)4-5-30(22)14-27-21/h2-5,7-8,10-12,14-15,20H,6,9,13H2,1H3,(H,26,33)	SSFMFCKDKLUQPB-UHFFFAOYSA-N	455019	US10730874, Compound I-43::US11352356, Compound I-43	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455019	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455019&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488122	440970868							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935354	CC1CC1c1ccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Br)cc34)cn2c1	InChI=1S/C24H22BrN7O/c1-15-6-20(15)16-2-3-23-29-19(12-31(23)10-16)13-32-11-17(8-28-32)24(33)26-9-21-22-7-18(25)4-5-30(22)14-27-21/h2-5,7-8,10-12,14-15,20H,6,9,13H2,1H3,(H,26,33)	PZXFFGGSCVPLCG-UHFFFAOYSA-N	455020	US10730874, Compound I-44::US11352356, Compound I-44	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455020	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455020&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487544	440970869							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935355	Ic1ccn2cnc(CNC(=O)c3cnn(Cc4cn5cc(ccc5n4)C4CC4)c3)c2c1	InChI=1S/C23H20IN7O/c24-18-5-6-29-14-26-20(21(29)7-18)9-25-23(32)17-8-27-31(11-17)13-19-12-30-10-16(15-1-2-15)3-4-22(30)28-19/h3-8,10-12,14-15H,1-2,9,13H2,(H,25,32)	AFFAQLVICDHIIB-UHFFFAOYSA-N	455021	US10730874, Compound I-45::US11352356, Compound I-45	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455021	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455021&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488030	440970870							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935356	CCc1cccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)cn12	InChI=1S/C22H20ClN7O/c1-2-18-4-3-5-21-27-17(13-30(18)21)12-29-11-15(9-26-29)22(31)24-10-19-20-8-16(23)6-7-28(20)14-25-19/h3-9,11,13-14H,2,10,12H2,1H3,(H,24,31)	WVZKDRCHHUVVAH-UHFFFAOYSA-N	455022	US10730874, Compound I-46::US11352356, Compound I-46	Plasma kallikrein					 55					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455022	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455022&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487377	440970871							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935357	C\C=C/c1ccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)cn2c1	InChI=1S/C23H20ClN7O/c1-2-3-16-4-5-22-28-19(13-30(22)11-16)14-31-12-17(9-27-31)23(32)25-10-20-21-8-18(24)6-7-29(21)15-26-20/h2-9,11-13,15H,10,14H2,1H3,(H,25,32)/b3-2-	RGVDNNCZAYQWIH-IHWYPQMZSA-N	455023	US10730874, Compound I-47::US11352356, Compound I-47	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455023	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455023&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487666	440970872							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935358	O=C(NCc1ncn2ccc(cc12)C1CC1)c1cnn(CC2N=CN3C=CC(=CC23)C2CC2)c1	InChI=1S/C26H27N7O/c34-26(27-12-22-24-9-19(17-1-2-17)5-7-31(24)15-28-22)21-11-30-33(13-21)14-23-25-10-20(18-3-4-18)6-8-32(25)16-29-23/h5-11,13,15-18,23,25H,1-4,12,14H2,(H,27,34)	SGWFIPAOAMDQBE-UHFFFAOYSA-N	455024	US10730874, Compound I-48	Plasma kallikrein					 1050					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455024	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455024&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155883674	440970873							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935359	CC1(C)CC1c1ccn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Br)cc34)nc2c1	InChI=1S/C25H24BrN7O/c1-25(2)9-20(25)16-3-5-31-13-19(30-23(31)7-16)14-33-12-17(10-29-33)24(34)27-11-21-22-8-18(26)4-6-32(22)15-28-21/h3-8,10,12-13,15,20H,9,11,14H2,1-2H3,(H,27,34)	RBCKTNKYUQTAFX-UHFFFAOYSA-N	455025	US10730874, Compound I-49::US11352356, Compound I-49	Plasma kallikrein					 55					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455025	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455025&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487906	440970874							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935360	Brc1ccn2cnc(CNC(=O)c3cnn(Cc4cc5cc(ccn5n4)C4CC4)c3)c2c1	InChI=1S/C23H20BrN7O/c24-18-4-5-29-14-26-21(22(29)8-18)11-25-23(32)17-10-27-30(12-17)13-19-9-20-7-16(15-1-2-15)3-6-31(20)28-19/h3-10,12,14-15H,1-2,11,13H2,(H,25,32)	XAEZFHDDBVLVMR-UHFFFAOYSA-N	455026	US10730874, Compound I-50::US10730874, Compound I-56::US11352356, Compound I-56	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455026	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455026&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487961	440970875							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935361	Clc1ccn2cnc(CNC(=O)c3nnc(Cc4cn5cc(ccc5n4)C4CC4)o3)c2c1	InChI=1S/C22H18ClN7O2/c23-15-5-6-29-12-25-17(18(29)7-15)9-24-21(31)22-28-27-20(32-22)8-16-11-30-10-14(13-1-2-13)3-4-19(30)26-16/h3-7,10-13H,1-2,8-9H2,(H,24,31)	UUBXAWITVKUYKN-UHFFFAOYSA-N	455027	US10730874, Compound I-51::US11352356, Compound I-51	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455027	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455027&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487477	440970876							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935362	Brc1ccn2cnc(CNC(=O)c3nnc(Cc4cn5cc(ccc5n4)C4CC4)o3)c2c1	InChI=1S/C22H18BrN7O2/c23-15-5-6-29-12-25-17(18(29)7-15)9-24-21(31)22-28-27-20(32-22)8-16-11-30-10-14(13-1-2-13)3-4-19(30)26-16/h3-7,10-13H,1-2,8-9H2,(H,24,31)	HQNBSHGXUMOTBE-UHFFFAOYSA-N	455028	US10730874, Compound I-52::US11352356, Compound I-52	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455028	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455028&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487943	440970877							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935363	Nc1ccc2c(CNC(=O)c3cnn(Cc4cn5cc(ccc5n4)C4CC4)c3)ncn2c1	InChI=1S/C23H22N8O/c24-18-4-5-21-20(26-14-30(21)11-18)8-25-23(32)17-7-27-31(10-17)13-19-12-29-9-16(15-1-2-15)3-6-22(29)28-19/h3-7,9-12,14-15H,1-2,8,13,24H2,(H,25,32)	ZLVVYLDXDWLPNJ-UHFFFAOYSA-N	455029	US10730874, Compound I-53::US11352356, Compound I-53	Plasma kallikrein					 1050					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455029	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455029&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487384	440970878							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935364	Clc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5c(cccc5n4)C#N)c3)c2c1	InChI=1S/C21H15ClN8O/c22-15-4-5-28-13-25-18(19(28)6-15)9-24-21(31)14-8-26-29(10-14)11-16-12-30-17(7-23)2-1-3-20(30)27-16/h1-6,8,10,12-13H,9,11H2,(H,24,31)	HAVHJCUOSIYYSO-UHFFFAOYSA-N	455030	US10730874, Compound I-54::US11352356, Compound I-54	Plasma kallikrein					 55					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455030	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455030&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487434	440970879							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935365	Brc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5c(cccc5n4)C#N)c3)c2c1	InChI=1S/C21H15BrN8O/c22-15-4-5-28-13-25-18(19(28)6-15)9-24-21(31)14-8-26-29(10-14)11-16-12-30-17(7-23)2-1-3-20(30)27-16/h1-6,8,10,12-13H,9,11H2,(H,24,31)	JGDVODYPRVOMBZ-UHFFFAOYSA-N	455031	US10730874, Compound I-55::US11352356, Compound I-55	Plasma kallikrein					 55					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455031	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455031&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487381	440970880							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935366	Brc1ccn2cnc(CNC(=O)c3cnn(Cc4cc5cc(ccn5n4)C4CC4)c3)c2c1	InChI=1S/C23H20BrN7O/c24-18-4-5-29-14-26-21(22(29)8-18)11-25-23(32)17-10-27-30(12-17)13-19-9-20-7-16(15-1-2-15)3-6-31(20)28-19/h3-10,12,14-15H,1-2,11,13H2,(H,25,32)	XAEZFHDDBVLVMR-UHFFFAOYSA-N	455026	US10730874, Compound I-50::US10730874, Compound I-56::US11352356, Compound I-56	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455026	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455026&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487961	440970875							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935367	Clc1c(ccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Br)cc34)cn12)C1CC1	InChI=1S/C23H19BrClN7O/c24-16-5-6-30-13-27-19(20(30)7-16)9-26-23(33)15-8-28-31(10-15)11-17-12-32-21(29-17)4-3-18(22(32)25)14-1-2-14/h3-8,10,12-14H,1-2,9,11H2,(H,26,33)	RORYYKUCHHMJHO-UHFFFAOYSA-N	455033	US10730874, Compound I-57::US11352356, Compound I-57	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455033	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455033&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487832	440970881							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935368	Cc1ccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4c(N)cc(Cl)cc34)cn2c1	InChI=1S/C21H19ClN8O/c1-13-2-3-20-27-16(10-28(20)8-13)11-29-9-14(6-26-29)21(31)24-7-17-18-4-15(22)5-19(23)30(18)12-25-17/h2-6,8-10,12H,7,11,23H2,1H3,(H,24,31)	CFAMCJKAHDLPQW-UHFFFAOYSA-N	455034	US10730874, Compound I-58::US11352356, Compound I-58	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455034	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455034&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487911	440970882							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935369	Fc1c(ccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)cn12)C1CC1	InChI=1S/C23H19ClFN7O/c24-16-5-6-30-13-27-19(20(30)7-16)9-26-23(33)15-8-28-31(10-15)11-17-12-32-21(29-17)4-3-18(22(32)25)14-1-2-14/h3-8,10,12-14H,1-2,9,11H2,(H,26,33)	VYHJMONPWYDNHA-UHFFFAOYSA-N	455035	US10730874, Compound I-59::US11352356, Compound I-59	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455035	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455035&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487947	440970883							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935370	Fc1c(ccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Br)cc34)cn12)C1CC1	InChI=1S/C23H19BrFN7O/c24-16-5-6-30-13-27-19(20(30)7-16)9-26-23(33)15-8-28-31(10-15)11-17-12-32-21(29-17)4-3-18(22(32)25)14-1-2-14/h3-8,10,12-14H,1-2,9,11H2,(H,26,33)	UNEMLGVRCMGXDB-UHFFFAOYSA-N	455036	US10730874, Compound I-60::US11352356, Compound I-60	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455036	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455036&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488217	440970884							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935371	COCc1nn(Cc2cn3cc(ccc3n2)C2CC2)cc1C(=O)NCc1ncn2ccc(Cl)cc12	InChI=1S/C25H24ClN7O2/c1-35-14-22-20(25(34)27-9-21-23-8-18(26)6-7-31(23)15-28-21)13-33(30-22)12-19-11-32-10-17(16-2-3-16)4-5-24(32)29-19/h4-8,10-11,13,15-16H,2-3,9,12,14H2,1H3,(H,27,34)	WNOWDWICFGNCLL-UHFFFAOYSA-N	455007	US10730874, Compound I-31::US10730874, Compound I-61::US11352356, Compound I-31	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455007	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455007&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488337	440970856							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935372	CCOC(=O)c1cccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)cn12	InChI=1S/C23H20ClN7O3/c1-2-34-23(33)19-4-3-5-21-28-17(13-31(19)21)12-30-11-15(9-27-30)22(32)25-10-18-20-8-16(24)6-7-29(20)14-26-18/h3-9,11,13-14H,2,10,12H2,1H3,(H,25,32)	YPSIESLUVAUYGF-UHFFFAOYSA-N	455038	US10730874, Compound I-62::US11352356, Compound I-62	Plasma kallikrein					 1050					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455038	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455038&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488042	440970885							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935373	COc1cccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)cn12	InChI=1S/C21H18ClN7O2/c1-31-20-4-2-3-19-26-16(12-29(19)20)11-28-10-14(8-25-28)21(30)23-9-17-18-7-15(22)5-6-27(18)13-24-17/h2-8,10,12-13H,9,11H2,1H3,(H,23,30)	QOKBWGTUZDETME-UHFFFAOYSA-N	455039	US10730874, Compound I-63::US11352356, Compound I-63	Plasma kallikrein					 55					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455039	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455039&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487309	440970886							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935374	Cc1ccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)cn2c1	InChI=1S/C21H18ClN7O/c1-14-2-3-20-26-17(11-28(20)9-14)12-29-10-15(7-25-29)21(30)23-8-18-19-6-16(22)4-5-27(19)13-24-18/h2-7,9-11,13H,8,12H2,1H3,(H,23,30)	DVJGRVPGFYHKTL-UHFFFAOYSA-N	455040	US10730874, Compound I-64::US11352356, Compound I-64	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455040	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455040&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487603	440970887							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935375	COC(=O)CCc1nn(Cc2cn3cc(ccc3n2)C2CC2)cc1C(=O)NCc1ncn2ccc(Cl)cc12	InChI=1S/C27H26ClN7O3/c1-38-26(36)7-5-22-21(27(37)29-11-23-24-10-19(28)8-9-33(24)16-30-23)15-35(32-22)14-20-13-34-12-18(17-2-3-17)4-6-25(34)31-20/h4,6,8-10,12-13,15-17H,2-3,5,7,11,14H2,1H3,(H,29,37)	OGHIIGGZSJWYTH-UHFFFAOYSA-N	455041	US10730874, Compound I-65::US11352356, Compound I-65	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455041	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455041&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487931	440970888							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935376	O=C(NCc1ncn2ccc(cc12)C#C)c1cnn(Cc2cn3cc(ccc3n2)C2CC2)c1	InChI=1S/C25H21N7O/c1-2-17-7-8-30-16-27-22(23(30)9-17)11-26-25(33)20-10-28-32(13-20)15-21-14-31-12-19(18-3-4-18)5-6-24(31)29-21/h1,5-10,12-14,16,18H,3-4,11,15H2,(H,26,33)	DSGRWACLUOGHNM-UHFFFAOYSA-N	455042	US10730874, Compound I-66::US11352356, Compound I-66	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455042	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455042&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488349	440970889							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935377	CCc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5cc(ccc5n4)C4CC4)c3)c2c1	InChI=1S/C25H25N7O/c1-2-17-7-8-30-16-27-22(23(30)9-17)11-26-25(33)20-10-28-32(13-20)15-21-14-31-12-19(18-3-4-18)5-6-24(31)29-21/h5-10,12-14,16,18H,2-4,11,15H2,1H3,(H,26,33)	YGULKCGHRSLKGO-UHFFFAOYSA-N	455043	US10730874, Compound I-67::US11352356, Compound I-67	Plasma kallikrein					 55					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455043	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455043&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488073	440970890							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935378	Brc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5nc(ccc5n4)C4CC4)c3)c2c1	InChI=1S/C22H19BrN8O/c23-16-5-6-29-13-25-19(20(29)7-16)9-24-22(32)15-8-26-30(10-15)11-17-12-31-21(27-17)4-3-18(28-31)14-1-2-14/h3-8,10,12-14H,1-2,9,11H2,(H,24,32)	OZTIETIWVJNNPD-UHFFFAOYSA-N	455044	US10730874, Compound I-68::US11352356, Compound I-68	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455044	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455044&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487772	440970891							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935379	Clc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5ccccc5n4)c3)c2c1	InChI=1S/C20H16ClN7O/c21-15-4-6-27-13-23-17(18(27)7-15)9-22-20(29)14-8-24-28(10-14)12-16-11-26-5-2-1-3-19(26)25-16/h1-8,10-11,13H,9,12H2,(H,22,29)	NSBYJUYKCREVJZ-UHFFFAOYSA-N	455045	US10730874, Compound I-69::US11352356, Compound I-69	Plasma kallikrein					 1050					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455045	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455045&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487485	440970892							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935380	Clc1ccn2cnc(CNC(=O)c3nnc(Cc4cn5cc(ccc5n4)C4CC4)s3)c2c1	InChI=1S/C22H18ClN7OS/c23-15-5-6-29-12-25-17(18(29)7-15)9-24-21(31)22-28-27-20(32-22)8-16-11-30-10-14(13-1-2-13)3-4-19(30)26-16/h3-7,10-13H,1-2,8-9H2,(H,24,31)	VRCBSLFIDYHWIN-UHFFFAOYSA-N	455046	US10730874, Compound I-70::US11352356, Compound I-70	Plasma kallikrein					 55					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455046	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455046&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487948	440970893							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935381	CCOC(=O)c1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1	InChI=1S/C26H24ClN7O3/c1-2-37-26(36)21-7-17(16-3-4-16)11-33-13-20(31-24(21)33)14-34-12-18(9-30-34)25(35)28-10-22-23-8-19(27)5-6-32(23)15-29-22/h5-9,11-13,15-16H,2-4,10,14H2,1H3,(H,28,35)	LYXCZPOSBFRUCX-UHFFFAOYSA-N	455047	US10730874, Compound I-104a::US10730874, Compound I-104b::US10730874, Compound I-71::US11352356, Compound I-71	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455047	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455047&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487407	440970894							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935382	OC(=O)c1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1	InChI=1S/C24H20ClN7O3/c25-17-3-4-30-13-27-20(21(30)6-17)8-26-23(33)16-7-28-32(10-16)12-18-11-31-9-15(14-1-2-14)5-19(24(34)35)22(31)29-18/h3-7,9-11,13-14H,1-2,8,12H2,(H,26,33)(H,34,35)	ZGDVXEJFDAKWKP-UHFFFAOYSA-N	455048	US10730874, Compound I-72::US11352356, Compound I-72	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455048	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455048&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487608	471695238							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935383	OC(=O)CCc1nn(Cc2cn3cc(ccc3n2)C2CC2)cc1C(=O)NCc1ncn2ccc(Cl)cc12	InChI=1S/C26H24ClN7O3/c27-18-7-8-32-15-29-22(23(32)9-18)10-28-26(37)20-14-34(31-21(20)4-6-25(35)36)13-19-12-33-11-17(16-1-2-16)3-5-24(33)30-19/h3,5,7-9,11-12,14-16H,1-2,4,6,10,13H2,(H,28,37)(H,35,36)	QXPVQRNZDQJGMB-UHFFFAOYSA-N	455049	US10730874, Compound I-73::US11352356, Compound I-73	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455049	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455049&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488163	440970895							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935384	CC(NC(=O)c1cnn(Cc2cn3cc(ccc3n2)C2CC2)c1)c1ncn2ccc(Br)cc12	InChI=1S/C24H22BrN7O/c1-15(23-21-8-19(25)6-7-30(21)14-26-23)28-24(33)18-9-27-32(11-18)13-20-12-31-10-17(16-2-3-16)4-5-22(31)29-20/h4-12,14-16H,2-3,13H2,1H3,(H,28,33)	ZHLCMZVGVOKALL-UHFFFAOYSA-N	455050	US10730874, Compound I-74::US11352356, Compound I-74	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455050	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455050&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488065	471695239							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935385	OCc1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1	InChI=1S/C24H22ClN7O2/c25-19-3-4-30-14-27-21(22(30)6-19)8-26-24(34)18-7-28-32(10-18)12-20-11-31-9-16(15-1-2-15)5-17(13-33)23(31)29-20/h3-7,9-11,14-15,33H,1-2,8,12-13H2,(H,26,34)	VVCOBANEAOECKG-UHFFFAOYSA-N	455051	US10730874, Compound I-75::US11352356, Compound I-75	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455051	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455051&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487804	471695240							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935386	Brc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5cc(cnc5n4)C4CC4)c3)c2c1	InChI=1S/C22H19BrN8O/c23-17-3-4-29-13-26-19(20(29)5-17)8-24-21(32)16-7-27-31(10-16)12-18-11-30-9-15(14-1-2-14)6-25-22(30)28-18/h3-7,9-11,13-14H,1-2,8,12H2,(H,24,32)	QPCNCZVIUOQTRX-UHFFFAOYSA-N	455052	US10730874, Compound I-76	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455052	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455052&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487618	440970896							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935387	CNc1cccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)cn12	InChI=1S/C21H19ClN8O/c1-23-19-3-2-4-20-27-16(12-30(19)20)11-29-10-14(8-26-29)21(31)24-9-17-18-7-15(22)5-6-28(18)13-25-17/h2-8,10,12-13,23H,9,11H2,1H3,(H,24,31)	VZVHPIXJGADPOG-UHFFFAOYSA-N	455053	US10730874, Compound I-77::US11352356, Compound I-77	Plasma kallikrein					 55					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455053	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455053&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487625	440970897							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935388	Clc1ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(ccc5n4)C4CC4)nc3C3CC3)c2c1	InChI=1S/C26H24ClN7O/c27-19-7-8-32-15-29-22(23(32)9-19)10-28-26(35)21-14-34(31-25(21)17-3-4-17)13-20-12-33-11-18(16-1-2-16)5-6-24(33)30-20/h5-9,11-12,14-17H,1-4,10,13H2,(H,28,35)	IPPXGAJJNKSSBG-UHFFFAOYSA-N	455054	US10730874, Compound I-78::US11352356, Compound I-78	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455054	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455054&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487376	440970898							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935389	Clc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5c(C#C)c(ccc5n4)C4CC4)c3)c2c1	InChI=1S/C25H20ClN7O/c1-2-22-20(16-3-4-16)5-6-24-30-19(14-33(22)24)13-32-12-17(10-29-32)25(34)27-11-21-23-9-18(26)7-8-31(23)15-28-21/h1,5-10,12,14-16H,3-4,11,13H2,(H,27,34)	JIVADXCNDRDGDY-UHFFFAOYSA-N	455055	US10730874, Compound I-79::US11352356, Compound I-79	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455055	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455055&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487326	440970899							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935390	Clc1ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(ccc5n4)C4CC4)nn3)c2c1	InChI=1S/C22H19ClN8O/c23-16-5-6-29-13-25-18(20(29)7-16)8-24-22(32)19-12-31(28-27-19)11-17-10-30-9-15(14-1-2-14)3-4-21(30)26-17/h3-7,9-10,12-14H,1-2,8,11H2,(H,24,32)	IGCUVSSEMNZYSQ-UHFFFAOYSA-N	455056	US10730874, Compound I-80::US11352356, Compound I-80	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455056	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455056&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487366	440970900							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935391	COC(=O)Cc1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1	InChI=1S/C26H24ClN7O3/c1-37-24(35)7-17-6-18(16-2-3-16)11-33-13-21(31-25(17)33)14-34-12-19(9-30-34)26(36)28-10-22-23-8-20(27)4-5-32(23)15-29-22/h4-6,8-9,11-13,15-16H,2-3,7,10,14H2,1H3,(H,28,36)	FQCQPCCFPZUNOM-UHFFFAOYSA-N	455057	US10730874, Compound I-81::US11352356, Compound I-81	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455057	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455057&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488067	440970901							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935392	COC(=O)CCc1c(cnn1Cc1cn2cc(ccc2n1)C1CC1)C(=O)NCc1ncn2ccc(Cl)cc12	InChI=1S/C27H26ClN7O3/c1-38-26(36)7-5-23-21(27(37)29-12-22-24-10-19(28)8-9-33(24)16-30-22)11-31-35(23)15-20-14-34-13-18(17-2-3-17)4-6-25(34)32-20/h4,6,8-11,13-14,16-17H,2-3,5,7,12,15H2,1H3,(H,29,37)	IMPPNGAYPDFVGK-UHFFFAOYSA-N	455058	US10730874, Compound I-82::US11352356, Compound I-82	Plasma kallikrein					 55					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455058	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455058&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487870	440970902							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935393	FC(F)c1nc(CNC(=O)c2cnn(Cc3cn4cc(ccc4n3)C3CC3)c2)c2cc(Br)ccn12	InChI=1S/C24H20BrF2N7O/c25-17-5-6-34-20(7-17)19(31-23(34)22(26)27)9-28-24(35)16-8-29-33(11-16)13-18-12-32-10-15(14-1-2-14)3-4-21(32)30-18/h3-8,10-12,14,22H,1-2,9,13H2,(H,28,35)	QEDYHOKNPOWSIO-UHFFFAOYSA-N	455059	US10730874, Compound I-83::US11352356, Compound I-83	Plasma kallikrein					 55					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455059	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455059&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488079	440970903							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935394	Clc1ccn2cnc(CNC(=O)c3cnn(CC4Cc5ncc(cc5N4)C4CC4)c3)c2c1	InChI=1S/C23H22ClN7O/c24-17-3-4-30-13-27-21(22(30)6-17)10-26-23(32)16-9-28-31(11-16)12-18-7-19-20(29-18)5-15(8-25-19)14-1-2-14/h3-6,8-9,11,13-14,18,29H,1-2,7,10,12H2,(H,26,32)	WDVAEILNIHITLJ-UHFFFAOYSA-N	455060	US10730874, Compound I-84	Plasma kallikrein					 55					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455060	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455060&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155883675	440970904							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935395	Brc1ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(ccc5n4)C4CC4)nc3C3CC3)c2c1	InChI=1S/C26H24BrN7O/c27-19-7-8-32-15-29-22(23(32)9-19)10-28-26(35)21-14-34(31-25(21)17-3-4-17)13-20-12-33-11-18(16-1-2-16)5-6-24(33)30-20/h5-9,11-12,14-17H,1-4,10,13H2,(H,28,35)	YBDPZBBZAWAOBS-UHFFFAOYSA-N	455061	US10730874, Compound I-85::US11352356, Compound I-85	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455061	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455061&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488255	440970905							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935396	OC(=O)Cc1cc(cn2cc(Cn3cc(C(=O)NCc4ncn5ccc(Cl)cc45)c(n3)C3CC3)nc12)C1CC1	InChI=1S/C28H26ClN7O3/c29-20-5-6-34-15-31-23(24(34)9-20)10-30-28(39)22-14-36(33-26(22)17-3-4-17)13-21-12-35-11-19(16-1-2-16)7-18(8-25(37)38)27(35)32-21/h5-7,9,11-12,14-17H,1-4,8,10,13H2,(H,30,39)(H,37,38)	KAOLMMGUXDLOJR-UHFFFAOYSA-N	455062	US10730874, Compound I-86	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455062	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455062&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			165112148	471695241							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935397	OCCc1cc(cn2cc(Cn3cc(C(=O)NCc4ncn5ccc(Cl)cc45)c(n3)C3CC3)nc12)C1CC1	InChI=1S/C28H28ClN7O2/c29-21-5-7-34-16-31-24(25(34)10-21)11-30-28(38)23-15-36(33-26(23)18-3-4-18)14-22-13-35-12-20(17-1-2-17)9-19(6-8-37)27(35)32-22/h5,7,9-10,12-13,15-18,37H,1-4,6,8,11,14H2,(H,30,38)	LVKGVYOGLJRQQF-UHFFFAOYSA-N	455063	US10730874, Compound I-87	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455063	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455063&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			165112149	471695242							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935398	Nc1c(ccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)cn12)C1CC1	InChI=1S/C23H21ClN8O/c24-16-5-6-30-13-27-19(20(30)7-16)9-26-23(33)15-8-28-31(10-15)11-17-12-32-21(29-17)4-3-18(22(32)25)14-1-2-14/h3-8,10,12-14H,1-2,9,11,25H2,(H,26,33)	HSUFUGUTSFGYAQ-UHFFFAOYSA-N	455064	US10730874, Compound I-88::US11352356, Compound I-88	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455064	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455064&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488102	440970906							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935399	Nc1ccc(C2CC2)c2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)cn12	InChI=1S/C23H21ClN8O/c24-16-5-6-30-13-27-19(20(30)7-16)9-26-23(33)15-8-28-31(10-15)11-17-12-32-21(25)4-3-18(14-1-2-14)22(32)29-17/h3-8,10,12-14H,1-2,9,11,25H2,(H,26,33)	UAYRURSMPONNMA-UHFFFAOYSA-N	455065	US10730874, Compound I-89::US12352356, Compound I-89	Plasma kallikrein					 1050					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455065	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455065&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487737	440970907							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935400	Clc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5cc(ccc5n4)C4CC4)c3)c2c1	InChI=1S/C23H20ClN7O/c24-18-5-6-29-14-26-20(21(29)7-18)9-25-23(32)17-8-27-31(11-17)13-19-12-30-10-16(15-1-2-15)3-4-22(30)28-19/h3-8,10-12,14-15H,1-2,9,13H2,(H,25,32)	JKVSCXTZILFUPG-UHFFFAOYSA-N	454849	US10730874, Compound I-147::US10730874, Compound I-2::US10730874, Compound I-90::US11352356, Compound I-90	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=454849	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=454849&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488035	440970702							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935401	COC(=O)c1ccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)cn2c1	InChI=1S/C22H18ClN7O3/c1-33-22(32)14-2-3-20-27-17(11-29(20)9-14)12-30-10-15(7-26-30)21(31)24-8-18-19-6-16(23)4-5-28(19)13-25-18/h2-7,9-11,13H,8,12H2,1H3,(H,24,31)	GAZFDHCGAJVTLJ-UHFFFAOYSA-N	455067	US10730874, Compound I-91::US10730874, Compound I-96::US11352356, Compound I-91	Plasma kallikrein					 55					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455067	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455067&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487699	440970908							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935402	Clc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5cc(cc(C#N)c5n4)C4CC4)c3)c2c1	InChI=1S/C24H19ClN8O/c25-19-3-4-31-14-28-21(22(31)6-19)9-27-24(34)18-8-29-33(11-18)13-20-12-32-10-17(15-1-2-15)5-16(7-26)23(32)30-20/h3-6,8,10-12,14-15H,1-2,9,13H2,(H,27,34)	SJUSWHJBZYVEMH-UHFFFAOYSA-N	455068	US10730874, Compound I-92::US11352356, Compound I-92	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455068	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455068&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488078	440970909							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935403	CCOC(=O)CCc1nn(Cc2cn3cc(ccc3n2)C2CC2)cc1C(=O)NCc1ncn2ccc(Cl)cc12	InChI=1S/C28H28ClN7O3/c1-2-39-27(37)8-6-23-22(28(38)30-12-24-25-11-20(29)9-10-34(25)17-31-24)16-36(33-23)15-21-14-35-13-19(18-3-4-18)5-7-26(35)32-21/h5,7,9-11,13-14,16-18H,2-4,6,8,12,15H2,1H3,(H,30,38)	XYNDIPKPPVOCHK-UHFFFAOYSA-N	455069	US10730874, Compound I-93::US11352356, Compound I-93	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455069	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455069&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488179	440970910							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935404	Clc1ccn2cnc(CCNC(=O)c3cnn(Cc4cn5cc(ccc5n4)C4CC4)c3)c2c1	InChI=1S/C24H22ClN7O/c25-19-6-8-30-15-27-21(22(30)9-19)5-7-26-24(33)18-10-28-32(12-18)14-20-13-31-11-17(16-1-2-16)3-4-23(31)29-20/h3-4,6,8-13,15-16H,1-2,5,7,14H2,(H,26,33)	WLPXNQDUDHZIIC-UHFFFAOYSA-N	455070	US10730874, Compound I-94::US11352356, Compound I-94	Plasma kallikrein					 55					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455070	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455070&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488324	440970911							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935405	FC(F)c1nn(Cc2cn3cc(ccc3n2)C2CC2)cc1C(=O)NCc1ncn2ccc(Br)cc12	InChI=1S/C24H20BrF2N7O/c25-16-5-6-32-13-29-19(20(32)7-16)8-28-24(35)18-12-34(31-22(18)23(26)27)11-17-10-33-9-15(14-1-2-14)3-4-21(33)30-17/h3-7,9-10,12-14,23H,1-2,8,11H2,(H,28,35)	FJCGOXXEPWDKCK-UHFFFAOYSA-N	455071	US10730874, Compound I-95::US11352356, Compound I-95	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455071	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455071&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488410	440970912							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935406	OC(=O)c1ccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)cn2c1	InChI=1S/C21H16ClN7O3/c22-15-3-4-27-12-24-17(18(27)5-15)7-23-20(30)14-6-25-29(9-14)11-16-10-28-8-13(21(31)32)1-2-19(28)26-16/h1-6,8-10,12H,7,11H2,(H,23,30)(H,31,32)	UAGJOEGYSOYONU-UHFFFAOYSA-N	455072	US10730874, Compound I-96	Plasma kallikrein					>2000					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455072	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455072&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487281	471695243							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935407	Fc1c(Br)ccn2cnc(CNC(=O)c3cnn(Cc4cn5cc(ccc5n4)C4CC4)c3)c12	InChI=1S/C23H19BrFN7O/c24-18-5-6-30-13-27-19(22(30)21(18)25)8-26-23(33)16-7-28-32(10-16)12-17-11-31-9-15(14-1-2-14)3-4-20(31)29-17/h3-7,9-11,13-14H,1-2,8,12H2,(H,26,33)	QAQHWZZEPDKRQP-UHFFFAOYSA-N	455073	US10730874, Compound I-97::US11352356, Compound I-97	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455073	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455073&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487357	440970913							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935408	O=C(NCc1ncn2ccc(cc12)C#C)c1cnn(Cc2cn3nc(ccc3n2)C2CC2)c1	InChI=1S/C24H20N8O/c1-2-16-7-8-30-15-26-21(22(30)9-16)11-25-24(33)18-10-27-31(12-18)13-19-14-32-23(28-19)6-5-20(29-32)17-3-4-17/h1,5-10,12,14-15,17H,3-4,11,13H2,(H,25,33)	XMKJDEVKEAAANO-UHFFFAOYSA-N	455074	US10730874, Compound I-98::US11352356, Compound I-98	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455074	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455074&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488292	440970914							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935409	FC(F)c1nn(Cc2cn3cc(ccc3n2)C2CC2)cc1C(=O)NCc1ncn2ccc(Cl)cc12	InChI=1S/C24H20ClF2N7O/c25-16-5-6-32-13-29-19(20(32)7-16)8-28-24(35)18-12-34(31-22(18)23(26)27)11-17-10-33-9-15(14-1-2-14)3-4-21(33)30-17/h3-7,9-10,12-14,23H,1-2,8,11H2,(H,28,35)	XWYZQCXTNXOARS-UHFFFAOYSA-N	455075	US10730874, Compound I-99::US11352356, Compound I-99	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455075	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455075&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487336	440970915							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935410	COC(=O)\C=C\c1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1	InChI=1S/C27H24ClN7O3/c1-38-25(36)5-4-18-8-19(17-2-3-17)12-34-14-22(32-26(18)34)15-35-13-20(10-31-35)27(37)29-11-23-24-9-21(28)6-7-33(24)16-30-23/h4-10,12-14,16-17H,2-3,11,15H2,1H3,(H,29,37)/b5-4+	NHPBAHWGIXIPAO-SNAWJCMRSA-N	455076	US10730874, Compound I-100a::US10730874, Compound I-100b::US10730874, Compound I-100c	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455076	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455076&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139505046	440970916							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935411	COC(=O)\C=C\c1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1	InChI=1S/C27H24ClN7O3/c1-38-25(36)5-4-18-8-19(17-2-3-17)12-34-14-22(32-26(18)34)15-35-13-20(10-31-35)27(37)29-11-23-24-9-21(28)6-7-33(24)16-30-23/h4-10,12-14,16-17H,2-3,11,15H2,1H3,(H,29,37)/b5-4+	NHPBAHWGIXIPAO-SNAWJCMRSA-N	455076	US10730874, Compound I-100a::US10730874, Compound I-100b::US10730874, Compound I-100c	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455076	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455076&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139505046	440970916							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935412	COC(=O)\C=C\c1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1	InChI=1S/C27H24ClN7O3/c1-38-25(36)5-4-18-8-19(17-2-3-17)12-34-14-22(32-26(18)34)15-35-13-20(10-31-35)27(37)29-11-23-24-9-21(28)6-7-33(24)16-30-23/h4-10,12-14,16-17H,2-3,11,15H2,1H3,(H,29,37)/b5-4+	NHPBAHWGIXIPAO-SNAWJCMRSA-N	455076	US10730874, Compound I-100a::US10730874, Compound I-100b::US10730874, Compound I-100c	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455076	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455076&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139505046	440970916							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935413	Clc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5cc(cc(CN6CCOCC6)c5n4)C4CC4)c3)c2c1	InChI=1S/C28H29ClN8O2/c29-23-3-4-35-18-31-25(26(35)10-23)12-30-28(38)22-11-32-37(15-22)17-24-16-36-14-20(19-1-2-19)9-21(27(36)33-24)13-34-5-7-39-8-6-34/h3-4,9-11,14-16,18-19H,1-2,5-8,12-13,17H2,(H,30,38)	QKEFOZQQJRERQX-UHFFFAOYSA-N	455079	US10730874, Compound I-101::US11352356, Compound I-101	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455079	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455079&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487271	440970917							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935414	Clc1ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(ccc5n4)C4CC4)nc3C3COC3)c2c1	InChI=1S/C26H24ClN7O2/c27-19-5-6-32-15-29-22(23(32)7-19)8-28-26(35)21-12-34(31-25(21)18-13-36-14-18)11-20-10-33-9-17(16-1-2-16)3-4-24(33)30-20/h3-7,9-10,12,15-16,18H,1-2,8,11,13-14H2,(H,28,35)	BCNWQEMBSUDFTG-UHFFFAOYSA-N	455080	US10730874, Compound I-102::US11352356, Compound I-102	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455080	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455080&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487857	440970918							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935415	COCCOc1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1	InChI=1S/C26H26ClN7O3/c1-36-6-7-37-24-8-18(17-2-3-17)12-33-14-21(31-25(24)33)15-34-13-19(10-30-34)26(35)28-11-22-23-9-20(27)4-5-32(23)16-29-22/h4-5,8-10,12-14,16-17H,2-3,6-7,11,15H2,1H3,(H,28,35)	HOAIBSHBEWOVJQ-UHFFFAOYSA-N	455081	US10730874, Compound I-103::US11352356, Compound I-103	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455081	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455081&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488406	440970919							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935416	CCOC(=O)c1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1	InChI=1S/C26H24ClN7O3/c1-2-37-26(36)21-7-17(16-3-4-16)11-33-13-20(31-24(21)33)14-34-12-18(9-30-34)25(35)28-10-22-23-8-19(27)5-6-32(23)15-29-22/h5-9,11-13,15-16H,2-4,10,14H2,1H3,(H,28,35)	LYXCZPOSBFRUCX-UHFFFAOYSA-N	455047	US10730874, Compound I-104a::US10730874, Compound I-104b::US10730874, Compound I-71::US11352356, Compound I-71	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455047	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455047&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487407	440970894							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935417	CCOC(=O)c1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1	InChI=1S/C26H24ClN7O3/c1-2-37-26(36)21-7-17(16-3-4-16)11-33-13-20(31-24(21)33)14-34-12-18(9-30-34)25(35)28-10-22-23-8-19(27)5-6-32(23)15-29-22/h5-9,11-13,15-16H,2-4,10,14H2,1H3,(H,28,35)	LYXCZPOSBFRUCX-UHFFFAOYSA-N	455047	US10730874, Compound I-104a::US10730874, Compound I-104b::US10730874, Compound I-71::US11352356, Compound I-71	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455047	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455047&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487407	440970894							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935418	CCCc1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Br)c(F)c34)nc12)C1CC1	InChI=1S/C26H25BrFN7O/c1-2-3-17-8-18(16-4-5-16)11-34-13-20(32-25(17)34)14-35-12-19(9-31-35)26(36)29-10-22-24-23(28)21(27)6-7-33(24)15-30-22/h6-9,11-13,15-16H,2-5,10,14H2,1H3,(H,29,36)	PEQQTLVSFKYSOP-UHFFFAOYSA-N	455084	US10730874, Compound I-105::US11352356, Compound I-105	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455084	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455084&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155624266	440970920							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935419	Fc1c(Br)ccn2cnc(CNC(=O)c3cnn(Cc4cn5cc(cc(COC=O)c5n4)C4CC4)c3)c12	InChI=1S/C25H21BrFN7O3/c26-20-3-4-32-13-29-21(23(32)22(20)27)7-28-25(36)18-6-30-34(9-18)11-19-10-33-8-16(15-1-2-15)5-17(12-37-14-35)24(33)31-19/h3-6,8-10,13-15H,1-2,7,11-12H2,(H,28,36)	WIBBKJRXWQZWPQ-UHFFFAOYSA-N	455085	US10730874, Compound I-106	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455085	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455085&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487836	440970921							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935420	CCOC(=O)CCc1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1	InChI=1S/C28H28ClN7O3/c1-2-39-26(37)6-5-19-9-20(18-3-4-18)13-35-15-23(33-27(19)35)16-36-14-21(11-32-36)28(38)30-12-24-25-10-22(29)7-8-34(25)17-31-24/h7-11,13-15,17-18H,2-6,12,16H2,1H3,(H,30,38)	ATPQNHZBVSAZFO-UHFFFAOYSA-N	455086	US10730874, Compound I-107::US11352356, Compound I-107	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455086	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455086&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488120	440970922							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935421	Fc1c(Br)ccn2cnc(CNC(=O)c3cnn(Cc4cn5nc(ccc5n4)C4CC4)c3)c12	InChI=1S/C22H18BrFN8O/c23-16-5-6-30-12-26-18(21(30)20(16)24)8-25-22(33)14-7-27-31(9-14)10-15-11-32-19(28-15)4-3-17(29-32)13-1-2-13/h3-7,9,11-13H,1-2,8,10H2,(H,25,33)	KJCJLAIODLIUMC-UHFFFAOYSA-N	455087	US10730874, Compound I-108::US11352356, Compound I-108	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455087	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455087&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487505	440970923							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935422	CC(C)(O)Cc1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1	InChI=1S/C27H28ClN7O2/c1-27(2,37)9-18-7-19(17-3-4-17)12-34-14-22(32-25(18)34)15-35-13-20(10-31-35)26(36)29-11-23-24-8-21(28)5-6-33(24)16-30-23/h5-8,10,12-14,16-17,37H,3-4,9,11,15H2,1-2H3,(H,29,36)	DHTIJURLPWVRKY-UHFFFAOYSA-N	455088	US10730874, Compound I-109::US11352356, Compound I-109	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455088	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455088&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487851	440970924							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935423	Clc1ccn2cnc(CNC(=O)c3nnn(Cc4cn5cc(ccc5n4)C4CC4)n3)c2c1	InChI=1S/C21H18ClN9O/c22-15-5-6-29-12-24-17(18(29)7-15)8-23-21(32)20-26-28-31(27-20)11-16-10-30-9-14(13-1-2-13)3-4-19(30)25-16/h3-7,9-10,12-13H,1-2,8,11H2,(H,23,32)	IHKRPOXHRVZUMN-UHFFFAOYSA-N	455089	US10730874, Compound I-110::US11352356, Compound I-110	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455089	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455089&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487412	440970925							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935424	Clc1ccn2cnc(CNC(=O)c3cn(Cc4cn5nc(ccc5n4)C4CC4)nn3)c2c1	InChI=1S/C21H18ClN9O/c22-14-5-6-29-12-24-17(19(29)7-14)8-23-21(32)18-11-30(28-26-18)9-15-10-31-20(25-15)4-3-16(27-31)13-1-2-13/h3-7,10-13H,1-2,8-9H2,(H,23,32)	GXBKPLPPJNIWOA-UHFFFAOYSA-N	455090	US10730874, Compound I-111::US11352356, Compound I-111	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455090	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455090&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488090	440970926							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935425	Clc1ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(cc(C#N)c5n4)C4CC4)nn3)c2c1	InChI=1S/C23H18ClN9O/c24-17-3-4-31-13-27-19(21(31)6-17)8-26-23(34)20-12-33(30-29-20)11-18-10-32-9-16(14-1-2-14)5-15(7-25)22(32)28-18/h3-6,9-10,12-14H,1-2,8,11H2,(H,26,34)	XBNODSKUNPKNLB-UHFFFAOYSA-N	455091	US10730874, Compound I-112::US11352356, Compound I-112	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455091	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455091&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487350	440970927							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935426	CCOC(=O)C1CC1c1nn(Cc2cn3cc(ccc3n2)C2CC2)cc1C(=O)NCc1ncn2ccc(Cl)cc12	InChI=1S/C29H28ClN7O3/c1-2-40-29(39)22-10-21(22)27-23(28(38)31-11-24-25-9-19(30)7-8-35(25)16-32-24)15-37(34-27)14-20-13-36-12-18(17-3-4-17)5-6-26(36)33-20/h5-9,12-13,15-17,21-22H,2-4,10-11,14H2,1H3,(H,31,38)	CRENUKZUIRVBAJ-UHFFFAOYSA-N	455092	US10730874, Compound I-113::US11352356, Compound I-113	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455092	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455092&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487673	440970928							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935427	Clc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5cc(cc(N6CCCC6=O)c5n4)C4CC4)c3)c2c1	InChI=1S/C27H25ClN8O2/c28-20-5-7-33-16-30-22(23(33)9-20)11-29-27(38)19-10-31-35(13-19)15-21-14-34-12-18(17-3-4-17)8-24(26(34)32-21)36-6-1-2-25(36)37/h5,7-10,12-14,16-17H,1-4,6,11,15H2,(H,29,38)	ABOLQZFVVWNUIM-UHFFFAOYSA-N	455093	US10730874, Compound I-114::US11352356, Compound I-114	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455093	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455093&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487594	440970929							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935428	CCOC(=O)C1(CC1)c1cccn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12	InChI=1S/C26H24ClN7O3/c1-2-37-25(36)26(6-7-26)20-4-3-8-32-14-19(31-23(20)32)15-34-13-17(11-30-34)24(35)28-12-21-22-10-18(27)5-9-33(22)16-29-21/h3-5,8-11,13-14,16H,2,6-7,12,15H2,1H3,(H,28,35)	UPVPQIXEILONOG-UHFFFAOYSA-N	455094	US10730874, Compound I-115::US11352356, Compound I-115	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455094	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455094&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488045	440970930							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935429	OC(=O)C1(CC1)c1cccn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12	InChI=1S/C24H20ClN7O3/c25-16-3-7-31-14-27-19(20(31)8-16)10-26-22(33)15-9-28-32(11-15)13-17-12-30-6-1-2-18(21(30)29-17)24(4-5-24)23(34)35/h1-3,6-9,11-12,14H,4-5,10,13H2,(H,26,33)(H,34,35)	YSANTMLYNUNAJE-UHFFFAOYSA-N	455095	US10730874, Compound I-116::US11352356, Compound I-116	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455095	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455095&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487852	471695244							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935430	OCC1(CC1)c1cccn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12	InChI=1S/C24H22ClN7O2/c25-17-3-7-31-15-27-20(21(31)8-17)10-26-23(34)16-9-28-32(11-16)13-18-12-30-6-1-2-19(22(30)29-18)24(14-33)4-5-24/h1-3,6-9,11-12,15,33H,4-5,10,13-14H2,(H,26,34)	IIPBJBYGAQNUNT-UHFFFAOYSA-N	455096	US10730874, Compound I-117::US11352356, Compound I-117	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455096	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455096&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488273	440970931							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935431	C=Cc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5cc(ccc5n4)C4CC4)c3)c2c1	InChI=1S/C25H23N7O/c1-2-17-7-8-30-16-27-22(23(30)9-17)11-26-25(33)20-10-28-32(13-20)15-21-14-31-12-19(18-3-4-18)5-6-24(31)29-21/h2,5-10,12-14,16,18H,1,3-4,11,15H2,(H,26,33)	ZPDUYVLEXRWNNG-UHFFFAOYSA-N	557289	US10730874, Compound I-118::US11352356, Compound I-118	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557289	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557289&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488215	471698000							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935432	CC(C)(O)CCc1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1	InChI=1S/C28H30ClN7O2/c1-28(2,38)7-5-19-9-20(18-3-4-18)13-35-15-23(33-26(19)35)16-36-14-21(11-32-36)27(37)30-12-24-25-10-22(29)6-8-34(25)17-31-24/h6,8-11,13-15,17-18,38H,3-5,7,12,16H2,1-2H3,(H,30,37)	MZDUQQVDGHZJQU-UHFFFAOYSA-N	455098	US10730874, Compound I-119	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455098	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455098&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487536	471695245							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935433	OC(=O)C1CC1c1nn(Cc2cn3cc(ccc3n2)C2CC2)cc1C(=O)NCc1ncn2ccc(Cl)cc12	InChI=1S/C27H24ClN7O3/c28-17-5-6-33-14-30-22(23(33)7-17)9-29-26(36)21-13-35(32-25(21)19-8-20(19)27(37)38)12-18-11-34-10-16(15-1-2-15)3-4-24(34)31-18/h3-7,10-11,13-15,19-20H,1-2,8-9,12H2,(H,29,36)(H,37,38)	MQLHVRWOMGYXOC-UHFFFAOYSA-N	455099	US10730874, Compound I-120::US11352356, Compound I-120	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455099	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455099&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487395	471695246							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935434	Clc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5cc(ccc5n4)C4CC4)n3)c2c1	InChI=1S/C22H19ClN8O/c23-16-5-6-29-13-25-18(20(29)7-16)8-24-22(32)19-9-26-31(28-19)12-17-11-30-10-15(14-1-2-14)3-4-21(30)27-17/h3-7,9-11,13-14H,1-2,8,12H2,(H,24,32)	PJTQWYMWEYPCFJ-UHFFFAOYSA-N	455100	US10730874, Compound I-121::US11352356, Compound I-121	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455100	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455100&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487900	440970932							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935435	OC1(COC1)c1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1	InChI=1S/C26H24ClN7O3/c27-19-3-4-32-15-29-22(23(32)6-19)8-28-25(35)18-7-30-34(10-18)12-20-11-33-9-17(16-1-2-16)5-21(24(33)31-20)26(36)13-37-14-26/h3-7,9-11,15-16,36H,1-2,8,12-14H2,(H,28,35)	VBGKPUNGPWJKLC-UHFFFAOYSA-N	455101	US10730874, Compound I-122	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455101	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455101&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487783	440970933							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935436	CS\C(=N\Cc1ncn2ccc(Cl)cc12)c1cnn(Cc2cn3cc(ccc3n2)C2CC2)c1	InChI=1S/C24H22ClN7S/c1-33-24(26-10-21-22-8-19(25)6-7-30(22)15-27-21)18-9-28-32(12-18)14-20-13-31-11-17(16-2-3-16)4-5-23(31)29-20/h4-9,11-13,15-16H,2-3,10,14H2,1H3/b26-24+	XUTGQZZLFINHIB-SHHOIMCASA-N	455102	US10730874, Compound I-123::US11352356, Compound I-123	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455102	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455102&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488178	440970934							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935437	CC(c1cn2cc(ccc2n1)C1CC1)n1cc(nn1)C(=O)NCc1ncn2ccc(Cl)cc12	InChI=1S/C23H21ClN8O/c1-14(19-11-31-10-16(15-2-3-15)4-5-22(31)27-19)32-12-20(28-29-32)23(33)25-9-18-21-8-17(24)6-7-30(21)13-26-18/h4-8,10-15H,2-3,9H2,1H3,(H,25,33)	VVCDHCBEQDIFHH-UHFFFAOYSA-N	455103	US10730874, Compound I-124::US11352356, Compound I-124	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455103	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455103&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487279	440970935							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935438	ClCc1cc(cn2cc(Cn3cc(cn3)C(=O)OCc3ccccc3)nc12)C1CC1	InChI=1S/C23H21ClN4O2/c24-9-18-8-19(17-6-7-17)11-27-13-21(26-22(18)27)14-28-12-20(10-25-28)23(29)30-15-16-4-2-1-3-5-16/h1-5,8,10-13,17H,6-7,9,14-15H2	HZMKCAKBIQJOOA-UHFFFAOYSA-N	455104	US10730874, Compound I-125	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455104	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455104&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487780	440970936							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935439	Clc1ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(ccc5n4)C4CC4)nc3Cc3nn[nH]n3)c2c1	InChI=1S/C25H22ClN11O/c26-17-5-6-35-14-28-21(22(35)7-17)9-27-25(38)19-13-37(32-20(19)8-23-30-33-34-31-23)12-18-11-36-10-16(15-1-2-15)3-4-24(36)29-18/h3-7,10-11,13-15H,1-2,8-9,12H2,(H,27,38)(H,30,31,33,34)	HQPCUVCFBWXFME-UHFFFAOYSA-N	455105	US10730874, Compound I-126::US11352356, Compound I-126	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455105	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455105&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488268	440970937							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935440	OCc1cc(cn2cc(Cn3cc(cn3)C(=O)OCc3ccccc3)nc12)C1CC1	InChI=1S/C23H22N4O3/c28-14-19-8-18(17-6-7-17)10-26-12-21(25-22(19)26)13-27-11-20(9-24-27)23(29)30-15-16-4-2-1-3-5-16/h1-5,8-12,17,28H,6-7,13-15H2	HCNDAULJWAVDGS-UHFFFAOYSA-N	455106	US10730874, Compound I-127	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455106	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455106&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487517	440970938							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935441	Clc1ccn2cnc(CNC(=O)c3nnc(Cc4cn5cc(cc(C#N)c5n4)C4CC4)o3)c2c1	InChI=1S/C23H17ClN8O2/c24-16-3-4-31-12-27-18(19(31)6-16)9-26-22(33)23-30-29-20(34-23)7-17-11-32-10-15(13-1-2-13)5-14(8-25)21(32)28-17/h3-6,10-13H,1-2,7,9H2,(H,26,33)	NFNMPYWZKFORJK-UHFFFAOYSA-N	455107	US10730874, Compound I-128::US11352356, Compound I-128	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455107	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455107&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487371	440970939							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935442	Clc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5cc(cnc5n4)C4CC4)c3)c2c1	InChI=1S/C22H19ClN8O/c23-17-3-4-29-13-26-19(20(29)5-17)8-24-21(32)16-7-27-31(10-16)12-18-11-30-9-15(14-1-2-14)6-25-22(30)28-18/h3-7,9-11,13-14H,1-2,8,12H2,(H,24,32)	RQAZEMXQEGTLNC-UHFFFAOYSA-N	455108	US10730874, Compound I-129::US11352356, Compound I-129	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455108	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455108&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487341	440970940							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935443	Cc1ccc2nc(Cn3cc(cn3)C(=O)NCc3cn4ccc(Cl)cc4n3)cn2c1C	InChI=1S/C22H20ClN7O/c1-14-3-4-20-27-19(13-30(20)15(14)2)12-29-10-16(8-25-29)22(31)24-9-18-11-28-6-5-17(23)7-21(28)26-18/h3-8,10-11,13H,9,12H2,1-2H3,(H,24,31)	CVGAULTVFNEYLR-UHFFFAOYSA-N	455109	US10730874, Compound I-130::US11352356, Compound I-130	Plasma kallikrein					 55					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455109	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455109&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487714	440970941							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935444	Fc1c(Br)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(cc(C#N)c5n4)C4CC4)nn3)c12	InChI=1S/C23H17BrFN9O/c24-17-3-4-32-12-28-18(21(32)20(17)25)7-27-23(35)19-11-34(31-30-19)10-16-9-33-8-15(13-1-2-13)5-14(6-26)22(33)29-16/h3-5,8-9,11-13H,1-2,7,10H2,(H,27,35)	KWEZNCIVYXLYPL-UHFFFAOYSA-N	455110	US10730874, Compound I-131::US11352356, Compound I-131	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455110	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455110&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487932	440970942							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935445	Clc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5cc(cc(C6COC6)c5n4)C4CC4)c3)c2c1	InChI=1S/C26H24ClN7O2/c27-20-3-4-32-15-29-23(24(32)6-20)8-28-26(35)18-7-30-34(10-18)12-21-11-33-9-17(16-1-2-16)5-22(25(33)31-21)19-13-36-14-19/h3-7,9-11,15-16,19H,1-2,8,12-14H2,(H,28,35)	ULXDJXXLVBXRPX-UHFFFAOYSA-N	455111	US10730874, Compound I-132::US11352356, Compound I-132	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455111	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455111&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488336	440970943							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935446	OC(=O)C1CC1c1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1	InChI=1S/C27H24ClN7O3/c28-18-3-4-33-14-30-23(24(33)6-18)9-29-26(36)17-8-31-35(11-17)13-19-12-34-10-16(15-1-2-15)5-21(25(34)32-19)20-7-22(20)27(37)38/h3-6,8,10-12,14-15,20,22H,1-2,7,9,13H2,(H,29,36)(H,37,38)	KPCTXBRNLNHRJR-UHFFFAOYSA-N	455112	US10730874, Compound I-133	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455112	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455112&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487475	440970944							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935447	Fc1c(Br)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(ccc5n4)C4CC4)nn3)c12	InChI=1S/C22H18BrFN8O/c23-16-5-6-30-12-26-17(21(30)20(16)24)7-25-22(33)18-11-32(29-28-18)10-15-9-31-8-14(13-1-2-13)3-4-19(31)27-15/h3-6,8-9,11-13H,1-2,7,10H2,(H,25,33)	IMMHVHRMZGOHBP-UHFFFAOYSA-N	455113	US10730874, Compound I-134::US11352356, Compound I-134	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455113	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455113&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488464	440970945							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935448	Fc1c(Br)ccn2cnc(CNC(=O)c3nnn(Cc4cn5cc(ccc5n4)C4CC4)n3)c12	InChI=1S/C21H17BrFN9O/c22-15-5-6-30-11-25-16(19(30)18(15)23)7-24-21(33)20-27-29-32(28-20)10-14-9-31-8-13(12-1-2-12)3-4-17(31)26-14/h3-6,8-9,11-12H,1-2,7,10H2,(H,24,33)	MYLRAXFXBPWHIZ-UHFFFAOYSA-N	455114	US10730874, Compound I-135::US11352356, Compound I-135	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455114	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455114&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488016	440970946							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935449	Fc1c(Br)ccn2cnc(CNC(=O)c3nnc(Cc4cn5cc(ccc5n4)C4CC4)o3)c12	InChI=1S/C22H17BrFN7O2/c23-15-5-6-30-11-26-16(20(30)19(15)24)8-25-21(32)22-29-28-18(33-22)7-14-10-31-9-13(12-1-2-12)3-4-17(31)27-14/h3-6,9-12H,1-2,7-8H2,(H,25,32)	HIHHWEAZUQMNPZ-UHFFFAOYSA-N	455115	US10730874, Compound I-136::US11352356, Compound I-136	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455115	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455115&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487750	440970947							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935450	Fc1c(Cl)ccn2cnc(CNC(=O)c3nnc(Cc4cn5cc(ccc5n4)C4CC4)o3)c12	InChI=1S/C22H17ClFN7O2/c23-15-5-6-30-11-26-16(20(30)19(15)24)8-25-21(32)22-29-28-18(33-22)7-14-10-31-9-13(12-1-2-12)3-4-17(31)27-14/h3-6,9-12H,1-2,7-8H2,(H,25,32)	LDCSBVKDBYGMHO-UHFFFAOYSA-N	455116	US10730874, Compound I-137::US11352356, Compound I-137	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455116	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455116&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488401	440970948							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935451	Clc1ccn2cnc(CNC(=O)c3nnc(Cc4cn5nc(ccc5n4)C4CC4)o3)c2c1	InChI=1S/C21H17ClN8O2/c22-13-5-6-29-11-24-16(17(29)7-13)9-23-20(31)21-27-26-19(32-21)8-14-10-30-18(25-14)4-3-15(28-30)12-1-2-12/h3-7,10-12H,1-2,8-9H2,(H,23,31)	KQDOPSGLZSCHJQ-UHFFFAOYSA-N	455117	US10730874, Compound I-138::US11352356, Compound I-138	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455117	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455117&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487756	440970949							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935452	Fc1c(Br)ccn2cnc(CNC(=O)c3cn(Cc4cn5nc(ccc5n4)C4CC4)nn3)c12	InChI=1S/C21H17BrFN9O/c22-14-5-6-30-11-25-16(20(30)19(14)23)7-24-21(33)17-10-31(29-27-17)8-13-9-32-18(26-13)4-3-15(28-32)12-1-2-12/h3-6,9-12H,1-2,7-8H2,(H,24,33)	FADJUVSQXUOJOW-UHFFFAOYSA-N	455118	US10730874, Compound I-139::US11352356, Compound I-139	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455118	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455118&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488383	440970950							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935453	Fc1c(Br)ccn2cnc(CNC(=O)c3nnc(Cc4cn5nc(ccc5n4)C4CC4)o3)c12	InChI=1S/C21H16BrFN8O2/c22-13-5-6-30-10-25-15(19(30)18(13)23)8-24-20(32)21-28-27-17(33-21)7-12-9-31-16(26-12)4-3-14(29-31)11-1-2-11/h3-6,9-11H,1-2,7-8H2,(H,24,32)	UEDVZORRLUQMJQ-UHFFFAOYSA-N	455119	US10730874, Compound I-140::US11352356, Compound I-140	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455119	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455119&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487876	440970951							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935454	OC(C1COC1)c1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1	InChI=1S/C27H26ClN7O3/c28-20-3-4-33-15-30-23(24(33)6-20)8-29-27(37)18-7-31-35(10-18)12-21-11-34-9-17(16-1-2-16)5-22(26(34)32-21)25(36)19-13-38-14-19/h3-7,9-11,15-16,19,25,36H,1-2,8,12-14H2,(H,29,37)	INVRGJIOLDKFHK-UHFFFAOYSA-N	455120	US10730874, Compound I-141::US11352356, Compound I-141	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455120	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455120&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487388	440970952							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935455	COc1c(ccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)cn12)C1CC1	InChI=1S/C24H22ClN7O2/c1-34-24-19(15-2-3-15)4-5-22-29-18(13-32(22)24)12-31-11-16(9-28-31)23(33)26-10-20-21-8-17(25)6-7-30(21)14-27-20/h4-9,11,13-15H,2-3,10,12H2,1H3,(H,26,33)	ZJBAISRMJIQURI-UHFFFAOYSA-N	455121	US10730874, Compound I-142::US11352356, Compound I-142	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455121	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455121&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487339	440970953							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935456	FC(F)(F)c1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1	InChI=1S/C24H19ClF3N7O/c25-17-3-4-33-13-30-20(21(33)6-17)8-29-23(36)16-7-31-35(10-16)12-18-11-34-9-15(14-1-2-14)5-19(22(34)32-18)24(26,27)28/h3-7,9-11,13-14H,1-2,8,12H2,(H,29,36)	YGWRFUXMNZFNMR-UHFFFAOYSA-N	455122	US10730874, Compound I-143::US11352356, Compound I-143	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455122	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455122&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488167	440970954							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935457	Fc1c(ccc2nc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)cc34)cn12)C1CC1	InChI=1S/C22H18ClFN8O/c23-14-5-6-30-12-26-17(19(30)7-14)8-25-22(33)18-11-31(29-28-18)9-15-10-32-20(27-15)4-3-16(21(32)24)13-1-2-13/h3-7,10-13H,1-2,8-9H2,(H,25,33)	KOUBNAVDNJOLRN-UHFFFAOYSA-N	455123	US10730874, Compound I-144	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455123	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455123&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488230	440970955							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935458	Fc1c(Br)ccn2cnc(CNC(=O)c3cn(Cc4cn5c(F)c(ccc5n4)C4CC4)nn3)c12	InChI=1S/C22H17BrF2N8O/c23-15-5-6-31-11-27-16(20(31)19(15)24)7-26-22(34)17-10-32(30-29-17)8-13-9-33-18(28-13)4-3-14(21(33)25)12-1-2-12/h3-6,9-12H,1-2,7-8H2,(H,26,34)	BJCPVXHRGPSPFS-UHFFFAOYSA-N	455124	US10730874, Compound I-145::US11352356, Compound I-145	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455124	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455124&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487841	440970956							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935459	Fc1c(Cl)ccn2cnc(CNC(=O)c3cnn(Cc4cn5nc(ccc5n4)C4CC4)c3)c12	InChI=1S/C22H18ClFN8O/c23-16-5-6-30-12-26-18(21(30)20(16)24)8-25-22(33)14-7-27-31(9-14)10-15-11-32-19(28-15)4-3-17(29-32)13-1-2-13/h3-7,9,11-13H,1-2,8,10H2,(H,25,33)	PKRWDYJZGDTDDC-UHFFFAOYSA-N	455125	US10730874, Compound I-146::US10730874, Compound I-151::US11352356, Compound I-146	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455125	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455125&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488058	440970957							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935460	Clc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5cc(ccc5n4)C4CC4)c3)c2c1	InChI=1S/C23H20ClN7O/c24-18-5-6-29-14-26-20(21(29)7-18)9-25-23(32)17-8-27-31(11-17)13-19-12-30-10-16(15-1-2-15)3-4-22(30)28-19/h3-8,10-12,14-15H,1-2,9,13H2,(H,25,32)	JKVSCXTZILFUPG-UHFFFAOYSA-N	454849	US10730874, Compound I-147::US10730874, Compound I-2::US10730874, Compound I-90::US11352356, Compound I-90	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=454849	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=454849&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488035	440970702							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935461	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(ccc5n4)C4CC4)nn3)c12	InChI=1S/C22H18ClFN8O/c23-16-5-6-30-12-26-17(21(30)20(16)24)7-25-22(33)18-11-32(29-28-18)10-15-9-31-8-14(13-1-2-13)3-4-19(31)27-15/h3-6,8-9,11-13H,1-2,7,10H2,(H,25,33)	XQXDDGRAVSBWHD-UHFFFAOYSA-N	455127	US10730874, Compound I-148	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455127	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455127&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487844	440970958							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935462	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(cc(C#N)c5n4)C4CC4)nn3)c12	InChI=1S/C23H17ClFN9O/c24-17-3-4-32-12-28-18(21(32)20(17)25)7-27-23(35)19-11-34(31-30-19)10-16-9-33-8-15(13-1-2-13)5-14(6-26)22(33)29-16/h3-5,8-9,11-13H,1-2,7,10H2,(H,27,35)	OZICYLIAIOPJLY-UHFFFAOYSA-N	455128	US10730874, Compound I-149::US11352356, Compound I-149	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455128	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455128&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488170	440970959							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935463	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5nc(ccc5n4)C4CC4)nn3)c12	InChI=1S/C21H17ClFN9O/c22-14-5-6-30-11-25-16(20(30)19(14)23)7-24-21(33)17-10-31(29-27-17)8-13-9-32-18(26-13)4-3-15(28-32)12-1-2-12/h3-6,9-12H,1-2,7-8H2,(H,24,33)	YEAZYWXIMOWHKZ-UHFFFAOYSA-N	455129	US10730874, Compound I-150::US11352356, Compound I-150	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455129	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455129&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488128	440970960							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935464	Fc1c(Cl)ccn2cnc(CNC(=O)c3cnn(Cc4cn5nc(ccc5n4)C4CC4)c3)c12	InChI=1S/C22H18ClFN8O/c23-16-5-6-30-12-26-18(21(30)20(16)24)8-25-22(33)14-7-27-31(9-14)10-15-11-32-19(28-15)4-3-17(29-32)13-1-2-13/h3-7,9,11-13H,1-2,8,10H2,(H,25,33)	PKRWDYJZGDTDDC-UHFFFAOYSA-N	455125	US10730874, Compound I-146::US10730874, Compound I-151::US11352356, Compound I-146	Plasma kallikrein					 55					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455125	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455125&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488058	440970957							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935465	Clc1ccn2cnc(CNC(=O)c3ncn(Cc4cn5cc(ccc5n4)C4CC4)n3)c2c1	InChI=1S/C22H19ClN8O/c23-16-5-6-29-12-25-18(19(29)7-16)8-24-22(32)21-26-13-31(28-21)11-17-10-30-9-15(14-1-2-14)3-4-20(30)27-17/h3-7,9-10,12-14H,1-2,8,11H2,(H,24,32)	QYOXNOFJBYTKSQ-UHFFFAOYSA-N	455131	US10730874, Compound I-152::US11352356, Compound I-152	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455131	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455131&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488494	440970961							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935466	OC1(COC1)c1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1	InChI=1S/C25H23ClN8O3/c26-17-3-4-32-14-28-20(22(32)6-17)7-27-24(35)21-11-34(31-30-21)10-18-9-33-8-16(15-1-2-15)5-19(23(33)29-18)25(36)12-37-13-25/h3-6,8-9,11,14-15,36H,1-2,7,10,12-13H2,(H,27,35)	UNWNQIIDASIOIA-UHFFFAOYSA-N	455132	US10730874, Compound I-153::US11352356, Compound I-153	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455132	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455132&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487323	440970962							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935467	Fc1c(Br)ccn2cnc(CNC(=O)c3nnc(Cc4cn5cc(cc(C#N)c5n4)C4CC4)o3)c12	InChI=1S/C23H16BrFN8O2/c24-16-3-4-32-11-28-17(20(32)19(16)25)8-27-22(34)23-31-30-18(35-23)6-15-10-33-9-14(12-1-2-12)5-13(7-26)21(33)29-15/h3-5,9-12H,1-2,6,8H2,(H,27,34)	BOEXVDRNOHZYSF-UHFFFAOYSA-N	455133	US10730874, Compound I-154::US11352356, Compound I-154	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455133	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455133&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487553	440970963							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935468	CCOC(=O)Cc1cc(cn2cc(Cn3cc(cn3)C(=O)OCc3ccccc3)nc12)C1CC1	InChI=1S/C26H26N4O4/c1-2-33-24(31)11-20-10-21(19-8-9-19)13-29-15-23(28-25(20)29)16-30-14-22(12-27-30)26(32)34-17-18-6-4-3-5-7-18/h3-7,10,12-15,19H,2,8-9,11,16-17H2,1H3	QTZVJJMSTUAAFE-UHFFFAOYSA-N	455134	US10730874, Compound I-155	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455134	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455134&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487461	440970964							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935469	Fc1c(Cl)ccn2cnc(CNC(=O)c3nnc(Cc4cn5nc(ccc5n4)C4CC4)o3)c12	InChI=1S/C21H16ClFN8O2/c22-13-5-6-30-10-25-15(19(30)18(13)23)8-24-20(32)21-28-27-17(33-21)7-12-9-31-16(26-12)4-3-14(29-31)11-1-2-11/h3-6,9-11H,1-2,7-8H2,(H,24,32)	YEYKHGAVIMFEBR-UHFFFAOYSA-N	455135	US10730874, Compound I-156::US11352356, Compound I-156	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455135	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455135&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487757	440970965							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935470	ClCc1cc(cn2cc(Cn3cc(nn3)C(=O)OCc3ccccc3)nc12)C1CC1	InChI=1S/C22H20ClN5O2/c23-9-17-8-18(16-6-7-16)10-27-11-19(24-21(17)27)12-28-13-20(25-26-28)22(29)30-14-15-4-2-1-3-5-15/h1-5,8,10-11,13,16H,6-7,9,12,14H2	MEIRZWHLSJXTIT-UHFFFAOYSA-N	455136	US10730874, Compound I-157a::US11352356, Compound I-157a	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455136	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455136&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488062	440970966							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935471	OC(=O)Cc1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C24H20ClFN8O3/c25-17-3-4-32-12-28-18(22(32)21(17)26)7-27-24(37)19-11-34(31-30-19)10-16-9-33-8-15(13-1-2-13)5-14(6-20(35)36)23(33)29-16/h3-5,8-9,11-13H,1-2,6-7,10H2,(H,27,37)(H,35,36)	HILAHFBQKJFGOS-UHFFFAOYSA-N	455137	US10730874, Compound I-157b::US11352356, Compound I-157b	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455137	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455137&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487706	471695247							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935472	Fc1c(Cl)ccn2cnc(CNC(=O)c3nnc(Cc4cn5cc(cc(C#N)c5n4)C4CC4)o3)c12	InChI=1S/C23H16ClFN8O2/c24-16-3-4-32-11-28-17(20(32)19(16)25)8-27-22(34)23-31-30-18(35-23)6-15-10-33-9-14(12-1-2-12)5-13(7-26)21(33)29-15/h3-5,9-12H,1-2,6,8H2,(H,27,34)	SKZNVADWTQUTDR-UHFFFAOYSA-N	455138	US10730874, Compound I-158::US11352356, Compound I-158	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455138	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455138&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487744	440970967							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935473	CS(=O)(=O)c1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1	InChI=1S/C24H22ClN7O3S/c1-36(34,35)22-6-16(15-2-3-15)10-31-12-19(29-23(22)31)13-32-11-17(8-28-32)24(33)26-9-20-21-7-18(25)4-5-30(21)14-27-20/h4-8,10-12,14-15H,2-3,9,13H2,1H3,(H,26,33)	JXYCVCMSYBYHLY-UHFFFAOYSA-N	455139	US10730874, Compound I-159::US11352356, Compound I-159	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455139	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455139&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487552	440970968							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935474	Cn1nc(nc1Cc1cn2cc(ccc2n1)C1CC1)C(=O)NCc1ncn2ccc(Cl)cc12	InChI=1S/C23H21ClN8O/c1-30-21(9-17-12-32-11-15(14-2-3-14)4-5-20(32)27-17)28-22(29-30)23(33)25-10-18-19-8-16(24)6-7-31(19)13-26-18/h4-8,11-14H,2-3,9-10H2,1H3,(H,25,33)	PBIJRGWOXAVYDI-UHFFFAOYSA-N	455140	US10730874, Compound I-160::US11352356, Compound I-160	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455140	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455140&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488001	440970969							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935475	Clc1ccn2cnc(CNC(=O)c3nnc(Cc4cn5cc(ccc5n4)C4CC4)[nH]3)c2c1	InChI=1S/C22H19ClN8O/c23-15-5-6-30-12-25-17(18(30)7-15)9-24-22(32)21-27-19(28-29-21)8-16-11-31-10-14(13-1-2-13)3-4-20(31)26-16/h3-7,10-13H,1-2,8-9H2,(H,24,32)(H,27,28,29)	BQFFCRSINIHETI-UHFFFAOYSA-N	455141	US10730874, Compound I-161::US11352356, Compound I-161	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455141	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455141&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488321	440970970							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935476	CCOC(=O)C(C)(C)Cc1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1	InChI=1S/C30H32ClN7O3/c1-4-41-29(40)30(2,3)11-20-9-21(19-5-6-19)14-37-16-24(35-27(20)37)17-38-15-22(12-34-38)28(39)32-13-25-26-10-23(31)7-8-36(26)18-33-25/h7-10,12,14-16,18-19H,4-6,11,13,17H2,1-3H3,(H,32,39)	FPILPBZKRTWQLG-UHFFFAOYSA-N	455142	US10730874, Compound I-162::US11352356, Compound I-162	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455142	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455142&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487888	440970971							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935477	CCOC(=O)CCc1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C27H26ClFN8O3/c1-2-40-23(38)6-5-17-9-18(16-3-4-16)11-36-12-19(32-26(17)36)13-37-14-22(33-34-37)27(39)30-10-21-25-24(29)20(28)7-8-35(25)15-31-21/h7-9,11-12,14-16H,2-6,10,13H2,1H3,(H,30,39)	VJVMPQRIQYWAIF-UHFFFAOYSA-N	455143	US10730874, Compound I-163a::US11352356, Compound I-163a	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455143	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455143&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488116	440970972							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935478	OC(=O)CCc1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C25H22ClFN8O3/c26-18-5-6-33-13-29-19(23(33)22(18)27)8-28-25(38)20-12-35(32-31-20)11-17-10-34-9-16(14-1-2-14)7-15(24(34)30-17)3-4-21(36)37/h5-7,9-10,12-14H,1-4,8,11H2,(H,28,38)(H,36,37)	MKUMXXAVFRWNKM-UHFFFAOYSA-N	455144	US10730874, Compound I-163b::US11352356, Compound I-163b	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455144	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455144&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488026	440970973							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935479	Fc1c(Br)ccn2cnc(CNC(=O)c3cnn(Cc4cn5c(F)c(ccc5n4)C4CC4)c3)c12	InChI=1S/C23H18BrF2N7O/c24-17-5-6-31-12-28-18(21(31)20(17)25)8-27-23(34)14-7-29-32(9-14)10-15-11-33-19(30-15)4-3-16(22(33)26)13-1-2-13/h3-7,9,11-13H,1-2,8,10H2,(H,27,34)	ACTPWCJUTZVHPO-UHFFFAOYSA-N	455145	US10730874, Compound I-164::US11352356, Compound I-164	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455145	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455145&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488208	440970974							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935480	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(cnc5n4)C4CC4)nn3)c12	InChI=1S/C21H17ClFN9O/c22-15-3-4-30-11-26-16(19(30)18(15)23)6-24-20(33)17-10-32(29-28-17)9-14-8-31-7-13(12-1-2-12)5-25-21(31)27-14/h3-5,7-8,10-12H,1-2,6,9H2,(H,24,33)	CLJBXLCMPPMYOH-UHFFFAOYSA-N	455146	US10730874, Compound I-165::US11352356, Compound I-165	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455146	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455146&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487324	440970975							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935481	CCOC(=O)c1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C25H22ClFN8O3/c1-2-38-25(37)17-7-15(14-3-4-14)9-34-10-16(30-23(17)34)11-35-12-20(31-32-35)24(36)28-8-19-22-21(27)18(26)5-6-33(22)13-29-19/h5-7,9-10,12-14H,2-4,8,11H2,1H3,(H,28,36)	LOERPDDAWHEZBE-UHFFFAOYSA-N	455147	US10730874, Compound I-166a::US10730874, Compound I-166b::US11352356, Compound I-166a	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455147	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455147&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488395	440970976							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935482	CCOC(=O)c1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C25H22ClFN8O3/c1-2-38-25(37)17-7-15(14-3-4-14)9-34-10-16(30-23(17)34)11-35-12-20(31-32-35)24(36)28-8-19-22-21(27)18(26)5-6-33(22)13-29-19/h5-7,9-10,12-14H,2-4,8,11H2,1H3,(H,28,36)	LOERPDDAWHEZBE-UHFFFAOYSA-N	455147	US10730874, Compound I-166a::US10730874, Compound I-166b::US11352356, Compound I-166a	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455147	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455147&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488395	440970976							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935483	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(cc(c5n4)C4(F)COC4)C4CC4)nn3)c12	InChI=1S/C25H21ClF2N8O2/c26-18-3-4-34-13-30-19(22(34)21(18)27)6-29-24(37)20-10-36(33-32-20)9-16-8-35-7-15(14-1-2-14)5-17(23(35)31-16)25(28)11-38-12-25/h3-5,7-8,10,13-14H,1-2,6,9,11-12H2,(H,29,37)	BVXXJJHLQNZVAO-UHFFFAOYSA-N	455149	US10730874, Compound I-167::US11352356, Compound I-167	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455149	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455149&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487749	440970977							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935484	CCOC(=O)C(C)(C)Cc1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1	InChI=1S/C29H31ClN8O3/c1-4-41-28(40)29(2,3)11-19-9-20(18-5-6-18)13-37-14-22(33-26(19)37)15-38-16-24(34-35-38)27(39)31-12-23-25-10-21(30)7-8-36(25)17-32-23/h7-10,13-14,16-18H,4-6,11-12,15H2,1-3H3,(H,31,39)	WPSWOPYBBAFGSI-UHFFFAOYSA-N	455150	US10730874, Compound I-168::US10730874, Compound I-170::US11352356, Compound I-168	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455150	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455150&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487862	440970978							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935485	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(cc(C6COC6)c5n4)C4CC4)nn3)c12	InChI=1S/C25H22ClFN8O2/c26-19-3-4-33-13-29-20(23(33)22(19)27)6-28-25(36)21-10-35(32-31-21)9-17-8-34-7-15(14-1-2-14)5-18(24(34)30-17)16-11-37-12-16/h3-5,7-8,10,13-14,16H,1-2,6,9,11-12H2,(H,28,36)	FXUKFZIQXJUNHW-UHFFFAOYSA-N	455151	US10730874, Compound I-169::US11352356, Compound I-169	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455151	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455151&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488361	440970979							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935486	CC(C)(Cc1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1)C(O)=O	InChI=1S/C27H27ClN8O3/c1-27(2,26(38)39)9-17-7-18(16-3-4-16)11-35-12-20(31-24(17)35)13-36-14-22(32-33-36)25(37)29-10-21-23-8-19(28)5-6-34(23)15-30-21/h5-8,11-12,14-16H,3-4,9-10,13H2,1-2H3,(H,29,37)(H,38,39)	NXJWSVPQIZEHSJ-UHFFFAOYSA-N	455152	US10730874, Compound I-170	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455152	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455152&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487511	471695248							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935487	Fc1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C22H17ClF2N8O/c23-15-3-4-31-11-27-17(20(31)19(15)25)6-26-22(34)18-10-33(30-29-18)9-14-8-32-7-13(12-1-2-12)5-16(24)21(32)28-14/h3-5,7-8,10-12H,1-2,6,9H2,(H,26,34)	UPMHECNJBYSZLT-UHFFFAOYSA-N	455153	US10730874, Compound I-171::US11352356, Compound I-171	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455153	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455153&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487440	440970980							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935488	Cc1c(Cl)ccc2nc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)cn12	InChI=1S/C20H15Cl2FN8O/c1-11-13(21)2-3-17-26-12(8-31(11)17)7-30-9-16(27-28-30)20(32)24-6-15-19-18(23)14(22)4-5-29(19)10-25-15/h2-5,8-10H,6-7H2,1H3,(H,24,32)	LRSPXNCNBHRBFB-UHFFFAOYSA-N	455154	US10730874, Compound I-172::US11352356, Compound I-172	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455154	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455154&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488364	440970981							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935489	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(cc(N6CCOCC6)c5n4)C4CC4)nn3)c12	InChI=1S/C26H25ClFN9O2/c27-19-3-4-35-15-30-20(24(35)23(19)28)10-29-26(38)21-14-37(33-32-21)13-18-12-36-11-17(16-1-2-16)9-22(25(36)31-18)34-5-7-39-8-6-34/h3-4,9,11-12,14-16H,1-2,5-8,10,13H2,(H,29,38)	AMKWJBVJHRSEMN-UHFFFAOYSA-N	455155	US10730874, Compound I-173::US11352356, Compound I-173	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455155	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455155&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488033	440970982							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935490	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(cc(-c6nn[nH]n6)c5n4)C4CC4)nn3)c12	InChI=1S/C23H18ClFN12O/c24-16-3-4-35-11-27-17(20(35)19(16)25)6-26-23(38)18-10-37(34-29-18)9-14-8-36-7-13(12-1-2-12)5-15(22(36)28-14)21-30-32-33-31-21/h3-5,7-8,10-12H,1-2,6,9H2,(H,26,38)(H,30,31,32,33)	UWNKGJKBQYTQMP-UHFFFAOYSA-N	455156	US10730874, Compound I-174::US11352356, Compound I-174	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455156	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455156&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487914	440970983							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935491	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cc5cc(ccn5n4)C4CC4)nn3)c12	InChI=1S/C22H18ClFN8O/c23-17-4-5-30-12-26-18(21(30)20(17)24)9-25-22(33)19-11-31(29-27-19)10-15-8-16-7-14(13-1-2-13)3-6-32(16)28-15/h3-8,11-13H,1-2,9-10H2,(H,25,33)	QECKLGRMLYZYDC-UHFFFAOYSA-N	455157	US10730874, Compound I-175::US11352356, Compound I-175	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455157	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455157&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487409	440970984							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935492	Clc1ccn2cnc(CNC(=O)c3cc(Cc4cn5cc(ccc5n4)C4CC4)on3)c2c1	InChI=1S/C23H19ClN6O2/c24-16-5-6-29-13-26-20(21(29)7-16)10-25-23(31)19-9-18(32-28-19)8-17-12-30-11-15(14-1-2-14)3-4-22(30)27-17/h3-7,9,11-14H,1-2,8,10H2,(H,25,31)	WYBCITHSFXROQY-UHFFFAOYSA-N	455158	US10730874, Compound I-176::US11352356, Compound I-176	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455158	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455158&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488191	440970985							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935493	Clc1ccn2cnc(CNC(=O)c3noc(Cc4cn5cc(ccc5n4)C4CC4)n3)c2c1	InChI=1S/C22H18ClN7O2/c23-15-5-6-29-12-25-17(18(29)7-15)9-24-22(31)21-27-20(32-28-21)8-16-11-30-10-14(13-1-2-13)3-4-19(30)26-16/h3-7,10-13H,1-2,8-9H2,(H,24,31)	QYPWNBJFEALFGI-UHFFFAOYSA-N	455159	US10730874, Compound I-177::US11352356, Compound I-177	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455159	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455159&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487397	440970986							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935494	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4nc5cc(ccn5n4)C4CC4)nn3)c12	InChI=1S/C21H17ClFN9O/c22-14-4-5-30-11-25-15(20(30)19(14)23)8-24-21(33)16-9-31(29-27-16)10-17-26-18-7-13(12-1-2-12)3-6-32(18)28-17/h3-7,9,11-12H,1-2,8,10H2,(H,24,33)	TXXITEACQAZRRV-UHFFFAOYSA-N	455160	US10730874, Compound I-178::US11352356, Compound I-178	Plasma kallikrein					 55					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455160	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455160&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487347	440970987							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935495	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(cc(-n6cnnn6)c5n4)C4CC4)nn3)c12	InChI=1S/C23H18ClFN12O/c24-16-3-4-34-11-27-17(21(34)20(16)25)6-26-23(38)18-10-36(32-30-18)9-15-8-35-7-14(13-1-2-13)5-19(22(35)29-15)37-12-28-31-33-37/h3-5,7-8,10-13H,1-2,6,9H2,(H,26,38)	UDEXSOCXNBAPNS-UHFFFAOYSA-N	455161	US10730874, Compound I-179::US11352356, Compound I-179	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455161	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455161&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487399	440970988							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935496	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(cc(-n6cnnc6)c5n4)C4CC4)nn3)c12	InChI=1S/C24H19ClFN11O/c25-17-3-4-34-11-28-18(22(34)21(17)26)6-27-24(38)19-10-37(33-32-19)9-16-8-35-7-15(14-1-2-14)5-20(23(35)31-16)36-12-29-30-13-36/h3-5,7-8,10-14H,1-2,6,9H2,(H,27,38)	ZZDUGASJVGDCNQ-UHFFFAOYSA-N	455162	US10730874, Compound I-180::US11352356, Compound I-180	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455162	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455162&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488100	440970989							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935497	OCc1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C23H20ClFN8O2/c24-17-3-4-31-12-27-18(21(31)20(17)25)6-26-23(35)19-10-33(30-29-19)9-16-8-32-7-14(13-1-2-13)5-15(11-34)22(32)28-16/h3-5,7-8,10,12-13,34H,1-2,6,9,11H2,(H,26,35)	CSJKDRLRMSWNBG-UHFFFAOYSA-N	455163	US10730874, Compound I-181::US11352356, Compound I-181	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455163	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455163&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487956	440970990							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935498	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(cc(C=O)c5n4)C4CC4)nn3)c12	InChI=1S/C23H18ClFN8O2/c24-17-3-4-31-12-27-18(21(31)20(17)25)6-26-23(35)19-10-33(30-29-19)9-16-8-32-7-14(13-1-2-13)5-15(11-34)22(32)28-16/h3-5,7-8,10-13H,1-2,6,9H2,(H,26,35)	OULYKXBARJPDHX-UHFFFAOYSA-N	455164	US10730874, Compound I-182::US11352356, Compound I-182	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455164	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455164&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488266	471695249							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935499	OC(=O)CCc1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1	InChI=1S/C25H23ClN8O3/c26-18-5-6-32-14-28-20(22(32)8-18)9-27-25(37)21-13-34(31-30-21)12-19-11-33-10-17(15-1-2-15)7-16(24(33)29-19)3-4-23(35)36/h5-8,10-11,13-15H,1-4,9,12H2,(H,27,37)(H,35,36)	BLDIVGDUJSDPMY-UHFFFAOYSA-N	455165	US10730874, Compound I-183::US11352356, Compound I-183	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455165	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455165&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487286	440970991							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935500	NC(=O)CCc1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1	InChI=1S/C25H24ClN9O2/c26-18-5-6-33-14-29-20(22(33)8-18)9-28-25(37)21-13-35(32-31-21)12-19-11-34-10-17(15-1-2-15)7-16(24(34)30-19)3-4-23(27)36/h5-8,10-11,13-15H,1-4,9,12H2,(H2,27,36)(H,28,37)	QHRHAQFKLLAKFN-UHFFFAOYSA-N	455166	US10730874, Compound I-184::US11352356, Compound I-184	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455166	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455166&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488251	440970992							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935501	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(cc(c5n4)C(F)(F)F)C4CC4)nn3)c12	InChI=1S/C23H17ClF4N8O/c24-16-3-4-34-11-30-17(20(34)19(16)25)6-29-22(37)18-10-36(33-32-18)9-14-8-35-7-13(12-1-2-12)5-15(21(35)31-14)23(26,27)28/h3-5,7-8,10-12H,1-2,6,9H2,(H,29,37)	USULODVGFTZIAI-UHFFFAOYSA-N	455167	US10730874, Compound I-185::US11352356, Compound I-185	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455167	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455167&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488124	440970993							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935502	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(cc(CC6COC6)c5n4)C4CC4)nn3)c12	InChI=1S/C26H24ClFN8O2/c27-20-3-4-34-14-30-21(24(34)23(20)28)7-29-26(37)22-11-36(33-32-22)10-19-9-35-8-18(16-1-2-16)6-17(25(35)31-19)5-15-12-38-13-15/h3-4,6,8-9,11,14-16H,1-2,5,7,10,12-13H2,(H,29,37)	JLQBGBAMTMYHSV-UHFFFAOYSA-N	455168	US10730874, Compound I-186::US11352356, Compound I-186	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455168	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455168&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488053	440970994							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935503	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(Cl)cc(C6COC6)c5n4)nn3)c12	InChI=1S/C22H17Cl2FN8O2/c23-13-3-15(12-9-35-10-12)21-28-14(6-32(21)5-13)7-33-8-18(29-30-33)22(34)26-4-17-20-19(25)16(24)1-2-31(20)11-27-17/h1-3,5-6,8,11-12H,4,7,9-10H2,(H,26,34)	DREOJJSYJRKADX-UHFFFAOYSA-N	455169	US10730874, Compound I-187::US11352356, Compound I-187	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455169	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455169&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487682	440970995							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935504	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(Cl)c(Cl)cc5n4)nn3)c12	InChI=1S/C19H12Cl3FN8O/c20-11-1-2-29-9-25-14(18(29)17(11)23)4-24-19(32)15-8-31(28-27-15)6-10-5-30-7-13(22)12(21)3-16(30)26-10/h1-3,5,7-9H,4,6H2,(H,24,32)	PPOPKLLAQZEWFC-UHFFFAOYSA-N	455170	US10730874, Compound I-188::US11352356, Compound I-188	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455170	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455170&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487869	440970996							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935505	Clc1cc2nc(Cn3cc(nn3)C(=O)NCc3cc4cc(cnc4s3)C3CC3)cn2cc1Cl	InChI=1S/C22H17Cl2N7OS/c23-17-5-20-27-15(8-30(20)10-18(17)24)9-31-11-19(28-29-31)21(32)25-7-16-4-13-3-14(12-1-2-12)6-26-22(13)33-16/h3-6,8,10-12H,1-2,7,9H2,(H,25,32)	VMIRRAWDNUAIQG-UHFFFAOYSA-N	455171	US10730874, Compound I-189	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455171	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455171&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155883676	440970997							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935506	Clc1ccn2cnc(CNC(=O)c3nc(Cc4cn5cc(ccc5n4)C4CC4)no3)c2c1	InChI=1S/C22H18ClN7O2/c23-15-5-6-29-12-25-17(18(29)7-15)9-24-21(31)22-27-19(28-32-22)8-16-11-30-10-14(13-1-2-13)3-4-20(30)26-16/h3-7,10-13H,1-2,8-9H2,(H,24,31)	QIHPBXTVCWDWIU-UHFFFAOYSA-N	455172	US10730874, Compound I-190::US11352356, Compound I-190	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455172	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455172&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487577	440970998							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935507	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cc5cc(ccc5o4)C4CC4)nn3)c12	InChI=1S/C23H18ClFN6O2/c24-17-5-6-30-12-27-18(22(30)21(17)25)9-26-23(32)19-11-31(29-28-19)10-16-8-15-7-14(13-1-2-13)3-4-20(15)33-16/h3-8,11-13H,1-2,9-10H2,(H,26,32)	IREKDXXEKQWYIB-UHFFFAOYSA-N	455173	US10730874, Compound I-191::US11352356, Compound I-191	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455173	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455173&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487781	440970999							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935508	FC(F)c1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C23H18ClF3N8O/c24-16-3-4-33-11-29-17(20(33)19(16)25)6-28-23(36)18-10-35(32-31-18)9-14-8-34-7-13(12-1-2-12)5-15(21(26)27)22(34)30-14/h3-5,7-8,10-12,21H,1-2,6,9H2,(H,28,36)	KRFFZINWKIKOQV-UHFFFAOYSA-N	455174	US10730874, Compound I-192::US11352356, Compound I-192	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455174	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455174&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487442	440971000							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935509	CCOC(=O)c1cnn(Cc2cc(cn3cc(Cn4cc(nn4)C(=O)NCc4ncn5ccc(Cl)c(F)c45)nc23)C2CC2)c1	InChI=1S/C29H26ClFN10O3/c1-2-44-29(43)20-8-34-40(12-20)11-19-7-18(17-3-4-17)10-39-13-21(35-27(19)39)14-41-15-24(36-37-41)28(42)32-9-23-26-25(31)22(30)5-6-38(26)16-33-23/h5-8,10,12-13,15-17H,2-4,9,11,14H2,1H3,(H,32,42)	UTKSPGSUTGQLPJ-UHFFFAOYSA-N	455175	US10730874, Compound I-193::US11352356, Compound I-193	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455175	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455175&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487645	440971001							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935510	Clc1ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(cc(CCc6nnn[nH]6)c5n4)C4CC4)nn3)c2c1	InChI=1S/C25H23ClN12O/c26-18-5-6-36-14-28-20(22(36)8-18)9-27-25(39)21-13-38(35-30-21)12-19-11-37-10-17(15-1-2-15)7-16(24(37)29-19)3-4-23-31-33-34-32-23/h5-8,10-11,13-15H,1-4,9,12H2,(H,27,39)(H,31,32,33,34)	CEFZLTMWWGJJIG-UHFFFAOYSA-N	455176	US10730874, Compound I-194::US11352356, Compound I-194	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455176	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455176&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487959	440971002							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935511	COC(=O)c1c(Cn2cc(nn2)C(=O)NCc2ncn3ccc(Cl)c(F)c23)nc2cc(ccc12)C1CC1			455177	US10730874, Compound I-195	Plasma kallikrein					 1050					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455177	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455177&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487462	440971003							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935512	Fc1c(Cl)ccn2cnc(CNC(=O)c3coc(Cc4cn5cc(ccc5n4)C4CC4)n3)c12	InChI=1S/C23H18ClFN6O2/c24-16-5-6-30-12-27-17(22(30)21(16)25)8-26-23(32)18-11-33-20(29-18)7-15-10-31-9-14(13-1-2-13)3-4-19(31)28-15/h3-6,9-13H,1-2,7-8H2,(H,26,32)	FZDKJKILBJBBHB-UHFFFAOYSA-N	455178	US10730874, Compound I-196::US11352356, Compound I-196	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455178	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455178&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488201	440971004							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935513	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5ccc(Cl)cc5o4)nn3)c12			455179	US10730874, Compound I-197	Plasma kallikrein					 1050					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455179	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455179&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155883677	440971005							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935514	CC(c1cn2cc(ccc2n1)C1CC1)n1cc(nn1)C(=O)NCc1ncn2ccc(Cl)c(F)c12	InChI=1S/C23H20ClFN8O/c1-13(18-10-32-9-15(14-2-3-14)4-5-20(32)28-18)33-11-19(29-30-33)23(34)26-8-17-22-21(25)16(24)6-7-31(22)12-27-17/h4-7,9-14H,2-3,8H2,1H3,(H,26,34)	SWWAWYDDCWOBQB-UHFFFAOYSA-N	455180	US10730874, Compound I-198::US11352356, Compound I-198	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455180	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455180&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488038	440971006							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935515	CC(c1cn2cc(cc(C3CCC(=O)O3)c2n1)C1CC1)n1cc(nn1)C(=O)NCc1ncn2ccc(Cl)c(F)c12	InChI=1S/C27H24ClFN8O3/c1-14(20-11-36-10-16(15-2-3-15)8-17(26(36)32-20)22-4-5-23(38)40-22)37-12-21(33-34-37)27(39)30-9-19-25-24(29)18(28)6-7-35(25)13-31-19/h6-8,10-15,22H,2-5,9H2,1H3,(H,30,39)	OCIUAWLYQAJILI-UHFFFAOYSA-N	455181	US10730874, Compound I-199	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455181	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455181&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155883678	440971007							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935516	Fc1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Br)c(F)c34)nc12)C1CC1	InChI=1S/C22H17BrF2N8O/c23-15-3-4-31-11-27-17(20(31)19(15)25)6-26-22(34)18-10-33(30-29-18)9-14-8-32-7-13(12-1-2-12)5-16(24)21(32)28-14/h3-5,7-8,10-12H,1-2,6,9H2,(H,26,34)	HBWQGKLPQPHKEV-UHFFFAOYSA-N	455182	US10730874, Compound I-200::US11352356, Compound I-200	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455182	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455182&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488265	440971008							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935517	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(cc(Cn6cccn6)c5n4)C4CC4)nn3)c12	InChI=1S/C26H22ClFN10O/c27-20-4-7-35-15-30-21(24(35)23(20)28)9-29-26(39)22-14-38(34-33-22)13-19-12-36-10-17(16-2-3-16)8-18(25(36)32-19)11-37-6-1-5-31-37/h1,4-8,10,12,14-16H,2-3,9,11,13H2,(H,29,39)	LXBOIMXGUUEOIP-UHFFFAOYSA-N	455183	US10730874, Compound I-201::US11352356, Compound I-201	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455183	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455183&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487953	440971009							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935518	CCOC(=O)c1ccn(Cc2cc(cn3cc(Cn4cc(nn4)C(=O)NCc4ncn5ccc(Cl)c(F)c45)nc23)C2CC2)n1	InChI=1S/C29H26ClFN10O3/c1-2-44-29(43)22-6-8-40(36-22)12-19-9-18(17-3-4-17)11-39-13-20(34-27(19)39)14-41-15-24(35-37-41)28(42)32-10-23-26-25(31)21(30)5-7-38(26)16-33-23/h5-9,11,13,15-17H,2-4,10,12,14H2,1H3,(H,32,42)	PDKWEHDNXUZCQG-UHFFFAOYSA-N	455184	US10730874, Compound I-202	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455184	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455184&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487695	440971010							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935519	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(cc(N6CCCC6=O)c5n4)C4CC4)nn3)c12	InChI=1S/C26H23ClFN9O2/c27-18-5-7-34-14-30-19(24(34)23(18)28)9-29-26(39)20-13-36(33-32-20)12-17-11-35-10-16(15-3-4-15)8-21(25(35)31-17)37-6-1-2-22(37)38/h5,7-8,10-11,13-15H,1-4,6,9,12H2,(H,29,39)	FAFQFOQROABJFU-UHFFFAOYSA-N	455185	US10730874, Compound I-203::US11352356, Compound I-203	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455185	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455185&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487942	440971011							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935520	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(cc(Br)c5n4)C4CC4)nn3)c12	InChI=1S/C22H17BrClFN8O/c23-15-5-13(12-1-2-12)7-32-8-14(28-21(15)32)9-33-10-18(29-30-33)22(34)26-6-17-20-19(25)16(24)3-4-31(20)11-27-17/h3-5,7-8,10-12H,1-2,6,9H2,(H,26,34)	PXNXGIUGOSFDHR-UHFFFAOYSA-N	455186	US10730874, Compound I-204::US11352356, Compound I-204	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455186	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455186&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487834	440971012							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
935521	CCOC(=O)C(C)(C)Cc1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C29H30ClFN8O3/c1-4-42-28(41)29(2,3)10-18-9-19(17-5-6-17)12-38-13-20(34-26(18)38)14-39-15-23(35-36-39)27(40)32-11-22-25-24(31)21(30)7-8-37(25)16-33-22/h7-9,12-13,15-17H,4-6,10-11,14H2,1-3H3,(H,32,40)	YJFRTTPITFSUCE-UHFFFAOYSA-N	455187	US10730874, Compound I-205::US11352356, Compound I-205	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RN3BXC		aid1804651	US10730874	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Shire Human Genetic Therapies, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455187	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455187&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487520	440971013							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957298	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)c2nccc(C#N)c12	InChI=1S/C27H22ClN7O/c1-15-7-24(30)34-16(2)21(15)12-33-27(36)22-14-35(26-25(22)18(10-29)5-6-31-26)13-17-3-4-23-19(8-17)9-20(28)11-32-23/h3-9,11,14H,12-13H2,1-2H3,(H2,30,34)(H,33,36)	HFIDVVPXOSGIDQ-UHFFFAOYSA-N	392640	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-4-cyano-1H-pyrrolo[2,3- b]pyridine-3-carboxamide::US10301284, Example 127::US10781200, Example 127	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392640	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392640&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178151	404960968							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957299	COc1ccc2n(Cc3ccc4ncc(Cl)cc4c3)cc(C(=O)NCc3c(C)cc(N)nc3C)c2n1	InChI=1S/C27H25ClN6O2/c1-15-8-24(29)32-16(2)20(15)12-31-27(35)21-14-34(23-6-7-25(36-3)33-26(21)23)13-17-4-5-22-18(9-17)10-19(28)11-30-22/h4-11,14H,12-13H2,1-3H3,(H2,29,32)(H,31,35)	VWMBRYCYRNXPCV-UHFFFAOYSA-N	392641	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-5-methoxy-1H-pyrrolo[3,2- b]pyridine-3-carboxamide::US10301284, Example 128::US10781200, Example 128	Plasma kallikrein			 5500							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392641	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392641&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178707	404960969							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957300	Cc1cc(N)nc(C)c1CNC(=O)c1nn(Cc2ccc3ncc(Cl)cc3c2)c2cncc(C#N)c12	InChI=1S/C26H21ClN8O/c1-14-5-23(29)33-15(2)20(14)11-32-26(36)25-24-18(8-28)9-30-12-22(24)35(34-25)13-16-3-4-21-17(6-16)7-19(27)10-31-21/h3-7,9-10,12H,11,13H2,1-2H3,(H2,29,33)(H,32,36)	DOYCANBVVULGAM-UHFFFAOYSA-N	392642	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-4-cyano-1H-pyrazolo[3,4- c]pyridine-3-carboxamide::US10301284, Example 129::US10781200, Example 129	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392642	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392642&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178160	404960970							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957301	Cc1cc(N)nc(C)c1CNC(=O)c1nn(Cc2ccc3ncc(Cl)cc3c2)c2cnc(cc12)C#N	InChI=1S/C26H21ClN8O/c1-14-5-24(29)33-15(2)21(14)11-32-26(36)25-20-8-19(9-28)30-12-23(20)35(34-25)13-16-3-4-22-17(6-16)7-18(27)10-31-22/h3-8,10,12H,11,13H2,1-2H3,(H2,29,33)(H,32,36)	UQNSZONADWWBQT-UHFFFAOYSA-N	392643	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-5-cyano-1H-pyrazolo[3,4- c]pyridine-3-carboxamide::US10301284, Example 130::US10781200, Example 130	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392643	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392643&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178150	404960971							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957302	COc1ncnc2n(Cc3ccc4ncc(Cl)cc4c3)cc(C(=O)NCc3c(C)cc(N)nc3C)c12	InChI=1S/C26H24ClN7O2/c1-14-6-22(28)33-15(2)19(14)10-30-25(35)20-12-34(24-23(20)26(36-3)32-13-31-24)11-16-4-5-21-17(7-16)8-18(27)9-29-21/h4-9,12-13H,10-11H2,1-3H3,(H2,28,33)(H,30,35)	CBZIOLZYDJEJLE-UHFFFAOYSA-N	392644	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-7-((3-chloroquinolin-6- yl)methyl)-4-methoxy-7H-pyrrolo[2,3- d]pyrimidine-5-carboxamide::US10301284, Example 131::US10781200, Example 131	Plasma kallikrein			 550							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392644	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392644&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178648	404960972							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957303	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)c2nc[nH]c(=O)c12	InChI=1S/C25H22ClN7O2/c1-13-5-21(27)32-14(2)18(13)9-29-24(34)19-11-33(23-22(19)25(35)31-12-30-23)10-15-3-4-20-16(6-15)7-17(26)8-28-20/h3-8,11-12H,9-10H2,1-2H3,(H2,27,32)(H,29,34)(H,30,31,35)	ZHYZSRYMWVTPNS-UHFFFAOYSA-N	392645	BDBM463686::N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-7-((3-chloroquinolin-6- yl)methyl)-4-oxo-4,7-dihydro-3H- pyrrolo[2,3-d]pyrimidine-5- carboxamide::US10301284, Example 132	Plasma kallikrein			>10000							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392645	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392645&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			146012340	404960973							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957304	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)c2ccnc(C#N)c12	InChI=1S/C27H22ClN7O/c1-15-7-25(30)34-16(2)20(15)12-33-27(36)21-14-35(24-5-6-31-23(10-29)26(21)24)13-17-3-4-22-18(8-17)9-19(28)11-32-22/h3-9,11,14H,12-13H2,1-2H3,(H2,30,34)(H,33,36)	FBWMCRMTDWAWGR-UHFFFAOYSA-N	392646	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-4-cyano-1H-pyrrolo[3,2- c]pyridine-3-carboxamide::US10301284, Example 133::US10781200, Example 133	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392646	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392646&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178831	404960974							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957305	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)c2cnc(cc12)C#N	InChI=1S/C27H22ClN7O/c1-15-5-26(30)34-16(2)22(15)11-33-27(36)23-14-35(25-12-31-20(9-29)8-21(23)25)13-17-3-4-24-18(6-17)7-19(28)10-32-24/h3-8,10,12,14H,11,13H2,1-2H3,(H2,30,34)(H,33,36)	ZZZYLKQDEHLLEY-UHFFFAOYSA-N	392647	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-5-cyano-1H-pyrrolo[2,3- c]pyridine-3-carboxamide::US10301284, Example 134::US10781200, Example 134	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392647	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392647&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178983	404960975							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957306	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)c2ncc(cc12)C#N	InChI=1S/C27H22ClN7O/c1-15-5-25(30)34-16(2)22(15)12-33-27(36)23-14-35(26-21(23)7-18(9-29)10-32-26)13-17-3-4-24-19(6-17)8-20(28)11-31-24/h3-8,10-11,14H,12-13H2,1-2H3,(H2,30,34)(H,33,36)	XUQVNZYJNNIDSK-UHFFFAOYSA-N	392648	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-5-cyano-1H-pyrrolo[2,3- b]pyridine-3-carboxamide::US10301284, Example 135::US10781200, Example 135	Plasma kallikrein			 550							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392648	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392648&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134177819	404960976							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957307	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)c2ncnc(C#N)c12	InChI=1S/C26H21ClN8O/c1-14-5-23(29)34-15(2)19(14)10-31-26(36)20-12-35(25-24(20)22(8-28)32-13-33-25)11-16-3-4-21-17(6-16)7-18(27)9-30-21/h3-7,9,12-13H,10-11H2,1-2H3,(H2,29,34)(H,31,36)	JEVRMRCQEQRXPS-UHFFFAOYSA-N	392649	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-7-((3-chloroquinolin-6- yl)methyl)-4-cyano-7H-pyrrolo[2,3- d]pyrimidine-5-carboxamide::US10301284, Example 136::US10781200, Example 136	Plasma kallikrein			 550							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392649	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392649&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178388	404960977							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957308	COc1ccc2n(Cc3ccc4ncc(Cl)cc4c3)nc(C(=O)NCc3c(C)cc(N)nc3C)c2n1	InChI=1S/C26H24ClN7O2/c1-14-8-22(28)31-15(2)19(14)12-30-26(35)25-24-21(6-7-23(32-24)36-3)34(33-25)13-16-4-5-20-17(9-16)10-18(27)11-29-20/h4-11H,12-13H2,1-3H3,(H2,28,31)(H,30,35)	ZSWVBLZEEQRHJX-UHFFFAOYSA-N	392650	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-5-methoxy-1H- pyrazolo[4,3-b]pyridine-3- carboxamide::US10301284, Example 137::US10781200, Example 137	Plasma kallikrein			 550							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392650	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392650&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178404	404960978							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957309	Cc1cc(N)nc(C)c1CNC(=O)c1nn(Cc2ccc3ncc(Cl)cc3c2)c2ccc(=O)[nH]c12	InChI=1S/C25H22ClN7O2/c1-13-7-21(27)30-14(2)18(13)11-29-25(35)24-23-20(5-6-22(34)31-23)33(32-24)12-15-3-4-19-16(8-15)9-17(26)10-28-19/h3-10H,11-12H2,1-2H3,(H2,27,30)(H,29,35)(H,31,34)	MSXCHOPMBMEYQZ-UHFFFAOYSA-N	392651	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-5-oxo-4,5-dihydro-1H- pyrazolo[4,3-b]pyridine-3- carboxamide::US10301284, Example 138::US10781200, Example 138	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392651	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392651&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			146012341	404960979							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957310	Cc1nc(N)ccc1CNC(=O)c1nn(Cc2ccc3ncc(Cl)cc3c2)c2ccc(=O)[nH]c12	InChI=1S/C24H20ClN7O2/c1-13-15(3-6-20(26)29-13)10-28-24(34)23-22-19(5-7-21(33)30-22)32(31-23)12-14-2-4-18-16(8-14)9-17(25)11-27-18/h2-9,11H,10,12H2,1H3,(H2,26,29)(H,28,34)(H,30,33)	SUSGOGCPZRQBIA-UHFFFAOYSA-N	392652	N-((6-amino-2-methylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-5-oxo-4,5-dihydro-1H- pyrazolo[4,3-b]pyridine-3- carboxamide::US10301284, Example 139::US10781200, Example 139	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392652	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392652&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			146012342	404960980							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957311	Cc1cc(N)nc(C)c1CNC(=O)c1n(Cc2ccc3ncc(Cl)cc3c2)nc2cccc(N)c12	InChI=1S/C26H24ClN7O/c1-14-8-23(29)32-15(2)19(14)12-31-26(35)25-24-20(28)4-3-5-22(24)33-34(25)13-16-6-7-21-17(9-16)10-18(27)11-30-21/h3-11H,12-13,28H2,1-2H3,(H2,29,32)(H,31,35)	VXICWXMHAZNFJG-UHFFFAOYSA-N	392653	4-amino-N-((6-amino-2,4- dimethylpyridin-3-yl)methyl)-2-((3- chloroquinolin-6-yl)methyl)-2H- indazole-3-carboxamide::US10301284, Example 140::US10781200, Example 140	Plasma kallikrein			>10000							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392653	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392653&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			138658600	404960981							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957312	Cc1cc(N)nc(C)c1CNC(=O)c1c(nnn1Cc1ccc2ncc(Cl)cc2c1)C(F)(F)F	InChI=1S/C22H19ClF3N7O/c1-11-5-18(27)30-12(2)16(11)9-29-21(34)19-20(22(24,25)26)31-32-33(19)10-13-3-4-17-14(6-13)7-15(23)8-28-17/h3-8H,9-10H2,1-2H3,(H2,27,30)(H,29,34)	YRRIRNYGGYIAHF-UHFFFAOYSA-N	392654	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-4-(trifluoromethyl)-1H- 1,2,3-triazole-5-carboxamide::US10301284, Example 141::US10781200, Example 141	Plasma kallikrein			>10000							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392654	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392654&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178148	404960982							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957313	CCOC(=O)c1nc(nn1Cc1ccc2ncc(Cl)cc2c1)C(=O)NCc1c(C)cc(N)nc1C	InChI=1S/C24H24ClN7O3/c1-4-35-24(34)22-30-21(23(33)28-11-18-13(2)7-20(26)29-14(18)3)31-32(22)12-15-5-6-19-16(8-15)9-17(25)10-27-19/h5-10H,4,11-12H2,1-3H3,(H2,26,29)(H,28,33)	FCYBAWFLNBGASR-UHFFFAOYSA-N	392655	US10301284, Example 142::US10781200, Example 142::ethyl 3-(((6-amino-2,4- dimethylpyridin-3- yl)methyl)carbamoyl)-1-((3- chloroquinolin-6-yl)methyl)-1H-1,2,4- triazole-5-carboxylate	Plasma kallikrein			>10000							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392655	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392655&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135354644	404960983							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956797	Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCOc1cccc(Cl)c1	InChI=1S/C25H24ClN5O3/c26-20-4-3-5-21(14-20)34-13-11-28-25(33)22-17-31(29-24(22)27)16-19-9-7-18(8-10-19)15-30-12-2-1-6-23(30)32/h1-10,12,14,17H,11,13,15-16H2,(H2,27,29)(H,28,33)	BKOMRHGWSXFZSH-UHFFFAOYSA-N	463332	3-Amino-1-[(4-(2-oxo-2H-pyridin-1-ylmethyl)-benzyl]-1H-pyrazole-4-carboxylic acid [2-(3-chloro-phenoxy)-ethyl]-amide::US10781181, Example 1	Plasma kallikrein			 2.90							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463332	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463332&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			132043552	441573178							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956799	Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCC(=O)Nc1cccc(Cl)c1	InChI=1S/C25H23ClN6O3/c26-19-4-3-5-20(12-19)29-22(33)13-28-25(35)21-16-32(30-24(21)27)15-18-9-7-17(8-10-18)14-31-11-2-1-6-23(31)34/h1-12,16H,13-15H2,(H2,27,30)(H,28,35)(H,29,33)	PDHPGDWMHDVKPX-UHFFFAOYSA-N	463333	3-Amino-1-[4-(2-oxo-2H-pyridin-1-ylmethyl)-benzyl]-1H-pyrazole-4-carboxylic acid [(3-chloro-phenylcarbamoyl)-methyl]-amide]::US10781181, Example 2	Plasma kallikrein			 60.2							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463333	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463333&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			132043553	441573179							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956801	C[C@@H](CNC(=O)c1cn(Cc2ccc(Cn3ccccc3=O)cc2)nc1N)Oc1cccc(Cl)c1	InChI=1S/C26H26ClN5O3/c1-18(35-22-6-4-5-21(27)13-22)14-29-26(34)23-17-32(30-25(23)28)16-20-10-8-19(9-11-20)15-31-12-3-2-7-24(31)33/h2-13,17-18H,14-16H2,1H3,(H2,28,30)(H,29,34)/t18-/m0/s1	ILFFTOFUUCFIFF-SFHVURJKSA-N	463334	3-Amino-N-[(2S)-2-(3-chlorophenoxy)propyl]-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)-pyrazole-4-carboxamide::US10781181, Example 115	Plasma kallikrein			 5.60							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463334	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463334&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364589	441573180							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956803	CNc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCOc1cccc(Cl)c1	InChI=1S/C26H26ClN5O3/c1-28-25-23(26(34)29-12-14-35-22-6-4-5-21(27)15-22)18-32(30-25)17-20-10-8-19(9-11-20)16-31-13-3-2-7-24(31)33/h2-11,13,15,18H,12,14,16-17H2,1H3,(H,28,30)(H,29,34)	LNZQMEQPMVGJKW-UHFFFAOYSA-N	463335	N-[2-(3-Chlorophenoxy)ethyl]-3-(methylamino)-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US10781181, Example 37	Plasma kallikrein			 18.5							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463335	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463335&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364636	441573181							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956805	Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCC(=O)Nc1ccccc1Cl	InChI=1S/C25H23ClN6O3/c26-20-5-1-2-6-21(20)29-22(33)13-28-25(35)19-16-32(30-24(19)27)15-18-10-8-17(9-11-18)14-31-12-4-3-7-23(31)34/h1-12,16H,13-15H2,(H2,27,30)(H,28,35)(H,29,33)	HYDFMOJNDSHUST-UHFFFAOYSA-N	463336	2-{[3-amino-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)pyrazol-4-yl]formamido}-::US10781181, Example 3	Plasma kallikrein			 5530							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463336	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463336&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			132017352	441573182							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956807	Cc1ccc(NC(=O)CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2N)cc1	InChI=1S/C26H26N6O3/c1-18-5-11-21(12-6-18)29-23(33)14-28-26(35)22-17-32(30-25(22)27)16-20-9-7-19(8-10-20)15-31-13-3-2-4-24(31)34/h2-13,17H,14-16H2,1H3,(H2,27,30)(H,28,35)(H,29,33)	IKOCGZFEXKVBPW-UHFFFAOYSA-N	463337	2-{[3-amino-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)pyrazol-4-yl]formamido}-::US10781181, Example 4	Plasma kallikrein			>10000							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463337	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463337&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155921789	441573183							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956809	Clc1cccc(OCCNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2C2CC2)c1	InChI=1S/C28H27ClN4O3/c29-23-4-3-5-24(16-23)36-15-13-30-28(35)25-19-33(31-27(25)22-11-12-22)18-21-9-7-20(8-10-21)17-32-14-2-1-6-26(32)34/h1-10,14,16,19,22H,11-13,15,17-18H2,(H,30,35)	IADVHCUBEXJOLV-UHFFFAOYSA-N	463338	N-[2-(3-chlorophenoxy)ethyl]-3-cyclopropyl-1-({4-[(2-oxopyridin-1-::US10781181, Example 5	Plasma kallikrein			 68.4							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463338	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463338&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364597	441573184							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956811	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCOc1ccccc1Cl	InChI=1S/C27H27ClN4O4/c1-35-19-24-22(27(34)29-13-15-36-25-7-3-2-6-23(25)28)18-32(30-24)17-21-11-9-20(10-12-21)16-31-14-5-4-8-26(31)33/h2-12,14,18H,13,15-17,19H2,1H3,(H,29,34)	WZRSDBUPAAXQBT-UHFFFAOYSA-N	463339	N-[2-(2-chlorophenoxy)ethyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-::US10781181, Example 6	Plasma kallikrein			 1890							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463339	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463339&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364697	441573185							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956813	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCOc1cccc(Cl)c1	InChI=1S/C27H27ClN4O4/c1-35-19-25-24(27(34)29-12-14-36-23-6-4-5-22(28)15-23)18-32(30-25)17-21-10-8-20(9-11-21)16-31-13-3-2-7-26(31)33/h2-11,13,15,18H,12,14,16-17,19H2,1H3,(H,29,34)	XNKYTFKDKMLPMD-UHFFFAOYSA-N	463340	N-[2-(3-chlorophenoxy)ethyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-::US10781181, Example 8	Plasma kallikrein			 16.6							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463340	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463340&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364684	441573186							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956815	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCOc1cc(Cl)ccc1F	InChI=1S/C27H26ClFN4O4/c1-36-18-24-22(27(35)30-11-13-37-25-14-21(28)9-10-23(25)29)17-33(31-24)16-20-7-5-19(6-8-20)15-32-12-3-2-4-26(32)34/h2-10,12,14,17H,11,13,15-16,18H2,1H3,(H,30,35)	VSFNMIHOXZTLHK-UHFFFAOYSA-N	463341	N-[2-(5-chloro-2-fluorophenoxy)ethyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-::US10781181, Example 9	Plasma kallikrein			 191							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463341	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463341&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364614	441573187							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956817	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCOc1cc(F)cc(Cl)c1	InChI=1S/C27H26ClFN4O4/c1-36-18-25-24(27(35)30-9-11-37-23-13-21(28)12-22(29)14-23)17-33(31-25)16-20-7-5-19(6-8-20)15-32-10-3-2-4-26(32)34/h2-8,10,12-14,17H,9,11,15-16,18H2,1H3,(H,30,35)	PESKEKJIRKNHGR-UHFFFAOYSA-N	463342	N-[2-(3-chloro-5-fluorophenoxy)ethyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-::US10781181, Example 10	Plasma kallikrein			 134							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463342	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463342&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364644	441573188							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956819	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCOc1cc(Cl)cc(OC)c1	InChI=1S/C28H29ClN4O5/c1-36-19-26-25(28(35)30-10-12-38-24-14-22(29)13-23(15-24)37-2)18-33(31-26)17-21-8-6-20(7-9-21)16-32-11-4-3-5-27(32)34/h3-9,11,13-15,18H,10,12,16-17,19H2,1-2H3,(H,30,35)	OJDVRNWBYOTOAD-UHFFFAOYSA-N	463343	N-[2-(3-chloro-5-methoxyphenoxy)ethyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-::US10781181, Example 11	Plasma kallikrein			>10000							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463343	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463343&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364623	441573189							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956821	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCOc1ccc(F)c(Cl)c1	InChI=1S/C27H26ClFN4O4/c1-36-18-25-22(27(35)30-11-13-37-21-9-10-24(29)23(28)14-21)17-33(31-25)16-20-7-5-19(6-8-20)15-32-12-3-2-4-26(32)34/h2-10,12,14,17H,11,13,15-16,18H2,1H3,(H,30,35)	YUQJMTWNZZCIDE-UHFFFAOYSA-N	463344	N-[2-(3-chloro-4-fluorophenoxy)ethyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-::US10781181, Example 12	Plasma kallikrein			 266							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463344	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463344&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364572	441573190							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956823	Cc1ccc(Cl)cc1OCCNC(=O)c1cn(Cc2ccc(Cn3ccccc3=O)cc2)nc1N	InChI=1S/C26H26ClN5O3/c1-18-5-10-21(27)14-23(18)35-13-11-29-26(34)22-17-32(30-25(22)28)16-20-8-6-19(7-9-20)15-31-12-3-2-4-24(31)33/h2-10,12,14,17H,11,13,15-16H2,1H3,(H2,28,30)(H,29,34)	HIPKPQWZXBVAPK-UHFFFAOYSA-N	463346	3-amino-N-[2-(5-chloro-2-methylphenoxy)ethyl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 14	Plasma kallikrein			 161							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463346	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463346&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364628	441573192							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956825	Cc1ccc(OCCNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2N)cc1Cl	InChI=1S/C26H26ClN5O3/c1-18-5-10-21(14-23(18)27)35-13-11-29-26(34)22-17-32(30-25(22)28)16-20-8-6-19(7-9-20)15-31-12-3-2-4-24(31)33/h2-10,12,14,17H,11,13,15-16H2,1H3,(H2,28,30)(H,29,34)	UAYOLTXUOBQDMG-UHFFFAOYSA-N	463347	3-amlno-N-[2-(3-chloro-4-methylphenoxy)ethyl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 15	Plasma kallikrein			 24.6							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463347	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463347&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364584	441573193							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956827	Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCOc1cccc(Cl)c1Cl	InChI=1S/C25H23Cl2N5O3/c26-20-4-3-5-21(23(20)27)35-13-11-29-25(34)19-16-32(30-24(19)28)15-18-9-7-17(8-10-18)14-31-12-2-1-6-22(31)33/h1-10,12,16H,11,13-15H2,(H2,28,30)(H,29,34)	ZGCKBZMPZCZLKY-UHFFFAOYSA-N	463348	3-amino-N-[2-(2,3-dichlorophenoxy}ethyl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 29	Plasma kallikrein			 2930							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463348	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463348&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			132017320	441573194							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956829	Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCOc1ccc(Cl)c(Cl)c1	InChI=1S/C25H23Cl2N5O3/c26-21-9-8-19(13-22(21)27)35-12-10-29-25(34)20-16-32(30-24(20)28)15-18-6-4-17(5-7-18)14-31-11-2-1-3-23(31)33/h1-9,11,13,16H,10,12,14-15H2,(H2,28,30)(H,29,34)	SPBVCSNNKRGRGB-UHFFFAOYSA-N	463349	3-amino-N-[2-(3,4-dichlorophenoxy}ethyl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 30	Plasma kallikrein			 96.8							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463349	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463349&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364637	441573195							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956831	Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCOc1cc(Cl)cc(Cl)c1	InChI=1S/C25H23Cl2N5O3/c26-19-11-20(27)13-21(12-19)35-10-8-29-25(34)22-16-32(30-24(22)28)15-18-6-4-17(5-7-18)14-31-9-2-1-3-23(31)33/h1-7,9,11-13,16H,8,10,14-15H2,(H2,28,30)(H,29,34)	WQUFZLCASNVIRK-UHFFFAOYSA-N	463350	3-amino-N-[2-(3,5-dichlorophenoxy)ethyl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 31	Plasma kallikrein			 646							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463350	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463350&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			132017339	441573196							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956833	Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCOc1cc(Cl)ccc1C#N	InChI=1S/C26H23ClN6O3/c27-21-9-8-20(14-28)23(13-21)36-12-10-30-26(35)22-17-33(31-25(22)29)16-19-6-4-18(5-7-19)15-32-11-2-1-3-24(32)34/h1-9,11,13,17H,10,12,15-16H2,(H2,29,31)(H,30,35)	PXPGXHDNNKEEMC-UHFFFAOYSA-N	463351	3-amino-N-[2-(5-chloro-2-cyanophenoxy)ethyl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 32	Plasma kallikrein			 10.1							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463351	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463351&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364653	441573197							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956835	Cc1cc(Cl)cc(OCCNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2N)c1	InChI=1S/C26H26ClN5O3/c1-18-12-21(27)14-22(13-18)35-11-9-29-26(34)23-17-32(30-25(23)28)16-20-7-5-19(6-8-20)15-31-10-3-2-4-24(31)33/h2-8,10,12-14,17H,9,11,15-16H2,1H3,(H2,28,30)(H,29,34)	MXRZHBPGBXCCGR-UHFFFAOYSA-N	463352	3-amino-N-[2-(3-chloro-5-methylphenoxy)ethyl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 33	Plasma kallikrein			 114							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463352	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463352&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364632	441573198							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956837	Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCOc1cc(Cl)ccc1Cl	InChI=1S/C25H23Cl2N5O3/c26-19-8-9-21(27)22(13-19)35-12-10-29-25(34)20-16-32(30-24(20)28)15-18-6-4-17(5-7-18)14-31-11-2-1-3-23(31)33/h1-9,11,13,16H,10,12,14-15H2,(H2,28,30)(H,29,34)	VUXFPZIXXCCTOE-UHFFFAOYSA-N	463353	3-amino-N-[2-(2,5-dichlorophenoxy)ethyl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 34	Plasma kallikrein			 92.8							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463353	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463353&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364640	441573199							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956839	CN(C)c1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCOc1cccc(Cl)c1	InChI=1S/C27H28ClN5O3/c1-31(2)26-24(27(35)29-13-15-36-23-7-5-6-22(28)16-23)19-33(30-26)18-21-11-9-20(10-12-21)17-32-14-4-3-8-25(32)34/h3-12,14,16,19H,13,15,17-18H2,1-2H3,(H,29,35)	RNNNIPHZWHWPLM-UHFFFAOYSA-N	463354	N-[2-(3-chlorophenoxy)ethyl]-3-(dimethylamino)-1-({4-[(2-oxopyridin-1-::US10781181, Example 35	Plasma kallikrein			 122							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463354	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463354&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364590	441573200							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956841	Clc1cccc(OCCNC(=O)c2cnn(Cc3ccc(Cn4ccccc4=O)cc3)c2)c1	InChI=1S/C25H23ClN4O3/c26-22-4-3-5-23(14-22)33-13-11-27-25(32)21-15-28-30(18-21)17-20-9-7-19(8-10-20)16-29-12-2-1-6-24(29)31/h1-10,12,14-15,18H,11,13,16-17H2,(H,27,32)	YTKAVTOCDDALCO-UHFFFAOYSA-N	463355	N-[2-(3-chlorophenoxy)ethyl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 36	Plasma kallikrein			 6.10							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463355	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463355&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364612	441573201							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956843	Clc1cccc(OCCNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2C#N)c1	InChI=1S/C26H22ClN5O3/c27-21-4-3-5-22(14-21)35-13-11-29-26(34)23-18-32(30-24(23)15-28)17-20-9-7-19(8-10-20)16-31-12-2-1-6-25(31)33/h1-10,12,14,18H,11,13,16-17H2,(H,29,34)	KPMIBBMTUQEJQB-UHFFFAOYSA-N	463356	N-[2-(3-chlorophenoxy)ethyl]-3-cyano-1-({4-[(2-oxopyridin-1-::US10781181, Example 38	Plasma kallikrein			 6.50							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463356	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463356&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364586	441573202							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956845	Cc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCOc1cccc(Cl)c1	InChI=1S/C26H25ClN4O3/c1-19-24(26(33)28-12-14-34-23-6-4-5-22(27)15-23)18-31(29-19)17-21-10-8-20(9-11-21)16-30-13-3-2-7-25(30)32/h2-11,13,15,18H,12,14,16-17H2,1H3,(H,28,33)	PKQDYDRNWWAIES-UHFFFAOYSA-N	463357	N-[2-(3-chlorophenoxy)ethyl]-3-methyl-1-({4-[(2-oxopyridin-1-::US10781181, Example 39	Plasma kallikrein			 16.3							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463357	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463357&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364647	441573203							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956847	CN(C(=O)CNC(=O)c1cn(Cc2ccc(Cn3ccccc3=O)cc2)nc1N)c1cccc(Cl)c1	InChI=1S/C26H25ClN6O3/c1-31(21-6-4-5-20(27)13-21)24(35)14-29-26(36)22-17-33(30-25(22)28)16-19-10-8-18(9-11-19)15-32-12-3-2-7-23(32)34/h2-13,17H,14-16H2,1H3,(H2,28,30)(H,29,36)	RQXNPQQKWSXANB-UHFFFAOYSA-N	463358	2-{[3-amino-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)pyrazol-4-yl]formamido}-::US10781181, Example 40	Plasma kallikrein			 12.6							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463358	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463358&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364692	441573204							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956849	CN(CCNC(=O)c1cn(Cc2ccc(Cn3ccccc3=O)cc2)nc1N)c1cccc(Cl)c1	InChI=1S/C26H27ClN6O2/c1-31(22-6-4-5-21(27)15-22)14-12-29-26(35)23-18-33(30-25(23)28)17-20-10-8-19(9-11-20)16-32-13-3-2-7-24(32)34/h2-11,13,15,18H,12,14,16-17H2,1H3,(H2,28,30)(H,29,35)	XWTAAEHIDPTKOV-UHFFFAOYSA-N	463359	3-amino-N-{2-[(3-chlorophenyl)(methyl)amino]ethyl}-1-({4-[(2-oxopyridin-1-::US10781181, Example 41	Plasma kallikrein			 264							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463359	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463359&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364625	441573205							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956851	Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCCc1cccc(Cl)c1	InChI=1S/C26H26ClN5O2/c27-22-7-3-5-19(15-22)6-4-13-29-26(34)23-18-32(30-25(23)28)17-21-11-9-20(10-12-21)16-31-14-2-1-8-24(31)33/h1-3,5,7-12,14-15,18H,4,6,13,16-17H2,(H2,28,30)(H,29,34)	SWKMBJSNIGEHAD-UHFFFAOYSA-N	463360	3-amino-N-[3-(3-chlorophenyl)propyl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 42	Plasma kallikrein			 3.20							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463360	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463360&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364656	441573206							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956853	Cc1nc(cn1Cc1ccc(Cn2ccccc2=O)cc1)C(=O)NCCOc1cccc(Cl)c1	InChI=1S/C26H25ClN4O3/c1-19-29-24(26(33)28-12-14-34-23-6-4-5-22(27)15-23)18-31(19)17-21-10-8-20(9-11-21)16-30-13-3-2-7-25(30)32/h2-11,13,15,18H,12,14,16-17H2,1H3,(H,28,33)	BDVFOCNCBZMLBI-UHFFFAOYSA-N	463361	N-[2-(3-chlorophenoxy)ethyl]-2-methyl-1-({4-[(2-oxopyridin-1-::US10781181, Example 43	Plasma kallikrein			 77.0							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463361	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463361&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364615	441573207							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956855	Nc1c(cnn1Cc1ccc(Cn2ccccc2=O)cc1)C(=O)NCCOc1cccc(Cl)c1	InChI=1S/C25H24ClN5O3/c26-20-4-3-5-21(14-20)34-13-11-28-25(33)22-15-29-31(24(22)27)17-19-9-7-18(8-10-19)16-30-12-2-1-6-23(30)32/h1-10,12,14-15H,11,13,16-17,27H2,(H,28,33)	LUJNONBRKHAYKZ-UHFFFAOYSA-N	463362	5-amino-N-[2-(3-chlorophenoxy)ethyl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 17	Plasma kallikrein			 96.0							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463362	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463362&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364616	441573208							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956857	Nc1c(cnn1Cc1ccc2[nH]ncc2c1)C(=O)NCCOc1cccc(Cl)c1	InChI=1S/C20H19ClN6O2/c21-15-2-1-3-16(9-15)29-7-6-23-20(28)17-11-25-27(19(17)22)12-13-4-5-18-14(8-13)10-24-26-18/h1-5,8-11H,6-7,12,22H2,(H,23,28)(H,24,26)	PKPGYVUOAXVWSZ-UHFFFAOYSA-N	463363	5-amino-N-[2-(3-chlorophenoxy)ethyl]-1-(1H-indazol-5-ylmethyl)pyrazole-4-::US10781181, Example 44	Plasma kallikrein			>10000							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463363	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463363&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155921791	441573209							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956859	Nc1c(cnn1Cc1ccc(cc1)C(=O)N1CCCC1)C(=O)NCCOc1cccc(Cl)c1	InChI=1S/C24H26ClN5O3/c25-19-4-3-5-20(14-19)33-13-10-27-23(31)21-15-28-30(22(21)26)16-17-6-8-18(9-7-17)24(32)29-11-1-2-12-29/h3-9,14-15H,1-2,10-13,16,26H2,(H,27,31)	DPXIZJYRSZUBHM-UHFFFAOYSA-N	463364	5-amino-N-[2-(3-chlorophenoxy)ethyl]-1-({4-[(pyrrolidin-1-::US10781181, Example 45	Plasma kallikrein			 6250							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463364	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463364&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364651	441573210							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956861	Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCOc1cncc(Cl)c1	InChI=1S/C24H23ClN6O3/c25-19-11-20(13-27-12-19)34-10-8-28-24(33)21-16-31(29-23(21)26)15-18-6-4-17(5-7-18)14-30-9-2-1-3-22(30)32/h1-7,9,11-13,16H,8,10,14-15H2,(H2,26,29)(H,28,33)	LFFMEKTWQQAJFX-UHFFFAOYSA-N	463365	3-amino-N-{2-[(5-chloropyridin-3-yl)oxy]ethyl}-1-({4-[(2-oxopyridin-1-::US10781181, Example 18	Plasma kallikrein			 2010							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463365	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463365&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364605	441573211							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956863	Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCCn1cc(Cl)cn1	InChI=1S/C23H24ClN7O2/c24-19-12-27-30(15-19)11-3-9-26-23(33)20-16-31(28-22(20)25)14-18-7-5-17(6-8-18)13-29-10-2-1-4-21(29)32/h1-2,4-8,10,12,15-16H,3,9,11,13-14H2,(H2,25,28)(H,26,33)	UTLZLZRSDCQGSD-UHFFFAOYSA-N	463366	3-amino-N-[3-(4-chloropyrazol-1-yl)propyl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 21	Plasma kallikrein			 2790							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463366	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463366&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364655	441573212							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956865	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCOc1cc(Cl)cnn1	InChI=1S/C25H25ClN6O4/c1-35-17-22-21(25(34)27-9-11-36-23-12-20(26)13-28-29-23)16-32(30-22)15-19-7-5-18(6-8-19)14-31-10-3-2-4-24(31)33/h2-8,10,12-13,16H,9,11,14-15,17H2,1H3,(H,27,34)	YMHBACIIJWPZMP-UHFFFAOYSA-N	463367	N-{2-[(5-chloropyridazin-3-yl)oxy]ethyl}-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-::US10781181, Example 46	Plasma kallikrein			>10000							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463367	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463367&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364603	441573213							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956867	Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCNc1cc(Cl)ccn1	InChI=1S/C24H24ClN7O2/c25-19-8-9-27-21(13-19)28-10-11-29-24(34)20-16-32(30-23(20)26)15-18-6-4-17(5-7-18)14-31-12-2-1-3-22(31)33/h1-9,12-13,16H,10-11,14-15H2,(H2,26,30)(H,27,28)(H,29,34)	CMGOOMKRMVBEPY-UHFFFAOYSA-N	463368	3-amino-N-{2-[(4-chloropyridin-2-yl)amino]ethyl}-1-({4-[(2-oxopyridin-1-::US10781181, Example 47	Plasma kallikrein			 30.1							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463368	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463368&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364618	441573214							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956869	COCc1nn(Cc2ccc(Cn3cc(C)cn3)cc2)cc1C(=O)NCCOc1cccc(Cl)c1	InChI=1S/C26H28ClN5O3/c1-19-13-29-31(14-19)15-20-6-8-21(9-7-20)16-32-17-24(25(30-32)18-34-2)26(33)28-10-11-35-23-5-3-4-22(27)12-23/h3-9,12-14,17H,10-11,15-16,18H2,1-2H3,(H,28,33)	YBVHXZVNVMGNJH-UHFFFAOYSA-N	463369	N-[2-(3-chlorophenoxy)ethyl]-3-(methoxymethyl)-1-({4-[(4-methylpyrazol-1-::US10781181, Example 27	Plasma kallikrein			 231							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463369	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463369&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364675	441573215							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956871	Cc1cc(C(=O)NCCOc2cccc(Cl)c2)c(C)n1Cc1csc(n1)-c1ccccc1	InChI=1S/C25H24ClN3O2S/c1-17-13-23(24(30)27-11-12-31-22-10-6-9-20(26)14-22)18(2)29(17)15-21-16-32-25(28-21)19-7-4-3-5-8-19/h3-10,13-14,16H,11-12,15H2,1-2H3,(H,27,30)	GQHOGBSEMUWETE-UHFFFAOYSA-N	463370	N-[2-(3-chlorophenoxy)ethyl]-2,5-dimethyl-1-[(2-phenyl-1,3-thiazol-4-::US10781181, Example 48	Plasma kallikrein			 6620							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463370	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463370&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			132017335	441573216							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956873	Nc1nn(Cc2ccc(nc2)N2CCCC2)cc1C(=O)NCCOc1cccc(Cl)c1	InChI=1S/C22H25ClN6O2/c23-17-4-3-5-18(12-17)31-11-8-25-22(30)19-15-29(27-21(19)24)14-16-6-7-20(26-13-16)28-9-1-2-10-28/h3-7,12-13,15H,1-2,8-11,14H2,(H2,24,27)(H,25,30)	GLDWFNRLYGEHRT-UHFFFAOYSA-N	463371	3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-{[6-(pyrrolidin-1-yl)pyridin-3-::US10781181, Example 49	Plasma kallikrein			 847							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463371	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463371&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364648	441573217							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956875	Nc1nn(Cc2ccnc(c2)N2CCCC2)cc1C(=O)NCCOc1cccc(Cl)c1	InChI=1S/C22H25ClN6O2/c23-17-4-3-5-18(13-17)31-11-8-26-22(30)19-15-29(27-21(19)24)14-16-6-7-25-20(12-16)28-9-1-2-10-28/h3-7,12-13,15H,1-2,8-11,14H2,(H2,24,27)(H,26,30)	AZZMPGUGDWTGGN-UHFFFAOYSA-N	463372	3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-{[2-(pyrrolidin-1-yl)pyridin-4-::US10781181, Example 50	Plasma kallikrein			 326							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463372	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463372&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364617	441573218							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956877	Nc1nn(Cc2ccc(cc2)C(=O)N2CCCC2)cc1C(=O)NCCOc1cccc(Cl)c1	InChI=1S/C24H26ClN5O3/c25-19-4-3-5-20(14-19)33-13-10-27-23(31)21-16-30(28-22(21)26)15-17-6-8-18(9-7-17)24(32)29-11-1-2-12-29/h3-9,14,16H,1-2,10-13,15H2,(H2,26,28)(H,27,31)	SMHRRWCCPUBJDL-UHFFFAOYSA-N	463373	3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-({4-[(pyrrolidin-1-::US10781181, Example 51	Plasma kallikrein			 427							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463373	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463373&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364562	441573219							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956879	Nc1nn(Cc2ccc(cc2)-n2ccccc2=O)cc1C(=O)NCCOc1cccc(Cl)c1	InChI=1S/C24H22ClN5O3/c25-18-4-3-5-20(14-18)33-13-11-27-24(32)21-16-29(28-23(21)26)15-17-7-9-19(10-8-17)30-12-2-1-6-22(30)31/h1-10,12,14,16H,11,13,15H2,(H2,26,28)(H,27,32)	RRMZZTMCFSXHCD-UHFFFAOYSA-N	463374	3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-{[4-(2-oxopyridin-1-::US10781181, Example 52	Plasma kallikrein			 335							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463374	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463374&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364558	441573220							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956881	Nc1nn(Cc2cccc(n2)N2CCCC2)cc1C(=O)NCCOc1cccc(Cl)c1	InChI=1S/C22H25ClN6O2/c23-16-5-3-7-18(13-16)31-12-9-25-22(30)19-15-29(27-21(19)24)14-17-6-4-8-20(26-17)28-10-1-2-11-28/h3-8,13,15H,1-2,9-12,14H2,(H2,24,27)(H,25,30)	JGWRRCJMVWBQES-UHFFFAOYSA-N	463375	3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-{[6-(pyrrolidin-1-yl)pyridin-2-::US10781181, Example 53	Plasma kallikrein			 4730							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463375	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463375&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364624	441573221							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956883	Cc1ccc2cc(Cn3cc(C(=O)NCCOc4cccc(Cl)c4)c(N)n3)ccc2n1	InChI=1S/C23H22ClN5O2/c1-15-5-7-17-11-16(6-8-21(17)27-15)13-29-14-20(22(25)28-29)23(30)26-9-10-31-19-4-2-3-18(24)12-19/h2-8,11-12,14H,9-10,13H2,1H3,(H2,25,28)(H,26,30)	KYJDNTKCQHHXSZ-UHFFFAOYSA-N	463376	3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-[(2-methylquinolin-6-yl)methyl]pyrazole-4-::US10781181, Example 54	Plasma kallikrein			 245							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463376	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463376&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			132017348	441573222							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956885	Nc1nn(Cc2ccc(Br)cc2)cc1C(=O)NCCOc1cccc(Cl)c1	InChI=1S/C19H18BrClN4O2/c20-14-6-4-13(5-7-14)11-25-12-17(18(22)24-25)19(26)23-8-9-27-16-3-1-2-15(21)10-16/h1-7,10,12H,8-9,11H2,(H2,22,24)(H,23,26)	WCUWJEOEEQOSKM-UHFFFAOYSA-N	463377	3-amino-1-[(4-bromophenyl)methyl]-N-[2-(3-chlorophenoxy)ethyl]pyrazole-4-::US10781181, Example 55	Plasma kallikrein			 6410							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463377	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463377&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			132017337	441573223							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956887	Nc1nn(Cc2cccc(Br)c2)cc1C(=O)NCCOc1cccc(Cl)c1	InChI=1S/C19H18BrClN4O2/c20-14-4-1-3-13(9-14)11-25-12-17(18(22)24-25)19(26)23-7-8-27-16-6-2-5-15(21)10-16/h1-6,9-10,12H,7-8,11H2,(H2,22,24)(H,23,26)	KGCHKHMBUCVUST-UHFFFAOYSA-N	463378	3-amino-1-[(3-bromophenyl)methyl]-N-[2-(3-chlorophenoxy)ethyl]pyrazole-4-::US10781181, Example 56	Plasma kallikrein			 8490							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463378	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463378&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			132017364	441573224							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956889	Nc1nn(Cc2cccc(c2)-c2cncs2)cc1C(=O)NCCOc1cccc(Cl)c1	InChI=1S/C22H20ClN5O2S/c23-17-5-2-6-18(10-17)30-8-7-26-22(29)19-13-28(27-21(19)24)12-15-3-1-4-16(9-15)20-11-25-14-31-20/h1-6,9-11,13-14H,7-8,12H2,(H2,24,27)(H,26,29)	GWFWFIUCZRAALU-UHFFFAOYSA-N	463379	3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-{[3-(1,3-thiazol-5-yl)phenyl]methyl}pyrazole-::US10781181, Example 57	Plasma kallikrein			 6830							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463379	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463379&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			132017330	441573225							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956891	COC(=O)c1ccc(Cn2cc(C(=O)NCCOc3cccc(Cl)c3)c(N)n2)cc1	InChI=1S/C21H21ClN4O4/c1-29-21(28)15-7-5-14(6-8-15)12-26-13-18(19(23)25-26)20(27)24-9-10-30-17-4-2-3-16(22)11-17/h2-8,11,13H,9-10,12H2,1H3,(H2,23,25)(H,24,27)	VMWNXMNJZZJVIS-UHFFFAOYSA-N	463380	US10781181, Example 58::methyl 4-[(3-amino-4-{[2-(3-chlorophenoxy)ethyl]carbamoyl}pyrazol-1-	Plasma kallikrein			 5420							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463380	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463380&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364661	441573226							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956893	CN(C)C(=O)c1ccc(Cn2cc(C(=O)NCCOc3cccc(Cl)c3)c(N)n2)cc1	InChI=1S/C22H24ClN5O3/c1-27(2)22(30)16-8-6-15(7-9-16)13-28-14-19(20(24)26-28)21(29)25-10-11-31-18-5-3-4-17(23)12-18/h3-9,12,14H,10-11,13H2,1-2H3,(H2,24,26)(H,25,29)	WPDVWPIECFDCIP-UHFFFAOYSA-N	463381	3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-{[4-::US10781181, Example 59	Plasma kallikrein			>10000							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463381	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463381&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			132017327	441573227							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956895	Nc1nn(Cc2ccc(cc2)C(=O)N2CCCCC2)cc1C(=O)NCCOc1cccc(Cl)c1	InChI=1S/C25H28ClN5O3/c26-20-5-4-6-21(15-20)34-14-11-28-24(32)22-17-31(29-23(22)27)16-18-7-9-19(10-8-18)25(33)30-12-2-1-3-13-30/h4-10,15,17H,1-3,11-14,16H2,(H2,27,29)(H,28,32)	KURGXUOQMFGGER-UHFFFAOYSA-N	463382	3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-({4-[(piperidin-1-::US10781181, Example 60	Plasma kallikrein			>10000							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463382	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463382&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364593	441573228							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956897	CNC(=O)c1ccc(Cn2cc(C(=O)NCCOc3cccc(Cl)c3)c(N)n2)cc1	InChI=1S/C21H22ClN5O3/c1-24-20(28)15-7-5-14(6-8-15)12-27-13-18(19(23)26-27)21(29)25-9-10-30-17-4-2-3-16(22)11-17/h2-8,11,13H,9-10,12H2,1H3,(H2,23,26)(H,24,28)(H,25,29)	GFNAJZVJIOCXDN-UHFFFAOYSA-N	463383	3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-{[4-::US10781181, Example 61	Plasma kallikrein			 7250							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463383	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463383&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			132017355	441573229							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956899	CCOC(=O)c1cccc(Cn2cc(C(=O)NCCOc3cccc(Cl)c3)c(N)n2)c1	InChI=1S/C22H23ClN4O4/c1-2-30-22(29)16-6-3-5-15(11-16)13-27-14-19(20(24)26-27)21(28)25-9-10-31-18-8-4-7-17(23)12-18/h3-8,11-12,14H,2,9-10,13H2,1H3,(H2,24,26)(H,25,28)	KPRMEECKXIGZBV-UHFFFAOYSA-N	463384	US10781181, Example 62::ethyl 3-[(3-amino-4-{[2-(3-chlorophenoxy)ethyl]carbamoyl}pyrazol-1-	Plasma kallikrein			 7150							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463384	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463384&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364577	441573230							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956901	Nc1nn(Cc2cccc(c2)C(O)=O)cc1C(=O)NCCOc1cccc(Cl)c1	InChI=1S/C20H19ClN4O4/c21-15-5-2-6-16(10-15)29-8-7-23-19(26)17-12-25(24-18(17)22)11-13-3-1-4-14(9-13)20(27)28/h1-6,9-10,12H,7-8,11H2,(H2,22,24)(H,23,26)(H,27,28)	BKBNAGUSMQXXCX-UHFFFAOYSA-N	463385	3-[(3-amino-4-{[2-(3-chlorophenoxy)ethyl]carbamoyl}pyrazol-1-yl)methyl]benzoic acid::US10781181, Example 63	Plasma kallikrein			>10000							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463385	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463385&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364702	441573231							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956903	CNC(=O)c1cccc(Cn2cc(C(=O)NCCOc3cccc(Cl)c3)c(N)n2)c1	InChI=1S/C21H22ClN5O3/c1-24-20(28)15-5-2-4-14(10-15)12-27-13-18(19(23)26-27)21(29)25-8-9-30-17-7-3-6-16(22)11-17/h2-7,10-11,13H,8-9,12H2,1H3,(H2,23,26)(H,24,28)(H,25,29)	UHMBFUDKJCHANI-UHFFFAOYSA-N	463386	3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-{[3-::US10781181, Example 64	Plasma kallikrein			>10000							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463386	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463386&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			132017365	441573232							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956905	CN(C)C(=O)c1cccc(Cn2cc(C(=O)NCCOc3cccc(Cl)c3)c(N)n2)c1	InChI=1S/C22H24ClN5O3/c1-27(2)22(30)16-6-3-5-15(11-16)13-28-14-19(20(24)26-28)21(29)25-9-10-31-18-8-4-7-17(23)12-18/h3-8,11-12,14H,9-10,13H2,1-2H3,(H2,24,26)(H,25,29)	GBDMHOKBAITSTR-UHFFFAOYSA-N	463387	3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-{[3-::US10781181, Example 65	Plasma kallikrein			>10000							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463387	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463387&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			132017370	441573233							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956907	Nc1nn(Cc2ccnc(c2)-n2cccn2)cc1C(=O)NCCOc1cccc(Cl)c1	InChI=1S/C21H20ClN7O2/c22-16-3-1-4-17(12-16)31-10-8-25-21(30)18-14-28(27-20(18)23)13-15-5-7-24-19(11-15)29-9-2-6-26-29/h1-7,9,11-12,14H,8,10,13H2,(H2,23,27)(H,25,30)	QAJNKGHUEALUSN-UHFFFAOYSA-N	463388	3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-{[2-(pyrazol-1-yl)pyridin-4-yl]methyl}pyrazole-::US10781181, Example 66	Plasma kallikrein			 4920							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463388	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463388&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364626	441573234							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956909	CN(CC(O)=O)c1cc(Cn2cc(C(=O)NCCOc3cccc(Cl)c3)c(N)n2)ccn1	InChI=1S/C21H23ClN6O4/c1-27(13-19(29)30)18-9-14(5-6-24-18)11-28-12-17(20(23)26-28)21(31)25-7-8-32-16-4-2-3-15(22)10-16/h2-6,9-10,12H,7-8,11,13H2,1H3,(H2,23,26)(H,25,31)(H,29,30)	WFNSOYUNKXGJOG-UHFFFAOYSA-N	463389	({4-[(3-amino-4-{[2-(3-chlorophenoxy)ethyl]carbamoyl}pyrazol-1-yl)methyl]pyridin-2-::US10781181, Example 67	Plasma kallikrein			>10000							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463389	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463389&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364645	441573235							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956911	CNC(=O)CNc1cc(Cn2cc(C(=O)NCCOc3cccc(Cl)c3)c(N)n2)ccn1	InChI=1S/C21H24ClN7O3/c1-24-19(30)11-27-18-9-14(5-6-25-18)12-29-13-17(20(23)28-29)21(31)26-7-8-32-16-4-2-3-15(22)10-16/h2-6,9-10,13H,7-8,11-12H2,1H3,(H2,23,28)(H,24,30)(H,25,27)(H,26,31)	RZRWVFIJPHJJEA-UHFFFAOYSA-N	463390	3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-[(2-::US10781181, Example 68	Plasma kallikrein			>10000							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463390	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463390&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			132017351	441573236							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956913	Nc1nn(Cc2ccc(cc2)C(O)=O)cc1C(=O)NCCOc1cccc(Cl)c1	InChI=1S/C20H19ClN4O4/c21-15-2-1-3-16(10-15)29-9-8-23-19(26)17-12-25(24-18(17)22)11-13-4-6-14(7-5-13)20(27)28/h1-7,10,12H,8-9,11H2,(H2,22,24)(H,23,26)(H,27,28)	IGGDLOGITQRPBW-UHFFFAOYSA-N	463391	4-[(3-amino-4-{[2-(3-chlorophenoxy)ethyl]carbamoyl}pyrazol-1-yl)methyl]benzoic acid::US10781181, Example 69	Plasma kallikrein			>10000							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463391	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463391&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364574	441573237							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956915	Nc1nn(Cc2cccc(c2)C(=O)N2CCCC2)cc1C(=O)NCCOc1cccc(Cl)c1	InChI=1S/C24H26ClN5O3/c25-19-7-4-8-20(14-19)33-12-9-27-23(31)21-16-30(28-22(21)26)15-17-5-3-6-18(13-17)24(32)29-10-1-2-11-29/h3-8,13-14,16H,1-2,9-12,15H2,(H2,26,28)(H,27,31)	FDSBGTCPRVRSDQ-UHFFFAOYSA-N	463392	3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-({3-[(pyrrolidin-1-::US10781181, Example 70	Plasma kallikrein			>10000							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463392	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463392&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364564	441573238							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956917	Nc1nn(Cc2ccc(Oc3ccccc3)cc2)cc1C(=O)NCCOc1cccc(Cl)c1	InChI=1S/C25H23ClN4O3/c26-19-5-4-8-22(15-19)32-14-13-28-25(31)23-17-30(29-24(23)27)16-18-9-11-21(12-10-18)33-20-6-2-1-3-7-20/h1-12,15,17H,13-14,16H2,(H2,27,29)(H,28,31)	AMXRUKQUJVHMDM-UHFFFAOYSA-N	463393	3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-[(4-phenoxyphenyl)methyl]pyrazole-4-::US10781181, Example 71	Plasma kallikrein			 2070							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463393	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463393&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			132017359	441573239							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956919	Nc1nn(Cc2cccc(n2)-c2ccccc2)cc1C(=O)NCCOc1cccc(Cl)c1	InChI=1S/C24H22ClN5O2/c25-18-8-4-10-20(14-18)32-13-12-27-24(31)21-16-30(29-23(21)26)15-19-9-5-11-22(28-19)17-6-2-1-3-7-17/h1-11,14,16H,12-13,15H2,(H2,26,29)(H,27,31)	GHIFXYCOHYHNQO-UHFFFAOYSA-N	463394	3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-[(6-phenylpyridin-2-yl)methyl]pyrazole-4-::US10781181, Example 72	Plasma kallikrein			 5940							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463394	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463394&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			132017347	441573240							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956921	Nc1nn(Cc2ccnc(O)c2)cc1C(=O)NCCOc1cccc(Cl)c1	InChI=1S/C18H18ClN5O3/c19-13-2-1-3-14(9-13)27-7-6-22-18(26)15-11-24(23-17(15)20)10-12-4-5-21-16(25)8-12/h1-5,8-9,11H,6-7,10H2,(H2,20,23)(H,21,25)(H,22,26)	TXXBXGLFCIWMSJ-UHFFFAOYSA-N	463395	3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-[(2-methoxypyridin-4-yl)methyl]pyrazole-4-::US10781181, Example 73	Plasma kallikrein			>10000							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463395	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463395&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155921792	441573241							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956923	CNC(=O)CN(C)c1cc(Cn2cc(C(=O)NCCOc3cccc(Cl)c3)c(N)n2)ccn1	InChI=1S/C22H26ClN7O3/c1-25-20(31)14-29(2)19-10-15(6-7-26-19)12-30-13-18(21(24)28-30)22(32)27-8-9-33-17-5-3-4-16(23)11-17/h3-7,10-11,13H,8-9,12,14H2,1-2H3,(H2,24,28)(H,25,31)(H,27,32)	BLLCAAPQWVZPQS-UHFFFAOYSA-N	463396	3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-[(2-::US10781181, Example 74	Plasma kallikrein			>10000							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463396	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463396&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			132017342	441573242							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956925	Nc1nn(Cc2ccc(COc3ncccn3)cc2)cc1C(=O)NCCOc1cccc(Cl)c1	InChI=1S/C24H23ClN6O3/c25-19-3-1-4-20(13-19)33-12-11-27-23(32)21-15-31(30-22(21)26)14-17-5-7-18(8-6-17)16-34-24-28-9-2-10-29-24/h1-10,13,15H,11-12,14,16H2,(H2,26,30)(H,27,32)	YIZFEKGERFZRIT-UHFFFAOYSA-N	463397	3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-({4-[(pyrimidin-2-::US10781181, Example 75	Plasma kallikrein			 3670							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463397	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463397&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			132017329	441573243							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956927	Nc1nn(Cc2ccc(CN3CCOCC3=O)cc2)cc1C(=O)NCCOc1cccc(Cl)c1	InChI=1S/C24H26ClN5O4/c25-19-2-1-3-20(12-19)34-10-8-27-24(32)21-15-30(28-23(21)26)14-18-6-4-17(5-7-18)13-29-9-11-33-16-22(29)31/h1-7,12,15H,8-11,13-14,16H2,(H2,26,28)(H,27,32)	ZQQDEPIFGBWRCU-UHFFFAOYSA-N	463398	3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-({4-[(3-oxomorpholin-4-::US10781181, Example 76	Plasma kallikrein			 227							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463398	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463398&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			132017319	441573244							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956929	Nc1nn(Cc2ccc(CN3CCCCC3=O)cc2)cc1C(=O)NCCOc1cccc(Cl)c1	InChI=1S/C25H28ClN5O3/c26-20-4-3-5-21(14-20)34-13-11-28-25(33)22-17-31(29-24(22)27)16-19-9-7-18(8-10-19)15-30-12-2-1-6-23(30)32/h3-5,7-10,14,17H,1-2,6,11-13,15-16H2,(H2,27,29)(H,28,33)	ODYDFHAUZLVWPR-UHFFFAOYSA-N	463399	3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-({4-[(2-oxopiperidin-1-::US10781181, Example 77	Plasma kallikrein			 112							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463399	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463399&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364598	441573245							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956931	CNC(=O)CNc1ccc(Cn2cc(C(=O)NCCOc3cccc(Cl)c3)c(N)n2)cn1	InChI=1S/C21H24ClN7O3/c1-24-19(30)11-27-18-6-5-14(10-26-18)12-29-13-17(20(23)28-29)21(31)25-7-8-32-16-4-2-3-15(22)9-16/h2-6,9-10,13H,7-8,11-12H2,1H3,(H2,23,28)(H,24,30)(H,25,31)(H,26,27)	BURQMAPZDBUBPP-UHFFFAOYSA-N	463400	3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-[(6-::US10781181, Example 78	Plasma kallikrein			 6930							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463400	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463400&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			132017324	441573246							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956933	Nc1nn(Cc2ccc(cc2)-c2ncccn2)cc1C(=O)NCCOc1cccc(Cl)c1	InChI=1S/C23H21ClN6O2/c24-18-3-1-4-19(13-18)32-12-11-28-23(31)20-15-30(29-21(20)25)14-16-5-7-17(8-6-16)22-26-9-2-10-27-22/h1-10,13,15H,11-12,14H2,(H2,25,29)(H,28,31)	LACQOZQIBKGKTF-UHFFFAOYSA-N	463401	3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-{[4-(pyrimidin-2-yl)phenyl]methyl}pyrazole-4-::US10781181, Example 79	Plasma kallikrein			 5870							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463401	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463401&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			132017328	441573247							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956935	Nc1nn(Cc2nc(no2)-c2ccccc2)cc1C(=O)NCCOc1cccc(Cl)c1	InChI=1S/C21H19ClN6O3/c22-15-7-4-8-16(11-15)30-10-9-24-21(29)17-12-28(26-19(17)23)13-18-25-20(27-31-18)14-5-2-1-3-6-14/h1-8,11-12H,9-10,13H2,(H2,23,26)(H,24,29)	XOOYNSPFSZXEDK-UHFFFAOYSA-N	463402	3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-[(3-phenyl-1,2,4-oxadiazol-5-::US10781181, Example 80	Plasma kallikrein			 6330							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463402	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463402&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364575	441573248							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956937	Nc1nn(Cc2cccc(Cl)n2)cc1C(=O)NCCOc1cccc(Cl)c1	InChI=1S/C18H17Cl2N5O2/c19-12-3-1-5-14(9-12)27-8-7-22-18(26)15-11-25(24-17(15)21)10-13-4-2-6-16(20)23-13/h1-6,9,11H,7-8,10H2,(H2,21,24)(H,22,26)	RVAUJIMGDCLMMS-UHFFFAOYSA-N	463403	3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-[(6-chloropyridin-2-yl)methyl]pyrazole-4-::US10781181, Example 81	Plasma kallikrein			>10000							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463403	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463403&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			132017341	441573249							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956939	CN(Cc1ccc(Cn2cc(C(=O)NCCOc3cccc(Cl)c3)c(N)n2)cc1)C(C)=O	InChI=1S/C23H26ClN5O3/c1-16(30)28(2)13-17-6-8-18(9-7-17)14-29-15-21(22(25)27-29)23(31)26-10-11-32-20-5-3-4-19(24)12-20/h3-9,12,15H,10-11,13-14H2,1-2H3,(H2,25,27)(H,26,31)	HEHWDOYRLZHDLS-UHFFFAOYSA-N	463404	3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-({4-[(N-::US10781181, Example 82	Plasma kallikrein			 710							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463404	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463404&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			132017363	441573250							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956941	CN(C)C(=O)N(C)Cc1ccc(Cn2cc(C(=O)NCCOc3cccc(Cl)c3)c(N)n2)cc1	InChI=1S/C24H29ClN6O3/c1-29(2)24(33)30(3)14-17-7-9-18(10-8-17)15-31-16-21(22(26)28-31)23(32)27-11-12-34-20-6-4-5-19(25)13-20/h4-10,13,16H,11-12,14-15H2,1-3H3,(H2,26,28)(H,27,32)	VOZTXJYHALVILY-UHFFFAOYSA-N	463405	3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-[(4-::US10781181, Example 83	Plasma kallikrein			 298							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463405	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463405&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			132017346	441573251							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956943	CC(C)C(=O)N(C)Cc1ccc(Cn2cc(C(=O)NCCOc3cccc(Cl)c3)c(N)n2)cc1	InChI=1S/C25H30ClN5O3/c1-17(2)25(33)30(3)14-18-7-9-19(10-8-18)15-31-16-22(23(27)29-31)24(32)28-11-12-34-21-6-4-5-20(26)13-21/h4-10,13,16-17H,11-12,14-15H2,1-3H3,(H2,27,29)(H,28,32)	GMSLMJGHQLOFIR-UHFFFAOYSA-N	463406	3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-({4-[(N,2-::US10781181, Example 84	Plasma kallikrein			 731							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463406	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463406&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			132017343	441573252							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956945	Cc1cccn(Cc2ccc(Cn3cc(C(=O)NCCOc4cccc(Cl)c4)c(N)n3)cc2)c1=O	InChI=1S/C26H26ClN5O3/c1-18-4-3-12-31(26(18)34)15-19-7-9-20(10-8-19)16-32-17-23(24(28)30-32)25(33)29-11-13-35-22-6-2-5-21(27)14-22/h2-10,12,14,17H,11,13,15-16H2,1H3,(H2,28,30)(H,29,33)	LXROWPJGZHKOKV-UHFFFAOYSA-N	463407	3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-({4-[(3-methyl-2-oxopyridin-1-::US10781181, Example 85	Plasma kallikrein			 3.50							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463407	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463407&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364611	441573253							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956947	Nc1nn(Cc2ccc(Cn3cccnc3=O)cc2)cc1C(=O)NCCOc1cccc(Cl)c1	InChI=1S/C24H23ClN6O3/c25-19-3-1-4-20(13-19)34-12-10-27-23(32)21-16-31(29-22(21)26)15-18-7-5-17(6-8-18)14-30-11-2-9-28-24(30)33/h1-9,11,13,16H,10,12,14-15H2,(H2,26,29)(H,27,32)	STLHBGIIMSIYDN-UHFFFAOYSA-N	463408	3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-({4-[(2-oxopyrimidin-1-::US10781181, Example 86	Plasma kallikrein			 30.2							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463408	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463408&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			132017322	441573254							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956949	CN(Cc1ccc(Cn2cc(C(=O)NCCOc3cccc(Cl)c3)c(N)n2)cc1)c1ccccn1	InChI=1S/C26H27ClN6O2/c1-32(24-7-2-3-12-29-24)16-19-8-10-20(11-9-19)17-33-18-23(25(28)31-33)26(34)30-13-14-35-22-6-4-5-21(27)15-22/h2-12,15,18H,13-14,16-17H2,1H3,(H2,28,31)(H,30,34)	DZOWXBNYWKUPJY-UHFFFAOYSA-N	463409	3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-[(4-{[methyl(pyridin-2-::US10781181, Example 87	Plasma kallikrein			 780							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463409	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463409&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364671	441573255							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956951	Nc1nn(Cc2ccc(nc2)-n2cccn2)cc1C(=O)NCCOc1cccc(Cl)c1	InChI=1S/C21H20ClN7O2/c22-16-3-1-4-17(11-16)31-10-8-24-21(30)18-14-28(27-20(18)23)13-15-5-6-19(25-12-15)29-9-2-7-26-29/h1-7,9,11-12,14H,8,10,13H2,(H2,23,27)(H,24,30)	JNIAQDLOTWTIRG-UHFFFAOYSA-N	463410	3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-{[6-(pyrazol-1-yl)pyridin-3-yl]methyl}pyrazole-::US10781181, Example 88	Plasma kallikrein			 9180							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463410	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463410&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364568	441573256							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956953	Cc1cnn(c1)-c1ccc(Cn2cc(C(=O)NCCOc3cccc(Cl)c3)c(N)n2)cn1	InChI=1S/C22H22ClN7O2/c1-15-10-27-30(12-15)20-6-5-16(11-26-20)13-29-14-19(21(24)28-29)22(31)25-7-8-32-18-4-2-3-17(23)9-18/h2-6,9-12,14H,7-8,13H2,1H3,(H2,24,28)(H,25,31)	KGECLGJANPHWDS-UHFFFAOYSA-N	463411	3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-{[6-(4-methylpyrazol-1-yl)pyridin-3-::US10781181, Example 89	Plasma kallikrein			 3350							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463411	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463411&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364666	441573257							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956955	Nc1nn(Cc2nc(Cc3ccccc3)no2)cc1C(=O)NCCOc1cccc(Cl)c1	InChI=1S/C22H21ClN6O3/c23-16-7-4-8-17(12-16)31-10-9-25-22(30)18-13-29(27-21(18)24)14-20-26-19(28-32-20)11-15-5-2-1-3-6-15/h1-8,12-13H,9-11,14H2,(H2,24,27)(H,25,30)	ZAVHRTIPTBDHGV-UHFFFAOYSA-N	463412	3-amino-1-[(3-benzyl-1,2,4-oxadiazol-5-yl)methyl]-N-[2-(3-::US10781181, Example 90	Plasma kallikrein			>10000							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463412	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463412&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364622	441573258							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956957	Nc1nn(Cc2ccnc(c2)-c2cccnc2)cc1C(=O)NCCOc1cccc(Cl)c1	InChI=1S/C23H21ClN6O2/c24-18-4-1-5-19(12-18)32-10-9-28-23(31)20-15-30(29-22(20)25)14-16-6-8-27-21(11-16)17-3-2-7-26-13-17/h1-8,11-13,15H,9-10,14H2,(H2,25,29)(H,28,31)	OJHPZGRDTHCYQP-UHFFFAOYSA-N	463413	3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-{[2-(pyridin-3-yl)pyridin-4-yl]methyl}pyrazole-::US10781181, Example 91	Plasma kallikrein			 3780							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463413	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463413&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			132017325	441573259							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956959	Nc1nn(Cc2ccc3[nH]ncc3c2)cc1C(=O)NCCOc1cccc(Cl)c1	InChI=1S/C20H19ClN6O2/c21-15-2-1-3-16(9-15)29-7-6-23-20(28)17-12-27(26-19(17)22)11-13-4-5-18-14(8-13)10-24-25-18/h1-5,8-10,12H,6-7,11H2,(H2,22,26)(H,23,28)(H,24,25)	FXFRSODTSSHENF-UHFFFAOYSA-N	463415	3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-(1H-indazol-5-ylmethyl)pyrazole-4-::US10781181, Example 92	Plasma kallikrein			>10000							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463415	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463415&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364689	441573261							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956961	Cn1ncc2cc(Cn3cc(C(=O)NCCOc4cccc(Cl)c4)c(N)n3)ccc12	InChI=1S/C21H21ClN6O2/c1-27-19-6-5-14(9-15(19)11-25-27)12-28-13-18(20(23)26-28)21(29)24-7-8-30-17-4-2-3-16(22)10-17/h2-6,9-11,13H,7-8,12H2,1H3,(H2,23,26)(H,24,29)	KWVPJVDKNQQKNI-UHFFFAOYSA-N	463416	3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-[(1-methylindazol-5-yl)methyl]pyrazole-4-::US10781181, Example 93	Plasma kallikrein			>10000							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463416	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463416&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			132017362	441573262							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956963	Nc1nn(Cc2ccnc(c2)N2CCCC2=O)cc1C(=O)NCCOc1cccc(Cl)c1	InChI=1S/C22H23ClN6O3/c23-16-3-1-4-17(12-16)32-10-8-26-22(31)18-14-28(27-21(18)24)13-15-6-7-25-19(11-15)29-9-2-5-20(29)30/h1,3-4,6-7,11-12,14H,2,5,8-10,13H2,(H2,24,27)(H,26,31)	SSVAZIQXGGSLQR-UHFFFAOYSA-N	463417	3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-{[2-(2-oxopyrrolidin-1-yl)pyridin-4-::US10781181, Example 94	Plasma kallikrein			 3140							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463417	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463417&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364585	441573263							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956965	Cc1nc2cc(Cn3cc(C(=O)NCCOc4cccc(Cl)c4)c(N)n3)ccc2n1C	InChI=1S/C22H23ClN6O2/c1-14-26-19-10-15(6-7-20(19)28(14)2)12-29-13-18(21(24)27-29)22(30)25-8-9-31-17-5-3-4-16(23)11-17/h3-7,10-11,13H,8-9,12H2,1-2H3,(H2,24,27)(H,25,30)	VDZWAOLYAZSWEL-UHFFFAOYSA-N	463418	3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-[(1,2-dimethyl-1,3-benzodiazol-5-::US10781181, Example 95	Plasma kallikrein			 1900							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463418	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463418&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364659	441573264							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956967	Nc1nn(Cc2ccc(nc2)N2CCCC2=O)cc1C(=O)NCCOc1cccc(Cl)c1	InChI=1S/C22H23ClN6O3/c23-16-3-1-4-17(11-16)32-10-8-25-22(31)18-14-28(27-21(18)24)13-15-6-7-19(26-12-15)29-9-2-5-20(29)30/h1,3-4,6-7,11-12,14H,2,5,8-10,13H2,(H2,24,27)(H,25,31)	GQBOCGWOKDHASZ-UHFFFAOYSA-N	463419	3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-{[6-(2-oxopyrrolidin-1-yl)pyridin-3-::US10781181, Example 96	Plasma kallikrein			 2230							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463419	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463419&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364662	441573265							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956969	Nc1nn(Cc2ccc(nc2)-c2cccnc2)cc1C(=O)NCCOc1cccc(Cl)c1	InChI=1S/C23H21ClN6O2/c24-18-4-1-5-19(11-18)32-10-9-27-23(31)20-15-30(29-22(20)25)14-16-6-7-21(28-12-16)17-3-2-8-26-13-17/h1-8,11-13,15H,9-10,14H2,(H2,25,29)(H,27,31)	KKVLDHSBIGIPMZ-UHFFFAOYSA-N	463420	3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-{[6-(pyridin-3-yl)pyridin-3-yl]methyl}pyrazole-::US10781181, Example 97	Plasma kallikrein			 1130							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463420	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463420&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			132017357	441573266							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956971	COc1cc(Cn2cc(C(=O)NCCOc3cccc(Cl)c3)c(N)n2)ccc1Cn1ccccc1=O	InChI=1S/C26H26ClN5O4/c1-35-23-13-18(8-9-19(23)16-31-11-3-2-7-24(31)33)15-32-17-22(25(28)30-32)26(34)29-10-12-36-21-6-4-5-20(27)14-21/h2-9,11,13-14,17H,10,12,15-16H2,1H3,(H2,28,30)(H,29,34)	YPTWWJVNXVZQJM-UHFFFAOYSA-N	463421	3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-({3-methoxy-4-[(2-oxopyridin-1-::US10781181, Example 98	Plasma kallikrein			 9.40							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463421	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463421&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364696	441573267							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956973	Nc1nn(Cc2ccc(Cn3c(F)cccc3=O)cc2)cc1C(=O)NCCOc1cccc(Cl)c1	InChI=1S/C25H23ClFN5O3/c26-19-3-1-4-20(13-19)35-12-11-29-25(34)21-16-31(30-24(21)28)14-17-7-9-18(10-8-17)15-32-22(27)5-2-6-23(32)33/h1-10,13,16H,11-12,14-15H2,(H2,28,30)(H,29,34)	HYYVIMQLEHYSJS-UHFFFAOYSA-N	463422	3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-({4-[(2-fluoro-6-oxopyridin-1-::US10781181, Example 99	Plasma kallikrein			 2070							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463422	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463422&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			132017331	441573268							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956975	Nc1nn(Cc2ccc(Cn3cc(F)ccc3=O)cc2)cc1C(=O)NCCOc1cccc(Cl)c1	InChI=1S/C25H23ClFN5O3/c26-19-2-1-3-21(12-19)35-11-10-29-25(34)22-16-32(30-24(22)28)14-18-6-4-17(5-7-18)13-31-15-20(27)8-9-23(31)33/h1-9,12,15-16H,10-11,13-14H2,(H2,28,30)(H,29,34)	KZWKGQOVLZMLEU-UHFFFAOYSA-N	463423	3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-({4-[(5-fluoro-2-oxopyridin-1-::US10781181, Example 100	Plasma kallikrein			 6.20							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463423	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463423&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364592	441573269							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956977	Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2F)cc1C(=O)NCCOc1cccc(Cl)c1	InChI=1S/C25H23ClFN5O3/c26-19-4-3-5-20(13-19)35-11-9-29-25(34)21-16-32(30-24(21)28)15-18-8-7-17(12-22(18)27)14-31-10-2-1-6-23(31)33/h1-8,10,12-13,16H,9,11,14-15H2,(H2,28,30)(H,29,34)	FWNOWWIMXHWURN-UHFFFAOYSA-N	463424	3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-({2-fluoro-4-[(2-oxopyridin-1-::US10781181, Example 101	Plasma kallikrein			 7.60							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463424	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463424&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364669	441573270							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956979	Nc1nn(Cc2ccc(Cn3ccccc3=O)cn2)cc1C(=O)NCCOc1cccc(Cl)c1	InChI=1S/C24H23ClN6O3/c25-18-4-3-5-20(12-18)34-11-9-27-24(33)21-16-31(29-23(21)26)15-19-8-7-17(13-28-19)14-30-10-2-1-6-22(30)32/h1-8,10,12-13,16H,9,11,14-15H2,(H2,26,29)(H,27,33)	CPRWTCGSTDZPML-UHFFFAOYSA-N	463425	3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-({5-[(2-oxopyridin-1-yl)methyl]pyridin-2-::US10781181, Example 102	Plasma kallikrein			 72.1							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463425	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463425&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364639	441573271							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956981	FC(F)(F)c1nn(Cc2ccc(nc2)N2CCCC2)cc1C(=O)NCCOc1cccc(Cl)c1	InChI=1S/C23H23ClF3N5O2/c24-17-4-3-5-18(12-17)34-11-8-28-22(33)19-15-32(30-21(19)23(25,26)27)14-16-6-7-20(29-13-16)31-9-1-2-10-31/h3-7,12-13,15H,1-2,8-11,14H2,(H,28,33)	WWEYVYYGKVXIBW-UHFFFAOYSA-N	463426	N-[2-(3-chlorophenoxy)ethyl]-1-{[6-(pyrrolidin-1-yl)pyridin-3-yl]methyl}-3-::US10781181, Example 28	Plasma kallikrein			 2390							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463426	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463426&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			132017340	441573272							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956983	Cc1nn(Cc2ccc(Cn3ccccc3=O)cc2)c(C)c1C(=O)NCCOc1cccc(Cl)c1	InChI=1S/C27H27ClN4O3/c1-19-26(27(34)29-13-15-35-24-7-5-6-23(28)16-24)20(2)32(30-19)18-22-11-9-21(10-12-22)17-31-14-4-3-8-25(31)33/h3-12,14,16H,13,15,17-18H2,1-2H3,(H,29,34)	SBEUCDJMURUTNS-UHFFFAOYSA-N	463427	N-[2-(3-chlorophenoxy)ethyl]-3,5-dimethyl-1-({4-[(2-oxopyridin-1-::US10781181, Example 103	Plasma kallikrein			>10000							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463427	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463427&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364629	441573273							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956985	COCc1nn(Cc2ccc(Cn3ccc(C)cc3=O)cc2)cc1C(=O)NCCOc1cccc(Cl)c1	InChI=1S/C28H29ClN4O4/c1-20-10-12-32(27(34)14-20)16-21-6-8-22(9-7-21)17-33-18-25(26(31-33)19-36-2)28(35)30-11-13-37-24-5-3-4-23(29)15-24/h3-10,12,14-15,18H,11,13,16-17,19H2,1-2H3,(H,30,35)	FTMLEBBQRKVAFL-UHFFFAOYSA-N	463428	N-[2-(3-chlorophenoxy)ethyl]-3-(methoxymethyl)-1-({4-[(4-methyl-2-oxopyridin-1-::US10781181, Example 104	Plasma kallikrein			 413							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463428	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463428&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364691	441573274							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956987	Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)N[C@H]1CCN(C1)c1cccc(Cl)c1	InChI=1S/C27H27ClN6O2/c28-21-4-3-5-23(14-21)32-13-11-22(17-32)30-27(36)24-18-34(31-26(24)29)16-20-9-7-19(8-10-20)15-33-12-2-1-6-25(33)35/h1-10,12,14,18,22H,11,13,15-17H2,(H2,29,31)(H,30,36)/t22-/m0/s1	QZVBCPBEJSYHNK-QFIPXVFZSA-N	463429	3-amino-N-[(3S)-1-(3-chlorophenyl)pyrrolidin-3-yl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 105	Plasma kallikrein			 3.80							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463429	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463429&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364650	441573275							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956989	Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)N[C@@H]1CCN(C1)c1cccc(Cl)c1	InChI=1S/C27H27ClN6O2/c28-21-4-3-5-23(14-21)32-13-11-22(17-32)30-27(36)24-18-34(31-26(24)29)16-20-9-7-19(8-10-20)15-33-12-2-1-6-25(33)35/h1-10,12,14,18,22H,11,13,15-17H2,(H2,29,31)(H,30,36)/t22-/m1/s1	QZVBCPBEJSYHNK-JOCHJYFZSA-N	463430	3-amino-N-[(3R)-1-(3-chlorophenyl)pyrrolidin-3-yl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 106	Plasma kallikrein			 684							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463430	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463430&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364678	441573276							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956991	Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)N[C@H]1CCN(C1=O)c1cccc(Cl)c1	InChI=1S/C27H25ClN6O3/c28-20-4-3-5-21(14-20)34-13-11-23(27(34)37)30-26(36)22-17-33(31-25(22)29)16-19-9-7-18(8-10-19)15-32-12-2-1-6-24(32)35/h1-10,12,14,17,23H,11,13,15-16H2,(H2,29,31)(H,30,36)/t23-/m0/s1	PLRXGUSRGDVYFS-QHCPKHFHSA-N	463431	3-amino-N-[(3S)-1-(3-chlorophenyl)-2-oxopyrrolidin-3-yl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 107	Plasma kallikrein			 4.80							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463431	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463431&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364607	441573277							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956993	Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)N[C@@H]1CCN(Cc2cccc(Cl)c2)C1	InChI=1S/C28H29ClN6O2/c29-23-5-3-4-22(14-23)15-33-13-11-24(18-33)31-28(37)25-19-35(32-27(25)30)17-21-9-7-20(8-10-21)16-34-12-2-1-6-26(34)36/h1-10,12,14,19,24H,11,13,15-18H2,(H2,30,32)(H,31,37)/t24-/m1/s1	AZEWSURGSXDQEJ-XMMPIXPASA-N	463432	3-amino-N-[(3R)-1-[(3-chlorophenyl)methyl]pyrrolidin-3-yl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 108	Plasma kallikrein			 299							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463432	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463432&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364643	441573278							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956995	Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)N[C@H]1CCN(Cc2cccc(Cl)c2)C1	InChI=1S/C28H29ClN6O2/c29-23-5-3-4-22(14-23)15-33-13-11-24(18-33)31-28(37)25-19-35(32-27(25)30)17-21-9-7-20(8-10-21)16-34-12-2-1-6-26(34)36/h1-10,12,14,19,24H,11,13,15-18H2,(H2,30,32)(H,31,37)/t24-/m0/s1	AZEWSURGSXDQEJ-DEOSSOPVSA-N	463433	3-amino-N-[(3S)-1-[(3-chlorophenyl)methyl]pyrrolidin-3-yl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 109	Plasma kallikrein			 384							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463433	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463433&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364633	441573279							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956997	Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)N[C@@H]1CCN(C1=O)c1cccc(Cl)c1	InChI=1S/C27H25ClN6O3/c28-20-4-3-5-21(14-20)34-13-11-23(27(34)37)30-26(36)22-17-33(31-25(22)29)16-19-9-7-18(8-10-19)15-32-12-2-1-6-24(32)35/h1-10,12,14,17,23H,11,13,15-16H2,(H2,29,31)(H,30,36)/t23-/m1/s1	PLRXGUSRGDVYFS-HSZRJFAPSA-N	463434	3-amino-N-[(3R)-1-(3-chlorophenyl)-2-oxopyrrolidin-3-yl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 110	Plasma kallikrein			 4.00							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463434	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463434&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364595	441573280							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
956999	Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)N[C@@H]1CN(C(=O)C1)c1cccc(Cl)c1	InChI=1S/C27H25ClN6O3/c28-20-4-3-5-22(12-20)34-16-21(13-25(34)36)30-27(37)23-17-33(31-26(23)29)15-19-9-7-18(8-10-19)14-32-11-2-1-6-24(32)35/h1-12,17,21H,13-16H2,(H2,29,31)(H,30,37)/t21-/m0/s1	VTHWJDWMGGWGJR-NRFANRHFSA-N	463435	3-amino-N-[(3S)-1-(3-chlorophenyl)-5-oxopyrrolidin-3-yl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 111	Plasma kallikrein			 42.1							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463435	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463435&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364652	441573281							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957001	Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)N[C@H]1CCN(C1)c1cc(Cl)ccn1	InChI=1S/C26H26ClN7O2/c27-20-8-10-29-23(13-20)32-12-9-21(16-32)30-26(36)22-17-34(31-25(22)28)15-19-6-4-18(5-7-19)14-33-11-2-1-3-24(33)35/h1-8,10-11,13,17,21H,9,12,14-16H2,(H2,28,31)(H,30,36)/t21-/m0/s1	HUUKZGJXVSYRHQ-NRFANRHFSA-N	463436	3-amino-N-[(3S)-1-(4-chloropyridin-2-yl)pyrrolidin-3-yl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 112	Plasma kallikrein			 7460							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463436	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463436&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364552	441573282							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957003	C[C@H](COc1cccc(Cl)c1)NC(=O)c1cn(Cc2ccc(Cn3ccccc3=O)cc2)nc1N	InChI=1S/C26H26ClN5O3/c1-18(17-35-22-6-4-5-21(27)13-22)29-26(34)23-16-32(30-25(23)28)15-20-10-8-19(9-11-20)14-31-12-3-2-7-24(31)33/h2-13,16,18H,14-15,17H2,1H3,(H2,28,30)(H,29,34)/t18-/m1/s1	WWDYKPQPCZPGFF-GOSISDBHSA-N	463437	3-amino-N-[(2R)-1-(3-chlorophenoxy)propan-2-yl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 113	Plasma kallikrein			 316							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463437	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463437&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			132017366	441573283							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957005	C[C@@H](COc1cccc(Cl)c1)NC(=O)c1cn(Cc2ccc(Cn3ccccc3=O)cc2)nc1N	InChI=1S/C26H26ClN5O3/c1-18(17-35-22-6-4-5-21(27)13-22)29-26(34)23-16-32(30-25(23)28)15-20-10-8-19(9-11-20)14-31-12-3-2-7-24(31)33/h2-13,16,18H,14-15,17H2,1H3,(H2,28,30)(H,29,34)/t18-/m0/s1	WWDYKPQPCZPGFF-SFHVURJKSA-N	463438	3-amino-N-[(2S)-1-(3-chlorophenoxy)propan-2-yl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 114	Plasma kallikrein			 140							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463438	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463438&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364621	441573284							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957007	C[C@H](NC(=O)c1cn(Cc2ccc(Cn3ccccc3=O)cc2)nc1N)C(=O)N(C)c1cccc(Cl)c1	InChI=1S/C27H27ClN6O3/c1-18(27(37)32(2)22-7-5-6-21(28)14-22)30-26(36)23-17-34(31-25(23)29)16-20-11-9-19(10-12-20)15-33-13-4-3-8-24(33)35/h3-14,17-18H,15-16H2,1-2H3,(H2,29,31)(H,30,36)/t18-/m0/s1	VVRWWUMFOFUNPL-SFHVURJKSA-N	463439	(2S)-2-{[3-amino-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)pyrazol-4-::US10781181, Example 116	Plasma kallikrein			 390							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463439	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463439&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364681	441573285							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957009	C[C@@H](NC(=O)c1cn(Cc2ccc(Cn3ccccc3=O)cc2)nc1N)C(=O)N(C)c1cccc(Cl)c1	InChI=1S/C27H27ClN6O3/c1-18(27(37)32(2)22-7-5-6-21(28)14-22)30-26(36)23-17-34(31-25(23)29)16-20-11-9-19(10-12-20)15-33-13-4-3-8-24(33)35/h3-14,17-18H,15-16H2,1-2H3,(H2,29,31)(H,30,36)/t18-/m1/s1	VVRWWUMFOFUNPL-GOSISDBHSA-N	463440	(2R)-2-{[3-amino-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)pyrazol-4-::US10781181, Example 117	Plasma kallikrein			 3020							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463440	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463440&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364867	441573286							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957011	C[C@@H](CNC(=O)c1cn(Cc2ccc(Cn3ccccc3=O)cc2)nc1N)Oc1cccc(Cl)c1	InChI=1S/C26H26ClN5O3/c1-18(35-22-6-4-5-21(27)13-22)14-29-26(34)23-17-32(30-25(23)28)16-20-10-8-19(9-11-20)15-31-12-3-2-7-24(31)33/h2-13,17-18H,14-16H2,1H3,(H2,28,30)(H,29,34)/t18-/m0/s1	ILFFTOFUUCFIFF-SFHVURJKSA-N	463441	3-amino-N-[(2R/S)-2-(3-chlorophenoxy)propyl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 118	Plasma kallikrein			 13.3							US Patent		10.7270/Q2P55RK5		aid1804814	US10781181	Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463441	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463441&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364589	441573287							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957174	Cc1cc(N)nc(C)c1CNC(=O)c1ccn(Cc2ccc3ncc(Cl)cc3c2)n1	InChI=1S/C22H21ClN6O/c1-13-7-21(24)27-14(2)18(13)11-26-22(30)20-5-6-29(28-20)12-15-3-4-19-16(8-15)9-17(23)10-25-19/h3-10H,11-12H2,1-2H3,(H2,24,27)(H,26,30)	VKIAGBWYTANQQQ-UHFFFAOYSA-N	392515	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-1H-pyrazole-3- carboxamide::US10301284, Example 1::US10781200, Example 1	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392515	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392515&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178166	404960845							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957175	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C22H21ClN6O/c1-13-5-21(24)28-14(2)19(13)10-26-22(30)17-8-27-29(12-17)11-15-3-4-20-16(6-15)7-18(23)9-25-20/h3-9,12H,10-11H2,1-2H3,(H2,24,28)(H,26,30)	KEVAKJMOXFNJON-UHFFFAOYSA-N	392516	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)-1-((3-chloroquinolin-6-yl)methyl)-1H-pyrazole-4-carboxamide::US10301284, Example 2::US10781200, Example 2	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392516	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392516&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			58081249	404960846							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957176	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)cn1	InChI=1S/C22H21ClN6O/c1-13-5-21(24)28-14(2)18(13)9-26-22(30)20-11-29(12-27-20)10-15-3-4-19-16(6-15)7-17(23)8-25-19/h3-8,11-12H,9-10H2,1-2H3,(H2,24,28)(H,26,30)	IYSVYKDNXSZWIU-UHFFFAOYSA-N	392517	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-1H-imidazole-4- carboxamide::US10301284, Example 3::US10781200, Example 3	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392517	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392517&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178766	404960847							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957177	Cc1cc(N)nc(C)c1CNC(=O)c1ncn(Cc2ccc3ncc(Cl)cc3c2)n1	InChI=1S/C21H20ClN7O/c1-12-5-19(23)27-13(2)17(12)9-25-21(30)20-26-11-29(28-20)10-14-3-4-18-15(6-14)7-16(22)8-24-18/h3-8,11H,9-10H2,1-2H3,(H2,23,27)(H,25,30)	ACDFLJFTAQVDFE-UHFFFAOYSA-N	392518	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-1H-1,2,4-triazole-3- carboxamide::US10301284, Example 4::US10781200, Example 4	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392518	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392518&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178767	404960848							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957178	Cc1cc(N)nc(C)c1CNC(=O)c1cnc(Cc2ccc3ncc(Cl)cc3c2)[nH]1	InChI=1S/C22H21ClN6O/c1-12-5-20(24)28-13(2)17(12)10-27-22(30)19-11-26-21(29-19)7-14-3-4-18-15(6-14)8-16(23)9-25-18/h3-6,8-9,11H,7,10H2,1-2H3,(H2,24,28)(H,26,29)(H,27,30)	HEBXTXYICXOMQA-UHFFFAOYSA-N	392519	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)-1H-imidazole-5- carboxamide::US10301284, Example 5::US10781200, Example 5	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392519	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392519&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178458	404960849							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957179	Cc1cc(N)nc(C)c1CNC(=O)c1nc(Cc2ccc3ncc(Cl)cc3c2)no1	InChI=1S/C21H19ClN6O2/c1-11-5-18(23)26-12(2)16(11)10-25-20(29)21-27-19(28-30-21)7-13-3-4-17-14(6-13)8-15(22)9-24-17/h3-6,8-9H,7,10H2,1-2H3,(H2,23,26)(H,25,29)	XIDDFVXNDJDMCJ-UHFFFAOYSA-N	392520	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-3-((3-chloroquinolin-6- yl)methyl)-1,2,4-oxadiazole-5- carboxamide::US10301284, Example 6::US10781200, Example 6	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392520	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392520&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178676	404960850							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957180	Cc1cc(N)nc(C)c1CNC(=O)c1noc(Cc2ccc3ncc(Cl)cc3c2)n1	InChI=1S/C21H19ClN6O2/c1-11-5-18(23)26-12(2)16(11)10-25-21(29)20-27-19(30-28-20)7-13-3-4-17-14(6-13)8-15(22)9-24-17/h3-6,8-9H,7,10H2,1-2H3,(H2,23,26)(H,25,29)	UQVCTRRWOSYTKA-UHFFFAOYSA-N	392521	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-5-((3-chloroquinolin-6- yl)methyl)-1,2,4-oxadiazole-3- carboxamide::US10301284, Example 7::US10781200, Example 7	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392521	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392521&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178180	404960851							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957181	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)c2cccnc12	InChI=1S/C26H23ClN6O/c1-15-8-24(28)32-16(2)20(15)12-31-26(34)21-14-33(23-4-3-7-29-25(21)23)13-17-5-6-22-18(9-17)10-19(27)11-30-22/h3-11,14H,12-13H2,1-2H3,(H2,28,32)(H,31,34)	KDELRJSGFBTOGO-UHFFFAOYSA-N	392522	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-1H-pyrrolo[3,2-b]pyridine- 3-carboxamide::US10301284, Example 8::US10781200, Example 8	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392522	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392522&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178464	404960852							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957182	Cc1cc(N)nc(C)c1CNC(=O)c1nc(Cc2ccc3ncc(Cl)cc3c2)n2ccccc12	InChI=1S/C26H23ClN6O/c1-15-9-23(28)31-16(2)20(15)14-30-26(34)25-22-5-3-4-8-33(22)24(32-25)11-17-6-7-21-18(10-17)12-19(27)13-29-21/h3-10,12-13H,11,14H2,1-2H3,(H2,28,31)(H,30,34)	SWRWGJKWQQWOOV-UHFFFAOYSA-N	392523	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-3-((3-chloroquinolin-6- yl)methyl)imidazo[1,5-a]pyridine-1- carboxamide::US10301284, Example 9::US10781200, Example 9	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392523	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392523&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178190	404960853							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957183	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)nn1	InChI=1S/C21H20ClN7O/c1-12-5-20(23)26-13(2)17(12)9-25-21(30)19-11-29(28-27-19)10-14-3-4-18-15(6-14)7-16(22)8-24-18/h3-8,11H,9-10H2,1-2H3,(H2,23,26)(H,25,30)	AHPGCVRPNQBODS-UHFFFAOYSA-N	392524	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-1H-1,2,3-triazole-4- carboxamide::US10301284, Example 10::US10781200, Example 10	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392524	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392524&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134177973	404960854							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957184	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)c2ccccc12	InChI=1S/C27H24ClN5O/c1-16-9-26(29)32-17(2)22(16)13-31-27(34)23-15-33(25-6-4-3-5-21(23)25)14-18-7-8-24-19(10-18)11-20(28)12-30-24/h3-12,15H,13-14H2,1-2H3,(H2,29,32)(H,31,34)	SJQDIMSVWPPDAT-UHFFFAOYSA-N	392525	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-1H-indole-3-carboxamide::US10301284, Example 11::US10781200, Example 11	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392525	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392525&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178472	404960855							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957185	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)c2ncccc12	InChI=1S/C26H23ClN6O/c1-15-8-24(28)32-16(2)21(15)12-31-26(34)22-14-33(25-20(22)4-3-7-29-25)13-17-5-6-23-18(9-17)10-19(27)11-30-23/h3-11,14H,12-13H2,1-2H3,(H2,28,32)(H,31,34)	KAHFCXDBNMIWGS-UHFFFAOYSA-N	392526	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-1H-pyrrolo[2,3-b]pyridine- 3-carboxamide::US10301284, Example 12::US10781200, Example 12	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392526	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392526&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178194	404960856							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957186	Cc1cc(N)nc(C)c1CNC(=O)c1nn(Cc2ccc3ncc(Cl)cc3c2)c2ccccc12	InChI=1S/C26H23ClN6O/c1-15-9-24(28)31-16(2)21(15)13-30-26(34)25-20-5-3-4-6-23(20)33(32-25)14-17-7-8-22-18(10-17)11-19(27)12-29-22/h3-12H,13-14H2,1-2H3,(H2,28,31)(H,30,34)	VQICXQYHCMJZFJ-UHFFFAOYSA-N	392527	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-1H-indazole-3- carboxamide::US10301284, Example 13::US10781200, Example 13	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392527	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392527&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134177977	404960857							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957187	Cc1cc(N)nc(C)c1CNC(=O)c1n(Cc2ccc3ncc(Cl)cc3c2)nc2ccccc12	InChI=1S/C26H23ClN6O/c1-15-9-24(28)31-16(2)21(15)13-30-26(34)25-20-5-3-4-6-23(20)32-33(25)14-17-7-8-22-18(10-17)11-19(27)12-29-22/h3-12H,13-14H2,1-2H3,(H2,28,31)(H,30,34)	ORCDLEWLNKYCIX-UHFFFAOYSA-N	392528	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)-2H-indazole-3- carboxamide::US10301284, Example 14::US10781200, Example 14	Plasma kallikrein			>10000							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392528	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392528&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178680	404960858							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957188	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)c2cnccc12	InChI=1S/C26H23ClN6O/c1-15-7-25(28)32-16(2)21(15)11-31-26(34)22-14-33(24-12-29-6-5-20(22)24)13-17-3-4-23-18(8-17)9-19(27)10-30-23/h3-10,12,14H,11,13H2,1-2H3,(H2,28,32)(H,31,34)	ALARXHMGODKARD-UHFFFAOYSA-N	392530	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-1H-pyrrolo[2,3-c]pyridine- 3-carboxamide::US10301284, Example 16::US10781200, Example 16	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392530	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392530&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178685	404960860							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957189	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)nc1N	InChI=1S/C22H22ClN7O/c1-12-5-20(24)28-13(2)17(12)9-27-22(31)18-11-30(29-21(18)25)10-14-3-4-19-15(6-14)7-16(23)8-26-19/h3-8,11H,9-10H2,1-2H3,(H2,24,28)(H2,25,29)(H,27,31)	HGONQWUUMOMYLI-UHFFFAOYSA-N	392531	3-amino-N-((6-amino-2,4- dimethylpyridin-3-yl)methyl)-1-((3- chloroquinolin-6-yl)methyl)-1H- pyrazole-4-carboxamide::US10301284, Example 17::US10781200, Example 17	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392531	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392531&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134177986	404960861							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957190	Cc1cc(N)nc(C)c1CNC(=O)c1nn(Cc2ccc3ncc(Cl)cc3c2)cc1[N+]([O-])=O	InChI=1S/C22H20ClN7O3/c1-12-5-20(24)27-13(2)17(12)9-26-22(31)21-19(30(32)33)11-29(28-21)10-14-3-4-18-15(6-14)7-16(23)8-25-18/h3-8,11H,9-10H2,1-2H3,(H2,24,27)(H,26,31)	XSIQQKKUXKCPCC-UHFFFAOYSA-N	392532	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-4-nitro-1H-pyrazole-3- carboxamide::US10301284, Example 18::US10781200, Example 18	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392532	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392532&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134177990	404960862							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957191	CC(=O)Nc1cn(Cc2ccc3ncc(Cl)cc3c2)nc1C(=O)NCc1c(C)cc(N)nc1C	InChI=1S/C24H24ClN7O2/c1-13-6-22(26)29-14(2)19(13)10-28-24(34)23-21(30-15(3)33)12-32(31-23)11-16-4-5-20-17(7-16)8-18(25)9-27-20/h4-9,12H,10-11H2,1-3H3,(H2,26,29)(H,28,34)(H,30,33)	BNAQXULXFFGAMA-UHFFFAOYSA-N	392533	4-acetamido-N-((6-amino-2,4- dimethylpyridin-3-yl)methyl)-1-((3- chloroquinolin-6-yl)methyl)-1H- pyrazole-3-carboxamide::US10301284, Example 19::US10781200, Example 19	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392533	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392533&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178487	404960863							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957192	Cc1cc(N)nc(C)c1CNC(=O)c1nc(N)n(Cc2ccc3ncc(Cl)cc3c2)n1	InChI=1S/C21H21ClN8O/c1-11-5-18(23)27-12(2)16(11)9-26-20(31)19-28-21(24)30(29-19)10-13-3-4-17-14(6-13)7-15(22)8-25-17/h3-8H,9-10H2,1-2H3,(H2,23,27)(H,26,31)(H2,24,28,29)	WDBBZFSOOMIEDT-UHFFFAOYSA-N	392534	5-amino-N-((6-amino-2,4- dimethylpyridin-3-yl)methyl)-1-((3- chloroquinolin-6-yl)methyl)-1H-1,2,4- triazole-3-carboxamide::US10301284, Example 20::US10781200, Example 20	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392534	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392534&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178488	404960864							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957193	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc3ncc(Cl)cc3c2)n1	InChI=1S/C21H20ClN7O/c1-12-5-20(23)27-13(2)17(12)9-25-21(30)19-10-26-29(28-19)11-14-3-4-18-15(6-14)7-16(22)8-24-18/h3-8,10H,9,11H2,1-2H3,(H2,23,27)(H,25,30)	UNBNQKMBDWSTOT-UHFFFAOYSA-N	392535	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)-2H-1,2,3-triazole-4- carboxamide::US10301284, Example 21::US10781200, Example 21	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392535	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392535&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178483	404960865							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957194	Cc1cc(N)nc(C)c1CNC(=O)c1nn(Cc2ccc3ncc(Cl)cc3c2)cc1C(F)(F)F	InChI=1S/C23H20ClF3N6O/c1-12-5-20(28)31-13(2)17(12)9-30-22(34)21-18(23(25,26)27)11-33(32-21)10-14-3-4-19-15(6-14)7-16(24)8-29-19/h3-8,11H,9-10H2,1-2H3,(H2,28,31)(H,30,34)	XFWLVBACPMNBMP-UHFFFAOYSA-N	392536	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-4-(trifluoromethyl)-1H- pyrazole-3-carboxamide::US10301284, Example 22::US10781200, Example 22	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392536	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392536&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178489	404960866							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957195	Cc1cc(N)nc(C)c1CNC(=O)c1nc(Cc2ccc3ncc(Cl)cc3c2)c2ccccn12	InChI=1S/C26H23ClN6O/c1-15-9-24(28)31-16(2)20(15)14-30-26(34)25-32-22(23-5-3-4-8-33(23)25)11-17-6-7-21-18(10-17)12-19(27)13-29-21/h3-10,12-13H,11,14H2,1-2H3,(H2,28,31)(H,30,34)	PMJMPOLQHRXHNS-UHFFFAOYSA-N	392537	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)imidazo[1,5-a]pyridine-3- carboxamide::US10301284, Example 23::US10781200, Example 23	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392537	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392537&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178211	404960867							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957196	Cc1cc(N)nc(C)c1CNC(=O)c1nn(Cc2ccc3ncc(Cl)cc3c2)cc1N	InChI=1S/C22H22ClN7O/c1-12-5-20(25)28-13(2)17(12)9-27-22(31)21-18(24)11-30(29-21)10-14-3-4-19-15(6-14)7-16(23)8-26-19/h3-8,11H,9-10,24H2,1-2H3,(H2,25,28)(H,27,31)	RAEHGJMOKLSBEU-UHFFFAOYSA-N	392538	4-amino-N-((6-amino-2,4- dimethylpyridin-3-yl)methyl)-1-((3- chloroquinolin-6-yl)methyl)-1H- pyrazole-3-carboxamide::US10301284, Example 24::US10781200, Example 24	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392538	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392538&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			138658473	404960868							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957197	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)nc1C#N	InChI=1S/C23H20ClN7O/c1-13-5-22(26)29-14(2)18(13)10-28-23(32)19-12-31(30-21(19)8-25)11-15-3-4-20-16(6-15)7-17(24)9-27-20/h3-7,9,12H,10-11H2,1-2H3,(H2,26,29)(H,28,32)	BCORIVPXZDAOIN-UHFFFAOYSA-N	392539	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-3-cyano-1H-pyrazole-4- carboxamide::US10301284, Example 25::US10781200, Example 25	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392539	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392539&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178214	404960869							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957198	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)nc1C(N)=O	InChI=1S/C23H22ClN7O2/c1-12-5-20(25)29-13(2)17(12)9-28-23(33)18-11-31(30-21(18)22(26)32)10-14-3-4-19-15(6-14)7-16(24)8-27-19/h3-8,11H,9-10H2,1-2H3,(H2,25,29)(H2,26,32)(H,28,33)	NDNGLLNCMHYNID-UHFFFAOYSA-N	392540	N4-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-1H-pyrazole-3,4- dicarboxamide::US10301284, Example 26::US10781200, Example 26	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392540	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392540&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178498	404960870							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957199	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)nc1CN	InChI=1S/C23H24ClN7O/c1-13-5-22(26)29-14(2)18(13)10-28-23(32)19-12-31(30-21(19)8-25)11-15-3-4-20-16(6-15)7-17(24)9-27-20/h3-7,9,12H,8,10-11,25H2,1-2H3,(H2,26,29)(H,28,32)	MTEWYIIDBDKBQW-UHFFFAOYSA-N	392541	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-3-(aminomethyl)-1-((3- chloroquinolin-6-yl)methyl)-1H- pyrazole-4-carboxamide::US10301284, Example 27::US10781200, Example 27	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392541	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392541&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178786	404960871							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957200	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)c(N)n1	InChI=1S/C22H22ClN7O/c1-12-5-20(24)28-13(2)17(12)9-27-21(31)19-11-30(22(25)29-19)10-14-3-4-18-15(6-14)7-16(23)8-26-18/h3-8,11H,9-10H2,1-2H3,(H2,24,28)(H2,25,29)(H,27,31)	SKQOIDQWNDVKDS-UHFFFAOYSA-N	392542	2-amino-N-((6-amino-2,4- dimethylpyridin-3-yl)methyl)-1-((3- chloroquinolin-6-yl)methyl)-1H- imidazole-4-carboxamide::US10301284, Example 28::US10781200, Example 28	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392542	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392542&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134177999	404960872							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957201	Cc1cc(N)nc(C)c1CNC(=O)c1coc(Cc2ccc3ncc(Cl)cc3c2)n1	InChI=1S/C22H20ClN5O2/c1-12-5-20(24)27-13(2)17(12)10-26-22(29)19-11-30-21(28-19)7-14-3-4-18-15(6-14)8-16(23)9-25-18/h3-6,8-9,11H,7,10H2,1-2H3,(H2,24,27)(H,26,29)	KBEIDEIEYCSPQD-UHFFFAOYSA-N	392543	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)oxazole-4-carboxamide::US10301284, Example 29::US10781200, Example 29	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392543	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392543&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178511	404960873							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957202	Cc1cc(N)nc(C)c1CNC(=O)c1nnc(Cc2ccc3ncc(Cl)cc3c2)o1	InChI=1S/C21H19ClN6O2/c1-11-5-18(23)26-12(2)16(11)10-25-20(29)21-28-27-19(30-21)7-13-3-4-17-14(6-13)8-15(22)9-24-17/h3-6,8-9H,7,10H2,1-2H3,(H2,23,26)(H,25,29)	YKVZBHZTIGFTLW-UHFFFAOYSA-N	392544	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-5-((3-chloroquinolin-6- yl)methyl)-1,3,4-oxadiazole-2- carboxamide::US10301284, Example 30::US10781200, Example 30	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392544	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392544&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178225	404960874							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957203	Cc1cc(N)nc(C)c1CNC(=O)c1ncc(Cc2ccc3ncc(Cl)cc3c2)o1	InChI=1S/C22H20ClN5O2/c1-12-5-20(24)28-13(2)18(12)11-26-21(29)22-27-10-17(30-22)7-14-3-4-19-15(6-14)8-16(23)9-25-19/h3-6,8-10H,7,11H2,1-2H3,(H2,24,28)(H,26,29)	GJNCWMJQWUCZEU-UHFFFAOYSA-N	392545	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-5-((3-chloroquinolin-6- yl)methyl)oxazole-2-carboxamide::US10301284, Example 31::US10781200, Example 31	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392545	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392545&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178003	404960875							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957204	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)c2ncncc12	InChI=1S/C25H22ClN7O/c1-14-5-23(27)32-15(2)19(14)10-30-25(34)21-12-33(24-20(21)9-28-13-31-24)11-16-3-4-22-17(6-16)7-18(26)8-29-22/h3-9,12-13H,10-11H2,1-2H3,(H2,27,32)(H,30,34)	KMELJRSHOBKADN-UHFFFAOYSA-N	392546	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-7-((3-chloroquinolin-6- yl)methyl)-7H-pyrrolo[2,3- d]pyrimidine-5-carboxamide::US10301284, Example 32::US10781200, Example 32	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392546	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392546&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178005	404960876							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957205	Cc1cc(N)nc(C)c1CNC(=O)c1nn(Cc2ccc3ncc(Cl)cc3c2)c2cccc(N)c12	InChI=1S/C26H24ClN7O/c1-14-8-23(29)32-15(2)19(14)12-31-26(35)25-24-20(28)4-3-5-22(24)34(33-25)13-16-6-7-21-17(9-16)10-18(27)11-30-21/h3-11H,12-13,28H2,1-2H3,(H2,29,32)(H,31,35)	NZUOVEDIDJEFJS-UHFFFAOYSA-N	392547	4-amino-N-((6-amino-2,4- dimethylpyridin-3-yl)methyl)-1-((3- chloroquinolin-6-yl)methyl)-1H- indazole-3-carboxamide::US10301284, Example 33::US10781200, Example 33	Plasma kallikrein			 550							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392547	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392547&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178009	404960877							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957206	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)c2ncnc(N)c12	InChI=1S/C25H23ClN8O/c1-13-5-21(27)33-14(2)18(13)9-30-25(35)19-11-34(24-22(19)23(28)31-12-32-24)10-15-3-4-20-16(6-15)7-17(26)8-29-20/h3-8,11-12H,9-10H2,1-2H3,(H2,27,33)(H,30,35)(H2,28,31,32)	KGPFROBTQTWIBZ-UHFFFAOYSA-N	392548	4-amino-N-((6-amino-2,4- dimethylpyridin-3-yl)methyl)-7-((3- chloroquinolin-6-yl)methyl)-7H- pyrrolo[2,3-d]pyrimidine-5- carboxamide::US10301284, Example 34::US10781200, Example 34	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392548	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392548&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178018	404960878							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957207	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)c2ccncc12	InChI=1S/C26H23ClN6O/c1-15-7-25(28)32-16(2)20(15)12-31-26(34)22-14-33(24-5-6-29-11-21(22)24)13-17-3-4-23-18(8-17)9-19(27)10-30-23/h3-11,14H,12-13H2,1-2H3,(H2,28,32)(H,31,34)	FWLAEBZLRADQOV-UHFFFAOYSA-N	392549	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-1H-pyrrolo[3,2-c]pyridine- 3-carboxamide::US10301284, Example 35::US10781200, Example 35	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392549	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392549&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178507	404960879							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957208	Cc1cc(N)nc(C)c1CNC(=O)c1nn(Cc2ccc3ncc(Cl)cc3c2)cc1C#N	InChI=1S/C23H20ClN7O/c1-13-5-21(26)29-14(2)19(13)10-28-23(32)22-17(8-25)12-31(30-22)11-15-3-4-20-16(6-15)7-18(24)9-27-20/h3-7,9,12H,10-11H2,1-2H3,(H2,26,29)(H,28,32)	HZGAZHPWZQRQKR-UHFFFAOYSA-N	392550	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-4-cyano-1H-pyrazole-3- carboxamide::US10301284, Example 36::US10781200, Example 36	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392550	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392550&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178518	404960880							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957209	Cc1cc(N)nc(C)c1CNC(=O)c1oc(Cc2ccc3ncc(Cl)cc3c2)nc1C(F)(F)F	InChI=1S/C23H19ClF3N5O2/c1-11-5-18(28)31-12(2)16(11)10-30-22(33)20-21(23(25,26)27)32-19(34-20)7-13-3-4-17-14(6-13)8-15(24)9-29-17/h3-6,8-9H,7,10H2,1-2H3,(H2,28,31)(H,30,33)	JDNRBENRMDAUBB-UHFFFAOYSA-N	392551	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)-4-(trifluoromethyl)oxazole- 5-carboxamide::US10301284, Example 37::US10781200, Example 37	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392551	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392551&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178522	404960881							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957210	Cc1nn(Cc2ccc3ncc(Cl)cc3c2)cc1C(=O)NCc1c(C)cc(N)nc1C	InChI=1S/C23H23ClN6O/c1-13-6-22(25)28-14(2)19(13)10-27-23(31)20-12-30(29-15(20)3)11-16-4-5-21-17(7-16)8-18(24)9-26-21/h4-9,12H,10-11H2,1-3H3,(H2,25,28)(H,27,31)	NOHQPKSFPNEIFR-UHFFFAOYSA-N	392552	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-3-methyl-1H-pyrazole-4- carboxamide::US10301284, Example 38::US10781200, Example 38	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392552	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392552&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178248	404960882							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957211	COc1nn(Cc2ccc3ncc(Cl)cc3c2)cc1C(=O)NCc1c(C)cc(N)nc1C	InChI=1S/C23H23ClN6O2/c1-13-6-21(25)28-14(2)18(13)10-27-22(31)19-12-30(29-23(19)32-3)11-15-4-5-20-16(7-15)8-17(24)9-26-20/h4-9,12H,10-11H2,1-3H3,(H2,25,28)(H,27,31)	IGEIBYRPRHIVMF-UHFFFAOYSA-N	392553	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-3-methoxy-1H-pyrazole-4- carboxamide::US10301284, Example 39::US10781200, Example 39	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392553	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392553&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178536	404960883							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957212	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc3ncc(Cl)cc3c2)c1C#N	InChI=1S/C23H20ClN7O/c1-13-5-22(26)30-14(2)18(13)10-28-23(32)19-11-29-31(21(19)8-25)12-15-3-4-20-16(6-15)7-17(24)9-27-20/h3-7,9,11H,10,12H2,1-2H3,(H2,26,30)(H,28,32)	JDHSXDQGXRVALU-UHFFFAOYSA-N	392554	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-5-cyano-1H-pyrazole-4- carboxamide::US10301284, Example 40::US10781200, Example 40	Plasma kallikrein			 5500							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392554	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392554&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178249	404960884							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957213	Cc1cc(N)nc(C)c1CNC(=O)c1ncc(Cc2ccc3ncc(Cl)cc3c2)[nH]1	InChI=1S/C22H21ClN6O/c1-12-5-20(24)28-13(2)18(12)11-27-22(30)21-26-10-17(29-21)7-14-3-4-19-15(6-14)8-16(23)9-25-19/h3-6,8-10H,7,11H2,1-2H3,(H2,24,28)(H,26,29)(H,27,30)	IJVOWAQEKPWMPD-UHFFFAOYSA-N	392555	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-5-((3-chloroquinolin-6- yl)methyl)-1H-imidazole-2- carboxamide::US10301284, Example 41::US10781200, Example 41	Plasma kallikrein			 550							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392555	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392555&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178259	404960885							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957214	Clc1ccc2[nH]nc(CNC(=O)c3nnc(Cc4ccc5ncc(Cl)cc5c4)o3)c2c1	InChI=1S/C21H14Cl2N6O2/c22-13-2-4-17-15(8-13)18(27-26-17)10-25-20(30)21-29-28-19(31-21)6-11-1-3-16-12(5-11)7-14(23)9-24-16/h1-5,7-9H,6,10H2,(H,25,30)(H,26,27)	ASSSRESORCJQOR-UHFFFAOYSA-N	392556	N-((5-chloro-1H-indazol-3-yl)methyl)- 5-((3-chloroquinolin-6-yl)methyl)- 1,3,4-oxadiazole-2-carboxamide::US10301284, Example 42::US10781200, Example 42	Plasma kallikrein			 550							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392556	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392556&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178025	404960886							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957215	Fc1c(CNC(=O)c2nnc(Cc3ccc4ncc(Cl)cc4c3)[nH]2)ccc2[nH]cc(Cl)c12	InChI=1S/C22H15Cl2FN6O/c23-14-7-13-5-11(1-3-16(13)26-9-14)6-18-29-21(31-30-18)22(32)28-8-12-2-4-17-19(20(12)25)15(24)10-27-17/h1-5,7,9-10,27H,6,8H2,(H,28,32)(H,29,30,31)	DDZREMLODRJQMS-UHFFFAOYSA-N	463598	N-((3-chloro-4-fluoro-1H-indol-5- yl)methyl)-5-((3-chloroquinolin-6- yl)methyl)-1,3,4-oxadiazole-2- carboxamide::US10781200, Example 43	Plasma kallikrein			 550							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463598	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463598&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139340908	441573442							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957216	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1nnc(Cc2ccc3ncc(Cl)cc3c2)o1	InChI=1S/C22H14Cl2FN5O2/c23-14-5-12-3-11(1-2-18(12)26-9-14)4-20-29-30-22(32-20)21(31)28-8-13-6-15-16(24)10-27-19(15)7-17(13)25/h1-3,5-7,9-10,27H,4,8H2,(H,28,31)	PPYGRAMAIMBPCH-UHFFFAOYSA-N	392558	N-((3-chloro-6-fluoro-1H-indol-5- yl)methyl)-5-((3-chloroquinolin-6- yl)methyl)-1,3,4-oxadiazole-2- carboxamide::US10301284, Example 44::US10781200, Example 44	Plasma kallikrein			 550							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392558	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392558&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178028	404960888							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957217	Clc1c[nH]c2ncc(CNC(=O)c3nnc(Cc4ccc5ncc(Cl)cc5c4)o3)cc12	InChI=1S/C21H14Cl2N6O2/c22-14-6-13-3-11(1-2-17(13)24-9-14)5-18-28-29-21(31-18)20(30)27-8-12-4-15-16(23)10-26-19(15)25-7-12/h1-4,6-7,9-10H,5,8H2,(H,25,26)(H,27,30)	ASIUEMSWDSFJCK-UHFFFAOYSA-N	392559	N-((3-chloro-1H-pyrrolo[2,3- b]pyridin-5-yl)methyl)-5-((3- chloroquinolin-6-yl)methyl)-1,3,4- oxadiazole-2-carboxamide::US10301284, Example 45::US10781200, Example 45	Plasma kallikrein			 550							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392559	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392559&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178553	404960889							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957218	Nc1nccc2cc(CNC(=O)c3nnc(Cc4ccc5ncc(Cl)cc5c4)o3)ccc12	InChI=1S/C23H17ClN6O2/c24-17-10-16-7-13(2-4-19(16)27-12-17)9-20-29-30-23(32-20)22(31)28-11-14-1-3-18-15(8-14)5-6-26-21(18)25/h1-8,10,12H,9,11H2,(H2,25,26)(H,28,31)	AACZHUCCAHCXNO-UHFFFAOYSA-N	392560	N-((1-aminoisoquinolin-6-yl)methyl)- 5-((3-chloroquinolin-6-yl)methyl)- 1,3,4-oxadiazole-2-carboxamide::US10301284, Example 46::US10781200, Example 46	Plasma kallikrein			 550							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392560	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392560&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178534	404960890							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957219	Fc1c(CNC(=O)c2cn(Cc3ccc4ncc(Cl)cc4c3)nc2C#N)ccc2[nH]cc(Cl)c12	InChI=1S/C24H15Cl2FN6O/c25-16-6-15-5-13(1-3-19(15)29-9-16)11-33-12-17(21(7-28)32-33)24(34)31-8-14-2-4-20-22(23(14)27)18(26)10-30-20/h1-6,9-10,12,30H,8,11H2,(H,31,34)	QQWUMTHJFCYDCM-UHFFFAOYSA-N	392561	N-((3-chloro-4-fluoro-1H-indol-5- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-3-cyano-1H-pyrazole-4- carboxamide::US10301284, Example 47::US10781200, Example 47	Plasma kallikrein			 550							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392561	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392561&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178740	404960891							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957220	Clc1ccc2[nH]nc(CNC(=O)c3cn(Cc4ccc5ncc(Cl)cc5c4)nc3C#N)c2c1	InChI=1S/C23H15Cl2N7O/c24-15-2-4-20-17(7-15)22(30-29-20)10-28-23(33)18-12-32(31-21(18)8-26)11-13-1-3-19-14(5-13)6-16(25)9-27-19/h1-7,9,12H,10-11H2,(H,28,33)(H,29,30)	SEMGAPGVYHRCIB-UHFFFAOYSA-N	392562	N-((5-chloro-1H-indazol-3-yl)methyl)- 1-((3-chloroquinolin-6-yl)methyl)-3- cyano-1H-pyrazole-4-carboxamide::US10301284, Example 48::US10781200, Example 48	Plasma kallikrein			 550							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392562	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392562&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178029	404960892							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957221	Nc1nccc2cc(CNC(=O)c3cn(Cc4ccc5ncc(Cl)cc5c4)nc3C#N)ccc12	InChI=1S/C25H18ClN7O/c26-19-9-18-8-16(2-4-22(18)30-12-19)13-33-14-21(23(10-27)32-33)25(34)31-11-15-1-3-20-17(7-15)5-6-29-24(20)28/h1-9,12,14H,11,13H2,(H2,28,29)(H,31,34)	LNXYHPIIXNZTBP-UHFFFAOYSA-N	392563	N-((1-aminoisoquinolin-6-yl)methyl)- 1-((3-chloroquinolin-6-yl)methyl)-3- cyano-1H-pyrazole-4-carboxamide::US10301284, Example 49::US10781200, Example 49	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392563	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392563&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178279	404960893							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957222	Clc1c[nH]c2ncc(CNC(=O)c3cn(Cc4ccc5ncc(Cl)cc5c4)nc3C#N)cc12	InChI=1S/C23H15Cl2N7O/c24-16-5-15-3-13(1-2-20(15)27-9-16)11-32-12-18(21(6-26)31-32)23(33)30-8-14-4-17-19(25)10-29-22(17)28-7-14/h1-5,7,9-10,12H,8,11H2,(H,28,29)(H,30,33)	WUPSQPWFFJCKGX-UHFFFAOYSA-N	392564	N-((3-chloro-1H-pyrrolo[2,3- b]pyridin-5-yl)methyl)-1-((3- chloroquinolin-6-yl)methyl)-3-cyano- 1H-pyrazole-4-carboxamide::US10301284, Example 50::US10781200, Example 50	Plasma kallikrein			 550							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392564	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392564&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178555	404960894							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957223	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)nc1C#N	InChI=1S/C24H15Cl2FN6O/c25-16-4-14-3-13(1-2-21(14)29-9-16)11-33-12-18(23(7-28)32-33)24(34)31-8-15-5-17-19(26)10-30-22(17)6-20(15)27/h1-6,9-10,12,30H,8,11H2,(H,31,34)	RHVPFAANQBLDPZ-UHFFFAOYSA-N	392565	N-((3-chloro-6-fluoro-1H-indol-5- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-3-cyano-1H-pyrazole-4- carboxamide::US10301284, Example 51::US10781200, Example 51	Plasma kallikrein			 550							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392565	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392565&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178282	404960895							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957224	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2cc(F)c3ncc(Cl)cc3c2)nc1C#N	InChI=1S/C23H19ClFN7O/c1-12-3-21(27)30-13(2)17(12)9-29-23(33)18-11-32(31-20(18)7-26)10-14-4-15-6-16(24)8-28-22(15)19(25)5-14/h3-6,8,11H,9-10H2,1-2H3,(H2,27,30)(H,29,33)	RXZGWIZLIKYBPD-UHFFFAOYSA-N	392566	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloro-8- fluoroquinolin-6-yl)methyl)-3-cyano- 1H-pyrazole-4-carboxamide::US10301284, Example 52::US10781200, Example 52	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392566	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392566&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178556	404960896							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957225	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1cn(Cc2cc(F)c3ncc(Cl)cc3c2)nc1C#N	InChI=1S/C24H14Cl2F2N6O/c25-15-3-13-1-12(2-20(28)23(13)31-8-15)10-34-11-17(22(6-29)33-34)24(35)32-7-14-4-16-18(26)9-30-21(16)5-19(14)27/h1-5,8-9,11,30H,7,10H2,(H,32,35)	OOXUSHJPYMHNBL-UHFFFAOYSA-N	392567	N-((3-chloro-6-fluoro-1H-indol-5- yl)methyl)-1-((3-chloro-8- fluoroquinolin-6-yl)methyl)-3-cyano- 1H-pyrazole-4-carboxamide::US10301284, Example 53::US10781200, Example 53	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392567	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392567&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178552	404960897							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957226	Nc1nccc2cc(CNC(=O)c3cn(Cc4cc(F)c5ncc(Cl)cc5c4)nc3C#N)ccc12	InChI=1S/C25H17ClFN7O/c26-18-8-17-6-15(7-21(27)23(17)31-11-18)12-34-13-20(22(9-28)33-34)25(35)32-10-14-1-2-19-16(5-14)3-4-30-24(19)29/h1-8,11,13H,10,12H2,(H2,29,30)(H,32,35)	TTYKYHQSIRGSBH-UHFFFAOYSA-N	392568	N-((1-aminoisoquinolin-6-yl)methyl)- 1-((3-chloro-8-fluoroquinolin-6- yl)methyl)-3-cyano-1H-pyrazole-4- carboxamide::US10301284, Example 54::US10781200, Example 54	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392568	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392568&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178037	404960898							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957227	Fc1cc(Cn2cc(C(=O)NCc3n[nH]c4ccc(Cl)cc34)c(n2)C#N)cc2cc(Cl)cnc12	InChI=1S/C23H14Cl2FN7O/c24-14-1-2-19-16(6-14)21(31-30-19)9-29-23(34)17-11-33(32-20(17)7-27)10-12-3-13-5-15(25)8-28-22(13)18(26)4-12/h1-6,8,11H,9-10H2,(H,29,34)(H,30,31)	FZQKNWVIDPCNAL-UHFFFAOYSA-N	392569	N-((5-chloro-1H-indazol-3-yl)methyl)- 1-((3-chloro-8-fluoroquinolin-6- yl)methyl)-3-cyano-1H-pyrazole-4- carboxamide::US10301284, Example 55::US10781200, Example 55	Plasma kallikrein			 550							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392569	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392569&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178038	404960899							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957228	Fc1cc(Cn2cc(C(=O)NCc3cnc4[nH]cc(Cl)c4c3)c(n2)C#N)cc2cc(Cl)cnc12	InChI=1S/C23H14Cl2FN7O/c24-15-4-14-1-12(3-19(26)21(14)28-8-15)10-33-11-17(20(5-27)32-33)23(34)31-7-13-2-16-18(25)9-30-22(16)29-6-13/h1-4,6,8-9,11H,7,10H2,(H,29,30)(H,31,34)	SDEPGTROUDXDFT-UHFFFAOYSA-N	392570	N-((3-chloro-1H-pyrrolo[2,3- b]pyridin-5-yl)methyl)-1-((3-chloro-8- fluoroquinolin-6-yl)methyl)-3-cyano- 1H-pyrazole-4-carboxamide::US10301284, Example 56::US10781200, Example 56	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392570	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392570&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178288	404960900							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957229	Fc1cc(Cn2cc(C(=O)NCc3ccc4[nH]cc(Cl)c4c3F)c(n2)C#N)cc2cc(Cl)cnc12	InChI=1S/C24H14Cl2F2N6O/c25-15-5-14-3-12(4-18(27)23(14)31-8-15)10-34-11-16(20(6-29)33-34)24(35)32-7-13-1-2-19-21(22(13)28)17(26)9-30-19/h1-5,8-9,11,30H,7,10H2,(H,32,35)	OMIWTSNONUWZIQ-UHFFFAOYSA-N	392571	N-((3-chloro-4-fluoro-1H-indol-5- yl)methyl)-1-((3-chloro-8- fluoroquinolin-6-yl)methyl)-3-cyano- 1H-pyrazole-4-carboxamide::US10301284, Example 57::US10781200, Example 57	Plasma kallikrein			 550							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392571	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392571&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178041	404960901							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957230	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2cc(c3ncc(Cl)cc3c2)C(C)(C)O)nc1C#N	InChI=1S/C26H26ClN7O2/c1-14-5-23(29)32-15(2)19(14)11-31-25(35)20-13-34(33-22(20)9-28)12-16-6-17-8-18(27)10-30-24(17)21(7-16)26(3,4)36/h5-8,10,13,36H,11-12H2,1-4H3,(H2,29,32)(H,31,35)	JBHSVGYJIWWDJV-UHFFFAOYSA-N	392572	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloro-8-(2- hydroxypropan-2-yl)quinolin-6- yl)methyl)-3-cyano-1H-pyrazole-4- carboxamide::US10301284, Example 58::US10781200, Example 58	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392572	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392572&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178742	404960902							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957231	CC(C)(O)c1cc(Cn2cc(C(=O)NCc3ccc4c(N)nccc4c3)c(n2)C#N)cc2cc(Cl)cnc12	InChI=1S/C28H24ClN7O2/c1-28(2,38)23-9-17(8-19-10-20(29)13-33-25(19)23)14-36-15-22(24(11-30)35-36)27(37)34-12-16-3-4-21-18(7-16)5-6-32-26(21)31/h3-10,13,15,38H,12,14H2,1-2H3,(H2,31,32)(H,34,37)	JFMWDYUDNMXWSX-UHFFFAOYSA-N	392573	N-((1-aminoisoquinolin-6-yl)methyl)- 1-((3-chloro-8-(2-hydroxypropan-2- yl)quinolin-6-yl)methyl)-3-cyano-1H- pyrazole-4-carboxamide::US10301284, Example 59::US10781200, Example 59	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392573	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392573&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178292	404960903							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957232	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2cc(c3ncc(Cl)cc3c2)S(N)(=O)=O)nc1C#N	InChI=1S/C23H21ClN8O3S/c1-12-3-21(26)30-13(2)17(12)9-29-23(33)18-11-32(31-19(18)7-25)10-14-4-15-6-16(24)8-28-22(15)20(5-14)36(27,34)35/h3-6,8,11H,9-10H2,1-2H3,(H2,26,30)(H,29,33)(H2,27,34,35)	JWZVQMGFSBRWLR-UHFFFAOYSA-N	392574	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloro-8- sulfamoylquinolin-6-yl)methyl)-3- cyano-1H-pyrazole-4-carboxamide::US10301284, Example 60::US10781200, Example 60	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392574	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392574&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178828	404960904							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957233	Cc1cnc2c(cc(Cn3cc(C(=O)NCc4c(C)cc(N)nc4C)c(n3)C#N)cc2c1)S(C)(=O)=O	InChI=1S/C25H25N7O3S/c1-14-5-18-7-17(8-22(36(4,34)35)24(18)28-10-14)12-32-13-20(21(9-26)31-32)25(33)29-11-19-15(2)6-23(27)30-16(19)3/h5-8,10,13H,11-12H2,1-4H3,(H2,27,30)(H,29,33)	XPRAOLSTLRFCRV-UHFFFAOYSA-N	392575	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-3-cyano-1-((3-methyl-8- (methylsulfonyl)quinolin-6- yl)methyl)-1H-pyrazole-4- carboxamide::US10301284, Example 61::US10781200, Example 61	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392575	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392575&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135354631	404960905							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957234	Cc1cnc2c(cc(Cn3cc(C(=O)NCc4c(C)cc(N)nc4C)c(n3)C#N)cc2c1)C#N	InChI=1S/C25H22N8O/c1-14-4-18-6-17(7-19(8-26)24(18)29-10-14)12-33-13-21(22(9-27)32-33)25(34)30-11-20-15(2)5-23(28)31-16(20)3/h4-7,10,13H,11-12H2,1-3H3,(H2,28,31)(H,30,34)	PPOODUNSOSWLJJ-UHFFFAOYSA-N	392576	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-3-cyano-1-((8-cyano-3- methylquinolin-6-yl)methyl)-1H- pyrazole-4-carboxamide::US10301284, Example 62::US10781200, Example 62	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392576	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392576&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178052	404960906							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957235	Cc1cnc2c(cc(Cn3cc(C(=O)NCc4c(C)cc(N)nc4C)c(n3)C(N)=O)cc2c1)C#N	InChI=1S/C25H24N8O2/c1-13-4-17-6-16(7-18(8-26)22(17)29-9-13)11-33-12-20(23(32-33)24(28)34)25(35)30-10-19-14(2)5-21(27)31-15(19)3/h4-7,9,12H,10-11H2,1-3H3,(H2,27,31)(H2,28,34)(H,30,35)	KOPPRFDMDJZZCZ-UHFFFAOYSA-N	392577	N4-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((8-cyano-3- methylquinolin-6-yl)methyl)-1H- pyrazole-3,4-dicarboxamide::US10301284, Example 63::US10781200, Example 63	Plasma kallikrein			 550							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392577	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392577&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178300	404960907							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957236	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(cc3c2)C2CC2)nc1C#N	InChI=1S/C26H25N7O/c1-15-7-25(28)31-16(2)21(15)12-30-26(34)22-14-33(32-24(22)10-27)13-17-3-6-23-19(8-17)9-20(11-29-23)18-4-5-18/h3,6-9,11,14,18H,4-5,12-13H2,1-2H3,(H2,28,31)(H,30,34)	NXWBCYNOFIKWBT-UHFFFAOYSA-N	392578	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-3-cyano-1-((3- cyclopropylquinolin-6-yl)methyl)-1H- pyrazole-4-carboxamide::US10301284, Example 65::US10781200, Example 65	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392578	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392578&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178747	404960908							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957237	Cc1nc(N)ccc1CNC(=O)c1cn(Cc2ccc3ncc(cc3c2)C2CC2)nc1C#N	InChI=1S/C25H23N7O/c1-15-18(5-7-24(27)30-15)11-29-25(33)21-14-32(31-23(21)10-26)13-16-2-6-22-19(8-16)9-20(12-28-22)17-3-4-17/h2,5-9,12,14,17H,3-4,11,13H2,1H3,(H2,27,30)(H,29,33)	XNBQSYYTSSLVFF-UHFFFAOYSA-N	392579	N-((6-amino-2-methylpyridin-3- yl)methyl)-3-cyano-1-((3- cyclopropylquinolin-6-yl)methyl)-1H- pyrazole-4-carboxamide::US10301284, Example 66::US10781200, Example 66	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392579	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392579&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178748	404960909							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957238	Cc1cnc2c(cc(Cn3ncc(C(=O)NCc4c(C)cc(N)nc4C)c3C#N)cc2c1)C(C)(C)O	InChI=1S/C27H29N7O2/c1-15-6-19-8-18(9-22(27(4,5)36)25(19)30-11-15)14-34-23(10-28)21(13-32-34)26(35)31-12-20-16(2)7-24(29)33-17(20)3/h6-9,11,13,36H,12,14H2,1-5H3,(H2,29,33)(H,31,35)	VGEXEBFWUMODSQ-UHFFFAOYSA-N	392580	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-5-cyano-1-((8-(2- hydroxypropan-2-yl)-3- methylquinolin-6-yl)methyl)-1H- pyrazole-4-carboxamide::US10301284, Example 67::US10781200, Example 67	Plasma kallikrein			 5500							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392580	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392580&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178836	404960910							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957239	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2cc(c3ncc(Cl)cc3c2)S(C)(=O)=O)nc1C#N	InChI=1S/C24H22ClN7O3S/c1-13-4-22(27)30-14(2)18(13)10-29-24(33)19-12-32(31-20(19)8-26)11-15-5-16-7-17(25)9-28-23(16)21(6-15)36(3,34)35/h4-7,9,12H,10-11H2,1-3H3,(H2,27,30)(H,29,33)	LCBLUFJTGZMWMW-UHFFFAOYSA-N	392581	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloro-8- (methylsulfonyl)quinolin-6- yl)methyl)-3-cyano-1H-pyrazole-4- carboxamide::US10301284, Example 68::US10781200, Example 68	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392581	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392581&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178301	404960911							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957240	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2cc(C#N)c3ncc(Cl)cc3c2)nc1C#N	InChI=1S/C24H19ClN8O/c1-13-3-22(28)31-14(2)19(13)10-30-24(34)20-12-33(32-21(20)8-27)11-15-4-16-6-18(25)9-29-23(16)17(5-15)7-26/h3-6,9,12H,10-11H2,1-2H3,(H2,28,31)(H,30,34)	ABUOKOXGYGWPDU-UHFFFAOYSA-N	392582	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloro-8- cyanoquinolin-6-yl)methyl)-3-cyano- 1H-pyrazole-4-carboxamide::US10301284, Example 69::US10781200, Example 69	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392582	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392582&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178753	404960912							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957241	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2cc(F)c3ncc(Cl)cc3c2)c1C#N	InChI=1S/C23H19ClFN7O/c1-12-3-21(27)31-13(2)17(12)9-29-23(33)18-10-30-32(20(18)7-26)11-14-4-15-6-16(24)8-28-22(15)19(25)5-14/h3-6,8,10H,9,11H2,1-2H3,(H2,27,31)(H,29,33)	AFIKLFDLPMFODS-UHFFFAOYSA-N	392583	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloro-8- fluoroquinolin-6-yl)methyl)-5-cyano- 1H-pyrazole-4-carboxamide::US10301284, Example 70::US10781200, Example 70	Plasma kallikrein			>10000							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392583	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392583&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178574	404960913							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957242	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2cc(F)c3ncc(Cl)cc3c2)c1C(N)=O	InChI=1S/C23H21ClFN7O2/c1-11-3-19(26)31-12(2)16(11)8-29-23(34)17-9-30-32(21(17)22(27)33)10-13-4-14-6-15(24)7-28-20(14)18(25)5-13/h3-7,9H,8,10H2,1-2H3,(H2,26,31)(H2,27,33)(H,29,34)	PYXFFFNKKGJNLF-UHFFFAOYSA-N	392584	N4-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloro-8- fluoroquinolin-6-yl)methyl)-1H- pyrazole-4,5-dicarboxamide::US10301284, Example 71::US10781200, Example 71	Plasma kallikrein			>10000							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392584	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392584&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178754	404960914							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957243	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2cc(C(N)=O)c3ncc(Cl)cc3c2)nc1C#N	InChI=1S/C24H21ClN8O2/c1-12-3-21(27)31-13(2)18(12)9-30-24(35)19-11-33(32-20(19)7-26)10-14-4-15-6-16(25)8-29-22(15)17(5-14)23(28)34/h3-6,8,11H,9-10H2,1-2H3,(H2,27,31)(H2,28,34)(H,30,35)	LXGUFOWDTCMHRM-UHFFFAOYSA-N	392585	6-((4-(((6-amino-2,4-dimethylpyridin- 3-yl)methyl)carbamoyl)-3-cyano-1H- pyrazol-1-yl)methyl)-3- chloroquinoline-8-carboxamide::US10301284, Example 72::US10781200, Example 72	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392585	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392585&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178607	404960915							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957244	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(cc3c2)C(F)(F)F)nc1C#N	InChI=1S/C24H20F3N7O/c1-13-5-22(29)32-14(2)18(13)10-31-23(35)19-12-34(33-21(19)8-28)11-15-3-4-20-16(6-15)7-17(9-30-20)24(25,26)27/h3-7,9,12H,10-11H2,1-2H3,(H2,29,32)(H,31,35)	AFPHIOZWMKEEPJ-UHFFFAOYSA-N	392586	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-3-cyano-1-((3- (trifluoromethyl)quinolin-6- yl)methyl)-1H-pyrazole-4- carboxamide::US10301284, Example 73::US10781200, Example 73	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392586	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392586&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178580	404960916							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957245	Cc1nc(N)ccc1CNC(=O)c1cn(Cc2ccc3ncc(cc3c2)C(F)(F)F)nc1C#N	InChI=1S/C23H18F3N7O/c1-13-15(3-5-21(28)31-13)9-30-22(34)18-12-33(32-20(18)8-27)11-14-2-4-19-16(6-14)7-17(10-29-19)23(24,25)26/h2-7,10,12H,9,11H2,1H3,(H2,28,31)(H,30,34)	HSOXCLRPEGJBFZ-UHFFFAOYSA-N	392587	N-((6-amino-2-methylpyridin-3- yl)methyl)-3-cyano-1-((3- (trifluoromethyl)quinolin-6- yl)methyl)-1H-pyrazole-4- carboxamide::US10301284, Example 74::US10781200, Example 74	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392587	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392587&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178612	404960917							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957246	Cc1cc(N)nc(C)c1CNC(=O)c1nnc(Cc2cc(F)c3ncc(Cl)cc3c2)o1	InChI=1S/C21H18ClFN6O2/c1-10-3-17(24)27-11(2)15(10)9-26-20(30)21-29-28-18(31-21)6-12-4-13-7-14(22)8-25-19(13)16(23)5-12/h3-5,7-8H,6,9H2,1-2H3,(H2,24,27)(H,26,30)	FZYUVHFBIXMQNM-UHFFFAOYSA-N	392588	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-5-((3-chloro-8- fluoroquinolin-6-yl)methyl)-1,3,4- oxadiazole-2-carboxamide::US10301284, Example 75::US10781200, Example 75	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392588	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392588&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178316	404960918							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957247	Cc1cc(N)nc(C)c1CNC(=O)c1nn(Cc2ccc3ncc(Cl)cc3c2)c2ccnc(C#N)c12	InChI=1S/C26H21ClN8O/c1-14-7-23(29)33-15(2)19(14)12-32-26(36)25-24-21(10-28)30-6-5-22(24)35(34-25)13-16-3-4-20-17(8-16)9-18(27)11-31-20/h3-9,11H,12-13H2,1-2H3,(H2,29,33)(H,32,36)	NXUPLLOGEOCWIG-UHFFFAOYSA-N	392589	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-4-cyano-1H-pyrazolo[4,3- c]pyridine-3-carboxamide::US10301284, Example 76::US10781200, Example 76	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392589	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392589&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178075	404960919							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957248	Cc1nc(N)ccc1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)nc1C#N	InChI=1S/C22H18ClN7O/c1-13-15(3-5-21(25)28-13)9-27-22(31)18-12-30(29-20(18)8-24)11-14-2-4-19-16(6-14)7-17(23)10-26-19/h2-7,10,12H,9,11H2,1H3,(H2,25,28)(H,27,31)	OMXOVARZDRTMGD-UHFFFAOYSA-N	392590	N-((6-amino-2-methylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-3-cyano-1H-pyrazole-4- carboxamide::US10301284, Example 77::US10781200, Example 77	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392590	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392590&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178076	404960920							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957249	Cc1cnc2c(cc(Cn3cc(C(=O)NCc4c(C)cc(N)nc4C)c(n3)C#N)cc2c1)C(N)=O	InChI=1S/C25H24N8O2/c1-13-4-17-6-16(7-18(24(28)34)23(17)29-9-13)11-33-12-20(21(8-26)32-33)25(35)30-10-19-14(2)5-22(27)31-15(19)3/h4-7,9,12H,10-11H2,1-3H3,(H2,27,31)(H2,28,34)(H,30,35)	KWOBNPHUEXOCGN-UHFFFAOYSA-N	392591	6-((4-(((6-amino-2,4-dimethylpyridin- 3-yl)methyl)carbamoyl)-3-cyano-1H- pyrazol-1-yl)methyl)-3- methylquinoline-8-carboxamide::US10301284, Example 78::US10781200, Example 78	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392591	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392591&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178624	404960921							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957250	Cc1nc(N)ccc1CNC(=O)c1nnc(Cc2ccc3ncc(Cl)cc3c2)o1	InChI=1S/C20H17ClN6O2/c1-11-13(3-5-17(22)25-11)9-24-19(28)20-27-26-18(29-20)7-12-2-4-16-14(6-12)8-15(21)10-23-16/h2-6,8,10H,7,9H2,1H3,(H2,22,25)(H,24,28)	AQHZJJWUYYGRQM-UHFFFAOYSA-N	392592	N-((6-amino-2-methylpyridin-3- yl)methyl)-5-((3-chloroquinolin-6- yl)methyl)-1,3,4-oxadiazole-2- carboxamide::US10301284, Example 79::US10781200, Example 79	Plasma kallikrein			 550							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392592	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392592&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178763	404960922							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957251	Cc1cc(N)nc(C)c1CNC(=O)c1cnc(o1)C(=O)c1ccc2ncc(Cl)cc2c1	InChI=1S/C22H18ClN5O3/c1-11-5-19(24)28-12(2)16(11)9-26-21(30)18-10-27-22(31-18)20(29)13-3-4-17-14(6-13)7-15(23)8-25-17/h3-8,10H,9H2,1-2H3,(H2,24,28)(H,26,30)	GTELKVRQDBZNKH-UHFFFAOYSA-N	392593	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-2-(3-chloroquinoline-6- carbonyl)oxazole-5-carboxamide::US10301284, Example 80::US10781200, Example 80	Plasma kallikrein			>10000							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392593	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392593&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178255	404960923							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957252	Cc1cnc2ccc(Cn3cc(C(=O)NCc4c(C)cc(N)nc4C)c(n3)C#N)cc2c1	InChI=1S/C24H23N7O/c1-14-6-18-8-17(4-5-21(18)27-10-14)12-31-13-20(22(9-25)30-31)24(32)28-11-19-15(2)7-23(26)29-16(19)3/h4-8,10,13H,11-12H2,1-3H3,(H2,26,29)(H,28,32)	RJJTWNPAAKOFGC-UHFFFAOYSA-N	392594	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-3-cyano-1-((3- methylquinolin-6-yl)methyl)-1H- pyrazole-4-carboxamide::US10301284, Example 81::US10781200, Example 81	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392594	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392594&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178770	404960924							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957253	Cc1cnc2ccc(Cn3cc(C(=O)NCc4ccc(N)nc4C)c(n3)C#N)cc2c1	InChI=1S/C23H21N7O/c1-14-7-18-8-16(3-5-20(18)26-10-14)12-30-13-19(21(9-24)29-30)23(31)27-11-17-4-6-22(25)28-15(17)2/h3-8,10,13H,11-12H2,1-2H3,(H2,25,28)(H,27,31)	VLKMZUJBTBGDEX-UHFFFAOYSA-N	392595	N-((6-amino-2-methylpyridin-3- yl)methyl)-3-cyano-1-((3- methylquinolin-6-yl)methyl)-1H- pyrazole-4-carboxamide::US10301284, Example 82::US10781200, Example 82	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392595	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392595&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178090	404960925							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957254	Cc1nc(N)ccc1CNC(=O)c1coc(Cc2ccc3ncc(Cl)cc3c2)n1	InChI=1S/C21H18ClN5O2/c1-12-14(3-5-19(23)26-12)9-25-21(28)18-11-29-20(27-18)7-13-2-4-17-15(6-13)8-16(22)10-24-17/h2-6,8,10-11H,7,9H2,1H3,(H2,23,26)(H,25,28)	STTJLBAGARXCNC-UHFFFAOYSA-N	392596	N-((6-amino-2-methylpyridin-3- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)oxazole-4-carboxamide::US10301284, Example 83::US10781200, Example 83	Plasma kallikrein			 550							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392596	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392596&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178093	404960926							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957255	Cc1nc(N)ccc1CNC(=O)c1ncc(Cc2ccc3ncc(Cl)cc3c2)o1	InChI=1S/C21H18ClN5O2/c1-12-14(3-5-19(23)27-12)9-25-20(28)21-26-11-17(29-21)7-13-2-4-18-15(6-13)8-16(22)10-24-18/h2-6,8,10-11H,7,9H2,1H3,(H2,23,27)(H,25,28)	DVQVQRZIBKJHBQ-UHFFFAOYSA-N	392597	N-((6-amino-2-methylpyridin-3- yl)methyl)-5-((3-chloroquinolin-6- yl)methyl)oxazole-2-carboxamide::US10301284, Example 84::US10781200, Example 84	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392597	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392597&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178094	404960927							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957256	Cc1nn(Cc2ccc3ncc(Cl)cc3c2)cc1C(=O)NCc1ccc(N)nc1C	InChI=1S/C22H21ClN6O/c1-13-16(4-6-21(24)27-13)9-26-22(30)19-12-29(28-14(19)2)11-15-3-5-20-17(7-15)8-18(23)10-25-20/h3-8,10,12H,9,11H2,1-2H3,(H2,24,27)(H,26,30)	VMLILBWSDVWDGN-UHFFFAOYSA-N	392598	N-((6-amino-2-methylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-3-methyl-1H-pyrazole-4- carboxamide::US10301284, Example 85::US10781200, Example 85	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392598	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392598&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178243	404960928							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957257	Cc1cc(N)nc(C)c1CNC(=O)c1nnc(Cc2cc(c3ncc(Cl)cc3c2)C(C)(C)O)o1	InChI=1S/C24H25ClN6O3/c1-12-5-19(26)29-13(2)17(12)11-28-22(32)23-31-30-20(34-23)8-14-6-15-9-16(25)10-27-21(15)18(7-14)24(3,4)33/h5-7,9-10,33H,8,11H2,1-4H3,(H2,26,29)(H,28,32)	XOKNJAVPHRBBRO-UHFFFAOYSA-N	392599	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-5-((3-chloro-8-(2- hydroxypropan-2-yl)quinolin-6- yl)methyl)-1,3,4-oxadiazole-2- carboxamide::US10301284, Example 86::US10781200, Example 86	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392599	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392599&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178326	404960929							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957258	Cc1cc(N)nc(C)c1CNC(=O)c1oc(Cc2ccc3ncc(Cl)cc3c2)nc1C#N	InChI=1S/C23H19ClN6O2/c1-12-5-20(26)29-13(2)17(12)11-28-23(31)22-19(9-25)30-21(32-22)7-14-3-4-18-15(6-14)8-16(24)10-27-18/h3-6,8,10H,7,11H2,1-2H3,(H2,26,29)(H,28,31)	KUUZATFFKQICAR-UHFFFAOYSA-N	392600	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)-4-cyanooxazole-5- carboxamide::US10301284, Example 87::US10781200, Example 87	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392600	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392600&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178781	404960930							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957259	Cc1nc(N)ccc1CNC(=O)c1oc(Cc2ccc3ncc(Cl)cc3c2)nc1C#N	InChI=1S/C22H17ClN6O2/c1-12-14(3-5-19(25)28-12)10-27-22(30)21-18(9-24)29-20(31-21)7-13-2-4-17-15(6-13)8-16(23)11-26-17/h2-6,8,11H,7,10H2,1H3,(H2,25,28)(H,27,30)	IYMMAGWPLVXHAE-UHFFFAOYSA-N	392601	N-((6-amino-2-methylpyridin-3- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)-4-cyanooxazole-5- carboxamide::US10301284, Example 88::US10781200, Example 88	Plasma kallikrein			 550							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392601	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392601&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178599	404960931							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957260	Cc1cc(N)nc(C)c1CNC(=O)c1cnc(Cc2ccc3ncc(Cl)cc3c2)o1	InChI=1S/C22H20ClN5O2/c1-12-5-20(24)28-13(2)17(12)10-27-22(29)19-11-26-21(30-19)7-14-3-4-18-15(6-14)8-16(23)9-25-18/h3-6,8-9,11H,7,10H2,1-2H3,(H2,24,28)(H,27,29)	BWAYCGGQOLRABV-UHFFFAOYSA-N	392602	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)oxazole-5-carboxamide::US10301284, Example 114::US10301284, Example 89::US10781200, Example 114	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392602	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392602&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178172	404960932							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957261	Cc1nc(N)ccc1CNC(=O)c1cnc(Cc2ccc3ncc(Cl)cc3c2)o1	InChI=1S/C21H18ClN5O2/c1-12-14(3-5-19(23)27-12)9-26-21(28)18-11-25-20(29-18)7-13-2-4-17-15(6-13)8-16(22)10-24-17/h2-6,8,10-11H,7,9H2,1H3,(H2,23,27)(H,26,28)	IDSATTJBDHIOKY-UHFFFAOYSA-N	392603	N-((6-amino-2-methylpyridin-3- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)oxazole-5-carboxamide::US10301284, Example 90::US10781200, Example 90	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392603	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392603&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178649	404960933							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957262	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)nc1C(F)F	InChI=1S/C23H21ClF2N6O/c1-12-5-20(27)30-13(2)17(12)9-29-23(33)18-11-32(31-21(18)22(25)26)10-14-3-4-19-15(6-14)7-16(24)8-28-19/h3-8,11,22H,9-10H2,1-2H3,(H2,27,30)(H,29,33)	LWOLUSSBTVYQPC-UHFFFAOYSA-N	392604	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-3-(difluoromethyl)-1H- pyrazole-4-carboxamide::US10301284, Example 91::US10781200, Example 91	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392604	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392604&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178601	404960934							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957263	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)nc1CO	InChI=1S/C23H23ClN6O2/c1-13-5-22(25)28-14(2)18(13)9-27-23(32)19-11-30(29-21(19)12-31)10-15-3-4-20-16(6-15)7-17(24)8-26-20/h3-8,11,31H,9-10,12H2,1-2H3,(H2,25,28)(H,27,32)	UEIKIRKDOQZEPL-UHFFFAOYSA-N	392605	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-3-(hydroxymethyl)-1H- pyrazole-4-carboxamide::US10301284, Example 92::US10781200, Example 92	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392605	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392605&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134177821	404960935							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957264	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)nc1CF	InChI=1S/C23H22ClFN6O/c1-13-5-22(26)29-14(2)18(13)10-28-23(32)19-12-31(30-21(19)8-25)11-15-3-4-20-16(6-15)7-17(24)9-27-20/h3-7,9,12H,8,10-11H2,1-2H3,(H2,26,29)(H,28,32)	MZZKZOACNKDJAF-UHFFFAOYSA-N	392606	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-3-(fluoromethyl)-1H- pyrazole-4-carboxamide::US10301284, Example 93::US10781200, Example 93	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392606	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392606&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178792	404960936							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957265	CC(O)c1nn(Cc2ccc3ncc(Cl)cc3c2)cc1C(=O)NCc1c(C)cc(N)nc1C	InChI=1S/C24H25ClN6O2/c1-13-6-22(26)29-14(2)19(13)10-28-24(33)20-12-31(30-23(20)15(3)32)11-16-4-5-21-17(7-16)8-18(25)9-27-21/h4-9,12,15,32H,10-11H2,1-3H3,(H2,26,29)(H,28,33)	AIXXOQKKNALNFF-UHFFFAOYSA-N	392607	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-3-(1-hydroxyethyl)-1H- pyrazole-4-carboxamide::US10301284, Example 94::US10781200, Example 94	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392607	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392607&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178108	404960937							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957266	Cc1cc(N)nc(C)c1CNC(=O)c1nn(Cc2ccc3ncc(Cl)cc3c2)nc1C#N	InChI=1S/C22H19ClN8O/c1-12-5-20(25)28-13(2)17(12)10-27-22(32)21-19(8-24)29-31(30-21)11-14-3-4-18-15(6-14)7-16(23)9-26-18/h3-7,9H,10-11H2,1-2H3,(H2,25,28)(H,27,32)	BGBQIVACHOGRQL-UHFFFAOYSA-N	392608	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)-5-cyano-2H-1,2,3-triazole- 4-carboxamide::US10301284, Example 95::US10781200, Example 95	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392608	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392608&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178112	404960938							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957267	Cc1cc(N)nc(C)c1CNC(=O)c1nnc(Cc2ccc3ncc(Cl)cc3c2)[nH]1	InChI=1S/C21H20ClN7O/c1-11-5-18(23)26-12(2)16(11)10-25-21(30)20-27-19(28-29-20)7-13-3-4-17-14(6-13)8-15(22)9-24-17/h3-6,8-9H,7,10H2,1-2H3,(H2,23,26)(H,25,30)(H,27,28,29)	GWZNHJDQNSQXBV-UHFFFAOYSA-N	392609	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-5-((3-chloroquinolin-6- yl)methyl)-4H-1,2,4-triazole-3- carboxamide::US10301284, Example 96::US10781200, Example 96	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392609	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392609&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178628	404960939							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957268	Cc1nc(N)ccc1CNC(=O)c1nnc(Cc2ccc3ncc(Cl)cc3c2)[nH]1	InChI=1S/C20H18ClN7O/c1-11-13(3-5-17(22)25-11)9-24-20(29)19-26-18(27-28-19)7-12-2-4-16-14(6-12)8-15(21)10-23-16/h2-6,8,10H,7,9H2,1H3,(H2,22,25)(H,24,29)(H,26,27,28)	LALNGWBKLQSSFH-UHFFFAOYSA-N	392610	N-((6-amino-2-methylpyridin-3- yl)methyl)-5-((3-chloroquinolin-6- yl)methyl)-4H-1,2,4-triazole-3- carboxamide::US10301284, Example 97::US10781200, Example 97	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392610	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392610&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134177935	404960940							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957269	Cc1cc(N)nc(C)c1CNC(=O)c1nnc(Cc2ccc3ncc(Cl)cc3c2)n1C	InChI=1S/C22H22ClN7O/c1-12-6-19(24)27-13(2)17(12)11-26-22(31)21-29-28-20(30(21)3)8-14-4-5-18-15(7-14)9-16(23)10-25-18/h4-7,9-10H,8,11H2,1-3H3,(H2,24,27)(H,26,31)	KNFHNBUOVPFSSJ-UHFFFAOYSA-N	392611	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-5-((3-chloroquinolin-6- yl)methyl)-4-methyl-4H-1,2,4-triazole- 3-carboxamide::US10301284, Example 98::US10781200, Example 98	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392611	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392611&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178115	404960941							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957270	Cc1cc(N)nc(C)c1CNC(=O)c1nc(Cc2ccc3ncc(Cl)cc3c2)nn1C	InChI=1S/C22H22ClN7O/c1-12-6-19(24)27-13(2)17(12)11-26-22(31)21-28-20(29-30(21)3)8-14-4-5-18-15(7-14)9-16(23)10-25-18/h4-7,9-10H,8,11H2,1-3H3,(H2,24,27)(H,26,31)	WYXVZAJMHRAVCY-UHFFFAOYSA-N	392612	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-3-((3-chloroquinolin-6- yl)methyl)-1-methyl-1H-1,2,4-triazole- 5-carboxamide::US10301284, Example 99::US10781200, Example 99	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392612	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392612&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178430	404960942							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957271	Cc1cc(N)nc(C)c1CNC(=O)c1nc(Br)n(Cc2ccc3ncc(Cl)cc3c2)n1	InChI=1S/C21H19BrClN7O/c1-11-5-18(24)27-12(2)16(11)9-26-20(31)19-28-21(22)30(29-19)10-13-3-4-17-14(6-13)7-15(23)8-25-17/h3-8H,9-10H2,1-2H3,(H2,24,27)(H,26,31)	CAYHJZWPQZWFHQ-UHFFFAOYSA-N	392613	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-5-bromo-1-((3- chloroquinolin-6-yl)methyl)-1H-1,2,4- triazole-3-carboxamide::US10301284, Example 100::US10781200, Example 100	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392613	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392613&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178441	404960943							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957272	Cc1cc(N)nc(C)c1CNC(=O)c1nc(C#N)n(Cc2ccc3ncc(Cl)cc3c2)n1	InChI=1S/C22H19ClN8O/c1-12-5-19(25)28-13(2)17(12)10-27-22(32)21-29-20(8-24)31(30-21)11-14-3-4-18-15(6-14)7-16(23)9-26-18/h3-7,9H,10-11H2,1-2H3,(H2,25,28)(H,27,32)	LUQXRLODCNWAOB-UHFFFAOYSA-N	392614	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-5-cyano-1H-1,2,4-triazole- 3-carboxamide::US10301284, Example 101::US10301284, Example 107::US10781200, Example 108	Plasma kallikrein			>10000							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392614	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392614&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178440	404960944							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957273	COC(=O)c1nc(nn1Cc1ccc2ncc(Cl)cc2c1)C(=O)NCc1c(C)cc(N)nc1C	InChI=1S/C23H22ClN7O3/c1-12-6-19(25)28-13(2)17(12)10-27-22(32)20-29-21(23(33)34-3)31(30-20)11-14-4-5-18-15(7-14)8-16(24)9-26-18/h4-9H,10-11H2,1-3H3,(H2,25,28)(H,27,32)	PDBYDGASNRJXIH-UHFFFAOYSA-N	392615	US10301284, Example 102::US10781200, Example 102::methyl 3-(((6-amino-2,4- dimethylpyridin-3- yl)methyl)carbamoyl)-1-((3- chloroquinolin-6-yl)methyl)-1H-1,2,4- triazole-5-carboxylate	Plasma kallikrein			>10000							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392615	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392615&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178456	404960945							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957274	Cc1cc(N)nc(C)c1CNC(=O)c1c[nH]c(Cc2ccc3ncc(Cl)cc3c2)n1	InChI=1S/C22H21ClN6O/c1-12-5-20(24)28-13(2)17(12)10-27-22(30)19-11-26-21(29-19)7-14-3-4-18-15(6-14)8-16(23)9-25-18/h3-6,8-9,11H,7,10H2,1-2H3,(H2,24,28)(H,26,29)(H,27,30)	HEBXTXYICXOMQA-UHFFFAOYSA-N	392616	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)-1H-imidazole-4- carboxamide::US10301284, Example 103::US10781200, Example 103	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392616	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392616&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178458	404960946							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957275	Cc1cc(N)nc(C)c1CNC(=O)c1cn(C)c(Cc2ccc3ncc(Cl)cc3c2)n1	InChI=1S/C23H23ClN6O/c1-13-6-21(25)28-14(2)18(13)11-27-23(31)20-12-30(3)22(29-20)8-15-4-5-19-16(7-15)9-17(24)10-26-19/h4-7,9-10,12H,8,11H2,1-3H3,(H2,25,28)(H,27,31)	UPEWXEYBWGKXKU-UHFFFAOYSA-N	392617	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)-1-methyl-1H-imidazole-4- carboxamide::US10301284, Example 104::US10781200, Example 104	Plasma kallikrein			>10000							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392617	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392617&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178455	404960947							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957276	Cc1cc(N)nc(C)c1CNC(=O)c1cnc(Cc2ccc3ncc(Cl)cc3c2)n1C	InChI=1S/C23H23ClN6O/c1-13-6-21(25)29-14(2)18(13)11-28-23(31)20-12-27-22(30(20)3)8-15-4-5-19-16(7-15)9-17(24)10-26-19/h4-7,9-10,12H,8,11H2,1-3H3,(H2,25,29)(H,28,31)	JKDTYUNBKGFNIV-UHFFFAOYSA-N	392618	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)-1-methyl-1H-imidazole-5- carboxamide::US10301284, Example 105::US10781200, Example 105	Plasma kallikrein			 5500							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392618	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392618&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134177927	404960948							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957277	Cc1cc(N)nc(C)c1CNC(=O)c1[nH]c(Cc2ccc3ncc(Cl)cc3c2)nc1Br	InChI=1S/C22H20BrClN6O/c1-11-5-18(25)28-12(2)16(11)10-27-22(31)20-21(23)30-19(29-20)7-13-3-4-17-14(6-13)8-15(24)9-26-17/h3-6,8-9H,7,10H2,1-2H3,(H2,25,28)(H,27,31)(H,29,30)	XEFKTWYRQYYWNW-UHFFFAOYSA-N	392619	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-4-bromo-2-((3- chloroquinolin-6-yl)methyl)-1H- imidazole-5-carboxamide::US10301284, Example 106::US10781200, Example 106	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392619	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392619&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178120	404960949							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957278	Cc1cc(N)nc(C)c1CNC(=O)c1nc(C#N)n(Cc2ccc3ncc(Cl)cc3c2)n1	InChI=1S/C22H19ClN8O/c1-12-5-19(25)28-13(2)17(12)10-27-22(32)21-29-20(8-24)31(30-21)11-14-3-4-18-15(6-14)7-16(23)9-26-18/h3-7,9H,10-11H2,1-2H3,(H2,25,28)(H,27,32)	LUQXRLODCNWAOB-UHFFFAOYSA-N	392614	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-5-cyano-1H-1,2,4-triazole- 3-carboxamide::US10301284, Example 101::US10301284, Example 107::US10781200, Example 108	Plasma kallikrein			 550							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392614	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392614&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178440	404960944							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957279	Cc1cc(N)nc(C)c1CNC(=O)c1nc(C#N)n(Cc2ccc3ncc(Cl)cc3c2)n1	InChI=1S/C22H19ClN8O/c1-12-5-19(25)28-13(2)17(12)10-27-22(32)21-29-20(8-24)31(30-21)11-14-3-4-18-15(6-14)7-16(23)9-26-18/h3-7,9H,10-11H2,1-2H3,(H2,25,28)(H,27,32)	LUQXRLODCNWAOB-UHFFFAOYSA-N	392614	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-5-cyano-1H-1,2,4-triazole- 3-carboxamide::US10301284, Example 101::US10301284, Example 107::US10781200, Example 108	Plasma kallikrein			 550							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392614	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392614&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178440	404960944							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957280	Cc1cc(N)nc(C)c1CNC(=O)c1cc(nn1Cc1ccc2ncc(Cl)cc2c1)C#N	InChI=1S/C23H20ClN7O/c1-13-5-22(26)29-14(2)19(13)11-28-23(32)21-8-18(9-25)30-31(21)12-15-3-4-20-16(6-15)7-17(24)10-27-20/h3-8,10H,11-12H2,1-2H3,(H2,26,29)(H,28,32)	CFWIUGJZUJJTDD-UHFFFAOYSA-N	392622	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-3-cyano-1H-pyrazole-5- carboxamide::US10301284, Example 109::US10781200, Example 109	Plasma kallikrein			>10000							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392622	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392622&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178125	404960951							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957281	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)c(CO)n1	InChI=1S/C23H23ClN6O2/c1-13-5-21(25)28-14(2)18(13)9-27-23(32)20-11-30(22(12-31)29-20)10-15-3-4-19-16(6-15)7-17(24)8-26-19/h3-8,11,31H,9-10,12H2,1-2H3,(H2,25,28)(H,27,32)	JDLJMUVSMCYMMH-UHFFFAOYSA-N	392623	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-2-(hydroxymethyl)-1H- imidazole-4-carboxamide::US10301284, Example 110::US10781200, Example 110	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392623	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392623&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178434	404960952							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957282	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)c(n1)C(N)=O	InChI=1S/C23H22ClN7O2/c1-12-5-20(25)29-13(2)17(12)9-28-23(33)19-11-31(22(30-19)21(26)32)10-14-3-4-18-15(6-14)7-16(24)8-27-18/h3-8,11H,9-10H2,1-2H3,(H2,25,29)(H2,26,32)(H,28,33)	INGHBSITETVSGZ-UHFFFAOYSA-N	463665	N4-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-1H-imidazole-2,4- dicarboxamide::US10781200, Example 111	Plasma kallikrein			 550							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463665	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463665&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178129	441573505							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957283	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)c(CN)n1	InChI=1S/C23H24ClN7O/c1-13-5-21(26)29-14(2)18(13)10-28-23(32)20-12-31(22(8-25)30-20)11-15-3-4-19-16(6-15)7-17(24)9-27-19/h3-7,9,12H,8,10-11,25H2,1-2H3,(H2,26,29)(H,28,32)	UMSUITBTAXIOKI-UHFFFAOYSA-N	392625	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-2-(aminomethyl)-1-((3- chloroquinolin-6-yl)methyl)-1H- imidazole-4-carboxamide::US10301284, Example 112::US10781200, Example 112	Plasma kallikrein			 550							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392625	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392625&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178616	404960954							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957284	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)c(n1)C#N	InChI=1S/C23H20ClN7O/c1-13-5-21(26)29-14(2)18(13)10-28-23(32)20-12-31(22(8-25)30-20)11-15-3-4-19-16(6-15)7-17(24)9-27-19/h3-7,9,12H,10-11H2,1-2H3,(H2,26,29)(H,28,32)	QRFIOVQERIMLRW-UHFFFAOYSA-N	392626	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-2-cyano-1H-imidazole-4- carboxamide::US10301284, Example 113::US10781200, Example 113	Plasma kallikrein			 550							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392626	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392626&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178350	404960955							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957285	Cc1cc(N)nc(C)c1CNC(=O)c1cnc(Cc2ccc3ncc(Cl)cc3c2)o1	InChI=1S/C22H20ClN5O2/c1-12-5-20(24)28-13(2)17(12)10-27-22(29)19-11-26-21(30-19)7-14-3-4-18-15(6-14)8-16(23)9-25-18/h3-6,8-9,11H,7,10H2,1-2H3,(H2,24,28)(H,27,29)	BWAYCGGQOLRABV-UHFFFAOYSA-N	392602	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)oxazole-5-carboxamide::US10301284, Example 114::US10301284, Example 89::US10781200, Example 114	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392602	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392602&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178172	404960932							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957286	Cc1cc(N)nc(C)c1CNC(=O)c1nn(Cc2ccc3ncc(Cl)cc3c2)nc1C(F)(F)F	InChI=1S/C22H19ClF3N7O/c1-11-5-18(27)30-12(2)16(11)9-29-21(34)19-20(22(24,25)26)32-33(31-19)10-13-3-4-17-14(6-13)7-15(23)8-28-17/h3-8H,9-10H2,1-2H3,(H2,27,30)(H,29,34)	QVJZSLPTEPTTJN-UHFFFAOYSA-N	392628	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)-5-(trifluoromethyl)-2H- 1,2,3-triazole-4-carboxamide::US10301284, Example 115::US10781200, Example 115	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392628	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392628&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178693	404960956							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957287	Cc1cc(N)nc(C)c1CNC(=O)c1cc(n(Cc2ccc3ncc(Cl)cc3c2)n1)C(F)(F)F	InChI=1S/C23H20ClF3N6O/c1-12-5-21(28)31-13(2)17(12)10-30-22(34)19-8-20(23(25,26)27)33(32-19)11-14-3-4-18-15(6-14)7-16(24)9-29-18/h3-9H,10-11H2,1-2H3,(H2,28,31)(H,30,34)	DDSXVVAYYHCPAS-UHFFFAOYSA-N	392629	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-5-(trifluoromethyl)-1H- pyrazole-3-carboxamide::US10301284, Example 116::US10781200, Example 116	Plasma kallikrein			 5500							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392629	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392629&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178640	404960957							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957288	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)c2cnc(Cl)cc12	InChI=1S/C26H22Cl2N6O/c1-14-5-25(29)33-15(2)20(14)10-32-26(35)21-13-34(23-11-31-24(28)8-19(21)23)12-16-3-4-22-17(6-16)7-18(27)9-30-22/h3-9,11,13H,10,12H2,1-2H3,(H2,29,33)(H,32,35)	VSUOKEQGVUESPJ-UHFFFAOYSA-N	392630	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-5-chloro-1-((3- chloroquinolin-6-yl)methyl)-1H- pyrrolo[2,3-c]pyridine-3-carboxamide::US10301284, Example 117::US10781200, Example 117	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392630	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392630&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178358	404960958							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957289	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)c2cc[nH]c(=O)c12	InChI=1S/C26H23ClN6O2/c1-14-7-23(28)32-15(2)19(14)11-31-25(34)20-13-33(22-5-6-29-26(35)24(20)22)12-16-3-4-21-17(8-16)9-18(27)10-30-21/h3-10,13H,11-12H2,1-2H3,(H2,28,32)(H,29,35)(H,31,34)	ILKWFMJGGDAPRD-UHFFFAOYSA-N	392631	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-4-oxo-4,5-dihydro-1H- pyrrolo[3,2-c]pyridine-3-carboxamide::US10301284, Example 118::US10781200, Example 118	Plasma kallikrein			>10000							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392631	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392631&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			146012335	404960959							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957290	Cc1cc(N)nc(C)c1CNC(=O)c1nn(Cc2ccc3ncc(Cl)cc3c2)c2ccnc(Cl)c12	InChI=1S/C25H21Cl2N7O/c1-13-7-21(28)32-14(2)18(13)11-31-25(35)23-22-20(5-6-29-24(22)27)34(33-23)12-15-3-4-19-16(8-15)9-17(26)10-30-19/h3-10H,11-12H2,1-2H3,(H2,28,32)(H,31,35)	YVVUSFNKWIJDRO-UHFFFAOYSA-N	392632	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-4-chloro-1-((3- chloroquinolin-6-yl)methyl)-1H- pyrazolo[4,3-c]pyridine-3- carboxamide::US10301284, Example 119::US10781200, Example 119	Plasma kallikrein			 550							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392632	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392632&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178824	404960960							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957291	Cc1cc(N)nc(C)c1CNC(=O)c1nn(Cc2ccc3ncc(Cl)cc3c2)c2cc[nH]c(=O)c12	InChI=1S/C25H22ClN7O2/c1-13-7-21(27)31-14(2)18(13)11-30-25(35)23-22-20(5-6-28-24(22)34)33(32-23)12-15-3-4-19-16(8-15)9-17(26)10-29-19/h3-10H,11-12H2,1-2H3,(H2,27,31)(H,28,34)(H,30,35)	JGZHQZLALCTIAI-UHFFFAOYSA-N	392633	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-4-oxo-4,5-dihydro-1H- pyrazolo[4,3-c]pyridine-3- carboxamide::US10301284, Example 120::US10781200, Example 120	Plasma kallikrein			 5500							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392633	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392633&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			146012336	404960961							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957292	COc1cc2c(cn(Cc3ccc4ncc(Cl)cc4c3)c2cn1)C(=O)NCc1c(C)cc(N)nc1C	InChI=1S/C27H25ClN6O2/c1-15-6-25(29)33-16(2)21(15)11-32-27(35)22-14-34(24-12-31-26(36-3)9-20(22)24)13-17-4-5-23-18(7-17)8-19(28)10-30-23/h4-10,12,14H,11,13H2,1-3H3,(H2,29,33)(H,32,35)	LWJZROFHXJWOKM-UHFFFAOYSA-N	392634	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-5-methoxy-1H-pyrrolo[2,3- c]pyridine-3-carboxamide::US10301284, Example 121::US10781200, Example 121	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392634	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392634&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134177829	404960962							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957293	COc1cc2c(nn(Cc3ccc4ncc(Cl)cc4c3)c2cn1)C(=O)NCc1c(C)cc(N)nc1C	InChI=1S/C26H24ClN7O2/c1-14-6-23(28)32-15(2)20(14)11-31-26(35)25-19-9-24(36-3)30-12-22(19)34(33-25)13-16-4-5-21-17(7-16)8-18(27)10-29-21/h4-10,12H,11,13H2,1-3H3,(H2,28,32)(H,31,35)	PSAXJTGHLNJLPE-UHFFFAOYSA-N	392635	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-5-methoxy-1H- pyrazolo[3,4-c]pyridine-3- carboxamide::US10301284, Example 122::US10781200, Example 122	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392635	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392635&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178921	404960963							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957294	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)c2cncc(C#N)c12	InChI=1S/C27H22ClN7O/c1-15-5-25(30)34-16(2)21(15)11-33-27(36)22-14-35(24-12-31-9-19(8-29)26(22)24)13-17-3-4-23-18(6-17)7-20(28)10-32-23/h3-7,9-10,12,14H,11,13H2,1-2H3,(H2,30,34)(H,33,36)	SSGRYFOBYQPFKP-UHFFFAOYSA-N	392636	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-4-cyano-1H-pyrrolo[2,3- c]pyridine-3-carboxamide::US10301284, Example 123::US10781200, Example 123	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392636	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392636&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134178629	404960964							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957295	Cc1cc(N)nc(C)c1CNC(=O)c1nn(Cc2ccc3ncc(Cl)cc3c2)c2c[nH]c(=O)cc12	InChI=1S/C25H22ClN7O2/c1-13-5-22(27)31-14(2)19(13)10-30-25(35)24-18-8-23(34)29-11-21(18)33(32-24)12-15-3-4-20-16(6-15)7-17(26)9-28-20/h3-9,11H,10,12H2,1-2H3,(H2,27,31)(H,29,34)(H,30,35)	IBWIDFNSDDXQSS-UHFFFAOYSA-N	392637	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-5-oxo-5,6-dihydro-1H- pyrazolo[3,4-c]pyridine-3- carboxamide::US10301284, Example 124::US10781200, Example 124	Plasma kallikrein			 550							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392637	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392637&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			146012337	404960965							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957296	Cc1nc(N)ccc1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)c2ccc(=O)[nH]c12	InChI=1S/C25H21ClN6O2/c1-14-16(3-6-22(27)30-14)10-29-25(34)19-13-32(21-5-7-23(33)31-24(19)21)12-15-2-4-20-17(8-15)9-18(26)11-28-20/h2-9,11,13H,10,12H2,1H3,(H2,27,30)(H,29,34)(H,31,33)	IWDBVKCJUBGXNQ-UHFFFAOYSA-N	392638	N-((6-amino-2-methylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-5-oxo-4,5-dihydro-1H- pyrrolo[3,2-b]pyridine-3-carboxamide::US10301284, Example 125::US10781200, Example 125	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392638	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392638&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			146012338	404960966							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
957297	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)c2ccc(=O)[nH]c12	InChI=1S/C26H23ClN6O2/c1-14-7-23(28)31-15(2)19(14)11-30-26(35)20-13-33(22-5-6-24(34)32-25(20)22)12-16-3-4-21-17(8-16)9-18(27)10-29-21/h3-10,13H,11-12H2,1-2H3,(H2,28,31)(H,30,35)(H,32,34)	ZSIYFIYIEHIJSA-UHFFFAOYSA-N	392639	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-1-((3-chloroquinolin-6- yl)methyl)-5-oxo-4,5-dihydro-1H- pyrrolo[3,2-b]pyridine-3-carboxamide::US10301284, Example 126::US10781200, Example 126	Plasma kallikrein			<100							US Patent		10.7270/Q29026VV		aid1804820	US10781200	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392639	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392639&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			146012339	404960967							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51340829	NCc1cccc(c1)-c1cccc(COc2ccccc2CC(O)=O)c1	InChI=1S/C22H21NO3/c23-14-16-5-3-8-18(11-16)19-9-4-6-17(12-19)15-26-21-10-2-1-7-20(21)13-22(24)25/h1-12H,13-15,23H2,(H,24,25)	CFIDHIDGDXATPD-UHFFFAOYSA-N	50524338	CHEMBL4468000	Plasma kallikrein			 3100							ChEMBL	10.1021/acs.jmedchem.0c00279	10.7270/Q2KS6W36	32551603			Lorthiois, E; Roache, J; Barnes-Seeman, D; Altmann, E; Hassiepen, U; Turner, G; Duvadie, R; Hornak, V; Karki, RG; Schiering, N; Weihofen, WA; Perruccio, F; Calhoun, A; Fazal, T; Dedic, D; Durand, C; Dussauge, S; Fettis, K; Tritsch, F; Dentel, C; Druet, A; Liu, D; Kirman, L; Lachal, J; Namoto, K; Bevan, D; Mo, R; Monnet, G; Muller, L; Zessis, R; Huang, X; Lindsley, L; Currie, T; Chiu, YH; Fridrich, C; Delgado, P; Wang, S; Hollis-Symynkywicz, M; Berghausen, J; Williams, E; Liu, H; Liang, G; Kim, H; Hoffmann, P; Hein, A; Ramage, P; D'Arcy, A; Harlfinger, S; Renatus, M; Ruedisser, S; Feldman, D; Elliott, J; Sedrani, R; Maibaum, J; Adams, CM	Novartis Institutes for BioMedical Research	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50524338	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50524338&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117820231	440732920							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51340839	NC1COc2ccc(cc12)-c1cccc(COc2ccccc2CC(O)=O)c1	InChI=1S/C23H21NO4/c24-20-14-28-22-9-8-17(11-19(20)22)16-6-3-4-15(10-16)13-27-21-7-2-1-5-18(21)12-23(25)26/h1-11,20H,12-14,24H2,(H,25,26)	YGRXRRBTUHETRD-UHFFFAOYSA-N	50542722	CHEMBL4647953	Plasma kallikrein			 1300							ChEMBL	10.1021/acs.jmedchem.0c00279	10.7270/Q2KS6W36	32551603			Lorthiois, E; Roache, J; Barnes-Seeman, D; Altmann, E; Hassiepen, U; Turner, G; Duvadie, R; Hornak, V; Karki, RG; Schiering, N; Weihofen, WA; Perruccio, F; Calhoun, A; Fazal, T; Dedic, D; Durand, C; Dussauge, S; Fettis, K; Tritsch, F; Dentel, C; Druet, A; Liu, D; Kirman, L; Lachal, J; Namoto, K; Bevan, D; Mo, R; Monnet, G; Muller, L; Zessis, R; Huang, X; Lindsley, L; Currie, T; Chiu, YH; Fridrich, C; Delgado, P; Wang, S; Hollis-Symynkywicz, M; Berghausen, J; Williams, E; Liu, H; Liang, G; Kim, H; Hoffmann, P; Hein, A; Ramage, P; D'Arcy, A; Harlfinger, S; Renatus, M; Ruedisser, S; Feldman, D; Elliott, J; Sedrani, R; Maibaum, J; Adams, CM	Novartis Institutes for BioMedical Research	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50542722	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50542722&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156020595	442144285							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51340842	CC(C)c1cc(COc2ccccc2CC(O)=O)cc(c1)-c1ccc2OC[C@@H](N)c2c1	InChI=1S/C26H27NO4/c1-16(2)20-9-17(14-30-24-6-4-3-5-19(24)13-26(28)29)10-21(11-20)18-7-8-25-22(12-18)23(27)15-31-25/h3-12,16,23H,13-15,27H2,1-2H3,(H,28,29)/t23-/m1/s1	WQVBAYOMZJYFJK-HSZRJFAPSA-N	50542723	CHEMBL4643449	Plasma kallikrein			 3.0							ChEMBL	10.1021/acs.jmedchem.0c00279	10.7270/Q2KS6W36	32551603			Lorthiois, E; Roache, J; Barnes-Seeman, D; Altmann, E; Hassiepen, U; Turner, G; Duvadie, R; Hornak, V; Karki, RG; Schiering, N; Weihofen, WA; Perruccio, F; Calhoun, A; Fazal, T; Dedic, D; Durand, C; Dussauge, S; Fettis, K; Tritsch, F; Dentel, C; Druet, A; Liu, D; Kirman, L; Lachal, J; Namoto, K; Bevan, D; Mo, R; Monnet, G; Muller, L; Zessis, R; Huang, X; Lindsley, L; Currie, T; Chiu, YH; Fridrich, C; Delgado, P; Wang, S; Hollis-Symynkywicz, M; Berghausen, J; Williams, E; Liu, H; Liang, G; Kim, H; Hoffmann, P; Hein, A; Ramage, P; D'Arcy, A; Harlfinger, S; Renatus, M; Ruedisser, S; Feldman, D; Elliott, J; Sedrani, R; Maibaum, J; Adams, CM	Novartis Institutes for BioMedical Research	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50542723	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50542723&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156019025	442144286							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51340861	CC(C)(C#N)c1cc(COc2ccccc2CC(O)=O)cc(c1)-c1ccc2OC[C@@H](N)c2c1	InChI=1S/C27H26N2O4/c1-27(2,16-28)21-10-17(14-32-24-6-4-3-5-19(24)13-26(30)31)9-20(11-21)18-7-8-25-22(12-18)23(29)15-33-25/h3-12,23H,13-15,29H2,1-2H3,(H,30,31)/t23-/m1/s1	SRKDCGUSWAONMJ-HSZRJFAPSA-N	50542724	CHEMBL4636415	Plasma kallikrein			 2.0							ChEMBL	10.1021/acs.jmedchem.0c00279	10.7270/Q2KS6W36	32551603			Lorthiois, E; Roache, J; Barnes-Seeman, D; Altmann, E; Hassiepen, U; Turner, G; Duvadie, R; Hornak, V; Karki, RG; Schiering, N; Weihofen, WA; Perruccio, F; Calhoun, A; Fazal, T; Dedic, D; Durand, C; Dussauge, S; Fettis, K; Tritsch, F; Dentel, C; Druet, A; Liu, D; Kirman, L; Lachal, J; Namoto, K; Bevan, D; Mo, R; Monnet, G; Muller, L; Zessis, R; Huang, X; Lindsley, L; Currie, T; Chiu, YH; Fridrich, C; Delgado, P; Wang, S; Hollis-Symynkywicz, M; Berghausen, J; Williams, E; Liu, H; Liang, G; Kim, H; Hoffmann, P; Hein, A; Ramage, P; D'Arcy, A; Harlfinger, S; Renatus, M; Ruedisser, S; Feldman, D; Elliott, J; Sedrani, R; Maibaum, J; Adams, CM	Novartis Institutes for BioMedical Research	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50542724	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50542724&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	NW5	6TS6	146673503	442144287							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51340865	CC(C)(O)c1cc(COc2ccccc2CC(O)=O)cc(c1)-c1ccc2OC[C@@H](N)c2c1	InChI=1S/C26H27NO5/c1-26(2,30)20-10-16(14-31-23-6-4-3-5-18(23)13-25(28)29)9-19(11-20)17-7-8-24-21(12-17)22(27)15-32-24/h3-12,22,30H,13-15,27H2,1-2H3,(H,28,29)/t22-/m1/s1	IEAPTAHBSJIEKO-JOCHJYFZSA-N	50542725	CHEMBL4637683	Plasma kallikrein			 6.0							ChEMBL	10.1021/acs.jmedchem.0c00279	10.7270/Q2KS6W36	32551603			Lorthiois, E; Roache, J; Barnes-Seeman, D; Altmann, E; Hassiepen, U; Turner, G; Duvadie, R; Hornak, V; Karki, RG; Schiering, N; Weihofen, WA; Perruccio, F; Calhoun, A; Fazal, T; Dedic, D; Durand, C; Dussauge, S; Fettis, K; Tritsch, F; Dentel, C; Druet, A; Liu, D; Kirman, L; Lachal, J; Namoto, K; Bevan, D; Mo, R; Monnet, G; Muller, L; Zessis, R; Huang, X; Lindsley, L; Currie, T; Chiu, YH; Fridrich, C; Delgado, P; Wang, S; Hollis-Symynkywicz, M; Berghausen, J; Williams, E; Liu, H; Liang, G; Kim, H; Hoffmann, P; Hein, A; Ramage, P; D'Arcy, A; Harlfinger, S; Renatus, M; Ruedisser, S; Feldman, D; Elliott, J; Sedrani, R; Maibaum, J; Adams, CM	Novartis Institutes for BioMedical Research	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50542725	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50542725&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156012692	442144288							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51340869	CC(C)(C(N)=O)c1cc(COc2ccccc2CC(O)=O)cc(c1)-c1ccc2OC[C@@H](N)c2c1	InChI=1S/C27H28N2O5/c1-27(2,26(29)32)20-10-16(14-33-23-6-4-3-5-18(23)13-25(30)31)9-19(11-20)17-7-8-24-21(12-17)22(28)15-34-24/h3-12,22H,13-15,28H2,1-2H3,(H2,29,32)(H,30,31)/t22-/m1/s1	YYZIUIZQIMNJMB-JOCHJYFZSA-N	50542726	CHEMBL4642766	Plasma kallikrein			 11							ChEMBL	10.1021/acs.jmedchem.0c00279	10.7270/Q2KS6W36	32551603			Lorthiois, E; Roache, J; Barnes-Seeman, D; Altmann, E; Hassiepen, U; Turner, G; Duvadie, R; Hornak, V; Karki, RG; Schiering, N; Weihofen, WA; Perruccio, F; Calhoun, A; Fazal, T; Dedic, D; Durand, C; Dussauge, S; Fettis, K; Tritsch, F; Dentel, C; Druet, A; Liu, D; Kirman, L; Lachal, J; Namoto, K; Bevan, D; Mo, R; Monnet, G; Muller, L; Zessis, R; Huang, X; Lindsley, L; Currie, T; Chiu, YH; Fridrich, C; Delgado, P; Wang, S; Hollis-Symynkywicz, M; Berghausen, J; Williams, E; Liu, H; Liang, G; Kim, H; Hoffmann, P; Hein, A; Ramage, P; D'Arcy, A; Harlfinger, S; Renatus, M; Ruedisser, S; Feldman, D; Elliott, J; Sedrani, R; Maibaum, J; Adams, CM	Novartis Institutes for BioMedical Research	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50542726	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50542726&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156017240	442144289							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51340873	CC(C)(O)c1cc(COc2ccccc2CC(O)=O)cc(c1)-c1ccc2CCNCc2c1	InChI=1S/C27H29NO4/c1-27(2,31)24-12-18(17-32-25-6-4-3-5-21(25)15-26(29)30)11-22(14-24)20-8-7-19-9-10-28-16-23(19)13-20/h3-8,11-14,28,31H,9-10,15-17H2,1-2H3,(H,29,30)	HURWGVYHBHPDHL-UHFFFAOYSA-N	50542727	CHEMBL4638019	Plasma kallikrein			 330							ChEMBL	10.1021/acs.jmedchem.0c00279	10.7270/Q2KS6W36	32551603			Lorthiois, E; Roache, J; Barnes-Seeman, D; Altmann, E; Hassiepen, U; Turner, G; Duvadie, R; Hornak, V; Karki, RG; Schiering, N; Weihofen, WA; Perruccio, F; Calhoun, A; Fazal, T; Dedic, D; Durand, C; Dussauge, S; Fettis, K; Tritsch, F; Dentel, C; Druet, A; Liu, D; Kirman, L; Lachal, J; Namoto, K; Bevan, D; Mo, R; Monnet, G; Muller, L; Zessis, R; Huang, X; Lindsley, L; Currie, T; Chiu, YH; Fridrich, C; Delgado, P; Wang, S; Hollis-Symynkywicz, M; Berghausen, J; Williams, E; Liu, H; Liang, G; Kim, H; Hoffmann, P; Hein, A; Ramage, P; D'Arcy, A; Harlfinger, S; Renatus, M; Ruedisser, S; Feldman, D; Elliott, J; Sedrani, R; Maibaum, J; Adams, CM	Novartis Institutes for BioMedical Research	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50542727	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50542727&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156012704	442144290							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51340877	CC1(C)COc2c1cc(cc2COc1ccccc1CC(O)=O)-c1ccc2OC[C@@H](N)c2c1	InChI=1S/C27H27NO5/c1-27(2)15-33-26-19(13-31-23-6-4-3-5-17(23)12-25(29)30)9-18(11-21(26)27)16-7-8-24-20(10-16)22(28)14-32-24/h3-11,22H,12-15,28H2,1-2H3,(H,29,30)/t22-/m1/s1	NTNRVRBIIZBTBR-JOCHJYFZSA-N	50542728	CHEMBL4635912	Plasma kallikrein			 7.0							ChEMBL	10.1021/acs.jmedchem.0c00279	10.7270/Q2KS6W36	32551603			Lorthiois, E; Roache, J; Barnes-Seeman, D; Altmann, E; Hassiepen, U; Turner, G; Duvadie, R; Hornak, V; Karki, RG; Schiering, N; Weihofen, WA; Perruccio, F; Calhoun, A; Fazal, T; Dedic, D; Durand, C; Dussauge, S; Fettis, K; Tritsch, F; Dentel, C; Druet, A; Liu, D; Kirman, L; Lachal, J; Namoto, K; Bevan, D; Mo, R; Monnet, G; Muller, L; Zessis, R; Huang, X; Lindsley, L; Currie, T; Chiu, YH; Fridrich, C; Delgado, P; Wang, S; Hollis-Symynkywicz, M; Berghausen, J; Williams, E; Liu, H; Liang, G; Kim, H; Hoffmann, P; Hein, A; Ramage, P; D'Arcy, A; Harlfinger, S; Renatus, M; Ruedisser, S; Feldman, D; Elliott, J; Sedrani, R; Maibaum, J; Adams, CM	Novartis Institutes for BioMedical Research	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50542728	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50542728&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156014221	442144291							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51340879	NC1COc2ccc(cc12)C(=O)N1C[C@H](C[C@H]1C(=O)Nc1cccc(Cl)c1)c1ccccc1	InChI=1S/C26H24ClN3O3/c27-19-7-4-8-20(13-19)29-25(31)23-12-18(16-5-2-1-3-6-16)14-30(23)26(32)17-9-10-24-21(11-17)22(28)15-33-24/h1-11,13,18,22-23H,12,14-15,28H2,(H,29,31)/t18-,22?,23-/m0/s1	XORBWNMOGAANNC-DGCGVQPYSA-N	50542729	CHEMBL4638904	Plasma kallikrein			 1200							ChEMBL	10.1021/acs.jmedchem.0c00279	10.7270/Q2KS6W36	32551603			Lorthiois, E; Roache, J; Barnes-Seeman, D; Altmann, E; Hassiepen, U; Turner, G; Duvadie, R; Hornak, V; Karki, RG; Schiering, N; Weihofen, WA; Perruccio, F; Calhoun, A; Fazal, T; Dedic, D; Durand, C; Dussauge, S; Fettis, K; Tritsch, F; Dentel, C; Druet, A; Liu, D; Kirman, L; Lachal, J; Namoto, K; Bevan, D; Mo, R; Monnet, G; Muller, L; Zessis, R; Huang, X; Lindsley, L; Currie, T; Chiu, YH; Fridrich, C; Delgado, P; Wang, S; Hollis-Symynkywicz, M; Berghausen, J; Williams, E; Liu, H; Liang, G; Kim, H; Hoffmann, P; Hein, A; Ramage, P; D'Arcy, A; Harlfinger, S; Renatus, M; Ruedisser, S; Feldman, D; Elliott, J; Sedrani, R; Maibaum, J; Adams, CM	Novartis Institutes for BioMedical Research	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50542729	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50542729&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156013247	442144292							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51340889	CC1(C)COc2c1cc(cc2COc1ccccc1CC(O)=O)-c1ccc2OCC[C@@H](N)c2c1	InChI=1S/C28H29NO5/c1-28(2)16-34-27-20(15-33-24-6-4-3-5-18(24)14-26(30)31)11-19(13-22(27)28)17-7-8-25-21(12-17)23(29)9-10-32-25/h3-8,11-13,23H,9-10,14-16,29H2,1-2H3,(H,30,31)/t23-/m1/s1	ZDMYKWNIEWNTLR-HSZRJFAPSA-N	50542730	CHEMBL4647909	Plasma kallikrein			 4.0							ChEMBL	10.1021/acs.jmedchem.0c00279	10.7270/Q2KS6W36	32551603			Lorthiois, E; Roache, J; Barnes-Seeman, D; Altmann, E; Hassiepen, U; Turner, G; Duvadie, R; Hornak, V; Karki, RG; Schiering, N; Weihofen, WA; Perruccio, F; Calhoun, A; Fazal, T; Dedic, D; Durand, C; Dussauge, S; Fettis, K; Tritsch, F; Dentel, C; Druet, A; Liu, D; Kirman, L; Lachal, J; Namoto, K; Bevan, D; Mo, R; Monnet, G; Muller, L; Zessis, R; Huang, X; Lindsley, L; Currie, T; Chiu, YH; Fridrich, C; Delgado, P; Wang, S; Hollis-Symynkywicz, M; Berghausen, J; Williams, E; Liu, H; Liang, G; Kim, H; Hoffmann, P; Hein, A; Ramage, P; D'Arcy, A; Harlfinger, S; Renatus, M; Ruedisser, S; Feldman, D; Elliott, J; Sedrani, R; Maibaum, J; Adams, CM	Novartis Institutes for BioMedical Research	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50542730	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50542730&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156020293	442144293							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51340904	CC(C)c1cc(cc(c1)-c1ccc2OC[C@@H](N)c2c1)[C@@H]1CNc2cccc(CC(O)=O)c2O1	InChI=1S/C27H28N2O4/c1-15(2)18-8-19(16-6-7-24-21(11-16)22(28)14-32-24)10-20(9-18)25-13-29-23-5-3-4-17(12-26(30)31)27(23)33-25/h3-11,15,22,25,29H,12-14,28H2,1-2H3,(H,30,31)/t22-,25+/m1/s1	HECONMODEBIAKY-RDGATRHJSA-N	50542731	CHEMBL4642845	Plasma kallikrein			 1.000000							ChEMBL	10.1021/acs.jmedchem.0c00279	10.7270/Q2KS6W36	32551603			Lorthiois, E; Roache, J; Barnes-Seeman, D; Altmann, E; Hassiepen, U; Turner, G; Duvadie, R; Hornak, V; Karki, RG; Schiering, N; Weihofen, WA; Perruccio, F; Calhoun, A; Fazal, T; Dedic, D; Durand, C; Dussauge, S; Fettis, K; Tritsch, F; Dentel, C; Druet, A; Liu, D; Kirman, L; Lachal, J; Namoto, K; Bevan, D; Mo, R; Monnet, G; Muller, L; Zessis, R; Huang, X; Lindsley, L; Currie, T; Chiu, YH; Fridrich, C; Delgado, P; Wang, S; Hollis-Symynkywicz, M; Berghausen, J; Williams, E; Liu, H; Liang, G; Kim, H; Hoffmann, P; Hein, A; Ramage, P; D'Arcy, A; Harlfinger, S; Renatus, M; Ruedisser, S; Feldman, D; Elliott, J; Sedrani, R; Maibaum, J; Adams, CM	Novartis Institutes for BioMedical Research	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50542731	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50542731&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156016549	442144294							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51340915	CC(C)c1cc(CCOc2ccccc2C(O)=O)cc(c1)-c1ccc2OC[C@@H](N)c2c1	InChI=1S/C26H27NO4/c1-16(2)19-11-17(9-10-30-24-6-4-3-5-21(24)26(28)29)12-20(13-19)18-7-8-25-22(14-18)23(27)15-31-25/h3-8,11-14,16,23H,9-10,15,27H2,1-2H3,(H,28,29)/t23-/m1/s1	RHEKWNPDSIWZKZ-HSZRJFAPSA-N	50542732	CHEMBL4647925	Plasma kallikrein			 25							ChEMBL	10.1021/acs.jmedchem.0c00279	10.7270/Q2KS6W36	32551603			Lorthiois, E; Roache, J; Barnes-Seeman, D; Altmann, E; Hassiepen, U; Turner, G; Duvadie, R; Hornak, V; Karki, RG; Schiering, N; Weihofen, WA; Perruccio, F; Calhoun, A; Fazal, T; Dedic, D; Durand, C; Dussauge, S; Fettis, K; Tritsch, F; Dentel, C; Druet, A; Liu, D; Kirman, L; Lachal, J; Namoto, K; Bevan, D; Mo, R; Monnet, G; Muller, L; Zessis, R; Huang, X; Lindsley, L; Currie, T; Chiu, YH; Fridrich, C; Delgado, P; Wang, S; Hollis-Symynkywicz, M; Berghausen, J; Williams, E; Liu, H; Liang, G; Kim, H; Hoffmann, P; Hein, A; Ramage, P; D'Arcy, A; Harlfinger, S; Renatus, M; Ruedisser, S; Feldman, D; Elliott, J; Sedrani, R; Maibaum, J; Adams, CM	Novartis Institutes for BioMedical Research	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50542732	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50542732&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156020508	442144295							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51340926	COc1cccc(C(O)=O)c1OCCc1cc(cc(c1)-c1ccc2OC[C@@H](N)c2c1)C(C)C	InChI=1S/C27H29NO5/c1-16(2)19-11-17(9-10-32-26-21(27(29)30)5-4-6-25(26)31-3)12-20(13-19)18-7-8-24-22(14-18)23(28)15-33-24/h4-8,11-14,16,23H,9-10,15,28H2,1-3H3,(H,29,30)/t23-/m1/s1	KXSZMPGKDDBJRE-HSZRJFAPSA-N	50542733	CHEMBL4646141	Plasma kallikrein			 9.0							ChEMBL	10.1021/acs.jmedchem.0c00279	10.7270/Q2KS6W36	32551603			Lorthiois, E; Roache, J; Barnes-Seeman, D; Altmann, E; Hassiepen, U; Turner, G; Duvadie, R; Hornak, V; Karki, RG; Schiering, N; Weihofen, WA; Perruccio, F; Calhoun, A; Fazal, T; Dedic, D; Durand, C; Dussauge, S; Fettis, K; Tritsch, F; Dentel, C; Druet, A; Liu, D; Kirman, L; Lachal, J; Namoto, K; Bevan, D; Mo, R; Monnet, G; Muller, L; Zessis, R; Huang, X; Lindsley, L; Currie, T; Chiu, YH; Fridrich, C; Delgado, P; Wang, S; Hollis-Symynkywicz, M; Berghausen, J; Williams, E; Liu, H; Liang, G; Kim, H; Hoffmann, P; Hein, A; Ramage, P; D'Arcy, A; Harlfinger, S; Renatus, M; Ruedisser, S; Feldman, D; Elliott, J; Sedrani, R; Maibaum, J; Adams, CM	Novartis Institutes for BioMedical Research	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50542733	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50542733&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	NW2	6TS5	146673502	442144296							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51340938	CC(C)c1cc(CCN2CCc3cccc(C(O)=O)c23)cc(c1)-c1ccc2OC[C@@H](N)c2c1	InChI=1S/C28H30N2O3/c1-17(2)21-12-18(8-10-30-11-9-19-4-3-5-23(27(19)30)28(31)32)13-22(14-21)20-6-7-26-24(15-20)25(29)16-33-26/h3-7,12-15,17,25H,8-11,16,29H2,1-2H3,(H,31,32)/t25-/m1/s1	CQQFREVZNRVIIM-RUZDIDTESA-N	50542735	CHEMBL4635286	Plasma kallikrein			 58							ChEMBL	10.1021/acs.jmedchem.0c00279	10.7270/Q2KS6W36	32551603			Lorthiois, E; Roache, J; Barnes-Seeman, D; Altmann, E; Hassiepen, U; Turner, G; Duvadie, R; Hornak, V; Karki, RG; Schiering, N; Weihofen, WA; Perruccio, F; Calhoun, A; Fazal, T; Dedic, D; Durand, C; Dussauge, S; Fettis, K; Tritsch, F; Dentel, C; Druet, A; Liu, D; Kirman, L; Lachal, J; Namoto, K; Bevan, D; Mo, R; Monnet, G; Muller, L; Zessis, R; Huang, X; Lindsley, L; Currie, T; Chiu, YH; Fridrich, C; Delgado, P; Wang, S; Hollis-Symynkywicz, M; Berghausen, J; Williams, E; Liu, H; Liang, G; Kim, H; Hoffmann, P; Hein, A; Ramage, P; D'Arcy, A; Harlfinger, S; Renatus, M; Ruedisser, S; Feldman, D; Elliott, J; Sedrani, R; Maibaum, J; Adams, CM	Novartis Institutes for BioMedical Research	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50542735	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50542735&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156014417	442144298							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51340949	CC(C)c1cc(CCOc2c(C)cccc2C(O)=O)cc(c1)-c1ccc2OC[C@@H](N)c2c1	InChI=1S/C27H29NO4/c1-16(2)20-11-18(9-10-31-26-17(3)5-4-6-22(26)27(29)30)12-21(13-20)19-7-8-25-23(14-19)24(28)15-32-25/h4-8,11-14,16,24H,9-10,15,28H2,1-3H3,(H,29,30)/t24-/m1/s1	RMBUAWJTXKFYEO-XMMPIXPASA-N	50542736	CHEMBL4633967	Plasma kallikrein			 41							ChEMBL	10.1021/acs.jmedchem.0c00279	10.7270/Q2KS6W36	32551603			Lorthiois, E; Roache, J; Barnes-Seeman, D; Altmann, E; Hassiepen, U; Turner, G; Duvadie, R; Hornak, V; Karki, RG; Schiering, N; Weihofen, WA; Perruccio, F; Calhoun, A; Fazal, T; Dedic, D; Durand, C; Dussauge, S; Fettis, K; Tritsch, F; Dentel, C; Druet, A; Liu, D; Kirman, L; Lachal, J; Namoto, K; Bevan, D; Mo, R; Monnet, G; Muller, L; Zessis, R; Huang, X; Lindsley, L; Currie, T; Chiu, YH; Fridrich, C; Delgado, P; Wang, S; Hollis-Symynkywicz, M; Berghausen, J; Williams, E; Liu, H; Liang, G; Kim, H; Hoffmann, P; Hein, A; Ramage, P; D'Arcy, A; Harlfinger, S; Renatus, M; Ruedisser, S; Feldman, D; Elliott, J; Sedrani, R; Maibaum, J; Adams, CM	Novartis Institutes for BioMedical Research	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50542736	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50542736&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156010875	442144299							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51338080	COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)ccc(Cl)c3F)c3cc-2ccn3)c1	InChI=1S/C31H29ClF2N4O4/c1-17-4-3-5-26(38-13-11-19(15-27(38)39)28-23(33)9-8-22(32)29(28)34)25-14-18(10-12-35-25)21-7-6-20(36-31(41)42-2)16-24(21)37-30(17)40/h6-10,12,14-17,26H,3-5,11,13H2,1-2H3,(H,36,41)(H,37,40)/t17-,26+/m1/s1	AXXYATYQRMPQSN-QUGAMOGWSA-N	50541586	CHEMBL4638245	Plasma kallikrein		>6000								ChEMBL	10.1021/acs.jmedchem.0c00464	10.7270/Q2J67MHG	32456431			Yang, W; Wang, Y; Lai, A; Clark, CG; Corte, JR; Fang, T; Gilligan, PJ; Jeon, Y; Pabbisetty, KB; Rampulla, RA; Mathur, A; Kaspady, M; Neithnadka, PR; Arumugam, A; Raju, S; Rossi, KA; Myers, JE; Sheriff, S; Lou, Z; Zheng, JJ; Chacko, SA; Bozarth, JM; Wu, Y; Crain, EJ; Wong, PC; Seiffert, DA; Luettgen, JM; Lam, PYS; Wexler, RR; Ewing, WR	Bristol Myers Squibb Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50541586	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50541586&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	SWP	6W50	72792438	442143149							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51340960	CC(C)c1cc(CCOc2c(Cl)cccc2C(O)=O)cc(c1)-c1ccc2OC[C@@H](N)c2c1	InChI=1S/C26H26ClNO4/c1-15(2)18-10-16(8-9-31-25-20(26(29)30)4-3-5-22(25)27)11-19(12-18)17-6-7-24-21(13-17)23(28)14-32-24/h3-7,10-13,15,23H,8-9,14,28H2,1-2H3,(H,29,30)/t23-/m1/s1	HMEJIACTKDVITD-HSZRJFAPSA-N	50542737	CHEMBL4645908	Plasma kallikrein			 21							ChEMBL	10.1021/acs.jmedchem.0c00279	10.7270/Q2KS6W36	32551603			Lorthiois, E; Roache, J; Barnes-Seeman, D; Altmann, E; Hassiepen, U; Turner, G; Duvadie, R; Hornak, V; Karki, RG; Schiering, N; Weihofen, WA; Perruccio, F; Calhoun, A; Fazal, T; Dedic, D; Durand, C; Dussauge, S; Fettis, K; Tritsch, F; Dentel, C; Druet, A; Liu, D; Kirman, L; Lachal, J; Namoto, K; Bevan, D; Mo, R; Monnet, G; Muller, L; Zessis, R; Huang, X; Lindsley, L; Currie, T; Chiu, YH; Fridrich, C; Delgado, P; Wang, S; Hollis-Symynkywicz, M; Berghausen, J; Williams, E; Liu, H; Liang, G; Kim, H; Hoffmann, P; Hein, A; Ramage, P; D'Arcy, A; Harlfinger, S; Renatus, M; Ruedisser, S; Feldman, D; Elliott, J; Sedrani, R; Maibaum, J; Adams, CM	Novartis Institutes for BioMedical Research	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50542737	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50542737&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156019784	442144300							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51340971	CC(C)c1cc(cc(c1)-c1ccc2OC[C@@H](N)c2c1)[C@H](O)Cn1ccc2cccc(C(O)=O)c12	InChI=1S/C28H28N2O4/c1-16(2)19-10-20(18-6-7-26-23(13-18)24(29)15-34-26)12-21(11-19)25(31)14-30-9-8-17-4-3-5-22(27(17)30)28(32)33/h3-13,16,24-25,31H,14-15,29H2,1-2H3,(H,32,33)/t24-,25-/m1/s1	GOERAAJVARXHDP-JWQCQUIFSA-N	50542738	CHEMBL4637027	Plasma kallikrein			 1.000000							ChEMBL	10.1021/acs.jmedchem.0c00279	10.7270/Q2KS6W36	32551603			Lorthiois, E; Roache, J; Barnes-Seeman, D; Altmann, E; Hassiepen, U; Turner, G; Duvadie, R; Hornak, V; Karki, RG; Schiering, N; Weihofen, WA; Perruccio, F; Calhoun, A; Fazal, T; Dedic, D; Durand, C; Dussauge, S; Fettis, K; Tritsch, F; Dentel, C; Druet, A; Liu, D; Kirman, L; Lachal, J; Namoto, K; Bevan, D; Mo, R; Monnet, G; Muller, L; Zessis, R; Huang, X; Lindsley, L; Currie, T; Chiu, YH; Fridrich, C; Delgado, P; Wang, S; Hollis-Symynkywicz, M; Berghausen, J; Williams, E; Liu, H; Liang, G; Kim, H; Hoffmann, P; Hein, A; Ramage, P; D'Arcy, A; Harlfinger, S; Renatus, M; Ruedisser, S; Feldman, D; Elliott, J; Sedrani, R; Maibaum, J; Adams, CM	Novartis Institutes for BioMedical Research	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50542738	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50542738&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	QGS	6USY	146672980	442144301							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51340984	COc1cccc(C(O)=O)c1OCC(O)c1cc(cc(c1)-c1ccc2OC[C@@H](N)c2c1)C(C)C	InChI=1S/C27H29NO6/c1-15(2)17-9-18(16-7-8-24-21(12-16)22(28)13-33-24)11-19(10-17)23(29)14-34-26-20(27(30)31)5-4-6-25(26)32-3/h4-12,15,22-23,29H,13-14,28H2,1-3H3,(H,30,31)/t22-,23?/m1/s1	BQMFNLPWJNBKOC-WTQRLHSKSA-N	50542739	CHEMBL4636760	Plasma kallikrein			 160							ChEMBL	10.1021/acs.jmedchem.0c00279	10.7270/Q2KS6W36	32551603			Lorthiois, E; Roache, J; Barnes-Seeman, D; Altmann, E; Hassiepen, U; Turner, G; Duvadie, R; Hornak, V; Karki, RG; Schiering, N; Weihofen, WA; Perruccio, F; Calhoun, A; Fazal, T; Dedic, D; Durand, C; Dussauge, S; Fettis, K; Tritsch, F; Dentel, C; Druet, A; Liu, D; Kirman, L; Lachal, J; Namoto, K; Bevan, D; Mo, R; Monnet, G; Muller, L; Zessis, R; Huang, X; Lindsley, L; Currie, T; Chiu, YH; Fridrich, C; Delgado, P; Wang, S; Hollis-Symynkywicz, M; Berghausen, J; Williams, E; Liu, H; Liang, G; Kim, H; Hoffmann, P; Hein, A; Ramage, P; D'Arcy, A; Harlfinger, S; Renatus, M; Ruedisser, S; Feldman, D; Elliott, J; Sedrani, R; Maibaum, J; Adams, CM	Novartis Institutes for BioMedical Research	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50542739	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50542739&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156011662	442144302							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51340995	CC(C)c1cc(cc(c1)-c1ccc2OC[C@@H](N)c2c1)C(O)CN1CCc2cccc(C(O)=O)c12	InChI=1S/C28H30N2O4/c1-16(2)19-10-20(18-6-7-26-23(13-18)24(29)15-34-26)12-21(11-19)25(31)14-30-9-8-17-4-3-5-22(27(17)30)28(32)33/h3-7,10-13,16,24-25,31H,8-9,14-15,29H2,1-2H3,(H,32,33)/t24-,25?/m1/s1	PKASBNFVFWUNOA-IKOFQBKESA-N	50542740	CHEMBL4646398	Plasma kallikrein			 2.0							ChEMBL	10.1021/acs.jmedchem.0c00279	10.7270/Q2KS6W36	32551603			Lorthiois, E; Roache, J; Barnes-Seeman, D; Altmann, E; Hassiepen, U; Turner, G; Duvadie, R; Hornak, V; Karki, RG; Schiering, N; Weihofen, WA; Perruccio, F; Calhoun, A; Fazal, T; Dedic, D; Durand, C; Dussauge, S; Fettis, K; Tritsch, F; Dentel, C; Druet, A; Liu, D; Kirman, L; Lachal, J; Namoto, K; Bevan, D; Mo, R; Monnet, G; Muller, L; Zessis, R; Huang, X; Lindsley, L; Currie, T; Chiu, YH; Fridrich, C; Delgado, P; Wang, S; Hollis-Symynkywicz, M; Berghausen, J; Williams, E; Liu, H; Liang, G; Kim, H; Hoffmann, P; Hein, A; Ramage, P; D'Arcy, A; Harlfinger, S; Renatus, M; Ruedisser, S; Feldman, D; Elliott, J; Sedrani, R; Maibaum, J; Adams, CM	Novartis Institutes for BioMedical Research	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50542740	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50542740&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156019641	442144303							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51341006	CC(C)c1cc(cc(c1)-c1ccc2OC[C@@H](N)c2c1)C(O)Cn1ccc2cccc(C(O)=O)c12	InChI=1S/C28H28N2O4/c1-16(2)19-10-20(18-6-7-26-23(13-18)24(29)15-34-26)12-21(11-19)25(31)14-30-9-8-17-4-3-5-22(27(17)30)28(32)33/h3-13,16,24-25,31H,14-15,29H2,1-2H3,(H,32,33)/t24-,25?/m1/s1	GOERAAJVARXHDP-IKOFQBKESA-N	50542741	CHEMBL4647950	Plasma kallikrein			 16							ChEMBL	10.1021/acs.jmedchem.0c00279	10.7270/Q2KS6W36	32551603			Lorthiois, E; Roache, J; Barnes-Seeman, D; Altmann, E; Hassiepen, U; Turner, G; Duvadie, R; Hornak, V; Karki, RG; Schiering, N; Weihofen, WA; Perruccio, F; Calhoun, A; Fazal, T; Dedic, D; Durand, C; Dussauge, S; Fettis, K; Tritsch, F; Dentel, C; Druet, A; Liu, D; Kirman, L; Lachal, J; Namoto, K; Bevan, D; Mo, R; Monnet, G; Muller, L; Zessis, R; Huang, X; Lindsley, L; Currie, T; Chiu, YH; Fridrich, C; Delgado, P; Wang, S; Hollis-Symynkywicz, M; Berghausen, J; Williams, E; Liu, H; Liang, G; Kim, H; Hoffmann, P; Hein, A; Ramage, P; D'Arcy, A; Harlfinger, S; Renatus, M; Ruedisser, S; Feldman, D; Elliott, J; Sedrani, R; Maibaum, J; Adams, CM	Novartis Institutes for BioMedical Research	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50542741	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50542741&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156020592	442144304							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1025299	FC(F)(F)c1ccccc1Cc1cncc(c1)C(=O)NCc1n[nH]c2ccc(Cl)cc12	InChI=1S/C22H16ClF3N4O/c23-16-5-6-19-17(9-16)20(30-29-19)12-28-21(31)15-8-13(10-27-11-15)7-14-3-1-2-4-18(14)22(24,25)26/h1-6,8-11H,7,12H2,(H,28,31)(H,29,30)	CNBJJXVVRQKAFE-UHFFFAOYSA-N	492872	N-((5-chloro-1H- indazol-3-yl)methyl)-5- (2- (trifluoromethyl)benzyl) nicotinamide::US10981893, Example 1	Plasma kallikrein			 5500							US Patent		10.7270/Q28P63N1		aid1805464	US10981893	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492872	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492872&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124173321	447119561							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1025300	Clc1ccc2[nH]nc(CNC(=O)c3cncc(Cc4ccc(cc4)C#N)c3)c2c1	InChI=1S/C22H16ClN5O/c23-18-5-6-20-19(9-18)21(28-27-20)13-26-22(29)17-8-16(11-25-12-17)7-14-1-3-15(10-24)4-2-14/h1-6,8-9,11-12H,7,13H2,(H,26,29)(H,27,28)	RDWVZVVMYWJFGU-UHFFFAOYSA-N	492873	N-((5-chloro-1H- indazol-3-yl)methyl)-5- (4- cyanobenzyl) nicotinamide::US10981893, Example 2	Plasma kallikrein			 5500							US Patent		10.7270/Q28P63N1		aid1805464	US10981893	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492873	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492873&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124173387	447119562							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1025301	FC(F)(F)c1ccc(Cc2cncc(c2)C(=O)NCc2n[nH]c3ccc(Cl)cc23)cc1	InChI=1S/C22H16ClF3N4O/c23-17-5-6-19-18(9-17)20(30-29-19)12-28-21(31)15-8-14(10-27-11-15)7-13-1-3-16(4-2-13)22(24,25)26/h1-6,8-11H,7,12H2,(H,28,31)(H,29,30)	VPKUXXXYKMYIMS-UHFFFAOYSA-N	492874	N-((5-chloro-1H- indazol-3-yl)methyl)-5- (4- (trifluoromethyl)benzyl) nicotinamide::US10981893, Example 3	Plasma kallikrein			 5500							US Patent		10.7270/Q28P63N1		aid1805464	US10981893	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492874	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492874&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124173376	447119563							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1025302	Cc1ccc(Cc2cncc(c2)C(=O)NCc2n[nH]c3ccc(Cl)cc23)cc1	InChI=1S/C22H19ClN4O/c1-14-2-4-15(5-3-14)8-16-9-17(12-24-11-16)22(28)25-13-21-19-10-18(23)6-7-20(19)26-27-21/h2-7,9-12H,8,13H2,1H3,(H,25,28)(H,26,27)	GYTIAVJQNUGOPW-UHFFFAOYSA-N	492875	N-((5-chloro-1H- indazol-3-yl)methyl)-5- (4- methylbenzyl) nicotinamide::US10981893, Example 4	Plasma kallikrein			 5500							US Patent		10.7270/Q28P63N1		aid1805464	US10981893	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492875	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492875&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124173320	447119564							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1025303	Clc1ccc2[nH]nc(CNC(=O)c3cncc(Cc4ccccc4)c3)c2c1	InChI=1S/C21H17ClN4O/c22-17-6-7-19-18(10-17)20(26-25-19)13-24-21(27)16-9-15(11-23-12-16)8-14-4-2-1-3-5-14/h1-7,9-12H,8,13H2,(H,24,27)(H,25,26)	SOYJMMULNNSPNJ-UHFFFAOYSA-N	492876	5-benzyl-N-((5-chloro- 1H-indazol-3- yl)methyl)nicotinamide::US10981893, Example 5	Plasma kallikrein			 5500							US Patent		10.7270/Q28P63N1		aid1805464	US10981893	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492876	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492876&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124173393	447119565							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1025304	NC(=O)c1ccccc1Cc1cncc(c1)C(=O)NCc1n[nH]c2ccc(Cl)cc12	InChI=1S/C22H18ClN5O2/c23-16-5-6-19-18(9-16)20(28-27-19)12-26-22(30)15-8-13(10-25-11-15)7-14-3-1-2-4-17(14)21(24)29/h1-6,8-11H,7,12H2,(H2,24,29)(H,26,30)(H,27,28)	ZITGZLAGIRUYRB-UHFFFAOYSA-N	492877	5-(2-carbamoylbenzyl)- N-((5-chloro-1H- indazol-3- yl)methyl)nicotinamide::US10981893, Example 6	Plasma kallikrein			 5500							US Patent		10.7270/Q28P63N1		aid1805464	US10981893	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492877	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492877&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124173378	447119566							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1025305	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1cncc(Cn2cc(cn2)C#N)c1	InChI=1S/C20H14ClFN6O/c21-17-9-25-19-3-18(22)14(2-16(17)19)8-26-20(29)15-1-12(5-24-7-15)10-28-11-13(4-23)6-27-28/h1-3,5-7,9,11,25H,8,10H2,(H,26,29)	LTFUKJDAZVVHNM-UHFFFAOYSA-N	492878	N-((3-chloro-6-fluoro- 1H-indol-5-yl)methyl)- 5-((4-cyano-1H- pyrazol-1- yl)methyl)nicotinamide::US10981893, Example 7	Plasma kallikrein			 5500							US Patent		10.7270/Q28P63N1		aid1805464	US10981893	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492878	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492878&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213255	447119567							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1025306	NC(=O)c1cnn(Cc2cncc(c2)C(=O)NCc2cc3c(Cl)c[nH]c3cc2F)c1	InChI=1S/C20H16ClFN6O2/c21-16-8-25-18-3-17(22)12(2-15(16)18)6-26-20(30)13-1-11(4-24-5-13)9-28-10-14(7-27-28)19(23)29/h1-5,7-8,10,25H,6,9H2,(H2,23,29)(H,26,30)	NCFVJBQEAZDLPI-UHFFFAOYSA-N	492879	5-((4-carbamoyl-1H- pyrazol-1-yl)methyl)-N- ((3-chloro-6-fluoro-1H- indol-5- yl)methyl)nicotinamide::US10981893, Example 8	Plasma kallikrein			 10000							US Patent		10.7270/Q28P63N1		aid1805464	US10981893	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492879	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492879&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124173322	447119568							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1025307	CC(=O)N(Cc1ccn(Cc2cc(ccn2)C(=O)NCc2cc3c(Cl)c[nH]c3cc2F)n1)C1CC1	InChI=1S/C25H24ClFN6O2/c1-15(34)33(20-2-3-20)14-18-5-7-32(31-18)13-19-8-16(4-6-28-19)25(35)30-11-17-9-21-22(26)12-29-24(21)10-23(17)27/h4-10,12,20,29H,2-3,11,13-14H2,1H3,(H,30,35)	ZTVDWIQBZNDENP-UHFFFAOYSA-N	492880	N-((3-chloro-6-fluoro- 1H-indol-5-yl)methyl)- 2-((3-((N- cyclopropylacetamido) methyl)-1H-pyrazol-1- yl)methyl) isonicotinamide::US10981893, Example 9	Plasma kallikrein			 10000							US Patent		10.7270/Q28P63N1		aid1805464	US10981893	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492880	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492880&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124173323	447119569							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1025308	CN(c1ccc(Cn2ccccc2=O)cc1)c1cncc(c1)C(=O)NCc1n[nH]c2ccc(Cl)cc12	InChI=1S/C27H23ClN6O2/c1-33(21-8-5-18(6-9-21)17-34-11-3-2-4-26(34)35)22-12-19(14-29-15-22)27(36)30-16-25-23-13-20(28)7-10-24(23)31-32-25/h2-15H,16-17H2,1H3,(H,30,36)(H,31,32)	HCMPSPCOWLYFIS-UHFFFAOYSA-N	492881	N-((5-chloro-1H- indazol-3-yl)methyl)-6- (methyl(4-((2- oxopyridin-1(2H)- yl)methyl)phenyl)amino) picolinamide::US10981893, Example 10	Plasma kallikrein			 10000							US Patent		10.7270/Q28P63N1		aid1805464	US10981893	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492881	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492881&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212393	447119570							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1025309	NC(=O)C(NC(=O)c1cncc(Cc2ccc(Cn3ccccc3=O)cc2)c1)c1n[nH]c2ccc(Cl)cc12			492882	N-(2-amino-1-(5- chloro-1H-indazol-3- yl)-2-oxoethyl)-5-(4- ((2-oxopyridin-1(2H)- yl)methyl)benzyl) nicotinamide::US10981893, Example 11	Plasma kallikrein			 5500							US Patent		10.7270/Q28P63N1		aid1805464	US10981893	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492882	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492882&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124173194	447119571							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1025310	OC(=O)C(NC(=O)c1cncc(Cc2ccc(Cn3ccccc3=O)cc2)c1)c1n[nH]c2ccc(Cl)cc12			492883	2-(5-chloro-1H-indazol- 3-yl)-2-(5-(4-((2- oxopyridin-1(2H)- yl)methyl)benzyl) nicotinamido)acetic acid::US10981893, Example 12	Plasma kallikrein			 5500							US Patent		10.7270/Q28P63N1		aid1805464	US10981893	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492883	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492883&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124173176	447119572							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1025311	Clc1ccc2[nH]nc(CNC(=O)c3cncc(c3)C(=C)c3ccc(Cn4ccccc4=O)cc3)c2c1	InChI=1S/C28H22ClN5O2/c1-18(20-7-5-19(6-8-20)17-34-11-3-2-4-27(34)35)21-12-22(15-30-14-21)28(36)31-16-26-24-13-23(29)9-10-25(24)32-33-26/h2-15H,1,16-17H2,(H,31,36)(H,32,33)	NOZOSROFZDYHIK-UHFFFAOYSA-N	492884	N-((5-chloro-1H- indazol-3-yl)methyl)-3- (1-(4-((2-oxopyridin- 1(2H)- yl)methyl)phenyl)vinyl) benzamide::US10981893, Example 13	Plasma kallikrein			 5500							US Patent		10.7270/Q28P63N1		aid1805464	US10981893	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492884	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492884&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124173181	447119573							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1025312	NC(=O)c1ccc(CNC(=O)c2cncc(Cc3ccc(Cn4ccccc4=O)cc3)c2)cc1	InChI=1S/C27H24N4O3/c28-26(33)23-10-8-20(9-11-23)16-30-27(34)24-14-22(15-29-17-24)13-19-4-6-21(7-5-19)18-31-12-2-1-3-25(31)32/h1-12,14-15,17H,13,16,18H2,(H2,28,33)(H,30,34)	HLHWFYOMXOFERK-UHFFFAOYSA-N	492885	N-(4-carbamoylbenzyl)- 5-(4-((2-oxopyridin- 1(2H)- yl)methyl)benzyl) nicotinamide::US10981893, Example 14	Plasma kallikrein			 5500							US Patent		10.7270/Q28P63N1		aid1805464	US10981893	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492885	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492885&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124173203	447119574							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1025313	Clc1ccc(CNC(=O)c2cncc(Cc3ccc(Cn4ccccc4=O)cc3)c2)cc1	InChI=1S/C26H22ClN3O2/c27-24-10-8-20(9-11-24)16-29-26(32)23-14-22(15-28-17-23)13-19-4-6-21(7-5-19)18-30-12-2-1-3-25(30)31/h1-12,14-15,17H,13,16,18H2,(H,29,32)	JJRAQIRHGFLFMY-UHFFFAOYSA-N	492886	N-(4-chlorobenzyl)-5- (4-((2-oxopyridin- 1(2H)- yl)methyl)benzyl) nicotinamide::US10981893, Example 15	Plasma kallikrein			 5500							US Patent		10.7270/Q28P63N1		aid1805464	US10981893	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492886	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492886&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124173171	447119575							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1025314	COc1ccc(CNC(=O)c2cncc(Cc3ccc(Cn4ccccc4=O)cc3)c2)cc1	InChI=1S/C27H25N3O3/c1-33-25-11-9-21(10-12-25)17-29-27(32)24-15-23(16-28-18-24)14-20-5-7-22(8-6-20)19-30-13-3-2-4-26(30)31/h2-13,15-16,18H,14,17,19H2,1H3,(H,29,32)	VJXSWMZUYNKIGO-UHFFFAOYSA-N	492887	N-(4-methoxybenzyl)- 5-(4-((2-oxopyridin- 1(2H)- yl)methyl)benzyl) nicotinamide::US10981893, Example 16	Plasma kallikrein			 5500							US Patent		10.7270/Q28P63N1		aid1805464	US10981893	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492887	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492887&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124173198	447119576							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1025315	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1ccc(=O)n(CC23CC(Cn4ccccc4=O)(C2)C3)c1	InChI=1S/C27H24ClFN4O3/c28-20-10-30-22-8-21(29)18(7-19(20)22)9-31-25(36)17-4-5-24(35)33(11-17)16-27-12-26(13-27,14-27)15-32-6-2-1-3-23(32)34/h1-8,10-11,30H,9,12-16H2,(H,31,36)	VWUFVUIAMMZKSK-UHFFFAOYSA-N	492888	N-((3-chloro-6-fluoro- 1H-indol-5-yl)methyl)- 6-oxo-1-((3-((2- oxopyridin-1(2H)- yl)methyl)bicyclo[1.1.1] pentan-1-yl)methyl)- 1,6-dihydropyridine-3- carboxamide::US10981893, Example 17	Plasma kallikrein			 5500							US Patent		10.7270/Q28P63N1		aid1805464	US10981893	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492888	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492888&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124173169	447119577							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1025316	Fc1cc(CNC(=O)c2ccnc(Cc3ccc(Cn4ccccc4=O)cc3)c2)ccc1Br	InChI=1S/C26H21BrFN3O2/c27-23-9-8-20(14-24(23)28)16-30-26(33)21-10-11-29-22(15-21)13-18-4-6-19(7-5-18)17-31-12-2-1-3-25(31)32/h1-12,14-15H,13,16-17H2,(H,30,33)	XHMCPNFNVRWHRO-UHFFFAOYSA-N	492889	N-(4-bromo-3- fluorobenzyl)-2-(4-((2- oxopyridin-1(2H)- yl)methyl)benzyl) isonicotinamide::US10981893, Example 18	Plasma kallikrein			 10000							US Patent		10.7270/Q28P63N1		aid1805464	US10981893	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492889	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492889&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124173172	447119578							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1025317	Cc1cc(ccc1CNC(=O)c1ccnc(Cc2ccc(Cn3ccccc3=O)cc2)c1)C#N	InChI=1S/C28H24N4O2/c1-20-14-23(17-29)9-10-25(20)18-31-28(34)24-11-12-30-26(16-24)15-21-5-7-22(8-6-21)19-32-13-3-2-4-27(32)33/h2-14,16H,15,18-19H2,1H3,(H,31,34)	QNLSFWAXNMYLMT-UHFFFAOYSA-N	492890	N-(4-cyano-2- methylbenzyl)-2-(4-((2- oxopyridin-1(2H)- yl)methyl)benzyl) isonicotinamide::US10981893, Example 19	Plasma kallikrein			 10000							US Patent		10.7270/Q28P63N1		aid1805464	US10981893	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492890	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492890&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124173173	447119579							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1025318	Cc1cc(Cc2cc(ccn2)C(=O)NCc2ccc3c(N)noc3c2)ccc1Cn1ccccc1=O	InChI=1S/C28H25N5O3/c1-18-12-19(5-7-22(18)17-33-11-3-2-4-26(33)34)13-23-15-21(9-10-30-23)28(35)31-16-20-6-8-24-25(14-20)36-32-27(24)29/h2-12,14-15H,13,16-17H2,1H3,(H2,29,32)(H,31,35)	HSHFXCSEZIQOJZ-UHFFFAOYSA-N	492891	N-((3- aminobenzo[d]isoxazol- 6-yl)methyl)-2-(3- (methylsulfonyl)-4-((2- oxopyridin-1(2H)- yl)methyl)benzyl) isonicotinamide::US10981893, Example 20	Plasma kallikrein			 550							US Patent		10.7270/Q28P63N1		aid1805464	US10981893	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492891	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492891&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			153425555	447119580							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1025319	Cc1cc(N)nc(C)c1CNC(=O)c1ccc(=O)n(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C24H22ClN5O2/c1-14-7-22(26)29-15(2)20(14)11-28-24(32)17-4-6-23(31)30(13-17)12-16-3-5-21-18(8-16)9-19(25)10-27-21/h3-10,13H,11-12H2,1-2H3,(H2,26,29)(H,28,32)	CAYHDQFXOVQMDI-UHFFFAOYSA-N	492892	N-((6-amino-2,4- dimethylpyridin-3- yl)methyl)-1-((3- chloroquinolin-6- yl)methyl)-6-oxo-1,6- dihydropyridine-3- carboxamide::US10981893, Example 21	Plasma kallikrein			<100							US Patent		10.7270/Q28P63N1		aid1805464	US10981893	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492892	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492892&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124173184	447119581							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1025320	Cc1cc(N)nc(C)c1CNC(=O)c1cncc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C24H22ClN5O/c1-14-5-23(26)30-15(2)21(14)13-29-24(31)19-8-17(10-27-11-19)6-16-3-4-22-18(7-16)9-20(25)12-28-22/h3-5,7-12H,6,13H2,1-2H3,(H2,26,30)(H,29,31)	ZCNTWWKRHUKJJH-UHFFFAOYSA-N	492893	N-((6-amino-2,4- dimethylpyridin-3- yl)methyl)-5-((3- chloroquinolin-6- yl)methyl)nicotinamide::US10981893, Example 22	Plasma kallikrein			<100							US Patent		10.7270/Q28P63N1		aid1805464	US10981893	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492893	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492893&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124173195	447119582							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1025321	Cc1cc(Cc2cc(ccn2)C(=O)NCc2ccc(N)nc2C)ccc1Cn1ccccc1=O	InChI=1S/C27H27N5O2/c1-18-13-20(6-7-23(18)17-32-12-4-3-5-26(32)33)14-24-15-21(10-11-29-24)27(34)30-16-22-8-9-25(28)31-19(22)2/h3-13,15H,14,16-17H2,1-2H3,(H2,28,31)(H,30,34)	KNKZRHCMHYDKGI-UHFFFAOYSA-N	492894	N-((6-amino-2- methylpyridin-3- yl)methyl)-2-(3- (methylsulfonyl)-4-((2- oxopyridin-1(2H)- yl)methyl)benzyl) isonicotinamide::US10981893, Example 23	Plasma kallikrein			<100							US Patent		10.7270/Q28P63N1		aid1805464	US10981893	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492894	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492894&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			153425554	447119583							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1025322	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)n1	InChI=1S/C23H21ClN6O/c1-13-7-21(25)29-14(2)18(13)12-28-23(31)20-5-6-26-22(30-20)9-15-3-4-19-16(8-15)10-17(24)11-27-19/h3-8,10-11H,9,12H2,1-2H3,(H2,25,29)(H,28,31)	GSSVWNIRIUATGU-UHFFFAOYSA-N	492895	N-((6-amino-2,4- dimethylpyridin-3- yl)methyl)-2-((3- chloroquinolin-6- yl)methyl)pyrimidine-4- carboxamide::US10981893, Example 24	Plasma kallikrein			<100							US Patent		10.7270/Q28P63N1		aid1805464	US10981893	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492895	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492895&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124173167	447119584							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1025323	Cc1cc(N)nc(C)c1CNC(=O)c1cncc(Cc2ccc3ncc(Cl)cc3c2)n1	InChI=1S/C23H21ClN6O/c1-13-5-22(25)29-14(2)19(13)11-28-23(31)21-12-26-10-18(30-21)7-15-3-4-20-16(6-15)8-17(24)9-27-20/h3-6,8-10,12H,7,11H2,1-2H3,(H2,25,29)(H,28,31)	WRWYHYBRQWNAMA-UHFFFAOYSA-N	492896	N-((6-amino-2,4- dimethylpyridin-3- yl)methyl)-6-((3- chloroquinolin-6- yl)methyl)pyrazine-2- carboxamide::US10981893, Example 25	Plasma kallikrein			<100							US Patent		10.7270/Q28P63N1		aid1805464	US10981893	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492896	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492896&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124173179	447119585							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1025324	CS(=O)(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2ccc(N)nc2C(F)(F)F)ccc1Cn1ccccc1=O	InChI=1S/C27H24F3N5O4S/c1-40(38,39)22-13-17(5-6-20(22)16-35-11-3-2-4-24(35)36)12-21-14-18(9-10-32-21)26(37)33-15-19-7-8-23(31)34-25(19)27(28,29)30/h2-11,13-14H,12,15-16H2,1H3,(H2,31,34)(H,33,37)	IKDANPKBIBXTJU-UHFFFAOYSA-N	492897	N-((6-amino-2- (trifluoromethyl)pyridin- 3-yl)methyl)-2-(3- (methylsulfonyl)-4-((2- oxopyridin-1(2H)- yl)methyl)benzyl) isonicotinamide::US10981893, Example 26	Plasma kallikrein			 5500							US Patent		10.7270/Q28P63N1		aid1805464	US10981893	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492897	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492897&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124173201	447119586							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1025325	CS(=O)(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2cnc(N)cc2C(F)(F)F)ccc1Cn1ccccc1=O	InChI=1S/C27H24F3N5O4S/c1-40(38,39)23-11-17(5-6-19(23)16-35-9-3-2-4-25(35)36)10-21-12-18(7-8-32-21)26(37)34-15-20-14-33-24(31)13-22(20)27(28,29)30/h2-9,11-14H,10,15-16H2,1H3,(H2,31,33)(H,34,37)	VIHGGQJKHQLOGY-UHFFFAOYSA-N	492898	N-((6-amino-4- (trifluoromethyl)pyridin- 3-yl)methyl)-2-(3- (methylsulfonyl)-4-((2- oxopyridin-1(2H)- yl)methyl)benzyl) isonicotinamide::US10981893, Example 27	Plasma kallikrein			 550							US Patent		10.7270/Q28P63N1		aid1805464	US10981893	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492898	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492898&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124173175	447119587							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1025326	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2ccc(Cn3ccccc3=O)c(c2)S(C)(=O)=O)c1	InChI=1S/C27H27N5O4S/c1-18-21(8-9-25(28)31-18)16-30-27(34)20-10-11-29-23(15-20)13-19-6-7-22(24(14-19)37(2,35)36)17-32-12-4-3-5-26(32)33/h3-12,14-15H,13,16-17H2,1-2H3,(H2,28,31)(H,30,34)	ZFCSXUNOGUUNST-UHFFFAOYSA-N	492899	N-((6-amino-2- methylpyridin-3- yl)methyl)-2-(3- (methylsulfonyl)-4-((2- oxopyridin-1(2H)- yl)methyl)benzyl) isonicotinamide::US10981893, Example 28	Plasma kallikrein			<100							US Patent		10.7270/Q28P63N1		aid1805464	US10981893	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492899	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492899&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124173408	447119588							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1025327	CS(=O)(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2cnc3[nH]cc(Cl)c3c2)ccc1Cn1ccccc1=O	InChI=1S/C28H24ClN5O4S/c1-39(37,38)25-12-18(5-6-21(25)17-34-9-3-2-4-26(34)35)10-22-13-20(7-8-30-22)28(36)33-15-19-11-23-24(29)16-32-27(23)31-14-19/h2-9,11-14,16H,10,15,17H2,1H3,(H,31,32)(H,33,36)	HQQGTGOLZSFJSE-UHFFFAOYSA-N	492900	N-((3-chloro-1H-indol- 5-yl)methyl)-2-(3- (methylsulfonyl)-4-((2- oxopyridin-1(2H)- yl)methyl)benzyl) isonicotinamide::US10981893, Example 29	Plasma kallikrein			<100							US Patent		10.7270/Q28P63N1		aid1805464	US10981893	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492900	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492900&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212995	447119589							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1025328	CS(=O)(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2n[nH]c3ccc(Cl)cc23)ccc1Cn1ccccc1=O	InChI=1S/C28H24ClN5O4S/c1-39(37,38)26-13-18(5-6-20(26)17-34-11-3-2-4-27(34)35)12-22-14-19(9-10-30-22)28(36)31-16-25-23-15-21(29)7-8-24(23)32-33-25/h2-11,13-15H,12,16-17H2,1H3,(H,31,36)(H,32,33)	BXJIPBXGIFVHTE-UHFFFAOYSA-N	492901	N-((5-chloro-1H- indazol-3-yl)methyl)-2- (3-(methylsulfonyl)-4- ((2-oxopyridin-1(2H)- yl)methyl)benzyl) isonicotinamide::US10981893, Example 30	Plasma kallikrein			<100							US Patent		10.7270/Q28P63N1		aid1805464	US10981893	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492901	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492901&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212798	447119590							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1025329	Cc1cc(N)nc(C)c1CNC(=O)c1ccc(=O)n(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C24H22ClN5O2/c1-14-7-22(26)29-15(2)20(14)11-28-24(32)17-4-6-23(31)30(13-17)12-16-3-5-21-18(8-16)9-19(25)10-27-21/h3-10,13H,11-12H2,1-2H3,(H2,26,29)(H,28,32)	CAYHDQFXOVQMDI-UHFFFAOYSA-N	492892	N-((6-amino-2,4- dimethylpyridin-3- yl)methyl)-1-((3- chloroquinolin-6- yl)methyl)-6-oxo-1,6- dihydropyridine-3- carboxamide::US10981893, Example 21	Plasma kallikrein					<100					US Patent		10.7270/Q28P63N1		aid1805465	US10981893	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492892	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492892&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124173184	447119581							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1025330	Cc1cc(N)nc(C)c1CNC(=O)c1cncc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C24H22ClN5O/c1-14-5-23(26)30-15(2)21(14)13-29-24(31)19-8-17(10-27-11-19)6-16-3-4-22-18(7-16)9-20(25)12-28-22/h3-5,7-12H,6,13H2,1-2H3,(H2,26,30)(H,29,31)	ZCNTWWKRHUKJJH-UHFFFAOYSA-N	492893	N-((6-amino-2,4- dimethylpyridin-3- yl)methyl)-5-((3- chloroquinolin-6- yl)methyl)nicotinamide::US10981893, Example 22	Plasma kallikrein					<100					US Patent		10.7270/Q28P63N1		aid1805465	US10981893	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492893	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492893&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124173195	447119582							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1025331	Cc1cc(Cc2cc(ccn2)C(=O)NCc2ccc(N)nc2C)ccc1Cn1ccccc1=O	InChI=1S/C27H27N5O2/c1-18-13-20(6-7-23(18)17-32-12-4-3-5-26(32)33)14-24-15-21(10-11-29-24)27(34)30-16-22-8-9-25(28)31-19(22)2/h3-13,15H,14,16-17H2,1-2H3,(H2,28,31)(H,30,34)	KNKZRHCMHYDKGI-UHFFFAOYSA-N	492894	N-((6-amino-2- methylpyridin-3- yl)methyl)-2-(3- (methylsulfonyl)-4-((2- oxopyridin-1(2H)- yl)methyl)benzyl) isonicotinamide::US10981893, Example 23	Plasma kallikrein					<100					US Patent		10.7270/Q28P63N1		aid1805465	US10981893	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492894	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492894&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			153425554	447119583							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1025332	Cc1cc(N)nc(C)c1CNC(=O)c1cncc(Cc2ccc3ncc(Cl)cc3c2)n1	InChI=1S/C23H21ClN6O/c1-13-5-22(25)29-14(2)19(13)11-28-23(31)21-12-26-10-18(30-21)7-15-3-4-20-16(6-15)8-17(24)9-27-20/h3-6,8-10,12H,7,11H2,1-2H3,(H2,25,29)(H,28,31)	WRWYHYBRQWNAMA-UHFFFAOYSA-N	492896	N-((6-amino-2,4- dimethylpyridin-3- yl)methyl)-6-((3- chloroquinolin-6- yl)methyl)pyrazine-2- carboxamide::US10981893, Example 25	Plasma kallikrein					<100					US Patent		10.7270/Q28P63N1		aid1805465	US10981893	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492896	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492896&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124173179	447119585							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1025333	CS(=O)(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2cnc3[nH]cc(Cl)c3c2)ccc1Cn1ccccc1=O	InChI=1S/C28H24ClN5O4S/c1-39(37,38)25-12-18(5-6-21(25)17-34-9-3-2-4-26(34)35)10-22-13-20(7-8-30-22)28(36)33-15-19-11-23-24(29)16-32-27(23)31-14-19/h2-9,11-14,16H,10,15,17H2,1H3,(H,31,32)(H,33,36)	HQQGTGOLZSFJSE-UHFFFAOYSA-N	492900	N-((3-chloro-1H-indol- 5-yl)methyl)-2-(3- (methylsulfonyl)-4-((2- oxopyridin-1(2H)- yl)methyl)benzyl) isonicotinamide::US10981893, Example 29	Plasma kallikrein					<100					US Patent		10.7270/Q28P63N1		aid1805465	US10981893	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492900	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492900&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212995	447119589							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035595	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(OC)cc(OC)c1	InChI=1S/C28H30N4O5/c1-35-19-26-25(28(34)29-15-22-12-23(36-2)14-24(13-22)37-3)18-32(30-26)17-21-9-7-20(8-10-21)16-31-11-5-4-6-27(31)33/h4-14,18H,15-17,19H2,1-3H3,(H,29,34)	BKELALJCIHUNCS-UHFFFAOYSA-N	408665	N-(3,5-Dimethoxybenzyl)-3-(methoxymethyl)-1-(4-((2-oxopyridin-1(2H)-yl)methyl)benzyl)-1H-pyrazole-4-carboxamide::US10364238, Example 1::US11001578, Example 1::US11084809, Example 1::US11198691, Example 1	Plasma kallikrein			 698							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408665	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408665&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364994	406799299							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035597	COc1cccc(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2N)c1F	InChI=1S/C25H24FN5O3/c1-34-21-6-4-5-19(23(21)26)13-28-25(33)20-16-31(29-24(20)27)15-18-10-8-17(9-11-18)14-30-12-3-2-7-22(30)32/h2-12,16H,13-15H2,1H3,(H2,27,29)(H,28,33)	HICYNMRHZGAFMT-UHFFFAOYSA-N	408666	3-Amino-1-[4-(2-oxo-2H-pyridin-1-ylmethyl)-benzyl]-1H-pyrazole-4-carboxylic acid 2-fluoro-3-methoxy-benzylamide::US10364238, Example 2::US11001578, Example 2::US11084809, Example 2::US11198691, Example 2	Plasma kallikrein			 8.70							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408666	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408666&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365045	406799300							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042045	NC(=O)c1ccc2cc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)ccc2n1	InChI=1S/C26H19ClFN5O2/c27-20-13-31-24-11-21(28)17(10-19(20)24)12-32-26(35)16-5-6-30-18(9-16)8-14-1-3-22-15(7-14)2-4-23(33-22)25(29)34/h1-7,9-11,13,31H,8,12H2,(H2,29,34)(H,32,35)	QFADKPXVEQNUDC-UHFFFAOYSA-N	283349	6-((4-(((3-chloro-6-fluoro-1H-indol-5- yl)methyl)carbamoyl)pyridin-2- yl)methyl)quinoline-2-carboxamide::US10023557, Example 1::US10266515, Example 1::US10308637, Example 1::US11021463, Example 1::US9611252, Example 1	Plasma kallikrein			 550							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283349	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283349&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665333	378164678							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042046	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3nc(ccc3c2)C(N)=O)c1	InChI=1S/C25H24N6O2/c1-14-9-23(26)30-15(2)20(14)13-29-25(33)18-7-8-28-19(12-18)11-16-3-5-21-17(10-16)4-6-22(31-21)24(27)32/h3-10,12H,11,13H2,1-2H3,(H2,26,30)(H2,27,32)(H,29,33)	STXHTXUTWCUJHH-UHFFFAOYSA-N	283350	6-((4-(((6-amino-2,4-dimethylpyridin-3- yl)methyl)carbamoyl)pyridin-2- yl)methyl)quinoline-2-carboxamide::US10023557, Example 2::US10266515, Example 2::US10308637, Example 2::US11021463, Example 2::US9611252, Example 2	Plasma kallikrein			 550							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283350	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283350&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665160	378164679							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042047	Nc1nccc2cc(CNC(=O)c3ccnc(Cc4ccc5nc(ccc5c4)C#N)c3)ccc12	InChI=1S/C27H20N6O/c28-15-22-4-3-20-11-17(2-6-25(20)33-22)13-23-14-21(8-9-30-23)27(34)32-16-18-1-5-24-19(12-18)7-10-31-26(24)29/h1-12,14H,13,16H2,(H2,29,31)(H,32,34)	DMXHLBYRSDVDMO-UHFFFAOYSA-N	283351	N-((1-aminoisoquinolin-6-yl)methyl)-2-((2- cyanoquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 3::US10266515, Example 3::US10308637, Example 3::US11021463, Example 3::US9611252, Example 3	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283351	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283351&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665133	378164680							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042048	NC(=O)c1ccc2cc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)ccc2n1	InChI=1S/C27H22N6O2/c28-25-22-4-1-17(12-18(22)7-10-31-25)15-32-27(35)20-8-9-30-21(14-20)13-16-2-5-23-19(11-16)3-6-24(33-23)26(29)34/h1-12,14H,13,15H2,(H2,28,31)(H2,29,34)(H,32,35)	SPVRYWSSDGGGFK-UHFFFAOYSA-N	283352	6-((4-(((1-aminoisoquinolin-6- yl)methyl)carbamoyl)pyridin-2- yl)methyl)quinoline-2-carboxamide::US10023557, Example 4::US10266515, Example 4::US10308637, Example 4::US11021463, Example 4::US9611252, Example 4	Plasma kallikrein			 550							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283352	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283352&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665212	378164681							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042049	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1ccnc(Cc2ccc3ncc(cc3c2)C#N)c1	InChI=1S/C26H17ClFN5O/c27-22-14-32-25-10-23(28)19(9-21(22)25)13-33-26(34)17-3-4-30-20(8-17)7-15-1-2-24-18(5-15)6-16(11-29)12-31-24/h1-6,8-10,12,14,32H,7,13H2,(H,33,34)	UMGVLTPEGADZAJ-UHFFFAOYSA-N	283353	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3-cyanoquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 5::US10266515, Example 5::US10308637, Example 5::US11021463, Example 5::US9611252, Example 5	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283353	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283353&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665332	378164682							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042050	Nc1nccc2cc(CNC(=O)c3ccnc(Cc4ccc5ncc(cc5c4)C#N)c3)ccc12	InChI=1S/C27H20N6O/c28-14-19-11-22-9-17(2-4-25(22)32-16-19)12-23-13-21(6-7-30-23)27(34)33-15-18-1-3-24-20(10-18)5-8-31-26(24)29/h1-11,13,16H,12,15H2,(H2,29,31)(H,33,34)	KYRAMUYNXMHHJI-UHFFFAOYSA-N	283354	N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- cyanoquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 6::US10266515, Example 6::US10308637, Example 6::US11021463, Example 6::US9611252, Example 6	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283354	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283354&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665279	378164683							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042051	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3ncc(cc3c2)C#N)c1	InChI=1S/C25H22N6O/c1-15-7-24(27)31-16(2)22(15)14-30-25(32)19-5-6-28-21(11-19)10-17-3-4-23-20(8-17)9-18(12-26)13-29-23/h3-9,11,13H,10,14H2,1-2H3,(H2,27,31)(H,30,32)	CBKARQMZIQUSSI-UHFFFAOYSA-N	283355	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-cyanoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 7::US10266515, Example 7::US10308637, Example 7::US11021463, Example 7::US9611252, Example 7	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283355	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283355&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665185	378164684							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042052	Nc1nccc2cc(CNC(=O)c3ccnc(Cc4cnc5ccc(F)cc5n4)c3)ccc12	InChI=1S/C25H19FN6O/c26-18-2-4-22-23(11-18)32-20(14-30-22)12-19-10-17(6-7-28-19)25(33)31-13-15-1-3-21-16(9-15)5-8-29-24(21)27/h1-11,14H,12-13H2,(H2,27,29)(H,31,33)	NAEBTWZBUODUEA-UHFFFAOYSA-N	283356	N-((1-aminoisoquinolin-6-yl)methyl)-2-((7- fluoroquinoxalin-2-yl)methyl)isonicotinamide::US10023557, Example 8::US10266515, Example 8::US10308637, Example 8::US11021463, Example 8::US9611252, Example 8	Plasma kallikrein			 550							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283356	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283356&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665180	378164685							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042053	CC(=O)NCc1ccc2cc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)ccc2n1	InChI=1S/C28H23ClFN5O2/c1-16(36)32-14-21-4-3-18-8-17(2-5-26(18)35-21)9-22-10-19(6-7-31-22)28(37)34-13-20-11-23-24(29)15-33-27(23)12-25(20)30/h2-8,10-12,15,33H,9,13-14H2,1H3,(H,32,36)(H,34,37)	VKZVWMJENMIADE-UHFFFAOYSA-N	283357	2-((2-(acetamidomethyl)quinolin-6-yl)methyl)- N-((3-chloro-6-fluoro-1H-indol-5- yl)methyl)isonicotinamide::US10023557, Example 9::US10266515, Example 9::US10308637, Example 9::US11021463, Example 9::US9611252, Example 9	Plasma kallikrein			 550							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283357	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283357&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665193	378164686							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042054	CC(=O)NCc1ccc2cc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)ccc2n1	InChI=1S/C29H26N6O2/c1-18(36)33-17-24-5-4-22-12-19(3-7-27(22)35-24)14-25-15-23(9-10-31-25)29(37)34-16-20-2-6-26-21(13-20)8-11-32-28(26)30/h2-13,15H,14,16-17H2,1H3,(H2,30,32)(H,33,36)(H,34,37)	ZYSYOACDZZDUSZ-UHFFFAOYSA-N	283358	2-((2-(acetamidomethyl)quinolin-6-yl)methyl)- N-((1-aminoisoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 10::US10266515, Example 10::US10308637, Example 10::US11021463, Example 10::US9611252, Example 10	Plasma kallikrein			 550							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283358	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283358&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665233	378164687							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042055	CC(=O)NCc1ccc2cc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)ccc2n1	InChI=1S/C27H28N6O2/c1-16-10-26(28)32-17(2)24(16)15-31-27(35)21-8-9-29-23(13-21)12-19-4-7-25-20(11-19)5-6-22(33-25)14-30-18(3)34/h4-11,13H,12,14-15H2,1-3H3,(H2,28,32)(H,30,34)(H,31,35)	GCIYNSCGYKCNRO-UHFFFAOYSA-N	283359	2-((2-(acetamidomethyl)quinolin-6-yl)methyl)- N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)isonicotinamide::US10023557, Example 11::US10266515, Example 11::US10308637, Example 11::US11021463, Example 11::US9611252, Example 11	Plasma kallikrein			 550							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283359	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283359&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665205	378164688							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042056	CS(=O)(=O)c1ccc2ncc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)cc2c1	InChI=1S/C26H20ClFN4O3S/c1-36(34,35)20-2-3-24-17(9-20)6-15(12-30-24)7-19-8-16(4-5-29-19)26(33)32-13-18-10-21-22(27)14-31-25(21)11-23(18)28/h2-6,8-12,14,31H,7,13H2,1H3,(H,32,33)	QNAPNSFSYRBKHH-UHFFFAOYSA-N	283360	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((6-(methylsulfonyl)quinolin-3- yl)methyl)isonicotinamide::US10023557, Example 12::US10266515, Example 12::US10308637, Example 12::US11021463, Example 12::US9611252, Example 12	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283360	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283360&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665393	378164689							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042057	CS(=O)(=O)c1ccc2ncc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)cc2c1	InChI=1S/C27H23N5O3S/c1-36(34,35)23-3-5-25-21(14-23)11-18(16-31-25)12-22-13-20(7-8-29-22)27(33)32-15-17-2-4-24-19(10-17)6-9-30-26(24)28/h2-11,13-14,16H,12,15H2,1H3,(H2,28,30)(H,32,33)	WYQOOVPHNNJHMZ-UHFFFAOYSA-N	283361	N-((1-aminoisoquinolin-6-yl)methyl)-2-((6- (methylsulfonyl)quinolin-3- yl)methyl)isonicotinamide::US10023557, Example 13::US10266515, Example 13::US10308637, Example 13::US11021463, Example 13::US9611252, Example 13	Plasma kallikrein			 550							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283361	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283361&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665105	378164690							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042058	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cnc3ccc(cc3c2)S(C)(=O)=O)c1	InChI=1S/C25H25N5O3S/c1-15-8-24(26)30-16(2)22(15)14-29-25(31)18-6-7-27-20(11-18)10-17-9-19-12-21(34(3,32)33)4-5-23(19)28-13-17/h4-9,11-13H,10,14H2,1-3H3,(H2,26,30)(H,29,31)	IISORMHFXQMHMH-UHFFFAOYSA-N	283362	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((6-(methylsulfonyl)quinolin-3- yl)methyl)isonicotinamide::US10023557, Example 14::US10266515, Example 14::US10308637, Example 14::US11021463, Example 14::US9611252, Example 14	Plasma kallikrein			 550							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283362	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283362&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665164	378164691							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042059	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2c1)S(C)(=O)=O	InChI=1S/C26H27N5O3S/c1-15-7-20-9-18(11-23(35(4,33)34)25(20)29-13-15)10-21-12-19(5-6-28-21)26(32)30-14-22-16(2)8-24(27)31-17(22)3/h5-9,11-13H,10,14H2,1-4H3,(H2,27,31)(H,30,32)	HXOKVKXTISERDZ-UHFFFAOYSA-N	283363	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-methyl-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 15::US10266515, Example 15::US10308637, Example 15::US11021463, Example 15::US9611252, Example 15	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283363	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283363&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213052	378164692							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042060	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)cc2c1)S(C)(=O)=O	InChI=1S/C28H25N5O3S/c1-17-9-22-11-19(13-25(37(2,35)36)26(22)32-15-17)12-23-14-21(6-7-30-23)28(34)33-16-18-3-4-24-20(10-18)5-8-31-27(24)29/h3-11,13-15H,12,16H2,1-2H3,(H2,29,31)(H,33,34)	AGLYWDINMJNVRE-UHFFFAOYSA-N	283364	N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- methyl-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 16::US10266515, Example 16::US10308637, Example 16::US11021463, Example 16::US9611252, Example 16	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283364	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283364&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665230	378164693							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042061	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)cc2c1)S(C)(=O)=O	InChI=1S/C27H22ClFN4O3S/c1-15-5-18-6-16(8-25(37(2,35)36)26(18)32-12-15)7-20-9-17(3-4-30-20)27(34)33-13-19-10-21-22(28)14-31-24(21)11-23(19)29/h3-6,8-12,14,31H,7,13H2,1-2H3,(H,33,34)	KNWYWDACHSZACS-UHFFFAOYSA-N	283365	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3-methyl-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 17::US10266515, Example 17::US10308637, Example 17::US11021463, Example 17::US9611252, Example 17	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283365	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283365&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213042	378164694							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042062	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cc4cc[nH]c4cc3F)cc2c1)S(C)(=O)=O	InChI=1S/C27H23FN4O3S/c1-16-7-20-8-17(10-25(36(2,34)35)26(20)31-14-16)9-22-12-19(4-5-29-22)27(33)32-15-21-11-18-3-6-30-24(18)13-23(21)28/h3-8,10-14,30H,9,15H2,1-2H3,(H,32,33)	JOIGNBGOTQEXSU-UHFFFAOYSA-N	283366	N-((6-fluoro-1H-indol-5-yl)methyl)-2-((3- methyl-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 18::US10266515, Example 18::US10308637, Example 18::US11021463, Example 18::US9611252, Example 18	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283366	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283366&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665345	378164695							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042063	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cnc4[nH]cc(Cl)c4c3)cc2c1)S(C)(=O)=O	InChI=1S/C26H22ClN5O3S/c1-15-5-19-6-16(9-23(36(2,34)35)24(19)29-11-15)7-20-10-18(3-4-28-20)26(33)32-13-17-8-21-22(27)14-31-25(21)30-12-17/h3-6,8-12,14H,7,13H2,1-2H3,(H,30,31)(H,32,33)	IIORZUFKRKFNHD-UHFFFAOYSA-N	283367	N-((3-chloro-1H-pyrrolo[2,3-b]pyridin-5- yl)methyl)-2-((3-methyl-8- (methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 19::US10266515, Example 19::US10308637, Example 19::US11021463, Example 19::US9611252, Example 19	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283367	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283367&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665214	378164696							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042064	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3n[nH]c4ccc(Cl)cc34)cc2c1)S(C)(=O)=O	InChI=1S/C26H22ClN5O3S/c1-15-7-18-8-16(10-24(36(2,34)35)25(18)29-13-15)9-20-11-17(5-6-28-20)26(33)30-14-23-21-12-19(27)3-4-22(21)31-32-23/h3-8,10-13H,9,14H2,1-2H3,(H,30,33)(H,31,32)	INPUBOYBDZWEOS-UHFFFAOYSA-N	283368	N-((5-chloro-1H-indazol-3-yl)methyl)-2-((3- methyl-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 20::US10266515, Example 20::US10308637, Example 20::US11021463, Example 20::US9611252, Example 20	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283368	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283368&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665285	378164697							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042065	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3ccc4[nH]cc(Cl)c4c3F)cc2c1)S(C)(=O)=O	InChI=1S/C27H22ClFN4O3S/c1-15-7-19-8-16(10-23(37(2,35)36)26(19)32-12-15)9-20-11-17(5-6-30-20)27(34)33-13-18-3-4-22-24(25(18)29)21(28)14-31-22/h3-8,10-12,14,31H,9,13H2,1-2H3,(H,33,34)	RIPJTLFXOCXAJL-UHFFFAOYSA-N	283369	N-((3-chloro-4-fluoro-1H-indol-5-yl)methyl)-2- ((3-methyl-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 21::US10266515, Example 21::US10308637, Example 21::US11021463, Example 21::US9611252, Example 21	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283369	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283369&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213012	378164698							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042066	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cn2ccc3c(Cl)cccc3c2=O)c1	InChI=1S/C24H22ClN5O2/c1-14-10-22(26)29-15(2)20(14)12-28-23(31)16-6-8-27-17(11-16)13-30-9-7-18-19(24(30)32)4-3-5-21(18)25/h3-11H,12-13H2,1-2H3,(H2,26,29)(H,28,31)	MEZFXRCCCIIGIW-UHFFFAOYSA-N	283370	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((5-chloro-1-oxoisoquinolin-2(1H)- yl)methyl)isonicotinamide::US10023557, Example 22::US10266515, Example 22::US10308637, Example 22::US11021463, Example 22::US9611252, Example 22	Plasma kallikrein			 550							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283370	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283370&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665187	378164699							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042067	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cn2ccc3cc(Cl)ccc3c2=O)c1	InChI=1S/C24H22ClN5O2/c1-14-9-22(26)29-15(2)21(14)12-28-23(31)17-5-7-27-19(11-17)13-30-8-6-16-10-18(25)3-4-20(16)24(30)32/h3-11H,12-13H2,1-2H3,(H2,26,29)(H,28,31)	AXAISOZEVYRCNQ-UHFFFAOYSA-N	283371	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((6-chloro-1-oxoisoquinolin-2(1H)- yl)methyl)isonicotinamide::US10023557, Example 23::US10266515, Example 23::US10308637, Example 23::US11021463, Example 23::US9611252, Example 23	Plasma kallikrein			 5500							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283371	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283371&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665258	378164700							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042068	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3[nH]cc(Cl)c3c2)c1	InChI=1S/C23H22ClN5O/c1-13-7-22(25)29-14(2)19(13)11-28-23(30)16-5-6-26-17(10-16)8-15-3-4-21-18(9-15)20(24)12-27-21/h3-7,9-10,12,27H,8,11H2,1-2H3,(H2,25,29)(H,28,30)	WGAUJZUEMJFDBD-UHFFFAOYSA-N	283372	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloro-1H-indol-5- yl)methyl)isonicotinamide::US10023557, Example 24::US10266515, Example 24::US10308637, Example 24::US11021463, Example 24::US9611252, Example 24	Plasma kallikrein			 550							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283372	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283372&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665371	378164701							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042069	Cc1c[nH]c2ccc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc12	InChI=1S/C24H25N5O/c1-14-8-23(25)29-16(3)21(14)13-28-24(30)18-6-7-26-19(11-18)9-17-4-5-22-20(10-17)15(2)12-27-22/h4-8,10-12,27H,9,13H2,1-3H3,(H2,25,29)(H,28,30)	POUWYQSQNNTBKE-UHFFFAOYSA-N	283373	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-methyl-1H-indol-5- yl)methyl)isonicotinamide::US10023557, Example 25::US10266515, Example 25::US10308637, Example 25::US11021463, Example 25::US9611252, Example 25	Plasma kallikrein			 550							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283373	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283373&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665395	378164702							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042070	Cc1nc(N)c(cc1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1)C#N	InChI=1S/C24H19ClN6O/c1-14-19(8-18(11-26)23(27)31-14)12-30-24(32)16-4-5-28-21(10-16)7-15-2-3-22-17(6-15)9-20(25)13-29-22/h2-6,8-10,13H,7,12H2,1H3,(H2,27,31)(H,30,32)	BSYAUMQSIQHPBV-UHFFFAOYSA-N	283374	N-((6-amino-5-cyano-2-methylpyridin-3- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 26::US10266515, Example 26::US10308637, Example 26::US11021463, Example 26::US9611252, Example 26	Plasma kallikrein			 5500							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283374	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283374&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665238	378164703							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042071	Cc1nc(N)c(cc1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1)C(N)=O	InChI=1S/C24H21ClN6O2/c1-13-17(10-20(23(27)32)22(26)31-13)11-30-24(33)15-4-5-28-19(9-15)7-14-2-3-21-16(6-14)8-18(25)12-29-21/h2-6,8-10,12H,7,11H2,1H3,(H2,26,31)(H2,27,32)(H,30,33)	AUZYMVREUCDBQL-UHFFFAOYSA-N	283375	2-amino-5-((2-((3-chloroquinolin-6- yl)methyl)isonicotinamido)methyl)-6- methylnicotinamide::US10023557, Example 27::US10266515, Example 27::US10308637, Example 27::US11021463, Example 27::US9611252, Example 27	Plasma kallikrein			>10000							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283375	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283375&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665169	378164704							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042072	Cc1nc(N)c(Cl)cc1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C23H19Cl2N5O/c1-13-17(10-20(25)22(26)30-13)11-29-23(31)15-4-5-27-19(9-15)7-14-2-3-21-16(6-14)8-18(24)12-28-21/h2-6,8-10,12H,7,11H2,1H3,(H2,26,30)(H,29,31)	QTDAMOULKXIHPX-UHFFFAOYSA-N	283376	N-((6-amino-5-chloro-2-methylpyridin-3- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 28::US10266515, Example 28::US10308637, Example 28::US11021463, Example 28::US9611252, Example 28	Plasma kallikrein			 5500							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283376	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283376&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665175	378164705							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042073	Cc1cc(N)ncc1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C23H20ClN5O/c1-14-6-22(25)28-11-18(14)12-29-23(30)16-4-5-26-20(10-16)8-15-2-3-21-17(7-15)9-19(24)13-27-21/h2-7,9-11,13H,8,12H2,1H3,(H2,25,28)(H,29,30)	VFDBWWVOFNVCCV-UHFFFAOYSA-N	283377	N-((6-amino-4-methylpyridin-3-yl)methyl)-2- ((3-chloroquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 29::US10266515, Example 29::US10308637, Example 29::US11021463, Example 29::US9611252, Example 29	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283377	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283377&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212275	378164706							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042074	Nc1ccc(CNC(=O)c2ccnc(Cc3ccc4ncc(Cl)cc4c3)c2)c(n1)C(F)(F)F	InChI=1S/C23H17ClF3N5O/c24-17-9-16-7-13(1-3-19(16)30-12-17)8-18-10-14(5-6-29-18)22(33)31-11-15-2-4-20(28)32-21(15)23(25,26)27/h1-7,9-10,12H,8,11H2,(H2,28,32)(H,31,33)	JQBVZTITQKTVTP-UHFFFAOYSA-N	283378	N-((6-amino-2-(trifluoromoethyl)pyridin-3- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 30::US10266515, Example 30::US10308637, Example 30::US11021463, Example 30::US9611252, Example 30	Plasma kallikrein			>10000							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283378	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283378&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665299	378164707							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042075	Nc1nccc2cc(CNC(=O)c3ccnc(Cc4ccc5ncc(Cl)cc5c4)c3)ccc12	InChI=1S/C26H20ClN5O/c27-21-12-20-9-16(2-4-24(20)31-15-21)11-22-13-19(6-7-29-22)26(33)32-14-17-1-3-23-18(10-17)5-8-30-25(23)28/h1-10,12-13,15H,11,14H2,(H2,28,30)(H,32,33)	WHHMKDFLRDNMQE-UHFFFAOYSA-N	283379	N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- chloroquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 179::US10023557, Example 31::US10266515, Example 31::US10308637, Example 179::US11021463, Example 31::US9611252, Example 31	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283379	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283379&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212700	378164708							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042076	Fc1cc2[nH]ncc2cc1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C24H17ClFN5O/c25-19-8-16-5-14(1-2-22(16)28-13-19)6-20-9-15(3-4-27-20)24(32)29-11-17-7-18-12-30-31-23(18)10-21(17)26/h1-5,7-10,12-13H,6,11H2,(H,29,32)(H,30,31)	AUINKNGACHEZIV-UHFFFAOYSA-N	283380	2-((3-chloroquinolin-6-yl)methyl)-N-((6-fluoro- 1H-indazol-5-yl)methyl)isonicotinamide::US10023557, Example 260::US10023557, Example 32::US10266515, Example 32::US10308637, Example 32::US11021463, Example 32::US9611252, Example 32	Plasma kallikrein			 5500							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283380	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283380&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665325	378164709							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042077	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C25H17Cl2FN4O/c26-18-7-16-5-14(1-2-23(16)30-12-18)6-19-8-15(3-4-29-19)25(33)32-11-17-9-20-21(27)13-31-24(20)10-22(17)28/h1-5,7-10,12-13,31H,6,11H2,(H,32,33)	XZUNAOLBBRHEMP-UHFFFAOYSA-N	283381	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3-chloroquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 33::US10266515, Example 33::US10308637, Example 33::US11021463, Example 33::US9611252, Example 33	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283381	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283381&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212875	378164710							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042078	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C23H20ClN5O/c1-14-17(3-5-22(25)29-14)12-28-23(30)16-6-7-26-20(11-16)9-15-2-4-21-18(8-15)10-19(24)13-27-21/h2-8,10-11,13H,9,12H2,1H3,(H2,25,29)(H,28,30)	ZGYIOYKVCAJRKO-UHFFFAOYSA-N	283382	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-chloroquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 34::US10266515, Example 39::US10308637, Example 39::US11021463, Example 39::US9611252, Example 39	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283382	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283382&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213054	378164711							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042079	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C24H22ClN5O/c1-14-7-23(26)30-15(2)21(14)13-29-24(31)17-5-6-27-20(11-17)9-16-3-4-22-18(8-16)10-19(25)12-28-22/h3-8,10-12H,9,13H2,1-2H3,(H2,26,30)(H,29,31)	BDLURRLRBKLEDL-UHFFFAOYSA-N	283383	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 35::US10266515, Example 35::US10308637, Example 35::US11021463, Example 35::US9611252, Example 35	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283383	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283383&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665163	378164712							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042080	Nc1noc2cc(CNC(=O)c3ccnc(Cc4ccc5ncc(Cl)cc5c4)c3)ccc12	InChI=1S/C24H18ClN5O2/c25-18-10-17-7-14(2-4-21(17)28-13-18)8-19-11-16(5-6-27-19)24(31)29-12-15-1-3-20-22(9-15)32-30-23(20)26/h1-7,9-11,13H,8,12H2,(H2,26,30)(H,29,31)	HNXHQCQPXRYRIC-UHFFFAOYSA-N	283384	N-((3-aminobenzo[d]isoxazol-6-yl)methyl)-2- ((3-chloroquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 36::US10266515, Example 36::US10308637, Example 36::US11021463, Example 36::US9611252, Example 36	Plasma kallikrein			 5500							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283384	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283384&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665141	378164713							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042081	Clc1ccc2[nH]nc(CNC(=O)c3ccnc(Cc4ccc5ncc(Cl)cc5c4)c3)c2c1	InChI=1S/C24H17Cl2N5O/c25-17-2-4-22-20(11-17)23(31-30-22)13-29-24(32)15-5-6-27-19(10-15)8-14-1-3-21-16(7-14)9-18(26)12-28-21/h1-7,9-12H,8,13H2,(H,29,32)(H,30,31)	YXHGJDJGKSPRKX-UHFFFAOYSA-N	283385	N-((5-chloro-1H-indazol-3-yl)methyl)-2-((3- chloroquinolin-6-yl)methyl)isonictotinamide::US10023557, Example 37::US10266515, Example 37::US10308637, Example 37::US11021463, Example 37::US9611252, Example 37	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283385	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283385&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212832	378164714							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042082	Clc1c[nH]c2ncc(CNC(=O)c3ccnc(Cc4ccc5ncc(Cl)cc5c4)c3)cc12	InChI=1S/C24H17Cl2N5O/c25-18-8-17-5-14(1-2-22(17)28-12-18)6-19-9-16(3-4-27-19)24(32)31-11-15-7-20-21(26)13-30-23(20)29-10-15/h1-5,7-10,12-13H,6,11H2,(H,29,30)(H,31,32)	QFSDBAJWKWRDTA-UHFFFAOYSA-N	283386	N-((3-chloro-1H-pyrrolo[2,3-b]pyridin-5- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 38::US10266515, Example 38::US10308637, Example 38::US11021463, Example 38::US9611252, Example 38	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283386	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283386&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665363	378164715							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042083	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C23H20ClN5O/c1-14-17(3-5-22(25)29-14)12-28-23(30)16-6-7-26-20(11-16)9-15-2-4-21-18(8-15)10-19(24)13-27-21/h2-8,10-11,13H,9,12H2,1H3,(H2,25,29)(H,28,30)	ZGYIOYKVCAJRKO-UHFFFAOYSA-N	283382	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-chloroquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 34::US10266515, Example 39::US10308637, Example 39::US11021463, Example 39::US9611252, Example 39	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283382	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283382&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213054	378164711							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042084	Fc1c(CNC(=O)c2ccnc(Cc3ccc4ncc(Cl)cc4c3)c2)ccc2[nH]cc(Cl)c12	InChI=1S/C25H17Cl2FN4O/c26-18-9-17-7-14(1-3-21(17)30-12-18)8-19-10-15(5-6-29-19)25(33)32-11-16-2-4-22-23(24(16)28)20(27)13-31-22/h1-7,9-10,12-13,31H,8,11H2,(H,32,33)	GVFULHFYDFFIFD-UHFFFAOYSA-N	283388	N-((3-chloro-4-fluoro-1H-indol-5-yl)methyl)-2- ((3-chloroquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 40::US10266515, Example 40::US10308637, Example 40::US11021463, Example 40::US9611252, Example 40	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283388	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283388&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665357	378164717							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042085	Fc1cc2[nH]ccc2cc1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C25H18ClFN4O/c26-20-10-18-7-15(1-2-23(18)30-14-20)8-21-11-17(4-5-28-21)25(32)31-13-19-9-16-3-6-29-24(16)12-22(19)27/h1-7,9-12,14,29H,8,13H2,(H,31,32)	SVAFKWRLBOEKGD-UHFFFAOYSA-N	283389	2-((3-chloroquinolin-6-yl)methyl)-N-((6-fluoro- 1H-indol-5-yl)methyl)isonicotinamide::US10023557, Example 259::US10023557, Example 41::US10266515, Example 41::US10308637, Example 41::US11021463, Example 41::US9611252, Example 41	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283389	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283389&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665368	378164718							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042086	CNc1ccc(CNC(=O)c2ccnc(Cc3ccc4ncc(Cl)cc4c3)c2)c(C)n1	InChI=1S/C24H22ClN5O/c1-15-18(4-6-23(26-2)30-15)13-29-24(31)17-7-8-27-21(12-17)10-16-3-5-22-19(9-16)11-20(25)14-28-22/h3-9,11-12,14H,10,13H2,1-2H3,(H,26,30)(H,29,31)	KRORJRNMSXNFRV-UHFFFAOYSA-N	283390	2-((3-chloroquinolin-6-yl)methyl)-N-((2-methyl- 6-(methylamino)pyridin-3- yl)methyl)isonicotinamide::US10023557, Example 42::US10266515, Example 42::US10308637, Example 42::US11021463, Example 42::US9611252, Example 42	Plasma kallikrein			 550							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283390	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283390&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665110	378164719							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042087	Nc1ccc(CNC(=O)c2ccnc(Cc3ccc4ncc(Cl)cc4c3)c2)c(n1)C1CC1	InChI=1S/C25H22ClN5O/c26-20-11-19-9-15(1-5-22(19)29-14-20)10-21-12-17(7-8-28-21)25(32)30-13-18-4-6-23(27)31-24(18)16-2-3-16/h1,4-9,11-12,14,16H,2-3,10,13H2,(H2,27,31)(H,30,32)	CZYMIYVLJPMDKR-UHFFFAOYSA-N	283391	N-((6-amino-2-cyclopropylpyridin-3-yl)methyl)- 2-((3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 43::US10266515, Example 43::US10308637, Example 43::US11021463, Example 43::US9611252, Example 43	Plasma kallikrein			 550							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283391	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283391&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665372	378164720							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042088	CN(C)c1ccc(CNC(=O)c2ccnc(Cc3ccc4ncc(Cl)cc4c3)c2)c(C)n1	InChI=1S/C25H24ClN5O/c1-16-19(5-7-24(30-16)31(2)3)14-29-25(32)18-8-9-27-22(13-18)11-17-4-6-23-20(10-17)12-21(26)15-28-23/h4-10,12-13,15H,11,14H2,1-3H3,(H,29,32)	RUFAAOLTGJTOMH-UHFFFAOYSA-N	283392	2-((3-chloroquinolin-6-yl)methyl)-N-((6- (dimethylamino)-2-methylpyridin-3- yl)methyl)isonicotinamide::US10023557, Example 44::US10266515, Example 44::US10308637, Example 44::US11021463, Example 44::US9611252, Example 44	Plasma kallikrein			>10000							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283392	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283392&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665107	378164721							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042089	NCc1ccc2cc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)ccc2n1	InChI=1S/C26H21ClFN5O/c27-22-14-31-25-11-23(28)18(10-21(22)25)13-32-26(34)17-5-6-30-20(9-17)8-15-1-4-24-16(7-15)2-3-19(12-29)33-24/h1-7,9-11,14,31H,8,12-13,29H2,(H,32,34)	JRFVVGICARMPKA-UHFFFAOYSA-N	283393	2-((2-(aminomethyl)quinolin-6-yl)methyl)-N- ((3-chloro-6-fluoro-1H-indol-5- yl)methyl)isonicotinamide::US10023557, Example 45::US10308637, Example 45::US11021463, Example 45::US9611252, Example 45	Plasma kallikrein			 550							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283393	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283393&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212391	378164722							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042090	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3nc(CN)ccc3c2)c1	InChI=1S/C25H26N6O/c1-15-9-24(27)30-16(2)22(15)14-29-25(32)19-7-8-28-21(12-19)11-17-3-6-23-18(10-17)4-5-20(13-26)31-23/h3-10,12H,11,13-14,26H2,1-2H3,(H2,27,30)(H,29,32)	VJXDXEYDWIAFJF-UHFFFAOYSA-N	283394	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((2-(aminomethyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 46::US10266515, Example 46::US10308637, Example 46::US11021463, Example 46::US9611252, Example 46	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283394	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283394&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212365	378164723							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042091	Cc1cnc2ccc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)noc4c3)cc2c1	InChI=1S/C25H21N5O2/c1-15-8-19-9-16(3-5-22(19)28-13-15)10-20-12-18(6-7-27-20)25(31)29-14-17-2-4-21-23(11-17)32-30-24(21)26/h2-9,11-13H,10,14H2,1H3,(H2,26,30)(H,29,31)	JIGUMEUDUOTSCV-UHFFFAOYSA-N	283395	N-((3-aminobenzo[d]isoxazol-6-yl)methyl)-2- ((3-methylquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 47::US10266515, Example 47::US10308637, Example 47::US11021463, Example 47::US9611252, Example 47	Plasma kallikrein			 5500							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283395	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283395&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212412	378164724							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042092	Cc1ccc2ncc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)noc4c3)cc2c1	InChI=1S/C25H21N5O2/c1-15-2-5-22-19(8-15)9-17(14-28-22)10-20-12-18(6-7-27-20)25(31)29-13-16-3-4-21-23(11-16)32-30-24(21)26/h2-9,11-12,14H,10,13H2,1H3,(H2,26,30)(H,29,31)	ZCNHTDLBGJQFLS-UHFFFAOYSA-N	283396	N-((3-aminobenzo[d]isoxazol-6-yl)methyl)-2- ((6-methylquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 48::US10266515, Example 48::US10308637, Example 48::US11021463, Example 48::US9611252, Example 48	Plasma kallikrein			>10000							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283396	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283396&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665294	378164725							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042093	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1ccnc(Cc2cc(C#N)c3ncc(Cl)cc3c2)c1	InChI=1S/C26H16Cl2FN5O/c27-19-6-16-3-14(4-17(10-30)25(16)33-12-19)5-20-7-15(1-2-31-20)26(35)34-11-18-8-21-22(28)13-32-24(21)9-23(18)29/h1-4,6-9,12-13,32H,5,11H2,(H,34,35)	GDWMEKXUNIOULX-UHFFFAOYSA-N	283397	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3-chloro-8-cyanoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 49::US10308637, Example 49::US11021463, Example 49::US9611252, Example 49	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283397	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283397&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665225	378164726							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042094	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc(C#N)c3ncc(Cl)cc3c2)c1	InChI=1S/C25H21ClN6O/c1-14-5-23(28)32-15(2)22(14)13-31-25(33)17-3-4-29-21(10-17)8-16-6-18-9-20(26)12-30-24(18)19(7-16)11-27/h3-7,9-10,12H,8,13H2,1-2H3,(H2,28,32)(H,31,33)	VSKYRJRRAUSIED-UHFFFAOYSA-N	283398	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloro-8-cyanoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 50::US10266515, Example 50::US10308637, Example 50::US11021463, Example 50::US9611252, Example 50	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283398	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283398&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665177	378164727							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042095	Fc1c(CNC(=O)c2ccnc(Cc3cc(C#N)c4ncc(Cl)cc4c3)c2)ccc2[nH]cc(Cl)c12	InChI=1S/C26H16Cl2FN5O/c27-19-8-17-5-14(6-18(10-30)25(17)33-12-19)7-20-9-15(3-4-31-20)26(35)34-11-16-1-2-22-23(24(16)29)21(28)13-32-22/h1-6,8-9,12-13,32H,7,11H2,(H,34,35)	RGFJCIZRNQJUFS-UHFFFAOYSA-N	283399	N-((3-chloro-4-fluoro-1H-indol-5-yl)methyl)-2- ((3-chloro-8-cyanoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 51::US10266515, Example 51::US10308637, Example 51::US11021463, Example 51::US9611252, Example 51	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283399	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283399&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665441	378164728							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042096	Fc1cc2[nH]ccc2cc1CNC(=O)c1ccnc(Cc2cc(C#N)c3ncc(Cl)cc3c2)c1	InChI=1S/C26H17ClFN5O/c27-21-9-18-5-15(6-19(12-29)25(18)32-14-21)7-22-10-17(2-3-30-22)26(34)33-13-20-8-16-1-4-31-24(16)11-23(20)28/h1-6,8-11,14,31H,7,13H2,(H,33,34)	DGMHYZXVTQSHTG-UHFFFAOYSA-N	283400	2-((3-chloro-8-cyanoquinolin-6-yl)methyl)-N- ((6-fluoro-1H-indol-5-yl)methyl)isonicotinamide::US10023557, Example 52::US10266515, Example 52::US10308637, Example 52::US11021463, Example 52::US9611252, Example 52	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283400	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283400&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665338	378164729							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042097	Cc1cc(N)ncc1CNC(=O)c1ccnc(Cc2cc(C#N)c3ncc(Cl)cc3c2)c1	InChI=1S/C24H19ClN6O/c1-14-4-22(27)29-11-19(14)12-31-24(32)16-2-3-28-21(9-16)7-15-5-17-8-20(25)13-30-23(17)18(6-15)10-26/h2-6,8-9,11,13H,7,12H2,1H3,(H2,27,29)(H,31,32)	WNDNOSDBRCNUAW-UHFFFAOYSA-N	283401	N-((6-amino-4-methylpyridin-3-yl)methyl)-2- ((3-chloro-8-cyanoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 53::US10266515, Example 53::US10308637, Example 53::US11021463, Example 53::US9611252, Example 53	Plasma kallikrein			 550							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283401	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283401&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665126	378164730							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042098	Clc1ccc2[nH]nc(CNC(=O)c3ccnc(Cc4cc(C#N)c5ncc(Cl)cc5c4)c3)c2c1	InChI=1S/C25H16Cl2N6O/c26-18-1-2-22-21(10-18)23(33-32-22)13-31-25(34)15-3-4-29-20(9-15)7-14-5-16-8-19(27)12-30-24(16)17(6-14)11-28/h1-6,8-10,12H,7,13H2,(H,31,34)(H,32,33)	KUYYPMPLUCLDIX-UHFFFAOYSA-N	283402	N-((5-chloro-1H-indazol-3-yl)methyl)-2-((3- chloro-8-cyanoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 54::US10266515, Example 54::US10308637, Example 54::US11021463, Example 54::US9611252, Example 54	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283402	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283402&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665197	378164731							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042099	Clc1c[nH]c2ncc(CNC(=O)c3ccnc(Cc4cc(C#N)c5ncc(Cl)cc5c4)c3)cc12	InChI=1S/C25H16Cl2N6O/c26-19-7-17-3-14(4-18(9-28)23(17)30-12-19)5-20-8-16(1-2-29-20)25(34)33-11-15-6-21-22(27)13-32-24(21)31-10-15/h1-4,6-8,10,12-13H,5,11H2,(H,31,32)(H,33,34)	DLZBPOOKWFQHBR-UHFFFAOYSA-N	283403	N-((3-chloro-1H-pyrrolo[2,3-b]pyridin-5- yl)methyl)-2-((3-chloro-8-cyanoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 55::US10266515, Example 55::US10308637, Example 55::US11021463, Example 55::US9611252, Example 55	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283403	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283403&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665328	378164732							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042100	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2cc(C#N)c3ncc(Cl)cc3c2)c1	InChI=1S/C24H19ClN6O/c1-14-17(2-3-22(27)31-14)12-30-24(32)16-4-5-28-21(10-16)8-15-6-18-9-20(25)13-29-23(18)19(7-15)11-26/h2-7,9-10,13H,8,12H2,1H3,(H2,27,31)(H,30,32)	FDKNUBSGWSPNRT-UHFFFAOYSA-N	283404	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-chloro-8-cyanoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 56::US10266515, Example 56::US10308637, Example 56::US11021463, Example 56::US9611252, Example 56	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283404	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283404&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665146	378164733							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042101	Nc1nccc2cc(CNC(=O)c3ccnc(Cc4cc(C#N)c5ncc(Cl)cc5c4)c3)ccc12	InChI=1S/C27H19ClN6O/c28-22-11-20-8-17(9-21(13-29)25(20)33-15-22)10-23-12-19(4-5-31-23)27(35)34-14-16-1-2-24-18(7-16)3-6-32-26(24)30/h1-9,11-12,15H,10,14H2,(H2,30,32)(H,34,35)	IDTYIYATNJINLX-UHFFFAOYSA-N	283405	N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- chloro-8-cyanoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 57::US10266515, Example 57::US10308637, Example 57::US11021463, Example 57::US9611252, Example 57	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283405	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283405&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665382	378164734							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042102	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc(C(N)=O)c3ncc(Cl)cc3c2)c1	InChI=1S/C25H23ClN6O2/c1-13-5-22(27)32-14(2)21(13)12-31-25(34)16-3-4-29-19(10-16)7-15-6-17-9-18(26)11-30-23(17)20(8-15)24(28)33/h3-6,8-11H,7,12H2,1-2H3,(H2,27,32)(H2,28,33)(H,31,34)	INWUNFFPSCFXCA-UHFFFAOYSA-N	283406	6-((4-(((6-amino-2,4-dimethylpyridin-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- chloroquinoline-8-carboxamide::US10023557, Example 58::US10266515, Example 58::US10308637, Example 58::US11021463, Example 58::US9611252, Example 58	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283406	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283406&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665386	378164735							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042103	NC(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2cc3c(Cl)c[nH]c3cc2F)cc2cc(Cl)cnc12	InChI=1S/C26H18Cl2FN5O2/c27-17-6-15-3-13(5-20(25(30)35)24(15)33-11-17)4-18-7-14(1-2-31-18)26(36)34-10-16-8-19-21(28)12-32-23(19)9-22(16)29/h1-3,5-9,11-12,32H,4,10H2,(H2,30,35)(H,34,36)	QMNRPOHMXWHKMB-UHFFFAOYSA-N	283407	3-chloro-6-((4-(((3-chloro-6-fluoro-1H-indol-5- yl)methyl)carbamoyl)pyridin-2- yl)methyl)quinoline-8-carboxamide::US10023557, Example 59::US10266515, Example 59::US11021463, Example 59::US9611252, Example 59	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283407	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283407&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665413	378164736							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042104	NC(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2n[nH]c3ccc(Cl)cc23)cc2cc(Cl)cnc12	InChI=1S/C25H18Cl2N6O2/c26-16-1-2-21-19(10-16)22(33-32-21)12-31-25(35)14-3-4-29-18(9-14)6-13-5-15-8-17(27)11-30-23(15)20(7-13)24(28)34/h1-5,7-11H,6,12H2,(H2,28,34)(H,31,35)(H,32,33)	RTJGKEBRSSQCHQ-UHFFFAOYSA-N	283408	3-chloro-6-((4-(((5-chloro-1H-indazol-3- yl)methyl)carbamoyl)pyridin-2- yl)methyl)quinoline-8-carboxamide::US10023557, Example 60::US10266515, Example 60::US10308637, Example 60::US11021463, Example 60::US9611252, Example 60	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283408	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283408&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665317	378164737							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042105	NC(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2cnc3[nH]cc(Cl)c3c2)cc2cc(Cl)cnc12	InChI=1S/C25H18Cl2N6O2/c26-17-7-16-3-13(5-20(23(28)34)22(16)30-11-17)4-18-8-15(1-2-29-18)25(35)33-10-14-6-19-21(27)12-32-24(19)31-9-14/h1-3,5-9,11-12H,4,10H2,(H2,28,34)(H,31,32)(H,33,35)	QHIFWJFJAOUBPC-UHFFFAOYSA-N	283409	3-chloro-6-((4-(((3-chloro-1H-pyrrolo[2,3- b]pyridin-5-yl)methyl)carbamoyl)pyridin-2- yl)methyl)quinoline-8-carboxamide::US10023557, Example 61::US10266515, Example 61::US10308637, Example 61::US11021463, Example 61::US9611252, Example 61	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283409	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283409&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665370	378164738							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042106	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2cc(C(N)=O)c3ncc(Cl)cc3c2)c1	InChI=1S/C24H21ClN6O2/c1-13-16(2-3-21(26)31-13)11-30-24(33)15-4-5-28-19(10-15)7-14-6-17-9-18(25)12-29-22(17)20(8-14)23(27)32/h2-6,8-10,12H,7,11H2,1H3,(H2,26,31)(H2,27,32)(H,30,33)	WTBBASBLRSFZPD-UHFFFAOYSA-N	283410	6-((4-(((6-amino-2-methylpyridin-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- chloroquinoline-8-carboxamide::US10023557, Example 62::US10266515, Example 62::US10308637, Example 62::US11021463, Example 62::US9611252, Example 62	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283410	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283410&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665142	378164739							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042107	Cc1cc(N)ncc1CNC(=O)c1ccnc(Cc2cc(C(N)=O)c3ncc(Cl)cc3c2)c1	InChI=1S/C24H21ClN6O2/c1-13-4-21(26)29-10-17(13)11-31-24(33)15-2-3-28-19(9-15)6-14-5-16-8-18(25)12-30-22(16)20(7-14)23(27)32/h2-5,7-10,12H,6,11H2,1H3,(H2,26,29)(H2,27,32)(H,31,33)	ZAZOBWBMBQVKFV-UHFFFAOYSA-N	283411	6-((4-(((6-amino-4-methylpyridin-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- chloroquinoline-8-carboxamide::US10023557, Example 63::US10266515, Example 63::US10308637, Example 63::US11021463, Example 63::US9611252, Example 63	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283411	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283411&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665130	378164740							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042108	NC(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2ccc3c(N)nccc3c2)cc2cc(Cl)cnc12	InChI=1S/C27H21ClN6O2/c28-20-11-19-8-16(10-23(26(30)35)24(19)33-14-20)9-21-12-18(4-5-31-21)27(36)34-13-15-1-2-22-17(7-15)3-6-32-25(22)29/h1-8,10-12,14H,9,13H2,(H2,29,32)(H2,30,35)(H,34,36)	ZEVNHPCICZZSBU-UHFFFAOYSA-N	283412	6-((4-(((1-aminoisoquinolin-6- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- chloroquinoline-8-carboxamide::US10023557, Example 64::US10266515, Example 64::US10308637, Example 64::US11021463, Example 64::US9611252, Example 64	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283412	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283412&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665252	378164741							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042109	NC(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2ccc3[nH]cc(Cl)c3c2F)cc2cc(Cl)cnc12	InChI=1S/C26H18Cl2FN5O2/c27-17-8-16-5-13(7-19(25(30)35)24(16)33-11-17)6-18-9-14(3-4-31-18)26(36)34-10-15-1-2-21-22(23(15)29)20(28)12-32-21/h1-5,7-9,11-12,32H,6,10H2,(H2,30,35)(H,34,36)	PBEXDTRCFFOFDU-UHFFFAOYSA-N	283413	3-chloro-6-((4-(((3-chloro-4-fluoro-1H-indol-5- yl)methyl)carbamoyl)pyridin-2- yl)methyl)quinoline-8-carboxamide::US10023557, Example 65::US10266515, Example 65::US10308637, Example 65::US11021463, Example 65::US9611252, Example 65	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283413	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283413&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665414	378164742							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042110	NC(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2cc3cc[nH]c3cc2F)cc2cc(Cl)cnc12	InChI=1S/C26H19ClFN5O2/c27-19-9-17-5-14(7-21(25(29)34)24(17)32-13-19)6-20-10-16(2-3-30-20)26(35)33-12-18-8-15-1-4-31-23(15)11-22(18)28/h1-5,7-11,13,31H,6,12H2,(H2,29,34)(H,33,35)	ZDVUWSXSXIPPGM-UHFFFAOYSA-N	283414	3-chloro-6-((4-(((6-fluoro-1H-indol-5- yl)methyl)carbamoyl)pyridin-2- yl)methyl)quinoline-8-carboxamide::US10023557, Example 66::US10266515, Example 66::US10308637, Example 66::US11021463, Example 66::US9611252, Example 66	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283414	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283414&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665192	378164743							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042111	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc(c3ncc(Cl)cc3c2)S(C)(=O)=O)c1	InChI=1S/C25H24ClN5O3S/c1-14-6-23(27)31-15(2)21(14)13-30-25(32)17-4-5-28-20(11-17)8-16-7-18-10-19(26)12-29-24(18)22(9-16)35(3,33)34/h4-7,9-12H,8,13H2,1-3H3,(H2,27,31)(H,30,32)	LOAAVKXHIOVCPQ-UHFFFAOYSA-N	283415	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloro-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 67::US10266515, Example 67::US10308637, Example 67::US11021463, Example 67::US9611252, Example 67	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283415	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283415&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213160	378164744							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042112	CS(=O)(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2cc3c(Cl)c[nH]c3cc2F)cc2cc(Cl)cnc12	InChI=1S/C26H19Cl2FN4O3S/c1-37(35,36)24-6-14(4-16-7-18(27)12-32-25(16)24)5-19-8-15(2-3-30-19)26(34)33-11-17-9-20-21(28)13-31-23(20)10-22(17)29/h2-4,6-10,12-13,31H,5,11H2,1H3,(H,33,34)	JHEOACUKXNFFDI-UHFFFAOYSA-N	283416	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3-chloro-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 68::US10266515, Example 68::US10308637, Example 68::US11021463, Example 68::US9611252, Example 68	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283416	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283416&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212213	378164745							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042113	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2cc(c3ncc(Cl)cc3c2)S(C)(=O)=O)c1	InChI=1S/C24H22ClN5O3S/c1-14-17(3-4-22(26)30-14)12-29-24(31)16-5-6-27-20(11-16)8-15-7-18-10-19(25)13-28-23(18)21(9-15)34(2,32)33/h3-7,9-11,13H,8,12H2,1-2H3,(H2,26,30)(H,29,31)	DAYVOWICNMKAHH-UHFFFAOYSA-N	283417	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-chloro-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 69::US10266515, Example 69::US10308637, Example 69::US11021463, Example 69::US9611252, Example 69	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283417	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283417&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665120	378164746							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042114	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2c1)C#N	InChI=1S/C26H24N6O/c1-15-6-20-8-18(9-21(12-27)25(20)30-13-15)10-22-11-19(4-5-29-22)26(33)31-14-23-16(2)7-24(28)32-17(23)3/h4-9,11,13H,10,14H2,1-3H3,(H2,28,32)(H,31,33)	FWOVJYZAXZFOSD-UHFFFAOYSA-N	283418	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((8-cyano-3-methylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 70::US10266515, Example 70::US10308637, Example 70::US11021463, Example 70::US9611252, Example 70	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283418	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283418&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665112	378164747							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042115	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)cc2c1)C#N	InChI=1S/C28H22N6O/c1-17-8-22-10-19(11-23(14-29)26(22)33-15-17)12-24-13-21(5-6-31-24)28(35)34-16-18-2-3-25-20(9-18)4-7-32-27(25)30/h2-11,13,15H,12,16H2,1H3,(H2,30,32)(H,34,35)	XJVZLICIUISDSM-UHFFFAOYSA-N	283419	N-((1-aminoisoquinolin-6-yl)methyl)-2-((8- cyano-3-methylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 71::US10266515, Example 71::US10308637, Example 71::US11021463, Example 71::US9611252, Example 71	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283419	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283419&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665353	378164748							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042116	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)cc2c1)C#N	InChI=1S/C27H19ClFN5O/c1-15-4-18-5-16(6-19(11-30)26(18)33-12-15)7-21-8-17(2-3-31-21)27(35)34-13-20-9-22-23(28)14-32-25(22)10-24(20)29/h2-6,8-10,12,14,32H,7,13H2,1H3,(H,34,35)	KVEDUIDZCUQFJJ-UHFFFAOYSA-N	283420	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((8-cyano-3-methylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 72::US10308637, Example 72::US11021463, Example 72::US9611252, Example 72	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283420	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283420&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665256	378164749							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042117	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cnc4[nH]cc(Cl)c4c3)cc2c1)C#N	InChI=1S/C26H19ClN6O/c1-15-4-19-5-16(6-20(10-28)24(19)30-11-15)7-21-9-18(2-3-29-21)26(34)33-13-17-8-22-23(27)14-32-25(22)31-12-17/h2-6,8-9,11-12,14H,7,13H2,1H3,(H,31,32)(H,33,34)	DUPQBZNXOTZIFE-UHFFFAOYSA-N	283421	N-((3-chloro-1H-pyrrolo[2,3-b]pyridin-5- yl)methyl)-2-((8-cyano-3-methylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 73::US10266515, Example 73::US10308637, Example 73::US11021463, Example 73::US9611252, Example 73	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283421	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283421&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665369	378164750							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042118	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3ccc4[nH]cc(Cl)c4c3F)cc2c1)C#N	InChI=1S/C27H19ClFN5O/c1-15-6-19-7-16(8-20(11-30)26(19)33-12-15)9-21-10-17(4-5-31-21)27(35)34-13-18-2-3-23-24(25(18)29)22(28)14-32-23/h2-8,10,12,14,32H,9,13H2,1H3,(H,34,35)	UJWAIKJCZKWWSO-UHFFFAOYSA-N	283422	N-((3-chloro-4-fluoro-1H-indol-5-yl)methyl)-2- ((8-cyano-3-methylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 74::US10266515, Example 74::US10308637, Example 74::US11021463, Example 74::US9611252, Example 74	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283422	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283422&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665323	378164751							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042119	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3n[nH]c4ccc(Cl)cc34)cc2c1)C#N	InChI=1S/C26H19ClN6O/c1-15-6-18-7-16(8-19(12-28)25(18)30-13-15)9-21-10-17(4-5-29-21)26(34)31-14-24-22-11-20(27)2-3-23(22)32-33-24/h2-8,10-11,13H,9,14H2,1H3,(H,31,34)(H,32,33)	SABOZYHOSJEBNR-UHFFFAOYSA-N	283423	N-((5-chloro-1H-indazol-3-yl)methyl)-2-((8- cyano-3-methylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 75::US10266515, Example 75::US10308637, Example 75::US11021463, Example 75::US9611252, Example 75	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283423	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283423&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665301	378164752							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042120	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cc4cc[nH]c4cc3F)cc2c1)C#N	InChI=1S/C27H20FN5O/c1-16-6-20-7-17(8-21(13-29)26(20)32-14-16)9-23-11-19(3-4-30-23)27(34)33-15-22-10-18-2-5-31-25(18)12-24(22)28/h2-8,10-12,14,31H,9,15H2,1H3,(H,33,34)	ZWLALZHUQUAZOX-UHFFFAOYSA-N	283424	2-((8-cyano-3-methylquinolin-6-yl)methyl)-N- ((6-fluoro-1H-indol-5-yl)methyl)isonicotinamide::US10023557, Example 76::US10266515, Example 76::US10308637, Example 76::US11021463, Example 76::US9611252, Example 76	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283424	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283424&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665344	378164753							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042121	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2c1)C(N)=O	InChI=1S/C26H26N6O2/c1-14-6-19-8-17(10-21(25(28)33)24(19)30-12-14)9-20-11-18(4-5-29-20)26(34)31-13-22-15(2)7-23(27)32-16(22)3/h4-8,10-12H,9,13H2,1-3H3,(H2,27,32)(H2,28,33)(H,31,34)	OOWBJQXCALEAFC-UHFFFAOYSA-N	283425	6-((4-(((6-amino-2,4-dimethylpyridin-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- methylquinoline-8-carboxamide::US10023557, Example 77::US10266515, Example 77::US10308637, Example 77::US11021463, Example 77::US9611252, Example 77	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283425	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283425&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665125	378164754							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042122	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)cc2c1)C(N)=O	InChI=1S/C27H21ClFN5O2/c1-14-4-17-5-15(7-21(26(30)35)25(17)33-11-14)6-19-8-16(2-3-31-19)27(36)34-12-18-9-20-22(28)13-32-24(20)10-23(18)29/h2-5,7-11,13,32H,6,12H2,1H3,(H2,30,35)(H,34,36)	WETFPOPVXHIHFG-UHFFFAOYSA-N	283426	6-((4-(((3-chloro-6-fluoro-1H-indol-5- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- methylquinoline-8-carboxamide::US10023557, Example 78::US10266515, Example 78::US10308637, Example 78::US11021463, Example 78::US9611252, Example 78	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283426	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283426&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665427	378164755							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042123	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)cc2c1)C(N)=O	InChI=1S/C28H24N6O2/c1-16-8-21-10-18(12-24(27(30)35)25(21)33-14-16)11-22-13-20(5-6-31-22)28(36)34-15-17-2-3-23-19(9-17)4-7-32-26(23)29/h2-10,12-14H,11,15H2,1H3,(H2,29,32)(H2,30,35)(H,34,36)	AVMNYBKKWARJKT-UHFFFAOYSA-N	283427	6-((4-(((1-aminoisoquinolin-6- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- methylquinoline-8-carboxamide::US10023557, Example 79::US10266515, Example 79::US10308637, Example 79::US11021463, Example 79::US9611252, Example 79	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283427	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283427&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665123	378164756							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042124	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cnc4[nH]cc(Cl)c4c3)cc2c1)C(N)=O	InChI=1S/C26H21ClN6O2/c1-14-4-18-5-15(7-21(24(28)34)23(18)30-10-14)6-19-9-17(2-3-29-19)26(35)33-12-16-8-20-22(27)13-32-25(20)31-11-16/h2-5,7-11,13H,6,12H2,1H3,(H2,28,34)(H,31,32)(H,33,35)	CFJXZEDRAADQFI-UHFFFAOYSA-N	283428	6-((4-(((3-chloro-1H-pyrrolo[2,3-b]pyridin-5- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- methylquinoline-8-carboxamide::US10023557, Example 80::US10266515, Example 80::US10308637, Example 80::US11021463, Example 80::US9611252, Example 80	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283428	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283428&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665254	378164757							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042125	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3ccc4[nH]cc(Cl)c4c3F)cc2c1)C(N)=O	InChI=1S/C27H21ClFN5O2/c1-14-6-18-7-15(9-20(26(30)35)25(18)33-11-14)8-19-10-16(4-5-31-19)27(36)34-12-17-2-3-22-23(24(17)29)21(28)13-32-22/h2-7,9-11,13,32H,8,12H2,1H3,(H2,30,35)(H,34,36)	LJDMUPONZYUBTQ-UHFFFAOYSA-N	283429	6-((4-(((3-chloro-4-fluoro-1H-indol-5- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- methylquinoline-8-carboxamide::US10023557, Example 81::US10266515, Example 81::US10308637, Example 81::US11021463, Example 81::US9611252, Example 81	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283429	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283429&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665251	378164758							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042126	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3n[nH]c4ccc(Cl)cc34)cc2c1)C(N)=O	InChI=1S/C26H21ClN6O2/c1-14-6-17-7-15(9-21(25(28)34)24(17)30-12-14)8-19-10-16(4-5-29-19)26(35)31-13-23-20-11-18(27)2-3-22(20)32-33-23/h2-7,9-12H,8,13H2,1H3,(H2,28,34)(H,31,35)(H,32,33)	KIVLLFJSACGLHN-UHFFFAOYSA-N	283430	6-((4-(((5-chloro-1H-indazol-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- methylquinoline-8-carboxamide::US10023557, Example 82::US10266515, Example 82::US10308637, Example 82::US11021463, Example 82::US9611252, Example 82	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283430	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283430&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665290	378164759							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042127	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cc4cc[nH]c4cc3F)cc2c1)C(N)=O	InChI=1S/C27H22FN5O2/c1-15-6-19-7-16(9-22(26(29)34)25(19)32-13-15)8-21-11-18(3-4-30-21)27(35)33-14-20-10-17-2-5-31-24(17)12-23(20)28/h2-7,9-13,31H,8,14H2,1H3,(H2,29,34)(H,33,35)	UZTOCULVDVRYTA-UHFFFAOYSA-N	283431	6-((4-(((6-fluoro-1H-indol-5- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- methylquinoline-8-carboxamide::US10023557, Example 83::US10266515, Example 83::US10308637, Example 83::US11021463, Example 83::US9611252, Example 83	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283431	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283431&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665428	378164760							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042128	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2c1)C(O)=O	InChI=1S/C26H25N5O3/c1-14-6-19-8-17(10-21(26(33)34)24(19)29-12-14)9-20-11-18(4-5-28-20)25(32)30-13-22-15(2)7-23(27)31-16(22)3/h4-8,10-12H,9,13H2,1-3H3,(H2,27,31)(H,30,32)(H,33,34)	IDXZVLZJXGFXKF-UHFFFAOYSA-N	283432	6-((4-(((6-amino-2,4-dimethylpyridin-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- methylquinoline-8-carboxylic acid::US10023557, Example 84::US10266515, Example 84::US10308637, Example 84::US11021463, Example 84::US9611252, Example 84	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283432	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283432&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665404	378164761							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042129	Cc1cc(N)ncc1CNC(=O)c1ccnc(Cn2cc3cc(Cl)ccc3cc2=O)c1	InChI=1S/C23H20ClN5O2/c1-14-6-21(25)27-10-18(14)11-28-23(31)16-4-5-26-20(8-16)13-29-12-17-7-19(24)3-2-15(17)9-22(29)30/h2-10,12H,11,13H2,1H3,(H2,25,27)(H,28,31)	DNSFNVWZLXWEIP-UHFFFAOYSA-N	283433	N-((6-amino-4-methylpyridin-3-yl)methyl)-2- ((7-chloro-3-oxoisoquinolin-2(3H)- yl)methyl)isonicotinamide::US10023557, Example 85::US10266515, Example 85::US10308637, Example 85::US11021463, Example 85::US9611252, Example 85	Plasma kallikrein			 550							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283433	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283433&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665165	378164762							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042130	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cn2cc3cc(Cl)ccc3cc2=O)c1	InChI=1S/C23H20ClN5O2/c1-14-17(3-5-21(25)28-14)11-27-23(31)16-6-7-26-20(9-16)13-29-12-18-8-19(24)4-2-15(18)10-22(29)30/h2-10,12H,11,13H2,1H3,(H2,25,28)(H,27,31)	BXRRZXRRYWPPRB-UHFFFAOYSA-N	283434	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((7-chloro-3-oxoisoquinolin-2(3H)- yl)methyl)isonicotinamide::US10023557, Example 86::US10266515, Example 86::US10308637, Example 86::US11021463, Example 86::US9611252, Example 86	Plasma kallikrein			 550							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283434	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283434&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665384	378164763							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042131	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cn2cc3cc(Cl)ccc3cc2=O)c1	InChI=1S/C24H22ClN5O2/c1-14-7-22(26)29-15(2)21(14)11-28-24(32)17-5-6-27-20(9-17)13-30-12-18-8-19(25)4-3-16(18)10-23(30)31/h3-10,12H,11,13H2,1-2H3,(H2,26,29)(H,28,32)	IRSFVELJVAKOKE-UHFFFAOYSA-N	283435	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((7-chloro-3-oxoisoquinolin-2(3H)- yl)methyl)isonicotinamide::US10023557, Example 87::US10266515, Example 87::US10308637, Example 87::US11021463, Example 87::US9611252, Example 87	Plasma kallikrein			 550							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283435	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283435&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665121	378164764							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042132	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1ccnc(Cn2cc3cc(Cl)ccc3cc2=O)c1	InChI=1S/C25H17Cl2FN4O2/c26-18-2-1-14-8-24(33)32(12-17(14)5-18)13-19-6-15(3-4-29-19)25(34)31-10-16-7-20-21(27)11-30-23(20)9-22(16)28/h1-9,11-12,30H,10,13H2,(H,31,34)	LIVKHBBLMAFTFP-UHFFFAOYSA-N	283436	2-((7-chloro-3-oxoisoquinolin-2(3H)-yl)methyl)- N-((3-chloro-6-fluoro-1H-indol-5- yl)methyl)isonicotinamide::US10023557, Example 88::US10266515, Example 88::US10308637, Example 88::US11021463, Example 88::US9611252, Example 88	Plasma kallikrein			 550							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283436	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283436&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665351	378164765							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042133	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc(F)c3ncc(Cl)cc3c2)c1	InChI=1S/C24H21ClFN5O/c1-13-5-22(27)31-14(2)20(13)12-30-24(32)16-3-4-28-19(10-16)7-15-6-17-9-18(25)11-29-23(17)21(26)8-15/h3-6,8-11H,7,12H2,1-2H3,(H2,27,31)(H,30,32)	NJQUWZKNWYIFOW-UHFFFAOYSA-N	283437	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloro-8-fluoroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 89::US10266515, Example 89::US10308637, Example 89::US11021463, Example 89::US9611252, Example 89	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283437	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283437&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665263	378164766							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042134	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1ccnc(Cc2cc(F)c3ncc(Cl)cc3c2)c1	InChI=1S/C25H16Cl2F2N4O/c26-17-6-15-3-13(5-22(29)24(15)32-11-17)4-18-7-14(1-2-30-18)25(34)33-10-16-8-19-20(27)12-31-23(19)9-21(16)28/h1-3,5-9,11-12,31H,4,10H2,(H,33,34)	WZBGVJNIHVUBGP-UHFFFAOYSA-N	283438	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3-chloro-8-fluoroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 90::US10266515, Example 90::US10308637, Example 90::US11021463, Example 90::US9611252, Example 90	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283438	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283438&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665313	378164767							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042135	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2cc(F)c3ncc(Cl)cc3c2)c1	InChI=1S/C23H19ClFN5O/c1-13-16(2-3-21(26)30-13)11-29-23(31)15-4-5-27-19(10-15)7-14-6-17-9-18(24)12-28-22(17)20(25)8-14/h2-6,8-10,12H,7,11H2,1H3,(H2,26,30)(H,29,31)	JKVPCVWDMOMIMY-UHFFFAOYSA-N	283439	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-chloro-8-fluoroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 91::US10266515, Example 91::US10308637, Example 91::US11021463, Example 91::US9611252, Example 91	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283439	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283439&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665234	378164768							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042136	COC(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2c(C)cc(N)nc2C)cc2cc(Cl)cnc12	InChI=1S/C26H24ClN5O3/c1-14-6-23(28)32-15(2)22(14)13-31-25(33)17-4-5-29-20(11-17)8-16-7-18-10-19(27)12-30-24(18)21(9-16)26(34)35-3/h4-7,9-12H,8,13H2,1-3H3,(H2,28,32)(H,31,33)	YFEQLRSQCAMBNR-UHFFFAOYSA-N	283440	US10023557, Example 92::US10266515, Example 92::US10308637, Example 92::US11021463, Example 92::US9611252, Example 92::methyl 6-((4-(((6-amino-2,4-dimethylpyridin-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- chloroquinoline-8-carboxylate	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283440	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283440&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665210	378164769							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042137	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc(C(O)=O)c3ncc(Cl)cc3c2)c1	InChI=1S/C25H22ClN5O3/c1-13-5-22(27)31-14(2)21(13)12-30-24(32)16-3-4-28-19(10-16)7-15-6-17-9-18(26)11-29-23(17)20(8-15)25(33)34/h3-6,8-11H,7,12H2,1-2H3,(H2,27,31)(H,30,32)(H,33,34)	BVAYWMZNSZGAMT-UHFFFAOYSA-N	283441	6-((4-(((6-amino-2,4-dimethylpyridin-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- chloroquinoline-8-carboxylic acid::US10023557, Example 93::US10266515, Example 93::US10308637, Example 93::US11021463, Example 93::US9611252, Example 93	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283441	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283441&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665155	378164770							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042138	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc(CO)c3ncc(Cl)cc3c2)c1	InChI=1S/C25H24ClN5O2/c1-14-5-23(27)31-15(2)22(14)12-30-25(33)17-3-4-28-21(10-17)8-16-6-18-9-20(26)11-29-24(18)19(7-16)13-32/h3-7,9-11,32H,8,12-13H2,1-2H3,(H2,27,31)(H,30,33)	CDDJVGAEPTXXCL-UHFFFAOYSA-N	283442	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloro-8-(hydroxymethyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 94::US10266515, Example 94::US10308637, Example 94::US11021463, Example 94::US9611252, Example 94	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283442	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283442&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665190	378164771							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042139	COC(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2ccc(N)nc2C)cc2cc(Cl)cnc12	InChI=1S/C25H22ClN5O3/c1-14-17(3-4-22(27)31-14)12-30-24(32)16-5-6-28-20(11-16)8-15-7-18-10-19(26)13-29-23(18)21(9-15)25(33)34-2/h3-7,9-11,13H,8,12H2,1-2H3,(H2,27,31)(H,30,32)	JHWMKRJZPWMJLH-UHFFFAOYSA-N	283443	US10023557, Example 95::US10266515, Example 95::US10308637, Example 95::US11021463, Example 95::US9611252, Example 95::methyl 6-((4-(((6-amino-2-methylpyridin-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- chloroquinoline-8-carboxylate	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283443	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283443&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665172	378164772							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042140	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2cc(C(O)=O)c3ncc(Cl)cc3c2)c1	InChI=1S/C24H20ClN5O3/c1-13-16(2-3-21(26)30-13)11-29-23(31)15-4-5-27-19(10-15)7-14-6-17-9-18(25)12-28-22(17)20(8-14)24(32)33/h2-6,8-10,12H,7,11H2,1H3,(H2,26,30)(H,29,31)(H,32,33)	OWMRLFMYSUGJHS-UHFFFAOYSA-N	283444	6-((4-(((6-amino-2-methylpyridin-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- chloroquinoline-8-carboxylic acid::US10023557, Example 96::US10266515, Example 96::US10308637, Example 96::US11021463, Example 96::US9611252, Example 96	Plasma kallikrein			 550							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283444	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283444&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665320	378164773							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042141	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2cc(CO)c3ncc(Cl)cc3c2)c1	InChI=1S/C24H22ClN5O2/c1-14-17(2-3-22(26)30-14)11-29-24(32)16-4-5-27-21(10-16)8-15-6-18-9-20(25)12-28-23(18)19(7-15)13-31/h2-7,9-10,12,31H,8,11,13H2,1H3,(H2,26,30)(H,29,32)	SCWQNZNCOWHKCU-UHFFFAOYSA-N	283445	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-chloro-8-(hydroxymethyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 97::US10266515, Example 97::US10308637, Example 97::US11021463, Example 97::US9611252, Example 97	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283445	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283445&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665282	378164774							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042142	Cc1cc(N)[n+]([O-])c(C)c1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C24H22ClN5O2/c1-14-7-23(26)30(32)15(2)21(14)13-29-24(31)17-5-6-27-20(11-17)9-16-3-4-22-18(8-16)10-19(25)12-28-22/h3-8,10-12H,9,13,26H2,1-2H3,(H,29,31)	JMNAJBKCXDWWFM-UHFFFAOYSA-N	283446	6-amino-3-((2-((3-chloroquinolin-6- yl)methyl)isonicotinamido)methyl)-2,4- dimethylpyridine 1-oxide::US10023557, Example 98::US10266515, Example 98::US10308637, Example 98::US11021463, Example 98::US9611252, Example 98	Plasma kallikrein			 550							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283446	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283446&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665244	378164775							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042143	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3[n+]([O-])cc(Cl)cc3c2)c1	InChI=1S/C24H22ClN5O2/c1-14-7-23(26)29-15(2)21(14)12-28-24(31)17-5-6-27-20(11-17)9-16-3-4-22-18(8-16)10-19(25)13-30(22)32/h3-8,10-11,13H,9,12H2,1-2H3,(H2,26,29)(H,28,31)	XRSVMKZHXCTYQX-UHFFFAOYSA-N	283447	6-((4-(((6-amino-2,4-dimethylpyridin-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- chloroquinoline 1-oxide::US10023557, Example 99::US10266515, Example 99::US10308637, Example 99::US11021463, Example 99::US9611252, Example 99	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283447	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283447&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665346	378164776							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042144	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc(Cl)c3ncc(Cl)cc3c2)c1	InChI=1S/C24H21Cl2N5O/c1-13-5-22(27)31-14(2)20(13)12-30-24(32)16-3-4-28-19(10-16)7-15-6-17-9-18(25)11-29-23(17)21(26)8-15/h3-6,8-11H,7,12H2,1-2H3,(H2,27,31)(H,30,32)	HHXMWQGWYOIRGQ-UHFFFAOYSA-N	283448	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3,8-dichloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 100::US10266515, Example 100::US10308637, Example 100::US11021463, Example 100::US9611252, Example 100	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283448	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283448&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665316	378164777							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042145	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2cc(Cl)c3ncc(Cl)cc3c2)c1	InChI=1S/C23H19Cl2N5O/c1-13-16(2-3-21(26)30-13)11-29-23(31)15-4-5-27-19(10-15)7-14-6-17-9-18(24)12-28-22(17)20(25)8-14/h2-6,8-10,12H,7,11H2,1H3,(H2,26,30)(H,29,31)	LGBIYJSQIIGQJI-UHFFFAOYSA-N	283449	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3,8-dichloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 101::US10266515, Example 101::US10308637, Example 101::US11021463, Example 101::US9611252, Example 101	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283449	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283449&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665134	378164778							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042146	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2F)c1	InChI=1S/C24H21ClFN5O/c1-13-7-22(27)31-14(2)20(13)12-30-24(32)16-5-6-28-18(9-16)8-15-3-4-21-19(23(15)26)10-17(25)11-29-21/h3-7,9-11H,8,12H2,1-2H3,(H2,27,31)(H,30,32)	MDLFAZWEMPYOEY-UHFFFAOYSA-N	283450	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloro-5-fluoroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 102::US10266515, Example 102::US10308637, Example 102::US11021463, Example 102::US9611252, Example 102	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283450	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283450&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665170	378164779							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042147	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2F)c1	InChI=1S/C23H19ClFN5O/c1-13-16(3-5-21(26)30-13)11-29-23(31)15-6-7-27-18(9-15)8-14-2-4-20-19(22(14)25)10-17(24)12-28-20/h2-7,9-10,12H,8,11H2,1H3,(H2,26,30)(H,29,31)	CMOKBXIVBITBDZ-UHFFFAOYSA-N	283451	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-chloro-5-fluoroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 103::US10266515, Example 103::US10308637, Example 103::US11021463, Example 103::US9611252, Example 103	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283451	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283451&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665235	378164780							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042148	Cc1cc(cc(Cc2ccc3ncc(Cl)cc3c2)n1)C(=O)NCc1c(C)cc(N)nc1C	InChI=1S/C25H24ClN5O/c1-14-6-24(27)31-16(3)22(14)13-29-25(32)19-7-15(2)30-21(11-19)9-17-4-5-23-18(8-17)10-20(26)12-28-23/h4-8,10-12H,9,13H2,1-3H3,(H2,27,31)(H,29,32)	WDMJJASBQUYWJX-UHFFFAOYSA-N	283452	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloroquinolin-6-yl)methyl)-6- methylisonicotinamide::US10023557, Example 104::US10023557, Example 197::US10266515, Example 104::US10308637, Example 197::US11021463, Example 104::US9611252, Example 104	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283452	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283452&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665211	378164781							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042149	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cn2ncc3cc(Cl)ccc23)c1	InChI=1S/C22H21ClN6O/c1-13-7-21(24)28-14(2)19(13)11-26-22(30)15-5-6-25-18(9-15)12-29-20-4-3-17(23)8-16(20)10-27-29/h3-10H,11-12H2,1-2H3,(H2,24,28)(H,26,30)	VIIRLZCJMXLFHW-UHFFFAOYSA-N	283549	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((5-chloro-1H-indazol-1- yl)methyl)isonicotinamide::US10023557, Example 198::US10308637, Example 202::US11021463, Example 105::US9611252, Example 105	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283549	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283549&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665148	378164875							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042150	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cn2cc3cc(Cl)ccc3n2)c1	InChI=1S/C22H21ClN6O/c1-13-7-21(24)27-14(2)19(13)10-26-22(30)15-5-6-25-18(9-15)12-29-11-16-8-17(23)3-4-20(16)28-29/h3-9,11H,10,12H2,1-2H3,(H2,24,27)(H,26,30)	JJKKHULUCHMWFC-UHFFFAOYSA-N	283454	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((5-chloro-2H-indazol-2- yl)methyl)isonicotinamide::US10023557, Example 106::US10023557, Example 107::US10023557, Example 199::US10266515, Example 107::US10308637, Example 199::US11021463, Example 106::US9611252, Example 106	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283454	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283454&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665275	378164783							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042151	Cc1ccc2nn(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2c1	InChI=1S/C23H24N6O/c1-14-4-5-21-18(8-14)12-29(28-21)13-19-10-17(6-7-25-19)23(30)26-11-20-15(2)9-22(24)27-16(20)3/h4-10,12H,11,13H2,1-3H3,(H2,24,27)(H,26,30)	ZFEUOGPGKMODOZ-UHFFFAOYSA-N	283551	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((5-methyl-2H-indazol-2- yl)methyl)isonicotinamide::US10023557, Example 200::US10308637, Example 200::US11021463, Example 107::US9611252, Example 107	Plasma kallikrein			 550							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283551	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283551&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665352	378164876							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042152	Cc1ccc2n(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)ncc2c1	InChI=1S/C23H24N6O/c1-14-4-5-21-18(8-14)11-27-29(21)13-19-10-17(6-7-25-19)23(30)26-12-20-15(2)9-22(24)28-16(20)3/h4-11H,12-13H2,1-3H3,(H2,24,28)(H,26,30)	PJQHDAQZXYWCRS-UHFFFAOYSA-N	283456	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((5-methyl-1H-indazol-1- yl)methyl)isonicotinamide::US10023557, Example 108::US10266515, Example 108::US10308637, Example 108::US11021463, Example 108::US9611252, Example 108	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283456	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283456&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665436	378164784							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042153	Cc1ccc2nc(c(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)cc2c1)S(C)(=O)=O	InChI=1S/C27H22ClFN4O3S/c1-15-3-4-24-17(7-15)8-18(27(33-24)37(2,35)36)10-20-9-16(5-6-30-20)26(34)32-13-19-11-21-22(28)14-31-25(21)12-23(19)29/h3-9,11-12,14,31H,10,13H2,1-2H3,(H,32,34)	OXDNNQYYISTXOB-UHFFFAOYSA-N	283457	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((6-methyl-2-(methylsulfonyl)quinolin-3- yl)methyl)isonicotinamide::US10023557, Example 109::US10266515, Example 109::US10308637, Example 109::US11021463, Example 109::US9611252, Example 109	Plasma kallikrein			 550							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283457	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283457&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213217	378164785							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042154	Cc1ccc2cc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)ccc2n1	InChI=1S/C26H20ClFN4O/c1-15-2-4-17-8-16(3-5-24(17)32-15)9-20-10-18(6-7-29-20)26(33)31-13-19-11-21-22(27)14-30-25(21)12-23(19)28/h2-8,10-12,14,30H,9,13H2,1H3,(H,31,33)	SQVVRWKBMIEHGU-UHFFFAOYSA-N	283458	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((2-methylquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 110::US10266515, Example 110::US10308637, Example 110::US11021463, Example 110::US9611252, Example 110	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283458	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283458&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212258	378164786							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042155	Cc1ccc2cc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)ccc2n1	InChI=1S/C27H23N5O/c1-17-2-5-21-12-18(4-7-25(21)32-17)14-23-15-22(9-10-29-23)27(33)31-16-19-3-6-24-20(13-19)8-11-30-26(24)28/h2-13,15H,14,16H2,1H3,(H2,28,30)(H,31,33)	BHHAKIOPTCXPSL-UHFFFAOYSA-N	283459	N-((1-aminoisoquinolin-6-yl)methyl)-2-((2- methylquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 111::US10266515, Example 111::US10308637, Example 111::US11021463, Example 111::US9611252, Example 111	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283459	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283459&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212697	378164787							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042156	Cc1ccc2cc(Cc3cc(ccn3)C(=O)NCc3ccc(N)nc3C)ccc2n1	InChI=1S/C24H23N5O/c1-15-3-5-18-11-17(4-7-22(18)28-15)12-21-13-19(9-10-26-21)24(30)27-14-20-6-8-23(25)29-16(20)2/h3-11,13H,12,14H2,1-2H3,(H2,25,29)(H,27,30)	XECXUFHBCFQVQM-UHFFFAOYSA-N	283460	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((2-methylquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 112::US10266515, Example 112::US10308637, Example 112::US11021463, Example 112::US9611252, Example 112	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283460	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283460&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212369	378164788							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042157	Cc1ccc2cc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)ccc2n1	InChI=1S/C25H25N5O/c1-15-10-24(26)30-17(3)22(15)14-28-25(31)20-8-9-27-21(13-20)12-18-5-7-23-19(11-18)6-4-16(2)29-23/h4-11,13H,12,14H2,1-3H3,(H2,26,30)(H,28,31)	SOGVYINZTNHWMJ-UHFFFAOYSA-N	283461	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((2-methylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 113::US10266515, Example 113::US10308637, Example 113::US11021463, Example 113::US9611252, Example 113	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283461	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283461&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212447	378164789							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042158	Cc1ccc2ncc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2c1	InChI=1S/C25H25N5O/c1-15-4-5-23-20(8-15)10-18(13-28-23)11-21-12-19(6-7-27-21)25(31)29-14-22-16(2)9-24(26)30-17(22)3/h4-10,12-13H,11,14H2,1-3H3,(H2,26,30)(H,29,31)	PERODSYFHIKGOQ-UHFFFAOYSA-N	283462	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((6-methylquinolin-3- yl)methyl)isonicotinamide::US10023557, Example 114::US10266515, Example 114::US10308637, Example 114::US11021463, Example 114::US9611252, Example 114	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283462	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283462&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212424	378164790							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042159	Cc1ccc2ncc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)cc2c1	InChI=1S/C27H23N5O/c1-17-2-5-25-22(10-17)12-19(16-31-25)13-23-14-21(7-8-29-23)27(33)32-15-18-3-4-24-20(11-18)6-9-30-26(24)28/h2-12,14,16H,13,15H2,1H3,(H2,28,30)(H,32,33)	YXYWWKCODFDZSQ-UHFFFAOYSA-N	283463	N-((1-aminoisoquinolin-6-yl)methyl)-2-((6- methylquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 115::US10266515, Example 115::US10308637, Example 115::US11021463, Example 115::US9611252, Example 115	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283463	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283463&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212341	378164791							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042160	Cc1ccc2ncc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)cc2c1	InChI=1S/C26H20ClFN4O/c1-15-2-3-24-18(6-15)7-16(12-30-24)8-20-9-17(4-5-29-20)26(33)32-13-19-10-21-22(27)14-31-25(21)11-23(19)28/h2-7,9-12,14,31H,8,13H2,1H3,(H,32,33)	HEFJFXWKPBYZLZ-UHFFFAOYSA-N	283464	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((6-methylquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 116::US10266515, Example 116::US10308637, Example 116::US11021463, Example 116::US9611252, Example 116	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283464	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283464&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212685	378164792							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042161	Cc1ccc2ncc(Cc3cc(ccn3)C(=O)NCc3ccc(N)nc3C)cc2c1	InChI=1S/C24H23N5O/c1-15-3-5-22-20(9-15)10-17(13-27-22)11-21-12-18(7-8-26-21)24(30)28-14-19-4-6-23(25)29-16(19)2/h3-10,12-13H,11,14H2,1-2H3,(H2,25,29)(H,28,30)	WNXNZZRXTORCMQ-UHFFFAOYSA-N	283465	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((6-methylquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 117::US10266515, Example 117::US10308637, Example 117::US11021463, Example 117::US9611252, Example 117	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283465	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283465&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212579	378164793							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042162	Nc1nccc2cc(CNC(=O)c3ccnc(Cc4cnc5ccc(F)cc5c4)c3)ccc12	InChI=1S/C26H20FN5O/c27-21-2-4-24-20(12-21)10-17(15-31-24)11-22-13-19(6-7-29-22)26(33)32-14-16-1-3-23-18(9-16)5-8-30-25(23)28/h1-10,12-13,15H,11,14H2,(H2,28,30)(H,32,33)	FEOOVYNQAJINSQ-UHFFFAOYSA-N	283466	N-((1-aminoisoquinolin-6-yl)methyl)-2-((6- fluoroquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 118::US10266515, Example 118::US10308637, Example 118::US11021463, Example 118::US9611252, Example 118	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283466	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283466&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212932	378164794							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042163	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cnc3ccc(F)cc3c2)c1	InChI=1S/C24H22FN5O/c1-14-7-23(26)30-15(2)21(14)13-29-24(31)17-5-6-27-20(11-17)9-16-8-18-10-19(25)3-4-22(18)28-12-16/h3-8,10-12H,9,13H2,1-2H3,(H2,26,30)(H,29,31)	VJYVCAQEIJFBMF-UHFFFAOYSA-N	283467	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((6-fluoroquinolin-3- yl)methyl)isonicotinamide::US10023557, Example 119::US10266515, Example 119::US10308637, Example 119::US11021463, Example 119::US9611252, Example 119	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283467	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283467&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212962	378164795							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042164	Fc1ccc2ncc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)cc2c1	InChI=1S/C25H17ClF2N4O/c26-21-13-31-24-10-22(28)17(9-20(21)24)12-32-25(33)15-3-4-29-19(8-15)6-14-5-16-7-18(27)1-2-23(16)30-11-14/h1-5,7-11,13,31H,6,12H2,(H,32,33)	PDPRSJXGOZQXDE-UHFFFAOYSA-N	283468	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((6-fluoroquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 120::US10266515, Example 120::US10308637, Example 120::US11021463, Example 120::US9611252, Example 120	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283468	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283468&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212861	378164796							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042165	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2cnc3ccc(F)cc3c2)c1	InChI=1S/C23H20FN5O/c1-14-17(2-5-22(25)29-14)13-28-23(30)16-6-7-26-20(11-16)9-15-8-18-10-19(24)3-4-21(18)27-12-15/h2-8,10-12H,9,13H2,1H3,(H2,25,29)(H,28,30)	HDWJBHJMHHEUTP-UHFFFAOYSA-N	283469	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((6-fluoroquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 121::US10266515, Example 121::US10308637, Example 121::US11021463, Example 121::US9611252, Example 121	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283469	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283469&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212359	378164797							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042166	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cnc3cc(F)ccc3c2)c1	InChI=1S/C24H22FN5O/c1-14-7-23(26)30-15(2)21(14)13-29-24(31)18-5-6-27-20(10-18)9-16-8-17-3-4-19(25)11-22(17)28-12-16/h3-8,10-12H,9,13H2,1-2H3,(H2,26,30)(H,29,31)	MWOHJBUVZJQGNX-UHFFFAOYSA-N	283470	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((7-fluoroquinolin-3- yl)methyl)isonicotinamide::US10023557, Example 122::US10266515, Example 122::US10308637, Example 122::US11021463, Example 122::US9611252, Example 122	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283470	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283470&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212621	378164798							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042167	Fc1ccc2cc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)cnc2c1	InChI=1S/C25H17ClF2N4O/c26-21-13-31-24-10-22(28)17(8-20(21)24)12-32-25(33)16-3-4-29-19(7-16)6-14-5-15-1-2-18(27)9-23(15)30-11-14/h1-5,7-11,13,31H,6,12H2,(H,32,33)	AMSTZJFOMLJWBY-UHFFFAOYSA-N	283471	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((7-fluoroquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 123::US10266515, Example 123::US10308637, Example 123::US11021463, Example 123::US9611252, Example 123	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283471	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283471&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212350	378164799							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042168	Nc1nccc2cc(CNC(=O)c3ccnc(Cc4cnc5cc(F)ccc5c4)c3)ccc12	InChI=1S/C26H20FN5O/c27-21-3-2-19-10-17(15-31-24(19)13-21)11-22-12-20(6-7-29-22)26(33)32-14-16-1-4-23-18(9-16)5-8-30-25(23)28/h1-10,12-13,15H,11,14H2,(H2,28,30)(H,32,33)	BBANODQRERYSMA-UHFFFAOYSA-N	283472	N-((1-aminoisoquinolin-6-yl)methyl)-2-((7- fluoroquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 124::US10266515, Example 124::US10308637, Example 124::US11021463, Example 124::US9611252, Example 124	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283472	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283472&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212446	378164800							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042169	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1ccnc(Cc2cnc3ccccc3c2)c1	InChI=1S/C25H18ClFN4O/c26-21-14-30-24-11-22(27)18(10-20(21)24)13-31-25(32)17-5-6-28-19(9-17)8-15-7-16-3-1-2-4-23(16)29-12-15/h1-7,9-12,14,30H,8,13H2,(H,31,32)	FYVVQNCFFZYQIZ-UHFFFAOYSA-N	283473	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- (quinolin-3-ylmethyl)isonicotinamide::US10023557, Example 125::US10266515, Example 125::US10308637, Example 125::US11021463, Example 125::US9611252, Example 125	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283473	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283473&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212449	378164801							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042170	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1ccnc(Cc2cnc3ccc(Cl)cc3c2)c1	InChI=1S/C25H17Cl2FN4O/c26-18-1-2-23-16(7-18)5-14(11-30-23)6-19-8-15(3-4-29-19)25(33)32-12-17-9-20-21(27)13-31-24(20)10-22(17)28/h1-5,7-11,13,31H,6,12H2,(H,32,33)	LRUSUFGKIZOKQY-UHFFFAOYSA-N	283474	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((6-chloroquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 126::US10266515, Example 126::US10308637, Example 126::US11021463, Example 126::US9611252, Example 126	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283474	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283474&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212638	378164802							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042171	Cc1ccc2ccc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)cc2n1	InChI=1S/C27H23N5O/c1-17-2-5-20-6-3-18(14-25(20)32-17)13-23-15-22(9-10-29-23)27(33)31-16-19-4-7-24-21(12-19)8-11-30-26(24)28/h2-12,14-15H,13,16H2,1H3,(H2,28,30)(H,31,33)	YUIGLCWKRLEJJV-UHFFFAOYSA-N	283475	N-((1-aminoisoquinolin-6-yl)methyl)-2-((2- methylquinolin-7-yl)methyl)isonicotinamide::US10023557, Example 127::US10266515, Example 127::US10308637, Example 127::US11021463, Example 127::US9611252, Example 127	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283475	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283475&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212220	378164803							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042172	Cc1ccc2ccc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)cc2n1	InChI=1S/C26H20ClFN4O/c1-15-2-4-17-5-3-16(9-24(17)32-15)8-20-10-18(6-7-29-20)26(33)31-13-19-11-21-22(27)14-30-25(21)12-23(19)28/h2-7,9-12,14,30H,8,13H2,1H3,(H,31,33)	ASHCCNPFZHFVAC-UHFFFAOYSA-N	283476	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((2-methylquinolin-7-yl)methyl)isonicotinamide::US10023557, Example 128::US10266515, Example 128::US10308637, Example 128::US11021463, Example 128::US9611252, Example 128	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283476	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283476&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212704	378164804							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042173	Cc1ccc2ccc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2n1	InChI=1S/C25H25N5O/c1-15-10-24(26)30-17(3)22(15)14-28-25(31)20-8-9-27-21(13-20)11-18-5-7-19-6-4-16(2)29-23(19)12-18/h4-10,12-13H,11,14H2,1-3H3,(H2,26,30)(H,28,31)	BOMAZLQSSNNLAL-UHFFFAOYSA-N	283477	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((2-methylquinolin-7- yl)methyl)isonicotinamide::US10023557, Example 129::US10266515, Example 129::US10308637, Example 129::US11021463, Example 129::US9611252, Example 129	Plasma kallikrein			 550							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283477	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283477&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212507	378164805							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042174	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1ccnc(Cc2ccc3nc(ccc3c2)C#N)c1	InChI=1S/C26H17ClFN5O/c27-22-14-31-25-11-23(28)18(10-21(22)25)13-32-26(34)17-5-6-30-20(9-17)8-15-1-4-24-16(7-15)2-3-19(12-29)33-24/h1-7,9-11,14,31H,8,13H2,(H,32,34)	XHYLSPCHHJFGNQ-UHFFFAOYSA-N	283478	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((2-isocyanoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 130::US10266515, Example 130::US10308637, Example 130::US11021463, Example 130::US9611252, Example 130	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283478	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283478&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213085	378164806							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042175	Cc1cc(N)nc(F)c1CNC(=O)c1ccnc(Cc2ccc3nc(ccc3c2)C#N)c1	InChI=1S/C24H19FN6O/c1-14-8-22(27)31-23(25)20(14)13-29-24(32)17-6-7-28-19(11-17)10-15-2-5-21-16(9-15)3-4-18(12-26)30-21/h2-9,11H,10,13H2,1H3,(H2,27,31)(H,29,32)	YAJOVNHXSYCRPA-UHFFFAOYSA-N	500277	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-2-((2-isocyanoquinolin-6- yl)methyl)isonicotinamide::US11021463, Example 131	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=500277	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=500277&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			146353554	459073105							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042176	Cc1cc2cc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)ccc2cn1	InChI=1S/C27H23N5O/c1-17-10-23-11-18(2-4-22(23)16-31-17)13-24-14-21(7-8-29-24)27(33)32-15-19-3-5-25-20(12-19)6-9-30-26(25)28/h2-12,14,16H,13,15H2,1H3,(H2,28,30)(H,32,33)	KZGIIODXNPBNJO-UHFFFAOYSA-N	283480	N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- methylisoquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 132::US10266515, Example 132::US10308637, Example 132::US11021463, Example 132::US9611252, Example 132	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283480	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283480&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213018	378164808							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042177	Cc1cc2cc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)ccc2cn1	InChI=1S/C26H20ClFN4O/c1-15-6-19-7-16(2-3-18(19)12-30-15)8-21-9-17(4-5-29-21)26(33)32-13-20-10-22-23(27)14-31-25(22)11-24(20)28/h2-7,9-12,14,31H,8,13H2,1H3,(H,32,33)	KRFVOCRTZLYSJU-UHFFFAOYSA-N	283481	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3-methylisoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 133::US10266515, Example 133::US10308637, Example 133::US11021463, Example 133::US9611252, Example 133	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283481	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283481&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212795	378164809							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042178	CS(=O)(=O)c1ccc2cc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)ccc2n1	InChI=1S/C27H23N5O3S/c1-36(34,35)25-7-4-20-12-17(3-6-24(20)32-25)14-22-15-21(9-10-29-22)27(33)31-16-18-2-5-23-19(13-18)8-11-30-26(23)28/h2-13,15H,14,16H2,1H3,(H2,28,30)(H,31,33)	QZLYZRALGDJSAC-UHFFFAOYSA-N	283482	N-((1-aminoisoquinolin-6-yl)methyl)-2-((2- (methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 134::US10266515, Example 134::US10308637, Example 134::US11021463, Example 134::US9611252, Example 134	Plasma kallikrein			 550							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283482	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283482&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212866	378164810							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042179	CS(=O)(=O)c1ccc2cc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)ccc2n1	InChI=1S/C26H20ClFN4O3S/c1-36(34,35)25-5-3-16-8-15(2-4-23(16)32-25)9-19-10-17(6-7-29-19)26(33)31-13-18-11-20-21(27)14-30-24(20)12-22(18)28/h2-8,10-12,14,30H,9,13H2,1H3,(H,31,33)	URHHGZRDZIHONJ-UHFFFAOYSA-N	283483	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((2-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 135::US10266515, Example 135::US10308637, Example 135::US11021463, Example 135::US9611252, Example 135	Plasma kallikrein			 550							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283483	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283483&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212678	378164811							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042180	Nc1nccc2cc(CNC(=O)c3ccnc(Cc4ccc5nccc(C#N)c5c4)c3)ccc12	InChI=1S/C27H20N6O/c28-15-21-7-9-31-25-4-2-17(13-24(21)25)12-22-14-20(6-8-30-22)27(34)33-16-18-1-3-23-19(11-18)5-10-32-26(23)29/h1-11,13-14H,12,16H2,(H2,29,32)(H,33,34)	GWYUQVNAIHTMAT-UHFFFAOYSA-N	283484	N-((1-aminoisoquinolin-6-yl)methyl)-2-((4- cyanoquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 136::US10266515, Example 136::US10308637, Example 136::US11021463, Example 136::US9611252, Example 136	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283484	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283484&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213035	378164812							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042181	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1ccnc(Cc2ccc3nccc(C#N)c3c2)c1	InChI=1S/C26H17ClFN5O/c27-22-14-32-25-11-23(28)18(10-21(22)25)13-33-26(34)16-3-5-30-19(9-16)7-15-1-2-24-20(8-15)17(12-29)4-6-31-24/h1-6,8-11,14,32H,7,13H2,(H,33,34)	NHUNQBFMIZILLQ-UHFFFAOYSA-N	378008	N-((3-chloro-6-fluoro-1H-indol-5- yl)methyl)-2-((4-cyanoquinolin-6- yl)methyl)isonicotinamide::US10266515, Example 137::US10308637, Example 137::US11021463, Example 137	Plasma kallikrein			 550							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378008	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378008&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213256	404346942							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042182	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3nccc(C#N)c3c2)c1	InChI=1S/C25H22N6O/c1-15-9-24(27)31-16(2)22(15)14-30-25(32)18-5-7-28-20(12-18)10-17-3-4-23-21(11-17)19(13-26)6-8-29-23/h3-9,11-12H,10,14H2,1-2H3,(H2,27,31)(H,30,32)	GBSCHYJOECITNK-UHFFFAOYSA-N	378009	N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-2-((4-cyanoquinolin-6- yl)methyl)isonicotinamide::US10266515, Example 138::US10308637, Example 138::US11021463, Example 138	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378009	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378009&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212566	404346943							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042183	Nc1nccc2cc(CNC(=O)c3ccnc(Cc4cnc5cc(Cl)ccc5c4)c3)ccc12	InChI=1S/C26H20ClN5O/c27-21-3-2-19-10-17(15-31-24(19)13-21)11-22-12-20(6-7-29-22)26(33)32-14-16-1-4-23-18(9-16)5-8-30-25(23)28/h1-10,12-13,15H,11,14H2,(H2,28,30)(H,32,33)	AIGLAHDLOIUXAW-UHFFFAOYSA-N	283487	N-((1-aminoisoquinolin-6-yl)methyl)-2-((7- chloroquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 139::US10266515, Example 139::US10308637, Example 139::US11021463, Example 139	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283487	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283487&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212540	378164815							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042184	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1ccnc(Cc2cnc3cc(Cl)ccc3c2)c1	InChI=1S/C25H17Cl2FN4O/c26-18-2-1-15-5-14(11-30-23(15)9-18)6-19-7-16(3-4-29-19)25(33)32-12-17-8-20-21(27)13-31-24(20)10-22(17)28/h1-5,7-11,13,31H,6,12H2,(H,32,33)	IKMVYXFFBLRHRM-UHFFFAOYSA-N	283488	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((7-chloroquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 140::US10266515, Example 140::US10308637, Example 140::US11021463, Example 140::US9611252, Example 140	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283488	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283488&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212776	378164816							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042185	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cnc3cc(Cl)ccc3c2)c1	InChI=1S/C24H22ClN5O/c1-14-7-23(26)30-15(2)21(14)13-29-24(31)18-5-6-27-20(10-18)9-16-8-17-3-4-19(25)11-22(17)28-12-16/h3-8,10-12H,9,13H2,1-2H3,(H2,26,30)(H,29,31)	CRTRNHYSRBELJZ-UHFFFAOYSA-N	283489	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((7-chloroquinolin-3- yl)methyl)isonicotinamide::US10023557, Example 141::US10266515, Example 141::US10308637, Example 141::US11021463, Example 141::US9611252, Example 141	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283489	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283489&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213050	378164817							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042186	Cc1cnc2ccc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)cc2c1	InChI=1S/C27H23N5O/c1-17-10-22-11-18(3-5-25(22)31-15-17)13-23-14-21(7-8-29-23)27(33)32-16-19-2-4-24-20(12-19)6-9-30-26(24)28/h2-12,14-15H,13,16H2,1H3,(H2,28,30)(H,32,33)	XPXFEZOWOODSMW-UHFFFAOYSA-N	283490	N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- methylquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 142::US10266515, Example 142::US10308637, Example 142::US11021463, Example 142::US9611252, Example 142	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283490	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283490&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212463	378164818							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042187	Cc1cnc2ccc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)cc2c1	InChI=1S/C26H20ClFN4O/c1-15-6-18-7-16(2-3-24(18)30-12-15)8-20-9-17(4-5-29-20)26(33)32-13-19-10-21-22(27)14-31-25(21)11-23(19)28/h2-7,9-12,14,31H,8,13H2,1H3,(H,32,33)	BAWQXCVTJNYXQW-UHFFFAOYSA-N	283491	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3-methylquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 143::US10266515, Example 143::US10308637, Example 143::US11021463, Example 143::US9611252, Example 143	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283491	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283491&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212764	378164819							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042188	Cc1cnc2ccc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2c1	InChI=1S/C25H25N5O/c1-15-8-20-10-18(4-5-23(20)28-13-15)11-21-12-19(6-7-27-21)25(31)29-14-22-16(2)9-24(26)30-17(22)3/h4-10,12-13H,11,14H2,1-3H3,(H2,26,30)(H,29,31)	BDBQXLZXRHXRJN-UHFFFAOYSA-N	283492	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-methylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 144::US10266515, Example 144::US10308637, Example 144::US11021463, Example 144::US9611252, Example 144	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283492	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283492&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212432	378164820							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042189	Cc1cc2cc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)ccc2cn1	InChI=1S/C25H25N5O/c1-15-8-24(26)30-17(3)23(15)14-29-25(31)19-6-7-27-22(12-19)11-18-4-5-20-13-28-16(2)9-21(20)10-18/h4-10,12-13H,11,14H2,1-3H3,(H2,26,30)(H,29,31)	IDPUQOZCEWQYLL-UHFFFAOYSA-N	283493	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-methylisoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 145::US10266515, Example 145::US10308637, Example 145::US11021463, Example 145::US9611252, Example 145	Plasma kallikrein			<100							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283493	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283493&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212443	378164821							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042190	NCc1ccc2cc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)ccc2n1	InChI=1S/C27H24N6O/c28-15-22-4-3-20-11-17(2-6-25(20)33-22)13-23-14-21(8-9-30-23)27(34)32-16-18-1-5-24-19(12-18)7-10-31-26(24)29/h1-12,14H,13,15-16,28H2,(H2,29,31)(H,32,34)	NBXVVYPBTMZIFQ-UHFFFAOYSA-N	283494	N-((1-aminoisoquinolin-6-yl)methyl)-2-((2- (aminomethyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 146::US10266515, Example 146::US10308637, Example 146::US11021463, Example 146::US9611252, Example 146Biochemical	Plasma kallikrein			 550							US Patent		10.7270/Q21R6TN7		aid1805604	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283494	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283494&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212893	378164822							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042191	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2c1)S(C)(=O)=O	InChI=1S/C26H27N5O3S/c1-15-7-20-9-18(11-23(35(4,33)34)25(20)29-13-15)10-21-12-19(5-6-28-21)26(32)30-14-22-16(2)8-24(27)31-17(22)3/h5-9,11-13H,10,14H2,1-4H3,(H2,27,31)(H,30,32)	HXOKVKXTISERDZ-UHFFFAOYSA-N	283363	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-methyl-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 15::US10266515, Example 15::US10308637, Example 15::US11021463, Example 15::US9611252, Example 15	Plasma kallikrein					<100					US Patent		10.7270/Q21R6TN7		aid1805605	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283363	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283363&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213052	378164692							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042192	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)cc2c1)S(C)(=O)=O	InChI=1S/C28H25N5O3S/c1-17-9-22-11-19(13-25(37(2,35)36)26(22)32-15-17)12-23-14-21(6-7-30-23)28(34)33-16-18-3-4-24-20(10-18)5-8-31-27(24)29/h3-11,13-15H,12,16H2,1-2H3,(H2,29,31)(H,33,34)	AGLYWDINMJNVRE-UHFFFAOYSA-N	283364	N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- methyl-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 16::US10266515, Example 16::US10308637, Example 16::US11021463, Example 16::US9611252, Example 16	Plasma kallikrein					<100					US Patent		10.7270/Q21R6TN7		aid1805605	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283364	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283364&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665230	378164693							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042193	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)cc2c1)S(C)(=O)=O	InChI=1S/C27H22ClFN4O3S/c1-15-5-18-6-16(8-25(37(2,35)36)26(18)32-12-15)7-20-9-17(3-4-30-20)27(34)33-13-19-10-21-22(28)14-31-24(21)11-23(19)29/h3-6,8-12,14,31H,7,13H2,1-2H3,(H,33,34)	KNWYWDACHSZACS-UHFFFAOYSA-N	283365	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3-methyl-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 17::US10266515, Example 17::US10308637, Example 17::US11021463, Example 17::US9611252, Example 17	Plasma kallikrein					<100					US Patent		10.7270/Q21R6TN7		aid1805605	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283365	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283365&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213042	378164694							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042194	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cc4cc[nH]c4cc3F)cc2c1)S(C)(=O)=O	InChI=1S/C27H23FN4O3S/c1-16-7-20-8-17(10-25(36(2,34)35)26(20)31-14-16)9-22-12-19(4-5-29-22)27(33)32-15-21-11-18-3-6-30-24(18)13-23(21)28/h3-8,10-14,30H,9,15H2,1-2H3,(H,32,33)	JOIGNBGOTQEXSU-UHFFFAOYSA-N	283366	N-((6-fluoro-1H-indol-5-yl)methyl)-2-((3- methyl-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 18::US10266515, Example 18::US10308637, Example 18::US11021463, Example 18::US9611252, Example 18	Plasma kallikrein					 550					US Patent		10.7270/Q21R6TN7		aid1805605	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283366	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283366&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665345	378164695							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042195	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cnc4[nH]cc(Cl)c4c3)cc2c1)S(C)(=O)=O	InChI=1S/C26H22ClN5O3S/c1-15-5-19-6-16(9-23(36(2,34)35)24(19)29-11-15)7-20-10-18(3-4-28-20)26(33)32-13-17-8-21-22(27)14-31-25(21)30-12-17/h3-6,8-12,14H,7,13H2,1-2H3,(H,30,31)(H,32,33)	IIORZUFKRKFNHD-UHFFFAOYSA-N	283367	N-((3-chloro-1H-pyrrolo[2,3-b]pyridin-5- yl)methyl)-2-((3-methyl-8- (methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 19::US10266515, Example 19::US10308637, Example 19::US11021463, Example 19::US9611252, Example 19	Plasma kallikrein					<100					US Patent		10.7270/Q21R6TN7		aid1805605	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283367	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283367&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665214	378164696							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042196	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3n[nH]c4ccc(Cl)cc34)cc2c1)S(C)(=O)=O	InChI=1S/C26H22ClN5O3S/c1-15-7-18-8-16(10-24(36(2,34)35)25(18)29-13-15)9-20-11-17(5-6-28-20)26(33)30-14-23-21-12-19(27)3-4-22(21)31-32-23/h3-8,10-13H,9,14H2,1-2H3,(H,30,33)(H,31,32)	INPUBOYBDZWEOS-UHFFFAOYSA-N	283368	N-((5-chloro-1H-indazol-3-yl)methyl)-2-((3- methyl-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 20::US10266515, Example 20::US10308637, Example 20::US11021463, Example 20::US9611252, Example 20	Plasma kallikrein					<100					US Patent		10.7270/Q21R6TN7		aid1805605	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283368	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283368&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665285	378164697							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042197	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3ccc4[nH]cc(Cl)c4c3F)cc2c1)S(C)(=O)=O	InChI=1S/C27H22ClFN4O3S/c1-15-7-19-8-16(10-23(37(2,35)36)26(19)32-12-15)9-20-11-17(5-6-30-20)27(34)33-13-18-3-4-22-24(25(18)29)21(28)14-31-22/h3-8,10-12,14,31H,9,13H2,1-2H3,(H,33,34)	RIPJTLFXOCXAJL-UHFFFAOYSA-N	283369	N-((3-chloro-4-fluoro-1H-indol-5-yl)methyl)-2- ((3-methyl-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 21::US10266515, Example 21::US10308637, Example 21::US11021463, Example 21::US9611252, Example 21	Plasma kallikrein					<100					US Patent		10.7270/Q21R6TN7		aid1805605	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283369	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283369&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213012	378164698							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042198	Nc1nccc2cc(CNC(=O)c3ccnc(Cc4ccc5ncc(Cl)cc5c4)c3)ccc12	InChI=1S/C26H20ClN5O/c27-21-12-20-9-16(2-4-24(20)31-15-21)11-22-13-19(6-7-29-22)26(33)32-14-17-1-3-23-18(10-17)5-8-30-25(23)28/h1-10,12-13,15H,11,14H2,(H2,28,30)(H,32,33)	WHHMKDFLRDNMQE-UHFFFAOYSA-N	283379	N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- chloroquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 179::US10023557, Example 31::US10266515, Example 31::US10308637, Example 179::US11021463, Example 31::US9611252, Example 31	Plasma kallikrein					<100					US Patent		10.7270/Q21R6TN7		aid1805605	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283379	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283379&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212700	378164708							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042199	Fc1cc2[nH]cc(Cl)c2cc1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C25H17Cl2FN4O/c26-18-7-16-5-14(1-2-23(16)30-12-18)6-19-8-15(3-4-29-19)25(33)32-11-17-9-20-21(27)13-31-24(20)10-22(17)28/h1-5,7-10,12-13,31H,6,11H2,(H,32,33)	XZUNAOLBBRHEMP-UHFFFAOYSA-N	283381	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3-chloroquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 33::US10266515, Example 33::US10308637, Example 33::US11021463, Example 33::US9611252, Example 33	Plasma kallikrein					 550					US Patent		10.7270/Q21R6TN7		aid1805605	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283381	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283381&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212875	378164710							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042200	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C23H20ClN5O/c1-14-17(3-5-22(25)29-14)12-28-23(30)16-6-7-26-20(11-16)9-15-2-4-21-18(8-15)10-19(24)13-27-21/h2-8,10-11,13H,9,12H2,1H3,(H2,25,29)(H,28,30)	ZGYIOYKVCAJRKO-UHFFFAOYSA-N	283382	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-chloroquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 34::US10266515, Example 39::US10308637, Example 39::US11021463, Example 39::US9611252, Example 39	Plasma kallikrein					<100					US Patent		10.7270/Q21R6TN7		aid1805605	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283382	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283382&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213054	378164711							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042201	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C24H22ClN5O/c1-14-7-23(26)30-15(2)21(14)13-29-24(31)17-5-6-27-20(11-17)9-16-3-4-22-18(8-16)10-19(25)12-28-22/h3-8,10-12H,9,13H2,1-2H3,(H2,26,30)(H,29,31)	BDLURRLRBKLEDL-UHFFFAOYSA-N	283383	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 35::US10266515, Example 35::US10308637, Example 35::US11021463, Example 35::US9611252, Example 35	Plasma kallikrein					<100					US Patent		10.7270/Q21R6TN7		aid1805605	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283383	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283383&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665163	378164712							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042202	Clc1c[nH]c2ncc(CNC(=O)c3ccnc(Cc4ccc5ncc(Cl)cc5c4)c3)cc12	InChI=1S/C24H17Cl2N5O/c25-18-8-17-5-14(1-2-22(17)28-12-18)6-19-9-16(3-4-27-19)24(32)31-11-15-7-20-21(26)13-30-23(20)29-10-15/h1-5,7-10,12-13H,6,11H2,(H,29,30)(H,31,32)	QFSDBAJWKWRDTA-UHFFFAOYSA-N	283386	N-((3-chloro-1H-pyrrolo[2,3-b]pyridin-5- yl)methyl)-2-((3-chloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 38::US10266515, Example 38::US10308637, Example 38::US11021463, Example 38::US9611252, Example 38	Plasma kallikrein					 550					US Patent		10.7270/Q21R6TN7		aid1805605	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283386	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283386&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665363	378164715							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042203	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C23H20ClN5O/c1-14-17(3-5-22(25)29-14)12-28-23(30)16-6-7-26-20(11-16)9-15-2-4-21-18(8-15)10-19(24)13-27-21/h2-8,10-11,13H,9,12H2,1H3,(H2,25,29)(H,28,30)	ZGYIOYKVCAJRKO-UHFFFAOYSA-N	283382	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-chloroquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 34::US10266515, Example 39::US10308637, Example 39::US11021463, Example 39::US9611252, Example 39	Plasma kallikrein					<100					US Patent		10.7270/Q21R6TN7		aid1805605	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283382	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283382&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213054	378164711							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042204	Fc1c(CNC(=O)c2ccnc(Cc3ccc4ncc(Cl)cc4c3)c2)ccc2[nH]cc(Cl)c12	InChI=1S/C25H17Cl2FN4O/c26-18-9-17-7-14(1-3-21(17)30-12-18)8-19-10-15(5-6-29-19)25(33)32-11-16-2-4-22-23(24(16)28)20(27)13-31-22/h1-7,9-10,12-13,31H,8,11H2,(H,32,33)	GVFULHFYDFFIFD-UHFFFAOYSA-N	283388	N-((3-chloro-4-fluoro-1H-indol-5-yl)methyl)-2- ((3-chloroquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 40::US10266515, Example 40::US10308637, Example 40::US11021463, Example 40::US9611252, Example 40	Plasma kallikrein					 550					US Patent		10.7270/Q21R6TN7		aid1805605	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283388	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283388&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665357	378164717							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042205	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc(C#N)c3ncc(Cl)cc3c2)c1	InChI=1S/C25H21ClN6O/c1-14-5-23(28)32-15(2)22(14)13-31-25(33)17-3-4-29-21(10-17)8-16-6-18-9-20(26)12-30-24(18)19(7-16)11-27/h3-7,9-10,12H,8,13H2,1-2H3,(H2,28,32)(H,31,33)	VSKYRJRRAUSIED-UHFFFAOYSA-N	283398	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloro-8-cyanoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 50::US10266515, Example 50::US10308637, Example 50::US11021463, Example 50::US9611252, Example 50	Plasma kallikrein					<100					US Patent		10.7270/Q21R6TN7		aid1805605	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283398	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283398&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665177	378164727							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1087922	C[C@@H]1CCC[C@@H](c2cc(ccn2)-c2c(NC1=O)cnn2C(F)F)n1cnc(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C28H23Cl2F2N9O2/c1-15-3-2-4-23(20-9-16(7-8-33-20)26-21(36-27(15)43)12-35-41(26)28(31)32)39-14-34-19(11-25(39)42)18-10-17(29)5-6-22(18)40-13-24(30)37-38-40/h5-15,23,28H,2-4H2,1H3,(H,36,43)/t15-,23+/m1/s1	FSWFYCYPTDLKON-CMJOXMDJSA-N	247411	US10336754, Example 353::US11053247, Example 353::US9453018, 353	Plasma kallikrein		 28.0								US Patent		10.7270/Q2HQ4325		aid1805883	US11053247	Dilger, AK; Corte, JR; De Lucca, I; Fang, T; Yang, W; Wang, Y; Pabbisetty, KB; Ewing, WR; Zhu, Y; Wexler, RR; Pinto, DJ; Orwat, MJ; Smith, II, LM	Bristol-Myers Squibb Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=247411	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=247411&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	YXG	7MBO	131635534	346541954							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1087923	C[C@@H]1CCC[C@@H](c2cc(ccn2)-c2nn(cc2NC1=O)-c1cccnc1)n1cnc(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C32H26Cl2N10O2/c1-19-4-2-6-28(42-18-37-24(14-30(42)45)23-13-21(33)7-8-27(23)44-17-29(34)39-41-44)25-12-20(9-11-36-25)31-26(38-32(19)46)16-43(40-31)22-5-3-10-35-15-22/h3,5,7-19,28H,2,4,6H2,1H3,(H,38,46)/t19-,28+/m1/s1	ASWFFXNYMLHVMO-GDJIYFAZSA-N	247412	US10336754, Example 354::US11053247, Example 354::US9453018, 354	Plasma kallikrein		 10.00								US Patent		10.7270/Q2HQ4325		aid1805883	US11053247	Dilger, AK; Corte, JR; De Lucca, I; Fang, T; Yang, W; Wang, Y; Pabbisetty, KB; Ewing, WR; Zhu, Y; Wexler, RR; Pinto, DJ; Orwat, MJ; Smith, II, LM	Bristol-Myers Squibb Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=247412	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=247412&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			131635535	346541955							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1087924	C[C@@H]1CCC[C@@H](c2ccnc(c2)-c2c(NC1=O)cnn2C)n1cnc(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C28H25Cl2N9O2/c1-16-4-3-5-23(17-8-9-31-21(10-17)27-22(34-28(16)41)13-33-37(27)2)38-15-32-20(12-26(38)40)19-11-18(29)6-7-24(19)39-14-25(30)35-36-39/h6-16,23H,3-5H2,1-2H3,(H,34,41)/t16-,23+/m1/s1	PYWPRMLFPPPQRF-MWTRTKDXSA-N	247413	US10336754, Example 363::US11053247, Example 363::US9453018, 362::US9453018, 363	Plasma kallikrein		 23.0								US Patent		10.7270/Q2HQ4325		aid1805883	US11053247	Dilger, AK; Corte, JR; De Lucca, I; Fang, T; Yang, W; Wang, Y; Pabbisetty, KB; Ewing, WR; Zhu, Y; Wexler, RR; Pinto, DJ; Orwat, MJ; Smith, II, LM	Bristol-Myers Squibb Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=247413	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=247413&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			131635536	346541956							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1087925	C[C@@H]1CCC[C@@H](c2ccnc(c2)-c2c(NC1=O)cnn2C)n1cnc(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C28H25Cl2N9O2/c1-16-4-3-5-23(17-8-9-31-21(10-17)27-22(34-28(16)41)13-33-37(27)2)38-15-32-20(12-26(38)40)19-11-18(29)6-7-24(19)39-14-25(30)35-36-39/h6-16,23H,3-5H2,1-2H3,(H,34,41)/t16-,23+/m1/s1	PYWPRMLFPPPQRF-MWTRTKDXSA-N	247413	US10336754, Example 363::US11053247, Example 363::US9453018, 362::US9453018, 363	Plasma kallikrein		 22.0								US Patent		10.7270/Q2HQ4325		aid1805883	US11053247	Dilger, AK; Corte, JR; De Lucca, I; Fang, T; Yang, W; Wang, Y; Pabbisetty, KB; Ewing, WR; Zhu, Y; Wexler, RR; Pinto, DJ; Orwat, MJ; Smith, II, LM	Bristol-Myers Squibb Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=247413	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=247413&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			131635536	346541956							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1087926	C[C@@H]1CCC[C@@H](c2cc(ccn2)-c2c(NC1=O)cnn2C)n1cnc(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)(F)F	InChI=1S/C29H25ClF3N9O2/c1-16-4-3-5-24(21-10-17(8-9-34-21)27-22(37-28(16)44)13-36-40(27)2)41-15-35-20(12-26(41)43)19-11-18(30)6-7-23(19)42-14-25(38-39-42)29(31,32)33/h6-16,24H,3-5H2,1-2H3,(H,37,44)/t16-,24+/m1/s1	SDMTXZKAASAJMI-GYCJOSAFSA-N	247414	US10336754, Example 368::US11053247, Example 368::US9453018, 367::US9453018, 368	Plasma kallikrein		 24.0								US Patent		10.7270/Q2HQ4325		aid1805883	US11053247	Dilger, AK; Corte, JR; De Lucca, I; Fang, T; Yang, W; Wang, Y; Pabbisetty, KB; Ewing, WR; Zhu, Y; Wexler, RR; Pinto, DJ; Orwat, MJ; Smith, II, LM	Bristol-Myers Squibb Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=247414	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=247414&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			131635537	346541957							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1087927	C[C@@H]1CCC[C@@H](c2cc(ccn2)-c2c(NC1=O)cnn2C)n1cnc(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)(F)F	InChI=1S/C29H25ClF3N9O2/c1-16-4-3-5-24(21-10-17(8-9-34-21)27-22(37-28(16)44)13-36-40(27)2)41-15-35-20(12-26(41)43)19-11-18(30)6-7-23(19)42-14-25(38-39-42)29(31,32)33/h6-16,24H,3-5H2,1-2H3,(H,37,44)/t16-,24+/m1/s1	SDMTXZKAASAJMI-GYCJOSAFSA-N	247414	US10336754, Example 368::US11053247, Example 368::US9453018, 367::US9453018, 368	Plasma kallikrein		 32.0								US Patent		10.7270/Q2HQ4325		aid1805883	US11053247	Dilger, AK; Corte, JR; De Lucca, I; Fang, T; Yang, W; Wang, Y; Pabbisetty, KB; Ewing, WR; Zhu, Y; Wexler, RR; Pinto, DJ; Orwat, MJ; Smith, II, LM	Bristol-Myers Squibb Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=247414	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=247414&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			131635537	346541957							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1087928	C[C@@H]1CCC[C@@H](c2cc(ccn2)-c2c(NC1=O)cnn2C(F)F)n1cnc(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)(F)F	InChI=1S/C29H23ClF5N9O2/c1-15-3-2-4-23(20-9-16(7-8-36-20)26-21(39-27(15)46)12-38-44(26)28(31)32)42-14-37-19(11-25(42)45)18-10-17(30)5-6-22(18)43-13-24(40-41-43)29(33,34)35/h5-15,23,28H,2-4H2,1H3,(H,39,46)/t15-,23+/m1/s1	OEFZCPJFLZPAHN-CMJOXMDJSA-N	247416	US10336754, Example 369::US11053247, Example 369::US9453018, 369	Plasma kallikrein		 33.0								US Patent		10.7270/Q2HQ4325		aid1805883	US11053247	Dilger, AK; Corte, JR; De Lucca, I; Fang, T; Yang, W; Wang, Y; Pabbisetty, KB; Ewing, WR; Zhu, Y; Wexler, RR; Pinto, DJ; Orwat, MJ; Smith, II, LM	Bristol-Myers Squibb Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=247416	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=247416&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			131635538	346541958							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1087929	C[C@@H]1CCC[C@@H](c2ccnc(c2)-c2c(NC1=O)cnn2C)n1cnc(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)(F)F	InChI=1S/C29H25ClF3N9O2/c1-16-4-3-5-23(17-8-9-34-21(10-17)27-22(37-28(16)44)13-36-40(27)2)41-15-35-20(12-26(41)43)19-11-18(30)6-7-24(19)42-14-25(38-39-42)29(31,32)33/h6-16,23H,3-5H2,1-2H3,(H,37,44)/t16-,23+/m1/s1	FQRJWJILLRZDIQ-MWTRTKDXSA-N	247417	US10336754, Example 371::US11053247, Example 371::US9453018, 370::US9453018, 371	Plasma kallikrein		 17.0								US Patent		10.7270/Q2HQ4325		aid1805883	US11053247	Dilger, AK; Corte, JR; De Lucca, I; Fang, T; Yang, W; Wang, Y; Pabbisetty, KB; Ewing, WR; Zhu, Y; Wexler, RR; Pinto, DJ; Orwat, MJ; Smith, II, LM	Bristol-Myers Squibb Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=247417	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=247417&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			131635539	346541959							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1087930	C[C@@H]1CCC[C@@H](c2ccnc(c2)-c2c(NC1=O)cnn2C)n1cnc(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)(F)F	InChI=1S/C29H25ClF3N9O2/c1-16-4-3-5-23(17-8-9-34-21(10-17)27-22(37-28(16)44)13-36-40(27)2)41-15-35-20(12-26(41)43)19-11-18(30)6-7-24(19)42-14-25(38-39-42)29(31,32)33/h6-16,23H,3-5H2,1-2H3,(H,37,44)/t16-,23+/m1/s1	FQRJWJILLRZDIQ-MWTRTKDXSA-N	247417	US10336754, Example 371::US11053247, Example 371::US9453018, 370::US9453018, 371	Plasma kallikrein		 19.0								US Patent		10.7270/Q2HQ4325		aid1805883	US11053247	Dilger, AK; Corte, JR; De Lucca, I; Fang, T; Yang, W; Wang, Y; Pabbisetty, KB; Ewing, WR; Zhu, Y; Wexler, RR; Pinto, DJ; Orwat, MJ; Smith, II, LM	Bristol-Myers Squibb Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=247417	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=247417&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			131635539	346541959							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1087931	C[C@@H]1CCC[C@@H](c2ccnc(c2)-c2c(NC1=O)cnn2C)n1cnc(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(O)=O	InChI=1S/C29H26ClN9O4/c1-16-4-3-5-24(17-8-9-31-21(10-17)27-22(34-28(16)41)13-33-37(27)2)38-15-32-20(12-26(38)40)19-11-18(30)6-7-25(19)39-14-23(29(42)43)35-36-39/h6-16,24H,3-5H2,1-2H3,(H,34,41)(H,42,43)/t16-,24+/m1/s1	ZEUDFUNISLCCKE-GYCJOSAFSA-N	247418	US10336754, Example 372::US11053247, Example 372::US9453018, 372	Plasma kallikrein		 35.0								US Patent		10.7270/Q2HQ4325		aid1805883	US11053247	Dilger, AK; Corte, JR; De Lucca, I; Fang, T; Yang, W; Wang, Y; Pabbisetty, KB; Ewing, WR; Zhu, Y; Wexler, RR; Pinto, DJ; Orwat, MJ; Smith, II, LM	Bristol-Myers Squibb Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=247418	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=247418&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			131635540	346541960							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1087932	C[C@@H]1CCC[C@@H](c2cc(ccn2)-c2c(NC1=O)cnn2C)n1cnc(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(O)=O	InChI=1S/C29H26ClN9O4/c1-16-4-3-5-25(21-10-17(8-9-31-21)27-22(34-28(16)41)13-33-37(27)2)38-15-32-20(12-26(38)40)19-11-18(30)6-7-24(19)39-14-23(29(42)43)35-36-39/h6-16,25H,3-5H2,1-2H3,(H,34,41)(H,42,43)/t16-,25+/m1/s1	MLTHDTRXOVPWLH-CPJLOUKISA-N	247419	US10336754, Example 373::US11053247, Example 373::US9453018, 373	Plasma kallikrein		 37.0								US Patent		10.7270/Q2HQ4325		aid1805883	US11053247	Dilger, AK; Corte, JR; De Lucca, I; Fang, T; Yang, W; Wang, Y; Pabbisetty, KB; Ewing, WR; Zhu, Y; Wexler, RR; Pinto, DJ; Orwat, MJ; Smith, II, LM	Bristol-Myers Squibb Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=247419	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=247419&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			131635541	346541961							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042206	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2cc(C#N)c3ncc(Cl)cc3c2)c1	InChI=1S/C24H19ClN6O/c1-14-17(2-3-22(27)31-14)12-30-24(32)16-4-5-28-21(10-16)8-15-6-18-9-20(25)13-29-23(18)19(7-15)11-26/h2-7,9-10,13H,8,12H2,1H3,(H2,27,31)(H,30,32)	FDKNUBSGWSPNRT-UHFFFAOYSA-N	283404	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-chloro-8-cyanoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 56::US10266515, Example 56::US10308637, Example 56::US11021463, Example 56::US9611252, Example 56	Plasma kallikrein					 550					US Patent		10.7270/Q21R6TN7		aid1805605	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283404	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283404&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665146	378164733							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042207	Nc1nccc2cc(CNC(=O)c3ccnc(Cc4cc(C#N)c5ncc(Cl)cc5c4)c3)ccc12	InChI=1S/C27H19ClN6O/c28-22-11-20-8-17(9-21(13-29)25(20)33-15-22)10-23-12-19(4-5-31-23)27(35)34-14-16-1-2-24-18(7-16)3-6-32-26(24)30/h1-9,11-12,15H,10,14H2,(H2,30,32)(H,34,35)	IDTYIYATNJINLX-UHFFFAOYSA-N	283405	N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- chloro-8-cyanoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 57::US10266515, Example 57::US10308637, Example 57::US11021463, Example 57::US9611252, Example 57	Plasma kallikrein					 550					US Patent		10.7270/Q21R6TN7		aid1805605	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283405	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283405&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665382	378164734							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042208	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc(C(N)=O)c3ncc(Cl)cc3c2)c1	InChI=1S/C25H23ClN6O2/c1-13-5-22(27)32-14(2)21(13)12-31-25(34)16-3-4-29-19(10-16)7-15-6-17-9-18(26)11-30-23(17)20(8-15)24(28)33/h3-6,8-11H,7,12H2,1-2H3,(H2,27,32)(H2,28,33)(H,31,34)	INWUNFFPSCFXCA-UHFFFAOYSA-N	283406	6-((4-(((6-amino-2,4-dimethylpyridin-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- chloroquinoline-8-carboxamide::US10023557, Example 58::US10266515, Example 58::US10308637, Example 58::US11021463, Example 58::US9611252, Example 58	Plasma kallikrein					<100					US Patent		10.7270/Q21R6TN7		aid1805605	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283406	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283406&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665386	378164735							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042209	NC(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2cc3c(Cl)c[nH]c3cc2F)cc2cc(Cl)cnc12	InChI=1S/C26H18Cl2FN5O2/c27-17-6-15-3-13(5-20(25(30)35)24(15)33-11-17)4-18-7-14(1-2-31-18)26(36)34-10-16-8-19-21(28)12-32-23(19)9-22(16)29/h1-3,5-9,11-12,32H,4,10H2,(H2,30,35)(H,34,36)	QMNRPOHMXWHKMB-UHFFFAOYSA-N	283407	3-chloro-6-((4-(((3-chloro-6-fluoro-1H-indol-5- yl)methyl)carbamoyl)pyridin-2- yl)methyl)quinoline-8-carboxamide::US10023557, Example 59::US10266515, Example 59::US11021463, Example 59::US9611252, Example 59	Plasma kallikrein					 550					US Patent		10.7270/Q21R6TN7		aid1805605	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283407	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283407&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665413	378164736							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042210	NC(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2n[nH]c3ccc(Cl)cc23)cc2cc(Cl)cnc12	InChI=1S/C25H18Cl2N6O2/c26-16-1-2-21-19(10-16)22(33-32-21)12-31-25(35)14-3-4-29-18(9-14)6-13-5-15-8-17(27)11-30-23(15)20(7-13)24(28)34/h1-5,7-11H,6,12H2,(H2,28,34)(H,31,35)(H,32,33)	RTJGKEBRSSQCHQ-UHFFFAOYSA-N	283408	3-chloro-6-((4-(((5-chloro-1H-indazol-3- yl)methyl)carbamoyl)pyridin-2- yl)methyl)quinoline-8-carboxamide::US10023557, Example 60::US10266515, Example 60::US10308637, Example 60::US11021463, Example 60::US9611252, Example 60	Plasma kallikrein					 550					US Patent		10.7270/Q21R6TN7		aid1805605	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283408	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283408&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665317	378164737							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042211	NC(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2cnc3[nH]cc(Cl)c3c2)cc2cc(Cl)cnc12	InChI=1S/C25H18Cl2N6O2/c26-17-7-16-3-13(5-20(23(28)34)22(16)30-11-17)4-18-8-15(1-2-29-18)25(35)33-10-14-6-19-21(27)12-32-24(19)31-9-14/h1-3,5-9,11-12H,4,10H2,(H2,28,34)(H,31,32)(H,33,35)	QHIFWJFJAOUBPC-UHFFFAOYSA-N	283409	3-chloro-6-((4-(((3-chloro-1H-pyrrolo[2,3- b]pyridin-5-yl)methyl)carbamoyl)pyridin-2- yl)methyl)quinoline-8-carboxamide::US10023557, Example 61::US10266515, Example 61::US10308637, Example 61::US11021463, Example 61::US9611252, Example 61	Plasma kallikrein					 550					US Patent		10.7270/Q21R6TN7		aid1805605	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283409	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283409&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665370	378164738							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042212	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2cc(C(N)=O)c3ncc(Cl)cc3c2)c1	InChI=1S/C24H21ClN6O2/c1-13-16(2-3-21(26)31-13)11-30-24(33)15-4-5-28-19(10-15)7-14-6-17-9-18(25)12-29-22(17)20(8-14)23(27)32/h2-6,8-10,12H,7,11H2,1H3,(H2,26,31)(H2,27,32)(H,30,33)	WTBBASBLRSFZPD-UHFFFAOYSA-N	283410	6-((4-(((6-amino-2-methylpyridin-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- chloroquinoline-8-carboxamide::US10023557, Example 62::US10266515, Example 62::US10308637, Example 62::US11021463, Example 62::US9611252, Example 62	Plasma kallikrein					<100					US Patent		10.7270/Q21R6TN7		aid1805605	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283410	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283410&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665142	378164739							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042213	NC(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2ccc3c(N)nccc3c2)cc2cc(Cl)cnc12	InChI=1S/C27H21ClN6O2/c28-20-11-19-8-16(10-23(26(30)35)24(19)33-14-20)9-21-12-18(4-5-31-21)27(36)34-13-15-1-2-22-17(7-15)3-6-32-25(22)29/h1-8,10-12,14H,9,13H2,(H2,29,32)(H2,30,35)(H,34,36)	ZEVNHPCICZZSBU-UHFFFAOYSA-N	283412	6-((4-(((1-aminoisoquinolin-6- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- chloroquinoline-8-carboxamide::US10023557, Example 64::US10266515, Example 64::US10308637, Example 64::US11021463, Example 64::US9611252, Example 64	Plasma kallikrein					<100					US Patent		10.7270/Q21R6TN7		aid1805605	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283412	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283412&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665252	378164741							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042214	NC(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2ccc3[nH]cc(Cl)c3c2F)cc2cc(Cl)cnc12	InChI=1S/C26H18Cl2FN5O2/c27-17-8-16-5-13(7-19(25(30)35)24(16)33-11-17)6-18-9-14(3-4-31-18)26(36)34-10-15-1-2-21-22(23(15)29)20(28)12-32-21/h1-5,7-9,11-12,32H,6,10H2,(H2,30,35)(H,34,36)	PBEXDTRCFFOFDU-UHFFFAOYSA-N	283413	3-chloro-6-((4-(((3-chloro-4-fluoro-1H-indol-5- yl)methyl)carbamoyl)pyridin-2- yl)methyl)quinoline-8-carboxamide::US10023557, Example 65::US10266515, Example 65::US10308637, Example 65::US11021463, Example 65::US9611252, Example 65	Plasma kallikrein					<100					US Patent		10.7270/Q21R6TN7		aid1805605	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283413	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283413&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665414	378164742							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042215	NC(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2cc3cc[nH]c3cc2F)cc2cc(Cl)cnc12	InChI=1S/C26H19ClFN5O2/c27-19-9-17-5-14(7-21(25(29)34)24(17)32-13-19)6-20-10-16(2-3-30-20)26(35)33-12-18-8-15-1-4-31-23(15)11-22(18)28/h1-5,7-11,13,31H,6,12H2,(H2,29,34)(H,33,35)	ZDVUWSXSXIPPGM-UHFFFAOYSA-N	283414	3-chloro-6-((4-(((6-fluoro-1H-indol-5- yl)methyl)carbamoyl)pyridin-2- yl)methyl)quinoline-8-carboxamide::US10023557, Example 66::US10266515, Example 66::US10308637, Example 66::US11021463, Example 66::US9611252, Example 66	Plasma kallikrein					 550					US Patent		10.7270/Q21R6TN7		aid1805605	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283414	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283414&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665192	378164743							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042216	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc(c3ncc(Cl)cc3c2)S(C)(=O)=O)c1	InChI=1S/C25H24ClN5O3S/c1-14-6-23(27)31-15(2)21(14)13-30-25(32)17-4-5-28-20(11-17)8-16-7-18-10-19(26)12-29-24(18)22(9-16)35(3,33)34/h4-7,9-12H,8,13H2,1-3H3,(H2,27,31)(H,30,32)	LOAAVKXHIOVCPQ-UHFFFAOYSA-N	283415	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloro-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 67::US10266515, Example 67::US10308637, Example 67::US11021463, Example 67::US9611252, Example 67	Plasma kallikrein					<100					US Patent		10.7270/Q21R6TN7		aid1805605	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283415	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283415&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213160	378164744							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042217	CS(=O)(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2cc3c(Cl)c[nH]c3cc2F)cc2cc(Cl)cnc12	InChI=1S/C26H19Cl2FN4O3S/c1-37(35,36)24-6-14(4-16-7-18(27)12-32-25(16)24)5-19-8-15(2-3-30-19)26(34)33-11-17-9-20-21(28)13-31-23(20)10-22(17)29/h2-4,6-10,12-13,31H,5,11H2,1H3,(H,33,34)	JHEOACUKXNFFDI-UHFFFAOYSA-N	283416	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3-chloro-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 68::US10266515, Example 68::US10308637, Example 68::US11021463, Example 68::US9611252, Example 68	Plasma kallikrein					<100					US Patent		10.7270/Q21R6TN7		aid1805605	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283416	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283416&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212213	378164745							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042218	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2cc(c3ncc(Cl)cc3c2)S(C)(=O)=O)c1	InChI=1S/C24H22ClN5O3S/c1-14-17(3-4-22(26)30-14)12-29-24(31)16-5-6-27-20(11-16)8-15-7-18-10-19(25)13-28-23(18)21(9-15)34(2,32)33/h3-7,9-11,13H,8,12H2,1-2H3,(H2,26,30)(H,29,31)	DAYVOWICNMKAHH-UHFFFAOYSA-N	283417	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-chloro-8-(methylsulfonyl)quinolin-6- yl)methyl)isonicotinamide::US10023557, Example 69::US10266515, Example 69::US10308637, Example 69::US11021463, Example 69::US9611252, Example 69	Plasma kallikrein					<100					US Patent		10.7270/Q21R6TN7		aid1805605	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283417	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283417&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665120	378164746							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042219	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2c1)C#N	InChI=1S/C26H24N6O/c1-15-6-20-8-18(9-21(12-27)25(20)30-13-15)10-22-11-19(4-5-29-22)26(33)31-14-23-16(2)7-24(28)32-17(23)3/h4-9,11,13H,10,14H2,1-3H3,(H2,28,32)(H,31,33)	FWOVJYZAXZFOSD-UHFFFAOYSA-N	283418	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((8-cyano-3-methylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 70::US10266515, Example 70::US10308637, Example 70::US11021463, Example 70::US9611252, Example 70	Plasma kallikrein					<100					US Patent		10.7270/Q21R6TN7		aid1805605	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283418	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283418&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665112	378164747							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042220	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)cc2c1)C#N	InChI=1S/C28H22N6O/c1-17-8-22-10-19(11-23(14-29)26(22)33-15-17)12-24-13-21(5-6-31-24)28(35)34-16-18-2-3-25-20(9-18)4-7-32-27(25)30/h2-11,13,15H,12,16H2,1H3,(H2,30,32)(H,34,35)	XJVZLICIUISDSM-UHFFFAOYSA-N	283419	N-((1-aminoisoquinolin-6-yl)methyl)-2-((8- cyano-3-methylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 71::US10266515, Example 71::US10308637, Example 71::US11021463, Example 71::US9611252, Example 71	Plasma kallikrein					<100					US Patent		10.7270/Q21R6TN7		aid1805605	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283419	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283419&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665353	378164748							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042221	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)cc2c1)C#N	InChI=1S/C27H19ClFN5O/c1-15-4-18-5-16(6-19(11-30)26(18)33-12-15)7-21-8-17(2-3-31-21)27(35)34-13-20-9-22-23(28)14-32-25(22)10-24(20)29/h2-6,8-10,12,14,32H,7,13H2,1H3,(H,34,35)	KVEDUIDZCUQFJJ-UHFFFAOYSA-N	283420	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((8-cyano-3-methylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 72::US10308637, Example 72::US11021463, Example 72::US9611252, Example 72	Plasma kallikrein					 550					US Patent		10.7270/Q21R6TN7		aid1805605	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283420	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283420&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665256	378164749							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042222	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cnc4[nH]cc(Cl)c4c3)cc2c1)C#N	InChI=1S/C26H19ClN6O/c1-15-4-19-5-16(6-20(10-28)24(19)30-11-15)7-21-9-18(2-3-29-21)26(34)33-13-17-8-22-23(27)14-32-25(22)31-12-17/h2-6,8-9,11-12,14H,7,13H2,1H3,(H,31,32)(H,33,34)	DUPQBZNXOTZIFE-UHFFFAOYSA-N	283421	N-((3-chloro-1H-pyrrolo[2,3-b]pyridin-5- yl)methyl)-2-((8-cyano-3-methylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 73::US10266515, Example 73::US10308637, Example 73::US11021463, Example 73::US9611252, Example 73	Plasma kallikrein					 550					US Patent		10.7270/Q21R6TN7		aid1805605	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283421	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283421&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665369	378164750							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042223	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2c1)C(N)=O	InChI=1S/C26H26N6O2/c1-14-6-19-8-17(10-21(25(28)33)24(19)30-12-14)9-20-11-18(4-5-29-20)26(34)31-13-22-15(2)7-23(27)32-16(22)3/h4-8,10-12H,9,13H2,1-3H3,(H2,27,32)(H2,28,33)(H,31,34)	OOWBJQXCALEAFC-UHFFFAOYSA-N	283425	6-((4-(((6-amino-2,4-dimethylpyridin-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- methylquinoline-8-carboxamide::US10023557, Example 77::US10266515, Example 77::US10308637, Example 77::US11021463, Example 77::US9611252, Example 77	Plasma kallikrein					<100					US Patent		10.7270/Q21R6TN7		aid1805605	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283425	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283425&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665125	378164754							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042224	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)cc2c1)C(N)=O	InChI=1S/C27H21ClFN5O2/c1-14-4-17-5-15(7-21(26(30)35)25(17)33-11-14)6-19-8-16(2-3-31-19)27(36)34-12-18-9-20-22(28)13-32-24(20)10-23(18)29/h2-5,7-11,13,32H,6,12H2,1H3,(H2,30,35)(H,34,36)	WETFPOPVXHIHFG-UHFFFAOYSA-N	283426	6-((4-(((3-chloro-6-fluoro-1H-indol-5- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- methylquinoline-8-carboxamide::US10023557, Example 78::US10266515, Example 78::US10308637, Example 78::US11021463, Example 78::US9611252, Example 78	Plasma kallikrein					<100					US Patent		10.7270/Q21R6TN7		aid1805605	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283426	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283426&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665427	378164755							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042225	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)cc2c1)C(N)=O	InChI=1S/C28H24N6O2/c1-16-8-21-10-18(12-24(27(30)35)25(21)33-14-16)11-22-13-20(5-6-31-22)28(36)34-15-17-2-3-23-19(9-17)4-7-32-26(23)29/h2-10,12-14H,11,15H2,1H3,(H2,29,32)(H2,30,35)(H,34,36)	AVMNYBKKWARJKT-UHFFFAOYSA-N	283427	6-((4-(((1-aminoisoquinolin-6- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- methylquinoline-8-carboxamide::US10023557, Example 79::US10266515, Example 79::US10308637, Example 79::US11021463, Example 79::US9611252, Example 79	Plasma kallikrein					<100					US Patent		10.7270/Q21R6TN7		aid1805605	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283427	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283427&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665123	378164756							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042226	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cnc4[nH]cc(Cl)c4c3)cc2c1)C(N)=O	InChI=1S/C26H21ClN6O2/c1-14-4-18-5-15(7-21(24(28)34)23(18)30-10-14)6-19-9-17(2-3-29-19)26(35)33-12-16-8-20-22(27)13-32-25(20)31-11-16/h2-5,7-11,13H,6,12H2,1H3,(H2,28,34)(H,31,32)(H,33,35)	CFJXZEDRAADQFI-UHFFFAOYSA-N	283428	6-((4-(((3-chloro-1H-pyrrolo[2,3-b]pyridin-5- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- methylquinoline-8-carboxamide::US10023557, Example 80::US10266515, Example 80::US10308637, Example 80::US11021463, Example 80::US9611252, Example 80	Plasma kallikrein					<100					US Patent		10.7270/Q21R6TN7		aid1805605	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283428	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283428&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665254	378164757							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042227	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3ccc4[nH]cc(Cl)c4c3F)cc2c1)C(N)=O	InChI=1S/C27H21ClFN5O2/c1-14-6-18-7-15(9-20(26(30)35)25(18)33-11-14)8-19-10-16(4-5-31-19)27(36)34-12-17-2-3-22-23(24(17)29)21(28)13-32-22/h2-7,9-11,13,32H,8,12H2,1H3,(H2,30,35)(H,34,36)	LJDMUPONZYUBTQ-UHFFFAOYSA-N	283429	6-((4-(((3-chloro-4-fluoro-1H-indol-5- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- methylquinoline-8-carboxamide::US10023557, Example 81::US10266515, Example 81::US10308637, Example 81::US11021463, Example 81::US9611252, Example 81	Plasma kallikrein					 550					US Patent		10.7270/Q21R6TN7		aid1805605	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283429	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283429&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665251	378164758							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042228	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3n[nH]c4ccc(Cl)cc34)cc2c1)C(N)=O	InChI=1S/C26H21ClN6O2/c1-14-6-17-7-15(9-21(25(28)34)24(17)30-12-14)8-19-10-16(4-5-29-19)26(35)31-13-23-20-11-18(27)2-3-22(20)32-33-23/h2-7,9-12H,8,13H2,1H3,(H2,28,34)(H,31,35)(H,32,33)	KIVLLFJSACGLHN-UHFFFAOYSA-N	283430	6-((4-(((5-chloro-1H-indazol-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- methylquinoline-8-carboxamide::US10023557, Example 82::US10266515, Example 82::US10308637, Example 82::US11021463, Example 82::US9611252, Example 82	Plasma kallikrein					 550					US Patent		10.7270/Q21R6TN7		aid1805605	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283430	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283430&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665290	378164759							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042229	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3cc4cc[nH]c4cc3F)cc2c1)C(N)=O	InChI=1S/C27H22FN5O2/c1-15-6-19-7-16(9-22(26(29)34)25(19)32-13-15)8-21-11-18(3-4-30-21)27(35)33-14-20-10-17-2-5-31-24(17)12-23(20)28/h2-7,9-13,31H,8,14H2,1H3,(H2,29,34)(H,33,35)	UZTOCULVDVRYTA-UHFFFAOYSA-N	283431	6-((4-(((6-fluoro-1H-indol-5- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- methylquinoline-8-carboxamide::US10023557, Example 83::US10266515, Example 83::US10308637, Example 83::US11021463, Example 83::US9611252, Example 83	Plasma kallikrein					 550					US Patent		10.7270/Q21R6TN7		aid1805605	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283431	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283431&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665428	378164760							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042230	Cc1cnc2c(cc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2c1)C(O)=O	InChI=1S/C26H25N5O3/c1-14-6-19-8-17(10-21(26(33)34)24(19)29-12-14)9-20-11-18(4-5-28-20)25(32)30-13-22-15(2)7-23(27)31-16(22)3/h4-8,10-12H,9,13H2,1-3H3,(H2,27,31)(H,30,32)(H,33,34)	IDXZVLZJXGFXKF-UHFFFAOYSA-N	283432	6-((4-(((6-amino-2,4-dimethylpyridin-3- yl)methyl)carbamoyl)pyridin-2-yl)methyl)-3- methylquinoline-8-carboxylic acid::US10023557, Example 84::US10266515, Example 84::US10308637, Example 84::US11021463, Example 84::US9611252, Example 84	Plasma kallikrein					<100					US Patent		10.7270/Q21R6TN7		aid1805605	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283432	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283432&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665404	378164761							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042231	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc(F)c3ncc(Cl)cc3c2)c1	InChI=1S/C24H21ClFN5O/c1-13-5-22(27)31-14(2)20(13)12-30-24(32)16-3-4-28-19(10-16)7-15-6-17-9-18(25)11-29-23(17)21(26)8-15/h3-6,8-11H,7,12H2,1-2H3,(H2,27,31)(H,30,32)	NJQUWZKNWYIFOW-UHFFFAOYSA-N	283437	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-chloro-8-fluoroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 89::US10266515, Example 89::US10308637, Example 89::US11021463, Example 89::US9611252, Example 89	Plasma kallikrein					<100					US Patent		10.7270/Q21R6TN7		aid1805605	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283437	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283437&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665263	378164766							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042232	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2cc(F)c3ncc(Cl)cc3c2)c1	InChI=1S/C23H19ClFN5O/c1-13-16(2-3-21(26)30-13)11-29-23(31)15-4-5-27-19(10-15)7-14-6-17-9-18(24)12-28-22(17)20(25)8-14/h2-6,8-10,12H,7,11H2,1H3,(H2,26,30)(H,29,31)	JKVPCVWDMOMIMY-UHFFFAOYSA-N	283439	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-chloro-8-fluoroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 91::US10266515, Example 91::US10308637, Example 91::US11021463, Example 91::US9611252, Example 91	Plasma kallikrein					<100					US Patent		10.7270/Q21R6TN7		aid1805605	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283439	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283439&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665234	378164768							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042233	Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2cc(Cl)c3ncc(Cl)cc3c2)c1	InChI=1S/C24H21Cl2N5O/c1-13-5-22(27)31-14(2)20(13)12-30-24(32)16-3-4-28-19(10-16)7-15-6-17-9-18(25)11-29-23(17)21(26)8-15/h3-6,8-11H,7,12H2,1-2H3,(H2,27,31)(H,30,32)	HHXMWQGWYOIRGQ-UHFFFAOYSA-N	283448	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3,8-dichloroquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 100::US10266515, Example 100::US10308637, Example 100::US11021463, Example 100::US9611252, Example 100	Plasma kallikrein					<100					US Patent		10.7270/Q21R6TN7		aid1805605	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283448	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283448&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665316	378164777							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042234	Cc1ccc2cc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)ccc2n1	InChI=1S/C26H20ClFN4O/c1-15-2-4-17-8-16(3-5-24(17)32-15)9-20-10-18(6-7-29-20)26(33)31-13-19-11-21-22(27)14-30-25(21)12-23(19)28/h2-8,10-12,14,30H,9,13H2,1H3,(H,31,33)	SQVVRWKBMIEHGU-UHFFFAOYSA-N	283458	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((2-methylquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 110::US10266515, Example 110::US10308637, Example 110::US11021463, Example 110::US9611252, Example 110	Plasma kallikrein					 550					US Patent		10.7270/Q21R6TN7		aid1805605	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283458	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283458&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212258	378164786							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042235	Cc1ccc2cc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)ccc2n1	InChI=1S/C27H23N5O/c1-17-2-5-21-12-18(4-7-25(21)32-17)14-23-15-22(9-10-29-23)27(33)31-16-19-3-6-24-20(13-19)8-11-30-26(24)28/h2-13,15H,14,16H2,1H3,(H2,28,30)(H,31,33)	BHHAKIOPTCXPSL-UHFFFAOYSA-N	283459	N-((1-aminoisoquinolin-6-yl)methyl)-2-((2- methylquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 111::US10266515, Example 111::US10308637, Example 111::US11021463, Example 111::US9611252, Example 111	Plasma kallikrein					 550					US Patent		10.7270/Q21R6TN7		aid1805605	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283459	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283459&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212697	378164787							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042236	Cc1ccc2cc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)ccc2n1	InChI=1S/C25H25N5O/c1-15-10-24(26)30-17(3)22(15)14-28-25(31)20-8-9-27-21(13-20)12-18-5-7-23-19(11-18)6-4-16(2)29-23/h4-11,13H,12,14H2,1-3H3,(H2,26,30)(H,28,31)	SOGVYINZTNHWMJ-UHFFFAOYSA-N	283461	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((2-methylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 113::US10266515, Example 113::US10308637, Example 113::US11021463, Example 113::US9611252, Example 113	Plasma kallikrein					<100					US Patent		10.7270/Q21R6TN7		aid1805605	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283461	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283461&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212447	378164789							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042237	Cc1ccc2ncc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2c1	InChI=1S/C25H25N5O/c1-15-4-5-23-20(8-15)10-18(13-28-23)11-21-12-19(6-7-27-21)25(31)29-14-22-16(2)9-24(26)30-17(22)3/h4-10,12-13H,11,14H2,1-3H3,(H2,26,30)(H,29,31)	PERODSYFHIKGOQ-UHFFFAOYSA-N	283462	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((6-methylquinolin-3- yl)methyl)isonicotinamide::US10023557, Example 114::US10266515, Example 114::US10308637, Example 114::US11021463, Example 114::US9611252, Example 114	Plasma kallikrein					<100					US Patent		10.7270/Q21R6TN7		aid1805605	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283462	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283462&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212424	378164790							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042238	Cc1ccc2ncc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)cc2c1	InChI=1S/C27H23N5O/c1-17-2-5-25-22(10-17)12-19(16-31-25)13-23-14-21(7-8-29-23)27(33)32-15-18-3-4-24-20(11-18)6-9-30-26(24)28/h2-12,14,16H,13,15H2,1H3,(H2,28,30)(H,32,33)	YXYWWKCODFDZSQ-UHFFFAOYSA-N	283463	N-((1-aminoisoquinolin-6-yl)methyl)-2-((6- methylquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 115::US10266515, Example 115::US10308637, Example 115::US11021463, Example 115::US9611252, Example 115	Plasma kallikrein					<100					US Patent		10.7270/Q21R6TN7		aid1805605	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283463	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283463&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212341	378164791							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042239	Cc1ccc2ncc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)cc2c1	InChI=1S/C26H20ClFN4O/c1-15-2-3-24-18(6-15)7-16(12-30-24)8-20-9-17(4-5-29-20)26(33)32-13-19-10-21-22(27)14-31-25(21)11-23(19)28/h2-7,9-12,14,31H,8,13H2,1H3,(H,32,33)	HEFJFXWKPBYZLZ-UHFFFAOYSA-N	283464	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((6-methylquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 116::US10266515, Example 116::US10308637, Example 116::US11021463, Example 116::US9611252, Example 116	Plasma kallikrein					 550					US Patent		10.7270/Q21R6TN7		aid1805605	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283464	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283464&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212685	378164792							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042240	Cc1ccc2ncc(Cc3cc(ccn3)C(=O)NCc3ccc(N)nc3C)cc2c1	InChI=1S/C24H23N5O/c1-15-3-5-22-20(9-15)10-17(13-27-22)11-21-12-18(7-8-26-21)24(30)28-14-19-4-6-23(25)29-16(19)2/h3-10,12-13H,11,14H2,1-2H3,(H2,25,29)(H,28,30)	WNXNZZRXTORCMQ-UHFFFAOYSA-N	283465	N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((6-methylquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 117::US10266515, Example 117::US10308637, Example 117::US11021463, Example 117::US9611252, Example 117	Plasma kallikrein					 550					US Patent		10.7270/Q21R6TN7		aid1805605	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283465	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283465&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212579	378164793							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042241	Nc1nccc2cc(CNC(=O)c3ccnc(Cc4cnc5ccc(F)cc5c4)c3)ccc12	InChI=1S/C26H20FN5O/c27-21-2-4-24-20(12-21)10-17(15-31-24)11-22-13-19(6-7-29-22)26(33)32-14-16-1-3-23-18(9-16)5-8-30-25(23)28/h1-10,12-13,15H,11,14H2,(H2,28,30)(H,32,33)	FEOOVYNQAJINSQ-UHFFFAOYSA-N	283466	N-((1-aminoisoquinolin-6-yl)methyl)-2-((6- fluoroquinolin-3-yl)methyl)isonicotinamide::US10023557, Example 118::US10266515, Example 118::US10308637, Example 118::US11021463, Example 118::US9611252, Example 118	Plasma kallikrein					<100					US Patent		10.7270/Q21R6TN7		aid1805605	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283466	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283466&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212932	378164794							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042242	Cc1cc2cc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)ccc2cn1	InChI=1S/C27H23N5O/c1-17-10-23-11-18(2-4-22(23)16-31-17)13-24-14-21(7-8-29-24)27(33)32-15-19-3-5-25-20(12-19)6-9-30-26(25)28/h2-12,14,16H,13,15H2,1H3,(H2,28,30)(H,32,33)	KZGIIODXNPBNJO-UHFFFAOYSA-N	283480	N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- methylisoquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 132::US10266515, Example 132::US10308637, Example 132::US11021463, Example 132::US9611252, Example 132	Plasma kallikrein					 550					US Patent		10.7270/Q21R6TN7		aid1805605	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283480	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283480&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118213018	378164808							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042243	Cc1cnc2ccc(Cc3cc(ccn3)C(=O)NCc3ccc4c(N)nccc4c3)cc2c1	InChI=1S/C27H23N5O/c1-17-10-22-11-18(3-5-25(22)31-15-17)13-23-14-21(7-8-29-23)27(33)32-16-19-2-4-24-20(12-19)6-9-30-26(24)28/h2-12,14-15H,13,16H2,1H3,(H2,28,30)(H,32,33)	XPXFEZOWOODSMW-UHFFFAOYSA-N	283490	N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- methylquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 142::US10266515, Example 142::US10308637, Example 142::US11021463, Example 142::US9611252, Example 142	Plasma kallikrein					<100					US Patent		10.7270/Q21R6TN7		aid1805605	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283490	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283490&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212463	378164818							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042244	Cc1cnc2ccc(Cc3cc(ccn3)C(=O)NCc3cc4c(Cl)c[nH]c4cc3F)cc2c1	InChI=1S/C26H20ClFN4O/c1-15-6-18-7-16(2-3-24(18)30-12-15)8-20-9-17(4-5-29-20)26(33)32-13-19-10-21-22(27)14-31-25(21)11-23(19)28/h2-7,9-12,14,31H,8,13H2,1H3,(H,32,33)	BAWQXCVTJNYXQW-UHFFFAOYSA-N	283491	N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3-methylquinolin-6-yl)methyl)isonicotinamide::US10023557, Example 143::US10266515, Example 143::US10308637, Example 143::US11021463, Example 143::US9611252, Example 143	Plasma kallikrein					 550					US Patent		10.7270/Q21R6TN7		aid1805605	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283491	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283491&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212764	378164819							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042245	Cc1cnc2ccc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)cc2c1	InChI=1S/C25H25N5O/c1-15-8-20-10-18(4-5-23(20)28-13-15)11-21-12-19(6-7-27-21)25(31)29-14-22-16(2)9-24(26)30-17(22)3/h4-10,12-13H,11,14H2,1-3H3,(H2,26,30)(H,29,31)	BDBQXLZXRHXRJN-UHFFFAOYSA-N	283492	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-methylquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 144::US10266515, Example 144::US10308637, Example 144::US11021463, Example 144::US9611252, Example 144	Plasma kallikrein					<100					US Patent		10.7270/Q21R6TN7		aid1805605	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283492	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283492&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212432	378164820							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1042246	Cc1cc2cc(Cc3cc(ccn3)C(=O)NCc3c(C)cc(N)nc3C)ccc2cn1	InChI=1S/C25H25N5O/c1-15-8-24(26)30-17(3)23(15)14-29-25(31)19-6-7-27-22(12-19)11-18-4-5-20-13-28-16(2)9-21(20)10-18/h4-10,12-13H,11,14H2,1-3H3,(H2,26,30)(H,29,31)	IDPUQOZCEWQYLL-UHFFFAOYSA-N	283493	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((3-methylisoquinolin-6- yl)methyl)isonicotinamide::US10023557, Example 145::US10266515, Example 145::US10308637, Example 145::US11021463, Example 145::US9611252, Example 145	Plasma kallikrein					<100					US Patent		10.7270/Q21R6TN7		aid1805605	US11021463	McDonald, A; Qian, S	ATTUNE PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283493	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283493&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212443	378164821							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073084	NC(=O)c1cccc(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2C2CC2)c1	InChI=1S/C28H27N5O3/c29-27(35)23-5-3-4-21(14-23)15-30-28(36)24-18-33(31-26(24)22-11-12-22)17-20-9-7-19(8-10-20)16-32-13-2-1-6-25(32)34/h1-10,13-14,18,22H,11-12,15-17H2,(H2,29,35)(H,30,36)	GLBUGHLBAAXCAZ-UHFFFAOYSA-N	408727	 N-[(3-carbamoylphenyl)methyl]-3-cyclopropyl-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide   ::US10364238, Example 49::US11001578, Example 49::US11084809, Example 49::US11198691, Example 49	Plasma kallikrein			 5450							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408727	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408727&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365022	406799358							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073086	NC(=O)c1ccc(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2C2CC2)cc1	InChI=1S/C28H27N5O3/c29-27(35)23-10-8-19(9-11-23)15-30-28(36)24-18-33(31-26(24)22-12-13-22)17-21-6-4-20(5-7-21)16-32-14-2-1-3-25(32)34/h1-11,14,18,22H,12-13,15-17H2,(H2,29,35)(H,30,36)	XDXGOIDNTUZASE-UHFFFAOYSA-N	408730	N-[(4-carbamoylphenyl)methyl]-3-cyclopropyl-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 50::US11001578, Example 50::US11084809, Example 50::US11198691, Example 50	Plasma kallikrein			 1800							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408730	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408730&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365075	406799361							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073088	Fc1cccc(c1CNC(=O)c1cn(Cc2ccc(Cn3ccccc3=O)cc2)nc1C(F)(F)F)C(F)(F)F	InChI=1S/C26H19F7N4O2/c27-21-5-3-4-20(25(28,29)30)18(21)12-34-24(39)19-15-37(35-23(19)26(31,32)33)14-17-9-7-16(8-10-17)13-36-11-2-1-6-22(36)38/h1-11,15H,12-14H2,(H,34,39)	ASCUMAURKSBUPS-UHFFFAOYSA-N	408732	 N-{[2-fluoro-6-(trifluoromethyl)phenyl]methyl}-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide::US10364238, Example 51::US11001578, Example 51::US11084809, Example 51::US11198691, Example 51	Plasma kallikrein			 48.9							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408732	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408732&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365085	406799363							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073090	COc1cccc(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2C2CC2)c1F	InChI=1S/C28H27FN4O3/c1-36-24-6-4-5-22(26(24)29)15-30-28(35)23-18-33(31-27(23)21-12-13-21)17-20-10-8-19(9-11-20)16-32-14-3-2-7-25(32)34/h2-11,14,18,21H,12-13,15-17H2,1H3,(H,30,35)	NFLOZDGNLCLQAJ-UHFFFAOYSA-N	408733	 3-cyclopropyl-N-[(2-fluoro-3-methoxyphenyl)methyl]-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 52::US11001578, Example 52::US11084809, Example 52::US11198691, Example 52	Plasma kallikrein			 23.3							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408733	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408733&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365123	406799364							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073060	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cnccc1C(F)(F)F	InChI=1S/C26H24F3N5O3/c1-37-17-23-21(25(36)31-13-20-12-30-10-9-22(20)26(27,28)29)16-34(32-23)15-19-7-5-18(6-8-19)14-33-11-3-2-4-24(33)35/h2-12,16H,13-15,17H2,1H3,(H,31,36)	ZHJJZIGZXRDDHP-UHFFFAOYSA-N	408711	3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)-N-{[4- (trifluoromethyl)pyridin-3-yl]methyl}pyrazole-4-carboxamide ::US10364238, Example 31::US10364238, Example 37::US11001578, Example 37::US11084809, Example 37::US11198691, Example 37	Plasma kallikrein			 392							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408711	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408711&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365063	406799344							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073092	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cccc(OC)c1F	InChI=1S/C27H27FN4O4/c1-35-18-23-22(27(34)29-14-21-6-5-7-24(36-2)26(21)28)17-32(30-23)16-20-11-9-19(10-12-20)15-31-13-4-3-8-25(31)33/h3-13,17H,14-16,18H2,1-2H3,(H,29,34)	MLCDWARNPOODOL-UHFFFAOYSA-N	408734	 N-[(2-fluoro-3-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US10364238, Example 53::US11001578, Example 53::US11084809, Example 53::US11198691, Example 53	Plasma kallikrein			 20.2							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408734	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408734&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365056	406799365							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073062	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1ccc(C)nc1	InChI=1S/C26H27N5O3/c1-19-6-7-22(13-27-19)14-28-26(33)23-17-31(29-24(23)18-34-2)16-21-10-8-20(9-11-21)15-30-12-4-3-5-25(30)32/h3-13,17H,14-16,18H2,1-2H3,(H,28,33)	IKFHJYIVYYFDCA-UHFFFAOYSA-N	408712	3-(methoxymethyl)-N-[(6-methylpyridin-3-yl)methyl]-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 32::US10364238, Example 39::US11001578, Example 39::US11084809, Example 39::US11198691, Example 39	Plasma kallikrein			 7870							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408712	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408712&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365092	406799345							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073094	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(OC)ccc(OC)c1F	InChI=1S/C28H29FN4O5/c1-36-18-23-22(28(35)30-14-21-24(37-2)11-12-25(38-3)27(21)29)17-33(31-23)16-20-9-7-19(8-10-20)15-32-13-5-4-6-26(32)34/h4-13,17H,14-16,18H2,1-3H3,(H,30,35)	TVHOOPXMFWZGQK-UHFFFAOYSA-N	408736	 N-[(2-fluoro-3,6-dimethoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin- 1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 54::US11001578, Example 54::US11084809, Example 54::US11198691, Example 54	Plasma kallikrein			 2.10							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408736	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408736&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365119	406799367							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073064	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cccnc1C(F)(F)F	InChI=1S/C26H24F3N5O3/c1-37-17-22-21(25(36)31-13-20-5-4-11-30-24(20)26(27,28)29)16-34(32-22)15-19-9-7-18(8-10-19)14-33-12-3-2-6-23(33)35/h2-12,16H,13-15,17H2,1H3,(H,31,36)	ULAOQOFMZICMAA-UHFFFAOYSA-N	408713	 3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)-N-{[2- (trifluoromethyl)pyridin-3-yl]methyl}pyrazole-4-carboxamide::US10364238, Example 36::US11001578, Example 36::US11084809, Example 36::US11198691, Example 36	Plasma kallikrein			 4170							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408713	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408713&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365101	406799346							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073096	Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1ccc(OC(F)(F)F)cc1	InChI=1S/C25H22F3N5O3/c26-25(27,28)36-20-10-8-17(9-11-20)13-30-24(35)21-16-33(31-23(21)29)15-19-6-4-18(5-7-19)14-32-12-2-1-3-22(32)34/h1-12,16H,13-15H2,(H2,29,31)(H,30,35)	KRHKQKBRWFYZPN-UHFFFAOYSA-N	408737	3-amino-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)-N-{[4- (trifluoromethoxy)phenyl]methyl}pyrazole-4-carboxamide ::US10364238, Example 58::US11001578, Example 58::US11084809, Example 58::US11198691, Example 58	Plasma kallikrein			 5780							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408737	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408737&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365068	406799368							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073066	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cnccc1C(F)(F)F	InChI=1S/C26H24F3N5O3/c1-37-17-23-21(25(36)31-13-20-12-30-10-9-22(20)26(27,28)29)16-34(32-23)15-19-7-5-18(6-8-19)14-33-11-3-2-4-24(33)35/h2-12,16H,13-15,17H2,1H3,(H,31,36)	ZHJJZIGZXRDDHP-UHFFFAOYSA-N	408711	3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)-N-{[4- (trifluoromethyl)pyridin-3-yl]methyl}pyrazole-4-carboxamide ::US10364238, Example 31::US10364238, Example 37::US11001578, Example 37::US11084809, Example 37::US11198691, Example 37	Plasma kallikrein			 392							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408711	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408711&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365063	406799344							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073098	COc1cccc(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2N(C)C)c1F	InChI=1S/C27H28FN5O3/c1-31(2)26-22(27(35)29-15-21-7-6-8-23(36-3)25(21)28)18-33(30-26)17-20-12-10-19(11-13-20)16-32-14-5-4-9-24(32)34/h4-14,18H,15-17H2,1-3H3,(H,29,35)	OMUPFLKDHHROJU-UHFFFAOYSA-N	408738	 3-(dimethylamino)-N-[(2-fluoro-3-methoxyphenyl)methyl]-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 59::US11001578, Example 59::US11084809, Example 59::US11198691, Example 59	Plasma kallikrein			 73.4							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408738	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408738&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365158	406799369							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073068	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1ccc(C)nc1	InChI=1S/C26H27N5O3/c1-19-6-7-22(13-27-19)14-28-26(33)23-17-31(29-24(23)18-34-2)16-21-10-8-20(9-11-21)15-30-12-4-3-5-25(30)32/h3-13,17H,14-16,18H2,1-2H3,(H,28,33)	IKFHJYIVYYFDCA-UHFFFAOYSA-N	408712	3-(methoxymethyl)-N-[(6-methylpyridin-3-yl)methyl]-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 32::US10364238, Example 39::US11001578, Example 39::US11084809, Example 39::US11198691, Example 39	Plasma kallikrein			 7870							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408712	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408712&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365092	406799345							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073100	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1ccccc1F	InChI=1S/C26H25FN4O3/c1-34-18-24-22(26(33)28-14-21-6-2-3-7-23(21)27)17-31(29-24)16-20-11-9-19(10-12-20)15-30-13-5-4-8-25(30)32/h2-13,17H,14-16,18H2,1H3,(H,28,33)	OMZXAEPYOCEHIS-UHFFFAOYSA-N	408740	N-[(2-fluorophenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 62::US11001578, Example 62::US11084809, Example 62::US11198691, Example 62	Plasma kallikrein			 572							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408740	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408740&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365055	406799371							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073070	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cccc(OC)n1	InChI=1S/C26H27N5O4/c1-34-18-23-22(26(33)27-14-21-6-5-7-24(28-21)35-2)17-31(29-23)16-20-11-9-19(10-12-20)15-30-13-4-3-8-25(30)32/h3-13,17H,14-16,18H2,1-2H3,(H,27,33)	XOCSKLGONWNPHT-UHFFFAOYSA-N	408716	3-(methoxymethyl)-N-[(6-methoxypyridin-2-yl)methyl]-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 40::US11001578, Example 40::US11084809, Example 40::US11198691, Example 40	Plasma kallikrein			 3700							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408716	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408716&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365155	406799347							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073000	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(OC)cc(OC)c1	InChI=1S/C28H30N4O5/c1-35-19-26-25(28(34)29-15-22-12-23(36-2)14-24(13-22)37-3)18-32(30-26)17-21-9-7-20(8-10-21)16-31-11-5-4-6-27(31)33/h4-14,18H,15-17,19H2,1-3H3,(H,29,34)	BKELALJCIHUNCS-UHFFFAOYSA-N	408665	N-(3,5-Dimethoxybenzyl)-3-(methoxymethyl)-1-(4-((2-oxopyridin-1(2H)-yl)methyl)benzyl)-1H-pyrazole-4-carboxamide::US10364238, Example 1::US11001578, Example 1::US11084809, Example 1::US11198691, Example 1	Plasma kallikrein			 698							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408665	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408665&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364994	406799299							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073002	COc1cccc(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2N)c1F	InChI=1S/C25H24FN5O3/c1-34-21-6-4-5-19(23(21)26)13-28-25(33)20-16-31(29-24(20)27)15-18-10-8-17(9-11-18)14-30-12-3-2-7-22(30)32/h2-12,16H,13-15H2,1H3,(H2,27,29)(H,28,33)	HICYNMRHZGAFMT-UHFFFAOYSA-N	408666	3-Amino-1-[4-(2-oxo-2H-pyridin-1-ylmethyl)-benzyl]-1H-pyrazole-4-carboxylic acid 2-fluoro-3-methoxy-benzylamide::US10364238, Example 2::US11001578, Example 2::US11084809, Example 2::US11198691, Example 2	Plasma kallikrein			 8.70							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408666	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408666&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365045	406799300							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073004	COCc1nn(Cc2cnc3cc(Cl)ccc3c2)cc1C(=O)NCc1cccc(OC)c1F	InChI=1S/C24H22ClFN4O3/c1-32-14-21-19(24(31)28-11-17-4-3-5-22(33-2)23(17)26)13-30(29-21)12-15-8-16-6-7-18(25)9-20(16)27-10-15/h3-10,13H,11-12,14H2,1-2H3,(H,28,31)	WPIUJKAYUGBTDW-UHFFFAOYSA-N	408667	1-(7-Chloro-quinolin-3-ylmethyl)-3-methoxymethyl-1H-pyrazole-4-carboxylic acid 2-fluoro-3-methoxy-benzylamide::US10364238, Example 3::US11001578, Example 3::US11084809, Example 3::US11198691, Example 3	Plasma kallikrein			 2580							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408667	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408667&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365013	406799301							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073006	COc1cccc(CNC(=O)c2cn(Cc3ccc(Cn4cc(C)cn4)cc3)nc2C(F)(F)F)c1F	InChI=1S/C25H23F4N5O2/c1-16-10-31-33(12-16)13-17-6-8-18(9-7-17)14-34-15-20(23(32-34)25(27,28)29)24(35)30-11-19-4-3-5-21(36-2)22(19)26/h3-10,12,15H,11,13-14H2,1-2H3,(H,30,35)	QZMZZOCEJPCAIJ-UHFFFAOYSA-N	408668	N-[(2-fluoro-3-methoxyphenyl)methyl]-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide::US10364238, Example 4::US11001578, Example 4::US11084809, Example 4::US11198691, Example 4	Plasma kallikrein			 136							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408668	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408668&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365107	406799302							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073008	COc1cccc(CNC(=O)c2cn(Cc3ccc(Cn4cc(C)cn4)cc3)nc2C(F)(F)F)c1	InChI=1S/C25H24F3N5O2/c1-17-11-30-32(13-17)14-18-6-8-19(9-7-18)15-33-16-22(23(31-33)25(26,27)28)24(34)29-12-20-4-3-5-21(10-20)35-2/h3-11,13,16H,12,14-15H2,1-2H3,(H,29,34)	JLGLPBSVAUHGOI-UHFFFAOYSA-N	408671	N-[(3-methoxyphenyl)methyl]-1-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)-3- (trifluoromethyl)pyrazole-4-carboxamide ::US10364238, Example 5::US11001578, Example 5::US11084809, Example 5::US11198691, Example 5	Plasma kallikrein			 364							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408671	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408671&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365083	406799304							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073010	CCOc1cccc(CNC(=O)c2cn(Cc3ccc(Cn4cc(C)cn4)cc3)nc2C(F)(F)F)c1	InChI=1S/C26H26F3N5O2/c1-3-36-22-6-4-5-21(11-22)13-30-25(35)23-17-34(32-24(23)26(27,28)29)16-20-9-7-19(8-10-20)15-33-14-18(2)12-31-33/h4-12,14,17H,3,13,15-16H2,1-2H3,(H,30,35)	UJVJDICDWMSCMO-UHFFFAOYSA-N	408672	N-[(3-ethoxyphenyl)methyl]-1-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)-3- (trifluoromethyl)pyrazole-4-carboxamide::US10364238, Example 6::US11001578, Example 6::US11084809, Example 6::US11198691, Example 6	Plasma kallikrein			 2360							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408672	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408672&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365014	406799305							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073012	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4cccc(OC(F)(F)F)c4)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C25H21F6N5O2/c1-16-10-33-35(12-16)13-17-5-7-18(8-6-17)14-36-15-21(22(34-36)24(26,27)28)23(37)32-11-19-3-2-4-20(9-19)38-25(29,30)31/h2-10,12,15H,11,13-14H2,1H3,(H,32,37)	IWQRRWVFCUYKBA-UHFFFAOYSA-N	408674	1-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)-N-{[3- (trifluoromethoxy)phenyl]methyl}-3-(trifluoromethyl)pyrazole-4-carboxamide ::US10364238, Example 7::US11001578, Example 7::US11084809, Example 7::US11198691, Example 7	Plasma kallikrein			>10000							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408674	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408674&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365116	406799307							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073014	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4ccc(C)cc4)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C25H24F3N5O/c1-17-3-5-19(6-4-17)12-29-24(34)22-16-33(31-23(22)25(26,27)28)15-21-9-7-20(8-10-21)14-32-13-18(2)11-30-32/h3-11,13,16H,12,14-15H2,1-2H3,(H,29,34)	UWKOAYQJMJZTCL-UHFFFAOYSA-N	497235	N-[(4-methylphenyl)methyl]-1-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)-3-::US11001578, Example 8::US11084809, Example 8::US11198691, Example 8	Plasma kallikrein			 539							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=497235	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=497235&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365038	459070223							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073016	COc1ccc(F)c(CNC(=O)c2cn(Cc3ccc(Cn4cc(C)cn4)cc3)nc2C(F)(F)F)c1	InChI=1S/C25H23F4N5O2/c1-16-10-31-33(12-16)13-17-3-5-18(6-4-17)14-34-15-21(23(32-34)25(27,28)29)24(35)30-11-19-9-20(36-2)7-8-22(19)26/h3-10,12,15H,11,13-14H2,1-2H3,(H,30,35)	HQJUOFQTROTCAB-UHFFFAOYSA-N	408678	N-[(2-fluoro-5-methoxyphenyl)methyl]-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide ::US10364238, Example 9::US11001578, Example 9::US11084809, Example 9::US11198691, Example 9	Plasma kallikrein			 239							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408678	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408678&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365002	406799311							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073018	COc1ccc(CNC(=O)c2cn(Cc3ccc(Cn4cc(C)cn4)cc3)nc2C(F)(F)F)c(OC)c1	InChI=1S/C26H26F3N5O3/c1-17-11-31-33(13-17)14-18-4-6-19(7-5-18)15-34-16-22(24(32-34)26(27,28)29)25(35)30-12-20-8-9-21(36-2)10-23(20)37-3/h4-11,13,16H,12,14-15H2,1-3H3,(H,30,35)	CXDMHDUCUCLAEV-UHFFFAOYSA-N	408681	N-[(2,4-dimethoxyphenyl)methyl]-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide ::US10364238, Example 10::US11001578, Example 10::US11084809, Example 10::US11198691, Example 10	Plasma kallikrein			 1270							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408681	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408681&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365034	406799314							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073020	COc1cc(F)c(CNC(=O)c2cn(Cc3ccc(Cn4cc(C)cn4)cc3)nc2C(F)(F)F)c(F)c1	InChI=1S/C25H22F5N5O2/c1-15-9-32-34(11-15)12-16-3-5-17(6-4-16)13-35-14-20(23(33-35)25(28,29)30)24(36)31-10-19-21(26)7-18(37-2)8-22(19)27/h3-9,11,14H,10,12-13H2,1-2H3,(H,31,36)	HRWXHWAUCMAPKJ-UHFFFAOYSA-N	408683	 N-[(2,6-difluoro-4-methoxyphenyl)methyl]-1-({4-[(4-methylpyrazol-1- yl)methyl]pheny}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide::US10364238, Example 11::US11001578, Example 11::US11084809, Example 11::US11198691, Example 11	Plasma kallikrein			 456							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408683	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408683&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365073	406799316							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073022	COc1ccc(CNC(=O)c2cn(Cc3ccc(Cn4cc(C)cn4)cc3)nc2C(F)(F)F)c(c1)C(F)(F)F	InChI=1S/C26H23F6N5O2/c1-16-10-34-36(12-16)13-17-3-5-18(6-4-17)14-37-15-21(23(35-37)26(30,31)32)24(38)33-11-19-7-8-20(39-2)9-22(19)25(27,28)29/h3-10,12,15H,11,13-14H2,1-2H3,(H,33,38)	UJRPEIINPALAES-UHFFFAOYSA-N	408685	N-{[4-methoxy-2-(trifluoromethyl)phenyl]methyl}-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide ::US10364238, Example 12::US11001578, Example 12::US11084809, Example 12::US11198691, Example 12	Plasma kallikrein			 746							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408685	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408685&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365025	406799318							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073024	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4c(F)cccc4F)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C24H20F5N5O/c1-15-9-31-33(11-15)12-16-5-7-17(8-6-16)13-34-14-19(22(32-34)24(27,28)29)23(35)30-10-18-20(25)3-2-4-21(18)26/h2-9,11,14H,10,12-13H2,1H3,(H,30,35)	DRFYBIDDXPOTJQ-UHFFFAOYSA-N	512283	N-[(2,6-difluorophenyl)methyl]-1-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide::US11084809, Example 13::US11198691, Example 13	Plasma kallikrein			 439							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512283	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512283&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364996	459629531							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073026	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4c(F)cccc4Cl)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C24H20ClF4N5O/c1-15-9-31-33(11-15)12-16-5-7-17(8-6-16)13-34-14-19(22(32-34)24(27,28)29)23(35)30-10-18-20(25)3-2-4-21(18)26/h2-9,11,14H,10,12-13H2,1H3,(H,30,35)	UCUUHDDHAAXSSH-UHFFFAOYSA-N	408689	N-[(2-chloro-6-fluorophenyl)methyl]-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide ::US10364238, Example 14::US11001578, Example 14::US11084809, Example 14::US11198691, Example 14	Plasma kallikrein			 514							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408689	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408689&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365058	406799322							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073028	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4c(F)cccc4C(F)(F)F)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C25H20F7N5O/c1-15-9-34-36(11-15)12-16-5-7-17(8-6-16)13-37-14-19(22(35-37)25(30,31)32)23(38)33-10-18-20(24(27,28)29)3-2-4-21(18)26/h2-9,11,14H,10,12-13H2,1H3,(H,33,38)	MRFKCVIKSCVIEK-UHFFFAOYSA-N	408691	N-{[2-fluoro-6-(trifluoromethyl)phenyl]methyl}-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide::US10364238, Example 15::US11001578, Example 15::US11084809, Example 15::US11198691, Example 15	Plasma kallikrein			 219							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408691	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408691&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365041	406799324							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073030	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4c(F)cc(Cl)cc4F)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C24H19ClF5N5O/c1-14-8-32-34(10-14)11-15-2-4-16(5-3-15)12-35-13-19(22(33-35)24(28,29)30)23(36)31-9-18-20(26)6-17(25)7-21(18)27/h2-8,10,13H,9,11-12H2,1H3,(H,31,36)	SXIKFYGPUGSYOC-UHFFFAOYSA-N	408692	N-[(4-chloro-2,6-difluorophenyl)methyl]-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide ::US10364238, Example 16::US11001578, Example 16::US11084809, Example 16::US11198691, Example 16	Plasma kallikrein			 263							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408692	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408692&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365003	406799325							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073032	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4ccc(Cl)cc4F)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C24H20ClF4N5O/c1-15-9-31-33(11-15)12-16-2-4-17(5-3-16)13-34-14-20(22(32-34)24(27,28)29)23(35)30-10-18-6-7-19(25)8-21(18)26/h2-9,11,14H,10,12-13H2,1H3,(H,30,35)	MPXDOEQMYFYSIT-UHFFFAOYSA-N	408693	 N-[(4-chloro-2-fluorophenyl)methyl]-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide ::US10364238, Example 17::US11001578, Example 17::US11084809, Example 17::US11198691, Example 17	Plasma kallikrein			 865							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408693	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408693&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365130	406799326							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073034	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4c(F)ccc(Cl)c4F)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C24H19ClF5N5O/c1-14-8-32-34(10-14)11-15-2-4-16(5-3-15)12-35-13-18(22(33-35)24(28,29)30)23(36)31-9-17-20(26)7-6-19(25)21(17)27/h2-8,10,13H,9,11-12H2,1H3,(H,31,36)	HNSAKACOONQHKG-UHFFFAOYSA-N	408694	N-[(3-chloro-2,6-difluorophenyl)methyl]-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide::US10364238, Example 18::US11001578, Example 18::US11084809, Example 18::US11198691, Example 18	Plasma kallikrein			 373							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408694	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408694&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365160	406799327							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073036	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4cccc(Cl)c4F)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C24H20ClF4N5O/c1-15-9-31-33(11-15)12-16-5-7-17(8-6-16)13-34-14-19(22(32-34)24(27,28)29)23(35)30-10-18-3-2-4-20(25)21(18)26/h2-9,11,14H,10,12-13H2,1H3,(H,30,35)	RFRZBYFPHZMTPR-UHFFFAOYSA-N	408695	N-[(3-chloro-2-fluorophenyl)methyl]-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide::US10364238, Example 19::US11001578, Example 19::US11084809, Example 19::US11198691, Example 19	Plasma kallikrein			 1130							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408695	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408695&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365137	406799328							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073038	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4cc(Cl)ccc4F)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C24H20ClF4N5O/c1-15-9-31-33(11-15)12-16-2-4-17(5-3-16)13-34-14-20(22(32-34)24(27,28)29)23(35)30-10-18-8-19(25)6-7-21(18)26/h2-9,11,14H,10,12-13H2,1H3,(H,30,35)	VQSXMSNNAGMGCB-UHFFFAOYSA-N	408696	N-[(5-chloro-2-fluorophenyl)methyl]-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide ::US10364238, Example 20::US11001578, Example 20::US11084809, Example 20::US11198691, Example 20	Plasma kallikrein			 740							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408696	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408696&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365077	406799329							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073040	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4c(F)c(Cl)ccc4C(F)(F)F)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C25H19ClF7N5O/c1-14-8-35-37(10-14)11-15-2-4-16(5-3-15)12-38-13-18(22(36-38)25(31,32)33)23(39)34-9-17-19(24(28,29)30)6-7-20(26)21(17)27/h2-8,10,13H,9,11-12H2,1H3,(H,34,39)	KVPLENMFVKIMRG-UHFFFAOYSA-N	408697	 N-{[3-chloro-2-fluoro-6-(trifluoromethyl)phenyl]methyl}-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide ::US10364238, Example 21::US11001578, Example 21::US11084809, Example 21::US11198691, Example 21	Plasma kallikrein			 257							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408697	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408697&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365161	406799330							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073042	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4c(Cl)cccc4Cl)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C24H20Cl2F3N5O/c1-15-9-31-33(11-15)12-16-5-7-17(8-6-16)13-34-14-19(22(32-34)24(27,28)29)23(35)30-10-18-20(25)3-2-4-21(18)26/h2-9,11,14H,10,12-13H2,1H3,(H,30,35)	UNJUOXQQTNMQSH-UHFFFAOYSA-N	497249	N-[(2,6-dichlorophenyl)methyl]-1-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)-::US11001578, Example 22::US11084809, Example 22::US11198691, Example 22	Plasma kallikrein			 1350							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=497249	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=497249&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365089	459070236							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073044	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4cc(Cl)ccc4C(F)(F)F)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C25H20ClF6N5O/c1-15-9-34-36(11-15)12-16-2-4-17(5-3-16)13-37-14-20(22(35-37)25(30,31)32)23(38)33-10-18-8-19(26)6-7-21(18)24(27,28)29/h2-9,11,14H,10,12-13H2,1H3,(H,33,38)	JUBFFEWNQIXKCQ-UHFFFAOYSA-N	408699	 N-{[5-chloro-2-(trifluoromethyl)phenyl]methyl}-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide ::US10364238, Example 23::US11001578, Example 23::US11084809, Example 23::US11198691, Example 23	Plasma kallikrein			 1060							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408699	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408699&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365020	406799332							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073046	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4ccc(C)cc4C)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C26H26F3N5O/c1-17-4-9-22(19(3)10-17)12-30-25(35)23-16-34(32-24(23)26(27,28)29)15-21-7-5-20(6-8-21)14-33-13-18(2)11-31-33/h4-11,13,16H,12,14-15H2,1-3H3,(H,30,35)	SJWYCGZDPHPMRJ-UHFFFAOYSA-N	497251	N-[(2,4-dimethylphenyl)methyl]-1-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)-::US11001578, Example 24::US11084809, Example 24::US11198691, Example 24	Plasma kallikrein			 717							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=497251	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=497251&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365032	459070238							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073048	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4c(C)cccc4C)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C26H26F3N5O/c1-17-11-31-33(13-17)14-20-7-9-21(10-8-20)15-34-16-23(24(32-34)26(27,28)29)25(35)30-12-22-18(2)5-4-6-19(22)3/h4-11,13,16H,12,14-15H2,1-3H3,(H,30,35)	GIPNBFUDUIQKSS-UHFFFAOYSA-N	497252	N-[(2,6-dimethylphenyl)methyl]-1-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)-::US11001578, Example 25::US11084809, Example 25::US11198691, Example 25	Plasma kallikrein			 1840							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=497252	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=497252&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365052	459070239							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073050	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4c(C)cc(C)cc4C)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C27H28F3N5O/c1-17-9-19(3)23(20(4)10-17)12-31-26(36)24-16-35(33-25(24)27(28,29)30)15-22-7-5-21(6-8-22)14-34-13-18(2)11-32-34/h5-11,13,16H,12,14-15H2,1-4H3,(H,31,36)	YRBWCDOHOBNJLH-UHFFFAOYSA-N	408705	 1-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)-3-(trifluoromethyl)-N-[(2,4,6- trimethylphenyl)methyl]pyrazole-4-carboxamide::US10364238, Example 26::US11001578, Example 26::US11084809, Example 26::US11198691, Example 26	Plasma kallikrein			 1340							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408705	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408705&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365037	406799338							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073052	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4cccc(F)c4C)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C25H23F4N5O/c1-16-10-31-33(12-16)13-18-6-8-19(9-7-18)14-34-15-21(23(32-34)25(27,28)29)24(35)30-11-20-4-3-5-22(26)17(20)2/h3-10,12,15H,11,13-14H2,1-2H3,(H,30,35)	VMUDSUQWHSSZHZ-UHFFFAOYSA-N	408707	N-[(3-fluoro-2-methylphenyl)methyl]-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide ::US10364238, Example 27::US11001578, Example 27::US11084809, Example 27::US11198691, Example 27	Plasma kallikrein			>10000							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408707	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408707&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365082	406799340							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073054	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4ccc(C)cc4F)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C25H23F4N5O/c1-16-3-8-20(22(26)9-16)11-30-24(35)21-15-34(32-23(21)25(27,28)29)14-19-6-4-18(5-7-19)13-33-12-17(2)10-31-33/h3-10,12,15H,11,13-14H2,1-2H3,(H,30,35)	OAWJOZMRPBQRIM-UHFFFAOYSA-N	408708	N-[(2-fluoro-4-methylphenyl)methyl]-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide ::US10364238, Example 28::US11001578, Example 28::US11084809, Example 28::US11198691, Example 28	Plasma kallikrein			 280							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408708	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408708&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365048	406799341							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073056	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4ncccc4F)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C23H20F4N6O/c1-15-9-30-32(11-15)12-16-4-6-17(7-5-16)13-33-14-18(21(31-33)23(25,26)27)22(34)29-10-20-19(24)3-2-8-28-20/h2-9,11,14H,10,12-13H2,1H3,(H,29,34)	VBWIRJJMHLFZTC-UHFFFAOYSA-N	497256	N-[(3-fluoropyridin-2-yl)methyl]-1-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)-::US11001578, Example 29::US11084809, Example 29::US11198691, Example 29	Plasma kallikrein			 2190							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=497256	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=497256&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365018	459070243							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073058	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4cc(Cl)ccn4)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C23H20ClF3N6O/c1-15-9-30-32(11-15)12-16-2-4-17(5-3-16)13-33-14-20(21(31-33)23(25,26)27)22(34)29-10-19-8-18(24)6-7-28-19/h2-9,11,14H,10,12-13H2,1H3,(H,29,34)	QSGBIRDROIJUJZ-UHFFFAOYSA-N	497257	N-[(4-chloropyridin-2-yl)methyl]-1-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)-::US11001578, Example 30::US11084809, Example 30::US11198691, Example 30	Plasma kallikrein			 915							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=497257	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=497257&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365099	459070244							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073072	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1nccc(OC)c1F	InChI=1S/C26H26FN5O4/c1-35-17-22-20(26(34)29-13-21-25(27)23(36-2)10-11-28-21)16-32(30-22)15-19-8-6-18(7-9-19)14-31-12-4-3-5-24(31)33/h3-12,16H,13-15,17H2,1-2H3,(H,29,34)	KGMPDQIYDKKXRD-UHFFFAOYSA-N	408717	 N-[(3-fluoro-4-methoxypyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin- 1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 41::US10730874, Example 00397::US11001578, Example 41::US11084809, Example 41::US11198691, Example 41::US11352356, Table II.3::US11584735, Example 41 of WO2016/083820	Plasma kallikrein			 3.30							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408717	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408717&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365142	406799348							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073102	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1ccccc1C(F)(F)F	InChI=1S/C27H25F3N4O3/c1-37-18-24-22(26(36)31-14-21-6-2-3-7-23(21)27(28,29)30)17-34(32-24)16-20-11-9-19(10-12-20)15-33-13-5-4-8-25(33)35/h2-13,17H,14-16,18H2,1H3,(H,31,36)	ZLZZEINFXWKIBR-UHFFFAOYSA-N	408742	 3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)-N-{[2- (trifluoromethyl)phenyl]methyl}pyrazole-4-carboxamide::US10364238, Example 63::US11001578, Example 63::US11084809, Example 63::US11198691, Example 63	Plasma kallikrein			 342							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408742	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408742&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365012	406799373							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073104	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(OC)ccc1F	InChI=1S/C27H27FN4O4/c1-35-18-25-23(27(34)29-14-21-13-22(36-2)10-11-24(21)28)17-32(30-25)16-20-8-6-19(7-9-20)15-31-12-4-3-5-26(31)33/h3-13,17H,14-16,18H2,1-2H3,(H,29,34)	NKTZDNHYVJSOOU-UHFFFAOYSA-N	408744	 N-[(2-fluoro-5-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US10364238, Example 64::US11001578, Example 64::US11084809, Example 64::US11198691, Example 64	Plasma kallikrein			 35.2							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408744	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408744&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365036	406799375							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073106	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1ccc(C)cc1F	InChI=1S/C27H27FN4O3/c1-19-6-11-22(24(28)13-19)14-29-27(34)23-17-32(30-25(23)18-35-2)16-21-9-7-20(8-10-21)15-31-12-4-3-5-26(31)33/h3-13,17H,14-16,18H2,1-2H3,(H,29,34)	XRBNFAVKAJTXOR-UHFFFAOYSA-N	408745	 N-[(2-fluoro-4-methylphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 65::US11001578, Example 65::US11084809, Example 65::US11198691, Example 65	Plasma kallikrein			 43.3							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408745	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408745&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365028	406799376							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073108	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(F)ccc(OC)c1F	InChI=1S/C27H26F2N4O4/c1-36-17-23-21(27(35)30-13-20-22(28)10-11-24(37-2)26(20)29)16-33(31-23)15-19-8-6-18(7-9-19)14-32-12-4-3-5-25(32)34/h3-12,16H,13-15,17H2,1-2H3,(H,30,35)	PIYDGHWVVUCTNS-UHFFFAOYSA-N	408746	 N-[(2,6-difluoro-3-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin- 1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US10364238, Example 66::US10730874, Example 00395::US11001578, Example 66::US11084809, Example 66::US11198691, Example 66::US11352356, Table II.1	Plasma kallikrein			 4.60							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408746	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408746&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365096	406799377							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073110	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(Cl)cc(OC)c1	InChI=1S/C27H27ClN4O4/c1-35-18-25-24(27(34)29-14-21-11-22(28)13-23(12-21)36-2)17-32(30-25)16-20-8-6-19(7-9-20)15-31-10-4-3-5-26(31)33/h3-13,17H,14-16,18H2,1-2H3,(H,29,34)	OABPMYGSJQVQPN-UHFFFAOYSA-N	408747	 N-[(3-chloro-5-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 67::US11001578, Example 67::US11084809, Example 67::US11198691, Example 67	Plasma kallikrein			 393							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408747	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408747&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365024	406799378							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073112	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1ccccc1C(F)F	InChI=1S/C27H26F2N4O3/c1-36-18-24-23(27(35)30-14-21-6-2-3-7-22(21)26(28)29)17-33(31-24)16-20-11-9-19(10-12-20)15-32-13-5-4-8-25(32)34/h2-13,17,26H,14-16,18H2,1H3,(H,30,35)	GEFVFTYILHWIGO-UHFFFAOYSA-N	408749	 N-{[2-(difluoromethyl)phenyl]methyl}-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 68::US11001578, Example 68::US11084809, Example 68::US11198691, Example 68	Plasma kallikrein			 81.1							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408749	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408749&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365084	406799380							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073114	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cccc(OC)c1C(F)F	InChI=1S/C28H28F2N4O4/c1-37-18-23-22(28(36)31-14-21-6-5-7-24(38-2)26(21)27(29)30)17-34(32-23)16-20-11-9-19(10-12-20)15-33-13-4-3-8-25(33)35/h3-13,17,27H,14-16,18H2,1-2H3,(H,31,36)	PTXDNBVAMADNIH-UHFFFAOYSA-N	408750	N-{[2-(difluoromethyl)-3-methoxyphenyl]methyl}-3-(methoxymethyl)-1-({4-[(2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 69::US11001578, Example 69::US11084809, Example 69::US11198691, Example 69	Plasma kallikrein			 16.8							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408750	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408750&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365140	406799381							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073116	Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(F)cccc1C(F)(F)F	InChI=1S/C25H21F4N5O2/c26-21-5-3-4-20(25(27,28)29)18(21)12-31-24(36)19-15-34(32-23(19)30)14-17-9-7-16(8-10-17)13-33-11-2-1-6-22(33)35/h1-11,15H,12-14H2,(H2,30,32)(H,31,36)	ZRDGSEIHHBOARU-UHFFFAOYSA-N	408753	 3-amino-N-{[2-fluoro-6-(trifluoromethyl)phenyl]methyl}-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 70::US11001578, Example 70::US11084809, Example 70::US11198691, Example 70	Plasma kallikrein			 26.7							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408753	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408753&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365067	406799384							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073118	COc1cccc(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2NC(C)=O)c1F	InChI=1S/C27H26FN5O4/c1-18(34)30-26-22(27(36)29-14-21-6-5-7-23(37-2)25(21)28)17-33(31-26)16-20-11-9-19(10-12-20)15-32-13-4-3-8-24(32)35/h3-13,17H,14-16H2,1-2H3,(H,29,36)(H,30,31,34)	JJEXYMJFQVLENB-UHFFFAOYSA-N	408755	 3-acetamido-N-[(2-fluoro-3-methoxyphenyl)methyl]-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 71::US11001578, Example 71::US11084809, Example 71::US11198691, Example 71	Plasma kallikrein			 300							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408755	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408755&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365125	406799386							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073120	COc1cccc(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2N(C)C(C)=O)c1F	InChI=1S/C28H28FN5O4/c1-19(35)32(2)27-23(28(37)30-15-22-7-6-8-24(38-3)26(22)29)18-34(31-27)17-21-12-10-20(11-13-21)16-33-14-5-4-9-25(33)36/h4-14,18H,15-17H2,1-3H3,(H,30,37)	QWMQDDAFZVHSLS-UHFFFAOYSA-N	408756	N-[(2-fluoro-3-methoxyphenyl)methyl]-3-(N-methylacetamido)-1-({4-[(2-oxopyridin- 1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 72::US11001578, Example 72::US11084809, Example 72::US11198691, Example 72	Plasma kallikrein			 6610							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408756	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408756&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365011	406799387							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073122	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(F)ccc(Cl)c1F	InChI=1S/C26H23ClF2N4O3/c1-36-16-23-20(26(35)30-12-19-22(28)10-9-21(27)25(19)29)15-33(31-23)14-18-7-5-17(6-8-18)13-32-11-3-2-4-24(32)34/h2-11,15H,12-14,16H2,1H3,(H,30,35)	ZHIGUNZKTJKAFE-UHFFFAOYSA-N	408757	 N-[(3-chloro-2,6-difluorophenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 73::US11001578, Example 73::US11084809, Example 73::US11198691, Example 73	Plasma kallikrein			 120							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408757	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408757&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365124	406799388							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073124	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(Cl)ccc1C#N	InChI=1S/C27H24ClN5O3/c1-36-18-25-24(27(35)30-14-22-12-23(28)10-9-21(22)13-29)17-33(31-25)16-20-7-5-19(6-8-20)15-32-11-3-2-4-26(32)34/h2-12,17H,14-16,18H2,1H3,(H,30,35)	AQJYHYPGWCFTGU-UHFFFAOYSA-N	408759	N-[(5-chloro-2-cyanophenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 76::US11001578, Example 76::US11084809, Example 76::US11198691, Example 76	Plasma kallikrein			 28.3							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408759	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408759&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365097	406799390							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073126	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(F)c(OC)ccc1C#N	InChI=1S/C28H26FN5O4/c1-37-18-24-23(28(36)31-14-22-21(13-30)10-11-25(38-2)27(22)29)17-34(32-24)16-20-8-6-19(7-9-20)15-33-12-4-3-5-26(33)35/h3-12,17H,14-16,18H2,1-2H3,(H,31,36)	SPXOTFDBWDBJRN-UHFFFAOYSA-N	408768	N-[(6-cyano-2-fluoro-3-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-::US10364238, Example 77::US10730874, Example 00398::US11001578, Example 77::US11084809, Example 77::US11198691, Example 77::US11352356, Table II.4	Plasma kallikrein			 0.600							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408768	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408768&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365006	406799399							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073128	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cccc(OC)c1C(F)(F)F	InChI=1S/C28H27F3N4O4/c1-38-18-23-22(27(37)32-14-21-6-5-7-24(39-2)26(21)28(29,30)31)17-35(33-23)16-20-11-9-19(10-12-20)15-34-13-4-3-8-25(34)36/h3-13,17H,14-16,18H2,1-2H3,(H,32,37)	LSXBZEBSXFDZEZ-UHFFFAOYSA-N	408769	 N-{[3-methoxy-2-(trifluoromethyl)phenyl]methyl}-3-(methoxymethyl)-1-({4-[(2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 78::US11001578, Example 78::US11084809, Example 78::US11198691, Example 78	Plasma kallikrein			 612							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408769	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408769&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365105	406799400							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073130	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(OC)ccc1C(F)(F)F	InChI=1S/C28H27F3N4O4/c1-38-18-25-23(27(37)32-14-21-13-22(39-2)10-11-24(21)28(29,30)31)17-35(33-25)16-20-8-6-19(7-9-20)15-34-12-4-3-5-26(34)36/h3-13,17H,14-16,18H2,1-2H3,(H,32,37)	FKGBWMYRUOPIHY-UHFFFAOYSA-N	408770	 N-{[5-methoxy-2-(trifluoromethyl)phenyl]methyl}-3-(methoxymethyl)-1-({4-[(2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 79::US11001578, Example 79::US11084809, Example 79::US11198691, Example 79	Plasma kallikrein			 14.7							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408770	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408770&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365060	406799401							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073132	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(F)cccc1C(F)F	InChI=1S/C27H25F3N4O3/c1-37-17-24-22(27(36)31-13-21-20(26(29)30)5-4-6-23(21)28)16-34(32-24)15-19-10-8-18(9-11-19)14-33-12-3-2-7-25(33)35/h2-12,16,26H,13-15,17H2,1H3,(H,31,36)	BZFADXUGNHDNKB-UHFFFAOYSA-N	408772	 N-{[2-(difluoromethyl)-6-fluorophenyl]methyl}-3-(methoxymethyl)-1-({4-[(2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 80::US11001578, Example 80::US11084809, Example 80::US11198691, Example 80	Plasma kallikrein			 20.4							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408772	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408772&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365145	406799403							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073134	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(OC)ccc1C(F)F	InChI=1S/C28H28F2N4O4/c1-37-18-25-24(28(36)31-14-21-13-22(38-2)10-11-23(21)27(29)30)17-34(32-25)16-20-8-6-19(7-9-20)15-33-12-4-3-5-26(33)35/h3-13,17,27H,14-16,18H2,1-2H3,(H,31,36)	IBBPTWWPBCQANZ-UHFFFAOYSA-N	408773	 N-{[2-(difluoromethyl)-5-methoxyphenyl]methyl}-3-(methoxymethyl)-1-({4-[(2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 81::US11001578, Example 81::US11084809, Example 81::US11198691, Example 81	Plasma kallikrein			 2.30							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408773	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408773&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365102	406799404							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073136	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(F)ccc(OC)c1C(F)F	InChI=1S/C28H27F3N4O4/c1-38-17-23-21(28(37)32-13-20-22(29)10-11-24(39-2)26(20)27(30)31)16-35(33-23)15-19-8-6-18(7-9-19)14-34-12-4-3-5-25(34)36/h3-12,16,27H,13-15,17H2,1-2H3,(H,32,37)	FDDKVGBGYLYHDV-UHFFFAOYSA-N	408775	 N-{[2-(difluoromethyl)-6-fluoro-3-methoxyphenyl]methyl}-3-(methoxymethyl)-1-({4- [(2-oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 83::US11001578, Example 83::US11084809, Example 83::US11198691, Example 83	Plasma kallikrein			 6.80							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408775	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408775&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365138	406799406							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073138	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(F)cccc1C(N)=O	InChI=1S/C27H26FN5O4/c1-37-17-24-22(27(36)30-13-21-20(26(29)35)5-4-6-23(21)28)16-33(31-24)15-19-10-8-18(9-11-19)14-32-12-3-2-7-25(32)34/h2-12,16H,13-15,17H2,1H3,(H2,29,35)(H,30,36)	PQVWIESRTSEZPB-UHFFFAOYSA-N	408778	 N-[(2-carbamoyl-6-fluorophenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 85::US11001578, Example 85::US11084809, Example 85::US11198691, Example 85	Plasma kallikrein			 79.2							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408778	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408778&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365001	406799409							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073140	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(OC)ccc1C(N)=O	InChI=1S/C28H29N5O5/c1-37-18-25-24(28(36)30-14-21-13-22(38-2)10-11-23(21)27(29)35)17-33(31-25)16-20-8-6-19(7-9-20)15-32-12-4-3-5-26(32)34/h3-13,17H,14-16,18H2,1-2H3,(H2,29,35)(H,30,36)	VTFAEOJNECOMFY-UHFFFAOYSA-N	408779	N-[(2-carbamoyl-5-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin- 1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 86::US11001578, Example 86::US11084809, Example 86::US11198691, Example 86	Plasma kallikrein			 8.70							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408779	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408779&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365131	406799410							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073142	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1ccccc1C(O)=O	InChI=1S/C27H26N4O5/c1-36-18-24-23(26(33)28-14-21-6-2-3-7-22(21)27(34)35)17-31(29-24)16-20-11-9-19(10-12-20)15-30-13-5-4-8-25(30)32/h2-13,17H,14-16,18H2,1H3,(H,28,33)(H,34,35)	MCBMZYKZJXHUKZ-UHFFFAOYSA-N	408780	 2-({[3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)pyrazol-4- yl]formamido}methyl)benzoic acid ::US10364238, Example 87::US11001578, Example 87::US11084809, Example 87::US11198691, Example 87	Plasma kallikrein			>10000							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408780	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408780&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365095	406799411							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073144	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cccc(OC(F)F)c1F	InChI=1S/C27H25F3N4O4/c1-37-17-22-21(26(36)31-13-20-5-4-6-23(25(20)28)38-27(29)30)16-34(32-22)15-19-10-8-18(9-11-19)14-33-12-3-2-7-24(33)35/h2-12,16,27H,13-15,17H2,1H3,(H,31,36)	CMNOMOOEIDZWNA-UHFFFAOYSA-N	408781	 N-{[3-(difluoromethoxy)-2-fluorophenyl]methyl}-3-(methoxymethyl)-1-({4-[(2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 90::US11001578, Example 90::US11084809, Example 90::US11198691, Example 90	Plasma kallikrein			 154							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408781	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408781&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365051	406799412							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035601	COc1cccc(CNC(=O)c2cn(Cc3ccc(Cn4cc(C)cn4)cc3)nc2C(F)(F)F)c1F	InChI=1S/C25H23F4N5O2/c1-16-10-31-33(12-16)13-17-6-8-18(9-7-17)14-34-15-20(23(32-34)25(27,28)29)24(35)30-11-19-4-3-5-21(36-2)22(19)26/h3-10,12,15H,11,13-14H2,1-2H3,(H,30,35)	QZMZZOCEJPCAIJ-UHFFFAOYSA-N	408668	N-[(2-fluoro-3-methoxyphenyl)methyl]-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide::US10364238, Example 4::US11001578, Example 4::US11084809, Example 4::US11198691, Example 4	Plasma kallikrein			 136							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408668	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408668&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365107	406799302							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035603	COc1cccc(CNC(=O)c2cn(Cc3ccc(Cn4cc(C)cn4)cc3)nc2C(F)(F)F)c1	InChI=1S/C25H24F3N5O2/c1-17-11-30-32(13-17)14-18-6-8-19(9-7-18)15-33-16-22(23(31-33)25(26,27)28)24(34)29-12-20-4-3-5-21(10-20)35-2/h3-11,13,16H,12,14-15H2,1-2H3,(H,29,34)	JLGLPBSVAUHGOI-UHFFFAOYSA-N	408671	N-[(3-methoxyphenyl)methyl]-1-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)-3- (trifluoromethyl)pyrazole-4-carboxamide ::US10364238, Example 5::US11001578, Example 5::US11084809, Example 5::US11198691, Example 5	Plasma kallikrein			 364							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408671	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408671&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365083	406799304							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035605	CCOc1cccc(CNC(=O)c2cn(Cc3ccc(Cn4cc(C)cn4)cc3)nc2C(F)(F)F)c1	InChI=1S/C26H26F3N5O2/c1-3-36-22-6-4-5-21(11-22)13-30-25(35)23-17-34(32-24(23)26(27,28)29)16-20-9-7-19(8-10-20)15-33-14-18(2)12-31-33/h4-12,14,17H,3,13,15-16H2,1-2H3,(H,30,35)	UJVJDICDWMSCMO-UHFFFAOYSA-N	408672	N-[(3-ethoxyphenyl)methyl]-1-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)-3- (trifluoromethyl)pyrazole-4-carboxamide::US10364238, Example 6::US11001578, Example 6::US11084809, Example 6::US11198691, Example 6	Plasma kallikrein			 2360							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408672	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408672&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365014	406799305							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035607	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4cccc(OC(F)(F)F)c4)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C25H21F6N5O2/c1-16-10-33-35(12-16)13-17-5-7-18(8-6-17)14-36-15-21(22(34-36)24(26,27)28)23(37)32-11-19-3-2-4-20(9-19)38-25(29,30)31/h2-10,12,15H,11,13-14H2,1H3,(H,32,37)	IWQRRWVFCUYKBA-UHFFFAOYSA-N	408674	1-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)-N-{[3- (trifluoromethoxy)phenyl]methyl}-3-(trifluoromethyl)pyrazole-4-carboxamide ::US10364238, Example 7::US11001578, Example 7::US11084809, Example 7::US11198691, Example 7	Plasma kallikrein			>10000							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408674	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408674&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365116	406799307							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035609	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4ccc(C)cc4)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C25H24F3N5O/c1-17-3-5-19(6-4-17)12-29-24(34)22-16-33(31-23(22)25(26,27)28)15-21-9-7-20(8-10-21)14-32-13-18(2)11-30-32/h3-11,13,16H,12,14-15H2,1-2H3,(H,29,34)	UWKOAYQJMJZTCL-UHFFFAOYSA-N	497235	N-[(4-methylphenyl)methyl]-1-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)-3-::US11001578, Example 8::US11084809, Example 8::US11198691, Example 8	Plasma kallikrein			 539							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=497235	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=497235&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365038	459070223							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035611	COc1ccc(F)c(CNC(=O)c2cn(Cc3ccc(Cn4cc(C)cn4)cc3)nc2C(F)(F)F)c1	InChI=1S/C25H23F4N5O2/c1-16-10-31-33(12-16)13-17-3-5-18(6-4-17)14-34-15-21(23(32-34)25(27,28)29)24(35)30-11-19-9-20(36-2)7-8-22(19)26/h3-10,12,15H,11,13-14H2,1-2H3,(H,30,35)	HQJUOFQTROTCAB-UHFFFAOYSA-N	408678	N-[(2-fluoro-5-methoxyphenyl)methyl]-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide ::US10364238, Example 9::US11001578, Example 9::US11084809, Example 9::US11198691, Example 9	Plasma kallikrein			 239							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408678	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408678&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365002	406799311							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035613	COc1ccc(CNC(=O)c2cn(Cc3ccc(Cn4cc(C)cn4)cc3)nc2C(F)(F)F)c(OC)c1	InChI=1S/C26H26F3N5O3/c1-17-11-31-33(13-17)14-18-4-6-19(7-5-18)15-34-16-22(24(32-34)26(27,28)29)25(35)30-12-20-8-9-21(36-2)10-23(20)37-3/h4-11,13,16H,12,14-15H2,1-3H3,(H,30,35)	CXDMHDUCUCLAEV-UHFFFAOYSA-N	408681	N-[(2,4-dimethoxyphenyl)methyl]-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide ::US10364238, Example 10::US11001578, Example 10::US11084809, Example 10::US11198691, Example 10	Plasma kallikrein			 1270							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408681	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408681&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365034	406799314							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035615	COc1cc(F)c(CNC(=O)c2cn(Cc3ccc(Cn4cc(C)cn4)cc3)nc2C(F)(F)F)c(F)c1	InChI=1S/C25H22F5N5O2/c1-15-9-32-34(11-15)12-16-3-5-17(6-4-16)13-35-14-20(23(33-35)25(28,29)30)24(36)31-10-19-21(26)7-18(37-2)8-22(19)27/h3-9,11,14H,10,12-13H2,1-2H3,(H,31,36)	HRWXHWAUCMAPKJ-UHFFFAOYSA-N	408683	 N-[(2,6-difluoro-4-methoxyphenyl)methyl]-1-({4-[(4-methylpyrazol-1- yl)methyl]pheny}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide::US10364238, Example 11::US11001578, Example 11::US11084809, Example 11::US11198691, Example 11	Plasma kallikrein			 456							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408683	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408683&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365073	406799316							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035617	COc1ccc(CNC(=O)c2cn(Cc3ccc(Cn4cc(C)cn4)cc3)nc2C(F)(F)F)c(c1)C(F)(F)F	InChI=1S/C26H23F6N5O2/c1-16-10-34-36(12-16)13-17-3-5-18(6-4-17)14-37-15-21(23(35-37)26(30,31)32)24(38)33-11-19-7-8-20(39-2)9-22(19)25(27,28)29/h3-10,12,15H,11,13-14H2,1-2H3,(H,33,38)	UJRPEIINPALAES-UHFFFAOYSA-N	408685	N-{[4-methoxy-2-(trifluoromethyl)phenyl]methyl}-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide ::US10364238, Example 12::US11001578, Example 12::US11084809, Example 12::US11198691, Example 12	Plasma kallikrein			 746							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408685	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408685&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365025	406799318							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035619	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4ccccc4F)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C24H21F4N5O/c1-16-10-30-32(12-16)13-17-6-8-18(9-7-17)14-33-15-20(22(31-33)24(26,27)28)23(34)29-11-19-4-2-3-5-21(19)25/h2-10,12,15H,11,13-14H2,1H3,(H,29,34)	JSPFEVIBZICBMR-UHFFFAOYSA-N	497240	N-[(2,6-difluorophenyl)methyl]-1-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)-::US11001578, Example 13	Plasma kallikrein			 439							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=497240	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=497240&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162369093	459070228							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035621	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4c(F)cccc4Cl)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C24H20ClF4N5O/c1-15-9-31-33(11-15)12-16-5-7-17(8-6-16)13-34-14-19(22(32-34)24(27,28)29)23(35)30-10-18-20(25)3-2-4-21(18)26/h2-9,11,14H,10,12-13H2,1H3,(H,30,35)	UCUUHDDHAAXSSH-UHFFFAOYSA-N	408689	N-[(2-chloro-6-fluorophenyl)methyl]-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide ::US10364238, Example 14::US11001578, Example 14::US11084809, Example 14::US11198691, Example 14	Plasma kallikrein			 514							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408689	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408689&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365058	406799322							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035623	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4c(F)cccc4C(F)(F)F)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C25H20F7N5O/c1-15-9-34-36(11-15)12-16-5-7-17(8-6-16)13-37-14-19(22(35-37)25(30,31)32)23(38)33-10-18-20(24(27,28)29)3-2-4-21(18)26/h2-9,11,14H,10,12-13H2,1H3,(H,33,38)	MRFKCVIKSCVIEK-UHFFFAOYSA-N	408691	N-{[2-fluoro-6-(trifluoromethyl)phenyl]methyl}-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide::US10364238, Example 15::US11001578, Example 15::US11084809, Example 15::US11198691, Example 15	Plasma kallikrein			 219							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408691	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408691&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365041	406799324							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035625	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4c(F)cc(Cl)cc4F)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C24H19ClF5N5O/c1-14-8-32-34(10-14)11-15-2-4-16(5-3-15)12-35-13-19(22(33-35)24(28,29)30)23(36)31-9-18-20(26)6-17(25)7-21(18)27/h2-8,10,13H,9,11-12H2,1H3,(H,31,36)	SXIKFYGPUGSYOC-UHFFFAOYSA-N	408692	N-[(4-chloro-2,6-difluorophenyl)methyl]-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide ::US10364238, Example 16::US11001578, Example 16::US11084809, Example 16::US11198691, Example 16	Plasma kallikrein			 263							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408692	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408692&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365003	406799325							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035627	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4ccc(Cl)cc4F)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C24H20ClF4N5O/c1-15-9-31-33(11-15)12-16-2-4-17(5-3-16)13-34-14-20(22(32-34)24(27,28)29)23(35)30-10-18-6-7-19(25)8-21(18)26/h2-9,11,14H,10,12-13H2,1H3,(H,30,35)	MPXDOEQMYFYSIT-UHFFFAOYSA-N	408693	 N-[(4-chloro-2-fluorophenyl)methyl]-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide ::US10364238, Example 17::US11001578, Example 17::US11084809, Example 17::US11198691, Example 17	Plasma kallikrein			 865							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408693	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408693&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365130	406799326							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035629	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4c(F)ccc(Cl)c4F)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C24H19ClF5N5O/c1-14-8-32-34(10-14)11-15-2-4-16(5-3-15)12-35-13-18(22(33-35)24(28,29)30)23(36)31-9-17-20(26)7-6-19(25)21(17)27/h2-8,10,13H,9,11-12H2,1H3,(H,31,36)	HNSAKACOONQHKG-UHFFFAOYSA-N	408694	N-[(3-chloro-2,6-difluorophenyl)methyl]-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide::US10364238, Example 18::US11001578, Example 18::US11084809, Example 18::US11198691, Example 18	Plasma kallikrein			 373							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408694	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408694&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365160	406799327							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035631	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4cccc(Cl)c4F)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C24H20ClF4N5O/c1-15-9-31-33(11-15)12-16-5-7-17(8-6-16)13-34-14-19(22(32-34)24(27,28)29)23(35)30-10-18-3-2-4-20(25)21(18)26/h2-9,11,14H,10,12-13H2,1H3,(H,30,35)	RFRZBYFPHZMTPR-UHFFFAOYSA-N	408695	N-[(3-chloro-2-fluorophenyl)methyl]-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide::US10364238, Example 19::US11001578, Example 19::US11084809, Example 19::US11198691, Example 19	Plasma kallikrein			 1130							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408695	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408695&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365137	406799328							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035633	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4cc(Cl)ccc4F)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C24H20ClF4N5O/c1-15-9-31-33(11-15)12-16-2-4-17(5-3-16)13-34-14-20(22(32-34)24(27,28)29)23(35)30-10-18-8-19(25)6-7-21(18)26/h2-9,11,14H,10,12-13H2,1H3,(H,30,35)	VQSXMSNNAGMGCB-UHFFFAOYSA-N	408696	N-[(5-chloro-2-fluorophenyl)methyl]-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide ::US10364238, Example 20::US11001578, Example 20::US11084809, Example 20::US11198691, Example 20	Plasma kallikrein			 740							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408696	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408696&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365077	406799329							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035635	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4c(F)c(Cl)ccc4C(F)(F)F)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C25H19ClF7N5O/c1-14-8-35-37(10-14)11-15-2-4-16(5-3-15)12-38-13-18(22(36-38)25(31,32)33)23(39)34-9-17-19(24(28,29)30)6-7-20(26)21(17)27/h2-8,10,13H,9,11-12H2,1H3,(H,34,39)	KVPLENMFVKIMRG-UHFFFAOYSA-N	408697	 N-{[3-chloro-2-fluoro-6-(trifluoromethyl)phenyl]methyl}-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide ::US10364238, Example 21::US11001578, Example 21::US11084809, Example 21::US11198691, Example 21	Plasma kallikrein			 257							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408697	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408697&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365161	406799330							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035637	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4c(Cl)cccc4Cl)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C24H20Cl2F3N5O/c1-15-9-31-33(11-15)12-16-5-7-17(8-6-16)13-34-14-19(22(32-34)24(27,28)29)23(35)30-10-18-20(25)3-2-4-21(18)26/h2-9,11,14H,10,12-13H2,1H3,(H,30,35)	UNJUOXQQTNMQSH-UHFFFAOYSA-N	497249	N-[(2,6-dichlorophenyl)methyl]-1-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)-::US11001578, Example 22::US11084809, Example 22::US11198691, Example 22	Plasma kallikrein			 1350							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=497249	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=497249&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365089	459070236							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035639	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4cc(Cl)ccc4C(F)(F)F)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C25H20ClF6N5O/c1-15-9-34-36(11-15)12-16-2-4-17(5-3-16)13-37-14-20(22(35-37)25(30,31)32)23(38)33-10-18-8-19(26)6-7-21(18)24(27,28)29/h2-9,11,14H,10,12-13H2,1H3,(H,33,38)	JUBFFEWNQIXKCQ-UHFFFAOYSA-N	408699	 N-{[5-chloro-2-(trifluoromethyl)phenyl]methyl}-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide ::US10364238, Example 23::US11001578, Example 23::US11084809, Example 23::US11198691, Example 23	Plasma kallikrein			 1060							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408699	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408699&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365020	406799332							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035641	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4ccc(C)cc4C)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C26H26F3N5O/c1-17-4-9-22(19(3)10-17)12-30-25(35)23-16-34(32-24(23)26(27,28)29)15-21-7-5-20(6-8-21)14-33-13-18(2)11-31-33/h4-11,13,16H,12,14-15H2,1-3H3,(H,30,35)	SJWYCGZDPHPMRJ-UHFFFAOYSA-N	497251	N-[(2,4-dimethylphenyl)methyl]-1-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)-::US11001578, Example 24::US11084809, Example 24::US11198691, Example 24	Plasma kallikrein			 717							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=497251	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=497251&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365032	459070238							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035643	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4c(C)cccc4C)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C26H26F3N5O/c1-17-11-31-33(13-17)14-20-7-9-21(10-8-20)15-34-16-23(24(32-34)26(27,28)29)25(35)30-12-22-18(2)5-4-6-19(22)3/h4-11,13,16H,12,14-15H2,1-3H3,(H,30,35)	GIPNBFUDUIQKSS-UHFFFAOYSA-N	497252	N-[(2,6-dimethylphenyl)methyl]-1-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)-::US11001578, Example 25::US11084809, Example 25::US11198691, Example 25	Plasma kallikrein			 1840							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=497252	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=497252&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365052	459070239							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035645	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4c(C)cc(C)cc4C)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C27H28F3N5O/c1-17-9-19(3)23(20(4)10-17)12-31-26(36)24-16-35(33-25(24)27(28,29)30)15-22-7-5-21(6-8-22)14-34-13-18(2)11-32-34/h5-11,13,16H,12,14-15H2,1-4H3,(H,31,36)	YRBWCDOHOBNJLH-UHFFFAOYSA-N	408705	 1-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)-3-(trifluoromethyl)-N-[(2,4,6- trimethylphenyl)methyl]pyrazole-4-carboxamide::US10364238, Example 26::US11001578, Example 26::US11084809, Example 26::US11198691, Example 26	Plasma kallikrein			 1340							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408705	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408705&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365037	406799338							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035647	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4cccc(F)c4C)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C25H23F4N5O/c1-16-10-31-33(12-16)13-18-6-8-19(9-7-18)14-34-15-21(23(32-34)25(27,28)29)24(35)30-11-20-4-3-5-22(26)17(20)2/h3-10,12,15H,11,13-14H2,1-2H3,(H,30,35)	VMUDSUQWHSSZHZ-UHFFFAOYSA-N	408707	N-[(3-fluoro-2-methylphenyl)methyl]-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide ::US10364238, Example 27::US11001578, Example 27::US11084809, Example 27::US11198691, Example 27	Plasma kallikrein			>10000							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408707	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408707&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365082	406799340							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035649	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4ccc(C)cc4F)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C25H23F4N5O/c1-16-3-8-20(22(26)9-16)11-30-24(35)21-15-34(32-23(21)25(27,28)29)14-19-6-4-18(5-7-19)13-33-12-17(2)10-31-33/h3-10,12,15H,11,13-14H2,1-2H3,(H,30,35)	OAWJOZMRPBQRIM-UHFFFAOYSA-N	408708	N-[(2-fluoro-4-methylphenyl)methyl]-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide ::US10364238, Example 28::US11001578, Example 28::US11084809, Example 28::US11198691, Example 28	Plasma kallikrein			 280							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408708	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408708&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365048	406799341							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035651	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4ncccc4F)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C23H20F4N6O/c1-15-9-30-32(11-15)12-16-4-6-17(7-5-16)13-33-14-18(21(31-33)23(25,26)27)22(34)29-10-20-19(24)3-2-8-28-20/h2-9,11,14H,10,12-13H2,1H3,(H,29,34)	VBWIRJJMHLFZTC-UHFFFAOYSA-N	497256	N-[(3-fluoropyridin-2-yl)methyl]-1-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)-::US11001578, Example 29::US11084809, Example 29::US11198691, Example 29	Plasma kallikrein			 2190							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=497256	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=497256&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365018	459070243							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035653	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4cc(Cl)ccn4)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C23H20ClF3N6O/c1-15-9-30-32(11-15)12-16-2-4-17(5-3-16)13-33-14-20(21(31-33)23(25,26)27)22(34)29-10-19-8-18(24)6-7-28-19/h2-9,11,14H,10,12-13H2,1H3,(H,29,34)	QSGBIRDROIJUJZ-UHFFFAOYSA-N	497257	N-[(4-chloropyridin-2-yl)methyl]-1-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)-::US11001578, Example 30::US11084809, Example 30::US11198691, Example 30	Plasma kallikrein			 915							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=497257	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=497257&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365099	459070244							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035655	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cnccc1C(F)(F)F	InChI=1S/C26H24F3N5O3/c1-37-17-23-21(25(36)31-13-20-12-30-10-9-22(20)26(27,28)29)16-34(32-23)15-19-7-5-18(6-8-19)14-33-11-3-2-4-24(33)35/h2-12,16H,13-15,17H2,1H3,(H,31,36)	ZHJJZIGZXRDDHP-UHFFFAOYSA-N	408711	3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)-N-{[4- (trifluoromethyl)pyridin-3-yl]methyl}pyrazole-4-carboxamide ::US10364238, Example 31::US10364238, Example 37::US11001578, Example 37::US11084809, Example 37::US11198691, Example 37	Plasma kallikrein			 392							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408711	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408711&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365063	406799344							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035657	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1ccc(C)nc1	InChI=1S/C26H27N5O3/c1-19-6-7-22(13-27-19)14-28-26(33)23-17-31(29-24(23)18-34-2)16-21-10-8-20(9-11-21)15-30-12-4-3-5-25(30)32/h3-13,17H,14-16,18H2,1-2H3,(H,28,33)	IKFHJYIVYYFDCA-UHFFFAOYSA-N	408712	3-(methoxymethyl)-N-[(6-methylpyridin-3-yl)methyl]-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 32::US10364238, Example 39::US11001578, Example 39::US11084809, Example 39::US11198691, Example 39	Plasma kallikrein			 7870							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408712	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408712&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365092	406799345							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035659	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cccnc1C(F)(F)F	InChI=1S/C26H24F3N5O3/c1-37-17-22-21(25(36)31-13-20-5-4-11-30-24(20)26(27,28)29)16-34(32-22)15-19-9-7-18(8-10-19)14-33-12-3-2-6-23(33)35/h2-12,16H,13-15,17H2,1H3,(H,31,36)	ULAOQOFMZICMAA-UHFFFAOYSA-N	408713	 3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)-N-{[2- (trifluoromethyl)pyridin-3-yl]methyl}pyrazole-4-carboxamide::US10364238, Example 36::US11001578, Example 36::US11084809, Example 36::US11198691, Example 36	Plasma kallikrein			 4170							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408713	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408713&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365101	406799346							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035661	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cnccc1C(F)(F)F	InChI=1S/C26H24F3N5O3/c1-37-17-23-21(25(36)31-13-20-12-30-10-9-22(20)26(27,28)29)16-34(32-23)15-19-7-5-18(6-8-19)14-33-11-3-2-4-24(33)35/h2-12,16H,13-15,17H2,1H3,(H,31,36)	ZHJJZIGZXRDDHP-UHFFFAOYSA-N	408711	3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)-N-{[4- (trifluoromethyl)pyridin-3-yl]methyl}pyrazole-4-carboxamide ::US10364238, Example 31::US10364238, Example 37::US11001578, Example 37::US11084809, Example 37::US11198691, Example 37	Plasma kallikrein			 392							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408711	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408711&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365063	406799344							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073074	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1nc(OC)ccc1F	InChI=1S/C26H26FN5O4/c1-35-17-23-20(26(34)28-13-22-21(27)10-11-24(29-22)36-2)16-32(30-23)15-19-8-6-18(7-9-19)14-31-12-4-3-5-25(31)33/h3-12,16H,13-15,17H2,1-2H3,(H,28,34)	KQSCQCAZZHSOOR-UHFFFAOYSA-N	408718	N-[(3-fluoro-6-methoxypyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin- 1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 42::US11001578, Example 42::US11084809, Example 42::US11198691, Example 42	Plasma kallikrein			 831							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408718	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408718&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365159	406799349							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073146	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cccc(OC(F)F)c1	InChI=1S/C27H26F2N4O4/c1-36-18-24-23(26(35)30-14-21-5-4-6-22(13-21)37-27(28)29)17-33(31-24)16-20-10-8-19(9-11-20)15-32-12-3-2-7-25(32)34/h2-13,17,27H,14-16,18H2,1H3,(H,30,35)	ZLXXVTBIWCEPEY-UHFFFAOYSA-N	408782	 N-{[3-(difluoromethoxy)phenyl]methyl}-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 91::US11001578, Example 91::US11084809, Example 91::US11198691, Example 91	Plasma kallikrein			 523							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408782	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408782&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365090	406799413							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073148	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(F)cccc1OC(F)F	InChI=1S/C27H25F3N4O4/c1-37-17-23-21(26(36)31-13-20-22(28)5-4-6-24(20)38-27(29)30)16-34(32-23)15-19-10-8-18(9-11-19)14-33-12-3-2-7-25(33)35/h2-12,16,27H,13-15,17H2,1H3,(H,31,36)	MKZIFUOKFBQCJL-UHFFFAOYSA-N	408783	N-{[2-(difluoromethoxy)-6-fluorophenyl]methyl}-3-(methoxymethyl)-1-({4-[(2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 92::US11001578, Example 92::US11084809, Example 92::US11198691, Example 92	Plasma kallikrein			 16.0							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408783	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408783&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365108	406799414							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073150	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(F)ccc1F	InChI=1S/C26H24F2N4O3/c1-35-17-24-22(26(34)29-13-20-12-21(27)9-10-23(20)28)16-32(30-24)15-19-7-5-18(6-8-19)14-31-11-3-2-4-25(31)33/h2-12,16H,13-15,17H2,1H3,(H,29,34)	XQLOPLZHIJLNDB-UHFFFAOYSA-N	408784	 N-[(2,5-difluorophenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US10364238, Example 94::US11001578, Example 94::US11084809, Example 94::US11198691, Example 94	Plasma kallikrein			 780							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408784	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408784&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365078	406799415							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073152	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(F)cc(OC)c1	InChI=1S/C27H27FN4O4/c1-35-18-25-24(27(34)29-14-21-11-22(28)13-23(12-21)36-2)17-32(30-25)16-20-8-6-19(7-9-20)15-31-10-4-3-5-26(31)33/h3-13,17H,14-16,18H2,1-2H3,(H,29,34)	AYOVCXXHHIWMRN-UHFFFAOYSA-N	408786	N-[(3-fluoro-5-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 95::US11001578, Example 95::US11084809, Example 95::US11198691, Example 95	Plasma kallikrein			 308							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408786	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408786&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365039	406799417							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073154	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(F)cc(OC)c1F	InChI=1S/C27H26F2N4O4/c1-36-17-23-22(27(35)30-13-20-11-21(28)12-24(37-2)26(20)29)16-33(31-23)15-19-8-6-18(7-9-19)14-32-10-4-3-5-25(32)34/h3-12,16H,13-15,17H2,1-2H3,(H,30,35)	FKXBPOXUNOOPGU-UHFFFAOYSA-N	408787	N-[(2,5-difluoro-3-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin- 1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 96::US11001578, Example 96::US11084809, Example 96::US11198691, Example 96	Plasma kallikrein			 75.0							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408787	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408787&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365093	406799418							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073156	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(C)cccc1F	InChI=1S/C27H27FN4O3/c1-19-6-5-7-24(28)22(19)14-29-27(34)23-17-32(30-25(23)18-35-2)16-21-11-9-20(10-12-21)15-31-13-4-3-8-26(31)33/h3-13,17H,14-16,18H2,1-2H3,(H,29,34)	NLVINHRIZCLAQG-UHFFFAOYSA-N	408788	 N-[(2-fluoro-6-methylphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US10364238, Example 97::US11001578, Example 97::US11084809, Example 97::US11198691, Example 97	Plasma kallikrein			 153							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408788	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408788&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365111	406799419							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073158	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(Cl)ccc(OC)c1F	InChI=1S/C27H26ClFN4O4/c1-36-17-23-21(27(35)30-13-20-22(28)10-11-24(37-2)26(20)29)16-33(31-23)15-19-8-6-18(7-9-19)14-32-12-4-3-5-25(32)34/h3-12,16H,13-15,17H2,1-2H3,(H,30,35)	AJVITEJNDAKYPL-UHFFFAOYSA-N	497307	N-[(6-chloro-2-fluoro-3-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-::US11001578, Example 99::US11084809, Example 99::US11198691, Example 99	Plasma kallikrein			 6.40							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=497307	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=497307&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365144	459070294							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073160	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cccc(O)c1F	InChI=1S/C26H25FN4O4/c1-35-17-22-21(26(34)28-13-20-5-4-6-23(32)25(20)27)16-31(29-22)15-19-10-8-18(9-11-19)14-30-12-3-2-7-24(30)33/h2-12,16,32H,13-15,17H2,1H3,(H,28,34)	JFAWWGDJBCGIDJ-UHFFFAOYSA-N	408790	N-[(2-fluoro-3-hydroxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 129::US11001578, Example 129::US11084809, Example 129::US11198691, Example 129	Plasma kallikrein			 437							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408790	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408790&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365133	406799421							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073162	Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cccc(O)c1F	InChI=1S/C24H22FN5O3/c25-22-18(4-3-5-20(22)31)12-27-24(33)19-15-30(28-23(19)26)14-17-9-7-16(8-10-17)13-29-11-2-1-6-21(29)32/h1-11,15,31H,12-14H2,(H2,26,28)(H,27,33)	OOXKEXDZGXUAST-UHFFFAOYSA-N	408792	 3-amino-N-[(2-fluoro-3-hydroxyphenyl)methyl]-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 130::US11001578, Example 130::US11084809, Example 130::US11198691, Example 130	Plasma kallikrein			 174							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408792	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408792&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365044	406799423							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073164	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1ccccc1C(=O)OC	InChI=1S/C28H28N4O5/c1-36-19-25-24(27(34)29-15-22-7-3-4-8-23(22)28(35)37-2)18-32(30-25)17-21-12-10-20(11-13-21)16-31-14-6-5-9-26(31)33/h3-14,18H,15-17,19H2,1-2H3,(H,29,34)	CLMIQCGDYIVGMD-UHFFFAOYSA-N	408793	 methyl 2-({[3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazol-4-yl]formamido}methyl)benzoate::US10364238, Example 131::US11001578, Example 131::US11084809, Example 131::US11198691, Example 131	Plasma kallikrein			 1510							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408793	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408793&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364999	406799424							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073166	CCc1cccc(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2COC)c1F	InChI=1S/C28H29FN4O3/c1-3-22-7-6-8-23(27(22)29)15-30-28(35)24-18-33(31-25(24)19-36-2)17-21-12-10-20(11-13-21)16-32-14-5-4-9-26(32)34/h4-14,18H,3,15-17,19H2,1-2H3,(H,30,35)	TVACIVBKATZGQV-UHFFFAOYSA-N	408794	 N-[(3-ethyl-2-fluorophenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 132::US11001578, Example 132::US11084809, Example 132::US11198691, Example 132	Plasma kallikrein			 135							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408794	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408794&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365023	406799425							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073168	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cccc(OC)c1	InChI=1S/C27H28N4O4/c1-34-19-25-24(27(33)28-15-22-6-5-7-23(14-22)35-2)18-31(29-25)17-21-11-9-20(10-12-21)16-30-13-4-3-8-26(30)32/h3-14,18H,15-17,19H2,1-2H3,(H,28,33)	YDHZFMPDUQUAJM-UHFFFAOYSA-N	408795	 3-(methoxymethyl)-N-[(3-methoxyphenyl)methyl]-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 133::US11001578, Example 133::US11084809, Example 133::US11198691, Example 133	Plasma kallikrein			 90.2							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408795	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408795&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365129	406799426							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073170	COCc1nn(Cc2ccc(Cn3ccncc3=O)cc2)cc1C(=O)NCc1cccc(OC)c1F	InChI=1S/C26H26FN5O4/c1-35-17-22-21(26(34)29-12-20-4-3-5-23(36-2)25(20)27)16-32(30-22)15-19-8-6-18(7-9-19)14-31-11-10-28-13-24(31)33/h3-11,13,16H,12,14-15,17H2,1-2H3,(H,29,34)	QNPXQCIYWHCURP-UHFFFAOYSA-N	408796	 N-[(2-fluoro-3-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyrazin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 104::US11001578, Example 104::US11084809, Example 104::US11198691, Example 104	Plasma kallikrein			 691							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408796	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408796&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365146	406799427							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073172	COCc1nn(Cc2ccc(Cn3ccc(C)cc3=O)cc2)cc1C(=O)NCc1c(F)ccc(OC)c1F	InChI=1S/C28H28F2N4O4/c1-18-10-11-33(26(35)12-18)14-19-4-6-20(7-5-19)15-34-16-22(24(32-34)17-37-2)28(36)31-13-21-23(29)8-9-25(38-3)27(21)30/h4-12,16H,13-15,17H2,1-3H3,(H,31,36)	BKTJDPOLKWOBHW-UHFFFAOYSA-N	408797	N-[(2,6-difluoro-3-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(4-methyl-2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US10364238, Example 106::US11001578, Example 106::US11084809, Example 106::US11198691, Example 106	Plasma kallikrein			 140							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408797	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408797&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365091	406799428							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073174	COCc1nn(Cc2ccc(Cn3cc(F)ccc3=O)cc2)cc1C(=O)NCc1c(F)ccc(OC)c1F	InChI=1S/C27H25F3N4O4/c1-37-16-23-21(27(36)31-11-20-22(29)8-9-24(38-2)26(20)30)15-34(32-23)13-18-5-3-17(4-6-18)12-33-14-19(28)7-10-25(33)35/h3-10,14-15H,11-13,16H2,1-2H3,(H,31,36)	JRSJFSJQRZMHDN-UHFFFAOYSA-N	408798	 N-[(2,6-difluoro-3-methoxyphenyl)methyl]-1-({4-[(5-fluoro-2-oxopyridin-1- yl)methyl]phenyl}methyl)-3-(methoxymethyl)pyrazole-4-carboxamide::US10364238, Example 108::US11001578, Example 108::US11084809, Example 108::US11198691, Example 108	Plasma kallikrein			 5.50							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408798	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408798&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365114	406799429							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073176	CCOc1ccn(Cc2ccc(Cn3cc(C(=O)NCc4c(F)ccc(OC)c4F)c(COC)n3)cc2)c(=O)c1	InChI=1S/C29H30F2N4O5/c1-4-40-21-11-12-34(27(36)13-21)15-19-5-7-20(8-6-19)16-35-17-23(25(33-35)18-38-2)29(37)32-14-22-24(30)9-10-26(39-3)28(22)31/h5-13,17H,4,14-16,18H2,1-3H3,(H,32,37)	MMGSTVOIQROITG-UHFFFAOYSA-N	408799	N-[(2,6-difluoro-3-methoxyphenyl)methyl]-1-({4-[(4-ethoxy-2-oxopyridin-1- yl)methyl]phenyl}methyl)-3-(methoxymethyl)pyrazole-4-carboxamide ::US10364238, Example 109::US11001578, Example 109::US11084809, Example 109::US11198691, Example 109	Plasma kallikrein			 2980							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408799	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408799&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364997	406799430							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073178	COc1cccc(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)c(C)n2)c1F	InChI=1S/C26H25FN4O3/c1-18-29-22(26(33)28-14-21-6-5-7-23(34-2)25(21)27)17-31(18)16-20-11-9-19(10-12-20)15-30-13-4-3-8-24(30)32/h3-13,17H,14-16H2,1-2H3,(H,28,33)	XCBLTBHUJNNESG-UHFFFAOYSA-N	408801	 N-[(2-fluoro-3-methoxyphenyl)methyl]-2-methyl-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)imidazole-4-carboxamide ::US10364238, Example 121::US11001578, Example 121::US11084809, Example 121::US11198691, Example 121	Plasma kallikrein			 43.9							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408801	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408801&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365087	406799432							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073180	COc1cccc(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)c(n2)C(F)(F)F)c1F	InChI=1S/C26H22F4N4O3/c1-37-21-6-4-5-19(23(21)27)13-31-24(36)20-16-34(25(32-20)26(28,29)30)15-18-10-8-17(9-11-18)14-33-12-3-2-7-22(33)35/h2-12,16H,13-15H2,1H3,(H,31,36)	UZZGYTADFHNIGM-UHFFFAOYSA-N	408803	 N-[(2-fluoro-3-methoxyphenyl)methyl]-1-({4-[(2-oxopyrldin-1- yl)methyl]phenyl}methyl)-2-(trifluoromethyl)imidazole-4-carboxamide ::US10364238, Example 124::US11001578, Example 124::US11084809, Example 124::US11198691, Example 124	Plasma kallikrein			 191							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408803	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408803&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365057	406799434							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073182	COc1cccc(CNC(=O)c2cn(Cc3ccc(nc3)N3CCCC3)nc2C(F)(F)F)c1F	InChI=1S/C23H23F4N5O2/c1-34-18-6-4-5-16(20(18)24)12-29-22(33)17-14-32(30-21(17)23(25,26)27)13-15-7-8-19(28-11-15)31-9-2-3-10-31/h4-8,11,14H,2-3,9-10,12-13H2,1H3,(H,29,33)	CWABZPWKGAMQLS-UHFFFAOYSA-N	408804	N-[(2-fluoro-3-methoxyphenyl)methyl]-1-{[6-(pyrrolidin-1-yl)pyridin-3-yl]methyl}-3- (trifluoromethyl)pyrazole-4-carboxamide::US10364238, Example 126::US11001578, Example 126::US11084809, Example 126::US11180484, Reference Example G	Plasma kallikrein			 742							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408804	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408804&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365050	406799435							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073184	CN1CC(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2N)Oc2cc(Cl)ccc12	InChI=1S/C27H27ClN6O3/c1-32-16-21(37-24-12-20(28)9-10-23(24)32)13-30-27(36)22-17-34(31-26(22)29)15-19-7-5-18(6-8-19)14-33-11-3-2-4-25(33)35/h2-12,17,21H,13-16H2,1H3,(H2,29,31)(H,30,36)	BZQHROALKROIIJ-UHFFFAOYSA-N	408805	 3-amino-N-[(7-chloro-4-methyl-2,3-dihydro-1,4-benzoxazin-2-yl)methyl]-1-({4-[(2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 139::US11001578, Example 139::US11084809, Example 139::US11198691, Example 139	Plasma kallikrein			 64.7							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408805	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408805&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365007	406799436							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073186	Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCC1CNc2ccc(Cl)cc2O1	InChI=1S/C26H25ClN6O3/c27-19-8-9-22-23(11-19)36-20(12-29-22)13-30-26(35)21-16-33(31-25(21)28)15-18-6-4-17(5-7-18)14-32-10-2-1-3-24(32)34/h1-11,16,20,29H,12-15H2,(H2,28,31)(H,30,35)	PIQXYEUIEZKEKB-UHFFFAOYSA-N	408806	3-amino-N-[(7-chloro-3,4-dihydro-2H-1,4-benzoxazin-2-yl)methyl]-1-({4-[(2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 140::US11001578, Example 140::US11084809, Example 140::US11198691, Example 140	Plasma kallikrein			 10.6							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408806	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408806&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365122	406799437							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035663	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1ccc(C)nc1	InChI=1S/C26H27N5O3/c1-19-6-7-22(13-27-19)14-28-26(33)23-17-31(29-24(23)18-34-2)16-21-10-8-20(9-11-21)15-30-12-4-3-5-25(30)32/h3-13,17H,14-16,18H2,1-2H3,(H,28,33)	IKFHJYIVYYFDCA-UHFFFAOYSA-N	408712	3-(methoxymethyl)-N-[(6-methylpyridin-3-yl)methyl]-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 32::US10364238, Example 39::US11001578, Example 39::US11084809, Example 39::US11198691, Example 39	Plasma kallikrein			 7870							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408712	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408712&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365092	406799345							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035665	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cccc(OC)n1	InChI=1S/C26H27N5O4/c1-34-18-23-22(26(33)27-14-21-6-5-7-24(28-21)35-2)17-31(29-23)16-20-11-9-19(10-12-20)15-30-13-4-3-8-25(30)32/h3-13,17H,14-16,18H2,1-2H3,(H,27,33)	XOCSKLGONWNPHT-UHFFFAOYSA-N	408716	3-(methoxymethyl)-N-[(6-methoxypyridin-2-yl)methyl]-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 40::US11001578, Example 40::US11084809, Example 40::US11198691, Example 40	Plasma kallikrein			 3700							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408716	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408716&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365155	406799347							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035667	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1nccc(OC)c1F	InChI=1S/C26H26FN5O4/c1-35-17-22-20(26(34)29-13-21-25(27)23(36-2)10-11-28-21)16-32(30-22)15-19-8-6-18(7-9-19)14-31-12-4-3-5-24(31)33/h3-12,16H,13-15,17H2,1-2H3,(H,29,34)	KGMPDQIYDKKXRD-UHFFFAOYSA-N	408717	 N-[(3-fluoro-4-methoxypyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin- 1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 41::US10730874, Example 00397::US11001578, Example 41::US11084809, Example 41::US11198691, Example 41::US11352356, Table II.3::US11584735, Example 41 of WO2016/083820	Plasma kallikrein			 3.30							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408717	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408717&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365142	406799348							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035669	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1nc(OC)ccc1F	InChI=1S/C26H26FN5O4/c1-35-17-23-20(26(34)28-13-22-21(27)10-11-24(29-22)36-2)16-32(30-23)15-19-8-6-18(7-9-19)14-31-12-4-3-5-25(31)33/h3-12,16H,13-15,17H2,1-2H3,(H,28,34)	KQSCQCAZZHSOOR-UHFFFAOYSA-N	408718	N-[(3-fluoro-6-methoxypyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin- 1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 42::US11001578, Example 42::US11084809, Example 42::US11198691, Example 42	Plasma kallikrein			 831							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408718	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408718&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365159	406799349							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035671	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1csc2ccc(Cl)cc12	InChI=1S/C28H25ClN4O3S/c1-36-17-25-24(28(35)30-13-21-18-37-26-10-9-22(29)12-23(21)26)16-33(31-25)15-20-7-5-19(6-8-20)14-32-11-3-2-4-27(32)34/h2-12,16,18H,13-15,17H2,1H3,(H,30,35)	TZULTWISCDFBIR-UHFFFAOYSA-N	408719	N-[(5-chloro-1-benzothiophen-3-yl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin- 1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 45::US11001578, Example 45::US11084809, Example 45::US11198691, Example 45	Plasma kallikrein			 144							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408719	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408719&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365070	406799350							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035673	COCc1nn(Cc2ccc(nc2)N2CCCC2)cc1C(=O)NCc1csc2ccc(Cl)cc12	InChI=1S/C25H26ClN5O2S/c1-33-15-22-21(25(32)28-12-18-16-34-23-6-5-19(26)10-20(18)23)14-31(29-22)13-17-4-7-24(27-11-17)30-8-2-3-9-30/h4-7,10-11,14,16H,2-3,8-9,12-13,15H2,1H3,(H,28,32)	WMNGADNOQNFZIE-UHFFFAOYSA-N	408720	N-[(5-chloro-1-benzothiophen-3-yl)methyl]-3-(methoxymethyl)-1-{[6-(pyrrolidin-1-::US10364238, Example 46::US11001578, Example 46::US11084809, Example 46::US11198691, Example 46	Plasma kallikrein			 2400							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408720	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408720&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365148	406799351							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035675	COCc1nn(Cc2ccc(Cn3cc(C)cn3)cc2)cc1C(=O)NCc1csc2ccc(Cl)cc12	InChI=1S/C27H26ClN5O2S/c1-18-10-30-32(12-18)13-19-3-5-20(6-4-19)14-33-15-24(25(31-33)16-35-2)27(34)29-11-21-17-36-26-8-7-22(28)9-23(21)26/h3-10,12,15,17H,11,13-14,16H2,1-2H3,(H,29,34)	OVCXPEFSYYWEMX-UHFFFAOYSA-N	408725	 N-[(5-chloro-1-benzothiophen-3-yl)methyl]-3-(methoxymethyl)-1-({4-[(4- methylpyrazol-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 47::US11001578, Example 47::US11084809, Example 47::US11198691, Example 47	Plasma kallikrein			 753							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408725	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408725&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365059	406799356							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035677	NC(=O)c1ccccc1CNC(=O)c1cn(Cc2ccc(Cn3ccccc3=O)cc2)nc1C1CC1	InChI=1S/C28H27N5O3/c29-27(35)23-6-2-1-5-22(23)15-30-28(36)24-18-33(31-26(24)21-12-13-21)17-20-10-8-19(9-11-20)16-32-14-4-3-7-25(32)34/h1-11,14,18,21H,12-13,15-17H2,(H2,29,35)(H,30,36)	KOYPCAXNSUCYIL-UHFFFAOYSA-N	408726	N-[(2-carbamoylphenyl)methyl]-3-cyclopropyl-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 48::US11001578, Example 48::US11084809, Example 48::US11198691, Example 48	Plasma kallikrein			 647							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408726	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408726&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365021	406799357							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035679	NC(=O)c1cccc(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2C2CC2)c1	InChI=1S/C28H27N5O3/c29-27(35)23-5-3-4-21(14-23)15-30-28(36)24-18-33(31-26(24)22-11-12-22)17-20-9-7-19(8-10-20)16-32-13-2-1-6-25(32)34/h1-10,13-14,18,22H,11-12,15-17H2,(H2,29,35)(H,30,36)	GLBUGHLBAAXCAZ-UHFFFAOYSA-N	408727	 N-[(3-carbamoylphenyl)methyl]-3-cyclopropyl-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide   ::US10364238, Example 49::US11001578, Example 49::US11084809, Example 49::US11198691, Example 49	Plasma kallikrein			 5450							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408727	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408727&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365022	406799358							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035681	NC(=O)c1ccc(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2C2CC2)cc1	InChI=1S/C28H27N5O3/c29-27(35)23-10-8-19(9-11-23)15-30-28(36)24-18-33(31-26(24)22-12-13-22)17-21-6-4-20(5-7-21)16-32-14-2-1-3-25(32)34/h1-11,14,18,22H,12-13,15-17H2,(H2,29,35)(H,30,36)	XDXGOIDNTUZASE-UHFFFAOYSA-N	408730	N-[(4-carbamoylphenyl)methyl]-3-cyclopropyl-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 50::US11001578, Example 50::US11084809, Example 50::US11198691, Example 50	Plasma kallikrein			 1800							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408730	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408730&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365075	406799361							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035683	Fc1cccc(c1CNC(=O)c1cn(Cc2ccc(Cn3ccccc3=O)cc2)nc1C(F)(F)F)C(F)(F)F	InChI=1S/C26H19F7N4O2/c27-21-5-3-4-20(25(28,29)30)18(21)12-34-24(39)19-15-37(35-23(19)26(31,32)33)14-17-9-7-16(8-10-17)13-36-11-2-1-6-22(36)38/h1-11,15H,12-14H2,(H,34,39)	ASCUMAURKSBUPS-UHFFFAOYSA-N	408732	 N-{[2-fluoro-6-(trifluoromethyl)phenyl]methyl}-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide::US10364238, Example 51::US11001578, Example 51::US11084809, Example 51::US11198691, Example 51	Plasma kallikrein			 48.9							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408732	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408732&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365085	406799363							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035685	COc1cccc(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2C2CC2)c1F	InChI=1S/C28H27FN4O3/c1-36-24-6-4-5-22(26(24)29)15-30-28(35)23-18-33(31-27(23)21-12-13-21)17-20-10-8-19(9-11-20)16-32-14-3-2-7-25(32)34/h2-11,14,18,21H,12-13,15-17H2,1H3,(H,30,35)	NFLOZDGNLCLQAJ-UHFFFAOYSA-N	408733	 3-cyclopropyl-N-[(2-fluoro-3-methoxyphenyl)methyl]-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 52::US11001578, Example 52::US11084809, Example 52::US11198691, Example 52	Plasma kallikrein			 23.3							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408733	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408733&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365123	406799364							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035687	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cccc(OC)c1F	InChI=1S/C27H27FN4O4/c1-35-18-23-22(27(34)29-14-21-6-5-7-24(36-2)26(21)28)17-32(30-23)16-20-11-9-19(10-12-20)15-31-13-4-3-8-25(31)33/h3-13,17H,14-16,18H2,1-2H3,(H,29,34)	MLCDWARNPOODOL-UHFFFAOYSA-N	408734	 N-[(2-fluoro-3-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US10364238, Example 53::US11001578, Example 53::US11084809, Example 53::US11198691, Example 53	Plasma kallikrein			 20.2							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408734	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408734&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365056	406799365							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035689	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(OC)ccc(OC)c1F	InChI=1S/C28H29FN4O5/c1-36-18-23-22(28(35)30-14-21-24(37-2)11-12-25(38-3)27(21)29)17-33(31-23)16-20-9-7-19(8-10-20)15-32-13-5-4-6-26(32)34/h4-13,17H,14-16,18H2,1-3H3,(H,30,35)	TVHOOPXMFWZGQK-UHFFFAOYSA-N	408736	 N-[(2-fluoro-3,6-dimethoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin- 1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 54::US11001578, Example 54::US11084809, Example 54::US11198691, Example 54	Plasma kallikrein			 2.10							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408736	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408736&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365119	406799367							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035691	Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1ccc(OC(F)(F)F)cc1	InChI=1S/C25H22F3N5O3/c26-25(27,28)36-20-10-8-17(9-11-20)13-30-24(35)21-16-33(31-23(21)29)15-19-6-4-18(5-7-19)14-32-12-2-1-3-22(32)34/h1-12,16H,13-15H2,(H2,29,31)(H,30,35)	KRHKQKBRWFYZPN-UHFFFAOYSA-N	408737	3-amino-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)-N-{[4- (trifluoromethoxy)phenyl]methyl}pyrazole-4-carboxamide ::US10364238, Example 58::US11001578, Example 58::US11084809, Example 58::US11198691, Example 58	Plasma kallikrein			 5780							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408737	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408737&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365068	406799368							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035693	COc1cccc(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2N(C)C)c1F	InChI=1S/C27H28FN5O3/c1-31(2)26-22(27(35)29-15-21-7-6-8-23(36-3)25(21)28)18-33(30-26)17-20-12-10-19(11-13-20)16-32-14-5-4-9-24(32)34/h4-14,18H,15-17H2,1-3H3,(H,29,35)	OMUPFLKDHHROJU-UHFFFAOYSA-N	408738	 3-(dimethylamino)-N-[(2-fluoro-3-methoxyphenyl)methyl]-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 59::US11001578, Example 59::US11084809, Example 59::US11198691, Example 59	Plasma kallikrein			 73.4							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408738	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408738&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365158	406799369							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035695	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1ccccc1F	InChI=1S/C26H25FN4O3/c1-34-18-24-22(26(33)28-14-21-6-2-3-7-23(21)27)17-31(29-24)16-20-11-9-19(10-12-20)15-30-13-5-4-8-25(30)32/h2-13,17H,14-16,18H2,1H3,(H,28,33)	OMZXAEPYOCEHIS-UHFFFAOYSA-N	408740	N-[(2-fluorophenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 62::US11001578, Example 62::US11084809, Example 62::US11198691, Example 62	Plasma kallikrein			 572							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408740	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408740&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365055	406799371							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035697	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1ccccc1C(F)(F)F	InChI=1S/C27H25F3N4O3/c1-37-18-24-22(26(36)31-14-21-6-2-3-7-23(21)27(28,29)30)17-34(32-24)16-20-11-9-19(10-12-20)15-33-13-5-4-8-25(33)35/h2-13,17H,14-16,18H2,1H3,(H,31,36)	ZLZZEINFXWKIBR-UHFFFAOYSA-N	408742	 3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)-N-{[2- (trifluoromethyl)phenyl]methyl}pyrazole-4-carboxamide::US10364238, Example 63::US11001578, Example 63::US11084809, Example 63::US11198691, Example 63	Plasma kallikrein			 342							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408742	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408742&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365012	406799373							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035699	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(OC)ccc1F	InChI=1S/C27H27FN4O4/c1-35-18-25-23(27(34)29-14-21-13-22(36-2)10-11-24(21)28)17-32(30-25)16-20-8-6-19(7-9-20)15-31-12-4-3-5-26(31)33/h3-13,17H,14-16,18H2,1-2H3,(H,29,34)	NKTZDNHYVJSOOU-UHFFFAOYSA-N	408744	 N-[(2-fluoro-5-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US10364238, Example 64::US11001578, Example 64::US11084809, Example 64::US11198691, Example 64	Plasma kallikrein			 35.2							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408744	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408744&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365036	406799375							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035701	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1ccc(C)cc1F	InChI=1S/C27H27FN4O3/c1-19-6-11-22(24(28)13-19)14-29-27(34)23-17-32(30-25(23)18-35-2)16-21-9-7-20(8-10-21)15-31-12-4-3-5-26(31)33/h3-13,17H,14-16,18H2,1-2H3,(H,29,34)	XRBNFAVKAJTXOR-UHFFFAOYSA-N	408745	 N-[(2-fluoro-4-methylphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 65::US11001578, Example 65::US11084809, Example 65::US11198691, Example 65	Plasma kallikrein			 43.3							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408745	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408745&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365028	406799376							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035703	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(F)ccc(OC)c1F	InChI=1S/C27H26F2N4O4/c1-36-17-23-21(27(35)30-13-20-22(28)10-11-24(37-2)26(20)29)16-33(31-23)15-19-8-6-18(7-9-19)14-32-12-4-3-5-25(32)34/h3-12,16H,13-15,17H2,1-2H3,(H,30,35)	PIYDGHWVVUCTNS-UHFFFAOYSA-N	408746	 N-[(2,6-difluoro-3-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin- 1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US10364238, Example 66::US10730874, Example 00395::US11001578, Example 66::US11084809, Example 66::US11198691, Example 66::US11352356, Table II.1	Plasma kallikrein			 4.60							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408746	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408746&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365096	406799377							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035705	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(Cl)cc(OC)c1	InChI=1S/C27H27ClN4O4/c1-35-18-25-24(27(34)29-14-21-11-22(28)13-23(12-21)36-2)17-32(30-25)16-20-8-6-19(7-9-20)15-31-10-4-3-5-26(31)33/h3-13,17H,14-16,18H2,1-2H3,(H,29,34)	OABPMYGSJQVQPN-UHFFFAOYSA-N	408747	 N-[(3-chloro-5-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 67::US11001578, Example 67::US11084809, Example 67::US11198691, Example 67	Plasma kallikrein			 393							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408747	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408747&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365024	406799378							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035707	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1ccccc1C(F)F	InChI=1S/C27H26F2N4O3/c1-36-18-24-23(27(35)30-14-21-6-2-3-7-22(21)26(28)29)17-33(31-24)16-20-11-9-19(10-12-20)15-32-13-5-4-8-25(32)34/h2-13,17,26H,14-16,18H2,1H3,(H,30,35)	GEFVFTYILHWIGO-UHFFFAOYSA-N	408749	 N-{[2-(difluoromethyl)phenyl]methyl}-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 68::US11001578, Example 68::US11084809, Example 68::US11198691, Example 68	Plasma kallikrein			 81.1							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408749	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408749&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365084	406799380							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035709	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cccc(OC)c1C(F)F	InChI=1S/C28H28F2N4O4/c1-37-18-23-22(28(36)31-14-21-6-5-7-24(38-2)26(21)27(29)30)17-34(32-23)16-20-11-9-19(10-12-20)15-33-13-4-3-8-25(33)35/h3-13,17,27H,14-16,18H2,1-2H3,(H,31,36)	PTXDNBVAMADNIH-UHFFFAOYSA-N	408750	N-{[2-(difluoromethyl)-3-methoxyphenyl]methyl}-3-(methoxymethyl)-1-({4-[(2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 69::US11001578, Example 69::US11084809, Example 69::US11198691, Example 69	Plasma kallikrein			 16.8							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408750	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408750&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365140	406799381							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035711	Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(F)cccc1C(F)(F)F	InChI=1S/C25H21F4N5O2/c26-21-5-3-4-20(25(27,28)29)18(21)12-31-24(36)19-15-34(32-23(19)30)14-17-9-7-16(8-10-17)13-33-11-2-1-6-22(33)35/h1-11,15H,12-14H2,(H2,30,32)(H,31,36)	ZRDGSEIHHBOARU-UHFFFAOYSA-N	408753	 3-amino-N-{[2-fluoro-6-(trifluoromethyl)phenyl]methyl}-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 70::US11001578, Example 70::US11084809, Example 70::US11198691, Example 70	Plasma kallikrein			 26.7							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408753	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408753&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365067	406799384							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035713	COc1cccc(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2NC(C)=O)c1F	InChI=1S/C27H26FN5O4/c1-18(34)30-26-22(27(36)29-14-21-6-5-7-23(37-2)25(21)28)17-33(31-26)16-20-11-9-19(10-12-20)15-32-13-4-3-8-24(32)35/h3-13,17H,14-16H2,1-2H3,(H,29,36)(H,30,31,34)	JJEXYMJFQVLENB-UHFFFAOYSA-N	408755	 3-acetamido-N-[(2-fluoro-3-methoxyphenyl)methyl]-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 71::US11001578, Example 71::US11084809, Example 71::US11198691, Example 71	Plasma kallikrein			 300							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408755	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408755&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365125	406799386							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035715	COc1cccc(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2N(C)C(C)=O)c1F	InChI=1S/C28H28FN5O4/c1-19(35)32(2)27-23(28(37)30-15-22-7-6-8-24(38-3)26(22)29)18-34(31-27)17-21-12-10-20(11-13-21)16-33-14-5-4-9-25(33)36/h4-14,18H,15-17H2,1-3H3,(H,30,37)	QWMQDDAFZVHSLS-UHFFFAOYSA-N	408756	N-[(2-fluoro-3-methoxyphenyl)methyl]-3-(N-methylacetamido)-1-({4-[(2-oxopyridin- 1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 72::US11001578, Example 72::US11084809, Example 72::US11198691, Example 72	Plasma kallikrein			 6610							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408756	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408756&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365011	406799387							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035717	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(F)ccc(Cl)c1F	InChI=1S/C26H23ClF2N4O3/c1-36-16-23-20(26(35)30-12-19-22(28)10-9-21(27)25(19)29)15-33(31-23)14-18-7-5-17(6-8-18)13-32-11-3-2-4-24(32)34/h2-11,15H,12-14,16H2,1H3,(H,30,35)	ZHIGUNZKTJKAFE-UHFFFAOYSA-N	408757	 N-[(3-chloro-2,6-difluorophenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 73::US11001578, Example 73::US11084809, Example 73::US11198691, Example 73	Plasma kallikrein			 120							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408757	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408757&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365124	406799388							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035719	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(Cl)ccc1C#N	InChI=1S/C27H24ClN5O3/c1-36-18-25-24(27(35)30-14-22-12-23(28)10-9-21(22)13-29)17-33(31-25)16-20-7-5-19(6-8-20)15-32-11-3-2-4-26(32)34/h2-12,17H,14-16,18H2,1H3,(H,30,35)	AQJYHYPGWCFTGU-UHFFFAOYSA-N	408759	N-[(5-chloro-2-cyanophenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 76::US11001578, Example 76::US11084809, Example 76::US11198691, Example 76	Plasma kallikrein			 28.3							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408759	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408759&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365097	406799390							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035721	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(F)c(OC)ccc1C#N	InChI=1S/C28H26FN5O4/c1-37-18-24-23(28(36)31-14-22-21(13-30)10-11-25(38-2)27(22)29)17-34(32-24)16-20-8-6-19(7-9-20)15-33-12-4-3-5-26(33)35/h3-12,17H,14-16,18H2,1-2H3,(H,31,36)	SPXOTFDBWDBJRN-UHFFFAOYSA-N	408768	N-[(6-cyano-2-fluoro-3-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-::US10364238, Example 77::US10730874, Example 00398::US11001578, Example 77::US11084809, Example 77::US11198691, Example 77::US11352356, Table II.4	Plasma kallikrein			 0.600							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408768	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408768&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365006	406799399							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035723	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cccc(OC)c1C(F)(F)F	InChI=1S/C28H27F3N4O4/c1-38-18-23-22(27(37)32-14-21-6-5-7-24(39-2)26(21)28(29,30)31)17-35(33-23)16-20-11-9-19(10-12-20)15-34-13-4-3-8-25(34)36/h3-13,17H,14-16,18H2,1-2H3,(H,32,37)	LSXBZEBSXFDZEZ-UHFFFAOYSA-N	408769	 N-{[3-methoxy-2-(trifluoromethyl)phenyl]methyl}-3-(methoxymethyl)-1-({4-[(2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 78::US11001578, Example 78::US11084809, Example 78::US11198691, Example 78	Plasma kallikrein			 612							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408769	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408769&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365105	406799400							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035725	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(OC)ccc1C(F)(F)F	InChI=1S/C28H27F3N4O4/c1-38-18-25-23(27(37)32-14-21-13-22(39-2)10-11-24(21)28(29,30)31)17-35(33-25)16-20-8-6-19(7-9-20)15-34-12-4-3-5-26(34)36/h3-13,17H,14-16,18H2,1-2H3,(H,32,37)	FKGBWMYRUOPIHY-UHFFFAOYSA-N	408770	 N-{[5-methoxy-2-(trifluoromethyl)phenyl]methyl}-3-(methoxymethyl)-1-({4-[(2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 79::US11001578, Example 79::US11084809, Example 79::US11198691, Example 79	Plasma kallikrein			 14.7							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408770	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408770&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365060	406799401							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073076	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1csc2ccc(Cl)cc12	InChI=1S/C28H25ClN4O3S/c1-36-17-25-24(28(35)30-13-21-18-37-26-10-9-22(29)12-23(21)26)16-33(31-25)15-20-7-5-19(6-8-20)14-32-11-3-2-4-27(32)34/h2-12,16,18H,13-15,17H2,1H3,(H,30,35)	TZULTWISCDFBIR-UHFFFAOYSA-N	408719	N-[(5-chloro-1-benzothiophen-3-yl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin- 1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 45::US11001578, Example 45::US11084809, Example 45::US11198691, Example 45	Plasma kallikrein			 144							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408719	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408719&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365070	406799350							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035727	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(F)cccc1C(F)F	InChI=1S/C27H25F3N4O3/c1-37-17-24-22(27(36)31-13-21-20(26(29)30)5-4-6-23(21)28)16-34(32-24)15-19-10-8-18(9-11-19)14-33-12-3-2-7-25(33)35/h2-12,16,26H,13-15,17H2,1H3,(H,31,36)	BZFADXUGNHDNKB-UHFFFAOYSA-N	408772	 N-{[2-(difluoromethyl)-6-fluorophenyl]methyl}-3-(methoxymethyl)-1-({4-[(2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 80::US11001578, Example 80::US11084809, Example 80::US11198691, Example 80	Plasma kallikrein			 20.4							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408772	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408772&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365145	406799403							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035729	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(OC)ccc1C(F)F	InChI=1S/C28H28F2N4O4/c1-37-18-25-24(28(36)31-14-21-13-22(38-2)10-11-23(21)27(29)30)17-34(32-25)16-20-8-6-19(7-9-20)15-33-12-4-3-5-26(33)35/h3-13,17,27H,14-16,18H2,1-2H3,(H,31,36)	IBBPTWWPBCQANZ-UHFFFAOYSA-N	408773	 N-{[2-(difluoromethyl)-5-methoxyphenyl]methyl}-3-(methoxymethyl)-1-({4-[(2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 81::US11001578, Example 81::US11084809, Example 81::US11198691, Example 81	Plasma kallikrein			 2.30							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408773	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408773&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365102	406799404							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035731	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(F)ccc(OC)c1C(F)F	InChI=1S/C28H27F3N4O4/c1-38-17-23-21(28(37)32-13-20-22(29)10-11-24(39-2)26(20)27(30)31)16-35(33-23)15-19-8-6-18(7-9-19)14-34-12-4-3-5-25(34)36/h3-12,16,27H,13-15,17H2,1-2H3,(H,32,37)	FDDKVGBGYLYHDV-UHFFFAOYSA-N	408775	 N-{[2-(difluoromethyl)-6-fluoro-3-methoxyphenyl]methyl}-3-(methoxymethyl)-1-({4- [(2-oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 83::US11001578, Example 83::US11084809, Example 83::US11198691, Example 83	Plasma kallikrein			 6.80							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408775	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408775&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365138	406799406							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035733	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(F)cccc1C(N)=O	InChI=1S/C27H26FN5O4/c1-37-17-24-22(27(36)30-13-21-20(26(29)35)5-4-6-23(21)28)16-33(31-24)15-19-10-8-18(9-11-19)14-32-12-3-2-7-25(32)34/h2-12,16H,13-15,17H2,1H3,(H2,29,35)(H,30,36)	PQVWIESRTSEZPB-UHFFFAOYSA-N	408778	 N-[(2-carbamoyl-6-fluorophenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 85::US11001578, Example 85::US11084809, Example 85::US11198691, Example 85	Plasma kallikrein			 79.2							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408778	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408778&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365001	406799409							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035735	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(OC)ccc1C(N)=O	InChI=1S/C28H29N5O5/c1-37-18-25-24(28(36)30-14-21-13-22(38-2)10-11-23(21)27(29)35)17-33(31-25)16-20-8-6-19(7-9-20)15-32-12-4-3-5-26(32)34/h3-13,17H,14-16,18H2,1-2H3,(H2,29,35)(H,30,36)	VTFAEOJNECOMFY-UHFFFAOYSA-N	408779	N-[(2-carbamoyl-5-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin- 1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 86::US11001578, Example 86::US11084809, Example 86::US11198691, Example 86	Plasma kallikrein			 8.70							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408779	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408779&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365131	406799410							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035737	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1ccccc1C(O)=O	InChI=1S/C27H26N4O5/c1-36-18-24-23(26(33)28-14-21-6-2-3-7-22(21)27(34)35)17-31(29-24)16-20-11-9-19(10-12-20)15-30-13-5-4-8-25(30)32/h2-13,17H,14-16,18H2,1H3,(H,28,33)(H,34,35)	MCBMZYKZJXHUKZ-UHFFFAOYSA-N	408780	 2-({[3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)pyrazol-4- yl]formamido}methyl)benzoic acid ::US10364238, Example 87::US11001578, Example 87::US11084809, Example 87::US11198691, Example 87	Plasma kallikrein			>10000							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408780	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408780&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365095	406799411							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035739	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cccc(OC(F)F)c1F	InChI=1S/C27H25F3N4O4/c1-37-17-22-21(26(36)31-13-20-5-4-6-23(25(20)28)38-27(29)30)16-34(32-22)15-19-10-8-18(9-11-19)14-33-12-3-2-7-24(33)35/h2-12,16,27H,13-15,17H2,1H3,(H,31,36)	CMNOMOOEIDZWNA-UHFFFAOYSA-N	408781	 N-{[3-(difluoromethoxy)-2-fluorophenyl]methyl}-3-(methoxymethyl)-1-({4-[(2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 90::US11001578, Example 90::US11084809, Example 90::US11198691, Example 90	Plasma kallikrein			 154							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408781	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408781&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365051	406799412							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035741	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cccc(OC(F)F)c1	InChI=1S/C27H26F2N4O4/c1-36-18-24-23(26(35)30-14-21-5-4-6-22(13-21)37-27(28)29)17-33(31-24)16-20-10-8-19(9-11-20)15-32-12-3-2-7-25(32)34/h2-13,17,27H,14-16,18H2,1H3,(H,30,35)	ZLXXVTBIWCEPEY-UHFFFAOYSA-N	408782	 N-{[3-(difluoromethoxy)phenyl]methyl}-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 91::US11001578, Example 91::US11084809, Example 91::US11198691, Example 91	Plasma kallikrein			 523							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408782	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408782&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365090	406799413							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035743	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(F)cccc1OC(F)F	InChI=1S/C27H25F3N4O4/c1-37-17-23-21(26(36)31-13-20-22(28)5-4-6-24(20)38-27(29)30)16-34(32-23)15-19-10-8-18(9-11-19)14-33-12-3-2-7-25(33)35/h2-12,16,27H,13-15,17H2,1H3,(H,31,36)	MKZIFUOKFBQCJL-UHFFFAOYSA-N	408783	N-{[2-(difluoromethoxy)-6-fluorophenyl]methyl}-3-(methoxymethyl)-1-({4-[(2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 92::US11001578, Example 92::US11084809, Example 92::US11198691, Example 92	Plasma kallikrein			 16.0							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408783	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408783&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365108	406799414							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035745	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(F)ccc1F	InChI=1S/C26H24F2N4O3/c1-35-17-24-22(26(34)29-13-20-12-21(27)9-10-23(20)28)16-32(30-24)15-19-7-5-18(6-8-19)14-31-11-3-2-4-25(31)33/h2-12,16H,13-15,17H2,1H3,(H,29,34)	XQLOPLZHIJLNDB-UHFFFAOYSA-N	408784	 N-[(2,5-difluorophenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US10364238, Example 94::US11001578, Example 94::US11084809, Example 94::US11198691, Example 94	Plasma kallikrein			 780							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408784	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408784&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365078	406799415							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035747	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(F)cc(OC)c1	InChI=1S/C27H27FN4O4/c1-35-18-25-24(27(34)29-14-21-11-22(28)13-23(12-21)36-2)17-32(30-25)16-20-8-6-19(7-9-20)15-31-10-4-3-5-26(31)33/h3-13,17H,14-16,18H2,1-2H3,(H,29,34)	AYOVCXXHHIWMRN-UHFFFAOYSA-N	408786	N-[(3-fluoro-5-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 95::US11001578, Example 95::US11084809, Example 95::US11198691, Example 95	Plasma kallikrein			 308							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408786	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408786&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365039	406799417							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035749	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(F)cc(OC)c1F	InChI=1S/C27H26F2N4O4/c1-36-17-23-22(27(35)30-13-20-11-21(28)12-24(37-2)26(20)29)16-33(31-23)15-19-8-6-18(7-9-19)14-32-10-4-3-5-25(32)34/h3-12,16H,13-15,17H2,1-2H3,(H,30,35)	FKXBPOXUNOOPGU-UHFFFAOYSA-N	408787	N-[(2,5-difluoro-3-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin- 1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 96::US11001578, Example 96::US11084809, Example 96::US11198691, Example 96	Plasma kallikrein			 75.0							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408787	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408787&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365093	406799418							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035751	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(C)cccc1F	InChI=1S/C27H27FN4O3/c1-19-6-5-7-24(28)22(19)14-29-27(34)23-17-32(30-25(23)18-35-2)16-21-11-9-20(10-12-21)15-31-13-4-3-8-26(31)33/h3-13,17H,14-16,18H2,1-2H3,(H,29,34)	NLVINHRIZCLAQG-UHFFFAOYSA-N	408788	 N-[(2-fluoro-6-methylphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US10364238, Example 97::US11001578, Example 97::US11084809, Example 97::US11198691, Example 97	Plasma kallikrein			 153							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408788	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408788&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365111	406799419							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035753	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(Cl)ccc(OC)c1F	InChI=1S/C27H26ClFN4O4/c1-36-17-23-21(27(35)30-13-20-22(28)10-11-24(37-2)26(20)29)16-33(31-23)15-19-8-6-18(7-9-19)14-32-12-4-3-5-25(32)34/h3-12,16H,13-15,17H2,1-2H3,(H,30,35)	AJVITEJNDAKYPL-UHFFFAOYSA-N	497307	N-[(6-chloro-2-fluoro-3-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-::US11001578, Example 99::US11084809, Example 99::US11198691, Example 99	Plasma kallikrein			 6.40							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=497307	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=497307&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365144	459070294							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035755	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cccc(O)c1F	InChI=1S/C26H25FN4O4/c1-35-17-22-21(26(34)28-13-20-5-4-6-23(32)25(20)27)16-31(29-22)15-19-10-8-18(9-11-19)14-30-12-3-2-7-24(30)33/h2-12,16,32H,13-15,17H2,1H3,(H,28,34)	JFAWWGDJBCGIDJ-UHFFFAOYSA-N	408790	N-[(2-fluoro-3-hydroxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 129::US11001578, Example 129::US11084809, Example 129::US11198691, Example 129	Plasma kallikrein			 437							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408790	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408790&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365133	406799421							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035757	Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cccc(O)c1F	InChI=1S/C24H22FN5O3/c25-22-18(4-3-5-20(22)31)12-27-24(33)19-15-30(28-23(19)26)14-17-9-7-16(8-10-17)13-29-11-2-1-6-21(29)32/h1-11,15,31H,12-14H2,(H2,26,28)(H,27,33)	OOXKEXDZGXUAST-UHFFFAOYSA-N	408792	 3-amino-N-[(2-fluoro-3-hydroxyphenyl)methyl]-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 130::US11001578, Example 130::US11084809, Example 130::US11198691, Example 130	Plasma kallikrein			 174							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408792	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408792&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365044	406799423							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035759	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1ccccc1C(=O)OC	InChI=1S/C28H28N4O5/c1-36-19-25-24(27(34)29-15-22-7-3-4-8-23(22)28(35)37-2)18-32(30-25)17-21-12-10-20(11-13-21)16-31-14-6-5-9-26(31)33/h3-14,18H,15-17,19H2,1-2H3,(H,29,34)	CLMIQCGDYIVGMD-UHFFFAOYSA-N	408793	 methyl 2-({[3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazol-4-yl]formamido}methyl)benzoate::US10364238, Example 131::US11001578, Example 131::US11084809, Example 131::US11198691, Example 131	Plasma kallikrein			 1510							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408793	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408793&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364999	406799424							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035761	CCc1cccc(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2COC)c1F	InChI=1S/C28H29FN4O3/c1-3-22-7-6-8-23(27(22)29)15-30-28(35)24-18-33(31-25(24)19-36-2)17-21-12-10-20(11-13-21)16-32-14-5-4-9-26(32)34/h4-14,18H,3,15-17,19H2,1-2H3,(H,30,35)	TVACIVBKATZGQV-UHFFFAOYSA-N	408794	 N-[(3-ethyl-2-fluorophenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 132::US11001578, Example 132::US11084809, Example 132::US11198691, Example 132	Plasma kallikrein			 135							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408794	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408794&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365023	406799425							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035763	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cccc(OC)c1	InChI=1S/C27H28N4O4/c1-34-19-25-24(27(33)28-15-22-6-5-7-23(14-22)35-2)18-31(29-25)17-21-11-9-20(10-12-21)16-30-13-4-3-8-26(30)32/h3-14,18H,15-17,19H2,1-2H3,(H,28,33)	YDHZFMPDUQUAJM-UHFFFAOYSA-N	408795	 3-(methoxymethyl)-N-[(3-methoxyphenyl)methyl]-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 133::US11001578, Example 133::US11084809, Example 133::US11198691, Example 133	Plasma kallikrein			 90.2							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408795	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408795&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365129	406799426							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035765	COCc1nn(Cc2ccc(Cn3ccncc3=O)cc2)cc1C(=O)NCc1cccc(OC)c1F	InChI=1S/C26H26FN5O4/c1-35-17-22-21(26(34)29-12-20-4-3-5-23(36-2)25(20)27)16-32(30-22)15-19-8-6-18(7-9-19)14-31-11-10-28-13-24(31)33/h3-11,13,16H,12,14-15,17H2,1-2H3,(H,29,34)	QNPXQCIYWHCURP-UHFFFAOYSA-N	408796	 N-[(2-fluoro-3-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyrazin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 104::US11001578, Example 104::US11084809, Example 104::US11198691, Example 104	Plasma kallikrein			 691							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408796	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408796&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365146	406799427							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035767	COCc1nn(Cc2ccc(Cn3ccc(C)cc3=O)cc2)cc1C(=O)NCc1c(F)ccc(OC)c1F	InChI=1S/C28H28F2N4O4/c1-18-10-11-33(26(35)12-18)14-19-4-6-20(7-5-19)15-34-16-22(24(32-34)17-37-2)28(36)31-13-21-23(29)8-9-25(38-3)27(21)30/h4-12,16H,13-15,17H2,1-3H3,(H,31,36)	BKTJDPOLKWOBHW-UHFFFAOYSA-N	408797	N-[(2,6-difluoro-3-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(4-methyl-2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US10364238, Example 106::US11001578, Example 106::US11084809, Example 106::US11198691, Example 106	Plasma kallikrein			 140							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408797	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408797&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365091	406799428							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035769	COCc1nn(Cc2ccc(Cn3cc(F)ccc3=O)cc2)cc1C(=O)NCc1c(F)ccc(OC)c1F	InChI=1S/C27H25F3N4O4/c1-37-16-23-21(27(36)31-11-20-22(29)8-9-24(38-2)26(20)30)15-34(32-23)13-18-5-3-17(4-6-18)12-33-14-19(28)7-10-25(33)35/h3-10,14-15H,11-13,16H2,1-2H3,(H,31,36)	JRSJFSJQRZMHDN-UHFFFAOYSA-N	408798	 N-[(2,6-difluoro-3-methoxyphenyl)methyl]-1-({4-[(5-fluoro-2-oxopyridin-1- yl)methyl]phenyl}methyl)-3-(methoxymethyl)pyrazole-4-carboxamide::US10364238, Example 108::US11001578, Example 108::US11084809, Example 108::US11198691, Example 108	Plasma kallikrein			 5.50							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408798	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408798&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365114	406799429							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035771	CCOc1ccn(Cc2ccc(Cn3cc(C(=O)NCc4c(F)ccc(OC)c4F)c(COC)n3)cc2)c(=O)c1	InChI=1S/C29H30F2N4O5/c1-4-40-21-11-12-34(27(36)13-21)15-19-5-7-20(8-6-19)16-35-17-23(25(33-35)18-38-2)29(37)32-14-22-24(30)9-10-26(39-3)28(22)31/h5-13,17H,4,14-16,18H2,1-3H3,(H,32,37)	MMGSTVOIQROITG-UHFFFAOYSA-N	408799	N-[(2,6-difluoro-3-methoxyphenyl)methyl]-1-({4-[(4-ethoxy-2-oxopyridin-1- yl)methyl]phenyl}methyl)-3-(methoxymethyl)pyrazole-4-carboxamide ::US10364238, Example 109::US11001578, Example 109::US11084809, Example 109::US11198691, Example 109	Plasma kallikrein			 2980							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408799	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408799&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364997	406799430							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035773	COc1cccc(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)c(C)n2)c1F	InChI=1S/C26H25FN4O3/c1-18-29-22(26(33)28-14-21-6-5-7-23(34-2)25(21)27)17-31(18)16-20-11-9-19(10-12-20)15-30-13-4-3-8-24(30)32/h3-13,17H,14-16H2,1-2H3,(H,28,33)	XCBLTBHUJNNESG-UHFFFAOYSA-N	408801	 N-[(2-fluoro-3-methoxyphenyl)methyl]-2-methyl-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)imidazole-4-carboxamide ::US10364238, Example 121::US11001578, Example 121::US11084809, Example 121::US11198691, Example 121	Plasma kallikrein			 43.9							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408801	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408801&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365087	406799432							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035775	COc1cccc(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)c(n2)C(F)(F)F)c1F	InChI=1S/C26H22F4N4O3/c1-37-21-6-4-5-19(23(21)27)13-31-24(36)20-16-34(25(32-20)26(28,29)30)15-18-10-8-17(9-11-18)14-33-12-3-2-7-22(33)35/h2-12,16H,13-15H2,1H3,(H,31,36)	UZZGYTADFHNIGM-UHFFFAOYSA-N	408803	 N-[(2-fluoro-3-methoxyphenyl)methyl]-1-({4-[(2-oxopyrldin-1- yl)methyl]phenyl}methyl)-2-(trifluoromethyl)imidazole-4-carboxamide ::US10364238, Example 124::US11001578, Example 124::US11084809, Example 124::US11198691, Example 124	Plasma kallikrein			 191							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408803	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408803&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365057	406799434							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035777	COc1cccc(CNC(=O)c2cn(Cc3ccc(nc3)N3CCCC3)nc2C(F)(F)F)c1F	InChI=1S/C23H23F4N5O2/c1-34-18-6-4-5-16(20(18)24)12-29-22(33)17-14-32(30-21(17)23(25,26)27)13-15-7-8-19(28-11-15)31-9-2-3-10-31/h4-8,11,14H,2-3,9-10,12-13H2,1H3,(H,29,33)	CWABZPWKGAMQLS-UHFFFAOYSA-N	408804	N-[(2-fluoro-3-methoxyphenyl)methyl]-1-{[6-(pyrrolidin-1-yl)pyridin-3-yl]methyl}-3- (trifluoromethyl)pyrazole-4-carboxamide::US10364238, Example 126::US11001578, Example 126::US11084809, Example 126::US11180484, Reference Example G	Plasma kallikrein			 742							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408804	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408804&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365050	406799435							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035779	CN1CC(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2N)Oc2cc(Cl)ccc12	InChI=1S/C27H27ClN6O3/c1-32-16-21(37-24-12-20(28)9-10-23(24)32)13-30-27(36)22-17-34(31-26(22)29)15-19-7-5-18(6-8-19)14-33-11-3-2-4-25(33)35/h2-12,17,21H,13-16H2,1H3,(H2,29,31)(H,30,36)	BZQHROALKROIIJ-UHFFFAOYSA-N	408805	 3-amino-N-[(7-chloro-4-methyl-2,3-dihydro-1,4-benzoxazin-2-yl)methyl]-1-({4-[(2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 139::US11001578, Example 139::US11084809, Example 139::US11198691, Example 139	Plasma kallikrein			 64.7							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408805	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408805&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365007	406799436							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035781	Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCC1CNc2ccc(Cl)cc2O1	InChI=1S/C26H25ClN6O3/c27-19-8-9-22-23(11-19)36-20(12-29-22)13-30-26(35)21-16-33(31-25(21)28)15-18-6-4-17(5-7-18)14-32-10-2-1-3-24(32)34/h1-11,16,20,29H,12-15H2,(H2,28,31)(H,30,35)	PIQXYEUIEZKEKB-UHFFFAOYSA-N	408806	3-amino-N-[(7-chloro-3,4-dihydro-2H-1,4-benzoxazin-2-yl)methyl]-1-({4-[(2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 140::US11001578, Example 140::US11084809, Example 140::US11198691, Example 140	Plasma kallikrein			 10.6							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408806	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408806&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365122	406799437							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073078	COCc1nn(Cc2ccc(nc2)N2CCCC2)cc1C(=O)NCc1csc2ccc(Cl)cc12	InChI=1S/C25H26ClN5O2S/c1-33-15-22-21(25(32)28-12-18-16-34-23-6-5-19(26)10-20(18)23)14-31(29-22)13-17-4-7-24(27-11-17)30-8-2-3-9-30/h4-7,10-11,14,16H,2-3,8-9,12-13,15H2,1H3,(H,28,32)	WMNGADNOQNFZIE-UHFFFAOYSA-N	408720	N-[(5-chloro-1-benzothiophen-3-yl)methyl]-3-(methoxymethyl)-1-{[6-(pyrrolidin-1-::US10364238, Example 46::US11001578, Example 46::US11084809, Example 46::US11198691, Example 46	Plasma kallikrein			 2400							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408720	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408720&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365148	406799351							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073080	COCc1nn(Cc2ccc(Cn3cc(C)cn3)cc2)cc1C(=O)NCc1csc2ccc(Cl)cc12	InChI=1S/C27H26ClN5O2S/c1-18-10-30-32(12-18)13-19-3-5-20(6-4-19)14-33-15-24(25(31-33)16-35-2)27(34)29-11-21-17-36-26-8-7-22(28)9-23(21)26/h3-10,12,15,17H,11,13-14,16H2,1-2H3,(H,29,34)	OVCXPEFSYYWEMX-UHFFFAOYSA-N	408725	 N-[(5-chloro-1-benzothiophen-3-yl)methyl]-3-(methoxymethyl)-1-({4-[(4- methylpyrazol-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 47::US11001578, Example 47::US11084809, Example 47::US11198691, Example 47	Plasma kallikrein			 753							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408725	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408725&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365059	406799356							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1073082	NC(=O)c1ccccc1CNC(=O)c1cn(Cc2ccc(Cn3ccccc3=O)cc2)nc1C1CC1	InChI=1S/C28H27N5O3/c29-27(35)23-6-2-1-5-22(23)15-30-28(36)24-18-33(31-26(24)21-12-13-21)17-20-10-8-19(9-11-20)16-32-14-4-3-7-25(32)34/h1-11,14,18,21H,12-13,15-17H2,(H2,29,35)(H,30,36)	KOYPCAXNSUCYIL-UHFFFAOYSA-N	408726	N-[(2-carbamoylphenyl)methyl]-3-cyclopropyl-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 48::US11001578, Example 48::US11084809, Example 48::US11198691, Example 48	Plasma kallikrein			 647							US Patent		10.7270/Q29G5R07		aid1805793	US11084809	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408726	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408726&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365021	406799357							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056117	O[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cc1)C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1	InChI=1S/C29H30ClFN4O3/c30-21-9-11-22(12-10-21)33-29(38)35-17-23(36)15-26(35)28(37)34-25-14-20(8-13-24(25)31)27(32-16-18-6-7-18)19-4-2-1-3-5-19/h1-5,8-14,18,23,26-27,32,36H,6-7,15-17H2,(H,33,38)(H,34,37)/t23-,26-,27?/m1/s1	HBBZGIHYHHTCAB-UTZIHYNGSA-N	433366	US10562850, Compound 1p::US10562850, Compound 3a::US11066360, Compound 3a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433366	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433366&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135281863	438642299							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056118	CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cc1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N	InChI=1S/C32H33ClFN5O3/c1-42-26-17-29(39(19-26)31(41)37-25-10-8-24(33)9-11-25)30(40)38-28-16-23(7-12-27(28)34)32(36,14-13-20-5-6-20)22-4-2-3-21(15-22)18-35/h2-4,7-12,15-16,20,26,29H,5-6,13-14,17,19,36H2,1H3,(H,37,41)(H,38,40)/t26-,29-,32?/m1/s1	YTGQPSYAWGTQEE-IYGDAUFUSA-N	433367	US10562850, Compound 17b::US11066360, Compound 17b	Plasma kallikrein		 75.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433367	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433367&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359623	438642300							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056119	CC(C)(C)[S@](=O)NC(CCC1CC1)(c1ccc(F)c(NC(=O)[C@H]2C[C@@H](O)CN2C(=O)Nc2ccc(Cl)cc2)c1)c1ccccn1	InChI=1S/C33H39ClFN5O4S/c1-32(2,3)45(44)39-33(16-15-21-7-8-21,29-6-4-5-17-36-29)22-9-14-26(35)27(18-22)38-30(42)28-19-25(41)20-40(28)31(43)37-24-12-10-23(34)11-13-24/h4-6,9-14,17-18,21,25,28,39,41H,7-8,15-16,19-20H2,1-3H3,(H,37,43)(H,38,42)/t25-,28-,33?,45+/m1/s1	JEVCIJSWWNTRIA-SMAHILNNSA-N	433368	US10562850, Compound 61b::US11066360, Compound 61b	Plasma kallikrein		<50.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433368	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433368&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			145750145	438642301							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056120	O[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cc1)C(=O)Nc1ccccc1F	InChI=1S/C18H17ClFN3O3/c19-11-5-7-12(8-6-11)21-18(26)23-10-13(24)9-16(23)17(25)22-15-4-2-1-3-14(15)20/h1-8,13,16,24H,9-10H2,(H,21,26)(H,22,25)/t13-,16-/m1/s1	YIUKCJACECLDEF-CZUORRHYSA-N	433369	US10562850, Compound 2a::US11066360, Compound 2a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433369	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433369&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359279	438642302							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056121	CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N	InChI=1S/C31H32ClFN6O3/c1-42-24-15-27(39(18-24)30(41)38-28-10-8-23(32)17-36-28)29(40)37-26-14-22(7-9-25(26)33)31(35,12-11-19-5-6-19)21-4-2-3-20(13-21)16-34/h2-4,7-10,13-14,17,19,24,27H,5-6,11-12,15,18,35H2,1H3,(H,37,40)(H,36,38,41)/t24-,27-,31?/m1/s1	XHEUJDABOZVRIR-QPLSPKJVSA-N	433370	US10562850, Compound 18b::US11066360, Compound 18b	Plasma kallikrein		<50.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433370	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433370&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359297	438642303							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056122	O[C@@]1(C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cc1)C(=O)Nc1cc(ccc1F)C(CCC1CC1)(NC(=O)Nc1ccc(Cl)cc1)c1cccc(c1)C#N)c1ccccc1	InChI=1S/C44H39Cl2FN6O4/c45-33-12-16-35(17-13-33)49-41(55)52-44(22-21-28-9-10-28,31-8-4-5-29(23-31)26-48)32-11-20-37(47)38(24-32)51-40(54)39-25-43(57,30-6-2-1-3-7-30)27-53(39)42(56)50-36-18-14-34(46)15-19-36/h1-8,11-20,23-24,28,39,57H,9-10,21-22,25,27H2,(H,50,56)(H,51,54)(H2,49,52,55)/t39-,43-,44?/m1/s1	UCADJOBQLTWIBK-TVHZFVKUSA-N	433371	US10562850, Compound 30b::US11066360, Compound 30b	Plasma kallikrein		 75.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433371	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433371&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359527	438642304							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056123	O[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cc1)C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1	InChI=1S/C29H30ClFN4O3/c30-21-9-11-22(12-10-21)33-29(38)35-17-23(36)15-26(35)28(37)34-25-14-20(8-13-24(25)31)27(32-16-18-6-7-18)19-4-2-1-3-5-19/h1-5,8-14,18,23,26-27,32,36H,6-7,15-17H2,(H,33,38)(H,34,37)/t23-,26-,27?/m1/s1	HBBZGIHYHHTCAB-UTZIHYNGSA-N	433366	US10562850, Compound 1p::US10562850, Compound 3a::US11066360, Compound 3a	Plasma kallikrein		 75.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433366	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433366&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135281863	438642299							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056124	CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(CCC1CC1)(N[S@](=O)C(C)(C)C)c1cccc(c1)C#N	InChI=1S/C35H40ClFN6O4S/c1-34(2,3)48(46)42-35(15-14-22-8-9-22,24-7-5-6-23(16-24)19-38)25-10-12-28(37)29(17-25)40-32(44)30-18-27(47-4)21-43(30)33(45)41-31-13-11-26(36)20-39-31/h5-7,10-13,16-17,20,22,27,30,42H,8-9,14-15,18,21H2,1-4H3,(H,40,44)(H,39,41,45)/t27-,30-,35?,48-/m1/s1	VAASFQVGQYBRMC-BEGVHSJBSA-N	433373	US10562850, Compound 18a::US11066360, Compound 18a	Plasma kallikrein		<50.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433373	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433373&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			145750015	438642305							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056125	NC(CCC1CC1)(c1ccc(F)c(NC(=O)[C@H]2C[C@@H](O)CN2C(=O)Nc2ccc(Cl)cn2)c1)c1ccccn1	InChI=1S/C28H30ClFN6O3/c29-19-7-9-25(33-15-19)35-27(39)36-16-20(37)14-23(36)26(38)34-22-13-18(6-8-21(22)30)28(31,11-10-17-4-5-17)24-3-1-2-12-32-24/h1-3,6-9,12-13,15,17,20,23,37H,4-5,10-11,14,16,31H2,(H,34,38)(H,33,35,39)/t20-,23-,28?/m1/s1	KXFZKEZPEDQJMM-JLGCCPRNSA-N	433374	US10562850, Compound 62c::US11066360, Compound 62c	Plasma kallikrein		<50.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433374	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433374&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359241	438642306							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056126	NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2C[C@@H](O)CN2C(=O)Nc2ccc(Cl)cc2)c1	InChI=1S/C31H31ClFN5O3/c32-23-7-9-24(10-8-23)36-30(41)38-18-25(39)16-28(38)29(40)37-27-15-22(6-11-26(27)33)31(35,13-12-19-4-5-19)21-3-1-2-20(14-21)17-34/h1-3,6-11,14-15,19,25,28,39H,4-5,12-13,16,18,35H2,(H,36,41)(H,37,40)/t25-,28-,31?/m1/s1	ZSOTVUHHWYEFAC-JADDJLNISA-N	433375	US10562850, Compound 4g::US11066360, Compound 4g	Plasma kallikrein		 75.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433375	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433375&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359354	438642307							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056127	N[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cc1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N	InChI=1S/C31H32ClFN6O2/c32-23-7-9-25(10-8-23)37-30(41)39-18-24(35)16-28(39)29(40)38-27-15-22(6-11-26(27)33)31(36,13-12-19-4-5-19)21-3-1-2-20(14-21)17-34/h1-3,6-11,14-15,19,24,28H,4-5,12-13,16,18,35-36H2,(H,37,41)(H,38,40)/t24-,28-,31?/m1/s1	TXDNHUJHLZWLQW-LLAOLMGESA-N	433376	US10562850, Compound 19c::US11066360, Compound 19c	Plasma kallikrein		>100.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433376	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433376&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359601	438642308							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056128	NC(CCC1CC1)(c1ccc(cc1)C#N)c1ccc(F)c(NC(=O)[C@H]2C[C@@H](O)CN2C(=O)Nc2ccc(Cl)cc2)c1	InChI=1S/C31H31ClFN5O3/c32-23-8-10-24(11-9-23)36-30(41)38-18-25(39)16-28(38)29(40)37-27-15-22(7-12-26(27)33)31(35,14-13-19-1-2-19)21-5-3-20(17-34)4-6-21/h3-12,15,19,25,28,39H,1-2,13-14,16,18,35H2,(H,36,41)(H,37,40)/t25-,28-,31?/m1/s1	NNIFNVSICNCVCW-JADDJLNISA-N	433377	US10562850, Compound 63g::US11066360, Compound 63g	Plasma kallikrein		 75.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433377	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433377&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359504	438642309							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056129	NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)Nc2ccc(Cl)cc2)c1	InChI=1S/C31H31ClFN5O3/c32-23-7-9-24(10-8-23)36-30(41)38-18-25(39)16-28(38)29(40)37-27-15-22(6-11-26(27)33)31(35,13-12-19-4-5-19)21-3-1-2-20(14-21)17-34/h1-3,6-11,14-15,19,25,28,39H,4-5,12-13,16,18,35H2,(H,36,41)(H,37,40)/t25-,28+,31?/m1/s1	ZSOTVUHHWYEFAC-LHPFXVGBSA-N	433378	US10562850, Compound 5e::US11066360, Compound 5e	Plasma kallikrein		>100.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433378	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433378&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135281905	438642310					C04398		1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056130	N[C@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cc1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N	InChI=1S/C31H32ClFN6O2/c32-23-7-9-25(10-8-23)37-30(41)39-18-24(35)16-28(39)29(40)38-27-15-22(6-11-26(27)33)31(36,13-12-19-4-5-19)21-3-1-2-20(14-21)17-34/h1-3,6-11,14-15,19,24,28H,4-5,12-13,16,18,35-36H2,(H,37,41)(H,38,40)/t24-,28+,31?/m0/s1	TXDNHUJHLZWLQW-MPAODNJVSA-N	433379	US10562850, Compound 33d::US11066360, Compound 33d	Plasma kallikrein		>100.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433379	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433379&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359561	438642311							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056131	NC(CCC1CC1)(c1cccnc1)c1ccc(F)c(NC(=O)[C@H]2C[C@@H](O)CN2C(=O)Nc2ccc(Cl)cc2)c1	InChI=1S/C29H31ClFN5O3/c30-21-6-8-22(9-7-21)34-28(39)36-17-23(37)15-26(36)27(38)35-25-14-19(5-10-24(25)31)29(32,12-11-18-3-4-18)20-2-1-13-33-16-20/h1-2,5-10,13-14,16,18,23,26,37H,3-4,11-12,15,17,32H2,(H,34,39)(H,35,38)/t23-,26-,29?/m1/s1	GXRAZUOSZNNHEA-XATCSJPRSA-N	433382	US10562850, Compound 64g::US11066360, Compound 64g	Plasma kallikrein		<50.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433382	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433382&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359617	438642314							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056132	CO[C@@H]1C[C@H](N(C1)C(=O)N(C)c1ccc(Cl)cc1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N	InChI=1S/C33H35ClFN5O3/c1-39(26-11-9-25(34)10-12-26)32(42)40-20-27(43-2)18-30(40)31(41)38-29-17-24(8-13-28(29)35)33(37,15-14-21-6-7-21)23-5-3-4-22(16-23)19-36/h3-5,8-13,16-17,21,27,30H,6-7,14-15,18,20,37H2,1-2H3,(H,38,41)/t27-,30+,33?/m1/s1	FPWZXKOIXOEUQB-RDJZJCQLSA-N	433383	US10562850, Compound 6f::US11066360, Compound 6f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433383	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433383&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359365	438642315							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056133	NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2CC(=O)CN2C(=O)Nc2ccc(Cl)cc2)c1	InChI=1S/C31H29ClFN5O3/c32-23-7-9-24(10-8-23)36-30(41)38-18-25(39)16-28(38)29(40)37-27-15-22(6-11-26(27)33)31(35,13-12-19-4-5-19)21-3-1-2-20(14-21)17-34/h1-3,6-11,14-15,19,28H,4-5,12-13,16,18,35H2,(H,36,41)(H,37,40)/t28-,31?/m1/s1	QMSQFJCSTHFEIQ-ZZTVPSNHSA-N	433384	US10562850, Compound 20b::US11066360, Compound 20b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433384	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433384&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359348	438642316							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056134	CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cc1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccn1	InChI=1S/C30H33ClFN5O3/c1-40-23-17-26(37(18-23)29(39)35-22-10-8-21(31)9-11-22)28(38)36-25-16-20(7-12-24(25)32)30(33,14-13-19-5-6-19)27-4-2-3-15-34-27/h2-4,7-12,15-16,19,23,26H,5-6,13-14,17-18,33H2,1H3,(H,35,39)(H,36,38)/t23-,26-,30?/m1/s1	VXUMWJIENCDFKX-JRSXUWQBSA-N	433385	US10562850, Compound 65b::US11066360, Compound 65b	Plasma kallikrein		<50.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433385	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433385&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359647	438642317							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056135	CO[C@@H]1C[C@@H](N(C1)C(=O)N(C)c1ccc(Cl)cc1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N	InChI=1S/C33H35ClFN5O3/c1-39(26-11-9-25(34)10-12-26)32(42)40-20-27(43-2)18-30(40)31(41)38-29-17-24(8-13-28(29)35)33(37,15-14-21-6-7-21)23-5-3-4-22(16-23)19-36/h3-5,8-13,16-17,21,27,30H,6-7,14-15,18,20,37H2,1-2H3,(H,38,41)/t27-,30-,33?/m1/s1	FPWZXKOIXOEUQB-QDZZTBPHSA-N	433386	US10562850, Compound 6e::US11066360, Compound 6e	Plasma kallikrein		>100.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433386	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433386&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359618	438642318							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056136	NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2C[C@@H](O)CN2C(=O)Nc2ccccc2)c1	InChI=1S/C31H32FN5O3/c32-26-12-11-23(31(34,14-13-20-9-10-20)22-6-4-5-21(15-22)18-33)16-27(26)36-29(39)28-17-25(38)19-37(28)30(40)35-24-7-2-1-3-8-24/h1-8,11-12,15-16,20,25,28,38H,9-10,13-14,17,19,34H2,(H,35,40)(H,36,39)/t25-,28-,31?/m1/s1	BHZFWFPHPBCYRY-JADDJLNISA-N	433387	US10562850, Compound 21d::US11066360, Compound 21d	Plasma kallikrein		>100.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433387	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433387&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359590	438642319							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056137	CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccn1	InChI=1S/C29H32ClFN6O3/c1-40-21-15-24(37(17-21)28(39)36-26-10-8-20(30)16-34-26)27(38)35-23-14-19(7-9-22(23)31)29(32,12-11-18-5-6-18)25-4-2-3-13-33-25/h2-4,7-10,13-14,16,18,21,24H,5-6,11-12,15,17,32H2,1H3,(H,35,38)(H,34,36,39)/t21-,24-,29?/m1/s1	HMKGSFLIMYOEKX-ZORXERLGSA-N	433388	BDBM433391::US10562850, Compound 36d::US10562850, Compound 37d::US11066360, Compound 37d	Plasma kallikrein		<50.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433388	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433388&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359283	438642320							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056138	NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2CCCN2C(=O)Nc2ccc(Cl)cc2)c1	InChI=1S/C31H31ClFN5O2/c32-24-9-11-25(12-10-24)36-30(40)38-16-2-5-28(38)29(39)37-27-18-23(8-13-26(27)33)31(35,15-14-20-6-7-20)22-4-1-3-21(17-22)19-34/h1,3-4,8-13,17-18,20,28H,2,5-7,14-16,35H2,(H,36,40)(H,37,39)/t28-,31?/m1/s1	LISQDGOQHUHLHR-ZZTVPSNHSA-N	433389	US10562850, Compound 7c::US11066360, Compound 7c	Plasma kallikrein		>100.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433389	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433389&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359645	438642321							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056139	Cc1ccc(NC(=O)N2C[C@H](O)C[C@@H]2C(=O)Nc2cc(ccc2F)C(N)(CCC2CC2)c2cccc(c2)C#N)cc1	InChI=1S/C32H34FN5O3/c1-20-5-10-25(11-6-20)36-31(41)38-19-26(39)17-29(38)30(40)37-28-16-24(9-12-27(28)33)32(35,14-13-21-7-8-21)23-4-2-3-22(15-23)18-34/h2-6,9-12,15-16,21,26,29,39H,7-8,13-14,17,19,35H2,1H3,(H,36,41)(H,37,40)/t26-,29-,32?/m1/s1	IWZUFFQUBYJSIV-IYGDAUFUSA-N	433390	US10562850, Compound 22b::US11066360, Compound 22b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433390	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433390&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359621	438642322							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056140	CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccn1	InChI=1S/C29H32ClFN6O3/c1-40-21-15-24(37(17-21)28(39)36-26-10-8-20(30)16-34-26)27(38)35-23-14-19(7-9-22(23)31)29(32,12-11-18-5-6-18)25-4-2-3-13-33-25/h2-4,7-10,13-14,16,18,21,24H,5-6,11-12,15,17,32H2,1H3,(H,35,38)(H,34,36,39)/t21-,24-,29?/m1/s1	HMKGSFLIMYOEKX-ZORXERLGSA-N	433388	BDBM433391::US10562850, Compound 36d::US10562850, Compound 37d::US11066360, Compound 37d	Plasma kallikrein		>100.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433388	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433388&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359283	438642320							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056141	NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@@H]2CCCN2C(=O)Nc2ccc(Cl)cc2)c1	InChI=1S/C31H31ClFN5O2/c32-24-9-11-25(12-10-24)36-30(40)38-16-2-5-28(38)29(39)37-27-18-23(8-13-26(27)33)31(35,15-14-20-6-7-20)22-4-1-3-21(17-22)19-34/h1,3-4,8-13,17-18,20,28H,2,5-7,14-16,35H2,(H,36,40)(H,37,39)/t28-,31?/m0/s1	LISQDGOQHUHLHR-NPHAVVRNSA-N	433392	US10562850, Compound 8c::US11066360, Compound 8c	Plasma kallikrein		>100.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433392	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433392&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359611	438642323							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056142	NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2C[C@@H](O)CN2C(=O)Nc2ccc(Br)cc2)c1	InChI=1S/C31H31BrFN5O3/c32-23-7-9-24(10-8-23)36-30(41)38-18-25(39)16-28(38)29(40)37-27-15-22(6-11-26(27)33)31(35,13-12-19-4-5-19)21-3-1-2-20(14-21)17-34/h1-3,6-11,14-15,19,25,28,39H,4-5,12-13,16,18,35H2,(H,36,41)(H,37,40)/t25-,28-,31?/m1/s1	LKZRDRGVMHMUQQ-JADDJLNISA-N	433393	US10562850, Compound 23b::US11066360, Compound 23b	Plasma kallikrein		 75.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433393	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433393&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135281908	438642324							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056143	NC(CCC1CC1)(c1ccc(F)c(NC(=O)[C@H]2C[C@@](O)(CN2C(=O)Nc2ccc(Cl)cc2)c2ccccc2)c1)c1ccccn1	InChI=1S/C35H35ClFN5O3/c36-26-12-14-27(15-13-26)40-33(44)42-22-34(45,24-6-2-1-3-7-24)21-30(42)32(43)41-29-20-25(11-16-28(29)37)35(38,18-17-23-9-10-23)31-8-4-5-19-39-31/h1-8,11-16,19-20,23,30,45H,9-10,17-18,21-22,38H2,(H,40,44)(H,41,43)/t30-,34-,35?/m1/s1	QSEWLZJVGPKOAW-WELJHWQCSA-N	433394	US10562850, Compound 31i::US11066360, Compound 31i	Plasma kallikrein		<50.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433394	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433394&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359587	438642325							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056144	NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2C[C@H](O)CN2C(=O)Nc2ccc(Cl)cc2)c1	InChI=1S/C31H31ClFN5O3/c32-23-7-9-24(10-8-23)36-30(41)38-18-25(39)16-28(38)29(40)37-27-15-22(6-11-26(27)33)31(35,13-12-19-4-5-19)21-3-1-2-20(14-21)17-34/h1-3,6-11,14-15,19,25,28,39H,4-5,12-13,16,18,35H2,(H,36,41)(H,37,40)/t25-,28+,31?/m0/s1	ZSOTVUHHWYEFAC-RKPVUUMKSA-N	433395	US10562850, Compound 9c::US11066360, Compound 9c	Plasma kallikrein		>100.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433395	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433395&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359482	438642326							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056145	NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2C[C@@H](O)CN2C(=O)Nc2ccc(F)cc2)c1	InChI=1S/C31H31F2N5O3/c32-23-7-9-24(10-8-23)36-30(41)38-18-25(39)16-28(38)29(40)37-27-15-22(6-11-26(27)33)31(35,13-12-19-4-5-19)21-3-1-2-20(14-21)17-34/h1-3,6-11,14-15,19,25,28,39H,4-5,12-13,16,18,35H2,(H,36,41)(H,37,40)/t25-,28-,31?/m1/s1	CEXKWMHOXZZHFS-JADDJLNISA-N	433396	US10562850, Compound 24b::US11066360, Compound 24b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433396	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433396&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359547	438642327							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056146	NC(CCC1CC1)(c1ccc(F)c(NC(=O)[C@H]2C[C@@](O)(CN2C(=O)Nc2ccc(Cl)cn2)c2ccccc2)c1)c1ccccn1	InChI=1S/C34H34ClFN6O3/c35-25-12-14-30(39-20-25)41-32(44)42-21-33(45,23-6-2-1-3-7-23)19-28(42)31(43)40-27-18-24(11-13-26(27)36)34(37,16-15-22-9-10-22)29-8-4-5-17-38-29/h1-8,11-14,17-18,20,22,28,45H,9-10,15-16,19,21,37H2,(H,40,43)(H,39,41,44)/t28-,33-,34?/m1/s1	CSRIYPJRLBVGQK-WHGMDWNTSA-N	433397	US10562850, Compound 32a::US11066360, Compound 32a	Plasma kallikrein		<50.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433397	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433397&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359570	438642328							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056147	NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@@H]2C[C@H](O)CN2C(=O)Nc2ccc(Cl)cc2)c1	InChI=1S/C31H31ClFN5O3/c32-23-7-9-24(10-8-23)36-30(41)38-18-25(39)16-28(38)29(40)37-27-15-22(6-11-26(27)33)31(35,13-12-19-4-5-19)21-3-1-2-20(14-21)17-34/h1-3,6-11,14-15,19,25,28,39H,4-5,12-13,16,18,35H2,(H,36,41)(H,37,40)/t25-,28-,31?/m0/s1	ZSOTVUHHWYEFAC-RXKSKBTASA-N	433398	US10562850, Compound 10c::US11066360, Compound 10c	Plasma kallikrein		>100.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433398	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433398&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359568	438642329							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056148	NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2C[C@@H](O)CN2C(=O)Nc2ccc(cc2)[N+]([O-])=O)c1	InChI=1S/C31H31FN6O5/c32-26-11-6-22(31(34,13-12-19-4-5-19)21-3-1-2-20(14-21)17-33)15-27(26)36-29(40)28-16-25(39)18-37(28)30(41)35-23-7-9-24(10-8-23)38(42)43/h1-3,6-11,14-15,19,25,28,39H,4-5,12-13,16,18,34H2,(H,35,41)(H,36,40)/t25-,28-,31?/m1/s1	GOFUDLSJSSMFGH-JADDJLNISA-N	433399	US10562850, Compound 25b::US11066360, Compound 25b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433399	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433399&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359649	438642330					C02125		1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056149	O[C@@]1(C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(CCC1CC1)(NC(=O)Nc1ccc(Cl)cn1)c1ccccn1)c1ccccc1	InChI=1S/C40H37Cl2FN8O4/c41-28-12-15-34(45-22-28)48-37(53)50-40(18-17-25-9-10-25,33-8-4-5-19-44-33)27-11-14-30(43)31(20-27)47-36(52)32-21-39(55,26-6-2-1-3-7-26)24-51(32)38(54)49-35-16-13-29(42)23-46-35/h1-8,11-16,19-20,22-23,25,32,55H,9-10,17-18,21,24H2,(H,47,52)(H,46,49,54)(H2,45,48,50,53)/t32-,39-,40?/m1/s1	LHPFAIGHMVQELS-HLYQHIASSA-N	433400	US10562850, Compound 32b::US11066360, Compound 32b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433400	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433400&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359518	438642331							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056150	CO[C@H]1C[C@H](N(C1)C(=O)Nc1ccc(Cl)cc1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N	InChI=1S/C32H33ClFN5O3/c1-42-26-17-29(39(19-26)31(41)37-25-10-8-24(33)9-11-25)30(40)38-28-16-23(7-12-27(28)34)32(36,14-13-20-5-6-20)22-4-2-3-21(15-22)18-35/h2-4,7-12,15-16,20,26,29H,5-6,13-14,17,19,36H2,1H3,(H,37,41)(H,38,40)/t26-,29-,32?/m0/s1	YTGQPSYAWGTQEE-RCESYNESSA-N	433401	US10562850, Compound 11e::US11066360, Compound 11e	Plasma kallikrein		>100.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433401	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433401&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135281907	438642332							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056151	NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2C[C@@H](O)CN2C(=O)Nc2cccc3ccccc23)c1	InChI=1S/C35H34FN5O3/c36-29-14-13-26(35(38,16-15-22-11-12-22)25-8-3-5-23(17-25)20-37)18-31(29)39-33(43)32-19-27(42)21-41(32)34(44)40-30-10-4-7-24-6-1-2-9-28(24)30/h1-10,13-14,17-18,22,27,32,42H,11-12,15-16,19,21,38H2,(H,39,43)(H,40,44)/t27-,32-,35?/m1/s1	XADXZHLGEJHMKA-GCMUPQKQSA-N	433402	US10562850, Compound 26b::US11066360, Compound 26b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433402	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433402&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359610	438642333							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056152	CO[C@@]1(C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cc1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccn1)c1ccccc1	InChI=1S/C36H37ClFN5O3/c1-46-35(25-7-3-2-4-8-25)22-31(43(23-35)34(45)41-28-15-13-27(37)14-16-28)33(44)42-30-21-26(12-17-29(30)38)36(39,19-18-24-10-11-24)32-9-5-6-20-40-32/h2-9,12-17,20-21,24,31H,10-11,18-19,22-23,39H2,1H3,(H,41,45)(H,42,44)/t31-,35-,36?/m1/s1	CVMRJSNJZIDFBV-HKGUWHNTSA-N	433403	US10562850, Compound 34d::US11066360, Compound 34d	Plasma kallikrein		<50.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433403	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433403&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359339	438642334							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056153	NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2CCCN2C(=O)Nc2ccc(Cl)cn2)c1	InChI=1S/C30H30ClFN6O2/c31-23-9-11-27(35-18-23)37-29(40)38-14-2-5-26(38)28(39)36-25-16-22(8-10-24(25)32)30(34,13-12-19-6-7-19)21-4-1-3-20(15-21)17-33/h1,3-4,8-11,15-16,18-19,26H,2,5-7,12-14,34H2,(H,36,39)(H,35,37,40)/t26-,30?/m1/s1	BHUHPYWDKYISKX-FIQOPJFZSA-N	433404	US10562850, Compound 13e::US11066360, Compound 13e	Plasma kallikrein		>100.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433404	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433404&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135281909	438642335							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056154	NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2C[C@@H](O)CN2C(=O)Nc2ccc(cc2)C(F)(F)F)c1	InChI=1S/C32H31F4N5O3/c33-26-11-8-23(31(38,13-12-19-4-5-19)22-3-1-2-20(14-22)17-37)15-27(26)40-29(43)28-16-25(42)18-41(28)30(44)39-24-9-6-21(7-10-24)32(34,35)36/h1-3,6-11,14-15,19,25,28,42H,4-5,12-13,16,18,38H2,(H,39,44)(H,40,43)/t25-,28-,31?/m1/s1	XJHRLFBDDQULDZ-JADDJLNISA-N	433405	US10562850, Compound 27b::US11066360, Compound 27b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433405	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433405&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359579	438642336							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056155	CO[C@@]1(C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccn1)c1ccccc1	InChI=1S/C35H36ClFN6O3/c1-46-34(24-7-3-2-4-8-24)20-29(43(22-34)33(45)42-31-15-13-26(36)21-40-31)32(44)41-28-19-25(12-14-27(28)37)35(38,17-16-23-10-11-23)30-9-5-6-18-39-30/h2-9,12-15,18-19,21,23,29H,10-11,16-17,20,22,38H2,1H3,(H,41,44)(H,40,42,45)/t29-,34-,35?/m1/s1	JDWCFHUHWOPMOA-QKKDUPNPSA-N	433406	US10562850, Compound 35a::US11066360, Compound 35a	Plasma kallikrein		 75.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433406	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433406&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359597	438642337							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056156	NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2C[C@@H](O)CN2C(=O)Nc2ccc(Cl)cn2)c1	InChI=1S/C30H30ClFN6O3/c31-22-7-9-27(35-16-22)37-29(41)38-17-23(39)14-26(38)28(40)36-25-13-21(6-8-24(25)32)30(34,11-10-18-4-5-18)20-3-1-2-19(12-20)15-33/h1-3,6-9,12-13,16,18,23,26,39H,4-5,10-11,14,17,34H2,(H,36,40)(H,35,37,41)/t23-,26-,30?/m1/s1	SXTWVJSROGJKOX-JRSXUWQBSA-N	433407	US10562850, Compound 14h::US11066360, Compound 14h	Plasma kallikrein		<50.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433407	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433407&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359350	438642338							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056157	Nc1ccc(NC(=O)N2C[C@H](O)C[C@@H]2C(=O)Nc2cc(ccc2F)C(N)(CCC2CC2)c2cccc(c2)C#N)cc1	InChI=1S/C31H33FN6O3/c32-26-11-6-22(31(35,13-12-19-4-5-19)21-3-1-2-20(14-21)17-33)15-27(26)37-29(40)28-16-25(39)18-38(28)30(41)36-24-9-7-23(34)8-10-24/h1-3,6-11,14-15,19,25,28,39H,4-5,12-13,16,18,34-35H2,(H,36,41)(H,37,40)/t25-,28-,31?/m1/s1	XAOKWPPAZPSJST-JADDJLNISA-N	433408	US10562850, Compound 28b::US11066360, Compound 28b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433408	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433408&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135281910	438642339							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056158	CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(CCC1CC1)(N[S@](=O)C(C)(C)C)c1ccccc1	InChI=1S/C34H41ClFN5O4S/c1-33(2,3)46(44)40-34(17-16-22-10-11-22,23-8-6-5-7-9-23)24-12-14-27(36)28(18-24)38-31(42)29-19-26(45-4)21-41(29)32(43)39-30-15-13-25(35)20-37-30/h5-9,12-15,18,20,22,26,29,40H,10-11,16-17,19,21H2,1-4H3,(H,38,42)(H,37,39,43)/t26-,29-,34?,46-/m1/s1	QAXCQTYVFNJQHP-CUFRGZMTSA-N	433409	US10562850, Compound 66c::US11066360, Compound 66c	Plasma kallikrein		>100.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433409	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433409&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			145750157	438642340							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056159	CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(cc1)C#N)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N	InChI=1S/C33H33FN6O3/c1-43-27-17-30(40(20-27)32(42)38-26-10-7-22(18-35)8-11-26)31(41)39-29-16-25(9-12-28(29)34)33(37,14-13-21-5-6-21)24-4-2-3-23(15-24)19-36/h2-4,7-12,15-16,21,27,30H,5-6,13-14,17,20,37H2,1H3,(H,38,42)(H,39,41)/t27-,30-,33?/m1/s1	XJUMLAKVFMNIFB-QDZZTBPHSA-N	433411	US10562850, Compound 15f::US11066360, Compound 15f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433411	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433411&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359523	438642342							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056160	NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2C[C@@](O)(CN2C(=O)Nc2ccc(Cl)cn2)c2ccccc2)c1	InChI=1S/C36H34ClFN6O3/c37-28-12-14-32(41-21-28)43-34(46)44-22-35(47,25-6-2-1-3-7-25)19-31(44)33(45)42-30-18-27(11-13-29(30)38)36(40,16-15-23-9-10-23)26-8-4-5-24(17-26)20-39/h1-8,11-14,17-18,21,23,31,47H,9-10,15-16,19,22,40H2,(H,42,45)(H,41,43,46)/t31-,35-,36?/m1/s1	HWYAZMPNKGJCSA-HKGUWHNTSA-N	433412	US10562850, Compound 29e::US11066360, Compound 29e	Plasma kallikrein		<50.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433412	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433412&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359341	438642343							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056161	CC(C)(C)[S@@](=O)NC(CCC1CC1)(c1ccncc1)c1ccc(F)c(NC(=O)[C@H]2C[C@@H](O)CN2C(=O)Nc2ccc(Cl)cc2)c1	InChI=1S/C33H39ClFN5O4S/c1-32(2,3)45(44)39-33(15-12-21-4-5-21,22-13-16-36-17-14-22)23-6-11-27(35)28(18-23)38-30(42)29-19-26(41)20-40(29)31(43)37-25-9-7-24(34)8-10-25/h6-11,13-14,16-18,21,26,29,39,41H,4-5,12,15,19-20H2,1-3H3,(H,37,43)(H,38,42)/t26-,29-,33?,45-/m1/s1	QQLAJCNDSPMTIP-WZPBTREFSA-N	433413	US10562850, Compound 68a::US11066360, Compound 68a	Plasma kallikrein		<50.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433413	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433413&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359286	438642344							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056162	CC(=O)O[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N	InChI=1S/C32H32ClFN6O4/c1-19(41)44-25-15-28(40(18-25)31(43)39-29-10-8-24(33)17-37-29)30(42)38-27-14-23(7-9-26(27)34)32(36,12-11-20-5-6-20)22-4-2-3-21(13-22)16-35/h2-4,7-10,13-14,17,20,25,28H,5-6,11-12,15,18,36H2,1H3,(H,38,42)(H,37,39,43)/t25-,28-,32?/m1/s1	SNYRVQXDQOVDKK-OHCGPUKPSA-N	433414	US10562850, Compound 14g::US11066360, Compound 14g	Plasma kallikrein		>100.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433414	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433414&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359520	438642345							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056163	NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2C[C@@](O)(CN2C(=O)Nc2ccc(Cl)cc2)c2ccccc2)c1	InChI=1S/C37H35ClFN5O3/c38-29-12-14-30(15-13-29)42-35(46)44-23-36(47,26-6-2-1-3-7-26)21-33(44)34(45)43-32-20-28(11-16-31(32)39)37(41,18-17-24-9-10-24)27-8-4-5-25(19-27)22-40/h1-8,11-16,19-20,24,33,47H,9-10,17-18,21,23,41H2,(H,42,46)(H,43,45)/t33-,36-,37?/m1/s1	BUDMXNKNTXVVSL-OJLDNJJMSA-N	433415	US10562850, Compound 30a::US11066360, Compound 30a	Plasma kallikrein		<50.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433415	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433415&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359662	438642346							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056164	NC(CCC1CC1)(c1ccncc1)c1ccc(F)c(NC(=O)[C@H]2C[C@@H](O)CN2C(=O)Nc2ccc(Cl)cc2)c1	InChI=1S/C29H31ClFN5O3/c30-21-4-6-22(7-5-21)34-28(39)36-17-23(37)16-26(36)27(38)35-25-15-20(3-8-24(25)31)29(32,12-9-18-1-2-18)19-10-13-33-14-11-19/h3-8,10-11,13-15,18,23,26,37H,1-2,9,12,16-17,32H2,(H,34,39)(H,35,38)/t23-,26-,29?/m1/s1	KWYZMIIVFJJBEL-XATCSJPRSA-N	433416	US10562850, Compound 69a::US11066360, Compound 69a	Plasma kallikrein		<50.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433416	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433416&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359521	438642347							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056165	CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(OC)cc1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N	InChI=1S/C33H36FN5O4/c1-42-26-11-9-25(10-12-26)37-32(41)39-20-27(43-2)18-30(39)31(40)38-29-17-24(8-13-28(29)34)33(36,15-14-21-6-7-21)23-5-3-4-22(16-23)19-35/h3-5,8-13,16-17,21,27,30H,6-7,14-15,18,20,36H2,1-2H3,(H,37,41)(H,38,40)/t27-,30-,33?/m1/s1	WXDFXBJELOTNBM-QDZZTBPHSA-N	504563	US11066360, Compound 16b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=504563	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=504563&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359605	459089805							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056166	O[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cc1)C(=O)Nc1cc(ccc1F)[C@H](NCC1CC1)c1cccc(c1)C#N	InChI=1S/C30H29ClFN5O3/c31-22-7-9-23(10-8-22)35-30(40)37-17-24(38)14-27(37)29(39)36-26-13-21(6-11-25(26)32)28(34-16-18-4-5-18)20-3-1-2-19(12-20)15-33/h1-3,6-13,18,24,27-28,34,38H,4-5,14,16-17H2,(H,35,40)(H,36,39)/t24-,27-,28-/m1/s1	SQGKFOGUTRWMGA-RYRVMRHHSA-N	433417	US10562850, Compound 60a::US11066360, Compound 60a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433417	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433417&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359582	438642348							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056167	NC(CCC1CC1)(c1ccncc1)c1ccc(F)c(NC(=O)[C@H]2C[C@@H](O)CN2C(=O)Nc2ccc(Cl)cn2)c1	InChI=1S/C28H30ClFN6O3/c29-20-4-6-25(33-15-20)35-27(39)36-16-21(37)14-24(36)26(38)34-23-13-19(3-5-22(23)30)28(31,10-7-17-1-2-17)18-8-11-32-12-9-18/h3-6,8-9,11-13,15,17,21,24,37H,1-2,7,10,14,16,31H2,(H,34,38)(H,33,35,39)/t21-,24-,28?/m1/s1	HQGRGSNARPYLCN-OWWYDEOISA-N	433418	US10562850, Compound 72c::US11066360, Compound 72c	Plasma kallikrein		<50.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433418	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433418&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359595	438642349							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056168	CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1	InChI=1S/C29H32ClFN6O3/c1-40-22-15-25(37(17-22)28(39)36-26-7-5-21(30)16-34-26)27(38)35-24-14-20(4-6-23(24)31)29(32,11-8-18-2-3-18)19-9-12-33-13-10-19/h4-7,9-10,12-14,16,18,22,25H,2-3,8,11,15,17,32H2,1H3,(H,35,38)(H,34,36,39)/t22-,25-,29?/m1/s1	VGGJBRJWCKLWRW-LKXBVVHWSA-N	433419	US10562850, Compound 70c::US11066360, Compound 70c	Plasma kallikrein		<50.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433419	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433419&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359295	438642350							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056169	CO[C@@H]1C[C@@H](N(C1)C(=O)Cc1ccc(Cl)cc1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1	InChI=1S/C31H34ClFN4O3/c1-40-25-18-28(37(19-25)29(38)16-21-4-7-24(32)8-5-21)30(39)36-27-17-23(6-9-26(27)33)31(34,13-10-20-2-3-20)22-11-14-35-15-12-22/h4-9,11-12,14-15,17,20,25,28H,2-3,10,13,16,18-19,34H2,1H3,(H,36,39)/t25-,28-,31?/m1/s1	DHVCRRDPZVVRDO-JADDJLNISA-N	433420	US10562850, Compound 76e::US11066360, Compound 76e	Plasma kallikrein		>100.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433420	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433420&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359516	438642351							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056170	CC(C)(C)[S@@](=O)NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@@H]2C[C@H](O)CN2C(=O)Nc2ccc(Cl)cc2)c1	InChI=1S/C35H39ClFN5O4S/c1-34(2,3)47(46)41-35(16-15-22-7-8-22,24-6-4-5-23(17-24)20-38)25-9-14-29(37)30(18-25)40-32(44)31-19-28(43)21-42(31)33(45)39-27-12-10-26(36)11-13-27/h4-6,9-14,17-18,22,28,31,41,43H,7-8,15-16,19,21H2,1-3H3,(H,39,45)(H,40,44)/t28-,31-,35?,47+/m0/s1	MJBIFAIWKFMNPW-GVNGFNKKSA-N	433421	US10562850, Compound 10b::US11066360, Compound 10b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433421	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433421&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			145750013	438642352							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056171	CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cc1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1	InChI=1S/C30H33ClFN5O3/c1-40-24-17-27(37(18-24)29(39)35-23-7-5-22(31)6-8-23)28(38)36-26-16-21(4-9-25(26)32)30(33,13-10-19-2-3-19)20-11-14-34-15-12-20/h4-9,11-12,14-16,19,24,27H,2-3,10,13,17-18,33H2,1H3,(H,35,39)(H,36,38)/t24-,27-,30?/m1/s1	SAMYKJCENRVZAI-CPBGAKQSSA-N	433422	US10562850, Compound 71a::US11066360, Compound 71a	Plasma kallikrein		<50.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433422	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433422&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359598	438642353							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056172	CCO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(CCC1CC1)(NS(C)(=O)=O)c1ccncc1	InChI=1S/C31H36ClFN6O5S/c1-3-44-24-17-27(39(19-24)30(41)37-28-9-7-23(32)18-35-28)29(40)36-26-16-22(6-8-25(26)33)31(38-45(2,42)43,13-10-20-4-5-20)21-11-14-34-15-12-21/h6-9,11-12,14-16,18,20,24,27,38H,3-5,10,13,17,19H2,1-2H3,(H,36,40)(H,35,37,41)/t24-,27-,31?/m1/s1	WFRSAFQXIIEVRI-QPLSPKJVSA-N	433423	US10562850, Compound 55a::US11066360, Compound 55a	Plasma kallikrein		<50.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433423	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433423&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359384	438642354							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056173	CC(C)(C)[S@@](=O)NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2C[C@@H](O)CN2C(=O)Nc2ccc(Cl)cc2)c1	InChI=1S/C35H39ClFN5O4S/c1-34(2,3)47(46)41-35(16-15-22-7-8-22,24-6-4-5-23(17-24)20-38)25-9-14-29(37)30(18-25)40-32(44)31-19-28(43)21-42(31)33(45)39-27-12-10-26(36)11-13-27/h4-6,9-14,17-18,22,28,31,41,43H,7-8,15-16,19,21H2,1-3H3,(H,39,45)(H,40,44)/t28-,31-,35?,47-/m1/s1	MJBIFAIWKFMNPW-ZQUSZWJISA-N	433424	US10562850, Compound 4f::US11066360, Compound 4f	Plasma kallikrein		 75.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433424	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433424&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			145750195	438642355							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056174	CCNC(CCC1CC1)(c1ccccc1)c1ccc(F)c(NC(=O)[C@H]2C[C@H](CN2C(=O)Nc2ccc(Cl)cn2)OC)c1	InChI=1S/C32H37ClFN5O3/c1-3-36-32(16-15-21-9-10-21,22-7-5-4-6-8-22)23-11-13-26(34)27(17-23)37-30(40)28-18-25(42-2)20-39(28)31(41)38-29-14-12-24(33)19-35-29/h4-8,11-14,17,19,21,25,28,36H,3,9-10,15-16,18,20H2,1-2H3,(H,37,40)(H,35,38,41)/t25-,28-,32?/m1/s1	LUJTUEOORDUTPD-OHCGPUKPSA-N	433425	US10562850, Compound 67b::US11066360, Compound 67b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433425	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433425&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359524	438642356							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056175	CCO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(CCC1CC1)(NC(C)=O)c1ccncc1	InChI=1S/C32H36ClFN6O4/c1-3-44-25-17-28(40(19-25)31(43)38-29-9-7-24(33)18-36-29)30(42)37-27-16-23(6-8-26(27)34)32(39-20(2)41,13-10-21-4-5-21)22-11-14-35-15-12-22/h6-9,11-12,14-16,18,21,25,28H,3-5,10,13,17,19H2,1-2H3,(H,37,42)(H,39,41)(H,36,38,43)/t25-,28-,32?/m1/s1	PBUISDDGSOCZAC-OHCGPUKPSA-N	433426	US10562850, Compound 56a::US11066360, Compound 56a	Plasma kallikrein		<50.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433426	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433426&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359338	438642357							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056176	CC(C)(C)[S@@](=O)NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2C[C@H](O)CN2C(=O)Nc2ccc(Cl)cc2)c1	InChI=1S/C35H39ClFN5O4S/c1-34(2,3)47(46)41-35(16-15-22-7-8-22,24-6-4-5-23(17-24)20-38)25-9-14-29(37)30(18-25)40-32(44)31-19-28(43)21-42(31)33(45)39-27-12-10-26(36)11-13-27/h4-6,9-14,17-18,22,28,31,41,43H,7-8,15-16,19,21H2,1-3H3,(H,39,45)(H,40,44)/t28-,31+,35?,47+/m0/s1	MJBIFAIWKFMNPW-CVFBLIOSSA-N	433427	US10562850, Compound 9b::US11066360, Compound 9b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433427	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433427&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			145750116	438642358							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056177	CCC1(O)C[C@@H](N(C1)C(=O)OC(C)(C)C)C(=O)Nc1cc(ccc1F)C(CCC1CC1)(N[S@@](=O)C(C)(C)C)c1ccccn1	InChI=1S/C33H47FN4O5S/c1-8-32(41)20-26(38(21-32)29(40)43-30(2,3)4)28(39)36-25-19-23(14-15-24(25)34)33(17-16-22-12-13-22,27-11-9-10-18-35-27)37-44(42)31(5,6)7/h9-11,14-15,18-19,22,26,37,41H,8,12-13,16-17,20-21H2,1-7H3,(H,36,39)/t26-,32?,33?,44+/m1/s1	LFTPBCWVQLYAOS-PAOCNZHCSA-N	433428	US10562850, Compound 38d::US11066360, Compound 38d	Plasma kallikrein		<50.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433428	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433428&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			145750041	438642359							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056178	CCNC(CCC1CC1)(c1ccncc1)c1ccc(F)c(NC(=O)[C@H]2C[C@H](CN2C(=O)Nc2ccc(Cl)cn2)OC)c1	InChI=1S/C31H36ClFN6O3/c1-3-36-31(13-10-20-4-5-20,21-11-14-34-15-12-21)22-6-8-25(33)26(16-22)37-29(40)27-17-24(42-2)19-39(27)30(41)38-28-9-7-23(32)18-35-28/h6-9,11-12,14-16,18,20,24,27,36H,3-5,10,13,17,19H2,1-2H3,(H,37,40)(H,35,38,41)/t24-,27-,31?/m1/s1	QJDWRBFXQVIGMO-QPLSPKJVSA-N	433429	US10562850, Compound 77a::US11066360, Compound 77a	Plasma kallikrein		<50.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433429	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433429&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359543	438642360							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056179	CO[C@H]1C[C@H](N(C1)C(=O)Nc1ccc(Cl)cc1)C(=O)Nc1cc(ccc1F)C(CCC1CC1)(N[S@](=O)C(C)(C)C)c1cccc(c1)C#N	InChI=1S/C36H41ClFN5O4S/c1-35(2,3)48(46)42-36(17-16-23-8-9-23,25-7-5-6-24(18-25)21-39)26-10-15-30(38)31(19-26)41-33(44)32-20-29(47-4)22-43(32)34(45)40-28-13-11-27(37)12-14-28/h5-7,10-15,18-19,23,29,32,42H,8-9,16-17,20,22H2,1-4H3,(H,40,45)(H,41,44)/t29-,32-,36?,48+/m0/s1	FHFCUESMMUURQU-AITDCACWSA-N	433430	US10562850, Compound 11d::US11066360, Compound 11d	Plasma kallikrein		>100.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433430	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433430&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359327	438642361							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056180	NC(CCC1CC1)(c1ccncc1)c1ccc(F)c(NC(=O)[C@H]2C[C@@](O)(CN2C(=O)Nc2ccc(Cl)cn2)c2ccccc2)c1	InChI=1S/C34H34ClFN6O3/c35-26-9-11-30(39-20-26)41-32(44)42-21-33(45,23-4-2-1-3-5-23)19-29(42)31(43)40-28-18-25(8-10-27(28)36)34(37,15-12-22-6-7-22)24-13-16-38-17-14-24/h1-5,8-11,13-14,16-18,20,22,29,45H,6-7,12,15,19,21,37H2,(H,40,43)(H,39,41,44)/t29-,33-,34?/m1/s1	FRTGSCXDLYWPRX-KLPUMSTOSA-N	433431	US10562850, Compound 39h::US11066360, Compound 39h	Plasma kallikrein		<50.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433431	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433431&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359380	438642362							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056181	CO[C@@]1(C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C30H31ClF4N6O3/c1-44-28(30(33,34)35)15-24(41(17-28)27(43)40-25-7-5-21(31)16-38-25)26(42)39-23-14-20(4-6-22(23)32)29(36,11-8-18-2-3-18)19-9-12-37-13-10-19/h4-7,9-10,12-14,16,18,24H,2-3,8,11,15,17,36H2,1H3,(H,39,42)(H,38,40,43)/t24-,28-,29?/m1/s1	LTSHZLULDHEDGR-KWPCEPOYSA-N	433432	US10562850, Compound 57d::US11066360, Compound 57d	Plasma kallikrein		<50.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433432	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433432&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359642	438642363							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056182	CC(C)(C)[S@@](=O)NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2CCCN2C(=O)OCc2ccccc2)c1	InChI=1S/C36H41FN4O4S/c1-35(2,3)46(44)40-36(19-18-25-14-15-25,28-12-7-11-27(21-28)23-38)29-16-17-30(37)31(22-29)39-33(42)32-13-8-20-41(32)34(43)45-24-26-9-5-4-6-10-26/h4-7,9-12,16-17,21-22,25,32,40H,8,13-15,18-20,24H2,1-3H3,(H,39,42)/t32-,36?,46-/m1/s1	QQQBZZFKCABGOT-BJXIDKMJSA-N	433433	US10562850, Compound 12b::US11066360, Compound 12b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433433	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433433&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			145750178	438642364							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056183	NC(CCC1CC1)(c1ccncc1)c1ccc(F)c(NC(=O)[C@H]2C[C@@](O)(CN2C(=O)Nc2ccc(Cl)cc2)c2ccccc2)c1	InChI=1S/C35H35ClFN5O3/c36-27-9-11-28(12-10-27)40-33(44)42-22-34(45,24-4-2-1-3-5-24)21-31(42)32(43)41-30-20-26(8-13-29(30)37)35(38,17-14-23-6-7-23)25-15-18-39-19-16-25/h1-5,8-13,15-16,18-20,23,31,45H,6-7,14,17,21-22,38H2,(H,40,44)(H,41,43)/t31-,34-,35?/m1/s1	XGAOCKOVDHHBDP-XUTBDEIESA-N	433434	US10562850, Compound 40a::US11066360, Compound 40a	Plasma kallikrein		<50.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433434	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433434&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359646	438642365							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056184	CNC(CCC1CC1)(c1ccncc1)c1ccc(F)c(NC(=O)[C@H]2C[C@@](O)(CN2C(=O)Nc2ccc(Cl)cn2)c2ccccc2)c1	InChI=1S/C35H36ClFN6O3/c1-38-35(16-13-23-7-8-23,25-14-17-39-18-15-25)26-9-11-28(37)29(19-26)41-32(44)30-20-34(46,24-5-3-2-4-6-24)22-43(30)33(45)42-31-12-10-27(36)21-40-31/h2-6,9-12,14-15,17-19,21,23,30,38,46H,7-8,13,16,20,22H2,1H3,(H,41,44)(H,40,42,45)/t30-,34-,35?/m1/s1	BQQGWVYCWOCVBA-WELJHWQCSA-N	433435	US10562850, Compound 41a::US11066360, Compound 41a	Plasma kallikrein		<50.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433435	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433435&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359385	438642366							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056185	CC(C)(C)[S@@](=O)NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2C[C@@H](O)CN2C(=O)Nc2ccc(cc2)C(F)(F)F)c1	InChI=1S/C36H39F4N5O4S/c1-34(2,3)50(49)44-35(16-15-22-7-8-22,25-6-4-5-23(17-25)20-41)26-11-14-29(37)30(18-26)43-32(47)31-19-28(46)21-45(31)33(48)42-27-12-9-24(10-13-27)36(38,39)40/h4-6,9-14,17-18,22,28,31,44,46H,7-8,15-16,19,21H2,1-3H3,(H,42,48)(H,43,47)/t28-,31-,35?,50-/m1/s1	LTFUBQNOSSPCKY-VGEWIOIYSA-N	433436	US10562850, Compound 27a::US11066360, Compound 27a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433436	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433436&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			141522419	438642367							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056186	NC(CCC1CC1)(c1ccncc1)c1ccc(F)c(NC(=O)[C@H]2C[C@@H](CN2C(=O)Nc2ccc(Cl)cn2)c2ccccc2)c1	InChI=1S/C34H34ClFN6O2/c35-27-9-11-31(39-20-27)41-33(44)42-21-24(23-4-2-1-3-5-23)18-30(42)32(43)40-29-19-26(8-10-28(29)36)34(37,15-12-22-6-7-22)25-13-16-38-17-14-25/h1-5,8-11,13-14,16-17,19-20,22,24,30H,6-7,12,15,18,21,37H2,(H,40,43)(H,39,41,44)/t24-,30+,34?/m0/s1	DYWQLBIPOOGHBX-DDNXYRJESA-N	433438	US10562850, Compound 47d::US11066360, Compound 47d	Plasma kallikrein		 75.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433438	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433438&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359360	438642369							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056187	CCO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1cccc(c1)C#N	InChI=1S/C31H32ClFN6O3/c1-2-42-24-14-27(39(18-24)31(41)38-28-11-9-23(32)17-35-28)30(40)37-26-13-22(8-10-25(26)33)29(36-16-19-6-7-19)21-5-3-4-20(12-21)15-34/h3-5,8-13,17,19,24,27,29,36H,2,6-7,14,16,18H2,1H3,(H,37,40)(H,35,38,41)/t24-,27-,29?/m1/s1	GBDNLKBWBYVNQM-MPXLCVCVSA-N	433439	US10562850, Compound 58j::US11066360, Compound 58j	Plasma kallikrein		<50.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433439	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433439&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359574	438642370							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056188	NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2C[C@@](O)(CN2)c2ccccc2)c1	InChI=1S/C30H31FN4O2/c31-25-12-11-24(30(33,14-13-20-9-10-20)23-8-4-5-21(15-23)18-32)16-26(25)35-28(36)27-17-29(37,19-34-27)22-6-2-1-3-7-22/h1-8,11-12,15-16,20,27,34,37H,9-10,13-14,17,19,33H2,(H,35,36)/t27-,29-,30?/m1/s1	JALINIFPYUQJSU-MODKJIOJSA-N	433440	US10562850, Compound 29d::US11066360, Compound 29d	Plasma kallikrein		>100.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433440	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433440&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359296	438642371							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056189	C[C@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1	InChI=1S/C29H32ClFN6O2/c1-18-14-25(37(17-18)28(39)36-26-7-5-22(30)16-34-26)27(38)35-24-15-21(4-6-23(24)31)29(32,11-8-19-2-3-19)20-9-12-33-13-10-20/h4-7,9-10,12-13,15-16,18-19,25H,2-3,8,11,14,17,32H2,1H3,(H,35,38)(H,34,36,39)/t18-,25+,29?/m0/s1	VKZOYNOIAPSODG-MEPMZUDESA-N	433441	US10562850, Compound 48d::US11066360, Compound 48d	Plasma kallikrein		<50.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433441	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433441&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359603	438642372							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056190	NC(CCC1CC1)(c1ccncc1)c1ccc(F)c(NC(=O)[C@H]2C[C@@](O)(CN2C(=O)Nc2ccc(Cl)cn2)C2CC2)c1	InChI=1S/C31H34ClFN6O3/c32-23-6-8-27(36-17-23)38-29(41)39-18-30(42,20-3-4-20)16-26(39)28(40)37-25-15-22(5-7-24(25)33)31(34,12-9-19-1-2-19)21-10-13-35-14-11-21/h5-8,10-11,13-15,17,19-20,26,42H,1-4,9,12,16,18,34H2,(H,37,40)(H,36,38,41)/t26-,30-,31?/m1/s1	NPTYSNQRJNJEBG-FIWLTRSASA-N	433443	US10562850, Compound 59d::US11066360, Compound 59d	Plasma kallikrein		<50.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433443	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433443&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359499	438642374							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056191	CC(C)(C)[S@@](=O)NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2C[C@@H](CN2C(=O)Nc2ccc(Cl)cc2)N=[N+]=[N-])c1	InChI=1S/C35H38ClFN8O3S/c1-34(2,3)49(48)43-35(16-15-22-7-8-22,24-6-4-5-23(17-24)20-38)25-9-14-29(37)30(18-25)41-32(46)31-19-28(42-44-39)21-45(31)33(47)40-27-12-10-26(36)11-13-27/h4-6,9-14,17-18,22,28,31,43H,7-8,15-16,19,21H2,1-3H3,(H,40,47)(H,41,46)/t28-,31+,35?,49+/m0/s1	DDAHRDRLWWWJFX-IOQIPRRTSA-N	433444	US10562850, Compound 33b::US11066360, Compound 33b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433444	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433444&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			145750144	438642375							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056192	C[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1	InChI=1S/C29H32ClFN6O2/c1-18-14-25(37(17-18)28(39)36-26-7-5-22(30)16-34-26)27(38)35-24-15-21(4-6-23(24)31)29(32,11-8-19-2-3-19)20-9-12-33-13-10-20/h4-7,9-10,12-13,15-16,18-19,25H,2-3,8,11,14,17,32H2,1H3,(H,35,38)(H,34,36,39)/t18-,25-,29?/m1/s1	VKZOYNOIAPSODG-OYRGDXRMSA-N	433445	US10562850, Compound 49d::US11066360, Compound 49d	Plasma kallikrein		 75.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433445	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433445&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359583	438642376							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056193	CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(CCC1CC1)N1CCCCC1=O	InChI=1S/C29H35ClFN5O4/c1-40-21-15-25(36(17-21)29(39)34-26-12-9-20(30)16-32-26)28(38)33-23-14-19(8-10-22(23)31)24(11-7-18-5-6-18)35-13-3-2-4-27(35)37/h8-10,12,14,16,18,21,24-25H,2-7,11,13,15,17H2,1H3,(H,33,38)(H,32,34,39)/t21-,24?,25-/m1/s1	UWRIUUXMKXAKLB-TYIXABJVSA-N	433446	US10562850, Compound 44e::US11066360, Compound 44e	Plasma kallikrein		>100.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433446	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433446&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359289	438642377							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056194	CO[C@@]1(C[C@@H](N(C1)C(=O)OC(C)(C)C)C(=O)Nc1cc(ccc1F)C(CCC1CC1)(N[S@@](=O)C(C)(C)C)c1ccccn1)c1ccccc1	InChI=1S/C38H49FN4O5S/c1-35(2,3)48-34(45)43-25-37(47-7,27-13-9-8-10-14-27)24-31(43)33(44)41-30-23-28(18-19-29(30)39)38(21-20-26-16-17-26,32-15-11-12-22-40-32)42-49(46)36(4,5)6/h8-15,18-19,22-23,26,31,42H,16-17,20-21,24-25H2,1-7H3,(H,41,44)/t31-,37-,38?,49+/m1/s1	WSLPEHAMZHBFSH-DQCGMSCASA-N	433447	US10562850, Compound 34b::US11066360, Compound 34b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433447	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433447&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			145750087	438642378							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056195	CCCO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1	InChI=1S/C31H36ClFN6O3/c1-2-15-42-24-17-27(39(19-24)30(41)38-28-8-6-23(32)18-36-28)29(40)37-26-16-22(5-7-25(26)33)31(34,12-9-20-3-4-20)21-10-13-35-14-11-21/h5-8,10-11,13-14,16,18,20,24,27H,2-4,9,12,15,17,19,34H2,1H3,(H,37,40)(H,36,38,41)/t24-,27-,31?/m1/s1	STHHQVRGMGLOTE-QPLSPKJVSA-N	433448	US10562850, Compound 52d::US11066360, Compound 52d	Plasma kallikrein		<50.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433448	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433448&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359656	438642379							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056196	CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccccc1=O	InChI=1S/C29H31ClFN5O4/c1-40-21-15-25(36(17-21)29(39)34-26-12-9-20(30)16-32-26)28(38)33-23-14-19(8-10-22(23)31)24(11-7-18-5-6-18)35-13-3-2-4-27(35)37/h2-4,8-10,12-14,16,18,21,24-25H,5-7,11,15,17H2,1H3,(H,33,38)(H,32,34,39)/t21-,24?,25-/m1/s1	XUORFTPJFLKHSK-TYIXABJVSA-N	433449	US10562850, Compound 42l::US10562850, Compound 43m::US11066360, Compound 43m	Plasma kallikrein		 75.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433449	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433449&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359367	438642380							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056197	CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)s1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1	InChI=1S/C28H31ClFN5O3S/c1-38-20-15-23(35(16-20)27(37)34-25-7-6-24(29)39-25)26(36)33-22-14-19(4-5-21(22)30)28(31,11-8-17-2-3-17)18-9-12-32-13-10-18/h4-7,9-10,12-14,17,20,23H,2-3,8,11,15-16,31H2,1H3,(H,33,36)(H,34,37)/t20-,23-,28?/m1/s1	VSBGZUFFBZVRNX-JLGCCPRNSA-N	433450	US10562850, Compound 81h::US11066360, Compound 81h	Plasma kallikrein		<50.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433450	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433450&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359293	438642381							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056198	NC(CCC1CC1)(c1ccncc1)c1ccc(F)c(NC(=O)[C@H]2CC(F)(F)CN2C(=O)Nc2ccc(Cl)cn2)c1	InChI=1S/C28H28ClF3N6O2/c29-20-4-6-24(35-15-20)37-26(40)38-16-27(31,32)14-23(38)25(39)36-22-13-19(3-5-21(22)30)28(33,10-7-17-1-2-17)18-8-11-34-12-9-18/h3-6,8-9,11-13,15,17,23H,1-2,7,10,14,16,33H2,(H,36,39)(H,35,37,40)/t23-,28?/m1/s1	MXPGAAAGVICXGQ-YFIOFSHDSA-N	433451	US10562850, Compound 53d::US11066360, Compound 53d	Plasma kallikrein		<50.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433451	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433451&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359378	438642382							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056199	CO[C@@]1(C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1)c1ccccc1	InChI=1S/C35H36ClFN6O3/c1-46-34(24-5-3-2-4-6-24)20-30(43(22-34)33(45)42-31-12-10-27(36)21-40-31)32(44)41-29-19-26(9-11-28(29)37)35(38,16-13-23-7-8-23)25-14-17-39-18-15-25/h2-6,9-12,14-15,17-19,21,23,30H,7-8,13,16,20,22,38H2,1H3,(H,41,44)(H,40,42,45)/t30-,34-,35?/m1/s1	OHOVUWGMVUKSAR-WELJHWQCSA-N	433452	US10562850, Compound 45c::US11066360, Compound 45c	Plasma kallikrein		>100.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433452	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433452&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359481	438642383							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056200	CNC(CCC1CC1)(c1ccnc(C)c1)c1ccc(F)c(NC(=O)[C@H]2C[C@H](CN2C(=O)Nc2ccc(Cl)cn2)OC)c1	InChI=1S/C31H36ClFN6O3/c1-19-14-22(11-13-35-19)31(34-2,12-10-20-4-5-20)21-6-8-25(33)26(15-21)37-29(40)27-16-24(42-3)18-39(27)30(41)38-28-9-7-23(32)17-36-28/h6-9,11,13-15,17,20,24,27,34H,4-5,10,12,16,18H2,1-3H3,(H,37,40)(H,36,38,41)/t24-,27-,31?/m1/s1	XOXPJMACNDGQNW-QPLSPKJVSA-N	433453	US10562850, Compound 79a::US11066360, Compound 79a	Plasma kallikrein		<50.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433453	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433453&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359239	438642384							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056201	CCO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1	InChI=1S/C30H34ClFN6O3/c1-2-41-23-16-26(38(18-23)29(40)37-27-8-6-22(31)17-35-27)28(39)36-25-15-21(5-7-24(25)32)30(33,12-9-19-3-4-19)20-10-13-34-14-11-20/h5-8,10-11,13-15,17,19,23,26H,2-4,9,12,16,18,33H2,1H3,(H,36,39)(H,35,37,40)/t23-,26-,30?/m1/s1	ZLNHEWKEIZHPQN-JRSXUWQBSA-N	433454	US10562850, Compound 51b::US11066360, Compound 51b	Plasma kallikrein		<50.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433454	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433454&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359548	438642385							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056202	CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccnc(C)c1	InChI=1S/C30H34ClFN6O3/c1-18-13-21(10-12-34-18)30(33,11-9-19-3-4-19)20-5-7-24(32)25(14-20)36-28(39)26-15-23(41-2)17-38(26)29(40)37-27-8-6-22(31)16-35-27/h5-8,10,12-14,16,19,23,26H,3-4,9,11,15,17,33H2,1-2H3,(H,36,39)(H,35,37,40)/t23-,26-,30?/m1/s1	LPEGODAKCBEEGJ-JRSXUWQBSA-N	433455	US10562850, Compound 46k::US11066360, Compound 46k	Plasma kallikrein		<50.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433455	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433455&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359589	438642386							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056203	CCNC(CCC1CC1)(c1ccnc(C)c1)c1ccc(F)c(NC(=O)[C@H]2C[C@H](CN2C(=O)Nc2ccc(Cl)cn2)OC)c1	InChI=1S/C32H38ClFN6O3/c1-4-37-32(13-11-21-5-6-21,23-12-14-35-20(2)15-23)22-7-9-26(34)27(16-22)38-30(41)28-17-25(43-3)19-40(28)31(42)39-29-10-8-24(33)18-36-29/h7-10,12,14-16,18,21,25,28,37H,4-6,11,13,17,19H2,1-3H3,(H,38,41)(H,36,39,42)/t25-,28-,32?/m1/s1	GNWSEMQWKUFLTO-OHCGPUKPSA-N	433456	US10562850, Compound 78a::US11066360, Compound 78a	Plasma kallikrein		<50.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433456	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433456&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359318	438642387							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056204	CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(CCC1CC1)(NC(C)=O)c1ccncc1	InChI=1S/C31H34ClFN6O4/c1-19(40)38-31(12-9-20-3-4-20,21-10-13-34-14-11-21)22-5-7-25(33)26(15-22)36-29(41)27-16-24(43-2)18-39(27)30(42)37-28-8-6-23(32)17-35-28/h5-8,10-11,13-15,17,20,24,27H,3-4,9,12,16,18H2,1-2H3,(H,36,41)(H,38,40)(H,35,37,42)/t24-,27-,31?/m1/s1	YDKUZDQMWDWMAQ-QPLSPKJVSA-N	433457	US10562850, Compound 73a::US11066360, Compound 73a	Plasma kallikrein		<50.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433457	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433457&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359571	438642388							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056205	CC(C)(C)[S@@](=O)NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)Nc2ccc(Cl)cc2)c1	InChI=1S/C35H39ClFN5O4S/c1-34(2,3)47(46)41-35(16-15-22-7-8-22,24-6-4-5-23(17-24)20-38)25-9-14-29(37)30(18-25)40-32(44)31-19-28(43)21-42(31)33(45)39-27-12-10-26(36)11-13-27/h4-6,9-14,17-18,22,28,31,41,43H,7-8,15-16,19,21H2,1-3H3,(H,39,45)(H,40,44)/t28-,31+,35?,47-/m1/s1	MJBIFAIWKFMNPW-JMDKQSTQSA-N	433458	US10562850, Compound 5d::US11066360, Compound 5d	Plasma kallikrein		>100.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433458	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433458&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			145750036	438642389					C04398		1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056206	NC(CCC1CC1)(c1ccncc1)c1ccc(F)c(NC(=O)[C@H]2C[C@H]3C[C@H]3N2)c1	InChI=1S/C23H27FN4O/c24-18-4-3-17(13-20(18)28-22(29)21-12-15-11-19(15)27-21)23(25,8-5-14-1-2-14)16-6-9-26-10-7-16/h3-4,6-7,9-10,13-15,19,21,27H,1-2,5,8,11-12,25H2,(H,28,29)/t15-,19-,21-,23?/m1/s1	NFWCRWGBHZCTPQ-PUJXVWCHSA-N	433459	US10562850, Compound 80c::US11066360, Compound 80c	Plasma kallikrein		 75.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433459	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433459&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359660	438642390							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056207	CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(CCC1CC1)(NS(C)(=O)=O)c1ccncc1	InChI=1S/C30H34ClFN6O5S/c1-43-23-16-26(38(18-23)29(40)36-27-8-6-22(31)17-34-27)28(39)35-25-15-21(5-7-24(25)32)30(37-44(2,41)42,12-9-19-3-4-19)20-10-13-33-14-11-20/h5-8,10-11,13-15,17,19,23,26,37H,3-4,9,12,16,18H2,1-2H3,(H,35,39)(H,34,36,40)/t23-,26-,30?/m1/s1	QWHRSMIIATYYJL-JRSXUWQBSA-N	433460	US10562850, Compound 74a::US11066360, Compound 74a	Plasma kallikrein		<50.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433460	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433460&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359654	438642391							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056208	CO[C@@H]1C[C@H](N(C1)C(=O)N(C)c1ccc(Cl)cc1)C(=O)Nc1cc(ccc1F)C(CCC1CC1)(N[S@](=O)C(C)(C)C)c1cccc(c1)C#N	InChI=1S/C37H43ClFN5O4S/c1-36(2,3)49(47)42-37(18-17-24-9-10-24,26-8-6-7-25(19-26)22-40)27-11-16-31(39)32(20-27)41-34(45)33-21-30(48-5)23-44(33)35(46)43(4)29-14-12-28(38)13-15-29/h6-8,11-16,19-20,24,30,33,42H,9-10,17-18,21,23H2,1-5H3,(H,41,45)/t30-,33+,37?,49-/m1/s1	QHCSTFXYRQGZKO-PCMIATBVSA-N	433461	US10562850, Compound 6d::US11066360, Compound 6d	Plasma kallikrein		>100.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433461	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433461&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359575	438642392							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056209	CO[C@@H]1C[C@@H](N(C1)C(=O)c1ccc2cc[nH]c2c1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1	InChI=1S/C32H34FN5O3/c1-41-25-18-29(38(19-25)31(40)22-5-4-21-9-15-36-27(21)16-22)30(39)37-28-17-24(6-7-26(28)33)32(34,12-8-20-2-3-20)23-10-13-35-14-11-23/h4-7,9-11,13-17,20,25,29,36H,2-3,8,12,18-19,34H2,1H3,(H,37,39)/t25-,29-,32?/m1/s1	MPOMDZOLMQUDDS-UCGPOHEZSA-N	433462	US10562850, Compound 82a::US11066360, Compound 82a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433462	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433462&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135281871	438642393							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056210	NC(CCC1CC1)(c1ccncc1)c1ccc(F)c(NC(=O)[C@H]2C[C@@](O)(CN2C(=O)Nc2ccc(Cl)cn2)C(F)(F)F)c1	InChI=1S/C29H29ClF4N6O3/c30-20-4-6-24(37-15-20)39-26(42)40-16-27(43,29(32,33)34)14-23(40)25(41)38-22-13-19(3-5-21(22)31)28(35,10-7-17-1-2-17)18-8-11-36-12-9-18/h3-6,8-9,11-13,15,17,23,43H,1-2,7,10,14,16,35H2,(H,38,41)(H,37,39,42)/t23-,27-,28?/m1/s1	VGCFWQXZFXYVKN-AFJRLBRLSA-N	433463	US10562850, Compound 54g::US11066360, Compound 54g	Plasma kallikrein		<50.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433463	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433463&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359502	438642394							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056211	CO[C@@H]1C[C@@H](N(C1)C(=O)N(C)c1ccc(Cl)cc1)C(=O)Nc1cc(ccc1F)C(CCC1CC1)(N[S@](=O)C(C)(C)C)c1cccc(c1)C#N	InChI=1S/C37H43ClFN5O4S/c1-36(2,3)49(47)42-37(18-17-24-9-10-24,26-8-6-7-25(19-26)22-40)27-11-16-31(39)32(20-27)41-34(45)33-21-30(48-5)23-44(33)35(46)43(4)29-14-12-28(38)13-15-29/h6-8,11-16,19-20,24,30,33,42H,9-10,17-18,21,23H2,1-5H3,(H,41,45)/t30-,33-,37?,49-/m1/s1	QHCSTFXYRQGZKO-VVHKCOIQSA-N	433464	US10562850, Compound 6c::US11066360, Compound 6c	Plasma kallikrein		>100.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433464	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433464&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			145750114	438642395							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056212	CO[C@@H]1C[C@@H](N(C1)C(=O)c1ccc2c(Cl)c[nH]c2c1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1	InChI=1S/C32H33ClFN5O3/c1-42-23-16-29(39(18-23)31(41)20-4-6-24-25(33)17-37-27(24)14-20)30(40)38-28-15-22(5-7-26(28)34)32(35,11-8-19-2-3-19)21-9-12-36-13-10-21/h4-7,9-10,12-15,17,19,23,29,37H,2-3,8,11,16,18,35H2,1H3,(H,38,40)/t23-,29-,32?/m1/s1	WCQRTVWTSVWTGK-ULZFTAANSA-N	433465	US10562850, Compound 83a::US11066360, Compound 83a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433465	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433465&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135281889	438642396							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056213	CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Cc1cc(ccc1F)C(CCC1CC1)n1ccccc1=O	InChI=1S/C29H30ClFN5O4/c1-40-21-15-25(36(17-21)29(39)34-26-12-9-20(30)16-32-26)28(38)33-23-14-19(8-10-22(23)31)24(11-7-18-5-6-18)35-13-3-2-4-27(35)37/h2-4,8-10,12-14,16,18,21,24-25H,5-7,11,15,17H2,1H3,(H,32,34,39)/t21-,24?,25-/m1/s1	IXQPOQAVALSLDF-TYIXABJVSA-N	433466	US10562850, Compound 42l::US11066360, Compound 42l	Plasma kallikrein		<50.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433466	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433466&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056214	CC(C)(C)[S@@](=O)NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2CCCN2C(=O)Nc2ccc(Cl)cc2)c1	InChI=1S/C35H39ClFN5O3S/c1-34(2,3)46(45)41-35(18-17-23-9-10-23,25-7-4-6-24(20-25)22-38)26-11-16-29(37)30(21-26)40-32(43)31-8-5-19-42(31)33(44)39-28-14-12-27(36)13-15-28/h4,6-7,11-16,20-21,23,31,41H,5,8-10,17-19H2,1-3H3,(H,39,44)(H,40,43)/t31-,35?,46-/m1/s1	QMMABOBRWWOXDM-BLQLWLDUSA-N	433467	US10562850, Compound 7b::US11066360, Compound 7b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433467	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433467&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			145750056	438642397							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056215	CO[C@@H]1C[C@@H](N(C1)C(=O)c1ccc(Cl)c(N)c1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1	InChI=1S/C30H33ClFN5O3/c1-40-22-16-27(37(17-22)29(39)19-4-6-23(31)25(33)14-19)28(38)36-26-15-21(5-7-24(26)32)30(34,11-8-18-2-3-18)20-9-12-35-13-10-20/h4-7,9-10,12-15,18,22,27H,2-3,8,11,16-17,33-34H2,1H3,(H,36,38)/t22-,27-,30?/m1/s1	SUBHSHKRDIKUKN-MPCSXZBSSA-N	433468	US10562850, Compound 84a::US11066360, Compound 84a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433468	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433468&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135281821	438642398							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056216	CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cccc(c1)C(N)(CCC1CC1)c1ccncc1	InChI=1S/C29H33ClN6O3/c1-39-24-16-25(36(18-24)28(38)35-26-8-7-22(30)17-33-26)27(37)34-23-4-2-3-21(15-23)29(31,12-9-19-5-6-19)20-10-13-32-14-11-20/h2-4,7-8,10-11,13-15,17,19,24-25H,5-6,9,12,16,18,31H2,1H3,(H,34,37)(H,33,35,38)/t24-,25-,29?/m1/s1	NBIGEYRETZSFJW-COJIHYBUSA-N	433469	US10562850, Compound 75e::US11066360, Compound 75e	Plasma kallikrein		<50.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433469	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433469&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359567	438642399							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056217	CC(C)(C)[S@@](=O)NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@@H]2CCCN2C(=O)Nc2ccc(Cl)cc2)c1	InChI=1S/C35H39ClFN5O3S/c1-34(2,3)46(45)41-35(18-17-23-9-10-23,25-7-4-6-24(20-25)22-38)26-11-16-29(37)30(21-26)40-32(43)31-8-5-19-42(31)33(44)39-28-14-12-27(36)13-15-28/h4,6-7,11-16,20-21,23,31,41H,5,8-10,17-19H2,1-3H3,(H,39,44)(H,40,43)/t31-,35?,46+/m0/s1	QMMABOBRWWOXDM-GFRNEHCDSA-N	433470	US10562850, Compound 8b::US11066360, Compound 8b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433470	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433470&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			145750194	438642400							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056218	CO[C@@H]1C[C@@H](N(C1)C(=O)c1ccc(F)c(N)c1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1	InChI=1S/C30H33F2N5O3/c1-40-22-16-27(37(17-22)29(39)19-4-6-23(31)25(33)14-19)28(38)36-26-15-21(5-7-24(26)32)30(34,11-8-18-2-3-18)20-9-12-35-13-10-20/h4-7,9-10,12-15,18,22,27H,2-3,8,11,16-17,33-34H2,1H3,(H,36,38)/t22-,27-,30?/m1/s1	YLALVSNPTPTFII-MPCSXZBSSA-N	433471	US10562850, Compound 85a::US11066360, Compound 85a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433471	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433471&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135281882	438642401							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056219	CO[C@@H]1C[C@@H](N(C1)C(=O)c1cccc(c1)C#N)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1	InChI=1S/C31H32FN5O3/c1-40-25-17-28(37(19-25)30(39)22-4-2-3-21(15-22)18-33)29(38)36-27-16-24(7-8-26(27)32)31(34,12-9-20-5-6-20)23-10-13-35-14-11-23/h2-4,7-8,10-11,13-16,20,25,28H,5-6,9,12,17,19,34H2,1H3,(H,36,38)/t25-,28-,31?/m1/s1	IYLXYRHOQVZYRJ-JADDJLNISA-N	433472	US10562850, Compound 86a::US11066360, Compound 86a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433472	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433472&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135281782	438642402							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1056220	CO[C@@H]1C[C@@H](N(C1)S(=O)(=O)c1cccc2c(Cl)cccc12)C(=O)Nc1cc(ccc1F)C(CCC1CC1)(N[S@](=O)C(C)(C)C)c1ccncc1	InChI=1S/C37H42ClFN4O5S2/c1-36(2,3)49(45)42-37(18-15-24-11-12-24,25-16-19-40-20-17-25)26-13-14-31(39)32(21-26)41-35(44)33-22-27(48-4)23-43(33)50(46,47)34-10-6-7-28-29(34)8-5-9-30(28)38/h5-10,13-14,16-17,19-21,24,27,33,42H,11-12,15,18,22-23H2,1-4H3,(H,41,44)/t27-,33-,37?,49-/m1/s1	HNTKROBOBZDWET-MYCXRTHGSA-N	433473	US10562850, Compound 87b::US11066360, Compound 87b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2SX6HCG		aid1805673	US11066360	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433473	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433473&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			145750019	438642403							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1035599	COCc1nn(Cc2cnc3cc(Cl)ccc3c2)cc1C(=O)NCc1cccc(OC)c1F	InChI=1S/C24H22ClFN4O3/c1-32-14-21-19(24(31)28-11-17-4-3-5-22(33-2)23(17)26)13-30(29-21)12-15-8-16-6-7-18(25)9-20(16)27-10-15/h3-10,13H,11-12,14H2,1-2H3,(H,28,31)	WPIUJKAYUGBTDW-UHFFFAOYSA-N	408667	1-(7-Chloro-quinolin-3-ylmethyl)-3-methoxymethyl-1H-pyrazole-4-carboxylic acid 2-fluoro-3-methoxy-benzylamide::US10364238, Example 3::US11001578, Example 3::US11084809, Example 3::US11198691, Example 3	Plasma kallikrein			 2580							US Patent		10.7270/Q2PK0K89		aid1805550	US11001578	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KALVISTA PHARMACEUTICALS LIMITED	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408667	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408667&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365013	406799301							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107519	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C24H31ClN10O3S/c1-29-20(36)15(4-2-3-7-30-24(27)28)32-21(37)17-12-39-22(33-17)18-8-14(26)10-35(18)23(38)16-11-34-9-13(25)5-6-19(34)31-16/h5-6,9,11-12,14-15,18H,2-4,7-8,10,26H2,1H3,(H,29,36)(H,32,37)(H4,27,28,30)/t14-,15+,18+/m1/s1	LLPPLVKHKYCFMU-VKJFTORMSA-N	524401	2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((S)-6- guanidino-1-(mcthylamino)-1- oxohexan-2-yl)thiazole-4-carboxamide::US11168083, Example 11	Plasma kallikrein					 32.0					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524401	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524401&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465010	461688798							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107524	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1CCCN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C24H30ClN9O3S/c1-28-20(35)15(5-2-3-9-29-24(26)27)31-21(36)17-13-38-22(32-17)18-6-4-10-34(18)23(37)16-12-33-11-14(25)7-8-19(33)30-16/h7-8,11-13,15,18H,2-6,9-10H2,1H3,(H,28,35)(H,31,36)(H4,26,27,29)/t15-,18-/m0/s1	JYHRVUUCZYFFGN-YJBOKZPZSA-N	524402	US11168083, Example 33	Plasma kallikrein					 3240					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524402	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524402&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137464944	461688799							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107529	N[C@@H]1C[C@H](N(C1)C(=O)c1cn2cc(Cl)ccc2n1)c1nc(cs1)C(=O)NCc1ncn2ccc(Cl)cc12	InChI=1S/C24H20Cl2N8O2S/c25-13-3-4-32-12-29-16(19(32)5-13)7-28-22(35)18-11-37-23(31-18)20-6-15(27)9-34(20)24(36)17-10-33-8-14(26)1-2-21(33)30-17/h1-5,8,10-12,15,20H,6-7,9,27H2,(H,28,35)/t15-,20+/m1/s1	FKQMDAAKAOWPEB-QRWLVFNGSA-N	524403	2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((7- chloroimidazo[1,5-a]pyridin-1- yl)methyl)thiazole-4-carboxamide::US11168083, Example 55	Plasma kallikrein					 15.0					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524403	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524403&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465054	461688800							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107534	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@H]1C[C@@H](N)CN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C24H31ClN10O3S/c1-29-20(36)15(4-2-3-7-30-24(27)28)32-21(37)17-12-39-22(33-17)18-8-14(26)10-35(18)23(38)16-11-34-9-13(25)5-6-19(34)31-16/h5-6,9,11-12,14-15,18H,2-4,7-8,10,26H2,1H3,(H,29,36)(H,32,37)(H4,27,28,30)/t14-,15+,18-/m1/s1	LLPPLVKHKYCFMU-RVKKMQEKSA-N	524404	2-((2R,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((S)-6- guanidino-1-(methylamino)-1- oxohexan-2-yl)thiazole-4-carboxamide::US11168083, Example 1	Plasma kallikrein					 3000					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524404	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524404&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465135	461688801							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107535	CNC(=O)[C@@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@H]1C[C@@H](N)CN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C24H31ClN10O3S/c1-29-20(36)15(4-2-3-7-30-24(27)28)32-21(37)17-12-39-22(33-17)18-8-14(26)10-35(18)23(38)16-11-34-9-13(25)5-6-19(34)31-16/h5-6,9,11-12,14-15,18H,2-4,7-8,10,26H2,1H3,(H,29,36)(H,32,37)(H4,27,28,30)/t14-,15-,18-/m1/s1	LLPPLVKHKYCFMU-IIDMSEBBSA-N	524405	2-((2R,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((R)-6- guanidino-1-(methylamino)-1- oxohexan-2-yl)thiazole-4-carboxamide::US11168083, Example 2	Plasma kallikrein					>9900					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524405	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524405&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465076	461688802							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107536	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@H]1CCCN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C24H30ClN9O3S/c1-28-20(35)15(5-2-3-9-29-24(26)27)31-21(36)17-13-38-22(32-17)18-6-4-10-34(18)23(37)16-12-33-11-14(25)7-8-19(33)30-16/h7-8,11-13,15,18H,2-6,9-10H2,1H3,(H,28,35)(H,31,36)(H4,26,27,29)/t15-,18+/m0/s1	JYHRVUUCZYFFGN-MAUKXSAKSA-N	524406	2-((R)-1-(6-Chloroimidazo[1,2-a]pyridine-2-carbonyl)pyrrolidin-2-yl)-N—((S)-6-guanidino-1-(methylamino)-1-oxohexan-2-yl)thiazole-4-carboxamide::US11168083, Example 3	Plasma kallikrein					>9900					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524406	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524406&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137473003	461688803							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107537	CNC(=O)[C@@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@H]1CCCN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C24H30ClN9O3S/c1-28-20(35)15(5-2-3-9-29-24(26)27)31-21(36)17-13-38-22(32-17)18-6-4-10-34(18)23(37)16-12-33-11-14(25)7-8-19(33)30-16/h7-8,11-13,15,18H,2-6,9-10H2,1H3,(H,28,35)(H,31,36)(H4,26,27,29)/t15-,18-/m1/s1	JYHRVUUCZYFFGN-CRAIPNDOSA-N	524407	US11168083, Example 4	Plasma kallikrein					>9900					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524407	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524407&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137473144	461688804							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107538	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@H]1C[C@H](CN1C(=O)c1cn2cc(Cl)ccc2n1)NC(C)=O	InChI=1S/C26H33ClN10O4S/c1-14(38)32-16-9-20(37(11-16)25(41)18-12-36-10-15(27)6-7-21(36)33-18)24-35-19(13-42-24)23(40)34-17(22(39)30-2)5-3-4-8-31-26(28)29/h6-7,10,12-13,16-17,20H,3-5,8-9,11H2,1-2H3,(H,30,39)(H,32,38)(H,34,40)(H4,28,29,31)/t16-,17+,20-/m1/s1	ZMMPESRTVFDXKA-FUHIMQAGSA-N	524408	2-((2R,4R)-4-acetamido-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((S)-6- guanidino-1-(methylamino)-1- oxohexan-2-yl)thiazole-4-carboxamide::US11168083, Example 5	Plasma kallikrein					>9900					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524408	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524408&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137464955	461688805							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107539	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@H]1C[C@H](N)CN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C24H31ClN10O3S/c1-29-20(36)15(4-2-3-7-30-24(27)28)32-21(37)17-12-39-22(33-17)18-8-14(26)10-35(18)23(38)16-11-34-9-13(25)5-6-19(34)31-16/h5-6,9,11-12,14-15,18H,2-4,7-8,10,26H2,1H3,(H,29,36)(H,32,37)(H4,27,28,30)/t14-,15-,18+/m0/s1	LLPPLVKHKYCFMU-RLFYNMQTSA-N	524409	2-((2R,4S)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((S)-6- guanidino-1-(mcthylamino)-1- oxohexan-2-yl)thiazole-4-carboxamide::US11168083, Example 6	Plasma kallikrein					 3000					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524409	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524409&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465082	461688806							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107540	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@H]1C[C@H](O)CN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C24H30ClN9O4S/c1-28-20(36)15(4-2-3-7-29-24(26)27)31-21(37)17-12-39-22(32-17)18-8-14(35)10-34(18)23(38)16-11-33-9-13(25)5-6-19(33)30-16/h5-6,9,11-12,14-15,18,35H,2-4,7-8,10H2,1H3,(H,28,36)(H,31,37)(H4,26,27,29)/t14-,15-,18+/m0/s1	GFAFFEOPNBYDEZ-RLFYNMQTSA-N	524410	US11168083, Example 7	Plasma kallikrein					>9900					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524410	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524410&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465029	461688807							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107541	CNC(=O)[C@@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@H]1C[C@H](O)CN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C24H30ClN9O4S/c1-28-20(36)15(4-2-3-7-29-24(26)27)31-21(37)17-12-39-22(32-17)18-8-14(35)10-34(18)23(38)16-11-33-9-13(25)5-6-19(33)30-16/h5-6,9,11-12,14-15,18,35H,2-4,7-8,10H2,1H3,(H,28,36)(H,31,37)(H4,26,27,29)/t14-,15+,18+/m0/s1	GFAFFEOPNBYDEZ-HDMKZQKVSA-N	524411	US11168083, Example 8	Plasma kallikrein					>9900					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524411	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524411&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137473024	461688808							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107542	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@H]1C[C@@H](O)CN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C24H30ClN9O4S/c1-28-20(36)15(4-2-3-7-29-24(26)27)31-21(37)17-12-39-22(32-17)18-8-14(35)10-34(18)23(38)16-11-33-9-13(25)5-6-19(33)30-16/h5-6,9,11-12,14-15,18,35H,2-4,7-8,10H2,1H3,(H,28,36)(H,31,37)(H4,26,27,29)/t14-,15+,18-/m1/s1	GFAFFEOPNBYDEZ-RVKKMQEKSA-N	524412	US11168083, Example 9	Plasma kallikrein					>9900					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524412	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524412&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465145	461688809							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107543	CNC(=O)[C@@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@H]1C[C@@H](O)CN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C24H30ClN9O4S/c1-28-20(36)15(4-2-3-7-29-24(26)27)31-21(37)17-12-39-22(32-17)18-8-14(35)10-34(18)23(38)16-11-33-9-13(25)5-6-19(33)30-16/h5-6,9,11-12,14-15,18,35H,2-4,7-8,10H2,1H3,(H,28,36)(H,31,37)(H4,26,27,29)/t14-,15-,18-/m1/s1	GFAFFEOPNBYDEZ-IIDMSEBBSA-N	524413	US11168083, Example 10	Plasma kallikrein					>9900					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524413	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524413&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137464993	461688810							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107544	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C24H31ClN10O3S/c1-29-20(36)15(4-2-3-7-30-24(27)28)32-21(37)17-12-39-22(33-17)18-8-14(26)10-35(18)23(38)16-11-34-9-13(25)5-6-19(34)31-16/h5-6,9,11-12,14-15,18H,2-4,7-8,10,26H2,1H3,(H,29,36)(H,32,37)(H4,27,28,30)/t14-,15+,18+/m1/s1	LLPPLVKHKYCFMU-VKJFTORMSA-N	524401	2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((S)-6- guanidino-1-(mcthylamino)-1- oxohexan-2-yl)thiazole-4-carboxamide::US11168083, Example 11	Plasma kallikrein					<100					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524401	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524401&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465010	461688798							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107545	CNC(=O)[C@@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C24H31ClN10O3S/c1-29-20(36)15(4-2-3-7-30-24(27)28)32-21(37)17-12-39-22(33-17)18-8-14(26)10-35(18)23(38)16-11-34-9-13(25)5-6-19(34)31-16/h5-6,9,11-12,14-15,18H,2-4,7-8,10,26H2,1H3,(H,29,36)(H,32,37)(H4,27,28,30)/t14-,15-,18+/m1/s1	LLPPLVKHKYCFMU-RKVPGOIHSA-N	524414	2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((R)-6- guanidino-1-(methylamino)-1- oxohexan-2-yl)thiazole-4-carboxamide::US11168083, Example 12::US11168083, Example 57	Plasma kallikrein					<100					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524414	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524414&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465120	461688811							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107546	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cn2ccccc2n1	InChI=1S/C24H32N10O3S/c1-28-20(35)15(6-2-4-8-29-24(26)27)31-21(36)17-13-38-22(32-17)18-10-14(25)11-34(18)23(37)16-12-33-9-5-3-7-19(33)30-16/h3,5,7,9,12-15,18H,2,4,6,8,10-11,25H2,1H3,(H,28,35)(H,31,36)(H4,26,27,29)/t14-,15+,18+/m1/s1	IQXORBRTZBSKJQ-VKJFTORMSA-N	524415	2-((2S,4R)-4-amino-1-(imidazo[1,2- a]pyridine-2-carbonyl)pyrrolidin-2-yl)- N-((S)-6-guanidino-1-(methylamino)- 1-oxohexan-2-yl)thiazole-4- carboxamide::US11168083, Example 13	Plasma kallikrein					 550					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524415	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524415&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465046	461688812							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107547	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cn(C)c(C)n1	InChI=1S/C22H34N10O3S/c1-12-28-15(10-31(12)3)21(35)32-9-13(23)8-17(32)20-30-16(11-36-20)19(34)29-14(18(33)26-2)6-4-5-7-27-22(24)25/h10-11,13-14,17H,4-9,23H2,1-3H3,(H,26,33)(H,29,34)(H4,24,25,27)/t13-,14+,17+/m1/s1	OMCCBPSINYKNOP-KEYYUXOJSA-N	524416	2-((2S,4R)-4-amino-1-(1,2-dimethyl- 1H-imidazole-4-carbonyl)pyrrolidin-2- yl)-N-((S)-6-guanidino-1- (methylamino)-1-oxohexan-2- yl)thiazole-4-carboxamide::US11168083, Example 14	Plasma kallikrein					>9900					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524416	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524416&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465111	461688813							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107548	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1ccccc1	InChI=1S/C23H32N8O3S/c1-27-19(32)16(9-5-6-10-28-23(25)26)29-20(33)17-13-35-21(30-17)18-11-15(24)12-31(18)22(34)14-7-3-2-4-8-14/h2-4,7-8,13,15-16,18H,5-6,9-12,24H2,1H3,(H,27,32)(H,29,33)(H4,25,26,28)/t15-,16+,18+/m1/s1	OCYCSLVKSPDLTL-RYRKJORJSA-N	524417	2-((2S,4R)-4-amino-1- benzoylpyrrolidin-2-yl)-N-((S)-6- guanidino-1-(methylamino)-1- oxohexan-2-yl)thiazole-4-carboxamide::US11168083, Example 15	Plasma kallikrein					>9900					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524417	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524417&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465048	461688814							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107549	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)OCc1cccc(Cl)c1	InChI=1S/C24H33ClN8O4S/c1-29-20(34)17(7-2-3-8-30-23(27)28)31-21(35)18-13-38-22(32-18)19-10-16(26)11-33(19)24(36)37-12-14-5-4-6-15(25)9-14/h4-6,9,13,16-17,19H,2-3,7-8,10-12,26H2,1H3,(H,29,34)(H,31,35)(H4,27,28,30)/t16-,17+,19+/m1/s1	PEWLWWZHNVFXPW-AOIWGVFYSA-N	524418	3-chlorobenzyl (2S,4R)-4-amino-2-(4- (((S)-6-guanidino-1-(methylamino)-1- oxohexan-2-yl)carbamoyl)thiazol-2- yl)pyrrolidine-1-carboxylate::US11168083, Example 16	Plasma kallikrein					 3000					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524418	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524418&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137473046	461688815							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107550	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)C1CCCCC1	InChI=1S/C23H38N8O3S/c1-27-19(32)16(9-5-6-10-28-23(25)26)29-20(33)17-13-35-21(30-17)18-11-15(24)12-31(18)22(34)14-7-3-2-4-8-14/h13-16,18H,2-12,24H2,1H3,(H,27,32)(H,29,33)(H4,25,26,28)/t15-,16+,18+/m1/s1	RAUVCEYTYCBNGN-RYRKJORJSA-N	524419	2-((2S,4R)-4-amino-l- (cyclohexanecarbonyl)pyrrolidin-2-yl)- N-((S)-6-guanidino-1-(methylamino)- 1-oxohexan-2-yl)thiazole-4- carboxamidc::US11168083, Example 17	Plasma kallikrein					>9900					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524419	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524419&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465035	461688816							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107551	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)C(C)C	InChI=1S/C20H34N8O3S/c1-11(2)19(31)28-9-12(21)8-15(28)18-27-14(10-32-18)17(30)26-13(16(29)24-3)6-4-5-7-25-20(22)23/h10-13,15H,4-9,21H2,1-3H3,(H,24,29)(H,26,30)(H4,22,23,25)/t12-,13+,15+/m1/s1	KSHXZRSWQOKILX-IPYPFGDCSA-N	524420	2-((2S,4R)-4-amino-1- isobutyrylpyrrolidin-2-yl)-N-((S)-6- guanidino-1-(methylamino)-1- oxohexan-2-yl)thiazole-4-carboxamide::US11168083, Example 18	Plasma kallikrein					>9900					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524420	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524420&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465126	461688817							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107552	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cn2cc(ccc2n1)C(F)(F)F	InChI=1S/C25H31F3N10O3S/c1-32-20(39)15(4-2-3-7-33-24(30)31)35-21(40)17-12-42-22(36-17)18-8-14(29)10-38(18)23(41)16-11-37-9-13(25(26,27)28)5-6-19(37)34-16/h5-6,9,11-12,14-15,18H,2-4,7-8,10,29H2,1H3,(H,32,39)(H,35,40)(H4,30,31,33)/t14-,15+,18+/m1/s1	KOVNKSCBSLWDLG-VKJFTORMSA-N	524421	2-((2S,4R)-4-amino-1-(6- (trifluoromethyl)imidazo[1,2- a]pyridine-2-carbonyl)pyrrolidin-2-yl)- N-((S)-6-guanidino-1-(methylamino)- 1-oxohexan-2-yl)thiazole-4- carboxamide::US11168083, Example 19	Plasma kallikrein					<100					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524421	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524421&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465117	461688818							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107553	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cn2cc(OC)ccc2n1	InChI=1S/C25H34N10O4S/c1-29-21(36)16(5-3-4-8-30-25(27)28)32-22(37)18-13-40-23(33-18)19-9-14(26)10-35(19)24(38)17-12-34-11-15(39-2)6-7-20(34)31-17/h6-7,11-14,16,19H,3-5,8-10,26H2,1-2H3,(H,29,36)(H,32,37)(H4,27,28,30)/t14-,16+,19+/m1/s1	HZBXWCRJRXMOSH-ALKREAHSSA-N	524422	2-((2S,4R)-4-amino-1-(6- methoxyimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((S)-6- guanidino-1-(methylamino)-1- oxohexan-2-yl)thiazole-4-carboxamide::US11168083, Example 20	Plasma kallikrein					 550					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524422	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524422&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465115	461688819							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107554	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cn2cc(I)ccc2n1	InChI=1S/C24H31IN10O3S/c1-29-20(36)15(4-2-3-7-30-24(27)28)32-21(37)17-12-39-22(33-17)18-8-14(26)10-35(18)23(38)16-11-34-9-13(25)5-6-19(34)31-16/h5-6,9,11-12,14-15,18H,2-4,7-8,10,26H2,1H3,(H,29,36)(H,32,37)(H4,27,28,30)/t14-,15+,18+/m1/s1	RIBQIUQETAVSCK-VKJFTORMSA-N	524423	2-((2S,4R)-4-amino-1-(6- iodoimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((S)-6- guanidino-1-(methylamino)-1- oxohexan-2-yl)thiazole-4-carboxamide::US11168083, Example 21	Plasma kallikrein					<100					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524423	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524423&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465058	461688820							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107555	N[C@@H]1C[C@H](N(C1)C(=O)c1cn2cc(Cl)ccc2n1)c1nc(cs1)C(=O)N[C@@H](CCCCNC(N)=N)C(N)=O	InChI=1S/C23H29ClN10O3S/c24-12-4-5-18-30-15(10-33(18)8-12)22(37)34-9-13(25)7-17(34)21-32-16(11-38-21)20(36)31-14(19(26)35)3-1-2-6-29-23(27)28/h4-5,8,10-11,13-14,17H,1-3,6-7,9,25H2,(H2,26,35)(H,31,36)(H4,27,28,29)/t13-,14+,17+/m1/s1	YGODCUSSYXRBRZ-KEYYUXOJSA-N	524424	2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((S)-1- amino-6-guanidino-1-oxohexan-2- yl)thiazole-4-carboxamide::US11168083, Example 22	Plasma kallikrein					<100					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524424	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524424&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137464973	461688821							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107556	N[C@@H]1C[C@H](N(C1)C(=O)c1cn2cc(Cl)ccc2n1)c1nc(cs1)C(=O)N[C@@H](CCCCNC(N)=N)C(O)=O	InChI=1S/C23H28ClN9O4S/c24-12-4-5-18-29-15(10-32(18)8-12)21(35)33-9-13(25)7-17(33)20-31-16(11-38-20)19(34)30-14(22(36)37)3-1-2-6-28-23(26)27/h4-5,8,10-11,13-14,17H,1-3,6-7,9,25H2,(H,30,34)(H,36,37)(H4,26,27,28)/t13-,14+,17+/m1/s1	KXJUMARQSGTPDT-KEYYUXOJSA-N	524425	N2-(2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)thiazole-4- carbonyl)-N6-carbamimidoyl-L-lysine::US11168083, Example 23	Plasma kallikrein					<100					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524425	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524425&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465110	461688822							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107557	CN(C)C(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C25H33ClN10O3S/c1-34(2)23(38)16(5-3-4-8-30-25(28)29)32-21(37)18-13-40-22(33-18)19-9-15(27)11-36(19)24(39)17-12-35-10-14(26)6-7-20(35)31-17/h6-7,10,12-13,15-16,19H,3-5,8-9,11,27H2,1-2H3,(H,32,37)(H4,28,29,30)/t15-,16+,19+/m1/s1	BPUYBKGHVHAYKC-GJYPPUQNSA-N	524426	2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((S)-1- (dimcthylamino)-6-guanidino-1- oxohexan-2-yl)thiazole-4-carboxamide::US11168083, Example 24	Plasma kallikrein					 550					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524426	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524426&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465101	461688823							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107558	CNC(=O)[C@H](CCCCN)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C23H29ClN8O3S/c1-27-20(33)15(4-2-3-7-25)29-21(34)17-12-36-22(30-17)18-8-14(26)10-32(18)23(35)16-11-31-9-13(24)5-6-19(31)28-16/h5-6,9,11-12,14-15,18H,2-4,7-8,10,25-26H2,1H3,(H,27,33)(H,29,34)/t14-,15+,18+/m1/s1	IQKGPQDSABYVQE-VKJFTORMSA-N	524427	2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((S)-6- amino-1-(methylamino)-1-oxohexan-2- yl)thiazole-4-carboxamide::US11168083, Example 25	Plasma kallikrein					>9900					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524427	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524427&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465057	461688824							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107559	CNC(=O)[C@H](CCCCNC(C)=O)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C25H31ClN8O4S/c1-14(35)29-8-4-3-5-17(22(36)28-2)31-23(37)19-13-39-24(32-19)20-9-16(27)11-34(20)25(38)18-12-33-10-15(26)6-7-21(33)30-18/h6-7,10,12-13,16-17,20H,3-5,8-9,11,27H2,1-2H3,(H,28,36)(H,29,35)(H,31,37)/t16-,17+,20+/m1/s1	QREFANRJXDCKQV-UWVAXJGDSA-N	524428	N-((S)-6-acetamido-1-(methylamino)- 1-oxohexan-2-yl)-2-((2S,4R)-4-amino- 1-(6-chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)thiazole-4- carboxamide::US11168083, Example 26	Plasma kallikrein					>9900					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524428	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524428&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465095	461688825					C04149		1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107560	CNC(=O)[C@H](CCCCNC(N)=O)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C24H30ClN9O4S/c1-28-20(35)15(4-2-3-7-29-24(27)38)31-21(36)17-12-39-22(32-17)18-8-14(26)10-34(18)23(37)16-11-33-9-13(25)5-6-19(33)30-16/h5-6,9,11-12,14-15,18H,2-4,7-8,10,26H2,1H3,(H,28,35)(H,31,36)(H3,27,29,38)/t14-,15+,18+/m1/s1	KIXZDQAGELDAQB-VKJFTORMSA-N	524429	2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((S)-1- (methylamino)-1-oxo-6-ureidohexan-2- yl)thiazole-4-carboxamidc::US11168083, Example 27	Plasma kallikrein					>9900					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524429	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524429&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465020	461688826							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107561	CNC(=O)[C@H](CCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C23H29ClN10O3S/c1-28-19(35)14(3-2-6-29-23(26)27)31-20(36)16-11-38-21(32-16)17-7-13(25)9-34(17)22(37)15-10-33-8-12(24)4-5-18(33)30-15/h4-5,8,10-11,13-14,17H,2-3,6-7,9,25H2,1H3,(H,28,35)(H,31,36)(H4,26,27,29)/t13-,14+,17+/m1/s1	UGKMOJZOTINLEE-KEYYUXOJSA-N	524430	2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((S)-5- guanidino-1-(methylamino)-1- oxopentan-2-yl)thiazole-4-carboxamide::US11168083, Example 28	Plasma kallikrein					 7500					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524430	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524430&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465136	461688827							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107562	CNC(=O)[C@H](CCC(N)=O)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C22H25ClN8O4S/c1-26-19(33)13(3-4-17(25)32)28-20(34)15-10-36-21(29-15)16-6-12(24)8-31(16)22(35)14-9-30-7-11(23)2-5-18(30)27-14/h2,5,7,9-10,12-13,16H,3-4,6,8,24H2,1H3,(H2,25,32)(H,26,33)(H,28,34)/t12-,13+,16+/m1/s1	VCKGTIQQFDCCCA-WWGRRREGSA-N	524431	(S)-2-(2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridinc-2- carbonyl)pyrrolidin-2-yl)thiazole-4- carboxamido)-N1- methylpentanediamide::US11168083, Example 29	Plasma kallikrein					>9900					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524431	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524431&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137473028	461688828							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107563	CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cn2cc(Cl)ccc2n1			524432	N-((S)-3-(1H-imidazol-4-yl)-1- (methylamino)-1-oxopropan-2-yl)-2- ((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)thiazole-4- carboxamide::US11168083, Example 30	Plasma kallikrein					>9900					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524432	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524432&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465100	461688829					C00615		1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107564	CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cn2cc(Cl)ccc2n1			524433	N-((S)-3-(1H-indol-3-yl)-1- (methylamino)-1-oxopropan-2-yl)-2- ((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)thiazole-4- carboxamide::US11168083, Example 31	Plasma kallikrein					>9900					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524433	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524433&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465094	461688830							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107565	CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C26H26ClN7O4S/c1-29-23(36)18(8-14-2-5-17(35)6-3-14)31-24(37)20-13-39-25(32-20)21-9-16(28)11-34(21)26(38)19-12-33-10-15(27)4-7-22(33)30-19/h2-7,10,12-13,16,18,21,35H,8-9,11,28H2,1H3,(H,29,36)(H,31,37)/t16-,18+,21+/m1/s1	DCRZJWUVOAVWGB-MMOPVJDHSA-N	524434	2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((S)-3-(4- hydroxyphenyl)-1-(methylamino)-1- oxopropan-2-yl)thiazole-4- carboxamide::US11168083, Example 32	Plasma kallikrein					>9900					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524434	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524434&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465106	461688831							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107566	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1CCCN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C24H30ClN9O3S/c1-28-20(35)15(5-2-3-9-29-24(26)27)31-21(36)17-13-38-22(32-17)18-6-4-10-34(18)23(37)16-12-33-11-14(25)7-8-19(33)30-16/h7-8,11-13,15,18H,2-6,9-10H2,1H3,(H,28,35)(H,31,36)(H4,26,27,29)/t15-,18-/m0/s1	JYHRVUUCZYFFGN-YJBOKZPZSA-N	524402	US11168083, Example 33	Plasma kallikrein					 3000					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524402	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524402&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137464944	461688799							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107567	CNC(=O)[C@@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1CCCN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C24H30ClN9O3S/c1-28-20(35)15(5-2-3-9-29-24(26)27)31-21(36)17-13-38-22(32-17)18-6-4-10-34(18)23(37)16-12-33-11-14(25)7-8-19(33)30-16/h7-8,11-13,15,18H,2-6,9-10H2,1H3,(H,28,35)(H,31,36)(H4,26,27,29)/t15-,18+/m1/s1	JYHRVUUCZYFFGN-QAPCUYQASA-N	524435	US11168083, Example 34	Plasma kallikrein					>9900					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524435	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524435&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465151	461688832							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107568	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@H](CN1C(=O)c1cn2cc(Cl)ccc2n1)NC(C)=O	InChI=1S/C26H33ClN10O4S/c1-14(38)32-16-9-20(37(11-16)25(41)18-12-36-10-15(27)6-7-21(36)33-18)24-35-19(13-42-24)23(40)34-17(22(39)30-2)5-3-4-8-31-26(28)29/h6-7,10,12-13,16-17,20H,3-5,8-9,11H2,1-2H3,(H,30,39)(H,32,38)(H,34,40)(H4,28,29,31)/t16-,17+,20+/m1/s1	ZMMPESRTVFDXKA-UWVAXJGDSA-N	524436	2-((2S,4R)-4-acetamido-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((S)-6- guanidino-1-(methylamino)-1- oxohcxan-2-yl)thiazole-4-carboxamide::US11168083, Example 35	Plasma kallikrein					 3000					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524436	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524436&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137464924	461688833							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107569	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@H](N)CN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C24H31ClN10O3S/c1-29-20(36)15(4-2-3-7-30-24(27)28)32-21(37)17-12-39-22(33-17)18-8-14(26)10-35(18)23(38)16-11-34-9-13(25)5-6-19(34)31-16/h5-6,9,11-12,14-15,18H,2-4,7-8,10,26H2,1H3,(H,29,36)(H,32,37)(H4,27,28,30)/t14-,15-,18-/m0/s1	LLPPLVKHKYCFMU-MPGHIAIKSA-N	524437	2-((2S,4S)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((S)-6- guanidino-1-(methylamino)-1- oxohexan-2-yl)thiazole-4-carboxamide::US11168083, Example 36	Plasma kallikrein					<100					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524437	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524437&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465103	461688834							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107570	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@H](O)CN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C24H30ClN9O4S/c1-28-20(36)15(4-2-3-7-29-24(26)27)31-21(37)17-12-39-22(32-17)18-8-14(35)10-34(18)23(38)16-11-33-9-13(25)5-6-19(33)30-16/h5-6,9,11-12,14-15,18,35H,2-4,7-8,10H2,1H3,(H,28,36)(H,31,37)(H4,26,27,29)/t14-,15-,18-/m0/s1	GFAFFEOPNBYDEZ-MPGHIAIKSA-N	524438	US11168083, Example 37	Plasma kallikrein					 3000					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524438	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524438&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465037	461688835							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107571	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](O)CN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C24H30ClN9O4S/c1-28-20(36)15(4-2-3-7-29-24(26)27)31-21(37)17-12-39-22(32-17)18-8-14(35)10-34(18)23(38)16-11-33-9-13(25)5-6-19(33)30-16/h5-6,9,11-12,14-15,18,35H,2-4,7-8,10H2,1H3,(H,28,36)(H,31,37)(H4,26,27,29)/t14-,15+,18+/m1/s1	GFAFFEOPNBYDEZ-VKJFTORMSA-N	524439	US11168083, Example 38	Plasma kallikrein					>9900					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524439	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524439&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465031	461688836							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107572	CNC(=O)[C@@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](O)CN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C24H30ClN9O4S/c1-28-20(36)15(4-2-3-7-29-24(26)27)31-21(37)17-12-39-22(32-17)18-8-14(35)10-34(18)23(38)16-11-33-9-13(25)5-6-19(33)30-16/h5-6,9,11-12,14-15,18,35H,2-4,7-8,10H2,1H3,(H,28,36)(H,31,37)(H4,26,27,29)/t14-,15-,18+/m1/s1	GFAFFEOPNBYDEZ-RKVPGOIHSA-N	524440	US11168083, Example 39	Plasma kallikrein					 7500					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524440	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524440&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465036	461688837							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107573	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1ccc2ccccc2c1	InChI=1S/C27H34N8O3S/c1-31-23(36)20(8-4-5-11-32-27(29)30)33-24(37)21-15-39-25(34-21)22-13-19(28)14-35(22)26(38)18-10-9-16-6-2-3-7-17(16)12-18/h2-3,6-7,9-10,12,15,19-20,22H,4-5,8,11,13-14,28H2,1H3,(H,31,36)(H,33,37)(H4,29,30,32)/t19-,20+,22+/m1/s1	BXOSIXVQJVFKRG-URVUXULASA-N	524441	2-((2S,4R)-1-(2-naphthoyl)-4- aminopyrrolidin-2-yl)-N-((S)-6- guanidino-1-(methylamino)-1- oxohexan-2-yl)thiazole-4-carboxamide::US11168083, Example 40	Plasma kallikrein					 3000					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524441	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524441&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137464976	461688838							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107574	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1ccc2ncc(Cl)cc2c1	InChI=1S/C26H32ClN9O3S/c1-31-22(37)19(4-2-3-7-32-26(29)30)34-23(38)20-13-40-24(35-20)21-10-17(28)12-36(21)25(39)14-5-6-18-15(8-14)9-16(27)11-33-18/h5-6,8-9,11,13,17,19,21H,2-4,7,10,12,28H2,1H3,(H,31,37)(H,34,38)(H4,29,30,32)/t17-,19+,21+/m1/s1	JBGMLHNBLWKMJG-LMNJBCLMSA-N	524442	2-((2S,4R)-4-amino-1-(3- chloroquinoline-6-carbonyl)pyrrolidin- 2-yl)-N-((S)-6-guanidino-1- (methylamino)-1-oxohexan-2- yl)thiazole-4-carboxamide::US11168083, Example 41	Plasma kallikrein					 550					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524442	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524442&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465061	461688839							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107575	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1ccc2cc(Cl)ccc2n1	InChI=1S/C26H32ClN9O3S/c1-31-22(37)18(4-2-3-9-32-26(29)30)34-23(38)20-13-40-24(35-20)21-11-16(28)12-36(21)25(39)19-7-5-14-10-15(27)6-8-17(14)33-19/h5-8,10,13,16,18,21H,2-4,9,11-12,28H2,1H3,(H,31,37)(H,34,38)(H4,29,30,32)/t16-,18+,21+/m1/s1	GEJBSTPNTAGZPN-MMOPVJDHSA-N	524443	2-((2S,4R)-4-amino-1-(6- chloroquinoline-2-carbonyl)pyrrolidin- 2-yl)-N-((S)-6-guanidino-1- (methylamino)-1-oxohexan-2- yl)thiazole-4-carboxamide::US11168083, Example 42	Plasma kallikrein					<100					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524443	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524443&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465065	461688840							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107576	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1ccc2c(Cl)csc2c1	InChI=1S/C25H31ClN8O3S2/c1-30-21(35)17(4-2-3-7-31-25(28)29)32-22(36)18-12-39-23(33-18)19-9-14(27)10-34(19)24(37)13-5-6-15-16(26)11-38-20(15)8-13/h5-6,8,11-12,14,17,19H,2-4,7,9-10,27H2,1H3,(H,30,35)(H,32,36)(H4,28,29,31)/t14-,17+,19+/m1/s1	MBWBDEMKWGRUJD-LJHODMEESA-N	524444	2-((2S,4R)-4-amino-1-(3- chlorobenzo[b]thiophene-6- carbonyl)pyrrolidin-2-yl)-N-((S)-6- guanidino-1-(methylamino)-1- oxohexan-2-yl)thiazole-4-carboxamide::US11168083, Example 43	Plasma kallikrein					 7500					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524444	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524444&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137464961	461688841							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107577	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)C1=CC2C=C(Cl)C=CC2S1	InChI=1S/C25H33ClN8O3S2/c1-30-21(35)16(4-2-3-7-31-25(28)29)32-22(36)17-12-38-23(33-17)18-10-15(27)11-34(18)24(37)20-9-13-8-14(26)5-6-19(13)39-20/h5-6,8-9,12-13,15-16,18-19H,2-4,7,10-11,27H2,1H3,(H,30,35)(H,32,36)(H4,28,29,31)/t13?,15-,16+,18+,19?/m1/s1	SNNFYFCMCOGUQV-HHOPHQQQSA-N	524445	2-((2S,4R)-4-amino-1-(5- chlorobenzo[b]thiophcne-2- carbonyl)pyrrolidin-2-yl)-N-((S)-6- guanidino-1-(methylamino)-1- oxohcxan-2-yl)thiazole-4-carboxamide::US11168083, Example 44	Plasma kallikrein					 550					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524445	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524445&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155020634	461688842							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107578	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)C1=NC2C=C(Cl)C=CC2S1	InChI=1S/C24H32ClN9O3S2/c1-29-19(35)14(4-2-3-7-30-24(27)28)31-20(36)16-11-38-21(33-16)17-9-13(26)10-34(17)23(37)22-32-15-8-12(25)5-6-18(15)39-22/h5-6,8,11,13-15,17-18H,2-4,7,9-10,26H2,1H3,(H,29,35)(H,31,36)(H4,27,28,30)/t13-,14+,15?,17+,18?/m1/s1	GJGFBTQCJROWAU-UFKRDZGPSA-N	524446	2-((2S,4R)-4-amino-1-(5- chlorobenzo[d]thiazole-2- carbonyl)pyrrolidin-2-yl)-N-((S)-6- guanidino-1-(methylamino)-1- oxohexan-2-yl)thiazole-4-carboxamide::US11168083, Example 45	Plasma kallikrein					<100					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524446	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524446&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155020626	461688843							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107579	N[C@@H]1C[C@H](N(C1)C(=O)c1cn2cc(Cl)ccc2n1)c1nc(cs1)C(=O)NCCCCCNC(N)=N	InChI=1S/C22H28ClN9O2S/c23-13-4-5-18-29-15(11-31(18)9-13)21(34)32-10-14(24)8-17(32)20-30-16(12-35-20)19(33)27-6-2-1-3-7-28-22(25)26/h4-5,9,11-12,14,17H,1-3,6-8,10,24H2,(H,27,33)(H4,25,26,28)/t14-,17+/m1/s1	KBCPCNVORWUACK-PBHICJAKSA-N	524447	2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-(5- guanidinopentyl)thiazole-4- carboxamide::US11168083, Example 46	Plasma kallikrein					 550					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524447	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524447&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465077	461688844							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107580	N[C@@H]1C[C@H](N(C1)C(=O)c1cn2cc(Cl)ccc2n1)c1nc(cs1)C(=O)NCc1ccc(cc1)C(N)=N	InChI=1S/C24H23ClN8O2S/c25-15-5-6-20-30-17(11-32(20)9-15)24(35)33-10-16(26)7-19(33)23-31-18(12-36-23)22(34)29-8-13-1-3-14(4-2-13)21(27)28/h1-6,9,11-12,16,19H,7-8,10,26H2,(H3,27,28)(H,29,34)/t16-,19+/m1/s1	ISBGVOZOKHEQDV-APWZRJJASA-N	524448	2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-(4- carbamimidoylbenzyl)thiazole-4- carboxamide::US11168083, Example 47	Plasma kallikrein					<100					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524448	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524448&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465056	461688845							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107581	Cc1cc(N)nc(C)c1CNC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C24H25ClN8O2S/c1-12-5-20(27)29-13(2)16(12)7-28-22(34)18-11-36-23(31-18)19-6-15(26)9-33(19)24(35)17-10-32-8-14(25)3-4-21(32)30-17/h3-5,8,10-11,15,19H,6-7,9,26H2,1-2H3,(H2,27,29)(H,28,34)/t15-,19+/m1/s1	NIKWDISSLUKVAJ-BEFAXECRSA-N	524449	2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((6-amino- 2,4-dimethylpyridin-3- yl)methyl)thiazole-4-carboxamide::US11168083, Example 48	Plasma kallikrein					 550					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524449	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524449&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465043	461688846							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107582	N[C@@H]1C[C@H](N(C1)C(=O)c1cn2cc(Cl)ccc2n1)c1nc(cs1)C(=O)NCc1ccc2c(N)nccc2c1	InChI=1S/C26H23ClN8O2S/c27-16-2-4-22-32-19(12-34(22)10-16)26(37)35-11-17(28)8-21(35)25-33-20(13-38-25)24(36)31-9-14-1-3-18-15(7-14)5-6-30-23(18)29/h1-7,10,12-13,17,21H,8-9,11,28H2,(H2,29,30)(H,31,36)/t17-,21+/m1/s1	SYUKSGXOSHFNNI-UTKZUKDTSA-N	524450	2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((1- aminoisoquinolin-6-yl)methyl)thiazole- 4-carboxamide::US11168083, Example 49	Plasma kallikrein					<100					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524450	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524450&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137464965	461688847							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107583	NCc1ccc(CNC(=O)c2csc(n2)[C@@H]2C[C@@H](N)CN2C(=O)c2cn3cc(Cl)ccc3n2)cc1	InChI=1S/C24H24ClN7O2S/c25-16-5-6-21-29-18(12-31(21)10-16)24(34)32-11-17(27)7-20(32)23-30-19(13-35-23)22(33)28-9-15-3-1-14(8-26)2-4-15/h1-6,10,12-13,17,20H,7-9,11,26-27H2,(H,28,33)/t17-,20+/m1/s1	FHGGDJNWGJXNMM-XLIONFOSSA-N	524451	2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-(4- (aminomethyl)benzyl)thiazole-4- carboxamide::US11168083, Example 50	Plasma kallikrein					 7500					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524451	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524451&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465052	461688848							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107584	N[C@@H]1C[C@H](N(C1)C(=O)c1cn2cc(Cl)ccc2n1)c1nc(cs1)C(=O)NCCc1ccc(cc1)C(N)=N	InChI=1S/C25H25ClN8O2S/c26-16-5-6-21-31-18(12-33(21)10-16)25(36)34-11-17(27)9-20(34)24-32-19(13-37-24)23(35)30-8-7-14-1-3-15(4-2-14)22(28)29/h1-6,10,12-13,17,20H,7-9,11,27H2,(H3,28,29)(H,30,35)/t17-,20+/m1/s1	VMZMWVBYMSGTPQ-XLIONFOSSA-N	524452	2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-(4- carbamimidoylphenethyl)thiazole-4- carboxamide::US11168083, Example 51	Plasma kallikrein					<100					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524452	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524452&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137464984	461688849							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107585	Cc1cc(N)nc(C)c1CCNC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C25H27ClN8O2S/c1-13-7-21(28)30-14(2)17(13)5-6-29-23(35)19-12-37-24(32-19)20-8-16(27)10-34(20)25(36)18-11-33-9-15(26)3-4-22(33)31-18/h3-4,7,9,11-12,16,20H,5-6,8,10,27H2,1-2H3,(H2,28,30)(H,29,35)/t16-,20+/m1/s1	LSDUXDLFSXDPQA-UZLBHIALSA-N	524453	2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-(2-(6- amino-2,4-dimethylpyridin-3- yl)ethyl)thiazole-4-carboxamide::US11168083, Example 52	Plasma kallikrein					>9900					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524453	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524453&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465062	461688850							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107586	N[C@@H]1C[C@H](N(C1)C(=O)c1cn2cc(Cl)ccc2n1)c1nc(cs1)C(=O)NCCc1ccc2c(N)nccc2c1	InChI=1S/C27H25ClN8O2S/c28-17-2-4-23-33-20(13-35(23)11-17)27(38)36-12-18(29)10-22(36)26-34-21(14-39-26)25(37)32-7-5-15-1-3-19-16(9-15)6-8-31-24(19)30/h1-4,6,8-9,11,13-14,18,22H,5,7,10,12,29H2,(H2,30,31)(H,32,37)/t18-,22+/m1/s1	GFDKMJFZUDZXRK-GCJKJVERSA-N	524454	2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-(2-(1- aminoisoquinolin-6-yl)ethyl)thiazole-4- carboxamide::US11168083, Example 53	Plasma kallikrein					<100					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524454	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524454&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137464970	461688851							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107587	NCc1ccc(CCNC(=O)c2csc(n2)[C@@H]2C[C@@H](N)CN2C(=O)c2cn3cc(Cl)ccc3n2)cc1	InChI=1S/C25H26ClN7O2S/c26-17-5-6-22-30-19(13-32(22)11-17)25(35)33-12-18(28)9-21(33)24-31-20(14-36-24)23(34)29-8-7-15-1-3-16(10-27)4-2-15/h1-6,11,13-14,18,21H,7-10,12,27-28H2,(H,29,34)/t18-,21+/m1/s1	YUPDPXYEIFAQRA-NQIIRXRSSA-N	524455	2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pynolidin-2-yl)-N-(4- (aminomethyl)phenethyl)thiazole-4- carboxamide::US11168083, Example 54	Plasma kallikrein					 3000					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524455	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524455&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465004	461688852							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107588	N[C@@H]1C[C@H](N(C1)C(=O)c1cn2cc(Cl)ccc2n1)c1nc(cs1)C(=O)NCc1ncn2ccc(Cl)cc12	InChI=1S/C24H20Cl2N8O2S/c25-13-3-4-32-12-29-16(19(32)5-13)7-28-22(35)18-11-37-23(31-18)20-6-15(27)9-34(20)24(36)17-10-33-8-14(26)1-2-21(33)30-17/h1-5,8,10-12,15,20H,6-7,9,27H2,(H,28,35)/t15-,20+/m1/s1	FKQMDAAKAOWPEB-QRWLVFNGSA-N	524403	2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((7- chloroimidazo[1,5-a]pyridin-1- yl)methyl)thiazole-4-carboxamide::US11168083, Example 55	Plasma kallikrein					 550					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524403	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524403&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465054	461688800							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107589	N[C@@H]1C[C@H](N(C1)C(=O)c1cn2cc(Cl)ccc2n1)c1nc(cs1)C(=O)NCc1ccc2cc(Cl)ccc2c1	InChI=1S/C27H22Cl2N6O2S/c28-18-4-3-16-7-15(1-2-17(16)8-18)10-31-25(36)22-14-38-26(33-22)23-9-20(30)12-35(23)27(37)21-13-34-11-19(29)5-6-24(34)32-21/h1-8,11,13-14,20,23H,9-10,12,30H2,(H,31,36)/t20-,23+/m1/s1	UGVFMASJHLZOFK-OFNKIYASSA-N	524456	2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((6- chloronaphthalen-2-yl)methyl)thiazole- 4-carboxamide::US11168083, Example 56	Plasma kallikrein					>9900					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524456	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524456&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465129	461688853							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107590	CNC(=O)[C@@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C24H31ClN10O3S/c1-29-20(36)15(4-2-3-7-30-24(27)28)32-21(37)17-12-39-22(33-17)18-8-14(26)10-35(18)23(38)16-11-34-9-13(25)5-6-19(34)31-16/h5-6,9,11-12,14-15,18H,2-4,7-8,10,26H2,1H3,(H,29,36)(H,32,37)(H4,27,28,30)/t14-,15-,18+/m1/s1	LLPPLVKHKYCFMU-RKVPGOIHSA-N	524414	2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((R)-6- guanidino-1-(methylamino)-1- oxohexan-2-yl)thiazole-4-carboxamide::US11168083, Example 12::US11168083, Example 57	Plasma kallikrein					 3000					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524414	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524414&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465120	461688811							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107591	N[C@@H]1C[C@H](N(C1)C(=O)c1cn2cc(Cl)ccc2n1)c1nc(cs1)C(=O)NCc1n[nH]c2ccc(Cl)cc12			524458	2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((5-chloro- 1H-indazol-3-yl)methyl)thiazole-4- carboxamide::US11168083, Example 58	Plasma kallikrein					 7500					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524458	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524458&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465067	461688854							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107592	N[C@@H]1C[C@H](N(C1)C(=O)c1cn2cc(Cl)ccc2n1)c1nc(cs1)C(=O)NCc1n[nH]c2cc(Cl)ccc12			524459	2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((6-chloro- 1H-indazol-3-yl)methyl)thiazole-4- carboxamide::US11168083, Example 59	Plasma kallikrein					>9900					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524459	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524459&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137464948	461688855							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107593	Cc1cc2c(N)nccc2c(C)c1CNC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C28H27ClN8O2S/c1-14-7-19-18(5-6-32-25(19)31)15(2)20(14)9-33-26(38)22-13-40-27(35-22)23-8-17(30)11-37(23)28(39)21-12-36-10-16(29)3-4-24(36)34-21/h3-7,10,12-13,17,23H,8-9,11,30H2,1-2H3,(H2,31,32)(H,33,38)/t17-,23+/m1/s1	BSTKXPMFPPOUDP-HXOBKFHXSA-N	524460	2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((1-amino- 5,7-dimethylisoquinolin-6- yl)methyl)thiazole-4-carboxamide::US11168083, Example 60	Plasma kallikrein					<100					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524460	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524460&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465073	461688856							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107594	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cc2cc(Cl)c(Cl)cc2s1	InChI=1S/C25H30Cl2N8O3S2/c1-31-21(36)16(4-2-3-5-32-25(29)30)33-22(37)17-11-39-23(34-17)18-8-13(28)10-35(18)24(38)20-7-12-6-14(26)15(27)9-19(12)40-20/h6-7,9,11,13,16,18H,2-5,8,10,28H2,1H3,(H,31,36)(H,33,37)(H4,29,30,32)/t13-,16+,18+/m1/s1	FDABKPHXIICLML-SKDZVZGDSA-N	524461	2-((2S,4R)-4-amino-1-(5,6- dichlorobenzo[b]thiophene-2- carbonyl)pyrrolidin-2-yl)-N-((S)-6- guanidino-1-(methylamino)-1- oxohexan-2-yl)thiazole-4-carboxamide::US11168083, Example 61	Plasma kallikrein					 550					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524461	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524461&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465092	461688857							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107595	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cc2ccc(Cl)cc2s1	InChI=1S/C25H31ClN8O3S2/c1-30-21(35)16(4-2-3-7-31-25(28)29)32-22(36)17-12-38-23(33-17)18-10-15(27)11-34(18)24(37)20-8-13-5-6-14(26)9-19(13)39-20/h5-6,8-9,12,15-16,18H,2-4,7,10-11,27H2,1H3,(H,30,35)(H,32,36)(H4,28,29,31)/t15-,16+,18+/m1/s1	UCKDBXMZROGZMA-RYRKJORJSA-N	524462	2-((2S,4R)-4-amino-1-(6- chlorobenzo[b]thiophene-2- carbonyl)pyrrolidin-2-yl)-N-((S)-6- guanidino-1-(methylamino)-1- oxohexan-2-yl)thiazole-4-carboxamide::US11168083, Example 62	Plasma kallikrein					 550					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524462	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524462&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465040	461688858							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107596	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cc2c(Cl)cccc2s1	InChI=1S/C25H31ClN8O3S2/c1-30-21(35)16(6-2-3-8-31-25(28)29)32-22(36)17-12-38-23(33-17)18-9-13(27)11-34(18)24(37)20-10-14-15(26)5-4-7-19(14)39-20/h4-5,7,10,12-13,16,18H,2-3,6,8-9,11,27H2,1H3,(H,30,35)(H,32,36)(H4,28,29,31)/t13-,16+,18+/m1/s1	SNRDAMCHFNCWJG-SKDZVZGDSA-N	524463	2-((2S,4R)-4-amino-1-(4- chlorobenzo[b]thiophene-2- carbonyl)pyrrolidin-2-yl)-N-((S)-6- guanidino-1-(methylamino)-1- oxohexan-2-yl)thiazole-4-carboxamide::US11168083, Example 63	Plasma kallikrein					 3000					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524463	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524463&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465081	461688859							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107597	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cc2cc(ccc2s1)C(F)(F)F	InChI=1S/C26H31F3N8O3S2/c1-33-21(38)16(4-2-3-7-34-25(31)32)35-22(39)17-12-41-23(36-17)18-10-15(30)11-37(18)24(40)20-9-13-8-14(26(27,28)29)5-6-19(13)42-20/h5-6,8-9,12,15-16,18H,2-4,7,10-11,30H2,1H3,(H,33,38)(H,35,39)(H4,31,32,34)/t15-,16+,18+/m1/s1	OZQHKLQLDUISBY-RYRKJORJSA-N	524464	2-((2S,4R)-4-amino-1-(5- (trifluoromethyl)benzo[b]thiophene-2- carbonyl)pyrrolidin-2-yl)-N-((S)-6- guanidino-1-(methylamino)-1- oxohexan-2-yl)thiazole-4-carboxamide::US11168083, Example 64	Plasma kallikrein					 550					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524464	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524464&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465146	461688860							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107598	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cc2ccc(C)cc2s1	InChI=1S/C26H34N8O3S2/c1-14-6-7-15-10-21(39-20(15)9-14)25(37)34-12-16(27)11-19(34)24-33-18(13-38-24)23(36)32-17(22(35)30-2)5-3-4-8-31-26(28)29/h6-7,9-10,13,16-17,19H,3-5,8,11-12,27H2,1-2H3,(H,30,35)(H,32,36)(H4,28,29,31)/t16-,17+,19+/m1/s1	CBXMSTBUKVKBJV-AOIWGVFYSA-N	524465	2-((2S,4R)-4-amino-1-(6- methylbenzo[b]thiophene-2- carbonyl)pyrrolidin-2-yl)-N-((S)-6- guanidino-1-(methylamino)-1- oxohexan-2-yl)thiazole-4-carboxamide::US11168083, Example 65	Plasma kallikrein					 550					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524465	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524465&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137464945	461688861							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107599	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cnc2ccc(Cl)cc2c1	InChI=1S/C26H32ClN9O3S/c1-31-22(37)19(4-2-3-7-32-26(29)30)34-23(38)20-13-40-24(35-20)21-10-17(28)12-36(21)25(39)15-8-14-9-16(27)5-6-18(14)33-11-15/h5-6,8-9,11,13,17,19,21H,2-4,7,10,12,28H2,1H3,(H,31,37)(H,34,38)(H4,29,30,32)/t17-,19+,21+/m1/s1	MLEJYXYWKYQGTH-LMNJBCLMSA-N	524466	2-((2S,4R)-4-amino-1-(6- chloroquinoline-3-carbonyl)pyrrolidin- 2-yl)-N-((S)-6-guanidino-1- (methylamino)-1-oxohexan-2- yl)thiazole-4-carboxamide::US11168083, Example 66	Plasma kallikrein					 550					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524466	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524466&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137464987	461688862							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1107600	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1ccc2nc(Cl)ccc2c1	InChI=1S/C26H32ClN9O3S/c1-31-22(37)18(4-2-3-9-32-26(29)30)34-23(38)19-13-40-24(35-19)20-11-16(28)12-36(20)25(39)15-5-7-17-14(10-15)6-8-21(27)33-17/h5-8,10,13,16,18,20H,2-4,9,11-12,28H2,1H3,(H,31,37)(H,34,38)(H4,29,30,32)/t16-,18+,20+/m1/s1	PBOYRHRFMVZNFR-KPFFTGBYSA-N	524467	2-((2S,4R)-4-amino-1-(2- chloroquinoline-6-carbonyl)pyrrolidin- 2-yl)-N-((S)-6-guanidino-1- (methylamino)-1-oxohexan-2- yl)thiazole-4-carboxamide::US11168083, Example 67	Plasma kallikrein					 3000					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524467	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524467&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137464953	461688863							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51356542	Nc1nc(nn1C(=O)Cc1ccccc1I)-c1ccccn1	InChI=1S/C15H12IN5O/c16-11-6-2-1-5-10(11)9-13(22)21-15(17)19-14(20-21)12-7-3-4-8-18-12/h1-8H,9H2,(H2,17,19,20)	YVFPJFVEQPRRJJ-UHFFFAOYSA-N	50548592	CHEMBL4786270	Plasma kallikrein			>5000							ChEMBL	10.1021/acs.jmedchem.0c01635	10.7270/Q2JM2F72	33089691			Korff, M; Imberg, L; Will, JM; Bückreiß, N; Kalinina, SA; Wenzel, BM; Kastner, GA; Daniliuc, CG; Barth, M; Ovsepyan, RA; Butov, KR; Humpf, HU; Lehr, M; Panteleev, MA; Poso, A; Karst, U; Steinmetzer, T; Bendas, G; Kalinin, DV	University of M&#163;nster	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50548592	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50548592&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162668215	461678932							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51356543	Nc1nc(nn1C(=O)c1ccc2ccccc2c1)-c1ccccn1	InChI=1S/C18H13N5O/c19-18-21-16(15-7-3-4-10-20-15)22-23(18)17(24)14-9-8-12-5-1-2-6-13(12)11-14/h1-11H,(H2,19,21,22)	LOMJHEAYYYPWDO-UHFFFAOYSA-N	50548593	CHEMBL4754247	Plasma kallikrein			>5000							ChEMBL	10.1021/acs.jmedchem.0c01635	10.7270/Q2JM2F72	33089691			Korff, M; Imberg, L; Will, JM; Bückreiß, N; Kalinina, SA; Wenzel, BM; Kastner, GA; Daniliuc, CG; Barth, M; Ovsepyan, RA; Butov, KR; Humpf, HU; Lehr, M; Panteleev, MA; Poso, A; Karst, U; Steinmetzer, T; Bendas, G; Kalinin, DV	University of M&#163;nster	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50548593	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50548593&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162654991	461678933							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51356544	Nc1nc(nn1C(=O)c1cccc2ccccc12)-c1ccccn1	InChI=1S/C18H13N5O/c19-18-21-16(15-10-3-4-11-20-15)22-23(18)17(24)14-9-5-7-12-6-1-2-8-13(12)14/h1-11H,(H2,19,21,22)	JSYAAQWLHIRCII-UHFFFAOYSA-N	50548594	CHEMBL4776259	Plasma kallikrein			>5000							ChEMBL	10.1021/acs.jmedchem.0c01635	10.7270/Q2JM2F72	33089691			Korff, M; Imberg, L; Will, JM; Bückreiß, N; Kalinina, SA; Wenzel, BM; Kastner, GA; Daniliuc, CG; Barth, M; Ovsepyan, RA; Butov, KR; Humpf, HU; Lehr, M; Panteleev, MA; Poso, A; Karst, U; Steinmetzer, T; Bendas, G; Kalinin, DV	University of M&#163;nster	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50548594	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50548594&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162642852	461678934							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51356545	Cc1ccc(cc1C)C(=O)n1nc(nc1N)-c1ccccn1	InChI=1S/C16H15N5O/c1-10-6-7-12(9-11(10)2)15(22)21-16(17)19-14(20-21)13-5-3-4-8-18-13/h3-9H,1-2H3,(H2,17,19,20)	DZGOQOXWBUEYTK-UHFFFAOYSA-N	50548595	CHEMBL4777212	Plasma kallikrein			>5000							ChEMBL	10.1021/acs.jmedchem.0c01635	10.7270/Q2JM2F72	33089691			Korff, M; Imberg, L; Will, JM; Bückreiß, N; Kalinina, SA; Wenzel, BM; Kastner, GA; Daniliuc, CG; Barth, M; Ovsepyan, RA; Butov, KR; Humpf, HU; Lehr, M; Panteleev, MA; Poso, A; Karst, U; Steinmetzer, T; Bendas, G; Kalinin, DV	University of M&#163;nster	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50548595	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50548595&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162643031	461678935							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51356546	O=C(Nc1nc(n[nH]1)-c1ccccn1)c1ccccc1	InChI=1S/C14H11N5O/c20-13(10-6-2-1-3-7-10)17-14-16-12(18-19-14)11-8-4-5-9-15-11/h1-9H,(H2,16,17,18,19,20)	LDGAAMMSVIUSAT-UHFFFAOYSA-N	50548596	CHEMBL4748137	Plasma kallikrein			>5000							ChEMBL	10.1021/acs.jmedchem.0c01635	10.7270/Q2JM2F72	33089691			Korff, M; Imberg, L; Will, JM; Bückreiß, N; Kalinina, SA; Wenzel, BM; Kastner, GA; Daniliuc, CG; Barth, M; Ovsepyan, RA; Butov, KR; Humpf, HU; Lehr, M; Panteleev, MA; Poso, A; Karst, U; Steinmetzer, T; Bendas, G; Kalinin, DV	University of M&#163;nster	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50548596	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50548596&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86992066	461678936							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117099	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc2CCNCc2cc1F)C(F)(F)F	InChI=1S/C21H19F4N5O/c22-16-7-14-11-27-5-4-13(14)8-17(16)28-20(31)18-9-19(21(23,24)25)29-30(18)15-3-1-2-12(6-15)10-26/h1-3,6-9,27H,4-5,10-11,26H2,(H,28,31)	XCBOZBQFIYATFU-UHFFFAOYSA-N	416716	1-(3-(aminomethyl)phenyl)-N-(7-fluoro-1,2,3,4-tetrahydroisoquinolin-6-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 161e::US10633345, Compound 161e::US10689346, Compound 161e::US11203574, Compound 161e::US11230530, Compound 161e::US11685721, Compound 161e	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416716	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416716&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356276	433916630							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117100	CN(Cc1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1)c1ccccc1	InChI=1S/C26H24F3N5O/c1-33(21-10-3-2-4-11-21)17-19-8-5-9-20(13-19)31-25(35)23-15-24(26(27,28)29)32-34(23)22-12-6-7-18(14-22)16-30/h2-15H,16-17,30H2,1H3,(H,31,35)	IEARPKHOKPOLCS-UHFFFAOYSA-N	416717	1-(3-(aminomethyl)phenyl)-N-(3-((methyl(phenyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 28f::US10633345, Compound 28f::US10689346, Compound 28f::US11203574, Compound 28f::US11230530, Compound 28f::US11685721, Compound 28f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416717	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416717&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665676	433916631							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117101	CCCN(c1ccccc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C27H25F4N5O/c1-2-13-35(19-8-4-3-5-9-19)20-11-12-22(28)23(15-20)33-26(37)24-16-25(27(29,30)31)34-36(24)21-10-6-7-18(14-21)17-32/h3-12,14-16H,2,13,17,32H2,1H3,(H,33,37)	NZQCKHUBEMVLQD-UHFFFAOYSA-N	416718	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-5-(phenyl(propyl)amino)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 77e::US10633345, Compound 77e::US10689346, Compound 77e::US11203574, Compound 77e::US11230530, Compound 77e::US11685721, Compound 77e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416718	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416718&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665730	433916632							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117102	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1ccc2CNCCc2c1F)C(F)(F)F	InChI=1S/C21H19F4N5O/c22-19-15-6-7-27-11-13(15)4-5-16(19)28-20(31)17-9-18(21(23,24)25)29-30(17)14-3-1-2-12(8-14)10-26/h1-5,8-9,27H,6-7,10-11,26H2,(H,28,31)	RYNJWLCYWDTYKF-UHFFFAOYSA-N	416719	1-(3-(aminomethyl)phenyl)-N-(5-fluoro-1,2,3,4-tetrahydroisoquinolin-6-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 162c::US10633345, Compound 162c::US10689346, Compound 162c::US11203574, Compound 162c::US11230530, Compound 162c::US11685721, Compound 162c	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416719	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416719&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665528	433916633							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117103	CCCN(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1F	InChI=1S/C27H25F4N5O/c1-2-14-35(19-9-4-3-5-10-19)22-13-7-12-21(25(22)28)33-26(37)23-16-24(27(29,30)31)34-36(23)20-11-6-8-18(15-20)17-32/h3-13,15-16H,2,14,17,32H2,1H3,(H,33,37)	SDFZIQBGIDPGAP-UHFFFAOYSA-N	416720	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-3-(phenyl(propyl)amino)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 29e::US10633345, Compound 29e::US10689346, Compound 29e::US11203574, Compound 29e::US11230530, Compound 29e::US11685721, Compound 29e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416720	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416720&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355654	433916634							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117104	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C28H26F3N5O2/c29-28(30,31)25-15-24(36(35-25)22-8-3-5-19(13-22)16-32)27(37)34-21-7-4-6-20(14-21)26(38-17-18-10-11-18)23-9-1-2-12-33-23/h1-9,12-15,18,26H,10-11,16-17,32H2,(H,34,37)	UBQUVYTUKOFUOF-UHFFFAOYSA-N	416721	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(pyridin-2-yl)methyl)-phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 43f::US10633345, Compound 43f::US10689346, Compound 43g::US11203574, Compound 43h::US11230530, Compound 43h::US11685721, Compound 43f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416721	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416721&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355947	433916635							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117105	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc2CNCCc2cc1F)C(F)(F)F	InChI=1S/C21H19F4N5O/c22-16-7-13-4-5-27-11-14(13)8-17(16)28-20(31)18-9-19(21(23,24)25)29-30(18)15-3-1-2-12(6-15)10-26/h1-3,6-9,27H,4-5,10-11,26H2,(H,28,31)	APLBFUXJEQDPBH-UHFFFAOYSA-N	416722	1-(3-(aminomethyl)phenyl)-N-(6-fluoro-1,2,3,4-tetrahydroisoquinolin-7-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 163g::US10633345, Compound 163g::US10689346, Compound 163g::US11203574, Compound 163g::US11230530, Compound 163g::US11685721, Compound 163g	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416722	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416722&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355616	433916636							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117106	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(Cn2ccnc2)ccc1F)C(F)(F)F	InChI=1S/C22H18F4N6O/c23-17-5-4-15(12-31-7-6-28-13-31)9-18(17)29-21(33)19-10-20(22(24,25)26)30-32(19)16-3-1-2-14(8-16)11-27/h1-10,13H,11-12,27H2,(H,29,33)	FOWNNAMOGPFGSS-UHFFFAOYSA-N	416723	N-(5-((1H-imidazol-1-yl)methyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 30g::US10633345, Compound 30g::US10689346, Compound 30g::US11203574, Compound 30g::US11230530, Compound 30g::US11685721, Compound 30g	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416723	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416723&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356018	433916637							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117107	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H26F3N5O2/c29-28(30,31)25-14-24(36(35-25)23-8-1-4-19(12-23)15-32)27(37)34-22-7-2-5-20(13-22)26(38-17-18-9-10-18)21-6-3-11-33-16-21/h1-8,11-14,16,18,26H,9-10,15,17,32H2,(H,34,37)	SHFRWTHPPCXLER-UHFFFAOYSA-N	416725	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(pyridin-3-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 44c::US10633345, Compound 44c::US10689346, Compound 44c::US11203574, Compound 44d::US11230530, Compound 44e::US11685721, Compound 44c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416725	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416725&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355578	433916639							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117108	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(Nc2ccccc2)c1)C(F)(F)F	InChI=1S/C24H20F3N5O/c25-24(26,27)22-14-21(32(31-22)20-11-4-6-16(12-20)15-28)23(33)30-19-10-5-9-18(13-19)29-17-7-2-1-3-8-17/h1-14,29H,15,28H2,(H,30,33)	BURYUTYBSGJGCF-UHFFFAOYSA-N	416728	1-(3-(aminomethyl)phenyl)-N-(3-(phenylamino)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 17d::US10689346, Compound 17d::US11203574, Compound 17d::US11230530, Compound 17d::US11685721, Compound 17d	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416728	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416728&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665499	433916642							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117109	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)c1cccnc1)C(F)(F)F	InChI=1S/C24H20F3N5O2/c25-24(26,27)21-12-20(32(31-21)19-8-1-4-15(10-19)13-28)23(34)30-18-7-2-5-16(11-18)22(33)17-6-3-9-29-14-17/h1-12,14,22,33H,13,28H2,(H,30,34)	ZKOHYLRGOQBIFH-UHFFFAOYSA-N	416729	1-(3-(aminomethyl)phenyl)-N-(3-(hydroxy(pyridin-3-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 31f::US10633345, Compound 31f::US10689346, Compound 31f::US11203574, Compound 31f::US11230530, Compound 31f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416729	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416729&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665970	433916643							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117110	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F3N4O/c31-30(32,33)28-18-27(37(36-28)25-11-4-6-21(16-25)19-34)29(38)35-24-10-5-9-23(17-24)26(15-14-20-12-13-20)22-7-2-1-3-8-22/h1-11,16-18,20,26H,12-15,19,34H2,(H,35,38)	LVGPKQXQIQRVCT-UHFFFAOYSA-N	416730	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-phenylpropyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 78d::US10633345, Compound 78d::US10689346, Compound 78d::US11203574, Compound 78d::US11230530, Compound 78d::US11685721, Compound 78d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416730	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416730&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665672	433916644							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117111	COC(c1ccccc1)c1cccc(NC(=O)c2cc(CF)nn2-c2cccc(CN)c2)c1	InChI=1S/C26H25FN4O2/c1-33-25(19-8-3-2-4-9-19)20-10-6-11-21(14-20)29-26(32)24-15-22(16-27)30-31(24)23-12-5-7-18(13-23)17-28/h2-15,25H,16-17,28H2,1H3,(H,29,32)	VRIPPYQYPXKELM-UHFFFAOYSA-N	528577	US11192861, Compound 18f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528577	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528577&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156065185	463792105							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117112	CCCCC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(C)c2)C(F)(F)F)c1	InChI=1S/C29H28F3N3O/c1-3-4-16-25(21-11-6-5-7-12-21)22-13-9-14-23(18-22)33-28(36)26-19-27(29(30,31)32)34-35(26)24-15-8-10-20(2)17-24/h5-15,17-19,25H,3-4,16H2,1-2H3,(H,33,36)	PIAXXJSITFQLQQ-UHFFFAOYSA-N	528578	US11192861, Compound 32f	Plasma kallikrein		 75.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528578	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528578&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163200120	463792106							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117113	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H27F3N6O/c29-28(30,31)25-14-24(37(36-25)23-8-1-4-19(12-23)15-32)27(38)35-22-7-2-5-20(13-22)26(34-16-18-9-10-18)21-6-3-11-33-17-21/h1-8,11-14,17-18,26,34H,9-10,15-16,32H2,(H,35,38)	KSDPGGAAGHTRLB-UHFFFAOYSA-N	416733	1-(3-(Aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(pyridin-3-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 79f::US10633345, Compound 79f::US10689346, Compound 79f::US11203574, Compound 79f::US11230530, Compound 79f::US11685721, Compound 79f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416733	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416733&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356066	433916647							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117114	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(Cc2ccccc2)c1)C(F)(F)F	InChI=1S/C25H21F3N4O/c26-25(27,28)23-15-22(32(31-23)21-11-5-9-19(14-21)16-29)24(33)30-20-10-4-8-18(13-20)12-17-6-2-1-3-7-17/h1-11,13-15H,12,16,29H2,(H,30,33)	GVRJCFWHVBXPLW-UHFFFAOYSA-N	416734	1-(3-(aminomethyl)phenyl)-N-(3-benzylphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 19d::US10633345, Compound 19d::US10689346, Compound 19d::US11203574, Compound 19d::US11230530, Compound 19d::US11685721, Compound 19d	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416734	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416734&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355715	433916648							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117115	CCOC(c1ccccc1)c1ccc(Cl)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C27H24ClF3N4O2/c1-2-37-25(18-8-4-3-5-9-18)19-11-12-21(28)22(14-19)33-26(36)23-15-24(27(29,30)31)34-35(23)20-10-6-7-17(13-20)16-32/h3-15,25H,2,16,32H2,1H3,(H,33,36)	XUCZWPPXZIMXPF-UHFFFAOYSA-N	416735	1-(3-(aminomethyl)phenyl)-N-(2-chloro-5-(ethoxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 33e::US10633345, Compound 33e::US10689346, Compound 33e::US11203574, Compound 33e::US11230530, Compound 33e::US11685721, Compound 33e	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416735	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416735&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665706	433916649							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117116	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(F)cc(c1)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-22-12-21(27(39-17-18-9-10-18)20-6-2-1-3-7-20)13-23(14-22)35-28(38)25-15-26(29(31,32)33)36-37(25)24-8-4-5-19(11-24)16-34/h1-8,11-15,18,27H,9-10,16-17,34H2,(H,35,38)	CECISELXZFBKBA-UHFFFAOYSA-N	416736	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)-5-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 80h::US10633345, Compound 80h::US10689346, Compound 80h::US11203574, Compound 80h::US11230530, Compound 80h::US11685721, Compound 80h	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416736	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416736&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356068	433916650							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117117	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(Oc2ccccc2)c1)C(F)(F)F	InChI=1S/C24H19F3N4O2/c25-24(26,27)22-14-21(31(30-22)18-8-4-6-16(12-18)15-28)23(32)29-17-7-5-11-20(13-17)33-19-9-2-1-3-10-19/h1-14H,15,28H2,(H,29,32)	CMENISUXWPWEPE-UHFFFAOYSA-N	416737	1-(3-(aminomethyl)phenyl)-N-(3-phenoxyphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 20d::US10689346, Compound 20d::US11203574, Compound 20d::US11230530, Compound 20d::US11685721, Compound 20d	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416737	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416737&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665805	433916651							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117118	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)c1cccnc1)C(F)(F)F	InChI=1S/C24H20F3N5O2/c25-24(26,27)21-12-20(32(31-21)19-8-1-4-15(10-19)13-28)23(34)30-18-7-2-5-16(11-18)22(33)17-6-3-9-29-14-17/h1-12,14,22,33H,13,28H2,(H,30,34)	ZKOHYLRGOQBIFH-UHFFFAOYSA-N	416729	1-(3-(aminomethyl)phenyl)-N-(3-(hydroxy(pyridin-3-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 31f::US10633345, Compound 31f::US10689346, Compound 31f::US11203574, Compound 31f::US11230530, Compound 31f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416729	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416729&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665970	433916643							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117119	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)N(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H28F3N5O/c30-29(31,32)27-18-26(37(35-27)25-11-4-6-21(16-25)19-33)28(38)34-22-7-5-10-24(17-22)36(15-14-20-12-13-20)23-8-2-1-3-9-23/h1-11,16-18,20H,12-15,19,33H2,(H,34,38)	BPUAEVGWEFCIEW-UHFFFAOYSA-N	416739	1-(3-(aminomethyl)phenyl)-N-(3-((2-cyclopropylethyl)(phenyl)amino)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 87f::US10633345, Compound 87f::US10689346, Compound 87f::US11203574, Compound 87f::US11230530, Compound 87f::US11685721, Compound 87f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416739	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416739&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665744	433916653							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117120	CCOC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C27H25F3N4O2/c1-2-36-25(19-9-4-3-5-10-19)20-11-7-12-21(15-20)32-26(35)23-16-24(27(28,29)30)33-34(23)22-13-6-8-18(14-22)17-31/h3-16,25H,2,17,31H2,1H3,(H,32,35)	NWRGIGNKIBZYEM-UHFFFAOYSA-N	416740	1-(3-(aminomethyl)phenyl)-N-(3-(ethoxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18g::US10633345, Compound 18g::US10689346, Compound 18g::US11203574, Compound 18g::US11230530, Compound 18g::US11685721, Compound 18g	Plasma kallikrein		 75.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416740	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416740&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356270	433916654							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117121	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)c1ccccc1)C(F)(F)F	InChI=1S/C25H20F4N4O2/c26-19-10-9-17(23(34)16-6-2-1-3-7-16)12-20(19)31-24(35)21-13-22(25(27,28)29)32-33(21)18-8-4-5-15(11-18)14-30/h1-13,23,34H,14,30H2,(H,31,35)	SUGJHCONPCVXKJ-UHFFFAOYSA-N	416741	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-5-(hydroxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 34d::US10633345, Compound 34d::US10689346, Compound 34d::US11203574, Compound 34d::US11230530, Compound 34d::US11685721, Compound 34d	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416741	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416741&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665740	433916655							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117122	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(C(NCC2CC2)c2ccccc2)c1F)C(F)(F)F	InChI=1S/C29H27F4N5O/c30-26-22(27(35-17-18-12-13-18)20-7-2-1-3-8-20)10-5-11-23(26)36-28(39)24-15-25(29(31,32)33)37-38(24)21-9-4-6-19(14-21)16-34/h1-11,14-15,18,27,35H,12-13,16-17,34H2,(H,36,39)	YDBPNMJFMRHCIG-UHFFFAOYSA-N	416742	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 88b::US10633345, Compound 88b::US10689346, Compound 88b::US11203574, Compound 88b::US11230530, Compound 88b::US11685721, Compound 88b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416742	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416742&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123349010	433916656							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117123	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(=O)c1ccccc1)C(F)(F)F	InChI=1S/C25H19F3N4O2/c26-25(27,28)22-14-21(32(31-22)20-11-4-6-16(12-20)15-29)24(34)30-19-10-5-9-18(13-19)23(33)17-7-2-1-3-8-17/h1-14H,15,29H2,(H,30,34)	ZRVRSUVIXBEHIJ-UHFFFAOYSA-N	416743	1-(3-(aminomethyl)phenyl)-N-(3-benzoylphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 22b::US10633345, Compound 22b::US10689346, Compound 22b::US11203574, Compound 22b::US11230530, Compound 22b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416743	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416743&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355917	433916657							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117124	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(C(O)c2ccccc2)c1F)C(F)(F)F	InChI=1S/C25H20F4N4O2/c26-22-18(23(34)16-7-2-1-3-8-16)10-5-11-19(22)31-24(35)20-13-21(25(27,28)29)32-33(20)17-9-4-6-15(12-17)14-30/h1-13,23,34H,14,30H2,(H,31,35)	DENXCWXVTOPLRK-UHFFFAOYSA-N	416744	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-3-(hydroxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 35g::US10633345, Compound 35g::US10689346, Compound 35g::US11203574, Compound 35g::US11230530, Compound 35g::US11685721, Compound 35g	Plasma kallikrein		 75.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416744	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416744&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355965	433916658							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117125	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1nccs1)C(F)(F)F	InChI=1S/C26H24F3N5O2S/c27-26(28,29)22-13-21(34(33-22)20-6-1-3-17(11-20)14-30)24(35)32-19-5-2-4-18(12-19)23(25-31-9-10-37-25)36-15-16-7-8-16/h1-6,9-13,16,23H,7-8,14-15,30H2,(H,32,35)	FKPORVMTXYTRPN-UHFFFAOYSA-N	416745	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(thiazol-2-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 82f::US10633345, Compound 82f::US10689346, Compound 82f::US11203574, Compound 82f::US11230530, Compound 82f::US11685721, Compound 82f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416745	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416745&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355763	433916659							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117126	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(Oc2ccccc2)c1F)C(F)(F)F	InChI=1S/C24H18F4N4O2/c25-22-18(10-5-11-20(22)34-17-8-2-1-3-9-17)30-23(33)19-13-21(24(26,27)28)31-32(19)16-7-4-6-15(12-16)14-29/h1-13H,14,29H2,(H,30,33)	VUYMCUFLTORTFW-UHFFFAOYSA-N	416746	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-3-phenoxyphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 23c::US10633345, Compound 23c::US10689346, Compound 23c::US11203574, Compound 23c::US11230530, Compound 23c::US11685721, Compound 23c	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416746	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416746&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665745	433916660							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117127	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1ccccc1)C(F)F	InChI=1S/C29H27F3N4O2/c30-23-12-11-21(27(38-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)34-29(37)26-15-25(28(31)32)35-36(26)22-8-4-5-19(13-22)16-33/h1-8,11-15,18,27-28H,9-10,16-17,33H2,(H,34,37)	FNRDWSHVPKCMBY-UHFFFAOYSA-N	528593	US11192861, Compound 34c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528593	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528593&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163200122	463792121							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117128	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C28H27F3N6O/c29-28(30,31)25-15-24(37(36-25)22-8-3-5-19(13-22)16-32)27(38)35-21-7-4-6-20(14-21)26(34-17-18-10-11-18)23-9-1-2-12-33-23/h1-9,12-15,18,26,34H,10-11,16-17,32H2,(H,35,38)	UTXGSCUKCKWESJ-UHFFFAOYSA-N	416748	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(pyridin-2-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 83c::US10633345, Compound 83c::US10689346, Compound 83c::US11203574, Compound 83c::US11230530, Compound 83c::US11685721, Compound 83c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416748	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416748&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355952	433916662							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117129	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(Oc2ccccc2)c1F)C(F)(F)F	InChI=1S/C24H18F4N4O2/c25-22-18(10-5-11-20(22)34-17-8-2-1-3-9-17)30-23(33)19-13-21(24(26,27)28)31-32(19)16-7-4-6-15(12-16)14-29/h1-13H,14,29H2,(H,30,33)	VUYMCUFLTORTFW-UHFFFAOYSA-N	416746	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-3-phenoxyphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 23c::US10633345, Compound 23c::US10689346, Compound 23c::US11203574, Compound 23c::US11230530, Compound 23c::US11685721, Compound 23c	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416746	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416746&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665745	433916660							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117130	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(Oc2ccccc2)c1)C(F)(F)F	InChI=1S/C24H19F3N4O2/c25-24(26,27)22-14-21(31(30-22)18-8-4-6-16(12-18)15-28)23(32)29-17-7-5-11-20(13-17)33-19-9-2-1-3-10-19/h1-14H,15,28H2,(H,29,32)	CMENISUXWPWEPE-UHFFFAOYSA-N	416737	1-(3-(aminomethyl)phenyl)-N-(3-phenoxyphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 20d::US10689346, Compound 20d::US11203574, Compound 20d::US11230530, Compound 20d::US11685721, Compound 20d	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416737	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416737&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665805	433916651							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117131	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F3N4O2/c31-30(32,33)27-18-26(37(36-27)25-11-4-6-21(16-25)19-34)28(38)35-24-10-5-9-23(17-24)29(39,15-14-20-12-13-20)22-7-2-1-3-8-22/h1-11,16-18,20,39H,12-15,19,34H2,(H,35,38)	DCGYPXFSNPCKGX-UHFFFAOYSA-N	416751	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 46g::US10633345, Compound 46g::US10689346, Compound 46g::US11203574, Compound 46i::US11230530, Compound 46i::US11685721, Compound 46g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416751	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416751&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355790	433916665							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117132	CCOC(c1ccccc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C27H24F4N4O2/c1-2-37-25(18-8-4-3-5-9-18)19-11-12-21(28)22(14-19)33-26(36)23-15-24(27(29,30)31)34-35(23)20-10-6-7-17(13-20)16-32/h3-15,25H,2,16,32H2,1H3,(H,33,36)	YVBRMUSUELCGNA-UHFFFAOYSA-N	416752	1-(3-(aminomethyl)phenyl)-N-(5-(ethoxy(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 25b::US10633345, Compound 25b::US10689346, Compound 25b::US11203574, Compound 25b::US11230530, Compound 25b::US11685721, Compound 25b	Plasma kallikrein		 75.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416752	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416752&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665520	433916666							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117133	CC(C)[C@H](N)C(=O)OC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O3/c1-18(2)26(35)29(40)41-27(20-9-4-3-5-10-20)21-11-7-12-22(15-21)36-28(39)24-16-25(30(31,32)33)37-38(24)23-13-6-8-19(14-23)17-34/h3-16,18,26-27H,17,34-35H2,1-2H3,(H,36,39)/t26-,27?/m0/s1	OQCWFOUCOSAWQU-QBHOUYDASA-N	416753	(2S)-(3-(1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamido)phenyl)(phenyl)methyl 2-amino-3-methylbutanoate::US10329260, Compound 81c::US10633345, Compound 81c::US10689346, Compound 81c::US11203574, Compound 81c::US11230530, Compound 81c::US11685721, Compound 81c	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416753	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416753&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355992	433916667					C03317		1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117134	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)[C@](N)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-22-10-9-20(28(35,12-11-18-7-8-18)25-6-1-2-13-36-25)15-23(22)37-27(40)24-16-26(29(31,32)33)38-39(24)21-5-3-4-19(14-21)17-34/h1-6,9-10,13-16,18H,7-8,11-12,17,34-35H2,(H,37,40)/t28-/m1/s1	IFWBAIGKQKRJGJ-MUUNZHRXSA-N	416754	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carb oxamide::US10329260, Compound 205f::US10633345, Compound 205e::US11203574, Compound 205f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416754	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416754&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			146207235	433916668							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117135	COC(c1ccccc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C26H22F4N4O2/c1-36-24(17-7-3-2-4-8-17)18-10-11-20(27)21(13-18)32-25(35)22-14-23(26(28,29)30)33-34(22)19-9-5-6-16(12-19)15-31/h2-14,24H,15,31H2,1H3,(H,32,35)	AJQPEPSKLFPFIU-UHFFFAOYSA-N	416755	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-5-(methoxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 25c::US10633345, Compound 25c::US10689346, Compound 25c::US11203574, Compound 25c::US11230530, Compound 25c::US11685721, Compound 25c	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416755	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416755&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126666045	433916669							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117136	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CC#N)c1ccccc1)C(F)(F)F	InChI=1S/C27H22F3N5O/c28-27(29,30)25-16-24(35(34-25)22-11-4-6-18(14-22)17-32)26(36)33-21-10-5-9-20(15-21)23(12-13-31)19-7-2-1-3-8-19/h1-11,14-16,23H,12,17,32H2,(H,33,36)	AUPCAIQBGWQVBR-UHFFFAOYSA-N	416756	1-(3-(aminomethyl)phenyl)-N-(3-(2-cyano-1-phenylethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 39e::US10633345, Compound 39e::US10689346, Compound 39e::US11203574, Compound 39e::US11230530, Compound 39e::US11685721, Compound 39e	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416756	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416756&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126666023	433916670							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117137	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CCC1CC1)n1ccnc1)C(F)(F)F	InChI=1S/C27H27F3N6O/c28-27(29,30)25-15-24(36(34-25)22-6-1-3-19(13-22)16-31)26(37)33-21-5-2-4-20(14-21)23(10-9-18-7-8-18)35-12-11-32-17-35/h1-6,11-15,17-18,23H,7-10,16,31H2,(H,33,37)	UPEDWOJFQGRWOZ-UHFFFAOYSA-N	416757	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-(1H-imidazol-1-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 89g::US10633345, Compound 89g::US10689346, Compound 89g::US11203574, Compound 89g::US11230530, Compound 89g::US11685721, Compound 89g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416757	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416757&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665540	433916671							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117138	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(Cc2ccccc2)ccc1F)C(F)(F)F	InChI=1S/C25H20F4N4O/c26-20-10-9-17(11-16-5-2-1-3-6-16)13-21(20)31-24(34)22-14-23(25(27,28)29)32-33(22)19-8-4-7-18(12-19)15-30/h1-10,12-14H,11,15,30H2,(H,31,34)	PFWDQKVXCJEZES-UHFFFAOYSA-N	416758	1-(3-(aminomethyl)phenyl)-N-(5-benzyl-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 26f::US10633345, Compound 26f::US10689346, Compound 26f::US11203574, Compound 26f::US11230530, Compound 26f::US11685721, Compound 26f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416758	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416758&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355900	433916672							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117139	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CC(N)=O)c1ccccc1)C(F)(F)F	InChI=1S/C27H24F3N5O2/c28-27(29,30)24-15-23(35(34-24)21-11-4-6-17(12-21)16-31)26(37)33-20-10-5-9-19(13-20)22(14-25(32)36)18-7-2-1-3-8-18/h1-13,15,22H,14,16,31H2,(H2,32,36)(H,33,37)	KDXRDWIYPXSJST-UHFFFAOYSA-N	416759	N-(3-(3-amino-3-oxo-1-phenylpropyl)phenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 40b::US10633345, Compound 40b::US10689346, Compound 40b::US11203574, Compound 40b::US11230530, Compound 40b::US11685721, Compound 40b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416759	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416759&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665680	433916673							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117140	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(=CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H27F3N4O/c31-30(32,33)28-18-27(37(36-28)25-11-4-6-21(16-25)19-34)29(38)35-24-10-5-9-23(17-24)26(15-14-20-12-13-20)22-7-2-1-3-8-22/h1-11,15-18,20H,12-14,19,34H2,(H,35,38)/b26-15+	VKLRLOSKQDEQAH-CVKSISIWSA-N	439345	US10633345, Compound 91a::US10689346, Compound 91a::US11192861, Compound 91a::US11230530, Compound 91a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439345	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439345&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			153066367	439660903							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117141	CC(C)COC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C29H29F3N4O2/c1-19(2)18-38-27(21-9-4-3-5-10-21)22-11-7-12-23(15-22)34-28(37)25-16-26(29(30,31)32)35-36(25)24-13-6-8-20(14-24)17-33/h3-16,19,27H,17-18,33H2,1-2H3,(H,34,37)	FMSXMXLNUZXXSC-UHFFFAOYSA-N	416762	1-(3-(aminomethyl)phenyl)-N-(3-(isobutoxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18i::US10633345, Compound 18i::US10689346, Compound 18i::US11203574, Compound 18i::US11230530, Compound 18i::US11685721, Compound 18i	Plasma kallikrein		 75.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416762	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416762&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356257	433916676							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117142	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H28F3N5O/c30-29(31,32)26-16-25(37(36-26)24-11-4-6-20(14-24)17-33)28(38)35-23-10-5-9-22(15-23)27(34-18-19-12-13-19)21-7-2-1-3-8-21/h1-11,14-16,19,27,34H,12-13,17-18,33H2,(H,35,38)	QZQLNMURVWFZTC-UHFFFAOYSA-N	439347	US10633345, Compound 41e::US10689346, Compound 41e::US11203574, Compound 41e::US11230530, Compound 41e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439347	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439347&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665751	439660905							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117143	FC(F)(F)c1cc(C(=O)Nc2cccc(c2)C(NCC2CC2)c2ccncc2)n(n1)-c1ccccc1	InChI=1S/C27H24F3N5O/c28-27(29,30)24-16-23(35(34-24)22-7-2-1-3-8-22)26(36)33-21-6-4-5-20(15-21)25(32-17-18-9-10-18)19-11-13-31-14-12-19/h1-8,11-16,18,25,32H,9-10,17H2,(H,33,36)	PWMVPNKZCJMGGG-UHFFFAOYSA-N	528609	US11192861, Compound 86g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528609	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528609&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163200125	463792137							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117144	CCCOC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C28H27F3N4O2/c1-2-14-37-26(20-9-4-3-5-10-20)21-11-7-12-22(16-21)33-27(36)24-17-25(28(29,30)31)34-35(24)23-13-6-8-19(15-23)18-32/h3-13,15-17,26H,2,14,18,32H2,1H3,(H,33,36)	ODVQLXVRAUDBCL-UHFFFAOYSA-N	416765	1-(3-(aminomethyl)phenyl)-N-(3-(phenyl(propoxy)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18h::US10633345, Compound 18k::US10689346, Compound 18h::US11203574, Compound 18h::US11230530, Compound 18h::US11685721, Compound 18h	Plasma kallikrein		 75.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416765	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416765&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665753	433916679							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117145	CC(C)(C)OC(=O)NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C35H37F3N4O4/c1-34(2,3)46-33(44)39-22-24-9-7-14-28(19-24)42-29(21-30(41-42)35(36,37)38)32(43)40-27-13-8-12-26(20-27)31(25-10-5-4-6-11-25)45-18-17-23-15-16-23/h4-14,19-21,23,31H,15-18,22H2,1-3H3,(H,39,44)(H,40,43)	LEPBJMSXOZRUDM-UHFFFAOYSA-N	528611	US11192861, Compound 74a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528611	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528611&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			146536180	463792139							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117146	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-17-24(37(36-26)23-8-3-5-20(15-23)18-33)27(38)35-22-7-4-6-21(16-22)28(39,13-12-19-10-11-19)25-9-1-2-14-34-25/h1-9,14-17,19,39H,10-13,18,33H2,(H,35,38)	BAOACYBKKSTHLE-UHFFFAOYSA-N	416767	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 45g::US10633345, Compound 45g::US10689346, Compound 45g::US11203574, Compound 45g::US11230530, Compound 45g::US11685721, Compound 45g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416767	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416767&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665639	433916681							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117147	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(=O)Nc1ccccc1)C(F)(F)F	InChI=1S/C25H20F3N5O2/c26-25(27,28)22-14-21(33(32-22)20-11-4-6-16(12-20)15-29)24(35)31-19-10-5-7-17(13-19)23(34)30-18-8-2-1-3-9-18/h1-14H,15,29H2,(H,30,34)(H,31,35)	HDBCJKHEPGEJHK-UHFFFAOYSA-N	416768	1-(3-(aminomethyl)phenyl)-N-(3-(phenylcarbamoyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 21e::US10633345, Compound 21e::US10689346, Compound 21e::US11203574, Compound 21e::US11230530, Compound 21e::US11685721, Compound 21e	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416768	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416768&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665523	433916682							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117148	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CCC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F3N4O2/c31-30(32,33)27-17-26(37(36-27)25-14-5-9-21(15-25)18-34)29(38)35-24-13-6-12-23(16-24)28(22-10-2-1-3-11-22)39-19-20-7-4-8-20/h1-3,5-6,9-17,20,28H,4,7-8,18-19,34H2,(H,35,38)	KBAGRISCOGFVJB-UHFFFAOYSA-N	416769	1-(3-(aminomethyl)phenyl)-N-(3-((cyclobutylmethoxy)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 75a::US10633345, Compound 75a::US10689346, Compound 75a::US11203574, Compound 75a::US11230530, Compound 75a::US11685721, Compound 75a	Plasma kallikrein		 75.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416769	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416769&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665761	433916683							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117149	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-16-25(37(36-26)24-8-1-4-20(14-24)17-33)27(38)35-23-7-2-5-21(15-23)28(39,12-11-19-9-10-19)22-6-3-13-34-18-22/h1-8,13-16,18-19,39H,9-12,17,33H2,(H,35,38)	AOCZEQQKIIWUBU-UHFFFAOYSA-N	416770	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 47f::US10633345, Compound 47f::US10689346, Compound 47f::US11203574, Compound 47g::US11230530, Compound 47h::US11685721, Compound 47f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416770	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416770&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355766	433916684							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117150	CCCCOC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C29H29F3N4O2/c1-2-3-15-38-27(21-10-5-4-6-11-21)22-12-8-13-23(17-22)34-28(37)25-18-26(29(30,31)32)35-36(25)24-14-7-9-20(16-24)19-33/h4-14,16-18,27H,2-3,15,19,33H2,1H3,(H,34,37)	PKUIOUWZEKKIOY-UHFFFAOYSA-N	416772	1-(3-(aminomethyl)phenyl)-N-(3-(butoxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18j::US10633345, Compound 18j::US10689346, Compound 18j::US11203574, Compound 18j::US11230530, Compound 18j::US11685721, Compound 18j	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416772	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416772&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356140	433916686							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117151	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F4N5O/c30-23-12-11-21(27(35-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27,35H,9-10,16-17,34H2,(H,36,39)	MCLZOCFEIKBMBA-UHFFFAOYSA-N	416773	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 38d::US10633345, Compound 38d::US10689346, Compound 42a::US11203574, Compound 42a::US11230530, Compound 42a::US11685721, Compound 38d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416773	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416773&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356124	433916687							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117152	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-17-25(37(36-26)24-6-1-3-20(15-24)18-33)27(38)35-23-5-2-4-22(16-23)28(39,12-9-19-7-8-19)21-10-13-34-14-11-21/h1-6,10-11,13-17,19,39H,7-9,12,18,33H2,(H,35,38)	HEXYKZQZIBBLLM-UHFFFAOYSA-N	416774	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-(pyridin-4-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 92g::US10633345, Compound 92g::US10689346, Compound 92g::US11203574, Compound 92g::US11230530, Compound 92g::US11685721, Compound 92g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416774	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416774&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355890	433916688							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117153	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F3N4O2/c30-29(31,32)26-16-25(36(35-26)24-11-4-6-20(14-24)17-33)28(37)34-23-10-5-9-22(15-23)27(38-18-19-12-13-19)21-7-2-1-3-8-21/h1-11,14-16,19,27H,12-13,17-18,33H2,(H,34,37)	PEZVPVUPSJXZCH-UHFFFAOYSA-N	416775	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18k::US10633345, Compound 74a::US10689346, Compound 165e::US11203574, Compound 165e::US11230530, Compound 165e::US11685721, Compound 18k	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416775	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416775&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			91884591	433916689							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117154	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1ccc(F)c(c1)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-24-12-11-21(14-23(24)27(39-17-18-9-10-18)20-6-2-1-3-7-20)35-28(38)25-15-26(29(31,32)33)36-37(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27H,9-10,16-17,34H2,(H,35,38)	SMAPKFCZNNYDET-UHFFFAOYSA-N	416776	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)-4-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 76h::US10633345, Compound 76h::US10689346, Compound 76h::US11203574, Compound 76h::US11230530, Compound 76h::US11685721, Compound 76h	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416776	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416776&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356199	433916690							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117155	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cn[nH]c1)C(F)(F)F			416777	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(1H-pyrazol-4-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 84h::US10633345, Compound 84h::US10689346, Compound 84h::US11203574, Compound 84h::US11230530, Compound 84h::US11685721, Compound 84h	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416777	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416777&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			154584214	433916691							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117156	CCCN(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C27H26F3N5O/c1-2-14-34(21-10-4-3-5-11-21)22-12-7-9-20(16-22)32-26(36)24-17-25(27(28,29)30)33-35(24)23-13-6-8-19(15-23)18-31/h3-13,15-17H,2,14,18,31H2,1H3,(H,32,36)	IKJCTSPODFFZCP-UHFFFAOYSA-N	416778	1-(3-(aminomethyl)phenyl)-N-(3-(phenyl(propyl)amino)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 27f::US10633345, Compound 27f::US10689346, Compound 27f::US11203574, Compound 27f::US11230530, Compound 27f::US11685721, Compound 27f	Plasma kallikrein		 75.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416778	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416778&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356135	433916692							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117157	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(C(OCC2CC2)c2ccccc2)c1F)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-26-22(27(39-17-18-12-13-18)20-7-2-1-3-8-20)10-5-11-23(26)35-28(38)24-15-25(29(31,32)33)36-37(24)21-9-4-6-19(14-21)16-34/h1-11,14-15,18,27H,12-13,16-17,34H2,(H,35,38)	OCYVMBLZCJPYSX-UHFFFAOYSA-N	416779	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 36d::US10633345, Compound 36d::US10689346, Compound 36d::US11203574, Compound 36d::US11230530, Compound 36d::US11685721, Compound 36d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416779	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416779&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356266	433916693							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117158	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1nccs1)C(F)(F)F	InChI=1S/C26H25F3N6OS/c27-26(28,29)22-13-21(35(34-22)20-6-1-3-17(11-20)14-30)24(36)33-19-5-2-4-18(12-19)23(25-31-9-10-37-25)32-15-16-7-8-16/h1-6,9-13,16,23,32H,7-8,14-15,30H2,(H,33,36)	BPCHTFOGBGFGRD-UHFFFAOYSA-N	416780	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(thiazol-2-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 85c::US10633345, Compound 85c::US10689346, Compound 85c::US11203574, Compound 85c::US11230530, Compound 85c::US11685721, Compound 85c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416780	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416780&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355975	433916694							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117159	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CCC1CC1)N1CCOCC1)C(F)(F)F	InChI=1S/C28H32F3N5O2/c29-28(30,31)26-17-25(36(34-26)23-6-1-3-20(15-23)18-32)27(37)33-22-5-2-4-21(16-22)24(10-9-19-7-8-19)35-11-13-38-14-12-35/h1-6,15-17,19,24H,7-14,18,32H2,(H,33,37)	JPSOHZUNYZMZBS-UHFFFAOYSA-N	416781	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-morpholinopropyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 93b::US10633345, Compound 93b::US10689346, Compound 93b::US11203574, Compound 93b::US11230530, Compound 93b::US11685721, Compound 93b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416781	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416781&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665612	433916695							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117160	COc1cccc(c1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O2/c1-40-25-10-4-7-22(15-25)28(35-18-19-11-12-19)21-6-3-8-23(14-21)36-29(39)26-16-27(30(31,32)33)37-38(26)24-9-2-5-20(13-24)17-34/h2-10,13-16,19,28,35H,11-12,17-18,34H2,1H3,(H,36,39)	DMSXJIPDGRICQW-UHFFFAOYSA-N	416782	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(3-methoxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 109f::US10633345, Compound 109f::US10689346, Compound 109f::US11203574, Compound 109f::US11230530, Compound 109f::US11685721, Compound 109f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416782	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416782&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356265	433916696							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117161	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc2ccccc2c1)C(F)(F)F	InChI=1S/C33H30F3N5O/c34-33(35,36)30-18-29(41(40-30)28-10-3-5-22(15-28)19-37)32(42)39-27-9-4-8-25(17-27)31(38-20-21-11-12-21)26-14-13-23-6-1-2-7-24(23)16-26/h1-10,13-18,21,31,38H,11-12,19-20,37H2,(H,39,42)	QCSULFNIDZTXJZ-UHFFFAOYSA-N	416783	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic acid {3-[(cyclopropylmethyl-amino)-naphthalen-2-yl-methyl]-phenyl}-amide::US10329260, Compound 128g::US10633345, Compound 128g::US10689346, Compound 128g::US11203574, Compound 128g::US11230530, Compound 128g::US11685721, Compound 128g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416783	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416783&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665786	433916697							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117162	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H26F4N6O/c29-22-9-8-19(26(35-15-17-6-7-17)20-4-2-10-34-16-20)12-23(22)36-27(39)24-13-25(28(30,31)32)37-38(24)21-5-1-3-18(11-21)14-33/h1-5,8-13,16-17,26,35H,6-7,14-15,33H2,(H,36,39)	SECDZDWRLPONSX-UHFFFAOYSA-N	416784	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(pyridin-3-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 94b::US10633345, Compound 94b::US10689346, Compound 94b::US11203574, Compound 94b::US11230530, Compound 94b::US11685721, Compound 94b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416784	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416784&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355774	433916698							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117163	Cc1cccc(c1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O/c1-19-5-2-7-22(13-19)28(35-18-20-11-12-20)23-8-4-9-24(15-23)36-29(39)26-16-27(30(31,32)33)37-38(26)25-10-3-6-21(14-25)17-34/h2-10,13-16,20,28,35H,11-12,17-18,34H2,1H3,(H,36,39)	ADKXWAHEFSGGQB-UHFFFAOYSA-N	416785	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(m-tolyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 110f::US10633345, Compound 110f::US10689346, Compound 110f::US11203574, Compound 110f::US11230530, Compound 110f::US11685721, Compound 110f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416785	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416785&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123875262	433916699							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117164	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc2ccccc12)C(F)(F)F	InChI=1S/C33H30F3N5O/c34-33(35,36)30-18-29(41(40-30)26-11-3-6-22(16-26)19-37)32(42)39-25-10-4-9-24(17-25)31(38-20-21-14-15-21)28-13-5-8-23-7-1-2-12-27(23)28/h1-13,16-18,21,31,38H,14-15,19-20,37H2,(H,39,42)	NFYBGLSBONMUGA-UHFFFAOYSA-N	416786	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic acid {3-[(cyclopropylmethyl-amino)-naphthalen-1-yl-methyl]-phenyl}-amide::US10329260, Compound 129f::US10633345, Compound 129f::US10689346, Compound 129f::US11203574, Compound 129f::US11230530, Compound 129f::US11685721, Compound 129f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416786	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416786&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356190	433916700							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117165	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(cc(c1)C1CC1)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C32H32F3N5O/c33-32(34,35)29-17-28(40(39-29)27-8-4-5-21(13-27)18-36)31(41)38-26-15-24(22-11-12-22)14-25(16-26)30(37-19-20-9-10-20)23-6-2-1-3-7-23/h1-8,13-17,20,22,30,37H,9-12,18-19,36H2,(H,38,41)	TXFPQXDVPCBKSX-UHFFFAOYSA-N	439372	US10633345, Compound 95i::US10689346, Compound 95i::US11203574, Compound 95i::US11230530, Compound 95i::US11685721, Compound 95i	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439372	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439372&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665927	439660930							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117166	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc(c1)C(F)(F)F)C(F)(F)F	InChI=1S/C30H27F6N5O/c31-29(32,33)22-7-2-5-20(13-22)27(38-17-18-10-11-18)21-6-3-8-23(14-21)39-28(42)25-15-26(30(34,35)36)40-41(25)24-9-1-4-19(12-24)16-37/h1-9,12-15,18,27,38H,10-11,16-17,37H2,(H,39,42)	FZSHDRVSVGSKOF-UHFFFAOYSA-N	416788	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(3-(trifluoromethyl) phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 111f::US10633345, Compound 111f::US10689346, Compound 111f::US11203574, Compound 111f::US11230530, Compound 111f::US11685721, Compound 111f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416788	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416788&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355816	433916702							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117167	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-23-10-9-20(27(36-16-17-7-8-17)19-4-2-5-21(35)12-19)13-24(23)37-28(40)25-14-26(29(31,32)33)38-39(25)22-6-1-3-18(11-22)15-34/h1-6,9-14,17,27,36H,7-8,15-16,34-35H2,(H,37,40)	HJMCNZIVUWWSBV-UHFFFAOYSA-N	416792	1-(3-(aminomethyl)phenyl)-N-(5-((3-aminophenyl)(cyclopropylmethylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 131b::US10633345, Compound 131b::US10689346, Compound 131b::US11203574, Compound 131b::US11230530, Compound 131b::US11685721, Compound 131b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416792	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416792&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665555	433916706							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117168	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1Cl)C(NCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H26ClF3N6O/c29-22-9-8-19(26(35-15-17-6-7-17)20-4-2-10-34-16-20)12-23(22)36-27(39)24-13-25(28(30,31)32)37-38(24)21-5-1-3-18(11-21)14-33/h1-5,8-13,16-17,26,35H,6-7,14-15,33H2,(H,36,39)	DCRDGEJSCMQMFA-UHFFFAOYSA-N	416790	1-(3-(Aminomethyl)phenyl)-N-(2-chloro-5-((cyclopropylmethylamino)(pyridin-3-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 96f::US10633345, Compound 96f::US10689346, Compound 96f::US11203574, Compound 96f::US11230530, Compound 96f::US11685721, Compound 96f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416790	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416790&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355757	433916704							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117169	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(cc1)S(N)(=O)=O)C(F)(F)F	InChI=1S/C29H29F3N6O3S/c30-29(31,32)26-15-25(38(37-26)23-6-1-3-19(13-23)16-33)28(39)36-22-5-2-4-21(14-22)27(35-17-18-7-8-18)20-9-11-24(12-10-20)42(34,40)41/h1-6,9-15,18,27,35H,7-8,16-17,33H2,(H,36,39)(H2,34,40,41)	BGEXZQITRMVFRR-UHFFFAOYSA-N	416791	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(4-sulfamoylphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 112g::US10633345, Compound 112g::US10689346, Compound 112g::US11203574, Compound 112g::US11230530, Compound 112g::US11685721, Compound 112g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416791	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416791&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355780	433916705							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117170	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-23-10-9-20(27(36-16-17-7-8-17)19-4-2-5-21(35)12-19)13-24(23)37-28(40)25-14-26(29(31,32)33)38-39(25)22-6-1-3-18(11-22)15-34/h1-6,9-14,17,27,36H,7-8,15-16,34-35H2,(H,37,40)	HJMCNZIVUWWSBV-UHFFFAOYSA-N	416792	1-(3-(aminomethyl)phenyl)-N-(5-((3-aminophenyl)(cyclopropylmethylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 131b::US10633345, Compound 131b::US10689346, Compound 131b::US11203574, Compound 131b::US11230530, Compound 131b::US11685721, Compound 131b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416792	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416792&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665555	433916706							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117171	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H25F4N5O2/c29-22-9-8-19(26(39-16-17-6-7-17)20-4-2-10-34-15-20)12-23(22)35-27(38)24-13-25(28(30,31)32)36-37(24)21-5-1-3-18(11-21)14-33/h1-5,8-13,15,17,26H,6-7,14,16,33H2,(H,35,38)	CNAFOXQNPWSINI-UHFFFAOYSA-N	416794	Racemic 1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethoxy)(pyridin-3-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 48f::US10633345, Compound 48f::US10689346, Compound 48f::US11203574, Compound 48g::US11230530, Compound 48h::US11685721, Compound 48f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416794	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416794&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355617	433916708							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117172	CS(=O)(=O)c1ccc(cc1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O3S/c1-42(40,41)25-12-10-21(11-13-25)28(35-18-19-8-9-19)22-5-3-6-23(15-22)36-29(39)26-16-27(30(31,32)33)37-38(26)24-7-2-4-20(14-24)17-34/h2-7,10-16,19,28,35H,8-9,17-18,34H2,1H3,(H,36,39)	UTLDYOFVUPHYMX-UHFFFAOYSA-N	416795	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(4-(methylsulfonyl)phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 113f::US10633345, Compound 113f::US10689346, Compound 113f::US11203574, Compound 113f::US11230530, Compound 113f::US11685721, Compound 113f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416795	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416795&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355808	433916709							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117173	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C28H26F4N6O/c29-22-7-6-20(26(35-16-17-4-5-17)19-8-10-34-11-9-19)13-23(22)36-27(39)24-14-25(28(30,31)32)37-38(24)21-3-1-2-18(12-21)15-33/h1-3,6-14,17,26,35H,4-5,15-16,33H2,(H,36,39)	JHXYEKYRIWFSRY-UHFFFAOYSA-N	416796	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(pyridin-4-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 132f::US10633345, Compound 132f::US10689346, Compound 132f::US11203574, Compound 132f::US11230530, Compound 132f::US11685721, Compound 132f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416796	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416796&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665438	433916710							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117174	CN1CCc2c(C1)ccc(NC(=O)c1cc(nn1-c1cccc(CN)c1)C(F)(F)F)c2F	InChI=1S/C22H21F4N5O/c1-30-8-7-16-14(12-30)5-6-17(20(16)23)28-21(32)18-10-19(22(24,25)26)29-31(18)15-4-2-3-13(9-15)11-27/h2-6,9-10H,7-8,11-12,27H2,1H3,(H,28,32)	XRSKJTRQFAFTLA-UHFFFAOYSA-N	416797	1-(3-(aminomethyl)phenyl)-N-(5-fluoro-2-methyl-1,2,3,4-tetrahydroisoquinolin-6-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 164e::US10633345, Compound 164e::US10689346, Compound 164e::US11203574, Compound 164e::US11230530, Compound 164e::US11685721, Compound 164e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416797	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416797&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665488	433916711							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117175	CS(=O)(=O)c1cccc(c1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O3S/c1-42(40,41)25-10-4-7-22(15-25)28(35-18-19-11-12-19)21-6-3-8-23(14-21)36-29(39)26-16-27(30(31,32)33)37-38(26)24-9-2-5-20(13-24)17-34/h2-10,13-16,19,28,35H,11-12,17-18,34H2,1H3,(H,36,39)	VJYAFYNZRBTGFW-UHFFFAOYSA-N	416798	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(3-(methylsulfonyl)phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 114f::US10633345, Compound 114f::US10689346, Compound 114f::US11203574, Compound 114f::US11230530, Compound 114f::US11685721, Compound 114f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416798	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416798&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665780	433916712							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117176	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(cc1)-c1ccccc1)C(F)(F)F	InChI=1S/C35H32F3N5O/c36-35(37,38)32-20-31(43(42-32)30-11-4-6-24(18-30)21-39)34(44)41-29-10-5-9-28(19-29)33(40-22-23-12-13-23)27-16-14-26(15-17-27)25-7-2-1-3-8-25/h1-11,14-20,23,33,40H,12-13,21-22,39H2,(H,41,44)	SZCMOETVRNQDRC-UHFFFAOYSA-N	416799	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic Acid {3-[biphenyl-4-yl-(cyclopropylmethyl-amino)-methyl]-phenyl}-amide::US10329260, Compound 133g::US10633345, Compound 133g::US10689346, Compound 133g::US11203574, Compound 133g::US11230530, Compound 133g::US11685721, Compound 133g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416799	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416799&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665928	433916713							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117177	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(F)cc(c1)C(O)c1ccccc1)C(F)(F)F	InChI=1S/C25H20F4N4O2/c26-18-10-17(23(34)16-6-2-1-3-7-16)11-19(12-18)31-24(35)21-13-22(25(27,28)29)32-33(21)20-8-4-5-15(9-20)14-30/h1-13,23,34H,14,30H2,(H,31,35)	WOQUHGPQEUKGPZ-UHFFFAOYSA-N	416800	1-(3-(aminomethyl)phenyl)-N-(3-fluoro-5-(hydroxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 97f::US10633345, Compound 97f::US10689346, Compound 97f::US11203574, Compound 97f::US11230530, Compound 97f::US11685721, Compound 97f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416800	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416800&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355887	433916714							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117178	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NC(=O)C1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F3N5O2/c30-29(31,32)25-16-24(37(36-25)23-11-4-6-18(14-23)17-33)28(39)34-22-10-5-9-21(15-22)26(19-7-2-1-3-8-19)35-27(38)20-12-13-20/h1-11,14-16,20,26H,12-13,17,33H2,(H,34,39)(H,35,38)	JNPDNCCSYJLXEM-UHFFFAOYSA-N	439388	US10633345, Compound 115e::US10689346, Compound 115e::US11203574, Compound 115e::US11230530, Compound 115e::US11685721, Compound 115e	Plasma kallikrein		 75.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439388	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439388&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665512	439660946							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117179	COc1ccc2cc(ccc2c1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H32F3N5O2/c1-44-29-13-12-23-15-26(11-10-24(23)17-29)32(39-20-21-8-9-21)25-5-3-6-27(16-25)40-33(43)30-18-31(34(35,36)37)41-42(30)28-7-2-4-22(14-28)19-38/h2-7,10-18,21,32,39H,8-9,19-20,38H2,1H3,(H,40,43)	YJEVEVIVXGFKBA-UHFFFAOYSA-N	416804	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic Acid {3-[(cyclopropylmethyl-amino)-(6-methoxy-naphthalen-2-yl)-methyl]-phenyl}-amide::US10329260, Compound 134f::US10633345, Compound 134f::US10689346, Compound 134f::US11203574, Compound 134f::US11230530, Compound 134f::US11685721, Compound 134f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416804	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416804&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356181	433916718							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117180	FC(F)(F)c1cc(C(=O)Nc2cccc(c2)C(CCC2CC2)N2CCCC2)n(n1)-c1cccc(c1)C#N	InChI=1S/C28H28F3N5O/c29-28(30,31)26-17-25(36(34-26)23-8-3-5-20(15-23)18-32)27(37)33-22-7-4-6-21(16-22)24(12-11-19-9-10-19)35-13-1-2-14-35/h3-8,15-17,19,24H,1-2,9-14H2,(H,33,37)	MJYCRZLDCMJLHR-UHFFFAOYSA-N	439390	US10633345, Compound 98b::US10689346, Compound 98b::US11203574, Compound 98b::US11230530, Compound 98b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439390	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439390&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355716	439660948							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117181	CCc1cccc(c1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C31H32F3N5O/c1-2-20-6-3-8-23(14-20)29(36-19-21-12-13-21)24-9-5-10-25(16-24)37-30(40)27-17-28(31(32,33)34)38-39(27)26-11-4-7-22(15-26)18-35/h3-11,14-17,21,29,36H,2,12-13,18-19,35H2,1H3,(H,37,40)	YUWQOWXTNOVILU-UHFFFAOYSA-N	416807	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(3-ethylphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 116e::US10633345, Compound 116e::US10689346, Compound 116e::US11203574, Compound 116e::US11230530, Compound 116e::US11685721, Compound 116e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416807	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416807&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123342870	433916721							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117182	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(O)cc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-25(37(36-26)23-6-1-3-19(13-23)16-33)28(39)35-22-5-2-4-21(14-22)27(34-17-18-7-8-18)20-9-11-24(38)12-10-20/h1-6,9-15,18,27,34,38H,7-8,16-17,33H2,(H,35,39)	GDUMJZLASJIDFD-UHFFFAOYSA-N	416808	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(4-hydroxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 135c::US10633345, Compound 135c::US10689346, Compound 135c::US11203574, Compound 135c::US11230530, Compound 135c::US11685721, Compound 135c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416808	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416808&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355747	433916722							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117183	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CNC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-16-25(37(36-26)24-11-4-6-19(14-24)17-33)27(38)35-23-10-5-9-21(15-23)28(39,18-34-22-12-13-22)20-7-2-1-3-8-20/h1-11,14-16,22,34,39H,12-13,17-18,33H2,(H,35,38)	WTFGPUOPMMMRIY-UHFFFAOYSA-N	416809	1-(3-(aminomethyl)phenyl)-N-(3-(2-(cyclopropylamino)-1-hydroxy-1-phenylethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 99g::US10633345, Compound 99g::US10689346, Compound 99g::US11203574, Compound 99g::US11230530, Compound 99g::US11685721, Compound 99g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416809	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416809&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355899	433916723							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117184	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1F)C(F)(F)F	InChI=1S/C29H27F4N5O/c30-24-10-2-1-9-23(24)27(35-17-18-11-12-18)20-6-4-7-21(14-20)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-3-5-19(13-22)16-34/h1-10,13-15,18,27,35H,11-12,16-17,34H2,(H,36,39)	XNBKWIREUIHXKI-UHFFFAOYSA-N	416810	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2-fluorophenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 117e::US10329260, Compound 119e::US10633345, Compound 117e::US10689346, Compound 117e::US11203574, Compound 117e::US11230530, Compound 117e::US11685721, Compound 117e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416810	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416810&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123243852	433916724							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117185	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(Cc2ccc(O)cc2)c1)C(F)(F)F	InChI=1S/C25H21F3N4O2/c26-25(27,28)23-14-22(32(31-23)20-6-2-4-18(13-20)15-29)24(34)30-19-5-1-3-17(12-19)11-16-7-9-21(33)10-8-16/h1-10,12-14,33H,11,15,29H2,(H,30,34)	OPPQXCJMBFITBL-UHFFFAOYSA-N	416811	1-(3-(Aminomethyl)phenyl)-N-(3-(4-hydroxybenzyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 136a::US10633345, Compound 136a::US10689346, Compound 136a::US11203574, Compound 136a::US11230530, Compound 136a::US11685721, Compound 136a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416811	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416811&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356271	433916725							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117186	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C28H26F4N6O/c29-21-10-9-19(26(35-16-17-7-8-17)22-6-1-2-11-34-22)13-23(21)36-27(39)24-14-25(28(30,31)32)37-38(24)20-5-3-4-18(12-20)15-33/h1-6,9-14,17,26,35H,7-8,15-16,33H2,(H,36,39)	NHHQSQFDXMXIJU-UHFFFAOYSA-N	416812	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(pyridin-2-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 100e::US10633345, Compound 100e::US10689346, Compound 100e::US11203574, Compound 100e::US11230530, Compound 100e::US11685721, Compound 100e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416812	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416812&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356158	433916726							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117187	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1c2ccccc2c(Cl)c2ccccc12)C(F)(F)F	InChI=1S/C37H31ClF3N5O/c38-34-29-13-3-1-11-27(29)33(28-12-2-4-14-30(28)34)35(43-21-22-15-16-22)24-8-6-9-25(18-24)44-36(47)31-19-32(37(39,40)41)45-46(31)26-10-5-7-23(17-26)20-42/h1-14,17-19,22,35,43H,15-16,20-21,42H2,(H,44,47)	WNAKJZQMCRSZKD-UHFFFAOYSA-N	416813	1-(3-(aminomethyl)phenyl)-N-(3-((10-chloroanthracen-9-yl)(cyclopropylmethylamino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 118f::US10633345, Compound 118f::US10689346, Compound 118f::US11203574, Compound 118f::US11230530, Compound 118f::US11685721, Compound 118f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416813	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416813&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355872	433916727							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117188	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc(O)c1)C(F)F	InChI=1S/C29H29F2N5O2/c30-28(31)25-15-26(36(35-25)23-8-1-4-19(12-23)16-32)29(38)34-22-7-2-5-20(13-22)27(33-17-18-10-11-18)21-6-3-9-24(37)14-21/h1-9,12-15,18,27-28,33,37H,10-11,16-17,32H2,(H,34,38)	VEVGVPVDOLXTKF-UHFFFAOYSA-N	528654	US11192861, Compound 137a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528654	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528654&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163200128	463792181							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117189	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1nccs1)C(F)(F)F	InChI=1S/C26H24F4N6OS/c27-19-7-6-17(23(25-32-8-9-38-25)33-14-15-4-5-15)11-20(19)34-24(37)21-12-22(26(28,29)30)35-36(21)18-3-1-2-16(10-18)13-31/h1-3,6-12,15,23,33H,4-5,13-14,31H2,(H,34,37)	FBQBHRBLNRXXHC-UHFFFAOYSA-N	416815	1-(3-(Aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(thiazol-2-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 101e::US10633345, Compound 101e::US10689346, Compound 101e::US11203574, Compound 101e::US11230530, Compound 101e::US11685721, Compound 101e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416815	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416815&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355606	433916729							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117190	COc1ccccc1C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O2/c1-40-26-11-3-2-10-24(26)28(35-18-19-12-13-19)21-7-5-8-22(15-21)36-29(39)25-16-27(30(31,32)33)37-38(25)23-9-4-6-20(14-23)17-34/h2-11,14-16,19,28,35H,12-13,17-18,34H2,1H3,(H,36,39)	DAKZTBMQWXCVFA-UHFFFAOYSA-N	439400	US10633345, Compound 119e::US10689346, Compound 119e::US11203574, Compound 119e::US11230530, Compound 119e::US11685721, Compound 120e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439400	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439400&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665475	439660958							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117191	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(Cc2cccc(O)c2)c1)C(F)(F)F	InChI=1S/C25H21F3N4O2/c26-25(27,28)23-14-22(32(31-23)20-8-2-6-18(12-20)15-29)24(34)30-19-7-1-4-16(11-19)10-17-5-3-9-21(33)13-17/h1-9,11-14,33H,10,15,29H2,(H,30,34)	SDKHQNOIRDBHTG-UHFFFAOYSA-N	416820	1-(3-(aminomethyl)phenyl)-N-(3-(3-hydroxybenzyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 137b::US10633345, Compound 137b::US10689346, Compound 137b::US11203574, Compound 137b::US11230530, Compound 137b::US11685721, Compound 137b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416820	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416820&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665628	433916733							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117192	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H29F3N6O/c30-29(31,32)26-15-25(38(37-26)24-9-1-4-19(12-24)16-33)28(39)36-23-8-3-6-21(14-23)27(35-17-18-10-11-18)20-5-2-7-22(34)13-20/h1-9,12-15,18,27,35H,10-11,16-17,33-34H2,(H,36,39)	JHOLOXZJFLDOCM-UHFFFAOYSA-N	416821	1-(3-(aminomethyl)phenyl)-N-(3-((3-aminophenyl)(cyclopropylmethylamino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 102b::US11192861, Compound 102b::US11685721, Compound 102b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416821	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416821&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665659	433916734							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117193	CC(C)c1ccc(cc1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C32H34F3N5O/c1-20(2)23-11-13-24(14-12-23)30(37-19-21-9-10-21)25-6-4-7-26(16-25)38-31(41)28-17-29(32(33,34)35)39-40(28)27-8-3-5-22(15-27)18-36/h3-8,11-17,20-21,30,37H,9-10,18-19,36H2,1-2H3,(H,38,41)	BFUXJPJTVQBLMT-UHFFFAOYSA-N	416823	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(4-isopropylphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 120e::US10633345, Compound 120e::US10689346, Compound 120e::US11203574, Compound 120e::US11230530, Compound 120e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416823	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416823&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355943	433916736							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117194	CC(=O)Nc1ccc(cc1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C31H31F3N6O2/c1-19(41)37-24-12-10-22(11-13-24)29(36-18-20-8-9-20)23-5-3-6-25(15-23)38-30(42)27-16-28(31(32,33)34)39-40(27)26-7-2-4-21(14-26)17-35/h2-7,10-16,20,29,36H,8-9,17-18,35H2,1H3,(H,37,41)(H,38,42)	JDALRNHKHTYPON-UHFFFAOYSA-N	416827	N-(3-((4-acetamidophenyl)(cyclopropylmethylamino)methyl)phenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 138f::US10633345, Compound 138f::US10689346, Compound 138f::US11203574, Compound 138f::US11230530, Compound 138f::US11685721, Compound 138f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416827	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416827&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355810	433916740							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117195	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CCC1CC1)c1cc[nH]c1)C(F)(F)F			416828	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-(1H-pyrrol-3-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 103b::US10633345, Compound 103b::US10689346, Compound 103b::US11203574, Compound 103b::US11230530, Compound 103b::US11685721, Compound 103b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416828	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416828&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355898	433916741							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117196	Cc1ccc(cc1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O/c1-19-8-12-22(13-9-19)28(35-18-20-10-11-20)23-5-3-6-24(15-23)36-29(39)26-16-27(30(31,32)33)37-38(26)25-7-2-4-21(14-25)17-34/h2-9,12-16,20,28,35H,10-11,17-18,34H2,1H3,(H,36,39)	HRCLMMKOPKWJGF-UHFFFAOYSA-N	416829	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(p-tolyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 122g::US10633345, Compound 122g::US10689346, Compound 122g::US11203574, Compound 122g::US11230530, Compound 122g::US11685721, Compound 122g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416829	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416829&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355867	433916742							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117197	CN(C(c1ccc(cc1)C#N)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1)C1CC1	InChI=1S/C30H26F4N6O/c1-39(22-10-11-22)28(20-7-5-18(16-35)6-8-20)21-9-12-24(31)25(14-21)37-29(41)26-15-27(30(32,33)34)38-40(26)23-4-2-3-19(13-23)17-36/h2-9,12-15,22,28H,10-11,17,36H2,1H3,(H,37,41)	BZIYYSLZWQNWBF-UHFFFAOYSA-N	439407	US10633345, Compound 52h::US10633345, Compound 71a::US10633345, Compound 71b::US10689346, Compound 71b::US11203574, Compound 71a::US11230530, Compound 71b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439407	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439407&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355581	439660965							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117198	Cn1cc(cn1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C27H28F3N7O/c1-36-16-20(15-33-36)25(32-14-17-8-9-17)19-5-3-6-21(11-19)34-26(38)23-12-24(27(28,29)30)35-37(23)22-7-2-4-18(10-22)13-31/h2-7,10-12,15-17,25,32H,8-9,13-14,31H2,1H3,(H,34,38)	GHANDLPUFXRHQK-UHFFFAOYSA-N	416831	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(1-methyl-1H-pyrazol-4-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 104f::US10633345, Compound 104f::US10689346, Compound 104f::US11203574, Compound 104f::US11230530, Compound 104f::US11685721, Compound 104f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416831	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416831&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356100	433916744							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117199	CS(=O)(=O)c1ccccc1C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O3S/c1-42(40,41)26-11-3-2-10-24(26)28(35-18-19-12-13-19)21-7-5-8-22(15-21)36-29(39)25-16-27(30(31,32)33)37-38(25)23-9-4-6-20(14-23)17-34/h2-11,14-16,19,28,35H,12-13,17-18,34H2,1H3,(H,36,39)	XEAXHMDONDJJBQ-UHFFFAOYSA-N	416832	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2-(methylsulfonyl)phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 121f::US10633345, Compound 121f::US10689346, Compound 121f::US11203574, Compound 121f::US11230530, Compound 121f::US11685721, Compound 121f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416832	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416832&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665701	433916745							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117200	CN(C(c1ccc(CN)cc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1)C1CC1	InChI=1S/C30H30F4N6O/c1-39(22-10-11-22)28(20-7-5-18(16-35)6-8-20)21-9-12-24(31)25(14-21)37-29(41)26-15-27(30(32,33)34)38-40(26)23-4-2-3-19(13-23)17-36/h2-9,12-15,22,28H,10-11,16-17,35-36H2,1H3,(H,37,41)	REFXZSDKKDUEPN-UHFFFAOYSA-N	439410	US10633345, Compound 139b::US10689346, Compound 139b::US11203574, Compound 139b::US11230530, Compound 139b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439410	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439410&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665496	439660968							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117201	COc1ccc(cc1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O2/c1-40-25-12-10-21(11-13-25)28(35-18-19-8-9-19)22-5-3-6-23(15-22)36-29(39)26-16-27(30(31,32)33)37-38(26)24-7-2-4-20(14-24)17-34/h2-7,10-16,19,28,35H,8-9,17-18,34H2,1H3,(H,36,39)	NTRWDZUFVXMYGD-UHFFFAOYSA-N	416834	1-(3-(Aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(4-methoxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 105g::US10633345, Compound 105g::US10689346, Compound 105g::US11203574, Compound 105g::US11230530, Compound 105g::US11685721, Compound 105g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416834	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416834&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665521	433916747							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117202	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(OCc2ccccc2)cc1)C(F)(F)F	InChI=1S/C36H34F3N5O2/c37-36(38,39)33-20-32(44(43-33)30-11-4-8-26(18-30)21-40)35(45)42-29-10-5-9-28(19-29)34(41-22-24-12-13-24)27-14-16-31(17-15-27)46-23-25-6-2-1-3-7-25/h1-11,14-20,24,34,41H,12-13,21-23,40H2,(H,42,45)	AKMGFHNAHQDIKU-UHFFFAOYSA-N	439412	US10633345, Compound 123g::US10689346, Compound 123g::US11203574, Compound 123g::US11230530, Compound 123g::US11685721, Compound 107f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439412	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439412&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665739	439660970							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117203	Cc1cccc(c1)C(NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H29F4N5O/c1-18-4-2-6-21(12-18)28(36-17-19-8-9-19)22-10-11-24(31)25(14-22)37-29(40)26-15-27(30(32,33)34)38-39(26)23-7-3-5-20(13-23)16-35/h2-7,10-15,19,28,36H,8-9,16-17,35H2,1H3,(H,37,40)	DWXIBXKRESUYFO-UHFFFAOYSA-N	416836	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(m-tolyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 140e::US10633345, Compound 140e::US10689346, Compound 140e::US11203574, Compound 140e::US11230530, Compound 140e::US11685721, Compound 140e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416836	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416836&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356147	433916749							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117204	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1O)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-24(37(36-26)22-8-3-5-19(13-22)16-33)28(39)35-21-7-4-6-20(14-21)27(34-17-18-11-12-18)23-9-1-2-10-25(23)38/h1-10,13-15,18,27,34,38H,11-12,16-17,33H2,(H,35,39)	PCNDJIQOMLHSEK-UHFFFAOYSA-N	416837	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2-hydroxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 49h::US10633345, Compound 49h::US10689346, Compound 49h::US11203574, Compound 49j::US11230530, Compound 49j::US11685721, Compound 49h	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416837	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416837&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355733	433916750							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117205	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc(OC(F)(F)F)c1)C(F)(F)F	InChI=1S/C30H27F6N5O2/c31-29(32,33)26-15-25(41(40-26)23-8-1-4-19(12-23)16-37)28(42)39-22-7-2-5-20(13-22)27(38-17-18-10-11-18)21-6-3-9-24(14-21)43-30(34,35)36/h1-9,12-15,18,27,38H,10-11,16-17,37H2,(H,39,42)	IVEYKJBEIIJLCR-UHFFFAOYSA-N	416838	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(3-(trifluoromethoxy) phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 124f::US10633345, Compound 124f::US10689346, Compound 124f::US11203574, Compound 124f::US11230530, Compound 124f::US11685721, Compound 124f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416838	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416838&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665809	433916751							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117206	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C1OC(=O)Nc2ccccc12)C(F)(F)F	InChI=1S/C26H20F3N5O3/c27-26(28,29)22-13-21(34(33-22)18-8-3-5-15(11-18)14-30)24(35)31-17-7-4-6-16(12-17)23-19-9-1-2-10-20(19)32-25(36)37-23/h1-13,23H,14,30H2,(H,31,35)(H,32,36)	LRCHTKOMIAYQHX-UHFFFAOYSA-N	416839	1-(3-(aminomethyl)phenyl)-N-(3-(2-oxo-2,4-dihydro-1H-benzo[d][1,3]oxazin-4-yl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 167f::US10633345, Compound 167f::US10689346, Compound 167f::US11203574, Compound 167f::US11230530, Compound 167f::US11685721, Compound 167f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416839	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416839&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665868	433916752							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117207	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1OCc1ccccc1)C(F)(F)F	InChI=1S/C36H34F3N5O2/c37-36(38,39)33-20-31(44(43-33)29-13-6-10-26(18-29)21-40)35(45)42-28-12-7-11-27(19-28)34(41-22-24-16-17-24)30-14-4-5-15-32(30)46-23-25-8-2-1-3-9-25/h1-15,18-20,24,34,41H,16-17,21-23,40H2,(H,42,45)	XAZZTVOUWUHFIG-UHFFFAOYSA-N	416840	1-(3-(aminomethyl)phenyl)-N-(3-((2-(benzyloxy)phenyl)(cyclopropylmethyl amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 106a::US10633345, Compound 106a::US10689346, Compound 106a::US11203574, Compound 106a::US11230530, Compound 106a::US11685721, Compound 106a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416840	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416840&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356273	433916753							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117208	COc1ccc2ccccc2c1C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H32F3N5O2/c1-44-29-15-14-23-7-2-3-11-27(23)31(29)32(39-20-21-12-13-21)24-8-5-9-25(17-24)40-33(43)28-18-30(34(35,36)37)41-42(28)26-10-4-6-22(16-26)19-38/h2-11,14-18,21,32,39H,12-13,19-20,38H2,1H3,(H,40,43)	XVOUQCJHWNZPKF-UHFFFAOYSA-N	416841	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2-methoxynaphthalen-1-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 51f::US10633345, Compound 51f::US10689346, Compound 51f::US11203574, Compound 51h::US11230530, Compound 51h::US11685721, Compound 51f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416841	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416841&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356155	433916754							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117209	COc1cccc(c1)C(NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H29F4N5O2/c1-41-23-7-3-5-20(13-23)28(36-17-18-8-9-18)21-10-11-24(31)25(14-21)37-29(40)26-15-27(30(32,33)34)38-39(26)22-6-2-4-19(12-22)16-35/h2-7,10-15,18,28,36H,8-9,16-17,35H2,1H3,(H,37,40)	MRNMVRANILFBMK-UHFFFAOYSA-N	416842	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(3-methoxyphenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 141e::US10633345, Compound 141e::US10689346, Compound 141e::US11203574, Compound 141e::US11230530, Compound 141e::US11685721, Compound 142f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416842	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416842&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355803	433916755							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119938	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc2CCNCc2cc1F)C(F)(F)F	InChI=1S/C21H19F4N5O/c22-16-7-14-11-27-5-4-13(14)8-17(16)28-20(31)18-9-19(21(23,24)25)29-30(18)15-3-1-2-12(6-15)10-26/h1-3,6-9,27H,4-5,10-11,26H2,(H,28,31)	XCBOZBQFIYATFU-UHFFFAOYSA-N	416716	1-(3-(aminomethyl)phenyl)-N-(7-fluoro-1,2,3,4-tetrahydroisoquinolin-6-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 161e::US10633345, Compound 161e::US10689346, Compound 161e::US11203574, Compound 161e::US11230530, Compound 161e::US11685721, Compound 161e	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416716	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416716&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356276	433916630							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119939	CN(Cc1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1)c1ccccc1	InChI=1S/C26H24F3N5O/c1-33(21-10-3-2-4-11-21)17-19-8-5-9-20(13-19)31-25(35)23-15-24(26(27,28)29)32-34(23)22-12-6-7-18(14-22)16-30/h2-15H,16-17,30H2,1H3,(H,31,35)	IEARPKHOKPOLCS-UHFFFAOYSA-N	416717	1-(3-(aminomethyl)phenyl)-N-(3-((methyl(phenyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 28f::US10633345, Compound 28f::US10689346, Compound 28f::US11203574, Compound 28f::US11230530, Compound 28f::US11685721, Compound 28f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416717	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416717&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665676	433916631							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119940	CCCN(c1ccccc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C27H25F4N5O/c1-2-13-35(19-8-4-3-5-9-19)20-11-12-22(28)23(15-20)33-26(37)24-16-25(27(29,30)31)34-36(24)21-10-6-7-18(14-21)17-32/h3-12,14-16H,2,13,17,32H2,1H3,(H,33,37)	NZQCKHUBEMVLQD-UHFFFAOYSA-N	416718	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-5-(phenyl(propyl)amino)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 77e::US10633345, Compound 77e::US10689346, Compound 77e::US11203574, Compound 77e::US11230530, Compound 77e::US11685721, Compound 77e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416718	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416718&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665730	433916632							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119941	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1ccc2CNCCc2c1F)C(F)(F)F	InChI=1S/C21H19F4N5O/c22-19-15-6-7-27-11-13(15)4-5-16(19)28-20(31)17-9-18(21(23,24)25)29-30(17)14-3-1-2-12(8-14)10-26/h1-5,8-9,27H,6-7,10-11,26H2,(H,28,31)	RYNJWLCYWDTYKF-UHFFFAOYSA-N	416719	1-(3-(aminomethyl)phenyl)-N-(5-fluoro-1,2,3,4-tetrahydroisoquinolin-6-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 162c::US10633345, Compound 162c::US10689346, Compound 162c::US11203574, Compound 162c::US11230530, Compound 162c::US11685721, Compound 162c	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416719	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416719&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665528	433916633							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119942	CCCN(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1F	InChI=1S/C27H25F4N5O/c1-2-14-35(19-9-4-3-5-10-19)22-13-7-12-21(25(22)28)33-26(37)23-16-24(27(29,30)31)34-36(23)20-11-6-8-18(15-20)17-32/h3-13,15-16H,2,14,17,32H2,1H3,(H,33,37)	SDFZIQBGIDPGAP-UHFFFAOYSA-N	416720	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-3-(phenyl(propyl)amino)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 29e::US10633345, Compound 29e::US10689346, Compound 29e::US11203574, Compound 29e::US11230530, Compound 29e::US11685721, Compound 29e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416720	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416720&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355654	433916634							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119943	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C28H26F3N5O2/c29-28(30,31)25-15-24(36(35-25)22-8-3-5-19(13-22)16-32)27(37)34-21-7-4-6-20(14-21)26(38-17-18-10-11-18)23-9-1-2-12-33-23/h1-9,12-15,18,26H,10-11,16-17,32H2,(H,34,37)	UBQUVYTUKOFUOF-UHFFFAOYSA-N	416721	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(pyridin-2-yl)methyl)-phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 43f::US10633345, Compound 43f::US10689346, Compound 43g::US11203574, Compound 43h::US11230530, Compound 43h::US11685721, Compound 43f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416721	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416721&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355947	433916635							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119944	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc2CNCCc2cc1F)C(F)(F)F	InChI=1S/C21H19F4N5O/c22-16-7-13-4-5-27-11-14(13)8-17(16)28-20(31)18-9-19(21(23,24)25)29-30(18)15-3-1-2-12(6-15)10-26/h1-3,6-9,27H,4-5,10-11,26H2,(H,28,31)	APLBFUXJEQDPBH-UHFFFAOYSA-N	416722	1-(3-(aminomethyl)phenyl)-N-(6-fluoro-1,2,3,4-tetrahydroisoquinolin-7-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 163g::US10633345, Compound 163g::US10689346, Compound 163g::US11203574, Compound 163g::US11230530, Compound 163g::US11685721, Compound 163g	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416722	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416722&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355616	433916636							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119945	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(Cn2ccnc2)ccc1F)C(F)(F)F	InChI=1S/C22H18F4N6O/c23-17-5-4-15(12-31-7-6-28-13-31)9-18(17)29-21(33)19-10-20(22(24,25)26)30-32(19)16-3-1-2-14(8-16)11-27/h1-10,13H,11-12,27H2,(H,29,33)	FOWNNAMOGPFGSS-UHFFFAOYSA-N	416723	N-(5-((1H-imidazol-1-yl)methyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 30g::US10633345, Compound 30g::US10689346, Compound 30g::US11203574, Compound 30g::US11230530, Compound 30g::US11685721, Compound 30g	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416723	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416723&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356018	433916637							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119946	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H26F3N5O2/c29-28(30,31)25-14-24(36(35-25)23-8-1-4-19(12-23)15-32)27(37)34-22-7-2-5-20(13-22)26(38-17-18-9-10-18)21-6-3-11-33-16-21/h1-8,11-14,16,18,26H,9-10,15,17,32H2,(H,34,37)	SHFRWTHPPCXLER-UHFFFAOYSA-N	416725	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(pyridin-3-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 44c::US10633345, Compound 44c::US10689346, Compound 44c::US11203574, Compound 44d::US11230530, Compound 44e::US11685721, Compound 44c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416725	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416725&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355578	433916639							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119947	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(Nc2ccccc2)c1)C(F)(F)F	InChI=1S/C24H20F3N5O/c25-24(26,27)22-14-21(32(31-22)20-11-4-6-16(12-20)15-28)23(33)30-19-10-5-9-18(13-19)29-17-7-2-1-3-8-17/h1-14,29H,15,28H2,(H,30,33)	BURYUTYBSGJGCF-UHFFFAOYSA-N	416728	1-(3-(aminomethyl)phenyl)-N-(3-(phenylamino)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 17d::US10689346, Compound 17d::US11203574, Compound 17d::US11230530, Compound 17d::US11685721, Compound 17d	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416728	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416728&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665499	433916642							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119948	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)c1cccnc1)C(F)(F)F	InChI=1S/C24H20F3N5O2/c25-24(26,27)21-12-20(32(31-21)19-8-1-4-15(10-19)13-28)23(34)30-18-7-2-5-16(11-18)22(33)17-6-3-9-29-14-17/h1-12,14,22,33H,13,28H2,(H,30,34)	ZKOHYLRGOQBIFH-UHFFFAOYSA-N	416729	1-(3-(aminomethyl)phenyl)-N-(3-(hydroxy(pyridin-3-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 31f::US10633345, Compound 31f::US10689346, Compound 31f::US11203574, Compound 31f::US11230530, Compound 31f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416729	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416729&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665970	433916643							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119949	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F3N4O/c31-30(32,33)28-18-27(37(36-28)25-11-4-6-21(16-25)19-34)29(38)35-24-10-5-9-23(17-24)26(15-14-20-12-13-20)22-7-2-1-3-8-22/h1-11,16-18,20,26H,12-15,19,34H2,(H,35,38)	LVGPKQXQIQRVCT-UHFFFAOYSA-N	416730	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-phenylpropyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 78d::US10633345, Compound 78d::US10689346, Compound 78d::US11203574, Compound 78d::US11230530, Compound 78d::US11685721, Compound 78d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416730	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416730&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665672	433916644							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119950	COC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C26H23F3N4O2/c1-35-24(18-8-3-2-4-9-18)19-10-6-11-20(14-19)31-25(34)22-15-23(26(27,28)29)32-33(22)21-12-5-7-17(13-21)16-30/h2-15,24H,16,30H2,1H3,(H,31,34)	XNHGZPIIDJTQKO-UHFFFAOYSA-N	416731	1-(3-(aminomethyl)phenyl)-N-(3-(methoxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18f::US10633345, Compound 18f::US10689346, Compound 18f::US11203574, Compound 18f::US11230530, Compound 18e::US11685721, Compound 18f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416731	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416731&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665801	433916645							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119951	CCCCC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C29H29F3N4O/c1-2-3-15-25(21-10-5-4-6-11-21)22-12-8-13-23(17-22)34-28(37)26-18-27(29(30,31)32)35-36(26)24-14-7-9-20(16-24)19-33/h4-14,16-18,25H,2-3,15,19,33H2,1H3,(H,34,37)	PEZPMDJZISDDKH-UHFFFAOYSA-N	416732	1-(3-(aminomethyl)phenyl)-N-(3-(1-phenylpentyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 32f::US10633345, Compound 32f::US10689346, Compound 32f::US11203574, Compound 32f::US11230530, Compound 32f::US11685721, Compound 32f	Plasma kallikrein		>75.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416732	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416732&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356224	433916646							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119952	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H27F3N6O/c29-28(30,31)25-14-24(37(36-25)23-8-1-4-19(12-23)15-32)27(38)35-22-7-2-5-20(13-22)26(34-16-18-9-10-18)21-6-3-11-33-17-21/h1-8,11-14,17-18,26,34H,9-10,15-16,32H2,(H,35,38)	KSDPGGAAGHTRLB-UHFFFAOYSA-N	416733	1-(3-(Aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(pyridin-3-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 79f::US10633345, Compound 79f::US10689346, Compound 79f::US11203574, Compound 79f::US11230530, Compound 79f::US11685721, Compound 79f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416733	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416733&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356066	433916647							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119953	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(Cc2ccccc2)c1)C(F)(F)F	InChI=1S/C25H21F3N4O/c26-25(27,28)23-15-22(32(31-23)21-11-5-9-19(14-21)16-29)24(33)30-20-10-4-8-18(13-20)12-17-6-2-1-3-7-17/h1-11,13-15H,12,16,29H2,(H,30,33)	GVRJCFWHVBXPLW-UHFFFAOYSA-N	416734	1-(3-(aminomethyl)phenyl)-N-(3-benzylphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 19d::US10633345, Compound 19d::US10689346, Compound 19d::US11203574, Compound 19d::US11230530, Compound 19d::US11685721, Compound 19d	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416734	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416734&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355715	433916648							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119954	CCOC(c1ccccc1)c1ccc(Cl)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C27H24ClF3N4O2/c1-2-37-25(18-8-4-3-5-9-18)19-11-12-21(28)22(14-19)33-26(36)23-15-24(27(29,30)31)34-35(23)20-10-6-7-17(13-20)16-32/h3-15,25H,2,16,32H2,1H3,(H,33,36)	XUCZWPPXZIMXPF-UHFFFAOYSA-N	416735	1-(3-(aminomethyl)phenyl)-N-(2-chloro-5-(ethoxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 33e::US10633345, Compound 33e::US10689346, Compound 33e::US11203574, Compound 33e::US11230530, Compound 33e::US11685721, Compound 33e	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416735	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416735&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665706	433916649							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119955	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(F)cc(c1)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-22-12-21(27(39-17-18-9-10-18)20-6-2-1-3-7-20)13-23(14-22)35-28(38)25-15-26(29(31,32)33)36-37(25)24-8-4-5-19(11-24)16-34/h1-8,11-15,18,27H,9-10,16-17,34H2,(H,35,38)	CECISELXZFBKBA-UHFFFAOYSA-N	416736	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)-5-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 80h::US10633345, Compound 80h::US10689346, Compound 80h::US11203574, Compound 80h::US11230530, Compound 80h::US11685721, Compound 80h	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416736	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416736&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356068	433916650							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119956	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(Oc2ccccc2)c1)C(F)(F)F	InChI=1S/C24H19F3N4O2/c25-24(26,27)22-14-21(31(30-22)18-8-4-6-16(12-18)15-28)23(32)29-17-7-5-11-20(13-17)33-19-9-2-1-3-10-19/h1-14H,15,28H2,(H,29,32)	CMENISUXWPWEPE-UHFFFAOYSA-N	416737	1-(3-(aminomethyl)phenyl)-N-(3-phenoxyphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 20d::US10689346, Compound 20d::US11203574, Compound 20d::US11230530, Compound 20d::US11685721, Compound 20d	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416737	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416737&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665805	433916651							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119957	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1Cl)C(O)c1ccccc1)C(F)(F)F	InChI=1S/C25H20ClF3N4O2/c26-19-10-9-17(23(34)16-6-2-1-3-7-16)12-20(19)31-24(35)21-13-22(25(27,28)29)32-33(21)18-8-4-5-15(11-18)14-30/h1-13,23,34H,14,30H2,(H,31,35)	RYPOCSQZGRAPIF-UHFFFAOYSA-N	416738	1-(3-(aminomethyl)phenyl)-N-(2-chloro-5-(hydroxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 33f::US10633345, Compound 33f::US10689346, Compound 33f::US11203574, Compound 33f::US11230530, Compound 33f::US11685721, Compound 33f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416738	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416738&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665810	433916652							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119958	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)N(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H28F3N5O/c30-29(31,32)27-18-26(37(35-27)25-11-4-6-21(16-25)19-33)28(38)34-22-7-5-10-24(17-22)36(15-14-20-12-13-20)23-8-2-1-3-9-23/h1-11,16-18,20H,12-15,19,33H2,(H,34,38)	BPUAEVGWEFCIEW-UHFFFAOYSA-N	416739	1-(3-(aminomethyl)phenyl)-N-(3-((2-cyclopropylethyl)(phenyl)amino)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 87f::US10633345, Compound 87f::US10689346, Compound 87f::US11203574, Compound 87f::US11230530, Compound 87f::US11685721, Compound 87f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416739	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416739&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665744	433916653							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119959	CCOC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C27H25F3N4O2/c1-2-36-25(19-9-4-3-5-10-19)20-11-7-12-21(15-20)32-26(35)23-16-24(27(28,29)30)33-34(23)22-13-6-8-18(14-22)17-31/h3-16,25H,2,17,31H2,1H3,(H,32,35)	NWRGIGNKIBZYEM-UHFFFAOYSA-N	416740	1-(3-(aminomethyl)phenyl)-N-(3-(ethoxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18g::US10633345, Compound 18g::US10689346, Compound 18g::US11203574, Compound 18g::US11230530, Compound 18g::US11685721, Compound 18g	Plasma kallikrein		>75.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416740	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416740&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356270	433916654							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119960	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)c1ccccc1)C(F)(F)F	InChI=1S/C25H20F4N4O2/c26-19-10-9-17(23(34)16-6-2-1-3-7-16)12-20(19)31-24(35)21-13-22(25(27,28)29)32-33(21)18-8-4-5-15(11-18)14-30/h1-13,23,34H,14,30H2,(H,31,35)	SUGJHCONPCVXKJ-UHFFFAOYSA-N	416741	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-5-(hydroxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 34d::US10633345, Compound 34d::US10689346, Compound 34d::US11203574, Compound 34d::US11230530, Compound 34d::US11685721, Compound 34d	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416741	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416741&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665740	433916655							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119961	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(C(NCC2CC2)c2ccccc2)c1F)C(F)(F)F	InChI=1S/C29H27F4N5O/c30-26-22(27(35-17-18-12-13-18)20-7-2-1-3-8-20)10-5-11-23(26)36-28(39)24-15-25(29(31,32)33)37-38(24)21-9-4-6-19(14-21)16-34/h1-11,14-15,18,27,35H,12-13,16-17,34H2,(H,36,39)	YDBPNMJFMRHCIG-UHFFFAOYSA-N	416742	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 88b::US10633345, Compound 88b::US10689346, Compound 88b::US11203574, Compound 88b::US11230530, Compound 88b::US11685721, Compound 88b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416742	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416742&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123349010	433916656							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119962	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(=O)c1ccccc1)C(F)(F)F	InChI=1S/C25H19F3N4O2/c26-25(27,28)22-14-21(32(31-22)20-11-4-6-16(12-20)15-29)24(34)30-19-10-5-9-18(13-19)23(33)17-7-2-1-3-8-17/h1-14H,15,29H2,(H,30,34)	ZRVRSUVIXBEHIJ-UHFFFAOYSA-N	416743	1-(3-(aminomethyl)phenyl)-N-(3-benzoylphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 22b::US10633345, Compound 22b::US10689346, Compound 22b::US11203574, Compound 22b::US11230530, Compound 22b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416743	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416743&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355917	433916657							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119963	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(C(O)c2ccccc2)c1F)C(F)(F)F	InChI=1S/C25H20F4N4O2/c26-22-18(23(34)16-7-2-1-3-8-16)10-5-11-19(22)31-24(35)20-13-21(25(27,28)29)32-33(20)17-9-4-6-15(12-17)14-30/h1-13,23,34H,14,30H2,(H,31,35)	DENXCWXVTOPLRK-UHFFFAOYSA-N	416744	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-3-(hydroxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 35g::US10633345, Compound 35g::US10689346, Compound 35g::US11203574, Compound 35g::US11230530, Compound 35g::US11685721, Compound 35g	Plasma kallikrein		>75.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416744	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416744&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355965	433916658							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119964	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1nccs1)C(F)(F)F	InChI=1S/C26H24F3N5O2S/c27-26(28,29)22-13-21(34(33-22)20-6-1-3-17(11-20)14-30)24(35)32-19-5-2-4-18(12-19)23(25-31-9-10-37-25)36-15-16-7-8-16/h1-6,9-13,16,23H,7-8,14-15,30H2,(H,32,35)	FKPORVMTXYTRPN-UHFFFAOYSA-N	416745	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(thiazol-2-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 82f::US10633345, Compound 82f::US10689346, Compound 82f::US11203574, Compound 82f::US11230530, Compound 82f::US11685721, Compound 82f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416745	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416745&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355763	433916659							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119965	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(Oc2ccccc2)c1F)C(F)(F)F	InChI=1S/C24H18F4N4O2/c25-22-18(10-5-11-20(22)34-17-8-2-1-3-9-17)30-23(33)19-13-21(24(26,27)28)31-32(19)16-7-4-6-15(12-16)14-29/h1-13H,14,29H2,(H,30,33)	VUYMCUFLTORTFW-UHFFFAOYSA-N	416746	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-3-phenoxyphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 23c::US10633345, Compound 23c::US10689346, Compound 23c::US11203574, Compound 23c::US11230530, Compound 23c::US11685721, Compound 23c	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416746	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416746&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665745	433916660							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119966	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-23-12-11-21(27(39-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)35-28(38)25-15-26(29(31,32)33)36-37(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27H,9-10,16-17,34H2,(H,35,38)	HIMJVDQVZQMIPM-UHFFFAOYSA-N	416747	1-(3-(Aminomethyl)phenyl)-N-(5-((cyclopropylmethoxy)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 34c::US10633345, Compound 34c::US10689346, Compound 34c::US11203574, Compound 37a::US11230530, Compound 37a::US11685721, Compound 34c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416747	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416747&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355729	433916661							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119967	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C28H27F3N6O/c29-28(30,31)25-15-24(37(36-25)22-8-3-5-19(13-22)16-32)27(38)35-21-7-4-6-20(14-21)26(34-17-18-10-11-18)23-9-1-2-12-33-23/h1-9,12-15,18,26,34H,10-11,16-17,32H2,(H,35,38)	UTXGSCUKCKWESJ-UHFFFAOYSA-N	416748	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(pyridin-2-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 83c::US10633345, Compound 83c::US10689346, Compound 83c::US11203574, Compound 83c::US11230530, Compound 83c::US11685721, Compound 83c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416748	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416748&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355952	433916662							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119968	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(Oc2ccccc2)ccc1F)C(F)(F)F	InChI=1S/C24H18F4N4O2/c25-19-10-9-18(34-17-7-2-1-3-8-17)12-20(19)30-23(33)21-13-22(24(26,27)28)31-32(21)16-6-4-5-15(11-16)14-29/h1-13H,14,29H2,(H,30,33)	RDALDQDNCYVLAM-UHFFFAOYSA-N	416749	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-5-phenoxyphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 24c::US10633345, Compound 24c::US10689346, Compound 24c::US11203574, Compound 24c::US11230530, Compound 24c::US11685721, Compound 24c	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416749	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416749&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356123	433916663							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119969	CC(C)(C)OC(=O)NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F3N4O4/c1-29(2,3)41-28(40)34-18-19-9-7-14-23(15-19)37-24(17-25(36-37)30(31,32)33)27(39)35-22-13-8-12-21(16-22)26(38)20-10-5-4-6-11-20/h4-17,26,38H,18H2,1-3H3,(H,34,40)(H,35,39)	HTUKEDKRJSOOMR-UHFFFAOYSA-N	529580	US11203574, Compound 18e	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=529580	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=529580&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355806	463793102							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119970	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F3N4O2/c31-30(32,33)27-18-26(37(36-27)25-11-4-6-21(16-25)19-34)28(38)35-24-10-5-9-23(17-24)29(39,15-14-20-12-13-20)22-7-2-1-3-8-22/h1-11,16-18,20,39H,12-15,19,34H2,(H,35,38)	DCGYPXFSNPCKGX-UHFFFAOYSA-N	416751	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 46g::US10633345, Compound 46g::US10689346, Compound 46g::US11203574, Compound 46i::US11230530, Compound 46i::US11685721, Compound 46g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416751	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416751&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355790	433916665							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119971	CCOC(c1ccccc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C27H24F4N4O2/c1-2-37-25(18-8-4-3-5-9-18)19-11-12-21(28)22(14-19)33-26(36)23-15-24(27(29,30)31)34-35(23)20-10-6-7-17(13-20)16-32/h3-15,25H,2,16,32H2,1H3,(H,33,36)	YVBRMUSUELCGNA-UHFFFAOYSA-N	416752	1-(3-(aminomethyl)phenyl)-N-(5-(ethoxy(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 25b::US10633345, Compound 25b::US10689346, Compound 25b::US11203574, Compound 25b::US11230530, Compound 25b::US11685721, Compound 25b	Plasma kallikrein		>75.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416752	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416752&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665520	433916666							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119972	CC(C)[C@H](N)C(=O)OC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O3/c1-18(2)26(35)29(40)41-27(20-9-4-3-5-10-20)21-11-7-12-22(15-21)36-28(39)24-16-25(30(31,32)33)37-38(24)23-13-6-8-19(14-23)17-34/h3-16,18,26-27H,17,34-35H2,1-2H3,(H,36,39)/t26-,27?/m0/s1	OQCWFOUCOSAWQU-QBHOUYDASA-N	416753	(2S)-(3-(1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamido)phenyl)(phenyl)methyl 2-amino-3-methylbutanoate::US10329260, Compound 81c::US10633345, Compound 81c::US10689346, Compound 81c::US11203574, Compound 81c::US11230530, Compound 81c::US11685721, Compound 81c	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416753	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416753&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355992	433916667					C03317		1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119973	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)[C@](N)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-22-10-9-20(28(35,12-11-18-7-8-18)25-6-1-2-13-36-25)15-23(22)37-27(40)24-16-26(29(31,32)33)38-39(24)21-5-3-4-19(14-21)17-34/h1-6,9-10,13-16,18H,7-8,11-12,17,34-35H2,(H,37,40)/t28-/m1/s1	IFWBAIGKQKRJGJ-MUUNZHRXSA-N	416754	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carb oxamide::US10329260, Compound 205f::US10633345, Compound 205e::US11203574, Compound 205f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416754	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416754&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			146207235	433916668							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119974	COC(c1ccccc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C26H22F4N4O2/c1-36-24(17-7-3-2-4-8-17)18-10-11-20(27)21(13-18)32-25(35)22-14-23(26(28,29)30)33-34(22)19-9-5-6-16(12-19)15-31/h2-14,24H,15,31H2,1H3,(H,32,35)	AJQPEPSKLFPFIU-UHFFFAOYSA-N	416755	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-5-(methoxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 25c::US10633345, Compound 25c::US10689346, Compound 25c::US11203574, Compound 25c::US11230530, Compound 25c::US11685721, Compound 25c	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416755	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416755&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126666045	433916669							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119975	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CC#N)c1ccccc1)C(F)(F)F	InChI=1S/C27H22F3N5O/c28-27(29,30)25-16-24(35(34-25)22-11-4-6-18(14-22)17-32)26(36)33-21-10-5-9-20(15-21)23(12-13-31)19-7-2-1-3-8-19/h1-11,14-16,23H,12,17,32H2,(H,33,36)	AUPCAIQBGWQVBR-UHFFFAOYSA-N	416756	1-(3-(aminomethyl)phenyl)-N-(3-(2-cyano-1-phenylethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 39e::US10633345, Compound 39e::US10689346, Compound 39e::US11203574, Compound 39e::US11230530, Compound 39e::US11685721, Compound 39e	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416756	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416756&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126666023	433916670							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119976	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CCC1CC1)n1ccnc1)C(F)(F)F	InChI=1S/C27H27F3N6O/c28-27(29,30)25-15-24(36(34-25)22-6-1-3-19(13-22)16-31)26(37)33-21-5-2-4-20(14-21)23(10-9-18-7-8-18)35-12-11-32-17-35/h1-6,11-15,17-18,23H,7-10,16,31H2,(H,33,37)	UPEDWOJFQGRWOZ-UHFFFAOYSA-N	416757	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-(1H-imidazol-1-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 89g::US10633345, Compound 89g::US10689346, Compound 89g::US11203574, Compound 89g::US11230530, Compound 89g::US11685721, Compound 89g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416757	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416757&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665540	433916671							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119977	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(Cc2ccccc2)ccc1F)C(F)(F)F	InChI=1S/C25H20F4N4O/c26-20-10-9-17(11-16-5-2-1-3-6-16)13-21(20)31-24(34)22-14-23(25(27,28)29)32-33(22)19-8-4-7-18(12-19)15-30/h1-10,12-14H,11,15,30H2,(H,31,34)	PFWDQKVXCJEZES-UHFFFAOYSA-N	416758	1-(3-(aminomethyl)phenyl)-N-(5-benzyl-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 26f::US10633345, Compound 26f::US10689346, Compound 26f::US11203574, Compound 26f::US11230530, Compound 26f::US11685721, Compound 26f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416758	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416758&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355900	433916672							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119978	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CC(N)=O)c1ccccc1)C(F)(F)F	InChI=1S/C27H24F3N5O2/c28-27(29,30)24-15-23(35(34-24)21-11-4-6-17(12-21)16-31)26(37)33-20-10-5-9-19(13-20)22(14-25(32)36)18-7-2-1-3-8-18/h1-13,15,22H,14,16,31H2,(H2,32,36)(H,33,37)	KDXRDWIYPXSJST-UHFFFAOYSA-N	416759	N-(3-(3-amino-3-oxo-1-phenylpropyl)phenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 40b::US10633345, Compound 40b::US10689346, Compound 40b::US11203574, Compound 40b::US11230530, Compound 40b::US11685721, Compound 40b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416759	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416759&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665680	433916673							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119979	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(=C\CC1CC1)\c1ccccc1)C(F)(F)F	InChI=1S/C30H27F3N4O/c31-30(32,33)28-18-27(37(36-28)25-11-4-6-21(16-25)19-34)29(38)35-24-10-5-9-23(17-24)26(15-14-20-12-13-20)22-7-2-1-3-8-22/h1-11,15-18,20H,12-14,19,34H2,(H,35,38)/b26-15+	VKLRLOSKQDEQAH-CVKSISIWSA-N	416760	(E/Z)-1-(3-(Aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-phenylprop-1-enyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide hydrochloride::US10329260, Compound 91a::US11203574, Compound 91a::US11685721, Compound 91a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416760	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416760&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			153066367	433916674							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119980	CC(C)COC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C29H29F3N4O2/c1-19(2)18-38-27(21-9-4-3-5-10-21)22-11-7-12-23(15-22)34-28(37)25-16-26(29(30,31)32)35-36(25)24-13-6-8-20(14-24)17-33/h3-16,19,27H,17-18,33H2,1-2H3,(H,34,37)	FMSXMXLNUZXXSC-UHFFFAOYSA-N	416762	1-(3-(aminomethyl)phenyl)-N-(3-(isobutoxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18i::US10633345, Compound 18i::US10689346, Compound 18i::US11203574, Compound 18i::US11230530, Compound 18i::US11685721, Compound 18i	Plasma kallikrein		>75.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416762	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416762&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356257	433916676							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119981	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H28F3N5O/c30-29(31,32)26-16-25(37(36-26)24-11-4-6-20(14-24)17-33)28(38)35-23-10-5-9-22(15-23)27(34-18-19-12-13-19)21-7-2-1-3-8-21/h1-11,14-16,19,27,34H,12-13,17-18,33H2,(H,35,38)	QZQLNMURVWFZTC-UHFFFAOYSA-N	439347	US10633345, Compound 41e::US10689346, Compound 41e::US11203574, Compound 41e::US11230530, Compound 41e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439347	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439347&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665751	439660905							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119982	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C28H27F3N6O/c29-28(30,31)25-15-24(37(36-25)23-6-1-3-19(13-23)16-32)27(38)35-22-5-2-4-21(14-22)26(34-17-18-7-8-18)20-9-11-33-12-10-20/h1-6,9-15,18,26,34H,7-8,16-17,32H2,(H,35,38)	VXJYGPKEYKOJCQ-UHFFFAOYSA-N	416764	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(pyridin-4-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 86g::US10633345, Compound 86g::US10689346, Compound 86g::US11203574, Compound 86g::US11230530, Compound 86g::US11685721, Compound 86g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416764	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416764&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355880	433916678							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119983	CCCOC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C28H27F3N4O2/c1-2-14-37-26(20-9-4-3-5-10-20)21-11-7-12-22(16-21)33-27(36)24-17-25(28(29,30)31)34-35(24)23-13-6-8-19(15-23)18-32/h3-13,15-17,26H,2,14,18,32H2,1H3,(H,33,36)	ODVQLXVRAUDBCL-UHFFFAOYSA-N	416765	1-(3-(aminomethyl)phenyl)-N-(3-(phenyl(propoxy)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18h::US10633345, Compound 18k::US10689346, Compound 18h::US11203574, Compound 18h::US11230530, Compound 18h::US11685721, Compound 18h	Plasma kallikrein		>75.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416765	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416765&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665753	433916679							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119984	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F3N4O2/c31-30(32,33)27-18-26(37(36-27)25-11-4-6-21(16-25)19-34)29(38)35-24-10-5-9-23(17-24)28(22-7-2-1-3-8-22)39-15-14-20-12-13-20/h1-11,16-18,20,28H,12-15,19,34H2,(H,35,38)	WCAGCVGZCBBZDT-UHFFFAOYSA-N	416766	1-(3-(aminomethyl)phenyl)-N-(3-((2-cyclopropylethoxy)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 74a::US10689346, Compound 74a::US11203574, Compound 74a::US11230530, Compound 74a::US11685721, Compound 74a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416766	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416766&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665775	433916680							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119985	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-17-24(37(36-26)23-8-3-5-20(15-23)18-33)27(38)35-22-7-4-6-21(16-22)28(39,13-12-19-10-11-19)25-9-1-2-14-34-25/h1-9,14-17,19,39H,10-13,18,33H2,(H,35,38)	BAOACYBKKSTHLE-UHFFFAOYSA-N	416767	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 45g::US10633345, Compound 45g::US10689346, Compound 45g::US11203574, Compound 45g::US11230530, Compound 45g::US11685721, Compound 45g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416767	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416767&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665639	433916681							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119986	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(=O)Nc1ccccc1)C(F)(F)F	InChI=1S/C25H20F3N5O2/c26-25(27,28)22-14-21(33(32-22)20-11-4-6-16(12-20)15-29)24(35)31-19-10-5-7-17(13-19)23(34)30-18-8-2-1-3-9-18/h1-14H,15,29H2,(H,30,34)(H,31,35)	HDBCJKHEPGEJHK-UHFFFAOYSA-N	416768	1-(3-(aminomethyl)phenyl)-N-(3-(phenylcarbamoyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 21e::US10633345, Compound 21e::US10689346, Compound 21e::US11203574, Compound 21e::US11230530, Compound 21e::US11685721, Compound 21e	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416768	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416768&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665523	433916682							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119987	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CCC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F3N4O2/c31-30(32,33)27-17-26(37(36-27)25-14-5-9-21(15-25)18-34)29(38)35-24-13-6-12-23(16-24)28(22-10-2-1-3-11-22)39-19-20-7-4-8-20/h1-3,5-6,9-17,20,28H,4,7-8,18-19,34H2,(H,35,38)	KBAGRISCOGFVJB-UHFFFAOYSA-N	416769	1-(3-(aminomethyl)phenyl)-N-(3-((cyclobutylmethoxy)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 75a::US10633345, Compound 75a::US10689346, Compound 75a::US11203574, Compound 75a::US11230530, Compound 75a::US11685721, Compound 75a	Plasma kallikrein		>75.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416769	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416769&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665761	433916683							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119988	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-16-25(37(36-26)24-8-1-4-20(14-24)17-33)27(38)35-23-7-2-5-21(15-23)28(39,12-11-19-9-10-19)22-6-3-13-34-18-22/h1-8,13-16,18-19,39H,9-12,17,33H2,(H,35,38)	AOCZEQQKIIWUBU-UHFFFAOYSA-N	416770	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 47f::US10633345, Compound 47f::US10689346, Compound 47f::US11203574, Compound 47g::US11230530, Compound 47h::US11685721, Compound 47f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416770	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416770&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355766	433916684							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119989	CCCCOC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C29H29F3N4O2/c1-2-3-15-38-27(21-10-5-4-6-11-21)22-12-8-13-23(17-22)34-28(37)25-18-26(29(30,31)32)35-36(25)24-14-7-9-20(16-24)19-33/h4-14,16-18,27H,2-3,15,19,33H2,1H3,(H,34,37)	PKUIOUWZEKKIOY-UHFFFAOYSA-N	416772	1-(3-(aminomethyl)phenyl)-N-(3-(butoxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18j::US10633345, Compound 18j::US10689346, Compound 18j::US11203574, Compound 18j::US11230530, Compound 18j::US11685721, Compound 18j	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416772	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416772&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356140	433916686							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119990	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F4N5O/c30-23-12-11-21(27(35-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27,35H,9-10,16-17,34H2,(H,36,39)	MCLZOCFEIKBMBA-UHFFFAOYSA-N	416773	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 38d::US10633345, Compound 38d::US10689346, Compound 42a::US11203574, Compound 42a::US11230530, Compound 42a::US11685721, Compound 38d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416773	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416773&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356124	433916687							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119991	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-17-25(37(36-26)24-6-1-3-20(15-24)18-33)27(38)35-23-5-2-4-22(16-23)28(39,12-9-19-7-8-19)21-10-13-34-14-11-21/h1-6,10-11,13-17,19,39H,7-9,12,18,33H2,(H,35,38)	HEXYKZQZIBBLLM-UHFFFAOYSA-N	416774	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-(pyridin-4-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 92g::US10633345, Compound 92g::US10689346, Compound 92g::US11203574, Compound 92g::US11230530, Compound 92g::US11685721, Compound 92g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416774	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416774&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355890	433916688							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119992	CCCOC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C28H27F3N4O2/c1-2-14-37-26(20-9-4-3-5-10-20)21-11-7-12-22(16-21)33-27(36)24-17-25(28(29,30)31)34-35(24)23-13-6-8-19(15-23)18-32/h3-13,15-17,26H,2,14,18,32H2,1H3,(H,33,36)	ODVQLXVRAUDBCL-UHFFFAOYSA-N	416765	1-(3-(aminomethyl)phenyl)-N-(3-(phenyl(propoxy)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18h::US10633345, Compound 18k::US10689346, Compound 18h::US11203574, Compound 18h::US11230530, Compound 18h::US11685721, Compound 18h	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416765	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416765&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665753	433916679							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119993	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1ccc(F)c(c1)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-24-12-11-21(14-23(24)27(39-17-18-9-10-18)20-6-2-1-3-7-20)35-28(38)25-15-26(29(31,32)33)36-37(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27H,9-10,16-17,34H2,(H,35,38)	SMAPKFCZNNYDET-UHFFFAOYSA-N	416776	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)-4-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 76h::US10633345, Compound 76h::US10689346, Compound 76h::US11203574, Compound 76h::US11230530, Compound 76h::US11685721, Compound 76h	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416776	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416776&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356199	433916690							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119994	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cn[nH]c1)C(F)(F)F			416777	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(1H-pyrazol-4-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 84h::US10633345, Compound 84h::US10689346, Compound 84h::US11203574, Compound 84h::US11230530, Compound 84h::US11685721, Compound 84h	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416777	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416777&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			154584214	433916691							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119995	CCCN(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C27H26F3N5O/c1-2-14-34(21-10-4-3-5-11-21)22-12-7-9-20(16-22)32-26(36)24-17-25(27(28,29)30)33-35(24)23-13-6-8-19(15-23)18-31/h3-13,15-17H,2,14,18,31H2,1H3,(H,32,36)	IKJCTSPODFFZCP-UHFFFAOYSA-N	416778	1-(3-(aminomethyl)phenyl)-N-(3-(phenyl(propyl)amino)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 27f::US10633345, Compound 27f::US10689346, Compound 27f::US11203574, Compound 27f::US11230530, Compound 27f::US11685721, Compound 27f	Plasma kallikrein		>75.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416778	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416778&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356135	433916692							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119996	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(C(OCC2CC2)c2ccccc2)c1F)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-26-22(27(39-17-18-12-13-18)20-7-2-1-3-8-20)10-5-11-23(26)35-28(38)24-15-25(29(31,32)33)36-37(24)21-9-4-6-19(14-21)16-34/h1-11,14-15,18,27H,12-13,16-17,34H2,(H,35,38)	OCYVMBLZCJPYSX-UHFFFAOYSA-N	416779	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 36d::US10633345, Compound 36d::US10689346, Compound 36d::US11203574, Compound 36d::US11230530, Compound 36d::US11685721, Compound 36d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416779	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416779&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356266	433916693							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119997	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1nccs1)C(F)(F)F	InChI=1S/C26H25F3N6OS/c27-26(28,29)22-13-21(35(34-22)20-6-1-3-17(11-20)14-30)24(36)33-19-5-2-4-18(12-19)23(25-31-9-10-37-25)32-15-16-7-8-16/h1-6,9-13,16,23,32H,7-8,14-15,30H2,(H,33,36)	BPCHTFOGBGFGRD-UHFFFAOYSA-N	416780	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(thiazol-2-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 85c::US10633345, Compound 85c::US10689346, Compound 85c::US11203574, Compound 85c::US11230530, Compound 85c::US11685721, Compound 85c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416780	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416780&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355975	433916694							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119998	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CCC1CC1)N1CCOCC1)C(F)(F)F	InChI=1S/C28H32F3N5O2/c29-28(30,31)26-17-25(36(34-26)23-6-1-3-20(15-23)18-32)27(37)33-22-5-2-4-21(16-22)24(10-9-19-7-8-19)35-11-13-38-14-12-35/h1-6,15-17,19,24H,7-14,18,32H2,(H,33,37)	JPSOHZUNYZMZBS-UHFFFAOYSA-N	416781	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-morpholinopropyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 93b::US10633345, Compound 93b::US10689346, Compound 93b::US11203574, Compound 93b::US11230530, Compound 93b::US11685721, Compound 93b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416781	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416781&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665612	433916695							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119999	COc1cccc(c1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O2/c1-40-25-10-4-7-22(15-25)28(35-18-19-11-12-19)21-6-3-8-23(14-21)36-29(39)26-16-27(30(31,32)33)37-38(26)24-9-2-5-20(13-24)17-34/h2-10,13-16,19,28,35H,11-12,17-18,34H2,1H3,(H,36,39)	DMSXJIPDGRICQW-UHFFFAOYSA-N	416782	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(3-methoxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 109f::US10633345, Compound 109f::US10689346, Compound 109f::US11203574, Compound 109f::US11230530, Compound 109f::US11685721, Compound 109f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416782	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416782&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356265	433916696							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120000	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc2ccccc2c1)C(F)(F)F	InChI=1S/C33H30F3N5O/c34-33(35,36)30-18-29(41(40-30)28-10-3-5-22(15-28)19-37)32(42)39-27-9-4-8-25(17-27)31(38-20-21-11-12-21)26-14-13-23-6-1-2-7-24(23)16-26/h1-10,13-18,21,31,38H,11-12,19-20,37H2,(H,39,42)	QCSULFNIDZTXJZ-UHFFFAOYSA-N	416783	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic acid {3-[(cyclopropylmethyl-amino)-naphthalen-2-yl-methyl]-phenyl}-amide::US10329260, Compound 128g::US10633345, Compound 128g::US10689346, Compound 128g::US11203574, Compound 128g::US11230530, Compound 128g::US11685721, Compound 128g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416783	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416783&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665786	433916697							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120001	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H26F4N6O/c29-22-9-8-19(26(35-15-17-6-7-17)20-4-2-10-34-16-20)12-23(22)36-27(39)24-13-25(28(30,31)32)37-38(24)21-5-1-3-18(11-21)14-33/h1-5,8-13,16-17,26,35H,6-7,14-15,33H2,(H,36,39)	SECDZDWRLPONSX-UHFFFAOYSA-N	416784	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(pyridin-3-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 94b::US10633345, Compound 94b::US10689346, Compound 94b::US11203574, Compound 94b::US11230530, Compound 94b::US11685721, Compound 94b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416784	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416784&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355774	433916698							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120002	Cc1cccc(c1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O/c1-19-5-2-7-22(13-19)28(35-18-20-11-12-20)23-8-4-9-24(15-23)36-29(39)26-16-27(30(31,32)33)37-38(26)25-10-3-6-21(14-25)17-34/h2-10,13-16,20,28,35H,11-12,17-18,34H2,1H3,(H,36,39)	ADKXWAHEFSGGQB-UHFFFAOYSA-N	416785	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(m-tolyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 110f::US10633345, Compound 110f::US10689346, Compound 110f::US11203574, Compound 110f::US11230530, Compound 110f::US11685721, Compound 110f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416785	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416785&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123875262	433916699							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120003	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc2ccccc12)C(F)(F)F	InChI=1S/C33H30F3N5O/c34-33(35,36)30-18-29(41(40-30)26-11-3-6-22(16-26)19-37)32(42)39-25-10-4-9-24(17-25)31(38-20-21-14-15-21)28-13-5-8-23-7-1-2-12-27(23)28/h1-13,16-18,21,31,38H,14-15,19-20,37H2,(H,39,42)	NFYBGLSBONMUGA-UHFFFAOYSA-N	416786	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic acid {3-[(cyclopropylmethyl-amino)-naphthalen-1-yl-methyl]-phenyl}-amide::US10329260, Compound 129f::US10633345, Compound 129f::US10689346, Compound 129f::US11203574, Compound 129f::US11230530, Compound 129f::US11685721, Compound 129f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416786	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416786&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356190	433916700							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120004	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(cc(c1)C1CC1)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C32H32F3N5O/c33-32(34,35)29-17-28(40(39-29)27-8-4-5-21(13-27)18-36)31(41)38-26-15-24(22-11-12-22)14-25(16-26)30(37-19-20-9-10-20)23-6-2-1-3-7-23/h1-8,13-17,20,22,30,37H,9-12,18-19,36H2,(H,38,41)	TXFPQXDVPCBKSX-UHFFFAOYSA-N	439372	US10633345, Compound 95i::US10689346, Compound 95i::US11203574, Compound 95i::US11230530, Compound 95i::US11685721, Compound 95i	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439372	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439372&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665927	439660930							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120005	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc(c1)C(F)(F)F)C(F)(F)F	InChI=1S/C30H27F6N5O/c31-29(32,33)22-7-2-5-20(13-22)27(38-17-18-10-11-18)21-6-3-8-23(14-21)39-28(42)25-15-26(30(34,35)36)40-41(25)24-9-1-4-19(12-24)16-37/h1-9,12-15,18,27,38H,10-11,16-17,37H2,(H,39,42)	FZSHDRVSVGSKOF-UHFFFAOYSA-N	416788	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(3-(trifluoromethyl) phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 111f::US10633345, Compound 111f::US10689346, Compound 111f::US11203574, Compound 111f::US11230530, Compound 111f::US11685721, Compound 111f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416788	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416788&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355816	433916702							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120006	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccc(N)cc1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-23-11-8-20(27(36-16-17-4-5-17)19-6-9-21(35)10-7-19)13-24(23)37-28(40)25-14-26(29(31,32)33)38-39(25)22-3-1-2-18(12-22)15-34/h1-3,6-14,17,27,36H,4-5,15-16,34-35H2,(H,37,40)	QTGVDKNDDSXZLM-UHFFFAOYSA-N	416789	1-(3-(aminomethyl)phenyl)-N-(5-((4-aminophenyl)(cyclopropylmethylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 130g::US10633345, Compound 130g::US10689346, Compound 130g::US11203574, Compound 130g::US11230530, Compound 130g::US11685721, Compound 130g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416789	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416789&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665503	433916703							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120007	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1Cl)C(NCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H26ClF3N6O/c29-22-9-8-19(26(35-15-17-6-7-17)20-4-2-10-34-16-20)12-23(22)36-27(39)24-13-25(28(30,31)32)37-38(24)21-5-1-3-18(11-21)14-33/h1-5,8-13,16-17,26,35H,6-7,14-15,33H2,(H,36,39)	DCRDGEJSCMQMFA-UHFFFAOYSA-N	416790	1-(3-(Aminomethyl)phenyl)-N-(2-chloro-5-((cyclopropylmethylamino)(pyridin-3-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 96f::US10633345, Compound 96f::US10689346, Compound 96f::US11203574, Compound 96f::US11230530, Compound 96f::US11685721, Compound 96f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416790	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416790&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355757	433916704							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120008	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(cc1)S(N)(=O)=O)C(F)(F)F	InChI=1S/C29H29F3N6O3S/c30-29(31,32)26-15-25(38(37-26)23-6-1-3-19(13-23)16-33)28(39)36-22-5-2-4-21(14-22)27(35-17-18-7-8-18)20-9-11-24(12-10-20)42(34,40)41/h1-6,9-15,18,27,35H,7-8,16-17,33H2,(H,36,39)(H2,34,40,41)	BGEXZQITRMVFRR-UHFFFAOYSA-N	416791	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(4-sulfamoylphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 112g::US10633345, Compound 112g::US10689346, Compound 112g::US11203574, Compound 112g::US11230530, Compound 112g::US11685721, Compound 112g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416791	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416791&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355780	433916705							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120009	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-23-10-9-20(27(36-16-17-7-8-17)19-4-2-5-21(35)12-19)13-24(23)37-28(40)25-14-26(29(31,32)33)38-39(25)22-6-1-3-18(11-22)15-34/h1-6,9-14,17,27,36H,7-8,15-16,34-35H2,(H,37,40)	HJMCNZIVUWWSBV-UHFFFAOYSA-N	416792	1-(3-(aminomethyl)phenyl)-N-(5-((3-aminophenyl)(cyclopropylmethylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 131b::US10633345, Compound 131b::US10689346, Compound 131b::US11203574, Compound 131b::US11230530, Compound 131b::US11685721, Compound 131b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416792	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416792&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665555	433916706							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120010	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H25F4N5O2/c29-22-9-8-19(26(39-16-17-6-7-17)20-4-2-10-34-15-20)12-23(22)35-27(38)24-13-25(28(30,31)32)36-37(24)21-5-1-3-18(11-21)14-33/h1-5,8-13,15,17,26H,6-7,14,16,33H2,(H,35,38)	CNAFOXQNPWSINI-UHFFFAOYSA-N	416794	Racemic 1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethoxy)(pyridin-3-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 48f::US10633345, Compound 48f::US10689346, Compound 48f::US11203574, Compound 48g::US11230530, Compound 48h::US11685721, Compound 48f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416794	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416794&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355617	433916708							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120011	CS(=O)(=O)c1ccc(cc1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O3S/c1-42(40,41)25-12-10-21(11-13-25)28(35-18-19-8-9-19)22-5-3-6-23(15-22)36-29(39)26-16-27(30(31,32)33)37-38(26)24-7-2-4-20(14-24)17-34/h2-7,10-16,19,28,35H,8-9,17-18,34H2,1H3,(H,36,39)	UTLDYOFVUPHYMX-UHFFFAOYSA-N	416795	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(4-(methylsulfonyl)phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 113f::US10633345, Compound 113f::US10689346, Compound 113f::US11203574, Compound 113f::US11230530, Compound 113f::US11685721, Compound 113f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416795	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416795&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355808	433916709							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120012	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C28H26F4N6O/c29-22-7-6-20(26(35-16-17-4-5-17)19-8-10-34-11-9-19)13-23(22)36-27(39)24-14-25(28(30,31)32)37-38(24)21-3-1-2-18(12-21)15-33/h1-3,6-14,17,26,35H,4-5,15-16,33H2,(H,36,39)	JHXYEKYRIWFSRY-UHFFFAOYSA-N	416796	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(pyridin-4-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 132f::US10633345, Compound 132f::US10689346, Compound 132f::US11203574, Compound 132f::US11230530, Compound 132f::US11685721, Compound 132f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416796	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416796&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665438	433916710							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120013	CN1CCc2c(C1)ccc(NC(=O)c1cc(nn1-c1cccc(CN)c1)C(F)(F)F)c2F	InChI=1S/C22H21F4N5O/c1-30-8-7-16-14(12-30)5-6-17(20(16)23)28-21(32)18-10-19(22(24,25)26)29-31(18)15-4-2-3-13(9-15)11-27/h2-6,9-10H,7-8,11-12,27H2,1H3,(H,28,32)	XRSKJTRQFAFTLA-UHFFFAOYSA-N	416797	1-(3-(aminomethyl)phenyl)-N-(5-fluoro-2-methyl-1,2,3,4-tetrahydroisoquinolin-6-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 164e::US10633345, Compound 164e::US10689346, Compound 164e::US11203574, Compound 164e::US11230530, Compound 164e::US11685721, Compound 164e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416797	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416797&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665488	433916711							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117210	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(N)cc1)C(F)(F)F	InChI=1S/C29H29F3N6O/c30-29(31,32)26-15-25(38(37-26)24-6-1-3-19(13-24)16-33)28(39)36-23-5-2-4-21(14-23)27(35-17-18-7-8-18)20-9-11-22(34)12-10-20/h1-6,9-15,18,27,35H,7-8,16-17,33-34H2,(H,36,39)	XDCYYWMSVYTRMZ-UHFFFAOYSA-N	416843	1-(3-(aminomethyl)phenyl)-N-(3-((4-aminophenyl)(cyclopropylmethyl-amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 50f::US10633345, Compound 50f::US10689346, Compound 50h::US11203574, Compound 50h::US11230530, Compound 50h::US11685721, Compound 50f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416843	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416843&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355587	433916756							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117211	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cc2ccccc2c2ccccc12)C(F)(F)F	InChI=1S/C37H32F3N5O/c38-37(39,40)34-20-33(45(44-34)28-11-5-7-24(17-28)21-41)36(46)43-27-10-6-9-26(18-27)35(42-22-23-15-16-23)32-19-25-8-1-2-12-29(25)30-13-3-4-14-31(30)32/h1-14,17-20,23,35,42H,15-16,21-22,41H2,(H,43,46)	OZXXGJIBGVGMMV-UHFFFAOYSA-N	416844	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic acid {3-[(cyclopropylmethyl-amino)-phenanthren-9-yl-methyl]-phenyl}-amide::US10329260, Compound 125g::US10633345, Compound 125g::US10689346, Compound 125g::US11203574, Compound 125g::US11230530, Compound 125g::US11685721, Compound 125g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416844	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416844&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665609	433916757							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117212	COc1ccc(cc1)C(NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H29F4N5O2/c1-41-23-10-7-20(8-11-23)28(36-17-18-5-6-18)21-9-12-24(31)25(14-21)37-29(40)26-15-27(30(32,33)34)38-39(26)22-4-2-3-19(13-22)16-35/h2-4,7-15,18,28,36H,5-6,16-17,35H2,1H3,(H,37,40)	GWNRXEFJAQDBCM-UHFFFAOYSA-N	416845	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(4-methoxyphenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 142f::US10633345, Compound 142f::US10689346, Compound 142f::US11203574, Compound 142f::US11230530, Compound 142f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416845	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416845&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355909	433916758							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117213	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc(OCc2ccccc2)c1)C(F)(F)F	InChI=1S/C36H34F3N5O2/c37-36(38,39)33-20-32(44(43-33)30-13-4-9-26(17-30)21-40)35(45)42-29-12-5-10-27(18-29)34(41-22-24-15-16-24)28-11-6-14-31(19-28)46-23-25-7-2-1-3-8-25/h1-14,17-20,24,34,41H,15-16,21-23,40H2,(H,42,45)	VWRITWGTGWRWCP-UHFFFAOYSA-N	439423	US10633345, Compound 107f::US11203574, Compound 107f::US11230530, Compound 107f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439423	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439423&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665642	439660981							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117214	CN(C)c1ccc(C(NCC2CC2)c2cccc(NC(=O)c3cc(nn3-c3cccc(CN)c3)C(F)(F)F)c2)c2ccccc12	InChI=1S/C35H35F3N6O/c1-43(2)30-16-15-29(27-11-3-4-12-28(27)30)33(40-21-22-13-14-22)24-8-6-9-25(18-24)41-34(45)31-19-32(35(36,37)38)42-44(31)26-10-5-7-23(17-26)20-39/h3-12,15-19,22,33,40H,13-14,20-21,39H2,1-2H3,(H,41,45)	IQAVMSNXUBZMCB-UHFFFAOYSA-N	416847	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic acid {3-[(cyclopropylmethyl-amino)-(4-dimethylamino-naphthalen-1-yl)-methyl]-phenyl}-amide::US10329260, Compound 126g::US10633345, Compound 126g::US10689346, Compound 126g::US11203574, Compound 126g::US11230530, Compound 126g::US11685721, Compound 126g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416847	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416847&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355601	433916760							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117215	Cc1cc(C(=O)Nc2cccc(c2)C(NCC2CC2)c2ccccc2)n(n1)-c1cccc(CN)c1	InChI=1S/C29H31N5O/c1-20-15-27(34(33-20)26-12-5-7-22(16-26)18-30)29(35)32-25-11-6-10-24(17-25)28(31-19-21-13-14-21)23-8-3-2-4-9-23/h2-12,15-17,21,28,31H,13-14,18-19,30H2,1H3,(H,32,35)	GPDBDHGXUBYWPY-UHFFFAOYSA-N	416848	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(phenyl)methyl)phenyl)-3-methyl-1H-pyrazole-5-carboxamid::US10329260, Compound 143l::US10633345, Compound 143l::US10689346, Compound 143l::US11203574, Compound 143l::US11230530, Compound 143l::US11685721, Compound 143l	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416848	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416848&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356139	433916761							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117216	NCc1cccc(c1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H31F3N6O/c31-30(32,33)27-15-26(39(38-27)25-9-2-5-21(13-25)17-35)29(40)37-24-8-3-7-23(14-24)28(36-18-19-10-11-19)22-6-1-4-20(12-22)16-34/h1-9,12-15,19,28,36H,10-11,16-18,34-35H2,(H,37,40)	CBXMVQRWSKIMMQ-UHFFFAOYSA-N	439426	US10633345, Compound 108e::US10689346, Compound 108e::US11203574, Compound 108e::US11230530, Compound 108e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439426	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439426&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665469	439660984							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117217	CCCOc1ccc(cc1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C32H34F3N5O2/c1-2-15-42-27-13-11-23(12-14-27)30(37-20-21-9-10-21)24-6-4-7-25(17-24)38-31(41)28-18-29(32(33,34)35)39-40(28)26-8-3-5-22(16-26)19-36/h3-8,11-14,16-18,21,30,37H,2,9-10,15,19-20,36H2,1H3,(H,38,41)	BSIABEDKJHMBRX-UHFFFAOYSA-N	416850	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic acid {3-[(cyclopropylmethyl-amino)-(4-propoxy-phenyl)-methyl]-phenyl}-amide::US10329260, Compound 127f::US10633345, Compound 127f::US10689346, Compound 127f::US11203574, Compound 127f::US11230530, Compound 127f::US11685721, Compound 127f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416850	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416850&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356061	433916763							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117218	CC(C)NC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C28H28F3N5O/c1-18(2)33-26(20-9-4-3-5-10-20)21-11-7-12-22(15-21)34-27(37)24-16-25(28(29,30)31)35-36(24)23-13-6-8-19(14-23)17-32/h3-16,18,26,33H,17,32H2,1-2H3,(H,34,37)	XNDGACONQUBLGK-UHFFFAOYSA-N	416851	1-(3-(Aminomethyl)phenyl)-N-(3-((isopropylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 144d::US10633345, Compound 144d::US10689346, Compound 144d::US11203574, Compound 144d::US11230530, Compound 144d::US11685721, Compound 144d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416851	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416851&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355596	433916764							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117219	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCCO)c1ccccc1)C(F)(F)F	InChI=1S/C27H26F3N5O2/c28-27(29,30)24-16-23(35(34-24)22-11-4-6-18(14-22)17-31)26(37)33-21-10-5-9-20(15-21)25(32-12-13-36)19-7-2-1-3-8-19/h1-11,14-16,25,32,36H,12-13,17,31H2,(H,33,37)	MMNKSYPQOFLCSY-UHFFFAOYSA-N	416852	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic acid {3-[(2-hydroxy-ethylamino)-phenyl-methyl]-phenyl}-amide::US10329260, Compound 145c::US10633345, Compound 145c::US10689346, Compound 145c::US11203574, Compound 145c::US11230530, Compound 145c::US11685721, Compound 145c	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416852	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416852&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123569320	433916765							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117220	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-10-9-20(27(40-16-17-7-8-17)19-4-2-5-21(35)12-19)13-24(23)36-28(39)25-14-26(29(31,32)33)37-38(25)22-6-1-3-18(11-22)15-34/h1-6,9-14,17,27H,7-8,15-16,34-35H2,(H,36,39)	GBDDXSAKQKODCG-UHFFFAOYSA-N	416853	1-(3-(aminomethyl)phenyl)-N-(5-((3-aminophenyl)(cyclopropylmethoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 57e::US10633345, Compound 65b::US10689346, Compound 65b::US11203574, Compound 65a::US11230530, Compound 65b::US11685721, Compound 57e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416853	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416853&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355865	433916766							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117221	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(N[C@H]1CC[C@H](O)CC1)c1ccccc1)C(F)(F)F	InChI=1S/C31H32F3N5O2/c32-31(33,34)28-18-27(39(38-28)25-11-4-6-20(16-25)19-35)30(41)37-24-10-5-9-22(17-24)29(21-7-2-1-3-8-21)36-23-12-14-26(40)15-13-23/h1-11,16-18,23,26,29,36,40H,12-15,19,35H2,(H,37,41)/t23-,26-,29?	QCYULPRIJNBHAA-APJPSQSRSA-N	416854	1-(3-(Aminomethyl)phenyl)-N-(3-((((trans)-4-hydroxycyclohexyl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 181b::US10633345, Compound 181b::US10689346, Compound 181b::US11203574, Compound 181b::US11230530, Compound 181b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416854	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416854&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665446	433916767							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117222	Cc1cc(C(=O)Nc2cccc(c2)C(NCC2CC2)c2cc(O)ccc2O)n(n1)-c1cccc(CN)c1	InChI=1S/C29H31N5O3/c1-18-12-26(34(33-18)23-7-2-4-20(13-23)16-30)29(37)32-22-6-3-5-21(14-22)28(31-17-19-8-9-19)25-15-24(35)10-11-27(25)36/h2-7,10-15,19,28,31,35-36H,8-9,16-17,30H2,1H3,(H,32,37)	LPEUWRVJEWZQCO-UHFFFAOYSA-N	416855	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2,5-dihydroxyphenyl)methyl) phenyl)-3-methyl-1H-pyrazole-5-carboxamide::US10329260, Compound 146g::US10633345, Compound 146g::US10689346, Compound 146g::US11203574, Compound 146g::US11230530, Compound 146g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416855	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416855&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356064	433916768							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117223	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1O)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-11-10-19(27(35-16-17-8-9-17)21-6-1-2-7-25(21)39)13-23(22)36-28(40)24-14-26(29(31,32)33)37-38(24)20-5-3-4-18(12-20)15-34/h1-7,10-14,17,27,35,39H,8-9,15-16,34H2,(H,36,40)	CKWWRAGQIQAYTL-UHFFFAOYSA-N	416856	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(2-hydroxyphenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 60e::US10633345, Compound 66b::US10689346, Compound 60e::US11203574, Compound 66b::US11230530, Compound 66b::US11685721, Compound 60e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416856	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416856&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665480	433916769							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117224	CC(O)CNC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C28H28F3N5O2/c1-18(37)17-33-26(20-8-3-2-4-9-20)21-10-6-11-22(14-21)34-27(38)24-15-25(28(29,30)31)35-36(24)23-12-5-7-19(13-23)16-32/h2-15,18,26,33,37H,16-17,32H2,1H3,(H,34,38)	XWEXCUNXVFBKNX-UHFFFAOYSA-N	416857	1-(3-(aminomethyl)phenyl)-N-(3-(((2-hydroxypropyl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 182b::US10633345, Compound 182b::US10689346, Compound 182b::US11203574, Compound 182b::US11230530, Compound 182b::US11685721, Compound 182b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416857	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416857&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355690	433916770							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117225	CC(=O)Nc1ccc(cc1)C(OCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C31H30F3N5O3/c1-19(40)36-24-12-10-22(11-13-24)29(42-18-20-8-9-20)23-5-3-6-25(15-23)37-30(41)27-16-28(31(32,33)34)38-39(27)26-7-2-4-21(14-26)17-35/h2-7,10-16,20,29H,8-9,17-18,35H2,1H3,(H,36,40)(H,37,41)	AETJNKBVQDZIDV-UHFFFAOYSA-N	416858	N-(3-((4-acetamidophenyl)(cyclopropylmethoxy)methyl)phenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 147e::US10633345, Compound 147e::US10689346, Compound 147e::US11203574, Compound 147e::US11230530, Compound 147e::US11685721, Compound 147e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416858	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416858&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355828	433916771							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117226	CN(C(c1ccc(cc1)C#N)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1)C1CC1	InChI=1S/C30H26F4N6O/c1-39(22-10-11-22)28(20-7-5-18(16-35)6-8-20)21-9-12-24(31)25(14-21)37-29(41)26-15-27(30(32,33)34)38-40(26)23-4-2-3-19(13-23)17-36/h2-9,12-15,22,28H,10-11,17,36H2,1H3,(H,37,41)	BZIYYSLZWQNWBF-UHFFFAOYSA-N	439407	US10633345, Compound 52h::US10633345, Compound 71a::US10633345, Compound 71b::US10689346, Compound 71b::US11203574, Compound 71a::US11230530, Compound 71b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439407	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439407&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355581	439660965							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117227	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCCCn1ccnc1)c1ccccc1)C(F)(F)F	InChI=1S/C31H30F3N7O/c32-31(33,34)28-19-27(41(39-28)26-12-4-7-22(17-26)20-35)30(42)38-25-11-5-10-24(18-25)29(23-8-2-1-3-9-23)37-13-6-15-40-16-14-36-21-40/h1-5,7-12,14,16-19,21,29,37H,6,13,15,20,35H2,(H,38,42)	XJDJXHWYZLFIJY-UHFFFAOYSA-N	416860	N-(3-(((3-(1H-Imidazol-1-yl)propyl)amino)(phenyl)methyl)phenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 183b::US10633345, Compound 183b::US10689346, Compound 183b::US11203574, Compound 183b::US11230530, Compound 183b::US11685721, Compound 183b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416860	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416860&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665638	433916773							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117228	COc1ccc2ccccc2c1C(OCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H31F3N4O3/c1-43-29-15-14-23-7-2-3-11-27(23)31(29)32(44-20-21-12-13-21)24-8-5-9-25(17-24)39-33(42)28-18-30(34(35,36)37)40-41(28)26-10-4-6-22(16-26)19-38/h2-11,14-18,21,32H,12-13,19-20,38H2,1H3,(H,39,42)	YJZQWEYZTCABEY-UHFFFAOYSA-N	416861	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(2-methoxynaphthalen-1-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 148b::US10633345, Compound 148b::US10689346, Compound 148b::US11203574, Compound 148b::US11230530, Compound 148b::US11685721, Compound 148b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416861	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416861&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665874	433916774							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117229	CN(C(c1ccc(cc1)C#N)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1)C1CC1	InChI=1S/C30H26F4N6O/c1-39(22-10-11-22)28(20-7-5-18(16-35)6-8-20)21-9-12-24(31)25(14-21)37-29(41)26-15-27(30(32,33)34)38-40(26)23-4-2-3-19(13-23)17-36/h2-9,12-15,22,28H,10-11,17,36H2,1H3,(H,37,41)	BZIYYSLZWQNWBF-UHFFFAOYSA-N	439407	US10633345, Compound 52h::US10633345, Compound 71a::US10633345, Compound 71b::US10689346, Compound 71b::US11203574, Compound 71a::US11230530, Compound 71b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439407	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439407&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355581	439660965							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117230	CN(C)C(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C27H26F3N5O/c1-34(2)25(19-9-4-3-5-10-19)20-11-7-12-21(15-20)32-26(36)23-16-24(27(28,29)30)33-35(23)22-13-6-8-18(14-22)17-31/h3-16,25H,17,31H2,1-2H3,(H,32,36)	BIAJBXPGRHVMIB-UHFFFAOYSA-N	416863	1-(3-(Aminomethyl)phenyl)-N-(3-((dimethylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 184b::US10633345, Compound 184b::US10689346, Compound 184b::US11203574, Compound 184b::US11230530, Compound 184b::US11685721, Compound 184b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416863	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416863&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356007	433916776							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117231	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccc(O)cc1)C(F)(F)F	InChI=1S/C29H27F3N4O3/c30-29(31,32)26-15-25(36(35-26)23-6-1-3-19(13-23)16-33)28(38)34-22-5-2-4-21(14-22)27(39-17-18-7-8-18)20-9-11-24(37)12-10-20/h1-6,9-15,18,27,37H,7-8,16-17,33H2,(H,34,38)	WIBHWKLQWUWRRF-UHFFFAOYSA-N	416864	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(4-hydroxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 149b::US10633345, Compound 149b::US10689346, Compound 149b::US11203574, Compound 149b::US11230530, Compound 149b::US11685721, Compound 149b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416864	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416864&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665542	433916777							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117232	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-10-9-20(27(40-16-17-7-8-17)19-4-2-5-21(35)12-19)13-24(23)36-28(39)25-14-26(29(31,32)33)37-38(25)22-6-1-3-18(11-22)15-34/h1-6,9-14,17,27H,7-8,15-16,34-35H2,(H,36,39)	GBDDXSAKQKODCG-UHFFFAOYSA-N	416853	1-(3-(aminomethyl)phenyl)-N-(5-((3-aminophenyl)(cyclopropylmethoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 57e::US10633345, Compound 65b::US10689346, Compound 65b::US11203574, Compound 65a::US11230530, Compound 65b::US11685721, Compound 57e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416853	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416853&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355865	433916766							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117233	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NC1CCCCC1)c1ccccc1)C(F)(F)F	InChI=1S/C31H32F3N5O/c32-31(33,34)28-19-27(39(38-28)26-16-7-9-21(17-26)20-35)30(40)37-25-15-8-12-23(18-25)29(22-10-3-1-4-11-22)36-24-13-5-2-6-14-24/h1,3-4,7-12,15-19,24,29,36H,2,5-6,13-14,20,35H2,(H,37,40)	MXMWHPZXCVOSEY-UHFFFAOYSA-N	416866	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclohexylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 185b::US10633345, Compound 185b::US10689346, Compound 185b::US11203574, Compound 185b::US11230530, Compound 185b::US11685721, Compound 185b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416866	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416866&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356164	433916779							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117234	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-25(37(36-26)24-9-1-4-19(12-24)16-33)28(38)35-23-8-3-6-21(14-23)27(39-17-18-10-11-18)20-5-2-7-22(34)13-20/h1-9,12-15,18,27H,10-11,16-17,33-34H2,(H,35,38)	FPQYUIIRVBKUDH-UHFFFAOYSA-N	416867	1-(3-(aminomethyl)phenyl)-N-(3-((3-aminophenyl)(cyclopropyl-methoxy)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 53f::US10633345, Compound 53f::US10689346, Compound 53f::US11203574, Compound 64b::US11230530, Compound 64b::US11685721, Compound 49j	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416867	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416867&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355845	433916780							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117235	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-10-9-20(27(40-16-17-7-8-17)19-4-2-5-21(35)12-19)13-24(23)36-28(39)25-14-26(29(31,32)33)37-38(25)22-6-1-3-18(11-22)15-34/h1-6,9-14,17,27H,7-8,15-16,34-35H2,(H,36,39)	GBDDXSAKQKODCG-UHFFFAOYSA-N	416853	1-(3-(aminomethyl)phenyl)-N-(5-((3-aminophenyl)(cyclopropylmethoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 57e::US10633345, Compound 65b::US10689346, Compound 65b::US11203574, Compound 65a::US11230530, Compound 65b::US11685721, Compound 57e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416853	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416853&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355865	433916766							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117236	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCc1ccncc1)c1ccccc1)C(F)(F)F	InChI=1S/C31H27F3N6O/c32-31(33,34)28-18-27(40(39-28)26-11-4-6-22(16-26)19-35)30(41)38-25-10-5-9-24(17-25)29(23-7-2-1-3-8-23)37-20-21-12-14-36-15-13-21/h1-18,29,37H,19-20,35H2,(H,38,41)	PXKQYONQBKMAKS-UHFFFAOYSA-N	416869	1-(3-(Aminomethyl)phenyl)-N-(3-(phenyl((pyridin-4-ylmethyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 186b::US10633345, Compound 186b::US10689346, Compound 186b::US11203574, Compound 186b::US11230530, Compound 186b::US11685721, Compound 186b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416869	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416869&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665494	433916782							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117237	Cc1cc(C(=O)Nc2cccc(c2)C(NCC2CC2)c2cccc(O)c2O)n(n1)-c1cccc(CN)c1	InChI=1S/C29H31N5O3/c1-18-13-25(34(33-18)23-8-2-5-20(14-23)16-30)29(37)32-22-7-3-6-21(15-22)27(31-17-19-11-12-19)24-9-4-10-26(35)28(24)36/h2-10,13-15,19,27,31,35-36H,11-12,16-17,30H2,1H3,(H,32,37)	VPKURNQNFXHFDB-UHFFFAOYSA-N	416870	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2,3-dihydroxyphenyl)methyl)phenyl)-3-methyl-1H-pyrazole-5-carboxamide::US10329260, Compound 150f::US10633345, Compound 150f::US10689346, Compound 150f::US11203574, Compound 150f::US11230530, Compound 150f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416870	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416870&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355949	433916783							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117238	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc2OCOc12)C(F)(F)F	InChI=1S/C30H28F3N5O3/c31-30(32,33)26-14-24(38(37-26)22-7-1-4-19(12-22)15-34)29(39)36-21-6-2-5-20(13-21)27(35-16-18-10-11-18)23-8-3-9-25-28(23)41-17-40-25/h1-9,12-14,18,27,35H,10-11,15-17,34H2,(H,36,39)	FVRZDZZJKCSOIR-UHFFFAOYSA-N	416871	1-(3-(aminomethyl)phenyl)-N-(3-(benzo[d][1,3]dioxol-4-yl(cyclopropylmethylamino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 192f::US10633345, Compound 192f::US10689346, Compound 192f::US11203574, Compound 192f::US11230530, Compound 192f::US11685721, Compound 192f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416871	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416871&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665720	433916784							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117239	CC(C)(C)CNC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H32F3N5O/c1-29(2,3)19-35-27(21-10-5-4-6-11-21)22-12-8-13-23(16-22)36-28(39)25-17-26(30(31,32)33)37-38(25)24-14-7-9-20(15-24)18-34/h4-17,27,35H,18-19,34H2,1-3H3,(H,36,39)	NWBNOBGYJRWWRK-UHFFFAOYSA-N	416872	1-(3-(Aminomethyl)phenyl)-N-(3-((neopentylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 187b::US10633345, Compound 187b::US10689346, Compound 187b::US11203574, Compound 187b::US11230530, Compound 187b::US11685721, Compound 187b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416872	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416872&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124028296	433916785							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117240	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccc(cc1)C(N)=O)C(F)(F)F	InChI=1S/C30H28F4N6O2/c31-23-11-10-21(27(37-16-17-4-5-17)19-6-8-20(9-7-19)28(36)41)13-24(23)38-29(42)25-14-26(30(32,33)34)39-40(25)22-3-1-2-18(12-22)15-35/h1-3,6-14,17,27,37H,4-5,15-16,35H2,(H2,36,41)(H,38,42)	AHHWWBRXILLXFU-UHFFFAOYSA-N	416873	1-(3-(aminomethyl)phenyl)-N-(5-((4-carbamoylphenyl)(cyclopropylmethylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 153b::US10633345, Compound 153b::US10689346, Compound 153b::US11203574, Compound 153b::US11230530, Compound 153b::US11685721, Compound 153b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416873	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416873&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355991	433916786							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117241	CCC(CO)NC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C29H30F3N5O2/c1-2-22(18-38)34-27(20-9-4-3-5-10-20)21-11-7-12-23(15-21)35-28(39)25-16-26(29(30,31)32)36-37(25)24-13-6-8-19(14-24)17-33/h3-16,22,27,34,38H,2,17-18,33H2,1H3,(H,35,39)	KIDPOTSBLNZGML-UHFFFAOYSA-N	416874	1-(3-(aminomethyl)phenyl)-N-(3-(((1-hydroxybutan-2-yl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 168b::US10633345, Compound 168b::US10689346, Compound 168b::US11192861, Compound 168b::US11230530, Compound 168b::US11685721, Compound 168b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416874	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416874&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356215	433916787							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117242	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NC1CCC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H28F3N5O/c30-29(31,32)26-17-25(37(36-26)24-14-4-7-19(15-24)18-33)28(38)35-23-13-5-10-21(16-23)27(34-22-11-6-12-22)20-8-2-1-3-9-20/h1-5,7-10,13-17,22,27,34H,6,11-12,18,33H2,(H,35,38)	UCFAODSDUNDTFF-UHFFFAOYSA-N	416875	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclobutylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 188b::US10633345, Compound 188b::US10689346, Compound 188b::US11203574, Compound 188b::US11230530, Compound 188b::US11685721, Compound 188b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416875	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416875&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123435501	433916788							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117243	COc1cccc(C(NCC2CC2)c2cccc(NC(=O)c3cc(nn3-c3cccc(CN)c3)C(F)(F)F)c2)c1O	InChI=1S/C30H30F3N5O3/c1-41-25-10-4-9-23(28(25)39)27(35-17-18-11-12-18)20-6-3-7-21(14-20)36-29(40)24-15-26(30(31,32)33)37-38(24)22-8-2-5-19(13-22)16-34/h2-10,13-15,18,27,35,39H,11-12,16-17,34H2,1H3,(H,36,40)	KCIFFUCEHRXTLF-UHFFFAOYSA-N	416876	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2-hydroxy-3-methoxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 151g::US10633345, Compound 151g::US10689346, Compound 151g::US11203574, Compound 151g::US11230530, Compound 151g::US11685721, Compound 151g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416876	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416876&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356165	433916789							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117244	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(N1CCCC1CO)c1ccccc1)C(F)(F)F	InChI=1S/C30H30F3N5O2/c31-30(32,33)27-17-26(38(36-27)24-12-4-7-20(15-24)18-34)29(40)35-23-11-5-10-22(16-23)28(21-8-2-1-3-9-21)37-14-6-13-25(37)19-39/h1-5,7-12,15-17,25,28,39H,6,13-14,18-19,34H2,(H,35,40)	BNZLGFQHSKUMEG-UHFFFAOYSA-N	416877	1-(3-(aminomethyl)phenyl)-N-(3-((2-(hydroxymethyl)pyrrolidin-1-yl)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 169b::US10633345, Compound 169b::US10689346, Compound 169b::US11203574, Compound 169b::US11230530, Compound 169b::US11685721, Compound 169b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416877	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416877&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356128	433916790							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117245	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCc1ccc(N)cc1)c1ccccc1)C(F)(F)F	InChI=1S/C32H29F3N6O/c33-32(34,35)29-18-28(41(40-29)27-11-4-6-22(16-27)19-36)31(42)39-26-10-5-9-24(17-26)30(23-7-2-1-3-8-23)38-20-21-12-14-25(37)15-13-21/h1-18,30,38H,19-20,36-37H2,(H,39,42)	BKOBJSLLJPHJRR-UHFFFAOYSA-N	416878	N-(3-(((4-Aminobenzyl)amino)(phenyl)methyl)phenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 189b::US10633345, Compound 189b::US10689346, Compound 189b::US11203574, Compound 189b::US11230530, Compound 189b::US11685721, Compound 189b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416878	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416878&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665871	433916791							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117246	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C30H27F3N6O/c31-30(32,33)27-15-26(39(38-27)25-9-2-5-21(13-25)17-35)29(40)37-24-8-3-7-23(14-24)28(36-18-19-10-11-19)22-6-1-4-20(12-22)16-34/h1-9,12-15,19,28,36H,10-11,17-18,35H2,(H,37,40)	VQJJJCIJWBDLSJ-UHFFFAOYSA-N	416879	1-(3-(aminomethyl)phenyl)-N-(3-((3-cyanophenyl)(cyclopropylmethyl amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 152d::US10633345, Compound 152d::US10689346, Compound 152d::US11203574, Compound 152d::US11230530, Compound 152d::US11685721, Compound 152d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416879	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416879&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356166	433916792							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117247	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(N1CCC(O)C1)c1ccccc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-16-25(37(35-26)23-11-4-6-19(14-23)17-33)28(39)34-22-10-5-9-21(15-22)27(20-7-2-1-3-8-20)36-13-12-24(38)18-36/h1-11,14-16,24,27,38H,12-13,17-18,33H2,(H,34,39)	FPAZEZULJGBLCM-UHFFFAOYSA-N	416880	1-(3-(aminomethyl)phenyl)-N-(3-((3-hydroxypyrrolidin-1-yl)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 170b::US10633345, Compound 170b::US10689346, Compound 170b::US11192861, Compound 170b::US11230530, Compound 170b::US11685721, Compound 170b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416880	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416880&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355902	433916793							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117248	CSCCNC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C28H28F3N5OS/c1-38-14-13-33-26(20-8-3-2-4-9-20)21-10-6-11-22(16-21)34-27(37)24-17-25(28(29,30)31)35-36(24)23-12-5-7-19(15-23)18-32/h2-12,15-17,26,33H,13-14,18,32H2,1H3,(H,34,37)	GMRUHWVMBSEBQV-UHFFFAOYSA-N	416881	1-(3-(aminomethyl)phenyl)-N-(3-(((2-(methylthio)ethyl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 190b::US10633345, Compound 190b::US10689346, Compound 190b::US11203574, Compound 190b::US11230530, Compound 190b::US11685721, Compound 190b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416881	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416881&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665913	433916794							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117249	COc1ccc(C(NCC2CC2)c2cccc(NC(=O)c3cc(nn3-c3cccc(CN)c3)C(F)(F)F)c2)c2ccccc12	InChI=1S/C34H32F3N5O2/c1-44-30-15-14-28(26-10-2-3-11-27(26)30)32(39-20-21-12-13-21)23-7-5-8-24(17-23)40-33(43)29-18-31(34(35,36)37)41-42(29)25-9-4-6-22(16-25)19-38/h2-11,14-18,21,32,39H,12-13,19-20,38H2,1H3,(H,40,43)	YOBACLFKAGKOLX-UHFFFAOYSA-N	416882	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(4-methoxynaphthalen-1-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 154e::US10633345, Compound 154e::US10689346, Compound 154e::US11203574, Compound 154e::US11230530, Compound 154e::US11685721, Compound 154e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416882	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416882&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665632	433916795							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117250	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NC1CCCCCC1)c1ccccc1)C(F)(F)F	InChI=1S/C32H34F3N5O/c33-32(34,35)29-20-28(40(39-29)27-17-8-10-22(18-27)21-36)31(41)38-26-16-9-13-24(19-26)30(23-11-4-3-5-12-23)37-25-14-6-1-2-7-15-25/h3-5,8-13,16-20,25,30,37H,1-2,6-7,14-15,21,36H2,(H,38,41)	DQWBWUNYPIEFTF-UHFFFAOYSA-N	416883	1-(3-(aminomethyl)phenyl)-N-(3-((cycloheptylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 171b::US10633345, Compound 171b::US10689346, Compound 171b::US11203574, Compound 171b::US11230530, Compound 171b::US11685721, Compound 171b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416883	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416883&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356134	433916796							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117251	Cc1ccccc1C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O/c1-19-6-2-3-11-25(19)28(35-18-20-12-13-20)22-8-5-9-23(15-22)36-29(39)26-16-27(30(31,32)33)37-38(26)24-10-4-7-21(14-24)17-34/h2-11,14-16,20,28,35H,12-13,17-18,34H2,1H3,(H,36,39)	NQOSRSVLDYDVDI-UHFFFAOYSA-N	416884	1-(3-(Aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(o-tolyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 193f::US10633345, Compound 193f::US10689346, Compound 193f::US11203574, Compound 193f::US11230530, Compound 193f::US11685721, Compound 193f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416884	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416884&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355753	433916797							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117252	NCc1cccc(c1)C(NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F4N6O/c31-24-10-9-22(28(37-17-18-7-8-18)21-5-1-3-19(11-21)15-35)13-25(24)38-29(41)26-14-27(30(32,33)34)39-40(26)23-6-2-4-20(12-23)16-36/h1-6,9-14,18,28,37H,7-8,15-17,35-36H2,(H,38,41)	PIDHZVXEDSCGNA-UHFFFAOYSA-N	416885	1-(3-(aminomethyl)phenyl)-N-(5-((3-(aminomethyl)phenyl)(cyclopropylmethylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 155c::US10633345, Compound 155c::US10689346, Compound 155c::US11203574, Compound 155c::US11230530, Compound 155c::US11685721, Compound 155c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416885	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416885&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355611	433916798							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117253	CCCCCNC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H32F3N5O/c1-2-3-7-16-35-28(22-11-5-4-6-12-22)23-13-9-14-24(18-23)36-29(39)26-19-27(30(31,32)33)37-38(26)25-15-8-10-21(17-25)20-34/h4-6,8-15,17-19,28,35H,2-3,7,16,20,34H2,1H3,(H,36,39)	LIINXFZWPJSNHF-UHFFFAOYSA-N	416886	1-(3-(Aminomethyl)phenyl)-N-(3-((pentylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 172b::US10633345, Compound 172b::US10689346, Compound 172b::US11203574, Compound 172b::US11230530, Compound 172b::US11685721, Compound 172b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416886	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416886&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355915	433916799							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117254	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCCCO)c1ccccc1)C(F)(F)F	InChI=1S/C28H28F3N5O2/c29-28(30,31)25-17-24(36(35-25)23-12-4-7-19(15-23)18-32)27(38)34-22-11-5-10-21(16-22)26(33-13-6-14-37)20-8-2-1-3-9-20/h1-5,7-12,15-17,26,33,37H,6,13-14,18,32H2,(H,34,38)	YSEURYDLGGVADI-UHFFFAOYSA-N	416887	1-(3-(Aminomethyl)phenyl)-N-(3-(((3-hydroxypropyl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 191b::US10633345, Compound 191b::US10689346, Compound 191b::US11203574, Compound 191b::US11230530, Compound 191b::US11685721, Compound 191b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416887	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416887&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665847	433916800							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117255	COC(CCC1CC1)(c1cccnc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O2/c1-40-29(13-12-20-10-11-20,23-7-4-14-35-19-23)22-6-3-8-24(16-22)36-28(39)26-17-27(30(31,32)33)37-38(26)25-9-2-5-21(15-25)18-34/h2-9,14-17,19-20H,10-13,18,34H2,1H3,(H,36,39)	HEQLXMARFGMGBQ-UHFFFAOYSA-N	416888	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-methoxy-1-(pyridin-3-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 156c::US10633345, Compound 156c::US10689346, Compound 156c::US11203574, Compound 156c::US11230530, Compound 156c::US11685721, Compound 156c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416888	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416888&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355759	433916801							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117256	CC(CO)NC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C28H28F3N5O2/c1-18(17-37)33-26(20-8-3-2-4-9-20)21-10-6-11-22(14-21)34-27(38)24-15-25(28(29,30)31)35-36(24)23-12-5-7-19(13-23)16-32/h2-15,18,26,33,37H,16-17,32H2,1H3,(H,34,38)	HGDYIKLNDBPRGN-UHFFFAOYSA-N	416889	1-(3-(aminomethyl)phenyl)-N-(3-(((1-hydroxypropan-2-yl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 173b::US10633345, Compound 173b::US10689346, Compound 173b::US11203574, Compound 173b::US11230530, Compound 173b::US11685721, Compound 173b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416889	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416889&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355997	433916802							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117257	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc(F)c1)C(F)(F)F	InChI=1S/C29H27F4N5O/c30-22-7-2-5-20(13-22)27(35-17-18-10-11-18)21-6-3-8-23(14-21)36-28(39)25-15-26(29(31,32)33)37-38(25)24-9-1-4-19(12-24)16-34/h1-9,12-15,18,27,35H,10-11,16-17,34H2,(H,36,39)	FVMNYLZQOFMPFE-UHFFFAOYSA-N	416890	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(3-fluorophenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 195f::US10633345, Compound 195f::US10689346, Compound 195f::US11203574, Compound 195f::US11230530, Compound 195f::US11685721, Compound 195f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416890	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416890&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665561	433916803							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117258	CN(C(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1)C1CC1	InChI=1S/C30H26F4N6O/c1-39(22-9-10-22)28(20-6-2-4-18(12-20)16-35)21-8-11-24(31)25(14-21)37-29(41)26-15-27(30(32,33)34)38-40(26)23-7-3-5-19(13-23)17-36/h2-8,11-15,22,28H,9-10,17,36H2,1H3,(H,37,41)	LONUELZOBAIWEW-UHFFFAOYSA-N	439471	US10633345, Compound 54e::US10633345, Compound 70a::US10633345, Compound 70b::US10689346, Compound 70a::US11203574, Compound 70b::US11230530, Compound 70b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439471	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439471&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355805	439661023							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117259	CC(C)(CO)NC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C29H30F3N5O2/c1-28(2,18-38)35-26(20-9-4-3-5-10-20)21-11-7-12-22(15-21)34-27(39)24-16-25(29(30,31)32)36-37(24)23-13-6-8-19(14-23)17-33/h3-16,26,35,38H,17-18,33H2,1-2H3,(H,34,39)	JPSBLISQAZCRFK-UHFFFAOYSA-N	416892	1-(3-(aminomethyl)phenyl)-N-(3-(((1-hydroxy-2-methylpropan-2-yl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 174b::US10633345, Compound 174b::US10689346, Compound 174b::US11203574, Compound 174b::US11230530, Compound 174b::US11685721, Compound 174b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416892	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416892&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665949	433916805							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117260	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(F)cc1F)C(F)(F)F	InChI=1S/C29H26F5N5O/c30-20-9-10-23(24(31)13-20)27(36-16-17-7-8-17)19-4-2-5-21(12-19)37-28(40)25-14-26(29(32,33)34)38-39(25)22-6-1-3-18(11-22)15-35/h1-6,9-14,17,27,36H,7-8,15-16,35H2,(H,37,40)	QIBXOBBXVAEMNW-UHFFFAOYSA-N	416893	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2,4-difluorophenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 196f::US10633345, Compound 196f::US10689346, Compound 196f::US11203574, Compound 196f::US11230530, Compound 196f::US11685721, Compound 196f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416893	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416893&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665453	433916806							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117261	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C30H25F4N5O2/c31-24-11-10-22(28(41-17-19-4-5-19)21-8-6-18(15-35)7-9-21)13-25(24)37-29(40)26-14-27(30(32,33)34)38-39(26)23-3-1-2-20(12-23)16-36/h1-3,6-14,19,28H,4-5,16-17,36H2,(H,37,40)	WXFHQCUXOOXGLO-UHFFFAOYSA-N	416894	1-(3-(aminomethyl)phenyl)-N-(5-((4-cyanophenyl)(cyclopropylmethoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 55b::US10633345, Compound 73b::US10689346, Compound 55b::US11203574, Compound 73b::US11230530, Compound 73b::US11685721, Compound 73b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416894	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416894&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665569	433916807							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117262	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CCCO1)c1ccccc1)C(F)(F)F	InChI=1S/C30H30F3N5O2/c31-30(32,33)27-17-26(38(37-27)24-12-4-7-20(15-24)18-34)29(39)36-23-11-5-10-22(16-23)28(21-8-2-1-3-9-21)35-19-25-13-6-14-40-25/h1-5,7-12,15-17,25,28,35H,6,13-14,18-19,34H2,(H,36,39)	SIOCTSAXUSNOCO-UHFFFAOYSA-N	416895	1-(3-(aminomethyl)phenyl)-N-(3-(phenyl(((tetrahydrofuran-2-yl)methyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 175b::US10633345, Compound 175b::US10689346, Compound 175b::US11203574, Compound 175b::US11230530, Compound 175b::US11685721, Compound 175b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416895	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416895&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355976	433916808							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117263	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cc(F)ccc1F)C(F)(F)F	InChI=1S/C29H26F5N5O/c30-20-9-10-24(31)23(13-20)27(36-16-17-7-8-17)19-4-2-5-21(12-19)37-28(40)25-14-26(29(32,33)34)38-39(25)22-6-1-3-18(11-22)15-35/h1-6,9-14,17,27,36H,7-8,15-16,35H2,(H,37,40)	DGRITJGAWATINU-UHFFFAOYSA-N	416896	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2,5-difluorophenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 197f::US10633345, Compound 197f::US10689346, Compound 197f::US11203574, Compound 197f::US11230530, Compound 197f::US11685721, Compound 197f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416896	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416896&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665599	433916809							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117264	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-9-8-20(28(40,11-10-18-6-7-18)21-4-2-12-35-17-21)14-24(23)36-27(39)25-15-26(29(31,32)33)37-38(25)22-5-1-3-19(13-22)16-34/h1-5,8-9,12-15,17-18,40H,6-7,10-11,16,34H2,(H,36,39)	VCHFZCHUEHQXSZ-UHFFFAOYSA-N	416897	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 58c::US10633345, Compound 67b::US10689346, Compound 67b::US11203574, Compound 67b::US11230530, Compound 67b::US11685721, Compound 67b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416897	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416897&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355889	433916810							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117265	CC(C)CCNC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H32F3N5O/c1-20(2)14-15-35-28(22-9-4-3-5-10-22)23-11-7-12-24(17-23)36-29(39)26-18-27(30(31,32)33)37-38(26)25-13-6-8-21(16-25)19-34/h3-13,16-18,20,28,35H,14-15,19,34H2,1-2H3,(H,36,39)	WPCVSFNABLNPTN-UHFFFAOYSA-N	416898	1-(3-(aminomethyl)phenyl)-N-(3-((isopentylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 176b::US10633345, Compound 176b::US10689346, Compound 176b::US11203574, Compound 176b::US11230530, Compound 176b::US11685721, Compound 176b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416898	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416898&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665776	433916811							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117266	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1c(F)cccc1F)C(F)(F)F	InChI=1S/C29H26F5N5O/c30-22-8-3-9-23(31)26(22)27(36-16-17-10-11-17)19-5-2-6-20(13-19)37-28(40)24-14-25(29(32,33)34)38-39(24)21-7-1-4-18(12-21)15-35/h1-9,12-14,17,27,36H,10-11,15-16,35H2,(H,37,40)	OHXCNQRJQHLAER-UHFFFAOYSA-N	416899	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2,6-difluorophenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 198f::US10633345, Compound 198f::US10689346, Compound 198f::US11203574, Compound 198f::US11230530, Compound 198f::US11685721, Compound 198f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416899	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416899&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665643	433916812							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117267	Cc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C30H24F4N4O2/c1-18-4-2-7-23(12-18)38-26(15-27(37-38)30(32,33)34)29(39)36-25-14-22(10-11-24(25)31)28(40-17-19-8-9-19)21-6-3-5-20(13-21)16-35/h2-7,10-15,19,28H,8-9,17H2,1H3,(H,36,39)	XZMALXLGDWDNON-UHFFFAOYSA-N	528733	US11192861, Compound 56c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528733	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528733&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163200155	463792260							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117268	CCC(C)CNC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H32F3N5O/c1-3-20(2)19-35-28(22-10-5-4-6-11-22)23-12-8-13-24(16-23)36-29(39)26-17-27(30(31,32)33)37-38(26)25-14-7-9-21(15-25)18-34/h4-17,20,28,35H,3,18-19,34H2,1-2H3,(H,36,39)	ZCSNRDNUIRVYLS-UHFFFAOYSA-N	416901	1-(3-(Aminomethyl)phenyl)-N-(3-(((2-methylbutyl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 177b::US10633345, Compound 177b::US10689346, Compound 177b::US11203574, Compound 177b::US11230530, Compound 177b::US11685721, Compound 177b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416901	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416901&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665478	433916814							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117269	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1Cl)C(F)(F)F	InChI=1S/C29H27ClF3N5O/c30-24-10-2-1-9-23(24)27(35-17-18-11-12-18)20-6-4-7-21(14-20)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-3-5-19(13-22)16-34/h1-10,13-15,18,27,35H,11-12,16-17,34H2,(H,36,39)	UQMCUIGBQDUSLW-UHFFFAOYSA-N	416902	1-(3-(aminomethyl)phenyl)-N-(3-((2-chlorophenyl)((cyclopropylmethyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 194f::US10329260, Compound 199f::US10633345, Compound 199f::US10689346, Compound 199f::US11203574, Compound 199f::US11230530, Compound 199f::US11685721, Compound 199f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416902	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416902&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356220	433916815							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117270	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1ccc(cc1F)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H28F4N4O2/c31-24-16-22(29(40,14-13-19-9-10-19)21-6-2-1-3-7-21)11-12-25(24)36-28(39)26-17-27(30(32,33)34)37-38(26)23-8-4-5-20(15-23)18-35/h1-8,11-12,15-17,19,40H,9-10,13-14,18,35H2,(H,36,39)	SCSQORKMIDQFBF-UHFFFAOYSA-N	528736	US11192861, Compound 68c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528736	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528736&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163200156	463792263							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117271	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(N(CCO)CCO)c1ccccc1)C(F)(F)F	InChI=1S/C29H30F3N5O3/c30-29(31,32)26-18-25(37(35-26)24-11-4-6-20(16-24)19-33)28(40)34-23-10-5-9-22(17-23)27(21-7-2-1-3-8-21)36(12-14-38)13-15-39/h1-11,16-18,27,38-39H,12-15,19,33H2,(H,34,40)	HFRFNKSEVVNXFK-UHFFFAOYSA-N	416904	1-(3-(aminomethyl)phenyl)-N-(3-((bis(2-hydroxyethyl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 178b::US10633345, Compound 178b::US10689346, Compound 178b::US11203574, Compound 178b::US11230530, Compound 178b::US11685721, Compound 178b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416904	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416904&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355913	433916817							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117272	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1Cl)C(F)(F)F	InChI=1S/C29H27ClF3N5O/c30-24-10-2-1-9-23(24)27(35-17-18-11-12-18)20-6-4-7-21(14-20)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-3-5-19(13-22)16-34/h1-10,13-15,18,27,35H,11-12,16-17,34H2,(H,36,39)	UQMCUIGBQDUSLW-UHFFFAOYSA-N	416902	1-(3-(aminomethyl)phenyl)-N-(3-((2-chlorophenyl)((cyclopropylmethyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 194f::US10329260, Compound 199f::US10633345, Compound 199f::US10689346, Compound 199f::US11203574, Compound 199f::US11230530, Compound 199f::US11685721, Compound 199f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416902	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416902&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356220	433916815							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120014	CS(=O)(=O)c1cccc(c1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O3S/c1-42(40,41)25-10-4-7-22(15-25)28(35-18-19-11-12-19)21-6-3-8-23(14-21)36-29(39)26-16-27(30(31,32)33)37-38(26)24-9-2-5-20(13-24)17-34/h2-10,13-16,19,28,35H,11-12,17-18,34H2,1H3,(H,36,39)	VJYAFYNZRBTGFW-UHFFFAOYSA-N	416798	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(3-(methylsulfonyl)phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 114f::US10633345, Compound 114f::US10689346, Compound 114f::US11203574, Compound 114f::US11230530, Compound 114f::US11685721, Compound 114f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416798	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416798&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665780	433916712							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120015	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(cc1)-c1ccccc1)C(F)(F)F	InChI=1S/C35H32F3N5O/c36-35(37,38)32-20-31(43(42-32)30-11-4-6-24(18-30)21-39)34(44)41-29-10-5-9-28(19-29)33(40-22-23-12-13-23)27-16-14-26(15-17-27)25-7-2-1-3-8-25/h1-11,14-20,23,33,40H,12-13,21-22,39H2,(H,41,44)	SZCMOETVRNQDRC-UHFFFAOYSA-N	416799	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic Acid {3-[biphenyl-4-yl-(cyclopropylmethyl-amino)-methyl]-phenyl}-amide::US10329260, Compound 133g::US10633345, Compound 133g::US10689346, Compound 133g::US11203574, Compound 133g::US11230530, Compound 133g::US11685721, Compound 133g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416799	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416799&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665928	433916713							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120016	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(F)cc(c1)C(O)c1ccccc1)C(F)(F)F	InChI=1S/C25H20F4N4O2/c26-18-10-17(23(34)16-6-2-1-3-7-16)11-19(12-18)31-24(35)21-13-22(25(27,28)29)32-33(21)20-8-4-5-15(9-20)14-30/h1-13,23,34H,14,30H2,(H,31,35)	WOQUHGPQEUKGPZ-UHFFFAOYSA-N	416800	1-(3-(aminomethyl)phenyl)-N-(3-fluoro-5-(hydroxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 97f::US10633345, Compound 97f::US10689346, Compound 97f::US11203574, Compound 97f::US11230530, Compound 97f::US11685721, Compound 97f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416800	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416800&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355887	433916714							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120017	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NC(=O)C1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F3N5O2/c30-29(31,32)25-16-24(37(36-25)23-11-4-6-18(14-23)17-33)28(39)34-22-10-5-9-21(15-22)26(19-7-2-1-3-8-19)35-27(38)20-12-13-20/h1-11,14-16,20,26H,12-13,17,33H2,(H,34,39)(H,35,38)	JNPDNCCSYJLXEM-UHFFFAOYSA-N	439388	US10633345, Compound 115e::US10689346, Compound 115e::US11203574, Compound 115e::US11230530, Compound 115e::US11685721, Compound 115e	Plasma kallikrein		>75.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439388	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439388&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665512	439660946							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120018	COc1ccc2cc(ccc2c1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H32F3N5O2/c1-44-29-13-12-23-15-26(11-10-24(23)17-29)32(39-20-21-8-9-21)25-5-3-6-27(16-25)40-33(43)30-18-31(34(35,36)37)41-42(30)28-7-2-4-22(14-28)19-38/h2-7,10-18,21,32,39H,8-9,19-20,38H2,1H3,(H,40,43)	YJEVEVIVXGFKBA-UHFFFAOYSA-N	416804	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic Acid {3-[(cyclopropylmethyl-amino)-(6-methoxy-naphthalen-2-yl)-methyl]-phenyl}-amide::US10329260, Compound 134f::US10633345, Compound 134f::US10689346, Compound 134f::US11203574, Compound 134f::US11230530, Compound 134f::US11685721, Compound 134f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416804	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416804&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356181	433916718							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120019	FC(F)(F)c1cc(C(=O)Nc2cccc(c2)C(CCC2CC2)N2CCCC2)n(n1)-c1cccc(c1)C#N	InChI=1S/C28H28F3N5O/c29-28(30,31)26-17-25(36(34-26)23-8-3-5-20(15-23)18-32)27(37)33-22-7-4-6-21(16-22)24(12-11-19-9-10-19)35-13-1-2-14-35/h3-8,15-17,19,24H,1-2,9-14H2,(H,33,37)	MJYCRZLDCMJLHR-UHFFFAOYSA-N	439390	US10633345, Compound 98b::US10689346, Compound 98b::US11203574, Compound 98b::US11230530, Compound 98b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439390	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439390&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355716	439660948							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120020	CCc1cccc(c1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C31H32F3N5O/c1-2-20-6-3-8-23(14-20)29(36-19-21-12-13-21)24-9-5-10-25(16-24)37-30(40)27-17-28(31(32,33)34)38-39(27)26-11-4-7-22(15-26)18-35/h3-11,14-17,21,29,36H,2,12-13,18-19,35H2,1H3,(H,37,40)	YUWQOWXTNOVILU-UHFFFAOYSA-N	416807	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(3-ethylphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 116e::US10633345, Compound 116e::US10689346, Compound 116e::US11203574, Compound 116e::US11230530, Compound 116e::US11685721, Compound 116e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416807	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416807&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123342870	433916721							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120021	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(O)cc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-25(37(36-26)23-6-1-3-19(13-23)16-33)28(39)35-22-5-2-4-21(14-22)27(34-17-18-7-8-18)20-9-11-24(38)12-10-20/h1-6,9-15,18,27,34,38H,7-8,16-17,33H2,(H,35,39)	GDUMJZLASJIDFD-UHFFFAOYSA-N	416808	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(4-hydroxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 135c::US10633345, Compound 135c::US10689346, Compound 135c::US11203574, Compound 135c::US11230530, Compound 135c::US11685721, Compound 135c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416808	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416808&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355747	433916722							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120022	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CNC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-16-25(37(36-26)24-11-4-6-19(14-24)17-33)27(38)35-23-10-5-9-21(15-23)28(39,18-34-22-12-13-22)20-7-2-1-3-8-20/h1-11,14-16,22,34,39H,12-13,17-18,33H2,(H,35,38)	WTFGPUOPMMMRIY-UHFFFAOYSA-N	416809	1-(3-(aminomethyl)phenyl)-N-(3-(2-(cyclopropylamino)-1-hydroxy-1-phenylethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 99g::US10633345, Compound 99g::US10689346, Compound 99g::US11203574, Compound 99g::US11230530, Compound 99g::US11685721, Compound 99g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416809	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416809&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355899	433916723							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120023	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1F)C(F)(F)F	InChI=1S/C29H27F4N5O/c30-24-10-2-1-9-23(24)27(35-17-18-11-12-18)20-6-4-7-21(14-20)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-3-5-19(13-22)16-34/h1-10,13-15,18,27,35H,11-12,16-17,34H2,(H,36,39)	XNBKWIREUIHXKI-UHFFFAOYSA-N	416810	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2-fluorophenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 117e::US10329260, Compound 119e::US10633345, Compound 117e::US10689346, Compound 117e::US11203574, Compound 117e::US11230530, Compound 117e::US11685721, Compound 117e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416810	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416810&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123243852	433916724							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120024	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(Cc2ccc(O)cc2)c1)C(F)(F)F	InChI=1S/C25H21F3N4O2/c26-25(27,28)23-14-22(32(31-23)20-6-2-4-18(13-20)15-29)24(34)30-19-5-1-3-17(12-19)11-16-7-9-21(33)10-8-16/h1-10,12-14,33H,11,15,29H2,(H,30,34)	OPPQXCJMBFITBL-UHFFFAOYSA-N	416811	1-(3-(Aminomethyl)phenyl)-N-(3-(4-hydroxybenzyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 136a::US10633345, Compound 136a::US10689346, Compound 136a::US11203574, Compound 136a::US11230530, Compound 136a::US11685721, Compound 136a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416811	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416811&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356271	433916725							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120025	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C28H26F4N6O/c29-21-10-9-19(26(35-16-17-7-8-17)22-6-1-2-11-34-22)13-23(21)36-27(39)24-14-25(28(30,31)32)37-38(24)20-5-3-4-18(12-20)15-33/h1-6,9-14,17,26,35H,7-8,15-16,33H2,(H,36,39)	NHHQSQFDXMXIJU-UHFFFAOYSA-N	416812	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(pyridin-2-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 100e::US10633345, Compound 100e::US10689346, Compound 100e::US11203574, Compound 100e::US11230530, Compound 100e::US11685721, Compound 100e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416812	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416812&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356158	433916726							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120026	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1c2ccccc2c(Cl)c2ccccc12)C(F)(F)F	InChI=1S/C37H31ClF3N5O/c38-34-29-13-3-1-11-27(29)33(28-12-2-4-14-30(28)34)35(43-21-22-15-16-22)24-8-6-9-25(18-24)44-36(47)31-19-32(37(39,40)41)45-46(31)26-10-5-7-23(17-26)20-42/h1-14,17-19,22,35,43H,15-16,20-21,42H2,(H,44,47)	WNAKJZQMCRSZKD-UHFFFAOYSA-N	416813	1-(3-(aminomethyl)phenyl)-N-(3-((10-chloroanthracen-9-yl)(cyclopropylmethylamino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 118f::US10633345, Compound 118f::US10689346, Compound 118f::US11203574, Compound 118f::US11230530, Compound 118f::US11685721, Compound 118f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416813	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416813&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355872	433916727							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120027	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc(O)c1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-25(37(36-26)23-8-1-4-19(12-23)16-33)28(39)35-22-7-2-5-20(13-22)27(34-17-18-10-11-18)21-6-3-9-24(38)14-21/h1-9,12-15,18,27,34,38H,10-11,16-17,33H2,(H,35,39)	WNKOEKOISOIHSR-UHFFFAOYSA-N	416814	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(3-hydroxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 137a::US10633345, Compound 137a::US10689346, Compound 137a::US11203574, Compound 137a::US11230530, Compound 137a::US11685721, Compound 137a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416814	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416814&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355922	433916728							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120028	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1nccs1)C(F)(F)F	InChI=1S/C26H24F4N6OS/c27-19-7-6-17(23(25-32-8-9-38-25)33-14-15-4-5-15)11-20(19)34-24(37)21-12-22(26(28,29)30)35-36(21)18-3-1-2-16(10-18)13-31/h1-3,6-12,15,23,33H,4-5,13-14,31H2,(H,34,37)	FBQBHRBLNRXXHC-UHFFFAOYSA-N	416815	1-(3-(Aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(thiazol-2-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 101e::US10633345, Compound 101e::US10689346, Compound 101e::US11203574, Compound 101e::US11230530, Compound 101e::US11685721, Compound 101e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416815	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416815&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355606	433916729							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120029	COc1ccccc1C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O2/c1-40-26-11-3-2-10-24(26)28(35-18-19-12-13-19)21-7-5-8-22(15-21)36-29(39)25-16-27(30(31,32)33)37-38(25)23-9-4-6-20(14-23)17-34/h2-11,14-16,19,28,35H,12-13,17-18,34H2,1H3,(H,36,39)	DAKZTBMQWXCVFA-UHFFFAOYSA-N	439400	US10633345, Compound 119e::US10689346, Compound 119e::US11203574, Compound 119e::US11230530, Compound 119e::US11685721, Compound 120e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439400	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439400&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665475	439660958							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120030	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(Cc2cccc(O)c2)c1)C(F)(F)F	InChI=1S/C25H21F3N4O2/c26-25(27,28)23-14-22(32(31-23)20-8-2-6-18(12-20)15-29)24(34)30-19-7-1-4-16(11-19)10-17-5-3-9-21(33)13-17/h1-9,11-14,33H,10,15,29H2,(H,30,34)	SDKHQNOIRDBHTG-UHFFFAOYSA-N	416820	1-(3-(aminomethyl)phenyl)-N-(3-(3-hydroxybenzyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 137b::US10633345, Compound 137b::US10689346, Compound 137b::US11203574, Compound 137b::US11230530, Compound 137b::US11685721, Compound 137b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416820	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416820&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665628	433916733							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120031	CN(C(c1cccc(N)c1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1)C1CC1	InChI=1S/C29H29F3N6O/c1-37(23-11-12-23)27(19-6-3-8-21(34)14-19)20-7-4-9-22(15-20)35-28(39)25-16-26(29(30,31)32)36-38(25)24-10-2-5-18(13-24)17-33/h2-10,13-16,23,27H,11-12,17,33-34H2,1H3,(H,35,39)	UUQWENBOKMRZFC-UHFFFAOYSA-N	439402	US10633345, Compound 102b::US10689346, Compound 102b::US11203574, Compound 102b::US11230530, Compound 102b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439402	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439402&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665661	439660960							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120032	CC(C)c1ccc(cc1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C32H34F3N5O/c1-20(2)23-11-13-24(14-12-23)30(37-19-21-9-10-21)25-6-4-7-26(16-25)38-31(41)28-17-29(32(33,34)35)39-40(28)27-8-3-5-22(15-27)18-36/h3-8,11-17,20-21,30,37H,9-10,18-19,36H2,1-2H3,(H,38,41)	BFUXJPJTVQBLMT-UHFFFAOYSA-N	416823	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(4-isopropylphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 120e::US10633345, Compound 120e::US10689346, Compound 120e::US11203574, Compound 120e::US11230530, Compound 120e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416823	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416823&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355943	433916736							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120033	CC(=O)Nc1ccc(cc1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C31H31F3N6O2/c1-19(41)37-24-12-10-22(11-13-24)29(36-18-20-8-9-20)23-5-3-6-25(15-23)38-30(42)27-16-28(31(32,33)34)39-40(27)26-7-2-4-21(14-26)17-35/h2-7,10-16,20,29,36H,8-9,17-18,35H2,1H3,(H,37,41)(H,38,42)	JDALRNHKHTYPON-UHFFFAOYSA-N	416827	N-(3-((4-acetamidophenyl)(cyclopropylmethylamino)methyl)phenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 138f::US10633345, Compound 138f::US10689346, Compound 138f::US11203574, Compound 138f::US11230530, Compound 138f::US11685721, Compound 138f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416827	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416827&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355810	433916740							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120034	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CCC1CC1)c1cc[nH]c1)C(F)(F)F			416828	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-(1H-pyrrol-3-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 103b::US10633345, Compound 103b::US10689346, Compound 103b::US11203574, Compound 103b::US11230530, Compound 103b::US11685721, Compound 103b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416828	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416828&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355898	433916741							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120035	Cc1ccc(cc1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O/c1-19-8-12-22(13-9-19)28(35-18-20-10-11-20)23-5-3-6-24(15-23)36-29(39)26-16-27(30(31,32)33)37-38(26)25-7-2-4-21(14-25)17-34/h2-9,12-16,20,28,35H,10-11,17-18,34H2,1H3,(H,36,39)	HRCLMMKOPKWJGF-UHFFFAOYSA-N	416829	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(p-tolyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 122g::US10633345, Compound 122g::US10689346, Compound 122g::US11203574, Compound 122g::US11230530, Compound 122g::US11685721, Compound 122g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416829	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416829&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355867	433916742							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120036	CN(C(c1ccc(cc1)C#N)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1)C1CC1	InChI=1S/C30H26F4N6O/c1-39(22-10-11-22)28(20-7-5-18(16-35)6-8-20)21-9-12-24(31)25(14-21)37-29(41)26-15-27(30(32,33)34)38-40(26)23-4-2-3-19(13-23)17-36/h2-9,12-15,22,28H,10-11,17,36H2,1H3,(H,37,41)	BZIYYSLZWQNWBF-UHFFFAOYSA-N	439407	US10633345, Compound 52h::US10633345, Compound 71a::US10633345, Compound 71b::US10689346, Compound 71b::US11203574, Compound 71a::US11230530, Compound 71b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439407	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439407&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355581	439660965							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120037	Cn1cc(cn1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C27H28F3N7O/c1-36-16-20(15-33-36)25(32-14-17-8-9-17)19-5-3-6-21(11-19)34-26(38)23-12-24(27(28,29)30)35-37(23)22-7-2-4-18(10-22)13-31/h2-7,10-12,15-17,25,32H,8-9,13-14,31H2,1H3,(H,34,38)	GHANDLPUFXRHQK-UHFFFAOYSA-N	416831	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(1-methyl-1H-pyrazol-4-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 104f::US10633345, Compound 104f::US10689346, Compound 104f::US11203574, Compound 104f::US11230530, Compound 104f::US11685721, Compound 104f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416831	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416831&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356100	433916744							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120038	CS(=O)(=O)c1ccccc1C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O3S/c1-42(40,41)26-11-3-2-10-24(26)28(35-18-19-12-13-19)21-7-5-8-22(15-21)36-29(39)25-16-27(30(31,32)33)37-38(25)23-9-4-6-20(14-23)17-34/h2-11,14-16,19,28,35H,12-13,17-18,34H2,1H3,(H,36,39)	XEAXHMDONDJJBQ-UHFFFAOYSA-N	416832	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2-(methylsulfonyl)phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 121f::US10633345, Compound 121f::US10689346, Compound 121f::US11203574, Compound 121f::US11230530, Compound 121f::US11685721, Compound 121f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416832	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416832&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665701	433916745							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120039	CN(C(c1ccc(CN)cc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1)C1CC1	InChI=1S/C30H30F4N6O/c1-39(22-10-11-22)28(20-7-5-18(16-35)6-8-20)21-9-12-24(31)25(14-21)37-29(41)26-15-27(30(32,33)34)38-40(26)23-4-2-3-19(13-23)17-36/h2-9,12-15,22,28H,10-11,16-17,35-36H2,1H3,(H,37,41)	REFXZSDKKDUEPN-UHFFFAOYSA-N	439410	US10633345, Compound 139b::US10689346, Compound 139b::US11203574, Compound 139b::US11230530, Compound 139b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439410	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439410&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665496	439660968							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120040	COc1ccc(cc1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O2/c1-40-25-12-10-21(11-13-25)28(35-18-19-8-9-19)22-5-3-6-23(15-22)36-29(39)26-16-27(30(31,32)33)37-38(26)24-7-2-4-20(14-24)17-34/h2-7,10-16,19,28,35H,8-9,17-18,34H2,1H3,(H,36,39)	NTRWDZUFVXMYGD-UHFFFAOYSA-N	416834	1-(3-(Aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(4-methoxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 105g::US10633345, Compound 105g::US10689346, Compound 105g::US11203574, Compound 105g::US11230530, Compound 105g::US11685721, Compound 105g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416834	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416834&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665521	433916747							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120041	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(OCc2ccccc2)cc1)C(F)(F)F	InChI=1S/C36H34F3N5O2/c37-36(38,39)33-20-32(44(43-33)30-11-4-8-26(18-30)21-40)35(45)42-29-10-5-9-28(19-29)34(41-22-24-12-13-24)27-14-16-31(17-15-27)46-23-25-6-2-1-3-7-25/h1-11,14-20,24,34,41H,12-13,21-23,40H2,(H,42,45)	AKMGFHNAHQDIKU-UHFFFAOYSA-N	439412	US10633345, Compound 123g::US10689346, Compound 123g::US11203574, Compound 123g::US11230530, Compound 123g::US11685721, Compound 107f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439412	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439412&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665739	439660970							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120042	Cc1cccc(c1)C(NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H29F4N5O/c1-18-4-2-6-21(12-18)28(36-17-19-8-9-19)22-10-11-24(31)25(14-22)37-29(40)26-15-27(30(32,33)34)38-39(26)23-7-3-5-20(13-23)16-35/h2-7,10-15,19,28,36H,8-9,16-17,35H2,1H3,(H,37,40)	DWXIBXKRESUYFO-UHFFFAOYSA-N	416836	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(m-tolyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 140e::US10633345, Compound 140e::US10689346, Compound 140e::US11203574, Compound 140e::US11230530, Compound 140e::US11685721, Compound 140e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416836	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416836&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356147	433916749							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120043	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1O)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-24(37(36-26)22-8-3-5-19(13-22)16-33)28(39)35-21-7-4-6-20(14-21)27(34-17-18-11-12-18)23-9-1-2-10-25(23)38/h1-10,13-15,18,27,34,38H,11-12,16-17,33H2,(H,35,39)	PCNDJIQOMLHSEK-UHFFFAOYSA-N	416837	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2-hydroxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 49h::US10633345, Compound 49h::US10689346, Compound 49h::US11203574, Compound 49j::US11230530, Compound 49j::US11685721, Compound 49h	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416837	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416837&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355733	433916750							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120044	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc(OC(F)(F)F)c1)C(F)(F)F	InChI=1S/C30H27F6N5O2/c31-29(32,33)26-15-25(41(40-26)23-8-1-4-19(12-23)16-37)28(42)39-22-7-2-5-20(13-22)27(38-17-18-10-11-18)21-6-3-9-24(14-21)43-30(34,35)36/h1-9,12-15,18,27,38H,10-11,16-17,37H2,(H,39,42)	IVEYKJBEIIJLCR-UHFFFAOYSA-N	416838	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(3-(trifluoromethoxy) phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 124f::US10633345, Compound 124f::US10689346, Compound 124f::US11203574, Compound 124f::US11230530, Compound 124f::US11685721, Compound 124f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416838	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416838&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665809	433916751							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120045	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C1OC(=O)Nc2ccccc12)C(F)(F)F	InChI=1S/C26H20F3N5O3/c27-26(28,29)22-13-21(34(33-22)18-8-3-5-15(11-18)14-30)24(35)31-17-7-4-6-16(12-17)23-19-9-1-2-10-20(19)32-25(36)37-23/h1-13,23H,14,30H2,(H,31,35)(H,32,36)	LRCHTKOMIAYQHX-UHFFFAOYSA-N	416839	1-(3-(aminomethyl)phenyl)-N-(3-(2-oxo-2,4-dihydro-1H-benzo[d][1,3]oxazin-4-yl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 167f::US10633345, Compound 167f::US10689346, Compound 167f::US11203574, Compound 167f::US11230530, Compound 167f::US11685721, Compound 167f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416839	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416839&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665868	433916752							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120046	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1OCc1ccccc1)C(F)(F)F	InChI=1S/C36H34F3N5O2/c37-36(38,39)33-20-31(44(43-33)29-13-6-10-26(18-29)21-40)35(45)42-28-12-7-11-27(19-28)34(41-22-24-16-17-24)30-14-4-5-15-32(30)46-23-25-8-2-1-3-9-25/h1-15,18-20,24,34,41H,16-17,21-23,40H2,(H,42,45)	XAZZTVOUWUHFIG-UHFFFAOYSA-N	416840	1-(3-(aminomethyl)phenyl)-N-(3-((2-(benzyloxy)phenyl)(cyclopropylmethyl amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 106a::US10633345, Compound 106a::US10689346, Compound 106a::US11203574, Compound 106a::US11230530, Compound 106a::US11685721, Compound 106a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416840	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416840&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356273	433916753							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120047	COc1ccc2ccccc2c1C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H32F3N5O2/c1-44-29-15-14-23-7-2-3-11-27(23)31(29)32(39-20-21-12-13-21)24-8-5-9-25(17-24)40-33(43)28-18-30(34(35,36)37)41-42(28)26-10-4-6-22(16-26)19-38/h2-11,14-18,21,32,39H,12-13,19-20,38H2,1H3,(H,40,43)	XVOUQCJHWNZPKF-UHFFFAOYSA-N	416841	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2-methoxynaphthalen-1-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 51f::US10633345, Compound 51f::US10689346, Compound 51f::US11203574, Compound 51h::US11230530, Compound 51h::US11685721, Compound 51f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416841	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416841&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356155	433916754							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120048	COc1cccc(c1)C(NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H29F4N5O2/c1-41-23-7-3-5-20(13-23)28(36-17-18-8-9-18)21-10-11-24(31)25(14-21)37-29(40)26-15-27(30(32,33)34)38-39(26)22-6-2-4-19(12-22)16-35/h2-7,10-15,18,28,36H,8-9,16-17,35H2,1H3,(H,37,40)	MRNMVRANILFBMK-UHFFFAOYSA-N	416842	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(3-methoxyphenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 141e::US10633345, Compound 141e::US10689346, Compound 141e::US11203574, Compound 141e::US11230530, Compound 141e::US11685721, Compound 142f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416842	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416842&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355803	433916755							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120049	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(N)cc1)C(F)(F)F	InChI=1S/C29H29F3N6O/c30-29(31,32)26-15-25(38(37-26)24-6-1-3-19(13-24)16-33)28(39)36-23-5-2-4-21(14-23)27(35-17-18-7-8-18)20-9-11-22(34)12-10-20/h1-6,9-15,18,27,35H,7-8,16-17,33-34H2,(H,36,39)	XDCYYWMSVYTRMZ-UHFFFAOYSA-N	416843	1-(3-(aminomethyl)phenyl)-N-(3-((4-aminophenyl)(cyclopropylmethyl-amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 50f::US10633345, Compound 50f::US10689346, Compound 50h::US11203574, Compound 50h::US11230530, Compound 50h::US11685721, Compound 50f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416843	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416843&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355587	433916756							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120050	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cc2ccccc2c2ccccc12)C(F)(F)F	InChI=1S/C37H32F3N5O/c38-37(39,40)34-20-33(45(44-34)28-11-5-7-24(17-28)21-41)36(46)43-27-10-6-9-26(18-27)35(42-22-23-15-16-23)32-19-25-8-1-2-12-29(25)30-13-3-4-14-31(30)32/h1-14,17-20,23,35,42H,15-16,21-22,41H2,(H,43,46)	OZXXGJIBGVGMMV-UHFFFAOYSA-N	416844	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic acid {3-[(cyclopropylmethyl-amino)-phenanthren-9-yl-methyl]-phenyl}-amide::US10329260, Compound 125g::US10633345, Compound 125g::US10689346, Compound 125g::US11203574, Compound 125g::US11230530, Compound 125g::US11685721, Compound 125g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416844	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416844&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665609	433916757							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120051	COc1ccc(cc1)C(NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H29F4N5O2/c1-41-23-10-7-20(8-11-23)28(36-17-18-5-6-18)21-9-12-24(31)25(14-21)37-29(40)26-15-27(30(32,33)34)38-39(26)22-4-2-3-19(13-22)16-35/h2-4,7-15,18,28,36H,5-6,16-17,35H2,1H3,(H,37,40)	GWNRXEFJAQDBCM-UHFFFAOYSA-N	416845	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(4-methoxyphenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 142f::US10633345, Compound 142f::US10689346, Compound 142f::US11203574, Compound 142f::US11230530, Compound 142f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416845	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416845&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355909	433916758							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120052	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc(OCc2ccccc2)c1)C(F)(F)F	InChI=1S/C36H34F3N5O2/c37-36(38,39)33-20-32(44(43-33)30-13-4-9-26(17-30)21-40)35(45)42-29-12-5-10-27(18-29)34(41-22-24-15-16-24)28-11-6-14-31(19-28)46-23-25-7-2-1-3-8-25/h1-14,17-20,24,34,41H,15-16,21-23,40H2,(H,42,45)	VWRITWGTGWRWCP-UHFFFAOYSA-N	439423	US10633345, Compound 107f::US11203574, Compound 107f::US11230530, Compound 107f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439423	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439423&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665642	439660981							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120053	CN(C)c1ccc(C(NCC2CC2)c2cccc(NC(=O)c3cc(nn3-c3cccc(CN)c3)C(F)(F)F)c2)c2ccccc12	InChI=1S/C35H35F3N6O/c1-43(2)30-16-15-29(27-11-3-4-12-28(27)30)33(40-21-22-13-14-22)24-8-6-9-25(18-24)41-34(45)31-19-32(35(36,37)38)42-44(31)26-10-5-7-23(17-26)20-39/h3-12,15-19,22,33,40H,13-14,20-21,39H2,1-2H3,(H,41,45)	IQAVMSNXUBZMCB-UHFFFAOYSA-N	416847	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic acid {3-[(cyclopropylmethyl-amino)-(4-dimethylamino-naphthalen-1-yl)-methyl]-phenyl}-amide::US10329260, Compound 126g::US10633345, Compound 126g::US10689346, Compound 126g::US11203574, Compound 126g::US11230530, Compound 126g::US11685721, Compound 126g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416847	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416847&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355601	433916760							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120054	Cc1cc(C(=O)Nc2cccc(c2)C(NCC2CC2)c2ccccc2)n(n1)-c1cccc(CN)c1	InChI=1S/C29H31N5O/c1-20-15-27(34(33-20)26-12-5-7-22(16-26)18-30)29(35)32-25-11-6-10-24(17-25)28(31-19-21-13-14-21)23-8-3-2-4-9-23/h2-12,15-17,21,28,31H,13-14,18-19,30H2,1H3,(H,32,35)	GPDBDHGXUBYWPY-UHFFFAOYSA-N	416848	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(phenyl)methyl)phenyl)-3-methyl-1H-pyrazole-5-carboxamid::US10329260, Compound 143l::US10633345, Compound 143l::US10689346, Compound 143l::US11203574, Compound 143l::US11230530, Compound 143l::US11685721, Compound 143l	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416848	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416848&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356139	433916761							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120055	NCc1cccc(c1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H31F3N6O/c31-30(32,33)27-15-26(39(38-27)25-9-2-5-21(13-25)17-35)29(40)37-24-8-3-7-23(14-24)28(36-18-19-10-11-19)22-6-1-4-20(12-22)16-34/h1-9,12-15,19,28,36H,10-11,16-18,34-35H2,(H,37,40)	CBXMVQRWSKIMMQ-UHFFFAOYSA-N	439426	US10633345, Compound 108e::US10689346, Compound 108e::US11203574, Compound 108e::US11230530, Compound 108e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439426	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439426&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665469	439660984							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120056	CCCOc1ccc(cc1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C32H34F3N5O2/c1-2-15-42-27-13-11-23(12-14-27)30(37-20-21-9-10-21)24-6-4-7-25(17-24)38-31(41)28-18-29(32(33,34)35)39-40(28)26-8-3-5-22(16-26)19-36/h3-8,11-14,16-18,21,30,37H,2,9-10,15,19-20,36H2,1H3,(H,38,41)	BSIABEDKJHMBRX-UHFFFAOYSA-N	416850	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic acid {3-[(cyclopropylmethyl-amino)-(4-propoxy-phenyl)-methyl]-phenyl}-amide::US10329260, Compound 127f::US10633345, Compound 127f::US10689346, Compound 127f::US11203574, Compound 127f::US11230530, Compound 127f::US11685721, Compound 127f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416850	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416850&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356061	433916763							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120057	CC(C)NC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C28H28F3N5O/c1-18(2)33-26(20-9-4-3-5-10-20)21-11-7-12-22(15-21)34-27(37)24-16-25(28(29,30)31)35-36(24)23-13-6-8-19(14-23)17-32/h3-16,18,26,33H,17,32H2,1-2H3,(H,34,37)	XNDGACONQUBLGK-UHFFFAOYSA-N	416851	1-(3-(Aminomethyl)phenyl)-N-(3-((isopropylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 144d::US10633345, Compound 144d::US10689346, Compound 144d::US11203574, Compound 144d::US11230530, Compound 144d::US11685721, Compound 144d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416851	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416851&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355596	433916764							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120058	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCCO)c1ccccc1)C(F)(F)F	InChI=1S/C27H26F3N5O2/c28-27(29,30)24-16-23(35(34-24)22-11-4-6-18(14-22)17-31)26(37)33-21-10-5-9-20(15-21)25(32-12-13-36)19-7-2-1-3-8-19/h1-11,14-16,25,32,36H,12-13,17,31H2,(H,33,37)	MMNKSYPQOFLCSY-UHFFFAOYSA-N	416852	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic acid {3-[(2-hydroxy-ethylamino)-phenyl-methyl]-phenyl}-amide::US10329260, Compound 145c::US10633345, Compound 145c::US10689346, Compound 145c::US11203574, Compound 145c::US11230530, Compound 145c::US11685721, Compound 145c	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416852	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416852&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123569320	433916765							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120059	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-10-9-20(27(40-16-17-7-8-17)19-4-2-5-21(35)12-19)13-24(23)36-28(39)25-14-26(29(31,32)33)37-38(25)22-6-1-3-18(11-22)15-34/h1-6,9-14,17,27H,7-8,15-16,34-35H2,(H,36,39)	GBDDXSAKQKODCG-UHFFFAOYSA-N	416853	1-(3-(aminomethyl)phenyl)-N-(5-((3-aminophenyl)(cyclopropylmethoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 57e::US10633345, Compound 65b::US10689346, Compound 65b::US11203574, Compound 65a::US11230530, Compound 65b::US11685721, Compound 57e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416853	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416853&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355865	433916766							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120060	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(N[C@H]1CC[C@H](O)CC1)c1ccccc1)C(F)(F)F	InChI=1S/C31H32F3N5O2/c32-31(33,34)28-18-27(39(38-28)25-11-4-6-20(16-25)19-35)30(41)37-24-10-5-9-22(17-24)29(21-7-2-1-3-8-21)36-23-12-14-26(40)15-13-23/h1-11,16-18,23,26,29,36,40H,12-15,19,35H2,(H,37,41)/t23-,26-,29?	QCYULPRIJNBHAA-APJPSQSRSA-N	416854	1-(3-(Aminomethyl)phenyl)-N-(3-((((trans)-4-hydroxycyclohexyl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 181b::US10633345, Compound 181b::US10689346, Compound 181b::US11203574, Compound 181b::US11230530, Compound 181b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416854	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416854&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665446	433916767							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120061	Cc1cc(C(=O)Nc2cccc(c2)C(NCC2CC2)c2cc(O)ccc2O)n(n1)-c1cccc(CN)c1	InChI=1S/C29H31N5O3/c1-18-12-26(34(33-18)23-7-2-4-20(13-23)16-30)29(37)32-22-6-3-5-21(14-22)28(31-17-19-8-9-19)25-15-24(35)10-11-27(25)36/h2-7,10-15,19,28,31,35-36H,8-9,16-17,30H2,1H3,(H,32,37)	LPEUWRVJEWZQCO-UHFFFAOYSA-N	416855	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2,5-dihydroxyphenyl)methyl) phenyl)-3-methyl-1H-pyrazole-5-carboxamide::US10329260, Compound 146g::US10633345, Compound 146g::US10689346, Compound 146g::US11203574, Compound 146g::US11230530, Compound 146g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416855	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416855&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356064	433916768							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120062	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1O)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-11-10-19(27(35-16-17-8-9-17)21-6-1-2-7-25(21)39)13-23(22)36-28(40)24-14-26(29(31,32)33)37-38(24)20-5-3-4-18(12-20)15-34/h1-7,10-14,17,27,35,39H,8-9,15-16,34H2,(H,36,40)	CKWWRAGQIQAYTL-UHFFFAOYSA-N	416856	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(2-hydroxyphenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 60e::US10633345, Compound 66b::US10689346, Compound 60e::US11203574, Compound 66b::US11230530, Compound 66b::US11685721, Compound 60e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416856	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416856&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665480	433916769							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120063	CC(O)CNC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C28H28F3N5O2/c1-18(37)17-33-26(20-8-3-2-4-9-20)21-10-6-11-22(14-21)34-27(38)24-15-25(28(29,30)31)35-36(24)23-12-5-7-19(13-23)16-32/h2-15,18,26,33,37H,16-17,32H2,1H3,(H,34,38)	XWEXCUNXVFBKNX-UHFFFAOYSA-N	416857	1-(3-(aminomethyl)phenyl)-N-(3-(((2-hydroxypropyl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 182b::US10633345, Compound 182b::US10689346, Compound 182b::US11203574, Compound 182b::US11230530, Compound 182b::US11685721, Compound 182b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416857	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416857&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355690	433916770							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120064	CC(=O)Nc1ccc(cc1)C(OCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C31H30F3N5O3/c1-19(40)36-24-12-10-22(11-13-24)29(42-18-20-8-9-20)23-5-3-6-25(15-23)37-30(41)27-16-28(31(32,33)34)38-39(27)26-7-2-4-21(14-26)17-35/h2-7,10-16,20,29H,8-9,17-18,35H2,1H3,(H,36,40)(H,37,41)	AETJNKBVQDZIDV-UHFFFAOYSA-N	416858	N-(3-((4-acetamidophenyl)(cyclopropylmethoxy)methyl)phenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 147e::US10633345, Compound 147e::US10689346, Compound 147e::US11203574, Compound 147e::US11230530, Compound 147e::US11685721, Compound 147e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416858	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416858&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355828	433916771							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120065	CN(C(c1ccc(cc1)C#N)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1)C1CC1	InChI=1S/C30H26F4N6O/c1-39(22-10-11-22)28(20-7-5-18(16-35)6-8-20)21-9-12-24(31)25(14-21)37-29(41)26-15-27(30(32,33)34)38-40(26)23-4-2-3-19(13-23)17-36/h2-9,12-15,22,28H,10-11,17,36H2,1H3,(H,37,41)	BZIYYSLZWQNWBF-UHFFFAOYSA-N	439407	US10633345, Compound 52h::US10633345, Compound 71a::US10633345, Compound 71b::US10689346, Compound 71b::US11203574, Compound 71a::US11230530, Compound 71b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439407	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439407&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355581	439660965							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120066	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCCCn1ccnc1)c1ccccc1)C(F)(F)F	InChI=1S/C31H30F3N7O/c32-31(33,34)28-19-27(41(39-28)26-12-4-7-22(17-26)20-35)30(42)38-25-11-5-10-24(18-25)29(23-8-2-1-3-9-23)37-13-6-15-40-16-14-36-21-40/h1-5,7-12,14,16-19,21,29,37H,6,13,15,20,35H2,(H,38,42)	XJDJXHWYZLFIJY-UHFFFAOYSA-N	416860	N-(3-(((3-(1H-Imidazol-1-yl)propyl)amino)(phenyl)methyl)phenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 183b::US10633345, Compound 183b::US10689346, Compound 183b::US11203574, Compound 183b::US11230530, Compound 183b::US11685721, Compound 183b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416860	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416860&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665638	433916773							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120067	COc1ccc2ccccc2c1C(OCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H31F3N4O3/c1-43-29-15-14-23-7-2-3-11-27(23)31(29)32(44-20-21-12-13-21)24-8-5-9-25(17-24)39-33(42)28-18-30(34(35,36)37)40-41(28)26-10-4-6-22(16-26)19-38/h2-11,14-18,21,32H,12-13,19-20,38H2,1H3,(H,39,42)	YJZQWEYZTCABEY-UHFFFAOYSA-N	416861	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(2-methoxynaphthalen-1-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 148b::US10633345, Compound 148b::US10689346, Compound 148b::US11203574, Compound 148b::US11230530, Compound 148b::US11685721, Compound 148b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416861	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416861&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665874	433916774							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120068	CN(C(c1ccc(cc1)C#N)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1)C1CC1	InChI=1S/C30H26F4N6O/c1-39(22-10-11-22)28(20-7-5-18(16-35)6-8-20)21-9-12-24(31)25(14-21)37-29(41)26-15-27(30(32,33)34)38-40(26)23-4-2-3-19(13-23)17-36/h2-9,12-15,22,28H,10-11,17,36H2,1H3,(H,37,41)	BZIYYSLZWQNWBF-UHFFFAOYSA-N	439407	US10633345, Compound 52h::US10633345, Compound 71a::US10633345, Compound 71b::US10689346, Compound 71b::US11203574, Compound 71a::US11230530, Compound 71b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439407	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439407&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355581	439660965							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120069	CN(C)C(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C27H26F3N5O/c1-34(2)25(19-9-4-3-5-10-19)20-11-7-12-21(15-20)32-26(36)23-16-24(27(28,29)30)33-35(23)22-13-6-8-18(14-22)17-31/h3-16,25H,17,31H2,1-2H3,(H,32,36)	BIAJBXPGRHVMIB-UHFFFAOYSA-N	416863	1-(3-(Aminomethyl)phenyl)-N-(3-((dimethylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 184b::US10633345, Compound 184b::US10689346, Compound 184b::US11203574, Compound 184b::US11230530, Compound 184b::US11685721, Compound 184b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416863	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416863&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356007	433916776							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120070	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccc(O)cc1)C(F)(F)F	InChI=1S/C29H27F3N4O3/c30-29(31,32)26-15-25(36(35-26)23-6-1-3-19(13-23)16-33)28(38)34-22-5-2-4-21(14-22)27(39-17-18-7-8-18)20-9-11-24(37)12-10-20/h1-6,9-15,18,27,37H,7-8,16-17,33H2,(H,34,38)	WIBHWKLQWUWRRF-UHFFFAOYSA-N	416864	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(4-hydroxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 149b::US10633345, Compound 149b::US10689346, Compound 149b::US11203574, Compound 149b::US11230530, Compound 149b::US11685721, Compound 149b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416864	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416864&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665542	433916777							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120071	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-10-9-20(27(40-16-17-7-8-17)19-4-2-5-21(35)12-19)13-24(23)36-28(39)25-14-26(29(31,32)33)37-38(25)22-6-1-3-18(11-22)15-34/h1-6,9-14,17,27H,7-8,15-16,34-35H2,(H,36,39)	GBDDXSAKQKODCG-UHFFFAOYSA-N	416853	1-(3-(aminomethyl)phenyl)-N-(5-((3-aminophenyl)(cyclopropylmethoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 57e::US10633345, Compound 65b::US10689346, Compound 65b::US11203574, Compound 65a::US11230530, Compound 65b::US11685721, Compound 57e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416853	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416853&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355865	433916766							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120072	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NC1CCCCC1)c1ccccc1)C(F)(F)F	InChI=1S/C31H32F3N5O/c32-31(33,34)28-19-27(39(38-28)26-16-7-9-21(17-26)20-35)30(40)37-25-15-8-12-23(18-25)29(22-10-3-1-4-11-22)36-24-13-5-2-6-14-24/h1,3-4,7-12,15-19,24,29,36H,2,5-6,13-14,20,35H2,(H,37,40)	MXMWHPZXCVOSEY-UHFFFAOYSA-N	416866	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclohexylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 185b::US10633345, Compound 185b::US10689346, Compound 185b::US11203574, Compound 185b::US11230530, Compound 185b::US11685721, Compound 185b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416866	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416866&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356164	433916779							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120073	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-25(37(36-26)24-9-1-4-19(12-24)16-33)28(38)35-23-8-3-6-21(14-23)27(39-17-18-10-11-18)20-5-2-7-22(34)13-20/h1-9,12-15,18,27H,10-11,16-17,33-34H2,(H,35,38)	FPQYUIIRVBKUDH-UHFFFAOYSA-N	416867	1-(3-(aminomethyl)phenyl)-N-(3-((3-aminophenyl)(cyclopropyl-methoxy)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 53f::US10633345, Compound 53f::US10689346, Compound 53f::US11203574, Compound 64b::US11230530, Compound 64b::US11685721, Compound 49j	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416867	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416867&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355845	433916780							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120074	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-10-9-20(27(40-16-17-7-8-17)19-4-2-5-21(35)12-19)13-24(23)36-28(39)25-14-26(29(31,32)33)37-38(25)22-6-1-3-18(11-22)15-34/h1-6,9-14,17,27H,7-8,15-16,34-35H2,(H,36,39)	GBDDXSAKQKODCG-UHFFFAOYSA-N	416853	1-(3-(aminomethyl)phenyl)-N-(5-((3-aminophenyl)(cyclopropylmethoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 57e::US10633345, Compound 65b::US10689346, Compound 65b::US11203574, Compound 65a::US11230530, Compound 65b::US11685721, Compound 57e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416853	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416853&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355865	433916766							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120075	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCc1ccncc1)c1ccccc1)C(F)(F)F	InChI=1S/C31H27F3N6O/c32-31(33,34)28-18-27(40(39-28)26-11-4-6-22(16-26)19-35)30(41)38-25-10-5-9-24(17-25)29(23-7-2-1-3-8-23)37-20-21-12-14-36-15-13-21/h1-18,29,37H,19-20,35H2,(H,38,41)	PXKQYONQBKMAKS-UHFFFAOYSA-N	416869	1-(3-(Aminomethyl)phenyl)-N-(3-(phenyl((pyridin-4-ylmethyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 186b::US10633345, Compound 186b::US10689346, Compound 186b::US11203574, Compound 186b::US11230530, Compound 186b::US11685721, Compound 186b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416869	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416869&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665494	433916782							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120076	Cc1cc(C(=O)Nc2cccc(c2)C(NCC2CC2)c2cccc(O)c2O)n(n1)-c1cccc(CN)c1	InChI=1S/C29H31N5O3/c1-18-13-25(34(33-18)23-8-2-5-20(14-23)16-30)29(37)32-22-7-3-6-21(15-22)27(31-17-19-11-12-19)24-9-4-10-26(35)28(24)36/h2-10,13-15,19,27,31,35-36H,11-12,16-17,30H2,1H3,(H,32,37)	VPKURNQNFXHFDB-UHFFFAOYSA-N	416870	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2,3-dihydroxyphenyl)methyl)phenyl)-3-methyl-1H-pyrazole-5-carboxamide::US10329260, Compound 150f::US10633345, Compound 150f::US10689346, Compound 150f::US11203574, Compound 150f::US11230530, Compound 150f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416870	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416870&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355949	433916783							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120077	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc2OCOc12)C(F)(F)F	InChI=1S/C30H28F3N5O3/c31-30(32,33)26-14-24(38(37-26)22-7-1-4-19(12-22)15-34)29(39)36-21-6-2-5-20(13-21)27(35-16-18-10-11-18)23-8-3-9-25-28(23)41-17-40-25/h1-9,12-14,18,27,35H,10-11,15-17,34H2,(H,36,39)	FVRZDZZJKCSOIR-UHFFFAOYSA-N	416871	1-(3-(aminomethyl)phenyl)-N-(3-(benzo[d][1,3]dioxol-4-yl(cyclopropylmethylamino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 192f::US10633345, Compound 192f::US10689346, Compound 192f::US11203574, Compound 192f::US11230530, Compound 192f::US11685721, Compound 192f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416871	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416871&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665720	433916784							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120078	CC(C)(C)CNC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H32F3N5O/c1-29(2,3)19-35-27(21-10-5-4-6-11-21)22-12-8-13-23(16-22)36-28(39)25-17-26(30(31,32)33)37-38(25)24-14-7-9-20(15-24)18-34/h4-17,27,35H,18-19,34H2,1-3H3,(H,36,39)	NWBNOBGYJRWWRK-UHFFFAOYSA-N	416872	1-(3-(Aminomethyl)phenyl)-N-(3-((neopentylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 187b::US10633345, Compound 187b::US10689346, Compound 187b::US11203574, Compound 187b::US11230530, Compound 187b::US11685721, Compound 187b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416872	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416872&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124028296	433916785							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120079	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccc(cc1)C(N)=O)C(F)(F)F	InChI=1S/C30H28F4N6O2/c31-23-11-10-21(27(37-16-17-4-5-17)19-6-8-20(9-7-19)28(36)41)13-24(23)38-29(42)25-14-26(30(32,33)34)39-40(25)22-3-1-2-18(12-22)15-35/h1-3,6-14,17,27,37H,4-5,15-16,35H2,(H2,36,41)(H,38,42)	AHHWWBRXILLXFU-UHFFFAOYSA-N	416873	1-(3-(aminomethyl)phenyl)-N-(5-((4-carbamoylphenyl)(cyclopropylmethylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 153b::US10633345, Compound 153b::US10689346, Compound 153b::US11203574, Compound 153b::US11230530, Compound 153b::US11685721, Compound 153b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416873	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416873&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355991	433916786							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120080	CCC(CO)NC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C29H30F3N5O2/c1-2-22(18-38)34-27(20-9-4-3-5-10-20)21-11-7-12-23(15-21)35-28(39)25-16-26(29(30,31)32)36-37(25)24-13-6-8-19(14-24)17-33/h3-16,22,27,34,38H,2,17-18,33H2,1H3,(H,35,39)	KIDPOTSBLNZGML-UHFFFAOYSA-N	416874	1-(3-(aminomethyl)phenyl)-N-(3-(((1-hydroxybutan-2-yl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 168b::US10633345, Compound 168b::US10689346, Compound 168b::US11192861, Compound 168b::US11230530, Compound 168b::US11685721, Compound 168b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416874	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416874&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356215	433916787							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120081	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NC1CCC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H28F3N5O/c30-29(31,32)26-17-25(37(36-26)24-14-4-7-19(15-24)18-33)28(38)35-23-13-5-10-21(16-23)27(34-22-11-6-12-22)20-8-2-1-3-9-20/h1-5,7-10,13-17,22,27,34H,6,11-12,18,33H2,(H,35,38)	UCFAODSDUNDTFF-UHFFFAOYSA-N	416875	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclobutylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 188b::US10633345, Compound 188b::US10689346, Compound 188b::US11203574, Compound 188b::US11230530, Compound 188b::US11685721, Compound 188b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416875	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416875&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123435501	433916788							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120082	COc1cccc(C(NCC2CC2)c2cccc(NC(=O)c3cc(nn3-c3cccc(CN)c3)C(F)(F)F)c2)c1O	InChI=1S/C30H30F3N5O3/c1-41-25-10-4-9-23(28(25)39)27(35-17-18-11-12-18)20-6-3-7-21(14-20)36-29(40)24-15-26(30(31,32)33)37-38(24)22-8-2-5-19(13-22)16-34/h2-10,13-15,18,27,35,39H,11-12,16-17,34H2,1H3,(H,36,40)	KCIFFUCEHRXTLF-UHFFFAOYSA-N	416876	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2-hydroxy-3-methoxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 151g::US10633345, Compound 151g::US10689346, Compound 151g::US11203574, Compound 151g::US11230530, Compound 151g::US11685721, Compound 151g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416876	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416876&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356165	433916789							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120083	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(N1CCCC1CO)c1ccccc1)C(F)(F)F	InChI=1S/C30H30F3N5O2/c31-30(32,33)27-17-26(38(36-27)24-12-4-7-20(15-24)18-34)29(40)35-23-11-5-10-22(16-23)28(21-8-2-1-3-9-21)37-14-6-13-25(37)19-39/h1-5,7-12,15-17,25,28,39H,6,13-14,18-19,34H2,(H,35,40)	BNZLGFQHSKUMEG-UHFFFAOYSA-N	416877	1-(3-(aminomethyl)phenyl)-N-(3-((2-(hydroxymethyl)pyrrolidin-1-yl)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 169b::US10633345, Compound 169b::US10689346, Compound 169b::US11203574, Compound 169b::US11230530, Compound 169b::US11685721, Compound 169b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416877	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416877&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356128	433916790							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120084	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCc1ccc(N)cc1)c1ccccc1)C(F)(F)F	InChI=1S/C32H29F3N6O/c33-32(34,35)29-18-28(41(40-29)27-11-4-6-22(16-27)19-36)31(42)39-26-10-5-9-24(17-26)30(23-7-2-1-3-8-23)38-20-21-12-14-25(37)15-13-21/h1-18,30,38H,19-20,36-37H2,(H,39,42)	BKOBJSLLJPHJRR-UHFFFAOYSA-N	416878	N-(3-(((4-Aminobenzyl)amino)(phenyl)methyl)phenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 189b::US10633345, Compound 189b::US10689346, Compound 189b::US11203574, Compound 189b::US11230530, Compound 189b::US11685721, Compound 189b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416878	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416878&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665871	433916791							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120085	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C30H27F3N6O/c31-30(32,33)27-15-26(39(38-27)25-9-2-5-21(13-25)17-35)29(40)37-24-8-3-7-23(14-24)28(36-18-19-10-11-19)22-6-1-4-20(12-22)16-34/h1-9,12-15,19,28,36H,10-11,17-18,35H2,(H,37,40)	VQJJJCIJWBDLSJ-UHFFFAOYSA-N	416879	1-(3-(aminomethyl)phenyl)-N-(3-((3-cyanophenyl)(cyclopropylmethyl amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 152d::US10633345, Compound 152d::US10689346, Compound 152d::US11203574, Compound 152d::US11230530, Compound 152d::US11685721, Compound 152d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416879	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416879&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356166	433916792							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120086	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(N1CCC(O)C1)c1ccccc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-16-25(37(35-26)23-11-4-6-19(14-23)17-33)28(39)34-22-10-5-9-21(15-22)27(20-7-2-1-3-8-20)36-13-12-24(38)18-36/h1-11,14-16,24,27,38H,12-13,17-18,33H2,(H,34,39)	FPAZEZULJGBLCM-UHFFFAOYSA-N	416880	1-(3-(aminomethyl)phenyl)-N-(3-((3-hydroxypyrrolidin-1-yl)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 170b::US10633345, Compound 170b::US10689346, Compound 170b::US11192861, Compound 170b::US11230530, Compound 170b::US11685721, Compound 170b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416880	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416880&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355902	433916793							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120087	CSCCNC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C28H28F3N5OS/c1-38-14-13-33-26(20-8-3-2-4-9-20)21-10-6-11-22(16-21)34-27(37)24-17-25(28(29,30)31)35-36(24)23-12-5-7-19(15-23)18-32/h2-12,15-17,26,33H,13-14,18,32H2,1H3,(H,34,37)	GMRUHWVMBSEBQV-UHFFFAOYSA-N	416881	1-(3-(aminomethyl)phenyl)-N-(3-(((2-(methylthio)ethyl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 190b::US10633345, Compound 190b::US10689346, Compound 190b::US11203574, Compound 190b::US11230530, Compound 190b::US11685721, Compound 190b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416881	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416881&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665913	433916794							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120088	COc1ccc(C(NCC2CC2)c2cccc(NC(=O)c3cc(nn3-c3cccc(CN)c3)C(F)(F)F)c2)c2ccccc12	InChI=1S/C34H32F3N5O2/c1-44-30-15-14-28(26-10-2-3-11-27(26)30)32(39-20-21-12-13-21)23-7-5-8-24(17-23)40-33(43)29-18-31(34(35,36)37)41-42(29)25-9-4-6-22(16-25)19-38/h2-11,14-18,21,32,39H,12-13,19-20,38H2,1H3,(H,40,43)	YOBACLFKAGKOLX-UHFFFAOYSA-N	416882	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(4-methoxynaphthalen-1-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 154e::US10633345, Compound 154e::US10689346, Compound 154e::US11203574, Compound 154e::US11230530, Compound 154e::US11685721, Compound 154e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416882	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416882&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665632	433916795							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117273	COc1ccc2ccccc2c1C(NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H31F4N5O2/c1-45-29-14-12-22-6-2-3-8-25(22)31(29)32(40-19-20-9-10-20)23-11-13-26(35)27(16-23)41-33(44)28-17-30(34(36,37)38)42-43(28)24-7-4-5-21(15-24)18-39/h2-8,11-17,20,32,40H,9-10,18-19,39H2,1H3,(H,41,44)	AYMFYNZEWAELBE-UHFFFAOYSA-N	416906	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(2-methoxynaphthalen-1-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide dihydrochloride::US10329260, Compound 61e::US10633345, Compound 63b::US10689346, Compound 61e::US11203574, Compound 63b::US11230530, Compound 63b::US11685721, Compound 63b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416906	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416906&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355591	433916818							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117274	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCc1cccnc1)c1ccccc1)C(F)(F)F	InChI=1S/C31H27F3N6O/c32-31(33,34)28-17-27(40(39-28)26-13-4-7-21(15-26)18-35)30(41)38-25-12-5-11-24(16-25)29(23-9-2-1-3-10-23)37-20-22-8-6-14-36-19-22/h1-17,19,29,37H,18,20,35H2,(H,38,41)	HIJVXEVWORHKBX-UHFFFAOYSA-N	416907	1-(3-(Aminomethyl)phenyl)-N-(3-(phenyl((pyridin-3-ylmethyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 179b::US10633345, Compound 179b::US10689346, Compound 179b::US11203574, Compound 179b::US11230530, Compound 179b::US11685721, Compound 179b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416907	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416907&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665526	433916819							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117275	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(Cl)cc1Cl)C(F)(F)F	InChI=1S/C29H26Cl2F3N5O/c30-20-9-10-23(24(31)13-20)27(36-16-17-7-8-17)19-4-2-5-21(12-19)37-28(40)25-14-26(29(32,33)34)38-39(25)22-6-1-3-18(11-22)15-35/h1-6,9-14,17,27,36H,7-8,15-16,35H2,(H,37,40)	CXLXHJIZVQBZJV-UHFFFAOYSA-N	416908	1-(3-(aminomethyl)phenyl)-N-(3-((2,4-dichlorophenyl)((cyclopropylmethyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 200f::US10633345, Compound 200f::US10689346, Compound 200f::US11203574, Compound 200f::US11230530, Compound 200f::US11685721, Compound 200f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416908	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416908&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126688969	433916820							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117276	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-10-9-20(28(40,12-11-18-7-8-18)25-6-1-2-13-35-25)15-23(22)36-27(39)24-16-26(29(31,32)33)37-38(24)21-5-3-4-19(14-21)17-34/h1-6,9-10,13-16,18,40H,7-8,11-12,17,34H2,(H,36,39)	XXMBQXWQIGCREG-UHFFFAOYSA-N	416909	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 59c::US10633345, Compound 69b::US10689346, Compound 59c::US11203574, Compound 69b::US11230530, Compound 69b::US11685721, Compound 69b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416909	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416909&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356067	433916821							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117277	CCCCNC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C29H30F3N5O/c1-2-3-15-34-27(21-10-5-4-6-11-21)22-12-8-13-23(17-22)35-28(38)25-18-26(29(30,31)32)36-37(25)24-14-7-9-20(16-24)19-33/h4-14,16-18,27,34H,2-3,15,19,33H2,1H3,(H,35,38)	IJFOMNKWJBCMSK-UHFFFAOYSA-N	416910	1-(3-(Aminomethyl)phenyl)-N-(3-((butylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 180b::US10633345, Compound 180b::US10689346, Compound 180b::US11203574, Compound 180b::US11230530, Compound 180b::US11685721, Compound 180b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416910	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416910&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665986	433916822							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117278	Cc1ccc(C(NCC2CC2)c2cccc(NC(=O)c3cc(nn3-c3cccc(CN)c3)C(F)(F)F)c2)c(C)c1	InChI=1S/C31H32F3N5O/c1-19-9-12-26(20(2)13-19)29(36-18-21-10-11-21)23-6-4-7-24(15-23)37-30(40)27-16-28(31(32,33)34)38-39(27)25-8-3-5-22(14-25)17-35/h3-9,12-16,21,29,36H,10-11,17-18,35H2,1-2H3,(H,37,40)	PPHLPILJSQAZAY-UHFFFAOYSA-N	416911	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2,4-dimethylphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 201f::US10689346, Compound 201f::US11192861, Compound 201f::US11230530, Compound 201f::US11685721, Compound 201f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416911	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416911&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665576	433916823							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117279	Cc1ccc(C)c(c1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2ccccc2)C(F)(F)F)c1	InChI=1S/C30H29F3N4O/c1-19-11-12-20(2)25(15-19)28(34-18-21-13-14-21)22-7-6-8-23(16-22)35-29(38)26-17-27(30(31,32)33)36-37(26)24-9-4-3-5-10-24/h3-12,15-17,21,28,34H,13-14,18H2,1-2H3,(H,35,38)	TXVGVDQAPWZCCQ-UHFFFAOYSA-N	528745	US11192861, Compound 202f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528745	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528745&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163200157	463792272							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117280	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F3N4O2/c30-29(31,32)26-16-25(36(35-26)24-11-4-6-20(14-24)17-33)28(37)34-23-10-5-9-22(15-23)27(38-18-19-12-13-19)21-7-2-1-3-8-21/h1-11,14-16,19,27H,12-13,17-18,33H2,(H,34,37)	PEZVPVUPSJXZCH-UHFFFAOYSA-N	416775	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18k::US10633345, Compound 74a::US10689346, Compound 165e::US11203574, Compound 165e::US11230530, Compound 165e::US11685721, Compound 18k	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416775	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416775&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			91884591	433916689							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117281	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F4N5O/c30-23-12-11-21(27(35-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27,35H,9-10,16-17,34H2,(H,36,39)	MCLZOCFEIKBMBA-UHFFFAOYSA-N	416773	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 38d::US10633345, Compound 38d::US10689346, Compound 42a::US11203574, Compound 42a::US11230530, Compound 42a::US11685721, Compound 38d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416773	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416773&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356124	433916687							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117282	CC(C)(C)c1ccc(cc1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C33H36F3N5O/c1-32(2,3)25-14-12-23(13-15-25)30(38-20-21-10-11-21)24-7-5-8-26(17-24)39-31(42)28-18-29(33(34,35)36)40-41(28)27-9-4-6-22(16-27)19-37/h4-9,12-18,21,30,38H,10-11,19-20,37H2,1-3H3,(H,39,42)	OVDVNIYCGDTOJR-UHFFFAOYSA-N	416915	1-(3-(aminomethyl)phenyl)-N-(3-((4-(tert-butyl)phenyl)((cyclopropylmethyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 203f::US10633345, Compound 203f::US10689346, Compound 203f::US11203574, Compound 203f::US11230530, Compound 203f::US11685721, Compound 203f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416915	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416915&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665458	433916827							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117283	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F3N4O2/c30-29(31,32)26-16-25(36(35-26)24-11-4-6-20(14-24)17-33)28(37)34-23-10-5-9-22(15-23)27(38-18-19-12-13-19)21-7-2-1-3-8-21/h1-11,14-16,19,27H,12-13,17-18,33H2,(H,34,37)	PEZVPVUPSJXZCH-UHFFFAOYSA-N	416775	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18k::US10633345, Compound 74a::US10689346, Compound 165e::US11203574, Compound 165e::US11230530, Compound 165e::US11685721, Compound 18k	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416775	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416775&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			91884591	433916689							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117284	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F4N5O/c30-23-12-11-21(27(35-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27,35H,9-10,16-17,34H2,(H,36,39)	MCLZOCFEIKBMBA-UHFFFAOYSA-N	416773	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 38d::US10633345, Compound 38d::US10689346, Compound 42a::US11203574, Compound 42a::US11230530, Compound 42a::US11685721, Compound 38d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416773	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416773&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356124	433916687							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117285	OC(CCC1CC1)(c1ccc(F)c(NC(=O)c2cc(nn2-c2ccc(Cl)cc2)C(F)(F)F)c1)c1ccccn1	InChI=1S/C28H23ClF4N4O2/c29-19-7-9-20(10-8-19)37-23(16-25(36-37)28(31,32)33)26(38)35-22-15-18(6-11-21(22)30)27(39,13-12-17-4-5-17)24-3-1-2-14-34-24/h1-3,6-11,14-17,39H,4-5,12-13H2,(H,35,38)	QWPFRWIQIFPXCC-UHFFFAOYSA-N	416918	1-(4-chlorophenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 157a::US10633345, Compound 157a::US10689346, Compound 157a::US11203574, Compound 157a::US11230530, Compound 157a::US11685721, Compound 157a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416918	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416918&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665679	433916830							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117286	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(N)cc1)C(F)(F)F	InChI=1S/C29H29F3N6O/c30-29(31,32)26-15-25(38(37-26)24-6-1-3-19(13-24)16-33)28(39)36-23-5-2-4-21(14-23)27(35-17-18-7-8-18)20-9-11-22(34)12-10-20/h1-6,9-15,18,27,35H,7-8,16-17,33-34H2,(H,36,39)	XDCYYWMSVYTRMZ-UHFFFAOYSA-N	416843	1-(3-(aminomethyl)phenyl)-N-(3-((4-aminophenyl)(cyclopropylmethyl-amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 50f::US10633345, Compound 50f::US10689346, Compound 50h::US11203574, Compound 50h::US11230530, Compound 50h::US11685721, Compound 50f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416843	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416843&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355587	433916756							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117287	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-9-8-20(28(40,11-10-18-6-7-18)21-4-2-12-35-17-21)14-24(23)36-27(39)25-15-26(29(31,32)33)37-38(25)22-5-1-3-19(13-22)16-34/h1-5,8-9,12-15,17-18,40H,6-7,10-11,16,34H2,(H,36,39)	VCHFZCHUEHQXSZ-UHFFFAOYSA-N	416897	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 58c::US10633345, Compound 67b::US10689346, Compound 67b::US11203574, Compound 67b::US11230530, Compound 67b::US11685721, Compound 67b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416897	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416897&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355889	433916810							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117288	OC(CCC1CC1)(c1ccc(F)c(NC(=O)c2cc(nn2-c2ccc3cc(Cl)ccc3c2)C(F)(F)F)c1)c1ccccn1	InChI=1S/C32H25ClF4N4O2/c33-23-9-6-21-16-24(10-7-20(21)15-23)41-27(18-29(40-41)32(35,36)37)30(42)39-26-17-22(8-11-25(26)34)31(43,13-12-19-4-5-19)28-3-1-2-14-38-28/h1-3,6-11,14-19,43H,4-5,12-13H2,(H,39,42)	XTIXOVGIMHWYOB-UHFFFAOYSA-N	416921	1-(6-chloronaphthalen-2-yl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 158a::US10633345, Compound 158a::US10689346, Compound 158a::US11203574, Compound 158a::US11230530, Compound 158a::US11685721, Compound 158a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416921	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416921&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355937	433916833							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117289	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(N)cc1)C(F)(F)F	InChI=1S/C29H29F3N6O/c30-29(31,32)26-15-25(38(37-26)24-6-1-3-19(13-24)16-33)28(39)36-23-5-2-4-21(14-23)27(35-17-18-7-8-18)20-9-11-22(34)12-10-20/h1-6,9-15,18,27,35H,7-8,16-17,33-34H2,(H,36,39)	XDCYYWMSVYTRMZ-UHFFFAOYSA-N	416843	1-(3-(aminomethyl)phenyl)-N-(3-((4-aminophenyl)(cyclopropylmethyl-amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 50f::US10633345, Compound 50f::US10689346, Compound 50h::US11203574, Compound 50h::US11230530, Compound 50h::US11685721, Compound 50f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416843	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416843&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355587	433916756							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117290	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-9-8-20(28(40,11-10-18-6-7-18)21-4-2-12-35-17-21)14-24(23)36-27(39)25-15-26(29(31,32)33)37-38(25)22-5-1-3-19(13-22)16-34/h1-5,8-9,12-15,17-18,40H,6-7,10-11,16,34H2,(H,36,39)	VCHFZCHUEHQXSZ-UHFFFAOYSA-N	416897	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 58c::US10633345, Compound 67b::US10689346, Compound 67b::US11203574, Compound 67b::US11230530, Compound 67b::US11685721, Compound 67b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416897	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416897&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355889	433916810							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117291	OC(CCC1CC1)(c1ccc(F)c(NC(=O)c2cc(nn2-c2ccc(Cl)cn2)C(F)(F)F)c1)c1ccccn1	InChI=1S/C27H22ClF4N5O2/c28-18-7-9-24(34-15-18)37-21(14-23(36-37)27(30,31)32)25(38)35-20-13-17(6-8-19(20)29)26(39,11-10-16-4-5-16)22-3-1-2-12-33-22/h1-3,6-9,12-16,39H,4-5,10-11H2,(H,35,38)	HMQODPUNPWDVSN-UHFFFAOYSA-N	416924	1-(5-chloropyridin-2-yl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 159a::US10633345, Compound 159a::US10689346, Compound 159a::US11203574, Compound 159a::US11230530, Compound 159a::US11685721, Compound 159a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416924	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416924&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355989	433916836							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117292	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C28H26F3N5O2/c29-28(30,31)25-15-24(36(35-25)22-8-3-5-19(13-22)16-32)27(37)34-21-7-4-6-20(14-21)26(38-17-18-10-11-18)23-9-1-2-12-33-23/h1-9,12-15,18,26H,10-11,16-17,32H2,(H,34,37)	UBQUVYTUKOFUOF-UHFFFAOYSA-N	416721	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(pyridin-2-yl)methyl)-phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 43f::US10633345, Compound 43f::US10689346, Compound 43g::US11203574, Compound 43h::US11230530, Compound 43h::US11685721, Compound 43f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416721	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416721&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355947	433916635							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117293	CN(C(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1)C1CC1	InChI=1S/C30H26F4N6O/c1-39(22-9-10-22)28(20-6-2-4-18(12-20)16-35)21-8-11-24(31)25(14-21)37-29(41)26-15-27(30(32,33)34)38-40(26)23-7-3-5-19(13-23)17-36/h2-8,11-15,22,28H,9-10,17,36H2,1H3,(H,37,41)	LONUELZOBAIWEW-UHFFFAOYSA-N	439471	US10633345, Compound 54e::US10633345, Compound 70a::US10633345, Compound 70b::US10689346, Compound 70a::US11203574, Compound 70b::US11230530, Compound 70b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439471	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439471&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355805	439661023							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117294	COc1ccc(cc1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H26F4N4O3/c1-40-21-10-8-20(9-11-21)37-24(17-26(36-37)29(31,32)33)27(38)35-23-16-19(7-12-22(23)30)28(39,14-13-18-5-6-18)25-4-2-3-15-34-25/h2-4,7-12,15-18,39H,5-6,13-14H2,1H3,(H,35,38)	YTPYYUUEYRYYOR-UHFFFAOYSA-N	416927	N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-1-(4-methoxyphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 160a::US10633345, Compound 160a::US10689346, Compound 160a::US11203574, Compound 160a::US11230530, Compound 160a::US11685721, Compound 160a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416927	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416927&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665840	433916839							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117295	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C28H26F3N5O2/c29-28(30,31)25-15-24(36(35-25)22-8-3-5-19(13-22)16-32)27(37)34-21-7-4-6-20(14-21)26(38-17-18-10-11-18)23-9-1-2-12-33-23/h1-9,12-15,18,26H,10-11,16-17,32H2,(H,34,37)	UBQUVYTUKOFUOF-UHFFFAOYSA-N	416721	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(pyridin-2-yl)methyl)-phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 43f::US10633345, Compound 43f::US10689346, Compound 43g::US11203574, Compound 43h::US11230530, Compound 43h::US11685721, Compound 43f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416721	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416721&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355947	433916635							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117296	CN(C(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1)C1CC1	InChI=1S/C30H26F4N6O/c1-39(22-9-10-22)28(20-6-2-4-18(12-20)16-35)21-8-11-24(31)25(14-21)37-29(41)26-15-27(30(32,33)34)38-40(26)23-7-3-5-19(13-23)17-36/h2-8,11-15,22,28H,9-10,17,36H2,1H3,(H,37,41)	LONUELZOBAIWEW-UHFFFAOYSA-N	439471	US10633345, Compound 54e::US10633345, Compound 70a::US10633345, Compound 70b::US10689346, Compound 70a::US11203574, Compound 70b::US11230530, Compound 70b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439471	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439471&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355805	439661023							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117297	Oc1ccc(cc1Br)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2ccccc2)C(F)(F)F)c1	InChI=1S/C28H24BrF3N4O2/c29-22-14-19(11-12-24(22)37)26(33-16-17-9-10-17)18-5-4-6-20(13-18)34-27(38)23-15-25(28(30,31)32)35-36(23)21-7-2-1-3-8-21/h1-8,11-15,17,26,33,37H,9-10,16H2,(H,34,38)	KEGUTLGERJBRMJ-UHFFFAOYSA-N	528763	US11192861, Compound 207j	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528763	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528763&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163200158	463792290							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117298	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H26F3N5O2/c29-28(30,31)25-14-24(36(35-25)23-8-1-4-19(12-23)15-32)27(37)34-22-7-2-5-20(13-22)26(38-17-18-9-10-18)21-6-3-11-33-16-21/h1-8,11-14,16,18,26H,9-10,15,17,32H2,(H,34,37)	SHFRWTHPPCXLER-UHFFFAOYSA-N	416725	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(pyridin-3-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 44c::US10633345, Compound 44c::US10689346, Compound 44c::US11203574, Compound 44d::US11230530, Compound 44e::US11685721, Compound 44c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416725	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416725&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355578	433916639							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117299	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-10-9-20(28(40,12-11-18-7-8-18)25-6-1-2-13-35-25)15-23(22)36-27(39)24-16-26(29(31,32)33)37-38(24)21-5-3-4-19(14-21)17-34/h1-6,9-10,13-16,18,40H,7-8,11-12,17,34H2,(H,36,39)	XXMBQXWQIGCREG-UHFFFAOYSA-N	416909	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 59c::US10633345, Compound 69b::US10689346, Compound 59c::US11203574, Compound 69b::US11230530, Compound 69b::US11685721, Compound 69b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416909	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416909&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356067	433916821							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117300	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CCC1CC1)n1ccccc1=O)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-17-25(37(35-26)23-8-3-5-20(15-23)18-33)28(39)34-22-7-4-6-21(16-22)24(13-12-19-10-11-19)36-14-2-1-9-27(36)38/h1-9,14-17,19,24H,10-13,18,33H2,(H,34,39)	OGNFHFCMBSJJNJ-UHFFFAOYSA-N	416933	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-(2-oxopyridin-1(2H)-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 247c::US10633345, Compound 247c::US10689346, Compound 247c::US11203574, Compound 247c::US11230530, Compound 247c::US11685721, Compound 247c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416933	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416933&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356133	433916845							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117301	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H26F3N5O2/c29-28(30,31)25-14-24(36(35-25)23-8-1-4-19(12-23)15-32)27(37)34-22-7-2-5-20(13-22)26(38-17-18-9-10-18)21-6-3-11-33-16-21/h1-8,11-14,16,18,26H,9-10,15,17,32H2,(H,34,37)	SHFRWTHPPCXLER-UHFFFAOYSA-N	416725	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(pyridin-3-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 44c::US10633345, Compound 44c::US10689346, Compound 44c::US11203574, Compound 44d::US11230530, Compound 44e::US11685721, Compound 44c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416725	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416725&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355578	433916639							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117302	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-10-9-20(28(40,12-11-18-7-8-18)25-6-1-2-13-35-25)15-23(22)36-27(39)24-16-26(29(31,32)33)37-38(24)21-5-3-4-19(14-21)17-34/h1-6,9-10,13-16,18,40H,7-8,11-12,17,34H2,(H,36,39)	XXMBQXWQIGCREG-UHFFFAOYSA-N	416909	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 59c::US10633345, Compound 69b::US10689346, Compound 59c::US11203574, Compound 69b::US11230530, Compound 69b::US11685721, Compound 69b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416909	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416909&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356067	433916821							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117303	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CCC1CC1)N1CCCC1=O)C(F)(F)F	InChI=1S/C28H30F3N5O2/c29-28(30,31)25-16-24(36(34-25)22-7-1-4-19(14-22)17-32)27(38)33-21-6-2-5-20(15-21)23(12-11-18-9-10-18)35-13-3-8-26(35)37/h1-2,4-7,14-16,18,23H,3,8-13,17,32H2,(H,33,38)	LEZWAIIPWSOOAE-UHFFFAOYSA-N	416936	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-(2-oxopyrrolidin-1-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 247e::US10633345, Compound 247e::US10689346, Compound 247e::US11203574, Compound 247e::US11230530, Compound 247e::US11685721, Compound 247e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416936	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416936&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665605	433916848							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117304	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-16-25(37(36-26)24-8-1-4-20(14-24)17-33)27(38)35-23-7-2-5-21(15-23)28(39,12-11-19-9-10-19)22-6-3-13-34-18-22/h1-8,13-16,18-19,39H,9-12,17,33H2,(H,35,38)	AOCZEQQKIIWUBU-UHFFFAOYSA-N	416770	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 47f::US10633345, Compound 47f::US10689346, Compound 47f::US11203574, Compound 47g::US11230530, Compound 47h::US11685721, Compound 47f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416770	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416770&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355766	433916684							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117305	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H28F4N4O2/c31-24-12-11-22(29(40,14-13-19-9-10-19)21-6-2-1-3-7-21)16-25(24)36-28(39)26-17-27(30(32,33)34)37-38(26)23-8-4-5-20(15-23)18-35/h1-8,11-12,15-17,19,40H,9-10,13-14,18,35H2,(H,36,39)	NIWMWYNGSALJGG-UHFFFAOYSA-N	416903	Racemic 1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 68c::US10633345, Compound 68e::US10689346, Compound 68c::US11203574, Compound 68e::US11230530, Compound 68e::US11685721, Compound 68e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416903	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416903&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355758	433916816							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117306	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccccc1=O)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-11-10-20(24(12-9-18-7-8-18)37-13-2-1-6-27(37)39)15-23(22)35-28(40)25-16-26(29(31,32)33)36-38(25)21-5-3-4-19(14-21)17-34/h1-6,10-11,13-16,18,24H,7-9,12,17,34H2,(H,35,40)	OFQQGSYWUFBMPP-UHFFFAOYSA-N	416939	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(2-oxopyridin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 248j::US10633345, Compound 248k::US10689346, Compound 248k::US11203574, Compound 248k::US11230530, Compound 248k::US11685721, Compound 248k	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416939	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416939&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355727	433916851							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117307	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-16-25(37(36-26)24-8-1-4-20(14-24)17-33)27(38)35-23-7-2-5-21(15-23)28(39,12-11-19-9-10-19)22-6-3-13-34-18-22/h1-8,13-16,18-19,39H,9-12,17,33H2,(H,35,38)	AOCZEQQKIIWUBU-UHFFFAOYSA-N	416770	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 47f::US10633345, Compound 47f::US10689346, Compound 47f::US11203574, Compound 47g::US11230530, Compound 47h::US11685721, Compound 47f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416770	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416770&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355766	433916684							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117308	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H28F4N4O2/c31-24-12-11-22(29(40,14-13-19-9-10-19)21-6-2-1-3-7-21)16-25(24)36-28(39)26-17-27(30(32,33)34)37-38(26)23-8-4-5-20(15-23)18-35/h1-8,11-12,15-17,19,40H,9-10,13-14,18,35H2,(H,36,39)	NIWMWYNGSALJGG-UHFFFAOYSA-N	416903	Racemic 1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 68c::US10633345, Compound 68e::US10689346, Compound 68c::US11203574, Compound 68e::US11230530, Compound 68e::US11685721, Compound 68e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416903	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416903&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355758	433916816							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117309	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccncc1=O)C(F)(F)F	InChI=1S/C28H26F4N6O2/c29-21-8-7-19(23(9-6-17-4-5-17)37-11-10-34-16-26(37)39)13-22(21)35-27(40)24-14-25(28(30,31)32)36-38(24)20-3-1-2-18(12-20)15-33/h1-3,7-8,10-14,16-17,23H,4-6,9,15,33H2,(H,35,40)	GLPOCDKMIDNWGE-UHFFFAOYSA-N	416942	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(2-oxopyrazin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 249b::US10633345, Compound 249b::US10689346, Compound 249b::US11203574, Compound 249b::US11230530, Compound 249b::US11685721, Compound 249b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416942	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416942&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665736	433916854							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117310	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F3N4O2/c31-30(32,33)27-18-26(37(36-27)25-11-4-6-21(16-25)19-34)28(38)35-24-10-5-9-23(17-24)29(39,15-14-20-12-13-20)22-7-2-1-3-8-22/h1-11,16-18,20,39H,12-15,19,34H2,(H,35,38)	DCGYPXFSNPCKGX-UHFFFAOYSA-N	416751	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 46g::US10633345, Compound 46g::US10689346, Compound 46g::US11203574, Compound 46i::US11230530, Compound 46i::US11685721, Compound 46g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416751	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416751&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355790	433916665							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117311	COc1ccc2ccccc2c1C(NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H31F4N5O2/c1-45-29-14-12-22-6-2-3-8-25(22)31(29)32(40-19-20-9-10-20)23-11-13-26(35)27(16-23)41-33(44)28-17-30(34(36,37)38)42-43(28)24-7-4-5-21(15-24)18-39/h2-8,11-17,20,32,40H,9-10,18-19,39H2,1H3,(H,41,44)	AYMFYNZEWAELBE-UHFFFAOYSA-N	416906	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(2-methoxynaphthalen-1-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide dihydrochloride::US10329260, Compound 61e::US10633345, Compound 63b::US10689346, Compound 61e::US11203574, Compound 63b::US11230530, Compound 63b::US11685721, Compound 63b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416906	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416906&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355591	433916818							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117312	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)Oc1ccccn1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-11-10-20(25(12-9-18-7-8-18)40-27-6-1-2-13-35-27)15-23(22)36-28(39)24-16-26(29(31,32)33)37-38(24)21-5-3-4-19(14-21)17-34/h1-6,10-11,13-16,18,25H,7-9,12,17,34H2,(H,36,39)	NLWJKTCXFARQOW-UHFFFAOYSA-N	416945	US10329260, Compound 250c::US10633345, Compound 250c::US11192861, Compound 250c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416945	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416945&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126689760	433916857							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117313	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F3N4O2/c31-30(32,33)27-18-26(37(36-27)25-11-4-6-21(16-25)19-34)28(38)35-24-10-5-9-23(17-24)29(39,15-14-20-12-13-20)22-7-2-1-3-8-22/h1-11,16-18,20,39H,12-15,19,34H2,(H,35,38)	DCGYPXFSNPCKGX-UHFFFAOYSA-N	416751	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 46g::US10633345, Compound 46g::US10689346, Compound 46g::US11203574, Compound 46i::US11230530, Compound 46i::US11685721, Compound 46g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416751	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416751&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355790	433916665							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117314	COc1ccc2ccccc2c1C(NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H31F4N5O2/c1-45-29-14-12-22-6-2-3-8-25(22)31(29)32(40-19-20-9-10-20)23-11-13-26(35)27(16-23)41-33(44)28-17-30(34(36,37)38)42-43(28)24-7-4-5-21(15-24)18-39/h2-8,11-17,20,32,40H,9-10,18-19,39H2,1H3,(H,41,44)	AYMFYNZEWAELBE-UHFFFAOYSA-N	416906	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(2-methoxynaphthalen-1-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide dihydrochloride::US10329260, Compound 61e::US10633345, Compound 63b::US10689346, Compound 61e::US11203574, Compound 63b::US11230530, Compound 63b::US11685721, Compound 63b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416906	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416906&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355591	433916818							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117315	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(=CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H26F4N4O/c31-25-14-12-22(24(13-11-19-9-10-19)21-6-2-1-3-7-21)16-26(25)36-29(39)27-17-28(30(32,33)34)37-38(27)23-8-4-5-20(15-23)18-35/h1-8,12-17,19H,9-11,18,35H2,(H,36,39)/b24-13-	BAAJKWZPAGFHDE-CFRMEGHHSA-N	416948	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-phenylprop-1-enyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 252c::US10633345, Compound 252c::US10689346, Compound 252c::US11203574, Compound 252c::US11230530, Compound 252c::US11685721, Compound 252c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416948	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416948&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			140777564	433916860							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117316	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H25F4N5O2/c29-22-9-8-19(26(39-16-17-6-7-17)20-4-2-10-34-15-20)12-23(22)35-27(38)24-13-25(28(30,31)32)36-37(24)21-5-1-3-18(11-21)14-33/h1-5,8-13,15,17,26H,6-7,14,16,33H2,(H,35,38)	CNAFOXQNPWSINI-UHFFFAOYSA-N	416794	Racemic 1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethoxy)(pyridin-3-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 48f::US10633345, Compound 48f::US10689346, Compound 48f::US11203574, Compound 48g::US11230530, Compound 48h::US11685721, Compound 48f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416794	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416794&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355617	433916708							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117317	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C30H25F4N5O2/c31-24-11-10-22(28(41-17-19-4-5-19)21-8-6-18(15-35)7-9-21)13-25(24)37-29(40)26-14-27(30(32,33)34)38-39(26)23-3-1-2-20(12-23)16-36/h1-3,6-14,19,28H,4-5,16-17,36H2,(H,37,40)	WXFHQCUXOOXGLO-UHFFFAOYSA-N	416894	1-(3-(aminomethyl)phenyl)-N-(5-((4-cyanophenyl)(cyclopropylmethoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 55b::US10633345, Compound 73b::US10689346, Compound 55b::US11203574, Compound 73b::US11230530, Compound 73b::US11685721, Compound 73b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416894	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416894&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665569	433916807							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117318	CN1CCCN(CC1)C(CCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H36F4N6O/c1-38-12-3-13-39(15-14-38)26(11-8-20-6-7-20)22-9-10-24(31)25(17-22)36-29(41)27-18-28(30(32,33)34)37-40(27)23-5-2-4-21(16-23)19-35/h2,4-5,9-10,16-18,20,26H,3,6-8,11-15,19,35H2,1H3,(H,36,41)	WXRMFESIILBOBA-UHFFFAOYSA-N	416951	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(4-methyl-1,4-diazepan-1-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 251e::US10633345, Compound 251e::US10689346, Compound 251e::US11203574, Compound 251e::US11230530, Compound 251e::US11685721, Compound 251e	Plasma kallikrein		 75.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416951	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416951&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355664	433916863							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117319	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H25F4N5O2/c29-22-9-8-19(26(39-16-17-6-7-17)20-4-2-10-34-15-20)12-23(22)35-27(38)24-13-25(28(30,31)32)36-37(24)21-5-1-3-18(11-21)14-33/h1-5,8-13,15,17,26H,6-7,14,16,33H2,(H,35,38)	CNAFOXQNPWSINI-UHFFFAOYSA-N	416794	Racemic 1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethoxy)(pyridin-3-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 48f::US10633345, Compound 48f::US10689346, Compound 48f::US11203574, Compound 48g::US11230530, Compound 48h::US11685721, Compound 48f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416794	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416794&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355617	433916708							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117320	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C30H25F4N5O2/c31-24-11-10-22(28(41-17-19-4-5-19)21-8-6-18(15-35)7-9-21)13-25(24)37-29(40)26-14-27(30(32,33)34)38-39(26)23-3-1-2-20(12-23)16-36/h1-3,6-14,19,28H,4-5,16-17,36H2,(H,37,40)	WXFHQCUXOOXGLO-UHFFFAOYSA-N	416894	1-(3-(aminomethyl)phenyl)-N-(5-((4-cyanophenyl)(cyclopropylmethoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 55b::US10633345, Compound 73b::US10689346, Compound 55b::US11203574, Compound 73b::US11230530, Compound 73b::US11685721, Compound 73b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416894	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416894&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665569	433916807							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117321	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)N1C(=O)CCC1=O)C(F)(F)F	InChI=1S/C28H27F4N5O3/c29-20-8-7-18(22(9-6-16-4-5-16)36-25(38)10-11-26(36)39)13-21(20)34-27(40)23-14-24(28(30,31)32)35-37(23)19-3-1-2-17(12-19)15-33/h1-3,7-8,12-14,16,22H,4-6,9-11,15,33H2,(H,34,40)	ZAWTZVLCOQSDBX-UHFFFAOYSA-N	416954	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(2,5-dioxopyrrolidin-1-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 260b::US10633345, Compound 260b::US10689346, Compound 260b::US11203574, Compound 260b::US11230530, Compound 260b::US11685721, Compound 260b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416954	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416954&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665563	433916866							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117322	COc1ccc2ccccc2c1C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H32F3N5O2/c1-44-29-15-14-23-7-2-3-11-27(23)31(29)32(39-20-21-12-13-21)24-8-5-9-25(17-24)40-33(43)28-18-30(34(35,36)37)41-42(28)26-10-4-6-22(16-26)19-38/h2-11,14-18,21,32,39H,12-13,19-20,38H2,1H3,(H,40,43)	XVOUQCJHWNZPKF-UHFFFAOYSA-N	416841	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2-methoxynaphthalen-1-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 51f::US10633345, Compound 51f::US10689346, Compound 51f::US11203574, Compound 51h::US11230530, Compound 51h::US11685721, Compound 51f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416841	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416841&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356155	433916754							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117323	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C30H25F4N5O2/c31-24-10-9-22(28(41-17-18-7-8-18)21-5-1-3-19(11-21)15-35)13-25(24)37-29(40)26-14-27(30(32,33)34)38-39(26)23-6-2-4-20(12-23)16-36/h1-6,9-14,18,28H,7-8,16-17,36H2,(H,37,40)	LSXFYXGKZDVRTL-UHFFFAOYSA-N	416900	1-(3-(aminomethyl)phenyl)-N-(5-((3-cyanophenyl)(cyclopropyl-methoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 56c::US10633345, Compound 72d::US10689346, Compound 56c::US11203574, Compound 72d::US11230530, Compound 72d::US11685721, Compound 72d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416900	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416900&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356211	433916813							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117324	CS(=O)(=O)NC(CCC1CC1)(c1ccncc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2ccc3ccnc(N)c3c2)C(F)(F)F)c1	InChI=1S/C32H29F4N7O3S/c1-47(45,46)42-31(12-8-19-2-3-19,21-10-13-38-14-11-21)22-5-7-25(33)26(16-22)40-30(44)27-18-28(32(34,35)36)41-43(27)23-6-4-20-9-15-39-29(37)24(20)17-23/h4-7,9-11,13-19,42H,2-3,8,12H2,1H3,(H2,37,39)(H,40,44)	WOIASLBXHIHYRY-UHFFFAOYSA-N	416957	(+-)-1-(1-aminoisoquinolin-7-yl)-N-(5-(3-cyclopropyl-1-(methylsulfonamido)-1-(pyridin-4-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 262f::US10633345, Compound 262f::US10689346, Compound 262f::US11192861, Compound 262f::US11230530, Compound 262f::US11685721, Compound 262f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416957	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416957&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355636	433916869							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117325	COc1ccc2ccccc2c1C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H32F3N5O2/c1-44-29-15-14-23-7-2-3-11-27(23)31(29)32(39-20-21-12-13-21)24-8-5-9-25(17-24)40-33(43)28-18-30(34(35,36)37)41-42(28)26-10-4-6-22(16-26)19-38/h2-11,14-18,21,32,39H,12-13,19-20,38H2,1H3,(H,40,43)	XVOUQCJHWNZPKF-UHFFFAOYSA-N	416841	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2-methoxynaphthalen-1-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 51f::US10633345, Compound 51f::US10689346, Compound 51f::US11203574, Compound 51h::US11230530, Compound 51h::US11685721, Compound 51f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416841	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416841&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356155	433916754							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117326	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C30H25F4N5O2/c31-24-10-9-22(28(41-17-18-7-8-18)21-5-1-3-19(11-21)15-35)13-25(24)37-29(40)26-14-27(30(32,33)34)38-39(26)23-6-2-4-20(12-23)16-36/h1-6,9-14,18,28H,7-8,16-17,36H2,(H,37,40)	LSXFYXGKZDVRTL-UHFFFAOYSA-N	416900	1-(3-(aminomethyl)phenyl)-N-(5-((3-cyanophenyl)(cyclopropyl-methoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 56c::US10633345, Compound 72d::US10689346, Compound 56c::US11203574, Compound 72d::US11230530, Compound 72d::US11685721, Compound 72d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416900	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416900&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356211	433916813							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117327	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccc(=O)[nH]c1=O)C(F)(F)F			416960	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 263d::US10633345, Compound 263d::US10689346, Compound 263d::US11203574, Compound 263d::US11230530, Compound 263d::US11685721, Compound 263d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416960	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416960&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			154584232	433916872							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117328	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-25(37(36-26)24-9-1-4-19(12-24)16-33)28(38)35-23-8-3-6-21(14-23)27(39-17-18-10-11-18)20-5-2-7-22(34)13-20/h1-9,12-15,18,27H,10-11,16-17,33-34H2,(H,35,38)	FPQYUIIRVBKUDH-UHFFFAOYSA-N	416867	1-(3-(aminomethyl)phenyl)-N-(3-((3-aminophenyl)(cyclopropyl-methoxy)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 53f::US10633345, Compound 53f::US10689346, Compound 53f::US11203574, Compound 64b::US11230530, Compound 64b::US11685721, Compound 49j	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416867	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416867&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355845	433916780							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117329	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1O)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-11-10-19(27(35-16-17-8-9-17)21-6-1-2-7-25(21)39)13-23(22)36-28(40)24-14-26(29(31,32)33)37-38(24)20-5-3-4-18(12-20)15-34/h1-7,10-14,17,27,35,39H,8-9,15-16,34H2,(H,36,40)	CKWWRAGQIQAYTL-UHFFFAOYSA-N	416856	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(2-hydroxyphenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 60e::US10633345, Compound 66b::US10689346, Compound 60e::US11203574, Compound 66b::US11230530, Compound 66b::US11685721, Compound 60e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416856	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416856&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665480	433916769							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117330	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1ccc(cc1F)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-23-14-21(27(39-17-18-9-10-18)20-6-2-1-3-7-20)11-12-24(23)35-28(38)25-15-26(29(31,32)33)36-37(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27H,9-10,16-17,34H2,(H,35,38)	HBXVQXKJLUQKAE-UHFFFAOYSA-N	416963	1-(3-(aminomethyl)phenyl)-N-(4-((cyclopropylmethoxy)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 15g::US10633345, Compound 15g::US10689346, Compound 15g::US11203574, Compound 15g::US11230530, Compound 15g::US11685721, Compound 15g	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416963	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416963&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355605	433916875							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117331	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-25(37(36-26)24-9-1-4-19(12-24)16-33)28(38)35-23-8-3-6-21(14-23)27(39-17-18-10-11-18)20-5-2-7-22(34)13-20/h1-9,12-15,18,27H,10-11,16-17,33-34H2,(H,35,38)	FPQYUIIRVBKUDH-UHFFFAOYSA-N	416867	1-(3-(aminomethyl)phenyl)-N-(3-((3-aminophenyl)(cyclopropyl-methoxy)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 53f::US10633345, Compound 53f::US10689346, Compound 53f::US11203574, Compound 64b::US11230530, Compound 64b::US11685721, Compound 49j	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416867	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416867&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355845	433916780							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117332	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1O)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-11-10-19(27(35-16-17-8-9-17)21-6-1-2-7-25(21)39)13-23(22)36-28(40)24-14-26(29(31,32)33)37-38(24)20-5-3-4-18(12-20)15-34/h1-7,10-14,17,27,35,39H,8-9,15-16,34H2,(H,36,40)	CKWWRAGQIQAYTL-UHFFFAOYSA-N	416856	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(2-hydroxyphenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 60e::US10633345, Compound 66b::US10689346, Compound 60e::US11203574, Compound 66b::US11230530, Compound 66b::US11685721, Compound 60e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416856	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416856&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665480	433916769							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117333	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1ccc(cc1F)C(O)c1ccccc1)C(F)(F)F	InChI=1S/C25H20F4N4O2/c26-19-12-17(23(34)16-6-2-1-3-7-16)9-10-20(19)31-24(35)21-13-22(25(27,28)29)32-33(21)18-8-4-5-15(11-18)14-30/h1-13,23,34H,14,30H2,(H,31,35)	WVBOXESRKOBMTK-UHFFFAOYSA-N	416966	1-(3-(Aminomethyl)phenyl)-N-(2-fluoro-4-(hydroxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 16b::US10633345, Compound 16b::US10689346, Compound 16b::US11203574, Compound 16b::US11230530, Compound 16b::US11685721, Compound 16b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416966	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416966&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665483	433916878							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117334	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1O)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-24(37(36-26)22-8-3-5-19(13-22)16-33)28(39)35-21-7-4-6-20(14-21)27(34-17-18-11-12-18)23-9-1-2-10-25(23)38/h1-10,13-15,18,27,34,38H,11-12,16-17,33H2,(H,35,39)	PCNDJIQOMLHSEK-UHFFFAOYSA-N	416837	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2-hydroxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 49h::US10633345, Compound 49h::US10689346, Compound 49h::US11203574, Compound 49j::US11230530, Compound 49j::US11685721, Compound 49h	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416837	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416837&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355733	433916750							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117335	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-23-12-11-21(27(39-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)35-28(38)25-15-26(29(31,32)33)36-37(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27H,9-10,16-17,34H2,(H,35,38)	HIMJVDQVZQMIPM-UHFFFAOYSA-N	416747	1-(3-(Aminomethyl)phenyl)-N-(5-((cyclopropylmethoxy)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 34c::US10633345, Compound 34c::US10689346, Compound 34c::US11203574, Compound 37a::US11230530, Compound 37a::US11685721, Compound 34c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416747	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416747&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355729	433916661							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117336	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1c(F)cccc1C(O)c1ccccc1)C(F)(F)F	InChI=1S/C25H20F4N4O2/c26-19-11-5-10-18(23(34)16-7-2-1-3-8-16)22(19)31-24(35)20-13-21(25(27,28)29)32-33(20)17-9-4-6-15(12-17)14-30/h1-13,23,34H,14,30H2,(H,31,35)	PIMJYQUHLMMZIO-UHFFFAOYSA-N	416969	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-6-(hydroxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 90f::US10633345, Compound 90f::US10689346, Compound 90f::US11203574, Compound 90f::US11230530, Compound 90f::US11685721, Compound 90f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416969	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416969&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356272	433916881							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120089	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NC1CCCCCC1)c1ccccc1)C(F)(F)F	InChI=1S/C32H34F3N5O/c33-32(34,35)29-20-28(40(39-29)27-17-8-10-22(18-27)21-36)31(41)38-26-16-9-13-24(19-26)30(23-11-4-3-5-12-23)37-25-14-6-1-2-7-15-25/h3-5,8-13,16-20,25,30,37H,1-2,6-7,14-15,21,36H2,(H,38,41)	DQWBWUNYPIEFTF-UHFFFAOYSA-N	416883	1-(3-(aminomethyl)phenyl)-N-(3-((cycloheptylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 171b::US10633345, Compound 171b::US10689346, Compound 171b::US11203574, Compound 171b::US11230530, Compound 171b::US11685721, Compound 171b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416883	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416883&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356134	433916796							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120090	Cc1ccccc1C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O/c1-19-6-2-3-11-25(19)28(35-18-20-12-13-20)22-8-5-9-23(15-22)36-29(39)26-16-27(30(31,32)33)37-38(26)24-10-4-7-21(14-24)17-34/h2-11,14-16,20,28,35H,12-13,17-18,34H2,1H3,(H,36,39)	NQOSRSVLDYDVDI-UHFFFAOYSA-N	416884	1-(3-(Aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(o-tolyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 193f::US10633345, Compound 193f::US10689346, Compound 193f::US11203574, Compound 193f::US11230530, Compound 193f::US11685721, Compound 193f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416884	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416884&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355753	433916797							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120091	NCc1cccc(c1)C(NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F4N6O/c31-24-10-9-22(28(37-17-18-7-8-18)21-5-1-3-19(11-21)15-35)13-25(24)38-29(41)26-14-27(30(32,33)34)39-40(26)23-6-2-4-20(12-23)16-36/h1-6,9-14,18,28,37H,7-8,15-17,35-36H2,(H,38,41)	PIDHZVXEDSCGNA-UHFFFAOYSA-N	416885	1-(3-(aminomethyl)phenyl)-N-(5-((3-(aminomethyl)phenyl)(cyclopropylmethylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 155c::US10633345, Compound 155c::US10689346, Compound 155c::US11203574, Compound 155c::US11230530, Compound 155c::US11685721, Compound 155c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416885	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416885&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355611	433916798							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120092	CCCCCNC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H32F3N5O/c1-2-3-7-16-35-28(22-11-5-4-6-12-22)23-13-9-14-24(18-23)36-29(39)26-19-27(30(31,32)33)37-38(26)25-15-8-10-21(17-25)20-34/h4-6,8-15,17-19,28,35H,2-3,7,16,20,34H2,1H3,(H,36,39)	LIINXFZWPJSNHF-UHFFFAOYSA-N	416886	1-(3-(Aminomethyl)phenyl)-N-(3-((pentylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 172b::US10633345, Compound 172b::US10689346, Compound 172b::US11203574, Compound 172b::US11230530, Compound 172b::US11685721, Compound 172b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416886	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416886&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355915	433916799							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120093	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCCCO)c1ccccc1)C(F)(F)F	InChI=1S/C28H28F3N5O2/c29-28(30,31)25-17-24(36(35-25)23-12-4-7-19(15-23)18-32)27(38)34-22-11-5-10-21(16-22)26(33-13-6-14-37)20-8-2-1-3-9-20/h1-5,7-12,15-17,26,33,37H,6,13-14,18,32H2,(H,34,38)	YSEURYDLGGVADI-UHFFFAOYSA-N	416887	1-(3-(Aminomethyl)phenyl)-N-(3-(((3-hydroxypropyl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 191b::US10633345, Compound 191b::US10689346, Compound 191b::US11203574, Compound 191b::US11230530, Compound 191b::US11685721, Compound 191b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416887	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416887&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665847	433916800							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120094	COC(CCC1CC1)(c1cccnc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O2/c1-40-29(13-12-20-10-11-20,23-7-4-14-35-19-23)22-6-3-8-24(16-22)36-28(39)26-17-27(30(31,32)33)37-38(26)25-9-2-5-21(15-25)18-34/h2-9,14-17,19-20H,10-13,18,34H2,1H3,(H,36,39)	HEQLXMARFGMGBQ-UHFFFAOYSA-N	416888	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-methoxy-1-(pyridin-3-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 156c::US10633345, Compound 156c::US10689346, Compound 156c::US11203574, Compound 156c::US11230530, Compound 156c::US11685721, Compound 156c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416888	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416888&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355759	433916801							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120095	CC(CO)NC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C28H28F3N5O2/c1-18(17-37)33-26(20-8-3-2-4-9-20)21-10-6-11-22(14-21)34-27(38)24-15-25(28(29,30)31)35-36(24)23-12-5-7-19(13-23)16-32/h2-15,18,26,33,37H,16-17,32H2,1H3,(H,34,38)	HGDYIKLNDBPRGN-UHFFFAOYSA-N	416889	1-(3-(aminomethyl)phenyl)-N-(3-(((1-hydroxypropan-2-yl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 173b::US10633345, Compound 173b::US10689346, Compound 173b::US11203574, Compound 173b::US11230530, Compound 173b::US11685721, Compound 173b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416889	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416889&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355997	433916802							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120096	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc(F)c1)C(F)(F)F	InChI=1S/C29H27F4N5O/c30-22-7-2-5-20(13-22)27(35-17-18-10-11-18)21-6-3-8-23(14-21)36-28(39)25-15-26(29(31,32)33)37-38(25)24-9-1-4-19(12-24)16-34/h1-9,12-15,18,27,35H,10-11,16-17,34H2,(H,36,39)	FVMNYLZQOFMPFE-UHFFFAOYSA-N	416890	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(3-fluorophenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 195f::US10633345, Compound 195f::US10689346, Compound 195f::US11203574, Compound 195f::US11230530, Compound 195f::US11685721, Compound 195f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416890	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416890&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665561	433916803							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120097	CN(C(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1)C1CC1	InChI=1S/C30H26F4N6O/c1-39(22-9-10-22)28(20-6-2-4-18(12-20)16-35)21-8-11-24(31)25(14-21)37-29(41)26-15-27(30(32,33)34)38-40(26)23-7-3-5-19(13-23)17-36/h2-8,11-15,22,28H,9-10,17,36H2,1H3,(H,37,41)	LONUELZOBAIWEW-UHFFFAOYSA-N	439471	US10633345, Compound 54e::US10633345, Compound 70a::US10633345, Compound 70b::US10689346, Compound 70a::US11203574, Compound 70b::US11230530, Compound 70b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439471	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439471&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355805	439661023							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120098	CC(C)(CO)NC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C29H30F3N5O2/c1-28(2,18-38)35-26(20-9-4-3-5-10-20)21-11-7-12-22(15-21)34-27(39)24-16-25(29(30,31)32)36-37(24)23-13-6-8-19(14-23)17-33/h3-16,26,35,38H,17-18,33H2,1-2H3,(H,34,39)	JPSBLISQAZCRFK-UHFFFAOYSA-N	416892	1-(3-(aminomethyl)phenyl)-N-(3-(((1-hydroxy-2-methylpropan-2-yl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 174b::US10633345, Compound 174b::US10689346, Compound 174b::US11203574, Compound 174b::US11230530, Compound 174b::US11685721, Compound 174b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416892	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416892&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665949	433916805							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120099	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(F)cc1F)C(F)(F)F	InChI=1S/C29H26F5N5O/c30-20-9-10-23(24(31)13-20)27(36-16-17-7-8-17)19-4-2-5-21(12-19)37-28(40)25-14-26(29(32,33)34)38-39(25)22-6-1-3-18(11-22)15-35/h1-6,9-14,17,27,36H,7-8,15-16,35H2,(H,37,40)	QIBXOBBXVAEMNW-UHFFFAOYSA-N	416893	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2,4-difluorophenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 196f::US10633345, Compound 196f::US10689346, Compound 196f::US11203574, Compound 196f::US11230530, Compound 196f::US11685721, Compound 196f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416893	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416893&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665453	433916806							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120100	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C30H25F4N5O2/c31-24-11-10-22(28(41-17-19-4-5-19)21-8-6-18(15-35)7-9-21)13-25(24)37-29(40)26-14-27(30(32,33)34)38-39(26)23-3-1-2-20(12-23)16-36/h1-3,6-14,19,28H,4-5,16-17,36H2,(H,37,40)	WXFHQCUXOOXGLO-UHFFFAOYSA-N	416894	1-(3-(aminomethyl)phenyl)-N-(5-((4-cyanophenyl)(cyclopropylmethoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 55b::US10633345, Compound 73b::US10689346, Compound 55b::US11203574, Compound 73b::US11230530, Compound 73b::US11685721, Compound 73b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416894	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416894&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665569	433916807							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120101	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CCCO1)c1ccccc1)C(F)(F)F	InChI=1S/C30H30F3N5O2/c31-30(32,33)27-17-26(38(37-27)24-12-4-7-20(15-24)18-34)29(39)36-23-11-5-10-22(16-23)28(21-8-2-1-3-9-21)35-19-25-13-6-14-40-25/h1-5,7-12,15-17,25,28,35H,6,13-14,18-19,34H2,(H,36,39)	SIOCTSAXUSNOCO-UHFFFAOYSA-N	416895	1-(3-(aminomethyl)phenyl)-N-(3-(phenyl(((tetrahydrofuran-2-yl)methyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 175b::US10633345, Compound 175b::US10689346, Compound 175b::US11203574, Compound 175b::US11230530, Compound 175b::US11685721, Compound 175b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416895	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416895&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355976	433916808							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120102	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cc(F)ccc1F)C(F)(F)F	InChI=1S/C29H26F5N5O/c30-20-9-10-24(31)23(13-20)27(36-16-17-7-8-17)19-4-2-5-21(12-19)37-28(40)25-14-26(29(32,33)34)38-39(25)22-6-1-3-18(11-22)15-35/h1-6,9-14,17,27,36H,7-8,15-16,35H2,(H,37,40)	DGRITJGAWATINU-UHFFFAOYSA-N	416896	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2,5-difluorophenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 197f::US10633345, Compound 197f::US10689346, Compound 197f::US11203574, Compound 197f::US11230530, Compound 197f::US11685721, Compound 197f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416896	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416896&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665599	433916809							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120103	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-9-8-20(28(40,11-10-18-6-7-18)21-4-2-12-35-17-21)14-24(23)36-27(39)25-15-26(29(31,32)33)37-38(25)22-5-1-3-19(13-22)16-34/h1-5,8-9,12-15,17-18,40H,6-7,10-11,16,34H2,(H,36,39)	VCHFZCHUEHQXSZ-UHFFFAOYSA-N	416897	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 58c::US10633345, Compound 67b::US10689346, Compound 67b::US11203574, Compound 67b::US11230530, Compound 67b::US11685721, Compound 67b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416897	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416897&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355889	433916810							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120104	CC(C)CCNC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H32F3N5O/c1-20(2)14-15-35-28(22-9-4-3-5-10-22)23-11-7-12-24(17-23)36-29(39)26-18-27(30(31,32)33)37-38(26)25-13-6-8-21(16-25)19-34/h3-13,16-18,20,28,35H,14-15,19,34H2,1-2H3,(H,36,39)	WPCVSFNABLNPTN-UHFFFAOYSA-N	416898	1-(3-(aminomethyl)phenyl)-N-(3-((isopentylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 176b::US10633345, Compound 176b::US10689346, Compound 176b::US11203574, Compound 176b::US11230530, Compound 176b::US11685721, Compound 176b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416898	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416898&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665776	433916811							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120105	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1c(F)cccc1F)C(F)(F)F	InChI=1S/C29H26F5N5O/c30-22-8-3-9-23(31)26(22)27(36-16-17-10-11-17)19-5-2-6-20(13-19)37-28(40)24-14-25(29(32,33)34)38-39(24)21-7-1-4-18(12-21)15-35/h1-9,12-14,17,27,36H,10-11,15-16,35H2,(H,37,40)	OHXCNQRJQHLAER-UHFFFAOYSA-N	416899	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2,6-difluorophenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 198f::US10633345, Compound 198f::US10689346, Compound 198f::US11203574, Compound 198f::US11230530, Compound 198f::US11685721, Compound 198f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416899	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416899&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665643	433916812							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120106	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C30H25F4N5O2/c31-24-10-9-22(28(41-17-18-7-8-18)21-5-1-3-19(11-21)15-35)13-25(24)37-29(40)26-14-27(30(32,33)34)38-39(26)23-6-2-4-20(12-23)16-36/h1-6,9-14,18,28H,7-8,16-17,36H2,(H,37,40)	LSXFYXGKZDVRTL-UHFFFAOYSA-N	416900	1-(3-(aminomethyl)phenyl)-N-(5-((3-cyanophenyl)(cyclopropyl-methoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 56c::US10633345, Compound 72d::US10689346, Compound 56c::US11203574, Compound 72d::US11230530, Compound 72d::US11685721, Compound 72d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416900	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416900&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356211	433916813							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120107	CCC(C)CNC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H32F3N5O/c1-3-20(2)19-35-28(22-10-5-4-6-11-22)23-12-8-13-24(16-23)36-29(39)26-17-27(30(31,32)33)37-38(26)25-14-7-9-21(15-25)18-34/h4-17,20,28,35H,3,18-19,34H2,1-2H3,(H,36,39)	ZCSNRDNUIRVYLS-UHFFFAOYSA-N	416901	1-(3-(Aminomethyl)phenyl)-N-(3-(((2-methylbutyl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 177b::US10633345, Compound 177b::US10689346, Compound 177b::US11203574, Compound 177b::US11230530, Compound 177b::US11685721, Compound 177b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416901	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416901&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665478	433916814							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120108	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1Cl)C(F)(F)F	InChI=1S/C29H27ClF3N5O/c30-24-10-2-1-9-23(24)27(35-17-18-11-12-18)20-6-4-7-21(14-20)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-3-5-19(13-22)16-34/h1-10,13-15,18,27,35H,11-12,16-17,34H2,(H,36,39)	UQMCUIGBQDUSLW-UHFFFAOYSA-N	416902	1-(3-(aminomethyl)phenyl)-N-(3-((2-chlorophenyl)((cyclopropylmethyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 194f::US10329260, Compound 199f::US10633345, Compound 199f::US10689346, Compound 199f::US11203574, Compound 199f::US11230530, Compound 199f::US11685721, Compound 199f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416902	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416902&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356220	433916815							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120109	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H28F4N4O2/c31-24-12-11-22(29(40,14-13-19-9-10-19)21-6-2-1-3-7-21)16-25(24)36-28(39)26-17-27(30(32,33)34)37-38(26)23-8-4-5-20(15-23)18-35/h1-8,11-12,15-17,19,40H,9-10,13-14,18,35H2,(H,36,39)	NIWMWYNGSALJGG-UHFFFAOYSA-N	416903	Racemic 1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 68c::US10633345, Compound 68e::US10689346, Compound 68c::US11203574, Compound 68e::US11230530, Compound 68e::US11685721, Compound 68e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416903	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416903&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355758	433916816							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120110	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(N(CCO)CCO)c1ccccc1)C(F)(F)F	InChI=1S/C29H30F3N5O3/c30-29(31,32)26-18-25(37(35-26)24-11-4-6-20(16-24)19-33)28(40)34-23-10-5-9-22(17-23)27(21-7-2-1-3-8-21)36(12-14-38)13-15-39/h1-11,16-18,27,38-39H,12-15,19,33H2,(H,34,40)	HFRFNKSEVVNXFK-UHFFFAOYSA-N	416904	1-(3-(aminomethyl)phenyl)-N-(3-((bis(2-hydroxyethyl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 178b::US10633345, Compound 178b::US10689346, Compound 178b::US11203574, Compound 178b::US11230530, Compound 178b::US11685721, Compound 178b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416904	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416904&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355913	433916817							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120111	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1Cl)C(F)(F)F	InChI=1S/C29H27ClF3N5O/c30-24-10-2-1-9-23(24)27(35-17-18-11-12-18)20-6-4-7-21(14-20)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-3-5-19(13-22)16-34/h1-10,13-15,18,27,35H,11-12,16-17,34H2,(H,36,39)	UQMCUIGBQDUSLW-UHFFFAOYSA-N	416902	1-(3-(aminomethyl)phenyl)-N-(3-((2-chlorophenyl)((cyclopropylmethyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 194f::US10329260, Compound 199f::US10633345, Compound 199f::US10689346, Compound 199f::US11203574, Compound 199f::US11230530, Compound 199f::US11685721, Compound 199f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416902	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416902&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356220	433916815							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120112	COc1ccc2ccccc2c1C(NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H31F4N5O2/c1-45-29-14-12-22-6-2-3-8-25(22)31(29)32(40-19-20-9-10-20)23-11-13-26(35)27(16-23)41-33(44)28-17-30(34(36,37)38)42-43(28)24-7-4-5-21(15-24)18-39/h2-8,11-17,20,32,40H,9-10,18-19,39H2,1H3,(H,41,44)	AYMFYNZEWAELBE-UHFFFAOYSA-N	416906	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(2-methoxynaphthalen-1-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide dihydrochloride::US10329260, Compound 61e::US10633345, Compound 63b::US10689346, Compound 61e::US11203574, Compound 63b::US11230530, Compound 63b::US11685721, Compound 63b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416906	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416906&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355591	433916818							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120113	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCc1cccnc1)c1ccccc1)C(F)(F)F	InChI=1S/C31H27F3N6O/c32-31(33,34)28-17-27(40(39-28)26-13-4-7-21(15-26)18-35)30(41)38-25-12-5-11-24(16-25)29(23-9-2-1-3-10-23)37-20-22-8-6-14-36-19-22/h1-17,19,29,37H,18,20,35H2,(H,38,41)	HIJVXEVWORHKBX-UHFFFAOYSA-N	416907	1-(3-(Aminomethyl)phenyl)-N-(3-(phenyl((pyridin-3-ylmethyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 179b::US10633345, Compound 179b::US10689346, Compound 179b::US11203574, Compound 179b::US11230530, Compound 179b::US11685721, Compound 179b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416907	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416907&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665526	433916819							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120114	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(Cl)cc1Cl)C(F)(F)F	InChI=1S/C29H26Cl2F3N5O/c30-20-9-10-23(24(31)13-20)27(36-16-17-7-8-17)19-4-2-5-21(12-19)37-28(40)25-14-26(29(32,33)34)38-39(25)22-6-1-3-18(11-22)15-35/h1-6,9-14,17,27,36H,7-8,15-16,35H2,(H,37,40)	CXLXHJIZVQBZJV-UHFFFAOYSA-N	416908	1-(3-(aminomethyl)phenyl)-N-(3-((2,4-dichlorophenyl)((cyclopropylmethyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 200f::US10633345, Compound 200f::US10689346, Compound 200f::US11203574, Compound 200f::US11230530, Compound 200f::US11685721, Compound 200f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416908	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416908&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126688969	433916820							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120115	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-10-9-20(28(40,12-11-18-7-8-18)25-6-1-2-13-35-25)15-23(22)36-27(39)24-16-26(29(31,32)33)37-38(24)21-5-3-4-19(14-21)17-34/h1-6,9-10,13-16,18,40H,7-8,11-12,17,34H2,(H,36,39)	XXMBQXWQIGCREG-UHFFFAOYSA-N	416909	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 59c::US10633345, Compound 69b::US10689346, Compound 59c::US11203574, Compound 69b::US11230530, Compound 69b::US11685721, Compound 69b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416909	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416909&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356067	433916821							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120116	CCCCNC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C29H30F3N5O/c1-2-3-15-34-27(21-10-5-4-6-11-21)22-12-8-13-23(17-22)35-28(38)25-18-26(29(30,31)32)36-37(25)24-14-7-9-20(16-24)19-33/h4-14,16-18,27,34H,2-3,15,19,33H2,1H3,(H,35,38)	IJFOMNKWJBCMSK-UHFFFAOYSA-N	416910	1-(3-(Aminomethyl)phenyl)-N-(3-((butylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 180b::US10633345, Compound 180b::US10689346, Compound 180b::US11203574, Compound 180b::US11230530, Compound 180b::US11685721, Compound 180b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416910	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416910&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665986	433916822							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120117	Cc1ccc(C(NCC2CC2)c2cccc(c2)-c2c(nn(c2C(N)=O)-c2cccc(CN)c2)C(F)(F)F)c(C)c1	InChI=1S/C31H32F3N5O/c1-18-9-12-25(19(2)13-18)27(37-17-20-10-11-20)23-7-4-6-22(15-23)26-28(30(36)40)39(38-29(26)31(32,33)34)24-8-3-5-21(14-24)16-35/h3-9,12-15,20,27,37H,10-11,16-17,35H2,1-2H3,(H2,36,40)	IKSMIEJRTWWXFV-UHFFFAOYSA-N	529728	US11203574, Compound 201f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=529728	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=529728&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156066657	463793250							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120118	Cc1ccc(C)c(c1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C31H32F3N5O/c1-19-9-10-20(2)26(13-19)29(36-18-21-11-12-21)23-6-4-7-24(15-23)37-30(40)27-16-28(31(32,33)34)38-39(27)25-8-3-5-22(14-25)17-35/h3-10,13-16,21,29,36H,11-12,17-18,35H2,1-2H3,(H,37,40)	NFGQIHGOUUFZHN-UHFFFAOYSA-N	416912	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2,5-dimethylphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 202f::US10633345, Compound 202f::US10689346, Compound 202f::US11203574, Compound 202f::US11230530, Compound 202f::US11685721, Compound 202f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416912	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416912&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665510	433916824							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120119	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F3N4O2/c30-29(31,32)26-16-25(36(35-26)24-11-4-6-20(14-24)17-33)28(37)34-23-10-5-9-22(15-23)27(38-18-19-12-13-19)21-7-2-1-3-8-21/h1-11,14-16,19,27H,12-13,17-18,33H2,(H,34,37)	PEZVPVUPSJXZCH-UHFFFAOYSA-N	416775	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18k::US10633345, Compound 74a::US10689346, Compound 165e::US11203574, Compound 165e::US11230530, Compound 165e::US11685721, Compound 18k	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416775	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416775&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			91884591	433916689							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120120	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F4N5O/c30-23-12-11-21(27(35-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27,35H,9-10,16-17,34H2,(H,36,39)	MCLZOCFEIKBMBA-UHFFFAOYSA-N	416773	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 38d::US10633345, Compound 38d::US10689346, Compound 42a::US11203574, Compound 42a::US11230530, Compound 42a::US11685721, Compound 38d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416773	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416773&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356124	433916687							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120121	CC(C)(C)c1ccc(cc1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C33H36F3N5O/c1-32(2,3)25-14-12-23(13-15-25)30(38-20-21-10-11-21)24-7-5-8-26(17-24)39-31(42)28-18-29(33(34,35)36)40-41(28)27-9-4-6-22(16-27)19-37/h4-9,12-18,21,30,38H,10-11,19-20,37H2,1-3H3,(H,39,42)	OVDVNIYCGDTOJR-UHFFFAOYSA-N	416915	1-(3-(aminomethyl)phenyl)-N-(3-((4-(tert-butyl)phenyl)((cyclopropylmethyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 203f::US10633345, Compound 203f::US10689346, Compound 203f::US11203574, Compound 203f::US11230530, Compound 203f::US11685721, Compound 203f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416915	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416915&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665458	433916827							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120122	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F3N4O2/c30-29(31,32)26-16-25(36(35-26)24-11-4-6-20(14-24)17-33)28(37)34-23-10-5-9-22(15-23)27(38-18-19-12-13-19)21-7-2-1-3-8-21/h1-11,14-16,19,27H,12-13,17-18,33H2,(H,34,37)	PEZVPVUPSJXZCH-UHFFFAOYSA-N	416775	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18k::US10633345, Compound 74a::US10689346, Compound 165e::US11203574, Compound 165e::US11230530, Compound 165e::US11685721, Compound 18k	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416775	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416775&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			91884591	433916689							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120123	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F4N5O/c30-23-12-11-21(27(35-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27,35H,9-10,16-17,34H2,(H,36,39)	MCLZOCFEIKBMBA-UHFFFAOYSA-N	416773	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 38d::US10633345, Compound 38d::US10689346, Compound 42a::US11203574, Compound 42a::US11230530, Compound 42a::US11685721, Compound 38d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416773	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416773&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356124	433916687							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120124	OC(CCC1CC1)(c1ccc(F)c(NC(=O)c2cc(nn2-c2ccc(Cl)cc2)C(F)(F)F)c1)c1ccccn1	InChI=1S/C28H23ClF4N4O2/c29-19-7-9-20(10-8-19)37-23(16-25(36-37)28(31,32)33)26(38)35-22-15-18(6-11-21(22)30)27(39,13-12-17-4-5-17)24-3-1-2-14-34-24/h1-3,6-11,14-17,39H,4-5,12-13H2,(H,35,38)	QWPFRWIQIFPXCC-UHFFFAOYSA-N	416918	1-(4-chlorophenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 157a::US10633345, Compound 157a::US10689346, Compound 157a::US11203574, Compound 157a::US11230530, Compound 157a::US11685721, Compound 157a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416918	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416918&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665679	433916830							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120125	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(N)cc1)C(F)(F)F	InChI=1S/C29H29F3N6O/c30-29(31,32)26-15-25(38(37-26)24-6-1-3-19(13-24)16-33)28(39)36-23-5-2-4-21(14-23)27(35-17-18-7-8-18)20-9-11-22(34)12-10-20/h1-6,9-15,18,27,35H,7-8,16-17,33-34H2,(H,36,39)	XDCYYWMSVYTRMZ-UHFFFAOYSA-N	416843	1-(3-(aminomethyl)phenyl)-N-(3-((4-aminophenyl)(cyclopropylmethyl-amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 50f::US10633345, Compound 50f::US10689346, Compound 50h::US11203574, Compound 50h::US11230530, Compound 50h::US11685721, Compound 50f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416843	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416843&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355587	433916756							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120126	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-9-8-20(28(40,11-10-18-6-7-18)21-4-2-12-35-17-21)14-24(23)36-27(39)25-15-26(29(31,32)33)37-38(25)22-5-1-3-19(13-22)16-34/h1-5,8-9,12-15,17-18,40H,6-7,10-11,16,34H2,(H,36,39)	VCHFZCHUEHQXSZ-UHFFFAOYSA-N	416897	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 58c::US10633345, Compound 67b::US10689346, Compound 67b::US11203574, Compound 67b::US11230530, Compound 67b::US11685721, Compound 67b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416897	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416897&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355889	433916810							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120127	OC(CCC1CC1)(c1ccc(F)c(NC(=O)c2cc(nn2-c2ccc3cc(Cl)ccc3c2)C(F)(F)F)c1)c1ccccn1	InChI=1S/C32H25ClF4N4O2/c33-23-9-6-21-16-24(10-7-20(21)15-23)41-27(18-29(40-41)32(35,36)37)30(42)39-26-17-22(8-11-25(26)34)31(43,13-12-19-4-5-19)28-3-1-2-14-38-28/h1-3,6-11,14-19,43H,4-5,12-13H2,(H,39,42)	XTIXOVGIMHWYOB-UHFFFAOYSA-N	416921	1-(6-chloronaphthalen-2-yl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 158a::US10633345, Compound 158a::US10689346, Compound 158a::US11203574, Compound 158a::US11230530, Compound 158a::US11685721, Compound 158a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416921	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416921&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355937	433916833							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120128	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(N)cc1)C(F)(F)F	InChI=1S/C29H29F3N6O/c30-29(31,32)26-15-25(38(37-26)24-6-1-3-19(13-24)16-33)28(39)36-23-5-2-4-21(14-23)27(35-17-18-7-8-18)20-9-11-22(34)12-10-20/h1-6,9-15,18,27,35H,7-8,16-17,33-34H2,(H,36,39)	XDCYYWMSVYTRMZ-UHFFFAOYSA-N	416843	1-(3-(aminomethyl)phenyl)-N-(3-((4-aminophenyl)(cyclopropylmethyl-amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 50f::US10633345, Compound 50f::US10689346, Compound 50h::US11203574, Compound 50h::US11230530, Compound 50h::US11685721, Compound 50f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416843	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416843&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355587	433916756							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120129	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-9-8-20(28(40,11-10-18-6-7-18)21-4-2-12-35-17-21)14-24(23)36-27(39)25-15-26(29(31,32)33)37-38(25)22-5-1-3-19(13-22)16-34/h1-5,8-9,12-15,17-18,40H,6-7,10-11,16,34H2,(H,36,39)	VCHFZCHUEHQXSZ-UHFFFAOYSA-N	416897	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 58c::US10633345, Compound 67b::US10689346, Compound 67b::US11203574, Compound 67b::US11230530, Compound 67b::US11685721, Compound 67b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416897	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416897&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355889	433916810							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120130	OC(CCC1CC1)(c1ccc(F)c(NC(=O)c2cc(nn2-c2ccc(Cl)cn2)C(F)(F)F)c1)c1ccccn1	InChI=1S/C27H22ClF4N5O2/c28-18-7-9-24(34-15-18)37-21(14-23(36-37)27(30,31)32)25(38)35-20-13-17(6-8-19(20)29)26(39,11-10-16-4-5-16)22-3-1-2-12-33-22/h1-3,6-9,12-16,39H,4-5,10-11H2,(H,35,38)	HMQODPUNPWDVSN-UHFFFAOYSA-N	416924	1-(5-chloropyridin-2-yl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 159a::US10633345, Compound 159a::US10689346, Compound 159a::US11203574, Compound 159a::US11230530, Compound 159a::US11685721, Compound 159a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416924	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416924&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355989	433916836							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120131	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C28H26F3N5O2/c29-28(30,31)25-15-24(36(35-25)22-8-3-5-19(13-22)16-32)27(37)34-21-7-4-6-20(14-21)26(38-17-18-10-11-18)23-9-1-2-12-33-23/h1-9,12-15,18,26H,10-11,16-17,32H2,(H,34,37)	UBQUVYTUKOFUOF-UHFFFAOYSA-N	416721	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(pyridin-2-yl)methyl)-phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 43f::US10633345, Compound 43f::US10689346, Compound 43g::US11203574, Compound 43h::US11230530, Compound 43h::US11685721, Compound 43f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416721	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416721&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355947	433916635							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120132	CN(C(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1)C1CC1	InChI=1S/C30H26F4N6O/c1-39(22-9-10-22)28(20-6-2-4-18(12-20)16-35)21-8-11-24(31)25(14-21)37-29(41)26-15-27(30(32,33)34)38-40(26)23-7-3-5-19(13-23)17-36/h2-8,11-15,22,28H,9-10,17,36H2,1H3,(H,37,41)	LONUELZOBAIWEW-UHFFFAOYSA-N	439471	US10633345, Compound 54e::US10633345, Compound 70a::US10633345, Compound 70b::US10689346, Compound 70a::US11203574, Compound 70b::US11230530, Compound 70b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439471	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439471&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355805	439661023							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120133	COc1ccc(cc1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H26F4N4O3/c1-40-21-10-8-20(9-11-21)37-24(17-26(36-37)29(31,32)33)27(38)35-23-16-19(7-12-22(23)30)28(39,14-13-18-5-6-18)25-4-2-3-15-34-25/h2-4,7-12,15-18,39H,5-6,13-14H2,1H3,(H,35,38)	YTPYYUUEYRYYOR-UHFFFAOYSA-N	416927	N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-1-(4-methoxyphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 160a::US10633345, Compound 160a::US10689346, Compound 160a::US11203574, Compound 160a::US11230530, Compound 160a::US11685721, Compound 160a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416927	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416927&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665840	433916839							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120134	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C28H26F3N5O2/c29-28(30,31)25-15-24(36(35-25)22-8-3-5-19(13-22)16-32)27(37)34-21-7-4-6-20(14-21)26(38-17-18-10-11-18)23-9-1-2-12-33-23/h1-9,12-15,18,26H,10-11,16-17,32H2,(H,34,37)	UBQUVYTUKOFUOF-UHFFFAOYSA-N	416721	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(pyridin-2-yl)methyl)-phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 43f::US10633345, Compound 43f::US10689346, Compound 43g::US11203574, Compound 43h::US11230530, Compound 43h::US11685721, Compound 43f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416721	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416721&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355947	433916635							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120135	CN(C(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1)C1CC1	InChI=1S/C30H26F4N6O/c1-39(22-9-10-22)28(20-6-2-4-18(12-20)16-35)21-8-11-24(31)25(14-21)37-29(41)26-15-27(30(32,33)34)38-40(26)23-7-3-5-19(13-23)17-36/h2-8,11-15,22,28H,9-10,17,36H2,1H3,(H,37,41)	LONUELZOBAIWEW-UHFFFAOYSA-N	439471	US10633345, Compound 54e::US10633345, Compound 70a::US10633345, Compound 70b::US10689346, Compound 70a::US11203574, Compound 70b::US11230530, Compound 70b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439471	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439471&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355805	439661023							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120136	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(O)c(Br)c1)C(F)(F)F	InChI=1S/C29H27BrF3N5O2/c30-23-13-20(9-10-25(23)39)27(35-16-17-7-8-17)19-4-2-5-21(12-19)36-28(40)24-14-26(29(31,32)33)37-38(24)22-6-1-3-18(11-22)15-34/h1-6,9-14,17,27,35,39H,7-8,15-16,34H2,(H,36,40)	VZKYGMDBRSVHHT-UHFFFAOYSA-N	416930	1-(3-(Aminomethyl)phenyl)-N-(3-((3-bromo-4-hydroxyphenyl)(cyclopropylmethylamino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 207j::US10633345, Compound 207j::US10689346, Compound 207j::US11203574, Compound 207j::US11230530, Compound 207j::US11685721, Compound 207j	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416930	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416930&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665574	433916842							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120137	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H26F3N5O2/c29-28(30,31)25-14-24(36(35-25)23-8-1-4-19(12-23)15-32)27(37)34-22-7-2-5-20(13-22)26(38-17-18-9-10-18)21-6-3-11-33-16-21/h1-8,11-14,16,18,26H,9-10,15,17,32H2,(H,34,37)	SHFRWTHPPCXLER-UHFFFAOYSA-N	416725	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(pyridin-3-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 44c::US10633345, Compound 44c::US10689346, Compound 44c::US11203574, Compound 44d::US11230530, Compound 44e::US11685721, Compound 44c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416725	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416725&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355578	433916639							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120138	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-10-9-20(28(40,12-11-18-7-8-18)25-6-1-2-13-35-25)15-23(22)36-27(39)24-16-26(29(31,32)33)37-38(24)21-5-3-4-19(14-21)17-34/h1-6,9-10,13-16,18,40H,7-8,11-12,17,34H2,(H,36,39)	XXMBQXWQIGCREG-UHFFFAOYSA-N	416909	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 59c::US10633345, Compound 69b::US10689346, Compound 59c::US11203574, Compound 69b::US11230530, Compound 69b::US11685721, Compound 69b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416909	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416909&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356067	433916821							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120139	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CCC1CC1)n1ccccc1=O)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-17-25(37(35-26)23-8-3-5-20(15-23)18-33)28(39)34-22-7-4-6-21(16-22)24(13-12-19-10-11-19)36-14-2-1-9-27(36)38/h1-9,14-17,19,24H,10-13,18,33H2,(H,34,39)	OGNFHFCMBSJJNJ-UHFFFAOYSA-N	416933	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-(2-oxopyridin-1(2H)-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 247c::US10633345, Compound 247c::US10689346, Compound 247c::US11203574, Compound 247c::US11230530, Compound 247c::US11685721, Compound 247c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416933	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416933&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356133	433916845							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120140	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H26F3N5O2/c29-28(30,31)25-14-24(36(35-25)23-8-1-4-19(12-23)15-32)27(37)34-22-7-2-5-20(13-22)26(38-17-18-9-10-18)21-6-3-11-33-16-21/h1-8,11-14,16,18,26H,9-10,15,17,32H2,(H,34,37)	SHFRWTHPPCXLER-UHFFFAOYSA-N	416725	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(pyridin-3-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 44c::US10633345, Compound 44c::US10689346, Compound 44c::US11203574, Compound 44d::US11230530, Compound 44e::US11685721, Compound 44c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416725	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416725&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355578	433916639							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120141	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-10-9-20(28(40,12-11-18-7-8-18)25-6-1-2-13-35-25)15-23(22)36-27(39)24-16-26(29(31,32)33)37-38(24)21-5-3-4-19(14-21)17-34/h1-6,9-10,13-16,18,40H,7-8,11-12,17,34H2,(H,36,39)	XXMBQXWQIGCREG-UHFFFAOYSA-N	416909	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 59c::US10633345, Compound 69b::US10689346, Compound 59c::US11203574, Compound 69b::US11230530, Compound 69b::US11685721, Compound 69b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416909	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416909&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356067	433916821							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120142	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CCC1CC1)N1CCCC1=O)C(F)(F)F	InChI=1S/C28H30F3N5O2/c29-28(30,31)25-16-24(36(34-25)22-7-1-4-19(14-22)17-32)27(38)33-21-6-2-5-20(15-21)23(12-11-18-9-10-18)35-13-3-8-26(35)37/h1-2,4-7,14-16,18,23H,3,8-13,17,32H2,(H,33,38)	LEZWAIIPWSOOAE-UHFFFAOYSA-N	416936	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-(2-oxopyrrolidin-1-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 247e::US10633345, Compound 247e::US10689346, Compound 247e::US11203574, Compound 247e::US11230530, Compound 247e::US11685721, Compound 247e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416936	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416936&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665605	433916848							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120143	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-16-25(37(36-26)24-8-1-4-20(14-24)17-33)27(38)35-23-7-2-5-21(15-23)28(39,12-11-19-9-10-19)22-6-3-13-34-18-22/h1-8,13-16,18-19,39H,9-12,17,33H2,(H,35,38)	AOCZEQQKIIWUBU-UHFFFAOYSA-N	416770	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 47f::US10633345, Compound 47f::US10689346, Compound 47f::US11203574, Compound 47g::US11230530, Compound 47h::US11685721, Compound 47f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416770	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416770&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355766	433916684							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120144	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H28F4N4O2/c31-24-12-11-22(29(40,14-13-19-9-10-19)21-6-2-1-3-7-21)16-25(24)36-28(39)26-17-27(30(32,33)34)37-38(26)23-8-4-5-20(15-23)18-35/h1-8,11-12,15-17,19,40H,9-10,13-14,18,35H2,(H,36,39)	NIWMWYNGSALJGG-UHFFFAOYSA-N	416903	Racemic 1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 68c::US10633345, Compound 68e::US10689346, Compound 68c::US11203574, Compound 68e::US11230530, Compound 68e::US11685721, Compound 68e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416903	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416903&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355758	433916816							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120145	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccccc1=O)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-11-10-20(24(12-9-18-7-8-18)37-13-2-1-6-27(37)39)15-23(22)35-28(40)25-16-26(29(31,32)33)36-38(25)21-5-3-4-19(14-21)17-34/h1-6,10-11,13-16,18,24H,7-9,12,17,34H2,(H,35,40)	OFQQGSYWUFBMPP-UHFFFAOYSA-N	416939	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(2-oxopyridin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 248j::US10633345, Compound 248k::US10689346, Compound 248k::US11203574, Compound 248k::US11230530, Compound 248k::US11685721, Compound 248k	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416939	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416939&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355727	433916851							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120146	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-16-25(37(36-26)24-8-1-4-20(14-24)17-33)27(38)35-23-7-2-5-21(15-23)28(39,12-11-19-9-10-19)22-6-3-13-34-18-22/h1-8,13-16,18-19,39H,9-12,17,33H2,(H,35,38)	AOCZEQQKIIWUBU-UHFFFAOYSA-N	416770	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 47f::US10633345, Compound 47f::US10689346, Compound 47f::US11203574, Compound 47g::US11230530, Compound 47h::US11685721, Compound 47f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416770	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416770&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355766	433916684							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120147	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H28F4N4O2/c31-24-12-11-22(29(40,14-13-19-9-10-19)21-6-2-1-3-7-21)16-25(24)36-28(39)26-17-27(30(32,33)34)37-38(26)23-8-4-5-20(15-23)18-35/h1-8,11-12,15-17,19,40H,9-10,13-14,18,35H2,(H,36,39)	NIWMWYNGSALJGG-UHFFFAOYSA-N	416903	Racemic 1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 68c::US10633345, Compound 68e::US10689346, Compound 68c::US11203574, Compound 68e::US11230530, Compound 68e::US11685721, Compound 68e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416903	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416903&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355758	433916816							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120148	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccncc1=O)C(F)(F)F	InChI=1S/C28H26F4N6O2/c29-21-8-7-19(23(9-6-17-4-5-17)37-11-10-34-16-26(37)39)13-22(21)35-27(40)24-14-25(28(30,31)32)36-38(24)20-3-1-2-18(12-20)15-33/h1-3,7-8,10-14,16-17,23H,4-6,9,15,33H2,(H,35,40)	GLPOCDKMIDNWGE-UHFFFAOYSA-N	416942	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(2-oxopyrazin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 249b::US10633345, Compound 249b::US10689346, Compound 249b::US11203574, Compound 249b::US11230530, Compound 249b::US11685721, Compound 249b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416942	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416942&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665736	433916854							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120149	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F3N4O2/c31-30(32,33)27-18-26(37(36-27)25-11-4-6-21(16-25)19-34)28(38)35-24-10-5-9-23(17-24)29(39,15-14-20-12-13-20)22-7-2-1-3-8-22/h1-11,16-18,20,39H,12-15,19,34H2,(H,35,38)	DCGYPXFSNPCKGX-UHFFFAOYSA-N	416751	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 46g::US10633345, Compound 46g::US10689346, Compound 46g::US11203574, Compound 46i::US11230530, Compound 46i::US11685721, Compound 46g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416751	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416751&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355790	433916665							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120150	COc1ccc2ccccc2c1C(NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H31F4N5O2/c1-45-29-14-12-22-6-2-3-8-25(22)31(29)32(40-19-20-9-10-20)23-11-13-26(35)27(16-23)41-33(44)28-17-30(34(36,37)38)42-43(28)24-7-4-5-21(15-24)18-39/h2-8,11-17,20,32,40H,9-10,18-19,39H2,1H3,(H,41,44)	AYMFYNZEWAELBE-UHFFFAOYSA-N	416906	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(2-methoxynaphthalen-1-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide dihydrochloride::US10329260, Compound 61e::US10633345, Compound 63b::US10689346, Compound 61e::US11203574, Compound 63b::US11230530, Compound 63b::US11685721, Compound 63b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416906	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416906&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355591	433916818							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120151	Fc1ccc(cc1NC(=O)c1cc(nn1-c1cccc(c1)C#N)C(F)(F)F)C(CCC1CC1)Oc1ccccn1	InChI=1S/C29H23F4N5O2/c30-22-11-10-20(25(12-9-18-7-8-18)40-27-6-1-2-13-35-27)15-23(22)36-28(39)24-16-26(29(31,32)33)37-38(24)21-5-3-4-19(14-21)17-34/h1-6,10-11,13-16,18,25H,7-9,12H2,(H,36,39)	SGHCSSRTSJXCIZ-UHFFFAOYSA-N	447737	US10689346, Compound 250c::US11203574, Compound 250c::US11230530, Compound 250c::US11685721, Compound 250c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=447737	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=447737&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355856	440709842							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120152	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F3N4O2/c31-30(32,33)27-18-26(37(36-27)25-11-4-6-21(16-25)19-34)28(38)35-24-10-5-9-23(17-24)29(39,15-14-20-12-13-20)22-7-2-1-3-8-22/h1-11,16-18,20,39H,12-15,19,34H2,(H,35,38)	DCGYPXFSNPCKGX-UHFFFAOYSA-N	416751	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 46g::US10633345, Compound 46g::US10689346, Compound 46g::US11203574, Compound 46i::US11230530, Compound 46i::US11685721, Compound 46g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416751	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416751&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355790	433916665							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120153	COc1ccc2ccccc2c1C(NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H31F4N5O2/c1-45-29-14-12-22-6-2-3-8-25(22)31(29)32(40-19-20-9-10-20)23-11-13-26(35)27(16-23)41-33(44)28-17-30(34(36,37)38)42-43(28)24-7-4-5-21(15-24)18-39/h2-8,11-17,20,32,40H,9-10,18-19,39H2,1H3,(H,41,44)	AYMFYNZEWAELBE-UHFFFAOYSA-N	416906	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(2-methoxynaphthalen-1-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide dihydrochloride::US10329260, Compound 61e::US10633345, Compound 63b::US10689346, Compound 61e::US11203574, Compound 63b::US11230530, Compound 63b::US11685721, Compound 63b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416906	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416906&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355591	433916818							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120154	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(=CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H26F4N4O/c31-25-14-12-22(24(13-11-19-9-10-19)21-6-2-1-3-7-21)16-26(25)36-29(39)27-17-28(30(32,33)34)37-38(27)23-8-4-5-20(15-23)18-35/h1-8,12-17,19H,9-11,18,35H2,(H,36,39)/b24-13-	BAAJKWZPAGFHDE-CFRMEGHHSA-N	416948	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-phenylprop-1-enyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 252c::US10633345, Compound 252c::US10689346, Compound 252c::US11203574, Compound 252c::US11230530, Compound 252c::US11685721, Compound 252c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416948	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416948&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			140777564	433916860							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120155	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H25F4N5O2/c29-22-9-8-19(26(39-16-17-6-7-17)20-4-2-10-34-15-20)12-23(22)35-27(38)24-13-25(28(30,31)32)36-37(24)21-5-1-3-18(11-21)14-33/h1-5,8-13,15,17,26H,6-7,14,16,33H2,(H,35,38)	CNAFOXQNPWSINI-UHFFFAOYSA-N	416794	Racemic 1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethoxy)(pyridin-3-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 48f::US10633345, Compound 48f::US10689346, Compound 48f::US11203574, Compound 48g::US11230530, Compound 48h::US11685721, Compound 48f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416794	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416794&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355617	433916708							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120156	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C30H25F4N5O2/c31-24-11-10-22(28(41-17-19-4-5-19)21-8-6-18(15-35)7-9-21)13-25(24)37-29(40)26-14-27(30(32,33)34)38-39(26)23-3-1-2-20(12-23)16-36/h1-3,6-14,19,28H,4-5,16-17,36H2,(H,37,40)	WXFHQCUXOOXGLO-UHFFFAOYSA-N	416894	1-(3-(aminomethyl)phenyl)-N-(5-((4-cyanophenyl)(cyclopropylmethoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 55b::US10633345, Compound 73b::US10689346, Compound 55b::US11203574, Compound 73b::US11230530, Compound 73b::US11685721, Compound 73b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416894	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416894&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665569	433916807							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120157	CN1CCCN(CC1)C(CCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H36F4N6O/c1-38-12-3-13-39(15-14-38)26(11-8-20-6-7-20)22-9-10-24(31)25(17-22)36-29(41)27-18-28(30(32,33)34)37-40(27)23-5-2-4-21(16-23)19-35/h2,4-5,9-10,16-18,20,26H,3,6-8,11-15,19,35H2,1H3,(H,36,41)	WXRMFESIILBOBA-UHFFFAOYSA-N	416951	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(4-methyl-1,4-diazepan-1-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 251e::US10633345, Compound 251e::US10689346, Compound 251e::US11203574, Compound 251e::US11230530, Compound 251e::US11685721, Compound 251e	Plasma kallikrein		>75.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416951	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416951&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355664	433916863							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120158	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H25F4N5O2/c29-22-9-8-19(26(39-16-17-6-7-17)20-4-2-10-34-15-20)12-23(22)35-27(38)24-13-25(28(30,31)32)36-37(24)21-5-1-3-18(11-21)14-33/h1-5,8-13,15,17,26H,6-7,14,16,33H2,(H,35,38)	CNAFOXQNPWSINI-UHFFFAOYSA-N	416794	Racemic 1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethoxy)(pyridin-3-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 48f::US10633345, Compound 48f::US10689346, Compound 48f::US11203574, Compound 48g::US11230530, Compound 48h::US11685721, Compound 48f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416794	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416794&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355617	433916708							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120159	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C30H25F4N5O2/c31-24-11-10-22(28(41-17-19-4-5-19)21-8-6-18(15-35)7-9-21)13-25(24)37-29(40)26-14-27(30(32,33)34)38-39(26)23-3-1-2-20(12-23)16-36/h1-3,6-14,19,28H,4-5,16-17,36H2,(H,37,40)	WXFHQCUXOOXGLO-UHFFFAOYSA-N	416894	1-(3-(aminomethyl)phenyl)-N-(5-((4-cyanophenyl)(cyclopropylmethoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 55b::US10633345, Compound 73b::US10689346, Compound 55b::US11203574, Compound 73b::US11230530, Compound 73b::US11685721, Compound 73b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416894	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416894&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665569	433916807							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120160	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)N1C(=O)CCC1=O)C(F)(F)F	InChI=1S/C28H27F4N5O3/c29-20-8-7-18(22(9-6-16-4-5-16)36-25(38)10-11-26(36)39)13-21(20)34-27(40)23-14-24(28(30,31)32)35-37(23)19-3-1-2-17(12-19)15-33/h1-3,7-8,12-14,16,22H,4-6,9-11,15,33H2,(H,34,40)	ZAWTZVLCOQSDBX-UHFFFAOYSA-N	416954	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(2,5-dioxopyrrolidin-1-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 260b::US10633345, Compound 260b::US10689346, Compound 260b::US11203574, Compound 260b::US11230530, Compound 260b::US11685721, Compound 260b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416954	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416954&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665563	433916866							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120161	COc1ccc2ccccc2c1C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H32F3N5O2/c1-44-29-15-14-23-7-2-3-11-27(23)31(29)32(39-20-21-12-13-21)24-8-5-9-25(17-24)40-33(43)28-18-30(34(35,36)37)41-42(28)26-10-4-6-22(16-26)19-38/h2-11,14-18,21,32,39H,12-13,19-20,38H2,1H3,(H,40,43)	XVOUQCJHWNZPKF-UHFFFAOYSA-N	416841	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2-methoxynaphthalen-1-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 51f::US10633345, Compound 51f::US10689346, Compound 51f::US11203574, Compound 51h::US11230530, Compound 51h::US11685721, Compound 51f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416841	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416841&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356155	433916754							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120162	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C30H25F4N5O2/c31-24-10-9-22(28(41-17-18-7-8-18)21-5-1-3-19(11-21)15-35)13-25(24)37-29(40)26-14-27(30(32,33)34)38-39(26)23-6-2-4-20(12-23)16-36/h1-6,9-14,18,28H,7-8,16-17,36H2,(H,37,40)	LSXFYXGKZDVRTL-UHFFFAOYSA-N	416900	1-(3-(aminomethyl)phenyl)-N-(5-((3-cyanophenyl)(cyclopropyl-methoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 56c::US10633345, Compound 72d::US10689346, Compound 56c::US11203574, Compound 72d::US11230530, Compound 72d::US11685721, Compound 72d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416900	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416900&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356211	433916813							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120163	CS(=O)(=O)NC(CCC1CC1)(c1ccncc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2ccc3ccnc(N)c3c2)C(F)(F)F)c1	InChI=1S/C32H29F4N7O3S/c1-47(45,46)42-31(12-8-19-2-3-19,21-10-13-38-14-11-21)22-5-7-25(33)26(16-22)40-30(44)27-18-28(32(34,35)36)41-43(27)23-6-4-20-9-15-39-29(37)24(20)17-23/h4-7,9-11,13-19,42H,2-3,8,12H2,1H3,(H2,37,39)(H,40,44)	WOIASLBXHIHYRY-UHFFFAOYSA-N	416957	(+-)-1-(1-aminoisoquinolin-7-yl)-N-(5-(3-cyclopropyl-1-(methylsulfonamido)-1-(pyridin-4-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 262f::US10633345, Compound 262f::US10689346, Compound 262f::US11192861, Compound 262f::US11230530, Compound 262f::US11685721, Compound 262f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416957	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416957&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355636	433916869							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117337	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1O)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-24(37(36-26)22-8-3-5-19(13-22)16-33)28(39)35-21-7-4-6-20(14-21)27(34-17-18-11-12-18)23-9-1-2-10-25(23)38/h1-10,13-15,18,27,34,38H,11-12,16-17,33H2,(H,35,39)	PCNDJIQOMLHSEK-UHFFFAOYSA-N	416837	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2-hydroxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 49h::US10633345, Compound 49h::US10689346, Compound 49h::US11203574, Compound 49j::US11230530, Compound 49j::US11685721, Compound 49h	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416837	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416837&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355733	433916750							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117338	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-23-12-11-21(27(39-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)35-28(38)25-15-26(29(31,32)33)36-37(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27H,9-10,16-17,34H2,(H,35,38)	HIMJVDQVZQMIPM-UHFFFAOYSA-N	416747	1-(3-(Aminomethyl)phenyl)-N-(5-((cyclopropylmethoxy)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 34c::US10633345, Compound 34c::US10689346, Compound 34c::US11203574, Compound 37a::US11230530, Compound 37a::US11685721, Compound 34c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416747	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416747&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355729	433916661							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117339	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N(CC1CC1)CC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C33H33F4N5O/c34-27-14-13-25(31(24-6-2-1-3-7-24)41(19-21-9-10-21)20-22-11-12-22)16-28(27)39-32(43)29-17-30(33(35,36)37)40-42(29)26-8-4-5-23(15-26)18-38/h1-8,13-17,21-22,31H,9-12,18-20,38H2,(H,39,43)	FVEYNTAGBBDICV-UHFFFAOYSA-N	416972	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-((bis(cyclopropylmethyl)amino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 206d::US10633345, Compound 206d::US10689346, Compound 206d::US11203574, Compound 206d::US11230530, Compound 206d::US11685721, Compound 206d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416972	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416972&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355791	433916884							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117340	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C#N)C(N)=O	InChI=1S/C31H30FN7O2/c32-25-11-10-23(31(36,13-12-19-4-5-19)22-8-6-20(17-33)7-9-22)15-26(25)37-30(41)28-16-27(29(35)40)38-39(28)24-3-1-2-21(14-24)18-34/h1-3,6-11,14-16,19H,4-5,12-13,18,34,36H2,(H2,35,40)(H,37,41)	BCLQAOJZVSDWEP-UHFFFAOYSA-N	416973	(+)-N5-(5-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-1H-pyrazole-3,5-dicarboxamide::US10329260, Compound 231d::US10633345, Compound 231d::US10689346, Compound 231d::US11203574, Compound 231d::US11230530, Compound 231d::US11685721, Compound 231d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416973	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416973&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665708	433916885							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117341	CC(C)(C)C(=O)NC(CCC1CC1)(c1cccnc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H36F4N6O2/c1-32(2,3)31(46)42-33(14-13-21-9-10-21,24-7-5-15-40-20-24)23-11-12-26(35)27(17-23)41-30(45)28-18-29(34(36,37)38)43-44(28)25-8-4-6-22(16-25)19-39/h4-8,11-12,15-18,20-21H,9-10,13-14,19,39H2,1-3H3,(H,41,45)(H,42,46)	QDJVSPVHYSLBHH-UHFFFAOYSA-N	416974	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-pivalamido-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 244g::US10689346, Compound 244g::US11203574, Compound 244g::US11230530, Compound 244g::US11685721, Compound 244g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416974	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416974&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665924	433916886							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117342	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-22-10-9-20(28(35,12-11-18-7-8-18)25-6-1-2-13-36-25)15-23(22)37-27(40)24-16-26(29(31,32)33)38-39(24)21-5-3-4-19(14-21)17-34/h1-6,9-10,13-16,18H,7-8,11-12,17,34-35H2,(H,37,40)	IFWBAIGKQKRJGJ-UHFFFAOYSA-N	416975	(+-)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 205d::US10633345, Compound 205c::US10689346, Compound 205e::US11203574, Compound 205e::US11230530, Compound 205e::US11685721, Compound 205f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416975	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416975&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665627	433916887							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117343	ONC(=N)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N6O2/c30-22-12-11-19(26(35-16-17-9-10-17)18-5-2-1-3-6-18)14-23(22)36-28(40)24-15-25(29(31,32)33)37-39(24)21-8-4-7-20(13-21)27(34)38-41/h1-8,11-15,17,26,35,41H,9-10,16H2,(H2,34,38)(H,36,40)	RKUBSDCTAQRJEX-UHFFFAOYSA-N	416976	(+-)-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-1-(3-(N-hydroxycarbamimidoyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 232a::US10633345, Compound 232a::US10689346, Compound 232a::US11203574, Compound 232a::US11230530, Compound 232a::US11685721, Compound 232a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416976	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416976&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665466	433916888							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117344	CC(=O)NC(CCC1CC1)(c1cccnc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C31H30F4N6O2/c1-19(42)39-30(12-11-20-7-8-20,23-5-3-13-37-18-23)22-9-10-25(32)26(15-22)38-29(43)27-16-28(31(33,34)35)40-41(27)24-6-2-4-21(14-24)17-36/h2-6,9-10,13-16,18,20H,7-8,11-12,17,36H2,1H3,(H,38,43)(H,39,42)	NXVHVPBDWBOZQI-UHFFFAOYSA-N	416977	(+-)-N-(5-(1-acetamido-3-cyclopropyl-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 244h::US10633345, Compound 244h::US10689346, Compound 244h::US11203574, Compound 244h::US11230530, Compound 244h::US11685721, Compound 244h	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416977	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416977&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355894	433916889							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117345	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-22-10-9-20(28(35,12-11-18-7-8-18)25-6-1-2-13-36-25)15-23(22)37-27(40)24-16-26(29(31,32)33)38-39(24)21-5-3-4-19(14-21)17-34/h1-6,9-10,13-16,18H,7-8,11-12,17,34-35H2,(H,37,40)	IFWBAIGKQKRJGJ-UHFFFAOYSA-N	416975	(+-)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 205d::US10633345, Compound 205c::US10689346, Compound 205e::US11203574, Compound 205e::US11230530, Compound 205e::US11685721, Compound 205f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416975	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416975&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665627	433916887							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117346	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(O)=O	InChI=1S/C29H28FN5O3/c30-23-12-11-21(27(32-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)33-28(36)26-15-25(29(37)38)34-35(26)22-8-4-5-19(13-22)16-31/h1-8,11-15,18,27,32H,9-10,16-17,31H2,(H,33,36)(H,37,38)	XPAISISGRLZRHF-UHFFFAOYSA-N	416979	(+)-1-(3-(aminomethyl)phenyl)-5-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenylcarbamoyl)-1H-pyrazole-3-carboxylic acid::US10329260, Compound 246f::US10633345, Compound 246f::US10689346, Compound 246f::US11203574, Compound 246f::US11230530, Compound 246f::US11685721, Compound 246f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416979	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416979&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356041	433916891							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117347	CCC(=O)NC(CCC1CC1)(c1cccnc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C32H32F4N6O2/c1-2-29(43)40-31(13-12-20-8-9-20,23-6-4-14-38-19-23)22-10-11-25(33)26(16-22)39-30(44)27-17-28(32(34,35)36)41-42(27)24-7-3-5-21(15-24)18-37/h3-7,10-11,14-17,19-20H,2,8-9,12-13,18,37H2,1H3,(H,39,44)(H,40,43)	VLEWWVBFKVHAND-UHFFFAOYSA-N	416980	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-propionamido-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 244i::US10633345, Compound 244i::US10689346, Compound 244i::US11203574, Compound 244i::US11230530, Compound 244j::US11685721, Compound 244i	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416980	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416980&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665945	433916892							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117348	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-23-9-8-20(28(35,11-10-18-6-7-18)21-4-2-12-36-17-21)14-24(23)37-27(40)25-15-26(29(31,32)33)38-39(25)22-5-1-3-19(13-22)16-34/h1-5,8-9,12-15,17-18H,6-7,10-11,16,34-35H2,(H,37,40)	QXMQDWOYOXVOQZ-UHFFFAOYSA-N	416981	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 208d::US10633345, Compound 209d::US10689346, Compound 209d::US11203574, Compound 209d::US11230530, Compound 209d::US11685721, Compound 209d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416981	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416981&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355646	433916893							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117349	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C#N)C#N	InChI=1S/C31H28FN7O/c32-27-11-10-24(31(36,13-12-20-4-5-20)23-8-6-21(17-33)7-9-23)15-28(27)37-30(40)29-16-25(19-35)38-39(29)26-3-1-2-22(14-26)18-34/h1-3,6-11,14-16,20H,4-5,12-13,18,34,36H2,(H,37,40)	SWSSXIJHEDUEIQ-UHFFFAOYSA-N	416982	(+)-N-(5-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-cyano-1H-pyrazole-5-carboxamide::US10329260, Compound 234d::US10633345, Compound 234d::US10689346, Compound 234d::US11203574, Compound 234d::US11230530, Compound 234d::US11685721, Compound 234d	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416982	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416982&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356248	433916894							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117350	CC(C)C(=O)NC(CCC1CC1)(c1cccnc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C33H34F4N6O2/c1-20(2)30(44)41-32(13-12-21-8-9-21,24-6-4-14-39-19-24)23-10-11-26(34)27(16-23)40-31(45)28-17-29(33(35,36)37)42-43(28)25-7-3-5-22(15-25)18-38/h3-7,10-11,14-17,19-21H,8-9,12-13,18,38H2,1-2H3,(H,40,45)(H,41,44)	POAUUALSNYEBRU-UHFFFAOYSA-N	416983	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-isobutyramido-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 244j::US10633345, Compound 244j::US10689346, Compound 244j::US11203574, Compound 244j::US11685721, Compound 244j	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416983	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416983&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356184	433916895							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117351	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-23-9-8-20(28(35,11-10-18-6-7-18)21-4-2-12-36-17-21)14-24(23)37-27(40)25-15-26(29(31,32)33)38-39(25)22-5-1-3-19(13-22)16-34/h1-5,8-9,12-15,17-18H,6-7,10-11,16,34-35H2,(H,37,40)	QXMQDWOYOXVOQZ-UHFFFAOYSA-N	416981	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 208d::US10633345, Compound 209d::US10689346, Compound 209d::US11203574, Compound 209d::US11230530, Compound 209d::US11685721, Compound 209d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416981	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416981&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355646	433916893							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117352	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C31H26F4N6O/c32-24-11-9-21(28(38-17-18-6-7-18)20-4-2-1-3-5-20)14-25(24)39-30(42)26-16-27(31(33,34)35)40-41(26)22-10-8-19-12-13-37-29(36)23(19)15-22/h1-5,8-16,18,28,38H,6-7,17H2,(H2,36,37)(H,39,42)	OUKVDAXUKVLTKB-UHFFFAOYSA-N	439568	US10633345, Compound 235g::US10689346, Compound 235g::US11192861, Compound 235g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439568	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439568&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665742	439661116							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117353	CC(C)CC(=O)NC(CCC1CC1)(c1cccnc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H36F4N6O2/c1-21(2)15-31(45)42-33(13-12-22-8-9-22,25-6-4-14-40-20-25)24-10-11-27(35)28(17-24)41-32(46)29-18-30(34(36,37)38)43-44(29)26-7-3-5-23(16-26)19-39/h3-7,10-11,14,16-18,20-22H,8-9,12-13,15,19,39H2,1-2H3,(H,41,46)(H,42,45)	WIIQCCUTLYCVOE-UHFFFAOYSA-N	416986	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(3-methylbutanamido)-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 244k::US10633345, Compound 244k::US10689346, Compound 244k::US11203574, Compound 244k::US11230530, Compound 244k::US11685721, Compound 244k	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416986	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416986&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665507	433916898							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117354	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F4N5O/c31-24-12-11-22(29(36,14-13-19-9-10-19)21-6-2-1-3-7-21)16-25(24)37-28(40)26-17-27(30(32,33)34)38-39(26)23-8-4-5-20(15-23)18-35/h1-8,11-12,15-17,19H,9-10,13-14,18,35-36H2,(H,37,40)	NQFNNZJJOCPZCP-UHFFFAOYSA-N	416987	(+-)-N-(5-(1-amino-3-cyclopropyl-1-phenylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 210d::US10633345, Compound 211d::US10689346, Compound 211d::US11203574, Compound 211d::US11230530, Compound 211d::US11685721, Compound 211d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416987	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416987&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355764	433916899							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117355	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(N)(CCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C31H29F3N6O/c32-31(33,34)28-17-27(40(39-28)26-6-1-3-22(15-26)19-36)29(41)38-25-5-2-4-24(16-25)30(37,14-13-20-7-8-20)23-11-9-21(18-35)10-12-23/h1-6,9-12,15-17,20H,7-8,13-14,19,36-37H2,(H,38,41)	WPWCLOAAAHRQMG-UHFFFAOYSA-N	416988	(+)-N-(3-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)phenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 218c::US10633345, Compound 218c::US10689346, Compound 218c::US11203574, Compound 218c::US11230530, Compound 218c::US11685721, Compound 218c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416988	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416988&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356070	433916900							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117356	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C31H27F4N7O/c32-24-6-4-21(30(37,11-7-18-1-2-18)20-9-12-38-13-10-20)15-25(24)40-29(43)26-17-27(31(33,34)35)41-42(26)22-5-3-19-8-14-39-28(36)23(19)16-22/h3-6,8-10,12-18H,1-2,7,11,37H2,(H2,36,39)(H,40,43)	BGYDOWYGLFEYGE-UHFFFAOYSA-N	416989	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-4-yl)propyl)-2-fluorophenyl)-1-(1-aminoisoquinolin-7-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 253e::US10633345, Compound 253e::US10689346, Compound 253e::US11203574, Compound 253e::US11230530, Compound 253e::US11685721, Compound 253e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416989	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416989&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665703	433916901							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117357	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F4N5O/c31-24-12-11-22(29(36,14-13-19-9-10-19)21-6-2-1-3-7-21)16-25(24)37-28(40)26-17-27(30(32,33)34)38-39(26)23-8-4-5-20(15-23)18-35/h1-8,11-12,15-17,19H,9-10,13-14,18,35-36H2,(H,37,40)	NQFNNZJJOCPZCP-UHFFFAOYSA-N	416987	(+-)-N-(5-(1-amino-3-cyclopropyl-1-phenylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 210d::US10633345, Compound 211d::US10689346, Compound 211d::US11203574, Compound 211d::US11230530, Compound 211d::US11685721, Compound 211d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416987	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416987&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355764	433916899							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117358	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(N)(CCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C31H29F3N6O/c32-31(33,34)28-17-27(40(39-28)26-9-2-5-22(15-26)19-36)29(41)38-25-8-3-7-24(16-25)30(37,13-12-20-10-11-20)23-6-1-4-21(14-23)18-35/h1-9,14-17,20H,10-13,19,36-37H2,(H,38,41)	JHGXWQQOSIGIHO-UHFFFAOYSA-N	416991	(+)-N-(3-(1-amino-1-(3-cyanophenyl)-3-cyclopropylpropyl)phenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 219c::US10633345, Compound 219c::US10689346, Compound 219c::US11203574, Compound 219c::US11230530, Compound 219c::US11685721, Compound 219c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416991	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416991&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355760	433916903							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117359	CS(=O)(=O)NC(CCC1CC1)(c1ccncc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F4N6O3S/c1-44(42,43)39-29(12-9-19-5-6-19,21-10-13-36-14-11-21)22-7-8-24(31)25(16-22)37-28(41)26-17-27(30(32,33)34)38-40(26)23-4-2-3-20(15-23)18-35/h2-4,7-8,10-11,13-17,19,39H,5-6,9,12,18,35H2,1H3,(H,37,41)	SFWRGGJAWAJGGN-UHFFFAOYSA-N	416992	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(methylsulfonamido)-1-(pyridin-4-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 245c::US10633345, Compound 245c::US10689346, Compound 245c::US11203574, Compound 245c::US11230530, Compound 245c::US11685721, Compound 245c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416992	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416992&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355707	433916904							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117360	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C31H28F4N6O/c32-25-11-10-23(30(38,13-12-19-4-5-19)22-8-6-20(17-36)7-9-22)15-26(25)39-29(42)27-16-28(31(33,34)35)40-41(27)24-3-1-2-21(14-24)18-37/h1-3,6-11,14-16,19H,4-5,12-13,18,37-38H2,(H,39,42)	JCBKPNPCGNTAQN-UHFFFAOYSA-N	416993	(+)-N-(5-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 212g::US10633345, Compound 213d::US10689346, Compound 213d::US11203574, Compound 213d::US11230530, Compound 213d::US11685721, Compound 213d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416993	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416993&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356170	433916905							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117361	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C(N)=O)C#N	InChI=1S/C31H30FN7O2/c32-26-11-10-23(31(36,13-12-19-4-5-19)22-8-6-21(7-9-22)29(35)40)15-27(26)37-30(41)28-16-24(18-34)38-39(28)25-3-1-2-20(14-25)17-33/h1-3,6-11,14-16,19H,4-5,12-13,17,33,36H2,(H2,35,40)(H,37,41)	KLZOEGIZCNFTHC-UHFFFAOYSA-N	416994	(-)-N-(5-(1-amino-1-(4-carbamoylphenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-cyano-1H-pyrazole-5-carboxamide::US10329260, Compound 239d::US10633345, Compound 239c::US10689346, Compound 239d::US11203574, Compound 239d::US11685721, Compound 239d	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416994	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416994&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356225	433916906							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117362	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C32H25F4N7O/c33-25-9-7-22(29(40-17-18-4-5-18)21-3-1-2-19(12-21)16-37)13-26(25)41-31(44)27-15-28(32(34,35)36)42-43(27)23-8-6-20-10-11-39-30(38)24(20)14-23/h1-3,6-15,18,29,40H,4-5,17H2,(H2,38,39)(H,41,44)	PQPAZBKFVDKERF-UHFFFAOYSA-N	439578	US10633345, Compound 257b::US10689346, Compound 257b::US11203574, Compound 257b::US11230530, Compound 257b::US11685721, Compound 257b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439578	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439578&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665471	439661126							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117363	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C31H28F4N6O/c32-25-10-9-23(30(38,12-11-19-7-8-19)22-5-1-3-20(13-22)17-36)15-26(25)39-29(42)27-16-28(31(33,34)35)40-41(27)24-6-2-4-21(14-24)18-37/h1-6,9-10,13-16,19H,7-8,11-12,18,37-38H2,(H,39,42)	ZBDDMFBNDOEVJT-UHFFFAOYSA-N	416996	(+)-N-(5-(1-amino-1-(3-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 214g::US10633345, Compound 215d::US10689346, Compound 215d::US11203574, Compound 215d::US11230530, Compound 215d::US11685721, Compound 215d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416996	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416996&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665709	433916908							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117364	NC(=O)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C31H26F4N6O2/c32-24-10-9-22(30(38,12-11-18-7-8-18)21-5-1-3-19(13-21)17-36)15-25(24)39-29(43)26-16-27(31(33,34)35)40-41(26)23-6-2-4-20(14-23)28(37)42/h1-6,9-10,13-16,18H,7-8,11-12,38H2,(H2,37,42)(H,39,43)	MJBRNYICMOSPEH-UHFFFAOYSA-N	416997	(+-)-N-(5-(1-amino-1-(3-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-carbamoylphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 267c::US10633345, Compound 267c::US10689346, Compound 267c::US11203574, Compound 267c::US11230530, Compound 267c::US11685721, Compound 267c	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416997	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416997&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665760	433916909							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117365	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C33H27F4N7O/c34-26-10-8-23(32(40,13-11-19-1-2-19)22-6-3-20(18-38)4-7-22)15-27(26)42-31(45)28-17-29(33(35,36)37)43-44(28)24-9-5-21-12-14-41-30(39)25(21)16-24/h3-10,12,14-17,19H,1-2,11,13,40H2,(H2,39,41)(H,42,45)	QUIZETAQJOZQJA-UHFFFAOYSA-N	416998	(+)-N-(5-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(1-aminoisoquinolin-7-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 254c::US10633345, Compound 254c::US10689346, Compound 254c::US11203574, Compound 254c::US11230530, Compound 254c::US11685721, Compound 254c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416998	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416998&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665477	433916910							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117366	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C31H28F4N6O/c32-25-11-10-23(30(38,13-12-19-4-5-19)22-8-6-20(17-36)7-9-22)15-26(25)39-29(42)27-16-28(31(33,34)35)40-41(27)24-3-1-2-21(14-24)18-37/h1-3,6-11,14-16,19H,4-5,12-13,18,37-38H2,(H,39,42)	JCBKPNPCGNTAQN-UHFFFAOYSA-N	416993	(+)-N-(5-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 212g::US10633345, Compound 213d::US10689346, Compound 213d::US11203574, Compound 213d::US11230530, Compound 213d::US11685721, Compound 213d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416993	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416993&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356170	433916905							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117367	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C#N	InChI=1S/C29H27FN6O/c30-25-12-11-22(28(33-18-19-9-10-19)21-6-2-1-3-7-21)14-26(25)34-29(37)27-15-23(17-32)35-36(27)24-8-4-5-20(13-24)16-31/h1-8,11-15,19,28,33H,9-10,16,18,31H2,(H,34,37)	OBANZZDEWOCPST-UHFFFAOYSA-N	417000	(+-)-1-(3-(aminomethyl)phenyl)-3-cyano-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 240b::US10633345, Compound 240b::US10689346, Compound 240b::US11203574, Compound 240b::US11230530, Compound 240b::US11685721, Compound 240b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417000	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417000&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355661	433916912							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117368	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C32H28F4N6O/c33-25-11-9-22(31(38,14-12-19-6-7-19)21-4-2-1-3-5-21)16-26(25)40-30(43)27-18-28(32(34,35)36)41-42(27)23-10-8-20-13-15-39-29(37)24(20)17-23/h1-5,8-11,13,15-19H,6-7,12,14,38H2,(H2,37,39)(H,40,43)	SUIQVQQNEUOJQB-UHFFFAOYSA-N	417001	(+)-N-(5-(1-amino-3-cyclopropyl-1-phenylpropyl)-2-fluorophenyl)-1-(1-aminoisoquinolin-7-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 255a::US10633345, Compound 255a::US10689346, Compound 255a::US11203574, Compound 255a::US11230530, Compound 255a::US11685721, Compound 255a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417001	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417001&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356059	433916913							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117369	Nc1noc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H24F4N6O2/c30-21-10-8-18(26(35-15-16-6-7-16)17-4-2-1-3-5-17)12-22(21)36-28(40)23-14-25(29(31,32)33)37-39(23)19-9-11-24-20(13-19)27(34)38-41-24/h1-5,8-14,16,26,35H,6-7,15H2,(H2,34,38)(H,36,40)	QWKNFIFTTXOPHF-UHFFFAOYSA-N	417002	(+-)-1-(3-aminobenzo[d]isoxazol-5-yl)-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 222k::US10329260, Compound 223f::US10633345, Compound 223f::US10689346, Compound 223f::US11203574, Compound 223f::US11230530, Compound 223f::US11685721, Compound 223f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417002	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417002&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123289526	433916914							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117370	NC(=N)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C30H25F4N7O/c31-23-10-9-20(27(38-16-17-7-8-17)19-4-1-3-18(11-19)15-35)13-24(23)39-29(42)25-14-26(30(32,33)34)40-41(25)22-6-2-5-21(12-22)28(36)37/h1-6,9-14,17,27,38H,7-8,16H2,(H3,36,37)(H,39,42)	VIRFLKJDRZOSPM-UHFFFAOYSA-N	417003	(+)-1-(3-carbamimidoylphenyl)-N-(5-((3-cyanophenyl)(cyclopropylmethylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 236h::US10633345, Compound 236h::US10689346, Compound 236h::US11203574, Compound 236h::US11230530, Compound 236h::US11685721, Compound 236h	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417003	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417003&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665908	433916915							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117371	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C30H25F4N7O/c31-23-6-4-20(27(38-16-17-1-2-17)19-7-10-36-11-8-19)13-24(23)39-29(42)25-15-26(30(32,33)34)40-41(25)21-5-3-18-9-12-37-28(35)22(18)14-21/h3-15,17,27,38H,1-2,16H2,(H2,35,37)(H,39,42)	UQWHIYYZYLIMKJ-UHFFFAOYSA-N	417004	(+-)-1-(1-aminoisoquinolin-7-yl)-N-(5-((cyclopropylmethylamino)(pyridin-4-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 265d::US10633345, Compound 264g::US10689346, Compound 264g::US11203574, Compound 264g::US11230530, Compound 264g::US11685721, Compound 264g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417004	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417004&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355979	433916916							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117372	Nc1noc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H24F4N6O2/c30-21-10-8-18(26(35-15-16-6-7-16)17-4-2-1-3-5-17)12-22(21)36-28(40)23-14-25(29(31,32)33)37-39(23)19-9-11-24-20(13-19)27(34)38-41-24/h1-5,8-14,16,26,35H,6-7,15H2,(H2,34,38)(H,36,40)	QWKNFIFTTXOPHF-UHFFFAOYSA-N	417002	(+-)-1-(3-aminobenzo[d]isoxazol-5-yl)-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 222k::US10329260, Compound 223f::US10633345, Compound 223f::US10689346, Compound 223f::US11203574, Compound 223f::US11230530, Compound 223f::US11685721, Compound 223f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417002	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417002&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123289526	433916914							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117373	NC(=N)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C31H27F4N7O/c32-24-10-9-22(30(39,12-11-18-7-8-18)21-5-1-3-19(13-21)17-36)15-25(24)40-29(43)26-16-27(31(33,34)35)41-42(26)23-6-2-4-20(14-23)28(37)38/h1-6,9-10,13-16,18H,7-8,11-12,39H2,(H3,37,38)(H,40,43)	BZRUVEYOOHPOOF-UHFFFAOYSA-N	417006	(+)-N-(5-(1-amino-1-(3-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-carbamimidoylphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 237a::US10633345, Compound 237a::US10689346, Compound 237a::US11192861, Compound 237a::US11230530, Compound 237a::US11685721, Compound 237a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417006	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417006&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356202	433916917							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117374	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C33H27F4N7O/c34-26-9-7-23(32(40,12-10-19-4-5-19)22-3-1-2-20(14-22)18-38)15-27(26)42-31(45)28-17-29(33(35,36)37)43-44(28)24-8-6-21-11-13-41-30(39)25(21)16-24/h1-3,6-9,11,13-17,19H,4-5,10,12,40H2,(H2,39,41)(H,42,45)	MNAPHYKXZOGSTD-UHFFFAOYSA-N	417007	(+)-N-(5-(1-amino-1-(3-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(1-aminoisoquinolin-7-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 256a::US10633345, Compound 256a::US10689346, Compound 256a::US11203574, Compound 256a::US11230530, Compound 256a::US11685721, Compound 256a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417007	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417007&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665459	433916918							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117375	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(n1)C#N)C(F)(F)F	InChI=1S/C30H27F4N7O/c31-23-10-9-20(29(37,12-11-18-7-8-18)26-6-2-4-21(17-36)38-26)14-24(23)39-28(42)25-15-27(30(32,33)34)40-41(25)22-5-1-3-19(13-22)16-35/h1-6,9-10,13-15,18H,7-8,11-12,16,35,37H2,(H,39,42)	UYAYDZPBNCJYMZ-UHFFFAOYSA-N	417008	(+)-N-(5-(1-amino-1-(6-cyanopyridin-2-yl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 220f::US10633345, Compound 220f::US10689346, Compound 220f::US11203574, Compound 220f::US11230530, Compound 220f::US11685721, Compound 220f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417008	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417008&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355858	433916919							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117376	CC(C)(C)[S@@](=O)NC(CCC1CC1)(c1cccnc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(c2)C(N)=N)C(F)(F)F)c1	InChI=1S/C33H35F4N7O2S/c1-31(2,3)47(46)43-32(14-13-20-9-10-20,23-7-5-15-40-19-23)22-11-12-25(34)26(17-22)41-30(45)27-18-28(33(35,36)37)42-44(27)24-8-4-6-21(16-24)29(38)39/h4-8,11-12,15-20,43H,9-10,13-14H2,1-3H3,(H3,38,39)(H,41,45)/t32?,47-/m1/s1	ORCJXCNQCCWVHD-HKYIEPEJSA-N	417009	1-(3-carbamimidoylphenyl)-N-(5-((+-)-3-cyclopropyl-1-((R)-1,1-dimethylethylsulfinamido)-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 238c::US10633345, Compound 238c::US10689346, Compound 238c::US11203574, Compound 238c::US11230530, Compound 238c::US11685721, Compound 238c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417009	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417009&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355741	433916920							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117377	Nc1nccc2ccc(cc12)-n1nc(cc1C(F)(F)F)C(=O)NC1(C=CC=CC1F)C(N)(CCC1CC1)c1ccncc1	InChI=1S/C31H29F4N7O/c32-25-3-1-2-12-30(25,29(37,13-8-19-4-5-19)21-10-14-38-15-11-21)40-28(43)24-18-26(31(33,34)35)42(41-24)22-7-6-20-9-16-39-27(36)23(20)17-22/h1-3,6-7,9-12,14-19,25H,4-5,8,13,37H2,(H2,36,39)(H,40,43)	MARAUFSXQGYMAY-UHFFFAOYSA-N	528843	US11192861, Compound 268g	Plasma kallikrein		 75.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528843	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528843&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156065196	463792370							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117378	Nc1n[nH]c2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F			439594	US10633345, Compound 224b::US10689346, Compound 224b::US11203574, Compound 224b::US11230530, Compound 224b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439594	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439594&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155295687	439661142							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117379	NC(=N)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C31H27F4N7O/c32-24-11-10-22(30(39,13-12-18-4-5-18)21-8-6-19(17-36)7-9-21)15-25(24)40-29(43)26-16-27(31(33,34)35)41-42(26)23-3-1-2-20(14-23)28(37)38/h1-3,6-11,14-16,18H,4-5,12-13,39H2,(H3,37,38)(H,40,43)	QLTPSVVBRYJDCX-UHFFFAOYSA-N	417012	(+)-N-(5-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-carbamimidoylphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 241a::US10633345, Compound 241a::US10689346, Compound 241a::US11192861, Compound 241a::US11230530, Compound 241a::US11685721, Compound 241a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417012	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417012&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665936	433916923							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117380	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccccc1=O)C(F)(F)F	InChI=1S/C31H26F4N6O2/c32-23-10-8-20(25(11-6-18-4-5-18)40-14-2-1-3-28(40)42)15-24(23)38-30(43)26-17-27(31(33,34)35)39-41(26)21-9-7-19-12-13-37-29(36)22(19)16-21/h1-3,7-10,12-18,25H,4-6,11H2,(H2,36,37)(H,38,43)	GNDQLXKOPYFGBP-UHFFFAOYSA-N	417013	1-(1-aminoisoquinolin-7-yl)-N-(5-(3-cyclopropyl-1-(2-oxopyridin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 258g::US10633345, Compound 258g::US10689346, Compound 258g::US11203574, Compound 258g::US11230530, Compound 258g::US11685721, Compound 258g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417013	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417013&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355895	433916924							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117381	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C(N)=O)C(F)(F)F	InChI=1S/C31H30F4N6O2/c32-24-10-9-22(30(38,12-11-18-7-8-18)21-5-2-4-20(14-21)28(37)42)15-25(24)39-29(43)26-16-27(31(33,34)35)40-41(26)23-6-1-3-19(13-23)17-36/h1-6,9-10,13-16,18H,7-8,11-12,17,36,38H2,(H2,37,42)(H,39,43)	DYGHBBDYRMOWAC-UHFFFAOYSA-N	417014	(+-)-N-(5-(1-amino-1-(3-carbamoylphenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 225a::US10633345, Compound 225a::US10689346, Compound 225a::US11203574, Compound 225a::US11230530, Compound 225a::US11685721, Compound 225a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417014	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417014&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665606	433916925							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117382	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C31H28F4N6O/c32-25-10-9-23(30(38,12-11-19-7-8-19)22-5-1-3-20(13-22)17-36)15-26(25)39-29(42)27-16-28(31(33,34)35)40-41(27)24-6-2-4-21(14-24)18-37/h1-6,9-10,13-16,19H,7-8,11-12,18,37-38H2,(H,39,42)	ZBDDMFBNDOEVJT-UHFFFAOYSA-N	416996	(+)-N-(5-(1-amino-1-(3-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 214g::US10633345, Compound 215d::US10689346, Compound 215d::US11203574, Compound 215d::US11230530, Compound 215d::US11685721, Compound 215d	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416996	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416996&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665709	433916908							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117383	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccccc1=O)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-11-10-20(24(12-9-18-7-8-18)37-13-2-1-6-27(37)39)15-23(22)35-28(40)25-16-26(29(31,32)33)36-38(25)21-5-3-4-19(14-21)17-34/h1-6,10-11,13-16,18,24H,7-9,12,17,34H2,(H,35,40)	OFQQGSYWUFBMPP-UHFFFAOYSA-N	416939	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(2-oxopyridin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 248j::US10633345, Compound 248k::US10689346, Compound 248k::US11203574, Compound 248k::US11230530, Compound 248k::US11685721, Compound 248k	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416939	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416939&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355727	433916851							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117384	Nc1ncnc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H25F4N7O/c31-22-10-8-19(27(36-15-17-6-7-17)18-4-2-1-3-5-18)12-24(22)39-29(42)25-14-26(30(32,33)34)40-41(25)20-9-11-23-21(13-20)28(35)38-16-37-23/h1-5,8-14,16-17,27,36H,6-7,15H2,(H,39,42)(H2,35,37,38)	NOYPEPJWHRTGGG-UHFFFAOYSA-N	417011	1-(4-aminoquinazolin-6-yl)-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 224b::US10329260, Compound 226a::US10633345, Compound 226a::US10689346, Compound 226a::US11203574, Compound 226a::US11230530, Compound 226a::US11685721, Compound 226a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417011	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417011&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665806	433916922							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117385	NC(=N)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H27F4N7O/c30-22-9-8-19(28(36,11-10-17-6-7-17)20-4-2-12-37-16-20)14-23(22)38-27(41)24-15-25(29(31,32)33)39-40(24)21-5-1-3-18(13-21)26(34)35/h1-5,8-9,12-17H,6-7,10-11,36H2,(H3,34,35)(H,38,41)	JBCZLPFSSAYNEJ-UHFFFAOYSA-N	417018	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-1-(3-carbamimidoylphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 238d::US10633345, Compound 238d::US10689346, Compound 238d::US11192861, Compound 238d::US11230530, Compound 238d::US11685721, Compound 238d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417018	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417018&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355839	433916928							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117386	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccccc1=O)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-11-10-20(24(12-9-18-7-8-18)37-13-2-1-6-27(37)39)15-23(22)35-28(40)25-16-26(29(31,32)33)36-38(25)21-5-3-4-19(14-21)17-34/h1-6,10-11,13-16,18,24H,7-9,12,17,34H2,(H,35,40)	OFQQGSYWUFBMPP-UHFFFAOYSA-N	416939	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(2-oxopyridin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 248j::US10633345, Compound 248k::US10689346, Compound 248k::US11203574, Compound 248k::US11230530, Compound 248k::US11685721, Compound 248k	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416939	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416939&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355727	433916851							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117387	NC(=N)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N6O/c30-22-12-11-19(26(36-16-17-9-10-17)18-5-2-1-3-6-18)14-23(22)37-28(40)24-15-25(29(31,32)33)38-39(24)21-8-4-7-20(13-21)27(34)35/h1-8,11-15,17,26,36H,9-10,16H2,(H3,34,35)(H,37,40)	HUIANTFJQLRTEM-UHFFFAOYSA-N	439603	US10633345, Compound 227d::US10689346, Compound 227d::US11203574, Compound 227d::US11230530, Compound 227d::US11685721, Compound 227d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439603	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439603&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356162	439661151							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117388	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(nc1)C(N)=O)C(F)(F)F	InChI=1S/C30H29F4N7O2/c31-22-8-6-19(29(37,11-10-17-4-5-17)20-7-9-23(27(36)42)38-16-20)13-24(22)39-28(43)25-14-26(30(32,33)34)40-41(25)21-3-1-2-18(12-21)15-35/h1-3,6-9,12-14,16-17H,4-5,10-11,15,35,37H2,(H2,36,42)(H,39,43)	IQWHGFSUUIEJQU-UHFFFAOYSA-N	417021	(+)-5-(1-amino-1-(3-(1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamido)-4-fluorophenyl)-3-cyclopropylpropyl)picolinamide::US10329260, Compound 221i::US10633345, Compound 221i::US10689346, Compound 221i::US11203574, Compound 221i::US11230530, Compound 221i::US11685721, Compound 221i	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417021	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417021&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665782	433916931							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117389	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C30H25F4N7O/c31-23-6-4-20(27(38-16-17-1-2-17)19-7-10-36-11-8-19)13-24(23)39-29(42)25-15-26(30(32,33)34)40-41(25)21-5-3-18-9-12-37-28(35)22(18)14-21/h3-15,17,27,38H,1-2,16H2,(H2,35,37)(H,39,42)	UQWHIYYZYLIMKJ-UHFFFAOYSA-N	417004	(+-)-1-(1-aminoisoquinolin-7-yl)-N-(5-((cyclopropylmethylamino)(pyridin-4-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 265d::US10633345, Compound 264g::US10689346, Compound 264g::US11203574, Compound 264g::US11230530, Compound 264g::US11685721, Compound 264g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417004	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417004&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355979	433916916							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117390	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C(N)=O)C(F)(F)F	InChI=1S/C31H30F4N6O2/c32-24-11-10-22(30(38,13-12-18-4-5-18)21-8-6-20(7-9-21)28(37)42)15-25(24)39-29(43)26-16-27(31(33,34)35)40-41(26)23-3-1-2-19(14-23)17-36/h1-3,6-11,14-16,18H,4-5,12-13,17,36,38H2,(H2,37,42)(H,39,43)	HZQICPCUMLWHPZ-UHFFFAOYSA-N	417023	(+)-N-(5-(1-amino-1-(4-carbamoylphenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 228a::US10633345, Compound 228a::US10689346, Compound 228a::US11203574, Compound 228a::US11230530, Compound 228a::US11685721, Compound 228a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417023	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417023&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665484	433916933							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117391	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-23-7-6-21(28(35,11-8-18-4-5-18)20-9-12-36-13-10-20)15-24(23)37-27(40)25-16-26(29(31,32)33)38-39(25)22-3-1-2-19(14-22)17-34/h1-3,6-7,9-10,12-16,18H,4-5,8,11,17,34-35H2,(H,37,40)	AGVFYPDLNPHKER-UHFFFAOYSA-N	417024	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-4-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 216d::US10633345, Compound 217d::US10689346, Compound 217d::US11192861, Compound 217d::US11230530, Compound 217d::US11685721, Compound 217d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417024	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417024&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665723	433916934							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117392	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)N1CCCCC1=O)C(F)(F)F	InChI=1S/C29H31F4N5O2/c30-22-11-10-20(24(12-9-18-7-8-18)37-13-2-1-6-27(37)39)15-23(22)35-28(40)25-16-26(29(31,32)33)36-38(25)21-5-3-4-19(14-21)17-34/h3-5,10-11,14-16,18,24H,1-2,6-9,12-13,17,34H2,(H,35,40)	BPULHNPIKAHCAG-UHFFFAOYSA-N	417025	(+)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(2-oxopiperidin-1-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 261k::US10633345, Compound 261k::US10689346, Compound 261k::US11203574, Compound 261k::US11230530, Compound 261k::US11685721, Compound 261k	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417025	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417025&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123312183	433916935							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117393	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(N)=O	InChI=1S/C29H29FN6O2/c30-23-12-11-21(27(33-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)34-29(38)26-15-25(28(32)37)35-36(26)22-8-4-5-19(13-22)16-31/h1-8,11-15,18,27,33H,9-10,16-17,31H2,(H2,32,37)(H,34,38)	UMNCVWUVWBVXCX-UHFFFAOYSA-N	417026	(+-)-1-(3-(aminomethyl)phenyl)-N5-(5-((cyclopropylmethylamino)-(phenyl)methyl)-2-fluorophenyl)-1H-pyrazole-3,5-dicarboxamide::US10329260, Compound 229i::US10633345, Compound 229i::US10689346, Compound 229i::US11203574, Compound 229i::US11230530, Compound 229i::US11685721, Compound 229i	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417026	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417026&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665747	433916936							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117394	CC(C)(C)[S@@](=O)NC(CCC1CC1)(c1cccnc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C33H36F4N6O2S/c1-31(2,3)46(45)42-32(14-13-21-9-10-21,24-7-5-15-39-20-24)23-11-12-26(34)27(17-23)40-30(44)28-18-29(33(35,36)37)41-43(28)25-8-4-6-22(16-25)19-38/h4-8,11-12,15-18,20-21,42H,9-10,13-14,19,38H2,1-3H3,(H,40,44)/t32?,46-/m1/s1	LAOWFCURFGDGCT-ODZHGNIVSA-N	417027	1-(3-(aminomethyl)phenyl)-N-(5-((+-)-3-cyclopropyl-1-((R)-1,1-dimethylethylsulfinamido)-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 243a::US10633345, Compound 243a::US10689346, Compound 243a::US11203574, Compound 243a::US11230530, Compound 243a::US11685721, Compound 243a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417027	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417027&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665825	433916937							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117395	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccncc1=O)C(F)(F)F	InChI=1S/C30H25F4N7O2/c31-22-7-5-19(24(8-3-17-1-2-17)40-12-11-36-16-27(40)42)13-23(22)38-29(43)25-15-26(30(32,33)34)39-41(25)20-6-4-18-9-10-37-28(35)21(18)14-20/h4-7,9-17,24H,1-3,8H2,(H2,35,37)(H,38,43)	RGAKSJSQGQBUGG-UHFFFAOYSA-N	417028	1-(1-aminoisoquinolin-7-yl)-N-(5-(3-cyclopropyl-1-(2-oxopyrazin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 259d::US10633345, Compound 259d::US10689346, Compound 259d::US11203574, Compound 259d::US11230530, Compound 259d::US11685721, Compound 259d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417028	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417028&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355792	433916938							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117396	NC(=O)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H25F4N5O2/c30-22-12-11-19(26(35-16-17-9-10-17)18-5-2-1-3-6-18)14-23(22)36-28(40)24-15-25(29(31,32)33)37-38(24)21-8-4-7-20(13-21)27(34)39/h1-8,11-15,17,26,35H,9-10,16H2,(H2,34,39)(H,36,40)	JMSFBJDWVQAENA-UHFFFAOYSA-N	417029	(+-)-1-(3-carbamoylphenyl)-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 230a::US10633345, Compound 230a::US10689346, Compound 230a::US11203574, Compound 230a::US11230530, Compound 230a::US11685721, Compound 230a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417029	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417029&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665857	433916939							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117397	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-23-7-6-21(28(35,11-8-18-4-5-18)20-9-12-36-13-10-20)15-24(23)37-27(40)25-16-26(29(31,32)33)38-39(25)22-3-1-2-19(14-22)17-34/h1-3,6-7,9-10,12-16,18H,4-5,8,11,17,34-35H2,(H,37,40)	AGVFYPDLNPHKER-UHFFFAOYSA-N	417024	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-4-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 216d::US10633345, Compound 217d::US10689346, Compound 217d::US11192861, Compound 217d::US11230530, Compound 217d::US11685721, Compound 217d	Plasma kallikrein		 75.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417024	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417024&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665723	433916934							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117398	Cc1cc(ccn1)C(N)(CCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F4N6O/c1-18-13-22(10-12-37-18)29(36,11-9-19-5-6-19)21-7-8-24(31)25(15-21)38-28(41)26-16-27(30(32,33)34)39-40(26)23-4-2-3-20(14-23)17-35/h2-4,7-8,10,12-16,19H,5-6,9,11,17,35-36H2,1H3,(H,38,41)	PYONXWOUVYIBRU-UHFFFAOYSA-N	417031	(+)-N-(5-(1-amino-3-cyclopropyl-1-(2-methylpyridin-4-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 266j::US10633345, Compound 266j::US10689346, Compound 266j::US11203574, Compound 266j::US11230530, Compound 266j::US11685721, Compound 266j	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417031	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417031&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665585	433916941							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117399	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccc(=O)[nH]c1=O)C(F)(F)F			417032	1-(1-aminoisoquinolin-7-yl)-N-(5-(3-cyclopropyl-1-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 269b::US10633345, Compound 269b::US10689346, Compound 269b::US11203574, Compound 269b::US11230530, Compound 269b::US11685721, Compound 269b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417032	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417032&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			154584237	433916942							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120164	COc1ccc2ccccc2c1C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H32F3N5O2/c1-44-29-15-14-23-7-2-3-11-27(23)31(29)32(39-20-21-12-13-21)24-8-5-9-25(17-24)40-33(43)28-18-30(34(35,36)37)41-42(28)26-10-4-6-22(16-26)19-38/h2-11,14-18,21,32,39H,12-13,19-20,38H2,1H3,(H,40,43)	XVOUQCJHWNZPKF-UHFFFAOYSA-N	416841	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2-methoxynaphthalen-1-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 51f::US10633345, Compound 51f::US10689346, Compound 51f::US11203574, Compound 51h::US11230530, Compound 51h::US11685721, Compound 51f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416841	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416841&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356155	433916754							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120165	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C30H25F4N5O2/c31-24-10-9-22(28(41-17-18-7-8-18)21-5-1-3-19(11-21)15-35)13-25(24)37-29(40)26-14-27(30(32,33)34)38-39(26)23-6-2-4-20(12-23)16-36/h1-6,9-14,18,28H,7-8,16-17,36H2,(H,37,40)	LSXFYXGKZDVRTL-UHFFFAOYSA-N	416900	1-(3-(aminomethyl)phenyl)-N-(5-((3-cyanophenyl)(cyclopropyl-methoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 56c::US10633345, Compound 72d::US10689346, Compound 56c::US11203574, Compound 72d::US11230530, Compound 72d::US11685721, Compound 72d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416900	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416900&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356211	433916813							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120166	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccc(=O)[nH]c1=O)C(F)(F)F			416960	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 263d::US10633345, Compound 263d::US10689346, Compound 263d::US11203574, Compound 263d::US11230530, Compound 263d::US11685721, Compound 263d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416960	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416960&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			154584232	433916872							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120167	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-25(37(36-26)24-9-1-4-19(12-24)16-33)28(38)35-23-8-3-6-21(14-23)27(39-17-18-10-11-18)20-5-2-7-22(34)13-20/h1-9,12-15,18,27H,10-11,16-17,33-34H2,(H,35,38)	FPQYUIIRVBKUDH-UHFFFAOYSA-N	416867	1-(3-(aminomethyl)phenyl)-N-(3-((3-aminophenyl)(cyclopropyl-methoxy)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 53f::US10633345, Compound 53f::US10689346, Compound 53f::US11203574, Compound 64b::US11230530, Compound 64b::US11685721, Compound 49j	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416867	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416867&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355845	433916780							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120168	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1O)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-11-10-19(27(35-16-17-8-9-17)21-6-1-2-7-25(21)39)13-23(22)36-28(40)24-14-26(29(31,32)33)37-38(24)20-5-3-4-18(12-20)15-34/h1-7,10-14,17,27,35,39H,8-9,15-16,34H2,(H,36,40)	CKWWRAGQIQAYTL-UHFFFAOYSA-N	416856	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(2-hydroxyphenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 60e::US10633345, Compound 66b::US10689346, Compound 60e::US11203574, Compound 66b::US11230530, Compound 66b::US11685721, Compound 60e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416856	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416856&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665480	433916769							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120169	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1ccc(cc1F)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-23-14-21(27(39-17-18-9-10-18)20-6-2-1-3-7-20)11-12-24(23)35-28(38)25-15-26(29(31,32)33)36-37(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27H,9-10,16-17,34H2,(H,35,38)	HBXVQXKJLUQKAE-UHFFFAOYSA-N	416963	1-(3-(aminomethyl)phenyl)-N-(4-((cyclopropylmethoxy)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 15g::US10633345, Compound 15g::US10689346, Compound 15g::US11203574, Compound 15g::US11230530, Compound 15g::US11685721, Compound 15g	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416963	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416963&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355605	433916875							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120170	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-25(37(36-26)24-9-1-4-19(12-24)16-33)28(38)35-23-8-3-6-21(14-23)27(39-17-18-10-11-18)20-5-2-7-22(34)13-20/h1-9,12-15,18,27H,10-11,16-17,33-34H2,(H,35,38)	FPQYUIIRVBKUDH-UHFFFAOYSA-N	416867	1-(3-(aminomethyl)phenyl)-N-(3-((3-aminophenyl)(cyclopropyl-methoxy)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 53f::US10633345, Compound 53f::US10689346, Compound 53f::US11203574, Compound 64b::US11230530, Compound 64b::US11685721, Compound 49j	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416867	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416867&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355845	433916780							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120171	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1O)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-11-10-19(27(35-16-17-8-9-17)21-6-1-2-7-25(21)39)13-23(22)36-28(40)24-14-26(29(31,32)33)37-38(24)20-5-3-4-18(12-20)15-34/h1-7,10-14,17,27,35,39H,8-9,15-16,34H2,(H,36,40)	CKWWRAGQIQAYTL-UHFFFAOYSA-N	416856	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(2-hydroxyphenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 60e::US10633345, Compound 66b::US10689346, Compound 60e::US11203574, Compound 66b::US11230530, Compound 66b::US11685721, Compound 60e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416856	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416856&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665480	433916769							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120172	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1ccc(cc1F)C(O)c1ccccc1)C(F)(F)F	InChI=1S/C25H20F4N4O2/c26-19-12-17(23(34)16-6-2-1-3-7-16)9-10-20(19)31-24(35)21-13-22(25(27,28)29)32-33(21)18-8-4-5-15(11-18)14-30/h1-13,23,34H,14,30H2,(H,31,35)	WVBOXESRKOBMTK-UHFFFAOYSA-N	416966	1-(3-(Aminomethyl)phenyl)-N-(2-fluoro-4-(hydroxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 16b::US10633345, Compound 16b::US10689346, Compound 16b::US11203574, Compound 16b::US11230530, Compound 16b::US11685721, Compound 16b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416966	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416966&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665483	433916878							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120173	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1O)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-24(37(36-26)22-8-3-5-19(13-22)16-33)28(39)35-21-7-4-6-20(14-21)27(34-17-18-11-12-18)23-9-1-2-10-25(23)38/h1-10,13-15,18,27,34,38H,11-12,16-17,33H2,(H,35,39)	PCNDJIQOMLHSEK-UHFFFAOYSA-N	416837	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2-hydroxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 49h::US10633345, Compound 49h::US10689346, Compound 49h::US11203574, Compound 49j::US11230530, Compound 49j::US11685721, Compound 49h	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416837	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416837&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355733	433916750							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120174	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-23-12-11-21(27(39-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)35-28(38)25-15-26(29(31,32)33)36-37(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27H,9-10,16-17,34H2,(H,35,38)	HIMJVDQVZQMIPM-UHFFFAOYSA-N	416747	1-(3-(Aminomethyl)phenyl)-N-(5-((cyclopropylmethoxy)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 34c::US10633345, Compound 34c::US10689346, Compound 34c::US11203574, Compound 37a::US11230530, Compound 37a::US11685721, Compound 34c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416747	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416747&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355729	433916661							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120175	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1c(F)cccc1C(O)c1ccccc1)C(F)(F)F	InChI=1S/C25H20F4N4O2/c26-19-11-5-10-18(23(34)16-7-2-1-3-8-16)22(19)31-24(35)20-13-21(25(27,28)29)32-33(20)17-9-4-6-15(12-17)14-30/h1-13,23,34H,14,30H2,(H,31,35)	PIMJYQUHLMMZIO-UHFFFAOYSA-N	416969	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-6-(hydroxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 90f::US10633345, Compound 90f::US10689346, Compound 90f::US11203574, Compound 90f::US11230530, Compound 90f::US11685721, Compound 90f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416969	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416969&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356272	433916881							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120176	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1O)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-24(37(36-26)22-8-3-5-19(13-22)16-33)28(39)35-21-7-4-6-20(14-21)27(34-17-18-11-12-18)23-9-1-2-10-25(23)38/h1-10,13-15,18,27,34,38H,11-12,16-17,33H2,(H,35,39)	PCNDJIQOMLHSEK-UHFFFAOYSA-N	416837	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2-hydroxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 49h::US10633345, Compound 49h::US10689346, Compound 49h::US11203574, Compound 49j::US11230530, Compound 49j::US11685721, Compound 49h	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416837	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416837&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355733	433916750							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120177	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-23-12-11-21(27(39-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)35-28(38)25-15-26(29(31,32)33)36-37(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27H,9-10,16-17,34H2,(H,35,38)	HIMJVDQVZQMIPM-UHFFFAOYSA-N	416747	1-(3-(Aminomethyl)phenyl)-N-(5-((cyclopropylmethoxy)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 34c::US10633345, Compound 34c::US10689346, Compound 34c::US11203574, Compound 37a::US11230530, Compound 37a::US11685721, Compound 34c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416747	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416747&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355729	433916661							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120178	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N(CC1CC1)CC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C33H33F4N5O/c34-27-14-13-25(31(24-6-2-1-3-7-24)41(19-21-9-10-21)20-22-11-12-22)16-28(27)39-32(43)29-17-30(33(35,36)37)40-42(29)26-8-4-5-23(15-26)18-38/h1-8,13-17,21-22,31H,9-12,18-20,38H2,(H,39,43)	FVEYNTAGBBDICV-UHFFFAOYSA-N	416972	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-((bis(cyclopropylmethyl)amino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 206d::US10633345, Compound 206d::US10689346, Compound 206d::US11203574, Compound 206d::US11230530, Compound 206d::US11685721, Compound 206d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416972	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416972&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355791	433916884							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120179	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C#N)C(N)=O	InChI=1S/C31H30FN7O2/c32-25-11-10-23(31(36,13-12-19-4-5-19)22-8-6-20(17-33)7-9-22)15-26(25)37-30(41)28-16-27(29(35)40)38-39(28)24-3-1-2-21(14-24)18-34/h1-3,6-11,14-16,19H,4-5,12-13,18,34,36H2,(H2,35,40)(H,37,41)	BCLQAOJZVSDWEP-UHFFFAOYSA-N	416973	(+)-N5-(5-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-1H-pyrazole-3,5-dicarboxamide::US10329260, Compound 231d::US10633345, Compound 231d::US10689346, Compound 231d::US11203574, Compound 231d::US11230530, Compound 231d::US11685721, Compound 231d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416973	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416973&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665708	433916885							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120180	CC(C)(C)C(=O)NC(CCC1CC1)(c1cccnc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H36F4N6O2/c1-32(2,3)31(46)42-33(14-13-21-9-10-21,24-7-5-15-40-20-24)23-11-12-26(35)27(17-23)41-30(45)28-18-29(34(36,37)38)43-44(28)25-8-4-6-22(16-25)19-39/h4-8,11-12,15-18,20-21H,9-10,13-14,19,39H2,1-3H3,(H,41,45)(H,42,46)	QDJVSPVHYSLBHH-UHFFFAOYSA-N	416974	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-pivalamido-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 244g::US10689346, Compound 244g::US11203574, Compound 244g::US11230530, Compound 244g::US11685721, Compound 244g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416974	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416974&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665924	433916886							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120181	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-22-10-9-20(28(35,12-11-18-7-8-18)25-6-1-2-13-36-25)15-23(22)37-27(40)24-16-26(29(31,32)33)38-39(24)21-5-3-4-19(14-21)17-34/h1-6,9-10,13-16,18H,7-8,11-12,17,34-35H2,(H,37,40)	IFWBAIGKQKRJGJ-UHFFFAOYSA-N	416975	(+-)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 205d::US10633345, Compound 205c::US10689346, Compound 205e::US11203574, Compound 205e::US11230530, Compound 205e::US11685721, Compound 205f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416975	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416975&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665627	433916887							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120182	ONC(=N)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N6O2/c30-22-12-11-19(26(35-16-17-9-10-17)18-5-2-1-3-6-18)14-23(22)36-28(40)24-15-25(29(31,32)33)37-39(24)21-8-4-7-20(13-21)27(34)38-41/h1-8,11-15,17,26,35,41H,9-10,16H2,(H2,34,38)(H,36,40)	RKUBSDCTAQRJEX-UHFFFAOYSA-N	416976	(+-)-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-1-(3-(N-hydroxycarbamimidoyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 232a::US10633345, Compound 232a::US10689346, Compound 232a::US11203574, Compound 232a::US11230530, Compound 232a::US11685721, Compound 232a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416976	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416976&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665466	433916888							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120183	CC(=O)NC(CCC1CC1)(c1cccnc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C31H30F4N6O2/c1-19(42)39-30(12-11-20-7-8-20,23-5-3-13-37-18-23)22-9-10-25(32)26(15-22)38-29(43)27-16-28(31(33,34)35)40-41(27)24-6-2-4-21(14-24)17-36/h2-6,9-10,13-16,18,20H,7-8,11-12,17,36H2,1H3,(H,38,43)(H,39,42)	NXVHVPBDWBOZQI-UHFFFAOYSA-N	416977	(+-)-N-(5-(1-acetamido-3-cyclopropyl-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 244h::US10633345, Compound 244h::US10689346, Compound 244h::US11203574, Compound 244h::US11230530, Compound 244h::US11685721, Compound 244h	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416977	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416977&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355894	433916889							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120184	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-22-10-9-20(28(35,12-11-18-7-8-18)25-6-1-2-13-36-25)15-23(22)37-27(40)24-16-26(29(31,32)33)38-39(24)21-5-3-4-19(14-21)17-34/h1-6,9-10,13-16,18H,7-8,11-12,17,34-35H2,(H,37,40)	IFWBAIGKQKRJGJ-UHFFFAOYSA-N	416975	(+-)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 205d::US10633345, Compound 205c::US10689346, Compound 205e::US11203574, Compound 205e::US11230530, Compound 205e::US11685721, Compound 205f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416975	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416975&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665627	433916887							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120185	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(O)=O	InChI=1S/C29H28FN5O3/c30-23-12-11-21(27(32-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)33-28(36)26-15-25(29(37)38)34-35(26)22-8-4-5-19(13-22)16-31/h1-8,11-15,18,27,32H,9-10,16-17,31H2,(H,33,36)(H,37,38)	XPAISISGRLZRHF-UHFFFAOYSA-N	416979	(+)-1-(3-(aminomethyl)phenyl)-5-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenylcarbamoyl)-1H-pyrazole-3-carboxylic acid::US10329260, Compound 246f::US10633345, Compound 246f::US10689346, Compound 246f::US11203574, Compound 246f::US11230530, Compound 246f::US11685721, Compound 246f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416979	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416979&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356041	433916891							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120186	CCC(=O)NC(CCC1CC1)(c1cccnc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C32H32F4N6O2/c1-2-29(43)40-31(13-12-20-8-9-20,23-6-4-14-38-19-23)22-10-11-25(33)26(16-22)39-30(44)27-17-28(32(34,35)36)41-42(27)24-7-3-5-21(15-24)18-37/h3-7,10-11,14-17,19-20H,2,8-9,12-13,18,37H2,1H3,(H,39,44)(H,40,43)	VLEWWVBFKVHAND-UHFFFAOYSA-N	416980	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-propionamido-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 244i::US10633345, Compound 244i::US10689346, Compound 244i::US11203574, Compound 244i::US11230530, Compound 244j::US11685721, Compound 244i	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416980	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416980&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665945	433916892							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120187	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-23-9-8-20(28(35,11-10-18-6-7-18)21-4-2-12-36-17-21)14-24(23)37-27(40)25-15-26(29(31,32)33)38-39(25)22-5-1-3-19(13-22)16-34/h1-5,8-9,12-15,17-18H,6-7,10-11,16,34-35H2,(H,37,40)	QXMQDWOYOXVOQZ-UHFFFAOYSA-N	416981	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 208d::US10633345, Compound 209d::US10689346, Compound 209d::US11203574, Compound 209d::US11230530, Compound 209d::US11685721, Compound 209d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416981	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416981&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355646	433916893							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120188	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C#N)C#N	InChI=1S/C31H28FN7O/c32-27-11-10-24(31(36,13-12-20-4-5-20)23-8-6-21(17-33)7-9-23)15-28(27)37-30(40)29-16-25(19-35)38-39(29)26-3-1-2-22(14-26)18-34/h1-3,6-11,14-16,20H,4-5,12-13,18,34,36H2,(H,37,40)	SWSSXIJHEDUEIQ-UHFFFAOYSA-N	416982	(+)-N-(5-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-cyano-1H-pyrazole-5-carboxamide::US10329260, Compound 234d::US10633345, Compound 234d::US10689346, Compound 234d::US11203574, Compound 234d::US11230530, Compound 234d::US11685721, Compound 234d	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416982	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416982&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356248	433916894							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120189	CC(C)C(=O)NC(CCC1CC1)(c1cccnc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C33H34F4N6O2/c1-20(2)30(44)41-32(13-12-21-8-9-21,24-6-4-14-39-19-24)23-10-11-26(34)27(16-23)40-31(45)28-17-29(33(35,36)37)42-43(28)25-7-3-5-22(15-25)18-38/h3-7,10-11,14-17,19-21H,8-9,12-13,18,38H2,1-2H3,(H,40,45)(H,41,44)	POAUUALSNYEBRU-UHFFFAOYSA-N	416983	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-isobutyramido-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 244j::US10633345, Compound 244j::US10689346, Compound 244j::US11203574, Compound 244j::US11685721, Compound 244j	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416983	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416983&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356184	433916895							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120190	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-23-9-8-20(28(35,11-10-18-6-7-18)21-4-2-12-36-17-21)14-24(23)37-27(40)25-15-26(29(31,32)33)38-39(25)22-5-1-3-19(13-22)16-34/h1-5,8-9,12-15,17-18H,6-7,10-11,16,34-35H2,(H,37,40)	QXMQDWOYOXVOQZ-UHFFFAOYSA-N	416981	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 208d::US10633345, Compound 209d::US10689346, Compound 209d::US11203574, Compound 209d::US11230530, Compound 209d::US11685721, Compound 209d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416981	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416981&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355646	433916893							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120191	COc1ccc(Cn2ccc3ccc(cc3c2=N)-n2nc(cc2C(O)=O)C(F)(F)F)c(OC)c1	InChI=1S/C23H19F3N4O4/c1-33-16-6-4-14(19(10-16)34-2)12-29-8-7-13-3-5-15(9-17(13)21(29)27)30-18(22(31)32)11-20(28-30)23(24,25)26/h3-11,27H,12H2,1-2H3,(H,31,32)	IOVSTWDPPGGMGX-UHFFFAOYSA-N	529802	US11203574, Compound 235g::US11230530, Compound 235g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=529802	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=529802&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355633	463793324							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120192	CC(C)CC(=O)NC(CCC1CC1)(c1cccnc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H36F4N6O2/c1-21(2)15-31(45)42-33(13-12-22-8-9-22,25-6-4-14-40-20-25)24-10-11-27(35)28(17-24)41-32(46)29-18-30(34(36,37)38)43-44(29)26-7-3-5-23(16-26)19-39/h3-7,10-11,14,16-18,20-22H,8-9,12-13,15,19,39H2,1-2H3,(H,41,46)(H,42,45)	WIIQCCUTLYCVOE-UHFFFAOYSA-N	416986	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(3-methylbutanamido)-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 244k::US10633345, Compound 244k::US10689346, Compound 244k::US11203574, Compound 244k::US11230530, Compound 244k::US11685721, Compound 244k	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416986	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416986&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665507	433916898							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120193	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F4N5O/c31-24-12-11-22(29(36,14-13-19-9-10-19)21-6-2-1-3-7-21)16-25(24)37-28(40)26-17-27(30(32,33)34)38-39(26)23-8-4-5-20(15-23)18-35/h1-8,11-12,15-17,19H,9-10,13-14,18,35-36H2,(H,37,40)	NQFNNZJJOCPZCP-UHFFFAOYSA-N	416987	(+-)-N-(5-(1-amino-3-cyclopropyl-1-phenylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 210d::US10633345, Compound 211d::US10689346, Compound 211d::US11203574, Compound 211d::US11230530, Compound 211d::US11685721, Compound 211d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416987	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416987&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355764	433916899							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120194	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(N)(CCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C31H29F3N6O/c32-31(33,34)28-17-27(40(39-28)26-6-1-3-22(15-26)19-36)29(41)38-25-5-2-4-24(16-25)30(37,14-13-20-7-8-20)23-11-9-21(18-35)10-12-23/h1-6,9-12,15-17,20H,7-8,13-14,19,36-37H2,(H,38,41)	WPWCLOAAAHRQMG-UHFFFAOYSA-N	416988	(+)-N-(3-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)phenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 218c::US10633345, Compound 218c::US10689346, Compound 218c::US11203574, Compound 218c::US11230530, Compound 218c::US11685721, Compound 218c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416988	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416988&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356070	433916900							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120195	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C31H27F4N7O/c32-24-6-4-21(30(37,11-7-18-1-2-18)20-9-12-38-13-10-20)15-25(24)40-29(43)26-17-27(31(33,34)35)41-42(26)22-5-3-19-8-14-39-28(36)23(19)16-22/h3-6,8-10,12-18H,1-2,7,11,37H2,(H2,36,39)(H,40,43)	BGYDOWYGLFEYGE-UHFFFAOYSA-N	416989	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-4-yl)propyl)-2-fluorophenyl)-1-(1-aminoisoquinolin-7-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 253e::US10633345, Compound 253e::US10689346, Compound 253e::US11203574, Compound 253e::US11230530, Compound 253e::US11685721, Compound 253e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416989	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416989&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665703	433916901							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120196	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F4N5O/c31-24-12-11-22(29(36,14-13-19-9-10-19)21-6-2-1-3-7-21)16-25(24)37-28(40)26-17-27(30(32,33)34)38-39(26)23-8-4-5-20(15-23)18-35/h1-8,11-12,15-17,19H,9-10,13-14,18,35-36H2,(H,37,40)	NQFNNZJJOCPZCP-UHFFFAOYSA-N	416987	(+-)-N-(5-(1-amino-3-cyclopropyl-1-phenylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 210d::US10633345, Compound 211d::US10689346, Compound 211d::US11203574, Compound 211d::US11230530, Compound 211d::US11685721, Compound 211d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416987	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416987&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355764	433916899							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120197	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(N)(CCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C31H29F3N6O/c32-31(33,34)28-17-27(40(39-28)26-9-2-5-22(15-26)19-36)29(41)38-25-8-3-7-24(16-25)30(37,13-12-20-10-11-20)23-6-1-4-21(14-23)18-35/h1-9,14-17,20H,10-13,19,36-37H2,(H,38,41)	JHGXWQQOSIGIHO-UHFFFAOYSA-N	416991	(+)-N-(3-(1-amino-1-(3-cyanophenyl)-3-cyclopropylpropyl)phenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 219c::US10633345, Compound 219c::US10689346, Compound 219c::US11203574, Compound 219c::US11230530, Compound 219c::US11685721, Compound 219c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416991	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416991&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355760	433916903							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120198	CS(=O)(=O)NC(CCC1CC1)(c1ccncc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F4N6O3S/c1-44(42,43)39-29(12-9-19-5-6-19,21-10-13-36-14-11-21)22-7-8-24(31)25(16-22)37-28(41)26-17-27(30(32,33)34)38-40(26)23-4-2-3-20(15-23)18-35/h2-4,7-8,10-11,13-17,19,39H,5-6,9,12,18,35H2,1H3,(H,37,41)	SFWRGGJAWAJGGN-UHFFFAOYSA-N	416992	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(methylsulfonamido)-1-(pyridin-4-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 245c::US10633345, Compound 245c::US10689346, Compound 245c::US11203574, Compound 245c::US11230530, Compound 245c::US11685721, Compound 245c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416992	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416992&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355707	433916904							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120199	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C31H28F4N6O/c32-25-11-10-23(30(38,13-12-19-4-5-19)22-8-6-20(17-36)7-9-22)15-26(25)39-29(42)27-16-28(31(33,34)35)40-41(27)24-3-1-2-21(14-24)18-37/h1-3,6-11,14-16,19H,4-5,12-13,18,37-38H2,(H,39,42)	JCBKPNPCGNTAQN-UHFFFAOYSA-N	416993	(+)-N-(5-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 212g::US10633345, Compound 213d::US10689346, Compound 213d::US11203574, Compound 213d::US11230530, Compound 213d::US11685721, Compound 213d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416993	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416993&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356170	433916905							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120200	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C(N)=O)C#N	InChI=1S/C31H30FN7O2/c32-26-11-10-23(31(36,13-12-19-4-5-19)22-8-6-21(7-9-22)29(35)40)15-27(26)37-30(41)28-16-24(18-34)38-39(28)25-3-1-2-20(14-25)17-33/h1-3,6-11,14-16,19H,4-5,12-13,17,33,36H2,(H2,35,40)(H,37,41)	KLZOEGIZCNFTHC-UHFFFAOYSA-N	416994	(-)-N-(5-(1-amino-1-(4-carbamoylphenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-cyano-1H-pyrazole-5-carboxamide::US10329260, Compound 239d::US10633345, Compound 239c::US10689346, Compound 239d::US11203574, Compound 239d::US11685721, Compound 239d	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416994	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416994&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356225	433916906							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120201	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C32H25F4N7O/c33-25-9-7-22(29(40-17-18-4-5-18)21-3-1-2-19(12-21)16-37)13-26(25)41-31(44)27-15-28(32(34,35)36)42-43(27)23-8-6-20-10-11-39-30(38)24(20)14-23/h1-3,6-15,18,29,40H,4-5,17H2,(H2,38,39)(H,41,44)	PQPAZBKFVDKERF-UHFFFAOYSA-N	439578	US10633345, Compound 257b::US10689346, Compound 257b::US11203574, Compound 257b::US11230530, Compound 257b::US11685721, Compound 257b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439578	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439578&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665471	439661126							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120202	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C31H28F4N6O/c32-25-10-9-23(30(38,12-11-19-7-8-19)22-5-1-3-20(13-22)17-36)15-26(25)39-29(42)27-16-28(31(33,34)35)40-41(27)24-6-2-4-21(14-24)18-37/h1-6,9-10,13-16,19H,7-8,11-12,18,37-38H2,(H,39,42)	ZBDDMFBNDOEVJT-UHFFFAOYSA-N	416996	(+)-N-(5-(1-amino-1-(3-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 214g::US10633345, Compound 215d::US10689346, Compound 215d::US11203574, Compound 215d::US11230530, Compound 215d::US11685721, Compound 215d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416996	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416996&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665709	433916908							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120203	NC(=O)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C31H26F4N6O2/c32-24-10-9-22(30(38,12-11-18-7-8-18)21-5-1-3-19(13-21)17-36)15-25(24)39-29(43)26-16-27(31(33,34)35)40-41(26)23-6-2-4-20(14-23)28(37)42/h1-6,9-10,13-16,18H,7-8,11-12,38H2,(H2,37,42)(H,39,43)	MJBRNYICMOSPEH-UHFFFAOYSA-N	416997	(+-)-N-(5-(1-amino-1-(3-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-carbamoylphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 267c::US10633345, Compound 267c::US10689346, Compound 267c::US11203574, Compound 267c::US11230530, Compound 267c::US11685721, Compound 267c	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416997	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416997&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665760	433916909							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120204	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C33H27F4N7O/c34-26-10-8-23(32(40,13-11-19-1-2-19)22-6-3-20(18-38)4-7-22)15-27(26)42-31(45)28-17-29(33(35,36)37)43-44(28)24-9-5-21-12-14-41-30(39)25(21)16-24/h3-10,12,14-17,19H,1-2,11,13,40H2,(H2,39,41)(H,42,45)	QUIZETAQJOZQJA-UHFFFAOYSA-N	416998	(+)-N-(5-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(1-aminoisoquinolin-7-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 254c::US10633345, Compound 254c::US10689346, Compound 254c::US11203574, Compound 254c::US11230530, Compound 254c::US11685721, Compound 254c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416998	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416998&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665477	433916910							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120205	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C31H28F4N6O/c32-25-11-10-23(30(38,13-12-19-4-5-19)22-8-6-20(17-36)7-9-22)15-26(25)39-29(42)27-16-28(31(33,34)35)40-41(27)24-3-1-2-21(14-24)18-37/h1-3,6-11,14-16,19H,4-5,12-13,18,37-38H2,(H,39,42)	JCBKPNPCGNTAQN-UHFFFAOYSA-N	416993	(+)-N-(5-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 212g::US10633345, Compound 213d::US10689346, Compound 213d::US11203574, Compound 213d::US11230530, Compound 213d::US11685721, Compound 213d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416993	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416993&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356170	433916905							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120206	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C#N	InChI=1S/C29H27FN6O/c30-25-12-11-22(28(33-18-19-9-10-19)21-6-2-1-3-7-21)14-26(25)34-29(37)27-15-23(17-32)35-36(27)24-8-4-5-20(13-24)16-31/h1-8,11-15,19,28,33H,9-10,16,18,31H2,(H,34,37)	OBANZZDEWOCPST-UHFFFAOYSA-N	417000	(+-)-1-(3-(aminomethyl)phenyl)-3-cyano-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 240b::US10633345, Compound 240b::US10689346, Compound 240b::US11203574, Compound 240b::US11230530, Compound 240b::US11685721, Compound 240b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417000	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417000&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355661	433916912							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120207	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C32H28F4N6O/c33-25-11-9-22(31(38,14-12-19-6-7-19)21-4-2-1-3-5-21)16-26(25)40-30(43)27-18-28(32(34,35)36)41-42(27)23-10-8-20-13-15-39-29(37)24(20)17-23/h1-5,8-11,13,15-19H,6-7,12,14,38H2,(H2,37,39)(H,40,43)	SUIQVQQNEUOJQB-UHFFFAOYSA-N	417001	(+)-N-(5-(1-amino-3-cyclopropyl-1-phenylpropyl)-2-fluorophenyl)-1-(1-aminoisoquinolin-7-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 255a::US10633345, Compound 255a::US10689346, Compound 255a::US11203574, Compound 255a::US11230530, Compound 255a::US11685721, Compound 255a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417001	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417001&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356059	433916913							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120208	Nc1noc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H24F4N6O2/c30-21-10-8-18(26(35-15-16-6-7-16)17-4-2-1-3-5-17)12-22(21)36-28(40)23-14-25(29(31,32)33)37-39(23)19-9-11-24-20(13-19)27(34)38-41-24/h1-5,8-14,16,26,35H,6-7,15H2,(H2,34,38)(H,36,40)	QWKNFIFTTXOPHF-UHFFFAOYSA-N	417002	(+-)-1-(3-aminobenzo[d]isoxazol-5-yl)-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 222k::US10329260, Compound 223f::US10633345, Compound 223f::US10689346, Compound 223f::US11203574, Compound 223f::US11230530, Compound 223f::US11685721, Compound 223f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417002	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417002&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123289526	433916914							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120209	NC(=N)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C30H25F4N7O/c31-23-10-9-20(27(38-16-17-7-8-17)19-4-1-3-18(11-19)15-35)13-24(23)39-29(42)25-14-26(30(32,33)34)40-41(25)22-6-2-5-21(12-22)28(36)37/h1-6,9-14,17,27,38H,7-8,16H2,(H3,36,37)(H,39,42)	VIRFLKJDRZOSPM-UHFFFAOYSA-N	417003	(+)-1-(3-carbamimidoylphenyl)-N-(5-((3-cyanophenyl)(cyclopropylmethylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 236h::US10633345, Compound 236h::US10689346, Compound 236h::US11203574, Compound 236h::US11230530, Compound 236h::US11685721, Compound 236h	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417003	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417003&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665908	433916915							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120210	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C30H25F4N7O/c31-23-6-4-20(27(38-16-17-1-2-17)19-7-10-36-11-8-19)13-24(23)39-29(42)25-15-26(30(32,33)34)40-41(25)21-5-3-18-9-12-37-28(35)22(18)14-21/h3-15,17,27,38H,1-2,16H2,(H2,35,37)(H,39,42)	UQWHIYYZYLIMKJ-UHFFFAOYSA-N	417004	(+-)-1-(1-aminoisoquinolin-7-yl)-N-(5-((cyclopropylmethylamino)(pyridin-4-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 265d::US10633345, Compound 264g::US10689346, Compound 264g::US11203574, Compound 264g::US11230530, Compound 264g::US11685721, Compound 264g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417004	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417004&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355979	433916916							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120211	Nc1noc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H24F4N6O2/c30-21-10-8-18(26(35-15-16-6-7-16)17-4-2-1-3-5-17)12-22(21)36-28(40)23-14-25(29(31,32)33)37-39(23)19-9-11-24-20(13-19)27(34)38-41-24/h1-5,8-14,16,26,35H,6-7,15H2,(H2,34,38)(H,36,40)	QWKNFIFTTXOPHF-UHFFFAOYSA-N	417002	(+-)-1-(3-aminobenzo[d]isoxazol-5-yl)-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 222k::US10329260, Compound 223f::US10633345, Compound 223f::US10689346, Compound 223f::US11203574, Compound 223f::US11230530, Compound 223f::US11685721, Compound 223f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417002	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417002&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123289526	433916914							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120212	NC(=N)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C31H27F4N7O/c32-24-10-9-22(30(39,12-11-18-7-8-18)21-5-1-3-19(13-21)17-36)15-25(24)40-29(43)26-16-27(31(33,34)35)41-42(26)23-6-2-4-20(14-23)28(37)38/h1-6,9-10,13-16,18H,7-8,11-12,39H2,(H3,37,38)(H,40,43)	BZRUVEYOOHPOOF-UHFFFAOYSA-N	417006	(+)-N-(5-(1-amino-1-(3-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-carbamimidoylphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 237a::US10633345, Compound 237a::US10689346, Compound 237a::US11192861, Compound 237a::US11230530, Compound 237a::US11685721, Compound 237a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417006	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417006&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356202	433916917							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120213	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C33H27F4N7O/c34-26-9-7-23(32(40,12-10-19-4-5-19)22-3-1-2-20(14-22)18-38)15-27(26)42-31(45)28-17-29(33(35,36)37)43-44(28)24-8-6-21-11-13-41-30(39)25(21)16-24/h1-3,6-9,11,13-17,19H,4-5,10,12,40H2,(H2,39,41)(H,42,45)	MNAPHYKXZOGSTD-UHFFFAOYSA-N	417007	(+)-N-(5-(1-amino-1-(3-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(1-aminoisoquinolin-7-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 256a::US10633345, Compound 256a::US10689346, Compound 256a::US11203574, Compound 256a::US11230530, Compound 256a::US11685721, Compound 256a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417007	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417007&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665459	433916918							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120214	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(n1)C#N)C(F)(F)F	InChI=1S/C30H27F4N7O/c31-23-10-9-20(29(37,12-11-18-7-8-18)26-6-2-4-21(17-36)38-26)14-24(23)39-28(42)25-15-27(30(32,33)34)40-41(25)22-5-1-3-19(13-22)16-35/h1-6,9-10,13-15,18H,7-8,11-12,16,35,37H2,(H,39,42)	UYAYDZPBNCJYMZ-UHFFFAOYSA-N	417008	(+)-N-(5-(1-amino-1-(6-cyanopyridin-2-yl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 220f::US10633345, Compound 220f::US10689346, Compound 220f::US11203574, Compound 220f::US11230530, Compound 220f::US11685721, Compound 220f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417008	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417008&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355858	433916919							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120215	CC(C)(C)[S@@](=O)NC(CCC1CC1)(c1cccnc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(c2)C(N)=N)C(F)(F)F)c1	InChI=1S/C33H35F4N7O2S/c1-31(2,3)47(46)43-32(14-13-20-9-10-20,23-7-5-15-40-19-23)22-11-12-25(34)26(17-22)41-30(45)27-18-28(33(35,36)37)42-44(27)24-8-4-6-21(16-24)29(38)39/h4-8,11-12,15-20,43H,9-10,13-14H2,1-3H3,(H3,38,39)(H,41,45)/t32?,47-/m1/s1	ORCJXCNQCCWVHD-HKYIEPEJSA-N	417009	1-(3-carbamimidoylphenyl)-N-(5-((+-)-3-cyclopropyl-1-((R)-1,1-dimethylethylsulfinamido)-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 238c::US10633345, Compound 238c::US10689346, Compound 238c::US11203574, Compound 238c::US11230530, Compound 238c::US11685721, Compound 238c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417009	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417009&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355741	433916920							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120216	Nc1nccc2ccc(cc12)-n1nc(cc1C(F)(F)F)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1	InChI=1S/C31H27F4N7O/c32-24-6-4-21(30(37,11-7-18-1-2-18)20-9-12-38-13-10-20)15-25(24)40-29(43)26-17-27(31(33,34)35)42(41-26)22-5-3-19-8-14-39-28(36)23(19)16-22/h3-6,8-10,12-18H,1-2,7,11,37H2,(H2,36,39)(H,40,43)	JTQCWLVRCRAKSI-UHFFFAOYSA-N	417010	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-4-yl)propyl)-2-fluorophenyl)-1-(1-aminoisoquinolin-7-yl)-5-(trifluoromethyl)-1H-pyrazole-3-carboxamide::US10329260, Compound 268g::US10633345, Compound 268g::US10689346, Compound 268g::US11203574, Compound 268g::US11230530, Compound 268g::US11685721, Compound 268g	Plasma kallikrein		>75.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417010	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417010&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356088	433916921							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120217	Nc1n[nH]c2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F			439594	US10633345, Compound 224b::US10689346, Compound 224b::US11203574, Compound 224b::US11230530, Compound 224b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439594	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439594&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155295687	439661142							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120218	NC(=N)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C31H27F4N7O/c32-24-11-10-22(30(39,13-12-18-4-5-18)21-8-6-19(17-36)7-9-21)15-25(24)40-29(43)26-16-27(31(33,34)35)41-42(26)23-3-1-2-20(14-23)28(37)38/h1-3,6-11,14-16,18H,4-5,12-13,39H2,(H3,37,38)(H,40,43)	QLTPSVVBRYJDCX-UHFFFAOYSA-N	417012	(+)-N-(5-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-carbamimidoylphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 241a::US10633345, Compound 241a::US10689346, Compound 241a::US11192861, Compound 241a::US11230530, Compound 241a::US11685721, Compound 241a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417012	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417012&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665936	433916923							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120219	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccccc1=O)C(F)(F)F	InChI=1S/C31H26F4N6O2/c32-23-10-8-20(25(11-6-18-4-5-18)40-14-2-1-3-28(40)42)15-24(23)38-30(43)26-17-27(31(33,34)35)39-41(26)21-9-7-19-12-13-37-29(36)22(19)16-21/h1-3,7-10,12-18,25H,4-6,11H2,(H2,36,37)(H,38,43)	GNDQLXKOPYFGBP-UHFFFAOYSA-N	417013	1-(1-aminoisoquinolin-7-yl)-N-(5-(3-cyclopropyl-1-(2-oxopyridin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 258g::US10633345, Compound 258g::US10689346, Compound 258g::US11203574, Compound 258g::US11230530, Compound 258g::US11685721, Compound 258g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417013	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417013&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355895	433916924							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120220	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C(N)=O)C(F)(F)F	InChI=1S/C31H30F4N6O2/c32-24-10-9-22(30(38,12-11-18-7-8-18)21-5-2-4-20(14-21)28(37)42)15-25(24)39-29(43)26-16-27(31(33,34)35)40-41(26)23-6-1-3-19(13-23)17-36/h1-6,9-10,13-16,18H,7-8,11-12,17,36,38H2,(H2,37,42)(H,39,43)	DYGHBBDYRMOWAC-UHFFFAOYSA-N	417014	(+-)-N-(5-(1-amino-1-(3-carbamoylphenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 225a::US10633345, Compound 225a::US10689346, Compound 225a::US11203574, Compound 225a::US11230530, Compound 225a::US11685721, Compound 225a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417014	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417014&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665606	433916925							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120221	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C31H28F4N6O/c32-25-10-9-23(30(38,12-11-19-7-8-19)22-5-1-3-20(13-22)17-36)15-26(25)39-29(42)27-16-28(31(33,34)35)40-41(27)24-6-2-4-21(14-24)18-37/h1-6,9-10,13-16,19H,7-8,11-12,18,37-38H2,(H,39,42)	ZBDDMFBNDOEVJT-UHFFFAOYSA-N	416996	(+)-N-(5-(1-amino-1-(3-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 214g::US10633345, Compound 215d::US10689346, Compound 215d::US11203574, Compound 215d::US11230530, Compound 215d::US11685721, Compound 215d	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416996	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416996&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665709	433916908							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120222	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccccc1=O)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-11-10-20(24(12-9-18-7-8-18)37-13-2-1-6-27(37)39)15-23(22)35-28(40)25-16-26(29(31,32)33)36-38(25)21-5-3-4-19(14-21)17-34/h1-6,10-11,13-16,18,24H,7-9,12,17,34H2,(H,35,40)	OFQQGSYWUFBMPP-UHFFFAOYSA-N	416939	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(2-oxopyridin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 248j::US10633345, Compound 248k::US10689346, Compound 248k::US11203574, Compound 248k::US11230530, Compound 248k::US11685721, Compound 248k	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416939	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416939&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355727	433916851							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120223	Nc1ncnc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H25F4N7O/c31-22-10-8-19(27(36-15-17-6-7-17)18-4-2-1-3-5-18)12-24(22)39-29(42)25-14-26(30(32,33)34)40-41(25)20-9-11-23-21(13-20)28(35)38-16-37-23/h1-5,8-14,16-17,27,36H,6-7,15H2,(H,39,42)(H2,35,37,38)	NOYPEPJWHRTGGG-UHFFFAOYSA-N	417011	1-(4-aminoquinazolin-6-yl)-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 224b::US10329260, Compound 226a::US10633345, Compound 226a::US10689346, Compound 226a::US11203574, Compound 226a::US11230530, Compound 226a::US11685721, Compound 226a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417011	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417011&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665806	433916922							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120224	NC(=N)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H27F4N7O/c30-22-9-8-19(28(36,11-10-17-6-7-17)20-4-2-12-37-16-20)14-23(22)38-27(41)24-15-25(29(31,32)33)39-40(24)21-5-1-3-18(13-21)26(34)35/h1-5,8-9,12-17H,6-7,10-11,36H2,(H3,34,35)(H,38,41)	JBCZLPFSSAYNEJ-UHFFFAOYSA-N	417018	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-1-(3-carbamimidoylphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 238d::US10633345, Compound 238d::US10689346, Compound 238d::US11192861, Compound 238d::US11230530, Compound 238d::US11685721, Compound 238d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417018	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417018&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355839	433916928							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120225	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccccc1=O)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-11-10-20(24(12-9-18-7-8-18)37-13-2-1-6-27(37)39)15-23(22)35-28(40)25-16-26(29(31,32)33)36-38(25)21-5-3-4-19(14-21)17-34/h1-6,10-11,13-16,18,24H,7-9,12,17,34H2,(H,35,40)	OFQQGSYWUFBMPP-UHFFFAOYSA-N	416939	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(2-oxopyridin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 248j::US10633345, Compound 248k::US10689346, Compound 248k::US11203574, Compound 248k::US11230530, Compound 248k::US11685721, Compound 248k	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416939	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416939&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355727	433916851							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120226	NC(=N)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N6O/c30-22-12-11-19(26(36-16-17-9-10-17)18-5-2-1-3-6-18)14-23(22)37-28(40)24-15-25(29(31,32)33)38-39(24)21-8-4-7-20(13-21)27(34)35/h1-8,11-15,17,26,36H,9-10,16H2,(H3,34,35)(H,37,40)	HUIANTFJQLRTEM-UHFFFAOYSA-N	439603	US10633345, Compound 227d::US10689346, Compound 227d::US11203574, Compound 227d::US11230530, Compound 227d::US11685721, Compound 227d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439603	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439603&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356162	439661151							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120227	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(nc1)C(N)=O)C(F)(F)F	InChI=1S/C30H29F4N7O2/c31-22-8-6-19(29(37,11-10-17-4-5-17)20-7-9-23(27(36)42)38-16-20)13-24(22)39-28(43)25-14-26(30(32,33)34)40-41(25)21-3-1-2-18(12-21)15-35/h1-3,6-9,12-14,16-17H,4-5,10-11,15,35,37H2,(H2,36,42)(H,39,43)	IQWHGFSUUIEJQU-UHFFFAOYSA-N	417021	(+)-5-(1-amino-1-(3-(1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamido)-4-fluorophenyl)-3-cyclopropylpropyl)picolinamide::US10329260, Compound 221i::US10633345, Compound 221i::US10689346, Compound 221i::US11203574, Compound 221i::US11230530, Compound 221i::US11685721, Compound 221i	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417021	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417021&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665782	433916931							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120228	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C30H25F4N7O/c31-23-6-4-20(27(38-16-17-1-2-17)19-7-10-36-11-8-19)13-24(23)39-29(42)25-15-26(30(32,33)34)40-41(25)21-5-3-18-9-12-37-28(35)22(18)14-21/h3-15,17,27,38H,1-2,16H2,(H2,35,37)(H,39,42)	UQWHIYYZYLIMKJ-UHFFFAOYSA-N	417004	(+-)-1-(1-aminoisoquinolin-7-yl)-N-(5-((cyclopropylmethylamino)(pyridin-4-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 265d::US10633345, Compound 264g::US10689346, Compound 264g::US11203574, Compound 264g::US11230530, Compound 264g::US11685721, Compound 264g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417004	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417004&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355979	433916916							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120229	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C(N)=O)C(F)(F)F	InChI=1S/C31H30F4N6O2/c32-24-11-10-22(30(38,13-12-18-4-5-18)21-8-6-20(7-9-21)28(37)42)15-25(24)39-29(43)26-16-27(31(33,34)35)40-41(26)23-3-1-2-19(14-23)17-36/h1-3,6-11,14-16,18H,4-5,12-13,17,36,38H2,(H2,37,42)(H,39,43)	HZQICPCUMLWHPZ-UHFFFAOYSA-N	417023	(+)-N-(5-(1-amino-1-(4-carbamoylphenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 228a::US10633345, Compound 228a::US10689346, Compound 228a::US11203574, Compound 228a::US11230530, Compound 228a::US11685721, Compound 228a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417023	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417023&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665484	433916933							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120230	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-23-7-6-21(28(35,11-8-18-4-5-18)20-9-12-36-13-10-20)15-24(23)37-27(40)25-16-26(29(31,32)33)38-39(25)22-3-1-2-19(14-22)17-34/h1-3,6-7,9-10,12-16,18H,4-5,8,11,17,34-35H2,(H,37,40)	AGVFYPDLNPHKER-UHFFFAOYSA-N	417024	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-4-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 216d::US10633345, Compound 217d::US10689346, Compound 217d::US11192861, Compound 217d::US11230530, Compound 217d::US11685721, Compound 217d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417024	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417024&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665723	433916934							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120231	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)N1CCCCC1=O)C(F)(F)F	InChI=1S/C29H31F4N5O2/c30-22-11-10-20(24(12-9-18-7-8-18)37-13-2-1-6-27(37)39)15-23(22)35-28(40)25-16-26(29(31,32)33)36-38(25)21-5-3-4-19(14-21)17-34/h3-5,10-11,14-16,18,24H,1-2,6-9,12-13,17,34H2,(H,35,40)	BPULHNPIKAHCAG-UHFFFAOYSA-N	417025	(+)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(2-oxopiperidin-1-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 261k::US10633345, Compound 261k::US10689346, Compound 261k::US11203574, Compound 261k::US11230530, Compound 261k::US11685721, Compound 261k	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417025	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417025&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123312183	433916935							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120232	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(N)=O	InChI=1S/C29H29FN6O2/c30-23-12-11-21(27(33-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)34-29(38)26-15-25(28(32)37)35-36(26)22-8-4-5-19(13-22)16-31/h1-8,11-15,18,27,33H,9-10,16-17,31H2,(H2,32,37)(H,34,38)	UMNCVWUVWBVXCX-UHFFFAOYSA-N	417026	(+-)-1-(3-(aminomethyl)phenyl)-N5-(5-((cyclopropylmethylamino)-(phenyl)methyl)-2-fluorophenyl)-1H-pyrazole-3,5-dicarboxamide::US10329260, Compound 229i::US10633345, Compound 229i::US10689346, Compound 229i::US11203574, Compound 229i::US11230530, Compound 229i::US11685721, Compound 229i	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417026	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417026&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665747	433916936							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120233	CC(C)(C)[S@@](=O)NC(CCC1CC1)(c1cccnc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C33H36F4N6O2S/c1-31(2,3)46(45)42-32(14-13-21-9-10-21,24-7-5-15-39-20-24)23-11-12-26(34)27(17-23)40-30(44)28-18-29(33(35,36)37)41-43(28)25-8-4-6-22(16-25)19-38/h4-8,11-12,15-18,20-21,42H,9-10,13-14,19,38H2,1-3H3,(H,40,44)/t32?,46-/m1/s1	LAOWFCURFGDGCT-ODZHGNIVSA-N	417027	1-(3-(aminomethyl)phenyl)-N-(5-((+-)-3-cyclopropyl-1-((R)-1,1-dimethylethylsulfinamido)-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 243a::US10633345, Compound 243a::US10689346, Compound 243a::US11203574, Compound 243a::US11230530, Compound 243a::US11685721, Compound 243a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417027	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417027&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665825	433916937							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120234	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccncc1=O)C(F)(F)F	InChI=1S/C30H25F4N7O2/c31-22-7-5-19(24(8-3-17-1-2-17)40-12-11-36-16-27(40)42)13-23(22)38-29(43)25-15-26(30(32,33)34)39-41(25)20-6-4-18-9-10-37-28(35)21(18)14-20/h4-7,9-17,24H,1-3,8H2,(H2,35,37)(H,38,43)	RGAKSJSQGQBUGG-UHFFFAOYSA-N	417028	1-(1-aminoisoquinolin-7-yl)-N-(5-(3-cyclopropyl-1-(2-oxopyrazin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 259d::US10633345, Compound 259d::US10689346, Compound 259d::US11203574, Compound 259d::US11230530, Compound 259d::US11685721, Compound 259d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417028	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417028&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355792	433916938							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120235	NC(=O)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H25F4N5O2/c30-22-12-11-19(26(35-16-17-9-10-17)18-5-2-1-3-6-18)14-23(22)36-28(40)24-15-25(29(31,32)33)37-38(24)21-8-4-7-20(13-21)27(34)39/h1-8,11-15,17,26,35H,9-10,16H2,(H2,34,39)(H,36,40)	JMSFBJDWVQAENA-UHFFFAOYSA-N	417029	(+-)-1-(3-carbamoylphenyl)-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 230a::US10633345, Compound 230a::US10689346, Compound 230a::US11203574, Compound 230a::US11230530, Compound 230a::US11685721, Compound 230a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417029	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417029&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665857	433916939							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120236	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-23-7-6-21(28(35,11-8-18-4-5-18)20-9-12-36-13-10-20)15-24(23)37-27(40)25-16-26(29(31,32)33)38-39(25)22-3-1-2-19(14-22)17-34/h1-3,6-7,9-10,12-16,18H,4-5,8,11,17,34-35H2,(H,37,40)	AGVFYPDLNPHKER-UHFFFAOYSA-N	417024	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-4-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 216d::US10633345, Compound 217d::US10689346, Compound 217d::US11192861, Compound 217d::US11230530, Compound 217d::US11685721, Compound 217d	Plasma kallikrein		>75.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417024	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417024&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665723	433916934							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120237	Cc1cc(ccn1)C(N)(CCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F4N6O/c1-18-13-22(10-12-37-18)29(36,11-9-19-5-6-19)21-7-8-24(31)25(15-21)38-28(41)26-16-27(30(32,33)34)39-40(26)23-4-2-3-20(14-23)17-35/h2-4,7-8,10,12-16,19H,5-6,9,11,17,35-36H2,1H3,(H,38,41)	PYONXWOUVYIBRU-UHFFFAOYSA-N	417031	(+)-N-(5-(1-amino-3-cyclopropyl-1-(2-methylpyridin-4-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 266j::US10633345, Compound 266j::US10689346, Compound 266j::US11203574, Compound 266j::US11230530, Compound 266j::US11685721, Compound 266j	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417031	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417031&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665585	433916941							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120238	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccc(=O)[nH]c1=O)C(F)(F)F			417032	1-(1-aminoisoquinolin-7-yl)-N-(5-(3-cyclopropyl-1-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 269b::US10633345, Compound 269b::US10689346, Compound 269b::US11203574, Compound 269b::US11230530, Compound 269b::US11685721, Compound 269b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417032	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417032&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			154584237	433916942							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1117400	CCNCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C31H31F4N5O/c1-2-36-18-21-7-6-10-24(15-21)40-27(17-28(39-40)31(33,34)35)30(41)38-26-16-23(13-14-25(26)32)29(37-19-20-11-12-20)22-8-4-3-5-9-22/h3-10,13-17,20,29,36-37H,2,11-12,18-19H2,1H3,(H,38,41)	RBEFOPDBDLERKF-UHFFFAOYSA-N	417033	(+-)-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-1-(3-((ethylamino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 270a::US10633345, Compound 270a::US10689346, Compound 270a::US11203574, Compound 270a::US11230530, Compound 270a::US11685721, Compound 270a	Plasma kallikrein		 75.0								US Patent		10.7270/Q2FT8Q7S		aid1806170	US11192861	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417033	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417033&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665791	433916943							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136263	CC(C)N(C)c1ccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)cn1	InChI=1S/C26H28N6O/c1-17(2)32(3)24-7-5-18(14-30-24)10-20-12-22(16-28-13-20)26(33)31-15-19-4-6-23-21(11-19)8-9-29-25(23)27/h4-9,11-14,16-17H,10,15H2,1-3H3,(H2,27,29)(H,31,33)	QHAUWEJXKZUUPP-UHFFFAOYSA-N	359689	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({6-[isopropyl(methyl)amino]pyridin-3-yl}methyl)pyridine-3-carboxamide::US10221161, Example 73::US11242333, Example 73	Plasma kallikrein			 51.1							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359689	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359689&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393184	386399142							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1120239	CCNCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C31H31F4N5O/c1-2-36-18-21-7-6-10-24(15-21)40-27(17-28(39-40)31(33,34)35)30(41)38-26-16-23(13-14-25(26)32)29(37-19-20-11-12-20)22-8-4-3-5-9-22/h3-10,13-17,20,29,36-37H,2,11-12,18-19H2,1H3,(H,38,41)	RBEFOPDBDLERKF-UHFFFAOYSA-N	417033	(+-)-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-1-(3-((ethylamino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 270a::US10633345, Compound 270a::US10689346, Compound 270a::US11203574, Compound 270a::US11230530, Compound 270a::US11685721, Compound 270a	Plasma kallikrein		>75.0								US Patent		10.7270/Q2HM5CNF		aid1806191	US11203574	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417033	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417033&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665791	433916943							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115912	CNC(=O)c1ccc(NC(=O)C(CCOC)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2-c2cc(C)no2)cn1	InChI=1S/C28H28ClN5O6/c1-16-11-24(40-33-16)19-7-5-17(29)12-20(19)21-13-26(35)34(15-25(21)39-4)23(9-10-38-3)28(37)32-18-6-8-22(31-14-18)27(36)30-2/h5-8,11-15,23H,9-10H2,1-4H3,(H,30,36)(H,32,37)	ROFGROGQJVVGAV-UHFFFAOYSA-N	413677	5-[(2-{4-[5-Chloro-2-(3-methyl-1,2-oxazol-5-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxybutanoyl)amino]-N-methylpyridine-2-carboxamide (Racemate)::US10421742, Example 71::US11180471, Example 71	Plasma kallikrein			 35.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413677	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413677&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205793	433913781							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115913	COCCC(C(=O)Nc1ccc2nccnc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1cc(C)no1	InChI=1S/C29H26ClN5O5/c1-17-12-26(40-34-17)20-6-4-18(30)13-21(20)22-15-28(36)35(16-27(22)39-3)25(8-11-38-2)29(37)33-19-5-7-23-24(14-19)32-10-9-31-23/h4-7,9-10,12-16,25H,8,11H2,1-3H3,(H,33,37)	BOMMICKHAGJNKQ-UHFFFAOYSA-N	413678	N-(Quinoxalin-6-yl)-2-{4-[5-chloro-2-(3-methyl-1,2-oxazol-5-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxybutanamide (Racemate)::US10421742, Example 72::US11180471, Example 72	Plasma kallikrein			 18.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413678	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413678&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205700	433913782							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115914	COCCC(C(=O)Nc1ccc(nc1)C(N)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(o1)C(F)(F)F	InChI=1S/C26H22ClF3N6O6/c1-40-8-7-19(23(39)33-14-4-6-18(22(31)38)32-11-14)36-12-20(41-2)17(10-21(36)37)16-9-13(27)3-5-15(16)24-34-35-25(42-24)26(28,29)30/h3-6,9-12,19H,7-8H2,1-2H3,(H2,31,38)(H,33,39)	LICUUHCNECQSQW-UHFFFAOYSA-N	413679	5-({2-[4-{5-Chloro-2-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)pyridine-2-carboxamide (Racemate)::US10421742, Example 73::US11180471, Example 73	Plasma kallikrein			 110							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413679	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413679&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205765	433913783							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115915	COCCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(o1)C(F)(F)F	InChI=1S/C27H22ClF4N5O6/c1-41-8-7-20(24(40)34-14-4-6-16(23(33)39)19(29)10-14)37-12-21(42-2)18(11-22(37)38)17-9-13(28)3-5-15(17)25-35-36-26(43-25)27(30,31)32/h3-6,9-12,20H,7-8H2,1-2H3,(H2,33,39)(H,34,40)	FGIRAZNDJOPUAW-UHFFFAOYSA-N	413680	4-({2-[4-{5-Chloro-2-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)-2-fluorobenzamide (Racemate)::US10421742, Example 74::US11180471, Example 74	Plasma kallikrein			 98.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413680	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413680&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205473	433913784							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115916	COCCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(o1)C(F)(F)F	InChI=1S/C28H24ClF3N6O5/c1-37-13-15-10-17(5-7-21(15)36-37)33-25(40)22(8-9-41-2)38-14-23(42-3)20(12-24(38)39)19-11-16(29)4-6-18(19)26-34-35-27(43-26)28(30,31)32/h4-7,10-14,22H,8-9H2,1-3H3,(H,33,40)	YOTPLZPCUXHOMZ-UHFFFAOYSA-N	413681	2-[4-{5-Chloro-2-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxy-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 75::US11180471, Example 75	Plasma kallikrein			 28.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413681	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413681&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205440	433913785							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115917	COCC[C@@H](C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(o1)C(F)(F)F	InChI=1S/C28H24ClF3N6O5/c1-37-13-15-10-17(5-7-21(15)36-37)33-25(40)22(8-9-41-2)38-14-23(42-3)20(12-24(38)39)19-11-16(29)4-6-18(19)26-34-35-27(43-26)28(30,31)32/h4-7,10-14,22H,8-9H2,1-3H3,(H,33,40)/t22-/m0/s1	YOTPLZPCUXHOMZ-QFIPXVFZSA-N	413682	(2S)-2-[4-{5-Chloro-2-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxy-N-(2-methyl-2H-indazol-5-yl)butanamide (Enantiomer 2)::US10421742, Example 76::US11180471, Example 76	Plasma kallikrein			 23.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413682	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413682&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205552	433913786							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115918	CNC(=O)c1ccc(NC(=O)C(CCOC)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2-c2nnc(o2)C(F)(F)F)cn1	InChI=1S/C27H24ClF3N6O6/c1-32-23(39)19-7-5-15(12-33-19)34-24(40)20(8-9-41-2)37-13-21(42-3)18(11-22(37)38)17-10-14(28)4-6-16(17)25-35-36-26(43-25)27(29,30)31/h4-7,10-13,20H,8-9H2,1-3H3,(H,32,39)(H,34,40)	NUOFQPYZYCWJHB-UHFFFAOYSA-N	413683	5-({2-[4-{5-Chloro-2-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)-N-methylpyridine-2-carboxamide (Racemate)::US10421742, Example 77::US11180471, Example 77	Plasma kallikrein			 47.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413683	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413683&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135206080	433913787							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115919	COCCC(C(=O)Nc1ccc2nccnc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(o1)C(F)(F)F	InChI=1S/C28H22ClF3N6O5/c1-41-10-7-22(25(40)35-16-4-6-20-21(12-16)34-9-8-33-20)38-14-23(42-2)19(13-24(38)39)18-11-15(29)3-5-17(18)26-36-37-27(43-26)28(30,31)32/h3-6,8-9,11-14,22H,7,10H2,1-2H3,(H,35,40)	RLFXIFOZOPMNCY-UHFFFAOYSA-N	413684	N-(Quinoxalin-6-yl)-2-[4-{5-chloro-2-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanamide (Racemate)::US10421742, Example 78::US11180471, Example 78	Plasma kallikrein			 14.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413684	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413684&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205675	433913788							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115920	COCC[C@@H](C(=O)Nc1ccc2nccnc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(o1)C(F)(F)F	InChI=1S/C28H22ClF3N6O5/c1-41-10-7-22(25(40)35-16-4-6-20-21(12-16)34-9-8-33-20)38-14-23(42-2)19(13-24(38)39)18-11-15(29)3-5-17(18)26-36-37-27(43-26)28(30,31)32/h3-6,8-9,11-14,22H,7,10H2,1-2H3,(H,35,40)/t22-/m0/s1	RLFXIFOZOPMNCY-QFIPXVFZSA-N	413685	N-(Quinoxalin-6-yl)-(2S)-2-[4-{5-chloro-2-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanamide (Enantiomer 2)::US10421742, Example 79::US11180471, Example 79	Plasma kallikrein			 9.80							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413685	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413685&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205803	433913789							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115921	COCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(o1)C(F)F	InChI=1S/C27H23ClF2N4O7/c1-39-10-9-20(24(36)31-16-6-3-14(4-7-16)27(37)38)34-13-21(40-2)19(12-22(34)35)18-11-15(28)5-8-17(18)25-32-33-26(41-25)23(29)30/h3-8,11-13,20,23H,9-10H2,1-2H3,(H,31,36)(H,37,38)	XNHWHTYAEJBBSE-UHFFFAOYSA-N	413686	4-({2-[4-{5-Chloro-2-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)benzoic acid (Racemate)::US10421742, Example 80::US11180471, Example 80	Plasma kallikrein			 78.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413686	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413686&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205800	433913790							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115922	COCCC(C(=O)Nc1ccc(nc1)C(N)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(o1)C(F)F	InChI=1S/C26H23ClF2N6O6/c1-39-8-7-19(24(38)32-14-4-6-18(23(30)37)31-11-14)35-12-20(40-2)17(10-21(35)36)16-9-13(27)3-5-15(16)25-33-34-26(41-25)22(28)29/h3-6,9-12,19,22H,7-8H2,1-2H3,(H2,30,37)(H,32,38)	MDWVKPVBVQCTPE-UHFFFAOYSA-N	413687	5-({2-[4-{5-Chloro-2-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)pyridine-2-carboxamide (Racemate)::US10421742, Example 81::US11180471, Example 81	Plasma kallikrein			 100.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413687	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413687&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135206035	433913791							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115923	COCCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(o1)C(F)F	InChI=1S/C27H23ClF3N5O6/c1-40-8-7-20(25(39)33-14-4-6-16(24(32)38)19(29)10-14)36-12-21(41-2)18(11-22(36)37)17-9-13(28)3-5-15(17)26-34-35-27(42-26)23(30)31/h3-6,9-12,20,23H,7-8H2,1-2H3,(H2,32,38)(H,33,39)	ZFLRJTQBCYIFEA-UHFFFAOYSA-N	413688	4-({2-[4-{5-Chloro-2-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)-2-fluorobenzamide (Racemate)::US10421742, Example 82::US11180471, Example 82	Plasma kallikrein			 67.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413688	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413688&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205342	433913792							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115924	COCCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(o1)C(F)F	InChI=1S/C28H25ClF2N6O5/c1-36-13-15-10-17(5-7-21(15)35-36)32-26(39)22(8-9-40-2)37-14-23(41-3)20(12-24(37)38)19-11-16(29)4-6-18(19)27-33-34-28(42-27)25(30)31/h4-7,10-14,22,25H,8-9H2,1-3H3,(H,32,39)	OYMYFSRVCJZGAS-UHFFFAOYSA-N	413689	2-[4-{5-Chloro-2-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxy-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 83::US11180471, Example 83	Plasma kallikrein			 21.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413689	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413689&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205398	433913793							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115925	CNC(=O)c1ccc(NC(=O)C(CCOC)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2-c2nnc(o2)C(F)F)cn1	InChI=1S/C27H25ClF2N6O6/c1-31-24(38)19-7-5-15(12-32-19)33-25(39)20(8-9-40-2)36-13-21(41-3)18(11-22(36)37)17-10-14(28)4-6-16(17)26-34-35-27(42-26)23(29)30/h4-7,10-13,20,23H,8-9H2,1-3H3,(H,31,38)(H,33,39)	HOPVUQHXIRDKQQ-UHFFFAOYSA-N	413690	5-({2-[4-{5-Chloro-2-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)-N-methylpyridine-2-carboxamide (Racemate)::US10421742, Example 84::US11180471, Example 84	Plasma kallikrein			 49.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413690	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413690&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205828	433913794							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115926	COCCC(C(=O)Nc1ccc2nccnc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(o1)C(F)F	InChI=1S/C28H23ClF2N6O5/c1-40-10-7-22(26(39)34-16-4-6-20-21(12-16)33-9-8-32-20)37-14-23(41-2)19(13-24(37)38)18-11-15(29)3-5-17(18)27-35-36-28(42-27)25(30)31/h3-6,8-9,11-14,22,25H,7,10H2,1-2H3,(H,34,39)	XQGAAZGSIZFZJH-UHFFFAOYSA-N	413691	N-(Quinoxalin-6-yl)-2-[4-{5-chloro-2-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanamide (Racemate)::US10421742, Example 85::US11180471, Example 85	Plasma kallikrein			 9.60							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413691	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413691&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205474	433913795							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115927	COCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1cnn(c1)C(F)F	InChI=1S/C28H25ClF2N4O6/c1-40-10-9-23(26(37)33-19-6-3-16(4-7-19)27(38)39)34-15-24(41-2)22(12-25(34)36)21-11-18(29)5-8-20(21)17-13-32-35(14-17)28(30)31/h3-8,11-15,23,28H,9-10H2,1-2H3,(H,33,37)(H,38,39)	KPDQGYYQHYCMAC-UHFFFAOYSA-N	413692	4-({2-[4-{5-Chloro-2-[1-(difluoromethyl)-1H-pyrazol-4-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)benzoic acid (Racemate)::US10421742, Example 86::US11180471, Example 86	Plasma kallikrein			 88.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413692	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413692&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205712	433913796							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115928	COCCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1cnn(c1)C(F)F	InChI=1S/C29H27ClF2N6O4/c1-36-14-17-10-20(5-7-24(17)35-36)34-28(40)25(8-9-41-2)37-16-26(42-3)23(12-27(37)39)22-11-19(30)4-6-21(22)18-13-33-38(15-18)29(31)32/h4-7,10-16,25,29H,8-9H2,1-3H3,(H,34,40)	FLLYAGGTZNJKNW-UHFFFAOYSA-N	413693	2-[4-{5-Chloro-2-[1-(difluoromethyl)-1H-pyrazol-4-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxy-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 87::US11180471, Example 87	Plasma kallikrein			 41.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413693	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413693&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205794	433913797							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115929	COCCC(C(=O)Nc1ccc(nc1)C(N)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1cnn(c1)C(F)F	InChI=1S/C27H25ClF2N6O5/c1-40-8-7-22(26(39)34-17-4-6-21(25(31)38)32-12-17)35-14-23(41-2)20(10-24(35)37)19-9-16(28)3-5-18(19)15-11-33-36(13-15)27(29)30/h3-6,9-14,22,27H,7-8H2,1-2H3,(H2,31,38)(H,34,39)	ZDGFODUVDKHNBN-UHFFFAOYSA-N	413694	5-({2-[4-{5-Chloro-2-[1-(difluoromethyl)-1H-pyrazol-4-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)pyridine-2-carboxamide (Racemate)::US10421742, Example 88::US11180471, Example 88	Plasma kallikrein			 110							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413694	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413694&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205957	433913798							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115930	COCCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nc(C)no1	InChI=1S/C27H25ClFN5O6/c1-14-31-27(40-33-14)17-6-4-15(28)10-19(17)20-12-24(35)34(13-23(20)39-3)22(8-9-38-2)26(37)32-16-5-7-18(25(30)36)21(29)11-16/h4-7,10-13,22H,8-9H2,1-3H3,(H2,30,36)(H,32,37)	KXEKQPUKVUVDQB-UHFFFAOYSA-N	413695	4-[(2-{4-[5-Chloro-2-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxybutanoyl)amino]-2-fluorobenzamide (Racemate)::US10421742, Example 89::US11180471, Example 89	Plasma kallikrein			 58.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413695	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413695&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205626	433913799							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115931	COCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nc(C)no1	InChI=1S/C27H25ClN4O7/c1-15-29-26(39-31-15)19-9-6-17(28)12-20(19)21-13-24(33)32(14-23(21)38-3)22(10-11-37-2)25(34)30-18-7-4-16(5-8-18)27(35)36/h4-9,12-14,22H,10-11H2,1-3H3,(H,30,34)(H,35,36)	NOYZMHMPNZKENJ-UHFFFAOYSA-N	413696	4-[(2-{4-[5-Chloro-2-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxybutanoyl)amino]benzoic acid (Racemate)::US10421742, Example 90::US11180471, Example 90	Plasma kallikrein			 54.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413696	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413696&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205964	433913800							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115932	COCCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nc(C)no1	InChI=1S/C28H27ClN6O5/c1-16-30-28(40-33-16)20-7-5-18(29)12-21(20)22-13-26(36)35(15-25(22)39-4)24(9-10-38-3)27(37)31-19-6-8-23-17(11-19)14-34(2)32-23/h5-8,11-15,24H,9-10H2,1-4H3,(H,31,37)	AKPADQIFUKNACD-UHFFFAOYSA-N	413697	2-{4-[5-Chloro-2-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxy-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 91::US11180471, Example 91	Plasma kallikrein			 25.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413697	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413697&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135204923	433913801							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115933	COc1cn(C(CCOC(C)(C)C)C(=O)Nc2ccc3nccnc3c2)c(=O)cc1-c1cc(Cl)ccc1-c1nc(C)no1	InChI=1S/C31H31ClN6O5/c1-18-35-30(43-37-18)21-8-6-19(32)14-22(21)23-16-28(39)38(17-27(23)41-5)26(10-13-42-31(2,3)4)29(40)36-20-7-9-24-25(15-20)34-12-11-33-24/h6-9,11-12,14-17,26H,10,13H2,1-5H3,(H,36,40)	WHJFAHUWUMDVIH-UHFFFAOYSA-N	413699	4-tert-Butoxy-N-(quinoxalin-6-yl)-2-{4-[5-chloro-2-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}butanamide (Racemate)::US10421742, Example 92::US11180471, Example 92	Plasma kallikrein			 24.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413699	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413699&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205417	433913802							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115934	COc1cn(C(CCOC(C)(C)C)C(=O)Nc2ccc(C(N)=O)c(F)c2)c(=O)cc1-c1cc(Cl)ccc1-c1nc(C)no1	InChI=1S/C30H31ClFN5O6/c1-16-34-29(43-36-16)19-8-6-17(31)12-21(19)22-14-26(38)37(15-25(22)41-5)24(10-11-42-30(2,3)4)28(40)35-18-7-9-20(27(33)39)23(32)13-18/h6-9,12-15,24H,10-11H2,1-5H3,(H2,33,39)(H,35,40)	NZUPFRNOGBEVPO-UHFFFAOYSA-N	413700	4-[(4-tert-Butoxy-2-{4-[5-chloro-2-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}butanoyl)amino]-2-fluorobenzamide (Racemate)::US10421742, Example 93::US11180471, Example 93	Plasma kallikrein			 87.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413700	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413700&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205738	433913803							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115935	COc1cn(C(CCOC(C)(C)C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1-c1nc(C)no1	InChI=1S/C30H31ClN4O7/c1-17-32-28(42-34-17)21-11-8-19(31)14-22(21)23-15-26(36)35(16-25(23)40-5)24(12-13-41-30(2,3)4)27(37)33-20-9-6-18(7-10-20)29(38)39/h6-11,14-16,24H,12-13H2,1-5H3,(H,33,37)(H,38,39)	ZWRNKDXMIOGALM-UHFFFAOYSA-N	413701	4-[(4-tert-Butoxy-2-{4-[5-chloro-2-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}butanoyl)amino]benzoic acid (Racemate)::US10421742, Example 94::US11180471, Example 94	Plasma kallikrein			 40.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413701	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413701&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205935	433913804							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115936	COc1cn(C(CCOC(C)(C)C)C(=O)Nc2ccc3nn(C)cc3c2)c(=O)cc1-c1cc(Cl)ccc1-c1nc(C)no1	InChI=1S/C31H33ClN6O5/c1-18-33-30(43-36-18)22-9-7-20(32)14-23(22)24-15-28(39)38(17-27(24)41-6)26(11-12-42-31(2,3)4)29(40)34-21-8-10-25-19(13-21)16-37(5)35-25/h7-10,13-17,26H,11-12H2,1-6H3,(H,34,40)	QVRAHCXUFLLOFP-UHFFFAOYSA-N	413702	4-tert-Butoxy-2-{4-[5-chloro-2-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 95::US11180471, Example 95	Plasma kallikrein			 51.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413702	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413702&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205986	433913805							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115937	COCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1cnn(CC(F)(F)F)c1	InChI=1S/C29H26ClF3N4O6/c1-42-10-9-24(27(39)35-20-6-3-17(4-7-20)28(40)41)37-15-25(43-2)23(12-26(37)38)22-11-19(30)5-8-21(22)18-13-34-36(14-18)16-29(31,32)33/h3-8,11-15,24H,9-10,16H2,1-2H3,(H,35,39)(H,40,41)	RUCWELAAUNKPGR-UHFFFAOYSA-N	413703	4-({2-[4-{5-Chloro-2-[1-(2,2,2-trifluoroethyl)-1H-pyrazol-4-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)benzoic acid (Racemate)::US10421742, Example 96::US11180471, Example 96	Plasma kallikrein			 230							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413703	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413703&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135211517	433913806							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115938	CNC(=O)c1ccc(NC(=O)C(CCOC)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2-c2cnn(CC(F)(F)F)c2)cn1	InChI=1S/C29H28ClF3N6O5/c1-34-27(41)23-7-5-19(13-35-23)37-28(42)24(8-9-43-2)39-15-25(44-3)22(11-26(39)40)21-10-18(30)4-6-20(21)17-12-36-38(14-17)16-29(31,32)33/h4-7,10-15,24H,8-9,16H2,1-3H3,(H,34,41)(H,37,42)	BSBZPHKWOOZTDV-UHFFFAOYSA-N	413704	5-({2-[4-{5-Chloro-2-[1-(2,2,2-trifluoroethyl)-1H-pyrazol-4-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)-N-methylpyridine-2-carboxamide (Racemate)::US10421742, Example 97::US11180471, Example 97	Plasma kallikrein			 190							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413704	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413704&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135211552	433913807							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115939	COCCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1cnn(CC(F)(F)F)c1	InChI=1S/C30H28ClF3N6O4/c1-38-14-18-10-21(5-7-25(18)37-38)36-29(42)26(8-9-43-2)40-16-27(44-3)24(12-28(40)41)23-11-20(31)4-6-22(23)19-13-35-39(15-19)17-30(32,33)34/h4-7,10-16,26H,8-9,17H2,1-3H3,(H,36,42)	SSDUONDHEXQWQO-UHFFFAOYSA-N	413705	2-[4-{5-Chloro-2-[1-(2,2,2-trifluoroethyl)-1H-pyrazol-4-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxy-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 98::US11180471, Example 98	Plasma kallikrein			 100.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413705	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413705&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205464	433913808							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115940	COCCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C27H25Cl2N7O4/c1-34-13-16-10-18(5-6-21(16)32-34)30-27(38)23(8-9-39-2)35-14-24(40-3)20(12-26(35)37)19-11-17(28)4-7-22(19)36-15-25(29)31-33-36/h4-7,10-15,23H,8-9H2,1-3H3,(H,30,38)	HQFBMTXLTXVRAL-UHFFFAOYSA-N	413706	2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxy-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 99::US11180471, Example 99	Plasma kallikrein			 3.20							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413706	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413706&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205773	433913809							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115941	COCCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C26H23Cl2FN6O5/c1-39-8-7-21(26(38)31-15-4-5-16(25(30)37)19(29)10-15)34-12-22(40-2)18(11-24(34)36)17-9-14(27)3-6-20(17)35-13-23(28)32-33-35/h3-6,9-13,21H,7-8H2,1-2H3,(H2,30,37)(H,31,38)	AITUBRIGGLTKMQ-UHFFFAOYSA-N	413707	4-[(2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxybutanoyl)amino]-2-fluorobenzamide (Racemate)::US10421742, Example 100::US11180471, Example 100	Plasma kallikrein			 5.00							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413707	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413707&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135206029	433913810							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115942	COCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C26H23Cl2N5O6/c1-38-10-9-21(25(35)29-17-6-3-15(4-7-17)26(36)37)32-13-22(39-2)19(12-24(32)34)18-11-16(27)5-8-20(18)33-14-23(28)30-31-33/h3-8,11-14,21H,9-10H2,1-2H3,(H,29,35)(H,36,37)	WCANIIANZRELQI-UHFFFAOYSA-N	413708	4-[(2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxybutanoyl)amino]benzoic acid (Racemate)::US10421742, Example 101::US11180471, Example 101	Plasma kallikrein			 6.00							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413708	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413708&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205978	433913811							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115943	COc1cn(C(CCOC(C)(C)C)C(=O)Nc2ccc(C(N)=O)c(F)c2)c(=O)cc1-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C29H29Cl2FN6O5/c1-29(2,3)43-10-9-23(28(41)34-17-6-7-18(27(33)40)21(32)12-17)37-14-24(42-4)20(13-26(37)39)19-11-16(30)5-8-22(19)38-15-25(31)35-36-38/h5-8,11-15,23H,9-10H2,1-4H3,(H2,33,40)(H,34,41)	JFTPUCJHGXFNAL-UHFFFAOYSA-N	413709	4-[(4-tert-Butoxy-2-{4-[5-chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}butanoyl)amino]-2-fluorobenzamide (Racemate)::US10421742, Example 102::US11180471, Example 102	Plasma kallikrein			 4.40							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413709	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413709&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205886	433913812							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115944	COc1cn(C(CCOC(C)(C)C)C(=O)Nc2ccc3nn(C)cc3c2)c(=O)cc1-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C30H31Cl2N7O4/c1-30(2,3)43-11-10-25(29(41)33-20-7-8-23-18(12-20)15-37(4)35-23)38-16-26(42-5)22(14-28(38)40)21-13-19(31)6-9-24(21)39-17-27(32)34-36-39/h6-9,12-17,25H,10-11H2,1-5H3,(H,33,41)	ZAKSQHPNZWUBFJ-UHFFFAOYSA-N	413710	4-tert-Butoxy-2-{4-[5-chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 103::US11180471, Example 103	Plasma kallikrein			 4.30							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413710	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413710&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205159	433913813							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115945	CCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnc(F)c1	InChI=1S/C27H24ClFN4O5/c1-3-4-22(26(35)31-18-8-5-16(6-9-18)27(36)37)33-13-23(38-2)20(12-25(33)34)19-11-17(28)7-10-21(19)32-14-24(29)30-15-32/h5-15,22H,3-4H2,1-2H3,(H,31,35)(H,36,37)	UEDRHDRNPGYCFA-UHFFFAOYSA-N	413711	4-{[2-{4-[5-Chloro-2-(4-fluoro-1H-imidazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}pentanoyl]amino}benzoic acid (Racemate)::US10421742, Example 104::US11180471, Example 104	Plasma kallikrein			 250							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413711	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413711&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205818	433913814							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115946	CCCC(C(=O)Nc1ccc2nccnc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnc(F)c1	InChI=1S/C28H24ClFN6O3/c1-3-4-24(28(38)34-18-6-7-21-22(12-18)32-10-9-31-21)36-14-25(39-2)20(13-27(36)37)19-11-17(29)5-8-23(19)35-15-26(30)33-16-35/h5-16,24H,3-4H2,1-2H3,(H,34,38)	ZJEBCRXBTDTSDY-UHFFFAOYSA-N	413712	N-(Quinoxalin-6-yl)-2-{4-[5-chloro-2-(4-fluoro-1H-imidazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}pentanamide (Racemate)::US10421742, Example 105::US11180471, Example 105	Plasma kallikrein			 47.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413712	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413712&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205899	433913815							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115947	CCCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnc(F)c1	InChI=1S/C28H26ClFN6O3/c1-4-5-24(28(38)32-19-7-8-22-17(10-19)13-34(2)33-22)36-14-25(39-3)21(12-27(36)37)20-11-18(29)6-9-23(20)35-15-26(30)31-16-35/h6-16,24H,4-5H2,1-3H3,(H,32,38)	ZFHCCWVEIZPKIK-UHFFFAOYSA-N	413713	2-{4-[5-Chloro-2-(4-fluoro-1H-imidazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(2-methyl-2H-indazol-5-yl)pentanamide (Racemate)::US10421742, Example 106::US11180471, Example 106	Plasma kallikrein			 85.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413713	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413713&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205875	433913816							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115948	CCCC(C(=O)Nc1ccc(nc1)C(N)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnc(Cl)c1	InChI=1S/C26H24Cl2N6O4/c1-3-4-21(26(37)32-16-6-7-19(25(29)36)30-11-16)34-12-22(38-2)18(10-24(34)35)17-9-15(27)5-8-20(17)33-13-23(28)31-14-33/h5-14,21H,3-4H2,1-2H3,(H2,29,36)(H,32,37)	ZZSYBTPQPYGNKT-UHFFFAOYSA-N	413714	5-{[2-{4-[5-Chloro-2-(4-chloro-1H-imidazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}pentanoyl]amino}pyridine-2-carboxamide (Racemate)::US10421742, Example 107::US11180471, Example 107	Plasma kallikrein			 200							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413714	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413714&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205208	433913817							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115949	CCCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnc(Cl)c1	InChI=1S/C28H26Cl2N6O3/c1-4-5-24(28(38)32-19-7-8-22-17(10-19)13-34(2)33-22)36-14-25(39-3)21(12-27(36)37)20-11-18(29)6-9-23(20)35-15-26(30)31-16-35/h6-16,24H,4-5H2,1-3H3,(H,32,38)	GJZFNUOEHXFLPK-UHFFFAOYSA-N	413715	2-{4-[5-Chloro-2-(4-chloro-1H-imidazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(2-methyl-2H-indazol-5-yl)pentanamide (Racemate)::US10421742, Example 108::US11180471, Example 108	Plasma kallikrein			 67.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413715	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413715&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205633	433913818							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115950	CCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnc(Cl)c1	InChI=1S/C27H24Cl2N4O5/c1-3-4-22(26(35)31-18-8-5-16(6-9-18)27(36)37)33-13-23(38-2)20(12-25(33)34)19-11-17(28)7-10-21(19)32-14-24(29)30-15-32/h5-15,22H,3-4H2,1-2H3,(H,31,35)(H,36,37)	PYCOXKADFBYSOX-UHFFFAOYSA-N	413716	4-{[2-{4-[5-Chloro-2-(4-chloro-1H-imidazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}pentanoyl]amino}benzoic acid (Racemate)::US10421742, Example 109::US11180471, Example 109	Plasma kallikrein			 180							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413716	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413716&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205936	433913819							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115951	COCCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnc(c1)C(F)(F)F	InChI=1S/C28H24ClF4N5O5/c1-42-8-7-22(27(41)36-16-4-5-17(26(34)40)20(30)10-16)38-12-23(43-2)19(11-25(38)39)18-9-15(29)3-6-21(18)37-13-24(35-14-37)28(31,32)33/h3-6,9-14,22H,7-8H2,1-2H3,(H2,34,40)(H,36,41)	NDZYZAAAWXQARZ-UHFFFAOYSA-N	413717	4-({2-[4-{5-Chloro-2-[4-(trifluoromethyl)-1H-imidazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)-2-fluorobenzamide (Racemate)::US10421742, Example 110::US11180471, Example 110	Plasma kallikrein			 330							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413717	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413717&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205099	433913820							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115952	COCCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnc(c1)C(F)(F)F	InChI=1S/C29H26ClF3N6O4/c1-37-13-17-10-19(5-6-22(17)36-37)35-28(41)24(8-9-42-2)39-14-25(43-3)21(12-27(39)40)20-11-18(30)4-7-23(20)38-15-26(34-16-38)29(31,32)33/h4-7,10-16,24H,8-9H2,1-3H3,(H,35,41)	MCUQCQLBAAKRPX-UHFFFAOYSA-N	413718	2-[4-{5-Chloro-2-[4-(trifluoromethyl)-1H-imidazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxy-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 111::US11180471, Example 111	Plasma kallikrein			 120							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413718	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413718&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205640	433913821							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115953	CCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C25H23ClN6O5/c1-3-4-21(24(34)28-17-8-5-15(6-9-17)25(35)36)31-13-22(37-2)19(12-23(31)33)18-11-16(26)7-10-20(18)32-14-27-29-30-32/h5-14,21H,3-4H2,1-2H3,(H,28,34)(H,35,36)	KXLAWRVDSZAFKG-UHFFFAOYSA-N	413719	4-{[2-{4-[5-Chloro-2-(1H-tetrazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}pentanoyl]amino}benzoic acid (Racemate)::US10421742, Example 112::US11180471, Example 112	Plasma kallikrein			 2.90							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413719	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413719&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205582	433913822							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115954	CCCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C25H23ClFN7O4/c1-3-4-21(25(37)30-15-6-7-16(24(28)36)19(27)10-15)33-12-22(38-2)18(11-23(33)35)17-9-14(26)5-8-20(17)34-13-29-31-32-34/h5-13,21H,3-4H2,1-2H3,(H2,28,36)(H,30,37)	CZWHJSKWMSOPRC-UHFFFAOYSA-N	413720	4-{[2-{4-[5-Chloro-2-(1H-tetrazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}pentanoyl]amino}-2-fluorobenzamide (Racemate)::US10421742, Example 113::US11180471, Example 113	Plasma kallikrein			 3.70							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413720	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413720&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205931	433913823							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115955	CCC[C@@H](C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C25H23ClFN7O4/c1-3-4-21(25(37)30-15-6-7-16(24(28)36)19(27)10-15)33-12-22(38-2)18(11-23(33)35)17-9-14(26)5-8-20(17)34-13-29-31-32-34/h5-13,21H,3-4H2,1-2H3,(H2,28,36)(H,30,37)/t21-/m0/s1	CZWHJSKWMSOPRC-NRFANRHFSA-N	413721	4-{[(2S)-2-{4-[5-Chloro-2-(1H-tetrazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}pentanoyl]amino}-2-fluorobenzamide (Enantiomer 1)::US10421742, Example 114::US11180471, Example 114	Plasma kallikrein			 1.30							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413721	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413721&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205929	433913824							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115956	CCCC(C(=O)Nc1ccc(nc1)C(N)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C24H23ClN8O4/c1-3-4-20(24(36)29-15-6-7-18(23(26)35)27-11-15)32-12-21(37-2)17(10-22(32)34)16-9-14(25)5-8-19(16)33-13-28-30-31-33/h5-13,20H,3-4H2,1-2H3,(H2,26,35)(H,29,36)	AWLPKPUSDZNVQR-UHFFFAOYSA-N	413722	5-{[2-{4-[5-Chloro-2-(1H-tetrazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}pentanoyl]amino}pyridine-2-carboxamide (Racemate)::US10421742, Example 115::US11180471, Example 115	Plasma kallikrein			 1.90							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413722	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413722&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205390	433913825							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115957	CCCC(C(=O)Nc1ccc(nc1)C(=O)NC)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C25H25ClN8O4/c1-4-5-21(25(37)30-16-7-8-19(28-12-16)24(36)27-2)33-13-22(38-3)18(11-23(33)35)17-10-15(26)6-9-20(17)34-14-29-31-32-34/h6-14,21H,4-5H2,1-3H3,(H,27,36)(H,30,37)	NZYSNSQHJHYDEI-UHFFFAOYSA-N	413723	5-{[2-{4-[5-Chloro-2-(1H-tetrazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}pentanoyl]-amino}-N-methylpyridine-2-carboxamide (Racemate)::US10421742, Example 116::US11180471, Example 116	Plasma kallikrein			 1.80							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413723	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413723&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205823	433913826							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115958	CCCC(C(=O)Nc1ccc2nccnc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C26H23ClN8O3/c1-3-4-23(26(37)31-17-6-7-20-21(12-17)29-10-9-28-20)34-14-24(38-2)19(13-25(34)36)18-11-16(27)5-8-22(18)35-15-30-32-33-35/h5-15,23H,3-4H2,1-2H3,(H,31,37)	BSNRZZUTVDCZAA-UHFFFAOYSA-N	413724	N-(Quinoxalin-6-yl)-2-{4-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}pentanamide (Racemate)::US10421742, Example 117::US11180471, Example 117	Plasma kallikrein			 0.970							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413724	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413724&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205052	433913827							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115959	CCC[C@@H](C(=O)Nc1ccc2nccnc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C26H23ClN8O3/c1-3-4-23(26(37)31-17-6-7-20-21(12-17)29-10-9-28-20)34-14-24(38-2)19(13-25(34)36)18-11-16(27)5-8-22(18)35-15-30-32-33-35/h5-15,23H,3-4H2,1-2H3,(H,31,37)/t23-/m0/s1	BSNRZZUTVDCZAA-QHCPKHFHSA-N	413725	N-(Quinoxalin-6-yl)-(2S)-2-{4-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}pentanamide (Enantiomer 2)::US10421742, Example 118::US11180471, Example 118	Plasma kallikrein			 0.570							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413725	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413725&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135211528	433913828							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115960	CCCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C26H25ClN8O3/c1-4-5-23(26(37)29-18-7-8-21-16(10-18)13-33(2)30-21)34-14-24(38-3)20(12-25(34)36)19-11-17(27)6-9-22(19)35-15-28-31-32-35/h6-15,23H,4-5H2,1-3H3,(H,29,37)	DROSFHKHAAIBHD-UHFFFAOYSA-N	413726	2-{4-[5-Chloro-2-(1H-tetrazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(2-methyl-2H-indazol-5-yl)pentanamide (Racemate)::US10421742, Example 119::US11180471, Example 119	Plasma kallikrein			 1.10							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413726	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413726&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135204930	433913829							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115961	CCC[C@@H](C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C26H25ClN8O3/c1-4-5-23(26(37)29-18-7-8-21-16(10-18)13-33(2)30-21)34-14-24(38-3)20(12-25(34)36)19-11-17(27)6-9-22(19)35-15-28-31-32-35/h6-15,23H,4-5H2,1-3H3,(H,29,37)/t23-/m0/s1	DROSFHKHAAIBHD-QHCPKHFHSA-N	413727	(2S)-2-{4-[5-Chloro-2-(1H-tetrazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(2-methyl-2H-indazol-5-yl)pentanamide (Enantiomer 2)::US10421742, Example 120::US11180471, Example 120	Plasma kallikrein			 0.780							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413727	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413727&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135204928	433913830							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115962	CCCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C27H24ClF3N6O4/c1-3-4-22(27(40)33-15-6-7-16(26(32)39)19(29)10-15)36-13-23(41-2)18(11-24(36)38)17-9-14(28)5-8-21(17)37-12-20(25(30)31)34-35-37/h5-13,22,25H,3-4H2,1-2H3,(H2,32,39)(H,33,40)	WZUXJAUBKKDABN-UHFFFAOYSA-N	413728	4-({2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]pentanoyl}amino)-2-fluorobenzamide (Racemate)::US10421742, Example 121::US11180471, Example 121	Plasma kallikrein			 39.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413728	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413728&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205311	433913831							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115963	CCCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C28H26ClF2N7O3/c1-4-5-24(28(40)32-18-7-8-21-16(10-18)13-36(2)34-21)37-15-25(41-3)20(12-26(37)39)19-11-17(29)6-9-23(19)38-14-22(27(30)31)33-35-38/h6-15,24,27H,4-5H2,1-3H3,(H,32,40)	TZKJUKFMINMKSP-UHFFFAOYSA-N	413729	2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-N-(2-methyl-2H-indazol-5-yl)pentanamide (Racemate)::US10421742, Example 122::US11180471, Example 122	Plasma kallikrein			 16.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413729	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413729&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205690	433913832							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115964	CCC[C@@H](C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C28H26ClF2N7O3/c1-4-5-24(28(40)32-18-7-8-21-16(10-18)13-36(2)34-21)37-15-25(41-3)20(12-26(37)39)19-11-17(29)6-9-23(19)38-14-22(27(30)31)33-35-38/h6-15,24,27H,4-5H2,1-3H3,(H,32,40)/t24-/m0/s1	TZKJUKFMINMKSP-DEOSSOPVSA-N	413730	(2S)-2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-N-(2-methyl-2H-indazol-5-yl)pentanamide (Enantiomer 2)::US10421742, Example 123::US11180471, Example 123	Plasma kallikrein			 4.50							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413730	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413730&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205688	433913833							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115965	CCCC(C(=O)Nc1ccc(nc1)C(=O)NC)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C27H26ClF2N7O4/c1-4-5-22(27(40)33-16-7-8-19(32-12-16)26(39)31-2)36-14-23(41-3)18(11-24(36)38)17-10-15(28)6-9-21(17)37-13-20(25(29)30)34-35-37/h6-14,22,25H,4-5H2,1-3H3,(H,31,39)(H,33,40)	ZZXQOEFXCPENDW-UHFFFAOYSA-N	413731	5-({2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]pentanoyl}amino)-N-methylpyridine-2-carboxamide (Racemate)::US10421742, Example 124::US11180471, Example 124	Plasma kallikrein			 24.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413731	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413731&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135204627	433913834							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115966	CCCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C26H23Cl2FN6O4/c1-3-4-21(26(38)31-15-6-7-16(25(30)37)19(29)10-15)34-12-22(39-2)18(11-24(34)36)17-9-14(27)5-8-20(17)35-13-23(28)32-33-35/h5-13,21H,3-4H2,1-2H3,(H2,30,37)(H,31,38)	KQZYQOJQXJGZMI-UHFFFAOYSA-N	413732	4-{[2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}pentanoyl]amino}-2-fluorobenzamide (Racemate)::US10421742, Example 125::US11180471, Example 125	Plasma kallikrein			 13.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413732	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413732&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135204823	433913835							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115967	CCCC(C(=O)Nc1ccc2nccnc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C27H23Cl2N7O3/c1-3-4-23(27(38)32-17-6-7-20-21(12-17)31-10-9-30-20)35-14-24(39-2)19(13-26(35)37)18-11-16(28)5-8-22(18)36-15-25(29)33-34-36/h5-15,23H,3-4H2,1-2H3,(H,32,38)	AJXCDVGDMKCSJV-UHFFFAOYSA-N	413733	N-(Quinoxalin-6-yl)-2-{4-[5-chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}pentanamide (Racemate)::US10421742, Example 126::US11180471, Example 126	Plasma kallikrein			 3.80							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413733	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413733&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135204993	433913836							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115968	CCCC(C(=O)Nc1ccc(nc1)C(=O)NC)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C26H25Cl2N7O4/c1-4-5-21(26(38)31-16-7-8-19(30-12-16)25(37)29-2)34-13-22(39-3)18(11-24(34)36)17-10-15(27)6-9-20(17)35-14-23(28)32-33-35/h6-14,21H,4-5H2,1-3H3,(H,29,37)(H,31,38)	RMNQUVGQJWBXRY-UHFFFAOYSA-N	413734	5-{[2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}pentanoyl]amino}-N-methylpyridine-2-carboxamide (Racemate)::US10421742, Example 127::US11180471, Example 127	Plasma kallikrein			 7.50							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413734	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413734&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205374	433913837							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115969	CCC[C@@H](C(=O)Nc1ccc(nc1)C(=O)NC)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C26H25Cl2N7O4/c1-4-5-21(26(38)31-16-7-8-19(30-12-16)25(37)29-2)34-13-22(39-3)18(11-24(34)36)17-10-15(27)6-9-20(17)35-14-23(28)32-33-35/h6-14,21H,4-5H2,1-3H3,(H,29,37)(H,31,38)/t21-/m0/s1	RMNQUVGQJWBXRY-NRFANRHFSA-N	413735	5-{[(2S)-2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}pentanoyl]amino}-N-methylpyridine-2-carboxamide (Enantiomer 2)::US10421742, Example 128::US11180471, Example 128	Plasma kallikrein			 4.60							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413735	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413735&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205795	433913838							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115970	CCCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C27H25Cl2N7O3/c1-4-5-23(27(38)30-18-7-8-21-16(10-18)13-34(2)32-21)35-14-24(39-3)20(12-26(35)37)19-11-17(28)6-9-22(19)36-15-25(29)31-33-36/h6-15,23H,4-5H2,1-3H3,(H,30,38)	XMGACJAVDNSYFS-UHFFFAOYSA-N	413736	2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(2-methyl-2H-indazol-5-yl)pentanamide (Racemate)::US10421742, Example 129::US11180471, Example 129	Plasma kallikrein			 6.80							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413736	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413736&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205483	433913839							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115971	CCC[C@@H](C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C27H25Cl2N7O3/c1-4-5-23(27(38)30-18-7-8-21-16(10-18)13-34(2)32-21)35-14-24(39-3)20(12-26(35)37)19-11-17(28)6-9-22(19)36-15-25(29)31-33-36/h6-15,23H,4-5H2,1-3H3,(H,30,38)/t23-/m0/s1	XMGACJAVDNSYFS-QHCPKHFHSA-N	413737	(2S)-2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(2-methyl-2H-indazol-5-yl)pentanamide (Enantiomer 2)::US10421742, Example 130::US11180471, Example 130	Plasma kallikrein			 3.10							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413737	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413737&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205651	433913840							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115972	CCCC(C(=O)Nc1ccc(nc1)C(=O)NC)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C1=NOCC1	InChI=1S/C27H28ClN5O5/c1-4-5-23(27(36)31-17-7-9-22(30-14-17)26(35)29-2)33-15-24(37-3)20(13-25(33)34)19-12-16(28)6-8-18(19)21-10-11-38-32-21/h6-9,12-15,23H,4-5,10-11H2,1-3H3,(H,29,35)(H,31,36)	FVMMOGSUTBHAJT-UHFFFAOYSA-N	413738	5-{[2-{4-[5-Chloro-2-(4,5-dihydro-1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}pentanoyl]amino}-N-methylpyridine-2-carboxamide (Racemate)::US10421742, Example 131::US11180471, Example 131	Plasma kallikrein			 250							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413738	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413738&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205781	433913841							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115973	CCCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C1=NOCC1	InChI=1S/C28H28ClN5O4/c1-4-5-25(28(36)30-19-7-9-23-17(12-19)15-33(2)31-23)34-16-26(37-3)22(14-27(34)35)21-13-18(29)6-8-20(21)24-10-11-38-32-24/h6-9,12-16,25H,4-5,10-11H2,1-3H3,(H,30,36)	GGCCNKNGPKYJET-UHFFFAOYSA-N	413739	2-{4-[5-Chloro-2-(4,5-dihydro-1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(2-methyl-2H-indazol-5-yl)pentanamide (Racemate)::US10421742, Example 132::US11180471, Example 132	Plasma kallikrein			 110							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413739	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413739&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205590	433913842							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115974	CCCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C1=NOCC1	InChI=1S/C27H26ClFN4O5/c1-3-4-23(27(36)31-16-6-8-18(26(30)35)21(29)12-16)33-14-24(37-2)20(13-25(33)34)19-11-15(28)5-7-17(19)22-9-10-38-32-22/h5-8,11-14,23H,3-4,9-10H2,1-2H3,(H2,30,35)(H,31,36)	CACLNVKPTHLQAL-UHFFFAOYSA-N	413740	4-{[2-{4-[5-Chloro-2-(4,5-dihydro-1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}pentanoyl]amino}-2-fluorobenzamide (Racemate)::US10421742, Example 133::US11180471, Example 133	Plasma kallikrein			 460							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413740	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413740&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135211499	433913843							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115975	CCCC(C(=O)Nc1ccc2nccnc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C1=NOCC1	InChI=1S/C28H26ClN5O4/c1-3-4-25(28(36)32-18-6-8-23-24(14-18)31-11-10-30-23)34-16-26(37-2)21(15-27(34)35)20-13-17(29)5-7-19(20)22-9-12-38-33-22/h5-8,10-11,13-16,25H,3-4,9,12H2,1-2H3,(H,32,36)	QYYKJTWIVWXLBD-UHFFFAOYSA-N	413741	N-(Quinoxalin-6-yl)-2-{4-[5-chloro-2-(4,5-dihydro-1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}pentanamide (Racemate)::US10421742, Example 134::US11180471, Example 134	Plasma kallikrein			 45.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413741	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413741&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135204822	433913844							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115976	CCCC(C(=O)Nc1ccc(nc1)C(N)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C1=NOCC1	InChI=1S/C26H26ClN5O5/c1-3-4-22(26(35)30-16-6-8-21(25(28)34)29-13-16)32-14-23(36-2)19(12-24(32)33)18-11-15(27)5-7-17(18)20-9-10-37-31-20/h5-8,11-14,22H,3-4,9-10H2,1-2H3,(H2,28,34)(H,30,35)	WRJUZVZDXJUFIS-UHFFFAOYSA-N	413742	5-{[2-{4-[5-Chloro-2-(4,5-dihydro-1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}pentanoyl]amino}pyridine-2-carboxamide (Racemate)::US10421742, Example 135::US11180471, Example 135	Plasma kallikrein			 380							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413742	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413742&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205806	433913845							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115977	CCCCC(C(=O)Nc1ccc(nc1)C(N)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C25H25ClN8O4/c1-3-4-5-21(25(37)30-16-7-8-19(24(27)36)28-12-16)33-13-22(38-2)18(11-23(33)35)17-10-15(26)6-9-20(17)34-14-29-31-32-34/h6-14,21H,3-5H2,1-2H3,(H2,27,36)(H,30,37)	ZIAUCGPBMPJNBL-UHFFFAOYSA-N	413743	5-{[2-{4-[5-Chloro-2-(1H-tetrazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}hexanoyl]amino}pyridine-2-carboxamide (Racemate)::US10421742, Example 136::US11180471, Example 136	Plasma kallikrein			 2.50							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413743	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413743&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205668	433913846							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115978	CCCCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C26H25ClFN7O4/c1-3-4-5-22(26(38)31-16-7-8-17(25(29)37)20(28)11-16)34-13-23(39-2)19(12-24(34)36)18-10-15(27)6-9-21(18)35-14-30-32-33-35/h6-14,22H,3-5H2,1-2H3,(H2,29,37)(H,31,38)	VQBUYPWHWZACJN-UHFFFAOYSA-N	413744	4-{[2-{4-[5-Chloro-2-(1H-tetrazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}hexanoyl]amino}-2-fluorobenzamide (Racemate)::US10421742, Example 137::US11180471, Example 137	Plasma kallikrein			 2.10							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413744	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413744&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205878	433913847							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115979	CCCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C26H25ClN6O5/c1-3-4-5-22(25(35)29-18-9-6-16(7-10-18)26(36)37)32-14-23(38-2)20(13-24(32)34)19-12-17(27)8-11-21(19)33-15-28-30-31-33/h6-15,22H,3-5H2,1-2H3,(H,29,35)(H,36,37)	FCSAYDZPMDLFSN-UHFFFAOYSA-N	413745	4-{[2-{4-[5-Chloro-2-(1H-tetrazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}hexanoyl]amino}benzoic acid (Racemate)::US10421742, Example 138::US11180471, Example 138	Plasma kallikrein			 1.80							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413745	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413745&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205666	433913848							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115980	CCCCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C27H27ClN8O3/c1-4-5-6-24(27(38)30-19-8-9-22-17(11-19)14-34(2)31-22)35-15-25(39-3)21(13-26(35)37)20-12-18(28)7-10-23(20)36-16-29-32-33-36/h7-16,24H,4-6H2,1-3H3,(H,30,38)	GTVFMNZALGQANW-UHFFFAOYSA-N	413746	2-{4-[5-Chloro-2-(1H-tetrazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(2-methyl-2H-indazol-5-yl)hexanamide (Racemate)::US10421742, Example 139::US11180471, Example 139	Plasma kallikrein			 1.000							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413746	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413746&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205025	433913849							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115981	CCCCC(C(=O)Nc1ccc2nccnc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C27H25ClN8O3/c1-3-4-5-24(27(38)32-18-7-8-21-22(13-18)30-11-10-29-21)35-15-25(39-2)20(14-26(35)37)19-12-17(28)6-9-23(19)36-16-31-33-34-36/h6-16,24H,3-5H2,1-2H3,(H,32,38)	DVTLDIPPLKDTBX-UHFFFAOYSA-N	413747	N-(Quinoxalin-6-yl)-2-{4-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}hexanamide (Racemate)::US10421742, Example 140::US11180471, Example 140	Plasma kallikrein			 1.50							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413747	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413747&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205988	433913850							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115982	CCCCC(C(=O)Nc1ccc(nc1)C(=O)NC)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C26H27ClN8O4/c1-4-5-6-22(26(38)31-17-8-9-20(29-13-17)25(37)28-2)34-14-23(39-3)19(12-24(34)36)18-11-16(27)7-10-21(18)35-15-30-32-33-35/h7-15,22H,4-6H2,1-3H3,(H,28,37)(H,31,38)	ORRIMSVBDDRCMC-UHFFFAOYSA-N	413748	5-{[2-{4-[5-Chloro-2-(1H-tetrazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}hexanoyl]amino}-N-methylpyridine-2-carboxamide (Racemate)::US10421742, Example 141::US11180471, Example 141	Plasma kallikrein			 1.40							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413748	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413748&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205579	433913851							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115983	CCCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C28H26ClF2N5O5/c1-3-4-5-23(27(38)32-18-9-6-16(7-10-18)28(39)40)35-15-24(41-2)20(13-25(35)37)19-12-17(29)8-11-22(19)36-14-21(26(30)31)33-34-36/h6-15,23,26H,3-5H2,1-2H3,(H,32,38)(H,39,40)	PSPFOZLTTSZDFP-UHFFFAOYSA-N	413749	4-({2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]hexanoyl}amino)benzoic acid (Racemate)::US10421742, Example 142::US11180471, Example 142	Plasma kallikrein			 11.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413749	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413749&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135204833	433913852							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115984	CCCCC(C(=O)Nc1ccc(nc1)C(N)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C27H26ClF2N7O4/c1-3-4-5-22(27(40)33-16-7-8-19(26(31)39)32-12-16)36-14-23(41-2)18(11-24(36)38)17-10-15(28)6-9-21(17)37-13-20(25(29)30)34-35-37/h6-14,22,25H,3-5H2,1-2H3,(H2,31,39)(H,33,40)	JSHWYUYKRGKALM-UHFFFAOYSA-N	413750	5-({2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]hexanoyl}amino)pyridine-2-carboxamide (Racemate)::US10421742, Example 143::US11180471, Example 143	Plasma kallikrein			 21.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413750	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413750&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205512	433913853							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115985	CCCCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C28H26ClF3N6O4/c1-3-4-5-23(28(41)34-16-7-8-17(27(33)40)20(30)11-16)37-14-24(42-2)19(12-25(37)39)18-10-15(29)6-9-22(18)38-13-21(26(31)32)35-36-38/h6-14,23,26H,3-5H2,1-2H3,(H2,33,40)(H,34,41)	HGCFEYDNSXOVOU-UHFFFAOYSA-N	413751	4-({2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]hexanoyl}amino)-2-fluorobenzamide (Racemate)::US10421742, Example 144::US11180471, Example 144	Plasma kallikrein			 30.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413751	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413751&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205069	433913854							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115986	CCCCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C29H28ClF2N7O3/c1-4-5-6-25(29(41)33-19-8-9-22-17(11-19)14-37(2)35-22)38-16-26(42-3)21(13-27(38)40)20-12-18(30)7-10-24(20)39-15-23(28(31)32)34-36-39/h7-16,25,28H,4-6H2,1-3H3,(H,33,41)	OUOIBTWZEMQDJD-UHFFFAOYSA-N	413752	2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-N-(2-methyl-2H-indazol-5-yl)hexanamide (Racemate)::US10421742, Example 145::US11180471, Example 145	Plasma kallikrein			 7.30							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413752	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413752&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205547	433913855							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115987	CCCCC(C(=O)Nc1ccc2nccnc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C29H26ClF2N7O3/c1-3-4-5-25(29(41)35-18-7-8-21-22(13-18)34-11-10-33-21)38-16-26(42-2)20(14-27(38)40)19-12-17(30)6-9-24(19)39-15-23(28(31)32)36-37-39/h6-16,25,28H,3-5H2,1-2H3,(H,35,41)	YGFSDBVKNXCHFA-UHFFFAOYSA-N	413753	N-(Quinoxalin-6-yl)-2-[4-{5-chloro-2-[4-(difluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]hexanamide (Racemate)::US10421742, Example 146::US11180471, Example 146	Plasma kallikrein			 5.60							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413753	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413753&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205951	433913856							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115988	CCCCC(C(=O)Nc1ccc(nc1)C(=O)NC)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C28H28ClF2N7O4/c1-4-5-6-23(28(41)34-17-8-9-20(33-13-17)27(40)32-2)37-15-24(42-3)19(12-25(37)39)18-11-16(29)7-10-22(18)38-14-21(26(30)31)35-36-38/h7-15,23,26H,4-6H2,1-3H3,(H,32,40)(H,34,41)	LATWNRFJRFBWAT-UHFFFAOYSA-N	413754	5-({2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]hexanoyl}amino)-N-methylpyridine-2-carboxamide (Racemate)::US10421742, Example 147::US11180471, Example 147	Plasma kallikrein			 13.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413754	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413754&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135206088	433913857							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115989	CCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(o1)C(F)(F)F	InChI=1S/C26H20ClF3N4O6/c1-3-19(22(36)31-15-7-4-13(5-8-15)24(37)38)34-12-20(39-2)18(11-21(34)35)17-10-14(27)6-9-16(17)23-32-33-25(40-23)26(28,29)30/h4-12,19H,3H2,1-2H3,(H,31,36)(H,37,38)	QIVMZHNMVQBPGT-UHFFFAOYSA-N	413755	4-({2-[4-{5-Chloro-2-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanoyl}amino)benzoic acid (Racemate)::US10421742, Example 148::US11180471, Example 148	Plasma kallikrein			 200							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413755	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413755&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205817	433913858							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115990	CCC(C(=O)Nc1ccc(nc1)C(N)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(o1)C(F)(F)F	InChI=1S/C25H20ClF3N6O5/c1-3-18(22(38)32-13-5-7-17(21(30)37)31-10-13)35-11-19(39-2)16(9-20(35)36)15-8-12(26)4-6-14(15)23-33-34-24(40-23)25(27,28)29/h4-11,18H,3H2,1-2H3,(H2,30,37)(H,32,38)	IQJSIJCMDLKBFX-UHFFFAOYSA-N	413756	5-({2-[4-{5-Chloro-2-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanoyl}amino)pyridine-2-carboxamide (Racemate)::US10421742, Example 149::US11180471, Example 149	Plasma kallikrein			 210							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413756	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413756&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135206048	433913859							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115991	CCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(o1)C(F)(F)F	InChI=1S/C26H20ClF4N5O5/c1-3-19(23(39)33-13-5-7-15(22(32)38)18(28)9-13)36-11-20(40-2)17(10-21(36)37)16-8-12(27)4-6-14(16)24-34-35-25(41-24)26(29,30)31/h4-11,19H,3H2,1-2H3,(H2,32,38)(H,33,39)	UHOHRXOOGVHYED-UHFFFAOYSA-N	413757	4-({2-[4-{5-Chloro-2-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanoyl}amino)-2-fluorobenzamide (Racemate)::US10421742, Example 150::US11180471, Example 150	Plasma kallikrein			 210							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413757	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413757&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205709	433913860							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115992	CCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(o1)C(F)(F)F	InChI=1S/C27H22ClF3N6O4/c1-4-21(24(39)32-16-6-8-20-14(9-16)12-36(2)35-20)37-13-22(40-3)19(11-23(37)38)18-10-15(28)5-7-17(18)25-33-34-26(41-25)27(29,30)31/h5-13,21H,4H2,1-3H3,(H,32,39)	HHSBQKYCPNEOQX-UHFFFAOYSA-N	413758	2-[4-{5-Chloro-2-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 151::US11180471, Example 151	Plasma kallikrein			 71.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413758	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413758&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205384	433913861							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115993	CCC(C(=O)Nc1ccc2nccnc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(o1)C(F)(F)F	InChI=1S/C27H20ClF3N6O4/c1-3-21(24(39)34-15-5-7-19-20(11-15)33-9-8-32-19)37-13-22(40-2)18(12-23(37)38)17-10-14(28)4-6-16(17)25-35-36-26(41-25)27(29,30)31/h4-13,21H,3H2,1-2H3,(H,34,39)	OLLLLNYOIWPNPJ-UHFFFAOYSA-N	413759	N-(Quinoxalin-6-yl)-2-[4-{5-chloro-2-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanamide (Racemate)::US10421742, Example 152::US11180471, Example 152	Plasma kallikrein			 40.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413759	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413759&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205969	433913862							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115994	CCC(C(=O)Nc1ccc(C(=O)NC)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(o1)C(F)(F)F	InChI=1S/C27H22ClF4N5O5/c1-4-20(24(40)34-14-6-8-16(19(29)10-14)23(39)33-2)37-12-21(41-3)18(11-22(37)38)17-9-13(28)5-7-15(17)25-35-36-26(42-25)27(30,31)32/h5-12,20H,4H2,1-3H3,(H,33,39)(H,34,40)	DLRRJLUTWALOOR-UHFFFAOYSA-N	413760	4-({2-[4-{5-Chloro-2-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanoyl}amino)-2-fluoro-N-methylbenzamide (Racemate)::US10421742, Example 153::US11180471, Example 153	Plasma kallikrein			 270							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413760	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413760&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135204746	433913863							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115995	CCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(o1)C(F)F	InChI=1S/C26H21ClF2N4O6/c1-3-19(23(35)30-15-7-4-13(5-8-15)26(36)37)33-12-20(38-2)18(11-21(33)34)17-10-14(27)6-9-16(17)24-31-32-25(39-24)22(28)29/h4-12,19,22H,3H2,1-2H3,(H,30,35)(H,36,37)	ARBVSWGIQYWRFI-UHFFFAOYSA-N	413761	4-({2-[4-{5-Chloro-2-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanoyl}amino)benzoic acid (Racemate)::US10421742, Example 154::US11180471, Example 154	Plasma kallikrein			 170							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413761	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413761&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205186	433913864							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115996	CCC(C(=O)Nc1ccc(nc1)C(N)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(o1)C(F)F	InChI=1S/C25H21ClF2N6O5/c1-3-18(23(37)31-13-5-7-17(22(29)36)30-10-13)34-11-19(38-2)16(9-20(34)35)15-8-12(26)4-6-14(15)24-32-33-25(39-24)21(27)28/h4-11,18,21H,3H2,1-2H3,(H2,29,36)(H,31,37)	MXCXAGMMMBQTPS-UHFFFAOYSA-N	413762	5-({2-[4-{5-Chloro-2-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanoyl}amino)pyridine-2-carboxamide (Racemate)::US10421742, Example 155::US11180471, Example 155	Plasma kallikrein			 140							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413762	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413762&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205309	433913865							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115997	CCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(o1)C(F)F	InChI=1S/C26H21ClF3N5O5/c1-3-19(24(38)32-13-5-7-15(23(31)37)18(28)9-13)35-11-20(39-2)17(10-21(35)36)16-8-12(27)4-6-14(16)25-33-34-26(40-25)22(29)30/h4-11,19,22H,3H2,1-2H3,(H2,31,37)(H,32,38)	GELPZCSNZJPUPR-UHFFFAOYSA-N	413763	4-({2-[4-{5-Chloro-2-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanoyl}amino)-2-fluorobenzamide (Racemate)::US10421742, Example 156::US11180471, Example 160	Plasma kallikrein			 170							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413763	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413763&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205925	433913866							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115998	CCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(o1)C(F)F	InChI=1S/C27H23ClF2N6O4/c1-4-21(25(38)31-16-6-8-20-14(9-16)12-35(2)34-20)36-13-22(39-3)19(11-23(36)37)18-10-15(28)5-7-17(18)26-32-33-27(40-26)24(29)30/h5-13,21,24H,4H2,1-3H3,(H,31,38)	HUAFIQJRZLYLOU-UHFFFAOYSA-N	413764	2-[4-{5-Chloro-2-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 157::US11180471, Example 157	Plasma kallikrein			 65.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413764	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413764&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205941	433913867							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115999	CCC(C(=O)Nc1ccc2nccnc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(o1)C(F)F	InChI=1S/C27H21ClF2N6O4/c1-3-21(25(38)33-15-5-7-19-20(11-15)32-9-8-31-19)36-13-22(39-2)18(12-23(36)37)17-10-14(28)4-6-16(17)26-34-35-27(40-26)24(29)30/h4-13,21,24H,3H2,1-2H3,(H,33,38)	ZXOWUCFZXVCGPI-UHFFFAOYSA-N	413765	N-(Quinoxalin-6-yl)-2-[4-{5-chloro-2-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanamide (Racemate)::US10421742, Example 158::US11180471, Example 158	Plasma kallikrein			 32.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413765	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413765&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205104	433913868							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116000	CCC(C(=O)Nc1ccc(C(=O)NC)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(o1)C(F)F	InChI=1S/C27H23ClF3N5O5/c1-4-20(25(39)33-14-6-8-16(19(29)10-14)24(38)32-2)36-12-21(40-3)18(11-22(36)37)17-9-13(28)5-7-15(17)26-34-35-27(41-26)23(30)31/h5-12,20,23H,4H2,1-3H3,(H,32,38)(H,33,39)	XEUUKFFBCFEEHJ-UHFFFAOYSA-N	413766	4-({2-[4-{5-Chloro-2-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanoyl}amino)-2-fluoro-N-methylbenzamide (Racemate)::US10421742, Example 159::US11180471, Example 159	Plasma kallikrein			 230							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413766	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413766&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205157	433913869							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116001	CCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(o1)C(F)F	InChI=1S/C26H21ClF3N5O5/c1-3-19(24(38)32-13-5-7-15(23(31)37)18(28)9-13)35-11-20(39-2)17(10-21(35)36)16-8-12(27)4-6-14(16)25-33-34-26(40-25)22(29)30/h4-11,19,22H,3H2,1-2H3,(H2,31,37)(H,32,38)	GELPZCSNZJPUPR-UHFFFAOYSA-N	413763	4-({2-[4-{5-Chloro-2-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanoyl}amino)-2-fluorobenzamide (Racemate)::US10421742, Example 156::US11180471, Example 160	Plasma kallikrein			 18.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413763	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413763&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205925	433913866							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116002	CC[C@@H](C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C26H22ClF3N6O4/c1-3-20(26(39)32-14-5-6-15(25(31)38)18(28)9-14)35-12-22(40-2)17(10-23(35)37)16-8-13(27)4-7-21(16)36-11-19(24(29)30)33-34-36/h4-12,20,24H,3H2,1-2H3,(H2,31,38)(H,32,39)/t20-/m0/s1	OETZVLILMHLZTG-FQEVSTJZSA-N	413768	4-({(2S)-2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanoyl}amino)-2-fluorobenzamide (Enantiomer 2)::US10421742, Example 161::US11180471, Example 161	Plasma kallikrein			 14.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413768	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413768&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205281	433913871							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116003	CCC(C(=O)Nc1ccc2nccnc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C27H22ClF2N7O3/c1-3-22(27(39)33-16-5-6-19-20(11-16)32-9-8-31-19)36-14-24(40-2)18(12-25(36)38)17-10-15(28)4-7-23(17)37-13-21(26(29)30)34-35-37/h4-14,22,26H,3H2,1-2H3,(H,33,39)	OEMBYSUFEIJUEQ-UHFFFAOYSA-N	413769	N-(Quinoxalin-6-yl)-2-[4-{5-chloro-2-[4-(difluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanamide (Racemate)::US10421742, Example 162::US11180471, Example 162	Plasma kallikrein			 5.90							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413769	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413769&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205522	433913872							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116004	CC[C@@H](C(=O)Nc1ccc2nccnc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C27H22ClF2N7O3/c1-3-22(27(39)33-16-5-6-19-20(11-16)32-9-8-31-19)36-14-24(40-2)18(12-25(36)38)17-10-15(28)4-7-23(17)37-13-21(26(29)30)34-35-37/h4-14,22,26H,3H2,1-2H3,(H,33,39)/t22-/m0/s1	OEMBYSUFEIJUEQ-QFIPXVFZSA-N	413770	N-(Quinoxalin-6-yl)-(2S)-2-[4-{5-chloro-2-[4-(difluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanamide (Enantiomer 2)::US10421742, Example 163::US11180471, Example 163	Plasma kallikrein			 1.70							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413770	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413770&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205521	433913873							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116005	CCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C27H24ClF2N7O3/c1-4-22(27(39)31-17-6-7-20-15(9-17)12-35(2)33-20)36-14-24(40-3)19(11-25(36)38)18-10-16(28)5-8-23(18)37-13-21(26(29)30)32-34-37/h5-14,22,26H,4H2,1-3H3,(H,31,39)	UAHXABWWDRJQRK-UHFFFAOYSA-N	413771	2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 164::US11180471, Example 164	Plasma kallikrein			 8.20							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413771	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413771&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205536	433913874							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116006	CC[C@@H](C(=O)Nc1ccc2cn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C28H25ClF2N6O3/c1-4-23(28(39)32-19-7-5-16-12-35(2)13-17(16)9-19)36-15-25(40-3)21(11-26(36)38)20-10-18(29)6-8-24(20)37-14-22(27(30)31)33-34-37/h5-15,23,27H,4H2,1-3H3,(H,32,39)/t23-/m0/s1	VFCPFXPPJSVUEB-QHCPKHFHSA-N	528187	(2S)-2-[4-{5-Chloro-2-[4-(difluoromethyl)-H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-N-(2-methyl-2H-indazol-5-yl)butanamide (enantiomer 2)::US11180471, Example 165	Plasma kallikrein			 3.20							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528187	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528187&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163200077	463791736							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116007	CCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C26H22ClF2N5O5/c1-3-20(25(36)30-16-7-4-14(5-8-16)26(37)38)33-13-22(39-2)18(11-23(33)35)17-10-15(27)6-9-21(17)34-12-19(24(28)29)31-32-34/h4-13,20,24H,3H2,1-2H3,(H,30,36)(H,37,38)	NNJGQRMOKIHSCI-UHFFFAOYSA-N	413773	4-({2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanoyl}amino)benzoic acid (Racemate)::US10421742, Example 166::US11180471, Example 166	Plasma kallikrein			 20.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413773	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413773&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205919	433913876							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116008	CCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C26H23Cl2N7O3/c1-4-21(26(37)29-17-6-7-20-15(9-17)12-33(2)31-20)34-13-23(38-3)19(11-25(34)36)18-10-16(27)5-8-22(18)35-14-24(28)30-32-35/h5-14,21H,4H2,1-3H3,(H,29,37)	QBWXHIMIUSZAOP-UHFFFAOYSA-N	413774	2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 167::US10421742, Example 225::US11180471, Example 225	Plasma kallikrein			 6.30							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413774	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413774&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205467	433913877							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116009	CC[C@@H](C(=O)Nc1ccc2cn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C27H24Cl2N6O3/c1-4-22(27(37)30-19-7-5-16-12-33(2)13-17(16)9-19)34-14-24(38-3)21(11-26(34)36)20-10-18(28)6-8-23(20)35-15-25(29)31-32-35/h5-15,22H,4H2,1-3H3,(H,30,37)/t22-/m0/s1	HNHBZVLOAXVGOW-QFIPXVFZSA-N	528190	(2S)-2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(2-methyl-2H-indazol-5-yl)butanamide (enantiomer 2)::US11180471, Example 168	Plasma kallikrein			 2.10							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528190	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528190&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163200078	463791738							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116010	CCC(C(=O)Nc1ccc2nccnc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C26H21Cl2N7O3/c1-3-21(26(37)31-16-5-6-19-20(11-16)30-9-8-29-19)34-13-23(38-2)18(12-25(34)36)17-10-15(27)4-7-22(17)35-14-24(28)32-33-35/h4-14,21H,3H2,1-2H3,(H,31,37)	QWJAHBCIMJSNPO-UHFFFAOYSA-N	413776	N-(Quinoxalin-6-yl)-2-{4-[5-chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}butanamide (Racemate)::US10421742, Example 169::US11180471, Example 169	Plasma kallikrein			 3.80							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413776	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413776&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205827	433913879							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116011	CC[C@@H](C(=O)Nc1ccc2nccnc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C26H21Cl2N7O3/c1-3-21(26(37)31-16-5-6-19-20(11-16)30-9-8-29-19)34-13-23(38-2)18(12-25(34)36)17-10-15(27)4-7-22(17)35-14-24(28)32-33-35/h4-14,21H,3H2,1-2H3,(H,31,37)/t21-/m0/s1	QWJAHBCIMJSNPO-NRFANRHFSA-N	413777	N-(Quinoxalin-6-yl)-(2S)-2-{4-[5-chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}butanamide (Enantiomer 2)::US10421742, Example 170::US11180471, Example 170	Plasma kallikrein			 1.50							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413777	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413777&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135206028	433913880							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116012	CCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C25H21Cl2FN6O4/c1-3-19(25(37)30-14-5-6-15(24(29)36)18(28)9-14)33-11-21(38-2)17(10-23(33)35)16-8-13(26)4-7-20(16)34-12-22(27)31-32-34/h4-12,19H,3H2,1-2H3,(H2,29,36)(H,30,37)	FPAKZDLGEHHCTC-UHFFFAOYSA-N	413778	4-[(2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}butanoyl)amino]-2-fluorobenzamide (Racemate)::US10421742, Example 171::US11180471, Example 171	Plasma kallikrein			 9.60							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413778	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413778&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205799	433913881							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116013	CCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C25H23ClN8O3/c1-4-21(25(36)28-17-6-7-20-15(9-17)12-32(2)29-20)33-13-23(37-3)19(11-24(33)35)18-10-16(26)5-8-22(18)34-14-27-30-31-34/h5-14,21H,4H2,1-3H3,(H,28,36)	IQNORUMXNDXEIL-UHFFFAOYSA-N	528194	2-{4-[5-Chloro-2-(1H-tetrazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(2-methyl-2H-indazol-5-yl)butanamide (racemate)::US11180471, Example 172	Plasma kallikrein			 1.70							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528194	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528194&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			142742732	463791741							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116014	COc1cn(C(CC2CCC2)C(=O)Nc2ccc3nccnc3c2)c(=O)cc1-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C29H25Cl2N7O3/c1-41-26-15-37(28(39)14-21(26)20-12-18(30)5-8-24(20)38-16-27(31)35-36-38)25(11-17-3-2-4-17)29(40)34-19-6-7-22-23(13-19)33-10-9-32-22/h5-10,12-17,25H,2-4,11H2,1H3,(H,34,40)	MZJDBIVMBJLQSX-UHFFFAOYSA-N	413780	N-(Quinoxalin-6-yl)-2-{4-[5-chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-3-cyclobutylpropanamide (Racemate)::US10421742, Example 173::US11180471, Example 173	Plasma kallikrein			 5.90							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413780	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413780&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135206019	433913883							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116015	CCC(C(=O)Nc1ccc(nc1)C(N)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1cc(on1)C(F)F	InChI=1S/C26H22ClF2N5O5/c1-3-20(26(37)32-14-5-7-18(25(30)36)31-11-14)34-12-22(38-2)17(9-23(34)35)16-8-13(27)4-6-15(16)19-10-21(24(28)29)39-33-19/h4-12,20,24H,3H2,1-2H3,(H2,30,36)(H,32,37)	CFZRHXMVQOAQBA-UHFFFAOYSA-N	413781	5-({2-[4-{5-Chloro-2-[5-(difluoromethyl)-1,2-oxazol-3-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanoyl}amino)pyridine-2-carboxamide (Racemate)::US10421742, Example 174::US11180471, Example 174	Plasma kallikrein			 15.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413781	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413781&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205546	433913884							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116016	CCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1cc(on1)C(F)F	InChI=1S/C27H22ClF3N4O5/c1-3-21(27(38)33-14-5-7-16(26(32)37)19(29)9-14)35-12-23(39-2)18(10-24(35)36)17-8-13(28)4-6-15(17)20-11-22(25(30)31)40-34-20/h4-12,21,25H,3H2,1-2H3,(H2,32,37)(H,33,38)	WJQZEXDXRMYEAJ-UHFFFAOYSA-N	413782	4-({2-[4-{5-Chloro-2-[5-(difluoromethyl)-1,2-oxazol-3-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanoyl}amino)-2-fluorobenzamide (Racemate)::US10421742, Example 175::US11180471, Example 175	Plasma kallikrein			 38.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413782	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413782&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205744	433913885							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116017	CCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1cc(on1)C(F)F	InChI=1S/C28H24ClF2N5O4/c1-4-23(28(38)32-17-6-8-21-15(9-17)13-35(2)33-21)36-14-25(39-3)20(11-26(36)37)19-10-16(29)5-7-18(19)22-12-24(27(30)31)40-34-22/h5-14,23,27H,4H2,1-3H3,(H,32,38)	YPTNTTHZSPASJM-UHFFFAOYSA-N	413783	2-[4-{5-Chloro-2-[5-(difluoromethyl)-1,2-oxazol-3-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 176::US11180471, Example 176	Plasma kallikrein			 14.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413783	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413783&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205796	433913886							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116018	CCC(C(=O)Nc1ccc(C(=O)NC)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1cc(on1)C(F)F	InChI=1S/C28H24ClF3N4O5/c1-4-22(28(39)34-15-6-8-17(20(30)10-15)27(38)33-2)36-13-24(40-3)19(11-25(36)37)18-9-14(29)5-7-16(18)21-12-23(26(31)32)41-35-21/h5-13,22,26H,4H2,1-3H3,(H,33,38)(H,34,39)	GWQBOPAUXMQWRD-UHFFFAOYSA-N	413784	4-({2-[4-{5-Chloro-2-[5-(difluoromethyl)-1,2-oxazol-3-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanoyl}amino)-2-fluoro-N-methylbenzamide (Racemate)::US10421742, Example 177::US11180471, Example 177	Plasma kallikrein			 43.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413784	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413784&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205630	433913887							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116019	CCC(C(=O)Nc1ccc2nccnc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1cc(on1)C(F)F	InChI=1S/C28H22ClF2N5O4/c1-3-23(28(38)34-16-5-7-20-22(11-16)33-9-8-32-20)36-14-25(39-2)19(12-26(36)37)18-10-15(29)4-6-17(18)21-13-24(27(30)31)40-35-21/h4-14,23,27H,3H2,1-2H3,(H,34,38)	VCYPQGRHNOEINV-UHFFFAOYSA-N	413785	N-(Quinoxalin-6-yl)-2-[4-{5-chloro-2-[5-(difluoromethyl)-1,2-oxazol-3-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanamide (Racemate)::US10421742, Example 178::US11180471, Example 178	Plasma kallikrein			 24.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413785	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413785&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205450	433913888							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116020	COc1cn(C(CCOC(C)(C)C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C1=NOCC1	InChI=1S/C30H32ClN3O7/c1-30(2,3)40-13-12-25(28(36)32-20-8-5-18(6-9-20)29(37)38)34-17-26(39-4)23(16-27(34)35)22-15-19(31)7-10-21(22)24-11-14-41-33-24/h5-10,15-17,25H,11-14H2,1-4H3,(H,32,36)(H,37,38)	IZEONOSVIATBHE-UHFFFAOYSA-N	413786	4-[(4-tert-Butoxy-2-{4-[5-chloro-2-(4,5-dihydro-1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}butanoyl)amino]benzoic acid (Racemate)::US10421742, Example 179::US11180471, Example 179	Plasma kallikrein			 260							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413786	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413786&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205653	433913889							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116021	COCC[C@@H](C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1cnn(c1)C(F)F	InChI=1S/C28H25ClF2N4O6/c1-40-10-9-23(26(37)33-19-6-3-16(4-7-19)27(38)39)34-15-24(41-2)22(12-25(34)36)21-11-18(29)5-8-20(21)17-13-32-35(14-17)28(30)31/h3-8,11-15,23,28H,9-10H2,1-2H3,(H,33,37)(H,38,39)/t23-/m0/s1	KPDQGYYQHYCMAC-QHCPKHFHSA-N	413787	4-({(2S)-2-[4-{5-Chloro-2-[1-(difluoromethyl)-1H-pyrazol-4-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)benzoic acid (Enantiomer 2)::US10421742, Example 180::US11180471, Example 180	Plasma kallikrein			 71.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413787	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413787&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205723	433913890							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116022	COCC[C@@H](C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(o1)C(F)(F)F	InChI=1S/C27H22ClF4N5O6/c1-41-8-7-20(24(40)34-14-4-6-16(23(33)39)19(29)10-14)37-12-21(42-2)18(11-22(37)38)17-9-13(28)3-5-15(17)25-35-36-26(43-25)27(30,31)32/h3-6,9-12,20H,7-8H2,1-2H3,(H2,33,39)(H,34,40)/t20-/m0/s1	FGIRAZNDJOPUAW-FQEVSTJZSA-N	413788	4-({(2S)-2-[4-{5-Chloro-2-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)-2-fluorobenzamide (Enantiomer 2)::US10421742, Example 181::US11180471, Example 181	Plasma kallikrein			 31.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413788	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413788&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205816	433913891							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116023	CCC[C@@H](C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C27H24ClF3N6O4/c1-3-4-22(27(40)33-15-6-7-16(26(32)39)19(29)10-15)36-13-23(41-2)18(11-24(36)38)17-9-14(28)5-8-21(17)37-12-20(25(30)31)34-35-37/h5-13,22,25H,3-4H2,1-2H3,(H2,32,39)(H,33,40)/t22-/m0/s1	WZUXJAUBKKDABN-QFIPXVFZSA-N	413789	4-({(2S)-2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]pentanoyl}amino)-2-fluorobenzamide (Enantiomer 2)::US10421742, Example 182::US11180471, Example 182	Plasma kallikrein			 19.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413789	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413789&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205866	433913892							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116024	CCC[C@@H](C(=O)Nc1ccc(nc1)C(=O)NC)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C27H26ClF2N7O4/c1-4-5-22(27(40)33-16-7-8-19(32-12-16)26(39)31-2)36-14-23(41-3)18(11-24(36)38)17-10-15(28)6-9-21(17)37-13-20(25(29)30)34-35-37/h6-14,22,25H,4-5H2,1-3H3,(H,31,39)(H,33,40)/t22-/m0/s1	ZZXQOEFXCPENDW-QFIPXVFZSA-N	413790	5-({(2S)-2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]pentanoyl}amino)-N-methylpyridine-2-carboxamide (Enantiomer 2)::US10421742, Example 183::US11180471, Example 183	Plasma kallikrein			 9.60							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413790	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413790&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205807	433913893							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116025	COc1cn(C(C)C(=O)Nc2ccc(C(N)=O)c(F)c2)c(=O)cc1-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C24H19Cl2FN6O4/c1-12(24(36)29-14-4-5-15(23(28)35)18(27)8-14)32-10-20(37-2)17(9-22(32)34)16-7-13(25)3-6-19(16)33-11-21(26)30-31-33/h3-12H,1-2H3,(H2,28,35)(H,29,36)	QGNJMTPKSKWTBQ-UHFFFAOYSA-N	413791	4-[(2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}propanoyl)amino]-2-fluorobenzamide (Racemate)::US10421742, Example 184::US11180471, Example 184	Plasma kallikrein			 9.00							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413791	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413791&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205405	433913894							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116026	COc1cn(C(C)C(=O)Nc2ccc3nccnc3c2)c(=O)cc1-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C25H19Cl2N7O3/c1-14(25(36)30-16-4-5-19-20(10-16)29-8-7-28-19)33-12-22(37-2)18(11-24(33)35)17-9-15(26)3-6-21(17)34-13-23(27)31-32-34/h3-14H,1-2H3,(H,30,36)	BJLPPNMAKGCMOT-UHFFFAOYSA-N	413792	N-(Quinoxalin-6-yl)-2-{4-[5-chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}propanamide (Racemate)::US10421742, Example 185::US11180471, Example 185	Plasma kallikrein			 1.50							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413792	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413792&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205724	433913895							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116027	COc1cn(C(C)C(=O)Nc2ccc3nn(C)cc3c2)c(=O)cc1-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C25H21Cl2N7O3/c1-14(25(36)28-17-5-6-20-15(8-17)11-32(2)30-20)33-12-22(37-3)19(10-24(33)35)18-9-16(26)4-7-21(18)34-13-23(27)29-31-34/h4-14H,1-3H3,(H,28,36)	GBMNOBITEYOELC-UHFFFAOYSA-N	413793	2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(2-methyl-2H-indazol-5-yl)propanamide (Racemate)::US10421742, Example 186::US11180471, Example 186	Plasma kallikrein			 3.00							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413793	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413793&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205501	433913896							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116028	COc1cn(CC(=O)Nc2ccc3nn(C)cc3c2)c(=O)cc1-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C23H19ClN8O3/c1-30-10-14-7-16(4-5-19(14)27-30)26-22(33)12-31-11-21(35-2)18(9-23(31)34)17-8-15(24)3-6-20(17)32-13-25-28-29-32/h3-11,13H,12H2,1-2H3,(H,26,33)	OGFVUXQMVAVOQF-UHFFFAOYSA-N	413794	2-{4-[5-Chloro-2-(1H-tetrazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(2-methyl-2H-indazol-5-yl)acetamide::US10421742, Example 187::US11180471, Example 187	Plasma kallikrein			 2.70							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413794	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413794&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205510	433913897							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116029	CNC(=O)c1ccc(NC(=O)Cn2cc(OC)c(cc2=O)-c2cc(Cl)ccc2-n2cnnn2)cn1	InChI=1S/C22H19ClN8O4/c1-24-22(34)17-5-4-14(9-25-17)27-20(32)11-30-10-19(35-2)16(8-21(30)33)15-7-13(23)3-6-18(15)31-12-26-28-29-31/h3-10,12H,11H2,1-2H3,(H,24,34)(H,27,32)	MPORBPNHVULGJP-UHFFFAOYSA-N	413795	5-[({4-[5-Chloro-2-(1H-tetrazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}acetyl)amino]-N-methylpyridine-2-carboxamide::US10421742, Example 188::US11180471, Example 188	Plasma kallikrein			 5.40							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413795	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413795&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205086	433913898							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116030	COc1cn(CC(=O)Nc2ccc3nccnc3c2)c(=O)cc1-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C23H17ClN8O3/c1-35-21-11-31(12-22(33)28-15-3-4-18-19(9-15)26-7-6-25-18)23(34)10-17(21)16-8-14(24)2-5-20(16)32-13-27-29-30-32/h2-11,13H,12H2,1H3,(H,28,33)	GOCDCIBQPRFDPL-UHFFFAOYSA-N	413796	N-(Quinoxalin-6-yl)-2-{4-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}acetamide::US10421742, Example 189::US11180471, Example 189	Plasma kallikrein			 1.000							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413796	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413796&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205044	433913899							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116031	COc1cn(CC(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C22H17ClN6O5/c1-34-19-10-28(11-20(30)25-15-5-2-13(3-6-15)22(32)33)21(31)9-17(19)16-8-14(23)4-7-18(16)29-12-24-26-27-29/h2-10,12H,11H2,1H3,(H,25,30)(H,32,33)	KWIOAPQMNXFJOI-UHFFFAOYSA-N	413797	4-[({4-[5-Chloro-2-(1H-tetrazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}acetyl)amino]benzoic acid::US10421742, Example 190::US11180471, Example 190	Plasma kallikrein			 9.40							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413797	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413797&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205876	433913900							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116032	COc1cn(CC(=O)Nc2ccc(C(N)=O)c(F)c2)c(=O)cc1-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C22H17ClFN7O4/c1-35-19-9-30(10-20(32)27-13-3-4-14(22(25)34)17(24)7-13)21(33)8-16(19)15-6-12(23)2-5-18(15)31-11-26-28-29-31/h2-9,11H,10H2,1H3,(H2,25,34)(H,27,32)	NEENJQHZEIXZHZ-UHFFFAOYSA-N	413798	4-[({4-[5-Chloro-2-(1H-tetrazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}acetyl)amino]-2-fluorobenzamide::US10421742, Example 191::US11180471, Example 191	Plasma kallikrein			 7.90							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413798	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413798&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205431	433913901							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116033	CCC(C(=O)Nc1ccc(nc1)C(N)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(s1)C(F)F	InChI=1S/C25H21ClF2N6O4S/c1-3-18(23(37)31-13-5-7-17(22(29)36)30-10-13)34-11-19(38-2)16(9-20(34)35)15-8-12(26)4-6-14(15)24-32-33-25(39-24)21(27)28/h4-11,18,21H,3H2,1-2H3,(H2,29,36)(H,31,37)	UMNQYPPSVMIHGW-UHFFFAOYSA-N	413799	5-({2-[4-{5-Chloro-2-[5-(difluoromethyl)-1,3,4-thiadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanoyl}amino)pyridine-2-carboxamide (Racemate)::US10421742, Example 192::US11180471, Example 192	Plasma kallikrein			 32.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413799	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413799&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205370	433913902							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116034	CCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(s1)C(F)F	InChI=1S/C26H21ClF3N5O4S/c1-3-19(24(38)32-13-5-7-15(23(31)37)18(28)9-13)35-11-20(39-2)17(10-21(35)36)16-8-12(27)4-6-14(16)25-33-34-26(40-25)22(29)30/h4-11,19,22H,3H2,1-2H3,(H2,31,37)(H,32,38)	CTFVRNUYERRNLZ-UHFFFAOYSA-N	413800	4-({2-[4-{5-Chloro-2-[5-(difluoromethyl)-1,3,4-thiadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanoyl}amino)-2-fluorobenzamide (Racemate)::US10421742, Example 193::US11180471, Example 193	Plasma kallikrein			 56.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413800	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413800&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205721	433913903							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116035	CCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(s1)C(F)F	InChI=1S/C27H23ClF2N6O3S/c1-4-21(25(38)31-16-6-8-20-14(9-16)12-35(2)34-20)36-13-22(39-3)19(11-23(36)37)18-10-15(28)5-7-17(18)26-32-33-27(40-26)24(29)30/h5-13,21,24H,4H2,1-3H3,(H,31,38)	DFCBCYSQFOUFPJ-UHFFFAOYSA-N	413801	2-[4-{5-Chloro-2-[5-(difluoroethyl)-1,3,4-thiadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 194::US11180471, Example 194	Plasma kallikrein			 23.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413801	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413801&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135211537	433913904							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116036	CCC(C(=O)Nc1ccc(C(=O)NC)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(s1)C(F)F	InChI=1S/C27H23ClF3N5O4S/c1-4-20(25(39)33-14-6-8-16(19(29)10-14)24(38)32-2)36-12-21(40-3)18(11-22(36)37)17-9-13(28)5-7-15(17)26-34-35-27(41-26)23(30)31/h5-12,20,23H,4H2,1-3H3,(H,32,38)(H,33,39)	DPAIONDPIWYBAL-UHFFFAOYSA-N	413802	4-({2-[4-{5-Chloro-2-[5-(difluoromethyl)-1,3,4-thiadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanoyl}amino)-2-fluoro-N-methylbenzamide (Racemate)::US10421742, Example 195::US11180471, Example 195	Plasma kallikrein			 72.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413802	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413802&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205747	433913905							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116037	CCC(C(=O)Nc1ccc2nccnc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(s1)C(F)F	InChI=1S/C27H21ClF2N6O3S/c1-3-21(25(38)33-15-5-7-19-20(11-15)32-9-8-31-19)36-13-22(39-2)18(12-23(36)37)17-10-14(28)4-6-16(17)26-34-35-27(40-26)24(29)30/h4-13,21,24H,3H2,1-2H3,(H,33,38)	CVGKJPRJDXNZKV-UHFFFAOYSA-N	413803	2-[4-{5-Chloro-2-[5-(difluoromethyl)-1,3,4-thiadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-N-(quinoxalin-6-yl)butanamide (Racemate)::US10421742, Example 196::US11180471, Example 196	Plasma kallikrein			 11.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413803	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413803&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135211531	433913906							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116038	CCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1cc(on1)C(F)(F)F	InChI=1S/C27H21ClF4N4O5/c1-3-21(26(39)34-14-5-7-16(25(33)38)19(29)9-14)36-12-22(40-2)18(10-24(36)37)17-8-13(28)4-6-15(17)20-11-23(41-35-20)27(30,31)32/h4-12,21H,3H2,1-2H3,(H2,33,38)(H,34,39)	VMJCKYNXJRHMKZ-UHFFFAOYSA-N	413804	4-({2-[4-{5-Chloro-2-[5-(trifluoromethyl)-1,2-oxazol-3-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanoyl}amino)-2-fluorobenzamide (Racemate)::US10421742, Example 197::US11180471, Example 197	Plasma kallikrein			 34.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413804	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413804&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135206067	433913907							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116039	CCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1cc(on1)C(F)(F)F	InChI=1S/C28H23ClF3N5O4/c1-4-23(27(39)33-17-6-8-21-15(9-17)13-36(2)34-21)37-14-24(40-3)20(11-26(37)38)19-10-16(29)5-7-18(19)22-12-25(41-35-22)28(30,31)32/h5-14,23H,4H2,1-3H3,(H,33,39)	KLVMLPOMRPNVJU-UHFFFAOYSA-N	413805	2-[4-{5-Chloro-2-[5-(trifluoromethyl)-1,2-oxazol-3-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 198::US11180471, Example 198	Plasma kallikrein			 20.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413805	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413805&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205719	433913908							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116040	CCC(C(=O)Nc1ccc2nc([NH3+])ccc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C27H23Cl2N7O3/c1-3-21(27(38)31-17-6-7-20-15(10-17)4-9-25(30)32-20)35-13-23(39-2)19(12-26(35)37)18-11-16(28)5-8-22(18)36-14-24(29)33-34-36/h4-14,21H,3H2,1-2H3,(H2,30,32)(H,31,38)/p+1	UOFFBMYRFFCNLY-UHFFFAOYSA-O	413806	6-[(2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}butanoyl)amino]quinolin-2-aminium formate (Racemate)::US10421742, Example 199::US11180471, Example 199	Plasma kallikrein			 3.60							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413806	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413806&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			152948432	433913909							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116041	CCC(C(=O)Nc1ccc2ncc(C)nc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C27H23Cl2N7O3/c1-4-22(27(38)32-17-6-7-20-21(10-17)31-15(2)12-30-20)35-13-24(39-3)19(11-26(35)37)18-9-16(28)5-8-23(18)36-14-25(29)33-34-36/h5-14,22H,4H2,1-3H3,(H,32,38)	SADGBXCCQGIXDH-UHFFFAOYSA-N	413807	2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(3-methylquinoxalin-6-yl)butanamide (Racemate)::US10421742, Example 200::US11180471, Example 200	Plasma kallikrein			 2.40							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413807	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413807&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205297	433913910							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116042	CC[C@@H](C(=O)Nc1ccc2ncc(C)nc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C27H23Cl2N7O3/c1-4-22(27(38)32-17-6-7-20-21(10-17)31-15(2)12-30-20)35-13-24(39-3)19(11-26(35)37)18-9-16(28)5-8-23(18)36-14-25(29)33-34-36/h5-14,22H,4H2,1-3H3,(H,32,38)/t22-/m0/s1	SADGBXCCQGIXDH-QFIPXVFZSA-N	413808	(S)-2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(3-methylquinoxalin-6-yl)butanamide (Enantiomer 2)::US10421742, Example 201::US11180471, Example 201	Plasma kallikrein			 2.20							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413808	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413808&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205797	433913911							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116043	CCC[C@@H](C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C26H23Cl2FN6O4/c1-3-4-21(26(38)31-15-6-7-16(25(30)37)19(29)10-15)34-12-22(39-2)18(11-24(34)36)17-9-14(27)5-8-20(17)35-13-23(28)32-33-35/h5-13,21H,3-4H2,1-2H3,(H2,30,37)(H,31,38)/t21-/m0/s1	KQZYQOJQXJGZMI-NRFANRHFSA-N	413809	4-{[(2S)-2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}pentanoyl]amino}-2-fluorobenzamide (Enantiomer 2)::US10421742, Example 202::US11180471, Example 202	Plasma kallikrein			 9.80							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413809	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413809&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205777	433913912							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116044	CCC(C(=O)Nc1ccc2ncc(nc2c1)C(F)(F)F)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C27H20Cl2F3N7O3/c1-3-20(26(41)34-15-5-6-18-19(9-15)35-23(11-33-18)27(30,31)32)38-12-22(42-2)17(10-25(38)40)16-8-14(28)4-7-21(16)39-13-24(29)36-37-39/h4-13,20H,3H2,1-2H3,(H,34,41)	ZIDSWWLSQTUOIZ-UHFFFAOYSA-N	413810	2-{4-[5-Chloro-2-(4-chloro-1H-H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-[3-(trifluoromethyl)quinoxalin-6-yl]butanamide (Racemate)::US10421742, Example 203::US10421742, Example 205::US11180471, Example 203	Plasma kallikrein			 29.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413810	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413810&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135211523	433913913							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116045	CCC(C(=O)Nc1ccc2nc(cnc2c1)C(F)(F)F)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C27H20Cl2F3N7O3/c1-3-20(26(41)34-15-5-6-18-19(9-15)33-11-23(35-18)27(30,31)32)38-12-22(42-2)17(10-25(38)40)16-8-14(28)4-7-21(16)39-13-24(29)36-37-39/h4-13,20H,3H2,1-2H3,(H,34,41)	AGDBQILBKXGVMA-UHFFFAOYSA-N	413811	2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-[2-(trifluoromethyl)quinoxalin-6-yl]butanamide (Racemate)::US10421742, Example 204::US10421742, Example 206::US11180471, Example 204	Plasma kallikrein			 10.00							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413811	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413811&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205251	433913914							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116046	CCC(C(=O)Nc1ccc2ncc(nc2c1)C(F)(F)F)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)(F)F	InChI=1S/C28H20ClF6N7O3/c1-3-20(26(44)37-15-5-6-18-19(9-15)38-23(11-36-18)27(30,31)32)41-12-22(45-2)17(10-25(41)43)16-8-14(29)4-7-21(16)42-13-24(39-40-42)28(33,34)35/h4-13,20H,3H2,1-2H3,(H,37,44)	HFIYSVHJSLVEKM-UHFFFAOYSA-N	528227	2-[4-{5-Chloro-2-[4-(trifluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-N-[3-(trifluoromethyl)quinoxalin-6-yl]butanamide (racemate)::US11180471, Example 205	Plasma kallikrein			 47.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528227	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528227&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205528	463791769							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116047	CCC(C(=O)Nc1ccc2nc(cnc2c1)C(F)(F)F)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)(F)F	InChI=1S/C28H20ClF6N7O3/c1-3-20(26(44)37-15-5-6-18-19(9-15)36-11-23(38-18)27(30,31)32)41-12-22(45-2)17(10-25(41)43)16-8-14(29)4-7-21(16)42-13-24(39-40-42)28(33,34)35/h4-13,20H,3H2,1-2H3,(H,37,44)	NCZFXYVMXDGJAQ-UHFFFAOYSA-N	528228	2-[4-{5-Chloro-2-[4-(trifluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-N-[2-(trifluoromethyl)quinoxalin-6-yl]butanamide (racemate)::US11180471, Example 206	Plasma kallikrein			 24.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528228	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528228&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205616	463791770							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116048	CCC(C(=O)Nc1ccc2cnncc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C26H21Cl2N7O3/c1-3-21(26(37)31-18-6-4-15-11-29-30-12-16(15)8-18)34-13-23(38-2)20(10-25(34)36)19-9-17(27)5-7-22(19)35-14-24(28)32-33-35/h4-14,21H,3H2,1-2H3,(H,31,37)	UENKHDMGQRVXOA-UHFFFAOYSA-N	413814	2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(phthalazin-6-yl)butanamide (Racemate)::US10421742, Example 207::US10421742, Example 208::US11180471, Example 207	Plasma kallikrein			 3.50							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413814	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413814&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205592	433913915							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116049	CCC(C(=O)Nc1ccc2cnncc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)(F)F	InChI=1S/C27H21ClF3N7O3/c1-3-21(26(40)34-18-6-4-15-11-32-33-12-16(15)8-18)37-13-23(41-2)20(10-25(37)39)19-9-17(28)5-7-22(19)38-14-24(35-36-38)27(29,30)31/h4-14,21H,3H2,1-2H3,(H,34,40)	AWJUPCORVZXGJV-UHFFFAOYSA-N	528230	2-[4-{5-Chloro-2-[4-(trifluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-N-(phthalazin-6-yl)butanamide (racemate)::US11180471, Example 208	Plasma kallikrein			 4.40							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528230	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528230&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135206097	463791772							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116050	CCC(C(=O)Nc1ccc2nn(cc2c1)C(F)F)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C27H22ClF4N7O3/c1-3-21(26(41)33-16-5-6-19-14(8-16)11-39(35-19)27(31)32)37-13-23(42-2)18(10-24(37)40)17-9-15(28)4-7-22(17)38-12-20(25(29)30)34-36-38/h4-13,21,25,27H,3H2,1-2H3,(H,33,41)	METWKYXLYOAEDA-UHFFFAOYSA-N	413816	2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-N-[2-(difluoromethyl)-2H-indazol-5-yl]butanamide (Racemate)::US10421742, Example 209::US11180471, Example 209	Plasma kallikrein			 9.10							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413816	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413816&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205934	433913916							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116051	CC[C@@H](C(=O)Nc1ccc2nn(cc2c1)C(F)F)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C27H22ClF4N7O3/c1-3-21(26(41)33-16-5-6-19-14(8-16)11-39(35-19)27(31)32)37-13-23(42-2)18(10-24(37)40)17-9-15(28)4-7-22(17)38-12-20(25(29)30)34-36-38/h4-13,21,25,27H,3H2,1-2H3,(H,33,41)/t21-/m0/s1	METWKYXLYOAEDA-NRFANRHFSA-N	413817	(2S)-2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-N-[2-(difluoromethyl)-2H-indazol-5-yl]butanamide (Enantiomer 2)::US10421742, Example 210::US11180471, Example 210	Plasma kallikrein			 3.50							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413817	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413817&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135206066	433913917							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116052	CCC(C(=O)Nc1ccc2nn(cc2c1)C(F)F)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C26H21Cl2F2N7O3/c1-3-20(25(39)31-16-5-6-19-14(8-16)11-37(33-19)26(29)30)35-12-22(40-2)18(10-24(35)38)17-9-15(27)4-7-21(17)36-13-23(28)32-34-36/h4-13,20,26H,3H2,1-2H3,(H,31,39)	ZXSDTWYIYKNDSR-UHFFFAOYSA-N	413818	2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-[2-(difluoromethyl)-2H-indazol-5-yl]butanamide (Racemate)::US10421742, Example 211::US11180471, Example 211	Plasma kallikrein			 5.40							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413818	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413818&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135204866	433913918							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116053	CC[C@@H](C(=O)Nc1ccc2nn(cc2c1)C(F)F)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C26H21Cl2F2N7O3/c1-3-20(25(39)31-16-5-6-19-14(8-16)11-37(33-19)26(29)30)35-12-22(40-2)18(10-24(35)38)17-9-15(27)4-7-21(17)36-13-23(28)32-34-36/h4-13,20,26H,3H2,1-2H3,(H,31,39)/t20-/m0/s1	ZXSDTWYIYKNDSR-FQEVSTJZSA-N	413819	(2S)-2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-[2-(difluoromethyl)-2H-indazol-5-yl]butanamide (Enantiomer 2)::US10421742, Example 212::US11180471, Example 212	Plasma kallikrein			 1.50							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413819	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413819&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135206089	433913919							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116054	CCC(C(=O)Nc1ccc2nn(CC3CC3)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C29H27Cl2N7O3/c1-3-24(29(40)32-20-7-8-23-18(10-20)14-36(34-23)13-17-4-5-17)37-15-26(41-2)22(12-28(37)39)21-11-19(30)6-9-25(21)38-16-27(31)33-35-38/h6-12,14-17,24H,3-5,13H2,1-2H3,(H,32,40)	TXLDRSXSUKQIEC-UHFFFAOYSA-N	413820	2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-[2-(cyclopropylmethyl)-2H-indazol-5-yl]butanamide (Racemate)::US10421742, Example 213::US11180471, Example 213	Plasma kallikrein			 12.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413820	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413820&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135206022	433913920							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116055	COc1cn(C(CC(F)F)C(=O)Nc2ccc(C(N)=O)c(F)c2)c(=O)cc1-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C25H19Cl2F3N6O4/c1-40-20-10-35(19(9-22(29)30)25(39)32-13-3-4-14(24(31)38)17(28)7-13)23(37)8-16(20)15-6-12(26)2-5-18(15)36-11-21(27)33-34-36/h2-8,10-11,19,22H,9H2,1H3,(H2,31,38)(H,32,39)	VICLFWRBPGESJU-UHFFFAOYSA-N	413821	4-[(2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4,4-difluorobutanoyl)amino]-2-fluorobenzamide (Racemate)::US10421742, Example 214::US11180471, Example 214	Plasma kallikrein			 21.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413821	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413821&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135206005	433913921							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116056	CCC(C(=O)Nc1ccc(nc1)C(=O)NC)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(s1)C(F)(F)F	InChI=1S/C26H22ClF3N6O4S/c1-4-19(23(39)33-14-6-8-18(32-11-14)22(38)31-2)36-12-20(40-3)17(10-21(36)37)16-9-13(27)5-7-15(16)24-34-35-25(41-24)26(28,29)30/h5-12,19H,4H2,1-3H3,(H,31,38)(H,33,39)	MTUVSPCBSRPPFH-UHFFFAOYSA-N	413822	5-({2-[4-{5-Chloro-2-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanoyl}amino)-N-methylpyridine-2-carboxamide (Racemate)::US10421742, Example 215::US11180471, Example 215	Plasma kallikrein			 20.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413822	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413822&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205910	433913922							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116057	COc1cn(C(CC(F)F)C(=O)Nc2ccc3nn(cc3c2)C(F)F)c(=O)cc1-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C26H19Cl2F4N7O3/c1-42-21-11-37(24(40)8-17(21)16-7-14(27)2-5-19(16)38-12-22(28)34-36-38)20(9-23(29)30)25(41)33-15-3-4-18-13(6-15)10-39(35-18)26(31)32/h2-8,10-12,20,23,26H,9H2,1H3,(H,33,41)	RTIMPDQMXMBUMW-UHFFFAOYSA-N	413823	2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-[2-(difluoromethyl)-2H-indazol-5-yl]-4,4-difluorobutanamide (Racemate)::US10421742, Example 216::US11180471, Example 216	Plasma kallikrein			 10.00							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413823	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413823&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135204789	433913923							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116058	COc1cn(C(CC(F)F)C(=O)Nc2ccc3nccnc3c2)c(=O)cc1-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C26H19Cl2F2N7O3/c1-40-22-12-36(21(11-24(29)30)26(39)33-15-3-4-18-19(9-15)32-7-6-31-18)25(38)10-17(22)16-8-14(27)2-5-20(16)37-13-23(28)34-35-37/h2-10,12-13,21,24H,11H2,1H3,(H,33,39)	SATGRGDFTKEDOC-UHFFFAOYSA-N	413824	2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4,4-difluoro-N-(quinoxalin-6-yl)butanamide (Racemate)::US10421742, Example 217::US11180471, Example 217	Plasma kallikrein			 4.90							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413824	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413824&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205462	433913924							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116059	COc1cn(C(CC(F)F)C(=O)Nc2ccc3nn(C)cc3c2)c(=O)cc1-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C26H21Cl2F2N7O3/c1-35-11-14-7-16(4-5-19(14)33-35)31-26(39)21(10-24(29)30)36-12-22(40-2)18(9-25(36)38)17-8-15(27)3-6-20(17)37-13-23(28)32-34-37/h3-9,11-13,21,24H,10H2,1-2H3,(H,31,39)	SVTFEVREYQHXOM-UHFFFAOYSA-N	413825	2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4,4-difluoro-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 218::US11180471, Example 218	Plasma kallikrein			 10.00							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413825	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413825&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205201	433913925							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116060	CCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(s1)C(F)(F)F	InChI=1S/C26H20ClF4N5O4S/c1-3-19(23(39)33-13-5-7-15(22(32)38)18(28)9-13)36-11-20(40-2)17(10-21(36)37)16-8-12(27)4-6-14(16)24-34-35-25(41-24)26(29,30)31/h4-11,19H,3H2,1-2H3,(H2,32,38)(H,33,39)	XRCANQJWEYJRNE-UHFFFAOYSA-N	413826	4-({2-[4-{5-Chloro-2-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanoyl}amino)-2-fluorobenzamide (Racemate)::US10421742, Example 219::US11180471, Example 219	Plasma kallikrein			 43.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413826	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413826&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205452	433913926							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116061	CCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnc(s1)C(F)(F)F	InChI=1S/C27H22ClF3N6O3S/c1-4-21(24(39)32-16-6-8-20-14(9-16)12-36(2)35-20)37-13-22(40-3)19(11-23(37)38)18-10-15(28)5-7-17(18)25-33-34-26(41-25)27(29,30)31/h5-13,21H,4H2,1-3H3,(H,32,39)	HCRLZPHBOLGRPG-UHFFFAOYSA-N	413827	2-[4-{5-Chloro-2-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 220::US11180471, Example 220	Plasma kallikrein			 14.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413827	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413827&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135206083	433913927							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116062	CCC(C(=O)Nc1ccc2nc(C)cnc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C27H23Cl2N7O3/c1-4-22(27(38)32-17-6-7-20-21(10-17)30-12-15(2)31-20)35-13-24(39-3)19(11-26(35)37)18-9-16(28)5-8-23(18)36-14-25(29)33-34-36/h5-14,22H,4H2,1-3H3,(H,32,38)	NINJGBVHUFUANQ-UHFFFAOYSA-N	413828	2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(2-methylquinoxalin-6-yl)butanamide (Racemate)::US10421742, Example 221::US11180471, Example 221	Plasma kallikrein			 2.80							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413828	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413828&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205262	433913928							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116063	CCC(C(=O)Nc1ccc2nc(C)c(C)nc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C28H25Cl2N7O3/c1-5-23(28(39)33-18-7-8-21-22(11-18)32-16(3)15(2)31-21)36-13-25(40-4)20(12-27(36)38)19-10-17(29)6-9-24(19)37-14-26(30)34-35-37/h6-14,23H,5H2,1-4H3,(H,33,39)	PQLJHTCQQFICKU-UHFFFAOYSA-N	413829	2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(2,3-dimethylquinoxalin-6-yl)butanamide (Racemate)::US10421742, Example 222::US11180471, Example 222	Plasma kallikrein			 2.40							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413829	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413829&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205457	433913929							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116064	CCC(C(=O)Nc1ccc2ncccc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C27H22Cl2N6O3/c1-3-22(27(37)31-18-7-8-21-16(11-18)5-4-10-30-21)34-14-24(38-2)20(13-26(34)36)19-12-17(28)6-9-23(19)35-15-25(29)32-33-35/h4-15,22H,3H2,1-2H3,(H,31,37)	FTLCKEYXULODRH-UHFFFAOYSA-N	413830	2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(quinolin-6-yl)butanamide (Racemate)::US10421742, Example 223::US11180471, Example 223	Plasma kallikrein			 3.60							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413830	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413830&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135211524	433913930							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116065	CCC(C(=O)Nc1ccc2cccnc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C27H22Cl2N6O3/c1-3-22(27(37)31-18-8-6-16-5-4-10-30-21(16)12-18)34-14-24(38-2)20(13-26(34)36)19-11-17(28)7-9-23(19)35-15-25(29)32-33-35/h4-15,22H,3H2,1-2H3,(H,31,37)	FQMWRNFRVKBREN-UHFFFAOYSA-N	413831	2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(quinolin-7-yl)butanamide (Racemate)::US10421742, Example 224::US11180471, Example 224	Plasma kallikrein			 4.60							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413831	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413831&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205567	433913931							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116066	CCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C26H23Cl2N7O3/c1-4-21(26(37)29-17-6-7-20-15(9-17)12-33(2)31-20)34-13-23(38-3)19(11-25(34)36)18-10-16(27)5-8-22(18)35-14-24(28)30-32-35/h5-14,21H,4H2,1-3H3,(H,29,37)	QBWXHIMIUSZAOP-UHFFFAOYSA-N	413774	2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 167::US10421742, Example 225::US11180471, Example 225	Plasma kallikrein			 3.50							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413774	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413774&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205467	433913877							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116067	CCC(C(=O)Nc1ccc2nn(CC(F)F)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C27H23Cl2F2N7O3/c1-3-21(27(40)32-17-5-6-20-15(8-17)11-36(34-20)14-25(30)31)37-12-23(41-2)19(10-26(37)39)18-9-16(28)4-7-22(18)38-13-24(29)33-35-38/h4-13,21,25H,3,14H2,1-2H3,(H,32,40)	GTOBEZUWBRGMLK-UHFFFAOYSA-N	413833	2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-[2-(2,2-difluoroethyl)-2H-indazol-5-yl]butanamide (Racemate)::US10421742, Example 226::US11180471, Example 226	Plasma kallikrein			 6.00							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413833	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413833&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205643	433913932							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116068	CCC(C(=O)Nc1ccc2nn(CC(F)(F)F)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C27H22Cl2F3N7O3/c1-3-21(26(41)33-17-5-6-20-15(8-17)11-37(35-20)14-27(30,31)32)38-12-23(42-2)19(10-25(38)40)18-9-16(28)4-7-22(18)39-13-24(29)34-36-39/h4-13,21H,3,14H2,1-2H3,(H,33,41)	DBBPDYZRKMIZOJ-UHFFFAOYSA-N	413834	2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-[2-(2,2,2-trifluoroethyl)-2H-indazol-5-yl]butanamide (Racemate)::US10421742, Example 227::US11180471, Example 227	Plasma kallikrein			 6.00							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413834	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413834&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135204990	433913933							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116069	CCC(C(=O)Nc1ccc2nc(C)ccc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C28H24Cl2N6O3/c1-4-23(28(38)32-19-8-9-22-17(11-19)6-5-16(2)31-22)35-14-25(39-3)21(13-27(35)37)20-12-18(29)7-10-24(20)36-15-26(30)33-34-36/h5-15,23H,4H2,1-3H3,(H,32,38)	AZYMEDAZJNOBLR-UHFFFAOYSA-N	413835	2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(2-methylquinolin-6-yl)butanamide (Racemate)::US10421742, Example 228::US11180471, Example 228	Plasma kallikrein			 2.90							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413835	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413835&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205176	433913934							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116070	CCC(C(=O)Nc1ccc2nc(C)ccc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C29H25ClF2N6O3/c1-4-24(29(40)34-19-8-9-22-17(11-19)6-5-16(2)33-22)37-15-26(41-3)21(13-27(37)39)20-12-18(30)7-10-25(20)38-14-23(28(31)32)35-36-38/h5-15,24,28H,4H2,1-3H3,(H,34,40)	FVOIRKKFLDCVKH-UHFFFAOYSA-N	413836	2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-N-(2-methylquinolin-6-yl)butanamide (Racemate)::US10421742, Example 229::US11180471, Example 229	Plasma kallikrein			 3.90							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413836	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413836&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205284	433913935							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116071	CCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C26H22ClF3N6O4/c1-3-20(26(39)32-14-5-6-15(25(31)38)18(28)9-14)35-12-22(40-2)17(10-23(35)37)16-8-13(27)4-7-21(16)36-11-19(24(29)30)33-34-36/h4-12,20,24H,3H2,1-2H3,(H2,31,38)(H,32,39)	OETZVLILMHLZTG-UHFFFAOYSA-N	413767	4-({2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanoyl}amino)-2-fluorobenzamide (Racemate)::US10421742, Example 160::US11180471, Example 230	Plasma kallikrein			 17.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413767	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413767&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205282	433913870							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116072	CCC[C@@H](C(=O)Nc1ccc2nccnc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C28H24ClF2N7O3/c1-3-4-24(28(40)34-17-6-7-20-21(12-17)33-10-9-32-20)37-15-25(41-2)19(13-26(37)39)18-11-16(29)5-8-23(18)38-14-22(27(30)31)35-36-38/h5-15,24,27H,3-4H2,1-2H3,(H,34,40)/t24-/m0/s1	NKCIMLZZOJBOGZ-DEOSSOPVSA-N	413838	(2S)-2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-N-(quinoxalin-6-yl)pentanamide (Enantiomer 2)::US10421742, Example 231::US11180471, Example 231	Plasma kallikrein			 3.30							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413838	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413838&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135204967	433913937							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116073	CCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)(F)F	InChI=1S/C27H23ClF3N7O3/c1-4-21(26(40)32-17-6-7-20-15(9-17)12-36(2)34-20)37-13-23(41-3)19(11-25(37)39)18-10-16(28)5-8-22(18)38-14-24(33-35-38)27(29,30)31/h5-14,21H,4H2,1-3H3,(H,32,40)	YXQQDNTZJAXMNL-UHFFFAOYSA-N	413839	2-[4-{5-Chloro-2-[4-(trifluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 232::US11180471, Example 232	Plasma kallikrein			 5.20							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413839	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413839&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205554	433913938							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116074	CC[C@@H](C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)(F)F	InChI=1S/C27H23ClF3N7O3/c1-4-21(26(40)32-17-6-7-20-15(9-17)12-36(2)34-20)37-13-23(41-3)19(11-25(37)39)18-10-16(28)5-8-22(18)38-14-24(33-35-38)27(29,30)31/h5-14,21H,4H2,1-3H3,(H,32,40)/t21-/m0/s1	YXQQDNTZJAXMNL-NRFANRHFSA-N	413840	(2S)-2-[4-{5-Chloro-2-[4-(trifluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-N-(2-methyl-2H-indazol-5-yl)butanamide (Enantiomer 2)::US10421742, Example 233::US11180471, Example 233	Plasma kallikrein			 3.50							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413840	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413840&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205553	433913939							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116075	CCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)(F)F	InChI=1S/C26H21ClF4N6O4/c1-3-19(25(40)33-14-5-6-15(24(32)39)18(28)9-14)36-11-21(41-2)17(10-23(36)38)16-8-13(27)4-7-20(16)37-12-22(34-35-37)26(29,30)31/h4-12,19H,3H2,1-2H3,(H2,32,39)(H,33,40)	XYWIPYBIIRTJMM-UHFFFAOYSA-N	413841	4-({2-[4-{5-Chloro-2-[4-(trifluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanoyl}amino)-2-fluorobenzamide (Racemate)::US10421742, Example 234::US11180471, Example 234	Plasma kallikrein			 14.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413841	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413841&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205380	433913940							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116076	CC[C@@H](C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)(F)F	InChI=1S/C26H21ClF4N6O4/c1-3-19(25(40)33-14-5-6-15(24(32)39)18(28)9-14)36-11-21(41-2)17(10-23(36)38)16-8-13(27)4-7-20(16)37-12-22(34-35-37)26(29,30)31/h4-12,19H,3H2,1-2H3,(H2,32,39)(H,33,40)/t19-/m0/s1	XYWIPYBIIRTJMM-IBGZPJMESA-N	413842	4-({(2S)-2-[4-{5-Chloro-2-[4-(trifluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanoyl}amino)-2-fluorobenzamide (Enantiomer 2)::US10421742, Example 235::US11180471, Example 235	Plasma kallikrein			 5.70							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413842	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413842&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135206011	433913941							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116077	CCC(C(=O)Nc1ccc2nc(C)c(C)nc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)(F)F	InChI=1S/C29H25ClF3N7O3/c1-5-23(28(42)36-18-7-8-21-22(11-18)35-16(3)15(2)34-21)39-13-25(43-4)20(12-27(39)41)19-10-17(30)6-9-24(19)40-14-26(37-38-40)29(31,32)33/h6-14,23H,5H2,1-4H3,(H,36,42)	UDQDURKQOJZYOA-UHFFFAOYSA-N	413843	2-[4-{5-Chloro-2-[4-(trifluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-N-(2,3-dimethylquinoxalin-6-yl)butanamide (Racemate)::US10421742, Example 236::US11180471, Example 236	Plasma kallikrein			 5.80							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413843	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413843&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205535	433913942							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116078	CC[C@@H](C(=O)Nc1ccc2nc(C)c(C)nc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)(F)F	InChI=1S/C29H25ClF3N7O3/c1-5-23(28(42)36-18-7-8-21-22(11-18)35-16(3)15(2)34-21)39-13-25(43-4)20(12-27(39)41)19-10-17(30)6-9-24(19)40-14-26(37-38-40)29(31,32)33/h6-14,23H,5H2,1-4H3,(H,36,42)/t23-/m0/s1	UDQDURKQOJZYOA-QHCPKHFHSA-N	413844	(2S)-2-[4-{5-Chloro-2-[4-(trifluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-N-(2,3-dimethylquinoxalin-6-yl)butanamide (Enantiomer 2)::US10421742, Example 237::US11180471, Example 237	Plasma kallikrein			 2.40							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413844	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413844&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205533	433913943							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116079	CCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1cnc(o1)C(F)F	InChI=1S/C27H22ClF2N3O6/c1-3-20(25(35)32-16-7-4-14(5-8-16)27(36)37)33-13-22(38-2)19(11-23(33)34)18-10-15(28)6-9-17(18)21-12-31-26(39-21)24(29)30/h4-13,20,24H,3H2,1-2H3,(H,32,35)(H,36,37)	QFFBKCKFGNVYBW-UHFFFAOYSA-N	413845	4-({2-[4-{5-Chloro-2-[2-(difluoromethyl)-1,3-oxazol-5-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanoyl}amino)benzoic acid (Racemate)::US10421742, Example 238::US11180471, Example 238	Plasma kallikrein			 850							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413845	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413845&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205970	433913944							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116080	COc1cn(C(C)C(=O)Nc2ccc(C(N)=O)c(F)c2)c(=O)cc1-c1cc(Cl)ccc1-n1cc(nn1)C(F)(F)F	InChI=1S/C25H19ClF4N6O4/c1-12(24(39)32-14-4-5-15(23(31)38)18(27)8-14)35-10-20(40-2)17(9-22(35)37)16-7-13(26)3-6-19(16)36-11-21(33-34-36)25(28,29)30/h3-12H,1-2H3,(H2,31,38)(H,32,39)	SNUMNATTXKTJQD-UHFFFAOYSA-N	413846	4-({2-[4-{5-Chloro-2-[4-(trifluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]propanoyl}amino)-2-fluorobenzamide (Racemate)::US10421742, Example 239::US11180471, Example 239	Plasma kallikrein			 6.90							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413846	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413846&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205033	433913945							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116081	COc1cn([C@@H](C)C(=O)Nc2ccc(C(N)=O)c(F)c2)c(=O)cc1-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C24H19Cl2FN6O4/c1-12(24(36)29-14-4-5-15(23(28)35)18(27)8-14)32-10-20(37-2)17(9-22(32)34)16-7-13(25)3-6-19(16)33-11-21(26)30-31-33/h3-12H,1-2H3,(H2,28,35)(H,29,36)/t12-/m0/s1	QGNJMTPKSKWTBQ-LBPRGKRZSA-N	413847	4-{[(2S)-2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}propanoyl]amino}-2-fluorobenzamide (Enantiomer 2)::US10421742, Example 240::US11180471, Example 240	Plasma kallikrein			 3.50							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413847	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413847&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205642	433913946							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116082	COc1cn([C@@H](C)C(=O)Nc2ccc(C(N)=O)c(F)c2)c(=O)cc1-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C25H20ClF3N6O4/c1-12(25(38)31-14-4-5-15(24(30)37)18(27)8-14)34-11-21(39-2)17(9-22(34)36)16-7-13(26)3-6-20(16)35-10-19(23(28)29)32-33-35/h3-12,23H,1-2H3,(H2,30,37)(H,31,38)/t12-/m0/s1	JVCAULOQATWKKF-LBPRGKRZSA-N	413848	4-({(2S)-2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]propanoyl}amino)-2-fluorobenzamide (Enantiomer 2)::US10421742, Example 241::US11180471, Example 241	Plasma kallikrein			 6.00							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413848	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413848&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205975	433913947							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116083	CC[C@@H](C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C25H21Cl2FN6O4/c1-3-19(25(37)30-14-5-6-15(24(29)36)18(28)9-14)33-11-21(38-2)17(10-23(33)35)16-8-13(26)4-7-20(16)34-12-22(27)31-32-34/h4-12,19H,3H2,1-2H3,(H2,29,36)(H,30,37)/t19-/m0/s1	FPAKZDLGEHHCTC-IBGZPJMESA-N	413849	4-{[(2S)-2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}butanoyl]amino}-2-fluorobenzamide (Enantiomer 2)::US10421742, Example 242::US11180471, Example 242	Plasma kallikrein			 5.40							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413849	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413849&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205798	433913948							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116084	CC[C@@H](C(=O)Nc1ccc2nc(C)ccc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C29H25ClF2N6O3/c1-4-24(29(40)34-19-8-9-22-17(11-19)6-5-16(2)33-22)37-15-26(41-3)21(13-27(37)39)20-12-18(30)7-10-25(20)38-14-23(28(31)32)35-36-38/h5-15,24,28H,4H2,1-3H3,(H,34,40)/t24-/m0/s1	FVOIRKKFLDCVKH-DEOSSOPVSA-N	413850	(2S)-2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-N-(2-methylquinolin-6-yl)butanamide (Enantiomer 2)::US10421742, Example 243::US11180471, Example 243	Plasma kallikrein			 1.70							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413850	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413850&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205377	433913949							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116085	CC[C@@H](C(=O)Nc1ccc2nc(C)ccc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C28H24Cl2N6O3/c1-4-23(28(38)32-19-8-9-22-17(11-19)6-5-16(2)31-22)35-14-25(39-3)21(13-27(35)37)20-12-18(29)7-10-24(20)36-15-26(30)33-34-36/h5-15,23H,4H2,1-3H3,(H,32,38)/t23-/m0/s1	AZYMEDAZJNOBLR-QHCPKHFHSA-N	413851	(2S)-2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(2-methylquinolin-6-yl)butanamide (Enantiomer 2)::US10421742, Example 244::US11180471, Example 244	Plasma kallikrein			 1.40							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413851	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413851&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205851	433913950							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116086	CCC(C(=O)Nc1ccc2nn(C)c(C)c2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C27H25Cl2N7O3/c1-5-22(27(38)30-17-7-8-21-18(11-17)15(2)34(3)32-21)35-13-24(39-4)20(12-26(35)37)19-10-16(28)6-9-23(19)36-14-25(29)31-33-36/h6-14,22H,5H2,1-4H3,(H,30,38)	SBXOMGIKOINZME-UHFFFAOYSA-N	413852	2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(2,3-dimethyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 245::US11180471, Example 245	Plasma kallikrein			 5.80							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413852	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413852&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205409	433913951							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116087	CCC(C(=O)Nc1ccc2nn(C)c(C)c2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)(F)F	InChI=1S/C28H25ClF3N7O3/c1-5-22(27(41)33-17-7-8-21-18(11-17)15(2)37(3)35-21)38-13-24(42-4)20(12-26(38)40)19-10-16(29)6-9-23(19)39-14-25(34-36-39)28(30,31)32/h6-14,22H,5H2,1-4H3,(H,33,41)	MKSVLCRJUVAEQS-UHFFFAOYSA-N	413853	2-[4-{5-Chloro-2-[4-(trifluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-N-(2,3-dimethyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 246::US11180471, Example 246	Plasma kallikrein			 7.80							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413853	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413853&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205407	433913952							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116088	CCC(C(=O)Nc1ccc2nc(ccc2c1)C(F)(F)F)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C28H21Cl2F3N6O3/c1-3-21(27(41)34-17-6-7-20-15(10-17)4-9-24(35-20)28(31,32)33)38-13-23(42-2)19(12-26(38)40)18-11-16(29)5-8-22(18)39-14-25(30)36-37-39/h4-14,21H,3H2,1-2H3,(H,34,41)	SEVBXRKORJAERT-UHFFFAOYSA-N	413854	2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-[2-(trifluoromethyl)quinolin-6-yl]butanamide (Racemate)::US10421742, Example 247::US11180471, Example 247	Plasma kallikrein			 17.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413854	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413854&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205363	433913953							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116089	CCC(C(=O)Nc1ccc2nc(ccc2c1)C(F)(F)F)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C29H22ClF5N6O3/c1-3-22(28(43)36-17-6-7-20-15(10-17)4-9-25(37-20)29(33,34)35)40-14-24(44-2)19(12-26(40)42)18-11-16(30)5-8-23(18)41-13-21(27(31)32)38-39-41/h4-14,22,27H,3H2,1-2H3,(H,36,43)	SDQAOZYYHXEPNT-UHFFFAOYSA-N	413855	2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-N-[2-(trifluoromethyl)quinolin-6-yl]butanamide (Racemate)::US10421742, Example 248::US11180471, Example 248	Plasma kallikrein			 21.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413855	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413855&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205958	433913954							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116090	CCC(C(=O)Nc1ccc2nn(C)nc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C25H22Cl2N8O3/c1-4-20(25(37)28-15-6-7-18-19(10-15)31-33(2)30-18)34-12-22(38-3)17(11-24(34)36)16-9-14(26)5-8-21(16)35-13-23(27)29-32-35/h5-13,20H,4H2,1-3H3,(H,28,37)	LZHGUODYTWJFHC-UHFFFAOYSA-N	413856	2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(2-methyl-2H-benzotriazol-5-yl)butanamide (Racemate)::US10421742, Example 249::US11180471, Example 249	Plasma kallikrein			 7.60							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413856	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413856&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205352	433913955							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116091	CCC(C(=O)Nc1ccc2nn(CC)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C27H25Cl2N7O3/c1-4-22(27(38)30-18-7-8-21-16(10-18)13-34(5-2)32-21)35-14-24(39-3)20(12-26(35)37)19-11-17(28)6-9-23(19)36-15-25(29)31-33-36/h6-15,22H,4-5H2,1-3H3,(H,30,38)	MSUOXKMCLUJSJC-UHFFFAOYSA-N	528272	2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(2-ethyl-2H-indazol-5-yl)butanamide (racemate)::US11180471, Example 250	Plasma kallikrein			 4.70							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528272	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528272&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135206108	463791812							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116092	COc1cn([C@@H](C)C(=O)Nc2ccc(C(N)=O)c(F)c2)c(=O)cc1-c1cc(Cl)ccc1-n1cc(nn1)C(F)(F)F	InChI=1S/C25H19ClF4N6O4/c1-12(24(39)32-14-4-5-15(23(31)38)18(27)8-14)35-10-20(40-2)17(9-22(35)37)16-7-13(26)3-6-19(16)36-11-21(33-34-36)25(28,29)30/h3-12H,1-2H3,(H2,31,38)(H,32,39)/t12-/m0/s1	SNUMNATTXKTJQD-LBPRGKRZSA-N	413858	4-({(2S)-2-[4-{5-Chloro-2-[4-(trifluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]propanoyl}amino)-2-fluorobenzamide (Enantiomer 2)::US10421742, Example 251::US11180471, Example 251	Plasma kallikrein			 4.60							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413858	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413858&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205940	433913957							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116093	CCC(C(=O)Nc1ccc2nc(ccc2c1)C#N)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C29H22ClF2N7O3/c1-3-24(29(41)35-18-7-8-22-16(10-18)4-6-19(13-33)34-22)38-15-26(42-2)21(12-27(38)40)20-11-17(30)5-9-25(20)39-14-23(28(31)32)36-37-39/h4-12,14-15,24,28H,3H2,1-2H3,(H,35,41)	DERODARCDQXYDI-UHFFFAOYSA-N	413859	2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-N-(2-cyanoquinolin-6-yl)butanamide (Racemate)::US10421742, Example 252::US11180471, Example 252	Plasma kallikrein			 11.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413859	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413859&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205841	433913958							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116094	CCC(C(=O)Nc1ccc2nc(ccc2c1)C#N)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C28H21Cl2N7O3/c1-3-23(28(39)33-18-7-8-22-16(10-18)4-6-19(13-31)32-22)36-14-25(40-2)21(12-27(36)38)20-11-17(29)5-9-24(20)37-15-26(30)34-35-37/h4-12,14-15,23H,3H2,1-2H3,(H,33,39)	QCAYWCRUVAGYIH-UHFFFAOYSA-N	413860	2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(2-cyanoquinolin-6-yl)butanamide (Racemate)::US10421742, Example 253::US11180471, Example 253	Plasma kallikrein			 6.80							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413860	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413860&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135211506	433913959							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116095	CCC(C(=O)Nc1ccc2nn(CCO)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C27H25Cl2N7O4/c1-3-22(27(39)30-18-5-6-21-16(10-18)13-34(32-21)8-9-37)35-14-24(40-2)20(12-26(35)38)19-11-17(28)4-7-23(19)36-15-25(29)31-33-36/h4-7,10-15,22,37H,3,8-9H2,1-2H3,(H,30,39)	CJLPNFNSEYZOKO-UHFFFAOYSA-N	413861	2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-[2-(2-hydroxyethyl)-2H-indazol-5-yl]butanamide (Racemate)::US10421742, Example 254::US11180471, Example 254	Plasma kallikrein			 3.50							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413861	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413861&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205337	433913960							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116096	CCC(C(=O)Nc1ccc2nn(CCO)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C28H26ClF2N7O4/c1-3-23(28(41)32-18-5-6-21-16(10-18)13-36(34-21)8-9-39)37-15-25(42-2)20(12-26(37)40)19-11-17(29)4-7-24(19)38-14-22(27(30)31)33-35-38/h4-7,10-15,23,27,39H,3,8-9H2,1-2H3,(H,32,41)	ZWZWZPJQIZBWFH-UHFFFAOYSA-N	413862	2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-N-[2-(2-hydroxyethyl)-2H-indazol-5-yl]butanamide (Racemate)::US10421742, Example 255::US11180471, Example 255	Plasma kallikrein			 8.90							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413862	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413862&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205193	433913961							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116097	CCC(C(=O)Nc1ccc2[nH]nc(c2c1)C(F)(F)F)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1			413863	2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-[3-(trifluoromethyl)-1H-indazol-5-yl]butanamide (Racemate)::US10421742, Example 256::US11180471, Example 256	Plasma kallikrein			 17.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413863	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413863&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205900	433913962							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116098	COc1cn([C@@H](CC(F)F)C(=O)Nc2ccc3nccnc3c2)c(=O)cc1-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C26H19Cl2F2N7O3/c1-40-22-12-36(21(11-24(29)30)26(39)33-15-3-4-18-19(9-15)32-7-6-31-18)25(38)10-17(22)16-8-14(27)2-5-20(16)37-13-23(28)34-35-37/h2-10,12-13,21,24H,11H2,1H3,(H,33,39)/t21-/m0/s1	SATGRGDFTKEDOC-NRFANRHFSA-N	413864	(2S)-2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4,4-difluoro-N-(quinoxalin-6-yl)butanamide (Enantiomer 2)::US10421742, Example 257::US11180471, Example 257	Plasma kallikrein			 2.70							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413864	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413864&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205541	433913963							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116099	CCCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)(F)F	InChI=1S/C27H23ClF4N6O4/c1-3-4-21(26(41)34-15-6-7-16(25(33)40)19(29)10-15)37-12-22(42-2)18(11-24(37)39)17-9-14(28)5-8-20(17)38-13-23(35-36-38)27(30,31)32/h5-13,21H,3-4H2,1-2H3,(H2,33,40)(H,34,41)	FQRNHVWJUMYDQS-UHFFFAOYSA-N	413865	4-({2-[4-{5-Chloro-2-[4-(trifluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]pentanoyl}amino)-2-fluorobenzamide (Racemate)::US10421742, Example 258::US11180471, Example 258	Plasma kallikrein			 34.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413865	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413865&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205430	433913964							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116148	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(OC)cc(OC)c1	InChI=1S/C28H30N4O5/c1-35-19-26-25(28(34)29-15-22-12-23(36-2)14-24(13-22)37-3)18-32(30-26)17-21-9-7-20(8-10-21)16-31-11-5-4-6-27(31)33/h4-14,18H,15-17,19H2,1-3H3,(H,29,34)	BKELALJCIHUNCS-UHFFFAOYSA-N	408665	N-(3,5-Dimethoxybenzyl)-3-(methoxymethyl)-1-(4-((2-oxopyridin-1(2H)-yl)methyl)benzyl)-1H-pyrazole-4-carboxamide::US10364238, Example 1::US11001578, Example 1::US11084809, Example 1::US11198691, Example 1	Plasma kallikrein			 698							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408665	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408665&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364994	406799299							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116151	COc1cccc(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2N)c1F	InChI=1S/C25H24FN5O3/c1-34-21-6-4-5-19(23(21)26)13-28-25(33)20-16-31(29-24(20)27)15-18-10-8-17(9-11-18)14-30-12-3-2-7-22(30)32/h2-12,16H,13-15H2,1H3,(H2,27,29)(H,28,33)	HICYNMRHZGAFMT-UHFFFAOYSA-N	408666	3-Amino-1-[4-(2-oxo-2H-pyridin-1-ylmethyl)-benzyl]-1H-pyrazole-4-carboxylic acid 2-fluoro-3-methoxy-benzylamide::US10364238, Example 2::US11001578, Example 2::US11084809, Example 2::US11198691, Example 2	Plasma kallikrein			 8.70							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408666	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408666&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365045	406799300							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133216	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc2CCNCc2cc1F)C(F)(F)F	InChI=1S/C21H19F4N5O/c22-16-7-14-11-27-5-4-13(14)8-17(16)28-20(31)18-9-19(21(23,24)25)29-30(18)15-3-1-2-12(6-15)10-26/h1-3,6-9,27H,4-5,10-11,26H2,(H,28,31)	XCBOZBQFIYATFU-UHFFFAOYSA-N	416716	1-(3-(aminomethyl)phenyl)-N-(7-fluoro-1,2,3,4-tetrahydroisoquinolin-6-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 161e::US10633345, Compound 161e::US10689346, Compound 161e::US11203574, Compound 161e::US11230530, Compound 161e::US11685721, Compound 161e	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416716	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416716&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356276	433916630							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133217	CN(Cc1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1)c1ccccc1	InChI=1S/C26H24F3N5O/c1-33(21-10-3-2-4-11-21)17-19-8-5-9-20(13-19)31-25(35)23-15-24(26(27,28)29)32-34(23)22-12-6-7-18(14-22)16-30/h2-15H,16-17,30H2,1H3,(H,31,35)	IEARPKHOKPOLCS-UHFFFAOYSA-N	416717	1-(3-(aminomethyl)phenyl)-N-(3-((methyl(phenyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 28f::US10633345, Compound 28f::US10689346, Compound 28f::US11203574, Compound 28f::US11230530, Compound 28f::US11685721, Compound 28f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416717	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416717&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665676	433916631							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133218	CCCN(c1ccccc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C27H25F4N5O/c1-2-13-35(19-8-4-3-5-9-19)20-11-12-22(28)23(15-20)33-26(37)24-16-25(27(29,30)31)34-36(24)21-10-6-7-18(14-21)17-32/h3-12,14-16H,2,13,17,32H2,1H3,(H,33,37)	NZQCKHUBEMVLQD-UHFFFAOYSA-N	416718	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-5-(phenyl(propyl)amino)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 77e::US10633345, Compound 77e::US10689346, Compound 77e::US11203574, Compound 77e::US11230530, Compound 77e::US11685721, Compound 77e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416718	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416718&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665730	433916632							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133219	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1ccc2CNCCc2c1F)C(F)(F)F	InChI=1S/C21H19F4N5O/c22-19-15-6-7-27-11-13(15)4-5-16(19)28-20(31)17-9-18(21(23,24)25)29-30(17)14-3-1-2-12(8-14)10-26/h1-5,8-9,27H,6-7,10-11,26H2,(H,28,31)	RYNJWLCYWDTYKF-UHFFFAOYSA-N	416719	1-(3-(aminomethyl)phenyl)-N-(5-fluoro-1,2,3,4-tetrahydroisoquinolin-6-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 162c::US10633345, Compound 162c::US10689346, Compound 162c::US11203574, Compound 162c::US11230530, Compound 162c::US11685721, Compound 162c	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416719	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416719&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665528	433916633							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133220	CCCN(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1F	InChI=1S/C27H25F4N5O/c1-2-14-35(19-9-4-3-5-10-19)22-13-7-12-21(25(22)28)33-26(37)23-16-24(27(29,30)31)34-36(23)20-11-6-8-18(15-20)17-32/h3-13,15-16H,2,14,17,32H2,1H3,(H,33,37)	SDFZIQBGIDPGAP-UHFFFAOYSA-N	416720	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-3-(phenyl(propyl)amino)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 29e::US10633345, Compound 29e::US10689346, Compound 29e::US11203574, Compound 29e::US11230530, Compound 29e::US11685721, Compound 29e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416720	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416720&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355654	433916634							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133221	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C28H26F3N5O2/c29-28(30,31)25-15-24(36(35-25)22-8-3-5-19(13-22)16-32)27(37)34-21-7-4-6-20(14-21)26(38-17-18-10-11-18)23-9-1-2-12-33-23/h1-9,12-15,18,26H,10-11,16-17,32H2,(H,34,37)	UBQUVYTUKOFUOF-UHFFFAOYSA-N	416721	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(pyridin-2-yl)methyl)-phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 43f::US10633345, Compound 43f::US10689346, Compound 43g::US11203574, Compound 43h::US11230530, Compound 43h::US11685721, Compound 43f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416721	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416721&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355947	433916635							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133222	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc2CNCCc2cc1F)C(F)(F)F	InChI=1S/C21H19F4N5O/c22-16-7-13-4-5-27-11-14(13)8-17(16)28-20(31)18-9-19(21(23,24)25)29-30(18)15-3-1-2-12(6-15)10-26/h1-3,6-9,27H,4-5,10-11,26H2,(H,28,31)	APLBFUXJEQDPBH-UHFFFAOYSA-N	416722	1-(3-(aminomethyl)phenyl)-N-(6-fluoro-1,2,3,4-tetrahydroisoquinolin-7-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 163g::US10633345, Compound 163g::US10689346, Compound 163g::US11203574, Compound 163g::US11230530, Compound 163g::US11685721, Compound 163g	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416722	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416722&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355616	433916636							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133223	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(Cn2ccnc2)ccc1F)C(F)(F)F	InChI=1S/C22H18F4N6O/c23-17-5-4-15(12-31-7-6-28-13-31)9-18(17)29-21(33)19-10-20(22(24,25)26)30-32(19)16-3-1-2-14(8-16)11-27/h1-10,13H,11-12,27H2,(H,29,33)	FOWNNAMOGPFGSS-UHFFFAOYSA-N	416723	N-(5-((1H-imidazol-1-yl)methyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 30g::US10633345, Compound 30g::US10689346, Compound 30g::US11203574, Compound 30g::US11230530, Compound 30g::US11685721, Compound 30g	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416723	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416723&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356018	433916637							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133224	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H26F3N5O2/c29-28(30,31)25-14-24(36(35-25)23-8-1-4-19(12-23)15-32)27(37)34-22-7-2-5-20(13-22)26(38-17-18-9-10-18)21-6-3-11-33-16-21/h1-8,11-14,16,18,26H,9-10,15,17,32H2,(H,34,37)	SHFRWTHPPCXLER-UHFFFAOYSA-N	416725	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(pyridin-3-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 44c::US10633345, Compound 44c::US10689346, Compound 44c::US11203574, Compound 44d::US11230530, Compound 44e::US11685721, Compound 44c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416725	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416725&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355578	433916639							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133225	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(Nc2ccccc2)c1)C(F)(F)F	InChI=1S/C24H20F3N5O/c25-24(26,27)22-14-21(32(31-22)20-11-4-6-16(12-20)15-28)23(33)30-19-10-5-9-18(13-19)29-17-7-2-1-3-8-17/h1-14,29H,15,28H2,(H,30,33)	BURYUTYBSGJGCF-UHFFFAOYSA-N	416728	1-(3-(aminomethyl)phenyl)-N-(3-(phenylamino)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 17d::US10689346, Compound 17d::US11203574, Compound 17d::US11230530, Compound 17d::US11685721, Compound 17d	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416728	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416728&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665499	433916642							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133226	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)c1cccnc1)C(F)(F)F	InChI=1S/C24H20F3N5O2/c25-24(26,27)21-12-20(32(31-21)19-8-1-4-15(10-19)13-28)23(34)30-18-7-2-5-16(11-18)22(33)17-6-3-9-29-14-17/h1-12,14,22,33H,13,28H2,(H,30,34)	ZKOHYLRGOQBIFH-UHFFFAOYSA-N	416729	1-(3-(aminomethyl)phenyl)-N-(3-(hydroxy(pyridin-3-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 31f::US10633345, Compound 31f::US10689346, Compound 31f::US11203574, Compound 31f::US11230530, Compound 31f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416729	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416729&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665970	433916643							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133227	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F3N4O/c31-30(32,33)28-18-27(37(36-28)25-11-4-6-21(16-25)19-34)29(38)35-24-10-5-9-23(17-24)26(15-14-20-12-13-20)22-7-2-1-3-8-22/h1-11,16-18,20,26H,12-15,19,34H2,(H,35,38)	LVGPKQXQIQRVCT-UHFFFAOYSA-N	416730	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-phenylpropyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 78d::US10633345, Compound 78d::US10689346, Compound 78d::US11203574, Compound 78d::US11230530, Compound 78d::US11685721, Compound 78d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416730	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416730&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665672	433916644							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133228	COC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C26H23F3N4O2/c1-35-24(18-8-3-2-4-9-18)19-10-6-11-20(14-19)31-25(34)22-15-23(26(27,28)29)32-33(22)21-12-5-7-17(13-21)16-30/h2-15,24H,16,30H2,1H3,(H,31,34)	XNHGZPIIDJTQKO-UHFFFAOYSA-N	416731	1-(3-(aminomethyl)phenyl)-N-(3-(methoxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18f::US10633345, Compound 18f::US10689346, Compound 18f::US11203574, Compound 18f::US11230530, Compound 18e::US11685721, Compound 18f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416731	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416731&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665801	433916645							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133229	CCCCC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C29H29F3N4O/c1-2-3-15-25(21-10-5-4-6-11-21)22-12-8-13-23(17-22)34-28(37)26-18-27(29(30,31)32)35-36(26)24-14-7-9-20(16-24)19-33/h4-14,16-18,25H,2-3,15,19,33H2,1H3,(H,34,37)	PEZPMDJZISDDKH-UHFFFAOYSA-N	416732	1-(3-(aminomethyl)phenyl)-N-(3-(1-phenylpentyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 32f::US10633345, Compound 32f::US10689346, Compound 32f::US11203574, Compound 32f::US11230530, Compound 32f::US11685721, Compound 32f	Plasma kallikrein		>75.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416732	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416732&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356224	433916646							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133230	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H27F3N6O/c29-28(30,31)25-14-24(37(36-25)23-8-1-4-19(12-23)15-32)27(38)35-22-7-2-5-20(13-22)26(34-16-18-9-10-18)21-6-3-11-33-17-21/h1-8,11-14,17-18,26,34H,9-10,15-16,32H2,(H,35,38)	KSDPGGAAGHTRLB-UHFFFAOYSA-N	416733	1-(3-(Aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(pyridin-3-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 79f::US10633345, Compound 79f::US10689346, Compound 79f::US11203574, Compound 79f::US11230530, Compound 79f::US11685721, Compound 79f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416733	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416733&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356066	433916647							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133231	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(Cc2ccccc2)c1)C(F)(F)F	InChI=1S/C25H21F3N4O/c26-25(27,28)23-15-22(32(31-23)21-11-5-9-19(14-21)16-29)24(33)30-20-10-4-8-18(13-20)12-17-6-2-1-3-7-17/h1-11,13-15H,12,16,29H2,(H,30,33)	GVRJCFWHVBXPLW-UHFFFAOYSA-N	416734	1-(3-(aminomethyl)phenyl)-N-(3-benzylphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 19d::US10633345, Compound 19d::US10689346, Compound 19d::US11203574, Compound 19d::US11230530, Compound 19d::US11685721, Compound 19d	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416734	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416734&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355715	433916648							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133232	CCOC(c1ccccc1)c1ccc(Cl)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C27H24ClF3N4O2/c1-2-37-25(18-8-4-3-5-9-18)19-11-12-21(28)22(14-19)33-26(36)23-15-24(27(29,30)31)34-35(23)20-10-6-7-17(13-20)16-32/h3-15,25H,2,16,32H2,1H3,(H,33,36)	XUCZWPPXZIMXPF-UHFFFAOYSA-N	416735	1-(3-(aminomethyl)phenyl)-N-(2-chloro-5-(ethoxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 33e::US10633345, Compound 33e::US10689346, Compound 33e::US11203574, Compound 33e::US11230530, Compound 33e::US11685721, Compound 33e	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416735	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416735&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665706	433916649							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133233	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(F)cc(c1)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-22-12-21(27(39-17-18-9-10-18)20-6-2-1-3-7-20)13-23(14-22)35-28(38)25-15-26(29(31,32)33)36-37(25)24-8-4-5-19(11-24)16-34/h1-8,11-15,18,27H,9-10,16-17,34H2,(H,35,38)	CECISELXZFBKBA-UHFFFAOYSA-N	416736	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)-5-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 80h::US10633345, Compound 80h::US10689346, Compound 80h::US11203574, Compound 80h::US11230530, Compound 80h::US11685721, Compound 80h	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416736	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416736&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356068	433916650							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133234	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(Oc2ccccc2)c1)C(F)(F)F	InChI=1S/C24H19F3N4O2/c25-24(26,27)22-14-21(31(30-22)18-8-4-6-16(12-18)15-28)23(32)29-17-7-5-11-20(13-17)33-19-9-2-1-3-10-19/h1-14H,15,28H2,(H,29,32)	CMENISUXWPWEPE-UHFFFAOYSA-N	416737	1-(3-(aminomethyl)phenyl)-N-(3-phenoxyphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 20d::US10689346, Compound 20d::US11203574, Compound 20d::US11230530, Compound 20d::US11685721, Compound 20d	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416737	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416737&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665805	433916651							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133235	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1Cl)C(O)c1ccccc1)C(F)(F)F	InChI=1S/C25H20ClF3N4O2/c26-19-10-9-17(23(34)16-6-2-1-3-7-16)12-20(19)31-24(35)21-13-22(25(27,28)29)32-33(21)18-8-4-5-15(11-18)14-30/h1-13,23,34H,14,30H2,(H,31,35)	RYPOCSQZGRAPIF-UHFFFAOYSA-N	416738	1-(3-(aminomethyl)phenyl)-N-(2-chloro-5-(hydroxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 33f::US10633345, Compound 33f::US10689346, Compound 33f::US11203574, Compound 33f::US11230530, Compound 33f::US11685721, Compound 33f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416738	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416738&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665810	433916652							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133236	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)N(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H28F3N5O/c30-29(31,32)27-18-26(37(35-27)25-11-4-6-21(16-25)19-33)28(38)34-22-7-5-10-24(17-22)36(15-14-20-12-13-20)23-8-2-1-3-9-23/h1-11,16-18,20H,12-15,19,33H2,(H,34,38)	BPUAEVGWEFCIEW-UHFFFAOYSA-N	416739	1-(3-(aminomethyl)phenyl)-N-(3-((2-cyclopropylethyl)(phenyl)amino)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 87f::US10633345, Compound 87f::US10689346, Compound 87f::US11203574, Compound 87f::US11230530, Compound 87f::US11685721, Compound 87f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416739	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416739&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665744	433916653							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133237	CCOC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C27H25F3N4O2/c1-2-36-25(19-9-4-3-5-10-19)20-11-7-12-21(15-20)32-26(35)23-16-24(27(28,29)30)33-34(23)22-13-6-8-18(14-22)17-31/h3-16,25H,2,17,31H2,1H3,(H,32,35)	NWRGIGNKIBZYEM-UHFFFAOYSA-N	416740	1-(3-(aminomethyl)phenyl)-N-(3-(ethoxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18g::US10633345, Compound 18g::US10689346, Compound 18g::US11203574, Compound 18g::US11230530, Compound 18g::US11685721, Compound 18g	Plasma kallikrein		>75.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416740	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416740&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356270	433916654							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133238	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)c1ccccc1)C(F)(F)F	InChI=1S/C25H20F4N4O2/c26-19-10-9-17(23(34)16-6-2-1-3-7-16)12-20(19)31-24(35)21-13-22(25(27,28)29)32-33(21)18-8-4-5-15(11-18)14-30/h1-13,23,34H,14,30H2,(H,31,35)	SUGJHCONPCVXKJ-UHFFFAOYSA-N	416741	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-5-(hydroxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 34d::US10633345, Compound 34d::US10689346, Compound 34d::US11203574, Compound 34d::US11230530, Compound 34d::US11685721, Compound 34d	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416741	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416741&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665740	433916655							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133239	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(C(NCC2CC2)c2ccccc2)c1F)C(F)(F)F	InChI=1S/C29H27F4N5O/c30-26-22(27(35-17-18-12-13-18)20-7-2-1-3-8-20)10-5-11-23(26)36-28(39)24-15-25(29(31,32)33)37-38(24)21-9-4-6-19(14-21)16-34/h1-11,14-15,18,27,35H,12-13,16-17,34H2,(H,36,39)	YDBPNMJFMRHCIG-UHFFFAOYSA-N	416742	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 88b::US10633345, Compound 88b::US10689346, Compound 88b::US11203574, Compound 88b::US11230530, Compound 88b::US11685721, Compound 88b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416742	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416742&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123349010	433916656							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133240	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(=O)c1ccccc1)C(F)(F)F	InChI=1S/C25H19F3N4O2/c26-25(27,28)22-14-21(32(31-22)20-11-4-6-16(12-20)15-29)24(34)30-19-10-5-9-18(13-19)23(33)17-7-2-1-3-8-17/h1-14H,15,29H2,(H,30,34)	ZRVRSUVIXBEHIJ-UHFFFAOYSA-N	416743	1-(3-(aminomethyl)phenyl)-N-(3-benzoylphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 22b::US10633345, Compound 22b::US10689346, Compound 22b::US11203574, Compound 22b::US11230530, Compound 22b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416743	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416743&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355917	433916657							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133241	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(C(O)c2ccccc2)c1F)C(F)(F)F	InChI=1S/C25H20F4N4O2/c26-22-18(23(34)16-7-2-1-3-8-16)10-5-11-19(22)31-24(35)20-13-21(25(27,28)29)32-33(20)17-9-4-6-15(12-17)14-30/h1-13,23,34H,14,30H2,(H,31,35)	DENXCWXVTOPLRK-UHFFFAOYSA-N	416744	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-3-(hydroxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 35g::US10633345, Compound 35g::US10689346, Compound 35g::US11203574, Compound 35g::US11230530, Compound 35g::US11685721, Compound 35g	Plasma kallikrein		>75.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416744	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416744&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355965	433916658							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133242	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1nccs1)C(F)(F)F	InChI=1S/C26H24F3N5O2S/c27-26(28,29)22-13-21(34(33-22)20-6-1-3-17(11-20)14-30)24(35)32-19-5-2-4-18(12-19)23(25-31-9-10-37-25)36-15-16-7-8-16/h1-6,9-13,16,23H,7-8,14-15,30H2,(H,32,35)	FKPORVMTXYTRPN-UHFFFAOYSA-N	416745	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(thiazol-2-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 82f::US10633345, Compound 82f::US10689346, Compound 82f::US11203574, Compound 82f::US11230530, Compound 82f::US11685721, Compound 82f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416745	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416745&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355763	433916659							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133243	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(Oc2ccccc2)c1F)C(F)(F)F	InChI=1S/C24H18F4N4O2/c25-22-18(10-5-11-20(22)34-17-8-2-1-3-9-17)30-23(33)19-13-21(24(26,27)28)31-32(19)16-7-4-6-15(12-16)14-29/h1-13H,14,29H2,(H,30,33)	VUYMCUFLTORTFW-UHFFFAOYSA-N	416746	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-3-phenoxyphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 23c::US10633345, Compound 23c::US10689346, Compound 23c::US11203574, Compound 23c::US11230530, Compound 23c::US11685721, Compound 23c	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416746	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416746&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665745	433916660							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133244	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-23-12-11-21(27(39-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)35-28(38)25-15-26(29(31,32)33)36-37(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27H,9-10,16-17,34H2,(H,35,38)	HIMJVDQVZQMIPM-UHFFFAOYSA-N	416747	1-(3-(Aminomethyl)phenyl)-N-(5-((cyclopropylmethoxy)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 34c::US10633345, Compound 34c::US10689346, Compound 34c::US11203574, Compound 37a::US11230530, Compound 37a::US11685721, Compound 34c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416747	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416747&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355729	433916661							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133245	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C28H27F3N6O/c29-28(30,31)25-15-24(37(36-25)22-8-3-5-19(13-22)16-32)27(38)35-21-7-4-6-20(14-21)26(34-17-18-10-11-18)23-9-1-2-12-33-23/h1-9,12-15,18,26,34H,10-11,16-17,32H2,(H,35,38)	UTXGSCUKCKWESJ-UHFFFAOYSA-N	416748	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(pyridin-2-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 83c::US10633345, Compound 83c::US10689346, Compound 83c::US11203574, Compound 83c::US11230530, Compound 83c::US11685721, Compound 83c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416748	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416748&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355952	433916662							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133246	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(Oc2ccccc2)ccc1F)C(F)(F)F	InChI=1S/C24H18F4N4O2/c25-19-10-9-18(34-17-7-2-1-3-8-17)12-20(19)30-23(33)21-13-22(24(26,27)28)31-32(21)16-6-4-5-15(11-16)14-29/h1-13H,14,29H2,(H,30,33)	RDALDQDNCYVLAM-UHFFFAOYSA-N	416749	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-5-phenoxyphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 24c::US10633345, Compound 24c::US10689346, Compound 24c::US11203574, Compound 24c::US11230530, Compound 24c::US11685721, Compound 24c	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416749	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416749&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356123	433916663							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133247	COC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C26H23F3N4O2/c1-35-24(18-8-3-2-4-9-18)19-10-6-11-20(14-19)31-25(34)22-15-23(26(27,28)29)32-33(22)21-12-5-7-17(13-21)16-30/h2-15,24H,16,30H2,1H3,(H,31,34)	XNHGZPIIDJTQKO-UHFFFAOYSA-N	416731	1-(3-(aminomethyl)phenyl)-N-(3-(methoxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18f::US10633345, Compound 18f::US10689346, Compound 18f::US11203574, Compound 18f::US11230530, Compound 18e::US11685721, Compound 18f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416731	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416731&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665801	433916645							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133248	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F3N4O2/c31-30(32,33)27-18-26(37(36-27)25-11-4-6-21(16-25)19-34)28(38)35-24-10-5-9-23(17-24)29(39,15-14-20-12-13-20)22-7-2-1-3-8-22/h1-11,16-18,20,39H,12-15,19,34H2,(H,35,38)	DCGYPXFSNPCKGX-UHFFFAOYSA-N	416751	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 46g::US10633345, Compound 46g::US10689346, Compound 46g::US11203574, Compound 46i::US11230530, Compound 46i::US11685721, Compound 46g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416751	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416751&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355790	433916665							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133249	CCOC(c1ccccc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C27H24F4N4O2/c1-2-37-25(18-8-4-3-5-9-18)19-11-12-21(28)22(14-19)33-26(36)23-15-24(27(29,30)31)34-35(23)20-10-6-7-17(13-20)16-32/h3-15,25H,2,16,32H2,1H3,(H,33,36)	YVBRMUSUELCGNA-UHFFFAOYSA-N	416752	1-(3-(aminomethyl)phenyl)-N-(5-(ethoxy(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 25b::US10633345, Compound 25b::US10689346, Compound 25b::US11203574, Compound 25b::US11230530, Compound 25b::US11685721, Compound 25b	Plasma kallikrein		>75.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416752	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416752&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665520	433916666							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133250	CC(C)[C@H](N)C(=O)OC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O3/c1-18(2)26(35)29(40)41-27(20-9-4-3-5-10-20)21-11-7-12-22(15-21)36-28(39)24-16-25(30(31,32)33)37-38(24)23-13-6-8-19(14-23)17-34/h3-16,18,26-27H,17,34-35H2,1-2H3,(H,36,39)/t26-,27?/m0/s1	OQCWFOUCOSAWQU-QBHOUYDASA-N	416753	(2S)-(3-(1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamido)phenyl)(phenyl)methyl 2-amino-3-methylbutanoate::US10329260, Compound 81c::US10633345, Compound 81c::US10689346, Compound 81c::US11203574, Compound 81c::US11230530, Compound 81c::US11685721, Compound 81c	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416753	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416753&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355992	433916667					C03317		1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133251	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-22-10-9-20(28(35,12-11-18-7-8-18)25-6-1-2-13-36-25)15-23(22)37-27(40)24-16-26(29(31,32)33)38-39(24)21-5-3-4-19(14-21)17-34/h1-6,9-10,13-16,18H,7-8,11-12,17,34-35H2,(H,37,40)	IFWBAIGKQKRJGJ-UHFFFAOYSA-N	416975	(+-)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 205d::US10633345, Compound 205c::US10689346, Compound 205e::US11203574, Compound 205e::US11230530, Compound 205e::US11685721, Compound 205f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416975	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416975&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665627	433916887							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133252	COC(c1ccccc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C26H22F4N4O2/c1-36-24(17-7-3-2-4-8-17)18-10-11-20(27)21(13-18)32-25(35)22-14-23(26(28,29)30)33-34(22)19-9-5-6-16(12-19)15-31/h2-14,24H,15,31H2,1H3,(H,32,35)	AJQPEPSKLFPFIU-UHFFFAOYSA-N	416755	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-5-(methoxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 25c::US10633345, Compound 25c::US10689346, Compound 25c::US11203574, Compound 25c::US11230530, Compound 25c::US11685721, Compound 25c	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416755	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416755&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126666045	433916669							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133253	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CC#N)c1ccccc1)C(F)(F)F	InChI=1S/C27H22F3N5O/c28-27(29,30)25-16-24(35(34-25)22-11-4-6-18(14-22)17-32)26(36)33-21-10-5-9-20(15-21)23(12-13-31)19-7-2-1-3-8-19/h1-11,14-16,23H,12,17,32H2,(H,33,36)	AUPCAIQBGWQVBR-UHFFFAOYSA-N	416756	1-(3-(aminomethyl)phenyl)-N-(3-(2-cyano-1-phenylethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 39e::US10633345, Compound 39e::US10689346, Compound 39e::US11203574, Compound 39e::US11230530, Compound 39e::US11685721, Compound 39e	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416756	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416756&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126666023	433916670							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116155	COCc1nn(Cc2cnc3cc(Cl)ccc3c2)cc1C(=O)NCc1cccc(OC)c1F	InChI=1S/C24H22ClFN4O3/c1-32-14-21-19(24(31)28-11-17-4-3-5-22(33-2)23(17)26)13-30(29-21)12-15-8-16-6-7-18(25)9-20(16)27-10-15/h3-10,13H,11-12,14H2,1-2H3,(H,28,31)	WPIUJKAYUGBTDW-UHFFFAOYSA-N	408667	1-(7-Chloro-quinolin-3-ylmethyl)-3-methoxymethyl-1H-pyrazole-4-carboxylic acid 2-fluoro-3-methoxy-benzylamide::US10364238, Example 3::US11001578, Example 3::US11084809, Example 3::US11198691, Example 3	Plasma kallikrein			 2580							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408667	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408667&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365013	406799301							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116158	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1nccc(OC)c1F	InChI=1S/C26H26FN5O4/c1-35-17-22-20(26(34)29-13-21-25(27)23(36-2)10-11-28-21)16-32(30-22)15-19-8-6-18(7-9-19)14-31-12-4-3-5-24(31)33/h3-12,16H,13-15,17H2,1-2H3,(H,29,34)	KGMPDQIYDKKXRD-UHFFFAOYSA-N	408717	 N-[(3-fluoro-4-methoxypyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin- 1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 41::US10730874, Example 00397::US11001578, Example 41::US11084809, Example 41::US11198691, Example 41::US11352356, Table II.3::US11584735, Example 41 of WO2016/083820	Plasma kallikrein			 3.30							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408717	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408717&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365142	406799348							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116162	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(F)c(OC)ccc1C#N	InChI=1S/C28H26FN5O4/c1-37-18-24-23(28(36)31-14-22-21(13-30)10-11-25(38-2)27(22)29)17-34(32-24)16-20-8-6-19(7-9-20)15-33-12-4-3-5-26(33)35/h3-12,17H,14-16,18H2,1-2H3,(H,31,36)	SPXOTFDBWDBJRN-UHFFFAOYSA-N	408768	N-[(6-cyano-2-fluoro-3-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-::US10364238, Example 77::US10730874, Example 00398::US11001578, Example 77::US11084809, Example 77::US11198691, Example 77::US11352356, Table II.4	Plasma kallikrein			 0.600							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408768	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408768&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365006	406799399							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116166	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(F)ccc(OC)c1C(F)F	InChI=1S/C28H27F3N4O4/c1-38-17-23-21(28(37)32-13-20-22(29)10-11-24(39-2)26(20)27(30)31)16-35(33-23)15-19-8-6-18(7-9-19)14-34-12-4-3-5-25(34)36/h3-12,16,27H,13-15,17H2,1-2H3,(H,32,37)	FDDKVGBGYLYHDV-UHFFFAOYSA-N	408775	 N-{[2-(difluoromethyl)-6-fluoro-3-methoxyphenyl]methyl}-3-(methoxymethyl)-1-({4- [(2-oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 83::US11001578, Example 83::US11084809, Example 83::US11198691, Example 83	Plasma kallikrein			 6.80							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408775	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408775&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365138	406799406							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116169	COc1cccc(CNC(=O)c2cn(Cc3ccc(nc3)N3CCCC3)nc2C(F)(F)F)c1F	InChI=1S/C23H23F4N5O2/c1-34-18-6-4-5-16(20(18)24)12-29-22(33)17-14-32(30-21(17)23(25,26)27)13-15-7-8-19(28-11-15)31-9-2-3-10-31/h4-8,11,14H,2-3,9-10,12-13H2,1H3,(H,29,33)	CWABZPWKGAMQLS-UHFFFAOYSA-N	408804	N-[(2-fluoro-3-methoxyphenyl)methyl]-1-{[6-(pyrrolidin-1-yl)pyridin-3-yl]methyl}-3- (trifluoromethyl)pyrazole-4-carboxamide::US10364238, Example 126::US11001578, Example 126::US11084809, Example 126::US11180484, Reference Example G	Plasma kallikrein			 742							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408804	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408804&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365050	406799435							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116172	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(F)cccc1-n1cnnn1	InChI=1S/C27H25FN8O3/c1-39-17-24-22(27(38)29-13-21-23(28)5-4-6-25(21)36-18-30-32-33-36)16-35(31-24)15-20-10-8-19(9-11-20)14-34-12-3-2-7-26(34)37/h2-12,16,18H,13-15,17H2,1H3,(H,29,38)	RFDDQESTEHOGAA-UHFFFAOYSA-N	528074	N-{[2-Fluoro-6-(1,2,3,4-tetrazol-1-yl)phenyl]methyl}-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US11180484, Reference Example H	Plasma kallikrein			 1.10							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528074	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528074&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365143	463791630							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116176	COCc1nn(Cc2ccc(Cn3cccn3)cc2)cc1C(=O)NCc1cccc(Cl)c1	InChI=1S/C24H24ClN5O2/c1-32-17-23-22(24(31)26-13-20-4-2-5-21(25)12-20)16-30(28-23)15-19-8-6-18(7-9-19)14-29-11-3-10-27-29/h2-12,16H,13-15,17H2,1H3,(H,26,31)	UVWDUNJLDUOHNO-UHFFFAOYSA-N	528075	US11180484, Example 7 from WO 013/111108::US11180484, Reference Example I	Plasma kallikrein			 2034							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528075	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528075&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			132203063	463791631							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116180	COCc1nn(Cc2ccc(Cn3cccn3)cc2)cc1C(=O)NCc1cccc(Cl)c1	InChI=1S/C24H24ClN5O2/c1-32-17-23-22(24(31)26-13-20-4-2-5-21(25)12-20)16-30(28-23)15-19-8-6-18(7-9-19)14-29-11-3-10-27-29/h2-12,16H,13-15,17H2,1H3,(H,26,31)	UVWDUNJLDUOHNO-UHFFFAOYSA-N	528075	US11180484, Example 7 from WO 013/111108::US11180484, Reference Example I	Plasma kallikrein			 2017							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528075	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528075&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			132203063	463791631							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116184	COc1ccc(Cl)c(CNC(=O)c2cn(Cc3ccc4nc(C)ccc4c3)nn2)c1F	InChI=1S/C22H19ClFN5O2/c1-13-3-5-15-9-14(4-7-18(15)26-13)11-29-12-19(27-28-29)22(30)25-10-16-17(23)6-8-20(31-2)21(16)24/h3-9,12H,10-11H2,1-2H3,(H,25,30)	DFJBJVOVYHHCOV-UHFFFAOYSA-N	528077	N-i6-chloro-2-fluoro-3-methoxybenzyl)-1 -ii2-methylquinolin-6-yl)methyl)-1 H-1 ,2,3-triazole-4-carboxamide::US11180484, Example 14 from WO 013/111108	Plasma kallikrein			 110							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528077	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528077&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71679117	463791632							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116188	COCc1nn(Cc2ccc(Cn3cccn3)cc2)cc1C(=O)NCc1cccc(Cl)c1F	InChI=1S/C24H23ClFN5O2/c1-33-16-22-20(24(32)27-12-19-4-2-5-21(25)23(19)26)15-31(29-22)14-18-8-6-17(7-9-18)13-30-11-3-10-28-30/h2-11,15H,12-14,16H2,1H3,(H,27,32)	DYIVTSZIHRLXBK-UHFFFAOYSA-N	528078	US11180484, Example 27 from WO 013/111108::US11180484, Reference Example J	Plasma kallikrein			 731							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528078	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528078&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			132203069	463791633							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116192	COCc1nn(Cc2ccc(Cn3cccn3)cc2)cc1C(=O)NCc1cccc(Cl)c1F	InChI=1S/C24H23ClFN5O2/c1-33-16-22-20(24(32)27-12-19-4-2-5-21(25)23(19)26)15-31(29-22)14-18-8-6-17(7-9-18)13-30-11-3-10-28-30/h2-11,15H,12-14,16H2,1H3,(H,27,32)	DYIVTSZIHRLXBK-UHFFFAOYSA-N	528078	US11180484, Example 27 from WO 013/111108::US11180484, Reference Example J	Plasma kallikrein			 2869							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528078	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528078&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			132203069	463791633							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116196	COCc1nn(Cc2ccc(Cn3cc(C)cn3)cc2)cc1C(=O)NCc1nccc(OC)c1F	InChI=1S/C25H27FN6O3/c1-17-10-29-31(12-17)13-18-4-6-19(7-5-18)14-32-15-20(22(30-32)16-34-2)25(33)28-11-21-24(26)23(35-3)8-9-27-21/h4-10,12,15H,11,13-14,16H2,1-3H3,(H,28,33)	AYLKBOMDSJTOGZ-UHFFFAOYSA-N	528081	N-[(3-fluoro-4-methoxypyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[(4- methylpyrazol-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US11180484, Example 1	Plasma kallikrein			 26.1							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528081	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528081&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301824	463791635							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116200	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(OC)ncn1	InChI=1S/C25H26N6O4/c1-34-16-22-21(25(33)26-12-20-11-23(35-2)28-17-27-20)15-31(29-22)14-19-8-6-18(7-9-19)13-30-10-4-3-5-24(30)32/h3-11,15,17H,12-14,16H2,1-2H3,(H,26,33)	WCADOIWPLIAFRR-UHFFFAOYSA-N	528082	3-(methoxymethyl)-N-[(6-methoxypyrimidin-4-yl)methyl]-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US11180484, Example 4	Plasma kallikrein			 2303							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528082	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528082&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301833	463791636							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116204	COc1ccnc(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2N)c1F	InChI=1S/C24H23FN6O3/c1-34-20-9-10-27-19(22(20)25)12-28-24(33)18-15-31(29-23(18)26)14-17-7-5-16(6-8-17)13-30-11-3-2-4-21(30)32/h2-11,15H,12-14H2,1H3,(H2,26,29)(H,28,33)	LHZHVJWEENFPHR-UHFFFAOYSA-N	528083	3-amino-N-[(3-fluoro-4-methoxypyridin-2-yl)methyl]-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US11180484, Example 5	Plasma kallikrein			 2.00							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528083	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528083&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301813	463791637							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116208	COc1ccnc(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2C(F)(F)F)c1F	InChI=1S/C25H21F4N5O3/c1-37-20-9-10-30-19(22(20)26)12-31-24(36)18-15-34(32-23(18)25(27,28)29)14-17-7-5-16(6-8-17)13-33-11-3-2-4-21(33)35/h2-11,15H,12-14H2,1H3,(H,31,36)	NKTBXDIJVDKJRR-UHFFFAOYSA-N	528084	N-[(3-fluoro-4-methoxypyridin-2-yl)methyl]-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide::US11180484, Example 6	Plasma kallikrein			 3.20							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528084	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528084&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301871	463791638							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116212	COc1ccnc(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2N(C)C)c1F	InChI=1S/C26H27FN6O3/c1-31(2)25-20(26(35)29-14-21-24(27)22(36-3)11-12-28-21)17-33(30-25)16-19-9-7-18(8-10-19)15-32-13-5-4-6-23(32)34/h4-13,17H,14-16H2,1-3H3,(H,29,35)	VBARDULQROXGKU-UHFFFAOYSA-N	528085	3-(dimethylamino)-N-[(3-fluoro-4-methoxypyridin-2-yl)methyl]-1-({4-[(2-oxopyridin- 1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US11180484, Example 7	Plasma kallikrein			 18.0							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528085	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528085&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301861	463791639							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116216	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(OC)ncc1C#N	InChI=1S/C27H26N6O4/c1-36-18-24-23(27(35)30-13-21-11-25(37-2)29-14-22(21)12-28)17-33(31-24)16-20-8-6-19(7-9-20)15-32-10-4-3-5-26(32)34/h3-11,14,17H,13,15-16,18H2,1-2H3,(H,30,35)	AXDZSJQRHYIUDG-UHFFFAOYSA-N	528086	N-[(5-cyano-2-methoxypyridin-4-yl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin- 1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US11180484, Example 8	Plasma kallikrein			 162							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528086	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528086&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301847	463791640							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116220	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1nccc(OC)n1	InChI=1S/C25H26N6O4/c1-34-17-21-20(25(33)27-13-22-26-11-10-23(28-22)35-2)16-31(29-21)15-19-8-6-18(7-9-19)14-30-12-4-3-5-24(30)32/h3-12,16H,13-15,17H2,1-2H3,(H,27,33)	MHQPAMQKPZNORS-UHFFFAOYSA-N	528087	3-(methoxymethyl)-N-[(4-methoxypyrimidin-2-yl)methyl]-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US11180484, Example 10	Plasma kallikrein			 2450							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528087	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528087&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301874	463791641							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133254	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CCC1CC1)n1ccnc1)C(F)(F)F	InChI=1S/C27H27F3N6O/c28-27(29,30)25-15-24(36(34-25)22-6-1-3-19(13-22)16-31)26(37)33-21-5-2-4-20(14-21)23(10-9-18-7-8-18)35-12-11-32-17-35/h1-6,11-15,17-18,23H,7-10,16,31H2,(H,33,37)	UPEDWOJFQGRWOZ-UHFFFAOYSA-N	416757	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-(1H-imidazol-1-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 89g::US10633345, Compound 89g::US10689346, Compound 89g::US11203574, Compound 89g::US11230530, Compound 89g::US11685721, Compound 89g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416757	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416757&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665540	433916671							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133255	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(Cc2ccccc2)ccc1F)C(F)(F)F	InChI=1S/C25H20F4N4O/c26-20-10-9-17(11-16-5-2-1-3-6-16)13-21(20)31-24(34)22-14-23(25(27,28)29)32-33(22)19-8-4-7-18(12-19)15-30/h1-10,12-14H,11,15,30H2,(H,31,34)	PFWDQKVXCJEZES-UHFFFAOYSA-N	416758	1-(3-(aminomethyl)phenyl)-N-(5-benzyl-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 26f::US10633345, Compound 26f::US10689346, Compound 26f::US11203574, Compound 26f::US11230530, Compound 26f::US11685721, Compound 26f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416758	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416758&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355900	433916672							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133256	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CC(N)=O)c1ccccc1)C(F)(F)F	InChI=1S/C27H24F3N5O2/c28-27(29,30)24-15-23(35(34-24)21-11-4-6-17(12-21)16-31)26(37)33-20-10-5-9-19(13-20)22(14-25(32)36)18-7-2-1-3-8-18/h1-13,15,22H,14,16,31H2,(H2,32,36)(H,33,37)	KDXRDWIYPXSJST-UHFFFAOYSA-N	416759	N-(3-(3-amino-3-oxo-1-phenylpropyl)phenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 40b::US10633345, Compound 40b::US10689346, Compound 40b::US11203574, Compound 40b::US11230530, Compound 40b::US11685721, Compound 40b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416759	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416759&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665680	433916673							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133257	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(=CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H27F3N4O/c31-30(32,33)28-18-27(37(36-28)25-11-4-6-21(16-25)19-34)29(38)35-24-10-5-9-23(17-24)26(15-14-20-12-13-20)22-7-2-1-3-8-22/h1-11,15-18,20H,12-14,19,34H2,(H,35,38)/b26-15+	VKLRLOSKQDEQAH-CVKSISIWSA-N	439345	US10633345, Compound 91a::US10689346, Compound 91a::US11192861, Compound 91a::US11230530, Compound 91a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439345	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439345&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			153066367	439660903							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133258	CC(C)COC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C29H29F3N4O2/c1-19(2)18-38-27(21-9-4-3-5-10-21)22-11-7-12-23(15-22)34-28(37)25-16-26(29(30,31)32)35-36(25)24-13-6-8-20(14-24)17-33/h3-16,19,27H,17-18,33H2,1-2H3,(H,34,37)	FMSXMXLNUZXXSC-UHFFFAOYSA-N	416762	1-(3-(aminomethyl)phenyl)-N-(3-(isobutoxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18i::US10633345, Compound 18i::US10689346, Compound 18i::US11203574, Compound 18i::US11230530, Compound 18i::US11685721, Compound 18i	Plasma kallikrein		>75.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416762	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416762&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356257	433916676							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133259	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H28F3N5O/c30-29(31,32)26-16-25(37(36-26)24-11-4-6-20(14-24)17-33)28(38)35-23-10-5-9-22(15-23)27(34-18-19-12-13-19)21-7-2-1-3-8-21/h1-11,14-16,19,27,34H,12-13,17-18,33H2,(H,35,38)	QZQLNMURVWFZTC-UHFFFAOYSA-N	439347	US10633345, Compound 41e::US10689346, Compound 41e::US11203574, Compound 41e::US11230530, Compound 41e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439347	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439347&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665751	439660905							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133260	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C28H27F3N6O/c29-28(30,31)25-15-24(37(36-25)23-6-1-3-19(13-23)16-32)27(38)35-22-5-2-4-21(14-22)26(34-17-18-7-8-18)20-9-11-33-12-10-20/h1-6,9-15,18,26,34H,7-8,16-17,32H2,(H,35,38)	VXJYGPKEYKOJCQ-UHFFFAOYSA-N	416764	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(pyridin-4-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 86g::US10633345, Compound 86g::US10689346, Compound 86g::US11203574, Compound 86g::US11230530, Compound 86g::US11685721, Compound 86g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416764	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416764&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355880	433916678							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133261	CCCOC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C28H27F3N4O2/c1-2-14-37-26(20-9-4-3-5-10-20)21-11-7-12-22(16-21)33-27(36)24-17-25(28(29,30)31)34-35(24)23-13-6-8-19(15-23)18-32/h3-13,15-17,26H,2,14,18,32H2,1H3,(H,33,36)	ODVQLXVRAUDBCL-UHFFFAOYSA-N	416765	1-(3-(aminomethyl)phenyl)-N-(3-(phenyl(propoxy)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18h::US10633345, Compound 18k::US10689346, Compound 18h::US11203574, Compound 18h::US11230530, Compound 18h::US11685721, Compound 18h	Plasma kallikrein		>75.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416765	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416765&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665753	433916679							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133262	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F3N4O2/c31-30(32,33)27-18-26(37(36-27)25-11-4-6-21(16-25)19-34)29(38)35-24-10-5-9-23(17-24)28(22-7-2-1-3-8-22)39-15-14-20-12-13-20/h1-11,16-18,20,28H,12-15,19,34H2,(H,35,38)	WCAGCVGZCBBZDT-UHFFFAOYSA-N	416766	1-(3-(aminomethyl)phenyl)-N-(3-((2-cyclopropylethoxy)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 74a::US10689346, Compound 74a::US11203574, Compound 74a::US11230530, Compound 74a::US11685721, Compound 74a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416766	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416766&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665775	433916680							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133263	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-17-24(37(36-26)23-8-3-5-20(15-23)18-33)27(38)35-22-7-4-6-21(16-22)28(39,13-12-19-10-11-19)25-9-1-2-14-34-25/h1-9,14-17,19,39H,10-13,18,33H2,(H,35,38)	BAOACYBKKSTHLE-UHFFFAOYSA-N	416767	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 45g::US10633345, Compound 45g::US10689346, Compound 45g::US11203574, Compound 45g::US11230530, Compound 45g::US11685721, Compound 45g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416767	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416767&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665639	433916681							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133264	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(=O)Nc1ccccc1)C(F)(F)F	InChI=1S/C25H20F3N5O2/c26-25(27,28)22-14-21(33(32-22)20-11-4-6-16(12-20)15-29)24(35)31-19-10-5-7-17(13-19)23(34)30-18-8-2-1-3-9-18/h1-14H,15,29H2,(H,30,34)(H,31,35)	HDBCJKHEPGEJHK-UHFFFAOYSA-N	416768	1-(3-(aminomethyl)phenyl)-N-(3-(phenylcarbamoyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 21e::US10633345, Compound 21e::US10689346, Compound 21e::US11203574, Compound 21e::US11230530, Compound 21e::US11685721, Compound 21e	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416768	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416768&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665523	433916682							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133265	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CCC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F3N4O2/c31-30(32,33)27-17-26(37(36-27)25-14-5-9-21(15-25)18-34)29(38)35-24-13-6-12-23(16-24)28(22-10-2-1-3-11-22)39-19-20-7-4-8-20/h1-3,5-6,9-17,20,28H,4,7-8,18-19,34H2,(H,35,38)	KBAGRISCOGFVJB-UHFFFAOYSA-N	416769	1-(3-(aminomethyl)phenyl)-N-(3-((cyclobutylmethoxy)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 75a::US10633345, Compound 75a::US10689346, Compound 75a::US11203574, Compound 75a::US11230530, Compound 75a::US11685721, Compound 75a	Plasma kallikrein		>75.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416769	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416769&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665761	433916683							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133266	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-16-25(37(36-26)24-8-1-4-20(14-24)17-33)27(38)35-23-7-2-5-21(15-23)28(39,12-11-19-9-10-19)22-6-3-13-34-18-22/h1-8,13-16,18-19,39H,9-12,17,33H2,(H,35,38)	AOCZEQQKIIWUBU-UHFFFAOYSA-N	416770	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 47f::US10633345, Compound 47f::US10689346, Compound 47f::US11203574, Compound 47g::US11230530, Compound 47h::US11685721, Compound 47f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416770	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416770&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355766	433916684							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133267	CCCCOC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C29H29F3N4O2/c1-2-3-15-38-27(21-10-5-4-6-11-21)22-12-8-13-23(17-22)34-28(37)25-18-26(29(30,31)32)35-36(25)24-14-7-9-20(16-24)19-33/h4-14,16-18,27H,2-3,15,19,33H2,1H3,(H,34,37)	PKUIOUWZEKKIOY-UHFFFAOYSA-N	416772	1-(3-(aminomethyl)phenyl)-N-(3-(butoxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18j::US10633345, Compound 18j::US10689346, Compound 18j::US11203574, Compound 18j::US11230530, Compound 18j::US11685721, Compound 18j	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416772	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416772&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356140	433916686							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133268	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F4N5O/c30-23-12-11-21(27(35-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27,35H,9-10,16-17,34H2,(H,36,39)	MCLZOCFEIKBMBA-UHFFFAOYSA-N	416773	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 38d::US10633345, Compound 38d::US10689346, Compound 42a::US11203574, Compound 42a::US11230530, Compound 42a::US11685721, Compound 38d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416773	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416773&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356124	433916687							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133269	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-17-25(37(36-26)24-6-1-3-20(15-24)18-33)27(38)35-23-5-2-4-22(16-23)28(39,12-9-19-7-8-19)21-10-13-34-14-11-21/h1-6,10-11,13-17,19,39H,7-9,12,18,33H2,(H,35,38)	HEXYKZQZIBBLLM-UHFFFAOYSA-N	416774	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-(pyridin-4-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 92g::US10633345, Compound 92g::US10689346, Compound 92g::US11203574, Compound 92g::US11230530, Compound 92g::US11685721, Compound 92g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416774	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416774&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355890	433916688							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133270	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F3N4O2/c30-29(31,32)26-16-25(36(35-26)24-11-4-6-20(14-24)17-33)28(37)34-23-10-5-9-22(15-23)27(38-18-19-12-13-19)21-7-2-1-3-8-21/h1-11,14-16,19,27H,12-13,17-18,33H2,(H,34,37)	PEZVPVUPSJXZCH-UHFFFAOYSA-N	416775	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18k::US10633345, Compound 74a::US10689346, Compound 165e::US11203574, Compound 165e::US11230530, Compound 165e::US11685721, Compound 18k	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416775	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416775&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			91884591	433916689							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133271	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1ccc(F)c(c1)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-24-12-11-21(14-23(24)27(39-17-18-9-10-18)20-6-2-1-3-7-20)35-28(38)25-15-26(29(31,32)33)36-37(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27H,9-10,16-17,34H2,(H,35,38)	SMAPKFCZNNYDET-UHFFFAOYSA-N	416776	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)-4-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 76h::US10633345, Compound 76h::US10689346, Compound 76h::US11203574, Compound 76h::US11230530, Compound 76h::US11685721, Compound 76h	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416776	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416776&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356199	433916690							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133272	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cn[nH]c1)C(F)(F)F			416777	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(1H-pyrazol-4-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 84h::US10633345, Compound 84h::US10689346, Compound 84h::US11203574, Compound 84h::US11230530, Compound 84h::US11685721, Compound 84h	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416777	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416777&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			154584214	433916691							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133273	CCCN(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C27H26F3N5O/c1-2-14-34(21-10-4-3-5-11-21)22-12-7-9-20(16-22)32-26(36)24-17-25(27(28,29)30)33-35(24)23-13-6-8-19(15-23)18-31/h3-13,15-17H,2,14,18,31H2,1H3,(H,32,36)	IKJCTSPODFFZCP-UHFFFAOYSA-N	416778	1-(3-(aminomethyl)phenyl)-N-(3-(phenyl(propyl)amino)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 27f::US10633345, Compound 27f::US10689346, Compound 27f::US11203574, Compound 27f::US11230530, Compound 27f::US11685721, Compound 27f	Plasma kallikrein		>75.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416778	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416778&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356135	433916692							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133274	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(C(OCC2CC2)c2ccccc2)c1F)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-26-22(27(39-17-18-12-13-18)20-7-2-1-3-8-20)10-5-11-23(26)35-28(38)24-15-25(29(31,32)33)36-37(24)21-9-4-6-19(14-21)16-34/h1-11,14-15,18,27H,12-13,16-17,34H2,(H,35,38)	OCYVMBLZCJPYSX-UHFFFAOYSA-N	416779	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 36d::US10633345, Compound 36d::US10689346, Compound 36d::US11203574, Compound 36d::US11230530, Compound 36d::US11685721, Compound 36d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416779	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416779&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356266	433916693							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133275	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1nccs1)C(F)(F)F	InChI=1S/C26H25F3N6OS/c27-26(28,29)22-13-21(35(34-22)20-6-1-3-17(11-20)14-30)24(36)33-19-5-2-4-18(12-19)23(25-31-9-10-37-25)32-15-16-7-8-16/h1-6,9-13,16,23,32H,7-8,14-15,30H2,(H,33,36)	BPCHTFOGBGFGRD-UHFFFAOYSA-N	416780	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(thiazol-2-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 85c::US10633345, Compound 85c::US10689346, Compound 85c::US11203574, Compound 85c::US11230530, Compound 85c::US11685721, Compound 85c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416780	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416780&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355975	433916694							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133276	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CCC1CC1)N1CCOCC1)C(F)(F)F	InChI=1S/C28H32F3N5O2/c29-28(30,31)26-17-25(36(34-26)23-6-1-3-20(15-23)18-32)27(37)33-22-5-2-4-21(16-22)24(10-9-19-7-8-19)35-11-13-38-14-12-35/h1-6,15-17,19,24H,7-14,18,32H2,(H,33,37)	JPSOHZUNYZMZBS-UHFFFAOYSA-N	416781	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-morpholinopropyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 93b::US10633345, Compound 93b::US10689346, Compound 93b::US11203574, Compound 93b::US11230530, Compound 93b::US11685721, Compound 93b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416781	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416781&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665612	433916695							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133277	COc1cccc(c1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O2/c1-40-25-10-4-7-22(15-25)28(35-18-19-11-12-19)21-6-3-8-23(14-21)36-29(39)26-16-27(30(31,32)33)37-38(26)24-9-2-5-20(13-24)17-34/h2-10,13-16,19,28,35H,11-12,17-18,34H2,1H3,(H,36,39)	DMSXJIPDGRICQW-UHFFFAOYSA-N	416782	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(3-methoxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 109f::US10633345, Compound 109f::US10689346, Compound 109f::US11203574, Compound 109f::US11230530, Compound 109f::US11685721, Compound 109f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416782	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416782&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356265	433916696							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133278	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc2ccccc2c1)C(F)(F)F	InChI=1S/C33H30F3N5O/c34-33(35,36)30-18-29(41(40-30)28-10-3-5-22(15-28)19-37)32(42)39-27-9-4-8-25(17-27)31(38-20-21-11-12-21)26-14-13-23-6-1-2-7-24(23)16-26/h1-10,13-18,21,31,38H,11-12,19-20,37H2,(H,39,42)	QCSULFNIDZTXJZ-UHFFFAOYSA-N	416783	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic acid {3-[(cyclopropylmethyl-amino)-naphthalen-2-yl-methyl]-phenyl}-amide::US10329260, Compound 128g::US10633345, Compound 128g::US10689346, Compound 128g::US11203574, Compound 128g::US11230530, Compound 128g::US11685721, Compound 128g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416783	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416783&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665786	433916697							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133279	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H26F4N6O/c29-22-9-8-19(26(35-15-17-6-7-17)20-4-2-10-34-16-20)12-23(22)36-27(39)24-13-25(28(30,31)32)37-38(24)21-5-1-3-18(11-21)14-33/h1-5,8-13,16-17,26,35H,6-7,14-15,33H2,(H,36,39)	SECDZDWRLPONSX-UHFFFAOYSA-N	416784	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(pyridin-3-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 94b::US10633345, Compound 94b::US10689346, Compound 94b::US11203574, Compound 94b::US11230530, Compound 94b::US11685721, Compound 94b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416784	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416784&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355774	433916698							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133280	Cc1cccc(c1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O/c1-19-5-2-7-22(13-19)28(35-18-20-11-12-20)23-8-4-9-24(15-23)36-29(39)26-16-27(30(31,32)33)37-38(26)25-10-3-6-21(14-25)17-34/h2-10,13-16,20,28,35H,11-12,17-18,34H2,1H3,(H,36,39)	ADKXWAHEFSGGQB-UHFFFAOYSA-N	416785	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(m-tolyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 110f::US10633345, Compound 110f::US10689346, Compound 110f::US11203574, Compound 110f::US11230530, Compound 110f::US11685721, Compound 110f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416785	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416785&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123875262	433916699							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133281	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc2ccccc12)C(F)(F)F	InChI=1S/C33H30F3N5O/c34-33(35,36)30-18-29(41(40-30)26-11-3-6-22(16-26)19-37)32(42)39-25-10-4-9-24(17-25)31(38-20-21-14-15-21)28-13-5-8-23-7-1-2-12-27(23)28/h1-13,16-18,21,31,38H,14-15,19-20,37H2,(H,39,42)	NFYBGLSBONMUGA-UHFFFAOYSA-N	416786	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic acid {3-[(cyclopropylmethyl-amino)-naphthalen-1-yl-methyl]-phenyl}-amide::US10329260, Compound 129f::US10633345, Compound 129f::US10689346, Compound 129f::US11203574, Compound 129f::US11230530, Compound 129f::US11685721, Compound 129f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416786	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416786&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356190	433916700							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133282	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(cc(c1)C1CC1)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C32H32F3N5O/c33-32(34,35)29-17-28(40(39-29)27-8-4-5-21(13-27)18-36)31(41)38-26-15-24(22-11-12-22)14-25(16-26)30(37-19-20-9-10-20)23-6-2-1-3-7-23/h1-8,13-17,20,22,30,37H,9-12,18-19,36H2,(H,38,41)	TXFPQXDVPCBKSX-UHFFFAOYSA-N	439372	US10633345, Compound 95i::US10689346, Compound 95i::US11203574, Compound 95i::US11230530, Compound 95i::US11685721, Compound 95i	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439372	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439372&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665927	439660930							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133283	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc(c1)C(F)(F)F)C(F)(F)F	InChI=1S/C30H27F6N5O/c31-29(32,33)22-7-2-5-20(13-22)27(38-17-18-10-11-18)21-6-3-8-23(14-21)39-28(42)25-15-26(30(34,35)36)40-41(25)24-9-1-4-19(12-24)16-37/h1-9,12-15,18,27,38H,10-11,16-17,37H2,(H,39,42)	FZSHDRVSVGSKOF-UHFFFAOYSA-N	416788	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(3-(trifluoromethyl) phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 111f::US10633345, Compound 111f::US10689346, Compound 111f::US11203574, Compound 111f::US11230530, Compound 111f::US11685721, Compound 111f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416788	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416788&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355816	433916702							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133284	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccc(N)cc1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-23-11-8-20(27(36-16-17-4-5-17)19-6-9-21(35)10-7-19)13-24(23)37-28(40)25-14-26(29(31,32)33)38-39(25)22-3-1-2-18(12-22)15-34/h1-3,6-14,17,27,36H,4-5,15-16,34-35H2,(H,37,40)	QTGVDKNDDSXZLM-UHFFFAOYSA-N	416789	1-(3-(aminomethyl)phenyl)-N-(5-((4-aminophenyl)(cyclopropylmethylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 130g::US10633345, Compound 130g::US10689346, Compound 130g::US11203574, Compound 130g::US11230530, Compound 130g::US11685721, Compound 130g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416789	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416789&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665503	433916703							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133285	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1Cl)C(NCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H26ClF3N6O/c29-22-9-8-19(26(35-15-17-6-7-17)20-4-2-10-34-16-20)12-23(22)36-27(39)24-13-25(28(30,31)32)37-38(24)21-5-1-3-18(11-21)14-33/h1-5,8-13,16-17,26,35H,6-7,14-15,33H2,(H,36,39)	DCRDGEJSCMQMFA-UHFFFAOYSA-N	416790	1-(3-(Aminomethyl)phenyl)-N-(2-chloro-5-((cyclopropylmethylamino)(pyridin-3-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 96f::US10633345, Compound 96f::US10689346, Compound 96f::US11203574, Compound 96f::US11230530, Compound 96f::US11685721, Compound 96f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416790	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416790&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355757	433916704							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133286	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(cc1)S(N)(=O)=O)C(F)(F)F	InChI=1S/C29H29F3N6O3S/c30-29(31,32)26-15-25(38(37-26)23-6-1-3-19(13-23)16-33)28(39)36-22-5-2-4-21(14-22)27(35-17-18-7-8-18)20-9-11-24(12-10-20)42(34,40)41/h1-6,9-15,18,27,35H,7-8,16-17,33H2,(H,36,39)(H2,34,40,41)	BGEXZQITRMVFRR-UHFFFAOYSA-N	416791	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(4-sulfamoylphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 112g::US10633345, Compound 112g::US10689346, Compound 112g::US11203574, Compound 112g::US11230530, Compound 112g::US11685721, Compound 112g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416791	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416791&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355780	433916705							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133287	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-23-10-9-20(27(36-16-17-7-8-17)19-4-2-5-21(35)12-19)13-24(23)37-28(40)25-14-26(29(31,32)33)38-39(25)22-6-1-3-18(11-22)15-34/h1-6,9-14,17,27,36H,7-8,15-16,34-35H2,(H,37,40)	HJMCNZIVUWWSBV-UHFFFAOYSA-N	416792	1-(3-(aminomethyl)phenyl)-N-(5-((3-aminophenyl)(cyclopropylmethylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 131b::US10633345, Compound 131b::US10689346, Compound 131b::US11203574, Compound 131b::US11230530, Compound 131b::US11685721, Compound 131b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416792	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416792&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665555	433916706							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133288	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H25F4N5O2/c29-22-9-8-19(26(39-16-17-6-7-17)20-4-2-10-34-15-20)12-23(22)35-27(38)24-13-25(28(30,31)32)36-37(24)21-5-1-3-18(11-21)14-33/h1-5,8-13,15,17,26H,6-7,14,16,33H2,(H,35,38)	CNAFOXQNPWSINI-UHFFFAOYSA-N	416794	Racemic 1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethoxy)(pyridin-3-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 48f::US10633345, Compound 48f::US10689346, Compound 48f::US11203574, Compound 48g::US11230530, Compound 48h::US11685721, Compound 48f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416794	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416794&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355617	433916708							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133289	CS(=O)(=O)c1ccc(cc1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O3S/c1-42(40,41)25-12-10-21(11-13-25)28(35-18-19-8-9-19)22-5-3-6-23(15-22)36-29(39)26-16-27(30(31,32)33)37-38(26)24-7-2-4-20(14-24)17-34/h2-7,10-16,19,28,35H,8-9,17-18,34H2,1H3,(H,36,39)	UTLDYOFVUPHYMX-UHFFFAOYSA-N	416795	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(4-(methylsulfonyl)phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 113f::US10633345, Compound 113f::US10689346, Compound 113f::US11203574, Compound 113f::US11230530, Compound 113f::US11685721, Compound 113f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416795	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416795&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355808	433916709							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133290	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C28H26F4N6O/c29-22-7-6-20(26(35-16-17-4-5-17)19-8-10-34-11-9-19)13-23(22)36-27(39)24-14-25(28(30,31)32)37-38(24)21-3-1-2-18(12-21)15-33/h1-3,6-14,17,26,35H,4-5,15-16,33H2,(H,36,39)	JHXYEKYRIWFSRY-UHFFFAOYSA-N	416796	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(pyridin-4-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 132f::US10633345, Compound 132f::US10689346, Compound 132f::US11203574, Compound 132f::US11230530, Compound 132f::US11685721, Compound 132f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416796	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416796&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665438	433916710							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133291	CN1CCc2c(C1)ccc(NC(=O)c1cc(nn1-c1cccc(CN)c1)C(F)(F)F)c2F	InChI=1S/C22H21F4N5O/c1-30-8-7-16-14(12-30)5-6-17(20(16)23)28-21(32)18-10-19(22(24,25)26)29-31(18)15-4-2-3-13(9-15)11-27/h2-6,9-10H,7-8,11-12,27H2,1H3,(H,28,32)	XRSKJTRQFAFTLA-UHFFFAOYSA-N	416797	1-(3-(aminomethyl)phenyl)-N-(5-fluoro-2-methyl-1,2,3,4-tetrahydroisoquinolin-6-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 164e::US10633345, Compound 164e::US10689346, Compound 164e::US11203574, Compound 164e::US11230530, Compound 164e::US11685721, Compound 164e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416797	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416797&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665488	433916711							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133292	CS(=O)(=O)c1cccc(c1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O3S/c1-42(40,41)25-10-4-7-22(15-25)28(35-18-19-11-12-19)21-6-3-8-23(14-21)36-29(39)26-16-27(30(31,32)33)37-38(26)24-9-2-5-20(13-24)17-34/h2-10,13-16,19,28,35H,11-12,17-18,34H2,1H3,(H,36,39)	VJYAFYNZRBTGFW-UHFFFAOYSA-N	416798	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(3-(methylsulfonyl)phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 114f::US10633345, Compound 114f::US10689346, Compound 114f::US11203574, Compound 114f::US11230530, Compound 114f::US11685721, Compound 114f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416798	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416798&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665780	433916712							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133293	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(cc1)-c1ccccc1)C(F)(F)F	InChI=1S/C35H32F3N5O/c36-35(37,38)32-20-31(43(42-32)30-11-4-6-24(18-30)21-39)34(44)41-29-10-5-9-28(19-29)33(40-22-23-12-13-23)27-16-14-26(15-17-27)25-7-2-1-3-8-25/h1-11,14-20,23,33,40H,12-13,21-22,39H2,(H,41,44)	SZCMOETVRNQDRC-UHFFFAOYSA-N	416799	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic Acid {3-[biphenyl-4-yl-(cyclopropylmethyl-amino)-methyl]-phenyl}-amide::US10329260, Compound 133g::US10633345, Compound 133g::US10689346, Compound 133g::US11203574, Compound 133g::US11230530, Compound 133g::US11685721, Compound 133g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416799	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416799&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665928	433916713							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133294	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(F)cc(c1)C(O)c1ccccc1)C(F)(F)F	InChI=1S/C25H20F4N4O2/c26-18-10-17(23(34)16-6-2-1-3-7-16)11-19(12-18)31-24(35)21-13-22(25(27,28)29)32-33(21)20-8-4-5-15(9-20)14-30/h1-13,23,34H,14,30H2,(H,31,35)	WOQUHGPQEUKGPZ-UHFFFAOYSA-N	416800	1-(3-(aminomethyl)phenyl)-N-(3-fluoro-5-(hydroxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 97f::US10633345, Compound 97f::US10689346, Compound 97f::US11203574, Compound 97f::US11230530, Compound 97f::US11685721, Compound 97f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416800	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416800&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355887	433916714							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133295	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NC(=O)C1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F3N5O2/c30-29(31,32)25-16-24(37(36-25)23-11-4-6-18(14-23)17-33)28(39)34-22-10-5-9-21(15-22)26(19-7-2-1-3-8-19)35-27(38)20-12-13-20/h1-11,14-16,20,26H,12-13,17,33H2,(H,34,39)(H,35,38)	JNPDNCCSYJLXEM-UHFFFAOYSA-N	439388	US10633345, Compound 115e::US10689346, Compound 115e::US11203574, Compound 115e::US11230530, Compound 115e::US11685721, Compound 115e	Plasma kallikrein		>75.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439388	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439388&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665512	439660946							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133296	COc1ccc2cc(ccc2c1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H32F3N5O2/c1-44-29-13-12-23-15-26(11-10-24(23)17-29)32(39-20-21-8-9-21)25-5-3-6-27(16-25)40-33(43)30-18-31(34(35,36)37)41-42(30)28-7-2-4-22(14-28)19-38/h2-7,10-18,21,32,39H,8-9,19-20,38H2,1H3,(H,40,43)	YJEVEVIVXGFKBA-UHFFFAOYSA-N	416804	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic Acid {3-[(cyclopropylmethyl-amino)-(6-methoxy-naphthalen-2-yl)-methyl]-phenyl}-amide::US10329260, Compound 134f::US10633345, Compound 134f::US10689346, Compound 134f::US11203574, Compound 134f::US11230530, Compound 134f::US11685721, Compound 134f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416804	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416804&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356181	433916718							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133297	FC(F)(F)c1cc(C(=O)Nc2cccc(c2)C(CCC2CC2)N2CCCC2)n(n1)-c1cccc(c1)C#N	InChI=1S/C28H28F3N5O/c29-28(30,31)26-17-25(36(34-26)23-8-3-5-20(15-23)18-32)27(37)33-22-7-4-6-21(16-22)24(12-11-19-9-10-19)35-13-1-2-14-35/h3-8,15-17,19,24H,1-2,9-14H2,(H,33,37)	MJYCRZLDCMJLHR-UHFFFAOYSA-N	439390	US10633345, Compound 98b::US10689346, Compound 98b::US11203574, Compound 98b::US11230530, Compound 98b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439390	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439390&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355716	439660948							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133298	CCc1cccc(c1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C31H32F3N5O/c1-2-20-6-3-8-23(14-20)29(36-19-21-12-13-21)24-9-5-10-25(16-24)37-30(40)27-17-28(31(32,33)34)38-39(27)26-11-4-7-22(15-26)18-35/h3-11,14-17,21,29,36H,2,12-13,18-19,35H2,1H3,(H,37,40)	YUWQOWXTNOVILU-UHFFFAOYSA-N	416807	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(3-ethylphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 116e::US10633345, Compound 116e::US10689346, Compound 116e::US11203574, Compound 116e::US11230530, Compound 116e::US11685721, Compound 116e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416807	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416807&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123342870	433916721							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133299	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(O)cc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-25(37(36-26)23-6-1-3-19(13-23)16-33)28(39)35-22-5-2-4-21(14-22)27(34-17-18-7-8-18)20-9-11-24(38)12-10-20/h1-6,9-15,18,27,34,38H,7-8,16-17,33H2,(H,35,39)	GDUMJZLASJIDFD-UHFFFAOYSA-N	416808	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(4-hydroxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 135c::US10633345, Compound 135c::US10689346, Compound 135c::US11203574, Compound 135c::US11230530, Compound 135c::US11685721, Compound 135c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416808	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416808&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355747	433916722							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133300	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CNC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-16-25(37(36-26)24-11-4-6-19(14-24)17-33)27(38)35-23-10-5-9-21(15-23)28(39,18-34-22-12-13-22)20-7-2-1-3-8-20/h1-11,14-16,22,34,39H,12-13,17-18,33H2,(H,35,38)	WTFGPUOPMMMRIY-UHFFFAOYSA-N	416809	1-(3-(aminomethyl)phenyl)-N-(3-(2-(cyclopropylamino)-1-hydroxy-1-phenylethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 99g::US10633345, Compound 99g::US10689346, Compound 99g::US11203574, Compound 99g::US11230530, Compound 99g::US11685721, Compound 99g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416809	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416809&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355899	433916723							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133301	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1F)C(F)(F)F	InChI=1S/C29H27F4N5O/c30-24-10-2-1-9-23(24)27(35-17-18-11-12-18)20-6-4-7-21(14-20)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-3-5-19(13-22)16-34/h1-10,13-15,18,27,35H,11-12,16-17,34H2,(H,36,39)	XNBKWIREUIHXKI-UHFFFAOYSA-N	416810	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2-fluorophenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 117e::US10329260, Compound 119e::US10633345, Compound 117e::US10689346, Compound 117e::US11203574, Compound 117e::US11230530, Compound 117e::US11685721, Compound 117e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416810	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416810&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123243852	433916724							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133302	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(Cc2ccc(O)cc2)c1)C(F)(F)F	InChI=1S/C25H21F3N4O2/c26-25(27,28)23-14-22(32(31-23)20-6-2-4-18(13-20)15-29)24(34)30-19-5-1-3-17(12-19)11-16-7-9-21(33)10-8-16/h1-10,12-14,33H,11,15,29H2,(H,30,34)	OPPQXCJMBFITBL-UHFFFAOYSA-N	416811	1-(3-(Aminomethyl)phenyl)-N-(3-(4-hydroxybenzyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 136a::US10633345, Compound 136a::US10689346, Compound 136a::US11203574, Compound 136a::US11230530, Compound 136a::US11685721, Compound 136a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416811	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416811&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356271	433916725							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133303	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C28H26F4N6O/c29-21-10-9-19(26(35-16-17-7-8-17)22-6-1-2-11-34-22)13-23(21)36-27(39)24-14-25(28(30,31)32)37-38(24)20-5-3-4-18(12-20)15-33/h1-6,9-14,17,26,35H,7-8,15-16,33H2,(H,36,39)	NHHQSQFDXMXIJU-UHFFFAOYSA-N	416812	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(pyridin-2-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 100e::US10633345, Compound 100e::US10689346, Compound 100e::US11203574, Compound 100e::US11230530, Compound 100e::US11685721, Compound 100e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416812	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416812&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356158	433916726							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133304	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1c2ccccc2c(Cl)c2ccccc12)C(F)(F)F	InChI=1S/C37H31ClF3N5O/c38-34-29-13-3-1-11-27(29)33(28-12-2-4-14-30(28)34)35(43-21-22-15-16-22)24-8-6-9-25(18-24)44-36(47)31-19-32(37(39,40)41)45-46(31)26-10-5-7-23(17-26)20-42/h1-14,17-19,22,35,43H,15-16,20-21,42H2,(H,44,47)	WNAKJZQMCRSZKD-UHFFFAOYSA-N	416813	1-(3-(aminomethyl)phenyl)-N-(3-((10-chloroanthracen-9-yl)(cyclopropylmethylamino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 118f::US10633345, Compound 118f::US10689346, Compound 118f::US11203574, Compound 118f::US11230530, Compound 118f::US11685721, Compound 118f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416813	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416813&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355872	433916727							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133305	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc(O)c1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-25(37(36-26)23-8-1-4-19(12-23)16-33)28(39)35-22-7-2-5-20(13-22)27(34-17-18-10-11-18)21-6-3-9-24(38)14-21/h1-9,12-15,18,27,34,38H,10-11,16-17,33H2,(H,35,39)	WNKOEKOISOIHSR-UHFFFAOYSA-N	416814	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(3-hydroxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 137a::US10633345, Compound 137a::US10689346, Compound 137a::US11203574, Compound 137a::US11230530, Compound 137a::US11685721, Compound 137a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416814	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416814&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355922	433916728							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133306	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1nccs1)C(F)(F)F	InChI=1S/C26H24F4N6OS/c27-19-7-6-17(23(25-32-8-9-38-25)33-14-15-4-5-15)11-20(19)34-24(37)21-12-22(26(28,29)30)35-36(21)18-3-1-2-16(10-18)13-31/h1-3,6-12,15,23,33H,4-5,13-14,31H2,(H,34,37)	FBQBHRBLNRXXHC-UHFFFAOYSA-N	416815	1-(3-(Aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(thiazol-2-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 101e::US10633345, Compound 101e::US10689346, Compound 101e::US11203574, Compound 101e::US11230530, Compound 101e::US11685721, Compound 101e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416815	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416815&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355606	433916729							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133307	COc1ccccc1C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O2/c1-40-26-11-3-2-10-24(26)28(35-18-19-12-13-19)21-7-5-8-22(15-21)36-29(39)25-16-27(30(31,32)33)37-38(25)23-9-4-6-20(14-23)17-34/h2-11,14-16,19,28,35H,12-13,17-18,34H2,1H3,(H,36,39)	DAKZTBMQWXCVFA-UHFFFAOYSA-N	439400	US10633345, Compound 119e::US10689346, Compound 119e::US11203574, Compound 119e::US11230530, Compound 119e::US11685721, Compound 120e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439400	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439400&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665475	439660958							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133308	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(Cc2cccc(O)c2)c1)C(F)(F)F	InChI=1S/C25H21F3N4O2/c26-25(27,28)23-14-22(32(31-23)20-8-2-6-18(12-20)15-29)24(34)30-19-7-1-4-16(11-19)10-17-5-3-9-21(33)13-17/h1-9,11-14,33H,10,15,29H2,(H,30,34)	SDKHQNOIRDBHTG-UHFFFAOYSA-N	416820	1-(3-(aminomethyl)phenyl)-N-(3-(3-hydroxybenzyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 137b::US10633345, Compound 137b::US10689346, Compound 137b::US11203574, Compound 137b::US11230530, Compound 137b::US11685721, Compound 137b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416820	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416820&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665628	433916733							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133309	CN(C(c1cccc(N)c1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1)C1CC1	InChI=1S/C29H29F3N6O/c1-37(23-11-12-23)27(19-6-3-8-21(34)14-19)20-7-4-9-22(15-20)35-28(39)25-16-26(29(30,31)32)36-38(25)24-10-2-5-18(13-24)17-33/h2-10,13-16,23,27H,11-12,17,33-34H2,1H3,(H,35,39)	UUQWENBOKMRZFC-UHFFFAOYSA-N	439402	US10633345, Compound 102b::US10689346, Compound 102b::US11203574, Compound 102b::US11230530, Compound 102b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439402	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439402&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665661	439660960							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133310	CC(C)c1ccc(cc1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C32H34F3N5O/c1-20(2)23-11-13-24(14-12-23)30(37-19-21-9-10-21)25-6-4-7-26(16-25)38-31(41)28-17-29(32(33,34)35)39-40(28)27-8-3-5-22(15-27)18-36/h3-8,11-17,20-21,30,37H,9-10,18-19,36H2,1-2H3,(H,38,41)	BFUXJPJTVQBLMT-UHFFFAOYSA-N	416823	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(4-isopropylphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 120e::US10633345, Compound 120e::US10689346, Compound 120e::US11203574, Compound 120e::US11230530, Compound 120e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416823	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416823&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355943	433916736							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133311	CC(=O)Nc1ccc(cc1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C31H31F3N6O2/c1-19(41)37-24-12-10-22(11-13-24)29(36-18-20-8-9-20)23-5-3-6-25(15-23)38-30(42)27-16-28(31(32,33)34)39-40(27)26-7-2-4-21(14-26)17-35/h2-7,10-16,20,29,36H,8-9,17-18,35H2,1H3,(H,37,41)(H,38,42)	JDALRNHKHTYPON-UHFFFAOYSA-N	416827	N-(3-((4-acetamidophenyl)(cyclopropylmethylamino)methyl)phenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 138f::US10633345, Compound 138f::US10689346, Compound 138f::US11203574, Compound 138f::US11230530, Compound 138f::US11685721, Compound 138f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416827	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416827&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355810	433916740							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133312	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CCC1CC1)c1cc[nH]c1)C(F)(F)F			416828	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-(1H-pyrrol-3-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 103b::US10633345, Compound 103b::US10689346, Compound 103b::US11203574, Compound 103b::US11230530, Compound 103b::US11685721, Compound 103b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416828	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416828&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355898	433916741							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133313	Cc1ccc(cc1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O/c1-19-8-12-22(13-9-19)28(35-18-20-10-11-20)23-5-3-6-24(15-23)36-29(39)26-16-27(30(31,32)33)37-38(26)25-7-2-4-21(14-25)17-34/h2-9,12-16,20,28,35H,10-11,17-18,34H2,1H3,(H,36,39)	HRCLMMKOPKWJGF-UHFFFAOYSA-N	416829	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(p-tolyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 122g::US10633345, Compound 122g::US10689346, Compound 122g::US11203574, Compound 122g::US11230530, Compound 122g::US11685721, Compound 122g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416829	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416829&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355867	433916742							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133314	CN(C(c1ccc(cc1)C#N)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1)C1CC1	InChI=1S/C30H26F4N6O/c1-39(22-10-11-22)28(20-7-5-18(16-35)6-8-20)21-9-12-24(31)25(14-21)37-29(41)26-15-27(30(32,33)34)38-40(26)23-4-2-3-19(13-23)17-36/h2-9,12-15,22,28H,10-11,17,36H2,1H3,(H,37,41)	BZIYYSLZWQNWBF-UHFFFAOYSA-N	439407	US10633345, Compound 52h::US10633345, Compound 71a::US10633345, Compound 71b::US10689346, Compound 71b::US11203574, Compound 71a::US11230530, Compound 71b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439407	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439407&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355581	439660965							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133315	Cn1cc(cn1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C27H28F3N7O/c1-36-16-20(15-33-36)25(32-14-17-8-9-17)19-5-3-6-21(11-19)34-26(38)23-12-24(27(28,29)30)35-37(23)22-7-2-4-18(10-22)13-31/h2-7,10-12,15-17,25,32H,8-9,13-14,31H2,1H3,(H,34,38)	GHANDLPUFXRHQK-UHFFFAOYSA-N	416831	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(1-methyl-1H-pyrazol-4-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 104f::US10633345, Compound 104f::US10689346, Compound 104f::US11203574, Compound 104f::US11230530, Compound 104f::US11685721, Compound 104f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416831	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416831&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356100	433916744							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133316	CS(=O)(=O)c1ccccc1C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O3S/c1-42(40,41)26-11-3-2-10-24(26)28(35-18-19-12-13-19)21-7-5-8-22(15-21)36-29(39)25-16-27(30(31,32)33)37-38(25)23-9-4-6-20(14-23)17-34/h2-11,14-16,19,28,35H,12-13,17-18,34H2,1H3,(H,36,39)	XEAXHMDONDJJBQ-UHFFFAOYSA-N	416832	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2-(methylsulfonyl)phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 121f::US10633345, Compound 121f::US10689346, Compound 121f::US11203574, Compound 121f::US11230530, Compound 121f::US11685721, Compound 121f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416832	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416832&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665701	433916745							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133317	CN(C(c1ccc(CN)cc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1)C1CC1	InChI=1S/C30H30F4N6O/c1-39(22-10-11-22)28(20-7-5-18(16-35)6-8-20)21-9-12-24(31)25(14-21)37-29(41)26-15-27(30(32,33)34)38-40(26)23-4-2-3-19(13-23)17-36/h2-9,12-15,22,28H,10-11,16-17,35-36H2,1H3,(H,37,41)	REFXZSDKKDUEPN-UHFFFAOYSA-N	439410	US10633345, Compound 139b::US10689346, Compound 139b::US11203574, Compound 139b::US11230530, Compound 139b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439410	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439410&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665496	439660968							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116224	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1ncc(C)c(OC)c1C	InChI=1S/C28H31N5O4/c1-19-13-29-24(20(2)27(19)37-4)14-30-28(35)23-17-33(31-25(23)18-36-3)16-22-10-8-21(9-11-22)15-32-12-6-5-7-26(32)34/h5-13,17H,14-16,18H2,1-4H3,(H,30,35)	GQIPLMKRGZCNHM-UHFFFAOYSA-N	528088	N-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[(2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US11180484, Example 11	Plasma kallikrein			 35.0							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528088	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528088&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301865	463791642							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116228	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1ncccc1C#N	InChI=1S/C26H24N6O3/c1-35-18-24-22(26(34)29-14-23-21(13-27)5-4-11-28-23)17-32(30-24)16-20-9-7-19(8-10-20)15-31-12-3-2-6-25(31)33/h2-12,17H,14-16,18H2,1H3,(H,29,34)	CXNMCPFLYVYHGI-UHFFFAOYSA-N	528090	N-[(3-cyanopyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US11180484, Example 13	Plasma kallikrein			 2952							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528090	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528090&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301816	463791644							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116232	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1ncc(Cl)cc1C#N	InChI=1S/C26H23ClN6O3/c1-36-17-24-22(26(35)30-13-23-20(11-28)10-21(27)12-29-23)16-33(31-24)15-19-7-5-18(6-8-19)14-32-9-3-2-4-25(32)34/h2-10,12,16H,13-15,17H2,1H3,(H,30,35)	DLOVVYIYYDQZJE-UHFFFAOYSA-N	528091	N-[(5-chloro-3-cyanopyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US11180484, Example 16	Plasma kallikrein			 187							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528091	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528091&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301878	463791645							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116236	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1ncc(Cl)cc1F	InChI=1S/C25H23ClFN5O3/c1-35-16-23-20(25(34)29-12-22-21(27)10-19(26)11-28-22)15-32(30-23)14-18-7-5-17(6-8-18)13-31-9-3-2-4-24(31)33/h2-11,15H,12-14,16H2,1H3,(H,29,34)	ZGVHOERMFFOQEE-UHFFFAOYSA-N	528092	N-[(5-chloro-3-fluoropyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US11180484, Example 17	Plasma kallikrein			 143							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528092	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528092&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301867	463791646							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116240	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(OC)c(C)cn1	InChI=1S/C27H29N5O4/c1-19-13-28-22(12-25(19)36-3)14-29-27(34)23-17-32(30-24(23)18-35-2)16-21-9-7-20(8-10-21)15-31-11-5-4-6-26(31)33/h4-13,17H,14-16,18H2,1-3H3,(H,29,34)	SSHUXJONDGHEDC-UHFFFAOYSA-N	528093	N-[(4-methoxy-5-methylpyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[(2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US11180484, Example 20	Plasma kallikrein			 3223							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528093	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528093&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301887	463791647							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116244	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1nccc(OC)c1C	InChI=1S/C27H29N5O4/c1-19-23(28-12-11-25(19)36-3)14-29-27(34)22-17-32(30-24(22)18-35-2)16-21-9-7-20(8-10-21)15-31-13-5-4-6-26(31)33/h4-13,17H,14-16,18H2,1-3H3,(H,29,34)	BUIQZUSRWDPBSM-UHFFFAOYSA-N	528094	N-[(4-methoxy-3-methylpyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[(2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US11180484, Example 22	Plasma kallikrein			 4.90							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528094	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528094&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301877	463791648							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116248	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1ncc(F)cc1F	InChI=1S/C25H23F2N5O3/c1-35-16-23-20(25(34)29-12-22-21(27)10-19(26)11-28-22)15-32(30-23)14-18-7-5-17(6-8-18)13-31-9-3-2-4-24(31)33/h2-11,15H,12-14,16H2,1H3,(H,29,34)	LBBWYBIVLDSOSM-UHFFFAOYSA-N	528095	N-[(3,5-difluoropyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US11180484, Example 26	Plasma kallikrein			 1760							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528095	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528095&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301863	463791649							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116252	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1nc(C)ccc1F	InChI=1S/C26H26FN5O3/c1-18-6-11-22(27)23(29-18)13-28-26(34)21-16-32(30-24(21)17-35-2)15-20-9-7-19(8-10-20)14-31-12-4-3-5-25(31)33/h3-12,16H,13-15,17H2,1-2H3,(H,28,34)	NFELVQQHZHAYGB-UHFFFAOYSA-N	528096	N-[(3-fluoro-6-methylpyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US11180484, Example 27	Plasma kallikrein			 775							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528096	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528096&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301864	463791650							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116256	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1nccc(C)c1F	InChI=1S/C26H26FN5O3/c1-18-10-11-28-22(25(18)27)13-29-26(34)21-16-32(30-23(21)17-35-2)15-20-8-6-19(7-9-20)14-31-12-4-3-5-24(31)33/h3-12,16H,13-15,17H2,1-2H3,(H,29,34)	KORWPMHMESLCMI-UHFFFAOYSA-N	528097	N-[(3-fluoro-4-methylpyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US11180484, Example 28	Plasma kallikrein			 163							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528097	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528097&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301835	463791651							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116260	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1nccc(C)c1Cl	InChI=1S/C26H26ClN5O3/c1-18-10-11-28-22(25(18)27)13-29-26(34)21-16-32(30-23(21)17-35-2)15-20-8-6-19(7-9-20)14-31-12-4-3-5-24(31)33/h3-12,16H,13-15,17H2,1-2H3,(H,29,34)	JGKXIESKLZBKHM-UHFFFAOYSA-N	528098	N-[(3-chloro-4-methylpyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US11180484, Example 29	Plasma kallikrein			 217							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528098	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528098&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301866	463791652							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116264	COCc1nn(Cc2ccc(Cn3cc(F)ccc3=O)cc2)cc1C(=O)NCc1nccc(OC)c1F	InChI=1S/C26H25F2N5O4/c1-36-16-22-20(26(35)30-11-21-25(28)23(37-2)9-10-29-21)15-33(31-22)13-18-5-3-17(4-6-18)12-32-14-19(27)7-8-24(32)34/h3-10,14-15H,11-13,16H2,1-2H3,(H,30,35)	ZRUFVDPYHLTYPD-UHFFFAOYSA-N	528099	1-({4-[(5-fluoro-2-oxopyridin-1-yl)methyl]phenyl}methyl)-N-[(3-fluoro-4- methoxypyridin-2-yl)methyl]-3-(methoxymethyl)pyrazole-4-carboxamide::US11180484, Example 30::US11584735, Compound of Formula A	Plasma kallikrein			 6.70							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528099	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528099&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301832	463791653							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116268	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(OC)n(C)n1	InChI=1S/C25H28N6O4/c1-29-24(35-3)12-20(27-29)13-26-25(33)21-16-31(28-22(21)17-34-2)15-19-9-7-18(8-10-19)14-30-11-5-4-6-23(30)32/h4-12,16H,13-15,17H2,1-3H3,(H,26,33)	AKTSEYYIYFHXQV-UHFFFAOYSA-N	528100	N-[(5-methoxy-1-methylpyrazol-3-yl)methyl]-3-(methoxymethyl)-1-({4-[(2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US11180484, Example 31	Plasma kallikrein			 462							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528100	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528100&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301821	463791654							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116272	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1nn(C)cc1Cl	InChI=1S/C24H25ClN6O3/c1-29-15-20(25)21(27-29)11-26-24(33)19-14-31(28-22(19)16-34-2)13-18-8-6-17(7-9-18)12-30-10-4-3-5-23(30)32/h3-10,14-15H,11-13,16H2,1-2H3,(H,26,33)	ABMBBXRKNLCOIT-UHFFFAOYSA-N	528101	N-[(4-chloro-1-methylpyrazol-3-yl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin- 1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US11180484, Example 34	Plasma kallikrein			 709							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528101	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528101&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301830	463791655							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116275	COc1ccc(F)c(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2N)c1F	InChI=1S/C25H23F2N5O3/c1-35-21-10-9-20(26)18(23(21)27)12-29-25(34)19-15-32(30-24(19)28)14-17-7-5-16(6-8-17)13-31-11-3-2-4-22(31)33/h2-11,15H,12-14H2,1H3,(H2,28,30)(H,29,34)	YPEAKNASZHJRPG-UHFFFAOYSA-N	528102	3-amino-N-[(2,6-difluoro-3-methoxyphenyl)methyl]-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US11180484, Example 35	Plasma kallikrein			 1.70							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528102	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528102&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365126	463791656							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116279	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(OC)ccc1C#N	InChI=1S/C28H27N5O4/c1-36-19-26-25(28(35)30-15-23-13-24(37-2)11-10-22(23)14-29)18-33(31-26)17-21-8-6-20(7-9-21)16-32-12-4-3-5-27(32)34/h3-13,18H,15-17,19H2,1-2H3,(H,30,35)	JWIURRVFGQJOEK-UHFFFAOYSA-N	528103	N-[(2-cyano-5-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US11180484, Example 37	Plasma kallikrein			 283							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528103	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528103&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365064	463791657							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116283	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cccc(OC)c1C#N	InChI=1S/C28H27N5O4/c1-36-19-25-24(28(35)30-15-22-6-5-7-26(37-2)23(22)14-29)18-33(31-25)17-21-11-9-20(10-12-21)16-32-13-4-3-8-27(32)34/h3-13,18H,15-17,19H2,1-2H3,(H,30,35)	YBWZNXCRUYMFTB-UHFFFAOYSA-N	528104	N-[(2-cyano-3-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US11180484, Example 38	Plasma kallikrein			 301							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528104	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528104&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301848	463791658							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116287	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cnnn1	InChI=1S/C28H27FN8O4/c1-40-17-23-22(28(39)30-13-21-24(37-18-31-33-34-37)10-11-25(41-2)27(21)29)16-36(32-23)15-20-8-6-19(7-9-20)14-35-12-4-3-5-26(35)38/h3-12,16,18H,13-15,17H2,1-2H3,(H,30,39)	CQJUCEDANVNSLY-UHFFFAOYSA-N	528105	N-{[2-fluoro-3-methoxy-6-(1,2,3,4-tetrazol-1-yl)phenyl]methyl}-3-(methoxymethyl)- 1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US11180484, Example 39	Plasma kallikrein			 0.600							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528105	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528105&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301841	463791659							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116291	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(OC)ccc1-n1cnnn1	InChI=1S/C28H28N8O4/c1-39-18-25-24(28(38)29-14-22-13-23(40-2)10-11-26(22)36-19-30-32-33-36)17-35(31-25)16-21-8-6-20(7-9-21)15-34-12-4-3-5-27(34)37/h3-13,17,19H,14-16,18H2,1-2H3,(H,29,38)	GOOYDEXCZNZXML-UHFFFAOYSA-N	528106	N-{[5-methoxy-2-(1,2,3,4-tetrazol-1-yl)phenyl]methyl}-3-(methoxymethyl)-1-({4-[(2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US11180484, Example 40	Plasma kallikrein			 0.400							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528106	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528106&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			132190788	463791660							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116295	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(OC)ccc1C	InChI=1S/C28H30N4O4/c1-20-7-12-24(36-3)14-23(20)15-29-28(34)25-18-32(30-26(25)19-35-2)17-22-10-8-21(9-11-22)16-31-13-5-4-6-27(31)33/h4-14,18H,15-17,19H2,1-3H3,(H,29,34)	IYZKNUPIGJTMIO-UHFFFAOYSA-N	528107	N-[(5-methoxy-2-methylphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US11180484, Example 41	Plasma kallikrein			 149							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528107	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528107&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301810	463791661							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133318	COc1ccc(cc1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O2/c1-40-25-12-10-21(11-13-25)28(35-18-19-8-9-19)22-5-3-6-23(15-22)36-29(39)26-16-27(30(31,32)33)37-38(26)24-7-2-4-20(14-24)17-34/h2-7,10-16,19,28,35H,8-9,17-18,34H2,1H3,(H,36,39)	NTRWDZUFVXMYGD-UHFFFAOYSA-N	416834	1-(3-(Aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(4-methoxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 105g::US10633345, Compound 105g::US10689346, Compound 105g::US11203574, Compound 105g::US11230530, Compound 105g::US11685721, Compound 105g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416834	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416834&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665521	433916747							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133319	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(OCc2ccccc2)cc1)C(F)(F)F	InChI=1S/C36H34F3N5O2/c37-36(38,39)33-20-32(44(43-33)30-11-4-8-26(18-30)21-40)35(45)42-29-10-5-9-28(19-29)34(41-22-24-12-13-24)27-14-16-31(17-15-27)46-23-25-6-2-1-3-7-25/h1-11,14-20,24,34,41H,12-13,21-23,40H2,(H,42,45)	AKMGFHNAHQDIKU-UHFFFAOYSA-N	439412	US10633345, Compound 123g::US10689346, Compound 123g::US11203574, Compound 123g::US11230530, Compound 123g::US11685721, Compound 107f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439412	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439412&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665739	439660970							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133320	Cc1cccc(c1)C(NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H29F4N5O/c1-18-4-2-6-21(12-18)28(36-17-19-8-9-19)22-10-11-24(31)25(14-22)37-29(40)26-15-27(30(32,33)34)38-39(26)23-7-3-5-20(13-23)16-35/h2-7,10-15,19,28,36H,8-9,16-17,35H2,1H3,(H,37,40)	DWXIBXKRESUYFO-UHFFFAOYSA-N	416836	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(m-tolyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 140e::US10633345, Compound 140e::US10689346, Compound 140e::US11203574, Compound 140e::US11230530, Compound 140e::US11685721, Compound 140e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416836	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416836&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356147	433916749							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133321	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1O)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-24(37(36-26)22-8-3-5-19(13-22)16-33)28(39)35-21-7-4-6-20(14-21)27(34-17-18-11-12-18)23-9-1-2-10-25(23)38/h1-10,13-15,18,27,34,38H,11-12,16-17,33H2,(H,35,39)	PCNDJIQOMLHSEK-UHFFFAOYSA-N	416837	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2-hydroxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 49h::US10633345, Compound 49h::US10689346, Compound 49h::US11203574, Compound 49j::US11230530, Compound 49j::US11685721, Compound 49h	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416837	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416837&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355733	433916750							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133322	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc(OC(F)(F)F)c1)C(F)(F)F	InChI=1S/C30H27F6N5O2/c31-29(32,33)26-15-25(41(40-26)23-8-1-4-19(12-23)16-37)28(42)39-22-7-2-5-20(13-22)27(38-17-18-10-11-18)21-6-3-9-24(14-21)43-30(34,35)36/h1-9,12-15,18,27,38H,10-11,16-17,37H2,(H,39,42)	IVEYKJBEIIJLCR-UHFFFAOYSA-N	416838	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(3-(trifluoromethoxy) phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 124f::US10633345, Compound 124f::US10689346, Compound 124f::US11203574, Compound 124f::US11230530, Compound 124f::US11685721, Compound 124f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416838	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416838&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665809	433916751							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133323	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C1OC(=O)Nc2ccccc12)C(F)(F)F	InChI=1S/C26H20F3N5O3/c27-26(28,29)22-13-21(34(33-22)18-8-3-5-15(11-18)14-30)24(35)31-17-7-4-6-16(12-17)23-19-9-1-2-10-20(19)32-25(36)37-23/h1-13,23H,14,30H2,(H,31,35)(H,32,36)	LRCHTKOMIAYQHX-UHFFFAOYSA-N	416839	1-(3-(aminomethyl)phenyl)-N-(3-(2-oxo-2,4-dihydro-1H-benzo[d][1,3]oxazin-4-yl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 167f::US10633345, Compound 167f::US10689346, Compound 167f::US11203574, Compound 167f::US11230530, Compound 167f::US11685721, Compound 167f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416839	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416839&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665868	433916752							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133324	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1OCc1ccccc1)C(F)(F)F	InChI=1S/C36H34F3N5O2/c37-36(38,39)33-20-31(44(43-33)29-13-6-10-26(18-29)21-40)35(45)42-28-12-7-11-27(19-28)34(41-22-24-16-17-24)30-14-4-5-15-32(30)46-23-25-8-2-1-3-9-25/h1-15,18-20,24,34,41H,16-17,21-23,40H2,(H,42,45)	XAZZTVOUWUHFIG-UHFFFAOYSA-N	416840	1-(3-(aminomethyl)phenyl)-N-(3-((2-(benzyloxy)phenyl)(cyclopropylmethyl amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 106a::US10633345, Compound 106a::US10689346, Compound 106a::US11203574, Compound 106a::US11230530, Compound 106a::US11685721, Compound 106a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416840	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416840&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356273	433916753							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133325	COc1ccc2ccccc2c1C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H32F3N5O2/c1-44-29-15-14-23-7-2-3-11-27(23)31(29)32(39-20-21-12-13-21)24-8-5-9-25(17-24)40-33(43)28-18-30(34(35,36)37)41-42(28)26-10-4-6-22(16-26)19-38/h2-11,14-18,21,32,39H,12-13,19-20,38H2,1H3,(H,40,43)	XVOUQCJHWNZPKF-UHFFFAOYSA-N	416841	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2-methoxynaphthalen-1-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 51f::US10633345, Compound 51f::US10689346, Compound 51f::US11203574, Compound 51h::US11230530, Compound 51h::US11685721, Compound 51f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416841	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416841&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356155	433916754							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133326	COc1cccc(c1)C(NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H29F4N5O2/c1-41-23-7-3-5-20(13-23)28(36-17-18-8-9-18)21-10-11-24(31)25(14-21)37-29(40)26-15-27(30(32,33)34)38-39(26)22-6-2-4-19(12-22)16-35/h2-7,10-15,18,28,36H,8-9,16-17,35H2,1H3,(H,37,40)	MRNMVRANILFBMK-UHFFFAOYSA-N	416842	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(3-methoxyphenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 141e::US10633345, Compound 141e::US10689346, Compound 141e::US11203574, Compound 141e::US11230530, Compound 141e::US11685721, Compound 142f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416842	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416842&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355803	433916755							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133327	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(N)cc1)C(F)(F)F	InChI=1S/C29H29F3N6O/c30-29(31,32)26-15-25(38(37-26)24-6-1-3-19(13-24)16-33)28(39)36-23-5-2-4-21(14-23)27(35-17-18-7-8-18)20-9-11-22(34)12-10-20/h1-6,9-15,18,27,35H,7-8,16-17,33-34H2,(H,36,39)	XDCYYWMSVYTRMZ-UHFFFAOYSA-N	416843	1-(3-(aminomethyl)phenyl)-N-(3-((4-aminophenyl)(cyclopropylmethyl-amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 50f::US10633345, Compound 50f::US10689346, Compound 50h::US11203574, Compound 50h::US11230530, Compound 50h::US11685721, Compound 50f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416843	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416843&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355587	433916756							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133328	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cc2ccccc2c2ccccc12)C(F)(F)F	InChI=1S/C37H32F3N5O/c38-37(39,40)34-20-33(45(44-34)28-11-5-7-24(17-28)21-41)36(46)43-27-10-6-9-26(18-27)35(42-22-23-15-16-23)32-19-25-8-1-2-12-29(25)30-13-3-4-14-31(30)32/h1-14,17-20,23,35,42H,15-16,21-22,41H2,(H,43,46)	OZXXGJIBGVGMMV-UHFFFAOYSA-N	416844	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic acid {3-[(cyclopropylmethyl-amino)-phenanthren-9-yl-methyl]-phenyl}-amide::US10329260, Compound 125g::US10633345, Compound 125g::US10689346, Compound 125g::US11203574, Compound 125g::US11230530, Compound 125g::US11685721, Compound 125g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416844	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416844&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665609	433916757							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133329	COc1ccc(cc1)C(NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H29F4N5O2/c1-41-23-10-7-20(8-11-23)28(36-17-18-5-6-18)21-9-12-24(31)25(14-21)37-29(40)26-15-27(30(32,33)34)38-39(26)22-4-2-3-19(13-22)16-35/h2-4,7-15,18,28,36H,5-6,16-17,35H2,1H3,(H,37,40)	GWNRXEFJAQDBCM-UHFFFAOYSA-N	416845	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(4-methoxyphenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 142f::US10633345, Compound 142f::US10689346, Compound 142f::US11203574, Compound 142f::US11230530, Compound 142f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416845	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416845&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355909	433916758							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133330	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc(OCc2ccccc2)c1)C(F)(F)F	InChI=1S/C36H34F3N5O2/c37-36(38,39)33-20-32(44(43-33)30-13-4-9-26(17-30)21-40)35(45)42-29-12-5-10-27(18-29)34(41-22-24-15-16-24)28-11-6-14-31(19-28)46-23-25-7-2-1-3-8-25/h1-14,17-20,24,34,41H,15-16,21-23,40H2,(H,42,45)	VWRITWGTGWRWCP-UHFFFAOYSA-N	439423	US10633345, Compound 107f::US11203574, Compound 107f::US11230530, Compound 107f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439423	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439423&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665642	439660981							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133331	CN(C)c1ccc(C(NCC2CC2)c2cccc(NC(=O)c3cc(nn3-c3cccc(CN)c3)C(F)(F)F)c2)c2ccccc12	InChI=1S/C35H35F3N6O/c1-43(2)30-16-15-29(27-11-3-4-12-28(27)30)33(40-21-22-13-14-22)24-8-6-9-25(18-24)41-34(45)31-19-32(35(36,37)38)42-44(31)26-10-5-7-23(17-26)20-39/h3-12,15-19,22,33,40H,13-14,20-21,39H2,1-2H3,(H,41,45)	IQAVMSNXUBZMCB-UHFFFAOYSA-N	416847	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic acid {3-[(cyclopropylmethyl-amino)-(4-dimethylamino-naphthalen-1-yl)-methyl]-phenyl}-amide::US10329260, Compound 126g::US10633345, Compound 126g::US10689346, Compound 126g::US11203574, Compound 126g::US11230530, Compound 126g::US11685721, Compound 126g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416847	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416847&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355601	433916760							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133332	Cc1cc(C(=O)Nc2cccc(c2)C(NCC2CC2)c2ccccc2)n(n1)-c1cccc(CN)c1	InChI=1S/C29H31N5O/c1-20-15-27(34(33-20)26-12-5-7-22(16-26)18-30)29(35)32-25-11-6-10-24(17-25)28(31-19-21-13-14-21)23-8-3-2-4-9-23/h2-12,15-17,21,28,31H,13-14,18-19,30H2,1H3,(H,32,35)	GPDBDHGXUBYWPY-UHFFFAOYSA-N	416848	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(phenyl)methyl)phenyl)-3-methyl-1H-pyrazole-5-carboxamid::US10329260, Compound 143l::US10633345, Compound 143l::US10689346, Compound 143l::US11203574, Compound 143l::US11230530, Compound 143l::US11685721, Compound 143l	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416848	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416848&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356139	433916761							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133333	NCc1cccc(c1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H31F3N6O/c31-30(32,33)27-15-26(39(38-27)25-9-2-5-21(13-25)17-35)29(40)37-24-8-3-7-23(14-24)28(36-18-19-10-11-19)22-6-1-4-20(12-22)16-34/h1-9,12-15,19,28,36H,10-11,16-18,34-35H2,(H,37,40)	CBXMVQRWSKIMMQ-UHFFFAOYSA-N	439426	US10633345, Compound 108e::US10689346, Compound 108e::US11203574, Compound 108e::US11230530, Compound 108e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439426	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439426&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665469	439660984							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133334	CCCOc1ccc(cc1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C32H34F3N5O2/c1-2-15-42-27-13-11-23(12-14-27)30(37-20-21-9-10-21)24-6-4-7-25(17-24)38-31(41)28-18-29(32(33,34)35)39-40(28)26-8-3-5-22(16-26)19-36/h3-8,11-14,16-18,21,30,37H,2,9-10,15,19-20,36H2,1H3,(H,38,41)	BSIABEDKJHMBRX-UHFFFAOYSA-N	416850	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic acid {3-[(cyclopropylmethyl-amino)-(4-propoxy-phenyl)-methyl]-phenyl}-amide::US10329260, Compound 127f::US10633345, Compound 127f::US10689346, Compound 127f::US11203574, Compound 127f::US11230530, Compound 127f::US11685721, Compound 127f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416850	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416850&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356061	433916763							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133335	CC(C)NC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C28H28F3N5O/c1-18(2)33-26(20-9-4-3-5-10-20)21-11-7-12-22(15-21)34-27(37)24-16-25(28(29,30)31)35-36(24)23-13-6-8-19(14-23)17-32/h3-16,18,26,33H,17,32H2,1-2H3,(H,34,37)	XNDGACONQUBLGK-UHFFFAOYSA-N	416851	1-(3-(Aminomethyl)phenyl)-N-(3-((isopropylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 144d::US10633345, Compound 144d::US10689346, Compound 144d::US11203574, Compound 144d::US11230530, Compound 144d::US11685721, Compound 144d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416851	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416851&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355596	433916764							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133336	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCCO)c1ccccc1)C(F)(F)F	InChI=1S/C27H26F3N5O2/c28-27(29,30)24-16-23(35(34-24)22-11-4-6-18(14-22)17-31)26(37)33-21-10-5-9-20(15-21)25(32-12-13-36)19-7-2-1-3-8-19/h1-11,14-16,25,32,36H,12-13,17,31H2,(H,33,37)	MMNKSYPQOFLCSY-UHFFFAOYSA-N	416852	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic acid {3-[(2-hydroxy-ethylamino)-phenyl-methyl]-phenyl}-amide::US10329260, Compound 145c::US10633345, Compound 145c::US10689346, Compound 145c::US11203574, Compound 145c::US11230530, Compound 145c::US11685721, Compound 145c	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416852	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416852&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123569320	433916765							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133337	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-10-9-20(27(40-16-17-7-8-17)19-4-2-5-21(35)12-19)13-24(23)36-28(39)25-14-26(29(31,32)33)37-38(25)22-6-1-3-18(11-22)15-34/h1-6,9-14,17,27H,7-8,15-16,34-35H2,(H,36,39)	GBDDXSAKQKODCG-UHFFFAOYSA-N	416853	1-(3-(aminomethyl)phenyl)-N-(5-((3-aminophenyl)(cyclopropylmethoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 57e::US10633345, Compound 65b::US10689346, Compound 65b::US11203574, Compound 65a::US11230530, Compound 65b::US11685721, Compound 57e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416853	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416853&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355865	433916766							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133338	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(N[C@H]1CC[C@H](O)CC1)c1ccccc1)C(F)(F)F	InChI=1S/C31H32F3N5O2/c32-31(33,34)28-18-27(39(38-28)25-11-4-6-20(16-25)19-35)30(41)37-24-10-5-9-22(17-24)29(21-7-2-1-3-8-21)36-23-12-14-26(40)15-13-23/h1-11,16-18,23,26,29,36,40H,12-15,19,35H2,(H,37,41)/t23-,26-,29?	QCYULPRIJNBHAA-APJPSQSRSA-N	416854	1-(3-(Aminomethyl)phenyl)-N-(3-((((trans)-4-hydroxycyclohexyl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 181b::US10633345, Compound 181b::US10689346, Compound 181b::US11203574, Compound 181b::US11230530, Compound 181b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416854	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416854&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665446	433916767							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133339	Cc1cc(C(=O)Nc2cccc(c2)C(NCC2CC2)c2cc(O)ccc2O)n(n1)-c1cccc(CN)c1	InChI=1S/C29H31N5O3/c1-18-12-26(34(33-18)23-7-2-4-20(13-23)16-30)29(37)32-22-6-3-5-21(14-22)28(31-17-19-8-9-19)25-15-24(35)10-11-27(25)36/h2-7,10-15,19,28,31,35-36H,8-9,16-17,30H2,1H3,(H,32,37)	LPEUWRVJEWZQCO-UHFFFAOYSA-N	416855	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2,5-dihydroxyphenyl)methyl) phenyl)-3-methyl-1H-pyrazole-5-carboxamide::US10329260, Compound 146g::US10633345, Compound 146g::US10689346, Compound 146g::US11203574, Compound 146g::US11230530, Compound 146g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416855	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416855&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356064	433916768							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133340	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1O)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-11-10-19(27(35-16-17-8-9-17)21-6-1-2-7-25(21)39)13-23(22)36-28(40)24-14-26(29(31,32)33)37-38(24)20-5-3-4-18(12-20)15-34/h1-7,10-14,17,27,35,39H,8-9,15-16,34H2,(H,36,40)	CKWWRAGQIQAYTL-UHFFFAOYSA-N	416856	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(2-hydroxyphenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 60e::US10633345, Compound 66b::US10689346, Compound 60e::US11203574, Compound 66b::US11230530, Compound 66b::US11685721, Compound 60e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416856	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416856&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665480	433916769							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133341	CC(O)CNC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C28H28F3N5O2/c1-18(37)17-33-26(20-8-3-2-4-9-20)21-10-6-11-22(14-21)34-27(38)24-15-25(28(29,30)31)35-36(24)23-12-5-7-19(13-23)16-32/h2-15,18,26,33,37H,16-17,32H2,1H3,(H,34,38)	XWEXCUNXVFBKNX-UHFFFAOYSA-N	416857	1-(3-(aminomethyl)phenyl)-N-(3-(((2-hydroxypropyl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 182b::US10633345, Compound 182b::US10689346, Compound 182b::US11203574, Compound 182b::US11230530, Compound 182b::US11685721, Compound 182b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416857	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416857&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355690	433916770							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133342	CC(=O)Nc1ccc(cc1)C(OCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C31H30F3N5O3/c1-19(40)36-24-12-10-22(11-13-24)29(42-18-20-8-9-20)23-5-3-6-25(15-23)37-30(41)27-16-28(31(32,33)34)38-39(27)26-7-2-4-21(14-26)17-35/h2-7,10-16,20,29H,8-9,17-18,35H2,1H3,(H,36,40)(H,37,41)	AETJNKBVQDZIDV-UHFFFAOYSA-N	416858	N-(3-((4-acetamidophenyl)(cyclopropylmethoxy)methyl)phenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 147e::US10633345, Compound 147e::US10689346, Compound 147e::US11203574, Compound 147e::US11230530, Compound 147e::US11685721, Compound 147e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416858	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416858&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355828	433916771							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133343	CN(C(c1ccc(cc1)C#N)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1)C1CC1	InChI=1S/C30H26F4N6O/c1-39(22-10-11-22)28(20-7-5-18(16-35)6-8-20)21-9-12-24(31)25(14-21)37-29(41)26-15-27(30(32,33)34)38-40(26)23-4-2-3-19(13-23)17-36/h2-9,12-15,22,28H,10-11,17,36H2,1H3,(H,37,41)	BZIYYSLZWQNWBF-UHFFFAOYSA-N	439407	US10633345, Compound 52h::US10633345, Compound 71a::US10633345, Compound 71b::US10689346, Compound 71b::US11203574, Compound 71a::US11230530, Compound 71b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439407	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439407&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355581	439660965							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133344	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCCCn1ccnc1)c1ccccc1)C(F)(F)F	InChI=1S/C31H30F3N7O/c32-31(33,34)28-19-27(41(39-28)26-12-4-7-22(17-26)20-35)30(42)38-25-11-5-10-24(18-25)29(23-8-2-1-3-9-23)37-13-6-15-40-16-14-36-21-40/h1-5,7-12,14,16-19,21,29,37H,6,13,15,20,35H2,(H,38,42)	XJDJXHWYZLFIJY-UHFFFAOYSA-N	416860	N-(3-(((3-(1H-Imidazol-1-yl)propyl)amino)(phenyl)methyl)phenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 183b::US10633345, Compound 183b::US10689346, Compound 183b::US11203574, Compound 183b::US11230530, Compound 183b::US11685721, Compound 183b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416860	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416860&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665638	433916773							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133345	COc1ccc2ccccc2c1C(OCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H31F3N4O3/c1-43-29-15-14-23-7-2-3-11-27(23)31(29)32(44-20-21-12-13-21)24-8-5-9-25(17-24)39-33(42)28-18-30(34(35,36)37)40-41(28)26-10-4-6-22(16-26)19-38/h2-11,14-18,21,32H,12-13,19-20,38H2,1H3,(H,39,42)	YJZQWEYZTCABEY-UHFFFAOYSA-N	416861	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(2-methoxynaphthalen-1-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 148b::US10633345, Compound 148b::US10689346, Compound 148b::US11203574, Compound 148b::US11230530, Compound 148b::US11685721, Compound 148b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416861	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416861&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665874	433916774							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133346	CN(C(c1ccc(cc1)C#N)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1)C1CC1	InChI=1S/C30H26F4N6O/c1-39(22-10-11-22)28(20-7-5-18(16-35)6-8-20)21-9-12-24(31)25(14-21)37-29(41)26-15-27(30(32,33)34)38-40(26)23-4-2-3-19(13-23)17-36/h2-9,12-15,22,28H,10-11,17,36H2,1H3,(H,37,41)	BZIYYSLZWQNWBF-UHFFFAOYSA-N	439407	US10633345, Compound 52h::US10633345, Compound 71a::US10633345, Compound 71b::US10689346, Compound 71b::US11203574, Compound 71a::US11230530, Compound 71b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439407	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439407&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355581	439660965							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133347	CN(C)C(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C27H26F3N5O/c1-34(2)25(19-9-4-3-5-10-19)20-11-7-12-21(15-20)32-26(36)23-16-24(27(28,29)30)33-35(23)22-13-6-8-18(14-22)17-31/h3-16,25H,17,31H2,1-2H3,(H,32,36)	BIAJBXPGRHVMIB-UHFFFAOYSA-N	416863	1-(3-(Aminomethyl)phenyl)-N-(3-((dimethylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 184b::US10633345, Compound 184b::US10689346, Compound 184b::US11203574, Compound 184b::US11230530, Compound 184b::US11685721, Compound 184b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416863	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416863&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356007	433916776							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133348	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccc(O)cc1)C(F)(F)F	InChI=1S/C29H27F3N4O3/c30-29(31,32)26-15-25(36(35-26)23-6-1-3-19(13-23)16-33)28(38)34-22-5-2-4-21(14-22)27(39-17-18-7-8-18)20-9-11-24(37)12-10-20/h1-6,9-15,18,27,37H,7-8,16-17,33H2,(H,34,38)	WIBHWKLQWUWRRF-UHFFFAOYSA-N	416864	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(4-hydroxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 149b::US10633345, Compound 149b::US10689346, Compound 149b::US11203574, Compound 149b::US11230530, Compound 149b::US11685721, Compound 149b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416864	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416864&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665542	433916777							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133349	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-10-9-20(27(40-16-17-7-8-17)19-4-2-5-21(35)12-19)13-24(23)36-28(39)25-14-26(29(31,32)33)37-38(25)22-6-1-3-18(11-22)15-34/h1-6,9-14,17,27H,7-8,15-16,34-35H2,(H,36,39)	GBDDXSAKQKODCG-UHFFFAOYSA-N	416853	1-(3-(aminomethyl)phenyl)-N-(5-((3-aminophenyl)(cyclopropylmethoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 57e::US10633345, Compound 65b::US10689346, Compound 65b::US11203574, Compound 65a::US11230530, Compound 65b::US11685721, Compound 57e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416853	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416853&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355865	433916766							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133350	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NC1CCCCC1)c1ccccc1)C(F)(F)F	InChI=1S/C31H32F3N5O/c32-31(33,34)28-19-27(39(38-28)26-16-7-9-21(17-26)20-35)30(40)37-25-15-8-12-23(18-25)29(22-10-3-1-4-11-22)36-24-13-5-2-6-14-24/h1,3-4,7-12,15-19,24,29,36H,2,5-6,13-14,20,35H2,(H,37,40)	MXMWHPZXCVOSEY-UHFFFAOYSA-N	416866	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclohexylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 185b::US10633345, Compound 185b::US10689346, Compound 185b::US11203574, Compound 185b::US11230530, Compound 185b::US11685721, Compound 185b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416866	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416866&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356164	433916779							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133351	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-25(37(36-26)24-9-1-4-19(12-24)16-33)28(38)35-23-8-3-6-21(14-23)27(39-17-18-10-11-18)20-5-2-7-22(34)13-20/h1-9,12-15,18,27H,10-11,16-17,33-34H2,(H,35,38)	FPQYUIIRVBKUDH-UHFFFAOYSA-N	416867	1-(3-(aminomethyl)phenyl)-N-(3-((3-aminophenyl)(cyclopropyl-methoxy)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 53f::US10633345, Compound 53f::US10689346, Compound 53f::US11203574, Compound 64b::US11230530, Compound 64b::US11685721, Compound 49j	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416867	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416867&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355845	433916780							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133352	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-10-9-20(27(40-16-17-7-8-17)19-4-2-5-21(35)12-19)13-24(23)36-28(39)25-14-26(29(31,32)33)37-38(25)22-6-1-3-18(11-22)15-34/h1-6,9-14,17,27H,7-8,15-16,34-35H2,(H,36,39)	GBDDXSAKQKODCG-UHFFFAOYSA-N	416853	1-(3-(aminomethyl)phenyl)-N-(5-((3-aminophenyl)(cyclopropylmethoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 57e::US10633345, Compound 65b::US10689346, Compound 65b::US11203574, Compound 65a::US11230530, Compound 65b::US11685721, Compound 57e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416853	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416853&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355865	433916766							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133353	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCc1ccncc1)c1ccccc1)C(F)(F)F	InChI=1S/C31H27F3N6O/c32-31(33,34)28-18-27(40(39-28)26-11-4-6-22(16-26)19-35)30(41)38-25-10-5-9-24(17-25)29(23-7-2-1-3-8-23)37-20-21-12-14-36-15-13-21/h1-18,29,37H,19-20,35H2,(H,38,41)	PXKQYONQBKMAKS-UHFFFAOYSA-N	416869	1-(3-(Aminomethyl)phenyl)-N-(3-(phenyl((pyridin-4-ylmethyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 186b::US10633345, Compound 186b::US10689346, Compound 186b::US11203574, Compound 186b::US11230530, Compound 186b::US11685721, Compound 186b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416869	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416869&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665494	433916782							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133354	Cc1cc(C(=O)Nc2cccc(c2)C(NCC2CC2)c2cccc(O)c2O)n(n1)-c1cccc(CN)c1	InChI=1S/C29H31N5O3/c1-18-13-25(34(33-18)23-8-2-5-20(14-23)16-30)29(37)32-22-7-3-6-21(15-22)27(31-17-19-11-12-19)24-9-4-10-26(35)28(24)36/h2-10,13-15,19,27,31,35-36H,11-12,16-17,30H2,1H3,(H,32,37)	VPKURNQNFXHFDB-UHFFFAOYSA-N	416870	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2,3-dihydroxyphenyl)methyl)phenyl)-3-methyl-1H-pyrazole-5-carboxamide::US10329260, Compound 150f::US10633345, Compound 150f::US10689346, Compound 150f::US11203574, Compound 150f::US11230530, Compound 150f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416870	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416870&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355949	433916783							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133355	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc2OCOc12)C(F)(F)F	InChI=1S/C30H28F3N5O3/c31-30(32,33)26-14-24(38(37-26)22-7-1-4-19(12-22)15-34)29(39)36-21-6-2-5-20(13-21)27(35-16-18-10-11-18)23-8-3-9-25-28(23)41-17-40-25/h1-9,12-14,18,27,35H,10-11,15-17,34H2,(H,36,39)	FVRZDZZJKCSOIR-UHFFFAOYSA-N	416871	1-(3-(aminomethyl)phenyl)-N-(3-(benzo[d][1,3]dioxol-4-yl(cyclopropylmethylamino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 192f::US10633345, Compound 192f::US10689346, Compound 192f::US11203574, Compound 192f::US11230530, Compound 192f::US11685721, Compound 192f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416871	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416871&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665720	433916784							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133356	CC(C)(C)CNC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H32F3N5O/c1-29(2,3)19-35-27(21-10-5-4-6-11-21)22-12-8-13-23(16-22)36-28(39)25-17-26(30(31,32)33)37-38(25)24-14-7-9-20(15-24)18-34/h4-17,27,35H,18-19,34H2,1-3H3,(H,36,39)	NWBNOBGYJRWWRK-UHFFFAOYSA-N	416872	1-(3-(Aminomethyl)phenyl)-N-(3-((neopentylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 187b::US10633345, Compound 187b::US10689346, Compound 187b::US11203574, Compound 187b::US11230530, Compound 187b::US11685721, Compound 187b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416872	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416872&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124028296	433916785							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133357	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccc(cc1)C(N)=O)C(F)(F)F	InChI=1S/C30H28F4N6O2/c31-23-11-10-21(27(37-16-17-4-5-17)19-6-8-20(9-7-19)28(36)41)13-24(23)38-29(42)25-14-26(30(32,33)34)39-40(25)22-3-1-2-18(12-22)15-35/h1-3,6-14,17,27,37H,4-5,15-16,35H2,(H2,36,41)(H,38,42)	AHHWWBRXILLXFU-UHFFFAOYSA-N	416873	1-(3-(aminomethyl)phenyl)-N-(5-((4-carbamoylphenyl)(cyclopropylmethylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 153b::US10633345, Compound 153b::US10689346, Compound 153b::US11203574, Compound 153b::US11230530, Compound 153b::US11685721, Compound 153b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416873	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416873&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355991	433916786							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133358	CCC(CO)NC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C29H30F3N5O2/c1-2-22(18-38)34-27(20-9-4-3-5-10-20)21-11-7-12-23(15-21)35-28(39)25-16-26(29(30,31)32)36-37(25)24-13-6-8-19(14-24)17-33/h3-16,22,27,34,38H,2,17-18,33H2,1H3,(H,35,39)	KIDPOTSBLNZGML-UHFFFAOYSA-N	416874	1-(3-(aminomethyl)phenyl)-N-(3-(((1-hydroxybutan-2-yl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 168b::US10633345, Compound 168b::US10689346, Compound 168b::US11192861, Compound 168b::US11230530, Compound 168b::US11685721, Compound 168b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416874	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416874&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356215	433916787							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133359	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NC1CCC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H28F3N5O/c30-29(31,32)26-17-25(37(36-26)24-14-4-7-19(15-24)18-33)28(38)35-23-13-5-10-21(16-23)27(34-22-11-6-12-22)20-8-2-1-3-9-20/h1-5,7-10,13-17,22,27,34H,6,11-12,18,33H2,(H,35,38)	UCFAODSDUNDTFF-UHFFFAOYSA-N	416875	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclobutylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 188b::US10633345, Compound 188b::US10689346, Compound 188b::US11203574, Compound 188b::US11230530, Compound 188b::US11685721, Compound 188b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416875	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416875&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123435501	433916788							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133360	COc1cccc(C(NCC2CC2)c2cccc(NC(=O)c3cc(nn3-c3cccc(CN)c3)C(F)(F)F)c2)c1O	InChI=1S/C30H30F3N5O3/c1-41-25-10-4-9-23(28(25)39)27(35-17-18-11-12-18)20-6-3-7-21(14-20)36-29(40)24-15-26(30(31,32)33)37-38(24)22-8-2-5-19(13-22)16-34/h2-10,13-15,18,27,35,39H,11-12,16-17,34H2,1H3,(H,36,40)	KCIFFUCEHRXTLF-UHFFFAOYSA-N	416876	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2-hydroxy-3-methoxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 151g::US10633345, Compound 151g::US10689346, Compound 151g::US11203574, Compound 151g::US11230530, Compound 151g::US11685721, Compound 151g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416876	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416876&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356165	433916789							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133361	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(N1CCCC1CO)c1ccccc1)C(F)(F)F	InChI=1S/C30H30F3N5O2/c31-30(32,33)27-17-26(38(36-27)24-12-4-7-20(15-24)18-34)29(40)35-23-11-5-10-22(16-23)28(21-8-2-1-3-9-21)37-14-6-13-25(37)19-39/h1-5,7-12,15-17,25,28,39H,6,13-14,18-19,34H2,(H,35,40)	BNZLGFQHSKUMEG-UHFFFAOYSA-N	416877	1-(3-(aminomethyl)phenyl)-N-(3-((2-(hydroxymethyl)pyrrolidin-1-yl)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 169b::US10633345, Compound 169b::US10689346, Compound 169b::US11203574, Compound 169b::US11230530, Compound 169b::US11685721, Compound 169b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416877	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416877&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356128	433916790							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133362	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCc1ccc(N)cc1)c1ccccc1)C(F)(F)F	InChI=1S/C32H29F3N6O/c33-32(34,35)29-18-28(41(40-29)27-11-4-6-22(16-27)19-36)31(42)39-26-10-5-9-24(17-26)30(23-7-2-1-3-8-23)38-20-21-12-14-25(37)15-13-21/h1-18,30,38H,19-20,36-37H2,(H,39,42)	BKOBJSLLJPHJRR-UHFFFAOYSA-N	416878	N-(3-(((4-Aminobenzyl)amino)(phenyl)methyl)phenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 189b::US10633345, Compound 189b::US10689346, Compound 189b::US11203574, Compound 189b::US11230530, Compound 189b::US11685721, Compound 189b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416878	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416878&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665871	433916791							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133363	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C30H27F3N6O/c31-30(32,33)27-15-26(39(38-27)25-9-2-5-21(13-25)17-35)29(40)37-24-8-3-7-23(14-24)28(36-18-19-10-11-19)22-6-1-4-20(12-22)16-34/h1-9,12-15,19,28,36H,10-11,17-18,35H2,(H,37,40)	VQJJJCIJWBDLSJ-UHFFFAOYSA-N	416879	1-(3-(aminomethyl)phenyl)-N-(3-((3-cyanophenyl)(cyclopropylmethyl amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 152d::US10633345, Compound 152d::US10689346, Compound 152d::US11203574, Compound 152d::US11230530, Compound 152d::US11685721, Compound 152d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416879	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416879&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356166	433916792							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133364	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(N1CCC(O)C1)c1ccccc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-16-25(37(35-26)23-11-4-6-19(14-23)17-33)28(39)34-22-10-5-9-21(15-22)27(20-7-2-1-3-8-20)36-13-12-24(38)18-36/h1-11,14-16,24,27,38H,12-13,17-18,33H2,(H,34,39)	FPAZEZULJGBLCM-UHFFFAOYSA-N	416880	1-(3-(aminomethyl)phenyl)-N-(3-((3-hydroxypyrrolidin-1-yl)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 170b::US10633345, Compound 170b::US10689346, Compound 170b::US11192861, Compound 170b::US11230530, Compound 170b::US11685721, Compound 170b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416880	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416880&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355902	433916793							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133365	CSCCNC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C28H28F3N5OS/c1-38-14-13-33-26(20-8-3-2-4-9-20)21-10-6-11-22(16-21)34-27(37)24-17-25(28(29,30)31)35-36(24)23-12-5-7-19(15-23)18-32/h2-12,15-17,26,33H,13-14,18,32H2,1H3,(H,34,37)	GMRUHWVMBSEBQV-UHFFFAOYSA-N	416881	1-(3-(aminomethyl)phenyl)-N-(3-(((2-(methylthio)ethyl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 190b::US10633345, Compound 190b::US10689346, Compound 190b::US11203574, Compound 190b::US11230530, Compound 190b::US11685721, Compound 190b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416881	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416881&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665913	433916794							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133366	COc1ccc(C(NCC2CC2)c2cccc(NC(=O)c3cc(nn3-c3cccc(CN)c3)C(F)(F)F)c2)c2ccccc12	InChI=1S/C34H32F3N5O2/c1-44-30-15-14-28(26-10-2-3-11-27(26)30)32(39-20-21-12-13-21)23-7-5-8-24(17-23)40-33(43)29-18-31(34(35,36)37)41-42(29)25-9-4-6-22(16-25)19-38/h2-11,14-18,21,32,39H,12-13,19-20,38H2,1H3,(H,40,43)	YOBACLFKAGKOLX-UHFFFAOYSA-N	416882	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(4-methoxynaphthalen-1-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 154e::US10633345, Compound 154e::US10689346, Compound 154e::US11203574, Compound 154e::US11230530, Compound 154e::US11685721, Compound 154e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416882	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416882&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665632	433916795							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133367	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NC1CCCCCC1)c1ccccc1)C(F)(F)F	InChI=1S/C32H34F3N5O/c33-32(34,35)29-20-28(40(39-29)27-17-8-10-22(18-27)21-36)31(41)38-26-16-9-13-24(19-26)30(23-11-4-3-5-12-23)37-25-14-6-1-2-7-15-25/h3-5,8-13,16-20,25,30,37H,1-2,6-7,14-15,21,36H2,(H,38,41)	DQWBWUNYPIEFTF-UHFFFAOYSA-N	416883	1-(3-(aminomethyl)phenyl)-N-(3-((cycloheptylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 171b::US10633345, Compound 171b::US10689346, Compound 171b::US11203574, Compound 171b::US11230530, Compound 171b::US11685721, Compound 171b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416883	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416883&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356134	433916796							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133368	Cc1ccccc1C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O/c1-19-6-2-3-11-25(19)28(35-18-20-12-13-20)22-8-5-9-23(15-22)36-29(39)26-16-27(30(31,32)33)37-38(26)24-10-4-7-21(14-24)17-34/h2-11,14-16,20,28,35H,12-13,17-18,34H2,1H3,(H,36,39)	NQOSRSVLDYDVDI-UHFFFAOYSA-N	416884	1-(3-(Aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(o-tolyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 193f::US10633345, Compound 193f::US10689346, Compound 193f::US11203574, Compound 193f::US11230530, Compound 193f::US11685721, Compound 193f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416884	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416884&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355753	433916797							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133369	NCc1cccc(c1)C(NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F4N6O/c31-24-10-9-22(28(37-17-18-7-8-18)21-5-1-3-19(11-21)15-35)13-25(24)38-29(41)26-14-27(30(32,33)34)39-40(26)23-6-2-4-20(12-23)16-36/h1-6,9-14,18,28,37H,7-8,15-17,35-36H2,(H,38,41)	PIDHZVXEDSCGNA-UHFFFAOYSA-N	416885	1-(3-(aminomethyl)phenyl)-N-(5-((3-(aminomethyl)phenyl)(cyclopropylmethylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 155c::US10633345, Compound 155c::US10689346, Compound 155c::US11203574, Compound 155c::US11230530, Compound 155c::US11685721, Compound 155c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416885	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416885&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355611	433916798							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133370	CCCCCNC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H32F3N5O/c1-2-3-7-16-35-28(22-11-5-4-6-12-22)23-13-9-14-24(18-23)36-29(39)26-19-27(30(31,32)33)37-38(26)25-15-8-10-21(17-25)20-34/h4-6,8-15,17-19,28,35H,2-3,7,16,20,34H2,1H3,(H,36,39)	LIINXFZWPJSNHF-UHFFFAOYSA-N	416886	1-(3-(Aminomethyl)phenyl)-N-(3-((pentylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 172b::US10633345, Compound 172b::US10689346, Compound 172b::US11203574, Compound 172b::US11230530, Compound 172b::US11685721, Compound 172b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416886	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416886&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355915	433916799							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133371	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCCCO)c1ccccc1)C(F)(F)F	InChI=1S/C28H28F3N5O2/c29-28(30,31)25-17-24(36(35-25)23-12-4-7-19(15-23)18-32)27(38)34-22-11-5-10-21(16-22)26(33-13-6-14-37)20-8-2-1-3-9-20/h1-5,7-12,15-17,26,33,37H,6,13-14,18,32H2,(H,34,38)	YSEURYDLGGVADI-UHFFFAOYSA-N	416887	1-(3-(Aminomethyl)phenyl)-N-(3-(((3-hydroxypropyl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 191b::US10633345, Compound 191b::US10689346, Compound 191b::US11203574, Compound 191b::US11230530, Compound 191b::US11685721, Compound 191b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416887	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416887&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665847	433916800							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133372	COC(CCC1CC1)(c1cccnc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O2/c1-40-29(13-12-20-10-11-20,23-7-4-14-35-19-23)22-6-3-8-24(16-22)36-28(39)26-17-27(30(31,32)33)37-38(26)25-9-2-5-21(15-25)18-34/h2-9,14-17,19-20H,10-13,18,34H2,1H3,(H,36,39)	HEQLXMARFGMGBQ-UHFFFAOYSA-N	416888	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-methoxy-1-(pyridin-3-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 156c::US10633345, Compound 156c::US10689346, Compound 156c::US11203574, Compound 156c::US11230530, Compound 156c::US11685721, Compound 156c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416888	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416888&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355759	433916801							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133373	CC(CO)NC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C28H28F3N5O2/c1-18(17-37)33-26(20-8-3-2-4-9-20)21-10-6-11-22(14-21)34-27(38)24-15-25(28(29,30)31)35-36(24)23-12-5-7-19(13-23)16-32/h2-15,18,26,33,37H,16-17,32H2,1H3,(H,34,38)	HGDYIKLNDBPRGN-UHFFFAOYSA-N	416889	1-(3-(aminomethyl)phenyl)-N-(3-(((1-hydroxypropan-2-yl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 173b::US10633345, Compound 173b::US10689346, Compound 173b::US11203574, Compound 173b::US11230530, Compound 173b::US11685721, Compound 173b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416889	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416889&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355997	433916802							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133374	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc(F)c1)C(F)(F)F	InChI=1S/C29H27F4N5O/c30-22-7-2-5-20(13-22)27(35-17-18-10-11-18)21-6-3-8-23(14-21)36-28(39)25-15-26(29(31,32)33)37-38(25)24-9-1-4-19(12-24)16-34/h1-9,12-15,18,27,35H,10-11,16-17,34H2,(H,36,39)	FVMNYLZQOFMPFE-UHFFFAOYSA-N	416890	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(3-fluorophenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 195f::US10633345, Compound 195f::US10689346, Compound 195f::US11203574, Compound 195f::US11230530, Compound 195f::US11685721, Compound 195f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416890	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416890&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665561	433916803							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133375	CN(C(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1)C1CC1	InChI=1S/C30H26F4N6O/c1-39(22-9-10-22)28(20-6-2-4-18(12-20)16-35)21-8-11-24(31)25(14-21)37-29(41)26-15-27(30(32,33)34)38-40(26)23-7-3-5-19(13-23)17-36/h2-8,11-15,22,28H,9-10,17,36H2,1H3,(H,37,41)	LONUELZOBAIWEW-UHFFFAOYSA-N	439471	US10633345, Compound 54e::US10633345, Compound 70a::US10633345, Compound 70b::US10689346, Compound 70a::US11203574, Compound 70b::US11230530, Compound 70b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439471	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439471&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355805	439661023							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133376	CC(C)(CO)NC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C29H30F3N5O2/c1-28(2,18-38)35-26(20-9-4-3-5-10-20)21-11-7-12-22(15-21)34-27(39)24-16-25(29(30,31)32)36-37(24)23-13-6-8-19(14-23)17-33/h3-16,26,35,38H,17-18,33H2,1-2H3,(H,34,39)	JPSBLISQAZCRFK-UHFFFAOYSA-N	416892	1-(3-(aminomethyl)phenyl)-N-(3-(((1-hydroxy-2-methylpropan-2-yl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 174b::US10633345, Compound 174b::US10689346, Compound 174b::US11203574, Compound 174b::US11230530, Compound 174b::US11685721, Compound 174b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416892	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416892&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665949	433916805							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133377	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(F)cc1F)C(F)(F)F	InChI=1S/C29H26F5N5O/c30-20-9-10-23(24(31)13-20)27(36-16-17-7-8-17)19-4-2-5-21(12-19)37-28(40)25-14-26(29(32,33)34)38-39(25)22-6-1-3-18(11-22)15-35/h1-6,9-14,17,27,36H,7-8,15-16,35H2,(H,37,40)	QIBXOBBXVAEMNW-UHFFFAOYSA-N	416893	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2,4-difluorophenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 196f::US10633345, Compound 196f::US10689346, Compound 196f::US11203574, Compound 196f::US11230530, Compound 196f::US11685721, Compound 196f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416893	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416893&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665453	433916806							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133378	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C30H25F4N5O2/c31-24-11-10-22(28(41-17-19-4-5-19)21-8-6-18(15-35)7-9-21)13-25(24)37-29(40)26-14-27(30(32,33)34)38-39(26)23-3-1-2-20(12-23)16-36/h1-3,6-14,19,28H,4-5,16-17,36H2,(H,37,40)	WXFHQCUXOOXGLO-UHFFFAOYSA-N	416894	1-(3-(aminomethyl)phenyl)-N-(5-((4-cyanophenyl)(cyclopropylmethoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 55b::US10633345, Compound 73b::US10689346, Compound 55b::US11203574, Compound 73b::US11230530, Compound 73b::US11685721, Compound 73b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416894	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416894&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665569	433916807							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133379	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CCCO1)c1ccccc1)C(F)(F)F	InChI=1S/C30H30F3N5O2/c31-30(32,33)27-17-26(38(37-27)24-12-4-7-20(15-24)18-34)29(39)36-23-11-5-10-22(16-23)28(21-8-2-1-3-9-21)35-19-25-13-6-14-40-25/h1-5,7-12,15-17,25,28,35H,6,13-14,18-19,34H2,(H,36,39)	SIOCTSAXUSNOCO-UHFFFAOYSA-N	416895	1-(3-(aminomethyl)phenyl)-N-(3-(phenyl(((tetrahydrofuran-2-yl)methyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 175b::US10633345, Compound 175b::US10689346, Compound 175b::US11203574, Compound 175b::US11230530, Compound 175b::US11685721, Compound 175b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416895	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416895&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355976	433916808							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133380	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cc(F)ccc1F)C(F)(F)F	InChI=1S/C29H26F5N5O/c30-20-9-10-24(31)23(13-20)27(36-16-17-7-8-17)19-4-2-5-21(12-19)37-28(40)25-14-26(29(32,33)34)38-39(25)22-6-1-3-18(11-22)15-35/h1-6,9-14,17,27,36H,7-8,15-16,35H2,(H,37,40)	DGRITJGAWATINU-UHFFFAOYSA-N	416896	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2,5-difluorophenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 197f::US10633345, Compound 197f::US10689346, Compound 197f::US11203574, Compound 197f::US11230530, Compound 197f::US11685721, Compound 197f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416896	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416896&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665599	433916809							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116299	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(F)c(OC)ccc1C(N)=O	InChI=1S/C28H28FN5O5/c1-38-17-23-22(28(37)31-13-21-20(27(30)36)10-11-24(39-2)26(21)29)16-34(32-23)15-19-8-6-18(7-9-19)14-33-12-4-3-5-25(33)35/h3-12,16H,13-15,17H2,1-2H3,(H2,30,36)(H,31,37)	HHFDDRTYFWHVIW-UHFFFAOYSA-N	528108	N-[(6-carbamoyl-2-fluoro-3-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US11180484, Example 42::US11180484, Example 43	Plasma kallikrein			 3.60							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528108	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528108&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301883	463791662							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116303	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(F)c(OC)ccc1C(N)=O	InChI=1S/C28H28FN5O5/c1-38-17-23-22(28(37)31-13-21-20(27(30)36)10-11-24(39-2)26(21)29)16-34(32-23)15-19-8-6-18(7-9-19)14-33-12-4-3-5-25(33)35/h3-12,16H,13-15,17H2,1-2H3,(H2,30,36)(H,31,37)	HHFDDRTYFWHVIW-UHFFFAOYSA-N	528108	N-[(6-carbamoyl-2-fluoro-3-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US11180484, Example 42::US11180484, Example 43	Plasma kallikrein			 0.600							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528108	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528108&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301883	463791662							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116307	COc1ccc(C#N)c(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2N(C)C)c1F	InChI=1S/C28H27FN6O3/c1-33(2)27-23(28(37)31-15-22-21(14-30)11-12-24(38-3)26(22)29)18-35(32-27)17-20-9-7-19(8-10-20)16-34-13-5-4-6-25(34)36/h4-13,18H,15-17H2,1-3H3,(H,31,37)	GLQJORYVDYGMMX-UHFFFAOYSA-N	528110	N-[(6-cyano-2-fluoro-3-methoxyphenyl)methyl]-3-(dimethylamino)-1-({4-[(2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US11180484, Example 44	Plasma kallikrein			 8.80							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528110	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528110&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301855	463791663							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116311	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(F)ccc1-n1cnnn1	InChI=1S/C27H25FN8O3/c1-39-17-24-23(27(38)29-13-21-12-22(28)9-10-25(21)36-18-30-32-33-36)16-35(31-24)15-20-7-5-19(6-8-20)14-34-11-3-2-4-26(34)37/h2-12,16,18H,13-15,17H2,1H3,(H,29,38)	HGAHDIXAZKUMIT-UHFFFAOYSA-N	528111	N-{[5-fluoro-2-(1,2,3,4-tetrazol-1-yl)phenyl]methyl}-3-(methoxymethyl)-1-({4-[(2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US11180484, Example 49	Plasma kallikrein			 15.9							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528111	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528111&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			132191131	463791664							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116315	COCc1nn(Cc2ccc(Cn3ccccc3=O)cn2)cc1C(=O)NCc1c(F)c(OC)ccc1C#N	InChI=1S/C27H25FN6O4/c1-37-17-23-22(27(36)31-13-21-19(11-29)7-9-24(38-2)26(21)28)16-34(32-23)15-20-8-6-18(12-30-20)14-33-10-4-3-5-25(33)35/h3-10,12,16H,13-15,17H2,1-2H3,(H,31,36)	VWRXUAIDRNILSA-UHFFFAOYSA-N	528113	N-[(6-cyano-2-fluoro-3-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({5-[(2- oxopyridin-1-yl)methyl]pyridin-2-yl}methyl)pyrazole-4-carboxamide::US11180484, Example 51	Plasma kallikrein			 21.3							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528113	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528113&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301836	463791666							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116319	COCc1nn(Cc2ccc(Cn3ccccc3=O)nc2)cc1C(=O)NCc1c(F)c(OC)ccc1C#N	InChI=1S/C27H25FN6O4/c1-37-17-23-22(27(36)31-13-21-19(11-29)7-9-24(38-2)26(21)28)16-34(32-23)14-18-6-8-20(30-12-18)15-33-10-4-3-5-25(33)35/h3-10,12,16H,13-15,17H2,1-2H3,(H,31,36)	YPPJNDBRBJRPMM-UHFFFAOYSA-N	528115	N-[(6-cyano-2-fluoro-3-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({6-[(2- oxopyridin-1-yl)methyl]pyridin-3-yl}methyl)pyrazole-4-carboxamide::US11180484, Example 52	Plasma kallikrein			 6.40							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528115	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528115&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301840	463791668							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116323	COCc1nn(Cc2ccc(Cn3cc(F)ccc3=O)cc2)cc1C(=O)NCc1c(F)c(OC)ccc1C#N	InChI=1S/C28H25F2N5O4/c1-38-17-24-23(28(37)32-12-22-20(11-31)7-9-25(39-2)27(22)30)16-35(33-24)14-19-5-3-18(4-6-19)13-34-15-21(29)8-10-26(34)36/h3-10,15-16H,12-14,17H2,1-2H3,(H,32,37)	WONUSGGEAIADDP-UHFFFAOYSA-N	528116	N-[(6-cyano-2-fluoro-3-methoxyphenyl)methyl]-1-({4-[(5-fluoro-2-oxopyridin-1- yl)methyl]phenyl}methyl)-3-(methoxymethyl)pyrazole-4-carboxamide::US11180484, Example 53	Plasma kallikrein			 1.70							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528116	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528116&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301886	463791669							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116327	COCc1nn(Cc2ccc(CN3CCCCC3=O)cc2)cc1C(=O)NCc1c(F)c(OC)ccc1C#N	InChI=1S/C28H30FN5O4/c1-37-18-24-23(28(36)31-14-22-21(13-30)10-11-25(38-2)27(22)29)17-34(32-24)16-20-8-6-19(7-9-20)15-33-12-4-3-5-26(33)35/h6-11,17H,3-5,12,14-16,18H2,1-2H3,(H,31,36)	XPTZMLCDXVNVHH-UHFFFAOYSA-N	528117	N-[(6-cyano-2-fluoro-3-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2- oxopiperidin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US11180484, Example 57	Plasma kallikrein			 27.9							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528117	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528117&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301879	463791670							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116331	COCc1nn(Cc2cnc(nc2)N2CCCC2)cc1C(=O)NCc1c(F)c(OC)ccc1C#N	InChI=1S/C24H26FN7O3/c1-34-15-20-19(23(33)27-12-18-17(9-26)5-6-21(35-2)22(18)25)14-32(30-20)13-16-10-28-24(29-11-16)31-7-3-4-8-31/h5-6,10-11,14H,3-4,7-8,12-13,15H2,1-2H3,(H,27,33)	SIRHHDJBZGUQGP-UHFFFAOYSA-N	528118	N-[(6-cyano-2-fluoro-3-methoxyphenyl)methyl]-3-(methoxymethyl)-1-{[2-(pyrrolidin- 1-yl)pyrimidin-5-yl]methyl}pyrazole-4-carboxamide::US11180484, Example 58	Plasma kallikrein			 57.0							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528118	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528118&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365010	463791671							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116335	COCc1nn(Cc2ccc(Cn3cc(C)cn3)cc2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cnnn1	InChI=1S/C27H28FN9O3/c1-18-10-31-35(12-18)13-19-4-6-20(7-5-19)14-36-15-22(23(32-36)16-39-2)27(38)29-11-21-24(37-17-30-33-34-37)8-9-25(40-3)26(21)28/h4-10,12,15,17H,11,13-14,16H2,1-3H3,(H,29,38)	RBMQELRIPLOTLF-UHFFFAOYSA-N	528119	N-{[2-fluoro-3-methoxy-6-(1,2,3,4-tetrazol-1-yl)phenyl]methyl}-3-(methoxymethyl)- 1-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US11180484, Example 60	Plasma kallikrein			 0.900							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528119	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528119&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			132190780	463791672							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116339	COCc1nn(Cc2ccc(Cn3cc(C)cn3)cc2)cc1C(=O)NCc1cc(OC)ccc1-n1cnnn1	InChI=1S/C27H29N9O3/c1-19-11-30-34(13-19)14-20-4-6-21(7-5-20)15-35-16-24(25(31-35)17-38-2)27(37)28-12-22-10-23(39-3)8-9-26(22)36-18-29-32-33-36/h4-11,13,16,18H,12,14-15,17H2,1-3H3,(H,28,37)	ZGDCEZCTTYIMHX-UHFFFAOYSA-N	528120	N-{[5-methoxy-2-(1,2,3,4-tetrazol-1-yl)phenyl]methyl}-3-(methoxymethyl)-1-({4-[(4- methylpyrazol-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US11180484, Example 61	Plasma kallikrein			 1.70							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528120	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528120&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			132190914	463791673							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116343	Fc1cccc(c1CNC(=O)c1cn(Cc2ccc(Cn3ccccc3=O)cc2)nc1C(F)(F)F)-n1cnnn1	InChI=1S/C26H20F4N8O2/c27-21-4-3-5-22(38-16-32-34-35-38)19(21)12-31-25(40)20-15-37(33-24(20)26(28,29)30)14-18-9-7-17(8-10-18)13-36-11-2-1-6-23(36)39/h1-11,15-16H,12-14H2,(H,31,40)	QIVLFDQQTJYRNZ-UHFFFAOYSA-N	528121	N-{[2-fluoro-6-(1,2,3,4-tetrazol-1-yl)phenyl]methyl}-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide::US11180484, Example 64	Plasma kallikrein			 0.600							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528121	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528121&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301858	463791674							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116347	Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(Cl)ccc1-n1cnnn1	InChI=1S/C25H22ClN9O2/c26-20-8-9-22(35-16-29-31-32-35)19(11-20)12-28-25(37)21-15-34(30-24(21)27)14-18-6-4-17(5-7-18)13-33-10-2-1-3-23(33)36/h1-11,15-16H,12-14H2,(H2,27,30)(H,28,37)	VRRRZDGKLGIBNH-UHFFFAOYSA-N	528122	3-amino-N-{[5-chloro-2-(1,2,3,4-tetrazol-1-yl)phenyl]methyl}-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US11180484, Example 71	Plasma kallikrein			 0.300							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528122	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528122&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			132190846	463791675							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116351	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(Cl)ccc1-n1cnnn1	InChI=1S/C27H25ClN8O3/c1-39-17-24-23(27(38)29-13-21-12-22(28)9-10-25(21)36-18-30-32-33-36)16-35(31-24)15-20-7-5-19(6-8-20)14-34-11-3-2-4-26(34)37/h2-12,16,18H,13-15,17H2,1H3,(H,29,38)	HXIVOBRAPHEKKR-UHFFFAOYSA-N	528123	N-{[5-chloro-2-(1,2,3,4-tetrazol-1-yl)phenyl]methyl}-3-(methoxymethyl)-1-({4-[(2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US11180484, Example 72	Plasma kallikrein			 0.700							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528123	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528123&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301839	463791676							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116355	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(Cl)cccc1-n1cnnn1	InChI=1S/C27H25ClN8O3/c1-39-17-24-22(27(38)29-13-21-23(28)5-4-6-25(21)36-18-30-32-33-36)16-35(31-24)15-20-10-8-19(9-11-20)14-34-12-3-2-7-26(34)37/h2-12,16,18H,13-15,17H2,1H3,(H,29,38)	NHDCXSLYRRLZMJ-UHFFFAOYSA-N	528124	N-{[2-chloro-6-(1,2,3,4-tetrazol-1-yl)phenyl]methyl}-3-(methoxymethyl)-1-({4-[(2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US11180484, Example 73	Plasma kallikrein			 23.1							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528124	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528124&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301885	463791677							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116359	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1ccccc1-n1cnnn1	InChI=1S/C27H26N8O3/c1-38-18-24-23(27(37)28-14-22-6-2-3-7-25(22)35-19-29-31-32-35)17-34(30-24)16-21-11-9-20(10-12-21)15-33-13-5-4-8-26(33)36/h2-13,17,19H,14-16,18H2,1H3,(H,28,37)	VGDXNXATYVCKMM-UHFFFAOYSA-N	528125	3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)-N-{[2-(1,2,3,4- tetrazol-1-yl)phenyl]methyl}pyrazole-4-carboxamide::US11180484, Example 74	Plasma kallikrein			 17.6							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528125	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528125&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			132190912	463791678							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116363	COCc1nn(Cc2ccc(nc2)N2CCCC2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cnnn1	InChI=1S/C25H28FN9O3/c1-37-15-20-19(14-34(30-20)13-17-5-8-23(27-11-17)33-9-3-4-10-33)25(36)28-12-18-21(35-16-29-31-32-35)6-7-22(38-2)24(18)26/h5-8,11,14,16H,3-4,9-10,12-13,15H2,1-2H3,(H,28,36)	DGIRMJAUTLUPMU-UHFFFAOYSA-N	455297	US10730874, Compound TABLE II.2::US11180484, Example 77::US11352356, Table II.2	Plasma kallikrein			 1.40							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455297	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455297&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301849	440971115							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116367	COCc1nn(Cc2cnc(nc2)N2CCCC2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cnnn1	InChI=1S/C24H27FN10O3/c1-37-14-19-18(13-34(30-19)12-16-9-27-24(28-10-16)33-7-3-4-8-33)23(36)26-11-17-20(35-15-29-31-32-35)5-6-21(38-2)22(17)25/h5-6,9-10,13,15H,3-4,7-8,11-12,14H2,1-2H3,(H,26,36)	GSFPQMPKJFXLTO-UHFFFAOYSA-N	528127	US11180484, Example 79::US11180484, Reference Example K::US11613527, Example RC4	Plasma kallikrein			 2.00							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528127	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528127&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			132203422	463791680							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116371	COCc1nn(Cc2cnc(nc2)N2CCCC2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cnnn1	InChI=1S/C24H27FN10O3/c1-37-14-19-18(13-34(30-19)12-16-9-27-24(28-10-16)33-7-3-4-8-33)23(36)26-11-17-20(35-15-29-31-32-35)5-6-21(38-2)22(17)25/h5-6,9-10,13,15H,3-4,7-8,11-12,14H2,1-2H3,(H,26,36)	GSFPQMPKJFXLTO-UHFFFAOYSA-N	528127	US11180484, Example 79::US11180484, Reference Example K::US11613527, Example RC4	Plasma kallikrein			 1.50							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528127	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528127&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			132203422	463791680							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133381	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-9-8-20(28(40,11-10-18-6-7-18)21-4-2-12-35-17-21)14-24(23)36-27(39)25-15-26(29(31,32)33)37-38(25)22-5-1-3-19(13-22)16-34/h1-5,8-9,12-15,17-18,40H,6-7,10-11,16,34H2,(H,36,39)	VCHFZCHUEHQXSZ-UHFFFAOYSA-N	416897	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 58c::US10633345, Compound 67b::US10689346, Compound 67b::US11203574, Compound 67b::US11230530, Compound 67b::US11685721, Compound 67b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416897	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416897&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355889	433916810							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133382	CC(C)CCNC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H32F3N5O/c1-20(2)14-15-35-28(22-9-4-3-5-10-22)23-11-7-12-24(17-23)36-29(39)26-18-27(30(31,32)33)37-38(26)25-13-6-8-21(16-25)19-34/h3-13,16-18,20,28,35H,14-15,19,34H2,1-2H3,(H,36,39)	WPCVSFNABLNPTN-UHFFFAOYSA-N	416898	1-(3-(aminomethyl)phenyl)-N-(3-((isopentylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 176b::US10633345, Compound 176b::US10689346, Compound 176b::US11203574, Compound 176b::US11230530, Compound 176b::US11685721, Compound 176b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416898	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416898&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665776	433916811							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133383	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1c(F)cccc1F)C(F)(F)F	InChI=1S/C29H26F5N5O/c30-22-8-3-9-23(31)26(22)27(36-16-17-10-11-17)19-5-2-6-20(13-19)37-28(40)24-14-25(29(32,33)34)38-39(24)21-7-1-4-18(12-21)15-35/h1-9,12-14,17,27,36H,10-11,15-16,35H2,(H,37,40)	OHXCNQRJQHLAER-UHFFFAOYSA-N	416899	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2,6-difluorophenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 198f::US10633345, Compound 198f::US10689346, Compound 198f::US11203574, Compound 198f::US11230530, Compound 198f::US11685721, Compound 198f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416899	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416899&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665643	433916812							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133384	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C30H25F4N5O2/c31-24-10-9-22(28(41-17-18-7-8-18)21-5-1-3-19(11-21)15-35)13-25(24)37-29(40)26-14-27(30(32,33)34)38-39(26)23-6-2-4-20(12-23)16-36/h1-6,9-14,18,28H,7-8,16-17,36H2,(H,37,40)	LSXFYXGKZDVRTL-UHFFFAOYSA-N	416900	1-(3-(aminomethyl)phenyl)-N-(5-((3-cyanophenyl)(cyclopropyl-methoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 56c::US10633345, Compound 72d::US10689346, Compound 56c::US11203574, Compound 72d::US11230530, Compound 72d::US11685721, Compound 72d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416900	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416900&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356211	433916813							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133385	CCC(C)CNC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H32F3N5O/c1-3-20(2)19-35-28(22-10-5-4-6-11-22)23-12-8-13-24(16-23)36-29(39)26-17-27(30(31,32)33)37-38(26)25-14-7-9-21(15-25)18-34/h4-17,20,28,35H,3,18-19,34H2,1-2H3,(H,36,39)	ZCSNRDNUIRVYLS-UHFFFAOYSA-N	416901	1-(3-(Aminomethyl)phenyl)-N-(3-(((2-methylbutyl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 177b::US10633345, Compound 177b::US10689346, Compound 177b::US11203574, Compound 177b::US11230530, Compound 177b::US11685721, Compound 177b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416901	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416901&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665478	433916814							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133386	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1Cl)C(F)(F)F	InChI=1S/C29H27ClF3N5O/c30-24-10-2-1-9-23(24)27(35-17-18-11-12-18)20-6-4-7-21(14-20)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-3-5-19(13-22)16-34/h1-10,13-15,18,27,35H,11-12,16-17,34H2,(H,36,39)	UQMCUIGBQDUSLW-UHFFFAOYSA-N	416902	1-(3-(aminomethyl)phenyl)-N-(3-((2-chlorophenyl)((cyclopropylmethyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 194f::US10329260, Compound 199f::US10633345, Compound 199f::US10689346, Compound 199f::US11203574, Compound 199f::US11230530, Compound 199f::US11685721, Compound 199f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416902	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416902&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356220	433916815							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133387	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H28F4N4O2/c31-24-12-11-22(29(40,14-13-19-9-10-19)21-6-2-1-3-7-21)16-25(24)36-28(39)26-17-27(30(32,33)34)37-38(26)23-8-4-5-20(15-23)18-35/h1-8,11-12,15-17,19,40H,9-10,13-14,18,35H2,(H,36,39)	NIWMWYNGSALJGG-UHFFFAOYSA-N	416903	Racemic 1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 68c::US10633345, Compound 68e::US10689346, Compound 68c::US11203574, Compound 68e::US11230530, Compound 68e::US11685721, Compound 68e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416903	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416903&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355758	433916816							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133388	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(N(CCO)CCO)c1ccccc1)C(F)(F)F	InChI=1S/C29H30F3N5O3/c30-29(31,32)26-18-25(37(35-26)24-11-4-6-20(16-24)19-33)28(40)34-23-10-5-9-22(17-23)27(21-7-2-1-3-8-21)36(12-14-38)13-15-39/h1-11,16-18,27,38-39H,12-15,19,33H2,(H,34,40)	HFRFNKSEVVNXFK-UHFFFAOYSA-N	416904	1-(3-(aminomethyl)phenyl)-N-(3-((bis(2-hydroxyethyl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 178b::US10633345, Compound 178b::US10689346, Compound 178b::US11203574, Compound 178b::US11230530, Compound 178b::US11685721, Compound 178b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416904	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416904&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355913	433916817							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133389	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1Cl)C(F)(F)F	InChI=1S/C29H27ClF3N5O/c30-24-10-2-1-9-23(24)27(35-17-18-11-12-18)20-6-4-7-21(14-20)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-3-5-19(13-22)16-34/h1-10,13-15,18,27,35H,11-12,16-17,34H2,(H,36,39)	UQMCUIGBQDUSLW-UHFFFAOYSA-N	416902	1-(3-(aminomethyl)phenyl)-N-(3-((2-chlorophenyl)((cyclopropylmethyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 194f::US10329260, Compound 199f::US10633345, Compound 199f::US10689346, Compound 199f::US11203574, Compound 199f::US11230530, Compound 199f::US11685721, Compound 199f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416902	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416902&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356220	433916815							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133390	COc1ccc2ccccc2c1C(NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H31F4N5O2/c1-45-29-14-12-22-6-2-3-8-25(22)31(29)32(40-19-20-9-10-20)23-11-13-26(35)27(16-23)41-33(44)28-17-30(34(36,37)38)42-43(28)24-7-4-5-21(15-24)18-39/h2-8,11-17,20,32,40H,9-10,18-19,39H2,1H3,(H,41,44)	AYMFYNZEWAELBE-UHFFFAOYSA-N	416906	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(2-methoxynaphthalen-1-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide dihydrochloride::US10329260, Compound 61e::US10633345, Compound 63b::US10689346, Compound 61e::US11203574, Compound 63b::US11230530, Compound 63b::US11685721, Compound 63b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416906	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416906&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355591	433916818							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133391	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCc1cccnc1)c1ccccc1)C(F)(F)F	InChI=1S/C31H27F3N6O/c32-31(33,34)28-17-27(40(39-28)26-13-4-7-21(15-26)18-35)30(41)38-25-12-5-11-24(16-25)29(23-9-2-1-3-10-23)37-20-22-8-6-14-36-19-22/h1-17,19,29,37H,18,20,35H2,(H,38,41)	HIJVXEVWORHKBX-UHFFFAOYSA-N	416907	1-(3-(Aminomethyl)phenyl)-N-(3-(phenyl((pyridin-3-ylmethyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 179b::US10633345, Compound 179b::US10689346, Compound 179b::US11203574, Compound 179b::US11230530, Compound 179b::US11685721, Compound 179b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416907	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416907&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665526	433916819							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133392	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(Cl)cc1Cl)C(F)(F)F	InChI=1S/C29H26Cl2F3N5O/c30-20-9-10-23(24(31)13-20)27(36-16-17-7-8-17)19-4-2-5-21(12-19)37-28(40)25-14-26(29(32,33)34)38-39(25)22-6-1-3-18(11-22)15-35/h1-6,9-14,17,27,36H,7-8,15-16,35H2,(H,37,40)	CXLXHJIZVQBZJV-UHFFFAOYSA-N	416908	1-(3-(aminomethyl)phenyl)-N-(3-((2,4-dichlorophenyl)((cyclopropylmethyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 200f::US10633345, Compound 200f::US10689346, Compound 200f::US11203574, Compound 200f::US11230530, Compound 200f::US11685721, Compound 200f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416908	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416908&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126688969	433916820							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133393	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-10-9-20(28(40,12-11-18-7-8-18)25-6-1-2-13-35-25)15-23(22)36-27(39)24-16-26(29(31,32)33)37-38(24)21-5-3-4-19(14-21)17-34/h1-6,9-10,13-16,18,40H,7-8,11-12,17,34H2,(H,36,39)	XXMBQXWQIGCREG-UHFFFAOYSA-N	416909	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 59c::US10633345, Compound 69b::US10689346, Compound 59c::US11203574, Compound 69b::US11230530, Compound 69b::US11685721, Compound 69b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416909	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416909&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356067	433916821							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133394	CCCCNC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C29H30F3N5O/c1-2-3-15-34-27(21-10-5-4-6-11-21)22-12-8-13-23(17-22)35-28(38)25-18-26(29(30,31)32)36-37(25)24-14-7-9-20(16-24)19-33/h4-14,16-18,27,34H,2-3,15,19,33H2,1H3,(H,35,38)	IJFOMNKWJBCMSK-UHFFFAOYSA-N	416910	1-(3-(Aminomethyl)phenyl)-N-(3-((butylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 180b::US10633345, Compound 180b::US10689346, Compound 180b::US11203574, Compound 180b::US11230530, Compound 180b::US11685721, Compound 180b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416910	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416910&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665986	433916822							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133395	Cc1ccc(C(NCC2CC2)c2cccc(NC(=O)c3cc(nn3-c3cccc(CN)c3)C(F)(F)F)c2)c(C)c1	InChI=1S/C31H32F3N5O/c1-19-9-12-26(20(2)13-19)29(36-18-21-10-11-21)23-6-4-7-24(15-23)37-30(40)27-16-28(31(32,33)34)38-39(27)25-8-3-5-22(14-25)17-35/h3-9,12-16,21,29,36H,10-11,17-18,35H2,1-2H3,(H,37,40)	PPHLPILJSQAZAY-UHFFFAOYSA-N	416911	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2,4-dimethylphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 201f::US10689346, Compound 201f::US11192861, Compound 201f::US11230530, Compound 201f::US11685721, Compound 201f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416911	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416911&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665576	433916823							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133396	Cc1ccc(C)c(c1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C31H32F3N5O/c1-19-9-10-20(2)26(13-19)29(36-18-21-11-12-21)23-6-4-7-24(15-23)37-30(40)27-16-28(31(32,33)34)38-39(27)25-8-3-5-22(14-25)17-35/h3-10,13-16,21,29,36H,11-12,17-18,35H2,1-2H3,(H,37,40)	NFGQIHGOUUFZHN-UHFFFAOYSA-N	416912	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2,5-dimethylphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 202f::US10633345, Compound 202f::US10689346, Compound 202f::US11203574, Compound 202f::US11230530, Compound 202f::US11685721, Compound 202f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416912	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416912&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665510	433916824							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133397	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F3N4O2/c30-29(31,32)26-16-25(36(35-26)24-11-4-6-20(14-24)17-33)28(37)34-23-10-5-9-22(15-23)27(38-18-19-12-13-19)21-7-2-1-3-8-21/h1-11,14-16,19,27H,12-13,17-18,33H2,(H,34,37)	PEZVPVUPSJXZCH-UHFFFAOYSA-N	416775	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18k::US10633345, Compound 74a::US10689346, Compound 165e::US11203574, Compound 165e::US11230530, Compound 165e::US11685721, Compound 18k	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416775	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416775&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			91884591	433916689							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133398	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F4N5O/c30-23-12-11-21(27(35-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27,35H,9-10,16-17,34H2,(H,36,39)	MCLZOCFEIKBMBA-UHFFFAOYSA-N	416773	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 38d::US10633345, Compound 38d::US10689346, Compound 42a::US11203574, Compound 42a::US11230530, Compound 42a::US11685721, Compound 38d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416773	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416773&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356124	433916687							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133399	CC(C)(C)c1ccc(cc1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C33H36F3N5O/c1-32(2,3)25-14-12-23(13-15-25)30(38-20-21-10-11-21)24-7-5-8-26(17-24)39-31(42)28-18-29(33(34,35)36)40-41(28)27-9-4-6-22(16-27)19-37/h4-9,12-18,21,30,38H,10-11,19-20,37H2,1-3H3,(H,39,42)	OVDVNIYCGDTOJR-UHFFFAOYSA-N	416915	1-(3-(aminomethyl)phenyl)-N-(3-((4-(tert-butyl)phenyl)((cyclopropylmethyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 203f::US10633345, Compound 203f::US10689346, Compound 203f::US11203574, Compound 203f::US11230530, Compound 203f::US11685721, Compound 203f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416915	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416915&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665458	433916827							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133400	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F3N4O2/c30-29(31,32)26-16-25(36(35-26)24-11-4-6-20(14-24)17-33)28(37)34-23-10-5-9-22(15-23)27(38-18-19-12-13-19)21-7-2-1-3-8-21/h1-11,14-16,19,27H,12-13,17-18,33H2,(H,34,37)	PEZVPVUPSJXZCH-UHFFFAOYSA-N	416775	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18k::US10633345, Compound 74a::US10689346, Compound 165e::US11203574, Compound 165e::US11230530, Compound 165e::US11685721, Compound 18k	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416775	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416775&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			91884591	433916689							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133401	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F4N5O/c30-23-12-11-21(27(35-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27,35H,9-10,16-17,34H2,(H,36,39)	MCLZOCFEIKBMBA-UHFFFAOYSA-N	416773	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 38d::US10633345, Compound 38d::US10689346, Compound 42a::US11203574, Compound 42a::US11230530, Compound 42a::US11685721, Compound 38d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416773	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416773&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356124	433916687							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133402	OC(CCC1CC1)(c1ccc(F)c(NC(=O)c2cc(nn2-c2ccc(Cl)cc2)C(F)(F)F)c1)c1ccccn1	InChI=1S/C28H23ClF4N4O2/c29-19-7-9-20(10-8-19)37-23(16-25(36-37)28(31,32)33)26(38)35-22-15-18(6-11-21(22)30)27(39,13-12-17-4-5-17)24-3-1-2-14-34-24/h1-3,6-11,14-17,39H,4-5,12-13H2,(H,35,38)	QWPFRWIQIFPXCC-UHFFFAOYSA-N	416918	1-(4-chlorophenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 157a::US10633345, Compound 157a::US10689346, Compound 157a::US11203574, Compound 157a::US11230530, Compound 157a::US11685721, Compound 157a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416918	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416918&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665679	433916830							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133403	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(N)cc1)C(F)(F)F	InChI=1S/C29H29F3N6O/c30-29(31,32)26-15-25(38(37-26)24-6-1-3-19(13-24)16-33)28(39)36-23-5-2-4-21(14-23)27(35-17-18-7-8-18)20-9-11-22(34)12-10-20/h1-6,9-15,18,27,35H,7-8,16-17,33-34H2,(H,36,39)	XDCYYWMSVYTRMZ-UHFFFAOYSA-N	416843	1-(3-(aminomethyl)phenyl)-N-(3-((4-aminophenyl)(cyclopropylmethyl-amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 50f::US10633345, Compound 50f::US10689346, Compound 50h::US11203574, Compound 50h::US11230530, Compound 50h::US11685721, Compound 50f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416843	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416843&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355587	433916756							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133404	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-9-8-20(28(40,11-10-18-6-7-18)21-4-2-12-35-17-21)14-24(23)36-27(39)25-15-26(29(31,32)33)37-38(25)22-5-1-3-19(13-22)16-34/h1-5,8-9,12-15,17-18,40H,6-7,10-11,16,34H2,(H,36,39)	VCHFZCHUEHQXSZ-UHFFFAOYSA-N	416897	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 58c::US10633345, Compound 67b::US10689346, Compound 67b::US11203574, Compound 67b::US11230530, Compound 67b::US11685721, Compound 67b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416897	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416897&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355889	433916810							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133405	OC(CCC1CC1)(c1ccc(F)c(NC(=O)c2cc(nn2-c2ccc3cc(Cl)ccc3c2)C(F)(F)F)c1)c1ccccn1	InChI=1S/C32H25ClF4N4O2/c33-23-9-6-21-16-24(10-7-20(21)15-23)41-27(18-29(40-41)32(35,36)37)30(42)39-26-17-22(8-11-25(26)34)31(43,13-12-19-4-5-19)28-3-1-2-14-38-28/h1-3,6-11,14-19,43H,4-5,12-13H2,(H,39,42)	XTIXOVGIMHWYOB-UHFFFAOYSA-N	416921	1-(6-chloronaphthalen-2-yl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 158a::US10633345, Compound 158a::US10689346, Compound 158a::US11203574, Compound 158a::US11230530, Compound 158a::US11685721, Compound 158a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416921	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416921&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355937	433916833							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133406	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(N)cc1)C(F)(F)F	InChI=1S/C29H29F3N6O/c30-29(31,32)26-15-25(38(37-26)24-6-1-3-19(13-24)16-33)28(39)36-23-5-2-4-21(14-23)27(35-17-18-7-8-18)20-9-11-22(34)12-10-20/h1-6,9-15,18,27,35H,7-8,16-17,33-34H2,(H,36,39)	XDCYYWMSVYTRMZ-UHFFFAOYSA-N	416843	1-(3-(aminomethyl)phenyl)-N-(3-((4-aminophenyl)(cyclopropylmethyl-amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 50f::US10633345, Compound 50f::US10689346, Compound 50h::US11203574, Compound 50h::US11230530, Compound 50h::US11685721, Compound 50f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416843	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416843&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355587	433916756							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133407	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-9-8-20(28(40,11-10-18-6-7-18)21-4-2-12-35-17-21)14-24(23)36-27(39)25-15-26(29(31,32)33)37-38(25)22-5-1-3-19(13-22)16-34/h1-5,8-9,12-15,17-18,40H,6-7,10-11,16,34H2,(H,36,39)	VCHFZCHUEHQXSZ-UHFFFAOYSA-N	416897	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 58c::US10633345, Compound 67b::US10689346, Compound 67b::US11203574, Compound 67b::US11230530, Compound 67b::US11685721, Compound 67b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416897	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416897&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355889	433916810							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133408	OC(CCC1CC1)(c1ccc(F)c(NC(=O)c2cc(nn2-c2ccc(Cl)cn2)C(F)(F)F)c1)c1ccccn1	InChI=1S/C27H22ClF4N5O2/c28-18-7-9-24(34-15-18)37-21(14-23(36-37)27(30,31)32)25(38)35-20-13-17(6-8-19(20)29)26(39,11-10-16-4-5-16)22-3-1-2-12-33-22/h1-3,6-9,12-16,39H,4-5,10-11H2,(H,35,38)	HMQODPUNPWDVSN-UHFFFAOYSA-N	416924	1-(5-chloropyridin-2-yl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 159a::US10633345, Compound 159a::US10689346, Compound 159a::US11203574, Compound 159a::US11230530, Compound 159a::US11685721, Compound 159a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416924	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416924&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355989	433916836							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133409	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C28H26F3N5O2/c29-28(30,31)25-15-24(36(35-25)22-8-3-5-19(13-22)16-32)27(37)34-21-7-4-6-20(14-21)26(38-17-18-10-11-18)23-9-1-2-12-33-23/h1-9,12-15,18,26H,10-11,16-17,32H2,(H,34,37)	UBQUVYTUKOFUOF-UHFFFAOYSA-N	416721	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(pyridin-2-yl)methyl)-phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 43f::US10633345, Compound 43f::US10689346, Compound 43g::US11203574, Compound 43h::US11230530, Compound 43h::US11685721, Compound 43f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416721	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416721&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355947	433916635							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133410	CN(C(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1)C1CC1	InChI=1S/C30H26F4N6O/c1-39(22-9-10-22)28(20-6-2-4-18(12-20)16-35)21-8-11-24(31)25(14-21)37-29(41)26-15-27(30(32,33)34)38-40(26)23-7-3-5-19(13-23)17-36/h2-8,11-15,22,28H,9-10,17,36H2,1H3,(H,37,41)	LONUELZOBAIWEW-UHFFFAOYSA-N	439471	US10633345, Compound 54e::US10633345, Compound 70a::US10633345, Compound 70b::US10689346, Compound 70a::US11203574, Compound 70b::US11230530, Compound 70b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439471	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439471&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355805	439661023							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133411	COc1ccc(cc1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H26F4N4O3/c1-40-21-10-8-20(9-11-21)37-24(17-26(36-37)29(31,32)33)27(38)35-23-16-19(7-12-22(23)30)28(39,14-13-18-5-6-18)25-4-2-3-15-34-25/h2-4,7-12,15-18,39H,5-6,13-14H2,1H3,(H,35,38)	YTPYYUUEYRYYOR-UHFFFAOYSA-N	416927	N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-1-(4-methoxyphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 160a::US10633345, Compound 160a::US10689346, Compound 160a::US11203574, Compound 160a::US11230530, Compound 160a::US11685721, Compound 160a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416927	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416927&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665840	433916839							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133412	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C28H26F3N5O2/c29-28(30,31)25-15-24(36(35-25)22-8-3-5-19(13-22)16-32)27(37)34-21-7-4-6-20(14-21)26(38-17-18-10-11-18)23-9-1-2-12-33-23/h1-9,12-15,18,26H,10-11,16-17,32H2,(H,34,37)	UBQUVYTUKOFUOF-UHFFFAOYSA-N	416721	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(pyridin-2-yl)methyl)-phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 43f::US10633345, Compound 43f::US10689346, Compound 43g::US11203574, Compound 43h::US11230530, Compound 43h::US11685721, Compound 43f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416721	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416721&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355947	433916635							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133413	CN(C(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1)C1CC1	InChI=1S/C30H26F4N6O/c1-39(22-9-10-22)28(20-6-2-4-18(12-20)16-35)21-8-11-24(31)25(14-21)37-29(41)26-15-27(30(32,33)34)38-40(26)23-7-3-5-19(13-23)17-36/h2-8,11-15,22,28H,9-10,17,36H2,1H3,(H,37,41)	LONUELZOBAIWEW-UHFFFAOYSA-N	439471	US10633345, Compound 54e::US10633345, Compound 70a::US10633345, Compound 70b::US10689346, Compound 70a::US11203574, Compound 70b::US11230530, Compound 70b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439471	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439471&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355805	439661023							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133414	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(O)c(Br)c1)C(F)(F)F	InChI=1S/C29H27BrF3N5O2/c30-23-13-20(9-10-25(23)39)27(35-16-17-7-8-17)19-4-2-5-21(12-19)36-28(40)24-14-26(29(31,32)33)37-38(24)22-6-1-3-18(11-22)15-34/h1-6,9-14,17,27,35,39H,7-8,15-16,34H2,(H,36,40)	VZKYGMDBRSVHHT-UHFFFAOYSA-N	416930	1-(3-(Aminomethyl)phenyl)-N-(3-((3-bromo-4-hydroxyphenyl)(cyclopropylmethylamino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 207j::US10633345, Compound 207j::US10689346, Compound 207j::US11203574, Compound 207j::US11230530, Compound 207j::US11685721, Compound 207j	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416930	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416930&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665574	433916842							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133415	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H26F3N5O2/c29-28(30,31)25-14-24(36(35-25)23-8-1-4-19(12-23)15-32)27(37)34-22-7-2-5-20(13-22)26(38-17-18-9-10-18)21-6-3-11-33-16-21/h1-8,11-14,16,18,26H,9-10,15,17,32H2,(H,34,37)	SHFRWTHPPCXLER-UHFFFAOYSA-N	416725	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(pyridin-3-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 44c::US10633345, Compound 44c::US10689346, Compound 44c::US11203574, Compound 44d::US11230530, Compound 44e::US11685721, Compound 44c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416725	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416725&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355578	433916639							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133416	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-10-9-20(28(40,12-11-18-7-8-18)25-6-1-2-13-35-25)15-23(22)36-27(39)24-16-26(29(31,32)33)37-38(24)21-5-3-4-19(14-21)17-34/h1-6,9-10,13-16,18,40H,7-8,11-12,17,34H2,(H,36,39)	XXMBQXWQIGCREG-UHFFFAOYSA-N	416909	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 59c::US10633345, Compound 69b::US10689346, Compound 59c::US11203574, Compound 69b::US11230530, Compound 69b::US11685721, Compound 69b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416909	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416909&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356067	433916821							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133417	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CCC1CC1)n1ccccc1=O)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-17-25(37(35-26)23-8-3-5-20(15-23)18-33)28(39)34-22-7-4-6-21(16-22)24(13-12-19-10-11-19)36-14-2-1-9-27(36)38/h1-9,14-17,19,24H,10-13,18,33H2,(H,34,39)	OGNFHFCMBSJJNJ-UHFFFAOYSA-N	416933	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-(2-oxopyridin-1(2H)-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 247c::US10633345, Compound 247c::US10689346, Compound 247c::US11203574, Compound 247c::US11230530, Compound 247c::US11685721, Compound 247c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416933	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416933&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356133	433916845							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133418	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H26F3N5O2/c29-28(30,31)25-14-24(36(35-25)23-8-1-4-19(12-23)15-32)27(37)34-22-7-2-5-20(13-22)26(38-17-18-9-10-18)21-6-3-11-33-16-21/h1-8,11-14,16,18,26H,9-10,15,17,32H2,(H,34,37)	SHFRWTHPPCXLER-UHFFFAOYSA-N	416725	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(pyridin-3-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 44c::US10633345, Compound 44c::US10689346, Compound 44c::US11203574, Compound 44d::US11230530, Compound 44e::US11685721, Compound 44c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416725	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416725&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355578	433916639							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133419	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-10-9-20(28(40,12-11-18-7-8-18)25-6-1-2-13-35-25)15-23(22)36-27(39)24-16-26(29(31,32)33)37-38(24)21-5-3-4-19(14-21)17-34/h1-6,9-10,13-16,18,40H,7-8,11-12,17,34H2,(H,36,39)	XXMBQXWQIGCREG-UHFFFAOYSA-N	416909	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 59c::US10633345, Compound 69b::US10689346, Compound 59c::US11203574, Compound 69b::US11230530, Compound 69b::US11685721, Compound 69b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416909	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416909&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356067	433916821							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133420	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CCC1CC1)N1CCCC1=O)C(F)(F)F	InChI=1S/C28H30F3N5O2/c29-28(30,31)25-16-24(36(34-25)22-7-1-4-19(14-22)17-32)27(38)33-21-6-2-5-20(15-21)23(12-11-18-9-10-18)35-13-3-8-26(35)37/h1-2,4-7,14-16,18,23H,3,8-13,17,32H2,(H,33,38)	LEZWAIIPWSOOAE-UHFFFAOYSA-N	416936	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-(2-oxopyrrolidin-1-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 247e::US10633345, Compound 247e::US10689346, Compound 247e::US11203574, Compound 247e::US11230530, Compound 247e::US11685721, Compound 247e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416936	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416936&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665605	433916848							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133421	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-16-25(37(36-26)24-8-1-4-20(14-24)17-33)27(38)35-23-7-2-5-21(15-23)28(39,12-11-19-9-10-19)22-6-3-13-34-18-22/h1-8,13-16,18-19,39H,9-12,17,33H2,(H,35,38)	AOCZEQQKIIWUBU-UHFFFAOYSA-N	416770	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 47f::US10633345, Compound 47f::US10689346, Compound 47f::US11203574, Compound 47g::US11230530, Compound 47h::US11685721, Compound 47f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416770	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416770&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355766	433916684							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133422	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H28F4N4O2/c31-24-12-11-22(29(40,14-13-19-9-10-19)21-6-2-1-3-7-21)16-25(24)36-28(39)26-17-27(30(32,33)34)37-38(26)23-8-4-5-20(15-23)18-35/h1-8,11-12,15-17,19,40H,9-10,13-14,18,35H2,(H,36,39)	NIWMWYNGSALJGG-UHFFFAOYSA-N	416903	Racemic 1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 68c::US10633345, Compound 68e::US10689346, Compound 68c::US11203574, Compound 68e::US11230530, Compound 68e::US11685721, Compound 68e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416903	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416903&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355758	433916816							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133423	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccccc1=O)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-11-10-20(24(12-9-18-7-8-18)37-13-2-1-6-27(37)39)15-23(22)35-28(40)25-16-26(29(31,32)33)36-38(25)21-5-3-4-19(14-21)17-34/h1-6,10-11,13-16,18,24H,7-9,12,17,34H2,(H,35,40)	OFQQGSYWUFBMPP-UHFFFAOYSA-N	416939	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(2-oxopyridin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 248j::US10633345, Compound 248k::US10689346, Compound 248k::US11203574, Compound 248k::US11230530, Compound 248k::US11685721, Compound 248k	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416939	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416939&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355727	433916851							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133424	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-16-25(37(36-26)24-8-1-4-20(14-24)17-33)27(38)35-23-7-2-5-21(15-23)28(39,12-11-19-9-10-19)22-6-3-13-34-18-22/h1-8,13-16,18-19,39H,9-12,17,33H2,(H,35,38)	AOCZEQQKIIWUBU-UHFFFAOYSA-N	416770	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 47f::US10633345, Compound 47f::US10689346, Compound 47f::US11203574, Compound 47g::US11230530, Compound 47h::US11685721, Compound 47f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416770	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416770&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355766	433916684							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133425	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H28F4N4O2/c31-24-12-11-22(29(40,14-13-19-9-10-19)21-6-2-1-3-7-21)16-25(24)36-28(39)26-17-27(30(32,33)34)37-38(26)23-8-4-5-20(15-23)18-35/h1-8,11-12,15-17,19,40H,9-10,13-14,18,35H2,(H,36,39)	NIWMWYNGSALJGG-UHFFFAOYSA-N	416903	Racemic 1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 68c::US10633345, Compound 68e::US10689346, Compound 68c::US11203574, Compound 68e::US11230530, Compound 68e::US11685721, Compound 68e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416903	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416903&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355758	433916816							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133426	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccncc1=O)C(F)(F)F	InChI=1S/C28H26F4N6O2/c29-21-8-7-19(23(9-6-17-4-5-17)37-11-10-34-16-26(37)39)13-22(21)35-27(40)24-14-25(28(30,31)32)36-38(24)20-3-1-2-18(12-20)15-33/h1-3,7-8,10-14,16-17,23H,4-6,9,15,33H2,(H,35,40)	GLPOCDKMIDNWGE-UHFFFAOYSA-N	416942	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(2-oxopyrazin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 249b::US10633345, Compound 249b::US10689346, Compound 249b::US11203574, Compound 249b::US11230530, Compound 249b::US11685721, Compound 249b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416942	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416942&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665736	433916854							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133427	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F3N4O2/c31-30(32,33)27-18-26(37(36-27)25-11-4-6-21(16-25)19-34)28(38)35-24-10-5-9-23(17-24)29(39,15-14-20-12-13-20)22-7-2-1-3-8-22/h1-11,16-18,20,39H,12-15,19,34H2,(H,35,38)	DCGYPXFSNPCKGX-UHFFFAOYSA-N	416751	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 46g::US10633345, Compound 46g::US10689346, Compound 46g::US11203574, Compound 46i::US11230530, Compound 46i::US11685721, Compound 46g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416751	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416751&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355790	433916665							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133428	COc1ccc2ccccc2c1C(NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H31F4N5O2/c1-45-29-14-12-22-6-2-3-8-25(22)31(29)32(40-19-20-9-10-20)23-11-13-26(35)27(16-23)41-33(44)28-17-30(34(36,37)38)42-43(28)24-7-4-5-21(15-24)18-39/h2-8,11-17,20,32,40H,9-10,18-19,39H2,1H3,(H,41,44)	AYMFYNZEWAELBE-UHFFFAOYSA-N	416906	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(2-methoxynaphthalen-1-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide dihydrochloride::US10329260, Compound 61e::US10633345, Compound 63b::US10689346, Compound 61e::US11203574, Compound 63b::US11230530, Compound 63b::US11685721, Compound 63b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416906	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416906&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355591	433916818							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133429	Fc1ccc(cc1NC(=O)c1cc(nn1-c1cccc(c1)C#N)C(F)(F)F)C(CCC1CC1)Oc1ccccn1	InChI=1S/C29H23F4N5O2/c30-22-11-10-20(25(12-9-18-7-8-18)40-27-6-1-2-13-35-27)15-23(22)36-28(39)24-16-26(29(31,32)33)37-38(24)21-5-3-4-19(14-21)17-34/h1-6,10-11,13-16,18,25H,7-9,12H2,(H,36,39)	SGHCSSRTSJXCIZ-UHFFFAOYSA-N	447737	US10689346, Compound 250c::US11203574, Compound 250c::US11230530, Compound 250c::US11685721, Compound 250c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=447737	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=447737&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355856	440709842							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133430	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F3N4O2/c31-30(32,33)27-18-26(37(36-27)25-11-4-6-21(16-25)19-34)28(38)35-24-10-5-9-23(17-24)29(39,15-14-20-12-13-20)22-7-2-1-3-8-22/h1-11,16-18,20,39H,12-15,19,34H2,(H,35,38)	DCGYPXFSNPCKGX-UHFFFAOYSA-N	416751	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 46g::US10633345, Compound 46g::US10689346, Compound 46g::US11203574, Compound 46i::US11230530, Compound 46i::US11685721, Compound 46g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416751	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416751&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355790	433916665							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133431	COc1ccc2ccccc2c1C(NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H31F4N5O2/c1-45-29-14-12-22-6-2-3-8-25(22)31(29)32(40-19-20-9-10-20)23-11-13-26(35)27(16-23)41-33(44)28-17-30(34(36,37)38)42-43(28)24-7-4-5-21(15-24)18-39/h2-8,11-17,20,32,40H,9-10,18-19,39H2,1H3,(H,41,44)	AYMFYNZEWAELBE-UHFFFAOYSA-N	416906	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(2-methoxynaphthalen-1-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide dihydrochloride::US10329260, Compound 61e::US10633345, Compound 63b::US10689346, Compound 61e::US11203574, Compound 63b::US11230530, Compound 63b::US11685721, Compound 63b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416906	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416906&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355591	433916818							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133432	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(=CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H26F4N4O/c31-25-14-12-22(24(13-11-19-9-10-19)21-6-2-1-3-7-21)16-26(25)36-29(39)27-17-28(30(32,33)34)37-38(27)23-8-4-5-20(15-23)18-35/h1-8,12-17,19H,9-11,18,35H2,(H,36,39)/b24-13-	BAAJKWZPAGFHDE-CFRMEGHHSA-N	416948	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-phenylprop-1-enyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 252c::US10633345, Compound 252c::US10689346, Compound 252c::US11203574, Compound 252c::US11230530, Compound 252c::US11685721, Compound 252c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416948	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416948&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			140777564	433916860							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133433	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H25F4N5O2/c29-22-9-8-19(26(39-16-17-6-7-17)20-4-2-10-34-15-20)12-23(22)35-27(38)24-13-25(28(30,31)32)36-37(24)21-5-1-3-18(11-21)14-33/h1-5,8-13,15,17,26H,6-7,14,16,33H2,(H,35,38)	CNAFOXQNPWSINI-UHFFFAOYSA-N	416794	Racemic 1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethoxy)(pyridin-3-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 48f::US10633345, Compound 48f::US10689346, Compound 48f::US11203574, Compound 48g::US11230530, Compound 48h::US11685721, Compound 48f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416794	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416794&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355617	433916708							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133434	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C30H25F4N5O2/c31-24-11-10-22(28(41-17-19-4-5-19)21-8-6-18(15-35)7-9-21)13-25(24)37-29(40)26-14-27(30(32,33)34)38-39(26)23-3-1-2-20(12-23)16-36/h1-3,6-14,19,28H,4-5,16-17,36H2,(H,37,40)	WXFHQCUXOOXGLO-UHFFFAOYSA-N	416894	1-(3-(aminomethyl)phenyl)-N-(5-((4-cyanophenyl)(cyclopropylmethoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 55b::US10633345, Compound 73b::US10689346, Compound 55b::US11203574, Compound 73b::US11230530, Compound 73b::US11685721, Compound 73b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416894	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416894&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665569	433916807							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133435	CN1CCCN(CC1)C(CCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H36F4N6O/c1-38-12-3-13-39(15-14-38)26(11-8-20-6-7-20)22-9-10-24(31)25(17-22)36-29(41)27-18-28(30(32,33)34)37-40(27)23-5-2-4-21(16-23)19-35/h2,4-5,9-10,16-18,20,26H,3,6-8,11-15,19,35H2,1H3,(H,36,41)	WXRMFESIILBOBA-UHFFFAOYSA-N	416951	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(4-methyl-1,4-diazepan-1-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 251e::US10633345, Compound 251e::US10689346, Compound 251e::US11203574, Compound 251e::US11230530, Compound 251e::US11685721, Compound 251e	Plasma kallikrein		>75.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416951	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416951&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355664	433916863							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133436	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H25F4N5O2/c29-22-9-8-19(26(39-16-17-6-7-17)20-4-2-10-34-15-20)12-23(22)35-27(38)24-13-25(28(30,31)32)36-37(24)21-5-1-3-18(11-21)14-33/h1-5,8-13,15,17,26H,6-7,14,16,33H2,(H,35,38)	CNAFOXQNPWSINI-UHFFFAOYSA-N	416794	Racemic 1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethoxy)(pyridin-3-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 48f::US10633345, Compound 48f::US10689346, Compound 48f::US11203574, Compound 48g::US11230530, Compound 48h::US11685721, Compound 48f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416794	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416794&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355617	433916708							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133437	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C30H25F4N5O2/c31-24-11-10-22(28(41-17-19-4-5-19)21-8-6-18(15-35)7-9-21)13-25(24)37-29(40)26-14-27(30(32,33)34)38-39(26)23-3-1-2-20(12-23)16-36/h1-3,6-14,19,28H,4-5,16-17,36H2,(H,37,40)	WXFHQCUXOOXGLO-UHFFFAOYSA-N	416894	1-(3-(aminomethyl)phenyl)-N-(5-((4-cyanophenyl)(cyclopropylmethoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 55b::US10633345, Compound 73b::US10689346, Compound 55b::US11203574, Compound 73b::US11230530, Compound 73b::US11685721, Compound 73b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416894	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416894&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665569	433916807							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133438	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)N1C(=O)CCC1=O)C(F)(F)F	InChI=1S/C28H27F4N5O3/c29-20-8-7-18(22(9-6-16-4-5-16)36-25(38)10-11-26(36)39)13-21(20)34-27(40)23-14-24(28(30,31)32)35-37(23)19-3-1-2-17(12-19)15-33/h1-3,7-8,12-14,16,22H,4-6,9-11,15,33H2,(H,34,40)	ZAWTZVLCOQSDBX-UHFFFAOYSA-N	416954	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(2,5-dioxopyrrolidin-1-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 260b::US10633345, Compound 260b::US10689346, Compound 260b::US11203574, Compound 260b::US11230530, Compound 260b::US11685721, Compound 260b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416954	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416954&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665563	433916866							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133439	COc1ccc2ccccc2c1C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H32F3N5O2/c1-44-29-15-14-23-7-2-3-11-27(23)31(29)32(39-20-21-12-13-21)24-8-5-9-25(17-24)40-33(43)28-18-30(34(35,36)37)41-42(28)26-10-4-6-22(16-26)19-38/h2-11,14-18,21,32,39H,12-13,19-20,38H2,1H3,(H,40,43)	XVOUQCJHWNZPKF-UHFFFAOYSA-N	416841	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2-methoxynaphthalen-1-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 51f::US10633345, Compound 51f::US10689346, Compound 51f::US11203574, Compound 51h::US11230530, Compound 51h::US11685721, Compound 51f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416841	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416841&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356155	433916754							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133440	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C30H25F4N5O2/c31-24-10-9-22(28(41-17-18-7-8-18)21-5-1-3-19(11-21)15-35)13-25(24)37-29(40)26-14-27(30(32,33)34)38-39(26)23-6-2-4-20(12-23)16-36/h1-6,9-14,18,28H,7-8,16-17,36H2,(H,37,40)	LSXFYXGKZDVRTL-UHFFFAOYSA-N	416900	1-(3-(aminomethyl)phenyl)-N-(5-((3-cyanophenyl)(cyclopropyl-methoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 56c::US10633345, Compound 72d::US10689346, Compound 56c::US11203574, Compound 72d::US11230530, Compound 72d::US11685721, Compound 72d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416900	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416900&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356211	433916813							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133441	CS(=O)(=O)NC(CCC1CC1)(c1ccncc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2ccc3ccnc(N)c3c2)C(F)(F)F)c1	InChI=1S/C32H29F4N7O3S/c1-47(45,46)42-31(12-8-19-2-3-19,21-10-13-38-14-11-21)22-5-7-25(33)26(16-22)40-30(44)27-18-28(32(34,35)36)41-43(27)23-6-4-20-9-15-39-29(37)24(20)17-23/h4-7,9-11,13-19,42H,2-3,8,12H2,1H3,(H2,37,39)(H,40,44)	WOIASLBXHIHYRY-UHFFFAOYSA-N	416957	(+-)-1-(1-aminoisoquinolin-7-yl)-N-(5-(3-cyclopropyl-1-(methylsulfonamido)-1-(pyridin-4-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 262f::US10633345, Compound 262f::US10689346, Compound 262f::US11192861, Compound 262f::US11230530, Compound 262f::US11685721, Compound 262f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416957	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416957&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355636	433916869							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133442	COc1ccc2ccccc2c1C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H32F3N5O2/c1-44-29-15-14-23-7-2-3-11-27(23)31(29)32(39-20-21-12-13-21)24-8-5-9-25(17-24)40-33(43)28-18-30(34(35,36)37)41-42(28)26-10-4-6-22(16-26)19-38/h2-11,14-18,21,32,39H,12-13,19-20,38H2,1H3,(H,40,43)	XVOUQCJHWNZPKF-UHFFFAOYSA-N	416841	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2-methoxynaphthalen-1-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 51f::US10633345, Compound 51f::US10689346, Compound 51f::US11203574, Compound 51h::US11230530, Compound 51h::US11685721, Compound 51f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416841	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416841&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356155	433916754							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133443	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C30H25F4N5O2/c31-24-10-9-22(28(41-17-18-7-8-18)21-5-1-3-19(11-21)15-35)13-25(24)37-29(40)26-14-27(30(32,33)34)38-39(26)23-6-2-4-20(12-23)16-36/h1-6,9-14,18,28H,7-8,16-17,36H2,(H,37,40)	LSXFYXGKZDVRTL-UHFFFAOYSA-N	416900	1-(3-(aminomethyl)phenyl)-N-(5-((3-cyanophenyl)(cyclopropyl-methoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 56c::US10633345, Compound 72d::US10689346, Compound 56c::US11203574, Compound 72d::US11230530, Compound 72d::US11685721, Compound 72d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416900	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416900&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356211	433916813							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133444	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccc(=O)[nH]c1=O)C(F)(F)F			416960	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 263d::US10633345, Compound 263d::US10689346, Compound 263d::US11203574, Compound 263d::US11230530, Compound 263d::US11685721, Compound 263d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416960	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416960&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			154584232	433916872							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116375	COCc1nn(Cc2cnc(nc2)N2CCCC2)cc1C(=O)NCc1cc(OC)ccc1-n1cnnn1	InChI=1S/C24H28N10O3/c1-36-15-21-20(14-33(29-21)13-17-10-26-24(27-11-17)32-7-3-4-8-32)23(35)25-12-18-9-19(37-2)5-6-22(18)34-16-28-30-31-34/h5-6,9-11,14,16H,3-4,7-8,12-13,15H2,1-2H3,(H,25,35)	OLELYTACRIKUHK-UHFFFAOYSA-N	528129	N-{[5-methoxy-2-(1,2,3,4-tetrazol-1-yl)phenyl]methyl}-3-(methoxymethyl)-1-{[2- (pyrrolidin-1-yl)pyrimidin-5-yl]methyl}pyrazole-4-carboxamide::US11180484, Example 80	Plasma kallikrein			 10.6							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528129	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528129&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301873	463791681							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116379	COc1ccc(c(CNC(=O)c2cn(Cc3ccc(nc3)N3CCCC3)nc2C(F)(F)F)c1F)-n1cnnn1	InChI=1S/C24H23F4N9O2/c1-39-19-6-5-18(37-14-31-33-34-37)16(21(19)25)11-30-23(38)17-13-36(32-22(17)24(26,27)28)12-15-4-7-20(29-10-15)35-8-2-3-9-35/h4-7,10,13-14H,2-3,8-9,11-12H2,1H3,(H,30,38)	SHZUCTHKVWMOJI-UHFFFAOYSA-N	528130	N-{[2-fluoro-3-methoxy-6-(1,2,3,4-tetrazol-1-yl)phenyl]methyl}-1-{[6-(pyrrolidin-1- yl)pyridin-3-yl]methyl}-3-(trifluoromethyl)pyrazole-4-carboxamide::US11180484, Example 83	Plasma kallikrein			 0.300							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528130	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528130&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301859	463791682							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116383	COCc1nn(Cc2cnc(nc2)N2CCC(F)(F)C2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cnnn1	InChI=1S/C24H25F3N10O3/c1-39-12-18-17(11-36(32-18)10-15-7-29-23(30-8-15)35-6-5-24(26,27)13-35)22(38)28-9-16-19(37-14-31-33-34-37)3-4-20(40-2)21(16)25/h3-4,7-8,11,14H,5-6,9-10,12-13H2,1-2H3,(H,28,38)	CEOSELUUHJNGPA-UHFFFAOYSA-N	528131	1-{[2-(3,3-Difluoropyrrolidin-1-yl)pyrimidin-5-yl]methyl}-N-{[2-fluoro-3-methoxy-6-(1,2,3,4-tetrazol-1-yl)phenyl]methyl}-3-(methoxymethyl)pyrazole-4-carboxamide::US11180484, Example 86	Plasma kallikrein			 1.70							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528131	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528131&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301811	463791683							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116387	COCc1nn(Cc2ccc(nc2)N2CCC(F)(F)C2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cnnn1	InChI=1S/C25H26F3N9O3/c1-39-13-19-18(12-36(32-19)11-16-3-6-22(29-9-16)35-8-7-25(27,28)14-35)24(38)30-10-17-20(37-15-31-33-34-37)4-5-21(40-2)23(17)26/h3-6,9,12,15H,7-8,10-11,13-14H2,1-2H3,(H,30,38)	HWYRMCCHOBIHJO-UHFFFAOYSA-N	528132	1-{[6-(3,3-difluoropyrrolidin-1-yl)pyridin-3-yl]methyl}-N-{[2-fluoro-3-methoxy-6- (1,2,3,4-tetrazol-1-yl)phenyl]methyl}-3-(methoxymethyl)pyrazole-4-carboxamide::US11180484, Example 87	Plasma kallikrein			 0.800							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528132	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528132&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301856	463791684							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116391	COCc1nn(Cc2cnc(nc2)N2CCC(F)(F)C2)cc1C(=O)NCc1cc(OC)ccc1-n1cnnn1	InChI=1S/C24H26F2N10O3/c1-38-13-20-19(22(37)27-10-17-7-18(39-2)3-4-21(17)36-15-30-32-33-36)12-35(31-20)11-16-8-28-23(29-9-16)34-6-5-24(25,26)14-34/h3-4,7-9,12,15H,5-6,10-11,13-14H2,1-2H3,(H,27,37)	GXMGYLDFFLDKJK-UHFFFAOYSA-N	528133	1-{[2-(3,3-difluoropyrrolidin-1-yl)pyrimidin-5-yl]methyl}-N-{[5-methoxy-2-(1,2,3,4- tetrazol-1-yl)phenyl]methyl}-3-(methoxymethyl)pyrazole-4-carboxamide::US11180484, Example 88	Plasma kallikrein			 8.30							US Patent		10.7270/Q2MG7SP5		aid1806151	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528133	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528133&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			132190827	463791685							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116395	COc1cccc(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2N)c1F	InChI=1S/C25H24FN5O3/c1-34-21-6-4-5-19(23(21)26)13-28-25(33)20-16-31(29-24(20)27)15-18-10-8-17(9-11-18)14-30-12-3-2-7-22(30)32/h2-12,16H,13-15H2,1H3,(H2,27,29)(H,28,33)	HICYNMRHZGAFMT-UHFFFAOYSA-N	408666	3-Amino-1-[4-(2-oxo-2H-pyridin-1-ylmethyl)-benzyl]-1H-pyrazole-4-carboxylic acid 2-fluoro-3-methoxy-benzylamide::US10364238, Example 2::US11001578, Example 2::US11084809, Example 2::US11198691, Example 2	Plasma kallikrein		 6.70								US Patent		10.7270/Q2MG7SP5		aid1806155	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408666	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408666&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365045	406799300							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116396	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(F)cccc1-n1cnnn1	InChI=1S/C27H25FN8O3/c1-39-17-24-22(27(38)29-13-21-23(28)5-4-6-25(21)36-18-30-32-33-36)16-35(31-24)15-20-10-8-19(9-11-20)14-34-12-3-2-7-26(34)37/h2-12,16,18H,13-15,17H2,1H3,(H,29,38)	RFDDQESTEHOGAA-UHFFFAOYSA-N	528074	N-{[2-Fluoro-6-(1,2,3,4-tetrazol-1-yl)phenyl]methyl}-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US11180484, Reference Example H	Plasma kallikrein		 0.520								US Patent		10.7270/Q2MG7SP5		aid1806155	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528074	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528074&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365143	463791630							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116397	COc1ccc(Cl)c(CNC(=O)c2cn(Cc3ccc4nc(C)ccc4c3)nn2)c1F	InChI=1S/C22H19ClFN5O2/c1-13-3-5-15-9-14(4-7-18(15)26-13)11-29-12-19(27-28-29)22(30)25-10-16-17(23)6-8-20(31-2)21(16)24/h3-9,12H,10-11H2,1-2H3,(H,25,30)	DFJBJVOVYHHCOV-UHFFFAOYSA-N	528077	N-i6-chloro-2-fluoro-3-methoxybenzyl)-1 -ii2-methylquinolin-6-yl)methyl)-1 H-1 ,2,3-triazole-4-carboxamide::US11180484, Example 14 from WO 013/111108	Plasma kallikrein		 139								US Patent		10.7270/Q2MG7SP5		aid1806155	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528077	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528077&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71679117	463791632							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116398	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1nccc(OC)c1C	InChI=1S/C27H29N5O4/c1-19-23(28-12-11-25(19)36-3)14-29-27(34)22-17-32(30-24(22)18-35-2)16-21-9-7-20(8-10-21)15-31-13-5-4-6-26(31)33/h4-13,17H,14-16,18H2,1-3H3,(H,29,34)	BUIQZUSRWDPBSM-UHFFFAOYSA-N	528094	N-[(4-methoxy-3-methylpyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[(2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US11180484, Example 22	Plasma kallikrein		 1.90								US Patent		10.7270/Q2MG7SP5		aid1806155	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528094	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528094&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301877	463791648							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116399	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cnnn1	InChI=1S/C28H27FN8O4/c1-40-17-23-22(28(39)30-13-21-24(37-18-31-33-34-37)10-11-25(41-2)27(21)29)16-36(32-23)15-20-8-6-19(7-9-20)14-35-12-4-3-5-26(35)38/h3-12,16,18H,13-15,17H2,1-2H3,(H,30,39)	CQJUCEDANVNSLY-UHFFFAOYSA-N	528105	N-{[2-fluoro-3-methoxy-6-(1,2,3,4-tetrazol-1-yl)phenyl]methyl}-3-(methoxymethyl)- 1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US11180484, Example 39	Plasma kallikrein		 0.260								US Patent		10.7270/Q2MG7SP5		aid1806155	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528105	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528105&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301841	463791659							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116400	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(OC)ccc1-n1cnnn1	InChI=1S/C28H28N8O4/c1-39-18-25-24(28(38)29-14-22-13-23(40-2)10-11-26(22)36-19-30-32-33-36)17-35(31-25)16-21-8-6-20(7-9-21)15-34-12-4-3-5-27(34)37/h3-13,17,19H,14-16,18H2,1-2H3,(H,29,38)	GOOYDEXCZNZXML-UHFFFAOYSA-N	528106	N-{[5-methoxy-2-(1,2,3,4-tetrazol-1-yl)phenyl]methyl}-3-(methoxymethyl)-1-({4-[(2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US11180484, Example 40	Plasma kallikrein		 0.100								US Patent		10.7270/Q2MG7SP5		aid1806155	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528106	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528106&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			132190788	463791660							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116401	COCc1nn(Cc2ccc(Cn3cc(C)cn3)cc2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cnnn1	InChI=1S/C27H28FN9O3/c1-18-10-31-35(12-18)13-19-4-6-20(7-5-19)14-36-15-22(23(32-36)16-39-2)27(38)29-11-21-24(37-17-30-33-34-37)8-9-25(40-3)26(21)28/h4-10,12,15,17H,11,13-14,16H2,1-3H3,(H,29,38)	RBMQELRIPLOTLF-UHFFFAOYSA-N	528119	N-{[2-fluoro-3-methoxy-6-(1,2,3,4-tetrazol-1-yl)phenyl]methyl}-3-(methoxymethyl)- 1-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US11180484, Example 60	Plasma kallikrein		 0.300								US Patent		10.7270/Q2MG7SP5		aid1806155	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528119	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528119&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			132190780	463791672							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116402	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(Cl)ccc1-n1cnnn1	InChI=1S/C27H25ClN8O3/c1-39-17-24-23(27(38)29-13-21-12-22(28)9-10-25(21)36-18-30-32-33-36)16-35(31-24)15-20-7-5-19(6-8-20)14-34-11-3-2-4-26(34)37/h2-12,16,18H,13-15,17H2,1H3,(H,29,38)	HXIVOBRAPHEKKR-UHFFFAOYSA-N	528123	N-{[5-chloro-2-(1,2,3,4-tetrazol-1-yl)phenyl]methyl}-3-(methoxymethyl)-1-({4-[(2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US11180484, Example 72	Plasma kallikrein		 0.160								US Patent		10.7270/Q2MG7SP5		aid1806155	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528123	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528123&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301839	463791676							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116403	COCc1nn(Cc2ccc(nc2)N2CCCC2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cnnn1	InChI=1S/C25H28FN9O3/c1-37-15-20-19(14-34(30-20)13-17-5-8-23(27-11-17)33-9-3-4-10-33)25(36)28-12-18-21(35-16-29-31-32-35)6-7-22(38-2)24(18)26/h5-8,11,14,16H,3-4,9-10,12-13,15H2,1-2H3,(H,28,36)	DGIRMJAUTLUPMU-UHFFFAOYSA-N	455297	US10730874, Compound TABLE II.2::US11180484, Example 77::US11352356, Table II.2	Plasma kallikrein		 0.170								US Patent		10.7270/Q2MG7SP5		aid1806155	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455297	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455297&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301849	440971115							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116404	COCc1nn(Cc2cnc(nc2)N2CCCC2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cnnn1	InChI=1S/C24H27FN10O3/c1-37-14-19-18(13-34(30-19)12-16-9-27-24(28-10-16)33-7-3-4-8-33)23(36)26-11-17-20(35-15-29-31-32-35)5-6-21(38-2)22(17)25/h5-6,9-10,13,15H,3-4,7-8,11-12,14H2,1-2H3,(H,26,36)	GSFPQMPKJFXLTO-UHFFFAOYSA-N	528127	US11180484, Example 79::US11180484, Reference Example K::US11613527, Example RC4	Plasma kallikrein		 0.380								US Patent		10.7270/Q2MG7SP5		aid1806155	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528127	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528127&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			132203422	463791680							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116405	COCc1nn(Cc2cnc(nc2)N2CCCC2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cnnn1	InChI=1S/C24H27FN10O3/c1-37-14-19-18(13-34(30-19)12-16-9-27-24(28-10-16)33-7-3-4-8-33)23(36)26-11-17-20(35-15-29-31-32-35)5-6-21(38-2)22(17)25/h5-6,9-10,13,15H,3-4,7-8,11-12,14H2,1-2H3,(H,26,36)	GSFPQMPKJFXLTO-UHFFFAOYSA-N	528127	US11180484, Example 79::US11180484, Reference Example K::US11613527, Example RC4	Plasma kallikrein		 0.230								US Patent		10.7270/Q2MG7SP5		aid1806155	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528127	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528127&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			132203422	463791680							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116406	COCc1nn(Cc2cnc(nc2)N2CCCC2)cc1C(=O)NCc1cc(OC)ccc1-n1cnnn1	InChI=1S/C24H28N10O3/c1-36-15-21-20(14-33(29-21)13-17-10-26-24(27-11-17)32-7-3-4-8-32)23(35)25-12-18-9-19(37-2)5-6-22(18)34-16-28-30-31-34/h5-6,9-11,14,16H,3-4,7-8,12-13,15H2,1-2H3,(H,25,35)	OLELYTACRIKUHK-UHFFFAOYSA-N	528129	N-{[5-methoxy-2-(1,2,3,4-tetrazol-1-yl)phenyl]methyl}-3-(methoxymethyl)-1-{[2- (pyrrolidin-1-yl)pyrimidin-5-yl]methyl}pyrazole-4-carboxamide::US11180484, Example 80	Plasma kallikrein		 2.40								US Patent		10.7270/Q2MG7SP5		aid1806155	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528129	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528129&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301873	463791681							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116407	COc1ccc(c(CNC(=O)c2cn(Cc3ccc(nc3)N3CCCC3)nc2C(F)(F)F)c1F)-n1cnnn1	InChI=1S/C24H23F4N9O2/c1-39-19-6-5-18(37-14-31-33-34-37)16(21(19)25)11-30-23(38)17-13-36(32-22(17)24(26,27)28)12-15-4-7-20(29-10-15)35-8-2-3-9-35/h4-7,10,13-14H,2-3,8-9,11-12H2,1H3,(H,30,38)	SHZUCTHKVWMOJI-UHFFFAOYSA-N	528130	N-{[2-fluoro-3-methoxy-6-(1,2,3,4-tetrazol-1-yl)phenyl]methyl}-1-{[6-(pyrrolidin-1- yl)pyridin-3-yl]methyl}-3-(trifluoromethyl)pyrazole-4-carboxamide::US11180484, Example 83	Plasma kallikrein		 0.530								US Patent		10.7270/Q2MG7SP5		aid1806155	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528130	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528130&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301859	463791682							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116408	COCc1nn(Cc2cnc(nc2)N2CCC(F)(F)C2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cnnn1	InChI=1S/C24H25F3N10O3/c1-39-12-18-17(11-36(32-18)10-15-7-29-23(30-8-15)35-6-5-24(26,27)13-35)22(38)28-9-16-19(37-14-31-33-34-37)3-4-20(40-2)21(16)25/h3-4,7-8,11,14H,5-6,9-10,12-13H2,1-2H3,(H,28,38)	CEOSELUUHJNGPA-UHFFFAOYSA-N	528131	1-{[2-(3,3-Difluoropyrrolidin-1-yl)pyrimidin-5-yl]methyl}-N-{[2-fluoro-3-methoxy-6-(1,2,3,4-tetrazol-1-yl)phenyl]methyl}-3-(methoxymethyl)pyrazole-4-carboxamide::US11180484, Example 86	Plasma kallikrein		 0.280								US Patent		10.7270/Q2MG7SP5		aid1806155	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528131	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528131&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301811	463791683							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1116409	COCc1nn(Cc2cnc(nc2)N2CCC(F)(F)C2)cc1C(=O)NCc1cc(OC)ccc1-n1cnnn1	InChI=1S/C24H26F2N10O3/c1-38-13-20-19(22(37)27-10-17-7-18(39-2)3-4-21(17)36-15-30-32-33-36)12-35(31-20)11-16-8-28-23(29-9-16)34-6-5-24(25,26)14-34/h3-4,7-9,12,15H,5-6,10-11,13-14H2,1-2H3,(H,27,37)	GXMGYLDFFLDKJK-UHFFFAOYSA-N	528133	1-{[2-(3,3-difluoropyrrolidin-1-yl)pyrimidin-5-yl]methyl}-N-{[5-methoxy-2-(1,2,3,4- tetrazol-1-yl)phenyl]methyl}-3-(methoxymethyl)pyrazole-4-carboxamide::US11180484, Example 88	Plasma kallikrein		 2.90								US Patent		10.7270/Q2MG7SP5		aid1806155	US11180484	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Pethen, SJ; Rooker, DP	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528133	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528133&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			132190827	463791685							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133445	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-25(37(36-26)24-9-1-4-19(12-24)16-33)28(38)35-23-8-3-6-21(14-23)27(39-17-18-10-11-18)20-5-2-7-22(34)13-20/h1-9,12-15,18,27H,10-11,16-17,33-34H2,(H,35,38)	FPQYUIIRVBKUDH-UHFFFAOYSA-N	416867	1-(3-(aminomethyl)phenyl)-N-(3-((3-aminophenyl)(cyclopropyl-methoxy)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 53f::US10633345, Compound 53f::US10689346, Compound 53f::US11203574, Compound 64b::US11230530, Compound 64b::US11685721, Compound 49j	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416867	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416867&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355845	433916780							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133446	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1O)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-11-10-19(27(35-16-17-8-9-17)21-6-1-2-7-25(21)39)13-23(22)36-28(40)24-14-26(29(31,32)33)37-38(24)20-5-3-4-18(12-20)15-34/h1-7,10-14,17,27,35,39H,8-9,15-16,34H2,(H,36,40)	CKWWRAGQIQAYTL-UHFFFAOYSA-N	416856	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(2-hydroxyphenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 60e::US10633345, Compound 66b::US10689346, Compound 60e::US11203574, Compound 66b::US11230530, Compound 66b::US11685721, Compound 60e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416856	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416856&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665480	433916769							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133447	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1ccc(cc1F)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-23-14-21(27(39-17-18-9-10-18)20-6-2-1-3-7-20)11-12-24(23)35-28(38)25-15-26(29(31,32)33)36-37(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27H,9-10,16-17,34H2,(H,35,38)	HBXVQXKJLUQKAE-UHFFFAOYSA-N	416963	1-(3-(aminomethyl)phenyl)-N-(4-((cyclopropylmethoxy)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 15g::US10633345, Compound 15g::US10689346, Compound 15g::US11203574, Compound 15g::US11230530, Compound 15g::US11685721, Compound 15g	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416963	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416963&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355605	433916875							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133448	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-25(37(36-26)24-9-1-4-19(12-24)16-33)28(38)35-23-8-3-6-21(14-23)27(39-17-18-10-11-18)20-5-2-7-22(34)13-20/h1-9,12-15,18,27H,10-11,16-17,33-34H2,(H,35,38)	FPQYUIIRVBKUDH-UHFFFAOYSA-N	416867	1-(3-(aminomethyl)phenyl)-N-(3-((3-aminophenyl)(cyclopropyl-methoxy)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 53f::US10633345, Compound 53f::US10689346, Compound 53f::US11203574, Compound 64b::US11230530, Compound 64b::US11685721, Compound 49j	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416867	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416867&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355845	433916780							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133449	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1O)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-11-10-19(27(35-16-17-8-9-17)21-6-1-2-7-25(21)39)13-23(22)36-28(40)24-14-26(29(31,32)33)37-38(24)20-5-3-4-18(12-20)15-34/h1-7,10-14,17,27,35,39H,8-9,15-16,34H2,(H,36,40)	CKWWRAGQIQAYTL-UHFFFAOYSA-N	416856	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(2-hydroxyphenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 60e::US10633345, Compound 66b::US10689346, Compound 60e::US11203574, Compound 66b::US11230530, Compound 66b::US11685721, Compound 60e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416856	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416856&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665480	433916769							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133450	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1ccc(cc1F)C(O)c1ccccc1)C(F)(F)F	InChI=1S/C25H20F4N4O2/c26-19-12-17(23(34)16-6-2-1-3-7-16)9-10-20(19)31-24(35)21-13-22(25(27,28)29)32-33(21)18-8-4-5-15(11-18)14-30/h1-13,23,34H,14,30H2,(H,31,35)	WVBOXESRKOBMTK-UHFFFAOYSA-N	416966	1-(3-(Aminomethyl)phenyl)-N-(2-fluoro-4-(hydroxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 16b::US10633345, Compound 16b::US10689346, Compound 16b::US11203574, Compound 16b::US11230530, Compound 16b::US11685721, Compound 16b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416966	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416966&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665483	433916878							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133451	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1O)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-24(37(36-26)22-8-3-5-19(13-22)16-33)28(39)35-21-7-4-6-20(14-21)27(34-17-18-11-12-18)23-9-1-2-10-25(23)38/h1-10,13-15,18,27,34,38H,11-12,16-17,33H2,(H,35,39)	PCNDJIQOMLHSEK-UHFFFAOYSA-N	416837	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2-hydroxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 49h::US10633345, Compound 49h::US10689346, Compound 49h::US11203574, Compound 49j::US11230530, Compound 49j::US11685721, Compound 49h	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416837	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416837&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355733	433916750							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133452	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-23-12-11-21(27(39-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)35-28(38)25-15-26(29(31,32)33)36-37(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27H,9-10,16-17,34H2,(H,35,38)	HIMJVDQVZQMIPM-UHFFFAOYSA-N	416747	1-(3-(Aminomethyl)phenyl)-N-(5-((cyclopropylmethoxy)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 34c::US10633345, Compound 34c::US10689346, Compound 34c::US11203574, Compound 37a::US11230530, Compound 37a::US11685721, Compound 34c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416747	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416747&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355729	433916661							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133453	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1c(F)cccc1C(O)c1ccccc1)C(F)(F)F	InChI=1S/C25H20F4N4O2/c26-19-11-5-10-18(23(34)16-7-2-1-3-8-16)22(19)31-24(35)20-13-21(25(27,28)29)32-33(20)17-9-4-6-15(12-17)14-30/h1-13,23,34H,14,30H2,(H,31,35)	PIMJYQUHLMMZIO-UHFFFAOYSA-N	416969	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-6-(hydroxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 90f::US10633345, Compound 90f::US10689346, Compound 90f::US11203574, Compound 90f::US11230530, Compound 90f::US11685721, Compound 90f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416969	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416969&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356272	433916881							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133454	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1O)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-24(37(36-26)22-8-3-5-19(13-22)16-33)28(39)35-21-7-4-6-20(14-21)27(34-17-18-11-12-18)23-9-1-2-10-25(23)38/h1-10,13-15,18,27,34,38H,11-12,16-17,33H2,(H,35,39)	PCNDJIQOMLHSEK-UHFFFAOYSA-N	416837	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2-hydroxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 49h::US10633345, Compound 49h::US10689346, Compound 49h::US11203574, Compound 49j::US11230530, Compound 49j::US11685721, Compound 49h	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416837	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416837&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355733	433916750							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133455	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-23-12-11-21(27(39-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)35-28(38)25-15-26(29(31,32)33)36-37(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27H,9-10,16-17,34H2,(H,35,38)	HIMJVDQVZQMIPM-UHFFFAOYSA-N	416747	1-(3-(Aminomethyl)phenyl)-N-(5-((cyclopropylmethoxy)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 34c::US10633345, Compound 34c::US10689346, Compound 34c::US11203574, Compound 37a::US11230530, Compound 37a::US11685721, Compound 34c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416747	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416747&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355729	433916661							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133456	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N(CC1CC1)CC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C33H33F4N5O/c34-27-14-13-25(31(24-6-2-1-3-7-24)41(19-21-9-10-21)20-22-11-12-22)16-28(27)39-32(43)29-17-30(33(35,36)37)40-42(29)26-8-4-5-23(15-26)18-38/h1-8,13-17,21-22,31H,9-12,18-20,38H2,(H,39,43)	FVEYNTAGBBDICV-UHFFFAOYSA-N	416972	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-((bis(cyclopropylmethyl)amino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 206d::US10633345, Compound 206d::US10689346, Compound 206d::US11203574, Compound 206d::US11230530, Compound 206d::US11685721, Compound 206d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416972	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416972&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355791	433916884							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133457	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C#N)C(N)=O	InChI=1S/C31H30FN7O2/c32-25-11-10-23(31(36,13-12-19-4-5-19)22-8-6-20(17-33)7-9-22)15-26(25)37-30(41)28-16-27(29(35)40)38-39(28)24-3-1-2-21(14-24)18-34/h1-3,6-11,14-16,19H,4-5,12-13,18,34,36H2,(H2,35,40)(H,37,41)	BCLQAOJZVSDWEP-UHFFFAOYSA-N	416973	(+)-N5-(5-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-1H-pyrazole-3,5-dicarboxamide::US10329260, Compound 231d::US10633345, Compound 231d::US10689346, Compound 231d::US11203574, Compound 231d::US11230530, Compound 231d::US11685721, Compound 231d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416973	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416973&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665708	433916885							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133458	CC(C)(C)C(=O)NC(CCC1CC1)(c1cccnc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H36F4N6O2/c1-32(2,3)31(46)42-33(14-13-21-9-10-21,24-7-5-15-40-20-24)23-11-12-26(35)27(17-23)41-30(45)28-18-29(34(36,37)38)43-44(28)25-8-4-6-22(16-25)19-39/h4-8,11-12,15-18,20-21H,9-10,13-14,19,39H2,1-3H3,(H,41,45)(H,42,46)	QDJVSPVHYSLBHH-UHFFFAOYSA-N	416974	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-pivalamido-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 244g::US10689346, Compound 244g::US11203574, Compound 244g::US11230530, Compound 244g::US11685721, Compound 244g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416974	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416974&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665924	433916886							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133459	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-22-10-9-20(28(35,12-11-18-7-8-18)25-6-1-2-13-36-25)15-23(22)37-27(40)24-16-26(29(31,32)33)38-39(24)21-5-3-4-19(14-21)17-34/h1-6,9-10,13-16,18H,7-8,11-12,17,34-35H2,(H,37,40)	IFWBAIGKQKRJGJ-UHFFFAOYSA-N	416975	(+-)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 205d::US10633345, Compound 205c::US10689346, Compound 205e::US11203574, Compound 205e::US11230530, Compound 205e::US11685721, Compound 205f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416975	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416975&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665627	433916887							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133460	ONC(=N)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N6O2/c30-22-12-11-19(26(35-16-17-9-10-17)18-5-2-1-3-6-18)14-23(22)36-28(40)24-15-25(29(31,32)33)37-39(24)21-8-4-7-20(13-21)27(34)38-41/h1-8,11-15,17,26,35,41H,9-10,16H2,(H2,34,38)(H,36,40)	RKUBSDCTAQRJEX-UHFFFAOYSA-N	416976	(+-)-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-1-(3-(N-hydroxycarbamimidoyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 232a::US10633345, Compound 232a::US10689346, Compound 232a::US11203574, Compound 232a::US11230530, Compound 232a::US11685721, Compound 232a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416976	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416976&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665466	433916888							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133461	CC(=O)NC(CCC1CC1)(c1cccnc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C31H30F4N6O2/c1-19(42)39-30(12-11-20-7-8-20,23-5-3-13-37-18-23)22-9-10-25(32)26(15-22)38-29(43)27-16-28(31(33,34)35)40-41(27)24-6-2-4-21(14-24)17-36/h2-6,9-10,13-16,18,20H,7-8,11-12,17,36H2,1H3,(H,38,43)(H,39,42)	NXVHVPBDWBOZQI-UHFFFAOYSA-N	416977	(+-)-N-(5-(1-acetamido-3-cyclopropyl-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 244h::US10633345, Compound 244h::US10689346, Compound 244h::US11203574, Compound 244h::US11230530, Compound 244h::US11685721, Compound 244h	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416977	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416977&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355894	433916889							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133462	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-22-10-9-20(28(35,12-11-18-7-8-18)25-6-1-2-13-36-25)15-23(22)37-27(40)24-16-26(29(31,32)33)38-39(24)21-5-3-4-19(14-21)17-34/h1-6,9-10,13-16,18H,7-8,11-12,17,34-35H2,(H,37,40)	IFWBAIGKQKRJGJ-UHFFFAOYSA-N	416975	(+-)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 205d::US10633345, Compound 205c::US10689346, Compound 205e::US11203574, Compound 205e::US11230530, Compound 205e::US11685721, Compound 205f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416975	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416975&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665627	433916887							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133463	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(O)=O	InChI=1S/C29H28FN5O3/c30-23-12-11-21(27(32-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)33-28(36)26-15-25(29(37)38)34-35(26)22-8-4-5-19(13-22)16-31/h1-8,11-15,18,27,32H,9-10,16-17,31H2,(H,33,36)(H,37,38)	XPAISISGRLZRHF-UHFFFAOYSA-N	416979	(+)-1-(3-(aminomethyl)phenyl)-5-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenylcarbamoyl)-1H-pyrazole-3-carboxylic acid::US10329260, Compound 246f::US10633345, Compound 246f::US10689346, Compound 246f::US11203574, Compound 246f::US11230530, Compound 246f::US11685721, Compound 246f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416979	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416979&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356041	433916891							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133464	CCC(=O)NC(CCC1CC1)(c1cccnc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C32H32F4N6O2/c1-2-29(43)40-31(13-12-20-8-9-20,23-6-4-14-38-19-23)22-10-11-25(33)26(16-22)39-30(44)27-17-28(32(34,35)36)41-42(27)24-7-3-5-21(15-24)18-37/h3-7,10-11,14-17,19-20H,2,8-9,12-13,18,37H2,1H3,(H,39,44)(H,40,43)	VLEWWVBFKVHAND-UHFFFAOYSA-N	416980	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-propionamido-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 244i::US10633345, Compound 244i::US10689346, Compound 244i::US11203574, Compound 244i::US11230530, Compound 244j::US11685721, Compound 244i	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416980	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416980&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665945	433916892							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133465	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-23-9-8-20(28(35,11-10-18-6-7-18)21-4-2-12-36-17-21)14-24(23)37-27(40)25-15-26(29(31,32)33)38-39(25)22-5-1-3-19(13-22)16-34/h1-5,8-9,12-15,17-18H,6-7,10-11,16,34-35H2,(H,37,40)	QXMQDWOYOXVOQZ-UHFFFAOYSA-N	416981	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 208d::US10633345, Compound 209d::US10689346, Compound 209d::US11203574, Compound 209d::US11230530, Compound 209d::US11685721, Compound 209d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416981	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416981&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355646	433916893							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133466	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C#N)C#N	InChI=1S/C31H28FN7O/c32-27-11-10-24(31(36,13-12-20-4-5-20)23-8-6-21(17-33)7-9-23)15-28(27)37-30(40)29-16-25(19-35)38-39(29)26-3-1-2-22(14-26)18-34/h1-3,6-11,14-16,20H,4-5,12-13,18,34,36H2,(H,37,40)	SWSSXIJHEDUEIQ-UHFFFAOYSA-N	416982	(+)-N-(5-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-cyano-1H-pyrazole-5-carboxamide::US10329260, Compound 234d::US10633345, Compound 234d::US10689346, Compound 234d::US11203574, Compound 234d::US11230530, Compound 234d::US11685721, Compound 234d	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416982	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416982&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356248	433916894							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133467	CCC(=O)NC(CCC1CC1)(c1cccnc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C32H32F4N6O2/c1-2-29(43)40-31(13-12-20-8-9-20,23-6-4-14-38-19-23)22-10-11-25(33)26(16-22)39-30(44)27-17-28(32(34,35)36)41-42(27)24-7-3-5-21(15-24)18-37/h3-7,10-11,14-17,19-20H,2,8-9,12-13,18,37H2,1H3,(H,39,44)(H,40,43)	VLEWWVBFKVHAND-UHFFFAOYSA-N	416980	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-propionamido-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 244i::US10633345, Compound 244i::US10689346, Compound 244i::US11203574, Compound 244i::US11230530, Compound 244j::US11685721, Compound 244i	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416980	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416980&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665945	433916892							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133468	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-23-9-8-20(28(35,11-10-18-6-7-18)21-4-2-12-36-17-21)14-24(23)37-27(40)25-15-26(29(31,32)33)38-39(25)22-5-1-3-19(13-22)16-34/h1-5,8-9,12-15,17-18H,6-7,10-11,16,34-35H2,(H,37,40)	QXMQDWOYOXVOQZ-UHFFFAOYSA-N	416981	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 208d::US10633345, Compound 209d::US10689346, Compound 209d::US11203574, Compound 209d::US11230530, Compound 209d::US11685721, Compound 209d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416981	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416981&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355646	433916893							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133469	COc1ccc(Cn2ccc3ccc(cc3c2=N)-n2nc(cc2C(O)=O)C(F)(F)F)c(OC)c1	InChI=1S/C23H19F3N4O4/c1-33-16-6-4-14(19(10-16)34-2)12-29-8-7-13-3-5-15(9-17(13)21(29)27)30-18(22(31)32)11-20(28-30)23(24,25)26/h3-11,27H,12H2,1-2H3,(H,31,32)	IOVSTWDPPGGMGX-UHFFFAOYSA-N	529802	US11203574, Compound 235g::US11230530, Compound 235g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=529802	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=529802&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355633	463793324							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133470	CC(C)CC(=O)NC(CCC1CC1)(c1cccnc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H36F4N6O2/c1-21(2)15-31(45)42-33(13-12-22-8-9-22,25-6-4-14-40-20-25)24-10-11-27(35)28(17-24)41-32(46)29-18-30(34(36,37)38)43-44(29)26-7-3-5-23(16-26)19-39/h3-7,10-11,14,16-18,20-22H,8-9,12-13,15,19,39H2,1-2H3,(H,41,46)(H,42,45)	WIIQCCUTLYCVOE-UHFFFAOYSA-N	416986	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(3-methylbutanamido)-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 244k::US10633345, Compound 244k::US10689346, Compound 244k::US11203574, Compound 244k::US11230530, Compound 244k::US11685721, Compound 244k	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416986	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416986&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665507	433916898							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133471	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F4N5O/c31-24-12-11-22(29(36,14-13-19-9-10-19)21-6-2-1-3-7-21)16-25(24)37-28(40)26-17-27(30(32,33)34)38-39(26)23-8-4-5-20(15-23)18-35/h1-8,11-12,15-17,19H,9-10,13-14,18,35-36H2,(H,37,40)	NQFNNZJJOCPZCP-UHFFFAOYSA-N	416987	(+-)-N-(5-(1-amino-3-cyclopropyl-1-phenylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 210d::US10633345, Compound 211d::US10689346, Compound 211d::US11203574, Compound 211d::US11230530, Compound 211d::US11685721, Compound 211d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416987	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416987&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355764	433916899							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133472	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(N)(CCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C31H29F3N6O/c32-31(33,34)28-17-27(40(39-28)26-6-1-3-22(15-26)19-36)29(41)38-25-5-2-4-24(16-25)30(37,14-13-20-7-8-20)23-11-9-21(18-35)10-12-23/h1-6,9-12,15-17,20H,7-8,13-14,19,36-37H2,(H,38,41)	WPWCLOAAAHRQMG-UHFFFAOYSA-N	416988	(+)-N-(3-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)phenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 218c::US10633345, Compound 218c::US10689346, Compound 218c::US11203574, Compound 218c::US11230530, Compound 218c::US11685721, Compound 218c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416988	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416988&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356070	433916900							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133473	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C31H27F4N7O/c32-24-6-4-21(30(37,11-7-18-1-2-18)20-9-12-38-13-10-20)15-25(24)40-29(43)26-17-27(31(33,34)35)41-42(26)22-5-3-19-8-14-39-28(36)23(19)16-22/h3-6,8-10,12-18H,1-2,7,11,37H2,(H2,36,39)(H,40,43)	BGYDOWYGLFEYGE-UHFFFAOYSA-N	416989	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-4-yl)propyl)-2-fluorophenyl)-1-(1-aminoisoquinolin-7-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 253e::US10633345, Compound 253e::US10689346, Compound 253e::US11203574, Compound 253e::US11230530, Compound 253e::US11685721, Compound 253e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416989	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416989&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665703	433916901							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133474	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F4N5O/c31-24-12-11-22(29(36,14-13-19-9-10-19)21-6-2-1-3-7-21)16-25(24)37-28(40)26-17-27(30(32,33)34)38-39(26)23-8-4-5-20(15-23)18-35/h1-8,11-12,15-17,19H,9-10,13-14,18,35-36H2,(H,37,40)	NQFNNZJJOCPZCP-UHFFFAOYSA-N	416987	(+-)-N-(5-(1-amino-3-cyclopropyl-1-phenylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 210d::US10633345, Compound 211d::US10689346, Compound 211d::US11203574, Compound 211d::US11230530, Compound 211d::US11685721, Compound 211d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416987	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416987&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355764	433916899							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133475	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(N)(CCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C31H29F3N6O/c32-31(33,34)28-17-27(40(39-28)26-9-2-5-22(15-26)19-36)29(41)38-25-8-3-7-24(16-25)30(37,13-12-20-10-11-20)23-6-1-4-21(14-23)18-35/h1-9,14-17,20H,10-13,19,36-37H2,(H,38,41)	JHGXWQQOSIGIHO-UHFFFAOYSA-N	416991	(+)-N-(3-(1-amino-1-(3-cyanophenyl)-3-cyclopropylpropyl)phenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 219c::US10633345, Compound 219c::US10689346, Compound 219c::US11203574, Compound 219c::US11230530, Compound 219c::US11685721, Compound 219c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416991	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416991&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355760	433916903							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133476	CS(=O)(=O)NC(CCC1CC1)(c1ccncc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F4N6O3S/c1-44(42,43)39-29(12-9-19-5-6-19,21-10-13-36-14-11-21)22-7-8-24(31)25(16-22)37-28(41)26-17-27(30(32,33)34)38-40(26)23-4-2-3-20(15-23)18-35/h2-4,7-8,10-11,13-17,19,39H,5-6,9,12,18,35H2,1H3,(H,37,41)	SFWRGGJAWAJGGN-UHFFFAOYSA-N	416992	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(methylsulfonamido)-1-(pyridin-4-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 245c::US10633345, Compound 245c::US10689346, Compound 245c::US11203574, Compound 245c::US11230530, Compound 245c::US11685721, Compound 245c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416992	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416992&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355707	433916904							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133477	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C31H28F4N6O/c32-25-11-10-23(30(38,13-12-19-4-5-19)22-8-6-20(17-36)7-9-22)15-26(25)39-29(42)27-16-28(31(33,34)35)40-41(27)24-3-1-2-21(14-24)18-37/h1-3,6-11,14-16,19H,4-5,12-13,18,37-38H2,(H,39,42)	JCBKPNPCGNTAQN-UHFFFAOYSA-N	416993	(+)-N-(5-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 212g::US10633345, Compound 213d::US10689346, Compound 213d::US11203574, Compound 213d::US11230530, Compound 213d::US11685721, Compound 213d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416993	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416993&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356170	433916905							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133478	CC(C)(C)OC(=O)NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)(N[S@](=O)C(C)(C)C)c1ccc(cc1)C(N)=O)C#N	InChI=1S/C40H46FN7O5S/c1-38(2,3)53-37(51)44-24-26-8-7-9-31(20-26)48-34(22-30(23-42)46-48)36(50)45-33-21-29(16-17-32(33)41)40(19-18-25-10-11-25,47-54(52)39(4,5)6)28-14-12-27(13-15-28)35(43)49/h7-9,12-17,20-22,25,47H,10-11,18-19,24H2,1-6H3,(H2,43,49)(H,44,51)(H,45,50)/t40?,54-/m1/s1	NPFNOOGGCUHKHF-MZBRZLFWSA-N	535060	US11230530, Compound 239d	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535060	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535060&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665668	464920350							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133479	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C32H25F4N7O/c33-25-9-7-22(29(40-17-18-4-5-18)21-3-1-2-19(12-21)16-37)13-26(25)41-31(44)27-15-28(32(34,35)36)42-43(27)23-8-6-20-10-11-39-30(38)24(20)14-23/h1-3,6-15,18,29,40H,4-5,17H2,(H2,38,39)(H,41,44)	PQPAZBKFVDKERF-UHFFFAOYSA-N	439578	US10633345, Compound 257b::US10689346, Compound 257b::US11203574, Compound 257b::US11230530, Compound 257b::US11685721, Compound 257b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439578	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439578&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665471	439661126							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133480	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C31H28F4N6O/c32-25-10-9-23(30(38,12-11-19-7-8-19)22-5-1-3-20(13-22)17-36)15-26(25)39-29(42)27-16-28(31(33,34)35)40-41(27)24-6-2-4-21(14-24)18-37/h1-6,9-10,13-16,19H,7-8,11-12,18,37-38H2,(H,39,42)	ZBDDMFBNDOEVJT-UHFFFAOYSA-N	416996	(+)-N-(5-(1-amino-1-(3-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 214g::US10633345, Compound 215d::US10689346, Compound 215d::US11203574, Compound 215d::US11230530, Compound 215d::US11685721, Compound 215d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416996	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416996&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665709	433916908							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133481	NC(=O)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C31H26F4N6O2/c32-24-10-9-22(30(38,12-11-18-7-8-18)21-5-1-3-19(13-21)17-36)15-25(24)39-29(43)26-16-27(31(33,34)35)40-41(26)23-6-2-4-20(14-23)28(37)42/h1-6,9-10,13-16,18H,7-8,11-12,38H2,(H2,37,42)(H,39,43)	MJBRNYICMOSPEH-UHFFFAOYSA-N	416997	(+-)-N-(5-(1-amino-1-(3-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-carbamoylphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 267c::US10633345, Compound 267c::US10689346, Compound 267c::US11203574, Compound 267c::US11230530, Compound 267c::US11685721, Compound 267c	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416997	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416997&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665760	433916909							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133482	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C33H27F4N7O/c34-26-10-8-23(32(40,13-11-19-1-2-19)22-6-3-20(18-38)4-7-22)15-27(26)42-31(45)28-17-29(33(35,36)37)43-44(28)24-9-5-21-12-14-41-30(39)25(21)16-24/h3-10,12,14-17,19H,1-2,11,13,40H2,(H2,39,41)(H,42,45)	QUIZETAQJOZQJA-UHFFFAOYSA-N	416998	(+)-N-(5-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(1-aminoisoquinolin-7-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 254c::US10633345, Compound 254c::US10689346, Compound 254c::US11203574, Compound 254c::US11230530, Compound 254c::US11685721, Compound 254c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416998	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416998&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665477	433916910							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133483	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C31H28F4N6O/c32-25-11-10-23(30(38,13-12-19-4-5-19)22-8-6-20(17-36)7-9-22)15-26(25)39-29(42)27-16-28(31(33,34)35)40-41(27)24-3-1-2-21(14-24)18-37/h1-3,6-11,14-16,19H,4-5,12-13,18,37-38H2,(H,39,42)	JCBKPNPCGNTAQN-UHFFFAOYSA-N	416993	(+)-N-(5-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 212g::US10633345, Compound 213d::US10689346, Compound 213d::US11203574, Compound 213d::US11230530, Compound 213d::US11685721, Compound 213d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416993	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416993&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356170	433916905							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133484	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C#N	InChI=1S/C29H27FN6O/c30-25-12-11-22(28(33-18-19-9-10-19)21-6-2-1-3-7-21)14-26(25)34-29(37)27-15-23(17-32)35-36(27)24-8-4-5-20(13-24)16-31/h1-8,11-15,19,28,33H,9-10,16,18,31H2,(H,34,37)	OBANZZDEWOCPST-UHFFFAOYSA-N	417000	(+-)-1-(3-(aminomethyl)phenyl)-3-cyano-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 240b::US10633345, Compound 240b::US10689346, Compound 240b::US11203574, Compound 240b::US11230530, Compound 240b::US11685721, Compound 240b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417000	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417000&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355661	433916912							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133485	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C32H28F4N6O/c33-25-11-9-22(31(38,14-12-19-6-7-19)21-4-2-1-3-5-21)16-26(25)40-30(43)27-18-28(32(34,35)36)41-42(27)23-10-8-20-13-15-39-29(37)24(20)17-23/h1-5,8-11,13,15-19H,6-7,12,14,38H2,(H2,37,39)(H,40,43)	SUIQVQQNEUOJQB-UHFFFAOYSA-N	417001	(+)-N-(5-(1-amino-3-cyclopropyl-1-phenylpropyl)-2-fluorophenyl)-1-(1-aminoisoquinolin-7-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 255a::US10633345, Compound 255a::US10689346, Compound 255a::US11203574, Compound 255a::US11230530, Compound 255a::US11685721, Compound 255a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417001	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417001&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356059	433916913							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133486	Nc1noc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H24F4N6O2/c30-21-10-8-18(26(35-15-16-6-7-16)17-4-2-1-3-5-17)12-22(21)36-28(40)23-14-25(29(31,32)33)37-39(23)19-9-11-24-20(13-19)27(34)38-41-24/h1-5,8-14,16,26,35H,6-7,15H2,(H2,34,38)(H,36,40)	QWKNFIFTTXOPHF-UHFFFAOYSA-N	417002	(+-)-1-(3-aminobenzo[d]isoxazol-5-yl)-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 222k::US10329260, Compound 223f::US10633345, Compound 223f::US10689346, Compound 223f::US11203574, Compound 223f::US11230530, Compound 223f::US11685721, Compound 223f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417002	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417002&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123289526	433916914							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133487	NC(=N)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C30H25F4N7O/c31-23-10-9-20(27(38-16-17-7-8-17)19-4-1-3-18(11-19)15-35)13-24(23)39-29(42)25-14-26(30(32,33)34)40-41(25)22-6-2-5-21(12-22)28(36)37/h1-6,9-14,17,27,38H,7-8,16H2,(H3,36,37)(H,39,42)	VIRFLKJDRZOSPM-UHFFFAOYSA-N	417003	(+)-1-(3-carbamimidoylphenyl)-N-(5-((3-cyanophenyl)(cyclopropylmethylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 236h::US10633345, Compound 236h::US10689346, Compound 236h::US11203574, Compound 236h::US11230530, Compound 236h::US11685721, Compound 236h	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417003	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417003&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665908	433916915							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133488	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C30H25F4N7O/c31-23-6-4-20(27(38-16-17-1-2-17)19-7-10-36-11-8-19)13-24(23)39-29(42)25-15-26(30(32,33)34)40-41(25)21-5-3-18-9-12-37-28(35)22(18)14-21/h3-15,17,27,38H,1-2,16H2,(H2,35,37)(H,39,42)	UQWHIYYZYLIMKJ-UHFFFAOYSA-N	417004	(+-)-1-(1-aminoisoquinolin-7-yl)-N-(5-((cyclopropylmethylamino)(pyridin-4-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 265d::US10633345, Compound 264g::US10689346, Compound 264g::US11203574, Compound 264g::US11230530, Compound 264g::US11685721, Compound 264g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417004	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417004&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355979	433916916							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133489	Nc1noc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H24F4N6O2/c30-21-10-8-18(26(35-15-16-6-7-16)17-4-2-1-3-5-17)12-22(21)36-28(40)23-14-25(29(31,32)33)37-39(23)19-9-11-24-20(13-19)27(34)38-41-24/h1-5,8-14,16,26,35H,6-7,15H2,(H2,34,38)(H,36,40)	QWKNFIFTTXOPHF-UHFFFAOYSA-N	417002	(+-)-1-(3-aminobenzo[d]isoxazol-5-yl)-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 222k::US10329260, Compound 223f::US10633345, Compound 223f::US10689346, Compound 223f::US11203574, Compound 223f::US11230530, Compound 223f::US11685721, Compound 223f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417002	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417002&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123289526	433916914							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133490	NC(=N)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C31H27F4N7O/c32-24-10-9-22(30(39,12-11-18-7-8-18)21-5-1-3-19(13-21)17-36)15-25(24)40-29(43)26-16-27(31(33,34)35)41-42(26)23-6-2-4-20(14-23)28(37)38/h1-6,9-10,13-16,18H,7-8,11-12,39H2,(H3,37,38)(H,40,43)	BZRUVEYOOHPOOF-UHFFFAOYSA-N	417006	(+)-N-(5-(1-amino-1-(3-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-carbamimidoylphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 237a::US10633345, Compound 237a::US10689346, Compound 237a::US11192861, Compound 237a::US11230530, Compound 237a::US11685721, Compound 237a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417006	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417006&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356202	433916917							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133491	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C33H27F4N7O/c34-26-9-7-23(32(40,12-10-19-4-5-19)22-3-1-2-20(14-22)18-38)15-27(26)42-31(45)28-17-29(33(35,36)37)43-44(28)24-8-6-21-11-13-41-30(39)25(21)16-24/h1-3,6-9,11,13-17,19H,4-5,10,12,40H2,(H2,39,41)(H,42,45)	MNAPHYKXZOGSTD-UHFFFAOYSA-N	417007	(+)-N-(5-(1-amino-1-(3-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(1-aminoisoquinolin-7-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 256a::US10633345, Compound 256a::US10689346, Compound 256a::US11203574, Compound 256a::US11230530, Compound 256a::US11685721, Compound 256a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417007	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417007&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665459	433916918							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133492	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(n1)C#N)C(F)(F)F	InChI=1S/C30H27F4N7O/c31-23-10-9-20(29(37,12-11-18-7-8-18)26-6-2-4-21(17-36)38-26)14-24(23)39-28(42)25-15-27(30(32,33)34)40-41(25)22-5-1-3-19(13-22)16-35/h1-6,9-10,13-15,18H,7-8,11-12,16,35,37H2,(H,39,42)	UYAYDZPBNCJYMZ-UHFFFAOYSA-N	417008	(+)-N-(5-(1-amino-1-(6-cyanopyridin-2-yl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 220f::US10633345, Compound 220f::US10689346, Compound 220f::US11203574, Compound 220f::US11230530, Compound 220f::US11685721, Compound 220f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417008	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417008&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355858	433916919							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133493	CC(C)(C)[S@@](=O)NC(CCC1CC1)(c1cccnc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(c2)C(N)=N)C(F)(F)F)c1	InChI=1S/C33H35F4N7O2S/c1-31(2,3)47(46)43-32(14-13-20-9-10-20,23-7-5-15-40-19-23)22-11-12-25(34)26(17-22)41-30(45)27-18-28(33(35,36)37)42-44(27)24-8-4-6-21(16-24)29(38)39/h4-8,11-12,15-20,43H,9-10,13-14H2,1-3H3,(H3,38,39)(H,41,45)/t32?,47-/m1/s1	ORCJXCNQCCWVHD-HKYIEPEJSA-N	417009	1-(3-carbamimidoylphenyl)-N-(5-((+-)-3-cyclopropyl-1-((R)-1,1-dimethylethylsulfinamido)-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 238c::US10633345, Compound 238c::US10689346, Compound 238c::US11203574, Compound 238c::US11230530, Compound 238c::US11685721, Compound 238c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417009	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417009&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355741	433916920							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133494	Nc1nccc2ccc(cc12)-n1nc(cc1C(F)(F)F)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1	InChI=1S/C31H27F4N7O/c32-24-6-4-21(30(37,11-7-18-1-2-18)20-9-12-38-13-10-20)15-25(24)40-29(43)26-17-27(31(33,34)35)42(41-26)22-5-3-19-8-14-39-28(36)23(19)16-22/h3-6,8-10,12-18H,1-2,7,11,37H2,(H2,36,39)(H,40,43)	JTQCWLVRCRAKSI-UHFFFAOYSA-N	417010	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-4-yl)propyl)-2-fluorophenyl)-1-(1-aminoisoquinolin-7-yl)-5-(trifluoromethyl)-1H-pyrazole-3-carboxamide::US10329260, Compound 268g::US10633345, Compound 268g::US10689346, Compound 268g::US11203574, Compound 268g::US11230530, Compound 268g::US11685721, Compound 268g	Plasma kallikrein		>75.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417010	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417010&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356088	433916921							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133495	Nc1n[nH]c2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F			439594	US10633345, Compound 224b::US10689346, Compound 224b::US11203574, Compound 224b::US11230530, Compound 224b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439594	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439594&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155295687	439661142							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133496	NC(=N)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C31H27F4N7O/c32-24-11-10-22(30(39,13-12-18-4-5-18)21-8-6-19(17-36)7-9-21)15-25(24)40-29(43)26-16-27(31(33,34)35)41-42(26)23-3-1-2-20(14-23)28(37)38/h1-3,6-11,14-16,18H,4-5,12-13,39H2,(H3,37,38)(H,40,43)	QLTPSVVBRYJDCX-UHFFFAOYSA-N	417012	(+)-N-(5-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-carbamimidoylphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 241a::US10633345, Compound 241a::US10689346, Compound 241a::US11192861, Compound 241a::US11230530, Compound 241a::US11685721, Compound 241a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417012	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417012&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665936	433916923							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133497	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccccc1=O)C(F)(F)F	InChI=1S/C31H26F4N6O2/c32-23-10-8-20(25(11-6-18-4-5-18)40-14-2-1-3-28(40)42)15-24(23)38-30(43)26-17-27(31(33,34)35)39-41(26)21-9-7-19-12-13-37-29(36)22(19)16-21/h1-3,7-10,12-18,25H,4-6,11H2,(H2,36,37)(H,38,43)	GNDQLXKOPYFGBP-UHFFFAOYSA-N	417013	1-(1-aminoisoquinolin-7-yl)-N-(5-(3-cyclopropyl-1-(2-oxopyridin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 258g::US10633345, Compound 258g::US10689346, Compound 258g::US11203574, Compound 258g::US11230530, Compound 258g::US11685721, Compound 258g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417013	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417013&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355895	433916924							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133498	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C(N)=O)C(F)(F)F	InChI=1S/C31H30F4N6O2/c32-24-10-9-22(30(38,12-11-18-7-8-18)21-5-2-4-20(14-21)28(37)42)15-25(24)39-29(43)26-16-27(31(33,34)35)40-41(26)23-6-1-3-19(13-23)17-36/h1-6,9-10,13-16,18H,7-8,11-12,17,36,38H2,(H2,37,42)(H,39,43)	DYGHBBDYRMOWAC-UHFFFAOYSA-N	417014	(+-)-N-(5-(1-amino-1-(3-carbamoylphenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 225a::US10633345, Compound 225a::US10689346, Compound 225a::US11203574, Compound 225a::US11230530, Compound 225a::US11685721, Compound 225a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417014	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417014&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665606	433916925							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133499	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C31H28F4N6O/c32-25-10-9-23(30(38,12-11-19-7-8-19)22-5-1-3-20(13-22)17-36)15-26(25)39-29(42)27-16-28(31(33,34)35)40-41(27)24-6-2-4-21(14-24)18-37/h1-6,9-10,13-16,19H,7-8,11-12,18,37-38H2,(H,39,42)	ZBDDMFBNDOEVJT-UHFFFAOYSA-N	416996	(+)-N-(5-(1-amino-1-(3-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 214g::US10633345, Compound 215d::US10689346, Compound 215d::US11203574, Compound 215d::US11230530, Compound 215d::US11685721, Compound 215d	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416996	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416996&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665709	433916908							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133500	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccccc1=O)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-11-10-20(24(12-9-18-7-8-18)37-13-2-1-6-27(37)39)15-23(22)35-28(40)25-16-26(29(31,32)33)36-38(25)21-5-3-4-19(14-21)17-34/h1-6,10-11,13-16,18,24H,7-9,12,17,34H2,(H,35,40)	OFQQGSYWUFBMPP-UHFFFAOYSA-N	416939	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(2-oxopyridin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 248j::US10633345, Compound 248k::US10689346, Compound 248k::US11203574, Compound 248k::US11230530, Compound 248k::US11685721, Compound 248k	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416939	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416939&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355727	433916851							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133501	Nc1ncnc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H25F4N7O/c31-22-10-8-19(27(36-15-17-6-7-17)18-4-2-1-3-5-18)12-24(22)39-29(42)25-14-26(30(32,33)34)40-41(25)20-9-11-23-21(13-20)28(35)38-16-37-23/h1-5,8-14,16-17,27,36H,6-7,15H2,(H,39,42)(H2,35,37,38)	NOYPEPJWHRTGGG-UHFFFAOYSA-N	417011	1-(4-aminoquinazolin-6-yl)-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 224b::US10329260, Compound 226a::US10633345, Compound 226a::US10689346, Compound 226a::US11203574, Compound 226a::US11230530, Compound 226a::US11685721, Compound 226a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417011	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417011&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665806	433916922							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133502	NC(=N)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H27F4N7O/c30-22-9-8-19(28(36,11-10-17-6-7-17)20-4-2-12-37-16-20)14-23(22)38-27(41)24-15-25(29(31,32)33)39-40(24)21-5-1-3-18(13-21)26(34)35/h1-5,8-9,12-17H,6-7,10-11,36H2,(H3,34,35)(H,38,41)	JBCZLPFSSAYNEJ-UHFFFAOYSA-N	417018	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-1-(3-carbamimidoylphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 238d::US10633345, Compound 238d::US10689346, Compound 238d::US11192861, Compound 238d::US11230530, Compound 238d::US11685721, Compound 238d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417018	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417018&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355839	433916928							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133503	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccccc1=O)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-11-10-20(24(12-9-18-7-8-18)37-13-2-1-6-27(37)39)15-23(22)35-28(40)25-16-26(29(31,32)33)36-38(25)21-5-3-4-19(14-21)17-34/h1-6,10-11,13-16,18,24H,7-9,12,17,34H2,(H,35,40)	OFQQGSYWUFBMPP-UHFFFAOYSA-N	416939	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(2-oxopyridin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 248j::US10633345, Compound 248k::US10689346, Compound 248k::US11203574, Compound 248k::US11230530, Compound 248k::US11685721, Compound 248k	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416939	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416939&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355727	433916851							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133504	NC(=N)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N6O/c30-22-12-11-19(26(36-16-17-9-10-17)18-5-2-1-3-6-18)14-23(22)37-28(40)24-15-25(29(31,32)33)38-39(24)21-8-4-7-20(13-21)27(34)35/h1-8,11-15,17,26,36H,9-10,16H2,(H3,34,35)(H,37,40)	HUIANTFJQLRTEM-UHFFFAOYSA-N	439603	US10633345, Compound 227d::US10689346, Compound 227d::US11203574, Compound 227d::US11230530, Compound 227d::US11685721, Compound 227d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439603	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439603&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356162	439661151							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133505	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(nc1)C(N)=O)C(F)(F)F	InChI=1S/C30H29F4N7O2/c31-22-8-6-19(29(37,11-10-17-4-5-17)20-7-9-23(27(36)42)38-16-20)13-24(22)39-28(43)25-14-26(30(32,33)34)40-41(25)21-3-1-2-18(12-21)15-35/h1-3,6-9,12-14,16-17H,4-5,10-11,15,35,37H2,(H2,36,42)(H,39,43)	IQWHGFSUUIEJQU-UHFFFAOYSA-N	417021	(+)-5-(1-amino-1-(3-(1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamido)-4-fluorophenyl)-3-cyclopropylpropyl)picolinamide::US10329260, Compound 221i::US10633345, Compound 221i::US10689346, Compound 221i::US11203574, Compound 221i::US11230530, Compound 221i::US11685721, Compound 221i	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417021	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417021&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665782	433916931							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133506	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C30H25F4N7O/c31-23-6-4-20(27(38-16-17-1-2-17)19-7-10-36-11-8-19)13-24(23)39-29(42)25-15-26(30(32,33)34)40-41(25)21-5-3-18-9-12-37-28(35)22(18)14-21/h3-15,17,27,38H,1-2,16H2,(H2,35,37)(H,39,42)	UQWHIYYZYLIMKJ-UHFFFAOYSA-N	417004	(+-)-1-(1-aminoisoquinolin-7-yl)-N-(5-((cyclopropylmethylamino)(pyridin-4-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 265d::US10633345, Compound 264g::US10689346, Compound 264g::US11203574, Compound 264g::US11230530, Compound 264g::US11685721, Compound 264g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417004	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417004&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355979	433916916							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133507	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C(N)=O)C(F)(F)F	InChI=1S/C31H30F4N6O2/c32-24-11-10-22(30(38,13-12-18-4-5-18)21-8-6-20(7-9-21)28(37)42)15-25(24)39-29(43)26-16-27(31(33,34)35)40-41(26)23-3-1-2-19(14-23)17-36/h1-3,6-11,14-16,18H,4-5,12-13,17,36,38H2,(H2,37,42)(H,39,43)	HZQICPCUMLWHPZ-UHFFFAOYSA-N	417023	(+)-N-(5-(1-amino-1-(4-carbamoylphenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 228a::US10633345, Compound 228a::US10689346, Compound 228a::US11203574, Compound 228a::US11230530, Compound 228a::US11685721, Compound 228a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417023	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417023&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665484	433916933							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133508	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-23-7-6-21(28(35,11-8-18-4-5-18)20-9-12-36-13-10-20)15-24(23)37-27(40)25-16-26(29(31,32)33)38-39(25)22-3-1-2-19(14-22)17-34/h1-3,6-7,9-10,12-16,18H,4-5,8,11,17,34-35H2,(H,37,40)	AGVFYPDLNPHKER-UHFFFAOYSA-N	417024	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-4-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 216d::US10633345, Compound 217d::US10689346, Compound 217d::US11192861, Compound 217d::US11230530, Compound 217d::US11685721, Compound 217d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417024	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417024&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665723	433916934							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133509	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)N1CCCCC1=O)C(F)(F)F	InChI=1S/C29H31F4N5O2/c30-22-11-10-20(24(12-9-18-7-8-18)37-13-2-1-6-27(37)39)15-23(22)35-28(40)25-16-26(29(31,32)33)36-38(25)21-5-3-4-19(14-21)17-34/h3-5,10-11,14-16,18,24H,1-2,6-9,12-13,17,34H2,(H,35,40)	BPULHNPIKAHCAG-UHFFFAOYSA-N	417025	(+)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(2-oxopiperidin-1-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 261k::US10633345, Compound 261k::US10689346, Compound 261k::US11203574, Compound 261k::US11230530, Compound 261k::US11685721, Compound 261k	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417025	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417025&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123312183	433916935							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133510	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(N)=O	InChI=1S/C29H29FN6O2/c30-23-12-11-21(27(33-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)34-29(38)26-15-25(28(32)37)35-36(26)22-8-4-5-19(13-22)16-31/h1-8,11-15,18,27,33H,9-10,16-17,31H2,(H2,32,37)(H,34,38)	UMNCVWUVWBVXCX-UHFFFAOYSA-N	417026	(+-)-1-(3-(aminomethyl)phenyl)-N5-(5-((cyclopropylmethylamino)-(phenyl)methyl)-2-fluorophenyl)-1H-pyrazole-3,5-dicarboxamide::US10329260, Compound 229i::US10633345, Compound 229i::US10689346, Compound 229i::US11203574, Compound 229i::US11230530, Compound 229i::US11685721, Compound 229i	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417026	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417026&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665747	433916936							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133511	CC(C)(C)[S@@](=O)NC(CCC1CC1)(c1cccnc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C33H36F4N6O2S/c1-31(2,3)46(45)42-32(14-13-21-9-10-21,24-7-5-15-39-20-24)23-11-12-26(34)27(17-23)40-30(44)28-18-29(33(35,36)37)41-43(28)25-8-4-6-22(16-25)19-38/h4-8,11-12,15-18,20-21,42H,9-10,13-14,19,38H2,1-3H3,(H,40,44)/t32?,46-/m1/s1	LAOWFCURFGDGCT-ODZHGNIVSA-N	417027	1-(3-(aminomethyl)phenyl)-N-(5-((+-)-3-cyclopropyl-1-((R)-1,1-dimethylethylsulfinamido)-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 243a::US10633345, Compound 243a::US10689346, Compound 243a::US11203574, Compound 243a::US11230530, Compound 243a::US11685721, Compound 243a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417027	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417027&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665825	433916937							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133512	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccncc1=O)C(F)(F)F	InChI=1S/C30H25F4N7O2/c31-22-7-5-19(24(8-3-17-1-2-17)40-12-11-36-16-27(40)42)13-23(22)38-29(43)25-15-26(30(32,33)34)39-41(25)20-6-4-18-9-10-37-28(35)21(18)14-20/h4-7,9-17,24H,1-3,8H2,(H2,35,37)(H,38,43)	RGAKSJSQGQBUGG-UHFFFAOYSA-N	417028	1-(1-aminoisoquinolin-7-yl)-N-(5-(3-cyclopropyl-1-(2-oxopyrazin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 259d::US10633345, Compound 259d::US10689346, Compound 259d::US11203574, Compound 259d::US11230530, Compound 259d::US11685721, Compound 259d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417028	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417028&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355792	433916938							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133513	NC(=O)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H25F4N5O2/c30-22-12-11-19(26(35-16-17-9-10-17)18-5-2-1-3-6-18)14-23(22)36-28(40)24-15-25(29(31,32)33)37-38(24)21-8-4-7-20(13-21)27(34)39/h1-8,11-15,17,26,35H,9-10,16H2,(H2,34,39)(H,36,40)	JMSFBJDWVQAENA-UHFFFAOYSA-N	417029	(+-)-1-(3-carbamoylphenyl)-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 230a::US10633345, Compound 230a::US10689346, Compound 230a::US11203574, Compound 230a::US11230530, Compound 230a::US11685721, Compound 230a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417029	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417029&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665857	433916939							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133514	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-23-7-6-21(28(35,11-8-18-4-5-18)20-9-12-36-13-10-20)15-24(23)37-27(40)25-16-26(29(31,32)33)38-39(25)22-3-1-2-19(14-22)17-34/h1-3,6-7,9-10,12-16,18H,4-5,8,11,17,34-35H2,(H,37,40)	AGVFYPDLNPHKER-UHFFFAOYSA-N	417024	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-4-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 216d::US10633345, Compound 217d::US10689346, Compound 217d::US11192861, Compound 217d::US11230530, Compound 217d::US11685721, Compound 217d	Plasma kallikrein		>75.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417024	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417024&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665723	433916934							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133515	Cc1cc(ccn1)C(N)(CCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F4N6O/c1-18-13-22(10-12-37-18)29(36,11-9-19-5-6-19)21-7-8-24(31)25(15-21)38-28(41)26-16-27(30(32,33)34)39-40(26)23-4-2-3-20(14-23)17-35/h2-4,7-8,10,12-16,19H,5-6,9,11,17,35-36H2,1H3,(H,38,41)	PYONXWOUVYIBRU-UHFFFAOYSA-N	417031	(+)-N-(5-(1-amino-3-cyclopropyl-1-(2-methylpyridin-4-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 266j::US10633345, Compound 266j::US10689346, Compound 266j::US11203574, Compound 266j::US11230530, Compound 266j::US11685721, Compound 266j	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417031	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417031&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665585	433916941							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133516	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccc(=O)[nH]c1=O)C(F)(F)F			417032	1-(1-aminoisoquinolin-7-yl)-N-(5-(3-cyclopropyl-1-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 269b::US10633345, Compound 269b::US10689346, Compound 269b::US11203574, Compound 269b::US11230530, Compound 269b::US11685721, Compound 269b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417032	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417032&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			154584237	433916942							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1133517	CCNCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C31H31F4N5O/c1-2-36-18-21-7-6-10-24(15-21)40-27(17-28(39-40)31(33,34)35)30(41)38-26-16-23(13-14-25(26)32)29(37-19-20-11-12-20)22-8-4-3-5-9-22/h3-10,13-17,20,29,36-37H,2,11-12,18-19H2,1H3,(H,38,41)	RBEFOPDBDLERKF-UHFFFAOYSA-N	417033	(+-)-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-1-(3-((ethylamino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 270a::US10633345, Compound 270a::US10689346, Compound 270a::US11203574, Compound 270a::US11230530, Compound 270a::US11685721, Compound 270a	Plasma kallikrein		>75.0								US Patent		10.7270/Q2ZC862H		aid1806293	US11230530	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417033	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417033&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665791	433916943							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136264	CC1(C)CCN(C1)c1ccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)cn1	InChI=1S/C28H30N6O/c1-28(2)8-10-34(18-28)25-6-4-19(15-32-25)11-21-13-23(17-30-14-21)27(35)33-16-20-3-5-24-22(12-20)7-9-31-26(24)29/h3-7,9,12-15,17H,8,10-11,16,18H2,1-2H3,(H2,29,31)(H,33,35)	ZLDDWJIJDXHGIU-UHFFFAOYSA-N	359692	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[6-(3,3-dimethylpyrrolidin-1-yl)pyridin-3-yl]methyl}pyridine-3-carboxamide::US10221161, Example 74::US11242333, Example 74	Plasma kallikrein			 83.1							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359692	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359692&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393206	386399145							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136265	Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccc(nc4)N4CCC(C4)C(O)=O)c3)ccc12	InChI=1S/C27H26N6O3/c28-25-23-3-1-18(10-20(23)5-7-30-25)14-32-26(34)22-11-19(12-29-15-22)9-17-2-4-24(31-13-17)33-8-6-21(16-33)27(35)36/h1-5,7,10-13,15,21H,6,8-9,14,16H2,(H2,28,30)(H,32,34)(H,35,36)	SAVRWXYQJVOYRM-UHFFFAOYSA-N	359693	1-{5-[(5-{[(1-Aminoisoquinolin-6-yl)methyl]carbamoyl}pyridin-3-yl)methyl]pyridin-2-yl}pyrrolidine-3-carboxylic acid::US10221161, Example 75::US11242333, Example 75	Plasma kallikrein			 6120							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359693	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359693&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393191	386399146							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136266	Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccnc(c4)N4CCCC4=O)c3)ccc12	InChI=1S/C26H24N6O2/c27-25-22-4-3-18(11-20(22)6-8-30-25)15-31-26(34)21-12-19(14-28-16-21)10-17-5-7-29-23(13-17)32-9-1-2-24(32)33/h3-8,11-14,16H,1-2,9-10,15H2,(H2,27,30)(H,31,34)	DWTKEQLXPBZTEF-UHFFFAOYSA-N	359694	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[2-(2-oxopyrrolidin-1-yl)pyridin-4-yl]methyl}pyridine-3-carboxamide::US10221161, Example 76::US11242333, Example 76	Plasma kallikrein			 242							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359694	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359694&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393217	386399147							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136267	Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccnc(c4)N4CCCC4)c3)ccc12	InChI=1S/C26H26N6O/c27-25-23-4-3-19(12-21(23)6-8-30-25)16-31-26(33)22-13-20(15-28-17-22)11-18-5-7-29-24(14-18)32-9-1-2-10-32/h3-8,12-15,17H,1-2,9-11,16H2,(H2,27,30)(H,31,33)	OKYNKPFZSOLVQE-UHFFFAOYSA-N	359695	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[2-(pyrrolidin-1-yl)pyridin-4-yl]methyl}pyridine-3-carboxamide::US10221161, Example 77::US11242333, Example 77	Plasma kallikrein			 37.7							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359695	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359695&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117890050	386399148							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136268	Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccnc(c4)N4CCCCC4)c3)ccc12	InChI=1S/C27H28N6O/c28-26-24-5-4-20(13-22(24)7-9-31-26)17-32-27(34)23-14-21(16-29-18-23)12-19-6-8-30-25(15-19)33-10-2-1-3-11-33/h4-9,13-16,18H,1-3,10-12,17H2,(H2,28,31)(H,32,34)	RJFGZABUVYSVKX-UHFFFAOYSA-N	359696	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[2-(piperidin-1-yl)pyridin-4-yl]methyl}pyridine-3-carboxamide::US10221161, Example 78::US11242333, Example 78	Plasma kallikrein			 164							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359696	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359696&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393189	386399149							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136269	CC1CCCN1c1cc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)ccn1	InChI=1S/C27H28N6O/c1-18-3-2-10-33(18)25-14-19(6-8-30-25)11-21-13-23(17-29-15-21)27(34)32-16-20-4-5-24-22(12-20)7-9-31-26(24)28/h4-9,12-15,17-18H,2-3,10-11,16H2,1H3,(H2,28,31)(H,32,34)	QJOGYBUMALCINT-UHFFFAOYSA-N	359697	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[2-(2-methylpyrrolidin-1-yl)pyridin-4-yl]methyl}pyridine-3-carboxamide::US10221161, Example 79::US11242333, Example 79	Plasma kallikrein			 155							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359697	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359697&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393170	386399150							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136270	Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccnc(c4)N4CCC(F)(F)C4)c3)ccc12	InChI=1S/C26H24F2N6O/c27-26(28)5-8-34(16-26)23-12-17(3-6-31-23)9-19-11-21(15-30-13-19)25(35)33-14-18-1-2-22-20(10-18)4-7-32-24(22)29/h1-4,6-7,10-13,15H,5,8-9,14,16H2,(H2,29,32)(H,33,35)	OTPILUCJJKOWPU-UHFFFAOYSA-N	359698	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[2-(3,3-difluoropyrrolidin-1-yl)pyridin-4-yl]methyl}pyridine-3-carboxamide::US10221161, Example 80::US11242333, Example 80	Plasma kallikrein			 88.5							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359698	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359698&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393213	386399151							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136271	Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccnc(c4)N4CCC(O)C4)c3)ccc12	InChI=1S/C26H26N6O2/c27-25-23-2-1-18(10-20(23)4-7-30-25)14-31-26(34)21-11-19(13-28-15-21)9-17-3-6-29-24(12-17)32-8-5-22(33)16-32/h1-4,6-7,10-13,15,22,33H,5,8-9,14,16H2,(H2,27,30)(H,31,34)	PSHMRDARMQOLRC-UHFFFAOYSA-N	359699	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[2-(3-hydroxypyrrolidin-1-yl)pyridin-4-yl]methyl}pyridine-3-carboxamide::US10221161, Example 81::US11242333, Example 81	Plasma kallikrein			 674							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359699	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359699&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393153	386399152							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136272	Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccnc(c4)N4CCC(F)C4)c3)ccc12	InChI=1S/C26H25FN6O/c27-22-5-8-33(16-22)24-12-17(3-6-30-24)9-19-11-21(15-29-13-19)26(34)32-14-18-1-2-23-20(10-18)4-7-31-25(23)28/h1-4,6-7,10-13,15,22H,5,8-9,14,16H2,(H2,28,31)(H,32,34)	UOVPCOMKDUSQBG-UHFFFAOYSA-N	359700	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[2-(3-fluoropyrrolidin-1-yl)pyridin-4-yl]methyl}pyridine-3-carboxamide::US10221161, Example 82::US11242333, Example 82	Plasma kallikrein			 67.8							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359700	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359700&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393198	386399153							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136273	CC1CCN(C1)c1cc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)ccn1	InChI=1S/C27H28N6O/c1-18-6-9-33(17-18)25-13-19(4-7-30-25)10-21-12-23(16-29-14-21)27(34)32-15-20-2-3-24-22(11-20)5-8-31-26(24)28/h2-5,7-8,11-14,16,18H,6,9-10,15,17H2,1H3,(H2,28,31)(H,32,34)	BDDHAZOVAFLCQY-UHFFFAOYSA-N	359701	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[2-(3-methylpyrrolidin-1-yl)pyridin-4-yl]methyl}pyridine-3-carboxamide::US10221161, Example 83::US11242333, Example 83	Plasma kallikrein			 106							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359701	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359701&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393220	386399154							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136274	CC1(C)CCCN1c1cc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)ccn1	InChI=1S/C28H30N6O/c1-28(2)8-3-11-34(28)25-15-19(6-9-31-25)12-21-14-23(18-30-16-21)27(35)33-17-20-4-5-24-22(13-20)7-10-32-26(24)29/h4-7,9-10,13-16,18H,3,8,11-12,17H2,1-2H3,(H2,29,32)(H,33,35)	UUAUDGVZIJLYSI-UHFFFAOYSA-N	359702	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[2-(2,2-dimethylpyrrolidin-1-yl)pyridin-4-yl]methyl}pyridine-3-carboxamide::US10221161, Example 84::US11242333, Example 84	Plasma kallikrein			 683							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359702	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359702&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393211	386399155							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136275	Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccnc(c4)N4CCOCC4)c3)ccc12	InChI=1S/C26H26N6O2/c27-25-23-2-1-19(12-21(23)4-6-30-25)16-31-26(33)22-13-20(15-28-17-22)11-18-3-5-29-24(14-18)32-7-9-34-10-8-32/h1-6,12-15,17H,7-11,16H2,(H2,27,30)(H,31,33)	WDTKDHOKUXYDRS-UHFFFAOYSA-N	359703	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[2-(morpholin-4-yl)pyridin-4-yl]methyl}pyridine-3-carboxamide::US10221161, Example 85::US11242333, Example 85	Plasma kallikrein			 1670							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359703	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359703&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393148	386399156							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136276	CN1CCN(CC1)c1cc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)ccn1	InChI=1S/C27H29N7O/c1-33-8-10-34(11-9-33)25-15-19(4-6-30-25)12-21-14-23(18-29-16-21)27(35)32-17-20-2-3-24-22(13-20)5-7-31-26(24)28/h2-7,13-16,18H,8-12,17H2,1H3,(H2,28,31)(H,32,35)	CCWAWYXGGKGFJT-UHFFFAOYSA-N	359704	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[2-(4-methylpiperazin-1-yl)pyridin-4-yl]methyl}pyridine-3-carboxamide::US10221161, Example 86::US11242333, Example 86	Plasma kallikrein			 395							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359704	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359704&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393188	386399157							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136277	CCN(CC)c1cc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)ccn1	InChI=1S/C26H28N6O/c1-3-32(4-2)24-14-18(7-9-29-24)11-20-13-22(17-28-15-20)26(33)31-16-19-5-6-23-21(12-19)8-10-30-25(23)27/h5-10,12-15,17H,3-4,11,16H2,1-2H3,(H2,27,30)(H,31,33)	BSYLXGAPHBOLPP-UHFFFAOYSA-N	359705	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[2-(diethylamino)pyridin-4-yl]methyl}pyridine-3-carboxamide::US10221161, Example 87::US11242333, Example 87	Plasma kallikrein			 358							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359705	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359705&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393200	386399158							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136278	COC1CCN(C1)c1cc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)ccn1	InChI=1S/C27H28N6O2/c1-35-23-6-9-33(17-23)25-13-18(4-7-30-25)10-20-12-22(16-29-14-20)27(34)32-15-19-2-3-24-21(11-19)5-8-31-26(24)28/h2-5,7-8,11-14,16,23H,6,9-10,15,17H2,1H3,(H2,28,31)(H,32,34)	AGESLAHMMMUCOA-UHFFFAOYSA-N	359706	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[2-(3-methoxypyrrolidin-1-yl)pyridin-4-yl]methyl}pyridine-3-carboxamide::US10221161, Example 88::US11242333, Example 92	Plasma kallikrein			 234							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359706	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359706&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393167	386399159							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136279	Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccnc(c4)N4CCCC4CO)c3)ccc12	InChI=1S/C27H28N6O2/c28-26-24-4-3-19(11-21(24)6-8-31-26)15-32-27(35)22-12-20(14-29-16-22)10-18-5-7-30-25(13-18)33-9-1-2-23(33)17-34/h3-8,11-14,16,23,34H,1-2,9-10,15,17H2,(H2,28,31)(H,32,35)	YEGMXIRGBOBRED-UHFFFAOYSA-N	359707	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({2-[2-(hydroxymethyl)pyrrolidin-1-yl]pyridin-4-yl}methyl)pyridine-3-carboxamide::US10221161, Example 89::US11242333, Example 89	Plasma kallikrein			 104							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359707	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359707&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117889851	386399160							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136280	CN(C)[C@H]1CCN(C1)c1cc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)ccn1	InChI=1S/C28H31N7O/c1-34(2)24-7-10-35(18-24)26-14-19(5-8-31-26)11-21-13-23(17-30-15-21)28(36)33-16-20-3-4-25-22(12-20)6-9-32-27(25)29/h3-6,8-9,12-15,17,24H,7,10-11,16,18H2,1-2H3,(H2,29,32)(H,33,36)/t24-/m0/s1	QLBNBADVDGUZLM-DEOSSOPVSA-N	535975	N-[(1-Aminoisoquinolin-6-yl(methyl]-5-({2-[3-(dimethylamino)pyrrolidin-::US11242333, Example 90	Plasma kallikrein			 1550							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535975	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535975&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163407724	464921155							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136281	CN(C)[C@@H]1CCN(C1)c1cc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)ccn1	InChI=1S/C28H31N7O/c1-34(2)24-7-10-35(18-24)26-14-19(5-8-31-26)11-21-13-23(17-30-15-21)28(36)33-16-20-3-4-25-22(12-20)6-9-32-27(25)29/h3-6,8-9,12-15,17,24H,7,10-11,16,18H2,1-2H3,(H2,29,32)(H,33,36)/t24-/m1/s1	QLBNBADVDGUZLM-XMMPIXPASA-N	535976	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({2-[3-(dimethylamino)pyrrolidin-::US11242333, Example 91	Plasma kallikrein			 1710							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535976	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535976&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163407725	464921156							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136282	COC1CCN(C1)c1cc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)ccn1	InChI=1S/C27H28N6O2/c1-35-23-6-9-33(17-23)25-13-18(4-7-30-25)10-20-12-22(16-29-14-20)27(34)32-15-19-2-3-24-21(11-19)5-8-31-26(24)28/h2-5,7-8,11-14,16,23H,6,9-10,15,17H2,1H3,(H2,28,31)(H,32,34)	AGESLAHMMMUCOA-UHFFFAOYSA-N	359706	N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[2-(3-methoxypyrrolidin-1-yl)pyridin-4-yl]methyl}pyridine-3-carboxamide::US10221161, Example 88::US11242333, Example 92	Plasma kallikrein			 355							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359706	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359706&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121393167	386399159							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136283	Cc1cnn(Cc2ccc(Cc3cccc(c3)C(=O)NCc3ccc(CN)cc3C)cc2)c1	InChI=1S/C28H30N4O/c1-20-16-31-32(18-20)19-23-8-6-22(7-9-23)13-24-4-3-5-26(14-24)28(33)30-17-27-11-10-25(15-29)12-21(27)2/h3-12,14,16,18H,13,15,17,19,29H2,1-2H3,(H,30,33)	GISQVARMDIQSOG-UHFFFAOYSA-N	535978	N-{[4-(Aminomethyl)-2-methylphenyl]methyl}-5-({4-[(4-methylpyrazol-::US11242333, Example 93	Plasma kallikrein			 14.4							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535978	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535978&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163407726	464921158							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136284	Cc1cnn(Cc2ccc(Cc3cccc(c3)C(=O)NCc3c(C)cc(CN)cc3C)cc2)c1	InChI=1S/C29H32N4O/c1-20-16-32-33(18-20)19-24-9-7-23(8-10-24)13-25-5-4-6-27(14-25)29(34)31-17-28-21(2)11-26(15-30)12-22(28)3/h4-12,14,16,18H,13,15,17,19,30H2,1-3H3,(H,31,34)	ZMEYSATZIFEUPK-UHFFFAOYSA-N	535979	N-{[4-(Aminomethyl)-2,6-dimethylphenyl]methyl}-5-({4-[(4-::US11242333, Example 94	Plasma kallikrein			 7.47							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535979	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535979&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163407727	464921159							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136285	Cc1cnn(Cc2ccc(Cc3cncc(n3)C(=O)NCc3c(C)cc(CN)cc3C)cc2)c1	InChI=1S/C27H30N6O/c1-18-12-31-33(16-18)17-22-6-4-21(5-7-22)10-24-13-29-15-26(32-24)27(34)30-14-25-19(2)8-23(11-28)9-20(25)3/h4-9,12-13,15-16H,10-11,14,17,28H2,1-3H3,(H,30,34)	QDRGMOCPSUXWFS-UHFFFAOYSA-N	359713	N-{[4-(Aminomethyl)-2,6-dimethylphenyl]methyl}-6-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)pyrazine-2-carboxamide::US10221161, Example 95::US11242333, Example 95	Plasma kallikrein			 53.6							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359713	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359713&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117889949	386399165							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1136286	Cc1cnn(Cc2ccc(Cc3cccc(c3)C(=O)NCc3ccc(CN)c(F)c3)cc2)c1	InChI=1S/C27H27FN4O/c1-19-15-31-32(17-19)18-21-7-5-20(6-8-21)11-22-3-2-4-24(12-22)27(33)30-16-23-9-10-25(14-29)26(28)13-23/h2-10,12-13,15,17H,11,14,16,18,29H2,1H3,(H,30,33)	VJCTZPNRSNCKKP-UHFFFAOYSA-N	535981	N-{[4-(Aminomethyl)-3-fluorophenyl]methyl}-5-({4-[(4-methylpyrazol-::US11242333, Example 96	Plasma kallikrein			 365							US Patent		10.7270/Q23X89VT		aid1806321	US11242333	Edwards, HJ; Evans, DM; Meghani, P; Novak, AR	Kalvista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535981	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535981&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163407728	464921161							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115842	COc1cn(C(CCOC(C)(C)C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1-c1cnco1	InChI=1S/C30H30ClN3O7/c1-30(2,3)41-12-11-24(28(36)33-20-8-5-18(6-9-20)29(37)38)34-16-26(39-4)23(14-27(34)35)22-13-19(31)7-10-21(22)25-15-32-17-40-25/h5-10,13-17,24H,11-12H2,1-4H3,(H,33,36)(H,37,38)	WPCCHOKPWHOVEL-UHFFFAOYSA-N	413602	4-[(4-tert-Butoxy-2-{4-[5-chloro-2-(1,3-oxazol-5-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}butanoyl)amino]benzoic acid (Racemate)::US10421742, Example 1::US11180471, Example 1	Plasma kallikrein			 41.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413602	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413602&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205829	433913710							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115843	COc1cn(C(CCOC(C)(C)C)C(=O)Nc2ccc3nn(C)cc3c2)c(=O)cc1-c1cc(Cl)ccc1-c1cnco1	InChI=1S/C31H32ClN5O5/c1-31(2,3)42-11-10-26(30(39)34-21-7-9-25-19(12-21)16-36(4)35-25)37-17-28(40-5)24(14-29(37)38)23-13-20(32)6-8-22(23)27-15-33-18-41-27/h6-9,12-18,26H,10-11H2,1-5H3,(H,34,39)	XCQGMIZGIJYINH-UHFFFAOYSA-N	413603	4-tert-Butoxy-2-{4-[5-chloro-2-(1,3-oxazol-5-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 2::US11180471, Example 2	Plasma kallikrein			 29.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413603	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413603&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205678	433913711							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115844	CCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1cnco1	InChI=1S/C26H22ClN3O6/c1-3-21(25(32)29-17-7-4-15(5-8-17)26(33)34)30-13-23(35-2)20(11-24(30)31)19-10-16(27)6-9-18(19)22-12-28-14-36-22/h4-14,21H,3H2,1-2H3,(H,29,32)(H,33,34)	IXCUXZHAJIAIIU-UHFFFAOYSA-N	413604	4-[(2-{4-[5-Chloro-2-(1,3-oxazol-5-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}butanoyl)amino]benzoic acid (Racemate)::US10421742, Example 3::US11180471, Example 3	Plasma kallikrein			 110							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413604	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413604&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205676	433913712							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115845	COc1cn(C(CCOC(F)(F)F)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1-c1cnco1	InChI=1S/C27H21ClF3N3O7/c1-39-23-13-34(24(35)11-20(23)19-10-16(28)4-7-18(19)22-12-32-14-40-22)21(8-9-41-27(29,30)31)25(36)33-17-5-2-15(3-6-17)26(37)38/h2-7,10-14,21H,8-9H2,1H3,(H,33,36)(H,37,38)	BNAZVDSXUSMSQR-UHFFFAOYSA-N	413605	4-{[2-{4-[5-Chloro-2-(1,3-oxazol-5-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-(trifluoromethoxy)butanoyl]amino}benzoic acid (Racemate)::US10421742, Example 4::US11180471, Example 4	Plasma kallikrein			 53.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413605	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413605&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135204648	433913713							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115846	COc1cn(C(C[C@@H]2CCCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1-c1cnco1	InChI=1S/C30H28ClN3O7/c1-39-27-16-34(28(35)14-24(27)23-12-19(31)7-10-22(23)26-15-32-17-41-26)25(13-21-4-2-3-11-40-21)29(36)33-20-8-5-18(6-9-20)30(37)38/h5-10,12,14-17,21,25H,2-4,11,13H2,1H3,(H,33,36)(H,37,38)/t21-,25?/m0/s1	DIXCLZVJKSCYHJ-BWDMCYIDSA-N	413608	4-[(2-{4-[5-Chloro-2-(1,3-oxazol-5-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-3-[(2S)-tetrahydro-2H-pyran-2-yl]propanoyl)amino]benzoic acid (Mixture of Enantiomerically Pure Diastereomers)::US10421742, Example 5::US11180471, Example 5	Plasma kallikrein			 53.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413608	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413608&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205983	433913716							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115847	COCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1cnco1	InChI=1S/C27H24ClN3O7/c1-36-10-9-22(26(33)30-18-6-3-16(4-7-18)27(34)35)31-14-24(37-2)21(12-25(31)32)20-11-17(28)5-8-19(20)23-13-29-15-38-23/h3-8,11-15,22H,9-10H2,1-2H3,(H,30,33)(H,34,35)	SEWAOULYQTXIQF-UHFFFAOYSA-N	413609	4-[(2-{4-[5-Chloro-2-(1,3-oxazol-5-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxy-butanoyl)amino]benzoic acid (Racemate)::US10421742, Example 6::US11180471, Example 6	Plasma kallikrein			 31.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413609	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413609&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135204684	433913717							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115848	COCC[C@@H](C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1cnco1	InChI=1S/C27H24ClN3O7/c1-36-10-9-22(26(33)30-18-6-3-16(4-7-18)27(34)35)31-14-24(37-2)21(12-25(31)32)20-11-17(28)5-8-19(20)23-13-29-15-38-23/h3-8,11-15,22H,9-10H2,1-2H3,(H,30,33)(H,34,35)/t22-/m0/s1	SEWAOULYQTXIQF-QFIPXVFZSA-N	413610	4-{[(2S)-2-{4-[5-Chloro-2-(1,3-oxazol-5-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxybutanoyl]amino}benzoic acid (Enantiomer 2)::US10421742, Example 7::US11180471, Example 7	Plasma kallikrein			 13.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413610	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413610&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205514	433913718							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115849	COCCC(C(=O)Nc1ccc(s1)C(=O)NC1CC1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1cnco1	InChI=1S/C28H27ClN4O6S/c1-37-10-9-21(27(35)32-25-8-7-24(40-25)28(36)31-17-4-5-17)33-14-23(38-2)20(12-26(33)34)19-11-16(29)3-6-18(19)22-13-30-15-39-22/h3,6-8,11-15,17,21H,4-5,9-10H2,1-2H3,(H,31,36)(H,32,35)	QJNOMWVCKLXXGM-UHFFFAOYSA-N	413612	5-[(2-{4-[5-Chloro-2-(1,3-oxazol-5-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxybutanoyl)amino]-N-cyclopropylthiophen-2-carboxamide (Racemate)::US10421742, Example 8::US11180471, Example 8	Plasma kallikrein			 21.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413612	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413612&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205789	433913720							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115850	COCCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1cnco1	InChI=1S/C28H26ClN5O5/c1-33-14-17-10-19(5-7-23(17)32-33)31-28(36)24(8-9-37-2)34-15-26(38-3)22(12-27(34)35)21-11-18(29)4-6-20(21)25-13-30-16-39-25/h4-7,10-16,24H,8-9H2,1-3H3,(H,31,36)	NAFNAAZYCZFUNR-UHFFFAOYSA-N	413613	2-{4-[5-Chloro-2-(1,3-oxazol-5-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxy-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 9::US11180471, Example 9	Plasma kallikrein			 11.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413613	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413613&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205704	433913721							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115851	CNC(=O)c1ccc(NC(=O)C(CCOC)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2-c2cnco2)cn1	InChI=1S/C27H26ClN5O6/c1-29-26(35)21-7-5-17(12-31-21)32-27(36)22(8-9-37-2)33-14-24(38-3)20(11-25(33)34)19-10-16(28)4-6-18(19)23-13-30-15-39-23/h4-7,10-15,22H,8-9H2,1-3H3,(H,29,35)(H,32,36)	BVTWDIIYCUBXNG-UHFFFAOYSA-N	413614	5-[(2-{4-[5-Chloro-2-(1,3-oxazol-5-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxybutanoyl)amino]-N-methylpyridine-2-carboxamide (Racemate)::US10421742, Example 10::US11180471, Example 10	Plasma kallikrein			 21.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413614	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413614&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205982	433913722							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115852	COCCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1cnco1	InChI=1S/C27H24ClFN4O6/c1-37-8-7-22(27(36)32-16-4-6-18(26(30)35)21(29)10-16)33-13-24(38-2)20(11-25(33)34)19-9-15(28)3-5-17(19)23-12-31-14-39-23/h3-6,9-14,22H,7-8H2,1-2H3,(H2,30,35)(H,32,36)	IQJRZUBQZPMNPH-UHFFFAOYSA-N	413615	4-[(2-{4-[5-Chloro-2-(1,3-oxazol-5-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxybutanoyl)amino]-2-fluorobenzamide (Racemate)::US10421742, Example 11::US11180471, Example 11	Plasma kallikrein			 19.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413615	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413615&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205451	433913723							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115853	COCCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C1=NOCC1	InChI=1S/C28H28ClN5O5/c1-33-15-17-12-19(5-7-23(17)31-33)30-28(36)25(9-10-37-2)34-16-26(38-3)22(14-27(34)35)21-13-18(29)4-6-20(21)24-8-11-39-32-24/h4-7,12-16,25H,8-11H2,1-3H3,(H,30,36)	NMQHQLHZXFJBKV-UHFFFAOYSA-N	413616	2-{4-[5-Chloro-2-(4,5-dihydro-1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxy-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 12::US11180471, Example 12	Plasma kallikrein			 34.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413616	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413616&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135204747	433913724							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115854	COCC[C@@H](C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C1=NOCC1	InChI=1S/C28H28ClN5O5/c1-33-15-17-12-19(5-7-23(17)31-33)30-28(36)25(9-10-37-2)34-16-26(38-3)22(14-27(34)35)21-13-18(29)4-6-20(21)24-8-11-39-32-24/h4-7,12-16,25H,8-11H2,1-3H3,(H,30,36)/t25-/m0/s1	NMQHQLHZXFJBKV-VWLOTQADSA-N	413617	(2S)-2-{4-[5-Chloro-2-(4,5-dihydro-1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxy-N-(2-methyl-2H-indazol-5-yl)butanamide (Enantiomer 2)::US10421742, Example 13::US11180471, Example 13	Plasma kallikrein			 34.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413617	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413617&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205289	433913725							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115855	COCCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C1=NOCC1	InChI=1S/C27H26ClFN4O6/c1-37-9-8-23(27(36)31-16-4-6-18(26(30)35)21(29)12-16)33-14-24(38-2)20(13-25(33)34)19-11-15(28)3-5-17(19)22-7-10-39-32-22/h3-6,11-14,23H,7-10H2,1-2H3,(H2,30,35)(H,31,36)	DABAFGKGZQBJDK-UHFFFAOYSA-N	413618	4-[(2-{4-[5-Chloro-2-(4,5-dihydro-1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxybutanoyl)amino]-2-fluorobenzamide (Racemate)::US10421742, Example 14::US11180471, Example 14	Plasma kallikrein			 85.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413618	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413618&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205928	433913726							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115856	COCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C1=NOCC1	InChI=1S/C27H26ClN3O7/c1-36-11-10-23(26(33)29-18-6-3-16(4-7-18)27(34)35)31-15-24(37-2)21(14-25(31)32)20-13-17(28)5-8-19(20)22-9-12-38-30-22/h3-8,13-15,23H,9-12H2,1-2H3,(H,29,33)(H,34,35)	LOUUMSPZPZILMW-UHFFFAOYSA-N	413620	4-[(2-{4-[5-Chloro-2-(4,5-dihydro-1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxybutanoyl)amino]benzoic acid (Racemate)::US10421742, Example 15::US11180471, Example 15	Plasma kallikrein			 85.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413620	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413620&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205416	433913727							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115857	CNC(=O)c1ccc(NC(=O)C(CCOC)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2C2=NOCC2)cc1F	InChI=1S/C28H28ClFN4O6/c1-31-27(36)19-7-5-17(13-22(19)30)32-28(37)24(9-10-38-2)34-15-25(39-3)21(14-26(34)35)20-12-16(29)4-6-18(20)23-8-11-40-33-23/h4-7,12-15,24H,8-11H2,1-3H3,(H,31,36)(H,32,37)	JFECOVHUSFKCIW-UHFFFAOYSA-N	413622	4-[(2-{4-[5-Chloro-2-(4,5-dihydro-1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxybutanoyl)amino]-2-fluoro-N-methylbenzamide (Racemate)::US10421742, Example 16::US11180471, Example 16	Plasma kallikrein			 99.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413622	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413622&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205842	433913728							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115858	COCCC(C(=O)Nc1ccc(nc1)C(N)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C1=NOCCO1	InChI=1S/C26H26ClN5O7/c1-36-8-7-21(25(35)30-16-4-6-20(24(28)34)29-13-16)32-14-22(37-2)19(12-23(32)33)18-11-15(27)3-5-17(18)26-31-39-10-9-38-26/h3-6,11-14,21H,7-10H2,1-2H3,(H2,28,34)(H,30,35)	KGGJSEUIYZFMSZ-UHFFFAOYSA-N	413623	5-[(2-{4-[5-Chloro-2-(5,6-dihydro-1,4,2-dioxazin-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxybutanoyl)amino]pyridine-2-carboxamide (Racemate)::US10421742, Example 17::US11180471, Example 17	Plasma kallikrein			 500							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413623	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413623&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205954	433913729							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115859	COCCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1C1=NOCCO1	InChI=1S/C28H28ClN5O6/c1-33-15-17-12-19(5-7-23(17)31-33)30-27(36)24(8-9-37-2)34-16-25(38-3)22(14-26(34)35)21-13-18(29)4-6-20(21)28-32-40-11-10-39-28/h4-7,12-16,24H,8-11H2,1-3H3,(H,30,36)	RGUMZXDJADTTSV-UHFFFAOYSA-N	413624	2-{4-[5-Chloro-2-(5,6-dihydro-1,4,2-dioxazin-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxy-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 18::US11180471, Example 18	Plasma kallikrein			 150							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413624	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413624&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205290	433913730							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115860	COCCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C26H25ClN8O4/c1-33-13-16-10-18(5-6-21(16)30-33)29-26(37)23(8-9-38-2)34-14-24(39-3)20(12-25(34)36)19-11-17(27)4-7-22(19)35-15-28-31-32-35/h4-7,10-15,23H,8-9H2,1-3H3,(H,29,37)	UUIHUWPHJJSKFX-UHFFFAOYSA-N	413625	2-{4-[5-Chloro-2-(1H-tetrazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxy-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 19::US11180471, Example 19	Plasma kallikrein			 1.10							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413625	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413625&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205820	433913731							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115861	COCCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnnn1	InChI=1S/C25H23ClFN7O5/c1-38-8-7-21(25(37)30-15-4-5-16(24(28)36)19(27)10-15)33-12-22(39-2)18(11-23(33)35)17-9-14(26)3-6-20(17)34-13-29-31-32-34/h3-6,9-13,21H,7-8H2,1-2H3,(H2,28,36)(H,30,37)	IICMIKXBIINPOO-UHFFFAOYSA-N	413626	4-[(2-{4-[5-Chloro-2-(1H-tetrazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxy-butanoyl)amino]-2-fluorobenzamide (Racemate)::US10421742, Example 20::US11180471, Example 20	Plasma kallikrein			 1.40							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413626	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413626&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205703	433913732							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115862	COCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1ccnc1	InChI=1S/C27H25ClN4O6/c1-37-12-9-23(26(34)30-19-6-3-17(4-7-19)27(35)36)32-15-24(38-2)21(14-25(32)33)20-13-18(28)5-8-22(20)31-11-10-29-16-31/h3-8,10-11,13-16,23H,9,12H2,1-2H3,(H,30,34)(H,35,36)	QAOJLVDDEDCBPJ-UHFFFAOYSA-N	413627	4-[(2-{4-[5-Chloro-2-(1H-imidazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxy-butanoyl)amino]benzoic acid (Racemate)::US10421742, Example 21::US11180471, Example 21	Plasma kallikrein			 69.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413627	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413627&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205879	433913733							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115863	COCCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1ccnc1	InChI=1S/C27H25ClFN5O5/c1-38-10-7-23(27(37)32-17-4-5-18(26(30)36)21(29)12-17)34-14-24(39-2)20(13-25(34)35)19-11-16(28)3-6-22(19)33-9-8-31-15-33/h3-6,8-9,11-15,23H,7,10H2,1-2H3,(H2,30,36)(H,32,37)	NHVDXTRNBLJMKL-UHFFFAOYSA-N	413628	4-[(2-{4-[5-Chloro-2-(1H-imidazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxy-butanoyl)amino]-2-fluorobenzamide (Racemate)::US10421742, Example 22::US11180471, Example 22	Plasma kallikrein			 31.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413628	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413628&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205815	433913734							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115864	COCCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1ccnc1	InChI=1S/C28H27ClN6O4/c1-33-15-18-12-20(5-6-23(18)32-33)31-28(37)25(8-11-38-2)35-16-26(39-3)22(14-27(35)36)21-13-19(29)4-7-24(21)34-10-9-30-17-34/h4-7,9-10,12-17,25H,8,11H2,1-3H3,(H,31,37)	HEMONLHVVQNSEO-UHFFFAOYSA-N	413629	2-{4-[5-Chloro-2-(1H-imidazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1 (2f)-yl}-4-methoxy-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 23::US11180471, Example 23	Plasma kallikrein			 12.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413629	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413629&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205442	433913735							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115865	COCCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1cocn1	InChI=1S/C27H24ClFN4O6/c1-37-8-7-23(27(36)32-16-4-6-18(26(30)35)21(29)10-16)33-12-24(38-2)20(11-25(33)34)19-9-15(28)3-5-17(19)22-13-39-14-31-22/h3-6,9-14,23H,7-8H2,1-2H3,(H2,30,35)(H,32,36)	WWYXXZQZSPIQLH-UHFFFAOYSA-N	413630	4-[(2-{4-[5-Chloro-2-(1,3-oxazol-4-yl)phenyl]-5-methoxy-2-oxopyridin-1 (2N)-yl}-4-methoxybutanoyl)amino]-2-fluorobenzamide (Racemate)::US10421742, Example 24::US11180471, Example 24	Plasma kallikrein			 360							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413630	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413630&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135211514	433913736							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115866	COCCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1cocn1	InChI=1S/C28H26ClN5O5/c1-33-13-17-10-19(5-7-23(17)32-33)31-28(36)25(8-9-37-2)34-14-26(38-3)22(12-27(34)35)21-11-18(29)4-6-20(21)24-15-39-16-30-24/h4-7,10-16,25H,8-9H2,1-3H3,(H,31,36)	LMABFZNOSCTFBL-UHFFFAOYSA-N	413631	2-{4-[5-Chloro-2-(1,3-oxazol-4-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxy-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 25::US11180471, Example 25	Plasma kallikrein			 170							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413631	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413631&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135206017	433913737							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115867	COCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1cocn1	InChI=1S/C27H24ClN3O7/c1-36-10-9-23(26(33)30-18-6-3-16(4-7-18)27(34)35)31-13-24(37-2)21(12-25(31)32)20-11-17(28)5-8-19(20)22-14-38-15-29-22/h3-8,11-15,23H,9-10H2,1-2H3,(H,30,33)(H,34,35)	DDOXVBZTTPBKNS-UHFFFAOYSA-N	413632	4-[(2-{4-[5-Chloro-2-(1,3-oxazol-4-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxybutanoyl)amino]benzoic acid (Racemate)::US10421742, Example 26::US11180471, Example 26	Plasma kallikrein			 510							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413632	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413632&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205923	433913738							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115868	COCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnco1	InChI=1S/C26H23ClN4O7/c1-36-10-9-21(24(33)29-17-6-3-15(4-7-17)26(34)35)31-13-22(37-2)20(12-23(31)32)19-11-16(27)5-8-18(19)25-30-28-14-38-25/h3-8,11-14,21H,9-10H2,1-2H3,(H,29,33)(H,34,35)	QIURUUZJCMOSSC-UHFFFAOYSA-N	413633	4-[(2-{4-[5-Chloro-2-(1,3,4-oxadiazol-2-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxybutanoyl)amino]benzoic acid (Racemate)::US10421742, Example 27::US11180471, Example 27	Plasma kallikrein			 18.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413633	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413633&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205873	433913739							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115869	COCCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnco1	InChI=1S/C26H23ClFN5O6/c1-37-8-7-21(25(36)31-15-4-6-17(24(29)35)20(28)10-15)33-12-22(38-2)19(11-23(33)34)18-9-14(27)3-5-16(18)26-32-30-13-39-26/h3-6,9-13,21H,7-8H2,1-2H3,(H2,29,35)(H,31,36)	UISHCWSATBUTQA-UHFFFAOYSA-N	413634	4-[(2-{4-[5-Chloro-2-(1,3,4-oxadiazol-2-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxybutanoyl)amino]-2-fluorobenzamide (Racemate)::US10421742, Example 28::US11180471, Example 28	Plasma kallikrein			 20.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413634	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413634&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205855	433913740							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115870	CNC(=O)c1ccc(NC(=O)C(CCOC)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2-n2cc(F)cn2)cn1	InChI=1S/C27H26ClFN6O5/c1-30-26(37)21-6-5-18(13-31-21)33-27(38)23(8-9-39-2)34-15-24(40-3)20(11-25(34)36)19-10-16(28)4-7-22(19)35-14-17(29)12-32-35/h4-7,10-15,23H,8-9H2,1-3H3,(H,30,37)(H,33,38)	VTZPJMDYPXOBMS-UHFFFAOYSA-N	413635	5-[(2-{4-[5-Chloro-2-(4-fluoro-1H-pyrazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2N)-yl}-4-methoxybutanoyl)amino]-N-methylpyridine-2-carboxamide (Racemate)::US10421742, Example 29::US11180471, Example 29	Plasma kallikrein			 870							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413635	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413635&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135211518	433913741							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115871	COCCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1nnco1	InChI=1S/C27H25ClN6O5/c1-33-13-16-10-18(5-7-22(16)32-33)30-26(36)23(8-9-37-2)34-14-24(38-3)21(12-25(34)35)20-11-17(28)4-6-19(20)27-31-29-15-39-27/h4-7,10-15,23H,8-9H2,1-3H3,(H,30,36)	VWKPWXZBFLVGCL-UHFFFAOYSA-N	413636	2-{4-[5-Chloro-2-(1,3,4-oxadiazol-2-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxy-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 30::US11180471, Example 30	Plasma kallikrein			 11.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413636	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413636&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205971	433913742							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115872	COc1cn(C(CC2COCCO2)C(=O)Nc2ccc3nccnc3c2)c(=O)cc1-c1cc(Cl)ccc1C1=NOCC1	InChI=1S/C30H28ClN5O6/c1-39-28-16-36(29(37)15-23(28)22-12-18(31)2-4-21(22)24-6-9-42-35-24)27(14-20-17-40-10-11-41-20)30(38)34-19-3-5-25-26(13-19)33-8-7-32-25/h2-5,7-8,12-13,15-16,20,27H,6,9-11,14,17H2,1H3,(H,34,38)	GRVRMTKUMARYRR-UHFFFAOYSA-N	413637	N-(Quinoxalin-6-yl)-2-{4-[5-chloro-2-(4,5-dihydro-1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-3-(1,4-dioxan-2-yl)propanamide (Diastereomer Mixture)::US10421742, Example 31::US11180471, Example 31	Plasma kallikrein			 21.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413637	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413637&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205330	433913743							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115873	COc1cn(C(CC2COCCO2)C(=O)Nc2ccc3nn(C)cc3c2)c(=O)cc1-c1cc(Cl)ccc1C1=NOCC1	InChI=1S/C30H30ClN5O6/c1-35-15-18-11-20(4-6-25(18)33-35)32-30(38)27(13-21-17-40-9-10-41-21)36-16-28(39-2)24(14-29(36)37)23-12-19(31)3-5-22(23)26-7-8-42-34-26/h3-6,11-12,14-16,21,27H,7-10,13,17H2,1-2H3,(H,32,38)	NOYWIPLIXQSLPY-UHFFFAOYSA-N	413638	2-{4-[5-Chloro-2-(4,5-dihydro-1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-3-(1,4-dioxan-2-yl)-N-(2-methyl-2H-indazol-5-yl)propanamide (Diastereomer Mixture)::US10421742, Example 32::US11180471, Example 32	Plasma kallikrein			 51.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413638	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413638&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205291	433913744							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115874	COc1cn(C(CC2COCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C1=NOCC1	InChI=1S/C29H28ClN3O8/c1-38-26-15-33(27(34)14-23(26)22-12-18(30)4-7-21(22)24-8-9-41-32-24)25(13-20-16-39-10-11-40-20)28(35)31-19-5-2-17(3-6-19)29(36)37/h2-7,12,14-15,20,25H,8-11,13,16H2,1H3,(H,31,35)(H,36,37)	DVWWRIVKJVUPDO-UHFFFAOYSA-N	413639	4-{[2-{4-[5-Chloro-2-(4,5-dihydro-1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-3-(1,4-dioxan-2-yl)propanoyl]amino}benzoic acid (Diastereomer Mixture)::US10421742, Example 33::US11180471, Example 33	Plasma kallikrein			 170							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413639	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413639&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205538	433913745							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115875	CNC(=O)c1ccc(NC(=O)C(CC2COCCO2)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2C2=NOCC2)cn1	InChI=1S/C29H30ClN5O7/c1-31-28(37)24-6-4-18(14-32-24)33-29(38)25(12-19-16-40-9-10-41-19)35-15-26(39-2)22(13-27(35)36)21-11-17(30)3-5-20(21)23-7-8-42-34-23/h3-6,11,13-15,19,25H,7-10,12,16H2,1-2H3,(H,31,37)(H,33,38)	DEFNAUKAAWHGKT-UHFFFAOYSA-N	413640	5-{[2-{4-[5-Chloro-2-(4,5-dihydro-1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-3-(1,4-dioxan-2-yl)propanoyl]amino}-N-methylpyridine-2-carboxamide (Diastereomer Mixture)::US10421742, Example 34::US11180471, Example 34	Plasma kallikrein			 140							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413640	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413640&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205531	433913746							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115876	COc1cn(C(C[C@@H]2CCCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C1=NOCC1	InChI=1S/C30H30ClN3O7/c1-39-27-17-34(28(35)16-24(27)23-14-19(31)7-10-22(23)25-11-13-41-33-25)26(15-21-4-2-3-12-40-21)29(36)32-20-8-5-18(6-9-20)30(37)38/h5-10,14,16-17,21,26H,2-4,11-13,15H2,1H3,(H,32,36)(H,37,38)/t21-,26?/m0/s1	DSSYHGODIQPLGT-GVNKFJBHSA-N	413641	4-[(2-{4-[5-Chloro-2-(4,5-dihydro-1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-3-[(2S)-tetrahydro-2H-pyran-2-yl]propanoyl)amino]benzoic acid (Diastereomer Mixture)::US10421742, Example 35::US10421742, Example 36::US11180471, Example 36	Plasma kallikrein			 83.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413641	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413641&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205730	433913747							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115877	COc1cn(C(C[C@@H]2CCCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C1=NOCC1	InChI=1S/C30H30ClN3O7/c1-39-27-17-34(28(35)16-24(27)23-14-19(31)7-10-22(23)25-11-13-41-33-25)26(15-21-4-2-3-12-40-21)29(36)32-20-8-5-18(6-9-20)30(37)38/h5-10,14,16-17,21,26H,2-4,11-13,15H2,1H3,(H,32,36)(H,37,38)/t21-,26?/m0/s1	DSSYHGODIQPLGT-GVNKFJBHSA-N	413641	4-[(2-{4-[5-Chloro-2-(4,5-dihydro-1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-3-[(2S)-tetrahydro-2H-pyran-2-yl]propanoyl)amino]benzoic acid (Diastereomer Mixture)::US10421742, Example 35::US10421742, Example 36::US11180471, Example 36	Plasma kallikrein			 96.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413641	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413641&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205730	433913747							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115878	CNC(=O)c1ccc(NC(=O)C(C[C@@H]2CCCCO2)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2C2=NOCC2)cn1	InChI=1S/C30H32ClN5O6/c1-32-29(38)25-9-7-19(16-33-25)34-30(39)26(14-20-5-3-4-11-41-20)36-17-27(40-2)23(15-28(36)37)22-13-18(31)6-8-21(22)24-10-12-42-35-24/h6-9,13,15-17,20,26H,3-5,10-12,14H2,1-2H3,(H,32,38)(H,34,39)/t20-,26?/m0/s1	YJLNILRUWJVMCG-DQUNLGLBSA-N	413643	5-[(2-{4-[5-Chloro-2-(4,5-dihydro-1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-3-[(2S)-tetrahydro-2H-pyran-2-yl]propanoyl)amino]-N-methylpyridine-2-carboxamide (Diastereomer Mixture)::US10421742, Example 37::US11180471, Example 37	Plasma kallikrein			 100.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413643	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413643&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205449	433913748							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115879	COc1cn(C(C[C@@H]2CCCCO2)C(=O)Nc2ccc3nn(C)cc3c2)c(=O)cc1-c1cc(Cl)ccc1C1=NOCC1	InChI=1S/C31H32ClN5O5/c1-36-17-19-13-21(7-9-26(19)34-36)33-31(39)28(15-22-5-3-4-11-41-22)37-18-29(40-2)25(16-30(37)38)24-14-20(32)6-8-23(24)27-10-12-42-35-27/h6-9,13-14,16-18,22,28H,3-5,10-12,15H2,1-2H3,(H,33,39)/t22-,28?/m0/s1	LNIZEAPOEAZWLH-XYXHBKGXSA-N	413644	2-{4-[5-Chloro-2-(4,5-dihydro-1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(2-methyl-2H-indazol-5-yl)-3-[(2S)-tetrahydro-2H-pyran-2-yl]propanamide (Diastereomer Mixture)::US10421742, Example 38::US11180471, Example 38	Plasma kallikrein			 46.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413644	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413644&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205844	433913749							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115880	COc1cn(C(C[C@H]2CCCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C1=NOCC1	InChI=1S/C30H30ClN3O7/c1-39-27-17-34(28(35)16-24(27)23-14-19(31)7-10-22(23)25-11-13-41-33-25)26(15-21-4-2-3-12-40-21)29(36)32-20-8-5-18(6-9-20)30(37)38/h5-10,14,16-17,21,26H,2-4,11-13,15H2,1H3,(H,32,36)(H,37,38)/t21-,26?/m1/s1	DSSYHGODIQPLGT-OSMGYRLQSA-N	413645	4-[(2-{4-[5-Chloro-2-(4,5-dihydro-1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-3-[(2R)-tetrahydro-2H-pyran-2-yl]propanoyl)amino]benzoic acid (Diastereomer Mixture)::US10421742, Example 39::US11180471, Example 39	Plasma kallikrein			 570							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413645	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413645&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205996	433913750							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115881	COc1cn(C(C[C@H]2CCCCO2)C(=O)Nc2ccc3nn(C)cc3c2)c(=O)cc1-c1cc(Cl)ccc1C1=NOCC1	InChI=1S/C31H32ClN5O5/c1-36-17-19-13-21(7-9-26(19)34-36)33-31(39)28(15-22-5-3-4-11-41-22)37-18-29(40-2)25(16-30(37)38)24-14-20(32)6-8-23(24)27-10-12-42-35-27/h6-9,13-14,16-18,22,28H,3-5,10-12,15H2,1-2H3,(H,33,39)/t22-,28?/m1/s1	LNIZEAPOEAZWLH-WZOMIXFGSA-N	413646	2-{4-[5-Chloro-2-(4,5-dihydro-1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-N-(2-methyl-2H-indazol-5-yl)-3-[(2R)-tetrahydro-2H-pyran-2-yl]propanamide (Diastereomer Mixture)::US10421742, Example 40::US11180471, Example 40	Plasma kallikrein			 130							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413646	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413646&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205645	433913751							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115882	COc1cn(C(C[C@H]2CCCCO2)C(=O)Nc2ccc(C(N)=O)c(F)c2)c(=O)cc1-c1cc(Cl)ccc1C1=NOCC1	InChI=1S/C30H30ClFN4O6/c1-40-27-16-36(28(37)15-23(27)22-12-17(31)5-7-20(22)25-9-11-42-35-25)26(14-19-4-2-3-10-41-19)30(39)34-18-6-8-21(29(33)38)24(32)13-18/h5-8,12-13,15-16,19,26H,2-4,9-11,14H2,1H3,(H2,33,38)(H,34,39)/t19-,26?/m1/s1	BKMNWKMPOGYRQA-ICCFGIFFSA-N	413647	4-[(2-{4-[5-Chloro-2-(4,5-dihydro-1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-3-[(2R)-tetrahydro-2H-pyran-2-yl]propanoyl)amino]-2-fluorobenzamide (Diastereomer Mixture)::US10421742, Example 41::US11180471, Example 41	Plasma kallikrein			 220							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413647	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413647&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205771	433913752							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115883	CNC(=O)c1ccc(NC(=O)C(CCOC)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2-c2ccon2)cn1	InChI=1S/C27H26ClN5O6/c1-29-26(35)22-7-5-17(14-30-22)31-27(36)23(9-10-37-2)33-15-24(38-3)20(13-25(33)34)19-12-16(28)4-6-18(19)21-8-11-39-32-21/h4-8,11-15,23H,9-10H2,1-3H3,(H,29,35)(H,31,36)	DGUWRYFZSHPSRF-UHFFFAOYSA-N	413648	5-[(2-{4-[5-Chloro-2-(1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxybutanoyl)amino]-N-methylpyridin-2-carboxamide (Racemate)::US10421742, Example 42::US11180471, Example 42	Plasma kallikrein			 24.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413648	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413648&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135206087	433913753							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115884	COCCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1ccon1	InChI=1S/C28H26ClN5O5/c1-33-15-17-12-19(5-7-23(17)31-33)30-28(36)25(9-10-37-2)34-16-26(38-3)22(14-27(34)35)21-13-18(29)4-6-20(21)24-8-11-39-32-24/h4-8,11-16,25H,9-10H2,1-3H3,(H,30,36)	MQPMEUJFEVBLRJ-UHFFFAOYSA-N	413649	2-{4-[5-Chloro-2-(1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxy-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 43::US11180471, Example 43	Plasma kallikrein			 18.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413649	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413649&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135206020	433913754							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115885	CNC(=O)c1ccc(NC(=O)C(CCOC(C)(C)C)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2-c2ccon2)cn1	InChI=1S/C30H32ClN5O6/c1-30(2,3)41-12-11-25(29(39)34-19-7-9-24(33-16-19)28(38)32-4)36-17-26(40-5)22(15-27(36)37)21-14-18(31)6-8-20(21)23-10-13-42-35-23/h6-10,13-17,25H,11-12H2,1-5H3,(H,32,38)(H,34,39)	XQIJVKWEUWNLCF-UHFFFAOYSA-N	413650	5-[(4-tert-Butoxy-2-{4-[5-chloro-2-(1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}butanoyl)amino]-N-methylpyridine-2-carboxamide (Racemate)::US10421742, Example 44::US11180471, Example 44	Plasma kallikrein			 18.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413650	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413650&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205942	433913755							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115886	COc1cn(C(CCOC(C)(C)C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1-c1ccon1	InChI=1S/C30H30ClN3O7/c1-30(2,3)40-13-12-25(28(36)32-20-8-5-18(6-9-20)29(37)38)34-17-26(39-4)23(16-27(34)35)22-15-19(31)7-10-21(22)24-11-14-41-33-24/h5-11,14-17,25H,12-13H2,1-4H3,(H,32,36)(H,37,38)	XVQJXIHGEMVIBL-UHFFFAOYSA-N	413651	4-[(4-tert-Butoxy-2-{4-[5-chloro-2-(1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}butanoyl)amino]benzoic acid (Racemate)::US10421742, Example 45::US11180471, Example 45	Plasma kallikrein			 28.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413651	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413651&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205454	433913756							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115887	COc1cn([C@@H](CCOC(C)(C)C)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1-c1ccon1	InChI=1S/C30H30ClN3O7/c1-30(2,3)40-13-12-25(28(36)32-20-8-5-18(6-9-20)29(37)38)34-17-26(39-4)23(16-27(34)35)22-15-19(31)7-10-21(22)24-11-14-41-33-24/h5-11,14-17,25H,12-13H2,1-4H3,(H,32,36)(H,37,38)/t25-/m0/s1	XVQJXIHGEMVIBL-VWLOTQADSA-N	413652	4-{[(2S)-4-tert-Butoxy-2-{4-[5-chloro-2-(1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}butanoyl]amino}benzoic acid (Enantiomer 2)::US10421742, Example 46::US11180471, Example 46	Plasma kallikrein			 15.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413652	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413652&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205453	433913757							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115888	COc1cn(C(C[C@@H]2CCCCO2)C(=O)Nc2ccc3nccnc3c2)c(=O)cc1-c1cc(Cl)ccc1-c1ccon1	InChI=1S/C31H28ClN5O5/c1-40-29-18-37(30(38)17-24(29)23-14-19(32)5-7-22(23)25-9-13-42-36-25)28(16-21-4-2-3-12-41-21)31(39)35-20-6-8-26-27(15-20)34-11-10-33-26/h5-11,13-15,17-18,21,28H,2-4,12,16H2,1H3,(H,35,39)/t21-,28?/m0/s1	QHFRLRVXSRUUOC-QDLLFRBVSA-N	413653	N-(Quinoxalin-6-yl)-2-{4-[5-chloro-2-(1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-3-[(2S)-tetrahydro-2H-pyran-2-yl]propanamide (Diastereomer Mixture)::US10421742, Example 47::US11180471, Example 47	Plasma kallikrein			 25.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413653	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413653&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205254	433913758							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115889	COc1cn(C(C[C@@H]2CCCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1-c1ccon1	InChI=1S/C30H28ClN3O7/c1-39-27-17-34(28(35)16-24(27)23-14-19(31)7-10-22(23)25-11-13-41-33-25)26(15-21-4-2-3-12-40-21)29(36)32-20-8-5-18(6-9-20)30(37)38/h5-11,13-14,16-17,21,26H,2-4,12,15H2,1H3,(H,32,36)(H,37,38)/t21-,26?/m0/s1	RTTPBBKILQCFGH-GVNKFJBHSA-N	413654	4-[(2-{4-[5-Chloro-2-(1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-3-[(2S)-tetrahydro-2H-pyran-2-yl]propanoyl)amino]benzoic acid (Diastereomer Mixture)::US10421742, Example 48::US10421742, Example 49::US11180471, Example 49	Plasma kallikrein			 49.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413654	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413654&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205526	433913759							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115890	COc1cn(C(C[C@@H]2CCCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1-c1ccon1	InChI=1S/C30H28ClN3O7/c1-39-27-17-34(28(35)16-24(27)23-14-19(31)7-10-22(23)25-11-13-41-33-25)26(15-21-4-2-3-12-40-21)29(36)32-20-8-5-18(6-9-20)30(37)38/h5-11,13-14,16-17,21,26H,2-4,12,15H2,1H3,(H,32,36)(H,37,38)/t21-,26?/m0/s1	RTTPBBKILQCFGH-GVNKFJBHSA-N	413654	4-[(2-{4-[5-Chloro-2-(1,2-oxazol-3-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-3-[(2S)-tetrahydro-2H-pyran-2-yl]propanoyl)amino]benzoic acid (Diastereomer Mixture)::US10421742, Example 48::US10421742, Example 49::US11180471, Example 49	Plasma kallikrein			 17.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413654	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413654&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205526	433913759							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115891	COCCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnc(F)c1	InChI=1S/C28H26ClFN6O4/c1-34-13-17-10-19(5-6-22(17)33-34)32-28(38)24(8-9-39-2)36-14-25(40-3)21(12-27(36)37)20-11-18(29)4-7-23(20)35-15-26(30)31-16-35/h4-7,10-16,24H,8-9H2,1-3H3,(H,32,38)	XXIIEASKYLNDLZ-UHFFFAOYSA-N	413656	2-{4-[5-Chloro-2-(4-fluoro-1H-imidazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxy-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 50::US11180471, Example 50	Plasma kallikrein			 95.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413656	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413656&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135206014	433913760							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115892	COCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnc(F)c1	InChI=1S/C27H24ClFN4O6/c1-38-10-9-22(26(35)31-18-6-3-16(4-7-18)27(36)37)33-13-23(39-2)20(12-25(33)34)19-11-17(28)5-8-21(19)32-14-24(29)30-15-32/h3-8,11-15,22H,9-10H2,1-2H3,(H,31,35)(H,36,37)	LQOPQTHAZLUPRF-UHFFFAOYSA-N	413657	4-[(2-{4-[5-Chloro-2-(4-fluoro-1H-imidazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxybutanoyl)amino]benzoic acid (Racemate)::US10421742, Example 51::US11180471, Example 51	Plasma kallikrein			 56.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413657	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413657&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205822	433913761							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115893	COCCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnc(Cl)c1	InChI=1S/C28H26Cl2N6O4/c1-34-13-17-10-19(5-6-22(17)33-34)32-28(38)24(8-9-39-2)36-14-25(40-3)21(12-27(36)37)20-11-18(29)4-7-23(20)35-15-26(30)31-16-35/h4-7,10-16,24H,8-9H2,1-3H3,(H,32,38)	VHDZGIZYASTKPK-UHFFFAOYSA-N	413658	2-{4-[5-Chloro-2-(4-chloro-1H-imidazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxy-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 52::US11180471, Example 52	Plasma kallikrein			 19.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413658	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413658&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205518	433913762							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115894	COCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnc(Cl)c1	InChI=1S/C27H24Cl2N4O6/c1-38-10-9-22(26(35)31-18-6-3-16(4-7-18)27(36)37)33-13-23(39-2)20(12-25(33)34)19-11-17(28)5-8-21(19)32-14-24(29)30-15-32/h3-8,11-15,22H,9-10H2,1-2H3,(H,31,35)(H,36,37)	ATCFLROFGUZFNA-UHFFFAOYSA-N	413659	4-[(2-{4-[5-Chloro-2-(4-chloro-1H-imidazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxybutanoyl)amino]benzoic acid (Racemate)::US10421742, Example 53::US11180471, Example 53	Plasma kallikrein			 37.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413659	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413659&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135206033	433913763							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115895	CNC(=O)c1ccc(NC(=O)C(CCOC)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2-n2cnc(Cl)c2)cn1	InChI=1S/C27H26Cl2N6O5/c1-30-26(37)20-6-5-17(12-31-20)33-27(38)22(8-9-39-2)35-13-23(40-3)19(11-25(35)36)18-10-16(28)4-7-21(18)34-14-24(29)32-15-34/h4-7,10-15,22H,8-9H2,1-3H3,(H,30,37)(H,33,38)	ILXCPIBUCWIAMK-UHFFFAOYSA-N	413660	5-[(2-{4-[5-Chloro-2-(4-chloro-1H-imidazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxybutanoyl)amino]-N-methylpyridine-2-carboxamide (Racemate)::US10421742, Example 54::US11180471, Example 54	Plasma kallikrein			 44.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413660	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413660&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135206034	433913764							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115896	COCCC(C(=O)Nc1ccc2nccnc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnc(Cl)c1	InChI=1S/C28H24Cl2N6O4/c1-39-10-7-24(28(38)34-18-4-5-21-22(12-18)32-9-8-31-21)36-14-25(40-2)20(13-27(36)37)19-11-17(29)3-6-23(19)35-15-26(30)33-16-35/h3-6,8-9,11-16,24H,7,10H2,1-2H3,(H,34,38)	FCJJBIBALYUNQH-UHFFFAOYSA-N	413661	N-(Quinoxalin-6-yl)-2-{4-[5-chloro-2-(4-chloro-1H-imidazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxybutanamide (Racemate)::US10421742, Example 55::US11180471, Example 55	Plasma kallikrein			 12.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413661	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413661&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205710	433913765							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115897	COCCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnnc1	InChI=1S/C26H24ClFN6O5/c1-38-8-7-22(26(37)32-16-4-5-17(25(29)36)20(28)10-16)34-12-23(39-2)19(11-24(34)35)18-9-15(27)3-6-21(18)33-13-30-31-14-33/h3-6,9-14,22H,7-8H2,1-2H3,(H2,29,36)(H,32,37)	YIFQLPJMHMOWFU-UHFFFAOYSA-N	413662	4-[(2-{4-[5-Chloro-2-(4H-1,2,4-triazol-4-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxybutanoyl)amino]-2-fluorobenzamide (Racemate)::US10421742, Example 56::US11180471, Example 56	Plasma kallikrein			 26.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413662	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413662&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205108	433913766							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115898	COCCC(C(=O)Nc1ccc2nccnc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnnc1	InChI=1S/C27H24ClN7O4/c1-38-10-7-24(27(37)33-18-4-5-21-22(12-18)30-9-8-29-21)35-14-25(39-2)20(13-26(35)36)19-11-17(28)3-6-23(19)34-15-31-32-16-34/h3-6,8-9,11-16,24H,7,10H2,1-2H3,(H,33,37)	QEUZUPMZRYSKJR-UHFFFAOYSA-N	413663	N-(Quinoxalin-6-yl)-2-{4-[5-chloro-2-(4H-1,2,4-triazol-4-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxybutanamide (Racemate)::US10421742, Example 57::US11180471, Example 57	Plasma kallikrein			 8.70							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413663	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413663&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205805	433913767							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115899	COCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnnc1	InChI=1S/C26H24ClN5O6/c1-37-10-9-22(25(34)30-18-6-3-16(4-7-18)26(35)36)32-13-23(38-2)20(12-24(32)33)19-11-17(27)5-8-21(19)31-14-28-29-15-31/h3-8,11-15,22H,9-10H2,1-2H3,(H,30,34)(H,35,36)	BABSEGOQVMFTTL-UHFFFAOYSA-N	413664	4-[(2-{4-[5-Chloro-2-(4H-1,2,4-triazol-4-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxybutanoyl)amino]benzoic acid (Racemate)::US10421742, Example 58::US11180471, Example 58	Plasma kallikrein			 47.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413664	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413664&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205192	433913768							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115900	COCCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnnc1	InChI=1S/C27H26ClN7O4/c1-33-13-17-10-19(5-6-22(17)32-33)31-27(37)24(8-9-38-2)35-14-25(39-3)21(12-26(35)36)20-11-18(28)4-7-23(20)34-15-29-30-16-34/h4-7,10-16,24H,8-9H2,1-3H3,(H,31,37)	FGCCTMXHTZVEGP-UHFFFAOYSA-N	413665	2-{4-[5-Chloro-2-(4H-1,2,4-triazol-4-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxy-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 59::US11180471, Example 59	Plasma kallikrein			 15.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413665	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413665&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135206021	433913769							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115901	COCCC(C(=O)Nc1ccc2nccnc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)F	InChI=1S/C28H24ClF2N7O4/c1-41-10-7-24(28(40)34-17-4-5-20-21(12-17)33-9-8-32-20)37-15-25(42-2)19(13-26(37)39)18-11-16(29)3-6-23(18)38-14-22(27(30)31)35-36-38/h3-6,8-9,11-15,24,27H,7,10H2,1-2H3,(H,34,40)	SSZTYGHNKCZYAF-UHFFFAOYSA-N	528079	N-(Quinoxalin-6-yl)-2-[4-{5-chloro-2-[4-(difluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]pentanamide (racemate)::US11180471, Example 60	Plasma kallikrein			 6.60							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528079	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528079&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163200076	463791634							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115902	COCCC(C(=O)Nc1ccc2nccnc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnc(c1)C(F)F	InChI=1S/C29H25ClF2N6O4/c1-41-10-7-25(29(40)36-18-4-5-21-22(12-18)34-9-8-33-21)38-15-26(42-2)20(13-27(38)39)19-11-17(30)3-6-24(19)37-14-23(28(31)32)35-16-37/h3-6,8-9,11-16,25,28H,7,10H2,1-2H3,(H,36,40)	JXACRAOKHLGFCC-UHFFFAOYSA-N	413667	N-(Quinoxalin-6-yl)-2-[4-{5-chloro-2-[4-(difluoromethyl)-1H-imidazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanamide (Racemate)::US10421742, Example 61::US11180471, Example 61	Plasma kallikrein			 15.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413667	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413667&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205843	433913771							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115903	COCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnc(c1)C(F)F	InChI=1S/C28H25ClF2N4O6/c1-40-10-9-23(27(37)33-18-6-3-16(4-7-18)28(38)39)35-14-24(41-2)20(12-25(35)36)19-11-17(29)5-8-22(19)34-13-21(26(30)31)32-15-34/h3-8,11-15,23,26H,9-10H2,1-2H3,(H,33,37)(H,38,39)	RXURALNQBFWKQS-UHFFFAOYSA-N	413668	4-({2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-imidazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)benzoic acid (Racemate)::US10421742, Example 62::US11180471, Example 62	Plasma kallikrein			 140							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413668	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413668&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205732	433913772							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115904	COCCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnc(c1)C(F)F	InChI=1S/C28H25ClF3N5O5/c1-41-8-7-23(28(40)35-16-4-5-17(27(33)39)20(30)10-16)37-13-24(42-2)19(11-25(37)38)18-9-15(29)3-6-22(18)36-12-21(26(31)32)34-14-36/h3-6,9-14,23,26H,7-8H2,1-2H3,(H2,33,39)(H,35,40)	LOOFPSIULDNXTC-UHFFFAOYSA-N	413669	4-({2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-imidazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)-2-fluorobenzamide (Racemate)::US10421742, Example 63::US11180471, Example 63	Plasma kallikrein			 170							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413669	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413669&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205511	433913773							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115905	COCCC(C(=O)Nc1ccc(nc1)C(N)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnc(c1)C(F)F	InChI=1S/C27H25ClF2N6O5/c1-40-8-7-22(27(39)34-16-4-5-19(26(31)38)32-11-16)36-13-23(41-2)18(10-24(36)37)17-9-15(28)3-6-21(17)35-12-20(25(29)30)33-14-35/h3-6,9-14,22,25H,7-8H2,1-2H3,(H2,31,38)(H,34,39)	SRNOHCLEBDLQNM-UHFFFAOYSA-N	413670	5-({2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-imidazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)pyridine-2-carboxamide (Racemate)::US10421742, Example 64::US11180471, Example 64	Plasma kallikrein			 180							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413670	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413670&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205917	433913774							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115906	CNC(=O)c1ccc(NC(=O)C(CCOC)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2-n2cnc(c2)C(F)F)cn1	InChI=1S/C28H27ClF2N6O5/c1-32-27(39)20-6-5-17(12-33-20)35-28(40)23(8-9-41-2)37-14-24(42-3)19(11-25(37)38)18-10-16(29)4-7-22(18)36-13-21(26(30)31)34-15-36/h4-7,10-15,23,26H,8-9H2,1-3H3,(H,32,39)(H,35,40)	BZGWCVVHLRMNJS-UHFFFAOYSA-N	413671	5-({2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-imidazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxybutanoyl}amino)-N-methylpyridine-2-carboxamide (Racemate)::US10421742, Example 65::US11180471, Example 65	Plasma kallikrein			 93.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413671	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413671&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135211501	433913775							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115907	COCCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cnc(c1)C(F)F	InChI=1S/C29H27ClF2N6O4/c1-36-13-17-10-19(5-6-22(17)35-36)34-29(40)25(8-9-41-2)38-15-26(42-3)21(12-27(38)39)20-11-18(30)4-7-24(20)37-14-23(28(31)32)33-16-37/h4-7,10-16,25,28H,8-9H2,1-3H3,(H,34,40)	RVACDGDJWAWWGJ-UHFFFAOYSA-N	413672	2-[4-{5-Chloro-2-[4-(difluoromethyl)-1H-imidazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]-4-methoxy-N-(2-methyl-2H-indazol-5-yl)butanamide (Racemate)::US10421742, Example 66::US11180471, Example 66	Plasma kallikrein			 43.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413672	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413672&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135211559	433913776							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115908	COCCC(C(=O)Nc1ccc(cc1)C(O)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1cc(C)no1	InChI=1S/C28H26ClN3O7/c1-16-12-24(39-31-16)20-9-6-18(29)13-21(20)22-14-26(33)32(15-25(22)38-3)23(10-11-37-2)27(34)30-19-7-4-17(5-8-19)28(35)36/h4-9,12-15,23H,10-11H2,1-3H3,(H,30,34)(H,35,36)	KHIKDAHZRTYQLP-UHFFFAOYSA-N	413673	4-[(2-{4-[5-Chloro-2-(3-methyl-1,2-oxazol-5-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxybutanoyl)amino]benzoic acid (Racemate)::US10421742, Example 67::US11180471, Example 67	Plasma kallikrein			 45.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413673	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413673&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205834	433913777							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115909	COCCC(C(=O)Nc1ccc(nc1)C(N)=O)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1cc(C)no1	InChI=1S/C27H26ClN5O6/c1-15-10-23(39-32-15)18-6-4-16(28)11-19(18)20-12-25(34)33(14-24(20)38-3)22(8-9-37-2)27(36)31-17-5-7-21(26(29)35)30-13-17/h4-7,10-14,22H,8-9H2,1-3H3,(H2,29,35)(H,31,36)	MJTYRMTXTRTXFO-UHFFFAOYSA-N	413674	5-[(2-{4-[5-Chloro-2-(3-methyl-1,2-oxazol-5-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxybutanoyl)amino]pyridine-2-carboxamide (Racemate)::US10421742, Example 68::US11180471, Example 68	Plasma kallikrein			 51.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413674	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413674&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205583	433913778							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115910	COCCC(C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1cc(C)no1	InChI=1S/C28H26ClFN4O6/c1-15-10-24(40-33-15)18-6-4-16(29)11-20(18)21-13-26(35)34(14-25(21)39-3)23(8-9-38-2)28(37)32-17-5-7-19(27(31)36)22(30)12-17/h4-7,10-14,23H,8-9H2,1-3H3,(H2,31,36)(H,32,37)	IOKBSWHNAJFKBB-UHFFFAOYSA-N	413675	4-[(2-{4-[5-Chloro-2-(3-methyl-1,2-oxazol-5-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxybutanoyl)amino]-2-fluorobenzamide (Racemate)::US10421742, Example 69::US11180471, Example 69	Plasma kallikrein			 58.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413675	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413675&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205883	433913779							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1115911	COCCC(C(=O)Nc1ccc2nn(C)cc2c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-c1cc(C)no1	InChI=1S/C29H28ClN5O5/c1-17-11-26(40-33-17)21-7-5-19(30)13-22(21)23-14-28(36)35(16-27(23)39-4)25(9-10-38-3)29(37)31-20-6-8-24-18(12-20)15-34(2)32-24/h5-8,11-16,25H,9-10H2,1-4H3,(H,31,37)	YKKFWRCDYBEJHT-UHFFFAOYSA-N	528089	2-{4-[5-Chloro-2-(3-methyl-1,2-oxazol-5-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}-4-methoxy-N-(2-methyl-2H-indazol-5-yl)butanamide (racemate)::US11180471, Example 70	Plasma kallikrein			 21.0							US Patent		10.7270/Q2W09935		aid1806149	US11180471	Jimenez Nunez, E; Ackerstaff, J; Roehrig, S; Hillisch, A; Meier, K; Heitmeier, S; Tersteegen, A; Stampfuss, J; Ellerbrock, P; Meibom, D; Lang, D	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528089	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528089&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			140885364	463791643							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1118979	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(OC)cc(OC)c1	InChI=1S/C28H30N4O5/c1-35-19-26-25(28(34)29-15-22-12-23(36-2)14-24(13-22)37-3)18-32(30-26)17-21-9-7-20(8-10-21)16-31-11-5-4-6-27(31)33/h4-14,18H,15-17,19H2,1-3H3,(H,29,34)	BKELALJCIHUNCS-UHFFFAOYSA-N	408665	N-(3,5-Dimethoxybenzyl)-3-(methoxymethyl)-1-(4-((2-oxopyridin-1(2H)-yl)methyl)benzyl)-1H-pyrazole-4-carboxamide::US10364238, Example 1::US11001578, Example 1::US11084809, Example 1::US11198691, Example 1	Plasma kallikrein			 698							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408665	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408665&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364994	406799299							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1118981	COc1cccc(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2N)c1F	InChI=1S/C25H24FN5O3/c1-34-21-6-4-5-19(23(21)26)13-28-25(33)20-16-31(29-24(20)27)15-18-10-8-17(9-11-18)14-30-12-3-2-7-22(30)32/h2-12,16H,13-15H2,1H3,(H2,27,29)(H,28,33)	HICYNMRHZGAFMT-UHFFFAOYSA-N	408666	3-Amino-1-[4-(2-oxo-2H-pyridin-1-ylmethyl)-benzyl]-1H-pyrazole-4-carboxylic acid 2-fluoro-3-methoxy-benzylamide::US10364238, Example 2::US11001578, Example 2::US11084809, Example 2::US11198691, Example 2	Plasma kallikrein			 8.70							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408666	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408666&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365045	406799300							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1118983	COCc1nn(Cc2cnc3cc(Cl)ccc3c2)cc1C(=O)NCc1cccc(OC)c1F	InChI=1S/C24H22ClFN4O3/c1-32-14-21-19(24(31)28-11-17-4-3-5-22(33-2)23(17)26)13-30(29-21)12-15-8-16-6-7-18(25)9-20(16)27-10-15/h3-10,13H,11-12,14H2,1-2H3,(H,28,31)	WPIUJKAYUGBTDW-UHFFFAOYSA-N	408667	1-(7-Chloro-quinolin-3-ylmethyl)-3-methoxymethyl-1H-pyrazole-4-carboxylic acid 2-fluoro-3-methoxy-benzylamide::US10364238, Example 3::US11001578, Example 3::US11084809, Example 3::US11198691, Example 3	Plasma kallikrein			 2580							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408667	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408667&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365013	406799301							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1118985	COc1cccc(CNC(=O)c2cn(Cc3ccc(Cn4cc(C)cn4)cc3)nc2C(F)(F)F)c1F	InChI=1S/C25H23F4N5O2/c1-16-10-31-33(12-16)13-17-6-8-18(9-7-17)14-34-15-20(23(32-34)25(27,28)29)24(35)30-11-19-4-3-5-21(36-2)22(19)26/h3-10,12,15H,11,13-14H2,1-2H3,(H,30,35)	QZMZZOCEJPCAIJ-UHFFFAOYSA-N	408668	N-[(2-fluoro-3-methoxyphenyl)methyl]-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide::US10364238, Example 4::US11001578, Example 4::US11084809, Example 4::US11198691, Example 4	Plasma kallikrein			 136							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408668	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408668&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365107	406799302							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1118987	COc1cccc(CNC(=O)c2cn(Cc3ccc(Cn4cc(C)cn4)cc3)nc2C(F)(F)F)c1	InChI=1S/C25H24F3N5O2/c1-17-11-30-32(13-17)14-18-6-8-19(9-7-18)15-33-16-22(23(31-33)25(26,27)28)24(34)29-12-20-4-3-5-21(10-20)35-2/h3-11,13,16H,12,14-15H2,1-2H3,(H,29,34)	JLGLPBSVAUHGOI-UHFFFAOYSA-N	408671	N-[(3-methoxyphenyl)methyl]-1-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)-3- (trifluoromethyl)pyrazole-4-carboxamide ::US10364238, Example 5::US11001578, Example 5::US11084809, Example 5::US11198691, Example 5	Plasma kallikrein			 364							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408671	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408671&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365083	406799304							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1118989	CCOc1cccc(CNC(=O)c2cn(Cc3ccc(Cn4cc(C)cn4)cc3)nc2C(F)(F)F)c1	InChI=1S/C26H26F3N5O2/c1-3-36-22-6-4-5-21(11-22)13-30-25(35)23-17-34(32-24(23)26(27,28)29)16-20-9-7-19(8-10-20)15-33-14-18(2)12-31-33/h4-12,14,17H,3,13,15-16H2,1-2H3,(H,30,35)	UJVJDICDWMSCMO-UHFFFAOYSA-N	408672	N-[(3-ethoxyphenyl)methyl]-1-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)-3- (trifluoromethyl)pyrazole-4-carboxamide::US10364238, Example 6::US11001578, Example 6::US11084809, Example 6::US11198691, Example 6	Plasma kallikrein			 2360							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408672	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408672&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365014	406799305							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1118991	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4cccc(OC(F)(F)F)c4)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C25H21F6N5O2/c1-16-10-33-35(12-16)13-17-5-7-18(8-6-17)14-36-15-21(22(34-36)24(26,27)28)23(37)32-11-19-3-2-4-20(9-19)38-25(29,30)31/h2-10,12,15H,11,13-14H2,1H3,(H,32,37)	IWQRRWVFCUYKBA-UHFFFAOYSA-N	408674	1-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)-N-{[3- (trifluoromethoxy)phenyl]methyl}-3-(trifluoromethyl)pyrazole-4-carboxamide ::US10364238, Example 7::US11001578, Example 7::US11084809, Example 7::US11198691, Example 7	Plasma kallikrein			>10000							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408674	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408674&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365116	406799307							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1118993	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4ccc(C)cc4)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C25H24F3N5O/c1-17-3-5-19(6-4-17)12-29-24(34)22-16-33(31-23(22)25(26,27)28)15-21-9-7-20(8-10-21)14-32-13-18(2)11-30-32/h3-11,13,16H,12,14-15H2,1-2H3,(H,29,34)	UWKOAYQJMJZTCL-UHFFFAOYSA-N	497235	N-[(4-methylphenyl)methyl]-1-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)-3-::US11001578, Example 8::US11084809, Example 8::US11198691, Example 8	Plasma kallikrein			 539							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=497235	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=497235&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365038	459070223							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1118995	COc1ccc(F)c(CNC(=O)c2cn(Cc3ccc(Cn4cc(C)cn4)cc3)nc2C(F)(F)F)c1	InChI=1S/C25H23F4N5O2/c1-16-10-31-33(12-16)13-17-3-5-18(6-4-17)14-34-15-21(23(32-34)25(27,28)29)24(35)30-11-19-9-20(36-2)7-8-22(19)26/h3-10,12,15H,11,13-14H2,1-2H3,(H,30,35)	HQJUOFQTROTCAB-UHFFFAOYSA-N	408678	N-[(2-fluoro-5-methoxyphenyl)methyl]-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide ::US10364238, Example 9::US11001578, Example 9::US11084809, Example 9::US11198691, Example 9	Plasma kallikrein			 239							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408678	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408678&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365002	406799311							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1118997	COc1ccc(CNC(=O)c2cn(Cc3ccc(Cn4cc(C)cn4)cc3)nc2C(F)(F)F)c(OC)c1	InChI=1S/C26H26F3N5O3/c1-17-11-31-33(13-17)14-18-4-6-19(7-5-18)15-34-16-22(24(32-34)26(27,28)29)25(35)30-12-20-8-9-21(36-2)10-23(20)37-3/h4-11,13,16H,12,14-15H2,1-3H3,(H,30,35)	CXDMHDUCUCLAEV-UHFFFAOYSA-N	408681	N-[(2,4-dimethoxyphenyl)methyl]-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide ::US10364238, Example 10::US11001578, Example 10::US11084809, Example 10::US11198691, Example 10	Plasma kallikrein			 1270							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408681	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408681&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365034	406799314							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1118999	COc1cc(F)c(CNC(=O)c2cn(Cc3ccc(Cn4cc(C)cn4)cc3)nc2C(F)(F)F)c(F)c1	InChI=1S/C25H22F5N5O2/c1-15-9-32-34(11-15)12-16-3-5-17(6-4-16)13-35-14-20(23(33-35)25(28,29)30)24(36)31-10-19-21(26)7-18(37-2)8-22(19)27/h3-9,11,14H,10,12-13H2,1-2H3,(H,31,36)	HRWXHWAUCMAPKJ-UHFFFAOYSA-N	408683	 N-[(2,6-difluoro-4-methoxyphenyl)methyl]-1-({4-[(4-methylpyrazol-1- yl)methyl]pheny}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide::US10364238, Example 11::US11001578, Example 11::US11084809, Example 11::US11198691, Example 11	Plasma kallikrein			 456							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408683	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408683&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365073	406799316							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119001	COc1ccc(CNC(=O)c2cn(Cc3ccc(Cn4cc(C)cn4)cc3)nc2C(F)(F)F)c(c1)C(F)(F)F	InChI=1S/C26H23F6N5O2/c1-16-10-34-36(12-16)13-17-3-5-18(6-4-17)14-37-15-21(23(35-37)26(30,31)32)24(38)33-11-19-7-8-20(39-2)9-22(19)25(27,28)29/h3-10,12,15H,11,13-14H2,1-2H3,(H,33,38)	UJRPEIINPALAES-UHFFFAOYSA-N	408685	N-{[4-methoxy-2-(trifluoromethyl)phenyl]methyl}-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide ::US10364238, Example 12::US11001578, Example 12::US11084809, Example 12::US11198691, Example 12	Plasma kallikrein			 746							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408685	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408685&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365025	406799318							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119003	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4c(F)cccc4F)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C24H20F5N5O/c1-15-9-31-33(11-15)12-16-5-7-17(8-6-16)13-34-14-19(22(32-34)24(27,28)29)23(35)30-10-18-20(25)3-2-4-21(18)26/h2-9,11,14H,10,12-13H2,1H3,(H,30,35)	DRFYBIDDXPOTJQ-UHFFFAOYSA-N	512283	N-[(2,6-difluorophenyl)methyl]-1-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide::US11084809, Example 13::US11198691, Example 13	Plasma kallikrein			 439							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=512283	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=512283&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364996	459629531							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119005	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4c(F)cccc4Cl)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C24H20ClF4N5O/c1-15-9-31-33(11-15)12-16-5-7-17(8-6-16)13-34-14-19(22(32-34)24(27,28)29)23(35)30-10-18-20(25)3-2-4-21(18)26/h2-9,11,14H,10,12-13H2,1H3,(H,30,35)	UCUUHDDHAAXSSH-UHFFFAOYSA-N	408689	N-[(2-chloro-6-fluorophenyl)methyl]-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide ::US10364238, Example 14::US11001578, Example 14::US11084809, Example 14::US11198691, Example 14	Plasma kallikrein			 514							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408689	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408689&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365058	406799322							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119007	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4c(F)cccc4C(F)(F)F)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C25H20F7N5O/c1-15-9-34-36(11-15)12-16-5-7-17(8-6-16)13-37-14-19(22(35-37)25(30,31)32)23(38)33-10-18-20(24(27,28)29)3-2-4-21(18)26/h2-9,11,14H,10,12-13H2,1H3,(H,33,38)	MRFKCVIKSCVIEK-UHFFFAOYSA-N	408691	N-{[2-fluoro-6-(trifluoromethyl)phenyl]methyl}-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide::US10364238, Example 15::US11001578, Example 15::US11084809, Example 15::US11198691, Example 15	Plasma kallikrein			 219							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408691	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408691&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365041	406799324							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119009	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4c(F)cc(Cl)cc4F)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C24H19ClF5N5O/c1-14-8-32-34(10-14)11-15-2-4-16(5-3-15)12-35-13-19(22(33-35)24(28,29)30)23(36)31-9-18-20(26)6-17(25)7-21(18)27/h2-8,10,13H,9,11-12H2,1H3,(H,31,36)	SXIKFYGPUGSYOC-UHFFFAOYSA-N	408692	N-[(4-chloro-2,6-difluorophenyl)methyl]-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide ::US10364238, Example 16::US11001578, Example 16::US11084809, Example 16::US11198691, Example 16	Plasma kallikrein			 263							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408692	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408692&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365003	406799325							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119011	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4ccc(Cl)cc4F)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C24H20ClF4N5O/c1-15-9-31-33(11-15)12-16-2-4-17(5-3-16)13-34-14-20(22(32-34)24(27,28)29)23(35)30-10-18-6-7-19(25)8-21(18)26/h2-9,11,14H,10,12-13H2,1H3,(H,30,35)	MPXDOEQMYFYSIT-UHFFFAOYSA-N	408693	 N-[(4-chloro-2-fluorophenyl)methyl]-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide ::US10364238, Example 17::US11001578, Example 17::US11084809, Example 17::US11198691, Example 17	Plasma kallikrein			 865							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408693	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408693&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365130	406799326							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119013	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4c(F)ccc(Cl)c4F)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C24H19ClF5N5O/c1-14-8-32-34(10-14)11-15-2-4-16(5-3-15)12-35-13-18(22(33-35)24(28,29)30)23(36)31-9-17-20(26)7-6-19(25)21(17)27/h2-8,10,13H,9,11-12H2,1H3,(H,31,36)	HNSAKACOONQHKG-UHFFFAOYSA-N	408694	N-[(3-chloro-2,6-difluorophenyl)methyl]-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide::US10364238, Example 18::US11001578, Example 18::US11084809, Example 18::US11198691, Example 18	Plasma kallikrein			 373							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408694	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408694&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365160	406799327							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119015	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4cccc(Cl)c4F)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C24H20ClF4N5O/c1-15-9-31-33(11-15)12-16-5-7-17(8-6-16)13-34-14-19(22(32-34)24(27,28)29)23(35)30-10-18-3-2-4-20(25)21(18)26/h2-9,11,14H,10,12-13H2,1H3,(H,30,35)	RFRZBYFPHZMTPR-UHFFFAOYSA-N	408695	N-[(3-chloro-2-fluorophenyl)methyl]-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide::US10364238, Example 19::US11001578, Example 19::US11084809, Example 19::US11198691, Example 19	Plasma kallikrein			 1130							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408695	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408695&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365137	406799328							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119017	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4cc(Cl)ccc4F)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C24H20ClF4N5O/c1-15-9-31-33(11-15)12-16-2-4-17(5-3-16)13-34-14-20(22(32-34)24(27,28)29)23(35)30-10-18-8-19(25)6-7-21(18)26/h2-9,11,14H,10,12-13H2,1H3,(H,30,35)	VQSXMSNNAGMGCB-UHFFFAOYSA-N	408696	N-[(5-chloro-2-fluorophenyl)methyl]-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide ::US10364238, Example 20::US11001578, Example 20::US11084809, Example 20::US11198691, Example 20	Plasma kallikrein			 740							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408696	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408696&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365077	406799329							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119019	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4c(F)c(Cl)ccc4C(F)(F)F)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C25H19ClF7N5O/c1-14-8-35-37(10-14)11-15-2-4-16(5-3-15)12-38-13-18(22(36-38)25(31,32)33)23(39)34-9-17-19(24(28,29)30)6-7-20(26)21(17)27/h2-8,10,13H,9,11-12H2,1H3,(H,34,39)	KVPLENMFVKIMRG-UHFFFAOYSA-N	408697	 N-{[3-chloro-2-fluoro-6-(trifluoromethyl)phenyl]methyl}-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide ::US10364238, Example 21::US11001578, Example 21::US11084809, Example 21::US11198691, Example 21	Plasma kallikrein			 257							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408697	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408697&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365161	406799330							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119021	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4c(Cl)cccc4Cl)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C24H20Cl2F3N5O/c1-15-9-31-33(11-15)12-16-5-7-17(8-6-16)13-34-14-19(22(32-34)24(27,28)29)23(35)30-10-18-20(25)3-2-4-21(18)26/h2-9,11,14H,10,12-13H2,1H3,(H,30,35)	UNJUOXQQTNMQSH-UHFFFAOYSA-N	497249	N-[(2,6-dichlorophenyl)methyl]-1-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)-::US11001578, Example 22::US11084809, Example 22::US11198691, Example 22	Plasma kallikrein			 1350							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=497249	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=497249&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365089	459070236							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119023	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4cc(Cl)ccc4C(F)(F)F)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C25H20ClF6N5O/c1-15-9-34-36(11-15)12-16-2-4-17(5-3-16)13-37-14-20(22(35-37)25(30,31)32)23(38)33-10-18-8-19(26)6-7-21(18)24(27,28)29/h2-9,11,14H,10,12-13H2,1H3,(H,33,38)	JUBFFEWNQIXKCQ-UHFFFAOYSA-N	408699	 N-{[5-chloro-2-(trifluoromethyl)phenyl]methyl}-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide ::US10364238, Example 23::US11001578, Example 23::US11084809, Example 23::US11198691, Example 23	Plasma kallikrein			 1060							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408699	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408699&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365020	406799332							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119025	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4ccc(C)cc4C)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C26H26F3N5O/c1-17-4-9-22(19(3)10-17)12-30-25(35)23-16-34(32-24(23)26(27,28)29)15-21-7-5-20(6-8-21)14-33-13-18(2)11-31-33/h4-11,13,16H,12,14-15H2,1-3H3,(H,30,35)	SJWYCGZDPHPMRJ-UHFFFAOYSA-N	497251	N-[(2,4-dimethylphenyl)methyl]-1-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)-::US11001578, Example 24::US11084809, Example 24::US11198691, Example 24	Plasma kallikrein			 717							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=497251	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=497251&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365032	459070238							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119027	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4c(C)cccc4C)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C26H26F3N5O/c1-17-11-31-33(13-17)14-20-7-9-21(10-8-20)15-34-16-23(24(32-34)26(27,28)29)25(35)30-12-22-18(2)5-4-6-19(22)3/h4-11,13,16H,12,14-15H2,1-3H3,(H,30,35)	GIPNBFUDUIQKSS-UHFFFAOYSA-N	497252	N-[(2,6-dimethylphenyl)methyl]-1-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)-::US11001578, Example 25::US11084809, Example 25::US11198691, Example 25	Plasma kallikrein			 1840							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=497252	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=497252&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365052	459070239							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119029	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4c(C)cc(C)cc4C)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C27H28F3N5O/c1-17-9-19(3)23(20(4)10-17)12-31-26(36)24-16-35(33-25(24)27(28,29)30)15-22-7-5-21(6-8-22)14-34-13-18(2)11-32-34/h5-11,13,16H,12,14-15H2,1-4H3,(H,31,36)	YRBWCDOHOBNJLH-UHFFFAOYSA-N	408705	 1-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)-3-(trifluoromethyl)-N-[(2,4,6- trimethylphenyl)methyl]pyrazole-4-carboxamide::US10364238, Example 26::US11001578, Example 26::US11084809, Example 26::US11198691, Example 26	Plasma kallikrein			 1340							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408705	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408705&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365037	406799338							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119031	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4cccc(F)c4C)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C25H23F4N5O/c1-16-10-31-33(12-16)13-18-6-8-19(9-7-18)14-34-15-21(23(32-34)25(27,28)29)24(35)30-11-20-4-3-5-22(26)17(20)2/h3-10,12,15H,11,13-14H2,1-2H3,(H,30,35)	VMUDSUQWHSSZHZ-UHFFFAOYSA-N	408707	N-[(3-fluoro-2-methylphenyl)methyl]-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide ::US10364238, Example 27::US11001578, Example 27::US11084809, Example 27::US11198691, Example 27	Plasma kallikrein			>10000							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408707	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408707&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365082	406799340							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119033	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4ccc(C)cc4F)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C25H23F4N5O/c1-16-3-8-20(22(26)9-16)11-30-24(35)21-15-34(32-23(21)25(27,28)29)14-19-6-4-18(5-7-19)13-33-12-17(2)10-31-33/h3-10,12,15H,11,13-14H2,1-2H3,(H,30,35)	OAWJOZMRPBQRIM-UHFFFAOYSA-N	408708	N-[(2-fluoro-4-methylphenyl)methyl]-1-({4-[(4-methylpyrazol-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide ::US10364238, Example 28::US11001578, Example 28::US11084809, Example 28::US11198691, Example 28	Plasma kallikrein			 280							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408708	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408708&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365048	406799341							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119035	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4ncccc4F)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C23H20F4N6O/c1-15-9-30-32(11-15)12-16-4-6-17(7-5-16)13-33-14-18(21(31-33)23(25,26)27)22(34)29-10-20-19(24)3-2-8-28-20/h2-9,11,14H,10,12-13H2,1H3,(H,29,34)	VBWIRJJMHLFZTC-UHFFFAOYSA-N	497256	N-[(3-fluoropyridin-2-yl)methyl]-1-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)-::US11001578, Example 29::US11084809, Example 29::US11198691, Example 29	Plasma kallikrein			 2190							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=497256	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=497256&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365018	459070243							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119037	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4cc(Cl)ccn4)c(n3)C(F)(F)F)cc2)c1	InChI=1S/C23H20ClF3N6O/c1-15-9-30-32(11-15)12-16-2-4-17(5-3-16)13-33-14-20(21(31-33)23(25,26)27)22(34)29-10-19-8-18(24)6-7-28-19/h2-9,11,14H,10,12-13H2,1H3,(H,29,34)	QSGBIRDROIJUJZ-UHFFFAOYSA-N	497257	N-[(4-chloropyridin-2-yl)methyl]-1-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)-::US11001578, Example 30::US11084809, Example 30::US11198691, Example 30	Plasma kallikrein			 915							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=497257	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=497257&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365099	459070244							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119039	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cnccc1C(F)(F)F	InChI=1S/C26H24F3N5O3/c1-37-17-23-21(25(36)31-13-20-12-30-10-9-22(20)26(27,28)29)16-34(32-23)15-19-7-5-18(6-8-19)14-33-11-3-2-4-24(33)35/h2-12,16H,13-15,17H2,1H3,(H,31,36)	ZHJJZIGZXRDDHP-UHFFFAOYSA-N	408711	3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)-N-{[4- (trifluoromethyl)pyridin-3-yl]methyl}pyrazole-4-carboxamide ::US10364238, Example 31::US10364238, Example 37::US11001578, Example 37::US11084809, Example 37::US11198691, Example 37	Plasma kallikrein			 392							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408711	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408711&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365063	406799344							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119041	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1ccc(C)nc1	InChI=1S/C26H27N5O3/c1-19-6-7-22(13-27-19)14-28-26(33)23-17-31(29-24(23)18-34-2)16-21-10-8-20(9-11-21)15-30-12-4-3-5-25(30)32/h3-13,17H,14-16,18H2,1-2H3,(H,28,33)	IKFHJYIVYYFDCA-UHFFFAOYSA-N	408712	3-(methoxymethyl)-N-[(6-methylpyridin-3-yl)methyl]-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 32::US10364238, Example 39::US11001578, Example 39::US11084809, Example 39::US11198691, Example 39	Plasma kallikrein			 7870							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408712	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408712&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365092	406799345							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119043	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cccnc1C(F)(F)F	InChI=1S/C26H24F3N5O3/c1-37-17-22-21(25(36)31-13-20-5-4-11-30-24(20)26(27,28)29)16-34(32-22)15-19-9-7-18(8-10-19)14-33-12-3-2-6-23(33)35/h2-12,16H,13-15,17H2,1H3,(H,31,36)	ULAOQOFMZICMAA-UHFFFAOYSA-N	408713	 3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)-N-{[2- (trifluoromethyl)pyridin-3-yl]methyl}pyrazole-4-carboxamide::US10364238, Example 36::US11001578, Example 36::US11084809, Example 36::US11198691, Example 36	Plasma kallikrein			 4170							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408713	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408713&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365101	406799346							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119045	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cnccc1C(F)(F)F	InChI=1S/C26H24F3N5O3/c1-37-17-23-21(25(36)31-13-20-12-30-10-9-22(20)26(27,28)29)16-34(32-23)15-19-7-5-18(6-8-19)14-33-11-3-2-4-24(33)35/h2-12,16H,13-15,17H2,1H3,(H,31,36)	ZHJJZIGZXRDDHP-UHFFFAOYSA-N	408711	3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)-N-{[4- (trifluoromethyl)pyridin-3-yl]methyl}pyrazole-4-carboxamide ::US10364238, Example 31::US10364238, Example 37::US11001578, Example 37::US11084809, Example 37::US11198691, Example 37	Plasma kallikrein			 392							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408711	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408711&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365063	406799344							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119047	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1ccc(C)nc1	InChI=1S/C26H27N5O3/c1-19-6-7-22(13-27-19)14-28-26(33)23-17-31(29-24(23)18-34-2)16-21-10-8-20(9-11-21)15-30-12-4-3-5-25(30)32/h3-13,17H,14-16,18H2,1-2H3,(H,28,33)	IKFHJYIVYYFDCA-UHFFFAOYSA-N	408712	3-(methoxymethyl)-N-[(6-methylpyridin-3-yl)methyl]-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 32::US10364238, Example 39::US11001578, Example 39::US11084809, Example 39::US11198691, Example 39	Plasma kallikrein			 7870							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408712	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408712&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365092	406799345							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119049	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cccc(OC)n1	InChI=1S/C26H27N5O4/c1-34-18-23-22(26(33)27-14-21-6-5-7-24(28-21)35-2)17-31(29-23)16-20-11-9-19(10-12-20)15-30-13-4-3-8-25(30)32/h3-13,17H,14-16,18H2,1-2H3,(H,27,33)	XOCSKLGONWNPHT-UHFFFAOYSA-N	408716	3-(methoxymethyl)-N-[(6-methoxypyridin-2-yl)methyl]-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 40::US11001578, Example 40::US11084809, Example 40::US11198691, Example 40	Plasma kallikrein			 3700							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408716	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408716&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365155	406799347							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119051	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1nccc(OC)c1F	InChI=1S/C26H26FN5O4/c1-35-17-22-20(26(34)29-13-21-25(27)23(36-2)10-11-28-21)16-32(30-22)15-19-8-6-18(7-9-19)14-31-12-4-3-5-24(31)33/h3-12,16H,13-15,17H2,1-2H3,(H,29,34)	KGMPDQIYDKKXRD-UHFFFAOYSA-N	408717	 N-[(3-fluoro-4-methoxypyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin- 1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 41::US10730874, Example 00397::US11001578, Example 41::US11084809, Example 41::US11198691, Example 41::US11352356, Table II.3::US11584735, Example 41 of WO2016/083820	Plasma kallikrein			 3.30							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408717	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408717&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365142	406799348							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119053	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1nc(OC)ccc1F	InChI=1S/C26H26FN5O4/c1-35-17-23-20(26(34)28-13-22-21(27)10-11-24(29-22)36-2)16-32(30-23)15-19-8-6-18(7-9-19)14-31-12-4-3-5-25(31)33/h3-12,16H,13-15,17H2,1-2H3,(H,28,34)	KQSCQCAZZHSOOR-UHFFFAOYSA-N	408718	N-[(3-fluoro-6-methoxypyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin- 1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 42::US11001578, Example 42::US11084809, Example 42::US11198691, Example 42	Plasma kallikrein			 831							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408718	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408718&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365159	406799349							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119055	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1csc2ccc(Cl)cc12	InChI=1S/C28H25ClN4O3S/c1-36-17-25-24(28(35)30-13-21-18-37-26-10-9-22(29)12-23(21)26)16-33(31-25)15-20-7-5-19(6-8-20)14-32-11-3-2-4-27(32)34/h2-12,16,18H,13-15,17H2,1H3,(H,30,35)	TZULTWISCDFBIR-UHFFFAOYSA-N	408719	N-[(5-chloro-1-benzothiophen-3-yl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin- 1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 45::US11001578, Example 45::US11084809, Example 45::US11198691, Example 45	Plasma kallikrein			 144							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408719	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408719&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365070	406799350							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119057	COCc1nn(Cc2ccc(nc2)N2CCCC2)cc1C(=O)NCc1csc2ccc(Cl)cc12	InChI=1S/C25H26ClN5O2S/c1-33-15-22-21(25(32)28-12-18-16-34-23-6-5-19(26)10-20(18)23)14-31(29-22)13-17-4-7-24(27-11-17)30-8-2-3-9-30/h4-7,10-11,14,16H,2-3,8-9,12-13,15H2,1H3,(H,28,32)	WMNGADNOQNFZIE-UHFFFAOYSA-N	408720	N-[(5-chloro-1-benzothiophen-3-yl)methyl]-3-(methoxymethyl)-1-{[6-(pyrrolidin-1-::US10364238, Example 46::US11001578, Example 46::US11084809, Example 46::US11198691, Example 46	Plasma kallikrein			 2400							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408720	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408720&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365148	406799351							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119059	COCc1nn(Cc2ccc(Cn3cc(C)cn3)cc2)cc1C(=O)NCc1csc2ccc(Cl)cc12	InChI=1S/C27H26ClN5O2S/c1-18-10-30-32(12-18)13-19-3-5-20(6-4-19)14-33-15-24(25(31-33)16-35-2)27(34)29-11-21-17-36-26-8-7-22(28)9-23(21)26/h3-10,12,15,17H,11,13-14,16H2,1-2H3,(H,29,34)	OVCXPEFSYYWEMX-UHFFFAOYSA-N	408725	 N-[(5-chloro-1-benzothiophen-3-yl)methyl]-3-(methoxymethyl)-1-({4-[(4- methylpyrazol-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 47::US11001578, Example 47::US11084809, Example 47::US11198691, Example 47	Plasma kallikrein			 753							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408725	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408725&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365059	406799356							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119061	NC(=O)c1ccccc1CNC(=O)c1cn(Cc2ccc(Cn3ccccc3=O)cc2)nc1C1CC1	InChI=1S/C28H27N5O3/c29-27(35)23-6-2-1-5-22(23)15-30-28(36)24-18-33(31-26(24)21-12-13-21)17-20-10-8-19(9-11-20)16-32-14-4-3-7-25(32)34/h1-11,14,18,21H,12-13,15-17H2,(H2,29,35)(H,30,36)	KOYPCAXNSUCYIL-UHFFFAOYSA-N	408726	N-[(2-carbamoylphenyl)methyl]-3-cyclopropyl-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 48::US11001578, Example 48::US11084809, Example 48::US11198691, Example 48	Plasma kallikrein			 647							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408726	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408726&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365021	406799357							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119063	NC(=O)c1cccc(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2C2CC2)c1	InChI=1S/C28H27N5O3/c29-27(35)23-5-3-4-21(14-23)15-30-28(36)24-18-33(31-26(24)22-11-12-22)17-20-9-7-19(8-10-20)16-32-13-2-1-6-25(32)34/h1-10,13-14,18,22H,11-12,15-17H2,(H2,29,35)(H,30,36)	GLBUGHLBAAXCAZ-UHFFFAOYSA-N	408727	 N-[(3-carbamoylphenyl)methyl]-3-cyclopropyl-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide   ::US10364238, Example 49::US11001578, Example 49::US11084809, Example 49::US11198691, Example 49	Plasma kallikrein			 5450							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408727	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408727&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365022	406799358							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119065	NC(=O)c1ccc(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2C2CC2)cc1	InChI=1S/C28H27N5O3/c29-27(35)23-10-8-19(9-11-23)15-30-28(36)24-18-33(31-26(24)22-12-13-22)17-21-6-4-20(5-7-21)16-32-14-2-1-3-25(32)34/h1-11,14,18,22H,12-13,15-17H2,(H2,29,35)(H,30,36)	XDXGOIDNTUZASE-UHFFFAOYSA-N	408730	N-[(4-carbamoylphenyl)methyl]-3-cyclopropyl-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 50::US11001578, Example 50::US11084809, Example 50::US11198691, Example 50	Plasma kallikrein			 1800							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408730	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408730&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365075	406799361							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119067	Fc1cccc(c1CNC(=O)c1cn(Cc2ccc(Cn3ccccc3=O)cc2)nc1C(F)(F)F)C(F)(F)F	InChI=1S/C26H19F7N4O2/c27-21-5-3-4-20(25(28,29)30)18(21)12-34-24(39)19-15-37(35-23(19)26(31,32)33)14-17-9-7-16(8-10-17)13-36-11-2-1-6-22(36)38/h1-11,15H,12-14H2,(H,34,39)	ASCUMAURKSBUPS-UHFFFAOYSA-N	408732	 N-{[2-fluoro-6-(trifluoromethyl)phenyl]methyl}-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide::US10364238, Example 51::US11001578, Example 51::US11084809, Example 51::US11198691, Example 51	Plasma kallikrein			 48.9							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408732	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408732&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365085	406799363							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119069	COc1cccc(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2C2CC2)c1F	InChI=1S/C28H27FN4O3/c1-36-24-6-4-5-22(26(24)29)15-30-28(35)23-18-33(31-27(23)21-12-13-21)17-20-10-8-19(9-11-20)16-32-14-3-2-7-25(32)34/h2-11,14,18,21H,12-13,15-17H2,1H3,(H,30,35)	NFLOZDGNLCLQAJ-UHFFFAOYSA-N	408733	 3-cyclopropyl-N-[(2-fluoro-3-methoxyphenyl)methyl]-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 52::US11001578, Example 52::US11084809, Example 52::US11198691, Example 52	Plasma kallikrein			 23.3							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408733	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408733&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365123	406799364							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119071	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cccc(OC)c1F	InChI=1S/C27H27FN4O4/c1-35-18-23-22(27(34)29-14-21-6-5-7-24(36-2)26(21)28)17-32(30-23)16-20-11-9-19(10-12-20)15-31-13-4-3-8-25(31)33/h3-13,17H,14-16,18H2,1-2H3,(H,29,34)	MLCDWARNPOODOL-UHFFFAOYSA-N	408734	 N-[(2-fluoro-3-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US10364238, Example 53::US11001578, Example 53::US11084809, Example 53::US11198691, Example 53	Plasma kallikrein			 20.2							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408734	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408734&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365056	406799365							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119073	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(OC)ccc(OC)c1F	InChI=1S/C28H29FN4O5/c1-36-18-23-22(28(35)30-14-21-24(37-2)11-12-25(38-3)27(21)29)17-33(31-23)16-20-9-7-19(8-10-20)15-32-13-5-4-6-26(32)34/h4-13,17H,14-16,18H2,1-3H3,(H,30,35)	TVHOOPXMFWZGQK-UHFFFAOYSA-N	408736	 N-[(2-fluoro-3,6-dimethoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin- 1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 54::US11001578, Example 54::US11084809, Example 54::US11198691, Example 54	Plasma kallikrein			 2.10							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408736	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408736&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365119	406799367							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119075	Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1ccc(OC(F)(F)F)cc1	InChI=1S/C25H22F3N5O3/c26-25(27,28)36-20-10-8-17(9-11-20)13-30-24(35)21-16-33(31-23(21)29)15-19-6-4-18(5-7-19)14-32-12-2-1-3-22(32)34/h1-12,16H,13-15H2,(H2,29,31)(H,30,35)	KRHKQKBRWFYZPN-UHFFFAOYSA-N	408737	3-amino-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)-N-{[4- (trifluoromethoxy)phenyl]methyl}pyrazole-4-carboxamide ::US10364238, Example 58::US11001578, Example 58::US11084809, Example 58::US11198691, Example 58	Plasma kallikrein			 5780							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408737	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408737&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365068	406799368							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119077	COc1cccc(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2N(C)C)c1F	InChI=1S/C27H28FN5O3/c1-31(2)26-22(27(35)29-15-21-7-6-8-23(36-3)25(21)28)18-33(30-26)17-20-12-10-19(11-13-20)16-32-14-5-4-9-24(32)34/h4-14,18H,15-17H2,1-3H3,(H,29,35)	OMUPFLKDHHROJU-UHFFFAOYSA-N	408738	 3-(dimethylamino)-N-[(2-fluoro-3-methoxyphenyl)methyl]-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 59::US11001578, Example 59::US11084809, Example 59::US11198691, Example 59	Plasma kallikrein			 73.4							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408738	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408738&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365158	406799369							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119079	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1ccccc1F	InChI=1S/C26H25FN4O3/c1-34-18-24-22(26(33)28-14-21-6-2-3-7-23(21)27)17-31(29-24)16-20-11-9-19(10-12-20)15-30-13-5-4-8-25(30)32/h2-13,17H,14-16,18H2,1H3,(H,28,33)	OMZXAEPYOCEHIS-UHFFFAOYSA-N	408740	N-[(2-fluorophenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 62::US11001578, Example 62::US11084809, Example 62::US11198691, Example 62	Plasma kallikrein			 572							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408740	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408740&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365055	406799371							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119081	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1ccccc1C(F)(F)F	InChI=1S/C27H25F3N4O3/c1-37-18-24-22(26(36)31-14-21-6-2-3-7-23(21)27(28,29)30)17-34(32-24)16-20-11-9-19(10-12-20)15-33-13-5-4-8-25(33)35/h2-13,17H,14-16,18H2,1H3,(H,31,36)	ZLZZEINFXWKIBR-UHFFFAOYSA-N	408742	 3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)-N-{[2- (trifluoromethyl)phenyl]methyl}pyrazole-4-carboxamide::US10364238, Example 63::US11001578, Example 63::US11084809, Example 63::US11198691, Example 63	Plasma kallikrein			 342							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408742	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408742&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365012	406799373							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119083	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(OC)ccc1F	InChI=1S/C27H27FN4O4/c1-35-18-25-23(27(34)29-14-21-13-22(36-2)10-11-24(21)28)17-32(30-25)16-20-8-6-19(7-9-20)15-31-12-4-3-5-26(31)33/h3-13,17H,14-16,18H2,1-2H3,(H,29,34)	NKTZDNHYVJSOOU-UHFFFAOYSA-N	408744	 N-[(2-fluoro-5-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US10364238, Example 64::US11001578, Example 64::US11084809, Example 64::US11198691, Example 64	Plasma kallikrein			 35.2							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408744	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408744&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365036	406799375							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119085	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1ccc(C)cc1F	InChI=1S/C27H27FN4O3/c1-19-6-11-22(24(28)13-19)14-29-27(34)23-17-32(30-25(23)18-35-2)16-21-9-7-20(8-10-21)15-31-12-4-3-5-26(31)33/h3-13,17H,14-16,18H2,1-2H3,(H,29,34)	XRBNFAVKAJTXOR-UHFFFAOYSA-N	408745	 N-[(2-fluoro-4-methylphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 65::US11001578, Example 65::US11084809, Example 65::US11198691, Example 65	Plasma kallikrein			 43.3							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408745	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408745&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365028	406799376							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119087	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(F)ccc(OC)c1F	InChI=1S/C27H26F2N4O4/c1-36-17-23-21(27(35)30-13-20-22(28)10-11-24(37-2)26(20)29)16-33(31-23)15-19-8-6-18(7-9-19)14-32-12-4-3-5-25(32)34/h3-12,16H,13-15,17H2,1-2H3,(H,30,35)	PIYDGHWVVUCTNS-UHFFFAOYSA-N	408746	 N-[(2,6-difluoro-3-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin- 1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US10364238, Example 66::US10730874, Example 00395::US11001578, Example 66::US11084809, Example 66::US11198691, Example 66::US11352356, Table II.1	Plasma kallikrein			 4.60							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408746	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408746&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365096	406799377							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119089	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(Cl)cc(OC)c1	InChI=1S/C27H27ClN4O4/c1-35-18-25-24(27(34)29-14-21-11-22(28)13-23(12-21)36-2)17-32(30-25)16-20-8-6-19(7-9-20)15-31-10-4-3-5-26(31)33/h3-13,17H,14-16,18H2,1-2H3,(H,29,34)	OABPMYGSJQVQPN-UHFFFAOYSA-N	408747	 N-[(3-chloro-5-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 67::US11001578, Example 67::US11084809, Example 67::US11198691, Example 67	Plasma kallikrein			 393							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408747	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408747&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365024	406799378							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119091	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1ccccc1C(F)F	InChI=1S/C27H26F2N4O3/c1-36-18-24-23(27(35)30-14-21-6-2-3-7-22(21)26(28)29)17-33(31-24)16-20-11-9-19(10-12-20)15-32-13-5-4-8-25(32)34/h2-13,17,26H,14-16,18H2,1H3,(H,30,35)	GEFVFTYILHWIGO-UHFFFAOYSA-N	408749	 N-{[2-(difluoromethyl)phenyl]methyl}-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 68::US11001578, Example 68::US11084809, Example 68::US11198691, Example 68	Plasma kallikrein			 81.1							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408749	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408749&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365084	406799380							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119093	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cccc(OC)c1C(F)F	InChI=1S/C28H28F2N4O4/c1-37-18-23-22(28(36)31-14-21-6-5-7-24(38-2)26(21)27(29)30)17-34(32-23)16-20-11-9-19(10-12-20)15-33-13-4-3-8-25(33)35/h3-13,17,27H,14-16,18H2,1-2H3,(H,31,36)	PTXDNBVAMADNIH-UHFFFAOYSA-N	408750	N-{[2-(difluoromethyl)-3-methoxyphenyl]methyl}-3-(methoxymethyl)-1-({4-[(2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 69::US11001578, Example 69::US11084809, Example 69::US11198691, Example 69	Plasma kallikrein			 16.8							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408750	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408750&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365140	406799381							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119095	Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(F)cccc1C(F)(F)F	InChI=1S/C25H21F4N5O2/c26-21-5-3-4-20(25(27,28)29)18(21)12-31-24(36)19-15-34(32-23(19)30)14-17-9-7-16(8-10-17)13-33-11-2-1-6-22(33)35/h1-11,15H,12-14H2,(H2,30,32)(H,31,36)	ZRDGSEIHHBOARU-UHFFFAOYSA-N	408753	 3-amino-N-{[2-fluoro-6-(trifluoromethyl)phenyl]methyl}-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 70::US11001578, Example 70::US11084809, Example 70::US11198691, Example 70	Plasma kallikrein			 26.7							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408753	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408753&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365067	406799384							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119097	COc1cccc(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2NC(C)=O)c1F	InChI=1S/C27H26FN5O4/c1-18(34)30-26-22(27(36)29-14-21-6-5-7-23(37-2)25(21)28)17-33(31-26)16-20-11-9-19(10-12-20)15-32-13-4-3-8-24(32)35/h3-13,17H,14-16H2,1-2H3,(H,29,36)(H,30,31,34)	JJEXYMJFQVLENB-UHFFFAOYSA-N	408755	 3-acetamido-N-[(2-fluoro-3-methoxyphenyl)methyl]-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 71::US11001578, Example 71::US11084809, Example 71::US11198691, Example 71	Plasma kallikrein			 300							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408755	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408755&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365125	406799386							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119099	COc1cccc(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2N(C)C(C)=O)c1F	InChI=1S/C28H28FN5O4/c1-19(35)32(2)27-23(28(37)30-15-22-7-6-8-24(38-3)26(22)29)18-34(31-27)17-21-12-10-20(11-13-21)16-33-14-5-4-9-25(33)36/h4-14,18H,15-17H2,1-3H3,(H,30,37)	QWMQDDAFZVHSLS-UHFFFAOYSA-N	408756	N-[(2-fluoro-3-methoxyphenyl)methyl]-3-(N-methylacetamido)-1-({4-[(2-oxopyridin- 1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 72::US11001578, Example 72::US11084809, Example 72::US11198691, Example 72	Plasma kallikrein			 6610							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408756	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408756&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365011	406799387							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119101	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(F)ccc(Cl)c1F	InChI=1S/C26H23ClF2N4O3/c1-36-16-23-20(26(35)30-12-19-22(28)10-9-21(27)25(19)29)15-33(31-23)14-18-7-5-17(6-8-18)13-32-11-3-2-4-24(32)34/h2-11,15H,12-14,16H2,1H3,(H,30,35)	ZHIGUNZKTJKAFE-UHFFFAOYSA-N	408757	 N-[(3-chloro-2,6-difluorophenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 73::US11001578, Example 73::US11084809, Example 73::US11198691, Example 73	Plasma kallikrein			 120							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408757	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408757&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365124	406799388							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119103	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(Cl)ccc1C#N	InChI=1S/C27H24ClN5O3/c1-36-18-25-24(27(35)30-14-22-12-23(28)10-9-21(22)13-29)17-33(31-25)16-20-7-5-19(6-8-20)15-32-11-3-2-4-26(32)34/h2-12,17H,14-16,18H2,1H3,(H,30,35)	AQJYHYPGWCFTGU-UHFFFAOYSA-N	408759	N-[(5-chloro-2-cyanophenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 76::US11001578, Example 76::US11084809, Example 76::US11198691, Example 76	Plasma kallikrein			 28.3							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408759	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408759&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365097	406799390							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119105	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(F)c(OC)ccc1C#N	InChI=1S/C28H26FN5O4/c1-37-18-24-23(28(36)31-14-22-21(13-30)10-11-25(38-2)27(22)29)17-34(32-24)16-20-8-6-19(7-9-20)15-33-12-4-3-5-26(33)35/h3-12,17H,14-16,18H2,1-2H3,(H,31,36)	SPXOTFDBWDBJRN-UHFFFAOYSA-N	408768	N-[(6-cyano-2-fluoro-3-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-::US10364238, Example 77::US10730874, Example 00398::US11001578, Example 77::US11084809, Example 77::US11198691, Example 77::US11352356, Table II.4	Plasma kallikrein			 0.600							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408768	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408768&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365006	406799399							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119107	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cccc(OC)c1C(F)(F)F	InChI=1S/C28H27F3N4O4/c1-38-18-23-22(27(37)32-14-21-6-5-7-24(39-2)26(21)28(29,30)31)17-35(33-23)16-20-11-9-19(10-12-20)15-34-13-4-3-8-25(34)36/h3-13,17H,14-16,18H2,1-2H3,(H,32,37)	LSXBZEBSXFDZEZ-UHFFFAOYSA-N	408769	 N-{[3-methoxy-2-(trifluoromethyl)phenyl]methyl}-3-(methoxymethyl)-1-({4-[(2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 78::US11001578, Example 78::US11084809, Example 78::US11198691, Example 78	Plasma kallikrein			 612							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408769	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408769&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365105	406799400							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119109	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(OC)ccc1C(F)(F)F	InChI=1S/C28H27F3N4O4/c1-38-18-25-23(27(37)32-14-21-13-22(39-2)10-11-24(21)28(29,30)31)17-35(33-25)16-20-8-6-19(7-9-20)15-34-12-4-3-5-26(34)36/h3-13,17H,14-16,18H2,1-2H3,(H,32,37)	FKGBWMYRUOPIHY-UHFFFAOYSA-N	408770	 N-{[5-methoxy-2-(trifluoromethyl)phenyl]methyl}-3-(methoxymethyl)-1-({4-[(2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 79::US11001578, Example 79::US11084809, Example 79::US11198691, Example 79	Plasma kallikrein			 14.7							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408770	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408770&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365060	406799401							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119111	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(F)cccc1C(F)F	InChI=1S/C27H25F3N4O3/c1-37-17-24-22(27(36)31-13-21-20(26(29)30)5-4-6-23(21)28)16-34(32-24)15-19-10-8-18(9-11-19)14-33-12-3-2-7-25(33)35/h2-12,16,26H,13-15,17H2,1H3,(H,31,36)	BZFADXUGNHDNKB-UHFFFAOYSA-N	408772	 N-{[2-(difluoromethyl)-6-fluorophenyl]methyl}-3-(methoxymethyl)-1-({4-[(2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 80::US11001578, Example 80::US11084809, Example 80::US11198691, Example 80	Plasma kallikrein			 20.4							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408772	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408772&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365145	406799403							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119113	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(OC)ccc1C(F)F	InChI=1S/C28H28F2N4O4/c1-37-18-25-24(28(36)31-14-21-13-22(38-2)10-11-23(21)27(29)30)17-34(32-25)16-20-8-6-19(7-9-20)15-33-12-4-3-5-26(33)35/h3-13,17,27H,14-16,18H2,1-2H3,(H,31,36)	IBBPTWWPBCQANZ-UHFFFAOYSA-N	408773	 N-{[2-(difluoromethyl)-5-methoxyphenyl]methyl}-3-(methoxymethyl)-1-({4-[(2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 81::US11001578, Example 81::US11084809, Example 81::US11198691, Example 81	Plasma kallikrein			 2.30							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408773	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408773&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365102	406799404							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119115	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(F)ccc(OC)c1C(F)F	InChI=1S/C28H27F3N4O4/c1-38-17-23-21(28(37)32-13-20-22(29)10-11-24(39-2)26(20)27(30)31)16-35(33-23)15-19-8-6-18(7-9-19)14-34-12-4-3-5-25(34)36/h3-12,16,27H,13-15,17H2,1-2H3,(H,32,37)	FDDKVGBGYLYHDV-UHFFFAOYSA-N	408775	 N-{[2-(difluoromethyl)-6-fluoro-3-methoxyphenyl]methyl}-3-(methoxymethyl)-1-({4- [(2-oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 83::US11001578, Example 83::US11084809, Example 83::US11198691, Example 83	Plasma kallikrein			 6.80							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408775	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408775&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365138	406799406							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119117	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(F)cccc1C(N)=O	InChI=1S/C27H26FN5O4/c1-37-17-24-22(27(36)30-13-21-20(26(29)35)5-4-6-23(21)28)16-33(31-24)15-19-10-8-18(9-11-19)14-32-12-3-2-7-25(32)34/h2-12,16H,13-15,17H2,1H3,(H2,29,35)(H,30,36)	PQVWIESRTSEZPB-UHFFFAOYSA-N	408778	 N-[(2-carbamoyl-6-fluorophenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 85::US11001578, Example 85::US11084809, Example 85::US11198691, Example 85	Plasma kallikrein			 79.2							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408778	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408778&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365001	406799409							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119119	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(OC)ccc1C(N)=O	InChI=1S/C28H29N5O5/c1-37-18-25-24(28(36)30-14-21-13-22(38-2)10-11-23(21)27(29)35)17-33(31-25)16-20-8-6-19(7-9-20)15-32-12-4-3-5-26(32)34/h3-13,17H,14-16,18H2,1-2H3,(H2,29,35)(H,30,36)	VTFAEOJNECOMFY-UHFFFAOYSA-N	408779	N-[(2-carbamoyl-5-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin- 1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 86::US11001578, Example 86::US11084809, Example 86::US11198691, Example 86	Plasma kallikrein			 8.70							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408779	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408779&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365131	406799410							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119121	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1ccccc1C(O)=O	InChI=1S/C27H26N4O5/c1-36-18-24-23(26(33)28-14-21-6-2-3-7-22(21)27(34)35)17-31(29-24)16-20-11-9-19(10-12-20)15-30-13-5-4-8-25(30)32/h2-13,17H,14-16,18H2,1H3,(H,28,33)(H,34,35)	MCBMZYKZJXHUKZ-UHFFFAOYSA-N	408780	 2-({[3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)pyrazol-4- yl]formamido}methyl)benzoic acid ::US10364238, Example 87::US11001578, Example 87::US11084809, Example 87::US11198691, Example 87	Plasma kallikrein			>10000							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408780	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408780&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365095	406799411							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119123	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cccc(OC(F)F)c1F	InChI=1S/C27H25F3N4O4/c1-37-17-22-21(26(36)31-13-20-5-4-6-23(25(20)28)38-27(29)30)16-34(32-22)15-19-10-8-18(9-11-19)14-33-12-3-2-7-24(33)35/h2-12,16,27H,13-15,17H2,1H3,(H,31,36)	CMNOMOOEIDZWNA-UHFFFAOYSA-N	408781	 N-{[3-(difluoromethoxy)-2-fluorophenyl]methyl}-3-(methoxymethyl)-1-({4-[(2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 90::US11001578, Example 90::US11084809, Example 90::US11198691, Example 90	Plasma kallikrein			 154							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408781	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408781&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365051	406799412							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119125	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cccc(OC(F)F)c1	InChI=1S/C27H26F2N4O4/c1-36-18-24-23(26(35)30-14-21-5-4-6-22(13-21)37-27(28)29)17-33(31-24)16-20-10-8-19(9-11-20)15-32-12-3-2-7-25(32)34/h2-13,17,27H,14-16,18H2,1H3,(H,30,35)	ZLXXVTBIWCEPEY-UHFFFAOYSA-N	408782	 N-{[3-(difluoromethoxy)phenyl]methyl}-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 91::US11001578, Example 91::US11084809, Example 91::US11198691, Example 91	Plasma kallikrein			 523							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408782	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408782&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365090	406799413							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119127	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(F)cccc1OC(F)F	InChI=1S/C27H25F3N4O4/c1-37-17-23-21(26(36)31-13-20-22(28)5-4-6-24(20)38-27(29)30)16-34(32-23)15-19-10-8-18(9-11-19)14-33-12-3-2-7-25(33)35/h2-12,16,27H,13-15,17H2,1H3,(H,31,36)	MKZIFUOKFBQCJL-UHFFFAOYSA-N	408783	N-{[2-(difluoromethoxy)-6-fluorophenyl]methyl}-3-(methoxymethyl)-1-({4-[(2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 92::US11001578, Example 92::US11084809, Example 92::US11198691, Example 92	Plasma kallikrein			 16.0							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408783	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408783&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365108	406799414							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119129	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(F)ccc1F	InChI=1S/C26H24F2N4O3/c1-35-17-24-22(26(34)29-13-20-12-21(27)9-10-23(20)28)16-32(30-24)15-19-7-5-18(6-8-19)14-31-11-3-2-4-25(31)33/h2-12,16H,13-15,17H2,1H3,(H,29,34)	XQLOPLZHIJLNDB-UHFFFAOYSA-N	408784	 N-[(2,5-difluorophenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US10364238, Example 94::US11001578, Example 94::US11084809, Example 94::US11198691, Example 94	Plasma kallikrein			 780							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408784	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408784&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365078	406799415							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119131	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(F)cc(OC)c1	InChI=1S/C27H27FN4O4/c1-35-18-25-24(27(34)29-14-21-11-22(28)13-23(12-21)36-2)17-32(30-25)16-20-8-6-19(7-9-20)15-31-10-4-3-5-26(31)33/h3-13,17H,14-16,18H2,1-2H3,(H,29,34)	AYOVCXXHHIWMRN-UHFFFAOYSA-N	408786	N-[(3-fluoro-5-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 95::US11001578, Example 95::US11084809, Example 95::US11198691, Example 95	Plasma kallikrein			 308							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408786	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408786&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365039	406799417							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119133	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(F)cc(OC)c1F	InChI=1S/C27H26F2N4O4/c1-36-17-23-22(27(35)30-13-20-11-21(28)12-24(37-2)26(20)29)16-33(31-23)15-19-8-6-18(7-9-19)14-32-10-4-3-5-25(32)34/h3-12,16H,13-15,17H2,1-2H3,(H,30,35)	FKXBPOXUNOOPGU-UHFFFAOYSA-N	408787	N-[(2,5-difluoro-3-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin- 1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 96::US11001578, Example 96::US11084809, Example 96::US11198691, Example 96	Plasma kallikrein			 75.0							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408787	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408787&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365093	406799418							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119135	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(C)cccc1F	InChI=1S/C27H27FN4O3/c1-19-6-5-7-24(28)22(19)14-29-27(34)23-17-32(30-25(23)18-35-2)16-21-11-9-20(10-12-21)15-31-13-4-3-8-26(31)33/h3-13,17H,14-16,18H2,1-2H3,(H,29,34)	NLVINHRIZCLAQG-UHFFFAOYSA-N	408788	 N-[(2-fluoro-6-methylphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US10364238, Example 97::US11001578, Example 97::US11084809, Example 97::US11198691, Example 97	Plasma kallikrein			 153							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408788	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408788&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365111	406799419							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119137	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(Cl)ccc(OC)c1F	InChI=1S/C27H26ClFN4O4/c1-36-17-23-21(27(35)30-13-20-22(28)10-11-24(37-2)26(20)29)16-33(31-23)15-19-8-6-18(7-9-19)14-32-12-4-3-5-25(32)34/h3-12,16H,13-15,17H2,1-2H3,(H,30,35)	AJVITEJNDAKYPL-UHFFFAOYSA-N	497307	N-[(6-chloro-2-fluoro-3-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-::US11001578, Example 99::US11084809, Example 99::US11198691, Example 99	Plasma kallikrein			 6.40							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=497307	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=497307&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365144	459070294							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119139	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cccc(O)c1F	InChI=1S/C26H25FN4O4/c1-35-17-22-21(26(34)28-13-20-5-4-6-23(32)25(20)27)16-31(29-22)15-19-10-8-18(9-11-19)14-30-12-3-2-7-24(30)33/h2-12,16,32H,13-15,17H2,1H3,(H,28,34)	JFAWWGDJBCGIDJ-UHFFFAOYSA-N	408790	N-[(2-fluoro-3-hydroxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 129::US11001578, Example 129::US11084809, Example 129::US11198691, Example 129	Plasma kallikrein			 437							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408790	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408790&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365133	406799421							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119141	Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cccc(O)c1F	InChI=1S/C24H22FN5O3/c25-22-18(4-3-5-20(22)31)12-27-24(33)19-15-30(28-23(19)26)14-17-9-7-16(8-10-17)13-29-11-2-1-6-21(29)32/h1-11,15,31H,12-14H2,(H2,26,28)(H,27,33)	OOXKEXDZGXUAST-UHFFFAOYSA-N	408792	 3-amino-N-[(2-fluoro-3-hydroxyphenyl)methyl]-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 130::US11001578, Example 130::US11084809, Example 130::US11198691, Example 130	Plasma kallikrein			 174							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408792	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408792&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365044	406799423							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119143	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1ccccc1C(=O)OC	InChI=1S/C28H28N4O5/c1-36-19-25-24(27(34)29-15-22-7-3-4-8-23(22)28(35)37-2)18-32(30-25)17-21-12-10-20(11-13-21)16-31-14-6-5-9-26(31)33/h3-14,18H,15-17,19H2,1-2H3,(H,29,34)	CLMIQCGDYIVGMD-UHFFFAOYSA-N	408793	 methyl 2-({[3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazol-4-yl]formamido}methyl)benzoate::US10364238, Example 131::US11001578, Example 131::US11084809, Example 131::US11198691, Example 131	Plasma kallikrein			 1510							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408793	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408793&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364999	406799424							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119145	CCc1cccc(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2COC)c1F	InChI=1S/C28H29FN4O3/c1-3-22-7-6-8-23(27(22)29)15-30-28(35)24-18-33(31-25(24)19-36-2)17-21-12-10-20(11-13-21)16-32-14-5-4-9-26(32)34/h4-14,18H,3,15-17,19H2,1-2H3,(H,30,35)	TVACIVBKATZGQV-UHFFFAOYSA-N	408794	 N-[(3-ethyl-2-fluorophenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 132::US11001578, Example 132::US11084809, Example 132::US11198691, Example 132	Plasma kallikrein			 135							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408794	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408794&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365023	406799425							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119147	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cccc(OC)c1	InChI=1S/C27H28N4O4/c1-34-19-25-24(27(33)28-15-22-6-5-7-23(14-22)35-2)18-31(29-25)17-21-11-9-20(10-12-21)16-30-13-4-3-8-26(30)32/h3-14,18H,15-17,19H2,1-2H3,(H,28,33)	YDHZFMPDUQUAJM-UHFFFAOYSA-N	408795	 3-(methoxymethyl)-N-[(3-methoxyphenyl)methyl]-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 133::US11001578, Example 133::US11084809, Example 133::US11198691, Example 133	Plasma kallikrein			 90.2							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408795	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408795&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365129	406799426							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119149	COCc1nn(Cc2ccc(Cn3ccncc3=O)cc2)cc1C(=O)NCc1cccc(OC)c1F	InChI=1S/C26H26FN5O4/c1-35-17-22-21(26(34)29-12-20-4-3-5-23(36-2)25(20)27)16-32(30-22)15-19-8-6-18(7-9-19)14-31-11-10-28-13-24(31)33/h3-11,13,16H,12,14-15,17H2,1-2H3,(H,29,34)	QNPXQCIYWHCURP-UHFFFAOYSA-N	408796	 N-[(2-fluoro-3-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyrazin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 104::US11001578, Example 104::US11084809, Example 104::US11198691, Example 104	Plasma kallikrein			 691							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408796	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408796&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365146	406799427							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119151	COCc1nn(Cc2ccc(Cn3ccc(C)cc3=O)cc2)cc1C(=O)NCc1c(F)ccc(OC)c1F	InChI=1S/C28H28F2N4O4/c1-18-10-11-33(26(35)12-18)14-19-4-6-20(7-5-19)15-34-16-22(24(32-34)17-37-2)28(36)31-13-21-23(29)8-9-25(38-3)27(21)30/h4-12,16H,13-15,17H2,1-3H3,(H,31,36)	BKTJDPOLKWOBHW-UHFFFAOYSA-N	408797	N-[(2,6-difluoro-3-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(4-methyl-2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US10364238, Example 106::US11001578, Example 106::US11084809, Example 106::US11198691, Example 106	Plasma kallikrein			 140							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408797	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408797&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365091	406799428							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119153	COCc1nn(Cc2ccc(Cn3cc(F)ccc3=O)cc2)cc1C(=O)NCc1c(F)ccc(OC)c1F	InChI=1S/C27H25F3N4O4/c1-37-16-23-21(27(36)31-11-20-22(29)8-9-24(38-2)26(20)30)15-34(32-23)13-18-5-3-17(4-6-18)12-33-14-19(28)7-10-25(33)35/h3-10,14-15H,11-13,16H2,1-2H3,(H,31,36)	JRSJFSJQRZMHDN-UHFFFAOYSA-N	408798	 N-[(2,6-difluoro-3-methoxyphenyl)methyl]-1-({4-[(5-fluoro-2-oxopyridin-1- yl)methyl]phenyl}methyl)-3-(methoxymethyl)pyrazole-4-carboxamide::US10364238, Example 108::US11001578, Example 108::US11084809, Example 108::US11198691, Example 108	Plasma kallikrein			 5.50							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408798	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408798&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365114	406799429							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119155	CCOc1ccn(Cc2ccc(Cn3cc(C(=O)NCc4c(F)ccc(OC)c4F)c(COC)n3)cc2)c(=O)c1	InChI=1S/C29H30F2N4O5/c1-4-40-21-11-12-34(27(36)13-21)15-19-5-7-20(8-6-19)16-35-17-23(25(33-35)18-38-2)29(37)32-14-22-24(30)9-10-26(39-3)28(22)31/h5-13,17H,4,14-16,18H2,1-3H3,(H,32,37)	MMGSTVOIQROITG-UHFFFAOYSA-N	408799	N-[(2,6-difluoro-3-methoxyphenyl)methyl]-1-({4-[(4-ethoxy-2-oxopyridin-1- yl)methyl]phenyl}methyl)-3-(methoxymethyl)pyrazole-4-carboxamide ::US10364238, Example 109::US11001578, Example 109::US11084809, Example 109::US11198691, Example 109	Plasma kallikrein			 2980							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408799	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408799&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364997	406799430							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119157	COc1cccc(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)c(C)n2)c1F	InChI=1S/C26H25FN4O3/c1-18-29-22(26(33)28-14-21-6-5-7-23(34-2)25(21)27)17-31(18)16-20-11-9-19(10-12-20)15-30-13-4-3-8-24(30)32/h3-13,17H,14-16H2,1-2H3,(H,28,33)	XCBLTBHUJNNESG-UHFFFAOYSA-N	408801	 N-[(2-fluoro-3-methoxyphenyl)methyl]-2-methyl-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)imidazole-4-carboxamide ::US10364238, Example 121::US11001578, Example 121::US11084809, Example 121::US11198691, Example 121	Plasma kallikrein			 43.9							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408801	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408801&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365087	406799432							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119159	COc1cccc(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)c(n2)C(F)(F)F)c1F	InChI=1S/C26H22F4N4O3/c1-37-21-6-4-5-19(23(21)27)13-31-24(36)20-16-34(25(32-20)26(28,29)30)15-18-10-8-17(9-11-18)14-33-12-3-2-7-22(33)35/h2-12,16H,13-15H2,1H3,(H,31,36)	UZZGYTADFHNIGM-UHFFFAOYSA-N	408803	 N-[(2-fluoro-3-methoxyphenyl)methyl]-1-({4-[(2-oxopyrldin-1- yl)methyl]phenyl}methyl)-2-(trifluoromethyl)imidazole-4-carboxamide ::US10364238, Example 124::US11001578, Example 124::US11084809, Example 124::US11198691, Example 124	Plasma kallikrein			 191							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408803	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408803&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365057	406799434							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119161	COCc1nc(cn1Cc1ccc(Cn2ccccc2=O)cc1)C(=O)NCc1cccc(OC)c1F	InChI=1S/C27H27FN4O4/c1-35-18-24-30-22(27(34)29-14-21-6-5-7-23(36-2)26(21)28)17-32(24)16-20-11-9-19(10-12-20)15-31-13-4-3-8-25(31)33/h3-13,17H,14-16,18H2,1-2H3,(H,29,34)	JRQUEVFCKNXJTM-UHFFFAOYSA-N	528885	N-[(2-fluoro-3-methoxyphenyl)methyl]-1-{[6-(pyrrolidin-1- yl)pyridin-3-yl]methyl}-3-(trifluoromethyl)pyrazole-4- carboxamide::US11198691, Example 126	Plasma kallikrein			 742							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528885	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528885&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365069	463792412							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119163	CN1CC(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2N)Oc2cc(Cl)ccc12	InChI=1S/C27H27ClN6O3/c1-32-16-21(37-24-12-20(28)9-10-23(24)32)13-30-27(36)22-17-34(31-26(22)29)15-19-7-5-18(6-8-19)14-33-11-3-2-4-25(33)35/h2-12,17,21H,13-16H2,1H3,(H2,29,31)(H,30,36)	BZQHROALKROIIJ-UHFFFAOYSA-N	408805	 3-amino-N-[(7-chloro-4-methyl-2,3-dihydro-1,4-benzoxazin-2-yl)methyl]-1-({4-[(2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 139::US11001578, Example 139::US11084809, Example 139::US11198691, Example 139	Plasma kallikrein			 64.7							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408805	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408805&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365007	406799436							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1119165	Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCC1CNc2ccc(Cl)cc2O1	InChI=1S/C26H25ClN6O3/c27-19-8-9-22-23(11-19)36-20(12-29-22)13-30-26(35)21-16-33(31-25(21)28)15-18-6-4-17(5-7-18)14-32-10-2-1-3-24(32)34/h1-11,16,20,29H,12-15H2,(H2,28,31)(H,30,35)	PIQXYEUIEZKEKB-UHFFFAOYSA-N	408806	3-amino-N-[(7-chloro-3,4-dihydro-2H-1,4-benzoxazin-2-yl)methyl]-1-({4-[(2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 140::US11001578, Example 140::US11084809, Example 140::US11198691, Example 140	Plasma kallikrein			 10.6							US Patent		10.7270/Q25B05N6		aid1806184	US11198691	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408806	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408806&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365122	406799437							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51417321	CC1CC1C(=O)Nc1ccc(C[C@H](NC(=O)c2c(C)nc(-c3cccc(Cl)c3F)n2O)C(=O)Nc2ccc3[nH]c(cc3c2)C(O)=O)cc1			50572517	CHEMBL4865339	Plasma kallikrein		 192								ChEMBL	10.1016/j.ejmech.2021.113437	10.7270/Q22N5622	33894565			Lei, Y; Zhang, B; Zhang, Y; Dai, X; Duan, Y; Mao, Q; Gao, J; Yang, Y; Bao, Z; Fu, X; Ping, K; Yan, C; Mou, Y; Wang, S	Shenyang Pharmaceutical University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50572517	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50572517&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			164620524	471062662							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51423554	Cc1[nH]nc2[C@@H](CCc12)NC(=O)c1cn(Cc2ccc(nc2C(F)F)N2CC3(CC3)C2)nn1			50575237	CHEMBL4860010	Plasma kallikrein			 0.500000							ChEMBL	10.1021/acsmedchemlett.1c00530	10.7270/Q20Z7735	34795850			Sabnis, RW	Smith, Gambrell & Russell LLP	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50575237	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50575237&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156825849	471065382							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51423555	Cc1[nH]nc2[C@@H](CCc12)NC(=O)c1cn(Cc2ccc(nc2C(F)F)N2CC3(CC3)C2)cn1			50575238	CHEMBL4846807	Plasma kallikrein			 0.500000							ChEMBL	10.1021/acsmedchemlett.1c00530	10.7270/Q20Z7735	34795850			Sabnis, RW	Smith, Gambrell & Russell LLP	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50575238	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50575238&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156825884	471065383							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51423556	Cc1[nH]nc2[C@@H](CCc12)NC(=O)c1cn(Cc2ccc(nc2C(F)F)N2CC3CC3C2)cn1			50575239	CHEMBL4863507	Plasma kallikrein			 0.700000							ChEMBL	10.1021/acsmedchemlett.1c00530	10.7270/Q20Z7735	34795850			Sabnis, RW	Smith, Gambrell & Russell LLP	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50575239	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50575239&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156825841	471065384							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51423557	Cc1[nH]nc2[C@@H](CCc12)NC(=O)c1cnn(Cc2ccc(nc2C(F)F)N2CC3CC3C2)c1			50575240	CHEMBL4846017	Plasma kallikrein			 0.800000							ChEMBL	10.1021/acsmedchemlett.1c00530	10.7270/Q20Z7735	34795850			Sabnis, RW	Smith, Gambrell & Russell LLP	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50575240	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50575240&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156825891	471065385							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51423558	Cc1[nH]nc2[C@@H](CCc12)NC(=O)c1cnn(Cc2ccc(nc2C(F)F)N2CC3C(C2)C3(F)F)c1			50575241	CHEMBL4877824	Plasma kallikrein			 0.800000							ChEMBL	10.1021/acsmedchemlett.1c00530	10.7270/Q20Z7735	34795850			Sabnis, RW	Smith, Gambrell & Russell LLP	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50575241	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50575241&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156825914	471065386							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51423559	Cc1[nH]nc2[C@@H](CCc12)NC(=O)c1cn(Cc2ccc(nc2C(F)F)N2CC3C(C2)C3(F)F)cn1			50575242	CHEMBL4858749	Plasma kallikrein			 0.600000							ChEMBL	10.1021/acsmedchemlett.1c00530	10.7270/Q20Z7735	34795850			Sabnis, RW	Smith, Gambrell & Russell LLP	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50575242	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50575242&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156825864	471065387							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51421860	Cc1c(Cn2cc(cn2)C(=O)N[C@@H]2CCc3c2ncn3C)cnc(N2CC3CC3C2)c1C#N	InChI=1S/C24H26N8O/c1-14-17(7-26-23(19(14)6-25)31-9-15-5-16(15)10-31)11-32-12-18(8-28-32)24(33)29-20-3-4-21-22(20)27-13-30(21)2/h7-8,12-13,15-16,20H,3-5,9-11H2,1-2H3,(H,29,33)/t15?,16?,20-/m1/s1	GQHOJYHITHIAKQ-ALLBUHFWSA-N	50574376	CHEMBL4867704	Plasma kallikrein			 0.400000							ChEMBL	10.1021/acsmedchemlett.1c00622	10.7270/Q2GB27WQ	34917251			Sabnis, RW	Smith, Gambrell & Russell LLP	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50574376	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50574376&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156826448	471064521							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51421861	Cc1c(Cn2cnc(c2)C(=O)N[C@@H]2CCc3c2ncn3C)cnc(N2CC3CC3C2)c1C#N	InChI=1S/C24H26N8O/c1-14-17(7-26-23(18(14)6-25)32-9-15-5-16(15)10-32)8-31-11-20(27-13-31)24(33)29-19-3-4-21-22(19)28-12-30(21)2/h7,11-13,15-16,19H,3-5,8-10H2,1-2H3,(H,29,33)/t15?,16?,19-/m1/s1	QBZPGBZHDJOJSL-LADRWXRNSA-N	50574377	CHEMBL4853430	Plasma kallikrein			 0.300000							ChEMBL	10.1021/acsmedchemlett.1c00622	10.7270/Q2GB27WQ	34917251			Sabnis, RW	Smith, Gambrell & Russell LLP	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50574377	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50574377&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156826097	471064522							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51421862	Cc1c(Cn2cc(cn2)C(=O)N[C@@H]2CCc3c2ncn3C)ccc(N2CC3CC3C2)c1C#N	InChI=1S/C25H27N7O/c1-15-16(3-5-22(20(15)8-26)31-10-17-7-18(17)11-31)12-32-13-19(9-28-32)25(33)29-21-4-6-23-24(21)27-14-30(23)2/h3,5,9,13-14,17-18,21H,4,6-7,10-12H2,1-2H3,(H,29,33)/t17?,18?,21-/m1/s1	RWWJGLSDNLGBOT-WIXQSORDSA-N	50574378	CHEMBL4867424	Plasma kallikrein			 0.400000							ChEMBL	10.1021/acsmedchemlett.1c00622	10.7270/Q2GB27WQ	34917251			Sabnis, RW	Smith, Gambrell & Russell LLP	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50574378	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50574378&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156826604	471064523							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51421863	Cc1c(Cn2cnc(c2)C(=O)N[C@@H]2CCc3c2ncn3C)ccc(N2CC3CC3C2)c1C#N	InChI=1S/C25H27N7O/c1-15-16(3-5-22(19(15)8-26)32-10-17-7-18(17)11-32)9-31-12-21(27-14-31)25(33)29-20-4-6-23-24(20)28-13-30(23)2/h3,5,12-14,17-18,20H,4,6-7,9-11H2,1-2H3,(H,29,33)/t17?,18?,20-/m1/s1	GIEYEOLNHMBEJX-AFMYVXGZSA-N	50574379	CHEMBL4875151	Plasma kallikrein			 0.300000							ChEMBL	10.1021/acsmedchemlett.1c00622	10.7270/Q2GB27WQ	34917251			Sabnis, RW	Smith, Gambrell & Russell LLP	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50574379	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50574379&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156826644	471064524							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51421864	Cn1cnc2[C@@H](CCc12)NC(=O)c1cn(Cc2ccc(cc2C#N)N2CC3CC3C2)cn1	InChI=1S/C24H25N7O/c1-29-13-27-23-20(4-5-22(23)29)28-24(32)21-12-30(14-26-21)9-15-2-3-19(7-16(15)8-25)31-10-17-6-18(17)11-31/h2-3,7,12-14,17-18,20H,4-6,9-11H2,1H3,(H,28,32)/t17?,18?,20-/m1/s1	KZLVQSNMHFYIJD-AFMYVXGZSA-N	50574380	CHEMBL4873547	Plasma kallikrein			 0.400000							ChEMBL	10.1021/acsmedchemlett.1c00622	10.7270/Q2GB27WQ	34917251			Sabnis, RW	Smith, Gambrell & Russell LLP	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50574380	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50574380&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156826324	471064525							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51421865	Cn1cnc2[C@@H](CCc12)NC(=O)c1cn(Cc2ccc(cc2C#N)N2CC3C(C2)C3(F)F)cn1	InChI=1S/C24H23F2N7O/c1-31-12-29-22-19(4-5-21(22)31)30-23(34)20-11-32(13-28-20)8-14-2-3-16(6-15(14)7-27)33-9-17-18(10-33)24(17,25)26/h2-3,6,11-13,17-19H,4-5,8-10H2,1H3,(H,30,34)/t17?,18?,19-/m1/s1	AJULYHREPZHBLX-CTWPCTMYSA-N	50574381	CHEMBL4854358	Plasma kallikrein			 0.400000							ChEMBL	10.1021/acsmedchemlett.1c00622	10.7270/Q2GB27WQ	34917251			Sabnis, RW	Smith, Gambrell & Russell LLP	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50574381	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50574381&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156826625	471064526							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1182400	Clc1ccn2cnc(CC(=O)NCc3cn(Cc4cn5cc(ccc5n4)C4CC4)nn3)c2c1	InChI=1S/C23H21ClN8O/c24-17-5-6-30-14-26-20(21(30)7-17)8-23(33)25-9-18-12-32(29-28-18)13-19-11-31-10-16(15-1-2-15)3-4-22(31)27-19/h3-7,10-12,14-15H,1-2,8-9,13H2,(H,25,33)	YYXBGTFBFCNPDA-UHFFFAOYSA-N	559635	US11370803, Compound I-1	Plasma kallikrein					<50					US Patent		10.7270/Q2GX4FR1		aid1806632	US11370803	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=559635	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=559635&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152491	471695031							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1182401	Fc1c(Cl)ccn2cnc(C(NCc3cn(Cc4cn5cc(ccc5n4)C4CC4)nn3)C(F)(F)F)c12	InChI=1S/C23H19ClF4N8/c24-17-5-6-34-12-30-20(21(34)19(17)25)22(23(26,27)28)29-7-15-10-36(33-32-15)11-16-9-35-8-14(13-1-2-13)3-4-18(35)31-16/h3-6,8-10,12-13,22,29H,1-2,7,11H2	IHZMHBCITXJBHK-UHFFFAOYSA-N	559636	US11370803, Compound I-2	Plasma kallikrein					>1000					US Patent		10.7270/Q2GX4FR1		aid1806632	US11370803	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=559636	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=559636&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152442	471695032							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1182402	Fc1c(Cl)ccn2cnc(C(=O)NCc3cn(Cc4cn5cc(ccc5n4)C4CC4)nn3)c12	InChI=1S/C22H18ClFN8O/c23-17-5-6-30-12-26-20(21(30)19(17)24)22(33)25-7-15-10-32(29-28-15)11-16-9-31-8-14(13-1-2-13)3-4-18(31)27-16/h3-6,8-10,12-13H,1-2,7,11H2,(H,25,33)	BZKRCVSPGUPNJR-UHFFFAOYSA-N	559637	US11370803, Compound I-3	Plasma kallikrein					 125					US Patent		10.7270/Q2GX4FR1		aid1806632	US11370803	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=559637	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=559637&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152150	471695033							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1182403	Fc1c(Cl)ccn2cnc(CNS(=O)(=O)c3cnn(Cc4cn5cc(ccc5n4)C4CC4)c3)c12	InChI=1S/C22H19ClFN7O2S/c23-18-5-6-29-13-25-19(22(29)21(18)24)8-27-34(32,33)17-7-26-31(12-17)11-16-10-30-9-15(14-1-2-14)3-4-20(30)28-16/h3-7,9-10,12-14,27H,1-2,8,11H2	PWYRIOSQAKLGMA-UHFFFAOYSA-N	559638	US11370803, Compound I-4	Plasma kallikrein					 600					US Patent		10.7270/Q2GX4FR1		aid1806632	US11370803	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=559638	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=559638&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152493	471695034							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1182404	Fc1c(Cl)ccn2cnc(CNS(=O)(=O)c3cn(Cc4cn5cc(ccc5n4)C4CC4)nn3)c12	InChI=1S/C21H18ClFN8O2S/c22-16-5-6-29-12-24-17(21(29)20(16)23)7-25-34(32,33)19-11-31(28-27-19)10-15-9-30-8-14(13-1-2-13)3-4-18(30)26-15/h3-6,8-9,11-13,25H,1-2,7,10H2	UELJQIPUSNOUDD-UHFFFAOYSA-N	559639	US11370803, Compound I-5	Plasma kallikrein					 600					US Patent		10.7270/Q2GX4FR1		aid1806632	US11370803	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=559639	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=559639&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152473	471695035							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1182405	Fc1c(Cl)ccn2cnc(c12)S(=O)(=O)NCc1cn(Cc2cn3cc(ccc3n2)C2CC2)nn1	InChI=1S/C21H18ClFN8O2S/c22-17-5-6-29-12-24-21(20(29)19(17)23)34(32,33)25-7-15-10-31(28-27-15)11-16-9-30-8-14(13-1-2-13)3-4-18(30)26-16/h3-6,8-10,12-13,25H,1-2,7,11H2	ZXKCXLNEFDFTTI-UHFFFAOYSA-N	559640	US11370803, Compound I-6	Plasma kallikrein					<50					US Patent		10.7270/Q2GX4FR1		aid1806632	US11370803	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=559640	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=559640&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152470	471695036							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1182406	CC(NS(=O)(=O)c1ncn2ccc(Cl)c(F)c12)c1cn(Cc2cn3cc(ccc3n2)C2CC2)nn1	InChI=1S/C22H20ClFN8O2S/c1-13(28-35(33,34)22-21-20(24)17(23)6-7-30(21)12-25-22)18-11-32(29-27-18)10-16-9-31-8-15(14-2-3-14)4-5-19(31)26-16/h4-9,11-14,28H,2-3,10H2,1H3	DEHMJYVKBIROGT-UHFFFAOYSA-N	559641	US11370803, Compound I-7	Plasma kallikrein					<50					US Patent		10.7270/Q2GX4FR1		aid1806632	US11370803	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=559641	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=559641&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152462	471695037							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1182407	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn4C(CCc4n3)c3cn4cc(ccc4n3)C3CC3)c12	InChI=1S/C25H21ClFN7O/c26-16-7-8-32-13-29-17(24(32)23(16)27)9-28-25(35)19-12-34-20(4-6-22(34)31-19)18-11-33-10-15(14-1-2-14)3-5-21(33)30-18/h3,5,7-8,10-14,20H,1-2,4,6,9H2,(H,28,35)	YSKJNXYWJODTSB-UHFFFAOYSA-N	559642	US11370803, Compound I-8	Plasma kallikrein					<50					US Patent		10.7270/Q2GX4FR1		aid1806632	US11370803	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=559642	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=559642&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152467	471695038							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1182408	Fc1c(Cl)ccn2cnc(CNC(=O)c3cnc4CCC(c5cn6cc(ccc6n5)C5CC5)n34)c12	InChI=1S/C25H21ClFN7O/c26-16-7-8-32-13-30-17(24(32)23(16)27)9-29-25(35)20-10-28-21-6-4-19(34(20)21)18-12-33-11-15(14-1-2-14)3-5-22(33)31-18/h3,5,7-8,10-14,19H,1-2,4,6,9H2,(H,29,35)	UTVJABIDZBRETF-UHFFFAOYSA-N	559643	US11370803, Compound I-9	Plasma kallikrein					 600					US Patent		10.7270/Q2GX4FR1		aid1806632	US11370803	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=559643	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=559643&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152486	471695039							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1182409	O=C(NCc1ncn2ccc(cc12)C#N)c1cnn(Cc2cn3cc(ccc3n2)C2CC2)c1	InChI=1S/C24H20N8O/c25-8-16-5-6-30-15-27-21(22(30)7-16)10-26-24(33)19-9-28-32(12-19)14-20-13-31-11-18(17-1-2-17)3-4-23(31)29-20/h3-7,9,11-13,15,17H,1-2,10,14H2,(H,26,33)	ARMHMQOFWZUCGQ-UHFFFAOYSA-N	559644	US11370803, Compound I-10	Plasma kallikrein					<50					US Patent		10.7270/Q2GX4FR1		aid1806632	US11370803	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=559644	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=559644&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152492	471695040							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1182410	Fc1c(Cl)ccn2cnc(CNCc3cn(Cc4cn5cc(ccc5n4)C4CC4)nn3)c12	InChI=1S/C22H20ClFN8/c23-18-5-6-30-13-26-19(22(30)21(18)24)8-25-7-16-11-32(29-28-16)12-17-10-31-9-15(14-1-2-14)3-4-20(31)27-17/h3-6,9-11,13-14,25H,1-2,7-8,12H2	QTRYJAILHOPXGN-UHFFFAOYSA-N	559645	US11370803, Compound I-11	Plasma kallikrein					<50					US Patent		10.7270/Q2GX4FR1		aid1806632	US11370803	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=559645	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=559645&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152484	471695041							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1182411	CC(NCc1ncn2ccc(Cl)c(F)c12)c1cn(Cc2cn3cc(ccc3n2)C2CC2)nn1	InChI=1S/C23H22ClFN8/c1-14(26-8-19-23-22(25)18(24)6-7-31(23)13-27-19)20-12-33(30-29-20)11-17-10-32-9-16(15-2-3-15)4-5-21(32)28-17/h4-7,9-10,12-15,26H,2-3,8,11H2,1H3	VGYSRFBNROEPPZ-UHFFFAOYSA-N	559646	US11370803, Compound I-12	Plasma kallikrein					 125					US Patent		10.7270/Q2GX4FR1		aid1806632	US11370803	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=559646	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=559646&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152490	471695042							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1182412	CC(NC(=O)Cc1ncn2ccc(Cl)cc12)c1cn(Cc2cn3cc(ccc3n2)C2CC2)nn1	InChI=1S/C24H23ClN8O/c1-15(27-24(34)9-20-22-8-18(25)6-7-31(22)14-26-20)21-13-33(30-29-21)12-19-11-32-10-17(16-2-3-16)4-5-23(32)28-19/h4-8,10-11,13-16H,2-3,9,12H2,1H3,(H,27,34)	AUFKPFZDZBTLCK-UHFFFAOYSA-N	559647	US11370803, Compound I-13	Plasma kallikrein					<50					US Patent		10.7270/Q2GX4FR1		aid1806632	US11370803	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=559647	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=559647&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152448	471695043							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1182413	COC(=O)c1cc(cn2cc(Cn3cc(CNCc4ncn5ccc(Cl)c(F)c45)nn3)nc12)C1CC1	InChI=1S/C24H22ClFN8O2/c1-36-24(35)18-6-15(14-2-3-14)9-33-10-17(29-23(18)33)12-34-11-16(30-31-34)7-27-8-20-22-21(26)19(25)4-5-32(22)13-28-20/h4-6,9-11,13-14,27H,2-3,7-8,12H2,1H3	FXHTURBYHYMVQU-UHFFFAOYSA-N	559648	US11370803, Compound I-14	Plasma kallikrein					<50					US Patent		10.7270/Q2GX4FR1		aid1806632	US11370803	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=559648	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=559648&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152446	471695044							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1182414	OC(=O)c1cc(cn2cc(Cn3cc(CNCc4ncn5ccc(Cl)c(F)c45)nn3)nc12)C1CC1	InChI=1S/C23H20ClFN8O2/c24-18-3-4-31-12-27-19(21(31)20(18)25)7-26-6-15-10-33(30-29-15)11-16-9-32-8-14(13-1-2-13)5-17(23(34)35)22(32)28-16/h3-5,8-10,12-13,26H,1-2,6-7,11H2,(H,34,35)	GFKODHWPXORRIK-UHFFFAOYSA-N	559649	US11370803, Compound I-15	Plasma kallikrein					 600					US Patent		10.7270/Q2GX4FR1		aid1806632	US11370803	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=559649	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=559649&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152444	471695045							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1182415	Fc1c(Cl)ccn2cnc(CNC(c3cnn(Cc4cn5cc(ccc5n4)C4CC4)c3)C(F)(F)F)c12	InChI=1S/C24H20ClF4N7/c25-18-5-6-34-13-31-19(22(34)21(18)26)8-30-23(24(27,28)29)16-7-32-36(10-16)12-17-11-35-9-15(14-1-2-14)3-4-20(35)33-17/h3-7,9-11,13-14,23,30H,1-2,8,12H2	MBBPCKSVOTVUHF-UHFFFAOYSA-N	559650	US11370803, Compound I-16	Plasma kallikrein					<50					US Patent		10.7270/Q2GX4FR1		aid1806632	US11370803	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=559650	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=559650&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152475	471695046							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1182416	CCOC(=O)CCc1cc(cn2cc(Cn3cc(CNCc4ncn5ccc(Cl)c(F)c45)nn3)nc12)C1CC1	InChI=1S/C27H28ClFN8O2/c1-2-39-24(38)6-5-18-9-19(17-3-4-17)12-36-13-21(32-27(18)36)15-37-14-20(33-34-37)10-30-11-23-26-25(29)22(28)7-8-35(26)16-31-23/h7-9,12-14,16-17,30H,2-6,10-11,15H2,1H3	NULSTEZBIBCANG-UHFFFAOYSA-N	559651	US11370803, Compound I-17a	Plasma kallikrein					<50					US Patent		10.7270/Q2GX4FR1		aid1806632	US11370803	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=559651	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=559651&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152464	471695047							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1182417	OC(=O)CCc1cc(cn2cc(Cn3cc(CNCc4ncn5ccc(Cl)c(F)c45)nn3)nc12)C1CC1	InChI=1S/C25H24ClFN8O2/c26-20-5-6-33-14-29-21(24(33)23(20)27)9-28-8-18-12-35(32-31-18)13-19-11-34-10-17(15-1-2-15)7-16(25(34)30-19)3-4-22(36)37/h5-7,10-12,14-15,28H,1-4,8-9,13H2,(H,36,37)	RDKNXJUKQBOPMP-UHFFFAOYSA-N	559652	US11370803, Compound I-17b	Plasma kallikrein					<50					US Patent		10.7270/Q2GX4FR1		aid1806632	US11370803	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=559652	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=559652&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152477	471695048							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1182418	Fc1c(Cl)ccn2cnc(CNCc3cn(Cc4cn5cc(cc(-n6cnnc6)c5n4)C4CC4)nn3)c12	InChI=1S/C24H21ClFN11/c25-19-3-4-34-12-28-20(23(34)22(19)26)7-27-6-17-10-37(33-32-17)11-18-9-35-8-16(15-1-2-15)5-21(24(35)31-18)36-13-29-30-14-36/h3-5,8-10,12-15,27H,1-2,6-7,11H2	FFPGMRIUTFIZQG-UHFFFAOYSA-N	559653	US11370803, Compound I-18	Plasma kallikrein					<50					US Patent		10.7270/Q2GX4FR1		aid1806632	US11370803	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=559653	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=559653&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152476	471695049							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1182419	FC(F)(F)C(NC(=O)Cc1ncn2ccc(Cl)cc12)c1cnn(Cc2cn3cc(ccc3n2)C2CC2)c1	InChI=1S/C25H21ClF3N7O/c26-18-5-6-34-14-30-20(21(34)7-18)8-23(37)33-24(25(27,28)29)17-9-31-36(11-17)13-19-12-35-10-16(15-1-2-15)3-4-22(35)32-19/h3-7,9-12,14-15,24H,1-2,8,13H2,(H,33,37)	PTXWNCPOMXNWEP-UHFFFAOYSA-N	559654	US11370803, Compound I-19	Plasma kallikrein					 125					US Patent		10.7270/Q2GX4FR1		aid1806632	US11370803	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=559654	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=559654&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152440	471695050							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1182420	CN1CCN(CC1)c1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C27H28ClFN10O/c1-35-6-8-36(9-7-35)23-10-18(17-2-3-17)12-38-13-19(32-26(23)38)14-39-15-22(33-34-39)27(40)30-11-21-25-24(29)20(28)4-5-37(25)16-31-21/h4-5,10,12-13,15-17H,2-3,6-9,11,14H2,1H3,(H,30,40)	NTOBYVHCGUIKSZ-UHFFFAOYSA-N	559655	US11370803, Compound 1-20	Plasma kallikrein					<50					US Patent		10.7270/Q2GX4FR1		aid1806632	US11370803	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=559655	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=559655&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152478	471695051							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176110	Fc1c(Br)ccn2cnc(CNC(=O)c3cnn(Cc4cn5cc(ccc5n4)C4CC4)c3)c12	InChI=1S/C23H19BrFN7O/c24-18-5-6-30-13-27-19(22(30)21(18)25)8-26-23(33)16-7-28-32(10-16)12-17-11-31-9-15(14-1-2-14)3-4-20(31)29-17/h3-7,9-11,13-14H,1-2,8,12H2,(H,26,33)	QAQHWZZEPDKRQP-UHFFFAOYSA-N	455073	US10730874, Compound I-97::US11352356, Compound I-97	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455073	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455073&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487357	440970913							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176111	O=C(NCc1ncn2ccc(cc12)C#C)c1cnn(Cc2cn3nc(ccc3n2)C2CC2)c1	InChI=1S/C24H20N8O/c1-2-16-7-8-30-15-26-21(22(30)9-16)11-25-24(33)18-10-27-31(12-18)13-19-14-32-23(28-19)6-5-20(29-32)17-3-4-17/h1,5-10,12,14-15,17H,3-4,11,13H2,(H,25,33)	XMKJDEVKEAAANO-UHFFFAOYSA-N	455074	US10730874, Compound I-98::US11352356, Compound I-98	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455074	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455074&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488292	440970914							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176112	FC(F)c1nn(Cc2cn3cc(ccc3n2)C2CC2)cc1C(=O)NCc1ncn2ccc(Cl)cc12	InChI=1S/C24H20ClF2N7O/c25-16-5-6-32-13-29-19(20(32)7-16)8-28-24(35)18-12-34(31-22(18)23(26)27)11-17-10-33-9-15(14-1-2-14)3-4-21(33)30-17/h3-7,9-10,12-14,23H,1-2,8,11H2,(H,28,35)	XWYZQCXTNXOARS-UHFFFAOYSA-N	455075	US10730874, Compound I-99::US11352356, Compound I-99	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455075	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455075&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487336	440970915							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176113	CCOC(=O)\C=C\c1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1	InChI=1S/C28H26ClN7O3/c1-2-39-26(37)6-5-19-9-20(18-3-4-18)13-35-15-23(33-27(19)35)16-36-14-21(11-32-36)28(38)30-12-24-25-10-22(29)7-8-34(25)17-31-24/h5-11,13-15,17-18H,2-4,12,16H2,1H3,(H,30,38)/b6-5+	SLJXBBZIHIEQJO-AATRIKPKSA-N	557438	US11352356, Compound I-100a	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557438	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557438&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488000	471698147							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176114	Cc1ccc(cc1Nc1cc(nc2[nH]ccc12)-c1cccnc1)C(=O)Nc1cccc(c1)C(F)(F)F	InChI=1S/C27H20F3N5O/c1-16-7-8-17(26(36)33-20-6-2-5-19(13-20)27(28,29)30)12-22(16)34-24-14-23(18-4-3-10-31-15-18)35-25-21(24)9-11-32-25/h2-15H,1H3,(H,33,36)(H2,32,34,35)	IURDCEGOMBFKEV-UHFFFAOYSA-N	557290	US11352356, Compound I-100b	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557290	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557290&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176115	OC(=O)CCc1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1	InChI=1S/C26H24ClN7O3/c27-20-5-6-32-15-29-22(23(32)8-20)10-28-26(37)19-9-30-34(12-19)14-21-13-33-11-18(16-1-2-16)7-17(25(33)31-21)3-4-24(35)36/h5-9,11-13,15-16H,1-4,10,14H2,(H,28,37)(H,35,36)	PYBUWKWYRFJYSY-UHFFFAOYSA-N	557440	US11352356, Compound I-100c	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557440	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557440&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488041	471698149							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176116	Clc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5cc(cc(CN6CCOCC6)c5n4)C4CC4)c3)c2c1	InChI=1S/C28H29ClN8O2/c29-23-3-4-35-18-31-25(26(35)10-23)12-30-28(38)22-11-32-37(15-22)17-24-16-36-14-20(19-1-2-19)9-21(27(36)33-24)13-34-5-7-39-8-6-34/h3-4,9-11,14-16,18-19H,1-2,5-8,12-13,17H2,(H,30,38)	QKEFOZQQJRERQX-UHFFFAOYSA-N	455079	US10730874, Compound I-101::US11352356, Compound I-101	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455079	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455079&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487271	440970917							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176117	Clc1ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(ccc5n4)C4CC4)nc3C3COC3)c2c1	InChI=1S/C26H24ClN7O2/c27-19-5-6-32-15-29-22(23(32)7-19)8-28-26(35)21-12-34(31-25(21)18-13-36-14-18)11-20-10-33-9-17(16-1-2-16)3-4-24(33)30-20/h3-7,9-10,12,15-16,18H,1-2,8,11,13-14H2,(H,28,35)	BCNWQEMBSUDFTG-UHFFFAOYSA-N	455080	US10730874, Compound I-102::US11352356, Compound I-102	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455080	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455080&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487857	440970918							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176118	COCCOc1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1	InChI=1S/C26H26ClN7O3/c1-36-6-7-37-24-8-18(17-2-3-17)12-33-14-21(31-25(24)33)15-34-13-19(10-30-34)26(35)28-11-22-23-9-20(27)4-5-32(23)16-29-22/h4-5,8-10,12-14,16-17H,2-3,6-7,11,15H2,1H3,(H,28,35)	HOAIBSHBEWOVJQ-UHFFFAOYSA-N	455081	US10730874, Compound I-103::US11352356, Compound I-103	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455081	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455081&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488406	440970919							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176119	CC(=O)c1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1	InChI=1S/C25H22ClN7O2/c1-15(34)21-6-17(16-2-3-16)10-32-12-20(30-24(21)32)13-33-11-18(8-29-33)25(35)27-9-22-23-7-19(26)4-5-31(23)14-28-22/h4-8,10-12,14,16H,2-3,9,13H2,1H3,(H,27,35)	HFENUAWNYQFIAJ-UHFFFAOYSA-N	557444	US11352356, Compound I-104a	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557444	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557444&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487352	471698153							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176120	CC(C)(O)c1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1	InChI=1S/C26H26ClN7O2/c1-26(2,36)21-7-17(16-3-4-16)11-33-13-20(31-24(21)33)14-34-12-18(9-30-34)25(35)28-10-22-23-8-19(27)5-6-32(23)15-29-22/h5-9,11-13,15-16,36H,3-4,10,14H2,1-2H3,(H,28,35)	BPQPMYMBGDKSGH-UHFFFAOYSA-N	557445	US11352356, Compound I-104b	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557445	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557445&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487988	471698154							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176121	CCCc1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Br)c(F)c34)nc12)C1CC1	InChI=1S/C26H25BrFN7O/c1-2-3-17-8-18(16-4-5-16)11-34-13-20(32-25(17)34)14-35-12-19(9-31-35)26(36)29-10-22-24-23(28)21(27)6-7-33(24)15-30-22/h6-9,11-13,15-16H,2-5,10,14H2,1H3,(H,29,36)	PEQQTLVSFKYSOP-UHFFFAOYSA-N	455084	US10730874, Compound I-105::US11352356, Compound I-105	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455084	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455084&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155624266	440970920							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176122	Fc1c(Br)ccn2cnc(CNC(=O)c3cnn(Cc4cn5cc(cc(COC=O)c5n4)C4CC4)c3)c12	InChI=1S/C25H21BrFN7O3/c26-20-3-4-32-13-29-21(23(32)22(20)27)7-28-25(36)18-6-30-34(9-18)11-19-10-33-8-16(15-1-2-15)5-17(12-37-14-35)24(33)31-19/h3-6,8-10,13-15H,1-2,7,11-12H2,(H,28,36)	WIBBKJRXWQZWPQ-UHFFFAOYSA-N	455085	US10730874, Compound I-106	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455085	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455085&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487836	440970921							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176123	CCOC(=O)CCc1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1	InChI=1S/C28H28ClN7O3/c1-2-39-26(37)6-5-19-9-20(18-3-4-18)13-35-15-23(33-27(19)35)16-36-14-21(11-32-36)28(38)30-12-24-25-10-22(29)7-8-34(25)17-31-24/h7-11,13-15,17-18H,2-6,12,16H2,1H3,(H,30,38)	ATPQNHZBVSAZFO-UHFFFAOYSA-N	455086	US10730874, Compound I-107::US11352356, Compound I-107	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455086	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455086&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488120	440970922							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176124	Fc1c(Br)ccn2cnc(CNC(=O)c3cnn(Cc4cn5nc(ccc5n4)C4CC4)c3)c12	InChI=1S/C22H18BrFN8O/c23-16-5-6-30-12-26-18(21(30)20(16)24)8-25-22(33)14-7-27-31(9-14)10-15-11-32-19(28-15)4-3-17(29-32)13-1-2-13/h3-7,9,11-13H,1-2,8,10H2,(H,25,33)	KJCJLAIODLIUMC-UHFFFAOYSA-N	455087	US10730874, Compound I-108::US11352356, Compound I-108	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455087	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455087&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487505	440970923							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176125	CC(C)(O)Cc1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1	InChI=1S/C27H28ClN7O2/c1-27(2,37)9-18-7-19(17-3-4-17)12-34-14-22(32-25(18)34)15-35-13-20(10-31-35)26(36)29-11-23-24-8-21(28)5-6-33(24)16-30-23/h5-8,10,12-14,16-17,37H,3-4,9,11,15H2,1-2H3,(H,29,36)	DHTIJURLPWVRKY-UHFFFAOYSA-N	455088	US10730874, Compound I-109::US11352356, Compound I-109	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455088	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455088&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487851	440970924							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176126	Clc1ccn2cnc(CNC(=O)c3nnn(Cc4cn5cc(ccc5n4)C4CC4)n3)c2c1	InChI=1S/C21H18ClN9O/c22-15-5-6-29-12-24-17(18(29)7-15)8-23-21(32)20-26-28-31(27-20)11-16-10-30-9-14(13-1-2-13)3-4-19(30)25-16/h3-7,9-10,12-13H,1-2,8,11H2,(H,23,32)	IHKRPOXHRVZUMN-UHFFFAOYSA-N	455089	US10730874, Compound I-110::US11352356, Compound I-110	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455089	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455089&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487412	440970925							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176127	Clc1ccn2cnc(CNC(=O)c3cn(Cc4cn5nc(ccc5n4)C4CC4)nn3)c2c1	InChI=1S/C21H18ClN9O/c22-14-5-6-29-12-24-17(19(29)7-14)8-23-21(32)18-11-30(28-26-18)9-15-10-31-20(25-15)4-3-16(27-31)13-1-2-13/h3-7,10-13H,1-2,8-9H2,(H,23,32)	GXBKPLPPJNIWOA-UHFFFAOYSA-N	455090	US10730874, Compound I-111::US11352356, Compound I-111	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455090	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455090&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488090	440970926							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176128	Clc1ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(cc(C#N)c5n4)C4CC4)nn3)c2c1	InChI=1S/C23H18ClN9O/c24-17-3-4-31-13-27-19(21(31)6-17)8-26-23(34)20-12-33(30-29-20)11-18-10-32-9-16(14-1-2-14)5-15(7-25)22(32)28-18/h3-6,9-10,12-14H,1-2,8,11H2,(H,26,34)	XBNODSKUNPKNLB-UHFFFAOYSA-N	455091	US10730874, Compound I-112::US11352356, Compound I-112	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455091	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455091&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487350	440970927							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176014	Clc1ccn2cnc(CNC(=O)c3cnn(Cc4ccc5ncc(Cl)cc5c4)c3)c2c1	InChI=1S/C22H16Cl2N6O/c23-17-3-4-29-13-27-20(21(29)7-17)10-26-22(31)16-8-28-30(12-16)11-14-1-2-19-15(5-14)6-18(24)9-25-19/h1-9,12-13H,10-11H2,(H,26,31)	YGHYRKGNWWNBNH-UHFFFAOYSA-N	454840	US10730874, Compound I-1::US11352356, Compound I-1	Plasma kallikrein					 55					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=454840	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=454840&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487760	440970693							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176015	Clc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5cc(ccc5n4)C4CC4)c3)c2c1	InChI=1S/C23H20ClN7O/c24-18-5-6-29-14-26-20(21(29)7-18)9-25-23(32)17-8-27-31(11-17)13-19-12-30-10-16(15-1-2-15)3-4-22(30)28-19/h3-8,10-12,14-15H,1-2,9,13H2,(H,25,32)	JKVSCXTZILFUPG-UHFFFAOYSA-N	454849	US10730874, Compound I-147::US10730874, Compound I-2::US10730874, Compound I-90::US11352356, Compound I-90	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=454849	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=454849&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488035	440970702							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176016	Clc1ccn2cnc(CNC(=O)c3ccnc(Cc4ccc5ncc(Cl)cc5c4)c3)c2c1	InChI=1S/C24H17Cl2N5O/c25-18-4-6-31-14-30-22(23(31)11-18)13-29-24(32)16-3-5-27-20(10-16)8-15-1-2-21-17(7-15)9-19(26)12-28-21/h1-7,9-12,14H,8,13H2,(H,29,32)	XLKFBGCZLDPHJM-UHFFFAOYSA-N	454918	US10730874, Compound I-3::US10730874, Compound TABLE II.5::US11352356, Table II.5	Plasma kallikrein					 55					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=454918	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=454918&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665434	440970771							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176017	Cc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5cc(ccc5n4)C4CC4)c3)c2c1	InChI=1S/C24H23N7O/c1-16-6-7-29-15-26-21(22(29)8-16)10-25-24(32)19-9-27-31(12-19)14-20-13-30-11-18(17-2-3-17)4-5-23(30)28-20/h4-9,11-13,15,17H,2-3,10,14H2,1H3,(H,25,32)	HNSDVTIBNOEEFK-UHFFFAOYSA-N	454941	US10730874, Compound I-4::US11352356, Compound I-4	Plasma kallikrein					 5.5					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=454941	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=454941&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487581	440970794							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176018	Brc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5cc(ccc5n4)C4CC4)c3)c2c1	InChI=1S/C23H20BrN7O/c24-18-5-6-29-14-26-20(21(29)7-18)9-25-23(32)17-8-27-31(11-17)13-19-12-30-10-16(15-1-2-15)3-4-22(30)28-19/h3-8,10-12,14-15H,1-2,9,13H2,(H,25,32)	ZEWKVFDLIOUNBA-UHFFFAOYSA-N	454966	US10730874, Compound I-5::US11352356, Compound I-5	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=454966	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=454966&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488150	440970816							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176019	Clc1ccn2cnc(CNC(=O)c3cnn(Cc4nc5ccc(cn5n4)C4CC4)c3)c2c1	InChI=1S/C22H19ClN8O/c23-17-5-6-29-13-25-18(19(29)7-17)9-24-22(32)16-8-26-30(10-16)12-20-27-21-4-3-15(14-1-2-14)11-31(21)28-20/h3-8,10-11,13-14H,1-2,9,12H2,(H,24,32)	VEPIXWXYKKGKCW-UHFFFAOYSA-N	557344	US11352356, Compound I-6	Plasma kallikrein					 5.5					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557344	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557344&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487860	471698053							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176020	Cc1c(Cl)ccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)cn12	InChI=1S/C21H17Cl2N7O/c1-13-17(23)2-3-20-27-16(11-30(13)20)10-29-9-14(7-26-29)21(31)24-8-18-19-6-15(22)4-5-28(19)12-25-18/h2-7,9,11-12H,8,10H2,1H3,(H,24,31)	OVKNWFRJGTWLTL-UHFFFAOYSA-N	454983	US10730874, Compound I-7::US11352356, Compound I-7	Plasma kallikrein					 5.5					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=454983	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=454983&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488222	440970832							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176021	CC(C)c1ccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)cn2c1	InChI=1S/C23H22ClN7O/c1-15(2)16-3-4-22-28-19(12-30(22)10-16)13-31-11-17(8-27-31)23(32)25-9-20-21-7-18(24)5-6-29(21)14-26-20/h3-8,10-12,14-15H,9,13H2,1-2H3,(H,25,32)	ZMTCXNYHBDKYAR-UHFFFAOYSA-N	454984	US10730874, Compound I-8::US11352356, Compound I-8	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=454984	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=454984&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488249	440970833							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176022	Cc1cccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)cn12	InChI=1S/C21H18ClN7O/c1-14-3-2-4-20-26-17(12-29(14)20)11-28-10-15(8-25-28)21(30)23-9-18-19-7-16(22)5-6-27(19)13-24-18/h2-8,10,12-13H,9,11H2,1H3,(H,23,30)	OYBHCKSHQPCSPX-UHFFFAOYSA-N	454985	US10730874, Compound I-9::US11352356, Compound I-9	Plasma kallikrein					 55					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=454985	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=454985&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488146	440970834							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176023	CC1(CC1)c1ccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)cn2c1	InChI=1S/C24H22ClN7O/c1-24(5-6-24)17-2-3-22-29-19(13-31(22)12-17)14-32-11-16(9-28-32)23(33)26-10-20-21-8-18(25)4-7-30(21)15-27-20/h2-4,7-9,11-13,15H,5-6,10,14H2,1H3,(H,26,33)	DFLQTEKKEFGFLD-UHFFFAOYSA-N	454986	US10730874, Compound I-10::US11352356, Compound I-10	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=454986	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=454986&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487939	440970835							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176024	Clc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5ccc(Cl)nc5n4)c3)c2c1	InChI=1S/C19H14Cl2N8O/c20-13-1-3-28-11-23-15(16(28)5-13)7-22-18(30)12-6-24-29(8-12)10-14-9-27-4-2-17(21)26-19(27)25-14/h1-6,8-9,11H,7,10H2,(H,22,30)	ZRSGONLLHRTVBL-UHFFFAOYSA-N	557349	US11352356, Compound I-11	Plasma kallikrein					 5.5					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557349	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557349&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155180226	471698058							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176025	COc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5ccc(cc5n4)C4CC4)c3)c2c1	InChI=1S/C24H23N7O2/c1-33-20-5-7-30-15-26-21(22(30)9-20)11-25-24(32)18-10-27-31(12-18)14-19-13-29-6-4-17(16-2-3-16)8-23(29)28-19/h4-10,12-13,15-16H,2-3,11,14H2,1H3,(H,25,32)	HUZVYWLUSMBIEW-UHFFFAOYSA-N	557350	US11352356, Compound I-12	Plasma kallikrein					 55					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557350	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557350&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139499132	471698059							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176026	Cc1c(ccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)cn12)C1CC1	InChI=1S/C24H22ClN7O/c1-15-20(16-2-3-16)4-5-23-29-19(13-32(15)23)12-31-11-17(9-28-31)24(33)26-10-21-22-8-18(25)6-7-30(22)14-27-21/h4-9,11,13-14,16H,2-3,10,12H2,1H3,(H,26,33)	FNFAWTYTWKPAIM-UHFFFAOYSA-N	454989	US10730874, Compound I-13::US11352356, Compound I-13	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=454989	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=454989&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487289	440970838							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176027	Cc1c(ccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Br)cc34)cn12)C1CC1	InChI=1S/C24H22BrN7O/c1-15-20(16-2-3-16)4-5-23-29-19(13-32(15)23)12-31-11-17(9-28-31)24(33)26-10-21-22-8-18(25)6-7-30(22)14-27-21/h4-9,11,13-14,16H,2-3,10,12H2,1H3,(H,26,33)	AYZDCCSRKYCBED-UHFFFAOYSA-N	454990	US10730874, Compound I-14::US11352356, Compound I-14	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=454990	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=454990&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487307	440970839							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176028	Clc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5nc(ccc5n4)C4CC4)c3)c2c1	InChI=1S/C22H19ClN8O/c23-16-5-6-29-13-25-19(20(29)7-16)9-24-22(32)15-8-26-30(10-15)11-17-12-31-21(27-17)4-3-18(28-31)14-1-2-14/h3-8,10,12-14H,1-2,9,11H2,(H,24,32)	ODQXINWZNJUUAM-UHFFFAOYSA-N	454991	US10730874, Compound I-15::US11352356, Compound I-15	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=454991	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=454991&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488083	440970840							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176029	Cc1cc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)cn2cc1C1CC1	InChI=1S/C24H22ClN7O/c1-15-6-23-29-19(11-31(23)13-20(15)16-2-3-16)12-32-10-17(8-28-32)24(33)26-9-21-22-7-18(25)4-5-30(22)14-27-21/h4-8,10-11,13-14,16H,2-3,9,12H2,1H3,(H,26,33)	BBISFGDBAJOETE-UHFFFAOYSA-N	454992	US10730874, Compound I-16::US11352356, Compound I-16	Plasma kallikrein					 5.5					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=454992	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=454992&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487602	440970841							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176030	Cc1cc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Br)cc34)cn2cc1C1CC1	InChI=1S/C24H22BrN7O/c1-15-6-23-29-19(11-31(23)13-20(15)16-2-3-16)12-32-10-17(8-28-32)24(33)26-9-21-22-7-18(25)4-5-30(22)14-27-21/h4-8,10-11,13-14,16H,2-3,9,12H2,1H3,(H,26,33)	IPYAFLZZLOACBG-UHFFFAOYSA-N	454993	US10730874, Compound I-17::US11352356, Compound I-17	Plasma kallikrein					 5.5					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=454993	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=454993&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487685	440970842							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176031	FC(F)(F)c1ccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)cn2c1	InChI=1S/C21H15ClF3N7O/c22-15-3-4-30-12-27-17(18(30)5-15)7-26-20(33)13-6-28-32(8-13)11-16-10-31-9-14(21(23,24)25)1-2-19(31)29-16/h1-6,8-10,12H,7,11H2,(H,26,33)	PKNOZGCFVCKNLS-UHFFFAOYSA-N	454994	US10730874, Compound I-18::US11352356, Compound I-18	Plasma kallikrein					 5.5					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=454994	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=454994&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488258	440970843							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176032	FC(F)(F)c1ccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Br)cc34)cn2c1	InChI=1S/C21H15BrF3N7O/c22-15-3-4-30-12-27-17(18(30)5-15)7-26-20(33)13-6-28-32(8-13)11-16-10-31-9-14(21(23,24)25)1-2-19(31)29-16/h1-6,8-10,12H,7,11H2,(H,26,33)	JVZOYIDCIORJAQ-UHFFFAOYSA-N	454995	US10730874, Compound I-19::US11352356, Compound I-19	Plasma kallikrein					 5.5					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=454995	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=454995&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487786	440970844							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176033	Fc1cc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Br)cc34)cn2cc1C1CC1	InChI=1S/C23H19BrFN7O/c24-16-3-4-30-13-27-20(21(30)5-16)8-26-23(33)15-7-28-32(9-15)11-17-10-31-12-18(14-1-2-14)19(25)6-22(31)29-17/h3-7,9-10,12-14H,1-2,8,11H2,(H,26,33)	VCUYOJBHLIHSGT-UHFFFAOYSA-N	454996	US10730874, Compound I-20::US11352356, Compound I-20	Plasma kallikrein					 5.5					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=454996	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=454996&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488070	440970845							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176034	FC1=CC2NC(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)CN2C=C1C1CC1	InChI=1S/C23H23ClFN7O/c24-16-3-4-30-13-27-20(21(30)5-16)8-26-23(33)15-7-28-32(9-15)11-17-10-31-12-18(14-1-2-14)19(25)6-22(31)29-17/h3-7,9,12-14,17,22,29H,1-2,8,10-11H2,(H,26,33)	KIPUVDFHKKQJSM-UHFFFAOYSA-N	557359	US11352356, Compound I-21	Plasma kallikrein					 5.5					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557359	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557359&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155180248	471698068							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176035	Clc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5c(cccc5n4)C4CC4)c3)c2c1	InChI=1S/C23H20ClN7O/c24-17-6-7-29-14-26-19(21(29)8-17)10-25-23(32)16-9-27-30(11-16)12-18-13-31-20(15-4-5-15)2-1-3-22(31)28-18/h1-3,6-9,11,13-15H,4-5,10,12H2,(H,25,32)	LFLIKARDRACBNG-UHFFFAOYSA-N	454998	US10730874, Compound I-22::US11352356, Compound I-22	Plasma kallikrein					 1050					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=454998	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=454998&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487693	440970847							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176036	Clc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5c(Cl)c(ccc5n4)C4CC4)c3)c2c1	InChI=1S/C23H19Cl2N7O/c24-16-5-6-30-13-27-19(20(30)7-16)9-26-23(33)15-8-28-31(10-15)11-17-12-32-21(29-17)4-3-18(22(32)25)14-1-2-14/h3-8,10,12-14H,1-2,9,11H2,(H,26,33)	YDIWPUMFVBGXGH-UHFFFAOYSA-N	454999	US10730874, Compound I-23::US11352356, Compound I-23	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=454999	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=454999&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487827	440970848							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176037	Clc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5cc(C6CC6)c(Cl)cc5n4)c3)c2c1	InChI=1S/C23H19Cl2N7O/c24-16-3-4-30-13-27-20(21(30)5-16)8-26-23(33)15-7-28-32(9-15)11-17-10-31-12-18(14-1-2-14)19(25)6-22(31)29-17/h3-7,9-10,12-14H,1-2,8,11H2,(H,26,33)	AEZJESJNGNUNDT-UHFFFAOYSA-N	455000	US10730874, Compound I-24::US11352356, Compound I-24	Plasma kallikrein					 5.5					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455000	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455000&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487875	440970849							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176038	Clc1cc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Br)cc34)cn2cc1C1CC1	InChI=1S/C23H19BrClN7O/c24-16-3-4-30-13-27-20(21(30)5-16)8-26-23(33)15-7-28-32(9-15)11-17-10-31-12-18(14-1-2-14)19(25)6-22(31)29-17/h3-7,9-10,12-14H,1-2,8,11H2,(H,26,33)	BQNJPCRXWFWFFQ-UHFFFAOYSA-N	455001	US10730874, Compound I-25::US11352356, Compound I-25	Plasma kallikrein					 5.5					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455001	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455001&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487393	440970850							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176039	Cc1ccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Br)cc34)cn2c1C	InChI=1S/C22H20BrN7O/c1-14-3-4-21-27-18(12-30(21)15(14)2)11-29-10-16(8-26-29)22(31)24-9-19-20-7-17(23)5-6-28(20)13-25-19/h3-8,10,12-13H,9,11H2,1-2H3,(H,24,31)	MGRDBYAJBXASLN-UHFFFAOYSA-N	455002	US10730874, Compound I-26::US11352356, Compound I-26	Plasma kallikrein					 5.5					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455002	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455002&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487504	440970851							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176040	Clc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5c(Br)cccc5n4)c3)c2c1	InChI=1S/C20H15BrClN7O/c21-18-2-1-3-19-26-15(11-29(18)19)10-28-9-13(7-25-28)20(30)23-8-16-17-6-14(22)4-5-27(17)12-24-16/h1-7,9,11-12H,8,10H2,(H,23,30)	OSQSMINIULXMEH-UHFFFAOYSA-N	455003	US10730874, Compound I-27::US11352356, Compound I-27	Plasma kallikrein					 5.5					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455003	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455003&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487803	440970852							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176041	Cc1cc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)cn2cc1Br	InChI=1S/C21H17BrClN7O/c1-13-4-20-27-16(9-29(20)11-17(13)22)10-30-8-14(6-26-30)21(31)24-7-18-19-5-15(23)2-3-28(19)12-25-18/h2-6,8-9,11-12H,7,10H2,1H3,(H,24,31)	KLHWAUVVXAOLFR-UHFFFAOYSA-N	455004	BDBM557366::US10730874, Compound I-28	Plasma kallikrein					 5.5					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455004	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455004&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487751	440970853							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176042	Clc1ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(ccc5n4)C4CC4)c4cccnc34)c2c1	InChI=1S/C27H22ClN7O/c28-19-7-9-33-16-31-22(24(33)10-19)11-30-27(36)21-15-34(23-2-1-8-29-26(21)23)13-20-14-35-12-18(17-3-4-17)5-6-25(35)32-20/h1-2,5-10,12,14-17H,3-4,11,13H2,(H,30,36)	KFUIEEVEXJQKAG-UHFFFAOYSA-N	455005	US10730874, Compound I-29::US11352356, Compound I-29	Plasma kallikrein					 55					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455005	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455005&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487433	440970854							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176043	Brc1ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(ccc5n4)C4CC4)c4cccnc34)c2c1	InChI=1S/C27H22BrN7O/c28-19-7-9-33-16-31-22(24(33)10-19)11-30-27(36)21-15-34(23-2-1-8-29-26(21)23)13-20-14-35-12-18(17-3-4-17)5-6-25(35)32-20/h1-2,5-10,12,14-17H,3-4,11,13H2,(H,30,36)	ZDVFFTJYLKRXRU-UHFFFAOYSA-N	455006	US10730874, Compound I-30::US11352356, Compound I-30	Plasma kallikrein					 5.5					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455006	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455006&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487916	440970855							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176044	COCc1nn(Cc2cn3cc(ccc3n2)C2CC2)cc1C(=O)NCc1ncn2ccc(Cl)cc12	InChI=1S/C25H24ClN7O2/c1-35-14-22-20(25(34)27-9-21-23-8-18(26)6-7-31(23)15-28-21)13-33(30-22)12-19-11-32-10-17(16-2-3-16)4-5-24(32)29-19/h4-8,10-11,13,15-16H,2-3,9,12,14H2,1H3,(H,27,34)	WNOWDWICFGNCLL-UHFFFAOYSA-N	455007	US10730874, Compound I-31::US10730874, Compound I-61::US11352356, Compound I-31	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455007	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455007&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488337	440970856							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176045	COCc1c(cnn1Cc1cn2cc(ccc2n1)C1CC1)C(=O)NCc1ncn2ccc(Cl)cc12	InChI=1S/C25H24ClN7O2/c1-35-14-23-20(25(34)27-10-21-22-8-18(26)6-7-31(22)15-28-21)9-29-33(23)13-19-12-32-11-17(16-2-3-16)4-5-24(32)30-19/h4-9,11-12,15-16H,2-3,10,13-14H2,1H3,(H,27,34)	JPBUEVOVRBEMTD-UHFFFAOYSA-N	455008	US10730874, Compound I-32::US11352356, Compound I-32	Plasma kallikrein					 55					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455008	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455008&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488264	440970857							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176046	Cc1ccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)c(Cl)c34)cn2c1	InChI=1S/C21H17Cl2N7O/c1-13-2-3-18-27-15(10-29(18)8-13)11-30-9-14(6-26-30)21(31)24-7-17-20-19(23)16(22)4-5-28(20)12-25-17/h2-6,8-10,12H,7,11H2,1H3,(H,24,31)	SLJAHBLTOHFKQU-UHFFFAOYSA-N	455009	US10730874, Compound I-33::US11352356, Compound I-33	Plasma kallikrein					 55					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455009	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455009&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487580	440970858							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176047	CCc1c(Cl)ccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)cn12	InChI=1S/C22H19Cl2N7O/c1-2-19-17(24)3-4-21-28-16(12-31(19)21)11-30-10-14(8-27-30)22(32)25-9-18-20-7-15(23)5-6-29(20)13-26-18/h3-8,10,12-13H,2,9,11H2,1H3,(H,25,32)	WAIAUTRIETUDII-UHFFFAOYSA-N	455010	US10730874, Compound I-34::US11352356, Compound I-34	Plasma kallikrein					 55					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455010	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455010&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488106	440970859							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176048	Cc1ccc2nc(CC3N=CC(=N3)C(=O)NCc3ncn4ccc(Cl)c(C)c34)cn2c1	InChI=1S/C22H20ClN7O/c1-13-3-4-20-27-15(11-30(20)10-13)7-19-24-9-18(28-19)22(31)25-8-17-21-14(2)16(23)5-6-29(21)12-26-17/h3-6,9-12,19H,7-8H2,1-2H3,(H,25,31)	BIZQVUWRKOCFQM-UHFFFAOYSA-N	557373	US11352356, Compound I-35	Plasma kallikrein					 1050					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557373	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557373&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155180094	471698082							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176049	ClC1=CC2N=C(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)C=[N]2C=C1Br	InChI=1S/C20H15BrCl2N7O/c21-15-10-29-8-14(27-19(29)4-16(15)23)9-30-7-12(5-26-30)20(31)24-6-17-18-3-13(22)1-2-28(18)11-25-17/h1-5,7-8,10-11,19H,6,9H2,(H,24,31)	NJFUUYRNJYFZPB-UHFFFAOYSA-N	557374	US11352356, Compound I-36	Plasma kallikrein					 55					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557374	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557374&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			165112486	471698083							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176050	ClC1=CC2N=C(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Br)cc34)C=[N]2C=C1Br	InChI=1S/C20H15Br2ClN7O/c21-13-1-2-28-11-25-17(18(28)3-13)6-24-20(31)12-5-26-30(7-12)9-14-8-29-10-15(22)16(23)4-19(29)27-14/h1-5,7-8,10-11,19H,6,9H2,(H,24,31)	UNQOWFPVCXVTRK-UHFFFAOYSA-N	557375	US11352356, Compound I-37	Plasma kallikrein					 55					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557375	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557375&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			165112487	471698084							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176051	Clc1ccn2cnc(CNC(=O)c3cnc(Cc4cn5cc(ccc5n4)C4CC4)s3)c2c1	InChI=1S/C23H19ClN6OS/c24-16-5-6-29-13-27-18(19(29)7-16)9-26-23(31)20-10-25-22(32-20)8-17-12-30-11-15(14-1-2-14)3-4-21(30)28-17/h3-7,10-14H,1-2,8-9H2,(H,26,31)	VTKXCXJDWRUNQV-UHFFFAOYSA-N	455014	US10730874, Compound I-38::US11352356, Compound I-38	Plasma kallikrein					 5.5					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455014	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455014&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487746	440970863							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176052	Clc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5c(Cl)c(Br)ccc5n4)c3)c2c1	InChI=1S/C20H14BrCl2N7O/c21-15-1-2-18-27-14(10-30(18)19(15)23)9-29-8-12(6-26-29)20(31)24-7-16-17-5-13(22)3-4-28(17)11-25-16/h1-6,8,10-11H,7,9H2,(H,24,31)	HBCOBHHFOHXVIF-UHFFFAOYSA-N	455015	US10730874, Compound I-39::US11352356, Compound I-39	Plasma kallikrein					 5.5					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455015	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455015&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487436	440970864							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176053	Clc1c(Br)ccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Br)cc34)cn12	InChI=1S/C20H14Br2ClN7O/c21-13-3-4-28-11-25-16(17(28)5-13)7-24-20(31)12-6-26-29(8-12)9-14-10-30-18(27-14)2-1-15(22)19(30)23/h1-6,8,10-11H,7,9H2,(H,24,31)	CSEMVCMVMSEKBC-UHFFFAOYSA-N	455016	US10730874, Compound I-40::US11352356, Compound I-40	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455016	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455016&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487481	440970865							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176054	CC1(C)CC1c1ccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)cn2c1	InChI=1S/C25H24ClN7O/c1-25(2)8-20(25)16-3-4-23-30-19(13-32(23)11-16)14-33-12-17(9-29-33)24(34)27-10-21-22-7-18(26)5-6-31(22)15-28-21/h3-7,9,11-13,15,20H,8,10,14H2,1-2H3,(H,27,34)	VUTOHOZEZIUGTI-UHFFFAOYSA-N	557379	US11352356, Compound I-41	Plasma kallikrein					 55					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557379	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557379&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155180304	471698088							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176055	CC(C)=Cc1ccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)cn2c1	InChI=1S/C24H22ClN7O/c1-16(2)7-17-3-4-23-29-20(13-31(23)11-17)14-32-12-18(9-28-32)24(33)26-10-21-22-8-19(25)5-6-30(22)15-27-21/h3-9,11-13,15H,10,14H2,1-2H3,(H,26,33)	SPMJGTPLUGKSDL-UHFFFAOYSA-N	557380	US11352356, Compound I-42	Plasma kallikrein					 55					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557380	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557380&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155180249	471698089							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176056	CC1CC1c1ccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)cn2c1	InChI=1S/C24H22ClN7O/c1-15-6-20(15)16-2-3-23-29-19(12-31(23)10-16)13-32-11-17(8-28-32)24(33)26-9-21-22-7-18(25)4-5-30(22)14-27-21/h2-5,7-8,10-12,14-15,20H,6,9,13H2,1H3,(H,26,33)	SSFMFCKDKLUQPB-UHFFFAOYSA-N	455019	US10730874, Compound I-43::US11352356, Compound I-43	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455019	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455019&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488122	440970868							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176057	CC1CC1c1ccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Br)cc34)cn2c1	InChI=1S/C24H22BrN7O/c1-15-6-20(15)16-2-3-23-29-19(12-31(23)10-16)13-32-11-17(8-28-32)24(33)26-9-21-22-7-18(25)4-5-30(22)14-27-21/h2-5,7-8,10-12,14-15,20H,6,9,13H2,1H3,(H,26,33)	PZXFFGGSCVPLCG-UHFFFAOYSA-N	455020	US10730874, Compound I-44::US11352356, Compound I-44	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455020	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455020&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487544	440970869							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176058	Ic1ccn2cnc(CNC(=O)c3cnn(Cc4cn5cc(ccc5n4)C4CC4)c3)c2c1	InChI=1S/C23H20IN7O/c24-18-5-6-29-14-26-20(21(29)7-18)9-25-23(32)17-8-27-31(11-17)13-19-12-30-10-16(15-1-2-15)3-4-22(30)28-19/h3-8,10-12,14-15H,1-2,9,13H2,(H,25,32)	AFFAQLVICDHIIB-UHFFFAOYSA-N	455021	US10730874, Compound I-45::US11352356, Compound I-45	Plasma kallikrein					 5.5					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455021	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455021&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488030	440970870							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176059	CCc1cccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)cn12	InChI=1S/C22H20ClN7O/c1-2-18-4-3-5-21-27-17(13-30(18)21)12-29-11-15(9-26-29)22(31)24-10-19-20-8-16(23)6-7-28(20)14-25-19/h3-9,11,13-14H,2,10,12H2,1H3,(H,24,31)	WVZKDRCHHUVVAH-UHFFFAOYSA-N	455022	US10730874, Compound I-46::US11352356, Compound I-46	Plasma kallikrein					 55					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455022	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455022&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487377	440970871							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176060	C\C=C/c1ccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)cn2c1	InChI=1S/C23H20ClN7O/c1-2-3-16-4-5-22-28-19(13-30(22)11-16)14-31-12-17(9-27-31)23(32)25-10-20-21-8-18(24)6-7-29(21)15-26-20/h2-9,11-13,15H,10,14H2,1H3,(H,25,32)/b3-2-	RGVDNNCZAYQWIH-IHWYPQMZSA-N	455023	US10730874, Compound I-47::US11352356, Compound I-47	Plasma kallikrein					 5.5					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455023	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455023&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487666	440970872							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176129	CCOC(=O)C1CC1c1nn(Cc2cn3cc(ccc3n2)C2CC2)cc1C(=O)NCc1ncn2ccc(Cl)cc12	InChI=1S/C29H28ClN7O3/c1-2-40-29(39)22-10-21(22)27-23(28(38)31-11-24-25-9-19(30)7-8-35(25)16-32-24)15-37(34-27)14-20-13-36-12-18(17-3-4-17)5-6-26(36)33-20/h5-9,12-13,15-17,21-22H,2-4,10-11,14H2,1H3,(H,31,38)	CRENUKZUIRVBAJ-UHFFFAOYSA-N	455092	US10730874, Compound I-113::US11352356, Compound I-113	Plasma kallikrein					 5.5					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455092	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455092&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487673	440970928							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176130	Clc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5cc(cc(N6CCCC6=O)c5n4)C4CC4)c3)c2c1	InChI=1S/C27H25ClN8O2/c28-20-5-7-33-16-30-22(23(33)9-20)11-29-27(38)19-10-31-35(13-19)15-21-14-34-12-18(17-3-4-17)8-24(26(34)32-21)36-6-1-2-25(36)37/h5,7-10,12-14,16-17H,1-4,6,11,15H2,(H,29,38)	ABOLQZFVVWNUIM-UHFFFAOYSA-N	455093	US10730874, Compound I-114::US11352356, Compound I-114	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455093	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455093&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487594	440970929							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176131	CCOC(=O)C1(CC1)c1cccn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12	InChI=1S/C26H24ClN7O3/c1-2-37-25(36)26(6-7-26)20-4-3-8-32-14-19(31-23(20)32)15-34-13-17(11-30-34)24(35)28-12-21-22-10-18(27)5-9-33(22)16-29-21/h3-5,8-11,13-14,16H,2,6-7,12,15H2,1H3,(H,28,35)	UPVPQIXEILONOG-UHFFFAOYSA-N	455094	US10730874, Compound I-115::US11352356, Compound I-115	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455094	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455094&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488045	440970930							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176132	OC(=O)C1(CC1)c1cccn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12	InChI=1S/C24H20ClN7O3/c25-16-3-7-31-14-27-19(20(31)8-16)10-26-22(33)15-9-28-32(11-15)13-17-12-30-6-1-2-18(21(30)29-17)24(4-5-24)23(34)35/h1-3,6-9,11-12,14H,4-5,10,13H2,(H,26,33)(H,34,35)	YSANTMLYNUNAJE-UHFFFAOYSA-N	455095	US10730874, Compound I-116::US11352356, Compound I-116	Plasma kallikrein					 5.5					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455095	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455095&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487852	471695244							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176133	OCC1(CC1)c1cccn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12	InChI=1S/C24H22ClN7O2/c25-17-3-7-31-15-27-20(21(31)8-17)10-26-23(34)16-9-28-32(11-16)13-18-12-30-6-1-2-19(22(30)29-18)24(14-33)4-5-24/h1-3,6-9,11-12,15,33H,4-5,10,13-14H2,(H,26,34)	IIPBJBYGAQNUNT-UHFFFAOYSA-N	455096	US10730874, Compound I-117::US11352356, Compound I-117	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455096	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455096&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488273	440970931							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176134	C=Cc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5cc(ccc5n4)C4CC4)c3)c2c1	InChI=1S/C25H23N7O/c1-2-17-7-8-30-16-27-22(23(30)9-17)11-26-25(33)20-10-28-32(13-20)15-21-14-31-12-19(18-3-4-18)5-6-24(31)29-21/h2,5-10,12-14,16,18H,1,3-4,11,15H2,(H,26,33)	ZPDUYVLEXRWNNG-UHFFFAOYSA-N	557289	US10730874, Compound I-118::US11352356, Compound I-118	Plasma kallikrein					 5.5					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557289	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557289&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488215	471698000							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176135	CC(C)(O)CCc1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1	InChI=1S/C28H30ClN7O2/c1-28(2,38)7-5-19-9-20(18-3-4-18)13-35-15-23(33-26(19)35)16-36-14-21(11-32-36)27(37)30-12-24-25-10-22(29)6-8-34(25)17-31-24/h6,8-11,13-15,17-18,38H,3-5,7,12,16H2,1-2H3,(H,30,37)	MZDUQQVDGHZJQU-UHFFFAOYSA-N	455098	US10730874, Compound I-119	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455098	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455098&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487536	471695245							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176136	OC(=O)C1CC1c1nn(Cc2cn3cc(ccc3n2)C2CC2)cc1C(=O)NCc1ncn2ccc(Cl)cc12	InChI=1S/C27H24ClN7O3/c28-17-5-6-33-14-30-22(23(33)7-17)9-29-26(36)21-13-35(32-25(21)19-8-20(19)27(37)38)12-18-11-34-10-16(15-1-2-15)3-4-24(34)31-18/h3-7,10-11,13-15,19-20H,1-2,8-9,12H2,(H,29,36)(H,37,38)	MQLHVRWOMGYXOC-UHFFFAOYSA-N	455099	US10730874, Compound I-120::US11352356, Compound I-120	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455099	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455099&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487395	471695246							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176137	Clc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5cc(ccc5n4)C4CC4)n3)c2c1	InChI=1S/C22H19ClN8O/c23-16-5-6-29-13-25-18(20(29)7-16)8-24-22(32)19-9-26-31(28-19)12-17-11-30-10-15(14-1-2-14)3-4-21(30)27-17/h3-7,9-11,13-14H,1-2,8,12H2,(H,24,32)	PJTQWYMWEYPCFJ-UHFFFAOYSA-N	455100	US10730874, Compound I-121::US11352356, Compound I-121	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455100	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455100&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487900	440970932							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176138	OC1(COC1)c1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4C=C[C](=O)=Cc34)nc12)C1CC1	InChI=1S/C26H24N7O4/c34-20-3-4-31-15-28-22(23(31)6-20)8-27-25(35)18-7-29-33(10-18)12-19-11-32-9-17(16-1-2-16)5-21(24(32)30-19)26(36)13-37-14-26/h3-7,9-11,15-16,36H,1-2,8,12-14H2,(H,27,35)	UVJWSMIDKNLWNX-UHFFFAOYSA-N	557463	US11352356, Compound I-122	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557463	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557463&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			165414234	471698172							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176139	CS\C(=N\Cc1ncn2ccc(Cl)cc12)c1cnn(Cc2cn3cc(ccc3n2)C2CC2)c1	InChI=1S/C24H22ClN7S/c1-33-24(26-10-21-22-8-19(25)6-7-30(22)15-27-21)18-9-28-32(12-18)14-20-13-31-11-17(16-2-3-16)4-5-23(31)29-20/h4-9,11-13,15-16H,2-3,10,14H2,1H3/b26-24+	XUTGQZZLFINHIB-SHHOIMCASA-N	455102	US10730874, Compound I-123::US11352356, Compound I-123	Plasma kallikrein					 5.5					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455102	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455102&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488178	440970934							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176140	CC(c1cn2cc(ccc2n1)C1CC1)n1cc(nn1)C(=O)NCc1ncn2ccc(Cl)cc12	InChI=1S/C23H21ClN8O/c1-14(19-11-31-10-16(15-2-3-15)4-5-22(31)27-19)32-12-20(28-29-32)23(33)25-9-18-21-8-17(24)6-7-30(21)13-26-18/h4-8,10-15H,2-3,9H2,1H3,(H,25,33)	VVCDHCBEQDIFHH-UHFFFAOYSA-N	455103	US10730874, Compound I-124::US11352356, Compound I-124	Plasma kallikrein					 5.5					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455103	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455103&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487279	440970935							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176141	COCCc1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1	InChI=1S/C26H26ClN7O2/c1-36-7-5-18-8-19(17-2-3-17)12-33-14-22(31-25(18)33)15-34-13-20(10-30-34)26(35)28-11-23-24-9-21(27)4-6-32(24)16-29-23/h4,6,8-10,12-14,16-17H,2-3,5,7,11,15H2,1H3,(H,28,35)	GAHFAGJQUIQEMZ-UHFFFAOYSA-N	557466	US11352356, Compound I-125	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557466	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557466&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488012	471698175							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176142	Clc1ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(ccc5n4)C4CC4)nc3Cc3nn[nH]n3)c2c1	InChI=1S/C25H22ClN11O/c26-17-5-6-35-14-28-21(22(35)7-17)9-27-25(38)19-13-37(32-20(19)8-23-30-33-34-31-23)12-18-11-36-10-16(15-1-2-15)3-4-24(36)29-18/h3-7,10-11,13-15H,1-2,8-9,12H2,(H,27,38)(H,30,31,33,34)	HQPCUVCFBWXFME-UHFFFAOYSA-N	455105	US10730874, Compound I-126::US11352356, Compound I-126	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455105	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455105&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488268	440970937							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176143	CCOC(=O)C1CC1c1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1	InChI=1S/C29H28ClN7O3/c1-2-40-29(39)24-9-22(24)23-7-18(17-3-4-17)12-36-14-21(34-27(23)36)15-37-13-19(10-33-37)28(38)31-11-25-26-8-20(30)5-6-35(26)16-32-25/h5-8,10,12-14,16-17,22,24H,2-4,9,11,15H2,1H3,(H,31,38)	SGBSYCROJDVRBR-UHFFFAOYSA-N	557468	US11352356, Compound I-127::US11352356, Compound I-133	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557468	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557468&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487444	471698177							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176144	Clc1ccn2cnc(CNC(=O)c3nnc(Cc4cn5cc(cc(C#N)c5n4)C4CC4)o3)c2c1	InChI=1S/C23H17ClN8O2/c24-16-3-4-31-12-27-18(19(31)6-16)9-26-22(33)23-30-29-20(34-23)7-17-11-32-10-15(13-1-2-13)5-14(8-25)21(32)28-17/h3-6,10-13H,1-2,7,9H2,(H,26,33)	NFNMPYWZKFORJK-UHFFFAOYSA-N	455107	US10730874, Compound I-128::US11352356, Compound I-128	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455107	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455107&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487371	440970939							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176145	Clc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5cc(cnc5n4)C4CC4)c3)c2c1	InChI=1S/C22H19ClN8O/c23-17-3-4-29-13-26-19(20(29)5-17)8-24-21(32)16-7-27-31(10-16)12-18-11-30-9-15(14-1-2-14)6-25-22(30)28-18/h3-7,9-11,13-14H,1-2,8,12H2,(H,24,32)	RQAZEMXQEGTLNC-UHFFFAOYSA-N	455108	US10730874, Compound I-129::US11352356, Compound I-129	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455108	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455108&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487341	440970940							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176146	Cc1ccc2nc(Cn3cc(cn3)C(=O)NCc3cn4ccc(Cl)cc4n3)cn2c1C	InChI=1S/C22H20ClN7O/c1-14-3-4-20-27-19(13-30(20)15(14)2)12-29-10-16(8-25-29)22(31)24-9-18-11-28-6-5-17(23)7-21(28)26-18/h3-8,10-11,13H,9,12H2,1-2H3,(H,24,31)	CVGAULTVFNEYLR-UHFFFAOYSA-N	455109	US10730874, Compound I-130::US11352356, Compound I-130	Plasma kallikrein					 55					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455109	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455109&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487714	440970941							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176147	Fc1c(Br)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(cc(C#N)c5n4)C4CC4)nn3)c12	InChI=1S/C23H17BrFN9O/c24-17-3-4-32-12-28-18(21(32)20(17)25)7-27-23(35)19-11-34(31-30-19)10-16-9-33-8-15(13-1-2-13)5-14(6-26)22(33)29-16/h3-5,8-9,11-13H,1-2,7,10H2,(H,27,35)	KWEZNCIVYXLYPL-UHFFFAOYSA-N	455110	US10730874, Compound I-131::US11352356, Compound I-131	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455110	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455110&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487932	440970942							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176148	Clc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5cc(cc(C6COC6)c5n4)C4CC4)c3)c2c1	InChI=1S/C26H24ClN7O2/c27-20-3-4-32-15-29-23(24(32)6-20)8-28-26(35)18-7-30-34(10-18)12-21-11-33-9-17(16-1-2-16)5-22(25(33)31-21)19-13-36-14-19/h3-7,9-11,15-16,19H,1-2,8,12-14H2,(H,28,35)	ULXDJXXLVBXRPX-UHFFFAOYSA-N	455111	US10730874, Compound I-132::US11352356, Compound I-132	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455111	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455111&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488336	440970943							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176149	CCOC(=O)C1CC1c1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1	InChI=1S/C29H28ClN7O3/c1-2-40-29(39)24-9-22(24)23-7-18(17-3-4-17)12-36-14-21(34-27(23)36)15-37-13-19(10-33-37)28(38)31-11-25-26-8-20(30)5-6-35(26)16-32-25/h5-8,10,12-14,16-17,22,24H,2-4,9,11,15H2,1H3,(H,31,38)	SGBSYCROJDVRBR-UHFFFAOYSA-N	557468	US11352356, Compound I-127::US11352356, Compound I-133	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557468	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557468&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487444	471698177							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176150	Fc1c(Br)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(ccc5n4)C4CC4)nn3)c12	InChI=1S/C22H18BrFN8O/c23-16-5-6-30-12-26-17(21(30)20(16)24)7-25-22(33)18-11-32(29-28-18)10-15-9-31-8-14(13-1-2-13)3-4-19(31)27-15/h3-6,8-9,11-13H,1-2,7,10H2,(H,25,33)	IMMHVHRMZGOHBP-UHFFFAOYSA-N	455113	US10730874, Compound I-134::US11352356, Compound I-134	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455113	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455113&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488464	440970945							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176151	Fc1c(Br)ccn2cnc(CNC(=O)c3nnn(Cc4cn5cc(ccc5n4)C4CC4)n3)c12	InChI=1S/C21H17BrFN9O/c22-15-5-6-30-11-25-16(19(30)18(15)23)7-24-21(33)20-27-29-32(28-20)10-14-9-31-8-13(12-1-2-12)3-4-17(31)26-14/h3-6,8-9,11-12H,1-2,7,10H2,(H,24,33)	MYLRAXFXBPWHIZ-UHFFFAOYSA-N	455114	US10730874, Compound I-135::US11352356, Compound I-135	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455114	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455114&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488016	440970946							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176152	Fc1c(Br)ccn2cnc(CNC(=O)c3nnc(Cc4cn5cc(ccc5n4)C4CC4)o3)c12	InChI=1S/C22H17BrFN7O2/c23-15-5-6-30-11-26-16(20(30)19(15)24)8-25-21(32)22-29-28-18(33-22)7-14-10-31-9-13(12-1-2-12)3-4-17(31)27-14/h3-6,9-12H,1-2,7-8H2,(H,25,32)	HIHHWEAZUQMNPZ-UHFFFAOYSA-N	455115	US10730874, Compound I-136::US11352356, Compound I-136	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455115	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455115&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487750	440970947							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176153	Fc1c(Cl)ccn2cnc(CNC(=O)c3nnc(Cc4cn5cc(ccc5n4)C4CC4)o3)c12	InChI=1S/C22H17ClFN7O2/c23-15-5-6-30-11-26-16(20(30)19(15)24)8-25-21(32)22-29-28-18(33-22)7-14-10-31-9-13(12-1-2-12)3-4-17(31)27-14/h3-6,9-12H,1-2,7-8H2,(H,25,32)	LDCSBVKDBYGMHO-UHFFFAOYSA-N	455116	US10730874, Compound I-137::US11352356, Compound I-137	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455116	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455116&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488401	440970948							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176154	Clc1ccn2cnc(CNC(=O)c3nnc(Cc4cn5nc(ccc5n4)C4CC4)o3)c2c1	InChI=1S/C21H17ClN8O2/c22-13-5-6-29-11-24-16(17(29)7-13)9-23-20(31)21-27-26-19(32-21)8-14-10-30-18(25-14)4-3-15(28-30)12-1-2-12/h3-7,10-12H,1-2,8-9H2,(H,23,31)	KQDOPSGLZSCHJQ-UHFFFAOYSA-N	455117	US10730874, Compound I-138::US11352356, Compound I-138	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455117	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455117&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487756	440970949							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176155	Fc1c(Br)ccn2cnc(CNC(=O)c3cn(Cc4cn5nc(ccc5n4)C4CC4)nn3)c12	InChI=1S/C21H17BrFN9O/c22-14-5-6-30-11-25-16(20(30)19(14)23)7-24-21(33)17-10-31(29-27-17)8-13-9-32-18(26-13)4-3-15(28-32)12-1-2-12/h3-6,9-12H,1-2,7-8H2,(H,24,33)	FADJUVSQXUOJOW-UHFFFAOYSA-N	455118	US10730874, Compound I-139::US11352356, Compound I-139	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455118	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455118&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488383	440970950							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176156	Fc1c(Br)ccn2cnc(CNC(=O)c3nnc(Cc4cn5nc(ccc5n4)C4CC4)o3)c12	InChI=1S/C21H16BrFN8O2/c22-13-5-6-30-10-25-15(19(30)18(13)23)8-24-20(32)21-28-27-17(33-21)7-12-9-31-16(26-12)4-3-14(29-31)11-1-2-11/h3-6,9-11H,1-2,7-8H2,(H,24,32)	UEDVZORRLUQMJQ-UHFFFAOYSA-N	455119	US10730874, Compound I-140::US11352356, Compound I-140	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455119	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455119&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487876	440970951							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176157	OC(C1COC1)c1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1	InChI=1S/C27H26ClN7O3/c28-20-3-4-33-15-30-23(24(33)6-20)8-29-27(37)18-7-31-35(10-18)12-21-11-34-9-17(16-1-2-16)5-22(26(34)32-21)25(36)19-13-38-14-19/h3-7,9-11,15-16,19,25,36H,1-2,8,12-14H2,(H,29,37)	INVRGJIOLDKFHK-UHFFFAOYSA-N	455120	US10730874, Compound I-141::US11352356, Compound I-141	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455120	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455120&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487388	440970952							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176158	COc1c(ccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)cn12)C1CC1	InChI=1S/C24H22ClN7O2/c1-34-24-19(15-2-3-15)4-5-22-29-18(13-32(22)24)12-31-11-16(9-28-31)23(33)26-10-20-21-8-17(25)6-7-30(21)14-27-20/h4-9,11,13-15H,2-3,10,12H2,1H3,(H,26,33)	ZJBAISRMJIQURI-UHFFFAOYSA-N	455121	US10730874, Compound I-142::US11352356, Compound I-142	Plasma kallikrein					 5.5					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455121	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455121&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487339	440970953							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176159	FC(F)(F)c1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1	InChI=1S/C24H19ClF3N7O/c25-17-3-4-33-13-30-20(21(33)6-17)8-29-23(36)16-7-31-35(10-16)12-18-11-34-9-15(14-1-2-14)5-19(22(34)32-18)24(26,27)28/h3-7,9-11,13-14H,1-2,8,12H2,(H,29,36)	YGWRFUXMNZFNMR-UHFFFAOYSA-N	455122	US10730874, Compound I-143::US11352356, Compound I-143	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455122	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455122&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488167	440970954							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176160	Fc1c(ccn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1	InChI=1S/C23H19ClFN7O/c24-16-3-5-31-13-27-19(20(31)7-16)9-26-23(33)15-8-28-32(10-15)12-17-11-30-6-4-18(14-1-2-14)21(25)22(30)29-17/h3-8,10-11,13-14H,1-2,9,12H2,(H,26,33)	SPMBSWXNYXKGBY-UHFFFAOYSA-N	557485	US11352356, Compound I-144	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557485	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557485&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155180117	471698193							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176161	Fc1c(Br)ccn2cnc(CNC(=O)c3cn(Cc4cn5c(F)c(ccc5n4)C4CC4)nn3)c12	InChI=1S/C22H17BrF2N8O/c23-15-5-6-31-11-27-16(20(31)19(15)24)7-26-22(34)17-10-32(30-29-17)8-13-9-33-18(28-13)4-3-14(21(33)25)12-1-2-12/h3-6,9-12H,1-2,7-8H2,(H,26,34)	BJCPVXHRGPSPFS-UHFFFAOYSA-N	455124	US10730874, Compound I-145::US11352356, Compound I-145	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455124	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455124&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487841	440970956							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176162	Fc1c(Cl)ccn2cnc(CNC(=O)c3cnn(Cc4cn5nc(ccc5n4)C4CC4)c3)c12	InChI=1S/C22H18ClFN8O/c23-16-5-6-30-12-26-18(21(30)20(16)24)8-25-22(33)14-7-27-31(9-14)10-15-11-32-19(28-15)4-3-17(29-32)13-1-2-13/h3-7,9,11-13H,1-2,8,10H2,(H,25,33)	PKRWDYJZGDTDDC-UHFFFAOYSA-N	455125	US10730874, Compound I-146::US10730874, Compound I-151::US11352356, Compound I-146	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455125	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455125&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488058	440970957							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176163	Fc1c(Cl)ccn2cnc(CNC(=O)c3cnn(Cc4cn5cc(ccc5n4)C4CC4)c3)c12	InChI=1S/C23H19ClFN7O/c24-18-5-6-30-13-27-19(22(30)21(18)25)8-26-23(33)16-7-28-32(10-16)12-17-11-31-9-15(14-1-2-14)3-4-20(31)29-17/h3-7,9-11,13-14H,1-2,8,12H2,(H,26,33)	KCPCDCPUDWFBKJ-UHFFFAOYSA-N	557488	US11352356, Compound I-147	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557488	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557488&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488318	471698196							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176164	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5ccc(cc5n4)C4CC4)nn3)c12	InChI=1S/C22H18ClFN8O/c23-16-4-6-31-12-26-17(21(31)20(16)24)8-25-22(33)18-11-32(29-28-18)10-15-9-30-5-3-14(13-1-2-13)7-19(30)27-15/h3-7,9,11-13H,1-2,8,10H2,(H,25,33)	DDGRQLLUWRVEGP-UHFFFAOYSA-N	455200	US10730874, Compound I-217::US11352356, Compound I-148	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455200	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455200&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155180310	440971025							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176165	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(cc(C#N)c5n4)C4CC4)nn3)c12	InChI=1S/C23H17ClFN9O/c24-17-3-4-32-12-28-18(21(32)20(17)25)7-27-23(35)19-11-34(31-30-19)10-16-9-33-8-15(13-1-2-13)5-14(6-26)22(33)29-16/h3-5,8-9,11-13H,1-2,7,10H2,(H,27,35)	OZICYLIAIOPJLY-UHFFFAOYSA-N	455128	US10730874, Compound I-149::US11352356, Compound I-149	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455128	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455128&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488170	440970959							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176166	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5nc(ccc5n4)C4CC4)nn3)c12	InChI=1S/C21H17ClFN9O/c22-14-5-6-30-11-25-16(20(30)19(14)23)7-24-21(33)17-10-31(29-27-17)8-13-9-32-18(26-13)4-3-15(28-32)12-1-2-12/h3-6,9-12H,1-2,7-8H2,(H,24,33)	YEAZYWXIMOWHKZ-UHFFFAOYSA-N	455129	US10730874, Compound I-150::US11352356, Compound I-150	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455129	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455129&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488128	440970960							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176167	Fc1cn2cnc(CNC(=O)c3cnn(Cc4cn5cc(ccc5n4)C4CC4)c3)c2cc1Br	InChI=1S/C23H19BrFN7O/c24-18-5-21-20(27-13-31(21)12-19(18)25)7-26-23(33)16-6-28-32(9-16)11-17-10-30-8-15(14-1-2-14)3-4-22(30)29-17/h3-6,8-10,12-14H,1-2,7,11H2,(H,26,33)	ZOWYDVQPULYRSX-UHFFFAOYSA-N	557492	US11352356, Compound I-151	Plasma kallikrein					 55					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557492	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557492&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487755	471698200							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176168	Clc1ccn2cnc(CNC(=O)c3ncn(Cc4cn5cc(ccc5n4)C4CC4)n3)c2c1	InChI=1S/C22H19ClN8O/c23-16-5-6-29-12-25-18(19(29)7-16)8-24-22(32)21-26-13-31(28-21)11-17-10-30-9-15(14-1-2-14)3-4-20(30)27-17/h3-7,9-10,12-14H,1-2,8,11H2,(H,24,32)	QYOXNOFJBYTKSQ-UHFFFAOYSA-N	455131	US10730874, Compound I-152::US11352356, Compound I-152	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455131	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455131&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488494	440970961							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176169	OC1(COC1)c1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1	InChI=1S/C25H23ClN8O3/c26-17-3-4-32-14-28-20(22(32)6-17)7-27-24(35)21-11-34(31-30-21)10-18-9-33-8-16(15-1-2-15)5-19(23(33)29-18)25(36)12-37-13-25/h3-6,8-9,11,14-15,36H,1-2,7,10,12-13H2,(H,27,35)	UNWNQIIDASIOIA-UHFFFAOYSA-N	455132	US10730874, Compound I-153::US11352356, Compound I-153	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455132	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455132&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487323	440970962							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176170	Fc1c(Br)ccn2cnc(CNC(=O)c3nnc(Cc4cn5cc(cc(C#N)c5n4)C4CC4)o3)c12	InChI=1S/C23H16BrFN8O2/c24-16-3-4-32-11-28-17(20(32)19(16)25)8-27-22(34)23-31-30-18(35-23)6-15-10-33-9-14(12-1-2-12)5-13(7-26)21(33)29-15/h3-5,9-12H,1-2,6,8H2,(H,27,34)	BOEXVDRNOHZYSF-UHFFFAOYSA-N	455133	US10730874, Compound I-154::US11352356, Compound I-154	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455133	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455133&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487553	440970963							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176171	Clc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5cc(cc(Cc6nnco6)c5n4)C4CC4)c3)c2c1	InChI=1S/C26H22ClN9O2/c27-20-3-4-34-14-29-22(23(34)7-20)9-28-26(37)19-8-31-36(11-19)13-21-12-35-10-18(16-1-2-16)5-17(25(35)32-21)6-24-33-30-15-38-24/h3-5,7-8,10-12,14-16H,1-2,6,9,13H2,(H,28,37)	DOPVMALAZOIAFN-UHFFFAOYSA-N	557496	US11352356, Compound I-155	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557496	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557496&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487356	471698204							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176172	Fc1c(Cl)ccn2cnc(CNC(=O)c3nnc(Cc4cn5nc(ccc5n4)C4CC4)o3)c12	InChI=1S/C21H16ClFN8O2/c22-13-5-6-30-10-25-15(19(30)18(13)23)8-24-20(32)21-28-27-17(33-21)7-12-9-31-16(26-12)4-3-14(29-31)11-1-2-11/h3-6,9-11H,1-2,7-8H2,(H,24,32)	YEYKHGAVIMFEBR-UHFFFAOYSA-N	455135	US10730874, Compound I-156::US11352356, Compound I-156	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455135	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455135&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487757	440970965							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176173	ClCc1cc(cn2cc(Cn3cc(nn3)C(=O)OCc3ccccc3)nc12)C1CC1	InChI=1S/C22H20ClN5O2/c23-9-17-8-18(16-6-7-16)10-27-11-19(24-21(17)27)12-28-13-20(25-26-28)22(29)30-14-15-4-2-1-3-5-15/h1-5,8,10-11,13,16H,6-7,9,12,14H2	MEIRZWHLSJXTIT-UHFFFAOYSA-N	455136	US10730874, Compound I-157a::US11352356, Compound I-157a	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455136	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455136&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488062	440970966							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176174	OC(=O)Cc1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C24H20ClFN8O3/c25-17-3-4-32-12-28-18(22(32)21(17)26)7-27-24(37)19-11-34(31-30-19)10-16-9-33-8-15(13-1-2-13)5-14(6-20(35)36)23(33)29-16/h3-5,8-9,11-13H,1-2,6-7,10H2,(H,27,37)(H,35,36)	HILAHFBQKJFGOS-UHFFFAOYSA-N	455137	US10730874, Compound I-157b::US11352356, Compound I-157b	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455137	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455137&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487706	471695247							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176175	Fc1c(Cl)ccn2cnc(CNC(=O)c3nnc(Cc4cn5cc(cc(C#N)c5n4)C4CC4)o3)c12	InChI=1S/C23H16ClFN8O2/c24-16-3-4-32-11-28-17(20(32)19(16)25)8-27-22(34)23-31-30-18(35-23)6-15-10-33-9-14(12-1-2-12)5-13(7-26)21(33)29-15/h3-5,9-12H,1-2,6,8H2,(H,27,34)	SKZNVADWTQUTDR-UHFFFAOYSA-N	455138	US10730874, Compound I-158::US11352356, Compound I-158	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455138	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455138&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487744	440970967							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176176	CS(=O)(=O)c1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1	InChI=1S/C24H22ClN7O3S/c1-36(34,35)22-6-16(15-2-3-15)10-31-12-19(29-23(22)31)13-32-11-17(8-28-32)24(33)26-9-20-21-7-18(25)4-5-30(21)14-27-20/h4-8,10-12,14-15H,2-3,9,13H2,1H3,(H,26,33)	JXYCVCMSYBYHLY-UHFFFAOYSA-N	455139	US10730874, Compound I-159::US11352356, Compound I-159	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455139	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455139&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487552	440970968							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176061	O=C(CCc1ncn2ccc(cc12)C1CC1)c1cnn(Cc2cn3cc(ccc3n2)C2CC2)c1	InChI=1S/C27H26N6O/c34-26(7-6-24-25-11-20(18-1-2-18)9-10-31(25)17-28-24)22-12-29-33(14-22)16-23-15-32-13-21(19-3-4-19)5-8-27(32)30-23/h5,8-15,17-19H,1-4,6-7,16H2	PWTXPIKSEPWVIJ-UHFFFAOYSA-N	557386	US11352356, Compound I-48	Plasma kallikrein					 1050					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557386	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557386&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155180220	471698095							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176062	CC1(C)CC1c1ccn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Br)cc34)nc2c1	InChI=1S/C25H24BrN7O/c1-25(2)9-20(25)16-3-5-31-13-19(30-23(31)7-16)14-33-12-17(10-29-33)24(34)27-11-21-22-8-18(26)4-6-32(22)15-28-21/h3-8,10,12-13,15,20H,9,11,14H2,1-2H3,(H,27,34)	RBCKTNKYUQTAFX-UHFFFAOYSA-N	455025	US10730874, Compound I-49::US11352356, Compound I-49	Plasma kallikrein					 55					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455025	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455025&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487906	440970874							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176063	Clc1ccn2cnc(CNC(=O)c3cnn(Cc4cc5cc(ccn5n4)C4CC4)c3)c2c1	InChI=1S/C23H20ClN7O/c24-18-4-5-29-14-26-21(22(29)8-18)11-25-23(32)17-10-27-30(12-17)13-19-9-20-7-16(15-1-2-15)3-6-31(20)28-19/h3-10,12,14-15H,1-2,11,13H2,(H,25,32)	BJTXEEINKHNXSW-UHFFFAOYSA-N	557388	US11352356, Compound I-50	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557388	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557388&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487348	471698097							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176064	Clc1ccn2cnc(CNC(=O)c3nnc(Cc4cn5cc(ccc5n4)C4CC4)o3)c2c1	InChI=1S/C22H18ClN7O2/c23-15-5-6-29-12-25-17(18(29)7-15)9-24-21(31)22-28-27-20(32-22)8-16-11-30-10-14(13-1-2-13)3-4-19(30)26-16/h3-7,10-13H,1-2,8-9H2,(H,24,31)	UUBXAWITVKUYKN-UHFFFAOYSA-N	455027	US10730874, Compound I-51::US11352356, Compound I-51	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455027	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455027&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487477	440970876							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176065	Brc1ccn2cnc(CNC(=O)c3nnc(Cc4cn5cc(ccc5n4)C4CC4)o3)c2c1	InChI=1S/C22H18BrN7O2/c23-15-5-6-29-12-25-17(18(29)7-15)9-24-21(31)22-28-27-20(32-22)8-16-11-30-10-14(13-1-2-13)3-4-19(30)26-16/h3-7,10-13H,1-2,8-9H2,(H,24,31)	HQNBSHGXUMOTBE-UHFFFAOYSA-N	455028	US10730874, Compound I-52::US11352356, Compound I-52	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455028	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455028&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487943	440970877							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176066	Nc1ccc2c(CNC(=O)c3cnn(Cc4cn5cc(ccc5n4)C4CC4)c3)ncn2c1	InChI=1S/C23H22N8O/c24-18-4-5-21-20(26-14-30(21)11-18)8-25-23(32)17-7-27-31(10-17)13-19-12-29-9-16(15-1-2-15)3-6-22(29)28-19/h3-7,9-12,14-15H,1-2,8,13,24H2,(H,25,32)	ZLVVYLDXDWLPNJ-UHFFFAOYSA-N	455029	US10730874, Compound I-53::US11352356, Compound I-53	Plasma kallikrein					 1050					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455029	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455029&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487384	440970878							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176067	Clc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5c(cccc5n4)C#N)c3)c2c1	InChI=1S/C21H15ClN8O/c22-15-4-5-28-13-25-18(19(28)6-15)9-24-21(31)14-8-26-29(10-14)11-16-12-30-17(7-23)2-1-3-20(30)27-16/h1-6,8,10,12-13H,9,11H2,(H,24,31)	HAVHJCUOSIYYSO-UHFFFAOYSA-N	455030	US10730874, Compound I-54::US11352356, Compound I-54	Plasma kallikrein					 55					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455030	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455030&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487434	440970879							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176068	Brc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5c(cccc5n4)C#N)c3)c2c1	InChI=1S/C21H15BrN8O/c22-15-4-5-28-13-25-18(19(28)6-15)9-24-21(31)14-8-26-29(10-14)11-16-12-30-17(7-23)2-1-3-20(30)27-16/h1-6,8,10,12-13H,9,11H2,(H,24,31)	JGDVODYPRVOMBZ-UHFFFAOYSA-N	455031	US10730874, Compound I-55::US11352356, Compound I-55	Plasma kallikrein					 55					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455031	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455031&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487381	440970880							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176069	Brc1ccn2cnc(CNC(=O)c3cnn(Cc4cc5cc(ccn5n4)C4CC4)c3)c2c1	InChI=1S/C23H20BrN7O/c24-18-4-5-29-14-26-21(22(29)8-18)11-25-23(32)17-10-27-30(12-17)13-19-9-20-7-16(15-1-2-15)3-6-31(20)28-19/h3-10,12,14-15H,1-2,11,13H2,(H,25,32)	XAEZFHDDBVLVMR-UHFFFAOYSA-N	455026	US10730874, Compound I-50::US10730874, Compound I-56::US11352356, Compound I-56	Plasma kallikrein					 5.5					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455026	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455026&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487961	440970875							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176070	Clc1c(ccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Br)cc34)cn12)C1CC1	InChI=1S/C23H19BrClN7O/c24-16-5-6-30-13-27-19(20(30)7-16)9-26-23(33)15-8-28-31(10-15)11-17-12-32-21(29-17)4-3-18(22(32)25)14-1-2-14/h3-8,10,12-14H,1-2,9,11H2,(H,26,33)	RORYYKUCHHMJHO-UHFFFAOYSA-N	455033	US10730874, Compound I-57::US11352356, Compound I-57	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455033	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455033&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487832	440970881							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176071	Cc1ccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4c(N)cc(Cl)cc34)cn2c1	InChI=1S/C21H19ClN8O/c1-13-2-3-20-27-16(10-28(20)8-13)11-29-9-14(6-26-29)21(31)24-7-17-18-4-15(22)5-19(23)30(18)12-25-17/h2-6,8-10,12H,7,11,23H2,1H3,(H,24,31)	CFAMCJKAHDLPQW-UHFFFAOYSA-N	455034	US10730874, Compound I-58::US11352356, Compound I-58	Plasma kallikrein					 5.5					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455034	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455034&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487911	440970882							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176072	Fc1c(ccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)cn12)C1CC1	InChI=1S/C23H19ClFN7O/c24-16-5-6-30-13-27-19(20(30)7-16)9-26-23(33)15-8-28-31(10-15)11-17-12-32-21(29-17)4-3-18(22(32)25)14-1-2-14/h3-8,10,12-14H,1-2,9,11H2,(H,26,33)	VYHJMONPWYDNHA-UHFFFAOYSA-N	455035	US10730874, Compound I-59::US11352356, Compound I-59	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455035	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455035&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487947	440970883							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176073	Fc1c(ccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Br)cc34)cn12)C1CC1	InChI=1S/C23H19BrFN7O/c24-16-5-6-30-13-27-19(20(30)7-16)9-26-23(33)15-8-28-31(10-15)11-17-12-32-21(29-17)4-3-18(22(32)25)14-1-2-14/h3-8,10,12-14H,1-2,9,11H2,(H,26,33)	UNEMLGVRCMGXDB-UHFFFAOYSA-N	455036	US10730874, Compound I-60::US11352356, Compound I-60	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455036	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455036&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488217	440970884							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176074	Clc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5cc(ccc5n4)C4CCC4)c3)c2c1	InChI=1S/C24H22ClN7O/c25-19-6-7-30-15-27-21(22(30)8-19)10-26-24(33)18-9-28-32(12-18)14-20-13-31-11-17(16-2-1-3-16)4-5-23(31)29-20/h4-9,11-13,15-16H,1-3,10,14H2,(H,26,33)	AOXUSDLVEVGIBC-UHFFFAOYSA-N	557399	US11352356, Compound I-61	Plasma kallikrein					 5.5					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557399	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557399&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487378	471698108							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176075	CCOC(=O)c1cccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)cn12	InChI=1S/C23H20ClN7O3/c1-2-34-23(33)19-4-3-5-21-28-17(13-31(19)21)12-30-11-15(9-27-30)22(32)25-10-18-20-8-16(24)6-7-29(20)14-26-18/h3-9,11,13-14H,2,10,12H2,1H3,(H,25,32)	YPSIESLUVAUYGF-UHFFFAOYSA-N	455038	US10730874, Compound I-62::US11352356, Compound I-62	Plasma kallikrein					 1050					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455038	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455038&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488042	440970885							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176076	COc1cccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)cn12	InChI=1S/C21H18ClN7O2/c1-31-20-4-2-3-19-26-16(12-29(19)20)11-28-10-14(8-25-28)21(30)23-9-17-18-7-15(22)5-6-27(18)13-24-17/h2-8,10,12-13H,9,11H2,1H3,(H,23,30)	QOKBWGTUZDETME-UHFFFAOYSA-N	455039	US10730874, Compound I-63::US11352356, Compound I-63	Plasma kallikrein					 55					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455039	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455039&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487309	440970886							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176077	Cc1ccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)cn2c1	InChI=1S/C21H18ClN7O/c1-14-2-3-20-26-17(11-28(20)9-14)12-29-10-15(7-25-29)21(30)23-8-18-19-6-16(22)4-5-27(19)13-24-18/h2-7,9-11,13H,8,12H2,1H3,(H,23,30)	DVJGRVPGFYHKTL-UHFFFAOYSA-N	455040	US10730874, Compound I-64::US11352356, Compound I-64	Plasma kallikrein					 5.5					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455040	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455040&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487603	440970887							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176078	COC(=O)CCc1nn(Cc2cn3cc(ccc3n2)C2CC2)cc1C(=O)NCc1ncn2ccc(Cl)cc12	InChI=1S/C27H26ClN7O3/c1-38-26(36)7-5-22-21(27(37)29-11-23-24-10-19(28)8-9-33(24)16-30-23)15-35(32-22)14-20-13-34-12-18(17-2-3-17)4-6-25(34)31-20/h4,6,8-10,12-13,15-17H,2-3,5,7,11,14H2,1H3,(H,29,37)	OGHIIGGZSJWYTH-UHFFFAOYSA-N	455041	US10730874, Compound I-65::US11352356, Compound I-65	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455041	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455041&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487931	440970888							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176079	O=C(NCc1ncn2ccc(cc12)C#C)c1cnn(Cc2cn3cc(ccc3n2)C2CC2)c1	InChI=1S/C25H21N7O/c1-2-17-7-8-30-16-27-22(23(30)9-17)11-26-25(33)20-10-28-32(13-20)15-21-14-31-12-19(18-3-4-18)5-6-24(31)29-21/h1,5-10,12-14,16,18H,3-4,11,15H2,(H,26,33)	DSGRWACLUOGHNM-UHFFFAOYSA-N	455042	US10730874, Compound I-66::US11352356, Compound I-66	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455042	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455042&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488349	440970889							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176080	CCc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5cc(ccc5n4)C4CC4)c3)c2c1	InChI=1S/C25H25N7O/c1-2-17-7-8-30-16-27-22(23(30)9-17)11-26-25(33)20-10-28-32(13-20)15-21-14-31-12-19(18-3-4-18)5-6-24(31)29-21/h5-10,12-14,16,18H,2-4,11,15H2,1H3,(H,26,33)	YGULKCGHRSLKGO-UHFFFAOYSA-N	455043	US10730874, Compound I-67::US11352356, Compound I-67	Plasma kallikrein					 55					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455043	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455043&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488073	440970890							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176081	Brc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5nc(ccc5n4)C4CC4)c3)c2c1	InChI=1S/C22H19BrN8O/c23-16-5-6-29-13-25-19(20(29)7-16)9-24-22(32)15-8-26-30(10-15)11-17-12-31-21(27-17)4-3-18(28-31)14-1-2-14/h3-8,10,12-14H,1-2,9,11H2,(H,24,32)	OZTIETIWVJNNPD-UHFFFAOYSA-N	455044	US10730874, Compound I-68::US11352356, Compound I-68	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455044	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455044&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487772	440970891							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176082	Clc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5ccccc5n4)c3)c2c1	InChI=1S/C20H16ClN7O/c21-15-4-6-27-13-23-17(18(27)7-15)9-22-20(29)14-8-24-28(10-14)12-16-11-26-5-2-1-3-19(26)25-16/h1-8,10-11,13H,9,12H2,(H,22,29)	NSBYJUYKCREVJZ-UHFFFAOYSA-N	455045	US10730874, Compound I-69::US11352356, Compound I-69	Plasma kallikrein					 1050					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455045	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455045&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487485	440970892							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176083	Clc1ccn2cnc(CNC(=O)c3nnc(Cc4cn5cc(ccc5n4)C4CC4)s3)c2c1	InChI=1S/C22H18ClN7OS/c23-15-5-6-29-12-25-17(18(29)7-15)9-24-21(31)22-28-27-20(32-22)8-16-11-30-10-14(13-1-2-13)3-4-19(30)26-16/h3-7,10-13H,1-2,8-9H2,(H,24,31)	VRCBSLFIDYHWIN-UHFFFAOYSA-N	455046	US10730874, Compound I-70::US11352356, Compound I-70	Plasma kallikrein					 55					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455046	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455046&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487948	440970893							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176084	CCOC(=O)c1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1	InChI=1S/C26H24ClN7O3/c1-2-37-26(36)21-7-17(16-3-4-16)11-33-13-20(31-24(21)33)14-34-12-18(9-30-34)25(35)28-10-22-23-8-19(27)5-6-32(23)15-29-22/h5-9,11-13,15-16H,2-4,10,14H2,1H3,(H,28,35)	LYXCZPOSBFRUCX-UHFFFAOYSA-N	455047	US10730874, Compound I-104a::US10730874, Compound I-104b::US10730874, Compound I-71::US11352356, Compound I-71	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455047	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455047&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487407	440970894							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176085	OC(=O)c1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1	InChI=1S/C24H20ClN7O3/c25-17-3-4-30-13-27-20(21(30)6-17)8-26-23(33)16-7-28-32(10-16)12-18-11-31-9-15(14-1-2-14)5-19(24(34)35)22(31)29-18/h3-7,9-11,13-14H,1-2,8,12H2,(H,26,33)(H,34,35)	ZGDVXEJFDAKWKP-UHFFFAOYSA-N	455048	US10730874, Compound I-72::US11352356, Compound I-72	Plasma kallikrein					 5.5					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455048	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455048&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487608	471695238							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176086	OC(=O)CCc1nn(Cc2cn3cc(ccc3n2)C2CC2)cc1C(=O)NCc1ncn2ccc(Cl)cc12	InChI=1S/C26H24ClN7O3/c27-18-7-8-32-15-29-22(23(32)9-18)10-28-26(37)20-14-34(31-21(20)4-6-25(35)36)13-19-12-33-11-17(16-1-2-16)3-5-24(33)30-19/h3,5,7-9,11-12,14-16H,1-2,4,6,10,13H2,(H,28,37)(H,35,36)	QXPVQRNZDQJGMB-UHFFFAOYSA-N	455049	US10730874, Compound I-73::US11352356, Compound I-73	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455049	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455049&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488163	440970895							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176087	CC(NC(=O)c1cnn(Cc2cn3cc(ccc3n2)C2CC2)c1)c1ncn2ccc(Br)cc12	InChI=1S/C24H22BrN7O/c1-15(23-21-8-19(25)6-7-30(21)14-26-23)28-24(33)18-9-27-32(11-18)13-20-12-31-10-17(16-2-3-16)4-5-22(31)29-20/h4-12,14-16H,2-3,13H2,1H3,(H,28,33)	ZHLCMZVGVOKALL-UHFFFAOYSA-N	455050	US10730874, Compound I-74::US11352356, Compound I-74	Plasma kallikrein					 5.5					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455050	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455050&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488065	471695239							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176088	OCc1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1	InChI=1S/C24H22ClN7O2/c25-19-3-4-30-14-27-21(22(30)6-19)8-26-24(34)18-7-28-32(10-18)12-20-11-31-9-16(15-1-2-15)5-17(13-33)23(31)29-20/h3-7,9-11,14-15,33H,1-2,8,12-13H2,(H,26,34)	VVCOBANEAOECKG-UHFFFAOYSA-N	455051	US10730874, Compound I-75::US11352356, Compound I-75	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455051	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455051&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487804	471695240							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176089	Brc1ccn2cnc(CNC(=O)C3=CN[N](Cc4cn5cc(cnc5n4)C4CC4)=C3)c2c1	InChI=1S/C22H20BrN8O/c23-17-3-4-29-13-26-19(20(29)5-17)8-24-21(32)16-7-27-31(10-16)12-18-11-30-9-15(14-1-2-14)6-25-22(30)28-18/h3-7,9-11,13-14,27H,1-2,8,12H2,(H,24,32)	FKNXDZUOGDZLCB-UHFFFAOYSA-N	557414	US11352356, Compound I-76	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557414	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557414&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			165112488	471698123							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176090	CNc1cccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)cn12	InChI=1S/C21H19ClN8O/c1-23-19-3-2-4-20-27-16(12-30(19)20)11-29-10-14(8-26-29)21(31)24-9-17-18-7-15(22)5-6-28(18)13-25-17/h2-8,10,12-13,23H,9,11H2,1H3,(H,24,31)	VZVHPIXJGADPOG-UHFFFAOYSA-N	455053	US10730874, Compound I-77::US11352356, Compound I-77	Plasma kallikrein					 55					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455053	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455053&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487625	440970897							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176091	Clc1ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(ccc5n4)C4CC4)nc3C3CC3)c2c1	InChI=1S/C26H24ClN7O/c27-19-7-8-32-15-29-22(23(32)9-19)10-28-26(35)21-14-34(31-25(21)17-3-4-17)13-20-12-33-11-18(16-1-2-16)5-6-24(33)30-20/h5-9,11-12,14-17H,1-4,10,13H2,(H,28,35)	IPPXGAJJNKSSBG-UHFFFAOYSA-N	455054	US10730874, Compound I-78::US11352356, Compound I-78	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455054	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455054&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487376	440970898							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176092	Clc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5c(C#C)c(ccc5n4)C4CC4)c3)c2c1	InChI=1S/C25H20ClN7O/c1-2-22-20(16-3-4-16)5-6-24-30-19(14-33(22)24)13-32-12-17(10-29-32)25(34)27-11-21-23-9-18(26)7-8-31(23)15-28-21/h1,5-10,12,14-16H,3-4,11,13H2,(H,27,34)	JIVADXCNDRDGDY-UHFFFAOYSA-N	455055	US10730874, Compound I-79::US11352356, Compound I-79	Plasma kallikrein					 5.5					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455055	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455055&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487326	440970899							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176093	Clc1ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(ccc5n4)C4CC4)nn3)c2c1	InChI=1S/C22H19ClN8O/c23-16-5-6-29-13-25-18(20(29)7-16)8-24-22(32)19-12-31(28-27-19)11-17-10-30-9-15(14-1-2-14)3-4-21(30)26-17/h3-7,9-10,12-14H,1-2,8,11H2,(H,24,32)	IGCUVSSEMNZYSQ-UHFFFAOYSA-N	455056	US10730874, Compound I-80::US11352356, Compound I-80	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455056	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455056&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487366	440970900							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176094	COC(=O)Cc1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1	InChI=1S/C26H24ClN7O3/c1-37-24(35)7-17-6-18(16-2-3-16)11-33-13-21(31-25(17)33)14-34-12-19(9-30-34)26(36)28-10-22-23-8-20(27)4-5-32(23)15-29-22/h4-6,8-9,11-13,15-16H,2-3,7,10,14H2,1H3,(H,28,36)	FQCQPCCFPZUNOM-UHFFFAOYSA-N	455057	US10730874, Compound I-81::US11352356, Compound I-81	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455057	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455057&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488067	440970901							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176095	COC(=O)CCc1c(cnn1Cc1cn2cc(ccc2n1)C1CC1)C(=O)NCc1ncn2ccc(Cl)cc12	InChI=1S/C27H26ClN7O3/c1-38-26(36)7-5-23-21(27(37)29-12-22-24-10-19(28)8-9-33(24)16-30-22)11-31-35(23)15-20-14-34-13-18(17-2-3-17)4-6-25(34)32-20/h4,6,8-11,13-14,16-17H,2-3,5,7,12,15H2,1H3,(H,29,37)	IMPPNGAYPDFVGK-UHFFFAOYSA-N	455058	US10730874, Compound I-82::US11352356, Compound I-82	Plasma kallikrein					 55					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455058	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455058&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487870	440970902							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176096	FC(F)c1nc(CNC(=O)c2cnn(Cc3cn4cc(ccc4n3)C3CC3)c2)c2cc(Br)ccn12	InChI=1S/C24H20BrF2N7O/c25-17-5-6-34-20(7-17)19(31-23(34)22(26)27)9-28-24(35)16-8-29-33(11-16)13-18-12-32-10-15(14-1-2-14)3-4-21(32)30-18/h3-8,10-12,14,22H,1-2,9,13H2,(H,28,35)	QEDYHOKNPOWSIO-UHFFFAOYSA-N	455059	US10730874, Compound I-83::US11352356, Compound I-83	Plasma kallikrein					 55					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455059	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455059&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488079	440970903							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176097	Cc1ccc(cc1)S(=O)(=O)n1c(Cn2cc(cn2)C(=O)NCc2ncn3ccc(Cl)cc23)cc2ncc(cc12)C1CC1	InChI=1S/C30H26ClN7O3S/c1-19-2-6-25(7-3-19)42(40,41)38-24(12-26-29(38)10-21(13-32-26)20-4-5-20)17-37-16-22(14-35-37)30(39)33-15-27-28-11-23(31)8-9-36(28)18-34-27/h2-3,6-14,16,18,20H,4-5,15,17H2,1H3,(H,33,39)	DBWVHCZOSBFIHR-UHFFFAOYSA-N	557422	US11352356, Compound I-84	Plasma kallikrein					 55					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557422	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557422&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487883	471698131							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176098	Brc1ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(ccc5n4)C4CC4)nc3C3CC3)c2c1	InChI=1S/C26H24BrN7O/c27-19-7-8-32-15-29-22(23(32)9-19)10-28-26(35)21-14-34(31-25(21)17-3-4-17)13-20-12-33-11-18(16-1-2-16)5-6-24(33)30-20/h5-9,11-12,14-17H,1-4,10,13H2,(H,28,35)	YBDPZBBZAWAOBS-UHFFFAOYSA-N	455061	US10730874, Compound I-85::US11352356, Compound I-85	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455061	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455061&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488255	440970905							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176099	OC(=O)Cc1cc(cn2cc(Cn3cc(C(=O)NCc4ncn5ccc(Cl)cc45)c(n3)C3CC3)nc12)C1CC1	InChI=1S/C28H26ClN7O3/c29-20-5-6-34-15-31-23(24(34)9-20)10-30-28(39)22-14-36(33-26(22)17-3-4-17)13-21-12-35-11-19(16-1-2-16)7-18(8-25(37)38)27(35)32-21/h5-7,9,11-12,14-17H,1-4,8,10,13H2,(H,30,39)(H,37,38)	KAOLMMGUXDLOJR-UHFFFAOYSA-N	455062	US10730874, Compound I-86	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455062	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455062&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			165112148	471695241							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176100	OCCc1cc(cn2cc(Cn3cc(C(=O)NCc4ncn5ccc(Cl)cc45)c(n3)C3CC3)nc12)C1CC1	InChI=1S/C28H28ClN7O2/c29-21-5-7-34-16-31-24(25(34)10-21)11-30-28(38)23-15-36(33-26(23)18-3-4-18)14-22-13-35-12-20(17-1-2-17)9-19(6-8-37)27(35)32-22/h5,7,9-10,12-13,15-18,37H,1-4,6,8,11,14H2,(H,30,38)	LVKGVYOGLJRQQF-UHFFFAOYSA-N	455063	US10730874, Compound I-87	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455063	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455063&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			165112149	471695242							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176101	Nc1c(ccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)cn12)C1CC1	InChI=1S/C23H21ClN8O/c24-16-5-6-30-13-27-19(20(30)7-16)9-26-23(33)15-8-28-31(10-15)11-17-12-32-21(29-17)4-3-18(22(32)25)14-1-2-14/h3-8,10,12-14H,1-2,9,11,25H2,(H,26,33)	HSUFUGUTSFGYAQ-UHFFFAOYSA-N	455064	US10730874, Compound I-88::US11352356, Compound I-88	Plasma kallikrein					 5.5					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455064	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455064&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488102	440970906							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176102	Nc1ccc(C2CC2)c2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)cn12	InChI=1S/C23H21ClN8O/c24-16-5-6-30-13-27-19(20(30)7-16)9-26-23(33)15-8-28-31(10-15)11-17-12-32-21(25)4-3-18(14-1-2-14)22(32)29-17/h3-8,10,12-14H,1-2,9,11,25H2,(H,26,33)	UAYRURSMPONNMA-UHFFFAOYSA-N	455065	US10730874, Compound I-89::US12352356, Compound I-89	Plasma kallikrein					 1050					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455065	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455065&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487737	440970907							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176103	Clc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5cc(ccc5n4)C4CC4)c3)c2c1	InChI=1S/C23H20ClN7O/c24-18-5-6-29-14-26-20(21(29)7-18)9-25-23(32)17-8-27-31(11-17)13-19-12-30-10-16(15-1-2-15)3-4-22(30)28-19/h3-8,10-12,14-15H,1-2,9,13H2,(H,25,32)	JKVSCXTZILFUPG-UHFFFAOYSA-N	454849	US10730874, Compound I-147::US10730874, Compound I-2::US10730874, Compound I-90::US11352356, Compound I-90	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=454849	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=454849&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488035	440970702							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176104	COC(=O)c1ccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)cn2c1	InChI=1S/C22H18ClN7O3/c1-33-22(32)14-2-3-20-27-17(11-29(20)9-14)12-30-10-15(7-26-30)21(31)24-8-18-19-6-16(23)4-5-28(19)13-25-18/h2-7,9-11,13H,8,12H2,1H3,(H,24,31)	GAZFDHCGAJVTLJ-UHFFFAOYSA-N	455067	US10730874, Compound I-91::US10730874, Compound I-96::US11352356, Compound I-91	Plasma kallikrein					 55					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455067	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455067&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487699	440970908							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176105	Clc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5cc(cc(C#N)c5n4)C4CC4)c3)c2c1	InChI=1S/C24H19ClN8O/c25-19-3-4-31-14-28-21(22(31)6-19)9-27-24(34)18-8-29-33(11-18)13-20-12-32-10-17(15-1-2-15)5-16(7-26)23(32)30-20/h3-6,8,10-12,14-15H,1-2,9,13H2,(H,27,34)	SJUSWHJBZYVEMH-UHFFFAOYSA-N	455068	US10730874, Compound I-92::US11352356, Compound I-92	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455068	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455068&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488078	440970909							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176106	CCOC(=O)CCc1nn(Cc2cn3cc(ccc3n2)C2CC2)cc1C(=O)NCc1ncn2ccc(Cl)cc12	InChI=1S/C28H28ClN7O3/c1-2-39-27(37)8-6-23-22(28(38)30-12-24-25-11-20(29)9-10-34(25)17-31-24)16-36(33-23)15-21-14-35-13-19(18-3-4-18)5-7-26(35)32-21/h5,7,9-11,13-14,16-18H,2-4,6,8,12,15H2,1H3,(H,30,38)	XYNDIPKPPVOCHK-UHFFFAOYSA-N	455069	US10730874, Compound I-93::US11352356, Compound I-93	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455069	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455069&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488179	440970910							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176107	Clc1ccn2cnc(CCNC(=O)c3cnn(Cc4cn5cc(ccc5n4)C4CC4)c3)c2c1	InChI=1S/C24H22ClN7O/c25-19-6-8-30-15-27-21(22(30)9-19)5-7-26-24(33)18-10-28-32(12-18)14-20-13-31-11-17(16-1-2-16)3-4-23(31)29-20/h3-4,6,8-13,15-16H,1-2,5,7,14H2,(H,26,33)	WLPXNQDUDHZIIC-UHFFFAOYSA-N	455070	US10730874, Compound I-94::US11352356, Compound I-94	Plasma kallikrein					 55					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455070	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455070&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488324	440970911							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176108	FC(F)c1nn(Cc2cn3cc(ccc3n2)C2CC2)cc1C(=O)NCc1ncn2ccc(Br)cc12	InChI=1S/C24H20BrF2N7O/c25-16-5-6-32-13-29-19(20(32)7-16)8-28-24(35)18-12-34(31-22(18)23(26)27)11-17-10-33-9-15(14-1-2-14)3-4-21(33)30-17/h3-7,9-10,12-14,23H,1-2,8,11H2,(H,28,35)	FJCGOXXEPWDKCK-UHFFFAOYSA-N	455071	US10730874, Compound I-95::US11352356, Compound I-95	Plasma kallikrein					 5.5					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455071	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455071&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488410	440970912							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176177	Cn1nc(nc1Cc1cn2cc(ccc2n1)C1CC1)C(=O)NCc1ncn2ccc(Cl)cc12	InChI=1S/C23H21ClN8O/c1-30-21(9-17-12-32-11-15(14-2-3-14)4-5-20(32)27-17)28-22(29-30)23(33)25-10-18-19-8-16(24)6-7-31(19)13-26-18/h4-8,11-14H,2-3,9-10H2,1H3,(H,25,33)	PBIJRGWOXAVYDI-UHFFFAOYSA-N	455140	US10730874, Compound I-160::US11352356, Compound I-160	Plasma kallikrein					 5.5					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455140	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455140&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488001	440970969							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176178	Clc1ccn2cnc(CNC(=O)c3nnc(Cc4cn5cc(ccc5n4)C4CC4)[nH]3)c2c1	InChI=1S/C22H19ClN8O/c23-15-5-6-30-12-25-17(18(30)7-15)9-24-22(32)21-27-19(28-29-21)8-16-11-31-10-14(13-1-2-13)3-4-20(31)26-16/h3-7,10-13H,1-2,8-9H2,(H,24,32)(H,27,28,29)	BQFFCRSINIHETI-UHFFFAOYSA-N	455141	US10730874, Compound I-161::US11352356, Compound I-161	Plasma kallikrein					 5.5					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455141	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455141&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488321	440970970							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176179	CCOC(=O)C(C)(C)Cc1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1	InChI=1S/C30H32ClN7O3/c1-4-41-29(40)30(2,3)11-20-9-21(19-5-6-19)14-37-16-24(35-27(20)37)17-38-15-22(12-34-38)28(39)32-13-25-26-10-23(31)7-8-36(26)18-33-25/h7-10,12,14-16,18-19H,4-6,11,13,17H2,1-3H3,(H,32,39)	FPILPBZKRTWQLG-UHFFFAOYSA-N	455142	US10730874, Compound I-162::US11352356, Compound I-162	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455142	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455142&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487888	440970971							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176180	CCOC(=O)CCc1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C27H26ClFN8O3/c1-2-40-23(38)6-5-17-9-18(16-3-4-16)11-36-12-19(32-26(17)36)13-37-14-22(33-34-37)27(39)30-10-21-25-24(29)20(28)7-8-35(25)15-31-21/h7-9,11-12,14-16H,2-6,10,13H2,1H3,(H,30,39)	VJVMPQRIQYWAIF-UHFFFAOYSA-N	455143	US10730874, Compound I-163a::US11352356, Compound I-163a	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455143	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455143&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488116	440970972							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176181	OC(=O)CCc1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C25H22ClFN8O3/c26-18-5-6-33-13-29-19(23(33)22(18)27)8-28-25(38)20-12-35(32-31-20)11-17-10-34-9-16(14-1-2-14)7-15(24(34)30-17)3-4-21(36)37/h5-7,9-10,12-14H,1-4,8,11H2,(H,28,38)(H,36,37)	MKUMXXAVFRWNKM-UHFFFAOYSA-N	455144	US10730874, Compound I-163b::US11352356, Compound I-163b	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455144	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455144&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488026	440970973							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176182	Fc1c(Br)ccn2cnc(CNC(=O)c3cnn(Cc4cn5c(F)c(ccc5n4)C4CC4)c3)c12	InChI=1S/C23H18BrF2N7O/c24-17-5-6-31-12-28-18(21(31)20(17)25)8-27-23(34)14-7-29-32(9-14)10-15-11-33-19(30-15)4-3-16(22(33)26)13-1-2-13/h3-7,9,11-13H,1-2,8,10H2,(H,27,34)	ACTPWCJUTZVHPO-UHFFFAOYSA-N	455145	US10730874, Compound I-164::US11352356, Compound I-164	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455145	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455145&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488208	440970974							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176183	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(cnc5n4)C4CC4)nn3)c12	InChI=1S/C21H17ClFN9O/c22-15-3-4-30-11-26-16(19(30)18(15)23)6-24-20(33)17-10-32(29-28-17)9-14-8-31-7-13(12-1-2-12)5-25-21(31)27-14/h3-5,7-8,10-12H,1-2,6,9H2,(H,24,33)	CLJBXLCMPPMYOH-UHFFFAOYSA-N	455146	US10730874, Compound I-165::US11352356, Compound I-165	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455146	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455146&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487324	440970975							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176184	CCOC(=O)c1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C25H22ClFN8O3/c1-2-38-25(37)17-7-15(14-3-4-14)9-34-10-16(30-23(17)34)11-35-12-20(31-32-35)24(36)28-8-19-22-21(27)18(26)5-6-33(22)13-29-19/h5-7,9-10,12-14H,2-4,8,11H2,1H3,(H,28,36)	LOERPDDAWHEZBE-UHFFFAOYSA-N	455147	US10730874, Compound I-166a::US10730874, Compound I-166b::US11352356, Compound I-166a	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455147	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455147&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488395	440970976							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176185	OC(=O)c1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C23H18ClFN8O3/c24-16-3-4-31-11-27-17(20(31)19(16)25)6-26-22(34)18-10-33(30-29-18)9-14-8-32-7-13(12-1-2-12)5-15(23(35)36)21(32)28-14/h3-5,7-8,10-12H,1-2,6,9H2,(H,26,34)(H,35,36)	RADQFDOBVNSYMI-UHFFFAOYSA-N	557510	US11352356, Compound I-166b	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557510	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557510&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488011	471698218							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176186	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(cc(c5n4)C4(F)COC4)C4CC4)nn3)c12	InChI=1S/C25H21ClF2N8O2/c26-18-3-4-34-13-30-19(22(34)21(18)27)6-29-24(37)20-10-36(33-32-20)9-16-8-35-7-15(14-1-2-14)5-17(23(35)31-16)25(28)11-38-12-25/h3-5,7-8,10,13-14H,1-2,6,9,11-12H2,(H,29,37)	BVXXJJHLQNZVAO-UHFFFAOYSA-N	455149	US10730874, Compound I-167::US11352356, Compound I-167	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455149	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455149&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487749	440970977							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176187	CCOC(=O)C(C)(C)Cc1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1	InChI=1S/C29H31ClN8O3/c1-4-41-28(40)29(2,3)11-19-9-20(18-5-6-18)13-37-14-22(33-26(19)37)15-38-16-24(34-35-38)27(39)31-12-23-25-10-21(30)7-8-36(25)17-32-23/h7-10,13-14,16-18H,4-6,11-12,15H2,1-3H3,(H,31,39)	WPSWOPYBBAFGSI-UHFFFAOYSA-N	455150	US10730874, Compound I-168::US10730874, Compound I-170::US11352356, Compound I-168	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455150	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455150&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487862	440970978							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176188	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(cc(C6COC6)c5n4)C4CC4)nn3)c12	InChI=1S/C25H22ClFN8O2/c26-19-3-4-33-13-29-20(23(33)22(19)27)6-28-25(36)21-10-35(32-31-21)9-17-8-34-7-15(14-1-2-14)5-18(24(34)30-17)16-11-37-12-16/h3-5,7-8,10,13-14,16H,1-2,6,9,11-12H2,(H,28,36)	FXUKFZIQXJUNHW-UHFFFAOYSA-N	455151	US10730874, Compound I-169::US11352356, Compound I-169	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455151	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455151&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488361	440970979							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176189	CC(C)(Cc1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1)C(O)=O	InChI=1S/C27H27ClN8O3/c1-27(2,26(38)39)9-17-7-18(16-3-4-16)11-35-12-20(31-24(17)35)13-36-14-22(32-33-36)25(37)29-10-21-23-8-19(28)5-6-34(23)15-30-21/h5-8,11-12,14-16H,3-4,9-10,13H2,1-2H3,(H,29,37)(H,38,39)	NXJWSVPQIZEHSJ-UHFFFAOYSA-N	455152	US10730874, Compound I-170	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455152	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455152&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487511	471695248							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176190	Fc1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C22H17ClF2N8O/c23-15-3-4-31-11-27-17(20(31)19(15)25)6-26-22(34)18-10-33(30-29-18)9-14-8-32-7-13(12-1-2-12)5-16(24)21(32)28-14/h3-5,7-8,10-12H,1-2,6,9H2,(H,26,34)	UPMHECNJBYSZLT-UHFFFAOYSA-N	455153	US10730874, Compound I-171::US11352356, Compound I-171	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455153	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455153&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487440	440970980							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176191	Cc1c(Cl)ccc2nc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)cn12	InChI=1S/C20H15Cl2FN8O/c1-11-13(21)2-3-17-26-12(8-31(11)17)7-30-9-16(27-28-30)20(32)24-6-15-19-18(23)14(22)4-5-29(19)10-25-15/h2-5,8-10H,6-7H2,1H3,(H,24,32)	LRSPXNCNBHRBFB-UHFFFAOYSA-N	455154	US10730874, Compound I-172::US11352356, Compound I-172	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455154	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455154&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488364	440970981							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176192	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(cc(N6CCOCC6)c5n4)C4CC4)nn3)c12	InChI=1S/C26H25ClFN9O2/c27-19-3-4-35-15-30-20(24(35)23(19)28)10-29-26(38)21-14-37(33-32-21)13-18-12-36-11-17(16-1-2-16)9-22(25(36)31-18)34-5-7-39-8-6-34/h3-4,9,11-12,14-16H,1-2,5-8,10,13H2,(H,29,38)	AMKWJBVJHRSEMN-UHFFFAOYSA-N	455155	US10730874, Compound I-173::US11352356, Compound I-173	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455155	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455155&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488033	440970982							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176193	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(cc(-c6nn[nH]n6)c5n4)C4CC4)nn3)c12	InChI=1S/C23H18ClFN12O/c24-16-3-4-35-11-27-17(20(35)19(16)25)6-26-23(38)18-10-37(34-29-18)9-14-8-36-7-13(12-1-2-12)5-15(22(36)28-14)21-30-32-33-31-21/h3-5,7-8,10-12H,1-2,6,9H2,(H,26,38)(H,30,31,32,33)	UWNKGJKBQYTQMP-UHFFFAOYSA-N	455156	US10730874, Compound I-174::US11352356, Compound I-174	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455156	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455156&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487914	440970983							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176194	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cc5cc(ccn5n4)C4CC4)nn3)c12	InChI=1S/C22H18ClFN8O/c23-17-4-5-30-12-26-18(21(30)20(17)24)9-25-22(33)19-11-31(29-27-19)10-15-8-16-7-14(13-1-2-13)3-6-32(16)28-15/h3-8,11-13H,1-2,9-10H2,(H,25,33)	QECKLGRMLYZYDC-UHFFFAOYSA-N	455157	US10730874, Compound I-175::US11352356, Compound I-175	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455157	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455157&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487409	440970984							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176195	Clc1ccn2cnc(CNC(=O)c3cc(Cc4cn5cc(ccc5n4)C4CC4)on3)c2c1	InChI=1S/C23H19ClN6O2/c24-16-5-6-29-13-26-20(21(29)7-16)10-25-23(31)19-9-18(32-28-19)8-17-12-30-11-15(14-1-2-14)3-4-22(30)27-17/h3-7,9,11-14H,1-2,8,10H2,(H,25,31)	WYBCITHSFXROQY-UHFFFAOYSA-N	455158	US10730874, Compound I-176::US11352356, Compound I-176	Plasma kallikrein					 5.5					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455158	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455158&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488191	440970985							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176196	Clc1ccn2cnc(CNC(=O)c3noc(Cc4cn5cc(ccc5n4)C4CC4)n3)c2c1	InChI=1S/C22H18ClN7O2/c23-15-5-6-29-12-25-17(18(29)7-15)9-24-22(31)21-27-20(32-28-21)8-16-11-30-10-14(13-1-2-13)3-4-19(30)26-16/h3-7,10-13H,1-2,8-9H2,(H,24,31)	QYPWNBJFEALFGI-UHFFFAOYSA-N	455159	US10730874, Compound I-177::US11352356, Compound I-177	Plasma kallikrein					 5.5					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455159	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455159&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487397	440970986							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176197	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4nc5cc(ccn5n4)C4CC4)nn3)c12	InChI=1S/C21H17ClFN9O/c22-14-4-5-30-11-25-15(20(30)19(14)23)8-24-21(33)16-9-31(29-27-16)10-17-26-18-7-13(12-1-2-12)3-6-32(18)28-17/h3-7,9,11-12H,1-2,8,10H2,(H,24,33)	TXXITEACQAZRRV-UHFFFAOYSA-N	455160	US10730874, Compound I-178::US11352356, Compound I-178	Plasma kallikrein					 55					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455160	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455160&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487347	440970987							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176198	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(cc(-n6cnnn6)c5n4)C4CC4)nn3)c12	InChI=1S/C23H18ClFN12O/c24-16-3-4-34-11-27-17(21(34)20(16)25)6-26-23(38)18-10-36(32-30-18)9-15-8-35-7-14(13-1-2-13)5-19(22(35)29-15)37-12-28-31-33-37/h3-5,7-8,10-13H,1-2,6,9H2,(H,26,38)	UDEXSOCXNBAPNS-UHFFFAOYSA-N	455161	US10730874, Compound I-179::US11352356, Compound I-179	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455161	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455161&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487399	440970988							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176199	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(cc(-n6cnnc6)c5n4)C4CC4)nn3)c12	InChI=1S/C24H19ClFN11O/c25-17-3-4-34-11-28-18(22(34)21(17)26)6-27-24(38)19-10-37(33-32-19)9-16-8-35-7-15(14-1-2-14)5-20(23(35)31-16)36-12-29-30-13-36/h3-5,7-8,10-14H,1-2,6,9H2,(H,27,38)	ZZDUGASJVGDCNQ-UHFFFAOYSA-N	455162	US10730874, Compound I-180::US11352356, Compound I-180	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455162	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455162&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488100	440970989							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176200	OCc1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C23H20ClFN8O2/c24-17-3-4-31-12-27-18(21(31)20(17)25)6-26-23(35)19-10-33(30-29-19)9-16-8-32-7-14(13-1-2-13)5-15(11-34)22(32)28-16/h3-5,7-8,10,12-13,34H,1-2,6,9,11H2,(H,26,35)	CSJKDRLRMSWNBG-UHFFFAOYSA-N	455163	US10730874, Compound I-181::US11352356, Compound I-181	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455163	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455163&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487956	440970990							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176201	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(cc(C=O)c5n4)C4CC4)nn3)c12	InChI=1S/C23H18ClFN8O2/c24-17-3-4-31-12-27-18(21(31)20(17)25)6-26-23(35)19-10-33(30-29-19)9-16-8-32-7-14(13-1-2-13)5-15(11-34)22(32)28-16/h3-5,7-8,10-13H,1-2,6,9H2,(H,26,35)	OULYKXBARJPDHX-UHFFFAOYSA-N	455164	US10730874, Compound I-182::US11352356, Compound I-182	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455164	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455164&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488266	471695249							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176202	OC(=O)CCc1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1	InChI=1S/C25H23ClN8O3/c26-18-5-6-32-14-28-20(22(32)8-18)9-27-25(37)21-13-34(31-30-21)12-19-11-33-10-17(15-1-2-15)7-16(24(33)29-19)3-4-23(35)36/h5-8,10-11,13-15H,1-4,9,12H2,(H,27,37)(H,35,36)	BLDIVGDUJSDPMY-UHFFFAOYSA-N	455165	US10730874, Compound I-183::US11352356, Compound I-183	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455165	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455165&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487286	440970991							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176203	NC(=O)CCc1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1	InChI=1S/C25H24ClN9O2/c26-18-5-6-33-14-29-20(22(33)8-18)9-28-25(37)21-13-35(32-31-21)12-19-11-34-10-17(15-1-2-15)7-16(24(34)30-19)3-4-23(27)36/h5-8,10-11,13-15H,1-4,9,12H2,(H2,27,36)(H,28,37)	QHRHAQFKLLAKFN-UHFFFAOYSA-N	455166	US10730874, Compound I-184::US11352356, Compound I-184	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455166	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455166&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488251	440970992							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176204	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(cc(c5n4)C(F)(F)F)C4CC4)nn3)c12	InChI=1S/C23H17ClF4N8O/c24-16-3-4-34-11-30-17(20(34)19(16)25)6-29-22(37)18-10-36(33-32-18)9-14-8-35-7-13(12-1-2-12)5-15(21(35)31-14)23(26,27)28/h3-5,7-8,10-12H,1-2,6,9H2,(H,29,37)	USULODVGFTZIAI-UHFFFAOYSA-N	455167	US10730874, Compound I-185::US11352356, Compound I-185	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455167	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455167&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488124	440970993							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176205	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(cc(CC6COC6)c5n4)C4CC4)nn3)c12	InChI=1S/C26H24ClFN8O2/c27-20-3-4-34-14-30-21(24(34)23(20)28)7-29-26(37)22-11-36(33-32-22)10-19-9-35-8-18(16-1-2-16)6-17(25(35)31-19)5-15-12-38-13-15/h3-4,6,8-9,11,14-16H,1-2,5,7,10,12-13H2,(H,29,37)	JLQBGBAMTMYHSV-UHFFFAOYSA-N	455168	US10730874, Compound I-186::US11352356, Compound I-186	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455168	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455168&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488053	440970994							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176206	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(Cl)cc(C6COC6)c5n4)nn3)c12	InChI=1S/C22H17Cl2FN8O2/c23-13-3-15(12-9-35-10-12)21-28-14(6-32(21)5-13)7-33-8-18(29-30-33)22(34)26-4-17-20-19(25)16(24)1-2-31(20)11-27-17/h1-3,5-6,8,11-12H,4,7,9-10H2,(H,26,34)	DREOJJSYJRKADX-UHFFFAOYSA-N	455169	US10730874, Compound I-187::US11352356, Compound I-187	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455169	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455169&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487682	440970995							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176207	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(Cl)c(Cl)cc5n4)nn3)c12	InChI=1S/C19H12Cl3FN8O/c20-11-1-2-29-9-25-14(18(29)17(11)23)4-24-19(32)15-8-31(28-27-15)6-10-5-30-7-13(22)12(21)3-16(30)26-10/h1-3,5,7-9H,4,6H2,(H,24,32)	PPOPKLLAQZEWFC-UHFFFAOYSA-N	455170	US10730874, Compound I-188::US11352356, Compound I-188	Plasma kallikrein					 5.5					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455170	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455170&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487869	440970996							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176208	Clc1ccn2cnc(CNC(=O)c3cn(Cc4cc5cc(cnc5s4)C4CC4)nn3)c2c1Cl	InChI=1S/C22H17Cl2N7OS/c23-16-3-4-30-11-27-17(20(30)19(16)24)8-25-21(32)18-10-31(29-28-18)9-15-6-13-5-14(12-1-2-12)7-26-22(13)33-15/h3-7,10-12H,1-2,8-9H2,(H,25,32)	WPNGUBCSLWTTFE-UHFFFAOYSA-N	557533	US11352356, Compound I-189	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557533	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557533&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			165112497	471698240							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176209	Clc1ccn2cnc(CNC(=O)c3nc(Cc4cn5cc(ccc5n4)C4CC4)no3)c2c1	InChI=1S/C22H18ClN7O2/c23-15-5-6-29-12-25-17(18(29)7-15)9-24-21(31)22-27-19(28-32-22)8-16-11-30-10-14(13-1-2-13)3-4-20(30)26-16/h3-7,10-13H,1-2,8-9H2,(H,24,31)	QIHPBXTVCWDWIU-UHFFFAOYSA-N	455172	US10730874, Compound I-190::US11352356, Compound I-190	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455172	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455172&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487577	440970998							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176210	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cc5cc(ccc5o4)C4CC4)nn3)c12	InChI=1S/C23H18ClFN6O2/c24-17-5-6-30-12-27-18(22(30)21(17)25)9-26-23(32)19-11-31(29-28-19)10-16-8-15-7-14(13-1-2-13)3-4-20(15)33-16/h3-8,11-13H,1-2,9-10H2,(H,26,32)	IREKDXXEKQWYIB-UHFFFAOYSA-N	455173	US10730874, Compound I-191::US11352356, Compound I-191	Plasma kallikrein					 5.5					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455173	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455173&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487781	440970999							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176211	FC(F)c1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C23H18ClF3N8O/c24-16-3-4-33-11-29-17(20(33)19(16)25)6-28-23(36)18-10-35(32-31-18)9-14-8-34-7-13(12-1-2-12)5-15(21(26)27)22(34)30-14/h3-5,7-8,10-12,21H,1-2,6,9H2,(H,28,36)	KRFFZINWKIKOQV-UHFFFAOYSA-N	455174	US10730874, Compound I-192::US11352356, Compound I-192	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455174	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455174&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487442	440971000							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176212	CCOC(=O)c1cnn(Cc2cc(cn3cc(Cn4cc(nn4)C(=O)NCc4ncn5ccc(Cl)c(F)c45)nc23)C2CC2)c1	InChI=1S/C29H26ClFN10O3/c1-2-44-29(43)20-8-34-40(12-20)11-19-7-18(17-3-4-17)10-39-13-21(35-27(19)39)14-41-15-24(36-37-41)28(42)32-9-23-26-25(31)22(30)5-6-38(26)16-33-23/h5-8,10,12-13,15-17H,2-4,9,11,14H2,1H3,(H,32,42)	UTKSPGSUTGQLPJ-UHFFFAOYSA-N	455175	US10730874, Compound I-193::US11352356, Compound I-193	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455175	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455175&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487645	440971001							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176213	Clc1ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(cc(CCc6nnn[nH]6)c5n4)C4CC4)nn3)c2c1	InChI=1S/C25H23ClN12O/c26-18-5-6-36-14-28-20(22(36)8-18)9-27-25(39)21-13-38(35-30-21)12-19-11-37-10-17(15-1-2-15)7-16(24(37)29-19)3-4-23-31-33-34-32-23/h5-8,10-11,13-15H,1-4,9,12H2,(H,27,39)(H,31,32,33,34)	CEFZLTMWWGJJIG-UHFFFAOYSA-N	455176	US10730874, Compound I-194::US11352356, Compound I-194	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455176	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455176&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487959	440971002							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176214	COC(=O)c1c(Cn2cc(nn2)C(=O)NCc2ncn3ccc(Cl)c(F)c23)[nH]c2cc(ccc12)C1CC1	InChI=1S/C25H21ClFN7O3/c1-37-25(36)21-15-5-4-14(13-2-3-13)8-17(15)30-19(21)10-34-11-20(31-32-34)24(35)28-9-18-23-22(27)16(26)6-7-33(23)12-29-18/h4-8,11-13,30H,2-3,9-10H2,1H3,(H,28,35)	NPZFCXWKNRYHNT-UHFFFAOYSA-N	557539	US11352356, Compound I-195	Plasma kallikrein					 1050					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557539	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557539&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487462	471698246							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176215	Fc1c(Cl)ccn2cnc(CNC(=O)c3coc(Cc4cn5cc(ccc5n4)C4CC4)n3)c12	InChI=1S/C23H18ClFN6O2/c24-16-5-6-30-12-27-17(22(30)21(16)25)8-26-23(32)18-11-33-20(29-18)7-15-10-31-9-14(13-1-2-13)3-4-19(31)28-15/h3-6,9-13H,1-2,7-8H2,(H,26,32)	FZDKJKILBJBBHB-UHFFFAOYSA-N	455178	US10730874, Compound I-196::US11352356, Compound I-196	Plasma kallikrein					 5.5					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455178	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455178&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488201	440971004							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176216	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cc5ccc(Cl)cc5o4)nn3)c12	InChI=1S/C20H13Cl2FN6O2/c21-12-2-1-11-5-13(31-17(11)6-12)8-29-9-16(26-27-29)20(30)24-7-15-19-18(23)14(22)3-4-28(19)10-25-15/h1-6,9-10H,7-8H2,(H,24,30)	RUNPXASSIAZTEM-UHFFFAOYSA-N	557541	US11352356, Compound I-197	Plasma kallikrein					 1050					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557541	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557541&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487928	471698248							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176217	CC(c1cn2cc(ccc2n1)C1CC1)n1cc(nn1)C(=O)NCc1ncn2ccc(Cl)c(F)c12	InChI=1S/C23H20ClFN8O/c1-13(18-10-32-9-15(14-2-3-14)4-5-20(32)28-18)33-11-19(29-30-33)23(34)26-8-17-22-21(25)16(24)6-7-31(22)12-27-17/h4-7,9-14H,2-3,8H2,1H3,(H,26,34)	SWWAWYDDCWOBQB-UHFFFAOYSA-N	455180	US10730874, Compound I-198::US11352356, Compound I-198	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455180	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455180&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488038	440971006							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176218	Fc1c(Cl)ccn2cnc(CCC(=O)c3cn(Cc4cn5cc(cc(C6CCOC6=O)c5n4)C4CC4)nn3)c12	InChI=1S/C26H21ClFN8O3/c27-19-3-5-34-13-30-20(23(34)22(19)28)8-29-25(37)21-12-36(33-32-21)11-16-10-35-9-15(14-1-2-14)7-18(24(35)31-16)17-4-6-39-26(17)38/h3,5,7,9-10,12-14,17H,1-2,4,6,8,11H2	QTVOSVOPAMKRGK-UHFFFAOYSA-N	557543	US11352356, Compound I-199	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557543	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557543&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487895	471698250							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176219	Fc1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Br)c(F)c34)nc12)C1CC1	InChI=1S/C22H17BrF2N8O/c23-15-3-4-31-11-27-17(20(31)19(15)25)6-26-22(34)18-10-33(30-29-18)9-14-8-32-7-13(12-1-2-12)5-16(24)21(32)28-14/h3-5,7-8,10-12H,1-2,6,9H2,(H,26,34)	HBWQGKLPQPHKEV-UHFFFAOYSA-N	455182	US10730874, Compound I-200::US11352356, Compound I-200	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455182	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455182&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488265	440971008							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176220	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(cc(Cn6cccn6)c5n4)C4CC4)nn3)c12	InChI=1S/C26H22ClFN10O/c27-20-4-7-35-15-30-21(24(35)23(20)28)9-29-26(39)22-14-38(34-33-22)13-19-12-36-10-17(16-2-3-16)8-18(25(36)32-19)11-37-6-1-5-31-37/h1,4-8,10,12,14-16H,2-3,9,11,13H2,(H,29,39)	LXBOIMXGUUEOIP-UHFFFAOYSA-N	455183	US10730874, Compound I-201::US11352356, Compound I-201	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455183	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455183&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487953	440971009							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176221	CCOC(=O)c1ccn(Cc2cc(cn3cc(Cn4cc(nn4)C(=O)NCc4ncn5ccc(Cl)c([*])c45)nc23)C2CC2)n1	InChI=1S/C27H22ClFN10O3/c28-19-3-5-36-14-31-21(24(36)23(19)29)8-30-26(40)22-13-39(35-33-22)12-18-11-37-9-16(15-1-2-15)7-17(25(37)32-18)10-38-6-4-20(34-38)27(41)42/h3-7,9,11,13-15H,1-2,8,10,12H2,(H,30,40)(H,41,42)	ZYNAUKGFRGLNQG-UHFFFAOYSA-N	557546	US11352356, Compound I-202	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557546	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557546&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487833	475740990							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176222	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(cc(N6CCCC6=O)c5n4)C4CC4)nn3)c12	InChI=1S/C26H23ClFN9O2/c27-18-5-7-34-14-30-19(24(34)23(18)28)9-29-26(39)20-13-36(33-32-20)12-17-11-35-10-16(15-3-4-15)8-21(25(35)31-17)37-6-1-2-22(37)38/h5,7-8,10-11,13-15H,1-4,6,9,12H2,(H,29,39)	FAFQFOQROABJFU-UHFFFAOYSA-N	455185	US10730874, Compound I-203::US11352356, Compound I-203	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455185	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455185&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487942	440971011							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176223	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(cc(Br)c5n4)C4CC4)nn3)c12	InChI=1S/C22H17BrClFN8O/c23-15-5-13(12-1-2-12)7-32-8-14(28-21(15)32)9-33-10-18(29-30-33)22(34)26-6-17-20-19(25)16(24)3-4-31(20)11-27-17/h3-5,7-8,10-12H,1-2,6,9H2,(H,26,34)	PXNXGIUGOSFDHR-UHFFFAOYSA-N	455186	US10730874, Compound I-204::US11352356, Compound I-204	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455186	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455186&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487834	440971012							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176224	CCOC(=O)C(C)(C)Cc1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C29H30ClFN8O3/c1-4-42-28(41)29(2,3)10-18-9-19(17-5-6-17)12-38-13-20(34-26(18)38)14-39-15-23(35-36-39)27(40)32-11-22-25-24(31)21(30)7-8-37(25)16-33-22/h7-9,12-13,15-17H,4-6,10-11,14H2,1-3H3,(H,32,40)	YJFRTTPITFSUCE-UHFFFAOYSA-N	455187	US10730874, Compound I-205::US11352356, Compound I-205	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455187	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455187&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487520	440971013							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176225	CC(C)(Cc1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1)C(O)=O	InChI=1S/C27H26ClFN8O3/c1-27(2,26(39)40)8-16-7-17(15-3-4-15)10-36-11-18(32-24(16)36)12-37-13-21(33-34-37)25(38)30-9-20-23-22(29)19(28)5-6-35(23)14-31-20/h5-7,10-11,13-15H,3-4,8-9,12H2,1-2H3,(H,30,38)(H,39,40)	WUNYVCBTCIBICM-UHFFFAOYSA-N	455188	US10730874, Compound I-206::US11352356, Compound I-206	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455188	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455188&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487663	440971014							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176226	CCOC(=O)COc1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C26H24ClFN8O4/c1-2-39-22(37)13-40-21-7-16(15-3-4-15)9-35-10-17(31-25(21)35)11-36-12-20(32-33-36)26(38)29-8-19-24-23(28)18(27)5-6-34(24)14-30-19/h5-7,9-10,12,14-15H,2-4,8,11,13H2,1H3,(H,29,38)	FWUDJTOFXCGHCR-UHFFFAOYSA-N	455189	US10730874, Compound I-207::US11352356, Compound I-207	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455189	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455189&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487470	440971015							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176227	OC(=O)COc1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C24H20ClFN8O4/c25-16-3-4-32-12-28-17(22(32)21(16)26)6-27-24(37)18-10-34(31-30-18)9-15-8-33-7-14(13-1-2-13)5-19(23(33)29-15)38-11-20(35)36/h3-5,7-8,10,12-13H,1-2,6,9,11H2,(H,27,37)(H,35,36)	LOQCZJXILCLEOY-UHFFFAOYSA-N	455190	US10730874, Compound I-208::US11352356, Compound I-208	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455190	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455190&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487408	471695250							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176228	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cc5ncc(cn5n4)C4CC4)nn3)c12	InChI=1S/C21H17ClFN9O/c22-15-3-4-30-11-26-16(20(30)19(15)23)7-25-21(33)17-10-31(29-27-17)9-14-5-18-24-6-13(12-1-2-12)8-32(18)28-14/h3-6,8,10-12H,1-2,7,9H2,(H,25,33)	BMMPQMYYBFRCDP-UHFFFAOYSA-N	455191	US10730874, Compound I-209::US11352356, Compound I-209	Plasma kallikrein					 5.5					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455191	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455191&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487537	440971016							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176229	CCOC(=O)c1nnc(Cc2cc(cn3cc(Cn4cc(nn4)C(=O)NCc4ncn5ccc(Cl)c(F)c45)nc23)C2CC2)o1	InChI=1S/C28H24ClFN10O4/c1-2-43-28(42)27-36-35-22(44-27)8-16-7-17(15-3-4-15)10-39-11-18(33-25(16)39)12-40-13-21(34-37-40)26(41)31-9-20-24-23(30)19(29)5-6-38(24)14-32-20/h5-7,10-11,13-15H,2-4,8-9,12H2,1H3,(H,31,41)	UQYHHOCGLOSLEQ-UHFFFAOYSA-N	557554	US11352356, Compound I-210a	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557554	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557554&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487799	471698260							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176230	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(cc(Cc6nnco6)c5n4)C4CC4)nn3)c12	InChI=1S/C25H20ClFN10O2/c26-18-3-4-35-12-29-19(23(35)22(18)27)7-28-25(38)20-11-37(34-32-20)10-17-9-36-8-16(14-1-2-14)5-15(24(36)31-17)6-21-33-30-13-39-21/h3-5,8-9,11-14H,1-2,6-7,10H2,(H,28,38)	FLKVURSRRFTMGI-UHFFFAOYSA-N	557555	US11352356, Compound I-210b	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557555	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557555&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487276	471698261							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176231	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4nc5ccc(cc5c4C(F)(F)F)C4CC4)nn3)c12	InChI=1S/C24H18ClF4N7O/c25-15-5-6-35-11-31-17(22(35)21(15)26)8-30-23(37)19-10-36(34-33-19)9-18-20(24(27,28)29)14-7-13(12-1-2-12)3-4-16(14)32-18/h3-7,10-12,32H,1-2,8-9H2,(H,30,37)	KTGRBLHYUSEPRF-UHFFFAOYSA-N	455194	US10730874, Compound I-211::US11352356, Compound I-211	Plasma kallikrein					 55					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455194	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455194&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487759	440971019							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176232	CC(C)(C)OC(=O)C(C)(C)Oc1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C30H32ClFN8O4/c1-29(2,3)44-28(42)30(4,5)43-23-10-18(17-6-7-17)12-39-13-19(35-26(23)39)14-40-15-22(36-37-40)27(41)33-11-21-25-24(32)20(31)8-9-38(25)16-34-21/h8-10,12-13,15-17H,6-7,11,14H2,1-5H3,(H,33,41)	HLLNIRQLURLEEM-UHFFFAOYSA-N	557557	US11352356, Compound I-212	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557557	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557557&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487720	471698262							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176233	CC(F)c1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C24H21ClF2N8O/c1-13(26)17-6-15(14-2-3-14)8-34-9-16(30-23(17)34)10-35-11-20(31-32-35)24(36)28-7-19-22-21(27)18(25)4-5-33(22)12-29-19/h4-6,8-9,11-14H,2-3,7,10H2,1H3,(H,28,36)	CEHRHYFXIRSYSG-UHFFFAOYSA-N	455196	US10730874, Compound I-213::US11352356, Compound I-213	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455196	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455196&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487908	440971021							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176234	Fc1c(Cl)ccn2cnc(CNC(=O)c3cnn(Cc4cn5cc(cc(Cc6nnco6)c5n4)C4CC4)c3)c12	InChI=1S/C26H21ClFN9O2/c27-20-3-4-35-13-30-21(24(35)23(20)28)8-29-26(38)18-7-32-37(10-18)12-19-11-36-9-17(15-1-2-15)5-16(25(36)33-19)6-22-34-31-14-39-22/h3-5,7,9-11,13-15H,1-2,6,8,12H2,(H,29,38)	QBAIWYMONSAABV-UHFFFAOYSA-N	455197	US10730874, Compound I-214::US11352356, Compound I-214	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455197	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455197&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487917	440971022							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176235	Fc1c(Cl)ccn2cnc(CNC(=O)c3cnn(Cc4cn5cc(cc(C6COC6)c5n4)C4CC4)c3)c12	InChI=1S/C26H23ClFN7O2/c27-21-3-4-33-14-30-22(24(33)23(21)28)7-29-26(36)17-6-31-35(9-17)11-19-10-34-8-16(15-1-2-15)5-20(25(34)32-19)18-12-37-13-18/h3-6,8-10,14-15,18H,1-2,7,11-13H2,(H,29,36)	GRVCFXZFAOPZNJ-UHFFFAOYSA-N	455198	US10730874, Compound I-215::US11352356, Compound I-215	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455198	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455198&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488057	440971023							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176236	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(cc(N6CCOC6=O)c5n4)C4CC4)nn3)c12	InChI=1S/C25H21ClFN9O3/c26-17-3-4-33-13-29-18(22(33)21(17)27)8-28-24(37)19-12-35(32-31-19)11-16-10-34-9-15(14-1-2-14)7-20(23(34)30-16)36-5-6-39-25(36)38/h3-4,7,9-10,12-14H,1-2,5-6,8,11H2,(H,28,37)	QOZPQJGJKRLSPV-UHFFFAOYSA-N	455199	US10730874, Compound I-216::US11352356, Compound I-216	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455199	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455199&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488328	440971024							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176237	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5ncc(cc5n4)C4CC4)nn3)c12	InChI=1S/C21H17ClFN9O/c22-15-3-4-30-11-25-16(20(30)19(15)23)7-24-21(33)17-10-31(29-28-17)8-14-9-32-18(27-14)5-13(6-26-32)12-1-2-12/h3-6,9-12H,1-2,7-8H2,(H,24,33)	IGQDDKKYDYQIJI-UHFFFAOYSA-N	557562	US11352356, Compound I-217	Plasma kallikrein					 5.5					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557562	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557562&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488420	471698267							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176238	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cc5cc(ccc5s4)C4CC4)nn3)c12	InChI=1S/C23H18ClFN6OS/c24-17-5-6-30-12-27-18(22(30)21(17)25)9-26-23(32)19-11-31(29-28-19)10-16-8-15-7-14(13-1-2-13)3-4-20(15)33-16/h3-8,11-13H,1-2,9-10H2,(H,26,32)	MOPFCOIADXHEFH-UHFFFAOYSA-N	455201	US10730874, Compound I-218::US11352356, Compound I-218	Plasma kallikrein					 5.5					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455201	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455201&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488039	440971026							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176239	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cc5ccc(cc5o4)C4CC4)nn3)c12	InChI=1S/C23H18ClFN6O2/c24-17-5-6-30-12-27-18(22(30)21(17)25)9-26-23(32)19-11-31(29-28-19)10-16-7-15-4-3-14(13-1-2-13)8-20(15)33-16/h3-8,11-13H,1-2,9-10H2,(H,26,32)	SSLSXHUJUZXTRN-UHFFFAOYSA-N	455202	US10730874, Compound I-219::US11352356, Compound I-219	Plasma kallikrein					 55					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455202	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455202&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487787	440971027							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176240	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(cc(-n6cccn6)c5n4)C4CC4)nn3)c12	InChI=1S/C25H20ClFN10O/c26-18-4-7-34-14-29-19(23(34)22(18)27)9-28-25(38)20-13-36(33-32-20)12-17-11-35-10-16(15-2-3-15)8-21(24(35)31-17)37-6-1-5-30-37/h1,4-8,10-11,13-15H,2-3,9,12H2,(H,28,38)	YPEIDQJFIUQZSH-UHFFFAOYSA-N	455203	US10730874, Compound I-220::US11352356, Compound I-220	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455203	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455203&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487971	440971028							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176241	COC(=O)C1(Cc2cc(cn3cc(Cn4cc(nn4)C(=O)NCc4ncn5ccc(Cl)c(F)c45)nc23)C2CC2)CCCC1	InChI=1S/C30H30ClFN8O3/c1-43-29(42)30(7-2-3-8-30)11-19-10-20(18-4-5-18)13-39-14-21(35-27(19)39)15-40-16-24(36-37-40)28(41)33-12-23-26-25(32)22(31)6-9-38(26)17-34-23/h6,9-10,13-14,16-18H,2-5,7-8,11-12,15H2,1H3,(H,33,41)	PHNONPBNKWJKRH-UHFFFAOYSA-N	557566	US11352356, Compound I-221a	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557566	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557566&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487653	471698271							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176242	OC(=O)C1(Cc2cc(cn3cc(Cn4cc(nn4)C(=O)NCc4ncn5ccc(Cl)c(F)c45)nc23)C2CC2)CCCC1	InChI=1S/C29H28ClFN8O3/c30-21-5-8-37-16-33-22(25(37)24(21)31)11-32-27(40)23-15-39(36-35-23)14-20-13-38-12-19(17-3-4-17)9-18(26(38)34-20)10-29(28(41)42)6-1-2-7-29/h5,8-9,12-13,15-17H,1-4,6-7,10-11,14H2,(H,32,40)(H,41,42)	XGKMBVOTQVWUCC-UHFFFAOYSA-N	557567	US11352356, Compound I-221b	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557567	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557567&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488243	471698272							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176243	CCOc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(cc(CC6(CCCC6)C(O)=O)c5n4)C4CC4)nn3)c12	InChI=1S/C31H33ClN8O4/c1-2-44-27-23(32)7-10-38-18-34-24(26(27)38)13-33-29(41)25-17-40(37-36-25)16-22-15-39-14-21(19-5-6-19)11-20(28(39)35-22)12-31(30(42)43)8-3-4-9-31/h7,10-11,14-15,17-19H,2-6,8-9,12-13,16H2,1H3,(H,33,41)(H,42,43)	ZAKHZOFIGIZBQD-UHFFFAOYSA-N	455204	US10730874, Compound I-221a::US10730874, Compound I-221b::US10730874, Compound I-221c::US11352356, Compound I-221c	Plasma kallikrein					 55					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455204	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455204&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487912	440971029							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176244	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cc5ccc(Cl)cc5[nH]4)nn3)c12	InChI=1S/C20H14Cl2FN7O/c21-12-2-1-11-5-13(26-15(11)6-12)8-30-9-17(27-28-30)20(31)24-7-16-19-18(23)14(22)3-4-29(19)10-25-16/h1-6,9-10,26H,7-8H2,(H,24,31)	OFEKCDHORHPTSX-UHFFFAOYSA-N	557569	US11352356, Compound I-222	Plasma kallikrein					 1050					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557569	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557569&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487670	471698274							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176245	CCOC(=O)C(C)(C)Oc1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C28H28ClFN8O4/c1-4-41-27(40)28(2,3)42-22-9-17(16-5-6-16)11-37-12-18(33-25(22)37)13-38-14-21(34-35-38)26(39)31-10-20-24-23(30)19(29)7-8-36(24)15-32-20/h7-9,11-12,14-16H,4-6,10,13H2,1-3H3,(H,31,39)	MZULJSVETYOZBO-UHFFFAOYSA-N	455208	US10730874, Compound I-223::US11352356, Compound I-223	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455208	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455208&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487764	440971031							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176246	COC(=O)C(F)Cc1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C26H23ClF2N8O3/c1-40-26(39)19(28)7-15-6-16(14-2-3-14)9-36-10-17(32-24(15)36)11-37-12-21(33-34-37)25(38)30-8-20-23-22(29)18(27)4-5-35(23)13-31-20/h4-6,9-10,12-14,19H,2-3,7-8,11H2,1H3,(H,30,38)	RNIMQONMTOFHJL-UHFFFAOYSA-N	557571	US11352356, Compound I-224a	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557571	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557571&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488293	471698276							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176247	OC(=O)C(F)Cc1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C25H21ClF2N8O3/c26-17-3-4-34-12-30-19(22(34)21(17)28)7-29-24(37)20-11-36(33-32-20)10-16-9-35-8-15(13-1-2-13)5-14(23(35)31-16)6-18(27)25(38)39/h3-5,8-9,11-13,18H,1-2,6-7,10H2,(H,29,37)(H,38,39)	YAEVGJPDSUVOII-UHFFFAOYSA-N	557572	US11352356, Compound I-224b	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557572	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557572&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488049	471698277							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176248	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(cc(-c6cnoc6)c5n4)C4CC4)nn3)c12	InChI=1S/C25H19ClFN9O2/c26-19-3-4-34-13-29-20(23(34)22(19)27)7-28-25(37)21-11-36(33-32-21)10-17-9-35-8-15(14-1-2-14)5-18(24(35)31-17)16-6-30-38-12-16/h3-6,8-9,11-14H,1-2,7,10H2,(H,28,37)	AFGPDDAXHBLMJY-UHFFFAOYSA-N	455211	US10730874, Compound I-225::US11352356, Compound I-225	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455211	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455211&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487456	440971033							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176249	OC(=O)c1cn(cn1)-c1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C26H20ClFN10O3/c27-17-3-4-35-12-30-18(23(35)22(17)28)6-29-25(39)19-11-38(34-33-19)9-16-8-36-7-15(14-1-2-14)5-21(24(36)32-16)37-10-20(26(40)41)31-13-37/h3-5,7-8,10-14H,1-2,6,9H2,(H,29,39)(H,40,41)	UTYNLOXXNUTIPN-UHFFFAOYSA-N	455212	US10730874, Compound I-226::US11352356, Compound I-226	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455212	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455212&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487562	440971034							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176250	CCOC(=O)CC(c1cn2cc(ccc2n1)C1CC1)n1cc(nn1)C(=O)NCc1ncn2ccc(Cl)c(F)c12	InChI=1S/C26H24ClFN8O3/c1-2-39-23(37)9-21(19-12-35-11-16(15-3-4-15)5-6-22(35)31-19)36-13-20(32-33-36)26(38)29-10-18-25-24(28)17(27)7-8-34(25)14-30-18/h5-8,11-15,21H,2-4,9-10H2,1H3,(H,29,38)	BGPPCGQQHKYGOX-UHFFFAOYSA-N	557575	US11352356, Compound I-227a	Plasma kallikrein					 55					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557575	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557575&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487400	471698280							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176251	OC(=O)CC(c1cn2cc(ccc2n1)C1CC1)n1cc(nn1)C(=O)NCc1ncn2ccc(Cl)c(F)c12	InChI=1S/C24H20ClFN8O3/c25-15-5-6-32-12-28-16(23(32)22(15)26)8-27-24(37)18-11-34(31-30-18)19(7-21(35)36)17-10-33-9-14(13-1-2-13)3-4-20(33)29-17/h3-6,9-13,19H,1-2,7-8H2,(H,27,37)(H,35,36)	OEVKLKFLMHRIMC-UHFFFAOYSA-N	557576	US11352356, Compound I-227b	Plasma kallikrein					 1050					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557576	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557576&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488209	471698281							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176252	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(cc(C#C)c5n4)C4CC4)nn3)c12	InChI=1S/C24H18ClFN8O/c1-2-14-7-16(15-3-4-15)9-33-10-17(29-23(14)33)11-34-12-20(30-31-34)24(35)27-8-19-22-21(26)18(25)5-6-32(22)13-28-19/h1,5-7,9-10,12-13,15H,3-4,8,11H2,(H,27,35)	MAYHRVBMCWJNCC-UHFFFAOYSA-N	455215	US10730874, Compound I-228::US11352356, Compound I-228	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455215	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455215&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487642	440971037							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176253	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cc5ccc(cc5s4)C4CC4)nn3)c12	InChI=1S/C23H18ClFN6OS/c24-17-5-6-30-12-27-18(22(30)21(17)25)9-26-23(32)19-11-31(29-28-19)10-16-7-15-4-3-14(13-1-2-13)8-20(15)33-16/h3-8,11-13H,1-2,9-10H2,(H,26,32)	ZOEACGAPJNATPL-UHFFFAOYSA-N	455216	US10730874, Compound I-229::US11352356, Compound I-229	Plasma kallikrein					 55					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455216	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455216&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487274	440971038							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176254	COC(=O)c1cnn(c1)-c1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C27H22ClFN10O3/c1-42-27(41)17-7-32-39(10-17)22-6-16(15-2-3-15)9-37-11-18(33-25(22)37)12-38-13-21(34-35-38)26(40)30-8-20-24-23(29)19(28)4-5-36(24)14-31-20/h4-7,9-11,13-15H,2-3,8,12H2,1H3,(H,30,40)	HFHVIVQFIYJSBM-UHFFFAOYSA-N	557579	US11352356, Compound I-230	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557579	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557579&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139505083	471698284							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176255	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cc5cc(cc(n5n4)C(F)(F)F)C4CC4)nn3)c12	InChI=1S/C23H17ClF4N8O/c24-16-3-4-34-11-30-17(21(34)20(16)25)8-29-22(37)18-10-35(33-31-18)9-14-7-15-5-13(12-1-2-12)6-19(23(26,27)28)36(15)32-14/h3-7,10-12H,1-2,8-9H2,(H,29,37)	OEAPVMVSQWGEDQ-UHFFFAOYSA-N	455218	US10730874, Compound I-231::US11352356, Compound I-231	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455218	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455218&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488389	440971040							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176256	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cc5cc(ccc5[nH]4)C4CC4)nn3)c12	InChI=1S/C23H19ClFN7O/c24-17-5-6-31-12-27-19(22(31)21(17)25)9-26-23(33)20-11-32(30-29-20)10-16-8-15-7-14(13-1-2-13)3-4-18(15)28-16/h3-8,11-13,28H,1-2,9-10H2,(H,26,33)	XJVYSSFMEXUMCC-UHFFFAOYSA-N	455219	US10730874, Compound I-232::US11352356, Compound I-232	Plasma kallikrein					 55					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455219	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455219&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488084	440971041							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176257	Cn1c(Cn2cc(nn2)C(=O)NCc2ncn3ccc(Cl)c(F)c23)cc2cc(ccc12)C1CC1	InChI=1S/C24H21ClFN7O/c1-31-17(9-16-8-15(14-2-3-14)4-5-21(16)31)11-33-12-20(29-30-33)24(34)27-10-19-23-22(26)18(25)6-7-32(23)13-28-19/h4-9,12-14H,2-3,10-11H2,1H3,(H,27,34)	DDGPUUXNVFDGHE-UHFFFAOYSA-N	455220	US10730874, Compound I-233::US11352356, Compound I-233	Plasma kallikrein					 5.5					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455220	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455220&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487417	440971042							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176258	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cc5ccc(Cl)cc5s4)nn3)c12	InChI=1S/C20H13Cl2FN6OS/c21-12-2-1-11-5-13(31-17(11)6-12)8-29-9-16(26-27-29)20(30)24-7-15-19-18(23)14(22)3-4-28(19)10-25-15/h1-6,9-10H,7-8H2,(H,24,30)	UDQXMMRHILVFQM-UHFFFAOYSA-N	455221	US10730874, Compound I-234::US11352356, Compound I-234	Plasma kallikrein					 55					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455221	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455221&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487622	440971043							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176259	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cc5ccc(cc5[nH]4)C4CC4)nn3)c12	InChI=1S/C23H19ClFN7O/c24-17-5-6-31-12-27-19(22(31)21(17)25)9-26-23(33)20-11-32(30-29-20)10-16-7-15-4-3-14(13-1-2-13)8-18(15)28-16/h3-8,11-13,28H,1-2,9-10H2,(H,26,33)	QYHIARHHDXPSGM-UHFFFAOYSA-N	455222	US10730874, Compound I-235::US11352356, Compound I-235	Plasma kallikrein					 1050					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455222	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455222&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488015	440971044							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176260	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4nc5cc(ccc5[nH]4)C4CC4)nn3)c12	InChI=1S/C22H18ClFN8O/c23-14-5-6-31-11-26-17(21(31)20(14)24)8-25-22(33)18-9-32(30-29-18)10-19-27-15-4-3-13(12-1-2-12)7-16(15)28-19/h3-7,9,11-12H,1-2,8,10H2,(H,25,33)(H,27,28)	SHIXYCBIXKHBFS-UHFFFAOYSA-N	455223	US10730874, Compound I-236::US11352356, Compound I-236	Plasma kallikrein					 55					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455223	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455223&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488305	440971045							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176261	CC(C)(Cc1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1)C(O)=O	InChI=1S/C28H27ClFN7O3/c1-28(2,27(39)40)8-17-7-18(16-3-4-16)11-36-13-20(34-25(17)36)14-37-12-19(9-33-37)26(38)31-10-22-24-23(30)21(29)5-6-35(24)15-32-22/h5-7,9,11-13,15-16H,3-4,8,10,14H2,1-2H3,(H,31,38)(H,39,40)	HJMRZQSPPGPLHS-UHFFFAOYSA-N	455224	US10730874, Compound I-237::US11352356, Compound I-237	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455224	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455224&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139490610	440971046							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176262	CC(C)(Cc1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1)c1nn[nH]n1	InChI=1S/C28H27ClFN11O/c1-28(2,27-35-37-38-36-27)8-17-7-18(16-3-4-16)11-40-13-20(34-25(17)40)14-41-12-19(9-33-41)26(42)31-10-22-24-23(30)21(29)5-6-39(24)15-32-22/h5-7,9,11-13,15-16H,3-4,8,10,14H2,1-2H3,(H,31,42)(H,35,36,37,38)	SCCRXLRICSMLTR-UHFFFAOYSA-N	455225	US10730874, Compound I-238::US11352356, Compound I-238	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455225	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455225&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487855	440971047							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176263	Fc1cc2nc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)cn2cc1C1CC1	InChI=1S/C22H17ClF2N8O/c23-15-3-4-31-11-27-17(21(31)20(15)25)6-26-22(34)18-10-33(30-29-18)8-13-7-32-9-14(12-1-2-12)16(24)5-19(32)28-13/h3-5,7,9-12H,1-2,6,8H2,(H,26,34)	HRYGBZFKJOGIPQ-UHFFFAOYSA-N	557588	US11352356, Compound I-239	Plasma kallikrein					 5.5					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557588	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557588&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488013	471698293							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176264	Fc1c(Cn2cc(nn2)C(=O)NCc2ncn3ccc(Cl)c(F)c23)nc2ccc(cn12)C1CC1	InChI=1S/C22H17ClF2N8O/c23-14-5-6-31-11-27-15(20(31)19(14)24)7-26-22(34)17-10-32(30-29-17)9-16-21(25)33-8-13(12-1-2-12)3-4-18(33)28-16/h3-6,8,10-12H,1-2,7,9H2,(H,26,34)	FIYCBKFNXUXFBP-UHFFFAOYSA-N	455227	US10730874, Compound I-240::US11352356, Compound I-240	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455227	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455227&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488052	440971049							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176265	CCOC(=O)C(C)(C)C(O)c1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C29H30ClFN8O4/c1-4-43-28(42)29(2,3)25(40)19-9-17(16-5-6-16)11-38-12-18(34-26(19)38)13-39-14-22(35-36-39)27(41)32-10-21-24-23(31)20(30)7-8-37(24)15-33-21/h7-9,11-12,14-16,25,40H,4-6,10,13H2,1-3H3,(H,32,41)	NFXYWWHOOYWZPT-UHFFFAOYSA-N	455228	US10730874, Compound I-241a::US11352356, Compound I-241a	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455228	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455228&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487636	440971050							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176266	CC(C)(C(O)c1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1)C(O)=O	InChI=1S/C27H26ClFN8O4/c1-27(2,26(40)41)23(38)17-7-15(14-3-4-14)9-36-10-16(32-24(17)36)11-37-12-20(33-34-37)25(39)30-8-19-22-21(29)18(28)5-6-35(22)13-31-19/h5-7,9-10,12-14,23,38H,3-4,8,11H2,1-2H3,(H,30,39)(H,40,41)	OZZKRVWVWFHSDG-UHFFFAOYSA-N	455229	US10730874, Compound I-241b::US11352356, Compound I-241b	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455229	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455229&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487275	440971051							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176267	CCn1ncn(-c2cc(cn3cc(Cn4cc(nn4)C(=O)NCc4ncn5ccc(Cl)c(F)c45)nc23)C2CC2)c(=O)c1=O	InChI=1S/C27H23ClFN11O3/c1-2-40-27(43)26(42)39(14-32-40)21-7-16(15-3-4-15)9-37-10-17(33-24(21)37)11-38-12-20(34-35-38)25(41)30-8-19-23-22(29)18(28)5-6-36(23)13-31-19/h5-7,9-10,12-15H,2-4,8,11H2,1H3,(H,30,41)	XPDLVYUDGVDSQA-UHFFFAOYSA-N	455230	US10730874, Compound I-242::US11352356, Compound I-242	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455230	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455230&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155883683	440971052							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176268	Fc1c(Cl)ccn2cnc(CNC(=O)c3nnc(o3)C(F)(F)c3cn4cc(ccc4n3)C3CC3)c12	InChI=1S/C22H15ClF3N7O2/c23-13-5-6-32-10-28-14(18(32)17(13)24)7-27-19(34)20-30-31-21(35-20)22(25,26)15-9-33-8-12(11-1-2-11)3-4-16(33)29-15/h3-6,8-11H,1-2,7H2,(H,27,34)	OLBRMLDSQFMHGN-UHFFFAOYSA-N	455231	US10730874, Compound I-243::US11352356, Compound I-243	Plasma kallikrein					 5.5					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455231	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455231&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488297	440971053							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176269	COC(=O)Cn1c(Cn2cc(nn2)C(=O)NCc2ncn3ccc(Cl)c(F)c23)cc2cc(ccc12)C1CC1	InChI=1S/C26H23ClFN7O3/c1-38-23(36)13-35-18(9-17-8-16(15-2-3-15)4-5-22(17)35)11-34-12-21(31-32-34)26(37)29-10-20-25-24(28)19(27)6-7-33(25)14-30-20/h4-9,12,14-15H,2-3,10-11,13H2,1H3,(H,29,37)	CARKALGDYODXNI-UHFFFAOYSA-N	455232	US10730874, Compound I-244::US11352356, Compound I-244	Plasma kallikrein					 55					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455232	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455232&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488148	440971054							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176270	CCOC(=O)C(C)Cc1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C28H28ClFN8O3/c1-3-41-28(40)16(2)8-18-9-19(17-4-5-17)11-37-12-20(33-26(18)37)13-38-14-23(34-35-38)27(39)31-10-22-25-24(30)21(29)6-7-36(25)15-32-22/h6-7,9,11-12,14-17H,3-5,8,10,13H2,1-2H3,(H,31,39)	DWFQWYQWENUHKB-UHFFFAOYSA-N	455233	US10730874, Compound I-245a::US11352356, Compound I-245a	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455233	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455233&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488291	440971055							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176271	CC(Cc1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1)C(O)=O	InChI=1S/C26H24ClFN8O3/c1-14(26(38)39)6-16-7-17(15-2-3-15)9-35-10-18(31-24(16)35)11-36-12-21(32-33-36)25(37)29-8-20-23-22(28)19(27)4-5-34(23)13-30-20/h4-5,7,9-10,12-15H,2-3,6,8,11H2,1H3,(H,29,37)(H,38,39)	SKNDRGROUPZYJA-UHFFFAOYSA-N	455234	US10730874, Compound I-245b::US11352356, Compound I-245b	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455234	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455234&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488269	440971056							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176272	OC(=O)Cn1c(Cn2cc(nn2)C(=O)NCc2ncn3ccc(Cl)c(F)c23)cc2cc(ccc12)C1CC1	InChI=1S/C25H21ClFN7O3/c26-18-5-6-32-13-29-19(24(32)23(18)27)9-28-25(37)20-11-33(31-30-20)10-17-8-16-7-15(14-1-2-14)3-4-21(16)34(17)12-22(35)36/h3-8,11,13-14H,1-2,9-10,12H2,(H,28,37)(H,35,36)	YMRXVMCXMGDLPL-UHFFFAOYSA-N	455235	US10730874, Compound I-246::US11352356, Compound I-246	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455235	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455235&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488221	471695251							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176273	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(cc(-n6cn[nH]c(=O)c6=O)c5n4)C4CC4)nn3)c12	InChI=1S/C25H19ClFN11O3/c26-16-3-4-35-11-29-17(21(35)20(16)27)6-28-23(39)18-10-37(34-32-18)9-15-8-36-7-14(13-1-2-13)5-19(22(36)31-15)38-12-30-33-24(40)25(38)41/h3-5,7-8,10-13H,1-2,6,9H2,(H,28,39)(H,33,40)	NFRQQTRYGIYGMO-UHFFFAOYSA-N	455236	US10730874, Compound I-247::US11352356, Compound I-247	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455236	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455236&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155883684	440971057							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176274	CCOC(=O)c1nncn1-c1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C27H23ClFN11O3/c1-2-43-27(42)25-35-32-14-40(25)21-7-16(15-3-4-15)9-38-10-17(33-24(21)38)11-39-12-20(34-36-39)26(41)30-8-19-23-22(29)18(28)5-6-37(23)13-31-19/h5-7,9-10,12-15H,2-4,8,11H2,1H3,(H,30,41)	NDOLKRIZGJGJOH-UHFFFAOYSA-N	455237	US10730874, Compound I-248::US11352356, Compound I-248	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455237	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455237&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487829	440971058							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176275	Cc1nncn1-c1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C25H21ClFN11O/c1-14-32-30-13-38(14)21-6-16(15-2-3-15)8-36-9-17(31-24(21)36)10-37-11-20(33-34-37)25(39)28-7-19-23-22(27)18(26)4-5-35(23)12-29-19/h4-6,8-9,11-13,15H,2-3,7,10H2,1H3,(H,28,39)	YCJBZBXZGIDXDX-UHFFFAOYSA-N	455238	US10730874, Compound I-249::US11352356, Compound I-249	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455238	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455238&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488147	440971059							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176276	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(cc(N6CC7(COC7)C6)c5n4)C4CC4)nn3)c12	InChI=1S/C27H25ClFN9O2/c28-19-3-4-35-15-31-20(24(35)23(19)29)6-30-26(39)21-10-38(34-33-21)9-18-8-36-7-17(16-1-2-16)5-22(25(36)32-18)37-11-27(12-37)13-40-14-27/h3-5,7-8,10,15-16H,1-2,6,9,11-14H2,(H,30,39)	AWWPNDXFOZUTGX-UHFFFAOYSA-N	455239	US10730874, Compound I-250::US11352356, Compound I-250	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455239	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455239&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487839	440971060							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176277	CCOC(=O)CCn1c(Cn2cc(nn2)C(=O)NCc2ncn3ccc(Cl)c(F)c23)cc2cc(ccc12)C1CC1	InChI=1S/C28H27ClFN7O3/c1-2-40-25(38)8-10-37-20(12-19-11-18(17-3-4-17)5-6-24(19)37)14-36-15-23(33-34-36)28(39)31-13-22-27-26(30)21(29)7-9-35(27)16-32-22/h5-7,9,11-12,15-17H,2-4,8,10,13-14H2,1H3,(H,31,39)	XFPMNJNQDSEDHM-UHFFFAOYSA-N	455241	US10730874, Compound I-251b::US11352356, Compound I-251a	Plasma kallikrein					 5.5					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455241	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455241&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488113	440971062							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176278	OC(=O)CCn1c(Cn2cc(nn2)C(=O)NCc2ncn3ccc(Cl)c(F)c23)cc2cc(ccc12)C1CC1	InChI=1S/C26H23ClFN7O3/c27-19-5-7-33-14-30-20(25(33)24(19)28)11-29-26(38)21-13-34(32-31-21)12-18-10-17-9-16(15-1-2-15)3-4-22(17)35(18)8-6-23(36)37/h3-5,7,9-10,13-15H,1-2,6,8,11-12H2,(H,29,38)(H,36,37)	VOMPCERFIBJDSW-UHFFFAOYSA-N	455240	US10730874, Compound I-251a::US11352356, Compound I-251b	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455240	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455240&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487926	440971061							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176279	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4nc5ccc(cc5s4)C4CC4)nn3)c12	InChI=1S/C22H17ClFN7OS/c23-14-5-6-30-11-26-16(21(30)20(14)24)8-25-22(32)17-9-31(29-28-17)10-19-27-15-4-3-13(12-1-2-12)7-18(15)33-19/h3-7,9,11-12H,1-2,8,10H2,(H,25,32)	QFQJJMPYEJONGW-UHFFFAOYSA-N	455242	US10730874, Compound I-252::US11352356, Compound I-252	Plasma kallikrein					 55					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455242	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455242&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487897	440971063							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176280	Cc1nnc(C)n1-c1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C26H23ClFN11O/c1-14-32-33-15(2)39(14)22-7-17(16-3-4-16)9-37-10-18(31-25(22)37)11-38-12-21(34-35-38)26(40)29-8-20-24-23(28)19(27)5-6-36(24)13-30-20/h5-7,9-10,12-13,16H,3-4,8,11H2,1-2H3,(H,29,40)	PCZUSEDWBDEHIR-UHFFFAOYSA-N	455243	US10730874, Compound I-253::US11352356, Compound I-253	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455243	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455243&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487874	440971064							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176281	COC(=O)c1ccc(cc1)-n1c(Cn2cc(nn2)C(=O)NCc2ncn3ccc(Cl)c(F)c23)cc2cc(ccc12)C1CC1	InChI=1S/C31H25ClFN7O3/c1-43-31(42)19-4-7-22(8-5-19)40-23(13-21-12-20(18-2-3-18)6-9-27(21)40)15-39-16-26(36-37-39)30(41)34-14-25-29-28(33)24(32)10-11-38(29)17-35-25/h4-13,16-18H,2-3,14-15H2,1H3,(H,34,41)	VPHHTERWGSFUGV-UHFFFAOYSA-N	455244	US10730874, Compound I-254::US11352356, Compound I-254	Plasma kallikrein					 5.5					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455244	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455244&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487835	440971065							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176282	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4nc5cc(cc(Cl)n5n4)C4CC4)nn3)c12	InChI=1S/C21H16Cl2FN9O/c22-13-3-4-31-10-26-14(20(31)19(13)24)7-25-21(34)15-8-32(30-28-15)9-17-27-18-6-12(11-1-2-11)5-16(23)33(18)29-17/h3-6,8,10-11H,1-2,7,9H2,(H,25,34)	NZPWPFJMHGOWNW-UHFFFAOYSA-N	455245	US10730874, Compound I-255::US11352356, Compound I-255	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455245	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455245&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487813	440971066							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176283	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cc5ccc(cn5c4)C4CC4)nn3)c12	InChI=1S/C23H19ClFN7O/c24-18-5-6-30-13-27-19(22(30)21(18)25)8-26-23(33)20-12-32(29-28-20)10-14-7-17-4-3-16(15-1-2-15)11-31(17)9-14/h3-7,9,11-13,15H,1-2,8,10H2,(H,26,33)	MORSAJTYBNUHRL-UHFFFAOYSA-N	455246	US10730874, Compound I-256::US11352356, Compound I-256	Plasma kallikrein					 5.5					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455246	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455246&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488295	440971067							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176284	Cc1ncc(s1)-c1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C26H21ClFN9OS/c1-14-29-8-22(39-14)18-6-16(15-2-3-15)9-36-10-17(32-25(18)36)11-37-12-21(33-34-37)26(38)30-7-20-24-23(28)19(27)4-5-35(24)13-31-20/h4-6,8-10,12-13,15H,2-3,7,11H2,1H3,(H,30,38)	WTMMADILQWOTEV-UHFFFAOYSA-N	455247	US10730874, Compound I-257::US11352356, Compound I-257	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455247	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455247&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487513	440971068							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176285	Cc1ncn(n1)-c1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C25H21ClFN11O/c1-14-29-13-38(33-14)21-6-16(15-2-3-15)8-36-9-17(31-24(21)36)10-37-11-20(32-34-37)25(39)28-7-19-23-22(27)18(26)4-5-35(23)12-30-19/h4-6,8-9,11-13,15H,2-3,7,10H2,1H3,(H,28,39)	IJRHLSLXZJLQLB-UHFFFAOYSA-N	557610	US11352356, Compound I-258	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557610	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557610&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488044	471698315							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176286	OC(=O)c1ccc(cc1)-n1c(Cn2cc(nn2)C(=O)NCc2ncn3ccc(Cl)c(F)c23)cc2cc(ccc12)C1CC1	InChI=1S/C30H23ClFN7O3/c31-23-9-10-37-16-34-24(28(37)27(23)32)13-33-29(40)25-15-38(36-35-25)14-22-12-20-11-19(17-1-2-17)5-8-26(20)39(22)21-6-3-18(4-7-21)30(41)42/h3-12,15-17H,1-2,13-14H2,(H,33,40)(H,41,42)	HMQMBBYTPJFINU-UHFFFAOYSA-N	455249	US10730874, Compound I-259::US11352356, Compound I-259	Plasma kallikrein					 5.5					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455249	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455249&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487713	471695252							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176287	CCOC(=O)c1nc(cn1Cc1cn2cc(ccc2n1)C1CC1)C(=O)NCc1ncn2ccc(Cl)c(F)c12	InChI=1S/C26H23ClFN7O3/c1-2-38-26(37)24-32-20(25(36)29-9-19-23-22(28)18(27)7-8-33(23)14-30-19)13-35(24)12-17-11-34-10-16(15-3-4-15)5-6-21(34)31-17/h5-8,10-11,13-15H,2-4,9,12H2,1H3,(H,29,36)	MQMYUXQXYJPBOV-UHFFFAOYSA-N	455250	US10730874, Compound I-260::US11352356, Compound I-260	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455250	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455250&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488252	440971070							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176288	OC(=O)c1nc(cn1Cc1cn2cc(ccc2n1)C1CC1)C(=O)NCc1ncn2ccc(Cl)c(F)c12	InChI=1S/C24H19ClFN7O3/c25-16-5-6-31-12-28-17(21(31)20(16)26)7-27-23(34)18-11-33(22(30-18)24(35)36)10-15-9-32-8-14(13-1-2-13)3-4-19(32)29-15/h3-6,8-9,11-13H,1-2,7,10H2,(H,27,34)(H,35,36)	QRIAWBAEIRHTDP-UHFFFAOYSA-N	455251	BDBM455263::US10730874, Compound I-261::US11352356, Compound I-261	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455251	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455251&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487725	471695253							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176289	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cc5cc(cc(N6CCCC6=O)n5n4)C4CC4)nn3)c12	InChI=1S/C26H23ClFN9O2/c27-19-5-7-34-14-30-20(25(34)24(19)28)11-29-26(39)21-13-35(33-31-21)12-17-10-18-8-16(15-3-4-15)9-22(37(18)32-17)36-6-1-2-23(36)38/h5,7-10,13-15H,1-4,6,11-12H2,(H,29,39)	VNYUOYWQIICEJF-UHFFFAOYSA-N	455252	US10730874, Compound I-262::US11352356, Compound I-262	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455252	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455252&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488322	440971071							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176290	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(cc(-c6cncs6)c5n4)C4CC4)nn3)c12	InChI=1S/C25H19ClFN9OS/c26-18-3-4-34-12-30-19(23(34)22(18)27)6-29-25(37)20-11-36(33-32-20)10-16-9-35-8-15(14-1-2-14)5-17(24(35)31-16)21-7-28-13-38-21/h3-5,7-9,11-14H,1-2,6,10H2,(H,29,37)	AZUCKQGHHWSZRR-UHFFFAOYSA-N	557615	US11352356, Compound I-263	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557615	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557615&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487904	471698320							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176291	OC(=O)C1CN(CCO1)c1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C27H25ClFN9O4/c28-18-3-4-36-14-31-19(24(36)23(18)29)8-30-26(39)20-12-38(34-33-20)11-17-10-37-9-16(15-1-2-15)7-21(25(37)32-17)35-5-6-42-22(13-35)27(40)41/h3-4,7,9-10,12,14-15,22H,1-2,5-6,8,11,13H2,(H,30,39)(H,40,41)	IDYUTGDBQUKFPD-UHFFFAOYSA-N	557616	US11352356, Compound I-264	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557616	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557616&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487762	471698321							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176292	COC(=O)C1CN(C1)c1cc(nn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C26H24ClFN10O3/c1-41-26(40)15-8-36(9-15)21-6-18(14-2-3-14)33-38-11-16(31-24(21)38)10-37-12-20(32-34-37)25(39)29-7-19-23-22(28)17(27)4-5-35(23)13-30-19/h4-6,11-15H,2-3,7-10H2,1H3,(H,29,39)	WCUZZJJIYBJJMV-UHFFFAOYSA-N	455255	US10730874, Compound I-265a::US11352356, Compound I-265a	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455255	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455255&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487530	440971074							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176293	OC(=O)C1CN(C1)c1cc(nn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C25H22ClFN10O3/c26-16-3-4-34-12-29-18(22(34)21(16)27)6-28-24(38)19-11-36(33-31-19)9-15-10-37-23(30-15)20(5-17(32-37)13-1-2-13)35-7-14(8-35)25(39)40/h3-5,10-14H,1-2,6-9H2,(H,28,38)(H,39,40)	VVBVZHUNSUIZJA-UHFFFAOYSA-N	455256	US10730874, Compound I-265b::US11352356, Compound I-265b	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455256	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455256&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488072	440971075							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176294	COC(=O)C1CCN(C1)c1cc(nn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C27H26ClFN10O3/c1-42-27(41)16-4-6-36(10-16)22-8-19(15-2-3-15)34-39-12-17(32-25(22)39)11-38-13-21(33-35-38)26(40)30-9-20-24-23(29)18(28)5-7-37(24)14-31-20/h5,7-8,12-16H,2-4,6,9-11H2,1H3,(H,30,40)	DPTXWIJTPPUXFX-UHFFFAOYSA-N	455257	US10730874, Compound I-266::US11352356, Compound I-266	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455257	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455257&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487566	440971076							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176295	OC(=O)C1CCN(C1)c1cc(nn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C26H24ClFN10O3/c27-17-4-6-36-13-30-19(23(36)22(17)28)8-29-25(39)20-12-37(34-32-20)10-16-11-38-24(31-16)21(7-18(33-38)14-1-2-14)35-5-3-15(9-35)26(40)41/h4,6-7,11-15H,1-3,5,8-10H2,(H,29,39)(H,40,41)	SUNUKMYKABZUNE-UHFFFAOYSA-N	455258	US10730874, Compound I-267::US11352356, Compound I-267	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455258	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455258&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487317	471695254							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176296	CCOC(=O)c1c(Cn2cc(nn2)C(=O)NCc2ncn3ccc(Cl)c(F)c23)cc2ccc(cn12)C1CC1	InChI=1S/C26H23ClFN7O3/c1-2-38-26(37)23-17(9-18-6-5-16(12-35(18)23)15-3-4-15)11-34-13-21(31-32-34)25(36)29-10-20-24-22(28)19(27)7-8-33(24)14-30-20/h5-9,12-15H,2-4,10-11H2,1H3,(H,29,36)	JDFNPHKJAYAIDT-UHFFFAOYSA-N	455259	US10730874, Compound I-268::US11352356, Compound I-268	Plasma kallikrein					 5.5					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455259	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455259&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487790	440971077							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176297	Cc1c(C)c2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)ccc2n1C	InChI=1S/C23H21ClFN7O/c1-13-14(2)30(3)20-5-4-15(8-16(13)20)10-32-11-19(28-29-32)23(33)26-9-18-22-21(25)17(24)6-7-31(22)12-27-18/h4-8,11-12H,9-10H2,1-3H3,(H,26,33)	XYYCBPGDXBGUAX-UHFFFAOYSA-N	455260	US10730874, Compound I-269::US11352356, Compound I-269	Plasma kallikrein					 5.5					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455260	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455260&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488107	440971078							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176298	COC(=O)c1cc(cn1Cc1cn2cc(ccc2n1)C1CC1)C(=O)NCc1ncn2ccc(Cl)c(F)c12	InChI=1S/C26H22ClFN6O3/c1-37-26(36)21-8-17(25(35)29-9-20-24-23(28)19(27)6-7-32(24)14-30-20)11-33(21)12-18-13-34-10-16(15-2-3-15)4-5-22(34)31-18/h4-8,10-11,13-15H,2-3,9,12H2,1H3,(H,29,35)	GFWSTLBWNVUUNX-UHFFFAOYSA-N	455261	US10730874, Compound I-270a::US11352356, Compound I-270a	Plasma kallikrein					 5.5					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455261	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455261&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487457	440971079							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176299	OC(=O)c1cc(cn1Cc1cn2cc(ccc2n1)C1CC1)C(=O)NCc1ncn2ccc(Cl)c(F)c12	InChI=1S/C25H20ClFN6O3/c26-18-5-6-31-13-29-19(23(31)22(18)27)8-28-24(34)16-7-20(25(35)36)32(10-16)11-17-12-33-9-15(14-1-2-14)3-4-21(33)30-17/h3-7,9-10,12-14H,1-2,8,11H2,(H,28,34)(H,35,36)	PUBUNCLOYXZPKC-UHFFFAOYSA-N	455262	US10730874, Compound I-270b::US11352356, Compound I-270b	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455262	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455262&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488190	440971080							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176300	OC(=O)c1nc(cn1Cc1cn2cc(ccc2n1)C1CC1)C(=O)NCc1ncn2ccc(Cl)c(F)c12	InChI=1S/C24H19ClFN7O3/c25-16-5-6-31-12-28-17(21(31)20(16)26)7-27-23(34)18-11-33(22(30-18)24(35)36)10-15-9-32-8-14(13-1-2-13)3-4-19(32)29-15/h3-6,8-9,11-13H,1-2,7,10H2,(H,27,34)(H,35,36)	QRIAWBAEIRHTDP-UHFFFAOYSA-N	455251	BDBM455263::US10730874, Compound I-261::US11352356, Compound I-261	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455251	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455251&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487725	471695253							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176301	CC(C)(C)[Si](OCC1(COC1)C(O)c1cc(cn2cc(Cn3cc(nn3)C(=O)OCc3ccccc3)nc12)C1CC1)(c1ccccc1)c1ccccc1	InChI=1S/C42H45N5O5Si/c1-41(2,3)53(34-15-9-5-10-16-34,35-17-11-6-12-18-35)52-29-42(27-50-28-42)38(48)36-21-32(31-19-20-31)22-46-23-33(43-39(36)46)24-47-25-37(44-45-47)40(49)51-26-30-13-7-4-8-14-30/h4-18,21-23,25,31,38,48H,19-20,24,26-29H2,1-3H3	XQSRQNAYNXHMHM-UHFFFAOYSA-N	557626	US11352356, Compound I-272	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557626	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557626&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			152437377	471698331							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176302	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cc(C#N)c5ncc(cc5c4)C4CC4)nn3)c12	InChI=1S/C25H18ClFN8O/c26-19-3-4-34-13-31-20(24(34)22(19)27)10-30-25(36)21-12-35(33-32-21)11-14-5-16-7-18(15-1-2-15)9-29-23(16)17(6-14)8-28/h3-7,9,12-13,15H,1-2,10-11H2,(H,30,36)	NJFYJOMANHGWBX-UHFFFAOYSA-N	557627	US11352356, Compound I-273	Plasma kallikrein					 5.5					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557627	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557627&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487353	471698332							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176303	COC(=O)c1c(Cn2cc(nn2)C(=O)OC(C)(C)C)n(COCC[Si](C)(C)C)c2cc(ccc12)C1CC1	InChI=1S/C27H38N4O5Si/c1-27(2,3)36-25(32)21-15-30(29-28-21)16-23-24(26(33)34-4)20-11-10-19(18-8-9-18)14-22(20)31(23)17-35-12-13-37(5,6)7/h10-11,14-15,18H,8-9,12-13,16-17H2,1-7H3	OVLMKNSPPCXEML-UHFFFAOYSA-N	557628	US11352356, Compound I-274	Plasma kallikrein					 1050					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557628	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557628&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			151395974	471698333							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176304	NC(=O)c1cc(Cn2cc(nn2)C(=O)NCc2ncn3ccc(Cl)c(F)c23)cc2cc(cnc12)C1CC1	InChI=1S/C25H20ClFN8O2/c26-18-3-4-34-12-31-19(23(34)21(18)27)9-30-25(37)20-11-35(33-32-20)10-13-5-15-7-16(14-1-2-14)8-29-22(15)17(6-13)24(28)36/h3-8,11-12,14H,1-2,9-10H2,(H2,28,36)(H,30,37)	BILHIKZWAIIMIU-UHFFFAOYSA-N	455267	US10730874, Compound I-275::US11352356, Compound I-275	Plasma kallikrein					 55					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455267	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455267&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487815	440971085							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176305	Fc1c(Cl)ccn2cnc(CNC(=O)c3ccn(Cc4cn5cc(ccc5n4)C4CC4)c3)c12	InChI=1S/C24H20ClFN6O/c25-19-6-8-31-14-28-20(23(31)22(19)26)9-27-24(33)17-5-7-30(10-17)12-18-13-32-11-16(15-1-2-15)3-4-21(32)29-18/h3-8,10-11,13-15H,1-2,9,12H2,(H,27,33)	AMUWISREKFTEKP-UHFFFAOYSA-N	455268	US10730874, Compound I-276::US11352356, Compound I-276	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455268	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455268&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487661	440971086							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176306	Fc1cn2cnc(CNC(=O)c3cn(Cc4cn5cc(ccc5n4)C4CC4)nn3)c2cc1Cl	InChI=1S/C22H18ClFN8O/c23-16-5-20-18(26-12-31(20)10-17(16)24)6-25-22(33)19-11-32(29-28-19)9-15-8-30-7-14(13-1-2-13)3-4-21(30)27-15/h3-5,7-8,10-13H,1-2,6,9H2,(H,25,33)	BZKHXEZUKFAFOG-UHFFFAOYSA-N	455269	US10730874, Compound I-277::US11352356, Compound I-277	Plasma kallikrein					 55					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455269	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455269&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487411	440971087							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176307	CC(NC(=O)c1cn(nn1)C(C)c1cn2cc(ccc2n1)C1CC1)c1ncn2ccc(Cl)c(F)c12	InChI=1S/C24H22ClFN8O/c1-13(22-23-21(26)17(25)7-8-32(23)12-27-22)28-24(35)19-11-34(31-30-19)14(2)18-10-33-9-16(15-3-4-15)5-6-20(33)29-18/h5-15H,3-4H2,1-2H3,(H,28,35)	GRUPCZYPBIIPSA-UHFFFAOYSA-N	455270	US10730874, Compound I-278::US11352356, Compound I-278	Plasma kallikrein					 1050					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455270	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455270&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488380	440971088							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176308	OC(C1COC1)c1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C26H24ClFN8O3/c27-19-3-4-34-13-30-20(23(34)22(19)28)6-29-26(38)21-10-36(33-32-21)9-17-8-35-7-15(14-1-2-14)5-18(25(35)31-17)24(37)16-11-39-12-16/h3-5,7-8,10,13-14,16,24,37H,1-2,6,9,11-12H2,(H,29,38)	ANJUXYVWPPFEHI-UHFFFAOYSA-N	455271	US10730874, Compound I-279::US11352356, Compound I-279	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455271	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455271&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487354	440971089							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176309	CC(NC(=O)c1cn(Cc2cn3cc(cc(C(O)C4COC4)c3n2)C2CC2)nn1)c1ncn2ccc(Cl)c(F)c12	InChI=1S/C27H26ClFN8O3/c1-14(23-24-22(29)20(28)4-5-35(24)13-30-23)31-27(39)21-10-37(34-33-21)9-18-8-36-7-16(15-2-3-15)6-19(26(36)32-18)25(38)17-11-40-12-17/h4-8,10,13-15,17,25,38H,2-3,9,11-12H2,1H3,(H,31,39)	VLWOOFCIHAHAPJ-UHFFFAOYSA-N	455272	US10730874, Compound I-280::US11352356, Compound I-280	Plasma kallikrein					 55					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455272	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455272&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487320	440971090							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176310	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(cc(CS(=O)(=O)NCC(F)(F)F)c5n4)C4CC4)nn3)c12	InChI=1S/C25H22ClF4N9O3S/c26-18-3-4-37-13-32-19(22(37)21(18)27)6-31-24(40)20-10-39(36-35-20)9-17-8-38-7-15(14-1-2-14)5-16(23(38)34-17)11-43(41,42)33-12-25(28,29)30/h3-5,7-8,10,13-14,33H,1-2,6,9,11-12H2,(H,31,40)	JCBINPZGFRKSJU-UHFFFAOYSA-N	455273	US10730874, Compound I-281::US11352356, Compound I-281	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455273	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455273&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487999	440971091							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176311	Fc1c(Cl)ccn2cnc(CNC(=O)c3cnn(Cc4nc5ccccn5n4)c3)c12	InChI=1S/C19H14ClFN8O/c20-13-4-6-27-11-23-14(18(27)17(13)21)8-22-19(30)12-7-24-28(9-12)10-15-25-16-3-1-2-5-29(16)26-15/h1-7,9,11H,8,10H2,(H,22,30)	CULJZVGPACAFDQ-UHFFFAOYSA-N	455274	US10730874, Compound I-282::US11352356, Compound I-282	Plasma kallikrein					 1050					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455274	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455274&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487976	440971092							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176312	OC(=O)c1c(Cn2cc(nn2)C(=O)NCc2ncn3ccc(Cl)c(F)c23)[nH]c2cc(ccc12)C1CC1	InChI=1S/C24H19ClFN7O3/c25-15-5-6-32-11-28-17(22(32)21(15)26)8-27-23(34)19-10-33(31-30-19)9-18-20(24(35)36)14-4-3-13(12-1-2-12)7-16(14)29-18/h3-7,10-12,29H,1-2,8-9H2,(H,27,34)(H,35,36)	SRZVOUXOYHHDQR-UHFFFAOYSA-N	455266	BDBM455275::US10730874, Compound I-274	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455266	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455266&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487810	440971084							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176313	Fc1c(Cl)ccn2cnc(CNC(=O)c3cnn(Cc4cn5ccccc5n4)c3)c12	InChI=1S/C20H15ClFN7O/c21-15-4-6-28-12-24-16(19(28)18(15)22)8-23-20(30)13-7-25-29(9-13)11-14-10-27-5-2-1-3-17(27)26-14/h1-7,9-10,12H,8,11H2,(H,23,30)	SRXDUMJRVNFNCU-UHFFFAOYSA-N	455276	US10730874, Compound I-284::US11352356, Compound I-284	Plasma kallikrein					 55					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455276	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455276&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488050	440971094							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176314	Fc1c(Cl)ccn2cnc(CNC(=O)c3cnn(Cc4cn5ncccc5n4)c3)c12	InChI=1S/C19H14ClFN8O/c20-14-3-5-27-11-23-15(18(27)17(14)21)7-22-19(30)12-6-25-28(8-12)9-13-10-29-16(26-13)2-1-4-24-29/h1-6,8,10-11H,7,9H2,(H,22,30)	MMPYVAQWIZLLEO-UHFFFAOYSA-N	455277	US10730874, Compound I-285::US11352356, Compound I-285	Plasma kallikrein					 55					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455277	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455277&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488226	440971095							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176315	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5ccccc5n4)nn3)c12	InChI=1S/C19H14ClFN8O/c20-13-4-6-28-11-23-14(18(28)17(13)21)7-22-19(30)15-10-29(26-25-15)9-12-8-27-5-2-1-3-16(27)24-12/h1-6,8,10-11H,7,9H2,(H,22,30)	MWMIWGWQBRCKCE-UHFFFAOYSA-N	455278	US10730874, Compound I-286::US11352356, Compound I-286	Plasma kallikrein					 55					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455278	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455278&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488043	440971096							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176316	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4nc5ccccn5n4)nn3)c12	InChI=1S/C18H13ClFN9O/c19-11-4-6-27-10-22-12(17(27)16(11)20)7-21-18(30)13-8-28(26-24-13)9-14-23-15-3-1-2-5-29(15)25-14/h1-6,8,10H,7,9H2,(H,21,30)	PHYWGECHSHCECS-UHFFFAOYSA-N	455279	US10730874, Compound I-287::US11352356, Compound I-287	Plasma kallikrein					 1050					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455279	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455279&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487736	440971097							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176317	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5nc(ccc5n4)C4CC4)cn3)c12	InChI=1S/C22H18ClFN8O/c23-15-5-6-31-12-27-17(21(31)20(15)24)7-25-22(33)18-10-30(11-26-18)8-14-9-32-19(28-14)4-3-16(29-32)13-1-2-13/h3-6,9-13H,1-2,7-8H2,(H,25,33)	ZYERBHNUHACZNF-UHFFFAOYSA-N	455280	US10730874, Compound I-288::US11352356, Compound I-288	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455280	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455280&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487740	440971098							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176318	Fc1c(Cl)ccn2cnc(CNC(=O)c3nnn(Cc4cn5nc(ccc5n4)C4CC4)n3)c12	InChI=1S/C20H16ClFN10O/c21-13-5-6-30-10-24-15(18(30)17(13)22)7-23-20(33)19-26-29-32(28-19)9-12-8-31-16(25-12)4-3-14(27-31)11-1-2-11/h3-6,8,10-11H,1-2,7,9H2,(H,23,33)	KJQMWGXATUXRIG-UHFFFAOYSA-N	455281	US10730874, Compound I-289::US11352356, Compound I-289	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455281	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455281&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488098	440971099							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176319	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5ncccc5n4)nn3)c12	InChI=1S/C18H13ClFN9O/c19-12-3-5-27-10-22-13(17(27)16(12)20)6-21-18(30)14-9-28(26-25-14)7-11-8-29-15(24-11)2-1-4-23-29/h1-5,8-10H,6-7H2,(H,21,30)	HWFRTGURAIEHHD-UHFFFAOYSA-N	455282	US10730874, Compound I-290::US11352356, Compound I-290	Plasma kallikrein					 55					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455282	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455282&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488117	440971100							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51433767	NCc1cccc(c1)-n1cccn1	InChI=1S/C10H11N3/c11-8-9-3-1-4-10(7-9)13-6-2-5-12-13/h1-7H,8,11H2	YWZKZHCZKIKAAC-UHFFFAOYSA-N	50579233	CHEMBL1622853	Plasma kallikrein			 3400000							ChEMBL	10.1021/acs.jmedchem.1c00511	10.7270/Q29C7288	34436898			Kotian, PL; Wu, M; Vadlakonda, S; Chintareddy, V; Lu, P; Juarez, L; Kellogg-Yelder, D; Chen, X; Muppa, S; Chambers-Wilson, R; Davis Parker, C; Williams, J; Polach, KJ; Zhang, W; Raman, K; Babu, YS	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50579233	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50579233&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	913	4ABE	730097	471055356							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51433768	NCc1cccc(c1)-n1ccc(n1)C(F)(F)F	InChI=1S/C11H10F3N3/c12-11(13,14)10-4-5-17(16-10)9-3-1-2-8(6-9)7-15/h1-6H,7,15H2	KOBBHNJIQFDDHJ-UHFFFAOYSA-N	50579234	CHEMBL4873539	Plasma kallikrein			 1000000							ChEMBL	10.1021/acs.jmedchem.1c00511	10.7270/Q29C7288	34436898			Kotian, PL; Wu, M; Vadlakonda, S; Chintareddy, V; Lu, P; Juarez, L; Kellogg-Yelder, D; Chen, X; Muppa, S; Chambers-Wilson, R; Davis Parker, C; Williams, J; Polach, KJ; Zhang, W; Raman, K; Babu, YS	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50579234	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50579234&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			63941712	471055357							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51433769	NCc1cccc(c1)-n1nc(cc1C(O)=O)C(F)(F)F	InChI=1S/C12H10F3N3O2/c13-12(14,15)10-5-9(11(19)20)18(17-10)8-3-1-2-7(4-8)6-16/h1-5H,6,16H2,(H,19,20)	AMUXDCKKFCHHLY-UHFFFAOYSA-N	50579235	CHEMBL4876796	Plasma kallikrein			 15400							ChEMBL	10.1021/acs.jmedchem.1c00511	10.7270/Q29C7288	34436898			Kotian, PL; Wu, M; Vadlakonda, S; Chintareddy, V; Lu, P; Juarez, L; Kellogg-Yelder, D; Chen, X; Muppa, S; Chambers-Wilson, R; Davis Parker, C; Williams, J; Polach, KJ; Zhang, W; Raman, K; Babu, YS	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50579235	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50579235&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			12114412	471055358							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51433770	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1ccccc1)C(F)(F)F	InChI=1S/C18H15F3N4O/c19-18(20,21)16-10-15(17(26)23-13-6-2-1-3-7-13)25(24-16)14-8-4-5-12(9-14)11-22/h1-10H,11,22H2,(H,23,26)	WVUIEQVUCUTHCK-UHFFFAOYSA-N	50579236	CHEMBL4849589	Plasma kallikrein			 22600							ChEMBL	10.1021/acs.jmedchem.1c00511	10.7270/Q29C7288	34436898			Kotian, PL; Wu, M; Vadlakonda, S; Chintareddy, V; Lu, P; Juarez, L; Kellogg-Yelder, D; Chen, X; Muppa, S; Chambers-Wilson, R; Davis Parker, C; Williams, J; Polach, KJ; Zhang, W; Raman, K; Babu, YS	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50579236	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50579236&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			164617250	471055359							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51433771	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1ccccc1F)C(F)(F)F	InChI=1S/C18H14F4N4O/c19-13-6-1-2-7-14(13)24-17(27)15-9-16(18(20,21)22)25-26(15)12-5-3-4-11(8-12)10-23/h1-9H,10,23H2,(H,24,27)	GNQGYMSQALZIKW-UHFFFAOYSA-N	50579237	CHEMBL4850991	Plasma kallikrein			 27300							ChEMBL	10.1021/acs.jmedchem.1c00511	10.7270/Q29C7288	34436898			Kotian, PL; Wu, M; Vadlakonda, S; Chintareddy, V; Lu, P; Juarez, L; Kellogg-Yelder, D; Chen, X; Muppa, S; Chambers-Wilson, R; Davis Parker, C; Williams, J; Polach, KJ; Zhang, W; Raman, K; Babu, YS	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50579237	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50579237&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			164611674	471055360							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51433772	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1ccc(cc1)-c1ccccc1)C(F)(F)F	InChI=1S/C24H19F3N4O/c25-24(26,27)22-14-21(31(30-22)20-8-4-5-16(13-20)15-28)23(32)29-19-11-9-18(10-12-19)17-6-2-1-3-7-17/h1-14H,15,28H2,(H,29,32)	YIZFXDITRHVCFH-UHFFFAOYSA-N	50579238	CHEMBL4848716	Plasma kallikrein			 2900							ChEMBL	10.1021/acs.jmedchem.1c00511	10.7270/Q29C7288	34436898			Kotian, PL; Wu, M; Vadlakonda, S; Chintareddy, V; Lu, P; Juarez, L; Kellogg-Yelder, D; Chen, X; Muppa, S; Chambers-Wilson, R; Davis Parker, C; Williams, J; Polach, KJ; Zhang, W; Raman, K; Babu, YS	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50579238	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50579238&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			164615499	471055361							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51433773	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1ccc(cc1F)-c1ccccc1)C(F)(F)F	InChI=1S/C24H18F4N4O/c25-19-12-17(16-6-2-1-3-7-16)9-10-20(19)30-23(33)21-13-22(24(26,27)28)31-32(21)18-8-4-5-15(11-18)14-29/h1-13H,14,29H2,(H,30,33)	NWTGPWOSGYTZMT-UHFFFAOYSA-N	50579239	CHEMBL4845951	Plasma kallikrein			 1020							ChEMBL	10.1021/acs.jmedchem.1c00511	10.7270/Q29C7288	34436898			Kotian, PL; Wu, M; Vadlakonda, S; Chintareddy, V; Lu, P; Juarez, L; Kellogg-Yelder, D; Chen, X; Muppa, S; Chambers-Wilson, R; Davis Parker, C; Williams, J; Polach, KJ; Zhang, W; Raman, K; Babu, YS	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50579239	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50579239&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			164609175	471055362							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51433774	CS(=O)(=O)c1cccc(c1)-c1ccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c(F)c1	InChI=1S/C25H20F4N4O3S/c1-37(35,36)19-7-3-5-16(11-19)17-8-9-21(20(26)12-17)31-24(34)22-13-23(25(27,28)29)32-33(22)18-6-2-4-15(10-18)14-30/h2-13H,14,30H2,1H3,(H,31,34)	JFZYZNSMVHQKCJ-UHFFFAOYSA-N	50579240	CHEMBL4867482	Plasma kallikrein			 1229							ChEMBL	10.1021/acs.jmedchem.1c00511	10.7270/Q29C7288	34436898			Kotian, PL; Wu, M; Vadlakonda, S; Chintareddy, V; Lu, P; Juarez, L; Kellogg-Yelder, D; Chen, X; Muppa, S; Chambers-Wilson, R; Davis Parker, C; Williams, J; Polach, KJ; Zhang, W; Raman, K; Babu, YS	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50579240	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50579240&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			164621441	471055363							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51433775	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1ccc(cc1F)-c1ccc(cc1)C(N)=O)C(F)(F)F	InChI=1S/C25H19F4N5O2/c26-19-11-17(15-4-6-16(7-5-15)23(31)35)8-9-20(19)32-24(36)21-12-22(25(27,28)29)33-34(21)18-3-1-2-14(10-18)13-30/h1-12H,13,30H2,(H2,31,35)(H,32,36)	NZWYXJWRRAUUNH-UHFFFAOYSA-N	50579241	CHEMBL4868267	Plasma kallikrein			 395							ChEMBL	10.1021/acs.jmedchem.1c00511	10.7270/Q29C7288	34436898			Kotian, PL; Wu, M; Vadlakonda, S; Chintareddy, V; Lu, P; Juarez, L; Kellogg-Yelder, D; Chen, X; Muppa, S; Chambers-Wilson, R; Davis Parker, C; Williams, J; Polach, KJ; Zhang, W; Raman, K; Babu, YS	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50579241	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50579241&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			164618865	471055364							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51433776	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1ccc(cc1F)-c1ccc(cc1)S(N)(=O)=O)C(F)(F)F	InChI=1S/C24H19F4N5O3S/c25-19-11-16(15-4-7-18(8-5-15)37(30,35)36)6-9-20(19)31-23(34)21-12-22(24(26,27)28)32-33(21)17-3-1-2-14(10-17)13-29/h1-12H,13,29H2,(H,31,34)(H2,30,35,36)	PLIYHNUKKXMDOV-UHFFFAOYSA-N	50579242	CHEMBL4848851	Plasma kallikrein			 395							ChEMBL	10.1021/acs.jmedchem.1c00511	10.7270/Q29C7288	34436898			Kotian, PL; Wu, M; Vadlakonda, S; Chintareddy, V; Lu, P; Juarez, L; Kellogg-Yelder, D; Chen, X; Muppa, S; Chambers-Wilson, R; Davis Parker, C; Williams, J; Polach, KJ; Zhang, W; Raman, K; Babu, YS	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50579242	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50579242&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			164618326	471055365							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51433777	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1ccc(cc1F)C1CC1)C(F)(F)F	InChI=1S/C21H18F4N4O/c22-16-9-14(13-4-5-13)6-7-17(16)27-20(30)18-10-19(21(23,24)25)28-29(18)15-3-1-2-12(8-15)11-26/h1-3,6-10,13H,4-5,11,26H2,(H,27,30)	KWKRSBLELBGGSQ-UHFFFAOYSA-N	50579243	CHEMBL4875350	Plasma kallikrein			 577							ChEMBL	10.1021/acs.jmedchem.1c00511	10.7270/Q29C7288	34436898			Kotian, PL; Wu, M; Vadlakonda, S; Chintareddy, V; Lu, P; Juarez, L; Kellogg-Yelder, D; Chen, X; Muppa, S; Chambers-Wilson, R; Davis Parker, C; Williams, J; Polach, KJ; Zhang, W; Raman, K; Babu, YS	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50579243	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50579243&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			164625932	471055366							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51433778	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1ccc(cc1F)C(O)c1ccccc1)C(F)(F)F	InChI=1S/C25H20F4N4O2/c26-19-12-17(23(34)16-6-2-1-3-7-16)9-10-20(19)31-24(35)21-13-22(25(27,28)29)32-33(21)18-8-4-5-15(11-18)14-30/h1-13,23,34H,14,30H2,(H,31,35)	WVBOXESRKOBMTK-UHFFFAOYSA-N	416966	1-(3-(Aminomethyl)phenyl)-N-(2-fluoro-4-(hydroxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 16b::US10633345, Compound 16b::US10689346, Compound 16b::US11203574, Compound 16b::US11230530, Compound 16b::US11685721, Compound 16b	Plasma kallikrein			 1000							ChEMBL	10.1021/acs.jmedchem.1c00511	10.7270/Q29C7288	34436898			Kotian, PL; Wu, M; Vadlakonda, S; Chintareddy, V; Lu, P; Juarez, L; Kellogg-Yelder, D; Chen, X; Muppa, S; Chambers-Wilson, R; Davis Parker, C; Williams, J; Polach, KJ; Zhang, W; Raman, K; Babu, YS	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416966	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416966&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665483	433916878							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51433779	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(C(O)c2ccccc2)c1F)C(F)(F)F	InChI=1S/C25H20F4N4O2/c26-22-18(23(34)16-7-2-1-3-8-16)10-5-11-19(22)31-24(35)20-13-21(25(27,28)29)32-33(20)17-9-4-6-15(12-17)14-30/h1-13,23,34H,14,30H2,(H,31,35)	DENXCWXVTOPLRK-UHFFFAOYSA-N	416744	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-3-(hydroxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 35g::US10633345, Compound 35g::US10689346, Compound 35g::US11203574, Compound 35g::US11230530, Compound 35g::US11685721, Compound 35g	Plasma kallikrein			 149							ChEMBL	10.1021/acs.jmedchem.1c00511	10.7270/Q29C7288	34436898			Kotian, PL; Wu, M; Vadlakonda, S; Chintareddy, V; Lu, P; Juarez, L; Kellogg-Yelder, D; Chen, X; Muppa, S; Chambers-Wilson, R; Davis Parker, C; Williams, J; Polach, KJ; Zhang, W; Raman, K; Babu, YS	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416744	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416744&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355965	433916658							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51433780	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)c1ccccc1)C(F)(F)F	InChI=1S/C25H20F4N4O2/c26-19-10-9-17(23(34)16-6-2-1-3-7-16)12-20(19)31-24(35)21-13-22(25(27,28)29)32-33(21)18-8-4-5-15(11-18)14-30/h1-13,23,34H,14,30H2,(H,31,35)	SUGJHCONPCVXKJ-UHFFFAOYSA-N	416741	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-5-(hydroxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 34d::US10633345, Compound 34d::US10689346, Compound 34d::US11203574, Compound 34d::US11230530, Compound 34d::US11685721, Compound 34d	Plasma kallikrein			 710							ChEMBL	10.1021/acs.jmedchem.1c00511	10.7270/Q29C7288	34436898			Kotian, PL; Wu, M; Vadlakonda, S; Chintareddy, V; Lu, P; Juarez, L; Kellogg-Yelder, D; Chen, X; Muppa, S; Chambers-Wilson, R; Davis Parker, C; Williams, J; Polach, KJ; Zhang, W; Raman, K; Babu, YS	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416741	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416741&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665740	433916655							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51433781	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(C(OCC2CC2)c2ccccc2)c1F)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-26-22(27(39-17-18-12-13-18)20-7-2-1-3-8-20)10-5-11-23(26)35-28(38)24-15-25(29(31,32)33)36-37(24)21-9-4-6-19(14-21)16-34/h1-11,14-15,18,27H,12-13,16-17,34H2,(H,35,38)	OCYVMBLZCJPYSX-UHFFFAOYSA-N	416779	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 36d::US10633345, Compound 36d::US10689346, Compound 36d::US11203574, Compound 36d::US11230530, Compound 36d::US11685721, Compound 36d	Plasma kallikrein			 37							ChEMBL	10.1021/acs.jmedchem.1c00511	10.7270/Q29C7288	34436898			Kotian, PL; Wu, M; Vadlakonda, S; Chintareddy, V; Lu, P; Juarez, L; Kellogg-Yelder, D; Chen, X; Muppa, S; Chambers-Wilson, R; Davis Parker, C; Williams, J; Polach, KJ; Zhang, W; Raman, K; Babu, YS	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416779	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416779&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356266	433916693							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51433782	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1ccc(cc1F)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-23-14-21(27(39-17-18-9-10-18)20-6-2-1-3-7-20)11-12-24(23)35-28(38)25-15-26(29(31,32)33)36-37(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27H,9-10,16-17,34H2,(H,35,38)	HBXVQXKJLUQKAE-UHFFFAOYSA-N	416963	1-(3-(aminomethyl)phenyl)-N-(4-((cyclopropylmethoxy)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 15g::US10633345, Compound 15g::US10689346, Compound 15g::US11203574, Compound 15g::US11230530, Compound 15g::US11685721, Compound 15g	Plasma kallikrein			 651							ChEMBL	10.1021/acs.jmedchem.1c00511	10.7270/Q29C7288	34436898			Kotian, PL; Wu, M; Vadlakonda, S; Chintareddy, V; Lu, P; Juarez, L; Kellogg-Yelder, D; Chen, X; Muppa, S; Chambers-Wilson, R; Davis Parker, C; Williams, J; Polach, KJ; Zhang, W; Raman, K; Babu, YS	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416963	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416963&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355605	433916875							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51433783	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-23-12-11-21(27(39-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)35-28(38)25-15-26(29(31,32)33)36-37(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27H,9-10,16-17,34H2,(H,35,38)	HIMJVDQVZQMIPM-UHFFFAOYSA-N	416968	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethoxy)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 37b	Plasma kallikrein			 6.4							ChEMBL	10.1021/acs.jmedchem.1c00511	10.7270/Q29C7288	34436898			Kotian, PL; Wu, M; Vadlakonda, S; Chintareddy, V; Lu, P; Juarez, L; Kellogg-Yelder, D; Chen, X; Muppa, S; Chambers-Wilson, R; Davis Parker, C; Williams, J; Polach, KJ; Zhang, W; Raman, K; Babu, YS	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416968	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416968&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355729	433916880							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51433784	COC(c1ccccc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C26H22F4N4O2/c1-36-24(17-7-3-2-4-8-17)18-10-11-20(27)21(13-18)32-25(35)22-14-23(26(28,29)30)33-34(22)19-9-5-6-16(12-19)15-31/h2-14,24H,15,31H2,1H3,(H,32,35)	AJQPEPSKLFPFIU-UHFFFAOYSA-N	416755	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-5-(methoxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 25c::US10633345, Compound 25c::US10689346, Compound 25c::US11203574, Compound 25c::US11230530, Compound 25c::US11685721, Compound 25c	Plasma kallikrein			 231							ChEMBL	10.1021/acs.jmedchem.1c00511	10.7270/Q29C7288	34436898			Kotian, PL; Wu, M; Vadlakonda, S; Chintareddy, V; Lu, P; Juarez, L; Kellogg-Yelder, D; Chen, X; Muppa, S; Chambers-Wilson, R; Davis Parker, C; Williams, J; Polach, KJ; Zhang, W; Raman, K; Babu, YS	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416755	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416755&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126666045	433916669							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51433785	CCOC(c1ccccc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C27H24F4N4O2/c1-2-37-25(18-8-4-3-5-9-18)19-11-12-21(28)22(14-19)33-26(36)23-15-24(27(29,30)31)34-35(23)20-10-6-7-17(13-20)16-32/h3-15,25H,2,16,32H2,1H3,(H,33,36)	YVBRMUSUELCGNA-UHFFFAOYSA-N	416752	1-(3-(aminomethyl)phenyl)-N-(5-(ethoxy(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 25b::US10633345, Compound 25b::US10689346, Compound 25b::US11203574, Compound 25b::US11230530, Compound 25b::US11685721, Compound 25b	Plasma kallikrein			 134							ChEMBL	10.1021/acs.jmedchem.1c00511	10.7270/Q29C7288	34436898			Kotian, PL; Wu, M; Vadlakonda, S; Chintareddy, V; Lu, P; Juarez, L; Kellogg-Yelder, D; Chen, X; Muppa, S; Chambers-Wilson, R; Davis Parker, C; Williams, J; Polach, KJ; Zhang, W; Raman, K; Babu, YS	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416752	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416752&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665520	433916666							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51433786	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F4N5O/c30-23-12-11-21(27(35-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27,35H,9-10,16-17,34H2,(H,36,39)	MCLZOCFEIKBMBA-UHFFFAOYSA-N	416773	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 38d::US10633345, Compound 38d::US10689346, Compound 42a::US11203574, Compound 42a::US11230530, Compound 42a::US11685721, Compound 38d	Plasma kallikrein			 9.0							ChEMBL	10.1021/acs.jmedchem.1c00511	10.7270/Q29C7288	34436898			Kotian, PL; Wu, M; Vadlakonda, S; Chintareddy, V; Lu, P; Juarez, L; Kellogg-Yelder, D; Chen, X; Muppa, S; Chambers-Wilson, R; Davis Parker, C; Williams, J; Polach, KJ; Zhang, W; Raman, K; Babu, YS	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416773	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416773&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356124	433916687							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51433787	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F3N4O2/c30-29(31,32)26-16-25(36(35-26)24-11-4-6-20(14-24)17-33)28(37)34-23-10-5-9-22(15-23)27(38-18-19-12-13-19)21-7-2-1-3-8-21/h1-11,14-16,19,27H,12-13,17-18,33H2,(H,34,37)	PEZVPVUPSJXZCH-UHFFFAOYSA-N	416775	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18k::US10633345, Compound 74a::US10689346, Compound 165e::US11203574, Compound 165e::US11230530, Compound 165e::US11685721, Compound 18k	Plasma kallikrein			 38							ChEMBL	10.1021/acs.jmedchem.1c00511	10.7270/Q29C7288	34436898			Kotian, PL; Wu, M; Vadlakonda, S; Chintareddy, V; Lu, P; Juarez, L; Kellogg-Yelder, D; Chen, X; Muppa, S; Chambers-Wilson, R; Davis Parker, C; Williams, J; Polach, KJ; Zhang, W; Raman, K; Babu, YS	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416775	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416775&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			91884591	433916689							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51433788	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(F)cc(c1)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-22-12-21(27(39-17-18-9-10-18)20-6-2-1-3-7-20)13-23(14-22)35-28(38)25-15-26(29(31,32)33)36-37(25)24-8-4-5-19(11-24)16-34/h1-8,11-15,18,27H,9-10,16-17,34H2,(H,35,38)	CECISELXZFBKBA-UHFFFAOYSA-N	416736	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)-5-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 80h::US10633345, Compound 80h::US10689346, Compound 80h::US11203574, Compound 80h::US11230530, Compound 80h::US11685721, Compound 80h	Plasma kallikrein			 100							ChEMBL	10.1021/acs.jmedchem.1c00511	10.7270/Q29C7288	34436898			Kotian, PL; Wu, M; Vadlakonda, S; Chintareddy, V; Lu, P; Juarez, L; Kellogg-Yelder, D; Chen, X; Muppa, S; Chambers-Wilson, R; Davis Parker, C; Williams, J; Polach, KJ; Zhang, W; Raman, K; Babu, YS	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416736	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416736&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356068	433916650							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51433789	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1ccc(F)c(c1)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-24-12-11-21(14-23(24)27(39-17-18-9-10-18)20-6-2-1-3-7-20)35-28(38)25-15-26(29(31,32)33)36-37(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27H,9-10,16-17,34H2,(H,35,38)	SMAPKFCZNNYDET-UHFFFAOYSA-N	416776	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)-4-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 76h::US10633345, Compound 76h::US10689346, Compound 76h::US11203574, Compound 76h::US11230530, Compound 76h::US11685721, Compound 76h	Plasma kallikrein			 708							ChEMBL	10.1021/acs.jmedchem.1c00511	10.7270/Q29C7288	34436898			Kotian, PL; Wu, M; Vadlakonda, S; Chintareddy, V; Lu, P; Juarez, L; Kellogg-Yelder, D; Chen, X; Muppa, S; Chambers-Wilson, R; Davis Parker, C; Williams, J; Polach, KJ; Zhang, W; Raman, K; Babu, YS	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416776	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416776&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356199	433916690							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51433790	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F4N5O/c30-23-12-11-21(27(35-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27,35H,9-10,16-17,34H2,(H,36,39)	MCLZOCFEIKBMBA-UHFFFAOYSA-N	416773	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 38d::US10633345, Compound 38d::US10689346, Compound 42a::US11203574, Compound 42a::US11230530, Compound 42a::US11685721, Compound 38d	Plasma kallikrein			 9.00							ChEMBL	10.1021/acs.jmedchem.1c00511	10.7270/Q29C7288	34436898			Kotian, PL; Wu, M; Vadlakonda, S; Chintareddy, V; Lu, P; Juarez, L; Kellogg-Yelder, D; Chen, X; Muppa, S; Chambers-Wilson, R; Davis Parker, C; Williams, J; Polach, KJ; Zhang, W; Raman, K; Babu, YS	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416773	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416773&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356124	433916687							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51433791	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F4N5O/c30-23-12-11-21(27(35-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27,35H,9-10,16-17,34H2,(H,36,39)	MCLZOCFEIKBMBA-UHFFFAOYSA-N	416773	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 38d::US10633345, Compound 38d::US10689346, Compound 42a::US11203574, Compound 42a::US11230530, Compound 42a::US11685721, Compound 38d	Plasma kallikrein			 1.20							ChEMBL	10.1021/acs.jmedchem.1c00511	10.7270/Q29C7288	34436898			Kotian, PL; Wu, M; Vadlakonda, S; Chintareddy, V; Lu, P; Juarez, L; Kellogg-Yelder, D; Chen, X; Muppa, S; Chambers-Wilson, R; Davis Parker, C; Williams, J; Polach, KJ; Zhang, W; Raman, K; Babu, YS	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416773	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416773&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356124	433916687							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51433792	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C28H26F4N6O/c29-21-10-9-19(26(35-16-17-7-8-17)22-6-1-2-11-34-22)13-23(21)36-27(39)24-14-25(28(30,31)32)37-38(24)20-5-3-4-18(12-20)15-33/h1-6,9-14,17,26,35H,7-8,15-16,33H2,(H,36,39)	NHHQSQFDXMXIJU-UHFFFAOYSA-N	416812	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(pyridin-2-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 100e::US10633345, Compound 100e::US10689346, Compound 100e::US11203574, Compound 100e::US11230530, Compound 100e::US11685721, Compound 100e	Plasma kallikrein			 10							ChEMBL	10.1021/acs.jmedchem.1c00511	10.7270/Q29C7288	34436898			Kotian, PL; Wu, M; Vadlakonda, S; Chintareddy, V; Lu, P; Juarez, L; Kellogg-Yelder, D; Chen, X; Muppa, S; Chambers-Wilson, R; Davis Parker, C; Williams, J; Polach, KJ; Zhang, W; Raman, K; Babu, YS	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416812	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416812&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356158	433916726							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51433793	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H26F4N6O/c29-22-9-8-19(26(35-15-17-6-7-17)20-4-2-10-34-16-20)12-23(22)36-27(39)24-13-25(28(30,31)32)37-38(24)21-5-1-3-18(11-21)14-33/h1-5,8-13,16-17,26,35H,6-7,14-15,33H2,(H,36,39)	SECDZDWRLPONSX-UHFFFAOYSA-N	416784	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(pyridin-3-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 94b::US10633345, Compound 94b::US10689346, Compound 94b::US11203574, Compound 94b::US11230530, Compound 94b::US11685721, Compound 94b	Plasma kallikrein			 10.0							ChEMBL	10.1021/acs.jmedchem.1c00511	10.7270/Q29C7288	34436898			Kotian, PL; Wu, M; Vadlakonda, S; Chintareddy, V; Lu, P; Juarez, L; Kellogg-Yelder, D; Chen, X; Muppa, S; Chambers-Wilson, R; Davis Parker, C; Williams, J; Polach, KJ; Zhang, W; Raman, K; Babu, YS	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416784	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416784&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355774	433916698							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51433794	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C28H26F4N6O/c29-22-7-6-20(26(35-16-17-4-5-17)19-8-10-34-11-9-19)13-23(22)36-27(39)24-14-25(28(30,31)32)37-38(24)21-3-1-2-18(12-21)15-33/h1-3,6-14,17,26,35H,4-5,15-16,33H2,(H,36,39)	JHXYEKYRIWFSRY-UHFFFAOYSA-N	416796	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(pyridin-4-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 132f::US10633345, Compound 132f::US10689346, Compound 132f::US11203574, Compound 132f::US11230530, Compound 132f::US11685721, Compound 132f	Plasma kallikrein			 5.2							ChEMBL	10.1021/acs.jmedchem.1c00511	10.7270/Q29C7288	34436898			Kotian, PL; Wu, M; Vadlakonda, S; Chintareddy, V; Lu, P; Juarez, L; Kellogg-Yelder, D; Chen, X; Muppa, S; Chambers-Wilson, R; Davis Parker, C; Williams, J; Polach, KJ; Zhang, W; Raman, K; Babu, YS	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416796	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416796&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665438	433916710							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51433795	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C30H26F4N6O/c31-24-10-9-22(28(37-17-18-7-8-18)21-5-1-3-19(11-21)15-35)13-25(24)38-29(41)26-14-27(30(32,33)34)39-40(26)23-6-2-4-20(12-23)16-36/h1-6,9-14,18,28,37H,7-8,16-17,36H2,(H,38,41)	UXNXMBYCBRBRFD-UHFFFAOYSA-N	416926	(+)-1-(3-(aminomethyl)phenyl)-N-(5-((3-cyanophenyl)(cyclopropyl-methylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 70a	Plasma kallikrein			 1.8							ChEMBL	10.1021/acs.jmedchem.1c00511	10.7270/Q29C7288	34436898			Kotian, PL; Wu, M; Vadlakonda, S; Chintareddy, V; Lu, P; Juarez, L; Kellogg-Yelder, D; Chen, X; Muppa, S; Chambers-Wilson, R; Davis Parker, C; Williams, J; Polach, KJ; Zhang, W; Raman, K; Babu, YS	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416926	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416926&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	0RI	7N7X	118355809	433916838							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51433796	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C30H26F4N6O/c31-24-10-9-22(28(37-17-18-7-8-18)21-5-1-3-19(11-21)15-35)13-25(24)38-29(41)26-14-27(30(32,33)34)39-40(26)23-6-2-4-20(12-23)16-36/h1-6,9-14,18,28,37H,7-8,16-17,36H2,(H,38,41)	UXNXMBYCBRBRFD-UHFFFAOYSA-N	416926	(+)-1-(3-(aminomethyl)phenyl)-N-(5-((3-cyanophenyl)(cyclopropyl-methylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 70a	Plasma kallikrein			 1.80							ChEMBL	10.1021/acs.jmedchem.1c00511	10.7270/Q29C7288	34436898			Kotian, PL; Wu, M; Vadlakonda, S; Chintareddy, V; Lu, P; Juarez, L; Kellogg-Yelder, D; Chen, X; Muppa, S; Chambers-Wilson, R; Davis Parker, C; Williams, J; Polach, KJ; Zhang, W; Raman, K; Babu, YS	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416926	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416926&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	0RI	7N7X	118355809	433916838							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51433797	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C30H26F4N6O/c31-24-10-9-22(28(37-17-18-7-8-18)21-5-1-3-19(11-21)15-35)13-25(24)38-29(41)26-14-27(30(32,33)34)39-40(26)23-6-2-4-20(12-23)16-36/h1-6,9-14,18,28,37H,7-8,16-17,36H2,(H,38,41)	UXNXMBYCBRBRFD-UHFFFAOYSA-N	416926	(+)-1-(3-(aminomethyl)phenyl)-N-(5-((3-cyanophenyl)(cyclopropyl-methylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 70a	Plasma kallikrein			 0.880							ChEMBL	10.1021/acs.jmedchem.1c00511	10.7270/Q29C7288	34436898			Kotian, PL; Wu, M; Vadlakonda, S; Chintareddy, V; Lu, P; Juarez, L; Kellogg-Yelder, D; Chen, X; Muppa, S; Chambers-Wilson, R; Davis Parker, C; Williams, J; Polach, KJ; Zhang, W; Raman, K; Babu, YS	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416926	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416926&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	0RI	7N7X	118355809	433916838							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51433798	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C30H26F4N6O/c31-24-11-10-22(28(37-17-19-4-5-19)21-8-6-18(15-35)7-9-21)13-25(24)38-29(41)26-14-27(30(32,33)34)39-40(26)23-3-1-2-20(12-23)16-36/h1-3,6-14,19,28,37H,4-5,16-17,36H2,(H,38,41)	GLPWOIBPISJWCH-UHFFFAOYSA-N	416830	1-(3-(aminomethyl)phenyl)-N-(5-((4-cyanophenyl)(cyclopropyl-methylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 52h::US11685721, Compound 71b	Plasma kallikrein			 7.2							ChEMBL	10.1021/acs.jmedchem.1c00511	10.7270/Q29C7288	34436898			Kotian, PL; Wu, M; Vadlakonda, S; Chintareddy, V; Lu, P; Juarez, L; Kellogg-Yelder, D; Chen, X; Muppa, S; Chambers-Wilson, R; Davis Parker, C; Williams, J; Polach, KJ; Zhang, W; Raman, K; Babu, YS	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416830	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416830&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355582	433916743							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51433799	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(C(OCC2CC2)c2ccccc2)c1F)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-26-22(27(39-17-18-12-13-18)20-7-2-1-3-8-20)10-5-11-23(26)35-28(38)24-15-25(29(31,32)33)36-37(24)21-9-4-6-19(14-21)16-34/h1-11,14-15,18,27H,12-13,16-17,34H2,(H,35,38)	OCYVMBLZCJPYSX-UHFFFAOYSA-N	416779	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 36d::US10633345, Compound 36d::US10689346, Compound 36d::US11203574, Compound 36d::US11230530, Compound 36d::US11685721, Compound 36d	Plasma kallikrein			>1000							ChEMBL	10.1021/acs.jmedchem.1c00511	10.7270/Q29C7288	34436898			Kotian, PL; Wu, M; Vadlakonda, S; Chintareddy, V; Lu, P; Juarez, L; Kellogg-Yelder, D; Chen, X; Muppa, S; Chambers-Wilson, R; Davis Parker, C; Williams, J; Polach, KJ; Zhang, W; Raman, K; Babu, YS	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416779	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416779&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356266	433916693							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51433800	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-23-12-11-21(27(39-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)35-28(38)25-15-26(29(31,32)33)36-37(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27H,9-10,16-17,34H2,(H,35,38)	HIMJVDQVZQMIPM-UHFFFAOYSA-N	416968	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethoxy)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 37b	Plasma kallikrein			 287							ChEMBL	10.1021/acs.jmedchem.1c00511	10.7270/Q29C7288	34436898			Kotian, PL; Wu, M; Vadlakonda, S; Chintareddy, V; Lu, P; Juarez, L; Kellogg-Yelder, D; Chen, X; Muppa, S; Chambers-Wilson, R; Davis Parker, C; Williams, J; Polach, KJ; Zhang, W; Raman, K; Babu, YS	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416968	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416968&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355729	433916880							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51433801	CCOC(c1ccccc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C27H24F4N4O2/c1-2-37-25(18-8-4-3-5-9-18)19-11-12-21(28)22(14-19)33-26(36)23-15-24(27(29,30)31)34-35(23)20-10-6-7-17(13-20)16-32/h3-15,25H,2,16,32H2,1H3,(H,33,36)	YVBRMUSUELCGNA-UHFFFAOYSA-N	416752	1-(3-(aminomethyl)phenyl)-N-(5-(ethoxy(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 25b::US10633345, Compound 25b::US10689346, Compound 25b::US11203574, Compound 25b::US11230530, Compound 25b::US11685721, Compound 25b	Plasma kallikrein			 1280							ChEMBL	10.1021/acs.jmedchem.1c00511	10.7270/Q29C7288	34436898			Kotian, PL; Wu, M; Vadlakonda, S; Chintareddy, V; Lu, P; Juarez, L; Kellogg-Yelder, D; Chen, X; Muppa, S; Chambers-Wilson, R; Davis Parker, C; Williams, J; Polach, KJ; Zhang, W; Raman, K; Babu, YS	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416752	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416752&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665520	433916666							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51433802	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F4N5O/c30-23-12-11-21(27(35-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27,35H,9-10,16-17,34H2,(H,36,39)	MCLZOCFEIKBMBA-UHFFFAOYSA-N	416773	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 38d::US10633345, Compound 38d::US10689346, Compound 42a::US11203574, Compound 42a::US11230530, Compound 42a::US11685721, Compound 38d	Plasma kallikrein			 19							ChEMBL	10.1021/acs.jmedchem.1c00511	10.7270/Q29C7288	34436898			Kotian, PL; Wu, M; Vadlakonda, S; Chintareddy, V; Lu, P; Juarez, L; Kellogg-Yelder, D; Chen, X; Muppa, S; Chambers-Wilson, R; Davis Parker, C; Williams, J; Polach, KJ; Zhang, W; Raman, K; Babu, YS	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416773	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416773&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356124	433916687							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51433803	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F3N4O2/c30-29(31,32)26-16-25(36(35-26)24-11-4-6-20(14-24)17-33)28(37)34-23-10-5-9-22(15-23)27(38-18-19-12-13-19)21-7-2-1-3-8-21/h1-11,14-16,19,27H,12-13,17-18,33H2,(H,34,37)	PEZVPVUPSJXZCH-UHFFFAOYSA-N	416775	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18k::US10633345, Compound 74a::US10689346, Compound 165e::US11203574, Compound 165e::US11230530, Compound 165e::US11685721, Compound 18k	Plasma kallikrein			 300							ChEMBL	10.1021/acs.jmedchem.1c00511	10.7270/Q29C7288	34436898			Kotian, PL; Wu, M; Vadlakonda, S; Chintareddy, V; Lu, P; Juarez, L; Kellogg-Yelder, D; Chen, X; Muppa, S; Chambers-Wilson, R; Davis Parker, C; Williams, J; Polach, KJ; Zhang, W; Raman, K; Babu, YS	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416775	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416775&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			91884591	433916689							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51433804	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(F)cc(c1)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-22-12-21(27(39-17-18-9-10-18)20-6-2-1-3-7-20)13-23(14-22)35-28(38)25-15-26(29(31,32)33)36-37(25)24-8-4-5-19(11-24)16-34/h1-8,11-15,18,27H,9-10,16-17,34H2,(H,35,38)	CECISELXZFBKBA-UHFFFAOYSA-N	416736	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)-5-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 80h::US10633345, Compound 80h::US10689346, Compound 80h::US11203574, Compound 80h::US11230530, Compound 80h::US11685721, Compound 80h	Plasma kallikrein			>1000							ChEMBL	10.1021/acs.jmedchem.1c00511	10.7270/Q29C7288	34436898			Kotian, PL; Wu, M; Vadlakonda, S; Chintareddy, V; Lu, P; Juarez, L; Kellogg-Yelder, D; Chen, X; Muppa, S; Chambers-Wilson, R; Davis Parker, C; Williams, J; Polach, KJ; Zhang, W; Raman, K; Babu, YS	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416736	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416736&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356068	433916650							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51433805	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1ccc(F)c(c1)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-24-12-11-21(14-23(24)27(39-17-18-9-10-18)20-6-2-1-3-7-20)35-28(38)25-15-26(29(31,32)33)36-37(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27H,9-10,16-17,34H2,(H,35,38)	SMAPKFCZNNYDET-UHFFFAOYSA-N	416776	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)-4-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 76h::US10633345, Compound 76h::US10689346, Compound 76h::US11203574, Compound 76h::US11230530, Compound 76h::US11685721, Compound 76h	Plasma kallikrein			>1000							ChEMBL	10.1021/acs.jmedchem.1c00511	10.7270/Q29C7288	34436898			Kotian, PL; Wu, M; Vadlakonda, S; Chintareddy, V; Lu, P; Juarez, L; Kellogg-Yelder, D; Chen, X; Muppa, S; Chambers-Wilson, R; Davis Parker, C; Williams, J; Polach, KJ; Zhang, W; Raman, K; Babu, YS	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416776	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416776&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356199	433916690							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51433806	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F4N5O/c30-23-12-11-21(27(35-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27,35H,9-10,16-17,34H2,(H,36,39)	MCLZOCFEIKBMBA-UHFFFAOYSA-N	416773	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 38d::US10633345, Compound 38d::US10689346, Compound 42a::US11203574, Compound 42a::US11230530, Compound 42a::US11685721, Compound 38d	Plasma kallikrein			 19.0							ChEMBL	10.1021/acs.jmedchem.1c00511	10.7270/Q29C7288	34436898			Kotian, PL; Wu, M; Vadlakonda, S; Chintareddy, V; Lu, P; Juarez, L; Kellogg-Yelder, D; Chen, X; Muppa, S; Chambers-Wilson, R; Davis Parker, C; Williams, J; Polach, KJ; Zhang, W; Raman, K; Babu, YS	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416773	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416773&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356124	433916687							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51433807	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F4N5O/c30-23-12-11-21(27(35-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27,35H,9-10,16-17,34H2,(H,36,39)	MCLZOCFEIKBMBA-UHFFFAOYSA-N	416773	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 38d::US10633345, Compound 38d::US10689346, Compound 42a::US11203574, Compound 42a::US11230530, Compound 42a::US11685721, Compound 38d	Plasma kallikrein			 8.51							ChEMBL	10.1021/acs.jmedchem.1c00511	10.7270/Q29C7288	34436898			Kotian, PL; Wu, M; Vadlakonda, S; Chintareddy, V; Lu, P; Juarez, L; Kellogg-Yelder, D; Chen, X; Muppa, S; Chambers-Wilson, R; Davis Parker, C; Williams, J; Polach, KJ; Zhang, W; Raman, K; Babu, YS	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416773	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416773&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356124	433916687							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51433808	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C28H26F4N6O/c29-21-10-9-19(26(35-16-17-7-8-17)22-6-1-2-11-34-22)13-23(21)36-27(39)24-14-25(28(30,31)32)37-38(24)20-5-3-4-18(12-20)15-33/h1-6,9-14,17,26,35H,7-8,15-16,33H2,(H,36,39)	NHHQSQFDXMXIJU-UHFFFAOYSA-N	416812	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(pyridin-2-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 100e::US10633345, Compound 100e::US10689346, Compound 100e::US11203574, Compound 100e::US11230530, Compound 100e::US11685721, Compound 100e	Plasma kallikrein			 27							ChEMBL	10.1021/acs.jmedchem.1c00511	10.7270/Q29C7288	34436898			Kotian, PL; Wu, M; Vadlakonda, S; Chintareddy, V; Lu, P; Juarez, L; Kellogg-Yelder, D; Chen, X; Muppa, S; Chambers-Wilson, R; Davis Parker, C; Williams, J; Polach, KJ; Zhang, W; Raman, K; Babu, YS	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416812	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416812&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356158	433916726							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51433809	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H26F4N6O/c29-22-9-8-19(26(35-15-17-6-7-17)20-4-2-10-34-16-20)12-23(22)36-27(39)24-13-25(28(30,31)32)37-38(24)21-5-1-3-18(11-21)14-33/h1-5,8-13,16-17,26,35H,6-7,14-15,33H2,(H,36,39)	SECDZDWRLPONSX-UHFFFAOYSA-N	416784	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(pyridin-3-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 94b::US10633345, Compound 94b::US10689346, Compound 94b::US11203574, Compound 94b::US11230530, Compound 94b::US11685721, Compound 94b	Plasma kallikrein			 10.0							ChEMBL	10.1021/acs.jmedchem.1c00511	10.7270/Q29C7288	34436898			Kotian, PL; Wu, M; Vadlakonda, S; Chintareddy, V; Lu, P; Juarez, L; Kellogg-Yelder, D; Chen, X; Muppa, S; Chambers-Wilson, R; Davis Parker, C; Williams, J; Polach, KJ; Zhang, W; Raman, K; Babu, YS	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416784	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416784&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355774	433916698							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51433810	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C28H26F4N6O/c29-22-7-6-20(26(35-16-17-4-5-17)19-8-10-34-11-9-19)13-23(22)36-27(39)24-14-25(28(30,31)32)37-38(24)21-3-1-2-18(12-21)15-33/h1-3,6-14,17,26,35H,4-5,15-16,33H2,(H,36,39)	JHXYEKYRIWFSRY-UHFFFAOYSA-N	416796	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(pyridin-4-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 132f::US10633345, Compound 132f::US10689346, Compound 132f::US11203574, Compound 132f::US11230530, Compound 132f::US11685721, Compound 132f	Plasma kallikrein			 17							ChEMBL	10.1021/acs.jmedchem.1c00511	10.7270/Q29C7288	34436898			Kotian, PL; Wu, M; Vadlakonda, S; Chintareddy, V; Lu, P; Juarez, L; Kellogg-Yelder, D; Chen, X; Muppa, S; Chambers-Wilson, R; Davis Parker, C; Williams, J; Polach, KJ; Zhang, W; Raman, K; Babu, YS	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416796	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416796&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665438	433916710							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51433811	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C30H26F4N6O/c31-24-10-9-22(28(37-17-18-7-8-18)21-5-1-3-19(11-21)15-35)13-25(24)38-29(41)26-14-27(30(32,33)34)39-40(26)23-6-2-4-20(12-23)16-36/h1-6,9-14,18,28,37H,7-8,16-17,36H2,(H,38,41)	UXNXMBYCBRBRFD-UHFFFAOYSA-N	416926	(+)-1-(3-(aminomethyl)phenyl)-N-(5-((3-cyanophenyl)(cyclopropyl-methylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 70a	Plasma kallikrein			 14							ChEMBL	10.1021/acs.jmedchem.1c00511	10.7270/Q29C7288	34436898			Kotian, PL; Wu, M; Vadlakonda, S; Chintareddy, V; Lu, P; Juarez, L; Kellogg-Yelder, D; Chen, X; Muppa, S; Chambers-Wilson, R; Davis Parker, C; Williams, J; Polach, KJ; Zhang, W; Raman, K; Babu, YS	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416926	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416926&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	0RI	7N7X	118355809	433916838							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51433812	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C30H26F4N6O/c31-24-10-9-22(28(37-17-18-7-8-18)21-5-1-3-19(11-21)15-35)13-25(24)38-29(41)26-14-27(30(32,33)34)39-40(26)23-6-2-4-20(12-23)16-36/h1-6,9-14,18,28,37H,7-8,16-17,36H2,(H,38,41)	UXNXMBYCBRBRFD-UHFFFAOYSA-N	416926	(+)-1-(3-(aminomethyl)phenyl)-N-(5-((3-cyanophenyl)(cyclopropyl-methylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 70a	Plasma kallikrein			 14.0							ChEMBL	10.1021/acs.jmedchem.1c00511	10.7270/Q29C7288	34436898			Kotian, PL; Wu, M; Vadlakonda, S; Chintareddy, V; Lu, P; Juarez, L; Kellogg-Yelder, D; Chen, X; Muppa, S; Chambers-Wilson, R; Davis Parker, C; Williams, J; Polach, KJ; Zhang, W; Raman, K; Babu, YS	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416926	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416926&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	0RI	7N7X	118355809	433916838							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51433813	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C30H26F4N6O/c31-24-10-9-22(28(37-17-18-7-8-18)21-5-1-3-19(11-21)15-35)13-25(24)38-29(41)26-14-27(30(32,33)34)39-40(26)23-6-2-4-20(12-23)16-36/h1-6,9-14,18,28,37H,7-8,16-17,36H2,(H,38,41)	UXNXMBYCBRBRFD-UHFFFAOYSA-N	416926	(+)-1-(3-(aminomethyl)phenyl)-N-(5-((3-cyanophenyl)(cyclopropyl-methylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 70a	Plasma kallikrein			 5.80							ChEMBL	10.1021/acs.jmedchem.1c00511	10.7270/Q29C7288	34436898			Kotian, PL; Wu, M; Vadlakonda, S; Chintareddy, V; Lu, P; Juarez, L; Kellogg-Yelder, D; Chen, X; Muppa, S; Chambers-Wilson, R; Davis Parker, C; Williams, J; Polach, KJ; Zhang, W; Raman, K; Babu, YS	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416926	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416926&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	0RI	7N7X	118355809	433916838							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51433814	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C30H26F4N6O/c31-24-11-10-22(28(37-17-19-4-5-19)21-8-6-18(15-35)7-9-21)13-25(24)38-29(41)26-14-27(30(32,33)34)39-40(26)23-3-1-2-20(12-23)16-36/h1-3,6-14,19,28,37H,4-5,16-17,36H2,(H,38,41)	GLPWOIBPISJWCH-UHFFFAOYSA-N	416830	1-(3-(aminomethyl)phenyl)-N-(5-((4-cyanophenyl)(cyclopropyl-methylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 52h::US11685721, Compound 71b	Plasma kallikrein			 19							ChEMBL	10.1021/acs.jmedchem.1c00511	10.7270/Q29C7288	34436898			Kotian, PL; Wu, M; Vadlakonda, S; Chintareddy, V; Lu, P; Juarez, L; Kellogg-Yelder, D; Chen, X; Muppa, S; Chambers-Wilson, R; Davis Parker, C; Williams, J; Polach, KJ; Zhang, W; Raman, K; Babu, YS	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416830	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416830&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355582	433916743							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51433823	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C30H26F4N6O/c31-24-10-9-22(28(37-17-18-7-8-18)21-5-1-3-19(11-21)15-35)13-25(24)38-29(41)26-14-27(30(32,33)34)39-40(26)23-6-2-4-20(12-23)16-36/h1-6,9-14,18,28,37H,7-8,16-17,36H2,(H,38,41)	UXNXMBYCBRBRFD-UHFFFAOYSA-N	416926	(+)-1-(3-(aminomethyl)phenyl)-N-(5-((3-cyanophenyl)(cyclopropyl-methylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 70a	Plasma kallikrein			>50000							ChEMBL	10.1021/acs.jmedchem.1c00511	10.7270/Q29C7288	34436898			Kotian, PL; Wu, M; Vadlakonda, S; Chintareddy, V; Lu, P; Juarez, L; Kellogg-Yelder, D; Chen, X; Muppa, S; Chambers-Wilson, R; Davis Parker, C; Williams, J; Polach, KJ; Zhang, W; Raman, K; Babu, YS	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416926	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416926&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	0RI	7N7X	118355809	433916838							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176320	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5ncccc5n4)cn3)c12	InChI=1S/C19H14ClFN8O/c20-13-3-5-28-11-24-14(18(28)17(13)21)6-22-19(30)15-9-27(10-23-15)7-12-8-29-16(26-12)2-1-4-25-29/h1-5,8-11H,6-7H2,(H,22,30)	FRQGCIVYEOXBAC-UHFFFAOYSA-N	455283	US10730874, Compound I-291::US11352356, Compound I-291	Plasma kallikrein					 55					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455283	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455283&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487958	440971101							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176321	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4ccc5nccnc5c4)nn3)c12	InChI=1S/C20H14ClFN8O/c21-13-3-6-29-11-26-16(19(29)18(13)22)8-25-20(31)17-10-30(28-27-17)9-12-1-2-14-15(7-12)24-5-4-23-14/h1-7,10-11H,8-9H2,(H,25,31)	IRUVVDHVOONSKW-UHFFFAOYSA-N	455284	US10730874, Compound I-292::US11352356, Compound I-292	Plasma kallikrein					 55					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455284	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455284&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488306	440971102							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176322	Fc1c(Cl)ccn2cnc(CNC(=O)c3cnn(Cc4ccc5nccnc5c4)c3)c12	InChI=1S/C21H15ClFN7O/c22-15-3-6-29-12-27-18(20(29)19(15)23)9-26-21(31)14-8-28-30(11-14)10-13-1-2-16-17(7-13)25-5-4-24-16/h1-8,11-12H,9-10H2,(H,26,31)	SREFSAFODKMNJQ-UHFFFAOYSA-N	455285	US10730874, Compound I-293::US11352356, Compound I-293	Plasma kallikrein					 55					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455285	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455285&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487828	440971103							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176323	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5nccc(-n6cnnc6)c5n4)nn3)c12	InChI=1S/C20H14ClFN12O/c21-13-2-4-31-9-24-14(18(31)17(13)22)5-23-20(35)15-8-33(30-29-15)6-12-7-34-19(28-12)16(1-3-27-34)32-10-25-26-11-32/h1-4,7-11H,5-6H2,(H,23,35)	NVCHMWNQRPXKPS-UHFFFAOYSA-N	557648	US11352356, Compound I-294	Plasma kallikrein					 55					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557648	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557648&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487593	471698352							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176324	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(cc(CN6CCCC6)c5n4)C4CC4)nn3)c12	InChI=1S/C27H27ClFN9O/c28-21-5-8-36-16-31-22(25(36)24(21)29)10-30-27(39)23-15-38(34-33-23)14-20-13-37-12-18(17-3-4-17)9-19(26(37)32-20)11-35-6-1-2-7-35/h5,8-9,12-13,15-17H,1-4,6-7,10-11,14H2,(H,30,39)	JMGPJASBTKSYPA-UHFFFAOYSA-N	557649	US11352356, Compound I-295	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557649	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557649&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487879	471698353							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176325	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5nccc(CC6COC6)c5n4)nn3)c12	InChI=1S/C22H19ClFN9O2/c23-16-2-4-31-12-26-17(20(31)19(16)24)6-25-22(34)18-9-32(30-29-18)7-15-8-33-21(28-15)14(1-3-27-33)5-13-10-35-11-13/h1-4,8-9,12-13H,5-7,10-11H2,(H,25,34)	RWKYQXBUKBZISL-UHFFFAOYSA-N	455288	US10730874, Compound I-296::US11352356, Compound I-296	Plasma kallikrein					 55					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455288	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455288&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488094	440971106							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176326	Fc1c(Cl)ccn2cnc(CNC(=O)c3cn(Cc4cn5ccccc5n4)cn3)c12	InChI=1S/C20H15ClFN7O/c21-14-4-6-29-12-25-15(19(29)18(14)22)7-23-20(30)16-10-27(11-24-16)8-13-9-28-5-2-1-3-17(28)26-13/h1-6,9-12H,7-8H2,(H,23,30)	AKFHCJZOAMDYLL-UHFFFAOYSA-N	455289	US10730874, Compound I-297::US11352356, Compound I-297	Plasma kallikrein					 55					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455289	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455289&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487675	440971107							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176327	NCc1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C23H21ClFN9O/c24-17-3-4-32-12-28-18(21(32)20(17)25)7-27-23(35)19-11-34(31-30-19)10-16-9-33-8-15(13-1-2-13)5-14(6-26)22(33)29-16/h3-5,8-9,11-13H,1-2,6-7,10,26H2,(H,27,35)	MEGRLAAWHTVKRH-UHFFFAOYSA-N	557652	US11352356, Compound I-298	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557652	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557652&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487674	471698356							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176328	CN(C)CCOCc1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C27H29ClFN9O2/c1-35(2)7-8-40-15-19-9-18(17-3-4-17)11-37-12-20(32-26(19)37)13-38-14-23(33-34-38)27(39)30-10-22-25-24(29)21(28)5-6-36(25)16-31-22/h5-6,9,11-12,14,16-17H,3-4,7-8,10,13,15H2,1-2H3,(H,30,39)	OGFDUILZJFFLLO-UHFFFAOYSA-N	455291	US10730874, Compound I-299::US11352356, Compound I-299	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455291	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455291&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487528	440971109							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176329	OC(CNCc1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1)C(F)(F)F	InChI=1S/C26H24ClF4N9O2/c27-18-3-4-38-13-34-19(23(38)22(18)28)7-33-25(42)20-12-40(37-36-20)11-17-10-39-9-16(14-1-2-14)5-15(24(39)35-17)6-32-8-21(41)26(29,30)31/h3-5,9-10,12-14,21,32,41H,1-2,6-8,11H2,(H,33,42)	CXKXYHXYEORTFI-UHFFFAOYSA-N	455292	US10730874, Compound I-300::US11352356, Compound I-300	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455292	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455292&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139488172	440971110							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176330	CCOC(COCc1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1)OCC	InChI=1S/C29H32ClFN8O4/c1-3-42-25(43-4-2)16-41-15-20-9-19(18-5-6-18)11-38-12-21(34-28(20)38)13-39-14-24(35-36-39)29(40)32-10-23-27-26(31)22(30)7-8-37(27)17-33-23/h7-9,11-12,14,17-18,25H,3-6,10,13,15-16H2,1-2H3,(H,32,40)	IESPOYJTFNNBPZ-UHFFFAOYSA-N	557655	US11352356, Compound I-301	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557655	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557655&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487648	471698359							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176331	CC(C)(C)S(=O)NCCOCc1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1	InChI=1S/C29H33ClFN9O3S/c1-29(2,3)44(42)34-7-9-43-16-20-10-19(18-4-5-18)12-39-13-21(35-27(20)39)14-40-15-24(36-37-40)28(41)32-11-23-26-25(31)22(30)6-8-38(26)17-33-23/h6,8,10,12-13,15,17-18,34H,4-5,7,9,11,14,16H2,1-3H3,(H,32,41)	SXRQXUSSOAAYEG-UHFFFAOYSA-N	557656	US11352356, Compound I-302	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557656	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557656&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487508	471698360							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176332	Brc1ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(ccc5n4)C4CC4)nn3)c2c1	InChI=1S/C22H19BrN8O/c23-16-5-6-29-13-25-18(20(29)7-16)8-24-22(32)19-12-31(28-27-19)11-17-10-30-9-15(14-1-2-14)3-4-21(30)26-17/h3-7,9-10,12-14H,1-2,8,11H2,(H,24,32)	YXGYCECUXYIXEZ-UHFFFAOYSA-N	455295	US10730874, Compound I-303::US11352356, Compound I-303	Plasma kallikrein					<1					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455295	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455295&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487532	440971113							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176333	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(F)ccc(OC)c1F	InChI=1S/C27H26F2N4O4/c1-36-17-23-21(27(35)30-13-20-22(28)10-11-24(37-2)26(20)29)16-33(31-23)15-19-8-6-18(7-9-19)14-32-12-4-3-5-25(32)34/h3-12,16H,13-15,17H2,1-2H3,(H,30,35)	PIYDGHWVVUCTNS-UHFFFAOYSA-N	408746	 N-[(2,6-difluoro-3-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin- 1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US10364238, Example 66::US10730874, Example 00395::US11001578, Example 66::US11084809, Example 66::US11198691, Example 66::US11352356, Table II.1	Plasma kallikrein					 55					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408746	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408746&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365096	406799377							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176334	COCc1nn(Cc2ccc(nc2)N2CCCC2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cnnn1	InChI=1S/C25H28FN9O3/c1-37-15-20-19(14-34(30-20)13-17-5-8-23(27-11-17)33-9-3-4-10-33)25(36)28-12-18-21(35-16-29-31-32-35)6-7-22(38-2)24(18)26/h5-8,11,14,16H,3-4,9-10,12-13,15H2,1-2H3,(H,28,36)	DGIRMJAUTLUPMU-UHFFFAOYSA-N	455297	US10730874, Compound TABLE II.2::US11180484, Example 77::US11352356, Table II.2	Plasma kallikrein					 5.5					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455297	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455297&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301849	440971115							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176335	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1nccc(OC)c1F	InChI=1S/C26H26FN5O4/c1-35-17-22-20(26(34)29-13-21-25(27)23(36-2)10-11-28-21)16-32(30-22)15-19-8-6-18(7-9-19)14-31-12-4-3-5-24(31)33/h3-12,16H,13-15,17H2,1-2H3,(H,29,34)	KGMPDQIYDKKXRD-UHFFFAOYSA-N	408717	 N-[(3-fluoro-4-methoxypyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin- 1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 41::US10730874, Example 00397::US11001578, Example 41::US11084809, Example 41::US11198691, Example 41::US11352356, Table II.3::US11584735, Example 41 of WO2016/083820	Plasma kallikrein					 55					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408717	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408717&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365142	406799348							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176336	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(F)c(OC)ccc1C#N	InChI=1S/C28H26FN5O4/c1-37-18-24-23(28(36)31-14-22-21(13-30)10-11-25(38-2)27(22)29)17-34(32-24)16-20-8-6-19(7-9-20)15-33-12-4-3-5-26(33)35/h3-12,17H,14-16,18H2,1-2H3,(H,31,36)	SPXOTFDBWDBJRN-UHFFFAOYSA-N	408768	N-[(6-cyano-2-fluoro-3-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-::US10364238, Example 77::US10730874, Example 00398::US11001578, Example 77::US11084809, Example 77::US11198691, Example 77::US11352356, Table II.4	Plasma kallikrein					 5.5					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408768	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408768&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365006	406799399							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176337	Clc1ccn2cnc(CNC(=O)c3ccnc(Cc4ccc5ncc(Cl)cc5c4)c3)c2c1	InChI=1S/C24H17Cl2N5O/c25-18-4-6-31-14-30-22(23(31)11-18)13-29-24(32)16-3-5-27-20(10-16)8-15-1-2-21-17(7-15)9-19(26)12-28-21/h1-7,9-12,14H,8,13H2,(H,29,32)	XLKFBGCZLDPHJM-UHFFFAOYSA-N	454918	US10730874, Compound I-3::US10730874, Compound TABLE II.5::US11352356, Table II.5	Plasma kallikrein					 55					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=454918	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=454918&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118665434	440970771							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176338	Clc1ccc2snc(CNC(=O)c3cnn(Cc4cn5cc(ccc5n4)C4CC4)c3)c2c1	InChI=1S/C23H19ClN6OS/c24-17-4-5-21-19(7-17)20(28-32-21)9-25-23(31)16-8-26-30(11-16)13-18-12-29-10-15(14-1-2-14)3-6-22(29)27-18/h3-8,10-12,14H,1-2,9,13H2,(H,25,31)	YSGNQMRGFQGWKZ-UHFFFAOYSA-N	455301	US10730874, Compound TABLE II.6::US11352356, Table II.6	Plasma kallikrein					 55					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455301	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455301&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139505217	440971118							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176339	Clc1ccc2nnc(CNC(=O)c3cnn(Cc4cn5cc(ccc5n4)C4CC4)c3)n2c1	InChI=1S/C22H19ClN8O/c23-17-4-6-20-27-28-21(31(20)11-17)8-24-22(32)16-7-25-30(10-16)13-18-12-29-9-15(14-1-2-14)3-5-19(29)26-18/h3-7,9-12,14H,1-2,8,13H2,(H,24,32)	QJZJZWMAEPTLGJ-UHFFFAOYSA-N	455302	US10730874, Compound TABLE II.7::US11352356, Table II.7	Plasma kallikrein					 1050					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455302	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455302&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139498761	440971119							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176340	Cc1ccn2cc(Cn3cc(cn3)C(=O)NCc3cnc4ccc(Cl)cn34)nc2c1	InChI=1S/C21H18ClN7O/c1-14-4-5-27-12-17(26-20(27)6-14)13-28-10-15(7-25-28)21(30)24-9-18-8-23-19-3-2-16(22)11-29(18)19/h2-8,10-12H,9,13H2,1H3,(H,24,30)	HJDYNOQVAODYOE-UHFFFAOYSA-N	557665	US11352356, Table II.8	Plasma kallikrein					 1050					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=557665	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=557665&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139498760	471698369							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176341	O=C(NCc1ncn2ccc(cc12)C1CC1)c1cnn(Cc2cn3cc(ccc3n2)C2CC2)c1	InChI=1S/C26H25N7O/c34-26(27-11-23-24-9-19(17-1-2-17)7-8-31(24)16-28-23)21-10-29-33(13-21)15-22-14-32-12-20(18-3-4-18)5-6-25(32)30-22/h5-10,12-14,16-18H,1-4,11,15H2,(H,27,34)	BRSPMWXQBHDJIL-UHFFFAOYSA-N	455304	US10730874, Compound TABLE II.9::US11352356, Table II.9	Plasma kallikrein					 1050					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455304	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455304&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487423	440971121							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51433824	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C30H26F4N6O/c31-24-10-9-22(28(37-17-18-7-8-18)21-5-1-3-19(11-21)15-35)13-25(24)38-29(41)26-14-27(30(32,33)34)39-40(26)23-6-2-4-20(12-23)16-36/h1-6,9-14,18,28,37H,7-8,16-17,36H2,(H,38,41)	UXNXMBYCBRBRFD-UHFFFAOYSA-N	416926	(+)-1-(3-(aminomethyl)phenyl)-N-(5-((3-cyanophenyl)(cyclopropyl-methylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 70a	Plasma kallikrein		 0.440000								ChEMBL	10.1021/acs.jmedchem.1c00511	10.7270/Q29C7288	34436898			Kotian, PL; Wu, M; Vadlakonda, S; Chintareddy, V; Lu, P; Juarez, L; Kellogg-Yelder, D; Chen, X; Muppa, S; Chambers-Wilson, R; Davis Parker, C; Williams, J; Polach, KJ; Zhang, W; Raman, K; Babu, YS	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416926	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416926&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	0RI	7N7X	118355809	433916838							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51433825	COc1cc(c(cc1C=C)C(=O)Nc1ccc(cc1)C(N)=N)-c1ccc(nc1C(O)=O)C(=O)NCC1CC1	InChI=1S/C28H27N5O5/c1-3-16-12-21(26(34)32-18-8-6-17(7-9-18)25(29)30)20(13-23(16)38-2)19-10-11-22(33-24(19)28(36)37)27(35)31-14-15-4-5-15/h3,6-13,15H,1,4-5,14H2,2H3,(H3,29,30)(H,31,35)(H,32,34)(H,36,37)	TUWMKPVJGGWGNL-UHFFFAOYSA-N	50579244	Avoralstat::BCX-4161	Plasma kallikrein		 0.260000								ChEMBL	10.1021/acs.jmedchem.1c00511	10.7270/Q29C7288	34436898			Kotian, PL; Wu, M; Vadlakonda, S; Chintareddy, V; Lu, P; Juarez, L; Kellogg-Yelder, D; Chen, X; Muppa, S; Chambers-Wilson, R; Davis Parker, C; Williams, J; Polach, KJ; Zhang, W; Raman, K; Babu, YS	TBA	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50579244	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50579244&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	DJY	6BFP	86566678	471055367							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1176109	OC(=O)c1ccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)cn2c1	InChI=1S/C21H16ClN7O3/c22-15-3-4-27-12-24-17(18(27)5-15)7-23-20(30)14-6-25-29(9-14)11-16-10-28-8-13(21(31)32)1-2-19(28)26-16/h1-6,8-10,12H,7,11H2,(H,23,30)(H,31,32)	UAGJOEGYSOYONU-UHFFFAOYSA-N	455072	US10730874, Compound I-96	Plasma kallikrein					>2000					US Patent		10.7270/Q2W95DCK		aid1806592	US11352356	Papaioannou, N; Fink, SJ; Miller, TA; Shipps, Jr., GW; Travins, JM; Ehmann, DE; Rae, A; Ellard, JM	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455072	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455072&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139487281	471695243							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51442720	C[C@@H]1CCC[C@@H](c2cc(ccn2)-c2c(NC1=O)cnn2C(F)F)n1cnc(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C28H23Cl2F2N9O2/c1-15-3-2-4-23(20-9-16(7-8-33-20)26-21(36-27(15)43)12-35-41(26)28(31)32)39-14-34-19(11-25(39)42)18-10-17(29)5-6-22(18)40-13-24(30)37-38-40/h5-15,23,28H,2-4H2,1H3,(H,36,43)/t15-,23+/m1/s1	FSWFYCYPTDLKON-CMJOXMDJSA-N	247411	US10336754, Example 353::US11053247, Example 353::US9453018, 353	Plasma kallikrein		 44								ChEMBL	10.1021/acs.jmedchem.1c00613	10.7270/Q20005Z7	34494428			Dilger, AK; Pabbisetty, KB; Corte, JR; De Lucca, I; Fang, T; Yang, W; Pinto, DJP; Wang, Y; Zhu, Y; Mathur, A; Li, J; Hou, X; Smith, D; Sun, D; Zhang, H; Krishnananthan, S; Wu, DR; Myers, JE; Sheriff, S; Rossi, KA; Chacko, S; Zheng, JJ; Galella, MA; Ziemba, T; Dierks, EA; Bozarth, JM; Wu, Y; Crain, E; Wong, PC; Luettgen, JM; Wexler, RR; Ewing, WR	Bristol Myers Squibb Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=247411	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=247411&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	YXG	7MBO	131635534	346541954							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51441402	C[C@@H](c1cnc(N2C[C@H]3C[C@H]3C2=O)c(F)c1C)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H22ClF4N7O2/c1-12-18(7-35-26(23(12)30)39-10-14-5-17(14)28(39)42)13(2)40-11-15(6-36-40)37-27(41)21-9-34-8-20(38-21)22-16(25(32)33)3-4-19(29)24(22)31/h3-4,6-9,11,13-14,17,25H,5,10H2,1-2H3,(H,37,41)/t13-,14+,17+/m0/s1	CVLQFTRLIWTTNO-JJRVBVJISA-N	50582286	CHEMBL5079924	Plasma kallikrein			 0.300000							ChEMBL	10.1021/acsmedchemlett.2c00085	10.7270/Q2QJ7N5D	35450363			Sabnis, RW	Smith, Gambrell & Russell LLP	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50582286	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50582286&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162520248	476027291							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51441403	Cc1cc(Cn2cc(NC(=O)c3nc(cnc3C)-c3c(F)c(Cl)ccc3C(F)F)cn2)cnc1N1C[C@H]2C[C@H]2C1=O	InChI=1S/C28H23ClF3N7O2/c1-13-5-15(7-34-26(13)39-11-16-6-19(16)28(39)41)10-38-12-17(8-35-38)36-27(40)24-14(2)33-9-21(37-24)22-18(25(31)32)3-4-20(29)23(22)30/h3-5,7-9,12,16,19,25H,6,10-11H2,1-2H3,(H,36,40)/t16-,19-/m1/s1	LQUYFWRKFWJAJB-VQIMIIECSA-N	50582287	CHEMBL5079850	Plasma kallikrein			 0.200000							ChEMBL	10.1021/acsmedchemlett.2c00085	10.7270/Q2QJ7N5D	35450363			Sabnis, RW	Smith, Gambrell & Russell LLP	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50582287	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50582287&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162520090	476027292							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51441404	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(F)c1C)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C#N)cn1	InChI=1S/C29H23ClF2N8O2/c1-13-20(9-35-27(24(13)31)39-11-17-6-19(17)29(39)42)15(3)40-12-18(8-36-40)37-28(41)26-14(2)34-10-22(38-26)23-16(7-33)4-5-21(30)25(23)32/h4-5,8-10,12,15,17,19H,6,11H2,1-3H3,(H,37,41)/t15?,17-,19-/m1/s1	DCLSJFXDVAAQJQ-GERZZCHPSA-N	50582288	CHEMBL5089406	Plasma kallikrein			 0.200000							ChEMBL	10.1021/acsmedchemlett.2c00085	10.7270/Q2QJ7N5D	35450363			Sabnis, RW	Smith, Gambrell & Russell LLP	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50582288	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50582288&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			166632971	476027293							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51441405	COc1c(C)c(cnc1N1C[C@H]2C[C@H]2C1=O)C(C)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C29H25ClF3N7O3/c1-13-19(8-35-27(25(13)43-3)39-11-15-6-18(15)29(39)42)14(2)40-12-16(7-36-40)37-28(41)22-10-34-9-21(38-22)23-17(26(32)33)4-5-20(30)24(23)31/h4-5,7-10,12,14-15,18,26H,6,11H2,1-3H3,(H,37,41)/t14?,15-,18-/m1/s1	AESNDDHBSPWNAX-QTLYGJNZSA-N	50582289	CHEMBL5076760	Plasma kallikrein			 0.300000							ChEMBL	10.1021/acsmedchemlett.2c00085	10.7270/Q2QJ7N5D	35450363			Sabnis, RW	Smith, Gambrell & Russell LLP	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50582289	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50582289&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			166626045	476027294							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51441406	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(C)n1)n1cc(NC(=O)c2nc(cnc2CO)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H24ClF3N8O3/c1-12-26(39-9-14-5-17(14)28(39)43)34-7-19(36-12)13(2)40-10-15(6-35-40)37-27(42)24-21(11-41)33-8-20(38-24)22-16(25(31)32)3-4-18(29)23(22)30/h3-4,6-8,10,13-14,17,25,41H,5,9,11H2,1-2H3,(H,37,42)/t13?,14-,17-/m1/s1	QTEIOTHWOLEZKV-DTLKIFBZSA-N	50582290	CHEMBL5082614	Plasma kallikrein			 0.100000							ChEMBL	10.1021/acsmedchemlett.2c00085	10.7270/Q2QJ7N5D	35450363			Sabnis, RW	Smith, Gambrell & Russell LLP	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50582290	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50582290&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162520326	476027295							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51441407	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(C)c1)n1cc(NC(=O)c2nc(cnc2CO)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C29H25ClF3N7O3/c1-13-5-15(7-35-27(13)39-10-16-6-19(16)29(39)43)14(2)40-11-17(8-36-40)37-28(42)25-22(12-41)34-9-21(38-25)23-18(26(32)33)3-4-20(30)24(23)31/h3-5,7-9,11,14,16,19,26,41H,6,10,12H2,1-2H3,(H,37,42)/t14?,16-,19-/m1/s1	ZAICGYJCCFAMHG-JDQGPONISA-N	50582291	CHEMBL5078294	Plasma kallikrein			 0.200000							ChEMBL	10.1021/acsmedchemlett.2c00085	10.7270/Q2QJ7N5D	35450363			Sabnis, RW	Smith, Gambrell & Russell LLP	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50582291	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50582291&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			166627800	476027296							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51444988	CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CSC[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC1=O)C(N)=O	InChI=1S/C66H103N23O16S/c1-36(2)28-44-58(100)83-42(16-9-25-76-65(71)72)57(99)87-46(29-37-12-4-3-5-13-37)60(102)85-43(17-10-26-77-66(73)74)63(105)89-27-11-18-49(89)62(104)84-41(14-6-7-23-67)56(98)88-47(31-53(94)95)61(103)82-40(15-8-24-75-64(69)70)55(97)79-32-50(91)78-33-51(92)81-48(54(68)96)34-106-35-52(93)80-45(59(101)86-44)30-38-19-21-39(90)22-20-38/h3-5,12-13,19-22,36,40-49,90H,6-11,14-18,23-35,67H2,1-2H3,(H2,68,96)(H,78,91)(H,79,97)(H,80,93)(H,81,92)(H,82,103)(H,83,100)(H,84,104)(H,85,102)(H,86,101)(H,87,99)(H,88,98)(H,94,95)(H4,69,70,75)(H4,71,72,76)(H4,73,74,77)/t40-,41-,42-,43-,44-,45-,46-,47-,48-,49-/m0/s1	IOYPAQFESXRNJZ-CUZNLEPHSA-N	50583790	CHEMBL5069416	Plasma kallikrein			>100000							ChEMBL	10.1021/acs.jmedchem.1c00651	10.7270/Q2MC93XR	34044534			Ford, DJ; Duggan, NM; Fry, SE; Ripoll-Rozada, J; Agten, SM; Liu, W; Corcilius, L; Hackeng, TM; van Oerle, R; Spronk, HMH; Ashhurst, AS; Mini Sasi, V; Kaczmarski, JA; Jackson, CJ; Pereira, PJB; Passioura, T; Suga, H; Payne, RJ	The University of Sydney	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50583790	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50583790&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			166625809	476019877							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51444989	CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC1=O)[C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(N)=O	InChI=1S/C72H114N24O18S/c1-36(2)28-46-61(106)87-45(18-12-26-83-72(79)80)60(105)90-49(30-40-14-8-7-9-15-40)65(110)95-56(39(6)98)68(113)92-47(29-37(3)4)62(107)94-52(34-115-35-55(101)85-48(63(108)89-46)31-41-20-22-42(99)23-21-41)66(111)88-44(17-11-25-82-71(77)78)59(104)86-43(16-10-24-81-70(75)76)58(103)84-38(5)69(114)96-27-13-19-53(96)67(112)91-50(32-54(73)100)64(109)93-51(33-97)57(74)102/h7-9,14-15,20-23,36-39,43-53,56,97-99H,10-13,16-19,24-35H2,1-6H3,(H2,73,100)(H2,74,102)(H,84,103)(H,85,101)(H,86,104)(H,87,106)(H,88,111)(H,89,108)(H,90,105)(H,91,112)(H,92,113)(H,93,109)(H,94,107)(H,95,110)(H4,75,76,81)(H4,77,78,82)(H4,79,80,83)/t38-,39+,43-,44-,45-,46-,47-,48-,49-,50-,51-,52-,53-,56-/m0/s1	MNCXDBZMFJGEHV-JPVKUASSSA-N	50583792	CHEMBL5090804	Plasma kallikrein			 43000							ChEMBL	10.1021/acs.jmedchem.1c00651	10.7270/Q2MC93XR	34044534			Ford, DJ; Duggan, NM; Fry, SE; Ripoll-Rozada, J; Agten, SM; Liu, W; Corcilius, L; Hackeng, TM; van Oerle, R; Spronk, HMH; Ashhurst, AS; Mini Sasi, V; Kaczmarski, JA; Jackson, CJ; Pereira, PJB; Passioura, T; Suga, H; Payne, RJ	The University of Sydney	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50583792	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50583792&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			166636448	476019879							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51444990	CC(C)C[C@@H]1NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CSC[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCCN)NC1=O)[C@@H](C)O)C(N)=O	InChI=1S/C60H97N19O17S/c1-30(2)22-38-53(90)72-35(11-8-20-67-60(65)66)52(89)75-39(23-31(3)4)54(91)74-37(10-6-7-19-61)59(96)79-21-9-12-43(79)57(94)78-49(32(5)80)58(95)77-41(25-45(63)83)56(93)73-36(17-18-44(62)82)51(88)69-26-46(84)68-27-47(85)71-42(50(64)87)28-97-29-48(86)70-40(55(92)76-38)24-33-13-15-34(81)16-14-33/h13-16,30-32,35-43,49,80-81H,6-12,17-29,61H2,1-5H3,(H2,62,82)(H2,63,83)(H2,64,87)(H,68,84)(H,69,88)(H,70,86)(H,71,85)(H,72,90)(H,73,93)(H,74,91)(H,75,89)(H,76,92)(H,77,95)(H,78,94)(H4,65,66,67)/t32-,35+,36+,37+,38+,39+,40+,41+,42+,43+,49+/m1/s1	UXLTZTRGAWBLIW-VGGLUEFWSA-N	50583794	CHEMBL5075493	Plasma kallikrein			>100000							ChEMBL	10.1021/acs.jmedchem.1c00651	10.7270/Q2MC93XR	34044534			Ford, DJ; Duggan, NM; Fry, SE; Ripoll-Rozada, J; Agten, SM; Liu, W; Corcilius, L; Hackeng, TM; van Oerle, R; Spronk, HMH; Ashhurst, AS; Mini Sasi, V; Kaczmarski, JA; Jackson, CJ; Pereira, PJB; Passioura, T; Suga, H; Payne, RJ	The University of Sydney	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50583794	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50583794&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			166626220	476019881							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51451438	OC(=O)c1ccc(NC(=O)[C@H](Cc2ccccc2)NC(=O)\C=C\c2cc(Cl)ccc2-n2cnnn2)cc1	InChI=1S/C26H21ClN6O4/c27-20-9-12-23(33-16-28-31-32-33)19(15-20)8-13-24(34)30-22(14-17-4-2-1-3-5-17)25(35)29-21-10-6-18(7-11-21)26(36)37/h1-13,15-16,22H,14H2,(H,29,35)(H,30,34)(H,36,37)/b13-8+/t22-/m0/s1	FMPAHDTULKAUPN-SYZXBLONSA-N	50136608	CHEMBL3754069	Plasma kallikrein			 1450							ChEMBL	10.1021/acs.jmedchem.1c02153	10.7270/Q2TF027H	35220720			Yao, N; Jia, Z; Tian, Y; Hou, S; Yang, X; Han, J; Duan, Y; Liao, C; Kong, Y; Xie, Z	Hefei University of Technology	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50136608	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50136608&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	5JM	5E2O	25166809	336951935		CHEMBL3754069					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51451439	CCCCN1CCN(CC1)C(=O)CC[C@H](NC(=O)\C=C\c1cc(Cl)ccc1-n1cnnn1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C30H35ClN8O5/c1-2-3-14-37-15-17-38(18-16-37)28(41)13-10-25(29(42)33-24-8-4-21(5-9-24)30(43)44)34-27(40)12-6-22-19-23(31)7-11-26(22)39-20-32-35-36-39/h4-9,11-12,19-20,25H,2-3,10,13-18H2,1H3,(H,33,42)(H,34,40)(H,43,44)/b12-6+/t25-/m0/s1	KLRFHHXKMLDMEL-CHKMETFLSA-N	50586030	CHEMBL5086567	Plasma kallikrein			 2700							ChEMBL	10.1021/acs.jmedchem.1c02153	10.7270/Q2TF027H	35220720			Yao, N; Jia, Z; Tian, Y; Hou, S; Yang, X; Han, J; Duan, Y; Liao, C; Kong, Y; Xie, Z	Hefei University of Technology	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50586030	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50586030&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			166634237	476022117							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51451440	OC(=O)c1ccc(NC(=O)[C@H](CCC(=O)N2CCN(CC3CC3)CC2)NC(=O)\C=C\c2cc(Cl)ccc2-n2cnnn2)cc1	InChI=1S/C30H33ClN8O5/c31-23-6-10-26(39-19-32-35-36-39)22(17-23)5-11-27(40)34-25(29(42)33-24-7-3-21(4-8-24)30(43)44)9-12-28(41)38-15-13-37(14-16-38)18-20-1-2-20/h3-8,10-11,17,19-20,25H,1-2,9,12-16,18H2,(H,33,42)(H,34,40)(H,43,44)/b11-5+/t25-/m0/s1	XZEYLRNFGVPTTN-YGGPNUISSA-N	50586031	CHEMBL5087759	Plasma kallikrein			 3100							ChEMBL	10.1021/acs.jmedchem.1c02153	10.7270/Q2TF027H	35220720			Yao, N; Jia, Z; Tian, Y; Hou, S; Yang, X; Han, J; Duan, Y; Liao, C; Kong, Y; Xie, Z	Hefei University of Technology	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50586031	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50586031&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			166635635	476022118							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51451441	OC(=O)c1ccc(NC(=O)[C@H](CCC(=O)N2CCSCC2)NC(=O)\C=C\c2cc(Cl)ccc2-n2cnnn2)cc1	InChI=1S/C26H26ClN7O5S/c27-19-4-8-22(34-16-28-31-32-34)18(15-19)3-9-23(35)30-21(7-10-24(36)33-11-13-40-14-12-33)25(37)29-20-5-1-17(2-6-20)26(38)39/h1-6,8-9,15-16,21H,7,10-14H2,(H,29,37)(H,30,35)(H,38,39)/b9-3+/t21-/m0/s1	FNSTWGOOSHCEGF-XFHFFWBUSA-N	50586018	CHEMBL5079467	Plasma kallikrein			 6700							ChEMBL	10.1021/acs.jmedchem.1c02153	10.7270/Q2TF027H	35220720			Yao, N; Jia, Z; Tian, Y; Hou, S; Yang, X; Han, J; Duan, Y; Liao, C; Kong, Y; Xie, Z	Hefei University of Technology	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50586018	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50586018&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			166628077	476022105							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51451442	CCN1CCN(CC1)C(=O)C[C@H](NC(=O)\C=C\c1cc(Cl)ccc1-n1cnnn1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C27H29ClN8O5/c1-2-34-11-13-35(14-12-34)25(38)16-22(26(39)30-21-7-3-18(4-8-21)27(40)41)31-24(37)10-5-19-15-20(28)6-9-23(19)36-17-29-32-33-36/h3-10,15,17,22H,2,11-14,16H2,1H3,(H,30,39)(H,31,37)(H,40,41)/b10-5+/t22-/m0/s1	MJXUHXWTNGBIBV-FNNZQJQASA-N	50586019	CHEMBL5091612	Plasma kallikrein			 2700							ChEMBL	10.1021/acs.jmedchem.1c02153	10.7270/Q2TF027H	35220720			Yao, N; Jia, Z; Tian, Y; Hou, S; Yang, X; Han, J; Duan, Y; Liao, C; Kong, Y; Xie, Z	Hefei University of Technology	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50586019	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50586019&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			166633736	476022106							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51451443	CC(C)N1CCN(CC1)C(=O)C[C@H](NC(=O)\C=C\c1cc(Cl)ccc1-n1cnnn1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C28H31ClN8O5/c1-18(2)35-11-13-36(14-12-35)26(39)16-23(27(40)31-22-7-3-19(4-8-22)28(41)42)32-25(38)10-5-20-15-21(29)6-9-24(20)37-17-30-33-34-37/h3-10,15,17-18,23H,11-14,16H2,1-2H3,(H,31,40)(H,32,38)(H,41,42)/b10-5+/t23-/m0/s1	JEPJXMQUDCBBRG-CRAXIPPQSA-N	50586020	CHEMBL5086454	Plasma kallikrein			 490							ChEMBL	10.1021/acs.jmedchem.1c02153	10.7270/Q2TF027H	35220720			Yao, N; Jia, Z; Tian, Y; Hou, S; Yang, X; Han, J; Duan, Y; Liao, C; Kong, Y; Xie, Z	Hefei University of Technology	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50586020	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50586020&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			166631971	476022107							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51451444	CC(=O)N1CCN(CC1)C(=O)C[C@H](NC(=O)\C=C\c1cc(Cl)ccc1-n1cnnn1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C27H27ClN8O6/c1-17(37)34-10-12-35(13-11-34)25(39)15-22(26(40)30-21-6-2-18(3-7-21)27(41)42)31-24(38)9-4-19-14-20(28)5-8-23(19)36-16-29-32-33-36/h2-9,14,16,22H,10-13,15H2,1H3,(H,30,40)(H,31,38)(H,41,42)/b9-4+/t22-/m0/s1	VPFPCJQNTAUVAB-DGOUCMFKSA-N	50586021	CHEMBL5091550	Plasma kallikrein			 17300							ChEMBL	10.1021/acs.jmedchem.1c02153	10.7270/Q2TF027H	35220720			Yao, N; Jia, Z; Tian, Y; Hou, S; Yang, X; Han, J; Duan, Y; Liao, C; Kong, Y; Xie, Z	Hefei University of Technology	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50586021	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50586021&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			166632425	476022108							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51451445	CCCCN1CCN(CC1)C(=O)C[C@H](NC(=O)\C=C\c1cc(Cl)ccc1-n1cnnn1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C29H33ClN8O5/c1-2-3-12-36-13-15-37(16-14-36)27(40)18-24(28(41)32-23-8-4-20(5-9-23)29(42)43)33-26(39)11-6-21-17-22(30)7-10-25(21)38-19-31-34-35-38/h4-11,17,19,24H,2-3,12-16,18H2,1H3,(H,32,41)(H,33,39)(H,42,43)/b11-6+/t24-/m0/s1	CAVVDVLMPQTJBJ-YDSNZTKKSA-N	50586022	CHEMBL5081633	Plasma kallikrein			 510							ChEMBL	10.1021/acs.jmedchem.1c02153	10.7270/Q2TF027H	35220720			Yao, N; Jia, Z; Tian, Y; Hou, S; Yang, X; Han, J; Duan, Y; Liao, C; Kong, Y; Xie, Z	Hefei University of Technology	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50586022	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50586022&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			166629109	476022109							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51451446	OCCN1CCN(CC1)C(=O)C[C@H](NC(=O)\C=C\c1cc(Cl)ccc1-n1cnnn1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C27H29ClN8O6/c28-20-4-7-23(36-17-29-32-33-36)19(15-20)3-8-24(38)31-22(16-25(39)35-11-9-34(10-12-35)13-14-37)26(40)30-21-5-1-18(2-6-21)27(41)42/h1-8,15,17,22,37H,9-14,16H2,(H,30,40)(H,31,38)(H,41,42)/b8-3+/t22-/m0/s1	CFGGTYDLTXKOFX-XMGLVOBQSA-N	50586023	CHEMBL5079287	Plasma kallikrein			 3400							ChEMBL	10.1021/acs.jmedchem.1c02153	10.7270/Q2TF027H	35220720			Yao, N; Jia, Z; Tian, Y; Hou, S; Yang, X; Han, J; Duan, Y; Liao, C; Kong, Y; Xie, Z	Hefei University of Technology	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50586023	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50586023&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			166629443	476022110							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51451447	OC(=O)c1ccc(NC(=O)[C@H](CC(=O)N2CCN(CC3CC3)CC2)NC(=O)\C=C\c2cc(Cl)ccc2-n2cnnn2)cc1	InChI=1S/C29H31ClN8O5/c30-22-6-9-25(38-18-31-34-35-38)21(15-22)5-10-26(39)33-24(28(41)32-23-7-3-20(4-8-23)29(42)43)16-27(40)37-13-11-36(12-14-37)17-19-1-2-19/h3-10,15,18-19,24H,1-2,11-14,16-17H2,(H,32,41)(H,33,39)(H,42,43)/b10-5+/t24-/m0/s1	PZCXVDADWAMAOV-OGZUKIFOSA-N	50586024	CHEMBL5086612	Plasma kallikrein			 600							ChEMBL	10.1021/acs.jmedchem.1c02153	10.7270/Q2TF027H	35220720			Yao, N; Jia, Z; Tian, Y; Hou, S; Yang, X; Han, J; Duan, Y; Liao, C; Kong, Y; Xie, Z	Hefei University of Technology	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50586024	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50586024&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			166635603	476022111							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51451448	OC(=O)c1ccc(NC(=O)[C@H](CC(=O)N2CCCN(CC3CC3)CC2)NC(=O)\C=C\c2cc(Cl)ccc2-n2cnnn2)cc1	InChI=1S/C30H33ClN8O5/c31-23-7-10-26(39-19-32-35-36-39)22(16-23)6-11-27(40)34-25(29(42)33-24-8-4-21(5-9-24)30(43)44)17-28(41)38-13-1-12-37(14-15-38)18-20-2-3-20/h4-11,16,19-20,25H,1-3,12-15,17-18H2,(H,33,42)(H,34,40)(H,43,44)/b11-6+/t25-/m0/s1	HOAXXKWHNWIOBB-DIPILFDCSA-N	50586025	CHEMBL5079000	Plasma kallikrein			 1400							ChEMBL	10.1021/acs.jmedchem.1c02153	10.7270/Q2TF027H	35220720			Yao, N; Jia, Z; Tian, Y; Hou, S; Yang, X; Han, J; Duan, Y; Liao, C; Kong, Y; Xie, Z	Hefei University of Technology	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50586025	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50586025&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			166628480	476022112							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51451449	OC(=O)c1ccc(NC(=O)[C@H](CC(=O)N2CCN(Cc3ccccc3)CC2)NC(=O)\C=C\c2cc(Cl)ccc2-n2cnnn2)cc1	InChI=1S/C32H31ClN8O5/c33-25-9-12-28(41-21-34-37-38-41)24(18-25)8-13-29(42)36-27(31(44)35-26-10-6-23(7-11-26)32(45)46)19-30(43)40-16-14-39(15-17-40)20-22-4-2-1-3-5-22/h1-13,18,21,27H,14-17,19-20H2,(H,35,44)(H,36,42)(H,45,46)/b13-8+/t27-/m0/s1	QIZADITWMZMFLB-MJZVOSTQSA-N	50586026	CHEMBL5091954	Plasma kallikrein			 1060							ChEMBL	10.1021/acs.jmedchem.1c02153	10.7270/Q2TF027H	35220720			Yao, N; Jia, Z; Tian, Y; Hou, S; Yang, X; Han, J; Duan, Y; Liao, C; Kong, Y; Xie, Z	Hefei University of Technology	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50586026	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50586026&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			166636491	476022113							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51451450	OC(=O)c1ccc(NC(=O)[C@H](CC(=O)N2CCN(CC2)c2ccccc2)NC(=O)\C=C\c2cc(Cl)ccc2-n2cnnn2)cc1	InChI=1S/C31H29ClN8O5/c32-23-9-12-27(40-20-33-36-37-40)22(18-23)8-13-28(41)35-26(30(43)34-24-10-6-21(7-11-24)31(44)45)19-29(42)39-16-14-38(15-17-39)25-4-2-1-3-5-25/h1-13,18,20,26H,14-17,19H2,(H,34,43)(H,35,41)(H,44,45)/b13-8+/t26-/m0/s1	AVSRJYMYJIKOOD-FQKQOIFNSA-N	50586027	CHEMBL5090877	Plasma kallikrein			 27900							ChEMBL	10.1021/acs.jmedchem.1c02153	10.7270/Q2TF027H	35220720			Yao, N; Jia, Z; Tian, Y; Hou, S; Yang, X; Han, J; Duan, Y; Liao, C; Kong, Y; Xie, Z	Hefei University of Technology	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50586027	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50586027&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163322272	476022114							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51451451	Cc1ccc(CN2CCN(CC2)C(=O)C[C@H](NC(=O)\C=C\c2cc(Cl)ccc2-n2cnnn2)C(=O)Nc2ccc(cc2)C(O)=O)cc1	InChI=1S/C33H33ClN8O5/c1-22-2-4-23(5-3-22)20-40-14-16-41(17-15-40)31(44)19-28(32(45)36-27-10-6-24(7-11-27)33(46)47)37-30(43)13-8-25-18-26(34)9-12-29(25)42-21-35-38-39-42/h2-13,18,21,28H,14-17,19-20H2,1H3,(H,36,45)(H,37,43)(H,46,47)/b13-8+/t28-/m0/s1	YJBRQSCKTZMVSH-OEGMZDAKSA-N	50586028	CHEMBL5084851	Plasma kallikrein			 1200							ChEMBL	10.1021/acs.jmedchem.1c02153	10.7270/Q2TF027H	35220720			Yao, N; Jia, Z; Tian, Y; Hou, S; Yang, X; Han, J; Duan, Y; Liao, C; Kong, Y; Xie, Z	Hefei University of Technology	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50586028	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50586028&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			166633476	476022115							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51451452	OC(=O)c1ccc(NC(=O)[C@H](CC(=O)N2CCSCC2)NC(=O)\C=C\c2cc(Cl)ccc2-n2cnnn2)cc1	InChI=1S/C25H24ClN7O5S/c26-18-4-7-21(33-15-27-30-31-33)17(13-18)3-8-22(34)29-20(14-23(35)32-9-11-39-12-10-32)24(36)28-19-5-1-16(2-6-19)25(37)38/h1-8,13,15,20H,9-12,14H2,(H,28,36)(H,29,34)(H,37,38)/b8-3+/t20-/m0/s1	UWGHSKOCOOVNLR-KRNDSPITSA-N	50586029	CHEMBL5079098	Plasma kallikrein			 14000							ChEMBL	10.1021/acs.jmedchem.1c02153	10.7270/Q2TF027H	35220720			Yao, N; Jia, Z; Tian, Y; Hou, S; Yang, X; Han, J; Duan, Y; Liao, C; Kong, Y; Xie, Z	Hefei University of Technology	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50586029	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50586029&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			166627536	476022116							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267742	COCc1nn(Cc2ccc3CCN(C)Cc3c2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cc(nn1)C(F)F	InChI=1S/C28H30F3N7O3/c1-36-9-8-18-5-4-17(10-19(18)13-36)12-37-14-21(23(34-37)16-40-2)28(39)32-11-20-24(6-7-25(41-3)26(20)29)38-15-22(27(30)31)33-35-38/h4-7,10,14-15,27H,8-9,11-13,16H2,1-3H3,(H,32,39)	JFEQNYUSVBTUGQ-UHFFFAOYSA-N	598399	N-({6-[4-(difluoromethyl)-1,2,3-triazol-1-yl]-2-fluoro-3-methoxyphenyl}methyl)-3- (methoxymethyl)-1-[(2-methyl-3,4-dihydro-1H-isoquinolin-7-yl)methyl]pyrazole-4- carboxamide::US11613527, Example 1	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598399	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598399&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779223	481722762							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267745	COCc1nn(Cc2ccc3CCN(C)Cc3c2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cc(C)nn1	InChI=1S/C28H32FN7O3/c1-18-13-36(33-31-18)25-7-8-26(39-4)27(29)22(25)12-30-28(37)23-16-35(32-24(23)17-38-3)14-19-5-6-20-9-10-34(2)15-21(20)11-19/h5-8,11,13,16H,9-10,12,14-15,17H2,1-4H3,(H,30,37)	LLEAECOPGZWWOJ-UHFFFAOYSA-N	598400	N-{[2-fluoro-3-methoxy-6-(4-methyl-1,2,3-triazol-1-yl)phenyl]methyl}-3- (methoxymethyl)-1-[(2-methyl-3,4-dihydro-1H-isoquinolin-7-yl)methyl]pyrazole-4- carboxamide::US11613527, Example 119::US11613527, Example 2	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598400	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598400&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156069615	481722763							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267748	COc1ccc(c(CNC(=O)c2cnn(Cc3ccc4CCN(C)Cc4c3)c2)c1F)-n1cc(C)nn1	InChI=1S/C26H28FN7O2/c1-17-13-34(31-30-17)23-6-7-24(36-3)25(27)22(23)12-28-26(35)21-11-29-33(16-21)14-18-4-5-19-8-9-32(2)15-20(19)10-18/h4-7,10-11,13,16H,8-9,12,14-15H2,1-3H3,(H,28,35)	CNPLWPSZYAHDDP-UHFFFAOYSA-N	598401	N-{[2-fluoro-3-methoxy-6-(4-methyl-1,2,3-triazol-1-yl)phenyl]methyl}-1-[(2-methyl- 3,4-dihydro-1H-isoquinolin-7-yl)methyl]pyrazole-4-carboxamide::US11613527, Example 3	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598401	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598401&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779144	481722764							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267751	COCc1nn(Cc2ccc3CCN(C)Cc3c2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cnc(C)n1	InChI=1S/C28H32FN7O3/c1-18-31-17-36(32-18)25-7-8-26(39-4)27(29)22(25)12-30-28(37)23-15-35(33-24(23)16-38-3)13-19-5-6-20-9-10-34(2)14-21(20)11-19/h5-8,11,15,17H,9-10,12-14,16H2,1-4H3,(H,30,37)	SZIMMYXTRPVACP-UHFFFAOYSA-N	598402	N-{[2-fluoro-3-methoxy-6-(3-methyl-1,2,4-triazol-1-yl)phenyl]methyl}-3- (methoxymethyl)-1-[(2-methyl-3,4-dihydro-1H-isoquinolin-7-yl)methyl]pyrazole-4- carboxamide::US11613527, Example 4	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598402	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598402&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779180	481722765							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267754	CCc1ncn(n1)-c1ccc(OC)c(F)c1CNC(=O)c1cn(Cc2ccc3CCN(C)Cc3c2)nc1COC	InChI=1S/C29H34FN7O3/c1-5-27-32-18-37(34-27)25-8-9-26(40-4)28(30)22(25)13-31-29(38)23-16-36(33-24(23)17-39-3)14-19-6-7-20-10-11-35(2)15-21(20)12-19/h6-9,12,16,18H,5,10-11,13-15,17H2,1-4H3,(H,31,38)	ZMNZVGIMJPIAMH-UHFFFAOYSA-N	598403	N-{[6-(3-ethyl-1,2,4-triazol-1-yl)-2-fluoro-3-methoxyphenyl]methyl}-3- (methoxymethyl)-1-[(2-methyl-3,4-dihydro-1H-isoquinolin-7-yl)methyl]pyrazole-4- carboxamide::US11613527, Example 6	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598403	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598403&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779154	481722766							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267757	COCc1nn(Cc2ccc3CCN(C)Cc3c2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cncn1	InChI=1S/C27H30FN7O3/c1-33-9-8-19-5-4-18(10-20(19)13-33)12-34-14-22(23(32-34)15-37-2)27(36)30-11-21-24(35-17-29-16-31-35)6-7-25(38-3)26(21)28/h4-7,10,14,16-17H,8-9,11-13,15H2,1-3H3,(H,30,36)	CVDALTLCOOEWHK-UHFFFAOYSA-N	598404	N-{[2-fluoro-3-methoxy-6-(1,2,4-triazol-1-yl)phenyl]methyl}-3-(methoxymethyl)-1- [(2-methyl-3,4-dihydro-1H-isoquinolin-7-yl)methyl]pyrazole-4-carboxamide::US11613527, Example 7	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598404	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598404&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156070735	481722767							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267760	COCc1nn(Cc2ccc3CCN(C)Cc3c2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1ccc(n1)C(F)(F)F	InChI=1S/C29H30F4N6O3/c1-37-10-8-19-5-4-18(12-20(19)15-37)14-38-16-22(23(35-38)17-41-2)28(40)34-13-21-24(6-7-25(42-3)27(21)30)39-11-9-26(36-39)29(31,32)33/h4-7,9,11-12,16H,8,10,13-15,17H2,1-3H3,(H,34,40)	AKZFGPGNZWZZNR-UHFFFAOYSA-N	598405	N-({2-fluoro-3-methoxy-6-[3-(trifluoromethyl)pyrazol-1-yl]phenyl}methyl)-3- (methoxymethyl)-1-[(2-methyl-3,4-dihydro-1H-isoquinolin-7-yl)methyl]pyrazole-4- carboxamide::US11613527, Example 8	Plasma kallikrein			 20							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598405	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598405&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779186	481722768							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267763	COCc1nn(Cc2ccc3CCN(C)Cc3c2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1ccc(n1)C1CC1	InChI=1S/C31H35FN6O3/c1-36-12-10-21-5-4-20(14-23(21)17-36)16-37-18-25(27(34-37)19-40-2)31(39)33-15-24-28(8-9-29(41-3)30(24)32)38-13-11-26(35-38)22-6-7-22/h4-5,8-9,11,13-14,18,22H,6-7,10,12,15-17,19H2,1-3H3,(H,33,39)	YOMQFNIHKVQDST-UHFFFAOYSA-N	598406	N-{[6-(3-cyclopropylpyrazol-1-yl)-2-fluoro-3-methoxyphenyl]methyl}-3- (methoxymethyl)-1-[(2-methyl-3,4-dihydro-1H-isoquinolin-7-yl)methyl]pyrazole-4- carboxamide::US11613527, Example 9	Plasma kallikrein			 65							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598406	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598406&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779201	481722769							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267766	COCc1nn(Cc2ccc3CCN(C)Cc3c2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1ccc(n1)C#N	InChI=1S/C29H30FN7O3/c1-35-10-8-20-5-4-19(12-21(20)16-35)15-36-17-24(25(34-36)18-39-2)29(38)32-14-23-26(6-7-27(40-3)28(23)30)37-11-9-22(13-31)33-37/h4-7,9,11-12,17H,8,10,14-16,18H2,1-3H3,(H,32,38)	BZALKRSTHRLVJK-UHFFFAOYSA-N	598407	N-{[6-(3-cyanopyrazol-1-yl)-2-fluoro-3-methoxyphenyl]methyl}-3-(methoxymethyl)- 1-[(2-methyl-3,4-dihydro-1H-isoquinolin-7-yl)methyl]pyrazole-4-carboxamide::US11613527, Example 11	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598407	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598407&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156070362	481722770							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267769	COCc1nn(Cc2ccc3CCN(C)Cc3c2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1ncnc1C	InChI=1S/C28H32FN7O3/c1-18-31-17-32-36(18)25-7-8-26(39-4)27(29)22(25)12-30-28(37)23-15-35(33-24(23)16-38-3)13-19-5-6-20-9-10-34(2)14-21(20)11-19/h5-8,11,15,17H,9-10,12-14,16H2,1-4H3,(H,30,37)	VZDWZUNUWKQPGQ-UHFFFAOYSA-N	598408	N-{[2-fluoro-3-methoxy-6-(5-methyl-1,2,4-triazol-1-yl)phenyl]methyl}-3- (methoxymethyl)-1-[(2-methyl-3,4-dihydro-1H-isoquinolin-7-yl)methyl]pyrazole-4- carboxamide::US11613527, Example 12	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598408	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598408&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779175	481722771							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267772	COCc1nn(Cc2ccc3CCN(C)Cc3c2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cnc(n1)C(F)(F)F	InChI=1S/C28H29F4N7O3/c1-37-9-8-18-5-4-17(10-19(18)13-37)12-38-14-21(22(35-38)15-41-2)26(40)33-11-20-23(6-7-24(42-3)25(20)29)39-16-34-27(36-39)28(30,31)32/h4-7,10,14,16H,8-9,11-13,15H2,1-3H3,(H,33,40)	VFDSRJFCGHJWBD-UHFFFAOYSA-N	598409	N-({2-fluoro-3-methoxy-6-[3-(trifluoromethyl)-1,2,4-triazol-1-yl]phenyl}methyl)-3- (methoxymethyl)-1-[(2-methyl-3,4-dihydro-1H-isoquinolin-7-yl)methyl]pyrazole-4- carboxamide::US11613527, Example 13	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598409	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598409&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779211	481722772							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267775	COCc1nn(Cc2ccc3CCN(Cc3c2)C2CC2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cc(C)nn1	InChI=1S/C30H34FN7O3/c1-19-14-38(35-33-19)27-8-9-28(41-3)29(31)24(27)13-32-30(39)25-17-37(34-26(25)18-40-2)15-20-4-5-21-10-11-36(23-6-7-23)16-22(21)12-20/h4-5,8-9,12,14,17,23H,6-7,10-11,13,15-16,18H2,1-3H3,(H,32,39)	WPOPGLBEIZOPEQ-UHFFFAOYSA-N	598410	1-[(2-cyclopropyl-3,4-dihydro-1H-isoquinolin-7-yl)methyl]-N-{[2-fluoro-3-methoxy-6- (4-methyl-1,2,3-triazol-1-yl)phenyl]methyl}-3-(methoxymethyl)pyrazole-4- carboxamide::US11613527, Example 14	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598410	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598410&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156070073	481722773							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267778	COCc1nn(Cc2ccc3CCN(C)Cc3c2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cnc(n1)C(F)F	InChI=1S/C28H30F3N7O3/c1-36-9-8-18-5-4-17(10-19(18)13-36)12-37-14-21(22(34-37)15-40-2)28(39)32-11-20-23(6-7-24(41-3)25(20)29)38-16-33-27(35-38)26(30)31/h4-7,10,14,16,26H,8-9,11-13,15H2,1-3H3,(H,32,39)	JSFXRSPFXCVKBY-UHFFFAOYSA-N	598411	N-({6-[3-(difluoromethyl)-1,2,4-triazol-1-yl]-2-fluoro-3-methoxyphenyl}methyl)-3- (methoxymethyl)-1-[(2-methyl-3,4-dihydro-1H-isoquinolin-7-yl)methyl]pyrazole-4- carboxamide::US11613527, Example 15	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598411	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598411&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779155	481722774							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267781	CCN1CCc2ccc(Cn3cc(C(=O)NCc4c(F)c(OC)ccc4-n4cc(C)nn4)c(COC)n3)cc2C1	InChI=1S/C29H34FN7O3/c1-5-35-11-10-21-7-6-20(12-22(21)16-35)15-36-17-24(25(33-36)18-39-3)29(38)31-13-23-26(37-14-19(2)32-34-37)8-9-27(40-4)28(23)30/h6-9,12,14,17H,5,10-11,13,15-16,18H2,1-4H3,(H,31,38)	GTLGOKCDUKJDFE-UHFFFAOYSA-N	598412	1-[(2-ethyl-3,4-dihydro-1H-isoquinolin-7-yl)methyl]-N-{[2-fluoro-3-methoxy-6-(4- methyl-1,2,3-triazol-1-yl)phenyl]methyl}-3-(methoxymethyl)pyrazole-4-carboxamide::US11613527, Example 16	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598412	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598412&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779159	481722775							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267784	COCc1nn(Cc2ccc3CCN(Cc3c2)C(C)C)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cc(C)nn1	InChI=1S/C30H36FN7O3/c1-19(2)36-11-10-22-7-6-21(12-23(22)16-36)15-37-17-25(26(34-37)18-40-4)30(39)32-13-24-27(38-14-20(3)33-35-38)8-9-28(41-5)29(24)31/h6-9,12,14,17,19H,10-11,13,15-16,18H2,1-5H3,(H,32,39)	MQIZCQUBKRAXRJ-UHFFFAOYSA-N	598413	N-{[2-fluoro-3-methoxy-6-(4-methyl-1,2,3-triazol-1-yl)phenyl]methyl}-1-[(2- isopropyl-3,4-dihydro-1H-isoquinolin-7-yl)methyl]-3-(methoxymethyl)pyrazole-4- carboxamide::US11613527, Example 17	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598413	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598413&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156069661	481722776							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267787	COCc1nn(Cc2ccc3CCN(Cc3c2)C2CCC2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cc(C)nn1	InChI=1S/C31H36FN7O3/c1-20-15-39(36-34-20)28-9-10-29(42-3)30(32)25(28)14-33-31(40)26-18-38(35-27(26)19-41-2)16-21-7-8-22-11-12-37(17-23(22)13-21)24-5-4-6-24/h7-10,13,15,18,24H,4-6,11-12,14,16-17,19H2,1-3H3,(H,33,40)	JPGFDJRAXZHQOA-UHFFFAOYSA-N	598414	1-((2-cyclobutyl-1,2,3,4-tetrahydroisoquinolin-7-yl)methyl)-N-(2-fluoro-3-methoxy-6- (4-methyl-1H-1,2,3-triazol-1-yl)benzyl)-3-(methoxymethyl)-1H-pyrazole-4- carboxamide::US11613527, Example 18	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598414	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598414&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163284758	481722777							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267790	COCc1nn(Cc2ccc3CCN(Cc3c2)C2CC2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cnc(n1)C(F)F	InChI=1S/C30H32F3N7O3/c1-42-16-24-23(15-39(36-24)13-18-3-4-19-9-10-38(21-5-6-21)14-20(19)11-18)30(41)34-12-22-25(7-8-26(43-2)27(22)31)40-17-35-29(37-40)28(32)33/h3-4,7-8,11,15,17,21,28H,5-6,9-10,12-14,16H2,1-2H3,(H,34,41)	KGSVHNBLOMKQQJ-UHFFFAOYSA-N	598415	1-[(2-cyclopropyl-3,4-dihydro-1H-isoquinolin-7-yl)methyl]-N-({6-[3-(difluoromethyl)- 1,2,4-triazol-1-yl]-2-fluoro-3-methoxyphenyl}methyl)-3-(methoxymethyl)pyrazole-4- carboxamide::US11613527, Example 19	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598415	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598415&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156070473	481722778							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267793	COCc1nn(Cc2ccc3CCN(Cc3c2)C2CC2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cnc(n1)C(F)(F)F	InChI=1S/C30H31F4N7O3/c1-43-16-24-23(15-40(37-24)13-18-3-4-19-9-10-39(21-5-6-21)14-20(19)11-18)28(42)35-12-22-25(7-8-26(44-2)27(22)31)41-17-36-29(38-41)30(32,33)34/h3-4,7-8,11,15,17,21H,5-6,9-10,12-14,16H2,1-2H3,(H,35,42)	HYNZYOUEVWWVCB-UHFFFAOYSA-N	598416	1-[(2-cyclopropyl-3,4-dihydro-1H-isoquinolin-7-yl)methyl]-N-({2-fluoro-3-methoxy-6- [3-(trifluoromethyl)-1,2,4-triazol-1-yl]phenyl}methyl)-3-(methoxymethyl)pyrazole-4- carboxamide::US11613527, Example 20	Plasma kallikrein			 20							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598416	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598416&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156070080	481722779							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267796	COCc1nn(Cc2ccc3CCN(Cc3c2)C2CC2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1ccc(n1)C#N	InChI=1S/C31H32FN7O3/c1-41-19-27-26(18-38(36-27)16-20-3-4-21-9-11-37(24-5-6-24)17-22(21)13-20)31(40)34-15-25-28(7-8-29(42-2)30(25)32)39-12-10-23(14-33)35-39/h3-4,7-8,10,12-13,18,24H,5-6,9,11,15-17,19H2,1-2H3,(H,34,40)	XIWORBXRSOPQIU-UHFFFAOYSA-N	598417	N-{[6-(3-cyanopyrazol-1-yl)-2-fluoro-3-methoxyphenyl]methyl}-1-[(2-cyclopropyl-3,4- dihydro-1H-isoquinolin-7-yl)methyl]-3-(methoxymethyl)pyrazole-4-carboxamide::US11613527, Example 21	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598417	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598417&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779202	481722780							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267799	COCc1nn(Cc2ccc3CCN(Cc3c2)C(C)C)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cnc(n1)C(F)(F)F	InChI=1S/C30H33F4N7O3/c1-18(2)39-10-9-20-6-5-19(11-21(20)14-39)13-40-15-23(24(37-40)16-43-3)28(42)35-12-22-25(7-8-26(44-4)27(22)31)41-17-36-29(38-41)30(32,33)34/h5-8,11,15,17-18H,9-10,12-14,16H2,1-4H3,(H,35,42)	SWEVXEGJTMEQED-UHFFFAOYSA-N	598418	N-({2-fluoro-3-methoxy-6-[3-(trifluoromethyl)-1,2,4-triazol-1-yl]phenyl}methyl)-1- [(2-isopropyl-3,4-dihydro-1H-isoquinolin-7-yl)methyl]-3-(methoxymethyl)pyrazole-4- carboxamide::US11613527, Example 22	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598418	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598418&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779194	481722781							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267802	COCc1nn(Cc2ccc3CCN(Cc3c2)C(C)C)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cnc(n1)C(F)F	InChI=1S/C30H34F3N7O3/c1-18(2)38-10-9-20-6-5-19(11-21(20)14-38)13-39-15-23(24(36-39)16-42-3)30(41)34-12-22-25(7-8-26(43-4)27(22)31)40-17-35-29(37-40)28(32)33/h5-8,11,15,17-18,28H,9-10,12-14,16H2,1-4H3,(H,34,41)	XCVARTNQAFLOMD-UHFFFAOYSA-N	598419	N-({6-[3-(difluoromethyl)-1,2,4-triazol-1-yl]-2-fluoro-3-methoxyphenyl}methyl)-1-[(2- isopropyl-3,4-dihydro-1H-isoquinolin-7-yl)methyl]-3-(methoxymethyl)pyrazole-4- carboxamide::US11613527, Example 23	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598419	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598419&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779130	481722782							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267805	COCc1nn(Cc2ccc3CCN(Cc3c2)C(C)C)cc1C(=O)NCc1c(F)c(OC)ccc1-n1ccc(n1)C#N	InChI=1S/C31H34FN7O3/c1-20(2)37-11-9-22-6-5-21(13-23(22)17-37)16-38-18-26(27(36-38)19-41-3)31(40)34-15-25-28(7-8-29(42-4)30(25)32)39-12-10-24(14-33)35-39/h5-8,10,12-13,18,20H,9,11,15-17,19H2,1-4H3,(H,34,40)	FXJLRLVYNJWUBM-UHFFFAOYSA-N	598420	N-{[6-(3-cyanopyrazol-1-yl)-2-fluoro-3-methoxyphenyl]methyl}-1-[(2-isopropyl-3,4- dihydro-1H-isoquinolin-7-yl)methyl]-3-(methoxymethyl)pyrazole-4-carboxamide::US11613527, Example 24	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598420	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598420&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156070048	481722783							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267808	CCN1CCc2ccc(Cn3cc(C(=O)NCc4c(F)c(OC)ccc4-n4cnc(n4)C(F)(F)F)c(COC)n3)cc2C1	InChI=1S/C29H31F4N7O3/c1-4-38-10-9-19-6-5-18(11-20(19)14-38)13-39-15-22(23(36-39)16-42-2)27(41)34-12-21-24(7-8-25(43-3)26(21)30)40-17-35-28(37-40)29(31,32)33/h5-8,11,15,17H,4,9-10,12-14,16H2,1-3H3,(H,34,41)	JHYYWEPNBPPOKM-UHFFFAOYSA-N	598421	1-[(2-ethyl-3,4-dihydro-1H-isoquinolin-7-yl)methyl]-N-({2-fluoro-3-methoxy-6-[3- (trifluoromethyl)-1,2,4-triazol-1-yl]phenyl}methyl)-3-(methoxymethyl)pyrazole-4- carboxamide::US11613527, Example 25	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598421	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598421&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156070119	481722784							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267811	CCN1CCc2ccc(Cn3cc(C(=O)NCc4c(F)c(OC)ccc4-n4cnc(n4)C(F)F)c(COC)n3)cc2C1	InChI=1S/C29H32F3N7O3/c1-4-37-10-9-19-6-5-18(11-20(19)14-37)13-38-15-22(23(35-38)16-41-2)29(40)33-12-21-24(7-8-25(42-3)26(21)30)39-17-34-28(36-39)27(31)32/h5-8,11,15,17,27H,4,9-10,12-14,16H2,1-3H3,(H,33,40)	PBYLBJBIIHFKDS-UHFFFAOYSA-N	598422	N-({6-[3-(difluoromethyl)-1,2,4-triazol-1-yl]-2-fluoro-3-methoxyphenyl}methyl)-1-[(2- ethyl-3,4-dihydro-1H-isoquinolin-7-yl)methyl]-3-(methoxymethyl)pyrazole-4- carboxamide::US11613527, Example 26	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598422	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598422&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156069275	481722785							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267814	CCN1CCc2ccc(Cn3cc(C(=O)NCc4c(F)c(OC)ccc4-n4ccc(n4)C#N)c(COC)n3)cc2C1	InChI=1S/C30H32FN7O3/c1-4-36-11-9-21-6-5-20(13-22(21)17-36)16-37-18-25(26(35-37)19-40-2)30(39)33-15-24-27(7-8-28(41-3)29(24)31)38-12-10-23(14-32)34-38/h5-8,10,12-13,18H,4,9,11,15-17,19H2,1-3H3,(H,33,39)	DUGJECXUZZTYAR-UHFFFAOYSA-N	598423	N-{[6-(3-cyanopyrazol-1-yl)-2-fluoro-3-methoxyphenyl]methyl}-1-[(2-ethyl-3,4- dihydro-1H-isoquinolin-7-yl)methyl]-3-(methoxymethyl)pyrazole-4-carboxamide::US11613527, Example 27	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598423	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598423&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779167	481722786							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267817	COCc1nn(Cc2ccc3CCN(C)Cc3c2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1nc(C)nc1C	InChI=1S/C29H34FN7O3/c1-18-32-19(2)37(33-18)26-8-9-27(40-5)28(30)23(26)13-31-29(38)24-16-36(34-25(24)17-39-4)14-20-6-7-21-10-11-35(3)15-22(21)12-20/h6-9,12,16H,10-11,13-15,17H2,1-5H3,(H,31,38)	YAHRASPYCBRSAH-UHFFFAOYSA-N	598424	N-{[6-(dimethyl-1,2,4-triazol-1-yl)-2-fluoro-3-methoxyphenyl]methyl}-3- (methoxymethyl)-1-[(2-methyl-3,4-dihydro-1H-isoquinolin-7-yl)methyl]pyrazole-4- carboxamide::US11613527, Example 29	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598424	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598424&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779191	481722787							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267820	COCc1nn(Cc2ccc3CCN(Cc3c2)C(C)C)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cc(cn1)C#N	InChI=1S/C31H34FN7O3/c1-20(2)37-10-9-23-6-5-21(11-24(23)17-37)15-38-18-26(27(36-38)19-41-3)31(40)34-14-25-28(7-8-29(42-4)30(25)32)39-16-22(12-33)13-35-39/h5-8,11,13,16,18,20H,9-10,14-15,17,19H2,1-4H3,(H,34,40)	ORUWMRFIIQNYKD-UHFFFAOYSA-N	598425	N-{[6-(4-cyanopyrazol-1-yl)-2-fluoro-3-methoxyphenyl]methyl}-1-[(2-isopropyl-3,4- dihydro-1H-isoquinolin-7-yl)methyl]-3-(methoxymethyl)pyrazole-4-carboxamide::US11613527, Example 30	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598425	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598425&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156070732	481722788							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267823	COc1ccc(c(CNC(=O)c2cnn(Cc3ccc4CCN(C)Cc4c3)c2)c1F)-n1cnc(n1)C(F)(F)F	InChI=1S/C26H25F4N7O2/c1-35-8-7-17-4-3-16(9-18(17)13-35)12-36-14-19(10-33-36)24(38)31-11-20-21(5-6-22(39-2)23(20)27)37-15-32-25(34-37)26(28,29)30/h3-6,9-10,14-15H,7-8,11-13H2,1-2H3,(H,31,38)	HAHIAVSEBBMYOG-UHFFFAOYSA-N	598426	N-({2-fluoro-3-methoxy-6-[3-(trifluoromethyl)-1,2,4-triazol-1-yl]phenyl}methyl)-1- [(2-methyl-3,4-dihydro-1H-isoquinolin-7-yl)methyl]pyrazole-4-carboxamide::US11613527, Example 31	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598426	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598426&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156070192	481722789							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267826	COc1ccc(c(CNC(=O)c2cnn(Cc3ccc4CCN(Cc4c3)C(C)C)c2)c1F)-n1cnc(n1)C(F)(F)F	InChI=1S/C28H29F4N7O2/c1-17(2)37-9-8-19-5-4-18(10-20(19)14-37)13-38-15-21(11-35-38)26(40)33-12-22-23(6-7-24(41-3)25(22)29)39-16-34-27(36-39)28(30,31)32/h4-7,10-11,15-17H,8-9,12-14H2,1-3H3,(H,33,40)	ZBUKMTTWLCWCBN-UHFFFAOYSA-N	598427	N-({2-fluoro-3-methoxy-6-[3-(trifluoromethyl)-1,2,4-triazol-1-yl]phenyl}methyl)-1- [(2-isopropyl-3,4-dihydro-1H-isoquinolin-7-yl)methyl]pyrazole-4-carboxamide::US11613527, Example 32	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598427	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598427&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156070372	481722790							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267829	COc1ccc(c(CNC(=O)c2cn(Cc3ccc4CCN(C)Cc4c3)nc2C(F)F)c1F)-n1cc(C)nn1	InChI=1S/C27H28F3N7O2/c1-16-12-37(34-32-16)22-6-7-23(39-3)24(28)20(22)11-31-27(38)21-15-36(33-25(21)26(29)30)13-17-4-5-18-8-9-35(2)14-19(18)10-17/h4-7,10,12,15,26H,8-9,11,13-14H2,1-3H3,(H,31,38)	MULIJFMSCBKFHB-UHFFFAOYSA-N	598428	3-(difluoromethyl)-N-{[2-fluoro-3-methoxy-6-(4-methyl-1,2,3-triazol-1- yl)phenyl]methyl}-1-[(2-methyl-3,4-dihydro-1H-isoquinolin-7-yl)methyl]pyrazole-4- carboxamide::US11613527, Example 33	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598428	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598428&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779164	481722791							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267830	COCc1nn(Cc2ccc3CN(C)CCc3c2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cc(nn1)C(F)F	InChI=1S/C28H30F3N7O3/c1-36-9-8-18-10-17(4-5-19(18)13-36)12-37-14-21(23(34-37)16-40-2)28(39)32-11-20-24(6-7-25(41-3)26(20)29)38-15-22(27(30)31)33-35-38/h4-7,10,14-15,27H,8-9,11-13,16H2,1-3H3,(H,32,39)	KEVLYGRRRQDXKC-UHFFFAOYSA-N	598429	N-({6-[4-(difluoromethyl)-1,2,3-triazol-1-yl]-2-fluoro-3-methoxyphenyl}methyl)-3- (methoxymethyl)-1-[(2-methyl-3,4-dihydro-1H-isoquinolin-6-yl)methyl]pyrazole-4- carboxamide::US11613527, Example 34	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598429	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598429&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779225	481722792							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267833	COCc1nn(Cc2ccc3CN(CCc3c2)C2CC2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cc(C)nn1	InChI=1S/C30H34FN7O3/c1-19-14-38(35-33-19)27-8-9-28(41-3)29(31)24(27)13-32-30(39)25-17-37(34-26(25)18-40-2)15-20-4-5-22-16-36(23-6-7-23)11-10-21(22)12-20/h4-5,8-9,12,14,17,23H,6-7,10-11,13,15-16,18H2,1-3H3,(H,32,39)	JMLHJJAPLCPJPY-UHFFFAOYSA-N	598430	1-[(2-cyclopropyl-3,4-dihydro-1H-isoquinolin-6-yl)methyl]-N-{[2-fluoro-3-methoxy-6- (4-methyl-1,2,3-triazol-1-yl)phenyl]methyl}-3-(methoxymethyl)pyrazole-4- carboxamide::US11613527, Example 35	Plasma kallikrein			 65							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598430	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598430&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779272	481722793							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267836	COCc1nn(Cc2ccc3CN(C)CCc3c2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cc(C)nn1	InChI=1S/C28H32FN7O3/c1-18-13-36(33-31-18)25-7-8-26(39-4)27(29)22(25)12-30-28(37)23-16-35(32-24(23)17-38-3)14-19-5-6-21-15-34(2)10-9-20(21)11-19/h5-8,11,13,16H,9-10,12,14-15,17H2,1-4H3,(H,30,37)	AVTQRESSHPXOFP-UHFFFAOYSA-N	598431	N-{[2-fluoro-3-methoxy-6-(4-methyl-1,2,3-triazol-1-yl)phenyl]methyl}-3- (methoxymethyl)-1-[(2-methyl-3,4-dihydro-1H-isoquinolin-6-yl)methyl]pyrazole-4- carboxamide::US11613527, Example 36	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598431	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598431&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779136	481722794							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267839	COCc1nn(Cc2ccc3CN(CCc3c2)C(C)C)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cc(C)nn1	InChI=1S/C30H36FN7O3/c1-19(2)36-11-10-22-12-21(6-7-23(22)16-36)15-37-17-25(26(34-37)18-40-4)30(39)32-13-24-27(38-14-20(3)33-35-38)8-9-28(41-5)29(24)31/h6-9,12,14,17,19H,10-11,13,15-16,18H2,1-5H3,(H,32,39)	IFAGTPYLDZYVOR-UHFFFAOYSA-N	598432	N-{[2-fluoro-3-methoxy-6-(4-methyl-1,2,3-triazol-1-yl)phenyl]methyl}-1-[(2- isopropyl-3,4-dihydro-1H-isoquinolin-6-yl)methyl]-3-(methoxymethyl)pyrazole-4- carboxamide::US11613527, Example 37	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598432	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598432&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779182	481722795							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267842	CCN1CCc2cc(Cn3cc(C(=O)NCc4c(F)c(OC)ccc4-n4cc(C)nn4)c(COC)n3)ccc2C1	InChI=1S/C29H34FN7O3/c1-5-35-11-10-21-12-20(6-7-22(21)16-35)15-36-17-24(25(33-36)18-39-3)29(38)31-13-23-26(37-14-19(2)32-34-37)8-9-27(40-4)28(23)30/h6-9,12,14,17H,5,10-11,13,15-16,18H2,1-4H3,(H,31,38)	DIQWJGILAGPFHT-UHFFFAOYSA-N	598433	1-[(2-ethyl-3,4-dihydro-1H-isoquinolin-6-yl)methyl]-N-{[2-fluoro-3-methoxy-6-(4- methyl-1,2,3-triazol-1-yl)phenyl]methyl}-3-(methoxymethyl)pyrazole-4-carboxamide::US11613527, Example 38	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598433	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598433&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779131	481722796							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267845	COCc1nn(Cc2ccc3CN(CCc3c2)C2CCC2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cc(C)nn1	InChI=1S/C31H36FN7O3/c1-20-15-39(36-34-20)28-9-10-29(42-3)30(32)25(28)14-33-31(40)26-18-38(35-27(26)19-41-2)16-21-7-8-23-17-37(24-5-4-6-24)12-11-22(23)13-21/h7-10,13,15,18,24H,4-6,11-12,14,16-17,19H2,1-3H3,(H,33,40)	XMRIUQZQXHSNDH-UHFFFAOYSA-N	598434	1-[(2-cyclobutyl-3,4-dihydro-1H-isoquinolin-6-yl)methyl]-N-{[2-fluoro-3-methoxy-6- (4-methyl-1,2,3-triazol-1-yl)phenyl]methyl}-3-(methoxymethyl)pyrazole-4- carboxamide::US11613527, Example 40	Plasma kallikrein			 20							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598434	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598434&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779226	481722797							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267848	COCc1nn(Cc2ccc3CN(C)CCc3c2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cnc(n1)C(F)F	InChI=1S/C28H30F3N7O3/c1-36-9-8-18-10-17(4-5-19(18)13-36)12-37-14-21(22(34-37)15-40-2)28(39)32-11-20-23(6-7-24(41-3)25(20)29)38-16-33-27(35-38)26(30)31/h4-7,10,14,16,26H,8-9,11-13,15H2,1-3H3,(H,32,39)	GLZSOIYYAWZBEJ-UHFFFAOYSA-N	598435	N-({6-[3-(difluoromethyl)-1,2,4-triazol-1-yl]-2-fluoro-3-methoxyphenyl}methyl)-3- (methoxymethyl)-1-[(2-methyl-3,4-dihydro-1H-isoquinolin-6-yl)methyl]pyrazole-4- carboxamide::US11613527, Example 41	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598435	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598435&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779209	481722798							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267851	COCc1nn(Cc2ccc3CN(C)CCc3c2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cnc(n1)C(F)(F)F	InChI=1S/C28H29F4N7O3/c1-37-9-8-18-10-17(4-5-19(18)13-37)12-38-14-21(22(35-38)15-41-2)26(40)33-11-20-23(6-7-24(42-3)25(20)29)39-16-34-27(36-39)28(30,31)32/h4-7,10,14,16H,8-9,11-13,15H2,1-3H3,(H,33,40)	BYDLNBVQNFBIKS-UHFFFAOYSA-N	598436	N-({2-fluoro-3-methoxy-6-[3-(trifluoromethyl)-1,2,4-triazol-1-yl]phenyl}methyl)-3- (methoxymethyl)-1-[(2-methyl-3,4-dihydro-1H-isoquinolin-6-yl)methyl]pyrazole-4- carboxamide::US11613527, Example 42	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598436	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598436&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779135	481722799							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267854	COCc1nn(Cc2ccc3CN(C)CCc3c2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1ccc(n1)C#N	InChI=1S/C29H30FN7O3/c1-35-10-8-20-12-19(4-5-21(20)16-35)15-36-17-24(25(34-36)18-39-2)29(38)32-14-23-26(6-7-27(40-3)28(23)30)37-11-9-22(13-31)33-37/h4-7,9,11-12,17H,8,10,14-16,18H2,1-3H3,(H,32,38)	NFYHGGHMDNEBTH-UHFFFAOYSA-N	598437	N-{[6-(3-cyanopyrazol-1-yl)-2-fluoro-3-methoxyphenyl]methyl}-3-(methoxymethyl)- 1-[(2-methyl-3,4-dihydro-1H-isoquinolin-6-yl)methyl]pyrazole-4-carboxamide::US11613527, Example 43	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598437	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598437&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156070020	481722800							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267857	COCc1nn(Cc2ccc3CN(CCc3c2)C(C)C)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cnc(n1)C(F)F	InChI=1S/C30H34F3N7O3/c1-18(2)38-10-9-20-11-19(5-6-21(20)14-38)13-39-15-23(24(36-39)16-42-3)30(41)34-12-22-25(7-8-26(43-4)27(22)31)40-17-35-29(37-40)28(32)33/h5-8,11,15,17-18,28H,9-10,12-14,16H2,1-4H3,(H,34,41)	RJHMHGJYXWHODK-UHFFFAOYSA-N	598438	N-({6-[3-(difluoromethyl)-1,2,4-triazol-1-yl]-2-fluoro-3-methoxyphenyl}methyl)-1-[(2- isopropyl-3,4-dihydro-1H-isoquinolin-6-yl)methyl]-3-(methoxymethyl)pyrazole-4- carboxamide::US11613527, Example 44	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598438	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598438&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156070230	481722801							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267860	COCc1nn(Cc2ccc3CN(CCc3c2)C(C)C)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cnc(n1)C(F)(F)F	InChI=1S/C30H33F4N7O3/c1-18(2)39-10-9-20-11-19(5-6-21(20)14-39)13-40-15-23(24(37-40)16-43-3)28(42)35-12-22-25(7-8-26(44-4)27(22)31)41-17-36-29(38-41)30(32,33)34/h5-8,11,15,17-18H,9-10,12-14,16H2,1-4H3,(H,35,42)	OFTLPMAMUNHPAG-UHFFFAOYSA-N	598439	N-({2-fluoro-3-methoxy-6-[3-(trifluoromethyl)-1,2,4-triazol-1-yl]phenyl}methyl)-1- [(2-isopropyl-3,4-dihydro-1H-isoquinolin-6-yl)methyl]-3-(methoxymethyl)pyrazole-4- carboxamide::US11613527, Example 45	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598439	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598439&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779188	481722802							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267863	COCc1nn(Cc2ccc3CN(CCc3c2)C(C)C)cc1C(=O)NCc1c(F)c(OC)ccc1-n1ccc(n1)C#N	InChI=1S/C31H34FN7O3/c1-20(2)37-11-9-22-13-21(5-6-23(22)17-37)16-38-18-26(27(36-38)19-41-3)31(40)34-15-25-28(7-8-29(42-4)30(25)32)39-12-10-24(14-33)35-39/h5-8,10,12-13,18,20H,9,11,15-17,19H2,1-4H3,(H,34,40)	JFGAIOSAWGTJCK-UHFFFAOYSA-N	598440	N-{[6-(3-cyanopyrazol-1-yl)-2-fluoro-3-methoxyphenyl]methyl}-1-[(2-isopropyl-3,4- dihydro-1H-isoquinolin-6-yl)methyl]-3-(methoxymethyl)pyrazole-4-carboxamide::US11613527, Example 46	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598440	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598440&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156070168	481722803							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267866	COCc1nn(Cc2ccc3CN(CCc3c2)C2CC2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cnc(n1)C(F)F	InChI=1S/C30H32F3N7O3/c1-42-16-24-23(15-39(36-24)13-18-3-4-20-14-38(21-5-6-21)10-9-19(20)11-18)30(41)34-12-22-25(7-8-26(43-2)27(22)31)40-17-35-29(37-40)28(32)33/h3-4,7-8,11,15,17,21,28H,5-6,9-10,12-14,16H2,1-2H3,(H,34,41)	ATXPYJVKXXHUIR-UHFFFAOYSA-N	598441	1-[(2-cyclopropyl-3,4-dihydro-1H-isoquinolin-6-yl)methyl]-N-({6-[3-(difluoromethyl)- 1,2,4-triazol-1-yl]-2-fluoro-3-methoxyphenyl}methyl)-3-(methoxymethyl)pyrazole-4- carboxamide::US11613527, Example 47	Plasma kallikrein			 65							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598441	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598441&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156069806	481722804							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267869	COCc1nn(Cc2ccc3CN(CCc3c2)C2CC2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cnc(n1)C(F)(F)F	InChI=1S/C30H31F4N7O3/c1-43-16-24-23(15-40(37-24)13-18-3-4-20-14-39(21-5-6-21)10-9-19(20)11-18)28(42)35-12-22-25(7-8-26(44-2)27(22)31)41-17-36-29(38-41)30(32,33)34/h3-4,7-8,11,15,17,21H,5-6,9-10,12-14,16H2,1-2H3,(H,35,42)	AUCDPPJAWANIOI-UHFFFAOYSA-N	598442	1-[(2-cyclopropyl-3,4-dihydro-1H-isoquinolin-6-yl)methyl]-N-({2-fluoro-3-methoxy-6- [3-(trifluoromethyl)-1,2,4-triazol-1-yl]phenyl}methyl)-3-(methoxymethyl)pyrazole-4- carboxamide::US11613527, Example 48	Plasma kallikrein			 65							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598442	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598442&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156069343	481722805							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267872	COCc1nn(Cc2ccc3CN(CCc3c2)C2CC2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1ccc(n1)C#N	InChI=1S/C31H32FN7O3/c1-41-19-27-26(18-38(36-27)16-20-3-4-22-17-37(24-5-6-24)11-9-21(22)13-20)31(40)34-15-25-28(7-8-29(42-2)30(25)32)39-12-10-23(14-33)35-39/h3-4,7-8,10,12-13,18,24H,5-6,9,11,15-17,19H2,1-2H3,(H,34,40)	JFGMKDZPSHUQSX-UHFFFAOYSA-N	598443	N-{[6-(3-cyanopyrazol-1-yl)-2-fluoro-3-methoxyphenyl]methyl}-1-[(2-cyclopropyl-3,4- dihydro-1H-isoquinolin-6-yl)methyl]-3-(methoxymethyl)pyrazole-4-carboxamide::US11613527, Example 49	Plasma kallikrein			 20							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598443	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598443&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156069943	481722806							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267875	CCN1CCc2cc(Cn3cc(C(=O)NCc4c(F)c(OC)ccc4-n4cnc(n4)C(F)F)c(COC)n3)ccc2C1	InChI=1S/C29H32F3N7O3/c1-4-37-10-9-19-11-18(5-6-20(19)14-37)13-38-15-22(23(35-38)16-41-2)29(40)33-12-21-24(7-8-25(42-3)26(21)30)39-17-34-28(36-39)27(31)32/h5-8,11,15,17,27H,4,9-10,12-14,16H2,1-3H3,(H,33,40)	GGDFZEFTTXBCKQ-UHFFFAOYSA-N	598444	N-({6-[3-(difluoromethyl)-1,2,4-triazol-1-yl]-2-fluoro-3-methoxyphenyl}methyl)-1-[(2- ethyl-3,4-dihydro-1H-isoquinolin-6-yl)methyl]-3-(methoxymethyl)pyrazole-4- carboxamide::US11613527, Example 50	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598444	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598444&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779172	481722807							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267878	CCN1CCc2cc(Cn3cc(C(=O)NCc4c(F)c(OC)ccc4-n4cnc(n4)C(F)(F)F)c(COC)n3)ccc2C1	InChI=1S/C29H31F4N7O3/c1-4-38-10-9-19-11-18(5-6-20(19)14-38)13-39-15-22(23(36-39)16-42-2)27(41)34-12-21-24(7-8-25(43-3)26(21)30)40-17-35-28(37-40)29(31,32)33/h5-8,11,15,17H,4,9-10,12-14,16H2,1-3H3,(H,34,41)	GMFXYGPPRKEYBH-UHFFFAOYSA-N	598445	1-[(2-ethyl-3,4-dihydro-1H-isoquinolin-6-yl)methyl]-N-({2-fluoro-3-methoxy-6-[3- (trifluoromethyl)-1,2,4-triazol-1-yl]phenyl}methyl)-3-(methoxymethyl)pyrazole-4- carboxamide::US11613527, Example 51	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598445	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598445&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779268	481722808							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267881	CCN1CCc2cc(Cn3cc(C(=O)NCc4c(F)c(OC)ccc4-n4ccc(n4)C#N)c(COC)n3)ccc2C1	InChI=1S/C30H32FN7O3/c1-4-36-11-9-21-13-20(5-6-22(21)17-36)16-37-18-25(26(35-37)19-40-2)30(39)33-15-24-27(7-8-28(41-3)29(24)31)38-12-10-23(14-32)34-38/h5-8,10,12-13,18H,4,9,11,15-17,19H2,1-3H3,(H,33,39)	GTQFHHSWSXFPHL-UHFFFAOYSA-N	598446	N-{[6-(3-cyanopyrazol-1-yl)-2-fluoro-3-methoxyphenyl]methyl}-1-[(2-ethyl-3,4- dihydro-1H-isoquinolin-6-yl)methyl]-3-(methoxymethyl)pyrazole-4-carboxamide::US11613527, Example 52	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598446	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598446&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779139	481722809							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267884	COCc1nn(Cc2ccc3CNCc3c2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cc(C)nn1	InChI=1S/C26H28FN7O3/c1-16-12-34(32-30-16)23-6-7-24(37-3)25(27)20(23)11-29-26(35)21-14-33(31-22(21)15-36-2)13-17-4-5-18-9-28-10-19(18)8-17/h4-8,12,14,28H,9-11,13,15H2,1-3H3,(H,29,35)	VBYNDKFUHYGDMV-UHFFFAOYSA-N	598447	1-(2,3-dihydro-1H-isoindol-5-ylmethyl)-N-{[2-fluoro-3-methoxy-6-(4-methyl-1,2,3- triazol-1-yl)phenyl]methyl}-3-(methoxymethyl)pyrazole-4-carboxamide::US11613527, Example 53	Plasma kallikrein			 65							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598447	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598447&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156069836	481722810							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267887	COCc1nn(Cc2ccc3CN(C)Cc3c2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cc(C)nn1	InChI=1S/C27H30FN7O3/c1-17-11-35(32-30-17)24-7-8-25(38-4)26(28)21(24)10-29-27(36)22-15-34(31-23(22)16-37-3)12-18-5-6-19-13-33(2)14-20(19)9-18/h5-9,11,15H,10,12-14,16H2,1-4H3,(H,29,36)	BNWIWFJZMBUBFZ-UHFFFAOYSA-N	598448	N-{[2-fluoro-3-methoxy-6-(4-methyl-1,2,3-triazol-1-yl)phenyl]methyl}-3- (methoxymethyl)-1-[(2-methyl-1,3-dihydroisoindol-5-yl)methyl]pyrazole-4- carboxamide::US11613527, Example 54	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598448	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598448&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779142	481722811							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267890	COCc1nn(Cc2ccc3CN(Cc3c2)C(C)C)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cc(C)nn1	InChI=1S/C29H34FN7O3/c1-18(2)35-14-21-7-6-20(10-22(21)15-35)13-36-16-24(25(33-36)17-39-4)29(38)31-11-23-26(37-12-19(3)32-34-37)8-9-27(40-5)28(23)30/h6-10,12,16,18H,11,13-15,17H2,1-5H3,(H,31,38)	VBCAXHWPXUYZDS-UHFFFAOYSA-N	598449	N-{[2-fluoro-3-methoxy-6-(4-methyl-1,2,3-triazol-1-yl)phenyl]methyl}-1-[(2- isopropyl-1,3-dihydroisoindol-5-yl)methyl]-3-(methoxymethyl)pyrazole-4- carboxamide::US11613527, Example 55	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598449	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598449&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156079274	481722812							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267893	CCN1Cc2ccc(Cn3cc(C(=O)NCc4c(F)c(OC)ccc4-n4cc(C)nn4)c(COC)n3)cc2C1	InChI=1S/C28H32FN7O3/c1-5-34-14-20-7-6-19(10-21(20)15-34)13-35-16-23(24(32-35)17-38-3)28(37)30-11-22-25(36-12-18(2)31-33-36)8-9-26(39-4)27(22)29/h6-10,12,16H,5,11,13-15,17H2,1-4H3,(H,30,37)	PTGZQVSMGINBBW-UHFFFAOYSA-N	598450	1-[(2-ethyl-1,3-dihydroisoindol-5-yl)methyl]-N-{[2-fluoro-3-methoxy-6-(4-methyl- 1,2,3-triazol-1-yl)phenyl]methyl}-3-(methoxymethyl)pyrazole-4-carboxamide::US11613527, Example 56	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598450	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598450&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779236	481722813							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267896	COCc1nn(Cc2ccc3CN(C)Cc3c2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cnc(n1)C(F)F	InChI=1S/C27H28F3N7O3/c1-35-11-17-5-4-16(8-18(17)12-35)10-36-13-20(21(33-36)14-39-2)27(38)31-9-19-22(6-7-23(40-3)24(19)28)37-15-32-26(34-37)25(29)30/h4-8,13,15,25H,9-12,14H2,1-3H3,(H,31,38)	ZNDXJXVBGIFOAU-UHFFFAOYSA-N	598451	N-({6-[3-(difluoromethyl)-1,2,4-triazol-1-yl]-2-fluoro-3-methoxyphenyl}methyl)-3- (methoxymethyl)-1-[(2-methyl-1,3-dihydroisoindol-5-yl)methyl]pyrazole-4- carboxamide::US11613527, Example 57	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598451	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598451&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779204	481722814							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267899	COCc1nn(Cc2ccc3CN(C)Cc3c2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cnc(n1)C(F)(F)F	InChI=1S/C27H27F4N7O3/c1-36-11-17-5-4-16(8-18(17)12-36)10-37-13-20(21(34-37)14-40-2)25(39)32-9-19-22(6-7-23(41-3)24(19)28)38-15-33-26(35-38)27(29,30)31/h4-8,13,15H,9-12,14H2,1-3H3,(H,32,39)	VEHQBDALDQKYBB-UHFFFAOYSA-N	598452	N-({2-fluoro-3-methoxy-6-[3-(trifluoromethyl)-1,2,4-triazol-1-yl]phenyl}methyl)-3- (methoxymethyl)-1-[(2-methyl-1,3-dihydroisoindol-5-yl)methyl]pyrazole-4- carboxamide::US11613527, Example 58	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598452	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598452&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779177	481722815							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267902	COCc1nn(Cc2ccc3CN(Cc3c2)C(C)C)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cnc(n1)C(F)F	InChI=1S/C29H32F3N7O3/c1-17(2)37-12-19-6-5-18(9-20(19)13-37)11-38-14-22(23(35-38)15-41-3)29(40)33-10-21-24(7-8-25(42-4)26(21)30)39-16-34-28(36-39)27(31)32/h5-9,14,16-17,27H,10-13,15H2,1-4H3,(H,33,40)	WBXCYJFUPOYNOR-UHFFFAOYSA-N	598453	N-({6-[3-(difluoromethyl)-1,2,4-triazol-1-yl]-2-fluoro-3-methoxyphenyl}methyl)-1-[(2- isopropyl-1,3-dihydroisoindol-5-yl)methyl]-3-(methoxymethyl)pyrazole-4- carboxamide::US11613527, Example 59	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598453	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598453&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163212378	481722816							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267905	COCc1nn(Cc2ccc3CN(Cc3c2)C(C)C)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cnc(n1)C(F)(F)F	InChI=1S/C29H31F4N7O3/c1-17(2)38-12-19-6-5-18(9-20(19)13-38)11-39-14-22(23(36-39)15-42-3)27(41)34-10-21-24(7-8-25(43-4)26(21)30)40-16-35-28(37-40)29(31,32)33/h5-9,14,16-17H,10-13,15H2,1-4H3,(H,34,41)	NBLCMZKABACNAG-UHFFFAOYSA-N	598454	N-({2-fluoro-3-methoxy-6-[3-(trifluoromethyl)-1,2,4-triazol-1-yl]phenyl}methyl)-1- [(2-isopropyl-1,3-dihydroisoindol-5-yl)methyl]-3-(methoxymethyl)pyrazole-4- carboxamide::US11613527, Example 60	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598454	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598454&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779162	481722817							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267908	COc1ccc(c(CNC(=O)c2cn(Cc3cn4CCN(C)Cc4n3)nc2C(F)(F)F)c1F)-n1cc(C)nn1	InChI=1S/C24H25F4N9O2/c1-14-9-37(33-31-14)18-4-5-19(39-3)21(25)16(18)8-29-23(38)17-12-36(32-22(17)24(26,27)28)11-15-10-35-7-6-34(2)13-20(35)30-15/h4-5,9-10,12H,6-8,11,13H2,1-3H3,(H,29,38)	PRVCWMQVRUYLAP-UHFFFAOYSA-N	598455	N-{[2-fluoro-3-methoxy-6-(4-methyl-1,2,3-triazol-1-yl)phenyl]methyl}-1-({7-methyl- 5H,6H,8H-imidazo[1,2-a]pyrazin-2-yl}methyl)-3-(trifluoromethyl)pyrazole-4- carboxamide::US11613527, Example 61	Plasma kallikrein			 65							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598455	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598455&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779207	481722818							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267911	COCc1nn(Cc2cnc3CN(C)CCc3c2Cl)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cc(C)nn1	InChI=1S/C27H30ClFN8O3/c1-16-11-37(34-32-16)23-5-6-24(40-4)26(29)19(23)10-31-27(38)20-13-36(33-22(20)15-39-3)12-17-9-30-21-14-35(2)8-7-18(21)25(17)28/h5-6,9,11,13H,7-8,10,12,14-15H2,1-4H3,(H,31,38)	HDNYQHTVSZSJAA-UHFFFAOYSA-N	598456	1-[(4-chloro-7-methyl-6,8-dihydro-5H-1,7-naphthyridin-3-yl)methyl]-N-{[2-fluoro-3- methoxy-6-(4-methyl-1,2,3-triazol-1-yl)phenyl]methyl}-3-(methoxymethyl)pyrazole- 4-carboxamide::US11613527, Example 64	Plasma kallikrein			 65							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598456	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598456&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779133	481722819							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267914	COCc1nn(Cc2ccc3COCCc3c2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cc(C)nn1	InChI=1S/C27H29FN6O4/c1-17-12-34(32-30-17)24-6-7-25(37-3)26(28)21(24)11-29-27(35)22-14-33(31-23(22)16-36-2)13-18-4-5-20-15-38-9-8-19(20)10-18/h4-7,10,12,14H,8-9,11,13,15-16H2,1-3H3,(H,29,35)	MHFWKJQTWIXXPA-UHFFFAOYSA-N	598457	1-(3,4-dihydro-1H-2-benzopyran-6-ylmethyl)-N-{[2-fluoro-3-methoxy-6-(4-methyl- 1,2,3-triazol-1-yl)phenyl]methyl}-3-(methoxymethyl)pyrazole-4-carboxamide::US11613527, Example 68	Plasma kallikrein			 20							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598457	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598457&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779195	481722820							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267917	COCc1nn(Cc2cc3CN(C)CCn3n2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cc(C)nn1	InChI=1S/C25H30FN9O3/c1-16-11-35(31-28-16)22-5-6-23(38-4)24(26)19(22)10-27-25(36)20-14-33(30-21(20)15-37-3)12-17-9-18-13-32(2)7-8-34(18)29-17/h5-6,9,11,14H,7-8,10,12-13,15H2,1-4H3,(H,27,36)	YVHWBMPIOKYJQX-UHFFFAOYSA-N	598458	N-{[2-fluoro-3-methoxy-6-(4-methyl-1,2,3-triazol-1-yl)phenyl]methyl}-3- (methoxymethyl)-1-({5-methyl-4H,6H,7H-pyrazolo[1,5-a]pyrazin-2- yl}methyl)pyrazole-4-carboxamide::US11613527, Example 70	Plasma kallikrein			 20							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598458	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598458&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779234	481722821							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267920	COCc1nn(Cc2ccc3CCN(C)C(=O)c3c2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cc(C)nn1	InChI=1S/C28H30FN7O4/c1-17-13-36(33-31-17)24-7-8-25(40-4)26(29)21(24)12-30-27(37)22-15-35(32-23(22)16-39-3)14-18-5-6-19-9-10-34(2)28(38)20(19)11-18/h5-8,11,13,15H,9-10,12,14,16H2,1-4H3,(H,30,37)	DXPHFQTWOYPJBH-UHFFFAOYSA-N	598459	N-{[2-fluoro-3-methoxy-6-(4-methyl-1,2,3-triazol-1-yl)phenyl]methyl}-3- (methoxymethyl)-1-[(2-methyl-1-oxo-3,4-dihydroisoquinolin-7-yl)methyl]pyrazole-4- carboxamide::US11613527, Example 73	Plasma kallikrein			 65							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598459	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598459&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779240	481722822							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267923	COc1ccc(c(CNC(=O)c2cn(Cc3cc4CN(C)CC5(CC5)n4n3)nc2C(F)F)c1F)-n1cc(C)nn1	InChI=1S/C26H28F3N9O2/c1-15-10-37(34-31-15)20-4-5-21(40-3)22(27)18(20)9-30-25(39)19-13-36(33-23(19)24(28)29)11-16-8-17-12-35(2)14-26(6-7-26)38(17)32-16/h4-5,8,10,13,24H,6-7,9,11-12,14H2,1-3H3,(H,30,39)	UHCQEUIVWUTLRZ-UHFFFAOYSA-N	598460	3-(difluoromethyl)-N-(2-fluoro-3-methoxy-6-(4-methyl-1H-1,2,3-triazol-1-yl)benzyl)- 1-((5'-methyl-5',6'-dihydro-4'H-spiro[cyclopropane-1,7'-pyrazolo[1,5-a]pyrazin]-2'- yl)methyl)-1H-pyrazole-4-carboxamide::US11613527, Example 82	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598460	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598460&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156070154	481722823							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267926	COCc1nn(Cc2cnc3CN(C)CCc3c2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cc(C)nn1	InChI=1S/C27H31FN8O3/c1-17-12-36(33-31-17)24-5-6-25(39-4)26(28)20(24)11-30-27(37)21-14-35(32-23(21)16-38-3)13-18-9-19-7-8-34(2)15-22(19)29-10-18/h5-6,9-10,12,14H,7-8,11,13,15-16H2,1-4H3,(H,30,37)	UBSRYGOWEWDVGY-UHFFFAOYSA-N	598461	N-{[2-fluoro-3-methoxy-6-(4-methyl-1,2,3-triazol-1-yl)phenyl]methyl}-3- (methoxymethyl)-1-[(7-methyl-6,8-dihydro-5H-1,7-naphthyridin-3- yl)methyl]pyrazole-4-carboxamide::US11613527, Example 102	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598461	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598461&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779229	481722824							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267929	COCc1nn(Cc2cc(F)cc3CN(C)CCc23)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cc(C)nn1	InChI=1S/C28H31F2N7O3/c1-17-12-37(34-32-17)25-5-6-26(40-4)27(30)22(25)11-31-28(38)23-15-36(33-24(23)16-39-3)14-19-10-20(29)9-18-13-35(2)8-7-21(18)19/h5-6,9-10,12,15H,7-8,11,13-14,16H2,1-4H3,(H,31,38)	BACPGPONZVUOCR-UHFFFAOYSA-N	598462	1-[(7-fluoro-2-methyl-3,4-dihydro-1H-isoquinolin-5-yl)methyl]-N-{[2-fluoro-3- methoxy-6-(4-methyl-1,2,3-triazol-1-yl)phenyl]methyl}-3-(methoxymethyl)pyrazole- 4-carboxamide::US11613527, Example 103	Plasma kallikrein			 65							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598462	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598462&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779181	481722825							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267932	COCc1nn(Cc2ccc3CN(C)CCc3c2Cl)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cc(C)nn1	InChI=1S/C28H31ClFN7O3/c1-17-12-37(34-32-17)24-7-8-25(40-4)27(30)21(24)11-31-28(38)22-15-36(33-23(22)16-39-3)14-19-6-5-18-13-35(2)10-9-20(18)26(19)29/h5-8,12,15H,9-11,13-14,16H2,1-4H3,(H,31,38)	HFDKBGVQWDMCTC-UHFFFAOYSA-N	598463	1-[(5-chloro-2-methyl-3,4-dihydro-1H-isoquinolin-6-yl)methyl]-N-{[2-fluoro-3- methoxy-6-(4-methyl-1,2,3-triazol-1-yl)phenyl]methyl}-3-(methoxymethyl)pyrazole- 4-carboxamide::US11613527, Example 104	Plasma kallikrein			 65							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598463	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598463&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779150	481722826							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267935	COCc1nn(Cc2ccc3CN(C)CC(F)(F)c3c2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cc(C)nn1	InChI=1S/C28H30F3N7O3/c1-17-11-38(35-33-17)24-7-8-25(41-4)26(29)20(24)10-32-27(39)21-14-37(34-23(21)15-40-3)12-18-5-6-19-13-36(2)16-28(30,31)22(19)9-18/h5-9,11,14H,10,12-13,15-16H2,1-4H3,(H,32,39)	ZDKJNWKQAAGNGE-UHFFFAOYSA-N	598464	1-[(4,4-difluoro-2-methyl-1,3-dihydroisoquinolin-6-yl)methyl]-N-{[2-fluoro-3- methoxy-6-(4-methyl-1,2,3-triazol-1-yl)phenyl]methyl}-3-(methoxymethyl)pyrazole- 4-carboxamide::US11613527, Example 105	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598464	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598464&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779248	481722827							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267938	COCc1nn(Cc2ccc3c(CN(C)CC3(F)F)c2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cc(C)nn1	InChI=1S/C28H30F3N7O3/c1-17-11-38(35-33-17)24-7-8-25(41-4)26(29)20(24)10-32-27(39)21-14-37(34-23(21)15-40-3)12-18-5-6-22-19(9-18)13-36(2)16-28(22,30)31/h5-9,11,14H,10,12-13,15-16H2,1-4H3,(H,32,39)	RIFYBYPOGWYRDG-UHFFFAOYSA-N	598465	1-[(4,4-difluoro-2-methyl-1,3-dihydroisoquinolin-7-yl)methyl]-N-{[2-fluoro-3- methoxy-6-(4-methyl-1,2,3-triazol-1-yl)phenyl]methyl}-3-(methoxymethyl)pyrazole- 4-carboxamide::US11613527, Example 106	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598465	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598465&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779183	481722828							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267941	COCc1nn(Cc2ccc3CCN(C)Cc3c2F)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cc(C)nn1	InChI=1S/C28H31F2N7O3/c1-17-12-37(34-32-17)24-7-8-25(40-4)27(30)20(24)11-31-28(38)22-15-36(33-23(22)16-39-3)13-19-6-5-18-9-10-35(2)14-21(18)26(19)29/h5-8,12,15H,9-11,13-14,16H2,1-4H3,(H,31,38)	PJIKUXXJUHTXIN-UHFFFAOYSA-N	598466	1-[(8-fluoro-2-methyl-3,4-dihydro-1H-isoquinolin-7-yl)methyl]-N-{[2-fluoro-3- methoxy-6-(4-methyl-1,2,3-triazol-1-yl)phenyl]methyl}-3-(methoxymethyl)pyrazole- 4-carboxamide::US11613527, Example 107	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598466	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598466&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779245	481722829							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267944	COCc1nn(Cc2ccc3OCCN(C)Cc3c2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cc(C)nn1	InChI=1S/C28H32FN7O4/c1-18-13-36(33-31-18)24-6-8-26(39-4)27(29)21(24)12-30-28(37)22-16-35(32-23(22)17-38-3)14-19-5-7-25-20(11-19)15-34(2)9-10-40-25/h5-8,11,13,16H,9-10,12,14-15,17H2,1-4H3,(H,30,37)	AUWJOBLWVJFWGH-UHFFFAOYSA-N	598467	N-{[2-fluoro-3-methoxy-6-(4-methyl-1,2,3-triazol-1-yl)phenyl]methyl}-3- (methoxymethyl)-1-[(4-methyl-3,5-dihydro-2H-1,4-benzoxazepin-7- yl)methyl]pyrazole-4-carboxamide::US11613527, Example 108	Plasma kallikrein			 550							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598467	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598467&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779273	481722830							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267947	COCc1nn(Cc2nc3CCN(C)Cc3s2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cc(C)nn1	InChI=1S/C25H29FN8O3S/c1-15-10-34(31-29-15)20-5-6-21(37-4)24(26)16(20)9-27-25(35)17-11-33(30-19(17)14-36-3)13-23-28-18-7-8-32(2)12-22(18)38-23/h5-6,10-11H,7-9,12-14H2,1-4H3,(H,27,35)	JDQVVSMTQXUMGC-UHFFFAOYSA-N	598468	N-{[2-fluoro-3-methoxy-6-(4-methyl-1,2,3-triazol-1-yl)phenyl]methyl}-3- (methoxymethyl)-1-({5-methyl-4H,6H,7H-[1,3]thiazolo[5,4-c]pyridin-2- yl}methyl)pyrazole-4-carboxamide::US11613527, Example 109	Plasma kallikrein			 550							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598468	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598468&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779189	481722831							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267950	COCc1nn(Cc2ccc3OCCNCc3c2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cc(C)nn1	InChI=1S/C27H30FN7O4/c1-17-13-35(33-31-17)23-5-7-25(38-3)26(28)20(23)12-30-27(36)21-15-34(32-22(21)16-37-2)14-18-4-6-24-19(10-18)11-29-8-9-39-24/h4-7,10,13,15,29H,8-9,11-12,14,16H2,1-3H3,(H,30,36)	VJCKJBKNJCONRY-UHFFFAOYSA-N	598469	N-{[2-fluoro-3-methoxy-6-(4-methyl-1,2,3-triazol-1-yl)phenyl]methyl}-3- (methoxymethyl)-1-(2,3,4,5-tetrahydro-1,4-benzoxazepin-7-ylmethyl)pyrazole-4- carboxamide::US11613527, Example 110	Plasma kallikrein			 550							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598469	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598469&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779260	481722832							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267953	COCc1nn(Cc2ccc3CN(C)CCc3c2F)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cc(C)nn1	InChI=1S/C28H31F2N7O3/c1-17-12-37(34-32-17)24-7-8-25(40-4)27(30)21(24)11-31-28(38)22-15-36(33-23(22)16-39-3)14-19-6-5-18-13-35(2)10-9-20(18)26(19)29/h5-8,12,15H,9-11,13-14,16H2,1-4H3,(H,31,38)	KPQPQQGCFVPOAL-UHFFFAOYSA-N	598470	1-[(5-fluoro-2-methyl-3,4-dihydro-1H-isoquinolin-6-yl)methyl]-N-{[2-fluoro-3- methoxy-6-(4-methyl-1,2,3-triazol-1-yl)phenyl]methyl}-3-(methoxymethyl)pyrazole- 4-carboxamide::US11613527, Example 114	Plasma kallikrein			 20							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598470	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598470&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779212	481722833							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267956	COCc1nn(Cc2cnc3CN(CC(F)F)CCc3c2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cc(C)nn1	InChI=1S/C28H31F3N8O3/c1-17-11-39(36-34-17)24-4-5-25(42-3)27(31)20(24)10-33-28(40)21-13-38(35-23(21)16-41-2)12-18-8-19-6-7-37(15-26(29)30)14-22(19)32-9-18/h4-5,8-9,11,13,26H,6-7,10,12,14-16H2,1-3H3,(H,33,40)	SQBPURNBOIXTKG-UHFFFAOYSA-N	598471	1-{[7-(2,2-difluoroethyl)-6,8-dihydro-5H-1,7-naphthyridin-3-yl]methyl}-N-{[2-fluoro- 3-methoxy-6-(4-methyl-1,2,3-triazol-1-yl)phenyl]methyl}-3- (methoxymethyl)pyrazole-4-carboxamide::US11613527, Example 115	Plasma kallikrein			 20							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598471	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598471&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156069992	481722834							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267959	COCc1nn(Cc2cc(F)c3CN(C)CCc3c2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cc(C)nn1	InChI=1S/C28H31F2N7O3/c1-17-12-37(34-32-17)25-5-6-26(40-4)27(30)20(25)11-31-28(38)22-15-36(33-24(22)16-39-3)13-18-9-19-7-8-35(2)14-21(19)23(29)10-18/h5-6,9-10,12,15H,7-8,11,13-14,16H2,1-4H3,(H,31,38)	VLCXTMQFJDLLME-UHFFFAOYSA-N	598472	1-[(8-fluoro-2-methyl-3,4-dihydro-1H-isoquinolin-6-yl)methyl]-N-{[2-fluoro-3- methoxy-6-(4-methyl-1,2,3-triazol-1-yl)phenyl]methyl}-3-(methoxymethyl)pyrazole- 4-carboxamide::US11613527, Example 116	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598472	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598472&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779214	481722835							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267962	COCc1nn(Cc2cnc3CN(CCc3c2)C(C)C)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cc(C)nn1	InChI=1S/C29H35FN8O3/c1-18(2)36-9-8-21-10-20(11-31-24(21)16-36)14-37-15-23(25(34-37)17-40-4)29(39)32-12-22-26(38-13-19(3)33-35-38)6-7-27(41-5)28(22)30/h6-7,10-11,13,15,18H,8-9,12,14,16-17H2,1-5H3,(H,32,39)	QGVSETSYGVGJFH-UHFFFAOYSA-N	598473	N-{[2-fluoro-3-methoxy-6-(4-methyl-1,2,3-triazol-1-yl)phenyl]methyl}-1-[(7- isopropyl-6,8-dihydro-5H-1,7-naphthyridin-3-yl)methyl]-3-(methoxymethyl)pyrazole- 4-carboxamide::US11613527, Example 117	Plasma kallikrein			 20							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598473	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598473&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779256	481722836							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267965	COCc1nn(Cc2cc3CN(C)CCc3cc2F)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cc(C)nn1	InChI=1S/C28H31F2N7O3/c1-17-12-37(34-32-17)25-5-6-26(40-4)27(30)21(25)11-31-28(38)22-15-36(33-24(22)16-39-3)14-20-9-19-13-35(2)8-7-18(19)10-23(20)29/h5-6,9-10,12,15H,7-8,11,13-14,16H2,1-4H3,(H,31,38)	YXCDOFZNPYSMNT-UHFFFAOYSA-N	598474	1-[(6-fluoro-2-methyl-3,4-dihydro-1H-isoquinolin-7-yl)methyl]-N-{[2-fluoro-3- methoxy-6-(4-methyl-1,2,3-triazol-1-yl)phenyl]methyl}-3-(methoxymethyl)pyrazole- 4-carboxamide::US11613527, Example 118	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598474	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598474&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779185	481722837							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267968	COCc1nn(Cc2ccc3CCN(C)Cc3c2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cc(C)nn1	InChI=1S/C28H32FN7O3/c1-18-13-36(33-31-18)25-7-8-26(39-4)27(29)22(25)12-30-28(37)23-16-35(32-24(23)17-38-3)14-19-5-6-20-9-10-34(2)15-21(20)11-19/h5-8,11,13,16H,9-10,12,14-15,17H2,1-4H3,(H,30,37)	LLEAECOPGZWWOJ-UHFFFAOYSA-N	598400	N-{[2-fluoro-3-methoxy-6-(4-methyl-1,2,3-triazol-1-yl)phenyl]methyl}-3- (methoxymethyl)-1-[(2-methyl-3,4-dihydro-1H-isoquinolin-7-yl)methyl]pyrazole-4- carboxamide::US11613527, Example 119::US11613527, Example 2	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598400	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598400&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156069615	481722763							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267969	COCc1nn(Cc2ccc3CCN4CCCC4c3c2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cc(C)nn1	InChI=1S/C30H34FN7O3/c1-19-15-38(35-33-19)27-8-9-28(41-3)29(31)23(27)14-32-30(39)24-17-37(34-25(24)18-40-2)16-20-6-7-21-10-12-36-11-4-5-26(36)22(21)13-20/h6-9,13,15,17,26H,4-5,10-12,14,16,18H2,1-3H3,(H,32,39)	PPBOPFJMGXYQKJ-UHFFFAOYSA-N	598476	1-{1H,2H,3H,5H,6H,10bH-pyrrolo[2,1-a]isoquinolin-9-ylmethyl}-N-{[2-fluoro-3- methoxy-6-(4-methyl-1,2,3-triazol-1-yl)phenyl]methyl}-3-(methoxymethyl)pyrazole- 4-carboxamide::US11613527, Example 120	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598476	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598476&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779242	481722838							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267972	COCc1nn(Cc2ccc3CCN(C)CCc3c2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cc(C)nn1	InChI=1S/C29H34FN7O3/c1-19-15-37(34-32-19)26-7-8-27(40-4)28(30)23(26)14-31-29(38)24-17-36(33-25(24)18-39-3)16-20-5-6-21-9-11-35(2)12-10-22(21)13-20/h5-8,13,15,17H,9-12,14,16,18H2,1-4H3,(H,31,38)	UWPLVECDRMFMNK-UHFFFAOYSA-N	598477	N-{[2-fluoro-3-methoxy-6-(4-methyl-1,2,3-triazol-1-yl)phenyl]methyl}-3- (methoxymethyl)-1-[(3-methyl-1,2,4,5-tetrahydro-3-benzazepin-7- yl)methyl]pyrazole-4-carboxamide::US11613527, Example 121	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598477	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598477&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779174	481722839							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267975	COCc1nn(Cc2ccc3CCN(CCc3c2)C(C)C)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cc(C)nn1	InChI=1S/C31H38FN7O3/c1-20(2)37-12-10-23-7-6-22(14-24(23)11-13-37)17-38-18-26(27(35-38)19-41-4)31(40)33-15-25-28(39-16-21(3)34-36-39)8-9-29(42-5)30(25)32/h6-9,14,16,18,20H,10-13,15,17,19H2,1-5H3,(H,33,40)	GCEVTWZOFJHQKI-UHFFFAOYSA-N	598478	N-{[2-fluoro-3-methoxy-6-(4-methyl-1,2,3-triazol-1-yl)phenyl]methyl}-1-[(3- isopropyl-1,2,4,5-tetrahydro-3-benzazepin-7-yl)methyl]-3-(methoxymethyl)pyrazole- 4-carboxamide::US11613527, Example 122	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598478	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598478&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156069981	481722840							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267978	COCc1nn(Cc2ccc3C4CCC(N4C(C)C)c3c2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cc(C)nn1	InChI=1S/C31H36FN7O3/c1-18(2)39-27-8-9-28(39)22-12-20(6-7-21(22)27)15-37-16-24(25(35-37)17-41-4)31(40)33-13-23-26(38-14-19(3)34-36-38)10-11-29(42-5)30(23)32/h6-7,10-12,14,16,18,27-28H,8-9,13,15,17H2,1-5H3,(H,33,40)	LNWZUWBXDIHKNI-UHFFFAOYSA-N	598479	N-{[2-fluoro-3-methoxy-6-(4-methyl-1,2,3-triazol-1-yl)phenyl]methyl}-1-({11- isopropyl-11-azatricyclo[6.2.1.0{circumflex over ( )}{2,7}]undeca-2(7),3,5-trien-4-yl}methyl)-3- (methoxymethyl)pyrazole-4-carboxamide::US11613527, Example 123	Plasma kallikrein			 65							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598479	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598479&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168058905	481722841							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267981	COCc1nn(Cc2ccc3CN(C)C(C)(C)c3c2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cc(C)nn1	InChI=1S/C29H34FN7O3/c1-18-13-37(34-32-18)25-9-10-26(40-6)27(30)21(25)12-31-28(38)22-16-36(33-24(22)17-39-5)14-19-7-8-20-15-35(4)29(2,3)23(20)11-19/h7-11,13,16H,12,14-15,17H2,1-6H3,(H,31,38)	NEPYZWIRSHWGBL-UHFFFAOYSA-N	598480	N-{[2-fluoro-3-methoxy-6-(4-methyl-1,2,3-triazol-1-yl)phenyl]methyl}-3- (methoxymethyl)-1-[(2,3,3-trimethyl-1H-isoindol-5-yl)methyl]pyrazole-4- carboxamide::US11613527, Example 124	Plasma kallikrein			 65							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598480	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598480&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779261	481722842							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465692	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1cccs1	InChI=1S/C20H23N3OS/c1-14-10-19(15(2)23(14)13-18-4-3-9-25-18)20(24)22-12-17-7-5-16(11-21)6-8-17/h3-10H,11-13,21H2,1-2H3,(H,22,24)	ZMXSBHQMBIJZCD-UHFFFAOYSA-N	186854	US9670157, 20 2,5-Dimethyl-1-thiophen-2-ylmethyl-1H-pyrrole-3-carboxylic acid4-amidomethyl-benzylamide::US9834513, 20	Plasma kallikrein			 2700							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186854	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186854&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90281198	373987421							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465693	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1CCc1ccccc1	InChI=1S/C23H27N3O/c1-17-14-22(18(2)26(17)13-12-19-6-4-3-5-7-19)23(27)25-16-21-10-8-20(15-24)9-11-21/h3-11,14H,12-13,15-16,24H2,1-2H3,(H,25,27)	OCGMPDBBYAECKB-UHFFFAOYSA-N	50591395	CHEMBL5183037	Plasma kallikrein			>10000							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50591395	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50591395&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168284118	482602247							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465694	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1CCCc1ccccc1	InChI=1S/C24H29N3O/c1-18-15-23(24(28)26-17-22-12-10-21(16-25)11-13-22)19(2)27(18)14-6-9-20-7-4-3-5-8-20/h3-5,7-8,10-13,15H,6,9,14,16-17,25H2,1-2H3,(H,26,28)	JNDSRVYUVOVZSS-UHFFFAOYSA-N	50591396	CHEMBL5177459	Plasma kallikrein			 4800							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50591396	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50591396&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168271702	482602248							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465695	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1CCCCc1ccccc1	InChI=1S/C25H31N3O/c1-19-16-24(25(29)27-18-23-13-11-22(17-26)12-14-23)20(2)28(19)15-7-6-10-21-8-4-3-5-9-21/h3-5,8-9,11-14,16H,6-7,10,15,17-18,26H2,1-2H3,(H,27,29)	KUPDSQQYKDYAGG-UHFFFAOYSA-N	50591397	CHEMBL5193469	Plasma kallikrein			 920							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50591397	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50591397&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168284635	482602249							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465696	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1CCCCCc1ccccc1	InChI=1S/C26H33N3O/c1-20-17-25(26(30)28-19-24-14-12-23(18-27)13-15-24)21(2)29(20)16-8-4-7-11-22-9-5-3-6-10-22/h3,5-6,9-10,12-15,17H,4,7-8,11,16,18-19,27H2,1-2H3,(H,28,30)	VEBWXYAKSUHXRJ-UHFFFAOYSA-N	50591398	CHEMBL5169622	Plasma kallikrein			 3800							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50591398	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50591398&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168270683	482602250							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465697	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1cc(cs1)-c1ccccc1	InChI=1S/C26H27N3OS/c1-18-12-25(26(30)28-15-21-10-8-20(14-27)9-11-21)19(2)29(18)16-24-13-23(17-31-24)22-6-4-3-5-7-22/h3-13,17H,14-16,27H2,1-2H3,(H,28,30)	WZOQSONUCUVTNE-UHFFFAOYSA-N	362189	2,5-Dimethyl-1-(4-phenyl-thiophen-2-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 9	Plasma kallikrein			 570							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=362189	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=362189&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465698	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1csc(c1)-c1cccnc1	InChI=1S/C25H26N4OS/c1-17-10-23(25(30)28-13-20-7-5-19(12-26)6-8-20)18(2)29(17)15-21-11-24(31-16-21)22-4-3-9-27-14-22/h3-11,14,16H,12-13,15,26H2,1-2H3,(H,28,30)	UIJXPAQBXCMOQM-UHFFFAOYSA-N	186842	US9670157, 19 2,5-Dimethyl-1-(5-methyl-2-phenyl-oxazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9670157, 8 2,5-Dimethyl-1-(5-pyridin-3-yl-thiophen-3-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 8	Plasma kallikrein			 440							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186842	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186842&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280284	373987411							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465699	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1csc(c1)-c1ccccc1	InChI=1S/C26H27N3OS/c1-18-12-24(26(30)28-15-21-10-8-20(14-27)9-11-21)19(2)29(18)16-22-13-25(31-17-22)23-6-4-3-5-7-23/h3-13,17H,14-16,27H2,1-2H3,(H,28,30)	AKTNRYFLMYWXLM-UHFFFAOYSA-N	186844	US9670157, 10 2,5-Dimethyl-1-(5-phenyl-thiophen-3-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 10	Plasma kallikrein			 600							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186844	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186844&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280153	373987413							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465700	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1csc(n1)-c1ccccc1	InChI=1S/C25H26N4OS/c1-17-12-23(24(30)27-14-20-10-8-19(13-26)9-11-20)18(2)29(17)15-22-16-31-25(28-22)21-6-4-3-5-7-21/h3-12,16H,13-15,26H2,1-2H3,(H,27,30)	SJVAITNWGSDKNM-UHFFFAOYSA-N	186835	US9670157, 1 2,5-Dimethyl-1-(2-phenyl-thiazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 1	Plasma kallikrein			 72							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186835	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186835&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290252	373987407							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465701	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1coc(n1)-c1ccccc1	InChI=1S/C25H26N4O2/c1-17-12-23(24(30)27-14-20-10-8-19(13-26)9-11-20)18(2)29(17)15-22-16-31-25(28-22)21-6-4-3-5-7-21/h3-12,16H,13-15,26H2,1-2H3,(H,27,30)	LEFWOFCETUSMFZ-UHFFFAOYSA-N	50591399	CHEMBL5194439	Plasma kallikrein			 480							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50591399	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50591399&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168287975	482602251							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465702	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1csc(Cc2ccccc2)n1	InChI=1S/C26H28N4OS/c1-18-12-24(26(31)28-15-22-10-8-21(14-27)9-11-22)19(2)30(18)16-23-17-32-25(29-23)13-20-6-4-3-5-7-20/h3-12,17H,13-16,27H2,1-2H3,(H,28,31)	KWYMDWISISCNQW-UHFFFAOYSA-N	186872	US9670157, 38 1-(2-Benzyl-thiazol-4-ylmethyl)-2,5-dimethyl-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 38	Plasma kallikrein			 2700							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186872	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186872&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280246	373987439							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465703	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1ccc(cc1)-c1ccccc1	InChI=1S/C28H29N3O/c1-20-16-27(28(32)30-18-23-10-8-22(17-29)9-11-23)21(2)31(20)19-24-12-14-26(15-13-24)25-6-4-3-5-7-25/h3-16H,17-19,29H2,1-2H3,(H,30,32)	DRILYKUMENWWJU-UHFFFAOYSA-N	186904	US9670157, 70 1-Biphenyl-4-ylmethyl-2,5-dimethyl-1H-pyrrole-3-carboxylic acid4-aminomethyl-benzylamide::US9834513, 70	Plasma kallikrein			 5600							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186904	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186904&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280290	373987471							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465704	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1cccc(c1)-c1ccccc1	InChI=1S/C28H29N3O/c1-20-15-27(28(32)30-18-23-13-11-22(17-29)12-14-23)21(2)31(20)19-24-7-6-10-26(16-24)25-8-4-3-5-9-25/h3-16H,17-19,29H2,1-2H3,(H,30,32)	UPJXJSJQGXMKHH-UHFFFAOYSA-N	186903	US9670157, 69 1-Biphenyl-3-ylmethyl-2,5-dimethyl-1H-pyrrole-3-carboxylic acid4-aminomethyl-benzylamide::US9834513, 69	Plasma kallikrein			 730							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186903	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186903&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280297	373987470							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465705	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1cccc(n1)-c1cccnc1	InChI=1S/C26H27N5O/c1-18-13-24(26(32)29-15-21-10-8-20(14-27)9-11-21)19(2)31(18)17-23-6-3-7-25(30-23)22-5-4-12-28-16-22/h3-13,16H,14-15,17,27H2,1-2H3,(H,29,32)	PBAAHHAGMWJRRK-UHFFFAOYSA-N	186851	US9670157, 17 1-[2,3&#8242;]Bipyridinyl-6-ylmethyl-2,5-dimethyl-1H-pyrrole-3-carboxylicacid 4-aminomethyl-benzylamide::US9834513, 17	Plasma kallikrein			 580							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186851	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186851&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280261	373987419							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465706	Cc1cnn(Cc2ccc(Cn3c(C)cc(C(=O)NCc4ccc(CN)cc4)c3C)cc2)c1	InChI=1S/C27H31N5O/c1-19-14-30-31(16-19)17-24-8-10-25(11-9-24)18-32-20(2)12-26(21(32)3)27(33)29-15-23-6-4-22(13-28)5-7-23/h4-12,14,16H,13,15,17-18,28H2,1-3H3,(H,29,33)	ZQYKZHHAAMTVKK-UHFFFAOYSA-N	186955	US9670157, 96 2,5-Dimethyl-1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 96	Plasma kallikrein			 65							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186955	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186955&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290636	373987497							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465707	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1ccc(Cn2ccccc2=O)cc1	InChI=1S/C28H30N4O2/c1-20-15-26(28(34)30-17-23-8-6-22(16-29)7-9-23)21(2)32(20)19-25-12-10-24(11-13-25)18-31-14-4-3-5-27(31)33/h3-15H,16-19,29H2,1-2H3,(H,30,34)	KVCQGKXGOOUPLT-UHFFFAOYSA-N	186948	US9670157, 90 2,5-Dimethyl-1-[4-(2-oxo-2H-pyridin-1-ylmethyl)-benzyl]-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 90	Plasma kallikrein			 110							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186948	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186948&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290351	373987491							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465708	NCc1ccc(CNC(=O)c2cnn(Cc3csc(n3)-c3ccccc3)c2)cc1	InChI=1S/C22H21N5OS/c23-10-16-6-8-17(9-7-16)11-24-21(28)19-12-25-27(13-19)14-20-15-29-22(26-20)18-4-2-1-3-5-18/h1-9,12-13,15H,10-11,14,23H2,(H,24,28)	RYULPDCERPNQTD-UHFFFAOYSA-N	50591400	CHEMBL5201625	Plasma kallikrein			 850							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50591400	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50591400&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168292184	482602252							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465709	Cc1cnn(Cc2ccc(Cn3cc(cn3)C(=O)NCc3ccc(CN)cc3)cc2)c1	InChI=1S/C24H26N6O/c1-18-11-27-29(14-18)15-21-6-8-22(9-7-21)16-30-17-23(13-28-30)24(31)26-12-20-4-2-19(10-25)3-5-20/h2-9,11,13-14,17H,10,12,15-16,25H2,1H3,(H,26,31)	HPJLQUVYLPKVEH-UHFFFAOYSA-N	186919	US9670157, 85 1-[4-(4-Methyl-pyrazol-1-ylmethyl)-benzyl]-1H-pyrazole-4-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 85	Plasma kallikrein			 11							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=186919	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=186919&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86290349	373987486							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465710	NCc1ccc(CNC(=O)c2cnn(Cc3ccc(Cn4ccccc4=O)cc3)c2)cc1	InChI=1S/C25H25N5O2/c26-13-19-4-6-20(7-5-19)14-27-25(32)23-15-28-30(18-23)17-22-10-8-21(9-11-22)16-29-12-2-1-3-24(29)31/h1-12,15,18H,13-14,16-17,26H2,(H,27,32)	SGUFBWXBYBJEPK-UHFFFAOYSA-N	50591401	CHEMBL5174626	Plasma kallikrein			 4.5							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50591401	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50591401&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90280145	482602253							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465711	Cc1cnn(Cc2ccc(Cn3cc(cn3)C(=O)NCc3ccc4c(N)nccc4c3)cc2)c1	InChI=1S/C26H25N7O/c1-18-11-30-32(14-18)15-19-2-4-20(5-3-19)16-33-17-23(13-31-33)26(34)29-12-21-6-7-24-22(10-21)8-9-28-25(24)27/h2-11,13-14,17H,12,15-16H2,1H3,(H2,27,28)(H,29,34)	FMTLECFLQCXJHV-UHFFFAOYSA-N	263248	1-[4-(4-methyl-pyrazol-1-ylmethyl)-benzyl]-1h-pyrazole-4-carboxylic acid (1-amino-isoquinolin-6-ylmethyl)-amide::US9533987, example 31	Plasma kallikrein			 2.0							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=263248	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=263248&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86344746	377002160							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465712	COc1cccc(CNC(=O)c2cnn(Cc3ccc(Cn4ccccc4=O)cc3)c2)c1	InChI=1S/C25H24N4O3/c1-32-23-6-4-5-21(13-23)14-26-25(31)22-15-27-29(18-22)17-20-10-8-19(9-11-20)16-28-12-3-2-7-24(28)30/h2-13,15,18H,14,16-17H2,1H3,(H,26,31)	AZVKHRPLCZJAME-UHFFFAOYSA-N	50591402	CHEMBL5204652	Plasma kallikrein			 90							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50591402	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50591402&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168296905	482602254							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465713	Cc1ccc(CNC(=O)c2cnn(Cc3ccc(Cn4ccccc4=O)cc3)c2)cc1	InChI=1S/C25H24N4O2/c1-19-5-7-20(8-6-19)14-26-25(31)23-15-27-29(18-23)17-22-11-9-21(10-12-22)16-28-13-3-2-4-24(28)30/h2-13,15,18H,14,16-17H2,1H3,(H,26,31)	ZRBKVOPXVZLIFE-UHFFFAOYSA-N	50591403	CHEMBL5176481	Plasma kallikrein			 88							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50591403	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50591403&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168274944	482602255							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465714	Fc1cccc(F)c1CNC(=O)c1cnn(Cc2ccc(Cn3ccccc3=O)cc2)c1	InChI=1S/C24H20F2N4O2/c25-21-4-3-5-22(26)20(21)13-27-24(32)19-12-28-30(16-19)15-18-9-7-17(8-10-18)14-29-11-2-1-6-23(29)31/h1-12,16H,13-15H2,(H,27,32)	QXJUUELMJGFYSL-UHFFFAOYSA-N	50591404	CHEMBL5192676	Plasma kallikrein			 62							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50591404	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50591404&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168290075	482602256							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465715	Fc1cccc(Cl)c1CNC(=O)c1cnn(Cc2ccc(Cn3ccccc3=O)cc2)c1	InChI=1S/C24H20ClFN4O2/c25-21-4-3-5-22(26)20(21)13-27-24(32)19-12-28-30(16-19)15-18-9-7-17(8-10-18)14-29-11-2-1-6-23(29)31/h1-12,16H,13-15H2,(H,27,32)	LFSHRVHJLSVHCM-UHFFFAOYSA-N	50591405	CHEMBL5198301	Plasma kallikrein			 31							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50591405	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50591405&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168287708	482602257							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267984	COc1ccc(c(CNC(=O)c2cn(Cc3cc4CN(C)CCn4n3)nc2C(F)(F)F)c1F)-n1cc(C)nn1	InChI=1S/C24H25F4N9O2/c1-14-10-37(33-30-14)19-4-5-20(39-3)21(25)17(19)9-29-23(38)18-13-35(32-22(18)24(26,27)28)11-15-8-16-12-34(2)6-7-36(16)31-15/h4-5,8,10,13H,6-7,9,11-12H2,1-3H3,(H,29,38)	AOEWRWPZOYEHDO-UHFFFAOYSA-N	598481	N-{[2-fluoro-3-methoxy-6-(4-methyl-1,2,3-triazol-1-yl)phenyl]methyl}-1-({5-methyl- 4H,6H,7H-pyrazolo[1,5-a]pyrazin-2-yl}methyl)-3-(trifluoromethyl)pyrazole-4- carboxamide::US11613527, Example 125	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598481	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598481&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779163	481722843							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267987	COCc1nn(Cc2ccc3c(CN(C)CC33CC3)c2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cc(C)nn1	InChI=1S/C30H34FN7O3/c1-19-13-38(35-33-19)26-7-8-27(41-4)28(31)22(26)12-32-29(39)23-16-37(34-25(23)17-40-3)14-20-5-6-24-21(11-20)15-36(2)18-30(24)9-10-30/h5-8,11,13,16H,9-10,12,14-15,17-18H2,1-4H3,(H,32,39)	BFMQGBTWPZEDFG-UHFFFAOYSA-N	598482	N-{[2-fluoro-3-methoxy-6-(4-methyl-1,2,3-triazol-1-yl)phenyl]methyl}-3- (methoxymethyl)-1-{2'-methyl-1',3'-dihydrospiro[cyclopropane-1,4'-isoquinoline]-7'- ylmethyl}pyrazole-4-carboxamide::US11613527, Example 126	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598482	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598482&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156070407	481722844							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267990	COCc1nn(Cc2ccc3c(CNCC33CC3)c2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cc(C)nn1	InChI=1S/C29H32FN7O3/c1-18-13-37(35-33-18)25-6-7-26(40-3)27(30)21(25)12-32-28(38)22-15-36(34-24(22)16-39-2)14-19-4-5-23-20(10-19)11-31-17-29(23)8-9-29/h4-7,10,13,15,31H,8-9,11-12,14,16-17H2,1-3H3,(H,32,38)	RWHNJLPWKZZVKE-UHFFFAOYSA-N	598483	1-{2',3'-dihydro-1'H-spiro[cyclopropane-1,4'-isoquinoline]-7'-ylmethyl}-N-{[2-fluoro- 3-methoxy-6-(4-methyl-1,2,3-triazol-1-yl)phenyl]methyl}-3- (methoxymethyl)pyrazole-4-carboxamide::US11613527, Example 127	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598483	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598483&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779171	481722845							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267993	COCc1nn(Cc2ccc3CCNC(C)(C)c3c2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cc(C)nn1	InChI=1S/C29H34FN7O3/c1-18-14-37(35-33-18)25-8-9-26(40-5)27(30)21(25)13-31-28(38)22-16-36(34-24(22)17-39-4)15-19-6-7-20-10-11-32-29(2,3)23(20)12-19/h6-9,12,14,16,32H,10-11,13,15,17H2,1-5H3,(H,31,38)	VTEMVTIQMLZMBZ-UHFFFAOYSA-N	598484	1-[(1,1-dimethyl-3,4-dihydro-2H-isoquinolin-7-yl)methyl]-N-{[2-fluoro-3-methoxy-6- (4-methyl-1,2,3-triazol-1-yl)phenyl]methyl}-3-(methoxymethyl)pyrazole-4- carboxamide::US11613527, Example 128	Plasma kallikrein			 65							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598484	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598484&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156069727	481722846							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267994	COCc1nn(Cc2ccc3CCN(C)C(C)(C)c3c2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cc(C)nn1	InChI=1S/C30H36FN7O3/c1-19-15-38(35-33-19)26-9-10-27(41-6)28(31)22(26)14-32-29(39)23-17-37(34-25(23)18-40-5)16-20-7-8-21-11-12-36(4)30(2,3)24(21)13-20/h7-10,13,15,17H,11-12,14,16,18H2,1-6H3,(H,32,39)	NMZJRKNLJLTTEW-UHFFFAOYSA-N	598485	N-{[2-fluoro-3-methoxy-6-(4-methyl-1,2,3-triazol-1-yl)phenyl]methyl}-3- (methoxymethyl)-1-[(1,1,2-trimethyl-3,4-dihydroisoquinolin-7-yl)methyl]pyrazole-4- carboxamide::US11613527, Example 129	Plasma kallikrein			 20							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598485	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598485&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779158	481722847							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267995	COCc1nn(Cc2ccc3c(CNCC3(C)C)c2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cc(C)nn1	InChI=1S/C29H34FN7O3/c1-18-13-37(35-33-18)25-8-9-26(40-5)27(30)21(25)12-32-28(38)22-15-36(34-24(22)16-39-4)14-19-6-7-23-20(10-19)11-31-17-29(23,2)3/h6-10,13,15,31H,11-12,14,16-17H2,1-5H3,(H,32,38)	IXEHTNPZBCUOFD-UHFFFAOYSA-N	598486	1-[(4,4-dimethyl-2,3-dihydro-1H-isoquinolin-7-yl)methyl]-N-{[2-fluoro-3-methoxy-6- (4-methyl-1,2,3-triazol-1-yl)phenyl]methyl}-3-(methoxymethyl)pyrazole-4- carboxamide::US11613527, Example 130	Plasma kallikrein			 20							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598486	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598486&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156069303	481722848							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267996	COc1ccc(c(CNC(=O)c2cn(Cc3ccc4CCN(C)Cc4n3)nc2C(F)(F)F)c1F)-n1cc(C)nn1	InChI=1S/C26H26F4N8O2/c1-15-11-38(35-33-15)21-6-7-22(40-3)23(27)18(21)10-31-25(39)19-13-37(34-24(19)26(28,29)30)12-17-5-4-16-8-9-36(2)14-20(16)32-17/h4-7,11,13H,8-10,12,14H2,1-3H3,(H,31,39)	FEVGVADNPDUGFL-UHFFFAOYSA-N	598487	N-{[2-fluoro-3-methoxy-6-(4-methyl-1H-1,2,3-triazol-1-yl)phenyl]methyl}-1-[(7- methyl-5,6,7,8-tetrahydro-1,7-naphthyridin-2-yl)methyl]-3-(trifluoromethyl)-1H- pyrazole-4-carboxamide::US11613527, Example 131	Plasma kallikrein			 20							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598487	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598487&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156069930	481722849							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267997	COCc1nn(Cc2cnc3CCN(Cc3c2)C(C)C)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cc(C)nn1	InChI=1S/C29H35FN8O3/c1-18(2)36-9-8-24-21(15-36)10-20(11-31-24)14-37-16-23(25(34-37)17-40-4)29(39)32-12-22-26(38-13-19(3)33-35-38)6-7-27(41-5)28(22)30/h6-7,10-11,13,16,18H,8-9,12,14-15,17H2,1-5H3,(H,32,39)	JKYCMFQLAUSKEK-UHFFFAOYSA-N	598488	N-{[2-fluoro-3-methoxy-6-(4-methyl-1H-1,2,3-triazol-1-yl)phenyl]methyl}-3- (methoxymethyl)-1-{[6-(propan-2-yl)-5,6,7,8-tetrahydro-1,6-naphthyridin-3- yl]methyl}-1H-pyrazole-4-carboxamide::US11613527, Example 132	Plasma kallikrein			 20							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598488	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598488&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779170	481722850							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1267998	COCc1nn(Cc2ccc3CCOCc3c2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cc(C)nn1	InChI=1S/C27H29FN6O4/c1-17-12-34(32-30-17)24-6-7-25(37-3)26(28)21(24)11-29-27(35)22-14-33(31-23(22)16-36-2)13-18-4-5-19-8-9-38-15-20(19)10-18/h4-7,10,12,14H,8-9,11,13,15-16H2,1-3H3,(H,29,35)	YVSDHMVQYIDVLC-UHFFFAOYSA-N	598489	1-(3,4-dihydro-1H-2-benzopyran-7-ylmethyl)-N-{[2-fluoro-3-methoxy-6-(4-methyl- 1,2,3-triazol-1-yl)phenyl]methyl}-3-(methoxymethyl)pyrazole-4-carboxamide::US11613527, Example 133	Plasma kallikrein			 550							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598489	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598489&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779274	481722851							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1268001	COCc1nn(Cc2ccc3c(CN(C)CC3(C)C)c2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cc(C)nn1	InChI=1S/C30H36FN7O3/c1-19-13-38(35-33-19)26-9-10-27(41-6)28(31)22(26)12-32-29(39)23-16-37(34-25(23)17-40-5)14-20-7-8-24-21(11-20)15-36(4)18-30(24,2)3/h7-11,13,16H,12,14-15,17-18H2,1-6H3,(H,32,39)	KHDBJZLGQAZZAM-UHFFFAOYSA-N	598490	N-{[2-fluoro-3-methoxy-6-(4-methyl-1,2,3-triazol-1-yl)phenyl]methyl}-3- (methoxymethyl)-1-[(2,4,4-trimethyl-1,3-dihydroisoquinolin-7-yl)methyl]pyrazole-4- carboxamide::US11613527, Example 134	Plasma kallikrein			 20							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598490	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598490&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779264	481722852							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1268004	COCc1nn(Cc2ccc3C(=O)N(C)CCc3c2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cc(C)nn1	InChI=1S/C28H30FN7O4/c1-17-13-36(33-31-17)24-7-8-25(40-4)26(29)21(24)12-30-27(37)22-15-35(32-23(22)16-39-3)14-18-5-6-20-19(11-18)9-10-34(2)28(20)38/h5-8,11,13,15H,9-10,12,14,16H2,1-4H3,(H,30,37)	KZNQQLKAZWNULP-UHFFFAOYSA-N	598491	N-{[2-fluoro-3-methoxy-6-(4-methyl-1,2,3-triazol-1-yl)phenyl]methyl}-3- (methoxymethyl)-1-[(2-methyl-1-oxo-3,4-dihydroisoquinolin-6-yl)methyl]pyrazole-4- carboxamide::US11613527, Example 135	Plasma kallikrein			 20							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598491	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598491&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779165	481722853							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1268007	COc1ccc(c(CNC(=O)c2cn(Cc3cc4CN(C)CCn4n3)nc2C(F)F)c1F)-n1cc(C)nn1	InChI=1S/C24H26F3N9O2/c1-14-10-36(32-29-14)19-4-5-20(38-3)21(25)17(19)9-28-24(37)18-13-34(31-22(18)23(26)27)11-15-8-16-12-33(2)6-7-35(16)30-15/h4-5,8,10,13,23H,6-7,9,11-12H2,1-3H3,(H,28,37)	HTNULYLWWMKYDA-UHFFFAOYSA-N	598492	3-(difluoromethyl)-N-{[2-fluoro-3-methoxy-6-(4-methyl-1,2,3-triazol-1- yl)phenyl]methyl}-1-({5-methyl-4H,6H,7H-pyrazolo[1,5-a]pyrazin-2- yl}methyl)pyrazole-4-carboxamide::US11613527, Example 136	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598492	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598492&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156070153	481722854							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1268010	COc1ccc(c(CNC(=O)c2cn(Cc3cnc4CN(C)CCc4c3)nc2C(F)F)c1F)-n1cc(C)nn1	InChI=1S/C26H27F3N8O2/c1-15-11-37(34-32-15)21-4-5-22(39-3)23(27)18(21)10-31-26(38)19-13-36(33-24(19)25(28)29)12-16-8-17-6-7-35(2)14-20(17)30-9-16/h4-5,8-9,11,13,25H,6-7,10,12,14H2,1-3H3,(H,31,38)	JAEGJBCKXFFKGJ-UHFFFAOYSA-N	598493	3-(difluoromethyl)-N-{[2-fluoro-3-methoxy-6-(4-methyl-1,2,3-triazol-1- yl)phenyl]methyl}-1-[(7-methyl-6,8-dihydro-5H-1,7-naphthyridin-3- yl)methyl]pyrazole-4-carboxamide::US11613527, Example 137	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598493	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598493&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156069645	481722855							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1268013	COc1ccc(c(CNC(=O)c2cn(Cc3ccc4CN(C)CCc4n3)nc2C(F)(F)F)c1F)-n1cc(C)nn1	InChI=1S/C26H26F4N8O2/c1-15-11-38(35-33-15)21-6-7-22(40-3)23(27)18(21)10-31-25(39)19-14-37(34-24(19)26(28,29)30)13-17-5-4-16-12-36(2)9-8-20(16)32-17/h4-7,11,14H,8-10,12-13H2,1-3H3,(H,31,39)	WLWFNESSYRBMGA-UHFFFAOYSA-N	598494	N-{[2-fluoro-3-methoxy-6-(4-methyl-1,2,3-triazol-1-yl)phenyl]methyl}-1-[(6-methyl- 7,8-dihydro-5H-1,6-naphthyridin-2-yl)methyl]-3-(trifluoromethyl)pyrazole-4- carboxamide::US11613527, Example 138	Plasma kallikrein			 20							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598494	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598494&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779184	481722856							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1268016	COCc1nc(cn1Cc1ccc2CN(Cc2c1)C(C)C)C(=O)NCc1c(F)c(OC)ccc1-n1cc(C)nn1	InChI=1S/C29H34FN7O3/c1-18(2)35-14-21-7-6-20(10-22(21)15-35)13-36-16-24(32-27(36)17-39-4)29(38)31-11-23-25(37-12-19(3)33-34-37)8-9-26(40-5)28(23)30/h6-10,12,16,18H,11,13-15,17H2,1-5H3,(H,31,38)	VCCIRXQQWCSIPA-UHFFFAOYSA-N	598495	N-{[2-fluoro-3-methoxy-6-(4-methyl-1,2,3-triazol-1-yl)phenyl]methyl}-1-[(2- isopropyl-1,3-dihydroisoindol-5-yl)methyl]-2-(methoxymethyl)imidazole-4- carboxamide::US11613527, Example 147	Plasma kallikrein			 20							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598495	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598495&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779230	481722857							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1268019	COCc1nc(cn1Cc1ccc2CCN(C)Cc2c1)C(=O)NCc1c(F)c(OC)ccc1-n1cc(C)nn1	InChI=1S/C28H32FN7O3/c1-18-13-36(33-32-18)24-7-8-25(39-4)27(29)22(24)12-30-28(37)23-16-35(26(31-23)17-38-3)14-19-5-6-20-9-10-34(2)15-21(20)11-19/h5-8,11,13,16H,9-10,12,14-15,17H2,1-4H3,(H,30,37)	SIYSLWZZSYALNO-UHFFFAOYSA-N	598496	N-{[2-fluoro-3-methoxy-6-(4-methyl-1,2,3-triazol-1-yl)phenyl]methyl}-2- (methoxymethyl)-1-[(2-methyl-3,4-dihydro-1H-isoquinolin-7-yl)methyl]imidazole-4- carboxamide::US11613527, Example 148	Plasma kallikrein			 20							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598496	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598496&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779239	481722858							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1268022	COc1ccc(c(CNC(=O)c2cn(Cc3ccc4CCN(C)Cc4c3)c(n2)C2CC2)c1F)-n1cc(C)nn1	InChI=1S/C29H32FN7O2/c1-18-14-37(34-33-18)25-8-9-26(39-3)27(30)23(25)13-31-29(38)24-17-36(28(32-24)21-6-7-21)15-19-4-5-20-10-11-35(2)16-22(20)12-19/h4-5,8-9,12,14,17,21H,6-7,10-11,13,15-16H2,1-3H3,(H,31,38)	LJJTVRKFYWTKEB-UHFFFAOYSA-N	598497	2-cyclopropyl-N-{[2-fluoro-3-methoxy-6-(4-methyl-1,2,3-triazol-1-yl)phenyl]methyl}- 1-[(2-methyl-3,4-dihydro-1H-isoquinolin-7-yl)methyl]imidazole-4-carboxamide::US11613527, Example 149	Plasma kallikrein			 20							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598497	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598497&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779269	481722859							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1268025	COc1ccc(c(CNC(=O)c2cn(Cc3ccc4CN(Cc4c3)C(C)C)c(n2)C2CC2)c1F)-n1cc(C)nn1	InChI=1S/C30H34FN7O2/c1-18(2)36-15-22-6-5-20(11-23(22)16-36)14-37-17-25(33-29(37)21-7-8-21)30(39)32-12-24-26(38-13-19(3)34-35-38)9-10-27(40-4)28(24)31/h5-6,9-11,13,17-18,21H,7-8,12,14-16H2,1-4H3,(H,32,39)	OXURLUSRPAOPDN-UHFFFAOYSA-N	598498	2-cyclopropyl-N-{[2-fluoro-3-methoxy-6-(4-methyl-1,2,3-triazol-1-yl)phenyl]methyl}- 1-[(2-isopropyl-1,3-dihydroisoindol-5-yl)methyl]imidazole-4-carboxamide::US11613527, Example 150	Plasma kallikrein			 20							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598498	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598498&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779258	481722860							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1268028	COc1ccc(c(CNC(=O)c2cn(Cc3ccc4CCN(C)Cc4c3)c(C)n2)c1F)-n1cc(C)nn1	InChI=1S/C27H30FN7O2/c1-17-13-35(32-31-17)24-7-8-25(37-4)26(28)22(24)12-29-27(36)23-16-34(18(2)30-23)14-19-5-6-20-9-10-33(3)15-21(20)11-19/h5-8,11,13,16H,9-10,12,14-15H2,1-4H3,(H,29,36)	RNJWQQQVPTUWMX-UHFFFAOYSA-N	598499	N-{[2-fluoro-3-methoxy-6-(4-methyl-1,2,3-triazol-1-yl)phenyl]methyl}-2-methyl-1-[(2- methyl-3,4-dihydro-1H-isoquinolin-7-yl)methyl]imidazole-4-carboxamide::US11613527, Example 151	Plasma kallikrein			 20							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598499	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598499&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779132	481722861							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1268031	COc1ccc(c(CNC(=O)c2cn(Cc3ccc4CCN(C)Cc4c3)nn2)c1F)-n1cc(C)nn1	InChI=1S/C25H27FN8O2/c1-16-12-34(31-28-16)22-6-7-23(36-3)24(26)20(22)11-27-25(35)21-15-33(30-29-21)13-17-4-5-18-8-9-32(2)14-19(18)10-17/h4-7,10,12,15H,8-9,11,13-14H2,1-3H3,(H,27,35)	OOCYGNFEBHFQMF-UHFFFAOYSA-N	598500	N-{[2-fluoro-3-methoxy-6-(4-methyl-1,2,3-triazol-1-yl)phenyl]methyl}-1-[(2-methyl- 3,4-dihydro-1H-isoquinolin-7-yl)methyl]-1,2,3-triazole-4-carboxamide::US11613527, Example 152	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598500	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598500&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156070784	481722862							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1268034	COc1ccc(c(CNC(=O)c2cn(Cc3ccc4CN(Cc4c3)C(C)C)nn2)c1F)-n1cc(C)nn1	InChI=1S/C26H29FN8O2/c1-16(2)33-13-19-6-5-18(9-20(19)14-33)12-34-15-22(30-31-34)26(36)28-10-21-23(35-11-17(3)29-32-35)7-8-24(37-4)25(21)27/h5-9,11,15-16H,10,12-14H2,1-4H3,(H,28,36)	HODOQGQAHUZRPG-UHFFFAOYSA-N	598501	N-{[2-fluoro-3-methoxy-6-(4-methyl-1,2,3-triazol-1-yl)phenyl]methyl}-1-[(2- isopropyl-1,3-dihydroisoindol-5-yl)methyl]-1,2,3-triazole-4-carboxamide::US11613527, Example 153	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598501	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598501&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779151	481722863							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1268037	COCc1nn(Cc2ccc3CCN(C)Cc3c2)cc1C(=O)NCc1c(F)c(Cl)ccc1-n1cnc(n1)C(F)F	InChI=1S/C27H27ClF3N7O2/c1-36-8-7-17-4-3-16(9-18(17)12-36)11-37-13-20(22(34-37)14-40-2)27(39)32-10-19-23(6-5-21(28)24(19)29)38-15-33-26(35-38)25(30)31/h3-6,9,13,15,25H,7-8,10-12,14H2,1-2H3,(H,32,39)	OCQWMDXZHRUZNC-UHFFFAOYSA-N	598502	N-({3-chloro-6-[3-(difluoromethyl)-1,2,4-triazol-1-yl]-2-fluorophenyl}methyl)-3- (methoxymethyl)-1-[(2-methyl-3,4-dihydro-1H-isoquinolin-7-yl)methyl]pyrazole-4- carboxamide::US11613527, Example 155	Plasma kallikrein			 550							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598502	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598502&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779124	481722864							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1268040	COCc1nn(Cc2ccc3CCN(C)Cc3c2)cc1C(=O)NCc1c(Cl)c(OC)ccc1-n1cnc(n1)C(F)F	InChI=1S/C28H30ClF2N7O3/c1-36-9-8-18-5-4-17(10-19(18)13-36)12-37-14-21(22(34-37)15-40-2)28(39)32-11-20-23(6-7-24(41-3)25(20)29)38-16-33-27(35-38)26(30)31/h4-7,10,14,16,26H,8-9,11-13,15H2,1-3H3,(H,32,39)	QETUJLNTHBUGNT-UHFFFAOYSA-N	598503	N-({2-chloro-6-[3-(difluoromethyl)-1,2,4-triazol-1-yl]-3-methoxyphenyl}methyl)-3- (methoxymethyl)-1-[(2-methyl-3,4-dihydro-1H-isoquinolin-7-yl)methyl]pyrazole-4- carboxamide::US11613527, Example 156	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598503	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598503&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162779267	481722865							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1268043	COCc1nn(Cc2ccc3CCN(C)Cc3c2)cc1C(=O)NCc1c(F)c(ccc1-n1cnc(n1)C(F)F)C(C)(F)F	InChI=1S/C29H30F5N7O2/c1-29(33,34)22-6-7-24(41-16-36-27(38-41)26(31)32)20(25(22)30)11-35-28(42)21-14-40(37-23(21)15-43-3)12-17-4-5-18-8-9-39(2)13-19(18)10-17/h4-7,10,14,16,26H,8-9,11-13,15H2,1-3H3,(H,35,42)	DXFPYTBJCLCZHZ-UHFFFAOYSA-N	598504	N-{[3-(1,1-difluoroethyl)-6-[3-(difluoromethyl)-1,2,4-triazol-1-yl]-2- fluorophenyl]methyl}-3-(methoxymethyl)-1-[(2-methyl-3,4-dihydro-1H-isoquinolin-7- yl)methyl]pyrazole-4-carboxamide::US11613527, Example 157	Plasma kallikrein			 550							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598504	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598504&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156069929	481722866							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465716	Fc1cccc(c1CNC(=O)c1cnn(Cc2ccc(Cn3ccccc3=O)cc2)c1)C(F)(F)F	InChI=1S/C25H20F4N4O2/c26-22-5-3-4-21(25(27,28)29)20(22)13-30-24(35)19-12-31-33(16-19)15-18-9-7-17(8-10-18)14-32-11-2-1-6-23(32)34/h1-12,16H,13-15H2,(H,30,35)	RJQPLNSENSHCDV-UHFFFAOYSA-N	50591406	CHEMBL5206249	Plasma kallikrein			 7.8							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50591406	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50591406&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168297624	482602258							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465717	Clc1cccc(Cl)c1CNC(=O)c1cnn(Cc2ccc(Cn3ccccc3=O)cc2)c1	InChI=1S/C24H20Cl2N4O2/c25-21-4-3-5-22(26)20(21)13-27-24(32)19-12-28-30(16-19)15-18-9-7-17(8-10-18)14-29-11-2-1-6-23(29)31/h1-12,16H,13-15H2,(H,27,32)	DZHCXPPYSSYMDE-UHFFFAOYSA-N	50591407	CHEMBL5172155	Plasma kallikrein			 40							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50591407	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50591407&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168269941	482602259							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465718	Cc1cccc(C)c1CNC(=O)c1cnn(Cc2ccc(Cn3ccccc3=O)cc2)c1	InChI=1S/C26H26N4O2/c1-19-6-5-7-20(2)24(19)15-27-26(32)23-14-28-30(18-23)17-22-11-9-21(10-12-22)16-29-13-4-3-8-25(29)31/h3-14,18H,15-17H2,1-2H3,(H,27,32)	AUQIQAIANBTCPD-UHFFFAOYSA-N	50591408	CHEMBL5194528	Plasma kallikrein			 68							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50591408	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50591408&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168285019	482602260							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465719	COc1ccc(F)c(CNC(=O)c2cnn(Cc3ccc(Cn4ccccc4=O)cc3)c2)c1F	InChI=1S/C25H22F2N4O3/c1-34-22-10-9-21(26)20(24(22)27)13-28-25(33)19-12-29-31(16-19)15-18-7-5-17(6-8-18)14-30-11-3-2-4-23(30)32/h2-12,16H,13-15H2,1H3,(H,28,33)	CMNRQAZXUPNFIU-UHFFFAOYSA-N	50591409	CHEMBL5192089	Plasma kallikrein			 3.0							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50591409	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50591409&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168284570	482602261							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465720	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(F)ccc(OC)c1F	InChI=1S/C27H26F2N4O4/c1-36-17-23-21(27(35)30-13-20-22(28)10-11-24(37-2)26(20)29)16-33(31-23)15-19-8-6-18(7-9-19)14-32-12-4-3-5-25(32)34/h3-12,16H,13-15,17H2,1-2H3,(H,30,35)	PIYDGHWVVUCTNS-UHFFFAOYSA-N	408746	 N-[(2,6-difluoro-3-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin- 1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US10364238, Example 66::US10730874, Example 00395::US11001578, Example 66::US11084809, Example 66::US11198691, Example 66::US11352356, Table II.1	Plasma kallikrein			 6.0							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408746	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408746&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365096	406799377							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465721	COc1ccc(F)c(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2CN(C)C)c1F	InChI=1S/C28H29F2N5O3/c1-33(2)18-24-22(28(37)31-14-21-23(29)11-12-25(38-3)27(21)30)17-35(32-24)16-20-9-7-19(8-10-20)15-34-13-5-4-6-26(34)36/h4-13,17H,14-16,18H2,1-3H3,(H,31,37)	CQQBUDXWZPVMPO-UHFFFAOYSA-N	50591410	CHEMBL5203063	Plasma kallikrein			 6.3							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50591410	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50591410&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168292747	482602262							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465722	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cccc(OC)c1F	InChI=1S/C27H27FN4O4/c1-35-18-23-22(27(34)29-14-21-6-5-7-24(36-2)26(21)28)17-32(30-23)16-20-11-9-19(10-12-20)15-31-13-4-3-8-25(31)33/h3-13,17H,14-16,18H2,1-2H3,(H,29,34)	MLCDWARNPOODOL-UHFFFAOYSA-N	408734	 N-[(2-fluoro-3-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US10364238, Example 53::US11001578, Example 53::US11084809, Example 53::US11198691, Example 53	Plasma kallikrein			 17							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408734	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408734&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365056	406799365							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465723	COc1cccc(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2N(C)C)c1F	InChI=1S/C27H28FN5O3/c1-31(2)26-22(27(35)29-15-21-7-6-8-23(36-3)25(21)28)18-33(30-26)17-20-12-10-19(11-13-20)16-32-14-5-4-9-24(32)34/h4-14,18H,15-17H2,1-3H3,(H,29,35)	OMUPFLKDHHROJU-UHFFFAOYSA-N	408738	 3-(dimethylamino)-N-[(2-fluoro-3-methoxyphenyl)methyl]-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 59::US11001578, Example 59::US11084809, Example 59::US11198691, Example 59	Plasma kallikrein			 73							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408738	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408738&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365158	406799369							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465724	COc1cccc(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2C2CC2)c1F	InChI=1S/C28H27FN4O3/c1-36-24-6-4-5-22(26(24)29)15-30-28(35)23-18-33(31-27(23)21-12-13-21)17-20-10-8-19(9-11-20)16-32-14-3-2-7-25(32)34/h2-11,14,18,21H,12-13,15-17H2,1H3,(H,30,35)	NFLOZDGNLCLQAJ-UHFFFAOYSA-N	408733	 3-cyclopropyl-N-[(2-fluoro-3-methoxyphenyl)methyl]-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 52::US11001578, Example 52::US11084809, Example 52::US11198691, Example 52	Plasma kallikrein			 23							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408733	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408733&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365123	406799364							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465725	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cccc(O)c1F	InChI=1S/C26H25FN4O4/c1-35-17-22-21(26(34)28-13-20-5-4-6-23(32)25(20)27)16-31(29-22)15-19-10-8-18(9-11-19)14-30-12-3-2-7-24(30)33/h2-12,16,32H,13-15,17H2,1H3,(H,28,34)	JFAWWGDJBCGIDJ-UHFFFAOYSA-N	408790	N-[(2-fluoro-3-hydroxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 129::US11001578, Example 129::US11084809, Example 129::US11198691, Example 129	Plasma kallikrein			 440							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408790	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408790&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365133	406799421							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465726	CCc1cccc(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2COC)c1F	InChI=1S/C28H29FN4O3/c1-3-22-7-6-8-23(27(22)29)15-30-28(35)24-18-33(31-25(24)19-36-2)17-21-12-10-20(11-13-21)16-32-14-5-4-9-26(32)34/h4-14,18H,3,15-17,19H2,1-2H3,(H,30,35)	TVACIVBKATZGQV-UHFFFAOYSA-N	408794	 N-[(3-ethyl-2-fluorophenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 132::US11001578, Example 132::US11084809, Example 132::US11198691, Example 132	Plasma kallikrein			 140							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408794	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408794&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365023	406799425							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465727	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cccc(OC(C)C)c1F	InChI=1S/C29H31FN4O4/c1-20(2)38-26-8-6-7-23(28(26)30)15-31-29(36)24-18-34(32-25(24)19-37-3)17-22-12-10-21(11-13-22)16-33-14-5-4-9-27(33)35/h4-14,18,20H,15-17,19H2,1-3H3,(H,31,36)	VINCIPMQXBXBTO-UHFFFAOYSA-N	50591411	CHEMBL5176433	Plasma kallikrein			 150							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50591411	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50591411&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168273099	482602263							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465728	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(Cl)ccc(OC)c1F	InChI=1S/C27H26ClFN4O4/c1-36-17-23-21(27(35)30-13-20-22(28)10-11-24(37-2)26(20)29)16-33(31-23)15-19-8-6-18(7-9-19)14-32-12-4-3-5-25(32)34/h3-12,16H,13-15,17H2,1-2H3,(H,30,35)	AJVITEJNDAKYPL-UHFFFAOYSA-N	497307	N-[(6-chloro-2-fluoro-3-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-::US11001578, Example 99::US11084809, Example 99::US11198691, Example 99	Plasma kallikrein			 5.5							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=497307	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=497307&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365144	459070294							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465729	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(F)c(OC)ccc1C#N	InChI=1S/C28H26FN5O4/c1-37-18-24-23(28(36)31-14-22-21(13-30)10-11-25(38-2)27(22)29)17-34(32-24)16-20-8-6-19(7-9-20)15-33-12-4-3-5-26(33)35/h3-12,17H,14-16,18H2,1-2H3,(H,31,36)	SPXOTFDBWDBJRN-UHFFFAOYSA-N	408768	N-[(6-cyano-2-fluoro-3-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-::US10364238, Example 77::US10730874, Example 00398::US11001578, Example 77::US11084809, Example 77::US11198691, Example 77::US11352356, Table II.4	Plasma kallikrein			 1.000000							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408768	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408768&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365006	406799399							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465730	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(OC)ccc1F	InChI=1S/C27H27FN4O4/c1-35-18-25-23(27(34)29-14-21-13-22(36-2)10-11-24(21)28)17-32(30-25)16-20-8-6-19(7-9-20)15-31-12-4-3-5-26(31)33/h3-13,17H,14-16,18H2,1-2H3,(H,29,34)	NKTZDNHYVJSOOU-UHFFFAOYSA-N	408744	 N-[(2-fluoro-5-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US10364238, Example 64::US11001578, Example 64::US11084809, Example 64::US11198691, Example 64	Plasma kallikrein			 35							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408744	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408744&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365036	406799375							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465731	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(F)ccc(OC)c1C(C)C	InChI=1S/C30H33FN4O4/c1-20(2)29-23(25(31)12-13-27(29)39-4)15-32-30(37)24-18-35(33-26(24)19-38-3)17-22-10-8-21(9-11-22)16-34-14-6-5-7-28(34)36/h5-14,18,20H,15-17,19H2,1-4H3,(H,32,37)	QBWSRBFJMHHDCE-UHFFFAOYSA-N	50591412	CHEMBL5191190	Plasma kallikrein			 6.8							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50591412	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50591412&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168285694	482602264							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465732	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cccc(OC)n1	InChI=1S/C26H27N5O4/c1-34-18-23-22(26(33)27-14-21-6-5-7-24(28-21)35-2)17-31(29-23)16-20-11-9-19(10-12-20)15-30-13-4-3-8-25(30)32/h3-13,17H,14-16,18H2,1-2H3,(H,27,33)	XOCSKLGONWNPHT-UHFFFAOYSA-N	408716	3-(methoxymethyl)-N-[(6-methoxypyridin-2-yl)methyl]-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 40::US11001578, Example 40::US11084809, Example 40::US11198691, Example 40	Plasma kallikrein			 3700							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408716	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408716&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365155	406799347							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465733	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1ncccc1C#N	InChI=1S/C26H24N6O3/c1-35-18-24-22(26(34)29-14-23-21(13-27)5-4-11-28-23)17-32(30-24)16-20-9-7-19(8-10-20)15-31-12-3-2-6-25(31)33/h2-12,17H,14-16,18H2,1H3,(H,29,34)	CXNMCPFLYVYHGI-UHFFFAOYSA-N	528090	N-[(3-cyanopyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US11180484, Example 13	Plasma kallikrein			 3000							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528090	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528090&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301816	463791644							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465734	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cnccc1C(F)(F)F	InChI=1S/C26H24F3N5O3/c1-37-17-23-21(25(36)31-13-20-12-30-10-9-22(20)26(27,28)29)16-34(32-23)15-19-7-5-18(6-8-19)14-33-11-3-2-4-24(33)35/h2-12,16H,13-15,17H2,1H3,(H,31,36)	ZHJJZIGZXRDDHP-UHFFFAOYSA-N	408711	3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)-N-{[4- (trifluoromethyl)pyridin-3-yl]methyl}pyrazole-4-carboxamide ::US10364238, Example 31::US10364238, Example 37::US11001578, Example 37::US11084809, Example 37::US11198691, Example 37	Plasma kallikrein			 460							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408711	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408711&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365063	406799344							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465735	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cccnc1C(F)(F)F	InChI=1S/C26H24F3N5O3/c1-37-17-22-21(25(36)31-13-20-5-4-11-30-24(20)26(27,28)29)16-34(32-22)15-19-9-7-18(8-10-19)14-33-12-3-2-6-23(33)35/h2-12,16H,13-15,17H2,1H3,(H,31,36)	ULAOQOFMZICMAA-UHFFFAOYSA-N	408713	 3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)-N-{[2- (trifluoromethyl)pyridin-3-yl]methyl}pyrazole-4-carboxamide::US10364238, Example 36::US11001578, Example 36::US11084809, Example 36::US11198691, Example 36	Plasma kallikrein			 4200							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408713	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408713&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365101	406799346							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465736	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1ccc(C)nc1	InChI=1S/C26H27N5O3/c1-19-6-7-22(13-27-19)14-28-26(33)23-17-31(29-24(23)18-34-2)16-21-10-8-20(9-11-21)15-30-12-4-3-5-25(30)32/h3-13,17H,14-16,18H2,1-2H3,(H,28,33)	IKFHJYIVYYFDCA-UHFFFAOYSA-N	408712	3-(methoxymethyl)-N-[(6-methylpyridin-3-yl)methyl]-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 32::US10364238, Example 39::US11001578, Example 39::US11084809, Example 39::US11198691, Example 39	Plasma kallikrein			 7900							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408712	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408712&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365092	406799345							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465737	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1nccc(OC)n1	InChI=1S/C25H26N6O4/c1-34-17-21-20(25(33)27-13-22-26-11-10-23(28-22)35-2)16-31(29-21)15-19-8-6-18(7-9-19)14-30-12-4-3-5-24(30)32/h3-12,16H,13-15,17H2,1-2H3,(H,27,33)	MHQPAMQKPZNORS-UHFFFAOYSA-N	528087	3-(methoxymethyl)-N-[(4-methoxypyrimidin-2-yl)methyl]-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US11180484, Example 10	Plasma kallikrein			 2500							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528087	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528087&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301874	463791641							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465738	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(OC)ncn1	InChI=1S/C25H26N6O4/c1-34-16-22-21(25(33)26-12-20-11-23(35-2)28-17-27-20)15-31(29-22)14-19-8-6-18(7-9-19)13-30-10-4-3-5-24(30)32/h3-11,15,17H,12-14,16H2,1-2H3,(H,26,33)	WCADOIWPLIAFRR-UHFFFAOYSA-N	528082	3-(methoxymethyl)-N-[(6-methoxypyrimidin-4-yl)methyl]-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US11180484, Example 4	Plasma kallikrein			 2300							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528082	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528082&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301833	463791636							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465739	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc[nH]n1	InChI=1S/C23H24N6O3/c1-32-16-21-20(23(31)24-12-19-9-10-25-26-19)15-29(27-21)14-18-7-5-17(6-8-18)13-28-11-3-2-4-22(28)30/h2-11,15H,12-14,16H2,1H3,(H,24,31)(H,25,26)	UVLNDLGFFZSXDD-UHFFFAOYSA-N	50591413	CHEMBL5205587	Plasma kallikrein			 570							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50591413	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50591413&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168294540	482602265							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465740	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(C)[nH]n1	InChI=1S/C24H26N6O3/c1-17-11-20(27-26-17)12-25-24(32)21-15-30(28-22(21)16-33-2)14-19-8-6-18(7-9-19)13-29-10-4-3-5-23(29)31/h3-11,15H,12-14,16H2,1-2H3,(H,25,32)(H,26,27)	BIRRSDWJJGTSDW-UHFFFAOYSA-N	50591414	CHEMBL5201841	Plasma kallikrein			 220							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50591414	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50591414&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168291136	482602266							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465741	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(OC)n(C)n1	InChI=1S/C25H28N6O4/c1-29-24(35-3)12-20(27-29)13-26-25(33)21-16-31(28-22(21)17-34-2)15-19-9-7-18(8-10-19)14-30-11-5-4-6-23(30)32/h4-12,16H,13-15,17H2,1-3H3,(H,26,33)	AKTSEYYIYFHXQV-UHFFFAOYSA-N	528100	N-[(5-methoxy-1-methylpyrazol-3-yl)methyl]-3-(methoxymethyl)-1-({4-[(2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US11180484, Example 31	Plasma kallikrein			 460							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528100	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528100&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301821	463791654							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465742	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1sccc1Cl	InChI=1S/C24H23ClN4O3S/c1-32-16-21-19(24(31)26-12-22-20(25)9-11-33-22)15-29(27-21)14-18-7-5-17(6-8-18)13-28-10-3-2-4-23(28)30/h2-11,15H,12-14,16H2,1H3,(H,26,31)	HAOFRUOYORMGKX-UHFFFAOYSA-N	50591415	CHEMBL5178736	Plasma kallikrein			 210							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50591415	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50591415&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365035	482602267							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465743	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1nc(OC)ccc1F	InChI=1S/C26H26FN5O4/c1-35-17-23-20(26(34)28-13-22-21(27)10-11-24(29-22)36-2)16-32(30-23)15-19-8-6-18(7-9-19)14-31-12-4-3-5-25(31)33/h3-12,16H,13-15,17H2,1-2H3,(H,28,34)	KQSCQCAZZHSOOR-UHFFFAOYSA-N	408718	N-[(3-fluoro-6-methoxypyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin- 1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 42::US11001578, Example 42::US11084809, Example 42::US11198691, Example 42	Plasma kallikrein			 900							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408718	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408718&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365159	406799349							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465744	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1ncc(Cl)cc1F	InChI=1S/C25H23ClFN5O3/c1-35-16-23-20(25(34)29-12-22-21(27)10-19(26)11-28-22)15-32(30-23)14-18-7-5-17(6-8-18)13-31-9-3-2-4-24(31)33/h2-11,15H,12-14,16H2,1H3,(H,29,34)	ZGVHOERMFFOQEE-UHFFFAOYSA-N	528092	N-[(5-chloro-3-fluoropyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US11180484, Example 17	Plasma kallikrein			 160							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528092	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528092&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301867	463791646							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465745	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1ncc(F)cc1F	InChI=1S/C25H23F2N5O3/c1-35-16-23-20(25(34)29-12-22-21(27)10-19(26)11-28-22)15-32(30-23)14-18-7-5-17(6-8-18)13-31-9-3-2-4-24(31)33/h2-11,15H,12-14,16H2,1H3,(H,29,34)	LBBWYBIVLDSOSM-UHFFFAOYSA-N	528095	N-[(3,5-difluoropyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US11180484, Example 26	Plasma kallikrein			 2220							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528095	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528095&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301863	463791649							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465746	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1ncc(Cl)cc1C#N	InChI=1S/C26H23ClN6O3/c1-36-17-24-22(26(35)30-13-23-20(11-28)10-21(27)12-29-23)16-33(31-24)15-19-7-5-18(6-8-19)14-32-9-3-2-4-25(32)34/h2-10,12,16H,13-15,17H2,1H3,(H,30,35)	DLOVVYIYYDQZJE-UHFFFAOYSA-N	528091	N-[(5-chloro-3-cyanopyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US11180484, Example 16	Plasma kallikrein			 250							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528091	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528091&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301878	463791645							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465747	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1nc(C)ccc1F	InChI=1S/C26H26FN5O3/c1-18-6-11-22(27)23(29-18)13-28-26(34)21-16-32(30-24(21)17-35-2)15-20-9-7-19(8-10-20)14-31-12-4-3-5-25(31)33/h3-12,16H,13-15,17H2,1-2H3,(H,28,34)	NFELVQQHZHAYGB-UHFFFAOYSA-N	528096	N-[(3-fluoro-6-methylpyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US11180484, Example 27	Plasma kallikrein			 900							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528096	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528096&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301864	463791650							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465748	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1nccc(C)c1F	InChI=1S/C26H26FN5O3/c1-18-10-11-28-22(25(18)27)13-29-26(34)21-16-32(30-23(21)17-35-2)15-20-8-6-19(7-9-20)14-31-12-4-3-5-24(31)33/h3-12,16H,13-15,17H2,1-2H3,(H,29,34)	KORWPMHMESLCMI-UHFFFAOYSA-N	528097	N-[(3-fluoro-4-methylpyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US11180484, Example 28	Plasma kallikrein			 140							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528097	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528097&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301835	463791651							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465749	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1nccc(C)c1Cl	InChI=1S/C26H26ClN5O3/c1-18-10-11-28-22(25(18)27)13-29-26(34)21-16-32(30-23(21)17-35-2)15-20-8-6-19(7-9-20)14-31-12-4-3-5-24(31)33/h3-12,16H,13-15,17H2,1-2H3,(H,29,34)	JGKXIESKLZBKHM-UHFFFAOYSA-N	528098	N-[(3-chloro-4-methylpyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US11180484, Example 29	Plasma kallikrein			 300							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528098	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528098&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301866	463791652							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465750	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1nccc(OC)c1C	InChI=1S/C27H29N5O4/c1-19-23(28-12-11-25(19)36-3)14-29-27(34)22-17-32(30-24(22)18-35-2)16-21-9-7-20(8-10-21)15-31-13-5-4-6-26(31)33/h4-13,17H,14-16,18H2,1-3H3,(H,29,34)	BUIQZUSRWDPBSM-UHFFFAOYSA-N	528094	N-[(4-methoxy-3-methylpyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[(2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US11180484, Example 22	Plasma kallikrein			 4.1							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528094	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528094&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301877	463791648							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465751	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(OC)c(C)cn1	InChI=1S/C27H29N5O4/c1-19-13-28-22(12-25(19)36-3)14-29-27(34)23-17-32(30-24(23)18-35-2)16-21-9-7-20(8-10-21)15-31-11-5-4-6-26(31)33/h4-13,17H,14-16,18H2,1-3H3,(H,29,34)	SSHUXJONDGHEDC-UHFFFAOYSA-N	528093	N-[(4-methoxy-5-methylpyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[(2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US11180484, Example 20	Plasma kallikrein			 3200							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528093	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528093&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301887	463791647							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465752	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1ncc(C)c(OC)c1C	InChI=1S/C28H31N5O4/c1-19-13-29-24(20(2)27(19)37-4)14-30-28(35)23-17-33(31-25(23)18-36-3)16-22-10-8-21(9-11-22)15-32-12-6-5-7-26(32)34/h5-13,17H,14-16,18H2,1-4H3,(H,30,35)	GQIPLMKRGZCNHM-UHFFFAOYSA-N	528088	N-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[(2- oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US11180484, Example 11	Plasma kallikrein			 37							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528088	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528088&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301865	463791642							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465753	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1nccc(Cl)c1F	InChI=1S/C25H23ClFN5O3/c1-35-16-22-19(25(34)29-12-21-24(27)20(26)9-10-28-21)15-32(30-22)14-18-7-5-17(6-8-18)13-31-11-3-2-4-23(31)33/h2-11,15H,12-14,16H2,1H3,(H,29,34)	YUQVECXMJHKKDM-UHFFFAOYSA-N	50591416	CHEMBL5177449	Plasma kallikrein			 93							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50591416	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50591416&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301812	482602268							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465754	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1nccc(OC)c1F	InChI=1S/C26H26FN5O4/c1-35-17-22-20(26(34)29-13-21-25(27)23(36-2)10-11-28-21)16-32(30-22)15-19-8-6-18(7-9-19)14-31-12-4-3-5-24(31)33/h3-12,16H,13-15,17H2,1-2H3,(H,29,34)	KGMPDQIYDKKXRD-UHFFFAOYSA-N	408717	 N-[(3-fluoro-4-methoxypyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin- 1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 41::US10730874, Example 00397::US11001578, Example 41::US11084809, Example 41::US11198691, Example 41::US11352356, Table II.3::US11584735, Example 41 of WO2016/083820	Plasma kallikrein			 6.0							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408717	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408717&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365142	406799348							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465755	CCOc1ccnc(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2COC)c1F	InChI=1S/C27H28FN5O4/c1-3-37-24-11-12-29-22(26(24)28)14-30-27(35)21-17-33(31-23(21)18-36-2)16-20-9-7-19(8-10-20)15-32-13-5-4-6-25(32)34/h4-13,17H,3,14-16,18H2,1-2H3,(H,30,35)	LJNKYDAPTBPTMQ-UHFFFAOYSA-N	50591417	CHEMBL5189174	Plasma kallikrein			 7.9							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50591417	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50591417&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168278399	482602269							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465756	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1nccc(OC(C)C)c1F	InChI=1S/C28H30FN5O4/c1-19(2)38-25-11-12-30-23(27(25)29)14-31-28(36)22-17-34(32-24(22)18-37-3)16-21-9-7-20(8-10-21)15-33-13-5-4-6-26(33)35/h4-13,17,19H,14-16,18H2,1-3H3,(H,31,36)	NCMVIHQOCPCVOO-UHFFFAOYSA-N	50591418	CHEMBL5178641	Plasma kallikrein			 2400							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50591418	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50591418&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168273236	482602270							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465757	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1cc(OC)ncc1C#N	InChI=1S/C27H26N6O4/c1-36-18-24-23(27(35)30-13-21-11-25(37-2)29-14-22(21)12-28)17-33(31-24)16-20-8-6-19(7-9-20)15-32-10-4-3-5-26(32)34/h3-11,14,17H,13,15-16,18H2,1-2H3,(H,30,35)	AXDZSJQRHYIUDG-UHFFFAOYSA-N	528086	N-[(5-cyano-2-methoxypyridin-4-yl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin- 1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US11180484, Example 8	Plasma kallikrein			 160							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528086	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528086&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301847	463791640							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465758	COc1ccnc(CNC(=O)c2cnn(Cc3ccc(Cn4ccccc4=O)cc3)c2)c1F	InChI=1S/C24H22FN5O3/c1-33-21-9-10-26-20(23(21)25)13-27-24(32)19-12-28-30(16-19)15-18-7-5-17(6-8-18)14-29-11-3-2-4-22(29)31/h2-12,16H,13-15H2,1H3,(H,27,32)	RPSVFYGAPZUHAM-UHFFFAOYSA-N	50591419	CHEMBL5171646	Plasma kallikrein			 5.1							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50591419	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50591419&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168270048	482602271							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465759	COc1ccnc(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2C(F)(F)F)c1F	InChI=1S/C25H21F4N5O3/c1-37-20-9-10-30-19(22(20)26)12-31-24(36)18-15-34(32-23(18)25(27,28)29)14-17-7-5-16(6-8-17)13-33-11-3-2-4-21(33)35/h2-11,15H,12-14H2,1H3,(H,31,36)	NKTBXDIJVDKJRR-UHFFFAOYSA-N	528084	N-[(3-fluoro-4-methoxypyridin-2-yl)methyl]-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide::US11180484, Example 6	Plasma kallikrein			 3.2							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528084	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528084&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301871	463791638							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465760	COc1ccnc(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2C2CC2)c1F	InChI=1S/C27H26FN5O3/c1-36-23-11-12-29-22(25(23)28)14-30-27(35)21-17-33(31-26(21)20-9-10-20)16-19-7-5-18(6-8-19)15-32-13-3-2-4-24(32)34/h2-8,11-13,17,20H,9-10,14-16H2,1H3,(H,30,35)	DYPPAAYTTSVIEX-UHFFFAOYSA-N	50591420	CHEMBL5172353	Plasma kallikrein			 4.4							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50591420	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50591420&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168269774	482602272							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465761	Cc1cc(C(=O)NCc2ccc(cc2)C(N)=N)c(C)n1Cc1ccccc1	InChI=1S/C22H24N4O/c1-15-12-20(16(2)26(15)14-18-6-4-3-5-7-18)22(27)25-13-17-8-10-19(11-9-17)21(23)24/h3-12H,13-14H2,1-2H3,(H3,23,24)(H,25,27)	QZFWJVBLYPSQCQ-UHFFFAOYSA-N	50591421	CHEMBL5176313	Plasma kallikrein			 5.5							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50591421	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50591421&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			24856467	482602273							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465762	NC(=N)c1ccc(CNC(=O)c2cnn(Cc3ccccc3)c2)cc1	InChI=1S/C19H19N5O/c20-18(21)16-8-6-14(7-9-16)10-22-19(25)17-11-23-24(13-17)12-15-4-2-1-3-5-15/h1-9,11,13H,10,12H2,(H3,20,21)(H,22,25)	SAVNTVHVERKVOD-UHFFFAOYSA-N	50591422	CHEMBL5175689	Plasma kallikrein			 62							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50591422	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50591422&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			24857697	482602274							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465763	Cc1cc(C(=O)NCc2ccc(CN)cc2)c(C)n1Cc1ccccc1	InChI=1S/C22H25N3O/c1-16-12-21(17(2)25(16)15-20-6-4-3-5-7-20)22(26)24-14-19-10-8-18(13-23)9-11-19/h3-12H,13-15,23H2,1-2H3,(H,24,26)	ZXWVKIBFYOVNCI-UHFFFAOYSA-N	362240	1-Benzyl-2,5-dimethyl-1H-pyrrole-3-carboxylic acid 4-aminomethyl-benzylamide::US9834513, 55	Plasma kallikrein			 3700							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=362240	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=362240&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465764	Nc1cccc2cc(CNC(=O)c3cnn(Cc4ccc(Cn5ccccc5=O)cc4)c3)ccc12	InChI=1S/C28H25N5O2/c29-26-5-3-4-23-14-22(11-12-25(23)26)15-30-28(35)24-16-31-33(19-24)18-21-9-7-20(8-10-21)17-32-13-2-1-6-27(32)34/h1-14,16,19H,15,17-18,29H2,(H,30,35)	ODCYNNCBBPSJJK-UHFFFAOYSA-N	50591423	CHEMBL5189653	Plasma kallikrein			 0.590000							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50591423	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50591423&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168282458	482602275							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465790	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(F)ccc(OC)c1F	InChI=1S/C27H26F2N4O4/c1-36-17-23-21(27(35)30-13-20-22(28)10-11-24(37-2)26(20)29)16-33(31-23)15-19-8-6-18(7-9-19)14-32-12-4-3-5-25(32)34/h3-12,16H,13-15,17H2,1-2H3,(H,30,35)	PIYDGHWVVUCTNS-UHFFFAOYSA-N	408746	 N-[(2,6-difluoro-3-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin- 1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US10364238, Example 66::US10730874, Example 00395::US11001578, Example 66::US11084809, Example 66::US11198691, Example 66::US11352356, Table II.1	Plasma kallikrein			 500							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408746	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408746&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365096	406799377							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465791	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1nccc(OC)c1F	InChI=1S/C26H26FN5O4/c1-35-17-22-20(26(34)29-13-21-25(27)23(36-2)10-11-28-21)16-32(30-22)15-19-8-6-18(7-9-19)14-31-12-4-3-5-24(31)33/h3-12,16H,13-15,17H2,1-2H3,(H,29,34)	KGMPDQIYDKKXRD-UHFFFAOYSA-N	408717	 N-[(3-fluoro-4-methoxypyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin- 1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 41::US10730874, Example 00397::US11001578, Example 41::US11084809, Example 41::US11198691, Example 41::US11352356, Table II.3::US11584735, Example 41 of WO2016/083820	Plasma kallikrein			 54							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408717	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408717&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365142	406799348							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465792	COc1ccnc(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2C(F)(F)F)c1F	InChI=1S/C25H21F4N5O3/c1-37-20-9-10-30-19(22(20)26)12-31-24(36)18-15-34(32-23(18)25(27,28)29)14-17-7-5-16(6-8-17)13-33-11-3-2-4-21(33)35/h2-11,15H,12-14H2,1H3,(H,31,36)	NKTBXDIJVDKJRR-UHFFFAOYSA-N	528084	N-[(3-fluoro-4-methoxypyridin-2-yl)methyl]-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide::US11180484, Example 6	Plasma kallikrein			 76							ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528084	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528084&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301871	463791638							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1268046	COCc1nn(Cc2ccc3CCN(C)CCc3c2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cnc(n1)C(F)(F)F	InChI=1S/C29H31F4N7O3/c1-38-10-8-19-5-4-18(12-20(19)9-11-38)14-39-15-22(23(36-39)16-42-2)27(41)34-13-21-24(6-7-25(43-3)26(21)30)40-17-35-28(37-40)29(31,32)33/h4-7,12,15,17H,8-11,13-14,16H2,1-3H3,(H,34,41)	KRQGYKHNVYSPEC-UHFFFAOYSA-N	598505	N-({2-fluoro-3-methoxy-6-[3-(trifluoromethyl)-1,2,4-triazol-1-yl]phenyl}methyl)-3- (methoxymethyl)-1-[(3-methyl-1,2,4,5-tetrahydro-3-benzazepin-7- yl)methyl]pyrazole-4-carboxamide::US11613527, Example 158	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598505	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598505&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156079321	481722867							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1268049	COc1ccc(c(CNC(=O)c2ccn(Cc3ccc4CCN(C)Cc4c3)c(=O)c2)c1F)-n1cc(C)nn1	InChI=1S/C28H29FN6O3/c1-18-15-35(32-31-18)24-6-7-25(38-3)27(29)23(24)14-30-28(37)21-9-11-34(26(36)13-21)16-19-4-5-20-8-10-33(2)17-22(20)12-19/h4-7,9,11-13,15H,8,10,14,16-17H2,1-3H3,(H,30,37)	LJIFERLCSUAZPC-UHFFFAOYSA-N	598506	N-{[2-fluoro-3-methoxy-6-(4-methyl-1,2,3-triazol-1-yl)phenyl]methyl}-1-[(2-methyl- 3,4-dihydro-1H-isoquinolin-7-yl)methyl]-2-oxopyridine-4-carboxamide::US11613527, Example 159	Plasma kallikrein			 550							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598506	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598506&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156079469	481722868							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1268052	COc1ccc(c(CNC(=O)c2ccc(=O)n(Cc3ccc4CCN(C)Cc4c3)c2)c1F)-n1cc(C)nn1	InChI=1S/C28H29FN6O3/c1-18-14-35(32-31-18)24-7-8-25(38-3)27(29)23(24)13-30-28(37)21-6-9-26(36)34(17-21)15-19-4-5-20-10-11-33(2)16-22(20)12-19/h4-9,12,14,17H,10-11,13,15-16H2,1-3H3,(H,30,37)	YIQFPUUXIZGCMT-UHFFFAOYSA-N	598507	N-{[2-fluoro-3-methoxy-6-(4-methyl-1,2,3-triazol-1-yl)phenyl]methyl}-1-[(2-methyl- 3,4-dihydro-1H-isoquinolin-7-yl)methyl]-6-oxopyridine-3-carboxamide::US11613527, Example 160	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598507	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598507&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156070086	481722869							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1268055	COc1ccc(c(CNC(=O)c2cncc(Cc3ccc4CCN(C)Cc4c3)c2)c1F)-n1cc(C)nn1	InChI=1S/C28H29FN6O2/c1-18-16-35(33-32-18)25-6-7-26(37-3)27(29)24(25)15-31-28(36)22-12-20(13-30-14-22)10-19-4-5-21-8-9-34(2)17-23(21)11-19/h4-7,11-14,16H,8-10,15,17H2,1-3H3,(H,31,36)	MPLQKVKDXCJZAJ-UHFFFAOYSA-N	598508	N-{[2-fluoro-3-methoxy-6-(4-methyl-1,2,3-triazol-1-yl)phenyl]methyl}-5-[(2-methyl- 3,4-dihydro-1H-isoquinolin-7-yl)methyl]pyridine-3-carboxamide::US11613527, Example 161	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598508	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598508&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156079316	481722870							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1268058	COCc1nn(Cc2ccc3ccncc3c2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cc(C)nn1	InChI=1S/C27H26FN7O3/c1-17-13-35(33-31-17)24-6-7-25(38-3)26(28)21(24)12-30-27(36)22-15-34(32-23(22)16-37-2)14-18-4-5-19-8-9-29-11-20(19)10-18/h4-11,13,15H,12,14,16H2,1-3H3,(H,30,36)	XEGNQBGXYNSORH-UHFFFAOYSA-N	598509	N-{[2-fluoro-3-methoxy-6-(4-methyl-1,2,3-triazol-1-yl)phenyl]methyl}-1-(isoquinolin- 7-ylmethyl)-3-(methoxymethyl)pyrazole-4-carboxamide::US11613527, Example RC1	Plasma kallikrein			 550							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598509	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598509&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163284777	481722871							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1268059	COCc1nn(Cc2ccc3nc(C)ccc3c2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cnnn1	InChI=1S/C26H25FN8O3/c1-16-4-6-18-10-17(5-7-21(18)30-16)12-34-13-20(22(31-34)14-37-2)26(36)28-11-19-23(35-15-29-32-33-35)8-9-24(38-3)25(19)27/h4-10,13,15H,11-12,14H2,1-3H3,(H,28,36)	WNAYYHCDJKNBHI-UHFFFAOYSA-N	598510	N-{[2-fluoro-3-methoxy-6-(1,2,3,4-tetrazol-1-yl)phenyl]methyl}-3-(methoxymethyl)- 1-[(2-methylquinolin-6-yl)methyl]pyrazole-4-carboxamide::US11613527, Example RC2	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598510	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598510&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163284747	481722872							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1268062	COCc1nn(Cc2ccc3ncccc3c2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cnnn1	InChI=1S/C25H23FN8O3/c1-36-14-21-19(13-33(30-21)12-16-5-6-20-17(10-16)4-3-9-27-20)25(35)28-11-18-22(34-15-29-31-32-34)7-8-23(37-2)24(18)26/h3-10,13,15H,11-12,14H2,1-2H3,(H,28,35)	WTZBXVFJJLJAMU-UHFFFAOYSA-N	598511	N-{[2-fluoro-3-methoxy-6-(1,2,3,4-tetrazol-1-yl)phenyl]methyl}-3-(methoxymethyl)- 1-(quinolin-6-ylmethyl)pyrazole-4-carboxamide::US11613527, Example RC3	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598511	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598511&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163284753	481722873							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1268065	COCc1nn(Cc2cnc(nc2)N2CCCC2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cnnn1	InChI=1S/C24H27FN10O3/c1-37-14-19-18(13-34(30-19)12-16-9-27-24(28-10-16)33-7-3-4-8-33)23(36)26-11-17-20(35-15-29-31-32-35)5-6-21(38-2)22(17)25/h5-6,9-10,13,15H,3-4,7-8,11-12,14H2,1-2H3,(H,26,36)	GSFPQMPKJFXLTO-UHFFFAOYSA-N	528127	US11180484, Example 79::US11180484, Reference Example K::US11613527, Example RC4	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528127	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528127&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			132203422	463791680							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1268068	COCc1nn(Cc2cnc(nc2)N2CCCC2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1ccnn1	InChI=1S/C25H28FN9O3/c1-37-16-20-19(15-34(31-20)14-17-11-28-25(29-12-17)33-8-3-4-9-33)24(36)27-13-18-21(35-10-7-30-32-35)5-6-22(38-2)23(18)26/h5-7,10-12,15H,3-4,8-9,13-14,16H2,1-2H3,(H,27,36)	XFHQXUOGKMUMLE-UHFFFAOYSA-N	598513	N-{[2-fluoro-3-methoxy-6-(1,2,3-triazol-1-yl)phenyl]methyl}-3-(methoxymethyl)-1- {[2-(pyrrolidin-1-yl)pyrimidin-5-yl]methyl}pyrazole-4-carboxamide::US11613527, Example RC5	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598513	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598513&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156637632	481722875							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1268071	COCc1nn(Cc2cnc(nc2)N2CCCC2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cc(C)nn1	InChI=1S/C26H30FN9O3/c1-17-13-36(33-31-17)22-6-7-23(39-3)24(27)19(22)12-28-25(37)20-15-35(32-21(20)16-38-2)14-18-10-29-26(30-11-18)34-8-4-5-9-34/h6-7,10-11,13,15H,4-5,8-9,12,14,16H2,1-3H3,(H,28,37)	DVKRUFCAACRVHI-UHFFFAOYSA-N	598514	N-{[2-fluoro-3-methoxy-6-(4-methyl-1,2,3-triazol-1-yl)phenyl]methyl}-3- (methoxymethyl)-1-{[2-(pyrrolidin-1-yl)pyrimidin-5-yl]methyl}pyrazole-4- carboxamide::US11613527, Example RC6	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598514	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598514&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156079550	481722876							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1268074	COCc1nn(Cc2cnc(nc2)N2CCCC2)cc1C(=O)NCc1c(F)c(OC)ccc1-n1cc(nn1)C(F)F	InChI=1S/C26H28F3N9O3/c1-40-15-20-18(13-37(34-20)12-16-9-31-26(32-10-16)36-7-3-4-8-36)25(39)30-11-17-21(5-6-22(41-2)23(17)27)38-14-19(24(28)29)33-35-38/h5-6,9-10,13-14,24H,3-4,7-8,11-12,15H2,1-2H3,(H,30,39)	NJQXDLRESLRGDI-UHFFFAOYSA-N	598515	N-({6-[4-(difluoromethyl)-1,2,3-triazol-1-yl]-2-fluoro-3-methoxyphenyl}methyl)-3- (methoxymethyl)-1-{[2-(pyrrolidin-1-yl)pyrimidin-5-yl]methyl}pyrazole-4- carboxamide::US11613527, Example RC7	Plasma kallikrein			<10							US Patent		10.7270/Q2RF5ZZZ			US11613527	Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Mazzacani, A; Stocks, MJ; Baker, TM; Conroy, MR; Smith, AJ; Clark, DE	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=598515	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=598515&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156079368	481722877							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51465807	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1nccc(OC)c1F	InChI=1S/C26H26FN5O4/c1-35-17-22-20(26(34)29-13-21-25(27)23(36-2)10-11-28-21)16-32(30-22)15-19-8-6-18(7-9-19)14-31-12-4-3-5-24(31)33/h3-12,16H,13-15,17H2,1-2H3,(H,29,34)	KGMPDQIYDKKXRD-UHFFFAOYSA-N	408717	 N-[(3-fluoro-4-methoxypyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin- 1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 41::US10730874, Example 00397::US11001578, Example 41::US11084809, Example 41::US11198691, Example 41::US11352356, Table II.3::US11584735, Example 41 of WO2016/083820	Plasma kallikrein		 3.0								ChEMBL		10.7270/Q2HT2TBQ	36251573			Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST; Stocks, MJ; Smith, AJ; Rushbrooke, LJ; Pethen, SJ; Roe, MB; Clark, DE; McEwan, PA; Hampton, SL	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408717	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408717&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365142	406799348							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51485864	Cn1nncc1-c1cnn(c1)[C@H](CCOC(F)F)c1ccc(c[n+]1[O-])-c1c(F)c(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C23H18Cl2F3N9O2/c1-34-19(9-29-32-34)14-8-30-35(10-14)16(6-7-39-23(27)28)17-4-2-13(11-37(17)38)21-18(5-3-15(24)22(21)26)36-12-20(25)31-33-36/h2-5,8-12,16,23H,6-7H2,1H3/t16-/m1/s1	BETDGMHNHGHORO-MRXNPFEDSA-N	50598724	CHEMBL5170592	Plasma kallikrein			 23							ChEMBL		10.7270/Q2C82FBD	35862732			Xu, G; Liu, Z; Wang, X; Lu, T; DesJarlais, RL; Thieu, T; Zhang, J; Devine, ZH; Du, F; Li, Q; Milligan, CM; Shaffer, P; Cedervall, PE; Spurlino, JC; Stratton, CF; Pietrak, B; Szewczuk, LM; Wong, V; Steele, RA; Bruinzeel, W; Chintala, M; Silva, J; Gaul, MD; Macielag, MJ; Nargund, R	Janssen Research & Development, L.L.C.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50598724	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50598724&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	OTX		164607233	482609576							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51486941	Nc1c(cnn1Cc1cccc(Cl)c1)C(=O)N1CCC[C@@]2(C1)OC(=O)Nc1ccc(Cl)c(F)c21	InChI=1S/C23H20Cl2FN5O3/c24-14-4-1-3-13(9-14)11-31-20(27)15(10-28-31)21(32)30-8-2-7-23(12-30)18-17(29-22(33)34-23)6-5-16(25)19(18)26/h1,3-6,9-10H,2,7-8,11-12,27H2,(H,29,33)/t23-/m0/s1	OQKBDMXLHPVFBS-QHCPKHFHSA-N	50599216	CHEMBL5176745	Plasma kallikrein			 0.500000							ChEMBL		10.7270/Q20V8HT7	35978687			Sabnis, RW	Smith, Gambrell & Russell LLP	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50599216	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50599216&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168272570	482610068							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51486942	Cc1ccc(Cn2ncc(C(=O)N3CCC[C@@]4(C3)OC(=O)Nc3ccc(Cl)c(F)c43)c2N)cc1	InChI=1S/C24H23ClFN5O3/c1-14-3-5-15(6-4-14)12-31-21(27)16(11-28-31)22(32)30-10-2-9-24(13-30)19-18(29-23(33)34-24)8-7-17(25)20(19)26/h3-8,11H,2,9-10,12-13,27H2,1H3,(H,29,33)/t24-/m0/s1	UWKMEEDDRJBVMR-DEOSSOPVSA-N	50599217	CHEMBL5193961	Plasma kallikrein			 0.500000							ChEMBL		10.7270/Q20V8HT7	35978687			Sabnis, RW	Smith, Gambrell & Russell LLP	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50599217	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50599217&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			167080903	482610069							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51486943	Nc1c(cnn1Cc1ccccc1)C(=O)N1CCC[C@@]2(C1)OC(=O)Nc1ccc(Cl)c(F)c21	InChI=1S/C23H21ClFN5O3/c24-16-7-8-17-18(19(16)25)23(33-22(32)28-17)9-4-10-29(13-23)21(31)15-11-27-30(20(15)26)12-14-5-2-1-3-6-14/h1-3,5-8,11H,4,9-10,12-13,26H2,(H,28,32)/t23-/m0/s1	GZJMYPKPSPANNT-QHCPKHFHSA-N	50599218	CHEMBL5192366	Plasma kallikrein			 0.600000							ChEMBL		10.7270/Q20V8HT7	35978687			Sabnis, RW	Smith, Gambrell & Russell LLP	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50599218	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50599218&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			167080905	482610070							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51486944	CCC(C1CCOCC1)n1ncc(C(=O)N2CCC[C@@]3(C2)OC(=O)Nc2ccc(Cl)c(F)c32)c1N	InChI=1S/C24H29ClFN5O4/c1-2-18(14-6-10-34-11-7-14)31-21(27)15(12-28-31)22(32)30-9-3-8-24(13-30)19-17(29-23(33)35-24)5-4-16(25)20(19)26/h4-5,12,14,18H,2-3,6-11,13,27H2,1H3,(H,29,33)/t18?,24-/m0/s1	WDZLSYOLVXGJPQ-LUTIACGYSA-N	50599219	CHEMBL5186731	Plasma kallikrein			 0.600000							ChEMBL		10.7270/Q20V8HT7	35978687			Sabnis, RW	Smith, Gambrell & Russell LLP	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50599219	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50599219&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163370695	482610071							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51486945	Nc1c(cnn1C(C(F)(F)F)C1(F)CC1)C(=O)N1CCC[C@@]2(C1)OC(=O)Nc1ccc(Cl)c(F)c21	InChI=1S/C21H19ClF5N5O3/c22-11-2-3-12-13(14(11)23)20(35-18(34)30-12)4-1-7-31(9-20)16(33)10-8-29-32(15(10)28)17(21(25,26)27)19(24)5-6-19/h2-3,8,17H,1,4-7,9,28H2,(H,30,34)/t17?,20-/m0/s1	IIIUCAYVYGGQGS-OZBJMMHXSA-N	50599220	CHEMBL5187286	Plasma kallikrein			 0.600000							ChEMBL		10.7270/Q20V8HT7	35978687			Sabnis, RW	Smith, Gambrell & Russell LLP	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50599220	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50599220&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163370596	482610072							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51486946	CCC(c1ccccc1)n1ncc(C(=O)N2CCC[C@@]3(C2)OC(=O)Nc2ccc(Cl)c(F)c32)c1N	InChI=1S/C25H25ClFN5O3/c1-2-19(15-7-4-3-5-8-15)32-22(28)16(13-29-32)23(33)31-12-6-11-25(14-31)20-18(30-24(34)35-25)10-9-17(26)21(20)27/h3-5,7-10,13,19H,2,6,11-12,14,28H2,1H3,(H,30,34)/t19?,25-/m0/s1	ZGMKEAIOTTZUKO-BIAFCPFJSA-N	50599221	CHEMBL5170785	Plasma kallikrein			 0.700000							ChEMBL		10.7270/Q20V8HT7	35978687			Sabnis, RW	Smith, Gambrell & Russell LLP	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50599221	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50599221&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163370643	482610073							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1259384	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1nccc(OC)c1F	InChI=1S/C26H26FN5O4/c1-35-17-22-20(26(34)29-13-21-25(27)23(36-2)10-11-28-21)16-32(30-22)15-19-8-6-18(7-9-19)14-31-12-4-3-5-24(31)33/h3-12,16H,13-15,17H2,1-2H3,(H,29,34)	KGMPDQIYDKKXRD-UHFFFAOYSA-N	408717	 N-[(3-fluoro-4-methoxypyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin- 1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 41::US10730874, Example 00397::US11001578, Example 41::US11084809, Example 41::US11198691, Example 41::US11352356, Table II.3::US11584735, Example 41 of WO2016/083820	Plasma kallikrein			 3.30							US Patent		10.7270/Q2BG2SXX			US11584735	Crowe, DM; Aret, E; Gandhi, K; Lelieveld, RH; Sharp, EK; Todd, RS	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408717	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408717&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365142	406799348							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1259388	COCc1nn(Cc2ccc(Cn3cc(F)ccc3=O)cc2)cc1C(=O)NCc1nccc(OC)c1F	InChI=1S/C26H25F2N5O4/c1-36-16-22-20(26(35)30-11-21-25(28)23(37-2)9-10-29-21)15-33(31-22)13-18-5-3-17(4-6-18)12-32-14-19(27)7-8-24(32)34/h3-10,14-15H,11-13,16H2,1-2H3,(H,30,35)	ZRUFVDPYHLTYPD-UHFFFAOYSA-N	528099	1-({4-[(5-fluoro-2-oxopyridin-1-yl)methyl]phenyl}methyl)-N-[(3-fluoro-4- methoxypyridin-2-yl)methyl]-3-(methoxymethyl)pyrazole-4-carboxamide::US11180484, Example 30::US11584735, Compound of Formula A	Plasma kallikrein			 6.70							US Patent		10.7270/Q2BG2SXX			US11584735	Crowe, DM; Aret, E; Gandhi, K; Lelieveld, RH; Sharp, EK; Todd, RS	KalVista Pharmaceuticals Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528099	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528099&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301832	463791653							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287338	CN(Cc1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1)c1ccccc1	InChI=1S/C26H24F3N5O/c1-33(21-10-3-2-4-11-21)17-19-8-5-9-20(13-19)31-25(35)23-15-24(26(27,28)29)32-34(23)22-12-6-7-18(14-22)16-30/h2-15H,16-17,30H2,1H3,(H,31,35)	IEARPKHOKPOLCS-UHFFFAOYSA-N	416717	1-(3-(aminomethyl)phenyl)-N-(3-((methyl(phenyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 28f::US10633345, Compound 28f::US10689346, Compound 28f::US11203574, Compound 28f::US11230530, Compound 28f::US11685721, Compound 28f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416717	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416717&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665676	433916631							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287339	CCCN(c1ccccc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C27H25F4N5O/c1-2-13-35(19-8-4-3-5-9-19)20-11-12-22(28)23(15-20)33-26(37)24-16-25(27(29,30)31)34-36(24)21-10-6-7-18(14-21)17-32/h3-12,14-16H,2,13,17,32H2,1H3,(H,33,37)	NZQCKHUBEMVLQD-UHFFFAOYSA-N	416718	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-5-(phenyl(propyl)amino)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 77e::US10633345, Compound 77e::US10689346, Compound 77e::US11203574, Compound 77e::US11230530, Compound 77e::US11685721, Compound 77e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416718	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416718&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665730	433916632							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287340	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1ccc2CNCCc2c1F)C(F)(F)F	InChI=1S/C21H19F4N5O/c22-19-15-6-7-27-11-13(15)4-5-16(19)28-20(31)17-9-18(21(23,24)25)29-30(17)14-3-1-2-12(8-14)10-26/h1-5,8-9,27H,6-7,10-11,26H2,(H,28,31)	RYNJWLCYWDTYKF-UHFFFAOYSA-N	416719	1-(3-(aminomethyl)phenyl)-N-(5-fluoro-1,2,3,4-tetrahydroisoquinolin-6-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 162c::US10633345, Compound 162c::US10689346, Compound 162c::US11203574, Compound 162c::US11230530, Compound 162c::US11685721, Compound 162c	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416719	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416719&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665528	433916633							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287341	CCCN(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1F	InChI=1S/C27H25F4N5O/c1-2-14-35(19-9-4-3-5-10-19)22-13-7-12-21(25(22)28)33-26(37)23-16-24(27(29,30)31)34-36(23)20-11-6-8-18(15-20)17-32/h3-13,15-16H,2,14,17,32H2,1H3,(H,33,37)	SDFZIQBGIDPGAP-UHFFFAOYSA-N	416720	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-3-(phenyl(propyl)amino)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 29e::US10633345, Compound 29e::US10689346, Compound 29e::US11203574, Compound 29e::US11230530, Compound 29e::US11685721, Compound 29e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416720	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416720&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355654	433916634							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51482085	CC(C)(O)CNC[C@@H]1[C@@H]2C[C@@H]2CN1c1ncc(Cn2cc(NC(=O)c3cncc(n3)-c3c(F)c(Cl)ccc3C(F)F)cn2)cn1	InChI=1S/C30H31ClF3N9O2/c1-30(2,45)15-36-11-24-20-5-17(20)13-43(24)29-37-6-16(7-38-29)12-42-14-18(8-39-42)40-28(44)23-10-35-9-22(41-23)25-19(27(33)34)3-4-21(31)26(25)32/h3-4,6-10,14,17,20,24,27,36,45H,5,11-13,15H2,1-2H3,(H,40,44)/t17-,20-,24-/m1/s1	GSZANWHYBACCOM-WSCWJOSJSA-N	50597230	CHEMBL5208510	Plasma kallikrein			 0.300000							ChEMBL		10.7270/Q27085FQ	35707157			Sabnis, RW	Smith, Gambrell & Russell LLP	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50597230	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50597230&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168297908	482608082							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51482086	CN(CC1CCCN1c1ncc(Cn2cc(NC(=O)c3cncc(n3)-c3c(F)c(Cl)ccc3C(F)F)cn2)cn1)CC1(O)CC1	InChI=1S/C30H31ClF3N9O2/c1-41(17-30(45)6-7-30)16-20-3-2-8-43(20)29-36-9-18(10-37-29)14-42-15-19(11-38-42)39-28(44)24-13-35-12-23(40-24)25-21(27(33)34)4-5-22(31)26(25)32/h4-5,9-13,15,20,27,45H,2-3,6-8,14,16-17H2,1H3,(H,39,44)	AKVGTSODHDMSCC-UHFFFAOYSA-N	50597231	CHEMBL5201574	Plasma kallikrein			 0.200000							ChEMBL		10.7270/Q27085FQ	35707157			Sabnis, RW	Smith, Gambrell & Russell LLP	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50597231	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50597231&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168290637	482608083							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51482087	O[C@@H]1CCN(C[C@@H]2CCCN2c2ncc(Cn3cc(NC(=O)c4cncc(n4)-c4c(F)c(Cl)ccc4C(F)F)cn3)cn2)C1	InChI=1S/C29H29ClF3N9O2/c30-22-4-3-21(27(32)33)25(26(22)31)23-11-34-12-24(39-23)28(44)38-18-10-37-41(14-18)13-17-8-35-29(36-9-17)42-6-1-2-19(42)15-40-7-5-20(43)16-40/h3-4,8-12,14,19-20,27,43H,1-2,5-7,13,15-16H2,(H,38,44)/t19-,20+/m0/s1	KZXKBBPFAOQBPA-VQTJNVASSA-N	50597232	CHEMBL5183312	Plasma kallikrein			 0.400000							ChEMBL		10.7270/Q27085FQ	35707157			Sabnis, RW	Smith, Gambrell & Russell LLP	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50597232	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50597232&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168282495	482608084							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51482088	C[C@H](CO)NC[C@@H]1[C@@H]2C[C@@H]2CN1c1ncc(Cn2cc(NC(=O)c3cncc(n3)-c3c(F)c(Cl)ccc3C(F)F)cn2)cn1	InChI=1S/C29H29ClF3N9O2/c1-15(14-43)35-10-24-20-4-17(20)12-42(24)29-36-5-16(6-37-29)11-41-13-18(7-38-41)39-28(44)23-9-34-8-22(40-23)25-19(27(32)33)2-3-21(30)26(25)31/h2-3,5-9,13,15,17,20,24,27,35,43H,4,10-12,14H2,1H3,(H,39,44)/t15-,17-,20-,24-/m1/s1	HRBMPPGWRBAPAC-WIVCMICYSA-N	50597233	CHEMBL5196003	Plasma kallikrein			 0.400000							ChEMBL		10.7270/Q27085FQ	35707157			Sabnis, RW	Smith, Gambrell & Russell LLP	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50597233	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50597233&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168287658	482608085							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51482089	CC1(O)CCN(C[C@@H]2CCCN2c2ncc(Cn3cc(NC(=O)c4cncc(n4)-c4c(F)c(Cl)ccc4C(F)F)cn3)cn2)C1	InChI=1S/C30H31ClF3N9O2/c1-30(45)6-8-41(17-30)16-20-3-2-7-43(20)29-36-9-18(10-37-29)14-42-15-19(11-38-42)39-28(44)24-13-35-12-23(40-24)25-21(27(33)34)4-5-22(31)26(25)32/h4-5,9-13,15,20,27,45H,2-3,6-8,14,16-17H2,1H3,(H,39,44)/t20-,30?/m0/s1	AOTDMCPWTWDFEH-JGZNSJETSA-N	50597234	CHEMBL5200467	Plasma kallikrein			 0.400000							ChEMBL		10.7270/Q27085FQ	35707157			Sabnis, RW	Smith, Gambrell & Russell LLP	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50597234	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50597234&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168291305	482608086							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51482090	CC1(O)CN(C[C@@H]2[C@@H]3C[C@@H]3CN2c2ncc(Cn3cc(NC(=O)c4cncc(n4)-c4c(F)c(Cl)ccc4C(F)F)cn3)cn2)C1	InChI=1S/C30H29ClF3N9O2/c1-30(45)14-41(15-30)13-24-20-4-17(20)11-43(24)29-36-5-16(6-37-29)10-42-12-18(7-38-42)39-28(44)23-9-35-8-22(40-23)25-19(27(33)34)2-3-21(31)26(25)32/h2-3,5-9,12,17,20,24,27,45H,4,10-11,13-15H2,1H3,(H,39,44)/t17-,20-,24-/m1/s1	JUBKBASFVQMBKM-WSCWJOSJSA-N	50597235	CHEMBL5181166	Plasma kallikrein			 0.500000							ChEMBL		10.7270/Q27085FQ	35707157			Sabnis, RW	Smith, Gambrell & Russell LLP	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50597235	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50597235&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168276004	482608087							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287469	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccc(O)cc1)C(F)(F)F	InChI=1S/C29H27F3N4O3/c30-29(31,32)26-15-25(36(35-26)23-6-1-3-19(13-23)16-33)28(38)34-22-5-2-4-21(14-22)27(39-17-18-7-8-18)20-9-11-24(37)12-10-20/h1-6,9-15,18,27,37H,7-8,16-17,33H2,(H,34,38)	WIBHWKLQWUWRRF-UHFFFAOYSA-N	416864	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(4-hydroxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 149b::US10633345, Compound 149b::US10689346, Compound 149b::US11203574, Compound 149b::US11230530, Compound 149b::US11685721, Compound 149b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416864	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416864&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665542	433916777							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287470	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-10-9-20(27(40-16-17-7-8-17)19-4-2-5-21(35)12-19)13-24(23)36-28(39)25-14-26(29(31,32)33)37-38(25)22-6-1-3-18(11-22)15-34/h1-6,9-14,17,27H,7-8,15-16,34-35H2,(H,36,39)	GBDDXSAKQKODCG-UHFFFAOYSA-N	416853	1-(3-(aminomethyl)phenyl)-N-(5-((3-aminophenyl)(cyclopropylmethoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 57e::US10633345, Compound 65b::US10689346, Compound 65b::US11203574, Compound 65a::US11230530, Compound 65b::US11685721, Compound 57e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416853	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416853&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355865	433916766							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287471	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NC1CCCCC1)c1ccccc1)C(F)(F)F	InChI=1S/C31H32F3N5O/c32-31(33,34)28-19-27(39(38-28)26-16-7-9-21(17-26)20-35)30(40)37-25-15-8-12-23(18-25)29(22-10-3-1-4-11-22)36-24-13-5-2-6-14-24/h1,3-4,7-12,15-19,24,29,36H,2,5-6,13-14,20,35H2,(H,37,40)	MXMWHPZXCVOSEY-UHFFFAOYSA-N	416866	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclohexylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 185b::US10633345, Compound 185b::US10689346, Compound 185b::US11203574, Compound 185b::US11230530, Compound 185b::US11685721, Compound 185b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416866	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416866&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356164	433916779							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287472	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-25(37(36-26)24-9-1-4-19(12-24)16-33)28(38)35-23-8-3-6-21(14-23)27(39-17-18-10-11-18)20-5-2-7-22(34)13-20/h1-9,12-15,18,27H,10-11,16-17,33-34H2,(H,35,38)	FPQYUIIRVBKUDH-UHFFFAOYSA-N	416867	1-(3-(aminomethyl)phenyl)-N-(3-((3-aminophenyl)(cyclopropyl-methoxy)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 53f::US10633345, Compound 53f::US10689346, Compound 53f::US11203574, Compound 64b::US11230530, Compound 64b::US11685721, Compound 49j	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416867	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416867&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355845	433916780							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287473	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-10-9-20(27(40-16-17-7-8-17)19-4-2-5-21(35)12-19)13-24(23)36-28(39)25-14-26(29(31,32)33)37-38(25)22-6-1-3-18(11-22)15-34/h1-6,9-14,17,27H,7-8,15-16,34-35H2,(H,36,39)	GBDDXSAKQKODCG-UHFFFAOYSA-N	416853	1-(3-(aminomethyl)phenyl)-N-(5-((3-aminophenyl)(cyclopropylmethoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 57e::US10633345, Compound 65b::US10689346, Compound 65b::US11203574, Compound 65a::US11230530, Compound 65b::US11685721, Compound 57e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416853	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416853&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355865	433916766							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287474	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCc1ccncc1)c1ccccc1)C(F)(F)F	InChI=1S/C31H27F3N6O/c32-31(33,34)28-18-27(40(39-28)26-11-4-6-22(16-26)19-35)30(41)38-25-10-5-9-24(17-25)29(23-7-2-1-3-8-23)37-20-21-12-14-36-15-13-21/h1-18,29,37H,19-20,35H2,(H,38,41)	PXKQYONQBKMAKS-UHFFFAOYSA-N	416869	1-(3-(Aminomethyl)phenyl)-N-(3-(phenyl((pyridin-4-ylmethyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 186b::US10633345, Compound 186b::US10689346, Compound 186b::US11203574, Compound 186b::US11230530, Compound 186b::US11685721, Compound 186b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416869	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416869&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665494	433916782							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287475	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc(O)c1O)C(F)(F)F	InChI=1S/C29H28F3N5O3/c30-29(31,32)25-14-23(37(36-25)21-7-1-4-18(12-21)15-33)28(40)35-20-6-2-5-19(13-20)26(34-16-17-10-11-17)22-8-3-9-24(38)27(22)39/h1-9,12-14,17,26,34,38-39H,10-11,15-16,33H2,(H,35,40)	SWUCJRLZRXYZEJ-UHFFFAOYSA-N	606402	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2,3-dihydroxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US11685721, Compound 150f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=606402	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=606402&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665487	483497837							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287476	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc2OCOc12)C(F)(F)F	InChI=1S/C30H28F3N5O3/c31-30(32,33)26-14-24(38(37-26)22-7-1-4-19(12-22)15-34)29(39)36-21-6-2-5-20(13-21)27(35-16-18-10-11-18)23-8-3-9-25-28(23)41-17-40-25/h1-9,12-14,18,27,35H,10-11,15-17,34H2,(H,36,39)	FVRZDZZJKCSOIR-UHFFFAOYSA-N	416871	1-(3-(aminomethyl)phenyl)-N-(3-(benzo[d][1,3]dioxol-4-yl(cyclopropylmethylamino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 192f::US10633345, Compound 192f::US10689346, Compound 192f::US11203574, Compound 192f::US11230530, Compound 192f::US11685721, Compound 192f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416871	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416871&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665720	433916784							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287477	CC(C)(C)CNC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H32F3N5O/c1-29(2,3)19-35-27(21-10-5-4-6-11-21)22-12-8-13-23(16-22)36-28(39)25-17-26(30(31,32)33)37-38(25)24-14-7-9-20(15-24)18-34/h4-17,27,35H,18-19,34H2,1-3H3,(H,36,39)	NWBNOBGYJRWWRK-UHFFFAOYSA-N	416872	1-(3-(Aminomethyl)phenyl)-N-(3-((neopentylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 187b::US10633345, Compound 187b::US10689346, Compound 187b::US11203574, Compound 187b::US11230530, Compound 187b::US11685721, Compound 187b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416872	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416872&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124028296	433916785							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287478	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccc(cc1)C(N)=O)C(F)(F)F	InChI=1S/C30H28F4N6O2/c31-23-11-10-21(27(37-16-17-4-5-17)19-6-8-20(9-7-19)28(36)41)13-24(23)38-29(42)25-14-26(30(32,33)34)39-40(25)22-3-1-2-18(12-22)15-35/h1-3,6-14,17,27,37H,4-5,15-16,35H2,(H2,36,41)(H,38,42)	AHHWWBRXILLXFU-UHFFFAOYSA-N	416873	1-(3-(aminomethyl)phenyl)-N-(5-((4-carbamoylphenyl)(cyclopropylmethylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 153b::US10633345, Compound 153b::US10689346, Compound 153b::US11203574, Compound 153b::US11230530, Compound 153b::US11685721, Compound 153b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416873	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416873&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355991	433916786							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287479	CCC(CO)NC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C29H30F3N5O2/c1-2-22(18-38)34-27(20-9-4-3-5-10-20)21-11-7-12-23(15-21)35-28(39)25-16-26(29(30,31)32)36-37(25)24-13-6-8-19(14-24)17-33/h3-16,22,27,34,38H,2,17-18,33H2,1H3,(H,35,39)	KIDPOTSBLNZGML-UHFFFAOYSA-N	416874	1-(3-(aminomethyl)phenyl)-N-(3-(((1-hydroxybutan-2-yl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 168b::US10633345, Compound 168b::US10689346, Compound 168b::US11192861, Compound 168b::US11230530, Compound 168b::US11685721, Compound 168b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416874	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416874&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356215	433916787							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287480	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NC1CCC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H28F3N5O/c30-29(31,32)26-17-25(37(36-26)24-14-4-7-19(15-24)18-33)28(38)35-23-13-5-10-21(16-23)27(34-22-11-6-12-22)20-8-2-1-3-9-20/h1-5,7-10,13-17,22,27,34H,6,11-12,18,33H2,(H,35,38)	UCFAODSDUNDTFF-UHFFFAOYSA-N	416875	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclobutylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 188b::US10633345, Compound 188b::US10689346, Compound 188b::US11203574, Compound 188b::US11230530, Compound 188b::US11685721, Compound 188b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416875	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416875&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123435501	433916788							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287481	COc1cccc(C(NCC2CC2)c2cccc(NC(=O)c3cc(nn3-c3cccc(CN)c3)C(F)(F)F)c2)c1O	InChI=1S/C30H30F3N5O3/c1-41-25-10-4-9-23(28(25)39)27(35-17-18-11-12-18)20-6-3-7-21(14-20)36-29(40)24-15-26(30(31,32)33)37-38(24)22-8-2-5-19(13-22)16-34/h2-10,13-15,18,27,35,39H,11-12,16-17,34H2,1H3,(H,36,40)	KCIFFUCEHRXTLF-UHFFFAOYSA-N	416876	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2-hydroxy-3-methoxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 151g::US10633345, Compound 151g::US10689346, Compound 151g::US11203574, Compound 151g::US11230530, Compound 151g::US11685721, Compound 151g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416876	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416876&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356165	433916789							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287482	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(N1CCCC1CO)c1ccccc1)C(F)(F)F	InChI=1S/C30H30F3N5O2/c31-30(32,33)27-17-26(38(36-27)24-12-4-7-20(15-24)18-34)29(40)35-23-11-5-10-22(16-23)28(21-8-2-1-3-9-21)37-14-6-13-25(37)19-39/h1-5,7-12,15-17,25,28,39H,6,13-14,18-19,34H2,(H,35,40)	BNZLGFQHSKUMEG-UHFFFAOYSA-N	416877	1-(3-(aminomethyl)phenyl)-N-(3-((2-(hydroxymethyl)pyrrolidin-1-yl)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 169b::US10633345, Compound 169b::US10689346, Compound 169b::US11203574, Compound 169b::US11230530, Compound 169b::US11685721, Compound 169b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416877	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416877&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356128	433916790							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287483	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCc1ccc(N)cc1)c1ccccc1)C(F)(F)F	InChI=1S/C32H29F3N6O/c33-32(34,35)29-18-28(41(40-29)27-11-4-6-22(16-27)19-36)31(42)39-26-10-5-9-24(17-26)30(23-7-2-1-3-8-23)38-20-21-12-14-25(37)15-13-21/h1-18,30,38H,19-20,36-37H2,(H,39,42)	BKOBJSLLJPHJRR-UHFFFAOYSA-N	416878	N-(3-(((4-Aminobenzyl)amino)(phenyl)methyl)phenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 189b::US10633345, Compound 189b::US10689346, Compound 189b::US11203574, Compound 189b::US11230530, Compound 189b::US11685721, Compound 189b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416878	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416878&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665871	433916791							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287484	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C30H27F3N6O/c31-30(32,33)27-15-26(39(38-27)25-9-2-5-21(13-25)17-35)29(40)37-24-8-3-7-23(14-24)28(36-18-19-10-11-19)22-6-1-4-20(12-22)16-34/h1-9,12-15,19,28,36H,10-11,17-18,35H2,(H,37,40)	VQJJJCIJWBDLSJ-UHFFFAOYSA-N	416879	1-(3-(aminomethyl)phenyl)-N-(3-((3-cyanophenyl)(cyclopropylmethyl amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 152d::US10633345, Compound 152d::US10689346, Compound 152d::US11203574, Compound 152d::US11230530, Compound 152d::US11685721, Compound 152d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416879	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416879&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356166	433916792							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287485	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(N1CCC(O)C1)c1ccccc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-16-25(37(35-26)23-11-4-6-19(14-23)17-33)28(39)34-22-10-5-9-21(15-22)27(20-7-2-1-3-8-20)36-13-12-24(38)18-36/h1-11,14-16,24,27,38H,12-13,17-18,33H2,(H,34,39)	FPAZEZULJGBLCM-UHFFFAOYSA-N	416880	1-(3-(aminomethyl)phenyl)-N-(3-((3-hydroxypyrrolidin-1-yl)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 170b::US10633345, Compound 170b::US10689346, Compound 170b::US11192861, Compound 170b::US11230530, Compound 170b::US11685721, Compound 170b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416880	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416880&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355902	433916793							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287486	CSCCNC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C28H28F3N5OS/c1-38-14-13-33-26(20-8-3-2-4-9-20)21-10-6-11-22(16-21)34-27(37)24-17-25(28(29,30)31)35-36(24)23-12-5-7-19(15-23)18-32/h2-12,15-17,26,33H,13-14,18,32H2,1H3,(H,34,37)	GMRUHWVMBSEBQV-UHFFFAOYSA-N	416881	1-(3-(aminomethyl)phenyl)-N-(3-(((2-(methylthio)ethyl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 190b::US10633345, Compound 190b::US10689346, Compound 190b::US11203574, Compound 190b::US11230530, Compound 190b::US11685721, Compound 190b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416881	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416881&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665913	433916794							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287487	COc1ccc(C(NCC2CC2)c2cccc(NC(=O)c3cc(nn3-c3cccc(CN)c3)C(F)(F)F)c2)c2ccccc12	InChI=1S/C34H32F3N5O2/c1-44-30-15-14-28(26-10-2-3-11-27(26)30)32(39-20-21-12-13-21)23-7-5-8-24(17-23)40-33(43)29-18-31(34(35,36)37)41-42(29)25-9-4-6-22(16-25)19-38/h2-11,14-18,21,32,39H,12-13,19-20,38H2,1H3,(H,40,43)	YOBACLFKAGKOLX-UHFFFAOYSA-N	416882	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(4-methoxynaphthalen-1-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 154e::US10633345, Compound 154e::US10689346, Compound 154e::US11203574, Compound 154e::US11230530, Compound 154e::US11685721, Compound 154e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416882	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416882&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665632	433916795							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287488	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NC1CCCCCC1)c1ccccc1)C(F)(F)F	InChI=1S/C32H34F3N5O/c33-32(34,35)29-20-28(40(39-29)27-17-8-10-22(18-27)21-36)31(41)38-26-16-9-13-24(19-26)30(23-11-4-3-5-12-23)37-25-14-6-1-2-7-15-25/h3-5,8-13,16-20,25,30,37H,1-2,6-7,14-15,21,36H2,(H,38,41)	DQWBWUNYPIEFTF-UHFFFAOYSA-N	416883	1-(3-(aminomethyl)phenyl)-N-(3-((cycloheptylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 171b::US10633345, Compound 171b::US10689346, Compound 171b::US11203574, Compound 171b::US11230530, Compound 171b::US11685721, Compound 171b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416883	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416883&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356134	433916796							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287489	Cc1ccccc1C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O/c1-19-6-2-3-11-25(19)28(35-18-20-12-13-20)22-8-5-9-23(15-22)36-29(39)26-16-27(30(31,32)33)37-38(26)24-10-4-7-21(14-24)17-34/h2-11,14-16,20,28,35H,12-13,17-18,34H2,1H3,(H,36,39)	NQOSRSVLDYDVDI-UHFFFAOYSA-N	416884	1-(3-(Aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(o-tolyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 193f::US10633345, Compound 193f::US10689346, Compound 193f::US11203574, Compound 193f::US11230530, Compound 193f::US11685721, Compound 193f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416884	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416884&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355753	433916797							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287490	NCc1cccc(c1)C(NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F4N6O/c31-24-10-9-22(28(37-17-18-7-8-18)21-5-1-3-19(11-21)15-35)13-25(24)38-29(41)26-14-27(30(32,33)34)39-40(26)23-6-2-4-20(12-23)16-36/h1-6,9-14,18,28,37H,7-8,15-17,35-36H2,(H,38,41)	PIDHZVXEDSCGNA-UHFFFAOYSA-N	416885	1-(3-(aminomethyl)phenyl)-N-(5-((3-(aminomethyl)phenyl)(cyclopropylmethylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 155c::US10633345, Compound 155c::US10689346, Compound 155c::US11203574, Compound 155c::US11230530, Compound 155c::US11685721, Compound 155c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416885	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416885&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355611	433916798							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287491	CCCCCNC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H32F3N5O/c1-2-3-7-16-35-28(22-11-5-4-6-12-22)23-13-9-14-24(18-23)36-29(39)26-19-27(30(31,32)33)37-38(26)25-15-8-10-21(17-25)20-34/h4-6,8-15,17-19,28,35H,2-3,7,16,20,34H2,1H3,(H,36,39)	LIINXFZWPJSNHF-UHFFFAOYSA-N	416886	1-(3-(Aminomethyl)phenyl)-N-(3-((pentylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 172b::US10633345, Compound 172b::US10689346, Compound 172b::US11203574, Compound 172b::US11230530, Compound 172b::US11685721, Compound 172b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416886	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416886&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355915	433916799							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287492	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCCCO)c1ccccc1)C(F)(F)F	InChI=1S/C28H28F3N5O2/c29-28(30,31)25-17-24(36(35-25)23-12-4-7-19(15-23)18-32)27(38)34-22-11-5-10-21(16-22)26(33-13-6-14-37)20-8-2-1-3-9-20/h1-5,7-12,15-17,26,33,37H,6,13-14,18,32H2,(H,34,38)	YSEURYDLGGVADI-UHFFFAOYSA-N	416887	1-(3-(Aminomethyl)phenyl)-N-(3-(((3-hydroxypropyl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 191b::US10633345, Compound 191b::US10689346, Compound 191b::US11203574, Compound 191b::US11230530, Compound 191b::US11685721, Compound 191b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416887	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416887&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665847	433916800							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287493	COC(CCC1CC1)(c1cccnc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O2/c1-40-29(13-12-20-10-11-20,23-7-4-14-35-19-23)22-6-3-8-24(16-22)36-28(39)26-17-27(30(31,32)33)37-38(26)25-9-2-5-21(15-25)18-34/h2-9,14-17,19-20H,10-13,18,34H2,1H3,(H,36,39)	HEQLXMARFGMGBQ-UHFFFAOYSA-N	416888	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-methoxy-1-(pyridin-3-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 156c::US10633345, Compound 156c::US10689346, Compound 156c::US11203574, Compound 156c::US11230530, Compound 156c::US11685721, Compound 156c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416888	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416888&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355759	433916801							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287494	CC(CO)NC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C28H28F3N5O2/c1-18(17-37)33-26(20-8-3-2-4-9-20)21-10-6-11-22(14-21)34-27(38)24-15-25(28(29,30)31)35-36(24)23-12-5-7-19(13-23)16-32/h2-15,18,26,33,37H,16-17,32H2,1H3,(H,34,38)	HGDYIKLNDBPRGN-UHFFFAOYSA-N	416889	1-(3-(aminomethyl)phenyl)-N-(3-(((1-hydroxypropan-2-yl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 173b::US10633345, Compound 173b::US10689346, Compound 173b::US11203574, Compound 173b::US11230530, Compound 173b::US11685721, Compound 173b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416889	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416889&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355997	433916802							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287495	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc(F)c1)C(F)(F)F	InChI=1S/C29H27F4N5O/c30-22-7-2-5-20(13-22)27(35-17-18-10-11-18)21-6-3-8-23(14-21)36-28(39)25-15-26(29(31,32)33)37-38(25)24-9-1-4-19(12-24)16-34/h1-9,12-15,18,27,35H,10-11,16-17,34H2,(H,36,39)	FVMNYLZQOFMPFE-UHFFFAOYSA-N	416890	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(3-fluorophenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 195f::US10633345, Compound 195f::US10689346, Compound 195f::US11203574, Compound 195f::US11230530, Compound 195f::US11685721, Compound 195f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416890	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416890&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665561	433916803							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287496	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C30H26F4N6O/c31-24-10-9-22(28(37-17-18-7-8-18)21-5-1-3-19(11-21)15-35)13-25(24)38-29(41)26-14-27(30(32,33)34)39-40(26)23-6-2-4-20(12-23)16-36/h1-6,9-14,18,28,37H,7-8,16-17,36H2,(H,38,41)	UXNXMBYCBRBRFD-UHFFFAOYSA-N	416891	1-(3-(aminomethyl)phenyl)-N-(5-((3-cyanophenyl)(cyclopropyl-methylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 54e::US11685721, Compound 70b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416891	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416891&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	0RI	7N7X	118355809	433916804							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287497	CC(C)(CO)NC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C29H30F3N5O2/c1-28(2,18-38)35-26(20-9-4-3-5-10-20)21-11-7-12-22(15-21)34-27(39)24-16-25(29(30,31)32)36-37(24)23-13-6-8-19(14-23)17-33/h3-16,26,35,38H,17-18,33H2,1-2H3,(H,34,39)	JPSBLISQAZCRFK-UHFFFAOYSA-N	416892	1-(3-(aminomethyl)phenyl)-N-(3-(((1-hydroxy-2-methylpropan-2-yl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 174b::US10633345, Compound 174b::US10689346, Compound 174b::US11203574, Compound 174b::US11230530, Compound 174b::US11685721, Compound 174b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416892	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416892&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665949	433916805							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287498	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(F)cc1F)C(F)(F)F	InChI=1S/C29H26F5N5O/c30-20-9-10-23(24(31)13-20)27(36-16-17-7-8-17)19-4-2-5-21(12-19)37-28(40)25-14-26(29(32,33)34)38-39(25)22-6-1-3-18(11-22)15-35/h1-6,9-14,17,27,36H,7-8,15-16,35H2,(H,37,40)	QIBXOBBXVAEMNW-UHFFFAOYSA-N	416893	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2,4-difluorophenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 196f::US10633345, Compound 196f::US10689346, Compound 196f::US11203574, Compound 196f::US11230530, Compound 196f::US11685721, Compound 196f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416893	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416893&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665453	433916806							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287499	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C30H25F4N5O2/c31-24-11-10-22(28(41-17-19-4-5-19)21-8-6-18(15-35)7-9-21)13-25(24)37-29(40)26-14-27(30(32,33)34)38-39(26)23-3-1-2-20(12-23)16-36/h1-3,6-14,19,28H,4-5,16-17,36H2,(H,37,40)	WXFHQCUXOOXGLO-UHFFFAOYSA-N	416894	1-(3-(aminomethyl)phenyl)-N-(5-((4-cyanophenyl)(cyclopropylmethoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 55b::US10633345, Compound 73b::US10689346, Compound 55b::US11203574, Compound 73b::US11230530, Compound 73b::US11685721, Compound 73b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416894	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416894&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665569	433916807							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287500	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CCCO1)c1ccccc1)C(F)(F)F	InChI=1S/C30H30F3N5O2/c31-30(32,33)27-17-26(38(37-27)24-12-4-7-20(15-24)18-34)29(39)36-23-11-5-10-22(16-23)28(21-8-2-1-3-9-21)35-19-25-13-6-14-40-25/h1-5,7-12,15-17,25,28,35H,6,13-14,18-19,34H2,(H,36,39)	SIOCTSAXUSNOCO-UHFFFAOYSA-N	416895	1-(3-(aminomethyl)phenyl)-N-(3-(phenyl(((tetrahydrofuran-2-yl)methyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 175b::US10633345, Compound 175b::US10689346, Compound 175b::US11203574, Compound 175b::US11230530, Compound 175b::US11685721, Compound 175b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416895	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416895&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355976	433916808							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287501	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cc(F)ccc1F)C(F)(F)F	InChI=1S/C29H26F5N5O/c30-20-9-10-24(31)23(13-20)27(36-16-17-7-8-17)19-4-2-5-21(12-19)37-28(40)25-14-26(29(32,33)34)38-39(25)22-6-1-3-18(11-22)15-35/h1-6,9-14,17,27,36H,7-8,15-16,35H2,(H,37,40)	DGRITJGAWATINU-UHFFFAOYSA-N	416896	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2,5-difluorophenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 197f::US10633345, Compound 197f::US10689346, Compound 197f::US11203574, Compound 197f::US11230530, Compound 197f::US11685721, Compound 197f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416896	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416896&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665599	433916809							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287502	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-9-8-20(28(40,11-10-18-6-7-18)21-4-2-12-35-17-21)14-24(23)36-27(39)25-15-26(29(31,32)33)37-38(25)22-5-1-3-19(13-22)16-34/h1-5,8-9,12-15,17-18,40H,6-7,10-11,16,34H2,(H,36,39)	VCHFZCHUEHQXSZ-UHFFFAOYSA-N	416897	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 58c::US10633345, Compound 67b::US10689346, Compound 67b::US11203574, Compound 67b::US11230530, Compound 67b::US11685721, Compound 67b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416897	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416897&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355889	433916810							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287503	CC(C)CCNC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H32F3N5O/c1-20(2)14-15-35-28(22-9-4-3-5-10-22)23-11-7-12-24(17-23)36-29(39)26-18-27(30(31,32)33)37-38(26)25-13-6-8-21(16-25)19-34/h3-13,16-18,20,28,35H,14-15,19,34H2,1-2H3,(H,36,39)	WPCVSFNABLNPTN-UHFFFAOYSA-N	416898	1-(3-(aminomethyl)phenyl)-N-(3-((isopentylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 176b::US10633345, Compound 176b::US10689346, Compound 176b::US11203574, Compound 176b::US11230530, Compound 176b::US11685721, Compound 176b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416898	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416898&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665776	433916811							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287504	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1c(F)cccc1F)C(F)(F)F	InChI=1S/C29H26F5N5O/c30-22-8-3-9-23(31)26(22)27(36-16-17-10-11-17)19-5-2-6-20(13-19)37-28(40)24-14-25(29(32,33)34)38-39(24)21-7-1-4-18(12-21)15-35/h1-9,12-14,17,27,36H,10-11,15-16,35H2,(H,37,40)	OHXCNQRJQHLAER-UHFFFAOYSA-N	416899	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2,6-difluorophenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 198f::US10633345, Compound 198f::US10689346, Compound 198f::US11203574, Compound 198f::US11230530, Compound 198f::US11685721, Compound 198f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416899	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416899&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665643	433916812							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287505	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C30H25F4N5O2/c31-24-10-9-22(28(41-17-18-7-8-18)21-5-1-3-19(11-21)15-35)13-25(24)37-29(40)26-14-27(30(32,33)34)38-39(26)23-6-2-4-20(12-23)16-36/h1-6,9-14,18,28H,7-8,16-17,36H2,(H,37,40)	LSXFYXGKZDVRTL-UHFFFAOYSA-N	416900	1-(3-(aminomethyl)phenyl)-N-(5-((3-cyanophenyl)(cyclopropyl-methoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 56c::US10633345, Compound 72d::US10689346, Compound 56c::US11203574, Compound 72d::US11230530, Compound 72d::US11685721, Compound 72d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416900	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416900&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356211	433916813							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287506	CCC(C)CNC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H32F3N5O/c1-3-20(2)19-35-28(22-10-5-4-6-11-22)23-12-8-13-24(16-23)36-29(39)26-17-27(30(31,32)33)37-38(26)25-14-7-9-21(15-25)18-34/h4-17,20,28,35H,3,18-19,34H2,1-2H3,(H,36,39)	ZCSNRDNUIRVYLS-UHFFFAOYSA-N	416901	1-(3-(Aminomethyl)phenyl)-N-(3-(((2-methylbutyl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 177b::US10633345, Compound 177b::US10689346, Compound 177b::US11203574, Compound 177b::US11230530, Compound 177b::US11685721, Compound 177b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416901	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416901&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665478	433916814							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287507	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1Cl)C(F)(F)F	InChI=1S/C29H27ClF3N5O/c30-24-10-2-1-9-23(24)27(35-17-18-11-12-18)20-6-4-7-21(14-20)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-3-5-19(13-22)16-34/h1-10,13-15,18,27,35H,11-12,16-17,34H2,(H,36,39)	UQMCUIGBQDUSLW-UHFFFAOYSA-N	416902	1-(3-(aminomethyl)phenyl)-N-(3-((2-chlorophenyl)((cyclopropylmethyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 194f::US10329260, Compound 199f::US10633345, Compound 199f::US10689346, Compound 199f::US11203574, Compound 199f::US11230530, Compound 199f::US11685721, Compound 199f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416902	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416902&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356220	433916815							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287508	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H28F4N4O2/c31-24-12-11-22(29(40,14-13-19-9-10-19)21-6-2-1-3-7-21)16-25(24)36-28(39)26-17-27(30(32,33)34)37-38(26)23-8-4-5-20(15-23)18-35/h1-8,11-12,15-17,19,40H,9-10,13-14,18,35H2,(H,36,39)	NIWMWYNGSALJGG-UHFFFAOYSA-N	416903	Racemic 1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 68c::US10633345, Compound 68e::US10689346, Compound 68c::US11203574, Compound 68e::US11230530, Compound 68e::US11685721, Compound 68e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416903	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416903&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355758	433916816							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287509	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(N(CCO)CCO)c1ccccc1)C(F)(F)F	InChI=1S/C29H30F3N5O3/c30-29(31,32)26-18-25(37(35-26)24-11-4-6-20(16-24)19-33)28(40)34-23-10-5-9-22(17-23)27(21-7-2-1-3-8-21)36(12-14-38)13-15-39/h1-11,16-18,27,38-39H,12-15,19,33H2,(H,34,40)	HFRFNKSEVVNXFK-UHFFFAOYSA-N	416904	1-(3-(aminomethyl)phenyl)-N-(3-((bis(2-hydroxyethyl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 178b::US10633345, Compound 178b::US10689346, Compound 178b::US11203574, Compound 178b::US11230530, Compound 178b::US11685721, Compound 178b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416904	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416904&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355913	433916817							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287510	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1Cl)C(F)(F)F	InChI=1S/C29H27ClF3N5O/c30-24-10-2-1-9-23(24)27(35-17-18-11-12-18)20-6-4-7-21(14-20)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-3-5-19(13-22)16-34/h1-10,13-15,18,27,35H,11-12,16-17,34H2,(H,36,39)	UQMCUIGBQDUSLW-UHFFFAOYSA-N	416902	1-(3-(aminomethyl)phenyl)-N-(3-((2-chlorophenyl)((cyclopropylmethyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 194f::US10329260, Compound 199f::US10633345, Compound 199f::US10689346, Compound 199f::US11203574, Compound 199f::US11230530, Compound 199f::US11685721, Compound 199f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416902	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416902&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356220	433916815							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287511	COc1ccc2ccccc2c1C(NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H31F4N5O2/c1-45-29-14-12-22-6-2-3-8-25(22)31(29)32(40-19-20-9-10-20)23-11-13-26(35)27(16-23)41-33(44)28-17-30(34(36,37)38)42-43(28)24-7-4-5-21(15-24)18-39/h2-8,11-17,20,32,40H,9-10,18-19,39H2,1H3,(H,41,44)	AYMFYNZEWAELBE-UHFFFAOYSA-N	416906	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(2-methoxynaphthalen-1-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide dihydrochloride::US10329260, Compound 61e::US10633345, Compound 63b::US10689346, Compound 61e::US11203574, Compound 63b::US11230530, Compound 63b::US11685721, Compound 63b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416906	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416906&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355591	433916818							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287512	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCc1cccnc1)c1ccccc1)C(F)(F)F	InChI=1S/C31H27F3N6O/c32-31(33,34)28-17-27(40(39-28)26-13-4-7-21(15-26)18-35)30(41)38-25-12-5-11-24(16-25)29(23-9-2-1-3-10-23)37-20-22-8-6-14-36-19-22/h1-17,19,29,37H,18,20,35H2,(H,38,41)	HIJVXEVWORHKBX-UHFFFAOYSA-N	416907	1-(3-(Aminomethyl)phenyl)-N-(3-(phenyl((pyridin-3-ylmethyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 179b::US10633345, Compound 179b::US10689346, Compound 179b::US11203574, Compound 179b::US11230530, Compound 179b::US11685721, Compound 179b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416907	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416907&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665526	433916819							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287513	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(Cl)cc1Cl)C(F)(F)F	InChI=1S/C29H26Cl2F3N5O/c30-20-9-10-23(24(31)13-20)27(36-16-17-7-8-17)19-4-2-5-21(12-19)37-28(40)25-14-26(29(32,33)34)38-39(25)22-6-1-3-18(11-22)15-35/h1-6,9-14,17,27,36H,7-8,15-16,35H2,(H,37,40)	CXLXHJIZVQBZJV-UHFFFAOYSA-N	416908	1-(3-(aminomethyl)phenyl)-N-(3-((2,4-dichlorophenyl)((cyclopropylmethyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 200f::US10633345, Compound 200f::US10689346, Compound 200f::US11203574, Compound 200f::US11230530, Compound 200f::US11685721, Compound 200f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416908	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416908&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126688969	433916820							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287514	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-10-9-20(28(40,12-11-18-7-8-18)25-6-1-2-13-35-25)15-23(22)36-27(39)24-16-26(29(31,32)33)37-38(24)21-5-3-4-19(14-21)17-34/h1-6,9-10,13-16,18,40H,7-8,11-12,17,34H2,(H,36,39)	XXMBQXWQIGCREG-UHFFFAOYSA-N	416909	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 59c::US10633345, Compound 69b::US10689346, Compound 59c::US11203574, Compound 69b::US11230530, Compound 69b::US11685721, Compound 69b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416909	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416909&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356067	433916821							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287515	CCCCNC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C29H30F3N5O/c1-2-3-15-34-27(21-10-5-4-6-11-21)22-12-8-13-23(17-22)35-28(38)25-18-26(29(30,31)32)36-37(25)24-14-7-9-20(16-24)19-33/h4-14,16-18,27,34H,2-3,15,19,33H2,1H3,(H,35,38)	IJFOMNKWJBCMSK-UHFFFAOYSA-N	416910	1-(3-(Aminomethyl)phenyl)-N-(3-((butylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 180b::US10633345, Compound 180b::US10689346, Compound 180b::US11203574, Compound 180b::US11230530, Compound 180b::US11685721, Compound 180b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416910	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416910&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665986	433916822							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287516	Cc1ccc(C(NCC2CC2)c2cccc(NC(=O)c3cc(nn3-c3cccc(CN)c3)C(F)(F)F)c2)c(C)c1	InChI=1S/C31H32F3N5O/c1-19-9-12-26(20(2)13-19)29(36-18-21-10-11-21)23-6-4-7-24(15-23)37-30(40)27-16-28(31(32,33)34)38-39(27)25-8-3-5-22(14-25)17-35/h3-9,12-16,21,29,36H,10-11,17-18,35H2,1-2H3,(H,37,40)	PPHLPILJSQAZAY-UHFFFAOYSA-N	416911	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2,4-dimethylphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 201f::US10689346, Compound 201f::US11192861, Compound 201f::US11230530, Compound 201f::US11685721, Compound 201f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416911	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416911&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665576	433916823							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287517	Cc1ccc(C)c(c1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C31H32F3N5O/c1-19-9-10-20(2)26(13-19)29(36-18-21-11-12-21)23-6-4-7-24(15-23)37-30(40)27-16-28(31(32,33)34)38-39(27)25-8-3-5-22(14-25)17-35/h3-10,13-16,21,29,36H,11-12,17-18,35H2,1-2H3,(H,37,40)	NFGQIHGOUUFZHN-UHFFFAOYSA-N	416912	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2,5-dimethylphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 202f::US10633345, Compound 202f::US10689346, Compound 202f::US11203574, Compound 202f::US11230530, Compound 202f::US11685721, Compound 202f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416912	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416912&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665510	433916824							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287518	FC(F)(F)c1cc(C(=O)Nc2cccc(c2)C(OCC2CC2)c2ccccc2)n(n1)-c1cccc(c1)C#N	InChI=1S/C29H23F3N4O2/c30-29(31,32)26-16-25(36(35-26)24-11-4-6-20(14-24)17-33)28(37)34-23-10-5-9-22(15-23)27(38-18-19-12-13-19)21-7-2-1-3-8-21/h1-11,14-16,19,27H,12-13,18H2,(H,34,37)	SPWAYDXCKKPOML-UHFFFAOYSA-N	606445	(+)-1-(3-cyanophenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US11685721, Compound 166e::US11708332, Compound 166e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=606445	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=606445&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355663	483497879							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287519	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F4N5O/c30-23-12-11-21(27(35-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27,35H,9-10,16-17,34H2,(H,36,39)	MCLZOCFEIKBMBA-UHFFFAOYSA-N	416773	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 38d::US10633345, Compound 38d::US10689346, Compound 42a::US11203574, Compound 42a::US11230530, Compound 42a::US11685721, Compound 38d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416773	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416773&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356124	433916687							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287520	CC(C)(C)c1ccc(cc1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C33H36F3N5O/c1-32(2,3)25-14-12-23(13-15-25)30(38-20-21-10-11-21)24-7-5-8-26(17-24)39-31(42)28-18-29(33(34,35)36)40-41(28)27-9-4-6-22(16-27)19-37/h4-9,12-18,21,30,38H,10-11,19-20,37H2,1-3H3,(H,39,42)	OVDVNIYCGDTOJR-UHFFFAOYSA-N	416915	1-(3-(aminomethyl)phenyl)-N-(3-((4-(tert-butyl)phenyl)((cyclopropylmethyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 203f::US10633345, Compound 203f::US10689346, Compound 203f::US11203574, Compound 203f::US11230530, Compound 203f::US11685721, Compound 203f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416915	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416915&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665458	433916827							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287521	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F3N4O2/c30-29(31,32)26-16-25(36(35-26)24-11-4-6-20(14-24)17-33)28(37)34-23-10-5-9-22(15-23)27(38-18-19-12-13-19)21-7-2-1-3-8-21/h1-11,14-16,19,27H,12-13,17-18,33H2,(H,34,37)	PEZVPVUPSJXZCH-UHFFFAOYSA-N	416775	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18k::US10633345, Compound 74a::US10689346, Compound 165e::US11203574, Compound 165e::US11230530, Compound 165e::US11685721, Compound 18k	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416775	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416775&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			91884591	433916689							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287522	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F4N5O/c30-23-12-11-21(27(35-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27,35H,9-10,16-17,34H2,(H,36,39)	MCLZOCFEIKBMBA-UHFFFAOYSA-N	416773	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 38d::US10633345, Compound 38d::US10689346, Compound 42a::US11203574, Compound 42a::US11230530, Compound 42a::US11685721, Compound 38d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416773	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416773&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356124	433916687							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287523	OC(CCC1CC1)(c1ccc(F)c(NC(=O)c2cc(nn2-c2ccc(Cl)cc2)C(F)(F)F)c1)c1ccccn1	InChI=1S/C28H23ClF4N4O2/c29-19-7-9-20(10-8-19)37-23(16-25(36-37)28(31,32)33)26(38)35-22-15-18(6-11-21(22)30)27(39,13-12-17-4-5-17)24-3-1-2-14-34-24/h1-3,6-11,14-17,39H,4-5,12-13H2,(H,35,38)	QWPFRWIQIFPXCC-UHFFFAOYSA-N	416918	1-(4-chlorophenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 157a::US10633345, Compound 157a::US10689346, Compound 157a::US11203574, Compound 157a::US11230530, Compound 157a::US11685721, Compound 157a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416918	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416918&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665679	433916830							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287524	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(N)cc1)C(F)(F)F	InChI=1S/C29H29F3N6O/c30-29(31,32)26-15-25(38(37-26)24-6-1-3-19(13-24)16-33)28(39)36-23-5-2-4-21(14-23)27(35-17-18-7-8-18)20-9-11-22(34)12-10-20/h1-6,9-15,18,27,35H,7-8,16-17,33-34H2,(H,36,39)	XDCYYWMSVYTRMZ-UHFFFAOYSA-N	416843	1-(3-(aminomethyl)phenyl)-N-(3-((4-aminophenyl)(cyclopropylmethyl-amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 50f::US10633345, Compound 50f::US10689346, Compound 50h::US11203574, Compound 50h::US11230530, Compound 50h::US11685721, Compound 50f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416843	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416843&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355587	433916756							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287525	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-9-8-20(28(40,11-10-18-6-7-18)21-4-2-12-35-17-21)14-24(23)36-27(39)25-15-26(29(31,32)33)37-38(25)22-5-1-3-19(13-22)16-34/h1-5,8-9,12-15,17-18,40H,6-7,10-11,16,34H2,(H,36,39)	VCHFZCHUEHQXSZ-UHFFFAOYSA-N	416897	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 58c::US10633345, Compound 67b::US10689346, Compound 67b::US11203574, Compound 67b::US11230530, Compound 67b::US11685721, Compound 67b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416897	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416897&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355889	433916810							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287526	OC(CCC1CC1)(c1ccc(F)c(NC(=O)c2cc(nn2-c2ccc3cc(Cl)ccc3c2)C(F)(F)F)c1)c1ccccn1	InChI=1S/C32H25ClF4N4O2/c33-23-9-6-21-16-24(10-7-20(21)15-23)41-27(18-29(40-41)32(35,36)37)30(42)39-26-17-22(8-11-25(26)34)31(43,13-12-19-4-5-19)28-3-1-2-14-38-28/h1-3,6-11,14-19,43H,4-5,12-13H2,(H,39,42)	XTIXOVGIMHWYOB-UHFFFAOYSA-N	416921	1-(6-chloronaphthalen-2-yl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 158a::US10633345, Compound 158a::US10689346, Compound 158a::US11203574, Compound 158a::US11230530, Compound 158a::US11685721, Compound 158a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416921	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416921&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355937	433916833							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287527	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(N)cc1)C(F)(F)F	InChI=1S/C29H29F3N6O/c30-29(31,32)26-15-25(38(37-26)24-6-1-3-19(13-24)16-33)28(39)36-23-5-2-4-21(14-23)27(35-17-18-7-8-18)20-9-11-22(34)12-10-20/h1-6,9-15,18,27,35H,7-8,16-17,33-34H2,(H,36,39)	XDCYYWMSVYTRMZ-UHFFFAOYSA-N	416843	1-(3-(aminomethyl)phenyl)-N-(3-((4-aminophenyl)(cyclopropylmethyl-amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 50f::US10633345, Compound 50f::US10689346, Compound 50h::US11203574, Compound 50h::US11230530, Compound 50h::US11685721, Compound 50f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416843	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416843&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355587	433916756							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287528	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-9-8-20(28(40,11-10-18-6-7-18)21-4-2-12-35-17-21)14-24(23)36-27(39)25-15-26(29(31,32)33)37-38(25)22-5-1-3-19(13-22)16-34/h1-5,8-9,12-15,17-18,40H,6-7,10-11,16,34H2,(H,36,39)	VCHFZCHUEHQXSZ-UHFFFAOYSA-N	416897	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 58c::US10633345, Compound 67b::US10689346, Compound 67b::US11203574, Compound 67b::US11230530, Compound 67b::US11685721, Compound 67b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416897	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416897&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355889	433916810							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287529	OC(CCC1CC1)(c1ccc(F)c(NC(=O)c2cc(nn2-c2ccc(Cl)cn2)C(F)(F)F)c1)c1ccccn1	InChI=1S/C27H22ClF4N5O2/c28-18-7-9-24(34-15-18)37-21(14-23(36-37)27(30,31)32)25(38)35-20-13-17(6-8-19(20)29)26(39,11-10-16-4-5-16)22-3-1-2-12-33-22/h1-3,6-9,12-16,39H,4-5,10-11H2,(H,35,38)	HMQODPUNPWDVSN-UHFFFAOYSA-N	416924	1-(5-chloropyridin-2-yl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 159a::US10633345, Compound 159a::US10689346, Compound 159a::US11203574, Compound 159a::US11230530, Compound 159a::US11685721, Compound 159a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416924	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416924&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355989	433916836							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287530	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C28H26F3N5O2/c29-28(30,31)25-15-24(36(35-25)22-8-3-5-19(13-22)16-32)27(37)34-21-7-4-6-20(14-21)26(38-17-18-10-11-18)23-9-1-2-12-33-23/h1-9,12-15,18,26H,10-11,16-17,32H2,(H,34,37)	UBQUVYTUKOFUOF-UHFFFAOYSA-N	416721	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(pyridin-2-yl)methyl)-phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 43f::US10633345, Compound 43f::US10689346, Compound 43g::US11203574, Compound 43h::US11230530, Compound 43h::US11685721, Compound 43f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416721	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416721&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355947	433916635							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287531	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C30H26F4N6O/c31-24-10-9-22(28(37-17-18-7-8-18)21-5-1-3-19(11-21)15-35)13-25(24)38-29(41)26-14-27(30(32,33)34)39-40(26)23-6-2-4-20(12-23)16-36/h1-6,9-14,18,28,37H,7-8,16-17,36H2,(H,38,41)	UXNXMBYCBRBRFD-UHFFFAOYSA-N	416891	1-(3-(aminomethyl)phenyl)-N-(5-((3-cyanophenyl)(cyclopropyl-methylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 54e::US11685721, Compound 70b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416891	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416891&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	0RI	7N7X	118355809	433916804							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287532	COc1ccc(cc1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H26F4N4O3/c1-40-21-10-8-20(9-11-21)37-24(17-26(36-37)29(31,32)33)27(38)35-23-16-19(7-12-22(23)30)28(39,14-13-18-5-6-18)25-4-2-3-15-34-25/h2-4,7-12,15-18,39H,5-6,13-14H2,1H3,(H,35,38)	YTPYYUUEYRYYOR-UHFFFAOYSA-N	416927	N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-1-(4-methoxyphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 160a::US10633345, Compound 160a::US10689346, Compound 160a::US11203574, Compound 160a::US11230530, Compound 160a::US11685721, Compound 160a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416927	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416927&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665840	433916839							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287533	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C28H26F3N5O2/c29-28(30,31)25-15-24(36(35-25)22-8-3-5-19(13-22)16-32)27(37)34-21-7-4-6-20(14-21)26(38-17-18-10-11-18)23-9-1-2-12-33-23/h1-9,12-15,18,26H,10-11,16-17,32H2,(H,34,37)	UBQUVYTUKOFUOF-UHFFFAOYSA-N	416721	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(pyridin-2-yl)methyl)-phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 43f::US10633345, Compound 43f::US10689346, Compound 43g::US11203574, Compound 43h::US11230530, Compound 43h::US11685721, Compound 43f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416721	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416721&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355947	433916635							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287534	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C30H26F4N6O/c31-24-10-9-22(28(37-17-18-7-8-18)21-5-1-3-19(11-21)15-35)13-25(24)38-29(41)26-14-27(30(32,33)34)39-40(26)23-6-2-4-20(12-23)16-36/h1-6,9-14,18,28,37H,7-8,16-17,36H2,(H,38,41)	UXNXMBYCBRBRFD-UHFFFAOYSA-N	416891	1-(3-(aminomethyl)phenyl)-N-(5-((3-cyanophenyl)(cyclopropyl-methylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 54e::US11685721, Compound 70b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416891	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416891&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	0RI	7N7X	118355809	433916804							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287535	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(O)c(Br)c1)C(F)(F)F	InChI=1S/C29H27BrF3N5O2/c30-23-13-20(9-10-25(23)39)27(35-16-17-7-8-17)19-4-2-5-21(12-19)36-28(40)24-14-26(29(31,32)33)37-38(24)22-6-1-3-18(11-22)15-34/h1-6,9-14,17,27,35,39H,7-8,15-16,34H2,(H,36,40)	VZKYGMDBRSVHHT-UHFFFAOYSA-N	416930	1-(3-(Aminomethyl)phenyl)-N-(3-((3-bromo-4-hydroxyphenyl)(cyclopropylmethylamino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 207j::US10633345, Compound 207j::US10689346, Compound 207j::US11203574, Compound 207j::US11230530, Compound 207j::US11685721, Compound 207j	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416930	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416930&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665574	433916842							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287536	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H26F3N5O2/c29-28(30,31)25-14-24(36(35-25)23-8-1-4-19(12-23)15-32)27(37)34-22-7-2-5-20(13-22)26(38-17-18-9-10-18)21-6-3-11-33-16-21/h1-8,11-14,16,18,26H,9-10,15,17,32H2,(H,34,37)	SHFRWTHPPCXLER-UHFFFAOYSA-N	416725	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(pyridin-3-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 44c::US10633345, Compound 44c::US10689346, Compound 44c::US11203574, Compound 44d::US11230530, Compound 44e::US11685721, Compound 44c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416725	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416725&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355578	433916639							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287537	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-10-9-20(28(40,12-11-18-7-8-18)25-6-1-2-13-35-25)15-23(22)36-27(39)24-16-26(29(31,32)33)37-38(24)21-5-3-4-19(14-21)17-34/h1-6,9-10,13-16,18,40H,7-8,11-12,17,34H2,(H,36,39)	XXMBQXWQIGCREG-UHFFFAOYSA-N	416909	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 59c::US10633345, Compound 69b::US10689346, Compound 59c::US11203574, Compound 69b::US11230530, Compound 69b::US11685721, Compound 69b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416909	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416909&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356067	433916821							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287538	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CCC1CC1)n1ccccc1=O)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-17-25(37(35-26)23-8-3-5-20(15-23)18-33)28(39)34-22-7-4-6-21(16-22)24(13-12-19-10-11-19)36-14-2-1-9-27(36)38/h1-9,14-17,19,24H,10-13,18,33H2,(H,34,39)	OGNFHFCMBSJJNJ-UHFFFAOYSA-N	416933	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-(2-oxopyridin-1(2H)-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 247c::US10633345, Compound 247c::US10689346, Compound 247c::US11203574, Compound 247c::US11230530, Compound 247c::US11685721, Compound 247c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416933	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416933&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356133	433916845							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287539	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H26F3N5O2/c29-28(30,31)25-14-24(36(35-25)23-8-1-4-19(12-23)15-32)27(37)34-22-7-2-5-20(13-22)26(38-17-18-9-10-18)21-6-3-11-33-16-21/h1-8,11-14,16,18,26H,9-10,15,17,32H2,(H,34,37)	SHFRWTHPPCXLER-UHFFFAOYSA-N	416725	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(pyridin-3-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 44c::US10633345, Compound 44c::US10689346, Compound 44c::US11203574, Compound 44d::US11230530, Compound 44e::US11685721, Compound 44c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416725	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416725&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355578	433916639							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287540	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-10-9-20(28(40,12-11-18-7-8-18)25-6-1-2-13-35-25)15-23(22)36-27(39)24-16-26(29(31,32)33)37-38(24)21-5-3-4-19(14-21)17-34/h1-6,9-10,13-16,18,40H,7-8,11-12,17,34H2,(H,36,39)	XXMBQXWQIGCREG-UHFFFAOYSA-N	416909	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 59c::US10633345, Compound 69b::US10689346, Compound 59c::US11203574, Compound 69b::US11230530, Compound 69b::US11685721, Compound 69b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416909	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416909&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356067	433916821							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287541	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CCC1CC1)N1CCCC1=O)C(F)(F)F	InChI=1S/C28H30F3N5O2/c29-28(30,31)25-16-24(36(34-25)22-7-1-4-19(14-22)17-32)27(38)33-21-6-2-5-20(15-21)23(12-11-18-9-10-18)35-13-3-8-26(35)37/h1-2,4-7,14-16,18,23H,3,8-13,17,32H2,(H,33,38)	LEZWAIIPWSOOAE-UHFFFAOYSA-N	416936	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-(2-oxopyrrolidin-1-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 247e::US10633345, Compound 247e::US10689346, Compound 247e::US11203574, Compound 247e::US11230530, Compound 247e::US11685721, Compound 247e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416936	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416936&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665605	433916848							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287542	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-16-25(37(36-26)24-8-1-4-20(14-24)17-33)27(38)35-23-7-2-5-21(15-23)28(39,12-11-19-9-10-19)22-6-3-13-34-18-22/h1-8,13-16,18-19,39H,9-12,17,33H2,(H,35,38)	AOCZEQQKIIWUBU-UHFFFAOYSA-N	416770	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 47f::US10633345, Compound 47f::US10689346, Compound 47f::US11203574, Compound 47g::US11230530, Compound 47h::US11685721, Compound 47f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416770	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416770&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355766	433916684							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287543	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H28F4N4O2/c31-24-12-11-22(29(40,14-13-19-9-10-19)21-6-2-1-3-7-21)16-25(24)36-28(39)26-17-27(30(32,33)34)37-38(26)23-8-4-5-20(15-23)18-35/h1-8,11-12,15-17,19,40H,9-10,13-14,18,35H2,(H,36,39)	NIWMWYNGSALJGG-UHFFFAOYSA-N	416903	Racemic 1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 68c::US10633345, Compound 68e::US10689346, Compound 68c::US11203574, Compound 68e::US11230530, Compound 68e::US11685721, Compound 68e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416903	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416903&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355758	433916816							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287544	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccccc1=O)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-11-10-20(24(12-9-18-7-8-18)37-13-2-1-6-27(37)39)15-23(22)35-28(40)25-16-26(29(31,32)33)36-38(25)21-5-3-4-19(14-21)17-34/h1-6,10-11,13-16,18,24H,7-9,12,17,34H2,(H,35,40)	OFQQGSYWUFBMPP-UHFFFAOYSA-N	416939	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(2-oxopyridin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 248j::US10633345, Compound 248k::US10689346, Compound 248k::US11203574, Compound 248k::US11230530, Compound 248k::US11685721, Compound 248k	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416939	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416939&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355727	433916851							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287545	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-16-25(37(36-26)24-8-1-4-20(14-24)17-33)27(38)35-23-7-2-5-21(15-23)28(39,12-11-19-9-10-19)22-6-3-13-34-18-22/h1-8,13-16,18-19,39H,9-12,17,33H2,(H,35,38)	AOCZEQQKIIWUBU-UHFFFAOYSA-N	416770	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 47f::US10633345, Compound 47f::US10689346, Compound 47f::US11203574, Compound 47g::US11230530, Compound 47h::US11685721, Compound 47f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416770	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416770&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355766	433916684							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287546	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H28F4N4O2/c31-24-12-11-22(29(40,14-13-19-9-10-19)21-6-2-1-3-7-21)16-25(24)36-28(39)26-17-27(30(32,33)34)37-38(26)23-8-4-5-20(15-23)18-35/h1-8,11-12,15-17,19,40H,9-10,13-14,18,35H2,(H,36,39)	NIWMWYNGSALJGG-UHFFFAOYSA-N	416903	Racemic 1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 68c::US10633345, Compound 68e::US10689346, Compound 68c::US11203574, Compound 68e::US11230530, Compound 68e::US11685721, Compound 68e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416903	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416903&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355758	433916816							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287547	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccncc1=O)C(F)(F)F	InChI=1S/C28H26F4N6O2/c29-21-8-7-19(23(9-6-17-4-5-17)37-11-10-34-16-26(37)39)13-22(21)35-27(40)24-14-25(28(30,31)32)36-38(24)20-3-1-2-18(12-20)15-33/h1-3,7-8,10-14,16-17,23H,4-6,9,15,33H2,(H,35,40)	GLPOCDKMIDNWGE-UHFFFAOYSA-N	416942	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(2-oxopyrazin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 249b::US10633345, Compound 249b::US10689346, Compound 249b::US11203574, Compound 249b::US11230530, Compound 249b::US11685721, Compound 249b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416942	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416942&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665736	433916854							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287548	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F3N4O2/c31-30(32,33)27-18-26(37(36-27)25-11-4-6-21(16-25)19-34)28(38)35-24-10-5-9-23(17-24)29(39,15-14-20-12-13-20)22-7-2-1-3-8-22/h1-11,16-18,20,39H,12-15,19,34H2,(H,35,38)	DCGYPXFSNPCKGX-UHFFFAOYSA-N	416751	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 46g::US10633345, Compound 46g::US10689346, Compound 46g::US11203574, Compound 46i::US11230530, Compound 46i::US11685721, Compound 46g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416751	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416751&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355790	433916665							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287549	COc1ccc2ccccc2c1C(NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H31F4N5O2/c1-45-29-14-12-22-6-2-3-8-25(22)31(29)32(40-19-20-9-10-20)23-11-13-26(35)27(16-23)41-33(44)28-17-30(34(36,37)38)42-43(28)24-7-4-5-21(15-24)18-39/h2-8,11-17,20,32,40H,9-10,18-19,39H2,1H3,(H,41,44)	AYMFYNZEWAELBE-UHFFFAOYSA-N	416906	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(2-methoxynaphthalen-1-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide dihydrochloride::US10329260, Compound 61e::US10633345, Compound 63b::US10689346, Compound 61e::US11203574, Compound 63b::US11230530, Compound 63b::US11685721, Compound 63b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416906	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416906&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355591	433916818							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287550	Fc1ccc(cc1NC(=O)c1cc(nn1-c1cccc(c1)C#N)C(F)(F)F)C(CCC1CC1)Oc1ccccn1	InChI=1S/C29H23F4N5O2/c30-22-11-10-20(25(12-9-18-7-8-18)40-27-6-1-2-13-35-27)15-23(22)36-28(39)24-16-26(29(31,32)33)37-38(24)21-5-3-4-19(14-21)17-34/h1-6,10-11,13-16,18,25H,7-9,12H2,(H,36,39)	SGHCSSRTSJXCIZ-UHFFFAOYSA-N	447737	US10689346, Compound 250c::US11203574, Compound 250c::US11230530, Compound 250c::US11685721, Compound 250c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=447737	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=447737&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355856	440709842							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287551	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F3N4O2/c31-30(32,33)27-18-26(37(36-27)25-11-4-6-21(16-25)19-34)28(38)35-24-10-5-9-23(17-24)29(39,15-14-20-12-13-20)22-7-2-1-3-8-22/h1-11,16-18,20,39H,12-15,19,34H2,(H,35,38)	DCGYPXFSNPCKGX-UHFFFAOYSA-N	416751	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 46g::US10633345, Compound 46g::US10689346, Compound 46g::US11203574, Compound 46i::US11230530, Compound 46i::US11685721, Compound 46g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416751	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416751&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355790	433916665							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287552	COc1ccc2ccccc2c1C(NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H31F4N5O2/c1-45-29-14-12-22-6-2-3-8-25(22)31(29)32(40-19-20-9-10-20)23-11-13-26(35)27(16-23)41-33(44)28-17-30(34(36,37)38)42-43(28)24-7-4-5-21(15-24)18-39/h2-8,11-17,20,32,40H,9-10,18-19,39H2,1H3,(H,41,44)	AYMFYNZEWAELBE-UHFFFAOYSA-N	416906	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(2-methoxynaphthalen-1-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide dihydrochloride::US10329260, Compound 61e::US10633345, Compound 63b::US10689346, Compound 61e::US11203574, Compound 63b::US11230530, Compound 63b::US11685721, Compound 63b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416906	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416906&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355591	433916818							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287553	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(=CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H26F4N4O/c31-25-14-12-22(24(13-11-19-9-10-19)21-6-2-1-3-7-21)16-26(25)36-29(39)27-17-28(30(32,33)34)37-38(27)23-8-4-5-20(15-23)18-35/h1-8,12-17,19H,9-11,18,35H2,(H,36,39)/b24-13-	BAAJKWZPAGFHDE-CFRMEGHHSA-N	416948	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-phenylprop-1-enyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 252c::US10633345, Compound 252c::US10689346, Compound 252c::US11203574, Compound 252c::US11230530, Compound 252c::US11685721, Compound 252c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416948	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416948&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			140777564	433916860							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287554	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H25F4N5O2/c29-22-9-8-19(26(39-16-17-6-7-17)20-4-2-10-34-15-20)12-23(22)35-27(38)24-13-25(28(30,31)32)36-37(24)21-5-1-3-18(11-21)14-33/h1-5,8-13,15,17,26H,6-7,14,16,33H2,(H,35,38)	CNAFOXQNPWSINI-UHFFFAOYSA-N	416794	Racemic 1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethoxy)(pyridin-3-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 48f::US10633345, Compound 48f::US10689346, Compound 48f::US11203574, Compound 48g::US11230530, Compound 48h::US11685721, Compound 48f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416794	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416794&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355617	433916708							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287555	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C30H25F4N5O2/c31-24-11-10-22(28(41-17-19-4-5-19)21-8-6-18(15-35)7-9-21)13-25(24)37-29(40)26-14-27(30(32,33)34)38-39(26)23-3-1-2-20(12-23)16-36/h1-3,6-14,19,28H,4-5,16-17,36H2,(H,37,40)	WXFHQCUXOOXGLO-UHFFFAOYSA-N	416894	1-(3-(aminomethyl)phenyl)-N-(5-((4-cyanophenyl)(cyclopropylmethoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 55b::US10633345, Compound 73b::US10689346, Compound 55b::US11203574, Compound 73b::US11230530, Compound 73b::US11685721, Compound 73b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416894	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416894&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665569	433916807							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287556	CN1CCCN(CC1)C(CCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H36F4N6O/c1-38-12-3-13-39(15-14-38)26(11-8-20-6-7-20)22-9-10-24(31)25(17-22)36-29(41)27-18-28(30(32,33)34)37-40(27)23-5-2-4-21(16-23)19-35/h2,4-5,9-10,16-18,20,26H,3,6-8,11-15,19,35H2,1H3,(H,36,41)	WXRMFESIILBOBA-UHFFFAOYSA-N	416951	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(4-methyl-1,4-diazepan-1-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 251e::US10633345, Compound 251e::US10689346, Compound 251e::US11203574, Compound 251e::US11230530, Compound 251e::US11685721, Compound 251e	Plasma kallikrein		>75.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416951	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416951&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355664	433916863							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287557	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H25F4N5O2/c29-22-9-8-19(26(39-16-17-6-7-17)20-4-2-10-34-15-20)12-23(22)35-27(38)24-13-25(28(30,31)32)36-37(24)21-5-1-3-18(11-21)14-33/h1-5,8-13,15,17,26H,6-7,14,16,33H2,(H,35,38)	CNAFOXQNPWSINI-UHFFFAOYSA-N	416794	Racemic 1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethoxy)(pyridin-3-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 48f::US10633345, Compound 48f::US10689346, Compound 48f::US11203574, Compound 48g::US11230530, Compound 48h::US11685721, Compound 48f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416794	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416794&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355617	433916708							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287558	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C30H25F4N5O2/c31-24-11-10-22(28(41-17-19-4-5-19)21-8-6-18(15-35)7-9-21)13-25(24)37-29(40)26-14-27(30(32,33)34)38-39(26)23-3-1-2-20(12-23)16-36/h1-3,6-14,19,28H,4-5,16-17,36H2,(H,37,40)	WXFHQCUXOOXGLO-UHFFFAOYSA-N	416894	1-(3-(aminomethyl)phenyl)-N-(5-((4-cyanophenyl)(cyclopropylmethoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 55b::US10633345, Compound 73b::US10689346, Compound 55b::US11203574, Compound 73b::US11230530, Compound 73b::US11685721, Compound 73b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416894	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416894&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665569	433916807							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287559	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)N1C(=O)CCC1=O)C(F)(F)F	InChI=1S/C28H27F4N5O3/c29-20-8-7-18(22(9-6-16-4-5-16)36-25(38)10-11-26(36)39)13-21(20)34-27(40)23-14-24(28(30,31)32)35-37(23)19-3-1-2-17(12-19)15-33/h1-3,7-8,12-14,16,22H,4-6,9-11,15,33H2,(H,34,40)	ZAWTZVLCOQSDBX-UHFFFAOYSA-N	416954	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(2,5-dioxopyrrolidin-1-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 260b::US10633345, Compound 260b::US10689346, Compound 260b::US11203574, Compound 260b::US11230530, Compound 260b::US11685721, Compound 260b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416954	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416954&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665563	433916866							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287560	COc1ccc2ccccc2c1C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H32F3N5O2/c1-44-29-15-14-23-7-2-3-11-27(23)31(29)32(39-20-21-12-13-21)24-8-5-9-25(17-24)40-33(43)28-18-30(34(35,36)37)41-42(28)26-10-4-6-22(16-26)19-38/h2-11,14-18,21,32,39H,12-13,19-20,38H2,1H3,(H,40,43)	XVOUQCJHWNZPKF-UHFFFAOYSA-N	416841	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2-methoxynaphthalen-1-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 51f::US10633345, Compound 51f::US10689346, Compound 51f::US11203574, Compound 51h::US11230530, Compound 51h::US11685721, Compound 51f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416841	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416841&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356155	433916754							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287561	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C30H25F4N5O2/c31-24-10-9-22(28(41-17-18-7-8-18)21-5-1-3-19(11-21)15-35)13-25(24)37-29(40)26-14-27(30(32,33)34)38-39(26)23-6-2-4-20(12-23)16-36/h1-6,9-14,18,28H,7-8,16-17,36H2,(H,37,40)	LSXFYXGKZDVRTL-UHFFFAOYSA-N	416900	1-(3-(aminomethyl)phenyl)-N-(5-((3-cyanophenyl)(cyclopropyl-methoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 56c::US10633345, Compound 72d::US10689346, Compound 56c::US11203574, Compound 72d::US11230530, Compound 72d::US11685721, Compound 72d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416900	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416900&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356211	433916813							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287562	CS(=O)(=O)NC(CCC1CC1)(c1ccncc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2ccc3ccnc(N)c3c2)C(F)(F)F)c1	InChI=1S/C32H29F4N7O3S/c1-47(45,46)42-31(12-8-19-2-3-19,21-10-13-38-14-11-21)22-5-7-25(33)26(16-22)40-30(44)27-18-28(32(34,35)36)41-43(27)23-6-4-20-9-15-39-29(37)24(20)17-23/h4-7,9-11,13-19,42H,2-3,8,12H2,1H3,(H2,37,39)(H,40,44)	WOIASLBXHIHYRY-UHFFFAOYSA-N	416957	(+-)-1-(1-aminoisoquinolin-7-yl)-N-(5-(3-cyclopropyl-1-(methylsulfonamido)-1-(pyridin-4-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 262f::US10633345, Compound 262f::US10689346, Compound 262f::US11192861, Compound 262f::US11230530, Compound 262f::US11685721, Compound 262f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416957	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416957&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355636	433916869							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287563	COc1ccc2ccccc2c1C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H32F3N5O2/c1-44-29-15-14-23-7-2-3-11-27(23)31(29)32(39-20-21-12-13-21)24-8-5-9-25(17-24)40-33(43)28-18-30(34(35,36)37)41-42(28)26-10-4-6-22(16-26)19-38/h2-11,14-18,21,32,39H,12-13,19-20,38H2,1H3,(H,40,43)	XVOUQCJHWNZPKF-UHFFFAOYSA-N	416841	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2-methoxynaphthalen-1-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 51f::US10633345, Compound 51f::US10689346, Compound 51f::US11203574, Compound 51h::US11230530, Compound 51h::US11685721, Compound 51f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416841	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416841&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356155	433916754							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287564	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C30H25F4N5O2/c31-24-10-9-22(28(41-17-18-7-8-18)21-5-1-3-19(11-21)15-35)13-25(24)37-29(40)26-14-27(30(32,33)34)38-39(26)23-6-2-4-20(12-23)16-36/h1-6,9-14,18,28H,7-8,16-17,36H2,(H,37,40)	LSXFYXGKZDVRTL-UHFFFAOYSA-N	416900	1-(3-(aminomethyl)phenyl)-N-(5-((3-cyanophenyl)(cyclopropyl-methoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 56c::US10633345, Compound 72d::US10689346, Compound 56c::US11203574, Compound 72d::US11230530, Compound 72d::US11685721, Compound 72d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416900	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416900&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356211	433916813							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287565	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccc(=O)[nH]c1=O)C(F)(F)F			416960	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 263d::US10633345, Compound 263d::US10689346, Compound 263d::US11203574, Compound 263d::US11230530, Compound 263d::US11685721, Compound 263d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416960	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416960&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			154584232	433916872							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287566	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-25(37(36-26)24-9-1-4-19(12-24)16-33)28(38)35-23-8-3-6-21(14-23)27(39-17-18-10-11-18)20-5-2-7-22(34)13-20/h1-9,12-15,18,27H,10-11,16-17,33-34H2,(H,35,38)	FPQYUIIRVBKUDH-UHFFFAOYSA-N	416867	1-(3-(aminomethyl)phenyl)-N-(3-((3-aminophenyl)(cyclopropyl-methoxy)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 53f::US10633345, Compound 53f::US10689346, Compound 53f::US11203574, Compound 64b::US11230530, Compound 64b::US11685721, Compound 49j	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416867	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416867&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355845	433916780							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287567	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1O)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-11-10-19(27(35-16-17-8-9-17)21-6-1-2-7-25(21)39)13-23(22)36-28(40)24-14-26(29(31,32)33)37-38(24)20-5-3-4-18(12-20)15-34/h1-7,10-14,17,27,35,39H,8-9,15-16,34H2,(H,36,40)	CKWWRAGQIQAYTL-UHFFFAOYSA-N	416856	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(2-hydroxyphenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 60e::US10633345, Compound 66b::US10689346, Compound 60e::US11203574, Compound 66b::US11230530, Compound 66b::US11685721, Compound 60e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416856	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416856&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665480	433916769							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287568	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1ccc(cc1F)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-23-14-21(27(39-17-18-9-10-18)20-6-2-1-3-7-20)11-12-24(23)35-28(38)25-15-26(29(31,32)33)36-37(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27H,9-10,16-17,34H2,(H,35,38)	HBXVQXKJLUQKAE-UHFFFAOYSA-N	416963	1-(3-(aminomethyl)phenyl)-N-(4-((cyclopropylmethoxy)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 15g::US10633345, Compound 15g::US10689346, Compound 15g::US11203574, Compound 15g::US11230530, Compound 15g::US11685721, Compound 15g	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416963	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416963&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355605	433916875							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287569	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-25(37(36-26)24-9-1-4-19(12-24)16-33)28(38)35-23-8-3-6-21(14-23)27(39-17-18-10-11-18)20-5-2-7-22(34)13-20/h1-9,12-15,18,27H,10-11,16-17,33-34H2,(H,35,38)	FPQYUIIRVBKUDH-UHFFFAOYSA-N	416867	1-(3-(aminomethyl)phenyl)-N-(3-((3-aminophenyl)(cyclopropyl-methoxy)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 53f::US10633345, Compound 53f::US10689346, Compound 53f::US11203574, Compound 64b::US11230530, Compound 64b::US11685721, Compound 49j	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416867	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416867&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355845	433916780							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287570	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1O)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-11-10-19(27(35-16-17-8-9-17)21-6-1-2-7-25(21)39)13-23(22)36-28(40)24-14-26(29(31,32)33)37-38(24)20-5-3-4-18(12-20)15-34/h1-7,10-14,17,27,35,39H,8-9,15-16,34H2,(H,36,40)	CKWWRAGQIQAYTL-UHFFFAOYSA-N	416856	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(2-hydroxyphenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 60e::US10633345, Compound 66b::US10689346, Compound 60e::US11203574, Compound 66b::US11230530, Compound 66b::US11685721, Compound 60e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416856	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416856&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665480	433916769							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287571	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1ccc(cc1F)C(O)c1ccccc1)C(F)(F)F	InChI=1S/C25H20F4N4O2/c26-19-12-17(23(34)16-6-2-1-3-7-16)9-10-20(19)31-24(35)21-13-22(25(27,28)29)32-33(21)18-8-4-5-15(11-18)14-30/h1-13,23,34H,14,30H2,(H,31,35)	WVBOXESRKOBMTK-UHFFFAOYSA-N	416966	1-(3-(Aminomethyl)phenyl)-N-(2-fluoro-4-(hydroxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 16b::US10633345, Compound 16b::US10689346, Compound 16b::US11203574, Compound 16b::US11230530, Compound 16b::US11685721, Compound 16b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416966	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416966&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665483	433916878							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287572	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1O)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-24(37(36-26)22-8-3-5-19(13-22)16-33)28(39)35-21-7-4-6-20(14-21)27(34-17-18-11-12-18)23-9-1-2-10-25(23)38/h1-10,13-15,18,27,34,38H,11-12,16-17,33H2,(H,35,39)	PCNDJIQOMLHSEK-UHFFFAOYSA-N	416837	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2-hydroxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 49h::US10633345, Compound 49h::US10689346, Compound 49h::US11203574, Compound 49j::US11230530, Compound 49j::US11685721, Compound 49h	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416837	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416837&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355733	433916750							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287573	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-23-12-11-21(27(39-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)35-28(38)25-15-26(29(31,32)33)36-37(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27H,9-10,16-17,34H2,(H,35,38)	HIMJVDQVZQMIPM-UHFFFAOYSA-N	416747	1-(3-(Aminomethyl)phenyl)-N-(5-((cyclopropylmethoxy)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 34c::US10633345, Compound 34c::US10689346, Compound 34c::US11203574, Compound 37a::US11230530, Compound 37a::US11685721, Compound 34c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416747	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416747&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355729	433916661							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287574	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1c(F)cccc1C(O)c1ccccc1)C(F)(F)F	InChI=1S/C25H20F4N4O2/c26-19-11-5-10-18(23(34)16-7-2-1-3-8-16)22(19)31-24(35)20-13-21(25(27,28)29)32-33(20)17-9-4-6-15(12-17)14-30/h1-13,23,34H,14,30H2,(H,31,35)	PIMJYQUHLMMZIO-UHFFFAOYSA-N	416969	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-6-(hydroxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 90f::US10633345, Compound 90f::US10689346, Compound 90f::US11203574, Compound 90f::US11230530, Compound 90f::US11685721, Compound 90f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416969	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416969&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356272	433916881							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287575	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-25(37(36-26)24-9-1-4-19(12-24)16-33)28(38)35-23-8-3-6-21(14-23)27(39-17-18-10-11-18)20-5-2-7-22(34)13-20/h1-9,12-15,18,27H,10-11,16-17,33-34H2,(H,35,38)	FPQYUIIRVBKUDH-UHFFFAOYSA-N	416867	1-(3-(aminomethyl)phenyl)-N-(3-((3-aminophenyl)(cyclopropyl-methoxy)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 53f::US10633345, Compound 53f::US10689346, Compound 53f::US11203574, Compound 64b::US11230530, Compound 64b::US11685721, Compound 49j	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416867	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416867&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355845	433916780							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287576	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-23-12-11-21(27(39-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)35-28(38)25-15-26(29(31,32)33)36-37(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27H,9-10,16-17,34H2,(H,35,38)	HIMJVDQVZQMIPM-UHFFFAOYSA-N	416747	1-(3-(Aminomethyl)phenyl)-N-(5-((cyclopropylmethoxy)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 34c::US10633345, Compound 34c::US10689346, Compound 34c::US11203574, Compound 37a::US11230530, Compound 37a::US11685721, Compound 34c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416747	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416747&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355729	433916661							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287577	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N(CC1CC1)CC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C33H33F4N5O/c34-27-14-13-25(31(24-6-2-1-3-7-24)41(19-21-9-10-21)20-22-11-12-22)16-28(27)39-32(43)29-17-30(33(35,36)37)40-42(29)26-8-4-5-23(15-26)18-38/h1-8,13-17,21-22,31H,9-12,18-20,38H2,(H,39,43)	FVEYNTAGBBDICV-UHFFFAOYSA-N	416972	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-((bis(cyclopropylmethyl)amino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 206d::US10633345, Compound 206d::US10689346, Compound 206d::US11203574, Compound 206d::US11230530, Compound 206d::US11685721, Compound 206d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416972	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416972&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355791	433916884							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287578	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C#N)C(N)=O	InChI=1S/C31H30FN7O2/c32-25-11-10-23(31(36,13-12-19-4-5-19)22-8-6-20(17-33)7-9-22)15-26(25)37-30(41)28-16-27(29(35)40)38-39(28)24-3-1-2-21(14-24)18-34/h1-3,6-11,14-16,19H,4-5,12-13,18,34,36H2,(H2,35,40)(H,37,41)	BCLQAOJZVSDWEP-UHFFFAOYSA-N	416973	(+)-N5-(5-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-1H-pyrazole-3,5-dicarboxamide::US10329260, Compound 231d::US10633345, Compound 231d::US10689346, Compound 231d::US11203574, Compound 231d::US11230530, Compound 231d::US11685721, Compound 231d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416973	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416973&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665708	433916885							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287579	CC(C)(C)C(=O)NC(CCC1CC1)(c1cccnc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H36F4N6O2/c1-32(2,3)31(46)42-33(14-13-21-9-10-21,24-7-5-15-40-20-24)23-11-12-26(35)27(17-23)41-30(45)28-18-29(34(36,37)38)43-44(28)25-8-4-6-22(16-25)19-39/h4-8,11-12,15-18,20-21H,9-10,13-14,19,39H2,1-3H3,(H,41,45)(H,42,46)	QDJVSPVHYSLBHH-UHFFFAOYSA-N	416974	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-pivalamido-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 244g::US10689346, Compound 244g::US11203574, Compound 244g::US11230530, Compound 244g::US11685721, Compound 244g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416974	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416974&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665924	433916886							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287580	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-22-10-9-20(28(35,12-11-18-7-8-18)25-6-1-2-13-36-25)15-23(22)37-27(40)24-16-26(29(31,32)33)38-39(24)21-5-3-4-19(14-21)17-34/h1-6,9-10,13-16,18H,7-8,11-12,17,34-35H2,(H,37,40)	IFWBAIGKQKRJGJ-UHFFFAOYSA-N	416975	(+-)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 205d::US10633345, Compound 205c::US10689346, Compound 205e::US11203574, Compound 205e::US11230530, Compound 205e::US11685721, Compound 205f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416975	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416975&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665627	433916887							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287581	ONC(=N)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N6O2/c30-22-12-11-19(26(35-16-17-9-10-17)18-5-2-1-3-6-18)14-23(22)36-28(40)24-15-25(29(31,32)33)37-39(24)21-8-4-7-20(13-21)27(34)38-41/h1-8,11-15,17,26,35,41H,9-10,16H2,(H2,34,38)(H,36,40)	RKUBSDCTAQRJEX-UHFFFAOYSA-N	416976	(+-)-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-1-(3-(N-hydroxycarbamimidoyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 232a::US10633345, Compound 232a::US10689346, Compound 232a::US11203574, Compound 232a::US11230530, Compound 232a::US11685721, Compound 232a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416976	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416976&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665466	433916888							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287582	CC(=O)NC(CCC1CC1)(c1cccnc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C31H30F4N6O2/c1-19(42)39-30(12-11-20-7-8-20,23-5-3-13-37-18-23)22-9-10-25(32)26(15-22)38-29(43)27-16-28(31(33,34)35)40-41(27)24-6-2-4-21(14-24)17-36/h2-6,9-10,13-16,18,20H,7-8,11-12,17,36H2,1H3,(H,38,43)(H,39,42)	NXVHVPBDWBOZQI-UHFFFAOYSA-N	416977	(+-)-N-(5-(1-acetamido-3-cyclopropyl-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 244h::US10633345, Compound 244h::US10689346, Compound 244h::US11203574, Compound 244h::US11230530, Compound 244h::US11685721, Compound 244h	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416977	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416977&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355894	433916889							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287583	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-22-10-9-20(28(35,12-11-18-7-8-18)25-6-1-2-13-36-25)15-23(22)37-27(40)24-16-26(29(31,32)33)38-39(24)21-5-3-4-19(14-21)17-34/h1-6,9-10,13-16,18H,7-8,11-12,17,34-35H2,(H,37,40)	IFWBAIGKQKRJGJ-UHFFFAOYSA-N	416975	(+-)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 205d::US10633345, Compound 205c::US10689346, Compound 205e::US11203574, Compound 205e::US11230530, Compound 205e::US11685721, Compound 205f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416975	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416975&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665627	433916887							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287584	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(O)=O	InChI=1S/C29H28FN5O3/c30-23-12-11-21(27(32-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)33-28(36)26-15-25(29(37)38)34-35(26)22-8-4-5-19(13-22)16-31/h1-8,11-15,18,27,32H,9-10,16-17,31H2,(H,33,36)(H,37,38)	XPAISISGRLZRHF-UHFFFAOYSA-N	416979	(+)-1-(3-(aminomethyl)phenyl)-5-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenylcarbamoyl)-1H-pyrazole-3-carboxylic acid::US10329260, Compound 246f::US10633345, Compound 246f::US10689346, Compound 246f::US11203574, Compound 246f::US11230530, Compound 246f::US11685721, Compound 246f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416979	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416979&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356041	433916891							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287585	CCC(=O)NC(CCC1CC1)(c1cccnc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C32H32F4N6O2/c1-2-29(43)40-31(13-12-20-8-9-20,23-6-4-14-38-19-23)22-10-11-25(33)26(16-22)39-30(44)27-17-28(32(34,35)36)41-42(27)24-7-3-5-21(15-24)18-37/h3-7,10-11,14-17,19-20H,2,8-9,12-13,18,37H2,1H3,(H,39,44)(H,40,43)	VLEWWVBFKVHAND-UHFFFAOYSA-N	416980	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-propionamido-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 244i::US10633345, Compound 244i::US10689346, Compound 244i::US11203574, Compound 244i::US11230530, Compound 244j::US11685721, Compound 244i	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416980	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416980&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665945	433916892							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287586	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-23-9-8-20(28(35,11-10-18-6-7-18)21-4-2-12-36-17-21)14-24(23)37-27(40)25-15-26(29(31,32)33)38-39(25)22-5-1-3-19(13-22)16-34/h1-5,8-9,12-15,17-18H,6-7,10-11,16,34-35H2,(H,37,40)	QXMQDWOYOXVOQZ-UHFFFAOYSA-N	416981	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 208d::US10633345, Compound 209d::US10689346, Compound 209d::US11203574, Compound 209d::US11230530, Compound 209d::US11685721, Compound 209d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416981	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416981&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355646	433916893							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287587	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C#N)C#N	InChI=1S/C31H28FN7O/c32-27-11-10-24(31(36,13-12-20-4-5-20)23-8-6-21(17-33)7-9-23)15-28(27)37-30(40)29-16-25(19-35)38-39(29)26-3-1-2-22(14-26)18-34/h1-3,6-11,14-16,20H,4-5,12-13,18,34,36H2,(H,37,40)	SWSSXIJHEDUEIQ-UHFFFAOYSA-N	416982	(+)-N-(5-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-cyano-1H-pyrazole-5-carboxamide::US10329260, Compound 234d::US10633345, Compound 234d::US10689346, Compound 234d::US11203574, Compound 234d::US11230530, Compound 234d::US11685721, Compound 234d	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416982	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416982&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356248	433916894							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287588	CC(C)C(=O)NC(CCC1CC1)(c1cccnc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C33H34F4N6O2/c1-20(2)30(44)41-32(13-12-21-8-9-21,24-6-4-14-39-19-24)23-10-11-26(34)27(16-23)40-31(45)28-17-29(33(35,36)37)42-43(28)25-7-3-5-22(15-25)18-38/h3-7,10-11,14-17,19-21H,8-9,12-13,18,38H2,1-2H3,(H,40,45)(H,41,44)	POAUUALSNYEBRU-UHFFFAOYSA-N	416983	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-isobutyramido-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 244j::US10633345, Compound 244j::US10689346, Compound 244j::US11203574, Compound 244j::US11685721, Compound 244j	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416983	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416983&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356184	433916895							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287589	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-23-9-8-20(28(35,11-10-18-6-7-18)21-4-2-12-36-17-21)14-24(23)37-27(40)25-15-26(29(31,32)33)38-39(25)22-5-1-3-19(13-22)16-34/h1-5,8-9,12-15,17-18H,6-7,10-11,16,34-35H2,(H,37,40)	QXMQDWOYOXVOQZ-UHFFFAOYSA-N	416981	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 208d::US10633345, Compound 209d::US10689346, Compound 209d::US11203574, Compound 209d::US11230530, Compound 209d::US11685721, Compound 209d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416981	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416981&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355646	433916893							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287590	NC(=N)c1cccc(c1)-n1nc(cc1C(O)=O)C(F)(F)F	InChI=1S/C12H9F3N4O2/c13-12(14,15)9-5-8(11(20)21)19(18-9)7-3-1-2-6(4-7)10(16)17/h1-5H,(H3,16,17)(H,20,21)	LNPPIWNSASSOBL-UHFFFAOYSA-N	606517	1-(3-carbamimidoylphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxylic acid::US11685721, Compound 235g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=606517	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=606517&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			89388223	483497951							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287591	CC(C)CC(=O)NC(CCC1CC1)(c1cccnc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H36F4N6O2/c1-21(2)15-31(45)42-33(13-12-22-8-9-22,25-6-4-14-40-20-25)24-10-11-27(35)28(17-24)41-32(46)29-18-30(34(36,37)38)43-44(29)26-7-3-5-23(16-26)19-39/h3-7,10-11,14,16-18,20-22H,8-9,12-13,15,19,39H2,1-2H3,(H,41,46)(H,42,45)	WIIQCCUTLYCVOE-UHFFFAOYSA-N	416986	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(3-methylbutanamido)-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 244k::US10633345, Compound 244k::US10689346, Compound 244k::US11203574, Compound 244k::US11230530, Compound 244k::US11685721, Compound 244k	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416986	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416986&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665507	433916898							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287592	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccc1)C(F)F	InChI=1S/C30H30F3N5O/c31-24-12-11-22(30(35,14-13-19-9-10-19)21-6-2-1-3-7-21)16-25(24)36-29(39)27-17-26(28(32)33)37-38(27)23-8-4-5-20(15-23)18-34/h1-8,11-12,15-17,19,28H,9-10,13-14,18,34-35H2,(H,36,39)	DLWYMOPDHKKRRS-UHFFFAOYSA-N	606519	(-)-N-(5-(1-amino-3-cyclopropyl-1-phenyl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US11685721, Compound 210d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=606519	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=606519&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168474278	483497953							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287593	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(N)(CCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C31H29F3N6O/c32-31(33,34)28-17-27(40(39-28)26-6-1-3-22(15-26)19-36)29(41)38-25-5-2-4-24(16-25)30(37,14-13-20-7-8-20)23-11-9-21(18-35)10-12-23/h1-6,9-12,15-17,20H,7-8,13-14,19,36-37H2,(H,38,41)	WPWCLOAAAHRQMG-UHFFFAOYSA-N	416988	(+)-N-(3-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)phenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 218c::US10633345, Compound 218c::US10689346, Compound 218c::US11203574, Compound 218c::US11230530, Compound 218c::US11685721, Compound 218c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416988	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416988&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356070	433916900							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287594	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C31H27F4N7O/c32-24-6-4-21(30(37,11-7-18-1-2-18)20-9-12-38-13-10-20)15-25(24)40-29(43)26-17-27(31(33,34)35)41-42(26)22-5-3-19-8-14-39-28(36)23(19)16-22/h3-6,8-10,12-18H,1-2,7,11,37H2,(H2,36,39)(H,40,43)	BGYDOWYGLFEYGE-UHFFFAOYSA-N	416989	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-4-yl)propyl)-2-fluorophenyl)-1-(1-aminoisoquinolin-7-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 253e::US10633345, Compound 253e::US10689346, Compound 253e::US11203574, Compound 253e::US11230530, Compound 253e::US11685721, Compound 253e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416989	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416989&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665703	433916901							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287595	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F4N5O/c31-24-12-11-22(29(36,14-13-19-9-10-19)21-6-2-1-3-7-21)16-25(24)37-28(40)26-17-27(30(32,33)34)38-39(26)23-8-4-5-20(15-23)18-35/h1-8,11-12,15-17,19H,9-10,13-14,18,35-36H2,(H,37,40)	NQFNNZJJOCPZCP-UHFFFAOYSA-N	416987	(+-)-N-(5-(1-amino-3-cyclopropyl-1-phenylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 210d::US10633345, Compound 211d::US10689346, Compound 211d::US11203574, Compound 211d::US11230530, Compound 211d::US11685721, Compound 211d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416987	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416987&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355764	433916899							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287596	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(N)(CCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C31H29F3N6O/c32-31(33,34)28-17-27(40(39-28)26-9-2-5-22(15-26)19-36)29(41)38-25-8-3-7-24(16-25)30(37,13-12-20-10-11-20)23-6-1-4-21(14-23)18-35/h1-9,14-17,20H,10-13,19,36-37H2,(H,38,41)	JHGXWQQOSIGIHO-UHFFFAOYSA-N	416991	(+)-N-(3-(1-amino-1-(3-cyanophenyl)-3-cyclopropylpropyl)phenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 219c::US10633345, Compound 219c::US10689346, Compound 219c::US11203574, Compound 219c::US11230530, Compound 219c::US11685721, Compound 219c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416991	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416991&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355760	433916903							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287597	CS(=O)(=O)NC(CCC1CC1)(c1ccncc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F4N6O3S/c1-44(42,43)39-29(12-9-19-5-6-19,21-10-13-36-14-11-21)22-7-8-24(31)25(16-22)37-28(41)26-17-27(30(32,33)34)38-40(26)23-4-2-3-20(15-23)18-35/h2-4,7-8,10-11,13-17,19,39H,5-6,9,12,18,35H2,1H3,(H,37,41)	SFWRGGJAWAJGGN-UHFFFAOYSA-N	416992	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(methylsulfonamido)-1-(pyridin-4-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 245c::US10633345, Compound 245c::US10689346, Compound 245c::US11203574, Compound 245c::US11230530, Compound 245c::US11685721, Compound 245c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416992	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416992&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355707	433916904							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287598	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C31H28F4N6O/c32-25-11-10-23(30(38,13-12-19-4-5-19)22-8-6-20(17-36)7-9-22)15-26(25)39-29(42)27-16-28(31(33,34)35)40-41(27)24-3-1-2-21(14-24)18-37/h1-3,6-11,14-16,19H,4-5,12-13,18,37-38H2,(H,39,42)	JCBKPNPCGNTAQN-UHFFFAOYSA-N	416993	(+)-N-(5-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 212g::US10633345, Compound 213d::US10689346, Compound 213d::US11203574, Compound 213d::US11230530, Compound 213d::US11685721, Compound 213d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416993	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416993&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356170	433916905							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287599	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C(N)=O)C#N	InChI=1S/C31H30FN7O2/c32-26-11-10-23(31(36,13-12-19-4-5-19)22-8-6-21(7-9-22)29(35)40)15-27(26)37-30(41)28-16-24(18-34)38-39(28)25-3-1-2-20(14-25)17-33/h1-3,6-11,14-16,19H,4-5,12-13,17,33,36H2,(H2,35,40)(H,37,41)	KLZOEGIZCNFTHC-UHFFFAOYSA-N	416994	(-)-N-(5-(1-amino-1-(4-carbamoylphenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-cyano-1H-pyrazole-5-carboxamide::US10329260, Compound 239d::US10633345, Compound 239c::US10689346, Compound 239d::US11203574, Compound 239d::US11685721, Compound 239d	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416994	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416994&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356225	433916906							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287600	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C32H25F4N7O/c33-25-9-7-22(29(40-17-18-4-5-18)21-3-1-2-19(12-21)16-37)13-26(25)41-31(44)27-15-28(32(34,35)36)42-43(27)23-8-6-20-10-11-39-30(38)24(20)14-23/h1-3,6-15,18,29,40H,4-5,17H2,(H2,38,39)(H,41,44)	PQPAZBKFVDKERF-UHFFFAOYSA-N	439578	US10633345, Compound 257b::US10689346, Compound 257b::US11203574, Compound 257b::US11230530, Compound 257b::US11685721, Compound 257b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439578	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439578&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665471	439661126							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287601	NCc1cccc(c1)-n1nc(CF)cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N	InChI=1S/C31H30F2N6O/c32-17-25-16-29(39(38-25)26-6-2-4-22(14-26)19-35)30(40)37-28-15-24(9-10-27(28)33)31(36,12-11-20-7-8-20)23-5-1-3-21(13-23)18-34/h1-6,9-10,13-16,20H,7-8,11-12,17,19,35-36H2,(H,37,40)	XHBJQKYQZCDFOP-UHFFFAOYSA-N	606528	(+)-N-(5-(1-amino-1-(3-cyanophenyl)-3-cyclopropyl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US11685721, Compound 214g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=606528	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=606528&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168474287	483497962							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287602	NC(=O)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C31H26F4N6O2/c32-24-10-9-22(30(38,12-11-18-7-8-18)21-5-1-3-19(13-21)17-36)15-25(24)39-29(43)26-16-27(31(33,34)35)40-41(26)23-6-2-4-20(14-23)28(37)42/h1-6,9-10,13-16,18H,7-8,11-12,38H2,(H2,37,42)(H,39,43)	MJBRNYICMOSPEH-UHFFFAOYSA-N	416997	(+-)-N-(5-(1-amino-1-(3-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-carbamoylphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 267c::US10633345, Compound 267c::US10689346, Compound 267c::US11203574, Compound 267c::US11230530, Compound 267c::US11685721, Compound 267c	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416997	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416997&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665760	433916909							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287603	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C33H27F4N7O/c34-26-10-8-23(32(40,13-11-19-1-2-19)22-6-3-20(18-38)4-7-22)15-27(26)42-31(45)28-17-29(33(35,36)37)43-44(28)24-9-5-21-12-14-41-30(39)25(21)16-24/h3-10,12,14-17,19H,1-2,11,13,40H2,(H2,39,41)(H,42,45)	QUIZETAQJOZQJA-UHFFFAOYSA-N	416998	(+)-N-(5-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(1-aminoisoquinolin-7-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 254c::US10633345, Compound 254c::US10689346, Compound 254c::US11203574, Compound 254c::US11230530, Compound 254c::US11685721, Compound 254c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416998	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416998&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665477	433916910							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287604	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C31H28F4N6O/c32-25-11-10-23(30(38,13-12-19-4-5-19)22-8-6-20(17-36)7-9-22)15-26(25)39-29(42)27-16-28(31(33,34)35)40-41(27)24-3-1-2-21(14-24)18-37/h1-3,6-11,14-16,19H,4-5,12-13,18,37-38H2,(H,39,42)	JCBKPNPCGNTAQN-UHFFFAOYSA-N	416993	(+)-N-(5-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 212g::US10633345, Compound 213d::US10689346, Compound 213d::US11203574, Compound 213d::US11230530, Compound 213d::US11685721, Compound 213d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416993	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416993&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356170	433916905							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287605	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C#N	InChI=1S/C29H27FN6O/c30-25-12-11-22(28(33-18-19-9-10-19)21-6-2-1-3-7-21)14-26(25)34-29(37)27-15-23(17-32)35-36(27)24-8-4-5-20(13-24)16-31/h1-8,11-15,19,28,33H,9-10,16,18,31H2,(H,34,37)	OBANZZDEWOCPST-UHFFFAOYSA-N	417000	(+-)-1-(3-(aminomethyl)phenyl)-3-cyano-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 240b::US10633345, Compound 240b::US10689346, Compound 240b::US11203574, Compound 240b::US11230530, Compound 240b::US11685721, Compound 240b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417000	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417000&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355661	433916912							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287606	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C32H28F4N6O/c33-25-11-9-22(31(38,14-12-19-6-7-19)21-4-2-1-3-5-21)16-26(25)40-30(43)27-18-28(32(34,35)36)41-42(27)23-10-8-20-13-15-39-29(37)24(20)17-23/h1-5,8-11,13,15-19H,6-7,12,14,38H2,(H2,37,39)(H,40,43)	SUIQVQQNEUOJQB-UHFFFAOYSA-N	417001	(+)-N-(5-(1-amino-3-cyclopropyl-1-phenylpropyl)-2-fluorophenyl)-1-(1-aminoisoquinolin-7-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 255a::US10633345, Compound 255a::US10689346, Compound 255a::US11203574, Compound 255a::US11230530, Compound 255a::US11685721, Compound 255a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417001	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417001&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356059	433916913							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287607	Nc1noc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H24F4N6O2/c30-21-10-8-18(26(35-15-16-6-7-16)17-4-2-1-3-5-17)12-22(21)36-28(40)23-14-25(29(31,32)33)37-39(23)19-9-11-24-20(13-19)27(34)38-41-24/h1-5,8-14,16,26,35H,6-7,15H2,(H2,34,38)(H,36,40)	QWKNFIFTTXOPHF-UHFFFAOYSA-N	417002	(+-)-1-(3-aminobenzo[d]isoxazol-5-yl)-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 222k::US10329260, Compound 223f::US10633345, Compound 223f::US10689346, Compound 223f::US11203574, Compound 223f::US11230530, Compound 223f::US11685721, Compound 223f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417002	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417002&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123289526	433916914							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287608	NC(=N)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C30H25F4N7O/c31-23-10-9-20(27(38-16-17-7-8-17)19-4-1-3-18(11-19)15-35)13-24(23)39-29(42)25-14-26(30(32,33)34)40-41(25)22-6-2-5-21(12-22)28(36)37/h1-6,9-14,17,27,38H,7-8,16H2,(H3,36,37)(H,39,42)	VIRFLKJDRZOSPM-UHFFFAOYSA-N	417003	(+)-1-(3-carbamimidoylphenyl)-N-(5-((3-cyanophenyl)(cyclopropylmethylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 236h::US10633345, Compound 236h::US10689346, Compound 236h::US11203574, Compound 236h::US11230530, Compound 236h::US11685721, Compound 236h	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417003	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417003&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665908	433916915							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287609	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C30H25F4N7O/c31-23-6-4-20(27(38-16-17-1-2-17)19-7-10-36-11-8-19)13-24(23)39-29(42)25-15-26(30(32,33)34)40-41(25)21-5-3-18-9-12-37-28(35)22(18)14-21/h3-15,17,27,38H,1-2,16H2,(H2,35,37)(H,39,42)	UQWHIYYZYLIMKJ-UHFFFAOYSA-N	417004	(+-)-1-(1-aminoisoquinolin-7-yl)-N-(5-((cyclopropylmethylamino)(pyridin-4-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 265d::US10633345, Compound 264g::US10689346, Compound 264g::US11203574, Compound 264g::US11230530, Compound 264g::US11685721, Compound 264g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417004	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417004&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355979	433916916							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287610	Nc1noc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H24F4N6O2/c30-21-10-8-18(26(35-15-16-6-7-16)17-4-2-1-3-5-17)12-22(21)36-28(40)23-14-25(29(31,32)33)37-39(23)19-9-11-24-20(13-19)27(34)38-41-24/h1-5,8-14,16,26,35H,6-7,15H2,(H2,34,38)(H,36,40)	QWKNFIFTTXOPHF-UHFFFAOYSA-N	417002	(+-)-1-(3-aminobenzo[d]isoxazol-5-yl)-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 222k::US10329260, Compound 223f::US10633345, Compound 223f::US10689346, Compound 223f::US11203574, Compound 223f::US11230530, Compound 223f::US11685721, Compound 223f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417002	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417002&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123289526	433916914							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287611	NC(=N)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C31H27F4N7O/c32-24-10-9-22(30(39,12-11-18-7-8-18)21-5-1-3-19(13-21)17-36)15-25(24)40-29(43)26-16-27(31(33,34)35)41-42(26)23-6-2-4-20(14-23)28(37)38/h1-6,9-10,13-16,18H,7-8,11-12,39H2,(H3,37,38)(H,40,43)	BZRUVEYOOHPOOF-UHFFFAOYSA-N	417006	(+)-N-(5-(1-amino-1-(3-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-carbamimidoylphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 237a::US10633345, Compound 237a::US10689346, Compound 237a::US11192861, Compound 237a::US11230530, Compound 237a::US11685721, Compound 237a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417006	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417006&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356202	433916917							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287612	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C33H27F4N7O/c34-26-9-7-23(32(40,12-10-19-4-5-19)22-3-1-2-20(14-22)18-38)15-27(26)42-31(45)28-17-29(33(35,36)37)43-44(28)24-8-6-21-11-13-41-30(39)25(21)16-24/h1-3,6-9,11,13-17,19H,4-5,10,12,40H2,(H2,39,41)(H,42,45)	MNAPHYKXZOGSTD-UHFFFAOYSA-N	417007	(+)-N-(5-(1-amino-1-(3-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(1-aminoisoquinolin-7-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 256a::US10633345, Compound 256a::US10689346, Compound 256a::US11203574, Compound 256a::US11230530, Compound 256a::US11685721, Compound 256a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417007	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417007&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665459	433916918							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287613	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(n1)C#N)C(F)(F)F	InChI=1S/C30H27F4N7O/c31-23-10-9-20(29(37,12-11-18-7-8-18)26-6-2-4-21(17-36)38-26)14-24(23)39-28(42)25-15-27(30(32,33)34)40-41(25)22-5-1-3-19(13-22)16-35/h1-6,9-10,13-15,18H,7-8,11-12,16,35,37H2,(H,39,42)	UYAYDZPBNCJYMZ-UHFFFAOYSA-N	417008	(+)-N-(5-(1-amino-1-(6-cyanopyridin-2-yl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 220f::US10633345, Compound 220f::US10689346, Compound 220f::US11203574, Compound 220f::US11230530, Compound 220f::US11685721, Compound 220f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417008	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417008&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355858	433916919							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287614	CC(C)(C)[S@@](=O)NC(CCC1CC1)(c1cccnc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(c2)C(N)=N)C(F)(F)F)c1	InChI=1S/C33H35F4N7O2S/c1-31(2,3)47(46)43-32(14-13-20-9-10-20,23-7-5-15-40-19-23)22-11-12-25(34)26(17-22)41-30(45)27-18-28(33(35,36)37)42-44(27)24-8-4-6-21(16-24)29(38)39/h4-8,11-12,15-20,43H,9-10,13-14H2,1-3H3,(H3,38,39)(H,41,45)/t32?,47-/m1/s1	ORCJXCNQCCWVHD-HKYIEPEJSA-N	417009	1-(3-carbamimidoylphenyl)-N-(5-((+-)-3-cyclopropyl-1-((R)-1,1-dimethylethylsulfinamido)-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 238c::US10633345, Compound 238c::US10689346, Compound 238c::US11203574, Compound 238c::US11230530, Compound 238c::US11685721, Compound 238c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417009	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417009&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355741	433916920							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287615	Nc1nccc2ccc(cc12)-n1nc(cc1C(F)(F)F)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1	InChI=1S/C31H27F4N7O/c32-24-6-4-21(30(37,11-7-18-1-2-18)20-9-12-38-13-10-20)15-25(24)40-29(43)26-17-27(31(33,34)35)42(41-26)22-5-3-19-8-14-39-28(36)23(19)16-22/h3-6,8-10,12-18H,1-2,7,11,37H2,(H2,36,39)(H,40,43)	JTQCWLVRCRAKSI-UHFFFAOYSA-N	417010	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-4-yl)propyl)-2-fluorophenyl)-1-(1-aminoisoquinolin-7-yl)-5-(trifluoromethyl)-1H-pyrazole-3-carboxamide::US10329260, Compound 268g::US10633345, Compound 268g::US10689346, Compound 268g::US11203574, Compound 268g::US11230530, Compound 268g::US11685721, Compound 268g	Plasma kallikrein		>75.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417010	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417010&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356088	433916921							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287616	Nc1ncnc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H25F4N7O/c31-22-10-8-19(27(36-15-17-6-7-17)18-4-2-1-3-5-18)12-24(22)39-29(42)25-14-26(30(32,33)34)40-41(25)20-9-11-23-21(13-20)28(35)38-16-37-23/h1-5,8-14,16-17,27,36H,6-7,15H2,(H,39,42)(H2,35,37,38)	NOYPEPJWHRTGGG-UHFFFAOYSA-N	417011	1-(4-aminoquinazolin-6-yl)-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 224b::US10329260, Compound 226a::US10633345, Compound 226a::US10689346, Compound 226a::US11203574, Compound 226a::US11230530, Compound 226a::US11685721, Compound 226a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417011	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417011&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665806	433916922							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287617	NC(=N)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C31H27F4N7O/c32-24-11-10-22(30(39,13-12-18-4-5-18)21-8-6-19(17-36)7-9-21)15-25(24)40-29(43)26-16-27(31(33,34)35)41-42(26)23-3-1-2-20(14-23)28(37)38/h1-3,6-11,14-16,18H,4-5,12-13,39H2,(H3,37,38)(H,40,43)	QLTPSVVBRYJDCX-UHFFFAOYSA-N	417012	(+)-N-(5-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-carbamimidoylphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 241a::US10633345, Compound 241a::US10689346, Compound 241a::US11192861, Compound 241a::US11230530, Compound 241a::US11685721, Compound 241a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417012	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417012&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665936	433916923							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287618	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccccc1=O)C(F)(F)F	InChI=1S/C31H26F4N6O2/c32-23-10-8-20(25(11-6-18-4-5-18)40-14-2-1-3-28(40)42)15-24(23)38-30(43)26-17-27(31(33,34)35)39-41(26)21-9-7-19-12-13-37-29(36)22(19)16-21/h1-3,7-10,12-18,25H,4-6,11H2,(H2,36,37)(H,38,43)	GNDQLXKOPYFGBP-UHFFFAOYSA-N	417013	1-(1-aminoisoquinolin-7-yl)-N-(5-(3-cyclopropyl-1-(2-oxopyridin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 258g::US10633345, Compound 258g::US10689346, Compound 258g::US11203574, Compound 258g::US11230530, Compound 258g::US11685721, Compound 258g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417013	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417013&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355895	433916924							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287619	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C(N)=O)C(F)(F)F	InChI=1S/C31H30F4N6O2/c32-24-10-9-22(30(38,12-11-18-7-8-18)21-5-2-4-20(14-21)28(37)42)15-25(24)39-29(43)26-16-27(31(33,34)35)40-41(26)23-6-1-3-19(13-23)17-36/h1-6,9-10,13-16,18H,7-8,11-12,17,36,38H2,(H2,37,42)(H,39,43)	DYGHBBDYRMOWAC-UHFFFAOYSA-N	417014	(+-)-N-(5-(1-amino-1-(3-carbamoylphenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 225a::US10633345, Compound 225a::US10689346, Compound 225a::US11203574, Compound 225a::US11230530, Compound 225a::US11685721, Compound 225a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417014	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417014&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665606	433916925							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287620	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C31H28F4N6O/c32-25-10-9-23(30(38,12-11-19-7-8-19)22-5-1-3-20(13-22)17-36)15-26(25)39-29(42)27-16-28(31(33,34)35)40-41(27)24-6-2-4-21(14-24)18-37/h1-6,9-10,13-16,19H,7-8,11-12,18,37-38H2,(H,39,42)	ZBDDMFBNDOEVJT-UHFFFAOYSA-N	416996	(+)-N-(5-(1-amino-1-(3-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 214g::US10633345, Compound 215d::US10689346, Compound 215d::US11203574, Compound 215d::US11230530, Compound 215d::US11685721, Compound 215d	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416996	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416996&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665709	433916908							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287621	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccccc1=O)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-11-10-20(24(12-9-18-7-8-18)37-13-2-1-6-27(37)39)15-23(22)35-28(40)25-16-26(29(31,32)33)36-38(25)21-5-3-4-19(14-21)17-34/h1-6,10-11,13-16,18,24H,7-9,12,17,34H2,(H,35,40)	OFQQGSYWUFBMPP-UHFFFAOYSA-N	416939	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(2-oxopyridin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 248j::US10633345, Compound 248k::US10689346, Compound 248k::US11203574, Compound 248k::US11230530, Compound 248k::US11685721, Compound 248k	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416939	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416939&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355727	433916851							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287622	Nc1ncnc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H25F4N7O/c31-22-10-8-19(27(36-15-17-6-7-17)18-4-2-1-3-5-18)12-24(22)39-29(42)25-14-26(30(32,33)34)40-41(25)20-9-11-23-21(13-20)28(35)38-16-37-23/h1-5,8-14,16-17,27,36H,6-7,15H2,(H,39,42)(H2,35,37,38)	NOYPEPJWHRTGGG-UHFFFAOYSA-N	417011	1-(4-aminoquinazolin-6-yl)-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 224b::US10329260, Compound 226a::US10633345, Compound 226a::US10689346, Compound 226a::US11203574, Compound 226a::US11230530, Compound 226a::US11685721, Compound 226a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417011	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417011&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665806	433916922							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287623	NC(=N)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H27F4N7O/c30-22-9-8-19(28(36,11-10-17-6-7-17)20-4-2-12-37-16-20)14-23(22)38-27(41)24-15-25(29(31,32)33)39-40(24)21-5-1-3-18(13-21)26(34)35/h1-5,8-9,12-17H,6-7,10-11,36H2,(H3,34,35)(H,38,41)	JBCZLPFSSAYNEJ-UHFFFAOYSA-N	417018	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-1-(3-carbamimidoylphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 238d::US10633345, Compound 238d::US10689346, Compound 238d::US11192861, Compound 238d::US11230530, Compound 238d::US11685721, Compound 238d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417018	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417018&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355839	433916928							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287624	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccccc1=O)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-11-10-20(24(12-9-18-7-8-18)37-13-2-1-6-27(37)39)15-23(22)35-28(40)25-16-26(29(31,32)33)36-38(25)21-5-3-4-19(14-21)17-34/h1-6,10-11,13-16,18,24H,7-9,12,17,34H2,(H,35,40)	OFQQGSYWUFBMPP-UHFFFAOYSA-N	416939	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(2-oxopyridin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 248j::US10633345, Compound 248k::US10689346, Compound 248k::US11203574, Compound 248k::US11230530, Compound 248k::US11685721, Compound 248k	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416939	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416939&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355727	433916851							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287625	NC(=N)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N6O/c30-22-12-11-19(26(36-16-17-9-10-17)18-5-2-1-3-6-18)14-23(22)37-28(40)24-15-25(29(31,32)33)38-39(24)21-8-4-7-20(13-21)27(34)35/h1-8,11-15,17,26,36H,9-10,16H2,(H3,34,35)(H,37,40)	HUIANTFJQLRTEM-UHFFFAOYSA-N	439603	US10633345, Compound 227d::US10689346, Compound 227d::US11203574, Compound 227d::US11230530, Compound 227d::US11685721, Compound 227d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439603	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439603&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356162	439661151							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287626	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(nc1)C(N)=O)C(F)(F)F	InChI=1S/C30H29F4N7O2/c31-22-8-6-19(29(37,11-10-17-4-5-17)20-7-9-23(27(36)42)38-16-20)13-24(22)39-28(43)25-14-26(30(32,33)34)40-41(25)21-3-1-2-18(12-21)15-35/h1-3,6-9,12-14,16-17H,4-5,10-11,15,35,37H2,(H2,36,42)(H,39,43)	IQWHGFSUUIEJQU-UHFFFAOYSA-N	417021	(+)-5-(1-amino-1-(3-(1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamido)-4-fluorophenyl)-3-cyclopropylpropyl)picolinamide::US10329260, Compound 221i::US10633345, Compound 221i::US10689346, Compound 221i::US11203574, Compound 221i::US11230530, Compound 221i::US11685721, Compound 221i	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417021	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417021&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665782	433916931							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287627	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C30H25F4N7O/c31-23-6-4-20(27(38-16-17-1-2-17)19-7-10-36-11-8-19)13-24(23)39-29(42)25-15-26(30(32,33)34)40-41(25)21-5-3-18-9-12-37-28(35)22(18)14-21/h3-15,17,27,38H,1-2,16H2,(H2,35,37)(H,39,42)	UQWHIYYZYLIMKJ-UHFFFAOYSA-N	417004	(+-)-1-(1-aminoisoquinolin-7-yl)-N-(5-((cyclopropylmethylamino)(pyridin-4-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 265d::US10633345, Compound 264g::US10689346, Compound 264g::US11203574, Compound 264g::US11230530, Compound 264g::US11685721, Compound 264g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417004	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417004&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355979	433916916							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287628	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C(N)=O)C(F)(F)F	InChI=1S/C31H30F4N6O2/c32-24-11-10-22(30(38,13-12-18-4-5-18)21-8-6-20(7-9-21)28(37)42)15-25(24)39-29(43)26-16-27(31(33,34)35)40-41(26)23-3-1-2-19(14-23)17-36/h1-3,6-11,14-16,18H,4-5,12-13,17,36,38H2,(H2,37,42)(H,39,43)	HZQICPCUMLWHPZ-UHFFFAOYSA-N	417023	(+)-N-(5-(1-amino-1-(4-carbamoylphenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 228a::US10633345, Compound 228a::US10689346, Compound 228a::US11203574, Compound 228a::US11230530, Compound 228a::US11685721, Compound 228a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417023	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417023&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665484	433916933							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287629	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-23-7-6-21(28(35,11-8-18-4-5-18)20-9-12-36-13-10-20)15-24(23)37-27(40)25-16-26(29(31,32)33)38-39(25)22-3-1-2-19(14-22)17-34/h1-3,6-7,9-10,12-16,18H,4-5,8,11,17,34-35H2,(H,37,40)	AGVFYPDLNPHKER-UHFFFAOYSA-N	417024	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-4-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 216d::US10633345, Compound 217d::US10689346, Compound 217d::US11192861, Compound 217d::US11230530, Compound 217d::US11685721, Compound 217d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417024	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417024&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665723	433916934							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287630	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)N1CCCCC1=O)C(F)(F)F	InChI=1S/C29H31F4N5O2/c30-22-11-10-20(24(12-9-18-7-8-18)37-13-2-1-6-27(37)39)15-23(22)35-28(40)25-16-26(29(31,32)33)36-38(25)21-5-3-4-19(14-21)17-34/h3-5,10-11,14-16,18,24H,1-2,6-9,12-13,17,34H2,(H,35,40)	BPULHNPIKAHCAG-UHFFFAOYSA-N	417025	(+)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(2-oxopiperidin-1-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 261k::US10633345, Compound 261k::US10689346, Compound 261k::US11203574, Compound 261k::US11230530, Compound 261k::US11685721, Compound 261k	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417025	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417025&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123312183	433916935							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287631	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(N)=O	InChI=1S/C29H29FN6O2/c30-23-12-11-21(27(33-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)34-29(38)26-15-25(28(32)37)35-36(26)22-8-4-5-19(13-22)16-31/h1-8,11-15,18,27,33H,9-10,16-17,31H2,(H2,32,37)(H,34,38)	UMNCVWUVWBVXCX-UHFFFAOYSA-N	417026	(+-)-1-(3-(aminomethyl)phenyl)-N5-(5-((cyclopropylmethylamino)-(phenyl)methyl)-2-fluorophenyl)-1H-pyrazole-3,5-dicarboxamide::US10329260, Compound 229i::US10633345, Compound 229i::US10689346, Compound 229i::US11203574, Compound 229i::US11230530, Compound 229i::US11685721, Compound 229i	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417026	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417026&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665747	433916936							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287632	CC(C)(C)[S@@](=O)NC(CCC1CC1)(c1cccnc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C33H36F4N6O2S/c1-31(2,3)46(45)42-32(14-13-21-9-10-21,24-7-5-15-39-20-24)23-11-12-26(34)27(17-23)40-30(44)28-18-29(33(35,36)37)41-43(28)25-8-4-6-22(16-25)19-38/h4-8,11-12,15-18,20-21,42H,9-10,13-14,19,38H2,1-3H3,(H,40,44)/t32?,46-/m1/s1	LAOWFCURFGDGCT-ODZHGNIVSA-N	417027	1-(3-(aminomethyl)phenyl)-N-(5-((+-)-3-cyclopropyl-1-((R)-1,1-dimethylethylsulfinamido)-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 243a::US10633345, Compound 243a::US10689346, Compound 243a::US11203574, Compound 243a::US11230530, Compound 243a::US11685721, Compound 243a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417027	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417027&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665825	433916937							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287633	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccncc1=O)C(F)(F)F	InChI=1S/C30H25F4N7O2/c31-22-7-5-19(24(8-3-17-1-2-17)40-12-11-36-16-27(40)42)13-23(22)38-29(43)25-15-26(30(32,33)34)39-41(25)20-6-4-18-9-10-37-28(35)21(18)14-20/h4-7,9-17,24H,1-3,8H2,(H2,35,37)(H,38,43)	RGAKSJSQGQBUGG-UHFFFAOYSA-N	417028	1-(1-aminoisoquinolin-7-yl)-N-(5-(3-cyclopropyl-1-(2-oxopyrazin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 259d::US10633345, Compound 259d::US10689346, Compound 259d::US11203574, Compound 259d::US11230530, Compound 259d::US11685721, Compound 259d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417028	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417028&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355792	433916938							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287634	NC(=O)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H25F4N5O2/c30-22-12-11-19(26(35-16-17-9-10-17)18-5-2-1-3-6-18)14-23(22)36-28(40)24-15-25(29(31,32)33)37-38(24)21-8-4-7-20(13-21)27(34)39/h1-8,11-15,17,26,35H,9-10,16H2,(H2,34,39)(H,36,40)	JMSFBJDWVQAENA-UHFFFAOYSA-N	417029	(+-)-1-(3-carbamoylphenyl)-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 230a::US10633345, Compound 230a::US10689346, Compound 230a::US11203574, Compound 230a::US11230530, Compound 230a::US11685721, Compound 230a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417029	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417029&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665857	433916939							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287635	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-23-7-6-21(28(35,11-8-18-4-5-18)20-9-12-36-13-10-20)15-24(23)37-27(40)25-16-26(29(31,32)33)38-39(25)22-3-1-2-19(14-22)17-34/h1-3,6-7,9-10,12-16,18H,4-5,8,11,17,34-35H2,(H,37,40)	AGVFYPDLNPHKER-UHFFFAOYSA-N	417024	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-4-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 216d::US10633345, Compound 217d::US10689346, Compound 217d::US11192861, Compound 217d::US11230530, Compound 217d::US11685721, Compound 217d	Plasma kallikrein		>75.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417024	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417024&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665723	433916934							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287636	Cc1cc(ccn1)C(N)(CCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F4N6O/c1-18-13-22(10-12-37-18)29(36,11-9-19-5-6-19)21-7-8-24(31)25(15-21)38-28(41)26-16-27(30(32,33)34)39-40(26)23-4-2-3-20(14-23)17-35/h2-4,7-8,10,12-16,19H,5-6,9,11,17,35-36H2,1H3,(H,38,41)	PYONXWOUVYIBRU-UHFFFAOYSA-N	417031	(+)-N-(5-(1-amino-3-cyclopropyl-1-(2-methylpyridin-4-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 266j::US10633345, Compound 266j::US10689346, Compound 266j::US11203574, Compound 266j::US11230530, Compound 266j::US11685721, Compound 266j	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417031	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417031&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665585	433916941							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287637	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccc(=O)[nH]c1=O)C(F)(F)F			417032	1-(1-aminoisoquinolin-7-yl)-N-(5-(3-cyclopropyl-1-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 269b::US10633345, Compound 269b::US10689346, Compound 269b::US11203574, Compound 269b::US11230530, Compound 269b::US11685721, Compound 269b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417032	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417032&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			154584237	433916942							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287638	CCNCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C31H31F4N5O/c1-2-36-18-21-7-6-10-24(15-21)40-27(17-28(39-40)31(33,34)35)30(41)38-26-16-23(13-14-25(26)32)29(37-19-20-11-12-20)22-8-4-3-5-9-22/h3-10,13-17,20,29,36-37H,2,11-12,18-19H2,1H3,(H,38,41)	RBEFOPDBDLERKF-UHFFFAOYSA-N	417033	(+-)-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-1-(3-((ethylamino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 270a::US10633345, Compound 270a::US10689346, Compound 270a::US11203574, Compound 270a::US11230530, Compound 270a::US11685721, Compound 270a	Plasma kallikrein		>75.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417033	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417033&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665791	433916943							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287342	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C28H26F3N5O2/c29-28(30,31)25-15-24(36(35-25)22-8-3-5-19(13-22)16-32)27(37)34-21-7-4-6-20(14-21)26(38-17-18-10-11-18)23-9-1-2-12-33-23/h1-9,12-15,18,26H,10-11,16-17,32H2,(H,34,37)	UBQUVYTUKOFUOF-UHFFFAOYSA-N	416721	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(pyridin-2-yl)methyl)-phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 43f::US10633345, Compound 43f::US10689346, Compound 43g::US11203574, Compound 43h::US11230530, Compound 43h::US11685721, Compound 43f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416721	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416721&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355947	433916635							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287343	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc2CNCCc2cc1F)C(F)(F)F	InChI=1S/C21H19F4N5O/c22-16-7-13-4-5-27-11-14(13)8-17(16)28-20(31)18-9-19(21(23,24)25)29-30(18)15-3-1-2-12(6-15)10-26/h1-3,6-9,27H,4-5,10-11,26H2,(H,28,31)	APLBFUXJEQDPBH-UHFFFAOYSA-N	416722	1-(3-(aminomethyl)phenyl)-N-(6-fluoro-1,2,3,4-tetrahydroisoquinolin-7-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 163g::US10633345, Compound 163g::US10689346, Compound 163g::US11203574, Compound 163g::US11230530, Compound 163g::US11685721, Compound 163g	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416722	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416722&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355616	433916636							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287344	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(Cn2ccnc2)ccc1F)C(F)(F)F	InChI=1S/C22H18F4N6O/c23-17-5-4-15(12-31-7-6-28-13-31)9-18(17)29-21(33)19-10-20(22(24,25)26)30-32(19)16-3-1-2-14(8-16)11-27/h1-10,13H,11-12,27H2,(H,29,33)	FOWNNAMOGPFGSS-UHFFFAOYSA-N	416723	N-(5-((1H-imidazol-1-yl)methyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 30g::US10633345, Compound 30g::US10689346, Compound 30g::US11203574, Compound 30g::US11230530, Compound 30g::US11685721, Compound 30g	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416723	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416723&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356018	433916637							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287345	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H26F3N5O2/c29-28(30,31)25-14-24(36(35-25)23-8-1-4-19(12-23)15-32)27(37)34-22-7-2-5-20(13-22)26(38-17-18-9-10-18)21-6-3-11-33-16-21/h1-8,11-14,16,18,26H,9-10,15,17,32H2,(H,34,37)	SHFRWTHPPCXLER-UHFFFAOYSA-N	416725	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(pyridin-3-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 44c::US10633345, Compound 44c::US10689346, Compound 44c::US11203574, Compound 44d::US11230530, Compound 44e::US11685721, Compound 44c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416725	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416725&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355578	433916639							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287346	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(Nc2ccccc2)c1)C(F)(F)F	InChI=1S/C24H20F3N5O/c25-24(26,27)22-14-21(32(31-22)20-11-4-6-16(12-20)15-28)23(33)30-19-10-5-9-18(13-19)29-17-7-2-1-3-8-17/h1-14,29H,15,28H2,(H,30,33)	BURYUTYBSGJGCF-UHFFFAOYSA-N	416728	1-(3-(aminomethyl)phenyl)-N-(3-(phenylamino)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 17d::US10689346, Compound 17d::US11203574, Compound 17d::US11230530, Compound 17d::US11685721, Compound 17d	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416728	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416728&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665499	433916642							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287347	OC(c1ccncc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(c2)C#N)C(F)(F)F)c1	InChI=1S/C24H16F3N5O2/c25-24(26,27)21-13-20(32(31-21)19-6-1-3-15(11-19)14-28)23(34)30-18-5-2-4-17(12-18)22(33)16-7-9-29-10-8-16/h1-13,22,33H,(H,30,34)	MZGXMRICEHCYLY-UHFFFAOYSA-N	606274	1-(3-cyanophenyl)-N-(3-(hydroxy(pyridin-4-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US11685721, Compound 31f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=606274	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=606274&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665773	483497710							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287348	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F3N4O/c31-30(32,33)28-18-27(37(36-28)25-11-4-6-21(16-25)19-34)29(38)35-24-10-5-9-23(17-24)26(15-14-20-12-13-20)22-7-2-1-3-8-22/h1-11,16-18,20,26H,12-15,19,34H2,(H,35,38)	LVGPKQXQIQRVCT-UHFFFAOYSA-N	416730	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-phenylpropyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 78d::US10633345, Compound 78d::US10689346, Compound 78d::US11203574, Compound 78d::US11230530, Compound 78d::US11685721, Compound 78d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416730	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416730&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665672	433916644							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287349	COC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C26H23F3N4O2/c1-35-24(18-8-3-2-4-9-18)19-10-6-11-20(14-19)31-25(34)22-15-23(26(27,28)29)32-33(22)21-12-5-7-17(13-21)16-30/h2-15,24H,16,30H2,1H3,(H,31,34)	XNHGZPIIDJTQKO-UHFFFAOYSA-N	416731	1-(3-(aminomethyl)phenyl)-N-(3-(methoxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18f::US10633345, Compound 18f::US10689346, Compound 18f::US11203574, Compound 18f::US11230530, Compound 18e::US11685721, Compound 18f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416731	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416731&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665801	433916645							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287350	CCCCC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C29H29F3N4O/c1-2-3-15-25(21-10-5-4-6-11-21)22-12-8-13-23(17-22)34-28(37)26-18-27(29(30,31)32)35-36(26)24-14-7-9-20(16-24)19-33/h4-14,16-18,25H,2-3,15,19,33H2,1H3,(H,34,37)	PEZPMDJZISDDKH-UHFFFAOYSA-N	416732	1-(3-(aminomethyl)phenyl)-N-(3-(1-phenylpentyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 32f::US10633345, Compound 32f::US10689346, Compound 32f::US11203574, Compound 32f::US11230530, Compound 32f::US11685721, Compound 32f	Plasma kallikrein		>75.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416732	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416732&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356224	433916646							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287351	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H27F3N6O/c29-28(30,31)25-14-24(37(36-25)23-8-1-4-19(12-23)15-32)27(38)35-22-7-2-5-20(13-22)26(34-16-18-9-10-18)21-6-3-11-33-17-21/h1-8,11-14,17-18,26,34H,9-10,15-16,32H2,(H,35,38)	KSDPGGAAGHTRLB-UHFFFAOYSA-N	416733	1-(3-(Aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(pyridin-3-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 79f::US10633345, Compound 79f::US10689346, Compound 79f::US11203574, Compound 79f::US11230530, Compound 79f::US11685721, Compound 79f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416733	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416733&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356066	433916647							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287352	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(Cc2ccccc2)c1)C(F)(F)F	InChI=1S/C25H21F3N4O/c26-25(27,28)23-15-22(32(31-23)21-11-5-9-19(14-21)16-29)24(33)30-20-10-4-8-18(13-20)12-17-6-2-1-3-7-17/h1-11,13-15H,12,16,29H2,(H,30,33)	GVRJCFWHVBXPLW-UHFFFAOYSA-N	416734	1-(3-(aminomethyl)phenyl)-N-(3-benzylphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 19d::US10633345, Compound 19d::US10689346, Compound 19d::US11203574, Compound 19d::US11230530, Compound 19d::US11685721, Compound 19d	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416734	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416734&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355715	433916648							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287353	CCOC(c1ccccc1)c1ccc(Cl)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C27H24ClF3N4O2/c1-2-37-25(18-8-4-3-5-9-18)19-11-12-21(28)22(14-19)33-26(36)23-15-24(27(29,30)31)34-35(23)20-10-6-7-17(13-20)16-32/h3-15,25H,2,16,32H2,1H3,(H,33,36)	XUCZWPPXZIMXPF-UHFFFAOYSA-N	416735	1-(3-(aminomethyl)phenyl)-N-(2-chloro-5-(ethoxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 33e::US10633345, Compound 33e::US10689346, Compound 33e::US11203574, Compound 33e::US11230530, Compound 33e::US11685721, Compound 33e	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416735	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416735&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665706	433916649							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287354	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(F)cc(c1)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-22-12-21(27(39-17-18-9-10-18)20-6-2-1-3-7-20)13-23(14-22)35-28(38)25-15-26(29(31,32)33)36-37(25)24-8-4-5-19(11-24)16-34/h1-8,11-15,18,27H,9-10,16-17,34H2,(H,35,38)	CECISELXZFBKBA-UHFFFAOYSA-N	416736	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)-5-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 80h::US10633345, Compound 80h::US10689346, Compound 80h::US11203574, Compound 80h::US11230530, Compound 80h::US11685721, Compound 80h	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416736	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416736&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356068	433916650							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287355	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(Oc2ccccc2)c1)C(F)(F)F	InChI=1S/C24H19F3N4O2/c25-24(26,27)22-14-21(31(30-22)18-8-4-6-16(12-18)15-28)23(32)29-17-7-5-11-20(13-17)33-19-9-2-1-3-10-19/h1-14H,15,28H2,(H,29,32)	CMENISUXWPWEPE-UHFFFAOYSA-N	416737	1-(3-(aminomethyl)phenyl)-N-(3-phenoxyphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 20d::US10689346, Compound 20d::US11203574, Compound 20d::US11230530, Compound 20d::US11685721, Compound 20d	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416737	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416737&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665805	433916651							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287356	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1Cl)C(O)c1ccccc1)C(F)(F)F	InChI=1S/C25H20ClF3N4O2/c26-19-10-9-17(23(34)16-6-2-1-3-7-16)12-20(19)31-24(35)21-13-22(25(27,28)29)32-33(21)18-8-4-5-15(11-18)14-30/h1-13,23,34H,14,30H2,(H,31,35)	RYPOCSQZGRAPIF-UHFFFAOYSA-N	416738	1-(3-(aminomethyl)phenyl)-N-(2-chloro-5-(hydroxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 33f::US10633345, Compound 33f::US10689346, Compound 33f::US11203574, Compound 33f::US11230530, Compound 33f::US11685721, Compound 33f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416738	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416738&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665810	433916652							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287357	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)N(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H28F3N5O/c30-29(31,32)27-18-26(37(35-27)25-11-4-6-21(16-25)19-33)28(38)34-22-7-5-10-24(17-22)36(15-14-20-12-13-20)23-8-2-1-3-9-23/h1-11,16-18,20H,12-15,19,33H2,(H,34,38)	BPUAEVGWEFCIEW-UHFFFAOYSA-N	416739	1-(3-(aminomethyl)phenyl)-N-(3-((2-cyclopropylethyl)(phenyl)amino)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 87f::US10633345, Compound 87f::US10689346, Compound 87f::US11203574, Compound 87f::US11230530, Compound 87f::US11685721, Compound 87f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416739	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416739&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665744	433916653							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287358	CCOC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C27H25F3N4O2/c1-2-36-25(19-9-4-3-5-10-19)20-11-7-12-21(15-20)32-26(35)23-16-24(27(28,29)30)33-34(23)22-13-6-8-18(14-22)17-31/h3-16,25H,2,17,31H2,1H3,(H,32,35)	NWRGIGNKIBZYEM-UHFFFAOYSA-N	416740	1-(3-(aminomethyl)phenyl)-N-(3-(ethoxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18g::US10633345, Compound 18g::US10689346, Compound 18g::US11203574, Compound 18g::US11230530, Compound 18g::US11685721, Compound 18g	Plasma kallikrein		>75.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416740	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416740&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356270	433916654							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287359	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)c1ccccc1)C(F)(F)F	InChI=1S/C25H20F4N4O2/c26-19-10-9-17(23(34)16-6-2-1-3-7-16)12-20(19)31-24(35)21-13-22(25(27,28)29)32-33(21)18-8-4-5-15(11-18)14-30/h1-13,23,34H,14,30H2,(H,31,35)	SUGJHCONPCVXKJ-UHFFFAOYSA-N	416741	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-5-(hydroxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 34d::US10633345, Compound 34d::US10689346, Compound 34d::US11203574, Compound 34d::US11230530, Compound 34d::US11685721, Compound 34d	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416741	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416741&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665740	433916655							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287360	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(C(NCC2CC2)c2ccccc2)c1F)C(F)(F)F	InChI=1S/C29H27F4N5O/c30-26-22(27(35-17-18-12-13-18)20-7-2-1-3-8-20)10-5-11-23(26)36-28(39)24-15-25(29(31,32)33)37-38(24)21-9-4-6-19(14-21)16-34/h1-11,14-15,18,27,35H,12-13,16-17,34H2,(H,36,39)	YDBPNMJFMRHCIG-UHFFFAOYSA-N	416742	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 88b::US10633345, Compound 88b::US10689346, Compound 88b::US11203574, Compound 88b::US11230530, Compound 88b::US11685721, Compound 88b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416742	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416742&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123349010	433916656							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287361	CC(C)(C)N(Cc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(=O)c1ccccc1)C(F)(F)F)C([O-])=O	InChI=1S/C30H27F3N4O4/c1-29(2,3)36(28(40)41)18-19-9-7-14-23(15-19)37-24(17-25(35-37)30(31,32)33)27(39)34-22-13-8-12-21(16-22)26(38)20-10-5-4-6-11-20/h4-17H,18H2,1-3H3,(H,34,39)(H,40,41)/p-1	XIDGOQGGLXWZKU-UHFFFAOYSA-M	606288	US11685721, Compound 22b::tert-butyl3-(5-(3-benzoylphenylcarbamoyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzylcarbamate	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=606288	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=606288&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168474115	483497724							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287362	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(C(O)c2ccccc2)c1F)C(F)(F)F	InChI=1S/C25H20F4N4O2/c26-22-18(23(34)16-7-2-1-3-8-16)10-5-11-19(22)31-24(35)20-13-21(25(27,28)29)32-33(20)17-9-4-6-15(12-17)14-30/h1-13,23,34H,14,30H2,(H,31,35)	DENXCWXVTOPLRK-UHFFFAOYSA-N	416744	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-3-(hydroxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 35g::US10633345, Compound 35g::US10689346, Compound 35g::US11203574, Compound 35g::US11230530, Compound 35g::US11685721, Compound 35g	Plasma kallikrein		>75.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416744	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416744&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355965	433916658							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287363	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1nccs1)C(F)(F)F	InChI=1S/C26H24F3N5O2S/c27-26(28,29)22-13-21(34(33-22)20-6-1-3-17(11-20)14-30)24(35)32-19-5-2-4-18(12-19)23(25-31-9-10-37-25)36-15-16-7-8-16/h1-6,9-13,16,23H,7-8,14-15,30H2,(H,32,35)	FKPORVMTXYTRPN-UHFFFAOYSA-N	416745	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(thiazol-2-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 82f::US10633345, Compound 82f::US10689346, Compound 82f::US11203574, Compound 82f::US11230530, Compound 82f::US11685721, Compound 82f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416745	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416745&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355763	433916659							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287364	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(Oc2ccccc2)c1F)C(F)(F)F	InChI=1S/C24H18F4N4O2/c25-22-18(10-5-11-20(22)34-17-8-2-1-3-9-17)30-23(33)19-13-21(24(26,27)28)31-32(19)16-7-4-6-15(12-16)14-29/h1-13H,14,29H2,(H,30,33)	VUYMCUFLTORTFW-UHFFFAOYSA-N	416746	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-3-phenoxyphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 23c::US10633345, Compound 23c::US10689346, Compound 23c::US11203574, Compound 23c::US11230530, Compound 23c::US11685721, Compound 23c	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416746	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416746&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665745	433916660							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287365	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-23-12-11-21(27(39-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)35-28(38)25-15-26(29(31,32)33)36-37(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27H,9-10,16-17,34H2,(H,35,38)	HIMJVDQVZQMIPM-UHFFFAOYSA-N	416747	1-(3-(Aminomethyl)phenyl)-N-(5-((cyclopropylmethoxy)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 34c::US10633345, Compound 34c::US10689346, Compound 34c::US11203574, Compound 37a::US11230530, Compound 37a::US11685721, Compound 34c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416747	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416747&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355729	433916661							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287366	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C28H27F3N6O/c29-28(30,31)25-15-24(37(36-25)22-8-3-5-19(13-22)16-32)27(38)35-21-7-4-6-20(14-21)26(34-17-18-10-11-18)23-9-1-2-12-33-23/h1-9,12-15,18,26,34H,10-11,16-17,32H2,(H,35,38)	UTXGSCUKCKWESJ-UHFFFAOYSA-N	416748	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(pyridin-2-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 83c::US10633345, Compound 83c::US10689346, Compound 83c::US11203574, Compound 83c::US11230530, Compound 83c::US11685721, Compound 83c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416748	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416748&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355952	433916662							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287367	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(Oc2ccccc2)ccc1F)C(F)(F)F	InChI=1S/C24H18F4N4O2/c25-19-10-9-18(34-17-7-2-1-3-8-17)12-20(19)30-23(33)21-13-22(24(26,27)28)31-32(21)16-6-4-5-15(11-16)14-29/h1-13H,14,29H2,(H,30,33)	RDALDQDNCYVLAM-UHFFFAOYSA-N	416749	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-5-phenoxyphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 24c::US10633345, Compound 24c::US10689346, Compound 24c::US11203574, Compound 24c::US11230530, Compound 24c::US11685721, Compound 24c	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416749	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416749&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356123	433916663							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287368	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(Cl)c1ccccc1)C(F)(F)F	InChI=1S/C25H20ClF3N4O/c26-23(17-7-2-1-3-8-17)18-9-5-10-19(13-18)31-24(34)21-14-22(25(27,28)29)32-33(21)20-11-4-6-16(12-20)15-30/h1-14,23H,15,30H2,(H,31,34)	FUPVRPYDMAHTGM-UHFFFAOYSA-N	606295	1-(3-(aminomethyl)phenyl)-N-(3-(chloro(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US11685721, Compound 18e	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=606295	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=606295&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665749	483497731							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287369	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F3N4O2/c31-30(32,33)27-18-26(37(36-27)25-11-4-6-21(16-25)19-34)28(38)35-24-10-5-9-23(17-24)29(39,15-14-20-12-13-20)22-7-2-1-3-8-22/h1-11,16-18,20,39H,12-15,19,34H2,(H,35,38)	DCGYPXFSNPCKGX-UHFFFAOYSA-N	416751	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 46g::US10633345, Compound 46g::US10689346, Compound 46g::US11203574, Compound 46i::US11230530, Compound 46i::US11685721, Compound 46g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416751	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416751&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355790	433916665							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287370	CCOC(c1ccccc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C27H24F4N4O2/c1-2-37-25(18-8-4-3-5-9-18)19-11-12-21(28)22(14-19)33-26(36)23-15-24(27(29,30)31)34-35(23)20-10-6-7-17(13-20)16-32/h3-15,25H,2,16,32H2,1H3,(H,33,36)	YVBRMUSUELCGNA-UHFFFAOYSA-N	416752	1-(3-(aminomethyl)phenyl)-N-(5-(ethoxy(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 25b::US10633345, Compound 25b::US10689346, Compound 25b::US11203574, Compound 25b::US11230530, Compound 25b::US11685721, Compound 25b	Plasma kallikrein		>75.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416752	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416752&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665520	433916666							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287371	CC(C)[C@H](N)C(=O)OC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O3/c1-18(2)26(35)29(40)41-27(20-9-4-3-5-10-20)21-11-7-12-22(15-21)36-28(39)24-16-25(30(31,32)33)37-38(24)23-13-6-8-19(14-23)17-34/h3-16,18,26-27H,17,34-35H2,1-2H3,(H,36,39)/t26-,27?/m0/s1	OQCWFOUCOSAWQU-QBHOUYDASA-N	416753	(2S)-(3-(1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamido)phenyl)(phenyl)methyl 2-amino-3-methylbutanoate::US10329260, Compound 81c::US10633345, Compound 81c::US10689346, Compound 81c::US11203574, Compound 81c::US11230530, Compound 81c::US11685721, Compound 81c	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416753	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416753&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355992	433916667					C03317		1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287372	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-22-10-9-20(28(35,12-11-18-7-8-18)25-6-1-2-13-36-25)15-23(22)37-27(40)24-16-26(29(31,32)33)38-39(24)21-5-3-4-19(14-21)17-34/h1-6,9-10,13-16,18H,7-8,11-12,17,34-35H2,(H,37,40)	IFWBAIGKQKRJGJ-UHFFFAOYSA-N	416975	(+-)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 205d::US10633345, Compound 205c::US10689346, Compound 205e::US11203574, Compound 205e::US11230530, Compound 205e::US11685721, Compound 205f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416975	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416975&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665627	433916887							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287373	COC(c1ccccc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C26H22F4N4O2/c1-36-24(17-7-3-2-4-8-17)18-10-11-20(27)21(13-18)32-25(35)22-14-23(26(28,29)30)33-34(22)19-9-5-6-16(12-19)15-31/h2-14,24H,15,31H2,1H3,(H,32,35)	AJQPEPSKLFPFIU-UHFFFAOYSA-N	416755	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-5-(methoxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 25c::US10633345, Compound 25c::US10689346, Compound 25c::US11203574, Compound 25c::US11230530, Compound 25c::US11685721, Compound 25c	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416755	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416755&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126666045	433916669							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287374	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CC#N)c1ccccc1)C(F)(F)F	InChI=1S/C27H22F3N5O/c28-27(29,30)25-16-24(35(34-25)22-11-4-6-18(14-22)17-32)26(36)33-21-10-5-9-20(15-21)23(12-13-31)19-7-2-1-3-8-19/h1-11,14-16,23H,12,17,32H2,(H,33,36)	AUPCAIQBGWQVBR-UHFFFAOYSA-N	416756	1-(3-(aminomethyl)phenyl)-N-(3-(2-cyano-1-phenylethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 39e::US10633345, Compound 39e::US10689346, Compound 39e::US11203574, Compound 39e::US11230530, Compound 39e::US11685721, Compound 39e	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416756	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416756&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126666023	433916670							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287375	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CCC1CC1)n1ccnc1)C(F)(F)F	InChI=1S/C27H27F3N6O/c28-27(29,30)25-15-24(36(34-25)22-6-1-3-19(13-22)16-31)26(37)33-21-5-2-4-20(14-21)23(10-9-18-7-8-18)35-12-11-32-17-35/h1-6,11-15,17-18,23H,7-10,16,31H2,(H,33,37)	UPEDWOJFQGRWOZ-UHFFFAOYSA-N	416757	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-(1H-imidazol-1-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 89g::US10633345, Compound 89g::US10689346, Compound 89g::US11203574, Compound 89g::US11230530, Compound 89g::US11685721, Compound 89g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416757	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416757&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665540	433916671							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287376	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(Cc2ccccc2)ccc1F)C(F)(F)F	InChI=1S/C25H20F4N4O/c26-20-10-9-17(11-16-5-2-1-3-6-16)13-21(20)31-24(34)22-14-23(25(27,28)29)32-33(22)19-8-4-7-18(12-19)15-30/h1-10,12-14H,11,15,30H2,(H,31,34)	PFWDQKVXCJEZES-UHFFFAOYSA-N	416758	1-(3-(aminomethyl)phenyl)-N-(5-benzyl-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 26f::US10633345, Compound 26f::US10689346, Compound 26f::US11203574, Compound 26f::US11230530, Compound 26f::US11685721, Compound 26f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416758	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416758&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355900	433916672							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287377	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CC(N)=O)c1ccccc1)C(F)(F)F	InChI=1S/C27H24F3N5O2/c28-27(29,30)24-15-23(35(34-24)21-11-4-6-17(12-21)16-31)26(37)33-20-10-5-9-19(13-20)22(14-25(32)36)18-7-2-1-3-8-18/h1-13,15,22H,14,16,31H2,(H2,32,36)(H,33,37)	KDXRDWIYPXSJST-UHFFFAOYSA-N	416759	N-(3-(3-amino-3-oxo-1-phenylpropyl)phenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 40b::US10633345, Compound 40b::US10689346, Compound 40b::US11203574, Compound 40b::US11230530, Compound 40b::US11685721, Compound 40b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416759	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416759&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665680	433916673							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287378	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(=C\CC1CC1)\c1ccccc1)C(F)(F)F	InChI=1S/C30H27F3N4O/c31-30(32,33)28-18-27(37(36-28)25-11-4-6-21(16-25)19-34)29(38)35-24-10-5-9-23(17-24)26(15-14-20-12-13-20)22-7-2-1-3-8-22/h1-11,15-18,20H,12-14,19,34H2,(H,35,38)/b26-15+	VKLRLOSKQDEQAH-CVKSISIWSA-N	416760	(E/Z)-1-(3-(Aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-phenylprop-1-enyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide hydrochloride::US10329260, Compound 91a::US11203574, Compound 91a::US11685721, Compound 91a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416760	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416760&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			153066367	433916674							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287379	CC(C)COC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C29H29F3N4O2/c1-19(2)18-38-27(21-9-4-3-5-10-21)22-11-7-12-23(15-22)34-28(37)25-16-26(29(30,31)32)35-36(25)24-13-6-8-20(14-24)17-33/h3-16,19,27H,17-18,33H2,1-2H3,(H,34,37)	FMSXMXLNUZXXSC-UHFFFAOYSA-N	416762	1-(3-(aminomethyl)phenyl)-N-(3-(isobutoxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18i::US10633345, Compound 18i::US10689346, Compound 18i::US11203574, Compound 18i::US11230530, Compound 18i::US11685721, Compound 18i	Plasma kallikrein		>75.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416762	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416762&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356257	433916676							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287380	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(Cc2ccccc2NCC2CC2)c1)C(F)(F)F	InChI=1S/C29H28F3N5O/c30-29(31,32)27-16-26(37(36-27)24-9-4-6-21(15-24)17-33)28(38)35-23-8-3-5-20(14-23)13-22-7-1-2-10-25(22)34-18-19-11-12-19/h1-10,14-16,19,34H,11-13,17-18,33H2,(H,35,38)	PECONQSWBUWDBN-UHFFFAOYSA-N	416763	1-(3-(Aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(phenyl) methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 41e::US11685721, Compound 41e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416763	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416763&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			154584212	433916677							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287381	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C28H27F3N6O/c29-28(30,31)25-15-24(37(36-25)23-6-1-3-19(13-23)16-32)27(38)35-22-5-2-4-21(14-22)26(34-17-18-7-8-18)20-9-11-33-12-10-20/h1-6,9-15,18,26,34H,7-8,16-17,32H2,(H,35,38)	VXJYGPKEYKOJCQ-UHFFFAOYSA-N	416764	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(pyridin-4-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 86g::US10633345, Compound 86g::US10689346, Compound 86g::US11203574, Compound 86g::US11230530, Compound 86g::US11685721, Compound 86g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416764	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416764&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355880	433916678							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287382	CCCOC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C28H27F3N4O2/c1-2-14-37-26(20-9-4-3-5-10-20)21-11-7-12-22(16-21)33-27(36)24-17-25(28(29,30)31)34-35(24)23-13-6-8-19(15-23)18-32/h3-13,15-17,26H,2,14,18,32H2,1H3,(H,33,36)	ODVQLXVRAUDBCL-UHFFFAOYSA-N	416765	1-(3-(aminomethyl)phenyl)-N-(3-(phenyl(propoxy)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18h::US10633345, Compound 18k::US10689346, Compound 18h::US11203574, Compound 18h::US11230530, Compound 18h::US11685721, Compound 18h	Plasma kallikrein		>75.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416765	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416765&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665753	433916679							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287383	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F3N4O2/c31-30(32,33)27-18-26(37(36-27)25-11-4-6-21(16-25)19-34)29(38)35-24-10-5-9-23(17-24)28(22-7-2-1-3-8-22)39-15-14-20-12-13-20/h1-11,16-18,20,28H,12-15,19,34H2,(H,35,38)	WCAGCVGZCBBZDT-UHFFFAOYSA-N	416766	1-(3-(aminomethyl)phenyl)-N-(3-((2-cyclopropylethoxy)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 74a::US10689346, Compound 74a::US11203574, Compound 74a::US11230530, Compound 74a::US11685721, Compound 74a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416766	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416766&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665775	433916680							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287384	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-17-24(37(36-26)23-8-3-5-20(15-23)18-33)27(38)35-22-7-4-6-21(16-22)28(39,13-12-19-10-11-19)25-9-1-2-14-34-25/h1-9,14-17,19,39H,10-13,18,33H2,(H,35,38)	BAOACYBKKSTHLE-UHFFFAOYSA-N	416767	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 45g::US10633345, Compound 45g::US10689346, Compound 45g::US11203574, Compound 45g::US11230530, Compound 45g::US11685721, Compound 45g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416767	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416767&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665639	433916681							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287385	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(=O)Nc1ccccc1)C(F)(F)F	InChI=1S/C25H20F3N5O2/c26-25(27,28)22-14-21(33(32-22)20-11-4-6-16(12-20)15-29)24(35)31-19-10-5-7-17(13-19)23(34)30-18-8-2-1-3-9-18/h1-14H,15,29H2,(H,30,34)(H,31,35)	HDBCJKHEPGEJHK-UHFFFAOYSA-N	416768	1-(3-(aminomethyl)phenyl)-N-(3-(phenylcarbamoyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 21e::US10633345, Compound 21e::US10689346, Compound 21e::US11203574, Compound 21e::US11230530, Compound 21e::US11685721, Compound 21e	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416768	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416768&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665523	433916682							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287386	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CCC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F3N4O2/c31-30(32,33)27-17-26(37(36-27)25-14-5-9-21(15-25)18-34)29(38)35-24-13-6-12-23(16-24)28(22-10-2-1-3-11-22)39-19-20-7-4-8-20/h1-3,5-6,9-17,20,28H,4,7-8,18-19,34H2,(H,35,38)	KBAGRISCOGFVJB-UHFFFAOYSA-N	416769	1-(3-(aminomethyl)phenyl)-N-(3-((cyclobutylmethoxy)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 75a::US10633345, Compound 75a::US10689346, Compound 75a::US11203574, Compound 75a::US11230530, Compound 75a::US11685721, Compound 75a	Plasma kallikrein		>75.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416769	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416769&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665761	433916683							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287387	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-16-25(37(36-26)24-8-1-4-20(14-24)17-33)27(38)35-23-7-2-5-21(15-23)28(39,12-11-19-9-10-19)22-6-3-13-34-18-22/h1-8,13-16,18-19,39H,9-12,17,33H2,(H,35,38)	AOCZEQQKIIWUBU-UHFFFAOYSA-N	416770	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 47f::US10633345, Compound 47f::US10689346, Compound 47f::US11203574, Compound 47g::US11230530, Compound 47h::US11685721, Compound 47f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416770	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416770&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355766	433916684							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287388	CCCCOC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C29H29F3N4O2/c1-2-3-15-38-27(21-10-5-4-6-11-21)22-12-8-13-23(17-22)34-28(37)25-18-26(29(30,31)32)35-36(25)24-14-7-9-20(16-24)19-33/h4-14,16-18,27H,2-3,15,19,33H2,1H3,(H,34,37)	PKUIOUWZEKKIOY-UHFFFAOYSA-N	416772	1-(3-(aminomethyl)phenyl)-N-(3-(butoxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18j::US10633345, Compound 18j::US10689346, Compound 18j::US11203574, Compound 18j::US11230530, Compound 18j::US11685721, Compound 18j	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416772	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416772&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356140	433916686							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287389	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F4N5O/c30-23-12-11-21(27(35-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27,35H,9-10,16-17,34H2,(H,36,39)	MCLZOCFEIKBMBA-UHFFFAOYSA-N	416773	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 38d::US10633345, Compound 38d::US10689346, Compound 42a::US11203574, Compound 42a::US11230530, Compound 42a::US11685721, Compound 38d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416773	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416773&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356124	433916687							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287390	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-17-25(37(36-26)24-6-1-3-20(15-24)18-33)27(38)35-23-5-2-4-22(16-23)28(39,12-9-19-7-8-19)21-10-13-34-14-11-21/h1-6,10-11,13-17,19,39H,7-9,12,18,33H2,(H,35,38)	HEXYKZQZIBBLLM-UHFFFAOYSA-N	416774	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-(pyridin-4-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 92g::US10633345, Compound 92g::US10689346, Compound 92g::US11203574, Compound 92g::US11230530, Compound 92g::US11685721, Compound 92g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416774	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416774&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355890	433916688							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287391	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F3N4O2/c30-29(31,32)26-16-25(36(35-26)24-11-4-6-20(14-24)17-33)28(37)34-23-10-5-9-22(15-23)27(38-18-19-12-13-19)21-7-2-1-3-8-21/h1-11,14-16,19,27H,12-13,17-18,33H2,(H,34,37)	PEZVPVUPSJXZCH-UHFFFAOYSA-N	416775	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18k::US10633345, Compound 74a::US10689346, Compound 165e::US11203574, Compound 165e::US11230530, Compound 165e::US11685721, Compound 18k	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416775	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416775&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			91884591	433916689							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287392	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1ccc(F)c(c1)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-24-12-11-21(14-23(24)27(39-17-18-9-10-18)20-6-2-1-3-7-20)35-28(38)25-15-26(29(31,32)33)36-37(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27H,9-10,16-17,34H2,(H,35,38)	SMAPKFCZNNYDET-UHFFFAOYSA-N	416776	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)-4-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 76h::US10633345, Compound 76h::US10689346, Compound 76h::US11203574, Compound 76h::US11230530, Compound 76h::US11685721, Compound 76h	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416776	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416776&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356199	433916690							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287393	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cn[nH]c1)C(F)(F)F			416777	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(1H-pyrazol-4-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 84h::US10633345, Compound 84h::US10689346, Compound 84h::US11203574, Compound 84h::US11230530, Compound 84h::US11685721, Compound 84h	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416777	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416777&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			154584214	433916691							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287394	CCCN(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C27H26F3N5O/c1-2-14-34(21-10-4-3-5-11-21)22-12-7-9-20(16-22)32-26(36)24-17-25(27(28,29)30)33-35(24)23-13-6-8-19(15-23)18-31/h3-13,15-17H,2,14,18,31H2,1H3,(H,32,36)	IKJCTSPODFFZCP-UHFFFAOYSA-N	416778	1-(3-(aminomethyl)phenyl)-N-(3-(phenyl(propyl)amino)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 27f::US10633345, Compound 27f::US10689346, Compound 27f::US11203574, Compound 27f::US11230530, Compound 27f::US11685721, Compound 27f	Plasma kallikrein		>75.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416778	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416778&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356135	433916692							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287395	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(C(OCC2CC2)c2ccccc2)c1F)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-26-22(27(39-17-18-12-13-18)20-7-2-1-3-8-20)10-5-11-23(26)35-28(38)24-15-25(29(31,32)33)36-37(24)21-9-4-6-19(14-21)16-34/h1-11,14-15,18,27H,12-13,16-17,34H2,(H,35,38)	OCYVMBLZCJPYSX-UHFFFAOYSA-N	416779	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 36d::US10633345, Compound 36d::US10689346, Compound 36d::US11203574, Compound 36d::US11230530, Compound 36d::US11685721, Compound 36d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416779	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416779&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356266	433916693							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287396	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1nccs1)C(F)(F)F	InChI=1S/C26H25F3N6OS/c27-26(28,29)22-13-21(35(34-22)20-6-1-3-17(11-20)14-30)24(36)33-19-5-2-4-18(12-19)23(25-31-9-10-37-25)32-15-16-7-8-16/h1-6,9-13,16,23,32H,7-8,14-15,30H2,(H,33,36)	BPCHTFOGBGFGRD-UHFFFAOYSA-N	416780	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(thiazol-2-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 85c::US10633345, Compound 85c::US10689346, Compound 85c::US11203574, Compound 85c::US11230530, Compound 85c::US11685721, Compound 85c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416780	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416780&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355975	433916694							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287397	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CCC1CC1)N1CCOCC1)C(F)(F)F	InChI=1S/C28H32F3N5O2/c29-28(30,31)26-17-25(36(34-26)23-6-1-3-20(15-23)18-32)27(37)33-22-5-2-4-21(16-22)24(10-9-19-7-8-19)35-11-13-38-14-12-35/h1-6,15-17,19,24H,7-14,18,32H2,(H,33,37)	JPSOHZUNYZMZBS-UHFFFAOYSA-N	416781	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-morpholinopropyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 93b::US10633345, Compound 93b::US10689346, Compound 93b::US11203574, Compound 93b::US11230530, Compound 93b::US11685721, Compound 93b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416781	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416781&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665612	433916695							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287398	COc1cccc(c1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O2/c1-40-25-10-4-7-22(15-25)28(35-18-19-11-12-19)21-6-3-8-23(14-21)36-29(39)26-16-27(30(31,32)33)37-38(26)24-9-2-5-20(13-24)17-34/h2-10,13-16,19,28,35H,11-12,17-18,34H2,1H3,(H,36,39)	DMSXJIPDGRICQW-UHFFFAOYSA-N	416782	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(3-methoxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 109f::US10633345, Compound 109f::US10689346, Compound 109f::US11203574, Compound 109f::US11230530, Compound 109f::US11685721, Compound 109f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416782	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416782&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356265	433916696							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287399	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc2ccccc2c1)C(F)(F)F	InChI=1S/C33H30F3N5O/c34-33(35,36)30-18-29(41(40-30)28-10-3-5-22(15-28)19-37)32(42)39-27-9-4-8-25(17-27)31(38-20-21-11-12-21)26-14-13-23-6-1-2-7-24(23)16-26/h1-10,13-18,21,31,38H,11-12,19-20,37H2,(H,39,42)	QCSULFNIDZTXJZ-UHFFFAOYSA-N	416783	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic acid {3-[(cyclopropylmethyl-amino)-naphthalen-2-yl-methyl]-phenyl}-amide::US10329260, Compound 128g::US10633345, Compound 128g::US10689346, Compound 128g::US11203574, Compound 128g::US11230530, Compound 128g::US11685721, Compound 128g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416783	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416783&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665786	433916697							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287400	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H26F4N6O/c29-22-9-8-19(26(35-15-17-6-7-17)20-4-2-10-34-16-20)12-23(22)36-27(39)24-13-25(28(30,31)32)37-38(24)21-5-1-3-18(11-21)14-33/h1-5,8-13,16-17,26,35H,6-7,14-15,33H2,(H,36,39)	SECDZDWRLPONSX-UHFFFAOYSA-N	416784	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(pyridin-3-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 94b::US10633345, Compound 94b::US10689346, Compound 94b::US11203574, Compound 94b::US11230530, Compound 94b::US11685721, Compound 94b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416784	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416784&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355774	433916698							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287401	Cc1cccc(c1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O/c1-19-5-2-7-22(13-19)28(35-18-20-11-12-20)23-8-4-9-24(15-23)36-29(39)26-16-27(30(31,32)33)37-38(26)25-10-3-6-21(14-25)17-34/h2-10,13-16,20,28,35H,11-12,17-18,34H2,1H3,(H,36,39)	ADKXWAHEFSGGQB-UHFFFAOYSA-N	416785	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(m-tolyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 110f::US10633345, Compound 110f::US10689346, Compound 110f::US11203574, Compound 110f::US11230530, Compound 110f::US11685721, Compound 110f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416785	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416785&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123875262	433916699							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287402	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc2ccccc12)C(F)(F)F	InChI=1S/C33H30F3N5O/c34-33(35,36)30-18-29(41(40-30)26-11-3-6-22(16-26)19-37)32(42)39-25-10-4-9-24(17-25)31(38-20-21-14-15-21)28-13-5-8-23-7-1-2-12-27(23)28/h1-13,16-18,21,31,38H,14-15,19-20,37H2,(H,39,42)	NFYBGLSBONMUGA-UHFFFAOYSA-N	416786	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic acid {3-[(cyclopropylmethyl-amino)-naphthalen-1-yl-methyl]-phenyl}-amide::US10329260, Compound 129f::US10633345, Compound 129f::US10689346, Compound 129f::US11203574, Compound 129f::US11230530, Compound 129f::US11685721, Compound 129f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416786	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416786&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356190	433916700							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287403	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(cc(c1)C1CC1)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C32H32F3N5O/c33-32(34,35)29-17-28(40(39-29)27-8-4-5-21(13-27)18-36)31(41)38-26-15-24(22-11-12-22)14-25(16-26)30(37-19-20-9-10-20)23-6-2-1-3-7-23/h1-8,13-17,20,22,30,37H,9-12,18-19,36H2,(H,38,41)	TXFPQXDVPCBKSX-UHFFFAOYSA-N	439372	US10633345, Compound 95i::US10689346, Compound 95i::US11203574, Compound 95i::US11230530, Compound 95i::US11685721, Compound 95i	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439372	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439372&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665927	439660930							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287404	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc(c1)C(F)(F)F)C(F)(F)F	InChI=1S/C30H27F6N5O/c31-29(32,33)22-7-2-5-20(13-22)27(38-17-18-10-11-18)21-6-3-8-23(14-21)39-28(42)25-15-26(30(34,35)36)40-41(25)24-9-1-4-19(12-24)16-37/h1-9,12-15,18,27,38H,10-11,16-17,37H2,(H,39,42)	FZSHDRVSVGSKOF-UHFFFAOYSA-N	416788	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(3-(trifluoromethyl) phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 111f::US10633345, Compound 111f::US10689346, Compound 111f::US11203574, Compound 111f::US11230530, Compound 111f::US11685721, Compound 111f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416788	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416788&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355816	433916702							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287405	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccc(N)cc1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-23-11-8-20(27(36-16-17-4-5-17)19-6-9-21(35)10-7-19)13-24(23)37-28(40)25-14-26(29(31,32)33)38-39(25)22-3-1-2-18(12-22)15-34/h1-3,6-14,17,27,36H,4-5,15-16,34-35H2,(H,37,40)	QTGVDKNDDSXZLM-UHFFFAOYSA-N	416789	1-(3-(aminomethyl)phenyl)-N-(5-((4-aminophenyl)(cyclopropylmethylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 130g::US10633345, Compound 130g::US10689346, Compound 130g::US11203574, Compound 130g::US11230530, Compound 130g::US11685721, Compound 130g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416789	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416789&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665503	433916703							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287406	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1Cl)C(NCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H26ClF3N6O/c29-22-9-8-19(26(35-15-17-6-7-17)20-4-2-10-34-16-20)12-23(22)36-27(39)24-13-25(28(30,31)32)37-38(24)21-5-1-3-18(11-21)14-33/h1-5,8-13,16-17,26,35H,6-7,14-15,33H2,(H,36,39)	DCRDGEJSCMQMFA-UHFFFAOYSA-N	416790	1-(3-(Aminomethyl)phenyl)-N-(2-chloro-5-((cyclopropylmethylamino)(pyridin-3-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 96f::US10633345, Compound 96f::US10689346, Compound 96f::US11203574, Compound 96f::US11230530, Compound 96f::US11685721, Compound 96f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416790	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416790&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355757	433916704							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287407	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(cc1)S(N)(=O)=O)C(F)(F)F	InChI=1S/C29H29F3N6O3S/c30-29(31,32)26-15-25(38(37-26)23-6-1-3-19(13-23)16-33)28(39)36-22-5-2-4-21(14-22)27(35-17-18-7-8-18)20-9-11-24(12-10-20)42(34,40)41/h1-6,9-15,18,27,35H,7-8,16-17,33H2,(H,36,39)(H2,34,40,41)	BGEXZQITRMVFRR-UHFFFAOYSA-N	416791	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(4-sulfamoylphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 112g::US10633345, Compound 112g::US10689346, Compound 112g::US11203574, Compound 112g::US11230530, Compound 112g::US11685721, Compound 112g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416791	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416791&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355780	433916705							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287408	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-23-10-9-20(27(36-16-17-7-8-17)19-4-2-5-21(35)12-19)13-24(23)37-28(40)25-14-26(29(31,32)33)38-39(25)22-6-1-3-18(11-22)15-34/h1-6,9-14,17,27,36H,7-8,15-16,34-35H2,(H,37,40)	HJMCNZIVUWWSBV-UHFFFAOYSA-N	416792	1-(3-(aminomethyl)phenyl)-N-(5-((3-aminophenyl)(cyclopropylmethylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 131b::US10633345, Compound 131b::US10689346, Compound 131b::US11203574, Compound 131b::US11230530, Compound 131b::US11685721, Compound 131b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416792	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416792&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665555	433916706							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287409	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H25F4N5O2/c29-22-9-8-19(26(39-16-17-6-7-17)20-4-2-10-34-15-20)12-23(22)35-27(38)24-13-25(28(30,31)32)36-37(24)21-5-1-3-18(11-21)14-33/h1-5,8-13,15,17,26H,6-7,14,16,33H2,(H,35,38)	CNAFOXQNPWSINI-UHFFFAOYSA-N	416794	Racemic 1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethoxy)(pyridin-3-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 48f::US10633345, Compound 48f::US10689346, Compound 48f::US11203574, Compound 48g::US11230530, Compound 48h::US11685721, Compound 48f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416794	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416794&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355617	433916708							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287410	CS(=O)(=O)c1ccc(cc1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O3S/c1-42(40,41)25-12-10-21(11-13-25)28(35-18-19-8-9-19)22-5-3-6-23(15-22)36-29(39)26-16-27(30(31,32)33)37-38(26)24-7-2-4-20(14-24)17-34/h2-7,10-16,19,28,35H,8-9,17-18,34H2,1H3,(H,36,39)	UTLDYOFVUPHYMX-UHFFFAOYSA-N	416795	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(4-(methylsulfonyl)phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 113f::US10633345, Compound 113f::US10689346, Compound 113f::US11203574, Compound 113f::US11230530, Compound 113f::US11685721, Compound 113f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416795	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416795&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355808	433916709							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287411	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C28H26F4N6O/c29-22-7-6-20(26(35-16-17-4-5-17)19-8-10-34-11-9-19)13-23(22)36-27(39)24-14-25(28(30,31)32)37-38(24)21-3-1-2-18(12-21)15-33/h1-3,6-14,17,26,35H,4-5,15-16,33H2,(H,36,39)	JHXYEKYRIWFSRY-UHFFFAOYSA-N	416796	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(pyridin-4-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 132f::US10633345, Compound 132f::US10689346, Compound 132f::US11203574, Compound 132f::US11230530, Compound 132f::US11685721, Compound 132f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416796	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416796&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665438	433916710							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287412	CN1CCc2c(C1)ccc(NC(=O)c1cc(nn1-c1cccc(CN)c1)C(F)(F)F)c2F	InChI=1S/C22H21F4N5O/c1-30-8-7-16-14(12-30)5-6-17(20(16)23)28-21(32)18-10-19(22(24,25)26)29-31(18)15-4-2-3-13(9-15)11-27/h2-6,9-10H,7-8,11-12,27H2,1H3,(H,28,32)	XRSKJTRQFAFTLA-UHFFFAOYSA-N	416797	1-(3-(aminomethyl)phenyl)-N-(5-fluoro-2-methyl-1,2,3,4-tetrahydroisoquinolin-6-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 164e::US10633345, Compound 164e::US10689346, Compound 164e::US11203574, Compound 164e::US11230530, Compound 164e::US11685721, Compound 164e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416797	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416797&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665488	433916711							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287413	CS(=O)(=O)c1cccc(c1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O3S/c1-42(40,41)25-10-4-7-22(15-25)28(35-18-19-11-12-19)21-6-3-8-23(14-21)36-29(39)26-16-27(30(31,32)33)37-38(26)24-9-2-5-20(13-24)17-34/h2-10,13-16,19,28,35H,11-12,17-18,34H2,1H3,(H,36,39)	VJYAFYNZRBTGFW-UHFFFAOYSA-N	416798	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(3-(methylsulfonyl)phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 114f::US10633345, Compound 114f::US10689346, Compound 114f::US11203574, Compound 114f::US11230530, Compound 114f::US11685721, Compound 114f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416798	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416798&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665780	433916712							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287414	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(cc1)-c1ccccc1)C(F)(F)F	InChI=1S/C35H32F3N5O/c36-35(37,38)32-20-31(43(42-32)30-11-4-6-24(18-30)21-39)34(44)41-29-10-5-9-28(19-29)33(40-22-23-12-13-23)27-16-14-26(15-17-27)25-7-2-1-3-8-25/h1-11,14-20,23,33,40H,12-13,21-22,39H2,(H,41,44)	SZCMOETVRNQDRC-UHFFFAOYSA-N	416799	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic Acid {3-[biphenyl-4-yl-(cyclopropylmethyl-amino)-methyl]-phenyl}-amide::US10329260, Compound 133g::US10633345, Compound 133g::US10689346, Compound 133g::US11203574, Compound 133g::US11230530, Compound 133g::US11685721, Compound 133g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416799	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416799&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665928	433916713							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287415	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(F)cc(c1)C(O)c1ccccc1)C(F)(F)F	InChI=1S/C25H20F4N4O2/c26-18-10-17(23(34)16-6-2-1-3-7-16)11-19(12-18)31-24(35)21-13-22(25(27,28)29)32-33(21)20-8-4-5-15(9-20)14-30/h1-13,23,34H,14,30H2,(H,31,35)	WOQUHGPQEUKGPZ-UHFFFAOYSA-N	416800	1-(3-(aminomethyl)phenyl)-N-(3-fluoro-5-(hydroxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 97f::US10633345, Compound 97f::US10689346, Compound 97f::US11203574, Compound 97f::US11230530, Compound 97f::US11685721, Compound 97f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416800	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416800&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355887	433916714							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287416	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NC(=O)C1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F3N5O2/c30-29(31,32)25-16-24(37(36-25)23-11-4-6-18(14-23)17-33)28(39)34-22-10-5-9-21(15-22)26(19-7-2-1-3-8-19)35-27(38)20-12-13-20/h1-11,14-16,20,26H,12-13,17,33H2,(H,34,39)(H,35,38)	JNPDNCCSYJLXEM-UHFFFAOYSA-N	439388	US10633345, Compound 115e::US10689346, Compound 115e::US11203574, Compound 115e::US11230530, Compound 115e::US11685721, Compound 115e	Plasma kallikrein		>75.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439388	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439388&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665512	439660946							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287417	COc1ccc2cc(ccc2c1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H32F3N5O2/c1-44-29-13-12-23-15-26(11-10-24(23)17-29)32(39-20-21-8-9-21)25-5-3-6-27(16-25)40-33(43)30-18-31(34(35,36)37)41-42(30)28-7-2-4-22(14-28)19-38/h2-7,10-18,21,32,39H,8-9,19-20,38H2,1H3,(H,40,43)	YJEVEVIVXGFKBA-UHFFFAOYSA-N	416804	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic Acid {3-[(cyclopropylmethyl-amino)-(6-methoxy-naphthalen-2-yl)-methyl]-phenyl}-amide::US10329260, Compound 134f::US10633345, Compound 134f::US10689346, Compound 134f::US11203574, Compound 134f::US11230530, Compound 134f::US11685721, Compound 134f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416804	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416804&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356181	433916718							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287418	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CCC1CC1)N1CCCC1)C(F)(F)F	InChI=1S/C28H32F3N5O/c29-28(30,31)26-17-25(36(34-26)23-8-3-5-20(15-23)18-32)27(37)33-22-7-4-6-21(16-22)24(12-11-19-9-10-19)35-13-1-2-14-35/h3-8,15-17,19,24H,1-2,9-14,18,32H2,(H,33,37)	LGRABUBILIXIOO-UHFFFAOYSA-N	416805	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-(pyrrolidin-1-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 98b::US11685721, Compound 98b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416805	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416805&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123509304	433916719							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287419	CCc1cccc(c1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C31H32F3N5O/c1-2-20-6-3-8-23(14-20)29(36-19-21-12-13-21)24-9-5-10-25(16-24)37-30(40)27-17-28(31(32,33)34)38-39(27)26-11-4-7-22(15-26)18-35/h3-11,14-17,21,29,36H,2,12-13,18-19,35H2,1H3,(H,37,40)	YUWQOWXTNOVILU-UHFFFAOYSA-N	416807	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(3-ethylphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 116e::US10633345, Compound 116e::US10689346, Compound 116e::US11203574, Compound 116e::US11230530, Compound 116e::US11685721, Compound 116e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416807	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416807&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123342870	433916721							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287420	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(O)cc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-25(37(36-26)23-6-1-3-19(13-23)16-33)28(39)35-22-5-2-4-21(14-22)27(34-17-18-7-8-18)20-9-11-24(38)12-10-20/h1-6,9-15,18,27,34,38H,7-8,16-17,33H2,(H,35,39)	GDUMJZLASJIDFD-UHFFFAOYSA-N	416808	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(4-hydroxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 135c::US10633345, Compound 135c::US10689346, Compound 135c::US11203574, Compound 135c::US11230530, Compound 135c::US11685721, Compound 135c	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416808	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416808&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355747	433916722							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287421	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CNC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-16-25(37(36-26)24-11-4-6-19(14-24)17-33)27(38)35-23-10-5-9-21(15-23)28(39,18-34-22-12-13-22)20-7-2-1-3-8-20/h1-11,14-16,22,34,39H,12-13,17-18,33H2,(H,35,38)	WTFGPUOPMMMRIY-UHFFFAOYSA-N	416809	1-(3-(aminomethyl)phenyl)-N-(3-(2-(cyclopropylamino)-1-hydroxy-1-phenylethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 99g::US10633345, Compound 99g::US10689346, Compound 99g::US11203574, Compound 99g::US11230530, Compound 99g::US11685721, Compound 99g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416809	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416809&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355899	433916723							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287422	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1F)C(F)(F)F	InChI=1S/C29H27F4N5O/c30-24-10-2-1-9-23(24)27(35-17-18-11-12-18)20-6-4-7-21(14-20)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-3-5-19(13-22)16-34/h1-10,13-15,18,27,35H,11-12,16-17,34H2,(H,36,39)	XNBKWIREUIHXKI-UHFFFAOYSA-N	416810	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2-fluorophenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 117e::US10329260, Compound 119e::US10633345, Compound 117e::US10689346, Compound 117e::US11203574, Compound 117e::US11230530, Compound 117e::US11685721, Compound 117e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416810	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416810&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123243852	433916724							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287423	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(Cc2ccc(O)cc2)c1)C(F)(F)F	InChI=1S/C25H21F3N4O2/c26-25(27,28)23-14-22(32(31-23)20-6-2-4-18(13-20)15-29)24(34)30-19-5-1-3-17(12-19)11-16-7-9-21(33)10-8-16/h1-10,12-14,33H,11,15,29H2,(H,30,34)	OPPQXCJMBFITBL-UHFFFAOYSA-N	416811	1-(3-(Aminomethyl)phenyl)-N-(3-(4-hydroxybenzyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 136a::US10633345, Compound 136a::US10689346, Compound 136a::US11203574, Compound 136a::US11230530, Compound 136a::US11685721, Compound 136a	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416811	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416811&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356271	433916725							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287424	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C28H26F4N6O/c29-21-10-9-19(26(35-16-17-7-8-17)22-6-1-2-11-34-22)13-23(21)36-27(39)24-14-25(28(30,31)32)37-38(24)20-5-3-4-18(12-20)15-33/h1-6,9-14,17,26,35H,7-8,15-16,33H2,(H,36,39)	NHHQSQFDXMXIJU-UHFFFAOYSA-N	416812	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(pyridin-2-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 100e::US10633345, Compound 100e::US10689346, Compound 100e::US11203574, Compound 100e::US11230530, Compound 100e::US11685721, Compound 100e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416812	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416812&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356158	433916726							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287425	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1c2ccccc2c(Cl)c2ccccc12)C(F)(F)F	InChI=1S/C37H31ClF3N5O/c38-34-29-13-3-1-11-27(29)33(28-12-2-4-14-30(28)34)35(43-21-22-15-16-22)24-8-6-9-25(18-24)44-36(47)31-19-32(37(39,40)41)45-46(31)26-10-5-7-23(17-26)20-42/h1-14,17-19,22,35,43H,15-16,20-21,42H2,(H,44,47)	WNAKJZQMCRSZKD-UHFFFAOYSA-N	416813	1-(3-(aminomethyl)phenyl)-N-(3-((10-chloroanthracen-9-yl)(cyclopropylmethylamino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 118f::US10633345, Compound 118f::US10689346, Compound 118f::US11203574, Compound 118f::US11230530, Compound 118f::US11685721, Compound 118f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416813	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416813&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355872	433916727							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287426	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc(O)c1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-25(37(36-26)23-8-1-4-19(12-23)16-33)28(39)35-22-7-2-5-20(13-22)27(34-17-18-10-11-18)21-6-3-9-24(38)14-21/h1-9,12-15,18,27,34,38H,10-11,16-17,33H2,(H,35,39)	WNKOEKOISOIHSR-UHFFFAOYSA-N	416814	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(3-hydroxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 137a::US10633345, Compound 137a::US10689346, Compound 137a::US11203574, Compound 137a::US11230530, Compound 137a::US11685721, Compound 137a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416814	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416814&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355922	433916728							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287427	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1nccs1)C(F)(F)F	InChI=1S/C26H24F4N6OS/c27-19-7-6-17(23(25-32-8-9-38-25)33-14-15-4-5-15)11-20(19)34-24(37)21-12-22(26(28,29)30)35-36(21)18-3-1-2-16(10-18)13-31/h1-3,6-12,15,23,33H,4-5,13-14,31H2,(H,34,37)	FBQBHRBLNRXXHC-UHFFFAOYSA-N	416815	1-(3-(Aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(thiazol-2-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 101e::US10633345, Compound 101e::US10689346, Compound 101e::US11203574, Compound 101e::US11230530, Compound 101e::US11685721, Compound 101e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416815	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416815&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355606	433916729							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287428	COc1ccccc1C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O2/c1-40-26-11-3-2-10-24(26)28(35-18-19-12-13-19)21-7-5-8-22(15-21)36-29(39)25-16-27(30(31,32)33)37-38(25)23-9-4-6-20(14-23)17-34/h2-11,14-16,19,28,35H,12-13,17-18,34H2,1H3,(H,36,39)	DAKZTBMQWXCVFA-UHFFFAOYSA-N	439400	US10633345, Compound 119e::US10689346, Compound 119e::US11203574, Compound 119e::US11230530, Compound 119e::US11685721, Compound 120e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439400	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439400&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665475	439660958							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287429	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(Cc2cccc(O)c2)c1)C(F)(F)F	InChI=1S/C25H21F3N4O2/c26-25(27,28)23-14-22(32(31-23)20-8-2-6-18(12-20)15-29)24(34)30-19-7-1-4-16(11-19)10-17-5-3-9-21(33)13-17/h1-9,11-14,33H,10,15,29H2,(H,30,34)	SDKHQNOIRDBHTG-UHFFFAOYSA-N	416820	1-(3-(aminomethyl)phenyl)-N-(3-(3-hydroxybenzyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 137b::US10633345, Compound 137b::US10689346, Compound 137b::US11203574, Compound 137b::US11230530, Compound 137b::US11685721, Compound 137b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416820	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416820&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665628	433916733							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287430	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H29F3N6O/c30-29(31,32)26-15-25(38(37-26)24-9-1-4-19(12-24)16-33)28(39)36-23-8-3-6-21(14-23)27(35-17-18-10-11-18)20-5-2-7-22(34)13-20/h1-9,12-15,18,27,35H,10-11,16-17,33-34H2,(H,36,39)	JHOLOXZJFLDOCM-UHFFFAOYSA-N	416821	1-(3-(aminomethyl)phenyl)-N-(3-((3-aminophenyl)(cyclopropylmethylamino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 102b::US11192861, Compound 102b::US11685721, Compound 102b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416821	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416821&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665659	433916734							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287431	COc1ccccc1C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O2/c1-40-26-11-3-2-10-24(26)28(35-18-19-12-13-19)21-7-5-8-22(15-21)36-29(39)25-16-27(30(31,32)33)37-38(25)23-9-4-6-20(14-23)17-34/h2-11,14-16,19,28,35H,12-13,17-18,34H2,1H3,(H,36,39)	DAKZTBMQWXCVFA-UHFFFAOYSA-N	439400	US10633345, Compound 119e::US10689346, Compound 119e::US11203574, Compound 119e::US11230530, Compound 119e::US11685721, Compound 120e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439400	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439400&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665475	439660958							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287432	CC(=O)Nc1ccc(cc1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C31H31F3N6O2/c1-19(41)37-24-12-10-22(11-13-24)29(36-18-20-8-9-20)23-5-3-6-25(15-23)38-30(42)27-16-28(31(32,33)34)39-40(27)26-7-2-4-21(14-26)17-35/h2-7,10-16,20,29,36H,8-9,17-18,35H2,1H3,(H,37,41)(H,38,42)	JDALRNHKHTYPON-UHFFFAOYSA-N	416827	N-(3-((4-acetamidophenyl)(cyclopropylmethylamino)methyl)phenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 138f::US10633345, Compound 138f::US10689346, Compound 138f::US11203574, Compound 138f::US11230530, Compound 138f::US11685721, Compound 138f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416827	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416827&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355810	433916740							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287433	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CCC1CC1)c1cc[nH]c1)C(F)(F)F			416828	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-(1H-pyrrol-3-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 103b::US10633345, Compound 103b::US10689346, Compound 103b::US11203574, Compound 103b::US11230530, Compound 103b::US11685721, Compound 103b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416828	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416828&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355898	433916741							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287434	Cc1ccc(cc1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O/c1-19-8-12-22(13-9-19)28(35-18-20-10-11-20)23-5-3-6-24(15-23)36-29(39)26-16-27(30(31,32)33)37-38(26)25-7-2-4-21(14-25)17-34/h2-9,12-16,20,28,35H,10-11,17-18,34H2,1H3,(H,36,39)	HRCLMMKOPKWJGF-UHFFFAOYSA-N	416829	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(p-tolyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 122g::US10633345, Compound 122g::US10689346, Compound 122g::US11203574, Compound 122g::US11230530, Compound 122g::US11685721, Compound 122g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416829	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416829&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355867	433916742							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287435	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C30H26F4N6O/c31-24-11-10-22(28(37-17-19-4-5-19)21-8-6-18(15-35)7-9-21)13-25(24)38-29(41)26-14-27(30(32,33)34)39-40(26)23-3-1-2-20(12-23)16-36/h1-3,6-14,19,28,37H,4-5,16-17,36H2,(H,38,41)	GLPWOIBPISJWCH-UHFFFAOYSA-N	416830	1-(3-(aminomethyl)phenyl)-N-(5-((4-cyanophenyl)(cyclopropyl-methylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 52h::US11685721, Compound 71b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416830	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416830&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355582	433916743							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287436	Cn1cc(cn1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C27H28F3N7O/c1-36-16-20(15-33-36)25(32-14-17-8-9-17)19-5-3-6-21(11-19)34-26(38)23-12-24(27(28,29)30)35-37(23)22-7-2-4-18(10-22)13-31/h2-7,10-12,15-17,25,32H,8-9,13-14,31H2,1H3,(H,34,38)	GHANDLPUFXRHQK-UHFFFAOYSA-N	416831	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(1-methyl-1H-pyrazol-4-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 104f::US10633345, Compound 104f::US10689346, Compound 104f::US11203574, Compound 104f::US11230530, Compound 104f::US11685721, Compound 104f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416831	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416831&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356100	433916744							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287437	CS(=O)(=O)c1ccccc1C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O3S/c1-42(40,41)26-11-3-2-10-24(26)28(35-18-19-12-13-19)21-7-5-8-22(15-21)36-29(39)25-16-27(30(31,32)33)37-38(25)23-9-4-6-20(14-23)17-34/h2-11,14-16,19,28,35H,12-13,17-18,34H2,1H3,(H,36,39)	XEAXHMDONDJJBQ-UHFFFAOYSA-N	416832	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2-(methylsulfonyl)phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 121f::US10633345, Compound 121f::US10689346, Compound 121f::US11203574, Compound 121f::US11230530, Compound 121f::US11685721, Compound 121f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416832	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416832&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665701	433916745							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287438	NCc1ccc(cc1)C(NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F4N6O/c31-24-11-10-22(28(37-17-19-4-5-19)21-8-6-18(15-35)7-9-21)13-25(24)38-29(41)26-14-27(30(32,33)34)39-40(26)23-3-1-2-20(12-23)16-36/h1-3,6-14,19,28,37H,4-5,15-17,35-36H2,(H,38,41)	AYTAHYJWZGLMOI-UHFFFAOYSA-N	416833	1-(3-(aminomethyl)phenyl)-N-(5-((4-(aminomethyl)phenyl)(cyclopropylmethylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 139b::US11685721, Compound 139b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416833	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416833&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665498	433916746							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287439	COc1ccc(cc1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O2/c1-40-25-12-10-21(11-13-25)28(35-18-19-8-9-19)22-5-3-6-23(15-22)36-29(39)26-16-27(30(31,32)33)37-38(26)24-7-2-4-20(14-24)17-34/h2-7,10-16,19,28,35H,8-9,17-18,34H2,1H3,(H,36,39)	NTRWDZUFVXMYGD-UHFFFAOYSA-N	416834	1-(3-(Aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(4-methoxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 105g::US10633345, Compound 105g::US10689346, Compound 105g::US11203574, Compound 105g::US11230530, Compound 105g::US11685721, Compound 105g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416834	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416834&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665521	433916747							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287440	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(OCc2ccccc2)cc1)C(F)(F)F	InChI=1S/C36H34F3N5O2/c37-36(38,39)33-20-32(44(43-33)30-11-4-8-26(18-30)21-40)35(45)42-29-10-5-9-28(19-29)34(41-22-24-12-13-24)27-14-16-31(17-15-27)46-23-25-6-2-1-3-7-25/h1-11,14-20,24,34,41H,12-13,21-23,40H2,(H,42,45)	AKMGFHNAHQDIKU-UHFFFAOYSA-N	439412	US10633345, Compound 123g::US10689346, Compound 123g::US11203574, Compound 123g::US11230530, Compound 123g::US11685721, Compound 107f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439412	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439412&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665739	439660970							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287441	Cc1cccc(c1)C(NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H29F4N5O/c1-18-4-2-6-21(12-18)28(36-17-19-8-9-19)22-10-11-24(31)25(14-22)37-29(40)26-15-27(30(32,33)34)38-39(26)23-7-3-5-20(13-23)16-35/h2-7,10-15,19,28,36H,8-9,16-17,35H2,1H3,(H,37,40)	DWXIBXKRESUYFO-UHFFFAOYSA-N	416836	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(m-tolyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 140e::US10633345, Compound 140e::US10689346, Compound 140e::US11203574, Compound 140e::US11230530, Compound 140e::US11685721, Compound 140e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416836	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416836&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356147	433916749							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287442	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1O)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-24(37(36-26)22-8-3-5-19(13-22)16-33)28(39)35-21-7-4-6-20(14-21)27(34-17-18-11-12-18)23-9-1-2-10-25(23)38/h1-10,13-15,18,27,34,38H,11-12,16-17,33H2,(H,35,39)	PCNDJIQOMLHSEK-UHFFFAOYSA-N	416837	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2-hydroxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 49h::US10633345, Compound 49h::US10689346, Compound 49h::US11203574, Compound 49j::US11230530, Compound 49j::US11685721, Compound 49h	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416837	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416837&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355733	433916750							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287443	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc(OC(F)(F)F)c1)C(F)(F)F	InChI=1S/C30H27F6N5O2/c31-29(32,33)26-15-25(41(40-26)23-8-1-4-19(12-23)16-37)28(42)39-22-7-2-5-20(13-22)27(38-17-18-10-11-18)21-6-3-9-24(14-21)43-30(34,35)36/h1-9,12-15,18,27,38H,10-11,16-17,37H2,(H,39,42)	IVEYKJBEIIJLCR-UHFFFAOYSA-N	416838	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(3-(trifluoromethoxy) phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 124f::US10633345, Compound 124f::US10689346, Compound 124f::US11203574, Compound 124f::US11230530, Compound 124f::US11685721, Compound 124f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416838	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416838&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665809	433916751							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287444	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C1OC(=O)Nc2ccccc12)C(F)(F)F	InChI=1S/C26H20F3N5O3/c27-26(28,29)22-13-21(34(33-22)18-8-3-5-15(11-18)14-30)24(35)31-17-7-4-6-16(12-17)23-19-9-1-2-10-20(19)32-25(36)37-23/h1-13,23H,14,30H2,(H,31,35)(H,32,36)	LRCHTKOMIAYQHX-UHFFFAOYSA-N	416839	1-(3-(aminomethyl)phenyl)-N-(3-(2-oxo-2,4-dihydro-1H-benzo[d][1,3]oxazin-4-yl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 167f::US10633345, Compound 167f::US10689346, Compound 167f::US11203574, Compound 167f::US11230530, Compound 167f::US11685721, Compound 167f	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416839	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416839&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665868	433916752							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287445	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1OCc1ccccc1)C(F)(F)F	InChI=1S/C36H34F3N5O2/c37-36(38,39)33-20-31(44(43-33)29-13-6-10-26(18-29)21-40)35(45)42-28-12-7-11-27(19-28)34(41-22-24-16-17-24)30-14-4-5-15-32(30)46-23-25-8-2-1-3-9-25/h1-15,18-20,24,34,41H,16-17,21-23,40H2,(H,42,45)	XAZZTVOUWUHFIG-UHFFFAOYSA-N	416840	1-(3-(aminomethyl)phenyl)-N-(3-((2-(benzyloxy)phenyl)(cyclopropylmethyl amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 106a::US10633345, Compound 106a::US10689346, Compound 106a::US11203574, Compound 106a::US11230530, Compound 106a::US11685721, Compound 106a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416840	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416840&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356273	433916753							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287446	COc1ccc2ccccc2c1C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H32F3N5O2/c1-44-29-15-14-23-7-2-3-11-27(23)31(29)32(39-20-21-12-13-21)24-8-5-9-25(17-24)40-33(43)28-18-30(34(35,36)37)41-42(28)26-10-4-6-22(16-26)19-38/h2-11,14-18,21,32,39H,12-13,19-20,38H2,1H3,(H,40,43)	XVOUQCJHWNZPKF-UHFFFAOYSA-N	416841	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2-methoxynaphthalen-1-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 51f::US10633345, Compound 51f::US10689346, Compound 51f::US11203574, Compound 51h::US11230530, Compound 51h::US11685721, Compound 51f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416841	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416841&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356155	433916754							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287447	COc1cccc(c1)C(NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H29F4N5O2/c1-41-23-7-3-5-20(13-23)28(36-17-18-8-9-18)21-10-11-24(31)25(14-21)37-29(40)26-15-27(30(32,33)34)38-39(26)22-6-2-4-19(12-22)16-35/h2-7,10-15,18,28,36H,8-9,16-17,35H2,1H3,(H,37,40)	MRNMVRANILFBMK-UHFFFAOYSA-N	416842	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(3-methoxyphenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 141e::US10633345, Compound 141e::US10689346, Compound 141e::US11203574, Compound 141e::US11230530, Compound 141e::US11685721, Compound 142f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416842	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416842&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355803	433916755							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287448	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(N)cc1)C(F)(F)F	InChI=1S/C29H29F3N6O/c30-29(31,32)26-15-25(38(37-26)24-6-1-3-19(13-24)16-33)28(39)36-23-5-2-4-21(14-23)27(35-17-18-7-8-18)20-9-11-22(34)12-10-20/h1-6,9-15,18,27,35H,7-8,16-17,33-34H2,(H,36,39)	XDCYYWMSVYTRMZ-UHFFFAOYSA-N	416843	1-(3-(aminomethyl)phenyl)-N-(3-((4-aminophenyl)(cyclopropylmethyl-amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 50f::US10633345, Compound 50f::US10689346, Compound 50h::US11203574, Compound 50h::US11230530, Compound 50h::US11685721, Compound 50f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416843	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416843&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355587	433916756							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287449	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cc2ccccc2c2ccccc12)C(F)(F)F	InChI=1S/C37H32F3N5O/c38-37(39,40)34-20-33(45(44-34)28-11-5-7-24(17-28)21-41)36(46)43-27-10-6-9-26(18-27)35(42-22-23-15-16-23)32-19-25-8-1-2-12-29(25)30-13-3-4-14-31(30)32/h1-14,17-20,23,35,42H,15-16,21-22,41H2,(H,43,46)	OZXXGJIBGVGMMV-UHFFFAOYSA-N	416844	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic acid {3-[(cyclopropylmethyl-amino)-phenanthren-9-yl-methyl]-phenyl}-amide::US10329260, Compound 125g::US10633345, Compound 125g::US10689346, Compound 125g::US11203574, Compound 125g::US11230530, Compound 125g::US11685721, Compound 125g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416844	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416844&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665609	433916757							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287450	COc1cccc(c1)C(NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H29F4N5O2/c1-41-23-7-3-5-20(13-23)28(36-17-18-8-9-18)21-10-11-24(31)25(14-21)37-29(40)26-15-27(30(32,33)34)38-39(26)22-6-2-4-19(12-22)16-35/h2-7,10-15,18,28,36H,8-9,16-17,35H2,1H3,(H,37,40)	MRNMVRANILFBMK-UHFFFAOYSA-N	416842	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(3-methoxyphenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 141e::US10633345, Compound 141e::US10689346, Compound 141e::US11203574, Compound 141e::US11230530, Compound 141e::US11685721, Compound 142f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416842	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416842&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355803	433916755							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287451	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(OCc2ccccc2)cc1)C(F)(F)F	InChI=1S/C36H34F3N5O2/c37-36(38,39)33-20-32(44(43-33)30-11-4-8-26(18-30)21-40)35(45)42-29-10-5-9-28(19-29)34(41-22-24-12-13-24)27-14-16-31(17-15-27)46-23-25-6-2-1-3-7-25/h1-11,14-20,24,34,41H,12-13,21-23,40H2,(H,42,45)	AKMGFHNAHQDIKU-UHFFFAOYSA-N	439412	US10633345, Compound 123g::US10689346, Compound 123g::US11203574, Compound 123g::US11230530, Compound 123g::US11685721, Compound 107f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439412	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439412&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665739	439660970							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287452	CN(C)c1ccc(C(NCC2CC2)c2cccc(NC(=O)c3cc(nn3-c3cccc(CN)c3)C(F)(F)F)c2)c2ccccc12	InChI=1S/C35H35F3N6O/c1-43(2)30-16-15-29(27-11-3-4-12-28(27)30)33(40-21-22-13-14-22)24-8-6-9-25(18-24)41-34(45)31-19-32(35(36,37)38)42-44(31)26-10-5-7-23(17-26)20-39/h3-12,15-19,22,33,40H,13-14,20-21,39H2,1-2H3,(H,41,45)	IQAVMSNXUBZMCB-UHFFFAOYSA-N	416847	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic acid {3-[(cyclopropylmethyl-amino)-(4-dimethylamino-naphthalen-1-yl)-methyl]-phenyl}-amide::US10329260, Compound 126g::US10633345, Compound 126g::US10689346, Compound 126g::US11203574, Compound 126g::US11230530, Compound 126g::US11685721, Compound 126g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416847	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416847&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355601	433916760							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287453	Cc1cc(C(=O)Nc2cccc(c2)C(NCC2CC2)c2ccccc2)n(n1)-c1cccc(CN)c1	InChI=1S/C29H31N5O/c1-20-15-27(34(33-20)26-12-5-7-22(16-26)18-30)29(35)32-25-11-6-10-24(17-25)28(31-19-21-13-14-21)23-8-3-2-4-9-23/h2-12,15-17,21,28,31H,13-14,18-19,30H2,1H3,(H,32,35)	GPDBDHGXUBYWPY-UHFFFAOYSA-N	416848	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(phenyl)methyl)phenyl)-3-methyl-1H-pyrazole-5-carboxamid::US10329260, Compound 143l::US10633345, Compound 143l::US10689346, Compound 143l::US11203574, Compound 143l::US11230530, Compound 143l::US11685721, Compound 143l	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416848	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416848&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356139	433916761							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287454	NCc1cccc(c1)N(CC1CC1)Cc1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H31F3N6O/c31-30(32,33)28-15-27(39(37-28)26-9-3-5-22(14-26)17-35)29(40)36-24-7-1-6-23(12-24)19-38(18-20-10-11-20)25-8-2-4-21(13-25)16-34/h1-9,12-15,20H,10-11,16-19,34-35H2,(H,36,40)	KWKGWXUNXWXADH-UHFFFAOYSA-N	416849	1-(3-(Aminomethyl)phenyl)-N-(3-((3-(aminomethyl)phenyl)(cyclopropylmethylamino) methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 108e::US11685721, Compound 108e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416849	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416849&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			154584226	433916762							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287455	CCCOc1ccc(cc1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C32H34F3N5O2/c1-2-15-42-27-13-11-23(12-14-27)30(37-20-21-9-10-21)24-6-4-7-25(17-24)38-31(41)28-18-29(32(33,34)35)39-40(28)26-8-3-5-22(16-26)19-36/h3-8,11-14,16-18,21,30,37H,2,9-10,15,19-20,36H2,1H3,(H,38,41)	BSIABEDKJHMBRX-UHFFFAOYSA-N	416850	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic acid {3-[(cyclopropylmethyl-amino)-(4-propoxy-phenyl)-methyl]-phenyl}-amide::US10329260, Compound 127f::US10633345, Compound 127f::US10689346, Compound 127f::US11203574, Compound 127f::US11230530, Compound 127f::US11685721, Compound 127f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416850	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416850&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356061	433916763							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287456	CC(C)NC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C28H28F3N5O/c1-18(2)33-26(20-9-4-3-5-10-20)21-11-7-12-22(15-21)34-27(37)24-16-25(28(29,30)31)35-36(24)23-13-6-8-19(14-23)17-32/h3-16,18,26,33H,17,32H2,1-2H3,(H,34,37)	XNDGACONQUBLGK-UHFFFAOYSA-N	416851	1-(3-(Aminomethyl)phenyl)-N-(3-((isopropylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 144d::US10633345, Compound 144d::US10689346, Compound 144d::US11203574, Compound 144d::US11230530, Compound 144d::US11685721, Compound 144d	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416851	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416851&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355596	433916764							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287457	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCCO)c1ccccc1)C(F)(F)F	InChI=1S/C27H26F3N5O2/c28-27(29,30)24-16-23(35(34-24)22-11-4-6-18(14-22)17-31)26(37)33-21-10-5-9-20(15-21)25(32-12-13-36)19-7-2-1-3-8-19/h1-11,14-16,25,32,36H,12-13,17,31H2,(H,33,37)	MMNKSYPQOFLCSY-UHFFFAOYSA-N	416852	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic acid {3-[(2-hydroxy-ethylamino)-phenyl-methyl]-phenyl}-amide::US10329260, Compound 145c::US10633345, Compound 145c::US10689346, Compound 145c::US11203574, Compound 145c::US11230530, Compound 145c::US11685721, Compound 145c	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416852	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416852&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123569320	433916765							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287458	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-10-9-20(27(40-16-17-7-8-17)19-4-2-5-21(35)12-19)13-24(23)36-28(39)25-14-26(29(31,32)33)37-38(25)22-6-1-3-18(11-22)15-34/h1-6,9-14,17,27H,7-8,15-16,34-35H2,(H,36,39)	GBDDXSAKQKODCG-UHFFFAOYSA-N	416853	1-(3-(aminomethyl)phenyl)-N-(5-((3-aminophenyl)(cyclopropylmethoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 57e::US10633345, Compound 65b::US10689346, Compound 65b::US11203574, Compound 65a::US11230530, Compound 65b::US11685721, Compound 57e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416853	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416853&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355865	433916766							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287459	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(N[C@H]1CC[C@H](O)CC1)c1ccccc1)C(F)F	InChI=1S/C31H33F2N5O2/c32-30(33)27-18-28(38(37-27)25-11-4-6-20(16-25)19-34)31(40)36-24-10-5-9-22(17-24)29(21-7-2-1-3-8-21)35-23-12-14-26(39)15-13-23/h1-11,16-18,23,26,29-30,35,39H,12-15,19,34H2,(H,36,40)/t23-,26-,29?	PTRYTCASPXUEMF-APJPSQSRSA-N	606386	1-(3-(Aminomethyl)phenyl)-N-(3-((((trans)-4-hydroxycyclohexyl)amino)(phenyl)(methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US11685721, Compound 181b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=606386	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=606386&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168474155	483497821							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287460	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cc(O)ccc1O)C(F)(F)F	InChI=1S/C29H28F3N5O3/c30-29(31,32)26-14-24(37(36-26)21-6-1-3-18(11-21)15-33)28(40)35-20-5-2-4-19(12-20)27(34-16-17-7-8-17)23-13-22(38)9-10-25(23)39/h1-6,9-14,17,27,34,38-39H,7-8,15-16,33H2,(H,35,40)	DKHIWHHPRHHORX-UHFFFAOYSA-N	606387	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2,5-dihydroxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US11685721, Compound 146g	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=606387	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=606387&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355642	483497822							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287461	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1O)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-11-10-19(27(35-16-17-8-9-17)21-6-1-2-7-25(21)39)13-23(22)36-28(40)24-14-26(29(31,32)33)37-38(24)20-5-3-4-18(12-20)15-34/h1-7,10-14,17,27,35,39H,8-9,15-16,34H2,(H,36,40)	CKWWRAGQIQAYTL-UHFFFAOYSA-N	416856	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(2-hydroxyphenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 60e::US10633345, Compound 66b::US10689346, Compound 60e::US11203574, Compound 66b::US11230530, Compound 66b::US11685721, Compound 60e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416856	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416856&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665480	433916769							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287462	CC(O)CNC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C28H28F3N5O2/c1-18(37)17-33-26(20-8-3-2-4-9-20)21-10-6-11-22(14-21)34-27(38)24-15-25(28(29,30)31)35-36(24)23-12-5-7-19(13-23)16-32/h2-15,18,26,33,37H,16-17,32H2,1H3,(H,34,38)	XWEXCUNXVFBKNX-UHFFFAOYSA-N	416857	1-(3-(aminomethyl)phenyl)-N-(3-(((2-hydroxypropyl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 182b::US10633345, Compound 182b::US10689346, Compound 182b::US11203574, Compound 182b::US11230530, Compound 182b::US11685721, Compound 182b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416857	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416857&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355690	433916770							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287463	CC(=O)Nc1ccc(cc1)C(OCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C31H30F3N5O3/c1-19(40)36-24-12-10-22(11-13-24)29(42-18-20-8-9-20)23-5-3-6-25(15-23)37-30(41)27-16-28(31(32,33)34)38-39(27)26-7-2-4-21(14-26)17-35/h2-7,10-16,20,29H,8-9,17-18,35H2,1H3,(H,36,40)(H,37,41)	AETJNKBVQDZIDV-UHFFFAOYSA-N	416858	N-(3-((4-acetamidophenyl)(cyclopropylmethoxy)methyl)phenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 147e::US10633345, Compound 147e::US10689346, Compound 147e::US11203574, Compound 147e::US11230530, Compound 147e::US11685721, Compound 147e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416858	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416858&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355828	433916771							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287464	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C30H26F4N6O/c31-24-11-10-22(28(37-17-19-4-5-19)21-8-6-18(15-35)7-9-21)13-25(24)38-29(41)26-14-27(30(32,33)34)39-40(26)23-3-1-2-20(12-23)16-36/h1-3,6-14,19,28,37H,4-5,16-17,36H2,(H,38,41)	GLPWOIBPISJWCH-UHFFFAOYSA-N	416830	1-(3-(aminomethyl)phenyl)-N-(5-((4-cyanophenyl)(cyclopropyl-methylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 52h::US11685721, Compound 71b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416830	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416830&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355582	433916743							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287465	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCCCn1ccnc1)c1ccccc1)C(F)(F)F	InChI=1S/C31H30F3N7O/c32-31(33,34)28-19-27(41(39-28)26-12-4-7-22(17-26)20-35)30(42)38-25-11-5-10-24(18-25)29(23-8-2-1-3-9-23)37-13-6-15-40-16-14-36-21-40/h1-5,7-12,14,16-19,21,29,37H,6,13,15,20,35H2,(H,38,42)	XJDJXHWYZLFIJY-UHFFFAOYSA-N	416860	N-(3-(((3-(1H-Imidazol-1-yl)propyl)amino)(phenyl)methyl)phenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 183b::US10633345, Compound 183b::US10689346, Compound 183b::US11203574, Compound 183b::US11230530, Compound 183b::US11685721, Compound 183b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416860	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416860&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665638	433916773							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287466	COc1ccc2ccccc2c1C(OCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H31F3N4O3/c1-43-29-15-14-23-7-2-3-11-27(23)31(29)32(44-20-21-12-13-21)24-8-5-9-25(17-24)39-33(42)28-18-30(34(35,36)37)40-41(28)26-10-4-6-22(16-26)19-38/h2-11,14-18,21,32H,12-13,19-20,38H2,1H3,(H,39,42)	YJZQWEYZTCABEY-UHFFFAOYSA-N	416861	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(2-methoxynaphthalen-1-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 148b::US10633345, Compound 148b::US10689346, Compound 148b::US11203574, Compound 148b::US11230530, Compound 148b::US11685721, Compound 148b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416861	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416861&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665874	433916774							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287467	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C30H26F4N6O/c31-24-11-10-22(28(37-17-19-4-5-19)21-8-6-18(15-35)7-9-21)13-25(24)38-29(41)26-14-27(30(32,33)34)39-40(26)23-3-1-2-20(12-23)16-36/h1-3,6-14,19,28,37H,4-5,16-17,36H2,(H,38,41)	GLPWOIBPISJWCH-UHFFFAOYSA-N	416830	1-(3-(aminomethyl)phenyl)-N-(5-((4-cyanophenyl)(cyclopropyl-methylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 52h::US11685721, Compound 71b	Plasma kallikrein		 25.1								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416830	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416830&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355582	433916743							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1287468	CN(C)C(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C27H26F3N5O/c1-34(2)25(19-9-4-3-5-10-19)20-11-7-12-21(15-20)32-26(36)23-16-24(27(28,29)30)33-35(23)22-13-6-8-18(14-22)17-31/h3-16,25H,17,31H2,1-2H3,(H,32,36)	BIAJBXPGRHVMIB-UHFFFAOYSA-N	416863	1-(3-(Aminomethyl)phenyl)-N-(3-((dimethylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 184b::US10633345, Compound 184b::US10689346, Compound 184b::US11203574, Compound 184b::US11230530, Compound 184b::US11685721, Compound 184b	Plasma kallikrein		>100.0								US Patent		10.7270/Q2J1078D			US11685721	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416863	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416863&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356007	433916776							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338148	O=C(NCc1cc2cc[nH]c2cn1)c1cn(Cc2cn3cc(ccc3n2)C2CC2)nn1	InChI=1S/C22H20N8O/c31-22(25-8-17-7-15-5-6-23-19(15)9-24-17)20-13-30(28-27-20)12-18-11-29-10-16(14-1-2-14)3-4-21(29)26-18/h3-7,9-11,13-14,23H,1-2,8,12H2,(H,25,31)	UILJXIMQWVNVBK-UHFFFAOYSA-N	626783	N-((1H-pyrrolo[2,3-c]pyridin-5-yl)methyl)-1-(6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-144	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626783	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626783&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152265	485655233							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338149	Clc1ccnc(CNC(=O)c2cn(Cc3cn4cc(ccc4n3)C3CC3)nn2)n1	InChI=1S/C19H17ClN8O/c20-16-5-6-21-17(24-16)7-22-19(29)15-11-28(26-25-15)10-14-9-27-8-13(12-1-2-12)3-4-18(27)23-14/h3-6,8-9,11-12H,1-2,7,10H2,(H,22,29)	KSVVHKJXYFJIIF-UHFFFAOYSA-N	626784	N-((4-chloropyrimidin-2-yl)methyl)-1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-145	Plasma kallikrein					 1050					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626784	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626784&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152165	485655234							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338150	Clc1c[nH]c2cnc(CNC(=O)c3cn(Cc4cn5cc(ccc5n4)C4CC4)nn3)cc12	InChI=1S/C22H19ClN8O/c23-18-7-25-19-8-24-15(5-17(18)19)6-26-22(32)20-12-31(29-28-20)11-16-10-30-9-14(13-1-2-13)3-4-21(30)27-16/h3-5,7-10,12-13,25H,1-2,6,11H2,(H,26,32)	VPBXABCBWLTKGC-UHFFFAOYSA-N	626785	N-((3-chloro-1H-pyrrolo[2,3-c]pyridin-5-yl)methyl)-1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-146	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626785	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626785&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152090	485655235							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338151	NCc1cc2CCN(C(=O)c3cn(Cc4cn5cc(ccc5n4)C4CC4)nn3)c2cn1	InChI=1S/C22H22N8O/c23-8-17-7-15-5-6-30(20(15)9-24-17)22(31)19-13-29(27-26-19)12-18-11-28-10-16(14-1-2-14)3-4-21(28)25-18/h3-4,7,9-11,13-14H,1-2,5-6,8,12,23H2	QELXNFVXIBWHKW-UHFFFAOYSA-N	626786	(5-(aminomethyl)-2,3-dihydro-1H-pyrrolo[2,3-c]pyridin-1-yl)(1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-1,2,3-triazol-4-yl)methanone ::US11787796, Compound I-147	Plasma kallikrein					 1050					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626786	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626786&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152237	485655236							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338152	O=C(NCc1cc2CCNc2cn1)c1cn(Cc2cn3cc(ccc3n2)C2CC2)nn1	InChI=1S/C22H22N8O/c31-22(25-8-17-7-15-5-6-23-19(15)9-24-17)20-13-30(28-27-20)12-18-11-29-10-16(14-1-2-14)3-4-21(29)26-18/h3-4,7,9-11,13-14,23H,1-2,5-6,8,12H2,(H,25,31)	IROJVIGDLNIWAO-UHFFFAOYSA-N	626787	1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-N-(2,3-dihydro-1H-pyrrolo[2,3-c]pyridin-5-yl)methyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-148	Plasma kallikrein					 1050					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626787	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626787&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152089	485655237							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338153	O=C(NCc1cc2OCCNc2cn1)c1cn(Cc2cn3cc(ccc3n2)C2CC2)nn1	InChI=1S/C22H22N8O2/c31-22(25-8-16-7-20-18(9-24-16)23-5-6-32-20)19-13-30(28-27-19)12-17-11-29-10-15(14-1-2-14)3-4-21(29)26-17/h3-4,7,9-11,13-14,23H,1-2,5-6,8,12H2,(H,25,31)	MZOFRAHYGHMGPQ-UHFFFAOYSA-N	626788	1-(6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-N-((3,4-dihydro-2H-pyrido[4,3-b][1,4]oxazin-7-yl)ethyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-149	Plasma kallikrein					 55					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626788	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626788&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156151885	485655238							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338154	O=C(NCc1cc2OCCCc2cn1)c1cn(Cc2cn3cc(ccc3n2)C2CC2)nn1	InChI=1S/C23H23N7O2/c31-23(25-10-18-8-21-16(9-24-18)2-1-7-32-21)20-14-30(28-27-20)13-19-12-29-11-17(15-3-4-15)5-6-22(29)26-19/h5-6,8-9,11-12,14-15H,1-4,7,10,13H2,(H,25,31)	OKECMVWRJUECQY-UHFFFAOYSA-N	626789	Synthesis of 1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-N-((3,4-dihydro-2H-pyrano[3,2-c]pyridin-7-yl)methyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-150	Plasma kallikrein					 1050					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626789	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626789&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152293	485655239							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297721	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(F)cc(c1)C(O)c1ccccc1)C(F)(F)F	InChI=1S/C25H20F4N4O2/c26-18-10-17(23(34)16-6-2-1-3-7-16)11-19(12-18)31-24(35)21-13-22(25(27,28)29)32-33(21)20-8-4-5-15(9-20)14-30/h1-13,23,34H,14,30H2,(H,31,35)	WOQUHGPQEUKGPZ-UHFFFAOYSA-N	416800	1-(3-(aminomethyl)phenyl)-N-(3-fluoro-5-(hydroxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 97f::US10633345, Compound 97f::US10689346, Compound 97f::US11203574, Compound 97f::US11230530, Compound 97f::US11685721, Compound 97f::US11708332, Compound 97f	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416800	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416800&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355887	433916714							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297722	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(Cc2ccccc2NC(=O)C2CC2)c1)C(F)(F)F	InChI=1S/C29H26F3N5O2/c30-29(31,32)26-16-25(37(36-26)23-9-4-6-19(15-23)17-33)28(39)34-22-8-3-5-18(14-22)13-21-7-1-2-10-24(21)35-27(38)20-11-12-20/h1-10,14-16,20H,11-13,17,33H2,(H,34,39)(H,35,38)	PMOFKIUBYLIJEG-UHFFFAOYSA-N	416803	1-(3-(aminomethyl)phenyl)-N-(3-(cyclopropanecarboxamido(phenyl) methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 115e::US11708332, Compound 115e	Plasma kallikrein		>75.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416803	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416803&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			154584219	433916717							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297723	COc1ccc2cc(ccc2c1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H32F3N5O2/c1-44-29-13-12-23-15-26(11-10-24(23)17-29)32(39-20-21-8-9-21)25-5-3-6-27(16-25)40-33(43)30-18-31(34(35,36)37)41-42(30)28-7-2-4-22(14-28)19-38/h2-7,10-18,21,32,39H,8-9,19-20,38H2,1H3,(H,40,43)	YJEVEVIVXGFKBA-UHFFFAOYSA-N	416804	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic Acid {3-[(cyclopropylmethyl-amino)-(6-methoxy-naphthalen-2-yl)-methyl]-phenyl}-amide::US10329260, Compound 134f::US10633345, Compound 134f::US10689346, Compound 134f::US11203574, Compound 134f::US11230530, Compound 134f::US11685721, Compound 134f::US11708332, Compound 134f	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416804	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416804&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356181	433916718							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297724	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CCC1CC1)N1CCCC1)C(F)(F)F	InChI=1S/C28H32F3N5O/c29-28(30,31)26-17-25(36(34-26)23-8-3-5-20(15-23)18-32)27(37)33-22-7-4-6-21(16-22)24(12-11-19-9-10-19)35-13-1-2-14-35/h3-8,15-17,19,24H,1-2,9-14,18,32H2,(H,33,37)	LGRABUBILIXIOO-UHFFFAOYSA-N	416805	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-(pyrrolidin-1-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 98b::US11685721, Compound 98b::US11708332, Compound 98b	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416805	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416805&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123509304	433916719							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297725	CCc1cccc(c1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C31H32F3N5O/c1-2-20-6-3-8-23(14-20)29(36-19-21-12-13-21)24-9-5-10-25(16-24)37-30(40)27-17-28(31(32,33)34)38-39(27)26-11-4-7-22(15-26)18-35/h3-11,14-17,21,29,36H,2,12-13,18-19,35H2,1H3,(H,37,40)	YUWQOWXTNOVILU-UHFFFAOYSA-N	416807	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(3-ethylphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 116e::US10633345, Compound 116e::US10689346, Compound 116e::US11203574, Compound 116e::US11230530, Compound 116e::US11685721, Compound 116e::US11708332, Compound 116e	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416807	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416807&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123342870	433916721							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297726	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(O)cc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-25(37(36-26)23-6-1-3-19(13-23)16-33)28(39)35-22-5-2-4-21(14-22)27(34-17-18-7-8-18)20-9-11-24(38)12-10-20/h1-6,9-15,18,27,34,38H,7-8,16-17,33H2,(H,35,39)	GDUMJZLASJIDFD-UHFFFAOYSA-N	416808	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(4-hydroxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 135c::US10633345, Compound 135c::US10689346, Compound 135c::US11203574, Compound 135c::US11230530, Compound 135c::US11685721, Compound 135c::US11708332, Compound 135c	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416808	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416808&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355747	433916722							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297727	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CNC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-16-25(37(36-26)24-11-4-6-19(14-24)17-33)27(38)35-23-10-5-9-21(15-23)28(39,18-34-22-12-13-22)20-7-2-1-3-8-20/h1-11,14-16,22,34,39H,12-13,17-18,33H2,(H,35,38)	WTFGPUOPMMMRIY-UHFFFAOYSA-N	416809	1-(3-(aminomethyl)phenyl)-N-(3-(2-(cyclopropylamino)-1-hydroxy-1-phenylethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 99g::US10633345, Compound 99g::US10689346, Compound 99g::US11203574, Compound 99g::US11230530, Compound 99g::US11685721, Compound 99g::US11708332, Compound 99g	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416809	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416809&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355899	433916723							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297728	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1F)C(F)(F)F	InChI=1S/C29H27F4N5O/c30-24-10-2-1-9-23(24)27(35-17-18-11-12-18)20-6-4-7-21(14-20)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-3-5-19(13-22)16-34/h1-10,13-15,18,27,35H,11-12,16-17,34H2,(H,36,39)	XNBKWIREUIHXKI-UHFFFAOYSA-N	416810	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2-fluorophenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 117e::US10329260, Compound 119e::US10633345, Compound 117e::US10689346, Compound 117e::US11203574, Compound 117e::US11230530, Compound 117e::US11685721, Compound 117e::US11708332, Compound 117e	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416810	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416810&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123243852	433916724							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297729	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(Cc2ccc(O)cc2)c1)C(F)(F)F	InChI=1S/C25H21F3N4O2/c26-25(27,28)23-14-22(32(31-23)20-6-2-4-18(13-20)15-29)24(34)30-19-5-1-3-17(12-19)11-16-7-9-21(33)10-8-16/h1-10,12-14,33H,11,15,29H2,(H,30,34)	OPPQXCJMBFITBL-UHFFFAOYSA-N	416811	1-(3-(Aminomethyl)phenyl)-N-(3-(4-hydroxybenzyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 136a::US10633345, Compound 136a::US10689346, Compound 136a::US11203574, Compound 136a::US11230530, Compound 136a::US11685721, Compound 136a::US11708332, Compound 136a	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416811	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416811&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356271	433916725							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297730	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C28H26F4N6O/c29-21-10-9-19(26(35-16-17-7-8-17)22-6-1-2-11-34-22)13-23(21)36-27(39)24-14-25(28(30,31)32)37-38(24)20-5-3-4-18(12-20)15-33/h1-6,9-14,17,26,35H,7-8,15-16,33H2,(H,36,39)	NHHQSQFDXMXIJU-UHFFFAOYSA-N	416812	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(pyridin-2-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 100e::US10633345, Compound 100e::US10689346, Compound 100e::US11203574, Compound 100e::US11230530, Compound 100e::US11685721, Compound 100e::US11708332, Compound 100e	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416812	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416812&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356158	433916726							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297731	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1c2ccccc2c(Cl)c2ccccc12)C(F)(F)F	InChI=1S/C37H31ClF3N5O/c38-34-29-13-3-1-11-27(29)33(28-12-2-4-14-30(28)34)35(43-21-22-15-16-22)24-8-6-9-25(18-24)44-36(47)31-19-32(37(39,40)41)45-46(31)26-10-5-7-23(17-26)20-42/h1-14,17-19,22,35,43H,15-16,20-21,42H2,(H,44,47)	WNAKJZQMCRSZKD-UHFFFAOYSA-N	416813	1-(3-(aminomethyl)phenyl)-N-(3-((10-chloroanthracen-9-yl)(cyclopropylmethylamino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 118f::US10633345, Compound 118f::US10689346, Compound 118f::US11203574, Compound 118f::US11230530, Compound 118f::US11685721, Compound 118f::US11708332, Compound 118f	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416813	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416813&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355872	433916727							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297758	CN(C)c1ccc(C(NCC2CC2)c2cccc(NC(=O)c3cc(nn3-c3cccc(CN)c3)C(F)(F)F)c2)c2ccccc12	InChI=1S/C35H35F3N6O/c1-43(2)30-16-15-29(27-11-3-4-12-28(27)30)33(40-21-22-13-14-22)24-8-6-9-25(18-24)41-34(45)31-19-32(35(36,37)38)42-44(31)26-10-5-7-23(17-26)20-39/h3-12,15-19,22,33,40H,13-14,20-21,39H2,1-2H3,(H,41,45)	IQAVMSNXUBZMCB-UHFFFAOYSA-N	416847	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic acid {3-[(cyclopropylmethyl-amino)-(4-dimethylamino-naphthalen-1-yl)-methyl]-phenyl}-amide::US10329260, Compound 126g::US10633345, Compound 126g::US10689346, Compound 126g::US11203574, Compound 126g::US11230530, Compound 126g::US11685721, Compound 126g::US11708332, Compound 126g	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416847	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416847&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355601	433916760							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297759	Cc1cc(C(=O)Nc2cccc(c2)C(NCC2CC2)c2ccccc2)n(n1)-c1cccc(CN)c1	InChI=1S/C29H31N5O/c1-20-15-27(34(33-20)26-12-5-7-22(16-26)18-30)29(35)32-25-11-6-10-24(17-25)28(31-19-21-13-14-21)23-8-3-2-4-9-23/h2-12,15-17,21,28,31H,13-14,18-19,30H2,1H3,(H,32,35)	GPDBDHGXUBYWPY-UHFFFAOYSA-N	416848	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(phenyl)methyl)phenyl)-3-methyl-1H-pyrazole-5-carboxamid::US10329260, Compound 143l::US10633345, Compound 143l::US10689346, Compound 143l::US11203574, Compound 143l::US11230530, Compound 143l::US11685721, Compound 143l::US11708332, Compound 143l	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416848	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416848&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356139	433916761							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297760	NCc1cccc(c1)N(CC1CC1)Cc1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H31F3N6O/c31-30(32,33)28-15-27(39(37-28)26-9-3-5-22(14-26)17-35)29(40)36-24-7-1-6-23(12-24)19-38(18-20-10-11-20)25-8-2-4-21(13-25)16-34/h1-9,12-15,20H,10-11,16-19,34-35H2,(H,36,40)	KWKGWXUNXWXADH-UHFFFAOYSA-N	416849	1-(3-(Aminomethyl)phenyl)-N-(3-((3-(aminomethyl)phenyl)(cyclopropylmethylamino) methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 108e::US11685721, Compound 108e::US11708332, Compound 108e	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416849	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416849&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			154584226	433916762							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297761	CCCOc1ccc(cc1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C32H34F3N5O2/c1-2-15-42-27-13-11-23(12-14-27)30(37-20-21-9-10-21)24-6-4-7-25(17-24)38-31(41)28-18-29(32(33,34)35)39-40(28)26-8-3-5-22(16-26)19-36/h3-8,11-14,16-18,21,30,37H,2,9-10,15,19-20,36H2,1H3,(H,38,41)	BSIABEDKJHMBRX-UHFFFAOYSA-N	416850	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic acid {3-[(cyclopropylmethyl-amino)-(4-propoxy-phenyl)-methyl]-phenyl}-amide::US10329260, Compound 127f::US10633345, Compound 127f::US10689346, Compound 127f::US11203574, Compound 127f::US11230530, Compound 127f::US11685721, Compound 127f::US11708332, Compound 127f	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416850	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416850&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356061	433916763							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297762	CC(C)NC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C28H28F3N5O/c1-18(2)33-26(20-9-4-3-5-10-20)21-11-7-12-22(15-21)34-27(37)24-16-25(28(29,30)31)35-36(24)23-13-6-8-19(14-23)17-32/h3-16,18,26,33H,17,32H2,1-2H3,(H,34,37)	XNDGACONQUBLGK-UHFFFAOYSA-N	416851	1-(3-(Aminomethyl)phenyl)-N-(3-((isopropylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 144d::US10633345, Compound 144d::US10689346, Compound 144d::US11203574, Compound 144d::US11230530, Compound 144d::US11685721, Compound 144d::US11708332, Compound 144d	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416851	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416851&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355596	433916764							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297763	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCCO)c1ccccc1)C(F)(F)F	InChI=1S/C27H26F3N5O2/c28-27(29,30)24-16-23(35(34-24)22-11-4-6-18(14-22)17-31)26(37)33-21-10-5-9-20(15-21)25(32-12-13-36)19-7-2-1-3-8-19/h1-11,14-16,25,32,36H,12-13,17,31H2,(H,33,37)	MMNKSYPQOFLCSY-UHFFFAOYSA-N	416852	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic acid {3-[(2-hydroxy-ethylamino)-phenyl-methyl]-phenyl}-amide::US10329260, Compound 145c::US10633345, Compound 145c::US10689346, Compound 145c::US11203574, Compound 145c::US11230530, Compound 145c::US11685721, Compound 145c::US11708332, Compound 145c	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416852	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416852&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123569320	433916765							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297764	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-10-9-20(27(40-16-17-7-8-17)19-4-2-5-21(35)12-19)13-24(23)36-28(39)25-14-26(29(31,32)33)37-38(25)22-6-1-3-18(11-22)15-34/h1-6,9-14,17,27H,7-8,15-16,34-35H2,(H,36,39)	GBDDXSAKQKODCG-UHFFFAOYSA-N	416853	1-(3-(aminomethyl)phenyl)-N-(5-((3-aminophenyl)(cyclopropylmethoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 57e::US10633345, Compound 65b::US10689346, Compound 65b::US11203574, Compound 65a::US11230530, Compound 65b::US11685721, Compound 57e::US11708332, Compound 65b	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416853	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416853&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355865	433916766							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297765	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(N[C@H]1CC[C@H](O)CC1)c1ccccc1)C(F)(F)F	InChI=1S/C31H32F3N5O2/c32-31(33,34)28-18-27(39(38-28)25-11-4-6-20(16-25)19-35)30(41)37-24-10-5-9-22(17-24)29(21-7-2-1-3-8-21)36-23-12-14-26(40)15-13-23/h1-11,16-18,23,26,29,36,40H,12-15,19,35H2,(H,37,41)/t23-,26-,29?	QCYULPRIJNBHAA-APJPSQSRSA-N	416854	1-(3-(Aminomethyl)phenyl)-N-(3-((((trans)-4-hydroxycyclohexyl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 181b::US10633345, Compound 181b::US10689346, Compound 181b::US11203574, Compound 181b::US11230530, Compound 181b::US11708332, Compound 181b	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416854	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416854&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665446	433916767							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297766	Cc1cc(C(=O)Nc2cccc(c2)C(NCC2CC2)c2cc(O)ccc2O)n(n1)-c1cccc(CN)c1	InChI=1S/C29H31N5O3/c1-18-12-26(34(33-18)23-7-2-4-20(13-23)16-30)29(37)32-22-6-3-5-21(14-22)28(31-17-19-8-9-19)25-15-24(35)10-11-27(25)36/h2-7,10-15,19,28,31,35-36H,8-9,16-17,30H2,1H3,(H,32,37)	LPEUWRVJEWZQCO-UHFFFAOYSA-N	416855	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2,5-dihydroxyphenyl)methyl) phenyl)-3-methyl-1H-pyrazole-5-carboxamide::US10329260, Compound 146g::US10633345, Compound 146g::US10689346, Compound 146g::US11203574, Compound 146g::US11230530, Compound 146g::US11708332, Compound 146g	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416855	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416855&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356064	433916768							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297767	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1O)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-11-10-19(27(35-16-17-8-9-17)21-6-1-2-7-25(21)39)13-23(22)36-28(40)24-14-26(29(31,32)33)37-38(24)20-5-3-4-18(12-20)15-34/h1-7,10-14,17,27,35,39H,8-9,15-16,34H2,(H,36,40)	CKWWRAGQIQAYTL-UHFFFAOYSA-N	416856	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(2-hydroxyphenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 60e::US10633345, Compound 66b::US10689346, Compound 60e::US11203574, Compound 66b::US11230530, Compound 66b::US11685721, Compound 60e::US11708332, Compound 66b	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416856	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416856&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665480	433916769							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297768	CC(O)CNC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C28H28F3N5O2/c1-18(37)17-33-26(20-8-3-2-4-9-20)21-10-6-11-22(14-21)34-27(38)24-15-25(28(29,30)31)35-36(24)23-12-5-7-19(13-23)16-32/h2-15,18,26,33,37H,16-17,32H2,1H3,(H,34,38)	XWEXCUNXVFBKNX-UHFFFAOYSA-N	416857	1-(3-(aminomethyl)phenyl)-N-(3-(((2-hydroxypropyl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 182b::US10633345, Compound 182b::US10689346, Compound 182b::US11203574, Compound 182b::US11230530, Compound 182b::US11685721, Compound 182b::US11708332, Compound 182b	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416857	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416857&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355690	433916770							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297769	CC(=O)Nc1ccc(cc1)C(OCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C31H30F3N5O3/c1-19(40)36-24-12-10-22(11-13-24)29(42-18-20-8-9-20)23-5-3-6-25(15-23)37-30(41)27-16-28(31(32,33)34)38-39(27)26-7-2-4-21(14-26)17-35/h2-7,10-16,20,29H,8-9,17-18,35H2,1H3,(H,36,40)(H,37,41)	AETJNKBVQDZIDV-UHFFFAOYSA-N	416858	N-(3-((4-acetamidophenyl)(cyclopropylmethoxy)methyl)phenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 147e::US10633345, Compound 147e::US10689346, Compound 147e::US11203574, Compound 147e::US11230530, Compound 147e::US11685721, Compound 147e::US11708332, Compound 147e	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416858	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416858&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355828	433916771							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297770	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C30H26F4N6O/c31-24-11-10-22(28(37-17-19-4-5-19)21-8-6-18(15-35)7-9-21)13-25(24)38-29(41)26-14-27(30(32,33)34)39-40(26)23-3-1-2-20(12-23)16-36/h1-3,6-14,19,28,37H,4-5,16-17,36H2,(H,38,41)	GLPWOIBPISJWCH-UHFFFAOYSA-N	416830	1-(3-(aminomethyl)phenyl)-N-(5-((4-cyanophenyl)(cyclopropyl-methylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 52h::US11685721, Compound 71b::US11708332, Compound 52h	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416830	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416830&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355582	433916743							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297771	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCCCn1ccnc1)c1ccccc1)C(F)(F)F	InChI=1S/C31H30F3N7O/c32-31(33,34)28-19-27(41(39-28)26-12-4-7-22(17-26)20-35)30(42)38-25-11-5-10-24(18-25)29(23-8-2-1-3-9-23)37-13-6-15-40-16-14-36-21-40/h1-5,7-12,14,16-19,21,29,37H,6,13,15,20,35H2,(H,38,42)	XJDJXHWYZLFIJY-UHFFFAOYSA-N	416860	N-(3-(((3-(1H-Imidazol-1-yl)propyl)amino)(phenyl)methyl)phenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 183b::US10633345, Compound 183b::US10689346, Compound 183b::US11203574, Compound 183b::US11230530, Compound 183b::US11685721, Compound 183b::US11708332, Compound 183b	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416860	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416860&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665638	433916773							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297772	COc1ccc2ccccc2c1C(OCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H31F3N4O3/c1-43-29-15-14-23-7-2-3-11-27(23)31(29)32(44-20-21-12-13-21)24-8-5-9-25(17-24)39-33(42)28-18-30(34(35,36)37)40-41(28)26-10-4-6-22(16-26)19-38/h2-11,14-18,21,32H,12-13,19-20,38H2,1H3,(H,39,42)	YJZQWEYZTCABEY-UHFFFAOYSA-N	416861	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(2-methoxynaphthalen-1-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 148b::US10633345, Compound 148b::US10689346, Compound 148b::US11203574, Compound 148b::US11230530, Compound 148b::US11685721, Compound 148b::US11708332, Compound 148b	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416861	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416861&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665874	433916774							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297773	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C30H26F4N6O/c31-24-11-10-22(28(37-17-19-4-5-19)21-8-6-18(15-35)7-9-21)13-25(24)38-29(41)26-14-27(30(32,33)34)39-40(26)23-3-1-2-20(12-23)16-36/h1-3,6-14,19,28,37H,4-5,16-17,36H2,(H,38,41)	GLPWOIBPISJWCH-UHFFFAOYSA-N	416830	1-(3-(aminomethyl)phenyl)-N-(5-((4-cyanophenyl)(cyclopropyl-methylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 52h::US11685721, Compound 71b::US11708332, Compound 52h	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416830	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416830&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355582	433916743							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297774	CN(C)C(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C27H26F3N5O/c1-34(2)25(19-9-4-3-5-10-19)20-11-7-12-21(15-20)32-26(36)23-16-24(27(28,29)30)33-35(23)22-13-6-8-18(14-22)17-31/h3-16,25H,17,31H2,1-2H3,(H,32,36)	BIAJBXPGRHVMIB-UHFFFAOYSA-N	416863	1-(3-(Aminomethyl)phenyl)-N-(3-((dimethylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 184b::US10633345, Compound 184b::US10689346, Compound 184b::US11203574, Compound 184b::US11230530, Compound 184b::US11685721, Compound 184b::US11708332, Compound 184b	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416863	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416863&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356007	433916776							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297775	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccc(O)cc1)C(F)(F)F	InChI=1S/C29H27F3N4O3/c30-29(31,32)26-15-25(36(35-26)23-6-1-3-19(13-23)16-33)28(38)34-22-5-2-4-21(14-22)27(39-17-18-7-8-18)20-9-11-24(37)12-10-20/h1-6,9-15,18,27,37H,7-8,16-17,33H2,(H,34,38)	WIBHWKLQWUWRRF-UHFFFAOYSA-N	416864	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(4-hydroxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 149b::US10633345, Compound 149b::US10689346, Compound 149b::US11203574, Compound 149b::US11230530, Compound 149b::US11685721, Compound 149b::US11708332, Compound 149b	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416864	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416864&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665542	433916777							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297776	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-10-9-20(27(40-16-17-7-8-17)19-4-2-5-21(35)12-19)13-24(23)36-28(39)25-14-26(29(31,32)33)37-38(25)22-6-1-3-18(11-22)15-34/h1-6,9-14,17,27H,7-8,15-16,34-35H2,(H,36,39)	GBDDXSAKQKODCG-UHFFFAOYSA-N	416853	1-(3-(aminomethyl)phenyl)-N-(5-((3-aminophenyl)(cyclopropylmethoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 57e::US10633345, Compound 65b::US10689346, Compound 65b::US11203574, Compound 65a::US11230530, Compound 65b::US11685721, Compound 57e::US11708332, Compound 65b	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416853	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416853&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355865	433916766							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297777	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NC1CCCCC1)c1ccccc1)C(F)(F)F	InChI=1S/C31H32F3N5O/c32-31(33,34)28-19-27(39(38-28)26-16-7-9-21(17-26)20-35)30(40)37-25-15-8-12-23(18-25)29(22-10-3-1-4-11-22)36-24-13-5-2-6-14-24/h1,3-4,7-12,15-19,24,29,36H,2,5-6,13-14,20,35H2,(H,37,40)	MXMWHPZXCVOSEY-UHFFFAOYSA-N	416866	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclohexylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 185b::US10633345, Compound 185b::US10689346, Compound 185b::US11203574, Compound 185b::US11230530, Compound 185b::US11685721, Compound 185b::US11708332, Compound 185b	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416866	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416866&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356164	433916779							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297778	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-25(37(36-26)24-9-1-4-19(12-24)16-33)28(38)35-23-8-3-6-21(14-23)27(39-17-18-10-11-18)20-5-2-7-22(34)13-20/h1-9,12-15,18,27H,10-11,16-17,33-34H2,(H,35,38)	FPQYUIIRVBKUDH-UHFFFAOYSA-N	416867	1-(3-(aminomethyl)phenyl)-N-(3-((3-aminophenyl)(cyclopropyl-methoxy)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 53f::US10633345, Compound 53f::US10689346, Compound 53f::US11203574, Compound 64b::US11230530, Compound 64b::US11685721, Compound 49j::US11708332, Compound 64b	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416867	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416867&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355845	433916780							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297779	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-10-9-20(27(40-16-17-7-8-17)19-4-2-5-21(35)12-19)13-24(23)36-28(39)25-14-26(29(31,32)33)37-38(25)22-6-1-3-18(11-22)15-34/h1-6,9-14,17,27H,7-8,15-16,34-35H2,(H,36,39)	GBDDXSAKQKODCG-UHFFFAOYSA-N	416853	1-(3-(aminomethyl)phenyl)-N-(5-((3-aminophenyl)(cyclopropylmethoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 57e::US10633345, Compound 65b::US10689346, Compound 65b::US11203574, Compound 65a::US11230530, Compound 65b::US11685721, Compound 57e::US11708332, Compound 65b	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416853	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416853&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355865	433916766							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297780	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCc1ccncc1)c1ccccc1)C(F)(F)F	InChI=1S/C31H27F3N6O/c32-31(33,34)28-18-27(40(39-28)26-11-4-6-22(16-26)19-35)30(41)38-25-10-5-9-24(17-25)29(23-7-2-1-3-8-23)37-20-21-12-14-36-15-13-21/h1-18,29,37H,19-20,35H2,(H,38,41)	PXKQYONQBKMAKS-UHFFFAOYSA-N	416869	1-(3-(Aminomethyl)phenyl)-N-(3-(phenyl((pyridin-4-ylmethyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 186b::US10633345, Compound 186b::US10689346, Compound 186b::US11203574, Compound 186b::US11230530, Compound 186b::US11685721, Compound 186b::US11708332, Compound 186b	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416869	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416869&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665494	433916782							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297781	Cc1cc(C(=O)Nc2cccc(c2)C(NCC2CC2)c2cccc(O)c2O)n(n1)-c1cccc(CN)c1	InChI=1S/C29H31N5O3/c1-18-13-25(34(33-18)23-8-2-5-20(14-23)16-30)29(37)32-22-7-3-6-21(15-22)27(31-17-19-11-12-19)24-9-4-10-26(35)28(24)36/h2-10,13-15,19,27,31,35-36H,11-12,16-17,30H2,1H3,(H,32,37)	VPKURNQNFXHFDB-UHFFFAOYSA-N	416870	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2,3-dihydroxyphenyl)methyl)phenyl)-3-methyl-1H-pyrazole-5-carboxamide::US10329260, Compound 150f::US10633345, Compound 150f::US10689346, Compound 150f::US11203574, Compound 150f::US11230530, Compound 150f::US11708332, Compound 150f	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416870	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416870&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355949	433916783							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297782	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc2OCOc12)C(F)(F)F	InChI=1S/C30H28F3N5O3/c31-30(32,33)26-14-24(38(37-26)22-7-1-4-19(12-22)15-34)29(39)36-21-6-2-5-20(13-21)27(35-16-18-10-11-18)23-8-3-9-25-28(23)41-17-40-25/h1-9,12-14,18,27,35H,10-11,15-17,34H2,(H,36,39)	FVRZDZZJKCSOIR-UHFFFAOYSA-N	416871	1-(3-(aminomethyl)phenyl)-N-(3-(benzo[d][1,3]dioxol-4-yl(cyclopropylmethylamino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 192f::US10633345, Compound 192f::US10689346, Compound 192f::US11203574, Compound 192f::US11230530, Compound 192f::US11685721, Compound 192f::US11708332, Compound 192f	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416871	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416871&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665720	433916784							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297783	CC(C)(C)CNC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H32F3N5O/c1-29(2,3)19-35-27(21-10-5-4-6-11-21)22-12-8-13-23(16-22)36-28(39)25-17-26(30(31,32)33)37-38(25)24-14-7-9-20(15-24)18-34/h4-17,27,35H,18-19,34H2,1-3H3,(H,36,39)	NWBNOBGYJRWWRK-UHFFFAOYSA-N	416872	1-(3-(Aminomethyl)phenyl)-N-(3-((neopentylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 187b::US10633345, Compound 187b::US10689346, Compound 187b::US11203574, Compound 187b::US11230530, Compound 187b::US11685721, Compound 187b::US11708332, Compound 187b	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416872	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416872&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124028296	433916785							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297784	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccc(cc1)C(N)=O)C(F)(F)F	InChI=1S/C30H28F4N6O2/c31-23-11-10-21(27(37-16-17-4-5-17)19-6-8-20(9-7-19)28(36)41)13-24(23)38-29(42)25-14-26(30(32,33)34)39-40(25)22-3-1-2-18(12-22)15-35/h1-3,6-14,17,27,37H,4-5,15-16,35H2,(H2,36,41)(H,38,42)	AHHWWBRXILLXFU-UHFFFAOYSA-N	416873	1-(3-(aminomethyl)phenyl)-N-(5-((4-carbamoylphenyl)(cyclopropylmethylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 153b::US10633345, Compound 153b::US10689346, Compound 153b::US11203574, Compound 153b::US11230530, Compound 153b::US11685721, Compound 153b::US11708332, Compound 153b	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416873	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416873&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355991	433916786							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297785	CCC(CO)NC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C29H30F3N5O2/c1-2-22(18-38)34-27(20-9-4-3-5-10-20)21-11-7-12-23(15-21)35-28(39)25-16-26(29(30,31)32)36-37(25)24-13-6-8-19(14-24)17-33/h3-16,22,27,34,38H,2,17-18,33H2,1H3,(H,35,39)	KIDPOTSBLNZGML-UHFFFAOYSA-N	416874	1-(3-(aminomethyl)phenyl)-N-(3-(((1-hydroxybutan-2-yl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 168b::US10633345, Compound 168b::US10689346, Compound 168b::US11192861, Compound 168b::US11230530, Compound 168b::US11685721, Compound 168b::US11708332, Compound 168b	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416874	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416874&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356215	433916787							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297786	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NC1CCC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H28F3N5O/c30-29(31,32)26-17-25(37(36-26)24-14-4-7-19(15-24)18-33)28(38)35-23-13-5-10-21(16-23)27(34-22-11-6-12-22)20-8-2-1-3-9-20/h1-5,7-10,13-17,22,27,34H,6,11-12,18,33H2,(H,35,38)	UCFAODSDUNDTFF-UHFFFAOYSA-N	416875	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclobutylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 188b::US10633345, Compound 188b::US10689346, Compound 188b::US11203574, Compound 188b::US11230530, Compound 188b::US11685721, Compound 188b::US11708332, Compound 188b	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416875	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416875&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123435501	433916788							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297787	COc1cccc(C(NCC2CC2)c2cccc(NC(=O)c3cc(nn3-c3cccc(CN)c3)C(F)(F)F)c2)c1O	InChI=1S/C30H30F3N5O3/c1-41-25-10-4-9-23(28(25)39)27(35-17-18-11-12-18)20-6-3-7-21(14-20)36-29(40)24-15-26(30(31,32)33)37-38(24)22-8-2-5-19(13-22)16-34/h2-10,13-15,18,27,35,39H,11-12,16-17,34H2,1H3,(H,36,40)	KCIFFUCEHRXTLF-UHFFFAOYSA-N	416876	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2-hydroxy-3-methoxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 151g::US10633345, Compound 151g::US10689346, Compound 151g::US11203574, Compound 151g::US11230530, Compound 151g::US11685721, Compound 151g::US11708332, Compound 151g	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416876	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416876&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356165	433916789							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297788	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(N1CCCC1CO)c1ccccc1)C(F)(F)F	InChI=1S/C30H30F3N5O2/c31-30(32,33)27-17-26(38(36-27)24-12-4-7-20(15-24)18-34)29(40)35-23-11-5-10-22(16-23)28(21-8-2-1-3-9-21)37-14-6-13-25(37)19-39/h1-5,7-12,15-17,25,28,39H,6,13-14,18-19,34H2,(H,35,40)	BNZLGFQHSKUMEG-UHFFFAOYSA-N	416877	1-(3-(aminomethyl)phenyl)-N-(3-((2-(hydroxymethyl)pyrrolidin-1-yl)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 169b::US10633345, Compound 169b::US10689346, Compound 169b::US11203574, Compound 169b::US11230530, Compound 169b::US11685721, Compound 169b::US11708332, Compound 169b	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416877	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416877&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356128	433916790							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297789	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCc1ccc(N)cc1)c1ccccc1)C(F)(F)F	InChI=1S/C32H29F3N6O/c33-32(34,35)29-18-28(41(40-29)27-11-4-6-22(16-27)19-36)31(42)39-26-10-5-9-24(17-26)30(23-7-2-1-3-8-23)38-20-21-12-14-25(37)15-13-21/h1-18,30,38H,19-20,36-37H2,(H,39,42)	BKOBJSLLJPHJRR-UHFFFAOYSA-N	416878	N-(3-(((4-Aminobenzyl)amino)(phenyl)methyl)phenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 189b::US10633345, Compound 189b::US10689346, Compound 189b::US11203574, Compound 189b::US11230530, Compound 189b::US11685721, Compound 189b::US11708332, Compound 189b	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416878	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416878&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665871	433916791							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297790	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C30H27F3N6O/c31-30(32,33)27-15-26(39(38-27)25-9-2-5-21(13-25)17-35)29(40)37-24-8-3-7-23(14-24)28(36-18-19-10-11-19)22-6-1-4-20(12-22)16-34/h1-9,12-15,19,28,36H,10-11,17-18,35H2,(H,37,40)	VQJJJCIJWBDLSJ-UHFFFAOYSA-N	416879	1-(3-(aminomethyl)phenyl)-N-(3-((3-cyanophenyl)(cyclopropylmethyl amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 152d::US10633345, Compound 152d::US10689346, Compound 152d::US11203574, Compound 152d::US11230530, Compound 152d::US11685721, Compound 152d::US11708332, Compound 152d	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416879	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416879&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356166	433916792							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297791	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(N1CCC(O)C1)c1ccccc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-16-25(37(35-26)23-11-4-6-19(14-23)17-33)28(39)34-22-10-5-9-21(15-22)27(20-7-2-1-3-8-20)36-13-12-24(38)18-36/h1-11,14-16,24,27,38H,12-13,17-18,33H2,(H,34,39)	FPAZEZULJGBLCM-UHFFFAOYSA-N	416880	1-(3-(aminomethyl)phenyl)-N-(3-((3-hydroxypyrrolidin-1-yl)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 170b::US10633345, Compound 170b::US10689346, Compound 170b::US11192861, Compound 170b::US11230530, Compound 170b::US11685721, Compound 170b::US11708332, Compound 170b	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416880	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416880&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355902	433916793							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297792	CSCCNC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C28H28F3N5OS/c1-38-14-13-33-26(20-8-3-2-4-9-20)21-10-6-11-22(16-21)34-27(37)24-17-25(28(29,30)31)35-36(24)23-12-5-7-19(15-23)18-32/h2-12,15-17,26,33H,13-14,18,32H2,1H3,(H,34,37)	GMRUHWVMBSEBQV-UHFFFAOYSA-N	416881	1-(3-(aminomethyl)phenyl)-N-(3-(((2-(methylthio)ethyl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 190b::US10633345, Compound 190b::US10689346, Compound 190b::US11203574, Compound 190b::US11230530, Compound 190b::US11685721, Compound 190b::US11708332, Compound 190b	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416881	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416881&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665913	433916794							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297793	COc1ccc(C(NCC2CC2)c2cccc(NC(=O)c3cc(nn3-c3cccc(CN)c3)C(F)(F)F)c2)c2ccccc12	InChI=1S/C34H32F3N5O2/c1-44-30-15-14-28(26-10-2-3-11-27(26)30)32(39-20-21-12-13-21)23-7-5-8-24(17-23)40-33(43)29-18-31(34(35,36)37)41-42(29)25-9-4-6-22(16-25)19-38/h2-11,14-18,21,32,39H,12-13,19-20,38H2,1H3,(H,40,43)	YOBACLFKAGKOLX-UHFFFAOYSA-N	416882	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(4-methoxynaphthalen-1-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 154e::US10633345, Compound 154e::US10689346, Compound 154e::US11203574, Compound 154e::US11230530, Compound 154e::US11685721, Compound 154e::US11708332, Compound 154e	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416882	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416882&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665632	433916795							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297794	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NC1CCCCCC1)c1ccccc1)C(F)(F)F	InChI=1S/C32H34F3N5O/c33-32(34,35)29-20-28(40(39-29)27-17-8-10-22(18-27)21-36)31(41)38-26-16-9-13-24(19-26)30(23-11-4-3-5-12-23)37-25-14-6-1-2-7-15-25/h3-5,8-13,16-20,25,30,37H,1-2,6-7,14-15,21,36H2,(H,38,41)	DQWBWUNYPIEFTF-UHFFFAOYSA-N	416883	1-(3-(aminomethyl)phenyl)-N-(3-((cycloheptylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 171b::US10633345, Compound 171b::US10689346, Compound 171b::US11203574, Compound 171b::US11230530, Compound 171b::US11685721, Compound 171b::US11708332, Compound 171b	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416883	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416883&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356134	433916796							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297795	Cc1ccccc1C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O/c1-19-6-2-3-11-25(19)28(35-18-20-12-13-20)22-8-5-9-23(15-22)36-29(39)26-16-27(30(31,32)33)37-38(26)24-10-4-7-21(14-24)17-34/h2-11,14-16,20,28,35H,12-13,17-18,34H2,1H3,(H,36,39)	NQOSRSVLDYDVDI-UHFFFAOYSA-N	416884	1-(3-(Aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(o-tolyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 193f::US10633345, Compound 193f::US10689346, Compound 193f::US11203574, Compound 193f::US11230530, Compound 193f::US11685721, Compound 193f::US11708332, Compound 193f	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416884	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416884&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355753	433916797							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297796	NCc1cccc(c1)C(NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F4N6O/c31-24-10-9-22(28(37-17-18-7-8-18)21-5-1-3-19(11-21)15-35)13-25(24)38-29(41)26-14-27(30(32,33)34)39-40(26)23-6-2-4-20(12-23)16-36/h1-6,9-14,18,28,37H,7-8,15-17,35-36H2,(H,38,41)	PIDHZVXEDSCGNA-UHFFFAOYSA-N	416885	1-(3-(aminomethyl)phenyl)-N-(5-((3-(aminomethyl)phenyl)(cyclopropylmethylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 155c::US10633345, Compound 155c::US10689346, Compound 155c::US11203574, Compound 155c::US11230530, Compound 155c::US11685721, Compound 155c::US11708332, Compound 155c	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416885	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416885&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355611	433916798							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1318003	CCc1ncc(nc1C(=O)Nc1cnn(Cc2cnc(N3C[C@H]4C[C@H]4C3=O)c3OCOc23)c1)-c1c(F)c(Cl)ccc1C(F)F	InChI=1S/C29H23ClF3N7O4/c1-2-19-23(38-20(8-34-19)21-16(26(32)33)3-4-18(30)22(21)31)28(41)37-15-7-36-39(11-15)9-14-6-35-27(25-24(14)43-12-44-25)40-10-13-5-17(13)29(40)42/h3-4,6-8,11,13,17,26H,2,5,9-10,12H2,1H3,(H,37,41)/t13-,17-/m1/s1	GEDGCUQVJCWBFY-CXAGYDPISA-N	618043	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-ethyl-N-(1-((4-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)-[1,3]dioxolo[4,5-c]pyridin-7-yl)methyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 255	Plasma kallikrein			 2.60							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618043	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618043&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168679609	484207209							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338005	COc1ccc(c(CNC(=O)c2cn(Cc3cn4cc(ccc4n3)C3CC3)nn2)c1F)-n1cc(Cl)nn1	InChI=1S/C24H21ClFN9O2/c1-37-20-6-5-19(35-13-21(25)30-32-35)17(23(20)26)8-27-24(36)18-12-34(31-29-18)11-16-10-33-9-15(14-2-3-14)4-7-22(33)28-16/h4-7,9-10,12-14H,2-3,8,11H2,1H3,(H,27,36)	PHIYQAOFKYPKKQ-UHFFFAOYSA-N	626638	N-(6-(4-chloro-1H-1,2,3-triazol-1-yl)-2-fluoro-3-methoxybenzyl)-1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-1	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626638	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626638&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152054	485655094							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338006	COc1ccc(c(CNC(=O)c2cc3C(CCn3n2)c2cn3cc(ccc3n2)C2CC2)c1F)-n1cnnn1	InChI=1S/C26H24FN9O2/c1-38-23-6-5-21(36-14-29-32-33-36)18(25(23)27)11-28-26(37)19-10-22-17(8-9-35(22)31-19)20-13-34-12-16(15-2-3-15)4-7-24(34)30-20/h4-7,10,12-15,17H,2-3,8-9,11H2,1H3,(H,28,37)	AMHLPFIUJQCNDZ-UHFFFAOYSA-N	626639	4-(6-cyclopropylimidazo[1,2-a]pyridin-2-yl)-N-(2-fluoro-3-methoxy-6-(1H-tetrazol-1-yl)benzyl)-5,6-dihydro-41-pyrrolo[1,2-b]pyrazole-2-carboxamide ::US11787796, Compound I-2	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626639	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626639&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152040	485655095							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338007	Clc1cn(nn1)-c1ccc(Cl)cc1CNC(=O)c1cn(Cc2cn3cc(ccc3n2)C2CC2)nn1	InChI=1S/C23H19Cl2N9O/c24-17-4-5-20(34-13-21(25)29-31-34)16(7-17)8-26-23(35)19-12-33(30-28-19)11-18-10-32-9-15(14-1-2-14)3-6-22(32)27-18/h3-7,9-10,12-14H,1-2,8,11H2,(H,26,35)	NVBBBHBVPJOEQS-UHFFFAOYSA-N	626640	N-(5-chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)benzyl)-1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-3	Plasma kallikrein					 55					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626640	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626640&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152175	485655096							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338008	COc1ccc(c(CNC(=O)c2nc3C(CCn3n2)c2cn3cc(ccc3n2)C2CC2)c1F)-n1cnnn1	InChI=1S/C25H23FN10O2/c1-38-20-6-5-19(36-13-28-32-33-36)17(22(20)26)10-27-25(37)23-30-24-16(8-9-35(24)31-23)18-12-34-11-15(14-2-3-14)4-7-21(34)29-18/h4-7,11-14,16H,2-3,8-10H2,1H3,(H,27,37)	RNPUKGYFRVHCER-UHFFFAOYSA-N	626641	7-(6-cyclopropylimidazo[1,2-a]pyridin-2-yl)-N-(2-fluoro-3-methoxy-6-(1H-tetrazol-1-yl)benzyl)-6,7-dihydro-5H-pyrrolo[1,2-b][1,2,4]triazole-2-carboxamide ::US11787796, Compound I-4	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626641	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626641&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152091	485655097							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338009	COc1ccnc(CNC(=O)c2cn3C(CCc3n2)c2cn3cc(ccc3n2)C2CC2)c1F	InChI=1S/C24H23FN6O2/c1-33-20-8-9-26-16(23(20)25)10-27-24(32)18-13-31-19(5-7-22(31)29-18)17-12-30-11-15(14-2-3-14)4-6-21(30)28-17/h4,6,8-9,11-14,19H,2-3,5,7,10H2,1H3,(H,27,32)	IJFLMDCQWRAZKE-UHFFFAOYSA-N	626642	5-(6-cyclopropylimidazo[1,2-a]pyridin-2-yl)-N-((3-fluoro-4-methoxypyridin-2-yl)methyl)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazole-2-carboxamide ::US11787796, Compound I-5	Plasma kallikrein					 55					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626642	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626642&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152137	485655098							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338010	COc1ccnc(CNC(=O)c2cnc3CCC(c4cn5cc(ccc5n4)C4CC4)n23)c1F	InChI=1S/C24H23FN6O2/c1-33-20-8-9-26-16(23(20)25)10-28-24(32)19-11-27-21-7-5-18(31(19)21)17-13-30-12-15(14-2-3-14)4-6-22(30)29-17/h4,6,8-9,11-14,18H,2-3,5,7,10H2,1H3,(H,28,32)	YYYWZPQNLBCECH-UHFFFAOYSA-N	626643	5-(6-cyclopropylimidazo[1,2-a]pyridin-2-yl)-N-((3-fluoro-4-methoxypyridin-2-yl)methyl)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazole-3-carboxamide ::US11787796, Compound I-6	Plasma kallikrein					>7100					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626643	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626643&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152276	485655099							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338011	COc1ccnc(CNC(=O)c2cn(Cc3cn4cc(ccc4n3)C3CC3)nn2)c1F	InChI=1S/C21H20FN7O2/c1-31-18-6-7-23-16(20(18)22)8-24-21(30)17-12-29(27-26-17)11-15-10-28-9-14(13-2-3-13)4-5-19(28)25-15/h4-7,9-10,12-13H,2-3,8,11H2,1H3,(H,24,30)	TVHDZPISGUIIBZ-UHFFFAOYSA-N	626644	1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-N-((3-fluoro-4-methoxypyridin-2-yl)methyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-7	Plasma kallikrein					 55					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626644	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626644&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152296	485655100							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338012	COc1ccc(F)c(CNC(=O)c2cn(Cc3cn4cc(cc(COCCN(C)C)c4n3)C3CC3)nn2)c1F	InChI=1S/C27H31F2N7O3/c1-34(2)8-9-39-16-19-10-18(17-4-5-17)12-35-13-20(31-26(19)35)14-36-15-23(32-33-36)27(37)30-11-21-22(28)6-7-24(38-3)25(21)29/h6-7,10,12-13,15,17H,4-5,8-9,11,14,16H2,1-3H3,(H,30,37)	JCXPEPBBKFQZMZ-UHFFFAOYSA-N	626646	1-((6-cyclopropyl-8-((2-(dimethylamino)ethoxy)methyl)imidazo[1,2-a]pyridin-2-yl)methyl)-N-(2,6-difluoro-3-ethoxybenzyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-8	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626646	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626646&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152194	485655102							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338013	COc1ccc(c(CNC(=O)c2cn3C(COc3n2)c2cn3cc(ccc3n2)C2CC2)c1F)-n1cnnn1	InChI=1S/C25H22FN9O3/c1-37-21-6-5-19(35-13-28-31-32-35)16(23(21)26)8-27-24(36)18-11-34-20(12-38-25(34)30-18)17-10-33-9-15(14-2-3-14)4-7-22(33)29-17/h4-7,9-11,13-14,20H,2-3,8,12H2,1H3,(H,27,36)	LWAMHWBOLQVVKB-UHFFFAOYSA-N	626647	3-(6-cyclopropylimidazo[1,2-a]pyridin-2-yl)-N-(2-fluoro-3-methoxy-6-(1H-tetrazol-1-yl)benzyl)-2,3-dihydroimidazo[2,1-b]oxazole-6-carboxamide ::US11787796, Compound I-9	Plasma kallikrein					 55					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626647	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626647&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152077	485655103							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338014	NCc1cc(cn2cc(Cn3cc(nn3)C(=O)NC3CCc4c3ccnc4N)nc12)C1CC1	InChI=1S/C23H25N9O/c24-8-14-7-15(13-1-2-13)9-31-10-16(27-22(14)31)11-32-12-20(29-30-32)23(33)28-19-4-3-18-17(19)5-6-26-21(18)25/h5-7,9-10,12-13,19H,1-4,8,11,24H2,(H2,25,26)(H,28,33)	AQXVBIGUWKHDLG-UHFFFAOYSA-N	626648	N-(1-amino-6,7-dihydro-5H-cyclopenta[c]pyridin-5-yl)-1-((8-(aminomethyl)-6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-10	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626648	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626648&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152003	485655104							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338015	Clc1nccc2sc(CNC(=O)c3cn(Cc4cn5cc(ccc5n4)C4CC4)nn3)cc12	InChI=1S/C22H18ClN7OS/c23-21-17-7-16(32-19(17)5-6-24-21)8-25-22(31)18-12-30(28-27-18)11-15-10-29-9-14(13-1-2-13)3-4-20(29)26-15/h3-7,9-10,12-13H,1-2,8,11H2,(H,25,31)	FYIGNIPMKUWYRV-UHFFFAOYSA-N	626649	N-((4-chlorothieno[3,2-c]pyridin-2-yl)methyl)-1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-11	Plasma kallikrein					>7100					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626649	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626649&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156151965	485655105							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338016	COc1ccc(F)c(CNC(=O)c2cn(Cc3cn4cc(cc(CC(C)(C)C#N)c4n3)C3CC3)nn2)c1F	InChI=1S/C27H27F2N7O2/c1-27(2,15-30)9-17-8-18(16-4-5-16)11-35-12-19(32-25(17)35)13-36-14-22(33-34-36)26(37)31-10-20-21(28)6-7-23(38-3)24(20)29/h6-8,11-12,14,16H,4-5,9-10,13H2,1-3H3,(H,31,37)	BPQYNLHCIUPEDQ-UHFFFAOYSA-N	626650	1-((8-(2-cyano-2-methylpropyl)-6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-N-(2,6-difluoro-3-methoxybenzyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-12	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626650	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626650&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156151992	485655106							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338017	COc1ccc(F)c(CNC(=O)c2cn(Cc3cn4cc(cc(CN)c4n3)C3CC3)nn2)c1F	InChI=1S/C23H23F2N7O2/c1-34-20-5-4-18(24)17(21(20)25)8-27-23(33)19-12-32(30-29-19)11-16-10-31-9-15(13-2-3-13)6-14(7-26)22(31)28-16/h4-6,9-10,12-13H,2-3,7-8,11,26H2,1H3,(H,27,33)	ZDLUZAALRFCBBE-UHFFFAOYSA-N	626651	1-((8-(aminomethyl)-6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-N-(2,6-difluoro-3-methoxybenzyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-13	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626651	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626651&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152120	485655107							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338018	Nc1nccc2C(CCc12)NC(=O)c1cn(Cc2cn3cc(cc(C#N)c3n2)C2CC2)nn1	InChI=1S/C23H21N9O/c24-8-14-7-15(13-1-2-13)9-31-10-16(27-22(14)31)11-32-12-20(29-30-32)23(33)28-19-4-3-18-17(19)5-6-26-21(18)25/h5-7,9-10,12-13,19H,1-4,11H2,(H2,25,26)(H,28,33)	YWTUUXPTZRXMJI-UHFFFAOYSA-N	626652	N-(1-amino-6,7-dihydro-5H-cyclopenta[c]pyridin-5-yl)-1-((8-cyano-6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-14	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626652	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626652&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156151942	485655108							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338019	COc1ccc(c(CNC(=O)c2c(C)nn(Cc3cn4cc(ccc4n3)C3CC3)c2C)c1F)-n1cnnn1	InChI=1S/C26H26FN9O2/c1-15-24(26(37)28-10-20-21(36-14-29-32-33-36)7-8-22(38-3)25(20)27)16(2)35(31-15)13-19-12-34-11-18(17-4-5-17)6-9-23(34)30-19/h6-9,11-12,14,17H,4-5,10,13H2,1-3H3,(H,28,37)	CQNNCXMLWGOIRH-UHFFFAOYSA-N	626653	1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-N-(2-fluoro-3-methoxy-6-(1H-tetrazol-1-yl)benzyl)-3,5-dimethyl-1H-pyrazole-4-carboxamide ::US11787796, Compound I-15	Plasma kallikrein					 1050					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626653	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626653&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152180	485655109							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338020	Cc1cc2C(CCc2c(N)n1)NC(=O)c1cn(Cc2cn3cc(ccc3n2)C2CC2)nn1	InChI=1S/C23H24N8O/c1-13-8-18-17(22(24)25-13)5-6-19(18)27-23(32)20-12-31(29-28-20)11-16-10-30-9-15(14-2-3-14)4-7-21(30)26-16/h4,7-10,12,14,19H,2-3,5-6,11H2,1H3,(H2,24,25)(H,27,32)	HRQIBSDVCIFNKJ-UHFFFAOYSA-N	626654	N-(1-amino-3-methyl-6,7-dihydro-5H-cyclopenta[c]pyridin-5-yl)-1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-16	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626654	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626654&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152108	485655110							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51511115	NC(=N)c1ccc(CNC(=O)c2cnn(Cc3ccccc3)c2)cc1	InChI=1S/C19H19N5O/c20-18(21)16-8-6-14(7-9-16)10-22-19(25)17-11-23-24(13-17)12-15-4-2-1-3-5-15/h1-9,11,13H,10,12H2,(H3,20,21)(H,22,25)	SAVNTVHVERKVOD-UHFFFAOYSA-N	50591422	CHEMBL5175689	Plasma kallikrein			 90							ChEMBL		10.7270/Q2R215K6	32066009			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50591422	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50591422&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			24857697	482602274							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51511116	COc1ccnc(CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2C(F)(F)F)c1F	InChI=1S/C25H21F4N5O3/c1-37-20-9-10-30-19(22(20)26)12-31-24(36)18-15-34(32-23(18)25(27,28)29)14-17-7-5-16(6-8-17)13-33-11-3-2-4-21(33)35/h2-11,15H,12-14H2,1H3,(H,31,36)	NKTBXDIJVDKJRR-UHFFFAOYSA-N	528084	N-[(3-fluoro-4-methoxypyridin-2-yl)methyl]-1-({4-[(2-oxopyridin-1- yl)methyl]phenyl}methyl)-3-(trifluoromethyl)pyrazole-4-carboxamide::US11180484, Example 6	Plasma kallikrein			 3.2							ChEMBL		10.7270/Q2R215K6	32066009			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528084	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528084&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301871	463791638							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51511117	COCc1nn(Cc2ccc(Cn3cc(F)ccc3=O)cc2)cc1C(=O)NCc1nccc(OC)c1F	InChI=1S/C26H25F2N5O4/c1-36-16-22-20(26(35)30-11-21-25(28)23(37-2)9-10-29-21)15-33(31-22)13-18-5-3-17(4-6-18)12-32-14-19(27)7-8-24(32)34/h3-10,14-15H,11-13,16H2,1-2H3,(H,30,35)	ZRUFVDPYHLTYPD-UHFFFAOYSA-N	528099	1-({4-[(5-fluoro-2-oxopyridin-1-yl)methyl]phenyl}methyl)-N-[(3-fluoro-4- methoxypyridin-2-yl)methyl]-3-(methoxymethyl)pyrazole-4-carboxamide::US11180484, Example 30::US11584735, Compound of Formula A	Plasma kallikrein			 6.7							ChEMBL		10.7270/Q2R215K6	32066009			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=528099	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=528099&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139301832	463791653							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51511118	CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C35H38N4O4/c1-2-43-30-19-17-26(18-20-30)22-32(38-33(40)29-11-7-4-8-12-29)35(42)39-31(21-25-9-5-3-6-10-25)34(41)37-24-28-15-13-27(23-36)14-16-28/h3-20,31-32H,2,21-24,36H2,1H3,(H,37,41)(H,38,40)(H,39,42)/t31-,32+/m0/s1	UCIXIQRCAGGOJY-AJQTZOPKSA-N	200012	US9234000, 3::US9512065, N-[(R)-1-[(S)-1-(4-aminomethyl-benzylcarbamoyl)-2-phenyl-ethylcarbamoyl]-2-(4-ethoxy-phenyl)-ethyl]-benzamide	Plasma kallikrein			 22							ChEMBL		10.7270/Q2R215K6	32066009			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200012	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200012&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185716	318589842							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51511119	COC(=O)c1ccc(NC(=O)[C@H](CCCCN)NC(=O)[C@H]2CCC(CN)CC2)cc1	InChI=1S/C22H34N4O4/c1-30-22(29)17-9-11-18(12-10-17)25-21(28)19(4-2-3-13-23)26-20(27)16-7-5-15(14-24)6-8-16/h9-12,15-16,19H,2-8,13-14,23-24H2,1H3,(H,25,28)(H,26,27)/t15?,16-,19-/m0/s1	ZSGBVMOYYGWZOY-RRSHCKCTSA-N	50608351	CHEMBL5290183	Plasma kallikrein			 50000							ChEMBL		10.7270/Q2R215K6	32066009			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50608351	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50608351&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			15101681	494498099							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51511120	CC(C)COC(=O)c1ccc(NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H]2CCC(CN)CC2)cc1	InChI=1S/C25H40N6O4/c1-16(2)15-35-24(34)19-9-11-20(12-10-19)30-23(33)21(4-3-13-29-25(27)28)31-22(32)18-7-5-17(14-26)6-8-18/h9-12,16-18,21H,3-8,13-15,26H2,1-2H3,(H,30,33)(H,31,32)(H4,27,28,29)/t17?,18-,21-/m0/s1	VCJXXPCXYYSRHF-VLQCZPCNSA-N	50608352	CHEMBL5285825	Plasma kallikrein			 15000							ChEMBL		10.7270/Q2R215K6	32066009			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50608352	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50608352&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			101615102	494498100							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51511121	COC(=O)c1ccc(NC(=O)[C@H](CCCCNC(N)=N)NC(=O)[C@H]2CCC(CN)CC2)cc1	InChI=1S/C23H36N6O4/c1-33-22(32)17-9-11-18(12-10-17)28-21(31)19(4-2-3-13-27-23(25)26)29-20(30)16-7-5-15(14-24)6-8-16/h9-12,15-16,19H,2-8,13-14,24H2,1H3,(H,28,31)(H,29,30)(H4,25,26,27)/t15?,16-,19-/m0/s1	GDDGGJVAQSAIJT-RRSHCKCTSA-N	50608353	CHEMBL5273370	Plasma kallikrein			 18000							ChEMBL		10.7270/Q2R215K6	32066009			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50608353	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50608353&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			101615657	494498101							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51511122	NCC1CC[C@@H](CC1)C(=O)N[C@@H](CCCCNC(N)=N)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C22H34N6O4/c23-13-14-4-6-15(7-5-14)19(29)28-18(3-1-2-12-26-22(24)25)20(30)27-17-10-8-16(9-11-17)21(31)32/h8-11,14-15,18H,1-7,12-13,23H2,(H,27,30)(H,28,29)(H,31,32)(H4,24,25,26)/t14?,15-,18-/m0/s1	FHXWZESCGSGPFS-UFFKYAFASA-N	50608354	CHEMBL5289986	Plasma kallikrein			 14000							ChEMBL		10.7270/Q2R215K6	32066009			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50608354	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50608354&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			101615656	494498102							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51511123	CC(=O)c1ccc(NC(=O)C(CCCNC(=N)NS(=O)(=O)c2c(C)cc(C)cc2C)NC(=O)[C@H]2CCC(CN)CC2)cc1	InChI=1S/C31H44N6O5S/c1-19-16-20(2)28(21(3)17-19)43(41,42)37-31(33)34-15-5-6-27(36-29(39)25-9-7-23(18-32)8-10-25)30(40)35-26-13-11-24(12-14-26)22(4)38/h11-14,16-17,23,25,27H,5-10,15,18,32H2,1-4H3,(H,35,40)(H,36,39)(H3,33,34,37)/t23?,25-,27?	FDGKAXKIEXUYMM-AOYJSYRCSA-N	50608355	CHEMBL5290514	Plasma kallikrein			 2000							ChEMBL		10.7270/Q2R215K6	32066009			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50608355	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50608355&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171358441	494498103							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51511124	NCC1CC[C@@H](CC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)Nc1ccc(CC(O)=O)cc1	InChI=1S/C25H31N3O4/c26-16-19-6-10-20(11-7-19)24(31)28-22(14-17-4-2-1-3-5-17)25(32)27-21-12-8-18(9-13-21)15-23(29)30/h1-5,8-9,12-13,19-20,22H,6-7,10-11,14-16,26H2,(H,27,32)(H,28,31)(H,29,30)/t19?,20-,22-/m0/s1	MHXICYJVWPVGLT-BXBRYHBFSA-N	50608356	CHEMBL5286067	Plasma kallikrein			 1300							ChEMBL		10.7270/Q2R215K6	32066009			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50608356	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50608356&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			125291	494498104							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51511125	CC(=O)c1ccc(NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]2CCC(CN)CC2)cc1	InChI=1S/C25H31N3O3/c1-17(29)20-11-13-22(14-12-20)27-25(31)23(15-18-5-3-2-4-6-18)28-24(30)21-9-7-19(16-26)8-10-21/h2-6,11-14,19,21,23H,7-10,15-16,26H2,1H3,(H,27,31)(H,28,30)/t19?,21-,23-/m0/s1	DLFGZBZOIOZRSV-FLJXZVEISA-N	50608357	CHEMBL5283915	Plasma kallikrein			 850							ChEMBL		10.7270/Q2R215K6	32066009			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50608357	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50608357&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171345309	494498105							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51511126	Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCOc1cccc(Cl)c1	InChI=1S/C25H24ClN5O3/c26-20-4-3-5-21(14-20)34-13-11-28-25(33)22-17-31(29-24(22)27)16-19-9-7-18(8-10-19)15-30-12-2-1-6-23(30)32/h1-10,12,14,17H,11,13,15-16H2,(H2,27,29)(H,28,33)	BKOMRHGWSXFZSH-UHFFFAOYSA-N	463332	3-Amino-1-[(4-(2-oxo-2H-pyridin-1-ylmethyl)-benzyl]-1H-pyrazole-4-carboxylic acid [2-(3-chloro-phenoxy)-ethyl]-amide::US10781181, Example 1	Plasma kallikrein			 2.9							ChEMBL		10.7270/Q2R215K6	32066009			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463332	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463332&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			132043552	441573178							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51511127	Nc1nn(Cc2ccc(Cn3cc(F)ccc3=O)cc2)cc1C(=O)NCCOc1cccc(Cl)c1	InChI=1S/C25H23ClFN5O3/c26-19-2-1-3-21(12-19)35-11-10-29-25(34)22-16-32(30-24(22)28)14-18-6-4-17(5-7-18)13-31-15-20(27)8-9-23(31)33/h1-9,12,15-16H,10-11,13-14H2,(H2,28,30)(H,29,34)	KZWKGQOVLZMLEU-UHFFFAOYSA-N	463423	3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-({4-[(5-fluoro-2-oxopyridin-1-::US10781181, Example 100	Plasma kallikrein			 6.2							ChEMBL		10.7270/Q2R215K6	32066009			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463423	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463423&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364592	441573269							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51511128	Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)N[C@@H]1CCN(C1)c1cccc(Cl)c1	InChI=1S/C27H27ClN6O2/c28-21-4-3-5-23(14-21)32-13-11-22(17-32)30-27(36)24-18-34(31-26(24)29)16-20-9-7-19(8-10-20)15-33-12-2-1-6-25(33)35/h1-10,12,14,18,22H,11,13,15-17H2,(H2,29,31)(H,30,36)/t22-/m1/s1	QZVBCPBEJSYHNK-JOCHJYFZSA-N	463430	3-amino-N-[(3R)-1-(3-chlorophenyl)pyrrolidin-3-yl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 106	Plasma kallikrein			 684							ChEMBL		10.7270/Q2R215K6	32066009			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463430	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463430&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364678	441573276							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51511129	Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)N[C@H]1CCN(C1)c1cccc(Cl)c1	InChI=1S/C27H27ClN6O2/c28-21-4-3-5-23(14-21)32-13-11-22(17-32)30-27(36)24-18-34(31-26(24)29)16-20-9-7-19(8-10-20)15-33-12-2-1-6-25(33)35/h1-10,12,14,18,22H,11,13,15-17H2,(H2,29,31)(H,30,36)/t22-/m0/s1	QZVBCPBEJSYHNK-QFIPXVFZSA-N	463429	3-amino-N-[(3S)-1-(3-chlorophenyl)pyrrolidin-3-yl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 105	Plasma kallikrein			 4.8							ChEMBL		10.7270/Q2R215K6	32066009			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463429	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463429&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121364650	441573275							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51511130	COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1c(OC)ccc(OC)c1F	InChI=1S/C28H29FN4O5/c1-36-18-23-22(28(35)30-14-21-24(37-2)11-12-25(38-3)27(21)29)17-33(31-23)16-20-9-7-19(8-10-20)15-32-13-5-4-6-26(32)34/h4-13,17H,14-16,18H2,1-3H3,(H,30,35)	TVHOOPXMFWZGQK-UHFFFAOYSA-N	408736	 N-[(2-fluoro-3,6-dimethoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin- 1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide ::US10364238, Example 54::US11001578, Example 54::US11084809, Example 54::US11198691, Example 54	Plasma kallikrein			 2.1							ChEMBL		10.7270/Q2R215K6	32066009			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=408736	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=408736&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121365119	406799367							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297732	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc(O)c1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-25(37(36-26)23-8-1-4-19(12-23)16-33)28(39)35-22-7-2-5-20(13-22)27(34-17-18-10-11-18)21-6-3-9-24(38)14-21/h1-9,12-15,18,27,34,38H,10-11,16-17,33H2,(H,35,39)	WNKOEKOISOIHSR-UHFFFAOYSA-N	416814	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(3-hydroxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 137a::US10633345, Compound 137a::US10689346, Compound 137a::US11203574, Compound 137a::US11230530, Compound 137a::US11685721, Compound 137a::US11708332, Compound 137a	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416814	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416814&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355922	433916728							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297733	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1nccs1)C(F)(F)F	InChI=1S/C26H24F4N6OS/c27-19-7-6-17(23(25-32-8-9-38-25)33-14-15-4-5-15)11-20(19)34-24(37)21-12-22(26(28,29)30)35-36(21)18-3-1-2-16(10-18)13-31/h1-3,6-12,15,23,33H,4-5,13-14,31H2,(H,34,37)	FBQBHRBLNRXXHC-UHFFFAOYSA-N	416815	1-(3-(Aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(thiazol-2-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 101e::US10633345, Compound 101e::US10689346, Compound 101e::US11203574, Compound 101e::US11230530, Compound 101e::US11685721, Compound 101e::US11708332, Compound 101e	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416815	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416815&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355606	433916729							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297734	COc1ccccc1C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O2/c1-40-26-11-3-2-10-24(26)28(35-18-19-12-13-19)21-7-5-8-22(15-21)36-29(39)25-16-27(30(31,32)33)37-38(25)23-9-4-6-20(14-23)17-34/h2-11,14-16,19,28,35H,12-13,17-18,34H2,1H3,(H,36,39)	DAKZTBMQWXCVFA-UHFFFAOYSA-N	439400	US10633345, Compound 119e::US10689346, Compound 119e::US11203574, Compound 119e::US11230530, Compound 119e::US11685721, Compound 120e::US11708332, Compound 119e	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439400	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439400&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665475	439660958							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297735	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(Cc2cccc(O)c2)c1)C(F)(F)F	InChI=1S/C25H21F3N4O2/c26-25(27,28)23-14-22(32(31-23)20-8-2-6-18(12-20)15-29)24(34)30-19-7-1-4-16(11-19)10-17-5-3-9-21(33)13-17/h1-9,11-14,33H,10,15,29H2,(H,30,34)	SDKHQNOIRDBHTG-UHFFFAOYSA-N	416820	1-(3-(aminomethyl)phenyl)-N-(3-(3-hydroxybenzyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 137b::US10633345, Compound 137b::US10689346, Compound 137b::US11203574, Compound 137b::US11230530, Compound 137b::US11685721, Compound 137b::US11708332, Compound 137b	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416820	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416820&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665628	433916733							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297736	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H29F3N6O/c30-29(31,32)26-15-25(38(37-26)24-9-1-4-19(12-24)16-33)28(39)36-23-8-3-6-21(14-23)27(35-17-18-10-11-18)20-5-2-7-22(34)13-20/h1-9,12-15,18,27,35H,10-11,16-17,33-34H2,(H,36,39)	JHOLOXZJFLDOCM-UHFFFAOYSA-N	416821	1-(3-(aminomethyl)phenyl)-N-(3-((3-aminophenyl)(cyclopropylmethylamino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 102b::US11192861, Compound 102b::US11685721, Compound 102b::US11708332, Compound 102b	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416821	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416821&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665659	433916734							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297737	CC(C)c1ccc(cc1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C32H34F3N5O/c1-20(2)23-11-13-24(14-12-23)30(37-19-21-9-10-21)25-6-4-7-26(16-25)38-31(41)28-17-29(32(33,34)35)39-40(28)27-8-3-5-22(15-27)18-36/h3-8,11-17,20-21,30,37H,9-10,18-19,36H2,1-2H3,(H,38,41)	BFUXJPJTVQBLMT-UHFFFAOYSA-N	416823	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(4-isopropylphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 120e::US10633345, Compound 120e::US10689346, Compound 120e::US11203574, Compound 120e::US11230530, Compound 120e::US11708332, Compound 120e	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416823	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416823&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355943	433916736							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297738	CC(=O)Nc1ccc(cc1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C31H31F3N6O2/c1-19(41)37-24-12-10-22(11-13-24)29(36-18-20-8-9-20)23-5-3-6-25(15-23)38-30(42)27-16-28(31(32,33)34)39-40(27)26-7-2-4-21(14-26)17-35/h2-7,10-16,20,29,36H,8-9,17-18,35H2,1H3,(H,37,41)(H,38,42)	JDALRNHKHTYPON-UHFFFAOYSA-N	416827	N-(3-((4-acetamidophenyl)(cyclopropylmethylamino)methyl)phenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 138f::US10633345, Compound 138f::US10689346, Compound 138f::US11203574, Compound 138f::US11230530, Compound 138f::US11685721, Compound 138f::US11708332, Compound 138f	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416827	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416827&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355810	433916740							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297739	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CCC1CC1)c1cc[nH]c1)C(F)(F)F			416828	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-(1H-pyrrol-3-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 103b::US10633345, Compound 103b::US10689346, Compound 103b::US11203574, Compound 103b::US11230530, Compound 103b::US11685721, Compound 103b::US11708332, Compound 103b	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416828	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416828&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355898	433916741							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297740	Cc1ccc(cc1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O/c1-19-8-12-22(13-9-19)28(35-18-20-10-11-20)23-5-3-6-24(15-23)36-29(39)26-16-27(30(31,32)33)37-38(26)25-7-2-4-21(14-25)17-34/h2-9,12-16,20,28,35H,10-11,17-18,34H2,1H3,(H,36,39)	HRCLMMKOPKWJGF-UHFFFAOYSA-N	416829	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(p-tolyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 122g::US10633345, Compound 122g::US10689346, Compound 122g::US11203574, Compound 122g::US11230530, Compound 122g::US11685721, Compound 122g::US11708332, Compound 122g	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416829	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416829&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355867	433916742							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297741	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C30H26F4N6O/c31-24-11-10-22(28(37-17-19-4-5-19)21-8-6-18(15-35)7-9-21)13-25(24)38-29(41)26-14-27(30(32,33)34)39-40(26)23-3-1-2-20(12-23)16-36/h1-3,6-14,19,28,37H,4-5,16-17,36H2,(H,38,41)	GLPWOIBPISJWCH-UHFFFAOYSA-N	416830	1-(3-(aminomethyl)phenyl)-N-(5-((4-cyanophenyl)(cyclopropyl-methylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 52h::US11685721, Compound 71b::US11708332, Compound 52h	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416830	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416830&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355582	433916743							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297742	Cn1cc(cn1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C27H28F3N7O/c1-36-16-20(15-33-36)25(32-14-17-8-9-17)19-5-3-6-21(11-19)34-26(38)23-12-24(27(28,29)30)35-37(23)22-7-2-4-18(10-22)13-31/h2-7,10-12,15-17,25,32H,8-9,13-14,31H2,1H3,(H,34,38)	GHANDLPUFXRHQK-UHFFFAOYSA-N	416831	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(1-methyl-1H-pyrazol-4-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 104f::US10633345, Compound 104f::US10689346, Compound 104f::US11203574, Compound 104f::US11230530, Compound 104f::US11685721, Compound 104f::US11708332, Compound 104f	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416831	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416831&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356100	433916744							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297743	CS(=O)(=O)c1ccccc1C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O3S/c1-42(40,41)26-11-3-2-10-24(26)28(35-18-19-12-13-19)21-7-5-8-22(15-21)36-29(39)25-16-27(30(31,32)33)37-38(25)23-9-4-6-20(14-23)17-34/h2-11,14-16,19,28,35H,12-13,17-18,34H2,1H3,(H,36,39)	XEAXHMDONDJJBQ-UHFFFAOYSA-N	416832	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2-(methylsulfonyl)phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 121f::US10633345, Compound 121f::US10689346, Compound 121f::US11203574, Compound 121f::US11230530, Compound 121f::US11685721, Compound 121f::US11708332, Compound 121f	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416832	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416832&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665701	433916745							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297797	CCCCCNC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H32F3N5O/c1-2-3-7-16-35-28(22-11-5-4-6-12-22)23-13-9-14-24(18-23)36-29(39)26-19-27(30(31,32)33)37-38(26)25-15-8-10-21(17-25)20-34/h4-6,8-15,17-19,28,35H,2-3,7,16,20,34H2,1H3,(H,36,39)	LIINXFZWPJSNHF-UHFFFAOYSA-N	416886	1-(3-(Aminomethyl)phenyl)-N-(3-((pentylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 172b::US10633345, Compound 172b::US10689346, Compound 172b::US11203574, Compound 172b::US11230530, Compound 172b::US11685721, Compound 172b::US11708332, Compound 172b	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416886	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416886&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355915	433916799							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297798	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCCCO)c1ccccc1)C(F)(F)F	InChI=1S/C28H28F3N5O2/c29-28(30,31)25-17-24(36(35-25)23-12-4-7-19(15-23)18-32)27(38)34-22-11-5-10-21(16-22)26(33-13-6-14-37)20-8-2-1-3-9-20/h1-5,7-12,15-17,26,33,37H,6,13-14,18,32H2,(H,34,38)	YSEURYDLGGVADI-UHFFFAOYSA-N	416887	1-(3-(Aminomethyl)phenyl)-N-(3-(((3-hydroxypropyl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 191b::US10633345, Compound 191b::US10689346, Compound 191b::US11203574, Compound 191b::US11230530, Compound 191b::US11685721, Compound 191b::US11708332, Compound 191b	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416887	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416887&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665847	433916800							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297799	COC(CCC1CC1)(c1cccnc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O2/c1-40-29(13-12-20-10-11-20,23-7-4-14-35-19-23)22-6-3-8-24(16-22)36-28(39)26-17-27(30(31,32)33)37-38(26)25-9-2-5-21(15-25)18-34/h2-9,14-17,19-20H,10-13,18,34H2,1H3,(H,36,39)	HEQLXMARFGMGBQ-UHFFFAOYSA-N	416888	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-methoxy-1-(pyridin-3-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 156c::US10633345, Compound 156c::US10689346, Compound 156c::US11203574, Compound 156c::US11230530, Compound 156c::US11685721, Compound 156c::US11708332, Compound 156c	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416888	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416888&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355759	433916801							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297800	CC(CO)NC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C28H28F3N5O2/c1-18(17-37)33-26(20-8-3-2-4-9-20)21-10-6-11-22(14-21)34-27(38)24-15-25(28(29,30)31)35-36(24)23-12-5-7-19(13-23)16-32/h2-15,18,26,33,37H,16-17,32H2,1H3,(H,34,38)	HGDYIKLNDBPRGN-UHFFFAOYSA-N	416889	1-(3-(aminomethyl)phenyl)-N-(3-(((1-hydroxypropan-2-yl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 173b::US10633345, Compound 173b::US10689346, Compound 173b::US11203574, Compound 173b::US11230530, Compound 173b::US11685721, Compound 173b::US11708332, Compound 173b	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416889	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416889&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355997	433916802							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297801	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc(F)c1)C(F)(F)F	InChI=1S/C29H27F4N5O/c30-22-7-2-5-20(13-22)27(35-17-18-10-11-18)21-6-3-8-23(14-21)36-28(39)25-15-26(29(31,32)33)37-38(25)24-9-1-4-19(12-24)16-34/h1-9,12-15,18,27,35H,10-11,16-17,34H2,(H,36,39)	FVMNYLZQOFMPFE-UHFFFAOYSA-N	416890	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(3-fluorophenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 195f::US10633345, Compound 195f::US10689346, Compound 195f::US11203574, Compound 195f::US11230530, Compound 195f::US11685721, Compound 195f::US11708332, Compound 195f	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416890	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416890&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665561	433916803							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297802	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C30H26F4N6O/c31-24-10-9-22(28(37-17-18-7-8-18)21-5-1-3-19(11-21)15-35)13-25(24)38-29(41)26-14-27(30(32,33)34)39-40(26)23-6-2-4-20(12-23)16-36/h1-6,9-14,18,28,37H,7-8,16-17,36H2,(H,38,41)	UXNXMBYCBRBRFD-UHFFFAOYSA-N	416891	1-(3-(aminomethyl)phenyl)-N-(5-((3-cyanophenyl)(cyclopropyl-methylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 54e::US11685721, Compound 70b::US11708332, Compound 70b	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416891	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416891&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	0RI	7N7X	118355809	433916804							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297803	CC(C)(CO)NC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C29H30F3N5O2/c1-28(2,18-38)35-26(20-9-4-3-5-10-20)21-11-7-12-22(15-21)34-27(39)24-16-25(29(30,31)32)36-37(24)23-13-6-8-19(14-23)17-33/h3-16,26,35,38H,17-18,33H2,1-2H3,(H,34,39)	JPSBLISQAZCRFK-UHFFFAOYSA-N	416892	1-(3-(aminomethyl)phenyl)-N-(3-(((1-hydroxy-2-methylpropan-2-yl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 174b::US10633345, Compound 174b::US10689346, Compound 174b::US11203574, Compound 174b::US11230530, Compound 174b::US11685721, Compound 174b::US11708332, Compound 174b	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416892	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416892&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665949	433916805							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297804	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(F)cc1F)C(F)(F)F	InChI=1S/C29H26F5N5O/c30-20-9-10-23(24(31)13-20)27(36-16-17-7-8-17)19-4-2-5-21(12-19)37-28(40)25-14-26(29(32,33)34)38-39(25)22-6-1-3-18(11-22)15-35/h1-6,9-14,17,27,36H,7-8,15-16,35H2,(H,37,40)	QIBXOBBXVAEMNW-UHFFFAOYSA-N	416893	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2,4-difluorophenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 196f::US10633345, Compound 196f::US10689346, Compound 196f::US11203574, Compound 196f::US11230530, Compound 196f::US11685721, Compound 196f::US11708332, Compound 196f	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416893	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416893&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665453	433916806							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297805	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C30H25F4N5O2/c31-24-11-10-22(28(41-17-19-4-5-19)21-8-6-18(15-35)7-9-21)13-25(24)37-29(40)26-14-27(30(32,33)34)38-39(26)23-3-1-2-20(12-23)16-36/h1-3,6-14,19,28H,4-5,16-17,36H2,(H,37,40)	WXFHQCUXOOXGLO-UHFFFAOYSA-N	416894	1-(3-(aminomethyl)phenyl)-N-(5-((4-cyanophenyl)(cyclopropylmethoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 55b::US10633345, Compound 73b::US10689346, Compound 55b::US11203574, Compound 73b::US11230530, Compound 73b::US11685721, Compound 73b::US11708332, Compound 73b	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416894	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416894&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665569	433916807							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297806	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CCCO1)c1ccccc1)C(F)(F)F	InChI=1S/C30H30F3N5O2/c31-30(32,33)27-17-26(38(37-27)24-12-4-7-20(15-24)18-34)29(39)36-23-11-5-10-22(16-23)28(21-8-2-1-3-9-21)35-19-25-13-6-14-40-25/h1-5,7-12,15-17,25,28,35H,6,13-14,18-19,34H2,(H,36,39)	SIOCTSAXUSNOCO-UHFFFAOYSA-N	416895	1-(3-(aminomethyl)phenyl)-N-(3-(phenyl(((tetrahydrofuran-2-yl)methyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 175b::US10633345, Compound 175b::US10689346, Compound 175b::US11203574, Compound 175b::US11230530, Compound 175b::US11685721, Compound 175b::US11708332, Compound 175b	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416895	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416895&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355976	433916808							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297807	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cc(F)ccc1F)C(F)(F)F	InChI=1S/C29H26F5N5O/c30-20-9-10-24(31)23(13-20)27(36-16-17-7-8-17)19-4-2-5-21(12-19)37-28(40)25-14-26(29(32,33)34)38-39(25)22-6-1-3-18(11-22)15-35/h1-6,9-14,17,27,36H,7-8,15-16,35H2,(H,37,40)	DGRITJGAWATINU-UHFFFAOYSA-N	416896	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2,5-difluorophenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 197f::US10633345, Compound 197f::US10689346, Compound 197f::US11203574, Compound 197f::US11230530, Compound 197f::US11685721, Compound 197f::US11708332, Compound 197f	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416896	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416896&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665599	433916809							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297808	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-9-8-20(28(40,11-10-18-6-7-18)21-4-2-12-35-17-21)14-24(23)36-27(39)25-15-26(29(31,32)33)37-38(25)22-5-1-3-19(13-22)16-34/h1-5,8-9,12-15,17-18,40H,6-7,10-11,16,34H2,(H,36,39)	VCHFZCHUEHQXSZ-UHFFFAOYSA-N	416897	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 58c::US10633345, Compound 67b::US10689346, Compound 67b::US11203574, Compound 67b::US11230530, Compound 67b::US11685721, Compound 67b::US11708332, Compound 67b	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416897	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416897&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355889	433916810							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297809	CC(C)CCNC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H32F3N5O/c1-20(2)14-15-35-28(22-9-4-3-5-10-22)23-11-7-12-24(17-23)36-29(39)26-18-27(30(31,32)33)37-38(26)25-13-6-8-21(16-25)19-34/h3-13,16-18,20,28,35H,14-15,19,34H2,1-2H3,(H,36,39)	WPCVSFNABLNPTN-UHFFFAOYSA-N	416898	1-(3-(aminomethyl)phenyl)-N-(3-((isopentylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 176b::US10633345, Compound 176b::US10689346, Compound 176b::US11203574, Compound 176b::US11230530, Compound 176b::US11685721, Compound 176b::US11708332, Compound 176b	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416898	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416898&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665776	433916811							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297810	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1c(F)cccc1F)C(F)(F)F	InChI=1S/C29H26F5N5O/c30-22-8-3-9-23(31)26(22)27(36-16-17-10-11-17)19-5-2-6-20(13-19)37-28(40)24-14-25(29(32,33)34)38-39(24)21-7-1-4-18(12-21)15-35/h1-9,12-14,17,27,36H,10-11,15-16,35H2,(H,37,40)	OHXCNQRJQHLAER-UHFFFAOYSA-N	416899	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2,6-difluorophenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 198f::US10633345, Compound 198f::US10689346, Compound 198f::US11203574, Compound 198f::US11230530, Compound 198f::US11685721, Compound 198f::US11708332, Compound 198f	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416899	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416899&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665643	433916812							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297811	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C30H25F4N5O2/c31-24-10-9-22(28(41-17-18-7-8-18)21-5-1-3-19(11-21)15-35)13-25(24)37-29(40)26-14-27(30(32,33)34)38-39(26)23-6-2-4-20(12-23)16-36/h1-6,9-14,18,28H,7-8,16-17,36H2,(H,37,40)	LSXFYXGKZDVRTL-UHFFFAOYSA-N	416900	1-(3-(aminomethyl)phenyl)-N-(5-((3-cyanophenyl)(cyclopropyl-methoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 56c::US10633345, Compound 72d::US10689346, Compound 56c::US11203574, Compound 72d::US11230530, Compound 72d::US11685721, Compound 72d::US11708332, Compound 72d	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416900	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416900&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356211	433916813							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297812	CCC(C)CNC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H32F3N5O/c1-3-20(2)19-35-28(22-10-5-4-6-11-22)23-12-8-13-24(16-23)36-29(39)26-17-27(30(31,32)33)37-38(26)25-14-7-9-21(15-25)18-34/h4-17,20,28,35H,3,18-19,34H2,1-2H3,(H,36,39)	ZCSNRDNUIRVYLS-UHFFFAOYSA-N	416901	1-(3-(Aminomethyl)phenyl)-N-(3-(((2-methylbutyl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 177b::US10633345, Compound 177b::US10689346, Compound 177b::US11203574, Compound 177b::US11230530, Compound 177b::US11685721, Compound 177b::US11708332, Compound 177b	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416901	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416901&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665478	433916814							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297813	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1Cl)C(F)(F)F	InChI=1S/C29H27ClF3N5O/c30-24-10-2-1-9-23(24)27(35-17-18-11-12-18)20-6-4-7-21(14-20)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-3-5-19(13-22)16-34/h1-10,13-15,18,27,35H,11-12,16-17,34H2,(H,36,39)	UQMCUIGBQDUSLW-UHFFFAOYSA-N	416902	1-(3-(aminomethyl)phenyl)-N-(3-((2-chlorophenyl)((cyclopropylmethyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 194f::US10329260, Compound 199f::US10633345, Compound 199f::US10689346, Compound 199f::US11203574, Compound 199f::US11230530, Compound 199f::US11685721, Compound 199f::US11708332, Compound 199f	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416902	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416902&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356220	433916815							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297814	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H28F4N4O2/c31-24-12-11-22(29(40,14-13-19-9-10-19)21-6-2-1-3-7-21)16-25(24)36-28(39)26-17-27(30(32,33)34)37-38(26)23-8-4-5-20(15-23)18-35/h1-8,11-12,15-17,19,40H,9-10,13-14,18,35H2,(H,36,39)	NIWMWYNGSALJGG-UHFFFAOYSA-N	416903	Racemic 1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 68c::US10633345, Compound 68e::US10689346, Compound 68c::US11203574, Compound 68e::US11230530, Compound 68e::US11685721, Compound 68e::US11708332, Compound 68e	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416903	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416903&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355758	433916816							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297815	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(N(CCO)CCO)c1ccccc1)C(F)(F)F	InChI=1S/C29H30F3N5O3/c30-29(31,32)26-18-25(37(35-26)24-11-4-6-20(16-24)19-33)28(40)34-23-10-5-9-22(17-23)27(21-7-2-1-3-8-21)36(12-14-38)13-15-39/h1-11,16-18,27,38-39H,12-15,19,33H2,(H,34,40)	HFRFNKSEVVNXFK-UHFFFAOYSA-N	416904	1-(3-(aminomethyl)phenyl)-N-(3-((bis(2-hydroxyethyl)amino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 178b::US10633345, Compound 178b::US10689346, Compound 178b::US11203574, Compound 178b::US11230530, Compound 178b::US11685721, Compound 178b::US11708332, Compound 178b	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416904	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416904&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355913	433916817							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297816	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1Cl)C(F)(F)F	InChI=1S/C29H27ClF3N5O/c30-24-10-2-1-9-23(24)27(35-17-18-11-12-18)20-6-4-7-21(14-20)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-3-5-19(13-22)16-34/h1-10,13-15,18,27,35H,11-12,16-17,34H2,(H,36,39)	UQMCUIGBQDUSLW-UHFFFAOYSA-N	416902	1-(3-(aminomethyl)phenyl)-N-(3-((2-chlorophenyl)((cyclopropylmethyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 194f::US10329260, Compound 199f::US10633345, Compound 199f::US10689346, Compound 199f::US11203574, Compound 199f::US11230530, Compound 199f::US11685721, Compound 199f::US11708332, Compound 199f	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416902	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416902&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356220	433916815							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297817	COc1ccc2ccccc2c1C(NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H31F4N5O2/c1-45-29-14-12-22-6-2-3-8-25(22)31(29)32(40-19-20-9-10-20)23-11-13-26(35)27(16-23)41-33(44)28-17-30(34(36,37)38)42-43(28)24-7-4-5-21(15-24)18-39/h2-8,11-17,20,32,40H,9-10,18-19,39H2,1H3,(H,41,44)	AYMFYNZEWAELBE-UHFFFAOYSA-N	416906	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(2-methoxynaphthalen-1-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide dihydrochloride::US10329260, Compound 61e::US10633345, Compound 63b::US10689346, Compound 61e::US11203574, Compound 63b::US11230530, Compound 63b::US11685721, Compound 63b::US11708332, Compound 63b	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416906	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416906&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355591	433916818							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297818	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCc1cccnc1)c1ccccc1)C(F)(F)F	InChI=1S/C31H27F3N6O/c32-31(33,34)28-17-27(40(39-28)26-13-4-7-21(15-26)18-35)30(41)38-25-12-5-11-24(16-25)29(23-9-2-1-3-10-23)37-20-22-8-6-14-36-19-22/h1-17,19,29,37H,18,20,35H2,(H,38,41)	HIJVXEVWORHKBX-UHFFFAOYSA-N	416907	1-(3-(Aminomethyl)phenyl)-N-(3-(phenyl((pyridin-3-ylmethyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 179b::US10633345, Compound 179b::US10689346, Compound 179b::US11203574, Compound 179b::US11230530, Compound 179b::US11685721, Compound 179b::US11708332, Compound 179b	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416907	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416907&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665526	433916819							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297819	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(Cl)cc1Cl)C(F)(F)F	InChI=1S/C29H26Cl2F3N5O/c30-20-9-10-23(24(31)13-20)27(36-16-17-7-8-17)19-4-2-5-21(12-19)37-28(40)25-14-26(29(32,33)34)38-39(25)22-6-1-3-18(11-22)15-35/h1-6,9-14,17,27,36H,7-8,15-16,35H2,(H,37,40)	CXLXHJIZVQBZJV-UHFFFAOYSA-N	416908	1-(3-(aminomethyl)phenyl)-N-(3-((2,4-dichlorophenyl)((cyclopropylmethyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 200f::US10633345, Compound 200f::US10689346, Compound 200f::US11203574, Compound 200f::US11230530, Compound 200f::US11685721, Compound 200f::US11708332, Compound 200f	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416908	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416908&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126688969	433916820							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297820	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-10-9-20(28(40,12-11-18-7-8-18)25-6-1-2-13-35-25)15-23(22)36-27(39)24-16-26(29(31,32)33)37-38(24)21-5-3-4-19(14-21)17-34/h1-6,9-10,13-16,18,40H,7-8,11-12,17,34H2,(H,36,39)	XXMBQXWQIGCREG-UHFFFAOYSA-N	416909	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 59c::US10633345, Compound 69b::US10689346, Compound 59c::US11203574, Compound 69b::US11230530, Compound 69b::US11685721, Compound 69b::US11708332, Compound 69b	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416909	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416909&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356067	433916821							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297821	CCCCNC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C29H30F3N5O/c1-2-3-15-34-27(21-10-5-4-6-11-21)22-12-8-13-23(17-22)35-28(38)25-18-26(29(30,31)32)36-37(25)24-14-7-9-20(16-24)19-33/h4-14,16-18,27,34H,2-3,15,19,33H2,1H3,(H,35,38)	IJFOMNKWJBCMSK-UHFFFAOYSA-N	416910	1-(3-(Aminomethyl)phenyl)-N-(3-((butylamino)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 180b::US10633345, Compound 180b::US10689346, Compound 180b::US11203574, Compound 180b::US11230530, Compound 180b::US11685721, Compound 180b::US11708332, Compound 180b	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416910	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416910&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665986	433916822							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297822	Cc1ccc(C(NCC2CC2)c2cccc(NC(=O)c3cc(nn3-c3cccc(CN)c3)C(F)(F)F)c2)c(C)c1	InChI=1S/C31H32F3N5O/c1-19-9-12-26(20(2)13-19)29(36-18-21-10-11-21)23-6-4-7-24(15-23)37-30(40)27-16-28(31(32,33)34)38-39(27)25-8-3-5-22(14-25)17-35/h3-9,12-16,21,29,36H,10-11,17-18,35H2,1-2H3,(H,37,40)	PPHLPILJSQAZAY-UHFFFAOYSA-N	416911	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2,4-dimethylphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 201f::US10689346, Compound 201f::US11192861, Compound 201f::US11230530, Compound 201f::US11685721, Compound 201f::US11708332, Compound 201f	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416911	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416911&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665576	433916823							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297823	Cc1ccc(C)c(c1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C31H32F3N5O/c1-19-9-10-20(2)26(13-19)29(36-18-21-11-12-21)23-6-4-7-24(15-23)37-30(40)27-16-28(31(32,33)34)38-39(27)25-8-3-5-22(14-25)17-35/h3-10,13-16,21,29,36H,11-12,17-18,35H2,1-2H3,(H,37,40)	NFGQIHGOUUFZHN-UHFFFAOYSA-N	416912	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2,5-dimethylphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 202f::US10633345, Compound 202f::US10689346, Compound 202f::US11203574, Compound 202f::US11230530, Compound 202f::US11685721, Compound 202f::US11708332, Compound 202f	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416912	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416912&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665510	433916824							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297824	FC(F)(F)c1cc(C(=O)Nc2cccc(c2)C(OCC2CC2)c2ccccc2)n(n1)-c1cccc(c1)C#N	InChI=1S/C29H23F3N4O2/c30-29(31,32)26-16-25(36(35-26)24-11-4-6-20(14-24)17-33)28(37)34-23-10-5-9-22(15-23)27(38-18-19-12-13-19)21-7-2-1-3-8-21/h1-11,14-16,19,27H,12-13,18H2,(H,34,37)	SPWAYDXCKKPOML-UHFFFAOYSA-N	606445	(+)-1-(3-cyanophenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US11685721, Compound 166e::US11708332, Compound 166e	Plasma kallikrein		 25.1								US Patent		10.7270/Q2XW4PXV			US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=606445	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=606445&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355663	483497879							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297825	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F4N5O/c30-23-12-11-21(27(35-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27,35H,9-10,16-17,34H2,(H,36,39)	MCLZOCFEIKBMBA-UHFFFAOYSA-N	416773	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 38d::US10633345, Compound 38d::US10689346, Compound 42a::US11203574, Compound 42a::US11230530, Compound 42a::US11685721, Compound 38d::US11708332, Compound 38d	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416773	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416773&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356124	433916687							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297826	CC(C)(C)c1ccc(cc1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C33H36F3N5O/c1-32(2,3)25-14-12-23(13-15-25)30(38-20-21-10-11-21)24-7-5-8-26(17-24)39-31(42)28-18-29(33(34,35)36)40-41(28)27-9-4-6-22(16-27)19-37/h4-9,12-18,21,30,38H,10-11,19-20,37H2,1-3H3,(H,39,42)	OVDVNIYCGDTOJR-UHFFFAOYSA-N	416915	1-(3-(aminomethyl)phenyl)-N-(3-((4-(tert-butyl)phenyl)((cyclopropylmethyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 203f::US10633345, Compound 203f::US10689346, Compound 203f::US11203574, Compound 203f::US11230530, Compound 203f::US11685721, Compound 203f::US11708332, Compound 203f	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416915	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416915&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665458	433916827							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297827	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F3N4O2/c30-29(31,32)26-16-25(36(35-26)24-11-4-6-20(14-24)17-33)28(37)34-23-10-5-9-22(15-23)27(38-18-19-12-13-19)21-7-2-1-3-8-21/h1-11,14-16,19,27H,12-13,17-18,33H2,(H,34,37)	PEZVPVUPSJXZCH-UHFFFAOYSA-N	416775	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18k::US10633345, Compound 74a::US10689346, Compound 165e::US11203574, Compound 165e::US11230530, Compound 165e::US11685721, Compound 18k::US11708332, Compound 18k	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416775	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416775&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			91884591	433916689							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297828	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F4N5O/c30-23-12-11-21(27(35-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27,35H,9-10,16-17,34H2,(H,36,39)	MCLZOCFEIKBMBA-UHFFFAOYSA-N	416773	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 38d::US10633345, Compound 38d::US10689346, Compound 42a::US11203574, Compound 42a::US11230530, Compound 42a::US11685721, Compound 38d::US11708332, Compound 38d	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416773	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416773&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356124	433916687							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297829	OC(CCC1CC1)(c1ccc(F)c(NC(=O)c2cc(nn2-c2ccc(Cl)cc2)C(F)(F)F)c1)c1ccccn1	InChI=1S/C28H23ClF4N4O2/c29-19-7-9-20(10-8-19)37-23(16-25(36-37)28(31,32)33)26(38)35-22-15-18(6-11-21(22)30)27(39,13-12-17-4-5-17)24-3-1-2-14-34-24/h1-3,6-11,14-17,39H,4-5,12-13H2,(H,35,38)	QWPFRWIQIFPXCC-UHFFFAOYSA-N	416918	1-(4-chlorophenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 157a::US10633345, Compound 157a::US10689346, Compound 157a::US11203574, Compound 157a::US11230530, Compound 157a::US11685721, Compound 157a::US11708332, Compound 157a	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416918	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416918&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665679	433916830							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297830	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(N)cc1)C(F)(F)F	InChI=1S/C29H29F3N6O/c30-29(31,32)26-15-25(38(37-26)24-6-1-3-19(13-24)16-33)28(39)36-23-5-2-4-21(14-23)27(35-17-18-7-8-18)20-9-11-22(34)12-10-20/h1-6,9-15,18,27,35H,7-8,16-17,33-34H2,(H,36,39)	XDCYYWMSVYTRMZ-UHFFFAOYSA-N	416843	1-(3-(aminomethyl)phenyl)-N-(3-((4-aminophenyl)(cyclopropylmethyl-amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 50f::US10633345, Compound 50f::US10689346, Compound 50h::US11203574, Compound 50h::US11230530, Compound 50h::US11685721, Compound 50f::US11708332, Compound 50h	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416843	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416843&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355587	433916756							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297831	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)[C@@](O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-9-8-20(28(40,11-10-18-6-7-18)21-4-2-12-35-17-21)14-24(23)36-27(39)25-15-26(29(31,32)33)37-38(25)22-5-1-3-19(13-22)16-34/h1-5,8-9,12-15,17-18,40H,6-7,10-11,16,34H2,(H,36,39)/t28-/m0/s1	VCHFZCHUEHQXSZ-NDEPHWFRSA-N	609992	(&#8722;)-1-(3-(aminomethyl)phenyl)-N-(5-(3-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US11708332, Compound 67a	Plasma kallikrein		 25.1								US Patent		10.7270/Q2XW4PXV			US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=609992	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=609992&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168489482	483620160							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297832	OC(CCC1CC1)(c1ccc(F)c(NC(=O)c2cc(nn2-c2ccc3cc(Cl)ccc3c2)C(F)(F)F)c1)c1ccccn1	InChI=1S/C32H25ClF4N4O2/c33-23-9-6-21-16-24(10-7-20(21)15-23)41-27(18-29(40-41)32(35,36)37)30(42)39-26-17-22(8-11-25(26)34)31(43,13-12-19-4-5-19)28-3-1-2-14-38-28/h1-3,6-11,14-19,43H,4-5,12-13H2,(H,39,42)	XTIXOVGIMHWYOB-UHFFFAOYSA-N	416921	1-(6-chloronaphthalen-2-yl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 158a::US10633345, Compound 158a::US10689346, Compound 158a::US11203574, Compound 158a::US11230530, Compound 158a::US11685721, Compound 158a::US11708332, Compound 158a	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416921	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416921&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355937	433916833							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297833	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(N)cc1)C(F)(F)F	InChI=1S/C29H29F3N6O/c30-29(31,32)26-15-25(38(37-26)24-6-1-3-19(13-24)16-33)28(39)36-23-5-2-4-21(14-23)27(35-17-18-7-8-18)20-9-11-22(34)12-10-20/h1-6,9-15,18,27,35H,7-8,16-17,33-34H2,(H,36,39)	XDCYYWMSVYTRMZ-UHFFFAOYSA-N	416843	1-(3-(aminomethyl)phenyl)-N-(3-((4-aminophenyl)(cyclopropylmethyl-amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 50f::US10633345, Compound 50f::US10689346, Compound 50h::US11203574, Compound 50h::US11230530, Compound 50h::US11685721, Compound 50f::US11708332, Compound 50h	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416843	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416843&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355587	433916756							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297834	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-9-8-20(28(40,11-10-18-6-7-18)21-4-2-12-35-17-21)14-24(23)36-27(39)25-15-26(29(31,32)33)37-38(25)22-5-1-3-19(13-22)16-34/h1-5,8-9,12-15,17-18,40H,6-7,10-11,16,34H2,(H,36,39)	VCHFZCHUEHQXSZ-UHFFFAOYSA-N	416897	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 58c::US10633345, Compound 67b::US10689346, Compound 67b::US11203574, Compound 67b::US11230530, Compound 67b::US11685721, Compound 67b::US11708332, Compound 67b	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416897	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416897&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355889	433916810							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297835	OC(CCC1CC1)(c1ccc(F)c(NC(=O)c2cc(nn2-c2ccc(Cl)cn2)C(F)(F)F)c1)c1ccccn1	InChI=1S/C27H22ClF4N5O2/c28-18-7-9-24(34-15-18)37-21(14-23(36-37)27(30,31)32)25(38)35-20-13-17(6-8-19(20)29)26(39,11-10-16-4-5-16)22-3-1-2-12-33-22/h1-3,6-9,12-16,39H,4-5,10-11H2,(H,35,38)	HMQODPUNPWDVSN-UHFFFAOYSA-N	416924	1-(5-chloropyridin-2-yl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 159a::US10633345, Compound 159a::US10689346, Compound 159a::US11203574, Compound 159a::US11230530, Compound 159a::US11685721, Compound 159a::US11708332, Compound 159a	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416924	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416924&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355989	433916836							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297836	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C28H26F3N5O2/c29-28(30,31)25-15-24(36(35-25)22-8-3-5-19(13-22)16-32)27(37)34-21-7-4-6-20(14-21)26(38-17-18-10-11-18)23-9-1-2-12-33-23/h1-9,12-15,18,26H,10-11,16-17,32H2,(H,34,37)	UBQUVYTUKOFUOF-UHFFFAOYSA-N	416721	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(pyridin-2-yl)methyl)-phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 43f::US10633345, Compound 43f::US10689346, Compound 43g::US11203574, Compound 43h::US11230530, Compound 43h::US11685721, Compound 43f::US11708332, Compound 43f	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416721	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416721&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355947	433916635							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297837	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C30H26F4N6O/c31-24-10-9-22(28(37-17-18-7-8-18)21-5-1-3-19(11-21)15-35)13-25(24)38-29(41)26-14-27(30(32,33)34)39-40(26)23-6-2-4-20(12-23)16-36/h1-6,9-14,18,28,37H,7-8,16-17,36H2,(H,38,41)	UXNXMBYCBRBRFD-UHFFFAOYSA-N	416891	1-(3-(aminomethyl)phenyl)-N-(5-((3-cyanophenyl)(cyclopropyl-methylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 54e::US11685721, Compound 70b::US11708332, Compound 70b	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416891	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416891&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	0RI	7N7X	118355809	433916804							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297838	COc1ccc(cc1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H26F4N4O3/c1-40-21-10-8-20(9-11-21)37-24(17-26(36-37)29(31,32)33)27(38)35-23-16-19(7-12-22(23)30)28(39,14-13-18-5-6-18)25-4-2-3-15-34-25/h2-4,7-12,15-18,39H,5-6,13-14H2,1H3,(H,35,38)	YTPYYUUEYRYYOR-UHFFFAOYSA-N	416927	N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-1-(4-methoxyphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 160a::US10633345, Compound 160a::US10689346, Compound 160a::US11203574, Compound 160a::US11230530, Compound 160a::US11685721, Compound 160a::US11708332, Compound 160a	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416927	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416927&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665840	433916839							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297839	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C28H26F3N5O2/c29-28(30,31)25-15-24(36(35-25)22-8-3-5-19(13-22)16-32)27(37)34-21-7-4-6-20(14-21)26(38-17-18-10-11-18)23-9-1-2-12-33-23/h1-9,12-15,18,26H,10-11,16-17,32H2,(H,34,37)	UBQUVYTUKOFUOF-UHFFFAOYSA-N	416721	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(pyridin-2-yl)methyl)-phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 43f::US10633345, Compound 43f::US10689346, Compound 43g::US11203574, Compound 43h::US11230530, Compound 43h::US11685721, Compound 43f::US11708332, Compound 43f	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416721	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416721&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355947	433916635							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297840	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C30H26F4N6O/c31-24-10-9-22(28(37-17-18-7-8-18)21-5-1-3-19(11-21)15-35)13-25(24)38-29(41)26-14-27(30(32,33)34)39-40(26)23-6-2-4-20(12-23)16-36/h1-6,9-14,18,28,37H,7-8,16-17,36H2,(H,38,41)	UXNXMBYCBRBRFD-UHFFFAOYSA-N	416891	1-(3-(aminomethyl)phenyl)-N-(5-((3-cyanophenyl)(cyclopropyl-methylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 54e::US11685721, Compound 70b::US11708332, Compound 70b	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416891	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416891&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	0RI	7N7X	118355809	433916804							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297841	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(O)c(Br)c1)C(F)(F)F	InChI=1S/C29H27BrF3N5O2/c30-23-13-20(9-10-25(23)39)27(35-16-17-7-8-17)19-4-2-5-21(12-19)36-28(40)24-14-26(29(31,32)33)37-38(24)22-6-1-3-18(11-22)15-34/h1-6,9-14,17,27,35,39H,7-8,15-16,34H2,(H,36,40)	VZKYGMDBRSVHHT-UHFFFAOYSA-N	416930	1-(3-(Aminomethyl)phenyl)-N-(3-((3-bromo-4-hydroxyphenyl)(cyclopropylmethylamino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 207j::US10633345, Compound 207j::US10689346, Compound 207j::US11203574, Compound 207j::US11230530, Compound 207j::US11685721, Compound 207j::US11708332, Compound 207j	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416930	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416930&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665574	433916842							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297842	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H26F3N5O2/c29-28(30,31)25-14-24(36(35-25)23-8-1-4-19(12-23)15-32)27(37)34-22-7-2-5-20(13-22)26(38-17-18-9-10-18)21-6-3-11-33-16-21/h1-8,11-14,16,18,26H,9-10,15,17,32H2,(H,34,37)	SHFRWTHPPCXLER-UHFFFAOYSA-N	416725	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(pyridin-3-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 44c::US10633345, Compound 44c::US10689346, Compound 44c::US11203574, Compound 44d::US11230530, Compound 44e::US11685721, Compound 44c::US11708332, Compound 44c	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416725	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416725&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355578	433916639							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297843	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-10-9-20(28(40,12-11-18-7-8-18)25-6-1-2-13-35-25)15-23(22)36-27(39)24-16-26(29(31,32)33)37-38(24)21-5-3-4-19(14-21)17-34/h1-6,9-10,13-16,18,40H,7-8,11-12,17,34H2,(H,36,39)	XXMBQXWQIGCREG-UHFFFAOYSA-N	416909	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 59c::US10633345, Compound 69b::US10689346, Compound 59c::US11203574, Compound 69b::US11230530, Compound 69b::US11685721, Compound 69b::US11708332, Compound 69b	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416909	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416909&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356067	433916821							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297844	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CCC1CC1)n1ccccc1=O)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-17-25(37(35-26)23-8-3-5-20(15-23)18-33)28(39)34-22-7-4-6-21(16-22)24(13-12-19-10-11-19)36-14-2-1-9-27(36)38/h1-9,14-17,19,24H,10-13,18,33H2,(H,34,39)	OGNFHFCMBSJJNJ-UHFFFAOYSA-N	416933	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-(2-oxopyridin-1(2H)-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 247c::US10633345, Compound 247c::US10689346, Compound 247c::US11203574, Compound 247c::US11230530, Compound 247c::US11685721, Compound 247c::US11708332, Compound 247c	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416933	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416933&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356133	433916845							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297845	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H26F3N5O2/c29-28(30,31)25-14-24(36(35-25)23-8-1-4-19(12-23)15-32)27(37)34-22-7-2-5-20(13-22)26(38-17-18-9-10-18)21-6-3-11-33-16-21/h1-8,11-14,16,18,26H,9-10,15,17,32H2,(H,34,37)	SHFRWTHPPCXLER-UHFFFAOYSA-N	416725	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(pyridin-3-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 44c::US10633345, Compound 44c::US10689346, Compound 44c::US11203574, Compound 44d::US11230530, Compound 44e::US11685721, Compound 44c::US11708332, Compound 44c	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416725	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416725&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355578	433916639							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297846	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-10-9-20(28(40,12-11-18-7-8-18)25-6-1-2-13-35-25)15-23(22)36-27(39)24-16-26(29(31,32)33)37-38(24)21-5-3-4-19(14-21)17-34/h1-6,9-10,13-16,18,40H,7-8,11-12,17,34H2,(H,36,39)	XXMBQXWQIGCREG-UHFFFAOYSA-N	416909	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 59c::US10633345, Compound 69b::US10689346, Compound 59c::US11203574, Compound 69b::US11230530, Compound 69b::US11685721, Compound 69b::US11708332, Compound 69b	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416909	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416909&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356067	433916821							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297847	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CCC1CC1)N1CCCC1=O)C(F)(F)F	InChI=1S/C28H30F3N5O2/c29-28(30,31)25-16-24(36(34-25)22-7-1-4-19(14-22)17-32)27(38)33-21-6-2-5-20(15-21)23(12-11-18-9-10-18)35-13-3-8-26(35)37/h1-2,4-7,14-16,18,23H,3,8-13,17,32H2,(H,33,38)	LEZWAIIPWSOOAE-UHFFFAOYSA-N	416936	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-(2-oxopyrrolidin-1-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 247e::US10633345, Compound 247e::US10689346, Compound 247e::US11203574, Compound 247e::US11230530, Compound 247e::US11685721, Compound 247e::US11708332, Compound 247e	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416936	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416936&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665605	433916848							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297848	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-16-25(37(36-26)24-8-1-4-20(14-24)17-33)27(38)35-23-7-2-5-21(15-23)28(39,12-11-19-9-10-19)22-6-3-13-34-18-22/h1-8,13-16,18-19,39H,9-12,17,33H2,(H,35,38)	AOCZEQQKIIWUBU-UHFFFAOYSA-N	416770	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 47f::US10633345, Compound 47f::US10689346, Compound 47f::US11203574, Compound 47g::US11230530, Compound 47h::US11685721, Compound 47f::US11708332, Compound 47f	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416770	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416770&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355766	433916684							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297849	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H28F4N4O2/c31-24-12-11-22(29(40,14-13-19-9-10-19)21-6-2-1-3-7-21)16-25(24)36-28(39)26-17-27(30(32,33)34)37-38(26)23-8-4-5-20(15-23)18-35/h1-8,11-12,15-17,19,40H,9-10,13-14,18,35H2,(H,36,39)	NIWMWYNGSALJGG-UHFFFAOYSA-N	416903	Racemic 1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 68c::US10633345, Compound 68e::US10689346, Compound 68c::US11203574, Compound 68e::US11230530, Compound 68e::US11685721, Compound 68e::US11708332, Compound 68e	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416903	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416903&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355758	433916816							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297850	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccccc1=O)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-11-10-20(24(12-9-18-7-8-18)37-13-2-1-6-27(37)39)15-23(22)35-28(40)25-16-26(29(31,32)33)36-38(25)21-5-3-4-19(14-21)17-34/h1-6,10-11,13-16,18,24H,7-9,12,17,34H2,(H,35,40)	OFQQGSYWUFBMPP-UHFFFAOYSA-N	416939	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(2-oxopyridin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 248j::US10633345, Compound 248k::US10689346, Compound 248k::US11203574, Compound 248k::US11230530, Compound 248k::US11685721, Compound 248k::US11708332, Compound 248k	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416939	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416939&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355727	433916851							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297851	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-16-25(37(36-26)24-8-1-4-20(14-24)17-33)27(38)35-23-7-2-5-21(15-23)28(39,12-11-19-9-10-19)22-6-3-13-34-18-22/h1-8,13-16,18-19,39H,9-12,17,33H2,(H,35,38)	AOCZEQQKIIWUBU-UHFFFAOYSA-N	416770	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 47f::US10633345, Compound 47f::US10689346, Compound 47f::US11203574, Compound 47g::US11230530, Compound 47h::US11685721, Compound 47f::US11708332, Compound 47f	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416770	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416770&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355766	433916684							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297852	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H28F4N4O2/c31-24-12-11-22(29(40,14-13-19-9-10-19)21-6-2-1-3-7-21)16-25(24)36-28(39)26-17-27(30(32,33)34)37-38(26)23-8-4-5-20(15-23)18-35/h1-8,11-12,15-17,19,40H,9-10,13-14,18,35H2,(H,36,39)	NIWMWYNGSALJGG-UHFFFAOYSA-N	416903	Racemic 1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 68c::US10633345, Compound 68e::US10689346, Compound 68c::US11203574, Compound 68e::US11230530, Compound 68e::US11685721, Compound 68e::US11708332, Compound 68e	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416903	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416903&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355758	433916816							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297853	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccncc1=O)C(F)(F)F	InChI=1S/C28H26F4N6O2/c29-21-8-7-19(23(9-6-17-4-5-17)37-11-10-34-16-26(37)39)13-22(21)35-27(40)24-14-25(28(30,31)32)36-38(24)20-3-1-2-18(12-20)15-33/h1-3,7-8,10-14,16-17,23H,4-6,9,15,33H2,(H,35,40)	GLPOCDKMIDNWGE-UHFFFAOYSA-N	416942	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(2-oxopyrazin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 249b::US10633345, Compound 249b::US10689346, Compound 249b::US11203574, Compound 249b::US11230530, Compound 249b::US11685721, Compound 249b::US11708332, Compound 249b	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416942	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416942&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665736	433916854							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297854	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F3N4O2/c31-30(32,33)27-18-26(37(36-27)25-11-4-6-21(16-25)19-34)28(38)35-24-10-5-9-23(17-24)29(39,15-14-20-12-13-20)22-7-2-1-3-8-22/h1-11,16-18,20,39H,12-15,19,34H2,(H,35,38)	DCGYPXFSNPCKGX-UHFFFAOYSA-N	416751	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 46g::US10633345, Compound 46g::US10689346, Compound 46g::US11203574, Compound 46i::US11230530, Compound 46i::US11685721, Compound 46g::US11708332, Compound 46g	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416751	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416751&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355790	433916665							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297855	COc1ccc2ccccc2c1C(NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H31F4N5O2/c1-45-29-14-12-22-6-2-3-8-25(22)31(29)32(40-19-20-9-10-20)23-11-13-26(35)27(16-23)41-33(44)28-17-30(34(36,37)38)42-43(28)24-7-4-5-21(15-24)18-39/h2-8,11-17,20,32,40H,9-10,18-19,39H2,1H3,(H,41,44)	AYMFYNZEWAELBE-UHFFFAOYSA-N	416906	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(2-methoxynaphthalen-1-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide dihydrochloride::US10329260, Compound 61e::US10633345, Compound 63b::US10689346, Compound 61e::US11203574, Compound 63b::US11230530, Compound 63b::US11685721, Compound 63b::US11708332, Compound 63b	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416906	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416906&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355591	433916818							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297856	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)Oc1ccccn1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-11-10-20(25(12-9-18-7-8-18)40-27-6-1-2-13-35-27)15-23(22)36-28(39)24-16-26(29(31,32)33)37-38(24)21-5-3-4-19(14-21)17-34/h1-6,10-11,13-16,18,25H,7-9,12,17,34H2,(H,36,39)	NLWJKTCXFARQOW-UHFFFAOYSA-N	416945	US10329260, Compound 250c::US10633345, Compound 250c::US11192861, Compound 250c::US11708332, Compound 250c	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416945	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416945&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126689760	433916857							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297857	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F3N4O2/c31-30(32,33)27-18-26(37(36-27)25-11-4-6-21(16-25)19-34)28(38)35-24-10-5-9-23(17-24)29(39,15-14-20-12-13-20)22-7-2-1-3-8-22/h1-11,16-18,20,39H,12-15,19,34H2,(H,35,38)	DCGYPXFSNPCKGX-UHFFFAOYSA-N	416751	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 46g::US10633345, Compound 46g::US10689346, Compound 46g::US11203574, Compound 46i::US11230530, Compound 46i::US11685721, Compound 46g::US11708332, Compound 46g	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416751	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416751&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355790	433916665							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297858	COc1ccc2ccccc2c1C(NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H31F4N5O2/c1-45-29-14-12-22-6-2-3-8-25(22)31(29)32(40-19-20-9-10-20)23-11-13-26(35)27(16-23)41-33(44)28-17-30(34(36,37)38)42-43(28)24-7-4-5-21(15-24)18-39/h2-8,11-17,20,32,40H,9-10,18-19,39H2,1H3,(H,41,44)	AYMFYNZEWAELBE-UHFFFAOYSA-N	416906	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(2-methoxynaphthalen-1-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide dihydrochloride::US10329260, Compound 61e::US10633345, Compound 63b::US10689346, Compound 61e::US11203574, Compound 63b::US11230530, Compound 63b::US11685721, Compound 63b::US11708332, Compound 63b	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416906	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416906&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355591	433916818							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297859	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(=CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H26F4N4O/c31-25-14-12-22(24(13-11-19-9-10-19)21-6-2-1-3-7-21)16-26(25)36-29(39)27-17-28(30(32,33)34)37-38(27)23-8-4-5-20(15-23)18-35/h1-8,12-17,19H,9-11,18,35H2,(H,36,39)/b24-13-	BAAJKWZPAGFHDE-CFRMEGHHSA-N	416948	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-phenylprop-1-enyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 252c::US10633345, Compound 252c::US10689346, Compound 252c::US11203574, Compound 252c::US11230530, Compound 252c::US11685721, Compound 252c::US11708332, Compound 252c	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416948	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416948&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			140777564	433916860							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297860	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H25F4N5O2/c29-22-9-8-19(26(39-16-17-6-7-17)20-4-2-10-34-15-20)12-23(22)35-27(38)24-13-25(28(30,31)32)36-37(24)21-5-1-3-18(11-21)14-33/h1-5,8-13,15,17,26H,6-7,14,16,33H2,(H,35,38)	CNAFOXQNPWSINI-UHFFFAOYSA-N	416794	Racemic 1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethoxy)(pyridin-3-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 48f::US10633345, Compound 48f::US10689346, Compound 48f::US11203574, Compound 48g::US11230530, Compound 48h::US11685721, Compound 48f::US11708332, Compound 48f	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416794	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416794&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355617	433916708							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338155	Clc1ccc2CC(NC(=O)c3cn(Cc4cn5cc(ccc5n4)C4CC4)nn3)c2c1	InChI=1S/C22H19ClN6O/c23-16-5-3-14-7-19(18(14)8-16)25-22(30)20-12-29(27-26-20)11-17-10-28-9-15(13-1-2-13)4-6-21(28)24-17/h3-6,8-10,12-13,19H,1-2,7,11H2,(H,25,30)	INJXBDABXVEEBX-UHFFFAOYSA-N	626790	N-(4-chlorobicyclo[4.2.0]octa-1(6),2,4-trien-7-yl)-1-(6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-151	Plasma kallikrein					 1050					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626790	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626790&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152209	485655240							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51511178	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc(OCc3ccccc3)cc2)c1	InChI=1S/C26H27N5O2/c1-18-12-25(27)30-19(2)24(18)14-28-26(32)22-13-29-31(16-22)15-20-8-10-23(11-9-20)33-17-21-6-4-3-5-7-21/h3-13,16H,14-15,17H2,1-2H3,(H2,27,30)(H,28,32)	QFRKZOVMPPMBKQ-UHFFFAOYSA-N	212062	US9290485, 94	Plasma kallikrein			 2.1							ChEMBL		10.7270/Q2R215K6	32066009			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212062	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212062&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56835923	329587939							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51511179	Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc(Cn3cccn3)cc2)c1	InChI=1S/C23H25N7O/c1-16-10-22(24)28-17(2)21(16)12-25-23(31)20-11-27-30(15-20)14-19-6-4-18(5-7-19)13-29-9-3-8-26-29/h3-11,15H,12-14H2,1-2H3,(H2,24,28)(H,25,31)	OINOKQVNBGAIMA-UHFFFAOYSA-N	212113	US9290485, 145	Plasma kallikrein			 2.4							ChEMBL		10.7270/Q2R215K6	32066009			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212113	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212113&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	7SD	6O1G,6O1S	58081298	329587989							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51511180	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc(Oc3ccccc3)cc2)cn1	InChI=1S/C25H25N5O2/c1-17-12-24(26)29-18(2)22(17)13-27-25(31)23-15-30(16-28-23)14-19-8-10-21(11-9-19)32-20-6-4-3-5-7-20/h3-12,15-16H,13-14H2,1-2H3,(H2,26,29)(H,27,31)	GTRZDWXIXSFZSJ-UHFFFAOYSA-N	211991	US9290485, 23	Plasma kallikrein			 9.0							ChEMBL		10.7270/Q2R215K6	32066009			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211991	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211991&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836330	329587868							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51511181	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc(Cn3cccn3)cc2)cn1	InChI=1S/C23H25N7O/c1-16-10-22(24)28-17(2)20(16)11-25-23(31)21-14-29(15-26-21)12-18-4-6-19(7-5-18)13-30-9-3-8-27-30/h3-10,14-15H,11-13H2,1-2H3,(H2,24,28)(H,25,31)	OUKWTWSWNLIIED-UHFFFAOYSA-N	211974	US9290485, 6	Plasma kallikrein			 0.200000							ChEMBL		10.7270/Q2R215K6	32066009			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211974	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211974&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			56836188	329587851							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51511182	Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4cnc5[nH]cc(Cl)c5c4)c(n3)C#N)cc2)c1	InChI=1S/C25H21ClN8O/c1-16-8-31-33(12-16)13-17-2-4-18(5-3-17)14-34-15-21(23(7-27)32-34)25(35)30-10-19-6-20-22(26)11-29-24(20)28-9-19/h2-6,8-9,11-12,15H,10,13-14H2,1H3,(H,28,29)(H,30,35)	ILKZENXPCIJVGP-UHFFFAOYSA-N	50608361	CHEMBL5280126	Plasma kallikrein			 1.000000							ChEMBL		10.7270/Q2R215K6	32066009			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50608361	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50608361&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			145088422	494498109							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51511183	Cc1nc(N)cc2OCC\C=C/CCCOc3cc(Cn4cccn4)ccc3Cn3cc(cn3)C(=O)NCc12	InChI=1S/C29H33N7O3/c1-21-25-17-31-29(37)24-16-33-36(20-24)19-23-9-8-22(18-35-11-7-10-32-35)14-26(23)38-12-5-3-2-4-6-13-39-27(25)15-28(30)34-21/h2,4,7-11,14-16,20H,3,5-6,12-13,17-19H2,1H3,(H2,30,34)(H,31,37)/b4-2-	ZVYLYYBRLJOHMS-RQOWECAXSA-N	50210073	CHEMBL3883461	Plasma kallikrein			 2.0							ChEMBL		10.7270/Q2R215K6	32066009			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50210073	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50210073&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134131084	375982546		CHEMBL3883461					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51511184	COCc1nn(Cc2ccc(Cn3cccn3)cc2)cc1C(=O)NCc1ccc2c(N)nccc2c1C	InChI=1S/C28H29N7O2/c1-19-22(8-9-24-23(19)10-12-30-27(24)29)14-31-28(36)25-17-35(33-26(25)18-37-2)16-21-6-4-20(5-7-21)15-34-13-3-11-32-34/h3-13,17H,14-16,18H2,1-2H3,(H2,29,30)(H,31,36)	PHIJQNWPPQPKQQ-UHFFFAOYSA-N	50608362	CHEMBL5284044	Plasma kallikrein			 0.560000							ChEMBL		10.7270/Q2R215K6	32066009			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50608362	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50608362&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121366348	494498110							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51511185	COCc1nn(Cc2ccc(Cn3cc(C)cn3)cc2)cc1C(=O)NCc1cnc2[nH]cc(Cl)c2c1	InChI=1S/C26H26ClN7O2/c1-17-8-31-33(12-17)13-18-3-5-19(6-4-18)14-34-15-22(24(32-34)16-36-2)26(35)30-10-20-7-21-23(27)11-29-25(21)28-9-20/h3-9,11-12,15H,10,13-14,16H2,1-2H3,(H,28,29)(H,30,35)	QBFWHUJFTCYQOE-UHFFFAOYSA-N	50608363	CHEMBL5269987	Plasma kallikrein			 8.7							ChEMBL		10.7270/Q2R215K6	32066009			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50608363	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50608363&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			145088425	494498111							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51511186	CCOc1ccc(C[C@@H](NC(=O)CC)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C31H38N4O4/c1-3-29(36)34-28(19-23-14-16-26(17-15-23)39-4-2)31(38)35-27(18-22-8-6-5-7-9-22)30(37)33-21-25-12-10-24(20-32)11-13-25/h5-17,27-28H,3-4,18-21,32H2,1-2H3,(H,33,37)(H,34,36)(H,35,38)/t27-,28+/m0/s1	BCVMEJPYJNFSMU-WUFINQPMSA-N	50608364	CHEMBL5277609	Plasma kallikrein			 89							ChEMBL		10.7270/Q2R215K6	32066009			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50608364	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50608364&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185504	494498112							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51511187	CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C35H38N4O4/c1-2-43-30-19-17-26(18-20-30)22-32(38-33(40)29-11-7-4-8-12-29)35(42)39-31(21-25-9-5-3-6-10-25)34(41)37-24-28-15-13-27(23-36)14-16-28/h3-20,31-32H,2,21-24,36H2,1H3,(H,37,41)(H,38,40)(H,39,42)/t31-,32+/m0/s1	UCIXIQRCAGGOJY-AJQTZOPKSA-N	200012	US9234000, 3::US9512065, N-[(R)-1-[(S)-1-(4-aminomethyl-benzylcarbamoyl)-2-phenyl-ethylcarbamoyl]-2-(4-ethoxy-phenyl)-ethyl]-benzamide	Plasma kallikrein			 22							ChEMBL		10.7270/Q2R215K6	32066009			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200012	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200012&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185716	318589842							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51511188	CCOc1ccc(C[C@@H](NC(=O)c2[nH]ccc2C)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C34H39N5O4/c1-3-43-28-15-13-25(14-16-28)20-30(39-34(42)31-23(2)17-18-36-31)33(41)38-29(19-24-7-5-4-6-8-24)32(40)37-22-27-11-9-26(21-35)10-12-27/h4-18,29-30,36H,3,19-22,35H2,1-2H3,(H,37,40)(H,38,41)(H,39,42)/t29-,30+/m0/s1	CIHUARIXQZFRDX-XZWHSSHBSA-N	200133	US9234000, 124	Plasma kallikrein			 20							ChEMBL		10.7270/Q2R215K6	32066009			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200133	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200133&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71499278	318589961							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51511189	CCOc1ccc(C[C@@H](NC(=O)c2sccc2C)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C34H38N4O4S/c1-3-42-28-15-13-25(14-16-28)20-30(38-34(41)31-23(2)17-18-43-31)33(40)37-29(19-24-7-5-4-6-8-24)32(39)36-22-27-11-9-26(21-35)10-12-27/h4-18,29-30H,3,19-22,35H2,1-2H3,(H,36,39)(H,37,40)(H,38,41)/t29-,30+/m0/s1	HBWHYKRQSALKFK-XZWHSSHBSA-N	200128	US9234000, 119	Plasma kallikrein			 10.0							ChEMBL		10.7270/Q2R215K6	32066009			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200128	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200128&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71499201	318589956							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51511190	NCc1ccc(CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](CC2CCCCC2)NC(=O)c2ccccc2)cc1	InChI=1S/C33H40N4O3/c34-22-26-16-18-27(19-17-26)23-35-32(39)29(20-24-10-4-1-5-11-24)37-33(40)30(21-25-12-6-2-7-13-25)36-31(38)28-14-8-3-9-15-28/h1,3-5,8-11,14-19,25,29-30H,2,6-7,12-13,20-23,34H2,(H,35,39)(H,36,38)(H,37,40)/t29-,30+/m0/s1	YIFIDQFIPIUXTH-XZWHSSHBSA-N	200135	US9234000, 126	Plasma kallikrein			 4000							ChEMBL		10.7270/Q2R215K6	32066009			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200135	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200135&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185486	318589963							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51511191	CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H]([C@H](O)c2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1	InChI=1S/C35H38N4O5/c1-2-44-29-19-17-24(18-20-29)21-30(38-33(41)28-11-7-4-8-12-28)34(42)39-31(32(40)27-9-5-3-6-10-27)35(43)37-23-26-15-13-25(22-36)14-16-26/h3-20,30-32,40H,2,21-23,36H2,1H3,(H,37,43)(H,38,41)(H,39,42)/t30-,31+,32-/m1/s1	BCBPQVFOASQXEY-YKILCQELSA-N	200206	US9234000, 197	Plasma kallikrein			 20							ChEMBL		10.7270/Q2R215K6	32066009			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200206	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200206&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			71185740	318590032							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51511194	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F3N4O2/c30-29(31,32)26-16-25(36(35-26)24-11-4-6-20(14-24)17-33)28(37)34-23-10-5-9-22(15-23)27(38-18-19-12-13-19)21-7-2-1-3-8-21/h1-11,14-16,19,27H,12-13,17-18,33H2,(H,34,37)	PEZVPVUPSJXZCH-UHFFFAOYSA-N	416775	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18k::US10633345, Compound 74a::US10689346, Compound 165e::US11203574, Compound 165e::US11230530, Compound 165e::US11685721, Compound 18k::US11708332, Compound 18k	Plasma kallikrein		 0.100000								ChEMBL		10.7270/Q2R215K6	32066009			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416775	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416775&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			91884591	433916689							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51511195	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(N)=O	InChI=1S/C29H29FN6O2/c30-23-12-11-21(27(33-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)34-29(38)26-15-25(28(32)37)35-36(26)22-8-4-5-19(13-22)16-31/h1-8,11-15,18,27,33H,9-10,16-17,31H2,(H2,32,37)(H,34,38)	UMNCVWUVWBVXCX-UHFFFAOYSA-N	417026	(+-)-1-(3-(aminomethyl)phenyl)-N5-(5-((cyclopropylmethylamino)-(phenyl)methyl)-2-fluorophenyl)-1H-pyrazole-3,5-dicarboxamide::US10329260, Compound 229i::US10633345, Compound 229i::US10689346, Compound 229i::US11203574, Compound 229i::US11230530, Compound 229i::US11685721, Compound 229i	Plasma kallikrein		 0.100000								ChEMBL		10.7270/Q2R215K6	32066009			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417026	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417026&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665747	433916936							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51511196	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F3N4O2/c30-29(31,32)26-16-25(36(35-26)24-11-4-6-20(14-24)17-33)28(37)34-23-10-5-9-22(15-23)27(38-18-19-12-13-19)21-7-2-1-3-8-21/h1-11,14-16,19,27H,12-13,17-18,33H2,(H,34,37)	PEZVPVUPSJXZCH-UHFFFAOYSA-N	416775	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18k::US10633345, Compound 74a::US10689346, Compound 165e::US11203574, Compound 165e::US11230530, Compound 165e::US11685721, Compound 18k::US11708332, Compound 18k	Plasma kallikrein			 100							ChEMBL		10.7270/Q2R215K6	32066009			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416775	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416775&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			91884591	433916689							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51511197	CCCOC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C28H27F3N4O2/c1-2-14-37-26(20-9-4-3-5-10-20)21-11-7-12-22(16-21)33-27(36)24-17-25(28(29,30)31)34-35(24)23-13-6-8-19(15-23)18-32/h3-13,15-17,26H,2,14,18,32H2,1H3,(H,33,36)	ODVQLXVRAUDBCL-UHFFFAOYSA-N	416765	1-(3-(aminomethyl)phenyl)-N-(3-(phenyl(propoxy)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18h::US10633345, Compound 18k::US10689346, Compound 18h::US11203574, Compound 18h::US11230530, Compound 18h::US11685721, Compound 18h::US11708332, Compound 18h	Plasma kallikrein			>50000							ChEMBL		10.7270/Q2R215K6	32066009			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416765	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416765&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665753	433916679							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51511198	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)c1ccccc1)C(F)(F)F	InChI=1S/C25H21F3N4O2/c26-25(27,28)22-14-21(32(31-22)20-11-4-6-16(12-20)15-29)24(34)30-19-10-5-9-18(13-19)23(33)17-7-2-1-3-8-17/h1-14,23,33H,15,29H2,(H,30,34)	RTXOPDIFOPLOGN-UHFFFAOYSA-N	416750	US10329260, Compound 18e	Plasma kallikrein			>50000							ChEMBL		10.7270/Q2R215K6	32066009			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416750	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416750&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126689238	433916664							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51511199	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-23-12-11-21(27(39-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)35-28(38)25-15-26(29(31,32)33)36-37(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27H,9-10,16-17,34H2,(H,35,38)	HIMJVDQVZQMIPM-UHFFFAOYSA-N	416968	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethoxy)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 37b	Plasma kallikrein			 100							ChEMBL		10.7270/Q2R215K6	32066009			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416968	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416968&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355729	433916880							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51511200	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-10-9-20(27(40-16-17-7-8-17)19-4-2-5-21(35)12-19)13-24(23)36-28(39)25-14-26(29(31,32)33)37-38(25)22-6-1-3-18(11-22)15-34/h1-6,9-14,17,27H,7-8,15-16,34-35H2,(H,36,39)	GBDDXSAKQKODCG-UHFFFAOYSA-N	416853	1-(3-(aminomethyl)phenyl)-N-(5-((3-aminophenyl)(cyclopropylmethoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 57e::US10633345, Compound 65b::US10689346, Compound 65b::US11203574, Compound 65a::US11230530, Compound 65b::US11685721, Compound 57e::US11708332, Compound 65b	Plasma kallikrein			 100							ChEMBL		10.7270/Q2R215K6	32066009			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416853	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416853&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355865	433916766							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51511201	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1ccccc1O)C(F)(F)F	InChI=1S/C29H26F4N4O3/c30-22-11-10-19(27(40-16-17-8-9-17)21-6-1-2-7-25(21)38)13-23(22)35-28(39)24-14-26(29(31,32)33)36-37(24)20-5-3-4-18(12-20)15-34/h1-7,10-14,17,27,38H,8-9,15-16,34H2,(H,35,39)	MRQCNDUNWFOAJG-UHFFFAOYSA-N	50608365	CHEMBL5282862	Plasma kallikrein			 100							ChEMBL		10.7270/Q2R215K6	32066009			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50608365	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50608365&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171353160	494498113							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51511202	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F4N5O/c30-23-12-11-21(27(35-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27,35H,9-10,16-17,34H2,(H,36,39)	MCLZOCFEIKBMBA-UHFFFAOYSA-N	416773	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 38d::US10633345, Compound 38d::US10689346, Compound 42a::US11203574, Compound 42a::US11230530, Compound 42a::US11685721, Compound 38d::US11708332, Compound 38d	Plasma kallikrein			 100							ChEMBL		10.7270/Q2R215K6	32066009			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416773	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416773&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356124	433916687							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51511203	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(N)=O	InChI=1S/C29H29FN6O2/c30-23-12-11-21(27(33-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)34-29(38)26-15-25(28(32)37)35-36(26)22-8-4-5-19(13-22)16-31/h1-8,11-15,18,27,33H,9-10,16-17,31H2,(H2,32,37)(H,34,38)	UMNCVWUVWBVXCX-UHFFFAOYSA-N	417026	(+-)-1-(3-(aminomethyl)phenyl)-N5-(5-((cyclopropylmethylamino)-(phenyl)methyl)-2-fluorophenyl)-1H-pyrazole-3,5-dicarboxamide::US10329260, Compound 229i::US10633345, Compound 229i::US10689346, Compound 229i::US11203574, Compound 229i::US11230530, Compound 229i::US11685721, Compound 229i	Plasma kallikrein			 100							ChEMBL		10.7270/Q2R215K6	32066009			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417026	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417026&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665747	433916936							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51511204	NC(=N)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N6O/c30-22-12-11-19(26(36-16-17-9-10-17)18-5-2-1-3-6-18)14-23(22)37-28(40)24-15-25(29(31,32)33)38-39(24)21-8-4-7-20(13-21)27(34)35/h1-8,11-15,17,26,36H,9-10,16H2,(H3,34,35)(H,37,40)	HUIANTFJQLRTEM-UHFFFAOYSA-N	439603	US10633345, Compound 227d::US10689346, Compound 227d::US11203574, Compound 227d::US11230530, Compound 227d::US11685721, Compound 227d::US11708332, Compound 227d	Plasma kallikrein			 100							ChEMBL		10.7270/Q2R215K6	32066009			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439603	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439603&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356162	439661151							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51511205	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C31H26F4N6O/c32-24-11-9-21(28(38-17-18-6-7-18)20-4-2-1-3-5-20)14-25(24)39-30(42)26-16-27(31(33,34)35)40-41(26)22-10-8-19-12-13-37-29(36)23(19)15-22/h1-5,8-16,18,28,38H,6-7,17H2,(H2,36,37)(H,39,42)	OUKVDAXUKVLTKB-UHFFFAOYSA-N	439568	US10633345, Compound 235g::US10689346, Compound 235g::US11192861, Compound 235g::US11708332, Compound 235g	Plasma kallikrein			 100							ChEMBL		10.7270/Q2R215K6	32066009			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439568	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439568&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665742	439661116							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51511206	CC(C)(C)[S@](=O)NC(CCC1CC1)(c1ccc(F)c(NC(=O)[C@H]2C[C@@H](O)CN2C(=O)Nc2ccc(Cl)cc2)c1)c1ccccn1	InChI=1S/C33H39ClFN5O4S/c1-32(2,3)45(44)39-33(16-15-21-7-8-21,29-6-4-5-17-36-29)22-9-14-26(35)27(18-22)38-30(42)28-19-25(41)20-40(28)31(43)37-24-12-10-23(34)11-13-24/h4-6,9-14,17-18,21,25,28,39,41H,7-8,15-16,19-20H2,1-3H3,(H,37,43)(H,38,42)/t25-,28-,33?,45+/m1/s1	JEVCIJSWWNTRIA-SMAHILNNSA-N	433368	US10562850, Compound 61b::US11066360, Compound 61b	Plasma kallikrein			<50							ChEMBL		10.7270/Q2R215K6	32066009			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433368	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433368&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			145750145	438642301							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51511207	CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cc1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccn1	InChI=1S/C30H33ClFN5O3/c1-40-23-17-26(37(18-23)29(39)35-22-10-8-21(31)9-11-22)28(38)36-25-16-20(7-12-24(25)32)30(33,14-13-19-5-6-19)27-4-2-3-15-34-27/h2-4,7-12,15-16,19,23,26H,5-6,13-14,17-18,33H2,1H3,(H,35,39)(H,36,38)/t23-,26-,30?/m1/s1	VXUMWJIENCDFKX-JRSXUWQBSA-N	433385	US10562850, Compound 65b::US11066360, Compound 65b	Plasma kallikrein			<50							ChEMBL		10.7270/Q2R215K6	32066009			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433385	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433385&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359647	438642317							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51511208	CCO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cc1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccn1	InChI=1S/C31H35ClFN5O3/c1-2-41-24-18-27(38(19-24)30(40)36-23-11-9-22(32)10-12-23)29(39)37-26-17-21(8-13-25(26)33)31(34,15-14-20-6-7-20)28-5-3-4-16-35-28/h3-5,8-13,16-17,20,24,27H,2,6-7,14-15,18-19,34H2,1H3,(H,36,40)(H,37,39)/t24-,27-,31?/m1/s1	QEFUQMCJIJWYKH-QPLSPKJVSA-N	50608366	CHEMBL5284982	Plasma kallikrein			<50							ChEMBL		10.7270/Q2R215K6	32066009			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50608366	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50608366&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171347410	494498114							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51511209	NC(CCC1CC1)(c1ccc(F)c(NC(=O)[C@H]2C[C@@](O)(CN2C(=O)Nc2ccc(Cl)cc2)c2ccccc2)c1)c1ccccn1	InChI=1S/C35H35ClFN5O3/c36-26-12-14-27(15-13-26)40-33(44)42-22-34(45,24-6-2-1-3-7-24)21-30(42)32(43)41-29-20-25(11-16-28(29)37)35(38,18-17-23-9-10-23)31-8-4-5-19-39-31/h1-8,11-16,19-20,23,30,45H,9-10,17-18,21-22,38H2,(H,40,44)(H,41,43)/t30-,34-,35?/m1/s1	QSEWLZJVGPKOAW-WELJHWQCSA-N	433394	US10562850, Compound 31i::US11066360, Compound 31i	Plasma kallikrein			<50							ChEMBL		10.7270/Q2R215K6	32066009			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433394	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433394&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359587	438642325							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51511210	CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccn1	InChI=1S/C29H32ClFN6O3/c1-40-21-15-24(37(17-21)28(39)36-26-10-8-20(30)16-34-26)27(38)35-23-14-19(7-9-22(23)31)29(32,12-11-18-5-6-18)25-4-2-3-13-33-25/h2-4,7-10,13-14,16,18,21,24H,5-6,11-12,15,17,32H2,1H3,(H,35,38)(H,34,36,39)/t21-,24-,29?/m1/s1	HMKGSFLIMYOEKX-ZORXERLGSA-N	433388	BDBM433391::US10562850, Compound 36d::US10562850, Compound 37d::US11066360, Compound 37d	Plasma kallikrein			<50							ChEMBL		10.7270/Q2R215K6	32066009			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433388	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433388&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359283	438642320							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51511211	CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N	InChI=1S/C31H32ClFN6O3/c1-42-24-15-27(39(18-24)30(41)38-28-10-8-23(32)17-36-28)29(40)37-26-14-22(7-9-25(26)33)31(35,12-11-19-5-6-19)21-4-2-3-20(13-21)16-34/h2-4,7-10,13-14,17,19,24,27H,5-6,11-12,15,18,35H2,1H3,(H,37,40)(H,36,38,41)/t24-,27-,31?/m1/s1	XHEUJDABOZVRIR-QPLSPKJVSA-N	433370	US10562850, Compound 18b::US11066360, Compound 18b	Plasma kallikrein			<50							ChEMBL		10.7270/Q2R215K6	32066009			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433370	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433370&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359297	438642303							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51511212	NC(CCC1CC1)(c1ccc(F)c(NC(=O)[C@H]2CC(F)(F)CN2C(=O)Nc2ccc(Cl)cn2)c1)c1ccccn1	InChI=1S/C28H28ClF3N6O2/c29-19-7-9-24(35-15-19)37-26(40)38-16-27(31,32)14-22(38)25(39)36-21-13-18(6-8-20(21)30)28(33,11-10-17-4-5-17)23-3-1-2-12-34-23/h1-3,6-9,12-13,15,17,22H,4-5,10-11,14,16,33H2,(H,36,39)(H,35,37,40)/t22-,28?/m1/s1	NFXIQJYENLBIHW-WZOMIXFGSA-N	50608367	CHEMBL5290319	Plasma kallikrein			<50							ChEMBL		10.7270/Q2R215K6	32066009			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50608367	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50608367&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171358239	494498115							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51511213	Fc1cc2[nH]cc(Cl)c2cc1CNc1ncnc2nc(Cc3ccc4ncc(Cl)cc4c3)[nH]c12	InChI=1S/C24H16Cl2FN7/c25-15-5-13-3-12(1-2-19(13)28-9-15)4-21-33-22-23(31-11-32-24(22)34-21)30-8-14-6-16-17(26)10-29-20(16)7-18(14)27/h1-3,5-7,9-11,29H,4,8H2,(H2,30,31,32,33,34)	HMMTYEFXIWSNDQ-UHFFFAOYSA-N	50608368	CHEMBL5271356	Plasma kallikrein			<100							ChEMBL		10.7270/Q2R215K6	32066009			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50608368	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50608368&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124183539	494498116							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297744	NCc1ccc(cc1)C(NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F4N6O/c31-24-11-10-22(28(37-17-19-4-5-19)21-8-6-18(15-35)7-9-21)13-25(24)38-29(41)26-14-27(30(32,33)34)39-40(26)23-3-1-2-20(12-23)16-36/h1-3,6-14,19,28,37H,4-5,15-17,35-36H2,(H,38,41)	AYTAHYJWZGLMOI-UHFFFAOYSA-N	416833	1-(3-(aminomethyl)phenyl)-N-(5-((4-(aminomethyl)phenyl)(cyclopropylmethylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 139b::US11685721, Compound 139b::US11708332, Compound 139b	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416833	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416833&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665498	433916746							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297745	COc1ccc(cc1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O2/c1-40-25-12-10-21(11-13-25)28(35-18-19-8-9-19)22-5-3-6-23(15-22)36-29(39)26-16-27(30(31,32)33)37-38(26)24-7-2-4-20(14-24)17-34/h2-7,10-16,19,28,35H,8-9,17-18,34H2,1H3,(H,36,39)	NTRWDZUFVXMYGD-UHFFFAOYSA-N	416834	1-(3-(Aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(4-methoxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 105g::US10633345, Compound 105g::US10689346, Compound 105g::US11203574, Compound 105g::US11230530, Compound 105g::US11685721, Compound 105g::US11708332, Compound 105g	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416834	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416834&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665521	433916747							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297746	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(CN(CC2CC2)c2ccc(OCc3ccccc3)cc2)c1)C(F)(F)F	InChI=1S/C36H34F3N5O2/c37-36(38,39)34-20-33(44(42-34)31-11-5-8-27(19-31)21-40)35(45)41-29-10-4-9-28(18-29)23-43(22-25-12-13-25)30-14-16-32(17-15-30)46-24-26-6-2-1-3-7-26/h1-11,14-20,25H,12-13,21-24,40H2,(H,41,45)	BDKFTABMYPATOF-UHFFFAOYSA-N	416835	1-(3-(Aminomethyl)phenyl)-N-(3-((4-(benzyloxy)phenyl)(cyclopropylmethylamino) methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 123g::US11708332, Compound 123g	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416835	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416835&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			154584224	433916748							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297747	Cc1cccc(c1)C(NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H29F4N5O/c1-18-4-2-6-21(12-18)28(36-17-19-8-9-19)22-10-11-24(31)25(14-22)37-29(40)26-15-27(30(32,33)34)38-39(26)23-7-3-5-20(13-23)16-35/h2-7,10-15,19,28,36H,8-9,16-17,35H2,1H3,(H,37,40)	DWXIBXKRESUYFO-UHFFFAOYSA-N	416836	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(m-tolyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 140e::US10633345, Compound 140e::US10689346, Compound 140e::US11203574, Compound 140e::US11230530, Compound 140e::US11685721, Compound 140e::US11708332, Compound 140e	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416836	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416836&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356147	433916749							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297748	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1O)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-24(37(36-26)22-8-3-5-19(13-22)16-33)28(39)35-21-7-4-6-20(14-21)27(34-17-18-11-12-18)23-9-1-2-10-25(23)38/h1-10,13-15,18,27,34,38H,11-12,16-17,33H2,(H,35,39)	PCNDJIQOMLHSEK-UHFFFAOYSA-N	416837	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2-hydroxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 49h::US10633345, Compound 49h::US10689346, Compound 49h::US11203574, Compound 49j::US11230530, Compound 49j::US11685721, Compound 49h::US11708332, Compound 49j	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416837	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416837&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355733	433916750							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297749	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc(OC(F)(F)F)c1)C(F)(F)F	InChI=1S/C30H27F6N5O2/c31-29(32,33)26-15-25(41(40-26)23-8-1-4-19(12-23)16-37)28(42)39-22-7-2-5-20(13-22)27(38-17-18-10-11-18)21-6-3-9-24(14-21)43-30(34,35)36/h1-9,12-15,18,27,38H,10-11,16-17,37H2,(H,39,42)	IVEYKJBEIIJLCR-UHFFFAOYSA-N	416838	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(3-(trifluoromethoxy) phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 124f::US10633345, Compound 124f::US10689346, Compound 124f::US11203574, Compound 124f::US11230530, Compound 124f::US11685721, Compound 124f::US11708332, Compound 124f	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416838	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416838&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665809	433916751							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297750	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C1OC(=O)Nc2ccccc12)C(F)(F)F	InChI=1S/C26H20F3N5O3/c27-26(28,29)22-13-21(34(33-22)18-8-3-5-15(11-18)14-30)24(35)31-17-7-4-6-16(12-17)23-19-9-1-2-10-20(19)32-25(36)37-23/h1-13,23H,14,30H2,(H,31,35)(H,32,36)	LRCHTKOMIAYQHX-UHFFFAOYSA-N	416839	1-(3-(aminomethyl)phenyl)-N-(3-(2-oxo-2,4-dihydro-1H-benzo[d][1,3]oxazin-4-yl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 167f::US10633345, Compound 167f::US10689346, Compound 167f::US11203574, Compound 167f::US11230530, Compound 167f::US11685721, Compound 167f::US11708332, Compound 167f	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416839	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416839&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665868	433916752							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297751	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1OCc1ccccc1)C(F)(F)F	InChI=1S/C36H34F3N5O2/c37-36(38,39)33-20-31(44(43-33)29-13-6-10-26(18-29)21-40)35(45)42-28-12-7-11-27(19-28)34(41-22-24-16-17-24)30-14-4-5-15-32(30)46-23-25-8-2-1-3-9-25/h1-15,18-20,24,34,41H,16-17,21-23,40H2,(H,42,45)	XAZZTVOUWUHFIG-UHFFFAOYSA-N	416840	1-(3-(aminomethyl)phenyl)-N-(3-((2-(benzyloxy)phenyl)(cyclopropylmethyl amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 106a::US10633345, Compound 106a::US10689346, Compound 106a::US11203574, Compound 106a::US11230530, Compound 106a::US11685721, Compound 106a::US11708332, Compound 106a	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416840	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416840&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356273	433916753							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297752	COc1ccc2ccccc2c1C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H32F3N5O2/c1-44-29-15-14-23-7-2-3-11-27(23)31(29)32(39-20-21-12-13-21)24-8-5-9-25(17-24)40-33(43)28-18-30(34(35,36)37)41-42(28)26-10-4-6-22(16-26)19-38/h2-11,14-18,21,32,39H,12-13,19-20,38H2,1H3,(H,40,43)	XVOUQCJHWNZPKF-UHFFFAOYSA-N	416841	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2-methoxynaphthalen-1-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 51f::US10633345, Compound 51f::US10689346, Compound 51f::US11203574, Compound 51h::US11230530, Compound 51h::US11685721, Compound 51f::US11708332, Compound 51h	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416841	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416841&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356155	433916754							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297753	COc1cccc(c1)C(NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H29F4N5O2/c1-41-23-7-3-5-20(13-23)28(36-17-18-8-9-18)21-10-11-24(31)25(14-21)37-29(40)26-15-27(30(32,33)34)38-39(26)22-6-2-4-19(12-22)16-35/h2-7,10-15,18,28,36H,8-9,16-17,35H2,1H3,(H,37,40)	MRNMVRANILFBMK-UHFFFAOYSA-N	416842	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(3-methoxyphenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 141e::US10633345, Compound 141e::US10689346, Compound 141e::US11203574, Compound 141e::US11230530, Compound 141e::US11685721, Compound 142f::US11708332, Compound 141e	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416842	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416842&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355803	433916755							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297754	CN(C(c1ccc(N)cc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1)C1CC1	InChI=1S/C29H29F3N6O/c1-37(23-12-13-23)27(19-8-10-21(34)11-9-19)20-5-3-6-22(15-20)35-28(39)25-16-26(29(30,31)32)36-38(25)24-7-2-4-18(14-24)17-33/h2-11,14-16,23,27H,12-13,17,33-34H2,1H3,(H,35,39)	KMTTZWHJWBFOGQ-UHFFFAOYSA-N	609908	1-(3-(aminomethyl)phenyl)-N-(3-((4-aminophenyl)(cyclopropyl methyl-amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US11708332, Compound 50f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2XW4PXV			US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=609908	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=609908&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137355128	483620076							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297755	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cc2ccccc2c2ccccc12)C(F)(F)F	InChI=1S/C37H32F3N5O/c38-37(39,40)34-20-33(45(44-34)28-11-5-7-24(17-28)21-41)36(46)43-27-10-6-9-26(18-27)35(42-22-23-15-16-23)32-19-25-8-1-2-12-29(25)30-13-3-4-14-31(30)32/h1-14,17-20,23,35,42H,15-16,21-22,41H2,(H,43,46)	OZXXGJIBGVGMMV-UHFFFAOYSA-N	416844	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic acid {3-[(cyclopropylmethyl-amino)-phenanthren-9-yl-methyl]-phenyl}-amide::US10329260, Compound 125g::US10633345, Compound 125g::US10689346, Compound 125g::US11203574, Compound 125g::US11230530, Compound 125g::US11685721, Compound 125g::US11708332, Compound 125g	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416844	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416844&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665609	433916757							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297756	COc1ccc(cc1)C(NCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H29F4N5O2/c1-41-23-10-7-20(8-11-23)28(36-17-18-5-6-18)21-9-12-24(31)25(14-21)37-29(40)26-15-27(30(32,33)34)38-39(26)22-4-2-3-19(13-22)16-35/h2-4,7-15,18,28,36H,5-6,16-17,35H2,1H3,(H,37,40)	GWNRXEFJAQDBCM-UHFFFAOYSA-N	416845	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(4-methoxyphenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 142f::US10633345, Compound 142f::US10689346, Compound 142f::US11203574, Compound 142f::US11230530, Compound 142f::US11708332, Compound 142f	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416845	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416845&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355909	433916758							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297757	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc(OCc2ccccc2)c1)C(F)(F)F	InChI=1S/C36H34F3N5O2/c37-36(38,39)33-20-32(44(43-33)30-13-4-9-26(17-30)21-40)35(45)42-29-12-5-10-27(18-29)34(41-22-24-15-16-24)28-11-6-14-31(19-28)46-23-25-7-2-1-3-8-25/h1-14,17-20,24,34,41H,15-16,21-23,40H2,(H,42,45)	VWRITWGTGWRWCP-UHFFFAOYSA-N	439423	US10633345, Compound 107f::US11203574, Compound 107f::US11230530, Compound 107f::US11708332, Compound 107f	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439423	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439423&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665642	439660981							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51511214	Clc1ccc2[nH]nc(CNc3ncnc4nc(Cc5ccc6ncc(Cl)cc6c5)[nH]c34)c2c1	InChI=1S/C23H16Cl2N8/c24-14-2-4-18-16(8-14)19(33-32-18)10-27-22-21-23(29-11-28-22)31-20(30-21)6-12-1-3-17-13(5-12)7-15(25)9-26-17/h1-5,7-9,11H,6,10H2,(H,32,33)(H2,27,28,29,30,31)	IEGUXBPRCAJWCM-UHFFFAOYSA-N	50608369	CHEMBL5267502	Plasma kallikrein			<100							ChEMBL		10.7270/Q2R215K6	32066009			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50608369	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50608369&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124183969	494498117							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51511215	Fc1c(CNc2ncnc3nc(Cc4ccc5ncc(Cl)cc5c4)[nH]c23)ccc2[nH]cc(Cl)c12	InChI=1S/C24H16Cl2FN7/c25-15-7-14-5-12(1-3-17(14)28-9-15)6-19-33-22-23(31-11-32-24(22)34-19)30-8-13-2-4-18-20(21(13)27)16(26)10-29-18/h1-5,7,9-11,29H,6,8H2,(H2,30,31,32,33,34)	OIBQXYUIVFCOAO-UHFFFAOYSA-N	50608370	CHEMBL5271379	Plasma kallikrein			<100							ChEMBL		10.7270/Q2R215K6	32066009			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50608370	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50608370&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124183501	494498118							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51511216	Fc1cc2[nH]cc(Cl)c2cc1CNc1ncnc2nc(Cc3ccc4ncc(cc4c3)C(F)(F)F)[nH]c12	InChI=1S/C25H16ClF4N7/c26-17-10-32-20-7-18(27)14(6-16(17)20)8-33-23-22-24(35-11-34-23)37-21(36-22)4-12-1-2-19-13(3-12)5-15(9-31-19)25(28,29)30/h1-3,5-7,9-11,32H,4,8H2,(H2,33,34,35,36,37)	WDRVDGYKFQXRHH-UHFFFAOYSA-N	50608371	CHEMBL5270732	Plasma kallikrein			<100							ChEMBL		10.7270/Q2R215K6	32066009			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50608371	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50608371&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124184073	494498119							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51511217	Cc1cc(N)nc(C)c1CNc1ncnc2nc(Cc3ccc4ncc(cc4c3)C(F)(F)F)[nH]c12	InChI=1S/C24H21F3N8/c1-12-5-19(28)33-13(2)17(12)10-30-22-21-23(32-11-31-22)35-20(34-21)7-14-3-4-18-15(6-14)8-16(9-29-18)24(25,26)27/h3-6,8-9,11H,7,10H2,1-2H3,(H2,28,33)(H2,30,31,32,34,35)	HKOAPLNESWWJTL-UHFFFAOYSA-N	50608372	CHEMBL5284917	Plasma kallikrein			<100							ChEMBL		10.7270/Q2R215K6	32066009			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50608372	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50608372&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124183991	494498120							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51511218	Cc1cc(N)nc(C)c1CNC(=O)c1cncc(Cc2ccc3ncc(Cl)cc3c2)c1	InChI=1S/C24H22ClN5O/c1-14-5-23(26)30-15(2)21(14)13-29-24(31)19-8-17(10-27-11-19)6-16-3-4-22-18(7-16)9-20(25)12-28-22/h3-5,7-12H,6,13H2,1-2H3,(H2,26,30)(H,29,31)	ZCNTWWKRHUKJJH-UHFFFAOYSA-N	492893	N-((6-amino-2,4- dimethylpyridin-3- yl)methyl)-5-((3- chloroquinolin-6- yl)methyl)nicotinamide::US10981893, Example 22	Plasma kallikrein			<100							ChEMBL		10.7270/Q2R215K6	32066009			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492893	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492893&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124173195	447119582							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51511219	Cc1nc(N)ccc1CNC(=O)c1ccnc(Cc2ccc(Cn3ccccc3=O)c(c2)S(C)(=O)=O)c1	InChI=1S/C27H27N5O4S/c1-18-21(8-9-25(28)31-18)16-30-27(34)20-10-11-29-23(15-20)13-19-6-7-22(24(14-19)37(2,35)36)17-32-12-4-3-5-26(32)33/h3-12,14-15H,13,16-17H2,1-2H3,(H2,28,31)(H,30,34)	ZFCSXUNOGUUNST-UHFFFAOYSA-N	492899	N-((6-amino-2- methylpyridin-3- yl)methyl)-2-(3- (methylsulfonyl)-4-((2- oxopyridin-1(2H)- yl)methyl)benzyl) isonicotinamide::US10981893, Example 28	Plasma kallikrein			<100							ChEMBL		10.7270/Q2R215K6	32066009			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492899	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492899&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			124173408	447119588							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51511220	CS(=O)(=O)c1cc(Cc2cc(ccn2)C(=O)NCc2cnc3[nH]cc(Cl)c3c2)ccc1Cn1ccccc1=O	InChI=1S/C28H24ClN5O4S/c1-39(37,38)25-12-18(5-6-21(25)17-34-9-3-2-4-26(34)35)10-22-13-20(7-8-30-22)28(36)33-15-19-11-23-24(29)16-32-27(23)31-14-19/h2-9,11-14,16H,10,15,17H2,1H3,(H,31,32)(H,33,36)	HQQGTGOLZSFJSE-UHFFFAOYSA-N	492900	N-((3-chloro-1H-indol- 5-yl)methyl)-2-(3- (methylsulfonyl)-4-((2- oxopyridin-1(2H)- yl)methyl)benzyl) isonicotinamide::US10981893, Example 29	Plasma kallikrein			<100							ChEMBL		10.7270/Q2R215K6	32066009			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492900	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492900&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118212995	447119589							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297861	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C30H25F4N5O2/c31-24-11-10-22(28(41-17-19-4-5-19)21-8-6-18(15-35)7-9-21)13-25(24)37-29(40)26-14-27(30(32,33)34)38-39(26)23-3-1-2-20(12-23)16-36/h1-3,6-14,19,28H,4-5,16-17,36H2,(H,37,40)	WXFHQCUXOOXGLO-UHFFFAOYSA-N	416894	1-(3-(aminomethyl)phenyl)-N-(5-((4-cyanophenyl)(cyclopropylmethoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 55b::US10633345, Compound 73b::US10689346, Compound 55b::US11203574, Compound 73b::US11230530, Compound 73b::US11685721, Compound 73b::US11708332, Compound 73b	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416894	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416894&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665569	433916807							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297862	CN1CCCN(CC1)C(CCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H36F4N6O/c1-38-12-3-13-39(15-14-38)26(11-8-20-6-7-20)22-9-10-24(31)25(17-22)36-29(41)27-18-28(30(32,33)34)37-40(27)23-5-2-4-21(16-23)19-35/h2,4-5,9-10,16-18,20,26H,3,6-8,11-15,19,35H2,1H3,(H,36,41)	WXRMFESIILBOBA-UHFFFAOYSA-N	416951	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(4-methyl-1,4-diazepan-1-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 251e::US10633345, Compound 251e::US10689346, Compound 251e::US11203574, Compound 251e::US11230530, Compound 251e::US11685721, Compound 251e::US11708332, Compound 251e	Plasma kallikrein		>75.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416951	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416951&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355664	433916863							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297863	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H25F4N5O2/c29-22-9-8-19(26(39-16-17-6-7-17)20-4-2-10-34-15-20)12-23(22)35-27(38)24-13-25(28(30,31)32)36-37(24)21-5-1-3-18(11-21)14-33/h1-5,8-13,15,17,26H,6-7,14,16,33H2,(H,35,38)	CNAFOXQNPWSINI-UHFFFAOYSA-N	416794	Racemic 1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethoxy)(pyridin-3-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 48f::US10633345, Compound 48f::US10689346, Compound 48f::US11203574, Compound 48g::US11230530, Compound 48h::US11685721, Compound 48f::US11708332, Compound 48f	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416794	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416794&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355617	433916708							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297864	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C30H25F4N5O2/c31-24-11-10-22(28(41-17-19-4-5-19)21-8-6-18(15-35)7-9-21)13-25(24)37-29(40)26-14-27(30(32,33)34)38-39(26)23-3-1-2-20(12-23)16-36/h1-3,6-14,19,28H,4-5,16-17,36H2,(H,37,40)	WXFHQCUXOOXGLO-UHFFFAOYSA-N	416894	1-(3-(aminomethyl)phenyl)-N-(5-((4-cyanophenyl)(cyclopropylmethoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 55b::US10633345, Compound 73b::US10689346, Compound 55b::US11203574, Compound 73b::US11230530, Compound 73b::US11685721, Compound 73b::US11708332, Compound 73b	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416894	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416894&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665569	433916807							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297865	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)N1C(=O)CCC1=O)C(F)(F)F	InChI=1S/C28H27F4N5O3/c29-20-8-7-18(22(9-6-16-4-5-16)36-25(38)10-11-26(36)39)13-21(20)34-27(40)23-14-24(28(30,31)32)35-37(23)19-3-1-2-17(12-19)15-33/h1-3,7-8,12-14,16,22H,4-6,9-11,15,33H2,(H,34,40)	ZAWTZVLCOQSDBX-UHFFFAOYSA-N	416954	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(2,5-dioxopyrrolidin-1-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 260b::US10633345, Compound 260b::US10689346, Compound 260b::US11203574, Compound 260b::US11230530, Compound 260b::US11685721, Compound 260b::US11708332, Compound 260b	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416954	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416954&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665563	433916866							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297866	COc1ccc2ccccc2c1C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H32F3N5O2/c1-44-29-15-14-23-7-2-3-11-27(23)31(29)32(39-20-21-12-13-21)24-8-5-9-25(17-24)40-33(43)28-18-30(34(35,36)37)41-42(28)26-10-4-6-22(16-26)19-38/h2-11,14-18,21,32,39H,12-13,19-20,38H2,1H3,(H,40,43)	XVOUQCJHWNZPKF-UHFFFAOYSA-N	416841	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2-methoxynaphthalen-1-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 51f::US10633345, Compound 51f::US10689346, Compound 51f::US11203574, Compound 51h::US11230530, Compound 51h::US11685721, Compound 51f::US11708332, Compound 51h	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416841	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416841&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356155	433916754							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297867	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C30H25F4N5O2/c31-24-10-9-22(28(41-17-18-7-8-18)21-5-1-3-19(11-21)15-35)13-25(24)37-29(40)26-14-27(30(32,33)34)38-39(26)23-6-2-4-20(12-23)16-36/h1-6,9-14,18,28H,7-8,16-17,36H2,(H,37,40)	LSXFYXGKZDVRTL-UHFFFAOYSA-N	416900	1-(3-(aminomethyl)phenyl)-N-(5-((3-cyanophenyl)(cyclopropyl-methoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 56c::US10633345, Compound 72d::US10689346, Compound 56c::US11203574, Compound 72d::US11230530, Compound 72d::US11685721, Compound 72d::US11708332, Compound 72d	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416900	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416900&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356211	433916813							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297868	CS(=O)(=O)NC(CCC1CC1)(c1ccncc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2ccc3ccnc(N)c3c2)C(F)(F)F)c1	InChI=1S/C32H29F4N7O3S/c1-47(45,46)42-31(12-8-19-2-3-19,21-10-13-38-14-11-21)22-5-7-25(33)26(16-22)40-30(44)27-18-28(32(34,35)36)41-43(27)23-6-4-20-9-15-39-29(37)24(20)17-23/h4-7,9-11,13-19,42H,2-3,8,12H2,1H3,(H2,37,39)(H,40,44)	WOIASLBXHIHYRY-UHFFFAOYSA-N	416957	(+-)-1-(1-aminoisoquinolin-7-yl)-N-(5-(3-cyclopropyl-1-(methylsulfonamido)-1-(pyridin-4-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 262f::US10633345, Compound 262f::US10689346, Compound 262f::US11192861, Compound 262f::US11230530, Compound 262f::US11685721, Compound 262f::US11708332, Compound 262f	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416957	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416957&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355636	433916869							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297869	COc1ccc2ccccc2c1C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H32F3N5O2/c1-44-29-15-14-23-7-2-3-11-27(23)31(29)32(39-20-21-12-13-21)24-8-5-9-25(17-24)40-33(43)28-18-30(34(35,36)37)41-42(28)26-10-4-6-22(16-26)19-38/h2-11,14-18,21,32,39H,12-13,19-20,38H2,1H3,(H,40,43)	XVOUQCJHWNZPKF-UHFFFAOYSA-N	416841	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(2-methoxynaphthalen-1-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 51f::US10633345, Compound 51f::US10689346, Compound 51f::US11203574, Compound 51h::US11230530, Compound 51h::US11685721, Compound 51f::US11708332, Compound 51h	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416841	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416841&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356155	433916754							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297870	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C30H25F4N5O2/c31-24-10-9-22(28(41-17-18-7-8-18)21-5-1-3-19(11-21)15-35)13-25(24)37-29(40)26-14-27(30(32,33)34)38-39(26)23-6-2-4-20(12-23)16-36/h1-6,9-14,18,28H,7-8,16-17,36H2,(H,37,40)	LSXFYXGKZDVRTL-UHFFFAOYSA-N	416900	1-(3-(aminomethyl)phenyl)-N-(5-((3-cyanophenyl)(cyclopropyl-methoxy)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 56c::US10633345, Compound 72d::US10689346, Compound 56c::US11203574, Compound 72d::US11230530, Compound 72d::US11685721, Compound 72d::US11708332, Compound 72d	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416900	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416900&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356211	433916813							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297871	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccc(=O)[nH]c1=O)C(F)(F)F			416960	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 263d::US10633345, Compound 263d::US10689346, Compound 263d::US11203574, Compound 263d::US11230530, Compound 263d::US11685721, Compound 263d::US11708332, Compound 263d	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416960	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416960&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			154584232	433916872							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297872	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-25(37(36-26)24-9-1-4-19(12-24)16-33)28(38)35-23-8-3-6-21(14-23)27(39-17-18-10-11-18)20-5-2-7-22(34)13-20/h1-9,12-15,18,27H,10-11,16-17,33-34H2,(H,35,38)	FPQYUIIRVBKUDH-UHFFFAOYSA-N	416867	1-(3-(aminomethyl)phenyl)-N-(3-((3-aminophenyl)(cyclopropyl-methoxy)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 53f::US10633345, Compound 53f::US10689346, Compound 53f::US11203574, Compound 64b::US11230530, Compound 64b::US11685721, Compound 49j::US11708332, Compound 64b	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416867	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416867&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355845	433916780							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297873	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1O)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-11-10-19(27(35-16-17-8-9-17)21-6-1-2-7-25(21)39)13-23(22)36-28(40)24-14-26(29(31,32)33)37-38(24)20-5-3-4-18(12-20)15-34/h1-7,10-14,17,27,35,39H,8-9,15-16,34H2,(H,36,40)	CKWWRAGQIQAYTL-UHFFFAOYSA-N	416856	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(2-hydroxyphenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 60e::US10633345, Compound 66b::US10689346, Compound 60e::US11203574, Compound 66b::US11230530, Compound 66b::US11685721, Compound 60e::US11708332, Compound 66b	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416856	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416856&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665480	433916769							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297874	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1ccc(cc1F)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-23-14-21(27(39-17-18-9-10-18)20-6-2-1-3-7-20)11-12-24(23)35-28(38)25-15-26(29(31,32)33)36-37(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27H,9-10,16-17,34H2,(H,35,38)	HBXVQXKJLUQKAE-UHFFFAOYSA-N	416963	1-(3-(aminomethyl)phenyl)-N-(4-((cyclopropylmethoxy)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 15g::US10633345, Compound 15g::US10689346, Compound 15g::US11203574, Compound 15g::US11230530, Compound 15g::US11685721, Compound 15g::US11708332, Compound 15g	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416963	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416963&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355605	433916875							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297875	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-25(37(36-26)24-9-1-4-19(12-24)16-33)28(38)35-23-8-3-6-21(14-23)27(39-17-18-10-11-18)20-5-2-7-22(34)13-20/h1-9,12-15,18,27H,10-11,16-17,33-34H2,(H,35,38)	FPQYUIIRVBKUDH-UHFFFAOYSA-N	416867	1-(3-(aminomethyl)phenyl)-N-(3-((3-aminophenyl)(cyclopropyl-methoxy)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 53f::US10633345, Compound 53f::US10689346, Compound 53f::US11203574, Compound 64b::US11230530, Compound 64b::US11685721, Compound 49j::US11708332, Compound 64b	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416867	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416867&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355845	433916780							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297876	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1O)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-11-10-19(27(35-16-17-8-9-17)21-6-1-2-7-25(21)39)13-23(22)36-28(40)24-14-26(29(31,32)33)37-38(24)20-5-3-4-18(12-20)15-34/h1-7,10-14,17,27,35,39H,8-9,15-16,34H2,(H,36,40)	CKWWRAGQIQAYTL-UHFFFAOYSA-N	416856	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(2-hydroxyphenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 60e::US10633345, Compound 66b::US10689346, Compound 60e::US11203574, Compound 66b::US11230530, Compound 66b::US11685721, Compound 60e::US11708332, Compound 66b	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416856	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416856&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665480	433916769							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297877	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1ccc(cc1F)C(O)c1ccccc1)C(F)(F)F	InChI=1S/C25H20F4N4O2/c26-19-12-17(23(34)16-6-2-1-3-7-16)9-10-20(19)31-24(35)21-13-22(25(27,28)29)32-33(21)18-8-4-5-15(11-18)14-30/h1-13,23,34H,14,30H2,(H,31,35)	WVBOXESRKOBMTK-UHFFFAOYSA-N	416966	1-(3-(Aminomethyl)phenyl)-N-(2-fluoro-4-(hydroxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 16b::US10633345, Compound 16b::US10689346, Compound 16b::US11203574, Compound 16b::US11230530, Compound 16b::US11685721, Compound 16b::US11708332, Compound 16b	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416966	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416966&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665483	433916878							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297878	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1O)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-24(37(36-26)22-8-3-5-19(13-22)16-33)28(39)35-21-7-4-6-20(14-21)27(34-17-18-11-12-18)23-9-1-2-10-25(23)38/h1-10,13-15,18,27,34,38H,11-12,16-17,33H2,(H,35,39)	PCNDJIQOMLHSEK-UHFFFAOYSA-N	416837	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2-hydroxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 49h::US10633345, Compound 49h::US10689346, Compound 49h::US11203574, Compound 49j::US11230530, Compound 49j::US11685721, Compound 49h::US11708332, Compound 49j	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416837	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416837&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355733	433916750							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297879	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-23-12-11-21(27(39-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)35-28(38)25-15-26(29(31,32)33)36-37(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27H,9-10,16-17,34H2,(H,35,38)	HIMJVDQVZQMIPM-UHFFFAOYSA-N	416747	1-(3-(Aminomethyl)phenyl)-N-(5-((cyclopropylmethoxy)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 34c::US10633345, Compound 34c::US10689346, Compound 34c::US11203574, Compound 37a::US11230530, Compound 37a::US11685721, Compound 34c::US11708332, Compound 34c	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416747	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416747&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355729	433916661							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297880	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1c(F)cccc1C(O)c1ccccc1)C(F)(F)F	InChI=1S/C25H20F4N4O2/c26-19-11-5-10-18(23(34)16-7-2-1-3-8-16)22(19)31-24(35)20-13-21(25(27,28)29)32-33(20)17-9-4-6-15(12-17)14-30/h1-13,23,34H,14,30H2,(H,31,35)	PIMJYQUHLMMZIO-UHFFFAOYSA-N	416969	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-6-(hydroxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 90f::US10633345, Compound 90f::US10689346, Compound 90f::US11203574, Compound 90f::US11230530, Compound 90f::US11685721, Compound 90f::US11708332, Compound 90f	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416969	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416969&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356272	433916881							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297881	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1O)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-15-24(37(36-26)22-8-3-5-19(13-22)16-33)28(39)35-21-7-4-6-20(14-21)27(34-17-18-11-12-18)23-9-1-2-10-25(23)38/h1-10,13-15,18,27,34,38H,11-12,16-17,33H2,(H,35,39)	PCNDJIQOMLHSEK-UHFFFAOYSA-N	416837	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(2-hydroxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 49h::US10633345, Compound 49h::US10689346, Compound 49h::US11203574, Compound 49j::US11230530, Compound 49j::US11685721, Compound 49h::US11708332, Compound 49j	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416837	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416837&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355733	433916750							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297882	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-23-12-11-21(27(39-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)35-28(38)25-15-26(29(31,32)33)36-37(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27H,9-10,16-17,34H2,(H,35,38)	HIMJVDQVZQMIPM-UHFFFAOYSA-N	416747	1-(3-(Aminomethyl)phenyl)-N-(5-((cyclopropylmethoxy)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 34c::US10633345, Compound 34c::US10689346, Compound 34c::US11203574, Compound 37a::US11230530, Compound 37a::US11685721, Compound 34c::US11708332, Compound 34c	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416747	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416747&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355729	433916661							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297883	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N(CC1CC1)CC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C33H33F4N5O/c34-27-14-13-25(31(24-6-2-1-3-7-24)41(19-21-9-10-21)20-22-11-12-22)16-28(27)39-32(43)29-17-30(33(35,36)37)40-42(29)26-8-4-5-23(15-26)18-38/h1-8,13-17,21-22,31H,9-12,18-20,38H2,(H,39,43)	FVEYNTAGBBDICV-UHFFFAOYSA-N	416972	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-((bis(cyclopropylmethyl)amino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 206d::US10633345, Compound 206d::US10689346, Compound 206d::US11203574, Compound 206d::US11230530, Compound 206d::US11685721, Compound 206d::US11708332, Compound 206d	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416972	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416972&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355791	433916884							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297884	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C#N)C(N)=O	InChI=1S/C31H30FN7O2/c32-25-11-10-23(31(36,13-12-19-4-5-19)22-8-6-20(17-33)7-9-22)15-26(25)37-30(41)28-16-27(29(35)40)38-39(28)24-3-1-2-21(14-24)18-34/h1-3,6-11,14-16,19H,4-5,12-13,18,34,36H2,(H2,35,40)(H,37,41)	BCLQAOJZVSDWEP-UHFFFAOYSA-N	416973	(+)-N5-(5-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-1H-pyrazole-3,5-dicarboxamide::US10329260, Compound 231d::US10633345, Compound 231d::US10689346, Compound 231d::US11203574, Compound 231d::US11230530, Compound 231d::US11685721, Compound 231d::US11708332, Compound 231d	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416973	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416973&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665708	433916885							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297885	CC(C)(C)C(=O)NC(CCC1CC1)(c1cccnc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H36F4N6O2/c1-32(2,3)31(46)42-33(14-13-21-9-10-21,24-7-5-15-40-20-24)23-11-12-26(35)27(17-23)41-30(45)28-18-29(34(36,37)38)43-44(28)25-8-4-6-22(16-25)19-39/h4-8,11-12,15-18,20-21H,9-10,13-14,19,39H2,1-3H3,(H,41,45)(H,42,46)	QDJVSPVHYSLBHH-UHFFFAOYSA-N	416974	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-pivalamido-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 244g::US10689346, Compound 244g::US11203574, Compound 244g::US11230530, Compound 244g::US11685721, Compound 244g::US11708332, Compound 244g	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416974	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416974&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665924	433916886							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297886	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-22-10-9-20(28(35,12-11-18-7-8-18)25-6-1-2-13-36-25)15-23(22)37-27(40)24-16-26(29(31,32)33)38-39(24)21-5-3-4-19(14-21)17-34/h1-6,9-10,13-16,18H,7-8,11-12,17,34-35H2,(H,37,40)	IFWBAIGKQKRJGJ-UHFFFAOYSA-N	416975	(+-)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 205d::US10633345, Compound 205c::US10689346, Compound 205e::US11203574, Compound 205e::US11230530, Compound 205e::US11685721, Compound 205f::US11708332, Compound 205e	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416975	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416975&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665627	433916887							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297887	ONC(=N)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N6O2/c30-22-12-11-19(26(35-16-17-9-10-17)18-5-2-1-3-6-18)14-23(22)36-28(40)24-15-25(29(31,32)33)37-39(24)21-8-4-7-20(13-21)27(34)38-41/h1-8,11-15,17,26,35,41H,9-10,16H2,(H2,34,38)(H,36,40)	RKUBSDCTAQRJEX-UHFFFAOYSA-N	416976	(+-)-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-1-(3-(N-hydroxycarbamimidoyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 232a::US10633345, Compound 232a::US10689346, Compound 232a::US11203574, Compound 232a::US11230530, Compound 232a::US11685721, Compound 232a::US11708332, Compound 232a	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416976	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416976&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665466	433916888							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297888	CC(=O)NC(CCC1CC1)(c1cccnc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C31H30F4N6O2/c1-19(42)39-30(12-11-20-7-8-20,23-5-3-13-37-18-23)22-9-10-25(32)26(15-22)38-29(43)27-16-28(31(33,34)35)40-41(27)24-6-2-4-21(14-24)17-36/h2-6,9-10,13-16,18,20H,7-8,11-12,17,36H2,1H3,(H,38,43)(H,39,42)	NXVHVPBDWBOZQI-UHFFFAOYSA-N	416977	(+-)-N-(5-(1-acetamido-3-cyclopropyl-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 244h::US10633345, Compound 244h::US10689346, Compound 244h::US11203574, Compound 244h::US11230530, Compound 244h::US11685721, Compound 244h::US11708332, Compound 244h	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416977	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416977&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355894	433916889							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297889	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-22-10-9-20(28(35,12-11-18-7-8-18)25-6-1-2-13-36-25)15-23(22)37-27(40)24-16-26(29(31,32)33)38-39(24)21-5-3-4-19(14-21)17-34/h1-6,9-10,13-16,18H,7-8,11-12,17,34-35H2,(H,37,40)	IFWBAIGKQKRJGJ-UHFFFAOYSA-N	416975	(+-)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 205d::US10633345, Compound 205c::US10689346, Compound 205e::US11203574, Compound 205e::US11230530, Compound 205e::US11685721, Compound 205f::US11708332, Compound 205e	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416975	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416975&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665627	433916887							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297890	CN(C(c1ccccc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(O)=O)c1)C1CC1	InChI=1S/C29H28FN5O3/c1-34(21-11-12-21)27(19-7-3-2-4-8-19)20-10-13-23(30)24(15-20)32-28(36)26-16-25(29(37)38)33-35(26)22-9-5-6-18(14-22)17-31/h2-10,13-16,21,27H,11-12,17,31H2,1H3,(H,32,36)(H,37,38)	NSHVGURHOPUGRD-UHFFFAOYSA-N	610052	(+)-1-(3-(aminomethyl)phenyl)-5-(5-((cyclopropyl methylamino)(phenyl)methyl)-2-fluorophenylcarbamoyl)-1H-pyrazole-3-carboxylic acid::US11708332, Compound 246f	Plasma kallikrein		 25.1								US Patent		10.7270/Q2XW4PXV			US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610052	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610052&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356050	483620219							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297891	CCC(=O)NC(CCC1CC1)(c1cccnc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C32H32F4N6O2/c1-2-29(43)40-31(13-12-20-8-9-20,23-6-4-14-38-19-23)22-10-11-25(33)26(16-22)39-30(44)27-17-28(32(34,35)36)41-42(27)24-7-3-5-21(15-24)18-37/h3-7,10-11,14-17,19-20H,2,8-9,12-13,18,37H2,1H3,(H,39,44)(H,40,43)	VLEWWVBFKVHAND-UHFFFAOYSA-N	416980	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-propionamido-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 244i::US10633345, Compound 244i::US10689346, Compound 244i::US11203574, Compound 244i::US11230530, Compound 244j::US11685721, Compound 244i::US11708332, Compound 244i	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416980	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416980&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665945	433916892							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297892	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-23-9-8-20(28(35,11-10-18-6-7-18)21-4-2-12-36-17-21)14-24(23)37-27(40)25-15-26(29(31,32)33)38-39(25)22-5-1-3-19(13-22)16-34/h1-5,8-9,12-15,17-18H,6-7,10-11,16,34-35H2,(H,37,40)	QXMQDWOYOXVOQZ-UHFFFAOYSA-N	416981	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 208d::US10633345, Compound 209d::US10689346, Compound 209d::US11203574, Compound 209d::US11230530, Compound 209d::US11685721, Compound 209d::US11708332, Compound 209d	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416981	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416981&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355646	433916893							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297893	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C#N)C#N	InChI=1S/C31H28FN7O/c32-27-11-10-24(31(36,13-12-20-4-5-20)23-8-6-21(17-33)7-9-23)15-28(27)37-30(40)29-16-25(19-35)38-39(29)26-3-1-2-22(14-26)18-34/h1-3,6-11,14-16,20H,4-5,12-13,18,34,36H2,(H,37,40)	SWSSXIJHEDUEIQ-UHFFFAOYSA-N	416982	(+)-N-(5-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-cyano-1H-pyrazole-5-carboxamide::US10329260, Compound 234d::US10633345, Compound 234d::US10689346, Compound 234d::US11203574, Compound 234d::US11230530, Compound 234d::US11685721, Compound 234d::US11708332, Compound 234d	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416982	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416982&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356248	433916894							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297894	CC(C)C(=O)NC(CCC1CC1)(c1cccnc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C33H34F4N6O2/c1-20(2)30(44)41-32(13-12-21-8-9-21,24-6-4-14-39-19-24)23-10-11-26(34)27(16-23)40-31(45)28-17-29(33(35,36)37)42-43(28)25-7-3-5-22(15-25)18-38/h3-7,10-11,14-17,19-21H,8-9,12-13,18,38H2,1-2H3,(H,40,45)(H,41,44)	POAUUALSNYEBRU-UHFFFAOYSA-N	416983	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-isobutyramido-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 244j::US10633345, Compound 244j::US10689346, Compound 244j::US11203574, Compound 244j::US11685721, Compound 244j::US11708332, Compound 244j	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416983	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416983&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356184	433916895							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297895	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-23-9-8-20(28(35,11-10-18-6-7-18)21-4-2-12-36-17-21)14-24(23)37-27(40)25-15-26(29(31,32)33)38-39(25)22-5-1-3-19(13-22)16-34/h1-5,8-9,12-15,17-18H,6-7,10-11,16,34-35H2,(H,37,40)	QXMQDWOYOXVOQZ-UHFFFAOYSA-N	416981	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 208d::US10633345, Compound 209d::US10689346, Compound 209d::US11203574, Compound 209d::US11230530, Compound 209d::US11685721, Compound 209d::US11708332, Compound 209d	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416981	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416981&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355646	433916893							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297896	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C31H26F4N6O/c32-24-11-9-21(28(38-17-18-6-7-18)20-4-2-1-3-5-20)14-25(24)39-30(42)26-16-27(31(33,34)35)40-41(26)22-10-8-19-12-13-37-29(36)23(19)15-22/h1-5,8-16,18,28,38H,6-7,17H2,(H2,36,37)(H,39,42)	OUKVDAXUKVLTKB-UHFFFAOYSA-N	439568	US10633345, Compound 235g::US10689346, Compound 235g::US11192861, Compound 235g::US11708332, Compound 235g	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439568	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439568&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665742	439661116							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297897	CC(C)CC(=O)NC(CCC1CC1)(c1cccnc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C34H36F4N6O2/c1-21(2)15-31(45)42-33(13-12-22-8-9-22,25-6-4-14-40-20-25)24-10-11-27(35)28(17-24)41-32(46)29-18-30(34(36,37)38)43-44(29)26-7-3-5-23(16-26)19-39/h3-7,10-11,14,16-18,20-22H,8-9,12-13,15,19,39H2,1-2H3,(H,41,46)(H,42,45)	WIIQCCUTLYCVOE-UHFFFAOYSA-N	416986	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(3-methylbutanamido)-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 244k::US10633345, Compound 244k::US10689346, Compound 244k::US11203574, Compound 244k::US11230530, Compound 244k::US11685721, Compound 244k::US11708332, Compound 244k	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416986	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416986&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665507	433916898							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297898	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F4N5O/c31-24-12-11-22(29(36,14-13-19-9-10-19)21-6-2-1-3-7-21)16-25(24)37-28(40)26-17-27(30(32,33)34)38-39(26)23-8-4-5-20(15-23)18-35/h1-8,11-12,15-17,19H,9-10,13-14,18,35-36H2,(H,37,40)	NQFNNZJJOCPZCP-UHFFFAOYSA-N	416987	(+-)-N-(5-(1-amino-3-cyclopropyl-1-phenylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 210d::US10633345, Compound 211d::US10689346, Compound 211d::US11203574, Compound 211d::US11230530, Compound 211d::US11685721, Compound 211d::US11708332, Compound 211d	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416987	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416987&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355764	433916899							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297899	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(N)(CCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C31H29F3N6O/c32-31(33,34)28-17-27(40(39-28)26-6-1-3-22(15-26)19-36)29(41)38-25-5-2-4-24(16-25)30(37,14-13-20-7-8-20)23-11-9-21(18-35)10-12-23/h1-6,9-12,15-17,20H,7-8,13-14,19,36-37H2,(H,38,41)	WPWCLOAAAHRQMG-UHFFFAOYSA-N	416988	(+)-N-(3-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)phenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 218c::US10633345, Compound 218c::US10689346, Compound 218c::US11203574, Compound 218c::US11230530, Compound 218c::US11685721, Compound 218c::US11708332, Compound 218c	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416988	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416988&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356070	433916900							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297900	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C31H27F4N7O/c32-24-6-4-21(30(37,11-7-18-1-2-18)20-9-12-38-13-10-20)15-25(24)40-29(43)26-17-27(31(33,34)35)41-42(26)22-5-3-19-8-14-39-28(36)23(19)16-22/h3-6,8-10,12-18H,1-2,7,11,37H2,(H2,36,39)(H,40,43)	BGYDOWYGLFEYGE-UHFFFAOYSA-N	416989	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-4-yl)propyl)-2-fluorophenyl)-1-(1-aminoisoquinolin-7-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 253e::US10633345, Compound 253e::US10689346, Compound 253e::US11203574, Compound 253e::US11230530, Compound 253e::US11685721, Compound 253e::US11708332, Compound 253e	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416989	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416989&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665703	433916901							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297901	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F4N5O/c31-24-12-11-22(29(36,14-13-19-9-10-19)21-6-2-1-3-7-21)16-25(24)37-28(40)26-17-27(30(32,33)34)38-39(26)23-8-4-5-20(15-23)18-35/h1-8,11-12,15-17,19H,9-10,13-14,18,35-36H2,(H,37,40)	NQFNNZJJOCPZCP-UHFFFAOYSA-N	416987	(+-)-N-(5-(1-amino-3-cyclopropyl-1-phenylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 210d::US10633345, Compound 211d::US10689346, Compound 211d::US11203574, Compound 211d::US11230530, Compound 211d::US11685721, Compound 211d::US11708332, Compound 211d	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416987	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416987&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355764	433916899							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297902	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(N)(CCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C31H29F3N6O/c32-31(33,34)28-17-27(40(39-28)26-9-2-5-22(15-26)19-36)29(41)38-25-8-3-7-24(16-25)30(37,13-12-20-10-11-20)23-6-1-4-21(14-23)18-35/h1-9,14-17,20H,10-13,19,36-37H2,(H,38,41)	JHGXWQQOSIGIHO-UHFFFAOYSA-N	416991	(+)-N-(3-(1-amino-1-(3-cyanophenyl)-3-cyclopropylpropyl)phenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 219c::US10633345, Compound 219c::US10689346, Compound 219c::US11203574, Compound 219c::US11230530, Compound 219c::US11685721, Compound 219c::US11708332, Compound 219c	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416991	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416991&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355760	433916903							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297903	CS(=O)(=O)NC(CCC1CC1)(c1ccncc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F4N6O3S/c1-44(42,43)39-29(12-9-19-5-6-19,21-10-13-36-14-11-21)22-7-8-24(31)25(16-22)37-28(41)26-17-27(30(32,33)34)38-40(26)23-4-2-3-20(15-23)18-35/h2-4,7-8,10-11,13-17,19,39H,5-6,9,12,18,35H2,1H3,(H,37,41)	SFWRGGJAWAJGGN-UHFFFAOYSA-N	416992	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(methylsulfonamido)-1-(pyridin-4-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 245c::US10633345, Compound 245c::US10689346, Compound 245c::US11203574, Compound 245c::US11230530, Compound 245c::US11685721, Compound 245c::US11708332, Compound 245c	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416992	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416992&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355707	433916904							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297904	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C31H28F4N6O/c32-25-11-10-23(30(38,13-12-19-4-5-19)22-8-6-20(17-36)7-9-22)15-26(25)39-29(42)27-16-28(31(33,34)35)40-41(27)24-3-1-2-21(14-24)18-37/h1-3,6-11,14-16,19H,4-5,12-13,18,37-38H2,(H,39,42)	JCBKPNPCGNTAQN-UHFFFAOYSA-N	416993	(+)-N-(5-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 212g::US10633345, Compound 213d::US10689346, Compound 213d::US11203574, Compound 213d::US11230530, Compound 213d::US11685721, Compound 213d::US11708332, Compound 213d	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416993	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416993&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356170	433916905							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297905	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C(N)=O)C#N	InChI=1S/C31H30FN7O2/c32-26-11-10-23(31(36,13-12-19-4-5-19)22-8-6-21(7-9-22)29(35)40)15-27(26)37-30(41)28-16-24(18-34)38-39(28)25-3-1-2-20(14-25)17-33/h1-3,6-11,14-16,19H,4-5,12-13,17,33,36H2,(H2,35,40)(H,37,41)	KLZOEGIZCNFTHC-UHFFFAOYSA-N	416994	(-)-N-(5-(1-amino-1-(4-carbamoylphenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-cyano-1H-pyrazole-5-carboxamide::US10329260, Compound 239d::US10633345, Compound 239c::US10689346, Compound 239d::US11203574, Compound 239d::US11685721, Compound 239d::US11708332, Compound 239d	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416994	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416994&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356225	433916906							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297906	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C32H25F4N7O/c33-25-9-7-22(29(40-17-18-4-5-18)21-3-1-2-19(12-21)16-37)13-26(25)41-31(44)27-15-28(32(34,35)36)42-43(27)23-8-6-20-10-11-39-30(38)24(20)14-23/h1-3,6-15,18,29,40H,4-5,17H2,(H2,38,39)(H,41,44)	PQPAZBKFVDKERF-UHFFFAOYSA-N	439578	US10633345, Compound 257b::US10689346, Compound 257b::US11203574, Compound 257b::US11230530, Compound 257b::US11685721, Compound 257b::US11708332, Compound 257b	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439578	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439578&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665471	439661126							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297907	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C31H28F4N6O/c32-25-10-9-23(30(38,12-11-19-7-8-19)22-5-1-3-20(13-22)17-36)15-26(25)39-29(42)27-16-28(31(33,34)35)40-41(27)24-6-2-4-21(14-24)18-37/h1-6,9-10,13-16,19H,7-8,11-12,18,37-38H2,(H,39,42)	ZBDDMFBNDOEVJT-UHFFFAOYSA-N	416996	(+)-N-(5-(1-amino-1-(3-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 214g::US10633345, Compound 215d::US10689346, Compound 215d::US11203574, Compound 215d::US11230530, Compound 215d::US11685721, Compound 215d::US11708332, Compound 215d	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416996	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416996&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665709	433916908							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297908	NC(=O)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C31H26F4N6O2/c32-24-10-9-22(30(38,12-11-18-7-8-18)21-5-1-3-19(13-21)17-36)15-25(24)39-29(43)26-16-27(31(33,34)35)40-41(26)23-6-2-4-20(14-23)28(37)42/h1-6,9-10,13-16,18H,7-8,11-12,38H2,(H2,37,42)(H,39,43)	MJBRNYICMOSPEH-UHFFFAOYSA-N	416997	(+-)-N-(5-(1-amino-1-(3-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-carbamoylphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 267c::US10633345, Compound 267c::US10689346, Compound 267c::US11203574, Compound 267c::US11230530, Compound 267c::US11685721, Compound 267c::US11708332, Compound 267c	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416997	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416997&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665760	433916909							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297909	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C33H27F4N7O/c34-26-10-8-23(32(40,13-11-19-1-2-19)22-6-3-20(18-38)4-7-22)15-27(26)42-31(45)28-17-29(33(35,36)37)43-44(28)24-9-5-21-12-14-41-30(39)25(21)16-24/h3-10,12,14-17,19H,1-2,11,13,40H2,(H2,39,41)(H,42,45)	QUIZETAQJOZQJA-UHFFFAOYSA-N	416998	(+)-N-(5-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(1-aminoisoquinolin-7-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 254c::US10633345, Compound 254c::US10689346, Compound 254c::US11203574, Compound 254c::US11230530, Compound 254c::US11685721, Compound 254c::US11708332, Compound 254c	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416998	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416998&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665477	433916910							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297910	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C31H28F4N6O/c32-25-11-10-23(30(38,13-12-19-4-5-19)22-8-6-20(17-36)7-9-22)15-26(25)39-29(42)27-16-28(31(33,34)35)40-41(27)24-3-1-2-21(14-24)18-37/h1-3,6-11,14-16,19H,4-5,12-13,18,37-38H2,(H,39,42)	JCBKPNPCGNTAQN-UHFFFAOYSA-N	416993	(+)-N-(5-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 212g::US10633345, Compound 213d::US10689346, Compound 213d::US11203574, Compound 213d::US11230530, Compound 213d::US11685721, Compound 213d::US11708332, Compound 213d	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416993	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416993&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356170	433916905							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297911	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C#N	InChI=1S/C29H27FN6O/c30-25-12-11-22(28(33-18-19-9-10-19)21-6-2-1-3-7-21)14-26(25)34-29(37)27-15-23(17-32)35-36(27)24-8-4-5-20(13-24)16-31/h1-8,11-15,19,28,33H,9-10,16,18,31H2,(H,34,37)	OBANZZDEWOCPST-UHFFFAOYSA-N	417000	(+-)-1-(3-(aminomethyl)phenyl)-3-cyano-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 240b::US10633345, Compound 240b::US10689346, Compound 240b::US11203574, Compound 240b::US11230530, Compound 240b::US11685721, Compound 240b::US11708332, Compound 240b	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417000	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417000&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355661	433916912							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297912	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C32H28F4N6O/c33-25-11-9-22(31(38,14-12-19-6-7-19)21-4-2-1-3-5-21)16-26(25)40-30(43)27-18-28(32(34,35)36)41-42(27)23-10-8-20-13-15-39-29(37)24(20)17-23/h1-5,8-11,13,15-19H,6-7,12,14,38H2,(H2,37,39)(H,40,43)	SUIQVQQNEUOJQB-UHFFFAOYSA-N	417001	(+)-N-(5-(1-amino-3-cyclopropyl-1-phenylpropyl)-2-fluorophenyl)-1-(1-aminoisoquinolin-7-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 255a::US10633345, Compound 255a::US10689346, Compound 255a::US11203574, Compound 255a::US11230530, Compound 255a::US11685721, Compound 255a::US11708332, Compound 255a	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417001	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417001&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356059	433916913							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297913	Nc1noc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H24F4N6O2/c30-21-10-8-18(26(35-15-16-6-7-16)17-4-2-1-3-5-17)12-22(21)36-28(40)23-14-25(29(31,32)33)37-39(23)19-9-11-24-20(13-19)27(34)38-41-24/h1-5,8-14,16,26,35H,6-7,15H2,(H2,34,38)(H,36,40)	QWKNFIFTTXOPHF-UHFFFAOYSA-N	417002	(+-)-1-(3-aminobenzo[d]isoxazol-5-yl)-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 222k::US10329260, Compound 223f::US10633345, Compound 223f::US10689346, Compound 223f::US11203574, Compound 223f::US11230530, Compound 223f::US11685721, Compound 223f::US11708332, Compound 223f	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417002	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417002&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123289526	433916914							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297914	NC(=N)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C30H25F4N7O/c31-23-10-9-20(27(38-16-17-7-8-17)19-4-1-3-18(11-19)15-35)13-24(23)39-29(42)25-14-26(30(32,33)34)40-41(25)22-6-2-5-21(12-22)28(36)37/h1-6,9-14,17,27,38H,7-8,16H2,(H3,36,37)(H,39,42)	VIRFLKJDRZOSPM-UHFFFAOYSA-N	417003	(+)-1-(3-carbamimidoylphenyl)-N-(5-((3-cyanophenyl)(cyclopropylmethylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 236h::US10633345, Compound 236h::US10689346, Compound 236h::US11203574, Compound 236h::US11230530, Compound 236h::US11685721, Compound 236h::US11708332, Compound 236h	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417003	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417003&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665908	433916915							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297915	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C30H25F4N7O/c31-23-6-4-20(27(38-16-17-1-2-17)19-7-10-36-11-8-19)13-24(23)39-29(42)25-15-26(30(32,33)34)40-41(25)21-5-3-18-9-12-37-28(35)22(18)14-21/h3-15,17,27,38H,1-2,16H2,(H2,35,37)(H,39,42)	UQWHIYYZYLIMKJ-UHFFFAOYSA-N	417004	(+-)-1-(1-aminoisoquinolin-7-yl)-N-(5-((cyclopropylmethylamino)(pyridin-4-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 265d::US10633345, Compound 264g::US10689346, Compound 264g::US11203574, Compound 264g::US11230530, Compound 264g::US11685721, Compound 264g::US11708332, Compound 264g	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417004	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417004&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355979	433916916							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297916	Nc1noc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H24F4N6O2/c30-21-10-8-18(26(35-15-16-6-7-16)17-4-2-1-3-5-17)12-22(21)36-28(40)23-14-25(29(31,32)33)37-39(23)19-9-11-24-20(13-19)27(34)38-41-24/h1-5,8-14,16,26,35H,6-7,15H2,(H2,34,38)(H,36,40)	QWKNFIFTTXOPHF-UHFFFAOYSA-N	417002	(+-)-1-(3-aminobenzo[d]isoxazol-5-yl)-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 222k::US10329260, Compound 223f::US10633345, Compound 223f::US10689346, Compound 223f::US11203574, Compound 223f::US11230530, Compound 223f::US11685721, Compound 223f::US11708332, Compound 223f	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417002	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417002&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123289526	433916914							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297917	NC(=N)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C31H27F4N7O/c32-24-10-9-22(30(39,12-11-18-7-8-18)21-5-1-3-19(13-21)17-36)15-25(24)40-29(43)26-16-27(31(33,34)35)41-42(26)23-6-2-4-20(14-23)28(37)38/h1-6,9-10,13-16,18H,7-8,11-12,39H2,(H3,37,38)(H,40,43)	BZRUVEYOOHPOOF-UHFFFAOYSA-N	417006	(+)-N-(5-(1-amino-1-(3-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-carbamimidoylphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 237a::US10633345, Compound 237a::US10689346, Compound 237a::US11192861, Compound 237a::US11230530, Compound 237a::US11685721, Compound 237a::US11708332, Compound 237a	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417006	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417006&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356202	433916917							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297918	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C33H27F4N7O/c34-26-9-7-23(32(40,12-10-19-4-5-19)22-3-1-2-20(14-22)18-38)15-27(26)42-31(45)28-17-29(33(35,36)37)43-44(28)24-8-6-21-11-13-41-30(39)25(21)16-24/h1-3,6-9,11,13-17,19H,4-5,10,12,40H2,(H2,39,41)(H,42,45)	MNAPHYKXZOGSTD-UHFFFAOYSA-N	417007	(+)-N-(5-(1-amino-1-(3-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(1-aminoisoquinolin-7-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 256a::US10633345, Compound 256a::US10689346, Compound 256a::US11203574, Compound 256a::US11230530, Compound 256a::US11685721, Compound 256a::US11708332, Compound 256a	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417007	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417007&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665459	433916918							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297919	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(n1)C#N)C(F)(F)F	InChI=1S/C30H27F4N7O/c31-23-10-9-20(29(37,12-11-18-7-8-18)26-6-2-4-21(17-36)38-26)14-24(23)39-28(42)25-15-27(30(32,33)34)40-41(25)22-5-1-3-19(13-22)16-35/h1-6,9-10,13-15,18H,7-8,11-12,16,35,37H2,(H,39,42)	UYAYDZPBNCJYMZ-UHFFFAOYSA-N	417008	(+)-N-(5-(1-amino-1-(6-cyanopyridin-2-yl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 220f::US10633345, Compound 220f::US10689346, Compound 220f::US11203574, Compound 220f::US11230530, Compound 220f::US11685721, Compound 220f::US11708332, Compound 220f	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417008	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417008&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355858	433916919							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297920	CC(C)(C)[S@@](=O)NC(CCC1CC1)(c1cccnc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(c2)C(N)=N)C(F)(F)F)c1	InChI=1S/C33H35F4N7O2S/c1-31(2,3)47(46)43-32(14-13-20-9-10-20,23-7-5-15-40-19-23)22-11-12-25(34)26(17-22)41-30(45)27-18-28(33(35,36)37)42-44(27)24-8-4-6-21(16-24)29(38)39/h4-8,11-12,15-20,43H,9-10,13-14H2,1-3H3,(H3,38,39)(H,41,45)/t32?,47-/m1/s1	ORCJXCNQCCWVHD-HKYIEPEJSA-N	417009	1-(3-carbamimidoylphenyl)-N-(5-((+-)-3-cyclopropyl-1-((R)-1,1-dimethylethylsulfinamido)-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 238c::US10633345, Compound 238c::US10689346, Compound 238c::US11203574, Compound 238c::US11230530, Compound 238c::US11685721, Compound 238c::US11708332, Compound 238c	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417009	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417009&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355741	433916920							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297921	Nc1nccc2ccc(cc12)-n1nc(cc1C(F)(F)F)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1	InChI=1S/C31H27F4N7O/c32-24-6-4-21(30(37,11-7-18-1-2-18)20-9-12-38-13-10-20)15-25(24)40-29(43)26-17-27(31(33,34)35)42(41-26)22-5-3-19-8-14-39-28(36)23(19)16-22/h3-6,8-10,12-18H,1-2,7,11,37H2,(H2,36,39)(H,40,43)	JTQCWLVRCRAKSI-UHFFFAOYSA-N	417010	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-4-yl)propyl)-2-fluorophenyl)-1-(1-aminoisoquinolin-7-yl)-5-(trifluoromethyl)-1H-pyrazole-3-carboxamide::US10329260, Compound 268g::US10633345, Compound 268g::US10689346, Compound 268g::US11203574, Compound 268g::US11230530, Compound 268g::US11685721, Compound 268g::US11708332, Compound 268g	Plasma kallikrein		>75.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417010	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417010&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356088	433916921							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297922	Nc1n[nH]c2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F			439594	US10633345, Compound 224b::US10689346, Compound 224b::US11203574, Compound 224b::US11230530, Compound 224b::US11708332, Compound 224b	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439594	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439594&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155295687	439661142							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297923	NC(=N)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C31H27F4N7O/c32-24-11-10-22(30(39,13-12-18-4-5-18)21-8-6-19(17-36)7-9-21)15-25(24)40-29(43)26-16-27(31(33,34)35)41-42(26)23-3-1-2-20(14-23)28(37)38/h1-3,6-11,14-16,18H,4-5,12-13,39H2,(H3,37,38)(H,40,43)	QLTPSVVBRYJDCX-UHFFFAOYSA-N	417012	(+)-N-(5-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-carbamimidoylphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 241a::US10633345, Compound 241a::US10689346, Compound 241a::US11192861, Compound 241a::US11230530, Compound 241a::US11685721, Compound 241a::US11708332, Compound 241a	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417012	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417012&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665936	433916923							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297924	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccccc1=O)C(F)(F)F	InChI=1S/C31H26F4N6O2/c32-23-10-8-20(25(11-6-18-4-5-18)40-14-2-1-3-28(40)42)15-24(23)38-30(43)26-17-27(31(33,34)35)39-41(26)21-9-7-19-12-13-37-29(36)22(19)16-21/h1-3,7-10,12-18,25H,4-6,11H2,(H2,36,37)(H,38,43)	GNDQLXKOPYFGBP-UHFFFAOYSA-N	417013	1-(1-aminoisoquinolin-7-yl)-N-(5-(3-cyclopropyl-1-(2-oxopyridin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 258g::US10633345, Compound 258g::US10689346, Compound 258g::US11203574, Compound 258g::US11230530, Compound 258g::US11685721, Compound 258g::US11708332, Compound 258g	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417013	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417013&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355895	433916924							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297925	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C(N)=O)C(F)(F)F	InChI=1S/C31H30F4N6O2/c32-24-10-9-22(30(38,12-11-18-7-8-18)21-5-2-4-20(14-21)28(37)42)15-25(24)39-29(43)26-16-27(31(33,34)35)40-41(26)23-6-1-3-19(13-23)17-36/h1-6,9-10,13-16,18H,7-8,11-12,17,36,38H2,(H2,37,42)(H,39,43)	DYGHBBDYRMOWAC-UHFFFAOYSA-N	417014	(+-)-N-(5-(1-amino-1-(3-carbamoylphenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 225a::US10633345, Compound 225a::US10689346, Compound 225a::US11203574, Compound 225a::US11230530, Compound 225a::US11685721, Compound 225a::US11708332, Compound 225a	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417014	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417014&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665606	433916925							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297926	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C31H28F4N6O/c32-25-10-9-23(30(38,12-11-19-7-8-19)22-5-1-3-20(13-22)17-36)15-26(25)39-29(42)27-16-28(31(33,34)35)40-41(27)24-6-2-4-21(14-24)18-37/h1-6,9-10,13-16,19H,7-8,11-12,18,37-38H2,(H,39,42)	ZBDDMFBNDOEVJT-UHFFFAOYSA-N	416996	(+)-N-(5-(1-amino-1-(3-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 214g::US10633345, Compound 215d::US10689346, Compound 215d::US11203574, Compound 215d::US11230530, Compound 215d::US11685721, Compound 215d::US11708332, Compound 215d	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416996	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416996&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665709	433916908							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297927	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccccc1=O)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-11-10-20(24(12-9-18-7-8-18)37-13-2-1-6-27(37)39)15-23(22)35-28(40)25-16-26(29(31,32)33)36-38(25)21-5-3-4-19(14-21)17-34/h1-6,10-11,13-16,18,24H,7-9,12,17,34H2,(H,35,40)	OFQQGSYWUFBMPP-UHFFFAOYSA-N	416939	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(2-oxopyridin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 248j::US10633345, Compound 248k::US10689346, Compound 248k::US11203574, Compound 248k::US11230530, Compound 248k::US11685721, Compound 248k::US11708332, Compound 248k	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416939	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416939&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355727	433916851							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297928	Nc1ncnc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H25F4N7O/c31-22-10-8-19(27(36-15-17-6-7-17)18-4-2-1-3-5-18)12-24(22)39-29(42)25-14-26(30(32,33)34)40-41(25)20-9-11-23-21(13-20)28(35)38-16-37-23/h1-5,8-14,16-17,27,36H,6-7,15H2,(H,39,42)(H2,35,37,38)	NOYPEPJWHRTGGG-UHFFFAOYSA-N	417011	1-(4-aminoquinazolin-6-yl)-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 224b::US10329260, Compound 226a::US10633345, Compound 226a::US10689346, Compound 226a::US11203574, Compound 226a::US11230530, Compound 226a::US11685721, Compound 226a::US11708332, Compound 226a	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417011	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417011&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665806	433916922							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297929	NC(=N)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H27F4N7O/c30-22-9-8-19(28(36,11-10-17-6-7-17)20-4-2-12-37-16-20)14-23(22)38-27(41)24-15-25(29(31,32)33)39-40(24)21-5-1-3-18(13-21)26(34)35/h1-5,8-9,12-17H,6-7,10-11,36H2,(H3,34,35)(H,38,41)	JBCZLPFSSAYNEJ-UHFFFAOYSA-N	417018	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-1-(3-carbamimidoylphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 238d::US10633345, Compound 238d::US10689346, Compound 238d::US11192861, Compound 238d::US11230530, Compound 238d::US11685721, Compound 238d::US11708332, Compound 238d	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417018	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417018&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355839	433916928							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297930	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccccc1=O)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-11-10-20(24(12-9-18-7-8-18)37-13-2-1-6-27(37)39)15-23(22)35-28(40)25-16-26(29(31,32)33)36-38(25)21-5-3-4-19(14-21)17-34/h1-6,10-11,13-16,18,24H,7-9,12,17,34H2,(H,35,40)	OFQQGSYWUFBMPP-UHFFFAOYSA-N	416939	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(2-oxopyridin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 248j::US10633345, Compound 248k::US10689346, Compound 248k::US11203574, Compound 248k::US11230530, Compound 248k::US11685721, Compound 248k::US11708332, Compound 248k	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416939	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416939&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355727	433916851							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297931	NC(=N)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N6O/c30-22-12-11-19(26(36-16-17-9-10-17)18-5-2-1-3-6-18)14-23(22)37-28(40)24-15-25(29(31,32)33)38-39(24)21-8-4-7-20(13-21)27(34)35/h1-8,11-15,17,26,36H,9-10,16H2,(H3,34,35)(H,37,40)	HUIANTFJQLRTEM-UHFFFAOYSA-N	439603	US10633345, Compound 227d::US10689346, Compound 227d::US11203574, Compound 227d::US11230530, Compound 227d::US11685721, Compound 227d::US11708332, Compound 227d	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439603	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439603&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356162	439661151							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297932	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(nc1)C(N)=O)C(F)(F)F	InChI=1S/C30H29F4N7O2/c31-22-8-6-19(29(37,11-10-17-4-5-17)20-7-9-23(27(36)42)38-16-20)13-24(22)39-28(43)25-14-26(30(32,33)34)40-41(25)21-3-1-2-18(12-21)15-35/h1-3,6-9,12-14,16-17H,4-5,10-11,15,35,37H2,(H2,36,42)(H,39,43)	IQWHGFSUUIEJQU-UHFFFAOYSA-N	417021	(+)-5-(1-amino-1-(3-(1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamido)-4-fluorophenyl)-3-cyclopropylpropyl)picolinamide::US10329260, Compound 221i::US10633345, Compound 221i::US10689346, Compound 221i::US11203574, Compound 221i::US11230530, Compound 221i::US11685721, Compound 221i::US11708332, Compound 221i	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417021	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417021&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665782	433916931							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297933	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C30H25F4N7O/c31-23-6-4-20(27(38-16-17-1-2-17)19-7-10-36-11-8-19)13-24(23)39-29(42)25-15-26(30(32,33)34)40-41(25)21-5-3-18-9-12-37-28(35)22(18)14-21/h3-15,17,27,38H,1-2,16H2,(H2,35,37)(H,39,42)	UQWHIYYZYLIMKJ-UHFFFAOYSA-N	417004	(+-)-1-(1-aminoisoquinolin-7-yl)-N-(5-((cyclopropylmethylamino)(pyridin-4-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 265d::US10633345, Compound 264g::US10689346, Compound 264g::US11203574, Compound 264g::US11230530, Compound 264g::US11685721, Compound 264g::US11708332, Compound 264g	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417004	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417004&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355979	433916916							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297934	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C(N)=O)C(F)(F)F	InChI=1S/C31H30F4N6O2/c32-24-11-10-22(30(38,13-12-18-4-5-18)21-8-6-20(7-9-21)28(37)42)15-25(24)39-29(43)26-16-27(31(33,34)35)40-41(26)23-3-1-2-19(14-23)17-36/h1-3,6-11,14-16,18H,4-5,12-13,17,36,38H2,(H2,37,42)(H,39,43)	HZQICPCUMLWHPZ-UHFFFAOYSA-N	417023	(+)-N-(5-(1-amino-1-(4-carbamoylphenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 228a::US10633345, Compound 228a::US10689346, Compound 228a::US11203574, Compound 228a::US11230530, Compound 228a::US11685721, Compound 228a::US11708332, Compound 228a	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417023	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417023&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665484	433916933							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297935	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-23-7-6-21(28(35,11-8-18-4-5-18)20-9-12-36-13-10-20)15-24(23)37-27(40)25-16-26(29(31,32)33)38-39(25)22-3-1-2-19(14-22)17-34/h1-3,6-7,9-10,12-16,18H,4-5,8,11,17,34-35H2,(H,37,40)	AGVFYPDLNPHKER-UHFFFAOYSA-N	417024	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-4-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 216d::US10633345, Compound 217d::US10689346, Compound 217d::US11192861, Compound 217d::US11230530, Compound 217d::US11685721, Compound 217d::US11708332, Compound 217d	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417024	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417024&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665723	433916934							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297936	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)N1CCCCC1=O)C(F)(F)F	InChI=1S/C29H31F4N5O2/c30-22-11-10-20(24(12-9-18-7-8-18)37-13-2-1-6-27(37)39)15-23(22)35-28(40)25-16-26(29(31,32)33)36-38(25)21-5-3-4-19(14-21)17-34/h3-5,10-11,14-16,18,24H,1-2,6-9,12-13,17,34H2,(H,35,40)	BPULHNPIKAHCAG-UHFFFAOYSA-N	417025	(+)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-(2-oxopiperidin-1-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 261k::US10633345, Compound 261k::US10689346, Compound 261k::US11203574, Compound 261k::US11230530, Compound 261k::US11685721, Compound 261k::US11708332, Compound 261k	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417025	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417025&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123312183	433916935							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297937	CN(C(c1ccccc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(N)=O)c1)C1CC1	InChI=1S/C29H29FN6O2/c1-35(21-11-12-21)27(19-7-3-2-4-8-19)20-10-13-23(30)24(15-20)33-29(38)26-16-25(28(32)37)34-36(26)22-9-5-6-18(14-22)17-31/h2-10,13-16,21,27H,11-12,17,31H2,1H3,(H2,32,37)(H,33,38)	IEIUPSKBNRXEAJ-UHFFFAOYSA-N	610099	(-)-1-(3-(aminomethyl)phenyl)-N5-(5-((cyclopropyl methylamino)-(phenyl)methyl)-2-fluorophenyl)-1H-pyrazole-3,5-dicarboxamide::US11708332, Compound 229i	Plasma kallikrein		 25.1								US Patent		10.7270/Q2XW4PXV			US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610099	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610099&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665746	483620266							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297938	CC(C)(C)[S@@](=O)NC(CCC1CC1)(c1cccnc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C33H36F4N6O2S/c1-31(2,3)46(45)42-32(14-13-21-9-10-21,24-7-5-15-39-20-24)23-11-12-26(34)27(17-23)40-30(44)28-18-29(33(35,36)37)41-43(28)25-8-4-6-22(16-25)19-38/h4-8,11-12,15-18,20-21,42H,9-10,13-14,19,38H2,1-3H3,(H,40,44)/t32?,46-/m1/s1	LAOWFCURFGDGCT-ODZHGNIVSA-N	417027	1-(3-(aminomethyl)phenyl)-N-(5-((+-)-3-cyclopropyl-1-((R)-1,1-dimethylethylsulfinamido)-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 243a::US10633345, Compound 243a::US10689346, Compound 243a::US11203574, Compound 243a::US11230530, Compound 243a::US11685721, Compound 243a::US11708332, Compound 243a	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417027	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417027&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665825	433916937							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297939	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccncc1=O)C(F)(F)F	InChI=1S/C30H25F4N7O2/c31-22-7-5-19(24(8-3-17-1-2-17)40-12-11-36-16-27(40)42)13-23(22)38-29(43)25-15-26(30(32,33)34)39-41(25)20-6-4-18-9-10-37-28(35)21(18)14-20/h4-7,9-17,24H,1-3,8H2,(H2,35,37)(H,38,43)	RGAKSJSQGQBUGG-UHFFFAOYSA-N	417028	1-(1-aminoisoquinolin-7-yl)-N-(5-(3-cyclopropyl-1-(2-oxopyrazin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 259d::US10633345, Compound 259d::US10689346, Compound 259d::US11203574, Compound 259d::US11230530, Compound 259d::US11685721, Compound 259d::US11708332, Compound 259d	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417028	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417028&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355792	433916938							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297940	NC(=O)c1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H25F4N5O2/c30-22-12-11-19(26(35-16-17-9-10-17)18-5-2-1-3-6-18)14-23(22)36-28(40)24-15-25(29(31,32)33)37-38(24)21-8-4-7-20(13-21)27(34)39/h1-8,11-15,17,26,35H,9-10,16H2,(H2,34,39)(H,36,40)	JMSFBJDWVQAENA-UHFFFAOYSA-N	417029	(+-)-1-(3-carbamoylphenyl)-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 230a::US10633345, Compound 230a::US10689346, Compound 230a::US11203574, Compound 230a::US11230530, Compound 230a::US11685721, Compound 230a::US11708332, Compound 230a	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417029	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417029&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665857	433916939							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297941	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-23-7-6-21(28(35,11-8-18-4-5-18)20-9-12-36-13-10-20)15-24(23)37-27(40)25-16-26(29(31,32)33)38-39(25)22-3-1-2-19(14-22)17-34/h1-3,6-7,9-10,12-16,18H,4-5,8,11,17,34-35H2,(H,37,40)	AGVFYPDLNPHKER-UHFFFAOYSA-N	417024	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-4-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 216d::US10633345, Compound 217d::US10689346, Compound 217d::US11192861, Compound 217d::US11230530, Compound 217d::US11685721, Compound 217d::US11708332, Compound 217d	Plasma kallikrein		>75.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417024	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417024&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665723	433916934							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297942	Cc1cc(ccn1)C(N)(CCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F4N6O/c1-18-13-22(10-12-37-18)29(36,11-9-19-5-6-19)21-7-8-24(31)25(15-21)38-28(41)26-16-27(30(32,33)34)39-40(26)23-4-2-3-20(14-23)17-35/h2-4,7-8,10,12-16,19H,5-6,9,11,17,35-36H2,1H3,(H,38,41)	PYONXWOUVYIBRU-UHFFFAOYSA-N	417031	(+)-N-(5-(1-amino-3-cyclopropyl-1-(2-methylpyridin-4-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 266j::US10633345, Compound 266j::US10689346, Compound 266j::US11203574, Compound 266j::US11230530, Compound 266j::US11685721, Compound 266j::US11708332, Compound 266j	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417031	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417031&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665585	433916941							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297943	Nc1nccc2ccc(cc12)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccc(=O)[nH]c1=O)C(F)(F)F			417032	1-(1-aminoisoquinolin-7-yl)-N-(5-(3-cyclopropyl-1-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 269b::US10633345, Compound 269b::US10689346, Compound 269b::US11203574, Compound 269b::US11230530, Compound 269b::US11685721, Compound 269b::US11708332, Compound 269b	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417032	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417032&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			154584237	433916942							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297944	CCNCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C31H31F4N5O/c1-2-36-18-21-7-6-10-24(15-21)40-27(17-28(39-40)31(33,34)35)30(41)38-26-16-23(13-14-25(26)32)29(37-19-20-11-12-20)22-8-4-3-5-9-22/h3-10,13-17,20,29,36-37H,2,11-12,18-19H2,1H3,(H,38,41)	RBEFOPDBDLERKF-UHFFFAOYSA-N	417033	(+-)-N-(5-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-1-(3-((ethylamino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 270a::US10633345, Compound 270a::US10689346, Compound 270a::US11203574, Compound 270a::US11230530, Compound 270a::US11685721, Compound 270a::US11708332, Compound 270a	Plasma kallikrein		>75.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417033	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417033&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665791	433916943							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317495	C[C@@H](c1ncc(N2C[C@H]3C[C@H]3C2=O)c(C)n1)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H24ClF3N8O2/c1-12-21(39-10-15-6-18(15)28(39)42)9-34-26(36-12)14(3)40-11-16(7-35-40)37-27(41)24-13(2)33-8-20(38-24)22-17(25(31)32)4-5-19(29)23(22)30/h4-5,7-9,11,14-15,18,25H,6,10H2,1-3H3,(H,37,41)/t14-,15+,18+/m0/s1	YZVPBYJTAFCQRA-HDMKZQKVSA-N	617789	US20230286958, Example 1	Plasma kallikrein			 0.900							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617789	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617789&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317497	C[C@H](c1ncc(N2C[C@H]3C[C@H]3C2=O)c(C)n1)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H24ClF3N8O2/c1-12-21(39-10-15-6-18(15)28(39)42)9-34-26(36-12)14(3)40-11-16(7-35-40)37-27(41)24-13(2)33-8-20(38-24)22-17(25(31)32)4-5-19(29)23(22)30/h4-5,7-9,11,14-15,18,25H,6,10H2,1-3H3,(H,37,41)/t14-,15-,18-/m1/s1	YZVPBYJTAFCQRA-IIDMSEBBSA-N	617790	US20230286958, Example 2	Plasma kallikrein			 11.9							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617790	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617790&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317499	CC(c1ncc(N2C[C@H]3C[C@H]3C2=O)c(C)n1)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C27H22ClF3N8O2/c1-12-21(38-10-14-5-17(14)27(38)41)9-33-25(35-12)13(2)39-11-15(6-34-39)36-26(40)20-8-32-7-19(37-20)22-16(24(30)31)3-4-18(28)23(22)29/h3-4,6-9,11,13-14,17,24H,5,10H2,1-2H3,(H,36,40)/t13?,14-,17-/m1/s1	FXCJWVTUNAZQDO-DTLKIFBZSA-N	617791	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N- (1 -((S or R)-1-(4-methyl-5-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-2-yl)ethyl)- 1H-pyrazol-4-::US20230286958, Example 3::US20230286958, Example 4	Plasma kallikrein			 1.000							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617791	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617791&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317501	CC(c1ncc(N2C[C@H]3C[C@H]3C2=O)c(C)n1)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C27H22ClF3N8O2/c1-12-21(38-10-14-5-17(14)27(38)41)9-33-25(35-12)13(2)39-11-15(6-34-39)36-26(40)20-8-32-7-19(37-20)22-16(24(30)31)3-4-18(28)23(22)29/h3-4,6-9,11,13-14,17,24H,5,10H2,1-2H3,(H,36,40)/t13?,14-,17-/m1/s1	FXCJWVTUNAZQDO-DTLKIFBZSA-N	617791	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N- (1 -((S or R)-1-(4-methyl-5-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-2-yl)ethyl)- 1H-pyrazol-4-::US20230286958, Example 3::US20230286958, Example 4	Plasma kallikrein			 16.8							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617791	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617791&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317503	CC(c1ncc(cn1)N1C[C@H]2C[C@H]2C1=O)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C26H20ClF3N8O2/c1-12(24-32-6-15(7-33-24)37-10-13-4-17(13)26(37)40)38-11-14(5-34-38)35-25(39)20-9-31-8-19(36-20)21-16(23(29)30)2-3-18(27)22(21)28/h2-3,5-9,11-13,17,23H,4,10H2,1H3,(H,35,39)/t12?,13-,17-/m1/s1	SCLLZMAGHZEJRQ-QQGYXAEISA-N	617793	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1 -((S or R)-1-(5-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-2-yl)ethyl)- 1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 5	Plasma kallikrein			 17.2							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617793	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617793&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317505	CC(c1ncc(cn1)N1C[C@H]2C[C@H]2C1=O)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C27H22ClF3N8O2/c1-12-23(37-20(9-32-12)21-17(24(30)31)3-4-19(28)22(21)29)26(40)36-15-6-35-39(11-15)13(2)25-33-7-16(8-34-25)38-10-14-5-18(14)27(38)41/h3-4,6-9,11,13-14,18,24H,5,10H2,1-2H3,(H,36,40)/t13?,14-,18-/m1/s1	AFWWEGFQILEDNB-JDPNFYKBSA-N	617794	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-methyl-N-(1-((R or S)-1-(5-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-2-yl)ethyl)- 1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 6	Plasma kallikrein			 0.900							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617794	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617794&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317507	Cc1ncc(nc1C(=O)Nc1cnn(Cc2cnc(N3C[C@H]4C[C@H]4C3=O)c(Cl)c2)c1)-c1c(F)c(Cl)ccc1C(F)F	InChI=1S/C27H20Cl2F3N7O2/c1-12-23(37-20(8-33-12)21-16(24(31)32)2-3-18(28)22(21)30)26(40)36-15-7-35-38(11-15)9-13-4-19(29)25(34-6-13)39-10-14-5-17(14)27(39)41/h2-4,6-8,11,14,17,24H,5,9-10H2,1H3,(H,36,40)/t14-,17-/m1/s1	KNJDMNATKQSVKK-RHSMWYFYSA-N	617795	N-(1-((5-Chloro-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)methyl)-1H-pyrazol-4-yl)-6-(3-chloro-6-(difluoromethyl)-2-fluorophenyl)-3-methylpyrazine-2-carboxamide::US20230286958, Example 7	Plasma kallikrein			 1.90							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617795	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617795&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317509	FC(F)c1ccc(Cl)c(F)c1-c1cncc(n1)C(=O)Nc1cnn(Cc2cnc(N3C[C@H]4C[C@H]4C3=O)c(Cl)c2)c1	InChI=1S/C26H18Cl2F3N7O2/c27-17-2-1-15(23(30)31)21(22(17)29)19-7-32-8-20(36-19)25(39)35-14-6-34-37(11-14)9-12-3-18(28)24(33-5-12)38-10-13-4-16(13)26(38)40/h1-3,5-8,11,13,16,23H,4,9-10H2,(H,35,39)/t13-,16-/m1/s1	FVUAZVCCRXWOIZ-CZUORRHYSA-N	617796	N-(1-((5-Chloro-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)methyl)-1H-pyrazol-4-yl)-6-(3-chloro-6-(difluoromethyl)-2-fluorophenyl)pyrazine-2-carboxamide::US20230286958, Example 8	Plasma kallikrein			 11.9							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617796	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617796&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317511	FC(F)c1ccc(Cl)c(F)c1-c1cncc(n1)C(=O)Nc1cnn(Cc2ccc(nc2)N2C[C@H]3C[C@H]3C2=O)c1	InChI=1S/C26H19ClF3N7O2/c27-18-3-2-16(24(29)30)22(23(18)28)19-8-31-9-20(35-19)25(38)34-15-7-33-36(12-15)10-13-1-4-21(32-6-13)37-11-14-5-17(14)26(37)39/h1-4,6-9,12,14,17,24H,5,10-11H2,(H,34,38)/t14-,17-/m1/s1	CGUAQMUKXSBBSE-RHSMWYFYSA-N	617797	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)methyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 9	Plasma kallikrein			 1.000							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617797	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617797&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317513	CC(c1ccc(nc1)N1CC2CC2C1=O)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C27H21ClF3N7O2/c1-13(14-2-5-22(33-7-14)37-11-15-6-18(15)27(37)40)38-12-16(8-34-38)35-26(39)21-10-32-9-20(36-21)23-17(25(30)31)3-4-19(28)24(23)29/h2-5,7-10,12-13,15,18,25H,6,11H2,1H3,(H,35,39)	QTJQDXXMHBABNT-UHFFFAOYSA-N	617798	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((S or R)-1-(6-((1R,5S or 1S,5R)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 10::US20230286958, Example 11	Plasma kallikrein			 16.8							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617798	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617798&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317515	CC(c1ccc(nc1)N1CC2CC2C1=O)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C27H21ClF3N7O2/c1-13(14-2-5-22(33-7-14)37-11-15-6-18(15)27(37)40)38-12-16(8-34-38)35-26(39)21-10-32-9-20(36-21)23-17(25(30)31)3-4-19(28)24(23)29/h2-5,7-10,12-13,15,18,25H,6,11H2,1H3,(H,35,39)	QTJQDXXMHBABNT-UHFFFAOYSA-N	617798	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((S or R)-1-(6-((1R,5S or 1S,5R)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 10::US20230286958, Example 11	Plasma kallikrein			 17.2							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617798	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617798&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317517	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(C)n1)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C27H22ClF3N8O2/c1-12-25(38-10-14-5-17(14)27(38)41)33-9-19(35-12)13(2)39-11-15(6-34-39)36-26(40)21-8-32-7-20(37-21)22-16(24(30)31)3-4-18(28)23(22)29/h3-4,6-9,11,13-14,17,24H,5,10H2,1-2H3,(H,36,40)/t13?,14-,17-/m1/s1	IXJAVQSZODNPSK-DTLKIFBZSA-N	617800	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N- (1 -((S or R)-1-(6-methyl-5-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrazin-2-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 12::US20230286958, Example 13	Plasma kallikrein			 1.90							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617800	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617800&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317519	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(C)n1)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C27H22ClF3N8O2/c1-12-25(38-10-14-5-17(14)27(38)41)33-9-19(35-12)13(2)39-11-15(6-34-39)36-26(40)21-8-32-7-20(37-21)22-16(24(30)31)3-4-18(28)23(22)29/h3-4,6-9,11,13-14,17,24H,5,10H2,1-2H3,(H,36,40)/t13?,14-,17-/m1/s1	IXJAVQSZODNPSK-DTLKIFBZSA-N	617800	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N- (1 -((S or R)-1-(6-methyl-5-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrazin-2-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 12::US20230286958, Example 13	Plasma kallikrein			 0.500							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617800	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617800&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317521	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(C)n1)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H24ClF3N8O2/c1-12-24(38-21(9-33-12)22-17(25(31)32)4-5-19(29)23(22)30)27(41)37-16-7-35-40(11-16)14(3)20-8-34-26(13(2)36-20)39-10-15-6-18(15)28(39)42/h4-5,7-9,11,14-15,18,25H,6,10H2,1-3H3,(H,37,41)/t14?,15-,18-/m1/s1	UCJSXODQQLYFFF-QTLYGJNZSA-N	617802	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-methyl-N-(1-((S or R)-1-(6-methyl-5-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrazin-2-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 14::US20230286958, Example 15	Plasma kallikrein			 0.800							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617802	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617802&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317523	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(C)n1)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H24ClF3N8O2/c1-12-24(38-21(9-33-12)22-17(25(31)32)4-5-19(29)23(22)30)27(41)37-16-7-35-40(11-16)14(3)20-8-34-26(13(2)36-20)39-10-15-6-18(15)28(39)42/h4-5,7-9,11,14-15,18,25H,6,10H2,1-3H3,(H,37,41)/t14?,15-,18-/m1/s1	UCJSXODQQLYFFF-QTLYGJNZSA-N	617802	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-methyl-N-(1-((S or R)-1-(6-methyl-5-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrazin-2-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 14::US20230286958, Example 15	Plasma kallikrein			 0.400							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617802	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617802&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317525	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(C)n1)n1cc(NC(=O)c2cncc(n2)-c2c(OC(F)F)ccc(Cl)c2F)cn1	InChI=1S/C27H22ClF3N8O3/c1-12-24(38-10-14-5-16(14)26(38)41)33-9-18(35-12)13(2)39-11-15(6-34-39)36-25(40)20-8-32-7-19(37-20)22-21(42-27(30)31)4-3-17(28)23(22)29/h3-4,6-9,11,13-14,16,27H,5,10H2,1-2H3,(H,36,40)/t13?,14-,16-/m1/s1	GIVXPUNNLANRCG-IGLHTZBQSA-N	617804	6-(3-Chloro-6-(difluoromethoxy)-2-fluorophenyl)-N-(1 -((S or R)-1-(6-methyl-5-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrazin-2-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 16::US20230286958, Example 17	Plasma kallikrein			 1.90							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617804	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617804&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317527	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(C)n1)n1cc(NC(=O)c2cncc(n2)-c2c(OC(F)F)ccc(Cl)c2F)cn1	InChI=1S/C27H22ClF3N8O3/c1-12-24(38-10-14-5-16(14)26(38)41)33-9-18(35-12)13(2)39-11-15(6-34-39)36-25(40)20-8-32-7-19(37-20)22-21(42-27(30)31)4-3-17(28)23(22)29/h3-4,6-9,11,13-14,16,27H,5,10H2,1-2H3,(H,36,40)/t13?,14-,16-/m1/s1	GIVXPUNNLANRCG-IGLHTZBQSA-N	617804	6-(3-Chloro-6-(difluoromethoxy)-2-fluorophenyl)-N-(1 -((S or R)-1-(6-methyl-5-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrazin-2-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 16::US20230286958, Example 17	Plasma kallikrein			 0.700							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617804	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617804&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317529	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(C)n1)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)(F)F)cn1	InChI=1S/C27H21ClF4N8O2/c1-12-24(39-10-14-5-16(14)26(39)42)34-9-19(36-12)13(2)40-11-15(6-35-40)37-25(41)21-8-33-7-20(38-21)22-17(27(30,31)32)3-4-18(28)23(22)29/h3-4,6-9,11,13-14,16H,5,10H2,1-2H3,(H,37,41)/t13?,14-,16-/m1/s1	CXRVSXAPUVPLPK-IGLHTZBQSA-N	617806	6-(3-Chloro-2-fluoro-6-(trifluoromethyl)phenyl)-N-(1-((S orR)-1-(6-methyl-5-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrazin-2-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 18::US20230286958, Example 19	Plasma kallikrein			 19.5							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617806	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617806&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317531	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(C)n1)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)(F)F)cn1	InChI=1S/C27H21ClF4N8O2/c1-12-24(39-10-14-5-16(14)26(39)42)34-9-19(36-12)13(2)40-11-15(6-35-40)37-25(41)21-8-33-7-20(38-21)22-17(27(30,31)32)3-4-18(28)23(22)29/h3-4,6-9,11,13-14,16H,5,10H2,1-2H3,(H,37,41)/t13?,14-,16-/m1/s1	CXRVSXAPUVPLPK-IGLHTZBQSA-N	617806	6-(3-Chloro-2-fluoro-6-(trifluoromethyl)phenyl)-N-(1-((S orR)-1-(6-methyl-5-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrazin-2-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 18::US20230286958, Example 19	Plasma kallikrein			 3.70							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617806	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617806&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317533	CC(c1cnc(cn1)N1C[C@H]2C[C@H]2C1=O)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C26H20ClF3N8O2/c1-12(18-8-33-21(9-32-18)37-10-13-4-16(13)26(37)40)38-11-14(5-34-38)35-25(39)20-7-31-6-19(36-20)22-15(24(29)30)2-3-17(27)23(22)28/h2-3,5-9,11-13,16,24H,4,10H2,1H3,(H,35,39)/t12?,13-,16-/m1/s1	RPHUHNOOZAVMHZ-LLQOJDTPSA-N	617808	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1 -((S or R)-1-(5-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrazin-2-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 20	Plasma kallikrein			 28.5							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617808	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617808&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317535	Cc1ncc(nc1C(=O)Nc1cnn(Cc2ccc(nn2)N2C[C@H]3C[C@H]3C2=O)c1)-c1c(F)c(Cl)ccc1C(F)F	InChI=1S/C26H20ClF3N8O2/c1-12-23(34-19(8-31-12)21-16(24(29)30)3-4-18(27)22(21)28)25(39)33-15-7-32-37(11-15)10-14-2-5-20(36-35-14)38-9-13-6-17(13)26(38)40/h2-5,7-8,11,13,17,24H,6,9-10H2,1H3,(H,33,39)/t13-,17-/m1/s1	CEEUVBZNHKBRMS-CXAGYDPISA-N	617809	US20230286958, Example 21	Plasma kallikrein			 38.0							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617809	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617809&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317537	C[C@@H](c1cnc(nc1C)N1C[C@H]2C[C@H]2C1=O)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C27H22ClF3N8O2/c1-12-18(7-33-27(35-12)38-10-14-5-17(14)26(38)41)13(2)39-11-15(6-34-39)36-25(40)21-9-32-8-20(37-21)22-16(24(30)31)3-4-19(28)23(22)29/h3-4,6-9,11,13-14,17,24H,5,10H2,1-2H3,(H,36,40)/t13-,14+,17+/m0/s1	WRBJFPQPLWLXFG-JJRVBVJISA-N	617810	US20230286958, Example 22	Plasma kallikrein			 1.80							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617810	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617810&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317539	C[C@H](c1cnc(nc1C)N1C[C@H]2C[C@H]2C1=O)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C27H22ClF3N8O2/c1-12-18(7-33-27(35-12)38-10-14-5-17(14)26(38)41)13(2)39-11-15(6-34-39)36-25(40)21-9-32-8-20(37-21)22-16(24(30)31)3-4-19(28)23(22)29/h3-4,6-9,11,13-14,17,24H,5,10H2,1-2H3,(H,36,40)/t13-,14-,17-/m1/s1	WRBJFPQPLWLXFG-CKEIUWERSA-N	617811	US20230286958, Example 23	Plasma kallikrein			 48.7							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617811	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617811&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317541	Cc1nc(ncc1Cn1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1)N1C[C@H]2C[C@H]2C1=O	InChI=1S/C26H20ClF3N8O2/c1-12-14(5-32-26(34-12)38-10-13-4-17(13)25(38)40)9-37-11-15(6-33-37)35-24(39)20-8-31-7-19(36-20)21-16(23(29)30)2-3-18(27)22(21)28/h2-3,5-8,11,13,17,23H,4,9-10H2,1H3,(H,35,39)/t13-,17-/m1/s1	VEZXJDJIQVJJEE-CXAGYDPISA-N	617812	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((4-methyl-2-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-5-yl)methyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 24	Plasma kallikrein			 10.5							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617812	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617812&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317543	FC(F)c1ccc(Cl)c(F)c1-c1cncc(n1)C(=O)Nc1cnn(Cc2cnc(nc2)N2C[C@H]3C[C@H]3C2=O)c1	InChI=1S/C25H18ClF3N8O2/c26-17-2-1-15(22(28)29)20(21(17)27)18-7-30-8-19(35-18)23(38)34-14-6-33-36(11-14)9-12-4-31-25(32-5-12)37-10-13-3-16(13)24(37)39/h1-2,4-8,11,13,16,22H,3,9-10H2,(H,34,38)/t13-,16-/m1/s1	DDRZBVJEBLWNAN-CZUORRHYSA-N	617813	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((2-((1R,5S)-2-oxo-3-azabicyclo-[3.1.0]hexan-3-yl)pyrimidin-5-yl)methyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 25	Plasma kallikrein			 27.7							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617813	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617813&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317545	CC(c1cnc(nc1)N1Cc2cccnc2C1=O)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H19ClF3N9O2/c1-14(16-7-35-28(36-8-16)40-12-15-3-2-6-34-24(15)27(40)43)41-13-17(9-37-41)38-26(42)21-11-33-10-20(39-21)22-18(25(31)32)4-5-19(29)23(22)30/h2-11,13-14,25H,12H2,1H3,(H,38,42)	TUMZXCAUICYEPY-UHFFFAOYSA-N	617814	(S and R)-6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-(1-(2-(7-oxo-5,7-dihydro-6H-pyrrolo[3,4-b]pyridin-6-::US20230286958, Example 26	Plasma kallikrein			 6.20							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617814	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617814&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317547	CC(c1cnc(nc1)N1Cc2ncccc2C1=O)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H19ClF3N9O2/c1-14(15-7-35-28(36-8-15)40-13-22-17(27(40)43)3-2-6-34-22)41-12-16(9-37-41)38-26(42)21-11-33-10-20(39-21)23-18(25(31)32)4-5-19(29)24(23)30/h2-12,14,25H,13H2,1H3,(H,38,42)	NJURILLREWSMRS-UHFFFAOYSA-N	617815	(S and R)-6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N(1-(1-(2-(5-oxo-5,7-dihydro-6H-pyrrolo[3,4-b]pyridin-6-yl)pyrimidin-5-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 27	Plasma kallikrein			 14.8							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617815	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617815&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317549	CC(c1cnc(nc1)N1CCN(C)C1=O)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C25H21ClF3N9O2/c1-13(14-7-31-24(32-8-14)37-6-5-36(2)25(37)40)38-12-15(9-33-38)34-23(39)19-11-30-10-18(35-19)20-16(22(28)29)3-4-17(26)21(20)27/h3-4,7-13,22H,5-6H2,1-2H3,(H,34,39)	XQJAKETWRZIPRV-UHFFFAOYSA-N	617816	(S and R)-6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-(1-(2-(3-methyl-2-oxoimidazolidin-1-yl)pyrimidin-5-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 28	Plasma kallikrein			 47.4							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617816	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617816&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317551	CC(c1cnc(nc1)N1C[C@H]2C[C@H]2C1=O)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C27H22ClF3N8O2/c1-12-23(37-20(9-32-12)21-17(24(30)31)3-4-19(28)22(21)29)25(40)36-16-8-35-39(11-16)13(2)15-6-33-27(34-7-15)38-10-14-5-18(14)26(38)41/h3-4,6-9,11,13-14,18,24H,5,10H2,1-2H3,(H,36,40)/t13?,14-,18-/m1/s1	QGHPJDKUDSLENJ-JDPNFYKBSA-N	617817	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-methyl-N-(1-((S or R)-1-(2-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-::US20230286958, Example 29::US20230286958, Example 30	Plasma kallikrein			 9.60							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617817	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617817&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317553	CC(c1cnc(nc1)N1C[C@H]2C[C@H]2C1=O)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C27H22ClF3N8O2/c1-12-23(37-20(9-32-12)21-17(24(30)31)3-4-19(28)22(21)29)25(40)36-16-8-35-39(11-16)13(2)15-6-33-27(34-7-15)38-10-14-5-18(14)26(38)41/h3-4,6-9,11,13-14,18,24H,5,10H2,1-2H3,(H,36,40)/t13?,14-,18-/m1/s1	QGHPJDKUDSLENJ-JDPNFYKBSA-N	617817	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-methyl-N-(1-((S or R)-1-(2-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-::US20230286958, Example 29::US20230286958, Example 30	Plasma kallikrein			 1.80							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617817	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617817&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317555	CC(c1cnc(nc1)N1C[C@H]2C[C@H]2C1=S)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C26H20ClF3N8OS/c1-12(14-5-32-26(33-6-14)37-10-13-4-17(13)25(37)40)38-11-15(7-34-38)35-24(39)20-9-31-8-19(36-20)21-16(23(29)30)2-3-18(27)22(21)28/h2-3,5-9,11-13,17,23H,4,10H2,1H3,(H,35,39)/t12?,13-,17-/m1/s1	NHMXBEXVXYTZFN-QQGYXAEISA-N	617819	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((S or R)-1-(2-((1R,5S)-2-thioxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-5-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 31::US20230286958, Example 32	Plasma kallikrein			 6.30							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617819	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617819&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317557	CC(c1cnc(nc1)N1C[C@H]2C[C@H]2C1=S)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C26H20ClF3N8OS/c1-12(14-5-32-26(33-6-14)37-10-13-4-17(13)25(37)40)38-11-15(7-34-38)35-24(39)20-9-31-8-19(36-20)21-16(23(29)30)2-3-18(27)22(21)28/h2-3,5-9,11-13,17,23H,4,10H2,1H3,(H,35,39)/t12?,13-,17-/m1/s1	NHMXBEXVXYTZFN-QQGYXAEISA-N	617819	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((S or R)-1-(2-((1R,5S)-2-thioxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-5-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 31::US20230286958, Example 32	Plasma kallikrein			 16.4							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617819	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617819&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317559	Cc1nc(ncc1Cn1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C(F)F)cn1)N1C[C@H]2C[C@H]2C1=O	InChI=1S/C27H22ClF3N8O2/c1-12-15(6-33-27(35-12)39-10-14-5-18(14)26(39)41)9-38-11-16(7-34-38)36-25(40)23-13(2)32-8-20(37-23)21-17(24(30)31)3-4-19(28)22(21)29/h3-4,6-8,11,14,18,24H,5,9-10H2,1-2H3,(H,36,40)/t14-,18-/m1/s1	ARIOOOOXKGGXCY-RDTXWAMCSA-N	617821	US20230286958, Example 33	Plasma kallikrein			 2.50							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617821	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617821&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317561	Cc1nc(ncc1Cn1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C(F)F)cn1)N1C[C@@H]2C[C@@H]2C1=O	InChI=1S/C27H22ClF3N8O2/c1-12-15(6-33-27(35-12)39-10-14-5-18(14)26(39)41)9-38-11-16(7-34-38)36-25(40)23-13(2)32-8-20(37-23)21-17(24(30)31)3-4-19(28)22(21)29/h3-4,6-8,11,14,18,24H,5,9-10H2,1-2H3,(H,36,40)/t14-,18-/m0/s1	ARIOOOOXKGGXCY-KSSFIOAISA-N	617822	US20230286958, Example 34	Plasma kallikrein			 19.3							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617822	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617822&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317563	Cc1nc(ncc1Cn1cc(NC(=O)c2nc(cnc2C=C)-c2c(F)c(Cl)ccc2C(F)F)cn1)N1C[C@H]2C[C@H]2C1=O	InChI=1S/C28H22ClF3N8O2/c1-3-20-24(38-21(9-33-20)22-17(25(31)32)4-5-19(29)23(22)30)26(41)37-16-8-35-39(12-16)10-15-7-34-28(36-13(15)2)40-11-14-6-18(14)27(40)42/h3-5,7-9,12,14,18,25H,1,6,10-11H2,2H3,(H,37,41)/t14-,18-/m1/s1	FGZWGHNUJSAWCC-RDTXWAMCSA-N	617823	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((4-methyl-2-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-5-yl)methyl)-1H-pyrazol-4-yl)-3-vinylpyrazine-2-carboxamide::US20230286958, Example 35	Plasma kallikrein			 6.80							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617823	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617823&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317565	Cc1nc(ncc1Cn1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2OC(F)F)cn1)N1C[C@H]2C[C@H]2C1=O	InChI=1S/C27H22ClF3N8O3/c1-12-15(6-33-27(35-12)39-10-14-5-17(14)25(39)41)9-38-11-16(7-34-38)36-24(40)23-13(2)32-8-19(37-23)21-20(42-26(30)31)4-3-18(28)22(21)29/h3-4,6-8,11,14,17,26H,5,9-10H2,1-2H3,(H,36,40)/t14-,17-/m1/s1	QKUJFWQNWXUDGB-RHSMWYFYSA-N	617824	6-(3-Chloro-6-(difluoromethoxy)-2-fluorophenyl)-3-methyl-N-(1-((4-methyl-2-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-5-yl)methyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 36	Plasma kallikrein			 3.00							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617824	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617824&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317567	C[C@H](c1cc(C)c(nn1)N1C[C@H]2C[C@H]2C1=O)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C27H22ClF3N8O2/c1-12-5-19(36-37-25(12)38-10-14-6-17(14)27(38)41)13(2)39-11-15(7-33-39)34-26(40)21-9-32-8-20(35-21)22-16(24(30)31)3-4-18(28)23(22)29/h3-5,7-9,11,13-14,17,24H,6,10H2,1-2H3,(H,34,40)/t13-,14-,17-/m1/s1	NHTJCIPCROASOS-CKEIUWERSA-N	617825	US20230286958, Example 37	Plasma kallikrein			 1.20							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617825	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617825&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317569	C[C@@H](c1cc(C)c(nn1)N1C[C@H]2C[C@H]2C1=O)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C27H22ClF3N8O2/c1-12-5-19(36-37-25(12)38-10-14-6-17(14)27(38)41)13(2)39-11-15(7-33-39)34-26(40)21-9-32-8-20(35-21)22-16(24(30)31)3-4-18(28)23(22)29/h3-5,7-9,11,13-14,17,24H,6,10H2,1-2H3,(H,34,40)/t13-,14+,17+/m0/s1	NHTJCIPCROASOS-JJRVBVJISA-N	617826	US20230286958, Example 38	Plasma kallikrein			 6.20							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617826	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617826&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317571	C[C@H](c1cc(C)c(nn1)N1C[C@H]2C[C@H]2C1=O)n1cc(NC(=O)c2nc(cnc2C)-c2c(OC(F)F)ccc(Cl)c2F)cn1	InChI=1S/C28H24ClF3N8O3/c1-12-6-19(37-38-25(12)39-10-15-7-17(15)27(39)42)14(3)40-11-16(8-34-40)35-26(41)24-13(2)33-9-20(36-24)22-21(43-28(31)32)5-4-18(29)23(22)30/h4-6,8-9,11,14-15,17,28H,7,10H2,1-3H3,(H,35,41)/t14-,15-,17-/m1/s1	ZOIAMJPHWFPPNK-BFYDXBDKSA-N	617827	US20230286958, Example 39	Plasma kallikrein			 0.400							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617827	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617827&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317573	C[C@@H](c1cc(C)c(nn1)N1C[C@H]2C[C@H]2C1=O)n1cc(NC(=O)c2nc(cnc2C)-c2c(OC(F)F)ccc(Cl)c2F)cn1	InChI=1S/C28H24ClF3N8O3/c1-12-6-19(37-38-25(12)39-10-15-7-17(15)27(39)42)14(3)40-11-16(8-34-40)35-26(41)24-13(2)33-9-20(36-24)22-21(43-28(31)32)5-4-18(29)23(22)30/h4-6,8-9,11,14-15,17,28H,7,10H2,1-3H3,(H,35,41)/t14-,15+,17+/m0/s1	ZOIAMJPHWFPPNK-ZMSDIMECSA-N	617828	US20230286958, Example 40	Plasma kallikrein			 1.80							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617828	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617828&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317575	Cc1cc(Cn2cc(NC(=O)c3nc(cnc3C)-c3c(F)c(Cl)ccc3C(F)F)cn2)cnc1N1C[C@H]2C[C@H]2C1=O	InChI=1S/C28H23ClF3N7O2/c1-13-5-15(7-34-26(13)39-11-16-6-19(16)28(39)41)10-38-12-17(8-35-38)36-27(40)24-14(2)33-9-21(37-24)22-18(25(31)32)3-4-20(29)23(22)30/h3-5,7-9,12,16,19,25H,6,10-11H2,1-2H3,(H,36,40)/t16-,19-/m1/s1	LQUYFWRKFWJAJB-VQIMIIECSA-N	50582287	CHEMBL5079850::US20230286958, Example 41	Plasma kallikrein			 0.200							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50582287	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50582287&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162520090	476027292							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317577	C[C@H](c1cnc(nc1C)N1C[C@H]2C[C@H]2C1=O)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H24ClF3N8O2/c1-12-19(8-34-28(36-12)39-10-15-6-18(15)27(39)42)14(3)40-11-16(7-35-40)37-26(41)24-13(2)33-9-21(38-24)22-17(25(31)32)4-5-20(29)23(22)30/h4-5,7-9,11,14-15,18,25H,6,10H2,1-3H3,(H,37,41)/t14-,15-,18-/m1/s1	XEGXBZUWPPGCRR-IIDMSEBBSA-N	617830	US20230286958, Example 42	Plasma kallikrein			 0.700							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617830	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617830&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317579	C[C@@H](c1cnc(nc1C)N1C[C@H]2C[C@H]2C1=O)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H24ClF3N8O2/c1-12-19(8-34-28(36-12)39-10-15-6-18(15)27(39)42)14(3)40-11-16(7-35-40)37-26(41)24-13(2)33-9-21(38-24)22-17(25(31)32)4-5-20(29)23(22)30/h4-5,7-9,11,14-15,18,25H,6,10H2,1-3H3,(H,37,41)/t14-,15+,18+/m0/s1	XEGXBZUWPPGCRR-HDMKZQKVSA-N	617831	US20230286958, Example 43	Plasma kallikrein			 73.4							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617831	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617831&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317581	C[C@H](c1cnc(N2C[C@H]3C[C@H]3C2=O)c(F)c1C)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H22ClF4N7O2/c1-12-18(7-35-26(23(12)30)39-10-14-5-17(14)28(39)42)13(2)40-11-15(6-36-40)37-27(41)21-9-34-8-20(38-21)22-16(25(32)33)3-4-19(29)24(22)31/h3-4,6-9,11,13-14,17,25H,5,10H2,1-2H3,(H,37,41)/t13-,14-,17-/m1/s1	CVLQFTRLIWTTNO-CKEIUWERSA-N	617832	US20230286958, Example 44	Plasma kallikrein			 0.300							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617832	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617832&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317583	C[C@@H](c1cnc(N2C[C@H]3C[C@H]3C2=O)c(F)c1C)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H22ClF4N7O2/c1-12-18(7-35-26(23(12)30)39-10-14-5-17(14)28(39)42)13(2)40-11-15(6-36-40)37-27(41)21-9-34-8-20(38-21)22-16(25(32)33)3-4-19(29)24(22)31/h3-4,6-9,11,13-14,17,25H,5,10H2,1-2H3,(H,37,41)/t13-,14+,17+/m0/s1	CVLQFTRLIWTTNO-JJRVBVJISA-N	50582286	CHEMBL5079924::US20230286958, Example 45	Plasma kallikrein			 6.10							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50582286	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50582286&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162520248	476027291							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317585	Cc1nc(Cn2cc(NC(=O)c3nc(cnc3C)-c3c(F)c(Cl)ccc3C(F)F)cn2)cnc1N1C[C@H]2C[C@H]2C1=O	InChI=1S/C27H22ClF3N8O2/c1-12-23(37-20(8-32-12)21-17(24(30)31)3-4-19(28)22(21)29)26(40)36-16-7-34-38(11-16)10-15-6-33-25(13(2)35-15)39-9-14-5-18(14)27(39)41/h3-4,6-8,11,14,18,24H,5,9-10H2,1-2H3,(H,36,40)/t14-,18-/m1/s1	BAVINDCBMIUDHY-RDTXWAMCSA-N	617834	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-methyl-N-(1-((6-methyl-5-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrazin-2-yl)methyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 46	Plasma kallikrein			 0.900							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617834	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617834&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317587	Cc1nc(Cn2cc(NC(=O)c3cncc(n3)-c3c(F)c(Cl)ccc3C(F)F)cn2)cnc1N1C[C@H]2C[C@H]2C1=O	InChI=1S/C26H20ClF3N8O2/c1-12-24(38-9-13-4-17(13)26(38)40)32-5-14(34-12)10-37-11-15(6-33-37)35-25(39)20-8-31-7-19(36-20)21-16(23(29)30)2-3-18(27)22(21)28/h2-3,5-8,11,13,17,23H,4,9-10H2,1H3,(H,35,39)/t13-,17-/m1/s1	IATPFTWVWXELQH-CXAGYDPISA-N	617835	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1 -((6-methyl-5-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrazin-2-yl)methyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 47	Plasma kallikrein			 2.50							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617835	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617835&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317589	Cc1c(Cn2cc(NC(=O)c3cncc(n3)-c3c(F)c(Cl)ccc3C(F)F)cn2)ccc(N2C[C@H]3C[C@H]3C2=O)c1C	InChI=1S/C29H24ClF3N6O2/c1-14-15(2)24(39-12-17-7-20(17)29(39)41)6-3-16(14)11-38-13-18(8-35-38)36-28(40)23-10-34-9-22(37-23)25-19(27(32)33)4-5-21(30)26(25)31/h3-6,8-10,13,17,20,27H,7,11-12H2,1-2H3,(H,36,40)/t17-,20-/m1/s1	CIEATFLQWXVGIZ-YLJYHZDGSA-N	617836	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-((1-(2,3-dimethyl-4-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)benzyl)-1H-pyrazol-::US20230286958, Example 48	Plasma kallikrein			 0.600							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617836	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617836&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317591	COc1cc(Cn2cc(NC(=O)c3cncc(n3)-c3c(F)c(Cl)ccc3C(F)F)cn2)cnc1N1C[C@H]2C[C@H]2C1=O	InChI=1S/C27H21ClF3N7O3/c1-41-21-4-13(6-33-25(21)38-11-14-5-17(14)27(38)40)10-37-12-15(7-34-37)35-26(39)20-9-32-8-19(36-20)22-16(24(30)31)2-3-18(28)23(22)29/h2-4,6-9,12,14,17,24H,5,10-11H2,1H3,(H,35,39)/t14-,17-/m1/s1	VGEIARNAACQQRK-RHSMWYFYSA-N	617837	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((5-methoxy-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)methyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 49	Plasma kallikrein			 3.50							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617837	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617837&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317593	FC(F)c1ccc(Cl)c(F)c1-c1cncc(n1)C(=O)Nc1cnn(Cc2cnc(N3C[C@H]4C[C@H]4C3=O)c(F)c2)c1	InChI=1S/C26H18ClF4N7O2/c27-17-2-1-15(23(30)31)21(22(17)29)19-7-32-8-20(36-19)25(39)35-14-6-34-37(11-14)9-12-3-18(28)24(33-5-12)38-10-13-4-16(13)26(38)40/h1-3,5-8,11,13,16,23H,4,9-10H2,(H,35,39)/t13-,16-/m1/s1	NGDKHQPXAJSRNF-CZUORRHYSA-N	617838	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((5-fluoro-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)methyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 50	Plasma kallikrein			 5.50							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617838	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617838&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317595	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(F)c1)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H22ClF4N7O2/c1-12-24(38-21(9-34-12)22-17(25(32)33)3-4-19(29)23(22)31)27(41)37-16-8-36-40(11-16)13(2)14-6-20(30)26(35-7-14)39-10-15-5-18(15)28(39)42/h3-4,6-9,11,13,15,18,25H,5,10H2,1-2H3,(H,37,41)/t13?,15-,18-/m1/s1	XUNBGTDHZSGPJF-HQKHBYFDSA-N	617839	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((S or R)-1-(5-fluoro-6-((1R,SS)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)ethyl)-1H-pyrazol-4-yl)-3-methylpyrazine-2-carboxamide::US20230286958, Example 51::US20230286958, Example 52	Plasma kallikrein			 2.40							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617839	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617839&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317597	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(F)c1)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H22ClF4N7O2/c1-12-24(38-21(9-34-12)22-17(25(32)33)3-4-19(29)23(22)31)27(41)37-16-8-36-40(11-16)13(2)14-6-20(30)26(35-7-14)39-10-15-5-18(15)28(39)42/h3-4,6-9,11,13,15,18,25H,5,10H2,1-2H3,(H,37,41)/t13?,15-,18-/m1/s1	XUNBGTDHZSGPJF-HQKHBYFDSA-N	617839	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((S or R)-1-(5-fluoro-6-((1R,SS)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)ethyl)-1H-pyrazol-4-yl)-3-methylpyrazine-2-carboxamide::US20230286958, Example 51::US20230286958, Example 52	Plasma kallikrein			 1.10							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617839	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617839&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317599	CC(c1ncc(nc1C)N1C[C@H]2C[C@H]2C1=O)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C27H22ClF3N8O2/c1-12-24(33-9-21(35-12)38-10-14-5-17(14)27(38)41)13(2)39-11-15(6-34-39)36-26(40)20-8-32-7-19(37-20)22-16(25(30)31)3-4-18(28)23(22)29/h3-4,6-9,11,13-14,17,25H,5,10H2,1-2H3,(H,36,40)/t13?,14-,17-/m1/s1	AZMNGIJIXWKDIM-DTLKIFBZSA-N	617841	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((S or R)-1-(3-methyl-5-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrazin-2-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 53	Plasma kallikrein			 38.3							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617841	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617841&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317601	Cc1ncc(nc1C(=O)Nc1cnn(c1)C1(CC1)c1cnc(nc1C)N1C[C@H]2C[C@H]2C1=O)-c1c(F)c(Cl)ccc1C(F)F	InChI=1S/C29H24ClF3N8O2/c1-13-19(9-35-28(37-13)40-11-15-7-18(15)27(40)43)29(5-6-29)41-12-16(8-36-41)38-26(42)24-14(2)34-10-21(39-24)22-17(25(32)33)3-4-20(30)23(22)31/h3-4,8-10,12,15,18,25H,5-7,11H2,1-2H3,(H,38,42)/t15-,18-/m1/s1	UMSVPQYDVTWAQU-CRAIPNDOSA-N	617842	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-methyl-N(1-(1-(4-methyl-2-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-5-yl)cyclopropyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 54	Plasma kallikrein			 2.40							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617842	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617842&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317603	CCc1nc(cnc1N1C[C@H]2C[C@H]2C1=O)C(C)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H24ClF3N8O2/c1-3-19-26(39-11-14-6-17(14)28(39)42)34-10-20(37-19)13(2)40-12-15(7-35-40)36-27(41)22-9-33-8-21(38-22)23-16(25(31)32)4-5-18(29)24(23)30/h4-5,7-10,12-14,17,25H,3,6,11H2,1-2H3,(H,36,41)/t13?,14-,17-/m1/s1	HPSNSYZUFKVTAX-DTLKIFBZSA-N	617843	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((S or R)-1-(6-ethyl-5-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrazin-2-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 55::US20230286958, Example 56	Plasma kallikrein			 5.80							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617843	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617843&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317605	CCc1nc(cnc1N1C[C@H]2C[C@H]2C1=O)C(C)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H24ClF3N8O2/c1-3-19-26(39-11-14-6-17(14)28(39)42)34-10-20(37-19)13(2)40-12-15(7-35-40)36-27(41)22-9-33-8-21(38-22)23-16(25(31)32)4-5-18(29)24(23)30/h4-5,7-10,12-14,17,25H,3,6,11H2,1-2H3,(H,36,41)/t13?,14-,17-/m1/s1	HPSNSYZUFKVTAX-DTLKIFBZSA-N	617843	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((S or R)-1-(6-ethyl-5-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrazin-2-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 55::US20230286958, Example 56	Plasma kallikrein			 1.50							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617843	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617843&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317607	Cc1cc(ncc1Cn1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1)N1C[C@H]2C[C@H]2C1=O	InChI=1S/C27H21ClF3N7O2/c1-13-4-22(38-11-14-5-18(14)27(38)40)33-6-15(13)10-37-12-16(7-34-37)35-26(39)21-9-32-8-20(36-21)23-17(25(30)31)2-3-19(28)24(23)29/h2-4,6-9,12,14,18,25H,5,10-11H2,1H3,(H,35,39)/t14-,18-/m1/s1	FSPZVNMJUSROKS-RDTXWAMCSA-N	617845	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((4-methyl-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)methyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 57	Plasma kallikrein			 4.90							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617845	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617845&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317609	CC(c1ccc(N2C[C@H]3C[C@H]3C2=O)c(C)n1)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C29H25ClF3N7O2/c1-13-23(39-11-16-8-19(16)29(39)42)7-6-21(36-13)15(3)40-12-17(9-35-40)37-28(41)26-14(2)34-10-22(38-26)24-18(27(32)33)4-5-20(30)25(24)31/h4-7,9-10,12,15-16,19,27H,8,11H2,1-3H3,(H,37,41)/t15?,16-,19-/m1/s1	VPGRJDRJCGQFDU-HFLHWUEFSA-N	617846	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-methyl-N-(1-((S or R)-1-(6-methyl-5-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-2-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 58::US20230286958, Example 59	Plasma kallikrein			 0.600							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617846	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617846&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317611	CC(c1ccc(N2C[C@H]3C[C@H]3C2=O)c(C)n1)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C29H25ClF3N7O2/c1-13-23(39-11-16-8-19(16)29(39)42)7-6-21(36-13)15(3)40-12-17(9-35-40)37-28(41)26-14(2)34-10-22(38-26)24-18(27(32)33)4-5-20(30)25(24)31/h4-7,9-10,12,15-16,19,27H,8,11H2,1-3H3,(H,37,41)/t15?,16-,19-/m1/s1	VPGRJDRJCGQFDU-HFLHWUEFSA-N	617846	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-methyl-N-(1-((S or R)-1-(6-methyl-5-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-2-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 58::US20230286958, Example 59	Plasma kallikrein			 3.20							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617846	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617846&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317613	CC(c1ccc(N2C[C@H]3C[C@H]3C2=O)c(C)n1)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H23ClF3N7O2/c1-13-23(38-11-15-7-18(15)28(38)41)6-5-20(35-13)14(2)39-12-16(8-34-39)36-27(40)22-10-33-9-21(37-22)24-17(26(31)32)3-4-19(29)25(24)30/h3-6,8-10,12,14-15,18,26H,7,11H2,1-2H3,(H,36,40)/t14?,15-,18-/m1/s1	OJNZQLHZGHVQEV-QTLYGJNZSA-N	617848	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((S or R)-1-(6-methyl-5-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-2-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 60::US20230286958, Example 61	Plasma kallikrein			 5.50							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617848	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617848&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317615	CC(c1ccc(N2C[C@H]3C[C@H]3C2=O)c(C)n1)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H23ClF3N7O2/c1-13-23(38-11-15-7-18(15)28(38)41)6-5-20(35-13)14(2)39-12-16(8-34-39)36-27(40)22-10-33-9-21(37-22)24-17(26(31)32)3-4-19(29)25(24)30/h3-6,8-10,12,14-15,18,26H,7,11H2,1-2H3,(H,36,40)/t14?,15-,18-/m1/s1	OJNZQLHZGHVQEV-QTLYGJNZSA-N	617848	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((S or R)-1-(6-methyl-5-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-2-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 60::US20230286958, Example 61	Plasma kallikrein			 0.700							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617848	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617848&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317617	CC(c1ncc(cc1C)N1C[C@H]2C[C@H]2C1=O)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H23ClF3N7O2/c1-13-5-17(38-11-15-6-19(15)28(38)41)8-34-25(13)14(2)39-12-16(7-35-39)36-27(40)22-10-33-9-21(37-22)23-18(26(31)32)3-4-20(29)24(23)30/h3-5,7-10,12,14-15,19,26H,6,11H2,1-2H3,(H,36,40)/t14?,15-,19-/m1/s1	JOVIKWTVBKVERL-PQYJZYHDSA-N	617850	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((S or R)-1-(3-methyl-5-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-2-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 62	Plasma kallikrein			 4.20							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617850	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617850&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317619	Cc1nc(Cn2cc(NC(=O)c3nc(cnc3C)-c3c(F)c(Cl)ccc3C(F)F)cn2)ccc1N1C[C@H]2C[C@H]2C1=O	InChI=1S/C28H23ClF3N7O2/c1-13-22(39-10-15-7-19(15)28(39)41)6-3-16(35-13)11-38-12-17(8-34-38)36-27(40)25-14(2)33-9-21(37-25)23-18(26(31)32)4-5-20(29)24(23)30/h3-6,8-9,12,15,19,26H,7,10-11H2,1-2H3,(H,36,40)/t15-,19-/m1/s1	KWYOOXBLQQDWHF-DNVCBOLYSA-N	617851	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-methyl-N-(1-((6-methyl-5-((1R,SS)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-2-yl)methyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 63	Plasma kallikrein			 1.70							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617851	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617851&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317621	Cc1nc(Cn2cc(NC(=O)c3cncc(n3)-c3c(F)c(Cl)ccc3C(F)F)cn2)ccc1N1C[C@H]2C[C@H]2C1=O	InChI=1S/C27H21ClF3N7O2/c1-13-22(38-10-14-6-18(14)27(38)40)5-2-15(34-13)11-37-12-16(7-33-37)35-26(39)21-9-32-8-20(36-21)23-17(25(30)31)3-4-19(28)24(23)29/h2-5,7-9,12,14,18,25H,6,10-11H2,1H3,(H,35,39)/t14-,18-/m1/s1	KABGNNIWGQDLTH-RDTXWAMCSA-N	617852	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((6-methyl-5-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-2-yl)methyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 64	Plasma kallikrein			 3.40							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617852	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617852&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317623	Cc1cc(Cn2cc(NC(=O)c3cncc(n3)-c3c(F)c(Cl)ccc3C(F)F)cn2)ncc1N1C[C@H]2C[C@H]2C1=O	InChI=1S/C27H21ClF3N7O2/c1-13-4-15(33-9-22(13)38-10-14-5-18(14)27(38)40)11-37-12-16(6-34-37)35-26(39)21-8-32-7-20(36-21)23-17(25(30)31)2-3-19(28)24(23)29/h2-4,6-9,12,14,18,25H,5,10-11H2,1H3,(H,35,39)/t14-,18-/m1/s1	RCWMZMJCTNMAPR-RDTXWAMCSA-N	617853	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((4-methyl-5-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-2-yl)methyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 65	Plasma kallikrein			 35.7							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617853	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617853&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317625	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(C)c1)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H23ClF3N7O2/c1-13-5-15(7-34-26(13)38-11-16-6-19(16)28(38)41)14(2)39-12-17(8-35-39)36-27(40)22-10-33-9-21(37-22)23-18(25(31)32)3-4-20(29)24(23)30/h3-5,7-10,12,14,16,19,25H,6,11H2,1-2H3,(H,36,40)/t14?,16-,19-/m1/s1	QZLHOCXIFYJRGS-JDQGPONISA-N	617854	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((S or R)-1-(5-methyl-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 66::US20230286958, Example 67	Plasma kallikrein			 0.600							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617854	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617854&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317627	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(C)c1)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H23ClF3N7O2/c1-13-5-15(7-34-26(13)38-11-16-6-19(16)28(38)41)14(2)39-12-17(8-35-39)36-27(40)22-10-33-9-21(37-22)23-18(25(31)32)3-4-20(29)24(23)30/h3-5,7-10,12,14,16,19,25H,6,11H2,1-2H3,(H,36,40)/t14?,16-,19-/m1/s1	QZLHOCXIFYJRGS-JDQGPONISA-N	617854	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((S or R)-1-(5-methyl-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 66::US20230286958, Example 67	Plasma kallikrein			 2.10							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617854	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617854&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317629	CC(c1cnc(cc1C)N1C[C@H]2C[C@H]2C1=O)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H23ClF3N7O2/c1-13-5-23(38-11-15-6-18(15)28(38)41)34-8-19(13)14(2)39-12-16(7-35-39)36-27(40)22-10-33-9-21(37-22)24-17(26(31)32)3-4-20(29)25(24)30/h3-5,7-10,12,14-15,18,26H,6,11H2,1-2H3,(H,36,40)/t14?,15-,18-/m1/s1	NAMMUUPCVJUBBI-QTLYGJNZSA-N	617856	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((S or R)-1-(4-methyl-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 68	Plasma kallikrein			 1.10							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617856	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617856&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317631	CC(c1ccc(cc1)N1C[C@H]2C[C@H]2C1=O)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H22ClF3N6O2/c1-14(15-2-4-18(5-3-15)37-12-16-8-20(16)28(37)40)38-13-17(9-34-38)35-27(39)23-11-33-10-22(36-23)24-19(26(31)32)6-7-21(29)25(24)30/h2-7,9-11,13-14,16,20,26H,8,12H2,1H3,(H,35,39)/t14?,16-,20-/m1/s1	LJEVLPBHWUFJDP-ANGYQSCVSA-N	617857	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((S and R)-1-(4-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)phenyl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 69	Plasma kallikrein			 10.00							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617857	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617857&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317633	CC(c1cnc(nc1)N1CC2CC2C1=O)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)(F)F)cn1	InChI=1S/C26H19ClF4N8O2/c1-12(14-5-33-25(34-6-14)38-10-13-4-16(13)24(38)41)39-11-15(7-35-39)36-23(40)20-9-32-8-19(37-20)21-17(26(29,30)31)2-3-18(27)22(21)28/h2-3,5-9,11-13,16H,4,10H2,1H3,(H,36,40)	OMULQEBDLOHVOZ-UHFFFAOYSA-N	617858	6-(3-Chloro-2-fluoro-6-(trifluoromethyl)phenyl)-N-(1-((S orR)-1-(2-((1R,5S or 1S,5R)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-5-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 70	Plasma kallikrein			 18.6							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617858	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617858&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317635	CC(c1cnc(nc1)N1CC2CC2C1=O)n1cc(NC(=O)c2cncc(n2)-c2c(OC(F)F)ccc(Cl)c2F)cn1	InChI=1S/C26H20ClF3N8O3/c1-12(14-5-32-26(33-6-14)37-10-13-4-16(13)24(37)40)38-11-15(7-34-38)35-23(39)19-9-31-8-18(36-19)21-20(41-25(29)30)3-2-17(27)22(21)28/h2-3,5-9,11-13,16,25H,4,10H2,1H3,(H,35,39)	UWJMUOBDAVWPPK-UHFFFAOYSA-N	617859	6-(3-Chloro-6-(difluoromethoxy)-2-fluorophenyl)-N-(1-((S or R)-1-(2-((1R,5S or 1S,5R)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-5-yl)ethyl)- 1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 71::US20230286958, Example 72::US20230286958, Example 73	Plasma kallikrein			 39.0							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617859	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617859&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317637	CC(c1cnc(nc1)N1CC2CC2C1=O)n1cc(NC(=O)c2cncc(n2)-c2c(OC(F)F)ccc(Cl)c2F)cn1	InChI=1S/C26H20ClF3N8O3/c1-12(14-5-32-26(33-6-14)37-10-13-4-16(13)24(37)40)38-11-15(7-34-38)35-23(39)19-9-31-8-18(36-19)21-20(41-25(29)30)3-2-17(27)22(21)28/h2-3,5-9,11-13,16,25H,4,10H2,1H3,(H,35,39)	UWJMUOBDAVWPPK-UHFFFAOYSA-N	617859	6-(3-Chloro-6-(difluoromethoxy)-2-fluorophenyl)-N-(1-((S or R)-1-(2-((1R,5S or 1S,5R)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-5-yl)ethyl)- 1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 71::US20230286958, Example 72::US20230286958, Example 73	Plasma kallikrein			 3.70							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617859	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617859&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317639	CC(c1cnc(nc1)N1CC2CC2C1=O)n1cc(NC(=O)c2cncc(n2)-c2c(OC(F)F)ccc(Cl)c2F)cn1	InChI=1S/C26H20ClF3N8O3/c1-12(14-5-32-26(33-6-14)37-10-13-4-16(13)24(37)40)38-11-15(7-34-38)35-23(39)19-9-31-8-18(36-19)21-20(41-25(29)30)3-2-17(27)22(21)28/h2-3,5-9,11-13,16,25H,4,10H2,1H3,(H,35,39)	UWJMUOBDAVWPPK-UHFFFAOYSA-N	617859	6-(3-Chloro-6-(difluoromethoxy)-2-fluorophenyl)-N-(1-((S or R)-1-(2-((1R,5S or 1S,5R)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-5-yl)ethyl)- 1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 71::US20230286958, Example 72::US20230286958, Example 73	Plasma kallikrein			 23.1							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617859	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617859&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317641	CC(c1ccc(nc1)N1CC2CC2C1=O)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H23ClF3N7O2/c1-13-25(37-21(10-33-13)23-18(26(31)32)4-5-20(29)24(23)30)27(40)36-17-9-35-39(12-17)14(2)15-3-6-22(34-8-15)38-11-16-7-19(16)28(38)41/h3-6,8-10,12,14,16,19,26H,7,11H2,1-2H3,(H,36,40)	OPBYEEGIANEDSH-UHFFFAOYSA-N	617862	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-methyl-N-(1-((S or R)-1-(6-((1R,5S or 1S,5R)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 74::US20230286958, Example 75::US20230286958, Example 76	Plasma kallikrein			 14.6							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617862	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617862&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317643	CC(c1ccc(nc1)N1CC2CC2C1=O)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H23ClF3N7O2/c1-13-25(37-21(10-33-13)23-18(26(31)32)4-5-20(29)24(23)30)27(40)36-17-9-35-39(12-17)14(2)15-3-6-22(34-8-15)38-11-16-7-19(16)28(38)41/h3-6,8-10,12,14,16,19,26H,7,11H2,1-2H3,(H,36,40)	OPBYEEGIANEDSH-UHFFFAOYSA-N	617862	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-methyl-N-(1-((S or R)-1-(6-((1R,5S or 1S,5R)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 74::US20230286958, Example 75::US20230286958, Example 76	Plasma kallikrein			 4.80							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617862	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617862&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317645	CC(c1ccc(nc1)N1CC2CC2C1=O)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H23ClF3N7O2/c1-13-25(37-21(10-33-13)23-18(26(31)32)4-5-20(29)24(23)30)27(40)36-17-9-35-39(12-17)14(2)15-3-6-22(34-8-15)38-11-16-7-19(16)28(38)41/h3-6,8-10,12,14,16,19,26H,7,11H2,1-2H3,(H,36,40)	OPBYEEGIANEDSH-UHFFFAOYSA-N	617862	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-methyl-N-(1-((S or R)-1-(6-((1R,5S or 1S,5R)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 74::US20230286958, Example 75::US20230286958, Example 76	Plasma kallikrein			 43.0							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617862	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617862&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317647	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(c1)C(F)F)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H21ClF5N7O2/c1-12(13-4-18(25(33)34)26(36-6-13)40-10-14-5-17(14)28(40)43)41-11-15(7-37-41)38-27(42)21-9-35-8-20(39-21)22-16(24(31)32)2-3-19(29)23(22)30/h2-4,6-9,11-12,14,17,24-25H,5,10H2,1H3,(H,38,42)/t12?,14-,17-/m1/s1	TWZIJJJQEYQQQX-MRXJRLSOSA-N	617865	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((S or R)-1-(5-(difluoromethyl)-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 77::US20230286958, Example 78	Plasma kallikrein			 12.6							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617865	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617865&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317649	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(c1)C(F)F)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H21ClF5N7O2/c1-12(13-4-18(25(33)34)26(36-6-13)40-10-14-5-17(14)28(40)43)41-11-15(7-37-41)38-27(42)21-9-35-8-20(39-21)22-16(24(31)32)2-3-19(29)23(22)30/h2-4,6-9,11-12,14,17,24-25H,5,10H2,1H3,(H,38,42)/t12?,14-,17-/m1/s1	TWZIJJJQEYQQQX-MRXJRLSOSA-N	617865	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((S or R)-1-(5-(difluoromethyl)-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 77::US20230286958, Example 78	Plasma kallikrein			 2.70							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617865	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617865&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317651	CC(c1cnc(nc1C)N1C[C@H]2C[C@H]2C1=O)n1cc(NC(=O)c2nc(cc(=O)n2C)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H24ClF3N8O3/c1-12-18(9-33-28(35-12)39-10-14-6-17(14)27(39)43)13(2)40-11-15(8-34-40)36-26(42)25-37-20(7-21(41)38(25)3)22-16(24(31)32)4-5-19(29)23(22)30/h4-5,7-9,11,13-14,17,24H,6,10H2,1-3H3,(H,36,42)/t13?,14-,17-/m1/s1	ZYCBZVOBLYDGQZ-DTLKIFBZSA-N	617867	4-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-1-methyl-N-(1-((S or R)-1-(4-methyl-2-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-5-yl)ethyl)- 1H-pyrazol-4-yl)-6-oxo-1,6-dihydropyrimidine-2-carboxamide::US20230286958, Example 79::US20230286958, Example 80	Plasma kallikrein			 0.500							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617867	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617867&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317653	CC(c1cnc(nc1C)N1C[C@H]2C[C@H]2C1=O)n1cc(NC(=O)c2nc(cc(=O)n2C)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H24ClF3N8O3/c1-12-18(9-33-28(35-12)39-10-14-6-17(14)27(39)43)13(2)40-11-15(8-34-40)36-26(42)25-37-20(7-21(41)38(25)3)22-16(24(31)32)4-5-19(29)23(22)30/h4-5,7-9,11,13-14,17,24H,6,10H2,1-3H3,(H,36,42)/t13?,14-,17-/m1/s1	ZYCBZVOBLYDGQZ-DTLKIFBZSA-N	617867	4-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-1-methyl-N-(1-((S or R)-1-(4-methyl-2-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-5-yl)ethyl)- 1H-pyrazol-4-yl)-6-oxo-1,6-dihydropyrimidine-2-carboxamide::US20230286958, Example 79::US20230286958, Example 80	Plasma kallikrein			 25.3							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617867	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617867&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317655	Cc1nc(ncc1Cn1cc(NC(=O)c2nc(cc(=O)n2C)-c2c(F)c(Cl)ccc2C(F)F)cn1)N1C[C@H]2C[C@H]2C1=O	InChI=1S/C27H22ClF3N8O3/c1-12-14(7-32-27(34-12)39-10-13-5-17(13)26(39)42)9-38-11-15(8-33-38)35-25(41)24-36-19(6-20(40)37(24)2)21-16(23(30)31)3-4-18(28)22(21)29/h3-4,6-8,11,13,17,23H,5,9-10H2,1-2H3,(H,35,41)/t13-,17-/m1/s1	WSCJCNZPEVIQIK-CXAGYDPISA-N	617869	4-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-1-methyl-N-(1-((4-methyl-2-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-5-yl)methyl)-1H-pyrazol-4-yl)-6-oxo-1,6-dihydropyrimidine-2-carboxamide::US20230286958, Example 81	Plasma kallikrein			 1.80							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617869	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617869&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317657	Cc1ncc(nc1C(=O)Nc1cnn(Cc2cnc(N3C[C@H]4C[C@H]4C3=O)c(F)c2)c1)-c1c(F)c(Cl)ccc1C(F)F	InChI=1S/C27H20ClF4N7O2/c1-12-23(37-20(8-33-12)21-16(24(31)32)2-3-18(28)22(21)30)26(40)36-15-7-35-38(11-15)9-13-4-19(29)25(34-6-13)39-10-14-5-17(14)27(39)41/h2-4,6-8,11,14,17,24H,5,9-10H2,1H3,(H,36,40)/t14-,17-/m1/s1	QEBKYPAJRRRDKH-RHSMWYFYSA-N	617870	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((5-fluoro-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)methyl)-1H-pyrazol-4-yl)-3-methylpyrazine-2-carboxamide::US20230286958, Example 82	Plasma kallikrein			 1.80							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617870	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617870&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317659	Cc1cc(Cn2cc(NC(=O)c3nc(cnc3C)-c3c(F)c(Cl)ccc3C(F)F)cn2)nnc1N1C[C@H]2C[C@H]2C1=O	InChI=1S/C27H22ClF3N8O2/c1-12-5-15(36-37-25(12)39-9-14-6-18(14)27(39)41)10-38-11-16(7-33-38)34-26(40)23-13(2)32-8-20(35-23)21-17(24(30)31)3-4-19(28)22(21)29/h3-5,7-8,11,14,18,24H,6,9-10H2,1-2H3,(H,34,40)/t14-,18-/m1/s1	AZBFGOGAJPTZRR-RDTXWAMCSA-N	617871	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-methyl-N-(1-((5-methyl-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridazin-3-yl)methyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 83	Plasma kallikrein			 3.40							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617871	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617871&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317661	Cc1cc(nnc1Cn1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C(F)F)cn1)N1C[C@H]2C[C@H]2C1=O	InChI=1S/C27H22ClF3N8O2/c1-12-5-21(39-9-14-6-17(14)27(39)41)37-36-20(12)11-38-10-15(7-33-38)34-26(40)24-13(2)32-8-19(35-24)22-16(25(30)31)3-4-18(28)23(22)29/h3-5,7-8,10,14,17,25H,6,9,11H2,1-2H3,(H,34,40)/t14-,17-/m1/s1	CDKGUOCXERCGHP-RHSMWYFYSA-N	617872	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-methyl-N-(1-((4-methyl-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridazin-3-yl)methyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 84	Plasma kallikrein			 20.7							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617872	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617872&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317663	Cc1nc(ncc1Cn1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2S(C)(=O)=O)cn1)N1C[C@H]2C[C@H]2C1=O	InChI=1S/C27H24ClFN8O4S/c1-13-16(7-31-27(33-13)37-11-15-6-18(15)26(37)39)10-36-12-17(8-32-36)34-25(38)24-14(2)30-9-20(35-24)22-21(42(3,40)41)5-4-19(28)23(22)29/h4-5,7-9,12,15,18H,6,10-11H2,1-3H3,(H,34,38)/t15-,18-/m1/s1	ZZUPLANWKURMNL-CRAIPNDOSA-N	617873	6-(3 -Chloro-2-fluoro-6-(methylsulfonyl)phenyl)-3-methyl-N-(1-((4-methyl-2-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-5-yl)methyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 85	Plasma kallikrein			 10.1							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617873	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617873&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317665	CC(c1cnc(nc1C)N1C[C@H]2C[C@H]2C1=O)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2S(C)(=O)=O)cn1	InChI=1S/C28H26ClFN8O4S/c1-13-19(9-32-28(34-13)37-11-16-7-18(16)27(37)40)15(3)38-12-17(8-33-38)35-26(39)25-14(2)31-10-21(36-25)23-22(43(4,41)42)6-5-20(29)24(23)30/h5-6,8-10,12,15-16,18H,7,11H2,1-4H3,(H,35,39)/t15?,16-,18-/m1/s1	FPPNGJAUDBKMNN-WOEZKJSCSA-N	617874	6-(3-Chloro-2-fluoro-6-(methylsulfonyl)phenyl)-N-(1-((S or R)-1-(4-methyl-2-((1R,SS)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-5-yl)ethyl)- 1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 86	Plasma kallikrein			 36.0							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617874	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617874&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317667	CC(c1cnc(nc1)N1CCC(O)C1=O)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C26H22ClF3N8O3/c1-12-22(36-18(10-31-12)20-16(23(29)30)3-4-17(27)21(20)28)24(40)35-15-9-34-38(11-15)13(2)14-7-32-26(33-8-14)37-6-5-19(39)25(37)41/h3-4,7-11,13,19,23,39H,5-6H2,1-2H3,(H,35,40)	MWUFVUJVOMTIPE-UHFFFAOYSA-N	617875	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((S or R)-1-(2-((R or S)-3-hydroxy-2-oxopyrrolidin-1-yl)pyrimidin-5-yl)ethyl)-1H-pyrazol-4-yl)-3-methylpyrazine-2-carboxamide::US20230286958, Example 87	Plasma kallikrein			 26.2							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617875	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617875&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317669	Cc1ncc(nc1C(=O)Nc1cnn(Cc2nnc(N3C[C@H]4C[C@H]4C3=O)c(C)c2C)c1)-c1c(F)c(Cl)ccc1C(F)F	InChI=1S/C28H24ClF3N8O2/c1-12-13(2)26(40-9-15-6-18(15)28(40)42)38-37-21(12)11-39-10-16(7-34-39)35-27(41)24-14(3)33-8-20(36-24)22-17(25(31)32)4-5-19(29)23(22)30/h4-5,7-8,10,15,18,25H,6,9,11H2,1-3H3,(H,35,41)/t15-,18-/m1/s1	NHHYXMBQJKVFNB-CRAIPNDOSA-N	617876	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((4,5-dimethyl-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridazin-3-yl)methyl)-1H-pyrazol-4-yl)-3-methylpyrazine-2-carboxamide::US20230286958, Example 88	Plasma kallikrein			 0.700							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617876	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617876&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317671	CC(c1ccc(nc1)N1C[C@H]2C[C@H]2C1=O)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C#N)cn1	InChI=1S/C27H20ClFN8O2/c1-14(16-3-5-23(32-8-16)36-12-17-6-19(17)27(36)39)37-13-18(9-33-37)34-26(38)22-11-31-10-21(35-22)24-15(7-30)2-4-20(28)25(24)29/h2-5,8-11,13-14,17,19H,6,12H2,1H3,(H,34,38)/t14?,17-,19-/m1/s1	UUQVMRNMJNFHLD-POWSATBFSA-N	617877	6-(3-Chloro-6-cyano-2-fluorophenyl)-N-(1-((S or R)-1-(6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 89::US20230286958, Example 90	Plasma kallikrein			 31.3							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617877	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617877&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317673	CC(c1ccc(nc1)N1C[C@H]2C[C@H]2C1=O)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C#N)cn1	InChI=1S/C27H20ClFN8O2/c1-14(16-3-5-23(32-8-16)36-12-17-6-19(17)27(36)39)37-13-18(9-33-37)34-26(38)22-11-31-10-21(35-22)24-15(7-30)2-4-20(28)25(24)29/h2-5,8-11,13-14,17,19H,6,12H2,1H3,(H,34,38)/t14?,17-,19-/m1/s1	UUQVMRNMJNFHLD-POWSATBFSA-N	617877	6-(3-Chloro-6-cyano-2-fluorophenyl)-N-(1-((S or R)-1-(6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 89::US20230286958, Example 90	Plasma kallikrein			 13.7							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617877	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617877&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317675	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(Cl)c1)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H22Cl2F3N7O2/c1-12-24(38-21(9-34-12)22-17(25(32)33)3-4-19(29)23(22)31)27(41)37-16-8-36-40(11-16)13(2)14-6-20(30)26(35-7-14)39-10-15-5-18(15)28(39)42/h3-4,6-9,11,13,15,18,25H,5,10H2,1-2H3,(H,37,41)/t13?,15-,18-/m1/s1	CYUSFSQPVJASKS-HQKHBYFDSA-N	617879	N-(1-((S)-1-(5-chloro-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)ethyl)-1H-pyrazol-4-yl)-6-(3-chloro-6-(difluoromethyl)-2-fluorophenyl)-3-methylpyrazine-2-carboxamide::US20230286958, Example 91::US20230286958, Example 92	Plasma kallikrein			 1.30							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617879	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617879&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317677	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(Cl)c1)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H22Cl2F3N7O2/c1-12-24(38-21(9-34-12)22-17(25(32)33)3-4-19(29)23(22)31)27(41)37-16-8-36-40(11-16)13(2)14-6-20(30)26(35-7-14)39-10-15-5-18(15)28(39)42/h3-4,6-9,11,13,15,18,25H,5,10H2,1-2H3,(H,37,41)/t13?,15-,18-/m1/s1	CYUSFSQPVJASKS-HQKHBYFDSA-N	617879	N-(1-((S)-1-(5-chloro-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)ethyl)-1H-pyrazol-4-yl)-6-(3-chloro-6-(difluoromethyl)-2-fluorophenyl)-3-methylpyrazine-2-carboxamide::US20230286958, Example 91::US20230286958, Example 92	Plasma kallikrein			 1.30							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617879	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617879&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317679	Cc1nc(Cn2cc(NC(=O)c3nc(cnc3C)-c3c(F)c(Cl)ccc3C(F)F)cn2)ncc1N1C[C@H]2C[C@H]2C1=O	InChI=1S/C27H22ClF3N8O2/c1-12-20(39-9-14-5-17(14)27(39)41)8-33-21(35-12)11-38-10-15(6-34-38)36-26(40)24-13(2)32-7-19(37-24)22-16(25(30)31)3-4-18(28)23(22)29/h3-4,6-8,10,14,17,25H,5,9,11H2,1-2H3,(H,36,40)/t14-,17-/m1/s1	YBOZCMSASAFOHB-RHSMWYFYSA-N	617881	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-methyl-N-(1-((4-methyl-5-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-2-yl)methyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 93	Plasma kallikrein			 19.9							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617881	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617881&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317681	Cc1nc(Cn2cc(NC(=O)c3nc(cnc3C(F)F)-c3c(F)c(Cl)ccc3C(F)F)cn2)cnc1N1C[C@H]2C[C@H]2C1=O	InChI=1S/C27H20ClF5N8O2/c1-11-25(41-8-12-4-16(12)27(41)43)35-5-13(37-11)9-40-10-14(6-36-40)38-26(42)22-21(24(32)33)34-7-18(39-22)19-15(23(30)31)2-3-17(28)20(19)29/h2-3,5-7,10,12,16,23-24H,4,8-9H2,1H3,(H,38,42)/t12-,16-/m1/s1	BOPXHUXXWQZSPR-MLGOLLRUSA-N	617882	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-(difluoromethyl)-N-(1 -((6-methyl-5-(( 1R, 5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrazin-2-yl)methyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 94	Plasma kallikrein			 1.60							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617882	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617882&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317683	COc1nc(ncc1Cn1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C(F)F)cn1)N1C[C@H]2C[C@H]2C1=O	InChI=1S/C27H22ClF3N8O3/c1-12-22(36-19(8-32-12)20-16(23(30)31)3-4-18(28)21(20)29)24(40)35-15-7-34-38(11-15)9-14-6-33-27(37-25(14)42-2)39-10-13-5-17(13)26(39)41/h3-4,6-8,11,13,17,23H,5,9-10H2,1-2H3,(H,35,40)/t13-,17-/m1/s1	JIVWYFYAGNIGTG-CXAGYDPISA-N	617883	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1 -((4-methoxy-2-(( 1R, 5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-5-yl)methyl)-1H-pyrazol-4-yl)-3-methylpyrazine-2-carboxamide::US20230286958, Example 95	Plasma kallikrein			 14.3							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617883	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617883&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317685	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(NC(=O)OC(C)(C)C)c1)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C33H32ClF3N8O4/c1-15-27(42-24(12-38-15)25-20(28(36)37)6-7-22(34)26(25)35)30(46)41-19-11-40-45(14-19)16(2)17-9-23(43-32(48)49-33(3,4)5)29(39-10-17)44-13-18-8-21(18)31(44)47/h6-7,9-12,14,16,18,21,28H,8,13H2,1-5H3,(H,41,46)(H,43,48)/t16?,18-,21-/m1/s1	PKGDHJVABRPYGJ-QHNQYTFYSA-N	617884	US20230286958, Example 96::tert-Butyl (5-((S and R)-1-(4-(6-(3-chloro-6-(difluoromethyl)-2-fluorophenyl)-3-methylpyrazine-2-carboxamido)-1H-pyrazol-1-yl) ethyl)-2-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)carbamate	Plasma kallikrein			 10.8							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617884	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617884&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317687	CC(c1ccc(cc1C)N1C[C@H]2C[C@H]2C1=O)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C30H26ClF3N6O2/c1-14-8-19(39-12-17-9-22(17)30(39)42)4-5-20(14)16(3)40-13-18(10-36-40)37-29(41)27-15(2)35-11-24(38-27)25-21(28(33)34)6-7-23(31)26(25)32/h4-8,10-11,13,16-17,22,28H,9,12H2,1-3H3,(H,37,41)/t16?,17-,22-/m1/s1	IWIMHJKXGOWFSS-UVMRWNARSA-N	617885	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-methyl-N-(1-((S or R)-1-(2-methyl-4-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)phenyl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 97	Plasma kallikrein			 1.30							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617885	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617885&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317689	CC(c1ccc(cc1C)N1C[C@H]2C[C@H]2C1=O)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C29H24ClF3N6O2/c1-14-7-18(38-12-16-8-21(16)29(38)41)3-4-19(14)15(2)39-13-17(9-35-39)36-28(40)24-11-34-10-23(37-24)25-20(27(32)33)5-6-22(30)26(25)31/h3-7,9-11,13,15-16,21,27H,8,12H2,1-2H3,(H,36,40)/t15?,16-,21-/m1/s1	BXTSFKLUWYUSNG-VWDLYUFVSA-N	617886	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((S or R)-1-(2-methyl-4-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)phenyl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 98::US20230286958, Example 99	Plasma kallikrein			 1.40							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617886	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617886&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317691	CC(c1ccc(cc1C)N1C[C@H]2C[C@H]2C1=O)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C29H24ClF3N6O2/c1-14-7-18(38-12-16-8-21(16)29(38)41)3-4-19(14)15(2)39-13-17(9-35-39)36-28(40)24-11-34-10-23(37-24)25-20(27(32)33)5-6-22(30)26(25)31/h3-7,9-11,13,15-16,21,27H,8,12H2,1-2H3,(H,36,40)/t15?,16-,21-/m1/s1	BXTSFKLUWYUSNG-VWDLYUFVSA-N	617886	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((S or R)-1-(2-methyl-4-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)phenyl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 98::US20230286958, Example 99	Plasma kallikrein			 49.1							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617886	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617886&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317693	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(C)n1)n1cc(NC(=O)c2nc(cnc2C(F)F)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H22ClF5N8O2/c1-11-26(41-9-13-5-16(13)28(41)44)36-7-18(38-11)12(2)42-10-14(6-37-42)39-27(43)23-22(25(33)34)35-8-19(40-23)20-15(24(31)32)3-4-17(29)21(20)30/h3-4,6-8,10,12-13,16,24-25H,5,9H2,1-2H3,(H,39,43)/t12?,13-,16-/m1/s1	WCELNPILWKOFSP-LLQOJDTPSA-N	617888	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-(difluoromethyl)-N-(1-((S or R)-1-(6-methyl-5-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrazin-2-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 100::US20230286958, Example 101	Plasma kallikrein			 1.70							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617888	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617888&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317695	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(C)n1)n1cc(NC(=O)c2nc(cnc2C(F)F)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H22ClF5N8O2/c1-11-26(41-9-13-5-16(13)28(41)44)36-7-18(38-11)12(2)42-10-14(6-37-42)39-27(43)23-22(25(33)34)35-8-19(40-23)20-15(24(31)32)3-4-17(29)21(20)30/h3-4,6-8,10,12-13,16,24-25H,5,9H2,1-2H3,(H,39,43)/t12?,13-,16-/m1/s1	WCELNPILWKOFSP-LLQOJDTPSA-N	617888	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-(difluoromethyl)-N-(1-((S or R)-1-(6-methyl-5-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrazin-2-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 100::US20230286958, Example 101	Plasma kallikrein			 0.600							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617888	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617888&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317697	CC(c1cc(C)c(nn1)N1C[C@H]2C[C@H]2C1=O)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H24ClF3N8O2/c1-12-6-20(37-38-26(12)39-10-15-7-18(15)28(39)42)14(3)40-11-16(8-34-40)35-27(41)24-13(2)33-9-21(36-24)22-17(25(31)32)4-5-19(29)23(22)30/h4-6,8-9,11,14-15,18,25H,7,10H2,1-3H3,(H,35,41)/t14?,15-,18-/m1/s1	XHOSJSGSUAYWPH-QTLYGJNZSA-N	617890	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-methyl-N-(1-((S or R)-1-(5-methyl-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridazin-3-yl)ethyl)- 1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 102::US20230286958, Example 103	Plasma kallikrein			 0.700							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617890	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617890&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317699	CC(c1cc(C)c(nn1)N1C[C@H]2C[C@H]2C1=O)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H24ClF3N8O2/c1-12-6-20(37-38-26(12)39-10-15-7-18(15)28(39)42)14(3)40-11-16(8-34-40)35-27(41)24-13(2)33-9-21(36-24)22-17(25(31)32)4-5-19(29)23(22)30/h4-6,8-9,11,14-15,18,25H,7,10H2,1-3H3,(H,35,41)/t14?,15-,18-/m1/s1	XHOSJSGSUAYWPH-QTLYGJNZSA-N	617890	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-methyl-N-(1-((S or R)-1-(5-methyl-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridazin-3-yl)ethyl)- 1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 102::US20230286958, Example 103	Plasma kallikrein			 1.80							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617890	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617890&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317701	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(C)c1C)n1cc(NC(=O)c2cncc(n2)-c2c(OC(F)F)ccc(Cl)c2F)cn1	InChI=1S/C29H25ClF3N7O3/c1-13-14(2)26(39-11-16-6-18(16)28(39)42)35-8-19(13)15(3)40-12-17(7-36-40)37-27(41)22-10-34-9-21(38-22)24-23(43-29(32)33)5-4-20(30)25(24)31/h4-5,7-10,12,15-16,18,29H,6,11H2,1-3H3,(H,37,41)/t15?,16-,18-/m1/s1	SOARPTXSWUKGOA-WOEZKJSCSA-N	617892	6-(3-Chloro-6-(difluoromethoxy)-2-fluorophenyl)-N-(1-((S or R)-1-(4,5-dimethyl-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 104::US20230286958, Example 105	Plasma kallikrein			 1.20							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617892	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617892&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317703	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(C)c1C)n1cc(NC(=O)c2cncc(n2)-c2c(OC(F)F)ccc(Cl)c2F)cn1	InChI=1S/C29H25ClF3N7O3/c1-13-14(2)26(39-11-16-6-18(16)28(39)42)35-8-19(13)15(3)40-12-17(7-36-40)37-27(41)22-10-34-9-21(38-22)24-23(43-29(32)33)5-4-20(30)25(24)31/h4-5,7-10,12,15-16,18,29H,6,11H2,1-3H3,(H,37,41)/t15?,16-,18-/m1/s1	SOARPTXSWUKGOA-WOEZKJSCSA-N	617892	6-(3-Chloro-6-(difluoromethoxy)-2-fluorophenyl)-N-(1-((S or R)-1-(4,5-dimethyl-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 104::US20230286958, Example 105	Plasma kallikrein			 0.600							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617892	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617892&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317705	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(C)c1)n1cc(NC(=O)c2cc(c[n+]([O-])c2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C29H24ClF3N6O3/c1-14-5-16(8-34-27(14)38-12-17-7-22(17)29(38)41)15(2)39-13-20(9-35-39)36-28(40)19-6-18(10-37(42)11-19)24-21(26(32)33)3-4-23(30)25(24)31/h3-6,8-11,13,15,17,22,26H,7,12H2,1-2H3,(H,36,40)/t15?,17-,22-/m1/s1	RZUBKNRJNSMNNO-DVUUYJHRSA-N	617894	5-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((S or R)-1-(5-methyl-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)ethyl)-1H-pyrazol-4-yl)-1-(l1-oxidanyl)-114-pyridine-3-carboxamide::US20230286958, Example 106::US20230286958, Example 107	Plasma kallikrein			 1.40							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617894	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617894&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317707	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(C)c1)n1cc(NC(=O)c2cc(c[n+]([O-])c2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C29H24ClF3N6O3/c1-14-5-16(8-34-27(14)38-12-17-7-22(17)29(38)41)15(2)39-13-20(9-35-39)36-28(40)19-6-18(10-37(42)11-19)24-21(26(32)33)3-4-23(30)25(24)31/h3-6,8-11,13,15,17,22,26H,7,12H2,1-2H3,(H,36,40)/t15?,17-,22-/m1/s1	RZUBKNRJNSMNNO-DVUUYJHRSA-N	617894	5-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((S or R)-1-(5-methyl-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)ethyl)-1H-pyrazol-4-yl)-1-(l1-oxidanyl)-114-pyridine-3-carboxamide::US20230286958, Example 106::US20230286958, Example 107	Plasma kallikrein			 1.50							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617894	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617894&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317709	CC(c1cnc(nc1C)N1C[C@H]2C[C@H]2C1=O)n1cc(NC(=O)c2cncc(n2)-c2c(C)ccc(Cl)c2F)cn1	InChI=1S/C27H24ClFN8O2/c1-13-4-5-20(28)24(29)23(13)21-9-30-10-22(35-21)25(38)34-17-7-32-37(12-17)15(3)19-8-31-27(33-14(19)2)36-11-16-6-18(16)26(36)39/h4-5,7-10,12,15-16,18H,6,11H2,1-3H3,(H,34,38)/t15?,16-,18-/m1/s1	MIJPOKFOSZKHFV-WOEZKJSCSA-N	617896	6-(3 -Chloro-2-fluoro-6-methylphenyl)-N-(1-((S or R)-1-(4-methyl-2-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-5-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 108::US20230286958, Example 109	Plasma kallikrein			 16.6							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617896	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617896&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317711	CC(c1cnc(nc1C)N1C[C@H]2C[C@H]2C1=O)n1cc(NC(=O)c2cncc(n2)-c2c(C)ccc(Cl)c2F)cn1	InChI=1S/C27H24ClFN8O2/c1-13-4-5-20(28)24(29)23(13)21-9-30-10-22(35-21)25(38)34-17-7-32-37(12-17)15(3)19-8-31-27(33-14(19)2)36-11-16-6-18(16)26(36)39/h4-5,7-10,12,15-16,18H,6,11H2,1-3H3,(H,34,38)/t15?,16-,18-/m1/s1	MIJPOKFOSZKHFV-WOEZKJSCSA-N	617896	6-(3 -Chloro-2-fluoro-6-methylphenyl)-N-(1-((S or R)-1-(4-methyl-2-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-5-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 108::US20230286958, Example 109	Plasma kallikrein			 5.10							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617896	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617896&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317713	CC(c1nnc(N2C[C@H]3C[C@H]3C2=O)c(C)c1C)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H24ClF3N8O2/c1-12-13(2)26(39-10-15-6-18(15)28(39)42)38-37-24(12)14(3)40-11-16(7-34-40)35-27(41)21-9-33-8-20(36-21)22-17(25(31)32)4-5-19(29)23(22)30/h4-5,7-9,11,14-15,18,25H,6,10H2,1-3H3,(H,35,41)/t14?,15-,18-/m1/s1	LQEJGKWBOTZIBV-QTLYGJNZSA-N	617898	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((S or R)-1-(4,5-dimethyl-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridazin-3-yl)ethyl)- 1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 110::US20230286958, Example 111	Plasma kallikrein			 14.0							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617898	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617898&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317715	CC(c1nnc(N2C[C@H]3C[C@H]3C2=O)c(C)c1C)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H24ClF3N8O2/c1-12-13(2)26(39-10-15-6-18(15)28(39)42)38-37-24(12)14(3)40-11-16(7-34-40)35-27(41)21-9-33-8-20(36-21)22-17(25(31)32)4-5-19(29)23(22)30/h4-5,7-9,11,14-15,18,25H,6,10H2,1-3H3,(H,35,41)/t14?,15-,18-/m1/s1	LQEJGKWBOTZIBV-QTLYGJNZSA-N	617898	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((S or R)-1-(4,5-dimethyl-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridazin-3-yl)ethyl)- 1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 110::US20230286958, Example 111	Plasma kallikrein			 0.400							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617898	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617898&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317717	Cc1ccc(Cl)c(F)c1-c1cnc(C)c(n1)C(=O)Nc1cnn(Cc2nnc(N3C[C@H]4C[C@H]4C3=O)c(C)c2C)c1	InChI=1S/C28H26ClFN8O2/c1-13-5-6-20(29)24(30)23(13)21-9-31-16(4)25(34-21)27(39)33-18-8-32-37(11-18)12-22-14(2)15(3)26(36-35-22)38-10-17-7-19(17)28(38)40/h5-6,8-9,11,17,19H,7,10,12H2,1-4H3,(H,33,39)/t17-,19-/m1/s1	CVTOIUOLKZVDEZ-IEBWSBKVSA-N	617900	6-(3 -Chloro-2-fluoro-6-methylphenyl)-N-(1-((4,5-dimethyl-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridazin-3-yl)methyl)-1H-pyrazol-4-yl)-3-methylpyrazine-2-carboxamide::US20230286958, Example 112	Plasma kallikrein			 4.80							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617900	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617900&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317719	Cc1cc(Cn2cc(NC(=O)c3nc(cnc3C)-c3c(F)c(Cl)ccc3OC(F)F)cn2)nnc1N1C[C@H]2C[C@H]2C1=O	InChI=1S/C27H22ClF3N8O3/c1-12-5-15(36-37-24(12)39-9-14-6-17(14)26(39)41)10-38-11-16(7-33-38)34-25(40)23-13(2)32-8-19(35-23)21-20(42-27(30)31)4-3-18(28)22(21)29/h3-5,7-8,11,14,17,27H,6,9-10H2,1-2H3,(H,34,40)/t14-,17-/m1/s1	YYLJKEYIZVRFEV-RHSMWYFYSA-N	617901	6-(3-Chloro-6-(difluoromethoxy)-2-fluorophenyl)-3-methyl-N-(1-((5-methyl-6-((1R,SS)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridazin-3-yl)methyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 113	Plasma kallikrein			 2.10							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617901	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617901&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317721	CC(c1cc(C)c(nn1)N1C[C@H]2C[C@H]2C1=O)n1cc(NC(=O)c2cncc(n2)-c2c(OC(F)F)ccc(Cl)c2F)cn1	InChI=1S/C27H22ClF3N8O3/c1-12-5-18(36-37-24(12)38-10-14-6-16(14)26(38)41)13(2)39-11-15(7-33-39)34-25(40)20-9-32-8-19(35-20)22-21(42-27(30)31)4-3-17(28)23(22)29/h3-5,7-9,11,13-14,16,27H,6,10H2,1-2H3,(H,34,40)/t13?,14-,16-/m1/s1	MNHRZKFGCZXRJO-IGLHTZBQSA-N	617902	6-(3-Chloro-6-(difluoromethoxy)-2-fluorophenyl)-N-(1-((S or R)-1-(5-methyl-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridazin-3-yl)ethyl)- 1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 114::US20230286958, Example 115	Plasma kallikrein			 0.700							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617902	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617902&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317723	CC(c1cc(C)c(nn1)N1C[C@H]2C[C@H]2C1=O)n1cc(NC(=O)c2cncc(n2)-c2c(OC(F)F)ccc(Cl)c2F)cn1	InChI=1S/C27H22ClF3N8O3/c1-12-5-18(36-37-24(12)38-10-14-6-16(14)26(38)41)13(2)39-11-15(7-33-39)34-25(40)20-9-32-8-19(35-20)22-21(42-27(30)31)4-3-17(28)23(22)29/h3-5,7-9,11,13-14,16,27H,6,10H2,1-2H3,(H,34,40)/t13?,14-,16-/m1/s1	MNHRZKFGCZXRJO-IGLHTZBQSA-N	617902	6-(3-Chloro-6-(difluoromethoxy)-2-fluorophenyl)-N-(1-((S or R)-1-(5-methyl-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridazin-3-yl)ethyl)- 1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 114::US20230286958, Example 115	Plasma kallikrein			 2.50							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617902	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617902&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317725	FC(F)c1ccc(Cl)c(F)c1-c1cnc(COC2CC2)c(n1)C(=O)Nc1cnn(Cc2cnc(nc2)N2C[C@H]3C[C@H]3C2=O)c1	InChI=1S/C29H24ClF3N8O3/c30-20-4-3-18(26(32)33)23(24(20)31)21-9-34-22(13-44-17-1-2-17)25(39-21)27(42)38-16-8-37-40(12-16)10-14-6-35-29(36-7-14)41-11-15-5-19(15)28(41)43/h3-4,6-9,12,15,17,19,26H,1-2,5,10-11,13H2,(H,38,42)/t15-,19-/m1/s1	HOLIJUWHVVFJFK-DNVCBOLYSA-N	617904	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-(cyclopropoxymethyl)-N-(1-((2-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-5-yl)methyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 116	Plasma kallikrein			 19.1							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617904	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617904&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317727	CC(c1ncc(N2C[C@H]3C[C@H]3C2=O)c(C)c1N)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H24ClF3N8O2/c1-12-21(39-10-14-5-17(14)28(39)42)9-35-25(24(12)33)13(2)40-11-15(6-36-40)37-27(41)20-8-34-7-19(38-20)22-16(26(31)32)3-4-18(29)23(22)30/h3-4,6-9,11,13-14,17,26H,5,10,33H2,1-2H3,(H,37,41)/t13?,14-,17-/m1/s1	LSSWPZUPDAAMGG-DTLKIFBZSA-N	617905	N-(1-((S or R)-1-(3-Amino-4-methyl-5-((1R,SS)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-2-yl)ethyl)-1H-pyrazol-4-yl)-6-(3-chloro-6-(difluoromethyl)-2-fluorophenyl)pyrazine-2-carboxamide::US20230286958, Example 117	Plasma kallikrein			 1.90							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617905	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617905&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317729	CC(c1ncc(N2C[C@H]3C[C@H]3C2=O)c(C)c1N)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C29H26ClF3N8O2/c1-12-21(40-10-15-6-18(15)29(40)43)9-36-26(24(12)34)14(3)41-11-16(7-37-41)38-28(42)25-13(2)35-8-20(39-25)22-17(27(32)33)4-5-19(30)23(22)31/h4-5,7-9,11,14-15,18,27H,6,10,34H2,1-3H3,(H,38,42)/t14?,15-,18-/m1/s1	HRMYSJACSDRELU-QTLYGJNZSA-N	617906	N-(1-((R or S)-1-(3-Amino-4-methyl-5-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-2-yl)ethyl)-1H-pyrazol-4-yl)-6-(3-chloro-6-(difluoromethyl)-2-fluorophenyl)-3-methylpyrazine-2-carboxamide::US20230286958, Example 118	Plasma kallikrein			 1.000							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617906	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617906&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317731	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(C)c1)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C29H25ClF3N7O2/c1-13-6-16(8-35-27(13)39-11-17-7-20(17)29(39)42)15(3)40-12-18(9-36-40)37-28(41)25-14(2)34-10-22(38-25)23-19(26(32)33)4-5-21(30)24(23)31/h4-6,8-10,12,15,17,20,26H,7,11H2,1-3H3,(H,37,41)/t15?,17-,20-/m1/s1	OTRDMMCGPKTUCO-LQRGHNGLSA-N	617907	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-methyl-N-(1-((S or R)-1-(5-methyl-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 119::US20230286958, Example 120	Plasma kallikrein			 0.600							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617907	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617907&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317733	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(C)c1)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C29H25ClF3N7O2/c1-13-6-16(8-35-27(13)39-11-17-7-20(17)29(39)42)15(3)40-12-18(9-36-40)37-28(41)25-14(2)34-10-22(38-25)23-19(26(32)33)4-5-21(30)24(23)31/h4-6,8-10,12,15,17,20,26H,7,11H2,1-3H3,(H,37,41)/t15?,17-,20-/m1/s1	OTRDMMCGPKTUCO-LQRGHNGLSA-N	617907	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-methyl-N-(1-((S or R)-1-(5-methyl-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 119::US20230286958, Example 120	Plasma kallikrein			 0.500							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617907	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617907&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317735	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(C)c1)n1cc(NC(=O)c2cc(nnc2C)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C29H25ClF3N7O2/c1-13-6-16(9-34-27(13)39-11-17-7-21(17)29(39)42)15(3)40-12-18(10-35-40)36-28(41)20-8-23(38-37-14(20)2)24-19(26(32)33)4-5-22(30)25(24)31/h4-6,8-10,12,15,17,21,26H,7,11H2,1-3H3,(H,36,41)/t15?,17-,21-/m1/s1	RELCPYVLSFLVPR-NZAAYYPMSA-N	617909	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-methyl-N-(1-((S or R)-1-(5-methyl-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)ethyl)-1H-pyrazol-4-yl)pyridazine-4-carboxamide::US20230286958, Example 121::US20230286958, Example 122	Plasma kallikrein			 4.50							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617909	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617909&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317737	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(C)c1)n1cc(NC(=O)c2cc(nnc2C)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C29H25ClF3N7O2/c1-13-6-16(9-34-27(13)39-11-17-7-21(17)29(39)42)15(3)40-12-18(10-35-40)36-28(41)20-8-23(38-37-14(20)2)24-19(26(32)33)4-5-22(30)25(24)31/h4-6,8-10,12,15,17,21,26H,7,11H2,1-3H3,(H,36,41)/t15?,17-,21-/m1/s1	RELCPYVLSFLVPR-NZAAYYPMSA-N	617909	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-methyl-N-(1-((S or R)-1-(5-methyl-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)ethyl)-1H-pyrazol-4-yl)pyridazine-4-carboxamide::US20230286958, Example 121::US20230286958, Example 122	Plasma kallikrein			 14.2							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617909	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617909&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317739	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(C)n1)n1cc(NC(=O)c2nc(cnc2C)-c2c(OC(F)F)ccc(Cl)c2F)cn1	InChI=1S/C28H24ClF3N8O3/c1-12-24(38-20(9-33-12)22-21(43-28(31)32)5-4-18(29)23(22)30)26(41)37-16-7-35-40(11-16)14(3)19-8-34-25(13(2)36-19)39-10-15-6-17(15)27(39)42/h4-5,7-9,11,14-15,17,28H,6,10H2,1-3H3,(H,37,41)/t14?,15-,17-/m1/s1	SAULAGCQOSOMSG-HOSQGPGDSA-N	617911	6-(3-Chloro-6-(difluoromethoxy)-2-fluorophenyl)-3-methyl-N-(1-((S or R)-1-(6-methyl-5-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrazin-2-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 123::US20230286958, Example 124	Plasma kallikrein			 1.000							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617911	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617911&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317741	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(C)n1)n1cc(NC(=O)c2nc(cnc2C)-c2c(OC(F)F)ccc(Cl)c2F)cn1	InChI=1S/C28H24ClF3N8O3/c1-12-24(38-20(9-33-12)22-21(43-28(31)32)5-4-18(29)23(22)30)26(41)37-16-7-35-40(11-16)14(3)19-8-34-25(13(2)36-19)39-10-15-6-17(15)27(39)42/h4-5,7-9,11,14-15,17,28H,6,10H2,1-3H3,(H,37,41)/t14?,15-,17-/m1/s1	SAULAGCQOSOMSG-HOSQGPGDSA-N	617911	6-(3-Chloro-6-(difluoromethoxy)-2-fluorophenyl)-3-methyl-N-(1-((S or R)-1-(6-methyl-5-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrazin-2-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 123::US20230286958, Example 124	Plasma kallikrein			 0.600							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617911	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617911&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338021	COc1ccc(c(CNC(=O)c2cn(Cc3cn4cc(cc(COCCN)c4n3)C3CC3)nn2)c1F)-n1cnnn1	InChI=1S/C26H28FN11O3/c1-40-23-5-4-22(38-15-30-33-35-38)20(24(23)27)9-29-26(39)21-13-37(34-32-21)12-19-11-36-10-17(16-2-3-16)8-18(25(36)31-19)14-41-7-6-28/h4-5,8,10-11,13,15-16H,2-3,6-7,9,12,14,28H2,1H3,(H,29,39)	BPZGPYUCRSZASA-UHFFFAOYSA-N	626655	1-((8-((2-aminoethoxy)methyl)-6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-N-(2-fluoro-3-methoxy-6-(1H-tetrazol-1-yl)benzyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-17	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626655	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626655&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152019	485655111							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338022	Nc1ncc(CNC(=O)c2cn(Cc3cn4cc(ccc4n3)C3CC3)nn2)s1	InChI=1S/C18H18N8OS/c19-18-21-6-14(28-18)5-20-17(27)15-10-26(24-23-15)9-13-8-25-7-12(11-1-2-11)3-4-16(25)22-13/h3-4,6-8,10-11H,1-2,5,9H2,(H2,19,21)(H,20,27)	CGDLTZQHSOPECY-UHFFFAOYSA-N	626657	N-((2-aminothiazol-5-yl)methyl)-1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-18	Plasma kallikrein					 1050					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626657	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626657&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152107	485655112							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338023	Nc1nnc(CNC(=O)c2cn(Cc3cn4cc(ccc4n3)C3CC3)nn2)o1	InChI=1S/C17H17N9O2/c18-17-23-22-15(28-17)5-19-16(27)13-9-26(24-21-13)8-12-7-25-6-11(10-1-2-10)3-4-14(25)20-12/h3-4,6-7,9-10H,1-2,5,8H2,(H2,18,23)(H,19,27)	STICVJDQZKCANA-UHFFFAOYSA-N	626658	N-((5-amino-1,3,4-oxadiazol-2-yl)methyl)-1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-19	Plasma kallikrein					 4550					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626658	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626658&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156151986	485655113							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338024	Nc1nnc(CNC(=O)c2cn(Cc3cn4cc(ccc4n3)C3CC3)nn2)s1	InChI=1S/C17H17N9OS/c18-17-23-22-15(28-17)5-19-16(27)13-9-26(24-21-13)8-12-7-25-6-11(10-1-2-10)3-4-14(25)20-12/h3-4,6-7,9-10H,1-2,5,8H2,(H2,18,23)(H,19,27)	GTJHXEZEXAVOIO-UHFFFAOYSA-N	626659	N-((5-amino-1,3,4-thiadiazol-2-yl)methyl)-1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-20	Plasma kallikrein					 4550					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626659	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626659&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152267	485655114							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338025	Nc1nnc(CNC(=O)c2cn(Cc3cn4cc(ccc4n3)C3CC3)nn2)[nH]1	InChI=1S/C17H18N10O/c18-17-21-14(23-24-17)5-19-16(28)13-9-27(25-22-13)8-12-7-26-6-11(10-1-2-10)3-4-15(26)20-12/h3-4,6-7,9-10H,1-2,5,8H2,(H,19,28)(H3,18,21,23,24)	NDHSHVAMWZHXIL-UHFFFAOYSA-N	626660	N-((5-amino-4H-1,2,4-triazol-3-yl)methyl)-1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-21	Plasma kallikrein					 4550					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626660	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626660&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152312	485655115							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338026	COc1ccc(c(CNC(=O)c2cn3C(CCc3n2)c2cn3cc(ccc3n2)C2CC2)c1F)-n1cnnn1	InChI=1S/C26H24FN9O2/c1-38-22-7-5-20(36-14-29-32-33-36)17(25(22)27)10-28-26(37)19-13-35-21(6-9-24(35)31-19)18-12-34-11-16(15-2-3-15)4-8-23(34)30-18/h4-5,7-8,11-15,21H,2-3,6,9-10H2,1H3,(H,28,37)	SOVMLZCHBMGBFO-UHFFFAOYSA-N	626661	5-(6-cyclopropylimidazo[1,2-a]pyridin-2-yl)-N-(2-fluoro-3-methoxy-6-(1H-tetrazol-1-yl)benzyl)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazole-2-carboxamide ::US11787796, Compound I-22	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626661	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626661&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152211	485655116							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338027	Nc1nccc2C(CCc12)NC(=O)c1cn(Cc2cn3cc(ccc3n2)C2CC2)nn1	InChI=1S/C22H22N8O/c23-21-17-4-5-18(16(17)7-8-24-21)26-22(31)19-12-30(28-27-19)11-15-10-29-9-14(13-1-2-13)3-6-20(29)25-15/h3,6-10,12-13,18H,1-2,4-5,11H2,(H2,23,24)(H,26,31)	GBKPXNPKOFORRH-UHFFFAOYSA-N	626662	N-(1-amino-6,7-dihydro-5H-cyclopenta[c]pyridin-5-yl)-1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-23	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626662	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626662&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156151902	485655117							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338028	COc1ccc(c(CNC(=O)c2cnc3CCC(c4cn5cc(ccc5n4)C4CC4)n23)c1F)-n1cnnn1	InChI=1S/C26H24FN9O2/c1-38-22-7-5-19(35-14-30-32-33-35)17(25(22)27)10-29-26(37)21-11-28-23-9-6-20(36(21)23)18-13-34-12-16(15-2-3-15)4-8-24(34)31-18/h4-5,7-8,11-15,20H,2-3,6,9-10H2,1H3,(H,29,37)	RHQSVKDIAMAKNR-UHFFFAOYSA-N	626663	5-(6-cyclopropylimidazo[1,2-a]pyridin-2-yl)-N-(2-fluoro-3-methoxy-6-(1H-tetrazol-1-yl)benzyl)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazole-3-carboxamide ::US11787796, Compound I-24	Plasma kallikrein					 4550					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626663	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626663&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152252	485655118							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338029	COc1ccc(c(CNC(=O)c2cn(Cc3cn4cc(cc(CN)c4n3)C3CC3)nn2)c1F)-n1cnnn1	InChI=1S/C24H24FN11O2/c1-38-21-5-4-20(36-13-28-31-33-36)18(22(21)25)8-27-24(37)19-12-35(32-30-19)11-17-10-34-9-16(14-2-3-14)6-15(7-26)23(34)29-17/h4-6,9-10,12-14H,2-3,7-8,11,26H2,1H3,(H,27,37)	ZQHCLBTWHHRJEJ-UHFFFAOYSA-N	626664	1-((8-(aminomethyl)-6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-N-(2-fluoro-3-methoxy-6-(1H-tetrazol-1-yl)benzyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-25	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626664	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626664&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156151897	485655119							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338030	Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2cn3cc(ccc3n2)C2CC2)nn1	InChI=1S/C22H24N8O/c1-13-7-20(23)25-14(2)18(13)8-24-22(31)19-12-30(28-27-19)11-17-10-29-9-16(15-3-4-15)5-6-21(29)26-17/h5-7,9-10,12,15H,3-4,8,11H2,1-2H3,(H2,23,25)(H,24,31)	QANNMSGRQOTJCB-UHFFFAOYSA-N	626665	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)-1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-26	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626665	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626665&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152164	485655120							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338031	COc1ccc(c(CNC(=O)c2cn(Cc3cn4cc(cc(C(O)C5COC5)c4n3)C3CC3)nn2)c1F)-n1cnnn1	InChI=1S/C27H27FN10O4/c1-41-23-5-4-22(38-14-30-33-35-38)20(24(23)28)7-29-27(40)21-11-37(34-32-21)10-18-9-36-8-16(15-2-3-15)6-19(26(36)31-18)25(39)17-12-42-13-17/h4-6,8-9,11,14-15,17,25,39H,2-3,7,10,12-13H2,1H3,(H,29,40)	CZPXGKKRCJNQMF-UHFFFAOYSA-N	626666	1-((6-cyclopropyl-8-(hydroxy(oxetan-3-yl)methyl)imidazo[1,2-a]pyridin-2-yl)methyl)-N-(2-fluoro-3-methoxy-6-(1H-tetrazol-1-yl)benzyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-27	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626666	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626666&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156151862	485655121							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338032	COc1ccc(c(CNC(=O)c2nnn(Cc3cn4cc(ccc4n3)C3CC3)n2)c1F)-n1cnnn1	InChI=1S/C22H20FN11O2/c1-36-18-6-5-17(33-12-25-29-31-33)16(20(18)23)8-24-22(35)21-27-30-34(28-21)11-15-10-32-9-14(13-2-3-13)4-7-19(32)26-15/h4-7,9-10,12-13H,2-3,8,11H2,1H3,(H,24,35)	SKLAJJJRONCPHS-UHFFFAOYSA-N	626667	2-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-N-(2-fluoro-3-methyl-6-(1H-tetrazol-1-yl)benzyl)-2H-tetrazole-5-carboxamide ::US11787796, Compound I-28	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626667	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626667&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152134	485655122							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338033	COc1ccc(c(CNC(=O)c2cn(Cc3cn4cc(ccc4n3)C3CC3)nn2)c1F)-n1cnnn1	InChI=1S/C23H21FN10O2/c1-36-20-6-5-19(34-13-26-29-31-34)17(22(20)24)8-25-23(35)18-12-33(30-28-18)11-16-10-32-9-15(14-2-3-14)4-7-21(32)27-16/h4-7,9-10,12-14H,2-3,8,11H2,1H3,(H,25,35)	SVBCYIOLAKYOHQ-UHFFFAOYSA-N	626668	1-(1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-1,2,3-triazol-4-yl)-N-(2-fluoro-3-methoxy-6-(1H-tetrazol-1-yl)benzyl)methanamine ::US11787796, Compound I-105::US11787796, Compound I-29::US11787796, Compound I-83	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626668	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626668&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152169	485655123							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338034	Fc1c(Cl)ccc(c1CNS(=O)(=O)c1cn(Cc2cn3cc(ccc3n2)C2CC2)nn1)-n1cnnn1	InChI=1S/C21H18ClFN10O2S/c22-17-4-5-18(33-12-24-28-30-33)16(21(17)23)7-25-36(34,35)20-11-32(29-27-20)10-15-9-31-8-14(13-1-2-13)3-6-19(31)26-15/h3-6,8-9,11-13,25H,1-2,7,10H2	DHAQRKBWDJHOKS-UHFFFAOYSA-N	626669	N-(3-chloro-2-fluoro-6-(1H-tetrazol-1-yl)benzyl)-1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-1,2,3-triazole-4-sulfonamide ::US11787796, Compound I-30	Plasma kallikrein					 1050					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626669	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626669&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152017	485655124							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338035	COc1ccc(c(C(C)NC(=O)c2cn(Cc3cn4cc(ccc4n3)C3CC3)nn2)c1F)-n1cnnn1	InChI=1S/C24H23FN10O2/c1-14(22-19(35-13-26-30-32-35)6-7-20(37-2)23(22)25)27-24(36)18-12-34(31-29-18)11-17-10-33-9-16(15-3-4-15)5-8-21(33)28-17/h5-10,12-15H,3-4,11H2,1-2H3,(H,27,36)	ZMQSQCBSLODRLJ-UHFFFAOYSA-N	626670	1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-N-(1-(2-fluoro-3-methoxy-6-(1H-tetrazol-1-yl)phenyl)ethyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-31	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626670	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626670&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152294	485655125							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338036	NC(=N)c1ccc(CNS(=O)(=O)c2cnn(Cc3cn4cc(ccc4n3)C3CC3)c2)cc1	InChI=1S/C22H23N7O2S/c23-22(24)17-3-1-15(2-4-17)9-26-32(30,31)20-10-25-29(14-20)13-19-12-28-11-18(16-5-6-16)7-8-21(28)27-19/h1-4,7-8,10-12,14,16,26H,5-6,9,13H2,(H3,23,24)	GVQOYQUGUFKMPY-UHFFFAOYSA-N	626671	4-(((1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-pyrazole)-4-sulfonamido)methyl)benzimidamide ::US11787796, Compound I-32	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626671	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626671&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152279	485655126							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338037	NCc1ccc(CNS(=O)(=O)c2cnn(Cc3cn4cc(ccc4n3)C3CC3)c2)cc1	InChI=1S/C22H24N6O2S/c23-9-16-1-3-17(4-2-16)10-25-31(29,30)21-11-24-28(15-21)14-20-13-27-12-19(18-5-6-18)7-8-22(27)26-20/h1-4,7-8,11-13,15,18,25H,5-6,9-10,14,23H2	CYMWTXGPYYQEJM-UHFFFAOYSA-N	626672	N-(4-(aminomethyl)benzyl)-1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)ethyl)-1H-pyrazole-4-sulfonamide ::US11787796, Compound I-33	Plasma kallikrein					 4550					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626672	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626672&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152254	485655127							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338038	O=S(=O)(NCc1ccc(cc1)C#N)c1cnn(Cc2cn3cc(ccc3n2)C2CC2)c1	InChI=1S/C22H20N6O2S/c23-9-16-1-3-17(4-2-16)10-25-31(29,30)21-11-24-28(15-21)14-20-13-27-12-19(18-5-6-18)7-8-22(27)26-20/h1-4,7-8,11-13,15,18,25H,5-6,10,14H2	SHDWXLXOGDCQLY-UHFFFAOYSA-N	626673	N-(4-cyanobenzyl)-1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-pyrazole-4-sulfonamide ::US11787796, Compound I-34	Plasma kallikrein					>7100					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626673	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626673&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152208	485655128							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338039	Clc1ccc(CCNS(=O)(=O)c2cnn(Cc3cn4cc(ccc4n3)C3CC3)c2)cc1	InChI=1S/C22H22ClN5O2S/c23-19-6-1-16(2-7-19)9-10-25-31(29,30)21-11-24-28(15-21)14-20-13-27-12-18(17-3-4-17)5-8-22(27)26-20/h1-2,5-8,11-13,15,17,25H,3-4,9-10,14H2	RBZUTOMQSITISF-UHFFFAOYSA-N	626674	N-(4-chlorophenethyl)-1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-pyrazole-4-sulfonamide ::US11787796, Compound I-35	Plasma kallikrein					>7100					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626674	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626674&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156151915	485655129							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317743	COCc1ncc(nc1C(=O)Nc1cnn(c1)C(C)c1cnc(N2C[C@H]3C[C@H]3C2=O)c(C)n1)-c1c(F)c(Cl)ccc1C(F)F	InChI=1S/C29H26ClF3N8O3/c1-13-27(40-10-15-6-18(15)29(40)43)35-8-20(37-13)14(2)41-11-16(7-36-41)38-28(42)25-22(12-44-3)34-9-21(39-25)23-17(26(32)33)4-5-19(30)24(23)31/h4-5,7-9,11,14-15,18,26H,6,10,12H2,1-3H3,(H,38,42)/t14?,15-,18-/m1/s1	KPLREYDSVWITHB-QTLYGJNZSA-N	617913	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-(methoxymethyl)-N-(1-((S or R)-1-(6-methyl-5-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrazin-2-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 125	Plasma kallikrein			 1.20							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617913	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617913&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317745	COCc1nnc(nc1C(=O)Nc1cnn(c1)C(C)c1cnc(N2C[C@H]3C[C@H]3C2=O)c(C)n1)-c1c(F)c(Cl)ccc1C(F)F	InChI=1S/C28H25ClF3N9O3/c1-12-26(40-9-14-6-17(14)28(40)43)33-8-19(35-12)13(2)41-10-15(7-34-41)36-27(42)23-20(11-44-3)38-39-25(37-23)21-16(24(31)32)4-5-18(29)22(21)30/h4-5,7-8,10,13-14,17,24H,6,9,11H2,1-3H3,(H,36,42)/t13?,14-,17-/m1/s1	HKSQPHGJEPXYBV-DTLKIFBZSA-N	617914	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-(methoxymethyl)-N-(1-((R or S)-1-(6-methyl-5-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrazin-2-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 126	Plasma kallikrein			 0.500							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617914	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617914&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317747	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(F)c1C)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C29H24ClF4N7O2/c1-12-19(8-36-27(23(12)31)40-10-15-6-18(15)29(40)43)14(3)41-11-16(7-37-41)38-28(42)25-13(2)35-9-21(39-25)22-17(26(33)34)4-5-20(30)24(22)32/h4-5,7-9,11,14-15,18,26H,6,10H2,1-3H3,(H,38,42)/t14?,15-,18-/m1/s1	UHRURUXVXNFGPR-QTLYGJNZSA-N	617915	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((S or i)-1-(5-fluoro-4-methyl-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)ethyl)-1H-pyrazol-4-yl)-3-methylpyrazine-2-carboxamide::US20230286958, Example 127::US20230286958, Example 128	Plasma kallikrein			 0.500							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617915	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617915&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317749	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(F)c1C)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C29H24ClF4N7O2/c1-12-19(8-36-27(23(12)31)40-10-15-6-18(15)29(40)43)14(3)41-11-16(7-37-41)38-28(42)25-13(2)35-9-21(39-25)22-17(26(33)34)4-5-20(30)24(22)32/h4-5,7-9,11,14-15,18,26H,6,10H2,1-3H3,(H,38,42)/t14?,15-,18-/m1/s1	UHRURUXVXNFGPR-QTLYGJNZSA-N	617915	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((S or i)-1-(5-fluoro-4-methyl-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)ethyl)-1H-pyrazol-4-yl)-3-methylpyrazine-2-carboxamide::US20230286958, Example 127::US20230286958, Example 128	Plasma kallikrein			 7.10							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617915	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617915&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317751	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(F)c1C)n1cc(NC(=O)c2nc(cnc2C)-c2c(OC(F)F)ccc(Cl)c2F)cn1	InChI=1S/C29H24ClF4N7O3/c1-12-18(8-36-26(23(12)31)40-10-15-6-17(15)28(40)43)14(3)41-11-16(7-37-41)38-27(42)25-13(2)35-9-20(39-25)22-21(44-29(33)34)5-4-19(30)24(22)32/h4-5,7-9,11,14-15,17,29H,6,10H2,1-3H3,(H,38,42)/t14?,15-,17-/m1/s1	OPAHIKCMESQWDF-HOSQGPGDSA-N	617917	6-(3-Chloro-6-(difluoromethoxy)-2-fluorophenyl)-N-(1-((S or R)-1-(5-fluoro-4-methyl-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)ethyl)-IH-pyrazol-4-yl)-3-methylpyrazine-2-carboxamide::US20230286958, Example 129::US20230286958, Example 130	Plasma kallikrein			 4.30							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617917	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617917&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317753	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(F)c1C)n1cc(NC(=O)c2nc(cnc2C)-c2c(OC(F)F)ccc(Cl)c2F)cn1	InChI=1S/C29H24ClF4N7O3/c1-12-18(8-36-26(23(12)31)40-10-15-6-17(15)28(40)43)14(3)41-11-16(7-37-41)38-27(42)25-13(2)35-9-20(39-25)22-21(44-29(33)34)5-4-19(30)24(22)32/h4-5,7-9,11,14-15,17,29H,6,10H2,1-3H3,(H,38,42)/t14?,15-,17-/m1/s1	OPAHIKCMESQWDF-HOSQGPGDSA-N	617917	6-(3-Chloro-6-(difluoromethoxy)-2-fluorophenyl)-N-(1-((S or R)-1-(5-fluoro-4-methyl-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)ethyl)-IH-pyrazol-4-yl)-3-methylpyrazine-2-carboxamide::US20230286958, Example 129::US20230286958, Example 130	Plasma kallikrein			 0.800							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617917	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617917&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317755	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(C)c1)n1cc(NC(=O)c2nc(cnc2C)-c2c(OC(F)F)ccc(Cl)c2F)cn1	InChI=1S/C29H25ClF3N7O3/c1-13-6-16(8-35-26(13)39-11-17-7-19(17)28(39)42)15(3)40-12-18(9-36-40)37-27(41)25-14(2)34-10-21(38-25)23-22(43-29(32)33)5-4-20(30)24(23)31/h4-6,8-10,12,15,17,19,29H,7,11H2,1-3H3,(H,37,41)/t15?,17-,19-/m1/s1	QWRMLYGJHYOEIN-GERZZCHPSA-N	617919	6-(3-Chloro-6-(difluoromethoxy)-2-fluorophenyl)-3-methyl-N-(1-((S or R)-1-(5-methyl-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 131::US20230286958, Example 132	Plasma kallikrein			 0.500							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617919	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617919&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317757	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(C)c1)n1cc(NC(=O)c2nc(cnc2C)-c2c(OC(F)F)ccc(Cl)c2F)cn1	InChI=1S/C29H25ClF3N7O3/c1-13-6-16(8-35-26(13)39-11-17-7-19(17)28(39)42)15(3)40-12-18(9-36-40)37-27(41)25-14(2)34-10-21(38-25)23-22(43-29(32)33)5-4-20(30)24(23)31/h4-6,8-10,12,15,17,19,29H,7,11H2,1-3H3,(H,37,41)/t15?,17-,19-/m1/s1	QWRMLYGJHYOEIN-GERZZCHPSA-N	617919	6-(3-Chloro-6-(difluoromethoxy)-2-fluorophenyl)-3-methyl-N-(1-((S or R)-1-(5-methyl-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 131::US20230286958, Example 132	Plasma kallikrein			 0.600							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617919	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617919&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317759	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(F)c1C)n1cc(NC(=O)c2cncc(n2)-c2c(OC(F)F)ccc(Cl)c2F)cn1	InChI=1S/C28H22ClF4N7O3/c1-12-17(7-35-25(23(12)30)39-10-14-5-16(14)27(39)42)13(2)40-11-15(6-36-40)37-26(41)20-9-34-8-19(38-20)22-21(43-28(32)33)4-3-18(29)24(22)31/h3-4,6-9,11,13-14,16,28H,5,10H2,1-2H3,(H,37,41)/t13?,14-,16-/m1/s1	XMXXHDVGILDRBZ-IGLHTZBQSA-N	617921	6-(3-Chloro-6-(difluoromethoxy)-2-fluorophenyl)-N-(1-((S or R)-1-(5-fluoro-4-methyl-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)ethyl)-1i-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 133::US20230286958, Example 134	Plasma kallikrein			 0.600							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617921	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617921&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317761	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(F)c1C)n1cc(NC(=O)c2cncc(n2)-c2c(OC(F)F)ccc(Cl)c2F)cn1	InChI=1S/C28H22ClF4N7O3/c1-12-17(7-35-25(23(12)30)39-10-14-5-16(14)27(39)42)13(2)40-11-15(6-36-40)37-26(41)20-9-34-8-19(38-20)22-21(43-28(32)33)4-3-18(29)24(22)31/h3-4,6-9,11,13-14,16,28H,5,10H2,1-2H3,(H,37,41)/t13?,14-,16-/m1/s1	XMXXHDVGILDRBZ-IGLHTZBQSA-N	617921	6-(3-Chloro-6-(difluoromethoxy)-2-fluorophenyl)-N-(1-((S or R)-1-(5-fluoro-4-methyl-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)ethyl)-1i-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 133::US20230286958, Example 134	Plasma kallikrein			 13.9							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617921	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617921&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317763	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(F)c1C)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C#N)cn1	InChI=1S/C29H23ClF2N8O2/c1-13-20(9-35-27(24(13)31)39-11-17-6-19(17)29(39)42)15(3)40-12-18(8-36-40)37-28(41)26-14(2)34-10-22(38-26)23-16(7-33)4-5-21(30)25(23)32/h4-5,8-10,12,15,17,19H,6,11H2,1-3H3,(H,37,41)/t15?,17-,19-/m1/s1	DCLSJFXDVAAQJQ-GERZZCHPSA-N	50582288	CHEMBL5089406::US20230286958, Example 136	Plasma kallikrein			 5.40							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50582288	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50582288&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			166632971	476027293							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317765	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(F)c1C)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C#N)cn1	InChI=1S/C29H23ClF2N8O2/c1-13-20(9-35-27(24(13)31)39-11-17-6-19(17)29(39)42)15(3)40-12-18(8-36-40)37-28(41)26-14(2)34-10-22(38-26)23-16(7-33)4-5-21(30)25(23)32/h4-5,8-10,12,15,17,19H,6,11H2,1-3H3,(H,37,41)/t15?,17-,19-/m1/s1	DCLSJFXDVAAQJQ-GERZZCHPSA-N	50582288	CHEMBL5089406::US20230286958, Example 136	Plasma kallikrein			 0.200							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50582288	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50582288&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			166632971	476027293							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317767	CC(c1ncc(cc1F)N1C[C@H]2C[C@H]2C1=O)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H22ClF4N7O2/c1-12-24(38-21(9-34-12)22-17(26(32)33)3-4-19(29)23(22)31)27(41)37-15-7-36-40(11-15)13(2)25-20(30)6-16(8-35-25)39-10-14-5-18(14)28(39)42/h3-4,6-9,11,13-14,18,26H,5,10H2,1-2H3,(H,37,41)/t13?,14-,18-/m1/s1	AQSWYLPMFSJMQZ-JDPNFYKBSA-N	617925	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((S or R)-1-(3-fluoro-5-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-2-yl)ethyl)-1H-pyrazol-4-yl)-3-methylpyrazine-2-carboxamide::US20230286958, Example 137	Plasma kallikrein			 7.70							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617925	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617925&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317769	Cc1ncc(nc1C(=O)Nc1cnn(Cc2ncc(cc2F)N2C[C@H]3C[C@H]3C2=O)c1)-c1c(F)c(Cl)ccc1C(F)F	InChI=1S/C27H20ClF4N7O2/c1-12-24(37-20(8-33-12)22-16(25(31)32)2-3-18(28)23(22)30)26(40)36-14-6-35-38(10-14)11-21-19(29)5-15(7-34-21)39-9-13-4-17(13)27(39)41/h2-3,5-8,10,13,17,25H,4,9,11H2,1H3,(H,36,40)/t13-,17-/m1/s1	YGZBIOWOALHTHZ-CXAGYDPISA-N	617926	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((3-fluoro-5-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-2-yl)methyl)-1H-pyrazol-4-yl)-3-methylpyrazine-2-carboxamide::US20230286958, Example 138	Plasma kallikrein			 47.0							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617926	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617926&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317771	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(C)c1)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C#N)cn1	InChI=1S/C29H24ClFN8O2/c1-14-6-18(9-34-27(14)38-12-19-7-21(19)29(38)41)16(3)39-13-20(10-35-39)36-28(40)26-15(2)33-11-23(37-26)24-17(8-32)4-5-22(30)25(24)31/h4-6,9-11,13,16,19,21H,7,12H2,1-3H3,(H,36,40)/t16?,19-,21-/m1/s1	BVIDABUHKFIJPH-MUVQZQTDSA-N	617927	6-(3-Chloro-6-cyano-2-fluorophenyl)-3-methyl-N-(1-((S or R)-1-(5-methyl-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 139::US20230286958, Example 140	Plasma kallikrein			 0.900							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617927	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617927&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317773	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(C)c1)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C#N)cn1	InChI=1S/C29H24ClFN8O2/c1-14-6-18(9-34-27(14)38-12-19-7-21(19)29(38)41)16(3)39-13-20(10-35-39)36-28(40)26-15(2)33-11-23(37-26)24-17(8-32)4-5-22(30)25(24)31/h4-6,9-11,13,16,19,21H,7,12H2,1-3H3,(H,36,40)/t16?,19-,21-/m1/s1	BVIDABUHKFIJPH-MUVQZQTDSA-N	617927	6-(3-Chloro-6-cyano-2-fluorophenyl)-3-methyl-N-(1-((S or R)-1-(5-methyl-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 139::US20230286958, Example 140	Plasma kallikrein			 0.600							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617927	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617927&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317775	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c2CCCc12)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C30H25ClF3N7O2/c1-14(21-9-36-28(18-4-2-3-17(18)21)40-12-15-7-20(15)30(40)43)41-13-16(8-37-41)38-29(42)24-11-35-10-23(39-24)25-19(27(33)34)5-6-22(31)26(25)32/h5-6,8-11,13-15,20,27H,2-4,7,12H2,1H3,(H,38,42)/t14?,15-,20-/m1/s1	MNXBWEWRFDRXBD-XUERPSFUSA-N	617929	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((S or R)-1-(1-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)-6,7-dihydro-5H-cyclopenta[c]pyridin-4-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 141::US20230286958, Example 142	Plasma kallikrein			 1.10							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617929	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617929&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317777	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c2CCCc12)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C30H25ClF3N7O2/c1-14(21-9-36-28(18-4-2-3-17(18)21)40-12-15-7-20(15)30(40)43)41-13-16(8-37-41)38-29(42)24-11-35-10-23(39-24)25-19(27(33)34)5-6-22(31)26(25)32/h5-6,8-11,13-15,20,27H,2-4,7,12H2,1H3,(H,38,42)/t14?,15-,20-/m1/s1	MNXBWEWRFDRXBD-XUERPSFUSA-N	617929	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((S or R)-1-(1-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)-6,7-dihydro-5H-cyclopenta[c]pyridin-4-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 141::US20230286958, Example 142	Plasma kallikrein			 0.600							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617929	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617929&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317779	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(F)c1)n1cc(NC(=O)c2nc(cnc2COC(C)(C)C)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C32H30ClF4N7O3/c1-15(16-8-22(34)29(39-9-16)43-12-17-7-20(17)31(43)46)44-13-18(10-40-44)41-30(45)27-24(14-47-32(2,3)4)38-11-23(42-27)25-19(28(36)37)5-6-21(33)26(25)35/h5-6,8-11,13,15,17,20,28H,7,12,14H2,1-4H3,(H,41,45)/t15?,17-,20-/m1/s1	CDOZAFSWYAPXPU-LQRGHNGLSA-N	617931	3-(tert-Butoxymethyl)-6-(3-chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((S or R)-1-(5-fluoro-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 143::US20230286958, Example 144	Plasma kallikrein			 4.90							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617931	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617931&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317781	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(F)c1)n1cc(NC(=O)c2nc(cnc2COC(C)(C)C)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C32H30ClF4N7O3/c1-15(16-8-22(34)29(39-9-16)43-12-17-7-20(17)31(43)46)44-13-18(10-40-44)41-30(45)27-24(14-47-32(2,3)4)38-11-23(42-27)25-19(28(36)37)5-6-21(33)26(25)35/h5-6,8-11,13,15,17,20,28H,7,12,14H2,1-4H3,(H,41,45)/t15?,17-,20-/m1/s1	CDOZAFSWYAPXPU-LQRGHNGLSA-N	617931	3-(tert-Butoxymethyl)-6-(3-chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((S or R)-1-(5-fluoro-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 143::US20230286958, Example 144	Plasma kallikrein			 1.60							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617931	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617931&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317783	FC(F)c1ccc(Cl)c(F)c1-c1cncc(n1)C(=O)Nc1cnn(Cc2ccc(cc2)N2C[C@H]3C[C@H]3C2=O)c1	InChI=1S/C27H20ClF3N6O2/c28-20-6-5-18(25(30)31)23(24(20)29)21-9-32-10-22(35-21)26(38)34-16-8-33-36(13-16)11-14-1-3-17(4-2-14)37-12-15-7-19(15)27(37)39/h1-6,8-10,13,15,19,25H,7,11-12H2,(H,34,38)/t15-,19-/m1/s1	FMMWWQNKQVCIEY-DNVCBOLYSA-N	617933	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-(4-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)benzyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 145	Plasma kallikrein			 2.40							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617933	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617933&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317785	CC(c1ncc(cc1F)N1C[C@H]2C[C@H]2C1=O)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C27H20ClF4N7O2/c1-12(24-19(29)5-15(7-34-24)38-10-13-4-17(13)27(38)41)39-11-14(6-35-39)36-26(40)21-9-33-8-20(37-21)22-16(25(31)32)2-3-18(28)23(22)30/h2-3,5-9,11-13,17,25H,4,10H2,1H3,(H,36,40)/t12?,13-,17-/m1/s1	DNUCXZKXZBADNW-QQGYXAEISA-N	617934	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((R or S)-1-(3-fluoro-5-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-2-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 146	Plasma kallikrein			 9.80							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617934	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617934&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317787	CC(c1ncc(cc1Cl)N1C[C@H]2C[C@H]2C1=O)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H22Cl2F3N7O2/c1-12-24(38-21(9-34-12)22-17(26(32)33)3-4-19(29)23(22)31)27(41)37-15-7-36-40(11-15)13(2)25-20(30)6-16(8-35-25)39-10-14-5-18(14)28(39)42/h3-4,6-9,11,13-14,18,26H,5,10H2,1-2H3,(H,37,41)/t13?,14-,18-/m1/s1	DSLFLYSMKNDAIE-JDPNFYKBSA-N	617935	N-(1-((R or S)-1-(3-Chloro-5-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-2-yl)ethyl)-1H-pyrazol-4-yl)-6-(3-chloro-6-(difluoromethyl)-2-fluorophenyl)-3-methylpyrazine-2-carboxamide::US20230286958, Example 147	Plasma kallikrein			 2.90							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617935	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617935&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317789	CC(c1ncc(cc1Cl)N1C[C@H]2C[C@H]2C1=O)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C27H20Cl2F3N7O2/c1-12(24-19(29)5-15(7-34-24)38-10-13-4-17(13)27(38)41)39-11-14(6-35-39)36-26(40)21-9-33-8-20(37-21)22-16(25(31)32)2-3-18(28)23(22)30/h2-3,5-9,11-13,17,25H,4,10H2,1H3,(H,36,40)/t12?,13-,17-/m1/s1	OWJQXYONBIAZPL-QQGYXAEISA-N	617936	N-(1-((R or S)-1-(3-Chloro-5-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3 -yl)pyridin-2-yl)ethyl)-1H-pyrazol-4-yl)-6-(3-chloro-6-(difluoromethyl)-2-fluorophenyl)-3-methylpyrazine-2-carboxamide::US20230286958, Example 148	Plasma kallikrein			 5.90							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617936	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617936&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317791	Cc1ncc(nc1C(=O)Nc1cnn(Cc2cnc(N3C[C@H]4C[C@H]4C3=O)c3OCOc23)c1)-c1c(F)c(Cl)ccc1C(F)F	InChI=1S/C28H21ClF3N7O4/c1-12-22(37-19(7-33-12)20-16(25(31)32)2-3-18(29)21(20)30)27(40)36-15-6-35-38(10-15)8-14-5-34-26(24-23(14)42-11-43-24)39-9-13-4-17(13)28(39)41/h2-3,5-7,10,13,17,25H,4,8-9,11H2,1H3,(H,36,40)/t13-,17-/m1/s1	OYUAZKUQDXYHFK-CXAGYDPISA-N	617937	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-methyl-N-(1-((4-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)-[1,3]dioxolo[4,5-c]pyridin-7-yl)methyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 149	Plasma kallikrein			 0.900							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617937	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617937&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317793	C[C@H](c1cc(F)c(nc1C)N1C[C@H]2C[C@H]2C1=O)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H22ClF4N7O2/c1-12-17(6-20(30)26(36-12)39-10-14-5-18(14)28(39)42)13(2)40-11-15(7-35-40)37-27(41)22-9-34-8-21(38-22)23-16(25(32)33)3-4-19(29)24(23)31/h3-4,6-9,11,13-14,18,25H,5,10H2,1-2H3,(H,37,41)/t13-,14-,18-/m1/s1	BQMIYGVARIGCAJ-HBUWYVDXSA-N	617938	US20230286958, Example 150	Plasma kallikrein			 177							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617938	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617938&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317795	C[C@@H](c1cc(F)c(nc1C)N1C[C@H]2C[C@H]2C1=O)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H22ClF4N7O2/c1-12-17(6-20(30)26(36-12)39-10-14-5-18(14)28(39)42)13(2)40-11-15(7-35-40)37-27(41)22-9-34-8-21(38-22)23-16(25(32)33)3-4-19(29)24(23)31/h3-4,6-9,11,13-14,18,25H,5,10H2,1-2H3,(H,37,41)/t13-,14+,18+/m0/s1	BQMIYGVARIGCAJ-PMUMKWKESA-N	617939	US20230286958, Example 151	Plasma kallikrein			 5.80							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617939	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617939&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317797	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(C)c1C)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C29H25ClF3N7O2/c1-13-14(2)27(39-11-16-6-19(16)29(39)42)35-8-20(13)15(3)40-12-17(7-36-40)37-28(41)23-10-34-9-22(38-23)24-18(26(32)33)4-5-21(30)25(24)31/h4-5,7-10,12,15-16,19,26H,6,11H2,1-3H3,(H,37,41)/t15?,16-,19-/m1/s1	BHKJUCWCWRSZFB-HFLHWUEFSA-N	617940	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((R or S)-1-(4,5-dimethyl-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 152::US20230286958, Example 153	Plasma kallikrein			 0.300							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617940	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617940&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317799	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(C)c1C)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C29H25ClF3N7O2/c1-13-14(2)27(39-11-16-6-19(16)29(39)42)35-8-20(13)15(3)40-12-17(7-36-40)37-28(41)23-10-34-9-22(38-23)24-18(26(32)33)4-5-21(30)25(24)31/h4-5,7-10,12,15-16,19,26H,6,11H2,1-3H3,(H,37,41)/t15?,16-,19-/m1/s1	BHKJUCWCWRSZFB-HFLHWUEFSA-N	617940	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((R or S)-1-(4,5-dimethyl-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 152::US20230286958, Example 153	Plasma kallikrein			 2.00							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617940	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617940&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317801	COc1c(C)c(cnc1N1C[C@H]2C[C@H]2C1=O)C(C)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C29H25ClF3N7O3/c1-13-19(8-35-27(25(13)43-3)39-11-15-6-18(15)29(39)42)14(2)40-12-16(7-36-40)37-28(41)22-10-34-9-21(38-22)23-17(26(32)33)4-5-20(30)24(23)31/h4-5,7-10,12,14-15,18,26H,6,11H2,1-3H3,(H,37,41)/t14?,15-,18-/m1/s1	AESNDDHBSPWNAX-QTLYGJNZSA-N	50582289	CHEMBL5076760::US20230286958, Example 155	Plasma kallikrein			 0.300							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50582289	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50582289&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			166626045	476027294							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338040	O=S(=O)(NCCOc1ccccc1)c1cnn(Cc2cn3cc(ccc3n2)C2CC2)c1	InChI=1S/C22H23N5O3S/c28-31(29,24-10-11-30-20-4-2-1-3-5-20)21-12-23-27(16-21)15-19-14-26-13-18(17-6-7-17)8-9-22(26)25-19/h1-5,8-9,12-14,16-17,24H,6-7,10-11,15H2	JTJGILPBJXKRDO-UHFFFAOYSA-N	626675	1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-N-(2-phenoxyethyl)-1H-pyrazole-4-sulfonamide ::US11787796, Compound I-36	Plasma kallikrein					>7100					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626675	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626675&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152174	485655130							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338041	CC(NS(=O)(=O)c1cnn(Cc2cn3cc(ccc3n2)C2CC2)c1)c1ccc(Cl)cc1	InChI=1S/C22H22ClN5O2S/c1-15(16-4-7-19(23)8-5-16)26-31(29,30)21-10-24-28(14-21)13-20-12-27-11-18(17-2-3-17)6-9-22(27)25-20/h4-12,14-15,17,26H,2-3,13H2,1H3	AVURKXYWOHVEFC-UHFFFAOYSA-N	626676	US11787796, Compound I-37::rrr	Plasma kallikrein					>7100					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626676	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626676&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156174792	485655131							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338042	CC(NS(=O)(=O)c1cnn(Cc2cn3cc(ccc3n2)C2CC2)c1)c1cccc(Cl)c1	InChI=1S/C22H22ClN5O2S/c1-15(17-3-2-4-19(23)9-17)26-31(29,30)21-10-24-28(14-21)13-20-12-27-11-18(16-5-6-16)7-8-22(27)25-20/h2-4,7-12,14-16,26H,5-6,13H2,1H3	ZCUZZYXJPPCJDM-UHFFFAOYSA-N	626677	N-(1-(3-chlorophenyl)ethyl)-1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-pyrazole-4-sulfonamide ::US11787796, Compound I-38	Plasma kallikrein					>7100					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626677	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626677&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152068	485655132							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338043	Cc1cc(cc(C)c1CNS(=O)(=O)c1cnn(Cc2cn3cc(ccc3n2)C2CC2)c1)C(N)=N	InChI=1S/C24H27N7O2S/c1-15-7-19(24(25)26)8-16(2)22(15)10-28-34(32,33)21-9-27-31(14-21)13-20-12-30-11-18(17-3-4-17)5-6-23(30)29-20/h5-9,11-12,14,17,28H,3-4,10,13H2,1-2H3,(H3,25,26)	KRRQGAFNLQSHJO-UHFFFAOYSA-N	626678	4-(((1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-pyrazole)-4-sulfonamido)methyl)-3,5-dimethylbenzimidamide ::US11787796, Compound I-39	Plasma kallikrein					 55					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626678	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626678&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152059	485655133							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338044	COc1ccc(c(CNS(=O)(=O)c2cn(Cc3cn4cc(ccc4n3)C3CC3)nn2)c1F)-n1cnnn1	InChI=1S/C22H21FN10O3S/c1-36-19-6-5-18(33-13-24-28-30-33)17(22(19)23)8-25-37(34,35)21-12-32(29-27-21)11-16-10-31-9-15(14-2-3-14)4-7-20(31)26-16/h4-7,9-10,12-14,25H,2-3,8,11H2,1H3	NQFBBKSBLRLDRW-UHFFFAOYSA-N	626679	1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-N-(2-fluoro-3-methoxy-6-(1H-tetrazol-1-yl)benzyl)-1H-1,2,3-triazole-4-sulfonamide ::US11787796, Compound I-40	Plasma kallikrein					 55					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626679	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626679&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156151934	485655134							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338045	Cc1cc(CN)cc(C)c1CNS(=O)(=O)c1cnn(Cc2cn3cc(ccc3n2)C2CC2)c1	InChI=1S/C24H28N6O2S/c1-16-7-18(9-25)8-17(2)23(16)11-27-33(31,32)22-10-26-30(15-22)14-21-13-29-12-20(19-3-4-19)5-6-24(29)28-21/h5-8,10,12-13,15,19,27H,3-4,9,11,14,25H2,1-2H3	LPYNGEIGTDYQMP-UHFFFAOYSA-N	626680	N-(4-(aminomethyl)-2,6-dimethylbenzyl)-1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-pyrazole-4-sulfonamide ::US11787796, Compound I-41	Plasma kallikrein					 4550					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626680	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626680&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152083	485655135							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338046	Clc1ccc(CNS(=O)(=O)c2cnn(Cc3cn4cc(ccc4n3)C3CC3)c2)cc1	InChI=1S/C21H20ClN5O2S/c22-18-6-1-15(2-7-18)9-24-30(28,29)20-10-23-27(14-20)13-19-12-26-11-17(16-3-4-16)5-8-21(26)25-19/h1-2,5-8,10-12,14,16,24H,3-4,9,13H2	REMIRDXGLSALHZ-UHFFFAOYSA-N	626681	N-(4-chlorobenzyl)-1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-pyrazole-4-sulfonamide ::US11787796, Compound I-42	Plasma kallikrein					>7100					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626681	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626681&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152099	485655136							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338047	Cc1cc(cc(C)c1CNS(=O)(=O)c1cnn(Cc2cn3cc(ccc3n2)C2CC2)c1)C#N	InChI=1S/C24H24N6O2S/c1-16-7-18(9-25)8-17(2)23(16)11-27-33(31,32)22-10-26-30(15-22)14-21-13-29-12-20(19-3-4-19)5-6-24(29)28-21/h5-8,10,12-13,15,19,27H,3-4,11,14H2,1-2H3	QOMBELKAVQKZDF-UHFFFAOYSA-N	626682	N-(4-cyano-2,6-dimethylbenzyl)-1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-pyrazole-4-sulfonamide ::US11787796, Compound I-43	Plasma kallikrein					>7100					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626682	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626682&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152118	485655137							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338048	Clc1cccc(CCNS(=O)(=O)c2cnn(Cc3cn4cc(ccc4n3)C3CC3)c2)c1	InChI=1S/C22H22ClN5O2S/c23-19-3-1-2-16(10-19)8-9-25-31(29,30)21-11-24-28(15-21)14-20-13-27-12-18(17-4-5-17)6-7-22(27)26-20/h1-3,6-7,10-13,15,17,25H,4-5,8-9,14H2	HOWTZHPOYDTUDX-UHFFFAOYSA-N	626683	N-(3-chlorophenethyl)-1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-pyrazole-4-sulfonamide ::US11787796, Compound I-44	Plasma kallikrein					>7100					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626683	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626683&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152066	485655138							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338049	COc1ccc(c(CNS(=O)(=O)c2cnn(Cc3cn4cc(ccc4n3)C3CC3)c2)c1F)-n1cnnn1	InChI=1S/C23H22FN9O3S/c1-36-21-6-5-20(33-14-25-29-30-33)19(23(21)24)9-27-37(34,35)18-8-26-32(13-18)12-17-11-31-10-16(15-2-3-15)4-7-22(31)28-17/h4-8,10-11,13-15,27H,2-3,9,12H2,1H3	KACPSTNMECDCDW-UHFFFAOYSA-N	626684	1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-N-(2-fluoro-3-methyl-6-(1H-tetrazol-1-yl)benzyl)-1H-pyrazole-4-sulfonamide ::US11787796, Compound I-45	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626684	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626684&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152223	485655139							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338050	Cc1cc(N)nc(C)c1CNS(=O)(=O)c1cnn(Cc2cn3cc(ccc3n2)C2CC2)c1	InChI=1S/C22H25N7O2S/c1-14-7-21(23)26-15(2)20(14)9-25-32(30,31)19-8-24-29(13-19)12-18-11-28-10-17(16-3-4-16)5-6-22(28)27-18/h5-8,10-11,13,16,25H,3-4,9,12H2,1-2H3,(H2,23,26)	WHAUUCYWQVGOKB-UHFFFAOYSA-N	626685	N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)-1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-pyrazole-4-sulfonamide ::US11787796, Compound I-46	Plasma kallikrein					 1050					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626685	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626685&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152306	485655140							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338051	Clc1cccc(CNS(=O)(=O)c2cnn(Cc3cn4cc(ccc4n3)C3CC3)c2)c1	InChI=1S/C21H20ClN5O2S/c22-18-3-1-2-15(8-18)9-24-30(28,29)20-10-23-27(14-20)13-19-12-26-11-17(16-4-5-16)6-7-21(26)25-19/h1-3,6-8,10-12,14,16,24H,4-5,9,13H2	YAOAEXAQISWJTA-UHFFFAOYSA-N	626686	N-(3-chlorobenzyl)-1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-pyrazole-4-sulfonamide ::US11787796, Compound I-47	Plasma kallikrein					>7100					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626686	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626686&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152152	485655141							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338052	COc1ccc(c(CNC(=O)c2cn(Cc3cn4cc(ccc4n3)C3CC3)nn2)c1F)S(=O)(=O)N1CCOCC1	InChI=1S/C26H28FN7O5S/c1-38-22-5-6-23(40(36,37)34-8-10-39-11-9-34)20(25(22)27)12-28-26(35)21-16-33(31-30-21)15-19-14-32-13-18(17-2-3-17)4-7-24(32)29-19/h4-7,13-14,16-17H,2-3,8-12,15H2,1H3,(H,28,35)	AMQOALKZSLRIMF-UHFFFAOYSA-N	626687	1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-N-(2-fluoro-3-methoxy-6-(morpholinosulfonyl)benzyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-48	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626687	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626687&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156151985	485655142							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338053	COc1ccc(-c2c[nH]nn2)c(CNC(=O)c2cn(Cc3cn4cc(ccc4n3)C3CC3)nn2)c1F	InChI=1S/C24H22FN9O2/c1-36-21-6-5-17(19-9-27-31-29-19)18(23(21)25)8-26-24(35)20-13-34(32-30-20)12-16-11-33-10-15(14-2-3-14)4-7-22(33)28-16/h4-7,9-11,13-14H,2-3,8,12H2,1H3,(H,26,35)(H,27,29,31)	WRBUNWDTBOJHDY-UHFFFAOYSA-N	626688	1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-N-(2-fluor-3-methoxy-6-(1H-1,2,3-triazol-4-yl)benzyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-49::US11787796, Compound I-50	Plasma kallikrein					 55					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626688	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626688&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152014	485655143							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338054	COc1ccc(-c2c[nH]nn2)c(CNC(=O)c2cn(Cc3cn4cc(ccc4n3)C3CC3)nn2)c1F	InChI=1S/C24H22FN9O2/c1-36-21-6-5-17(19-9-27-31-29-19)18(23(21)25)8-26-24(35)20-13-34(32-30-20)12-16-11-33-10-15(14-2-3-14)4-7-22(33)28-16/h4-7,9-11,13-14H,2-3,8,12H2,1H3,(H,26,35)(H,27,29,31)	WRBUNWDTBOJHDY-UHFFFAOYSA-N	626688	1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-N-(2-fluor-3-methoxy-6-(1H-1,2,3-triazol-4-yl)benzyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-49::US11787796, Compound I-50	Plasma kallikrein					>7100					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626688	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626688&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152014	485655143							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338055	CS(=O)(=O)c1ccccc1CNC(=O)c1cn(Cc2cn3cc(ccc3n2)C2CC2)nn1	InChI=1S/C22H22N6O3S/c1-32(30,31)20-5-3-2-4-16(20)10-23-22(29)19-14-28(26-25-19)13-18-12-27-11-17(15-6-7-15)8-9-21(27)24-18/h2-5,8-9,11-12,14-15H,6-7,10,13H2,1H3,(H,23,29)	XPPCPMTXWINCFF-UHFFFAOYSA-N	626690	1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-N-(2-(methylsulfonyl)benzyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-51	Plasma kallikrein					 1050					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626690	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626690&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152007	485655144							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338056	COc1ccc(c(CNC(=O)c2cn(Cc3cn4cc(ccc4n3)C3CC3)nn2)c1F)-n1cnc(n1)C(F)(F)F	InChI=1S/C25H21F4N9O2/c1-40-20-6-5-19(38-13-31-24(34-38)25(27,28)29)17(22(20)26)8-30-23(39)18-12-37(35-33-18)11-16-10-36-9-15(14-2-3-14)4-7-21(36)32-16/h4-7,9-10,12-14H,2-3,8,11H2,1H3,(H,30,39)	RLNQJBMAFXNVBU-UHFFFAOYSA-N	626691	1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-N-(2-fluoro-3-methoxy-6-(3-(trifluoromethyl)-1H-1,2,4-triazol-1-yl)benzyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-52	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626691	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626691&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152142	485655145							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338057	COc1ccc(c(CNC(=O)c2cn(Cc3cn4cc(ccc4n3)C3CC3)nn2)c1F)S(C)(=O)=O	InChI=1S/C23H23FN6O4S/c1-34-19-6-7-20(35(2,32)33)17(22(19)24)9-25-23(31)18-13-30(28-27-18)12-16-11-29-10-15(14-3-4-14)5-8-21(29)26-16/h5-8,10-11,13-14H,3-4,9,12H2,1-2H3,(H,25,31)	TZSJPZOEULWSAQ-UHFFFAOYSA-N	626692	1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-N-(2-fluoro-3-methoxy-6-(methylsulfonyl)benzyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-53	Plasma kallikrein					 1050					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626692	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626692&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156151917	485655146							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338058	COc1ccc(c(CNC(=O)c2ccn(Cc3cn4cc(ccc4n3)C3CC3)c2)c1F)-n1cnnn1	InChI=1S/C25H23FN8O2/c1-36-22-6-5-21(34-15-28-30-31-34)20(24(22)26)10-27-25(35)18-8-9-32(11-18)13-19-14-33-12-17(16-2-3-16)4-7-23(33)29-19/h4-9,11-12,14-16H,2-3,10,13H2,1H3,(H,27,35)	NXKHMPWEZDZMOZ-UHFFFAOYSA-N	626693	1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-N-(2-fluoro-3-methoxy-6-(1H-tetrazol-1-yl)benzyl)-1H-pyrrole-3-carboxamide ::US11787796, Compound I-54	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626693	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626693&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152291	485655147							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338059	COc1ccc(c(CNC(=O)c2cn(Cc3cn4cc(ccc4n3)C3CC3)cn2)c1F)-n1cnnn1	InChI=1S/C24H22FN9O2/c1-36-21-6-5-20(34-14-28-30-31-34)18(23(21)25)8-26-24(35)19-12-32(13-27-19)10-17-11-33-9-16(15-2-3-15)4-7-22(33)29-17/h4-7,9,11-15H,2-3,8,10H2,1H3,(H,26,35)	AMLNCKDLKNZIIB-UHFFFAOYSA-N	626694	1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-N-(2-fluoro-3-methoxy-6-(1H-tetrazol-1-yl)benzyl)-1H-imidazole-4-carboxamide ::US11787796, Compound I-55	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626694	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626694&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152126	485655148							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338060	Fc1c(Cl)ccn2c(ncc12)C(=O)NCc1cn(Cc2cn3cc(ccc3n2)C2CC2)nn1	InChI=1S/C22H18ClFN8O/c23-17-5-6-32-18(20(17)24)8-25-21(32)22(33)26-7-15-11-31(29-28-15)12-16-10-30-9-14(13-1-2-13)3-4-19(30)27-16/h3-6,8-11,13H,1-2,7,12H2,(H,26,33)	BHHQDIZFAGVGIO-UHFFFAOYSA-N	626695	7-chloro-N-((1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-1,2,3-triazol-4-yl)methyl)-8-fluoroimidazo[1,5-a]pyridine-3-carboxamide ::US11787796, Compound I-56	Plasma kallikrein					>7100					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626695	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626695&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156151905	485655149							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338061	COc1ccc(c(CNC(=O)c2cn(Cc3cn4cc(ccc4n3)C3CC3)nn2)c1F)S(=O)(=O)N(C)C	InChI=1S/C24H26FN7O4S/c1-30(2)37(34,35)21-8-7-20(36-3)23(25)18(21)10-26-24(33)19-14-32(29-28-19)13-17-12-31-11-16(15-4-5-15)6-9-22(31)27-17/h6-9,11-12,14-15H,4-5,10,13H2,1-3H3,(H,26,33)	WAKADGMYMABGDU-UHFFFAOYSA-N	626696	1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-N-(6-(N,N-dimethylsulfamoyl)-2-fluoro-3-methoxybenzyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-57	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626696	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626696&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156151877	485655150							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338062	COc1ccc(c(CNC(=O)c2cn(Cc3cn4cc(ccc4n3)C3CC3)nn2)c1F)S(C)=O	InChI=1S/C23H23FN6O3S/c1-33-19-6-7-20(34(2)32)17(22(19)24)9-25-23(31)18-13-30(28-27-18)12-16-11-29-10-15(14-3-4-14)5-8-21(29)26-16/h5-8,10-11,13-14H,3-4,9,12H2,1-2H3,(H,25,31)	CJQVDKWRDBKKLR-UHFFFAOYSA-N	626697	1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-N-(2-fluoro-3-methoxy-6-(methylsulfinyl)benzyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-58	Plasma kallikrein					 4550					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626697	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626697&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152147	485655151							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338063	COc1ccc(c(CNC(=O)c2cncn2Cc2cn3cc(ccc3n2)C2CC2)c1F)-n1cnnn1	InChI=1S/C24H22FN9O2/c1-36-21-6-5-19(34-14-28-30-31-34)18(23(21)25)8-27-24(35)20-9-26-13-33(20)12-17-11-32-10-16(15-2-3-15)4-7-22(32)29-17/h4-7,9-11,13-15H,2-3,8,12H2,1H3,(H,27,35)	CHEKVDUOWAJOJK-UHFFFAOYSA-N	626698	1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-N-(2-fluoro-3-methoxy-6-(1H-tetrazol-1-yl)benzyl)-1H-imidazole-5-carboxamide ::US11787796, Compound I-59	Plasma kallikrein					>7100					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626698	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626698&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152179	485655152							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338064	O=C(NCc1ccccc1)c1cn(Cc2cn3cc(ccc3n2)C2CC2)nn1	InChI=1S/C21H20N6O/c28-21(22-10-15-4-2-1-3-5-15)19-14-27(25-24-19)13-18-12-26-11-17(16-6-7-16)8-9-20(26)23-18/h1-5,8-9,11-12,14,16H,6-7,10,13H2,(H,22,28)	JDLJPYOGKUEGEP-UHFFFAOYSA-N	626699	N-benzyl-1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-60	Plasma kallikrein					>7100					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626699	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626699&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156151991	485655153							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338065	COc1ccc(c(CNC(=O)c2cn(Cc3cn4cc(ccc4n3)C3CC3)nn2)c1F)-n1cncn1	InChI=1S/C24H22FN9O2/c1-36-21-6-5-20(34-14-26-13-28-34)18(23(21)25)8-27-24(35)19-12-33(31-30-19)11-17-10-32-9-16(15-2-3-15)4-7-22(32)29-17/h4-7,9-10,12-15H,2-3,8,11H2,1H3,(H,27,35)	CWDQTAFWHQQPMQ-UHFFFAOYSA-N	626700	1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-N-(2-fluoro-3-methoxy-6-(1H-1,2,4-triazol-1-yl)benzyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-61	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626700	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626700&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152266	485655154							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338066	COc1ccc(c(CNC(=O)c2cn(Cc3cn4cc(ccc4n3)C3CC3)nn2)c1F)-n1ccc(n1)C(F)(F)F	InChI=1S/C26H22F4N8O2/c1-40-21-6-5-20(38-9-8-22(34-38)26(28,29)30)18(24(21)27)10-31-25(39)19-14-37(35-33-19)13-17-12-36-11-16(15-2-3-15)4-7-23(36)32-17/h4-9,11-12,14-15H,2-3,10,13H2,1H3,(H,31,39)	FQHFKRKIBNCALN-UHFFFAOYSA-N	626701	1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-N-(2-fluoro-3-methoxy-6-(3-(trifluoromethyl)-1H-pyrazol-1-yl)benzyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-62	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626701	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626701&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156151886	485655155							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338067	COc1ccc(-c2cc3ccccn3n2)c(CNC(=O)c2cn(Cc3cn4cc(ccc4n3)C3CC3)nn2)c1F	InChI=1S/C29H25FN8O2/c1-40-26-9-8-22(24-12-21-4-2-3-11-38(21)34-24)23(28(26)30)13-31-29(39)25-17-37(35-33-25)16-20-15-36-14-19(18-5-6-18)7-10-27(36)32-20/h2-4,7-12,14-15,17-18H,5-6,13,16H2,1H3,(H,31,39)	UVCVZDBEVMNUGH-UHFFFAOYSA-N	626702	1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-N-(2-fluoro-3-methoxy-6-(pyrazolo[1,5-a]pyridin-2-yl)benzyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-63	Plasma kallikrein					 1050					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626702	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626702&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152297	485655156							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338068	COc1ccc(F)c(CNC(=O)c2cn(Cc3cn4cc(ccc4n3)C3CC3)nn2)c1F	InChI=1S/C22H20F2N6O2/c1-32-19-6-5-17(23)16(21(19)24)8-25-22(31)18-12-30(28-27-18)11-15-10-29-9-14(13-2-3-13)4-7-20(29)26-15/h4-7,9-10,12-13H,2-3,8,11H2,1H3,(H,25,31)	ONPYRRHIHBDWLR-UHFFFAOYSA-N	626703	1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-N-(2,6-difluoro-3-methoxybenzyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-64	Plasma kallikrein					 55					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626703	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626703&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152274	485655157							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338069	Clc1c[nH]c2ccc(CNC(=O)c3cn(Cc4cn5cc(ccc5n4)C4CC4)nn3)cc12	InChI=1S/C23H20ClN7O/c24-19-9-25-20-5-1-14(7-18(19)20)8-26-23(32)21-13-31(29-28-21)12-17-11-30-10-16(15-2-3-15)4-6-22(30)27-17/h1,4-7,9-11,13,15,25H,2-3,8,12H2,(H,26,32)	OHCDCDJPKXGVIU-UHFFFAOYSA-N	626704	N-((3-chloro-1H-indol-5-yl)methyl)-1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-65	Plasma kallikrein					 55					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626704	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626704&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152138	485655158							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338070	COc1ccc(c(CN(C)C(=O)c2cn(Cc3cn4cc(ccc4n3)C3CC3)nn2)c1F)-n1cnnn1	InChI=1S/C24H23FN10O2/c1-32(12-18-20(35-14-26-29-31-35)6-7-21(37-2)23(18)25)24(36)19-13-34(30-28-19)11-17-10-33-9-16(15-3-4-15)5-8-22(33)27-17/h5-10,13-15H,3-4,11-12H2,1-2H3	SPZCPDJIVZRPFB-UHFFFAOYSA-N	626705	1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl) methyl)-N-(2-fluoro-3-methoxy-6-(1H-tetrazol-1-yl) benzyl)-N-methyl-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-66	Plasma kallikrein					 1050					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626705	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626705&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152037	485655159							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338071	COc1ccc(-c2cn[nH]c2)c(CNC(=O)c2cn(Cc3cn4cc(ccc4n3)C3CC3)nn2)c1F	InChI=1S/C25H23FN8O2/c1-36-22-6-5-19(17-8-28-29-9-17)20(24(22)26)10-27-25(35)21-14-34(32-31-21)13-18-12-33-11-16(15-2-3-15)4-7-23(33)30-18/h4-9,11-12,14-15H,2-3,10,13H2,1H3,(H,27,35)(H,28,29)	VGQYHFMTCBUFPS-UHFFFAOYSA-N	626706	1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-N-(2-fluoro-3-methoxy-6-(1H-pyrazol-4-yl)benzyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-67	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626706	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626706&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152162	485655160							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338072	COc1ccc(c(CNC(=O)c2cn(Cc3cn4cc(cc(CC5COC5)c4n3)C3CC3)nn2)c1F)-n1cnnn1	InChI=1S/C27H27FN10O3/c1-40-24-5-4-23(38-15-30-33-35-38)21(25(24)28)8-29-27(39)22-12-37(34-32-22)11-20-10-36-9-19(17-2-3-17)7-18(26(36)31-20)6-16-13-41-14-16/h4-5,7,9-10,12,15-17H,2-3,6,8,11,13-14H2,1H3,(H,29,39)	LXZBCAXSVYJLBU-UHFFFAOYSA-N	626707	1-((6-cyclopropyl-8-(oxetan-3-ylethyl)imidazo[1,2-a]pyridin-2-yl) methyl)-N-(2-fluoro-3-methoxy-6-(1H-tetrazol-1-yl) benzyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-68	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626707	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626707&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152044	485655161							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338073	COc1ccc(c(CNC(=O)c2nnn(Cc3cn4cc(cc(F)c4n3)C3CC3)n2)c1F)-n1cnnn1	InChI=1S/C22H19F2N11O2/c1-37-18-5-4-17(34-11-26-30-32-34)15(19(18)24)7-25-22(36)20-28-31-35(29-20)10-14-9-33-8-13(12-2-3-12)6-16(23)21(33)27-14/h4-6,8-9,11-12H,2-3,7,10H2,1H3,(H,25,36)	ZYMSLNIFTHIAPI-UHFFFAOYSA-N	626708	2-((6-cyclopropyl-8-fluoroimidazo[1,2-a]pyridin-2-yl)methyl)-N-(2-fluoro-3-methoxy-6-(1H-tetrazol-1-yl)benzyl)-2H-tetrazole-5-carboxamide ::US11787796, Compound I-69	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626708	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626708&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152033	485655162							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338074	COc1ccc(-c2cn3ccccc3n2)c(CNC(=O)c2cn(Cc3cn4cc(ccc4n3)C3CC3)nn2)c1F	InChI=1S/C29H25FN8O2/c1-40-25-9-8-21(23-16-36-11-3-2-4-26(36)33-23)22(28(25)30)12-31-29(39)24-17-38(35-34-24)15-20-14-37-13-19(18-5-6-18)7-10-27(37)32-20/h2-4,7-11,13-14,16-18H,5-6,12,15H2,1H3,(H,31,39)	IKUSGEWKJLEMFD-UHFFFAOYSA-N	626709	1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-N-(2-fluoro-6-(imidazo[1,2-a]pyridin-2-yl)-3-methoxybenzyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-70	Plasma kallikrein					 55					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626709	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626709&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152140	485655163							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338075	COc1ccc(c(CNC(=O)c2cn(Cc3cn4cc(cc(-n5cnnc5)c4n3)C3CC3)nn2)c1F)-n1cnnn1	InChI=1S/C25H22FN13O2/c1-41-22-5-4-20(39-14-30-33-35-39)18(23(22)26)7-27-25(40)19-11-38(34-32-19)10-17-9-36-8-16(15-2-3-15)6-21(24(36)31-17)37-12-28-29-13-37/h4-6,8-9,11-15H,2-3,7,10H2,1H3,(H,27,40)	DWBIRHDJCPDJAI-UHFFFAOYSA-N	626710	1-((6-cyclopropyl-8-(4H-1,2,4-triazol-4-yl)imidazo[1,2-a]pyridin-2-yl)methyl)-N-(2-fluoro-3-methoxy-6-(1H-tetrazol-1-yl)benzyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-71	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626710	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626710&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152176	485655164							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338076	COc1ncc(C#N)c(CNC(=O)c2cn(Cc3cn4cc(ccc4n3)C3CC3)nn2)c1F	InChI=1S/C22H19FN8O2/c1-33-22-20(23)17(15(6-24)7-26-22)8-25-21(32)18-12-31(29-28-18)11-16-10-30-9-14(13-2-3-13)4-5-19(30)27-16/h4-5,7,9-10,12-13H,2-3,8,11H2,1H3,(H,25,32)	NNPGUNRYHXSYAL-UHFFFAOYSA-N	626711	N-((5-cyano-3-fluoro-2-methoxypyridin-4-yl)methyl)-1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-72	Plasma kallikrein					 1050					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626711	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626711&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152311	485655165							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338077	COc1ccc(c(CNC(=O)c2cn(Cc3cn4cc(ccc4n3)C3CC3)nn2)c1F)-n1cc(C)c(C)n1	InChI=1S/C27H27FN8O2/c1-16-11-36(32-17(16)2)23-7-8-24(38-3)26(28)21(23)10-29-27(37)22-15-35(33-31-22)14-20-13-34-12-19(18-4-5-18)6-9-25(34)30-20/h6-9,11-13,15,18H,4-5,10,14H2,1-3H3,(H,29,37)	NCJMDVHILMIIRX-UHFFFAOYSA-N	626712	1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-N-(6-(3,4-dimethyl-1H-pyrazol-1-yl)-2-fluoro-3-methoxybenzyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-73	Plasma kallikrein					 55					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626712	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626712&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152224	485655166							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338078	COc1ccc(c(CNC(=O)c2cn(Cc3cn4cc(ccc4n3)C3CC3)nn2)c1F)-c1cnc(nc1)C(O)=O	InChI=1S/C27H23FN8O4/c1-40-22-6-5-19(17-8-29-25(27(38)39)30-9-17)20(24(22)28)10-31-26(37)21-14-36(34-33-21)13-18-12-35-11-16(15-2-3-15)4-7-23(35)32-18/h4-9,11-12,14-15H,2-3,10,13H2,1H3,(H,31,37)(H,38,39)	HGPNWDBVHFVAJK-UHFFFAOYSA-N	626713	5-(2-((1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-1,2,3-triazole-4-carboxamido)methyl)-3-fluoro-4-methoxyphenyl)pyrimidine-2-carboxylic Acid ::US11787796, Compound I-74	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626713	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626713&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152232	485655167							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338079	COC(=O)c1ncc(cn1)-c1ccc(OC)c(F)c1CNC(=O)c1cn(Cc2cn3cc(ccc3n2)C2CC2)nn1	InChI=1S/C28H25FN8O4/c1-40-23-7-6-20(18-9-30-26(31-10-18)28(39)41-2)21(25(23)29)11-32-27(38)22-15-37(35-34-22)14-19-13-36-12-17(16-3-4-16)5-8-24(36)33-19/h5-10,12-13,15-16H,3-4,11,14H2,1-2H3,(H,32,38)	GSLOUDIYUAAMJD-UHFFFAOYSA-N	626714	Methyl 5-(2-((1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-1,2,3-triazole-4-carboxamido)methyl)-3-fluoro-4-methoxyphenyl)pyrimidine-2-carboxylate ::US11787796, Compound I-75	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626714	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626714&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156151941	485655168							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338080	COc1ccc(c(CNC(=O)c2cn(Cc3cn4cc(ccc4n3)C3CC3)nn2)c1F)-n1ccnn1	InChI=1S/C24H22FN9O2/c1-36-21-6-5-20(34-9-8-27-30-34)18(23(21)25)10-26-24(35)19-14-33(31-29-19)13-17-12-32-11-16(15-2-3-15)4-7-22(32)28-17/h4-9,11-12,14-15H,2-3,10,13H2,1H3,(H,26,35)	QTIHBMVHTGZEAM-UHFFFAOYSA-N	626715	1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-N-(2-fluoro-3-methoxy-6-(1H-1,2,3-triazol-1-yl)benzyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-76	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626715	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626715&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152172	485655169							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338081	Clc1ccc2cc(CNC(=O)c3cn(Cc4cn5cc(ccc5n4)C4CC4)nn3)sc2c1	InChI=1S/C23H19ClN6OS/c24-17-5-3-15-7-19(32-21(15)8-17)9-25-23(31)20-13-30(28-27-20)12-18-11-29-10-16(14-1-2-14)4-6-22(29)26-18/h3-8,10-11,13-14H,1-2,9,12H2,(H,25,31)	ARFDMQMENBBRMI-UHFFFAOYSA-N	626716	N-((6-chlorobenzo[b]thiophen-2-yl)methyl)-1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-77	Plasma kallikrein					>7100					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626716	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626716&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152185	485655170							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338082	Fc1c(CNC(=O)c2cn(Cc3cn4cc(ccc4n3)C3CC3)nn2)c(ccc1C1CC1)-n1cnnn1	InChI=1S/C25H23FN10O/c26-24-19(16-3-4-16)6-7-22(36-14-28-31-33-36)20(24)9-27-25(37)21-13-35(32-30-21)12-18-11-34-10-17(15-1-2-15)5-8-23(34)29-18/h5-8,10-11,13-16H,1-4,9,12H2,(H,27,37)	AIDHLVZBDAWGBJ-UHFFFAOYSA-N	626717	N-(3-cyclopropyl-2-fluoro-6-(1H-tetrazol-1-yl)benzyl)-1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-78	Plasma kallikrein					 55					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626717	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626717&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152249	485655171							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338083	FC(F)c1ccc(Cl)c(F)c1CNC(=O)c1cn(Cc2cn3cc(ccc3n2)C2CC2)nn1	InChI=1S/C22H18ClF3N6O/c23-17-5-4-15(21(25)26)16(20(17)24)7-27-22(33)18-11-32(30-29-18)10-14-9-31-8-13(12-1-2-12)3-6-19(31)28-14/h3-6,8-9,11-12,21H,1-2,7,10H2,(H,27,33)	VBOJPTJLKMYOIN-UHFFFAOYSA-N	626718	N-(3-chloro-6-(difluoromethyl)-2-fluorobenzyl)-1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-79	Plasma kallikrein					 55					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626718	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626718&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156151975	485655172							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338084	Fc1c(Cl)ccc(c1CNC(=O)c1cn(Cc2cn3cc(ccc3n2)C2CC2)nn1)-n1cnnn1	InChI=1S/C22H18ClFN10O/c23-17-4-5-19(34-12-26-29-31-34)16(21(17)24)7-25-22(35)18-11-33(30-28-18)10-15-9-32-8-14(13-1-2-13)3-6-20(32)27-15/h3-6,8-9,11-13H,1-2,7,10H2,(H,25,35)	CJAJWIOWWQOPQT-UHFFFAOYSA-N	626719	N-(3-chloro-2-methyl-6-(1H-tetrazol-1-yl)benzyl)-1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-106::US11787796, Compound I-80	Plasma kallikrein					 1050					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626719	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626719&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156151919	485655173							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338085	COc1ccc(c(CNC(=O)c2cn(Cc3cn4cc(cc(CC(C)(C)C(O)=O)c4n3)C3CC3)nn2)c1F)-n1cnnn1	InChI=1S/C28H29FN10O4/c1-28(2,27(41)42)9-17-8-18(16-4-5-16)11-37-12-19(32-25(17)37)13-38-14-21(33-35-38)26(40)30-10-20-22(39-15-31-34-36-39)6-7-23(43-3)24(20)29/h6-8,11-12,14-16H,4-5,9-10,13H2,1-3H3,(H,30,40)(H,41,42)	ALZICCAYECCNDN-UHFFFAOYSA-N	626720	3-(6-cyclopropyl-2-((4-((2-fluoro-3-methoxy-6-(1H-tetrazol-1-yl)benzyl)carbamoyl)-1H-1,2,3-triazol-1-yl)methyl)imidazo[1,2-a]pyridin-8-yl)-2,2-dimethylpropanoic acid ::US11787796, Compound I-81	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626720	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626720&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152135	485655174							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338086	O=C(NCc1ccc2ccsc2c1)c1cn(Cc2cn3cc(ccc3n2)C2CC2)nn1	InChI=1S/C23H20N6OS/c30-23(24-10-15-1-2-17-7-8-31-21(17)9-15)20-14-29(27-26-20)13-19-12-28-11-18(16-3-4-16)5-6-22(28)25-19/h1-2,5-9,11-12,14,16H,3-4,10,13H2,(H,24,30)	XHRXYUFVOJJOEZ-UHFFFAOYSA-N	626721	7-(6-cyclopropylimidazo[1,2-a]pyridin-2-yl)-N-(2-fluoro-3-methoxy-6-(1H-tetrazol-1-yl)benzyl)-6,7-dihydro-5H-pyrrolo[1,2-b][1,2,4]triazole-2-carboxamide ::US11787796, Compound I-82	Plasma kallikrein					 4550					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626721	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626721&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152048	485655175							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338087	COc1ccc(c(CNC(=O)c2cn(Cc3cn4cc(ccc4n3)C3CC3)nn2)c1F)-n1cnnn1	InChI=1S/C23H21FN10O2/c1-36-20-6-5-19(34-13-26-29-31-34)17(22(20)24)8-25-23(35)18-12-33(30-28-18)11-16-10-32-9-15(14-2-3-14)4-7-21(32)27-16/h4-7,9-10,12-14H,2-3,8,11H2,1H3,(H,25,35)	SVBCYIOLAKYOHQ-UHFFFAOYSA-N	626668	1-(1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-1,2,3-triazol-4-yl)-N-(2-fluoro-3-methoxy-6-(1H-tetrazol-1-yl)benzyl)methanamine ::US11787796, Compound I-105::US11787796, Compound I-29::US11787796, Compound I-83	Plasma kallikrein					 55					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626668	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626668&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152169	485655123							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338088	O=C(NCc1ccc2sccc2c1)c1cn(Cc2cn3cc(ccc3n2)C2CC2)nn1	InChI=1S/C23H20N6OS/c30-23(24-10-15-1-5-21-17(9-15)7-8-31-21)20-14-29(27-26-20)13-19-12-28-11-18(16-2-3-16)4-6-22(28)25-19/h1,4-9,11-12,14,16H,2-3,10,13H2,(H,24,30)	VVQJVXSOWGMMJC-UHFFFAOYSA-N	626723	N-(benzo[b]thiophen-5-ylmethyl)-1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-84	Plasma kallikrein					 1050					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626723	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626723&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156151861	485655176							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338089	CCOC(=O)C(C)(C)Cc1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3c(F)c(OC)ccc3-n3cnnn3)nc12)C1CC1	InChI=1S/C30H33FN10O4/c1-5-45-29(43)30(2,3)11-19-10-20(18-6-7-18)13-39-14-21(34-27(19)39)15-40-16-23(35-37-40)28(42)32-12-22-24(41-17-33-36-38-41)8-9-25(44-4)26(22)31/h8-10,13-14,16-18H,5-7,11-12,15H2,1-4H3,(H,32,42)	NJCYCSFIIGOMAE-UHFFFAOYSA-N	626724	US11787796, Compound I-85::ethyl 3-(6-cyclopropyl-2-((4-((2-fluoro-3-methoxy-6-(1H-tetrazol-1-yl)benzyl)carbamoyl)-1H-1,2,3-triazol-1-yl)methyl)imidazo[1,2-a]pyridin-8-yl)-2,2-dimethylpropanoate 	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626724	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626724&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152188	485655177							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338090	COc1ccc(c(CNC(=O)c2cn(Cc3cn4cc(ccc4n3)C3CC3)nn2)c1F)-c1ccnnc1	InChI=1S/C26H23FN8O2/c1-37-23-6-5-20(17-8-9-29-30-10-17)21(25(23)27)11-28-26(36)22-15-35(33-32-22)14-19-13-34-12-18(16-2-3-16)4-7-24(34)31-19/h4-10,12-13,15-16H,2-3,11,14H2,1H3,(H,28,36)	IVNHRVVFLDFGGE-UHFFFAOYSA-N	626725	1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-N-(2-fluoro-3-methoxy-6-(pyridazin-4-yl)benzyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-86	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626725	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626725&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156151855	485655178							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338091	COC(=O)c1ccc(cc1)-c1ccc(OC)c(F)c1CNC(=O)c1cn(Cc2cn3cc(ccc3n2)C2CC2)nn1	InChI=1S/C30H27FN6O4/c1-40-26-11-10-23(19-5-7-20(8-6-19)30(39)41-2)24(28(26)31)13-32-29(38)25-17-37(35-34-25)16-22-15-36-14-21(18-3-4-18)9-12-27(36)33-22/h5-12,14-15,17-18H,3-4,13,16H2,1-2H3,(H,32,38)	KRBCRTKKFBLTMP-UHFFFAOYSA-N	626726	Methyl 2'-((1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-1,2,3-triazole-4-carboxamido)methyl)-3'-fluoro-4'-methoxy-[1,1'-biphenyl]-4-carboxylate ::US11787796, Compound I-87	Plasma kallikrein					 55					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626726	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626726&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156151958	485655179							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338092	COc1ccc(c(CNC(=O)c2cn(Cc3cn4cc(ccc4n3)C3CC3)nn2)c1F)-c1ccc(cc1)C(O)=O	InChI=1S/C29H25FN6O4/c1-40-25-10-9-22(18-4-6-19(7-5-18)29(38)39)23(27(25)30)12-31-28(37)24-16-36(34-33-24)15-21-14-35-13-20(17-2-3-17)8-11-26(35)32-21/h4-11,13-14,16-17H,2-3,12,15H2,1H3,(H,31,37)(H,38,39)	BPZCKRMBEWPPAD-UHFFFAOYSA-N	626727	2'-((1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-1,2,3-triazole-4-carboxamido)methyl)-3'-fluoro-4'-methoxy-[1,1'-biphenyl]-4-carboxylic acid ::US11787796, Compound I-88	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626727	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626727&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156151929	485655180							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338093	CCOC(=O)CCc1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3c(F)c(OC)ccc3-n3cnnn3)nc12)C1CC1	InChI=1S/C28H29FN10O4/c1-3-43-25(40)9-6-18-10-19(17-4-5-17)12-37-13-20(32-27(18)37)14-38-15-22(33-35-38)28(41)30-11-21-23(39-16-31-34-36-39)7-8-24(42-2)26(21)29/h7-8,10,12-13,15-17H,3-6,9,11,14H2,1-2H3,(H,30,41)	JHMJPFHBGFYVPE-UHFFFAOYSA-N	626728	US11787796, Compound I-89::ethyl 3-(6-cyclopropyl-2-((4-((2-fluoro-3-methoxy-6-(1H-tetrazol-1-yl)benzyl)carbamoyl)-1H-1,2,3-triazol-1-yl)methyl)imidazo[1,2-a]pyridin-8-yl)propanoate 	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626728	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626728&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152094	485655181							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338094	Fc1c(Br)ccc(c1CNC(=O)c1cn(Cc2cn3cc(ccc3n2)C2CC2)nn1)-n1cnnn1	InChI=1S/C22H18BrFN10O/c23-17-4-5-19(34-12-26-29-31-34)16(21(17)24)7-25-22(35)18-11-33(30-28-18)10-15-9-32-8-14(13-1-2-13)3-6-20(32)27-15/h3-6,8-9,11-13H,1-2,7,10H2,(H,25,35)	GKKCMEYCZYVYFT-UHFFFAOYSA-N	626729	N-(3-bromo-2-fluoro-6-(1H-tetrazol-1-yl)benzyl)-1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-90	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626729	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626729&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156151930	485655182							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338095	COc1ccc(c(CNC(=O)c2cn(Cc3cn4cc(cc(c4n3)C3(F)COC3)C3CC3)nn2)c1F)-n1cnnn1	InChI=1S/C26H24F2N10O3/c1-40-22-5-4-21(38-14-30-33-35-38)18(23(22)27)7-29-25(39)20-11-37(34-32-20)10-17-9-36-8-16(15-2-3-15)6-19(24(36)31-17)26(28)12-41-13-26/h4-6,8-9,11,14-15H,2-3,7,10,12-13H2,1H3,(H,29,39)	ACMZOJNJBXJRIJ-UHFFFAOYSA-N	626730	1-((6-cyclopropyl-8-(3-fluorooxetan-3-yl)imidazo[1,2-a]pyridin-2-yl)methyl)-N-(2-fluoro-3-methoxy-6-(1H-tetrazol-1-yl)benzyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-91	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626730	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626730&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152057	485655183							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338096	COc1ccc(c(CNC(=O)c2cn(Cc3cn4cc(cc(CCC(O)=O)c4n3)C3CC3)nn2)c1F)-n1cnnn1	InChI=1S/C26H25FN10O4/c1-41-22-6-5-21(37-14-29-32-34-37)19(24(22)27)9-28-26(40)20-13-36(33-31-20)12-18-11-35-10-17(15-2-3-15)8-16(25(35)30-18)4-7-23(38)39/h5-6,8,10-11,13-15H,2-4,7,9,12H2,1H3,(H,28,40)(H,38,39)	PTVPCXDCCGUGGH-UHFFFAOYSA-N	626731	3-(6-cyclopropyl-2-((4-((2-fluoro-3-methoxy-6-(1H-tetrazol-1-yl)benzyl)carbamoyl)-1H-1,2,3-triazol-1-yl)methyl)imidazo[1,2-a]pyridin-8-yl)propanoic acid ::US11787796, Compound I-92	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626731	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626731&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152230	485655184							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338097	COc1ccc(c(CNC(=O)c2cn(Cc3cn4cc(cc(c4n3)C(F)(F)F)C3CC3)nn2)c1F)-n1cnnn1	InChI=1S/C24H20F4N10O2/c1-40-20-5-4-19(38-12-30-33-35-38)16(21(20)25)7-29-23(39)18-11-37(34-32-18)10-15-9-36-8-14(13-2-3-13)6-17(22(36)31-15)24(26,27)28/h4-6,8-9,11-13H,2-3,7,10H2,1H3,(H,29,39)	PQUJWIBGLMCLQR-UHFFFAOYSA-N	626732	1-((6-cyclopropyl-8-(trifluoromethyl)imidazo[1,2-a]pyridin-2-yl)methyl)-N-(2-fluoro-3-methoxy-6-(1H-tetrazol-1-yl)benzyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-93	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626732	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626732&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152136	485655185							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338098	COc1ccc(c(CNC(=O)c2nnc(Cc3cn4cc(ccc4n3)C3CC3)o2)c1F)-n1cnnn1	InChI=1S/C23H20FN9O3/c1-35-18-6-5-17(33-12-26-30-31-33)16(21(18)24)9-25-22(34)23-29-28-20(36-23)8-15-11-32-10-14(13-2-3-13)4-7-19(32)27-15/h4-7,10-13H,2-3,8-9H2,1H3,(H,25,34)	BGMXHBCUMLBMJG-UHFFFAOYSA-N	626733	5-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-N-(2-fluoro-3-methoxy-6-(1H-tetrazol-1-yl)benzyl)-1,3,4-oxadiazole-2-carboxamide ::US11787796, Compound I-94	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626733	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626733&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152229	485655186							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338099	COc1ccc(c(CNC(=O)c2cn(Cc3cn4cc(ccc4n3)C3CC3)nn2)c1F)-n1cccn1	InChI=1S/C25H23FN8O2/c1-36-22-7-6-21(34-10-2-9-28-34)19(24(22)26)11-27-25(35)20-15-33(31-30-20)14-18-13-32-12-17(16-3-4-16)5-8-23(32)29-18/h2,5-10,12-13,15-16H,3-4,11,14H2,1H3,(H,27,35)	SFOYYSALWSTUAZ-UHFFFAOYSA-N	626734	1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-N-(2-fluoro-3-methoxy-6-(1H-pyrazol-1-yl)benzyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-95	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626734	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626734&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156151883	485655187							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338156	FC(F)Oc1ccnc(CNC(=O)c2cn(Cc3cn4cc(cc(N5CCN(CC(F)(F)F)CC5)c4n3)C3CC3)nn2)c1F	InChI=1S/C27H27F6N9O2/c28-23-19(34-4-3-22(23)44-26(29)30)10-35-25(43)20-14-42(38-37-20)13-18-12-41-11-17(16-1-2-16)9-21(24(41)36-18)40-7-5-39(6-8-40)15-27(31,32)33/h3-4,9,11-12,14,16,26H,1-2,5-8,10,13,15H2,(H,35,43)	KKYQHGPKWIMLDV-UHFFFAOYSA-N	626791	1-((6-cyclopropyl-8-(4-(2,2,2-trifluoroethyl)piperazin-1-yl)imidazo[1,2-a]pyridin-2-yl)methyl)-N-((4-(difluoromethoxy)-3-fluoropyridin-2-yl)methyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-152	Plasma kallikrein					 1050					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626791	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626791&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152300	485655241							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338157	CN1CCN(CC1)c1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3nccc(OC(F)F)c3F)nc12)C1CC1	InChI=1S/C26H28F3N9O2/c1-35-6-8-36(9-7-35)21-10-17(16-2-3-16)12-37-13-18(32-24(21)37)14-38-15-20(33-34-38)25(39)31-11-19-23(27)22(4-5-30-19)40-26(28)29/h4-5,10,12-13,15-16,26H,2-3,6-9,11,14H2,1H3,(H,31,39)	IOOVVIKVQXISGT-UHFFFAOYSA-N	626792	1-((6-cyclopropyl-8-(4-methylpiperazin-1-yl)imidazo[1,2-a]pyridin-2-yl)methyl)-N-((4-(difluoromethoxy)-3-fluoropyridin-2-yl))ethyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-153	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626792	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626792&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152231	485655242							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338158	Cc1[nH]nc2[C@@H](CCc12)NC(=O)c1cn(Cc2cn3cc(ccc3n2)C2CC2)nn1			626793	(R)-1-((6-cyclopropylimidazo[1,2-a]pyridin-2-ylmethyl)-N-(3-methyl-2,4,5,6-tetrahydrocyclopenta[c]pyrazol-6-yl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-154	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626793	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626793&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152210	485655243							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338159	Cc1[nH]nc2[C@@H](CCc12)NC(=O)c1cnn(Cc2cn3cc(ccc3n2)C2CC2)c1			626794	(R)-1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-N-(3-methy-2,4,5,6-tetrahydrocyclopenta[c]pyrazol-6-yl-1H-pyrazole-4-carboxamide ::US11787796, Compound I-155	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626794	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626794&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152196	485655244							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317803	COc1c(C)c(cnc1N1C[C@H]2C[C@H]2C1=O)C(C)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C29H25ClF3N7O3/c1-13-19(8-35-27(25(13)43-3)39-11-15-6-18(15)29(39)42)14(2)40-12-16(7-36-40)37-28(41)22-10-34-9-21(38-22)23-17(26(32)33)4-5-20(30)24(23)31/h4-5,7-10,12,14-15,18,26H,6,11H2,1-3H3,(H,37,41)/t14?,15-,18-/m1/s1	AESNDDHBSPWNAX-QTLYGJNZSA-N	50582289	CHEMBL5076760::US20230286958, Example 155	Plasma kallikrein			 7.10							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50582289	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50582289&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			166626045	476027294							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317805	Cc1nc(ncc1Cn1cc(NC(=O)c2nc(cnc2CO)-c2c(F)c(Cl)ccc2C(F)F)cn1)N1C[C@H]2C[C@H]2C1=O	InChI=1S/C27H22ClF3N8O3/c1-12-14(5-33-27(35-12)39-9-13-4-17(13)26(39)42)8-38-10-15(6-34-38)36-25(41)23-20(11-40)32-7-19(37-23)21-16(24(30)31)2-3-18(28)22(21)29/h2-3,5-7,10,13,17,24,40H,4,8-9,11H2,1H3,(H,36,41)/t13-,17-/m1/s1	OZSFFGZNHVNMND-CXAGYDPISA-N	617944	US20230286958, Example 156	Plasma kallikrein			 0.900							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617944	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617944&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317807	Cc1nc(ncc1[C@@H](CO)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1)N1C[C@H]2C[C@H]2C1=O	InChI=1S/C27H22ClF3N8O3/c1-12-17(6-33-27(35-12)38-9-13-4-16(13)26(38)42)21(11-40)39-10-14(5-34-39)36-25(41)20-8-32-7-19(37-20)22-15(24(30)31)2-3-18(28)23(22)29/h2-3,5-8,10,13,16,21,24,40H,4,9,11H2,1H3,(H,36,41)/t13-,16-,21-/m1/s1	BYQIKVYOGZXMSE-NZCGUCNHSA-N	617945	US20230286958, Example 157	Plasma kallikrein			 1019							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617945	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617945&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317809	Cc1nc(ncc1[C@H](CO)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1)N1C[C@H]2C[C@H]2C1=O	InChI=1S/C27H22ClF3N8O3/c1-12-17(6-33-27(35-12)38-9-13-4-16(13)26(38)42)21(11-40)39-10-14(5-34-39)36-25(41)20-8-32-7-19(37-20)22-15(24(30)31)2-3-18(28)23(22)29/h2-3,5-8,10,13,16,21,24,40H,4,9,11H2,1H3,(H,36,41)/t13-,16-,21+/m1/s1	BYQIKVYOGZXMSE-FQWGINHLSA-N	617946	US20230286958, Example 158	Plasma kallikrein			 2716							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617946	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617946&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317811	Cc1nc(ncc1[C@H](CO)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1)N1C[C@@H]2C[C@@H]2C1=O	InChI=1S/C27H22ClF3N8O3/c1-12-17(6-33-27(35-12)38-9-13-4-16(13)26(38)42)21(11-40)39-10-14(5-34-39)36-25(41)20-8-32-7-19(37-20)22-15(24(30)31)2-3-18(28)23(22)29/h2-3,5-8,10,13,16,21,24,40H,4,9,11H2,1H3,(H,36,41)/t13-,16-,21-/m0/s1	BYQIKVYOGZXMSE-PCMMCCAGSA-N	617947	US20230286958, Example 159	Plasma kallikrein			 11.2							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617947	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617947&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317813	Cc1nc(ncc1[C@@H](CO)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1)N1C[C@@H]2C[C@@H]2C1=O	InChI=1S/C27H22ClF3N8O3/c1-12-17(6-33-27(35-12)38-9-13-4-16(13)26(38)42)21(11-40)39-10-14(5-34-39)36-25(41)20-8-32-7-19(37-20)22-15(24(30)31)2-3-18(28)23(22)29/h2-3,5-8,10,13,16,21,24,40H,4,9,11H2,1H3,(H,36,41)/t13-,16-,21+/m0/s1	BYQIKVYOGZXMSE-UYTHQXMGSA-N	617948	US20230286958, Example 160	Plasma kallikrein			 249							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617948	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617948&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317815	OCC(c1cnc(nc1)N1CC2CC2C1=O)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C26H20ClF3N8O3/c27-17-2-1-15(23(29)30)21(22(17)28)18-7-31-8-19(36-18)24(40)35-14-6-34-38(10-14)20(11-39)13-4-32-26(33-5-13)37-9-12-3-16(12)25(37)41/h1-2,4-8,10,12,16,20,23,39H,3,9,11H2,(H,35,40)	WRTOFYFIDMGDGV-UHFFFAOYSA-N	617949	6-(3-chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((S or R)-2-hydroxy-1-(2-((1S,5R or 1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-5-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 161	Plasma kallikrein			 26.7							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617949	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617949&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317817	Cc1ncc(nc1C(=O)Nc1cnn(c1)C(CO)c1ccc(nc1)N1CC2CC2C1=O)-c1c(F)c(Cl)ccc1C(F)F	InChI=1S/C28H23ClF3N7O3/c1-13-25(37-20(9-33-13)23-17(26(31)32)3-4-19(29)24(23)30)27(41)36-16-8-35-39(11-16)21(12-40)14-2-5-22(34-7-14)38-10-15-6-18(15)28(38)42/h2-5,7-9,11,15,18,21,26,40H,6,10,12H2,1H3,(H,36,41)	QHHHZJLPHRTRAQ-UHFFFAOYSA-N	617950	6-(3-chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((S or R)-2-hydroxy-1-(6-((1S,5R or 1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)ethyl)-1H-pyrazol-4-::US20230286958, Example 162::US20230286958, Example 163	Plasma kallikrein			 8.70							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617950	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617950&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317819	Cc1ncc(nc1C(=O)Nc1cnn(c1)C(CO)c1ccc(nc1)N1CC2CC2C1=O)-c1c(F)c(Cl)ccc1C(F)F	InChI=1S/C28H23ClF3N7O3/c1-13-25(37-20(9-33-13)23-17(26(31)32)3-4-19(29)24(23)30)27(41)36-16-8-35-39(11-16)21(12-40)14-2-5-22(34-7-14)38-10-15-6-18(15)28(38)42/h2-5,7-9,11,15,18,21,26,40H,6,10,12H2,1H3,(H,36,41)	QHHHZJLPHRTRAQ-UHFFFAOYSA-N	617950	6-(3-chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((S or R)-2-hydroxy-1-(6-((1S,5R or 1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)ethyl)-1H-pyrazol-4-::US20230286958, Example 162::US20230286958, Example 163	Plasma kallikrein			 9.20							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617950	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617950&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317821	Cc1ncc(nc1C(=O)Nc1cnn(c1)C(CO)c1cnc(nc1)N1C[C@H]2C[C@H]2C1=O)-c1c(F)c(Cl)ccc1C(F)F	InChI=1S/C27H22ClF3N8O3/c1-12-23(37-19(8-32-12)21-16(24(30)31)2-3-18(28)22(21)29)25(41)36-15-7-35-39(10-15)20(11-40)14-5-33-27(34-6-14)38-9-13-4-17(13)26(38)42/h2-3,5-8,10,13,17,20,24,40H,4,9,11H2,1H3,(H,36,41)/t13-,17-,20?/m1/s1	NMESODJGNQZLIJ-YOMGNNPMSA-N	617952	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((R or S)-2-hydroxy-1-(2-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-5-yl)ethyl)-1H-pyrazol-4-yl)-3-methylpyrazine-2-carboxamide::US20230286958, Example 164::US20230286958, Example 165	Plasma kallikrein			 5.40							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617952	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617952&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317823	Cc1ncc(nc1C(=O)Nc1cnn(c1)C(CO)c1cnc(nc1)N1C[C@H]2C[C@H]2C1=O)-c1c(F)c(Cl)ccc1C(F)F	InChI=1S/C27H22ClF3N8O3/c1-12-23(37-19(8-32-12)21-16(24(30)31)2-3-18(28)22(21)29)25(41)36-15-7-35-39(10-15)20(11-40)14-5-33-27(34-6-14)38-9-13-4-17(13)26(38)42/h2-3,5-8,10,13,17,20,24,40H,4,9,11H2,1H3,(H,36,41)/t13-,17-,20?/m1/s1	NMESODJGNQZLIJ-YOMGNNPMSA-N	617952	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((R or S)-2-hydroxy-1-(2-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-5-yl)ethyl)-1H-pyrazol-4-yl)-3-methylpyrazine-2-carboxamide::US20230286958, Example 164::US20230286958, Example 165	Plasma kallikrein			 20.7							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617952	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617952&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317825	Cc1ncc(nc1C(=O)Nc1cnn(c1)C(CO)c1cnc(nc1)N1C[C@H]2C[C@H]2C1=O)-c1c(F)c(Cl)ccc1C#N	InChI=1S/C27H21ClFN9O3/c1-13-24(36-20(9-31-13)22-14(5-30)2-3-19(28)23(22)29)25(40)35-17-8-34-38(11-17)21(12-39)16-6-32-27(33-7-16)37-10-15-4-18(15)26(37)41/h2-3,6-9,11,15,18,21,39H,4,10,12H2,1H3,(H,35,40)/t15-,18-,21?/m1/s1	XNRSEFPFDUMJNR-SRMPMCCKSA-N	617954	6-(3-Chloro-6-cyano-2-fluorophenyl)-N-(1-((R or S)-2-hydroxy-1-(2-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-5-yl)ethyl)-1H-pyrazol-4-yl)-3-methylpyrazine-2-carboxamide::US20230286958, Example 166	Plasma kallikrein			 19.7							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617954	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617954&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317827	Cc1c(C)c(ncc1C(CO)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1)N1C[C@H]2C[C@H]2C1=O	InChI=1S/C29H25ClF3N7O3/c1-13-14(2)27(39-10-15-5-18(15)29(39)43)35-7-19(13)23(12-41)40-11-16(6-36-40)37-28(42)22-9-34-8-21(38-22)24-17(26(32)33)3-4-20(30)25(24)31/h3-4,6-9,11,15,18,23,26,41H,5,10,12H2,1-2H3,(H,37,42)/t15-,18-,23?/m1/s1	CYVJFYJEJKTVCI-ZONLSGFUSA-N	617955	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-([R or S)-1-(4,5-dimethyl-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)-2-hydroxyethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 167::US20230286958, Example 168	Plasma kallikrein			 10.5							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617955	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617955&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			166898704	484207145							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317829	Cc1c(C)c(ncc1C(CO)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1)N1C[C@H]2C[C@H]2C1=O	InChI=1S/C29H25ClF3N7O3/c1-13-14(2)27(39-10-15-5-18(15)29(39)43)35-7-19(13)23(12-41)40-11-16(6-36-40)37-28(42)22-9-34-8-21(38-22)24-17(26(32)33)3-4-20(30)25(24)31/h3-4,6-9,11,15,18,23,26,41H,5,10,12H2,1-2H3,(H,37,42)/t15-,18-,23?/m1/s1	CYVJFYJEJKTVCI-ZONLSGFUSA-N	617955	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-([R or S)-1-(4,5-dimethyl-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)-2-hydroxyethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 167::US20230286958, Example 168	Plasma kallikrein			 0.400							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617955	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617955&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			166898704	484207145							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317831	CC(c1cnc(nc1CO)N1C[C@H]2C[C@H]2C1=O)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C27H22ClF3N8O3/c1-12(17-6-33-27(37-21(17)11-40)38-9-13-4-16(13)26(38)42)39-10-14(5-34-39)35-25(41)20-8-32-7-19(36-20)22-15(24(30)31)2-3-18(28)23(22)29/h2-3,5-8,10,12-13,16,24,40H,4,9,11H2,1H3,(H,35,41)/t12?,13-,16-/m1/s1	USWKBQSSFSUDKG-LLQOJDTPSA-N	617957	US20230286958, Example 169	Plasma kallikrein			 15.2							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617957	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617957&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162520247	484207146							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317833	C[C@H](c1cnc(nc1N)N1C[C@H]2C[C@H]2C1=O)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C26H21ClF3N9O2/c1-11(16-6-33-26(37-23(16)31)38-9-12-4-15(12)25(38)41)39-10-13(5-34-39)35-24(40)19-8-32-7-18(36-19)20-14(22(29)30)2-3-17(27)21(20)28/h2-3,5-8,10-12,15,22H,4,9H2,1H3,(H,35,40)(H2,31,33,37)/t11-,12-,15-/m1/s1	HUISNUYIWIEFNP-LALPHHSUSA-N	617958	US20230286958, Example 170	Plasma kallikrein			 20.7							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617958	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617958&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162520446	484207147							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317835	C[C@@H](c1cnc(nc1N)N1C[C@H]2C[C@H]2C1=O)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C26H21ClF3N9O2/c1-11(16-6-33-26(37-23(16)31)38-9-12-4-15(12)25(38)41)39-10-13(5-34-39)35-24(40)19-8-32-7-18(36-19)20-14(22(29)30)2-3-17(27)21(20)28/h2-3,5-8,10-12,15,22H,4,9H2,1H3,(H,35,40)(H2,31,33,37)/t11-,12+,15+/m0/s1	HUISNUYIWIEFNP-YWPYICTPSA-N	617959	US20230286958, Example 171	Plasma kallikrein			 713							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617959	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617959&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162520447	484207148							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317837	C[C@@H](c1cnc(nc1)N1C[C@H]2C[C@H]2C1=O)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C26H20ClF3N8O2/c1-12(14-5-32-26(33-6-14)37-10-13-4-17(13)25(37)40)38-11-15(7-34-38)35-24(39)20-9-31-8-19(36-20)21-16(23(29)30)2-3-18(27)22(21)28/h2-3,5-9,11-13,17,23H,4,10H2,1H3,(H,35,39)/t12-,13+,17+/m0/s1	BMKQYMBEHNGCOC-OGHNNQOOSA-N	617960	US20230286958, Example 172	Plasma kallikrein			 6.40							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617960	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617960&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162520401	484207149							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317839	C[C@@H](c1cnc(nc1)N1C[C@H]2C[C@H]2C1=O)n1cc(NC(=O)c2c[n+]([O-])cc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C26H20ClF3N8O3/c1-12(14-5-31-26(32-6-14)37-8-13-4-17(13)25(37)40)38-9-15(7-33-38)34-24(39)20-11-36(41)10-19(35-20)21-16(23(29)30)2-3-18(27)22(21)28/h2-3,5-7,9-13,17,23H,4,8H2,1H3,(H,34,39)/t12-,13+,17+/m0/s1	OURZXXRIQVBEGK-OGHNNQOOSA-N	617961	3-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-5-((1-((S)-1-(2-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-5-yl)ethyl)-1H-pyrazol-4-yl)carbamoyl)pyridine 1-oxide::US20230286958, Example 173	Plasma kallikrein			 3.60							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617961	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617961&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168679579	484207150							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317841	C[C@@H](c1cnc(nc1)N1C[C@H]2C[C@H]2C1=O)n1cc(NC(=O)c2nc(cnc2C(F)F)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C27H20ClF5N8O2/c1-11(13-5-35-27(36-6-13)40-9-12-4-16(12)26(40)43)41-10-14(7-37-41)38-25(42)22-21(24(32)33)34-8-18(39-22)19-15(23(30)31)2-3-17(28)20(19)29/h2-3,5-8,10-12,16,23-24H,4,9H2,1H3,(H,38,42)/t11-,12+,16+/m0/s1	JVBJFCGWUHCACB-HWWQOWPSSA-N	617962	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-(difluoromethyl)-N-(1-((S)-1-(2-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-5-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 174	Plasma kallikrein			 6.50							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617962	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617962&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			166898471	484207151							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317843	COCc1ncc(nc1C(=O)Nc1cnn(c1)[C@@H](C)c1cnc(nc1)N1C[C@H]2C[C@H]2C1=O)-c1c(F)c(Cl)ccc1C(F)F	InChI=1S/C28H24ClF3N8O3/c1-13(15-6-34-28(35-7-15)39-10-14-5-18(14)27(39)42)40-11-16(8-36-40)37-26(41)24-21(12-43-2)33-9-20(38-24)22-17(25(31)32)3-4-19(29)23(22)30/h3-4,6-9,11,13-14,18,25H,5,10,12H2,1-2H3,(H,37,41)/t13-,14+,18+/m0/s1	HFMLWHSNJNMJIC-PMUMKWKESA-N	617963	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-(methoxymethy-((S)-1-(2-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-5-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 175	Plasma kallikrein			 3.00							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617963	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617963&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168679580	484207152							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317845	C[C@@H](c1cnc(nc1)N1C[C@H]2C[C@H]2C1=O)n1cc(NC(=O)c2nc(cnc2C(O)C(F)(F)F)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H21ClF6N8O3/c1-11(13-5-37-27(38-6-13)42-9-12-4-16(12)26(42)46)43-10-14(7-39-43)40-25(45)22-21(23(44)28(33,34)35)36-8-18(41-22)19-15(24(31)32)2-3-17(29)20(19)30/h2-3,5-8,10-12,16,23-24,44H,4,9H2,1H3,(H,40,45)/t11-,12+,16+,23?/m0/s1	RVMCLVALPBCZQZ-DBEIEYIQSA-N	617964	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((S)-1-(2-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-5-yl)ethyl)-1H-pyrazol-4-yl)-3-((S or R)-2,2,2-::US20230286958, Example 176::US20230286958, Example 177	Plasma kallikrein			 5.30							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617964	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617964&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162520481	484207153							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317847	C[C@@H](c1cnc(nc1)N1C[C@H]2C[C@H]2C1=O)n1cc(NC(=O)c2nc(cnc2C(O)C(F)(F)F)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H21ClF6N8O3/c1-11(13-5-37-27(38-6-13)42-9-12-4-16(12)26(42)46)43-10-14(7-39-43)40-25(45)22-21(23(44)28(33,34)35)36-8-18(41-22)19-15(24(31)32)2-3-17(29)20(19)30/h2-3,5-8,10-12,16,23-24,44H,4,9H2,1H3,(H,40,45)/t11-,12+,16+,23?/m0/s1	RVMCLVALPBCZQZ-DBEIEYIQSA-N	617964	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((S)-1-(2-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-5-yl)ethyl)-1H-pyrazol-4-yl)-3-((S or R)-2,2,2-::US20230286958, Example 176::US20230286958, Example 177	Plasma kallikrein			 47.8							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617964	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617964&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162520481	484207153							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317849	C[C@@H](c1cnc(nc1C)N1CC2CC2C1=O)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H24ClF3N8O2/c1-12-19(8-34-28(36-12)39-10-15-6-18(15)27(39)42)14(3)40-11-16(7-35-40)37-26(41)24-13(2)33-9-21(38-24)22-17(25(31)32)4-5-20(29)23(22)30/h4-5,7-9,11,14-15,18,25H,6,10H2,1-3H3,(H,37,41)/t14-,15?,18?/m0/s1	XEGXBZUWPPGCRR-SYJJWHGVSA-N	617966	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-methyl-N-(1-((S)-1-(4-methyl-2-((1R,5S or 1S,5R)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl-4,4-d2)pyrimidin-5-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 178::US20230286958, Example 179	Plasma kallikrein			 14.2							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617966	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617966&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168679581	484207154							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317851	C[C@@H](c1cnc(nc1C)N1CC2CC2C1=O)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H24ClF3N8O2/c1-12-19(8-34-28(36-12)39-10-15-6-18(15)27(39)42)14(3)40-11-16(7-35-40)37-26(41)24-13(2)33-9-21(38-24)22-17(25(31)32)4-5-20(29)23(22)30/h4-5,7-9,11,14-15,18,25H,6,10H2,1-3H3,(H,37,41)/t14-,15?,18?/m0/s1	XEGXBZUWPPGCRR-SYJJWHGVSA-N	617966	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-methyl-N-(1-((S)-1-(4-methyl-2-((1R,5S or 1S,5R)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl-4,4-d2)pyrimidin-5-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 178::US20230286958, Example 179	Plasma kallikrein			 0.700							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617966	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617966&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168679581	484207154							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317853	C[C@@H](c1cnc(nc1)N1C[C@H]2C[C@H]2C1=O)n1cc(NC(=O)c2nc(cnc2CC(C)(C)O)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C30H28ClF3N8O3/c1-14(16-8-36-29(37-9-16)41-12-15-6-19(15)28(41)44)42-13-17(10-38-42)39-27(43)25-21(7-30(2,3)45)35-11-22(40-25)23-18(26(33)34)4-5-20(31)24(23)32/h4-5,8-11,13-15,19,26,45H,6-7,12H2,1-3H3,(H,39,43)/t14-,15+,19+/m0/s1	UCNRXDNLUCTJCV-QMTMVMCOSA-N	617968	US20230286958, Example 180	Plasma kallikrein			 7.70							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617968	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617968&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			167527819	484207155							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317855	C[C@@H](c1cnc(nc1)N1C[C@H]2C[C@H]2C1=O)n1cc(NC(=O)c2nc(cnc2C(C)(C)O)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C29H26ClF3N8O3/c1-13(15-7-35-28(36-8-15)40-11-14-6-18(14)27(40)43)41-12-16(9-37-41)38-26(42)23-24(29(2,3)44)34-10-20(39-23)21-17(25(32)33)4-5-19(30)22(21)31/h4-5,7-10,12-14,18,25,44H,6,11H2,1-3H3,(H,38,42)/t13-,14+,18+/m0/s1	CKEGFUSYPFFTDE-PMUMKWKESA-N	617969	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-(2-hydroxypropan-2-yl)-N-(1-((S)-1-(2-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-5-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 181	Plasma kallikrein			 37.1							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617969	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617969&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168679582	484207156							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317857	C[C@@H](c1cnc(nc1)N1C[C@H]2C[C@H]2C1=O)n1cc(NC(=O)c2nc(cnc2CO)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C27H22ClF3N8O3/c1-12(14-5-33-27(34-6-14)38-9-13-4-17(13)26(38)42)39-10-15(7-35-39)36-25(41)23-20(11-40)32-8-19(37-23)21-16(24(30)31)2-3-18(28)22(21)29/h2-3,5-8,10,12-13,17,24,40H,4,9,11H2,1H3,(H,36,41)/t12-,13+,17+/m0/s1	FUSZQUYKUCNCED-OGHNNQOOSA-N	617970	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-(hydroxymethyl-d2)-N-(1-((S)-1-(2-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-5-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 182::US20230286958, Example 193	Plasma kallikrein			 0.700							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617970	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617970&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162520315	484207157							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317859	Cc1nc(ncc1Cn1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C(F)F)nn1)N1C[C@H]2C[C@H]2C1=O	InChI=1S/C26H21ClF3N9O2/c1-11-14(6-32-26(33-11)39-9-13-5-16(13)25(39)41)8-38-10-19(36-37-38)35-24(40)22-12(2)31-7-18(34-22)20-15(23(29)30)3-4-17(27)21(20)28/h3-4,6-7,10,13,16,23H,5,8-9H2,1-2H3,(H,35,40)/t13-,16-/m1/s1	URVZLKZXSXJWGI-CZUORRHYSA-N	617971	US20230286958, Example 183	Plasma kallikrein			 30.6							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617971	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617971&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162520476	484207158							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317861	Cc1nc(ncc1Cn1ncc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C(F)F)n1)N1C[C@H]2C[C@H]2C1=O	InChI=1S/C26H21ClF3N9O2/c1-11-14(6-32-26(34-11)38-9-13-5-16(13)25(38)41)10-39-33-8-19(37-39)36-24(40)22-12(2)31-7-18(35-22)20-15(23(29)30)3-4-17(27)21(20)28/h3-4,6-8,13,16,23H,5,9-10H2,1-2H3,(H,36,37,40)/t13-,16-/m1/s1	QLPBCKIBHZRFFN-CZUORRHYSA-N	617972	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-methyl-N-(2-((4-methyl-2-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-5-yl)methyl)-2H-1,2,3-triazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 184	Plasma kallikrein			 8.10							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617972	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617972&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162520485	484207159							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338100	COc1ccc(c(CNC(=O)c2cn(Cc3cn4cc(ccc4n3)C3CC3)nn2)c1F)-n1cnnc1	InChI=1S/C24H22FN9O2/c1-36-21-6-5-20(33-13-27-28-14-33)18(23(21)25)8-26-24(35)19-12-34(31-30-19)11-17-10-32-9-16(15-2-3-15)4-7-22(32)29-17/h4-7,9-10,12-15H,2-3,8,11H2,1H3,(H,26,35)	NLVVTOKDMAMOBG-UHFFFAOYSA-N	626735	1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-N-(2-fluoro-3-methoxy-6-(4H-1,2,4-triazol-4-yl)benzyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-96	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626735	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626735&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156151957	485655188							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338101	COc1ccc(-c2nnco2)c(CNC(=O)c2cn(Cc3cn4cc(ccc4n3)C3CC3)nn2)c1F	InChI=1S/C24H21FN8O3/c1-35-20-6-5-17(24-30-27-13-36-24)18(22(20)25)8-26-23(34)19-12-33(31-29-19)11-16-10-32-9-15(14-2-3-14)4-7-21(32)28-16/h4-7,9-10,12-14H,2-3,8,11H2,1H3,(H,26,34)	IEHLDOCDFXCKAP-UHFFFAOYSA-N	626736	1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-N-(2-fluoro-3-methoxy-6-(1,3,4-oxadiazol-2-yl)benzyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-97	Plasma kallikrein					 55					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626736	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626736&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152283	485655189							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338102	Fc1c(OC(F)(F)F)ccc(c1CNC(=O)c1cn(Cc2cn3cc(ccc3n2)C2CC2)nn1)-n1cnnn1	InChI=1S/C23H18F4N10O2/c24-21-16(18(37-12-29-32-34-37)4-5-19(21)39-23(25,26)27)7-28-22(38)17-11-36(33-31-17)10-15-9-35-8-14(13-1-2-13)3-6-20(35)30-15/h3-6,8-9,11-13H,1-2,7,10H2,(H,28,38)	HXPCMZFCTANWIH-UHFFFAOYSA-N	626737	1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-N-(2-fluoro-6-(1H-tetrazol-1-yl)-3-(trifluoromethoxy)benzyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-98	Plasma kallikrein					 1050					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626737	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626737&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152011	485655190							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338103	COc1ccc(c(CNC(=O)c2cn(Cc3cn4cc(cc(F)c4n3)C3CC3)nn2)c1F)-n1cnnn1	InChI=1S/C23H20F2N10O2/c1-37-20-5-4-19(35-12-27-30-32-35)16(21(20)25)7-26-23(36)18-11-34(31-29-18)10-15-9-33-8-14(13-2-3-13)6-17(24)22(33)28-15/h4-6,8-9,11-13H,2-3,7,10H2,1H3,(H,26,36)	FTXOLDCJUSPNEF-UHFFFAOYSA-N	626738	1-((6-cyclopropyl-8-fluoroimidazo[1,2-a]pyridin-2-yl)methyl)-N-(2-fluoro-3-methoxy-6-(1H-tetrazol-1-yl)benzyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-99	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626738	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626738&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152001	485655191							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338104	COc1cccc(CNC(=O)c2cn(Cc3cn4cc(ccc4n3)C3CC3)nn2)c1F	InChI=1S/C22H21FN6O2/c1-31-19-4-2-3-15(21(19)23)9-24-22(30)18-13-29(27-26-18)12-17-11-28-10-16(14-5-6-14)7-8-20(28)25-17/h2-4,7-8,10-11,13-14H,5-6,9,12H2,1H3,(H,24,30)	QBDYJQQKXFIUBZ-UHFFFAOYSA-N	626739	1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-N-(2-fluoro-3-methoxybenzyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-100::US11787796, Compound I-101	Plasma kallikrein					 1050					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626739	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626739&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156151937	485655192							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338105	COc1cccc(CNC(=O)c2cn(Cc3cn4cc(ccc4n3)C3CC3)nn2)c1F	InChI=1S/C22H21FN6O2/c1-31-19-4-2-3-15(21(19)23)9-24-22(30)18-13-29(27-26-18)12-17-11-28-10-16(14-5-6-14)7-8-20(28)25-17/h2-4,7-8,10-11,13-14H,5-6,9,12H2,1H3,(H,24,30)	QBDYJQQKXFIUBZ-UHFFFAOYSA-N	626739	1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-N-(2-fluoro-3-methoxybenzyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-100::US11787796, Compound I-101	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626739	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626739&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156151937	485655192							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338106	COc1ccc(Br)c(CNC(=O)c2cn(Cc3cn4cc(ccc4n3)C3CC3)nn2)c1F	InChI=1S/C22H20BrFN6O2/c1-32-19-6-5-17(23)16(21(19)24)8-25-22(31)18-12-30(28-27-18)11-15-10-29-9-14(13-2-3-13)4-7-20(29)26-15/h4-7,9-10,12-13H,2-3,8,11H2,1H3,(H,25,31)	AHVGRFIBDLMDOU-UHFFFAOYSA-N	626741	N-(6-bromo-2-fluoro-3-methoxybenzyl)-1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-102	Plasma kallikrein					 55					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626741	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626741&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156151978	485655193							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297643	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc2CCNCc2cc1F)C(F)(F)F	InChI=1S/C21H19F4N5O/c22-16-7-14-11-27-5-4-13(14)8-17(16)28-20(31)18-9-19(21(23,24)25)29-30(18)15-3-1-2-12(6-15)10-26/h1-3,6-9,27H,4-5,10-11,26H2,(H,28,31)	XCBOZBQFIYATFU-UHFFFAOYSA-N	416716	1-(3-(aminomethyl)phenyl)-N-(7-fluoro-1,2,3,4-tetrahydroisoquinolin-6-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 161e::US10633345, Compound 161e::US10689346, Compound 161e::US11203574, Compound 161e::US11230530, Compound 161e::US11685721, Compound 161e::US11708332, Compound 161e	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416716	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416716&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356276	433916630							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297644	CN(Cc1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1)c1ccccc1	InChI=1S/C26H24F3N5O/c1-33(21-10-3-2-4-11-21)17-19-8-5-9-20(13-19)31-25(35)23-15-24(26(27,28)29)32-34(23)22-12-6-7-18(14-22)16-30/h2-15H,16-17,30H2,1H3,(H,31,35)	IEARPKHOKPOLCS-UHFFFAOYSA-N	416717	1-(3-(aminomethyl)phenyl)-N-(3-((methyl(phenyl)amino)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 28f::US10633345, Compound 28f::US10689346, Compound 28f::US11203574, Compound 28f::US11230530, Compound 28f::US11685721, Compound 28f::US11708332, Compound 28f	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416717	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416717&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665676	433916631							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297645	CCCN(c1ccccc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C27H25F4N5O/c1-2-13-35(19-8-4-3-5-9-19)20-11-12-22(28)23(15-20)33-26(37)24-16-25(27(29,30)31)34-36(24)21-10-6-7-18(14-21)17-32/h3-12,14-16H,2,13,17,32H2,1H3,(H,33,37)	NZQCKHUBEMVLQD-UHFFFAOYSA-N	416718	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-5-(phenyl(propyl)amino)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 77e::US10633345, Compound 77e::US10689346, Compound 77e::US11203574, Compound 77e::US11230530, Compound 77e::US11685721, Compound 77e::US11708332, Compound 77e	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416718	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416718&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665730	433916632							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297646	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1ccc2CNCCc2c1F)C(F)(F)F	InChI=1S/C21H19F4N5O/c22-19-15-6-7-27-11-13(15)4-5-16(19)28-20(31)17-9-18(21(23,24)25)29-30(17)14-3-1-2-12(8-14)10-26/h1-5,8-9,27H,6-7,10-11,26H2,(H,28,31)	RYNJWLCYWDTYKF-UHFFFAOYSA-N	416719	1-(3-(aminomethyl)phenyl)-N-(5-fluoro-1,2,3,4-tetrahydroisoquinolin-6-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 162c::US10633345, Compound 162c::US10689346, Compound 162c::US11203574, Compound 162c::US11230530, Compound 162c::US11685721, Compound 162c::US11708332, Compound 162c	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416719	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416719&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665528	433916633							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297647	CCCN(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1F	InChI=1S/C27H25F4N5O/c1-2-14-35(19-9-4-3-5-10-19)22-13-7-12-21(25(22)28)33-26(37)23-16-24(27(29,30)31)34-36(23)20-11-6-8-18(15-20)17-32/h3-13,15-16H,2,14,17,32H2,1H3,(H,33,37)	SDFZIQBGIDPGAP-UHFFFAOYSA-N	416720	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-3-(phenyl(propyl)amino)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 29e::US10633345, Compound 29e::US10689346, Compound 29e::US11203574, Compound 29e::US11230530, Compound 29e::US11685721, Compound 29e::US11708332, Compound 29e	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416720	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416720&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355654	433916634							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297648	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C28H26F3N5O2/c29-28(30,31)25-15-24(36(35-25)22-8-3-5-19(13-22)16-32)27(37)34-21-7-4-6-20(14-21)26(38-17-18-10-11-18)23-9-1-2-12-33-23/h1-9,12-15,18,26H,10-11,16-17,32H2,(H,34,37)	UBQUVYTUKOFUOF-UHFFFAOYSA-N	416721	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(pyridin-2-yl)methyl)-phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 43f::US10633345, Compound 43f::US10689346, Compound 43g::US11203574, Compound 43h::US11230530, Compound 43h::US11685721, Compound 43f::US11708332, Compound 43f	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416721	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416721&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355947	433916635							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297649	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc2CNCCc2cc1F)C(F)(F)F	InChI=1S/C21H19F4N5O/c22-16-7-13-4-5-27-11-14(13)8-17(16)28-20(31)18-9-19(21(23,24)25)29-30(18)15-3-1-2-12(6-15)10-26/h1-3,6-9,27H,4-5,10-11,26H2,(H,28,31)	APLBFUXJEQDPBH-UHFFFAOYSA-N	416722	1-(3-(aminomethyl)phenyl)-N-(6-fluoro-1,2,3,4-tetrahydroisoquinolin-7-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 163g::US10633345, Compound 163g::US10689346, Compound 163g::US11203574, Compound 163g::US11230530, Compound 163g::US11685721, Compound 163g::US11708332, Compound 163g	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416722	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416722&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355616	433916636							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297650	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(Cn2ccnc2)ccc1F)C(F)(F)F	InChI=1S/C22H18F4N6O/c23-17-5-4-15(12-31-7-6-28-13-31)9-18(17)29-21(33)19-10-20(22(24,25)26)30-32(19)16-3-1-2-14(8-16)11-27/h1-10,13H,11-12,27H2,(H,29,33)	FOWNNAMOGPFGSS-UHFFFAOYSA-N	416723	N-(5-((1H-imidazol-1-yl)methyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 30g::US10633345, Compound 30g::US10689346, Compound 30g::US11203574, Compound 30g::US11230530, Compound 30g::US11685721, Compound 30g::US11708332, Compound 30g	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416723	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416723&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356018	433916637							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297651	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H26F3N5O2/c29-28(30,31)25-14-24(36(35-25)23-8-1-4-19(12-23)15-32)27(37)34-22-7-2-5-20(13-22)26(38-17-18-9-10-18)21-6-3-11-33-16-21/h1-8,11-14,16,18,26H,9-10,15,17,32H2,(H,34,37)	SHFRWTHPPCXLER-UHFFFAOYSA-N	416725	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(pyridin-3-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 44c::US10633345, Compound 44c::US10689346, Compound 44c::US11203574, Compound 44d::US11230530, Compound 44e::US11685721, Compound 44c::US11708332, Compound 44c	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416725	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416725&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355578	433916639							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297652	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(Nc2ccccc2)c1)C(F)(F)F	InChI=1S/C24H20F3N5O/c25-24(26,27)22-14-21(32(31-22)20-11-4-6-16(12-20)15-28)23(33)30-19-10-5-9-18(13-19)29-17-7-2-1-3-8-17/h1-14,29H,15,28H2,(H,30,33)	BURYUTYBSGJGCF-UHFFFAOYSA-N	416728	1-(3-(aminomethyl)phenyl)-N-(3-(phenylamino)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 17d::US10689346, Compound 17d::US11203574, Compound 17d::US11230530, Compound 17d::US11685721, Compound 17d::US11708332, Compound 17d	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416728	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416728&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665499	433916642							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297653	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)c1cccnc1)C(F)(F)F	InChI=1S/C24H20F3N5O2/c25-24(26,27)21-12-20(32(31-21)19-8-1-4-15(10-19)13-28)23(34)30-18-7-2-5-16(11-18)22(33)17-6-3-9-29-14-17/h1-12,14,22,33H,13,28H2,(H,30,34)	ZKOHYLRGOQBIFH-UHFFFAOYSA-N	416729	1-(3-(aminomethyl)phenyl)-N-(3-(hydroxy(pyridin-3-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 31f::US10633345, Compound 31f::US10689346, Compound 31f::US11203574, Compound 31f::US11230530, Compound 31f::US11708332, Compound 31f	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416729	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416729&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665970	433916643							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317863	Cc1nc(Cn2cc(NC(=O)c3nc(cnc3C)-c3c(F)c(Cl)ccc3C(F)F)nn2)cnc1N1C[C@H]2C[C@H]2C1=O	InChI=1S/C26H21ClF3N9O2/c1-11-22(34-18(7-31-11)20-15(23(29)30)3-4-17(27)21(20)28)25(40)35-19-10-38(37-36-19)9-14-6-32-24(12(2)33-14)39-8-13-5-16(13)26(39)41/h3-4,6-7,10,13,16,23H,5,8-9H2,1-2H3,(H,35,40)/t13-,16-/m1/s1	ZMSWJONSCKAGKF-CZUORRHYSA-N	617973	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-methyl-N-(1-((6-methyl-5-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrazin-2-yl)methyl)-1H-1,2,3-triazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 185	Plasma kallikrein			 2.40							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617973	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617973&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168679583	484207160							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317865	Cc1nc(Cn2ncc(NC(=O)c3nc(cnc3C)-c3c(F)c(Cl)ccc3C(F)F)n2)cnc1N1C[C@H]2C[C@H]2C1=O	InChI=1S/C26H21ClF3N9O2/c1-11-22(35-18(7-31-11)20-15(23(29)30)3-4-17(27)21(20)28)25(40)36-19-8-33-39(37-19)10-14-6-32-24(12(2)34-14)38-9-13-5-16(13)26(38)41/h3-4,6-8,13,16,23H,5,9-10H2,1-2H3,(H,36,37,40)/t13-,16-/m1/s1	CJMBBLJOHVVHFJ-CZUORRHYSA-N	617974	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-methyl-N-(2-((6-methyl-5-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrazin-2-yl)methyl)-2H-1,2,3-triazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 186	Plasma kallikrein			 1.40							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617974	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617974&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168679584	484207161							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317867	Cc1cc(Cn2ncc(NC(=O)c3nc(cnc3C)-c3c(F)c(Cl)ccc3C(F)F)n2)cnc1N1C[C@H]2C[C@H]2C1=O	InChI=1S/C27H22ClF3N8O2/c1-12-5-14(7-33-25(12)38-11-15-6-17(15)27(38)41)10-39-34-9-20(37-39)36-26(40)23-13(2)32-8-19(35-23)21-16(24(30)31)3-4-18(28)22(21)29/h3-5,7-9,15,17,24H,6,10-11H2,1-2H3,(H,36,37,40)/t15-,17-/m1/s1	RSDZTFKJVKOWDN-NVXWUHKLSA-N	617975	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-methyl-N-(2-((5-methyl-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)methyl)-2H-1,2,3-triazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 187	Plasma kallikrein			 4.30							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617975	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617975&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168679585	484207162							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317869	Cc1ncc(nc1C(=O)Nc1cnn(c1)C1(CCC1)c1cnc(nc1C)N1C[C@H]2C[C@H]2C1=O)-c1c(F)c(Cl)ccc1C(F)F	InChI=1S/C30H26ClF3N8O2/c1-14-20(10-36-29(38-14)41-12-16-8-19(16)28(41)44)30(6-3-7-30)42-13-17(9-37-42)39-27(43)25-15(2)35-11-22(40-25)23-18(26(33)34)4-5-21(31)24(23)32/h4-5,9-11,13,16,19,26H,3,6-8,12H2,1-2H3,(H,39,43)/t16-,19-/m1/s1	CCSCRSNEMFIQKV-VQIMIIECSA-N	617976	US20230286958, Example 188	Plasma kallikrein			 6.50							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617976	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617976&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162520392	484207163							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317871	C[C@H](c1cnc(N2C[C@H]3C[C@H]3C2=O)c(N)c1)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H24ClF3N8O2/c1-12-24(38-21(9-34-12)22-17(25(31)32)3-4-19(29)23(22)30)27(41)37-16-8-36-40(11-16)13(2)14-6-20(33)26(35-7-14)39-10-15-5-18(15)28(39)42/h3-4,6-9,11,13,15,18,25H,5,10,33H2,1-2H3,(H,37,41)/t13-,15-,18-/m1/s1	RVENPILMUUNNIX-DDUZABMNSA-N	617977	US20230286958, Example 189	Plasma kallikrein			 1.30							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617977	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617977&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			167527826	484207164							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317873	C[C@@H](c1cnc(N2C[C@H]3C[C@H]3C2=O)c(N)c1)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H24ClF3N8O2/c1-12-24(38-21(9-34-12)22-17(25(31)32)3-4-19(29)23(22)30)27(41)37-16-8-36-40(11-16)13(2)14-6-20(33)26(35-7-14)39-10-15-5-18(15)28(39)42/h3-4,6-9,11,13,15,18,25H,5,10,33H2,1-2H3,(H,37,41)/t13-,15+,18+/m0/s1	RVENPILMUUNNIX-JCKWVBRZSA-N	617978	US20230286958, Example 190	Plasma kallikrein			 0.700							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617978	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617978&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162520361	484207165							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317875	Cc1ncc(nc1C(=O)Nc1cnn(Cc2cnc(N3C[C@H]4C[C@H]4C3=O)c(N)c2)c1)-c1c(F)c(Cl)ccc1C(F)F	InChI=1S/C27H22ClF3N8O2/c1-12-23(37-20(8-33-12)21-16(24(30)31)2-3-18(28)22(21)29)26(40)36-15-7-35-38(11-15)9-13-4-19(32)25(34-6-13)39-10-14-5-17(14)27(39)41/h2-4,6-8,11,14,17,24H,5,9-10,32H2,1H3,(H,36,40)/t14-,17-/m1/s1	MUXOTMXNFWFKTR-RHSMWYFYSA-N	617979	N-(1-((5-Amino-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)methyl)-1H-pyrazol-4-yl)-6-(3-chloro-6-(difluoromethyl)-2-fluorophenyl)-3-methylpyrazine-2-carboxamide::US20230286958, Example 191	Plasma kallikrein			 1.10							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617979	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617979&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168679586	484207166							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317877	C[C@@H](c1cnc(nc1)N1C[C@H]2C[C@H]2C1=O)n1cc(NC(=O)c2nc(cnc2COC(C)(C)C)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C31H30ClF3N8O3/c1-15(17-8-37-30(38-9-17)42-12-16-7-20(16)29(42)45)43-13-18(10-39-43)40-28(44)26-23(14-46-31(2,3)4)36-11-22(41-26)24-19(27(34)35)5-6-21(32)25(24)33/h5-6,8-11,13,15-16,20,27H,7,12,14H2,1-4H3,(H,40,44)/t15-,16+,20+/m0/s1	CJCORRXUHKQATP-RZQQEMMASA-N	617980	US20230286958, Example 192	Plasma kallikrein			 4.40							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617980	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617980&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162520432	484207167							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317879	C[C@@H](c1cnc(nc1)N1C[C@H]2C[C@H]2C1=O)n1cc(NC(=O)c2nc(cnc2CO)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C27H22ClF3N8O3/c1-12(14-5-33-27(34-6-14)38-9-13-4-17(13)26(38)42)39-10-15(7-35-39)36-25(41)23-20(11-40)32-8-19(37-23)21-16(24(30)31)2-3-18(28)22(21)29/h2-3,5-8,10,12-13,17,24,40H,4,9,11H2,1H3,(H,36,41)/t12-,13+,17+/m0/s1	FUSZQUYKUCNCED-OGHNNQOOSA-N	617970	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-(hydroxymethyl-d2)-N-(1-((S)-1-(2-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-5-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 182::US20230286958, Example 193	Plasma kallikrein			 0.400							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617970	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617970&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162520315	484207157							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317881	CC(c1cnc(nc1C)N1C[C@H]2C[C@H]2C1=O)n1cc(NC(=O)c2nc(cnc2CO)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H24ClF3N8O3/c1-12-18(7-34-28(36-12)39-9-14-5-17(14)27(39)43)13(2)40-10-15(6-35-40)37-26(42)24-21(11-41)33-8-20(38-24)22-16(25(31)32)3-4-19(29)23(22)30/h3-4,6-8,10,13-14,17,25,41H,5,9,11H2,1-2H3,(H,37,42)/t13?,14-,17-/m1/s1	DHWRFOFVRNXWFE-DTLKIFBZSA-N	617982	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-(hydroxymethyl)-N-(1-((S or R)-1-(4-methyl-2-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-5-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 194::US20230286958, Example 195	Plasma kallikrein			 0.500							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617982	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617982&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168679587	484207168							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317883	CC(c1cnc(nc1C)N1C[C@H]2C[C@H]2C1=O)n1cc(NC(=O)c2nc(cnc2CO)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H24ClF3N8O3/c1-12-18(7-34-28(36-12)39-9-14-5-17(14)27(39)43)13(2)40-10-15(6-35-40)37-26(42)24-21(11-41)33-8-20(38-24)22-16(25(31)32)3-4-19(29)23(22)30/h3-4,6-8,10,13-14,17,25,41H,5,9,11H2,1-2H3,(H,37,42)/t13?,14-,17-/m1/s1	DHWRFOFVRNXWFE-DTLKIFBZSA-N	617982	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-(hydroxymethyl)-N-(1-((S or R)-1-(4-methyl-2-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-5-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 194::US20230286958, Example 195	Plasma kallikrein			 18.2							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617982	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617982&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168679587	484207168							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317885	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(C)n1)n1cc(NC(=O)c2nc(cnc2COC(C)(C)C)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C32H32ClF3N8O3/c1-15-29(43-12-17-8-20(17)31(43)46)38-10-22(40-15)16(2)44-13-18(9-39-44)41-30(45)27-24(14-47-32(3,4)5)37-11-23(42-27)25-19(28(35)36)6-7-21(33)26(25)34/h6-7,9-11,13,16-17,20,28H,8,12,14H2,1-5H3,(H,41,45)/t16?,17-,20-/m1/s1	FJFUYOQDBLQINF-HMEKMZBJSA-N	617984	3-(tert-Butoxymethyl)-6-(3-chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((S and R)-1-(6-methyl-5-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrazin-2-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 196	Plasma kallikrein			 0.900							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617984	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617984&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168679588	484207169							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317887	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(C)n1)n1cc(NC(=O)c2nc(cnc2CO)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H24ClF3N8O3/c1-12-26(39-9-14-5-17(14)28(39)43)34-7-19(36-12)13(2)40-10-15(6-35-40)37-27(42)24-21(11-41)33-8-20(38-24)22-16(25(31)32)3-4-18(29)23(22)30/h3-4,6-8,10,13-14,17,25,41H,5,9,11H2,1-2H3,(H,37,42)/t13?,14-,17-/m1/s1	QTEIOTHWOLEZKV-DTLKIFBZSA-N	50582290	CHEMBL5082614::US20230286958, Example 198	Plasma kallikrein			 0.200							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50582290	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50582290&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162520326	476027295							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317889	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(C)n1)n1cc(NC(=O)c2nc(cnc2CO)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H24ClF3N8O3/c1-12-26(39-9-14-5-17(14)28(39)43)34-7-19(36-12)13(2)40-10-15(6-35-40)37-27(42)24-21(11-41)33-8-20(38-24)22-16(25(31)32)3-4-18(29)23(22)30/h3-4,6-8,10,13-14,17,25,41H,5,9,11H2,1-2H3,(H,37,42)/t13?,14-,17-/m1/s1	QTEIOTHWOLEZKV-DTLKIFBZSA-N	50582290	CHEMBL5082614::US20230286958, Example 198	Plasma kallikrein			 0.100							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50582290	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50582290&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162520326	476027295							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317891	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(C)c1)n1cc(NC(=O)c2nc(cnc2CO)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C29H25ClF3N7O3/c1-13-5-15(7-35-27(13)39-10-16-6-19(16)29(39)43)14(2)40-11-17(8-36-40)37-28(42)25-22(12-41)34-9-21(38-25)23-18(26(32)33)3-4-20(30)24(23)31/h3-5,7-9,11,14,16,19,26,41H,6,10,12H2,1-2H3,(H,37,42)/t14?,16-,19-/m1/s1	ZAICGYJCCFAMHG-JDQGPONISA-N	50582291	CHEMBL5078294::US20230286958, Example 200	Plasma kallikrein			 0.200							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50582291	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50582291&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			166627800	476027296							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317893	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(C)c1)n1cc(NC(=O)c2nc(cnc2CO)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C29H25ClF3N7O3/c1-13-5-15(7-35-27(13)39-10-16-6-19(16)29(39)43)14(2)40-11-17(8-36-40)37-28(42)25-22(12-41)34-9-21(38-25)23-18(26(32)33)3-4-20(30)24(23)31/h3-5,7-9,11,14,16,19,26,41H,6,10,12H2,1-2H3,(H,37,42)/t14?,16-,19-/m1/s1	ZAICGYJCCFAMHG-JDQGPONISA-N	50582291	CHEMBL5078294::US20230286958, Example 200	Plasma kallikrein			 0.200							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50582291	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50582291&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			166627800	476027296							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317895	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(C)c1C)n1cc(NC(=O)c2nc(cnc2CO)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C30H27ClF3N7O3/c1-13-14(2)28(40-10-16-6-19(16)30(40)44)36-8-20(13)15(3)41-11-17(7-37-41)38-29(43)26-23(12-42)35-9-22(39-26)24-18(27(33)34)4-5-21(31)25(24)32/h4-5,7-9,11,15-16,19,27,42H,6,10,12H2,1-3H3,(H,38,43)/t15?,16-,19-/m1/s1	HDFVEEOQSFUVTL-HFLHWUEFSA-N	617989	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((S or R)-1-(4,5-dimethyl-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)ethyl)-1H-pyrazol-4-yl)-3-(hydroxymethyl)pyrazine-2-carboxamide::US20230286958, Example 201::US20230286958, Example 202	Plasma kallikrein			 0.400							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617989	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617989&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168679589	484207174							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317897	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(C)c1C)n1cc(NC(=O)c2nc(cnc2CO)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C30H27ClF3N7O3/c1-13-14(2)28(40-10-16-6-19(16)30(40)44)36-8-20(13)15(3)41-11-17(7-37-41)38-29(43)26-23(12-42)35-9-22(39-26)24-18(27(33)34)4-5-21(31)25(24)32/h4-5,7-9,11,15-16,19,27,42H,6,10,12H2,1-3H3,(H,38,43)/t15?,16-,19-/m1/s1	HDFVEEOQSFUVTL-HFLHWUEFSA-N	617989	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((S or R)-1-(4,5-dimethyl-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)ethyl)-1H-pyrazol-4-yl)-3-(hydroxymethyl)pyrazine-2-carboxamide::US20230286958, Example 201::US20230286958, Example 202	Plasma kallikrein			 0.300							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617989	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617989&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168679589	484207174							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317899	CC(c1cnc(cc1C)N1C[C@H]2C[C@H]2C1=O)n1cc(NC(=O)c2nc(cnc2CO)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C29H25ClF3N7O3/c1-13-5-23(39-10-15-6-18(15)29(39)43)35-8-19(13)14(2)40-11-16(7-36-40)37-28(42)26-22(12-41)34-9-21(38-26)24-17(27(32)33)3-4-20(30)25(24)31/h3-5,7-9,11,14-15,18,27,41H,6,10,12H2,1-2H3,(H,37,42)/t14?,15-,18-/m1/s1	WCNRFBOCXRIWNE-QTLYGJNZSA-N	617991	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-(hydroxymethyl)-N-(1-((S or R)-1-(4-methyl-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 203::US20230286958, Example 204	Plasma kallikrein			 0.300							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617991	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617991&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168679590	484207175							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317901	CC(c1cnc(cc1C)N1C[C@H]2C[C@H]2C1=O)n1cc(NC(=O)c2nc(cnc2CO)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C29H25ClF3N7O3/c1-13-5-23(39-10-15-6-18(15)29(39)43)35-8-19(13)14(2)40-11-16(7-36-40)37-28(42)26-22(12-41)34-9-21(38-26)24-17(27(32)33)3-4-20(30)25(24)31/h3-5,7-9,11,14-15,18,27,41H,6,10,12H2,1-2H3,(H,37,42)/t14?,15-,18-/m1/s1	WCNRFBOCXRIWNE-QTLYGJNZSA-N	617991	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-(hydroxymethyl)-N-(1-((S or R)-1-(4-methyl-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 203::US20230286958, Example 204	Plasma kallikrein			 5.90							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617991	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617991&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168679590	484207175							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317903	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(F)c1)n1cc(NC(=O)c2nc(cnc2CO)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H22ClF4N7O3/c1-12(13-5-19(30)26(35-6-13)39-9-14-4-17(14)28(39)43)40-10-15(7-36-40)37-27(42)24-21(11-41)34-8-20(38-24)22-16(25(32)33)2-3-18(29)23(22)31/h2-3,5-8,10,12,14,17,25,41H,4,9,11H2,1H3,(H,37,42)/t12?,14-,17-/m1/s1	VGFJEINHJGJRSC-MRXJRLSOSA-N	617993	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((S or R)-1-(5-fluoro-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)ethyl)-1H-pyrazol-4-yl)-3-(hydroxymethyl)pyrazine-2-carboxamide::US20230286958, Example 205::US20230286958, Example 206	Plasma kallikrein			 0.300							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617993	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617993&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			166898477	484207176							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317905	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(F)c1)n1cc(NC(=O)c2nc(cnc2CO)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H22ClF4N7O3/c1-12(13-5-19(30)26(35-6-13)39-9-14-4-17(14)28(39)43)40-10-15(7-36-40)37-27(42)24-21(11-41)34-8-20(38-24)22-16(25(32)33)2-3-18(29)23(22)31/h2-3,5-8,10,12,14,17,25,41H,4,9,11H2,1H3,(H,37,42)/t12?,14-,17-/m1/s1	VGFJEINHJGJRSC-MRXJRLSOSA-N	617993	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((S or R)-1-(5-fluoro-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)ethyl)-1H-pyrazol-4-yl)-3-(hydroxymethyl)pyrazine-2-carboxamide::US20230286958, Example 205::US20230286958, Example 206	Plasma kallikrein			 0.300							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617993	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617993&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			166898477	484207176							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317907	C[C@@H](c1cnc(nc1C)N1CCN(C)C1=O)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C27H25ClF3N9O2/c1-13-18(10-33-26(35-13)39-8-7-38(4)27(39)42)15(3)40-12-16(9-34-40)36-25(41)23-14(2)32-11-20(37-23)21-17(24(30)31)5-6-19(28)22(21)29/h5-6,9-12,15,24H,7-8H2,1-4H3,(H,36,41)/t15-/m0/s1	CFJHRNXYORLPRA-HNNXBMFYSA-N	617995	US20230286958, Example 207	Plasma kallikrein			 8.60							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617995	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617995&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162520519	484207177							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317909	C[C@@H](O)c1ncc(nc1C(=O)Nc1cnn(Cc2cc(C)c(nn2)N2C[C@H]3C[C@H]3C2=O)c1)-c1c(F)c(Cl)ccc1C(F)F	InChI=1S/C28H24ClF3N8O3/c1-12-5-15(37-38-26(12)40-9-14-6-18(14)28(40)43)10-39-11-16(7-34-39)35-27(42)24-23(13(2)41)33-8-20(36-24)21-17(25(31)32)3-4-19(29)22(21)30/h3-5,7-8,11,13-14,18,25,41H,6,9-10H2,1-2H3,(H,35,42)/t13-,14-,18-/m1/s1	DAVIKZRXBAXBIC-HBUWYVDXSA-N	617996	US20230286958, Example 208	Plasma kallikrein			 12.7							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617996	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617996&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162520375	484207178							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317911	C[C@H](O)c1ncc(nc1C(=O)Nc1cnn(Cc2cc(C)c(nn2)N2C[C@H]3C[C@H]3C2=O)c1)-c1c(F)c(Cl)ccc1C(F)F	InChI=1S/C28H24ClF3N8O3/c1-12-5-15(37-38-26(12)40-9-14-6-18(14)28(40)43)10-39-11-16(7-34-39)35-27(42)24-23(13(2)41)33-8-20(36-24)21-17(25(31)32)3-4-19(29)22(21)30/h3-5,7-8,11,13-14,18,25,41H,6,9-10H2,1-2H3,(H,35,42)/t13-,14+,18+/m0/s1	DAVIKZRXBAXBIC-PMUMKWKESA-N	617997	US20230286958, Example 209	Plasma kallikrein			 3.80							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617997	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617997&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			166898719	484207179							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317913	CC(O)c1ncc(nc1C(=O)Nc1cnn(c1)C(C)c1cnc(N2C[C@H]3C[C@H]3C2=O)c(C)c1)-c1c(F)c(Cl)ccc1C(F)F	InChI=1S/C30H27ClF3N7O3/c1-13-6-16(8-36-28(13)40-11-17-7-20(17)30(40)44)14(2)41-12-18(9-37-41)38-29(43)26-25(15(3)42)35-10-22(39-26)23-19(27(33)34)4-5-21(31)24(23)32/h4-6,8-10,12,14-15,17,20,27,42H,7,11H2,1-3H3,(H,38,43)/t14?,15?,17-,20-/m1/s1	DVMWQVLBMQQBHU-RLFPARDHSA-N	617998	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-((S or R)-1-hydroxyethyl)-N-(1-((S or R)-1-(5-methyl-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 210::US20230286958, Example 211::US20230286958, Example 212::US20230286958, Example 213	Plasma kallikrein			 0.400							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617998	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617998&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162520417	484207180							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317915	CC(O)c1ncc(nc1C(=O)Nc1cnn(c1)C(C)c1cnc(N2C[C@H]3C[C@H]3C2=O)c(C)c1)-c1c(F)c(Cl)ccc1C(F)F	InChI=1S/C30H27ClF3N7O3/c1-13-6-16(8-36-28(13)40-11-17-7-20(17)30(40)44)14(2)41-12-18(9-37-41)38-29(43)26-25(15(3)42)35-10-22(39-26)23-19(27(33)34)4-5-21(31)24(23)32/h4-6,8-10,12,14-15,17,20,27,42H,7,11H2,1-3H3,(H,38,43)/t14?,15?,17-,20-/m1/s1	DVMWQVLBMQQBHU-RLFPARDHSA-N	617998	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-((S or R)-1-hydroxyethyl)-N-(1-((S or R)-1-(5-methyl-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 210::US20230286958, Example 211::US20230286958, Example 212::US20230286958, Example 213	Plasma kallikrein			 0.600							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617998	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617998&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162520417	484207180							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317917	CC(O)c1ncc(nc1C(=O)Nc1cnn(c1)C(C)c1cnc(N2C[C@H]3C[C@H]3C2=O)c(C)c1)-c1c(F)c(Cl)ccc1C(F)F	InChI=1S/C30H27ClF3N7O3/c1-13-6-16(8-36-28(13)40-11-17-7-20(17)30(40)44)14(2)41-12-18(9-37-41)38-29(43)26-25(15(3)42)35-10-22(39-26)23-19(27(33)34)4-5-21(31)24(23)32/h4-6,8-10,12,14-15,17,20,27,42H,7,11H2,1-3H3,(H,38,43)/t14?,15?,17-,20-/m1/s1	DVMWQVLBMQQBHU-RLFPARDHSA-N	617998	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-((S or R)-1-hydroxyethyl)-N-(1-((S or R)-1-(5-methyl-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 210::US20230286958, Example 211::US20230286958, Example 212::US20230286958, Example 213	Plasma kallikrein			 1.000							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617998	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617998&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162520417	484207180							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317919	CC(O)c1ncc(nc1C(=O)Nc1cnn(c1)C(C)c1cnc(N2C[C@H]3C[C@H]3C2=O)c(C)c1)-c1c(F)c(Cl)ccc1C(F)F	InChI=1S/C30H27ClF3N7O3/c1-13-6-16(8-36-28(13)40-11-17-7-20(17)30(40)44)14(2)41-12-18(9-37-41)38-29(43)26-25(15(3)42)35-10-22(39-26)23-19(27(33)34)4-5-21(31)24(23)32/h4-6,8-10,12,14-15,17,20,27,42H,7,11H2,1-3H3,(H,38,43)/t14?,15?,17-,20-/m1/s1	DVMWQVLBMQQBHU-RLFPARDHSA-N	617998	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-((S or R)-1-hydroxyethyl)-N-(1-((S or R)-1-(5-methyl-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 210::US20230286958, Example 211::US20230286958, Example 212::US20230286958, Example 213	Plasma kallikrein			 0.900							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=617998	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=617998&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162520417	484207180							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317921	CCc1ncc(nc1C(=O)Nc1cnn(c1)C(C)c1cnc(N2C[C@H]3C[C@H]3C2=O)c(C)c1)-c1c(F)c(Cl)ccc1C(F)F	InChI=1S/C30H27ClF3N7O2/c1-4-22-26(39-23(11-35-22)24-19(27(33)34)5-6-21(31)25(24)32)29(42)38-18-10-37-41(13-18)15(3)16-7-14(2)28(36-9-16)40-12-17-8-20(17)30(40)43/h5-7,9-11,13,15,17,20,27H,4,8,12H2,1-3H3,(H,38,42)/t15?,17-,20-/m1/s1	AEJZMQKSVVZBAW-LQRGHNGLSA-N	618002	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-ethyl-N-(1-((S and R)-1-(5-methyl-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-::US20230286958, Example 214	Plasma kallikrein			 1.20							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618002	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618002&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168679591	484207181							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338107	Cc1cc(cc(C)c1CNC(=O)c1cnn(Cc2cn3cc(ccc3n2)C2CC2)c1)C(N)=N	InChI=1S/C25H27N7O/c1-15-7-19(24(26)27)8-16(2)22(15)10-28-25(33)20-9-29-32(12-20)14-21-13-31-11-18(17-3-4-17)5-6-23(31)30-21/h5-9,11-13,17H,3-4,10,14H2,1-2H3,(H3,26,27)(H,28,33)	DUKOVVCBNTWDEQ-UHFFFAOYSA-N	626742	N-(4-carbamimidoyl-2,6-dimethylbenzyl)-1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-pyrazole-4-carboxamide ::US11787796, Compound I-103	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626742	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626742&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156151868	485655194							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338108	COc1ccc(c(CNC(=O)c2cn(Cc3cn4cc(ccc4n3)C3CC3)nn2)c1F)-n1ccnc1	InChI=1S/C25H23FN8O2/c1-36-22-6-5-21(32-9-8-27-15-32)19(24(22)26)10-28-25(35)20-14-34(31-30-20)13-18-12-33-11-17(16-2-3-16)4-7-23(33)29-18/h4-9,11-12,14-16H,2-3,10,13H2,1H3,(H,28,35)	IKFKBBZBESSLKJ-UHFFFAOYSA-N	626743	1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-N-(2-fluoro-6-(1H-imidazol-1-yl)-3-methoxybenzyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-104	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626743	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626743&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152062	485655195							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338109	COc1ccc(c(CNC(=O)c2cn(Cc3cn4cc(ccc4n3)C3CC3)nn2)c1F)-n1cnnn1	InChI=1S/C23H21FN10O2/c1-36-20-6-5-19(34-13-26-29-31-34)17(22(20)24)8-25-23(35)18-12-33(30-28-18)11-16-10-32-9-15(14-2-3-14)4-7-21(32)27-16/h4-7,9-10,12-14H,2-3,8,11H2,1H3,(H,25,35)	SVBCYIOLAKYOHQ-UHFFFAOYSA-N	626668	1-(1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-1,2,3-triazol-4-yl)-N-(2-fluoro-3-methoxy-6-(1H-tetrazol-1-yl)benzyl)methanamine ::US11787796, Compound I-105::US11787796, Compound I-29::US11787796, Compound I-83	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626668	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626668&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152169	485655123							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338110	Fc1c(Cl)ccc(c1CNC(=O)c1cn(Cc2cn3cc(ccc3n2)C2CC2)nn1)-n1cnnn1	InChI=1S/C22H18ClFN10O/c23-17-4-5-19(34-12-26-29-31-34)16(21(17)24)7-25-22(35)18-11-33(30-28-18)10-15-9-32-8-14(13-1-2-13)3-6-20(32)27-15/h3-6,8-9,11-13H,1-2,7,10H2,(H,25,35)	CJAJWIOWWQOPQT-UHFFFAOYSA-N	626719	N-(3-chloro-2-methyl-6-(1H-tetrazol-1-yl)benzyl)-1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-106::US11787796, Compound I-80	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626719	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626719&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156151919	485655173							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338111	COc1ccc(C#N)c(CNC(=O)c2cn(Cc3cn4cc(cc(CCC(O)=O)c4n3)C3CC3)nn2)c1F	InChI=1S/C26H24FN7O4/c1-38-22-6-4-17(9-28)20(24(22)27)10-29-26(37)21-14-34(32-31-21)13-19-12-33-11-18(15-2-3-15)8-16(25(33)30-19)5-7-23(35)36/h4,6,8,11-12,14-15H,2-3,5,7,10,13H2,1H3,(H,29,37)(H,35,36)	RUFKZYHJTBNJEV-UHFFFAOYSA-N	626746	3-(2-((4-((6-cyano-2-fluor-3-methoxybenzyl)carbamoyl)-1H-1,2,3-triazol-1-yl)methyl)-6-cyclopropylimidazo[1,2-a]pyridin-8-yl)propanoic Acid ::US11787796, Compound I-107	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626746	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626746&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156151852	485655196							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338112	CCOC(=O)CCc1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3c(F)c(OC)ccc3C#N)nc12)C1CC1	InChI=1S/C28H28FN7O4/c1-3-40-25(37)9-7-18-10-20(17-4-5-17)13-35-14-21(32-27(18)35)15-36-16-23(33-34-36)28(38)31-12-22-19(11-30)6-8-24(39-2)26(22)29/h6,8,10,13-14,16-17H,3-5,7,9,12,15H2,1-2H3,(H,31,38)	CCESIBRDQKVQRN-UHFFFAOYSA-N	626747	US11787796, Compound I-108::ethyl 3-(2-((4-((6-cyano-2-fluoro-3-methoxybenzyl)carbamoyl)-1H-1,2,3-triazol-1-yl)methyl)-6-cyclopropylimidazo[1,2-a]pyridin-8-yl)propanoate 	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626747	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626747&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152301	485655197							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338113	OC(=O)CCc1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3c(F)c(Cl)ccc3-n3cnnn3)nc12)C1CC1	InChI=1S/C25H22ClFN10O3/c26-19-4-5-21(37-13-29-32-34-37)18(23(19)27)8-28-25(40)20-12-36(33-31-20)11-17-10-35-9-16(14-1-2-14)7-15(24(35)30-17)3-6-22(38)39/h4-5,7,9-10,12-14H,1-3,6,8,11H2,(H,28,40)(H,38,39)	QWZYJLDJHGQVCO-UHFFFAOYSA-N	626748	3-(2-((4-((3-choro-2-fluoro-6-(1H-tetrazol-1-yl)benzyl)carbamoyl)-1H-1,2,3-triazol-1-yl)methyl)-6-cyclopropylimidazo[1,2-a]pyridin-8-yl)propanoic Acid ::US11787796, Compound I-109	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626748	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626748&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156151884	485655198							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297654	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F3N4O/c31-30(32,33)28-18-27(37(36-28)25-11-4-6-21(16-25)19-34)29(38)35-24-10-5-9-23(17-24)26(15-14-20-12-13-20)22-7-2-1-3-8-22/h1-11,16-18,20,26H,12-15,19,34H2,(H,35,38)	LVGPKQXQIQRVCT-UHFFFAOYSA-N	416730	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-phenylpropyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 78d::US10633345, Compound 78d::US10689346, Compound 78d::US11203574, Compound 78d::US11230530, Compound 78d::US11685721, Compound 78d::US11708332, Compound 78d	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416730	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416730&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665672	433916644							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297655	COC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C26H23F3N4O2/c1-35-24(18-8-3-2-4-9-18)19-10-6-11-20(14-19)31-25(34)22-15-23(26(27,28)29)32-33(22)21-12-5-7-17(13-21)16-30/h2-15,24H,16,30H2,1H3,(H,31,34)	XNHGZPIIDJTQKO-UHFFFAOYSA-N	416731	1-(3-(aminomethyl)phenyl)-N-(3-(methoxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18f::US10633345, Compound 18f::US10689346, Compound 18f::US11203574, Compound 18f::US11230530, Compound 18e::US11685721, Compound 18f::US11708332, Compound 18f	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416731	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416731&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665801	433916645							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297656	CCCCC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C29H29F3N4O/c1-2-3-15-25(21-10-5-4-6-11-21)22-12-8-13-23(17-22)34-28(37)26-18-27(29(30,31)32)35-36(26)24-14-7-9-20(16-24)19-33/h4-14,16-18,25H,2-3,15,19,33H2,1H3,(H,34,37)	PEZPMDJZISDDKH-UHFFFAOYSA-N	416732	1-(3-(aminomethyl)phenyl)-N-(3-(1-phenylpentyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 32f::US10633345, Compound 32f::US10689346, Compound 32f::US11203574, Compound 32f::US11230530, Compound 32f::US11685721, Compound 32f::US11708332, Compound 32f	Plasma kallikrein		>75.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416732	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416732&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356224	433916646							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297657	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H27F3N6O/c29-28(30,31)25-14-24(37(36-25)23-8-1-4-19(12-23)15-32)27(38)35-22-7-2-5-20(13-22)26(34-16-18-9-10-18)21-6-3-11-33-17-21/h1-8,11-14,17-18,26,34H,9-10,15-16,32H2,(H,35,38)	KSDPGGAAGHTRLB-UHFFFAOYSA-N	416733	1-(3-(Aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(pyridin-3-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 79f::US10633345, Compound 79f::US10689346, Compound 79f::US11203574, Compound 79f::US11230530, Compound 79f::US11685721, Compound 79f::US11708332, Compound 79f	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416733	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416733&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356066	433916647							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297658	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(Cc2ccccc2)c1)C(F)(F)F	InChI=1S/C25H21F3N4O/c26-25(27,28)23-15-22(32(31-23)21-11-5-9-19(14-21)16-29)24(33)30-20-10-4-8-18(13-20)12-17-6-2-1-3-7-17/h1-11,13-15H,12,16,29H2,(H,30,33)	GVRJCFWHVBXPLW-UHFFFAOYSA-N	416734	1-(3-(aminomethyl)phenyl)-N-(3-benzylphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 19d::US10633345, Compound 19d::US10689346, Compound 19d::US11203574, Compound 19d::US11230530, Compound 19d::US11685721, Compound 19d::US11708332, Compound 19d	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416734	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416734&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355715	433916648							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297659	CCOC(c1ccccc1)c1ccc(Cl)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C27H24ClF3N4O2/c1-2-37-25(18-8-4-3-5-9-18)19-11-12-21(28)22(14-19)33-26(36)23-15-24(27(29,30)31)34-35(23)20-10-6-7-17(13-20)16-32/h3-15,25H,2,16,32H2,1H3,(H,33,36)	XUCZWPPXZIMXPF-UHFFFAOYSA-N	416735	1-(3-(aminomethyl)phenyl)-N-(2-chloro-5-(ethoxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 33e::US10633345, Compound 33e::US10689346, Compound 33e::US11203574, Compound 33e::US11230530, Compound 33e::US11685721, Compound 33e::US11708332, Compound 33e	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416735	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416735&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665706	433916649							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297660	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(F)cc(c1)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-22-12-21(27(39-17-18-9-10-18)20-6-2-1-3-7-20)13-23(14-22)35-28(38)25-15-26(29(31,32)33)36-37(25)24-8-4-5-19(11-24)16-34/h1-8,11-15,18,27H,9-10,16-17,34H2,(H,35,38)	CECISELXZFBKBA-UHFFFAOYSA-N	416736	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)-5-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 80h::US10633345, Compound 80h::US10689346, Compound 80h::US11203574, Compound 80h::US11230530, Compound 80h::US11685721, Compound 80h::US11708332, Compound 80h	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416736	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416736&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356068	433916650							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297661	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(Oc2ccccc2)c1)C(F)(F)F	InChI=1S/C24H19F3N4O2/c25-24(26,27)22-14-21(31(30-22)18-8-4-6-16(12-18)15-28)23(32)29-17-7-5-11-20(13-17)33-19-9-2-1-3-10-19/h1-14H,15,28H2,(H,29,32)	CMENISUXWPWEPE-UHFFFAOYSA-N	416737	1-(3-(aminomethyl)phenyl)-N-(3-phenoxyphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 20d::US10689346, Compound 20d::US11203574, Compound 20d::US11230530, Compound 20d::US11685721, Compound 20d::US11708332, Compound 20d	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416737	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416737&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665805	433916651							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297662	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1Cl)C(O)c1ccccc1)C(F)(F)F	InChI=1S/C25H20ClF3N4O2/c26-19-10-9-17(23(34)16-6-2-1-3-7-16)12-20(19)31-24(35)21-13-22(25(27,28)29)32-33(21)18-8-4-5-15(11-18)14-30/h1-13,23,34H,14,30H2,(H,31,35)	RYPOCSQZGRAPIF-UHFFFAOYSA-N	416738	1-(3-(aminomethyl)phenyl)-N-(2-chloro-5-(hydroxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 33f::US10633345, Compound 33f::US10689346, Compound 33f::US11203574, Compound 33f::US11230530, Compound 33f::US11685721, Compound 33f::US11708332, Compound 33f	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416738	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416738&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665810	433916652							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297663	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)N(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H28F3N5O/c30-29(31,32)27-18-26(37(35-27)25-11-4-6-21(16-25)19-33)28(38)34-22-7-5-10-24(17-22)36(15-14-20-12-13-20)23-8-2-1-3-9-23/h1-11,16-18,20H,12-15,19,33H2,(H,34,38)	BPUAEVGWEFCIEW-UHFFFAOYSA-N	416739	1-(3-(aminomethyl)phenyl)-N-(3-((2-cyclopropylethyl)(phenyl)amino)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 87f::US10633345, Compound 87f::US10689346, Compound 87f::US11203574, Compound 87f::US11230530, Compound 87f::US11685721, Compound 87f::US11708332, Compound 87f	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416739	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416739&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665744	433916653							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297664	CCOC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C27H25F3N4O2/c1-2-36-25(19-9-4-3-5-10-19)20-11-7-12-21(15-20)32-26(35)23-16-24(27(28,29)30)33-34(23)22-13-6-8-18(14-22)17-31/h3-16,25H,2,17,31H2,1H3,(H,32,35)	NWRGIGNKIBZYEM-UHFFFAOYSA-N	416740	1-(3-(aminomethyl)phenyl)-N-(3-(ethoxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18g::US10633345, Compound 18g::US10689346, Compound 18g::US11203574, Compound 18g::US11230530, Compound 18g::US11685721, Compound 18g::US11708332, Compound 18g	Plasma kallikrein		>75.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416740	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416740&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356270	433916654							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338114	OC(=O)CCc1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3c(F)c(Cl)ccc3NC#N)nc12)C1CC1	InChI=1S/C25H22ClFN8O3/c26-19-4-5-20(30-13-28)18(23(19)27)8-29-25(38)21-12-35(33-32-21)11-17-10-34-9-16(14-1-2-14)7-15(24(34)31-17)3-6-22(36)37/h4-5,7,9-10,12,14,30H,1-3,6,8,11H2,(H,29,38)(H,36,37)	VEIYOPNPFAAKRJ-UHFFFAOYSA-N	626749	3-(2-((4-((3-chloro-6-cyanamido-2-fluorobenzyl)carbamoyl)-1H-1,2,3-triazol-1-yl)methyl)-6-cyclopropylimidazo[1,2-a]pyridin-8-yl)propanoic Acid ::US11787796, Compound I-110	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626749	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626749&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152191	485655199							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338115	Cc1cc(cc(C)c1CNC(=O)c1cn(Cc2cn3cc(cc(C(O)=O)c3n2)C2CC2)nn1)C(N)=N	InChI=1S/C25H26N8O3/c1-13-5-16(22(26)27)6-14(2)20(13)8-28-24(34)21-12-33(31-30-21)11-18-10-32-9-17(15-3-4-15)7-19(25(35)36)23(32)29-18/h5-7,9-10,12,15H,3-4,8,11H2,1-2H3,(H3,26,27)(H,28,34)(H,35,36)	MVZMNSBKCPYBKT-UHFFFAOYSA-N	626750	2-((4-((4-carbamimidoyl-2,6-dimethylbenzyl)carbamoyl)-1H-1,2,3-triazol-1-yl)methyl)-6-cyclopropylimidazo[1,2-a]pyridine-8-carboxylic Acid ::US11787796, Compound I-111	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626750	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626750&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152195	485655200							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338116	CCOC(=O)c1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3c(C)cc(cc3C)C(N)=N)nc12)C1CC1	InChI=1S/C27H30N8O3/c1-4-38-27(37)21-9-19(17-5-6-17)11-34-12-20(31-25(21)34)13-35-14-23(32-33-35)26(36)30-10-22-15(2)7-18(24(28)29)8-16(22)3/h7-9,11-12,14,17H,4-6,10,13H2,1-3H3,(H3,28,29)(H,30,36)	COXOMZDUZPXHPO-UHFFFAOYSA-N	626751	US11787796, Compound I-112::ethyl 2-((4-((4-carbamimidoyl-2,6-dimethylbenzyl)carbamoyl)-1H-1,2,3-triazol-1-yl)methyl)-6-cyclopropylimidazo[1,2-a]pyridine-8-carboxylate 	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626751	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626751&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152242	485655201							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338117	CCOC(=O)CCc1cc(cn2cc(Cn3cc(nn3)C(=O)NCc3c(F)c(Cl)ccc3-n3cnnn3)nc12)C1CC1	InChI=1S/C27H26ClFN10O3/c1-2-42-24(40)8-5-17-9-18(16-3-4-16)11-37-12-19(32-26(17)37)13-38-14-22(33-35-38)27(41)30-10-20-23(39-15-31-34-36-39)7-6-21(28)25(20)29/h6-7,9,11-12,14-16H,2-5,8,10,13H2,1H3,(H,30,41)	HWPVTKRAQQXNFL-UHFFFAOYSA-N	626752	US11787796, Compound I-113::ethyl 3-(2-((4-((3-chloro-2-fluoro-6-(1H-tetrazol-1-yl)benzyl)carbamoyl)-1H-1,2,3-triazol-1-yl)methyl)-6-cyclopropylimidazo[1,2-a]pyridin-8-yl)propanoate 	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626752	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626752&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152093	485655202							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338118	Fc1c(Cl)ccc(N2CC3(COC3)C2)c1CNC(=O)c1cnn(Cc2cn3cc(ccc3n2)C2CC2)c1	InChI=1S/C27H26ClFN6O2/c28-22-4-5-23(34-13-27(14-34)15-37-16-27)21(25(22)29)8-30-26(36)19-7-31-35(10-19)12-20-11-33-9-18(17-1-2-17)3-6-24(33)32-20/h3-7,9-11,17H,1-2,8,12-16H2,(H,30,36)	IFLMSADOQFRSDO-UHFFFAOYSA-N	626753	N-(3-chloro-2-fluoro-6-(2-oxa-6-azaspiro[3.3]heptan-6-yl)benzyl)-1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-pyrazole-4-carboxamide ::US11787796, Compound I-114	Plasma kallikrein					 1050					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626753	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626753&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152010	485655203							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338119	Cc1cc(cc(C)c1CNC(=O)c1cn(Cc2cn3cc(ccc3n2)C2CC2)nn1)C(N)=N	InChI=1S/C24H26N8O/c1-14-7-18(23(25)26)8-15(2)20(14)9-27-24(33)21-13-32(30-29-21)12-19-11-31-10-17(16-3-4-16)5-6-22(31)28-19/h5-8,10-11,13,16H,3-4,9,12H2,1-2H3,(H3,25,26)(H,27,33)	HSBAKMYVZVSCKP-UHFFFAOYSA-N	626754	4-((4-carbamimidoyl-2,6-dimethylbenzyl)amino)-6-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methoxy)pyrimidine-2-carboxylic acid ::US11787796, Compound I-115	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626754	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626754&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156151959	485655204							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338120	Fc1c(Cl)ccc(c1CNC(=O)c1cnn(Cc2cn3cc(ccc3n2)C2CC2)c1)-n1cnnn1	InChI=1S/C23H19ClFN9O/c24-19-4-5-20(34-13-27-30-31-34)18(22(19)25)8-26-23(35)16-7-28-33(10-16)12-17-11-32-9-15(14-1-2-14)3-6-21(32)29-17/h3-7,9-11,13-14H,1-2,8,12H2,(H,26,35)	TVEIQRHNWRIVOY-UHFFFAOYSA-N	626755	N-(3-chloro-2-fluoro-6-(1H-tetrazol-1-yl)benzyl)-1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-pyrazole-4-carboxamide ::US11787796, Compound I-116	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626755	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626755&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152285	485655205							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297665	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)c1ccccc1)C(F)(F)F	InChI=1S/C25H20F4N4O2/c26-19-10-9-17(23(34)16-6-2-1-3-7-16)12-20(19)31-24(35)21-13-22(25(27,28)29)32-33(21)18-8-4-5-15(11-18)14-30/h1-13,23,34H,14,30H2,(H,31,35)	SUGJHCONPCVXKJ-UHFFFAOYSA-N	416741	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-5-(hydroxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 34d::US10633345, Compound 34d::US10689346, Compound 34d::US11203574, Compound 34d::US11230530, Compound 34d::US11685721, Compound 34d::US11708332, Compound 34d	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416741	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416741&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665740	433916655							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297666	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(C(NCC2CC2)c2ccccc2)c1F)C(F)(F)F	InChI=1S/C29H27F4N5O/c30-26-22(27(35-17-18-12-13-18)20-7-2-1-3-8-20)10-5-11-23(26)36-28(39)24-15-25(29(31,32)33)37-38(24)21-9-4-6-19(14-21)16-34/h1-11,14-15,18,27,35H,12-13,16-17,34H2,(H,36,39)	YDBPNMJFMRHCIG-UHFFFAOYSA-N	416742	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 88b::US10633345, Compound 88b::US10689346, Compound 88b::US11203574, Compound 88b::US11230530, Compound 88b::US11685721, Compound 88b::US11708332, Compound 88b	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416742	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416742&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123349010	433916656							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297667	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(=O)c1ccccc1)C(F)(F)F	InChI=1S/C25H19F3N4O2/c26-25(27,28)22-14-21(32(31-22)20-11-4-6-16(12-20)15-29)24(34)30-19-10-5-9-18(13-19)23(33)17-7-2-1-3-8-17/h1-14H,15,29H2,(H,30,34)	ZRVRSUVIXBEHIJ-UHFFFAOYSA-N	416743	1-(3-(aminomethyl)phenyl)-N-(3-benzoylphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 22b::US10633345, Compound 22b::US10689346, Compound 22b::US11203574, Compound 22b::US11230530, Compound 22b::US11708332, Compound 22b	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416743	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416743&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355917	433916657							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297668	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(C(O)c2ccccc2)c1F)C(F)(F)F	InChI=1S/C25H20F4N4O2/c26-22-18(23(34)16-7-2-1-3-8-16)10-5-11-19(22)31-24(35)20-13-21(25(27,28)29)32-33(20)17-9-4-6-15(12-17)14-30/h1-13,23,34H,14,30H2,(H,31,35)	DENXCWXVTOPLRK-UHFFFAOYSA-N	416744	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-3-(hydroxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 35g::US10633345, Compound 35g::US10689346, Compound 35g::US11203574, Compound 35g::US11230530, Compound 35g::US11685721, Compound 35g::US11708332, Compound 35g	Plasma kallikrein		>75.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416744	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416744&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355965	433916658							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297669	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1nccs1)C(F)(F)F	InChI=1S/C26H24F3N5O2S/c27-26(28,29)22-13-21(34(33-22)20-6-1-3-17(11-20)14-30)24(35)32-19-5-2-4-18(12-19)23(25-31-9-10-37-25)36-15-16-7-8-16/h1-6,9-13,16,23H,7-8,14-15,30H2,(H,32,35)	FKPORVMTXYTRPN-UHFFFAOYSA-N	416745	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(thiazol-2-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 82f::US10633345, Compound 82f::US10689346, Compound 82f::US11203574, Compound 82f::US11230530, Compound 82f::US11685721, Compound 82f::US11708332, Compound 82f	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416745	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416745&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355763	433916659							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297670	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(Oc2ccccc2)c1F)C(F)(F)F	InChI=1S/C24H18F4N4O2/c25-22-18(10-5-11-20(22)34-17-8-2-1-3-9-17)30-23(33)19-13-21(24(26,27)28)31-32(19)16-7-4-6-15(12-16)14-29/h1-13H,14,29H2,(H,30,33)	VUYMCUFLTORTFW-UHFFFAOYSA-N	416746	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-3-phenoxyphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 23c::US10633345, Compound 23c::US10689346, Compound 23c::US11203574, Compound 23c::US11230530, Compound 23c::US11685721, Compound 23c::US11708332, Compound 23c	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416746	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416746&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665745	433916660							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297671	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-23-12-11-21(27(39-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)35-28(38)25-15-26(29(31,32)33)36-37(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27H,9-10,16-17,34H2,(H,35,38)	HIMJVDQVZQMIPM-UHFFFAOYSA-N	416747	1-(3-(Aminomethyl)phenyl)-N-(5-((cyclopropylmethoxy)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 34c::US10633345, Compound 34c::US10689346, Compound 34c::US11203574, Compound 37a::US11230530, Compound 37a::US11685721, Compound 34c::US11708332, Compound 34c	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416747	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416747&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355729	433916661							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297672	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C28H27F3N6O/c29-28(30,31)25-15-24(37(36-25)22-8-3-5-19(13-22)16-32)27(38)35-21-7-4-6-20(14-21)26(34-17-18-10-11-18)23-9-1-2-12-33-23/h1-9,12-15,18,26,34H,10-11,16-17,32H2,(H,35,38)	UTXGSCUKCKWESJ-UHFFFAOYSA-N	416748	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(pyridin-2-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 83c::US10633345, Compound 83c::US10689346, Compound 83c::US11203574, Compound 83c::US11230530, Compound 83c::US11685721, Compound 83c::US11708332, Compound 83c	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416748	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416748&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355952	433916662							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297673	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(Oc2ccccc2)ccc1F)C(F)(F)F	InChI=1S/C24H18F4N4O2/c25-19-10-9-18(34-17-7-2-1-3-8-17)12-20(19)30-23(33)21-13-22(24(26,27)28)31-32(21)16-6-4-5-15(11-16)14-29/h1-13H,14,29H2,(H,30,33)	RDALDQDNCYVLAM-UHFFFAOYSA-N	416749	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-5-phenoxyphenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 24c::US10633345, Compound 24c::US10689346, Compound 24c::US11203574, Compound 24c::US11230530, Compound 24c::US11685721, Compound 24c::US11708332, Compound 24c	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416749	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416749&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356123	433916663							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297674	CC(C)(C)OC(=O)NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F3N4O4/c1-29(2,3)41-28(40)34-18-19-9-7-14-23(15-19)37-24(17-25(36-37)30(31,32)33)27(39)35-22-13-8-12-21(16-22)26(38)20-10-5-4-6-11-20/h4-17,26,38H,18H2,1-3H3,(H,34,40)(H,35,39)	HTUKEDKRJSOOMR-UHFFFAOYSA-N	529580	US11203574, Compound 18e::US11708332, Compound 18e	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=529580	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=529580&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355806	463793102							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297675	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F3N4O2/c31-30(32,33)27-18-26(37(36-27)25-11-4-6-21(16-25)19-34)28(38)35-24-10-5-9-23(17-24)29(39,15-14-20-12-13-20)22-7-2-1-3-8-22/h1-11,16-18,20,39H,12-15,19,34H2,(H,35,38)	DCGYPXFSNPCKGX-UHFFFAOYSA-N	416751	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 46g::US10633345, Compound 46g::US10689346, Compound 46g::US11203574, Compound 46i::US11230530, Compound 46i::US11685721, Compound 46g::US11708332, Compound 46g	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416751	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416751&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355790	433916665							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297676	CCOC(c1ccccc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C27H24F4N4O2/c1-2-37-25(18-8-4-3-5-9-18)19-11-12-21(28)22(14-19)33-26(36)23-15-24(27(29,30)31)34-35(23)20-10-6-7-17(13-20)16-32/h3-15,25H,2,16,32H2,1H3,(H,33,36)	YVBRMUSUELCGNA-UHFFFAOYSA-N	416752	1-(3-(aminomethyl)phenyl)-N-(5-(ethoxy(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 25b::US10633345, Compound 25b::US10689346, Compound 25b::US11203574, Compound 25b::US11230530, Compound 25b::US11685721, Compound 25b::US11708332, Compound 25b	Plasma kallikrein		>75.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416752	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416752&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665520	433916666							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317923	Cc1ncc(nc1C(=O)Nc1cnn(Cc2ncc(N3C[C@H]4C[C@H]4C3=O)c(C)c2F)c1)-c1c(F)c(Cl)ccc1C(F)F	InChI=1S/C28H22ClF4N7O2/c1-12-21(40-9-14-5-17(14)28(40)42)8-35-20(23(12)30)11-39-10-15(6-36-39)37-27(41)25-13(2)34-7-19(38-25)22-16(26(32)33)3-4-18(29)24(22)31/h3-4,6-8,10,14,17,26H,5,9,11H2,1-2H3,(H,37,41)/t14-,17-/m1/s1	CKVNHLSPFMOXHD-RHSMWYFYSA-N	618003	US20230286958, Example 215	Plasma kallikrein			 7.80							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618003	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618003&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162520442	484207182							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317925	C[C@@H](c1cnc(N2C[C@H]3C[C@H]3C2=O)c(O)c1)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H23ClF3N7O3/c1-12-24(37-20(9-33-12)22-17(25(31)32)3-4-19(29)23(22)30)27(41)36-16-8-35-39(11-16)13(2)14-6-21(40)26(34-7-14)38-10-15-5-18(15)28(38)42/h3-4,6-9,11,13,15,18,25,40H,5,10H2,1-2H3,(H,36,41)/t13-,15+,18+/m0/s1	NBVLXHXTGWQYBO-JCKWVBRZSA-N	618004	US20230286958, Example 216	Plasma kallikrein			 2.80							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618004	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618004&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162520351	484207183							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317927	C[C@H](c1cnc(N2C[C@H]3C[C@H]3C2=O)c(O)c1)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H23ClF3N7O3/c1-12-24(37-20(9-33-12)22-17(25(31)32)3-4-19(29)23(22)30)27(41)36-16-8-35-39(11-16)13(2)14-6-21(40)26(34-7-14)38-10-15-5-18(15)28(38)42/h3-4,6-9,11,13,15,18,25,40H,5,10H2,1-2H3,(H,36,41)/t13-,15-,18-/m1/s1	NBVLXHXTGWQYBO-DDUZABMNSA-N	618005	US20230286958, Example 217	Plasma kallikrein			 14.9							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618005	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618005&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162520477	484207184							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317929	COc1cc(cnc1N1C[C@H]2C[C@H]2C1=O)C(C)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C29H25ClF3N7O3/c1-13-25(38-21(10-34-13)23-18(26(32)33)4-5-20(30)24(23)31)28(41)37-17-9-36-40(12-17)14(2)15-7-22(43-3)27(35-8-15)39-11-16-6-19(16)29(39)42/h4-5,7-10,12,14,16,19,26H,6,11H2,1-3H3,(H,37,41)/t14?,16-,19-/m1/s1	XCOPLNVIDMHZTN-JDQGPONISA-N	618006	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N(1-((S or R)-1-(5-methoxy-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)ethyl)-1H-pyrazol-4-yl)-3-methylpyrazine-2-carboxamide::US20230286958, Example 218::US20230286958, Example 219	Plasma kallikrein			 1.80							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618006	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618006&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			166898797	484207185							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317931	COc1cc(cnc1N1C[C@H]2C[C@H]2C1=O)C(C)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C29H25ClF3N7O3/c1-13-25(38-21(10-34-13)23-18(26(32)33)4-5-20(30)24(23)31)28(41)37-17-9-36-40(12-17)14(2)15-7-22(43-3)27(35-8-15)39-11-16-6-19(16)29(39)42/h4-5,7-10,12,14,16,19,26H,6,11H2,1-3H3,(H,37,41)/t14?,16-,19-/m1/s1	XCOPLNVIDMHZTN-JDQGPONISA-N	618006	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N(1-((S or R)-1-(5-methoxy-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-3-yl)ethyl)-1H-pyrazol-4-yl)-3-methylpyrazine-2-carboxamide::US20230286958, Example 218::US20230286958, Example 219	Plasma kallikrein			 0.300							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618006	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618006&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			166898797	484207185							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317933	Cc1nc(cnc1N1C[C@H]2C[C@H]2C1=O)C1(CC1)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C29H24ClF3N8O2/c1-13-24(39-20(9-34-13)22-17(25(32)33)3-4-19(30)23(22)31)27(42)38-16-8-36-41(12-16)29(5-6-29)21-10-35-26(14(2)37-21)40-11-15-7-18(15)28(40)43/h3-4,8-10,12,15,18,25H,5-7,11H2,1-2H3,(H,38,42)/t15-,18-/m1/s1	MPDQHRMFHMEGJV-CRAIPNDOSA-N	618008	US20230286958, Example 220	Plasma kallikrein			 7.80							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618008	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618008&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162520265	484207186							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317935	COCc1ncc(nc1C(=O)Nc1cnn(c1)C1(CC1)c1cnc(N2C[C@H]3C[C@H]3C2=O)c(C)n1)-c1c(F)c(Cl)ccc1C(F)F	InChI=1S/C30H26ClF3N8O3/c1-14-27(41-11-15-7-18(15)29(41)44)36-10-22(38-14)30(5-6-30)42-12-16(8-37-42)39-28(43)25-21(13-45-2)35-9-20(40-25)23-17(26(33)34)3-4-19(31)24(23)32/h3-4,8-10,12,15,18,26H,5-7,11,13H2,1-2H3,(H,39,43)/t15-,18-/m1/s1	VVVYCOAYVYORAE-CRAIPNDOSA-N	618009	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-(methoxymethyl)-N-(1-(1-(6-methyl-5-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrazin-2-yl)cyclopropyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 221	Plasma kallikrein			 14.9							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618009	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618009&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168679592	484207187							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317937	Cc1nc(cnc1N1C[C@H]2C[C@H]2C1=O)C1(CC1)n1cc(NC(=O)c2nc(cnc2COC(C)(C)C)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C33H32ClF3N8O3/c1-16-29(44-13-17-9-20(17)31(44)47)39-12-24(41-16)33(7-8-33)45-14-18(10-40-45)42-30(46)27-23(15-48-32(2,3)4)38-11-22(43-27)25-19(28(36)37)5-6-21(34)26(25)35/h5-6,10-12,14,17,20,28H,7-9,13,15H2,1-4H3,(H,42,46)/t17-,20-/m1/s1	KRWZDZLMCHPLAT-YLJYHZDGSA-N	618010	3-(tert-Butoxymethyl)-6-(3-chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-(1-(6-methyl-5-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrazin-2-yl)cyclopropyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 222	Plasma kallikrein			 16.7							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618010	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618010&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168679593	484207188							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317939	Cc1nc(cnc1N1C[C@H]2C[C@H]2C1=O)C1(CC1)n1cc(NC(=O)c2nc(cnc2CO)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C29H24ClF3N8O3/c1-13-26(40-10-14-6-17(14)28(40)44)35-9-21(37-13)29(4-5-29)41-11-15(7-36-41)38-27(43)24-20(12-42)34-8-19(39-24)22-16(25(32)33)2-3-18(30)23(22)31/h2-3,7-9,11,14,17,25,42H,4-6,10,12H2,1H3,(H,38,43)/t14-,17-/m1/s1	VKUMHTSAUBEFOZ-RHSMWYFYSA-N	618011	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-(hydroxymethyl)-N-(1-(1-(6-methyl-5-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrazin-2-yl)cyclopropyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 223	Plasma kallikrein			 1.000							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618011	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618011&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168679594	484207189							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317941	C[C@@H](c1cnc(N2C[C@H]3C[C@H]3C2=O)c(OC(F)F)c1C)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C30H25ClF5N7O3/c1-12-19(8-38-27(25(12)46-30(35)36)42-10-15-6-18(15)29(42)45)14(3)43-11-16(7-39-43)40-28(44)24-13(2)37-9-21(41-24)22-17(26(33)34)4-5-20(31)23(22)32/h4-5,7-9,11,14-15,18,26,30H,6,10H2,1-3H3,(H,40,44)/t14-,15+,18+/m0/s1	YZMANIBEIMBHDE-HDMKZQKVSA-N	618012	US20230286958, Example 224	Plasma kallikrein			 66.1							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618012	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618012&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162520159	484207190							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317943	C[C@H](c1cnc(N2C[C@H]3C[C@H]3C2=O)c(OC(F)F)c1C)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C30H25ClF5N7O3/c1-12-19(8-38-27(25(12)46-30(35)36)42-10-15-6-18(15)29(42)45)14(3)43-11-16(7-39-43)40-28(44)24-13(2)37-9-21(41-24)22-17(26(33)34)4-5-20(31)23(22)32/h4-5,7-9,11,14-15,18,26,30H,6,10H2,1-3H3,(H,40,44)/t14-,15-,18-/m1/s1	YZMANIBEIMBHDE-IIDMSEBBSA-N	618013	US20230286958, Example 225	Plasma kallikrein			 0.900							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618013	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618013&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162520272	484207191							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317945	C[C@H](c1cnc(N2C[C@H]3C[C@H]3C2=O)c(C)c1)n1cc(NC(=O)c2nc(cnc2CO)-c2c(F)c(Cl)ccc2OC(F)F)cn1	InChI=1S/C29H25ClF3N7O4/c1-13-5-15(7-35-26(13)39-10-16-6-18(16)28(39)43)14(2)40-11-17(8-36-40)37-27(42)25-21(12-41)34-9-20(38-25)23-22(44-29(32)33)4-3-19(30)24(23)31/h3-5,7-9,11,14,16,18,29,41H,6,10,12H2,1-2H3,(H,37,42)/t14-,16-,18-/m1/s1	DKUIMPNNWCHYFQ-QGPMSJSTSA-N	618014	US20230286958, Example 226	Plasma kallikrein			 0.400							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618014	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618014&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162520292	484207192							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317947	C[C@@H](c1cnc(N2C[C@H]3C[C@H]3C2=O)c(C)c1)n1cc(NC(=O)c2nc(cnc2CO)-c2c(F)c(Cl)ccc2OC(F)F)cn1	InChI=1S/C29H25ClF3N7O4/c1-13-5-15(7-35-26(13)39-10-16-6-18(16)28(39)43)14(2)40-11-17(8-36-40)37-27(42)25-21(12-41)34-9-20(38-25)23-22(44-29(32)33)4-3-19(30)24(23)31/h3-5,7-9,11,14,16,18,29,41H,6,10,12H2,1-2H3,(H,37,42)/t14-,16+,18+/m0/s1	DKUIMPNNWCHYFQ-YXJHDRRASA-N	618015	US20230286958, Example 227	Plasma kallikrein			 0.600							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618015	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618015&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			162520276	484207193							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317949	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(C)c1)n1cc(NC(=O)c2nc(cnc2COC(C)(C)C)-c2c(F)c(Cl)ccc2OC(F)F)cn1	InChI=1S/C33H33ClF3N7O4/c1-16-8-18(10-39-29(16)43-13-19-9-21(19)31(43)46)17(2)44-14-20(11-40-44)41-30(45)28-24(15-47-33(3,4)5)38-12-23(42-28)26-25(48-32(36)37)7-6-22(34)27(26)35/h6-8,10-12,14,17,19,21,32H,9,13,15H2,1-5H3,(H,41,45)/t17?,19-,21-/m1/s1	GTZXEPXZPDKLLW-FIALGKLESA-N	618016	US20230286958, Example 228	Plasma kallikrein			 1.60							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618016	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618016&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			166898717	484207194							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317951	CC(O)c1ncc(nc1C(=O)Nc1cnn(c1)C(C)c1cc(C)c(nn1)N1C[C@H]2C[C@H]2C1=O)-c1c(F)c(Cl)ccc1C(F)F	InChI=1S/C29H26ClF3N8O3/c1-12-6-20(38-39-27(12)40-10-15-7-18(15)29(40)44)13(2)41-11-16(8-35-41)36-28(43)25-24(14(3)42)34-9-21(37-25)22-17(26(32)33)4-5-19(30)23(22)31/h4-6,8-9,11,13-15,18,26,42H,7,10H2,1-3H3,(H,36,43)/t13?,14?,15-,18-/m1/s1	QMYPKRMOPLSDIX-PPPKJHQXSA-N	618017	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-((R or S)-1-hydroxyethyl)-N-(1-((S or R)-1-(5-methyl-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridazin-3-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 229::US20230286958, Example 230::US20230286958, Example 231::US20230286958, Example 232	Plasma kallikrein			 0.370							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618017	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618017&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168679595	484207195							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317953	CC(O)c1ncc(nc1C(=O)Nc1cnn(c1)C(C)c1cc(C)c(nn1)N1C[C@H]2C[C@H]2C1=O)-c1c(F)c(Cl)ccc1C(F)F	InChI=1S/C29H26ClF3N8O3/c1-12-6-20(38-39-27(12)40-10-15-7-18(15)29(40)44)13(2)41-11-16(8-35-41)36-28(43)25-24(14(3)42)34-9-21(37-25)22-17(26(32)33)4-5-19(30)23(22)31/h4-6,8-9,11,13-15,18,26,42H,7,10H2,1-3H3,(H,36,43)/t13?,14?,15-,18-/m1/s1	QMYPKRMOPLSDIX-PPPKJHQXSA-N	618017	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-((R or S)-1-hydroxyethyl)-N-(1-((S or R)-1-(5-methyl-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridazin-3-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 229::US20230286958, Example 230::US20230286958, Example 231::US20230286958, Example 232	Plasma kallikrein			 1.10							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618017	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618017&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168679595	484207195							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317955	CC(O)c1ncc(nc1C(=O)Nc1cnn(c1)C(C)c1cc(C)c(nn1)N1C[C@H]2C[C@H]2C1=O)-c1c(F)c(Cl)ccc1C(F)F	InChI=1S/C29H26ClF3N8O3/c1-12-6-20(38-39-27(12)40-10-15-7-18(15)29(40)44)13(2)41-11-16(8-35-41)36-28(43)25-24(14(3)42)34-9-21(37-25)22-17(26(32)33)4-5-19(30)23(22)31/h4-6,8-9,11,13-15,18,26,42H,7,10H2,1-3H3,(H,36,43)/t13?,14?,15-,18-/m1/s1	QMYPKRMOPLSDIX-PPPKJHQXSA-N	618017	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-((R or S)-1-hydroxyethyl)-N-(1-((S or R)-1-(5-methyl-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridazin-3-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 229::US20230286958, Example 230::US20230286958, Example 231::US20230286958, Example 232	Plasma kallikrein			 5.00							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618017	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618017&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168679595	484207195							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317957	CC(O)c1ncc(nc1C(=O)Nc1cnn(c1)C(C)c1cc(C)c(nn1)N1C[C@H]2C[C@H]2C1=O)-c1c(F)c(Cl)ccc1C(F)F	InChI=1S/C29H26ClF3N8O3/c1-12-6-20(38-39-27(12)40-10-15-7-18(15)29(40)44)13(2)41-11-16(8-35-41)36-28(43)25-24(14(3)42)34-9-21(37-25)22-17(26(32)33)4-5-19(30)23(22)31/h4-6,8-9,11,13-15,18,26,42H,7,10H2,1-3H3,(H,36,43)/t13?,14?,15-,18-/m1/s1	QMYPKRMOPLSDIX-PPPKJHQXSA-N	618017	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-((R or S)-1-hydroxyethyl)-N-(1-((S or R)-1-(5-methyl-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridazin-3-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 229::US20230286958, Example 230::US20230286958, Example 231::US20230286958, Example 232	Plasma kallikrein			 1.80							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618017	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618017&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168679595	484207195							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317959	CCc1ncc(nc1C(=O)Nc1cnn(Cc2cc(C)c(nn2)N2C[C@H]3C[C@H]3C2=O)c1)-c1c(F)c(Cl)ccc1C(F)F	InChI=1S/C28H24ClF3N8O2/c1-3-20-24(36-21(9-33-20)22-17(25(31)32)4-5-19(29)23(22)30)27(41)35-16-8-34-39(12-16)11-15-6-13(2)26(38-37-15)40-10-14-7-18(14)28(40)42/h4-6,8-9,12,14,18,25H,3,7,10-11H2,1-2H3,(H,35,41)/t14-,18-/m1/s1	GGFOWEJTKNBXNX-RDTXWAMCSA-N	618021	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-ethyl-N-(1-((5-methyl-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridazin-3-yl)methyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 233	Plasma kallikrein			 19.7							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618021	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618021&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168679596	484207196							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317961	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(C)n1)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C#N)cn1	InChI=1S/C28H23ClFN9O2/c1-13-25(37-22(10-32-13)23-16(7-31)4-5-20(29)24(23)30)27(40)36-18-8-34-39(12-18)15(3)21-9-33-26(14(2)35-21)38-11-17-6-19(17)28(38)41/h4-5,8-10,12,15,17,19H,6,11H2,1-3H3,(H,36,40)/t15?,17-,19-/m1/s1	KVJUZBSCFYFGMJ-GERZZCHPSA-N	618022	6-(3-Chloro-6-cyano-2-fluorophenyl)-3-methyl-N-(1-((R or S)-1-(6-methyl-5-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrazin-2-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 234::US20230286958, Example 235	Plasma kallikrein			 1.000							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618022	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618022&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168679597	484207197							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317963	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c(C)n1)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C#N)cn1	InChI=1S/C28H23ClFN9O2/c1-13-25(37-22(10-32-13)23-16(7-31)4-5-20(29)24(23)30)27(40)36-18-8-34-39(12-18)15(3)21-9-33-26(14(2)35-21)38-11-17-6-19(17)28(38)41/h4-5,8-10,12,15,17,19H,6,11H2,1-3H3,(H,36,40)/t15?,17-,19-/m1/s1	KVJUZBSCFYFGMJ-GERZZCHPSA-N	618022	6-(3-Chloro-6-cyano-2-fluorophenyl)-3-methyl-N-(1-((R or S)-1-(6-methyl-5-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrazin-2-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 234::US20230286958, Example 235	Plasma kallikrein			 0.400							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618022	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618022&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168679597	484207197							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317965	CC(c1cc(C)c(nn1)N1C[C@H]2C[C@H]2C1=O)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C#N)cn1	InChI=1S/C28H23ClFN9O2/c1-13-6-21(36-37-26(13)38-11-17-7-19(17)28(38)41)15(3)39-12-18(9-33-39)34-27(40)25-14(2)32-10-22(35-25)23-16(8-31)4-5-20(29)24(23)30/h4-6,9-10,12,15,17,19H,7,11H2,1-3H3,(H,34,40)/t15?,17-,19-/m1/s1	HOSBKCRSFCXIDE-GERZZCHPSA-N	618024	6-(3-Chloro-6-cyano-2-fluorophenyl)-3-methyl-N-(1-((R or S)-1-(5-methyl-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridazin-3-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 236::US20230286958, Example 237	Plasma kallikrein			 0.700							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618024	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618024&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168679598	484207198							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317967	CC(c1cc(C)c(nn1)N1C[C@H]2C[C@H]2C1=O)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C#N)cn1	InChI=1S/C28H23ClFN9O2/c1-13-6-21(36-37-26(13)38-11-17-7-19(17)28(38)41)15(3)39-12-18(9-33-39)34-27(40)25-14(2)32-10-22(35-25)23-16(8-31)4-5-20(29)24(23)30/h4-6,9-10,12,15,17,19H,7,11H2,1-3H3,(H,34,40)/t15?,17-,19-/m1/s1	HOSBKCRSFCXIDE-GERZZCHPSA-N	618024	6-(3-Chloro-6-cyano-2-fluorophenyl)-3-methyl-N-(1-((R or S)-1-(5-methyl-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridazin-3-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 236::US20230286958, Example 237	Plasma kallikrein			 4.30							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618024	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618024&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168679598	484207198							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317969	CCc1ncc(nc1C(=O)Nc1cnn(c1)C(C)c1cc(C)c(nn1)N1C[C@H]2C[C@H]2C1=O)-c1c(F)c(Cl)ccc1C(F)F	InChI=1S/C29H26ClF3N8O2/c1-4-20-25(37-22(10-34-20)23-17(26(32)33)5-6-19(30)24(23)31)28(42)36-16-9-35-41(12-16)14(3)21-7-13(2)27(39-38-21)40-11-15-8-18(15)29(40)43/h5-7,9-10,12,14-15,18,26H,4,8,11H2,1-3H3,(H,36,42)/t14?,15-,18-/m1/s1	CGRKOXZKWKCFAG-QTLYGJNZSA-N	618026	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-ethyl-N-(1-((R or S)-1-(5-methyl-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridazin-3-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 238::US20230286958, Example 239	Plasma kallikrein			 6.30							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618026	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618026&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168679599	484207199							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317971	CCc1ncc(nc1C(=O)Nc1cnn(c1)C(C)c1cc(C)c(nn1)N1C[C@H]2C[C@H]2C1=O)-c1c(F)c(Cl)ccc1C(F)F	InChI=1S/C29H26ClF3N8O2/c1-4-20-25(37-22(10-34-20)23-17(26(32)33)5-6-19(30)24(23)31)28(42)36-16-9-35-41(12-16)14(3)21-7-13(2)27(39-38-21)40-11-15-8-18(15)29(40)43/h5-7,9-10,12,14-15,18,26H,4,8,11H2,1-3H3,(H,36,42)/t14?,15-,18-/m1/s1	CGRKOXZKWKCFAG-QTLYGJNZSA-N	618026	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-ethyl-N-(1-((R or S)-1-(5-methyl-6-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridazin-3-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 238::US20230286958, Example 239	Plasma kallikrein			 1.80							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618026	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618026&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168679599	484207199							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317973	COc1ncc(nc1C(=O)Nc1cnn(c1)C(C)c1cnc(N2C[C@H]3C[C@H]3C2=O)c(C)n1)-c1c(OC(F)F)ccc(Cl)c1F	InChI=1S/C28H24ClF3N8O4/c1-12-24(39-10-14-6-16(14)27(39)42)33-8-18(36-12)13(2)40-11-15(7-35-40)37-25(41)23-26(43-3)34-9-19(38-23)21-20(44-28(31)32)5-4-17(29)22(21)30/h4-5,7-9,11,13-14,16,28H,6,10H2,1-3H3,(H,37,41)/t13?,14-,16-/m1/s1	PCSCBPUPCOBODL-IGLHTZBQSA-N	618028	6-(3-Chloro-6-(difluoromethoxy)-2-fluorophenyl)-3-methoxy-N-(1-((R or S)-1-(6-methyl-5-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrazin-2-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-::US20230286958, Example 240::US20230286958, Example 241	Plasma kallikrein			 0.400							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618028	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618028&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168679600	484207200							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317975	COc1ncc(nc1C(=O)Nc1cnn(c1)C(C)c1cnc(N2C[C@H]3C[C@H]3C2=O)c(C)n1)-c1c(OC(F)F)ccc(Cl)c1F	InChI=1S/C28H24ClF3N8O4/c1-12-24(39-10-14-6-16(14)27(39)42)33-8-18(36-12)13(2)40-11-15(7-35-40)37-25(41)23-26(43-3)34-9-19(38-23)21-20(44-28(31)32)5-4-17(29)22(21)30/h4-5,7-9,11,13-14,16,28H,6,10H2,1-3H3,(H,37,41)/t13?,14-,16-/m1/s1	PCSCBPUPCOBODL-IGLHTZBQSA-N	618028	6-(3-Chloro-6-(difluoromethoxy)-2-fluorophenyl)-3-methoxy-N-(1-((R or S)-1-(6-methyl-5-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyrazin-2-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-::US20230286958, Example 240::US20230286958, Example 241	Plasma kallikrein			 0.700							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618028	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618028&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168679600	484207200							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317977	CC(c1ncc(N2C[C@H]3C[C@H]3C2=O)c(C)c1C)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C30H27ClF3N7O2/c1-13-14(2)26(36-10-23(13)40-11-17-7-20(17)30(40)43)16(4)41-12-18(8-37-41)38-29(42)27-15(3)35-9-22(39-27)24-19(28(33)34)5-6-21(31)25(24)32/h5-6,8-10,12,16-17,20,28H,7,11H2,1-4H3,(H,38,42)/t16?,17-,20-/m1/s1	YWTUIBGKFKJVGQ-HMEKMZBJSA-N	618030	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((R or S)-1-(3,4-dimethyl-5-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-2-yl)ethyl)-1H-pyrazol-4-yl)-3-methylpyrazine-2-carboxamide::US20230286958, Example 242	Plasma kallikrein			 0.800							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618030	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618030&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168679601	484207201							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317979	CC(c1ncc(N2C[C@H]3C[C@H]3C2=O)c(C)c1C)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C29H25ClF3N7O2/c1-13-14(2)26(35-10-23(13)39-11-16-6-19(16)29(39)42)15(3)40-12-17(7-36-40)37-28(41)22-9-34-8-21(38-22)24-18(27(32)33)4-5-20(30)25(24)31/h4-5,7-10,12,15-16,19,27H,6,11H2,1-3H3,(H,37,41)/t15?,16-,19-/m1/s1	BQQUPLGHBAXXTC-HFLHWUEFSA-N	618031	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((R or S)-1-(3,4-dimethyl-5-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-2-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 243	Plasma kallikrein			 0.600							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618031	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618031&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168679602	484207202							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338121	Clc1ccc(-c2nn[nH]n2)c(CNC(=O)c2cnn(Cc3cn4cc(ccc4n3)C3CC3)c2)c1	InChI=1S/C23H20ClN9O/c24-18-4-5-20(22-28-30-31-29-22)16(7-18)8-25-23(34)17-9-26-33(11-17)13-19-12-32-10-15(14-1-2-14)3-6-21(32)27-19/h3-7,9-12,14H,1-2,8,13H2,(H,25,34)(H,28,29,30,31)	SKERFVVXXVRHKY-UHFFFAOYSA-N	626756	N-(5-chloro-2-(2H-tetrazol-5-yl)benzyl)-1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-pyrazole-4-carboxamide ::US11787796, Compound I-117	Plasma kallikrein					>7100					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626756	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626756&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152310	485655206							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338122	COc1ccc(C#N)c(CNC(=O)c2cnn(Cc3cn4cc(cc(C#N)c4n3)C3CC3)c2)c1F	InChI=1S/C25H20FN7O2/c1-35-22-5-4-16(7-27)21(23(22)26)10-29-25(34)19-9-30-33(12-19)14-20-13-32-11-18(15-2-3-15)6-17(8-28)24(32)31-20/h4-6,9,11-13,15H,2-3,10,14H2,1H3,(H,29,34)	FPKDNZOKIUDEKF-UHFFFAOYSA-N	626757	N-(6-cyano-2-fluoro-3-methoxybenzyl)-1-((8-cyano-6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-pyrazole-4-carboxamide ::US11787796, Compound I-118	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626757	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626757&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156151977	485655207							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338123	COc1ccc(C#N)c(CNC(=O)c2cnn(Cc3cn4cc(ccc4n3)C3CC3)c2)c1F	InChI=1S/C24H21FN6O2/c1-33-21-6-4-16(8-26)20(23(21)25)10-27-24(32)18-9-28-31(12-18)14-19-13-30-11-17(15-2-3-15)5-7-22(30)29-19/h4-7,9,11-13,15H,2-3,10,14H2,1H3,(H,27,32)	UCWRGQSLECWDHY-UHFFFAOYSA-N	626758	N-(6-cyano-2-fluoro-3-methoxybenzyl)-1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-pyrazole-4-carboxamide ::US11787796, Compound I-119	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626758	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626758&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156151909	485655208							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338124	O=C(NCc1cc(=O)[nH]c2ccccc12)c1cnn(Cc2cn3cc(ccc3n2)C2CC2)c1	InChI=1S/C25H22N6O2/c32-24-9-18(21-3-1-2-4-22(21)29-24)10-26-25(33)19-11-27-31(13-19)15-20-14-30-12-17(16-5-6-16)7-8-23(30)28-20/h1-4,7-9,11-14,16H,5-6,10,15H2,(H,26,33)(H,29,32)	CVMQEGYFAYNEMP-UHFFFAOYSA-N	626759	1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-N-((2-oxo-1,2-dihydroquinolin-4-yl)methyl)-1H-pyrazole-4-carboxamide ::US11787796, Compound I-120	Plasma kallikrein					 55					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626759	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626759&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			169489579	485655209							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338125	Clc1cccc(CNC(=O)c2cnn(Cc3cn4cc(ccc4n3)C3CC3)c2)c1	InChI=1S/C22H20ClN5O/c23-19-3-1-2-15(8-19)9-24-22(29)18-10-25-28(12-18)14-20-13-27-11-17(16-4-5-16)6-7-21(27)26-20/h1-3,6-8,10-13,16H,4-5,9,14H2,(H,24,29)	LMEJPMCURKAJSN-UHFFFAOYSA-N	626760	N-(3-chlorobenzyl)-1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-pyrazole-4-carboxamide ::US11787796, Compound I-121	Plasma kallikrein					 1050					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626760	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626760&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156151866	485655210							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338126	Brc1ccc2[nH]c(=O)cc(CNC(=O)c3cnn(Cc4cn5cc(ccc5n4)C4CC4)c3)c2c1	InChI=1S/C25H21BrN6O2/c26-19-4-5-22-21(8-19)17(7-24(33)30-22)9-27-25(34)18-10-28-32(12-18)14-20-13-31-11-16(15-1-2-15)3-6-23(31)29-20/h3-8,10-13,15H,1-2,9,14H2,(H,27,34)(H,30,33)	VTCNHLGKFRVOOI-UHFFFAOYSA-N	626761	N-((6-bromo-2-oxo-1,2-dihydroquinolin-4-yl)methyl)-1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-pyrazole-4-carboxamide ::US11787796, Compound I-122	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626761	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626761&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			169489580	485655211							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338127	Cc1cc2[nH]cc(Cl)c2c(C)c1CNC(=O)c1cnn(Cc2cn3cc(ccc3n2)C2CC2)c1	InChI=1S/C26H25ClN6O/c1-15-7-23-25(22(27)10-28-23)16(2)21(15)9-29-26(34)19-8-30-33(12-19)14-20-13-32-11-18(17-3-4-17)5-6-24(32)31-20/h5-8,10-13,17,28H,3-4,9,14H2,1-2H3,(H,29,34)	YMNAFRZGFHSIRX-UHFFFAOYSA-N	626762	N-((3-chloro-4,6-dimethyl-1H-indol-5-yl)methyl)-1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-pyrazole-4-carboxamide ::US11787796, Compound I-123	Plasma kallikrein					 55					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626762	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626762&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156151927	485655212							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297677	CC(C)[C@H](N)C(=O)OC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O3/c1-18(2)26(35)29(40)41-27(20-9-4-3-5-10-20)21-11-7-12-22(15-21)36-28(39)24-16-25(30(31,32)33)37-38(24)23-13-6-8-19(14-23)17-34/h3-16,18,26-27H,17,34-35H2,1-2H3,(H,36,39)/t26-,27?/m0/s1	OQCWFOUCOSAWQU-QBHOUYDASA-N	416753	(2S)-(3-(1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamido)phenyl)(phenyl)methyl 2-amino-3-methylbutanoate::US10329260, Compound 81c::US10633345, Compound 81c::US10689346, Compound 81c::US11203574, Compound 81c::US11230530, Compound 81c::US11685721, Compound 81c::US11708332, Compound 81c	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416753	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416753&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355992	433916667					C03317		1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297678	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)[C@](N)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-22-10-9-20(28(35,12-11-18-7-8-18)25-6-1-2-13-36-25)15-23(22)37-27(40)24-16-26(29(31,32)33)38-39(24)21-5-3-4-19(14-21)17-34/h1-6,9-10,13-16,18H,7-8,11-12,17,34-35H2,(H,37,40)/t28-/m1/s1	IFWBAIGKQKRJGJ-MUUNZHRXSA-N	416754	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carb oxamide::US10329260, Compound 205f::US10633345, Compound 205e::US11203574, Compound 205f::US11708332, Compound 205f	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416754	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416754&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			146207235	433916668							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297679	COC(c1ccccc1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C26H22F4N4O2/c1-36-24(17-7-3-2-4-8-17)18-10-11-20(27)21(13-18)32-25(35)22-14-23(26(28,29)30)33-34(22)19-9-5-6-16(12-19)15-31/h2-14,24H,15,31H2,1H3,(H,32,35)	AJQPEPSKLFPFIU-UHFFFAOYSA-N	416755	1-(3-(aminomethyl)phenyl)-N-(2-fluoro-5-(methoxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 25c::US10633345, Compound 25c::US10689346, Compound 25c::US11203574, Compound 25c::US11230530, Compound 25c::US11685721, Compound 25c::US11708332, Compound 25c	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416755	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416755&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126666045	433916669							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297680	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CC#N)c1ccccc1)C(F)(F)F	InChI=1S/C27H22F3N5O/c28-27(29,30)25-16-24(35(34-25)22-11-4-6-18(14-22)17-32)26(36)33-21-10-5-9-20(15-21)23(12-13-31)19-7-2-1-3-8-19/h1-11,14-16,23H,12,17,32H2,(H,33,36)	AUPCAIQBGWQVBR-UHFFFAOYSA-N	416756	1-(3-(aminomethyl)phenyl)-N-(3-(2-cyano-1-phenylethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 39e::US10633345, Compound 39e::US10689346, Compound 39e::US11203574, Compound 39e::US11230530, Compound 39e::US11685721, Compound 39e::US11708332, Compound 39e	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416756	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416756&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126666023	433916670							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297681	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CCC1CC1)n1ccnc1)C(F)(F)F	InChI=1S/C27H27F3N6O/c28-27(29,30)25-15-24(36(34-25)22-6-1-3-19(13-22)16-31)26(37)33-21-5-2-4-20(14-21)23(10-9-18-7-8-18)35-12-11-32-17-35/h1-6,11-15,17-18,23H,7-10,16,31H2,(H,33,37)	UPEDWOJFQGRWOZ-UHFFFAOYSA-N	416757	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-(1H-imidazol-1-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 89g::US10633345, Compound 89g::US10689346, Compound 89g::US11203574, Compound 89g::US11230530, Compound 89g::US11685721, Compound 89g::US11708332, Compound 89g	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416757	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416757&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665540	433916671							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297682	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(Cc2ccccc2)ccc1F)C(F)(F)F	InChI=1S/C25H20F4N4O/c26-20-10-9-17(11-16-5-2-1-3-6-16)13-21(20)31-24(34)22-14-23(25(27,28)29)32-33(22)19-8-4-7-18(12-19)15-30/h1-10,12-14H,11,15,30H2,(H,31,34)	PFWDQKVXCJEZES-UHFFFAOYSA-N	416758	1-(3-(aminomethyl)phenyl)-N-(5-benzyl-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 26f::US10633345, Compound 26f::US10689346, Compound 26f::US11203574, Compound 26f::US11230530, Compound 26f::US11685721, Compound 26f::US11708332, Compound 26f	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416758	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416758&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355900	433916672							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297683	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CC(N)=O)c1ccccc1)C(F)(F)F	InChI=1S/C27H24F3N5O2/c28-27(29,30)24-15-23(35(34-24)21-11-4-6-17(12-21)16-31)26(37)33-20-10-5-9-19(13-20)22(14-25(32)36)18-7-2-1-3-8-18/h1-13,15,22H,14,16,31H2,(H2,32,36)(H,33,37)	KDXRDWIYPXSJST-UHFFFAOYSA-N	416759	N-(3-(3-amino-3-oxo-1-phenylpropyl)phenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 40b::US10633345, Compound 40b::US10689346, Compound 40b::US11203574, Compound 40b::US11230530, Compound 40b::US11685721, Compound 40b::US11708332, Compound 40b	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416759	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416759&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665680	433916673							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297684	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(=C\CC1CC1)\c1ccccc1)C(F)(F)F	InChI=1S/C30H27F3N4O/c31-30(32,33)28-18-27(37(36-28)25-11-4-6-21(16-25)19-34)29(38)35-24-10-5-9-23(17-24)26(15-14-20-12-13-20)22-7-2-1-3-8-22/h1-11,15-18,20H,12-14,19,34H2,(H,35,38)/b26-15+	VKLRLOSKQDEQAH-CVKSISIWSA-N	416760	(E/Z)-1-(3-(Aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-phenylprop-1-enyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide hydrochloride::US10329260, Compound 91a::US11203574, Compound 91a::US11685721, Compound 91a::US11708332, Compound 91a	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416760	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416760&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			153066367	433916674							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297685	CC(C)COC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C29H29F3N4O2/c1-19(2)18-38-27(21-9-4-3-5-10-21)22-11-7-12-23(15-22)34-28(37)25-16-26(29(30,31)32)35-36(25)24-13-6-8-20(14-24)17-33/h3-16,19,27H,17-18,33H2,1-2H3,(H,34,37)	FMSXMXLNUZXXSC-UHFFFAOYSA-N	416762	1-(3-(aminomethyl)phenyl)-N-(3-(isobutoxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18i::US10633345, Compound 18i::US10689346, Compound 18i::US11203574, Compound 18i::US11230530, Compound 18i::US11685721, Compound 18i::US11708332, Compound 18i	Plasma kallikrein		>75.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416762	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416762&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356257	433916676							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297686	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(Cc2ccccc2NCC2CC2)c1)C(F)(F)F	InChI=1S/C29H28F3N5O/c30-29(31,32)27-16-26(37(36-27)24-9-4-6-21(15-24)17-33)28(38)35-23-8-3-5-20(14-23)13-22-7-1-2-10-25(22)34-18-19-11-12-19/h1-10,14-16,19,34H,11-13,17-18,33H2,(H,35,38)	PECONQSWBUWDBN-UHFFFAOYSA-N	416763	1-(3-(Aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(phenyl) methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 41e::US11685721, Compound 41e::US11708332, Compound 41e	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416763	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416763&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			154584212	433916677							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297687	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C28H27F3N6O/c29-28(30,31)25-15-24(37(36-25)23-6-1-3-19(13-23)16-32)27(38)35-22-5-2-4-21(14-22)26(34-17-18-7-8-18)20-9-11-33-12-10-20/h1-6,9-15,18,26,34H,7-8,16-17,32H2,(H,35,38)	VXJYGPKEYKOJCQ-UHFFFAOYSA-N	416764	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(pyridin-4-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 86g::US10633345, Compound 86g::US10689346, Compound 86g::US11203574, Compound 86g::US11230530, Compound 86g::US11685721, Compound 86g::US11708332, Compound 86g	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416764	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416764&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355880	433916678							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317981	CC(c1ncc(N2C[C@H]3C[C@H]3C2=O)c(C)c1F)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C29H24ClF4N7O2/c1-12-21(40-10-15-6-18(15)29(40)43)9-36-26(23(12)31)14(3)41-11-16(7-37-41)38-28(42)25-13(2)35-8-20(39-25)22-17(27(33)34)4-5-19(30)24(22)32/h4-5,7-9,11,14-15,18,27H,6,10H2,1-3H3,(H,38,42)/t14?,15-,18-/m1/s1	UKYKBVNPMADRDU-QTLYGJNZSA-N	618032	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((R or S)-1-(3-fluoro-4-methyl-5-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-2-yl)ethyl)-1H-pyrazol-4-yl)-3-methylpyrazine-2-carboxamide::US20230286958, Example 244::US20230286958, Example 245	Plasma kallikrein			 46.8							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618032	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618032&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168679603	484207203							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317983	CC(c1ncc(N2C[C@H]3C[C@H]3C2=O)c(C)c1F)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C29H24ClF4N7O2/c1-12-21(40-10-15-6-18(15)29(40)43)9-36-26(23(12)31)14(3)41-11-16(7-37-41)38-28(42)25-13(2)35-8-20(39-25)22-17(27(33)34)4-5-19(30)24(22)32/h4-5,7-9,11,14-15,18,27H,6,10H2,1-3H3,(H,38,42)/t14?,15-,18-/m1/s1	UKYKBVNPMADRDU-QTLYGJNZSA-N	618032	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((R or S)-1-(3-fluoro-4-methyl-5-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-2-yl)ethyl)-1H-pyrazol-4-yl)-3-methylpyrazine-2-carboxamide::US20230286958, Example 244::US20230286958, Example 245	Plasma kallikrein			 0.900							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618032	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618032&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168679603	484207203							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317985	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c2OC(F)(F)Oc12)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C29H21ClF5N7O4/c1-11-22(40-19(8-36-11)20-15(25(32)33)3-4-18(30)21(20)31)27(43)39-14-6-38-42(10-14)12(2)17-7-37-26(24-23(17)45-29(34,35)46-24)41-9-13-5-16(13)28(41)44/h3-4,6-8,10,12-13,16,25H,5,9H2,1-2H3,(H,39,43)/t12?,13-,16-/m1/s1	ALGDWXFVYWYXGX-LLQOJDTPSA-N	618034	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((R or S)-1-(2,2-difluoro-4-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)-[1,3]dioxolo[4,5-c]pyridin-7-yl)ethyl)-1H-pyrazol-4-yl)-3-methylpyrazine-2-carboxamide::US20230286958, Example 246::US20230286958, Example 247	Plasma kallikrein			 6.00							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618034	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618034&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168679604	484207204							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338128	Cc1cc2[nH]ccc2c(C)c1CNC(=O)c1cnn(Cc2cn3cc(ccc3n2)C2CC2)c1	InChI=1S/C26H26N6O/c1-16-9-24-22(7-8-27-24)17(2)23(16)11-28-26(33)20-10-29-32(13-20)15-21-14-31-12-19(18-3-4-18)5-6-25(31)30-21/h5-10,12-14,18,27H,3-4,11,15H2,1-2H3,(H,28,33)	AGFUEZIVAGZYPN-UHFFFAOYSA-N	626763	1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-N-((4,6-dimethyl-1H-indol-5-yl)methyl)-1H-pyrazole-4-carboxamide ::US11787796, Compound I-124	Plasma kallikrein					 55					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626763	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626763&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152302	485655213							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338129	Clc1ccc(c(CNC(=O)c2cnn(Cc3cn4cc(ccc4n3)C3CC3)c2)c1)-n1cnnn1	InChI=1S/C23H20ClN9O/c24-19-4-5-21(33-14-26-29-30-33)17(7-19)8-25-23(34)18-9-27-32(11-18)13-20-12-31-10-16(15-1-2-15)3-6-22(31)28-20/h3-7,9-12,14-15H,1-2,8,13H2,(H,25,34)	ACEGTBPCGXEEDL-UHFFFAOYSA-N	626764	N-(5-chloro-2-(1H-tetrazol-1-yl)benzyl)-1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-pyrazole-4-carboxamide ::US11787796, Compound I-125	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626764	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626764&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156151997	485655214							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338130	Clc1ccc2nnc(CNC(=O)c3cnn(Cc4cn5cc(ccc5n4)C4CC4)c3)n2c1	InChI=1S/C22H19ClN8O/c23-17-4-6-20-27-28-21(31(20)11-17)8-24-22(32)16-7-25-30(10-16)13-18-12-29-9-15(14-1-2-14)3-5-19(29)26-18/h3-7,9-12,14H,1-2,8,13H2,(H,24,32)	QJZJZWMAEPTLGJ-UHFFFAOYSA-N	455302	US10730874, Compound TABLE II.7::US11352356, Table II.7::US11787796, Compound I-126	Plasma kallikrein					 1050					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455302	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455302&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139498761	440971119							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338131	Clc1ccc2snc(CNC(=O)c3cnn(Cc4cn5cc(ccc5n4)C4CC4)c3)c2c1	InChI=1S/C23H19ClN6OS/c24-17-4-5-21-19(7-17)20(28-32-21)9-25-23(31)16-8-26-30(11-16)13-18-12-29-10-15(14-1-2-14)3-6-22(29)27-18/h3-8,10-12,14H,1-2,9,13H2,(H,25,31)	YSGNQMRGFQGWKZ-UHFFFAOYSA-N	455301	US10730874, Compound TABLE II.6::US11352356, Table II.6::US11787796, Compound I-127	Plasma kallikrein					 55					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=455301	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=455301&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			139505217	440971118							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338132	Clc1ccc2scc(CNC(=O)c3cnn(Cc4cn5cc(ccc5n4)C4CC4)c3)c2c1	InChI=1S/C24H20ClN5OS/c25-19-4-5-22-21(7-19)18(14-32-22)8-26-24(31)17-9-27-30(11-17)13-20-12-29-10-16(15-1-2-15)3-6-23(29)28-20/h3-7,9-12,14-15H,1-2,8,13H2,(H,26,31)	FAQNSGDLQBVIOV-UHFFFAOYSA-N	626767	N-((5-chlorobenzo[b]thiophen-3-yl)methyl)-1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-pyrazole-4-carboxamide ::US11787796, Compound I-128	Plasma kallikrein					 1050					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626767	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626767&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156151926	485655217							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338133	Clc1cccc(OCCNC(=O)c2cnn(Cc3cn4cc(ccc4n3)C3CC3)c2)c1	InChI=1S/C23H22ClN5O2/c24-19-2-1-3-21(10-19)31-9-8-25-23(30)18-11-26-29(13-18)15-20-14-28-12-17(16-4-5-16)6-7-22(28)27-20/h1-3,6-7,10-14,16H,4-5,8-9,15H2,(H,25,30)	LFZQMOLJWPHECZ-UHFFFAOYSA-N	626768	N-(2-(3-chlorophenoxy)ethyl)-1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-pyrazole-4-carboxamide ::US11787796, Compound I-129	Plasma kallikrein					 1050					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626768	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626768&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152005	485655218							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338134	Clc1ccc2cccc(CNC(=O)c3cnn(Cc4cn5cc(ccc5n4)C4CC4)c3)c2c1	InChI=1S/C26H22ClN5O/c27-22-8-6-18-2-1-3-19(24(18)10-22)11-28-26(33)21-12-29-32(14-21)16-23-15-31-13-20(17-4-5-17)7-9-25(31)30-23/h1-3,6-10,12-15,17H,4-5,11,16H2,(H,28,33)	ROOUBJRFHLTEER-UHFFFAOYSA-N	626769	N-((7-chloronaphthalen-1-yl)methyl)-1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-pyrazole-4-carboxamide ::US11787796, Compound I-130	Plasma kallikrein					 4550					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626769	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626769&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156151984	485655219							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297688	CCCOC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C28H27F3N4O2/c1-2-14-37-26(20-9-4-3-5-10-20)21-11-7-12-22(16-21)33-27(36)24-17-25(28(29,30)31)34-35(24)23-13-6-8-19(15-23)18-32/h3-13,15-17,26H,2,14,18,32H2,1H3,(H,33,36)	ODVQLXVRAUDBCL-UHFFFAOYSA-N	416765	1-(3-(aminomethyl)phenyl)-N-(3-(phenyl(propoxy)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18h::US10633345, Compound 18k::US10689346, Compound 18h::US11203574, Compound 18h::US11230530, Compound 18h::US11685721, Compound 18h::US11708332, Compound 18h	Plasma kallikrein		>75.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416765	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416765&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665753	433916679							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297689	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F3N4O2/c31-30(32,33)27-18-26(37(36-27)25-11-4-6-21(16-25)19-34)29(38)35-24-10-5-9-23(17-24)28(22-7-2-1-3-8-22)39-15-14-20-12-13-20/h1-11,16-18,20,28H,12-15,19,34H2,(H,35,38)	WCAGCVGZCBBZDT-UHFFFAOYSA-N	416766	1-(3-(aminomethyl)phenyl)-N-(3-((2-cyclopropylethoxy)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 74a::US10689346, Compound 74a::US11203574, Compound 74a::US11230530, Compound 74a::US11685721, Compound 74a::US11708332, Compound 74a	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416766	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416766&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665775	433916680							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297690	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-17-24(37(36-26)23-8-3-5-20(15-23)18-33)27(38)35-22-7-4-6-21(16-22)28(39,13-12-19-10-11-19)25-9-1-2-14-34-25/h1-9,14-17,19,39H,10-13,18,33H2,(H,35,38)	BAOACYBKKSTHLE-UHFFFAOYSA-N	416767	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 45g::US10633345, Compound 45g::US10689346, Compound 45g::US11203574, Compound 45g::US11230530, Compound 45g::US11685721, Compound 45g::US11708332, Compound 45g	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416767	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416767&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665639	433916681							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297691	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(=O)Nc1ccccc1)C(F)(F)F	InChI=1S/C25H20F3N5O2/c26-25(27,28)22-14-21(33(32-22)20-11-4-6-16(12-20)15-29)24(35)31-19-10-5-7-17(13-19)23(34)30-18-8-2-1-3-9-18/h1-14H,15,29H2,(H,30,34)(H,31,35)	HDBCJKHEPGEJHK-UHFFFAOYSA-N	416768	1-(3-(aminomethyl)phenyl)-N-(3-(phenylcarbamoyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 21e::US10633345, Compound 21e::US10689346, Compound 21e::US11203574, Compound 21e::US11230530, Compound 21e::US11685721, Compound 21e::US11708332, Compound 21e	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416768	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416768&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665523	433916682							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297692	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CCC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F3N4O2/c31-30(32,33)27-17-26(37(36-27)25-14-5-9-21(15-25)18-34)29(38)35-24-13-6-12-23(16-24)28(22-10-2-1-3-11-22)39-19-20-7-4-8-20/h1-3,5-6,9-17,20,28H,4,7-8,18-19,34H2,(H,35,38)	KBAGRISCOGFVJB-UHFFFAOYSA-N	416769	1-(3-(aminomethyl)phenyl)-N-(3-((cyclobutylmethoxy)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 75a::US10633345, Compound 75a::US10689346, Compound 75a::US11203574, Compound 75a::US11230530, Compound 75a::US11685721, Compound 75a::US11708332, Compound 75a	Plasma kallikrein		>75.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416769	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416769&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665761	433916683							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297693	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-16-25(37(36-26)24-8-1-4-20(14-24)17-33)27(38)35-23-7-2-5-21(15-23)28(39,12-11-19-9-10-19)22-6-3-13-34-18-22/h1-8,13-16,18-19,39H,9-12,17,33H2,(H,35,38)	AOCZEQQKIIWUBU-UHFFFAOYSA-N	416770	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 47f::US10633345, Compound 47f::US10689346, Compound 47f::US11203574, Compound 47g::US11230530, Compound 47h::US11685721, Compound 47f::US11708332, Compound 47f	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416770	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416770&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355766	433916684							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297694	CCCCOC(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C29H29F3N4O2/c1-2-3-15-38-27(21-10-5-4-6-11-21)22-12-8-13-23(17-22)34-28(37)25-18-26(29(30,31)32)35-36(25)24-14-7-9-20(16-24)19-33/h4-14,16-18,27H,2-3,15,19,33H2,1H3,(H,34,37)	PKUIOUWZEKKIOY-UHFFFAOYSA-N	416772	1-(3-(aminomethyl)phenyl)-N-(3-(butoxy(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18j::US10633345, Compound 18j::US10689346, Compound 18j::US11203574, Compound 18j::US11230530, Compound 18j::US11685721, Compound 18j::US11708332, Compound 18j	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416772	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416772&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356140	433916686							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297695	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F4N5O/c30-23-12-11-21(27(35-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27,35H,9-10,16-17,34H2,(H,36,39)	MCLZOCFEIKBMBA-UHFFFAOYSA-N	416773	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 38d::US10633345, Compound 38d::US10689346, Compound 42a::US11203574, Compound 42a::US11230530, Compound 42a::US11685721, Compound 38d::US11708332, Compound 38d	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416773	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416773&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356124	433916687							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297696	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-17-25(37(36-26)24-6-1-3-20(15-24)18-33)27(38)35-23-5-2-4-22(16-23)28(39,12-9-19-7-8-19)21-10-13-34-14-11-21/h1-6,10-11,13-17,19,39H,7-9,12,18,33H2,(H,35,38)	HEXYKZQZIBBLLM-UHFFFAOYSA-N	416774	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-(pyridin-4-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 92g::US10633345, Compound 92g::US10689346, Compound 92g::US11203574, Compound 92g::US11230530, Compound 92g::US11685721, Compound 92g::US11708332, Compound 92g	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416774	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416774&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355890	433916688							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297697	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F3N4O2/c30-29(31,32)26-16-25(36(35-26)24-11-4-6-20(14-24)17-33)28(37)34-23-10-5-9-22(15-23)27(38-18-19-12-13-19)21-7-2-1-3-8-21/h1-11,14-16,19,27H,12-13,17-18,33H2,(H,34,37)	PEZVPVUPSJXZCH-UHFFFAOYSA-N	416775	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18k::US10633345, Compound 74a::US10689346, Compound 165e::US11203574, Compound 165e::US11230530, Compound 165e::US11685721, Compound 18k::US11708332, Compound 18k	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416775	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416775&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			91884591	433916689							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297698	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1ccc(F)c(c1)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-24-12-11-21(14-23(24)27(39-17-18-9-10-18)20-6-2-1-3-7-20)35-28(38)25-15-26(29(31,32)33)36-37(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27H,9-10,16-17,34H2,(H,35,38)	SMAPKFCZNNYDET-UHFFFAOYSA-N	416776	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)-4-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 76h::US10633345, Compound 76h::US10689346, Compound 76h::US11203574, Compound 76h::US11230530, Compound 76h::US11685721, Compound 76h::US11708332, Compound 76h	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416776	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416776&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356199	433916690							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317987	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c2OC(F)(F)Oc12)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C29H21ClF5N7O4/c1-11-22(40-19(8-36-11)20-15(25(32)33)3-4-18(30)21(20)31)27(43)39-14-6-38-42(10-14)12(2)17-7-37-26(24-23(17)45-29(34,35)46-24)41-9-13-5-16(13)28(41)44/h3-4,6-8,10,12-13,16,25H,5,9H2,1-2H3,(H,39,43)/t12?,13-,16-/m1/s1	ALGDWXFVYWYXGX-LLQOJDTPSA-N	618034	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((R or S)-1-(2,2-difluoro-4-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)-[1,3]dioxolo[4,5-c]pyridin-7-yl)ethyl)-1H-pyrazol-4-yl)-3-methylpyrazine-2-carboxamide::US20230286958, Example 246::US20230286958, Example 247	Plasma kallikrein			 0.800							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618034	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618034&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168679604	484207204							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317989	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c2OC(F)(F)Oc12)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H19ClF5N7O4/c1-11(16-6-36-25(23-22(16)44-28(33,34)45-23)40-9-12-4-15(12)27(40)43)41-10-13(5-37-41)38-26(42)19-8-35-7-18(39-19)20-14(24(31)32)2-3-17(29)21(20)30/h2-3,5-8,10-12,15,24H,4,9H2,1H3,(H,38,42)/t11?,12-,15-/m1/s1	JWJNNTATXVTWNR-AADWAWOOSA-N	618036	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((R or S)-1-(2,2-difluoro-4-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)-[1,3]dioxolo[4,5-c]pyridin-7-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-::US20230286958, Example 248::US20230286958, Example 249	Plasma kallikrein			 22.3							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618036	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618036&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168679605	484207205							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317991	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c2OC(F)(F)Oc12)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H19ClF5N7O4/c1-11(16-6-36-25(23-22(16)44-28(33,34)45-23)40-9-12-4-15(12)27(40)43)41-10-13(5-37-41)38-26(42)19-8-35-7-18(39-19)20-14(24(31)32)2-3-17(29)21(20)30/h2-3,5-8,10-12,15,24H,4,9H2,1H3,(H,38,42)/t11?,12-,15-/m1/s1	JWJNNTATXVTWNR-AADWAWOOSA-N	618036	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((R or S)-1-(2,2-difluoro-4-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)-[1,3]dioxolo[4,5-c]pyridin-7-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-::US20230286958, Example 248::US20230286958, Example 249	Plasma kallikrein			 2.10							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618036	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618036&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168679605	484207205							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338135	Clc1ccc2ccnc(CNC(=O)c3cnn(Cc4cn5cc(ccc5n4)C4CC4)c3)c2c1	InChI=1S/C25H21ClN6O/c26-20-5-3-17-7-8-27-23(22(17)9-20)11-28-25(33)19-10-29-32(13-19)15-21-14-31-12-18(16-1-2-16)4-6-24(31)30-21/h3-10,12-14,16H,1-2,11,15H2,(H,28,33)	SSFJMSCFYDVLOA-UHFFFAOYSA-N	626770	N-((7-chloroisoquinolin-1-yl)methyl)-1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-pyrazole-4-carboxamide ::US11787796, Compound I-131	Plasma kallikrein					 1050					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626770	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626770&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152087	485655220							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338136	Brc1ccc(CNC(=O)c2cnn(Cc3cn4cc(ccc4n3)C3CC3)c2)cc1	InChI=1S/C22H20BrN5O/c23-19-6-1-15(2-7-19)9-24-22(29)18-10-25-28(12-18)14-20-13-27-11-17(16-3-4-16)5-8-21(27)26-20/h1-2,5-8,10-13,16H,3-4,9,14H2,(H,24,29)	NLIVOHOWPZDOBC-UHFFFAOYSA-N	626771	N-(3-bromophenethyl)-1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-pyrazole-4-carboxamide ::US11787796, Compound I-132	Plasma kallikrein					 1050					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626771	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626771&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156174783	485655221							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338137	Brc1ccc2cccc(CNC(=O)c3cnn(Cc4cn5cc(ccc5n4)C4CC4)c3)c2c1	InChI=1S/C26H22BrN5O/c27-22-8-6-18-2-1-3-19(24(18)10-22)11-28-26(33)21-12-29-32(14-21)16-23-15-31-13-20(17-4-5-17)7-9-25(31)30-23/h1-3,6-10,12-15,17H,4-5,11,16H2,(H,28,33)	UFYMIKLEVLDREW-UHFFFAOYSA-N	626772	N-((7-bromonaphthalen-1-yl)methyl)-1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-pyrazole-4-carboxamide ::US11787796, Compound I-133	Plasma kallikrein					 4550					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626772	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626772&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152143	485655222							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338138	Cc1cc2c(N)noc2c(C)c1CNC(=O)c1cnn(Cc2cn3cc(ccc3n2)C2CC2)c1	InChI=1S/C25H25N7O2/c1-14-7-20-23(34-30-24(20)26)15(2)21(14)9-27-25(33)18-8-28-32(11-18)13-19-12-31-10-17(16-3-4-16)5-6-22(31)29-19/h5-8,10-12,16H,3-4,9,13H2,1-2H3,(H2,26,30)(H,27,33)	SIFPGWCUBGBQIZ-UHFFFAOYSA-N	626773	N-((3-amino-5,7-dimethylbenzo[d]isoxazol-6-yl)methyl)-1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-pyrazole-4-carboxamide ::US11787796, Compound I-134	Plasma kallikrein					 4550					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626773	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626773&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152104	485655223							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338139	Clc1ccn2cnc3C(CCc1c23)NC(=O)c1cn(Cc2cn3cc(ccc3n2)C2CC2)nn1	InChI=1S/C24H21ClN8O/c25-18-7-8-31-13-26-22-19(5-4-17(18)23(22)31)28-24(34)20-12-33(30-29-20)11-16-10-32-9-15(14-1-2-14)3-6-21(32)27-16/h3,6-10,12-14,19H,1-2,4-5,11H2,(H,28,34)	IWSNWECCGNJSJI-UHFFFAOYSA-N	626774	N-(6-chloro-8,9-dihydro-7H-imidazo[4,5,1-ij]quinolin-9-yl)-1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-135	Plasma kallikrein					 55					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626774	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626774&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152282	485655224							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338140	O=C(NCc1ccc2nccn2c1)c1cn(Cc2cn3cc(ccc3n2)C2CC2)nn1	InChI=1S/C22H20N8O/c31-22(24-9-15-1-5-20-23-7-8-28(20)10-15)19-14-30(27-26-19)13-18-12-29-11-17(16-2-3-16)4-6-21(29)25-18/h1,4-8,10-12,14,16H,2-3,9,13H2,(H,24,31)	VOLAETVMXJFCAY-UHFFFAOYSA-N	626775	1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-N-(imidazo[1,2-a]pyridin-6-ylmethyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-136	Plasma kallikrein					 1050					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626775	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626775&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152186	485655225							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338141	Fc1cc(Cl)cn2c(CNC(=O)c3cnn(Cc4cn5cc(ccc5n4)C4CC4)c3)ncc12	InChI=1S/C23H19ClFN7O/c24-17-5-19(25)20-7-26-22(32(20)11-17)8-27-23(33)16-6-28-31(10-16)13-18-12-30-9-15(14-1-2-14)3-4-21(30)29-18/h3-7,9-12,14H,1-2,8,13H2,(H,27,33)	RLEMBPINWLJBPH-UHFFFAOYSA-N	626776	N-((6-chloro-8-fluoroimidazo[1,5-a]pyridin-3-yl)methyl)-1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-pyrazole-4-carboxamide ::US11787796, Compound I-137	Plasma kallikrein					 1050					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626776	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626776&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156151994	485655226							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297699	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cn[nH]c1)C(F)(F)F			416777	1-(3-(aminomethyl)phenyl)-N-(3-(((cyclopropylmethyl)amino)(1H-pyrazol-4-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 84h::US10633345, Compound 84h::US10689346, Compound 84h::US11203574, Compound 84h::US11230530, Compound 84h::US11685721, Compound 84h::US11708332, Compound 84h	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416777	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416777&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			154584214	433916691							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297700	CCCN(c1ccccc1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C27H26F3N5O/c1-2-14-34(21-10-4-3-5-11-21)22-12-7-9-20(16-22)32-26(36)24-17-25(27(28,29)30)33-35(24)23-13-6-8-19(15-23)18-31/h3-13,15-17H,2,14,18,31H2,1H3,(H,32,36)	IKJCTSPODFFZCP-UHFFFAOYSA-N	416778	1-(3-(aminomethyl)phenyl)-N-(3-(phenyl(propyl)amino)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 27f::US10633345, Compound 27f::US10689346, Compound 27f::US11203574, Compound 27f::US11230530, Compound 27f::US11685721, Compound 27f::US11708332, Compound 27f	Plasma kallikrein		>75.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416778	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416778&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356135	433916692							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297701	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(C(OCC2CC2)c2ccccc2)c1F)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-26-22(27(39-17-18-12-13-18)20-7-2-1-3-8-20)10-5-11-23(26)35-28(38)24-15-25(29(31,32)33)36-37(24)21-9-4-6-19(14-21)16-34/h1-11,14-15,18,27H,12-13,16-17,34H2,(H,35,38)	OCYVMBLZCJPYSX-UHFFFAOYSA-N	416779	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 36d::US10633345, Compound 36d::US10689346, Compound 36d::US11203574, Compound 36d::US11230530, Compound 36d::US11685721, Compound 36d::US11708332, Compound 36d	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416779	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416779&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356266	433916693							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297702	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1nccs1)C(F)(F)F	InChI=1S/C26H25F3N6OS/c27-26(28,29)22-13-21(35(34-22)20-6-1-3-17(11-20)14-30)24(36)33-19-5-2-4-18(12-19)23(25-31-9-10-37-25)32-15-16-7-8-16/h1-6,9-13,16,23,32H,7-8,14-15,30H2,(H,33,36)	BPCHTFOGBGFGRD-UHFFFAOYSA-N	416780	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(thiazol-2-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 85c::US10633345, Compound 85c::US10689346, Compound 85c::US11203574, Compound 85c::US11230530, Compound 85c::US11685721, Compound 85c::US11708332, Compound 85c	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416780	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416780&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355975	433916694							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297703	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CCC1CC1)N1CCOCC1)C(F)(F)F	InChI=1S/C28H32F3N5O2/c29-28(30,31)26-17-25(36(34-26)23-6-1-3-20(15-23)18-32)27(37)33-22-5-2-4-21(16-22)24(10-9-19-7-8-19)35-11-13-38-14-12-35/h1-6,15-17,19,24H,7-14,18,32H2,(H,33,37)	JPSOHZUNYZMZBS-UHFFFAOYSA-N	416781	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-morpholinopropyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 93b::US10633345, Compound 93b::US10689346, Compound 93b::US11203574, Compound 93b::US11230530, Compound 93b::US11685721, Compound 93b::US11708332, Compound 93b	Plasma kallikrein		>100.0								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416781	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416781&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665612	433916695							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297704	COc1cccc(c1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O2/c1-40-25-10-4-7-22(15-25)28(35-18-19-11-12-19)21-6-3-8-23(14-21)36-29(39)26-16-27(30(31,32)33)37-38(26)24-9-2-5-20(13-24)17-34/h2-10,13-16,19,28,35H,11-12,17-18,34H2,1H3,(H,36,39)	DMSXJIPDGRICQW-UHFFFAOYSA-N	416782	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(3-methoxyphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 109f::US10633345, Compound 109f::US10689346, Compound 109f::US11203574, Compound 109f::US11230530, Compound 109f::US11685721, Compound 109f::US11708332, Compound 109f	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416782	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416782&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356265	433916696							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297705	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc2ccccc2c1)C(F)(F)F	InChI=1S/C33H30F3N5O/c34-33(35,36)30-18-29(41(40-30)28-10-3-5-22(15-28)19-37)32(42)39-27-9-4-8-25(17-27)31(38-20-21-11-12-21)26-14-13-23-6-1-2-7-24(23)16-26/h1-10,13-18,21,31,38H,11-12,19-20,37H2,(H,39,42)	QCSULFNIDZTXJZ-UHFFFAOYSA-N	416783	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic acid {3-[(cyclopropylmethyl-amino)-naphthalen-2-yl-methyl]-phenyl}-amide::US10329260, Compound 128g::US10633345, Compound 128g::US10689346, Compound 128g::US11203574, Compound 128g::US11230530, Compound 128g::US11685721, Compound 128g::US11708332, Compound 128g	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416783	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416783&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665786	433916697							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297706	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H26F4N6O/c29-22-9-8-19(26(35-15-17-6-7-17)20-4-2-10-34-16-20)12-23(22)36-27(39)24-13-25(28(30,31)32)37-38(24)21-5-1-3-18(11-21)14-33/h1-5,8-13,16-17,26,35H,6-7,14-15,33H2,(H,36,39)	SECDZDWRLPONSX-UHFFFAOYSA-N	416784	1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethylamino)(pyridin-3-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 94b::US10633345, Compound 94b::US10689346, Compound 94b::US11203574, Compound 94b::US11230530, Compound 94b::US11685721, Compound 94b::US11708332, Compound 94b	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416784	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416784&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355774	433916698							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297707	Cc1cccc(c1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O/c1-19-5-2-7-22(13-19)28(35-18-20-11-12-20)23-8-4-9-24(15-23)36-29(39)26-16-27(30(31,32)33)37-38(26)25-10-3-6-21(14-25)17-34/h2-10,13-16,20,28,35H,11-12,17-18,34H2,1H3,(H,36,39)	ADKXWAHEFSGGQB-UHFFFAOYSA-N	416785	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(m-tolyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 110f::US10633345, Compound 110f::US10689346, Compound 110f::US11203574, Compound 110f::US11230530, Compound 110f::US11685721, Compound 110f::US11708332, Compound 110f	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416785	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416785&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			123875262	433916699							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297708	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc2ccccc12)C(F)(F)F	InChI=1S/C33H30F3N5O/c34-33(35,36)30-18-29(41(40-30)26-11-3-6-22(16-26)19-37)32(42)39-25-10-4-9-24(17-25)31(38-20-21-14-15-21)28-13-5-8-23-7-1-2-12-27(23)28/h1-13,16-18,21,31,38H,14-15,19-20,37H2,(H,39,42)	NFYBGLSBONMUGA-UHFFFAOYSA-N	416786	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic acid {3-[(cyclopropylmethyl-amino)-naphthalen-1-yl-methyl]-phenyl}-amide::US10329260, Compound 129f::US10633345, Compound 129f::US10689346, Compound 129f::US11203574, Compound 129f::US11230530, Compound 129f::US11685721, Compound 129f::US11708332, Compound 129f	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416786	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416786&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356190	433916700							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297709	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(Cc2ccccc2NCC2CC2)cc(c1)C1CC1)C(F)(F)F	InChI=1S/C32H32F3N5O/c33-32(34,35)30-17-29(40(39-30)27-6-3-4-21(15-27)18-36)31(41)38-26-14-22(13-25(16-26)23-10-11-23)12-24-5-1-2-7-28(24)37-19-20-8-9-20/h1-7,13-17,20,23,37H,8-12,18-19,36H2,(H,38,41)	YGERAFNXGPIXIA-UHFFFAOYSA-N	416787	1-(3-(aminomethyl)phenyl)-N-(3-cyclopropyl-5-((cyclopropylmethylamino)(phenyl) methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 95i::US11708332, Compound 95i	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416787	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416787&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			154584215	433916701							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317993	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c2OCOc12)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H21ClF3N7O4/c1-12(17-6-34-26(24-23(17)42-11-43-24)38-9-13-4-16(13)28(38)41)39-10-14(5-35-39)36-27(40)20-8-33-7-19(37-20)21-15(25(31)32)2-3-18(29)22(21)30/h2-3,5-8,10,12-13,16,25H,4,9,11H2,1H3,(H,36,40)/t12?,13-,16-/m1/s1	SDIDDDYPZKBCPS-LLQOJDTPSA-N	618038	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((R or S)-1-(4-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)-[1,3]dioxolo[4,5-c]pyridin-7-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 250::US20230286958, Example 251	Plasma kallikrein			 3.20							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618038	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618038&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168679606	484207206							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317995	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c2OCOc12)n1cc(NC(=O)c2cncc(n2)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C28H21ClF3N7O4/c1-12(17-6-34-26(24-23(17)42-11-43-24)38-9-13-4-16(13)28(38)41)39-10-14(5-35-39)36-27(40)20-8-33-7-19(37-20)21-15(25(31)32)2-3-18(29)22(21)30/h2-3,5-8,10,12-13,16,25H,4,9,11H2,1H3,(H,36,40)/t12?,13-,16-/m1/s1	SDIDDDYPZKBCPS-LLQOJDTPSA-N	618038	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-N-(1-((R or S)-1-(4-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)-[1,3]dioxolo[4,5-c]pyridin-7-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 250::US20230286958, Example 251	Plasma kallikrein			 1.000							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618038	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618038&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168679606	484207206							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317997	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c2OCOc12)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C29H23ClF3N7O4/c1-12-23(38-20(8-34-12)21-16(26(32)33)3-4-19(30)22(21)31)28(41)37-15-6-36-40(10-15)13(2)18-7-35-27(25-24(18)43-11-44-25)39-9-14-5-17(14)29(39)42/h3-4,6-8,10,13-14,17,26H,5,9,11H2,1-2H3,(H,37,41)/t13?,14-,17-/m1/s1	AEBJMLIAWHLLQF-DTLKIFBZSA-N	618040	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-methyl-N-(1-((R or S)-1-(4-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)-[1,3]dioxolo[4,5-c]pyridin-7-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 252::US20230286958, Example 253	Plasma kallikrein			 0.900							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618040	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618040&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168679607	484207207							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338142	COc1ccnc(CNC(=O)c2cn(Cc3cn4cc(cc(CCN(C)C)c4n3)C3CC3)nn2)c1F	InChI=1S/C25H29FN8O2/c1-32(2)9-7-17-10-18(16-4-5-16)12-33-13-19(29-24(17)33)14-34-15-21(30-31-34)25(35)28-11-20-23(26)22(36-3)6-8-27-20/h6,8,10,12-13,15-16H,4-5,7,9,11,14H2,1-3H3,(H,28,35)	XTIYMPYCBRTJQB-UHFFFAOYSA-N	626777	4-methoxypyridin-2-yl)methyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-138	Plasma kallikrein					 5.5					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626777	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626777&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152260	485655227							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338143	COc1ccnc(CNC(=O)c2cn(Cc3cn4cc(cc(N5CCN(C)CC5)c4n3)C3CC3)nn2)c1F	InChI=1S/C26H30FN9O2/c1-33-7-9-34(10-8-33)22-11-18(17-3-4-17)13-35-14-19(30-25(22)35)15-36-16-21(31-32-36)26(37)29-12-20-24(27)23(38-2)5-6-28-20/h5-6,11,13-14,16-17H,3-4,7-10,12,15H2,1-2H3,(H,29,37)	CCNCMXFQKUPOMP-UHFFFAOYSA-N	626778	1-((6-cyclopropyl-8-(4-methylpiperazin-1-yl)imidazo[1,2-a]pyridin-2-yl)methyl)-N-(3-fluoro-4-methoxypyridin-2-yl)methyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-139	Plasma kallikrein					<1.0					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626778	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626778&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152264	485655228							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338144	O=C(NCc1cc2occc2cn1)c1cn(Cc2cn3cc(ccc3n2)C2CC2)nn1	InChI=1S/C22H19N7O2/c30-22(24-9-17-7-20-15(8-23-17)5-6-31-20)19-13-29(27-26-19)12-18-11-28-10-16(14-1-2-14)3-4-21(28)25-18/h3-8,10-11,13-14H,1-2,9,12H2,(H,24,30)	DDECAJIRHGMWBG-UHFFFAOYSA-N	626779	1-(6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-N-(furo[3,2-c]pyridin-6-ylmethyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-140	Plasma kallikrein					 1050					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626779	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626779&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152106	485655229							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338145	O=C(NCc1cc2OCCc2cn1)c1cn(Cc2cn3cc(ccc3n2)C2CC2)nn1	InChI=1S/C22H21N7O2/c30-22(24-9-17-7-20-15(8-23-17)5-6-31-20)19-13-29(27-26-19)12-18-11-28-10-16(14-1-2-14)3-4-21(28)25-18/h3-4,7-8,10-11,13-14H,1-2,5-6,9,12H2,(H,24,30)	OZOSDYRGMDBYNU-UHFFFAOYSA-N	626780	1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-N-((2,3-dihydrofuro[3,2-c]pyridin-6-yl)methyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-141	Plasma kallikrein					 55					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626780	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626780&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152081	485655230							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338146	Clc1ccnc(CNC(=O)c2cn(Cc3cn4cc(ccc4n3)C3CC3)nn2)c1	InChI=1S/C20H18ClN7O/c21-15-5-6-22-16(7-15)8-23-20(29)18-12-28(26-25-18)11-17-10-27-9-14(13-1-2-13)3-4-19(27)24-17/h3-7,9-10,12-13H,1-2,8,11H2,(H,23,29)	ZFAXQXZATMUGFC-UHFFFAOYSA-N	626781	N-((4-chloropyridin-2-yl)methyl)-1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-142	Plasma kallikrein					 4550					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626781	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626781&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156152270	485655231							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1338147	COc1cnc(CNC(=O)c2cn(Cc3cn4cc(ccc4n3)C3CC3)nn2)cc1OC	InChI=1S/C22H23N7O3/c1-31-19-7-16(23-9-20(19)32-2)8-24-22(30)18-13-29(27-26-18)12-17-11-28-10-15(14-3-4-14)5-6-21(28)25-17/h5-7,9-11,13-14H,3-4,8,12H2,1-2H3,(H,24,30)	ZGFSEHIDSUIJQK-UHFFFAOYSA-N	626782	1-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)-N-((2,3-dihydro-[1,4]dioxino[2,3-c]pyridin-7-yl)methyl)-1H-1,2,3-triazole-4-carboxamide ::US11787796, Compound I-143	Plasma kallikrein					 1050					US Patent		10.7270/Q2RX9H62			US11787796	Papaioannou, N; Travins, JM; Fink, SJ; Ellard, JM; Rae, A	Takeda Pharmaceutical Company	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626782	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=626782&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156175089	485655232							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297710	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1cccc(c1)C(F)(F)F)C(F)(F)F	InChI=1S/C30H27F6N5O/c31-29(32,33)22-7-2-5-20(13-22)27(38-17-18-10-11-18)21-6-3-8-23(14-21)39-28(42)25-15-26(30(34,35)36)40-41(25)24-9-1-4-19(12-24)16-37/h1-9,12-15,18,27,38H,10-11,16-17,37H2,(H,39,42)	FZSHDRVSVGSKOF-UHFFFAOYSA-N	416788	1-(3-(Aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(3-(trifluoromethyl) phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 111f::US10633345, Compound 111f::US10689346, Compound 111f::US11203574, Compound 111f::US11230530, Compound 111f::US11685721, Compound 111f::US11708332, Compound 111f	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416788	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416788&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355816	433916702							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297711	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccc(N)cc1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-23-11-8-20(27(36-16-17-4-5-17)19-6-9-21(35)10-7-19)13-24(23)37-28(40)25-14-26(29(31,32)33)38-39(25)22-3-1-2-18(12-22)15-34/h1-3,6-14,17,27,36H,4-5,15-16,34-35H2,(H,37,40)	QTGVDKNDDSXZLM-UHFFFAOYSA-N	416789	1-(3-(aminomethyl)phenyl)-N-(5-((4-aminophenyl)(cyclopropylmethylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 130g::US10633345, Compound 130g::US10689346, Compound 130g::US11203574, Compound 130g::US11230530, Compound 130g::US11685721, Compound 130g::US11708332, Compound 130g	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416789	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416789&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665503	433916703							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297712	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1Cl)C(NCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H26ClF3N6O/c29-22-9-8-19(26(35-15-17-6-7-17)20-4-2-10-34-16-20)12-23(22)36-27(39)24-13-25(28(30,31)32)37-38(24)21-5-1-3-18(11-21)14-33/h1-5,8-13,16-17,26,35H,6-7,14-15,33H2,(H,36,39)	DCRDGEJSCMQMFA-UHFFFAOYSA-N	416790	1-(3-(Aminomethyl)phenyl)-N-(2-chloro-5-((cyclopropylmethylamino)(pyridin-3-yl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 96f::US10633345, Compound 96f::US10689346, Compound 96f::US11203574, Compound 96f::US11230530, Compound 96f::US11685721, Compound 96f::US11708332, Compound 96f	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416790	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416790&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355757	433916704							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297713	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(cc1)S(N)(=O)=O)C(F)(F)F	InChI=1S/C29H29F3N6O3S/c30-29(31,32)26-15-25(38(37-26)23-6-1-3-19(13-23)16-33)28(39)36-22-5-2-4-21(14-22)27(35-17-18-7-8-18)20-9-11-24(12-10-20)42(34,40)41/h1-6,9-15,18,27,35H,7-8,16-17,33H2,(H,36,39)(H2,34,40,41)	BGEXZQITRMVFRR-UHFFFAOYSA-N	416791	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(4-sulfamoylphenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 112g::US10633345, Compound 112g::US10689346, Compound 112g::US11203574, Compound 112g::US11230530, Compound 112g::US11685721, Compound 112g::US11708332, Compound 112g	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416791	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416791&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355780	433916705							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297714	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1cccc(N)c1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-23-10-9-20(27(36-16-17-7-8-17)19-4-2-5-21(35)12-19)13-24(23)37-28(40)25-14-26(29(31,32)33)38-39(25)22-6-1-3-18(11-22)15-34/h1-6,9-14,17,27,36H,7-8,15-16,34-35H2,(H,37,40)	HJMCNZIVUWWSBV-UHFFFAOYSA-N	416792	1-(3-(aminomethyl)phenyl)-N-(5-((3-aminophenyl)(cyclopropylmethylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 131b::US10633345, Compound 131b::US10689346, Compound 131b::US11203574, Compound 131b::US11230530, Compound 131b::US11685721, Compound 131b::US11708332, Compound 131b	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416792	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416792&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665555	433916706							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297715	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C28H25F4N5O2/c29-22-9-8-19(26(39-16-17-6-7-17)20-4-2-10-34-15-20)12-23(22)35-27(38)24-13-25(28(30,31)32)36-37(24)21-5-1-3-18(11-21)14-33/h1-5,8-13,15,17,26H,6-7,14,16,33H2,(H,35,38)	CNAFOXQNPWSINI-UHFFFAOYSA-N	416794	Racemic 1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethoxy)(pyridin-3-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 48f::US10633345, Compound 48f::US10689346, Compound 48f::US11203574, Compound 48g::US11230530, Compound 48h::US11685721, Compound 48f::US11708332, Compound 48f	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416794	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416794&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355617	433916708							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297716	CS(=O)(=O)c1ccc(cc1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O3S/c1-42(40,41)25-12-10-21(11-13-25)28(35-18-19-8-9-19)22-5-3-6-23(15-22)36-29(39)26-16-27(30(31,32)33)37-38(26)24-7-2-4-20(14-24)17-34/h2-7,10-16,19,28,35H,8-9,17-18,34H2,1H3,(H,36,39)	UTLDYOFVUPHYMX-UHFFFAOYSA-N	416795	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(4-(methylsulfonyl)phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 113f::US10633345, Compound 113f::US10689346, Compound 113f::US11203574, Compound 113f::US11230530, Compound 113f::US11685721, Compound 113f::US11708332, Compound 113f	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416795	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416795&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355808	433916709							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297717	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C28H26F4N6O/c29-22-7-6-20(26(35-16-17-4-5-17)19-8-10-34-11-9-19)13-23(22)36-27(39)24-14-25(28(30,31)32)37-38(24)21-3-1-2-18(12-21)15-33/h1-3,6-14,17,26,35H,4-5,15-16,33H2,(H,36,39)	JHXYEKYRIWFSRY-UHFFFAOYSA-N	416796	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(pyridin-4-yl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 132f::US10633345, Compound 132f::US10689346, Compound 132f::US11203574, Compound 132f::US11230530, Compound 132f::US11685721, Compound 132f::US11708332, Compound 132f	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416796	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416796&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665438	433916710							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297718	CN1CCc2c(C1)ccc(NC(=O)c1cc(nn1-c1cccc(CN)c1)C(F)(F)F)c2F	InChI=1S/C22H21F4N5O/c1-30-8-7-16-14(12-30)5-6-17(20(16)23)28-21(32)18-10-19(22(24,25)26)29-31(18)15-4-2-3-13(9-15)11-27/h2-6,9-10H,7-8,11-12,27H2,1H3,(H,28,32)	XRSKJTRQFAFTLA-UHFFFAOYSA-N	416797	1-(3-(aminomethyl)phenyl)-N-(5-fluoro-2-methyl-1,2,3,4-tetrahydroisoquinolin-6-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 164e::US10633345, Compound 164e::US10689346, Compound 164e::US11203574, Compound 164e::US11230530, Compound 164e::US11685721, Compound 164e::US11708332, Compound 164e	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416797	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416797&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665488	433916711							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297719	CS(=O)(=O)c1cccc(c1)C(NCC1CC1)c1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F3N5O3S/c1-42(40,41)25-10-4-7-22(15-25)28(35-18-19-11-12-19)21-6-3-8-23(14-21)36-29(39)26-16-27(30(31,32)33)37-38(26)24-9-2-5-20(13-24)17-34/h2-10,13-16,19,28,35H,11-12,17-18,34H2,1H3,(H,36,39)	VJYAFYNZRBTGFW-UHFFFAOYSA-N	416798	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethylamino)(3-(methylsulfonyl)phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 114f::US10633345, Compound 114f::US10689346, Compound 114f::US11203574, Compound 114f::US11230530, Compound 114f::US11685721, Compound 114f::US11708332, Compound 114f	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416798	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416798&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665780	433916712							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1297720	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccc(cc1)-c1ccccc1)C(F)(F)F	InChI=1S/C35H32F3N5O/c36-35(37,38)32-20-31(43(42-32)30-11-4-6-24(18-30)21-39)34(44)41-29-10-5-9-28(19-29)33(40-22-23-12-13-23)27-16-14-26(15-17-27)25-7-2-1-3-8-25/h1-11,14-20,23,33,40H,12-13,21-22,39H2,(H,41,44)	SZCMOETVRNQDRC-UHFFFAOYSA-N	416799	2-(3-Aminomethyl-phenyl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic Acid {3-[biphenyl-4-yl-(cyclopropylmethyl-amino)-methyl]-phenyl}-amide::US10329260, Compound 133g::US10633345, Compound 133g::US10689346, Compound 133g::US11203574, Compound 133g::US11230530, Compound 133g::US11685721, Compound 133g::US11708332, Compound 133g	Plasma kallikrein		 25.1								US Patent					US11708332	Kotian, PL; Babu, YS; Wu, M; Chintareddy, VR; Kumar, VS; Zhang, W	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416799	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416799&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665928	433916713							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1317999	CC(c1cnc(N2C[C@H]3C[C@H]3C2=O)c2OCOc12)n1cc(NC(=O)c2nc(cnc2C)-c2c(F)c(Cl)ccc2C(F)F)cn1	InChI=1S/C29H23ClF3N7O4/c1-12-23(38-20(8-34-12)21-16(26(32)33)3-4-19(30)22(21)31)28(41)37-15-6-36-40(10-15)13(2)18-7-35-27(25-24(18)43-11-44-25)39-9-14-5-17(14)29(39)42/h3-4,6-8,10,13-14,17,26H,5,9,11H2,1-2H3,(H,37,41)/t13?,14-,17-/m1/s1	AEBJMLIAWHLLQF-DTLKIFBZSA-N	618040	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-methyl-N-(1-((R or S)-1-(4-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)-[1,3]dioxolo[4,5-c]pyridin-7-yl)ethyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 252::US20230286958, Example 253	Plasma kallikrein			 2.20							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618040	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618040&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168679607	484207207							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1318001	CC(O)c1ncc(nc1C(=O)Nc1cnn(Cc2cnc(N3C[C@H]4C[C@H]4C3=O)c3OCOc23)c1)-c1c(F)c(Cl)ccc1C(F)F	InChI=1S/C29H23ClF3N7O5/c1-12(41)22-23(38-19(7-34-22)20-16(26(32)33)2-3-18(30)21(20)31)28(42)37-15-6-36-39(10-15)8-14-5-35-27(25-24(14)44-11-45-25)40-9-13-4-17(13)29(40)43/h2-3,5-7,10,12-13,17,26,41H,4,8-9,11H2,1H3,(H,37,42)/t12?,13-,17-/m1/s1	IAWTUPZVMCVDDL-QQGYXAEISA-N	618042	6-(3-Chloro-6-(difluoromethyl)-2-fluorophenyl)-3-((R or S)-1-hydroxyethyl)-N-(1-((4-((1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl)-[1,3]dioxolo[4,5-c]pyridin-7-yl)methyl)-1H-pyrazol-4-yl)pyrazine-2-carboxamide::US20230286958, Example 254	Plasma kallikrein			 1.40							US Patent		10.7270/Q2DB8609			US20230286958	Jabri, S; Ogawa, AK; Sinz, CJ; Hicks, JD; Cheng, AC; Gao, Y; Yang, S; Bao, J; Hayes, DA; Lang, SB; Taoka, BM; Tian, M; Shearn-Nance, GP; Kuang, R; Lombardo, MJ; Wu, Z; Zhao, Z	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=618042	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=618042&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168679608	484207208							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507172	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H28F3N5O/c30-29(31,32)26-16-25(37(36-26)24-11-4-6-20(14-24)17-33)28(38)35-23-10-5-9-22(15-23)27(34-18-19-12-13-19)21-7-2-1-3-8-21/h1-11,14-16,19,27,34H,12-13,17-18,33H2,(H,35,38)	QZQLNMURVWFZTC-UHFFFAOYSA-N	439347	US10633345, Compound 41e::US10689346, Compound 41e::US11203574, Compound 41e::US11230530, Compound 41e	Plasma kallikrein			 5.4							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439347	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439347&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665751	439660905							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507173	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F4N5O/c30-23-12-11-21(27(35-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27,35H,9-10,16-17,34H2,(H,36,39)	MCLZOCFEIKBMBA-UHFFFAOYSA-N	416773	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 38d::US10633345, Compound 38d::US10689346, Compound 42a::US11203574, Compound 42a::US11230530, Compound 42a::US11685721, Compound 38d	Plasma kallikrein			 9.0							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416773	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416773&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356124	433916687							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507174	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F3N4O2/c30-29(31,32)26-16-25(36(35-26)24-11-4-6-20(14-24)17-33)28(37)34-23-10-5-9-22(15-23)27(38-18-19-12-13-19)21-7-2-1-3-8-21/h1-11,14-16,19,27H,12-13,17-18,33H2,(H,34,37)	PEZVPVUPSJXZCH-UHFFFAOYSA-N	416775	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18k::US10633345, Compound 74a::US10689346, Compound 165e::US11203574, Compound 165e::US11230530, Compound 165e::US11685721, Compound 18k	Plasma kallikrein			 38							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416775	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416775&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			91884591	433916689							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507175	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-23-12-11-21(27(39-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)35-28(38)25-15-26(29(31,32)33)36-37(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27H,9-10,16-17,34H2,(H,35,38)	HIMJVDQVZQMIPM-UHFFFAOYSA-N	416968	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethoxy)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 37b	Plasma kallikrein			 64							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416968	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416968&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355729	433916880							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507176	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F3N4O/c31-30(32,33)28-18-27(37(36-28)25-11-4-6-21(16-25)19-34)29(38)35-24-10-5-9-23(17-24)26(15-14-20-12-13-20)22-7-2-1-3-8-22/h1-11,16-18,20,26H,12-15,19,34H2,(H,35,38)	LVGPKQXQIQRVCT-UHFFFAOYSA-N	416730	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-phenylpropyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 78d::US10633345, Compound 78d::US10689346, Compound 78d::US11203574, Compound 78d::US11230530, Compound 78d::US11685721, Compound 78d	Plasma kallikrein			 10							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416730	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416730&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665672	433916644							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507177	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F3N4O2/c31-30(32,33)27-18-26(37(36-27)25-11-4-6-21(16-25)19-34)28(38)35-24-10-5-9-23(17-24)29(39,15-14-20-12-13-20)22-7-2-1-3-8-22/h1-11,16-18,20,39H,12-15,19,34H2,(H,35,38)	DCGYPXFSNPCKGX-UHFFFAOYSA-N	416946	(+-)-1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 46i	Plasma kallikrein			 14							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416946	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416946&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355790	433916858							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507178	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-17-24(37(36-26)23-8-3-5-20(15-23)18-33)27(38)35-22-7-4-6-21(16-22)28(39,13-12-19-10-11-19)25-9-1-2-14-34-25/h1-9,14-17,19,39H,10-13,18,33H2,(H,35,38)	BAOACYBKKSTHLE-UHFFFAOYSA-N	416767	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 45g::US10633345, Compound 45g::US10689346, Compound 45g::US11203574, Compound 45g::US11230530, Compound 45g::US11685721, Compound 45g	Plasma kallikrein			 19							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416767	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416767&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665639	433916681							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507179	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-16-25(37(36-26)24-8-1-4-20(14-24)17-33)27(38)35-23-7-2-5-21(15-23)28(39,12-11-19-9-10-19)22-6-3-13-34-18-22/h1-8,13-16,18-19,39H,9-12,17,33H2,(H,35,38)	AOCZEQQKIIWUBU-UHFFFAOYSA-N	416770	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 47f::US10633345, Compound 47f::US10689346, Compound 47f::US11203574, Compound 47g::US11230530, Compound 47h::US11685721, Compound 47f	Plasma kallikrein			 5.7							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416770	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416770&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355766	433916684							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507180	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-17-25(37(36-26)24-6-1-3-20(15-24)18-33)27(38)35-23-5-2-4-22(16-23)28(39,12-9-19-7-8-19)21-10-13-34-14-11-21/h1-6,10-11,13-17,19,39H,7-9,12,18,33H2,(H,35,38)	HEXYKZQZIBBLLM-UHFFFAOYSA-N	416774	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-(pyridin-4-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 92g::US10633345, Compound 92g::US10689346, Compound 92g::US11203574, Compound 92g::US11230530, Compound 92g::US11685721, Compound 92g	Plasma kallikrein			 4.7							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416774	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416774&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355890	433916688							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507181	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F3N4O2/c31-30(32,33)27-18-26(37(36-27)25-11-4-6-21(16-25)19-34)28(38)35-24-10-5-9-23(17-24)29(39,15-14-20-12-13-20)22-7-2-1-3-8-22/h1-11,16-18,20,39H,12-15,19,34H2,(H,35,38)	DCGYPXFSNPCKGX-UHFFFAOYSA-N	416946	(+-)-1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 46i	Plasma kallikrein			 14.0							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416946	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416946&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355790	433916858							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507182	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F3N4O2/c31-30(32,33)27-18-26(37(36-27)25-11-4-6-21(16-25)19-34)28(38)35-24-10-5-9-23(17-24)29(39,15-14-20-12-13-20)22-7-2-1-3-8-22/h1-11,16-18,20,39H,12-15,19,34H2,(H,35,38)	DCGYPXFSNPCKGX-UHFFFAOYSA-N	416946	(+-)-1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 46i	Plasma kallikrein			 1.20							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416946	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416946&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355790	433916858							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507183	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H28F4N4O2/c31-24-12-11-22(29(40,14-13-19-9-10-19)21-6-2-1-3-7-21)16-25(24)36-28(39)26-17-27(30(32,33)34)37-38(26)23-8-4-5-20(15-23)18-35/h1-8,11-12,15-17,19,40H,9-10,13-14,18,35H2,(H,36,39)	NIWMWYNGSALJGG-UHFFFAOYSA-N	416938	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 68d	Plasma kallikrein			 5.0							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416938	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416938&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355758	433916850							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507184	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H28F4N4O2/c31-24-12-11-22(29(40,14-13-19-9-10-19)21-6-2-1-3-7-21)16-25(24)36-28(39)26-17-27(30(32,33)34)37-38(26)23-8-4-5-20(15-23)18-35/h1-8,11-12,15-17,19,40H,9-10,13-14,18,35H2,(H,36,39)	NIWMWYNGSALJGG-UHFFFAOYSA-N	416938	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 68d	Plasma kallikrein			 5.00							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416938	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416938&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355758	433916850							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507185	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H28F4N4O2/c31-24-12-11-22(29(40,14-13-19-9-10-19)21-6-2-1-3-7-21)16-25(24)36-28(39)26-17-27(30(32,33)34)37-38(26)23-8-4-5-20(15-23)18-35/h1-8,11-12,15-17,19,40H,9-10,13-14,18,35H2,(H,36,39)	NIWMWYNGSALJGG-UHFFFAOYSA-N	416938	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 68d	Plasma kallikrein			 3.60							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416938	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416938&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355758	433916850							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507186	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-10-9-20(28(40,12-11-18-7-8-18)25-6-1-2-13-35-25)15-23(22)36-27(39)24-16-26(29(31,32)33)37-38(24)21-5-3-4-19(14-21)17-34/h1-6,9-10,13-16,18,40H,7-8,11-12,17,34H2,(H,36,39)	XXMBQXWQIGCREG-UHFFFAOYSA-N	416909	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 59c::US10633345, Compound 69b::US10689346, Compound 59c::US11203574, Compound 69b::US11230530, Compound 69b::US11685721, Compound 69b	Plasma kallikrein			 11							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416909	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416909&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356067	433916821							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507187	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-10-9-20(28(40,12-11-18-7-8-18)25-6-1-2-13-35-25)15-23(22)36-27(39)24-16-26(29(31,32)33)37-38(24)21-5-3-4-19(14-21)17-34/h1-6,9-10,13-16,18,40H,7-8,11-12,17,34H2,(H,36,39)	XXMBQXWQIGCREG-UHFFFAOYSA-N	416909	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 59c::US10633345, Compound 69b::US10689346, Compound 59c::US11203574, Compound 69b::US11230530, Compound 69b::US11685721, Compound 69b	Plasma kallikrein			 11.0							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416909	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416909&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356067	433916821							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507188	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-10-9-20(28(40,12-11-18-7-8-18)25-6-1-2-13-35-25)15-23(22)36-27(39)24-16-26(29(31,32)33)37-38(24)21-5-3-4-19(14-21)17-34/h1-6,9-10,13-16,18,40H,7-8,11-12,17,34H2,(H,36,39)	XXMBQXWQIGCREG-UHFFFAOYSA-N	416909	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 59c::US10633345, Compound 69b::US10689346, Compound 59c::US11203574, Compound 69b::US11230530, Compound 69b::US11685721, Compound 69b	Plasma kallikrein			 3.00							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416909	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416909&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356067	433916821							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507189	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-16-25(37(36-26)24-8-1-4-20(14-24)17-33)27(38)35-23-7-2-5-21(15-23)28(39,12-11-19-9-10-19)22-6-3-13-34-18-22/h1-8,13-16,18-19,39H,9-12,17,33H2,(H,35,38)	AOCZEQQKIIWUBU-UHFFFAOYSA-N	416770	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 47f::US10633345, Compound 47f::US10689346, Compound 47f::US11203574, Compound 47g::US11230530, Compound 47h::US11685721, Compound 47f	Plasma kallikrein			 5.70							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416770	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416770&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355766	433916684							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507190	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-16-25(37(36-26)24-8-1-4-20(14-24)17-33)27(38)35-23-7-2-5-21(15-23)28(39,12-11-19-9-10-19)22-6-3-13-34-18-22/h1-8,13-16,18-19,39H,9-12,17,33H2,(H,35,38)	AOCZEQQKIIWUBU-UHFFFAOYSA-N	416770	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 47f::US10633345, Compound 47f::US10689346, Compound 47f::US11203574, Compound 47g::US11230530, Compound 47h::US11685721, Compound 47f	Plasma kallikrein			 1.90							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416770	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416770&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355766	433916684							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507191	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-9-8-20(28(40,11-10-18-6-7-18)21-4-2-12-35-17-21)14-24(23)36-27(39)25-15-26(29(31,32)33)37-38(25)22-5-1-3-19(13-22)16-34/h1-5,8-9,12-15,17-18,40H,6-7,10-11,16,34H2,(H,36,39)	VCHFZCHUEHQXSZ-UHFFFAOYSA-N	416897	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 58c::US10633345, Compound 67b::US10689346, Compound 67b::US11203574, Compound 67b::US11230530, Compound 67b::US11685721, Compound 67b	Plasma kallikrein			 3.6							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416897	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416897&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355889	433916810							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507192	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-9-8-20(28(40,11-10-18-6-7-18)21-4-2-12-35-17-21)14-24(23)36-27(39)25-15-26(29(31,32)33)37-38(25)22-5-1-3-19(13-22)16-34/h1-5,8-9,12-15,17-18,40H,6-7,10-11,16,34H2,(H,36,39)	VCHFZCHUEHQXSZ-UHFFFAOYSA-N	416897	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 58c::US10633345, Compound 67b::US10689346, Compound 67b::US11203574, Compound 67b::US11230530, Compound 67b::US11685721, Compound 67b	Plasma kallikrein			 3.60							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416897	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416897&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355889	433916810							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507193	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-9-8-20(28(40,11-10-18-6-7-18)21-4-2-12-35-17-21)14-24(23)36-27(39)25-15-26(29(31,32)33)37-38(25)22-5-1-3-19(13-22)16-34/h1-5,8-9,12-15,17-18,40H,6-7,10-11,16,34H2,(H,36,39)	VCHFZCHUEHQXSZ-UHFFFAOYSA-N	416897	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 58c::US10633345, Compound 67b::US10689346, Compound 67b::US11203574, Compound 67b::US11230530, Compound 67b::US11685721, Compound 67b	Plasma kallikrein			 1.10							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416897	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416897&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355889	433916810							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507194	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-17-25(37(36-26)24-6-1-3-20(15-24)18-33)27(38)35-23-5-2-4-22(16-23)28(39,12-9-19-7-8-19)21-10-13-34-14-11-21/h1-6,10-11,13-17,19,39H,7-9,12,18,33H2,(H,35,38)	HEXYKZQZIBBLLM-UHFFFAOYSA-N	416774	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-(pyridin-4-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 92g::US10633345, Compound 92g::US10689346, Compound 92g::US11203574, Compound 92g::US11230530, Compound 92g::US11685721, Compound 92g	Plasma kallikrein			 4.70							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416774	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416774&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355890	433916688							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507195	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-17-25(37(36-26)24-6-1-3-20(15-24)18-33)27(38)35-23-5-2-4-22(16-23)28(39,12-9-19-7-8-19)21-10-13-34-14-11-21/h1-6,10-11,13-17,19,39H,7-9,12,18,33H2,(H,35,38)	HEXYKZQZIBBLLM-UHFFFAOYSA-N	416774	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-(pyridin-4-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 92g::US10633345, Compound 92g::US10689346, Compound 92g::US11203574, Compound 92g::US11230530, Compound 92g::US11685721, Compound 92g	Plasma kallikrein			 1.30							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416774	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416774&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355890	433916688							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507196	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-7-6-21(28(40,11-8-18-4-5-18)20-9-12-35-13-10-20)15-24(23)36-27(39)25-16-26(29(31,32)33)37-38(25)22-3-1-2-19(14-22)17-34/h1-3,6-7,9-10,12-16,18,40H,4-5,8,11,17,34H2,(H,36,39)	BHLLHZZJYJWRRD-UHFFFAOYSA-N	50607250	CHEMBL5219146	Plasma kallikrein			 1.1							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50607250	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50607250&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168297994	482618101							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507197	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-7-6-21(28(40,11-8-18-4-5-18)20-9-12-35-13-10-20)15-24(23)36-27(39)25-16-26(29(31,32)33)37-38(25)22-3-1-2-19(14-22)17-34/h1-3,6-7,9-10,12-16,18,40H,4-5,8,11,17,34H2,(H,36,39)	BHLLHZZJYJWRRD-UHFFFAOYSA-N	50607250	CHEMBL5219146	Plasma kallikrein			 1.10							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50607250	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50607250&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168297994	482618101							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507198	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F4N5O/c31-24-12-11-22(29(36,14-13-19-9-10-19)21-6-2-1-3-7-21)16-25(24)37-28(40)26-17-27(30(32,33)34)38-39(26)23-8-4-5-20(15-23)18-35/h1-8,11-12,15-17,19H,9-10,13-14,18,35-36H2,(H,37,40)	NQFNNZJJOCPZCP-UHFFFAOYSA-N	416987	(+-)-N-(5-(1-amino-3-cyclopropyl-1-phenylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 210d::US10633345, Compound 211d::US10689346, Compound 211d::US11203574, Compound 211d::US11230530, Compound 211d::US11685721, Compound 211d	Plasma kallikrein			 2.2							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416987	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416987&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355764	433916899							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507199	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F4N5O/c31-24-12-11-22(29(36,14-13-19-9-10-19)21-6-2-1-3-7-21)16-25(24)37-28(40)26-17-27(30(32,33)34)38-39(26)23-8-4-5-20(15-23)18-35/h1-8,11-12,15-17,19H,9-10,13-14,18,35-36H2,(H,37,40)	NQFNNZJJOCPZCP-UHFFFAOYSA-N	416987	(+-)-N-(5-(1-amino-3-cyclopropyl-1-phenylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 210d::US10633345, Compound 211d::US10689346, Compound 211d::US11203574, Compound 211d::US11230530, Compound 211d::US11685721, Compound 211d	Plasma kallikrein			 2.20							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416987	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416987&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355764	433916899							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507200	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-22-10-9-20(28(35,12-11-18-7-8-18)25-6-1-2-13-36-25)15-23(22)37-27(40)24-16-26(29(31,32)33)38-39(24)21-5-3-4-19(14-21)17-34/h1-6,9-10,13-16,18H,7-8,11-12,17,34-35H2,(H,37,40)	IFWBAIGKQKRJGJ-UHFFFAOYSA-N	416975	(+-)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 205d::US10633345, Compound 205c::US10689346, Compound 205e::US11203574, Compound 205e::US11230530, Compound 205e::US11685721, Compound 205f	Plasma kallikrein			 1.3							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416975	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416975&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665627	433916887							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507201	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-22-10-9-20(28(35,12-11-18-7-8-18)25-6-1-2-13-36-25)15-23(22)37-27(40)24-16-26(29(31,32)33)38-39(24)21-5-3-4-19(14-21)17-34/h1-6,9-10,13-16,18H,7-8,11-12,17,34-35H2,(H,37,40)	IFWBAIGKQKRJGJ-UHFFFAOYSA-N	416975	(+-)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 205d::US10633345, Compound 205c::US10689346, Compound 205e::US11203574, Compound 205e::US11230530, Compound 205e::US11685721, Compound 205f	Plasma kallikrein			 1.30							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416975	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416975&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665627	433916887							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507202	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-23-9-8-20(28(35,11-10-18-6-7-18)21-4-2-12-36-17-21)14-24(23)37-27(40)25-15-26(29(31,32)33)38-39(25)22-5-1-3-19(13-22)16-34/h1-5,8-9,12-15,17-18H,6-7,10-11,16,34-35H2,(H,37,40)	QXMQDWOYOXVOQZ-UHFFFAOYSA-N	416981	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 208d::US10633345, Compound 209d::US10689346, Compound 209d::US11203574, Compound 209d::US11230530, Compound 209d::US11685721, Compound 209d	Plasma kallikrein			 0.660000							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416981	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416981&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355646	433916893							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507203	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-23-9-8-20(28(35,11-10-18-6-7-18)21-4-2-12-36-17-21)14-24(23)37-27(40)25-15-26(29(31,32)33)38-39(25)22-5-1-3-19(13-22)16-34/h1-5,8-9,12-15,17-18H,6-7,10-11,16,34-35H2,(H,37,40)	QXMQDWOYOXVOQZ-UHFFFAOYSA-N	416981	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 208d::US10633345, Compound 209d::US10689346, Compound 209d::US11203574, Compound 209d::US11230530, Compound 209d::US11685721, Compound 209d	Plasma kallikrein			 0.660							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416981	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416981&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355646	433916893							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507204	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-23-7-6-21(28(35,11-8-18-4-5-18)20-9-12-36-13-10-20)15-24(23)37-27(40)25-16-26(29(31,32)33)38-39(25)22-3-1-2-19(14-22)17-34/h1-3,6-7,9-10,12-16,18H,4-5,8,11,17,34-35H2,(H,37,40)	AGVFYPDLNPHKER-UHFFFAOYSA-N	417024	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-4-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 216d::US10633345, Compound 217d::US10689346, Compound 217d::US11192861, Compound 217d::US11230530, Compound 217d::US11685721, Compound 217d	Plasma kallikrein			 1.5							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417024	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417024&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665723	433916934							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507205	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-23-7-6-21(28(35,11-8-18-4-5-18)20-9-12-36-13-10-20)15-24(23)37-27(40)25-16-26(29(31,32)33)38-39(25)22-3-1-2-19(14-22)17-34/h1-3,6-7,9-10,12-16,18H,4-5,8,11,17,34-35H2,(H,37,40)	AGVFYPDLNPHKER-UHFFFAOYSA-N	417024	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-4-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 216d::US10633345, Compound 217d::US10689346, Compound 217d::US11192861, Compound 217d::US11230530, Compound 217d::US11685721, Compound 217d	Plasma kallikrein			 1.50							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417024	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417024&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665723	433916934							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507206	Cc1cc(ccn1)C(N)(CCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F4N6O/c1-18-13-22(10-12-37-18)29(36,11-9-19-5-6-19)21-7-8-24(31)25(15-21)38-28(41)26-16-27(30(32,33)34)39-40(26)23-4-2-3-20(14-23)17-35/h2-4,7-8,10,12-16,19H,5-6,9,11,17,35-36H2,1H3,(H,38,41)	PYONXWOUVYIBRU-UHFFFAOYSA-N	417031	(+)-N-(5-(1-amino-3-cyclopropyl-1-(2-methylpyridin-4-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 266j::US10633345, Compound 266j::US10689346, Compound 266j::US11203574, Compound 266j::US11230530, Compound 266j::US11685721, Compound 266j	Plasma kallikrein			 1.2							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417031	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417031&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665585	433916941							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507207	Cc1cc(ccn1)C(N)(CCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F4N6O/c1-18-13-22(10-12-37-18)29(36,11-9-19-5-6-19)21-7-8-24(31)25(15-21)38-28(41)26-16-27(30(32,33)34)39-40(26)23-4-2-3-20(14-23)17-35/h2-4,7-8,10,12-16,19H,5-6,9,11,17,35-36H2,1H3,(H,38,41)	PYONXWOUVYIBRU-UHFFFAOYSA-N	417031	(+)-N-(5-(1-amino-3-cyclopropyl-1-(2-methylpyridin-4-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 266j::US10633345, Compound 266j::US10689346, Compound 266j::US11203574, Compound 266j::US11230530, Compound 266j::US11685721, Compound 266j	Plasma kallikrein			 1.20							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417031	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417031&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665585	433916941							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507208	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C31H28F4N6O/c32-25-10-9-23(30(38,12-11-19-7-8-19)22-5-1-3-20(13-22)17-36)15-26(25)39-29(42)27-16-28(31(33,34)35)40-41(27)24-6-2-4-21(14-24)18-37/h1-6,9-10,13-16,19H,7-8,11-12,18,37-38H2,(H,39,42)	ZBDDMFBNDOEVJT-UHFFFAOYSA-N	416996	(+)-N-(5-(1-amino-1-(3-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 214g::US10633345, Compound 215d::US10689346, Compound 215d::US11203574, Compound 215d::US11230530, Compound 215d::US11685721, Compound 215d	Plasma kallikrein			 1.3							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416996	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416996&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665709	433916908							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507209	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C31H28F4N6O/c32-25-10-9-23(30(38,12-11-19-7-8-19)22-5-1-3-20(13-22)17-36)15-26(25)39-29(42)27-16-28(31(33,34)35)40-41(27)24-6-2-4-21(14-24)18-37/h1-6,9-10,13-16,19H,7-8,11-12,18,37-38H2,(H,39,42)	ZBDDMFBNDOEVJT-UHFFFAOYSA-N	416996	(+)-N-(5-(1-amino-1-(3-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 214g::US10633345, Compound 215d::US10689346, Compound 215d::US11203574, Compound 215d::US11230530, Compound 215d::US11685721, Compound 215d	Plasma kallikrein			 1.30							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416996	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416996&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665709	433916908							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507210	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C(N)=O)C(F)(F)F	InChI=1S/C31H30F4N6O2/c32-24-10-9-22(30(38,12-11-18-7-8-18)21-5-2-4-20(14-21)28(37)42)15-25(24)39-29(43)26-16-27(31(33,34)35)40-41(26)23-6-1-3-19(13-23)17-36/h1-6,9-10,13-16,18H,7-8,11-12,17,36,38H2,(H2,37,42)(H,39,43)	DYGHBBDYRMOWAC-UHFFFAOYSA-N	417014	(+-)-N-(5-(1-amino-1-(3-carbamoylphenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 225a::US10633345, Compound 225a::US10689346, Compound 225a::US11203574, Compound 225a::US11230530, Compound 225a::US11685721, Compound 225a	Plasma kallikrein			 1.3							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417014	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417014&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665606	433916925							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507211	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(n1)C#N)C(F)(F)F	InChI=1S/C30H27F4N7O/c31-23-10-9-20(29(37,12-11-18-7-8-18)26-6-2-4-21(17-36)38-26)14-24(23)39-28(42)25-15-27(30(32,33)34)40-41(25)22-5-1-3-19(13-22)16-35/h1-6,9-10,13-15,18H,7-8,11-12,16,35,37H2,(H,39,42)	UYAYDZPBNCJYMZ-UHFFFAOYSA-N	417008	(+)-N-(5-(1-amino-1-(6-cyanopyridin-2-yl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 220f::US10633345, Compound 220f::US10689346, Compound 220f::US11203574, Compound 220f::US11230530, Compound 220f::US11685721, Compound 220f	Plasma kallikrein			 2.9							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417008	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417008&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355858	433916919							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507212	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C31H28F4N6O/c32-25-11-10-23(30(38,13-12-19-4-5-19)22-8-6-20(17-36)7-9-22)15-26(25)39-29(42)27-16-28(31(33,34)35)40-41(27)24-3-1-2-21(14-24)18-37/h1-3,6-11,14-16,19H,4-5,12-13,18,37-38H2,(H,39,42)	JCBKPNPCGNTAQN-UHFFFAOYSA-N	416993	(+)-N-(5-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 212g::US10633345, Compound 213d::US10689346, Compound 213d::US11203574, Compound 213d::US11230530, Compound 213d::US11685721, Compound 213d	Plasma kallikrein			 2.8							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416993	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416993&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356170	433916905							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507213	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C31H28F4N6O/c32-25-11-10-23(30(38,13-12-19-4-5-19)22-8-6-20(17-36)7-9-22)15-26(25)39-29(42)27-16-28(31(33,34)35)40-41(27)24-3-1-2-21(14-24)18-37/h1-3,6-11,14-16,19H,4-5,12-13,18,37-38H2,(H,39,42)	JCBKPNPCGNTAQN-UHFFFAOYSA-N	416993	(+)-N-(5-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 212g::US10633345, Compound 213d::US10689346, Compound 213d::US11203574, Compound 213d::US11230530, Compound 213d::US11685721, Compound 213d	Plasma kallikrein			 2.80							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416993	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416993&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356170	433916905							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507214	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C(N)=O)C(F)(F)F	InChI=1S/C31H30F4N6O2/c32-24-11-10-22(30(38,13-12-18-4-5-18)21-8-6-20(7-9-21)28(37)42)15-25(24)39-29(43)26-16-27(31(33,34)35)40-41(26)23-3-1-2-19(14-23)17-36/h1-3,6-11,14-16,18H,4-5,12-13,17,36,38H2,(H2,37,42)(H,39,43)	HZQICPCUMLWHPZ-UHFFFAOYSA-N	417023	(+)-N-(5-(1-amino-1-(4-carbamoylphenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 228a::US10633345, Compound 228a::US10689346, Compound 228a::US11203574, Compound 228a::US11230530, Compound 228a::US11685721, Compound 228a	Plasma kallikrein			 0.900000							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417023	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417023&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665484	433916933							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507215	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(nc1)C(N)=O)C(F)(F)F	InChI=1S/C30H29F4N7O2/c31-22-8-6-19(29(37,11-10-17-4-5-17)20-7-9-23(27(36)42)38-16-20)13-24(22)39-28(43)25-14-26(30(32,33)34)40-41(25)21-3-1-2-18(12-21)15-35/h1-3,6-9,12-14,16-17H,4-5,10-11,15,35,37H2,(H2,36,42)(H,39,43)	IQWHGFSUUIEJQU-UHFFFAOYSA-N	417021	(+)-5-(1-amino-1-(3-(1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamido)-4-fluorophenyl)-3-cyclopropylpropyl)picolinamide::US10329260, Compound 221i::US10633345, Compound 221i::US10689346, Compound 221i::US11203574, Compound 221i::US11230530, Compound 221i::US11685721, Compound 221i	Plasma kallikrein			 2.3							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417021	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417021&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665782	433916931							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507216	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H28F3N5O/c30-29(31,32)26-16-25(37(36-26)24-11-4-6-20(14-24)17-33)28(38)35-23-10-5-9-22(15-23)27(34-18-19-12-13-19)21-7-2-1-3-8-21/h1-11,14-16,19,27,34H,12-13,17-18,33H2,(H,35,38)	QZQLNMURVWFZTC-UHFFFAOYSA-N	439347	US10633345, Compound 41e::US10689346, Compound 41e::US11203574, Compound 41e::US11230530, Compound 41e	Plasma kallikrein			 19							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=439347	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=439347&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665751	439660905							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507217	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F4N5O/c30-23-12-11-21(27(35-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)36-28(39)25-15-26(29(31,32)33)37-38(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27,35H,9-10,16-17,34H2,(H,36,39)	MCLZOCFEIKBMBA-UHFFFAOYSA-N	416773	1-(3-(aminomethyl)phenyl)-N-(5-(((cyclopropylmethyl)amino)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 38d::US10633345, Compound 38d::US10689346, Compound 42a::US11203574, Compound 42a::US11230530, Compound 42a::US11685721, Compound 38d	Plasma kallikrein			 19							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416773	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416773&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356124	433916687							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507218	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H27F3N4O2/c30-29(31,32)26-16-25(36(35-26)24-11-4-6-20(14-24)17-33)28(37)34-23-10-5-9-22(15-23)27(38-18-19-12-13-19)21-7-2-1-3-8-21/h1-11,14-16,19,27H,12-13,17-18,33H2,(H,34,37)	PEZVPVUPSJXZCH-UHFFFAOYSA-N	416775	1-(3-(aminomethyl)phenyl)-N-(3-((cyclopropylmethoxy)(phenyl)methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 18k::US10633345, Compound 74a::US10689346, Compound 165e::US11203574, Compound 165e::US11230530, Compound 165e::US11685721, Compound 18k	Plasma kallikrein			 300							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416775	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416775&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			91884591	433916689							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507219	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(OCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C29H26F4N4O2/c30-23-12-11-21(27(39-17-18-9-10-18)20-6-2-1-3-7-20)14-24(23)35-28(38)25-15-26(29(31,32)33)36-37(25)22-8-4-5-19(13-22)16-34/h1-8,11-15,18,27H,9-10,16-17,34H2,(H,35,38)	HIMJVDQVZQMIPM-UHFFFAOYSA-N	416968	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-((cyclopropylmethoxy)(phenyl)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 37b	Plasma kallikrein			 287							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416968	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416968&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355729	433916880							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507220	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F3N4O/c31-30(32,33)28-18-27(37(36-28)25-11-4-6-21(16-25)19-34)29(38)35-24-10-5-9-23(17-24)26(15-14-20-12-13-20)22-7-2-1-3-8-22/h1-11,16-18,20,26H,12-15,19,34H2,(H,35,38)	LVGPKQXQIQRVCT-UHFFFAOYSA-N	416730	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-phenylpropyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 78d::US10633345, Compound 78d::US10689346, Compound 78d::US11203574, Compound 78d::US11230530, Compound 78d::US11685721, Compound 78d	Plasma kallikrein			 2030							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416730	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416730&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665672	433916644							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507221	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F3N4O2/c31-30(32,33)27-18-26(37(36-27)25-11-4-6-21(16-25)19-34)28(38)35-24-10-5-9-23(17-24)29(39,15-14-20-12-13-20)22-7-2-1-3-8-22/h1-11,16-18,20,39H,12-15,19,34H2,(H,35,38)	DCGYPXFSNPCKGX-UHFFFAOYSA-N	416946	(+-)-1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 46i	Plasma kallikrein			 191							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416946	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416946&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355790	433916858							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507222	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-17-24(37(36-26)23-8-3-5-20(15-23)18-33)27(38)35-22-7-4-6-21(16-22)28(39,13-12-19-10-11-19)25-9-1-2-14-34-25/h1-9,14-17,19,39H,10-13,18,33H2,(H,35,38)	BAOACYBKKSTHLE-UHFFFAOYSA-N	416767	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 45g::US10633345, Compound 45g::US10689346, Compound 45g::US11203574, Compound 45g::US11230530, Compound 45g::US11685721, Compound 45g	Plasma kallikrein			 104							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416767	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416767&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665639	433916681							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507223	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-16-25(37(36-26)24-8-1-4-20(14-24)17-33)27(38)35-23-7-2-5-21(15-23)28(39,12-11-19-9-10-19)22-6-3-13-34-18-22/h1-8,13-16,18-19,39H,9-12,17,33H2,(H,35,38)	AOCZEQQKIIWUBU-UHFFFAOYSA-N	416770	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 47f::US10633345, Compound 47f::US10689346, Compound 47f::US11203574, Compound 47g::US11230530, Compound 47h::US11685721, Compound 47f	Plasma kallikrein			 23							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416770	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416770&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355766	433916684							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507224	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-17-25(37(36-26)24-6-1-3-20(15-24)18-33)27(38)35-23-5-2-4-22(16-23)28(39,12-9-19-7-8-19)21-10-13-34-14-11-21/h1-6,10-11,13-17,19,39H,7-9,12,18,33H2,(H,35,38)	HEXYKZQZIBBLLM-UHFFFAOYSA-N	416774	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-(pyridin-4-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 92g::US10633345, Compound 92g::US10689346, Compound 92g::US11203574, Compound 92g::US11230530, Compound 92g::US11685721, Compound 92g	Plasma kallikrein			 17							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416774	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416774&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355890	433916688							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507225	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F3N4O2/c31-30(32,33)27-18-26(37(36-27)25-11-4-6-21(16-25)19-34)28(38)35-24-10-5-9-23(17-24)29(39,15-14-20-12-13-20)22-7-2-1-3-8-22/h1-11,16-18,20,39H,12-15,19,34H2,(H,35,38)	DCGYPXFSNPCKGX-UHFFFAOYSA-N	416946	(+-)-1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 46i	Plasma kallikrein			 191							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416946	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416946&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355790	433916858							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507226	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F3N4O2/c31-30(32,33)27-18-26(37(36-27)25-11-4-6-21(16-25)19-34)28(38)35-24-10-5-9-23(17-24)29(39,15-14-20-12-13-20)22-7-2-1-3-8-22/h1-11,16-18,20,39H,12-15,19,34H2,(H,35,38)	DCGYPXFSNPCKGX-UHFFFAOYSA-N	416946	(+-)-1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 46i	Plasma kallikrein			 56.0							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416946	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416946&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355790	433916858							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507227	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H28F4N4O2/c31-24-12-11-22(29(40,14-13-19-9-10-19)21-6-2-1-3-7-21)16-25(24)36-28(39)26-17-27(30(32,33)34)37-38(26)23-8-4-5-20(15-23)18-35/h1-8,11-12,15-17,19,40H,9-10,13-14,18,35H2,(H,36,39)	NIWMWYNGSALJGG-UHFFFAOYSA-N	416938	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 68d	Plasma kallikrein			 91							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416938	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416938&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355758	433916850							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507228	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H28F4N4O2/c31-24-12-11-22(29(40,14-13-19-9-10-19)21-6-2-1-3-7-21)16-25(24)36-28(39)26-17-27(30(32,33)34)37-38(26)23-8-4-5-20(15-23)18-35/h1-8,11-12,15-17,19,40H,9-10,13-14,18,35H2,(H,36,39)	NIWMWYNGSALJGG-UHFFFAOYSA-N	416938	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 68d	Plasma kallikrein			 91.0							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416938	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416938&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355758	433916850							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507229	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H28F4N4O2/c31-24-12-11-22(29(40,14-13-19-9-10-19)21-6-2-1-3-7-21)16-25(24)36-28(39)26-17-27(30(32,33)34)37-38(26)23-8-4-5-20(15-23)18-35/h1-8,11-12,15-17,19,40H,9-10,13-14,18,35H2,(H,36,39)	NIWMWYNGSALJGG-UHFFFAOYSA-N	416938	(+-)-1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-phenylpropyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 68d	Plasma kallikrein			 49.0							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416938	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416938&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355758	433916850							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507230	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-10-9-20(28(40,12-11-18-7-8-18)25-6-1-2-13-35-25)15-23(22)36-27(39)24-16-26(29(31,32)33)37-38(24)21-5-3-4-19(14-21)17-34/h1-6,9-10,13-16,18,40H,7-8,11-12,17,34H2,(H,36,39)	XXMBQXWQIGCREG-UHFFFAOYSA-N	416909	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 59c::US10633345, Compound 69b::US10689346, Compound 59c::US11203574, Compound 69b::US11230530, Compound 69b::US11685721, Compound 69b	Plasma kallikrein			 72							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416909	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416909&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356067	433916821							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507231	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-10-9-20(28(40,12-11-18-7-8-18)25-6-1-2-13-35-25)15-23(22)36-27(39)24-16-26(29(31,32)33)37-38(24)21-5-3-4-19(14-21)17-34/h1-6,9-10,13-16,18,40H,7-8,11-12,17,34H2,(H,36,39)	XXMBQXWQIGCREG-UHFFFAOYSA-N	416909	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 59c::US10633345, Compound 69b::US10689346, Compound 59c::US11203574, Compound 69b::US11230530, Compound 69b::US11685721, Compound 69b	Plasma kallikrein			 72.0							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416909	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416909&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356067	433916821							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507232	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-22-10-9-20(28(40,12-11-18-7-8-18)25-6-1-2-13-35-25)15-23(22)36-27(39)24-16-26(29(31,32)33)37-38(24)21-5-3-4-19(14-21)17-34/h1-6,9-10,13-16,18,40H,7-8,11-12,17,34H2,(H,36,39)	XXMBQXWQIGCREG-UHFFFAOYSA-N	416909	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 59c::US10633345, Compound 69b::US10689346, Compound 59c::US11203574, Compound 69b::US11230530, Compound 69b::US11685721, Compound 69b	Plasma kallikrein			 32.0							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416909	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416909&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356067	433916821							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507233	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-16-25(37(36-26)24-8-1-4-20(14-24)17-33)27(38)35-23-7-2-5-21(15-23)28(39,12-11-19-9-10-19)22-6-3-13-34-18-22/h1-8,13-16,18-19,39H,9-12,17,33H2,(H,35,38)	AOCZEQQKIIWUBU-UHFFFAOYSA-N	416770	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 47f::US10633345, Compound 47f::US10689346, Compound 47f::US11203574, Compound 47g::US11230530, Compound 47h::US11685721, Compound 47f	Plasma kallikrein			 23.0							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416770	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416770&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355766	433916684							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507234	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-16-25(37(36-26)24-8-1-4-20(14-24)17-33)27(38)35-23-7-2-5-21(15-23)28(39,12-11-19-9-10-19)22-6-3-13-34-18-22/h1-8,13-16,18-19,39H,9-12,17,33H2,(H,35,38)	AOCZEQQKIIWUBU-UHFFFAOYSA-N	416770	Racemic 1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 47f::US10633345, Compound 47f::US10689346, Compound 47f::US11203574, Compound 47g::US11230530, Compound 47h::US11685721, Compound 47f	Plasma kallikrein			 9.00							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416770	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416770&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355766	433916684							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507235	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-9-8-20(28(40,11-10-18-6-7-18)21-4-2-12-35-17-21)14-24(23)36-27(39)25-15-26(29(31,32)33)37-38(25)22-5-1-3-19(13-22)16-34/h1-5,8-9,12-15,17-18,40H,6-7,10-11,16,34H2,(H,36,39)	VCHFZCHUEHQXSZ-UHFFFAOYSA-N	416897	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 58c::US10633345, Compound 67b::US10689346, Compound 67b::US11203574, Compound 67b::US11230530, Compound 67b::US11685721, Compound 67b	Plasma kallikrein			 19							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416897	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416897&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355889	433916810							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507236	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-9-8-20(28(40,11-10-18-6-7-18)21-4-2-12-35-17-21)14-24(23)36-27(39)25-15-26(29(31,32)33)37-38(25)22-5-1-3-19(13-22)16-34/h1-5,8-9,12-15,17-18,40H,6-7,10-11,16,34H2,(H,36,39)	VCHFZCHUEHQXSZ-UHFFFAOYSA-N	416897	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 58c::US10633345, Compound 67b::US10689346, Compound 67b::US11203574, Compound 67b::US11230530, Compound 67b::US11685721, Compound 67b	Plasma kallikrein			 19.0							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416897	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416897&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355889	433916810							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507237	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-9-8-20(28(40,11-10-18-6-7-18)21-4-2-12-35-17-21)14-24(23)36-27(39)25-15-26(29(31,32)33)37-38(25)22-5-1-3-19(13-22)16-34/h1-5,8-9,12-15,17-18,40H,6-7,10-11,16,34H2,(H,36,39)	VCHFZCHUEHQXSZ-UHFFFAOYSA-N	416897	1-(3-(aminomethyl)phenyl)-N-(5-(3-cyclopropyl-1-hydroxy-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 58c::US10633345, Compound 67b::US10689346, Compound 67b::US11203574, Compound 67b::US11230530, Compound 67b::US11685721, Compound 67b	Plasma kallikrein			 9.00							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416897	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416897&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355889	433916810							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507238	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-17-25(37(36-26)24-6-1-3-20(15-24)18-33)27(38)35-23-5-2-4-22(16-23)28(39,12-9-19-7-8-19)21-10-13-34-14-11-21/h1-6,10-11,13-17,19,39H,7-9,12,18,33H2,(H,35,38)	HEXYKZQZIBBLLM-UHFFFAOYSA-N	416774	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-(pyridin-4-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 92g::US10633345, Compound 92g::US10689346, Compound 92g::US11203574, Compound 92g::US11230530, Compound 92g::US11685721, Compound 92g	Plasma kallikrein			 17.0							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416774	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416774&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355890	433916688							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507239	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cccc(c1)C(O)(CCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C29H28F3N5O2/c30-29(31,32)26-17-25(37(36-26)24-6-1-3-20(15-24)18-33)27(38)35-23-5-2-4-22(16-23)28(39,12-9-19-7-8-19)21-10-13-34-14-11-21/h1-6,10-11,13-17,19,39H,7-9,12,18,33H2,(H,35,38)	HEXYKZQZIBBLLM-UHFFFAOYSA-N	416774	1-(3-(aminomethyl)phenyl)-N-(3-(3-cyclopropyl-1-hydroxy-1-(pyridin-4-yl)propyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 92g::US10633345, Compound 92g::US10689346, Compound 92g::US11203574, Compound 92g::US11230530, Compound 92g::US11685721, Compound 92g	Plasma kallikrein			 7.60							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416774	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416774&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355890	433916688							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507240	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-7-6-21(28(40,11-8-18-4-5-18)20-9-12-35-13-10-20)15-24(23)36-27(39)25-16-26(29(31,32)33)37-38(25)22-3-1-2-19(14-22)17-34/h1-3,6-7,9-10,12-16,18,40H,4-5,8,11,17,34H2,(H,36,39)	BHLLHZZJYJWRRD-UHFFFAOYSA-N	50607250	CHEMBL5219146	Plasma kallikrein			 7.7							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50607250	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50607250&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168297994	482618101							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507241	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(O)(CCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C29H27F4N5O2/c30-23-7-6-21(28(40,11-8-18-4-5-18)20-9-12-35-13-10-20)15-24(23)36-27(39)25-16-26(29(31,32)33)37-38(25)22-3-1-2-19(14-22)17-34/h1-3,6-7,9-10,12-16,18,40H,4-5,8,11,17,34H2,(H,36,39)	BHLLHZZJYJWRRD-UHFFFAOYSA-N	50607250	CHEMBL5219146	Plasma kallikrein			 7.70							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50607250	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50607250&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			168297994	482618101							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507242	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F4N5O/c31-24-12-11-22(29(36,14-13-19-9-10-19)21-6-2-1-3-7-21)16-25(24)37-28(40)26-17-27(30(32,33)34)38-39(26)23-8-4-5-20(15-23)18-35/h1-8,11-12,15-17,19H,9-10,13-14,18,35-36H2,(H,37,40)	NQFNNZJJOCPZCP-UHFFFAOYSA-N	416987	(+-)-N-(5-(1-amino-3-cyclopropyl-1-phenylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 210d::US10633345, Compound 211d::US10689346, Compound 211d::US11203574, Compound 211d::US11230530, Compound 211d::US11685721, Compound 211d	Plasma kallikrein			 24							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416987	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416987&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355764	433916899							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507243	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccc1)C(F)(F)F	InChI=1S/C30H29F4N5O/c31-24-12-11-22(29(36,14-13-19-9-10-19)21-6-2-1-3-7-21)16-25(24)37-28(40)26-17-27(30(32,33)34)38-39(26)23-8-4-5-20(15-23)18-35/h1-8,11-12,15-17,19H,9-10,13-14,18,35-36H2,(H,37,40)	NQFNNZJJOCPZCP-UHFFFAOYSA-N	416987	(+-)-N-(5-(1-amino-3-cyclopropyl-1-phenylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 210d::US10633345, Compound 211d::US10689346, Compound 211d::US11203574, Compound 211d::US11230530, Compound 211d::US11685721, Compound 211d	Plasma kallikrein			 24.0							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416987	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416987&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355764	433916899							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507244	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-22-10-9-20(28(35,12-11-18-7-8-18)25-6-1-2-13-36-25)15-23(22)37-27(40)24-16-26(29(31,32)33)38-39(24)21-5-3-4-19(14-21)17-34/h1-6,9-10,13-16,18H,7-8,11-12,17,34-35H2,(H,37,40)	IFWBAIGKQKRJGJ-UHFFFAOYSA-N	416975	(+-)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 205d::US10633345, Compound 205c::US10689346, Compound 205e::US11203574, Compound 205e::US11230530, Compound 205e::US11685721, Compound 205f	Plasma kallikrein			 7.0							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416975	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416975&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665627	433916887							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507245	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccn1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-22-10-9-20(28(35,12-11-18-7-8-18)25-6-1-2-13-36-25)15-23(22)37-27(40)24-16-26(29(31,32)33)38-39(24)21-5-3-4-19(14-21)17-34/h1-6,9-10,13-16,18H,7-8,11-12,17,34-35H2,(H,37,40)	IFWBAIGKQKRJGJ-UHFFFAOYSA-N	416975	(+-)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-2-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 205d::US10633345, Compound 205c::US10689346, Compound 205e::US11203574, Compound 205e::US11230530, Compound 205e::US11685721, Compound 205f	Plasma kallikrein			 7.00							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416975	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416975&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665627	433916887							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507246	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-23-9-8-20(28(35,11-10-18-6-7-18)21-4-2-12-36-17-21)14-24(23)37-27(40)25-15-26(29(31,32)33)38-39(25)22-5-1-3-19(13-22)16-34/h1-5,8-9,12-15,17-18H,6-7,10-11,16,34-35H2,(H,37,40)	QXMQDWOYOXVOQZ-UHFFFAOYSA-N	416981	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 208d::US10633345, Compound 209d::US10689346, Compound 209d::US11203574, Compound 209d::US11230530, Compound 209d::US11685721, Compound 209d	Plasma kallikrein			 8.0							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416981	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416981&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355646	433916893							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507247	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccnc1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-23-9-8-20(28(35,11-10-18-6-7-18)21-4-2-12-36-17-21)14-24(23)37-27(40)25-15-26(29(31,32)33)38-39(25)22-5-1-3-19(13-22)16-34/h1-5,8-9,12-15,17-18H,6-7,10-11,16,34-35H2,(H,37,40)	QXMQDWOYOXVOQZ-UHFFFAOYSA-N	416981	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-3-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 208d::US10633345, Compound 209d::US10689346, Compound 209d::US11203574, Compound 209d::US11230530, Compound 209d::US11685721, Compound 209d	Plasma kallikrein			 8.00							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416981	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416981&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355646	433916893							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507248	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-23-7-6-21(28(35,11-8-18-4-5-18)20-9-12-36-13-10-20)15-24(23)37-27(40)25-16-26(29(31,32)33)38-39(25)22-3-1-2-19(14-22)17-34/h1-3,6-7,9-10,12-16,18H,4-5,8,11,17,34-35H2,(H,37,40)	AGVFYPDLNPHKER-UHFFFAOYSA-N	417024	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-4-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 216d::US10633345, Compound 217d::US10689346, Compound 217d::US11192861, Compound 217d::US11230530, Compound 217d::US11685721, Compound 217d	Plasma kallikrein			 3.0							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417024	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417024&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665723	433916934							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507249	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C29H28F4N6O/c30-23-7-6-21(28(35,11-8-18-4-5-18)20-9-12-36-13-10-20)15-24(23)37-27(40)25-16-26(29(31,32)33)38-39(25)22-3-1-2-19(14-22)17-34/h1-3,6-7,9-10,12-16,18H,4-5,8,11,17,34-35H2,(H,37,40)	AGVFYPDLNPHKER-UHFFFAOYSA-N	417024	(+)-N-(5-(1-amino-3-cyclopropyl-1-(pyridin-4-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 216d::US10633345, Compound 217d::US10689346, Compound 217d::US11192861, Compound 217d::US11230530, Compound 217d::US11685721, Compound 217d	Plasma kallikrein			 3.00							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417024	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417024&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665723	433916934							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507250	Cc1cc(ccn1)C(N)(CCC1CC1)c1ccc(F)c(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1	InChI=1S/C30H30F4N6O/c1-18-13-22(10-12-37-18)29(36,11-9-19-5-6-19)21-7-8-24(31)25(15-21)38-28(41)26-16-27(30(32,33)34)39-40(26)23-4-2-3-20(14-23)17-35/h2-4,7-8,10,12-16,19H,5-6,9,11,17,35-36H2,1H3,(H,38,41)	PYONXWOUVYIBRU-UHFFFAOYSA-N	417031	(+)-N-(5-(1-amino-3-cyclopropyl-1-(2-methylpyridin-4-yl)propyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 266j::US10633345, Compound 266j::US10689346, Compound 266j::US11203574, Compound 266j::US11230530, Compound 266j::US11685721, Compound 266j	Plasma kallikrein			 3.0							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417031	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417031&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665585	433916941							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507251	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C31H28F4N6O/c32-25-10-9-23(30(38,12-11-19-7-8-19)22-5-1-3-20(13-22)17-36)15-26(25)39-29(42)27-16-28(31(33,34)35)40-41(27)24-6-2-4-21(14-24)18-37/h1-6,9-10,13-16,19H,7-8,11-12,18,37-38H2,(H,39,42)	ZBDDMFBNDOEVJT-UHFFFAOYSA-N	416996	(+)-N-(5-(1-amino-1-(3-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 214g::US10633345, Compound 215d::US10689346, Compound 215d::US11203574, Compound 215d::US11230530, Compound 215d::US11685721, Compound 215d	Plasma kallikrein			 3.2							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416996	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416996&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665709	433916908							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507252	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C31H28F4N6O/c32-25-10-9-23(30(38,12-11-19-7-8-19)22-5-1-3-20(13-22)17-36)15-26(25)39-29(42)27-16-28(31(33,34)35)40-41(27)24-6-2-4-21(14-24)18-37/h1-6,9-10,13-16,19H,7-8,11-12,18,37-38H2,(H,39,42)	ZBDDMFBNDOEVJT-UHFFFAOYSA-N	416996	(+)-N-(5-(1-amino-1-(3-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 214g::US10633345, Compound 215d::US10689346, Compound 215d::US11203574, Compound 215d::US11230530, Compound 215d::US11685721, Compound 215d	Plasma kallikrein			 3.20							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416996	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416996&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665709	433916908							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507253	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C(N)=O)C(F)(F)F	InChI=1S/C31H30F4N6O2/c32-24-10-9-22(30(38,12-11-18-7-8-18)21-5-2-4-20(14-21)28(37)42)15-25(24)39-29(43)26-16-27(31(33,34)35)40-41(26)23-6-1-3-19(13-23)17-36/h1-6,9-10,13-16,18H,7-8,11-12,17,36,38H2,(H2,37,42)(H,39,43)	DYGHBBDYRMOWAC-UHFFFAOYSA-N	417014	(+-)-N-(5-(1-amino-1-(3-carbamoylphenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 225a::US10633345, Compound 225a::US10689346, Compound 225a::US11203574, Compound 225a::US11230530, Compound 225a::US11685721, Compound 225a	Plasma kallikrein			 6.0							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417014	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417014&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665606	433916925							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507254	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(n1)C#N)C(F)(F)F	InChI=1S/C30H27F4N7O/c31-23-10-9-20(29(37,12-11-18-7-8-18)26-6-2-4-21(17-36)38-26)14-24(23)39-28(42)25-15-27(30(32,33)34)40-41(25)22-5-1-3-19(13-22)16-35/h1-6,9-10,13-15,18H,7-8,11-12,16,35,37H2,(H,39,42)	UYAYDZPBNCJYMZ-UHFFFAOYSA-N	417008	(+)-N-(5-(1-amino-1-(6-cyanopyridin-2-yl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 220f::US10633345, Compound 220f::US10689346, Compound 220f::US11203574, Compound 220f::US11230530, Compound 220f::US11685721, Compound 220f	Plasma kallikrein			 12							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417008	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417008&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118355858	433916919							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507255	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C31H28F4N6O/c32-25-11-10-23(30(38,13-12-19-4-5-19)22-8-6-20(17-36)7-9-22)15-26(25)39-29(42)27-16-28(31(33,34)35)40-41(27)24-3-1-2-21(14-24)18-37/h1-3,6-11,14-16,19H,4-5,12-13,18,37-38H2,(H,39,42)	JCBKPNPCGNTAQN-UHFFFAOYSA-N	416993	(+)-N-(5-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 212g::US10633345, Compound 213d::US10689346, Compound 213d::US11203574, Compound 213d::US11230530, Compound 213d::US11685721, Compound 213d	Plasma kallikrein			 8.0							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416993	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416993&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356170	433916905							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507256	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C#N)C(F)(F)F	InChI=1S/C31H28F4N6O/c32-25-11-10-23(30(38,13-12-19-4-5-19)22-8-6-20(17-36)7-9-22)15-26(25)39-29(42)27-16-28(31(33,34)35)40-41(27)24-3-1-2-21(14-24)18-37/h1-3,6-11,14-16,19H,4-5,12-13,18,37-38H2,(H,39,42)	JCBKPNPCGNTAQN-UHFFFAOYSA-N	416993	(+)-N-(5-(1-amino-1-(4-cyanophenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 212g::US10633345, Compound 213d::US10689346, Compound 213d::US11203574, Compound 213d::US11230530, Compound 213d::US11685721, Compound 213d	Plasma kallikrein			 8.00							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416993	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416993&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			118356170	433916905							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507257	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(cc1)C(N)=O)C(F)(F)F	InChI=1S/C31H30F4N6O2/c32-24-11-10-22(30(38,13-12-18-4-5-18)21-8-6-20(7-9-21)28(37)42)15-25(24)39-29(43)26-16-27(31(33,34)35)40-41(26)23-3-1-2-19(14-23)17-36/h1-3,6-11,14-16,18H,4-5,12-13,17,36,38H2,(H2,37,42)(H,39,43)	HZQICPCUMLWHPZ-UHFFFAOYSA-N	417023	(+)-N-(5-(1-amino-1-(4-carbamoylphenyl)-3-cyclopropylpropyl)-2-fluorophenyl)-1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide::US10329260, Compound 228a::US10633345, Compound 228a::US10689346, Compound 228a::US11203574, Compound 228a::US11230530, Compound 228a::US11685721, Compound 228a	Plasma kallikrein			 3.8							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417023	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417023&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665484	433916933							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51507258	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccc(nc1)C(N)=O)C(F)(F)F	InChI=1S/C30H29F4N7O2/c31-22-8-6-19(29(37,11-10-17-4-5-17)20-7-9-23(27(36)42)38-16-20)13-24(22)39-28(43)25-14-26(30(32,33)34)40-41(25)21-3-1-2-18(12-21)15-35/h1-3,6-9,12-14,16-17H,4-5,10-11,15,35,37H2,(H2,36,42)(H,39,43)	IQWHGFSUUIEJQU-UHFFFAOYSA-N	417021	(+)-5-(1-amino-1-(3-(1-(3-(aminomethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamido)-4-fluorophenyl)-3-cyclopropylpropyl)picolinamide::US10329260, Compound 221i::US10633345, Compound 221i::US10689346, Compound 221i::US11203574, Compound 221i::US11230530, Compound 221i::US11685721, Compound 221i	Plasma kallikrein			 1.7							ChEMBL		10.7270/Q2FB572S	36208543			Zhang, W; Vadlakonda, S; Wu, M; Chintareddy, V; Vogeti, LN; Juarez, L; Muppa, S; Parker, C; Kellogg-Yelder, D; Williams, J; Polach, K; Chen, X; Raman, K; Babu, YS; Kotian, P	BioCryst Pharmaceuticals Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=417021	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=417021&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			126665782	433916931							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51494882	NCc1cccc(c1)-n1nc(cc1C(=O)Nc1cc(ccc1F)[C@H](NCC1CC1)c1cccc(c1)C#N)C(F)(F)F	InChI=1S/C30H26F4N6O/c31-24-10-9-22(28(37-17-18-7-8-18)21-5-1-3-19(11-21)15-35)13-25(24)38-29(41)26-14-27(30(32,33)34)39-40(26)23-6-2-4-20(12-23)16-36/h1-6,9-14,18,28,37H,7-8,16-17,36H2,(H,38,41)/t28-/m1/s1	UXNXMBYCBRBRFD-MUUNZHRXSA-N	50602174	CHEMBL5189739	Plasma kallikrein			 1.000000							ChEMBL		10.7270/Q2PC36F2	36439976			Li, G; Cheng, Y; Han, C; Song, C; Huang, N; Du, Y	Tianjin University	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50602174	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50602174&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137528262	482613025							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51514400	CC[C@H](C)[C@@H]1NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CSSC[C@@H]2NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]3CCCN3C(=O)[C@@H]3CSSC[C@H](NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CSSC[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC1=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N3)NC(=O)[C@@H](NC2=O)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CO)C(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CNC(=O)CN	InChI=1S/C134H217N49O40S6/c1-8-66(5)103-126(219)173-79(45-65(3)4)115(208)167-74(25-13-15-37-135)110(203)165-75(26-14-16-38-136)113(206)178-88-60-225-227-62-90-122(215)164-72(27-17-39-149-130(139)140)106(199)155-54-99(192)162-82(48-94(138)187)107(200)156-55-98(191)161-80(47-70-33-35-71(186)36-34-70)116(209)176-87(108(201)157-56-100(193)163-86(58-185)129(222)223)59-224-229-64-92(180-119(212)84(50-102(196)197)172-120(213)85(57-184)174-118(211)83(49-101(194)195)171-112(205)77(30-20-42-152-133(145)146)166-111(204)76(169-121(88)214)29-19-41-151-132(143)144)128(221)183-44-22-32-93(183)125(218)158-53-96(189)159-68(7)105(198)175-91(124(217)182-104(67(6)9-2)127(220)179-90)63-228-226-61-89(177-109(202)73(28-18-40-150-131(141)142)160-97(190)52-154-95(188)51-137)123(216)170-81(46-69-23-11-10-12-24-69)117(210)168-78(114(207)181-103)31-21-43-153-134(147)148/h10-12,23-24,33-36,65-68,72-93,103-104,184-186H,8-9,13-22,25-32,37-64,135-137H2,1-7H3,(H2,138,187)(H,154,188)(H,155,199)(H,156,200)(H,157,201)(H,158,218)(H,159,189)(H,160,190)(H,161,191)(H,162,192)(H,163,193)(H,164,215)(H,165,203)(H,166,204)(H,167,208)(H,168,210)(H,169,214)(H,170,216)(H,171,205)(H,172,213)(H,173,219)(H,174,211)(H,175,198)(H,176,209)(H,177,202)(H,178,206)(H,179,220)(H,180,212)(H,181,207)(H,182,217)(H,194,195)(H,196,197)(H,222,223)(H4,139,140,149)(H4,141,142,150)(H4,143,144,151)(H4,145,146,152)(H4,147,148,153)/t66-,67-,68-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,87-,88+,89-,90-,91-,92-,93-,103-,104-/m0/s1	JANHCNHLQNQZQS-WZMYVTDBSA-N	50609474	CHEMBL5288174	Plasma kallikrein			>5000							ChEMBL		10.7270/Q2K35ZW2	36383928			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50609474	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50609474&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171349331	494499222							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51514401	CC[C@H](C)[C@@H]1NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CSSC[C@@H]2NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]3CCCN3C(=O)[C@@H]3CSSC[C@H](NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CSSC[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CNC1=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N3)NC(=O)[C@@H](NC2=O)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CO)C(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CNC(=O)CN	InChI=1S/C130H209N49O40S6/c1-6-63(3)100-122(215)155-54-94(187)157-70(23-11-13-35-131)106(199)163-72(24-12-14-36-132)110(203)174-84-58-221-223-60-86-118(211)162-69(25-15-37-145-126(135)136)103(196)151-51-96(189)160-78(45-90(134)183)104(197)152-52-95(188)159-76(44-67-31-33-68(182)34-32-67)112(205)172-83(105(198)153-53-97(190)161-82(56-181)125(218)219)57-220-225-62-88(176-115(208)80(47-99(193)194)169-116(209)81(55-180)170-114(207)79(46-98(191)192)168-109(202)74(28-18-40-148-129(141)142)164-108(201)73(166-117(84)210)27-17-39-147-128(139)140)124(217)179-42-20-30-89(179)121(214)154-50-92(185)156-65(5)102(195)171-87(120(213)178-101(64(4)7-2)123(216)175-86)61-224-222-59-85(173-107(200)71(26-16-38-146-127(137)138)158-93(186)49-150-91(184)48-133)119(212)167-77(43-66-21-9-8-10-22-66)113(206)165-75(111(204)177-100)29-19-41-149-130(143)144/h8-10,21-22,31-34,63-65,69-89,100-101,180-182H,6-7,11-20,23-30,35-62,131-133H2,1-5H3,(H2,134,183)(H,150,184)(H,151,196)(H,152,197)(H,153,198)(H,154,214)(H,155,215)(H,156,185)(H,157,187)(H,158,186)(H,159,188)(H,160,189)(H,161,190)(H,162,211)(H,163,199)(H,164,201)(H,165,206)(H,166,210)(H,167,212)(H,168,202)(H,169,209)(H,170,207)(H,171,195)(H,172,205)(H,173,200)(H,174,203)(H,175,216)(H,176,208)(H,177,204)(H,178,213)(H,191,192)(H,193,194)(H,218,219)(H4,135,136,145)(H4,137,138,146)(H4,139,140,147)(H4,141,142,148)(H4,143,144,149)/t63-,64-,65-,69-,70-,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84+,85-,86-,87-,88-,89-,100-,101-/m0/s1	LONNDNYWMXEIQJ-PHIYFGQBSA-N	50609475	CHEMBL5272637	Plasma kallikrein			>5000							ChEMBL		10.7270/Q2K35ZW2	36383928			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50609475	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50609475&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171347613	494499223							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1369675	COc1cn(C(C(C)CCCN)C(=O)Nc2ccn3ncc(C(N)=O)c3c2)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C28H28ClN7O4/c1-16(4-3-8-30)26(28(39)34-19-7-9-36-23(11-19)22(14-33-36)27(32)38)35-15-24(40-2)21(12-25(35)37)20-10-18(29)6-5-17(20)13-31/h5-7,9-12,14-16,26H,3-4,8,30H2,1-2H3,(H2,32,38)(H,34,39)	DMZIQKQZJWOEOD-UHFFFAOYSA-N	648221	5-({6-Amino-2-[4-(5-chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-3-methyl-hexanoyl}amino)pyrazolo[1,5-a]pyridine-3-carboxamidetrifluoroacetate (Racemic Mixture of Diastereomers)::US11884660, Example 1	Plasma kallikrein			 5.60							US Patent		10.7270/Q20869H3			US11884660	Lobell, M; Schirok, H; Tersteegen, A	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=648221	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=648221&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			146180455	490945191							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1369676	COc1cn([C@@H](C(C)CCCN)C(=O)Nc2ccn3ncc(C(N)=O)c3c2)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C28H28ClN7O4/c1-16(4-3-8-30)26(28(39)34-19-7-9-36-23(11-19)22(14-33-36)27(32)38)35-15-24(40-2)21(12-25(35)37)20-10-18(29)6-5-17(20)13-31/h5-7,9-12,14-16,26H,3-4,8,30H2,1-2H3,(H2,32,38)(H,34,39)/t16?,26-/m0/s1	DMZIQKQZJWOEOD-TZHIXCAUSA-N	648222	5-({(2S)-6-Amino-2-[4-(5-chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-3-methylhexanoyl}amino)pyrazolo[1,5-a]pyridine-3-carboxamide trifluoroacetate (Stereoisomer 3)::US11884660, Example 2::US11884660, Example 3	Plasma kallikrein			 1.80							US Patent		10.7270/Q20869H3			US11884660	Lobell, M; Schirok, H; Tersteegen, A	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=648222	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=648222&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			146180457	490945192							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1369677	COc1cn([C@@H](C(C)CCCN)C(=O)Nc2ccn3ncc(C(N)=O)c3c2)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C28H28ClN7O4/c1-16(4-3-8-30)26(28(39)34-19-7-9-36-23(11-19)22(14-33-36)27(32)38)35-15-24(40-2)21(12-25(35)37)20-10-18(29)6-5-17(20)13-31/h5-7,9-12,14-16,26H,3-4,8,30H2,1-2H3,(H2,32,38)(H,34,39)/t16?,26-/m0/s1	DMZIQKQZJWOEOD-TZHIXCAUSA-N	648222	5-({(2S)-6-Amino-2-[4-(5-chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]-3-methylhexanoyl}amino)pyrazolo[1,5-a]pyridine-3-carboxamide trifluoroacetate (Stereoisomer 3)::US11884660, Example 2::US11884660, Example 3	Plasma kallikrein			 2.10							US Patent		10.7270/Q20869H3			US11884660	Lobell, M; Schirok, H; Tersteegen, A	Bayer Pharma Aktiengesellschaft	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=648222	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=648222&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			146180457	490945192							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50993101	O=C(NCCN1CCN(Cc2ccccc2)CC1)c1ccccc1	InChI=1S/C20H25N3O/c24-20(19-9-5-2-6-10-19)21-11-12-22-13-15-23(16-14-22)17-18-7-3-1-4-8-18/h1-10H,11-17H2,(H,21,24)	LRJYSUQXFXGBMT-UHFFFAOYSA-N	50406171	CHEMBL5283110	Plasma kallikrein			 19							ChEMBL		10.7270/Q2183BRT	36793429			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50406171	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50406171&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			14762573	163355195		CHEMBL101927				ZINC26746266	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50993102	CCOc1ccc(C[C@@H](NC(=O)Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCN=C(N)N)C(N)=O)cc1	InChI=1S/C54H77N13O10/c1-4-77-37-24-22-36(23-25-37)30-40(61-45(69)31-35-17-9-6-10-18-35)48(71)64-41(29-34-15-7-5-8-16-34)50(73)66-46(33(2)3)52(75)65-42(32-44(56)68)49(72)63-39(19-11-12-26-55)53(76)67-28-14-21-43(67)51(74)62-38(47(57)70)20-13-27-60-54(58)59/h5-10,15-18,22-25,33,38-43,46H,4,11-14,19-21,26-32,55H2,1-3H3,(H2,56,68)(H2,57,70)(H,61,69)(H,62,74)(H,63,72)(H,64,71)(H,65,75)(H,66,73)(H4,58,59,60)/t38-,39-,40+,41-,42-,43+,46-/m0/s1	FALCSTYLQGBSFB-KMRGNHMASA-N	50406172	CHEMBL5290426	Plasma kallikrein			 1.2							ChEMBL		10.7270/Q2183BRT	36793429			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50406172	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50406172&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			44335051	163355196		CHEMBL2373516					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50993103	CCOc1ccc(C[C@@H](NC(=O)Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O)cc1	InChI=1S/C58H84N16O11/c1-4-85-39-25-23-38(24-26-39)32-42(68-47(76)33-37-17-9-6-10-18-37)53(81)71-43(31-36-15-7-5-8-16-36)54(82)73-49(35(2)3)56(84)72-44(34-46(59)75)51(79)65-27-13-22-48(77)74-30-14-21-45(74)55(83)70-41(20-12-29-67-58(63)64)52(80)69-40(50(60)78)19-11-28-66-57(61)62/h5-10,15-18,23-26,35,40-45,49H,4,11-14,19-22,27-34H2,1-3H3,(H2,59,75)(H2,60,78)(H,65,79)(H,68,76)(H,69,80)(H,70,83)(H,71,81)(H,72,84)(H,73,82)(H4,61,62,66)(H4,63,64,67)/t40-,41-,42+,43-,44-,45+,49-/m0/s1	LYFCQFCFMNYSKF-MNAHPMOWSA-N	50406173	CHEMBL5270511	Plasma kallikrein			 2.5							ChEMBL		10.7270/Q2183BRT	36793429			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50406173	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50406173&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			44335330	163355197		CHEMBL410838					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50993104	CCOc1ccc(C[C@@H](NC(=O)CC(C)(C)C)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N(C)[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O)cc1	InChI=1S/C51H81N15O10/c1-9-76-33-21-19-32(20-22-33)26-36(60-40(68)28-51(5,6)7)44(71)63-37(25-31-15-11-10-12-16-31)46(73)65-41(29(2)3)47(74)64-38(27-39(52)67)45(72)62-35(18-14-24-59-50(56)57)48(75)66(8)30(4)43(70)61-34(42(53)69)17-13-23-58-49(54)55/h10-12,15-16,19-22,29-30,34-38,41H,9,13-14,17-18,23-28H2,1-8H3,(H2,52,67)(H2,53,69)(H,60,68)(H,61,70)(H,62,72)(H,63,71)(H,64,74)(H,65,73)(H4,54,55,58)(H4,56,57,59)/t30-,34-,35-,36+,37-,38-,41-/m0/s1	FVGXLFBTFMMMAF-LJHFUDNJSA-N	50406174	CHEMBL5274983	Plasma kallikrein			 1.6							ChEMBL		10.7270/Q2183BRT	36793429			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50406174	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50406174&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			14730755	163355198		CHEMBL269251					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50993105	CCOc1ccc(C[C@H]2NC(=O)CC3(CCCCC3)SSC[C@@H](NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](Cc3ccccc3)NC2=O)C(C)C)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(N)=O)cc1	InChI=1S/C53H77N13O11S2/c1-4-77-34-19-17-33(18-20-34)26-36-46(71)62-37(25-32-13-7-5-8-14-32)48(73)65-44(31(2)3)50(75)63-38(27-41(54)67)47(72)64-39(30-78-79-53(28-43(69)60-36)21-9-6-10-22-53)51(76)66-24-12-16-40(66)49(74)61-35(15-11-23-58-52(56)57)45(70)59-29-42(55)68/h5,7-8,13-14,17-20,31,35-40,44H,4,6,9-12,15-16,21-30H2,1-3H3,(H2,54,67)(H2,55,68)(H,59,70)(H,60,69)(H,61,74)(H,62,71)(H,63,75)(H,64,72)(H,65,73)(H4,56,57,58)/t35-,36+,37+,38+,39+,40-,44-/m0/s1	SDFJYGJKEXYVCG-RNGNQRBOSA-N	50406177	CHEMBL5285047	Plasma kallikrein			 0.600000							ChEMBL		10.7270/Q2183BRT	36793429			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50406177	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50406177&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			44335358	163355201		CHEMBL406184					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50993131	CCOc1ccc(C[C@@H](NC(=O)CC23C[C@H]4C[C@H](C[C@H](C4)C2)C3)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O)cc1	InChI=1S/C62H94N16O11/c1-4-89-42-20-18-38(19-21-42)30-45(72-50(80)35-62-32-39-26-40(33-62)28-41(27-39)34-62)56(85)75-46(29-37-12-6-5-7-13-37)57(86)77-52(36(2)3)59(88)76-47(31-49(63)79)54(83)69-22-10-17-51(81)78-25-11-16-48(78)58(87)74-44(15-9-24-71-61(67)68)55(84)73-43(53(64)82)14-8-23-70-60(65)66/h5-7,12-13,18-21,36,39-41,43-48,52H,4,8-11,14-17,22-35H2,1-3H3,(H2,63,79)(H2,64,82)(H,69,83)(H,72,80)(H,73,84)(H,74,87)(H,75,85)(H,76,88)(H,77,86)(H4,65,66,70)(H4,67,68,71)/t39-,40+,41-,43-,44-,45+,46-,47-,48+,52-,62?/m0/s1	SKWPFZDNAAJPMH-DAHZNBDNSA-N	50406178	CHEMBL5267934	Plasma kallikrein			 1.3							ChEMBL		10.7270/Q2183BRT	36793429			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50406178	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50406178&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			44335231	163355202		CHEMBL408038					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50993132	CCOc1ccc(C[C@@H](NC(=O)CC(C)(C)C)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O)cc1	InChI=1S/C56H88N16O11/c1-7-83-36-23-21-35(22-24-36)30-39(66-44(74)32-56(4,5)6)50(79)69-40(29-34-15-9-8-10-16-34)51(80)71-46(33(2)3)53(82)70-41(31-43(57)73)48(77)63-25-13-20-45(75)72-28-14-19-42(72)52(81)68-38(18-12-27-65-55(61)62)49(78)67-37(47(58)76)17-11-26-64-54(59)60/h8-10,15-16,21-24,33,37-42,46H,7,11-14,17-20,25-32H2,1-6H3,(H2,57,73)(H2,58,76)(H,63,77)(H,66,74)(H,67,78)(H,68,81)(H,69,79)(H,70,82)(H,71,80)(H4,59,60,64)(H4,61,62,65)/t37-,38-,39+,40-,41-,42+,46-/m0/s1	YFUFEYOOOAXDMX-PTZPFOTQSA-N	50406180	CHEMBL5276780	Plasma kallikrein			 0.500000							ChEMBL		10.7270/Q2183BRT	36793429			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50406180	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50406180&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			44335436	163355204		CHEMBL267111					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50993133	CCOc1ccc(C[C@@H](NC(=O)CC23C[C@H]4C[C@H](C[C@H](C4)C2)C3)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCNC(N)=N)C(N)=O)cc1	InChI=1S/C56H82N12O10/c1-4-78-39-18-16-35(17-19-39)27-41(63-46(70)32-56-29-36-23-37(30-56)25-38(24-36)31-56)51(74)65-42(26-34-11-6-5-7-12-34)52(75)67-48(33(2)3)54(77)66-43(28-45(57)69)50(73)61-20-9-15-47(71)68-22-10-14-44(68)53(76)64-40(49(58)72)13-8-21-62-55(59)60/h5-7,11-12,16-19,33,36-38,40-44,48H,4,8-10,13-15,20-32H2,1-3H3,(H2,57,69)(H2,58,72)(H,61,73)(H,63,70)(H,64,76)(H,65,74)(H,66,77)(H,67,75)(H4,59,60,62)/t36-,37+,38-,40-,41+,42-,43-,44+,48-,56?/m0/s1	GGHXHACFKDZBIY-ZKPFMCOWSA-N	50406182	CHEMBL5268598	Plasma kallikrein			 44							ChEMBL		10.7270/Q2183BRT	36793429			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50406182	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50406182&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			44335434	163355206		CHEMBL411320					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50993134	COc1ccc2[nH]c(cc2c1)S(N)(=O)=O	InChI=1S/C9H10N2O3S/c1-14-7-2-3-8-6(4-7)5-9(11-8)15(10,12)13/h2-5,11H,1H3,(H2,10,12,13)	ZRYYCTSRCVQELV-UHFFFAOYSA-N	50406322	CHEMBL5267385	Plasma kallikrein			 1.7							ChEMBL		10.7270/Q2183BRT	36793429			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50406322	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50406322&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			14476489	163355346		CHEMBL165362				ZINC27868487	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50993135	COc1ccc2cc([nH]c2c1)S(N)(=O)=O	InChI=1S/C9H10N2O3S/c1-14-7-3-2-6-4-9(15(10,12)13)11-8(6)5-7/h2-5,11H,1H3,(H2,10,12,13)	WGJXVQVMOKCESQ-UHFFFAOYSA-N	50406323	CHEMBL5273808	Plasma kallikrein			 27							ChEMBL		10.7270/Q2183BRT	36793429			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50406323	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50406323&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			14476490	163355347		CHEMBL165245				ZINC27868484	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50993155	O=C(NCCN1CCN(Cc2ccccc2)CC1)c1ccccc1	InChI=1S/C20H25N3O/c24-20(19-9-5-2-6-10-19)21-11-12-22-13-15-23(16-14-22)17-18-7-3-1-4-8-18/h1-10H,11-17H2,(H,21,24)	LRJYSUQXFXGBMT-UHFFFAOYSA-N	50406171	CHEMBL5283110	Plasma kallikrein			 10000							ChEMBL		10.7270/Q2183BRT	36793429			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50406171	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50406171&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			14762573	163355195		CHEMBL101927				ZINC26746266	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50993158	CCOc1ccc(C[C@@H](NC(=O)Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCN=C(N)N)C(N)=O)cc1	InChI=1S/C54H77N13O10/c1-4-77-37-24-22-36(23-25-37)30-40(61-45(69)31-35-17-9-6-10-18-35)48(71)64-41(29-34-15-7-5-8-16-34)50(73)66-46(33(2)3)52(75)65-42(32-44(56)68)49(72)63-39(19-11-12-26-55)53(76)67-28-14-21-43(67)51(74)62-38(47(57)70)20-13-27-60-54(58)59/h5-10,15-18,22-25,33,38-43,46H,4,11-14,19-21,26-32,55H2,1-3H3,(H2,56,68)(H2,57,70)(H,61,69)(H,62,74)(H,63,72)(H,64,71)(H,65,75)(H,66,73)(H4,58,59,60)/t38-,39-,40+,41-,42-,43+,46-/m0/s1	FALCSTYLQGBSFB-KMRGNHMASA-N	50406172	CHEMBL5290426	Plasma kallikrein			 7439							ChEMBL		10.7270/Q2183BRT	36793429			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50406172	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50406172&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			44335051	163355196		CHEMBL2373516					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50993159	CCOc1ccc(C[C@@H](NC(=O)Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O)cc1	InChI=1S/C58H84N16O11/c1-4-85-39-25-23-38(24-26-39)32-42(68-47(76)33-37-17-9-6-10-18-37)53(81)71-43(31-36-15-7-5-8-16-36)54(82)73-49(35(2)3)56(84)72-44(34-46(59)75)51(79)65-27-13-22-48(77)74-30-14-21-45(74)55(83)70-41(20-12-29-67-58(63)64)52(80)69-40(50(60)78)19-11-28-66-57(61)62/h5-10,15-18,23-26,35,40-45,49H,4,11-14,19-22,27-34H2,1-3H3,(H2,59,75)(H2,60,78)(H,65,79)(H,68,76)(H,69,80)(H,70,83)(H,71,81)(H,72,84)(H,73,82)(H4,61,62,66)(H4,63,64,67)/t40-,41-,42+,43-,44-,45+,49-/m0/s1	LYFCQFCFMNYSKF-MNAHPMOWSA-N	50406173	CHEMBL5270511	Plasma kallikrein			 10000							ChEMBL		10.7270/Q2183BRT	36793429			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50406173	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50406173&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			44335330	163355197		CHEMBL410838					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50993160	CCOc1ccc(C[C@@H](NC(=O)CC(C)(C)C)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N(C)[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O)cc1	InChI=1S/C51H81N15O10/c1-9-76-33-21-19-32(20-22-33)26-36(60-40(68)28-51(5,6)7)44(71)63-37(25-31-15-11-10-12-16-31)46(73)65-41(29(2)3)47(74)64-38(27-39(52)67)45(72)62-35(18-14-24-59-50(56)57)48(75)66(8)30(4)43(70)61-34(42(53)69)17-13-23-58-49(54)55/h10-12,15-16,19-22,29-30,34-38,41H,9,13-14,17-18,23-28H2,1-8H3,(H2,52,67)(H2,53,69)(H,60,68)(H,61,70)(H,62,72)(H,63,71)(H,64,74)(H,65,73)(H4,54,55,58)(H4,56,57,59)/t30-,34-,35-,36+,37-,38-,41-/m0/s1	FVGXLFBTFMMMAF-LJHFUDNJSA-N	50406174	CHEMBL5274983	Plasma kallikrein			 10000							ChEMBL		10.7270/Q2183BRT	36793429			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50406174	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50406174&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			14730755	163355198		CHEMBL269251					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50993164	CCOc1ccc(C[C@H]2NC(=O)CC3(CCCCC3)SSC[C@@H](NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](Cc3ccccc3)NC2=O)C(C)C)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(N)=O)cc1	InChI=1S/C53H77N13O11S2/c1-4-77-34-19-17-33(18-20-34)26-36-46(71)62-37(25-32-13-7-5-8-14-32)48(73)65-44(31(2)3)50(75)63-38(27-41(54)67)47(72)64-39(30-78-79-53(28-43(69)60-36)21-9-6-10-22-53)51(76)66-24-12-16-40(66)49(74)61-35(15-11-23-58-52(56)57)45(70)59-29-42(55)68/h5,7-8,13-14,17-20,31,35-40,44H,4,6,9-12,15-16,21-30H2,1-3H3,(H2,54,67)(H2,55,68)(H,59,70)(H,60,69)(H,61,74)(H,62,71)(H,63,75)(H,64,72)(H,65,73)(H4,56,57,58)/t35-,36+,37+,38+,39+,40-,44-/m0/s1	SDFJYGJKEXYVCG-RNGNQRBOSA-N	50406177	CHEMBL5285047	Plasma kallikrein			 10000							ChEMBL		10.7270/Q2183BRT	36793429			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50406177	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50406177&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			44335358	163355201		CHEMBL406184					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50993169	CCOc1ccc(C[C@@H](NC(=O)CC23C[C@H]4C[C@H](C[C@H](C4)C2)C3)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O)cc1	InChI=1S/C62H94N16O11/c1-4-89-42-20-18-38(19-21-42)30-45(72-50(80)35-62-32-39-26-40(33-62)28-41(27-39)34-62)56(85)75-46(29-37-12-6-5-7-13-37)57(86)77-52(36(2)3)59(88)76-47(31-49(63)79)54(83)69-22-10-17-51(81)78-25-11-16-48(78)58(87)74-44(15-9-24-71-61(67)68)55(84)73-43(53(64)82)14-8-23-70-60(65)66/h5-7,12-13,18-21,36,39-41,43-48,52H,4,8-11,14-17,22-35H2,1-3H3,(H2,63,79)(H2,64,82)(H,69,83)(H,72,80)(H,73,84)(H,74,87)(H,75,85)(H,76,88)(H,77,86)(H4,65,66,70)(H4,67,68,71)/t39-,40+,41-,43-,44-,45+,46-,47-,48+,52-,62?/m0/s1	SKWPFZDNAAJPMH-DAHZNBDNSA-N	50406178	CHEMBL5267934	Plasma kallikrein			 10000							ChEMBL		10.7270/Q2183BRT	36793429			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50406178	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50406178&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			44335231	163355202		CHEMBL408038					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50993174	CCOc1ccc(C[C@@H](NC(=O)CC(C)(C)C)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O)cc1	InChI=1S/C56H88N16O11/c1-7-83-36-23-21-35(22-24-36)30-39(66-44(74)32-56(4,5)6)50(79)69-40(29-34-15-9-8-10-16-34)51(80)71-46(33(2)3)53(82)70-41(31-43(57)73)48(77)63-25-13-20-45(75)72-28-14-19-42(72)52(81)68-38(18-12-27-65-55(61)62)49(78)67-37(47(58)76)17-11-26-64-54(59)60/h8-10,15-16,21-24,33,37-42,46H,7,11-14,17-20,25-32H2,1-6H3,(H2,57,73)(H2,58,76)(H,63,77)(H,66,74)(H,67,78)(H,68,81)(H,69,79)(H,70,82)(H,71,80)(H4,59,60,64)(H4,61,62,65)/t37-,38-,39+,40-,41-,42+,46-/m0/s1	YFUFEYOOOAXDMX-PTZPFOTQSA-N	50406180	CHEMBL5276780	Plasma kallikrein			 10000							ChEMBL		10.7270/Q2183BRT	36793429			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50406180	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50406180&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			44335436	163355204		CHEMBL267111					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50993175	CCOc1ccc(C[C@@H](NC(=O)CC23C[C@H]4C[C@H](C[C@H](C4)C2)C3)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCNC(N)=N)C(N)=O)cc1	InChI=1S/C56H82N12O10/c1-4-78-39-18-16-35(17-19-39)27-41(63-46(70)32-56-29-36-23-37(30-56)25-38(24-36)31-56)51(74)65-42(26-34-11-6-5-7-12-34)52(75)67-48(33(2)3)54(77)66-43(28-45(57)69)50(73)61-20-9-15-47(71)68-22-10-14-44(68)53(76)64-40(49(58)72)13-8-21-62-55(59)60/h5-7,11-12,16-19,33,36-38,40-44,48H,4,8-10,13-15,20-32H2,1-3H3,(H2,57,69)(H2,58,72)(H,61,73)(H,63,70)(H,64,76)(H,65,74)(H,66,77)(H,67,75)(H4,59,60,62)/t36-,37+,38-,40-,41+,42-,43-,44+,48-,56?/m0/s1	GGHXHACFKDZBIY-ZKPFMCOWSA-N	50406182	CHEMBL5268598	Plasma kallikrein			 10000							ChEMBL		10.7270/Q2183BRT	36793429			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50406182	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50406182&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			44335434	163355206		CHEMBL411320					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50993176	COc1ccc2[nH]c(cc2c1)S(N)(=O)=O	InChI=1S/C9H10N2O3S/c1-14-7-2-3-8-6(4-7)5-9(11-8)15(10,12)13/h2-5,11H,1H3,(H2,10,12,13)	ZRYYCTSRCVQELV-UHFFFAOYSA-N	50406322	CHEMBL5267385	Plasma kallikrein			 10000							ChEMBL		10.7270/Q2183BRT	36793429			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50406322	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50406322&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			14476489	163355346		CHEMBL165362				ZINC27868487	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
50993180	COc1ccc2cc([nH]c2c1)S(N)(=O)=O	InChI=1S/C9H10N2O3S/c1-14-7-3-2-6-4-9(15(10,12)13)11-8(6)5-7/h2-5,11H,1H3,(H2,10,12,13)	WGJXVQVMOKCESQ-UHFFFAOYSA-N	50406323	CHEMBL5273808	Plasma kallikrein			 10000							ChEMBL		10.7270/Q2183BRT	36793429			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50406323	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50406323&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			14476490	163355347		CHEMBL165245				ZINC27868484	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378142	CC(C)N1CC2CCC(C1)C2COc1cc(CNc2cccc3c(N)nccc23)ccn1	InChI=1S/C26H33N5O/c1-17(2)31-14-19-6-7-20(15-31)23(19)16-32-25-12-18(8-10-28-25)13-30-24-5-3-4-22-21(24)9-11-29-26(22)27/h3-5,8-12,17,19-20,23,30H,6-7,13-16H2,1-2H3,(H2,27,29)	ZGZPKQSHBQJIGW-UHFFFAOYSA-N	652680	N5-((2-((3-isopropyl-3-azabicyclo[3.2.1]octan-8-yl)methoxy)pyridin-4- yl)methyl)isoquinoline-1,5-diamine::US20240059691, Example 4297	Plasma kallikrein			 1.000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652680	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652680&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362805	494496827							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378143	Nc1nccc2c(NCc3ccnc(OCC4CCn5ccnc5C4)c3)cccc12	InChI=1S/C23H24N6O/c24-23-19-2-1-3-20(18(19)5-8-27-23)28-14-16-4-7-26-22(13-16)30-15-17-6-10-29-11-9-25-21(29)12-17/h1-5,7-9,11,13,17,28H,6,10,12,14-15H2,(H2,24,27)	NDQYBUYVXIWGNJ-UHFFFAOYSA-N	652681	N5-[[2-(5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-7-ylmethoxy)-4- pyridyl]methyl]isoquinoline-1,5-diamine::US20240059691, Example 4298	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652681	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652681&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163390393	494496828							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378147	CC(C)N1CCC(COc2cc(CNc3cccc4c(N)nccc34)ccn2)CC1	InChI=1S/C24H31N5O/c1-17(2)29-12-8-18(9-13-29)16-30-23-14-19(6-10-26-23)15-28-22-5-3-4-21-20(22)7-11-27-24(21)25/h3-7,10-11,14,17-18,28H,8-9,12-13,15-16H2,1-2H3,(H2,25,27)	AIRGERSZASMAFK-UHFFFAOYSA-N	652682	5-N-({2-[(1-isopropylpiperidin-4-yl)methoxy]pyridin-4-yl}methyl)isoquinoline-1,5- diamine::US20240059691, Example 4299	Plasma kallikrein			 1.000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652682	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652682&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163390572	494496829							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378148	Nc1ncc(Cl)c2cc(NCc3ccnc(OCC4CCn5ccnc5C4)c3)ccc12	InChI=1S/C23H23ClN6O/c24-20-13-29-23(25)18-2-1-17(11-19(18)20)28-12-15-3-5-27-22(10-15)31-14-16-4-7-30-8-6-26-21(30)9-16/h1-3,5-6,8,10-11,13,16,28H,4,7,9,12,14H2,(H2,25,29)	MABZHGPFQUEHHT-UHFFFAOYSA-N	652683	4-chloro-6-N-[(2-{5H,6H,7H,8H-imidazo[1,2-a]pyridin-7-ylmethoxy}pyridin-4- yl)methyl]isoquinoline-1,6-diamine::US20240059691, Example 4300	Plasma kallikrein			 25000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652683	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652683&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163390458	494496830							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378149	Cn1ccc(COc2cc(CNc3cccc4c(N)nccc34)ccn2)cc1=O	InChI=1S/C22H21N5O2/c1-27-10-7-16(12-21(27)28)14-29-20-11-15(5-8-24-20)13-26-19-4-2-3-18-17(19)6-9-25-22(18)23/h2-12,26H,13-14H2,1H3,(H2,23,25)	MBFJFSDXDXLAQN-UHFFFAOYSA-N	652684	4-{[(4-{[(1-aminoisoquinolin-5-yl)amino]methyl}pyridin-2-yl)oxy]methyl}-1- methylpyridin-2-one::US20240059691, Example 4301	Plasma kallikrein			 1.000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652684	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652684&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163390251	494496831							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378150	Nc1nccc2c(NCc3ccnc(NCCC(=O)N4CCCC4)c3)cccc12	InChI=1S/C22H26N6O/c23-22-18-4-3-5-19(17(18)7-10-26-22)27-15-16-6-9-24-20(14-16)25-11-8-21(29)28-12-1-2-13-28/h3-7,9-10,14,27H,1-2,8,11-13,15H2,(H2,23,26)(H,24,25)	MXRVUBAIYLEIBV-UHFFFAOYSA-N	652685	3-[(4-{[(1-aminoisoquinolin-5-yl)amino]methyl}pyridin-2-yl)amino]-1-(pyrrolidin-1- yl)propan-1-one::US20240059691, Example 4302	Plasma kallikrein			 25000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652685	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652685&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362806	494496832							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378151	Nc1ncc(Cl)c2cc(NCc3ccnc(NCC4CCn5ccnc5C4)c3)ccc12	InChI=1S/C23H24ClN7/c24-20-14-30-23(25)18-2-1-17(11-19(18)20)28-12-15-3-5-26-21(9-15)29-13-16-4-7-31-8-6-27-22(31)10-16/h1-3,5-6,8-9,11,14,16,28H,4,7,10,12-13H2,(H2,25,30)(H,26,29)	OJOAPDZWILJFFF-UHFFFAOYSA-N	652686	4-chloro-6-N-{[2-({5H,6H,7H,8H-imidazo[1,2-a]pyridin-7-ylmethyl}amino)pyridin-4- yl]methyl}isoquinoline-1,6-diamine::US20240059691, Example 4303	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652686	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652686&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362807	494496833							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378152	Nc1nccc2c(NCc3ccnc(OC4CCn5ccnc5C4)c3)cccc12	InChI=1S/C22H22N6O/c23-22-18-2-1-3-19(17(18)5-8-26-22)27-14-15-4-7-25-21(12-15)29-16-6-10-28-11-9-24-20(28)13-16/h1-5,7-9,11-12,16,27H,6,10,13-14H2,(H2,23,26)	VXRIIFJJYHZTRZ-UHFFFAOYSA-N	652687	5-N-[(2-{5H,6H,7H,8H-imidazo[1,2-a]pyridin-7-yloxy}pyridin-4-yl) methyl]isoquinoline- 1,5-diamine::US20240059691, Example 4306	Plasma kallikrein			 25000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652687	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652687&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362808	494496834							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378153	Nc1ncc(F)c2cc(NCc3ccnc(OCC4CCn5ccnc5C4)c3)ccc12	InChI=1S/C23H23FN6O/c24-20-13-29-23(25)18-2-1-17(11-19(18)20)28-12-15-3-5-27-22(10-15)31-14-16-4-7-30-8-6-26-21(30)9-16/h1-3,5-6,8,10-11,13,16,28H,4,7,9,12,14H2,(H2,25,29)	HMMQIOFQLZWHKO-UHFFFAOYSA-N	652688	4-fluoro-6-N-[(2-{5H,6H,7H,8H-imidazo[1,2-a]pyridin-7-ylmethoxy}pyridin-4- yl)methyl]isoquinoline-1,6-diamine::US20240059691, Example 4307	Plasma kallikrein			 1.000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652688	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652688&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362809	494496835							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378154	Nc1ncc(F)c2c(NCc3ccnc(OCC4CCn5ccnc5C4)c3)cccc12	InChI=1S/C23H23FN6O/c24-18-13-29-23(25)17-2-1-3-19(22(17)18)28-12-15-4-6-27-21(11-15)31-14-16-5-8-30-9-7-26-20(30)10-16/h1-4,6-7,9,11,13,16,28H,5,8,10,12,14H2,(H2,25,29)	AJQGZKKQAAWAPQ-UHFFFAOYSA-N	652689	4-fluoro-5-N-[(2-{5H,6H,7H,8H-imidazo[1,2-a]pyridin-7-ylmethoxy}pyridin-4- yl)methyl]isoquinoline-1,5-diamine::US20240059691, Example 4308	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652689	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652689&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362810	494496836							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378161	Cc1cn2CCC(COc3cc(CNc4ccc5c(N)ncc(Cl)c5c4)ccn3)Cc2n1	InChI=1S/C24H25ClN6O/c1-15-13-31-7-5-17(8-22(31)30-15)14-32-23-9-16(4-6-27-23)11-28-18-2-3-19-20(10-18)21(25)12-29-24(19)26/h2-4,6,9-10,12-13,17,28H,5,7-8,11,14H2,1H3,(H2,26,29)	CSNSELBEUILYAV-UHFFFAOYSA-N	652690	4-chloro-6-N-{[2-({2-methyl-5H,6H,7H,8H-imidazo[1,2-a]pyridin-7-yl}methoxy)pyridin-4- yl]methyl}isoquinoline-1,6-diamine::US20240059691, Example 4309	Plasma kallikrein			 1.000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652690	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652690&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362811	494496837							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378162	Cc1cn2CCC(COc3cc(CNc4cccc5c(N)nccc45)ccn3)Cc2n1	InChI=1S/C24H26N6O/c1-16-14-30-10-7-18(11-22(30)29-16)15-31-23-12-17(5-8-26-23)13-28-21-4-2-3-20-19(21)6-9-27-24(20)25/h2-6,8-9,12,14,18,28H,7,10-11,13,15H2,1H3,(H2,25,27)	PGGPSANDIMXVMM-UHFFFAOYSA-N	652691	5-N-{[2-({2-methyl-5H,6H,7H,8H-imidazo[1,2-a]pyridin-7-yl}methoxy)pyridin-4- yl]methyl}isoquinoline-1,5-diamine::US20240059691, Example 4319	Plasma kallikrein			 6500							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652691	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652691&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163390276	494496838							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378166	Cc1cnc2CC(COc3cc(CNc4cccc5c(N)nccc45)ccn3)CCn12	InChI=1S/C24H26N6O/c1-16-13-29-22-11-18(7-10-30(16)22)15-31-23-12-17(5-8-26-23)14-28-21-4-2-3-20-19(21)6-9-27-24(20)25/h2-6,8-9,12-13,18,28H,7,10-11,14-15H2,1H3,(H2,25,27)	VHTYTOFIDWLOHE-UHFFFAOYSA-N	652692	5-N-{[2-({3-methyl-5H,6H,7H,8H-imidazo[1,2-a]pyridin-7-yl}methoxy)pyridin-4- yl]methyl}isoquinoline-1,5-diamine::US20240059691, Example 4320	Plasma kallikrein			 6500							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652692	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652692&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163390197	494496839							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378167	CN1CCN(CC1)c1cc(CNc2cccc3c(N)nccc23)ccn1	InChI=1S/C20H24N6/c1-25-9-11-26(12-10-25)19-13-15(5-7-22-19)14-24-18-4-2-3-17-16(18)6-8-23-20(17)21/h2-8,13,24H,9-12,14H2,1H3,(H2,21,23)	ILJYYWNJCGUIRQ-UHFFFAOYSA-N	652711	5-N-{[2-(4-methylpiperazin-1-yl)pyridin-4-yl]methyl}isoquinoline-1,5-diamine::US20240059691, Example 4426	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652711	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652711&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			170928346	494496857							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378168	CN1CCN(CC1)c1cc(CNc2ccc3c(N)ncc(Cl)c3c2)ccn1	InChI=1S/C20H23ClN6/c1-26-6-8-27(9-7-26)19-10-14(4-5-23-19)12-24-15-2-3-16-17(11-15)18(21)13-25-20(16)22/h2-5,10-11,13,24H,6-9,12H2,1H3,(H2,22,25)	RVZGGBVSLRRBBB-UHFFFAOYSA-N	652712	4-chloro-6-N-{[2-(4-methylpiperazin-1-yl)pyridin-4-yl]methyl}isoquinoline-1,6-diamine::US20240059691, Example 4427	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652712	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652712&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			170928358	494496858							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378169	Nc1ncc(Cl)c2cc(NCc3ccnc(NCCC(=O)N4CCCC4)c3)ccc12	InChI=1S/C22H25ClN6O/c23-19-14-28-22(24)17-4-3-16(12-18(17)19)27-13-15-5-7-25-20(11-15)26-8-6-21(30)29-9-1-2-10-29/h3-5,7,11-12,14,27H,1-2,6,8-10,13H2,(H2,24,28)(H,25,26)	MPMXSQAVVNWKKX-UHFFFAOYSA-N	652713	3-[(4-{[(1-amino-4-chloroisoquinolin-6-yl)amino]methyl}pyridin-2-yl)amino]-1- (pyrrolidin-1-yl)propan-1-one::US20240059691, Example 4428	Plasma kallikrein			 1.000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652713	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652713&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362822	494496859							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378170	Nc1nccc2cc(NCc3ccnc(OCC4CCn5ccnc5C4)c3)ncc12	InChI=1S/C22H23N7O/c23-22-18-13-28-19(11-17(18)2-5-26-22)27-12-15-1-4-25-21(10-15)30-14-16-3-7-29-8-6-24-20(29)9-16/h1-2,4-6,8,10-11,13,16H,3,7,9,12,14H2,(H2,23,26)(H,27,28)	QYAKYTAQLVVGGM-UHFFFAOYSA-N	652714	6-N-[(2-{5H,6H,7H,8H-imidazo[1,2-a]pyridin-7-ylmethoxy}pyridin-4-yl)methyl]-2,7- naphthyridine-1,6-diamine::US20240059691, Example 4429	Plasma kallikrein			 6500							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652714	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652714&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163390300	494496860							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378171	Nc1nccc2c(NCc3ccnc(OC[C@H]4CCn5ccnc5C4)c3)cccc12	InChI=1S/C23H24N6O/c24-23-19-2-1-3-20(18(19)5-8-27-23)28-14-16-4-7-26-22(13-16)30-15-17-6-10-29-11-9-25-21(29)12-17/h1-5,7-9,11,13,17,28H,6,10,12,14-15H2,(H2,24,27)/t17-/m0/s1	NDQYBUYVXIWGNJ-KRWDZBQOSA-N	652715	(S*)-N5-((2-((5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-7-yl)methoxy)pyridin-4- yl)methyl)isoquinoline-1,5-diamine::US20240059691, Example 4430	Plasma kallikrein			 1.000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652715	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652715&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362823	494496861							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378172	Nc1nccc2c(NCc3ccnc(OC[C@@H]4CCn5ccnc5C4)c3)cccc12	InChI=1S/C23H24N6O/c24-23-19-2-1-3-20(18(19)5-8-27-23)28-14-16-4-7-26-22(13-16)30-15-17-6-10-29-11-9-25-21(29)12-17/h1-5,7-9,11,13,17,28H,6,10,12,14-15H2,(H2,24,27)/t17-/m1/s1	NDQYBUYVXIWGNJ-QGZVFWFLSA-N	652716	(R*)-N5-((2-((5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-7-yl)methoxy)pyridin-4- yl)methyl)isoquinoline-1,5-diamine::US20240059691, Example 4431	Plasma kallikrein			 1.000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652716	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652716&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362824	494496862							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378173	Nc1ncc(Cl)c2cc(NCc3ccnc(OC4CCn5ccnc5C4)c3)ccc12	InChI=1S/C22H21ClN6O/c23-19-13-28-22(24)17-2-1-15(10-18(17)19)27-12-14-3-5-26-21(9-14)30-16-4-7-29-8-6-25-20(29)11-16/h1-3,5-6,8-10,13,16,27H,4,7,11-12H2,(H2,24,28)	ASSIORTXMOIMSW-UHFFFAOYSA-N	652717	4-chloro-6-N-[(2-{5H,6H,7H,8H-imidazo[1,2-a]pyridin-7-yloxy}pyridin-4- yl)methyl]isoquinoline-1,6-diamine::US20240059691, Example 4432	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652717	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652717&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362825	494496863							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378174	Nc1ncc(Cl)c2cc(NCc3ccnc(OCc4ccn5ccnc5c4)c3)ccc12	InChI=1S/C23H19ClN6O/c24-20-13-29-23(25)18-2-1-17(11-19(18)20)28-12-15-3-5-27-22(10-15)31-14-16-4-7-30-8-6-26-21(30)9-16/h1-11,13,28H,12,14H2,(H2,25,29)	KPCPBXOSEJYJMI-UHFFFAOYSA-N	652718	4-chloro-6-N-[(2-{imidazo[1,2-a]pyridin-7-ylmethoxy}pyridin-4-yl)methyl]isoquinoline- 1,6-diamine::US20240059691, Example 4433	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652718	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652718&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362826	494496864							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378175	Nc1nccc2cc(NCc3ccnc(c3)-c3cccc(CN4CCCC4)c3)ccc12	InChI=1S/C26H27N5/c27-26-24-7-6-23(16-21(24)9-11-29-26)30-17-19-8-10-28-25(15-19)22-5-3-4-20(14-22)18-31-12-1-2-13-31/h3-11,14-16,30H,1-2,12-13,17-18H2,(H2,27,29)	RJQLFWVERDFMFU-UHFFFAOYSA-N	652719	6-N-({2-[3-(pyrrolidin-1-ylmethyl)phenyl]pyridin-4-yl}methyl)isoquinoline-1,6-diamine::US20240059691, Example 4434::US20240059691, Example 5434	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652719	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652719&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			170928378	494496865							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378179	CN1CC(C1)C1CN(C1)c1cc(CNc2ccc3c(N)nccc3c2)ccn1	InChI=1S/C22H26N6/c1-27-11-17(12-27)18-13-28(14-18)21-8-15(4-6-24-21)10-26-19-2-3-20-16(9-19)5-7-25-22(20)23/h2-9,17-18,26H,10-14H2,1H3,(H2,23,25)	QCLWJMUFTKLIAE-UHFFFAOYSA-N	652720	6-N-({2-[3-(1-methylazetidin-3-yl)azetidin-1-yl]pyridin-4-yl}methyl)isoquinoline-1,6- diamine::US20240059691, Example 4435::US20240059691, Example 5435	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652720	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652720&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			170928438	494496866							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378180	Nc1nccc2c(NCc3ccnc(c3)N3CCn4ccnc4C3)cccc12	InChI=1S/C21H21N7/c22-21-17-2-1-3-18(16(17)5-7-25-21)26-13-15-4-6-23-19(12-15)28-11-10-27-9-8-24-20(27)14-28/h1-9,12,26H,10-11,13-14H2,(H2,22,25)	DVKBAFOJFMJCAO-UHFFFAOYSA-N	652721	5-N-[(2-{5H,6H,8H-imidazo[1,2-a]pyrazin-7-yl}pyridin-4-yl)methyl]isoquinoline-1,5- diamine::US20240059691, Example 4436::US20240059691, Example 5436	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652721	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652721&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362827	494496867							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378181	Nc1ncc(Cl)c2cc(NCc3ccnc(c3)N3CCn4ccnc4C3)ccc12	InChI=1S/C21H20ClN7/c22-18-12-27-21(23)16-2-1-15(10-17(16)18)26-11-14-3-4-24-19(9-14)29-8-7-28-6-5-25-20(28)13-29/h1-6,9-10,12,26H,7-8,11,13H2,(H2,23,27)	LAEZPLWSRMVDKT-UHFFFAOYSA-N	652722	4-chloro-6-N-[(2-{5H,6H,8H-imidazo[1,2-a]pyrazin-7-yl}pyridin-4-yl)methyl]isoquinoline- 1,6-diamine::US20240059691, Example 4437::US20240059691, Example 5437	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652722	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652722&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362828	494496868							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378188	Nc1ncc(Cl)c2cc(NCc3ccnc(OC[C@H]4CCn5ccnc5C4)c3)ccc12	InChI=1S/C23H23ClN6O/c24-20-13-29-23(25)18-2-1-17(11-19(18)20)28-12-15-3-5-27-22(10-15)31-14-16-4-7-30-8-6-26-21(30)9-16/h1-3,5-6,8,10-11,13,16,28H,4,7,9,12,14H2,(H2,25,29)/t16-/m0/s1	MABZHGPFQUEHHT-INIZCTEOSA-N	652723	(S*)-4-chloro-N6-((2-((5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-7-yl)methoxy)pyridin-4- yl)methyl)isoquinoline-1,6-diamine::US20240059691, Example 4438	Plasma kallikrein			 25000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652723	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652723&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362829	494496869							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378195	Nc1ncc(Cl)c2cc(NCc3ccnc(OC[C@@H]4CCn5ccnc5C4)c3)ccc12	InChI=1S/C23H23ClN6O/c24-20-13-29-23(25)18-2-1-17(11-19(18)20)28-12-15-3-5-27-22(10-15)31-14-16-4-7-30-8-6-26-21(30)9-16/h1-3,5-6,8,10-11,13,16,28H,4,7,9,12,14H2,(H2,25,29)/t16-/m1/s1	MABZHGPFQUEHHT-MRXNPFEDSA-N	652724	(R*)-4-chloro-N6-((2-((5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-7-yl)methoxy)pyridin-4- yl)methyl)isoquinoline-1,6-diamine::US20240059691, Example 4439	Plasma kallikrein			 25000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652724	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652724&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362830	494496870							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378196	Cc1n[nH]c2C(CCc12)Nc1cc(CNc2ccc3c(N)ncc(Cl)c3c2)ccn1			652725	4-chloro-N6-((2-((3-methyl-1,4,5,6-tetrahydrocyclopenta[c]pyrazol-6-yl)amino)pyridin- 4-yl)methyl)isoquinoline-1,6-diamine::US20240059691, Example 4440	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652725	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652725&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362831	494496871							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378197	CC(C)N1CCC(CN(CCCO)C(=O)c2cccc(CNc3cccc4c(N)nccc34)c2)CC1	InChI=1S/C29H39N5O2/c1-21(2)33-15-11-22(12-16-33)20-34(14-5-17-35)29(36)24-7-3-6-23(18-24)19-32-27-9-4-8-26-25(27)10-13-31-28(26)30/h3-4,6-10,13,18,21-22,32,35H,5,11-12,14-17,19-20H2,1-2H3,(H2,30,31)	CQDVUJSXYFSSHR-UHFFFAOYSA-N	652726	3-{[(1-aminoisoquinolin-5-yl)amino]methyl}-N-(3-hydroxypropyl)-N-[(1- isopropylpiperidin-4-yl)methyl]benzamide::US20240059691, Example 4441::US20240059691, Example 5441	Plasma kallikrein			 25000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652726	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652726&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362832	494496872							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378201	Cc1cn2CC[C@@H](COc3cc(CNc4ccc5c(N)ncc(Cl)c5c4)ccn3)Cc2n1	InChI=1S/C24H25ClN6O/c1-15-13-31-7-5-17(8-22(31)30-15)14-32-23-9-16(4-6-27-23)11-28-18-2-3-19-20(10-18)21(25)12-29-24(19)26/h2-4,6,9-10,12-13,17,28H,5,7-8,11,14H2,1H3,(H2,26,29)/t17-/m1/s1	CSNSELBEUILYAV-QGZVFWFLSA-N	652727	(R*)-4-chloro-N6-((2-((2-methyl-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-7- yl)methoxy)pyridin-4-yl)methyl)isoquinoline-1,6-diamine::US20240059691, Example 4442	Plasma kallikrein			 25000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652727	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652727&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362833	494496873							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378202	Nc1ncc(Cl)c2cc(NCc3ccnc(OCC4CCCn5ccnc45)c3)ccc12	InChI=1S/C23H23ClN6O/c24-20-13-29-22(25)18-4-3-17(11-19(18)20)28-12-15-5-6-26-21(10-15)31-14-16-2-1-8-30-9-7-27-23(16)30/h3-7,9-11,13,16,28H,1-2,8,12,14H2,(H2,25,29)	PIUDHEFNICCZME-UHFFFAOYSA-N	652728	4-chloro-N6-((2-((5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-8-yl)methoxy)pyridin-4- yl)methyl)isoquinoline-1,6-diamine::US20240059691, Example 4443	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652728	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652728&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362834	494496874							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378203	Cc1cnc2C[C@@H](COc3cc(CNc4cccc5c(N)nccc45)ccn3)CCn12	InChI=1S/C24H26N6O/c1-16-13-29-22-11-18(7-10-30(16)22)15-31-23-12-17(5-8-26-23)14-28-21-4-2-3-20-19(21)6-9-27-24(20)25/h2-6,8-9,12-13,18,28H,7,10-11,14-15H2,1H3,(H2,25,27)/t18-/m0/s1	VHTYTOFIDWLOHE-SFHVURJKSA-N	652729	(S*)-N5-((2-((3-methyl-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-7-yl)methoxy)pyridin-4- yl)methyl)isoquinoline-1,5-diamine::US20240059691, Example 4444	Plasma kallikrein			 6500							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652729	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652729&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362835	494496875							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378204	Cc1cnc2C[C@H](COc3cc(CNc4cccc5c(N)nccc45)ccn3)CCn12	InChI=1S/C24H26N6O/c1-16-13-29-22-11-18(7-10-30(16)22)15-31-23-12-17(5-8-26-23)14-28-21-4-2-3-20-19(21)6-9-27-24(20)25/h2-6,8-9,12-13,18,28H,7,10-11,14-15H2,1H3,(H2,25,27)/t18-/m1/s1	VHTYTOFIDWLOHE-GOSISDBHSA-N	652730	(R*)-N5-((2-((3-methyl-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-7-yl)methoxy)pyridin-4- yl)methyl)isoquinoline-1,5-diamine::US20240059691, Example 4445	Plasma kallikrein			 6500							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652730	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652730&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362836	494496876							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378205	Cc1cn2CC[C@H](COc3cc(CNc4cccc5c(N)nccc45)ccn3)Cc2n1	InChI=1S/C24H26N6O/c1-16-14-30-10-7-18(11-22(30)29-16)15-31-23-12-17(5-8-26-23)13-28-21-4-2-3-20-19(21)6-9-27-24(20)25/h2-6,8-9,12,14,18,28H,7,10-11,13,15H2,1H3,(H2,25,27)/t18-/m0/s1	PGGPSANDIMXVMM-SFHVURJKSA-N	652731	(S*)-N5-((2-((2-methyl-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-7-yl)methoxy)pyridin-4- yl)methyl)isoquinoline-1,5-diamine::US20240059691, Example 4446	Plasma kallikrein			 6500							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652731	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652731&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362837	494496877							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378212	Cc1cn2CC[C@@H](COc3cc(CNc4cccc5c(N)nccc45)ccn3)Cc2n1	InChI=1S/C24H26N6O/c1-16-14-30-10-7-18(11-22(30)29-16)15-31-23-12-17(5-8-26-23)13-28-21-4-2-3-20-19(21)6-9-27-24(20)25/h2-6,8-9,12,14,18,28H,7,10-11,13,15H2,1H3,(H2,25,27)/t18-/m1/s1	PGGPSANDIMXVMM-GOSISDBHSA-N	652732	(R*)-N5-((2-((2-methyl-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-7-yl)methoxy)pyridin-4- yl)methyl)isoquinoline-1,5-diamine::US20240059691, Example 4447	Plasma kallikrein			 6500							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652732	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652732&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362838	494496878							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378213	Nc1ncc(Cl)c2cc(NCc3ccnc(OCC4CCn5c(CO)cnc5C4)c3)ccc12	InChI=1S/C24H25ClN6O2/c25-21-12-30-24(26)19-2-1-17(9-20(19)21)28-10-15-3-5-27-23(8-15)33-14-16-4-6-31-18(13-32)11-29-22(31)7-16/h1-3,5,8-9,11-12,16,28,32H,4,6-7,10,13-14H2,(H2,26,30)	SWVWAZLEARISBG-UHFFFAOYSA-N	652733	(7-(((4-(((1-amino-4-chloroisoquinolin-6-yl)amino)methyl)pyridin-2-yl)oxy)methyl)- 5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-3-yl)methanol::US20240059691, Example 4448	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652733	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652733&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362839	494496879							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378214	Nc1ncc(Cl)c2cc(NCc3ccnc(OCC4CCn5cc(CO)nc5C4)c3)ccc12	InChI=1S/C24H25ClN6O2/c25-21-11-29-24(26)19-2-1-17(9-20(19)21)28-10-15-3-5-27-23(8-15)33-14-16-4-6-31-12-18(13-32)30-22(31)7-16/h1-3,5,8-9,11-12,16,28,32H,4,6-7,10,13-14H2,(H2,26,29)	XQRKYMOJJOXHBZ-UHFFFAOYSA-N	652734	(7-(((4-(((1-amino-4-chloroisoquinolin-6-yl)amino)methyl)pyridin-2-yl)oxy)methyl)- 5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-2-yl)methanol::US20240059691, Example 4449	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652734	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652734&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362840	494496880							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378215	Nc1ncc(Cl)c2cc(NCc3ccnc(OC[C@H]4CCCn5ccnc45)c3)ccc12	InChI=1S/C23H23ClN6O/c24-20-13-29-22(25)18-4-3-17(11-19(18)20)28-12-15-5-6-26-21(10-15)31-14-16-2-1-8-30-9-7-27-23(16)30/h3-7,9-11,13,16,28H,1-2,8,12,14H2,(H2,25,29)/t16-/m1/s1	PIUDHEFNICCZME-MRXNPFEDSA-N	652735	(S*)-4-chloro-N6-((2-((5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-8-yl)methoxy)pyridin-4- yl)methyl)isoquinoline-1,6-diamine::US20240059691, Example 4450	Plasma kallikrein			 25000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652735	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652735&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362841	494496881							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378216	Nc1ncc(Cl)c2cc(NCc3ccnc(OC[C@@H]4CCCn5ccnc45)c3)ccc12	InChI=1S/C23H23ClN6O/c24-20-13-29-22(25)18-4-3-17(11-19(18)20)28-12-15-5-6-26-21(10-15)31-14-16-2-1-8-30-9-7-27-23(16)30/h3-7,9-11,13,16,28H,1-2,8,12,14H2,(H2,25,29)/t16-/m0/s1	PIUDHEFNICCZME-INIZCTEOSA-N	652736	(R*)-4-chloro-N6-((2-((5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-8-yl)methoxy)pyridin-4- yl)methyl)isoquinoline-1,6-diamine::US20240059691, Example 4451	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652736	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652736&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362842	494496882							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378217	Nc1nccc2c(CCc3ccnc(OCC4CCn5ccnc5C4)c3)cccc12	InChI=1S/C24H25N5O/c25-24-21-3-1-2-19(20(21)7-10-28-24)5-4-17-6-9-27-23(15-17)30-16-18-8-12-29-13-11-26-22(29)14-18/h1-3,6-7,9-11,13,15,18H,4-5,8,12,14,16H2,(H2,25,28)	GANUYKJXFODNNH-UHFFFAOYSA-N	652737	5-(2-(2-((5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-7-yl)methoxy)pyridin-4- yl)ethyl)isoquinolin-1-amine::US20240059691, Example 4452	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652737	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652737&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362843	494496883							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378218	Nc1ncc(Cl)c2cc(NCc3ccnc(OCC4CCn5c(C4)ncc5C(O)=O)c3)ccc12	InChI=1S/C24H23ClN6O3/c25-19-11-30-23(26)17-2-1-16(9-18(17)19)28-10-14-3-5-27-22(8-14)34-13-15-4-6-31-20(24(32)33)12-29-21(31)7-15/h1-3,5,8-9,11-12,15,28H,4,6-7,10,13H2,(H2,26,30)(H,32,33)	OESQFLRTXWVAQT-UHFFFAOYSA-N	652812	7-(((4-(((1-amino-4-chloroisoquinolin-6-yl)amino)methyl)pyridin-2-yl)oxy)methyl)- 5,6,7,8-tetrahydroimidazo[1,2-a]pyridine-3-carboxylic acid::US20240059691, Example 4453	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652812	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652812&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362904	494496952							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378219	CN1CCC(COc2cc(CNc3cccc4[nH]nc(Cl)c34)ccn2)CC1	InChI=1S/C20H24ClN5O/c1-26-9-6-14(7-10-26)13-27-18-11-15(5-8-22-18)12-23-16-3-2-4-17-19(16)20(21)25-24-17/h2-5,8,11,14,23H,6-7,9-10,12-13H2,1H3,(H,24,25)	DUTABFFYBPSPBP-UHFFFAOYSA-N	652813	3-chloro-N-((2-((1-methylpiperidin-4-yl)methoxy)pyridin-4-yl)methyl)-1H-indazol-4- amine::US20240059691, Example 4454	Plasma kallikrein			 4.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652813	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652813&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362905	494496953							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378226	CN(c1ccnc(OCC2CCN(C)CC2)c1)c1cncc(c1)C(C)=O	InChI=1S/C20H26N4O2/c1-15(25)17-10-19(13-21-12-17)24(3)18-4-7-22-20(11-18)26-14-16-5-8-23(2)9-6-16/h4,7,10-13,16H,5-6,8-9,14H2,1-3H3	LXKITORZDFIYOM-UHFFFAOYSA-N	652814	1-(5-(methyl(2-((1-methylpiperidin-4-yl)methoxy)pyridin-4-yl)amino)pyridin-3-yl)ethan- 1-one::US20240059691, Example 4455	Plasma kallikrein			 4.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652814	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652814&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362906	494496954							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378227	CN(c1ccnc(OCC2CCN(C)CC2)c1)c1ccc2ncc(=O)[nH]c2c1	InChI=1S/C21H25N5O2/c1-25-9-6-15(7-10-25)14-28-21-12-17(5-8-22-21)26(2)16-3-4-18-19(11-16)24-20(27)13-23-18/h3-5,8,11-13,15H,6-7,9-10,14H2,1-2H3,(H,24,27)	KXQJLZZKIBAROO-UHFFFAOYSA-N	652738	7-(methyl(2-((1-methylpiperidin-4-yl)methoxy)pyridin-4-yl)amino)quinoxalin-2(1H)-one::US20240059691, Example 4456	Plasma kallikrein			 25000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652738	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652738&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362844	494496884							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378228	CN1CCC(COc2cc(CNc3ccc(cc3)-c3nnc(C)o3)ccn2)CC1	InChI=1S/C22H27N5O2/c1-16-25-26-22(29-16)19-3-5-20(6-4-19)24-14-18-7-10-23-21(13-18)28-15-17-8-11-27(2)12-9-17/h3-7,10,13,17,24H,8-9,11-12,14-15H2,1-2H3	IRJYFWXGGGVTFU-UHFFFAOYSA-N	652815	4-(5-methyl-1,3,4-oxadiazol-2-yl)-N-((2-((1-methylpiperidin-4-yl)methoxy)pyridin-4- yl)methyl)aniline::US20240059691, Example 4457	Plasma kallikrein			 4.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652815	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652815&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362907	494496955							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378229	CN(C)c1ccc(NCc2ccnc(OCC3CCN(C)CC3)c2)nn1	InChI=1S/C19H28N6O/c1-24(2)18-5-4-17(22-23-18)21-13-16-6-9-20-19(12-16)26-14-15-7-10-25(3)11-8-15/h4-6,9,12,15H,7-8,10-11,13-14H2,1-3H3,(H,21,22)	IXARYSGVNQXBDG-UHFFFAOYSA-N	652816	N3,N3-dimethyl-N6-((2-((1-methylpiperidin-4-yl)methoxy)pyridin-4- yl)methyl)pyridazine-3,6-diamine::US20240059691, Example 4458	Plasma kallikrein			 4.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652816	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652816&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362908	494496956							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378230	CN1CCC(COc2cc(CNc3ccnc4[nH]ccc34)ccn2)CC1	InChI=1S/C20H25N5O/c1-25-10-5-15(6-11-25)14-26-19-12-16(2-7-21-19)13-24-18-4-9-23-20-17(18)3-8-22-20/h2-4,7-9,12,15H,5-6,10-11,13-14H2,1H3,(H2,22,23,24)	JYTMJESYCLLJDR-UHFFFAOYSA-N	652739	N-((2-((1-methylpiperidin-4-yl)methoxy)pyridin-4-yl)methyl)-1H-pyrrolo[2,3-b]pyridin-4- amine::US20240059691, Example 4459	Plasma kallikrein			 4.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652739	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652739&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362845	494496885							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378231	CN(c1ccnc(OCC2CCN(C)CC2)c1)c1cnc2[nH]cc(C#N)c2c1	InChI=1S/C21H24N6O/c1-26-7-4-15(5-8-26)14-28-20-10-17(3-6-23-20)27(2)18-9-19-16(11-22)12-24-21(19)25-13-18/h3,6,9-10,12-13,15H,4-5,7-8,14H2,1-2H3,(H,24,25)	LBGKPJIADAFZOI-UHFFFAOYSA-N	652740	5-(methyl(2-((1-methylpiperidin-4-yl)methoxy)pyridin-4-yl)amino)-1H-pyrrolo[2,3- b]pyridine-3-carbonitrile::US20240059691, Example 4460	Plasma kallikrein			 4.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652740	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652740&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362846	494496886							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378232	CN1CCC(COc2cc(CNc3cccc4c(N)ncc(F)c34)ccn2)CC1	InChI=1S/C22H26FN5O/c1-28-9-6-15(7-10-28)14-29-20-11-16(5-8-25-20)12-26-19-4-2-3-17-21(19)18(23)13-27-22(17)24/h2-5,8,11,13,15,26H,6-7,9-10,12,14H2,1H3,(H2,24,27)	DVZGMBMRSZYOQY-UHFFFAOYSA-N	652741	4-fluoro-N5-((2-((1-methylpiperidin-4-yl)methoxy)pyridin-4-yl)methyl)isoquinoline-1,5- diamine::US20240059691, Example 4461	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652741	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652741&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362847	494496887							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378233	COc1cc(NCc2ccnc(OCC3CCN(C)CC3)c2)cc2ccncc12	InChI=1S/C23H28N4O2/c1-27-9-5-17(6-10-27)16-29-23-11-18(3-8-25-23)14-26-20-12-19-4-7-24-15-21(19)22(13-20)28-2/h3-4,7-8,11-13,15,17,26H,5-6,9-10,14,16H2,1-2H3	VCIKYAMULKYYHT-UHFFFAOYSA-N	652742	8-methoxy-N-((2-((1-methylpiperidin-4-yl)methoxy)pyridin-4-yl)methyl)isoquinolin-6- amine::US20240059691, Example 4462	Plasma kallikrein			 4.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652742	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652742&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362848	494496888							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378234	CNC(=O)c1cc(cc2ccncc12)N(C)c1ccnc(OCC2CCN(C)CC2)c1	InChI=1S/C24H29N5O2/c1-25-24(30)21-13-20(12-18-4-8-26-15-22(18)21)29(3)19-5-9-27-23(14-19)31-16-17-6-10-28(2)11-7-17/h4-5,8-9,12-15,17H,6-7,10-11,16H2,1-3H3,(H,25,30)	OPOOBCSVRFDHBZ-UHFFFAOYSA-N	652743	N-methyl-6-(methyl(2-((1-methylpiperidin-4-yl)methoxy)pyridin-4- yl)amino)isoquinoline-8-carboxamide::US20240059691, Example 4463	Plasma kallikrein			 4.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652743	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652743&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362849	494496889							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378235	CN1CCC(COc2cc(CNc3cc(C)c4cnccc4c3)ccn2)CC1	InChI=1S/C23H28N4O/c1-17-11-21(13-20-4-7-24-15-22(17)20)26-14-19-3-8-25-23(12-19)28-16-18-5-9-27(2)10-6-18/h3-4,7-8,11-13,15,18,26H,5-6,9-10,14,16H2,1-2H3	HKBDZTCNUODKEC-UHFFFAOYSA-N	652744	8-methyl-N-((2-((1-methylpiperidin-4-yl)methoxy)pyridin-4-yl)methyl)isoquinolin-6- amine::US20240059691, Example 4464	Plasma kallikrein			 2.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652744	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652744&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362850	494496890							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378239	CN1CCC(COc2cc(CNc3ccnc4[nH]c(C)cc34)ccn2)CC1	InChI=1S/C21H27N5O/c1-15-11-18-19(4-8-23-21(18)25-15)24-13-17-3-7-22-20(12-17)27-14-16-5-9-26(2)10-6-16/h3-4,7-8,11-12,16H,5-6,9-10,13-14H2,1-2H3,(H2,23,24,25)	HDYDEOLDSIUJSX-UHFFFAOYSA-N	652745	2-methyl-N-((2-((1-methylpiperidin-4-yl)methoxy)pyridin-4-yl)methyl)-1H-pyrrolo[2,3- b]pyridin-4-amine::US20240059691, Example 4465	Plasma kallikrein			 4.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652745	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652745&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362851	494496891							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378240	CN1CCC(COc2cc(CNc3ccc4cnccc4c3F)ccn2)CC1	InChI=1S/C22H25FN4O/c1-27-10-6-16(7-11-27)15-28-21-12-17(4-9-25-21)13-26-20-3-2-18-14-24-8-5-19(18)22(20)23/h2-5,8-9,12,14,16,26H,6-7,10-11,13,15H2,1H3	RCOQXBPCGJCFQX-UHFFFAOYSA-N	652746	5-fluoro-N-((2-((1-methylpiperidin-4-yl)methoxy)pyridin-4-yl)methyl)isoquinolin-6- amine::US20240059691, Example 4466	Plasma kallikrein			 4.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652746	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652746&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362852	494496892							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378241	Nc1nccc2c(NCc3ccnc(OCC4CCn5c(C4)nnc5C(F)F)c3)cccc12	InChI=1S/C23H23F2N7O/c24-21(25)23-31-30-19-10-15(6-9-32(19)23)13-33-20-11-14(4-7-27-20)12-29-18-3-1-2-17-16(18)5-8-28-22(17)26/h1-5,7-8,11,15,21,29H,6,9-10,12-13H2,(H2,26,28)	YHMGDTWUZGOVRL-UHFFFAOYSA-N	652747	N5-((2-((3-(difluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-7- yl)methoxy)pyridin-4-yl)methyl)isoquinoline-1,5-diamine::US20240059691, Example 4467	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652747	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652747&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362853	494496893							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378245	Cn1c(COc2cc(CNc3cccc4c(N)nccc34)ccn2)nnc1C1CC1	InChI=1S/C22H23N7O/c1-29-19(27-28-22(29)15-5-6-15)13-30-20-11-14(7-9-24-20)12-26-18-4-2-3-17-16(18)8-10-25-21(17)23/h2-4,7-11,15,26H,5-6,12-13H2,1H3,(H2,23,25)	VCSMMVIIOANDQA-UHFFFAOYSA-N	652748	N5-((2-((5-cyclopropyl-4-methyl-4H-1,2,4-triazol-3-yl)methoxy)pyridin-4- yl)methyl)isoquinoline-1,5-diamine::US20240059691, Example 4468	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652748	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652748&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362854	494496894							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378246	CN1CCC(COc2cc(CNc3ccc(F)c4c(N)nccc34)ccn2)CC1	InChI=1S/C22H26FN5O/c1-28-10-6-15(7-11-28)14-29-20-12-16(4-8-25-20)13-27-19-3-2-18(23)21-17(19)5-9-26-22(21)24/h2-5,8-9,12,15,27H,6-7,10-11,13-14H2,1H3,(H2,24,26)	LSKPXPLWMKWCHU-UHFFFAOYSA-N	652749	8-fluoro-N5-((2-((1-methylpiperidin-4-yl)methoxy)pyridin-4-yl)methyl)isoquinoline-1,5- diamine::US20240059691, Example 4469	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652749	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652749&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362855	494496895							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378247	COc1ccc(NCc2ccnc(OCC3CCN(C)CC3)c2)c2ccnc(N)c12	InChI=1S/C23H29N5O2/c1-28-11-7-16(8-12-28)15-30-21-13-17(5-9-25-21)14-27-19-3-4-20(29-2)22-18(19)6-10-26-23(22)24/h3-6,9-10,13,16,27H,7-8,11-12,14-15H2,1-2H3,(H2,24,26)	OBRMYBVETQYTBA-UHFFFAOYSA-N	652750	8-methoxy-N5-((2-((1-methylpiperidin-4-yl)methoxy)pyridin-4-yl)methyl)isoquinoline- 1,5-diamine::US20240059691, Example 4470	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652750	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652750&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362856	494496896							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378248	Nc1nccc2cc(NCc3ccnc(c3)-c3cccc(CN4CCCC4)c3)ccc12	InChI=1S/C26H27N5/c27-26-24-7-6-23(16-21(24)9-11-29-26)30-17-19-8-10-28-25(15-19)22-5-3-4-20(14-22)18-31-12-1-2-13-31/h3-11,14-16,30H,1-2,12-13,17-18H2,(H2,27,29)	RJQLFWVERDFMFU-UHFFFAOYSA-N	652719	6-N-({2-[3-(pyrrolidin-1-ylmethyl)phenyl]pyridin-4-yl}methyl)isoquinoline-1,6-diamine::US20240059691, Example 4434::US20240059691, Example 5434	Plasma kallikrein			 2000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652719	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652719&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			170928378	494496865							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378252	CN1CC(C1)C1CN(C1)c1cc(CNc2ccc3c(N)nccc3c2)ccn1	InChI=1S/C22H26N6/c1-27-11-17(12-27)18-13-28(14-18)21-8-15(4-6-24-21)10-26-19-2-3-20-16(9-19)5-7-25-22(20)23/h2-9,17-18,26H,10-14H2,1H3,(H2,23,25)	QCLWJMUFTKLIAE-UHFFFAOYSA-N	652720	6-N-({2-[3-(1-methylazetidin-3-yl)azetidin-1-yl]pyridin-4-yl}methyl)isoquinoline-1,6- diamine::US20240059691, Example 4435::US20240059691, Example 5435	Plasma kallikrein			 25000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652720	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652720&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			170928438	494496866							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378256	Nc1nccc2c(NCc3ccnc(c3)N3CCn4ccnc4C3)cccc12	InChI=1S/C21H21N7/c22-21-17-2-1-3-18(16(17)5-7-25-21)26-13-15-4-6-23-19(12-15)28-11-10-27-9-8-24-20(27)14-28/h1-9,12,26H,10-11,13-14H2,(H2,22,25)	DVKBAFOJFMJCAO-UHFFFAOYSA-N	652721	5-N-[(2-{5H,6H,8H-imidazo[1,2-a]pyrazin-7-yl}pyridin-4-yl)methyl]isoquinoline-1,5- diamine::US20240059691, Example 4436::US20240059691, Example 5436	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652721	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652721&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362827	494496867							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378257	Nc1ncc(Cl)c2cc(NCc3ccnc(c3)N3CCn4ccnc4C3)ccc12	InChI=1S/C21H20ClN7/c22-18-12-27-21(23)16-2-1-15(10-17(16)18)26-11-14-3-4-24-19(9-14)29-8-7-28-6-5-25-20(28)13-29/h1-6,9-10,12,26H,7-8,11,13H2,(H2,23,27)	LAEZPLWSRMVDKT-UHFFFAOYSA-N	652722	4-chloro-6-N-[(2-{5H,6H,8H-imidazo[1,2-a]pyrazin-7-yl}pyridin-4-yl)methyl]isoquinoline- 1,6-diamine::US20240059691, Example 4437::US20240059691, Example 5437	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652722	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652722&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362828	494496868							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378258	CC(C)N1CCC(CN(CCCO)C(=O)c2cccc(CNc3cccc4c(N)nccc34)c2)CC1	InChI=1S/C29H39N5O2/c1-21(2)33-15-11-22(12-16-33)20-34(14-5-17-35)29(36)24-7-3-6-23(18-24)19-32-27-9-4-8-26-25(27)10-13-31-28(26)30/h3-4,6-10,13,18,21-22,32,35H,5,11-12,14-17,19-20H2,1-2H3,(H2,30,31)	CQDVUJSXYFSSHR-UHFFFAOYSA-N	652726	3-{[(1-aminoisoquinolin-5-yl)amino]methyl}-N-(3-hydroxypropyl)-N-[(1- isopropylpiperidin-4-yl)methyl]benzamide::US20240059691, Example 4441::US20240059691, Example 5441	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652726	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652726&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362832	494496872							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378259	Nc1ncc(Cl)c2cc(NCc3cccc(CC(=O)N4CCn5ccnc5C4)c3)ccc12	InChI=1S/C24H23ClN6O/c25-21-14-29-24(26)19-5-4-18(12-20(19)21)28-13-17-3-1-2-16(10-17)11-23(32)31-9-8-30-7-6-27-22(30)15-31/h1-7,10,12,14,28H,8-9,11,13,15H2,(H2,26,29)	JWEQJWUQLJRRCI-UHFFFAOYSA-N	652758	2-(3-(((1-amino-4-chloroisoquinolin-6-yl)amino)methyl)phenyl)-1-(5,6- dihydroimidazo[1,2-a]pyrazin-7(8H)-yl)ethan-1-one::US20240059691, Example 5442	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652758	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652758&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362859	494496899							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378260	Nc1nccc2c(NCc3ccc(cn3)N3CCn4c(C3)nnc4C(F)(F)F)cccc12	InChI=1S/C21H19F3N8/c22-21(23,24)20-30-29-18-12-31(8-9-32(18)20)14-5-4-13(27-11-14)10-28-17-3-1-2-16-15(17)6-7-26-19(16)25/h1-7,11,28H,8-10,12H2,(H2,25,26)	PHLLDHUJAMWXHD-UHFFFAOYSA-N	652760	N5-((5-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)pyridin-2- yl)methyl)isoquinoline-1,5-diamine::US20240059691, Example 9001	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652760	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652760&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362860	494496901							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378267	Cc1cc(nc(C)c1CNc1cccc2c(N)nccc12)N1CCn2c(C1)nnc2C(F)(F)F	InChI=1S/C23H23F3N8/c1-13-10-19(33-8-9-34-20(12-33)31-32-22(34)23(24,25)26)30-14(2)17(13)11-29-18-5-3-4-16-15(18)6-7-28-21(16)27/h3-7,10,29H,8-9,11-12H2,1-2H3,(H2,27,28)	SBFVHGJSVOMQJH-UHFFFAOYSA-N	652765	N5-((2,4-dimethyl-6-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin- 7(8H)-yl)pyridin-3-yl)methyl)isoquinoline-1,5-diamine::US20240059691, Example 9006	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652765	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652765&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362862	494496906							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378270	Nc1nccc2c(cccc12)N1CCCC1c1ccc(nc1)N1CCn2c(C1)nnc2C(F)F	InChI=1S/C24H24F2N8/c25-22(26)24-31-30-21-14-32(11-12-34(21)24)20-7-6-15(13-29-20)18-5-2-10-33(18)19-4-1-3-17-16(19)8-9-28-23(17)27/h1,3-4,6-9,13,18,22H,2,5,10-12,14H2,(H2,27,28)	WNPIAQBIXAUOBA-UHFFFAOYSA-N	652768	5-(2-(6-(3-(difluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)pyridin-3- yl)pyrrolidin-1-yl)isoquinolin-1-amine::US20240059691, Example 10001	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652768	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652768&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362865	494496909							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377591	CN1CCC(CC1)Oc1ccc(CNc2ccc3c(N)nccc3c2)cn1	InChI=1S/C21H25N5O/c1-26-10-7-18(8-11-26)27-20-5-2-15(14-25-20)13-24-17-3-4-19-16(12-17)6-9-23-21(19)22/h2-6,9,12,14,18,24H,7-8,10-11,13H2,1H3,(H2,22,23)	GXJGGSLRORREAO-UHFFFAOYSA-N	652421	6-N-({6-[(1-methylpiperidin-4-yl)oxy]pyridin-3-yl}methyl)isoquinoline-1,6-diamine::US20240059691, Example 1001	Plasma kallikrein			 2000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652421	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652421&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			170928349	494496573							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377600	CN1CCC(CC1)Oc1ccc(CNc2ccc3ccnc(N)c3c2)cc1	InChI=1S/C22H26N4O/c1-26-12-9-20(10-13-26)27-19-6-2-16(3-7-19)15-25-18-5-4-17-8-11-24-22(23)21(17)14-18/h2-8,11,14,20,25H,9-10,12-13,15H2,1H3,(H2,23,24)	NKLMFKCXUKBJOU-UHFFFAOYSA-N	652423	7-N-({4-[(1-methylpiperidin-4-yl)oxy]phenyl}methyl)isoquinoline-1,7-diamine::US20240059691, Example 1003	Plasma kallikrein			 25000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652423	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652423&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163390390	494496575							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377601	CN1CCC(CC1)Oc1ccc(CNc2cnc3[nH]cc(Cl)c3c2)cc1	InChI=1S/C20H23ClN4O/c1-25-8-6-17(7-9-25)26-16-4-2-14(3-5-16)11-22-15-10-18-19(21)13-24-20(18)23-12-15/h2-5,10,12-13,17,22H,6-9,11H2,1H3,(H,23,24)	ITXMGHQYSZOAPX-UHFFFAOYSA-N	652424	3-chloro-N-(4-((1-methylpiperidin-4-yl)oxy)benzyl)-1H-pyrrolo[2,3-b]pyridin-5-amine::US20240059691, Example 1004	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652424	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652424&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163390384	494496576							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377602	CN1CCC(COc2ccc(CNc3ccc4c(N)nccc4c3)cn2)CC1	InChI=1S/C22H27N5O/c1-27-10-7-16(8-11-27)15-28-21-5-2-17(14-26-21)13-25-19-3-4-20-18(12-19)6-9-24-22(20)23/h2-6,9,12,14,16,25H,7-8,10-11,13,15H2,1H3,(H2,23,24)	UXQJFMQHQIXERQ-UHFFFAOYSA-N	652425	6-N-({6-[(1-methylpiperidin-4-yl)methoxy]pyridin-3-yl}methyl)isoquinoline-1,6-diamine::US20240059691, Example 1005	Plasma kallikrein			 6500							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652425	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652425&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163390445	494496577							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377606	Nc1nccc2cc(NCc3ccc(OCC4CCn5ccnc5C4)nc3)ccc12	InChI=1S/C23H24N6O/c24-23-20-3-2-19(12-18(20)5-7-26-23)27-13-17-1-4-22(28-14-17)30-15-16-6-9-29-10-8-25-21(29)11-16/h1-5,7-8,10,12,14,16,27H,6,9,11,13,15H2,(H2,24,26)	CKNZDXKTBCVSIY-UHFFFAOYSA-N	652426	6-N-[(6-{5H,6H,7H,8H-imidazo[1,2-a]pyridin-7-ylmethoxy}pyridin-3- yl)methyl]isoquinoline-1,6-diamine::US20240059691, Example 1006::US20240059691, Example 1023::US20240059691, Example 1024	Plasma kallikrein			 2000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652426	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652426&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163390232	494496578							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377610	CN1CCC(COc2ccc(CNc3ccc4cnccc4c3)cn2)CC1	InChI=1S/C22H26N4O/c1-26-10-7-17(8-11-26)16-27-22-5-2-18(14-25-22)13-24-21-4-3-20-15-23-9-6-19(20)12-21/h2-6,9,12,14-15,17,24H,7-8,10-11,13,16H2,1H3	LPENKDDSJSQSIP-UHFFFAOYSA-N	652428	N-({6-[(1-methylpiperidin-4-yl)methoxy]pyridin-3-yl}methyl)isoquinolin-6-amine::US20240059691, Example 1008	Plasma kallikrein			 25000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652428	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652428&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163390374	494496580							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377614	CN1CCC(COc2ccc(CNc3cccc4c(N)nccc34)cn2)CC1	InChI=1S/C22H27N5O/c1-27-11-8-16(9-12-27)15-28-21-6-5-17(14-26-21)13-25-20-4-2-3-19-18(20)7-10-24-22(19)23/h2-7,10,14,16,25H,8-9,11-13,15H2,1H3,(H2,23,24)	RTTUBFUCOXOZCQ-UHFFFAOYSA-N	652429	5-N-({6-[(1-methylpiperidin-4-yl)methoxy]pyridin-3-yl}methyl)isoquinoline-1,5-diamine::US20240059691, Example 1009	Plasma kallikrein			 6500							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652429	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652429&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163390547	494496581							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377618	CCN1CCC(COc2ccc(CNc3ccc4c(N)nccc4c3)cn2)CC1	InChI=1S/C23H29N5O/c1-2-28-11-8-17(9-12-28)16-29-22-6-3-18(15-27-22)14-26-20-4-5-21-19(13-20)7-10-25-23(21)24/h3-7,10,13,15,17,26H,2,8-9,11-12,14,16H2,1H3,(H2,24,25)	PRHIFYJJLKNAIF-UHFFFAOYSA-N	652430	6-N-({6-[(1-ethylpiperidin-4-yl)methoxy]pyridin-3-yl}methyl)isoquinoline-1,6-diamine::US20240059691, Example 1010	Plasma kallikrein			 6500							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652430	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652430&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			170928402	494496582							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377622	CN1CCC(CC1)OCc1ccc(COc2ccc3c(N)nccc3c2)cc1	InChI=1S/C23H27N3O2/c1-26-12-9-20(10-13-26)27-15-17-2-4-18(5-3-17)16-28-21-6-7-22-19(14-21)8-11-25-23(22)24/h2-8,11,14,20H,9-10,12-13,15-16H2,1H3,(H2,24,25)	QDUVSTRMUNWXBX-UHFFFAOYSA-N	652431	6-[(4-{[(1-methylpiperidin-4-yl)oxy]methyl}phenyl)methoxy]isoquinolin-1-amine::US20240059691, Example 1011	Plasma kallikrein			 25000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652431	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652431&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163390482	494496583							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377623	CC(C)N1CCC(COc2ccc(CNc3ccc4c(N)nccc4c3)cn2)CC1	InChI=1S/C24H31N5O/c1-17(2)29-11-8-18(9-12-29)16-30-23-6-3-19(15-28-23)14-27-21-4-5-22-20(13-21)7-10-26-24(22)25/h3-7,10,13,15,17-18,27H,8-9,11-12,14,16H2,1-2H3,(H2,25,26)	RBVSANJGHRPNCU-UHFFFAOYSA-N	652432	6-N-({6-[(1-isopropylpiperidin-4-yl)methoxy]pyridin-3-yl}methyl)isoquinoline-1,6- diamine::US20240059691, Example 1012	Plasma kallikrein			 2000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652432	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652432&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163390504	494496584							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377627	CN1CCC(COc2ncc(CNc3ccc4c(N)nccc4c3)cn2)CC1	InChI=1S/C21H26N6O/c1-27-8-5-15(6-9-27)14-28-21-25-12-16(13-26-21)11-24-18-2-3-19-17(10-18)4-7-23-20(19)22/h2-4,7,10,12-13,15,24H,5-6,8-9,11,14H2,1H3,(H2,22,23)	XEVLXXSTUOLYHZ-UHFFFAOYSA-N	652433	6-N-({2-[(1-methylpiperidin-4-yl)methoxy]pyrimidin-5-yl}methyl)isoquinoline-1,6- diamine::US20240059691, Example 1013	Plasma kallikrein			 6500							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652433	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652433&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362648	494496585							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377631	Nc1nccc2c(NCc3ccc(OCC4CCn5ccnc5C4)nc3)cccc12	InChI=1S/C23H24N6O/c24-23-19-2-1-3-20(18(19)6-8-26-23)27-13-17-4-5-22(28-14-17)30-15-16-7-10-29-11-9-25-21(29)12-16/h1-6,8-9,11,14,16,27H,7,10,12-13,15H2,(H2,24,26)	QSELANVBWNKHHL-UHFFFAOYSA-N	652449	N5-((6-((5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-7-yl)methoxy)pyridin-3-yl)methyl)isoquinoline-1,5-diamine::US20240059691, Example 1029::US20240059691, Example 1030	Plasma kallikrein			 25000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652449	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652449&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163390440	494496599							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377635	Nc1nccc2c(NCc3ccc(OCC4CCn5ccnc5C4)nc3)cccc12	InChI=1S/C23H24N6O/c24-23-19-2-1-3-20(18(19)6-8-26-23)27-13-17-4-5-22(28-14-17)30-15-16-7-10-29-11-9-25-21(29)12-16/h1-6,8-9,11,14,16,27H,7,10,12-13,15H2,(H2,24,26)	QSELANVBWNKHHL-UHFFFAOYSA-N	652449	N5-((6-((5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-7-yl)methoxy)pyridin-3-yl)methyl)isoquinoline-1,5-diamine::US20240059691, Example 1029::US20240059691, Example 1030	Plasma kallikrein			 25000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652449	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652449&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163390440	494496599							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377639	CN1CCC(CNc2ccc(CNc3ccc4c(N)nccc4c3)cn2)CC1	InChI=1S/C22H28N6/c1-28-10-7-16(8-11-28)13-26-21-5-2-17(15-27-21)14-25-19-3-4-20-18(12-19)6-9-24-22(20)23/h2-6,9,12,15-16,25H,7-8,10-11,13-14H2,1H3,(H2,23,24)(H,26,27)	HSNORKMSWCSMOD-UHFFFAOYSA-N	652453	N6-((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)methyl)isoquinoline-1,6- diamine::US20240059691, Example 1033	Plasma kallikrein			 2000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652453	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652453&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163390486	494496602							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377643	Nc1nccc2c(NCc3ccc(CN4CCOCC4)cc3F)cccc12	InChI=1S/C21H23FN4O/c22-19-12-15(14-26-8-10-27-11-9-26)4-5-16(19)13-25-20-3-1-2-18-17(20)6-7-24-21(18)23/h1-7,12,25H,8-11,13-14H2,(H2,23,24)	ABVVTLDDAJPMKZ-UHFFFAOYSA-N	652454	5-N-{[2-fluoro-4-(morpholin-4-ylmethyl)phenyl]methyl}isoquinoline-1,5-diamine::US20240059691, Example 1034	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652454	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652454&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			170928485	494496603							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377647	Cn1ccnc1CCCOc1ncc(CNc2cccc3c(N)nccc23)cn1	InChI=1S/C21H23N7O/c1-28-10-9-23-19(28)6-3-11-29-21-26-13-15(14-27-21)12-25-18-5-2-4-17-16(18)7-8-24-20(17)22/h2,4-5,7-10,13-14,25H,3,6,11-12H2,1H3,(H2,22,24)	RGZWSMZUUVHSMD-UHFFFAOYSA-N	652455	N5-((2-(3-(1-methyl-1H-imidazol-2-yl)propoxy)pyrimidin-5-yl)methyl)isoquinoline-1,5- diamine::US20240059691, Example 1035	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652455	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652455&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362651	494496604							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377651	CC(C)N1CC2(CN(Cc3ccc(CNc4cccc5c(N)nccc45)c(F)c3)C2)C1	InChI=1S/C25H30FN5/c1-17(2)31-15-25(16-31)13-30(14-25)12-18-6-7-19(22(26)10-18)11-29-23-5-3-4-21-20(23)8-9-28-24(21)27/h3-10,17,29H,11-16H2,1-2H3,(H2,27,28)	XEJIXVCRPCLTGX-UHFFFAOYSA-N	652456	N5-(2-fluoro-4-((6-isopropyl-2,6-diazaspiro[3.3]heptan-2-yl)methyl)benzyl)isoquinoline- 1,5-diamine::US20240059691, Example 1036	Plasma kallikrein			 25000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652456	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652456&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362652	494496605							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377655	CC(C)N1CC2(CN(Cc3ccc(CNc4ccc5c(N)nccc5c4)c(F)c3)C2)C1	InChI=1S/C25H30FN5/c1-17(2)31-15-25(16-31)13-30(14-25)12-18-3-4-20(23(26)9-18)11-29-21-5-6-22-19(10-21)7-8-28-24(22)27/h3-10,17,29H,11-16H2,1-2H3,(H2,27,28)	IVQXOYFHEXATGH-UHFFFAOYSA-N	652457	6-N-{[2-fluoro-4-({6-isopropyl-2,6-diazaspiro[3.3]heptan-2- yl}methyl)phenyl]methyl}isoquinoline-1,6-diamine::US20240059691, Example 1037	Plasma kallikrein			 25000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652457	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652457&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362653	494496606							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377660	Nc1nccc2c(NCc3cnc(NCCC(=O)N4CCCC4)nc3)cccc12	InChI=1S/C21H25N7O/c22-20-17-4-3-5-18(16(17)6-8-23-20)25-12-15-13-26-21(27-14-15)24-9-7-19(29)28-10-1-2-11-28/h3-6,8,13-14,25H,1-2,7,9-12H2,(H2,22,23)(H,24,26,27)	LQPBUGNVRFSDSO-UHFFFAOYSA-N	652459	3-[(5-{[(1-aminoisoquinolin-5-yl)amino]methyl}pyrimidin-2-yl)amino]-1-(pyrrolidin-1- yl)propan-1-one::US20240059691, Example 1039	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652459	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652459&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362655	494496608							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377661	Nc1ncc(Cl)c2cc(NCc3cnc(NCCC(=O)N4CCCC4)nc3)ccc12	InChI=1S/C21H24ClN7O/c22-18-13-26-20(23)16-4-3-15(9-17(16)18)25-10-14-11-27-21(28-12-14)24-6-5-19(30)29-7-1-2-8-29/h3-4,9,11-13,25H,1-2,5-8,10H2,(H2,23,26)(H,24,27,28)	HCXAXUJNHUHROI-UHFFFAOYSA-N	652460	3-[(5-{[(1-amino-4-chloroisoquinolin-6-yl)amino]methyl}pyrimidin-2-yl)amino]-1- (pyrrolidin-1-yl)propan-1-one::US20240059691, Example 1040	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652460	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652460&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362656	494496609							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377662	Nc1nccc2c(NCc3cnc(OCC4CCn5ccnc5C4)nc3)cccc12	InChI=1S/C22H23N7O/c23-21-18-2-1-3-19(17(18)4-6-25-21)26-11-16-12-27-22(28-13-16)30-14-15-5-8-29-9-7-24-20(29)10-15/h1-4,6-7,9,12-13,15,26H,5,8,10-11,14H2,(H2,23,25)	MAMDUCKALBRXSZ-UHFFFAOYSA-N	652462	5-N-[(2-{5H,6H,7H,8H-imidazo[1,2-a]pyridin-7-ylmethoxy}pyrimidin-5- yl)methyl]isoquinoline-1,5-diamine::US20240059691, Example 1042	Plasma kallikrein			 1.000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652462	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652462&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362657	494496611							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377663	Nc1ncc(Cl)c2cc(NCc3cnc(NCC4CCn5ccnc5C4)nc3)ccc12	InChI=1S/C22H23ClN8/c23-19-13-27-21(24)17-2-1-16(8-18(17)19)26-10-15-11-29-22(30-12-15)28-9-14-3-5-31-6-4-25-20(31)7-14/h1-2,4,6,8,11-14,26H,3,5,7,9-10H2,(H2,24,27)(H,28,29,30)	YFZZZDLTOGMQRM-UHFFFAOYSA-N	652463	4-chloro-6-N-{[2-({5H,6H,7H,8H-imidazo[1,2-a]pyridin-7-ylmethyl}amino)pyrimidin-5- yl]methyl}isoquinoline-1,6-diamine::US20240059691, Example 1043	Plasma kallikrein			 6500							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652463	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652463&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362658	494496612							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377664	Nc1ncc(Cl)c2cc(NCc3ccc(NCC4CCn5ccnc5C4)nc3)ccc12	InChI=1S/C23H24ClN7/c24-20-14-30-23(25)18-3-2-17(10-19(18)20)27-12-16-1-4-21(29-13-16)28-11-15-5-7-31-8-6-26-22(31)9-15/h1-4,6,8,10,13-15,27H,5,7,9,11-12H2,(H2,25,30)(H,28,29)	HNVSWPCXRZMYHN-UHFFFAOYSA-N	652464	4-chloro-6-N-{[6-({5H,6H,7H,8H-imidazo[1,2-a]pyridin-7-ylmethyl}amino)pyridin-3- yl]methyl}isoquinoline-1,6-diamine::US20240059691, Example 1044	Plasma kallikrein			 6500							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652464	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652464&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163390515	494496613							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377665	Nc1nccc2c(NCc3ccc(OC4CCn5ccnc5C4)nc3)cccc12	InChI=1S/C22H22N6O/c23-22-18-2-1-3-19(17(18)6-8-25-22)26-13-15-4-5-21(27-14-15)29-16-7-10-28-11-9-24-20(28)12-16/h1-6,8-9,11,14,16,26H,7,10,12-13H2,(H2,23,25)	WZFGKOMTANPZBQ-UHFFFAOYSA-N	652465	5-N-[(6-{5H,6H,7H,8H-imidazo[1,2-a]pyridin-7-yloxy}pyridin-3-yl)methyl]isoquinoline- 1,5-diamine::US20240059691, Example 1049	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652465	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652465&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163390192	494496614							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377666	Nc1ncc(Cl)c2cc(NCc3ccc(OC4CCn5ccnc5C4)nc3)ccc12	InChI=1S/C22H21ClN6O/c23-19-13-28-22(24)17-3-2-15(9-18(17)19)26-11-14-1-4-21(27-12-14)30-16-5-7-29-8-6-25-20(29)10-16/h1-4,6,8-9,12-13,16,26H,5,7,10-11H2,(H2,24,28)	WEJGUKCOAPTWKH-UHFFFAOYSA-N	652466	4-chloro-6-N-[(6-{5H,6H,7H,8H-imidazo[1,2-a]pyridin-7-yloxy}pyridin-3- yl)methyl]isoquinoline-1,6-diamine::US20240059691, Example 1050	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652466	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652466&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362659	494496615							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377667	Nc1ncc(Cl)c2cc(NCc3cnc(OCC4CCn5ccnc5C4)nc3)ccc12	InChI=1S/C22H22ClN7O/c23-19-12-27-21(24)17-2-1-16(8-18(17)19)26-9-15-10-28-22(29-11-15)31-13-14-3-5-30-6-4-25-20(30)7-14/h1-2,4,6,8,10-12,14,26H,3,5,7,9,13H2,(H2,24,27)	RRDABEWIPOYJNA-UHFFFAOYSA-N	652467	4-chloro-6-N-[(2-{5H,6H,7H,8H-imidazo[1,2-a]pyridin-7-ylmethoxy}pyrimidin-5- yl)methyl]isoquinoline-1,6-diamine::US20240059691, Example 1052	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652467	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652467&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163390364	494496616							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377668	CN1CCC(CNc2ccc(CNc3ccnc(N)c3)cn2)CC1	InChI=1S/C18H26N6/c1-24-8-5-14(6-9-24)11-22-18-3-2-15(13-23-18)12-21-16-4-7-20-17(19)10-16/h2-4,7,10,13-14H,5-6,8-9,11-12H2,1H3,(H,22,23)(H3,19,20,21)	QKQCKOXDCZGXQL-UHFFFAOYSA-N	652468	N4-((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)methyl)pyridine-2,4-diamine::US20240059691, Example 1096	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652468	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652468&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			170928464	494496617							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377672	CN1CCC(CNc2ccc(CNc3cc(C)c4cnccc4c3)cn2)CC1	InChI=1S/C23H29N5/c1-17-11-21(12-20-5-8-24-16-22(17)20)25-14-19-3-4-23(27-15-19)26-13-18-6-9-28(2)10-7-18/h3-5,8,11-12,15-16,18,25H,6-7,9-10,13-14H2,1-2H3,(H,26,27)	ILUPZBBEIXEYJU-UHFFFAOYSA-N	652469	8-methyl-N-((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)methyl)isoquinolin- 6-amine::US20240059691, Example 1102	Plasma kallikrein			 25000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652469	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652469&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362660	494496618							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377673	COc1cc(NCc2ccc(NCC3CCN(C)CC3)nc2)cc2ccncc12	InChI=1S/C23H29N5O/c1-28-9-6-17(7-10-28)13-26-23-4-3-18(15-27-23)14-25-20-11-19-5-8-24-16-21(19)22(12-20)29-2/h3-5,8,11-12,15-17,25H,6-7,9-10,13-14H2,1-2H3,(H,26,27)	JDUYWQCNVTWRCC-UHFFFAOYSA-N	652470	8-methoxy-N-((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)methyl)isoquinolin- 6-amine::US20240059691, Example 1103	Plasma kallikrein			 25000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652470	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652470&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362661	494496619							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377674	CN1CCC(CNc2ccc(CNc3cnn(c3)-c3cccc(Cl)c3)cn2)CC1	InChI=1S/C22H27ClN6/c1-28-9-7-17(8-10-28)12-25-22-6-5-18(14-26-22)13-24-20-15-27-29(16-20)21-4-2-3-19(23)11-21/h2-6,11,14-17,24H,7-10,12-13H2,1H3,(H,25,26)	NHSYGUVXLYWGTI-UHFFFAOYSA-N	652772	5-(((1-(3-chlorophenyl)-1H-pyrazol-4-yl)amino)methyl)-N-((1-methylpiperidin-4- yl)methyl)pyridin-2-amine::US20240059691, Example 1116	Plasma kallikrein			 4.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652772	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652772&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362866	494496913							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377675	Cc1n[nH]c2C(CCc12)Nc1ccc(CNc2ccc3c(N)ncc(Cl)c3c2)cn1			652471	4-chloro-6-N-{[6-({3-methyl-1H,4H,5H,6H-cyclopenta[c]pyrazol-6-yl}amino)pyridin-3- yl]methyl}isoquinoline-1,6-diamine::US20240059691, Example 1118	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652471	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652471&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362662	494496620							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377676	Cc1n[nH]c2C(CCc12)Nc1ccc(CNc2cccc3c(N)nccc23)cn1			652472	N5-((6-((3-methyl-1,4,5,6-tetrahydrocyclopenta[c]pyrazol-6-yl)amino)pyridin-3- yl)methyl)isoquinoline-1,5-diamine::US20240059691, Example 1119	Plasma kallikrein			 25000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652472	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652472&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362663	494496621							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377677	Nc1nccc2c(NCc3ccc(nc3)N3CCn4ccnc4C3)cccc12	InChI=1S/C21H21N7/c22-21-17-2-1-3-18(16(17)6-7-24-21)25-12-15-4-5-19(26-13-15)28-11-10-27-9-8-23-20(27)14-28/h1-9,13,25H,10-12,14H2,(H2,22,24)	YCUHYXGBQOXOJG-UHFFFAOYSA-N	652473	5-N-[(6-{5H,6H,8H-imidazo[1,2-a]piperazin-7-yl}pyridin-3-yl)methyl]isoquinoline-1,5- diamine::US20240059691, Example 1128	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652473	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652473&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362664	494496622							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377684	Nc1ncc(Cl)c2cc(NCc3ccc(nc3)N3CCn4ccnc4C3)ccc12	InChI=1S/C21H20ClN7/c22-18-12-27-21(23)16-3-2-15(9-17(16)18)25-10-14-1-4-19(26-11-14)29-8-7-28-6-5-24-20(28)13-29/h1-6,9,11-12,25H,7-8,10,13H2,(H2,23,27)	QMDJPULBAHNRPP-UHFFFAOYSA-N	652474	4-chloro-6-N-[(6-{5H,6H,8H-imidazo[1,2-a]pyrazin-7-yl}pyridin-3-yl)methyl]isoquinoline- 1,6-diamine::US20240059691, Example 1129	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652474	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652474&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362665	494496623							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377685	CC(C)(O)[C@@H]1CCN(C1)c1ccc(CNc2cccc3c(N)nccc23)cn1	InChI=1S/C22H27N5O/c1-22(2,28)16-9-11-27(14-16)20-7-6-15(13-26-20)12-25-19-5-3-4-18-17(19)8-10-24-21(18)23/h3-8,10,13,16,25,28H,9,11-12,14H2,1-2H3,(H2,23,24)/t16-/m1/s1	RVZMGIRXGXNIQX-MRXNPFEDSA-N	652475	(R)-2-(1-(5-(((1-aminoisoquinolin-5-yl)amino)methyl)pyridin-2- yl)pyrrolidin-3-yl)propan-2-ol::US20240059691, Example 1130	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652475	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652475&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362666	494496624							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377686	CC(C)(O)[C@H]1CCN(C1)c1ccc(CNc2cccc3c(N)nccc23)cn1	InChI=1S/C22H27N5O/c1-22(2,28)16-9-11-27(14-16)20-7-6-15(13-26-20)12-25-19-5-3-4-18-17(19)8-10-24-21(18)23/h3-8,10,13,16,25,28H,9,11-12,14H2,1-2H3,(H2,23,24)/t16-/m0/s1	RVZMGIRXGXNIQX-INIZCTEOSA-N	652476	(S)-2-(1-(5-(((1-aminoisoquinolin-5-yl)amino)methyl)pyridin-2- yl)pyrrolidin-3-yl)propan-2-ol::US20240059691, Example 1131	Plasma kallikrein			 25000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652476	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652476&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163390317	494496625							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377687	Nc1nccc2c(NCc3ccc(nc3)N3CC(CO)n4ccnc4C3)cccc12	InChI=1S/C22H23N7O/c23-22-18-2-1-3-19(17(18)6-7-25-22)26-10-15-4-5-20(27-11-15)28-12-16(14-30)29-9-8-24-21(29)13-28/h1-9,11,16,26,30H,10,12-14H2,(H2,23,25)	JZPODAVPOMGNMF-UHFFFAOYSA-N	652477	(7-(5-(((1-aminoisoquinolin-5-yl)amino)methyl)pyridin-2-yl)-5,6,7,8- tetrahydroimidazo[1,2-a]pyrazin-5-yl)methanol::US20240059691, Example 1133	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652477	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652477&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362667	494496626							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377688	CC(C)(O)C1CN(Cc2nccn12)c1ccc(CNc2cccc3c(N)nccc23)cn1	InChI=1S/C24H27N7O/c1-24(2,32)20-14-30(15-22-26-10-11-31(20)22)21-7-6-16(13-29-21)12-28-19-5-3-4-18-17(19)8-9-27-23(18)25/h3-11,13,20,28,32H,12,14-15H2,1-2H3,(H2,25,27)	HTMRVUDGLWUJCD-UHFFFAOYSA-N	652478	2-(7-(5-(((1-aminoisoquinolin-5-yl)amino)methyl)pyridin-2-yl)-5,6,7,8- tetrahydroimidazo[1,2-a]pyrazin-5-yl)propan-2-ol::US20240059691, Example 1135	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652478	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652478&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362668	494496627							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377689	Nc1nccc2c(NCc3ccc(nc3)N3Cc4nccn4CC3CO)cccc12	InChI=1S/C22H23N7O/c23-22-18-2-1-3-19(17(18)6-7-25-22)26-10-15-4-5-20(27-11-15)29-13-21-24-8-9-28(21)12-16(29)14-30/h1-9,11,16,26,30H,10,12-14H2,(H2,23,25)	IJQWOBZCCZVVSR-UHFFFAOYSA-N	652479	(7-(5-(((1-aminoisoquinolin-5-yl)amino)methyl)pyridin-2-yl)-5,6,7,8- tetrahydroimidazo[1,2-a]pyrazin-6-yl)methanol::US20240059691, Example 1137	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652479	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652479&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362669	494496628							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377690	Nc1nccc2c(NCc3ccc(nc3)N3CCn4ccnc4C3CO)cccc12	InChI=1S/C22H23N7O/c23-21-17-2-1-3-18(16(17)6-7-24-21)26-12-15-4-5-20(27-13-15)29-11-10-28-9-8-25-22(28)19(29)14-30/h1-9,13,19,26,30H,10-12,14H2,(H2,23,24)	ODJCCFVIXSQTJB-UHFFFAOYSA-N	652480	(7-(5-(((1-aminoisoquinolin-5-yl)amino)methyl)pyridin-2-yl)-5,6,7,8- tetrahydroimidazo[1,2-a]pyrazin-8-yl)methanol::US20240059691, Example 1140	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652480	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652480&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362670	494496629							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377691	CC1N(CCn2ccnc12)c1ccc(CNc2cccc3c(N)nccc23)cn1	InChI=1S/C22H23N7/c1-15-22-25-9-10-28(22)11-12-29(15)20-6-5-16(14-27-20)13-26-19-4-2-3-18-17(19)7-8-24-21(18)23/h2-10,14-15,26H,11-13H2,1H3,(H2,23,24)	YSHBWHHQCNCYQM-UHFFFAOYSA-N	652481	N5-((6-(8-methyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl)pyridin-3- yl)methyl)isoquinoline-1,5-diamine::US20240059691, Example 1150	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652481	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652481&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362671	494496630							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377692	Nc1nccc2c(NCc3ccc(nc3)N3CCn4nccc4C3)cccc12	InChI=1S/C21H21N7/c22-21-18-2-1-3-19(17(18)7-8-23-21)24-12-15-4-5-20(25-13-15)27-10-11-28-16(14-27)6-9-26-28/h1-9,13,24H,10-12,14H2,(H2,22,23)	IHVYENJPKMBNDT-UHFFFAOYSA-N	652482	N5-((6-(6,7-dihydropyrazolo[1,5-a]pyrazin-5(4H)-yl)pyridin-3-yl)methyl)isoquinoline-1,5- diamine::US20240059691, Example 1156	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652482	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652482&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362672	494496631							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377693	Nc1ncc(Cl)c2cc(NCc3ccc(nc3)N3CCn4nccc4C3)ccc12	InChI=1S/C21H20ClN7/c22-19-12-26-21(23)17-3-2-15(9-18(17)19)24-10-14-1-4-20(25-11-14)28-7-8-29-16(13-28)5-6-27-29/h1-6,9,11-12,24H,7-8,10,13H2,(H2,23,26)	LWQSKYBRVMKAIH-UHFFFAOYSA-N	652773	4-chloro-N6-((6-(6,7-dihydropyrazolo[1,5-a]pyrazin-5(4H)-yl)pyridin-3- yl)methyl)isoquinoline-1,6-diamine::US20240059691, Example 1157	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652773	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652773&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362867	494496914							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377694	CC(C)(O)c1cn2CCN(Cc2n1)c1ccc(CNc2cccc3c(N)nccc23)cn1	InChI=1S/C24H27N7O/c1-24(2,32)20-14-30-10-11-31(15-22(30)29-20)21-7-6-16(13-28-21)12-27-19-5-3-4-18-17(19)8-9-26-23(18)25/h3-9,13-14,27,32H,10-12,15H2,1-2H3,(H2,25,26)	CFABJMBLMVPGCU-UHFFFAOYSA-N	652483	2-(7-(5-(((1-aminoisoquinolin-5-yl)amino)methyl)pyridin-2-yl)-5,6,7,8- tetrahydroimidazo[1,2-a]pyrazin-2-yl)propan-2-ol::US20240059691, Example 1163	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652483	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652483&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362673	494496632							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377695	CC(C)(O)c1cnc2CN(CCn12)c1ccc(CNc2cccc3c(N)nccc23)cn1	InChI=1S/C24H27N7O/c1-24(2,32)20-14-29-22-15-30(10-11-31(20)22)21-7-6-16(13-28-21)12-27-19-5-3-4-18-17(19)8-9-26-23(18)25/h3-9,13-14,27,32H,10-12,15H2,1-2H3,(H2,25,26)	FXLFPPCHWPIUAR-UHFFFAOYSA-N	652484	2-(7-(5-(((1-aminoisoquinolin-5-yl)amino)methyl)pyridin-2-yl)-5,6,7,8- tetrahydroimidazo[1,2-a]pyrazin-3-yl)propan-2-ol::US20240059691, Example 1167	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652484	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652484&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362674	494496633							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377696	CC(C)(O)[C@H]1CCN(C1)c1ccc(CNc2ccc3c(N)ncc(Cl)c3c2)cn1	InChI=1S/C22H26ClN5O/c1-22(2,29)15-7-8-28(13-15)20-6-3-14(11-26-20)10-25-16-4-5-17-18(9-16)19(23)12-27-21(17)24/h3-6,9,11-12,15,25,29H,7-8,10,13H2,1-2H3,(H2,24,27)/t15-/m0/s1	MXLBORNZGRKMKV-HNNXBMFYSA-N	652486	2-[(3S)-1-(5-{[(1-amino-4-chloroisoquinolin-6-yl)amino]methyl}pyridin-2-yl)pyrrolidin-3- yl]propan-2-ol::US20240059691, Example 1176	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652486	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652486&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362676	494496635							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377697	COc1ccc2ncc(NCc3ccc(NCC4CCN(C)CC4)nc3)cc2c1	InChI=1S/C23H29N5O/c1-28-9-7-17(8-10-28)13-26-23-6-3-18(15-27-23)14-24-20-11-19-12-21(29-2)4-5-22(19)25-16-20/h3-6,11-12,15-17,24H,7-10,13-14H2,1-2H3,(H,26,27)	PRDOOCNMTGAUKJ-UHFFFAOYSA-N	652774	6-methoxy-N-((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)methyl)quinolin- 3-amine::US20240059691, Example 1177	Plasma kallikrein			 4.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652774	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652774&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362868	494496915							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377698	COc1cccc2ccc(NCc3ccc(NCC4CCN(C)CC4)nc3)cc12	InChI=1S/C24H30N4O/c1-28-12-10-18(11-13-28)15-26-24-9-6-19(17-27-24)16-25-21-8-7-20-4-3-5-23(29-2)22(20)14-21/h3-9,14,17-18,25H,10-13,15-16H2,1-2H3,(H,26,27)	ORMZBSPKNSYEIW-UHFFFAOYSA-N	652775	5-(((8-methoxynaphthalen-2-yl)amino)methyl)-N-((1-methylpiperidin-4- yl)methyl)pyridin-2-amine::US20240059691, Example 1178	Plasma kallikrein			 4.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652775	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652775&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362869	494496916							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377699	COc1ccc2cc(NCc3ccc(NCC4CCN(C)CC4)nc3)ccc2c1	InChI=1S/C24H30N4O/c1-28-11-9-18(10-12-28)15-26-24-8-3-19(17-27-24)16-25-22-6-4-21-14-23(29-2)7-5-20(21)13-22/h3-8,13-14,17-18,25H,9-12,15-16H2,1-2H3,(H,26,27)	KEYFRJQQFXCCIR-UHFFFAOYSA-N	652776	5-(((6-methoxynaphthalen-2-yl)amino)methyl)-N-((1-methylpiperidin-4- yl)methyl)pyridin-2-amine::US20240059691, Example 1180	Plasma kallikrein			 4.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652776	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652776&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362870	494496917							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377700	Nc1nccc2c(NCc3ccc(NCCc4nccn4C(F)F)nc3)cccc12	InChI=1S/C21H21F2N7/c22-21(23)30-11-10-26-19(30)7-9-25-18-5-4-14(13-29-18)12-28-17-3-1-2-16-15(17)6-8-27-20(16)24/h1-6,8,10-11,13,21,28H,7,9,12H2,(H2,24,27)(H,25,29)	LZTSERAEHCDHEM-UHFFFAOYSA-N	652487	N5-((6-((2-(1-(difluoromethyl)-1H-imidazol-2-yl)ethyl)amino)pyridin-3- yl)methyl)isoquinoline-1,5-diamine::US20240059691, Example 1181	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652487	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652487&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362677	494496636							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377701	Nc1ncc(Cl)c2cc(NCc3ccc(NCCc4nccn4C(F)F)nc3)ccc12	InChI=1S/C21H20ClF2N7/c22-17-12-30-20(25)15-3-2-14(9-16(15)17)28-10-13-1-4-18(29-11-13)26-6-5-19-27-7-8-31(19)21(23)24/h1-4,7-9,11-12,21,28H,5-6,10H2,(H2,25,30)(H,26,29)	FDVFMMRGPVOTGK-UHFFFAOYSA-N	652488	4-chloro-N6-((6-((2-(1-(difluoromethyl)-1H-imidazol-2-yl)ethyl)amino)pyridin-3- yl)methyl)isoquinoline-1,6-diamine::US20240059691, Example 1182	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652488	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652488&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362678	494496637							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377702	CN1CCC(CNc2ccc(CNc3cnc4ccccc4c3)cn2)CC1	InChI=1S/C22H27N5/c1-27-10-8-17(9-11-27)13-25-22-7-6-18(15-26-22)14-23-20-12-19-4-2-3-5-21(19)24-16-20/h2-7,12,15-17,23H,8-11,13-14H2,1H3,(H,25,26)	BCVRCMFGEFRPPG-UHFFFAOYSA-N	652777	N-((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)methyl)quinolin-3-amine::US20240059691, Example 1183	Plasma kallikrein			 4.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652777	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652777&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			170928364	494496918							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377703	CN1CCC(CNc2ccc(CNc3ccc4cccnc4c3)cn2)CC1	InChI=1S/C22H27N5/c1-27-11-8-17(9-12-27)14-25-22-7-4-18(16-26-22)15-24-20-6-5-19-3-2-10-23-21(19)13-20/h2-7,10,13,16-17,24H,8-9,11-12,14-15H2,1H3,(H,25,26)	JHSNXLWITGYTLS-UHFFFAOYSA-N	652489	N-((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)methyl)quinolin-7-amine::US20240059691, Example 1184	Plasma kallikrein			 4.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652489	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652489&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			170928361	494496638							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377704	CN(c1nccn1C(F)F)c1ccc(CNc2ccc3c(N)ncc(Cl)c3c2)cn1	InChI=1S/C20H18ClF2N7/c1-29(20-25-6-7-30(20)19(22)23)17-5-2-12(10-27-17)9-26-13-3-4-14-15(8-13)16(21)11-28-18(14)24/h2-8,10-11,19,26H,9H2,1H3,(H2,24,28)	OYVCWOTWAAYBLZ-UHFFFAOYSA-N	652490	4-chloro-N6-((6-((1-(difluoromethyl)-1H-imidazol-2-yl)(methyl)amino)pyridin-3- yl)methyl)isoquinoline-1,6-diamine::US20240059691, Example 1185	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652490	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652490&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362679	494496639							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377705	CN(C)c1ccc(NCc2ccc(NCC3CCN(C)CC3)nc2)nn1	InChI=1S/C19H29N7/c1-25(2)19-7-6-18(23-24-19)22-14-16-4-5-17(21-13-16)20-12-15-8-10-26(3)11-9-15/h4-7,13,15H,8-12,14H2,1-3H3,(H,20,21)(H,22,23)	DFGACCKQXURGBX-UHFFFAOYSA-N	652778	N3,N3-dimethyl-N6-((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3- yl)methyl)pyridazine-3,6-diamine::US20240059691, Example 1186	Plasma kallikrein			 4.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652778	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652778&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362871	494496919							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377706	CN1CCC(CNc2ccc(CNc3cnc4cccnn34)cn2)CC1	InChI=1S/C19H25N7/c1-25-9-6-15(7-10-25)11-20-17-5-4-16(12-21-17)13-22-19-14-23-18-3-2-8-24-26(18)19/h2-5,8,12,14-15,22H,6-7,9-11,13H2,1H3,(H,20,21)	VTFSXGGUBFONIP-UHFFFAOYSA-N	652779	N-((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)methyl)imidazo[1,2- b]pyridazin-3-amine::US20240059691, Example 1187	Plasma kallikrein			 4.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652779	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652779&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362872	494496920							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377707	CN1CCC(CNc2ccc(CNc3ccc4cncc(Cl)c4c3)cn2)CC1	InChI=1S/C22H26ClN5/c1-28-8-6-16(7-9-28)11-26-22-5-2-17(13-27-22)12-25-19-4-3-18-14-24-15-21(23)20(18)10-19/h2-5,10,13-16,25H,6-9,11-12H2,1H3,(H,26,27)	BMEUZVFXSXLVOA-UHFFFAOYSA-N	652491	4-chloro-N-((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)methyl)isoquinolin- 6-amine::US20240059691, Example 1188	Plasma kallikrein			 4.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652491	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652491&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362680	494496640							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377708	CN1CCC(CNc2ccc(CNc3cnc4nccnc4c3)cn2)CC1	InChI=1S/C20H25N7/c1-27-8-4-15(5-9-27)11-24-19-3-2-16(13-25-19)12-23-17-10-18-20(26-14-17)22-7-6-21-18/h2-3,6-7,10,13-15,23H,4-5,8-9,11-12H2,1H3,(H,24,25)	UDIDAFGDTQEITD-UHFFFAOYSA-N	652492	N-((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)methyl)pyrido[2,3-b]pyrazin- 7-amine::US20240059691, Example 1189	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652492	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652492&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362681	494496641							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377709	CN1CCC(CNc2ccc(CNc3cccn4ccnc34)cn2)CC1	InChI=1S/C20H26N6/c1-25-10-6-16(7-11-25)13-23-19-5-4-17(15-24-19)14-22-18-3-2-9-26-12-8-21-20(18)26/h2-5,8-9,12,15-16,22H,6-7,10-11,13-14H2,1H3,(H,23,24)	NHZYLZMZWKDMRI-UHFFFAOYSA-N	652780	N-((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)methyl)imidazo[1,2-a]pyridin- 8-amine::US20240059691, Example 1190	Plasma kallikrein			 4.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652780	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652780&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362873	494496921							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377710	CN1CCC(CNc2ccc(CNc3ccc4[nH]cnc4c3F)cn2)CC1	InChI=1S/C20H25FN6/c1-27-8-6-14(7-9-27)10-23-18-5-2-15(12-24-18)11-22-16-3-4-17-20(19(16)21)26-13-25-17/h2-5,12-14,22H,6-11H2,1H3,(H,23,24)(H,25,26)	ODJGOZLPJGUXRQ-UHFFFAOYSA-N	652781	4-fluoro-N-((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)methyl)-1H- benzo[d]imidazol-5-amine::US20240059691, Example 1191	Plasma kallikrein			 4.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652781	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652781&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362874	494496922							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377711	CN1CCC(CNc2ccc(CNc3nc4ccccc4n3C)cn2)CC1	InChI=1S/C21H28N6/c1-26-11-9-16(10-12-26)13-22-20-8-7-17(14-23-20)15-24-21-25-18-5-3-4-6-19(18)27(21)2/h3-8,14,16H,9-13,15H2,1-2H3,(H,22,23)(H,24,25)	XPABXPVKWADXSD-UHFFFAOYSA-N	652782	1-methyl-N-((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)methyl)-1H- benzo[d]imidazol-2-amine::US20240059691, Example 1192	Plasma kallikrein			 4.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652782	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652782&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362875	494496923							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377712	CN1CCC(CNc2ccc(CNc3ccc4c(N)ncc(Cl)c4c3)cn2)CC1	InChI=1S/C22H27ClN6/c1-29-8-6-15(7-9-29)11-26-21-5-2-16(13-27-21)12-25-17-3-4-18-19(10-17)20(23)14-28-22(18)24/h2-5,10,13-15,25H,6-9,11-12H2,1H3,(H2,24,28)(H,26,27)	IRNZVUXYIYRDLA-UHFFFAOYSA-N	652493	4-chloro-N6-((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3- yl)methyl)isoquinoline-1,6-diamine::US20240059691, Example 1193	Plasma kallikrein			 6500							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652493	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652493&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362682	494496642							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377713	CN1CCC(CNc2ccc(CNc3cccc4c(N)ncc(F)c34)cn2)CC1	InChI=1S/C22H27FN6/c1-29-9-7-15(8-10-29)11-26-20-6-5-16(13-27-20)12-25-19-4-2-3-17-21(19)18(23)14-28-22(17)24/h2-6,13-15,25H,7-12H2,1H3,(H2,24,28)(H,26,27)	JIJJXSHEUUVQGS-UHFFFAOYSA-N	652494	4-fluoro-N5-((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3- yl)methyl)isoquinoline-1,5-diamine::US20240059691, Example 1194	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652494	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652494&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362683	494496643							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377714	CN1CCC(CNc2ccc(CNc3ccc4c(N)ncc(F)c4c3)cn2)CC1	InChI=1S/C22H27FN6/c1-29-8-6-15(7-9-29)11-26-21-5-2-16(13-27-21)12-25-17-3-4-18-19(10-17)20(23)14-28-22(18)24/h2-5,10,13-15,25H,6-9,11-12H2,1H3,(H2,24,28)(H,26,27)	UAPHILZRWZABNH-UHFFFAOYSA-N	652495	4-fluoro-N6-((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3- yl)methyl)isoquinoline-1,6-diamine::US20240059691, Example 1195	Plasma kallikrein			 6500							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652495	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652495&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362684	494496644							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377715	CN1CCC(CNc2ccc(CNc3cc4ccnc(N)c4cn3)cn2)CC1	InChI=1S/C21H27N7/c1-28-8-5-15(6-9-28)11-24-19-3-2-16(12-25-19)13-26-20-10-17-4-7-23-21(22)18(17)14-27-20/h2-4,7,10,12,14-15H,5-6,8-9,11,13H2,1H3,(H2,22,23)(H,24,25)(H,26,27)	NZYPDXBDQWJTAF-UHFFFAOYSA-N	652496	N6-((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)methyl)-2,7-naphthyridine- 1,6-diamine::US20240059691, Example 1196	Plasma kallikrein			 6500							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652496	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652496&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362685	494496645							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377716	CN1CCC(CNc2ccc(CNc3ccnc4[nH]ccc34)cn2)CC1	InChI=1S/C20H26N6/c1-26-10-6-15(7-11-26)12-24-19-3-2-16(14-25-19)13-23-18-5-9-22-20-17(18)4-8-21-20/h2-5,8-9,14-15H,6-7,10-13H2,1H3,(H,24,25)(H2,21,22,23)	OQHYZXMZPSUAEY-UHFFFAOYSA-N	652497	N-((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)methyl)-1H-pyrrolo[2,3- b]pyridin-4-amine::US20240059691, Example 1197	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652497	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652497&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362686	494496646							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377723	CN1CCC(CNc2ccc(CNc3ccc4cncc(N5CCCCC5)c4c3)cn2)CC1	InChI=1S/C27H36N6/c1-32-13-9-21(10-14-32)16-30-27-8-5-22(18-31-27)17-29-24-7-6-23-19-28-20-26(25(23)15-24)33-11-3-2-4-12-33/h5-8,15,18-21,29H,2-4,9-14,16-17H2,1H3,(H,30,31)	RCCGPWQOIKOWGO-UHFFFAOYSA-N	652498	N-((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)methyl)-4-(piperidin-1- yl)isoquinolin-6-amine::US20240059691, Example 1198	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652498	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652498&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362687	494496647							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377724	CN1CCC(CNc2ccc(CNc3cc4n(c3)cc[nH]c4=O)cn2)CC1	InChI=1S/C20H26N6O/c1-25-7-4-15(5-8-25)11-23-19-3-2-16(13-24-19)12-22-17-10-18-20(27)21-6-9-26(18)14-17/h2-3,6,9-10,13-15,22H,4-5,7-8,11-12H2,1H3,(H,21,27)(H,23,24)	PUHNXFQRVAVWLE-UHFFFAOYSA-N	652783	7-(((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)methyl)amino)pyrrolo[1,2- a]pyrazin-1(2H)-one::US20240059691, Example 1199	Plasma kallikrein			 4.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652783	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652783&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362876	494496924							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377725	COc1cccc2sc(NCc3ccc(NCC4CCN(C)CC4)nc3)nc12	InChI=1S/C21H27N5OS/c1-26-10-8-15(9-11-26)12-22-19-7-6-16(13-23-19)14-24-21-25-20-17(27-2)4-3-5-18(20)28-21/h3-7,13,15H,8-12,14H2,1-2H3,(H,22,23)(H,24,25)	HCYXLWMYIVHUJT-UHFFFAOYSA-N	652784	4-methoxy-N-((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3- yl)methyl)benzo[d]thiazol-2-amine::US20240059691, Example 1200	Plasma kallikrein			 4.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652784	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652784&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362877	494496925							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377726	CN1CCC(CNc2ccc(CNc3ccc4c[nH]c(=O)cc4c3)cn2)CC1	InChI=1S/C22H27N5O/c1-27-8-6-16(7-9-27)12-24-21-5-2-17(14-25-21)13-23-20-4-3-18-15-26-22(28)11-19(18)10-20/h2-5,10-11,14-16,23H,6-9,12-13H2,1H3,(H,24,25)(H,26,28)	JEYUDBDSRYRUCL-UHFFFAOYSA-N	652499	6-(((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)methyl)amino)isoquinolin- 3(2H)-one::US20240059691, Example 1201	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652499	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652499&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362688	494496648							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377727	CN1CCC(CNc2ccc(CNc3ccnc4[nH]c(C)cc34)cn2)CC1	InChI=1S/C21H28N6/c1-15-11-18-19(5-8-22-21(18)26-15)23-13-17-3-4-20(25-14-17)24-12-16-6-9-27(2)10-7-16/h3-5,8,11,14,16H,6-7,9-10,12-13H2,1-2H3,(H,24,25)(H2,22,23,26)	OGEBHANRXXUPQA-UHFFFAOYSA-N	652500	2-methyl-N-((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)methyl)-1H- pyrrolo[2,3-b]pyridin-4-amine::US20240059691, Example 1202	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652500	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652500&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163390287	494496649							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377731	CN1CCC(CNc2ccc(CNc3cc(C(O)=O)c4cnccc4c3)cn2)CC1	InChI=1S/C23H27N5O2/c1-28-8-5-16(6-9-28)12-26-22-3-2-17(14-27-22)13-25-19-10-18-4-7-24-15-21(18)20(11-19)23(29)30/h2-4,7,10-11,14-16,25H,5-6,8-9,12-13H2,1H3,(H,26,27)(H,29,30)	BIBNJLIRLDCTLY-UHFFFAOYSA-N	652785	6-(((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)methyl)amino)isoquinoline- 8-carboxylic acid::US20240059691, Example 1203	Plasma kallikrein			 4.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652785	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652785&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362878	494496926							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377732	CN1CCC(CNc2ccc(CNc3cc(C(O)=O)c4[nH]cc(Cl)c4c3)cn2)CC1	InChI=1S/C22H26ClN5O2/c1-28-6-4-14(5-7-28)10-25-20-3-2-15(12-26-20)11-24-16-8-17-19(23)13-27-21(17)18(9-16)22(29)30/h2-3,8-9,12-14,24,27H,4-7,10-11H2,1H3,(H,25,26)(H,29,30)	HZVSMARWGYYNCC-UHFFFAOYSA-N	652786	3-chloro-5-(((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)methyl)amino)-1H- indole-7-carboxylic acid::US20240059691, Example 1204	Plasma kallikrein			 4.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652786	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652786&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362879	494496927							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377733	CN1CCC(CNc2ccc(CNc3c(C)cnc4[nH]ccc34)cn2)CC1	InChI=1S/C21H28N6/c1-15-11-26-21-18(5-8-22-21)20(15)25-14-17-3-4-19(24-13-17)23-12-16-6-9-27(2)10-7-16/h3-5,8,11,13,16H,6-7,9-10,12,14H2,1-2H3,(H,23,24)(H2,22,25,26)	ZOBCVLJKICJDRG-UHFFFAOYSA-N	652501	5-methyl-N-((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)methyl)-1H- pyrrolo[2,3-b]pyridin-4-amine::US20240059691, Example 1205	Plasma kallikrein			 4.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652501	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652501&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362689	494496650							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377734	CN1CCC(CNc2ccc(CNc3c(F)cnc4[nH]ccc34)cn2)CC1	InChI=1S/C20H25FN6/c1-27-8-5-14(6-9-27)10-23-18-3-2-15(11-24-18)12-25-19-16-4-7-22-20(16)26-13-17(19)21/h2-4,7,11,13-14H,5-6,8-10,12H2,1H3,(H,23,24)(H2,22,25,26)	YOKRLSMCQUNZNE-UHFFFAOYSA-N	652502	5-fluoro-N-((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)methyl)-1H- pyrrolo[2,3-b]pyridin-4-amine::US20240059691, Example 1206	Plasma kallikrein			 4.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652502	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652502&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362690	494496651							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377735	CN1CCC(CNc2ccc(CNc3cc(F)c4cnccc4c3)cn2)CC1	InChI=1S/C22H26FN5/c1-28-8-5-16(6-9-28)12-26-22-3-2-17(14-27-22)13-25-19-10-18-4-7-24-15-20(18)21(23)11-19/h2-4,7,10-11,14-16,25H,5-6,8-9,12-13H2,1H3,(H,26,27)	NNCBCXSQAYLZFN-UHFFFAOYSA-N	652503	8-fluoro-N-((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)methyl)isoquinolin- 6-amine::US20240059691, Example 1207	Plasma kallikrein			 4.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652503	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652503&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362691	494496652							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377736	CN1CCC(CNc2ccc(CNc3cc(Cl)c4cnccc4c3)cn2)CC1	InChI=1S/C22H26ClN5/c1-28-8-5-16(6-9-28)12-26-22-3-2-17(14-27-22)13-25-19-10-18-4-7-24-15-20(18)21(23)11-19/h2-4,7,10-11,14-16,25H,5-6,8-9,12-13H2,1H3,(H,26,27)	PVNIDTGGTDOTSU-UHFFFAOYSA-N	652504	8-chloro-N-((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)methyl)isoquinolin- 6-amine::US20240059691, Example 1208	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652504	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652504&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362692	494496653							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377737	CN1CCC(CNc2ccc(CNc3ccc4cnccc4c3Cl)cn2)CC1	InChI=1S/C22H26ClN5/c1-28-10-7-16(8-11-28)12-26-21-5-2-17(14-27-21)13-25-20-4-3-18-15-24-9-6-19(18)22(20)23/h2-6,9,14-16,25H,7-8,10-13H2,1H3,(H,26,27)	DVMDKOVGIYJULU-UHFFFAOYSA-N	652505	5-chloro-N-((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)methyl)isoquinolin- 6-amine::US20240059691, Example 1209	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652505	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652505&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362693	494496654							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377741	CNC(=O)c1cc(NCc2ccc(NCC3CCN(C)CC3)nc2)cc2ccncc12	InChI=1S/C24H30N6O/c1-25-24(31)21-12-20(11-19-5-8-26-16-22(19)21)27-14-18-3-4-23(29-15-18)28-13-17-6-9-30(2)10-7-17/h3-5,8,11-12,15-17,27H,6-7,9-10,13-14H2,1-2H3,(H,25,31)(H,28,29)	IYTVKSKOPUCERH-UHFFFAOYSA-N	652787	N-methyl-6-(((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3- yl)methyl)amino)isoquinoline-8-carboxamide::US20240059691, Example 1210	Plasma kallikrein			 4.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652787	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652787&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362880	494496928							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377742	CN1CCC(CNc2ccc(CNc3cc(CO)c4cnccc4c3)cn2)CC1	InChI=1S/C23H29N5O/c1-28-8-5-17(6-9-28)12-26-23-3-2-18(14-27-23)13-25-21-10-19-4-7-24-15-22(19)20(11-21)16-29/h2-4,7,10-11,14-15,17,25,29H,5-6,8-9,12-13,16H2,1H3,(H,26,27)	ODSQCNVIINTDDI-UHFFFAOYSA-N	652506	(6-(((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)methyl)amino)isoquinolin-8- yl)methanol::US20240059691, Example 1211	Plasma kallikrein			 25000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652506	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652506&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362694	494496655							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377743	CN1CCC(CNc2ccc(CNc3cnc4[nH]cc(C#N)c4c3)cn2)CC1	InChI=1S/C21H25N7/c1-28-6-4-15(5-7-28)10-24-20-3-2-16(12-25-20)11-23-18-8-19-17(9-22)13-26-21(19)27-14-18/h2-3,8,12-15,23H,4-7,10-11H2,1H3,(H,24,25)(H,26,27)	BZJGREGXUZMZHW-UHFFFAOYSA-N	652788	5-(((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)methyl)amino)-1H- pyrrolo[2,3-b]pyridine-3-carbonitrile::US20240059691, Example 1212	Plasma kallikrein			 4.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652788	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652788&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362881	494496929							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377744	CN1CCC(CNc2ccc(CNc3cncc4[nH]ccc34)cn2)CC1	InChI=1S/C20H26N6/c1-26-8-5-15(6-9-26)10-24-20-3-2-16(12-25-20)11-23-19-14-21-13-18-17(19)4-7-22-18/h2-4,7,12-15,22-23H,5-6,8-11H2,1H3,(H,24,25)	ICXJDHNNRWEYID-UHFFFAOYSA-N	652507	N-((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)methyl)-1H-pyrrolo[2,3- c]pyridin-4-amine::US20240059691, Example 1213	Plasma kallikrein			 25000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652507	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652507&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362695	494496656							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377748	CN1CCC(CNc2ccc(CNc3ccc(F)c4cnccc34)cn2)CC1	InChI=1S/C22H26FN5/c1-28-10-7-16(8-11-28)12-26-22-5-2-17(14-27-22)13-25-21-4-3-20(23)19-15-24-9-6-18(19)21/h2-6,9,14-16,25H,7-8,10-13H2,1H3,(H,26,27)	JHYAFLZASKTZRA-UHFFFAOYSA-N	652789	8-fluoro-N-((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)methyl)isoquinolin- 5-amine::US20240059691, Example 1214	Plasma kallikrein			 4.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652789	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652789&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362882	494496930							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377749	CN1CCC(CNc2ccc(CNc3cc(C)cc4[nH]ccc34)cn2)CC1	InChI=1S/C22H29N5/c1-16-11-20-19(5-8-23-20)21(12-16)24-14-18-3-4-22(26-15-18)25-13-17-6-9-27(2)10-7-17/h3-5,8,11-12,15,17,23-24H,6-7,9-10,13-14H2,1-2H3,(H,25,26)	VGUCIKWAVMNVIU-UHFFFAOYSA-N	652790	6-methyl-N-((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)methyl)-1H-indol-4- amine::US20240059691, Example 1215	Plasma kallikrein			 4.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652790	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652790&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362883	494496931							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377750	CN1CCC(CNc2ccc(CNc3ccnc4n(C)c(C)cc34)cn2)CC1	InChI=1S/C22H30N6/c1-16-12-19-20(6-9-23-22(19)28(16)3)24-14-18-4-5-21(26-15-18)25-13-17-7-10-27(2)11-8-17/h4-6,9,12,15,17H,7-8,10-11,13-14H2,1-3H3,(H,23,24)(H,25,26)	QZDMAGNXJZMVEL-UHFFFAOYSA-N	652791	1,2-dimethyl-N-((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)methyl)-1H- pyrrolo[2,3-b]pyridin-4-amine::US20240059691, Example 1216	Plasma kallikrein			 4.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652791	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652791&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362884	494496932							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377751	COc1ccc2c(NCc3ccc(NCC4CCN(C)CC4)nc3)ccnc2c1	InChI=1S/C23H29N5O/c1-28-11-8-17(9-12-28)14-26-23-6-3-18(16-27-23)15-25-21-7-10-24-22-13-19(29-2)4-5-20(21)22/h3-7,10,13,16-17H,8-9,11-12,14-15H2,1-2H3,(H,24,25)(H,26,27)	PKYSKNQPNMACJN-UHFFFAOYSA-N	652508	7-methoxy-N-((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)methyl)quinolin- 4-amine::US20240059691, Example 1217	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652508	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652508&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362696	494496657							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377752	CN1CCC(CNc2ccc(CNc3ccnc4[nH]ncc34)cn2)CC1	InChI=1S/C19H25N7/c1-26-8-5-14(6-9-26)10-22-18-3-2-15(12-23-18)11-21-17-4-7-20-19-16(17)13-24-25-19/h2-4,7,12-14H,5-6,8-11H2,1H3,(H,22,23)(H2,20,21,24,25)	PNQLUOHMGQJZIJ-UHFFFAOYSA-N	652792	N-((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)methyl)-1H-pyrazolo[3,4- b]pyridin-4-amine::US20240059691, Example 1218	Plasma kallikrein			 4.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652792	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652792&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362885	494496933							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377753	CNc1cc(NCc2ccc(NCC3CCN(C)CC3)nc2)ccn1	InChI=1S/C19H28N6/c1-20-19-11-17(5-8-21-19)22-13-16-3-4-18(24-14-16)23-12-15-6-9-25(2)10-7-15/h3-5,8,11,14-15H,6-7,9-10,12-13H2,1-2H3,(H,23,24)(H2,20,21,22)	YJGVSRUWMTWYSN-UHFFFAOYSA-N	652509	N2-methyl-N4-((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)methyl)pyridine- 2,4-diamine::US20240059691, Example 1219	Plasma kallikrein			 4.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652509	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652509&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163390326	494496658							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377754	CNC(=O)c1cc(NCc2ccc(NCC3CCN(C)CC3)nc2)cc2c(Cl)c[nH]c12	InChI=1S/C23H29ClN6O/c1-25-23(31)19-10-17(9-18-20(24)14-29-22(18)19)26-12-16-3-4-21(28-13-16)27-11-15-5-7-30(2)8-6-15/h3-4,9-10,13-15,26,29H,5-8,11-12H2,1-2H3,(H,25,31)(H,27,28)	XURCOCCDRVXHPF-UHFFFAOYSA-N	652793	3-chloro-N-methyl-5-(((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3- yl)methyl)amino)-1H-indole-7-carboxamide::US20240059691, Example 1220	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652793	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652793&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362886	494496934							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377755	CN1CCC(CNc2ccc(CNc3ccnc4[nH]cc(C#N)c34)cn2)CC1	InChI=1S/C21H25N7/c1-28-8-5-15(6-9-28)11-25-19-3-2-16(13-26-19)12-24-18-4-7-23-21-20(18)17(10-22)14-27-21/h2-4,7,13-15H,5-6,8-9,11-12H2,1H3,(H,25,26)(H2,23,24,27)	CFIBONDXCAMHBO-UHFFFAOYSA-N	652794	4-(((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)methyl)amino)-1H- pyrrolo[2,3-b]pyridine-3-carbonitrile::US20240059691, Example 1221	Plasma kallikrein			 4.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652794	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652794&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362887	494496935							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377756	CN1CCC(CNc2ccc(CNc3ccn4ccnc4c3)cn2)CC1	InChI=1S/C20H26N6/c1-25-8-4-16(5-9-25)13-23-19-3-2-17(15-24-19)14-22-18-6-10-26-11-7-21-20(26)12-18/h2-3,6-7,10-12,15-16,22H,4-5,8-9,13-14H2,1H3,(H,23,24)	SMNCFILXGDNFMX-UHFFFAOYSA-N	652795	N-((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)methyl)imidazo[1,2-a]pyridin- 7-amine::US20240059691, Example 1222	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652795	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652795&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362888	494496936							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377757	CN1CCC(CNc2ccc(CNc3nccc4[nH]ccc34)cn2)CC1	InChI=1S/C20H26N6/c1-26-10-6-15(7-11-26)12-23-19-3-2-16(13-24-19)14-25-20-17-4-8-21-18(17)5-9-22-20/h2-5,8-9,13,15,21H,6-7,10-12,14H2,1H3,(H,22,25)(H,23,24)	CFHMDIFNCPNJPN-UHFFFAOYSA-N	652510	N-((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)methyl)-1H-pyrrolo[3,2- c]pyridin-4-amine::US20240059691, Example 1223	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652510	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652510&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362697	494496659							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377758	CN1CCC(CNc2ccc(CNc3ccc4cnccc4c3F)cn2)CC1	InChI=1S/C22H26FN5/c1-28-10-7-16(8-11-28)12-26-21-5-2-17(14-27-21)13-25-20-4-3-18-15-24-9-6-19(18)22(20)23/h2-6,9,14-16,25H,7-8,10-13H2,1H3,(H,26,27)	DXCOONBXASCQJO-UHFFFAOYSA-N	652511	5-fluoro-N-((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)methyl)isoquinolin- 6-amine::US20240059691, Example 1224	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652511	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652511&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362698	494496660							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377762	CN1CCC(CNc2ccc(CNc3ccnc4n(C)ccc34)cn2)CC1	InChI=1S/C21H28N6/c1-26-10-6-16(7-11-26)13-24-20-4-3-17(15-25-20)14-23-19-5-9-22-21-18(19)8-12-27(21)2/h3-5,8-9,12,15-16H,6-7,10-11,13-14H2,1-2H3,(H,22,23)(H,24,25)	SZELELKVDLJRCP-UHFFFAOYSA-N	652796	1-methyl-N-((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)methyl)-1H- pyrrolo[2,3-b]pyridin-4-amine::US20240059691, Example 1225	Plasma kallikrein			 4.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652796	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652796&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362889	494496937							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377763	CN1CCC(CNc2ccc(CNc3ccnc4[nH]cc(C)c34)cn2)CC1	InChI=1S/C21H28N6/c1-15-11-26-21-20(15)18(5-8-22-21)23-13-17-3-4-19(25-14-17)24-12-16-6-9-27(2)10-7-16/h3-5,8,11,14,16H,6-7,9-10,12-13H2,1-2H3,(H,24,25)(H2,22,23,26)	FVDDSGCNQITVMM-UHFFFAOYSA-N	652512	3-methyl-N-((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)methyl)-1H- pyrrolo[2,3-b]pyridin-4-amine::US20240059691, Example 1226	Plasma kallikrein			 4.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652512	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652512&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362699	494496661							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377764	CN1CCC(CNc2ccc(CNc3ncnc4[nH]ccc34)cn2)CC1	InChI=1S/C19H25N7/c1-26-8-5-14(6-9-26)10-21-17-3-2-15(11-22-17)12-23-19-16-4-7-20-18(16)24-13-25-19/h2-4,7,11,13-14H,5-6,8-10,12H2,1H3,(H,21,22)(H2,20,23,24,25)	SXGVFLNIZNFHTR-UHFFFAOYSA-N	652797	N-((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)methyl)-7H-pyrrolo[2,3- d]pyrimidin-4-amine::US20240059691, Example 1227	Plasma kallikrein			 4.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652797	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652797&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362890	494496938							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377765	CN1CCC(CNc2ccc(CNc3cncc4[nH]c(C)cc34)cn2)CC1	InChI=1S/C21H28N6/c1-15-9-18-19(13-22-14-20(18)26-15)23-11-17-3-4-21(25-12-17)24-10-16-5-7-27(2)8-6-16/h3-4,9,12-14,16,23,26H,5-8,10-11H2,1-2H3,(H,24,25)	VSXFBJUEISWNHO-UHFFFAOYSA-N	652513	2-methyl-N-((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)methyl)-1H- pyrrolo[2,3-c]pyridin-4-amine::US20240059691, Example 1232	Plasma kallikrein			 25000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652513	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652513&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163390377	494496662							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377766	CN1CCC(CNc2ccc(CNc3ccnc4[nH]c(Cl)cc34)cn2)CC1	InChI=1S/C20H25ClN6/c1-27-8-5-14(6-9-27)11-24-19-3-2-15(13-25-19)12-23-17-4-7-22-20-16(17)10-18(21)26-20/h2-4,7,10,13-14H,5-6,8-9,11-12H2,1H3,(H,24,25)(H2,22,23,26)	FCXNRNCBQJLWDJ-UHFFFAOYSA-N	652517	2-chloro-N-((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)methyl)-1H- pyrrolo [2,3-b]pyridin-4-amine::US20240059691, Example 1243	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652517	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652517&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362703	494496666							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377770	CN1CCC(CNc2ccc(CNc3cnc(C)c4[nH]ccc34)cn2)CC1	InChI=1S/C21H28N6/c1-15-21-18(5-8-22-21)19(14-23-15)24-12-17-3-4-20(26-13-17)25-11-16-6-9-27(2)10-7-16/h3-5,8,13-14,16,22,24H,6-7,9-12H2,1-2H3,(H,25,26)	LXOKMUCAUGXQFD-UHFFFAOYSA-N	652798	7-methyl-N-((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)methyl)-1H- pyrrolo[2,3-c]pyridin-4-amine::US20240059691, Example 1244	Plasma kallikrein			 4.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652798	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652798&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362891	494496939							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377771	CN1CCC(CNc2ccc(CNc3cc(F)c4c(N)nccc4c3)cn2)CC1	InChI=1S/C22H27FN6/c1-29-8-5-15(6-9-29)12-27-20-3-2-16(14-28-20)13-26-18-10-17-4-7-25-22(24)21(17)19(23)11-18/h2-4,7,10-11,14-15,26H,5-6,8-9,12-13H2,1H3,(H2,24,25)(H,27,28)	YZLZPUCHZLJNNM-UHFFFAOYSA-N	652518	8-fluoro-N6-((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3- yl)methyl)isoquinoline-1,6-diamine::US20240059691, Example 1245	Plasma kallikrein			 6500							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652518	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652518&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362704	494496667							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377772	CN1CCC(CNc2ccc(CNc3cc(C)nc4[nH]ccc34)cn2)CC1	InChI=1S/C21H28N6/c1-15-11-19(18-5-8-22-21(18)26-15)23-13-17-3-4-20(25-14-17)24-12-16-6-9-27(2)10-7-16/h3-5,8,11,14,16H,6-7,9-10,12-13H2,1-2H3,(H,24,25)(H2,22,23,26)	QNINDNUZAIYODL-UHFFFAOYSA-N	652519	6-methyl-N-((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)methyl)-1H- pyrrolo[2,3-b]pyridin-4-amine::US20240059691, Example 1246	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652519	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652519&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362705	494496668							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377773	COC(=O)c1cc2c(NCc3ccc(NCC4CCN(C)CC4)nc3)ccnc2[nH]1	InChI=1S/C22H28N6O2/c1-28-9-6-15(7-10-28)12-25-20-4-3-16(14-26-20)13-24-18-5-8-23-21-17(18)11-19(27-21)22(29)30-2/h3-5,8,11,14-15H,6-7,9-10,12-13H2,1-2H3,(H,25,26)(H2,23,24,27)	OPOMGPXJXBXAIT-UHFFFAOYSA-N	652799	US20240059691, Example 1247::methyl 4-(((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)methyl)amino)-1H- pyrrolo[2,3-b]pyridine-2-carboxylate	Plasma kallikrein			 4.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652799	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652799&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362892	494496940							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377774	COC(=O)c1c[nH]c2nccc(NCc3ccc(NCC4CCN(C)CC4)nc3)c12	InChI=1S/C22H28N6O2/c1-28-9-6-15(7-10-28)11-25-19-4-3-16(13-26-19)12-24-18-5-8-23-21-20(18)17(14-27-21)22(29)30-2/h3-5,8,13-15H,6-7,9-12H2,1-2H3,(H,25,26)(H2,23,24,27)	RYNBOZPKKSEGCY-UHFFFAOYSA-N	652520	US20240059691, Example 1248::methyl 4-(((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)methyl)amino)-1H- pyrrolo[2,3-b]pyridine-3-carboxylate	Plasma kallikrein			 2.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652520	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652520&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362706	494496669							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377775	CN1CCC(COc2ccc(CNc3ccnc4[nH]c(C)cc34)cn2)CC1	InChI=1S/C21H27N5O/c1-15-11-18-19(5-8-22-21(18)25-15)23-12-17-3-4-20(24-13-17)27-14-16-6-9-26(2)10-7-16/h3-5,8,11,13,16H,6-7,9-10,12,14H2,1-2H3,(H2,22,23,25)	CSOIEWKCRIAOFP-UHFFFAOYSA-N	652521	2-methyl-N-((6-((1-methylpiperidin-4-yl)methoxy)pyridin-3-yl)methyl)-1H-pyrrolo[2,3- b]pyridin-4-amine::US20240059691, Example 1249	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652521	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652521&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362707	494496670							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377776	COc1nnc2CN(CCn12)c1ccc(CNc2cccc3c(N)nccc23)cn1	InChI=1S/C21H22N8O/c1-30-21-27-26-19-13-28(9-10-29(19)21)18-6-5-14(12-25-18)11-24-17-4-2-3-16-15(17)7-8-23-20(16)22/h2-8,12,24H,9-11,13H2,1H3,(H2,22,23)	VARXLQCHRPURJT-UHFFFAOYSA-N	652522	N5-((6-(3-methoxy-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)pyridin-3- yl)methyl)isoquinoline-1,5-diamine::US20240059691, Example 1250	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652522	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652522&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362708	494496671							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377780	CN1CCC(CNc2ccc(CNc3cncc4[nH]c(Cl)cc34)cn2)CC1	InChI=1S/C20H25ClN6/c1-27-6-4-14(5-7-27)9-24-20-3-2-15(11-25-20)10-23-17-12-22-13-18-16(17)8-19(21)26-18/h2-3,8,11-14,23,26H,4-7,9-10H2,1H3,(H,24,25)	HGFUJSGIMRORNA-UHFFFAOYSA-N	652523	2-chloro-N-((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)methyl)-1H- pyrrolo[2,3-c]pyridin-4-amine::US20240059691, Example 1251	Plasma kallikrein			 25000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652523	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652523&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163390441	494496672							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377784	CN1CCC(CNc2ccc(CNc3ccnc4[nH]c(cc34)C(N)=O)cn2)CC1	InChI=1S/C21H27N7O/c1-28-8-5-14(6-9-28)11-25-19-3-2-15(13-26-19)12-24-17-4-7-23-21-16(17)10-18(27-21)20(22)29/h2-4,7,10,13-14H,5-6,8-9,11-12H2,1H3,(H2,22,29)(H,25,26)(H2,23,24,27)	AZSFOLIEUYXOIM-UHFFFAOYSA-N	652524	4-(((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)methyl)amino)-1H- pyrrolo[2,3-b]pyridine-2-carboxamide::US20240059691, Example 1252	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652524	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652524&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362709	494496673							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377785	CN1CCC(CNc2ccc(CNc3ccnc4[nH]c(cc34)C(O)=O)cn2)CC1	InChI=1S/C21H26N6O2/c1-27-8-5-14(6-9-27)11-24-19-3-2-15(13-25-19)12-23-17-4-7-22-20-16(17)10-18(26-20)21(28)29/h2-4,7,10,13-14H,5-6,8-9,11-12H2,1H3,(H,24,25)(H,28,29)(H2,22,23,26)	XIQYYGQCOZPBCL-UHFFFAOYSA-N	652800	4-(((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)methyl)amino)-1H- pyrrolo [2,3-b]pyridine-2-carboxylic acid::US20240059691, Example 1253	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652800	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652800&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362893	494496941							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377786	CN1CCC(CNc2ccc(CNc3ncnc4[nH]c(C)cc34)cn2)CC1	InChI=1S/C20H27N7/c1-14-9-17-19(24-13-25-20(17)26-14)23-12-16-3-4-18(22-11-16)21-10-15-5-7-27(2)8-6-15/h3-4,9,11,13,15H,5-8,10,12H2,1-2H3,(H,21,22)(H2,23,24,25,26)	NWYVADAYUACKJE-UHFFFAOYSA-N	652525	6-methyl-N-((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)methyl)-7H- pyrrolo[2,3-d]pyrimidin-4-amine::US20240059691, Example 1254	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652525	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652525&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362710	494496674							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377787	CN1CCC(CNc2ccc(CNc3c(C)cnc4[nH]c(Cl)cc34)cn2)CC1	InChI=1S/C21H27ClN6/c1-14-10-26-21-17(9-18(22)27-21)20(14)25-13-16-3-4-19(24-12-16)23-11-15-5-7-28(2)8-6-15/h3-4,9-10,12,15H,5-8,11,13H2,1-2H3,(H,23,24)(H2,25,26,27)	IBIQIHTZQNFAJZ-UHFFFAOYSA-N	652526	2-chloro-5-methyl-N-((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)methyl)- 1H-pyrrolo[2,3-b]pyridin-4-amine::US20240059691, Example 1255	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652526	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652526&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362711	494496675							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377788	CN(c1ccc(NCC2CCN(C)CC2)nc1)c1cc(cc2[nH]ccc12)C#N	InChI=1S/C22H26N6/c1-27-9-6-16(7-10-27)14-25-22-4-3-18(15-26-22)28(2)21-12-17(13-23)11-20-19(21)5-8-24-20/h3-5,8,11-12,15-16,24H,6-7,9-10,14H2,1-2H3,(H,25,26)	KMGSVVLZZXBRIS-UHFFFAOYSA-N	652527	4-(methyl(6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)amino)-1H-indole-6- carbonitrile::US20240059691, Example 1256::US20240059691, Example 1259	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652527	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652527&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362712	494496676							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377789	CN1CCC(CNc2ccc(CNc3ccnc4NC(C)(C)Cc34)cn2)CC1	InChI=1S/C22H32N6/c1-22(2)12-18-19(6-9-23-21(18)27-22)24-14-17-4-5-20(26-15-17)25-13-16-7-10-28(3)11-8-16/h4-6,9,15-16H,7-8,10-14H2,1-3H3,(H,25,26)(H2,23,24,27)	QBNFQSUCZHCPHS-UHFFFAOYSA-N	652801	2,2-dimethyl-N-((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)methyl)-2,3- dihydro-1H-pyrrolo[2,3-b]pyridin-4-amine::US20240059691, Example 1257	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652801	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652801&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362894	494496942							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377790	CN1CCC(CNc2ccc(CNc3ccncc3)cn2)CC1	InChI=1S/C18H25N5/c1-23-10-6-15(7-11-23)12-21-18-3-2-16(14-22-18)13-20-17-4-8-19-9-5-17/h2-5,8-9,14-15H,6-7,10-13H2,1H3,(H,19,20)(H,21,22)	HIIDKOYKBYPIAD-UHFFFAOYSA-N	652528	N-((1-methylpiperidin-4-yl)methyl)-5-((pyridin-4-ylamino)methyl)pyridin-2-amine::US20240059691, Example 1258	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652528	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652528&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			170928472	494496677							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377791	CN(c1ccc(NCC2CCN(C)CC2)nc1)c1cc(cc2[nH]ccc12)C#N	InChI=1S/C22H26N6/c1-27-9-6-16(7-10-27)14-25-22-4-3-18(15-26-22)28(2)21-12-17(13-23)11-20-19(21)5-8-24-20/h3-5,8,11-12,15-16,24H,6-7,9-10,14H2,1-2H3,(H,25,26)	KMGSVVLZZXBRIS-UHFFFAOYSA-N	652527	4-(methyl(6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)amino)-1H-indole-6- carbonitrile::US20240059691, Example 1256::US20240059691, Example 1259	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652527	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652527&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362712	494496676							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377792	CN1CCC(CNc2ccc(CNc3ccc4cncc(N5CCC(F)(F)C5)c4c3)cn2)CC1	InChI=1S/C26H32F2N6/c1-33-9-6-19(7-10-33)13-31-25-5-2-20(15-32-25)14-30-22-4-3-21-16-29-17-24(23(21)12-22)34-11-8-26(27,28)18-34/h2-5,12,15-17,19,30H,6-11,13-14,18H2,1H3,(H,31,32)	XUGPRSSMQHTMIV-UHFFFAOYSA-N	652803	4-(3,3-difluoropyrrolidin-1-yl)-N-((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3- yl)methyl)isoquinolin-6-amine::US20240059691, Example 1260	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652803	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652803&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362895	494496943							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377793	CN1CCC(CNc2ccc(CNc3cc(nc4[nH]ccc34)C#N)cn2)CC1	InChI=1S/C21H25N7/c1-28-8-5-15(6-9-28)12-25-20-3-2-16(14-26-20)13-24-19-10-17(11-22)27-21-18(19)4-7-23-21/h2-4,7,10,14-15H,5-6,8-9,12-13H2,1H3,(H,25,26)(H2,23,24,27)	AQLAEQYOSZMZCP-UHFFFAOYSA-N	652804	4-(((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)methyl)amino)-1H- pyrrolo[2,3-b]pyridine-6-carbonitrile::US20240059691, Example 1261	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652804	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652804&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362896	494496944							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377794	CN1CCC(CNc2ccc(CNc3cc(cc4[nH]c(Cl)cc34)C(F)(F)F)cn2)CC1	InChI=1S/C22H25ClF3N5/c1-31-6-4-14(5-7-31)11-28-21-3-2-15(13-29-21)12-27-18-8-16(22(24,25)26)9-19-17(18)10-20(23)30-19/h2-3,8-10,13-14,27,30H,4-7,11-12H2,1H3,(H,28,29)	LVUOLQMVRZXWQL-UHFFFAOYSA-N	652529	2-chloro-N-((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)methyl)-6- (trifluoromethyl)-1H-indol-4-amine::US20240059691, Example 1262	Plasma kallikrein			 6500							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652529	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652529&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362713	494496678							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377795	CN1CCC(CNc2ccc(CNc3cc(nc4[nH]ccc34)C(O)=O)cn2)CC1	InChI=1S/C21H26N6O2/c1-27-8-5-14(6-9-27)11-24-19-3-2-15(13-25-19)12-23-17-10-18(21(28)29)26-20-16(17)4-7-22-20/h2-4,7,10,13-14H,5-6,8-9,11-12H2,1H3,(H,24,25)(H,28,29)(H2,22,23,26)	NEZXKNOMWDQBLX-UHFFFAOYSA-N	652530	4-(((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)methyl)amino)-1H- pyrrolo [2,3-b]pyridine-6-carboxylic acid::US20240059691, Example 1263	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652530	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652530&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362714	494496679							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377796	CN1CCC(CNc2ccc(CNc3cc(nc4[nH]ccc34)C(N)=O)cn2)CC1	InChI=1S/C21H27N7O/c1-28-8-5-14(6-9-28)11-25-19-3-2-15(13-26-19)12-24-17-10-18(20(22)29)27-21-16(17)4-7-23-21/h2-4,7,10,13-14H,5-6,8-9,11-12H2,1H3,(H2,22,29)(H,25,26)(H2,23,24,27)	LIFLBHRENFJXGJ-UHFFFAOYSA-N	652805	4-(((6-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-3-yl)methyl)amino)-1H- pyrrolo[2,3-b]pyridine-6-carboxamide::US20240059691, Example 1264	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652805	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652805&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362897	494496945							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377797	Nc1nccc2c(NCc3ccc(nc3)N3CCC(CC(F)F)C3)cccc12	InChI=1S/C21H23F2N5/c22-19(23)10-14-7-9-28(13-14)20-5-4-15(12-27-20)11-26-18-3-1-2-17-16(18)6-8-25-21(17)24/h1-6,8,12,14,19,26H,7,9-11,13H2,(H2,24,25)	MVLCYOKJALGQGT-UHFFFAOYSA-N	652531	N5-((6-(3-(2,2-difluoroethyl)pyrrolidin-1-yl)pyridin-3-yl)methyl)isoquinoline-1,5-diamine::US20240059691, Example 1265	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652531	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652531&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			170928356	494496680							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377798	Nc1ncc(Cl)c2cc(NCc3ccc(nc3)N3CCC(CC(F)F)C3)ccc12	InChI=1S/C21H22ClF2N5/c22-18-11-28-21(25)16-3-2-15(8-17(16)18)26-9-14-1-4-20(27-10-14)29-6-5-13(12-29)7-19(23)24/h1-4,8,10-11,13,19,26H,5-7,9,12H2,(H2,25,28)	KDVBJPKZCZCFAN-UHFFFAOYSA-N	652532	4-chloro-N6-((6-(3-(2,2-difluoroethyl)pyrrolidin-1-yl)pyridin-3-yl)methyl)isoquinoline- 1,6-diamine::US20240059691, Example 1266	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652532	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652532&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362715	494496681							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377799	Nc1ncc(Cl)c2cc(NCc3ccc(nc3)N3CCn4ncc(O)c4C3)ccc12	InChI=1S/C21H20ClN7O/c22-17-10-26-21(23)15-3-2-14(7-16(15)17)24-8-13-1-4-20(25-9-13)28-5-6-29-18(12-28)19(30)11-27-29/h1-4,7,9-11,24,30H,5-6,8,12H2,(H2,23,26)	ADUOAROXLDRSRP-UHFFFAOYSA-N	652533	5-(5-(((1-amino-4-chloroisoquinolin-6-yl)amino)methyl)pyridin-2-yl)-4,5,6,7- tetrahydropyrazolo[1,5-a]pyrazin-3-ol::US20240059691, Example 1267	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652533	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652533&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362716	494496682							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377800	Nc1nccc2c(NCc3ccc(nc3)N3CCn4nccc4C3CO)cccc12	InChI=1S/C22H23N7O/c23-22-17-2-1-3-18(16(17)6-8-24-22)25-12-15-4-5-21(26-13-15)28-10-11-29-19(7-9-27-29)20(28)14-30/h1-9,13,20,25,30H,10-12,14H2,(H2,23,24)	CAWZCEFZKOCTQR-UHFFFAOYSA-N	652534	(5-(5-(((1-aminoisoquinolin-5-yl)amino)methyl)pyridin-2-yl)-4,5,6,7- tetrahydropyrazolo[1,5-a]pyrazin-4-yl)methanol::US20240059691, Example 1268	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652534	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652534&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362717	494496683							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377801	Nc1nccc2c(NCc3ccc(nc3)N3CCn4ncc(CO)c4C3)cccc12	InChI=1S/C22H23N7O/c23-22-18-2-1-3-19(17(18)6-7-24-22)25-10-15-4-5-21(26-11-15)28-8-9-29-20(13-28)16(14-30)12-27-29/h1-7,11-12,25,30H,8-10,13-14H2,(H2,23,24)	VIUASCZPJYFLLF-UHFFFAOYSA-N	652535	(5-(5-(((1-aminoisoquinolin-5-yl)amino)methyl)pyridin-2-yl)-4,5,6,7- tetrahydropyrazolo[1,5-a]pyrazin-3-yl)methanol::US20240059691, Example 1269	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652535	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652535&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362718	494496684							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377802	Nc1ncc(Cl)c2cc(NCc3ccc(nc3)N3CC4(C3)CC(O)c3nccn43)ccc12	InChI=1S/C23H22ClN7O/c24-18-11-29-21(25)16-3-2-15(7-17(16)18)27-9-14-1-4-20(28-10-14)30-12-23(13-30)8-19(32)22-26-5-6-31(22)23/h1-7,10-11,19,27,32H,8-9,12-13H2,(H2,25,29)	GVDJCUMMMLEGOV-UHFFFAOYSA-N	652536	1-(5-(((1-amino-4-chloroisoquinolin-6-yl)amino)methyl)pyridin-2-yl)-6',7'- dihydrospiro[azetidine-3,5'-pyrrolo[1,2-a]imidazol]-7'-ol::US20240059691, Example 1270	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652536	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652536&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362719	494496685							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377803	Nc1nccc2c(NCc3ccc(nc3)N3CCc4nccn4CC3)cccc12	InChI=1S/C22H23N7/c23-22-18-2-1-3-19(17(18)6-8-25-22)26-14-16-4-5-20(27-15-16)28-10-7-21-24-9-11-29(21)13-12-28/h1-6,8-9,11,15,26H,7,10,12-14H2,(H2,23,25)	XWDIPHXELLKWBS-UHFFFAOYSA-N	652537	N5-((6-(5,6,8,9-tetrahydro-7H-imidazo[1,2-d][1,4]diazepin-7-yl)pyridin-3- yl)methyl)isoquinoline-1,5-diamine::US20240059691, Example 1271	Plasma kallikrein			 25000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652537	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652537&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362720	494496686							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377804	Nc1ncc(Cl)c2cc(NCc3ccc(nc3)N3CCc4nccn4CC3)ccc12	InChI=1S/C22H22ClN7/c23-19-14-28-22(24)17-3-2-16(11-18(17)19)26-12-15-1-4-20(27-13-15)29-7-5-21-25-6-8-30(21)10-9-29/h1-4,6,8,11,13-14,26H,5,7,9-10,12H2,(H2,24,28)	WNQXYNFRIYHSDI-UHFFFAOYSA-N	652538	4-chloro-N6-((6-(5,6,8,9-tetrahydro-7H-imidazo[1,2-d][1,4]diazepin-7-yl)pyridin-3- yl)methyl)isoquinoline-1,6-diamine::US20240059691, Example 1272	Plasma kallikrein			 25000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652538	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652538&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362721	494496687							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377805	Nc1ncc(Cl)c2cc(NCc3ccc(nc3)N3CCn4nccc4C3CO)ccc12	InChI=1S/C22H22ClN7O/c23-18-12-27-22(24)16-3-2-15(9-17(16)18)25-10-14-1-4-21(26-11-14)29-7-8-30-19(5-6-28-30)20(29)13-31/h1-6,9,11-12,20,25,31H,7-8,10,13H2,(H2,24,27)	ZYINTEFXTIDKCX-UHFFFAOYSA-N	652539	(5-(5-(((1-amino-4-chloroisoquinolin-6-yl)amino)methyl)pyridin-2-yl)-4,5,6,7- tetrahydropyrazolo[1,5-a]pyrazin-4-yl)methanol::US20240059691, Example 1273	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652539	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652539&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362722	494496688							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377806	Nc1nccc2c(NCc3ccc(nc3)N3CCn4c(C3)nnc4C(F)F)cccc12	InChI=1S/C21H20F2N8/c22-19(23)21-29-28-18-12-30(8-9-31(18)21)17-5-4-13(11-27-17)10-26-16-3-1-2-15-14(16)6-7-25-20(15)24/h1-7,11,19,26H,8-10,12H2,(H2,24,25)	KPFQKUFJYSBYBL-UHFFFAOYSA-N	652540	N5-((6-(3-(difluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)pyridin-3- yl)methyl)isoquinoline-1,5-diamine::US20240059691, Example 1274	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652540	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652540&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163390499	494496689							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377810	Nc1nccc2c(NCc3ccc(nc3)N3CCn4c(C3)nnc4C(F)(F)F)cccc12	InChI=1S/C21H19F3N8/c22-21(23,24)20-30-29-18-12-31(8-9-32(18)20)17-5-4-13(11-28-17)10-27-16-3-1-2-15-14(16)6-7-26-19(15)25/h1-7,11,27H,8-10,12H2,(H2,25,26)	SJKSASQLXWHGFH-UHFFFAOYSA-N	652541	N5-((6-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)pyridin-3- yl)methyl)isoquinoline-1,5-diamine::US20240059691, Example 1275	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652541	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652541&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362723	494496690							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377814	Nc1nccc2c(NCc3ccc(nc3)N3CCn4cnnc4C3)cccc12	InChI=1S/C20H20N8/c21-20-16-2-1-3-17(15(16)6-7-22-20)23-10-14-4-5-18(24-11-14)27-8-9-28-13-25-26-19(28)12-27/h1-7,11,13,23H,8-10,12H2,(H2,21,22)	KCIOIUFLNNRKTB-UHFFFAOYSA-N	652542	N5-((6-(5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)pyridin-3- yl)methyl)isoquinoline-1,5-diamine::US20240059691, Example 1276	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652542	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652542&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362724	494496691							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377815	FC(F)c1nnc2CN(CCn12)c1ccc(CNc2ccnc3[nH]c(Cl)cc23)cn1	InChI=1S/C19H17ClF2N8/c20-14-7-12-13(3-4-23-18(12)26-14)24-8-11-1-2-15(25-9-11)29-5-6-30-16(10-29)27-28-19(30)17(21)22/h1-4,7,9,17H,5-6,8,10H2,(H2,23,24,26)	UPPRVHQOSXWZLP-UHFFFAOYSA-N	652543	2-chloro-N-((6-(3-(difluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)- yl)pyridin-3-yl)methyl)-1H-pyrrolo[2,3-b]pyridin-4-amine::US20240059691, Example 1277	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652543	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652543&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362725	494496692							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377819	Cc1cc2c(NCc3ccc(nc3)N3CCn4c(C3)nnc4C(F)F)ccnc2[nH]1	InChI=1S/C20H20F2N8/c1-12-8-14-15(4-5-23-19(14)26-12)24-9-13-2-3-16(25-10-13)29-6-7-30-17(11-29)27-28-20(30)18(21)22/h2-5,8,10,18H,6-7,9,11H2,1H3,(H2,23,24,26)	GCECYENXVZLRPW-UHFFFAOYSA-N	652544	N-((6-(3-(difluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)pyridin-3- yl)methyl)-2-methyl-1H-pyrrolo[2,3-b]pyridin-4-amine::US20240059691, Example 1278	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652544	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652544&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163390199	494496693							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377820	Cc1nnc2CN(CCn12)c1ccc(CNc2cccc3c(N)nccc23)cn1	InChI=1S/C21H22N8/c1-14-26-27-20-13-28(9-10-29(14)20)19-6-5-15(12-25-19)11-24-18-4-2-3-17-16(18)7-8-23-21(17)22/h2-8,12,24H,9-11,13H2,1H3,(H2,22,23)	SXVRJEWRROULBO-UHFFFAOYSA-N	652545	N5-((6-(3-methyl-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)pyridin-3- yl)methyl)isoquinoline-1,5-diamine::US20240059691, Example 1279	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652545	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652545&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362726	494496694							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377824	FC(F)(F)c1nnc2CN(CCn12)c1ccc(CNc2ccnc3[nH]c(Cl)cc23)cn1	InChI=1S/C19H16ClF3N8/c20-14-7-12-13(3-4-24-17(12)27-14)25-8-11-1-2-15(26-9-11)30-5-6-31-16(10-30)28-29-18(31)19(21,22)23/h1-4,7,9H,5-6,8,10H2,(H2,24,25,27)	QSWJYWCLHVAJEZ-UHFFFAOYSA-N	652546	2-chloro-N-((6-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)- yl)pyridin-3-yl)methyl)-1H-pyrrolo[2,3-b]pyridin-4-amine::US20240059691, Example 1280	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652546	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652546&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362727	494496695							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377825	CNc1cc(NCc2ccc(nc2)N2CCn3c(C2)nnc3C(F)F)ccn1	InChI=1S/C18H20F2N8/c1-21-14-8-13(4-5-22-14)23-9-12-2-3-15(24-10-12)27-6-7-28-16(11-27)25-26-18(28)17(19)20/h2-5,8,10,17H,6-7,9,11H2,1H3,(H2,21,22,23)	MVTSWVVCDNHUJS-UHFFFAOYSA-N	652547	N4-((6-(3-(difluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)pyridin-3- yl)methyl)-N2-methylpyridine-2,4-diamine::US20240059691, Example 1281	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652547	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652547&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362728	494496696							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377826	Cc1cc(ncc1CNc1cccc2c(N)nccc12)N1CCn2c(C1)nnc2C(F)(F)F	InChI=1S/C22H21F3N8/c1-13-9-18(32-7-8-33-19(12-32)30-31-21(33)22(23,24)25)29-11-14(13)10-28-17-4-2-3-16-15(17)5-6-27-20(16)26/h2-6,9,11,28H,7-8,10,12H2,1H3,(H2,26,27)	XGBLRGJOWPDUDW-UHFFFAOYSA-N	652548	N5-((4-methyl-6-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)- yl)pyridin-3-yl)methyl)isoquinoline-1,5-diamine::US20240059691, Example 1282	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652548	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652548&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163390231	494496697							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377829	FC(F)(F)c1nnc2CN(CCn12)c1ccc(CNc2ccc3cnccc3c2)cn1	InChI=1S/C21H18F3N7/c22-21(23,24)20-29-28-19-13-30(7-8-31(19)20)18-4-1-14(11-27-18)10-26-17-3-2-16-12-25-6-5-15(16)9-17/h1-6,9,11-12,26H,7-8,10,13H2	NWQFBSICCGLHCE-UHFFFAOYSA-N	652549	N-((6-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)pyridin-3- yl)methyl)isoquinolin-6-amine::US20240059691, Example 1283	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652549	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652549&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362729	494496698							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377850	C[C@H]1N(CCn2c1nnc2C(F)(F)F)c1ccc(CNc2cccc3c(N)nccc23)cn1	InChI=1S/C22H21F3N8/c1-13-20-30-31-21(22(23,24)25)33(20)10-9-32(13)18-6-5-14(12-29-18)11-28-17-4-2-3-16-15(17)7-8-27-19(16)26/h2-8,12-13,28H,9-11H2,1H3,(H2,26,27)/t13-/m1/s1	BKGCNONNVNNPCJ-CYBMUJFWSA-N	652555	(R*)-N5-((6-(8-methyl-3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin- 7(8H)-yl)pyridin-3-yl)methyl)isoquinoline-1,5-diamine::US20240059691, Example 1294::US20240059691, Example 1296	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652555	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652555&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362735	494496704							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377853	C[C@@H]1N(CCn2c1nnc2C(F)(F)F)c1ccc(CNc2cccc3c(N)nccc23)cn1	InChI=1S/C22H21F3N8/c1-13-20-30-31-21(22(23,24)25)33(20)10-9-32(13)18-6-5-14(12-29-18)11-28-17-4-2-3-16-15(17)7-8-27-19(16)26/h2-8,12-13,28H,9-11H2,1H3,(H2,26,27)/t13-/m0/s1	BKGCNONNVNNPCJ-ZDUSSCGKSA-N	652556	(S*)-N5-((6-(8-methyl-3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin- 7(8H)-yl)pyridin-3-yl)methyl)isoquinoline-1,5-diamine::US20240059691, Example 1295	Plasma kallikrein			 25000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652556	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652556&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362736	494496705							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377856	C[C@H]1N(CCn2c1nnc2C(F)(F)F)c1ccc(CNc2cccc3c(N)nccc23)cn1	InChI=1S/C22H21F3N8/c1-13-20-30-31-21(22(23,24)25)33(20)10-9-32(13)18-6-5-14(12-29-18)11-28-17-4-2-3-16-15(17)7-8-27-19(16)26/h2-8,12-13,28H,9-11H2,1H3,(H2,26,27)/t13-/m1/s1	BKGCNONNVNNPCJ-CYBMUJFWSA-N	652555	(R*)-N5-((6-(8-methyl-3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin- 7(8H)-yl)pyridin-3-yl)methyl)isoquinoline-1,5-diamine::US20240059691, Example 1294::US20240059691, Example 1296	Plasma kallikrein			 25000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652555	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652555&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362735	494496704							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377859	C[C@H]1CN(Cc2nnc(n12)C(F)(F)F)c1ccc(CNc2cccc3c(N)nccc23)cn1	InChI=1S/C22H21F3N8/c1-13-11-32(12-19-30-31-21(33(13)19)22(23,24)25)18-6-5-14(10-29-18)9-28-17-4-2-3-16-15(17)7-8-27-20(16)26/h2-8,10,13,28H,9,11-12H2,1H3,(H2,26,27)/t13-/m0/s1	GLWZFGZVOWCXPQ-ZDUSSCGKSA-N	652558	(S*)-N5-((6-(5-methyl-3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin- 7(8H)-yl)pyridin-3-yl)methyl)isoquinoline-1,5-diamine::US20240059691, Example 1297	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652558	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652558&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362737	494496706							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377862	Nc1nccc2c(NCc3ccc(nc3C(F)(F)F)N3CCn4c(C3)nnc4C(F)(F)F)cccc12	InChI=1S/C22H18F6N8/c23-21(24,25)18-12(10-31-15-3-1-2-14-13(15)6-7-30-19(14)29)4-5-16(32-18)35-8-9-36-17(11-35)33-34-20(36)22(26,27)28/h1-7,31H,8-11H2,(H2,29,30)	FTZQENZGWYGYSA-UHFFFAOYSA-N	652559	N5-((2-(trifluoromethyl)-6-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin- 7(8H)-yl)pyridin-3-yl)methyl)isoquinoline-1,5-diamine::US20240059691, Example 1298	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652559	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652559&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362738	494496707							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377865	Nc1nccc2c(NCc3cnc(cc3Cl)N3CCn4c(C3)nnc4C(F)(F)F)cccc12	InChI=1S/C21H18ClF3N8/c22-15-8-17(32-6-7-33-18(11-32)30-31-20(33)21(23,24)25)29-10-12(15)9-28-16-3-1-2-14-13(16)4-5-27-19(14)26/h1-5,8,10,28H,6-7,9,11H2,(H2,26,27)	COGDLYORVLPAJK-UHFFFAOYSA-N	652560	N5-((4-chloro-6-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)- yl)pyridin-3-yl)methyl)isoquinoline-1,5-diamine::US20240059691, Example 1299	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652560	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652560&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163390271	494496708							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377868	Nc1nccc2c(NCc3ccc(cc3)N3CCn4c(C3)nnc4C(F)(F)F)cccc12	InChI=1S/C22H20F3N7/c23-22(24,25)21-30-29-19-13-31(10-11-32(19)21)15-6-4-14(5-7-15)12-28-18-3-1-2-17-16(18)8-9-27-20(17)26/h1-9,28H,10-13H2,(H2,26,27)	WDKUDBORIDKNNF-UHFFFAOYSA-N	652561	N5-(4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)- yl)benzyl)isoquinoline-1,5-diamine::US20240059691, Example 1300	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652561	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652561&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362739	494496709							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377871	Nc1nccc2c(NCc3cnc(cc3C(F)(F)F)N3CCn4c(C3)nnc4C(F)(F)F)cccc12	InChI=1S/C22H18F6N8/c23-21(24,25)15-8-17(35-6-7-36-18(11-35)33-34-20(36)22(26,27)28)32-10-12(15)9-31-16-3-1-2-14-13(16)4-5-30-19(14)29/h1-5,8,10,31H,6-7,9,11H2,(H2,29,30)	SXIFTOXSOJHIGC-UHFFFAOYSA-N	652562	N5-((4-(trifluoromethyl)-6-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin- 7(8H)-yl)pyridin-3-yl)methyl)isoquinoline-1,5-diamine::US20240059691, Example 1301	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652562	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652562&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362740	494496710							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377874	Cc1cc(CNc2cccc3c(N)nccc23)cnc1N1CCn2c(C1)nnc2C(F)(F)F	InChI=1S/C22H21F3N8/c1-13-9-14(10-28-17-4-2-3-16-15(17)5-6-27-19(16)26)11-29-20(13)32-7-8-33-18(12-32)30-31-21(33)22(23,24)25/h2-6,9,11,28H,7-8,10,12H2,1H3,(H2,26,27)	SVNOPUCNGHXZDH-UHFFFAOYSA-N	652563	N5-((5-methyl-6-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)- yl)pyridin-3-yl)methyl)isoquinoline-1,5-diamine::US20240059691, Example 1302	Plasma kallikrein			 25000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652563	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652563&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362741	494496711							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377886	Nc1nccc2c(NCc3ccc(nc3)N3CCn4ncc(O)c4C3)cccc12	InChI=1S/C21H21N7O/c22-21-16-2-1-3-17(15(16)6-7-23-21)24-10-14-4-5-20(25-11-14)27-8-9-28-18(13-27)19(29)12-26-28/h1-7,11-12,24,29H,8-10,13H2,(H2,22,23)	ZVTGWYQGHKXHGR-UHFFFAOYSA-N	652572	5-(5-(((1-aminoisoquinolin-5-yl)amino)methyl)pyridin-2-yl)-4,5,6,7- tetrahydropyrazolo[1,5-a]pyrazin-3-ol::US20240059691, Example 1312	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652572	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652572&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362746	494496720							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377888	CN1CCC(CCc2ccc(CNc3ccc4c(N)nccc4c3)cc2)CC1	InChI=1S/C24H30N4/c1-28-14-11-19(12-15-28)3-2-18-4-6-20(7-5-18)17-27-22-8-9-23-21(16-22)10-13-26-24(23)25/h4-10,13,16,19,27H,2-3,11-12,14-15,17H2,1H3,(H2,25,26)	JRGKULXTRBRGAB-UHFFFAOYSA-N	652597	6-N-({4-[2-(1-methylpiperidin-4-yl)ethyl]phenyl}methyl)isoquinoline-1,6-diamine::US20240059691, Example 2177	Plasma kallikrein			 2000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652597	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652597&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163390290	494496745							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377892	CN1CCC(CCc2ccc(CNc3cccc4c(N)nccc34)cc2)CC1	InChI=1S/C24H30N4/c1-28-15-12-19(13-16-28)6-5-18-7-9-20(10-8-18)17-27-23-4-2-3-22-21(23)11-14-26-24(22)25/h2-4,7-11,14,19,27H,5-6,12-13,15-17H2,1H3,(H2,25,26)	ADOGWSXMKPYQAU-UHFFFAOYSA-N	652598	5-N-({4-[2-(1-methylpiperidin-4-yl)ethyl]phenyl}methyl)isoquinoline-1,5-diamine::US20240059691, Example 2178	Plasma kallikrein			 25000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652598	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652598&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			170928437	494496746							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377896	CN1CCN(CCc2ccc(CNc3ccc4c(N)nccc4c3)c(F)c2)CC1	InChI=1S/C23H28FN5/c1-28-10-12-29(13-11-28)9-7-17-2-3-19(22(24)14-17)16-27-20-4-5-21-18(15-20)6-8-26-23(21)25/h2-6,8,14-15,27H,7,9-13,16H2,1H3,(H2,25,26)	QEKIKQCZDOHATQ-UHFFFAOYSA-N	652601	6-N-({2-fluoro-4-[2-(4-methylpiperazin-1-yl)ethyl]phenyl}methyl)isoquinoline-1,6- diamine::US20240059691, Example 2181	Plasma kallikrein			 25000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652601	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652601&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362768	494496749							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377900	CN1CCN(CCc2ccc(CNc3cccc4c(N)nccc34)c(F)c2)CC1	InChI=1S/C23H28FN5/c1-28-11-13-29(14-12-28)10-8-17-5-6-18(21(24)15-17)16-27-22-4-2-3-20-19(22)7-9-26-23(20)25/h2-7,9,15,27H,8,10-14,16H2,1H3,(H2,25,26)	RJGXWYMMSWXDBY-UHFFFAOYSA-N	652602	5-N-({2-fluoro-4-[2-(4-methylpiperazin-1-yl)ethyl]phenyl}methyl)isoquinoline-1,5- diamine::US20240059691, Example 2182	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652602	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652602&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362769	494496750							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377904	Nc1nccc2c(NCc3ccc(CCN4CCOCC4)cc3F)cccc12	InChI=1S/C22H25FN4O/c23-20-14-16(7-9-27-10-12-28-13-11-27)4-5-17(20)15-26-21-3-1-2-19-18(21)6-8-25-22(19)24/h1-6,8,14,26H,7,9-13,15H2,(H2,24,25)	RWQRQTTUCTXRQC-UHFFFAOYSA-N	652603	5-N-({2-fluoro-4-[2-(morpholin-4-yl)ethyl]phenyl}methyl)isoquinoline-1,5-diamine::US20240059691, Example 2183	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652603	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652603&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163390220	494496751							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377908	CN1CCN(CCc2ccc(CNc3ccc4c(N)ncc(Cl)c4c3)c(F)c2)CC1	InChI=1S/C23H27ClFN5/c1-29-8-10-30(11-9-29)7-6-16-2-3-17(22(25)12-16)14-27-18-4-5-19-20(13-18)21(24)15-28-23(19)26/h2-5,12-13,15,27H,6-11,14H2,1H3,(H2,26,28)	OTZKOBJGNWYHCY-UHFFFAOYSA-N	652604	4-chloro-6-N-({2-fluoro-4-[2-(4-methylpiperazin-1-yl)ethyl]phenyl}methyl)isoquinoline- 1,6-diamine::US20240059691, Example 2184	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652604	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652604&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163390559	494496752							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377912	CN1CCC(CC1)OCc1ccc(CNc2ccc3c(N)nccc3c2)cc1	InChI=1S/C23H28N4O/c1-27-12-9-21(10-13-27)28-16-18-4-2-17(3-5-18)15-26-20-6-7-22-19(14-20)8-11-25-23(22)24/h2-8,11,14,21,26H,9-10,12-13,15-16H2,1H3,(H2,24,25)	IFOVGASEQCOJAP-UHFFFAOYSA-N	652605	6-N-[(4-{[(1-methylpiperidin-4-yl)oxy]methyl}phenyl)methyl]isoquinoline-1,6-diamine::US20240059691, Example 2185	Plasma kallikrein			 6500							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652605	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652605&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163390477	494496753							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377916	CN1CCC(CC1)OCc1ccc(CNc2cccc3c(N)nccc23)cc1	InChI=1S/C23H28N4O/c1-27-13-10-19(11-14-27)28-16-18-7-5-17(6-8-18)15-26-22-4-2-3-21-20(22)9-12-25-23(21)24/h2-9,12,19,26H,10-11,13-16H2,1H3,(H2,24,25)	YGRNPRKEECJLCM-UHFFFAOYSA-N	652606	5-N-[(4-{[(1-methylpiperidin-4-yl)oxy]methyl}phenyl)methyl]isoquinoline-1,5-diamine::US20240059691, Example 2186	Plasma kallikrein			 25000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652606	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652606&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163390213	494496754							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377920	CN1CCC(CC1)OCc1ccc(CNc2ccc3nc(N)ccc3c2)cc1	InChI=1S/C23H28N4O/c1-27-12-10-21(11-13-27)28-16-18-4-2-17(3-5-18)15-25-20-7-8-22-19(14-20)6-9-23(24)26-22/h2-9,14,21,25H,10-13,15-16H2,1H3,(H2,24,26)	IUBAXPVGRHDTKV-UHFFFAOYSA-N	652607	6-N-[(4-{[(1-methylpiperidin-4-yl)oxy]methyl}phenyl)methyl]quinoline-2,6-diamine::US20240059691, Example 2187	Plasma kallikrein			 25000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652607	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652607&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163390297	494496755							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377921	CN1CCC(CC1)OCc1ccc(CNc2ccc3cc(N)ncc3c2)cc1	InChI=1S/C23H28N4O/c1-27-10-8-22(9-11-27)28-16-18-4-2-17(3-5-18)14-25-21-7-6-19-13-23(24)26-15-20(19)12-21/h2-7,12-13,15,22,25H,8-11,14,16H2,1H3,(H2,24,26)	XIFNXPCBWYAEJW-UHFFFAOYSA-N	652608	7-N-[(4-{[(1-methylpiperidin-4-yl)oxy]methyl}phenyl)methyl]isoquinoline-3,7-diamine::US20240059691, Example 2188	Plasma kallikrein			 25000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652608	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652608&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			170928454	494496756							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377922	CN1CCC(CC1)OCc1ccc(CNc2ccc3cnc(N)cc3c2)cc1	InChI=1S/C23H28N4O/c1-27-10-8-22(9-11-27)28-16-18-4-2-17(3-5-18)14-25-21-7-6-19-15-26-23(24)13-20(19)12-21/h2-7,12-13,15,22,25H,8-11,14,16H2,1H3,(H2,24,26)	UCVKVZZDWKEDST-UHFFFAOYSA-N	652609	6-N-[(4-{[(1-methylpiperidin-4-yl)oxy]methyl}phenyl)methyl]isoquinoline-3,6-diamine::US20240059691, Example 2189	Plasma kallikrein			 25000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652609	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652609&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163390438	494496757							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377923	CN(Cc1ccc(COC2CCN(C)CC2)cc1)c1ccc2c(N)nccc2c1	InChI=1S/C24H30N4O/c1-27-13-10-22(11-14-27)29-17-19-5-3-18(4-6-19)16-28(2)21-7-8-23-20(15-21)9-12-26-24(23)25/h3-9,12,15,22H,10-11,13-14,16-17H2,1-2H3,(H2,25,26)	OAHIADQZXPBYGD-UHFFFAOYSA-N	652610	6-N-methyl-6-N-[(4-{[(1-methylpiperidin-4-yl)oxy]methyl}phenyl)methyl]isoquinoline- 1,6-diamine::US20240059691, Example 2190	Plasma kallikrein			 6500							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652610	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652610&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163390383	494496758							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377924	CN1CCC(CC1)OCc1ccc(CNc2ccc3c(N)nccc3c2)c(F)c1	InChI=1S/C23H27FN4O/c1-28-10-7-20(8-11-28)29-15-16-2-3-18(22(24)12-16)14-27-19-4-5-21-17(13-19)6-9-26-23(21)25/h2-6,9,12-13,20,27H,7-8,10-11,14-15H2,1H3,(H2,25,26)	QDOYQXPRWRGBKF-UHFFFAOYSA-N	652611	6-N-[(2-fluoro-4-{[(1-methylpiperidin-4-yl)oxy]methyl}phenyl)methyl]isoquinoline- 1,6-diamine::US20240059691, Example 2191	Plasma kallikrein			 25000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652611	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652611&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163390206	494496759							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377928	CN1CCC(CC1)OCc1ccc(CNc2ccc3c(N)nccc3c2)c(Cl)c1	InChI=1S/C23H27ClN4O/c1-28-10-7-20(8-11-28)29-15-16-2-3-18(22(24)12-16)14-27-19-4-5-21-17(13-19)6-9-26-23(21)25/h2-6,9,12-13,20,27H,7-8,10-11,14-15H2,1H3,(H2,25,26)	PUSHOPRQHUASRC-UHFFFAOYSA-N	652612	6-N-[(2-chloro-4-{[(1-methylpiperidin-4-yl)oxy]methyl}phenyl)methyl]isoquinoline- 1,6-diamine::US20240059691, Example 2192	Plasma kallikrein			 6500							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652612	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652612&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163390318	494496760							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377932	CN1CCC(CC1)OCc1ccc(CNc2ccc3cnccc3c2)cc1	InChI=1S/C23H27N3O/c1-26-12-9-23(10-13-26)27-17-19-4-2-18(3-5-19)15-25-22-7-6-21-16-24-11-8-20(21)14-22/h2-8,11,14,16,23,25H,9-10,12-13,15,17H2,1H3	BOCSUPFQLFIHFX-UHFFFAOYSA-N	652613	N-[(4-{[(1-methylpiperidin-4-yl)oxy]methyl}phenyl)methyl]isoquinolin-6-amine::US20240059691, Example 2193	Plasma kallikrein			 2.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652613	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652613&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163390373	494496761							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377936	CN1CCC(OCc2ccc(CNc3ccc4c(N)nccc4c3)cc2)C(F)(F)C1	InChI=1S/C23H26F2N4O/c1-29-11-9-21(23(24,25)15-29)30-14-17-4-2-16(3-5-17)13-28-19-6-7-20-18(12-19)8-10-27-22(20)26/h2-8,10,12,21,28H,9,11,13-15H2,1H3,(H2,26,27)	BFXHXEUYAPQSKF-UHFFFAOYSA-N	652614	6-N-[(4-{[(3,3-difluoro-1-methylpiperidin-4-yl)oxy]methyl}phenyl)methyl]isoquinoline- 1,6-diamine::US20240059691, Example 2194	Plasma kallikrein			 25000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652614	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652614&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163390187	494496762							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377940	Nc1nccc2cc(NCc3ccc(COC4CCN(CC4)C4CC4)cc3)ccc12	InChI=1S/C25H30N4O/c26-25-24-8-5-21(15-20(24)9-12-27-25)28-16-18-1-3-19(4-2-18)17-30-23-10-13-29(14-11-23)22-6-7-22/h1-5,8-9,12,15,22-23,28H,6-7,10-11,13-14,16-17H2,(H2,26,27)	WDKFWBZIMKMRIR-UHFFFAOYSA-N	652615	6-N-[(4-{[(1-cyclopropylpiperidin-4-yl)oxy]methyl}phenyl)methyl]isoquinoline-1,6- diamine::US20240059691, Example 2195	Plasma kallikrein			 6500							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652615	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652615&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362770	494496763							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377944	Nc1nccc2cc(NCc3ccc(COC4CCN(CC(F)F)CC4)cc3)ccc12	InChI=1S/C24H28F2N4O/c25-23(26)15-30-11-8-21(9-12-30)31-16-18-3-1-17(2-4-18)14-29-20-5-6-22-19(13-20)7-10-28-24(22)27/h1-7,10,13,21,23,29H,8-9,11-12,14-16H2,(H2,27,28)	NNSGOPRWQAVYAK-UHFFFAOYSA-N	652616	6-N-{[4-({[1-(2,2-difluoroethyl)piperidin-4-yl]oxy}methyl)phenyl]methyl}isoquinoline- 1,6-diamine::US20240059691, Example 2196	Plasma kallikrein			 25000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652616	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652616&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362771	494496764							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377948	CN1CCC(CC1)OCc1ccc(CNc2cccc3c(N)nccc23)c(F)c1	InChI=1S/C23H27FN4O/c1-28-11-8-18(9-12-28)29-15-16-5-6-17(21(24)13-16)14-27-22-4-2-3-20-19(22)7-10-26-23(20)25/h2-7,10,13,18,27H,8-9,11-12,14-15H2,1H3,(H2,25,26)	FANJUXPUAIHWDE-UHFFFAOYSA-N	652617	5-N-[(2-fluoro-4-{[(1-methylpiperidin-4-yl)oxy]methyl}phenyl)methyl]isoquinoline-1,5- diamine::US20240059691, Example 2197	Plasma kallikrein			 2.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652617	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652617&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163390208	494496765							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377952	CN1C[C@H]2CC1C[C@H]2OCc1ccc(CNc2ccc3c(N)nccc3c2)c(F)c1	InChI=1S/C24H27FN4O/c1-29-13-18-10-20(29)11-23(18)30-14-15-2-3-17(22(25)8-15)12-28-19-4-5-21-16(9-19)6-7-27-24(21)26/h2-9,18,20,23,28H,10-14H2,1H3,(H2,26,27)/t18-,20?,23-/m1/s1	CYDSMQBZTXOTJO-ZBOFDPRTSA-N	652618	N6-(2-fluoro-4-((((4R*,5R*)-2-methyl-2-azabicyclo[2.2.1]heptan-5- yl)oxy)methyl)benzyl)isoquinoline-1,6-diamine::US20240059691, Example 2198	Plasma kallikrein			 6500							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652618	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652618&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			169100189	494496766							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377956	CN1C[C@H]2CC1C[C@@H]2OCc1ccc(CNc2ccc3c(N)nccc3c2)c(F)c1	InChI=1S/C24H27FN4O/c1-29-13-18-10-20(29)11-23(18)30-14-15-2-3-17(22(25)8-15)12-28-19-4-5-21-16(9-19)6-7-27-24(21)26/h2-9,18,20,23,28H,10-14H2,1H3,(H2,26,27)/t18-,20?,23+/m1/s1	CYDSMQBZTXOTJO-RAWUHTOPSA-N	652619	N6-(2-fluoro-4-((((4R*,5S*)-2-methyl-2-azabicyclo[2.2.1]heptan-5- yl)oxy)methyl)benzyl)isoquinoline-1,6-diamine::US20240059691, Example 2199	Plasma kallikrein			 6500							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652619	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652619&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			169100197	494496767							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377960	CCN1CCC(CC1)OCc1ccc(CNc2cccc3c(N)nccc23)c(F)c1	InChI=1S/C24H29FN4O/c1-2-29-12-9-19(10-13-29)30-16-17-6-7-18(22(25)14-17)15-28-23-5-3-4-21-20(23)8-11-27-24(21)26/h3-8,11,14,19,28H,2,9-10,12-13,15-16H2,1H3,(H2,26,27)	JRXMHNDYGQNYAI-UHFFFAOYSA-N	652621	5-N-[(4-{[(1-ethylpiperidin-4-yl)oxy]methyl}-2-fluorophenyl)methyl]isoquinoline-1,5- diamine::US20240059691, Example 2201	Plasma kallikrein			 25000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652621	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652621&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362773	494496769							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377964	CCN1CCC(CC1)OCc1ccc(CNc2ccc3c(N)nccc3c2)c(F)c1	InChI=1S/C24H29FN4O/c1-2-29-11-8-21(9-12-29)30-16-17-3-4-19(23(25)13-17)15-28-20-5-6-22-18(14-20)7-10-27-24(22)26/h3-7,10,13-14,21,28H,2,8-9,11-12,15-16H2,1H3,(H2,26,27)	QXBVZJVFQPOKBL-UHFFFAOYSA-N	652622	6-N-[(4-{[(1-ethylpiperidin-4-yl)oxy]methyl}-2-fluorophenyl)methyl]isoquinoline-1,6- diamine::US20240059691, Example 2202	Plasma kallikrein			 2000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652622	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652622&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362774	494496770							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377968	CN1CC2(CC(C2)OCc2ccc(CNc3cccc4c(N)nccc34)c(F)c2)C1	InChI=1S/C24H27FN4O/c1-29-14-24(15-29)10-18(11-24)30-13-16-5-6-17(21(25)9-16)12-28-22-4-2-3-20-19(22)7-8-27-23(20)26/h2-9,18,28H,10-15H2,1H3,(H2,26,27)	AHIHNTAORHPRDF-UHFFFAOYSA-N	652626	5-N-[[2-fluoro-4-[(2-methyl-2-azaspiro[3.3]heptan-6- yl)oxymethyl]phenyl]methyl]isoquinoline-1,5-diamine::US20240059691, Example 2206	Plasma kallikrein			 25000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652626	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652626&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362778	494496774							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377972	Cn1ccnc1COCc1ccc(CNc2cccc3c(N)nccc23)c(F)c1	InChI=1S/C22H22FN5O/c1-28-10-9-25-21(28)14-29-13-15-5-6-16(19(23)11-15)12-27-20-4-2-3-18-17(20)7-8-26-22(18)24/h2-11,27H,12-14H2,1H3,(H2,24,26)	XQVNEJZHIUXQSZ-UHFFFAOYSA-N	652627	N5-(2-fluoro-4-(((1-methyl-1H-imidazol-2-yl)methoxy)methyl)benzyl)isoquinoline-1,5- diamine::US20240059691, Example 2207	Plasma kallikrein			 6500							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652627	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652627&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362779	494496775							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377976	Cn1ccnc1CCOCc1ccc(CNc2cccc3c(N)nccc23)c(F)c1	InChI=1S/C23H24FN5O/c1-29-11-10-26-22(29)8-12-30-15-16-5-6-17(20(24)13-16)14-28-21-4-2-3-19-18(21)7-9-27-23(19)25/h2-7,9-11,13,28H,8,12,14-15H2,1H3,(H2,25,27)	VFLSIFZSTSWSDC-UHFFFAOYSA-N	652628	5-N-[[2-fluoro-4-[2-(1-methylimidazol-2-yl)ethoxymethyl]phenyl]methyl]isoquinoline- 1,5-diamine::US20240059691, Example 2208	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652628	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652628&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163390462	494496776							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377980	CN1CC(CCC1=O)OCc1ccc(CNc2cccc3c(N)nccc23)c(F)c1	InChI=1S/C23H25FN4O2/c1-28-13-17(7-8-22(28)29)30-14-15-5-6-16(20(24)11-15)12-27-21-4-2-3-19-18(21)9-10-26-23(19)25/h2-6,9-11,17,27H,7-8,12-14H2,1H3,(H2,25,26)	NTFAJFSJGVPGAC-UHFFFAOYSA-N	652629	5-[[4-[[(1-amino-5-isoquinolyl)amino]methyl]-3-fluoro-phenyl]methoxy]-1-methyl- piperidin-2-one::US20240059691, Example 2209	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652629	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652629&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362780	494496777							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377984	Cn1ccnc1CC(=O)NCc1ccc(CNc2cccc3c(N)nccc23)c(F)c1	InChI=1S/C23H23FN6O/c1-30-10-9-26-21(30)12-22(31)29-13-15-5-6-16(19(24)11-15)14-28-20-4-2-3-18-17(20)7-8-27-23(18)25/h2-11,28H,12-14H2,1H3,(H2,25,27)(H,29,31)	WMVZLWYOHAUGMC-UHFFFAOYSA-N	652631	N-(4-(((1-aminoisoquinolin-5-yl)amino)methyl)-3-fluorobenzyl)-2-(1-methyl-1H- imidazol-2-yl)acetamide::US20240059691, Example 2211	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652631	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652631&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362781	494496779							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377988	CC(C)N1CC2CC1CN2CCc1ccc(CNc2cccc3c(N)nccc23)c(F)c1	InChI=1S/C26H32FN5/c1-17(2)32-16-20-13-21(32)15-31(20)11-9-18-6-7-19(24(27)12-18)14-30-25-5-3-4-23-22(25)8-10-29-26(23)28/h3-8,10,12,17,20-21,30H,9,11,13-16H2,1-2H3,(H2,28,29)	UMCJVSRVNNGRDY-UHFFFAOYSA-N	652632	5-N-[(2-fluoro-4-{2-[(15,4S)-5-isopropyl-2,5-diazabicyclo[2.2.1]heptan-2- yl]ethyl}phenyl)methyl]isoquinoline-1,5-diamine::US20240059691, Example 2212	Plasma kallikrein			 6500							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652632	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652632&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163390298	494496780							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1377995	CC(C)N1C[C@H]2C[C@@H]1CN2CCc1ccc(CNc2cccc3c(N)nccc23)c(F)c1	InChI=1S/C26H32FN5/c1-17(2)32-16-20-13-21(32)15-31(20)11-9-18-6-7-19(24(27)12-18)14-30-25-5-3-4-23-22(25)8-10-29-26(23)28/h3-8,10,12,17,20-21,30H,9,11,13-16H2,1-2H3,(H2,28,29)/t20-,21-/m1/s1	UMCJVSRVNNGRDY-NHCUHLMSSA-N	652633	5-N-[(2-fluoro-4-{2-[(1R,4R)-5-isopropyl-2,5-diazabicyclo[2.2.1]heptan-2- yl]ethyl}phenyl)methyl]isoquinoline-1,5-diamine::US20240059691, Example 2213	Plasma kallikrein			 25000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652633	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652633&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			167098831	494496781							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378000	CC(C)N1C[C@H]2C[C@@H]1CN2CCc1ccc(CNc2ccc3c(N)ncc(Cl)c3c2)c(F)c1	InChI=1S/C26H31ClFN5/c1-16(2)33-15-20-11-21(33)14-32(20)8-7-17-3-4-18(25(28)9-17)12-30-19-5-6-22-23(10-19)24(27)13-31-26(22)29/h3-6,9-10,13,16,20-21,30H,7-8,11-12,14-15H2,1-2H3,(H2,29,31)/t20-,21-/m1/s1	HDPSRBDROYEPJE-NHCUHLMSSA-N	652634	4-chloro-6-N-[(2-fluoro-4-{2-[(1R,4R)-5-isopropyl-2,5-diazabicyclo[2.2.1]heptan-2- yl]ethyl}phenyl)methyl]isoquinoline-1,6-diamine::US20240059691, Example 2214	Plasma kallikrein			 25000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652634	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652634&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362782	494496782							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378004	Nc1ncc(Cl)c2cc(NCc3ccc(CCN4CCOCC4)cc3F)ccc12	InChI=1S/C22H24ClFN4O/c23-20-14-27-22(25)18-4-3-17(12-19(18)20)26-13-16-2-1-15(11-21(16)24)5-6-28-7-9-29-10-8-28/h1-4,11-12,14,26H,5-10,13H2,(H2,25,27)	SAQOYLCNEVUQKH-UHFFFAOYSA-N	652635	4-chloro-6-N-({2-fluoro-4-[2-(morpholin-4-yl)ethyl]phenyl}methyl)isoquinoline-1,6- diamine::US20240059691, Example 2215	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652635	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652635&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362783	494496783							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378008	CC(C)N1CCC(CC1)OCc1ccc(CNc2ccc3c(N)nccc3c2)c(F)c1	InChI=1S/C25H31FN4O/c1-17(2)30-11-8-22(9-12-30)31-16-18-3-4-20(24(26)13-18)15-29-21-5-6-23-19(14-21)7-10-28-25(23)27/h3-7,10,13-14,17,22,29H,8-9,11-12,15-16H2,1-2H3,(H2,27,28)	DMWHRKUTGAXYTO-UHFFFAOYSA-N	652636	6-N-[(2-fluoro-4-{[(1-isopropylpiperidin-4-yl)oxy]methyl}phenyl)methyl]isoquinoline- 1,6-diamine::US20240059691, Example 2216	Plasma kallikrein			 2000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652636	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652636&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362784	494496784							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378009	Nc1nccc2c(NCc3ccc(cc3)N3CC4(C3)CC(O)c3nccn43)cccc12	InChI=1S/C24H24N6O/c25-22-19-2-1-3-20(18(19)8-9-26-22)28-13-16-4-6-17(7-5-16)29-14-24(15-29)12-21(31)23-27-10-11-30(23)24/h1-11,21,28,31H,12-15H2,(H2,25,26)	JIVCKBWBZVHAIV-UHFFFAOYSA-N	652638	1-(4-(((1-aminoisoquinolin-5-yl)amino)methyl)phenyl)-6',7'-dihydrospiro[azetidine-3,5'- pyrrolo[1,2-a]imidazol]-7'-ol::US20240059691, Example 2253	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652638	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652638&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362786	494496786							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378010	CN1[C@H]2COC[C@@H]1CC(C2)OCc1ccc(CNc2cccc3c(N)nccc23)c(F)c1	InChI=1S/C25H29FN4O2/c1-30-18-10-20(11-19(30)15-31-14-18)32-13-16-5-6-17(23(26)9-16)12-29-24-4-2-3-22-21(24)7-8-28-25(22)27/h2-9,18-20,29H,10-15H2,1H3,(H2,27,28)/t18-,19+,20?	KITXJRBAWLMDQM-YOFSQIOKSA-N	652639	N5-(2-fluoro-4-((((1R,5S)-9-methyl-3-oxa-9-azabicyclo[3.3.1]nonan-7- yl)oxy)methyl)benzyl)isoquinoline-1,5-diamine::US20240059691, Example 2254	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652639	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652639&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362787	494496787							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378014	CN1CCC(CCn2cc(CNc3ccc4c(N)nccc4c3)cn2)CC1	InChI=1S/C21H28N6/c1-26-9-5-16(6-10-26)7-11-27-15-17(14-25-27)13-24-19-2-3-20-18(12-19)4-8-23-21(20)22/h2-4,8,12,14-16,24H,5-7,9-11,13H2,1H3,(H2,22,23)	SOTJCXRFTOZWTE-UHFFFAOYSA-N	652643	6-N-({1-[2-(1-methylpiperidin-4-yl)ethyl]pyrazol-4-yl}methyl)isoquinoline-1,6-diamine::US20240059691, Example 3254	Plasma kallikrein			 6500							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652643	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652643&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163390266	494496791							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378018	CN1CCC(CC1)Oc1cc(CNc2ccc3c(N)nccc3c2)ccn1	InChI=1S/C21H25N5O/c1-26-10-6-18(7-11-26)27-20-12-15(4-8-23-20)14-25-17-2-3-19-16(13-17)5-9-24-21(19)22/h2-5,8-9,12-13,18,25H,6-7,10-11,14H2,1H3,(H2,22,24)	BAPGDFQYYPBNAG-UHFFFAOYSA-N	652645	N6-((2-((1-methylpiperidin-4-yl)oxy)pyridin-4-yl)methyl)isoquinoline-1,6-diamine::US20240059691, Example 4259	Plasma kallikrein			 25000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652645	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652645&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			170928486	494496793							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378025	CN1CCC(COc2cc(CNc3cccc4c(N)nccc34)ccn2)CC1	InChI=1S/C22H27N5O/c1-27-11-7-16(8-12-27)15-28-21-13-17(5-9-24-21)14-26-20-4-2-3-19-18(20)6-10-25-22(19)23/h2-6,9-10,13,16,26H,7-8,11-12,14-15H2,1H3,(H2,23,25)	LEOZSBNDFVBQQT-UHFFFAOYSA-N	652646	5-N-[[2-[(1-methyl-4-piperidyl)methoxy]-4-pyridyl]methyl]isoquinoline-1,5-diamine::US20240059691, Example 4260	Plasma kallikrein			 2.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652646	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652646&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163390502	494496794							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378029	CN1CCC(COc2cc(CNc3ccc4c(N)nccc4c3)ccn2)CC1	InChI=1S/C22H27N5O/c1-27-10-6-16(7-11-27)15-28-21-12-17(4-8-24-21)14-26-19-2-3-20-18(13-19)5-9-25-22(20)23/h2-5,8-9,12-13,16,26H,6-7,10-11,14-15H2,1H3,(H2,23,25)	YXPALMWXBGWOBZ-UHFFFAOYSA-N	652647	6-N-({2-[(1-methylpiperidin-4-yl)methoxy]pyridin-4-yl}methyl)isoquinoline-1,6-diamine::US20240059691, Example 4261	Plasma kallikrein			 6500							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652647	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652647&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163390110	494496795							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378033	CN1CCC(COc2cc(CNc3ccc4cnccc4c3)ccn2)CC1	InChI=1S/C22H26N4O/c1-26-10-6-17(7-11-26)16-27-22-12-18(4-9-24-22)14-25-21-3-2-20-15-23-8-5-19(20)13-21/h2-5,8-9,12-13,15,17,25H,6-7,10-11,14,16H2,1H3	YUGVXCKQXRQZMT-UHFFFAOYSA-N	652648	N-({2-[(1-methylpiperidin-4-yl)methoxy]pyridin-4-yl}methyl)isoquinolin-6-amine::US20240059691, Example 4262	Plasma kallikrein			 25000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652648	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652648&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			170928363	494496796							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378043	Nc1nccc2cc(NCc3ccnc(OCC4CCn5ccnc5C4)c3)ccc12	InChI=1S/C23H24N6O/c24-23-20-2-1-19(13-18(20)4-7-27-23)28-14-16-3-6-26-22(12-16)30-15-17-5-9-29-10-8-25-21(29)11-17/h1-4,6-8,10,12-13,17,28H,5,9,11,14-15H2,(H2,24,27)	RNYFAJPMYTZRIV-UHFFFAOYSA-N	652653	6-N-({2-[(7S*)-5H,6H,7H,8H-imidazo[1,2-a]pyridin-7-ylmethoxy]pyridin-4- yl}methyl)isoquinoline-1,6-diamine::US20240059691, Example 4267::US20240059691, Example 4408	Plasma kallikrein			 6500							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652653	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652653&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163390500	494496801							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378047	CN1CCC(COc2cc(CNc3ccc4c(N)ncc(Cl)c4c3)ccn2)CC1	InChI=1S/C22H26ClN5O/c1-28-8-5-15(6-9-28)14-29-21-10-16(4-7-25-21)12-26-17-2-3-18-19(11-17)20(23)13-27-22(18)24/h2-4,7,10-11,13,15,26H,5-6,8-9,12,14H2,1H3,(H2,24,27)	WPHHTTMLRJZZSE-UHFFFAOYSA-N	652654	4-chloro-6-N-({2-[(1-methylpiperidin-4-yl)methoxy]pyridin-4-yl}methyl)isoquinoline-1,6- diamine::US20240059691, Example 4268	Plasma kallikrein			 25000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652654	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652654&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163390523	494496802							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378054	CN1CC2C(COc3cc(CNc4ccc5c(N)nccc5c4)ccn3)C2C1	InChI=1S/C22H25N5O/c1-27-11-18-19(12-27)20(18)13-28-21-8-14(4-6-24-21)10-26-16-2-3-17-15(9-16)5-7-25-22(17)23/h2-9,18-20,26H,10-13H2,1H3,(H2,23,25)	DLIVTYIYTMUJNA-UHFFFAOYSA-N	652655	N6-((2-((3-methyl-3-azabicyclo[3.1.0]hexan-6-yl)methoxy)pyridin-4- yl)methyl)isoquinoline-1,6-diamine::US20240059691, Example 4269	Plasma kallikrein			 6500							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652655	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652655&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362791	494496803							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378058	CN1CC2CCC(C1)C2COc1cc(CNc2ccc3c(N)nccc3c2)ccn1	InChI=1S/C24H29N5O/c1-29-13-18-2-3-19(14-29)22(18)15-30-23-10-16(6-8-26-23)12-28-20-4-5-21-17(11-20)7-9-27-24(21)25/h4-11,18-19,22,28H,2-3,12-15H2,1H3,(H2,25,27)	VZCLQKXKPFPMJM-UHFFFAOYSA-N	652656	6-N-[[2-[(3-methyl-3-azabicyclo[3.2.1]octan-8-yl)methoxy]-4- pyridyl]methyl]isoquinoline-1,6-diamine::US20240059691, Example 4270	Plasma kallikrein			 6500							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652656	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652656&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			169100193	494496804							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378062	CN1CCC(COc2cc(CNc3cc4ccnc(N)c4cn3)ccn2)CC1	InChI=1S/C21H26N6O/c1-27-8-4-15(5-9-27)14-28-20-10-16(2-6-23-20)12-25-19-11-17-3-7-24-21(22)18(17)13-26-19/h2-3,6-7,10-11,13,15H,4-5,8-9,12,14H2,1H3,(H2,22,24)(H,25,26)	HFEOGDZAKNSAKC-UHFFFAOYSA-N	652657	6-N-({2-[(1-methylpiperidin-4-yl)methoxy]pyridin-4-yl}methyl)-2,7-naphthyridine-1,6- diamine::US20240059691, Example 4271	Plasma kallikrein			 25000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652657	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652657&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362792	494496805							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378069	CN1CCC(COc2cc(CNc3ccnc4c(N)nccc34)ccn2)CC1	InChI=1S/C21H26N6O/c1-27-10-5-15(6-11-27)14-28-19-12-16(2-7-23-19)13-26-18-4-9-24-20-17(18)3-8-25-21(20)22/h2-4,7-9,12,15H,5-6,10-11,13-14H2,1H3,(H2,22,25)(H,24,26)	KPLOPAOSJILVIG-UHFFFAOYSA-N	652658	4-N-[[2-[(1-methyl-4-piperidyl)methoxy]-4-pyridyl]methyl]-1,7-naphthyridine-4,8- diamine::US20240059691, Example 4272	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652658	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652658&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362793	494496806							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378073	CN1CCC(COc2cc(CNc3nccc4c(N)ccnc34)ccn2)CC1	InChI=1S/C21H26N6O/c1-27-10-5-15(6-11-27)14-28-19-12-16(2-7-23-19)13-26-21-20-17(3-8-25-21)18(22)4-9-24-20/h2-4,7-9,12,15H,5-6,10-11,13-14H2,1H3,(H2,22,24)(H,25,26)	IIHKCWBLAFVPAV-UHFFFAOYSA-N	652659	N8-((2-((1-methylpiperidin-4-yl)methoxy)pyridin-4-yl)methyl)-1,7-naphthyridine-4,8- diamine::US20240059691, Example 4273	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652659	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652659&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362794	494496807							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378077	CC(=O)N1CC2CC1CC2COc1cc(CNc2cccc3c(N)nccc23)ccn1	InChI=1S/C24H27N5O2/c1-15(30)29-13-17-10-19(29)11-18(17)14-31-23-9-16(5-7-26-23)12-28-22-4-2-3-21-20(22)6-8-27-24(21)25/h2-9,17-19,28H,10-14H2,1H3,(H2,25,27)	MQDHBZFMRCCJMC-UHFFFAOYSA-N	652660	1-(5-{[(4-{[(1-aminoisoquinolin-5-yl)amino]methyl}pyridin-2-yl)oxy]methyl}-2- azabicyclo[2.2.1]heptan-2-yl)ethanone::US20240059691, Example 4274	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652660	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652660&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163390261	494496808							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378081	CC(=O)N1CC2CC1CC2COc1cc(CNc2ccc3c(N)nccc3c2)ccn1	InChI=1S/C24H27N5O2/c1-15(30)29-13-18-10-21(29)11-19(18)14-31-23-8-16(4-6-26-23)12-28-20-2-3-22-17(9-20)5-7-27-24(22)25/h2-9,18-19,21,28H,10-14H2,1H3,(H2,25,27)	FEDZONCTGWFBNX-UHFFFAOYSA-N	652661	1-(5-{[(4-{[(1-aminoisoquinolin-6-yl)amino]methyl}pyridin-2-yl)oxy]methyl}-2- azabicyclo[2.2.1]heptan-2-yl)ethanone::US20240059691, Example 4275	Plasma kallikrein			 25000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652661	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652661&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163390402	494496809							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378085	CN1CC2CC1CC2COc1cc(CNc2cccc3c(N)nccc23)ccn1	InChI=1S/C23H27N5O/c1-28-13-16-10-18(28)11-17(16)14-29-22-9-15(5-7-25-22)12-27-21-4-2-3-20-19(21)6-8-26-23(20)24/h2-9,16-18,27H,10-14H2,1H3,(H2,24,26)	CUJAMZMFVUMLMN-UHFFFAOYSA-N	652662	5-N-{[2-({2-methyl-2-azabicyclo[2.2.1]heptan-5-yl}methoxy)pyridin-4- yl]methyl}isoquinoline-1,5-diamine::US20240059691, Example 4276	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652662	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652662&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362795	494496810							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378089	CN1CC2CC1CC2COc1cc(CNc2ccc3c(N)nccc3c2)ccn1	InChI=1S/C23H27N5O/c1-28-13-17-10-20(28)11-18(17)14-29-22-8-15(4-6-25-22)12-27-19-2-3-21-16(9-19)5-7-26-23(21)24/h2-9,17-18,20,27H,10-14H2,1H3,(H2,24,26)	LRIAAYQSNNESBQ-UHFFFAOYSA-N	652663	6-N-{[2-({2-methyl-2-azabicyclo[2.2.1]heptan-5-yl}methoxy)pyridin-4- yl]methyl}isoquinoline-1,6-diamine::US20240059691, Example 4277	Plasma kallikrein			 6500							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652663	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652663&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163390550	494496811							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378093	CN1CC2CCC(C1)C2COc1cc(CNc2cccc3c(N)nccc23)ccn1	InChI=1S/C24H29N5O/c1-29-13-17-5-6-18(14-29)21(17)15-30-23-11-16(7-9-26-23)12-28-22-4-2-3-20-19(22)8-10-27-24(20)25/h2-4,7-11,17-18,21,28H,5-6,12-15H2,1H3,(H2,25,27)	RMNYKKOMVGKWMF-UHFFFAOYSA-N	652664	5-N-[[2-[(3-methyl-3-azabicyclo[3.2.1]octan-8-yl)methoxy]-4- pyridyl]methyl]isoquinoline-1,5-diamine::US20240059691, Example 4278	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652664	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652664&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362796	494496812							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378097	CN1C[C@@H](COc2cc(CNc3cccc4c(N)nccc34)ccn2)OC1=O	InChI=1S/C20H21N5O3/c1-25-11-14(28-20(25)26)12-27-18-9-13(5-7-22-18)10-24-17-4-2-3-16-15(17)6-8-23-19(16)21/h2-9,14,24H,10-12H2,1H3,(H2,21,23)/t14-/m0/s1	JIRZTKNHLRBCKF-AWEZNQCLSA-N	652665	(5S)-5-{[(4-{[(1-aminoisoquinolin-5-yl)amino]methyl}pyridin-2-yl)oxy]methyl}-3-methyl- 1,3-oxazolidin-2-one::US20240059691, Example 4279	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652665	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652665&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362797	494496813							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378101	CN1C[C@H](COc2cc(CNc3cccc4c(N)nccc34)ccn2)OC1=O	InChI=1S/C20H21N5O3/c1-25-11-14(28-20(25)26)12-27-18-9-13(5-7-22-18)10-24-17-4-2-3-16-15(17)6-8-23-19(16)21/h2-9,14,24H,10-12H2,1H3,(H2,21,23)/t14-/m1/s1	JIRZTKNHLRBCKF-CQSZACIVSA-N	652666	(5R)-5-{[(4-{[(1-aminoisoquinolin-5-yl)amino]methyl}pyridin-2-yl)oxy]methyl}-3-methyl- 1,3-oxazolidin-2-one::US20240059691, Example 4280	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652666	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652666&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362798	494496814							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378105	CN1CCC(COc2cc(CNc3cccc4c(N)nccc34)cc(n2)C(F)(F)F)CC1	InChI=1S/C23H26F3N5O/c1-31-9-6-15(7-10-31)14-32-21-12-16(11-20(30-21)23(24,25)26)13-29-19-4-2-3-18-17(19)5-8-28-22(18)27/h2-5,8,11-12,15,29H,6-7,9-10,13-14H2,1H3,(H2,27,28)	ZKYUOZOXYNXLAA-UHFFFAOYSA-N	652667	5-N-[[2-[(1-methyl-4-piperidyl)methoxy]-6-(trifluoromethyl)-4- pyridyl]methyl]isoquinoline-1,5-diamine::US20240059691, Example 4281	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652667	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652667&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362799	494496815							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378109	Cn1ccnc1CCOc1cc(CNc2cccc3c(N)nccc23)ccn1	InChI=1S/C21H22N6O/c1-27-11-10-23-19(27)7-12-28-20-13-15(5-8-24-20)14-26-18-4-2-3-17-16(18)6-9-25-21(17)22/h2-6,8-11,13,26H,7,12,14H2,1H3,(H2,22,25)	WJAIHAMGHSKLNB-UHFFFAOYSA-N	652668	5-N-({2-[2-(1-methylimidazol-2-yl)ethoxy]pyridin-4-yl}methyl)isoquinoline-1,5-diamine::US20240059691, Example 4282	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652668	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652668&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			170928467	494496816							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378113	Cn1ccnc1CCOc1cc(CNc2ccc3c(N)nccc3c2)ccn1	InChI=1S/C21H22N6O/c1-27-10-9-23-19(27)6-11-28-20-12-15(4-7-24-20)14-26-17-2-3-18-16(13-17)5-8-25-21(18)22/h2-5,7-10,12-13,26H,6,11,14H2,1H3,(H2,22,25)	QBUFVHZXADLMLN-UHFFFAOYSA-N	652669	6-N-({2-[2-(1-methylimidazol-2-yl)ethoxy]pyridin-4-yl}methyl)isoquinoline-1,6-diamine::US20240059691, Example 4283	Plasma kallikrein			 6500							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652669	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652669&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			170928370	494496817							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378117	CN1CCC(CNc2cc(CNc3ccc4c(N)nccc4c3)ccn2)CC1	InChI=1S/C22H28N6/c1-28-10-6-16(7-11-28)14-27-21-12-17(4-8-24-21)15-26-19-2-3-20-18(13-19)5-9-25-22(20)23/h2-5,8-9,12-13,16,26H,6-7,10-11,14-15H2,1H3,(H2,23,25)(H,24,27)	AYQRIBJCWHYQNN-UHFFFAOYSA-N	652670	6-N-[(2-{[(1-methylpiperidin-4-yl)methyl]amino}pyridin-4-yl)methyl]isoquinoline-1,6- diamine::US20240059691, Example 4284	Plasma kallikrein			 25000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652670	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652670&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362800	494496818							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378121	CN1CCC(CNc2cc(CNc3ccc4c(N)ncc(Cl)c4c3)ccn2)CC1	InChI=1S/C22H27ClN6/c1-29-8-5-15(6-9-29)12-27-21-10-16(4-7-25-21)13-26-17-2-3-18-19(11-17)20(23)14-28-22(18)24/h2-4,7,10-11,14-15,26H,5-6,8-9,12-13H2,1H3,(H2,24,28)(H,25,27)	VFEVHMYHGBXCLM-UHFFFAOYSA-N	652671	4-chloro-6-N-[(2-{[(1-methylpiperidin-4-yl)methyl]amino}pyridin-4- yl)methyl]isoquinoline-1,6-diamine::US20240059691, Example 4285	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652671	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652671&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163390570	494496819							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378125	CN1CCC(CNc2cc(CNc3cccc4c(N)nccc34)ccn2)CC1	InChI=1S/C22H28N6/c1-28-11-7-16(8-12-28)14-27-21-13-17(5-9-24-21)15-26-20-4-2-3-19-18(20)6-10-25-22(19)23/h2-6,9-10,13,16,26H,7-8,11-12,14-15H2,1H3,(H2,23,25)(H,24,27)	UXTLTIOXBOHGKL-UHFFFAOYSA-N	652672	N5-((2-(((1-methylpiperidin-4-yl)methyl)amino)pyridin-4-yl)methyl)isoquinoline-1,5- diamine::US20240059691, Example 4286	Plasma kallikrein			 25000							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652672	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652672&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362801	494496820							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378129	CN1CCC(CC1)NC(=O)c1cc(CNc2cccc3c(N)nccc23)ccn1	InChI=1S/C22H26N6O/c1-28-11-7-16(8-12-28)27-22(29)20-13-15(5-9-24-20)14-26-19-4-2-3-18-17(19)6-10-25-21(18)23/h2-6,9-10,13,16,26H,7-8,11-12,14H2,1H3,(H2,23,25)(H,27,29)	FUQWXNUBICSJBF-UHFFFAOYSA-N	652675	4-(((1-aminoisoquinolin-5-yl)amino)methyl)-N-(1-methylpiperidin-4-yl)picolinamide::US20240059691, Example 4289	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652675	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652675&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			170928380	494496823							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378133	CN1CCC(COc2cc(CNc3cnc4c(N)nccc4c3)ccn2)CC1	InChI=1S/C21H26N6O/c1-27-8-4-15(5-9-27)14-28-19-10-16(2-6-23-19)12-25-18-11-17-3-7-24-21(22)20(17)26-13-18/h2-3,6-7,10-11,13,15,25H,4-5,8-9,12,14H2,1H3,(H2,22,24)	JBHALIPUGWBOFZ-UHFFFAOYSA-N	652676	3-N-({2-[(1-methylpiperidin-4-yl)methoxy]pyridin-4-yl}methyl)-1,7-naphthyridine-3,8- diamine::US20240059691, Example 4293	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652676	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652676&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362802	494496824							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378134	CC(C)N1C[C@H]2C[C@@H]1CN2Cc1cc(CNc2cccc3c(N)nccc23)ccn1	InChI=1S/C24H30N6/c1-16(2)30-15-19-11-20(30)14-29(19)13-18-10-17(6-8-26-18)12-28-23-5-3-4-22-21(23)7-9-27-24(22)25/h3-10,16,19-20,28H,11-15H2,1-2H3,(H2,25,27)/t19-,20-/m1/s1	GZWDTTNGXUYGCU-WOJBJXKFSA-N	652677	5-N-[(2-{[(1R,4R)-5-isopropyl-2,5-diazabicyclo[2.2.1]heptan-2-yl]methyl}pyridin-4- yl)methyl]isoquinoline-1,5-diamine::US20240059691, Example 4294::US20240059691, Example 4295	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652677	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652677&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362803	494496825							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1378138	CC(C)N1C[C@H]2C[C@@H]1CN2Cc1cc(CNc2cccc3c(N)nccc23)ccn1	InChI=1S/C24H30N6/c1-16(2)30-15-19-11-20(30)14-29(19)13-18-10-17(6-8-26-18)12-28-23-5-3-4-22-21(23)7-9-27-24(22)25/h3-10,16,19-20,28H,11-15H2,1-2H3,(H2,25,27)/t19-,20-/m1/s1	GZWDTTNGXUYGCU-WOJBJXKFSA-N	652677	5-N-[(2-{[(1R,4R)-5-isopropyl-2,5-diazabicyclo[2.2.1]heptan-2-yl]methyl}pyridin-4- yl)methyl]isoquinoline-1,5-diamine::US20240059691, Example 4294::US20240059691, Example 4295	Plasma kallikrein			 3.00							US Patent		10.7270/Q2NG4VVD			US20240059691	CHILDS, ML; DAVIE, RL; EDWARDS, HJ; EVANS, DM; GREVES, WJ; HODGSON, ST; MAZZACANI, A; NORTH, CL; OBARA, AS; ROE, MB; ROOKER, DP; STOCKS, MJ; BIRCH, LM; PICHOWICZ, M; PITTAWAY, R; SMITH, AJ; THROUP, AE; WRIGGLESWORTH, JW; YANG, X; CLARK, DE	Kalvista Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=652677	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=652677&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171362803	494496825							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P,8FGX	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51544676	Nc1nccc2cc(ccc12)-c1cccc(c1)B(O)O	InChI=1S/C15H13BN2O2/c17-15-14-5-4-11(8-12(14)6-7-18-15)10-2-1-3-13(9-10)16(19)20/h1-9,19-20H,(H2,17,18)	CCUGLTODPQTEBR-UHFFFAOYSA-N	50621294	CHEMBL5425528	Plasma kallikrein	Homo sapiens		 45							ChEMBL	10.1021/acsmedchemlett.3c00572	10.7270/Q2RR23NJ	38628785			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50621294	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50621294&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	CWV    	6B77									1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51544681	Cl.CC1(C)OB(OC1(C)C)C(N)c1cccc(Cl)c1	InChI=1S/C13H19BClNO2.ClH/c1-12(2)13(3,4)18-14(17-12)11(16)9-6-5-7-10(15)8-9;/h5-8,11H,16H2,1-4H3;1H	PZFHFPLIZUGLNF-UHFFFAOYSA-N	50621295	CHEMBL5409864	Plasma kallikrein	Homo sapiens		>400000							ChEMBL	10.1021/acsmedchemlett.3c00572	10.7270/Q2RR23NJ	38628785			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50621295	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50621295&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51544682	CC1(C)OB(OC1(C)C)C(NC(=O)c1cnn(Cc2ccccc2)c1)c1cccc(Cl)c1	InChI=1S/C24H27BClN3O3/c1-23(2)24(3,4)32-25(31-23)21(18-11-8-12-20(26)13-18)28-22(30)19-14-27-29(16-19)15-17-9-6-5-7-10-17/h5-14,16,21H,15H2,1-4H3,(H,28,30)	VRPVNXMPAVISSZ-UHFFFAOYSA-N	50621296	CHEMBL5397200	Plasma kallikrein	Homo sapiens		>400000							ChEMBL	10.1021/acsmedchemlett.3c00572	10.7270/Q2RR23NJ	38628785			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50621296	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50621296&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51544683	Cc1ccc(C(NC(=O)c2cnn(Cc3ccccc3)c2)B2OC(C)(C)C(C)(C)O2)c(F)c1	InChI=1S/C25H29BFN3O3/c1-17-11-12-20(21(27)13-17)22(26-32-24(2,3)25(4,5)33-26)29-23(31)19-14-28-30(16-19)15-18-9-7-6-8-10-18/h6-14,16,22H,15H2,1-5H3,(H,29,31)	FOOYQBFAGIVGFV-UHFFFAOYSA-N	50621297	CHEMBL5427122	Plasma kallikrein	Homo sapiens		 2300							ChEMBL	10.1021/acsmedchemlett.3c00572	10.7270/Q2RR23NJ	38628785			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50621297	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50621297&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51544684	OB(O)C(NC(=O)c1cnn(Cc2ccccc2)c1)c1cccc(Cl)c1	InChI=1S/C18H17BClN3O3/c20-16-8-4-7-14(9-16)17(19(25)26)22-18(24)15-10-21-23(12-15)11-13-5-2-1-3-6-13/h1-10,12,17,25-26H,11H2,(H,22,24)	ZXWADSDWEAQLAR-UHFFFAOYSA-N	50621298	CHEMBL5414831	Plasma kallikrein	Homo sapiens		>400000							ChEMBL	10.1021/acsmedchemlett.3c00572	10.7270/Q2RR23NJ	38628785			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50621298	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50621298&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51544685	Cl.CC1(C)OB(OC1(C)C)C(N)c1cccc(Cl)c1	InChI=1S/C13H19BClNO2.ClH/c1-12(2)13(3,4)18-14(17-12)11(16)9-6-5-7-10(15)8-9;/h5-8,11H,16H2,1-4H3;1H	PZFHFPLIZUGLNF-UHFFFAOYSA-N	50621295	CHEMBL5409864	Plasma kallikrein	Homo sapiens		>400000							ChEMBL	10.1021/acsmedchemlett.3c00572	10.7270/Q2RR23NJ	38628785			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50621295	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50621295&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51544686	CC1(C)OB(OC1(C)C)C(NC(=O)c1cnn(Cc2ccccc2)c1)c1cccc(Cl)c1	InChI=1S/C24H27BClN3O3/c1-23(2)24(3,4)32-25(31-23)21(18-11-8-12-20(26)13-18)28-22(30)19-14-27-29(16-19)15-17-9-6-5-7-10-17/h5-14,16,21H,15H2,1-4H3,(H,28,30)	VRPVNXMPAVISSZ-UHFFFAOYSA-N	50621296	CHEMBL5397200	Plasma kallikrein	Homo sapiens		 64000							ChEMBL	10.1021/acsmedchemlett.3c00572	10.7270/Q2RR23NJ	38628785			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50621296	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50621296&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51544687	Cc1ccc(C(NC(=O)c2cnn(Cc3ccccc3)c2)B2OC(C)(C)C(C)(C)O2)c(F)c1	InChI=1S/C25H29BFN3O3/c1-17-11-12-20(21(27)13-17)22(26-32-24(2,3)25(4,5)33-26)29-23(31)19-14-28-30(16-19)15-18-9-7-6-8-10-18/h6-14,16,22H,15H2,1-5H3,(H,29,31)	FOOYQBFAGIVGFV-UHFFFAOYSA-N	50621297	CHEMBL5427122	Plasma kallikrein	Homo sapiens		 33							ChEMBL	10.1021/acsmedchemlett.3c00572	10.7270/Q2RR23NJ	38628785			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50621297	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50621297&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51544688	OB(O)C(NC(=O)c1cnn(Cc2ccccc2)c1)c1cccc(Cl)c1	InChI=1S/C18H17BClN3O3/c20-16-8-4-7-14(9-16)17(19(25)26)22-18(24)15-10-21-23(12-15)11-13-5-2-1-3-6-13/h1-10,12,17,25-26H,11H2,(H,22,24)	ZXWADSDWEAQLAR-UHFFFAOYSA-N	50621298	CHEMBL5414831	Plasma kallikrein	Homo sapiens		>400000							ChEMBL	10.1021/acsmedchemlett.3c00572	10.7270/Q2RR23NJ	38628785			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50621298	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50621298&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51544689	CC1(C)OB(OC1(C)C)C(NC(=O)c1cnn(Cc2ccc(Cn3cccn3)cc2)c1)c1cccc(Cl)c1	InChI=1S/C28H31BClN5O3/c1-27(2)28(3,4)38-29(37-27)25(22-7-5-8-24(30)15-22)33-26(36)23-16-32-35(19-23)18-21-11-9-20(10-12-21)17-34-14-6-13-31-34/h5-16,19,25H,17-18H2,1-4H3,(H,33,36)	UCWICSYWXORFBE-UHFFFAOYSA-N	50621299	CHEMBL5434581	Plasma kallikrein	Homo sapiens		 5.2							ChEMBL	10.1021/acsmedchemlett.3c00572	10.7270/Q2RR23NJ	38628785			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50621299	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50621299&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51544690	Cc1ccc(C(NC(=O)c2cnn(Cc3ccc(Cn4cccn4)cc3)c2)B2OC(C)(C)C(C)(C)O2)c(F)c1	InChI=1S/C29H33BFN5O3/c1-20-7-12-24(25(31)15-20)26(30-38-28(2,3)29(4,5)39-30)34-27(37)23-16-33-36(19-23)18-22-10-8-21(9-11-22)17-35-14-6-13-32-35/h6-16,19,26H,17-18H2,1-5H3,(H,34,37)	SLGOZYZQXDRCEI-UHFFFAOYSA-N	50621300	CHEMBL5417094	Plasma kallikrein	Homo sapiens		 0.300000							ChEMBL	10.1021/acsmedchemlett.3c00572	10.7270/Q2RR23NJ	38628785			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50621300	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50621300&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51544691	Cc1ccc(C(NC(=O)c2cnn(Cc3ccc(Cn4ccccc4=O)cc3)c2)B2OC(C)(C)C(C)(C)O2)c(F)c1	InChI=1S/C31H34BFN4O4/c1-21-9-14-25(26(33)16-21)28(32-40-30(2,3)31(4,5)41-32)35-29(39)24-17-34-37(20-24)19-23-12-10-22(11-13-23)18-36-15-7-6-8-27(36)38/h6-17,20,28H,18-19H2,1-5H3,(H,35,39)	AFMXDJSYGSJSDR-UHFFFAOYSA-N	50621301	CHEMBL5405101	Plasma kallikrein	Homo sapiens		 1.9							ChEMBL	10.1021/acsmedchemlett.3c00572	10.7270/Q2RR23NJ	38628785			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50621301	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50621301&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51544692	Cc1ccc(C(NC(=O)c2cnn(Cc3ccccc3)c2)B2OC(C)(C)C(C)(C)O2)c(F)c1	InChI=1S/C25H29BFN3O3/c1-17-11-12-20(21(27)13-17)22(26-32-24(2,3)25(4,5)33-26)29-23(31)19-14-28-30(16-19)15-18-9-7-6-8-10-18/h6-14,16,22H,15H2,1-5H3,(H,29,31)	FOOYQBFAGIVGFV-UHFFFAOYSA-N	50621297	CHEMBL5427122	Plasma kallikrein	Homo sapiens		 33							ChEMBL	10.1021/acsmedchemlett.3c00572	10.7270/Q2RR23NJ	38628785			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50621297	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50621297&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51544693	NC(=N)NCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H]1CCCN1)C(=O)CCl	InChI=1S/C20H29ClN6O3/c21-12-17(28)14(8-10-25-20(22)23)26-19(30)16(11-13-5-2-1-3-6-13)27-18(29)15-7-4-9-24-15/h1-3,5-6,14-16,24H,4,7-12H2,(H,26,30)(H,27,29)(H4,22,23,25)/t14-,15+,16-/m0/s1	DMPXIFGNDCFZRQ-XHSDSOJGSA-N	50621302	CHEMBL5397741	Plasma kallikrein	Homo sapiens		 2.1							ChEMBL	10.1021/acsmedchemlett.3c00572	10.7270/Q2RR23NJ	38628785			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50621302	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50621302&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51544694	Clc1cccc(CNC(=O)c2cnn(Cc3ccc(Cn4cccn4)cc3)c2)c1	InChI=1S/C22H20ClN5O/c23-21-4-1-3-19(11-21)12-24-22(29)20-13-26-28(16-20)15-18-7-5-17(6-8-18)14-27-10-2-9-25-27/h1-11,13,16H,12,14-15H2,(H,24,29)	QNEZAIFSXKLMLC-UHFFFAOYSA-N	50621303	CHEMBL5404014	Plasma kallikrein	Homo sapiens		>40000							ChEMBL	10.1021/acsmedchemlett.3c00572	10.7270/Q2RR23NJ	38628785			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50621303	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50621303&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51544695	Clc1cccc(CNC(=O)c2cnn(Cc3ccc(Cn4ccccc4=O)cc3)c2)c1	InChI=1S/C24H21ClN4O2/c25-22-5-3-4-20(12-22)13-26-24(31)21-14-27-29(17-21)16-19-9-7-18(8-10-19)15-28-11-2-1-6-23(28)30/h1-12,14,17H,13,15-16H2,(H,26,31)	GINLXBCPSORJBF-UHFFFAOYSA-N	50621304	CHEMBL5178779	Plasma kallikrein	Homo sapiens		 278							ChEMBL	10.1021/acsmedchemlett.3c00572	10.7270/Q2RR23NJ	38628785			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50621304	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50621304&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51544696	Cc1ccc(CNC(=O)c2cnn(Cc3ccc(Cn4cccn4)cc3)c2)c(F)c1	InChI=1S/C23H22FN5O/c1-17-3-8-20(22(24)11-17)12-25-23(30)21-13-27-29(16-21)15-19-6-4-18(5-7-19)14-28-10-2-9-26-28/h2-11,13,16H,12,14-15H2,1H3,(H,25,30)	FLXKUVMQIHUOBX-UHFFFAOYSA-N	50621305	CHEMBL5421724	Plasma kallikrein	Homo sapiens		 196							ChEMBL	10.1021/acsmedchemlett.3c00572	10.7270/Q2RR23NJ	38628785			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50621305	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50621305&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51544697	Cc1ccc(CNC(=O)c2cnn(Cc3ccc(Cn4ccccc4=O)cc3)c2)c(F)c1	InChI=1S/C25H23FN4O2/c1-18-5-10-21(23(26)12-18)13-27-25(32)22-14-28-30(17-22)16-20-8-6-19(7-9-20)15-29-11-3-2-4-24(29)31/h2-12,14,17H,13,15-16H2,1H3,(H,27,32)	VJHIABWNHKPRHK-UHFFFAOYSA-N	50621306	CHEMBL5413387	Plasma kallikrein	Homo sapiens		 35							ChEMBL	10.1021/acsmedchemlett.3c00572	10.7270/Q2RR23NJ	38628785			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50621306	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50621306&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51544698	Clc1cccc(\C=C\C(=O)c2cnn(Cc3ccc(Cn4cccn4)cc3)c2)c1	InChI=1S/C23H19ClN4O/c24-22-4-1-3-18(13-22)9-10-23(29)21-14-26-28(17-21)16-20-7-5-19(6-8-20)15-27-12-2-11-25-27/h1-14,17H,15-16H2/b10-9+	YGPZVEMMDGGZOO-MDZDMXLPSA-N	50621307	CHEMBL5399272	Plasma kallikrein	Homo sapiens		>40000							ChEMBL	10.1021/acsmedchemlett.3c00572	10.7270/Q2RR23NJ	38628785			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50621307	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50621307&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51544699	Cc1ccc(\C=C\C(=O)c2cnn(Cc3ccc(Cn4cccn4)cc3)c2)c(F)c1	InChI=1S/C24H21FN4O/c1-18-3-8-21(23(25)13-18)9-10-24(30)22-14-27-29(17-22)16-20-6-4-19(5-7-20)15-28-12-2-11-26-28/h2-14,17H,15-16H2,1H3/b10-9+	LOFDEQUBUKAINK-MDZDMXLPSA-N	50621308	CHEMBL5438897	Plasma kallikrein	Homo sapiens		 5975							ChEMBL	10.1021/acsmedchemlett.3c00572	10.7270/Q2RR23NJ	38628785			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50621308	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50621308&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51544700	CC1(C)OB(OC1(C)C)C(CC(=O)c1cnn(Cc2ccc(Cn3cccn3)cc2)c1)c1cccc(Cl)c1	InChI=1S/C29H32BClN4O3/c1-28(2)29(3,4)38-30(37-28)26(23-7-5-8-25(31)15-23)16-27(36)24-17-33-35(20-24)19-22-11-9-21(10-12-22)18-34-14-6-13-32-34/h5-15,17,20,26H,16,18-19H2,1-4H3	LDXMZOMDZGUUTO-UHFFFAOYSA-N	50621309	CHEMBL5403349	Plasma kallikrein	Homo sapiens		 2637							ChEMBL	10.1021/acsmedchemlett.3c00572	10.7270/Q2RR23NJ	38628785			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50621309	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50621309&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51544701	Cc1ccc(C(CC(=O)c2cnn(Cc3ccc(Cn4cccn4)cc3)c2)B2OC(C)(C)C(C)(C)O2)c(F)c1	InChI=1S/C30H34BFN4O3/c1-21-7-12-25(27(32)15-21)26(31-38-29(2,3)30(4,5)39-31)16-28(37)24-17-34-36(20-24)19-23-10-8-22(9-11-23)18-35-14-6-13-33-35/h6-15,17,20,26H,16,18-19H2,1-5H3	IRZIUXYJTSGQCW-UHFFFAOYSA-N	50621310	CHEMBL5417079	Plasma kallikrein	Homo sapiens		 34							ChEMBL	10.1021/acsmedchemlett.3c00572	10.7270/Q2RR23NJ	38628785			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50621310	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50621310&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51544710	CC1(C)OB(OC1(C)C)C(NC(=O)c1cnn(Cc2ccc(Cn3cccn3)cc2)c1)c1cccc(Cl)c1	InChI=1S/C28H31BClN5O3/c1-27(2)28(3,4)38-29(37-27)25(22-7-5-8-24(30)15-22)33-26(36)23-16-32-35(19-23)18-21-11-9-20(10-12-21)17-34-14-6-13-31-34/h5-16,19,25H,17-18H2,1-4H3,(H,33,36)	UCWICSYWXORFBE-UHFFFAOYSA-N	50621299	CHEMBL5434581	Plasma kallikrein	Homo sapiens		 255							ChEMBL	10.1021/acsmedchemlett.3c00572	10.7270/Q2RR23NJ	38628785			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50621299	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50621299&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51544711	Cc1ccc(C(NC(=O)c2cnn(Cc3ccc(Cn4cccn4)cc3)c2)B2OC(C)(C)C(C)(C)O2)c(F)c1	InChI=1S/C29H33BFN5O3/c1-20-7-12-24(25(31)15-20)26(30-38-28(2,3)29(4,5)39-30)34-27(37)23-16-33-36(19-23)18-22-10-8-21(9-11-22)17-35-14-6-13-32-35/h6-16,19,26H,17-18H2,1-5H3,(H,34,37)	SLGOZYZQXDRCEI-UHFFFAOYSA-N	50621300	CHEMBL5417094	Plasma kallikrein	Homo sapiens		 66							ChEMBL	10.1021/acsmedchemlett.3c00572	10.7270/Q2RR23NJ	38628785			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50621300	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50621300&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51544712	Cc1ccc(C(NC(=O)c2cnn(Cc3ccc(Cn4ccccc4=O)cc3)c2)B2OC(C)(C)C(C)(C)O2)c(F)c1	InChI=1S/C31H34BFN4O4/c1-21-9-14-25(26(33)16-21)28(32-40-30(2,3)31(4,5)41-32)35-29(39)24-17-34-37(20-24)19-23-12-10-22(11-13-23)18-36-15-7-6-8-27(36)38/h6-17,20,28H,18-19H2,1-5H3,(H,35,39)	AFMXDJSYGSJSDR-UHFFFAOYSA-N	50621301	CHEMBL5405101	Plasma kallikrein	Homo sapiens		 94							ChEMBL	10.1021/acsmedchemlett.3c00572	10.7270/Q2RR23NJ	38628785			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50621301	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50621301&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51544713	Cc1ccc(C(NC(=O)c2cnn(Cc3ccccc3)c2)B2OC(C)(C)C(C)(C)O2)c(F)c1	InChI=1S/C25H29BFN3O3/c1-17-11-12-20(21(27)13-17)22(26-32-24(2,3)25(4,5)33-26)29-23(31)19-14-28-30(16-19)15-18-9-7-6-8-10-18/h6-14,16,22H,15H2,1-5H3,(H,29,31)	FOOYQBFAGIVGFV-UHFFFAOYSA-N	50621297	CHEMBL5427122	Plasma kallikrein	Homo sapiens		 2307							ChEMBL	10.1021/acsmedchemlett.3c00572	10.7270/Q2RR23NJ	38628785			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50621297	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50621297&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51544714	NC(=N)NCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H]1CCCN1)C(=O)CCl	InChI=1S/C20H29ClN6O3/c21-12-17(28)14(8-10-25-20(22)23)26-19(30)16(11-13-5-2-1-3-6-13)27-18(29)15-7-4-9-24-15/h1-3,5-6,14-16,24H,4,7-12H2,(H,26,30)(H,27,29)(H4,22,23,25)/t14-,15+,16-/m0/s1	DMPXIFGNDCFZRQ-XHSDSOJGSA-N	50621302	CHEMBL5397741	Plasma kallikrein	Homo sapiens		 86							ChEMBL	10.1021/acsmedchemlett.3c00572	10.7270/Q2RR23NJ	38628785			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50621302	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50621302&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51544715	Clc1cccc(CNC(=O)c2cnn(Cc3ccc(Cn4cccn4)cc3)c2)c1	InChI=1S/C22H20ClN5O/c23-21-4-1-3-19(11-21)12-24-22(29)20-13-26-28(16-20)15-18-7-5-17(6-8-18)14-27-10-2-9-25-27/h1-11,13,16H,12,14-15H2,(H,24,29)	QNEZAIFSXKLMLC-UHFFFAOYSA-N	50621303	CHEMBL5404014	Plasma kallikrein	Homo sapiens		>40000							ChEMBL	10.1021/acsmedchemlett.3c00572	10.7270/Q2RR23NJ	38628785			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50621303	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50621303&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51544716	Clc1cccc(CNC(=O)c2cnn(Cc3ccc(Cn4ccccc4=O)cc3)c2)c1	InChI=1S/C24H21ClN4O2/c25-22-5-3-4-20(12-22)13-26-24(31)21-14-27-29(17-21)16-19-9-7-18(8-10-19)15-28-11-2-1-6-23(28)30/h1-12,14,17H,13,15-16H2,(H,26,31)	GINLXBCPSORJBF-UHFFFAOYSA-N	50621304	CHEMBL5178779	Plasma kallikrein	Homo sapiens		 270							ChEMBL	10.1021/acsmedchemlett.3c00572	10.7270/Q2RR23NJ	38628785			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50621304	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50621304&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51544717	Cc1ccc(CNC(=O)c2cnn(Cc3ccc(Cn4cccn4)cc3)c2)c(F)c1	InChI=1S/C23H22FN5O/c1-17-3-8-20(22(24)11-17)12-25-23(30)21-13-27-29(16-21)15-19-6-4-18(5-7-19)14-28-10-2-9-26-28/h2-11,13,16H,12,14-15H2,1H3,(H,25,30)	FLXKUVMQIHUOBX-UHFFFAOYSA-N	50621305	CHEMBL5421724	Plasma kallikrein	Homo sapiens		 199							ChEMBL	10.1021/acsmedchemlett.3c00572	10.7270/Q2RR23NJ	38628785			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50621305	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50621305&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51544718	Cc1ccc(CNC(=O)c2cnn(Cc3ccc(Cn4ccccc4=O)cc3)c2)c(F)c1	InChI=1S/C25H23FN4O2/c1-18-5-10-21(23(26)12-18)13-27-25(32)22-14-28-30(17-22)16-20-8-6-19(7-9-20)15-29-11-3-2-4-24(29)31/h2-12,14,17H,13,15-16H2,1H3,(H,27,32)	VJHIABWNHKPRHK-UHFFFAOYSA-N	50621306	CHEMBL5413387	Plasma kallikrein	Homo sapiens		 37							ChEMBL	10.1021/acsmedchemlett.3c00572	10.7270/Q2RR23NJ	38628785			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50621306	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50621306&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51544719	Clc1cccc(\C=C\C(=O)c2cnn(Cc3ccc(Cn4cccn4)cc3)c2)c1	InChI=1S/C23H19ClN4O/c24-22-4-1-3-18(13-22)9-10-23(29)21-14-26-28(17-21)16-20-7-5-19(6-8-20)15-27-12-2-11-25-27/h1-14,17H,15-16H2/b10-9+	YGPZVEMMDGGZOO-MDZDMXLPSA-N	50621307	CHEMBL5399272	Plasma kallikrein	Homo sapiens		>40000							ChEMBL	10.1021/acsmedchemlett.3c00572	10.7270/Q2RR23NJ	38628785			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50621307	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50621307&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51544720	Cc1ccc(\C=C\C(=O)c2cnn(Cc3ccc(Cn4cccn4)cc3)c2)c(F)c1	InChI=1S/C24H21FN4O/c1-18-3-8-21(23(25)13-18)9-10-24(30)22-14-27-29(17-22)16-20-6-4-19(5-7-20)15-28-12-2-11-26-28/h2-14,17H,15-16H2,1H3/b10-9+	LOFDEQUBUKAINK-MDZDMXLPSA-N	50621308	CHEMBL5438897	Plasma kallikrein	Homo sapiens		>40000							ChEMBL	10.1021/acsmedchemlett.3c00572	10.7270/Q2RR23NJ	38628785			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50621308	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50621308&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51544721	CC1(C)OB(OC1(C)C)C(CC(=O)c1cnn(Cc2ccc(Cn3cccn3)cc2)c1)c1cccc(Cl)c1	InChI=1S/C29H32BClN4O3/c1-28(2)29(3,4)38-30(37-28)26(23-7-5-8-25(31)15-23)16-27(36)24-17-33-35(20-24)19-22-11-9-21(10-12-22)18-34-14-6-13-32-34/h5-15,17,20,26H,16,18-19H2,1-4H3	LDXMZOMDZGUUTO-UHFFFAOYSA-N	50621309	CHEMBL5403349	Plasma kallikrein	Homo sapiens		 1534							ChEMBL	10.1021/acsmedchemlett.3c00572	10.7270/Q2RR23NJ	38628785			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50621309	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50621309&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51544722	Cc1ccc(C(CC(=O)c2cnn(Cc3ccc(Cn4cccn4)cc3)c2)B2OC(C)(C)C(C)(C)O2)c(F)c1	InChI=1S/C30H34BFN4O3/c1-21-7-12-25(27(32)15-21)26(31-38-29(2,3)30(4,5)39-31)16-28(37)24-17-34-36(20-24)19-23-10-8-22(9-11-23)18-35-14-6-13-33-35/h6-15,17,20,26H,16,18-19H2,1-5H3	IRZIUXYJTSGQCW-UHFFFAOYSA-N	50621310	CHEMBL5417079	Plasma kallikrein	Homo sapiens		 41							ChEMBL	10.1021/acsmedchemlett.3c00572	10.7270/Q2RR23NJ	38628785			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50621310	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50621310&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51544723	CC1(C)OB(OC1(C)C)C(NC(=O)c1cnn(Cc2ccc(Cn3cccn3)cc2)c1)c1cccc(Cl)c1	InChI=1S/C28H31BClN5O3/c1-27(2)28(3,4)38-29(37-27)25(22-7-5-8-24(30)15-22)33-26(36)23-16-32-35(19-23)18-21-11-9-20(10-12-21)17-34-14-6-13-31-34/h5-16,19,25H,17-18H2,1-4H3,(H,33,36)	UCWICSYWXORFBE-UHFFFAOYSA-N	50621299	CHEMBL5434581	Plasma kallikrein	Homo sapiens		 46							ChEMBL	10.1021/acsmedchemlett.3c00572	10.7270/Q2RR23NJ	38628785			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50621299	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50621299&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51544724	Cc1ccc(C(NC(=O)c2cnn(Cc3ccc(Cn4cccn4)cc3)c2)B2OC(C)(C)C(C)(C)O2)c(F)c1	InChI=1S/C29H33BFN5O3/c1-20-7-12-24(25(31)15-20)26(30-38-28(2,3)29(4,5)39-30)34-27(37)23-16-33-36(19-23)18-22-10-8-21(9-11-22)17-35-14-6-13-32-35/h6-16,19,26H,17-18H2,1-5H3,(H,34,37)	SLGOZYZQXDRCEI-UHFFFAOYSA-N	50621300	CHEMBL5417094	Plasma kallikrein	Homo sapiens		 6.9							ChEMBL	10.1021/acsmedchemlett.3c00572	10.7270/Q2RR23NJ	38628785			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50621300	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50621300&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51544725	Cc1ccc(C(NC(=O)c2cnn(Cc3ccc(Cn4ccccc4=O)cc3)c2)B2OC(C)(C)C(C)(C)O2)c(F)c1	InChI=1S/C31H34BFN4O4/c1-21-9-14-25(26(33)16-21)28(32-40-30(2,3)31(4,5)41-32)35-29(39)24-17-34-37(20-24)19-23-12-10-22(11-13-23)18-36-15-7-6-8-27(36)38/h6-17,20,28H,18-19H2,1-5H3,(H,35,39)	AFMXDJSYGSJSDR-UHFFFAOYSA-N	50621301	CHEMBL5405101	Plasma kallikrein	Homo sapiens		 17							ChEMBL	10.1021/acsmedchemlett.3c00572	10.7270/Q2RR23NJ	38628785			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50621301	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50621301&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51545762	CC[C@@H](C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)(F)F	InChI=1S/C26H21ClF4N6O4/c1-3-19(25(40)33-14-5-6-15(24(32)39)18(28)9-14)36-11-21(41-2)17(10-23(36)38)16-8-13(27)4-7-20(16)37-12-22(34-35-37)26(29,30)31/h4-12,19H,3H2,1-2H3,(H2,32,39)(H,33,40)/t19-/m0/s1	XYWIPYBIIRTJMM-IBGZPJMESA-N	413842	4-({(2S)-2-[4-{5-Chloro-2-[4-(trifluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanoyl}amino)-2-fluorobenzamide (Enantiomer 2)::US10421742, Example 235::US11180471, Example 235	Plasma kallikrein	Homo sapiens		 6.7							ChEMBL	10.1021/acs.jmedchem.2c02130	10.7270/Q2CC1525	37037122			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413842	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413842&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	QV3    	8BO3	135206011	433913941							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51545763	OC(=O)c1ccc(NC(=O)[C@H](CC(=O)N2CCN(CC2)c2ccccc2)NC(=O)\C=C\c2cc(Cl)ccc2-n2cnnn2)cc1	InChI=1S/C31H29ClN8O5/c32-23-9-12-27(40-20-33-36-37-40)22(18-23)8-13-28(41)35-26(30(43)34-24-10-6-21(7-11-24)31(44)45)19-29(42)39-16-14-38(15-17-39)25-4-2-1-3-5-25/h1-13,18,20,26H,14-17,19H2,(H,34,43)(H,35,41)(H,44,45)/b13-8+/t26-/m0/s1	AVSRJYMYJIKOOD-FQKQOIFNSA-N	50586027	CHEMBL5090877	Plasma kallikrein	Homo sapiens		>14000							ChEMBL	10.1021/acs.jmedchem.2c02130	10.7270/Q2CC1525	37037122			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50586027	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50586027&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			163322272	476022114							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51545764	CC[C@@H](C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1	InChI=1S/C25H21Cl2FN6O4/c1-3-19(25(37)30-14-5-6-15(24(29)36)18(28)9-14)33-11-21(38-2)17(10-23(33)35)16-8-13(26)4-7-20(16)34-12-22(27)31-32-34/h4-12,19H,3H2,1-2H3,(H2,29,36)(H,30,37)/t19-/m0/s1	FPAKZDLGEHHCTC-IBGZPJMESA-N	413849	4-{[(2S)-2-{4-[5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}butanoyl]amino}-2-fluorobenzamide (Enantiomer 2)::US10421742, Example 242::US11180471, Example 242	Plasma kallikrein	Homo sapiens		 5.4							ChEMBL	10.1021/acs.jmedchem.2c02130	10.7270/Q2CC1525	37037122			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413849	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413849&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135205798	433913948							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51545765	OC(=O)c1ccc(NC(=O)[C@H](CC2CC2)c2ccc(c[n+]2[O-])-c2c(F)c(Cl)ccc2C(F)F)cc1	InChI=1S/C25H20ClF3N2O4/c26-19-9-8-17(23(28)29)21(22(19)27)15-5-10-20(31(35)12-15)18(11-13-1-2-13)24(32)30-16-6-3-14(4-7-16)25(33)34/h3-10,12-13,18,23H,1-2,11H2,(H,30,32)(H,33,34)/t18-/m1/s1	YTPAQVBXJDTTMW-GOSISDBHSA-N	304114	(R)-2-(1-((4-carboxyphenyl)amino)-3-cyclopropyl-1-oxopropan-2-yl)-5-(3-chloro-6-(difluoromethyl)-2-fluorophenyl)pyridine 1-oxide::US10143681, Example 23	Plasma kallikrein	Homo sapiens		 22							ChEMBL	10.1021/acs.jmedchem.2c02130	10.7270/Q2CC1525	37037122			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304114	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304114&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			134261848	381752844							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51545766	OC(=O)c1ccc(NC(=O)C2CCc3cc(c[n+]([O-])c23)-c2cc(Cl)ccc2-n2cnnn2)cc1	InChI=1S/C23H17ClN6O4/c24-16-4-8-20(29-12-25-27-28-29)19(10-16)15-9-14-3-7-18(21(14)30(34)11-15)22(31)26-17-5-1-13(2-6-17)23(32)33/h1-2,4-6,8-12,18H,3,7H2,(H,26,31)(H,32,33)	AKJAQNYBFISUTH-UHFFFAOYSA-N	50621690	CHEMBL5436769	Plasma kallikrein	Homo sapiens		 472							ChEMBL	10.1021/acs.jmedchem.2c02130	10.7270/Q2CC1525	37037122			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50621690	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50621690&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51545767	OC(=O)c1ccc(NC(=O)[C@H](Cc2ccccc2)n2cnc(cc2=O)-c2cc(Cl)ccc2-n2cc(Cl)nn2)cc1	InChI=1S/C28H20Cl2N6O4/c29-19-8-11-23(36-15-25(30)33-34-36)21(13-19)22-14-26(37)35(16-31-22)24(12-17-4-2-1-3-5-17)27(38)32-20-9-6-18(7-10-20)28(39)40/h1-11,13-16,24H,12H2,(H,32,38)(H,39,40)/t24-/m0/s1	LHHWGVJWRQQRST-DEOSSOPVSA-N	50621691	CHEMBL5407365	Plasma kallikrein	Homo sapiens		 189							ChEMBL	10.1021/acs.jmedchem.2c02130	10.7270/Q2CC1525	37037122			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50621691	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50621691&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51545768	COc1nn([C@@H](Cc2ccccc2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C(C)=O	InChI=1S/C29H24ClN3O6/c1-17(34)22-13-10-20(30)15-23(22)24-16-26(35)33(32-28(24)39-2)25(14-18-6-4-3-5-7-18)27(36)31-21-11-8-19(9-12-21)29(37)38/h3-13,15-16,25H,14H2,1-2H3,(H,31,36)(H,37,38)/t25-/m0/s1	YXWHISHHLLHZOG-VWLOTQADSA-N	50621711	CHEMBL5405738	Plasma kallikrein	Homo sapiens	 103								ChEMBL	10.1021/acs.jmedchem.2c02130	10.7270/Q2CC1525	37037122			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50621711	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50621711&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51545769	OC(=O)c1ccc(NC(=O)C(Cc2ccccc2)n2cc3c(cc2=O)-c2cc(Cl)ccc2CC2(CC2)NC3=O)cc1	InChI=1S/C32H26ClN3O5/c33-22-9-6-21-17-32(12-13-32)35-29(38)26-18-36(28(37)16-25(26)24(21)15-22)27(14-19-4-2-1-3-5-19)30(39)34-23-10-7-20(8-11-23)31(40)41/h1-11,15-16,18,27H,12-14,17H2,(H,34,39)(H,35,38)(H,40,41)	IJIWFVZSETXIFG-UHFFFAOYSA-N	303810	4-{[2-(11&#8242;-Chloro-2&#8242;,5&#8242;-dioxo-2&#8242;,5&#8242;,6&#8242;,8&#8242;-tetrahydro-3&#8242;H-spiro[cyclopropane-1,7&#8242;-pyrido[3,4-e][3]benzazocine]-3&#8242;-yl)-3-phenylpropanoyl]amino}benzoic acid (Stereoisomer Mixture)::US10138236, Example 28	Plasma kallikrein	Homo sapiens		 55							ChEMBL	10.1021/acs.jmedchem.2c02130	10.7270/Q2CC1525	37037122			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303810	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303810&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121247962	381752541							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51545770	C[C@H]1COc2cn([C@@H](CC3CCCCO3)C(=O)Nc3ccc(cc3)C(N)=O)c(=O)cc2-c2c(F)c(Cl)ccc2C1	InChI=1S/C30H31ClFN3O5/c1-17-12-19-7-10-23(31)28(32)27(19)22-14-26(36)35(15-25(22)40-16-17)24(13-21-4-2-3-11-39-21)30(38)34-20-8-5-18(6-9-20)29(33)37/h5-10,14-15,17,21,24H,2-4,11-13,16H2,1H3,(H2,33,37)(H,34,38)/t17-,21?,24+/m1/s1	XSQAIMYMMFHVBE-JMBMXREFSA-N	50621693	CHEMBL5395901	Plasma kallikrein	Homo sapiens		 60							ChEMBL	10.1021/acs.jmedchem.2c02130	10.7270/Q2CC1525	37037122			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50621693	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50621693&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51545771	Nc1ccc(-c2cnc([nH]2)[C@H](CC2CC2)c2ccc(c[n+]2[O-])-c2cc(Cl)ccc2-n2cnnn2)c(Cl)n1	InChI=1S/C25H21Cl2N9O/c26-16-4-7-21(35-13-30-33-34-35)18(10-16)15-3-6-22(36(37)12-15)19(9-14-1-2-14)25-29-11-20(31-25)17-5-8-23(28)32-24(17)27/h3-8,10-14,19H,1-2,9H2,(H2,28,32)(H,29,31)/t19-/m1/s1	JLRBAVZPDZQFGE-LJQANCHMSA-N	50621695	CHEMBL5397593	Plasma kallikrein	Homo sapiens		 80							ChEMBL	10.1021/acs.jmedchem.2c02130	10.7270/Q2CC1525	37037122			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50621695	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50621695&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51545772	OCc1nccc(-c2ccc([nH]2)[C@@H]2CCc3cc(cc(=O)n23)-c2c(F)c(Cl)ccc2-n2cnnn2)c1F	InChI=1S/C25H18ClF2N7O2/c26-16-2-6-21(34-12-30-32-33-34)23(25(16)28)13-9-14-1-5-20(35(14)22(37)10-13)18-4-3-17(31-18)15-7-8-29-19(11-36)24(15)27/h2-4,6-10,12,20,31,36H,1,5,11H2/t20-/m0/s1	JYAYTTBATXVKFQ-FQEVSTJZSA-N	50621699	CHEMBL5403224	Plasma kallikrein	Homo sapiens		 13							ChEMBL	10.1021/acs.jmedchem.2c02130	10.7270/Q2CC1525	37037122			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50621699	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50621699&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51545773	COC(=O)Nc1ccc2-c3nc([nH]c3C)[C@H](CCC[C@@H](C)C(=O)Nc2c1)c1ccc(c[n+]1[O-])-c1cc(Cl)ccc1-n1cc(cn1)C(F)(F)F	InChI=1S/C34H31ClF3N7O4/c1-18-5-4-6-25(31-40-19(2)30(43-31)24-10-9-23(41-33(47)49-3)14-27(24)42-32(18)46)29-11-7-20(16-45(29)48)26-13-22(35)8-12-28(26)44-17-21(15-39-44)34(36,37)38/h7-18,25H,4-6H2,1-3H3,(H,40,43)(H,41,47)(H,42,46)/t18-,25-/m1/s1	KYKYYIZLPRIANX-IQGLISFBSA-N	50621701	CHEMBL5426898	Plasma kallikrein	Homo sapiens		 42							ChEMBL	10.1021/acs.jmedchem.2c02130	10.7270/Q2CC1525	37037122			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50621701	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50621701&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51545774	CC(C)c1cc(COc2ccccc2CC(O)=O)cc(c1)-c1ccc2OC[C@@H](N)c2c1	InChI=1S/C26H27NO4/c1-16(2)20-9-17(14-30-24-6-4-3-5-19(24)13-26(28)29)10-21(11-20)18-7-8-25-22(12-18)23(27)15-31-25/h3-12,16,23H,13-15,27H2,1-2H3,(H,28,29)/t23-/m1/s1	WQVBAYOMZJYFJK-HSZRJFAPSA-N	50542723	CHEMBL4643449	Plasma kallikrein	Homo sapiens		 3.0							ChEMBL	10.1021/acs.jmedchem.2c02130	10.7270/Q2CC1525	37037122			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50542723	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50542723&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156019025	442144286							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51545775	CC(C)c1cc(CCN2CCc3cccc(C(O)=O)c23)cc(c1)-c1ccc2OC[C@@H](N)c2c1	InChI=1S/C28H30N2O3/c1-17(2)21-12-18(8-10-30-11-9-19-4-3-5-23(27(19)30)28(31)32)13-22(14-21)20-6-7-26-24(15-20)25(29)16-33-26/h3-7,12-15,17,25H,8-11,16,29H2,1-2H3,(H,31,32)/t25-/m1/s1	CQQFREVZNRVIIM-RUZDIDTESA-N	50542735	CHEMBL4635286	Plasma kallikrein	Homo sapiens		 58							ChEMBL	10.1021/acs.jmedchem.2c02130	10.7270/Q2CC1525	37037122			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50542735	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50542735&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			156014417	442144298							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51545776	CC(C)c1cc(cc(c1)-c1ccc2OC[C@@H](N)c2c1)[C@@H](O)CN1CCc2cccc(C(O)=O)c12	InChI=1S/C28H30N2O4/c1-16(2)19-10-20(18-6-7-26-23(13-18)24(29)15-34-26)12-21(11-19)25(31)14-30-9-8-17-4-3-5-22(27(17)30)28(32)33/h3-7,10-13,16,24-25,31H,8-9,14-15,29H2,1-2H3,(H,32,33)/t24-,25+/m1/s1	PKASBNFVFWUNOA-RPBOFIJWSA-N	50621705	CHEMBL5399926	Plasma kallikrein	Homo sapiens		 1.000000							ChEMBL	10.1021/acs.jmedchem.2c02130	10.7270/Q2CC1525	37037122			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50621705	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50621705&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51545783	COC(=O)NCC[C@@H]1Cc2cccc(c2)[C@H](CCC[C@@H](C)C(=O)N1)n1cnc(cc1=O)-c1cc(Cl)ccc1-n1cc(cn1)C(F)(F)F	InChI=1S/C33H34ClF3N6O4/c1-20-5-3-8-28(22-7-4-6-21(13-22)14-25(41-31(20)45)11-12-38-32(46)47-2)42-19-39-27(16-30(42)44)26-15-24(34)9-10-29(26)43-18-23(17-40-43)33(35,36)37/h4,6-7,9-10,13,15-20,25,28H,3,5,8,11-12,14H2,1-2H3,(H,38,46)(H,41,45)/t20-,25-,28+/m1/s1	QFDLZRZHPVGTMG-VGTADKHUSA-N	50621715	CHEMBL5416393	Plasma kallikrein	Homo sapiens	 1794								ChEMBL	10.1021/acs.jmedchem.2c02130	10.7270/Q2CC1525	37037122			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50621715	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50621715&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51544726	Cc1ccc(C(NC(=O)c2cnn(Cc3ccccc3)c2)B2OC(C)(C)C(C)(C)O2)c(F)c1	InChI=1S/C25H29BFN3O3/c1-17-11-12-20(21(27)13-17)22(26-32-24(2,3)25(4,5)33-26)29-23(31)19-14-28-30(16-19)15-18-9-7-6-8-10-18/h6-14,16,22H,15H2,1-5H3,(H,29,31)	FOOYQBFAGIVGFV-UHFFFAOYSA-N	50621297	CHEMBL5427122	Plasma kallikrein	Homo sapiens		 152							ChEMBL	10.1021/acsmedchemlett.3c00572	10.7270/Q2RR23NJ	38628785			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50621297	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50621297&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51544727	NC(=N)NCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H]1CCCN1)C(=O)CCl	InChI=1S/C20H29ClN6O3/c21-12-17(28)14(8-10-25-20(22)23)26-19(30)16(11-13-5-2-1-3-6-13)27-18(29)15-7-4-9-24-15/h1-3,5-6,14-16,24H,4,7-12H2,(H,26,30)(H,27,29)(H4,22,23,25)/t14-,15+,16-/m0/s1	DMPXIFGNDCFZRQ-XHSDSOJGSA-N	50621302	CHEMBL5397741	Plasma kallikrein	Homo sapiens		 15							ChEMBL	10.1021/acsmedchemlett.3c00572	10.7270/Q2RR23NJ	38628785			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50621302	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50621302&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51544728	Clc1cccc(CNC(=O)c2cnn(Cc3ccc(Cn4cccn4)cc3)c2)c1	InChI=1S/C22H20ClN5O/c23-21-4-1-3-19(11-21)12-24-22(29)20-13-26-28(16-20)15-18-7-5-17(6-8-18)14-27-10-2-9-25-27/h1-11,13,16H,12,14-15H2,(H,24,29)	QNEZAIFSXKLMLC-UHFFFAOYSA-N	50621303	CHEMBL5404014	Plasma kallikrein	Homo sapiens		>40000							ChEMBL	10.1021/acsmedchemlett.3c00572	10.7270/Q2RR23NJ	38628785			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50621303	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50621303&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51544729	Clc1cccc(CNC(=O)c2cnn(Cc3ccc(Cn4ccccc4=O)cc3)c2)c1	InChI=1S/C24H21ClN4O2/c25-22-5-3-4-20(12-22)13-26-24(31)21-14-27-29(17-21)16-19-9-7-18(8-10-19)15-28-11-2-1-6-23(28)30/h1-12,14,17H,13,15-16H2,(H,26,31)	GINLXBCPSORJBF-UHFFFAOYSA-N	50621304	CHEMBL5178779	Plasma kallikrein	Homo sapiens		 284							ChEMBL	10.1021/acsmedchemlett.3c00572	10.7270/Q2RR23NJ	38628785			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50621304	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50621304&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51544730	Cc1ccc(CNC(=O)c2cnn(Cc3ccc(Cn4cccn4)cc3)c2)c(F)c1	InChI=1S/C23H22FN5O/c1-17-3-8-20(22(24)11-17)12-25-23(30)21-13-27-29(16-21)15-19-6-4-18(5-7-19)14-28-10-2-9-26-28/h2-11,13,16H,12,14-15H2,1H3,(H,25,30)	FLXKUVMQIHUOBX-UHFFFAOYSA-N	50621305	CHEMBL5421724	Plasma kallikrein	Homo sapiens		 203							ChEMBL	10.1021/acsmedchemlett.3c00572	10.7270/Q2RR23NJ	38628785			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50621305	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50621305&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51544731	Cc1ccc(CNC(=O)c2cnn(Cc3ccc(Cn4ccccc4=O)cc3)c2)c(F)c1	InChI=1S/C25H23FN4O2/c1-18-5-10-21(23(26)12-18)13-27-25(32)22-14-28-30(17-22)16-20-8-6-19(7-9-20)15-29-11-3-2-4-24(29)31/h2-12,14,17H,13,15-16H2,1H3,(H,27,32)	VJHIABWNHKPRHK-UHFFFAOYSA-N	50621306	CHEMBL5413387	Plasma kallikrein	Homo sapiens		 37							ChEMBL	10.1021/acsmedchemlett.3c00572	10.7270/Q2RR23NJ	38628785			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50621306	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50621306&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51544732	Clc1cccc(\C=C\C(=O)c2cnn(Cc3ccc(Cn4cccn4)cc3)c2)c1	InChI=1S/C23H19ClN4O/c24-22-4-1-3-18(13-22)9-10-23(29)21-14-26-28(17-21)16-20-7-5-19(6-8-20)15-27-12-2-11-25-27/h1-14,17H,15-16H2/b10-9+	YGPZVEMMDGGZOO-MDZDMXLPSA-N	50621307	CHEMBL5399272	Plasma kallikrein	Homo sapiens		>40000							ChEMBL	10.1021/acsmedchemlett.3c00572	10.7270/Q2RR23NJ	38628785			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50621307	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50621307&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51544733	Cc1ccc(\C=C\C(=O)c2cnn(Cc3ccc(Cn4cccn4)cc3)c2)c(F)c1	InChI=1S/C24H21FN4O/c1-18-3-8-21(23(25)13-18)9-10-24(30)22-14-27-29(17-22)16-20-6-4-19(5-7-20)15-28-12-2-11-26-28/h2-14,17H,15-16H2,1H3/b10-9+	LOFDEQUBUKAINK-MDZDMXLPSA-N	50621308	CHEMBL5438897	Plasma kallikrein	Homo sapiens		 7263							ChEMBL	10.1021/acsmedchemlett.3c00572	10.7270/Q2RR23NJ	38628785			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50621308	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50621308&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51544734	CC1(C)OB(OC1(C)C)C(CC(=O)c1cnn(Cc2ccc(Cn3cccn3)cc2)c1)c1cccc(Cl)c1	InChI=1S/C29H32BClN4O3/c1-28(2)29(3,4)38-30(37-28)26(23-7-5-8-25(31)15-23)16-27(36)24-17-33-35(20-24)19-22-11-9-21(10-12-22)18-34-14-6-13-32-34/h5-15,17,20,26H,16,18-19H2,1-4H3	LDXMZOMDZGUUTO-UHFFFAOYSA-N	50621309	CHEMBL5403349	Plasma kallikrein	Homo sapiens		 2173							ChEMBL	10.1021/acsmedchemlett.3c00572	10.7270/Q2RR23NJ	38628785			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50621309	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50621309&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51544735	Cc1ccc(C(CC(=O)c2cnn(Cc3ccc(Cn4cccn4)cc3)c2)B2OC(C)(C)C(C)(C)O2)c(F)c1	InChI=1S/C30H34BFN4O3/c1-21-7-12-25(27(32)15-21)26(31-38-29(2,3)30(4,5)39-31)16-28(37)24-17-34-36(20-24)19-23-10-8-22(9-11-23)18-35-14-6-13-33-35/h6-15,17,20,26H,16,18-19H2,1-5H3	IRZIUXYJTSGQCW-UHFFFAOYSA-N	50621310	CHEMBL5417079	Plasma kallikrein	Homo sapiens		 41							ChEMBL	10.1021/acsmedchemlett.3c00572	10.7270/Q2RR23NJ	38628785			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50621310	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50621310&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51553574	COc1ccccc1C(=O)n1nc(cc1NCc1ccc(Cl)s1)-c1ccccn1	InChI=1S/C21H17ClN4O2S/c1-28-18-8-3-2-6-15(18)21(27)26-20(24-13-14-9-10-19(22)29-14)12-17(25-26)16-7-4-5-11-23-16/h2-12,24H,13H2,1H3	CPBDFCXKCBYWQN-UHFFFAOYSA-N	163407	US9687479, 278 1-[(2-methoxyphenyl)carbonyl]-3-(pyridin-2-yl)-N-(thiophen-2-ylmethyl)-1H-pyrazol-5-amine::US9687479, 285 N-[(5-chlorothiophen-2-yl)methyl]-1-[(2-methoxyphenyl)carbonyl]-3-(pyridin-2-yl)-1H-pyrazol-5-amine	Plasma kallikrein	Homo sapiens		 1800							ChEMBL	10.1016/j.ejmech.2022.114855	10.7270/Q22V2MJ7	36462436			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=163407	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=163407&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081351	363890803							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51553575	CC(C)(C)C(=O)n1nc(cc1NCc1ccc(Cl)s1)-c1ccc[nH]c1=O	InChI=1S/C18H19ClN4O2S/c1-18(2,3)17(25)23-15(21-10-11-6-7-14(19)26-11)9-13(22-23)12-5-4-8-20-16(12)24/h4-9,21H,10H2,1-3H3,(H,20,24)	IELDEMOVCFANHT-UHFFFAOYSA-N	162366	BDBM162611::US9687479, 3 3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-(2,2-dimethylpropanoyl)-1H-pyrazol-3-yl)-1,2-dihydropyridin-2-one	Plasma kallikrein	Homo sapiens		 20100							ChEMBL	10.1016/j.ejmech.2022.114855	10.7270/Q22V2MJ7	36462436			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=162366	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=162366&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			133081096	363890530							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1433859	O=C(NCCN1CCN(Cc2ccccc2)CC1)c1ccccc1	InChI=1S/C20H25N3O/c24-20(19-9-5-2-6-10-19)21-11-12-22-13-15-23(16-14-22)17-18-7-3-1-4-8-18/h1-10H,11-17H2,(H,21,24)	LRJYSUQXFXGBMT-UHFFFAOYSA-N	50406171	CHEMBL5283110::US20240190892, Example 1	Plasma kallikrein	Homo sapiens		 19.3							US Patent		10.7270/Q2R49W3B			US20240190892	Cernaka, N; Ogawa, AK; Cheng, AC; Bao, J; Sharp, PP; Lopez, JA; Xiao, D; Tang, H	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50406171	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50406171&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			14762573	163355195		CHEMBL101927				ZINC26746266	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1433861	Fc1c(Cl)ccc2NC(=O)O[C@@]3(CCN(C3)c3cncc(n3)C(=O)NCc3ccc(nc3)N3CCCC3)c12	InChI=1S/C26H25ClFN7O3/c27-17-4-5-18-22(23(17)28)26(38-25(37)33-18)7-10-35(15-26)21-14-29-13-19(32-21)24(36)31-12-16-3-6-20(30-11-16)34-8-1-2-9-34/h3-6,11,13-14H,1-2,7-10,12,15H2,(H,31,36)(H,33,37)/t26-/m1/s1	ACUSUSNPULCIPN-AREMUKBSSA-N	689044	US20240190892, Example 2	Plasma kallikrein	Homo sapiens		 6.80							US Patent		10.7270/Q2R49W3B			US20240190892	Cernaka, N; Ogawa, AK; Cheng, AC; Bao, J; Sharp, PP; Lopez, JA; Xiao, D; Tang, H	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689044	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689044&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171725692	504490708							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1433863	C[C@H]1CCN(C1)c1ccc(CNC(=O)c2cncc(c2)N2CC[C@]3(C2)OC(=O)Nc2ccc(Cl)c(F)c32)cn1	InChI=1S/C28H28ClFN6O3/c1-17-6-8-35(15-17)23-5-2-18(11-32-23)12-33-26(37)19-10-20(14-31-13-19)36-9-7-28(16-36)24-22(34-27(38)39-28)4-3-21(29)25(24)30/h2-5,10-11,13-14,17H,6-9,12,15-16H2,1H3,(H,33,37)(H,34,38)/t17-,28+/m0/s1	NMBKMCMYGMOELX-YMGMXPECSA-N	689045	(S)-5-(6-Chloro-5-fluoro-2-oxo-1,2- dihydrospiro[benzo[d][1,3]oxazine- 4,3'-pyrrolidin]-1'-yl)-N-((6-((S)-3- methylpyrrolidin-1-yl)pyridin-3- yl)methyl)nicotinamide::US20240190892, Example 3	Plasma kallikrein	Homo sapiens		 9.50							US Patent		10.7270/Q2R49W3B			US20240190892	Cernaka, N; Ogawa, AK; Cheng, AC; Bao, J; Sharp, PP; Lopez, JA; Xiao, D; Tang, H	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689045	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689045&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			165133707	504490709							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1433865	CCOc1ccc(C[C@@H](NC(=O)Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCN=C(N)N)C(N)=O)cc1	InChI=1S/C54H77N13O10/c1-4-77-37-24-22-36(23-25-37)30-40(61-45(69)31-35-17-9-6-10-18-35)48(71)64-41(29-34-15-7-5-8-16-34)50(73)66-46(33(2)3)52(75)65-42(32-44(56)68)49(72)63-39(19-11-12-26-55)53(76)67-28-14-21-43(67)51(74)62-38(47(57)70)20-13-27-60-54(58)59/h5-10,15-18,22-25,33,38-43,46H,4,11-14,19-21,26-32,55H2,1-3H3,(H2,56,68)(H2,57,70)(H,61,69)(H,62,74)(H,63,72)(H,64,71)(H,65,75)(H,66,73)(H4,58,59,60)/t38-,39-,40+,41-,42-,43+,46-/m0/s1	FALCSTYLQGBSFB-KMRGNHMASA-N	50406172	CHEMBL5290426::US20240190892, Example 4	Plasma kallikrein	Homo sapiens		 1.20							US Patent		10.7270/Q2R49W3B			US20240190892	Cernaka, N; Ogawa, AK; Cheng, AC; Bao, J; Sharp, PP; Lopez, JA; Xiao, D; Tang, H	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50406172	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50406172&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			44335051	163355196		CHEMBL2373516					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1433867	F[C@H]1CCN(C1)c1ccc(CNC(=O)c2cnnc(c2)N2CC[C@]3(C2)OC(=O)Nc2ccc(Cl)c(F)c32)cn1	InChI=1S/C26H24ClF2N7O3/c27-18-2-3-19-22(23(18)29)26(39-25(38)33-19)6-8-36(14-26)21-9-16(12-32-34-21)24(37)31-11-15-1-4-20(30-10-15)35-7-5-17(28)13-35/h1-4,9-10,12,17H,5-8,11,13-14H2,(H,31,37)(H,33,38)/t17-,26+/m0/s1	KFNLHPWUBHKESI-MRDQGFSESA-N	689047	(S)-6-(6-Chloro-5-fluoro-2-oxo-1,2- dihydrospiro[benzo[d][1,3]oxazine- 4,3'-pyrrolidin]-1'-yl)-N-((6-((S)-3- fluoropyrrolidin-1-yl)pyridin-3- yl)methyl)pyridazine-4-carboxamide::US20240190892, Example 5	Plasma kallikrein	Homo sapiens		 3.00							US Patent		10.7270/Q2R49W3B			US20240190892	Cernaka, N; Ogawa, AK; Cheng, AC; Bao, J; Sharp, PP; Lopez, JA; Xiao, D; Tang, H	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689047	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689047&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171725680	504490710							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1433869	Fc1c(Cl)ccc2NC(=O)O[C@@]3(CCN(C3)c3cc(cnn3)C(=O)NCc3ccc(nc3)N3CCC(F)(F)C3)c12	InChI=1S/C26H23ClF3N7O3/c27-17-2-3-18-21(22(17)28)25(40-24(39)34-18)5-7-36(13-25)20-9-16(12-33-35-20)23(38)32-11-15-1-4-19(31-10-15)37-8-6-26(29,30)14-37/h1-4,9-10,12H,5-8,11,13-14H2,(H,32,38)(H,34,39)/t25-/m1/s1	RFIWBKAPTDXXAO-RUZDIDTESA-N	689048	(S)-6-(6-Chloro-5-fluoro-2-oxo-1,2- dihydrospiro[benzo[d][1,3]oxazine- 4,3'-pyrrolidin]-1'-yl)-N-((6-(3,3- difluoropyrrolidin-1-yl)pyridin-3- yl)methyl)pyridazine-4-carboxamide::US20240190892, Example 6	Plasma kallikrein	Homo sapiens		 4.00							US Patent		10.7270/Q2R49W3B			US20240190892	Cernaka, N; Ogawa, AK; Cheng, AC; Bao, J; Sharp, PP; Lopez, JA; Xiao, D; Tang, H	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689048	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689048&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171725673	504490711							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1433871	Fc1cc(CNC(=O)c2cnnc(c2)N2CC[C@]3(C2)OC(=O)Nc2ccc(Cl)c(F)c32)ccc1N1CCC(F)(F)C1	InChI=1S/C27H23ClF4N6O3/c28-17-2-3-19-22(23(17)30)26(41-25(40)35-19)5-7-38(13-26)21-10-16(12-34-36-21)24(39)33-11-15-1-4-20(18(29)9-15)37-8-6-27(31,32)14-37/h1-4,9-10,12H,5-8,11,13-14H2,(H,33,39)(H,35,40)/t26-/m1/s1	WXVAHHZUWSLXNY-AREMUKBSSA-N	689049	(S)-6-(6-Chloro-5-fluoro-2-oxo-1,2- dihydrospiro[benzo[d][1,3]oxazine- 4,3'-pyrrolidin]-1'-yl)-N-(4-(3,3- difluoropyrrolidin-1-yl)-3- fluorobenzyl)pyridazine-4- carboxamide::US20240190892, Example 7	Plasma kallikrein	Homo sapiens		 33.5							US Patent		10.7270/Q2R49W3B			US20240190892	Cernaka, N; Ogawa, AK; Cheng, AC; Bao, J; Sharp, PP; Lopez, JA; Xiao, D; Tang, H	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689049	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689049&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			165133713	504490712							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1433873	Fc1cc(ccc1CNC(=O)c1cnnc(c1)N1CC[C@]2(C1)OC(=O)Nc1ccc(Cl)c(F)c21)N1CCC(F)(F)C1	InChI=1S/C27H23ClF4N6O3/c28-18-3-4-20-22(23(18)30)26(41-25(40)35-20)5-7-38(13-26)21-9-16(12-34-36-21)24(39)33-11-15-1-2-17(10-19(15)29)37-8-6-27(31,32)14-37/h1-4,9-10,12H,5-8,11,13-14H2,(H,33,39)(H,35,40)/t26-/m1/s1	OVRFKRPULKEARA-AREMUKBSSA-N	689050	(S)-6-(6-Chloro-5-fluoro-2-oxo-1,2- dihydrospiro[benzo[d][1,3]oxazine- 4,3'-pyrrolidin]-1'-yl)-N-(4-(3,3- difluoropyrrolidin-1-yl)-2- fluorobenzyl)pyridazine-4- carboxamide::US20240190892, Example 8	Plasma kallikrein	Homo sapiens		 30.4							US Patent		10.7270/Q2R49W3B			US20240190892	Cernaka, N; Ogawa, AK; Cheng, AC; Bao, J; Sharp, PP; Lopez, JA; Xiao, D; Tang, H	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689050	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689050&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			165133760	504490713							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1433875	Fc1c(Cl)ccc2NC(=O)O[C@@]3(CCN(C3)c3cc(cnn3)C(=O)NCc3ccc(nc3)N3CCC(C3)C(F)(F)F)c12	InChI=1S/C27H24ClF4N7O3/c28-18-2-3-19-22(23(18)29)26(42-25(41)36-19)6-8-39(14-26)21-9-16(12-35-37-21)24(40)34-11-15-1-4-20(33-10-15)38-7-5-17(13-38)27(30,31)32/h1-4,9-10,12,17H,5-8,11,13-14H2,(H,34,40)(H,36,41)/t17?,26-/m1/s1	LBDQUKZYUUYBEA-XJCVEMOTSA-N	689051	(S)-6-(6-Chloro-5-fluoro-2-oxo-1,2- dihydrospiro[benzo[d][1,3]oxazine- 4,3'-pyrrolidin]-1'-yl)-N-((6-(3- (trifluoromethyl)pyrrolidin-1- yl)pyridin-3-yl)methyl)pyridazine-4- carboxamide::US20240190892, Example 9	Plasma kallikrein	Homo sapiens		 7.50							US Patent		10.7270/Q2R49W3B			US20240190892	Cernaka, N; Ogawa, AK; Cheng, AC; Bao, J; Sharp, PP; Lopez, JA; Xiao, D; Tang, H	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689051	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689051&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			172430142	504490714							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1433877	CCOc1ccc(C[C@@H](NC(=O)Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O)cc1	InChI=1S/C58H84N16O11/c1-4-85-39-25-23-38(24-26-39)32-42(68-47(76)33-37-17-9-6-10-18-37)53(81)71-43(31-36-15-7-5-8-16-36)54(82)73-49(35(2)3)56(84)72-44(34-46(59)75)51(79)65-27-13-22-48(77)74-30-14-21-45(74)55(83)70-41(20-12-29-67-58(63)64)52(80)69-40(50(60)78)19-11-28-66-57(61)62/h5-10,15-18,23-26,35,40-45,49H,4,11-14,19-22,27-34H2,1-3H3,(H2,59,75)(H2,60,78)(H,65,79)(H,68,76)(H,69,80)(H,70,83)(H,71,81)(H,72,84)(H,73,82)(H4,61,62,66)(H4,63,64,67)/t40-,41-,42+,43-,44-,45+,49-/m0/s1	LYFCQFCFMNYSKF-MNAHPMOWSA-N	50406173	CHEMBL5270511::US20240190892, Example 10	Plasma kallikrein	Homo sapiens		 2.50							US Patent		10.7270/Q2R49W3B			US20240190892	Cernaka, N; Ogawa, AK; Cheng, AC; Bao, J; Sharp, PP; Lopez, JA; Xiao, D; Tang, H	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50406173	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50406173&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			44335330	163355197		CHEMBL410838					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1433879	CN1CCCC1c1ccc(CNC(=O)c2cnnc(c2)N2CC[C@]3(C2)OC(=O)Nc2ccc(Cl)c(F)c32)cn1	InChI=1S/C27H27ClFN7O3/c1-35-9-2-3-21(35)19-6-4-16(12-30-19)13-31-25(37)17-11-22(34-32-14-17)36-10-8-27(15-36)23-20(33-26(38)39-27)7-5-18(28)24(23)29/h4-7,11-12,14,21H,2-3,8-10,13,15H2,1H3,(H,31,37)(H,33,38)/t21?,27-/m1/s1	DETJVLCCIWOVQU-IAIRZMIISA-N	689053	(S)-6-(6-Chloro-5-fluoro-2-oxo-1,2- dihydrospiro[benzo[d][1,3]oxazine- 4,3'-pyrrolidin]-1'-yl)-N-((6-(1- methylpyrrolidin-2-yl)pyridin-3- yl)methyl)pyridazine-4-carboxamide::US20240190892, Example 11	Plasma kallikrein	Homo sapiens		 3.90							US Patent		10.7270/Q2R49W3B			US20240190892	Cernaka, N; Ogawa, AK; Cheng, AC; Bao, J; Sharp, PP; Lopez, JA; Xiao, D; Tang, H	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689053	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689053&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			165133749	504490715							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1433881	CN1CC(F)(F)CC1c1ccc(CNC(=O)c2cnnc(c2)N2CC[C@]3(C2)OC(=O)Nc2ccc(Cl)c(F)c32)cn1	InChI=1S/C27H25ClF3N7O3/c1-37-14-27(30,31)9-20(37)18-4-2-15(10-32-18)11-33-24(39)16-8-21(36-34-12-16)38-7-6-26(13-38)22-19(35-25(40)41-26)5-3-17(28)23(22)29/h2-5,8,10,12,20H,6-7,9,11,13-14H2,1H3,(H,33,39)(H,35,40)/t20?,26-/m1/s1	WITWHHAOOGYZEU-NBXNUCLWSA-N	689054	(S)-6-(6-Chloro-5-fluoro-2-oxo-1,2- dihydrospiro[benzo[d][1,3]oxazine- 4,3'-pyrrolidin]-1'-yl)-N-(4-(4,4- difluoro-1-methylpyrrolidin-2- yl)benzyl)pyridazine-4-carboxamide::US20240190892, Example 12::US20240190892, Example 13	Plasma kallikrein	Homo sapiens		 39.6							US Patent		10.7270/Q2R49W3B			US20240190892	Cernaka, N; Ogawa, AK; Cheng, AC; Bao, J; Sharp, PP; Lopez, JA; Xiao, D; Tang, H	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689054	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689054&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			165133716	504490716							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1433883	CN1CC(F)(F)CC1c1ccc(CNC(=O)c2cnnc(c2)N2CC[C@]3(C2)OC(=O)Nc2ccc(Cl)c(F)c32)cn1	InChI=1S/C27H25ClF3N7O3/c1-37-14-27(30,31)9-20(37)18-4-2-15(10-32-18)11-33-24(39)16-8-21(36-34-12-16)38-7-6-26(13-38)22-19(35-25(40)41-26)5-3-17(28)23(22)29/h2-5,8,10,12,20H,6-7,9,11,13-14H2,1H3,(H,33,39)(H,35,40)/t20?,26-/m1/s1	WITWHHAOOGYZEU-NBXNUCLWSA-N	689054	(S)-6-(6-Chloro-5-fluoro-2-oxo-1,2- dihydrospiro[benzo[d][1,3]oxazine- 4,3'-pyrrolidin]-1'-yl)-N-(4-(4,4- difluoro-1-methylpyrrolidin-2- yl)benzyl)pyridazine-4-carboxamide::US20240190892, Example 12::US20240190892, Example 13	Plasma kallikrein	Homo sapiens		 81.6							US Patent		10.7270/Q2R49W3B			US20240190892	Cernaka, N; Ogawa, AK; Cheng, AC; Bao, J; Sharp, PP; Lopez, JA; Xiao, D; Tang, H	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689054	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689054&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			165133716	504490716							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1433885	CCOc1ccc(C[C@@H](NC(=O)CC(C)(C)C)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N(C)[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O)cc1	InChI=1S/C51H81N15O10/c1-9-76-33-21-19-32(20-22-33)26-36(60-40(68)28-51(5,6)7)44(71)63-37(25-31-15-11-10-12-16-31)46(73)65-41(29(2)3)47(74)64-38(27-39(52)67)45(72)62-35(18-14-24-59-50(56)57)48(75)66(8)30(4)43(70)61-34(42(53)69)17-13-23-58-49(54)55/h10-12,15-16,19-22,29-30,34-38,41H,9,13-14,17-18,23-28H2,1-8H3,(H2,52,67)(H2,53,69)(H,60,68)(H,61,70)(H,62,72)(H,63,71)(H,64,74)(H,65,73)(H4,54,55,58)(H4,56,57,59)/t30-,34-,35-,36+,37-,38-,41-/m0/s1	FVGXLFBTFMMMAF-LJHFUDNJSA-N	50406174	CHEMBL5274983::US20240190892, Example 14	Plasma kallikrein	Homo sapiens		 1.60							US Patent		10.7270/Q2R49W3B			US20240190892	Cernaka, N; Ogawa, AK; Cheng, AC; Bao, J; Sharp, PP; Lopez, JA; Xiao, D; Tang, H	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50406174	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50406174&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			14730755	163355198		CHEMBL269251					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1433887	CCOc1ccc(C[C@H]2NC(=O)CC3(CCCCC3)SSC[C@@H](NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](Cc3ccccc3)NC2=O)C(C)C)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(N)=O)cc1	InChI=1S/C53H77N13O11S2/c1-4-77-34-19-17-33(18-20-34)26-36-46(71)62-37(25-32-13-7-5-8-14-32)48(73)65-44(31(2)3)50(75)63-38(27-41(54)67)47(72)64-39(30-78-79-53(28-43(69)60-36)21-9-6-10-22-53)51(76)66-24-12-16-40(66)49(74)61-35(15-11-23-58-52(56)57)45(70)59-29-42(55)68/h5,7-8,13-14,17-20,31,35-40,44H,4,6,9-12,15-16,21-30H2,1-3H3,(H2,54,67)(H2,55,68)(H,59,70)(H,60,69)(H,61,74)(H,62,71)(H,63,75)(H,64,72)(H,65,73)(H4,56,57,58)/t35-,36+,37+,38+,39+,40-,44-/m0/s1	SDFJYGJKEXYVCG-RNGNQRBOSA-N	50406177	CHEMBL5285047::US20240190892, Example 15	Plasma kallikrein	Homo sapiens		 0.600							US Patent		10.7270/Q2R49W3B			US20240190892	Cernaka, N; Ogawa, AK; Cheng, AC; Bao, J; Sharp, PP; Lopez, JA; Xiao, D; Tang, H	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50406177	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50406177&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			44335358	163355201		CHEMBL406184					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1433889	Fc1c(Cl)ccc2NC(=O)O[C@@]3(CCN(C3)c3cc(ccn3)C(=O)NCc3ccc(Cn4ccccc4=O)cc3)c12	InChI=1S/C30H25ClFN5O4/c31-22-8-9-23-26(27(22)32)30(41-29(40)35-23)11-14-37(18-30)24-15-21(10-12-33-24)28(39)34-16-19-4-6-20(7-5-19)17-36-13-2-1-3-25(36)38/h1-10,12-13,15H,11,14,16-18H2,(H,34,39)(H,35,40)/t30-/m1/s1	HHYBPMNLFCNFHW-SSEXGKCCSA-N	689058	(S)-2-(6-Chloro-5-fluoro-2-oxo-1,2- dihydrospiro[benzo[d][1,3]oxazine- 4,3'-pyrrolidin]-1'-yl)-N-(4-((2- oxopyridin-1(2H)- yl)methyl)benzyl)isonicotinamide::US20240190892, Example 16	Plasma kallikrein	Homo sapiens		 50.0							US Patent		10.7270/Q2R49W3B			US20240190892	Cernaka, N; Ogawa, AK; Cheng, AC; Bao, J; Sharp, PP; Lopez, JA; Xiao, D; Tang, H	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689058	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689058&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			165133720	504490719							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1433891	Fc1c(Cl)ccc2NC(=O)O[C@@]3(CCN(C3)c3cc(cnn3)C(=O)NCc3ccc(Cn4ccccc4=O)cc3)c12	InChI=1S/C29H24ClFN6O4/c30-21-8-9-22-25(26(21)31)29(41-28(40)34-22)10-12-37(17-29)23-13-20(15-33-35-23)27(39)32-14-18-4-6-19(7-5-18)16-36-11-2-1-3-24(36)38/h1-9,11,13,15H,10,12,14,16-17H2,(H,32,39)(H,34,40)/t29-/m1/s1	NYJCLHRBQYDWDV-GDLZYMKVSA-N	689059	(S)-6-(6-Chloro-5-fluoro-2-oxo-1,2- dihydrospiro[benzo[d][1,3]oxazine- 4,3'-pyrrolidin]-1'-yl)-N-(4-((2- oxopyridin-1(2H)- yl)methyl)benzyl)pyridazine-4- carboxamide::US20240190892, Example 17	Plasma kallikrein	Homo sapiens		 16.3							US Patent		10.7270/Q2R49W3B			US20240190892	Cernaka, N; Ogawa, AK; Cheng, AC; Bao, J; Sharp, PP; Lopez, JA; Xiao, D; Tang, H	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689059	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689059&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			165133730	504490720							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1433893	Cc1cnn(Cc2ccc(CNC(=O)c3cncc(n3)N3CC[C@]4(C3)OC(=O)Nc3ccc(Cl)c(F)c43)cc2)c1	InChI=1S/C28H25ClFN7O3/c1-17-10-33-37(14-17)15-19-4-2-18(3-5-19)11-32-26(38)22-12-31-13-23(34-22)36-9-8-28(16-36)24-21(35-27(39)40-28)7-6-20(29)25(24)30/h2-7,10,12-14H,8-9,11,15-16H2,1H3,(H,32,38)(H,35,39)/t28-/m1/s1	GZGLQDDCSAPNOC-MUUNZHRXSA-N	689060	(S)-6-(6-Chloro-5-fluoro-2-oxo-1,2- dihydrospiro[benzo[d][1,3]oxazine- 4,3'-pyrrolidin]-1'-yl)-N-(4-((4-methyl- 1H-pyrazol-1- yl)methyl)benzyl)pyrazine-2- carboxamide::US20240190892, Example 18	Plasma kallikrein	Homo sapiens		 12.8							US Patent		10.7270/Q2R49W3B			US20240190892	Cernaka, N; Ogawa, AK; Cheng, AC; Bao, J; Sharp, PP; Lopez, JA; Xiao, D; Tang, H	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689060	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689060&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171725681	504490721							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1433895	Cc1cnn(Cc2ccc(CNC(=O)c3cc(ncn3)N3CC[C@]4(C3)OC(=O)Nc3ccc(Cl)c(F)c43)cc2)c1	InChI=1S/C28H25ClFN7O3/c1-17-11-34-37(13-17)14-19-4-2-18(3-5-19)12-31-26(38)22-10-23(33-16-32-22)36-9-8-28(15-36)24-21(35-27(39)40-28)7-6-20(29)25(24)30/h2-7,10-11,13,16H,8-9,12,14-15H2,1H3,(H,31,38)(H,35,39)/t28-/m1/s1	BKBGPEWTJMCXOG-MUUNZHRXSA-N	689061	(S)-6-(6-Chloro-5-fluoro-2-oxo-1,2- dihydrospiro[benzo[d][1,3]oxazine- 4,3'-pyrrolidin]-1'-yl)-N-(4-((4-methyl- 1H-pyrazol-1- yl)methyl)benzyl)pyrimidine-4- carboxamide::US20240190892, Example 19	Plasma kallikrein	Homo sapiens		 25.6							US Patent		10.7270/Q2R49W3B			US20240190892	Cernaka, N; Ogawa, AK; Cheng, AC; Bao, J; Sharp, PP; Lopez, JA; Xiao, D; Tang, H	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689061	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689061&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171725677	504490722							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1433897	CCOc1ccc(C[C@@H](NC(=O)CC23C[C@H]4C[C@H](C[C@H](C4)C2)C3)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O)cc1	InChI=1S/C62H94N16O11/c1-4-89-42-20-18-38(19-21-42)30-45(72-50(80)35-62-32-39-26-40(33-62)28-41(27-39)34-62)56(85)75-46(29-37-12-6-5-7-13-37)57(86)77-52(36(2)3)59(88)76-47(31-49(63)79)54(83)69-22-10-17-51(81)78-25-11-16-48(78)58(87)74-44(15-9-24-71-61(67)68)55(84)73-43(53(64)82)14-8-23-70-60(65)66/h5-7,12-13,18-21,36,39-41,43-48,52H,4,8-11,14-17,22-35H2,1-3H3,(H2,63,79)(H2,64,82)(H,69,83)(H,72,80)(H,73,84)(H,74,87)(H,75,85)(H,76,88)(H,77,86)(H4,65,66,70)(H4,67,68,71)/t39-,40+,41-,43-,44-,45+,46-,47-,48+,52-,62?/m0/s1	SKWPFZDNAAJPMH-DAHZNBDNSA-N	50406178	CHEMBL5267934::US20240190892, Example 20	Plasma kallikrein	Homo sapiens		 1.30							US Patent		10.7270/Q2R49W3B			US20240190892	Cernaka, N; Ogawa, AK; Cheng, AC; Bao, J; Sharp, PP; Lopez, JA; Xiao, D; Tang, H	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50406178	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50406178&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			44335231	163355202		CHEMBL408038					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1433899	Cc1cnn(Cc2ccc(CNC(=O)c3cncc(n3)N3CC[C@]4(C3)OC(=O)Nc3ccc(Cl)c(F)c43)cn2)c1	InChI=1S/C27H24ClFN8O3/c1-16-8-33-37(13-16)14-18-3-2-17(9-31-18)10-32-25(38)21-11-30-12-22(34-21)36-7-6-27(15-36)23-20(35-26(39)40-27)5-4-19(28)24(23)29/h2-5,8-9,11-13H,6-7,10,14-15H2,1H3,(H,32,38)(H,35,39)/t27-/m1/s1	CDEFUOLWJPPIBW-HHHXNRCGSA-N	689063	(S)-6-(6-Chloro-5-fluoro-2-oxo-1,2- dihydrospiro[benzo[d][1,3]oxazine- 4,3'-pyrrolidin]-1'-yl)-N-((6-((4- methyl-1H-pyrazol-1- yl)methyl)pyridin-3- yl)methyl)pyrazine-2-carboxamide::US20240190892, Example 21	Plasma kallikrein	Homo sapiens		 2.30							US Patent		10.7270/Q2R49W3B			US20240190892	Cernaka, N; Ogawa, AK; Cheng, AC; Bao, J; Sharp, PP; Lopez, JA; Xiao, D; Tang, H	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689063	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689063&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			165133767	504490724							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1433901	Cc1cnn(Cc2ccc(CNC(=O)c3ccnc(c3)N3CC[C@]4(C3)OC(=O)Nc3ccc(Cl)c(F)c43)cc2)c1	InChI=1S/C29H26ClFN6O3/c1-18-13-34-37(15-18)16-20-4-2-19(3-5-20)14-33-27(38)21-8-10-32-24(12-21)36-11-9-29(17-36)25-23(35-28(39)40-29)7-6-22(30)26(25)31/h2-8,10,12-13,15H,9,11,14,16-17H2,1H3,(H,33,38)(H,35,39)/t29-/m1/s1	UPTHVFONJRRCOV-GDLZYMKVSA-N	689064	(S)-2-(6-Chloro-5-fluoro-2-oxo-1,2- dihydrospiro[benzo[d][1,3]oxazine- 4,3'-pyrrolidin]-1'-yl)-N-(4-((4-methyl- 1H-pyrazol-1- yl)methyl)benzyl)isonicotinamide::US20240190892, Example 22	Plasma kallikrein	Homo sapiens		 4.70							US Patent		10.7270/Q2R49W3B			US20240190892	Cernaka, N; Ogawa, AK; Cheng, AC; Bao, J; Sharp, PP; Lopez, JA; Xiao, D; Tang, H	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689064	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689064&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			165133766	504490725							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1433903	CCOc1ccc(C[C@@H](NC(=O)CC(C)(C)C)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O)cc1	InChI=1S/C56H88N16O11/c1-7-83-36-23-21-35(22-24-36)30-39(66-44(74)32-56(4,5)6)50(79)69-40(29-34-15-9-8-10-16-34)51(80)71-46(33(2)3)53(82)70-41(31-43(57)73)48(77)63-25-13-20-45(75)72-28-14-19-42(72)52(81)68-38(18-12-27-65-55(61)62)49(78)67-37(47(58)76)17-11-26-64-54(59)60/h8-10,15-16,21-24,33,37-42,46H,7,11-14,17-20,25-32H2,1-6H3,(H2,57,73)(H2,58,76)(H,63,77)(H,66,74)(H,67,78)(H,68,81)(H,69,79)(H,70,82)(H,71,80)(H4,59,60,64)(H4,61,62,65)/t37-,38-,39+,40-,41-,42+,46-/m0/s1	YFUFEYOOOAXDMX-PTZPFOTQSA-N	50406180	CHEMBL5276780::US20240190892, Example 23	Plasma kallikrein	Homo sapiens		 0.500							US Patent		10.7270/Q2R49W3B			US20240190892	Cernaka, N; Ogawa, AK; Cheng, AC; Bao, J; Sharp, PP; Lopez, JA; Xiao, D; Tang, H	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50406180	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50406180&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			44335436	163355204		CHEMBL267111					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1433905	Cc1cnn(Cc2ccc(CNC(=O)c3ccnc(n3)N3CC[C@]4(C3)OC(=O)Nc3ccc(Cl)c(F)c43)cc2)c1	InChI=1S/C28H25ClFN7O3/c1-17-12-33-37(14-17)15-19-4-2-18(3-5-19)13-32-25(38)22-8-10-31-26(34-22)36-11-9-28(16-36)23-21(35-27(39)40-28)7-6-20(29)24(23)30/h2-8,10,12,14H,9,11,13,15-16H2,1H3,(H,32,38)(H,35,39)/t28-/m1/s1	WTDLUEPEXHBEEM-MUUNZHRXSA-N	689066	(S)-2-(6-Chloro-5-fluoro-2-oxo-1,2- dihydrospiro[benzo[d][1,3]oxazine- 4,3'-pyrrolidin]-1'-yl)-N-(4-((4-methyl- 1H-pyrazol-1- yl)methyl)benzyl)pyrimidine-4- carboxamide::US20240190892, Example 24	Plasma kallikrein	Homo sapiens		 13.6							US Patent		10.7270/Q2R49W3B			US20240190892	Cernaka, N; Ogawa, AK; Cheng, AC; Bao, J; Sharp, PP; Lopez, JA; Xiao, D; Tang, H	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689066	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689066&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171725690	504490726							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1433907	Cc1cnn(Cc2ccc(CNC(=O)c3cc(ccn3)N3CC[C@]4(C3)OC(=O)Nc3ccc(Cl)c(F)c43)cc2)c1	InChI=1S/C29H26ClFN6O3/c1-18-13-34-37(15-18)16-20-4-2-19(3-5-20)14-33-27(38)24-12-21(8-10-32-24)36-11-9-29(17-36)25-23(35-28(39)40-29)7-6-22(30)26(25)31/h2-8,10,12-13,15H,9,11,14,16-17H2,1H3,(H,33,38)(H,35,39)/t29-/m1/s1	FVUFKMMUMUMPFL-GDLZYMKVSA-N	689067	(S)-4-(6-Chloro-5-fluoro-2-oxo-1,2- dihydrospiro[benzo[d][1,3]oxazine- 4,3'-pyrrolidin]-1'-yl)-N-(4-((4-methyl- 1H-pyrazol-1- yl)methyl)benzyl)picolinamide::US20240190892, Example 25	Plasma kallikrein	Homo sapiens		 16.5							US Patent		10.7270/Q2R49W3B			US20240190892	Cernaka, N; Ogawa, AK; Cheng, AC; Bao, J; Sharp, PP; Lopez, JA; Xiao, D; Tang, H	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689067	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689067&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			165133763	504490727							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1433909	Cc1cnn(Cc2ccc(CNC(=O)c3cncc(c3)N3CC[C@]4(C3)OC(=O)Nc3ccc(Cl)c(F)c43)cc2)c1	InChI=1S/C29H26ClFN6O3/c1-18-11-34-37(15-18)16-20-4-2-19(3-5-20)12-33-27(38)21-10-22(14-32-13-21)36-9-8-29(17-36)25-24(35-28(39)40-29)7-6-23(30)26(25)31/h2-7,10-11,13-15H,8-9,12,16-17H2,1H3,(H,33,38)(H,35,39)/t29-/m1/s1	QVHBYXSEQZSIDT-GDLZYMKVSA-N	689068	(S)-5-(6-Chloro-5-fluoro-2-oxo-1,2- dihydrospiro[benzo[d][1,3]oxazine- 4,3'-pyrrolidin]-1'-yl)-N-(4-((4-methyl- 1H-pyrazol-1- yl)methyl)benzyl)nicotinamide::US20240190892, Example 26	Plasma kallikrein	Homo sapiens		 3.10							US Patent		10.7270/Q2R49W3B			US20240190892	Cernaka, N; Ogawa, AK; Cheng, AC; Bao, J; Sharp, PP; Lopez, JA; Xiao, D; Tang, H	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689068	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689068&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			165133768	504490728							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1433911	COCC1CN(C1)c1ccc(CNC(=O)c2cnnc(c2)N2CC[C@]3(C2)OC(=O)Nc2ccc(Cl)c(F)c32)cn1	InChI=1S/C27H27ClFN7O4/c1-39-14-17-12-36(13-17)21-5-2-16(9-30-21)10-31-25(37)18-8-22(34-32-11-18)35-7-6-27(15-35)23-20(33-26(38)40-27)4-3-19(28)24(23)29/h2-5,8-9,11,17H,6-7,10,12-15H2,1H3,(H,31,37)(H,33,38)/t27-/m1/s1	WKKRRONXHINRAF-HHHXNRCGSA-N	689069	(S)-6-(6-Chloro-5-fluoro-2-oxo-1,2- dihydrospiro[benzo[d][1,3]oxazine- 4,3'-pyrrolidin]-1'-yl)-N-((6-(3- (methoxymethyl)azetidin-1-yl)pyridin- 3-yl)methyl)pyridazine-4-carboxamide::US20240190892, Example 27	Plasma kallikrein	Homo sapiens		 14.3							US Patent		10.7270/Q2R49W3B			US20240190892	Cernaka, N; Ogawa, AK; Cheng, AC; Bao, J; Sharp, PP; Lopez, JA; Xiao, D; Tang, H	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689069	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689069&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			165133745	504490729							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1433913	CN1CCN(CC1)c1ccc(CNC(=O)c2cnnc(c2)N2CC[C@]3(C2)OC(=O)Nc2ccc(Cl)c(F)c32)cn1	InChI=1S/C27H28ClFN8O3/c1-35-8-10-36(11-9-35)21-5-2-17(13-30-21)14-31-25(38)18-12-22(34-32-15-18)37-7-6-27(16-37)23-20(33-26(39)40-27)4-3-19(28)24(23)29/h2-5,12-13,15H,6-11,14,16H2,1H3,(H,31,38)(H,33,39)/t27-/m1/s1	PAMKHRKEUGGZQQ-HHHXNRCGSA-N	689070	(S)-6-(6-Chloro-5-fluoro-2-oxo-1,2- dihydrospiro[benzo[d][1,3]oxazine- 4,3'-pyrrolidin]-1'-yl)-N-((6-(4- methylpiperazin-1-yl)pyridin-3- yl)methyl)pyridazine-4-carboxamide::US20240190892, Example 28	Plasma kallikrein	Homo sapiens		 1.90							US Patent		10.7270/Q2R49W3B			US20240190892	Cernaka, N; Ogawa, AK; Cheng, AC; Bao, J; Sharp, PP; Lopez, JA; Xiao, D; Tang, H	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689070	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689070&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171725668	504490730							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1433915	Fc1c(Cl)ccc2NC(=O)O[C@@]3(CCN(C3)c3cc(cnn3)C(=O)NCc3ccc(nc3)N3CCOCC3)c12	InChI=1S/C26H25ClFN7O4/c27-18-2-3-19-22(23(18)28)26(39-25(37)32-19)5-6-35(15-26)21-11-17(14-31-33-21)24(36)30-13-16-1-4-20(29-12-16)34-7-9-38-10-8-34/h1-4,11-12,14H,5-10,13,15H2,(H,30,36)(H,32,37)/t26-/m1/s1	NPUREGXCHHROCT-AREMUKBSSA-N	689071	(S)-6-(6-Chloro-5-fluoro-2-oxo-1,2- dihydrospiro[benzo[d][1,3]oxazine- 4,3'-pyrrolidin]-1'-yl)-N-((6- morpholinopyridin-3- yl)methyl)pyridazine-4-carboxamide::US20240190892, Example 29	Plasma kallikrein	Homo sapiens		 5.00							US Patent		10.7270/Q2R49W3B			US20240190892	Cernaka, N; Ogawa, AK; Cheng, AC; Bao, J; Sharp, PP; Lopez, JA; Xiao, D; Tang, H	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689071	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689071&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171725679	504490731							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1433917	Fc1c(Cl)ccc2NC(=O)O[C@@]3(CCN(C3)c3cncc(n3)C(=O)NCc3ccc4ccc(=O)oc4c3)c12	InChI=1S/C26H19ClFN5O5/c27-16-4-5-17-22(23(16)28)26(38-25(36)32-17)7-8-33(13-26)20-12-29-11-18(31-20)24(35)30-10-14-1-2-15-3-6-21(34)37-19(15)9-14/h1-6,9,11-12H,7-8,10,13H2,(H,30,35)(H,32,36)/t26-/m1/s1	ZKXSIUXXJJHEMK-AREMUKBSSA-N	689072	(S)-6-(6-Chloro-5-fluoro-2-oxo-1,2- dihydrospiro[benzo[d][1,3]oxazine- 4,3'-pyrrolidin]-1'-yl)-N-((2-oxo-2H- chromen-7-yl)methyl)pyrazine-2- carboxamide::US20240190892, Example 30	Plasma kallikrein	Homo sapiens		 20.9							US Patent		10.7270/Q2R49W3B			US20240190892	Cernaka, N; Ogawa, AK; Cheng, AC; Bao, J; Sharp, PP; Lopez, JA; Xiao, D; Tang, H	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689072	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689072&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			165133736	504490732							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1433919	Fc1c(Cl)ccc2NC(=O)O[C@@]3(CCN(C3)c3cncc(n3)C(=O)NCc3ccc4CCCNc4n3)c12	InChI=1S/C25H23ClFN7O3/c26-16-5-6-17-20(21(16)27)25(37-24(36)33-17)7-9-34(13-25)19-12-28-11-18(32-19)23(35)30-10-15-4-3-14-2-1-8-29-22(14)31-15/h3-6,11-12H,1-2,7-10,13H2,(H,29,31)(H,30,35)(H,33,36)/t25-/m1/s1	GHSFKJMWTMKDHL-RUZDIDTESA-N	689073	(S)-6-(6-Chloro-5-fluoro-2-oxo-1,2- dihydrospiro[benzo[d][1,3]oxazine- 4,3'-pyrrolidin]-1'-yl)-N-((5,6,7,8- tetrahydro-1,8-naphthyridin-2- yl)methyl)pyrazine-2-carboxamide::US20240190892, Example 31	Plasma kallikrein	Homo sapiens		 8.60							US Patent		10.7270/Q2R49W3B			US20240190892	Cernaka, N; Ogawa, AK; Cheng, AC; Bao, J; Sharp, PP; Lopez, JA; Xiao, D; Tang, H	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689073	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689073&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			165133742	504490733							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1433921	Nc1nccc2cc(CNC(=O)c3cncc(n3)N3CC[C@]4(C3)OC(=O)Nc3ccc(Cl)c(F)c43)ccc12	InChI=1S/C26H21ClFN7O3/c27-17-3-4-18-21(22(17)28)26(38-25(37)34-18)6-8-35(13-26)20-12-30-11-19(33-20)24(36)32-10-14-1-2-16-15(9-14)5-7-31-23(16)29/h1-5,7,9,11-12H,6,8,10,13H2,(H2,29,31)(H,32,36)(H,34,37)/t26-/m1/s1	SXDOHQWEEIWSEE-AREMUKBSSA-N	689074	(S)-N-((1-Aminoisoquinolin-6- yl)methyl)-6-(6-chloro-5-fluoro-2-oxo- 1,2- dihydrospiro[benzo[d][1,3]oxazine- 4,3'-pyrrolidin]-1'-yl)pyrazine-2- carboxamide::US20240190892, Example 32	Plasma kallikrein	Homo sapiens		 19.0							US Patent		10.7270/Q2R49W3B			US20240190892	Cernaka, N; Ogawa, AK; Cheng, AC; Bao, J; Sharp, PP; Lopez, JA; Xiao, D; Tang, H	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689074	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689074&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171725656	504490734							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1433923	FC1CN(C1)c1ccc(CNC(=O)c2cncc(n2)N2CC[C@]3(C2)OC(=O)Nc2ccc(Cl)c(F)c32)cn1	InChI=1S/C25H22ClF2N7O3/c26-16-2-3-17-21(22(16)28)25(38-24(37)33-17)5-6-34(13-25)20-10-29-9-18(32-20)23(36)31-8-14-1-4-19(30-7-14)35-11-15(27)12-35/h1-4,7,9-10,15H,5-6,8,11-13H2,(H,31,36)(H,33,37)/t25-/m1/s1	PFWTVCRLLDKAEE-RUZDIDTESA-N	689075	(S)-6-(6-Chloro-5-fluoro-2-oxo-1,2- dihydrospiro[benzo[d][1,3]oxazine- 4,3'-pyrrolidin]-1'-yl)-N-((6-(3- fluoroazetidin-1-yl)pyridin-3- yl)methyl)pyrazine-2-carboxamide::US20240190892, Example 33	Plasma kallikrein	Homo sapiens		 25.4							US Patent		10.7270/Q2R49W3B			US20240190892	Cernaka, N; Ogawa, AK; Cheng, AC; Bao, J; Sharp, PP; Lopez, JA; Xiao, D; Tang, H	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689075	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689075&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			165133740	504490735							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1433925	COCC1CN(C1)c1ccc(CNC(=O)c2cncc(n2)N2CC[C@]3(C2)OC(=O)Nc2ccc(Cl)c(F)c32)cn1	InChI=1S/C27H27ClFN7O4/c1-39-14-17-12-36(13-17)21-5-2-16(8-31-21)9-32-25(37)20-10-30-11-22(33-20)35-7-6-27(15-35)23-19(34-26(38)40-27)4-3-18(28)24(23)29/h2-5,8,10-11,17H,6-7,9,12-15H2,1H3,(H,32,37)(H,34,38)/t27-/m1/s1	HGZPKILOXKRFTP-HHHXNRCGSA-N	689076	(S)-6-(6-Chloro-5-fluoro-2-oxo-1,2- dihydrospiro[benzo[d][1,3]oxazine- 4,3'-pyrrolidin]-1'-yl)-N-((6-(3- (methoxymethyl)azetidin-1-yl)pyridin- 3-yl)methyl)pyrazine-2-carboxamide::US20240190892, Example 34	Plasma kallikrein	Homo sapiens		 5.40							US Patent		10.7270/Q2R49W3B			US20240190892	Cernaka, N; Ogawa, AK; Cheng, AC; Bao, J; Sharp, PP; Lopez, JA; Xiao, D; Tang, H	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689076	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689076&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			165133721	504490736							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1433927	CC1(O)CN(C1)c1ccc(CNC(=O)c2cncc(n2)N2CC[C@]3(C2)OC(=O)Nc2ccc(Cl)c(F)c32)cn1	InChI=1S/C26H25ClFN7O4/c1-25(38)12-35(13-25)19-5-2-15(8-30-19)9-31-23(36)18-10-29-11-20(32-18)34-7-6-26(14-34)21-17(33-24(37)39-26)4-3-16(27)22(21)28/h2-5,8,10-11,38H,6-7,9,12-14H2,1H3,(H,31,36)(H,33,37)/t26-/m1/s1	SNZCWPJABFPSNF-AREMUKBSSA-N	689077	(S)-6-(6-chloro-5-fluoro-2-oxo-1,2- dihydrospiro[benzo[d][1,3]oxazine- 4,3'-pyrrolidin]-1'-yl)-N-((6-(3- hydroxy-3-methylazetidin-1- yl)pyridin-3-yl)methyl)pyrazine-2- carboxamide::US20240190892, Example 35	Plasma kallikrein	Homo sapiens		 28.4							US Patent		10.7270/Q2R49W3B			US20240190892	Cernaka, N; Ogawa, AK; Cheng, AC; Bao, J; Sharp, PP; Lopez, JA; Xiao, D; Tang, H	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689077	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689077&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171725674	504490737							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1433929	OC1(CN(C1)c1ccc(CNC(=O)c2cncc(n2)N2CC[C@]3(C2)OC(=O)Nc2ccc(Cl)c(F)c32)cn1)C(F)(F)F	InChI=1S/C26H22ClF4N7O4/c27-15-2-3-16-20(21(15)28)24(42-23(40)36-16)5-6-37(11-24)19-10-32-9-17(35-19)22(39)34-8-14-1-4-18(33-7-14)38-12-25(41,13-38)26(29,30)31/h1-4,7,9-10,41H,5-6,8,11-13H2,(H,34,39)(H,36,40)/t24-/m1/s1	VWJZAVUFFKTIKL-XMMPIXPASA-N	689078	(S)-6-(6-Chloro-5-fluoro-2-oxo-1,2- dihydrospiro[benzo[d][1,3]oxazine- 4,3'-pyrrolidin]-1'-yl)-N-((6-(3- hydroxy-3-(trifluoromethyl)azetidin-1- yl)pyridin-3-yl)methyl)pyrazine-2- carboxamide::US20240190892, Example 36	Plasma kallikrein	Homo sapiens		 43.7							US Patent		10.7270/Q2R49W3B			US20240190892	Cernaka, N; Ogawa, AK; Cheng, AC; Bao, J; Sharp, PP; Lopez, JA; Xiao, D; Tang, H	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689078	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689078&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171725658	504490738							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1433931	CCOc1ccc(C[C@@H](NC(=O)CC23C[C@H]4C[C@H](C[C@H](C4)C2)C3)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCNC(N)=N)C(N)=O)cc1	InChI=1S/C56H82N12O10/c1-4-78-39-18-16-35(17-19-39)27-41(63-46(70)32-56-29-36-23-37(30-56)25-38(24-36)31-56)51(74)65-42(26-34-11-6-5-7-12-34)52(75)67-48(33(2)3)54(77)66-43(28-45(57)69)50(73)61-20-9-15-47(71)68-22-10-14-44(68)53(76)64-40(49(58)72)13-8-21-62-55(59)60/h5-7,11-12,16-19,33,36-38,40-44,48H,4,8-10,13-15,20-32H2,1-3H3,(H2,57,69)(H2,58,72)(H,61,73)(H,63,70)(H,64,76)(H,65,74)(H,66,77)(H,67,75)(H4,59,60,62)/t36-,37+,38-,40-,41+,42-,43-,44+,48-,56?/m0/s1	GGHXHACFKDZBIY-ZKPFMCOWSA-N	50406182	CHEMBL5268598::US20240190892, Example 37	Plasma kallikrein	Homo sapiens		 44.4							US Patent		10.7270/Q2R49W3B			US20240190892	Cernaka, N; Ogawa, AK; Cheng, AC; Bao, J; Sharp, PP; Lopez, JA; Xiao, D; Tang, H	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50406182	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50406182&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			44335434	163355206		CHEMBL411320					1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1433933	F[C@H]1CCN(C1)c1ccc(CNC(=O)c2cncc(n2)N2CC[C@]3(C2)OC(=O)Nc2ccc(Cl)c(F)c32)cn1	InChI=1S/C26H24ClF2N7O3/c27-17-2-3-18-22(23(17)29)26(39-25(38)34-18)6-8-36(14-26)21-12-30-11-19(33-21)24(37)32-10-15-1-4-20(31-9-15)35-7-5-16(28)13-35/h1-4,9,11-12,16H,5-8,10,13-14H2,(H,32,37)(H,34,38)/t16-,26+/m0/s1	FZXXHWCOTLKGMZ-YHAMSUFESA-N	689080	(S)-6-(6-Chloro-5-fluoro-2-oxo-1,2- dihydrospiro[benzo[d][1,3]oxazine- 4,3'-pyrrolidin]-1'-yl)-N-((6-((S)-3- fluoropyrrolidin-1-yl)pyridin-3- yl)methyl)pyrazine-2-carboxamide::US20240190892, Example 38	Plasma kallikrein	Homo sapiens		 35.8							US Patent		10.7270/Q2R49W3B			US20240190892	Cernaka, N; Ogawa, AK; Cheng, AC; Bao, J; Sharp, PP; Lopez, JA; Xiao, D; Tang, H	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689080	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689080&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			165133717	504490740							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1433935	F[C@@H]1CCN(C1)c1ccc(CNC(=O)c2cncc(n2)N2CC[C@]3(C2)OC(=O)Nc2ccc(Cl)c(F)c32)cn1	InChI=1S/C26H24ClF2N7O3/c27-17-2-3-18-22(23(17)29)26(39-25(38)34-18)6-8-36(14-26)21-12-30-11-19(33-21)24(37)32-10-15-1-4-20(31-9-15)35-7-5-16(28)13-35/h1-4,9,11-12,16H,5-8,10,13-14H2,(H,32,37)(H,34,38)/t16-,26-/m1/s1	FZXXHWCOTLKGMZ-AKJBCIBTSA-N	689081	(S)-6-(6-Chloro-5-fluoro-2-oxo-1,2- dihydrospiro[benzo[d][1,3]oxazine- 4,3'-pyrrolidin]-1'-yl)-N-((6-((R)-3- fluoropyrrolidin-1-yl)pyridin-3- yl)methyl)pyrazine-2-carboxamide::US20240190892, Example 39	Plasma kallikrein	Homo sapiens		 25.8							US Patent		10.7270/Q2R49W3B			US20240190892	Cernaka, N; Ogawa, AK; Cheng, AC; Bao, J; Sharp, PP; Lopez, JA; Xiao, D; Tang, H	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689081	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689081&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			165133726	504490741							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1433937	Fc1c(Cl)ccc2NC(=O)O[C@@]3(CCN(C3)c3cncc(n3)C(=O)NCc3ccc(nc3)N3CC4CC4C3)c12	InChI=1S/C27H25ClFN7O3/c28-18-2-3-19-23(24(18)29)27(39-26(38)34-19)5-6-35(14-27)22-11-30-10-20(33-22)25(37)32-9-15-1-4-21(31-8-15)36-12-16-7-17(16)13-36/h1-4,8,10-11,16-17H,5-7,9,12-14H2,(H,32,37)(H,34,38)/t16?,17?,27-/m1/s1	JPTKZUHECQEYOD-IYIBJFCGSA-N	689082	N-((6-(3-Azabicyclo[3.1.0]hexan-3- yl)pyridin-3-yl)methyl)-6-((S)-6- chloro-5-fluoro-2-oxo-1,2- dihydrospiro[benzo[d][1,3]oxazine- 4,3'-pyrrolidin]-1'-yl)pyrazine-2- carboxamide::US20240190892, Example 40	Plasma kallikrein	Homo sapiens		 18.6							US Patent		10.7270/Q2R49W3B			US20240190892	Cernaka, N; Ogawa, AK; Cheng, AC; Bao, J; Sharp, PP; Lopez, JA; Xiao, D; Tang, H	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689082	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689082&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171725672	504490742							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1433939	Fc1c(Cl)ccc2NC(=O)O[C@@]3(CCN(C3)c3cncc(n3)C(=O)NCc3ccc(nc3)N3CCCCC3)c12	InChI=1S/C27H27ClFN7O3/c28-18-5-6-19-23(24(18)29)27(39-26(38)34-19)8-11-36(16-27)22-15-30-14-20(33-22)25(37)32-13-17-4-7-21(31-12-17)35-9-2-1-3-10-35/h4-7,12,14-15H,1-3,8-11,13,16H2,(H,32,37)(H,34,38)/t27-/m1/s1	NPDUOONVIQTNCX-HHHXNRCGSA-N	689083	(S)-6-(6-Chloro-5-fluoro-2-oxo-1,2- dihydrospiro[benzo[d][1,3]oxazine- 4,3'-pyrrolidin]-1'-yl)-N-((6-(piperidin- 1-yl)pyridin-3-yl)methyl)pyrazine-2- carboxamide::US20240190892, Example 41	Plasma kallikrein	Homo sapiens		 35.4							US Patent		10.7270/Q2R49W3B			US20240190892	Cernaka, N; Ogawa, AK; Cheng, AC; Bao, J; Sharp, PP; Lopez, JA; Xiao, D; Tang, H	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689083	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689083&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			165133705	504490743							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1433941	Fc1c(Cl)ccc2NC(=O)O[C@@]3(CCN(C3)c3cncc(n3)C(=O)NCc3ccc(nc3)N3CCOCC3)c12	InChI=1S/C26H25ClFN7O4/c27-17-2-3-18-22(23(17)28)26(39-25(37)33-18)5-6-35(15-26)21-14-29-13-19(32-21)24(36)31-12-16-1-4-20(30-11-16)34-7-9-38-10-8-34/h1-4,11,13-14H,5-10,12,15H2,(H,31,36)(H,33,37)/t26-/m1/s1	RCDQIRKRQQVBNN-AREMUKBSSA-N	689084	(S)-6-(6-Chloro-5-fluoro-2-oxo-1,2- dihydrospiro[benzo[d][1,3]oxazine- 4,3'-pyrrolidin]-1'-yl)-N-((6- morpholinopyridin-3- yl)methyl)pyrazine-2-carboxamide::US20240190892, Example 42	Plasma kallikrein	Homo sapiens		 11.8							US Patent		10.7270/Q2R49W3B			US20240190892	Cernaka, N; Ogawa, AK; Cheng, AC; Bao, J; Sharp, PP; Lopez, JA; Xiao, D; Tang, H	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689084	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689084&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			165133709	504490744							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1433943	COc1ccc2[nH]c(cc2c1)S(N)(=O)=O	InChI=1S/C9H10N2O3S/c1-14-7-2-3-8-6(4-7)5-9(11-8)15(10,12)13/h2-5,11H,1H3,(H2,10,12,13)	ZRYYCTSRCVQELV-UHFFFAOYSA-N	50406322	CHEMBL5267385::US20240190892, Example 43	Plasma kallikrein	Homo sapiens		 1.70							US Patent		10.7270/Q2R49W3B			US20240190892	Cernaka, N; Ogawa, AK; Cheng, AC; Bao, J; Sharp, PP; Lopez, JA; Xiao, D; Tang, H	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50406322	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50406322&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			14476489	163355346		CHEMBL165362				ZINC27868487	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1433945	CCC(F)(F)NCc1ccc(CNC(=O)c2cnnc(c2)N2CC[C@]3(C2)OC(=O)Nc2ccc(Cl)c(F)c32)cc1	InChI=1S/C27H26ClF3N6O3/c1-2-27(30,31)33-13-17-5-3-16(4-6-17)12-32-24(38)18-11-21(36-34-14-18)37-10-9-26(15-37)22-20(35-25(39)40-26)8-7-19(28)23(22)29/h3-8,11,14,33H,2,9-10,12-13,15H2,1H3,(H,32,38)(H,35,39)/t26-/m1/s1	ZHZADBSWVRWGKO-AREMUKBSSA-N	689086	US20240190892, Example 44	Plasma kallikrein	Homo sapiens		 58.3							US Patent		10.7270/Q2R49W3B			US20240190892	Cernaka, N; Ogawa, AK; Cheng, AC; Bao, J; Sharp, PP; Lopez, JA; Xiao, D; Tang, H	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689086	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689086&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			165133762	504490746							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1433947	CCC(C)NCc1ccc(CNC(=O)c2cnnc(c2)N2CC[C@]3(C2)OC(=O)Nc2ccc(Cl)c(F)c32)cc1	InChI=1S/C28H30ClFN6O3/c1-3-17(2)31-13-18-4-6-19(7-5-18)14-32-26(37)20-12-23(35-33-15-20)36-11-10-28(16-36)24-22(34-27(38)39-28)9-8-21(29)25(24)30/h4-9,12,15,17,31H,3,10-11,13-14,16H2,1-2H3,(H,32,37)(H,34,38)/t17?,28-/m1/s1	FLSZPURICKQPBW-BBAYJXMYSA-N	689087	N-(4-((sec- Butylamino)methyl)benzyl)-6- ((S)-6-chloro-5-fluoro-2-oxo- 1,2- dihydrospiro[benzo[d][1,3] oxazine-4,3'-pyrrolidin]-1'- yl)pyridazine-4-carboxamide::US20240190892, Example 45	Plasma kallikrein	Homo sapiens		 15.8							US Patent		10.7270/Q2R49W3B			US20240190892	Cernaka, N; Ogawa, AK; Cheng, AC; Bao, J; Sharp, PP; Lopez, JA; Xiao, D; Tang, H	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689087	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689087&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171725686	504490747							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1433949	CCC(NCc1ccc(CNC(=O)c2cnnc(c2)N2CC[C@]3(C2)OC(=O)Nc2ccc(Cl)c(F)c32)cc1)C(F)(F)F	InChI=1S/C28H27ClF4N6O3/c1-2-21(28(31,32)33)34-12-16-3-5-17(6-4-16)13-35-25(40)18-11-22(38-36-14-18)39-10-9-27(15-39)23-20(37-26(41)42-27)8-7-19(29)24(23)30/h3-8,11,14,21,34H,2,9-10,12-13,15H2,1H3,(H,35,40)(H,37,41)/t21?,27-/m1/s1	DHUHCCUVAXNULV-IAIRZMIISA-N	689088	(S)-6-(6-Chloro-5-fluoro-2-oxo- 1,2- dihydrospiro[benzo[d][1,3] oxazine-4,3'-pyrrolidin]-1'-yl)- N-(4-(((1,1,1-trifluorobutan-2- yl)amino)methyl)benzyl) pyridazine-4-carboxamide::US20240190892, Example 46	Plasma kallikrein	Homo sapiens		 38.0							US Patent		10.7270/Q2R49W3B			US20240190892	Cernaka, N; Ogawa, AK; Cheng, AC; Bao, J; Sharp, PP; Lopez, JA; Xiao, D; Tang, H	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689088	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689088&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			165133725	504490748							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1433951	FC1CN(Cc2ccc(CNC(=O)c3cnnc(c3)N3CC[C@]4(C3)OC(=O)Nc3ccc(Cl)c(F)c43)cc2)C1	InChI=1S/C27H25ClF2N6O3/c28-20-5-6-21-23(24(20)30)27(39-26(38)33-21)7-8-36(15-27)22-9-18(11-32-34-22)25(37)31-10-16-1-3-17(4-2-16)12-35-13-19(29)14-35/h1-6,9,11,19H,7-8,10,12-15H2,(H,31,37)(H,33,38)/t27-/m1/s1	PEHVECFKNKWWHW-HHHXNRCGSA-N	689089	(S)-6-(6-chloro-5-fluoro-2-oxo- 1,2- dihydrospiro[benzo[d][1,3] oxazine-4,3'-pyrrolidin]-1'- yl)-N-(4-((3-fluoroazetidin-1- yl)methyl)benzyl)pyridazine-4- carboxamide::US20240190892, Example 47	Plasma kallikrein	Homo sapiens		 13.8							US Patent		10.7270/Q2R49W3B			US20240190892	Cernaka, N; Ogawa, AK; Cheng, AC; Bao, J; Sharp, PP; Lopez, JA; Xiao, D; Tang, H	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689089	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689089&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171725657	504490749							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1433953	CC(C)N(C)Cc1ccc(CNC(=O)c2cnnc(c2)N2CC[C@]3(C2)OC(=O)Nc2ccc(Cl)c(F)c32)cc1	InChI=1S/C28H30ClFN6O3/c1-17(2)35(3)15-19-6-4-18(5-7-19)13-31-26(37)20-12-23(34-32-14-20)36-11-10-28(16-36)24-22(33-27(38)39-28)9-8-21(29)25(24)30/h4-9,12,14,17H,10-11,13,15-16H2,1-3H3,(H,31,37)(H,33,38)/t28-/m1/s1	JMNSDWGHRYMVAQ-MUUNZHRXSA-N	689090	(S)-6-(6-Chloro-5-fluoro-2-oxo- 1,2- dihydrospiro[benzo[d][1,3] oxazine-4,3'-pyrrolidin]-1'-yl)- N-(4-((isopropyl(methyl)amino) methyl)benzyl)pyridazine-4- carboxamide::US20240190892, Example 48	Plasma kallikrein	Homo sapiens		 5.90							US Patent		10.7270/Q2R49W3B			US20240190892	Cernaka, N; Ogawa, AK; Cheng, AC; Bao, J; Sharp, PP; Lopez, JA; Xiao, D; Tang, H	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689090	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689090&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			165133761	504490750							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1433955	Fc1c(Cl)ccc2NC(=O)O[C@@]3(CCN(C3)c3cc(cnn3)C(=O)NCc3ccc(CN(CCC#N)C4CC4)cc3)c12	InChI=1S/C30H29ClFN7O3/c31-23-8-9-24-26(27(23)32)30(42-29(41)36-24)10-13-39(18-30)25-14-21(16-35-37-25)28(40)34-15-19-2-4-20(5-3-19)17-38(12-1-11-33)22-6-7-22/h2-5,8-9,14,16,22H,1,6-7,10,12-13,15,17-18H2,(H,34,40)(H,36,41)/t30-/m1/s1	CULFQEREUMPQKL-SSEXGKCCSA-N	689091	(S)-6-(6-Chloro-5-fluoro-2-oxo- 1,2- dihydrospiro[benzo[d][1,3] oxazine-4,3'-pyrrolidin]-1'- yl)-N-(4-(((2- cyanoethyl)(cyclopropyl)amino) methyl)benzyl)pyridazine-4- carboxamide::US20240190892, Example 49	Plasma kallikrein	Homo sapiens		 8.90							US Patent		10.7270/Q2R49W3B			US20240190892	Cernaka, N; Ogawa, AK; Cheng, AC; Bao, J; Sharp, PP; Lopez, JA; Xiao, D; Tang, H	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689091	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689091&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			165133728	504490751							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1433957	COc1ccc2cc([nH]c2c1)S(N)(=O)=O	InChI=1S/C9H10N2O3S/c1-14-7-3-2-6-4-9(15(10,12)13)11-8(6)5-7/h2-5,11H,1H3,(H2,10,12,13)	WGJXVQVMOKCESQ-UHFFFAOYSA-N	50406323	CHEMBL5273808::US20240190892, Example 50	Plasma kallikrein	Homo sapiens		 26.6							US Patent		10.7270/Q2R49W3B			US20240190892	Cernaka, N; Ogawa, AK; Cheng, AC; Bao, J; Sharp, PP; Lopez, JA; Xiao, D; Tang, H	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50406323	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50406323&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			14476490	163355347		CHEMBL165245				ZINC27868484	1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1433959	Fc1c(Cl)ccc2NC(=O)O[C@@]3(CCN(C3)c3cncc4CN(Cc5ccc(Cn6ccccc6=O)cc5)CCc34)c12	InChI=1S/C32H29ClFN5O3/c33-25-8-9-26-29(30(25)34)32(42-31(41)36-26)11-14-39(20-32)27-16-35-15-23-19-37(13-10-24(23)27)17-21-4-6-22(7-5-21)18-38-12-2-1-3-28(38)40/h1-9,12,15-16H,10-11,13-14,17-20H2,(H,36,41)/t32-/m1/s1	OPHNFIQROGQNSD-JGCGQSQUSA-N	689093	US20240190892, Example 51	Plasma kallikrein	Homo sapiens		 45.9							US Patent		10.7270/Q2R49W3B			US20240190892	Cernaka, N; Ogawa, AK; Cheng, AC; Bao, J; Sharp, PP; Lopez, JA; Xiao, D; Tang, H	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689093	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689093&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			171725691	504490752							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
1433961	Fc1c(Cl)ccc2NC(=O)O[C@@]3(CCN(C3)c3cncc(NC(=O)Cc4ccc(Cn5ccccc5=O)cc4)c3)c12	InChI=1S/C30H25ClFN5O4/c31-23-8-9-24-27(28(23)32)30(41-29(40)35-24)10-12-37(18-30)22-14-21(15-33-16-22)34-25(38)13-19-4-6-20(7-5-19)17-36-11-2-1-3-26(36)39/h1-9,11,14-16H,10,12-13,17-18H2,(H,34,38)(H,35,40)/t30-/m1/s1	BJZFSZGJWSZYHX-SSEXGKCCSA-N	689094	US20240190892, Example 52	Plasma kallikrein	Homo sapiens		 19.0							US Patent		10.7270/Q2R49W3B			US20240190892	Cernaka, N; Ogawa, AK; Cheng, AC; Bao, J; Sharp, PP; Lopez, JA; Xiao, D; Tang, H	Merck Sharp & Dohme LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689094	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689094&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			165133751	504490753							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51568422	CCC(c1cc(C)c2nc[nH]c2c1)n1cc(cn1)C(=O)N1CCC[C@@]2(C1)OC(=O)Nc1ccc(Cl)c(F)c21	InChI=1S/C27H26ClFN6O3/c1-3-21(16-9-15(2)24-20(10-16)30-14-31-24)35-12-17(11-32-35)25(36)34-8-4-7-27(13-34)22-19(33-26(37)38-27)6-5-18(28)23(22)29/h5-6,9-12,14,21H,3-4,7-8,13H2,1-2H3,(H,30,31)(H,33,37)/t21?,27-/m0/s1	XBRZGRISICPSOA-YQAGWJQESA-N	50630789	CHEMBL5412447	Plasma kallikrein	Homo sapiens		 0.800000							ChEMBL	10.1021/acsmedchemlett.3c00441	10.7270/Q20V8J71	37974944			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50630789	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50630789&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51568423	Fc1c(Cl)ccc2NC(=O)O[C@]3(CCCN(C3)C(=O)c3nnc([nH]3)C(CC(F)(F)F)c3ccccc3)c12	InChI=1S/C24H20ClF4N5O3/c25-15-7-8-16-17(18(15)26)23(37-22(36)30-16)9-4-10-34(12-23)21(35)20-31-19(32-33-20)14(11-24(27,28)29)13-5-2-1-3-6-13/h1-3,5-8,14H,4,9-12H2,(H,30,36)(H,31,32,33)/t14?,23-/m0/s1	UFZZSIOOGUCAEB-AQJFCTLQSA-N	50630790	CHEMBL5398693	Plasma kallikrein	Homo sapiens		 1.3							ChEMBL	10.1021/acsmedchemlett.3c00441	10.7270/Q20V8J71	37974944			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50630790	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50630790&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51568424	Fc1c(Cl)ccc2NC(=O)O[C@]3(CCCN(C3)C(=O)c3nnc([nH]3)C(C3CC3)c3ccccc3)c12	InChI=1S/C25H23ClFN5O3/c26-16-9-10-17-19(20(16)27)25(35-24(34)28-17)11-4-12-32(13-25)23(33)22-29-21(30-31-22)18(15-7-8-15)14-5-2-1-3-6-14/h1-3,5-6,9-10,15,18H,4,7-8,11-13H2,(H,28,34)(H,29,30,31)/t18?,25-/m0/s1	KZQMSZYVOYGZGO-LYIYLXCWSA-N	50630791	CHEMBL5424389	Plasma kallikrein	Homo sapiens		 1.6							ChEMBL	10.1021/acsmedchemlett.3c00441	10.7270/Q20V8J71	37974944			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50630791	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50630791&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51568425	CC[C@H](c1n[nH]c(n1)C(=O)N1CCC[C@@]2(C1)OC(=O)Nc1ccc(Cl)c(F)c21)c1cc(C)c2nc[nH]c2c1	InChI=1S/C26H25ClFN7O3/c1-3-15(14-9-13(2)21-18(10-14)29-12-30-21)22-32-23(34-33-22)24(36)35-8-4-7-26(11-35)19-17(31-25(37)38-26)6-5-16(27)20(19)28/h5-6,9-10,12,15H,3-4,7-8,11H2,1-2H3,(H,29,30)(H,31,37)(H,32,33,34)/t15-,26-/m0/s1	FAKFKFHBKRIBKM-HAWMADMCSA-N	50630792	CHEMBL5414875	Plasma kallikrein	Homo sapiens		 1.3							ChEMBL	10.1021/acsmedchemlett.3c00441	10.7270/Q20V8J71	37974944			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50630792	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50630792&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51568426	CC[C@@H](c1n[nH]c(n1)C(=O)N1CCC[C@@]2(C1)OC(=O)Nc1ccc(Cl)c(F)c21)c1cc(C)c2nc[nH]c2c1	InChI=1S/C26H25ClFN7O3/c1-3-15(14-9-13(2)21-18(10-14)29-12-30-21)22-32-23(34-33-22)24(36)35-8-4-7-26(11-35)19-17(31-25(37)38-26)6-5-16(27)20(19)28/h5-6,9-10,12,15H,3-4,7-8,11H2,1-2H3,(H,29,30)(H,31,37)(H,32,33,34)/t15-,26+/m1/s1	FAKFKFHBKRIBKM-WZQKQDCOSA-N	50630793	CHEMBL5418736	Plasma kallikrein	Homo sapiens		 1.000000							ChEMBL	10.1021/acsmedchemlett.3c00441	10.7270/Q20V8J71	37974944			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50630793	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50630793&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51568427	CCC(c1nnc([nH]1)C(=O)N1CCC[C@@]2(C1)OC(=O)Nc1ccc(Cl)c(F)c21)c1ccc2COCc2c1	InChI=1S/C26H25ClFN5O4/c1-2-17(14-4-5-15-11-36-12-16(15)10-14)22-30-23(32-31-22)24(34)33-9-3-8-26(13-33)20-19(29-25(35)37-26)7-6-18(27)21(20)28/h4-7,10,17H,2-3,8-9,11-13H2,1H3,(H,29,35)(H,30,31,32)/t17?,26-/m0/s1	NJCYQQRIIYESCE-KKFPZRRJSA-N	50630794	CHEMBL5421872	Plasma kallikrein	Homo sapiens		 1.000000							ChEMBL	10.1021/acsmedchemlett.3c00441	10.7270/Q20V8J71	37974944			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50630794	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50630794&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51563618	CC[C@@H](C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)(F)F	InChI=1S/C26H21ClF4N6O4/c1-3-19(25(40)33-14-5-6-15(24(32)39)18(28)9-14)36-11-21(41-2)17(10-23(36)38)16-8-13(27)4-7-20(16)37-12-22(34-35-37)26(29,30)31/h4-12,19H,3H2,1-2H3,(H2,32,39)(H,33,40)/t19-/m0/s1	XYWIPYBIIRTJMM-IBGZPJMESA-N	413842	4-({(2S)-2-[4-{5-Chloro-2-[4-(trifluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanoyl}amino)-2-fluorobenzamide (Enantiomer 2)::US10421742, Example 235::US11180471, Example 235	Plasma kallikrein	Homo sapiens		 6.7							ChEMBL	10.1021/acs.jmedchem.3c00795	10.7270/Q2HM5DW0	37669040			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413842	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413842&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	QV3    	8BO3	135206011	433913941							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51563619	CC[C@@H](C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)(F)F	InChI=1S/C26H21ClF4N6O4/c1-3-19(25(40)33-14-5-6-15(24(32)39)18(28)9-14)36-11-21(41-2)17(10-23(36)38)16-8-13(27)4-7-20(16)37-12-22(34-35-37)26(29,30)31/h4-12,19H,3H2,1-2H3,(H2,32,39)(H,33,40)/t19-/m0/s1	XYWIPYBIIRTJMM-IBGZPJMESA-N	413842	4-({(2S)-2-[4-{5-Chloro-2-[4-(trifluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]butanoyl}amino)-2-fluorobenzamide (Enantiomer 2)::US10421742, Example 235::US11180471, Example 235	Plasma kallikrein	Homo sapiens		 1.2							ChEMBL	10.1021/acs.jmedchem.3c00795	10.7270/Q2HM5DW0	37669040			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=413842	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=413842&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	QV3    	8BO3	135206011	433913941							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51563621	COc1cn([C@@H](C[C@@H]2CCCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1C#N	InChI=1S/C28H26ClN3O6/c1-37-25-16-32(26(33)14-23(25)22-12-19(29)8-5-18(22)15-30)24(13-21-4-2-3-11-38-21)27(34)31-20-9-6-17(7-10-20)28(35)36/h5-10,12,14,16,21,24H,2-4,11,13H2,1H3,(H,31,34)(H,35,36)/t21-,24-/m0/s1	WVQIDDPAQZTNTF-URXFXBBRSA-N	50628681	CHEMBL5440284	Plasma kallikrein	Homo sapiens		 4.9							ChEMBL	10.1021/acs.jmedchem.3c00795	10.7270/Q2HM5DW0	37669040			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50628681	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50628681&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search											1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3						
51563623	Clc1cccc(c1)-c1cc(=O)n(CC(=O)Nc2ccc(cc2)-c2nnn[nH]2)c2CNC(=O)c12	InChI=1S/C22H16ClN7O3/c23-14-3-1-2-13(8-14)16-9-19(32)30(17-10-24-22(33)20(16)17)11-18(31)25-15-6-4-12(5-7-15)21-26-28-29-27-21/h1-9H,10-11H2,(H,24,33)(H,25,31)(H,26,27,28,29)	BUVUMAPNDQFBAF-UHFFFAOYSA-N	251889	US9475809, 1::US9918969, 1	Plasma kallikrein	Homo sapiens		 43000							ChEMBL	10.1021/acs.jmedchem.3c00795	10.7270/Q2HM5DW0	37669040			n/a	n/a	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=251889	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=251889&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			90646896	346546337							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6T7P,7N7X	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3